Citrus Sinensis ID: 019195

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340----
Protein Sequence
MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTFSLQSVEEITKIVEEAKVPPPVSRSIGGFGWGGEEDGDEKEEETDADEEDEYEKTVKEAQQSGEVSVS
Secondary Structure (PSIPRED)
cccEEEEEEEcccccEEEEEEEEcccccEEEEEEEEccccccHHHHHHHHHHHHccccccccEEEEEccccEEEEEEEEcccccHHHHHHHcccccHHHHHHHHHHHHHccccccccccccccccccccccEEEEcccccccccccccccccccccccccHHHcccccccccccccHHHHHHHHHHHHccccccccccHHHHHHHHccccEEEEEccccccccHHHHHHHHHHHcccccccccHHHHHcccccccccccccHHHHHHHHHcccccccccccHHHHHHHHHHHcccccccccccccccccccccccccccccccHHHHHHHHHHHHHHccccccc
Secondary Structure Prediction (SSPRO)
ccccEEEEEcccccccEEEEEEEcccccEEEEEEEccccEccHHHHHHHHHHHHcccccEEEEEEEEcccccEEEEEEEccccHHHHHHHHcccccHHHHHHHHHHHHHccEEcccccHHHEEEcccccccEEEEEccccEEEccccccccccccHHHHcHHHHccccccccccHHHHHHHHHHHHHcccccccccccHHHHHHHHHHHHcccccccccccccHHHHHHHHHHHcccHHHcccHHHHHcccHHHccccccccccHHHHHHHccccccccccHHHHHHHHHHHccccccccccccccccHHHHHccHccccccHHHHHHHHHHHHHcccccEEcc
Coil and Loop (DISEMBL)
MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINhkqlrhpniirfkevvltpTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGQICHRDLKLentlldgspaprlkicdfgyskssllhsrpkstvgtpayiapevlsrreydgkladVWSCGVTLYVMLVgaypfedqedpknFRKTISRIMAVQykipdyvhiSQDCRNLLSRIfvanpsrritikeikshpwflknlpRELTETAQAIYYrkenptfslqSVEEITKIVEeakvpppvsrsiggfgwggeedgdekeeetdadeedEYEKTVKEAQQSGEVSVS
Flexible Loop (DISEMBL)
mekyelmkdigsgnfgvarlmrNKNTKELVAMKYIERGHKIDANVAREIINhkqlrhpniirFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGQICHRDLKLENTLLDGSPAPRLKICDFGYSKSsllhsrpkstvgtpayiapevlSRREYDGKLADVWSCGVTLYVMLVGAypfedqedpkNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIfvanpsrritikeikshpwflknlPRELTETAQAIYYRKENPTFSLQSVEEITKIveeakvpppvsrsiggfgwggeedgdEKEEEtdadeedeyeKTVKeaqqsgevsvs
Low Complexity Region (SEG)
MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTFSLQSVEEITKIVEEAKVPPPVSRSIggfgwggeedgdekeeetdadeedeyeKTVKEAQQSGEVSVS
Disordered region (IsUnstruct)
***********SGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH*****TVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTFSLQSVEEITKIVE******************************************************
Disordered Region (DISOPRED)
*EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLPRELTE*********************************************************************K***********
Disordered Region (DISEMBL)
MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTFSLQSVEEITKIVEEAKVPPPVSRSIGGFGWG************************************
Disordered Region (DISPRO)
*EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTFSLQSVEEITKIVEEAKVP*PVSRSIGGFGWGGEED*D******DADEEDEYEKTVKEAQQSGEVSVS
Transmembrane Helix (TMHMM)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhhhhooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (MEMSAT_SVM)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (Phobius)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTFSLQSVEEITKIVEEAKVPPPVSRSIGGFGWGGEEDGDEKEEETDADEEDEYEKTVKEAQQSGEVSVS
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	344	2.2.26 [Sep-21-2011]
Q9C958	361	Serine/threonine-protein	yes	no	1.0	0.952	0.814	1e-165
P43291	363	Serine/threonine-protein	no	no	1.0	0.947	0.823	1e-165
Q7XQP4	359	Serine/threonine-protein	yes	no	1.0	0.958	0.774	1e-161
Q6ZI44	365	Serine/threonine-protein	no	no	0.915	0.863	0.817	1e-159
Q9FFP9	360	Serine/threonine-protein	no	no	0.886	0.847	0.817	1e-152
Q5N942	360	Serine/threonine-protein	no	no	0.988	0.944	0.744	1e-150
P43292	353	Serine/threonine-protein	no	no	0.985	0.960	0.757	1e-149
Q7XKA8	370	Serine/threonine-protein	no	no	1.0	0.929	0.712	1e-148
O64812	339	Serine/threonine-protein	no	no	0.950	0.964	0.727	1e-141
P0C5D6	334	Serine/threonine-protein	no	no	0.944	0.973	0.712	1e-137

>sp|Q9C958|SRK2B_ARATH Serine/threonine-protein kinase SRK2B OS=Arabidopsis thaliana GN=SRK2B PE=1 SV=1

 Score =  582 bits (1500), Expect = e-165,   Method: Compositional matrix adjust.
 Identities = 294/361 (81%), Positives = 315/361 (87%), Gaps = 17/361 (4%)

Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNI 60
           M+KYEL+KDIG+GNFGVARLMR KN+KELVAMKYIERG KID NVAREIINH+ LRHPNI
Sbjct: 1   MDKYELVKDIGAGNFGVARLMRVKNSKELVAMKYIERGPKIDENVAREIINHRSLRHPNI 60

Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-------QIC 113
           IRFKEVVLTPTH+AI MEYAAGGELFERIC+AGRFSEDEARYFFQQLISG       QIC
Sbjct: 61  IRFKEVVLTPTHIAIAMEYAAGGELFERICSAGRFSEDEARYFFQQLISGVSYCHAMQIC 120

Query: 114 HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKL 173
           HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS PKSTVGTPAYIAPEVLSR EYDGK+
Sbjct: 121 HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSMPKSTVGTPAYIAPEVLSRGEYDGKM 180

Query: 174 ADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRI 233
           ADVWSCGVTLYVMLVGAYPFEDQEDPKNF+KTI RIMAV+YKIPDYVHISQDC++LLSRI
Sbjct: 181 ADVWSCGVTLYVMLVGAYPFEDQEDPKNFKKTIQRIMAVKYKIPDYVHISQDCKHLLSRI 240

Query: 234 FVANPSRRITIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTFSLQSVEEITKIVEEAK 293
           FV N ++RITI +IK HPWFLKNLPRELTE AQA Y+RKENPTFSLQSVEEI KIVEEAK
Sbjct: 241 FVTNSNKRITIGDIKKHPWFLKNLPRELTEIAQAAYFRKENPTFSLQSVEEIMKIVEEAK 300

Query: 294 VPPPVSRSIGGFGWGGEEDG---------DEKEEETDADEEDEYEKTVKEAQQS-GEVSV 343
            P  VSRSIG FGWGG ED          + +E E + DEEDEY+KTVK+   S GEV V
Sbjct: 301 TPARVSRSIGAFGWGGGEDAEGKEEDAEEEVEEVEEEEDEEDEYDKTVKQVHASMGEVRV 360

Query: 344 S 344
           S
Sbjct: 361 S 361

Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|P43291|SRK2A_ARATH Serine/threonine-protein kinase SRK2A OS=Arabidopsis thaliana GN=SRK2A PE=1 SV=1

 Score =  581 bits (1497), Expect = e-165,   Method: Compositional matrix adjust.
 Identities = 299/363 (82%), Positives = 318/363 (87%), Gaps = 19/363 (5%)

Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNI 60
           M+KYEL+KDIG+GNFGVARLM+ KN+KELVAMKYIERG KID NVAREIINH+ LRHPNI
Sbjct: 1   MDKYELVKDIGAGNFGVARLMKVKNSKELVAMKYIERGPKIDENVAREIINHRSLRHPNI 60

Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-------QIC 113
           IRFKEVVLTPTHLAI MEYAAGGELFERIC+AGRFSEDEARYFFQQLISG       QIC
Sbjct: 61  IRFKEVVLTPTHLAIAMEYAAGGELFERICSAGRFSEDEARYFFQQLISGVSYCHAMQIC 120

Query: 114 HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKL 173
           HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGK+
Sbjct: 121 HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKM 180

Query: 174 ADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRI 233
           ADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTI +IMAVQYKIPDYVHISQDC+NLLSRI
Sbjct: 181 ADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTIQKIMAVQYKIPDYVHISQDCKNLLSRI 240

Query: 234 FVANPSRRITIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTFSLQSVEEITKIVEEAK 293
           FVAN  +RITI EIK H WFLKNLPRELTETAQA Y++KENPTFSLQ+VEEI KIV +AK
Sbjct: 241 FVANSLKRITIAEIKKHSWFLKNLPRELTETAQAAYFKKENPTFSLQTVEEIMKIVADAK 300

Query: 294 VPPPVSRSIGGFGWGGEEDGDEK------------EEETDADEEDEYEKTVKEAQQSGEV 341
            PPPVSRSIGGFGWGG  D D K            E E + D+EDEY+KTVKE   SGEV
Sbjct: 301 TPPPVSRSIGGFGWGGNGDADGKEEDAEDVEEEEEEVEEEEDDEDEYDKTVKEVHASGEV 360

Query: 342 SVS 344
            +S
Sbjct: 361 RIS 363

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q7XQP4|SAPK7_ORYSJ Serine/threonine-protein kinase SAPK7 OS=Oryza sativa subsp. japonica GN=SAPK7 PE=2 SV=2

 Score =  567 bits (1460), Expect = e-161,   Method: Compositional matrix adjust.
 Identities = 278/359 (77%), Positives = 312/359 (86%), Gaps = 15/359 (4%)

Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNI 60
           ME+YEL+KDIG+GNFGVARLMRNK TKELVAMKYI RG KID NVAREIINH+ LRHPNI
Sbjct: 1   MERYELLKDIGAGNFGVARLMRNKETKELVAMKYIPRGLKIDENVAREIINHRSLRHPNI 60

Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-------QIC 113
           IRFKEVV+TPTHLAIVMEYAAGGELF+RICNAGRFSEDEARYFFQQLI G       QIC
Sbjct: 61  IRFKEVVVTPTHLAIVMEYAAGGELFDRICNAGRFSEDEARYFFQQLICGVSYCHFMQIC 120

Query: 114 HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKL 173
           HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS+PKSTVGTPAYIAPEVLSRREYDGK 
Sbjct: 121 HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSKPKSTVGTPAYIAPEVLSRREYDGKT 180

Query: 174 ADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRI 233
           ADVWSCGVTLYVMLVGAYPFED +DPKNFRKTI RIM++QYKIP+YVH+SQDCR LLSRI
Sbjct: 181 ADVWSCGVTLYVMLVGAYPFEDPDDPKNFRKTIGRIMSIQYKIPEYVHVSQDCRQLLSRI 240

Query: 234 FVANPSRRITIKEIKSHPWFLKNLPRELTETAQAIYYRKEN--PTFSLQSVEEITKIVEE 291
           FVANP++RITI+EI++HPWFLKNLPRELTE AQA+YY+K+N  PT+S+QSVEEI KIVEE
Sbjct: 241 FVANPAKRITIREIRNHPWFLKNLPRELTEAAQAMYYKKDNSAPTYSVQSVEEIMKIVEE 300

Query: 292 AKVPPPVSRSIGGFGWGGEEDGDEKEEE------TDADEEDEYEKTVKEAQQSGEVSVS 344
           A+ PP  S  + GFGW  E++ ++  ++       + D EDEY+K VK+   SGE  +S
Sbjct: 301 ARTPPRSSTPVAGFGWQEEDEQEDNSKKPEEEQEEEEDAEDEYDKQVKQVHASGEFQLS 359

May play a role in signal transduction of hyperosmotic response.

Oryza sativa subsp. japonica (taxid: 39947)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q6ZI44|SAPK6_ORYSJ Serine/threonine-protein kinase SAPK6 OS=Oryza sativa subsp. japonica GN=SAPK6 PE=2 SV=1

 Score =  559 bits (1441), Expect = e-159,   Method: Compositional matrix adjust.
 Identities = 265/324 (81%), Positives = 293/324 (90%), Gaps = 9/324 (2%)

Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNI 60
           MEKYEL+KDIGSGNFGVARLMRN+ TKELVAMKYI RG KID NVAREIINH+ LRHPNI
Sbjct: 1   MEKYELLKDIGSGNFGVARLMRNRETKELVAMKYIPRGLKIDENVAREIINHRSLRHPNI 60

Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-------QIC 113
           IRFKEVVLTPTHLAIVMEYAAGGELF+RIC+AGRFSEDE+RYFFQQLI G       QIC
Sbjct: 61  IRFKEVVLTPTHLAIVMEYAAGGELFDRICSAGRFSEDESRYFFQQLICGVSYCHFMQIC 120

Query: 114 HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKL 173
           HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS+PKSTVGTPAYIAPEVLSRREYDGK+
Sbjct: 121 HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSKPKSTVGTPAYIAPEVLSRREYDGKM 180

Query: 174 ADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRI 233
           ADVWSCGVTLYVMLVGAYPFED +DPKNFRKTI RI+++QYKIP+YVHISQDCR LLSRI
Sbjct: 181 ADVWSCGVTLYVMLVGAYPFEDPDDPKNFRKTIGRIVSIQYKIPEYVHISQDCRQLLSRI 240

Query: 234 FVANPSRRITIKEIKSHPWFLKNLPRELTETAQAIYYRKENP--TFSLQSVEEITKIVEE 291
           FVANP++RITI+EI++HPWF+KNLPRELTE AQA YY+K+N   TFS Q+V+EI KIV+E
Sbjct: 241 FVANPAKRITIREIRNHPWFMKNLPRELTEAAQAKYYKKDNSARTFSDQTVDEIMKIVQE 300

Query: 292 AKVPPPVSRSIGGFGWGGEEDGDE 315
           AK PPP S  + GFGW  EE+ ++
Sbjct: 301 AKTPPPSSTPVAGFGWTEEEEQED 324

May play a role in signal transduction of hyperosmotic response.

Oryza sativa subsp. japonica (taxid: 39947)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9FFP9|SRK2H_ARATH Serine/threonine-protein kinase SRK2H OS=Arabidopsis thaliana GN=SRK2H PE=1 SV=1

 Score =  539 bits (1389), Expect = e-152,   Method: Compositional matrix adjust.
 Identities = 255/312 (81%), Positives = 281/312 (90%), Gaps = 7/312 (2%)

Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNI 60
           M+KYE++KD+G+GNFGVARL+R+K TKELVAMKYIERG KID NVAREIINH+ LRHPNI
Sbjct: 1   MDKYEVVKDLGAGNFGVARLLRHKETKELVAMKYIERGRKIDENVAREIINHRSLRHPNI 60

Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-------QIC 113
           IRFKEV+LTPTHLAIVMEYA+GGELFERICNAGRFSE EARYFFQQLI G       QIC
Sbjct: 61  IRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEAEARYFFQQLICGVDYCHSLQIC 120

Query: 114 HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKL 173
           HRDLKLENTLLDGSPAP LKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGK 
Sbjct: 121 HRDLKLENTLLDGSPAPLLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKH 180

Query: 174 ADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRI 233
           ADVWSCGVTLYVMLVG YPFED +DP+NFRKTI RIMAVQYKIPDYVHISQ+CR+LLSRI
Sbjct: 181 ADVWSCGVTLYVMLVGGYPFEDPDDPRNFRKTIQRIMAVQYKIPDYVHISQECRHLLSRI 240

Query: 234 FVANPSRRITIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTFSLQSVEEITKIVEEAK 293
           FV N ++RIT+KEIK HPW+LKNLP+ELTE AQA YY++E P+FSLQSVE+I KIV EA+
Sbjct: 241 FVTNSAKRITLKEIKKHPWYLKNLPKELTEPAQAAYYKRETPSFSLQSVEDIMKIVGEAR 300

Query: 294 VPPPVSRSIGGF 305
            P P S ++ GF
Sbjct: 301 NPAPSSNAVKGF 312

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q5N942|SAPK4_ORYSJ Serine/threonine-protein kinase SAPK4 OS=Oryza sativa subsp. japonica GN=SAPK4 PE=2 SV=2

 Score =  532 bits (1370), Expect = e-150,   Method: Compositional matrix adjust.
 Identities = 268/360 (74%), Positives = 303/360 (84%), Gaps = 20/360 (5%)

Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNI 60
           MEKYE ++DIGSGNFGVARLMRN+ T+ELVA+K IERGH+ID NV REIINH+ LRHPNI
Sbjct: 1   MEKYEAVRDIGSGNFGVARLMRNRETRELVAVKCIERGHRIDENVYREIINHRSLRHPNI 60

Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-------QIC 113
           IRFKEV+LTPTHL IVME+AAGGELF+RIC+ GRFSEDEARYFFQQLI G       QIC
Sbjct: 61  IRFKEVILTPTHLMIVMEFAAGGELFDRICDRGRFSEDEARYFFQQLICGVSYCHHMQIC 120

Query: 114 HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKL 173
           HRDLKLEN LLDGSPAPRLKICDFGYSKSS+LHSRPKS VGTPAYIAPEVLSRREYDGKL
Sbjct: 121 HRDLKLENVLLDGSPAPRLKICDFGYSKSSVLHSRPKSAVGTPAYIAPEVLSRREYDGKL 180

Query: 174 ADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRI 233
           ADVWSCGVTLYVMLVGAYPFEDQ+DPKN RKTI RIM+VQYKIPDYVHIS +C+ L++RI
Sbjct: 181 ADVWSCGVTLYVMLVGAYPFEDQDDPKNIRKTIQRIMSVQYKIPDYVHISAECKQLIARI 240

Query: 234 FVANPSRRITIKEIKSHPWFLKNLPRELTETAQAIYYRKEN--PTFSLQSVEEITKIVEE 291
           FV NP RRIT+KEIKSHPWFLKNLPRELTETAQA+YYR++N  P+FS Q+ EEI KIV+E
Sbjct: 241 FVNNPLRRITMKEIKSHPWFLKNLPRELTETAQAMYYRRDNSVPSFSDQTSEEIMKIVQE 300

Query: 292 AKVPPPVSRSIGGFGWGGEEDGD-------EKEEETDADEEDEYEKTVKEAQQSGEVSVS 344
           A+  P  SR+    G+  +   D       E+ EE + +EEDEY+K VKE   SGE+ +S
Sbjct: 301 ARTMPKSSRT----GYWSDAGSDEEEKEEEERPEENEEEEEDEYDKRVKEVHASGELRMS 356

May play a role in signal transduction of hyperosmotic response.

Oryza sativa subsp. japonica (taxid: 39947)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P43292|SRK2G_ARATH Serine/threonine-protein kinase SRK2G OS=Arabidopsis thaliana GN=SRK2G PE=1 SV=2

 Score =  526 bits (1356), Expect = e-149,   Method: Compositional matrix adjust.
 Identities = 265/350 (75%), Positives = 302/350 (86%), Gaps = 11/350 (3%)

Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNI 60
           M+KY+++KD+G+GNFGVARL+R+K+TKELVAMKYIERG KID NVAREIINH+ L+HPNI
Sbjct: 1   MDKYDVVKDLGAGNFGVARLLRHKDTKELVAMKYIERGRKIDENVAREIINHRSLKHPNI 60

Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-------QIC 113
           IRFKEV+LTPTHLAIVMEYA+GGELF+RIC AGRFSE EARYFFQQLI G       QIC
Sbjct: 61  IRFKEVILTPTHLAIVMEYASGGELFDRICTAGRFSEAEARYFFQQLICGVDYCHSLQIC 120

Query: 114 HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKL 173
           HRDLKLENTLLDGSPAP LKICDFGYSKSS+LHSRPKSTVGTPAYIAPEVLSRREYDGK 
Sbjct: 121 HRDLKLENTLLDGSPAPLLKICDFGYSKSSILHSRPKSTVGTPAYIAPEVLSRREYDGKH 180

Query: 174 ADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRI 233
           ADVWSCGVTLYVMLVGAYPFED  DPKNFRKTI RIMAVQYKIPDYVHISQ+C++LLSRI
Sbjct: 181 ADVWSCGVTLYVMLVGAYPFEDPNDPKNFRKTIQRIMAVQYKIPDYVHISQECKHLLSRI 240

Query: 234 FVANPSRRITIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTFSLQSVEEITKIVEEAK 293
           FV N ++RIT+KEIK+HPW+LKNLP+EL E+AQA YY+++  +FSLQSVE+I KIV EA+
Sbjct: 241 FVTNSAKRITLKEIKNHPWYLKNLPKELLESAQAAYYKRDT-SFSLQSVEDIMKIVGEAR 299

Query: 294 VPPPVSRSIGGFGWG---GEEDGDEKEEETDADEEDEYEKTVKEAQQSGE 340
            P P + ++   G G    EE+  E E E + D+EDEYEK VKEAQ   E
Sbjct: 300 NPAPSTSAVKSSGSGADEEEEEDVEAEVEEEEDDEDEYEKHVKEAQSCQE 349

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q7XKA8|SAPK5_ORYSJ Serine/threonine-protein kinase SAPK5 OS=Oryza sativa subsp. japonica GN=SAPK5 PE=2 SV=1

 Score =  525 bits (1351), Expect = e-148,   Method: Compositional matrix adjust.
 Identities = 260/365 (71%), Positives = 303/365 (83%), Gaps = 21/365 (5%)

Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNI 60
           MEKYE +++IG+GNFGVA+LMRNK T+ELVAMK+IERG++ID NV REI+NH+ LRHPNI
Sbjct: 1   MEKYEPVREIGAGNFGVAKLMRNKETRELVAMKFIERGNRIDENVFREIVNHRSLRHPNI 60

Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-------QIC 113
           IRFKEVV+T  HLAIVMEYAAGGELFERIC AGRF EDEARYFFQQL+ G       QIC
Sbjct: 61  IRFKEVVVTGRHLAIVMEYAAGGELFERICEAGRFHEDEARYFFQQLVCGVSYCHAMQIC 120

Query: 114 HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKL 173
           HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKL
Sbjct: 121 HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKL 180

Query: 174 ADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRI 233
           ADVWSCGVTLYVMLVGAYPFED +DPKNFRKTISRIM+VQYKIP+YVH+SQ CR+LLSRI
Sbjct: 181 ADVWSCGVTLYVMLVGAYPFEDPKDPKNFRKTISRIMSVQYKIPEYVHVSQPCRHLLSRI 240

Query: 234 FVANPSRRITIKEIKSHPWFLKNLPRELTETAQAIYYRKENP--------------TFSL 279
           FVANP +RI++ EIKSHPWFLKNLPREL E AQA+YY +                  FS 
Sbjct: 241 FVANPYKRISMGEIKSHPWFLKNLPRELKEEAQAVYYNRRGADHAASSASSAAAAAAFSP 300

Query: 280 QSVEEITKIVEEAKVPPPVSRSIGGFGWGGEEDGDEKEEETDADEEDEYEKTVKEAQQSG 339
           QSVE+I +IV+EA+  P   + + G+GWG ++D D+++   + DEED+Y++TV+E   S 
Sbjct: 301 QSVEDIMRIVQEAQTVPKPDKPVSGYGWGTDDDDDDQQPAEEEDEEDDYDRTVREVHASV 360

Query: 340 EVSVS 344
           ++ +S
Sbjct: 361 DLDMS 365

May play a role in signal transduction of hyperosmotic response.

Oryza sativa subsp. japonica (taxid: 39947)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O64812|SRK2J_ARATH Serine/threonine-protein kinase SRK2J OS=Arabidopsis thaliana GN=SRK2J PE=1 SV=1

 Score =  501 bits (1289), Expect = e-141,   Method: Compositional matrix adjust.
 Identities = 246/338 (72%), Positives = 277/338 (81%), Gaps = 11/338 (3%)

Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNI 60
           MEKYE++KD+G GNFG+ARLMRNK T ELVA+K+I+RG+KID NVAREIINH+ L HPNI
Sbjct: 1   MEKYEMVKDLGFGNFGLARLMRNKQTNELVAVKFIDRGYKIDENVAREIINHRALNHPNI 60

Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-------QIC 113
           +RFKEVVLTPTHL IVMEYAAGGELFERI + GRFSE EARYFFQQLI G       QIC
Sbjct: 61  VRFKEVVLTPTHLGIVMEYAAGGELFERISSVGRFSEAEARYFFQQLICGVHYLHALQIC 120

Query: 114 HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKL 173
           HRDLKLENTLLDGSPAPRLKICDFGYSKSS+LHS PKSTVGTPAYIAPEV  R EYDGK 
Sbjct: 121 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSNPKSTVGTPAYIAPEVFCRSEYDGKS 180

Query: 174 ADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRI 233
            DVWSCGV LYVMLVGAYPFED +DP+NFRKT+ +IMAV YKIP YVHIS+DCR LLSRI
Sbjct: 181 VDVWSCGVALYVMLVGAYPFEDPKDPRNFRKTVQKIMAVNYKIPGYVHISEDCRKLLSRI 240

Query: 234 FVANPSRRITIKEIKSHPWFLKNLPRELTETAQAIYYRKENP--TFSLQSVEEITKIVEE 291
           FVANP  R T+KEIKSH WFLKNLPREL E AQAIYY++      FS Q VEEI KIV E
Sbjct: 241 FVANPLHRSTLKEIKSHAWFLKNLPRELKEPAQAIYYQRNVNLINFSPQRVEEIMKIVGE 300

Query: 292 AKVPPPVSRSIGGFGWGGEEDGDEKEEETDADEEDEYE 329
           A+  P +SR +     G ++  D++EE  DA++E+ Y+
Sbjct: 301 ARTIPNLSRPVESL--GSDKKDDDEEEYLDANDEEWYD 336

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P0C5D6|SAPK3_ORYSJ Serine/threonine-protein kinase SAPK3 OS=Oryza sativa subsp. japonica GN=SAPK3 PE=1 SV=1

 Score =  487 bits (1253), Expect = e-137,   Method: Compositional matrix adjust.
 Identities = 238/334 (71%), Positives = 276/334 (82%), Gaps = 9/334 (2%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNII 61
           E+YE +K++G+GNFGVARL+R+K +KELVA+KYIERG KID NV REIINH+ LRHPNII
Sbjct: 3   ERYEALKELGAGNFGVARLVRDKRSKELVAVKYIERGKKIDENVQREIINHRSLRHPNII 62

Query: 62  RFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-------QICH 114
           RFKEV LTPTHLAIVMEYAAGGELFE+IC AGRFSEDEARYFFQQLISG       +ICH
Sbjct: 63  RFKEVCLTPTHLAIVMEYAAGGELFEQICTAGRFSEDEARYFFQQLISGVSYCHSLEICH 122

Query: 115 RDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLA 174
           RDLKLENTLLDGSP PR+KICDFGYSKS+LLHS+PKSTVGTPAYIAPEVLSR+EYDGK+A
Sbjct: 123 RDLKLENTLLDGSPTPRVKICDFGYSKSALLHSKPKSTVGTPAYIAPEVLSRKEYDGKVA 182

Query: 175 DVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIF 234
           DVWSCGVTLYVMLVG+YPFED  DP+NFRKTISRI+ VQY IPDYV +S DCR LLS+IF
Sbjct: 183 DVWSCGVTLYVMLVGSYPFEDPGDPRNFRKTISRILGVQYSIPDYVRVSSDCRRLLSQIF 242

Query: 235 VANPSRRITIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTFSLQSVEEITKIVEEAKV 294
           VA+PS+RITI EIK H WFLKNLP+E++E  +A  Y+  +     Q+VEEI +I++EAKV
Sbjct: 243 VADPSKRITIPEIKKHTWFLKNLPKEISEREKAD-YKDTDAAPPTQAVEEIMRIIQEAKV 301

Query: 295 PPPVSRSIGGFGWGGEEDGDEKEEETDADEEDEY 328
           P  ++ +         E   + EEE  ADE D Y
Sbjct: 302 PGDMAAADPALLAELAELKSDDEEEA-ADEYDTY 334

May play a role in signal transduction of hyperosmotic response.

Oryza sativa subsp. japonica (taxid: 39947)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	344
356543422	359	PREDICTED: serine/threonine-protein kina	0.997	0.955	0.869	1e-176
357445405	351	Serine/threonine protein kinase [Medicag	1.0	0.980	0.866	1e-175
388490962	351	unknown [Medicago truncatula]	0.991	0.971	0.870	1e-174
225448215	356	PREDICTED: serine/threonine-protein kina	1.0	0.966	0.879	1e-174
224118462	353	predicted protein [Populus trichocarpa]	1.0	0.974	0.883	1e-174
147864363	357	hypothetical protein VITISV_028464 [Viti	1.0	0.963	0.865	1e-173
255579673	357	Serine/threonine-protein kinase ASK1, pu	1.0	0.963	0.893	1e-172
297739581	335	unnamed protein product [Vitis vinifera]	0.898	0.922	0.917	1e-172
356525969	352	PREDICTED: serine/threonine-protein kina	1.0	0.977	0.880	1e-172
441433481	352	sucrose non-fermenting-1-related protein	0.997	0.974	0.855	1e-172

>gi|356543422|ref|XP_003540159.1| PREDICTED: serine/threonine-protein kinase SRK2B-like [Glycine max]

 Score =  624 bits (1609), Expect = e-176,   Method: Compositional matrix adjust.
 Identities = 313/360 (86%), Positives = 327/360 (90%), Gaps = 17/360 (4%)

Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNI 60
           M+KYEL+KDIGSGNFGVARLMR+K+TKELVAMKYIERGHKID NVAREIINH+ LRHPNI
Sbjct: 1   MDKYELVKDIGSGNFGVARLMRHKDTKELVAMKYIERGHKIDENVAREIINHRSLRHPNI 60

Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-------QIC 113
           IRFKEVVLTPTHL IVMEYAAGGELFERIC+AGRFSEDEARYFFQQLISG       QIC
Sbjct: 61  IRFKEVVLTPTHLGIVMEYAAGGELFERICSAGRFSEDEARYFFQQLISGVSYCHSMQIC 120

Query: 114 HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKL 173
           HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKL
Sbjct: 121 HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKL 180

Query: 174 ADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRI 233
           ADVWSCGVTLYVMLVGAYPFEDQ+DPKNFRKTI+RIMAVQYKIPDYVHISQDCR+LLSRI
Sbjct: 181 ADVWSCGVTLYVMLVGAYPFEDQDDPKNFRKTINRIMAVQYKIPDYVHISQDCRHLLSRI 240

Query: 234 FVANPSRRITIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTFSLQSVEEITKIVEEAK 293
           FVANP+RRITIKEIKSHPWFLKNLPRELTE AQA YYRKENPTFSLQS+E I  IVEEAK
Sbjct: 241 FVANPARRITIKEIKSHPWFLKNLPRELTEVAQAAYYRKENPTFSLQSIEGIMNIVEEAK 300

Query: 294 VPPPVSRSIGGFGWGGEEDGDEKEEE---------TDADEEDEYEKTVKEAQQSGEVSVS 344
            PPP SRSIGGFGWGGEE+ DE +EE         T+A EEDEYEK VKEAQ SGE  VS
Sbjct: 301 TPPPASRSIGGFGWGGEEEEDETKEEEDETKEEAVTEA-EEDEYEKRVKEAQASGEFHVS 359

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|357445405|ref|XP_003592980.1| Serine/threonine protein kinase [Medicago truncatula] gi|55140609|gb|AAV41842.1| stress kinase [Medicago truncatula] gi|55140611|gb|AAV41843.1| stress kinase [Medicago truncatula] gi|355482028|gb|AES63231.1| Serine/threonine protein kinase [Medicago truncatula]

 Score =  619 bits (1596), Expect = e-175,   Method: Compositional matrix adjust.
 Identities = 304/351 (86%), Positives = 326/351 (92%), Gaps = 7/351 (1%)

Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNI 60
           MEKYE++KDIGSGNFGVARLMR+K+TK+LVAMKYIERGHKID NVAREIINH+ LRHPNI
Sbjct: 1   MEKYEVVKDIGSGNFGVARLMRHKDTKQLVAMKYIERGHKIDENVAREIINHRSLRHPNI 60

Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-------QIC 113
           IRFKEVVLTPTHL IVMEYAAGGELF+RIC+AGRFSEDEARYFFQQLISG       QIC
Sbjct: 61  IRFKEVVLTPTHLGIVMEYAAGGELFDRICSAGRFSEDEARYFFQQLISGVSYCHSMQIC 120

Query: 114 HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKL 173
           HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKL
Sbjct: 121 HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKL 180

Query: 174 ADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRI 233
           ADVWSCGVTLYVMLVGAYPFEDQ+DPKNFRKTI+RIMAVQYKIPDYVHISQ+CR+LLSRI
Sbjct: 181 ADVWSCGVTLYVMLVGAYPFEDQDDPKNFRKTINRIMAVQYKIPDYVHISQECRHLLSRI 240

Query: 234 FVANPSRRITIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTFSLQSVEEITKIVEEAK 293
           FVA+P+RRITIKEIKSHPWFLKNLPRELTE AQA+YYRKENPT+SLQS+E+I KIVEEAK
Sbjct: 241 FVASPARRITIKEIKSHPWFLKNLPRELTEMAQAVYYRKENPTYSLQSIEDIMKIVEEAK 300

Query: 294 VPPPVSRSIGGFGWGGEEDGDEKEEETDADEEDEYEKTVKEAQQSGEVSVS 344
            PP  SRS+GGFGWGGEED DE  E     EEDEYEK VKEAQ+SGE+ V+
Sbjct: 301 NPPQASRSVGGFGWGGEEDDDEINEAEAELEEDEYEKRVKEAQESGEIHVN 351

Source: Medicago truncatula

Species: Medicago truncatula

Genus: Medicago

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|388490962|gb|AFK33547.1| unknown [Medicago truncatula]

 Score =  617 bits (1592), Expect = e-174,   Method: Compositional matrix adjust.
 Identities = 303/348 (87%), Positives = 324/348 (93%), Gaps = 7/348 (2%)

Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNI 60
           MEKYE++KDIGSGNFGVARLMR+K+TK+LVAMKYIERGHKID NVAREIINH+ LRHPNI
Sbjct: 1   MEKYEVVKDIGSGNFGVARLMRHKDTKQLVAMKYIERGHKIDENVAREIINHRSLRHPNI 60

Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-------QIC 113
           IRFKEVVLTPTHL IVMEYAAGGELF+RIC+AGRFSEDEARYFFQQLISG       QIC
Sbjct: 61  IRFKEVVLTPTHLGIVMEYAAGGELFDRICSAGRFSEDEARYFFQQLISGVSYCHSMQIC 120

Query: 114 HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKL 173
           HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKL
Sbjct: 121 HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKL 180

Query: 174 ADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRI 233
           ADVWSCGVTLYVMLVGAYPFEDQ+DPKNFRKTI+RIMAVQYKIPDYVHISQ+CR+LLSRI
Sbjct: 181 ADVWSCGVTLYVMLVGAYPFEDQDDPKNFRKTINRIMAVQYKIPDYVHISQECRHLLSRI 240

Query: 234 FVANPSRRITIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTFSLQSVEEITKIVEEAK 293
           FVA+P+RRITIKEIKSHPWFLKNLPRELTE AQA+YYRKENPT+SLQS+E+I KIVEEAK
Sbjct: 241 FVASPARRITIKEIKSHPWFLKNLPRELTEMAQAVYYRKENPTYSLQSIEDIMKIVEEAK 300

Query: 294 VPPPVSRSIGGFGWGGEEDGDEKEEETDADEEDEYEKTVKEAQQSGEV 341
            PP  SRS+GGFGWGGEED DE  E     EEDEYEK VKEAQ+SGE+
Sbjct: 301 NPPQASRSVGGFGWGGEEDDDEINEAEAELEEDEYEKRVKEAQESGEI 348

Source: Medicago truncatula

Species: Medicago truncatula

Genus: Medicago

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|225448215|ref|XP_002269221.1| PREDICTED: serine/threonine-protein kinase SRK2B isoform 1 [Vitis vinifera]

 Score =  617 bits (1590), Expect = e-174,   Method: Compositional matrix adjust.
 Identities = 313/356 (87%), Positives = 329/356 (92%), Gaps = 12/356 (3%)

Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNI 60
           MEKYEL+KDIGSGNFGVARLMRNK TKELVAMKYIERG KID NVAREIINH+ LRHPNI
Sbjct: 1   MEKYELVKDIGSGNFGVARLMRNKETKELVAMKYIERGQKIDENVAREIINHRSLRHPNI 60

Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-------QIC 113
           IRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG       QIC
Sbjct: 61  IRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQIC 120

Query: 114 HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKL 173
           HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKL
Sbjct: 121 HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKL 180

Query: 174 ADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRI 233
           ADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCR+LL+RI
Sbjct: 181 ADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRHLLARI 240

Query: 234 FVANPSRRITIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTFSLQSVEEITKIVEEAK 293
           FVANPSRR+TIK+IK+HPWFLKNLPRELTE AQA+YYR+ENPTFSLQS+E+I KIV+EAK
Sbjct: 241 FVANPSRRVTIKDIKNHPWFLKNLPRELTEAAQALYYRRENPTFSLQSIEDIMKIVDEAK 300

Query: 294 VPPPVSRSIGGFGWGG-----EEDGDEKEEETDADEEDEYEKTVKEAQQSGEVSVS 344
            PPPVSRSIGGFGWGG     EE+  E+E ET+ +EEDEYEK VKEA  SGEV VS
Sbjct: 301 TPPPVSRSIGGFGWGGEEEEEEEEEKEEEVETEEEEEDEYEKQVKEAHASGEVHVS 356

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224118462|ref|XP_002331488.1| predicted protein [Populus trichocarpa] gi|222873566|gb|EEF10697.1| predicted protein [Populus trichocarpa]

 Score =  616 bits (1589), Expect = e-174,   Method: Compositional matrix adjust.
 Identities = 312/353 (88%), Positives = 327/353 (92%), Gaps = 9/353 (2%)

Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNI 60
           ME+YEL+KDIGSGNFGVARLMR+K TKELVAMKYIERG KID NVAREIINH+ LRHPNI
Sbjct: 1   MERYELVKDIGSGNFGVARLMRHKQTKELVAMKYIERGLKIDENVAREIINHRSLRHPNI 60

Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-------QIC 113
           IRFKEVV+TPTHLAI+MEYAAGGELFERICNAGRFSEDEARYFFQQLISG       QIC
Sbjct: 61  IRFKEVVVTPTHLAIIMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQIC 120

Query: 114 HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKL 173
           HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKL
Sbjct: 121 HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKL 180

Query: 174 ADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRI 233
           ADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTI+RIMAVQYKIPDYVHISQDCR+LLSRI
Sbjct: 181 ADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTINRIMAVQYKIPDYVHISQDCRHLLSRI 240

Query: 234 FVANPSRRITIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTFSLQSVEEITKIVEEAK 293
           FVANP RRITIKEIKSHPWFLKNLPRELTE AQA+YYRKENPTFSLQSVEEI KIVEEAK
Sbjct: 241 FVANPIRRITIKEIKSHPWFLKNLPRELTEAAQAMYYRKENPTFSLQSVEEIMKIVEEAK 300

Query: 294 VPPPVSRSIGGFGWGG--EEDGDEKEEETDADEEDEYEKTVKEAQQSGEVSVS 344
           +PPPVSRSIGGFGW G  ++D  E + E + +EEDEYEK VKEAQ SGEV VS
Sbjct: 301 IPPPVSRSIGGFGWVGEEDDDVKEDDAEEEEEEEDEYEKRVKEAQASGEVHVS 353

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|147864363|emb|CAN78793.1| hypothetical protein VITISV_028464 [Vitis vinifera]

 Score =  614 bits (1584), Expect = e-173,   Method: Compositional matrix adjust.
 Identities = 309/357 (86%), Positives = 326/357 (91%), Gaps = 13/357 (3%)

Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNI 60
           MEKYEL+KDIGSGNFGVARLMRNK TKELVAMKYIERG KID NVAREIINH+ LRHPNI
Sbjct: 1   MEKYELVKDIGSGNFGVARLMRNKETKELVAMKYIERGQKIDENVAREIINHRSLRHPNI 60

Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-------QIC 113
           IRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG       QIC
Sbjct: 61  IRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQIC 120

Query: 114 HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKL 173
           HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKL
Sbjct: 121 HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKL 180

Query: 174 ADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRI 233
           ADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCR+LL+RI
Sbjct: 181 ADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRHLLARI 240

Query: 234 FVANPSRRITIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTFSLQSVEEITKIVEEAK 293
           FVANPSRR+TIK+IK+HPWFLKNLPRELTE AQA+YYR+ENPTFSLQS+E+I KIV+EAK
Sbjct: 241 FVANPSRRVTIKDIKNHPWFLKNLPRELTEAAQALYYRRENPTFSLQSIEDIMKIVDEAK 300

Query: 294 VPPPVSRSIGGFGWGGEEDGDEKEEETDADEEDEYEKT------VKEAQQSGEVSVS 344
            PPPVSRSIGGFGWGGEE  +E+EEE + + E E E+       VKEA  SGEV VS
Sbjct: 301 TPPPVSRSIGGFGWGGEEKKEEEEEEKEEEVETEEEEEDEYEKQVKEAHASGEVHVS 357

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255579673|ref|XP_002530676.1| Serine/threonine-protein kinase ASK1, putative [Ricinus communis] gi|223529769|gb|EEF31707.1| Serine/threonine-protein kinase ASK1, putative [Ricinus communis]

 Score =  611 bits (1576), Expect = e-172,   Method: Compositional matrix adjust.
 Identities = 319/357 (89%), Positives = 330/357 (92%), Gaps = 13/357 (3%)

Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNI 60
           MEKYEL+KDIGSGNFGVARLMRNK TKELVAMKYIERGHKID NVAREIINH+ LRHPNI
Sbjct: 1   MEKYELVKDIGSGNFGVARLMRNKETKELVAMKYIERGHKIDENVAREIINHRSLRHPNI 60

Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-------QIC 113
           IRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG       QIC
Sbjct: 61  IRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSLQIC 120

Query: 114 HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKL 173
           HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGK+
Sbjct: 121 HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKM 180

Query: 174 ADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRI 233
           ADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTI+RIMAVQYKIPDYVHISQDCR+LLSRI
Sbjct: 181 ADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTINRIMAVQYKIPDYVHISQDCRHLLSRI 240

Query: 234 FVANPSRRITIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTFSLQSVEEITKIVEEAK 293
           FVANPSRR+TIK+IKSHPWFLKNLPRELTE AQA+YYRKENPTFSLQ+ EEI KIVEEAK
Sbjct: 241 FVANPSRRVTIKDIKSHPWFLKNLPRELTEAAQAMYYRKENPTFSLQTAEEIMKIVEEAK 300

Query: 294 VPPPVSRSIGGFGWGGEEDGDEK------EEETDADEEDEYEKTVKEAQQSGEVSVS 344
           +PPPVSRSIGGFGWGGEEDGD K      EEE +  EEDEYEK VKEAQ SGE  VS
Sbjct: 301 IPPPVSRSIGGFGWGGEEDGDGKEDDTEAEEEEEVGEEDEYEKRVKEAQASGEFHVS 357

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|297739581|emb|CBI29763.3| unnamed protein product [Vitis vinifera]

 Score =  611 bits (1575), Expect = e-172,   Method: Compositional matrix adjust.
 Identities = 290/316 (91%), Positives = 302/316 (95%), Gaps = 7/316 (2%)

Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNI 60
           MEKYEL+KDIGSGNFGVARLMRNK TKELVAMKYIERG KID NVAREIINH+ LRHPNI
Sbjct: 1   MEKYELVKDIGSGNFGVARLMRNKETKELVAMKYIERGQKIDENVAREIINHRSLRHPNI 60

Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-------QIC 113
           IRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG       QIC
Sbjct: 61  IRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQIC 120

Query: 114 HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKL 173
           HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKL
Sbjct: 121 HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKL 180

Query: 174 ADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRI 233
           ADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCR+LL+RI
Sbjct: 181 ADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRHLLARI 240

Query: 234 FVANPSRRITIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTFSLQSVEEITKIVEEAK 293
           FVANPSRR+TIK+IK+HPWFLKNLPRELTE AQA+YYR+ENPTFSLQS+E+I KIV+EAK
Sbjct: 241 FVANPSRRVTIKDIKNHPWFLKNLPRELTEAAQALYYRRENPTFSLQSIEDIMKIVDEAK 300

Query: 294 VPPPVSRSIGGFGWGG 309
            PPPVSRSIGGFGWGG
Sbjct: 301 TPPPVSRSIGGFGWGG 316

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356525969|ref|XP_003531593.1| PREDICTED: serine/threonine-protein kinase SRK2B-like [Glycine max]

 Score =  609 bits (1571), Expect = e-172,   Method: Compositional matrix adjust.
 Identities = 310/352 (88%), Positives = 327/352 (92%), Gaps = 8/352 (2%)

Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNI 60
           MEKYEL+KDIGSGNFGVARLMR+K+TKELVAMKYIERGHKID NVAREIINH+ LRHPNI
Sbjct: 1   MEKYELVKDIGSGNFGVARLMRHKDTKELVAMKYIERGHKIDENVAREIINHRSLRHPNI 60

Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-------QIC 113
           IRFKEVVLTPTHL IVMEYAAGGELFERIC+AGRFSEDEARYFFQQLISG       QIC
Sbjct: 61  IRFKEVVLTPTHLGIVMEYAAGGELFERICSAGRFSEDEARYFFQQLISGVSYCHSMQIC 120

Query: 114 HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKL 173
           HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKL
Sbjct: 121 HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKL 180

Query: 174 ADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRI 233
           ADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTI+RIMAVQYKIPDYVHISQDCR+LLSRI
Sbjct: 181 ADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTINRIMAVQYKIPDYVHISQDCRHLLSRI 240

Query: 234 FVANPSRRITIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTFSLQSVEEITKIVEEAK 293
           FVANP+RRITIKEIKSHPWF+KNLPRELTE AQA YYRKENPTFSLQS+E+I  IVEEAK
Sbjct: 241 FVANPARRITIKEIKSHPWFVKNLPRELTEVAQAAYYRKENPTFSLQSIEDIMNIVEEAK 300

Query: 294 VPPPVSRSIGGFGWGGEEDGDEKEEETDAD-EEDEYEKTVKEAQQSGEVSVS 344
            PPP SRSIGGFGWGGEE+ +++ +E  A+ EEDEYEK VKEAQ SGE  VS
Sbjct: 301 APPPASRSIGGFGWGGEEEEEDETKEAVAETEEDEYEKRVKEAQASGEFHVS 352

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|441433481|gb|AGC31662.1| sucrose non-fermenting-1-related protein kinase [Malus x domestica]

 Score =  609 bits (1570), Expect = e-172,   Method: Compositional matrix adjust.
 Identities = 302/353 (85%), Positives = 321/353 (90%), Gaps = 10/353 (2%)

Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNI 60
           MEKYE++KDIGSGNFGVARLMRNK TKELVAMKYI+RGHKID NVAREIINH+ LRHPNI
Sbjct: 1   MEKYEVVKDIGSGNFGVARLMRNKETKELVAMKYIDRGHKIDENVAREIINHRSLRHPNI 60

Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-------QIC 113
           IRF+EVVLTPTHL IVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG       QIC
Sbjct: 61  IRFREVVLTPTHLGIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSLQIC 120

Query: 114 HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKL 173
           HRDLKLENTLLDGS APRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKL
Sbjct: 121 HRDLKLENTLLDGSAAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKL 180

Query: 174 ADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRI 233
           ADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKT+ +IM V YKIPD+VH+SQ+CR+LLSRI
Sbjct: 181 ADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTMKKIMGVHYKIPDHVHMSQECRHLLSRI 240

Query: 234 FVANPSRRITIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTFSLQSVEEITKIVEEAK 293
           FVANP+RRITIK+IK+HPWFLKNLPRELTE AQ IYYRKENPTFS Q+VE+I KIVEEAK
Sbjct: 241 FVANPARRITIKDIKNHPWFLKNLPRELTEAAQIIYYRKENPTFSPQTVEDIMKIVEEAK 300

Query: 294 VPPPVSRSIGGFGWGGEEDGDEK--EEETDADEEDEYEKTVKEAQQSGEVSVS 344
           +PPPVSRSIGGF W GEEDGD K   E  + +EEDEY KTVKE   SGEVSVS
Sbjct: 301 IPPPVSRSIGGFSW-GEEDGDTKEEVEGEEEEEEDEYVKTVKEVHASGEVSVS 352

Source: Malus x domestica

Species: Malus x domestica

Genus: Malus

Family: Rosaceae

Order: Rosales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	344
TAIR|locus:2206046	361	SNRK2.10 "SNF1-related protein	0.877	0.836	0.867	2.1e-141
TAIR|locus:2160559	360	SNRK2.5 "SNF1-related protein	0.877	0.838	0.818	5.2e-136
TAIR|locus:2159597	353	SNRK2.1 "SNF1-related protein	0.875	0.852	0.792	9.1e-132
TAIR|locus:2045319	339	SNRK2.9 "SNF1-related protein	0.877	0.890	0.768	1.9e-124
TAIR|locus:2118929	362	OST1 "OPEN STOMATA 1" [Arabido	0.866	0.823	0.738	8.3e-122
TAIR|locus:2174999	361	SNRK2.3 "sucrose nonfermenting	0.872	0.831	0.707	2.1e-116
TAIR|locus:2032075	343	SNRK2-8 "SNF1-RELATED PROTEIN	0.860	0.862	0.715	6.4e-115
TAIR|locus:2140104	350	SNRK2.7 "SNF1-related protein	0.851	0.837	0.699	8.4e-113
DICTYBASE|DDB_G0277905	727	snfA "AMP-activated protein ki	0.729	0.345	0.431	1.2e-48
POMBASE|SPCC74.03c	576	ssp2 "serine/threonine protein	0.747	0.446	0.433	2.9e-48

TAIR|locus:2206046 SNRK2.10 "SNF1-related protein kinase 2.10" [Arabidopsis thaliana (taxid:3702)]

 Score = 1383 (491.9 bits), Expect = 2.1e-141, P = 2.1e-141
 Identities = 268/309 (86%), Positives = 284/309 (91%)

Query:     1 MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNI 60
             M+KYEL+KDIG+GNFGVARLMR KN+KELVAMKYIERG KID NVAREIINH+ LRHPNI
Sbjct:     1 MDKYELVKDIGAGNFGVARLMRVKNSKELVAMKYIERGPKIDENVAREIINHRSLRHPNI 60

Query:    61 IRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-------QIC 113
             IRFKEVVLTPTH+AI MEYAAGGELFERIC+AGRFSEDEARYFFQQLISG       QIC
Sbjct:    61 IRFKEVVLTPTHIAIAMEYAAGGELFERICSAGRFSEDEARYFFQQLISGVSYCHAMQIC 120

Query:   114 HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKL 173
             HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS PKSTVGTPAYIAPEVLSR EYDGK+
Sbjct:   121 HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSMPKSTVGTPAYIAPEVLSRGEYDGKM 180

Query:   174 ADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRI 233
             ADVWSCGVTLYVMLVGAYPFEDQEDPKNF+KTI RIMAV+YKIPDYVHISQDC++LLSRI
Sbjct:   181 ADVWSCGVTLYVMLVGAYPFEDQEDPKNFKKTIQRIMAVKYKIPDYVHISQDCKHLLSRI 240

Query:   234 FVANPSRRITIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTFSLQSVEEITKIVEEAK 293
             FV N ++RITI +IK HPWFLKNLPRELTE AQA Y+RKENPTFSLQSVEEI KIVEEAK
Sbjct:   241 FVTNSNKRITIGDIKKHPWFLKNLPRELTEIAQAAYFRKENPTFSLQSVEEIMKIVEEAK 300

Query:   294 VPPPVSRSI 302
              P  VSRSI
Sbjct:   301 TPARVSRSI 309

GO:0005886 "plasma membrane" evidence=ISM

GO:0016301 "kinase activity" evidence=ISS;IDA

GO:0006970 "response to osmotic stress" evidence=IGI;IDA

GO:0009651 "response to salt stress" evidence=IDA

GO:0005829 "cytosol" evidence=IDA;RCA

GO:0004672 "protein kinase activity" evidence=IDA

GO:0006468 "protein phosphorylation" evidence=IDA

GO:0048527 "lateral root development" evidence=IMP

GO:0070300 "phosphatidic acid binding" evidence=IDA

TAIR|locus:2160559 SNRK2.5 "SNF1-related protein kinase 2.5" [Arabidopsis thaliana (taxid:3702)]

 Score = 1332 (473.9 bits), Expect = 5.2e-136, P = 5.2e-136
 Identities = 253/309 (81%), Positives = 279/309 (90%)

Query:     1 MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNI 60
             M+KYE++KD+G+GNFGVARL+R+K TKELVAMKYIERG KID NVAREIINH+ LRHPNI
Sbjct:     1 MDKYEVVKDLGAGNFGVARLLRHKETKELVAMKYIERGRKIDENVAREIINHRSLRHPNI 60

Query:    61 IRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-------QIC 113
             IRFKEV+LTPTHLAIVMEYA+GGELFERICNAGRFSE EARYFFQQLI G       QIC
Sbjct:    61 IRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEAEARYFFQQLICGVDYCHSLQIC 120

Query:   114 HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKL 173
             HRDLKLENTLLDGSPAP LKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGK 
Sbjct:   121 HRDLKLENTLLDGSPAPLLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKH 180

Query:   174 ADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRI 233
             ADVWSCGVTLYVMLVG YPFED +DP+NFRKTI RIMAVQYKIPDYVHISQ+CR+LLSRI
Sbjct:   181 ADVWSCGVTLYVMLVGGYPFEDPDDPRNFRKTIQRIMAVQYKIPDYVHISQECRHLLSRI 240

Query:   234 FVANPSRRITIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTFSLQSVEEITKIVEEAK 293
             FV N ++RIT+KEIK HPW+LKNLP+ELTE AQA YY++E P+FSLQSVE+I KIV EA+
Sbjct:   241 FVTNSAKRITLKEIKKHPWYLKNLPKELTEPAQAAYYKRETPSFSLQSVEDIMKIVGEAR 300

Query:   294 VPPPVSRSI 302
              P P S ++
Sbjct:   301 NPAPSSNAV 309

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS;IDA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0006970 "response to osmotic stress" evidence=IGI;IDA

GO:0009651 "response to salt stress" evidence=IDA

TAIR|locus:2159597 SNRK2.1 "SNF1-related protein kinase 2.1" [Arabidopsis thaliana (taxid:3702)]

 Score = 1292 (459.9 bits), Expect = 9.1e-132, P = 9.1e-132
 Identities = 245/309 (79%), Positives = 279/309 (90%)

Query:     1 MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNI 60
             M+KY+++KD+G+GNFGVARL+R+K+TKELVAMKYIERG KID NVAREIINH+ L+HPNI
Sbjct:     1 MDKYDVVKDLGAGNFGVARLLRHKDTKELVAMKYIERGRKIDENVAREIINHRSLKHPNI 60

Query:    61 IRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-------QIC 113
             IRFKEV+LTPTHLAIVMEYA+GGELF+RIC AGRFSE EARYFFQQLI G       QIC
Sbjct:    61 IRFKEVILTPTHLAIVMEYASGGELFDRICTAGRFSEAEARYFFQQLICGVDYCHSLQIC 120

Query:   114 HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKL 173
             HRDLKLENTLLDGSPAP LKICDFGYSKSS+LHSRPKSTVGTPAYIAPEVLSRREYDGK 
Sbjct:   121 HRDLKLENTLLDGSPAPLLKICDFGYSKSSILHSRPKSTVGTPAYIAPEVLSRREYDGKH 180

Query:   174 ADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRI 233
             ADVWSCGVTLYVMLVGAYPFED  DPKNFRKTI RIMAVQYKIPDYVHISQ+C++LLSRI
Sbjct:   181 ADVWSCGVTLYVMLVGAYPFEDPNDPKNFRKTIQRIMAVQYKIPDYVHISQECKHLLSRI 240

Query:   234 FVANPSRRITIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTFSLQSVEEITKIVEEAK 293
             FV N ++RIT+KEIK+HPW+LKNLP+EL E+AQA YY+++  +FSLQSVE+I KIV EA+
Sbjct:   241 FVTNSAKRITLKEIKNHPWYLKNLPKELLESAQAAYYKRDT-SFSLQSVEDIMKIVGEAR 299

Query:   294 VPPPVSRSI 302
              P P + ++
Sbjct:   300 NPAPSTSAV 308

GO:0004672 "protein kinase activity" evidence=IEA;TAS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA;TAS

GO:0016301 "kinase activity" evidence=ISS;IDA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005515 "protein binding" evidence=IPI

GO:0006970 "response to osmotic stress" evidence=IGI;IDA

GO:0009651 "response to salt stress" evidence=IDA

TAIR|locus:2045319 SNRK2.9 "SNF1-related protein kinase 2.9" [Arabidopsis thaliana (taxid:3702)]

 Score = 1223 (435.6 bits), Expect = 1.9e-124, P = 1.9e-124
 Identities = 239/311 (76%), Positives = 262/311 (84%)

Query:     1 MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNI 60
             MEKYE++KD+G GNFG+ARLMRNK T ELVA+K+I+RG+KID NVAREIINH+ L HPNI
Sbjct:     1 MEKYEMVKDLGFGNFGLARLMRNKQTNELVAVKFIDRGYKIDENVAREIINHRALNHPNI 60

Query:    61 IRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-------QIC 113
             +RFKEVVLTPTHL IVMEYAAGGELFERI + GRFSE EARYFFQQLI G       QIC
Sbjct:    61 VRFKEVVLTPTHLGIVMEYAAGGELFERISSVGRFSEAEARYFFQQLICGVHYLHALQIC 120

Query:   114 HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKL 173
             HRDLKLENTLLDGSPAPRLKICDFGYSKSS+LHS PKSTVGTPAYIAPEV  R EYDGK 
Sbjct:   121 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSNPKSTVGTPAYIAPEVFCRSEYDGKS 180

Query:   174 ADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRI 233
              DVWSCGV LYVMLVGAYPFED +DP+NFRKT+ +IMAV YKIP YVHIS+DCR LLSRI
Sbjct:   181 VDVWSCGVALYVMLVGAYPFEDPKDPRNFRKTVQKIMAVNYKIPGYVHISEDCRKLLSRI 240

Query:   234 FVANPSRRITIKEIKSHPWFLKNLPRELTETAQAIYYRKE-NP-TFSLQSVEEITKIVEE 291
             FVANP  R T+KEIKSH WFLKNLPREL E AQAIYY++  N   FS Q VEEI KIV E
Sbjct:   241 FVANPLHRSTLKEIKSHAWFLKNLPRELKEPAQAIYYQRNVNLINFSPQRVEEIMKIVGE 300

Query:   292 AKVPPPVSRSI 302
             A+  P +SR +
Sbjct:   301 ARTIPNLSRPV 311

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005829 "cytosol" evidence=RCA

GO:0006970 "response to osmotic stress" evidence=IGI

GO:0006826 "iron ion transport" evidence=RCA

GO:0010106 "cellular response to iron ion starvation" evidence=RCA

GO:0010167 "response to nitrate" evidence=RCA

GO:0015706 "nitrate transport" evidence=RCA

TAIR|locus:2118929 OST1 "OPEN STOMATA 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 1198 (426.8 bits), Expect = 8.3e-122, P = 8.3e-122
 Identities = 229/310 (73%), Positives = 267/310 (86%)

Query:     2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNII 61
             ++YEL+KDIGSGNFGVARLMR+K + ELVA+KYIERG KID NV REIINH+ LRHPNI+
Sbjct:    19 DRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKIDENVKREIINHRSLRHPNIV 78

Query:    62 RFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-------QICH 114
             RFKEV+LTPTHLAIVMEYA+GGELFERICNAGRFSEDEAR+FFQQLISG       Q+CH
Sbjct:    79 RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCH 138

Query:   115 RDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLA 174
             RDLKLENTLLDGSPAPRLKICDFGYSKSS+LHS+PKSTVGTPAYIAPEVL ++EYDGK+A
Sbjct:   139 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKVA 198

Query:   175 DVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIF 234
             DVWSCGVTLYVMLVGAYPFED E+PKNFRKTI RI+ VQY IPDYVHIS +CR+L+SRIF
Sbjct:   199 DVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPDYVHISPECRHLISRIF 258

Query:   235 VANPSRRITIKEIKSHPWFLKNLPRELTE--TAQAIYYRKENPTFSLQSVEEITKIVEEA 292
             VA+P++RI+I EI++H WFLKNLP +L    T    +   + P    QS+EEI +I+ EA
Sbjct:   259 VADPAKRISIPEIRNHEWFLKNLPADLMNDNTMTTQFDESDQPG---QSIEEIMQIIAEA 315

Query:   293 KVPPPVSRSI 302
              VPP  ++++
Sbjct:   316 TVPPAGTQNL 325

GO:0004672 "protein kinase activity" evidence=IEA;IDA;TAS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS;IDA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009414 "response to water deprivation" evidence=IGI;IMP

GO:0009737 "response to abscisic acid stimulus" evidence=IDA;IMP

GO:0010119 "regulation of stomatal movement" evidence=IMP

GO:0009931 "calcium-dependent protein serine/threonine kinase activity" evidence=ISS

GO:0009738 "abscisic acid mediated signaling pathway" evidence=TAS

GO:2000377 "regulation of reactive oxygen species metabolic process" evidence=IMP

GO:0006970 "response to osmotic stress" evidence=IGI;IDA

GO:0009651 "response to salt stress" evidence=IDA

GO:0005515 "protein binding" evidence=IPI

GO:0010118 "stomatal movement" evidence=IMP

GO:0042742 "defense response to bacterium" evidence=IMP

GO:0005829 "cytosol" evidence=RCA;IDA

GO:0005737 "cytoplasm" evidence=IDA

GO:0005985 "sucrose metabolic process" evidence=IMP

GO:0006636 "unsaturated fatty acid biosynthetic process" evidence=IMP

GO:0019432 "triglyceride biosynthetic process" evidence=IMP

GO:0040007 "growth" evidence=IMP

GO:0048366 "leaf development" evidence=IMP

GO:0042744 "hydrogen peroxide catabolic process" evidence=RCA

TAIR|locus:2174999 SNRK2.3 "sucrose nonfermenting 1(SNF1)-related protein kinase 2.3" [Arabidopsis thaliana (taxid:3702)]

 Score = 1147 (408.8 bits), Expect = 2.1e-116, P = 2.1e-116
 Identities = 218/308 (70%), Positives = 262/308 (85%)

Query:     2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNII 61
             ++Y+ +KDIGSGNFGVARLMR+K TKELVA+KYIERG KID NV REIINH+ LRHPNI+
Sbjct:    20 DRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIV 79

Query:    62 RFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-------QICH 114
             RFKEV+LTPTHLAI+MEYA+GGEL+ERICNAGRFSEDEAR+FFQQL+SG       QICH
Sbjct:    80 RFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICH 139

Query:   115 RDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLA 174
             RDLKLENTLLDGSPAPRLKICDFGYSKSS+LHS+PKSTVGTPAYIAPEVL R+EYDGK+A
Sbjct:   140 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRQEYDGKIA 199

Query:   175 DVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIF 234
             DVWSCGVTLYVMLVGAYPFED E+P+++RKTI RI++V+Y IPD + IS +C +L+SRIF
Sbjct:   200 DVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRISPECCHLISRIF 259

Query:   235 VANPSRRITIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTFSLQSVEEITKIVEEAKV 294
             VA+P+ RI+I EIK+H WFLKNLP +L   +      +E P   +QS++ I +I+ EA +
Sbjct:   260 VADPATRISIPEIKTHSWFLKNLPADLMNESNTGSQFQE-PEQPMQSLDTIMQIISEATI 318

Query:   295 PPPVSRSI 302
             P   +R +
Sbjct:   319 PAVRNRCL 326

GO:0004672 "protein kinase activity" evidence=IEA;IDA;TAS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005737 "cytoplasm" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS;IDA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009738 "abscisic acid mediated signaling pathway" evidence=TAS

GO:0006970 "response to osmotic stress" evidence=IGI;IDA

GO:0009651 "response to salt stress" evidence=IDA

GO:0009737 "response to abscisic acid stimulus" evidence=IDA

GO:0009789 "positive regulation of abscisic acid mediated signaling pathway" evidence=IGI

GO:0005829 "cytosol" evidence=RCA;IDA

GO:0009739 "response to gibberellin stimulus" evidence=IGI

GO:0010029 "regulation of seed germination" evidence=IGI;RCA

GO:0005515 "protein binding" evidence=IPI

GO:0005634 "nucleus" evidence=IDA

GO:0009414 "response to water deprivation" evidence=IGI

TAIR|locus:2032075 SNRK2-8 "SNF1-RELATED PROTEIN KINASE 2-8" [Arabidopsis thaliana (taxid:3702)]

 Score = 1133 (403.9 bits), Expect = 6.4e-115, P = 6.4e-115
 Identities = 221/309 (71%), Positives = 259/309 (83%)

Query:     1 MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNI 60
             ME+YE++KDIGSGNFGVA+L+R+K +KEL A+K+IERG KID +V REI+NH+ L HPNI
Sbjct:     1 MERYEIVKDIGSGNFGVAKLVRDKFSKELFAVKFIERGQKIDEHVQREIMNHRSLIHPNI 60

Query:    61 IRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-------QIC 113
             IRFKEV+LT THLA+VMEYAAGGELF RIC+AGRFSEDEAR+FFQQLISG       QIC
Sbjct:    61 IRFKEVLLTATHLALVMEYAAGGELFGRICSAGRFSEDEARFFFQQLISGVNYCHSLQIC 120

Query:   114 HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKL 173
             HRDLKLENTLLDGS APR+KICDFGYSKS +LHS+PK+TVGTPAYIAPEVLS +EYDGK+
Sbjct:   121 HRDLKLENTLLDGSEAPRVKICDFGYSKSGVLHSQPKTTVGTPAYIAPEVLSTKEYDGKI 180

Query:   174 ADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRI 233
             ADVWSCGVTLYVMLVGAYPFED  DPK+FRKTI RI+  QY IPDYV +S +CR+LLSRI
Sbjct:   181 ADVWSCGVTLYVMLVGAYPFEDPSDPKDFRKTIGRILKAQYAIPDYVRVSDECRHLLSRI 240

Query:   234 FVANPSRRITIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTFSLQSVEEITKIVEEAK 293
             FVANP +RITI+EIK+H WFLKNLP E+ E +  +      P  S Q+VEEI  I+EEA+
Sbjct:   241 FVANPEKRITIEEIKNHSWFLKNLPVEMYEGSLMM----NGP--STQTVEEIVWIIEEAR 294

Query:   294 VPPPVSRSI 302
              P  V+  +
Sbjct:   295 KPITVATGL 303

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0080167 "response to karrikin" evidence=IEP

GO:0005737 "cytoplasm" evidence=IDA

GO:0006970 "response to osmotic stress" evidence=IGI

TAIR|locus:2140104 SNRK2.7 "SNF1-related protein kinase 2.7" [Arabidopsis thaliana (taxid:3702)]

 Score = 1113 (396.9 bits), Expect = 8.4e-113, P = 8.4e-113
 Identities = 212/303 (69%), Positives = 250/303 (82%)

Query:     1 MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNI 60
             ME+Y++++D+GSGNFGVA+L+R K   E  A+KYIERG KID +V REIINH+ L+HPNI
Sbjct:     1 MERYDILRDLGSGNFGVAKLVREKANGEFYAVKYIERGLKIDEHVQREIINHRDLKHPNI 60

Query:    61 IRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-------QIC 113
             IRFKEV +TPTHLAIVMEYAAGGELFERICNAGRFSEDE RY+F+QLISG       QIC
Sbjct:    61 IRFKEVFVTPTHLAIVMEYAAGGELFERICNAGRFSEDEGRYYFKQLISGVSYCHAMQIC 120

Query:   114 HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKL 173
             HRDLKLENTLLDGSP+  LKICDFGYSKSS+LHS+PKSTVGTPAY+APEVLSR+EY+GK+
Sbjct:   121 HRDLKLENTLLDGSPSSHLKICDFGYSKSSVLHSQPKSTVGTPAYVAPEVLSRKEYNGKI 180

Query:   174 ADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRI 233
             ADVWSCGVTLYVMLVGAYPFED EDP+N R TI RI++V Y IPDYV IS +C++LLSRI
Sbjct:   181 ADVWSCGVTLYVMLVGAYPFEDPEDPRNIRNTIQRILSVHYTIPDYVRISSECKHLLSRI 240

Query:   234 FVANPSRRITIKEIKSHPWFLKN---LPRELTETAQAIYYRKENPTFSLQSVEEITKIVE 290
             FVA+P +RIT+ EI+ HPWFLK    +P E  +    +   +E      QSVEEI KI+E
Sbjct:   241 FVADPDKRITVPEIEKHPWFLKGPLVVPPEEEKCDNGVEEEEEEEEKCRQSVEEIVKIIE 300

Query:   291 EAK 293
             EA+
Sbjct:   301 EAR 303

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS;IDA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0006970 "response to osmotic stress" evidence=IGI;IDA

GO:0009651 "response to salt stress" evidence=IDA

GO:0005829 "cytosol" evidence=IDA

GO:0005737 "cytoplasm" evidence=IDA

DICTYBASE|DDB_G0277905 snfA "AMP-activated protein kinase alpha subunit" [Dictyostelium discoideum (taxid:44689)]

 Score = 508 (183.9 bits), Expect = 1.2e-48, P = 1.2e-48
 Identities = 117/271 (43%), Positives = 157/271 (57%)

Query:     4 YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH----KIDANVAREIINHKQLRHPN 59
             Y L K +G G+FG  +L  +  T   VA+K + R      K+D  + REI N K  RHP+
Sbjct:    31 YRLDKTLGIGSFGKVKLAEHIRTGVKVAIKILNRTKIKNLKMDEKIRREIQNMKLFRHPH 90

Query:    60 IIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-------QI 112
             II+  EV+ T T + +VMEY  GGELFE I   G+  EDE+R  FQQ+ISG        +
Sbjct:    91 IIKLYEVIETTTDIFMVMEYVTGGELFEYIVKNGKLLEDESRRLFQQMISGVDYCHHHMV 150

Query:   113 CHRDLKLENTLLDGSPAPR-LKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDG 171
              HRDLK EN LLD  P  + +KI DFG S         K++ G+P Y APEV+S + Y G
Sbjct:   151 VHRDLKPENLLLD--PINKCIKIADFGLSNMMQDGDFLKTSCGSPNYAAPEVISGKLYAG 208

Query:   172 KLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLS 231
                DVWSCGV LY  L    PF+D+  P  F+K    +    + IPD+V  S  C +L+ 
Sbjct:   209 PEVDVWSCGVILYAFLCAKLPFDDESIPMLFKKIREGV----FSIPDFV--SPSCADLIK 262

Query:   232 RIFVANPSRRITIKEIKSHPWFLKNLPRELT 262
             ++ V +P +RITI EI++HPWF   LP+ L+
Sbjct:   263 KMLVVDPVKRITIHEIRNHPWFQVKLPKYLS 293

GO:0046956 "positive phototaxis" evidence=IMP

GO:0008283 "cell proliferation" evidence=IMP

GO:0007005 "mitochondrion organization" evidence=IMP

GO:0006754 "ATP biosynthetic process" evidence=IMP

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004672 "protein kinase activity" evidence=IEA

GO:0005575 "cellular_component" evidence=ND

GO:0007165 "signal transduction" evidence=ISS

GO:0004679 "AMP-activated protein kinase activity" evidence=ISS

GO:0016740 "transferase activity" evidence=IEA

GO:0016310 "phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=IEA

GO:0000166 "nucleotide binding" evidence=IEA

POMBASE|SPCC74.03c ssp2 "serine/threonine protein kinase Ssp2" [Schizosaccharomyces pombe (taxid:4896)]

 Score = 504 (182.5 bits), Expect = 2.9e-48, P = 2.9e-48
 Identities = 121/279 (43%), Positives = 168/279 (60%)

Query:     4 YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERG--HKIDAN--VAREIINHKQLRHPN 59
             Y + + +G G+FG  +L  +  T++ VA+K+I R    K D +  V REI   K LRHP+
Sbjct:    34 YIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPH 93

Query:    60 IIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-------QI 112
             II+  +V+ TPT + +V+EYA GGELF+ I    R +EDE R FFQQ+I         +I
Sbjct:    94 IIKLYDVITTPTDIVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKI 152

Query:   113 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGK 172
              HRDLK EN LLD +    +KI DFG S      +  K++ G+P Y APEV++ + Y G 
Sbjct:   153 VHRDLKPENLLLDDNL--NVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVINGKLYAGP 210

Query:   173 LADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSR 232
               DVWSCG+ LYVMLVG  PF+D+  P  F+K  S +    Y +PD+  +S   ++L+ R
Sbjct:   211 EVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCV----YVMPDF--LSPGAQSLIRR 264

Query:   233 IFVANPSRRITIKEIKSHPWFLKNLPRELT--ETAQAIY 269
             + VA+P +RITI+EI+  PWF  NLP  L   E  Q  Y
Sbjct:   265 MIVADPMQRITIQEIRRDPWFNVNLPDYLRPMEEVQGSY 303

GO:0004674 "protein serine/threonine kinase activity" evidence=ISM

GO:0005524 "ATP binding" evidence=ISM

GO:0005634 "nucleus" evidence=IDA

GO:0005737 "cytoplasm" evidence=IDA

GO:0005829 "cytosol" evidence=IDA

GO:0006468 "protein phosphorylation" evidence=ISM

GO:0007165 "signal transduction" evidence=IC

GO:0031593 "polyubiquitin binding" evidence=TAS

GO:0044732 "mitotic spindle pole body" evidence=IDA

GO:0046015 "regulation of transcription by glucose" evidence=ISO

GO:0051519 "activation of bipolar cell growth" evidence=IMP

GO:2000766 "negative regulation of cytoplasmic translation" evidence=ISO

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
Q9C958	SRK2B_ARATH	2, ., 7, ., 1, 1, ., 1	0.8144	1.0	0.9529	yes	no
Q9FFP9	SRK2H_ARATH	2, ., 7, ., 1, 1, ., 1	0.8173	0.8866	0.8472	no	no
A2ZAB5	SAPK3_ORYSI	2, ., 7, ., 1, 1, ., 1	0.7125	0.9447	0.9730	N/A	no
P0C5D6	SAPK3_ORYSJ	2, ., 7, ., 1, 1, ., 1	0.7125	0.9447	0.9730	no	no
O64812	SRK2J_ARATH	2, ., 7, ., 1, 1, ., 1	0.7278	0.9505	0.9646	no	no
Q5N942	SAPK4_ORYSJ	2, ., 7, ., 1, 1, ., 1	0.7444	0.9883	0.9444	no	no
Q02066	AAIP_WHEAT	2, ., 7, ., 1, 1, ., 1	0.7209	0.8517	0.8825	N/A	no
Q9M9E9	SRK2C_ARATH	2, ., 7, ., 1, 1, ., 1	0.7222	0.8517	0.8542	no	no
Q7XQP4	SAPK7_ORYSJ	2, ., 7, ., 1, 1, ., 1	0.7743	1.0	0.9582	yes	no
Q75LR7	SAPK1_ORYSJ	2, ., 7, ., 1, 1, ., 1	0.7483	0.8546	0.8596	no	no
P43292	SRK2G_ARATH	2, ., 7, ., 1, 1, ., 1	0.7571	0.9854	0.9603	no	no
P43291	SRK2A_ARATH	2, ., 7, ., 1, 1, ., 1	0.8236	1.0	0.9476	no	no
Q39193	SRK2I_ARATH	2, ., 7, ., 1, 1, ., 1	0.7041	0.8808	0.8393	no	no
Q7XKA8	SAPK5_ORYSJ	2, ., 7, ., 1, 1, ., 1	0.7123	1.0	0.9297	no	no
Q940H6	SRK2E_ARATH	2, ., 7, ., 1, 1, ., 1	0.7151	0.9040	0.8591	no	no
Q75H77	SAPKA_ORYSJ	2, ., 7, ., 1, 1, ., 1	0.7266	0.8808	0.8370	no	no
A2YNT8	SAPK2_ORYSI	2, ., 7, ., 1, 1, ., 1	0.7272	0.9011	0.9144	N/A	no
Q6ZI44	SAPK6_ORYSJ	2, ., 7, ., 1, 1, ., 1	0.8179	0.9156	0.8630	no	no
Q0D4J7	SAPK2_ORYSJ	2, ., 7, ., 1, 1, ., 1	0.7304	0.9011	0.9144	no	no
Q7Y0B9	SAPK8_ORYSJ	2, ., 7, ., 1, 1, ., 1	0.7254	0.8662	0.8032	no	no
Q75V57	SAPK9_ORYSJ	2, ., 7, ., 1, 1, ., 1	0.7138	0.8808	0.8393	no	no

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	0.994
3rd Layer	2.7.11	0.998

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Fail to connect to STRING server

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	344
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	2e-93
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	6e-79
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	5e-61
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	2e-59
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	5e-59
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	1e-54
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	2e-54
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	8e-50
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	4e-49
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	2e-47
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	1e-46
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	1e-42
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	1e-42
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	2e-42
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	4e-42
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	2e-41
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	7e-41
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	9e-41
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	3e-39
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	5e-39
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	8e-39
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	3e-38
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	3e-38
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	5e-38
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	1e-37
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	3e-37
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	8e-37
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	3e-36
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	3e-36
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	3e-36
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	9e-36
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	1e-35
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	1e-35
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	1e-35
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	3e-35
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	5e-35
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	7e-35
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	1e-34
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	1e-34
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	6e-34
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	7e-34
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	1e-33
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	6e-33
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	1e-32
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	1e-32
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	2e-32
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	6e-32
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	1e-31
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	1e-31
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	2e-31
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	2e-31
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	2e-31
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	3e-31
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	1e-30
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	2e-30
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	2e-30
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	4e-30
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	4e-30
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	7e-30
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	9e-30
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	1e-29
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	2e-29
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	3e-29
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	3e-29
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	4e-29
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	7e-29
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	1e-28
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	2e-28
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	4e-28
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	5e-28
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	5e-28
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	8e-28
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	9e-28
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	1e-27
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	1e-27
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	1e-27
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	1e-27
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	2e-27
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	4e-27
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	4e-27
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	5e-27
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	8e-27
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	1e-26
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	2e-26
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	2e-26
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	3e-26
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	5e-26
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	5e-26
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	1e-25
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	2e-25
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	2e-25
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	4e-25
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	6e-25
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	7e-25
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	8e-25
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	1e-24
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	3e-24
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	3e-24
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	3e-24
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	4e-24
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	4e-24
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	5e-24
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	5e-24
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	6e-24
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	8e-24
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	8e-24
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	8e-24
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	1e-23
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	2e-23
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	3e-23
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	4e-23
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	5e-23
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	8e-23
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	1e-22
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	1e-22
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	1e-22
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	2e-22
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	2e-22
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	4e-22
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	9e-22
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	1e-21
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	1e-21
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	1e-21
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	2e-21
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	2e-21
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	2e-21
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	4e-21
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	5e-21
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	6e-21
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	9e-21
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	1e-20
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	1e-20
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	2e-20
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	2e-20
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	2e-20
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	3e-20
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	4e-20
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	6e-20
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	6e-20
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	9e-20
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	1e-19
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	1e-19
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	1e-19
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	2e-19
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	2e-19
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	2e-19
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	5e-19
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	6e-19
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	8e-19
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	9e-19
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	1e-18
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	2e-18
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	3e-18
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	4e-18
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	8e-18
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	1e-17
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	2e-17
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	2e-17
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	2e-17
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	2e-17
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	2e-17
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	3e-17
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	7e-17
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	1e-16
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	3e-16
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	4e-16
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	4e-16
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	4e-16
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	5e-16
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	5e-16
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	8e-16
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	1e-15
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	1e-15
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	1e-15
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	2e-15
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	2e-15
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	3e-15
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	4e-15
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	5e-15
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	6e-15
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	6e-15
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	1e-14
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	1e-14
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	1e-14
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	2e-14
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	3e-14
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	5e-14
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	6e-14
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	8e-14
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	1e-13
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	1e-13
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	1e-13
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	1e-13
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	1e-13
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	2e-13
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	3e-13
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	4e-13
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	4e-13
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	4e-13
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	7e-13
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	2e-12
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	2e-12
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	2e-12
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	2e-12
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	3e-12
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	3e-12
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	3e-12
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	3e-12
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	4e-12
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	5e-12
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	6e-12
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	8e-12
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	1e-11
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	2e-11
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	4e-11
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	4e-11
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	4e-11
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	6e-11
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	7e-11
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	9e-11
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	1e-10
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	1e-10
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	2e-10
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	2e-10
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	3e-10
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	3e-10
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	3e-10
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	4e-10
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	7e-10
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	9e-10
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	1e-09
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	2e-09
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	4e-09
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	4e-09
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	8e-09
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	1e-08
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	2e-08
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	5e-08
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	7e-08
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	8e-08
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	3e-07
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	4e-07
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	5e-07
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	5e-07
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	5e-07
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	5e-07
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	7e-07
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	8e-07
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	8e-07
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	1e-06
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	1e-06
cd08227	327	cd08227, PK_STRAD_alpha, Pseudokinase domain of ST	1e-06
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	1e-06
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	2e-06
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	2e-06
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	2e-06
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	2e-06
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	2e-06
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	9e-06
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	9e-06
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	2e-05
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	2e-05
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	3e-05
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	3e-05
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	3e-05
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	3e-05
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	4e-05
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	4e-05
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	5e-05
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	5e-05
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	6e-05
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	6e-05
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	6e-05
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	6e-05
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	1e-04
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	1e-04
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	1e-04
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	2e-04
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	2e-04
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	3e-04
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	3e-04
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	4e-04
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	4e-04
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	0.001
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	0.001
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	0.001
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	0.001
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	0.002
cd08226	328	cd08226, PK_STRAD_beta, Pseudokinase domain of STE	0.004

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  278 bits (714), Expect = 2e-93
 Identities = 95/260 (36%), Positives = 144/260 (55%), Gaps = 16/260 (6%)

Query: 4   YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKID--ANVAREIINHKQLRHPNII 61
           YE+++ +G G+FG   L R+K T +LVA+K I++         + REI   K+L+HPNI+
Sbjct: 1   YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60

Query: 62  RFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-------QICH 114
           R  +V      L +VMEY  GG+LF+ +   GR SEDEAR++ +Q++S         I H
Sbjct: 61  RLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYLHSKGIVH 120

Query: 115 RDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLA 174
           RDLK EN LLD      +K+ DFG ++      +  + VGTP Y+APEVL  + Y     
Sbjct: 121 RDLKPENILLDED--GHVKLADFGLARQLDPGEKLTTFVGTPEYMAPEVLLGKGYGKA-V 177

Query: 175 DVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIP-DYVHISQDCRNLLSRI 233
           D+WS GV LY +L G  PF   +      +   +I   +   P     IS + ++L+ ++
Sbjct: 178 DIWSLGVILYELLTGKPPFPGDDQLL---ELFKKIGKPKPPFPPPEWDISPEAKDLIRKL 234

Query: 234 FVANPSRRITIKEIKSHPWF 253
            V +P +R+T +E   HP+F
Sbjct: 235 LVKDPEKRLTAEEALQHPFF 254

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  241 bits (618), Expect = 6e-79
 Identities = 101/263 (38%), Positives = 143/263 (54%), Gaps = 16/263 (6%)

Query: 4   YELMKDIGSGNFGVARLMRNKNTKELVAMKYI---ERGHKIDANVAREIINHKQLRHPNI 60
           YEL++ +GSG+FG     ++K T ++VA+K +       K D    REI   ++L HPNI
Sbjct: 1   YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNI 60

Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-------QIC 113
           +R  +      HL +VMEY  GG+LF+ +   G  SEDEA+    Q++ G        I 
Sbjct: 61  VRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLHSNGII 120

Query: 114 HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST-VGTPAYIAPEVLSRREYDGK 172
           HRDLK EN LLD +    +KI DFG +K  L  S   +T VGTP Y+APEVL      G 
Sbjct: 121 HRDLKPENILLDEN--GVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGGNGYGP 178

Query: 173 LADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVH--ISQDCRNLL 230
             DVWS GV LY +L G  PF   E+  +  + I RI+    +  +      S++ ++L+
Sbjct: 179 KVDVWSLGVILYELLTGKPPFSG-ENILDQLQLIRRILGPPLEFDEPKWSSGSEEAKDLI 237

Query: 231 SRIFVANPSRRITIKEIKSHPWF 253
            +    +PS+R T +EI  HPWF
Sbjct: 238 KKCLNKDPSKRPTAEEILQHPWF 260

Length = 260

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  193 bits (494), Expect = 5e-61
 Identities = 85/253 (33%), Positives = 121/253 (47%), Gaps = 49/253 (19%)

Query: 10  IGSGNFGVARLMRNKNTKELVAMKYIERGHKIDA--NVAREIINHKQLRHPNIIRFKEVV 67
           +G G FG   L R+K T + VA+K I++         + REI   K+L HPNI++   V 
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60

Query: 68  LTPTHLAIVMEYAAGGELFERIC-NAGRFSEDEARYFFQQLISG-------QICHRDLKL 119
               HL +VMEY  GG L + +  N G+ SEDE      Q++ G        I HRDLK 
Sbjct: 61  EDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKP 120

Query: 120 ENTLLDGSPAPRLKICDFGYSK-SSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLADVWS 178
           EN LLD S   ++K+ DFG SK  +   S  K+ VGTPAY+APEVL  + Y  + +D+WS
Sbjct: 121 ENILLD-SDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSDIWS 179

Query: 179 CGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANP 238
            GV LY +                                      + ++L+ ++   +P
Sbjct: 180 LGVILYEL-------------------------------------PELKDLIRKMLQKDP 202

Query: 239 SRRITIKEIKSHP 251
            +R + KEI  H 
Sbjct: 203 EKRPSAKEILEHL 215

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  191 bits (488), Expect = 2e-59
 Identities = 93/261 (35%), Positives = 140/261 (53%), Gaps = 28/261 (10%)

Query: 10  IGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQ----LRHPNIIRFKE 65
           +G G+FG   L+R K+T +L AMK +++   I        +  +     + HP I++   
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60

Query: 66  VVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-------QICHRDLK 118
              T   L +V+EYA GGELF  +   GRFSE+ AR++  +++          I +RDLK
Sbjct: 61  AFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLK 120

Query: 119 LENTLLD--GSPAPRLKICDFGYSKSSLLH-SRPKSTVGTPAYIAPEVLSRREYDGKLAD 175
            EN LLD  G     +K+ DFG +K      SR  +  GTP Y+APEVL  + Y GK  D
Sbjct: 121 PENILLDADG----HIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGKGY-GKAVD 175

Query: 176 VWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFV 235
            WS GV LY ML G  PF   ED K   +   +I+    + P+++  S + R+L+S +  
Sbjct: 176 WWSLGVLLYEMLTGKPPFYA-EDRK---EIYEKILKDPLRFPEFL--SPEARDLISGLLQ 229

Query: 236 ANPSRRIT---IKEIKSHPWF 253
            +P++R+     +EIK+HP+F
Sbjct: 230 KDPTKRLGSGGAEEIKAHPFF 250

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  190 bits (485), Expect = 5e-59
 Identities = 89/262 (33%), Positives = 134/262 (51%), Gaps = 27/262 (10%)

Query: 3   KYELMKDIGSGNFGVARLMRNKNTKELVAMKYI---ERGHKIDANVAREIINHKQLRHPN 59
           KYE++K IG G+FG   L+R K+  +L  +K I       K   +   E+   K+L HPN
Sbjct: 1   KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPN 60

Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGR----FSEDEARYFFQQLISG----- 110
           II++ E       L IVMEYA GG+L ++I    +    F E++   +F QL        
Sbjct: 61  IIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLH 120

Query: 111 --QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP--KSTVGTPAYIAPEVLSR 166
             +I HRD+K +N  L       +K+ DFG SK  L  +    K+ VGTP Y++PE+   
Sbjct: 121 SRKILHRDIKPQNIFLT--SNGLVKLGDFGISK-VLSSTVDLAKTVVGTPYYLSPELCQN 177

Query: 167 REYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYK-IPDYVHISQD 225
           + Y+ K +D+WS G  LY +    +PFE +    N  +   +I+  QY  IP     S +
Sbjct: 178 KPYNYK-SDIWSLGCVLYELCTLKHPFEGE----NLLELALKILKGQYPPIPS--QYSSE 230

Query: 226 CRNLLSRIFVANPSRRITIKEI 247
            RNL+S +   +P  R +I +I
Sbjct: 231 LRNLVSSLLQKDPEERPSIAQI 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  179 bits (456), Expect = 1e-54
 Identities = 83/268 (30%), Positives = 128/268 (47%), Gaps = 39/268 (14%)

Query: 10  IGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVA---REIINHKQLRHPNIIRFK-- 64
           +G G+FG   L  +K+T EL+A+K +E     +  +    REI     L+HPNI+R+   
Sbjct: 8   LGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGS 67

Query: 65  EVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-------QICHRDL 117
           E       L I +EY +GG L   +   G+  E   R + +Q++ G        I HRD+
Sbjct: 68  ERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDI 127

Query: 118 KLENTLLDGSPAPRLKICDFGYSK---SSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLA 174
           K  N L+D      +K+ DFG +K            S  GTP ++APEV+ R E  G+ A
Sbjct: 128 KGANILVDSD--GVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVI-RGEEYGRAA 184

Query: 175 DVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKI---------PDYVHISQD 225
           D+WS G T+  M  G  P+ +  +P          MA  YKI         P+  H+S++
Sbjct: 185 DIWSLGCTVIEMATGKPPWSELGNP----------MAALYKIGSSGEPPEIPE--HLSEE 232

Query: 226 CRNLLSRIFVANPSRRITIKEIKSHPWF 253
            ++ L +    +P +R T  E+  HP+ 
Sbjct: 233 AKDFLRKCLRRDPKKRPTADELLQHPFL 260

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score =  179 bits (457), Expect = 2e-54
 Identities = 87/281 (30%), Positives = 143/281 (50%), Gaps = 57/281 (20%)

Query: 4   YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQ--------- 54
           +E +K +G+G+FG   L+R+K + +  A+K + +          +I+  KQ         
Sbjct: 3   FEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSK---------AKIVKLKQVEHVLNEKR 53

Query: 55  ----LRHPNIIR----FKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYF--- 103
               +RHP ++     F++     ++L +VMEY  GGELF  +  +GRF E  AR++   
Sbjct: 54  ILQSIRHPFLVNLYGSFQD----DSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQ 109

Query: 104 ----FQQLISGQICHRDLKLENTLLD--GSPAPRLKICDFGYSKSSLLHSRPKSTVGTPA 157
                + L S  I +RDLK EN LLD  G     +KI DFG++K   +  R  +  GTP 
Sbjct: 110 VVLALEYLHSLDIVYRDLKPENLLLDSDGY----IKITDFGFAK--RVKGRTYTLCGTPE 163

Query: 158 YIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIP 217
           Y+APE++  + Y GK  D W+ G+ +Y ML G  PF D    + + K    I+  + + P
Sbjct: 164 YLAPEIILSKGY-GKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEK----ILEGKVRFP 218

Query: 218 DYVHISQDCRNLLSRIFVANPSRRI-----TIKEIKSHPWF 253
                S D ++L+  +   + ++R+      + +IK+HPWF
Sbjct: 219 --SFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWF 257

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score =  167 bits (424), Expect = 8e-50
 Identities = 85/267 (31%), Positives = 136/267 (50%), Gaps = 30/267 (11%)

Query: 10  IGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHK----QLRHPNIIRFKE 65
           I  G +G   L + K+T ++ A+K I++   I  N   +++  +    Q + P +++   
Sbjct: 1   ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYY 60

Query: 66  VVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLI-------SGQICHRDLK 118
                 +L +VMEY  GG+L   + N G   ED AR +  +++       S  I HRDLK
Sbjct: 61  SFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLK 120

Query: 119 LENTLLDGSPAPRLKICDFGYSKSSL------LHSRPKST---VGTPAYIAPEVLSRREY 169
            +N L+D +    LK+ DFG SK  L      L+   K     VGTP YIAPEV+  + +
Sbjct: 121 PDNILIDSN--GHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGH 178

Query: 170 DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 229
             K  D WS G  LY  LVG  PF      +   +    I+  + + P+ V +S +  +L
Sbjct: 179 -SKTVDWWSLGCILYEFLVGIPPFHG----ETPEEIFQNILNGKIEWPEDVEVSDEAIDL 233

Query: 230 LSRIFVANPSRRI---TIKEIKSHPWF 253
           +S++ V +P +R+   +I+EIK+HP+F
Sbjct: 234 ISKLLVPDPEKRLGAKSIEEIKNHPFF 260

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score =  165 bits (421), Expect = 4e-49
 Identities = 81/291 (27%), Positives = 133/291 (45%), Gaps = 54/291 (18%)

Query: 4   YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQL-----RHP 58
           ++  K IG G+F    L + K T +  A+K +++   I     + +   K++      HP
Sbjct: 3   FKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHP 62

Query: 59  NIIR----FKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG---- 110
            II+    F++      +L  V+EYA  GEL + I   G   E   R++  +++      
Sbjct: 63  GIIKLYYTFQD----EENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYL 118

Query: 111 ---QICHRDLKLENTLLDGSPAPRLKICDFGYSK---------------------SSLLH 146
               I HRDLK EN LLD      +KI DFG +K                          
Sbjct: 119 HSKGIIHRDLKPENILLDKD--MHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNR 176

Query: 147 SRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTI 206
            R  S VGT  Y++PE+L+ +   GK +D+W+ G  +Y ML G  PF    +   F+K  
Sbjct: 177 RRFASFVGTAEYVSPELLNEKPA-GKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQK-- 233

Query: 207 SRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIK----EIKSHPWF 253
             I+ ++Y  P   +   D ++L+ ++ V +P  R+ +     E+K+HP+F
Sbjct: 234 --ILKLEYSFPP--NFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF 280

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  160 bits (407), Expect = 2e-47
 Identities = 77/262 (29%), Positives = 129/262 (49%), Gaps = 21/262 (8%)

Query: 3   KYELMKDIGSGNFGVARLMRNKNTKELVAMKYI-ERGHKIDANVAREIINHKQLRHPNII 61
            +E+++ IG G FG     R+K T + VA+K I     +    +  EI   K+ +HPNI+
Sbjct: 1   LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIV 60

Query: 62  RFKEVVLTPTHLAIVMEYAAGGELFERICNAGR-FSEDEARYFFQQLISG-------QIC 113
           ++    L    L IVME+ +GG L + + +  +  +E +  Y  ++L+ G        I 
Sbjct: 61  KYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGII 120

Query: 114 HRDLKLENTLL--DGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDG 171
           HRD+K  N LL  DG     +K+ DFG S          + VGTP ++APEV++ + YD 
Sbjct: 121 HRDIKAANILLTSDGE----VKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVINGKPYDY 176

Query: 172 KLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAV-QYKIPDYVHISQDCRNLL 230
           K AD+WS G+T   +  G  P+ +        K + +I       + +    S + ++ L
Sbjct: 177 K-ADIWSLGITAIELAEGKPPYSEL----PPMKALFKIATNGPPGLRNPEKWSDEFKDFL 231

Query: 231 SRIFVANPSRRITIKEIKSHPW 252
            +    NP +R T +++  HP+
Sbjct: 232 KKCLQKNPEKRPTAEQLLKHPF 253

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score =  158 bits (402), Expect = 1e-46
 Identities = 83/263 (31%), Positives = 135/263 (51%), Gaps = 27/263 (10%)

Query: 10  IGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQ----LRHPNIIRFKE 65
           +G G FG   L++ K+     A+K +++ H ++      I + K+      HP I++   
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60

Query: 66  VVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYF-------FQQLISGQICHRDLK 118
                 ++ ++MEY  GGEL+  + + G F E  AR++       F+ L +  I +RDLK
Sbjct: 61  TFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLK 120

Query: 119 LENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLADVWS 178
            EN LLD +    +K+ DFG++K      +  +  GTP Y+APE++  + YD    D WS
Sbjct: 121 PENLLLDSNG--YVKLVDFGFAKKLKSGQKTWTFCGTPEYVAPEIILNKGYD-FSVDYWS 177

Query: 179 CGVTLYVMLVGAYPF-EDQEDPKNFRKTISRIMAVQYKI--PDYVHISQDCRNLLSRIFV 235
            G+ LY +L G  PF ED EDP    +  + I+    K+  P+Y  I +  ++L+ ++  
Sbjct: 178 LGILLYELLTGRPPFGEDDEDP---MEIYNDILKGNGKLEFPNY--IDKAAKDLIKQLLR 232

Query: 236 ANPSRRI-----TIKEIKSHPWF 253
            NP  R+      IK+IK H WF
Sbjct: 233 RNPEERLGNLKGGIKDIKKHKWF 255

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score =  149 bits (379), Expect = 1e-42
 Identities = 95/298 (31%), Positives = 140/298 (46%), Gaps = 41/298 (13%)

Query: 8   KDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINH--------KQLRHPN 59
           K +G G FG   L+R K T +  AMK +    K +  +A++ + H        +  RHP 
Sbjct: 1   KLLGKGTFGKVILVREKATGKYYAMKIL----KKEVIIAKDEVAHTLTESRVLQNTRHPF 56

Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLIS-------GQI 112
           +   K    T   L  VMEYA GGELF  +     FSED AR++  +++S         +
Sbjct: 57  LTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDV 116

Query: 113 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST-VGTPAYIAPEVLSRREYDG 171
            +RDLKLEN +LD      +KI DFG  K  +       T  GTP Y+APEVL   +Y G
Sbjct: 117 VYRDLKLENLMLDKD--GHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDY-G 173

Query: 172 KLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLS 231
           +  D W  GV +Y M+ G  PF +Q+  K F      I+  + + P    +S + ++LL+
Sbjct: 174 RAVDWWGLGVVMYEMMCGRLPFYNQDHEKLF----ELILMEEIRFPR--TLSPEAKSLLA 227

Query: 232 RIFVANPSRRI-----TIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTFSLQSVEE 284
            +   +P +R+       KEI  H +F        +   Q +  +K  P F  Q   E
Sbjct: 228 GLLKKDPKQRLGGGPEDAKEIMEHRFF-------ASINWQDVVQKKLEPPFKPQVTSE 278

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score =  148 bits (375), Expect = 1e-42
 Identities = 80/269 (29%), Positives = 132/269 (49%), Gaps = 25/269 (9%)

Query: 3   KYELMKDIGSGNFGVARLMRNKNTKELVAMKYI--ERG-HKIDANVAREIINHKQLRHPN 59
           +++    IG G FG      N +T EL+A+K I  +    K    +A E+   + L+HPN
Sbjct: 1   RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPN 60

Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEA--RYFFQQLISG------- 110
           ++++  V +    + I MEY +GG L E +   GR   DE   R +  QL+ G       
Sbjct: 61  LVKYYGVEVHREKVYIFMEYCSGGTL-EELLEHGRI-LDEHVIRVYTLQLLEGLAYLHSH 118

Query: 111 QICHRDLKLENTLLDGSPAPRLKICDFGYSK-----SSLLHSRPKSTVGTPAYIAPEVLS 165
            I HRD+K  N  LD +    +K+ DFG +      ++ +    +S  GTPAY+APEV++
Sbjct: 119 GIVHRDIKPANIFLDHNGV--IKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVIT 176

Query: 166 RREYDGKL--ADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHIS 223
             +  G    AD+WS G  +  M  G  P+ + ++   F+         +  IPD + +S
Sbjct: 177 GGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDN--EFQIMFHVGAGHKPPIPDSLQLS 234

Query: 224 QDCRNLLSRIFVANPSRRITIKEIKSHPW 252
            + ++ L R   ++P +R T  E+  HP+
Sbjct: 235 PEGKDFLDRCLESDPKKRPTASELLQHPF 263

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  147 bits (373), Expect = 2e-42
 Identities = 86/273 (31%), Positives = 127/273 (46%), Gaps = 41/273 (15%)

Query: 3   KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINH----KQLRHP 58
            Y+L   IG G FGV     N  T + VA+K I    KI     + I+      K L+HP
Sbjct: 1   NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISL-EKIKEEALKSIMQEIDLLKNLKHP 59

Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDE-ARYFFQQL-----ISGQ- 111
           NI+++   + T   L I++EYA  G L + I   G F E   A Y +Q L     +  Q 
Sbjct: 60  NIVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQG 119

Query: 112 ICHRDLKLENTLL--DGSPAPRLKICDFGYS-KSSLLHSRPKSTVGTPAYIAPEVLSRRE 168
           + HRD+K  N L   DG     +K+ DFG + K + +     S VGTP ++APEV+    
Sbjct: 120 VIHRDIKAANILTTKDGV----VKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEMSG 175

Query: 169 YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKI--------PDYV 220
                +D+WS G T+  +L G  P+ D              MA  ++I        P+  
Sbjct: 176 ASTA-SDIWSLGCTVIELLTGNPPYYDLNP-----------MAALFRIVQDDHPPLPE-- 221

Query: 221 HISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 253
            IS + ++ L + F  +P+ R T K++  HPW 
Sbjct: 222 GISPELKDFLMQCFQKDPNLRPTAKQLLKHPWI 254

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score =  149 bits (378), Expect = 4e-42
 Identities = 91/309 (29%), Positives = 139/309 (44%), Gaps = 78/309 (25%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNII 61
           + +E++K IG G FG   L+R+K+T ++ AMK + +          ++I   Q+ H   +
Sbjct: 1   DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRK---------SDMIKRNQIAH---V 48

Query: 62  RFKEVVLTPT----------------HLAIVMEYAAGGELFERICNAGRFSEDEARYFFQ 105
           R +  +L                   HL +VMEY  GG+L   +     F E+ AR++  
Sbjct: 49  RAERDILADADSPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIA 108

Query: 106 QLIS--------GQICHRDLKLENTLLDGSPAPRLKICDFGYSK---------------- 141
           +L+         G I HRD+K +N L+D      +K+ DFG  K                
Sbjct: 109 ELVLALDSVHKLGFI-HRDIKPDNILIDADG--HIKLADFGLCKKMNKAKDREYYLNDSH 165

Query: 142 ------SSLLHSRPK--------STVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVML 187
                 + L+  R          STVGTP YIAPEVL    Y G   D WS GV LY ML
Sbjct: 166 NLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPY-GLECDWWSLGVILYEML 224

Query: 188 VGAYPFEDQEDPKNFRKTISRIMAVQ--YKIPDYVHISQDCRNLLSRIFVANPSRRIT-I 244
            G  PF         ++T ++I+  +   + P    +S +  +L+ R  + +P  R+   
Sbjct: 225 YGFPPFYSD----TLQETYNKIINWKESLRFPPDPPVSPEAIDLICR-LLCDPEDRLGSF 279

Query: 245 KEIKSHPWF 253
           +EIKSHP+F
Sbjct: 280 EEIKSHPFF 288

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  148 bits (374), Expect = 2e-41
 Identities = 86/331 (25%), Positives = 144/331 (43%), Gaps = 37/331 (11%)

Query: 3   KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDAN----VAREIINHKQLRHP 58
            Y +++ +G G+FG   L R++   +LVA+K + +  +  +       REI     L HP
Sbjct: 1   SYRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHP 57

Query: 59  -NIIRFKEVVLTPTHLAIVMEYAAGGELFERICN---AGRFSEDEARYFFQQLISG---- 110
            NI++  +       L +VMEY  GG L + +      G  SE EA +   Q++S     
Sbjct: 58  PNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYL 117

Query: 111 ---QICHRDLKLENTLLDGSPAPRLKICDFGYSK-------SSLLHSRPKSTVGTPAYIA 160
               I HRD+K EN LLD      +K+ DFG +K       +S + + P ++VGTP Y+A
Sbjct: 118 HSKGIIHRDIKPENILLD-RDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMA 176

Query: 161 PEVLS--RREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRI-------MA 211
           PEVL      Y    +D+WS G+TLY +L G  PFE +++     +T+  I       +A
Sbjct: 177 PEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLA 236

Query: 212 VQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLPRELTETAQAIYYR 271
                 +   IS+   +LL ++   +P  R++     SH        +        +   
Sbjct: 237 SPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLL--AHLKLKESDLSDLLKP 294

Query: 272 KENPTFSLQSVEEITKIVEEAKVPPPVSRSI 302
            ++    L     +  ++            +
Sbjct: 295 DDSAPLRLSLPPSLEALISSLNSLAISGSDL 325

Length = 384

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score =  145 bits (367), Expect = 7e-41
 Identities = 87/262 (33%), Positives = 133/262 (50%), Gaps = 27/262 (10%)

Query: 10  IGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQL-----RHPNIIRFK 64
           +G G+FG   L   K T EL A+K +++   +  +     +  K++     +HP + +  
Sbjct: 3   LGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLH 62

Query: 65  EVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-------QICHRDL 117
               T   L  VMEY  GG+L   I  +GRF E  AR++  +++ G        I +RDL
Sbjct: 63  SCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDL 122

Query: 118 KLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST-VGTPAYIAPEVLSRREYDGKLADV 176
           KL+N LLD      +KI DFG  K  +L     ST  GTP YIAPE+LS + Y G   D 
Sbjct: 123 KLDNVLLDSE--GHIKIADFGMCKEGILGGVTTSTFCGTPDYIAPEILSYQPY-GPAVDW 179

Query: 177 WSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVA 236
           W+ GV LY ML G  PFE  ++ + F+     I+  + + P    +S++ +++L      
Sbjct: 180 WALGVLLYEMLAGQSPFEGDDEDELFQS----ILEDEVRYP--RWLSKEAKSILKSFLTK 233

Query: 237 NPSRRITI-----KEIKSHPWF 253
           NP +R+       ++IK HP+F
Sbjct: 234 NPEKRLGCLPTGEQDIKGHPFF 255

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score =  143 bits (362), Expect = 9e-41
 Identities = 72/267 (26%), Positives = 134/267 (50%), Gaps = 27/267 (10%)

Query: 4   YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQ----LRHPN 59
           +EL++ IG G FG   +++ ++TK++ AMKY+ +   ++    R ++N ++    L HP 
Sbjct: 2   FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPF 61

Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-------QI 112
           ++          ++ +V++   GG+L   +    +FSE++ +++  +++          I
Sbjct: 62  LVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGI 121

Query: 113 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST--VGTPAYIAPEVLSRREYD 170
            HRD+K +N LLD      + I DF    ++ +     +T   GTP Y+APEVL R+ Y 
Sbjct: 122 IHRDIKPDNILLDEQ--GHVHITDFNI--ATKVTPDTLTTSTSGTPGYMAPEVLCRQGY- 176

Query: 171 GKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQ-YKIPDY-VHISQDCRN 228
               D WS GVT Y  L G  P+       + R    +I A Q      Y    S +  +
Sbjct: 177 SVAVDWWSLGVTAYECLRGKRPYR-----GHSRTIRDQIRAKQETADVLYPATWSTEAID 231

Query: 229 LLSRIFVANPSRRI--TIKEIKSHPWF 253
            ++++   +P +R+   +K++K+HP+F
Sbjct: 232 AINKLLERDPQKRLGDNLKDLKNHPYF 258

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  140 bits (354), Expect = 3e-39
 Identities = 85/281 (30%), Positives = 138/281 (49%), Gaps = 27/281 (9%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNII 61
           E Y+ ++ IG G  G      ++ T + VA+K +    +    +  EI+  K  +HPNI+
Sbjct: 19  ELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIV 78

Query: 62  RFKEVVLTPTHLAIVMEYAAGGELFERI-CNAGRFSEDEARYFFQQLISG-------QIC 113
            + +  L    L +VMEY  GG L + I  N  R +E +  Y  ++++ G        + 
Sbjct: 79  DYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVI 138

Query: 114 HRDLKLENTLL--DGSPAPRLKICDFGYS-KSSLLHSRPKSTVGTPAYIAPEVLSRREYD 170
           HRD+K +N LL  DGS    +K+ DFG++ + +   S+  S VGTP ++APEV+ R++Y 
Sbjct: 139 HRDIKSDNILLSKDGS----VKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVIKRKDYG 194

Query: 171 GKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHI---SQDCR 227
            K  D+WS G+    M  G  P+   E P      I+        IP   +    S + +
Sbjct: 195 PK-VDIWSLGIMCIEMAEGEPPYLR-EPPLRALFLIT-----TKGIPPLKNPEKWSPEFK 247

Query: 228 NLLSRIFVANPSRRITIKEIKSHPWFLKNLPRELTETAQAI 268
           + L++  V +P +R + +E+  HP FLK       E A  I
Sbjct: 248 DFLNKCLVKDPEKRPSAEELLQHP-FLKK-ACPKEEFAPLI 286

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score =  139 bits (352), Expect = 5e-39
 Identities = 80/286 (27%), Positives = 128/286 (44%), Gaps = 40/286 (13%)

Query: 4   YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKID---ANVAREIINHKQLRHPNI 60
           YE ++ +G G +GV    R+K T E+VA+K I   ++ +   +   REI   K+L+HPNI
Sbjct: 1   YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNI 60

Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFERICN-AGRFSEDEARYFFQQLISG-------QI 112
           ++  +V+ T   L +V EY    +L + +    G  S +  +    QL+ G       +I
Sbjct: 61  VKLLDVIHTERKLYLVFEYCD-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRI 119

Query: 113 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST-VGTPAYIAPEVL-SRREYD 170
            HRDLK +N L++      LK+ DFG +++  +  R  +  V T  Y APE+L   + Y 
Sbjct: 120 LHRDLKPQNILINRD--GVLKLADFGLARAFGIPLRTYTHEVVTLWYRAPEILLGSKHYS 177

Query: 171 GKLADVWSCGVTLYVMLVGAYPF-----EDQ-------------EDPKNFRK--TISRIM 210
             + D+WS G     M+ G   F      DQ             E      K        
Sbjct: 178 TAV-DIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTF 236

Query: 211 AVQYKIPDYVHIS---QDCRNLLSRIFVANPSRRITIKEIKSHPWF 253
                      +     +  +LLS++   NP++RI+ KE   HP+F
Sbjct: 237 PKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score =  138 bits (348), Expect = 8e-39
 Identities = 92/261 (35%), Positives = 127/261 (48%), Gaps = 19/261 (7%)

Query: 3   KYELMKDIGSGNFGVARLMRNKNTKELVAMKYI--ERGHKIDANVAREIIN-HKQLRHPN 59
           KYE ++ +G G FG+  L R K  ++LV +K I  E+  K +   A+      K L HPN
Sbjct: 1   KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPN 60

Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGR--FSEDEARYFFQQLI-------SG 110
           II + E  L    L IVMEYA GG L E I         ED   +FF Q++       + 
Sbjct: 61  IIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTK 120

Query: 111 QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYD 170
            I HRDLK +N LLD      +KI DFG SK     S+  + VGTP YI+PE+   + Y+
Sbjct: 121 LILHRDLKTQNILLDKHKMV-VKIGDFGISKILSSKSKAYTVVGTPCYISPELCEGKPYN 179

Query: 171 GKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLL 230
            K +D+W+ G  LY +      FE    P    K +S   A     P     S D R L+
Sbjct: 180 QK-SDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFA-----PISDRYSPDLRQLI 233

Query: 231 SRIFVANPSRRITIKEIKSHP 251
             +   +PS+R  + +I + P
Sbjct: 234 LSMLNLDPSKRPQLSQIMAQP 254

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score =  137 bits (347), Expect = 3e-38
 Identities = 84/286 (29%), Positives = 128/286 (44%), Gaps = 39/286 (13%)

Query: 4   YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH--KIDANVA-REIINHKQLRHPNI 60
           Y+ +  IG G +GV    R+K T E+VA+K I+     +     A REI   K+L HPNI
Sbjct: 1   YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNI 60

Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFERICNAGR-FSEDEARYFFQQLISG-------QI 112
           I+  +V      L +V E+    +L++ I +  R   E   + +  QL+ G        I
Sbjct: 61  IKLLDVFRHKGDLYLVFEFMD-TDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGI 119

Query: 113 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST-VGTPAYIAPEVLSRREYDG 171
            HRDLK EN L++      LK+ DFG ++S     RP +  V T  Y APE+L   +   
Sbjct: 120 LHRDLKPENLLINTEGV--LKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLGDKGYS 177

Query: 172 KLADVWSCGVTLYVMLVGAYPFE-----DQ----------EDPKNFRKTISRIMAVQYKI 216
              D+WS G     +L     F      DQ           DP+ + K  S     ++  
Sbjct: 178 TPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSF 237

Query: 217 PDYVHI---------SQDCRNLLSRIFVANPSRRITIKEIKSHPWF 253
           P    +         S    +LLS++   +P +RIT ++  +HP+F
Sbjct: 238 PKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score =  136 bits (345), Expect = 3e-38
 Identities = 75/275 (27%), Positives = 134/275 (48%), Gaps = 38/275 (13%)

Query: 3   KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINH----KQLRHP 58
            YE+++ IG G+FG  R +R K+  +++  K I+ G+ +     +++++     ++L+HP
Sbjct: 1   DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGN-MTEKEKQQLVSEVNILRELKHP 59

Query: 59  NIIRF--KEVVLTPTHLAIVMEYAAGGELFERICNA----GRFSEDEARYFFQQLI---- 108
           NI+R+  + +  +   L IVMEY  GG+L + I           E+       QL+    
Sbjct: 60  NIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALY 119

Query: 109 --------SGQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR---PKSTVGTPA 157
                      + HRDLK  N  LD +    +K+ DFG +K  +L       K+ VGTP 
Sbjct: 120 ECHNRSDPGNTVLHRDLKPANIFLDANNN--VKLGDFGLAK--ILGHDSSFAKTYVGTPY 175

Query: 158 YIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQY-KI 216
           Y++PE L+   YD K +D+WS G  +Y +   + PF      +N  +  S+I   ++ +I
Sbjct: 176 YMSPEQLNHMSYDEK-SDIWSLGCLIYELCALSPPFT----ARNQLQLASKIKEGKFRRI 230

Query: 217 PDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHP 251
           P     S +   ++  +   +P +R + +E+   P
Sbjct: 231 PY--RYSSELNEVIKSMLNVDPDKRPSTEELLQLP 263

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score =  137 bits (347), Expect = 5e-38
 Identities = 88/295 (29%), Positives = 136/295 (46%), Gaps = 50/295 (16%)

Query: 4   YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQ----LRHPN 59
           ++ +K +G G+ G   L+R K T +L A+K +++   I  N  + ++  ++    L HP 
Sbjct: 3   FKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPF 62

Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFE--RICNAGRFSEDEARYFFQQLISG------- 110
           +        T T+L +VM+Y  GGELF   +       SE+ AR++  +++         
Sbjct: 63  LPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLL 122

Query: 111 QICHRDLKLENTLLDGS-----------------PAPRLKICDFGYSKSSLLHS------ 147
            I +RDLK EN LL  S                 P P  K    G  +SS+         
Sbjct: 123 GIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFS 182

Query: 148 -----RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNF 202
                R  S VGT  YIAPEV+S   +   + D W+ G+ LY ML G  PF+      N 
Sbjct: 183 EEPSFRSNSFVGTEEYIAPEVISGDGHGSAV-DWWTLGILLYEMLYGTTPFKG----SNR 237

Query: 203 RKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIK----EIKSHPWF 253
            +T S I+  +   P    +S   R+L+ ++ V +PS+R+  K    EIK HP+F
Sbjct: 238 DETFSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFF 292

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score =  135 bits (342), Expect = 1e-37
 Identities = 83/268 (30%), Positives = 137/268 (51%), Gaps = 27/268 (10%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHK----QLRH 57
           +  E +K +G+G FG   L+R++ ++   A+K +     I     + + N K    ++ H
Sbjct: 1   DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSH 60

Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLI-------SG 110
           P IIR          L ++MEY  GGELF  + N+GRFS     ++  +++       S 
Sbjct: 61  PFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSK 120

Query: 111 QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYD 170
           +I +RDLK EN LLD      +K+ DFG++K   L  R  +  GTP Y+APEV+  + + 
Sbjct: 121 EIVYRDLKPENILLDKE--GHIKLTDFGFAKK--LRDRTWTLCGTPEYLAPEVIQSKGH- 175

Query: 171 GKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLL 230
            K  D W+ G+ +Y MLVG  PF D     N      +I+A + + P   H+    ++L+
Sbjct: 176 NKAVDWWALGILIYEMLVGYPPFFD----DNPFGIYEKILAGKLEFPR--HLDLYAKDLI 229

Query: 231 SRIFVANPSRRI-----TIKEIKSHPWF 253
            ++ V + +RR+        ++K+H WF
Sbjct: 230 KKLLVVDRTRRLGNMKNGADDVKNHRWF 257

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score =  135 bits (341), Expect = 3e-37
 Identities = 96/325 (29%), Positives = 157/325 (48%), Gaps = 40/325 (12%)

Query: 10  IGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHK--------QLRHPNII 61
           IG G+FG    +R ++T+ + A+K I + H     V+R  + H         Q+  P I+
Sbjct: 1   IGKGSFGKVMQVRKRDTQRIYALKTIRKAHI----VSRSEVTHTLAERTVLAQVNCPFIV 56

Query: 62  RFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLI-------SGQICH 114
             K    +P  L +V+ +  GGELF  +   GRF    AR++  +L+          + +
Sbjct: 57  PLKFSFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIY 116

Query: 115 RDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST-VGTPAYIAPEVLSRREYDGKL 173
           RDLK EN LLD      + +CDFG  K ++      +T  GTP Y+APE+L    Y  K 
Sbjct: 117 RDLKPENILLD--YQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHGYT-KA 173

Query: 174 ADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRI 233
            D W+ GV LY ML G  PF D+   + +RK    I+    + PD     +D ++LL  +
Sbjct: 174 VDWWTLGVLLYEMLTGLPPFYDENVNEMYRK----ILQEPLRFPD--GFDRDAKDLLIGL 227

Query: 234 FVANPSRRITI---KEIKSHPWFLK-NLPRELTETAQ-----AIYYRKENPTFSLQSVEE 284
              +P+RR+     +EIK+HP+F + +  + L +  Q     A+    +   F  +   E
Sbjct: 228 LSRDPTRRLGYNGAQEIKNHPFFSQLSWKKLLMKGIQPPFKPAVSSAIDTSNFDEEFTRE 287

Query: 285 --ITKIVEEAKVPPPVSRSIGGFGW 307
             I  +V+++ +   V +  GG+ +
Sbjct: 288 KPIDSVVDDSHLSETVQQQFGGWSY 312

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score =  134 bits (340), Expect = 8e-37
 Identities = 82/277 (29%), Positives = 141/277 (50%), Gaps = 37/277 (13%)

Query: 4   YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHK----QLRHPN 59
           ++++  +G G +G   L + K+T E+VA+K +++      N  R ++  +      +   
Sbjct: 3   FQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEW 62

Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-------QI 112
           +++         +L + MEY  GG+    + N G  SED AR++  ++            
Sbjct: 63  LVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGY 122

Query: 113 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGK 172
            HRDLK EN L+D S    +K+ DFG SK  +  +   S VG+P Y+APEVL  + YD  
Sbjct: 123 IHRDLKPENFLIDASG--HIKLTDFGLSKGIV--TYANSVVGSPDYMAPEVLRGKGYDFT 178

Query: 173 LADVWSCGVTLYVMLVGAYPF------EDQEDPKNFRKTISRIMAVQYKIPDYV----HI 222
           + D WS G  LY  L G  PF      E  E+ K +++T+ R        P Y     ++
Sbjct: 179 V-DYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQR--------PVYDDPRFNL 229

Query: 223 SQDCRNLLSRIFVANPSRRI-TIKEIKSHPWFLKNLP 258
           S +  +L++++ + +PSRR  ++++IK+HP+F K + 
Sbjct: 230 SDEAWDLITKL-INDPSRRFGSLEDIKNHPFF-KEVD 264

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  131 bits (332), Expect = 3e-36
 Identities = 74/264 (28%), Positives = 119/264 (45%), Gaps = 25/264 (9%)

Query: 5   ELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDA--NVAREIINHKQLR---HPN 59
           E +K +G G+ GV   +R+K T ++ A+K I      +    + RE+   K LR    P 
Sbjct: 4   ERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLREL---KTLRSCESPY 60

Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG--------Q 111
           +++          ++IV+EY  GG L + +   G+  E    Y  +Q++ G         
Sbjct: 61  VVKCYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRH 120

Query: 112 ICHRDLKLENTLL--DGSPAPRLKICDFGYSKSSLLHSRPKST-VGTPAYIAPEVLSRRE 168
           I HRD+K  N L+   G      KI DFG SK         +T VGT  Y++PE + + E
Sbjct: 121 IIHRDIKPSNLLINSKGEV----KIADFGISKVLENTLDQCNTFVGTVTYMSPERI-QGE 175

Query: 169 YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRN 228
                AD+WS G+TL    +G +PF     P +F + +  I             S + R+
Sbjct: 176 SYSYAADIWSLGLTLLECALGKFPFLPPGQP-SFFELMQAICDGPPPSLPAEEFSPEFRD 234

Query: 229 LLSRIFVANPSRRITIKEIKSHPW 252
            +S     +P +R +  E+  HP+
Sbjct: 235 FISACLQKDPKKRPSAAELLQHPF 258

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score =  133 bits (336), Expect = 3e-36
 Identities = 87/275 (31%), Positives = 142/275 (51%), Gaps = 45/275 (16%)

Query: 4   YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQ--------- 54
           +E+ + +G+G+FG  R+ ++K T E  A+K +++         REI+  KQ         
Sbjct: 20  FEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKK---------REILKMKQVQHVAQEKS 70

Query: 55  ----LRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYF------- 103
               L HP I+           +  ++E+  GGELF  +  AGRF  D A+++       
Sbjct: 71  ILMELSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLA 130

Query: 104 FQQLISGQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEV 163
           F+ L S  I +RDLK EN LLD      +K+ DFG++K   +  R  +  GTP Y+APEV
Sbjct: 131 FEYLHSKDIIYRDLKPENLLLDNK--GHVKVTDFGFAKK--VPDRTFTLCGTPEYLAPEV 186

Query: 164 LSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHIS 223
           +  + + GK  D W+ GV LY  + G  PF D + P  FR    +I+A + K P++    
Sbjct: 187 IQSKGH-GKAVDWWTMGVLLYEFIAGYPPFFD-DTP--FR-IYEKILAGRLKFPNWF--D 239

Query: 224 QDCRNLLSRIFVANPSRRI-TIK----EIKSHPWF 253
              R+L+  +   + ++R+ T+K    ++K+HP+F
Sbjct: 240 GRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYF 274

Length = 329

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score =  132 bits (335), Expect = 3e-36
 Identities = 88/261 (33%), Positives = 138/261 (52%), Gaps = 25/261 (9%)

Query: 8   KDIGSGNFGVARLMRNKNTKELVAMKYIERGHK-IDANVAREIINHKQL----RHPNIIR 62
           K +G G+FG   L   K T E  A+K +++     D +V   ++  + L     HP +  
Sbjct: 1   KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTH 60

Query: 63  FKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-------QICHR 115
                 T  HL  VMEY  GG+L   I ++GRF E  AR++  ++I G        I +R
Sbjct: 61  LFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYR 120

Query: 116 DLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST-VGTPAYIAPEVLSRREYDGKLA 174
           DLKL+N LLD      +KI DFG  K ++      ST  GTP YIAPE+L  ++Y+  + 
Sbjct: 121 DLKLDNVLLDKD--GHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKGQKYNESV- 177

Query: 175 DVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDY-VHISQDCRNLLSRI 233
           D WS GV LY ML+G  PF  +++ + F        ++    P +   IS++ ++ LS++
Sbjct: 178 DWWSFGVLLYEMLIGQSPFHGEDEDELFD-------SILNDRPHFPRWISKEAKDCLSKL 230

Query: 234 FVANPSRRITIK-EIKSHPWF 253
           F  +P++R+ +  +I+ HP+F
Sbjct: 231 FERDPTKRLGVDGDIRQHPFF 251

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score =  129 bits (327), Expect = 9e-36
 Identities = 83/265 (31%), Positives = 137/265 (51%), Gaps = 27/265 (10%)

Query: 3   KYELMKDIGSGNFGVARLMRNKNTKELVAMKYI---ERGHKIDANVAREIINHKQLRHPN 59
           KY  +K IG G+FG A L+++K   +   +K I   +   K      +E+     ++HPN
Sbjct: 1   KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPN 60

Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGR---FSEDEARYFFQQLISG------ 110
           I++++E      +L IVM+Y  GG+L+++I NA R   F ED+   +F Q+         
Sbjct: 61  IVQYQESFEENGNLYIVMDYCEGGDLYKKI-NAQRGVLFPEDQILDWFVQICLALKHVHD 119

Query: 111 -QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR---PKSTVGTPAYIAPEVLSR 166
            +I HRD+K +N  L       +K+ DFG ++  +L+S     ++ +GTP Y++PE+   
Sbjct: 120 RKILHRDIKSQNIFLTKDGT--IKLGDFGIAR--VLNSTVELARTCIGTPYYLSPEICEN 175

Query: 167 REYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDC 226
           R Y+ K +D+W+ G  LY M    + FE      N +  + +I+   Y  P   H S D 
Sbjct: 176 RPYNNK-SDIWALGCVLYEMCTLKHAFE----AGNMKNLVLKIIRGSYP-PVSSHYSYDL 229

Query: 227 RNLLSRIFVANPSRRITIKEIKSHP 251
           RNL+S++F  NP  R ++  I    
Sbjct: 230 RNLVSQLFKRNPRDRPSVNSILEKN 254

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score =  131 bits (332), Expect = 1e-35
 Identities = 94/311 (30%), Positives = 150/311 (48%), Gaps = 39/311 (12%)

Query: 10  IGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQL-------RHPNIIR 62
           +G G+FG   L   K T EL A+K +++G  I  +    ++  K++       RHP ++ 
Sbjct: 7   LGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVN 66

Query: 63  FKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYF-------FQQLISGQICHR 115
                 T  H+  VMEYAAGG+L   I +   FSE  A ++        Q L   +I +R
Sbjct: 67  LFACFQTEDHVCFVMEYAAGGDLMMHI-HTDVFSEPRAVFYAACVVLGLQYLHENKIVYR 125

Query: 116 DLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST-VGTPAYIAPEVLSRREYDGKLA 174
           DLKL+N LLD      +KI DFG  K  +      ST  GTP ++APEVL+   Y  +  
Sbjct: 126 DLKLDNLLLD--TEGFVKIADFGLCKEGMGFGDRTSTFCGTPEFLAPEVLTETSY-TRAV 182

Query: 175 DVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIF 234
           D W  GV +Y MLVG  PF   ++ + F   ++    V+Y       +S++  +++ R+ 
Sbjct: 183 DWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVN--DEVRYPR----FLSREAISIMRRLL 236

Query: 235 VANPSRRI-----TIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTF--SLQSVEEITK 287
             NP RR+       +++K  P+F +++          +  RK  P F  +++  E+++ 
Sbjct: 237 RRNPERRLGSGEKDAEDVKKQPFF-RDI------NWDDLLARKIKPPFVPTIKGPEDVSN 289

Query: 288 IVEEAKVPPPV 298
             EE     PV
Sbjct: 290 FDEEFTSEAPV 300

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score =  130 bits (329), Expect = 1e-35
 Identities = 79/274 (28%), Positives = 127/274 (46%), Gaps = 37/274 (13%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKID--ANVAREIINHKQLRHPN 59
           E + L++ IG G+FG      +K T ++VA+K I+     D   ++ +EI    Q R P 
Sbjct: 1   ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPY 60

Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGQIC------ 113
           I ++    L  + L I+MEY  GG   + +   G+  E    +  ++++ G         
Sbjct: 61  ITKYYGSFLKGSKLWIIMEYCGGGSCLDLL-KPGKLDETYIAFILREVLLGLEYLHEEGK 119

Query: 114 -HRDLKLENTLL--DGSPAPRLKICDFGYSKS-SLLHSRPKSTVGTPAYIAPEVLSRREY 169
            HRD+K  N LL  +G     +K+ DFG S   +   S+  + VGTP ++APEV+ +  Y
Sbjct: 120 IHRDIKAANILLSEEGD----VKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVIKQSGY 175

Query: 170 DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIP-------DYVHI 222
           D K AD+WS G+T   +  G  P  D   P          M V + IP       +    
Sbjct: 176 DEK-ADIWSLGITAIELAKGEPPLSDL-HP----------MRVLFLIPKNNPPSLEGNKF 223

Query: 223 SQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKN 256
           S+  ++ +S     +P  R + KE+  H  F+K 
Sbjct: 224 SKPFKDFVSLCLNKDPKERPSAKELLKHK-FIKK 256

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score =  131 bits (330), Expect = 1e-35
 Identities = 98/298 (32%), Positives = 144/298 (48%), Gaps = 41/298 (13%)

Query: 8   KDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINH--------KQLRHPN 59
           K +G G FG   L+R K + +  AMK +++    +  +A++ + H        K  RHP 
Sbjct: 1   KLLGKGTFGKVILVREKASGKYYAMKILKK----EVIIAKDEVAHTLTESRVLKNTRHPF 56

Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLI-------SGQI 112
           +   K    T   L  VMEY  GGELF  +     FSED  R++  +++       SG+I
Sbjct: 57  LTSLKYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKI 116

Query: 113 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP-KSTVGTPAYIAPEVLSRREYDG 171
            +RDLKLEN +LD      +KI DFG  K  +  +   K+  GTP Y+APEVL   +Y G
Sbjct: 117 VYRDLKLENLMLDKD--GHIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLEDNDY-G 173

Query: 172 KLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLS 231
           +  D W  GV +Y M+ G  PF +Q+  K F      I+    K P    +S D ++LLS
Sbjct: 174 RAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFE----LILMEDIKFPRT--LSADAKSLLS 227

Query: 232 RIFVANPSRRI-----TIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTFSLQSVEE 284
            + + +P++R+       KEI  H +F            Q +Y +K  P F  Q   E
Sbjct: 228 GLLIKDPNKRLGGGPDDAKEIMRHSFFTG-------VNWQDVYDKKLVPPFKPQVTSE 278

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score =  129 bits (326), Expect = 3e-35
 Identities = 81/273 (29%), Positives = 132/273 (48%), Gaps = 28/273 (10%)

Query: 4   YELMKDIGSGNFGVARLMR---NKNTKELVAMKYIERGHKID-ANVAREIINHKQL---- 55
           +EL++ +G+G +G   L+R     +  +L AMK +++   +  A  A      +Q+    
Sbjct: 2   FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAV 61

Query: 56  -RHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG---- 110
            R P ++       T T L ++++Y  GGELF  +     F+E E R +  +++      
Sbjct: 62  RRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHL 121

Query: 111 ---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS--RPKSTVGTPAYIAPEVLS 165
               I +RD+KLEN LLD      + + DFG SK  L     R  S  GT  Y+APEV+ 
Sbjct: 122 HQLGIIYRDIKLENILLDSE--GHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIR 179

Query: 166 RREYD-GKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTIS-RIMAVQYKIPDYVHIS 223
                  K  D WS GV  + +L GA PF   +  +N +  IS RI+  +   P    +S
Sbjct: 180 GGSGGHDKAVDWWSLGVLTFELLTGASPFT-VDGEQNSQSEISRRILKSKPPFPK--TMS 236

Query: 224 QDCRNLLSRIFVANPSRRI---TIKEIKSHPWF 253
            + R+ + ++   +P +R+      EIK+HP+F
Sbjct: 237 AEARDFIQKLLEKDPKKRLGANGADEIKNHPFF 269

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score =  131 bits (330), Expect = 5e-35
 Identities = 90/276 (32%), Positives = 137/276 (49%), Gaps = 35/276 (12%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKID-ANVA-----REIINHKQL 55
           E ++++K IG G FG  +L+R+K++K++ AMK + +   I  ++ A     R+I+ H   
Sbjct: 43  EDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHAN- 101

Query: 56  RHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLI------- 108
               I++         +L +VMEY  GG+L   + N     E  AR++  +++       
Sbjct: 102 -SEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSNY-DIPEKWARFYTAEVVLALDAIH 159

Query: 109 SGQICHRDLKLENTLLDGSPAPRLKICDFG----YSKSSLLHSRPKSTVGTPAYIAPEVL 164
           S    HRD+K +N LLD S    LK+ DFG       + ++     + VGTP YI+PEVL
Sbjct: 160 SMGFIHRDVKPDNMLLDKS--GHLKLADFGTCMKMDANGMVRC--DTAVGTPDYISPEVL 215

Query: 165 SRREYD---GKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIM--AVQYKIPDY 219
             +  D   G+  D WS GV LY MLVG  PF       +   T S+IM        PD 
Sbjct: 216 KSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYAD----SLVGTYSKIMDHKNSLTFPDD 271

Query: 220 VHISQDCRNLLSRIFVANPSR--RITIKEIKSHPWF 253
           + IS+  ++L+         R  R  + EIKSHP+F
Sbjct: 272 IEISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFF 307

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score =  130 bits (329), Expect = 7e-35
 Identities = 90/310 (29%), Positives = 140/310 (45%), Gaps = 69/310 (22%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMK------YIERGHKIDANVAREIINHKQL 55
           + +E +K IG G FG  RL++ K+T  + AMK       +E+         R+I+   + 
Sbjct: 1   DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDIL--AEA 58

Query: 56  RHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLI------- 108
            +P +++         +L ++MEY  GG++   +     F+E+E R++  + I       
Sbjct: 59  DNPWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIH 118

Query: 109 -SGQICHRDLKLENTLLDGSPAPRLKICDFGYSKS-----------SLLHSRPK------ 150
             G I HRD+K +N LLD      +K+ DFG                L H+ P       
Sbjct: 119 KLGYI-HRDIKPDNLLLDAKG--HIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFI 175

Query: 151 ----------------------STVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV 188
                                 STVGTP YIAPEV  +  Y  K  D WS GV +Y MLV
Sbjct: 176 SKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGY-NKECDWWSLGVIMYEMLV 234

Query: 189 GAYPFEDQEDPKNFRKTISRIMAVQ--YKIPDYVHISQDCRNLLSRIFVANPSRRI---T 243
           G  PF   ++P   ++T  +I+  +   + PD V +S + ++L+ R       RR+    
Sbjct: 235 GYPPFC-SDNP---QETYRKIINWKETLQFPDEVPLSPEAKDLIKR-LCCEAERRLGNNG 289

Query: 244 IKEIKSHPWF 253
           + EIKSHP+F
Sbjct: 290 VNEIKSHPFF 299

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score =  127 bits (322), Expect = 1e-34
 Identities = 75/293 (25%), Positives = 123/293 (41%), Gaps = 50/293 (17%)

Query: 3   KYELMKDIGSGNFGVARLMRNKNTKELVAMKYI---ERGHKIDANVAREIINHKQLRHPN 59
           +Y+++  IG G  G+    +++ T E VA+K +        I     REI   +  +HP 
Sbjct: 1   RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPY 60

Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGR-FSEDEARYFFQQLISG-------Q 111
           +++  +V    +   +VMEY     L E + +  R   E + + + + L+ G        
Sbjct: 61  VVKLLDVFPHGSGFVLVMEYMPSD-LSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANG 119

Query: 112 ICHRDLKLENTLLDGSPAPRLKICDFGYSK--SSLLHSRPKSTVGTPAYIAPEVL-SRRE 168
           I HRDLK  N L+  S    LKI DFG ++  S          V T  Y APE+L   R+
Sbjct: 120 IMHRDLKPANLLI--SADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARK 177

Query: 169 YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAV----------QYK-IP 217
           YD    D+W+ G     +L G+  F  + D +     ++ +                 +P
Sbjct: 178 YDP-GVDLWAVGCIFAELLNGSPLFPGENDIEQ----LAIVFRTLGTPNEETWPGLTSLP 232

Query: 218 DYVHISQ-------------DCR----NLLSRIFVANPSRRITIKEIKSHPWF 253
           DY  I+              D      +LL  + V +PS+R++  E   HP+F
Sbjct: 233 DYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYF 285

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score =  126 bits (319), Expect = 1e-34
 Identities = 84/266 (31%), Positives = 123/266 (46%), Gaps = 31/266 (11%)

Query: 4   YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDA---NVAREIINHKQLRHPNI 60
           ++++K +G G++G    ++  +  +  A+K ++ G        +   EI     + HPNI
Sbjct: 2   FKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNI 61

Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFERICNAGR----FSEDEARYFFQQLISG------ 110
           I +KE  L    L IVMEYA  G+L + I    +      E E    F QL+ G      
Sbjct: 62  ISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHE 121

Query: 111 -QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR-PKSTVGTPAYIAPEVLSRRE 168
            +I HRDLK  N LL       +KI D G SK  +L     K+ +GTP Y+APEV   R 
Sbjct: 122 QKILHRDLKSANILL--VANDLVKIGDLGISK--VLKKNMAKTQIGTPHYMAPEVWKGRP 177

Query: 169 YDGKLADVWSCGVTLYVMLVGAYPFE--DQEDPKNFRKTISRIMAVQY-KIPDYVHISQD 225
           Y  K +D+WS G  LY M   A PFE    +D +       ++   +Y  IP     SQD
Sbjct: 178 YSYK-SDIWSLGCLLYEMATFAPPFEARSMQDLRY------KVQRGKYPPIPP--IYSQD 228

Query: 226 CRNLLSRIFVANPSRRITIKEIKSHP 251
            +N +  +    P  R    +I + P
Sbjct: 229 LQNFIRSMLQVKPKLRPNCDKILASP 254

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score =  126 bits (319), Expect = 6e-34
 Identities = 79/264 (29%), Positives = 127/264 (48%), Gaps = 26/264 (9%)

Query: 8   KDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINH-----KQLRHPNIIR 62
           K IG G+FG   L ++K   +  A+K +++   +     + I+       K ++HP ++ 
Sbjct: 1   KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVG 60

Query: 63  FKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-------QICHR 115
                 T   L  V++Y  GGELF  +     F E  AR++  ++ S         I +R
Sbjct: 61  LHYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYR 120

Query: 116 DLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST-VGTPAYIAPEVLSRREYDGKLA 174
           DLK EN LLD      L   DFG  K  + HS+  ST  GTP Y+APEVL ++ YD +  
Sbjct: 121 DLKPENILLDSQGHVVLT--DFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRKQPYD-RTV 177

Query: 175 DVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIF 234
           D W  G  LY ML G  PF  ++  + +   +++ + ++       +IS   R+LL  + 
Sbjct: 178 DWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRLKP------NISVSARHLLEGLL 231

Query: 235 VANPSRRI----TIKEIKSHPWFL 254
             + ++R+       EIK+H +F 
Sbjct: 232 QKDRTKRLGAKDDFLEIKNHVFFS 255

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score =  126 bits (319), Expect = 7e-34
 Identities = 85/272 (31%), Positives = 132/272 (48%), Gaps = 44/272 (16%)

Query: 10  IGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRH------------ 57
           IG G FG    +R K+T+ + AMK + +         +EI+  K++ H            
Sbjct: 1   IGKGTFGQVYQVRKKDTRRIYAMKVLSK---------KEIVAKKEVAHTIGERNILVRTL 51

Query: 58  ----PNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLI----- 108
               P I+  K    T + L +V +Y +GGELF  +   GRFSED A+++  +L+     
Sbjct: 52  LDESPFIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEH 111

Query: 109 --SGQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST-VGTPAYIAPEVLS 165
                I +RDLK EN LLD +    + +CDFG SK++L  ++  +T  GT  Y+APEVL 
Sbjct: 112 LHKYDIVYRDLKPENILLDAT--GHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLL 169

Query: 166 RREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQD 225
             +   K  D WS GV ++ M  G  PF  ++  + +R     I   + + P  V +S +
Sbjct: 170 DEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRN----IAFGKVRFPKNV-LSDE 224

Query: 226 CRNLLSRIFVANPSRRI----TIKEIKSHPWF 253
            R  +  +   NP  R+       E+K HP+F
Sbjct: 225 GRQFVKGLLNRNPQHRLGAHRDAVELKEHPFF 256

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score =  126 bits (317), Expect = 1e-33
 Identities = 82/268 (30%), Positives = 146/268 (54%), Gaps = 32/268 (11%)

Query: 7   MKDIGSGNFGVARLMRN---KNTKELVAMKYIERG-----HKIDANVAREIINHKQLRHP 58
           +K +G G+FG   L+R     +  +L AMK +++       ++   + R+I+    + HP
Sbjct: 1   LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAE--VNHP 58

Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-------Q 111
            I++      T   L +++++  GG+LF R+     F+E++ +++  +L           
Sbjct: 59  FIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLG 118

Query: 112 ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH-SRPKSTVGTPAYIAPEVLSRREYD 170
           I +RDLK EN LLD      +K+ DFG SK S+ H  +  S  GT  Y+APEV++RR + 
Sbjct: 119 IIYRDLKPENILLDEE--GHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHT 176

Query: 171 GKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLL 230
            + AD WS GV ++ ML G+ PF+     K+ ++T++ I+  +  +P +  +S + ++LL
Sbjct: 177 -QSADWWSFGVLMFEMLTGSLPFQG----KDRKETMTMILKAKLGMPQF--LSPEAQSLL 229

Query: 231 SRIFVANPSRRI-----TIKEIKSHPWF 253
             +F  NP+ R+      ++EIK HP+F
Sbjct: 230 RALFKRNPANRLGAGPDGVEEIKRHPFF 257

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score =  122 bits (308), Expect = 6e-33
 Identities = 75/255 (29%), Positives = 124/255 (48%), Gaps = 19/255 (7%)

Query: 10  IGSGNFGVARLMRNKNTKELVAMKYI------ERGHKIDANVAREIINHKQLRHPNIIRF 63
           +GSG+FG      N +  +  A+K +      + G +    + +EI    +L+HPNI+++
Sbjct: 8   LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67

Query: 64  KEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-------QICHRD 116
                   +L I +E   GG L + +   G F E   R + +Q++ G          HRD
Sbjct: 68  LGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRD 127

Query: 117 LKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLADV 176
           +K  N L+D +    +K+ DFG +K  +  S  KS  G+P ++APEV++++   G  AD+
Sbjct: 128 IKGANILVDTNGV--VKLADFGMAKQVVEFSFAKSFKGSPYWMAPEVIAQQGGYGLAADI 185

Query: 177 WSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVA 236
           WS G T+  M  G  P+   E      K I R   +   IPD  H+S + ++ + +    
Sbjct: 186 WSLGCTVLEMATGKPPWSQLEGVAAVFK-IGRSKELP-PIPD--HLSDEAKDFILKCLQR 241

Query: 237 NPSRRITIKEIKSHP 251
           +PS R T  E+  HP
Sbjct: 242 DPSLRPTAAELLEHP 256

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score =  121 bits (306), Expect = 1e-32
 Identities = 78/262 (29%), Positives = 124/262 (47%), Gaps = 23/262 (8%)

Query: 7   MKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDAN-----VAREIINHKQLRHPNII 61
           +K I  G FG   L + ++T +  A+K +++   I  N      A   I   Q   P + 
Sbjct: 1   LKPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVA 60

Query: 62  RFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-------QICH 114
           +      +  +L +VMEY  GG+    I   G   ED A+ +  +++ G        I H
Sbjct: 61  KLYYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIH 120

Query: 115 RDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLA 174
           RD+K EN L+D      LK+ DFG S++ L     K  VGTP Y+APE +     D K++
Sbjct: 121 RDIKPENLLIDQ--TGHLKLTDFGLSRNGLE---NKKFVGTPDYLAPETILGVG-DDKMS 174

Query: 175 DVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIF 234
           D WS G  ++  L G  PF  +     F   +SR   + +        S +  +L++R+ 
Sbjct: 175 DWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRR--INWPEEVKEFCSPEAVDLINRLL 232

Query: 235 VANPSRRI---TIKEIKSHPWF 253
             +P++R+     +EIKSHP+F
Sbjct: 233 CMDPAKRLGANGYQEIKSHPFF 254

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score =  123 bits (309), Expect = 1e-32
 Identities = 92/295 (31%), Positives = 142/295 (48%), Gaps = 33/295 (11%)

Query: 8   KDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDAN-VAREIINHKQL---RHPNIIRF 63
           K +G G FG   L+R K T    AMK + +   I  + VA  +   + L   RHP +   
Sbjct: 1   KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 60

Query: 64  KEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-------QICHRD 116
           K    T   L  VMEYA GGELF  +     F+E+ AR++  +++S         + +RD
Sbjct: 61  KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRD 120

Query: 117 LKLENTLLDGSPAPRLKICDFGYSKSSLLH-SRPKSTVGTPAYIAPEVLSRREYDGKLAD 175
           +KLEN +LD      +KI DFG  K  +   +  K+  GTP Y+APEVL   +Y G+  D
Sbjct: 121 IKLENLMLDKD--GHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDY-GRAVD 177

Query: 176 VWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFV 235
            W  GV +Y M+ G  PF +Q+  + F      I+  + + P    +S + ++LL+ +  
Sbjct: 178 WWGLGVVMYEMMCGRLPFYNQDHERLFEL----ILMEEIRFPR--TLSPEAKSLLAGLLK 231

Query: 236 ANPSRRI-----TIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTFSLQSVEEI 285
            +P +R+       KE+  H +F       L+   Q +  +K  P F  Q   E+
Sbjct: 232 KDPKQRLGGGPSDAKEVMEHRFF-------LSINWQDVVQKKLLPPFKPQVTSEV 279

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score =  123 bits (309), Expect = 2e-32
 Identities = 96/299 (32%), Positives = 142/299 (47%), Gaps = 42/299 (14%)

Query: 8   KDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINH--------KQLRHPN 59
           K +G G FG   L++ K T    AMK +++    +  VA++ + H        +  RHP 
Sbjct: 1   KLLGKGTFGKVILVKEKATGRYYAMKILKK----EVIVAKDEVAHTLTENRVLQNSRHPF 56

Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG--------Q 111
           +   K    T   L  VMEYA GGELF  +     FSED AR++  +++S          
Sbjct: 57  LTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKN 116

Query: 112 ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH-SRPKSTVGTPAYIAPEVLSRREYD 170
           + +RDLKLEN +LD      +KI DFG  K  +   +  K+  GTP Y+APEVL   +Y 
Sbjct: 117 VVYRDLKLENLMLDKD--GHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDY- 173

Query: 171 GKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLL 230
           G+  D W  GV +Y M+ G  PF +Q+  K F      I+  + + P    +S + ++LL
Sbjct: 174 GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFE----LILMEEIRFPRT--LSPEAKSLL 227

Query: 231 SRIFVANPSRRI-----TIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTFSLQSVEE 284
           S +   +P +R+       KEI  H +F            Q +Y +K  P F  Q   E
Sbjct: 228 SGLLKKDPKQRLGGGPDDAKEIMQHKFF-------AGIVWQDVYEKKLVPPFKPQVTSE 279

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score =  121 bits (305), Expect = 6e-32
 Identities = 82/261 (31%), Positives = 136/261 (52%), Gaps = 25/261 (9%)

Query: 8   KDIGSGNFGVARLMRNKNTKELVAMKYIERGHKI-DANVAREIINHKQL----RHPNIIR 62
           K +G G+FG   L   K T +  A+K +++   + D +V   ++  + L     HP +  
Sbjct: 1   KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 60

Query: 63  FKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-------QICHR 115
                 T  +L  VMEY  GG+L   I +  +F    A ++  ++I G        I +R
Sbjct: 61  LYCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYR 120

Query: 116 DLKLENTLLDGSPAPRLKICDFGYSKSSLL-HSRPKSTVGTPAYIAPEVLSRREYDGKLA 174
           DLKL+N LLD      +KI DFG  K ++L  ++  +  GTP YIAPE+L  ++Y     
Sbjct: 121 DLKLDNILLDTDG--HIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLGQKY-NTSV 177

Query: 175 DVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVH-ISQDCRNLLSRI 233
           D WS GV LY ML+G  PF   ++ + F+       +++   P Y   ++++ +++L ++
Sbjct: 178 DWWSFGVLLYEMLIGQSPFHGHDEEELFQ-------SIRMDNPCYPRWLTREAKDILVKL 230

Query: 234 FVANPSRRITIK-EIKSHPWF 253
           FV  P RR+ +K +I+ HP+F
Sbjct: 231 FVREPERRLGVKGDIRQHPFF 251

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score =  120 bits (303), Expect = 1e-31
 Identities = 82/261 (31%), Positives = 133/261 (50%), Gaps = 25/261 (9%)

Query: 8   KDIGSGNFGVARLMRNKNTKELVAMKYIERGHK-IDANVAREIINHKQL----RHPNIIR 62
           K +G G+FG   L   K   E  A+K +++    ID +V   ++  + L     +P +  
Sbjct: 1   KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTH 60

Query: 63  FKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-QICH------R 115
                 T  HL  VME+  GG+L   I + GRF    A ++  +++ G Q  H      R
Sbjct: 61  LYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYR 120

Query: 116 DLKLENTLLDGSPAPRLKICDFGYSKSSLL-HSRPKSTVGTPAYIAPEVLSRREYDGKLA 174
           DLKL+N +LD      +KI DFG  K ++   +R  +  GTP YIAPE+L   +Y   + 
Sbjct: 121 DLKLDNVMLDRD--GHIKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQGLKYTFSV- 177

Query: 175 DVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVH-ISQDCRNLLSRI 233
           D WS GV LY ML+G  PF   ++ + F        +++   P Y   I+++ +++L ++
Sbjct: 178 DWWSFGVLLYEMLIGQSPFHGDDEDELFE-------SIRVDTPHYPRWITKESKDILEKL 230

Query: 234 FVANPSRRITIK-EIKSHPWF 253
           F  +P+RR+ +   I+ HP+F
Sbjct: 231 FERDPTRRLGVVGNIRGHPFF 251

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score =  119 bits (301), Expect = 1e-31
 Identities = 83/304 (27%), Positives = 126/304 (41%), Gaps = 75/304 (24%)

Query: 4   YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERG-HKIDANVA-REIINHKQLR----H 57
           Y+++K +G G FG   L RNK T ELVA+K +++  +  +  +  RE+   K LR    H
Sbjct: 1   YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREV---KSLRKLNEH 57

Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFERIC--NAGRFSEDEARYFFQQLISG----- 110
           PNI++ KEV      L  V EY   G L++ +       FSE   R    Q++ G     
Sbjct: 58  PNIVKLKEVFRENDELYFVFEYME-GNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIH 116

Query: 111 --QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST--VGTPAYIAPEVLSR 166
                HRDLK EN L+  S    +KI DFG ++   + SRP  T  V T  Y APE+L R
Sbjct: 117 KHGFFHRDLKPENLLV--SGPEVVKIADFGLARE--IRSRPPYTDYVSTRWYRAPEILLR 172

Query: 167 REYDGKLADVWSCGVTLYVMLVGAYPFE---------DQEDPKNFRKTISRIMAV----- 212
                   D+W+ G     ++   Y            DQ         + +I +V     
Sbjct: 173 STSYSSPVDIWALG----CIMAELYTLRPLFPGSSEIDQ---------LYKICSVLGTPT 219

Query: 213 --------------QYKIPDYVHI---------SQDCRNLLSRIFVANPSRRITIKEIKS 249
                          ++ P +            S +  +L+  +   +P +R T  +   
Sbjct: 220 KQDWPEGYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ 279

Query: 250 HPWF 253
           HP+F
Sbjct: 280 HPYF 283

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score =  118 bits (298), Expect = 2e-31
 Identities = 83/255 (32%), Positives = 136/255 (53%), Gaps = 28/255 (10%)

Query: 3   KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVA---REIINHKQLRHPN 59
           +Y +++ +G G+FG A L+++ N+ +  AMK I R  K  + V    +E +   +++HPN
Sbjct: 1   QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEI-RLPKSSSAVEDSRKEAVLLAKMKHPN 59

Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFERI-CNAGR-FSEDEARYFFQQLISG------- 110
           I+ FKE      HL IVMEY  GG+L ++I    G+ F ED    +F Q+  G       
Sbjct: 60  IVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEK 119

Query: 111 QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKS----TVGTPAYIAPEVLSR 166
           ++ HRD+K +N  L  +   ++K+ DFG   S+ L + P +     VGTP Y+ PE+   
Sbjct: 120 RVLHRDIKSKNIFL--TQNGKVKLGDFG---SARLLTSPGAYACTYVGTPYYVPPEIWEN 174

Query: 167 REYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDC 226
             Y+ K +D+WS G  LY +    +PF+      +++  I ++    YK P   H S + 
Sbjct: 175 MPYNNK-SDIWSLGCILYELCTLKHPFQ----ANSWKNLILKVCQGSYK-PLPSHYSYEL 228

Query: 227 RNLLSRIFVANPSRR 241
           R+L+ ++F  NP  R
Sbjct: 229 RSLIKQMFKRNPRSR 243

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score =  120 bits (303), Expect = 2e-31
 Identities = 99/341 (29%), Positives = 163/341 (47%), Gaps = 50/341 (14%)

Query: 4   YELMKDIGSGNFGVARLMRN---KNTKELVAMKYIERGHKID-------ANVAREIINHK 53
           +EL+K +G+G +G   L+R     +T +L AMK +++   +            R ++ H 
Sbjct: 2   FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHV 61

Query: 54  QLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG--- 110
           + + P ++       T   L ++++Y +GGE+F  +     FSEDE R++  ++I     
Sbjct: 62  R-QSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEH 120

Query: 111 ----QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS--RPKSTVGTPAYIAPEVL 164
                I +RD+KLEN LLD      + + DFG SK  L     R  S  GT  Y+APE++
Sbjct: 121 LHKLGIVYRDIKLENILLDSEG--HVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEII 178

Query: 165 SRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTIS-RIMAVQYKIPDYVHIS 223
             +   GK  D WS G+ ++ +L GA PF   E  +N +  +S RI+      P +  I 
Sbjct: 179 RGKGGHGKAVDWWSLGILIFELLTGASPFT-LEGERNTQSEVSRRILKCDPPFPSF--IG 235

Query: 224 QDCRNLLSRIFVANPSRRI-----TIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTF- 277
            + ++LL ++   +P +R+        EIK HP+F K L  E      A+  RK NP F 
Sbjct: 236 PEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFF-KGLDWE------ALALRKVNPPFR 288

Query: 278 -SLQSVEEITKIVEE----------AKVPPPVSRSIGGFGW 307
            S+++  ++    EE          A  PP  +R   G+ +
Sbjct: 289 PSIRNELDVGNFAEEFTNLEPVYSPAGTPPSGARVFQGYSF 329

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score =  118 bits (298), Expect = 2e-31
 Identities = 89/269 (33%), Positives = 132/269 (49%), Gaps = 36/269 (13%)

Query: 10  IGSGNFGVARLMRNKNTKELVAMKYIE----------RGHKIDANVAREIINHKQLRHPN 59
           IGSG+FG   L  N ++ EL+A+K +E          R   +   +AREI   K+L+H N
Sbjct: 8   IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67

Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-------QI 112
           I+++    L   HL I +EY  GG +   + N G F E   R F +Q++ G        I
Sbjct: 68  IVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGI 127

Query: 113 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS--------RPKSTVGTPAYIAPEVL 164
            HRD+K  N L+D      +KI DFG SK    +S        RP S  G+  ++APEV+
Sbjct: 128 IHRDIKGANILVDNKGG--IKISDFGISKKLEANSLSTKTNGARP-SLQGSVFWMAPEVV 184

Query: 165 SRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMA-VQYKIPDYVHIS 223
            +  Y  K AD+WS G  +  ML G +PF D        + I +I      +IP   +IS
Sbjct: 185 KQTSYTRK-ADIWSLGCLVVEMLTGKHPFPDC----TQLQAIFKIGENASPEIPS--NIS 237

Query: 224 QDCRNLLSRIFVANPSRRITIKEIKSHPW 252
            +  + L + F  + ++R T  E+  HP+
Sbjct: 238 SEAIDFLEKTFEIDHNKRPTAAELLKHPF 266

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score =  117 bits (296), Expect = 3e-31
 Identities = 83/271 (30%), Positives = 128/271 (47%), Gaps = 40/271 (14%)

Query: 8   KDIGSGNFGVARLMRNKNTKELVAMKYIERG-------HKIDANVAREIINHKQLRHPNI 60
           K +G G FG   L  + +T   +A+K +           +++A +  EI   K L+H  I
Sbjct: 8   KLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNA-LECEIQLLKNLQHERI 66

Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-------QIC 113
           +++   +     L+I MEY  GG + +++   G  +E   R + +Q++ G        I 
Sbjct: 67  VQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIV 126

Query: 114 HRDLKLENTLLDGSPAPRLKICDFGYSKS-SLLHSR---PKSTVGTPAYIAPEVLSRREY 169
           HRD+K  N L D   A  +K+ DFG SK    + S     KS  GTP +++PEV+S   Y
Sbjct: 127 HRDIKGANILRDS--AGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGY 184

Query: 170 DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKI----PDYV---HI 222
            G+ ADVWS G T+  ML    P+ + E            MA  +KI     +     H+
Sbjct: 185 -GRKADVWSVGCTVVEMLTEKPPWAEFEA-----------MAAIFKIATQPTNPQLPSHV 232

Query: 223 SQDCRNLLSRIFVANPSRRITIKEIKSHPWF 253
           S D RN L R FV N  +R + +E+  H + 
Sbjct: 233 SPDARNFLRRTFVENAKKRPSAEELLRHFFV 263

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score =  118 bits (297), Expect = 1e-30
 Identities = 88/268 (32%), Positives = 133/268 (49%), Gaps = 30/268 (11%)

Query: 7   MKDIGSGNFG---VARLMRNKNTKELVAMKY-----IERGHKIDANVAREIINHKQLRHP 58
           +K +G G +G     R +   +T ++ AMK      I R  K  A+   E    + ++HP
Sbjct: 1   LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHP 60

Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLI-------SGQ 111
            I+       T   L +++EY +GGELF  +   G F ED A ++  ++           
Sbjct: 61  FIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQG 120

Query: 112 ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST-VGTPAYIAPEVLSRREYD 170
           I +RDLK EN LLD      +K+ DFG  K S+       T  GT  Y+APE+L R  + 
Sbjct: 121 IIYRDLKPENILLDAQ--GHVKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEILMRSGH- 177

Query: 171 GKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLL 230
           GK  D WS G  +Y ML GA PF  +    N +KTI +I+  +  +P Y  ++ + R+LL
Sbjct: 178 GKAVDWWSLGALMYDMLTGAPPFTAE----NRKKTIDKILKGKLNLPPY--LTPEARDLL 231

Query: 231 SRIFVANPSRRI-----TIKEIKSHPWF 253
            ++   NPS R+        E++SHP+F
Sbjct: 232 KKLLKRNPSSRLGAGPGDAAEVQSHPFF 259

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score =  115 bits (290), Expect = 2e-30
 Identities = 89/268 (33%), Positives = 136/268 (50%), Gaps = 28/268 (10%)

Query: 3   KYELMKDIGSGNFGVARLMRNKNTKELVAMKYI---ERGHKIDANVAREIINHKQLRHPN 59
           +YE++K IG G+FG   L + K+  E   +K I   +   K      +E+I   +++HPN
Sbjct: 1   RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPN 60

Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGR---FSEDEARYFFQQLISG------ 110
           I+ F         L IVMEY  GG+L +RI N  R   FSED+   +F Q+  G      
Sbjct: 61  IVTFFASFQENGRLFIVMEYCDGGDLMKRI-NRQRGVLFSEDQILSWFVQISLGLKHIHD 119

Query: 111 -QICHRDLKLENTLL--DGSPAPRLKICDFGYSKSSLLHSR--PKSTVGTPAYIAPEVLS 165
            +I HRD+K +N  L  +G  A   K+ DFG ++  L  S     + VGTP Y++PE+  
Sbjct: 120 RKILHRDIKSQNIFLSKNGMVA---KLGDFGIAR-QLNDSMELAYTCVGTPYYLSPEICQ 175

Query: 166 RREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQD 225
            R Y+ K  D+WS G  LY +    +PFE      N  + + +I    +  P   + S+D
Sbjct: 176 NRPYNNK-TDIWSLGCVLYELCTLKHPFEGN----NLHQLVLKICQGYFA-PISPNFSRD 229

Query: 226 CRNLLSRIFVANPSRRITIKEIKSHPWF 253
            R+L+S++F  +P  R +I  I   P+ 
Sbjct: 230 LRSLISQLFKVSPRDRPSITSILKRPFL 257

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score =  116 bits (291), Expect = 2e-30
 Identities = 83/268 (30%), Positives = 124/268 (46%), Gaps = 30/268 (11%)

Query: 10  IGSGNFGVARLMRNKNTKELVAMKYIE-----------RGHKIDANVAREIINHKQLRHP 58
           IG G +G   L  N  T E++A+K +E           R   +   +  EI   K L H 
Sbjct: 9   IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68

Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-------Q 111
           NI+++     T  +L+I +EY  GG +   +   GRF E   R+F +Q++ G        
Sbjct: 69  NIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKG 128

Query: 112 ICHRDLKLENTLLDGSPAPRLKICDFGYSKSS---LLHSRPKSTVGTPAYIAPEV--LSR 166
           I HRDLK +N L+D       KI DFG SK S     + +  S  G+  ++APEV     
Sbjct: 129 ILHRDLKADNLLVDADGI--CKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYS 186

Query: 167 REYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYV--HISQ 224
           + Y  K+ D+WS G  +  M  G  P+ D+E      K  ++  A    IP  V  ++S 
Sbjct: 187 QGYSAKV-DIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAP--PIPPDVSMNLSP 243

Query: 225 DCRNLLSRIFVANPSRRITIKEIKSHPW 252
              + L+  F  NP  R T +E+  HP+
Sbjct: 244 VALDFLNACFTINPDNRPTARELLQHPF 271

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score =  115 bits (289), Expect = 4e-30
 Identities = 75/268 (27%), Positives = 130/268 (48%), Gaps = 26/268 (9%)

Query: 5   ELMKDIGSGNFGVARLMRNKNTKELVAMKYIERG--HKIDANVAREI-INHKQLRHPNII 61
           E + ++G+GN GV   + ++ T +++A+K I       I   + RE+ I HK    P I+
Sbjct: 4   EYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHK-CNSPYIV 62

Query: 62  RFKEVVLTPTHLAIVMEYAAGGEL--FERICNAGRFSEDEARYFFQQLISG--------Q 111
            F         ++I MEY  GG L    +    GR  E         ++ G        +
Sbjct: 63  GFYGAFYNNGDISICMEYMDGGSLDKILKEVQ-GRIPERILGKIAVAVLKGLTYLHEKHK 121

Query: 112 ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDG 171
           I HRD+K  N L++     ++K+CDFG S   L++S  K+ VGT +Y+APE +   +Y  
Sbjct: 122 IIHRDVKPSNILVNSR--GQIKLCDFGVSG-QLVNSLAKTFVGTSSYMAPERIQGNDYSV 178

Query: 172 KLADVWSCGVTLYVMLVGAYPF-EDQEDPKNFRKTISRIMAVQY---KIPDYVHISQDCR 227
           K +D+WS G++L  +  G +P+  + + P    + +  I  V     ++P     S D +
Sbjct: 179 K-SDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYI--VNEPPPRLPSGKF-SPDFQ 234

Query: 228 NLLSRIFVANPSRRITIKEIKSHPWFLK 255
           + ++   + +P  R + KE+  HP+  K
Sbjct: 235 DFVNLCLIKDPRERPSYKELLEHPFIKK 262

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score =  116 bits (293), Expect = 4e-30
 Identities = 79/267 (29%), Positives = 126/267 (47%), Gaps = 32/267 (11%)

Query: 10  IGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVA------REIINHKQLRHPNIIRF 63
           +G G+FG  +++R K T ++ AMK +++   +           R+I++      P I + 
Sbjct: 9   VGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILS--ISNSPWIPQL 66

Query: 64  KEVVLTPTHLAIVMEYAAGGELFERICN-AGRFSEDEARYFFQQLISG-------QICHR 115
           +       +L +VMEY  GG+L   +     +F ED A+++  +L+            HR
Sbjct: 67  QYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHR 126

Query: 116 DLKLENTLLDGSPAPRLKICDFGYSK--SSLLHSRPKSTVGTPAYIAPEVLSRREYDGKL 173
           D+K EN L+D +    +K+ DFG +   ++      K  VGTP YIAPEVL+    DGK 
Sbjct: 127 DIKPENVLIDRTG--HIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKG 184

Query: 174 A-----DVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQ--YKIPDYVHISQDC 226
                 D WS GV  Y M+ G  PF   E      KT + IM  Q   K P+   +S D 
Sbjct: 185 TYGVECDWWSLGVIAYEMIYGRSPFH--EG--TSAKTYNNIMNFQRFLKFPEDPKVSSDF 240

Query: 227 RNLLSRIFVANPSRRITIKEIKSHPWF 253
            +L+  + +     R+  + +  HP+F
Sbjct: 241 LDLIQSL-LCGQKERLGYEGLCCHPFF 266

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score =  114 bits (288), Expect = 7e-30
 Identities = 74/264 (28%), Positives = 118/264 (44%), Gaps = 27/264 (10%)

Query: 10  IGSGNFGVARLMRNKNTKELVAMKYIE------RGHKIDANVAREIINHKQLRHPNIIRF 63
           +G G FG     + K T ++ A K ++      R  +  A   ++I+  +++    I+  
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKIL--EKVSSRFIVSL 58

Query: 64  KEVVLTPTHLAIVMEYAAGGELFERICNAGR--FSEDEARYFFQQLISG-------QICH 114
                T   L +VM    GG+L   I N G   F E  A ++  Q+I G       +I +
Sbjct: 59  AYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVY 118

Query: 115 RDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLA 174
           RDLK EN LLD     R  I D G +       + K   GTP Y+APEVL    YD    
Sbjct: 119 RDLKPENVLLDDHGNVR--ISDLGLAVELKGGKKIKGRAGTPGYMAPEVLQGEVYDFS-V 175

Query: 175 DVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIF 234
           D ++ G TLY M+ G  PF  +++     +   R + +  + PD    S + ++L   + 
Sbjct: 176 DWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPD--KFSPEAKDLCEALL 233

Query: 235 VANPSRRI-----TIKEIKSHPWF 253
             +P +R+     +  E++ HP F
Sbjct: 234 QKDPEKRLGCRGGSADEVREHPLF 257

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score =  115 bits (289), Expect = 9e-30
 Identities = 90/286 (31%), Positives = 135/286 (47%), Gaps = 42/286 (14%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDAN------VAREIINHKQL 55
           E +E +K I +G +G   L+R+K T++  AMK I + + I  N      V R+I+   + 
Sbjct: 1   EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAE- 59

Query: 56  RHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLI------- 108
            +P ++       T  HL +VMEY  GG+    + N G    D AR +F + +       
Sbjct: 60  -NPFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLH 118

Query: 109 SGQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP----------------KST 152
           +  I HRDLK +N L+  +    +K+ DFG SK  L+                    K  
Sbjct: 119 NYGIVHRDLKPDNLLI--TSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQV 176

Query: 153 VGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAV 212
            GTP YIAPEV+ R+ Y GK  D W+ G+ LY  LVG  PF      + F + IS     
Sbjct: 177 CGTPEYIAPEVILRQGY-GKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVIS----D 231

Query: 213 QYKIPDYVH-ISQDCRNLLSRIFVANPSRRI---TIKEIKSHPWFL 254
             + P+    +  D ++L+SR+   NP  R+      E+K H +FL
Sbjct: 232 DIEWPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFL 277

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score =  115 bits (289), Expect = 1e-29
 Identities = 94/318 (29%), Positives = 145/318 (45%), Gaps = 41/318 (12%)

Query: 10  IGSGNFGVARLMRNKNTKELVAMKYIERG-----HKIDANVAREIINHKQLRHPNIIRFK 64
           +G G+FG   L R K +  L A+K +++        ++  +  + I      HP + +  
Sbjct: 3   LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLY 62

Query: 65  EVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-------QICHRDL 117
               TP  L  VME+  GG+L   I  + RF E  AR++  ++ S         I +RDL
Sbjct: 63  CCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDL 122

Query: 118 KLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST-VGTPAYIAPEVLSRREYDGKLADV 176
           KL+N LLD       K+ DFG  K  + + +  ST  GTP YIAPE+L    Y G   D 
Sbjct: 123 KLDNVLLDHE--GHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEMLY-GPSVDW 179

Query: 177 WSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVA 236
           W+ GV LY ML G  PFE + +   F      I+  +   P ++   QD  ++L      
Sbjct: 180 WAMGVLLYEMLCGHAPFEAENEDDLFEA----ILNDEVVYPTWLS--QDAVDILKAFMTK 233

Query: 237 NPSRRITI------KEIKSHPWFLKNLPRELTETAQAIYYRKENPTFS--LQSVEEITK- 287
           NP+ R+        + I  HP+F K L  E       +  R+  P F   ++S E+++  
Sbjct: 234 NPTMRLGSLTLGGEEAILRHPFF-KELDWEK------LNRRQIEPPFRPRIKSREDVSNF 286

Query: 288 ---IVEEAKVPPPVSRSI 302
               ++E  V  P+  S+
Sbjct: 287 DPDFIKEDPVLTPIEESL 304

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score =  112 bits (283), Expect = 2e-29
 Identities = 80/252 (31%), Positives = 119/252 (47%), Gaps = 23/252 (9%)

Query: 4   YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINH----KQLRHPN 59
           +E++  IG G+FGV   +  K  K + AMK I+   K++     E I+      +L    
Sbjct: 2   FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDL-SKMNRREREEAIDEARVLAKLDSSY 60

Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFERI--CNAGRFSEDEA-RYFFQQLI------SG 110
           IIR+ E  L    L IVMEYA  G+L + +         ED+  R+F Q L+      S 
Sbjct: 61  IIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSK 120

Query: 111 QICHRDLKLENTLLDGSPAPRLKICDFGYSKS-SLLHSRPKSTVGTPAYIAPEVLSRREY 169
           +I HRD+K  N  LD      +KI D G +K  S   +   + VGTP Y++PE+   + Y
Sbjct: 121 KILHRDIKSLNLFLDAY--DNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPELCEDKPY 178

Query: 170 DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 229
           + K +DVW+ GV LY    G +PF    D  N    I +I+   +  P     SQ    L
Sbjct: 179 NEK-SDVWALGVVLYECCTGKHPF----DANNQGALILKIIRGVFP-PVSQMYSQQLAQL 232

Query: 230 LSRIFVANPSRR 241
           + +    +  +R
Sbjct: 233 IDQCLTKDYRQR 244

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  113 bits (284), Expect = 3e-29
 Identities = 66/264 (25%), Positives = 105/264 (39%), Gaps = 32/264 (12%)

Query: 5   ELMKDIGSGNFGVARL----MRNKNTKELVAMKYIERGHKIDA--NVAREIINHKQLRHP 58
            L K +G G FG         +    +  VA+K ++            RE    ++L HP
Sbjct: 2   TLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHP 61

Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGEL--FERICNAGRFSEDEARYFFQQ-------LIS 109
           NI++   V      L IVMEY  GG+L  + R       S  +   F  Q       L S
Sbjct: 62  NIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLES 121

Query: 110 GQICHRDLKLENTLLDGSPAPRLKICDFG-----YSKSSLLHSRPKSTVGTPAYIAPEVL 164
               HRDL   N L+  +    +KI DFG     Y          K  +    ++APE L
Sbjct: 122 KNFIHRDLAARNCLVGEN--LVVKISDFGLSRDLYDDDYYKVKGGKLPI---RWMAPESL 176

Query: 165 SRREYDGKLADVWSCGVTLYVML-VGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHIS 223
              ++  K +DVWS GV L+ +  +G  P+       +  + +  +    Y++P   +  
Sbjct: 177 KEGKFTSK-SDVWSFGVLLWEIFTLGEEPYPG----MSNAEVLEYLKK-GYRLPKPPNCP 230

Query: 224 QDCRNLLSRIFVANPSRRITIKEI 247
            +   L+ + +  +P  R T  E+
Sbjct: 231 PELYKLMLQCWAEDPEDRPTFSEL 254

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  113 bits (284), Expect = 3e-29
 Identities = 66/266 (24%), Positives = 109/266 (40%), Gaps = 33/266 (12%)

Query: 5   ELMKDIGSGNFGVARL----MRNKNTKELVAMKYIERGHKIDANVA---REIINHKQLRH 57
            L K +G G FG         +    K  VA+K + +    +  +    RE    ++L H
Sbjct: 2   TLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTL-KEDASEQQIEEFLREARIMRKLDH 60

Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFERI-CNAGRFSEDEARYFFQQ-------LIS 109
           PN+++   V      L IVMEY  GG+L   +  N  + S  +   F  Q       L S
Sbjct: 61  PNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLES 120

Query: 110 GQICHRDLKLENTLLDGSPAPRLKICDFG-----YSKSSLLHSRPKSTVGTPAYIAPEVL 164
               HRDL   N L+  +    +KI DFG     Y          K  +    ++APE L
Sbjct: 121 KNFIHRDLAARNCLVGEN--LVVKISDFGLSRDLYDDDYYRKRGGKLPI---RWMAPESL 175

Query: 165 SRREYDGKLADVWSCGVTLYVML-VGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHIS 223
              ++  K +DVWS GV L+ +  +G  P+       +  + +  +    Y++P   +  
Sbjct: 176 KEGKFTSK-SDVWSFGVLLWEIFTLGEQPYPG----MSNEEVLEYLKN-GYRLPQPPNCP 229

Query: 224 QDCRNLLSRIFVANPSRRITIKEIKS 249
            +  +L+ + +  +P  R T  E+  
Sbjct: 230 PELYDLMLQCWAEDPEDRPTFSELVE 255

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score =  113 bits (285), Expect = 4e-29
 Identities = 91/291 (31%), Positives = 133/291 (45%), Gaps = 38/291 (13%)

Query: 8   KDIGSGNFGVARLMRNKNTKELVAMKYIERGHKI-DANVAREIINHKQL----RHPNIIR 62
           K +G G+FG   L   K T E+ A+K +++   + D +V   +   + L    +HP +  
Sbjct: 1   KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTA 60

Query: 63  FKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYF-------FQQLISGQICHR 115
                 T   L  VMEY  GG+L  +I  + +F E  +R++          L    + +R
Sbjct: 61  LHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYR 120

Query: 116 DLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST-VGTPAYIAPEVLSRREYDGKLA 174
           DLKL+N LLD       K+ DFG  K  +L+    +T  GTP YIAPE+L   EY G   
Sbjct: 121 DLKLDNILLDAE--GHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQELEY-GPSV 177

Query: 175 DVWSCGVTLYVMLVGAYPFE-DQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRI 233
           D W+ GV +Y M+ G  PFE D ED          I+      P  V +S++  ++L   
Sbjct: 178 DWWALGVLMYEMMAGQPPFEADNED-----DLFESILHDDVLYP--VWLSKEAVSILKAF 230

Query: 234 FVANPSRRI-------TIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTF 277
              NP++R+           IK HP+F K +   L E       RK  P F
Sbjct: 231 MTKNPNKRLGCVASQGGEDAIKQHPFF-KEIDWVLLEQ------RKIKPPF 274

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  111 bits (281), Expect = 7e-29
 Identities = 65/268 (24%), Positives = 106/268 (39%), Gaps = 33/268 (12%)

Query: 8   KDIGSGNFGV---ARLMRNKNTKELVAMKYIERGHKIDANVA--REIINHKQLRHPNIIR 62
           K +G G FG     +L         VA+K ++     +      +E    K+L HPN++R
Sbjct: 1   KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60

Query: 63  FKEVVLTPTHLAIVMEYAAGGEL--FERICNAGRFSEDEARYFFQQL--ISGQIC----- 113
              V      L +V+EY  GG+L  + R       S +++    + L   + QI      
Sbjct: 61  LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120

Query: 114 -------HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYI---APEV 163
                  HRDL   N L+       +KI DFG S+        +   G    I   APE 
Sbjct: 121 LASKKFVHRDLAARNCLVGED--LVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPES 178

Query: 164 LSRREYDGKLADVWSCGVTLY-VMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHI 222
           L    +  K +DVWS GV L+ +  +GA P+      +   + + +     Y++P   + 
Sbjct: 179 LKDGIFTSK-SDVWSFGVLLWEIFTLGATPYPGL-SNEEVLEYLRK----GYRLPKPEYC 232

Query: 223 SQDCRNLLSRIFVANPSRRITIKEIKSH 250
             +   L+   +  +P  R T  E+   
Sbjct: 233 PDELYELMLSCWQLDPEDRPTFSELVER 260

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score =  111 bits (279), Expect = 1e-28
 Identities = 85/271 (31%), Positives = 127/271 (46%), Gaps = 33/271 (12%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKID-----ANVAREIINHKQLR 56
           E YEL++ IGSG +G     R+  T ELVA+K I    K++       + +EI   K+ R
Sbjct: 3   EDYELIQRIGSGTYGDVYKARDIATGELVAIKVI----KLEPGDDFEIIQQEISMLKECR 58

Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERIC-NAGRFSEDEARYFFQQLISG----- 110
           HPNI+ +    L    L IVMEY  GG L +      G  SE +  Y  ++ + G     
Sbjct: 59  HPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLH 118

Query: 111 --QICHRDLKLENTLL--DGSPAPRLKICDFGYS---KSSLLHSRPKSTVGTPAYIAPEV 163
                HRD+K  N LL  DG     +K+ DFG S    +++  ++ KS +GTP ++APEV
Sbjct: 119 ETGKIHRDIKGANILLTEDGD----VKLADFGVSAQLTATI--AKRKSFIGTPYWMAPEV 172

Query: 164 L---SRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYV 220
                +  YDGK  D+W+ G+T   +     P  D   P      IS+      K+ D  
Sbjct: 173 AAVERKGGYDGK-CDIWALGITAIELAELQPPMFDL-HPMRALFLISKSNFPPPKLKDKE 230

Query: 221 HISQDCRNLLSRIFVANPSRRITIKEIKSHP 251
             S    + + +    +P +R T  ++  HP
Sbjct: 231 KWSPVFHDFIKKCLTKDPKKRPTATKLLQHP 261

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score =  111 bits (279), Expect = 2e-28
 Identities = 80/261 (30%), Positives = 132/261 (50%), Gaps = 28/261 (10%)

Query: 10  IGSGNFGVARLMRNKNTKELVAMKYIE-RGHKIDANVAREIINHKQLRHPNIIRFKEVVL 68
           IG G+ G+  +  +K+T   VA+K ++ R  +    +  E++  +  +HPNI+      L
Sbjct: 27  IGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYL 86

Query: 69  TPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQ-------LISGQICHRDLKLEN 121
               L +VME+  GG L + I    R +E++              L +  + HRD+K ++
Sbjct: 87  VGDELWVVMEFLEGGALTD-IVTHTRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDS 145

Query: 122 TLL--DGSPAPRLKICDFGY-SKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLADVWS 178
            LL  DG    R+K+ DFG+ ++ S    R KS VGTP ++APEV+SR  Y G   D+WS
Sbjct: 146 ILLTSDG----RVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEVISRLPY-GTEVDIWS 200

Query: 179 CGVTLYVMLVGAYPFEDQEDP----KNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIF 234
            G+ +  M+ G  P+ + E P    K  R  +        K+ +   +S   R+ L R+ 
Sbjct: 201 LGIMVIEMVDGEPPYFN-EPPLQAMKRIRDNLPP------KLKNLHKVSPRLRSFLDRML 253

Query: 235 VANPSRRITIKEIKSHPWFLK 255
           V +P++R T  E+ +HP+  K
Sbjct: 254 VRDPAQRATAAELLNHPFLAK 274

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score =  109 bits (275), Expect = 4e-28
 Identities = 71/263 (26%), Positives = 120/263 (45%), Gaps = 20/263 (7%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNII 61
           E +++++ +G G++G      +K T ++VA+K +     +   + +EI   KQ   P I+
Sbjct: 3   EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQ-EIIKEISILKQCDSPYIV 61

Query: 62  RFKEVVLTPTHLAIVMEYAAGGELFE--RICNAGRFSEDEARYFFQQLISG-------QI 112
           ++       T L IVMEY   G + +  +I N    +E+E      Q + G       + 
Sbjct: 62  KYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNK-TLTEEEIAAILYQTLKGLEYLHSNKK 120

Query: 113 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPK--STVGTPAYIAPEVLSRREYD 170
            HRD+K  N LL+       K+ DFG S   L  +  K  + +GTP ++APEV+    Y+
Sbjct: 121 IHRDIKAGNILLNEEGQA--KLADFGVS-GQLTDTMAKRNTVIGTPFWMAPEVIQEIGYN 177

Query: 171 GKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLL 230
            K AD+WS G+T   M  G  P+ D   P      I          P+    S +  + +
Sbjct: 178 NK-ADIWSLGITAIEMAEGKPPYSDIH-PMRAIFMIPNKPPPTLSDPE--KWSPEFNDFV 233

Query: 231 SRIFVANPSRRITIKEIKSHPWF 253
            +  V +P  R +  ++  HP+ 
Sbjct: 234 KKCLVKDPEERPSAIQLLQHPFI 256

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score =  112 bits (280), Expect = 5e-28
 Identities = 86/271 (31%), Positives = 132/271 (48%), Gaps = 25/271 (9%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQL----RH 57
           E YE++K IG G FG  +L+R+K+T+++ AMK + +   I  + +      + +      
Sbjct: 43  EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANS 102

Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNA------GRFSEDEARYFFQQLISGQ 111
           P +++         +L +VMEY  GG+L   + N        RF   E       + S  
Sbjct: 103 PWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMG 162

Query: 112 ICHRDLKLENTLLDGSPAPRLKICDFG----YSKSSLLHSRPKSTVGTPAYIAPEVLSRR 167
             HRD+K +N LLD S    LK+ DFG     +K  ++  R  + VGTP YI+PEVL  +
Sbjct: 163 FIHRDVKPDNMLLDKS--GHLKLADFGTCMKMNKEGMV--RCDTAVGTPDYISPEVLKSQ 218

Query: 168 ---EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQ 224
               Y G+  D WS GV LY MLVG  PF        + K ++   ++ +  PD   IS+
Sbjct: 219 GGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTF--PDDNDISK 276

Query: 225 DCRNLLSRIFVANPSR--RITIKEIKSHPWF 253
           + +NL+         R  R  ++EIK H +F
Sbjct: 277 EAKNLICAFLTDREVRLGRNGVEEIKRHLFF 307

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score =  111 bits (279), Expect = 5e-28
 Identities = 85/300 (28%), Positives = 128/300 (42%), Gaps = 57/300 (19%)

Query: 3   KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIER--GHKIDAN-VAREIINHKQLRHPN 59
           +YEL+K IGSG +GV     +K T   VA+K I       IDA  + REI   + LRH N
Sbjct: 1   RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHEN 60

Query: 60  IIRFKEVVLTPT-----HLAIVMEYAAGGELFERICNAGRF-SEDEARYFFQQLI----- 108
           II   +++  P+      + IV E     +L  ++  + +  ++D  +YF  Q++     
Sbjct: 61  IIGLLDILRPPSPEDFNDVYIVTEL-METDL-HKVIKSPQPLTDDHIQYFLYQILRGLKY 118

Query: 109 --SGQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST----VGTPAYIAPE 162
             S  + HRDLK  N L++ +    LKICDFG ++        K      V T  Y APE
Sbjct: 119 LHSANVIHRDLKPSNILVNSNCD--LKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPE 176

Query: 163 V-LSRREYDGKLADVWSCGVTLYVML---------------------VGAYPFED--QED 198
           + LS   Y  K  D+WS G     +L                     +G    ED     
Sbjct: 177 LLLSSSRYT-KAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFIT 235

Query: 199 PKNFRKTISRIMAVQYK-----IPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 253
            +  R  +  +     K      P     S +  +LL ++ V +P +RIT  E  +HP+ 
Sbjct: 236 SEKARNYLKSLPKKPKKPLSKLFPG---ASPEAIDLLEKMLVFDPKKRITADEALAHPYL 292

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score =  109 bits (275), Expect = 8e-28
 Identities = 82/296 (27%), Positives = 127/296 (42%), Gaps = 55/296 (18%)

Query: 4   YELMKDIGSGNFGVARLMRNKNTKELVAMKYI----ER-GHKIDANVAREIINHKQLRHP 58
           YE +  IG G +G     RNK T ELVA+K I    E+ G  I A   REI   ++LRHP
Sbjct: 1   YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITA--IREIKLLQKLRHP 58

Query: 59  NIIRFKEVVLTPTHLAI--VMEYA----AGGELFERICNAGRFSEDEARYFFQQLISG-- 110
           NI+R KE+V +    +I  V EY      G  L +      +F+E + + + +QL+ G  
Sbjct: 59  NIVRLKEIVTSKGKGSIYMVFEYMDHDLTG--LLDS--PEVKFTESQIKCYMKQLLEGLQ 114

Query: 111 -----QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST--VGTPAYIAPEV 163
                 I HRD+K  N L++      LK+ DFG ++     +    T  V T  Y  PE+
Sbjct: 115 YLHSNGILHRDIKGSNILINND--GVLKLADFGLARPYTKRNSADYTNRVITLWYRPPEL 172

Query: 164 L-SRREYDGKLADVWSCGVTLYVMLVGAYPFE---DQE------------DPKNFRKTIS 207
           L     Y  ++ D+WS G  L  + +G   F+   + E              +N+     
Sbjct: 173 LLGATRYGPEV-DMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSK 231

Query: 208 RIMAVQYKIP--------DYVH--ISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 253
                  K          ++    I     +LL ++   +P +RI+  +   H +F
Sbjct: 232 LPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score =  110 bits (277), Expect = 9e-28
 Identities = 80/271 (29%), Positives = 134/271 (49%), Gaps = 32/271 (11%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTK-ELVAMKYIERGHKIDANVA------REIINHKQ 54
           E +  ++ +G+G+FG   L   KN     VA+K  E+   I           R+I+N+  
Sbjct: 30  EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNY-- 87

Query: 55  LRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYF-------FQQL 107
           + HP  +         ++L +V+E+  GGE F  +    RF  D   ++       F+ L
Sbjct: 88  INHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYL 147

Query: 108 ISGQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRR 167
            S  I +RDLK EN LLD      +K+ DFG++K  ++ +R  +  GTP YIAPE+L   
Sbjct: 148 QSLNIVYRDLKPENLLLDKDGF--IKMTDFGFAK--VVDTRTYTLCGTPEYIAPEILLNV 203

Query: 168 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCR 227
            + GK AD W+ G+ +Y +LVG  PF   E    ++K +  I+      P +  +  +C+
Sbjct: 204 GH-GKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIY----FPKF--LDNNCK 256

Query: 228 NLLSRIFVANPSRRI-----TIKEIKSHPWF 253
           +L+ ++   + ++R        + +K HPWF
Sbjct: 257 HLMKKLLSHDLTKRYGNLKKGAQNVKEHPWF 287

Length = 340

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score =  110 bits (276), Expect = 1e-27
 Identities = 79/268 (29%), Positives = 132/268 (49%), Gaps = 27/268 (10%)

Query: 4   YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKI-DANVAREIINHKQL----RHP 58
           +  +  +G G+FG   L   K T EL A+K +++   I D +V   ++  + L    + P
Sbjct: 2   FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPP 61

Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-------Q 111
            + +      T   L  VMEY  GG+L   I   G+F E  A ++  ++  G        
Sbjct: 62  FLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKG 121

Query: 112 ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST-VGTPAYIAPEVLSRREYD 170
           I +RDLKL+N +LD      +KI DFG  K ++   +   T  GTP YIAPE+++ + Y 
Sbjct: 122 IIYRDLKLDNVMLDAEG--HIKIADFGMCKENIFGGKTTRTFCGTPDYIAPEIIAYQPY- 178

Query: 171 GKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLL 230
           GK  D W+ GV LY ML G  PF+ +++ + F+     IM      P    +S++  ++ 
Sbjct: 179 GKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQS----IMEHNVSYPK--SLSKEAVSIC 232

Query: 231 SRIFVANPSRRITI-----KEIKSHPWF 253
             +   +P++R+       ++I+ H +F
Sbjct: 233 KGLLTKHPAKRLGCGPTGERDIREHAFF 260

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score =  111 bits (278), Expect = 1e-27
 Identities = 92/317 (29%), Positives = 132/317 (41%), Gaps = 82/317 (25%)

Query: 4   YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVA------REIINHKQLRH 57
           +  +K IG G FG   L+R  +T  L AMK + +   +  N A      R+I+   +  +
Sbjct: 3   FVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDIL--AEADN 60

Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLIS-------- 109
             +++         +L  VM+Y  GG++   +   G F ED AR++  +L          
Sbjct: 61  EWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKM 120

Query: 110 GQICHRDLKLENTLLDGSPAPRLKICDFG-------------YSK--------------- 141
           G I HRD+K +N L+D      +K+ DFG             Y K               
Sbjct: 121 GFI-HRDIKPDNILIDRDG--HIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEW 177

Query: 142 SSLLHSRPK----------------STVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYV 185
           S +   R K                S VGTP YIAPEVL R  Y  +L D WS GV LY 
Sbjct: 178 SEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYT-QLCDWWSVGVILYE 236

Query: 186 MLVGAYPF------EDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPS 239
           MLVG  PF      E Q    N+  T+         IP    +S++  +L+ R+      
Sbjct: 237 MLVGQPPFLADTPAETQLKVINWETTL--------HIPSQAKLSREASDLILRL-CCGAE 287

Query: 240 RRI---TIKEIKSHPWF 253
            R+      EIK+HP+F
Sbjct: 288 DRLGKNGADEIKAHPFF 304

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score =  109 bits (273), Expect = 1e-27
 Identities = 77/264 (29%), Positives = 127/264 (48%), Gaps = 25/264 (9%)

Query: 3   KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKID--ANVAREIINHKQLRH--- 57
           + EL   IG G +G     ++  T  +VA+K I      D  +++ RE+    QLR    
Sbjct: 5   RLEL---IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQP 61

Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLI-------SG 110
           PNI ++    L    L I+MEYA GG +   +  AG  +E       ++++         
Sbjct: 62  PNITKYYGSYLKGPRLWIIMEYAEGGSV-RTLMKAGPIAEKYISVIIREVLVALKYIHKV 120

Query: 111 QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST-VGTPAYIAPEVLSR-RE 168
            + HRD+K  N L+  +    +K+CDFG +     +S  +ST VGTP ++APEV++  + 
Sbjct: 121 GVIHRDIKAANILV--TNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEGKY 178

Query: 169 YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRN 228
           YD K AD+WS G+T+Y M  G  P+ D +    FR  +    +   ++ D    S+  R 
Sbjct: 179 YDTK-ADIWSLGITIYEMATGNPPYSDVD---AFRAMMLIPKSKPPRLEDN-GYSKLLRE 233

Query: 229 LLSRIFVANPSRRITIKEIKSHPW 252
            ++      P  R++ +E+    W
Sbjct: 234 FVAACLDEEPKERLSAEELLKSKW 257

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score =  109 bits (274), Expect = 1e-27
 Identities = 83/268 (30%), Positives = 131/268 (48%), Gaps = 27/268 (10%)

Query: 4   YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKI-DANVAREIINHKQL----RHP 58
           +  +  +G G+FG   L   K T EL A+K +++   I D +V   ++  + L    + P
Sbjct: 2   FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPP 61

Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQ-------LISGQ 111
            + +      T   L  VMEY  GG+L  +I   GRF E  A ++  +       L S  
Sbjct: 62  FLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKG 121

Query: 112 ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS-RPKSTVGTPAYIAPEVLSRREYD 170
           I +RDLKL+N +LD      +KI DFG  K ++      K+  GTP YIAPE+++ + Y 
Sbjct: 122 IIYRDLKLDNVMLDSEG--HIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEIIAYQPY- 178

Query: 171 GKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLL 230
           GK  D W+ GV LY ML G  PFE +++ + F+     IM      P    +S++   + 
Sbjct: 179 GKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQS----IMEHNVAYPK--SMSKEAVAIC 232

Query: 231 SRIFVANPSRRITI-----KEIKSHPWF 253
             +   +P +R+       ++IK H +F
Sbjct: 233 KGLMTKHPGKRLGCGPEGERDIKEHAFF 260

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score =  109 bits (273), Expect = 2e-27
 Identities = 79/263 (30%), Positives = 131/263 (49%), Gaps = 26/263 (9%)

Query: 8   KDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINH-----KQLRHPNIIR 62
           K IG G+FG   L R+K  ++  A+K +++   +     + I++      K ++HP ++ 
Sbjct: 1   KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 60

Query: 63  FKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-------QICHR 115
                 T   L  V++Y  GGELF  +     F E  AR++  ++ S         I +R
Sbjct: 61  LHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYR 120

Query: 116 DLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST-VGTPAYIAPEVLSRREYDGKLA 174
           DLK EN LLD      + + DFG  K ++ H+   ST  GTP Y+APEVL ++ YD +  
Sbjct: 121 DLKPENILLDSQ--GHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHKQPYD-RTV 177

Query: 175 DVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIF 234
           D W  G  LY ML G  PF  +   + +   +++ + ++   P+   I+   R+LL  + 
Sbjct: 178 DWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLK---PN---ITNSARHLLEGLL 231

Query: 235 VANPSRRITIK----EIKSHPWF 253
             + ++R+  K    EIK+H +F
Sbjct: 232 QKDRTKRLGAKDDFMEIKNHIFF 254

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score =  108 bits (271), Expect = 4e-27
 Identities = 82/308 (26%), Positives = 127/308 (41%), Gaps = 69/308 (22%)

Query: 3   KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK------IDANVAREIINHKQLR 56
           +YE  K +G G + V    R+K T  +VA+K I+ G +      I+    REI   ++L+
Sbjct: 1   RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELK 60

Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAG--RFSEDEARYFFQQLISG---- 110
           HPNII   +V    +++ +V E+    +L E++        +  + + +    + G    
Sbjct: 61  HPNIIGLLDVFGHKSNINLVFEFMET-DL-EKVIKDKSIVLTPADIKSYMLMTLRGLEYL 118

Query: 111 ---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPK----STVGTPAYIAPEV 163
               I HRDLK  N L+       LK+ DFG ++S      P       V T  Y APE+
Sbjct: 119 HSNWILHRDLKPNNLLIA--SDGVLKLADFGLARS---FGSPNRKMTHQVVTRWYRAPEL 173

Query: 164 LSRREYDGKLADVWSCGVTLYVMLVGAYPF------EDQEDPKNFRKTISRIMAV----- 212
           L    + G   D+WS G     +L+   PF       DQ         + +I        
Sbjct: 174 LFGARHYGVGVDMWSVGCIFAELLLRV-PFLPGDSDIDQ---------LGKIFEALGTPT 223

Query: 213 ------QYKIPDYV---------------HISQDCRNLLSRIFVANPSRRITIKEIKSHP 251
                    +PDYV                 S D  +LL R+   NP++RIT ++   HP
Sbjct: 224 EENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHP 283

Query: 252 WFLKNLPR 259
           +F  N P 
Sbjct: 284 YF-SNDPA 290

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score =  107 bits (268), Expect = 4e-27
 Identities = 84/280 (30%), Positives = 125/280 (44%), Gaps = 41/280 (14%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIE---RGHKIDANVAREIINHKQLRHP 58
           + YEL++ IG G   V          E VA+K I+       +D  + +E+    Q  HP
Sbjct: 1   DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVD-ELRKEVQAMSQCNHP 59

Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGELFE---RICNAGRFSEDEARYFFQQLI------- 108
           N++++    +    L +VM Y +GG L +        G   E       ++++       
Sbjct: 60  NVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLH 119

Query: 109 -SGQICHRDLKLENTLL--DGSPAPRLKICDFGYSKS-----SLLHSRPKSTVGTPAYIA 160
            +GQI HRD+K  N LL  DGS    +KI DFG S S            K+ VGTP ++A
Sbjct: 120 SNGQI-HRDIKAGNILLGEDGS----VKIADFGVSASLADGGDRTRKVRKTFVGTPCWMA 174

Query: 161 PEVLS-RREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIP-- 217
           PEV+     YD K AD+WS G+T   +  GA P+      K    T+      Q   P  
Sbjct: 175 PEVMEQVHGYDFK-ADIWSFGITAIELATGAAPYSKYPPMKVLMLTL------QNDPPSL 227

Query: 218 ----DYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 253
               DY   S+  R ++S     +PS+R T +E+  H +F
Sbjct: 228 ETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKHKFF 267

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score =  108 bits (270), Expect = 5e-27
 Identities = 80/262 (30%), Positives = 130/262 (49%), Gaps = 27/262 (10%)

Query: 10  IGSGNFGVARLMRNKNTKELVAMKYIERGHKI-DANVAREIINHKQL----RHPNIIRFK 64
           +G G+FG   L   K T EL A+K +++   I D +V   ++  + L    + P + +  
Sbjct: 8   LGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLH 67

Query: 65  EVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-------QICHRDL 117
               T   L  VMEY  GG+L   I   G+F E +A ++  ++  G        I +RDL
Sbjct: 68  SCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDL 127

Query: 118 KLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST-VGTPAYIAPEVLSRREYDGKLADV 176
           KL+N +LD      +KI DFG  K  ++      T  GTP YIAPE+++ + Y GK  D 
Sbjct: 128 KLDNVMLDSEG--HIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEIIAYQPY-GKSVDW 184

Query: 177 WSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVA 236
           W+ GV LY ML G  PF+ +++ + F+     IM      P    +S++  ++   +   
Sbjct: 185 WAYGVLLYEMLAGQPPFDGEDEDELFQS----IMEHNVSYPK--SLSKEAVSICKGLMTK 238

Query: 237 NPSRRITI-----KEIKSHPWF 253
           +PS+R+       ++I+ H +F
Sbjct: 239 HPSKRLGCGPEGERDIREHAFF 260

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score =  105 bits (265), Expect = 8e-27
 Identities = 78/266 (29%), Positives = 123/266 (46%), Gaps = 31/266 (11%)

Query: 4   YELMKDIGSGNFGVARLMRNKNTKELVAMKYI------ERGHKIDANVAREIINHKQLRH 57
           Y  ++ +G G FG A L R      LV  K +      E+  +   N   EI+    L+H
Sbjct: 2   YIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALN---EIVILSLLQH 58

Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFERIC--NAGRFSEDEARYFFQQLISG----- 110
           PNII +    +    L I MEYA GG L+++I       F E+   ++  Q++S      
Sbjct: 59  PNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIH 118

Query: 111 --QICHRDLKLENTLLDGSPAPRLKICDFGYSK---SSLLHSRPKSTVGTPAYIAPEVLS 165
              I HRD+K  N  L  + A  +K+ DFG SK   S    +  ++ VGTP Y++PE+  
Sbjct: 119 KAGILHRDIKTLNIFL--TKAGLIKLGDFGISKILGSEYSMA--ETVVGTPYYMSPELCQ 174

Query: 166 RREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQD 225
             +Y+ K +D+W+ G  LY +L     F    D  N    + +I+   Y     V+ S +
Sbjct: 175 GVKYNFK-SDIWALGCVLYELLTLKRTF----DATNPLNLVVKIVQGNYTPVVSVY-SSE 228

Query: 226 CRNLLSRIFVANPSRRITIKEIKSHP 251
             +L+  +   +P +R T  E+   P
Sbjct: 229 LISLVHSLLQQDPEKRPTADEVLDQP 254

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score =  105 bits (265), Expect = 1e-26
 Identities = 78/287 (27%), Positives = 127/287 (44%), Gaps = 54/287 (18%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREI-INHKQLRHPNI 60
             +EL++ IG G +G     R+K T +LVA+K ++     +  +  E  I  K   HPNI
Sbjct: 6   GIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNI 65

Query: 61  IRFKEVVLTPTH------LAIVMEYAAGG---ELFERICNAG-RFSEDEARYFFQQLISG 110
             F    +          L +VME   GG   +L + +   G R  E+   Y  ++ + G
Sbjct: 66  ATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRG 125

Query: 111 -------QICHRDLKLENTLL--DGSPAPRLKICDFGYS---KSSLLHSRPKSTVGTPAY 158
                  ++ HRD+K +N LL  +      +K+ DFG S    S+L   R  + +GTP +
Sbjct: 126 LAYLHENKVIHRDIKGQNILLTKNA----EVKLVDFGVSAQLDSTL--GRRNTFIGTPYW 179

Query: 159 IAPEVLS-----RREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQ 213
           +APEV++        YD + +DVWS G+T   +  G  P  D   P          M   
Sbjct: 180 MAPEVIACDEQPDASYDAR-SDVWSLGITAIELADGKPPLCDMH-P----------MRAL 227

Query: 214 YKIPDYV--------HISQDCRNLLSRIFVANPSRRITIKEIKSHPW 252
           +KIP           + S+   + +S   + N  +R  ++E+  HP+
Sbjct: 228 FKIPRNPPPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPF 274

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score =  105 bits (263), Expect = 2e-26
 Identities = 79/272 (29%), Positives = 125/272 (45%), Gaps = 34/272 (12%)

Query: 4   YELMKDIGSGNFGVARLMRNKNT-KELVAMKYI------------ERGHKIDANVAREII 50
           Y +++ +GSG FG    +R KN  + L+A+K I            ER   I   V+   I
Sbjct: 2   YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTI 61

Query: 51  NHKQLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICN----AGRFSEDEARYFFQQ 106
             +QLRHPNI+R+ +  L    L IVM+   G  L E   +      RF+E+     F Q
Sbjct: 62  IKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQ 121

Query: 107 LI--------SGQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAY 158
           ++          +I HRDL   N +L      ++ I DFG +K     S+  S VGT  Y
Sbjct: 122 MVLALRYLHKEKRIVHRDLTPNNIML--GEDDKVTITDFGLAKQKQPESKLTSVVGTILY 179

Query: 159 IAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYK-IP 217
             PE++    Y G+ ADVW+ G  LY M     PF       N     ++I+   Y+ +P
Sbjct: 180 SCPEIVKNEPY-GEKADVWAFGCILYQMCTLQPPFYST----NMLSLATKIVEAVYEPLP 234

Query: 218 DYVHISQDCRNLLSRIFVANPSRRITIKEIKS 249
           + ++ S+D  ++++     +   R  I ++ +
Sbjct: 235 EGMY-SEDVTDVITSCLTPDAEARPDIIQVSA 265

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score =  105 bits (263), Expect = 2e-26
 Identities = 77/272 (28%), Positives = 121/272 (44%), Gaps = 40/272 (14%)

Query: 10  IGSGNFGVARLMRNKNTKELVAMKYIE--RGHKIDAN-----VAREIINHKQLRHPNIIR 62
           +G+G F      R+  T  L+A+K +   R    +       + +EI    +L HP+IIR
Sbjct: 8   LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIR 67

Query: 63  FKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-------QICHR 115
                   +H  + +E+ AGG +   +   G F E     + +QL+ G       QI HR
Sbjct: 68  MLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHR 127

Query: 116 DLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST-------VGTPAYIAPEVLSRRE 168
           D+K  N L+D S   RL+I DFG   ++ L ++           +GT A++APEVL   +
Sbjct: 128 DVKGANLLID-STGQRLRIADFG--AAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQ 184

Query: 169 YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKI------PDY-VH 221
           Y G+  DVWS G  +  M     P+  ++         S  +A+ +KI      P    H
Sbjct: 185 Y-GRSCDVWSVGCVIIEMATAKPPWNAEK--------HSNHLALIFKIASATTAPSIPEH 235

Query: 222 ISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 253
           +S   R++  R     P  R   +E+  HP F
Sbjct: 236 LSPGLRDVTLRCLELQPEDRPPSRELLKHPVF 267

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score =  105 bits (263), Expect = 3e-26
 Identities = 73/205 (35%), Positives = 99/205 (48%), Gaps = 24/205 (11%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVA---MKYIERGHKIDANVAREIINHKQLRHP 58
            KYE++  +G G +GV    RNK T E+VA    K  E    +     RE+   +QLRH 
Sbjct: 1   NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHE 60

Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGG--ELFERICNAGRFSEDEARYFFQQLISG------ 110
           NI+  KE       L +V EY      EL E   + G    D  R +  QL+        
Sbjct: 61  NIVNLKEAFRRKGRLYLVFEYVERTLLELLEA--SPGGLPPDAVRSYIWQLLQAIAYCHS 118

Query: 111 -QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST----VGTPAYIAPEVL- 164
             I HRD+K EN L+  S +  LK+CDFG++++  L +RP S     V T  Y APE+L 
Sbjct: 119 HNIIHRDIKPENILV--SESGVLKLCDFGFARA--LRARPASPLTDYVATRWYRAPELLV 174

Query: 165 SRREYDGKLADVWSCGVTLYVMLVG 189
               Y GK  DVW+ G  +  +L G
Sbjct: 175 GDTNY-GKPVDVWAIGCIMAELLDG 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score =  106 bits (265), Expect = 5e-26
 Identities = 83/273 (30%), Positives = 133/273 (48%), Gaps = 29/273 (10%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQL----RH 57
           E Y+++K IG G FG  +L+R+K+++++ AMK + +   I  + +      + +      
Sbjct: 43  EDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANS 102

Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNA------GRFSEDEARYFFQQLISGQ 111
           P +++         +L +VMEY  GG+L   + N        +F   E       + S  
Sbjct: 103 PWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLALDAIHSMG 162

Query: 112 ICHRDLKLENTLLDGSPAPRLKICDFG----YSKSSLLHSRPKSTVGTPAYIAPEVLSRR 167
           + HRD+K +N LLD      LK+ DFG      ++ ++     + VGTP YI+PEVL  +
Sbjct: 163 LIHRDVKPDNMLLD--KHGHLKLADFGTCMKMDETGMVRC--DTAVGTPDYISPEVLKSQ 218

Query: 168 ---EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKI--PDYVHI 222
               Y G+  D WS GV L+ MLVG  PF       +   T S+IM  +  +  P+ V I
Sbjct: 219 GGDGYYGRECDWWSVGVFLFEMLVGDTPFY----ADSLVGTYSKIMDHKNSLNFPEDVEI 274

Query: 223 SQDCRNLLSRIFVANPSR--RITIKEIKSHPWF 253
           S+  +NL+         R  R  ++EIK HP+F
Sbjct: 275 SKHAKNLICAFLTDREVRLGRNGVEEIKQHPFF 307

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score =  105 bits (262), Expect = 5e-26
 Identities = 77/278 (27%), Positives = 136/278 (48%), Gaps = 32/278 (11%)

Query: 4   YELMKDIGSGNFGVARLMRN---KNTKELVAMKYIERGHKID-------ANVAREIINHK 53
           +EL+K +G+G +G   L+R     ++ +L AMK +++   +            R+++ H 
Sbjct: 2   FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI 61

Query: 54  QLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG--- 110
           + + P ++       T T L ++++Y  GGELF  +    RF E E + +  +++     
Sbjct: 62  R-QSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEH 120

Query: 111 ----QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS--RPKSTVGTPAYIAPEVL 164
                I +RD+KLEN LLD +    + + DFG SK        R  S  GT  Y+AP+++
Sbjct: 121 LHKLGIIYRDIKLENILLDSN--GHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIV 178

Query: 165 SRRE--YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHI 222
              +  +D K  D WS GV +Y +L GA PF    +  +  +   RI+  +   P    +
Sbjct: 179 RGGDGGHD-KAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQ--EM 235

Query: 223 SQDCRNLLSRIFVANPSRRI-----TIKEIKSHPWFLK 255
           S   ++++ R+ + +P +R+        EIK HP+F K
Sbjct: 236 SALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQK 273

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  102 bits (258), Expect = 1e-25
 Identities = 67/267 (25%), Positives = 107/267 (40%), Gaps = 32/267 (11%)

Query: 5   ELMKDIGSGNFGV---ARL-MRNKNTKELVAMKYIERGHKIDANVA--REIINHKQLRHP 58
           EL K +G G FG      L    + T+  VA+K ++ G   +       E    K+L HP
Sbjct: 2   ELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHP 61

Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGEL--FERICNAGRFSEDEARYFFQQLISG------ 110
           NI+R   V      L IV EY  GG+L  F R  +  + +  +      Q+  G      
Sbjct: 62  NIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRK-HGEKLTLKDLLQMALQIAKGMEYLES 120

Query: 111 -QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYI-----APEVL 164
               HRDL   N L+  +    +KI DFG S+   ++            +     APE L
Sbjct: 121 KNFVHRDLAARNCLVTEN--LVVKISDFGLSR--DIYEDDYYRKRGGGKLPIKWMAPESL 176

Query: 165 SRREYDGKLADVWSCGVTLY-VMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHIS 223
              ++  K +DVWS GV L+ +  +G  P+    + +             Y++P   +  
Sbjct: 177 KDGKFTSK-SDVWSFGVLLWEIFTLGEQPYPGMSNEEVLELLEDG-----YRLPRPENCP 230

Query: 224 QDCRNLLSRIFVANPSRRITIKEIKSH 250
            +   L+ + +  +P  R T  E+   
Sbjct: 231 DELYELMLQCWAYDPEDRPTFSELVED 257

Length = 258

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score =  103 bits (258), Expect = 2e-25
 Identities = 80/290 (27%), Positives = 127/290 (43%), Gaps = 47/290 (16%)

Query: 4   YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDAN------VAREIINHKQLRH 57
           ++ ++ +G G +      RN+ T E+VA+K I     +DA         REI   K+L+H
Sbjct: 2   FKQLEKLGEGTYATVYKGRNRTTGEIVALKEI----HLDAEEGTPSTAIREISLMKELKH 57

Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGG--ELFERICNAGRFSEDEARYFFQQLISG----- 110
            NI+R  +V+ T   L +V EY      +  +     G    +  + F  QL+ G     
Sbjct: 58  ENIVRLHDVIHTENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCH 117

Query: 111 --QICHRDLKLENTLLDGSPAPRLKICDFGYSKS-SLLHSRPKSTVGTPAYIAPEVL-SR 166
             ++ HRDLK +N L++      LK+ DFG +++  +  +   + V T  Y AP+VL   
Sbjct: 118 ENRVLHRDLKPQNLLINKR--GELKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVLLGS 175

Query: 167 REYDGKLADVWSCGVTLYVMLVGA--YPFEDQEDP--KNFR----------KTISRIMAV 212
           R Y   + D+WS G  +  M+ G   +P  + ED   K FR            IS++   
Sbjct: 176 RTYSTSI-DIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEY 234

Query: 213 QYKIPDYVHISQ---------DCRNLLSRIFVANPSRRITIKEIKSHPWF 253
           +   P Y                 +LL R+   NP  RI+  +   HPWF
Sbjct: 235 KPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score =  102 bits (257), Expect = 2e-25
 Identities = 76/280 (27%), Positives = 120/280 (42%), Gaps = 47/280 (16%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKI---DANVAREIINHKQLRHP 58
           + +E++ ++G G FG     ++K T    A K I+   +    D  V  +I++  + +HP
Sbjct: 5   DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILS--ECKHP 62

Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGR-FSEDEARYFFQQLISG------- 110
           NI+   E       L I++E+  GG L   +    R  +E + RY  +Q++         
Sbjct: 63  NIVGLYEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSH 122

Query: 111 QICHRDLKLENTLL--DGSPAPRLKICDFGYSKSSLLHSRPK--STVGTPAYIAPEVL-- 164
           ++ HRDLK  N LL  DG     +K+ DFG S +    +  K  + +GTP ++APEV+  
Sbjct: 123 KVIHRDLKAGNILLTLDGD----VKLADFGVS-AKNKSTLQKRDTFIGTPYWMAPEVVAC 177

Query: 165 ---SRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDY-- 219
                  YD K AD+WS G+TL  +     P  +              M V  KI     
Sbjct: 178 ETFKDNPYDYK-ADIWSLGITLIELAQMEPPHHELN-----------PMRVLLKILKSEP 225

Query: 220 ------VHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 253
                    S    + L    V +P  R T  E+  HP+ 
Sbjct: 226 PTLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPFV 265

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score =  103 bits (257), Expect = 4e-25
 Identities = 77/263 (29%), Positives = 117/263 (44%), Gaps = 26/263 (9%)

Query: 8   KDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINH-----KQLRHPNIIR 62
           K IG G+FG   L + K+     A+K +++   +       I+       K L+HP ++ 
Sbjct: 1   KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVG 60

Query: 63  FKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-------QICHR 115
                 T   L  V++Y  GGELF  +     F E  AR++  ++ S         I +R
Sbjct: 61  LHYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYR 120

Query: 116 DLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST-VGTPAYIAPEVLSRREYDGKLA 174
           DLK EN LLD      + + DFG  K  +      ST  GTP Y+APEVL +  YD +  
Sbjct: 121 DLKPENILLDSQ--GHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEVLRKEPYD-RTV 177

Query: 175 DVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIF 234
           D W  G  LY ML G  PF  ++  + +   + + + +             C +LL  + 
Sbjct: 178 DWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQLPGGKTVAA-----C-DLLVGLL 231

Query: 235 VANPSRRITIK----EIKSHPWF 253
             +  RR+  K    EIK+H +F
Sbjct: 232 HKDQRRRLGAKADFLEIKNHVFF 254

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score =  101 bits (253), Expect = 6e-25
 Identities = 79/268 (29%), Positives = 119/268 (44%), Gaps = 31/268 (11%)

Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAR-----EIINHKQL 55
           +  +++ K IG G F V           +VA+K ++    +DA  AR     EI   KQL
Sbjct: 1   LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAK-ARQDCLKEIDLLKQL 59

Query: 56  RHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGR----FSEDEARYFFQQLISG- 110
            HPN+I++    +    L IV+E A  G+L   I +  +      E     +F QL S  
Sbjct: 60  DHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSAL 119

Query: 111 ------QICHRDLKLENTLLDGSPAPRLKICDFGY-----SKSSLLHSRPKSTVGTPAYI 159
                 +I HRD+K  N  +  +    +K+ D G      SK++  HS     VGTP Y+
Sbjct: 120 EHMHSKRIMHRDIKPANVFITATGV--VKLGDLGLGRFFSSKTTAAHSL----VGTPYYM 173

Query: 160 APEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDY 219
           +PE +    Y+ K +D+WS G  LY M     PF    D  N      +I    Y     
Sbjct: 174 SPERIHENGYNFK-SDIWSLGCLLYEMAALQSPFY--GDKMNLYSLCKKIEKCDYPPLPA 230

Query: 220 VHISQDCRNLLSRIFVANPSRRITIKEI 247
            H S++ R+L+SR    +P +R  I  +
Sbjct: 231 DHYSEELRDLVSRCINPDPEKRPDISYV 258

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score =  101 bits (253), Expect = 7e-25
 Identities = 74/292 (25%), Positives = 134/292 (45%), Gaps = 33/292 (11%)

Query: 5   ELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRH----PNI 60
           E++ ++G GN+G    + ++ T   +AMK I    ++D +   +II    + H    P I
Sbjct: 4   EVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRL--ELDESKFNQIIMELDILHKAVSPYI 61

Query: 61  IRFKEVVLTPTHLAIVMEYAAGG---ELFERICNAGRFSEDEARYFFQQLISG------- 110
           + F         + + MEY   G   +L+          ED  R     ++ G       
Sbjct: 62  VDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEE 121

Query: 111 -QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREY 169
             I HRD+K  N L++G+   ++K+CDFG S  +L+ S  K+ +G  +Y+APE +     
Sbjct: 122 HNIIHRDVKPTNVLVNGNG--QVKLCDFGVS-GNLVASLAKTNIGCQSYMAPERIKSGGP 178

Query: 170 DGKL-----ADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYV--HI 222
           +        +DVWS G+++  M +G YP+     P+ +    +++ A+    P  +    
Sbjct: 179 NQNPTYTVQSDVWSLGLSILEMALGRYPYP----PETYANIFAQLSAIVDGDPPTLPSGY 234

Query: 223 SQDCRNLLSRIFVANPSRRITIKEIKSHPWFLK--NLPRELTETAQAIYYRK 272
           S D ++ +++     P+RR T  ++  HPW +K  N   ++ E       RK
Sbjct: 235 SDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYKNADVDMAEWVTGALKRK 286

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score =  101 bits (254), Expect = 8e-25
 Identities = 83/302 (27%), Positives = 125/302 (41%), Gaps = 67/302 (22%)

Query: 4   YELMKDIGSGNFGVARLMRNKNTKELVAMKYI-----ERGHKIDANVAREIINHKQLR-- 56
           YE + +IG G +G     R+ NT   VA+K +     E G  I  +  REI   KQL   
Sbjct: 1   YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEG--IPLSTLREIALLKQLESF 58

Query: 57  -HPNIIRFKEVVLTP-----THLAIVMEYA----AGGELFERICNAGRFSEDEARYFFQQ 106
            HPNI+R  +V   P       L +V E+     A    +   C       +  +   +Q
Sbjct: 59  EHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLAT---YLSKCPKPGLPPETIKDLMRQ 115

Query: 107 LISG-------QICHRDLKLENTLL--DGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPA 157
           L+ G       +I HRDLK +N L+  DG    ++KI DFG ++         S V T  
Sbjct: 116 LLRGVDFLHSHRIVHRDLKPQNILVTSDG----QVKIADFGLARIYSFEMALTSVVVTLW 171

Query: 158 YIAPEVLSRREYDGKLADVWSCGVTLYVM--LVGAYP-----------FE-----DQED- 198
           Y APEVL +  Y   + D+WS G     +      +            F+      +E+ 
Sbjct: 172 YRAPEVLLQSSYATPV-DMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEW 230

Query: 199 PKN-------FRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHP 251
           P+N       F     R       +P+   I ++  +LL ++   NP +RI+  E   HP
Sbjct: 231 PRNVSLPRSSFPSYTPRSFKSF--VPE---ICEEGLDLLKKMLTFNPHKRISAFEALQHP 285

Query: 252 WF 253
           +F
Sbjct: 286 YF 287

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score =  100 bits (251), Expect = 1e-24
 Identities = 81/264 (30%), Positives = 123/264 (46%), Gaps = 18/264 (6%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYI--ERGHKIDANVAREIINHKQLRHPN 59
           E +EL++ IGSG +G     RN NT EL A+K I  E G      V +EII  K  +H N
Sbjct: 9   EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAV-VQQEIIMMKDCKHSN 67

Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGQI------- 112
           I+ +    L    L I ME+  GG L +     G  SE +  Y  ++ + G         
Sbjct: 68  IVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGK 127

Query: 113 CHRDLKLENTLLDGSPAPRLKICDFGYSKS-SLLHSRPKSTVGTPAYIAPEV--LSRREY 169
            HRD+K  N LL  +    +K+ DFG S   +   ++ KS +GTP ++APEV  + R+  
Sbjct: 128 MHRDIKGANILL--TDNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERKGG 185

Query: 170 DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKN-FRKTISRIMAVQYKIPDYVHISQDCRN 228
             +L D+W+ G+T   +     P  D    +  F  T S       K+ D +  S    +
Sbjct: 186 YNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPP--KLKDKMKWSNSFHH 243

Query: 229 LLSRIFVANPSRRITIKEIKSHPW 252
            +      NP +R T +++  HP+
Sbjct: 244 FVKMALTKNPKKRPTAEKLLQHPF 267

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score =   99 bits (250), Expect = 3e-24
 Identities = 89/301 (29%), Positives = 135/301 (44%), Gaps = 61/301 (20%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYI----ER-GHKIDANVAREIINHKQLR 56
           ++YE +  I  G +GV    R+K T E+VA+K +    E+ G  I +   REI    +L+
Sbjct: 5   DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITS--LREINILLKLQ 62

Query: 57  HPNIIRFKEVVL--TPTHLAIVMEYAAGGE-----LFERICNAGRFSEDEARYFFQQLIS 109
           HPNI+  KEVV+      + +VMEY    E     L E +     F + E +    QL+S
Sbjct: 63  HPNIVTVKEVVVGSNLDKIYMVMEYV---EHDLKSLMETM--KQPFLQSEVKCLMLQLLS 117

Query: 110 G-------QICHRDLKLENTLLDGSPAPRLKICDFGYSK--SSLLHSRPKSTVGTPAYIA 160
           G        I HRDLK  N LL  +    LKICDFG ++   S L    +  V T  Y A
Sbjct: 118 GVAHLHDNWILHRDLKTSNLLL--NNRGILKICDFGLAREYGSPLKPYTQLVV-TLWYRA 174

Query: 161 PEVL-SRREYDGKLADVWSCGVTLYVMLVGAYPFE-----DQEDPKNFR----------- 203
           PE+L   +EY   + D+WS G     +L     F      DQ + K F+           
Sbjct: 175 PELLLGAKEYSTAI-DMWSVGCIFAELLTKKPLFPGKSEIDQLN-KIFKLLGTPTEKIWP 232

Query: 204 --KTISRIMAVQYKIPDY---------VHISQDCRNLLSRIFVANPSRRITIKEIKSHPW 252
               +       +    Y         + +S +  +LL+R+   +P++RI+ ++   HP+
Sbjct: 233 GFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPY 292

Query: 253 F 253
           F
Sbjct: 293 F 293

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score =  100 bits (251), Expect = 3e-24
 Identities = 83/304 (27%), Positives = 125/304 (41%), Gaps = 73/304 (24%)

Query: 4   YELMKDIGSGNFGVARLMRNKNTKELVAMKYI----ERGHKIDANVAREIINHKQLRHPN 59
           +E +  IG G +G+    R+  + E+VA+K +    ER   I  +  REI     LRHPN
Sbjct: 9   FEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERD-GIPISSLREITLLLNLRHPN 67

Query: 60  IIRFKEVVLTPTHLA---IVMEYAAG--GELFERICNAGRFSEDEARYFFQQLISGQ--- 111
           I+  KEVV    HL    +VMEY       L + +     FSE + +    QL+ G    
Sbjct: 68  IVELKEVV-VGKHLDSIFLVMEYCEQDLASLLDNMPTP--FSESQVKCLMLQLLRGLQYL 124

Query: 112 ----ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKS-TVGTPAYIAPEVL-S 165
               I HRDLK+ N LL       LKI DFG +++  L ++P +  V T  Y APE+L  
Sbjct: 125 HENFIIHRDLKVSNLLLTDKGC--LKIADFGLARTYGLPAKPMTPKVVTLWYRAPELLLG 182

Query: 166 RREYDGKLADVWSCG---------------------VTLYVMLVGA-----YP------- 192
              Y     D+W+ G                     + L + L+G      +P       
Sbjct: 183 CTTYT-TAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPL 241

Query: 193 ---FEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKS 249
              F   + P N  K              +  +S+    LL+ + + +P +R T +E   
Sbjct: 242 VGKFTLPKQPYNNLK------------HKFPWLSEAGLRLLNFLLMYDPKKRATAEEALE 289

Query: 250 HPWF 253
             +F
Sbjct: 290 SSYF 293

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 99.7 bits (249), Expect = 3e-24
 Identities = 78/290 (26%), Positives = 122/290 (42%), Gaps = 48/290 (16%)

Query: 4   YELMKDIGSGNFGVARLMRNKNTKELVAMKY-IERGHKID-ANVAREIINHKQLR-HPNI 60
           Y+++  IG G F      +++ T +  A+K   +    ++  N  REI   ++L  HPNI
Sbjct: 1   YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNI 60

Query: 61  IRFKEVVLTPTH--LAIVMEYAAGGELFERICNAGR-FSEDEARYFFQQLISG------- 110
           +R  EV+       LA+V E      L+E I    R   E   + +  QL+         
Sbjct: 61  LRLIEVLFDRKTGRLALVFELMDM-NLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRN 119

Query: 111 QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST--VGTPAYIAPEVLSRRE 168
            I HRD+K EN L+       LK+ DFG  +   ++S+P  T  + T  Y APE L    
Sbjct: 120 GIFHRDIKPENILIKDD---ILKLADFGSCRG--IYSKPPYTEYISTRWYRAPECLLTDG 174

Query: 169 YDGKLADVWSCGVTLYVM--LVGAYPFEDQED-----------PK---NFRKTISRIMAV 212
           Y G   D+W+ G   + +  L   +P  ++ D           P      +   SR M  
Sbjct: 175 YYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHM-- 232

Query: 213 QYKIPD---------YVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 253
            Y  P            + S +  +LL ++   +P  RIT K+   HP+F
Sbjct: 233 NYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 99.4 bits (248), Expect = 4e-24
 Identities = 78/289 (26%), Positives = 132/289 (45%), Gaps = 43/289 (14%)

Query: 3   KYELMKDIGSGNFGVARLMRNKNTKELVAMKYI---ERGHKIDANVAREIINHKQLRHPN 59
           KYE ++ IG G +G     +N+ T E+VA+K +   +    + ++  REI   K+L+H N
Sbjct: 1   KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKN 60

Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFERICNA--GRFSEDEARYFFQQLISG------- 110
           I+R  +V+ +   L +V EY    +  ++  ++  G    +  + F  QL+ G       
Sbjct: 61  IVRLYDVLHSDKKLTLVFEYC--DQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSH 118

Query: 111 QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST-VGTPAYIAPEVL-SRRE 168
            + HRDLK +N L++ +    LK+ DFG +++  +  R  S  V T  Y  P+VL   + 
Sbjct: 119 NVLHRDLKPQNLLINKN--GELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKL 176

Query: 169 YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQ--------YKIPDYV 220
           Y   + D+WS G     +     P     D  +  K I R++            K+PDY 
Sbjct: 177 YSTSI-DMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYK 235

Query: 221 ----------------HISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 253
                            ++   R+LL  + V NP +RI+ +E   HP+F
Sbjct: 236 PYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 99.1 bits (247), Expect = 4e-24
 Identities = 73/259 (28%), Positives = 129/259 (49%), Gaps = 23/259 (8%)

Query: 10  IGSGNFGVARLMRNKNTKELVAMKYI-ERGHKIDANVAREIINHKQLRHPNIIRFKEVVL 68
           +G G +G+    R+ +T+  +A+K I ER  +    +  EI  H  L+H NI+++     
Sbjct: 16  LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDS 75

Query: 69  TPTHLAIVMEYAAGG---ELFERICNAGRFSEDEARYFFQQLISG-------QICHRDLK 118
                 I ME   GG    L        + +E    ++ +Q++ G       QI HRD+K
Sbjct: 76  ENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIK 135

Query: 119 LENTLLDGSPAPRLKICDFGYSKS-SLLHSRPKSTVGTPAYIAPEVLSR--REYDGKLAD 175
            +N L++ + +  +KI DFG SK  + ++   ++  GT  Y+APEV+ +  R Y G  AD
Sbjct: 136 GDNVLVN-TYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDKGPRGY-GAPAD 193

Query: 176 VWSCGVTLYVMLVGAYPFEDQEDPKN--FRKTISRIMAVQYKIPDYVHISQDCRNLLSRI 233
           +WS G T+  M  G  PF +  +P+   F+  + +I     +IP+   +S + +N + R 
Sbjct: 194 IWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHP---EIPE--SLSAEAKNFILRC 248

Query: 234 FVANPSRRITIKEIKSHPW 252
           F  +P +R +  ++   P+
Sbjct: 249 FEPDPDKRASAHDLLQDPF 267

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score =  100 bits (251), Expect = 5e-24
 Identities = 78/274 (28%), Positives = 129/274 (47%), Gaps = 30/274 (10%)

Query: 5   ELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK--IDANVAREIINHKQLRHPNIIR 62
           E +  IGSG  G    + ++ T  L A+K I   H+  +   + REI   + + HPN+++
Sbjct: 77  ERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVK 136

Query: 63  FKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-------QICHR 115
             ++      + +++E+  GG L        +F  D AR    Q++SG        I HR
Sbjct: 137 CHDMFDHNGEIQVLLEFMDGGSLEGTHIADEQFLADVAR----QILSGIAYLHRRHIVHR 192

Query: 116 DLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP-KSTVGTPAYIAPEV----LSRREYD 170
           D+K  N L++   A  +KI DFG S+       P  S+VGT AY++PE     L+   YD
Sbjct: 193 DIKPSNLLINS--AKNVKIADFGVSRILAQTMDPCNSSVGTIAYMSPERINTDLNHGAYD 250

Query: 171 GKLADVWSCGVTLYVMLVGAYPFE--DQEDPKNFRKTISRIMAVQYKIPDY--VHISQDC 226
           G   D+WS GV++    +G +PF    Q D        S + A+    P       S++ 
Sbjct: 251 GYAGDIWSLGVSILEFYLGRFPFGVGRQGD------WASLMCAICMSQPPEAPATASREF 304

Query: 227 RNLLSRIFVANPSRRITIKEIKSHPWFLKNLPRE 260
           R+ +S      P++R +  ++  HP+ L+  P +
Sbjct: 305 RHFISCCLQREPAKRWSAMQLLQHPFILRAQPGQ 338

Length = 353

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score =  100 bits (251), Expect = 5e-24
 Identities = 84/323 (26%), Positives = 136/323 (42%), Gaps = 86/323 (26%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRH---- 57
           E +  +K IG G FG  RL++ K+T ++ AMK +         +  E+    QL H    
Sbjct: 1   EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTL---------LKSEMFKKDQLAHVKAE 51

Query: 58  ---------PNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLI 108
                    P ++          +L ++ME+  GG+L   +     FSED  R++  + +
Sbjct: 52  RDVLAESDSPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECV 111

Query: 109 --------SGQICHRDLKLENTLLDGSPAPRLKICDFGYSK------------------- 141
                    G I HRD+K +N L+D      +K+ DFG S                    
Sbjct: 112 LAIEAVHKLGFI-HRDIKPDNILIDRGG--HIKLSDFGLSTGFHKQHDSAYYQKLLQGKS 168

Query: 142 ----------------SSLLHSRPK-------------STVGTPAYIAPEVLSRREYDGK 172
                           +  + S+ +             STVGTP YIAPE+  ++ Y G+
Sbjct: 169 NKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGY-GQ 227

Query: 173 LADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSR 232
             D WS G  ++  L+G  PF  +   + +RK I+    + +  PD +H+S +  +L+ R
Sbjct: 228 ECDWWSLGAIMFECLIGWPPFCSENSHETYRKIINWRETLYF--PDDIHLSVEAEDLIRR 285

Query: 233 IFVANPSR--RITIKEIKSHPWF 253
           +     +R  R    EIKSHP+F
Sbjct: 286 LITNAENRLGRGGAHEIKSHPFF 308

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score =  100 bits (250), Expect = 6e-24
 Identities = 77/307 (25%), Positives = 125/307 (40%), Gaps = 50/307 (16%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERG---HKIDANVAREIINHKQLRHP 58
            +Y+ +++IGSG +GV     +  + + VA+K I        +     RE+   +  +H 
Sbjct: 5   SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHD 64

Query: 59  NIIRFKEVVLTP----THLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG---- 110
           NII  ++++  P      + +VM+     +L   I +    +E+  RYF  QL+ G    
Sbjct: 65  NIIAIRDILRPPGADFKDVYVVMDL-MESDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYI 123

Query: 111 ---QICHRDLKLENTLLDGSPAPRLKICDFG----YSKSSLLHSR-PKSTVGTPAYIAPE 162
               + HRDLK  N L++      L+I DFG     S S   H       V T  Y APE
Sbjct: 124 HSANVIHRDLKPSNLLVNED--CELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPE 181

Query: 163 VL-SRREYDGKLADVWSCGVTLYVMLVGA--YPFEDQED------------PKNFRKTIS 207
           +L S  EY   + D+WS G     ML     +P ++                +     I 
Sbjct: 182 LLLSLPEYTTAI-DMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIG 240

Query: 208 --RIMAVQYKIPD---------YVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKN 256
             R+      +P          +   S +  +LLS++   +P  RIT+++   HP FL  
Sbjct: 241 SDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHP-FLAQ 299

Query: 257 LPRELTE 263
                 E
Sbjct: 300 YHDPDDE 306

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 98.4 bits (246), Expect = 8e-24
 Identities = 76/271 (28%), Positives = 128/271 (47%), Gaps = 33/271 (12%)

Query: 2   EKYELMKDIGS--GNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLR-HP 58
           +  E++K +    G FG   ++++K T++L   K I+  +    N A E + H+ ++ +P
Sbjct: 14  KNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKN---FN-AIEPMVHQLMKDNP 69

Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-------Q 111
           N I+    V T     ++M+Y   G+LF+ +   G+ SE E +   +QL+          
Sbjct: 70  NFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHN 129

Query: 112 ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTV-GTPAYIAPEVLSRREYD 170
           I H D+KLEN L D +   R+ +CD+G  K         S   GT  Y +PE +    YD
Sbjct: 130 IIHNDIKLENVLYDRA-KDRIYLCDYGLCK----IIGTPSCYDGTLDYFSPEKIKGHNYD 184

Query: 171 GKLADVWSCGVTLYVMLVGAYPFEDQED----PKNFRKTISRIMAVQYKIPDYVHISQDC 226
               D W+ GV  Y +L G +PF++ ED     ++  K   +      K+P   ++S++ 
Sbjct: 185 VSF-DWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQK------KLPFIKNVSKNA 237

Query: 227 RNLLSRIFVANPSRR-ITIKEIKSHPWFLKN 256
            + +  +   N + R     EI  HP FLK 
Sbjct: 238 NDFVQSMLKYNINYRLTNYNEIIKHP-FLKI 267

Length = 267

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score =  100 bits (249), Expect = 8e-24
 Identities = 81/302 (26%), Positives = 135/302 (44%), Gaps = 56/302 (18%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPN-- 59
           + +E +K IG G FG  RL++ K+T  + AMK + +   ++      I   + +      
Sbjct: 1   DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADG 60

Query: 60  --IIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG------- 110
             +++         +L ++ME+  GG++   +      SE+  +++  + +         
Sbjct: 61  AWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQL 120

Query: 111 QICHRDLKLENTLLDGSPAPRLKICDFGYSKS-----------SLLHSRPK--------- 150
              HRD+K +N LLD      +K+ DFG               +L H+ P          
Sbjct: 121 GFIHRDIKPDNLLLDAKG--HVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNS 178

Query: 151 ----------------STVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFE 194
                           STVGTP YIAPEV  +  Y+ KL D WS GV +Y ML+G  PF 
Sbjct: 179 KRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYN-KLCDWWSLGVIMYEMLIGYPPFC 237

Query: 195 DQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRI---TIKEIKSHP 251
            +   + +RK ++    + +  P  V IS+  ++L+ R F  +   RI    ++EIKSHP
Sbjct: 238 SETPQETYRKVMNWKETLVF--PPEVPISEKAKDLILR-FCTDSENRIGSNGVEEIKSHP 294

Query: 252 WF 253
           +F
Sbjct: 295 FF 296

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 98.1 bits (244), Expect = 8e-24
 Identities = 82/272 (30%), Positives = 131/272 (48%), Gaps = 35/272 (12%)

Query: 3   KYELMKDIGSGNFGVARLMRNKNTK---ELVAMKYIERG-----HKIDANVAREIINHKQ 54
           +Y L + +G G+FG   L+++K       L  +K I  G       + AN   ++++  +
Sbjct: 1   RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLS--K 58

Query: 55  LRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERI----CNAGRFSEDEARYFFQQLISG 110
           L HP I++F    L      I+ EY  G +L  ++          SE++   +F QL+ G
Sbjct: 59  LDHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLG 118

Query: 111 -------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTV--GTPAYIAP 161
                  +I HRDLK +N  L  +    LKI DFG S+  L+ S   +T   GTP Y++P
Sbjct: 119 VHYMHQRRILHRDLKAKNIFLKNN---LLKIGDFGVSRL-LMGSCDLATTFTGTPYYMSP 174

Query: 162 EVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQY-KIPDYV 220
           E L  + YD K +D+WS G  LY M   A+ FE Q    NF   + RI+      +P+  
Sbjct: 175 EALKHQGYDSK-SDIWSLGCILYEMCCLAHAFEGQ----NFLSVVLRIVEGPTPSLPE-- 227

Query: 221 HISQDCRNLLSRIFVANPSRRITIKEIKSHPW 252
             S+   +++  +   +PS R +  EI  +P+
Sbjct: 228 TYSRQLNSIMQSMLNKDPSLRPSAAEILRNPF 259

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 99.1 bits (247), Expect = 1e-23
 Identities = 78/281 (27%), Positives = 128/281 (45%), Gaps = 30/281 (10%)

Query: 10  IGSGNFGVARLMRNKNTKELVAMKYIER-----GHKIDANVAREIINHKQLRHPNIIRFK 64
           IG G++    L+  K T+ + AMK I++        ID     + +      HP ++   
Sbjct: 3   IGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLH 62

Query: 65  EVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLI-------SGQICHRDL 117
               T + L  V+E+ +GG+L   +    +  E+ AR++  ++           I +RDL
Sbjct: 63  SCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDL 122

Query: 118 KLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST-VGTPAYIAPEVLSRREYDGKLADV 176
           KL+N LLD      +K+ D+G  K  +      ST  GTP YIAPE+L   +Y   + D 
Sbjct: 123 KLDNVLLDAEG--HIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRGEDYGFSV-DW 179

Query: 177 WSCGVTLYVMLVGAYPFE-----DQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLS 231
           W+ GV ++ M+ G  PF+     D  D          I+  Q +IP    +S    ++L 
Sbjct: 180 WALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPRS--LSVKASSVLK 237

Query: 232 RIFVANPSRRI------TIKEIKSHPWFLKNLPRELTETAQ 266
                +P  R+        ++IKSHP+F +N+  +L E  Q
Sbjct: 238 GFLNKDPKERLGCHPQTGFRDIKSHPFF-RNIDWDLLEQKQ 277

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 98.1 bits (244), Expect = 2e-23
 Identities = 82/264 (31%), Positives = 131/264 (49%), Gaps = 19/264 (7%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDAN-VAREIINHKQLRHPNI 60
           +KY   + IG G  G      +  T + VA+K +    +     +  EI+  ++ +HPNI
Sbjct: 19  KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNI 78

Query: 61  IRFKEVVLTPTHLAIVMEYAAGGEL----FERICNAGRFSE--DEARYFFQQLISGQICH 114
           + + +  L    L +VMEY AGG L     E   + G+ +    E     + L S Q+ H
Sbjct: 79  VNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIH 138

Query: 115 RDLKLENTLL--DGSPAPRLKICDFGYSKSSLLHSRPKST-VGTPAYIAPEVLSRREYDG 171
           RD+K +N LL  DGS    +K+ DFG+          +ST VGTP ++APEV++R+ Y G
Sbjct: 139 RDIKSDNILLGMDGS----VKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAY-G 193

Query: 172 KLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLS 231
              D+WS G+    M+ G  P+ + E+P      I+     + + P+   +S   R+ L+
Sbjct: 194 PKVDIWSLGIMAIEMVEGEPPYLN-ENPLRALYLIATNGTPELQNPE--KLSAIFRDFLN 250

Query: 232 RIFVANPSRRITIKEIKSHPWFLK 255
           R    +  +R + KE+  HP FLK
Sbjct: 251 RCLEMDVEKRGSAKELLQHP-FLK 273

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 98.2 bits (245), Expect = 3e-23
 Identities = 89/295 (30%), Positives = 135/295 (45%), Gaps = 50/295 (16%)

Query: 3   KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERG--HKIDA-NVAREIINHKQLRHPN 59
           KY  +K IG G +G+    +N  T E VA+K I     ++IDA    REI   + L H N
Sbjct: 6   KYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHEN 65

Query: 60  IIRFKEVVLTPTH------LAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLI----- 108
           +I  K+++  P H      + IV E     +L + I ++   S+D  +YF  QL+     
Sbjct: 66  VIAIKDIM-PPPHREAFNDVYIVYELM-DTDLHQIIRSSQTLSDDHCQYFLYQLLRGLKY 123

Query: 109 --SGQICHRDLKLENTLLDGSPAPRLKICDFGYSK-SSLLHSRPKSTVGTPAYIAPEV-L 164
             S  + HRDLK  N LL+ +    LKICDFG ++ +S         V T  Y APE+ L
Sbjct: 124 IHSANVLHRDLKPSNLLLNANC--DLKICDFGLARTTSEKGDFMTEYVVTRWYRAPELLL 181

Query: 165 SRREYDGKLADVWSCG---------------------VTLYVMLVGAYPFEDQE--DPKN 201
           +  EY     DVWS G                     + L   L+G+   ED      + 
Sbjct: 182 NCSEY-TTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEK 240

Query: 202 FRKTISRIMAVQYKIP---DYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 253
            R+ I R +    +      + H +    +LL ++ V +PS+RIT++E  +HP+ 
Sbjct: 241 ARRYI-RSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYL 294

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 97.4 bits (242), Expect = 4e-23
 Identities = 83/292 (28%), Positives = 130/292 (44%), Gaps = 36/292 (12%)

Query: 10  IGSGNFGVARLMRNKNTKELVAMKYIER-----GHKIDANVAREIINHKQLRHPNIIRFK 64
           IG G++    L+R K T+ + AMK +++        ID     + +  +   HP ++   
Sbjct: 3   IGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 62

Query: 65  EVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYF-------FQQLISGQICHRDL 117
               T + L  V+EY  GG+L   +    +  E+ AR++          L    I +RDL
Sbjct: 63  SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDL 122

Query: 118 KLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTV----GTPAYIAPEVLSRREYDGKL 173
           KL+N LLD      +K+ D+G  K  L   RP  T     GTP YIAPE+L   +Y G  
Sbjct: 123 KLDNVLLDSE--GHIKLTDYGMCKEGL---RPGDTTSTFCGTPNYIAPEILRGEDY-GFS 176

Query: 174 ADVWSCGVTLYVMLVGAYPFE-----DQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRN 228
            D W+ GV ++ M+ G  PF+     D  D          I+  Q +IP    +S    +
Sbjct: 177 VDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPR--SLSVKAAS 234

Query: 229 LLSRIFVANPSRRI------TIKEIKSHPWFLKNLPRELTETAQAIYYRKEN 274
           +L      +P  R+         +I+ HP+F +N+  +L E  Q +   K N
Sbjct: 235 VLKSFLNKDPKERLGCHPQTGFADIQGHPFF-RNVDWDLMEQKQVVPPFKPN 285

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 96.4 bits (240), Expect = 5e-23
 Identities = 80/287 (27%), Positives = 130/287 (45%), Gaps = 41/287 (14%)

Query: 4   YELMKDIGSGNFGVARLMRNKNTKELVAMKYIE---RGHKIDANVAREIINHKQLRHPNI 60
           ++ ++ IG G +GV    RNK T E+VA+K I        + +   REI   K+L HPNI
Sbjct: 2   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 61

Query: 61  IRFKEVVLTPTHLAIVMEYAAGG-ELFERICNAGRFSEDEARYFFQQLISG-------QI 112
           ++  +V+ T   L +V E+     + F              + +  QL+ G       ++
Sbjct: 62  VKLLDVIHTENKLYLVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRV 121

Query: 113 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKS-TVGTPAYIAPEVLSRREYDG 171
            HRDLK +N L++   A  +K+ DFG +++  +  R  +  V T  Y APE+L   +Y  
Sbjct: 122 LHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYS 179

Query: 172 KLADVWSCGVTLYVMLVGAYPFE-DQEDPKNFRKTISRIMAVQ--------YKIPDYV-- 220
              D+WS G     M+     F  D E  + FR  I R +             +PDY   
Sbjct: 180 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFR--IFRTLGTPDEVVWPGVTSLPDYKPS 237

Query: 221 --------------HISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 253
                          + +D R+LLS++   +P++RI+ K   +HP+F
Sbjct: 238 FPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 96.3 bits (239), Expect = 8e-23
 Identities = 86/282 (30%), Positives = 140/282 (49%), Gaps = 20/282 (7%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDAN-VAREIINHKQLRHPNI 60
           +KY   + IG G  G      +  T + VA+K +    +     +  EI+  ++ ++PNI
Sbjct: 19  KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNI 78

Query: 61  IRFKEVVLTPTHLAIVMEYAAGGEL----FERICNAGRFSE--DEARYFFQQLISGQICH 114
           + + +  L    L +VMEY AGG L     E   + G+ +    E       L S Q+ H
Sbjct: 79  VNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALDFLHSNQVIH 138

Query: 115 RDLKLENTLL--DGSPAPRLKICDFGY-SKSSLLHSRPKSTVGTPAYIAPEVLSRREYDG 171
           RD+K +N LL  DGS    +K+ DFG+ ++ +   S+  + VGTP ++APEV++R+ Y G
Sbjct: 139 RDIKSDNILLGMDGS----VKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAY-G 193

Query: 172 KLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLS 231
              D+WS G+    M+ G  P+ + E+P      I+     + + P+   +S   R+ L+
Sbjct: 194 PKVDIWSLGIMAIEMVEGEPPYLN-ENPLRALYLIATNGTPELQNPE--RLSAVFRDFLN 250

Query: 232 RIFVANPSRRITIKEIKSHPWFLKNLPRELTETAQAIYYRKE 273
           R    +  RR + KE+  HP FLK L + L+     I   KE
Sbjct: 251 RCLEMDVDRRGSAKELLQHP-FLK-LAKPLSSLTPLIIAAKE 290

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 96.4 bits (240), Expect = 1e-22
 Identities = 84/282 (29%), Positives = 134/282 (47%), Gaps = 43/282 (15%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKID-ANVA-----REIINHKQL 55
           + +E++K IG G FG   +++ KNT ++ AMK + +   +  A  A     R+++ +   
Sbjct: 1   DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDR 60

Query: 56  RHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAG-RFSEDEARYFFQQLISG---- 110
           R   I           +L +VM+Y  GG+L   +     R  ED AR++  +++      
Sbjct: 61  RW--ITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSV 118

Query: 111 ---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTV------GTPAYIAP 161
                 HRD+K +N LLD +   RL   DFG    S L      TV      GTP YI+P
Sbjct: 119 HQLGYVHRDIKPDNVLLDKNGHIRL--ADFG----SCLRLLADGTVQSNVAVGTPDYISP 172

Query: 162 EVLSRREYDGK-----LADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKI 216
           E+L   E DGK       D WS GV +Y ML G  PF  +    +  +T  +IM  +   
Sbjct: 173 EILQAME-DGKGRYGPECDWWSLGVCMYEMLYGETPFYAE----SLVETYGKIMNHKEHF 227

Query: 217 ---PDYVHISQDCRNLLSRIFVANPSR--RITIKEIKSHPWF 253
              PD   +S++ ++L+ R+  +  +R  R  +++ K HP+F
Sbjct: 228 QFPPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDHPFF 269

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 95.5 bits (237), Expect = 1e-22
 Identities = 82/279 (29%), Positives = 139/279 (49%), Gaps = 23/279 (8%)

Query: 10  IGSGNFGVARLMRNKNTKELVAMKYIE-RGHKIDANVAREIINHKQLRHPNIIRFKEVVL 68
           IG G+ G+  + R K++   VA+K ++ R  +    +  E++  +  +H N++   +  L
Sbjct: 29  IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYL 88

Query: 69  TPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLI-------SGQICHRDLKLEN 121
               L ++ME+  GG L + I +  R +E++     + ++       S  + HRD+K ++
Sbjct: 89  VGEELWVLMEFLQGGALTD-IVSQTRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDS 147

Query: 122 TLL--DGSPAPRLKICDFGY-SKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLADVWS 178
            LL  DG    R+K+ DFG+ ++ S    + KS VGTP ++APEV+SR  Y G   D+WS
Sbjct: 148 ILLTLDG----RVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRTPY-GTEVDIWS 202

Query: 179 CGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANP 238
            G+ +  M+ G  P+   + P    K +    +   K+ +   IS   R+ L R+    P
Sbjct: 203 LGIMVIEMVDGEPPYF-SDSPVQAMKRLRD--SPPPKLKNAHKISPVLRDFLERMLTREP 259

Query: 239 SRRITIKEIKSHPWFLK-NLPRELTETAQAIYYRKENPT 276
             R T +E+  HP+ L+  LP  L    Q   YRK   T
Sbjct: 260 QERATAQELLDHPFLLQTGLPECLVPLIQQ--YRKRTST 296

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 96.2 bits (239), Expect = 1e-22
 Identities = 74/263 (28%), Positives = 122/263 (46%), Gaps = 26/263 (9%)

Query: 8   KDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINH-----KQLRHPNIIR 62
           K IG G+FG   L + K   +  A+K +++   ++    + I+       K ++HP ++ 
Sbjct: 1   KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVG 60

Query: 63  FKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-------QICHR 115
                 T   L  V+++  GGELF  +     F E  AR++  ++ S         I +R
Sbjct: 61  LHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYR 120

Query: 116 DLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST-VGTPAYIAPEVLSRREYDGKLA 174
           DLK EN LLD      + + DFG  K  +  S   +T  GTP Y+APEV+ ++ YD    
Sbjct: 121 DLKPENILLDSQ--GHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRKQPYD-NTV 177

Query: 175 DVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIF 234
           D W  G  LY ML G  PF  ++  + +   + + + ++   P     S    ++L  + 
Sbjct: 178 DWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLR---PG---ASLTAWSILEELL 231

Query: 235 VANPSRRITIK----EIKSHPWF 253
             +  RR+  K    EI+ HP+F
Sbjct: 232 EKDRQRRLGAKEDFLEIQEHPFF 254

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 95.1 bits (236), Expect = 2e-22
 Identities = 77/260 (29%), Positives = 131/260 (50%), Gaps = 20/260 (7%)

Query: 10  IGSGNFGVARLMRNKNTKELVAMKYIE-RGHKIDANVAREIINHKQLRHPNIIRFKEVVL 68
           IG G+ G+  +   K++ +LVA+K ++ R  +    +  E++  +  +H N++      L
Sbjct: 28  IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87

Query: 69  TPTHLAIVMEYAAGGELFERICNAGRFSEDEARYF-------FQQLISGQICHRDLKLEN 121
               L +VME+  GG L + I    R +E++              L +  + HRD+K ++
Sbjct: 88  VGDELWVVMEFLEGGALTD-IVTHTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDS 146

Query: 122 TLL--DGSPAPRLKICDFGY-SKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLADVWS 178
            LL  DG    R+K+ DFG+ ++ S    R KS VGTP ++APE++SR  Y G   D+WS
Sbjct: 147 ILLTHDG----RVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPY-GPEVDIWS 201

Query: 179 CGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANP 238
            G+ +  M+ G  P+ + E P    K I   +  + K  +   +S   +  L R+ V +P
Sbjct: 202 LGIMVIEMVDGEPPYFN-EPPLKAMKMIRDNLPPKLK--NLHKVSPSLKGFLDRLLVRDP 258

Query: 239 SRRITIKEIKSHPWFLKNLP 258
           ++R T  E+  HP+  K  P
Sbjct: 259 AQRATAAELLKHPFLAKAGP 278

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 95.2 bits (236), Expect = 2e-22
 Identities = 88/285 (30%), Positives = 142/285 (49%), Gaps = 26/285 (9%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDAN-VAREIINHKQLRHPNI 60
           +KY   + IG G  G      +  T + VA+K I    +     +  EI+  K+L++PNI
Sbjct: 19  KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNI 78

Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARY---------FFQQLISGQ 111
           + F +  L    L +VMEY AGG L + +        DEA+            + L + Q
Sbjct: 79  VNFLDSFLVGDELFVVMEYLAGGSLTDVVTET---CMDEAQIAAVCRECLQALEFLHANQ 135

Query: 112 ICHRDLKLENTLL--DGSPAPRLKICDFGY-SKSSLLHSRPKSTVGTPAYIAPEVLSRRE 168
           + HRD+K +N LL  DGS    +K+ DFG+ ++ +   S+  + VGTP ++APEV++R+ 
Sbjct: 136 VIHRDIKSDNVLLGMDGS----VKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKA 191

Query: 169 YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRN 228
           Y G   D+WS G+    M+ G  P+ + E+P      I+     + + P+   +S   R+
Sbjct: 192 Y-GPKVDIWSLGIMAIEMVEGEPPYLN-ENPLRALYLIATNGTPELQNPE--KLSPIFRD 247

Query: 229 LLSRIFVANPSRRITIKEIKSHPWFLKNLPRELTETAQAIYYRKE 273
            L+R    +  +R + KE+  HP FLK L + L+     I   KE
Sbjct: 248 FLNRCLEMDVEKRGSAKELLQHP-FLK-LAKPLSSLTPLILAAKE 290

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 94.1 bits (234), Expect = 4e-22
 Identities = 78/292 (26%), Positives = 139/292 (47%), Gaps = 44/292 (15%)

Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYI---ERGHKIDANVAREIINHKQLRH 57
           M++YE ++ IG G +GV    R++ T E +A+K I   +    + +   REI   K+++H
Sbjct: 1   MDQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQH 60

Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDE--ARYFFQQLISG----- 110
            NI+R ++VV +   L +V EY    +L + + ++  F+++    + +  Q++ G     
Sbjct: 61  GNIVRLQDVVHSEKRLYLVFEY-LDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCH 119

Query: 111 --QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKS-TVGTPAYIAPEVLSRR 167
             ++ HRDLK +N L+D      LK+ DFG +++  +  R  +  V T  Y APE+L   
Sbjct: 120 SHRVLHRDLKPQNLLIDRR-TNALKLADFGLARAFGIPVRTFTHEVVTLWYRAPEILLGS 178

Query: 168 EYDGKLADVWSCGVTLYVMLVGAYPF--EDQEDPKNFRKTISRIMAVQYK--------IP 217
            +     D+WS G  ++  +V   P    D E  + F+  I RI+    +        +P
Sbjct: 179 RHYSTPVDIWSVGC-IFAEMVNQKPLFPGDSEIDELFK--IFRILGTPNEETWPGVTSLP 235

Query: 218 DYVH----------------ISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 253
           DY                  +     +LLS++   +PS+RIT +    H +F
Sbjct: 236 DYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYF 287

Length = 294

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 93.3 bits (232), Expect = 9e-22
 Identities = 86/307 (28%), Positives = 130/307 (42%), Gaps = 66/307 (21%)

Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYI-----ERGHKIDANVAREIINHKQL 55
           ++K++++  IG G +G     R+K+T ELVA+K +     + G  I A   REI   +QL
Sbjct: 6   VDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITA--IREIKILRQL 63

Query: 56  RHPNIIRFKEVVLTPTH----------LAIVMEYAAG---GELFERICNAGRFSEDEARY 102
            H NI+  KE+V                 +V EY      G L   + +   FSED  + 
Sbjct: 64  NHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVH---FSEDHIKS 120

Query: 103 FFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFG----YSKSSLLHSRPKS 151
           F +QL+ G          HRD+K  N LL+     ++K+ DFG    Y+      SRP +
Sbjct: 121 FMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKG--QIKLADFGLARLYNSEE---SRPYT 175

Query: 152 T-VGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRI- 209
             V T  Y  PE+L   E  G   DVWSCG  L  +      F+  ++     + ISR+ 
Sbjct: 176 NKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQL-ELISRLC 234

Query: 210 ---------------------MAVQYK---IPDYVHISQDCRNLLSRIFVANPSRRITIK 245
                                   QY+     ++  I     +LL  +   +PS+R T +
Sbjct: 235 GSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAE 294

Query: 246 EIKSHPW 252
           E  + PW
Sbjct: 295 EALNSPW 301

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 92.4 bits (229), Expect = 1e-21
 Identities = 82/270 (30%), Positives = 131/270 (48%), Gaps = 29/270 (10%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYI-------ERGHKIDANVAREIINHKQ 54
             + L K +G G FG   L  + +T   +A+K +       E   +++A +  EI   K 
Sbjct: 2   VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNA-LECEIQLLKN 60

Query: 55  LRHPNIIRFKEVVLTPTH--LAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-- 110
           LRH  I+++   +  P    L+I +EY  GG + +++   G  +E+  R + +Q++ G  
Sbjct: 61  LRHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVS 120

Query: 111 -----QICHRDLKLENTLLDGSPAPRLKICDFGYSKS----SLLHSRPKSTVGTPAYIAP 161
                 I HRD+K  N L D   A  +K+ DFG SK      +  +  KS  GTP +++P
Sbjct: 121 YLHSNMIVHRDIKGANILRDS--AGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSP 178

Query: 162 EVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVH 221
           EV+S   Y G+ ADVWS   T+  ML    P+ + E      K  ++    +  +PD   
Sbjct: 179 EVISGEGY-GRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQ--PTKPMLPD--G 233

Query: 222 ISQDCRNLLSRIFVANPSRRITIKEIKSHP 251
           +S  CR+ L +IFV    RR T + +  HP
Sbjct: 234 VSDACRDFLKQIFVEE-KRRPTAEFLLRHP 262

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 93.5 bits (232), Expect = 1e-21
 Identities = 82/326 (25%), Positives = 152/326 (46%), Gaps = 36/326 (11%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKID-ANVA-----REIINHKQL 55
           + +E++K IG G FG   +++ K+T+ + AMK + +   +  A  A     R ++ +   
Sbjct: 1   DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDC 60

Query: 56  RHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICN-AGRFSEDEARYFFQQLISG---- 110
           +    + +        +L +VM+Y  GG+L   +     R  ED AR++  +++      
Sbjct: 61  QWITTLHY--AFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSI 118

Query: 111 ---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTV--GTPAYIAPEVLS 165
                 HRD+K +N LLD +   RL   DFG           +S+V  GTP YI+PE+L 
Sbjct: 119 HQLHYVHRDIKPDNVLLDMNGHIRL--ADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQ 176

Query: 166 RREYD----GKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIM--AVQYKIPDY 219
             E      G   D WS GV +Y ML G  PF  +    +  +T  +IM    +++ P +
Sbjct: 177 AMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAE----SLVETYGKIMNHEERFQFPSH 232

Query: 220 V-HISQDCRNLLSRIFVANPSRRI---TIKEIKSHPWFLKNLPRELTETAQAIYYRKENP 275
           +  +S++ ++L+ R+ + +  RR+    I++ K H +F + +  E     +A Y    + 
Sbjct: 233 ITDVSEEAKDLIQRL-ICSRERRLGQNGIEDFKKHAFF-EGIDWENIRNLEAPYIPDVSS 290

Query: 276 TFSLQSVEEITKIVEEAKVPPPVSRS 301
                + +    ++   ++ PP S +
Sbjct: 291 PSDTSNFDVDDDVLRNPEIAPPSSHT 316

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 92.6 bits (230), Expect = 1e-21
 Identities = 67/275 (24%), Positives = 127/275 (46%), Gaps = 31/275 (11%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRH---- 57
           E  E + D+G+GN G    +++  T  ++A K +  G K  ++V ++I+   Q+ H    
Sbjct: 5   EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAK--SSVRKQILRELQIMHECRS 62

Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG------- 110
           P I+ F    L   ++ + ME+   G L       G    +        ++ G       
Sbjct: 63  PYIVSFYGAFLNENNICMCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNV 122

Query: 111 -QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREY 169
            +I HRD+K  N L++     ++K+CDFG S   L++S   + VGT  Y++PE +   +Y
Sbjct: 123 HRIMHRDIKPSNILVNS--RGQIKLCDFGVS-GELINSIADTFVGTSTYMSPERIQGGKY 179

Query: 170 DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVH-------- 221
             K +DVWS G+++  + +G +PF       + +     I+ +  +I   V         
Sbjct: 180 TVK-SDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQI---VQEPPPRLPS 235

Query: 222 --ISQDCRNLLSRIFVANPSRRITIKEIKSHPWFL 254
               +D R+ +    + +P+ R T +++ + P F+
Sbjct: 236 SDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFI 270

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 93.6 bits (232), Expect = 2e-21
 Identities = 81/306 (26%), Positives = 138/306 (45%), Gaps = 64/306 (20%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNII 61
           E +E +K IG G FG  RL++ K+T  + AMK + +   ++    +E + H +     ++
Sbjct: 1   EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLE----KEQVGHIRAERDILV 56

Query: 62  RFKEVVLTPT--------HLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG--- 110
               + +           +L ++ME+  GG++   +      +E+E +++  + +     
Sbjct: 57  EADSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDS 116

Query: 111 ----QICHRDLKLENTLLDGSPAPRLKICDFGYSKS-----------SLLHSRPK----- 150
                  HRD+K +N LLD      +K+ DFG               +L HS P      
Sbjct: 117 IHQLGFIHRDIKPDNLLLDSKG--HVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQ 174

Query: 151 --------------------STVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGA 190
                               STVGTP YIAPEV  +  Y+ KL D WS GV +Y ML+G 
Sbjct: 175 NMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYN-KLCDWWSLGVIMYEMLIGY 233

Query: 191 YPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRI---TIKEI 247
            PF  +   + ++K ++    + +  P  V IS+  ++L+ R F      RI    ++EI
Sbjct: 234 PPFCSETPQETYKKVMNWKETLIF--PPEVPISEKAKDLILR-FCCEWEHRIGAPGVEEI 290

Query: 248 KSHPWF 253
           K++P+F
Sbjct: 291 KTNPFF 296

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 92.1 bits (229), Expect = 2e-21
 Identities = 76/277 (27%), Positives = 123/277 (44%), Gaps = 31/277 (11%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIER--GHKIDANVAREIINHKQLRHPN 59
           EK   +  +G G  G     R KNT  + A+K I       +   + RE+  +K  + P 
Sbjct: 1   EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPY 60

Query: 60  IIRFKEVVLTP--THLAIVMEYAAGGELFERI-----CNAGRFSEDEARYFFQQLISG-- 110
           I+++    L    + + I MEY  GG L + I        GR  E       + ++ G  
Sbjct: 61  IVKYYGAFLDESSSSIGIAMEYCEGGSL-DSIYKKVKKRGGRIGEKVLGKIAESVLKGLS 119

Query: 111 -----QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLS 165
                +I HRD+K  N LL       +K+CDFG S   L++S   +  GT  Y+APE + 
Sbjct: 120 YLHSRKIIHRDIKPSNILLTRKGQ--VKLCDFGVS-GELVNSLAGTFTGTSFYMAPERIQ 176

Query: 166 RREYDGKLADVWSCGVTLYVMLVGAYPFE-DQEDPKNFRKTISRIMAVQYKIP------- 217
            + Y    +DVWS G+TL  +    +PF  + E P    + +S I  V    P       
Sbjct: 177 GKPYSIT-SDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYI--VNMPNPELKDEPG 233

Query: 218 DYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFL 254
           + +  S++ ++ + +    +P+RR T  ++  HPW  
Sbjct: 234 NGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIK 270

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 92.5 bits (230), Expect = 2e-21
 Identities = 77/300 (25%), Positives = 135/300 (45%), Gaps = 54/300 (18%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH-KIDANVAREIINHKQLRH--- 57
           + +E + ++G+GN GV   + ++ +  ++A K I   H +I   +  +II   ++ H   
Sbjct: 1   DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLI---HLEIKPAIRNQIIRELKVLHECN 57

Query: 58  -PNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG------ 110
            P I+ F     +   ++I ME+  GG L + +  AGR  E+        ++ G      
Sbjct: 58  SPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLRE 117

Query: 111 --QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRRE 168
             +I HRD+K  N L++      +K+CDFG S   L+ S   S VGT +Y++PE L    
Sbjct: 118 KHKIMHRDVKPSNILVNSRG--EIKLCDFGVS-GQLIDSMANSFVGTRSYMSPERLQGTH 174

Query: 169 YDGKLADVWSCGVTLYVMLVGAYP------------FEDQEDP---KNFRKTIS------ 207
           Y    +D+WS G++L  M +G YP            F         K   + +S      
Sbjct: 175 Y-TVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDS 233

Query: 208 -RIMAVQYKIPDYV-----------HISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLK 255
            R MA+ +++ DY+             S + ++ + +    NP  R  +KE+  HP+  +
Sbjct: 234 PRPMAI-FELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKR 292

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 92.3 bits (230), Expect = 4e-21
 Identities = 90/307 (29%), Positives = 136/307 (44%), Gaps = 68/307 (22%)

Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKI-DA--NVA------REIIN 51
           + KYE+++ +G G +G+     ++ TKE+VA+K      KI DA  N        REI+ 
Sbjct: 6   LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALK------KIFDAFRNATDAQRTFREIMF 59

Query: 52  HKQLR-HPNIIRFKEVVLTPTHLAIVMEYAAGGELFE----RICNAGRFSEDEARYFFQQ 106
            ++L  HPNI++   V+       I + +    E  E     +  A    +   RY   Q
Sbjct: 60  LQELGDHPNIVKLLNVIKAENDKDIYLVF----EYMETDLHAVIRANILEDVHKRYIMYQ 115

Query: 107 LI-------SGQICHRDLKLENTLLDGSPAPRLKICDFGYSKS----SLLHSRPKST--V 153
           L+       SG + HRDLK  N LL+     R+K+ DFG ++S          P  T  V
Sbjct: 116 LLKALKYIHSGNVIHRDLKPSNILLNS--DCRVKLADFGLARSLSELEENPENPVLTDYV 173

Query: 154 GTPAYIAPEVL--SRREYDGKLADVWSCGVTLYVMLVGAYPF------------------ 193
            T  Y APE+L  S R Y  K  D+WS G  L  ML+G   F                  
Sbjct: 174 ATRWYRAPEILLGSTR-YT-KGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGP 231

Query: 194 ---EDQEDPK-NFRKTISRIMAVQYK--IPDYV-HISQDCRNLLSRIFVANPSRRITIKE 246
              ED E  K  F  T+   +  + +  + + +   S D  +LL ++ V NP++R+T +E
Sbjct: 232 PSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEE 291

Query: 247 IKSHPWF 253
              HP+ 
Sbjct: 292 ALEHPYV 298

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 90.5 bits (224), Expect = 5e-21
 Identities = 78/257 (30%), Positives = 124/257 (48%), Gaps = 28/257 (10%)

Query: 4   YELMKDIGSGNFGVARLMRNKNTKELVAMKYI-------ERGHKIDANVAREIINHKQLR 56
           + L K +G G FG   L  + +T   +A+K +       E   +++A +  EI   K L 
Sbjct: 4   WRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNA-LECEIQLLKNLL 62

Query: 57  HPNIIRFKEVVLTPTH--LAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG---- 110
           H  I+++   +  P    L+I ME+  GG + +++ + G  +E+  R + +Q++ G    
Sbjct: 63  HERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYL 122

Query: 111 ---QICHRDLKLENTLLDGSPAPRLKICDFGYSKS----SLLHSRPKSTVGTPAYIAPEV 163
               I HRD+K  N L D      +K+ DFG SK      L  +  KS  GTP +++PEV
Sbjct: 123 HSNMIVHRDIKGANILRDS--VGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEV 180

Query: 164 LSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHIS 223
           +S   Y G+ AD+WS G T+  ML    P+ + E      K  ++       +P   H+S
Sbjct: 181 ISGEGY-GRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQ--PTNPVLP--PHVS 235

Query: 224 QDCRNLLSRIFVANPSR 240
             CR+ L RIFV    R
Sbjct: 236 DHCRDFLKRIFVEAKLR 252

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 90.6 bits (225), Expect = 6e-21
 Identities = 81/294 (27%), Positives = 141/294 (47%), Gaps = 52/294 (17%)

Query: 3   KYELMKDIGSGNFGVARLMRNKNTKELVAMKYI-----ERGHKIDANVAREIINHKQLRH 57
            Y  ++ IG G +GV    RNK T ++VAMK I     E G  + +   REI   K+L+H
Sbjct: 1   DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEG--VPSTAIREISLLKELQH 58

Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGG--ELFERICNAGRFSEDEARYFFQQLISG----- 110
           PNI+  ++V++  + L ++ E+ +    +  + +        +  + +  Q++ G     
Sbjct: 59  PNIVCLQDVLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCH 118

Query: 111 --QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKS-TVGTPAYIAPEVL--S 165
             ++ HRDLK +N L+D      +K+ DFG +++  +  R  +  V T  Y APEVL  S
Sbjct: 119 SRRVLHRDLKPQNLLIDNKGV--IKLADFGLARAFGIPVRVYTHEVVTLWYRAPEVLLGS 176

Query: 166 RREYDGKLADVWSCGVTLYVMLVGAYPF--EDQEDPKNFRKTISRIMAVQ--------YK 215
            R Y   + D+WS G T++  +    P    D E  + FR  I RI+             
Sbjct: 177 PR-YSTPV-DIWSIG-TIFAEMATKKPLFHGDSEIDQLFR--IFRILGTPTEDVWPGVTS 231

Query: 216 IPDY----------------VHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 253
           +PDY                 ++ +D  +LL ++ + +P++RI+ K+  +HP+F
Sbjct: 232 LPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 91.3 bits (226), Expect = 9e-21
 Identities = 77/275 (28%), Positives = 132/275 (48%), Gaps = 29/275 (10%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKID-ANVA-----REIINHKQL 55
           E +E++K IG G FG   +++ KN  ++ AMK + +   +  A  A     R+++ +   
Sbjct: 1   EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDN 60

Query: 56  RHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICN-AGRFSEDEARYFFQQLISG---- 110
           +    + +        +L +VM+Y  GG+L   +     R  ED AR++  +++      
Sbjct: 61  QWITTLHY--AFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSV 118

Query: 111 ---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTV--GTPAYIAPEVLS 165
                 HRD+K +N L+D +   RL   DFG     +     +S+V  GTP YI+PE+L 
Sbjct: 119 HQLHYVHRDIKPDNILMDMNGHIRL--ADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQ 176

Query: 166 RREYDGK-----LADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYV 220
             E DGK       D WS GV +Y ML G  PF  +   + + K ++     Q+      
Sbjct: 177 AME-DGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFP-AQVT 234

Query: 221 HISQDCRNLLSRIFVANPSR--RITIKEIKSHPWF 253
            +S+D ++L+ R+  +   R  +  I++ K HP+F
Sbjct: 235 DVSEDAKDLIRRLICSREHRLGQNGIEDFKQHPFF 269

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 90.1 bits (224), Expect = 1e-20
 Identities = 89/291 (30%), Positives = 139/291 (47%), Gaps = 49/291 (16%)

Query: 4   YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVA----REIINHKQLRHPN 59
           Y+ ++ IG G +GV    R+K T E+VA+K I R    D  V     REI   K+L HPN
Sbjct: 1   YQKVEKIGEGTYGVVYKARDKLTGEIVALKKI-RLETEDEGVPSTAIREISLLKELNHPN 59

Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEA--RYFFQQLISG------- 110
           I+R  +VV +   L +V E+    +L + + ++     D    + +  QL+ G       
Sbjct: 60  IVRLLDVVHSENKLYLVFEF-LDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSH 118

Query: 111 QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKS-TVGTPAYIAPEV-LSRRE 168
           ++ HRDLK +N L+D   A  LK+ DFG +++  +  R  +  V T  Y APE+ L  R+
Sbjct: 119 RVLHRDLKPQNLLIDREGA--LKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGSRQ 176

Query: 169 YDGKLADVWSCGVTLYVMLVGAYPFE-DQEDPKNFRKTISRIMA---------VQYKIPD 218
           Y   + D+WS G     M+     F  D E  + FR  I R +          V   +PD
Sbjct: 177 YSTPV-DIWSIGCIFAEMVNRRPLFPGDSEIDQLFR--IFRTLGTPDEDVWPGVTS-LPD 232

Query: 219 YV----------------HISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 253
           Y                 ++ +D  +LLS++ V +P++RI+ K    HP+F
Sbjct: 233 YKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 90.1 bits (223), Expect = 1e-20
 Identities = 76/257 (29%), Positives = 128/257 (49%), Gaps = 21/257 (8%)

Query: 10  IGSGNFGVARLMRNKNTKELVAMKYIE-RGHKIDANVAREIINHKQLRHPNIIRFKEVVL 68
           IG G+ G+  +   K+T + VA+K ++ R  +    +  E++  +   H N++      L
Sbjct: 30  IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYL 89

Query: 69  TPTHLAIVMEYAAGGELFERICNAGRFSEDEARYF-------FQQLISGQICHRDLKLEN 121
               L +VME+  GG L + I    R +E++              L +  + HRD+K ++
Sbjct: 90  VGDELWVVMEFLEGGALTD-IVTHTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDS 148

Query: 122 TLL--DGSPAPRLKICDFGY-SKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLADVWS 178
            LL  DG    R+K+ DFG+ ++ S    + KS VGTP ++APEV+SR  Y G   D+WS
Sbjct: 149 ILLTSDG----RIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISRLPY-GTEVDIWS 203

Query: 179 CGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANP 238
            G+ +  M+ G  P+ ++   +  R+    +     ++ D   +S   R  L  + V  P
Sbjct: 204 LGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPP---RVKDSHKVSSVLRGFLDLMLVREP 260

Query: 239 SRRITIKEIKSHPWFLK 255
           S+R T +E+  HP FLK
Sbjct: 261 SQRATAQELLQHP-FLK 276

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 90.1 bits (223), Expect = 2e-20
 Identities = 78/281 (27%), Positives = 128/281 (45%), Gaps = 28/281 (9%)

Query: 10  IGSGNFGVARLMRNKNTKELVAMKYIER-----GHKIDANVAREIINHKQLRHPNIIRFK 64
           IG G++    L+R K   ++ AMK +++        ID     + +  +   +P ++   
Sbjct: 3   IGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLH 62

Query: 65  EVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQ-------LISGQICHRDL 117
               T + L +V+EY  GG+L   +    +  E+ AR++  +       L    I +RDL
Sbjct: 63  SCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDL 122

Query: 118 KLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST-VGTPAYIAPEVLSRREYDGKLADV 176
           KL+N LLD      +K+ D+G  K  L      ST  GTP YIAPE+L   EY G   D 
Sbjct: 123 KLDNVLLDADG--HIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEY-GFSVDW 179

Query: 177 WSCGVTLYVMLVGAYPFE---DQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRI 233
           W+ GV ++ M+ G  PF+   D  D          I+    +IP +  +S    ++L   
Sbjct: 180 WALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPRF--LSVKASHVLKGF 237

Query: 234 FVANPSRRITIK------EIKSHPWFLKNLPRELTETAQAI 268
              +P  R+  +      +IKSH +F +++  +L E  Q  
Sbjct: 238 LNKDPKERLGCQPQTGFSDIKSHTFF-RSIDWDLLEKKQVT 277

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 88.9 bits (220), Expect = 2e-20
 Identities = 76/258 (29%), Positives = 122/258 (47%), Gaps = 14/258 (5%)

Query: 4   YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDAN-VAREIINHKQLRHPNIIR 62
           YEL++ +GSG +G     RN +T EL A+K I+     D + + +EI   K+ +H NI+ 
Sbjct: 11  YELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVA 70

Query: 63  FKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGQI-------CHR 115
           +    L+   L I MEY  GG L +     G  SE +  Y  ++ + G          HR
Sbjct: 71  YFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHR 130

Query: 116 DLKLENTLLDGSPAPRLKICDFGY-SKSSLLHSRPKSTVGTPAYIAPEVLSRREYDG--K 172
           D+K  N LL  +    +K+ DFG  +K +   ++ KS +GTP ++APEV +  +  G  +
Sbjct: 131 DIKGANILL--TDNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEVAAVEKNGGYNQ 188

Query: 173 LADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSR 232
           L D+W+ G+T   +     P  D   P      +S+      K+ D    S    N +  
Sbjct: 189 LCDIWAVGITAIELAELQPPMFDLH-PMRALFLMSKSNFQPPKLKDKTKWSSTFHNFVKI 247

Query: 233 IFVANPSRRITIKEIKSH 250
               NP +R T + + +H
Sbjct: 248 SLTKNPKKRPTAERLLTH 265

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 89.4 bits (221), Expect = 2e-20
 Identities = 78/264 (29%), Positives = 133/264 (50%), Gaps = 19/264 (7%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDAN-VAREIINHKQLRHPNI 60
           +KY   + IG G  G      +  T + VA++ +    +     +  EI+  ++ ++PNI
Sbjct: 20  KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNI 79

Query: 61  IRFKEVVLTPTHLAIVMEYAAGGEL----FERICNAGRFSE--DEARYFFQQLISGQICH 114
           + + +  L    L +VMEY AGG L     E   + G+ +    E     + L S Q+ H
Sbjct: 80  VNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIH 139

Query: 115 RDLKLENTLL--DGSPAPRLKICDFGY-SKSSLLHSRPKSTVGTPAYIAPEVLSRREYDG 171
           RD+K +N LL  DGS    +K+ DFG+ ++ +   S+  + VGTP ++APEV++R+ Y G
Sbjct: 140 RDIKSDNILLGMDGS----VKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAY-G 194

Query: 172 KLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLS 231
              D+WS G+    M+ G  P+ + E+P      I+     + + P+   +S   R+ L+
Sbjct: 195 PKVDIWSLGIMAIEMIEGEPPYLN-ENPLRALYLIATNGTPELQNPE--KLSAIFRDFLN 251

Query: 232 RIFVANPSRRITIKEIKSHPWFLK 255
           R    +  +R + KE+  H  FLK
Sbjct: 252 RCLDMDVEKRGSAKELLQHQ-FLK 274

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 88.8 bits (220), Expect = 3e-20
 Identities = 77/269 (28%), Positives = 124/269 (46%), Gaps = 37/269 (13%)

Query: 10  IGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREI-INHKQLRH-------PNII 61
           IG G FG     R  +T ++ AMK +++  +I       + +N + +         P I+
Sbjct: 2   IGRGGFGEVYGCRKADTGKMYAMKCLDK-KRIKMKQGETLALNERIMLSLVSTGDCPFIV 60

Query: 62  RFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGQ-------ICH 114
                  TP  L+ +++   GG+L   +   G FSE E R++  ++I G        + +
Sbjct: 61  CMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVY 120

Query: 115 RDLKLENTLLDGSPAPRLK----ICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSR-REY 169
           RDLK  N LLD     R+      CDF   K       P ++VGT  Y+APEVL +   Y
Sbjct: 121 RDLKPANILLDEHGHVRISDLGLACDFSKKK-------PHASVGTHGYMAPEVLQKGVAY 173

Query: 170 DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 229
           D   AD +S G  L+ +L G  PF  Q   K+  +     + +  ++PD    S + R+L
Sbjct: 174 DSS-ADWFSLGCMLFKLLRGHSPFR-QHKTKDKHEIDRMTLTMAVELPD--SFSPELRSL 229

Query: 230 LSRIFVANPSRRITI-----KEIKSHPWF 253
           L  +   + +RR+       +E+K HP+F
Sbjct: 230 LEGLLQRDVNRRLGCLGRGAQEVKEHPFF 258

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 88.2 bits (218), Expect = 4e-20
 Identities = 79/265 (29%), Positives = 122/265 (46%), Gaps = 29/265 (10%)

Query: 8   KDIGSGNFGVARLMRNKNTKELVAMKYI-------ERGHKIDANVAREIINHKQLRHPNI 60
           K +G G FG   L  + +T   +A K +       E   ++ A +  EI   K L+H  I
Sbjct: 8   KLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSA-LECEIQLLKNLQHERI 66

Query: 61  IRFKEVVLTPTH--LAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-------Q 111
           +++   +       L I MEY  GG + +++   G  +E   R + +Q++ G        
Sbjct: 67  VQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNM 126

Query: 112 ICHRDLKLENTLLDGSPAPRLKICDFGYSKS----SLLHSRPKSTVGTPAYIAPEVLSRR 167
           I HRD+K  N L D   A  +K+ DFG SK      +  +  +S  GTP +++PEV+S  
Sbjct: 127 IVHRDIKGANILRDS--AGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGE 184

Query: 168 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCR 227
            Y G+ ADVWS G T+  ML    P+ + E        I +I           HIS+  R
Sbjct: 185 GY-GRKADVWSLGCTVVEMLTEKPPWAEYEA----MAAIFKIATQPTNPQLPSHISEHAR 239

Query: 228 NLLSRIFVANPSRRITIKEIKSHPW 252
           + L  IFV     R + +E+  HP+
Sbjct: 240 DFLGCIFV-EARHRPSAEELLRHPF 263

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 90.1 bits (223), Expect = 6e-20
 Identities = 88/299 (29%), Positives = 140/299 (46%), Gaps = 38/299 (12%)

Query: 21  MRNKNTKELVAMKYIERGHKIDANVAR-EIINHKQLRHPNIIRFKEVVLTPTHLAIVMEY 79
            R  + KE V  K++    +  A  AR E+       H  I++  +   +   L ++MEY
Sbjct: 87  TRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEY 146

Query: 80  AAGGELFERICNAGR----FSEDEARYFFQQLI-------SGQICHRDLKLENTLLDGSP 128
            +GG+L ++I    +    F E E    F Q++       S ++ HRDLK  N  L   P
Sbjct: 147 GSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFL--MP 204

Query: 129 APRLKICDFGYSKS---SLLHSRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYV 185
              +K+ DFG+SK    S+      S  GTP Y+APE+  R+ Y  K AD+WS GV LY 
Sbjct: 205 TGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKK-ADMWSLGVILYE 263

Query: 186 MLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIK 245
           +L    PF+        R+ + +++  +Y  P    +S   + LL  +   NP+ R T +
Sbjct: 264 LLTLHRPFKGPSQ----REIMQQVLYGKYD-PFPCPVSSGMKALLDPLLSKNPALRPTTQ 318

Query: 246 EIKSHPWFLK---NLPRELTETAQAIYYRKENPTFSLQSVEEITKIVEE--AKVPPPVS 299
           ++  H  FLK   NL +++   ++ I         S    EEI + ++E   + PPP S
Sbjct: 319 QL-LHTEFLKYVANLFQDIVRHSETI---------SPHDREEILRQLQESGERAPPPSS 367

Length = 478

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 88.2 bits (219), Expect = 6e-20
 Identities = 80/313 (25%), Positives = 131/313 (41%), Gaps = 77/313 (24%)

Query: 3   KYELMKDIGSGNFGVARLMRNKNTKELVAMKYI-----ERGHKIDANVAREIINHKQLRH 57
           KYE +  IG G FG     R+K TK++VA+K +     + G  I A   REI   + L+H
Sbjct: 13  KYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITA--LREIKILQLLKH 70

Query: 58  PNIIRFKEVVLTPT--------HLAIVMEYAAGGELFERICNAG-RFSEDEARYFFQQLI 108
            N++   E+  T             +V E+    +L   + N   +F+  E +   + L+
Sbjct: 71  ENVVNLIEICRTKATPYNRYKGSFYLVFEFCE-HDLAGLLSNKNVKFTLSEIKKVMKMLL 129

Query: 109 SG-------QICHRDLKLENTLL--DGSPAPRLKICDFGYSKSSLLHSRPKST-----VG 154
           +G       +I HRD+K  N L+  DG     LK+ DFG +++  L    K       V 
Sbjct: 130 NGLYYIHRNKILHRDMKAANILITKDGI----LKLADFGLARAFSLSKNSKPNRYTNRVV 185

Query: 155 TPAYIAPEV-LSRREYDGKLADVWSCG---------------------VTLYVMLVGA-- 190
           T  Y  PE+ L  R+Y G   D+W  G                     +TL   L G+  
Sbjct: 186 TLWYRPPELLLGERDY-GPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSIT 244

Query: 191 ---YP-------FEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSR 240
              +P       F+  E P+  ++       V+ ++  YV       +L+ ++ V +P++
Sbjct: 245 PEVWPGVDKLELFKKMELPQGQKR------KVKERLKPYVK-DPHALDLIDKLLVLDPAK 297

Query: 241 RITIKEIKSHPWF 253
           RI      +H +F
Sbjct: 298 RIDADTALNHDFF 310

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 88.0 bits (218), Expect = 9e-20
 Identities = 74/288 (25%), Positives = 129/288 (44%), Gaps = 44/288 (15%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVA---REIINHKQLRHP 58
            +Y  ++ +G G FG+    R++ T + VA+K I +            RE+   K LRH 
Sbjct: 10  NRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHE 69

Query: 59  NIIRFKEVVLTP-THLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG------- 110
           NII   ++ ++P   +  V E    G    R+  +    +   +YF  Q++ G       
Sbjct: 70  NIISLSDIFISPLEDIYFVTELL--GTDLHRLLTSRPLEKQFIQYFLYQILRGLKYVHSA 127

Query: 111 QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEV-LSRREY 169
            + HRDLK  N L++ +    LKICDFG ++  +   +    V T  Y APE+ L+ ++Y
Sbjct: 128 GVVHRDLKPSNILINEN--CDLKICDFGLAR--IQDPQMTGYVSTRYYRAPEIMLTWQKY 183

Query: 170 DGKLADVWSCGVTLYVMLVGA--YPFEDQED------------PKNFRKTISRIMAVQY- 214
           D ++ D+WS G     ML G   +P +D  +            P +   TI     +++ 
Sbjct: 184 DVEV-DIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRFV 242

Query: 215 -------KIP---DYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPW 252
                   +P    + +      +LL ++ V +P +RI+  E  +HP+
Sbjct: 243 QSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPY 290

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 86.8 bits (215), Expect = 1e-19
 Identities = 75/267 (28%), Positives = 117/267 (43%), Gaps = 30/267 (11%)

Query: 10  IGSGNFGVARLMRNKNTKELVAMKYI------ERGHKIDANVAREIINHKQLRHPNIIRF 63
           +G G FG     + + T +L A K +      +R     A V + I+     R   I+  
Sbjct: 1   LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRF--IVSL 58

Query: 64  KEVVLTPTHLAIVMEYAAGGELFERICNAGR----FSEDEARYFFQQLISG-------QI 112
                T T L +VM    GG+L   I N       F E  A ++  Q+ISG       +I
Sbjct: 59  AYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRI 118

Query: 113 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSLL-HSRPKSTVGTPAYIAPEVLSRREYDG 171
            +RDLK EN LLD      ++I D G +       S+ K   GTP ++APE+L   EYD 
Sbjct: 119 IYRDLKPENVLLDN--DGNVRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQGEEYDF 176

Query: 172 KLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLS 231
            + D ++ GVTLY M+    PF  + +    ++   RI+      PD    S   ++   
Sbjct: 177 SV-DYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPD--KFSPASKSFCE 233

Query: 232 RIFVANPSRRITIK-----EIKSHPWF 253
            +   +P +R+  +      +++HP F
Sbjct: 234 ALLAKDPEKRLGFRDGNCDGLRTHPLF 260

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 87.7 bits (218), Expect = 1e-19
 Identities = 79/296 (26%), Positives = 122/296 (41%), Gaps = 51/296 (17%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIE--RGHKIDANVAREIINHKQLRHPN 59
            +Y+ +  IG G +G+     +K T   VA+K I             REI   ++ +H N
Sbjct: 5   PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHEN 64

Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFE----RICNAGRFSEDEARYFFQQLI------- 108
           II   + ++ P       +     EL E    ++      S D  +YF  Q++       
Sbjct: 65  IIGILD-IIRPPSFESFNDVYIVQELMETDLYKLIKTQHLSNDHIQYFLYQILRGLKYIH 123

Query: 109 SGQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST----VGTPAYIAPEV- 163
           S  + HRDLK  N LL+      LKICDFG ++ +             V T  Y APE+ 
Sbjct: 124 SANVLHRDLKPSNLLLNT--NCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIM 181

Query: 164 LSRREYDGKLADVWSCGVTLYVMLVGA--YPFED----------------QEDPKNFRKT 205
           L+ + Y  K  D+WS G  L  ML     +P +D                QED       
Sbjct: 182 LNSKGYT-KAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIISL 240

Query: 206 ISR--IMAVQYKIPDYVHISQDCRN-------LLSRIFVANPSRRITIKEIKSHPW 252
            +R  I ++ +K    V  ++   N       LL ++   NP +RIT++E  +HP+
Sbjct: 241 RARNYIKSLPFK--PKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPY 294

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 86.6 bits (214), Expect = 1e-19
 Identities = 76/271 (28%), Positives = 124/271 (45%), Gaps = 31/271 (11%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDA--NVAREIINHKQLRHPN 59
           E +  ++ IG G+FG      +  T+++VA+K I+     D   ++ +EI    Q   P 
Sbjct: 4   ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 63

Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-------QI 112
           + ++    L  T L I+MEY  GG   + +  AG F E +     ++++ G       + 
Sbjct: 64  VTKYYGSYLKGTKLWIIMEYLGGGSALD-LLRAGPFDEFQIATMLKEILKGLDYLHSEKK 122

Query: 113 CHRDLKLENTLLDGSPAPRLKICDFGYS-KSSLLHSRPKSTVGTPAYIAPEVLSRREYDG 171
            HRD+K  N LL  S    +K+ DFG + + +    +  + VGTP ++APEV+ +  YD 
Sbjct: 123 IHRDIKAANVLL--SEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDS 180

Query: 172 KLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYV------HISQD 225
           K AD+WS G+T   +  G  P  D              M V + IP           S+ 
Sbjct: 181 K-ADIWSLGITAIELAKGEPPNSDMHP-----------MRVLFLIPKNNPPTLTGEFSKP 228

Query: 226 CRNLLSRIFVANPSRRITIKEIKSHPWFLKN 256
            +  +      +PS R T KE+  H + +KN
Sbjct: 229 FKEFIDACLNKDPSFRPTAKELLKHKFIVKN 259

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 86.2 bits (213), Expect = 2e-19
 Identities = 75/265 (28%), Positives = 117/265 (44%), Gaps = 31/265 (11%)

Query: 1   MEKYELMKDIGSGNFG-VARLMRNKNTKELVAMKYIERGHKIDANVAREIINH----KQL 55
           +  +++ K IG G F  V R     + K  VA+K ++    +DA   ++ +      KQL
Sbjct: 1   LANFQIEKKIGRGQFSEVYRATCLLDRKP-VALKKVQIFEMMDAKARQDCVKEIDLLKQL 59

Query: 56  RHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGR----FSEDEARYFFQQLISG- 110
            HPN+I++ +  +    L IV+E A  G+L + I    +      E     +F QL S  
Sbjct: 60  NHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAV 119

Query: 111 ------QICHRDLKLENTLLDGSPAPRLKICDFGY-----SKSSLLHSRPKSTVGTPAYI 159
                 ++ HRD+K  N  +  +    +K+ D G      SK++  H    S VGTP Y+
Sbjct: 120 EHMHSRRVMHRDIKPANVFITATGV--VKLGDLGLGRFFSSKTTAAH----SLVGTPYYM 173

Query: 160 APEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDY 219
           +PE +    Y+ K +D+WS G  LY M     PF    D  N      +I    Y     
Sbjct: 174 SPERIHENGYNFK-SDIWSLGCLLYEMAALQSPF--YGDKMNLFSLCQKIEQCDYPPLPT 230

Query: 220 VHISQDCRNLLSRIFVANPSRRITI 244
            H S+  R L+S     +P +R  I
Sbjct: 231 EHYSEKLRELVSMCIYPDPDQRPDI 255

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 86.8 bits (215), Expect = 2e-19
 Identities = 65/197 (32%), Positives = 95/197 (48%), Gaps = 24/197 (12%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINH----KQLRH 57
           + +  +++IG G+FG     R+  T E+VA+K +    K      ++II      +QLRH
Sbjct: 15  KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRH 74

Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAG--GELFERICNAGRFSEDEARYFFQQLISG----- 110
           PN I +K   L      +VMEY  G   ++ E   +     E E        + G     
Sbjct: 75  PNTIEYKGCYLREHTAWLVMEYCLGSASDILE--VHKKPLQEVEIAAICHGALQGLAYLH 132

Query: 111 --QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEV---LS 165
             +  HRD+K  N LL  +    +K+ DFG   S+ L S   S VGTP ++APEV   + 
Sbjct: 133 SHERIHRDIKAGNILL--TEPGTVKLADFG---SASLVSPANSFVGTPYWMAPEVILAMD 187

Query: 166 RREYDGKLADVWSCGVT 182
             +YDGK  DVWS G+T
Sbjct: 188 EGQYDGK-VDVWSLGIT 203

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 87.8 bits (217), Expect = 2e-19
 Identities = 86/314 (27%), Positives = 127/314 (40%), Gaps = 72/314 (22%)

Query: 4   YELMKDIGSGNFGVARLMRNKNTKELVAMKYIE------RGHKIDANVAREIINHKQLRH 57
           +  +K +G G FG   L R  +TK L AMK +       R         R+I+   +  +
Sbjct: 3   FVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDIL--AEADN 60

Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG------- 110
             ++R         +L  VM+Y  GG++   +   G F ED AR++  +L          
Sbjct: 61  EWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKM 120

Query: 111 QICHRDLKLENTLLDGSPAPRLKICDFGYS------------------------------ 140
              HRD+K +N L+D      +K+ DFG                                
Sbjct: 121 GFIHRDIKPDNILIDRDG--HIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWG 178

Query: 141 ----------------KSSLLHSR--PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVT 182
                           +++  H R    S VGTP YIAPEVL R  Y  +L D WS GV 
Sbjct: 179 DPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYT-QLCDWWSVGVI 237

Query: 183 LYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRI 242
           LY MLVG  PF  Q   +   K I+   ++   IP    +S +  +L+ ++    P  R+
Sbjct: 238 LYEMLVGQPPFLAQTPLETQMKVINWQTSLH--IPPQAKLSPEASDLIIKL-CRGPEDRL 294

Query: 243 ---TIKEIKSHPWF 253
                 EIK+HP+F
Sbjct: 295 GKNGADEIKAHPFF 308

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 85.5 bits (212), Expect = 5e-19
 Identities = 68/226 (30%), Positives = 97/226 (42%), Gaps = 35/226 (15%)

Query: 6   LMKDIGSGNFGVARLMR----NKNTKELVAMKYIER--GHKIDANVAREIINHKQLRHPN 59
            +K +G G+FG   L R      NT E VA+K +      +  ++  REI   + L H N
Sbjct: 8   FIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHEN 67

Query: 60  IIRFKEVVLTPTH--LAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGQIC---- 113
           I+++K V   P    L ++MEY   G L + +    +   D+       L S QIC    
Sbjct: 68  IVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYL----QRHRDQINLKRLLLFSSQICKGMD 123

Query: 114 --------HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPA-----YIA 160
                   HRDL   N L++      +KI DFG +K  L   +    V  P      + A
Sbjct: 124 YLGSQRYIHRDLAARNILVESED--LVKISDFGLAKV-LPEDKDYYYVKEPGESPIFWYA 180

Query: 161 PEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTI 206
           PE L   ++    +DVWS GVTLY +    Y    Q  P  F + I
Sbjct: 181 PECLRTSKFSSA-SDVWSFGVTLYELF--TYGDPSQSPPAEFLRMI 223

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 86.6 bits (214), Expect = 6e-19
 Identities = 86/325 (26%), Positives = 127/325 (39%), Gaps = 100/325 (30%)

Query: 7   MKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPN------- 59
           +K +G G FG   L    +T  L AMK + +         ++++N  Q+ H         
Sbjct: 6   IKTLGIGAFGEVCLACKVDTHALYAMKTLRK---------KDVLNRNQVAHVKAERDILA 56

Query: 60  ------IIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG--- 110
                 +++         +L  VM+Y  GG++   +     F E  AR++  +L      
Sbjct: 57  EADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIES 116

Query: 111 ----QICHRDLKLENTL--LDGSPAPRLKICDFG-------------YSKSS-------- 143
                  HRD+K +N L  LDG     +K+ DFG             Y K S        
Sbjct: 117 VHKMGFIHRDIKPDNILIDLDG----HIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSME 172

Query: 144 ------------------LLHSRPK---------STVGTPAYIAPEVLSRREYDGKLADV 176
                              L  R           S VGTP YIAPEVL R+ Y  +L D 
Sbjct: 173 PSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYT-QLCDW 231

Query: 177 WSCGVTLYVMLVGAYPF------EDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLL 230
           WS GV L+ MLVG  PF      E Q    N+  T+         IP  V +S +  +L+
Sbjct: 232 WSVGVILFEMLVGQPPFLAPTPTETQLKVINWENTL--------HIPPQVKLSPEAVDLI 283

Query: 231 SRIFVANPSR--RITIKEIKSHPWF 253
           +++  +   R  R    +IK+HP+F
Sbjct: 284 TKLCCSAEERLGRNGADDIKAHPFF 308

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 84.8 bits (210), Expect = 8e-19
 Identities = 68/201 (33%), Positives = 102/201 (50%), Gaps = 17/201 (8%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMK-YIER-GHKIDANVA-REIINHKQLRHP 58
           EKYE +  +G G++G+    ++K T ++VA+K ++E    K+   +A REI   KQLRH 
Sbjct: 1   EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHE 60

Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGEL--FERICNAGRFSEDEARYFFQQLI------SG 110
           N++   EV      L +V E+     L   E+  N G       +Y FQ L       S 
Sbjct: 61  NLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPN-GLDESRVRKYLFQILRGIEFCHSH 119

Query: 111 QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST--VGTPAYIAPEVLSRRE 168
            I HRD+K EN L+  S +  +K+CDFG+++ +L       T  V T  Y APE+L    
Sbjct: 120 NIIHRDIKPENILV--SQSGVVKLCDFGFAR-TLAAPGEVYTDYVATRWYRAPELLVGDT 176

Query: 169 YDGKLADVWSCGVTLYVMLVG 189
             G+  D+W+ G  +  ML G
Sbjct: 177 KYGRAVDIWAVGCLVTEMLTG 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 84.7 bits (210), Expect = 9e-19
 Identities = 83/294 (28%), Positives = 127/294 (43%), Gaps = 50/294 (17%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMK-YIERG-----HKIDANVAREIINHKQL 55
           EKYE +  IG G++GV    RN+ T ++VA+K ++E        KI     REI   KQL
Sbjct: 1   EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKI---ALREIRMLKQL 57

Query: 56  RHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG----- 110
           +HPN++   EV      L +V EY     L E   N     E   +    Q +       
Sbjct: 58  KHPNLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCH 117

Query: 111 -QIC-HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST----VGTPAYIAPEVL 164
              C HRD+K EN L+  +   ++K+CDFG+++   + + P       V T  Y APE+L
Sbjct: 118 KHNCIHRDVKPENILI--TKQGQIKLCDFGFAR---ILTGPGDDYTDYVATRWYRAPELL 172

Query: 165 SRREYDGKLADVWSCGVTLYVMLVGA--YPFEDQEDP-----KNFRKTISRIMAV----Q 213
                 G   DVW+ G     +L G   +P +   D      K     I R   +    Q
Sbjct: 173 VGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQ 232

Query: 214 Y----KIPD----------YVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 253
           +     IP+          + +IS    + L      +P+ R++ +E+  HP+F
Sbjct: 233 FFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF 286

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 83.9 bits (207), Expect = 1e-18
 Identities = 85/286 (29%), Positives = 132/286 (46%), Gaps = 28/286 (9%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKID-ANVAREIINHKQLRHPNI 60
           E +E++ ++G G FG     +NK T  L A K I+   + +  +   EI       HPNI
Sbjct: 5   EFWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNI 64

Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFERICNAGR-FSEDEARYFFQQLISG-------QI 112
           ++  +      +L I++E+ AGG +   +    R  +E + R   +Q +         +I
Sbjct: 65  VKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKI 124

Query: 113 CHRDLKLENTL--LDGSPAPRLKICDFGYS-KSSLLHSRPKSTVGTPAYIAPEVL----- 164
            HRDLK  N L  LDG     +K+ DFG S K++    R  S +GTP ++APEV+     
Sbjct: 125 IHRDLKAGNILFTLDGD----IKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETS 180

Query: 165 SRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQ 224
             R YD K ADVWS G+TL + +    P   + +P      I++        P     S 
Sbjct: 181 KDRPYDYK-ADVWSLGITL-IEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPS--RWSS 236

Query: 225 DCRNLLSRIFVANPSRRITIKEIKSHPWFL--KNLP-RELTETAQA 267
           + ++ L +    N   R T  ++  HP+     N P REL   A+A
Sbjct: 237 EFKDFLKKCLEKNVDARWTTTQLLQHPFVTVNSNKPIRELIAEAKA 282

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 83.5 bits (206), Expect = 2e-18
 Identities = 76/269 (28%), Positives = 122/269 (45%), Gaps = 37/269 (13%)

Query: 10  IGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREI-INHKQLRH-------PNII 61
           IG G FG     R  +T ++ AMK +++  +I       + +N + +         P I+
Sbjct: 2   IGRGGFGEVYGCRKADTGKMYAMKCLDK-KRIKMKQGETLALNERIMLSLVSTGDCPFIV 60

Query: 62  RFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGQ-------ICH 114
                  TP  L  +++   GG+L   +   G FSE E R++  ++I G        + +
Sbjct: 61  CMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVY 120

Query: 115 RDLKLENTLLDGSPAPRLK----ICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSR-REY 169
           RDLK  N LLD     R+      CDF   K       P ++VGT  Y+APEVL +   Y
Sbjct: 121 RDLKPANILLDEHGHVRISDLGLACDFSKKK-------PHASVGTHGYMAPEVLQKGTAY 173

Query: 170 DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 229
           D   AD +S G  L+ +L G  PF  Q   K+  +     + V  ++PD    S + ++L
Sbjct: 174 DSS-ADWFSLGCMLFKLLRGHSPFR-QHKTKDKHEIDRMTLTVNVELPD--SFSPELKSL 229

Query: 230 LSRIFVANPSRRITI-----KEIKSHPWF 253
           L  +   + S+R+       +E+K H +F
Sbjct: 230 LEGLLQRDVSKRLGCLGRGAQEVKEHVFF 258

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 83.9 bits (207), Expect = 3e-18
 Identities = 61/203 (30%), Positives = 103/203 (50%), Gaps = 18/203 (8%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRH---- 57
           + +E + ++G+GN GV   +++K +  ++A K I    +I   +  +II   Q+ H    
Sbjct: 5   DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHL--EIKPAIRNQIIRELQVLHECNS 62

Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG------- 110
           P I+ F     +   ++I ME+  GG L + +  A R  E+        ++ G       
Sbjct: 63  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREK 122

Query: 111 -QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREY 169
            QI HRD+K  N L++      +K+CDFG S   L+ S   S VGT +Y++PE L    Y
Sbjct: 123 HQIMHRDVKPSNILVNSRG--EIKLCDFGVS-GQLIDSMANSFVGTRSYMSPERLQGTHY 179

Query: 170 DGKLADVWSCGVTLYVMLVGAYP 192
             + +D+WS G++L  + +G YP
Sbjct: 180 SVQ-SDIWSMGLSLVELAIGRYP 201

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 85.2 bits (210), Expect = 4e-18
 Identities = 78/255 (30%), Positives = 115/255 (45%), Gaps = 56/255 (21%)

Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIE-RGHK--------IDANVAREIIN 51
           + +YE++K IG+G FG   L+++K T+E    K I  RG K        I+ NV RE   
Sbjct: 12  LNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRE--- 68

Query: 52  HKQLRHPNIIRFKEVVLTPTH--LAIVMEYAAGGELFERICNA----GRFSEDEARYFFQ 105
              L+H NI+R+ +  L   +  L I+ME+   G+L   I       G+  E       +
Sbjct: 69  ---LKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITR 125

Query: 106 QLISG--------------QICHRDLKLENTLLDG---------------SPAPRLKICD 136
           QL+                ++ HRDLK +N  L                 +  P  KI D
Sbjct: 126 QLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGD 185

Query: 137 FGYSKSSLLHSRPKSTVGTPAYIAPEVL--SRREYDGKLADVWSCGVTLYVMLVGAYPFE 194
           FG SK+  + S   S VGTP Y +PE+L    + YD K +D+W+ G  +Y +  G  PF 
Sbjct: 186 FGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDK-SDMWALGCIIYELCSGKTPFH 244

Query: 195 DQEDPKNFRKTISRI 209
                 NF + IS +
Sbjct: 245 KA---NNFSQLISEL 256

Length = 1021

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 83.8 bits (207), Expect = 8e-18
 Identities = 68/239 (28%), Positives = 122/239 (51%), Gaps = 37/239 (15%)

Query: 73  LAIVMEYAAGGELFERICN---AGR-FSEDEARYFFQQLI-------SGQICHRDLKLEN 121
           +A+V++YA  G+L + I +     R F E EA   F Q++       S  + HRD+K  N
Sbjct: 114 IALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSAN 173

Query: 122 TLLDGSPAPRLKICDFGYSK---SSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLADVWS 178
            LL  +    +K+ DFG+SK   +++     ++  GTP Y+APE+  R+ Y  K AD++S
Sbjct: 174 ILLCSNGL--VKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKK-ADMFS 230

Query: 179 CGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYK-IPDYVHISQDCRNLLSRIFVAN 237
            GV LY +L    PF    D +N  + + + +A +Y  +P    IS + + +++ +  ++
Sbjct: 231 LGVLLYELLTLKRPF----DGENMEEVMHKTLAGRYDPLPP--SISPEMQEIVTALLSSD 284

Query: 238 PSRRITIKEIKSHP---WFLKNLPRELTETAQAIYYRKENPTFSLQSVEEITKIVEEAK 293
           P RR +  ++ + P    F+  L  E+ +T          P FS    + I++ +++ K
Sbjct: 285 PKRRPSSSKLLNMPICKLFISGL-LEIVQTQ---------PGFSGPLRDTISRQIQQTK 333

Length = 496

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 81.6 bits (201), Expect = 1e-17
 Identities = 83/291 (28%), Positives = 127/291 (43%), Gaps = 45/291 (15%)

Query: 3   KYELMKDIGSGNFGVARLMRNKNTKELVAMKYI---ERGHKIDANVAREIINHKQLRHPN 59
           K+E++  +G G +GV    R+K TKE+VA+K     E   ++     RE+   + L+  N
Sbjct: 2   KFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQEN 61

Query: 60  IIRFKEVVLTPTHLAIVMEYAAGG--ELFERICNAGRFSEDEARYFFQQLISG------- 110
           I+  KE       L +V EY      EL E + N      ++ R +  QLI         
Sbjct: 62  IVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGV--PPEKVRSYIYQLIKAIHWCHKN 119

Query: 111 QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST--VGTPAYIAPEVLSRRE 168
            I HRD+K EN L+  S    LK+CDFG++++    S    T  V T  Y +PE+L    
Sbjct: 120 DIVHRDIKPENLLI--SHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAP 177

Query: 169 YDGKLADVWSCGVTLYVMLVGA--YPFEDQEDPK-NFRKTISRIMAVQYKI--------- 216
           Y GK  D+WS G  L  +  G   +P E + D     +K +  + A Q K+         
Sbjct: 178 Y-GKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHG 236

Query: 217 ---PDYVH-----------ISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 253
              P   H           +S    +L+  +   NP+ R   ++  +HP F
Sbjct: 237 LRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF 287

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 81.2 bits (200), Expect = 2e-17
 Identities = 80/278 (28%), Positives = 128/278 (46%), Gaps = 36/278 (12%)

Query: 4   YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQL-RHPNIIR 62
           +E+++ IG G +G    + NK    L A+K ++    +D  +  E    + L  HPN+++
Sbjct: 24  WEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVK 83

Query: 63  F-----KEVVLTPTHLAIVMEYAAGG---ELFERICNAG-RFSEDEARYFF-------QQ 106
           F     K   L    L +V+E   GG   EL + +   G R  E    Y         Q 
Sbjct: 84  FYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQH 143

Query: 107 LISGQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPK--STVGTPAYIAPEVL 164
           L + +I HRD+K  N LL       +K+ DFG S + L  +R +  ++VGTP ++APEV+
Sbjct: 144 LHNNRIIHRDVKGNNILLTTEGG--VKLVDFGVS-AQLTSTRLRRNTSVGTPFWMAPEVI 200

Query: 165 S-RREYDGKL---ADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYV 220
           +  ++YD       DVWS G+T   +  G  P  D    K   K I R        P  +
Sbjct: 201 ACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFK-IPRNPP-----PTLL 254

Query: 221 HISQDCR---NLLSRIFVANPSRRITIKEIKSHPWFLK 255
           H  + CR   + +S+  + +   R ++  +  HP F+K
Sbjct: 255 HPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHP-FIK 291

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 81.3 bits (201), Expect = 2e-17
 Identities = 68/272 (25%), Positives = 125/272 (45%), Gaps = 28/272 (10%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDAN--VAREI-INHKQLRHP 58
              E + +IGSG  G    MR K T  ++A+K + R    + N  +  ++ +  K    P
Sbjct: 15  NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCP 74

Query: 59  NIIRFKEVVLTPTHLAIVMEYAA----------GGELFERICNAGRFSEDEARYFFQQLI 108
            I++     +T + + I ME  +           G + E I      +  +A ++ ++  
Sbjct: 75  YIVKCYGYFITDSDVFICMELMSTCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKE-- 132

Query: 109 SGQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKS-TVGTPAYIAPEVL--- 164
              + HRD+K  N LLD S    +K+CDFG S   L+ S+ K+ + G  AY+APE +   
Sbjct: 133 KHGVIHRDVKPSNILLDASG--NVKLCDFGIS-GRLVDSKAKTRSAGCAAYMAPERIDPP 189

Query: 165 -SRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDY-VHI 222
               +YD + ADVWS G++L  +  G +P+++ +    F + +++I+  +          
Sbjct: 190 DPNPKYDIR-ADVWSLGISLVELATGQFPYKNCK--TEF-EVLTKILQEEPPSLPPNEGF 245

Query: 223 SQDCRNLLSRIFVANPSRRITIKEIKSHPWFL 254
           S D  + +      +  +R   +E+  HP+  
Sbjct: 246 SPDFCSFVDLCLTKDHRKRPKYRELLQHPFIR 277

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 80.9 bits (199), Expect = 2e-17
 Identities = 73/273 (26%), Positives = 121/273 (44%), Gaps = 35/273 (12%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDA--NVAREIINHKQLRHPN 59
           E +  ++ IG G+FG      +  T+++VA+K I+     D   ++ +EI    Q   P 
Sbjct: 4   ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 63

Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-------QI 112
           + ++    L  T L I+MEY  GG   + +   G   E +     ++++ G       + 
Sbjct: 64  VTKYYGSYLKDTKLWIIMEYLGGGSALD-LLEPGPLDETQIATILREILKGLDYLHSEKK 122

Query: 113 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST--VGTPAYIAPEVLSRREYD 170
            HRD+K  N LL  S    +K+ DFG +   L  ++ K    VGTP ++APEV+ +  YD
Sbjct: 123 IHRDIKAANVLL--SEHGEVKLADFGVA-GQLTDTQIKRNTFVGTPFWMAPEVIKQSAYD 179

Query: 171 GKLADVWSCGVTLYVMLVGAYPFEDQED-------PKNFRKTISRIMAVQYKIPDYVHIS 223
            K AD+WS G+T   +  G  P  +          PKN   T+              + S
Sbjct: 180 SK-ADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPPTLEG------------NYS 226

Query: 224 QDCRNLLSRIFVANPSRRITIKEIKSHPWFLKN 256
           +  +  +       PS R T KE+  H + ++ 
Sbjct: 227 KPLKEFVEACLNKEPSFRPTAKELLKHKFIVRF 259

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 81.6 bits (201), Expect = 2e-17
 Identities = 63/203 (31%), Positives = 102/203 (50%), Gaps = 18/203 (8%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRH---- 57
           + +E + ++G+GN GV   + +K +  ++A K I    +I   +  +II   Q+ H    
Sbjct: 5   DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHL--EIKPAIRNQIIRELQVLHECNS 62

Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG------- 110
           P I+ F     +   ++I ME+  GG L + +  AGR  E         +I G       
Sbjct: 63  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK 122

Query: 111 -QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREY 169
            +I HRD+K  N L++      +K+CDFG S   L+ S   S VGT +Y++PE L    Y
Sbjct: 123 HKIMHRDVKPSNILVNSRG--EIKLCDFGVS-GQLIDSMANSFVGTRSYMSPERLQGTHY 179

Query: 170 DGKLADVWSCGVTLYVMLVGAYP 192
             + +D+WS G++L  M +G YP
Sbjct: 180 SVQ-SDIWSMGLSLVEMAIGRYP 201

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 80.5 bits (198), Expect = 2e-17
 Identities = 71/261 (27%), Positives = 110/261 (42%), Gaps = 29/261 (11%)

Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINH----KQLR 56
           +  + + K IG G F              VA+K ++    +DA    + I      KQL 
Sbjct: 1   LANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLN 60

Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGR----FSEDEARYFFQQLISG-- 110
           HPN+I++    +    L IV+E A  G+L   I +  +      E     +F QL S   
Sbjct: 61  HPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALE 120

Query: 111 -----QICHRDLKLENTLLDGSPAPRLKICDFGY-----SKSSLLHSRPKSTVGTPAYIA 160
                ++ HRD+K  N  +  +    +K+ D G      SK++  H    S VGTP Y++
Sbjct: 121 HMHSRRVMHRDIKPANVFITATGV--VKLGDLGLGRFFSSKTTAAH----SLVGTPYYMS 174

Query: 161 PEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYV 220
           PE +    Y+ K +D+WS G  LY M     PF    D  N      +I    Y      
Sbjct: 175 PERIHENGYNFK-SDIWSLGCLLYEMAALQSPFYG--DKMNLYSLCKKIEQCDYPPLPSD 231

Query: 221 HISQDCRNLLSRIFVANPSRR 241
           H S++ R L++     +P +R
Sbjct: 232 HYSEELRQLVNMCINPDPEKR 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 80.5 bits (198), Expect = 3e-17
 Identities = 80/271 (29%), Positives = 120/271 (44%), Gaps = 33/271 (12%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDA--NVAREIINHKQLRHPN 59
           E +  ++ IG G+FG      +  TKE+VA+K I+     D   ++ +EI    Q   P 
Sbjct: 4   ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 63

Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-------QI 112
           I R+    L  T L I+MEY  GG   + +   G   E       ++++ G       + 
Sbjct: 64  ITRYYGSYLKGTKLWIIMEYLGGGSALD-LLKPGPLEETYIATILREILKGLDYLHSERK 122

Query: 113 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST-VGTPAYIAPEVLSRREYDG 171
            HRD+K  N LL  S    +K+ DFG +         ++T VGTP ++APEV+ +  YD 
Sbjct: 123 IHRDIKAANVLL--SEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDF 180

Query: 172 KLADVWSCGVTLYVMLVGAYPFEDQED-------PKNFRKTISRIMAVQYKIPDYVHISQ 224
           K AD+WS G+T   +  G  P  D          PKN   T+      QY  P +    +
Sbjct: 181 K-ADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPTLEG----QYSKP-FKEFVE 234

Query: 225 DCRNLLSRIFVANPSRRITIKEIKSHPWFLK 255
            C N        +P  R T KE+  H +  +
Sbjct: 235 ACLN-------KDPRFRPTAKELLKHKFITR 258

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 79.7 bits (196), Expect = 7e-17
 Identities = 64/192 (33%), Positives = 98/192 (51%), Gaps = 24/192 (12%)

Query: 7   MKDIGSGNFGVARLMRNKNTKELVAMKYI----ERGHKIDANVAREIINHKQLRHPNIIR 62
           + +IG G+FG      N +T E+VA+K +    ++ ++   ++ +E+   +QL+HPN I 
Sbjct: 26  LHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIE 85

Query: 63  FKEVVLTPTHLAIVMEYAAG--GELFERICNAGRFSEDE-------ARYFFQQLISGQIC 113
           +K   L      +VMEY  G   +L E   +     E E       A      L S  + 
Sbjct: 86  YKGCYLKEHTAWLVMEYCLGSASDLLE--VHKKPLQEVEIAAITHGALQGLAYLHSHNMI 143

Query: 114 HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEV---LSRREYD 170
           HRD+K  N LL  +   ++K+ DFG   S+   S   S VGTP ++APEV   +   +YD
Sbjct: 144 HRDIKAGNILL--TEPGQVKLADFG---SASKSSPANSFVGTPYWMAPEVILAMDEGQYD 198

Query: 171 GKLADVWSCGVT 182
           GK+ DVWS G+T
Sbjct: 199 GKV-DVWSLGIT 209

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 79.6 bits (197), Expect = 1e-16
 Identities = 75/302 (24%), Positives = 124/302 (41%), Gaps = 65/302 (21%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK--IDANVA-REIINHKQLRHP 58
           ++Y+ +  +GSG +G      +  T   VA+K + R  +  I A    RE+   K + H 
Sbjct: 15  DRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHE 74

Query: 59  NIIRFKEVVLTPTHLA------IVMEYAAGGELFERICNAGRFSEDEARYFFQQLI---- 108
           N+I   +V    + L       +V     G +L   I    + S+D  ++   Q++    
Sbjct: 75  NVIGLLDVFTPASSLEDFQDVYLVTHL-MGADL-NNIVKCQKLSDDHIQFLVYQILRGLK 132

Query: 109 ---SGQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST--VGTPAYIAPEV 163
              S  I HRDLK  N  ++      LKI DFG ++    H+  + T  V T  Y APE+
Sbjct: 133 YIHSAGIIHRDLKPSNIAVNED--CELKILDFGLAR----HTDDEMTGYVATRWYRAPEI 186

Query: 164 -LSRREYDGKLADVWSCGVTLYVMLVGA--YPFEDQEDPKNFRKTISRIMAV-------- 212
            L+   Y+ +  D+WS G  +  +L G   +P  D  D       + RIM +        
Sbjct: 187 MLNWMHYN-QTVDIWSVGCIMAELLTGKTLFPGSDHID------QLKRIMNLVGTPDEEL 239

Query: 213 -----------------QYKIPDYVHI----SQDCRNLLSRIFVANPSRRITIKEIKSHP 251
                            Q    D+  +    +    +LL ++ V +P +RIT  E  +HP
Sbjct: 240 LQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHP 299

Query: 252 WF 253
           + 
Sbjct: 300 YL 301

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 77.3 bits (190), Expect = 3e-16
 Identities = 70/269 (26%), Positives = 128/269 (47%), Gaps = 34/269 (12%)

Query: 4   YELMKDIGSGNFGVARLMRNKNTKELVAMKYI-----ERGHKIDANVAREIINHKQLRHP 58
           Y  ++ +G G++G   L+R++   +   +K +      R  +  A    ++++  QL+HP
Sbjct: 2   YCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLS--QLKHP 59

Query: 59  NIIRFKEVVL-TPTHLAIVMEYAAGGELFERI--CNAGRFSEDEARYFF-------QQLI 108
           NI+ ++E        L IVM +  GG+L+ ++         E++   +F       Q L 
Sbjct: 60  NIVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLH 119

Query: 109 SGQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST-VGTPAYIAPEVLSRR 167
              I HRDLK +N  L  +    +K+ D G ++         ST +GTP Y++PE+ S +
Sbjct: 120 EKHILHRDLKTQNVFLTRTNI--IKVGDLGIARVLENQCDMASTLIGTPYYMSPELFSNK 177

Query: 168 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIP----DYVHIS 223
            Y+ K +DVW+ G  +Y M    + F    + K+    + RI  ++ K+P    DY   S
Sbjct: 178 PYNYK-SDVWALGCCVYEMATLKHAF----NAKDMNSLVYRI--IEGKLPPMPKDY---S 227

Query: 224 QDCRNLLSRIFVANPSRRITIKEIKSHPW 252
            +   L++ +    P +R ++K I   P+
Sbjct: 228 PELGELIATMLSKRPEKRPSVKSILRQPY 256

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 77.2 bits (190), Expect = 4e-16
 Identities = 58/192 (30%), Positives = 100/192 (52%), Gaps = 15/192 (7%)

Query: 10  IGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRH----PNIIRFKE 65
           +G GN G      +  T+ ++A+K I     I   + ++I++  ++ +    P II F  
Sbjct: 9   LGHGNGGTVYKAYHLLTRRILAVKVIPL--DITVELQKQIMSELEILYKCDSPYIIGFYG 66

Query: 66  VVLTPTHLAIVMEYAAGGEL--FERICNA--GRFSEDEARYFFQQLISGQICHRDLKLEN 121
                  ++I  E+  GG L  + +I     GR +    +     L S +I HRD+K  N
Sbjct: 67  AFFVENRISICTEFMDGGSLDVYRKIPEHVLGRIAVAVVKGL-TYLWSLKILHRDVKPSN 125

Query: 122 TLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGV 181
            L++     ++K+CDFG S + L++S  K+ VGT AY+APE +S  +Y G  +DVWS G+
Sbjct: 126 MLVNTRG--QVKLCDFGVS-TQLVNSIAKTYVGTNAYMAPERISGEQY-GIHSDVWSLGI 181

Query: 182 TLYVMLVGAYPF 193
           +   + +G +P+
Sbjct: 182 SFMELALGRFPY 193

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 77.4 bits (190), Expect = 4e-16
 Identities = 84/289 (29%), Positives = 129/289 (44%), Gaps = 33/289 (11%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKI---DANVAREIINHKQLRHP 58
           E +E++ ++G G FG     +NK T  L A K IE   +    D  V  EI+      HP
Sbjct: 12  EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEIL--ATCNHP 69

Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGR-FSEDEARYFFQQLI-------SG 110
            I++          L I++E+  GG +   +    R  +E + +   +Q++       S 
Sbjct: 70  YIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSM 129

Query: 111 QICHRDLKLENTLL--DGSPAPRLKICDFGYS-KSSLLHSRPKSTVGTPAYIAPEV---- 163
           +I HRDLK  N LL  DG     +K+ DFG S K+     R  S +GTP ++APEV    
Sbjct: 130 KIIHRDLKAGNVLLTLDGD----IKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCE 185

Query: 164 -LSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHI 222
            +    YD K AD+WS G+TL + +    P   + +P      I++        P     
Sbjct: 186 TMKDTPYDYK-ADIWSLGITL-IEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQPS--KW 241

Query: 223 SQDCRNLLSRIFVANPSRRITIKEIKSHPWFLK---NLP-RELTETAQA 267
           S + R+ L      +P  R +  ++  HP+      N P REL   A+A
Sbjct: 242 SMEFRDFLKTALDKHPETRPSAAQLLEHPFVSSVTSNRPLRELVAEAKA 290

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score = 76.7 bits (189), Expect = 4e-16
 Identities = 74/272 (27%), Positives = 113/272 (41%), Gaps = 48/272 (17%)

Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIER-GHKIDANVAREIINHKQLRHPN 59
            ++ +L   IG G FG   L   +  K  VA+K ++       A +A E      LRHPN
Sbjct: 5   SKELKLGATIGKGEFGDVMLGDYRGQK--VAVKCLKDDSTAAQAFLA-EASVMTTLRHPN 61

Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGR----------FSEDEA---RYFFQQ 106
           +++   VVL    L IV EY A G L + + + GR          F+ D      Y    
Sbjct: 62  LVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEY---- 117

Query: 107 LISGQICHRDLKLENTLLDGSPAPRLKICDFGYSK-SSLLHSRPKSTVGTPAYIAPEVLS 165
           L      HRDL   N L+        K+ DFG +K +S      K  V    + APE L 
Sbjct: 118 LEEKNFVHRDLAARNVLVSEDLVA--KVSDFGLAKEASQGQDSGKLPV---KWTAPEALR 172

Query: 166 RREYDGKLADVWSCGVTLY-VMLVG--AYPFEDQED-----PKNFRKTISRIMAVQYKIP 217
            +++  K +DVWS G+ L+ +   G   YP    +D      K +R      M      P
Sbjct: 173 EKKFSTK-SDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYR------MEAPEGCP 225

Query: 218 DYVHISQDCRNLLSRIFVANPSRRITIKEIKS 249
             V+       ++   +  +P++R T K+++ 
Sbjct: 226 PEVY------KVMKDCWELDPAKRPTFKQLRE 251

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 76.9 bits (189), Expect = 5e-16
 Identities = 70/271 (25%), Positives = 121/271 (44%), Gaps = 28/271 (10%)

Query: 10  IGSGNFGVARLMRNKNTKELVAMKYIER-------GHKIDANVAREIINHKQLRHPNIIR 62
           +G G FG    ++ KNT ++ A K +++       G K+ A + +EI+  +++  P I+ 
Sbjct: 1   LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKM-ALLEKEIL--EKVNSPFIVN 57

Query: 63  FKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEAR--YFFQQLISG-------QIC 113
                 + THL +VM    GG+L   I N G    +  R  ++  Q+  G        I 
Sbjct: 58  LAYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIV 117

Query: 114 HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKL 173
           +RD+K EN LLD     RL   D G +             GT  Y+APE+L    Y   +
Sbjct: 118 YRDMKPENVLLDDQGNCRLS--DLGLAVELKDGKTITQRAGTNGYMAPEILKEEPYSYPV 175

Query: 174 ADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRI 233
            D ++ G ++Y M+ G  PF+D ++     +   R +  + K  ++ + +++ +++    
Sbjct: 176 -DWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKF-EHQNFTEESKDICRLF 233

Query: 234 FVANPSRRITIKEIKSHP---WFLK--NLPR 259
               P  R+  +E    P    F K  N PR
Sbjct: 234 LAKKPEDRLGSREKNDDPRKHEFFKTINFPR 264

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 76.5 bits (188), Expect = 5e-16
 Identities = 57/205 (27%), Positives = 94/205 (45%), Gaps = 25/205 (12%)

Query: 10  IGSGNFGVARLMRNKNTKELVAMKYIE-------RGHKIDANVAREIINHKQLRHPNIIR 62
           +G G +G        N  +L+A+K +E          K    +  E+   K L+H NI++
Sbjct: 8   LGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQ 66

Query: 63  FKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-------QICHR 115
           +    L    ++I ME+  GG +   +   G   E     + +Q++ G        + HR
Sbjct: 67  YLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHR 126

Query: 116 DLKLENTLLDGSPAPRLKICDFGYSKS------SLLHSRP-KSTVGTPAYIAPEVLSRRE 168
           D+K  N +L   P   +K+ DFG ++          HS   KS  GTP ++APEV++   
Sbjct: 127 DIKGNNVML--MPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESG 184

Query: 169 YDGKLADVWSCGVTLYVMLVGAYPF 193
           Y G+ +D+WS G T++ M  G  P 
Sbjct: 185 Y-GRKSDIWSIGCTVFEMATGKPPL 208

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 76.0 bits (187), Expect = 8e-16
 Identities = 66/262 (25%), Positives = 109/262 (41%), Gaps = 23/262 (8%)

Query: 10  IGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQL----RHPNIIRFKE 65
           +G G FG     + + T ++ A K +E+            +N KQ+        ++    
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAY 67

Query: 66  VVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFF---------QQLISGQICHRD 116
              T   L +V+    GG+L   I N G    DE R  F         + L   +I +RD
Sbjct: 68  AYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRD 127

Query: 117 LKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLADV 176
           LK EN LLD      ++I D G +         +  VGT  Y+APEV+    Y     D 
Sbjct: 128 LKPENILLDDY--GHIRISDLGLAVEIPEGETIRGRVGTVGYMAPEVVKNERY-TFSPDW 184

Query: 177 WSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVA 236
           W  G  +Y M+ G  PF  +++     +   R+   Q +  +    S+  R++  ++   
Sbjct: 185 WGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSE--KFSEAARSICRQLLTK 242

Query: 237 NPSRRITIK-----EIKSHPWF 253
           +P  R+  +     E+K+HP+F
Sbjct: 243 DPGFRLGCRGEGAEEVKAHPFF 264

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 76.3 bits (187), Expect = 1e-15
 Identities = 64/192 (33%), Positives = 96/192 (50%), Gaps = 24/192 (12%)

Query: 7   MKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINH----KQLRHPNIIR 62
           +++IG G+FG     R+  T E+VA+K +    K      ++II      ++++HPN I 
Sbjct: 30  LREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIE 89

Query: 63  FKEVVLTPTHLAIVMEYAAG--GELFERICNAGRFSEDE-------ARYFFQQLISGQIC 113
           +K   L      +VMEY  G   +L E   +     E E       A      L S  + 
Sbjct: 90  YKGCYLREHTAWLVMEYCLGSASDLLE--VHKKPLQEVEIAAITHGALQGLAYLHSHNMI 147

Query: 114 HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEV---LSRREYD 170
           HRD+K  N LL  +   ++K+ DFG   S+ + S   S VGTP ++APEV   +   +YD
Sbjct: 148 HRDIKAGNILL--TEPGQVKLADFG---SASIASPANSFVGTPYWMAPEVILAMDEGQYD 202

Query: 171 GKLADVWSCGVT 182
           GK+ DVWS G+T
Sbjct: 203 GKV-DVWSLGIT 213

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 75.7 bits (186), Expect = 1e-15
 Identities = 72/271 (26%), Positives = 129/271 (47%), Gaps = 33/271 (12%)

Query: 7   MKDIGSGNFGVARLMR----NKNTKELVAMKYI--ERGHKIDANVAREIINHKQLRHPNI 60
           ++D+G G+FG   L R      NT E VA+K +  E G    A++ +EI   + L H NI
Sbjct: 9   IRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENI 68

Query: 61  IRFKEVVLTP--THLAIVMEYAAGGELFERIC-NAGRFSEDEARYFFQQLISG------- 110
           +++K +        + ++ME+   G L E +  N  + +  +   +  Q+  G       
Sbjct: 69  VKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSR 128

Query: 111 QICHRDLKLENTLLDGSPAPRLKICDFGYSKS---SLLHSRPKSTVGTPAY-IAPEVLSR 166
           Q  HRDL   N L++     ++KI DFG +K+      +   K  + +P +  APE L +
Sbjct: 129 QYVHRDLAARNVLVESEH--QVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQ 186

Query: 167 REYDGKLADVWSCGVTLYVMLV----GAYP---FEDQEDPKNFRKTISRIMAV---QYKI 216
            ++    +DVWS GVTLY +L      + P   F     P + + T++R++ V     ++
Sbjct: 187 SKF-YIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEEGKRL 245

Query: 217 PDYVHISQDCRNLLSRIFVANPSRRITIKEI 247
           P   +  ++   L+ + +   PS+R T + +
Sbjct: 246 PRPPNCPEEVYQLMRKCWEFQPSKRTTFQNL 276

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 75.8 bits (186), Expect = 1e-15
 Identities = 75/273 (27%), Positives = 121/273 (44%), Gaps = 31/273 (11%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLR-HPNI 60
           + +E+++ IG G +G    + NK      A+K ++  H ID  +  E    K L  HPN+
Sbjct: 18  DTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNV 77

Query: 61  IRF-----KEVVLTPTHLAIVMEYAAGG---ELFERICNAG-RFSE-------DEARYFF 104
           ++F     K+ V     L +V+E   GG   +L +     G R  E        EA    
Sbjct: 78  VKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGL 137

Query: 105 QQLISGQICHRDLKLENTLLDGSPAPRLKICDFGYSK--SSLLHSRPKSTVGTPAYIAPE 162
           Q L   +  HRD+K  N LL  +    +K+ DFG S   +S    R  ++VGTP ++APE
Sbjct: 138 QHLHVNKTIHRDVKGNNILL--TTEGGVKLVDFGVSAQLTSTRLRR-NTSVGTPFWMAPE 194

Query: 163 VLSRRE-----YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIP 217
           V++  +     YD +  DVWS G+T   +  G  P  D    +   K I R        P
Sbjct: 195 VIACEQQLDSTYDAR-CDVWSLGITAIELGDGDPPLADLHPMRALFK-IPRNPPPTLHQP 252

Query: 218 DYVHISQDCRNLLSRIFVANPSRRITIKEIKSH 250
           +    S +  + + +    +  +R T+ ++  H
Sbjct: 253 EL--WSNEFNDFIRKCLTKDYEKRPTVSDLLQH 283

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 75.5 bits (185), Expect = 2e-15
 Identities = 61/192 (31%), Positives = 93/192 (48%), Gaps = 24/192 (12%)

Query: 7   MKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINH----KQLRHPNIIR 62
           +++IG G+FG     R+    E+VA+K +    K      ++II      ++LRHPN I+
Sbjct: 20  LREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQ 79

Query: 63  FKEVVLTPTHLAIVMEYAAG--GELFERICNAGRFSEDEARYFFQQLISG-------QIC 113
           ++   L      +VMEY  G   +L E   +     E E        + G        + 
Sbjct: 80  YRGCYLREHTAWLVMEYCLGSASDLLE--VHKKPLQEVEIAAVTHGALQGLAYLHSHNMI 137

Query: 114 HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEV---LSRREYD 170
           HRD+K  N LL  S    +K+ DFG   S+ + +     VGTP ++APEV   +   +YD
Sbjct: 138 HRDVKAGNILL--SEPGLVKLGDFG---SASIMAPANXFVGTPYWMAPEVILAMDEGQYD 192

Query: 171 GKLADVWSCGVT 182
           GK+ DVWS G+T
Sbjct: 193 GKV-DVWSLGIT 203

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 75.4 bits (186), Expect = 2e-15
 Identities = 68/319 (21%), Positives = 114/319 (35%), Gaps = 71/319 (22%)

Query: 3   KYELMKDIGSGNFGVARLMRNKN--TKELVAMKYIE----RGHKIDANVAREIINHKQLR 56
           KYE+   IG G +G     + KN    +  A+K  +    +   I  +  REI   ++L+
Sbjct: 1   KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELK 60

Query: 57  HPNIIRFKEVVLTPTHLAIVM--EYAAGGEL----FERICNAGRFSEDEARYFFQQLISG 110
           H N++   EV L     ++ +  +YA         F R            +    Q+++G
Sbjct: 61  HENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNG 120

Query: 111 -------QICHRDLKLENTLL--DGSPAPRLKICDFGYSKSSLLHSRPKS------TVGT 155
                   + HRDLK  N L+  +G     +KI D G ++  L ++  K        V T
Sbjct: 121 VHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLAR--LFNAPLKPLADLDPVVVT 178

Query: 156 PAYIAPEV-LSRREYDGKLADVWSCGVTLYVMLVGAYPFE-DQEDPK------------- 200
             Y APE+ L  R Y  K  D+W+ G     +L     F+  +   K             
Sbjct: 179 IWYRAPELLLGARHYT-KAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERI 237

Query: 201 ----------------------NFRKTISRIMAVQYKIPDYVHI----SQDCRNLLSRIF 234
                                    K           +  ++           +LL ++ 
Sbjct: 238 FEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLL 297

Query: 235 VANPSRRITIKEIKSHPWF 253
             +P++RIT +E   HP+F
Sbjct: 298 EYDPTKRITAEEALEHPYF 316

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 74.4 bits (182), Expect = 3e-15
 Identities = 73/271 (26%), Positives = 126/271 (46%), Gaps = 29/271 (10%)

Query: 4   YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREI-INHKQLRHPNIIR 62
           +EL++ +G+G +G     R+  T +L A+K ++     +  + +EI +  K   H NI  
Sbjct: 8   FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIAT 67

Query: 63  FKEVVLTPT------HLAIVMEYAAGGELFERICN--AGRFSEDEARYFFQQLISG---- 110
           +    +          L +VME+   G + + I N       E+   Y  ++++ G    
Sbjct: 68  YYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHL 127

Query: 111 ---QICHRDLKLENTLLDGSPAPRLKICDFGYSKS-SLLHSRPKSTVGTPAYIAPEVLSR 166
              ++ HRD+K +N LL  +    +K+ DFG S        R  + +GTP ++APEV++ 
Sbjct: 128 HQHKVIHRDIKGQNVLL--TENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIAC 185

Query: 167 RE-----YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVH 221
            E     YD K +D+WS G+T   M  GA P  D   P      I R  A + K   +  
Sbjct: 186 DENPDATYDFK-SDLWSLGITAIEMAEGAPPLCDMH-PMRALFLIPRNPAPRLKSKKW-- 241

Query: 222 ISQDCRNLLSRIFVANPSRRITIKEIKSHPW 252
            S+  ++ +    V N S+R T +++  HP+
Sbjct: 242 -SKKFQSFIESCLVKNHSQRPTTEQLMKHPF 271

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 74.7 bits (184), Expect = 4e-15
 Identities = 72/314 (22%), Positives = 116/314 (36%), Gaps = 76/314 (24%)

Query: 4   YELMKDIGSGNFGVARLMRNKNTKELVAMKYI----ER-GHKIDANVAREIINHKQLRHP 58
           YE++  +G G FG     R   T  +VA+K I    E+ G  I A   REI   K+L+HP
Sbjct: 10  YEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITA--LREIKILKKLKHP 67

Query: 59  NIIRFKEVVL--------TPTHLAIVMEYA----AGGELFE--RICNAGRFSEDEARYFF 104
           N++   ++ +            + +V  Y     +G  L E   +    + +E + + + 
Sbjct: 68  NVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSG--LLENPSV----KLTESQIKCYM 121

Query: 105 QQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGY------SKSSLLHSRPKS 151
            QL+ G        I HRD+K  N L+D      LKI DFG          +        
Sbjct: 122 LQLLEGINYLHENHILHRDIKAANILIDNQGI--LKIADFGLARPYDGPPPNPKGGGGGG 179

Query: 152 T------VGTPAYIAPE-VLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRK 204
           T      V T  Y  PE +L  R Y     D+W  G     M       + + D      
Sbjct: 180 TRKYTNLVVTRWYRPPELLLGERRY-TTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHL 238

Query: 205 TISRIMAV-----------------QYKIPDYV--------HISQDCRNLLSRIFVANPS 239
            I ++                     +   +Y          +  +  +LLS++   +P 
Sbjct: 239 -IFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPY 297

Query: 240 RRITIKEIKSHPWF 253
           +R+T  +   HP+F
Sbjct: 298 KRLTASDALEHPYF 311

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 74.0 bits (182), Expect = 5e-15
 Identities = 80/292 (27%), Positives = 122/292 (41%), Gaps = 43/292 (14%)

Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDA--NVAREIINHKQLRHP 58
           +E Y+ +  +G G++      R+K T +LVA+K I   H+  A     RE    K L+H 
Sbjct: 4   LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHA 63

Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRF-SEDEARYFFQQLISG------- 110
           NI+   +++ T   L +V EY    +L + + + G   S    R F  QL+ G       
Sbjct: 64  NIVTLHDIIHTKKTLTLVFEYLD-TDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQR 122

Query: 111 QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST-VGTPAYIAPEVL-SRRE 168
           ++ HRDLK +N L+  S    LK+ DFG +++  + S+  S  V T  Y  P+VL    E
Sbjct: 123 RVLHRDLKPQNLLI--SERGELKLADFGLARAKSVPSKTYSNEVVTLWYRPPDVLLGSTE 180

Query: 169 YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMA----------------V 212
           Y   L D+W  G   Y M  G   F    D ++    I R++                  
Sbjct: 181 YSTSL-DMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFK 239

Query: 213 QYKIPDY------VHISQ-----DCRNLLSRIFVANPSRRITIKEIKSHPWF 253
            Y  P Y       H  +         L  +     P +RI+  E   HP+F
Sbjct: 240 PYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 73.9 bits (181), Expect = 6e-15
 Identities = 76/293 (25%), Positives = 126/293 (43%), Gaps = 46/293 (15%)

Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDA--NVAREIINHKQLRHP 58
           +E Y  +  +G G +      R+K T  LVA+K I   H+  A     RE+   K L+H 
Sbjct: 5   LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHA 64

Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGR-FSEDEARYFFQQLISG------- 110
           NI+   +++ T   L +V EY    +L + + + G   +    + F  QL+ G       
Sbjct: 65  NIVTLHDIIHTEKSLTLVFEY-LDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRR 123

Query: 111 QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST-VGTPAYIAPEV-LSRRE 168
           ++ HRDLK +N L++      LK+ DFG +++  + ++  S  V T  Y  P++ L   +
Sbjct: 124 KVLHRDLKPQNLLINER--GELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDILLGSTD 181

Query: 169 YDGKLADVWSCGVTLYVMLVGA--YPFEDQEDPKNFRKTISRIMA--------------- 211
           Y  ++ D+W  G   Y M  G   +P    E+  +F   I RI+                
Sbjct: 182 YSTQI-DMWGVGCIFYEMSTGRPLFPGSTVEEQLHF---IFRILGTPTEETWPGILSNEE 237

Query: 212 -VQYKIPDY---------VHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFL 254
              Y  P Y           +  D   LLS++      +RI+ +E   HP+F 
Sbjct: 238 FKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFH 290

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 73.9 bits (181), Expect = 6e-15
 Identities = 63/201 (31%), Positives = 97/201 (48%), Gaps = 16/201 (7%)

Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDA--NVAREIINHKQLRHP 58
           +E Y  +  +G G +      R+K T+ LVA+K I   H+  A     RE+   K L+H 
Sbjct: 4   LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHA 63

Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRF-SEDEARYFFQQLISG------- 110
           NI+   +++ T   L +V EY    +L + + N G   S    + F  QL+ G       
Sbjct: 64  NIVTLHDIIHTERCLTLVFEY-LDSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKR 122

Query: 111 QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST-VGTPAYIAPEV-LSRRE 168
           +I HRDLK +N L++      LK+ DFG +++  + ++  S  V T  Y  P+V L   E
Sbjct: 123 KILHRDLKPQNLLINEK--GELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSTE 180

Query: 169 YDGKLADVWSCGVTLYVMLVG 189
           Y   + D+W  G  LY M  G
Sbjct: 181 YSTPI-DMWGVGCILYEMATG 200

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 73.1 bits (179), Expect = 1e-14
 Identities = 61/214 (28%), Positives = 103/214 (48%), Gaps = 25/214 (11%)

Query: 4   YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREI-INHKQLRHPNIIR 62
           +EL++ +G+G +G     R+  T +L A+K ++     +  +  EI +  K   H NI  
Sbjct: 18  FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIAT 77

Query: 63  FKEVVLT---PTH---LAIVMEYAAGGELFERICN--AGRFSEDEARYFFQQLISG---- 110
           +    +    P H   L +VME+   G + + + N       ED   Y  ++++ G    
Sbjct: 78  YYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHL 137

Query: 111 ---QICHRDLKLENTLLDGSPAPRLKICDFGYSKS-SLLHSRPKSTVGTPAYIAPEVLSR 166
              ++ HRD+K +N LL  +    +K+ DFG S        R  + +GTP ++APEV++ 
Sbjct: 138 HAHKVIHRDIKGQNVLL--TENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIAC 195

Query: 167 RE-----YDGKLADVWSCGVTLYVMLVGAYPFED 195
            E     YD + +D+WS G+T   M  GA P  D
Sbjct: 196 DENPDATYDYR-SDIWSLGITAIEMAEGAPPLCD 228

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 72.4 bits (178), Expect = 1e-14
 Identities = 62/210 (29%), Positives = 90/210 (42%), Gaps = 31/210 (14%)

Query: 8   KDIGSGNFGVAR--LMRNKNTKEL-VAMKYIERGHKIDANVA---REIINHKQLRHPNII 61
           K++G GNFG     +   K+ KE+ VA+K +++ H I A      RE     QL HP I+
Sbjct: 1   KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEH-IAAGKKEFLREASVMAQLDHPCIV 59

Query: 62  RFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-------QICH 114
           R   V      L +VME A  G L + +         + +    Q+  G          H
Sbjct: 60  RLIGVCKGEP-LMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVH 118

Query: 115 RDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPA--------YIAPEVLSR 166
           RDL   N LL      + KI DFG S++        S              + APE ++ 
Sbjct: 119 RDLAARNVLLVNRH--QAKISDFGMSRAL----GAGSDYYRATTAGRWPLKWYAPECINY 172

Query: 167 REYDGKLADVWSCGVTLYVML-VGAYPFED 195
            ++  K +DVWS GVTL+     GA P+ +
Sbjct: 173 GKFSSK-SDVWSYGVTLWEAFSYGAKPYGE 201

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 73.1 bits (179), Expect = 1e-14
 Identities = 74/263 (28%), Positives = 111/263 (42%), Gaps = 25/263 (9%)

Query: 10  IGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRF----KE 65
           +G G FG     + + T ++ A K +E+            +N KQ+      RF      
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAY 67

Query: 66  VVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFF---------QQLISGQICHRD 116
              T   L +V+    GG+L   I + G    +E R  F         + L   +I +RD
Sbjct: 68  AYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRD 127

Query: 117 LKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLADV 176
           LK EN LLD      ++I D G +         K  VGT  Y+APEV+    Y     D 
Sbjct: 128 LKPENILLDDHG--HIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFS-PDW 184

Query: 177 WSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMA-VQYKIPDYVHISQDCRNLLSRIFV 235
           W+ G  LY M+ G  PF+ Q   K  R+ + R++  VQ +  +    S D R+L   +  
Sbjct: 185 WALGCLLYEMIAGQSPFQ-QRKKKIKREEVERLVKEVQEEYSE--KFSPDARSLCKMLLC 241

Query: 236 ANPSRRI-----TIKEIKSHPWF 253
            +P  R+       +E+K HP F
Sbjct: 242 KDPKERLGCQGGGAREVKEHPLF 264

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 72.4 bits (177), Expect = 2e-14
 Identities = 83/307 (27%), Positives = 129/307 (42%), Gaps = 53/307 (17%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYI----ERGHKIDANVAREIINHKQLRH 57
           + YE ++ +G G++      ++K   +LVA+K I    E G    A   RE    K L+H
Sbjct: 5   DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTA--IREASLLKGLKH 62

Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG------- 110
            NI+   +++ T   L +V EY           + G    +  + F  QL+ G       
Sbjct: 63  ANIVLLHDIIHTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQR 122

Query: 111 QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST-VGTPAYIAPEV-LSRRE 168
            I HRDLK +N L+  S    LK+ DFG +++  + S   S  V T  Y  P+V L   E
Sbjct: 123 YILHRDLKPQNLLI--SDTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVLLGSTE 180

Query: 169 YDGKLADVWSCGVTLYVML--VGAYP----FEDQ------------ED------------ 198
           Y   L D+W  G     M+  V A+P     +DQ            ED            
Sbjct: 181 YSTCL-DMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHFK 239

Query: 199 PKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLP 258
           P+ F     + +   +    YV+ ++D   L S++    P  R++ +   SH +F    P
Sbjct: 240 PERFTLYSPKNLRQAWNKLSYVNHAED---LASKLLQCFPKNRLSAQAALSHEYFSDLPP 296

Query: 259 R--ELTE 263
           R  ELT+
Sbjct: 297 RLWELTD 303

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 71.6 bits (176), Expect = 3e-14
 Identities = 62/208 (29%), Positives = 86/208 (41%), Gaps = 44/208 (21%)

Query: 8   KDIGSGNFGVAR--LMRNKNTKEL-VAMKYIERG--HKIDANVAREIINHKQLRHPNIIR 62
           K +G G+FGV R         K + VA+K ++      I  +  +E      L H N+IR
Sbjct: 1   KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIR 60

Query: 63  FKEVVLTPTHLAIVMEYAAGGELFER--------------------ICNAGRFSEDEARY 102
              VVLT   L +V E A  G L +R                    I N  R+ E     
Sbjct: 61  LYGVVLTHP-LMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLE----- 114

Query: 103 FFQQLISGQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLL---HSRPKSTVGTP-AY 158
                 S +  HRDL   N LL  +   ++KI DFG  ++      H   +  +  P A+
Sbjct: 115 ------SKRFIHRDLAARNILL--ASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAW 166

Query: 159 IAPEVLSRREYDGKLADVWSCGVTLYVM 186
            APE L  R +    +DVW  GVTL+ M
Sbjct: 167 CAPESLRTRTFS-HASDVWMFGVTLWEM 193

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 70.9 bits (174), Expect = 5e-14
 Identities = 63/204 (30%), Positives = 93/204 (45%), Gaps = 36/204 (17%)

Query: 7   MKDIGSGNFGVARLMR----NKNTKELVAMKYIERGHKID-ANVAREIINHKQLRHPNII 61
           ++ +G GNFG   L R      NT E+VA+K ++        +  REI   K L+H NI+
Sbjct: 9   IQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIV 68

Query: 62  RFKEVVLTP--THLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLI--SGQIC---- 113
           ++K V  +    +L +VMEY   G L           +   R   ++L+  + QIC    
Sbjct: 69  KYKGVCYSAGRRNLRLVMEYLPYGSL------RDYLQKHRERLDHRKLLLYASQICKGME 122

Query: 114 --------HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPA-----YIA 160
                   HRDL   N L++     R+KI DFG +K  L   +    V  P      + A
Sbjct: 123 YLGSKRYVHRDLATRNILVESEN--RVKIGDFGLTKV-LPQDKEYYKVREPGESPIFWYA 179

Query: 161 PEVLSRREYDGKLADVWSCGVTLY 184
           PE L+  ++    +DVWS GV LY
Sbjct: 180 PESLTESKFS-VASDVWSFGVVLY 202

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 70.9 bits (174), Expect = 6e-14
 Identities = 60/216 (27%), Positives = 97/216 (44%), Gaps = 43/216 (19%)

Query: 7   MKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRH--------- 57
           + +IG G FG    M +K +  ++A+K      +I + V  +    K+L           
Sbjct: 9   LGEIGRGAFGTVNKMLHKPSGTIMAVK------RIRSTVDEK--EQKRLLMDLDVVMRSS 60

Query: 58  --PNIIRFKEVVLTPTHLAIVME-------------YAAG-GELFERICNAGRFSEDEAR 101
             P I++F   +       I ME             Y      + E I      +  +A 
Sbjct: 61  DCPYIVKFYGALFREGDCWICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKAL 120

Query: 102 YFFQQLISGQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST-VGTPAYIA 160
            + ++ +  +I HRD+K  N LLD +    +K+CDFG S   L+ S  K+   G   Y+A
Sbjct: 121 NYLKEEL--KIIHRDVKPSNILLDRNGN--IKLCDFGIS-GQLVDSIAKTRDAGCRPYMA 175

Query: 161 PEVL--SRRE-YDGKLADVWSCGVTLYVMLVGAYPF 193
           PE +  S R+ YD + +DVWS G+TLY +  G +P+
Sbjct: 176 PERIDPSARDGYDVR-SDVWSLGITLYEVATGKFPY 210

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 71.1 bits (174), Expect = 8e-14
 Identities = 75/294 (25%), Positives = 122/294 (41%), Gaps = 49/294 (16%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKID---ANVAREIINHKQLRHP 58
           ++Y  +K +GSG +G      ++ T   VA+K + R  + +       RE+   K ++H 
Sbjct: 15  DRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHE 74

Query: 59  NIIRFKEVVLTPTHLA------IVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-- 110
           N+I   +V      L       +VM +   G    ++    + SED  ++   Q++ G  
Sbjct: 75  NVIGLLDVFTPDLSLDRFHDFYLVMPFM--GTDLGKLMKHEKLSEDRIQFLVYQMLKGLK 132

Query: 111 -----QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLS 165
                 I HRDLK  N  L  +    LKI DFG ++ +   S     V T  Y APEV+ 
Sbjct: 133 YIHAAGIIHRDLKPGN--LAVNEDCELKILDFGLARQT--DSEMTGYVVTRWYRAPEVIL 188

Query: 166 RREYDGKLADVWSCGVTLYVMLVGAYPFE-----DQ---------------------EDP 199
              +  +  D+WS G  +  ML G   F+     DQ                     ED 
Sbjct: 189 NWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDA 248

Query: 200 KNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 253
           KN+ K + R     ++     + +    N+L ++ V +   RIT  E  +HP+F
Sbjct: 249 KNYVKKLPRFRKKDFRSL-LPNANPLAVNVLEKMLVLDAESRITAAEALAHPYF 301

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 70.9 bits (174), Expect = 1e-13
 Identities = 73/299 (24%), Positives = 117/299 (39%), Gaps = 62/299 (20%)

Query: 5   ELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQ---------- 54
           E  + IG G FGV   + +    + VA+K +        NV + +++ K+          
Sbjct: 3   EPDRPIGYGAFGVVWSVTDPRDGKRVALKKM-------PNVFQNLVSCKRVFRELKMLCF 55

Query: 55  LRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFER-----ICNAGRFSEDEARYFFQQLIS 109
            +H N++   ++ L P H+    E     EL +      I +    S D  + F  Q++ 
Sbjct: 56  FKHDNVLSALDI-LQPPHIDPFEEIYVVTELMQSDLHKIIVSPQPLSSDHVKVFLYQILR 114

Query: 110 G-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST--VGTPAYIA 160
           G        I HRD+K  N L++ +    LKICDFG ++          T  V T  Y A
Sbjct: 115 GLKYLHSAGILHRDIKPGNLLVNSNC--VLKICDFGLARVEEPDESKHMTQEVVTQYYRA 172

Query: 161 PEVL-SRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIM--------- 210
           PE+L   R Y   + D+WS G     +L     F+ Q   +        +          
Sbjct: 173 PEILMGSRHYTSAV-DIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRS 231

Query: 211 ----AVQY------KIPD----YVHISQDCR---NLLSRIFVANPSRRITIKEIKSHPW 252
               A  +      K P     Y   SQ      +LL R+ V +P +RI+  +  +HP+
Sbjct: 232 ACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPY 290

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 70.6 bits (173), Expect = 1e-13
 Identities = 86/316 (27%), Positives = 136/316 (43%), Gaps = 58/316 (18%)

Query: 3   KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIER--GHKIDAN-VAREIINHKQLRHPN 59
           +Y++ + IG G++GV     + +T E VA+K I     H  DA  + REI   + LRHP+
Sbjct: 1   RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPD 60

Query: 60  IIRFKEVVLTPTH-----LAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG---- 110
           I+  K ++L P+      + +V E     +L + I      + +  ++F  QL+      
Sbjct: 61  IVEIKHIMLPPSRREFKDIYVVFEL-MESDLHQVIKANDDLTPEHHQFFLYQLLRALKYI 119

Query: 111 ---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPK----STVGTPAYIAPEV 163
               + HRDLK +N L +     +LKICDFG ++ +   +         V T  Y APE+
Sbjct: 120 HTANVFHRDLKPKNILANAD--CKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPEL 177

Query: 164 LSRREYDGKLA---DVWSCGVTLYVMLVGAYPFEDQEDPKNFR-----------KTISRI 209
                +  K     D+WS G     +L G   F  +                  +TISR+
Sbjct: 178 CG--SFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRV 235

Query: 210 ---------MAVQYKIPDYVHISQDCRN-------LLSRIFVANPSRRITIKEIKSHPWF 253
                     +++ K P  V  SQ   N       LL R+   +P  R T +E  + P+F
Sbjct: 236 RNEKARRYLSSMRKKQP--VPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYF 293

Query: 254 LKNLPRELTE-TAQAI 268
            K L +   E +AQ I
Sbjct: 294 -KGLAKVEREPSAQPI 308

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 70.4 bits (172), Expect = 1e-13
 Identities = 63/212 (29%), Positives = 102/212 (48%), Gaps = 18/212 (8%)

Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDA--NVAREIINHKQLRHP 58
           ME Y  ++ +G G +      R+K T+ LVA+K I   H+  A     RE+   K L+H 
Sbjct: 5   METYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHA 64

Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGR-FSEDEARYFFQQLISG------- 110
           NI+   ++V T   L +V EY    +L + + + G   S    + F  Q++ G       
Sbjct: 65  NIVTLHDIVHTDKSLTLVFEY-LDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRR 123

Query: 111 QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST-VGTPAYIAPEV-LSRRE 168
           ++ HRDLK +N L++      LK+ DFG +++  + ++  S  V T  Y  P+V L   E
Sbjct: 124 KVLHRDLKPQNLLIN--ERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSSE 181

Query: 169 YDGKLADVWSCGVTLYVMLVGA--YPFEDQED 198
           Y  ++ D+W  G   + M  G   +P    ED
Sbjct: 182 YSTQI-DMWGVGCIFFEMASGRPLFPGSTVED 212

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 69.6 bits (170), Expect = 1e-13
 Identities = 68/263 (25%), Positives = 112/263 (42%), Gaps = 25/263 (9%)

Query: 10  IGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKEVVLT 69
           +G G FG     + + T ++ A K +E+            +N K++      RF  V L 
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFV-VSLA 66

Query: 70  PTH-----LAIVMEYAAGGELFERICNAGR--FSEDEARYFFQQLISG-------QICHR 115
             +     L +V+    GG+L   I N G   F E  A ++  +L  G       +I +R
Sbjct: 67  YAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYR 126

Query: 116 DLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLAD 175
           DLK EN LLD      ++I D G +         +  VGT  Y+APEV++  +Y     D
Sbjct: 127 DLKPENILLDDRG--HIRISDLGLAVQIPEGETVRGRVGTVGYMAPEVINNEKYTFS-PD 183

Query: 176 VWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFV 235
            W  G  +Y M+ G  PF  +++     +   R+   Q +  +    S+D +++   +  
Sbjct: 184 WWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSE--KFSEDAKSICRMLLT 241

Query: 236 ANPSRRITIK-----EIKSHPWF 253
            NP  R+  +      +K HP F
Sbjct: 242 KNPKERLGCRGNGAAGVKQHPIF 264

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 69.1 bits (169), Expect = 1e-13
 Identities = 57/207 (27%), Positives = 92/207 (44%), Gaps = 29/207 (14%)

Query: 6   LMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKE 65
            +K++G+G FGV +  + +   + VA+K I+ G   +     E     +L H  +++   
Sbjct: 8   FLKELGTGQFGVVKYGKWRGQYD-VAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYG 66

Query: 66  VVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLI--------------SGQ 111
           V      + IV EY + G      C      E   R+   QL+              S Q
Sbjct: 67  VCTKQRPIYIVTEYMSNG------CLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQ 120

Query: 112 ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTP---AYIAPEVLSRRE 168
             HRDL   N L+D      +K+ DFG S+  +L     S+VG+     +  PEVL   +
Sbjct: 121 FIHRDLAARNCLVDDQGC--VKVSDFGLSR-YVLDDEYTSSVGSKFPVRWSPPEVLLYSK 177

Query: 169 YDGKLADVWSCGVTLY-VMLVGAYPFE 194
           +  K +DVW+ GV ++ V  +G  P+E
Sbjct: 178 FSSK-SDVWAFGVLMWEVYSLGKMPYE 203

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 69.0 bits (169), Expect = 2e-13
 Identities = 63/263 (23%), Positives = 103/263 (39%), Gaps = 27/263 (10%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDA-NVAREIINHKQLRHPNI 60
           E++ L + +GSG FG       KN    VA+K ++    +   +  +E+   K+LRH ++
Sbjct: 6   EEFTLERKLGSGYFGEVWEGLWKNRVR-VAIKILKSDDLLKQQDFQKEVQALKRLRHKHL 64

Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEAR--YFFQQLISG-------Q 111
           I    V      + I+ E    G L   + +        A       Q+  G        
Sbjct: 65  ISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQN 124

Query: 112 ICHRDLKLENTLLDGSPAPRLKICDFGYSK----SSLLHSRPKSTVGTPAYIAPEVLSRR 167
             HRDL   N L+        K+ DFG ++       L S  K       + APE  S  
Sbjct: 125 SIHRDLAARNILVGEDLV--CKVADFGLARLIKEDVYLSSDKKIPY---KWTAPEAASHG 179

Query: 168 EYDGKLADVWSCGVTLY-VMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDC 226
            +  K +DVWS G+ LY +   G  P+       N  +   +I A  Y++P      Q+ 
Sbjct: 180 TFSTK-SDVWSFGILLYEMFTYGQVPYPG----MNNHEVYDQITA-GYRMPCPAKCPQEI 233

Query: 227 RNLLSRIFVANPSRRITIKEIKS 249
             ++   + A P  R + K ++ 
Sbjct: 234 YKIMLECWAAEPEDRPSFKALRE 256

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 69.2 bits (169), Expect = 3e-13
 Identities = 77/297 (25%), Positives = 124/297 (41%), Gaps = 56/297 (18%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIER--GHKIDANVA-REIINHKQLRHP 58
           E+Y  +K +GSG +G      +K T E VA+K + R    +I A  A RE+   K ++H 
Sbjct: 15  ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHE 74

Query: 59  NIIRFKEVVLTPTHLA------IVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-- 110
           N+I   +V  +           +VM Y       ++I      SED+ +Y   Q++ G  
Sbjct: 75  NVIGLLDVFTSAVSGDEFQDFYLVMPYMQTD--LQKI-MGHPLSEDKVQYLVYQMLCGLK 131

Query: 111 -----QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLS 165
                 I HRDLK  N  L  +    LKI DFG ++ +   +     V T  Y APEV+ 
Sbjct: 132 YIHSAGIIHRDLKPGN--LAVNEDCELKILDFGLARHA--DAEMTGYVVTRWYRAPEVIL 187

Query: 166 RREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQ-YKIPDYVH--- 221
              +  +  D+WS G  +  ML G   F+     K++   +++I+ V     P++V    
Sbjct: 188 NWMHYNQTVDIWSVGCIMAEMLTGKTLFKG----KDYLDQLTQILKVTGVPGPEFVQKLE 243

Query: 222 -------------------------ISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 253
                                     S    +LL ++   +  +R+T  E   HP+F
Sbjct: 244 DKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYF 300

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 68.5 bits (167), Expect = 4e-13
 Identities = 66/266 (24%), Positives = 115/266 (43%), Gaps = 24/266 (9%)

Query: 10  IGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQ-LRHPN---IIRFKE 65
           +G G FG     + + T ++ A K +E+            +N KQ L   N   ++    
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAY 67

Query: 66  VVLTPTHLAIVMEYAAGGELFERICNAGR--FSEDEARYFFQQLISG-------QICHRD 116
              T   L +V+    GG+L   I N G   F E+ A ++  +++ G          +RD
Sbjct: 68  AYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRD 127

Query: 117 LKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLADV 176
           LK EN LLD      ++I D G +         +  VGT  Y+APEVL+ + Y     D 
Sbjct: 128 LKPENILLDDYG--HIRISDLGLAVKIPEGESIRGRVGTVGYMAPEVLNNQRY-TLSPDY 184

Query: 177 WSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVA 236
           W  G  +Y M+ G  PF  +++     +   R++  +         S++ +++   +   
Sbjct: 185 WGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYS--AKFSEEAKSICKMLLTK 242

Query: 237 NPSRRITIK-----EIKSHPWFLKNL 257
           +P +R+  +     E+K HP F +N+
Sbjct: 243 DPKQRLGCQEEGAGEVKRHP-FFRNM 267

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 69.0 bits (169), Expect = 4e-13
 Identities = 66/265 (24%), Positives = 97/265 (36%), Gaps = 70/265 (26%)

Query: 47  REIINHKQLRHPNIIRFKEV-----------VLTPTHLA---IVMEYAAGGELFERICNA 92
           REI   ++L H NI++  EV           V + T L    IV EY         +   
Sbjct: 51  REIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETD--LANVLEQ 108

Query: 93  GRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFG------- 138
           G  SE+ AR F  QL+ G        + HRDLK  N  ++ +    LKI DFG       
Sbjct: 109 GPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFIN-TEDLVLKIGDFGLARIVDP 167

Query: 139 -YSKSSLLHSRPKSTVGTPAYIAPE-VLSRREYDGKLADVWSCGVTLYVMLVG------- 189
            YS    L       + T  Y +P  +LS   Y  K  D+W+ G     ML G       
Sbjct: 168 HYSHKGYL----SEGLVTKWYRSPRLLLSPNNYT-KAIDMWAAGCIFAEMLTGKPLFAGA 222

Query: 190 -----------AYPFEDQEDPKNFRKTISRIMAVQYKIPD-YVH---------ISQDCRN 228
                      + P   +ED    R  +  ++    +                ++ +  +
Sbjct: 223 HELEQMQLILESVPVVREED----RNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALD 278

Query: 229 LLSRIFVANPSRRITIKEIKSHPWF 253
            L +I   NP  R+T +E   HP+ 
Sbjct: 279 FLEQILTFNPMDRLTAEEALMHPYM 303

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 68.2 bits (167), Expect = 4e-13
 Identities = 57/207 (27%), Positives = 90/207 (43%), Gaps = 29/207 (14%)

Query: 6   LMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKE 65
            +K++GSG FGV  L + +   + VA+K I  G   + +   E     +L HPN+++   
Sbjct: 8   FLKELGSGQFGVVHLGKWRGKID-VAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYG 66

Query: 66  VVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLIS--GQIC---------- 113
           V      + IV EY A G      C      E + +   + L+     +C          
Sbjct: 67  VCTKQRPIFIVTEYMANG------CLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNG 120

Query: 114 --HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYI---APEVLSRRE 168
             HRDL   N L+       +K+ DFG ++  +L  +  S+ GT   +    PEV     
Sbjct: 121 FIHRDLAARNCLVGEDNV--VKVSDFGLAR-YVLDDQYTSSQGTKFPVKWAPPEVFDYSR 177

Query: 169 YDGKLADVWSCGVTLY-VMLVGAYPFE 194
           +  K +DVWS GV ++ V   G  P+E
Sbjct: 178 FSSK-SDVWSFGVLMWEVFSEGKMPYE 203

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 67.6 bits (165), Expect = 7e-13
 Identities = 67/222 (30%), Positives = 100/222 (45%), Gaps = 27/222 (12%)

Query: 5   ELMKDIGSGNFGVARLMR----NKNTKELVAMKYIER--GHKIDANVAREIINHKQLRHP 58
           + ++ +G G+FG   L      N  T E+VA+K ++R  G +  +   +EI   K L H 
Sbjct: 7   KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHE 66

Query: 59  NIIRFKEVVLTP--THLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG------ 110
           NI+++K          L ++MEY   G L + +    + +  +   F QQ+  G      
Sbjct: 67  NIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYL-PKHKLNLAQLLLFAQQICEGMAYLHS 125

Query: 111 -QICHRDLKLENTLLDGSPAPRLKICDFGYSKS---SLLHSRPKSTVGTPAY-IAPEVLS 165
               HRDL   N LLD      +KI DFG +K+      + R +    +P +  A E L 
Sbjct: 126 QHYIHRDLAARNVLLDNDRL--VKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECL- 182

Query: 166 RREYDGKLA-DVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTI 206
            +E     A DVWS GVTLY +L        Q  PK F + I
Sbjct: 183 -KENKFSYASDVWSFGVTLYELLTHCDSK--QSPPKKFEEMI 221

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 67.2 bits (164), Expect = 2e-12
 Identities = 54/205 (26%), Positives = 101/205 (49%), Gaps = 21/205 (10%)

Query: 4   YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK-IDANVAREIINHKQLRHPNIIR 62
           Y ++K +  G+ G   +       + V +K  ++G   I+A + + +       HP++IR
Sbjct: 68  YTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKGTTLIEAMLLQNV------NHPSVIR 121

Query: 63  FKEVVLTPTHLAIVMEYAAGGELFERIC-NAGRFSEDEARYFFQQLISG-------QICH 114
            K+ +++     +V+ + +  +L+  +   +     D+A    +Q++ G       +I H
Sbjct: 122 MKDTLVSGAITCMVLPHYSS-DLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIH 180

Query: 115 RDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLA 174
           RD+K EN  ++     ++ I D G ++  ++        GT    APEVL+R +Y+ K A
Sbjct: 181 RDVKTENIFIND--VDQVCIGDLGAAQFPVVAPAFLGLAGTVETNAPEVLARDKYNSK-A 237

Query: 175 DVWSCGVTLYVMLVGAYPFEDQEDP 199
           D+WS G+ L+ ML  AYP    EDP
Sbjct: 238 DIWSAGIVLFEML--AYPSTIFEDP 260

Length = 357

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 66.2 bits (162), Expect = 2e-12
 Identities = 64/269 (23%), Positives = 114/269 (42%), Gaps = 39/269 (14%)

Query: 2   EKYELMKDIGSGNFG-VARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNI 60
           E  +L + +G+G FG V     N  TK  VA+K ++ G        +E    K+LRH  +
Sbjct: 6   ESLKLERKLGAGQFGEVWMGTWNGTTK--VAVKTLKPGTMSPEAFLQEAQIMKKLRHDKL 63

Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYF-FQQLI--SGQIC---- 113
           ++   V      + IV EY + G L + +         E +     QL+  + QI     
Sbjct: 64  VQLYAVCSEEEPIYIVTEYMSKGSLLDFL------KSGEGKKLRLPQLVDMAAQIAEGMA 117

Query: 114 --------HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR---PKSTVGTP-AYIAP 161
                   HRDL   N L+  +     KI DFG ++  L+       +     P  + AP
Sbjct: 118 YLESRNYIHRDLAARNILVGENLV--CKIADFGLAR--LIEDDEYTAREGAKFPIKWTAP 173

Query: 162 EVLSRREYDGKLADVWSCGVTLY-VMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYV 220
           E  +   +  K +DVWS G+ L  ++  G  P+         R+ + ++    Y++P   
Sbjct: 174 EAANYGRFTIK-SDVWSFGILLTEIVTYGRVPYPGM----TNREVLEQVER-GYRMPRPP 227

Query: 221 HISQDCRNLLSRIFVANPSRRITIKEIKS 249
           +  ++  +L+ + +  +P  R T + ++S
Sbjct: 228 NCPEELYDLMLQCWDKDPEERPTFEYLQS 256

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 66.7 bits (163), Expect = 2e-12
 Identities = 91/358 (25%), Positives = 141/358 (39%), Gaps = 95/358 (26%)

Query: 3   KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVA------REIINHKQLR 56
           +Y+ +K IGSG  G+     +  T + VA+K + R  +   NV       RE++  K + 
Sbjct: 17  RYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQ---NVTHAKRAYRELVLMKLVN 73

Query: 57  HPNIIRFKEVVLTP-------THLAIVMEYAAGGELFERICNAGRFSEDEAR--YFFQQL 107
           H NII     V TP         + +VME      +   +C   +   D  R  Y   Q+
Sbjct: 74  HKNIIGLLN-VFTPQKSLEEFQDVYLVMEL-----MDANLCQVIQMDLDHERMSYLLYQM 127

Query: 108 ISG-------QICHRDLKLENTLL--DGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAY 158
           + G        I HRDLK  N ++  D +    LKI DFG ++++         V T  Y
Sbjct: 128 LCGIKHLHSAGIIHRDLKPSNIVVKSDCT----LKILDFGLARTAGTSFMMTPYVVTRYY 183

Query: 159 IAPEVLSRREYDGKLADVWSCGVTLYVMLVGA--YPFEDQEDPKNFRKTISR-------- 208
            APEV+    Y   + D+WS G  +  M+ G   +P  D  D  N  K I +        
Sbjct: 184 RAPEVILGMGYKENV-DIWSVGCIMGEMIRGTVLFPGTDHIDQWN--KIIEQLGTPSDEF 240

Query: 209 IMAVQYKIPDYVH-----------------------------ISQDCRNLLSRIFVANPS 239
           +  +Q  + +YV                               +   R+LLS++ V +P 
Sbjct: 241 MSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPE 300

Query: 240 RRITIKEIKSHP----WFLKNLPRELTETAQAIYYRKENPTFSLQSVEEITKIVEEAK 293
           +RI++ +   HP    W+    P E+     A Y           S++E    VEE K
Sbjct: 301 KRISVDDALQHPYINVWY---DPSEVEAPPPAPYD---------HSIDEREHTVEEWK 346

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 66.7 bits (163), Expect = 2e-12
 Identities = 83/309 (26%), Positives = 122/309 (39%), Gaps = 76/309 (24%)

Query: 4   YELMKDIGSGNFGVARLMRNKNTK--ELVAMKYIER--GHKIDANVA-REIINHKQLR-H 57
           YEL+K++G G +G+    RN  T   E VA+K I      KI A  A RE+   +  R H
Sbjct: 2   YELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGH 61

Query: 58  PNII-----------RFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQ 106
            NI             F E+ L       +ME     +L + I +    ++   + F  Q
Sbjct: 62  KNITCLYDMDIVFPGNFNELYLYEE----LMEA----DLHQIIRSGQPLTDAHFQSFIYQ 113

Query: 107 LI-------SGQICHRDLKLENTL--LDGSPAPRLKICDFGYSKSSLLHSRPKST----- 152
           ++       S  + HRDLK  N L   D      LKICDFG ++       P        
Sbjct: 114 ILCGLKYIHSANVLHRDLKPGNLLVNADC----ELKICDFGLARG--FSENPGENAGFMT 167

Query: 153 --VGTPAYIAPEV-LSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQED----------- 198
             V T  Y APE+ LS + Y  K  DVWS G  L   L+G  P    +D           
Sbjct: 168 EYVATRWYRAPEIMLSFQSYT-KAIDVWSVGCIL-AELLGRKPVFKGKDYVDQLNQILQV 225

Query: 199 ----PKNFRKTISRIMAVQY--KIPDYVHI---------SQDCRNLLSRIFVANPSRRIT 243
                +     I    A  Y   +P+             +    +LL ++   +P++RI+
Sbjct: 226 LGTPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRIS 285

Query: 244 IKEIKSHPW 252
           ++E   HP+
Sbjct: 286 VEEALEHPY 294

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 66.3 bits (162), Expect = 3e-12
 Identities = 69/318 (21%), Positives = 118/318 (37%), Gaps = 75/318 (23%)

Query: 2   EKYE-LMKDIGSGNFGVARLMRNKNTKELVAMKYI----------ERGHKIDA-----NV 45
           E+Y      +G G +G      +  T ++VA+K +          +    +         
Sbjct: 8   ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTT 67

Query: 46  AREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQ 105
            RE+    +++H NI+   +V +    + +VM+  A  +L + +    R +E + +    
Sbjct: 68  LRELKIMNEIKHENIMGLVDVYVEGDFINLVMDIMA-SDLKKVVDRKIRLTESQVKCILL 126

Query: 106 QLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSK-----------SSLLHS 147
           Q+++G          HRDL   N  ++       KI DFG ++           S     
Sbjct: 127 QILNGLNVLHKWYFMHRDLSPANIFINSKGI--CKIADFGLARRYGYPPYSDTLSKDETM 184

Query: 148 RPK----STVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGA--YPFEDQEDPKN 201
           + +    S V T  Y APE+L   E      D+WS G     +L G   +P E++ D   
Sbjct: 185 QRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEID--- 241

Query: 202 FRKTISRIMAV-----------QYKIPDYV---------------HISQDCRNLLSRIFV 235
               + RI  +             K+P Y                + S D  +LL  +  
Sbjct: 242 ---QLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLK 298

Query: 236 ANPSRRITIKEIKSHPWF 253
            NP  RI+ KE   H +F
Sbjct: 299 LNPLERISAKEALKHEYF 316

Length = 335

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 67.0 bits (163), Expect = 3e-12
 Identities = 80/299 (26%), Positives = 120/299 (40%), Gaps = 61/299 (20%)

Query: 4   YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRF 63
           Y+L   IG+G+FGV       +T E VA+K + +  +      RE++  K L H NII  
Sbjct: 68  YKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKN---RELLIMKNLNHINIIFL 124

Query: 64  KEVVLTPT--------HLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGQ---- 111
           K+   T           L +VME+    +   +       +      F  +L S Q    
Sbjct: 125 KDYYYTECFKKNEKNIFLNVVMEFIP--QTVHKYMKHYARNNHALPLFLVKLYSYQLCRA 182

Query: 112 --------ICHRDLKLENTLLDGSPAPR---LKICDFGYSKSSLLHSRPKSTVGTPAYIA 160
                   ICHRDLK +N L+D    P    LK+CDFG +K+ L   R  S + +  Y A
Sbjct: 183 LAYIHSKFICHRDLKPQNLLID----PNTHTLKLCDFGSAKNLLAGQRSVSYICSRFYRA 238

Query: 161 PEV-LSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTIS----------RI 209
           PE+ L    Y   + D+WS G  +  M++G   F  Q       + I           + 
Sbjct: 239 PELMLGATNYTTHI-DLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKE 297

Query: 210 MAVQY---KIPDYVHISQDCR------------NLLSRIFVANPSRRITIKEIKSHPWF 253
           M   Y   K PD     +D +            N +S+     P +R+   E  + P+F
Sbjct: 298 MNPNYADIKFPDVK--PKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFF 354

Length = 440

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 65.4 bits (159), Expect = 3e-12
 Identities = 61/196 (31%), Positives = 93/196 (47%), Gaps = 22/196 (11%)

Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNI 60
           M++ +L++ IG G FG   L   +  K  VA+K I+      A +A   +   QLRH N+
Sbjct: 5   MKELKLLQTIGKGEFGDVMLGDYRGNK--VAVKCIKNDATAQAFLAEASV-MTQLRHSNL 61

Query: 61  IRFKEVVLTP-THLAIVMEYAAGGELFERICNAGR----------FSEDEARYFFQQLIS 109
           ++   V++     L IV EY A G L + + + GR          FS D      + L +
Sbjct: 62  VQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEA-MEYLEA 120

Query: 110 GQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPA-YIAPEVLSRRE 168
               HRDL   N L+  S     K+ DFG +K +   S  + T   P  + APE L  ++
Sbjct: 121 NNFVHRDLAARNVLV--SEDNVAKVSDFGLTKEA---SSTQDTGKLPVKWTAPEALREKK 175

Query: 169 YDGKLADVWSCGVTLY 184
           +  K +DVWS G+ L+
Sbjct: 176 FSTK-SDVWSFGILLW 190

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 65.4 bits (160), Expect = 3e-12
 Identities = 73/270 (27%), Positives = 117/270 (43%), Gaps = 41/270 (15%)

Query: 6   LMKDIGSGNFG---VARLMRNKNTKELVAMKYIERGH--KIDANVAREIINHKQLRHPNI 60
           + K IG G FG     RL      +  VA+K ++ G   K   +   E     Q  HPNI
Sbjct: 8   IEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNI 67

Query: 61  IRFKEVVLTPTHLAIVMEYAAGGEL--FERICNAGRFSEDEARYFFQQLISGQ------- 111
           IR + VV     + I+ EY   G L  F R  N G+F+  +     + + SG        
Sbjct: 68  IRLEGVVTKSRPVMIITEYMENGSLDKFLRE-NDGKFTVGQLVGMLRGIASGMKYLSEMN 126

Query: 112 ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGT-----PA-YIAPEVLS 165
             HRDL   N L++ +     K+ DFG S+        ++T  T     P  + APE ++
Sbjct: 127 YVHRDLAARNILVNSN--LVCKVSDFGLSR---RLEDSEATYTTKGGKIPIRWTAPEAIA 181

Query: 166 RREYDGKLADVWSCGVTLY-VMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQ 224
            R++    +DVWS G+ ++ VM  G  P+ D  +    +  I  +    Y++P  +    
Sbjct: 182 YRKFTSA-SDVWSFGIVMWEVMSYGERPYWDMSN----QDVIKAVED-GYRLPPPM---- 231

Query: 225 DCRNLLSRIFV----ANPSRRITIKEIKSH 250
           DC + L ++ +     + + R T  +I S 
Sbjct: 232 DCPSALYQLMLDCWQKDRNERPTFSQIVST 261

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 66.2 bits (161), Expect = 4e-12
 Identities = 71/301 (23%), Positives = 123/301 (40%), Gaps = 52/301 (17%)

Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAR---EIINHKQLRH 57
           +++Y+ +K IGSG  G+     +      VA+K + R  +   +  R   E++  K + H
Sbjct: 20  LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNH 79

Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFE-RICNAGRFSEDEAR--YFFQQLISG---- 110
            NII    V      L    +     EL +  +C       D  R  Y   Q++ G    
Sbjct: 80  KNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLCGIKHL 139

Query: 111 ---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRR 167
               I HRDLK  N ++       LKI DFG ++++  +      V T  Y APEV+   
Sbjct: 140 HSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTACTNFMMTPYVVTRYYRAPEVILGM 197

Query: 168 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRI------------------ 209
            Y   + D+WS G  +  ++ G+  F+  +    + K I ++                  
Sbjct: 198 GYKENV-DIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTVRNY 256

Query: 210 ---------MAVQYKIPDYVHISQD---------CRNLLSRIFVANPSRRITIKEIKSHP 251
                    ++ +   PD++  S+           R+LLS++ V +P +RI++ E   HP
Sbjct: 257 VENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHP 316

Query: 252 W 252
           +
Sbjct: 317 Y 317

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 65.4 bits (159), Expect = 5e-12
 Identities = 72/288 (25%), Positives = 117/288 (40%), Gaps = 41/288 (14%)

Query: 4   YELMKDIGSGNFGVARLMRNKNTKELVAMKYI--ERGHKIDANVAREIINHKQLRHPNII 61
           Y  ++ +G G++       ++   +LVA+K I  +    +     RE    K L+H NI+
Sbjct: 7   YLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIV 66

Query: 62  RFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-------QICH 114
              +++ T   L  V EY         I + G       R F  QL+ G        I H
Sbjct: 67  LLHDIIHTKETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILH 126

Query: 115 RDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST-VGTPAYIAPEVL-SRREYDGK 172
           RDLK +N L+  S    LK+ DFG +++  + S+  S+ V T  Y  P+VL    +Y   
Sbjct: 127 RDLKPQNLLI--SYLGELKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVLLGATDYSSA 184

Query: 173 LADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQY--------KIPDY----- 219
           L D+W  G     ML G   F    D     + I  ++ V          K+P+Y     
Sbjct: 185 L-DIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKPEWF 243

Query: 220 -------VHISQD-------CRNLLSRIFVANPSRRITIKEIKSHPWF 253
                  + +            +L S++ +  P  RI+ ++   HP+F
Sbjct: 244 LPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF 291

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 65.2 bits (159), Expect = 6e-12
 Identities = 77/301 (25%), Positives = 121/301 (40%), Gaps = 56/301 (18%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYI-----ERGHKIDANVAREIINHKQLR 56
           + YE ++ IG G +G     R+KNT +LVA+K       E G  I     REI   + L 
Sbjct: 1   DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEG--IPPTALREISLLQMLS 58

Query: 57  H-PNIIRFKEVVLTPTH-----LAIVMEYAAGGELFERICNAGR-----FSEDEARYFFQ 105
               I+R  +V           L +V EY    +L + + + GR           + F  
Sbjct: 59  ESIYIVRLLDVEHVEEKNGKPSLYLVFEYLD-SDLKKFMDSNGRGPGRPLPAKTIKSFMY 117

Query: 106 QLISGQ-------ICHRDLKLENTLLDGSPAPRLKICDFGYSKS-SLLHSRPKSTVGTPA 157
           QL+ G        + HRDLK +N L+D      LKI D G  ++ S+        + T  
Sbjct: 118 QLLKGVAHCHKHGVMHRDLKPQNLLVDKQKG-LLKIADLGLGRAFSIPVKSYTHEIVTLW 176

Query: 158 YIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPF----EDQEDPKNFR-------KTI 206
           Y APEVL    +     D+WS G     M      F    E Q+    F+       +  
Sbjct: 177 YRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVW 236

Query: 207 SRIMAVQ--------------YKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPW 252
             +  ++                +PD   +S +  +LL ++   +P++RI+ K   +HP+
Sbjct: 237 PGVSKLRDWHEFPQWKPQDLSRAVPD---LSPEGLDLLQKMLRYDPAKRISAKAALTHPY 293

Query: 253 F 253
           F
Sbjct: 294 F 294

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 64.1 bits (156), Expect = 8e-12
 Identities = 60/200 (30%), Positives = 90/200 (45%), Gaps = 17/200 (8%)

Query: 7   MKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKEV 66
           MK++GSG FGV  L + +   + VA+K I  G   + +   E     +L HP +++   V
Sbjct: 9   MKELGSGQFGVVHLGKWRAQIK-VAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGV 67

Query: 67  VLTPTHLAIVMEYAAGGELFERI-CNAGRFSEDEARYFFQQLISG-------QICHRDLK 118
                 L IV E+   G L   +    G+ S+D      Q +  G          HRDL 
Sbjct: 68  CTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLA 127

Query: 119 LENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTP---AYIAPEVLSRREYDGKLAD 175
             N L+  S    +K+ DFG ++  +L     S+ G      +  PEV +  +Y  K +D
Sbjct: 128 ARNCLV--SSTGVVKVSDFGMTR-YVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSK-SD 183

Query: 176 VWSCGVTLY-VMLVGAYPFE 194
           VWS GV ++ V   G  PFE
Sbjct: 184 VWSFGVLMWEVFTEGKMPFE 203

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 63.6 bits (155), Expect = 1e-11
 Identities = 69/278 (24%), Positives = 122/278 (43%), Gaps = 46/278 (16%)

Query: 5   ELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRH------- 57
           E+++++G G +GV   MR+  T  ++A+K      +I A V       K+L         
Sbjct: 4   EVIEELGRGAYGVVDKMRHVPTGTIMAVK------RIRATV--NSQEQKRLLMDLDISMR 55

Query: 58  ----PNIIRFKEVVLTPTHLAIVME-------------YAAGGELFERICNAGRFSEDEA 100
               P  + F   +     + I ME             Y  G  + E I      S  +A
Sbjct: 56  SVDCPYTVTFYGALFREGDVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKA 115

Query: 101 RYFFQQLISGQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST-VGTPAYI 159
             +    +S  + HRD+K  N L++     ++K+CDFG S   L+ S  K+   G   Y+
Sbjct: 116 LEYLHSKLS--VIHRDVKPSNVLIN--RNGQVKLCDFGIS-GYLVDSVAKTIDAGCKPYM 170

Query: 160 APE----VLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYK 215
           APE     L+++ YD K +DVWS G+T+  +  G +P++  + P  F++    +     +
Sbjct: 171 APERINPELNQKGYDVK-SDVWSLGITMIELATGRFPYDSWKTP--FQQLKQVVEEPSPQ 227

Query: 216 IPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 253
           +P     S + ++ +++    N   R    E+  HP+F
Sbjct: 228 LPAE-KFSPEFQDFVNKCLKKNYKERPNYPELLQHPFF 264

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 64.9 bits (158), Expect = 2e-11
 Identities = 44/155 (28%), Positives = 76/155 (49%), Gaps = 13/155 (8%)

Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQL----R 56
           +E++ ++K I  G FG   L R KN  +L A+K +++   I+ N+  ++   +      +
Sbjct: 3   IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSK 62

Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYF-------FQQLIS 109
            P I+     + +  ++ +VMEY  GG++   +   G F E+ A  +          L  
Sbjct: 63  SPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHR 122

Query: 110 GQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSL 144
             I HRDLK +N L+  S    +K+ DFG SK +L
Sbjct: 123 HGIIHRDLKPDNMLI--SNEGHIKLTDFGLSKVTL 155

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 62.7 bits (153), Expect = 4e-11
 Identities = 53/214 (24%), Positives = 94/214 (43%), Gaps = 29/214 (13%)

Query: 10  IGSGNFG--VARLMRNKNTKELVAMKYIERGHKIDANVAR---EIINHKQLRHPNIIRFK 64
           IG       +  L ++K T  LVA+K I        ++     EII  +QL+HPNI+ + 
Sbjct: 6   IGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYV 65

Query: 65  EVVLTPTHLAIVMEYAAGG---ELFERICNAGRFSEDEARYFFQQLISG-------QICH 114
              +  + L +V    A G   +L +     G   E    +  + +++           H
Sbjct: 66  TSFIVDSELYVVSPLMAYGSCEDLLKTHFPEG-LPELAIAFILKDVLNALDYIHSKGFIH 124

Query: 115 RDLKLENTLLDGSPAPRLKICDFGYS--------KSSLLHSRPKSTVGTPAYIAPEVLSR 166
           R +K  + LL G    ++ +    YS        +  ++H  PKS+V    +++PEVL +
Sbjct: 125 RSVKASHILLSGD--GKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQ 182

Query: 167 --REYDGKLADVWSCGVTLYVMLVGAYPFEDQED 198
             + Y+ K +D++S G+T   +  G  PF+D   
Sbjct: 183 NLQGYNEK-SDIYSVGITACELANGHVPFKDMPA 215

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 62.3 bits (151), Expect = 4e-11
 Identities = 56/208 (26%), Positives = 100/208 (48%), Gaps = 23/208 (11%)

Query: 6   LMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKE 65
           L+++IGSG FG+  L      ++ VA+K I  G   + +   E     +L HP +++   
Sbjct: 8   LVQEIGSGQFGLVWLGYWLEKRK-VAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYG 66

Query: 66  VVLTPTHLAIVMEYAAGGELFERI-CNAGRFSED----------EARYFFQQLISGQICH 114
           V    + + +V E+   G L + +    G+FS++          E   + +      + H
Sbjct: 67  VCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLES---SNVIH 123

Query: 115 RDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTP---AYIAPEVLSRREYDG 171
           RDL   N L+  +    +K+ DFG ++  +L  +  S+ GT     + +PEV S  +Y  
Sbjct: 124 RDLAARNCLVGENQV--VKVSDFGMTR-FVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSS 180

Query: 172 KLADVWSCGVTLY-VMLVGAYPFEDQED 198
           K +DVWS GV ++ V   G  P+E++ +
Sbjct: 181 K-SDVWSFGVLMWEVFSEGKTPYENRSN 207

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 62.0 bits (150), Expect = 4e-11
 Identities = 68/247 (27%), Positives = 102/247 (41%), Gaps = 24/247 (9%)

Query: 10  IGSGNFGVARLMRNKNTKELVAMKYIERGHKID--ANVAREIINHKQLRHPNIIRFKEVV 67
           IG GNFG     R +     VA+K        D  A   +E    KQ  HPNI+R   V 
Sbjct: 3   IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62

Query: 68  LTPTHLAIVMEYAAGGELFERICNAG---------RFSEDEARYFFQQLISGQICHRDLK 118
                + IVME   GG+    +   G         +  E+ A    + L S    HRDL 
Sbjct: 63  TQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAG-MEYLESKHCIHRDLA 121

Query: 119 LENTLLDGSPAPRLKICDFGYSKSSL--LHSRPKSTVGTPA-YIAPEVLSRREYDGKLAD 175
             N L+       LKI DFG S+     +++        P  + APE L+   Y  + +D
Sbjct: 122 ARNCLVTEKNV--LKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSE-SD 178

Query: 176 VWSCGVTLY-VMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIF 234
           VWS G+ L+    +GA P+ +  + +  R+ I +   V+   P+          L+ R +
Sbjct: 179 VWSFGILLWEAFSLGAVPYANLSNQQT-REAIEQ--GVRLPCPE--LCPDAVYRLMERCW 233

Query: 235 VANPSRR 241
             +P +R
Sbjct: 234 EYDPGQR 240

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 62.4 bits (151), Expect = 6e-11
 Identities = 80/319 (25%), Positives = 131/319 (41%), Gaps = 72/319 (22%)

Query: 3   KYELMKDIGSGNFGVARLMRNKNTKEL--VAMKYIERGHKIDANVAREIINHKQLRHPNI 60
           +YE  K +G G +G     + K+ K+    A+K IE G  I  +  REI   ++L+HPN+
Sbjct: 3   EYEGCK-VGRGTYGHVYKAKRKDGKDEKEYALKQIE-GTGISMSACREIALLRELKHPNV 60

Query: 61  IRFKEVVLTPT--HLAIVMEYAAGGEL----FERICNAGRFSEDEARYFFQQLI------ 108
           I  ++V L+ +   + ++ +YA         F R   A +      R   + L+      
Sbjct: 61  IALQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDG 120

Query: 109 -----SGQICHRDLKLENTLL--DGSPAPRLKICDFGYSKSSLLHSRPK------STVGT 155
                +  + HRDLK  N L+  +G    R+KI D G+++  L +S  K        V T
Sbjct: 121 IHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFAR--LFNSPLKPLADLDPVVVT 178

Query: 156 PAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFE-DQEDPKN----FRKTISRIM 210
             Y APE+L    +  K  D+W+ G     +L     F   QED K         + RI 
Sbjct: 179 FWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIF 238

Query: 211 AVQ-----------YKIPDYVHISQDCRN-------------------------LLSRIF 234
           +V             K+P+Y  + +D R                          LL ++ 
Sbjct: 239 SVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLL 298

Query: 235 VANPSRRITIKEIKSHPWF 253
             +P++RIT ++    P+F
Sbjct: 299 TMDPTKRITSEQALQDPYF 317

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 61.6 bits (150), Expect = 7e-11
 Identities = 66/284 (23%), Positives = 109/284 (38%), Gaps = 54/284 (19%)

Query: 1   MEKYELMKDIGSGNFG-----VARLMRNKNTKELVAMKYIERGHKIDANVAREIINH--- 52
            EK  L++++G G+FG     +A+ +     +  VA+K +      +    RE I     
Sbjct: 5   REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVN-----ENASMRERIEFLNE 59

Query: 53  ----KQLRHPNIIRFKEVVLTPTHLAIVMEYAAGGEL--FERICNAGRFSEDEARYF--- 103
               K+    +++R   VV T     +VME  A G+L  + R     R   +        
Sbjct: 60  ASVMKEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSR---RPEAENNPGLGPP 116

Query: 104 -FQQLI--SGQI------------CHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS- 147
             Q+ I  + +I             HRDL   N ++       +KI DFG ++       
Sbjct: 117 TLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLT--VKIGDFGMTRDIYETDY 174

Query: 148 -RPKSTVGTPA-YIAPEVLSRREYDGKLADVWSCGVTLYVML-VGAYPFEDQEDPKNFRK 204
            R       P  ++APE L    +  K +DVWS GV L+ M  +   P++   + +  + 
Sbjct: 175 YRKGGKGLLPVRWMAPESLKDGVFTTK-SDVWSFGVVLWEMATLAEQPYQGLSNEEVLKF 233

Query: 205 TISR-IMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEI 247
            I    + +    PD          L+   +  NP  R T  EI
Sbjct: 234 VIDGGHLDLPENCPDK------LLELMRMCWQYNPKMRPTFLEI 271

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 61.5 bits (149), Expect = 9e-11
 Identities = 75/299 (25%), Positives = 118/299 (39%), Gaps = 59/299 (19%)

Query: 3   KYELMKDIGSGNFGVARLMRNKNTKELVAMKYI-----ERGHKIDANVAREIINHKQLR- 56
           +YE + +IG G +G     R+ ++   VA+K +     E G  +  +  RE+   K+L  
Sbjct: 1   QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPL--STVREVALLKRLEA 58

Query: 57  --HPNIIRFKEVVLT-----PTHLAIVMEYAAGG--ELFERICNAGRFSEDEARYFFQQL 107
             HPNI+R  +V  T      T + +V E+         +++   G    +  +   +Q 
Sbjct: 59  FDHPNIVRLMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPG-LPAETIKDLMRQF 117

Query: 108 ISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIA 160
           + G        I HRDLK EN L+  +   ++K+ DFG ++           V T  Y A
Sbjct: 118 LRGLDFLHANCIVHRDLKPENILV--TSGGQVKLADFGLARIYSCQMALTPVVVTLWYRA 175

Query: 161 PEVLSRREYDGKLADVWSCGVTLYVML--------------------VGAYPFEDQ---- 196
           PEVL +  Y     D+WS G     M                     +   P ED     
Sbjct: 176 PEVLLQSTY-ATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRD 234

Query: 197 -EDPK-NFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 253
              P+  F     R   VQ  +P+   I +    LL  +   NP +RI+      HP+F
Sbjct: 235 VTLPRGAFSPRGPR--PVQSVVPE---IEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 61.2 bits (149), Expect = 1e-10
 Identities = 70/299 (23%), Positives = 111/299 (37%), Gaps = 66/299 (22%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKE----------------LVAMKYIERGHKIDANV 45
           +    ++ +G G FG   L      ++                LVA+K +    + DA+ 
Sbjct: 5   QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVL----RPDASD 60

Query: 46  A------REIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYAAGGEL--FER--------- 88
                  +E+    +L  PNI R   V      L ++MEY   G+L  F +         
Sbjct: 61  NAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGL 120

Query: 89  ICNAGRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSK 141
            CN+   S     Y   Q+ SG          HRDL   N L+       +KI DFG S+
Sbjct: 121 ACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVG--KNYTIKIADFGMSR 178

Query: 142 SSLLHSRPKSTVG--TPAYI---APEVLSRREYDGKLADVWSCGVTLY--VMLVGAYPFE 194
           +  L+S     V    P  I   A E +   ++  K +DVW+ GVTL+  + L    P+E
Sbjct: 179 N--LYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTK-SDVWAFGVTLWEILTLCREQPYE 235

Query: 195 DQEDPKNFRKTISRIMAVQYKIPDYVHISQ------DCRNLLSRIFVANPSRRITIKEI 247
              D     + I             +++ +      D   L+   +  +   R T +EI
Sbjct: 236 HLTDQ----QVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREI 290

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 61.2 bits (148), Expect = 1e-10
 Identities = 72/294 (24%), Positives = 123/294 (41%), Gaps = 49/294 (16%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK--IDAN-VAREIINHKQLRHP 58
           E+Y+ +  +GSG +G      +  T   VA+K + R  +  I A    RE+   K ++H 
Sbjct: 17  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 76

Query: 59  NIIRFKEVVLTPTHL-----AIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG--- 110
           N+I   +V      L       ++ +  G +L   I    + ++D  ++   Q++ G   
Sbjct: 77  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 135

Query: 111 ----QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST--VGTPAYIAPEVL 164
                I HRDLK  N  L  +    LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 136 IHSADIIHRDLKPSN--LAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 189

Query: 165 SRREYDGKLADVWSCGVTLYVMLVGA--YPFEDQED------------PKNFRKTISRIM 210
               +  +  D+WS G  +  +L G   +P  D  D                 K IS   
Sbjct: 190 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 249

Query: 211 AVQY-----KIPD------YVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 253
           A  Y     ++P       ++  +    +LL ++ V +  +RIT  +  +H +F
Sbjct: 250 ARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 303

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 61.8 bits (150), Expect = 2e-10
 Identities = 54/188 (28%), Positives = 75/188 (39%), Gaps = 28/188 (14%)

Query: 26  TKELVAMKYI-----ERGHKIDANVAREIINHKQLRHPNIIRF-KEVVLTPTHLAIVMEY 79
           T   VA+K +     E  H+  A   RE     +L HPNI+         P  L  V EY
Sbjct: 2   TGHEVAIKLLRTDAPEEEHQR-ARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEY 60

Query: 80  AAGGELFERICNAGRFSEDEARYFFQQLISGQIC-------HRDLKLENTLLDGSP-APR 131
             G  L E +   G     E      Q++    C       HRDLK +N ++  +   P 
Sbjct: 61  VPGRTLREVLAADGALPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVRPH 120

Query: 132 LKICDFGYSKSSLLH----------SRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGV 181
            K+ DFG    +LL           +R    +GTP Y APE L R E     +D+++ G+
Sbjct: 121 AKVLDFGIG--TLLPGVRDADVATLTRTTEVLGTPTYCAPEQL-RGEPVTPNSDLYAWGL 177

Query: 182 TLYVMLVG 189
                L G
Sbjct: 178 IFLECLTG 185

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 60.0 bits (145), Expect = 2e-10
 Identities = 67/259 (25%), Positives = 112/259 (43%), Gaps = 26/259 (10%)

Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNI 60
           ++K  L + IG G FG   +++ + T + VA+K I+      A +    +  K L H N+
Sbjct: 5   LQKLTLGEIIGEGEFGA--VLQGEYTGQKVAVKNIKCDVTAQAFLEETAVMTK-LHHKNL 61

Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYF---------FQQLISGQ 111
           +R   V+L    L IVME  + G L   +   GR      +            + L S +
Sbjct: 62  VRLLGVILH-NGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKK 120

Query: 112 ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPA-YIAPEVLSRREYD 170
           + HRDL   N L+  S     K+ DFG ++   + S        P  + APE L  +++ 
Sbjct: 121 LVHRDLAARNILV--SEDGVAKVSDFGLAR---VGSMGVDNSKLPVKWTAPEALKHKKFS 175

Query: 171 GKLADVWSCGVTLY-VMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 229
            K +DVWS GV L+ V   G  P+     PK   K +   +   Y++        D   L
Sbjct: 176 SK-SDVWSYGVLLWEVFSYGRAPY-----PKMSLKEVKECVEKGYRMEPPEGCPADVYVL 229

Query: 230 LSRIFVANPSRRITIKEIK 248
           ++  +   P +R +  +++
Sbjct: 230 MTSCWETEPKKRPSFHKLR 248

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 60.0 bits (145), Expect = 3e-10
 Identities = 62/208 (29%), Positives = 98/208 (47%), Gaps = 25/208 (12%)

Query: 8   KDIGSGNFG-VAR-LMRNKNTKEL-VAMKYIERGH--KIDANVAREIINHKQLRHPNIIR 62
           K IG+G FG V R +++    KE+ VA+K ++ G+  K   +   E     Q  H NIIR
Sbjct: 11  KVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIR 70

Query: 63  FKEVVLTPTHLAIVMEYAAGGELFERIC-NAGRFSEDEARYFFQQLISG-------QICH 114
            + VV       I+ EY   G L + +  + G FS  +     + + +G          H
Sbjct: 71  LEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVH 130

Query: 115 RDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPA------YIAPEVLSRRE 168
           RDL   N L++ +     K+ DFG S+  +L   P+ T  T        + APE ++ R+
Sbjct: 131 RDLAARNILVNSNLE--CKVSDFGLSR--VLEDDPEGTYTTSGGKIPIRWTAPEAIAYRK 186

Query: 169 YDGKLADVWSCGVTLY-VMLVGAYPFED 195
           +    +DVWS G+ ++ VM  G  P+ D
Sbjct: 187 FTSA-SDVWSFGIVMWEVMSFGERPYWD 213

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 59.9 bits (145), Expect = 3e-10
 Identities = 61/209 (29%), Positives = 95/209 (45%), Gaps = 27/209 (12%)

Query: 8   KDIGSGNFG---VARLMRNKNTKELVAMKYIERGH--KIDANVAREIINHKQLRHPNIIR 62
           K IG+G FG     RL      +  VA+K ++ G+  K   +   E     Q  HPNII 
Sbjct: 10  KVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIH 69

Query: 63  FKEVVLTPTHLAIVMEYAAGGEL--FERICNAGRFSEDEARYFFQQLISGQ-------IC 113
            + VV     + IV EY   G L  F R  + G+F+  +     + + SG          
Sbjct: 70  LEGVVTKSKPVMIVTEYMENGSLDAFLRK-HDGQFTVIQLVGMLRGIASGMKYLSDMGYV 128

Query: 114 HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPA------YIAPEVLSRR 167
           HRDL   N L++ +     K+ DFG S+  +L   P++   T        + APE ++ R
Sbjct: 129 HRDLAARNILVNSNLV--CKVSDFGLSR--VLEDDPEAAYTTRGGKIPIRWTAPEAIAYR 184

Query: 168 EYDGKLADVWSCGVTLY-VMLVGAYPFED 195
           ++    +DVWS G+ ++ VM  G  P+ +
Sbjct: 185 KFTSA-SDVWSYGIVMWEVMSYGERPYWE 212

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 60.4 bits (146), Expect = 3e-10
 Identities = 75/307 (24%), Positives = 122/307 (39%), Gaps = 64/307 (20%)

Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAR---EIINHKQLRH 57
           +++Y+ +K IGSG  G+     +   +  VA+K + R  +   +  R   E++  K + H
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 82

Query: 58  PNIIRFKEVVLTPTH-------LAIVMEYAAGGELFERICNAGRFSEDEAR--YFFQQLI 108
            NII    V  TP         + IVME      +   +C   +   D  R  Y   Q++
Sbjct: 83  KNIIGLLNV-FTPQKSLEEFQDVYIVMEL-----MDANLCQVIQMELDHERMSYLLYQML 136

Query: 109 SG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAP 161
            G        I HRDLK  N ++       LKI DFG ++++         V T  Y AP
Sbjct: 137 CGIKHLHSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSFMMTPYVVTRYYRAP 194

Query: 162 EVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRI--------MAVQ 213
           EV+    Y   + D+WS G  +  M+ G   F   +    + K I ++          +Q
Sbjct: 195 EVILGMGYKENV-DIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQ 253

Query: 214 YKIPDYVH----------------------------ISQDCRNLLSRIFVANPSRRITIK 245
             +  YV                              +   R+LLS++ V + S+RI++ 
Sbjct: 254 PTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVD 313

Query: 246 EIKSHPW 252
           E   HP+
Sbjct: 314 EALQHPY 320

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 60.1 bits (145), Expect = 4e-10
 Identities = 76/325 (23%), Positives = 132/325 (40%), Gaps = 45/325 (13%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK--IDAN-VAREIINHKQLRHP 58
           E+Y+ +  +GSG +G      +   ++ VA+K + R  +  I A    RE+   K ++H 
Sbjct: 15  ERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHE 74

Query: 59  NIIRFKEVVLTPTHLA----IVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG---- 110
           N+I   +V    T +     + +     G     I    + S++  ++   QL+ G    
Sbjct: 75  NVIGLLDVFTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQLLRGLKYI 134

Query: 111 ---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRR 167
               I HRDLK  N  ++      L+I DFG ++ +         V T  Y APE++   
Sbjct: 135 HSAGIIHRDLKPSNVAVNEDC--ELRILDFGLARQA--DDEMTGYVATRWYRAPEIMLNW 190

Query: 168 EYDGKLADVWSCGVTLYVMLVGA--YPFEDQED------------PKNFRKTISRIMAVQ 213
            +  +  D+WS G  +  +L G   +P  D  D                 K IS   A +
Sbjct: 191 MHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEHARK 250

Query: 214 YKIPDYVHISQD------------CRNLLSRIFVANPSRRITIKEIKSHPWFLKNLPREL 261
           Y I    H+ Q               +LL ++ V +  +RI+  E  +HP+F +    E 
Sbjct: 251 Y-IQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQYHDPED 309

Query: 262 TETAQAIYYRKENPTFSLQSVEEIT 286
              A+      EN   +++  +E+T
Sbjct: 310 EPEAEPYDESPENKERTIEEWKELT 334

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 58.3 bits (141), Expect = 7e-10
 Identities = 58/247 (23%), Positives = 109/247 (44%), Gaps = 33/247 (13%)

Query: 20  LMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEY 79
           L+ +  T++   +K + +  +        II H     PN++   + +++   + +V+++
Sbjct: 11  LVMDTRTQQTFILKGLRKSSEYSRE-RLTIIPHCV---PNMVCLHKYIVSEDSVFLVLQH 66

Query: 80  AAGGELFERICNAGRFSEDEARYFFQQLI--------SGQICHRDLKLENTLLDGSPAPR 131
           A GG+L+  I       E+  + +  +++         G +C RDL   N LLD     +
Sbjct: 67  AEGGKLWSHISKFLNIPEECVKRWAAEMVVALDALHREGIVC-RDLNPNNILLDDRGHIQ 125

Query: 132 LKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAY 191
           L      +S+ S +            Y APEV    E + +  D WS G  L+ +L G  
Sbjct: 126 LTY----FSRWSEVEDSCDGEAVENMYCAPEVGGISE-ETEACDWWSLGAILFELLTGKT 180

Query: 192 PFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRI-----TIKE 246
             E      N   T++        IP+   +S++ R+LL ++   NP+ R+      +++
Sbjct: 181 LVECHPSGINTHTTLN--------IPE--WVSEEARSLLQQLLQFNPTERLGAGVAGVED 230

Query: 247 IKSHPWF 253
           IKSHP+F
Sbjct: 231 IKSHPFF 237

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 58.9 bits (142), Expect = 9e-10
 Identities = 71/301 (23%), Positives = 120/301 (39%), Gaps = 52/301 (17%)

Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAR---EIINHKQLRH 57
           +++Y+ +K IGSG  G+     +      VA+K + R  +   +  R   E++  K + H
Sbjct: 16  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 75

Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFE-RICNAGRFSEDEAR--YFFQQLISG---- 110
            NII    V      L    +     EL +  +C   +   D  R  Y   Q++ G    
Sbjct: 76  KNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHL 135

Query: 111 ---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRR 167
               I HRDLK  N ++       LKI DFG ++++         V T  Y APEV+   
Sbjct: 136 HSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM 193

Query: 168 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRI--------MAVQYKIPDY 219
            Y   + D+WS G  +  M+     F  ++    + K I ++          +Q  + +Y
Sbjct: 194 GYKENV-DIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNY 252

Query: 220 VH----------------------------ISQDCRNLLSRIFVANPSRRITIKEIKSHP 251
           V                              +   R+LLS++ V +P++RI++ E   HP
Sbjct: 253 VENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHP 312

Query: 252 W 252
           +
Sbjct: 313 Y 313

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 58.0 bits (140), Expect = 1e-09
 Identities = 57/211 (27%), Positives = 92/211 (43%), Gaps = 33/211 (15%)

Query: 10  IGSGNFG---VARLMRNKNTKELVAMKYIERGHKIDANVAREIINHK----QLRHPNIIR 62
           IG+G FG     RL      +  VA+K ++ G+       R+ ++      Q  HPNII 
Sbjct: 12  IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYT--EKQRRDFLSEASIMGQFDHPNIIH 69

Query: 63  FKEVVLTPTHLAIVMEYAAGGEL--FERICNAGRFSEDEARYFFQQLISG-------QIC 113
            + VV     + I+ E+   G L  F R  N G+F+  +     + + +G          
Sbjct: 70  LEGVVTKSRPVMIITEFMENGALDSFLRQ-NDGQFTVIQLVGMLRGIAAGMKYLSEMNYV 128

Query: 114 HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPA--------YIAPEVLS 165
           HRDL   N L++ +     K+ DFG S+   L         T +        + APE ++
Sbjct: 129 HRDLAARNILVNSNLV--CKVSDFGLSR--FLEDDTSDPTYTSSLGGKIPIRWTAPEAIA 184

Query: 166 RREYDGKLADVWSCGVTLY-VMLVGAYPFED 195
            R++    +DVWS G+ ++ VM  G  P+ D
Sbjct: 185 YRKFTSA-SDVWSYGIVMWEVMSYGERPYWD 214

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 57.1 bits (138), Expect = 2e-09
 Identities = 72/262 (27%), Positives = 106/262 (40%), Gaps = 43/262 (16%)

Query: 10  IGSGNFG-VARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKEVVL 68
           IG GNFG V + +   NT+  V          +     +E    KQ  HPNI++   V +
Sbjct: 3   IGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCV 62

Query: 69  TPTHLAIVMEYAAGGELFE---------RICNAGRFSEDEA---RYFFQQLISGQICHRD 116
               + IVME   GG L            +    + S D A    Y    L S    HRD
Sbjct: 63  QKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEY----LESKNCIHRD 118

Query: 117 LKLENTLLDGSPAPRLKICDFG---------YSKSSLLHSRP-KSTVGTPAYIAPEVLSR 166
           L   N L+  +    LKI DFG         Y+ S  L   P K T       APE L+ 
Sbjct: 119 LAARNCLVGENNV--LKISDFGMSREEEGGIYTVSDGLKQIPIKWT-------APEALNY 169

Query: 167 REYDGKLADVWSCGVTLY-VMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQD 225
             Y  + +DVWS G+ L+    +G  P+    +    ++T  RI +  Y++P      ++
Sbjct: 170 GRYTSE-SDVWSYGILLWETFSLGDTPYPGMSN----QQTRERIES-GYRMPAPQLCPEE 223

Query: 226 CRNLLSRIFVANPSRRITIKEI 247
              L+ + +  +P  R +  EI
Sbjct: 224 IYRLMLQCWAYDPENRPSFSEI 245

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 56.6 bits (136), Expect = 4e-09
 Identities = 75/298 (25%), Positives = 118/298 (39%), Gaps = 54/298 (18%)

Query: 2   EKYELMKDIGSGNFGVARLMRN-KNTKELVAMKYI-----ERGHKIDANVAREIINHKQL 55
           ++YE + +IG G +G     R+ KN    VA+K +     E G  +  +  RE+   + L
Sbjct: 1   QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPL--STIREVAVLRHL 58

Query: 56  R---HPNIIRFKEVVLTP-----THLAIVMEYAAGG--ELFERICNAGRFSEDEARYFFQ 105
               HPN++R  +V         T L +V E+         +++   G  +E      FQ
Sbjct: 59  ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ 118

Query: 106 Q------LISGQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYI 159
                  L S ++ HRDLK +N L+  S   ++K+ DFG ++         S V T  Y 
Sbjct: 119 LLRGLDFLHSHRVVHRDLKPQNILVTSSG--QIKLADFGLARIYSFQMALTSVVVTLWYR 176

Query: 160 APEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRI---------- 209
           APEVL +  Y     D+WS G     M      F    D     K +  I          
Sbjct: 177 APEVLLQSSY-ATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPR 235

Query: 210 --------------MAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 253
                           ++  + D   + +D   LL +    NP++RI+     SHP+F
Sbjct: 236 DVALPRQAFHSKSAQPIEKFVTDIDELGKD---LLLKCLTFNPAKRISAYSALSHPYF 290

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 56.6 bits (136), Expect = 4e-09
 Identities = 79/319 (24%), Positives = 129/319 (40%), Gaps = 72/319 (22%)

Query: 3   KYELMKDIGSGNFGVARLMRNKNTKEL--VAMKYIERGHKIDANVAREIINHKQLRHPNI 60
           +YE  K +G G +G     + K+ K+    A+K IE G  I  +  REI   ++L+HPN+
Sbjct: 3   EYEGCK-VGRGTYGHVYKAKRKDGKDDRDYALKQIE-GTGISMSACREIALLRELKHPNV 60

Query: 61  IRFKEVVLTPT--HLAIVMEYAAGGEL----FERICNAGR----FSEDEARYFFQQLISG 110
           I  ++V L+     + ++ +YA         F R   A +          +    Q++ G
Sbjct: 61  ISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDG 120

Query: 111 -------QICHRDLKLENTLL--DGSPAPRLKICDFGYSKSSLLHSRPK------STVGT 155
                   + HRDLK  N L+  +G    R+KI D G+++  L +S  K        V T
Sbjct: 121 IHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFAR--LFNSPLKPLADLDPVVVT 178

Query: 156 PAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFE-DQEDPKN----FRKTISRIM 210
             Y APE+L    +  K  D+W+ G     +L     F   QED K         + RI 
Sbjct: 179 FWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIF 238

Query: 211 AVQ-----------YKIPDYVHISQDCR-------------------------NLLSRIF 234
            V             K+P++  + +D R                         +LL ++ 
Sbjct: 239 NVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLL 298

Query: 235 VANPSRRITIKEIKSHPWF 253
             +P +RIT ++    P+F
Sbjct: 299 TMDPIKRITSEQAMQDPYF 317

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 55.5 bits (134), Expect = 8e-09
 Identities = 55/211 (26%), Positives = 91/211 (43%), Gaps = 26/211 (12%)

Query: 5   ELMKDIGSGNFGVAR----LMRNKNTKELVAMKYI--ERGHKIDANVAREIINHKQLRHP 58
           E +K +GSG FG       +   +  K  VA+K +  E   K +  +  E      + HP
Sbjct: 10  EKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHP 69

Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGELFERI-CNAGRFSEDEARYFFQQLISG------- 110
           +++R   + L+     ++ +    G L + +  +           +  Q+  G       
Sbjct: 70  HVVRLLGICLSSQV-QLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEK 128

Query: 111 QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPA-----YIAPEVLS 165
           ++ HRDL   N L+  +P   +KI DFG +K  LL    K            ++A E + 
Sbjct: 129 RLVHRDLAARNVLVK-TPQ-HVKITDFGLAK--LLDVDEKEYHAEGGKVPIKWMALESIL 184

Query: 166 RREYDGKLADVWSCGVTLY-VMLVGAYPFED 195
            R Y  K +DVWS GVT++ +M  GA P+E 
Sbjct: 185 HRIYTHK-SDVWSYGVTVWELMTFGAKPYEG 214

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 55.9 bits (134), Expect = 1e-08
 Identities = 58/235 (24%), Positives = 102/235 (43%), Gaps = 30/235 (12%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNII 61
           E+ E  + + S N G  +       + L+A K ++ G +    +  EI+   +L H NI+
Sbjct: 174 EEAEARRGVNSTNQGKPK------CERLIA-KRVKAGSRAAIQLENEILALGRLNHENIL 226

Query: 62  RFKEVVLTPTH-LAIVMEYAAGGELFERICNAGRFSED-----EARYFFQQLISG----- 110
           + +E++ +  +   I  +Y    +L+  + +     +D     + R   +QL+       
Sbjct: 227 KIEEILRSEANTYMITQKYDF--DLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIH 284

Query: 111 --QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST--VGTPAYIAPEVLSR 166
             ++ HRD+KLEN  L+      L   DFG +              VGT A  +PE+L+ 
Sbjct: 285 DKKLIHRDIKLENIFLNCDGKIVLG--DFGTAMPFEKEREAFDYGWVGTVATNSPEILAG 342

Query: 167 REYDGKLADVWSCGVTLYVMLVGAY-PFED--QEDPKNFRKTISRIMAVQYKIPD 218
             Y  ++ D+WSCG+ L  ML   + P  D   +  K   K I  +     + PD
Sbjct: 343 DGY-CEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKIIDSLSVCDEEFPD 396

Length = 501

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 54.4 bits (131), Expect = 2e-08
 Identities = 72/288 (25%), Positives = 120/288 (41%), Gaps = 73/288 (25%)

Query: 2   EKYELMKDIGSGNFG---VARLMRNKNTKELVAMKYIERGHKIDANVAR------EIINH 52
           E   L + IG G FG       M  +N K  VA+K      K   + +       E    
Sbjct: 6   EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTC----KNCTSPSVREKFLQEAYIM 61

Query: 53  KQLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQ------ 106
           +Q  HP+I++   V+ T   + IVME A  GEL               R + Q       
Sbjct: 62  RQFDHPHIVKLIGVI-TENPVWIVMELAPLGEL---------------RSYLQVNKYSLD 105

Query: 107 -----LISGQIC------------HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP 149
                L S Q+             HRD+   N L+  SP   +K+ DFG S+     S  
Sbjct: 106 LASLILYSYQLSTALAYLESKRFVHRDIAARNVLV-SSPDC-VKLGDFGLSRYLEDESYY 163

Query: 150 KSTVGT-P-AYIAPEVLSRREYDGKLADVWSCGVTLY-VMLVGAYPFEDQEDPKNFRKTI 206
           K++ G  P  ++APE ++ R +    +DVW  GV ++ ++++G  PF+  ++       I
Sbjct: 164 KASKGKLPIKWMAPESINFRRFTSA-SDVWMFGVCMWEILMLGVKPFQGVKN----NDVI 218

Query: 207 SRI-----MAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKS 249
            RI     + +    P  ++      +L+++ +  +PS+R    E+K+
Sbjct: 219 GRIENGERLPMPPNCPPTLY------SLMTKCWAYDPSKRPRFTELKA 260

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 53.2 bits (128), Expect = 5e-08
 Identities = 77/290 (26%), Positives = 119/290 (41%), Gaps = 61/290 (21%)

Query: 2   EKYELMKDIGSGNFG-----VARLMRNKNTKELVAMKYIERGHKIDAN------VAREII 50
           ++  L K +G G FG      A  + N N    VA+K +    K DA       +  E+ 
Sbjct: 12  DRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKML----KDDATEKDLSDLVSEME 67

Query: 51  NHKQL-RHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLIS 109
             K + +H NII    V      L +V+EYAA G L + +  A R   + A     +   
Sbjct: 68  MMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFL-RARRPPGEYASPDDPRPPE 126

Query: 110 GQI-----------------------C-HRDLKLENTLLDGSPAPRLKICDFGYSKSSLL 145
             +                       C HRDL   N L+  +    +KI DFG ++   +
Sbjct: 127 ETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLV--TEDHVMKIADFGLARD--I 182

Query: 146 HSRP---KSTVG-TPA-YIAPEVLSRREYDGKLADVWSCGVTLY-VMLVGAYPFEDQEDP 199
           H      K+T G  P  ++APE L  R Y  + +DVWS GV L+ +  +G  P+      
Sbjct: 183 HHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGVLLWEIFTLGGSPYPGIPVE 241

Query: 200 KNFR--KTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEI 247
           + F+  K   R+   Q    +  H+ +DC       +   PS+R T K++
Sbjct: 242 ELFKLLKEGYRMEKPQNCTQELYHLMRDC-------WHEVPSQRPTFKQL 284

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 52.5 bits (126), Expect = 7e-08
 Identities = 69/269 (25%), Positives = 119/269 (44%), Gaps = 40/269 (14%)

Query: 2   EKYELMKDIGSGNFG-VARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNI 60
           E  +L+K +G+G FG V     N +TK  VA+K +++G         E    KQL+HP +
Sbjct: 6   ETLKLVKKLGAGQFGEVWMGYYNGHTK--VAIKSLKQGSMSPEAFLAEANLMKQLQHPRL 63

Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLI--SGQIC----- 113
           +R   VV T   + I+ EY   G L + +      + +  +    +LI  + QI      
Sbjct: 64  VRLYAVV-TQEPIYIITEYMENGSLVDFLK-----TPEGIKLTINKLIDMAAQIAEGMAF 117

Query: 114 -------HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPA-----YIAP 161
                  HRDL+  N L+  S     KI DFG ++   L    + T    A     + AP
Sbjct: 118 IERKNYIHRDLRAANILV--SETLCCKIADFGLAR---LIEDNEYTAREGAKFPIKWTAP 172

Query: 162 EVLSRREYDGKLADVWSCGVTLY-VMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYV 220
           E ++   +  K +DVWS G+ L  ++  G  P+    +P+     + + +   Y++P   
Sbjct: 173 EAINYGTFTIK-SDVWSFGILLTEIVTYGRIPYPGMTNPE-----VIQNLERGYRMPRPD 226

Query: 221 HISQDCRNLLSRIFVANPSRRITIKEIKS 249
           +  ++   L+   +   P  R T + ++S
Sbjct: 227 NCPEELYELMRLCWKEKPEERPTFEYLRS 255

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 53.3 bits (128), Expect = 8e-08
 Identities = 33/104 (31%), Positives = 55/104 (52%), Gaps = 10/104 (9%)

Query: 153 VGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAV 212
           +GTP Y+APE+L  + + G   D W+ GV L+  L G  PF D+   + F+  ++R    
Sbjct: 541 LGTPDYLAPELLLGKPH-GPAVDWWALGVCLFEFLTGIPPFNDETPQQVFQNILNR---- 595

Query: 213 QYKIP---DYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 253
              IP       +S + +N +  +   +P++R  +KE+K HP F
Sbjct: 596 --DIPWPEGEEKLSVNAQNAIEILLTMDPTKRAGLKELKQHPLF 637

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 50.4 bits (120), Expect = 3e-07
 Identities = 55/214 (25%), Positives = 85/214 (39%), Gaps = 33/214 (15%)

Query: 53  KQLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFE---------RICNAGRFSEDEARYF 103
           KQ  HPNI++   V      + IVME   GG+            +     +F+ D A   
Sbjct: 47  KQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAG- 105

Query: 104 FQQLISGQICHRDLKLENTLLDGSPAPRLKICDFGYSK--------SSLLHSRPKSTVGT 155
              L S    HRDL   N L+  +    LKI DFG S+        SS L   P      
Sbjct: 106 MAYLESKNCIHRDLAARNCLVGENNV--LKISDFGMSRQEDDGIYSSSGLKQIPIK---- 159

Query: 156 PAYIAPEVLSRREYDGKLADVWSCGVTLY-VMLVGAYPFEDQEDPKNFRKTISRIMAVQY 214
             + APE L+   Y  + +DVWS G+ L+    +G  P+    + +  R+ + +     Y
Sbjct: 160 --WTAPEALNYGRYSSE-SDVWSYGILLWETFSLGVCPYPGMTN-QQAREQVEK----GY 211

Query: 215 KIPDYVHISQDCRNLLSRIFVANPSRRITIKEIK 248
           ++        D   ++ R +   P  R    E++
Sbjct: 212 RMSCPQKCPDDVYKVMQRCWDYKPENRPKFSELQ 245

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 50.4 bits (120), Expect = 4e-07
 Identities = 59/210 (28%), Positives = 95/210 (45%), Gaps = 28/210 (13%)

Query: 2   EKYELMKDIGSGNFG-VARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNI 60
           E  +L+K +G+G FG V     N +TK  VA+K ++ G         E    K L+H  +
Sbjct: 6   ESIKLVKKLGAGQFGEVWMGYYNNSTK--VAVKTLKPGTMSVQAFLEEANLMKTLQHDKL 63

Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLI--SGQIC----- 113
           +R   VV     + I+ EY A G L + +      S++  +    +LI  S QI      
Sbjct: 64  VRLYAVVTKEEPIYIITEYMAKGSLLDFLK-----SDEGGKVLLPKLIDFSAQIAEGMAY 118

Query: 114 -------HRDLKLENTLLDGSPAPRLKICDFGYSK--SSLLHSRPKSTVGTPAYIAPEVL 164
                  HRDL+  N L+  S +   KI DFG ++      ++  +       + APE +
Sbjct: 119 IERKNYIHRDLRAANVLV--SESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAI 176

Query: 165 SRREYDGKLADVWSCGVTLY-VMLVGAYPF 193
           +   +  K +DVWS G+ LY ++  G  P+
Sbjct: 177 NFGSFTIK-SDVWSFGILLYEIVTYGKIPY 205

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 50.1 bits (120), Expect = 5e-07
 Identities = 67/276 (24%), Positives = 110/276 (39%), Gaps = 44/276 (15%)

Query: 6   LMKDIGSGNFGVARL-----MRNKNTKELVAMKYIERGHKIDA--NVAREIINHKQLRHP 58
           L +++G G FG   L     +  +N KELVA+K ++     DA  +  RE       +H 
Sbjct: 9   LKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHE 68

Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGELFERI--------------CNAGRFSEDEARYFF 104
           NI++F  V        +V EY   G+L + +                 G  +  +     
Sbjct: 69  NIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIA 128

Query: 105 QQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKS--SLLHSRPKSTVGT 155
            Q+ SG          HRDL   N L+       +KI DFG S+   +  + R       
Sbjct: 129 VQIASGMVYLASQHFVHRDLATRNCLV--GYDLVVKIGDFGMSRDVYTTDYYRVGGHTML 186

Query: 156 PA-YIAPEVLSRREYDGKLADVWSCGVTLY-VMLVGAYPFEDQEDPKNFRKTISRIMAVQ 213
           P  ++ PE +  R++  + +DVWS GV L+ +   G  P+    + +         +  +
Sbjct: 187 PIRWMPPESIMYRKFTTE-SDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQGRLLQR 245

Query: 214 YKI-PDYV-HISQDCRNLLSRIFVANPSRRITIKEI 247
            +  P  V  I   C       +  +P +RI IK+I
Sbjct: 246 PRTCPSEVYDIMLGC-------WKRDPQQRINIKDI 274

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 50.1 bits (120), Expect = 5e-07
 Identities = 63/292 (21%), Positives = 110/292 (37%), Gaps = 58/292 (19%)

Query: 1   MEKYELMKDIGSGNFG-VAR----LMRNKNTKELVAMKYIERGHKIDA--NVAREIINHK 53
           +     ++++G G FG V +        + +   VA+K ++   +        +E     
Sbjct: 4   LSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMS 63

Query: 54  QLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFE----RICNAGRFSEDEARYF------ 103
            L+HPNI+    V        ++ EY A G+L E       ++   +E            
Sbjct: 64  DLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDC 123

Query: 104 -------------FQQLISGQICHRDLKLENTLLDGSPAPRLKICDFGYSK---SSLLHS 147
                         + L S    HRDL   N L+       +KI DFG S+   S+  + 
Sbjct: 124 SDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLV--GEGLTVKISDFGLSRDIYSADYYR 181

Query: 148 RPKSTVGTPAYIAPE-VLSRREYDGKL---ADVWSCGVTLY-VMLVGAYP---FEDQEDP 199
               ++    ++ PE +L      GK    +D+WS GV L+ +   G  P   F +QE  
Sbjct: 182 VQSKSLLPVRWMPPEAILY-----GKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVI 236

Query: 200 KNFRKTISRIMAVQYKIPDYVH-ISQDCRNLLSRIFVANPSRRITIKEIKSH 250
           +  R     ++      P  V+ +  +C N +       P+RR   K+I + 
Sbjct: 237 EMIRSRQ--LLPCPEDCPARVYALMIECWNEI-------PARRPRFKDIHTR 279

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 50.4 bits (120), Expect = 5e-07
 Identities = 53/169 (31%), Positives = 76/169 (44%), Gaps = 27/169 (15%)

Query: 97  EDEARYFFQQ------LISGQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP- 149
           ED   Y FQ       L S +  HRDL   N LL  S    +KICDFG ++   ++  P 
Sbjct: 179 EDLICYSFQVAKGMEFLASRKCIHRDLAARNILL--SENNVVKICDFGLARD--IYKDPD 234

Query: 150 ---KSTVGTP-AYIAPEVLSRREYDGKLADVWSCGVTLY-VMLVGAYPFEDQEDPKNF-- 202
              K     P  ++APE +  R Y  + +DVWS GV L+ +  +GA P+   +  + F  
Sbjct: 235 YVRKGDARLPLKWMAPETIFDRVYTIQ-SDVWSFGVLLWEIFSLGASPYPGVKIDEEFCR 293

Query: 203 -RKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSH 250
             K  +R+ A  Y  P+      DC +         PS+R T  E+  H
Sbjct: 294 RLKEGTRMRAPDYTTPEMYQTMLDCWH-------GEPSQRPTFSELVEH 335

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 50.0 bits (119), Expect = 5e-07
 Identities = 57/235 (24%), Positives = 97/235 (41%), Gaps = 49/235 (20%)

Query: 53  KQLRHPNIIRFKEVVLTPTHLAIVMEYAAGGEL--FERIC---------------NAGRF 95
           KQ+ HP++I+          L +++EYA  G L  F R                 ++   
Sbjct: 58  KQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLD 117

Query: 96  SEDEARYFFQQLIS--GQIC------------HRDLKLENTLLDGSPAPRLKICDFGYSK 141
           + DE       LIS   QI             HRDL   N L+  +   ++KI DFG S+
Sbjct: 118 NPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLV--AEGRKMKISDFGLSR 175

Query: 142 ------SSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLY-VMLVGAYPFE 194
                 S +  S+ +  V    ++A E L    Y  + +DVWS GV L+ ++ +G  P+ 
Sbjct: 176 DVYEEDSYVKRSKGRIPV---KWMAIESLFDHIYTTQ-SDVWSFGVLLWEIVTLGGNPY- 230

Query: 195 DQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKS 249
               P    + +  ++   Y++    + S++  NL+   +   P +R T  +I  
Sbjct: 231 ----PGIAPERLFNLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISK 281

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 49.6 bits (118), Expect = 7e-07
 Identities = 53/194 (27%), Positives = 87/194 (44%), Gaps = 22/194 (11%)

Query: 8   KDIGSGNFGVAR--LMRNKNTKELVAMKYIERGHKIDANVAREIINH----KQLRHPNII 61
            ++GSGNFG  +  + + K +++ VA+K I +    D  +  E++      +QL +P I+
Sbjct: 1   GELGSGNFGTVKKGMYKMKKSEKTVAVK-ILKNDNNDPALKDELLREANVMQQLDNPYIV 59

Query: 62  RFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-------QICH 114
           R   +        +VME A  G L + +      +E        Q+  G          H
Sbjct: 60  RMIGIC-EAESWMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVH 118

Query: 115 RDLKLENTLLDGSPAPRLKICDFGYSK---SSLLHSRPKSTVGTPA-YIAPEVLSRREYD 170
           RDL   N LL        KI DFG SK   +   + + K+    P  + APE ++  ++ 
Sbjct: 119 RDLAARNVLL--VTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFS 176

Query: 171 GKLADVWSCGVTLY 184
            K +DVWS GV ++
Sbjct: 177 SK-SDVWSFGVLMW 189

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 49.3 bits (117), Expect = 8e-07
 Identities = 61/219 (27%), Positives = 92/219 (42%), Gaps = 44/219 (20%)

Query: 10  IGSGNFG-VARLMRNKNTKEL-VAMKYI-----ERGHKIDANVAREI-INHKQLRHPNII 61
           IG GNFG V +    K+   +  A+K +     +  H+   + A E+ +  K   HPNII
Sbjct: 3   IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHR---DFAGELEVLCKLGHHPNII 59

Query: 62  RFKEVVLTPTHLAIVMEYAAGGELFE-----RICNAG-------------------RFSE 97
                     +L + +EYA  G L +     R+                        F+ 
Sbjct: 60  NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 119

Query: 98  DEARYFFQQLISGQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGT-P 156
           D AR     L   Q  HRDL   N L+  +     KI DFG S+   ++   K T+G  P
Sbjct: 120 DVARGM-DYLSQKQFIHRDLAARNILVGENYVA--KIADFGLSRGQEVYV--KKTMGRLP 174

Query: 157 A-YIAPEVLSRREYDGKLADVWSCGVTLY-VMLVGAYPF 193
             ++A E L+   Y    +DVWS GV L+ ++ +G  P+
Sbjct: 175 VRWMAIESLNYSVYTTN-SDVWSYGVLLWEIVSLGGTPY 212

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 49.2 bits (117), Expect = 8e-07
 Identities = 58/213 (27%), Positives = 96/213 (45%), Gaps = 29/213 (13%)

Query: 9   DIGSGNFGVARL----MRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRH----PNI 60
           ++GSGNFG  +     MR K     VA+K ++  +  + +V  E++   ++ H    P I
Sbjct: 2   ELGSGNFGCVKKGVYKMRKKQID--VAIKVLKNEN--EKSVRDEMMREAEIMHQLDNPYI 57

Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFERIC-NAGRFSEDEARYFFQQLISG-------QI 112
           +R   V      L +VME A+GG L + +       +         Q+  G         
Sbjct: 58  VRMIGVC-EAEALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNF 116

Query: 113 CHRDLKLENTLLDGSPAPRLKICDFGYSKS---SLLHSRPKSTVGTP-AYIAPEVLSRRE 168
            HRDL   N LL        KI DFG SK+      + + +S    P  + APE ++ R+
Sbjct: 117 VHRDLAARNVLLVNQHYA--KISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRK 174

Query: 169 YDGKLADVWSCGVTLYVML-VGAYPFEDQEDPK 200
           +  + +DVWS G+T++     G  P++  + P+
Sbjct: 175 FSSR-SDVWSYGITMWEAFSYGQKPYKKMKGPE 206

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 49.2 bits (117), Expect = 1e-06
 Identities = 55/225 (24%), Positives = 86/225 (38%), Gaps = 41/225 (18%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH----------KIDAN------V 45
           ++  L + +G G FG   L   +   E +     E             + D         
Sbjct: 5   QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDF 64

Query: 46  AREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYAAGGEL------------FERICNAG 93
            +EI    +L++PNIIR   V ++   L ++ EY   G+L            F    N  
Sbjct: 65  LKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIP 124

Query: 94  RFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKS--SL 144
             S     Y   Q+ SG          HRDL   N L+       +KI DFG S++  S 
Sbjct: 125 SVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYT--IKIADFGMSRNLYSG 182

Query: 145 LHSRPKSTVGTPA-YIAPEVLSRREYDGKLADVWSCGVTLYVMLV 188
            + R +     P  ++A E +   ++    +DVW+ GVTL+ M  
Sbjct: 183 DYYRIQGRAVLPIRWMAWESILLGKFT-TASDVWAFGVTLWEMFT 226

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 49.0 bits (117), Expect = 1e-06
 Identities = 65/281 (23%), Positives = 114/281 (40%), Gaps = 51/281 (18%)

Query: 6   LMKDIGSGNFGV---ARLMRNKNTKELVAMKYIERGHKIDANVAREI-------INHKQL 55
           L K +G G FG     +L ++  ++  VA+K +    K+D +   EI          K  
Sbjct: 3   LGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTM----KLDIHTYSEIEEFLSEAACMKDF 58

Query: 56  RHPNIIRFKEVVLTPTHLA------IVMEYAAGGEL-----FERICNAG---------RF 95
            HPN+++   V    + L       +++ +   G+L     + R+             +F
Sbjct: 59  DHPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKF 118

Query: 96  SEDEARYFFQQLISGQICHRDLKLENTLLDGSPAPRLKIC--DFGYSKS--SLLHSRPKS 151
             D A    + L +    HRDL   N +L       + +C  DFG SK   S  + R   
Sbjct: 119 MVDIALGM-EYLSNRNFIHRDLAARNCMLRED----MTVCVADFGLSKKIYSGDYYRQGR 173

Query: 152 TVGTPA-YIAPEVLSRREYDGKLADVWSCGVTLY-VMLVGAYPFEDQEDPKNFRKTISRI 209
               P  +IA E L+ R Y  K +DVW+ GVT++ +   G  P+   E+ + +       
Sbjct: 174 IAKMPVKWIAIESLADRVYTSK-SDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRH-- 230

Query: 210 MAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSH 250
              + K P+      +  +L+   + A+P  R T  +++  
Sbjct: 231 -GNRLKQPE--DCLDELYDLMYSCWRADPKDRPTFTKLREV 268

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha

 Score = 49.2 bits (117), Expect = 1e-06
 Identities = 56/219 (25%), Positives = 90/219 (41%), Gaps = 35/219 (15%)

Query: 5   ELMKDIGSG--NFGVARLMRNKNTKELVAMKYIERGHKIDANVA---REIINHKQLRHPN 59
           EL+  IG G  +     L R K T E V ++ I      +  V     E+   K   HPN
Sbjct: 1   ELLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPN 60

Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFERICN--AGRFSEDEARYFFQQLISG------- 110
           I+ ++   +    L +V  + A G   + IC       SE    Y  Q ++         
Sbjct: 61  IVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHM 120

Query: 111 QICHRDLKLENTL--LDGSPAPRLKICDFGY----------SKSSLLHSRPKSTVGTPAY 158
              HR +K  + L  +DG      K+   G            +  ++H  PK +V    +
Sbjct: 121 GYVHRSVKASHILISVDG------KVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLPW 174

Query: 159 IAPEVLSR--REYDGKLADVWSCGVTLYVMLVGAYPFED 195
           ++PEVL +  + YD K +D++S G+T   +  G  PF+D
Sbjct: 175 LSPEVLQQNLQGYDAK-SDIYSVGITACELANGHVPFKD 212

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 48.6 bits (116), Expect = 1e-06
 Identities = 55/209 (26%), Positives = 86/209 (41%), Gaps = 32/209 (15%)

Query: 5   ELMKDIGSGNFG-VARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRF 63
           +L++ +G+G FG V   + N  T   VA+K ++ G     +   E    K+LRHP +I+ 
Sbjct: 9   QLLRKLGAGQFGEVWEGLWNNTTP--VAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQL 66

Query: 64  KEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYF-FQQLI--SGQIC------- 113
             V      + IV E    G L E +           R     QLI  + Q+        
Sbjct: 67  YAVCTLEEPIYIVTELMKYGSLLEYLQG------GAGRALKLPQLIDMAAQVASGMAYLE 120

Query: 114 -----HRDLKLENTLLDGSPAPRLKICDFGYS---KSSLLHSRPKSTVGTPAYIAPEVLS 165
                HRDL   N L+  +     K+ DFG +   K  +  +R  +      + APE   
Sbjct: 121 AQNYIHRDLAARNVLVGENNI--CKVADFGLARVIKEDIYEAREGAKFPI-KWTAPEAAL 177

Query: 166 RREYDGKLADVWSCGVTLY-VMLVGAYPF 193
              +  K +DVWS G+ L  ++  G  P+
Sbjct: 178 YNRFSIK-SDVWSFGILLTEIVTYGRMPY 205

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 49.4 bits (118), Expect = 2e-06
 Identities = 69/328 (21%), Positives = 114/328 (34%), Gaps = 101/328 (30%)

Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYI-------ERGHKIDANVAREIINHK 53
           M++Y++++ IG G  G   L  +      VA+K I           K      RE     
Sbjct: 1   MQRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKK---RFLREAKIAA 57

Query: 54  QLRHPNII-------------------------------RFKEVVLTPTHLAIVMEYAAG 82
            L HP I+                                 KE +     LA      A 
Sbjct: 58  DLIHPGIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESL--SKELAEKTSVGAF 115

Query: 83  GELFERICNAGRFSEDEARYFFQQLISGQICHRDLKLENTLLDGSPAPRLKICDFG---- 138
             +F +IC    +             S  + HRDLK +N LL       + I D+G    
Sbjct: 116 LSIFHKICATIEYVH-----------SKGVLHRDLKPDNILL--GLFGEVVILDWGAAIF 162

Query: 139 ------------YSKSSLLHSR---PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTL 183
                         + ++ +S    P   VGTP Y+APE L          D+++ GV L
Sbjct: 163 KKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASES-TDIYALGVIL 221

Query: 184 YVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHIS--QDCRNLLSRI----FVAN 237
           Y ML  ++P+      K  RK     ++ +  I   + ++  ++    LS+I       +
Sbjct: 222 YQMLTLSFPYRR----KKGRK-----ISYRDVILSPIEVAPYREIPPFLSQIAMKALAVD 272

Query: 238 PSRRIT-----IKEIKSH-----PWFLK 255
           P+ R +      ++++ H      W +K
Sbjct: 273 PAERYSSVQELKQDLEPHLQGSPEWTVK 300

Length = 932

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 48.3 bits (115), Expect = 2e-06
 Identities = 68/277 (24%), Positives = 110/277 (39%), Gaps = 53/277 (19%)

Query: 10  IGSGNFG-----VARLMRNKNTKEL-VAMKYIERGHKIDANVAREIINHKQL----RHPN 59
           +GSG FG      A  +    +  + VA+K + +G         E +    L     HPN
Sbjct: 3   LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKK--EFLKEAHLMSNFNHPN 60

Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGQIC------ 113
           I++   V L      I+ME   GG+L   + +A            ++L+   IC      
Sbjct: 61  IVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELL--DICLDVAKG 118

Query: 114 ----------HRDLKLENTLLD--GSPAPR-LKICDFGYSK---SSLLHSRPKSTVGTPA 157
                     HRDL   N L+   G  A R +KI DFG ++    S  + +    +    
Sbjct: 119 CVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVR 178

Query: 158 YIAPEVLSRREYDGKL---ADVWSCGVTLY-VMLVG--AYPFEDQEDPKNFRKTISRIMA 211
           ++APE L     DGK    +DVWS GV ++ ++ +G   YP  + ++         R+  
Sbjct: 179 WMAPESL----LDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGGRLQK 234

Query: 212 VQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIK 248
            +   PD          L++  +  +PS R T   I+
Sbjct: 235 PE-NCPD------KIYQLMTNCWAQDPSERPTFDRIQ 264

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 48.7 bits (116), Expect = 2e-06
 Identities = 51/170 (30%), Positives = 80/170 (47%), Gaps = 29/170 (17%)

Query: 97  EDEARYFFQ-----QLISGQIC-HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP- 149
           ED   Y FQ     + ++ + C HRDL   N LL  S    +KICDFG ++   ++  P 
Sbjct: 173 EDLISYSFQVARGMEFLASRKCIHRDLAARNILL--SENNVVKICDFGLARD--IYKDPD 228

Query: 150 ---KSTVGTP-AYIAPEVLSRREYDGKLADVWSCGVTLY-VMLVGAYPFE----DQEDPK 200
              K     P  ++APE +  + Y  + +DVWS GV L+ +  +GA P+     D+E  +
Sbjct: 229 YVRKGDARLPLKWMAPESIFDKVYTTQ-SDVWSFGVLLWEIFSLGASPYPGVQIDEEFCR 287

Query: 201 NFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSH 250
             ++  +R+ A +Y  P+   I  DC       +  NP  R T  E+   
Sbjct: 288 RLKEG-TRMRAPEYATPEIYSIMLDC-------WHNNPEDRPTFSELVEI 329

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 48.5 bits (115), Expect = 2e-06
 Identities = 67/219 (30%), Positives = 97/219 (44%), Gaps = 44/219 (20%)

Query: 10  IGSGNFG-VARLMRNKNTKEL-VAMKYI-----ERGHKIDANVAREI-INHKQLRHPNII 61
           IG GNFG V R M  K+  ++  A+K +     E  H+   + A E+ +  K   HPNII
Sbjct: 10  IGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHR---DFAGELEVLCKLGHHPNII 66

Query: 62  RFKEVVLTPTHLAIVMEYAAGGELFE-----RICNAG-------------------RFSE 97
                     +L I +EYA  G L +     R+                       +F+ 
Sbjct: 67  NLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFAS 126

Query: 98  DEARYFFQQLISGQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGT-P 156
           D A    Q L   Q  HRDL   N L+  + A   KI DFG S+   ++   K T+G  P
Sbjct: 127 DVATG-MQYLSEKQFIHRDLAARNVLVGENLAS--KIADFGLSRGEEVYV--KKTMGRLP 181

Query: 157 A-YIAPEVLSRREYDGKLADVWSCGVTLY-VMLVGAYPF 193
             ++A E L+   Y  K +DVWS GV L+ ++ +G  P+
Sbjct: 182 VRWMAIESLNYSVYTTK-SDVWSFGVLLWEIVSLGGTPY 219

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 48.2 bits (115), Expect = 2e-06
 Identities = 58/252 (23%), Positives = 94/252 (37%), Gaps = 50/252 (19%)

Query: 5   ELMKDIGSGNFG-----VARLMRNKNTKELVAMKYIER--GHKIDANVAREIINHKQLRH 57
            L++ +G G FG     + R       +  VA+K +      + +++   E +   +  H
Sbjct: 9   TLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNH 68

Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGEL--FERIC--NAGRFSE-----------DEA-- 100
            NI+R   V        I++E  AGG+L  F R       R S            D A  
Sbjct: 69  QNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKG 128

Query: 101 -RYFFQQLISGQICHRDLKLENTLLDGSPAPRL-KICDFGYSKS---SLLHSRPKSTVGT 155
            +Y    L      HRD+   N LL      R+ KI DFG ++    +  + +    +  
Sbjct: 129 CKY----LEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLP 184

Query: 156 PAYIAPEVLSRREYDGKLADVWSCGVTLY-VMLVGAYPFEDQ---------------EDP 199
             ++ PE      +  K  DVWS GV L+ +  +G  P+  +               + P
Sbjct: 185 IKWMPPEAFLDGIFTSK-TDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGGGRLDPP 243

Query: 200 KNFRKTISRIMA 211
           K     + RIM 
Sbjct: 244 KGCPGPVYRIMT 255

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 46.3 bits (110), Expect = 9e-06
 Identities = 60/210 (28%), Positives = 91/210 (43%), Gaps = 31/210 (14%)

Query: 10  IGSGNFGV---ARLMRNKNTKELVAMKYIERGHKID--ANVAREIINHKQLRHPNIIRFK 64
           IG G+FG      L+ +   K   A+K + R   ++      +E I  K   HPN++   
Sbjct: 3   IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLL 62

Query: 65  EVVLTPTHLA-IVMEYAAGGELFERICNAGR---------FSEDEARYFFQQLISGQICH 114
            + L       +V+ Y   G+L   I +            F    A+   + L S +  H
Sbjct: 63  GICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGM-EYLASKKFVH 121

Query: 115 RDLKLENTLLDGSPAPRLKICDFG-----YSK---SSLLHSRPKSTVGTPAYIAPEVLSR 166
           RDL   N +LD S    +K+ DFG     Y K   S   H+  K  V    ++A E L  
Sbjct: 122 RDLAARNCMLDESFT--VKVADFGLARDIYDKEYYSVHNHTGAKLPV---KWMALESLQT 176

Query: 167 REYDGKLADVWSCGVTLY-VMLVGAYPFED 195
           +++  K +DVWS GV L+ +M  GA P+ D
Sbjct: 177 QKFTTK-SDVWSFGVLLWELMTRGAPPYPD 205

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 46.5 bits (110), Expect = 9e-06
 Identities = 44/146 (30%), Positives = 69/146 (47%), Gaps = 22/146 (15%)

Query: 97  EDEARYFFQQ------LISGQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP- 149
           ED   Y FQ       L S +  HRDL   N LL  S    +KICDFG ++   ++  P 
Sbjct: 174 EDLICYSFQVARGMEFLASRKCIHRDLAARNILL--SENNVVKICDFGLARD--IYKDPD 229

Query: 150 ---KSTVGTP-AYIAPEVLSRREYDGKLADVWSCGVTLY-VMLVGAYPFE----DQEDPK 200
              K +   P  ++APE +  + Y  + +DVWS GV L+ +  +GA P+     ++E  +
Sbjct: 230 YVRKGSARLPLKWMAPESIFDKVYTTQ-SDVWSFGVLLWEIFSLGASPYPGVQINEEFCQ 288

Query: 201 NFRKTISRIMAVQYKIPDYVHISQDC 226
             +   +R+ A +   P+   I   C
Sbjct: 289 RLKDG-TRMRAPENATPEIYRIMLAC 313

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 45.4 bits (107), Expect = 2e-05
 Identities = 55/218 (25%), Positives = 95/218 (43%), Gaps = 33/218 (15%)

Query: 6   LMKDIGSGNFGVARLMRNKN-----TKELVAMKYI-ERGHKIDANVAREIINHKQLRHPN 59
           L +++G G FG   L    N      K LVA+K + +       +  RE      L+H +
Sbjct: 9   LKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEH 68

Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFERICNAG-------------RFSEDEARYFFQQ 106
           I++F  V +    L +V EY   G+L + +   G               ++ +  +  QQ
Sbjct: 69  IVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQ 128

Query: 107 LISGQI-------CHRDLKLENTLLDGSPAPRLKICDFGYSK---SSLLHSRPKSTVGTP 156
           + +G +        HRDL   N L+  +    +KI DFG S+   S+  +     T+   
Sbjct: 129 IAAGMVYLASQHFVHRDLATRNCLVGENLL--VKIGDFGMSRDVYSTDYYRVGGHTMLPI 186

Query: 157 AYIAPEVLSRREYDGKLADVWSCGVTLY-VMLVGAYPF 193
            ++ PE +  R++  + +DVWS GV L+ +   G  P+
Sbjct: 187 RWMPPESIMYRKFTTE-SDVWSLGVVLWEIFTYGKQPW 223

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 45.2 bits (107), Expect = 2e-05
 Identities = 41/147 (27%), Positives = 66/147 (44%), Gaps = 11/147 (7%)

Query: 107 LISGQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR--PKSTVGTPA-YIAPEV 163
           L S    HRDL   N LL  +    +KICDFG ++  +  S    K     P  ++APE 
Sbjct: 157 LASKNCIHRDLAARNVLL--THGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPES 214

Query: 164 LSRREYDGKLADVWSCGVTLY-VMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHI 222
           +    Y    +DVWS G+ L+ +  +G+ P+        F K I       Y++    H 
Sbjct: 215 IFNCVYT-FESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKE----GYRMAQPEHA 269

Query: 223 SQDCRNLLSRIFVANPSRRITIKEIKS 249
             +  +++   + A+P +R T K+I  
Sbjct: 270 PAEIYDIMKTCWDADPLKRPTFKQIVQ 296

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 45.0 bits (106), Expect = 3e-05
 Identities = 75/305 (24%), Positives = 131/305 (42%), Gaps = 53/305 (17%)

Query: 3   KYELMKDIGSGNFG---------VARLMRNKNTKELVAMKYIERGHKIDANVAREIINHK 53
           +  L K +G G FG         + +   NK     V M   +   K  +++  E+   K
Sbjct: 13  RLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMK 72

Query: 54  QL-RHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGR-----FSEDEARYFFQQL 107
            + +H NII           L +++EYA+ G L E +  A R     +S D  +   +QL
Sbjct: 73  MIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYL-RARRPPGMDYSFDTCKLPEEQL 131

Query: 108 ------------------ISGQIC-HRDLKLENTLLDGSPAPRLKICDFGYSKS-SLLHS 147
                             ++ Q C HRDL   N L+       +KI DFG ++    +  
Sbjct: 132 TFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDNV--MKIADFGLARDVHNIDY 189

Query: 148 RPKSTVGT-PA-YIAPEVLSRREYDGKLADVWSCGVTLY-VMLVGAYPFEDQEDPKNFRK 204
             K+T G  P  ++APE L  R Y  + +DVWS GV L+ +  +G  P+     P    +
Sbjct: 190 YKKTTNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGVLLWEIFTLGGSPY-----PGIPVE 243

Query: 205 TISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLPRELTET 264
            + +++   +++    + + +   ++   + A PS+R T K++      +++L R LT T
Sbjct: 244 ELFKLLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQL------VEDLDRVLTVT 297

Query: 265 AQAIY 269
           +   Y
Sbjct: 298 STDEY 302

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 45.4 bits (107), Expect = 3e-05
 Identities = 55/192 (28%), Positives = 83/192 (43%), Gaps = 28/192 (14%)

Query: 11  GSGNFGVARLMRNKNTKELVAMKYIERGHKI-DANVAREIINHKQLRHPNIIRFK----- 64
           G+  F  A  + NK T E V +K  +RG    +A++ R I       HP+II+ K     
Sbjct: 103 GAEGFAFA-CIDNK-TCEHVVIKAGQRGGTATEAHILRAI------NHPSIIQLKGTFTY 154

Query: 65  ---EVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGQICHRDLKLEN 121
                ++ P +   +  Y A       IC+         R   Q L   +I HRD+K EN
Sbjct: 155 NKFTCLILPRYKTDLYCYLAAKRNIA-ICDILAIERSVLRAI-QYLHENRIIHRDIKAEN 212

Query: 122 TLLDGSPAPRLKIC--DFGYS--KSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLADVW 177
             ++  P     +C  DFG +     +  ++     GT A  APE+L+R  Y G   D+W
Sbjct: 213 IFIN-HPG---DVCLGDFGAACFPVDINANKYYGWAGTIATNAPELLARDPY-GPAVDIW 267

Query: 178 SCGVTLYVMLVG 189
           S G+ L+ M   
Sbjct: 268 SAGIVLFEMATC 279

Length = 391

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 45.0 bits (106), Expect = 3e-05
 Identities = 69/283 (24%), Positives = 115/283 (40%), Gaps = 55/283 (19%)

Query: 6   LMKDIGSGNFGVARL-----MRNKNTKELVAMKYIERGHKIDANVA------REIINHKQ 54
           L +++G G FG   L     +     K LVA+K ++     D  +A      RE      
Sbjct: 9   LKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALK-----DPTLAARKDFQREAELLTN 63

Query: 55  LRHPNIIRFKEVVLTPTHLAIVMEYAAGGEL--FER--------------ICNAGRFSED 98
           L+H +I++F  V      L +V EY   G+L  F R                  G     
Sbjct: 64  LQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLS 123

Query: 99  EARYFFQQLISGQI-------CHRDLKLENTLLDGSPAPRLKICDFGYSK---SSLLHSR 148
           +  +   Q+ SG +        HRDL   N L+  +    +KI DFG S+   S+  +  
Sbjct: 124 QMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLL--VKIGDFGMSRDVYSTDYYRV 181

Query: 149 PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLY-VMLVGAYPFEDQEDPKNFRKTIS 207
              T+    ++ PE +  R++  + +DVWS GV L+ +   G  P+  Q       + I+
Sbjct: 182 GGHTMLPIRWMPPESIMYRKFTTE-SDVWSFGVILWEIFTYGKQPWF-QLSNTEVIECIT 239

Query: 208 --RIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIK 248
             R++      P  V+      +++   +   P +R+ IKEI 
Sbjct: 240 QGRVLERPRVCPKEVY------DIMLGCWQREPQQRLNIKEIY 276

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 44.5 bits (105), Expect = 3e-05
 Identities = 37/146 (25%), Positives = 63/146 (43%), Gaps = 20/146 (13%)

Query: 53  KQLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEAR--YFFQQLISG 110
           K+++HPN+++   V        I+ E+   G L + +    R   +     Y   Q+ S 
Sbjct: 57  KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSA 116

Query: 111 -------QICHRDLKLENTLLDGSPAPRLKICDFGYSK-----SSLLHSRPKSTVGTPAY 158
                     HRDL   N L+       +K+ DFG S+     +   H+  K  +    +
Sbjct: 117 MEYLEKKNFIHRDLAARNCLV--GENHLVKVADFGLSRLMTGDTYTAHAGAKFPI---KW 171

Query: 159 IAPEVLSRREYDGKLADVWSCGVTLY 184
            APE L+  ++  K +DVW+ GV L+
Sbjct: 172 TAPESLAYNKFSIK-SDVWAFGVLLW 196

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 45.0 bits (106), Expect = 4e-05
 Identities = 37/140 (26%), Positives = 65/140 (46%), Gaps = 13/140 (9%)

Query: 107 LISGQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTP----AYIAPE 162
           L S    HRDL   N LL  +    +KICDFG ++  ++H     + G+      ++APE
Sbjct: 253 LASKNCVHRDLAARNVLL--AQGKIVKICDFGLARD-IMHDSNYVSKGSTFLPVKWMAPE 309

Query: 163 VLSRREYDGKLADVWSCGVTLY-VMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVH 221
            +    Y   L+DVWS G+ L+ +  +G  P+        F   I       Y++    H
Sbjct: 310 SIFDNLYT-TLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNKIKS----GYRMAKPDH 364

Query: 222 ISQDCRNLLSRIFVANPSRR 241
            +Q+  +++ + + + P +R
Sbjct: 365 ATQEVYDIMVKCWNSEPEKR 384

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 44.6 bits (105), Expect = 4e-05
 Identities = 36/130 (27%), Positives = 58/130 (44%), Gaps = 11/130 (8%)

Query: 107 LISGQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR---PKSTVGTPAYIAPEV 163
           L S    HRDL   N L+       +KICDFG ++  +  S      ST     ++APE 
Sbjct: 255 LASKNCVHRDLAARNVLI--CEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPES 312

Query: 164 LSRREYDGKLADVWSCGVTLY-VMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHI 222
           +    Y   L+DVWS G+ L+ +  +G  P+ +    + F   I R     Y++    H 
Sbjct: 313 IFNNLYT-TLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYNAIKR----GYRMAKPAHA 367

Query: 223 SQDCRNLLSR 232
           S +   ++ +
Sbjct: 368 SDEIYEIMQK 377

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 44.2 bits (104), Expect = 5e-05
 Identities = 60/237 (25%), Positives = 108/237 (45%), Gaps = 43/237 (18%)

Query: 56  RHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGR-----FSEDEAR-----YFFQ 105
           +H NII           L +++EYA+ G L E +  A R     +S D AR       F+
Sbjct: 79  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYL-RARRPPGMEYSYDIARVPDEQMTFK 137

Query: 106 QLIS-------------GQIC-HRDLKLENTLLDGSPAPRLKICDFGYSK--SSLLHSRP 149
            L+S              Q C HRDL   N L+  +    +KI DFG ++  +++ + + 
Sbjct: 138 DLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTENNV--MKIADFGLARDVNNIDYYKK 195

Query: 150 KSTVGTPA-YIAPEVLSRREYDGKLADVWSCGVTLY-VMLVGAYPFEDQEDPKNFRKTIS 207
            +    P  ++APE L  R Y  + +DVWS GV ++ +  +G  P+     P    + + 
Sbjct: 196 TTNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGVLMWEIFTLGGSPY-----PGIPVEELF 249

Query: 208 RIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLPRELTET 264
           +++   +++    + + +   ++   + A PS R T K++      +++L R LT T
Sbjct: 250 KLLKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQL------VEDLDRILTLT 300

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 43.9 bits (103), Expect = 5e-05
 Identities = 57/226 (25%), Positives = 94/226 (41%), Gaps = 41/226 (18%)

Query: 6   LMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKID-------ANVAREIINHKQLRHP 58
           L K +G G FG   +M  +  ++   +K   +  KI         +   E +  K+  HP
Sbjct: 3   LGKTLGEGEFG--SVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHP 60

Query: 59  NIIRFKEVVLTPTHL------AIVMEYAAGGEL-----FERICNAG---------RFSED 98
           N++R   V L            +++ +   G+L     + R+ +           +F  D
Sbjct: 61  NVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTD 120

Query: 99  EARYFFQQLISGQICHRDLKLENTLLDGSPAPRLKIC--DFGYSKS--SLLHSRPKSTVG 154
            A    + L S    HRDL   N +L+ +    + +C  DFG SK   +  + R      
Sbjct: 121 IASGM-EYLSSKSFIHRDLAARNCMLNEN----MNVCVADFGLSKKIYNGDYYRQGRIAK 175

Query: 155 TPA-YIAPEVLSRREYDGKLADVWSCGVTLY-VMLVGAYPFEDQED 198
            P  +IA E L+ R Y  K +DVWS GVT++ +   G  P+   E+
Sbjct: 176 MPVKWIAIESLADRVYTTK-SDVWSFGVTMWEIATRGQTPYPGVEN 220

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 43.8 bits (103), Expect = 6e-05
 Identities = 55/239 (23%), Positives = 96/239 (40%), Gaps = 54/239 (22%)

Query: 10  IGSGNFGVARLMRNKNTKELVAMKY---IERGHKI---------DAN------VAREIIN 51
           +G G FG   L    N ++L  +++   + +G  +         DAN        +E+  
Sbjct: 13  LGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKI 72

Query: 52  HKQLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYF-------- 103
             +L+ PNIIR   V +    L ++ EY   G+L  +  ++    + E            
Sbjct: 73  LSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDL-NQFLSSHHLDDKEENGNDAVPPAHC 131

Query: 104 -----FQQLIS--GQIC------------HRDLKLENTLLDGSPAPRLKICDFGYSKSSL 144
                +  L+    QI             HRDL   N L+  +    +KI DFG S++  
Sbjct: 132 LPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLVGENLT--IKIADFGMSRNLY 189

Query: 145 L--HSRPKSTVGTPA-YIAPEVLSRREYDGKLADVWSCGVTLY--VMLVGAYPFEDQED 198
              + R +     P  ++A E +   ++    +DVW+ GVTL+  +ML    P+ +  D
Sbjct: 190 AGDYYRIQGRAVLPIRWMAWECILMGKFT-TASDVWAFGVTLWEILMLCKEQPYGELTD 247

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 43.9 bits (103), Expect = 6e-05
 Identities = 54/208 (25%), Positives = 93/208 (44%), Gaps = 26/208 (12%)

Query: 7   MKDIGSGNFGVAR----LMRNKNTKELVAMKYIER--GHKIDANVAREIINHKQLRHPNI 60
           +K +GSG FG       +   +  K  VA+K +    G K +     E +    + HP++
Sbjct: 12  VKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHL 71

Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFERIC-NAGRFSEDEARYFFQQLISG-------QI 112
           +R   V L+PT + +V +    G L + +  +           +  Q+  G       ++
Sbjct: 72  VRLLGVCLSPT-IQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRL 130

Query: 113 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPA-----YIAPEVLSRR 167
            HRDL   N L+  SP   +KI DFG ++  LL    K            ++A E +  R
Sbjct: 131 VHRDLAARNVLVK-SPN-HVKITDFGLAR--LLEGDEKEYNADGGKMPIKWMALECIHYR 186

Query: 168 EYDGKLADVWSCGVTLY-VMLVGAYPFE 194
           ++  + +DVWS GVT++ +M  G  P++
Sbjct: 187 KFTHQ-SDVWSYGVTIWELMTFGGKPYD 213

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 43.7 bits (103), Expect = 6e-05
 Identities = 52/187 (27%), Positives = 80/187 (42%), Gaps = 36/187 (19%)

Query: 29  LVAMKYIERGHKIDAN------VAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYAAG 82
           LVA+K +    + DAN        +EI    +L+ PNIIR   V +T   L ++ EY   
Sbjct: 48  LVAVKML----REDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMEN 103

Query: 83  GELFERIC-----------NAGRFSEDEARYFFQQLISG-------QICHRDLKLENTLL 124
           G+L + +            +    S     +   Q+ SG          HRDL   N L+
Sbjct: 104 GDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLV 163

Query: 125 DGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRRE-YDGKL---ADVWSCG 180
             +    +KI DFG S++  L+S     +   A +    +S      GK    +DVW+ G
Sbjct: 164 GKNYT--IKIADFGMSRN--LYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFG 219

Query: 181 VTLYVML 187
           VTL+ +L
Sbjct: 220 VTLWEIL 226

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 43.8 bits (103), Expect = 6e-05
 Identities = 53/217 (24%), Positives = 84/217 (38%), Gaps = 39/217 (17%)

Query: 54  QLRHPNIIRFKEVVLTPTHLAIVMEYAAGGEL--FERICNAGRFSEDEARYFFQQLISGQ 111
           Q  H NI+R + V+     + IV EY + G L  F R  + G+    +       L SG 
Sbjct: 62  QFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRK-HEGQLVAGQLMGMLPGLASGM 120

Query: 112 -------ICHRDLKLENTLLDGSPAPRLKICDFG---YSKSSLLHS--RPKSTVGTPAYI 159
                    H+ L     L++       KI  F      KS  +++    KS V    + 
Sbjct: 121 KYLSEMGYVHKGLAAHKVLVNSDLV--CKISGFRRLQEDKSEAIYTTMSGKSPV---LWA 175

Query: 160 APEVLSRREYDGKLADVWSCGVTLY-VMLVGAYPFEDQEDPKNFRKTISRIMAVQ--YKI 216
           APE +    +    +DVWS G+ ++ VM  G  P+ D             I AV+  +++
Sbjct: 176 APEAIQYHHFSSA-SDVWSFGIVMWEVMSYGERPYWDMSGQ-------DVIKAVEDGFRL 227

Query: 217 PDYVHISQDCRNLLSRIFV----ANPSRRITIKEIKS 249
           P   +    C NLL ++ +         R    +I S
Sbjct: 228 PAPRN----CPNLLHQLMLDCWQKERGERPRFSQIHS 260

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 43.1 bits (101), Expect = 1e-04
 Identities = 55/208 (26%), Positives = 93/208 (44%), Gaps = 26/208 (12%)

Query: 7   MKDIGSGNFGVAR----LMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLR----HP 58
           +K +GSG FG       +   +N K  VA+K +       AN  +EI++   +      P
Sbjct: 12  VKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKAN--KEILDEAYVMAGVGSP 69

Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGELFERIC-NAGRFSEDEARYFFQQLISG------- 110
            + R   + LT T + +V +    G L + +  N  R    +   +  Q+  G       
Sbjct: 70  YVCRLLGICLTST-VQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEV 128

Query: 111 QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPA---YIAPEVLSRR 167
           ++ HRDL   N L+  SP   +KI DFG ++   +        G      ++A E +  R
Sbjct: 129 RLVHRDLAARNVLVK-SPN-HVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHR 186

Query: 168 EYDGKLADVWSCGVTLY-VMLVGAYPFE 194
            +  + +DVWS GVT++ +M  GA P++
Sbjct: 187 RFTHQ-SDVWSYGVTVWELMTFGAKPYD 213

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 43.3 bits (102), Expect = 1e-04
 Identities = 44/184 (23%), Positives = 68/184 (36%), Gaps = 37/184 (20%)

Query: 112 ICHRDLKLENTLLDGSPAPRLKICDFGYS-KSSLLHSRPKST--VGTPAYIAPEVLSRRE 168
           I HRD+K EN  LD      L   DFG + K       P+     GT    +PE+L+   
Sbjct: 206 IIHRDVKTENIFLDEPENAVLG--DFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDP 263

Query: 169 YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQ--------------- 213
           Y  K  D+WS G+ L+ M V       ++   +  +  S I  +Q               
Sbjct: 264 YCAK-TDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTNLC 322

Query: 214 -------------YKIPDYVH---ISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNL 257
                        Y IP  +    +  D   L++++   +   R + ++I S P F K  
Sbjct: 323 KHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKEP 382

Query: 258 PREL 261
              L
Sbjct: 383 INLL 386

Length = 392

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 42.5 bits (100), Expect = 1e-04
 Identities = 36/177 (20%), Positives = 69/177 (38%), Gaps = 34/177 (19%)

Query: 30  VAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYAAGG------ 83
           V +K +   H+             QL H ++++   V +   ++ +V EY   G      
Sbjct: 33  VVLKVLGSDHRDSLAFFETASLMSQLSHKHLVKLYGVCVRDENI-MVEEYVKFGPLDVFL 91

Query: 84  -------------ELFERICNAGRFSEDEARYFFQQLISGQICHRDLKLENTLLDGSPAP 130
                        ++ +++ +A  + ED      ++L+ G +C +++ +    L+    P
Sbjct: 92  HREKNNVSLHWKLDVAKQLASALHYLED------KKLVHGNVCGKNILVARYGLNEGYVP 145

Query: 131 RLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKL---ADVWSCGVTLY 184
            +K+ D G   + L        +    +IAPE +  R     L   AD WS G TL 
Sbjct: 146 FIKLSDPGIPITVLSREERVERI---PWIAPECI--RNGQASLTIAADKWSFGTTLL 197

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 42.5 bits (100), Expect = 2e-04
 Identities = 54/221 (24%), Positives = 88/221 (39%), Gaps = 42/221 (19%)

Query: 3   KYELMKDIGSGNFGV---ARLMRNKNTKE--LVAMKYIERGHKID--ANVAREIINHKQL 55
             E ++DIG G FG    AR       +   +VA+K ++     D  A+  RE     + 
Sbjct: 6   NIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEF 65

Query: 56  RHPNIIRFKEVVLTPTHLAIVMEYAAGGELFE--------RICNAGRFSEDEARY----- 102
            HPNI++   V      + ++ EY A G+L E          C+    +    +      
Sbjct: 66  DHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPL 125

Query: 103 ----FFQQLISGQIC------------HRDLKLENTLLDGSPAPRLKICDFGYSKS--SL 144
                 Q  I+ Q+             HRDL   N L+  +    +KI DFG S++  S 
Sbjct: 126 PLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGEN--MVVKIADFGLSRNIYSA 183

Query: 145 LHSRPKSTVGTPA-YIAPEVLSRREYDGKLADVWSCGVTLY 184
            + +       P  ++ PE +    Y  + +DVW+ GV L+
Sbjct: 184 DYYKASENDAIPIRWMPPESIFYNRYTTE-SDVWAYGVVLW 223

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 41.9 bits (98), Expect = 2e-04
 Identities = 53/207 (25%), Positives = 91/207 (43%), Gaps = 26/207 (12%)

Query: 7   MKDIGSGNFGVAR----LMRNKNTKELVAMKYIE--RGHKIDANVAREIINHKQLRHPNI 60
           +K +GSG FG       +    + K  VA+K I+   G +    +   ++    L H  I
Sbjct: 12  LKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYI 71

Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFERI-CNAGRFSEDEARYFFQQLISG-------QI 112
           +R   +    + L +V + +  G L + +  +           +  Q+  G       ++
Sbjct: 72  VRLLGICPGAS-LQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRM 130

Query: 113 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPK----STVGTP-AYIAPEVLSRR 167
            HR+L   N LL  S +  ++I DFG +   LL+   K    S   TP  ++A E +   
Sbjct: 131 VHRNLAARNILLK-SDS-IVQIADFGVA--DLLYPDDKKYFYSEHKTPIKWMALESILFG 186

Query: 168 EYDGKLADVWSCGVTLYVMLV-GAYPF 193
            Y  + +DVWS GVT++ M+  GA P+
Sbjct: 187 RYTHQ-SDVWSYGVTVWEMMSYGAEPY 212

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 41.4 bits (97), Expect = 3e-04
 Identities = 52/245 (21%), Positives = 92/245 (37%), Gaps = 49/245 (20%)

Query: 8   KDIGSGNFG------VARLMRNKNTKELVAMKYIERGHKIDANVA--REIINHKQLRHPN 59
            +IG+G FG        R M     K  V +K +      D  +   +E+  +++L HPN
Sbjct: 1   DEIGNGWFGKVLLGEAHRGMS----KARVVVKELRASATPDEQLLFLQEVQPYRELNHPN 56

Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGEL-----FERICNAGRFSEDEARYFFQQLISG---- 110
           +++     +      +V+E+   G+L       R   A    +D  +    ++ SG    
Sbjct: 57  VLQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWL 116

Query: 111 ---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPA--------YI 159
                 H DL L N  L    +  +KI D+G     L   +                 ++
Sbjct: 117 HQADFIHSDLALRNCQLTADLS--VKIGDYG-----LALEQYPEDYYITKDCHAVPLRWL 169

Query: 160 APEVLSRREYDGKLAD------VWSCGVTLYVML-VGAYPFEDQEDPKNFRKTISRIMAV 212
           APE++  R  D    D      +WS GVT++ +      P+ D  D +  ++    +   
Sbjct: 170 APELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQV---VREQ 226

Query: 213 QYKIP 217
             K+P
Sbjct: 227 DIKLP 231

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 41.5 bits (97), Expect = 3e-04
 Identities = 55/218 (25%), Positives = 99/218 (45%), Gaps = 38/218 (17%)

Query: 3   KYELMKDIGSGNFGVAR----LMRNKNTKELVAMKYIERGHKIDANVAREIINHK----Q 54
           +++ +K +GSG FG       +   +  K  VA+K +       AN  +EI++       
Sbjct: 8   EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDEAYVMAS 65

Query: 55  LRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDE--ARYFFQ---QLIS 109
           + +P++ R   + LT T + ++ +    G L + +    R  +D   ++Y      Q+  
Sbjct: 66  VDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYV----REHKDNIGSQYLLNWCVQIAK 120

Query: 110 G-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPA----- 157
           G       ++ HRDL   N L+       +KI DFG +K  LL +  K            
Sbjct: 121 GMNYLEERRLVHRDLAARNVLVKTPQ--HVKITDFGLAK--LLGADEKEYHAEGGKVPIK 176

Query: 158 YIAPEVLSRREYDGKLADVWSCGVTLY-VMLVGAYPFE 194
           ++A E +  R Y  + +DVWS GVT++ +M  G+ P++
Sbjct: 177 WMALESILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYD 213

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 41.4 bits (97), Expect = 4e-04
 Identities = 42/148 (28%), Positives = 66/148 (44%), Gaps = 17/148 (11%)

Query: 107 LISGQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR--PKSTVGTPA-YIAPEV 163
           L S    HRDL   N LL  +     KICDFG ++     S    K     P  ++APE 
Sbjct: 230 LASKNCIHRDLAARNILL--THGRITKICDFGLARDIRNDSNYVVKGNARLPVKWMAPES 287

Query: 164 LSRREYDGKLADVWSCGVTLYVML-VGAYPFEDQEDPKNFRKTIS---RIMAVQYKIPDY 219
           +    Y  + +DVWS G+ L+ +  +G+ P+        F K I    R+++ +    + 
Sbjct: 288 IFNCVYTFE-SDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRMLSPECAPSEM 346

Query: 220 VHISQDCRNLLSRIFVANPSRRITIKEI 247
             I + C +       A+P +R T K+I
Sbjct: 347 YDIMKSCWD-------ADPLKRPTFKQI 367

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 41.1 bits (96), Expect = 4e-04
 Identities = 67/282 (23%), Positives = 110/282 (39%), Gaps = 51/282 (18%)

Query: 4   YELMKDIGSGNFGVAR---LMRNKNTKELVAMKYIERGHKIDANVA-------REIINHK 53
           + L + +G G FG  R   L     + + VA+K +    K D   +       RE    K
Sbjct: 1   FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKML----KADIFSSSDIEEFLREAACMK 56

Query: 54  QLRHPNIIRFKEVVL---TPTHLAIVM---EYAAGGELFERICNAGRFSEDEARYFFQQL 107
           +  HPN+I+   V L       L I M    +   G+L   +    R  E+      Q L
Sbjct: 57  EFDHPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLL-MSRIGEEPFTLPLQTL 115

Query: 108 I--------------SGQICHRDLKLENTLLDGSPAPRLKIC--DFGYSKS--SLLHSRP 149
           +              S    HRDL   N +L+ +    + +C  DFG SK   S  + R 
Sbjct: 116 VRFMIDIASGMEYLSSKNFIHRDLAARNCMLNEN----MTVCVADFGLSKKIYSGDYYRQ 171

Query: 150 KSTVGTPA-YIAPEVLSRREYDGKLADVWSCGVTLY-VMLVGAYPFEDQEDPKNFRKTIS 207
                 P  ++A E L+   Y    +DVW+ GVT++ +M  G  P+   E+ + +   I 
Sbjct: 172 GCASKLPVKWLALESLADNVYTTH-SDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIK 230

Query: 208 RIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKS 249
                + K P      +D   L+ + +   P  R + + ++ 
Sbjct: 231 ---GNRLKQP--PDCLEDVYELMCQCWSPEPKCRPSFQHLRD 267

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 40.0 bits (93), Expect = 0.001
 Identities = 56/209 (26%), Positives = 85/209 (40%), Gaps = 38/209 (18%)

Query: 9   DIGSGNFGVARLMRNKN-----TKELVAMKYI-ERGHKIDANVAREIINHKQLRHPNIIR 62
           ++G G FG   L    N      K LVA+K + E       +  RE      L+H +I+R
Sbjct: 12  ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVR 71

Query: 63  FKEVVLTPTHLAIVMEYAAGGEL--FER-------------ICNAGRFSEDEARYFFQQL 107
           F  V      L +V EY   G+L  F R                 G+ +  +      Q+
Sbjct: 72  FYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQI 131

Query: 108 ISGQI-------CHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPA--- 157
            SG +        HRDL   N L+       +KI DFG S+   ++S     VG      
Sbjct: 132 ASGMVYLASLHFVHRDLATRNCLVGQGLV--VKIGDFGMSRD--IYSTDYYRVGGRTMLP 187

Query: 158 --YIAPEVLSRREYDGKLADVWSCGVTLY 184
             ++ PE +  R++  + +D+WS GV L+
Sbjct: 188 IRWMPPESILYRKFTTE-SDIWSFGVVLW 215

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 39.9 bits (93), Expect = 0.001
 Identities = 57/231 (24%), Positives = 100/231 (43%), Gaps = 44/231 (19%)

Query: 2   EKYELMKDIGSGNFG-VARL------MRNKNTKELVAMKYIERGHKIDANVAREIINHKQ 54
           ++  L K +G G FG V R           +    VA+K + + +  D ++A ++I+  +
Sbjct: 12  DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKML-KDNATDKDLA-DLISEME 69

Query: 55  L-----RHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERI-----------CNAGRFSED 98
           L     +H NII    V      L +++EYAA G L E +            +  +  E+
Sbjct: 70  LMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEE 129

Query: 99  EARY------------FFQQLISGQICHRDLKLENTLLDGSPAPRLKICDFGYSKS--SL 144
           +  +              + L S +  HRDL   N L+       +KI DFG ++    +
Sbjct: 130 QLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTEDNV--MKIADFGLARGVHDI 187

Query: 145 LHSRPKSTVGTPA-YIAPEVLSRREYDGKLADVWSCGVTLY-VMLVGAYPF 193
            + +  S    P  ++APE L  R Y  + +DVWS G+ ++ +  +G  P+
Sbjct: 188 DYYKKTSNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGILMWEIFTLGGSPY 237

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 39.8 bits (93), Expect = 0.001
 Identities = 44/144 (30%), Positives = 63/144 (43%), Gaps = 23/144 (15%)

Query: 114 HRDLKLENTLL-DGSPAPRLKICDFGYSKSSLLHSR--PKSTVGTPA-YIAPEVLSRREY 169
           HRD+   N LL DG  A   KICDFG ++  +  S    K     P  ++APE +    Y
Sbjct: 235 HRDVAARNVLLTDGRVA---KICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFDCVY 291

Query: 170 DGKLADVWSCGVTLYVML-VGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYV-----HIS 223
             + +DVWS G+ L+ +  +G  P+        F K + R    Q   PD+       I 
Sbjct: 292 TVQ-SDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKR--GYQMSRPDFAPPEIYSIM 348

Query: 224 QDCRNLLSRIFVANPSRRITIKEI 247
           + C NL        P+ R T  +I
Sbjct: 349 KMCWNL-------EPTERPTFSQI 365

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 39.7 bits (93), Expect = 0.001
 Identities = 42/174 (24%), Positives = 65/174 (37%), Gaps = 49/174 (28%)

Query: 55  LRHPNIIRFKEVVLTPTHLAI--------VMEYAAGGEL--FERIC------NAGRFSED 98
           L H NI       L   H+ I        +  Y   G L  F + C      N    S  
Sbjct: 65  LSHQNI-------LPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQ 117

Query: 99  EARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKS---SLLHS- 147
           +  +   Q+  G        + H+D+   N ++D     ++KI D   S+       H  
Sbjct: 118 QLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEEL--QVKITDNALSRDLFPMDYHCL 175

Query: 148 -----RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLY-VMLVGAYPFED 195
                RP        ++A E L  +EY    +DVWS GV L+ +M +G  P+ +
Sbjct: 176 GDNENRPVK------WMALESLVNKEYSSA-SDVWSFGVLLWELMTLGQTPYVE 222

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 38.8 bits (90), Expect = 0.002
 Identities = 62/219 (28%), Positives = 92/219 (42%), Gaps = 44/219 (20%)

Query: 10  IGSGNFGV---ARLMRNKNTKELVAMKYIERGHKID-ANVAREI-INHKQLRHPNIIRFK 64
           IG GNFG    AR+ ++    +    +  E   K D  + A E+ +  K   HPNII   
Sbjct: 15  IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 74

Query: 65  EVVLTPTHLAIVMEYAAGGELFE-----RICNAG-------------------RFSEDEA 100
                  +L + +EYA  G L +     R+                        F+ D A
Sbjct: 75  GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 134

Query: 101 R---YFFQQLISGQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGT-P 156
           R   Y  Q+    Q  HRDL   N L+  +     KI DFG S+   ++   K T+G  P
Sbjct: 135 RGMDYLSQK----QFIHRDLAARNILVGENYVA--KIADFGLSRGQEVYV--KKTMGRLP 186

Query: 157 A-YIAPEVLSRREYDGKLADVWSCGVTLY-VMLVGAYPF 193
             ++A E L+   Y    +DVWS GV L+ ++ +G  P+
Sbjct: 187 VRWMAIESLNYSVYTTN-SDVWSYGVLLWEIVSLGGTPY 224

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta

 Score = 38.4 bits (89), Expect = 0.004
 Identities = 50/215 (23%), Positives = 91/215 (42%), Gaps = 27/215 (12%)

Query: 5   ELMKDIGSG--NFGVARLMRNKNTKELVAMKYIERGHKIDANV---AREIINHKQLRHPN 59
           EL  +IG G  N     L R+  T  LV ++  +  +  + ++     E++     RHPN
Sbjct: 1   ELQVEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPN 60

Query: 60  IIRFKEVVLTPTHLAIV---MEYAAGGELF---------ERICNAGRFSEDEARYFFQQL 107
           I+    V  T + L ++   M Y +   L          E +     F       +  Q 
Sbjct: 61  IMTSWTVFTTGSWLWVISPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQ- 119

Query: 108 ISGQICHRDLKLENTLLDGSPAPRLKICDFGYS------KSSLLHSRPKSTVGTPAYIAP 161
            +G I HR++K  + L+ G     L      YS      K+ +++  P+ +     +++P
Sbjct: 120 -NGYI-HRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSP 177

Query: 162 EVLSRREYDGKL-ADVWSCGVTLYVMLVGAYPFED 195
           E+L +  Y   + +D++S G+T   +  G  PF+D
Sbjct: 178 ELLRQDLYGYNVKSDIYSVGITACELATGRVPFQD 212

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	344
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
KOG0696	683	consensus Serine/threonine protein kinase [Signal	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	100.0
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
KOG0695	593	consensus Serine/threonine protein kinase [Signal	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG1290	590	consensus Serine/threonine protein kinase [Signal	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	100.0
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	100.0
PLN03224	507	probable serine/threonine protein kinase; Provisio	100.0
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	100.0
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
KOG0576	829	consensus Mitogen-activated protein kinase kinase	100.0
KOG1027	903	consensus Serine/threonine protein kinase and endo	100.0
KOG1167	418	consensus Serine/threonine protein kinase of the C	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG1152	772	consensus Signal transduction serine/threonine kin	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.97
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.97
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	99.97
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.97
PLN00181	793	protein SPA1-RELATED; Provisional	99.96
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.95
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.95
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.94
PRK09188	365	serine/threonine protein kinase; Provisional	99.94
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.94
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.93
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.93
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	99.93
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.92
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.92
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.91
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.9
PRK12274	218	serine/threonine protein kinase; Provisional	99.88
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.88
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.87
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.87
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.87
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.86
PRK10345	210	hypothetical protein; Provisional	99.84
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.83
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.82
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.82
smart00090	237	RIO RIO-like kinase.	99.8
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.78
PRK14879	211	serine/threonine protein kinase; Provisional	99.76
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.75
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.74
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.71
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.66
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.66
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.65
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.62
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.62
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.57
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.56
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.48
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.44
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.41
KOG1243	690	consensus Protein kinase [General function predict	99.38
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.28
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.26
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.16
KOG2137	700	consensus Protein kinase [Signal transduction mech	99.02
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	98.99
KOG3087	229	consensus Serine/threonine protein kinase [General	98.98
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	98.95
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	98.91
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.89
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.83
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.74
KOG0576	829	consensus Mitogen-activated protein kinase kinase	98.69
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.66
COG4248	637	Uncharacterized protein with protein kinase and he	98.57
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.54
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.51
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	98.46
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.38
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.37
PRK09902	216	hypothetical protein; Provisional	98.33
PF01636	239	APH: Phosphotransferase enzyme family This family	98.32
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	98.25
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	98.24
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	98.19
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	98.18
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	98.18
PRK09550	401	mtnK methylthioribose kinase; Reviewed	98.16
PLN02876	822	acyl-CoA dehydrogenase	98.15
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	98.08
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	98.05
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	97.98
PRK05231	319	homoserine kinase; Provisional	97.91
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	97.91
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	97.87
PRK10593	297	hypothetical protein; Provisional	97.79
KOG1093	725	consensus Predicted protein kinase (contains TBC a	97.75
KOG2268	465	consensus Serine/threonine protein kinase [Signal	97.53
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	97.48
PLN02236	344	choline kinase	97.48
PLN02756	418	S-methyl-5-thioribose kinase	97.44
KOG2270	520	consensus Serine/threonine protein kinase involved	97.43
PRK12396	409	5-methylribose kinase; Reviewed	97.41
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	97.12
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	97.06
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	97.01
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	96.87
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	96.85
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	96.75
COG2334	331	Putative homoserine kinase type II (protein kinase	96.72
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	96.52
KOG1236	565	consensus Predicted unusual protein kinase [Genera	96.25
PRK11768	325	serine/threonine protein kinase; Provisional	96.25
PF01633	211	Choline_kinase: Choline/ethanolamine kinase; Inter	96.2
PRK06148	1013	hypothetical protein; Provisional	96.05
PRK10271	188	thiK thiamine kinase; Provisional	95.96
PF02958	294	EcKinase: Ecdysteroid kinase; InterPro: IPR004119	95.65
PTZ00384	383	choline kinase; Provisional	95.64
PF04655	253	APH_6_hur: Aminoglycoside/hydroxyurea antibiotic r	95.42

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=8.4e-61  Score=419.56  Aligned_cols=253  Identities=36%  Similarity=0.603  Sum_probs=218.6

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCcc--------ccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEE
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK--------IDANVAREIINHKQLRHPNIIRFKEVVLTPTHL   73 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--------~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~   73 (344)
                      +.|.+.+.||+|+||.|.+|..+.||+.||||++++...        ....+.+|+++|++|+|||||+++++|...+..
T Consensus       172 d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds~  251 (475)
T KOG0615|consen  172 DYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDSS  251 (475)
T ss_pred             ceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCce
Confidence            568999999999999999999999999999999986322        123467999999999999999999999999999


Q ss_pred             EEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCC-CCCCEEEeecCCCcccCC
Q 019195           74 AIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGS-PAPRLKICDFGYSKSSLL  145 (344)
Q Consensus        74 ~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~-~~~~vkL~DFg~a~~~~~  145 (344)
                      |+||||+.||+|++.+...+.+.+...+.+++||+.|       ||+||||||+|||+..+ ....+||+|||+|+....
T Consensus       252 YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK~~g~  331 (475)
T KOG0615|consen  252 YMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLAKVSGE  331 (475)
T ss_pred             EEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchhhcccc
Confidence            9999999999999999999988888878777776655       99999999999999765 334599999999998887


Q ss_pred             CCCCCCCccCCcccCCccccCCCC--CCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhcccc--CCCCCC
Q 019195          146 HSRPKSTVGTPAYIAPEVLSRREY--DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYK--IPDYVH  221 (344)
Q Consensus       146 ~~~~~~~~gt~~y~aPE~~~~~~~--~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~--~~~~~~  221 (344)
                      .....+.||||.|.|||++.+..+  +..++|||||||++|.+++|.+||........+.+   ++..+.+.  .+.+..
T Consensus       332 ~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~e---QI~~G~y~f~p~~w~~  408 (475)
T KOG0615|consen  332 GSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKE---QILKGRYAFGPLQWDR  408 (475)
T ss_pred             ceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHH---HHhcCcccccChhhhh
Confidence            888899999999999999976553  44568999999999999999999988766553333   34444443  356778


Q ss_pred             CCHhHHHHHHHhcccCCCCCCChHHHhcCcccccCC
Q 019195          222 ISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNL  257 (344)
Q Consensus       222 ~s~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~~~  257 (344)
                      +|.++.+||.+||..||++|||++++|+||||+...
T Consensus       409 Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~~  444 (475)
T KOG0615|consen  409 ISEEALDLINWMLVVDPENRPSADEALNHPWFKDAP  444 (475)
T ss_pred             hhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhccc
Confidence            999999999999999999999999999999997653

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1e-58  Score=425.05  Aligned_cols=245  Identities=36%  Similarity=0.630  Sum_probs=225.0

Q ss_pred             CceeeeeeeecCceEEEEEEEcCCCcEEEEEEeec----CccccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEEe
Q 019195            3 KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIER----GHKIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVME   78 (344)
Q Consensus         3 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~----~~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e   78 (344)
                      +|+..+.||+|||+.||.+.+..+|..||+|++.+    .......+.+||++.++|+|||||+++++|++.+++|||+|
T Consensus        19 ~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivLE   98 (592)
T KOG0575|consen   19 RYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVLE   98 (592)
T ss_pred             eeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEEE
Confidence            69999999999999999999999999999999987    44556789999999999999999999999999999999999


Q ss_pred             cCCCCChHHHHHhCCCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccC-CCCCCC
Q 019195           79 YAAGGELFERICNAGRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSL-LHSRPK  150 (344)
Q Consensus        79 ~~~~g~L~~~i~~~~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~-~~~~~~  150 (344)
                      +|..++|..+++.++.++|.+++.+++||+.|       +|+|||||..|+|++.+..  |||+|||+|.... ......
T Consensus        99 LC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~--VKIgDFGLAt~le~~~Erk~  176 (592)
T KOG0575|consen   99 LCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMN--VKIGDFGLATQLEYDGERKK  176 (592)
T ss_pred             ecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCc--EEecccceeeeecCcccccc
Confidence            99999999999999999999999999998876       9999999999999998876  9999999998866 447778


Q ss_pred             CCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCHhHHHHH
Q 019195          151 STVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLL  230 (344)
Q Consensus       151 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li  230 (344)
                      +.||||.|.|||++.+.+. +..+||||+||+||.|+.|+|||..    ..+.+++.++....+.+|.  .+|.++++||
T Consensus       177 TlCGTPNYIAPEVl~k~gH-sfEvDiWSlGcvmYtLL~G~PPFet----k~vkety~~Ik~~~Y~~P~--~ls~~A~dLI  249 (592)
T KOG0575|consen  177 TLCGTPNYIAPEVLNKSGH-SFEVDIWSLGCVMYTLLVGRPPFET----KTVKETYNKIKLNEYSMPS--HLSAEAKDLI  249 (592)
T ss_pred             eecCCCcccChhHhccCCC-CCchhhhhhhhHHHhhhhCCCCccc----chHHHHHHHHHhcCccccc--ccCHHHHHHH
Confidence            8899999999999987765 4559999999999999999999977    4567777788888998888  7899999999


Q ss_pred             HHhcccCCCCCCChHHHhcCcccccC
Q 019195          231 SRIFVANPSRRITIKEIKSHPWFLKN  256 (344)
Q Consensus       231 ~~~L~~dp~~R~s~~ell~hp~~~~~  256 (344)
                      .+||+.||.+|||++++|.|+||...
T Consensus       250 ~~lL~~~P~~Rpsl~~vL~h~Ff~~g  275 (592)
T KOG0575|consen  250 RKLLRPNPSERPSLDEVLDHPFFKSG  275 (592)
T ss_pred             HHHhcCCcccCCCHHHHhcCHhhhCC
Confidence            99999999999999999999999543

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=5.7e-59  Score=404.77  Aligned_cols=253  Identities=28%  Similarity=0.469  Sum_probs=220.6

Q ss_pred             CceeeeeeeecCceEEEEEEEcCCCcEEEEEEeec--CccccHHHHHHHHHHhcCCCCCcceeeEEEEcCC-EEEEEEec
Q 019195            3 KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIER--GHKIDANVAREIINHKQLRHPNIIRFKEVVLTPT-HLAIVMEY   79 (344)
Q Consensus         3 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~--~~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~-~~~lv~e~   79 (344)
                      +.+.++.||+|..|+||+|+++.|++.+|+|++..  ......++.+|+++++.++|||||++|++|..+. .++|+|||
T Consensus        80 dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEY  159 (364)
T KOG0581|consen   80 DLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEY  159 (364)
T ss_pred             HhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhh
Confidence            56778999999999999999999999999999954  3445578999999999999999999999999999 49999999


Q ss_pred             CCCCChHHHHHhCCCCCHHHHHHHHHHHHHC--------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCCCCCC
Q 019195           80 AAGGELFERICNAGRFSEDEARYFFQQLISG--------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKS  151 (344)
Q Consensus        80 ~~~g~L~~~i~~~~~~~~~~~~~~~~ql~~~--------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~~~~~  151 (344)
                      |++|+|..++...++++|..+..++.+++++        +||||||||+|||++..+.  |||||||.++..... ...+
T Consensus       160 MDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGe--VKicDFGVS~~lvnS-~a~t  236 (364)
T KOG0581|consen  160 MDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGE--VKICDFGVSGILVNS-IANT  236 (364)
T ss_pred             cCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCC--EEeccccccHHhhhh-hccc
Confidence            9999999999999999999999998888766        9999999999999987665  999999999865544 6788


Q ss_pred             CccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCC-CChHHHHHHHHHHhh-ccccCCCCCCCCHhHHHH
Q 019195          152 TVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQ-EDPKNFRKTISRIMA-VQYKIPDYVHISQDCRNL  229 (344)
Q Consensus       152 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~-~~~~~~~~~~~~~~~-~~~~~~~~~~~s~~~~~l  229 (344)
                      .+||..|||||.+.+..|..+ +||||||++++||++|++||... .........+..+.. ....+|.. .+|+++++|
T Consensus       237 fvGT~~YMsPERi~g~~Ys~~-sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~lP~~-~fS~ef~~F  314 (364)
T KOG0581|consen  237 FVGTSAYMSPERISGESYSVK-SDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPRLPEG-EFSPEFRSF  314 (364)
T ss_pred             ccccccccChhhhcCCcCCcc-cceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCCCCcc-cCCHHHHHH
Confidence            999999999999999998766 99999999999999999999875 223344555666655 44455553 489999999


Q ss_pred             HHHhcccCCCCCCChHHHhcCcccccCCChh
Q 019195          230 LSRIFVANPSRRITIKEIKSHPWFLKNLPRE  260 (344)
Q Consensus       230 i~~~L~~dp~~R~s~~ell~hp~~~~~~~~~  260 (344)
                      |..||++||.+|||+.|+++|||+++.....
T Consensus       315 V~~CL~Kdp~~R~s~~qLl~Hpfi~~~~~~~  345 (364)
T KOG0581|consen  315 VSCCLRKDPSERPSAKQLLQHPFIKKFEDPN  345 (364)
T ss_pred             HHHHhcCCcccCCCHHHHhcCHHHhhccccc
Confidence            9999999999999999999999998765543

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-56  Score=389.44  Aligned_cols=251  Identities=35%  Similarity=0.604  Sum_probs=214.7

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCcc----ccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEE
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK----IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVM   77 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~   77 (344)
                      ++|+++++||+|+||+||+++.+.|++.||+|++++..-    ..+....|..+|..++||.||+++..|++...+|+|+
T Consensus        25 ~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylVl  104 (357)
T KOG0598|consen   25 DDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLVL  104 (357)
T ss_pred             hheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEEE
Confidence            679999999999999999999999999999999987532    3457889999999999999999999999999999999


Q ss_pred             ecCCCCChHHHHHhCCCCCHHHHHHHHHHHH-------HCCeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCC-CCC
Q 019195           78 EYAAGGELFERICNAGRFSEDEARYFFQQLI-------SGQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH-SRP  149 (344)
Q Consensus        78 e~~~~g~L~~~i~~~~~~~~~~~~~~~~ql~-------~~~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~-~~~  149 (344)
                      ||+.||.|+.+|++.+.|++..++.++..|+       +.|||||||||+|||+|.++  +++|+|||+++..... ...
T Consensus       105 d~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~G--Hi~LtDFgL~k~~~~~~~~t  182 (357)
T KOG0598|consen  105 DYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQG--HIKLTDFGLCKEDLKDGDAT  182 (357)
T ss_pred             eccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCC--cEEEeccccchhcccCCCcc
Confidence            9999999999999999999998887765554       55999999999999998776  4999999999865444 445


Q ss_pred             CCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCHhHHHH
Q 019195          150 KSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL  229 (344)
Q Consensus       150 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  229 (344)
                      .+.|||+.|||||++.+.+|+. ++|+|||||++|+|++|.+||...+....    +..+.......+. ..++.++++|
T Consensus       183 ~tfcGT~eYmAPEil~~~gy~~-~vDWWsLGillYeML~G~pPF~~~~~~~~----~~~I~~~k~~~~p-~~ls~~ardl  256 (357)
T KOG0598|consen  183 RTFCGTPEYMAPEILLGKGYDK-AVDWWSLGILLYEMLTGKPPFYAEDVKKM----YDKILKGKLPLPP-GYLSEEARDL  256 (357)
T ss_pred             ccccCCccccChHHHhcCCCCc-ccchHhHHHHHHHHhhCCCCCcCccHHHH----HHHHhcCcCCCCC-ccCCHHHHHH
Confidence            5679999999999999998865 49999999999999999999998765444    4444444422222 2489999999


Q ss_pred             HHHhcccCCCCCC----ChHHHhcCcccccCCChh
Q 019195          230 LSRIFVANPSRRI----TIKEIKSHPWFLKNLPRE  260 (344)
Q Consensus       230 i~~~L~~dp~~R~----s~~ell~hp~~~~~~~~~  260 (344)
                      |+++|+.||.+|.    ++.++.+||||...-...
T Consensus       257 l~~LL~rdp~~RLg~~~d~~~ik~HpfF~~inW~~  291 (357)
T KOG0598|consen  257 LKKLLKRDPRQRLGGPGDAEEIKRHPFFKGINWEK  291 (357)
T ss_pred             HHHHhccCHHHhcCCCCChHHhhcCcccccCCHHH
Confidence            9999999999996    789999999998764433

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=2.6e-57  Score=383.42  Aligned_cols=253  Identities=28%  Similarity=0.474  Sum_probs=216.4

Q ss_pred             CCCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCcc---ccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEE
Q 019195            1 MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK---IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVM   77 (344)
Q Consensus         1 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~   77 (344)
                      |++|+.+.++|+|+||+||+|+++.||++||||++..+..   ..+-.+|||++|++|+|+|+|.++++|.....+++|+
T Consensus         1 MekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVF   80 (396)
T KOG0593|consen    1 MEKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVF   80 (396)
T ss_pred             CcHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEe
Confidence            7999999999999999999999999999999999976543   3356789999999999999999999999999999999


Q ss_pred             ecCCCCChHHHHHh-CCCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccC-CCCC
Q 019195           78 EYAAGGELFERICN-AGRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSL-LHSR  148 (344)
Q Consensus        78 e~~~~g~L~~~i~~-~~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~-~~~~  148 (344)
                      |||+. ++.+.+.. ...++...++.+++|++.|       ++|||||||+||||..++.  +||||||+|+... +...
T Consensus        81 E~~dh-TvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gv--vKLCDFGFAR~L~~pgd~  157 (396)
T KOG0593|consen   81 EYCDH-TVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGV--VKLCDFGFARTLSAPGDN  157 (396)
T ss_pred             eecch-HHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCc--EEeccchhhHhhcCCcch
Confidence            99976 55555544 4568999999999998876       9999999999999987765  9999999999876 4445


Q ss_pred             CCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhcc---------------
Q 019195          149 PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQ---------------  213 (344)
Q Consensus       149 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~---------------  213 (344)
                      -+.++.|.+|+|||++.+...+++.+||||+||++.||++|.+.|.+.++.+++..+........               
T Consensus       158 YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~G  237 (396)
T KOG0593|consen  158 YTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHG  237 (396)
T ss_pred             hhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceee
Confidence            56678999999999999987778889999999999999999999999999888876665432211               


Q ss_pred             ccCC----------CCCCCCHhHHHHHHHhcccCCCCCCChHHHhcCcccccC
Q 019195          214 YKIP----------DYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKN  256 (344)
Q Consensus       214 ~~~~----------~~~~~s~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~~  256 (344)
                      ..+|          .+..++.-+.+|+++||..||.+|++.+|+|.||||...
T Consensus       238 v~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd~~  290 (396)
T KOG0593|consen  238 VRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFDGF  290 (396)
T ss_pred             eecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHHHHH
Confidence            1122          133467789999999999999999999999999999543

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=6.2e-56  Score=389.17  Aligned_cols=252  Identities=37%  Similarity=0.601  Sum_probs=220.9

Q ss_pred             CCCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCc---cccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEE
Q 019195            1 MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH---KIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVM   77 (344)
Q Consensus         1 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~   77 (344)
                      +.+|.+.+.||+|+||+||+++++.++..||||.+.+..   +..+.+..|+.+|+.++|||||++++++..++.+|+||
T Consensus         9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM   88 (429)
T KOG0595|consen    9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM   88 (429)
T ss_pred             cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence            368999999999999999999999999999999998764   23456789999999999999999999999999999999


Q ss_pred             ecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCC-CC---CCEEEeecCCCcccCCC
Q 019195           78 EYAAGGELFERICNAGRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGS-PA---PRLKICDFGYSKSSLLH  146 (344)
Q Consensus        78 e~~~~g~L~~~i~~~~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~-~~---~~vkL~DFg~a~~~~~~  146 (344)
                      |||.||+|..+|++.+.+++..++.++.||++|       +||||||||+|||+... ..   ..+||+|||+|+.....
T Consensus        89 EyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~~~  168 (429)
T KOG0595|consen   89 EYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQPG  168 (429)
T ss_pred             EeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhhCCch
Confidence            999999999999999999999999999999987       99999999999999764 22   56999999999998888


Q ss_pred             CCCCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCCC-CCCCCHh
Q 019195          147 SRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPD-YVHISQD  225 (344)
Q Consensus       147 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~s~~  225 (344)
                      ....+.||||.|||||++....|+.+ +|+||+|+|+|+|++|++||...+..+.+.    .+.......|. ...+++.
T Consensus       169 ~~a~tlcGSplYMAPEV~~~~~YdAK-ADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~----~~~k~~~~~~~~~~~~s~~  243 (429)
T KOG0595|consen  169 SMAETLCGSPLYMAPEVIMSQQYDAK-ADLWSIGTILYQCLTGKPPFDAETPKELLL----YIKKGNEIVPVLPAELSNP  243 (429)
T ss_pred             hHHHHhhCCccccCHHHHHhccccch-hhHHHHHHHHHHHHhCCCCccccCHHHHHH----HHhccccccCchhhhccCc
Confidence            88888999999999999999998877 899999999999999999998876655444    23223332332 1246777


Q ss_pred             HHHHHHHhcccCCCCCCChHHHhcCcccccCC
Q 019195          226 CRNLLSRIFVANPSRRITIKEIKSHPWFLKNL  257 (344)
Q Consensus       226 ~~~li~~~L~~dp~~R~s~~ell~hp~~~~~~  257 (344)
                      ..+|+..+|+.+|..|.+..+-+.|+++....
T Consensus       244 ~~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~~p  275 (429)
T KOG0595|consen  244 LRELLISLLQRNPKDRISFEDFFDHPFLAANP  275 (429)
T ss_pred             hhhhhhHHHhcCccccCchHHhhhhhhcccCc
Confidence            88999999999999999999999999987664

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.7e-55  Score=399.71  Aligned_cols=248  Identities=52%  Similarity=0.845  Sum_probs=224.3

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecC-----c-cccHHHHHHHHHHhcCC-CCCcceeeEEEEcCCEEE
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERG-----H-KIDANVAREIINHKQLR-HPNIIRFKEVVLTPTHLA   74 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~-~~~~~~~~ei~~l~~l~-h~niv~~~~~~~~~~~~~   74 (344)
                      .+|++.+.||+|+||+|+.|.+..+++.||+|++.+.     . .....+.+|+.+++.++ ||||+++++++.....+|
T Consensus        17 g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~~~   96 (370)
T KOG0583|consen   17 GKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTKIY   96 (370)
T ss_pred             CceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCeEE
Confidence            5899999999999999999999999999999987763     1 23456779999999998 999999999999999999


Q ss_pred             EEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCccc-CCC
Q 019195           75 IVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSS-LLH  146 (344)
Q Consensus        75 lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~-~~~  146 (344)
                      +|||||.||+|+++|.+.+++.+.+++.+++||++|       ||+||||||+|||++.+. +++||+|||++... ...
T Consensus        97 ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~-~~~Kl~DFG~s~~~~~~~  175 (370)
T KOG0583|consen   97 IVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNE-GNLKLSDFGLSAISPGED  175 (370)
T ss_pred             EEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCC-CCEEEeccccccccCCCC
Confidence            999999999999999999999999999999999987       999999999999998873 45999999999877 456


Q ss_pred             CCCCCCccCCcccCCccccCCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCHh
Q 019195          147 SRPKSTVGTPAYIAPEVLSRRE-YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQD  225 (344)
Q Consensus       147 ~~~~~~~gt~~y~aPE~~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~  225 (344)
                      ....+.|||+.|+|||++.+.. |.+.++||||+||+||.|++|+.||...+...    ....+....+.+|.+.. |++
T Consensus       176 ~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~----l~~ki~~~~~~~p~~~~-S~~  250 (370)
T KOG0583|consen  176 GLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPN----LYRKIRKGEFKIPSYLL-SPE  250 (370)
T ss_pred             CcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHH----HHHHHhcCCccCCCCcC-CHH
Confidence            6778899999999999999988 99999999999999999999999999855443    34446778888888544 999


Q ss_pred             HHHHHHHhcccCCCCCCChHHHhcCccccc
Q 019195          226 CRNLLSRIFVANPSRRITIKEIKSHPWFLK  255 (344)
Q Consensus       226 ~~~li~~~L~~dp~~R~s~~ell~hp~~~~  255 (344)
                      +++||.+||..||.+|+|+.+++.||||+.
T Consensus       251 ~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~  280 (370)
T KOG0583|consen  251 ARSLIEKMLVPDPSTRITLLEILEHPWFQK  280 (370)
T ss_pred             HHHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence            999999999999999999999999999987

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=1.6e-55  Score=398.18  Aligned_cols=257  Identities=34%  Similarity=0.573  Sum_probs=220.6

Q ss_pred             CCCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCcc----ccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEE
Q 019195            1 MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK----IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIV   76 (344)
Q Consensus         1 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv   76 (344)
                      +++|+++++||+|+||.||+|+.+.||.+||+|+++++..    ....++.|-.+|....+|+||++|..|++...+|||
T Consensus       140 ~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLi  219 (550)
T KOG0605|consen  140 LDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLI  219 (550)
T ss_pred             cccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEE
Confidence            4789999999999999999999999999999999998653    335688899999999999999999999999999999


Q ss_pred             EecCCCCChHHHHHhCCCCCHHHHHHHHHHHHH-------CCeeecCCCCCCeEecCCCCCCEEEeecCCCcccCC----
Q 019195           77 MEYAAGGELFERICNAGRFSEDEARYFFQQLIS-------GQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLL----  145 (344)
Q Consensus        77 ~e~~~~g~L~~~i~~~~~~~~~~~~~~~~ql~~-------~~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~----  145 (344)
                      |||++||++..+|.+.+.|++..++.++.+++-       .|+|||||||+|+|||..+  ++||+||||+.....    
T Consensus       220 MEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~G--HiKLSDFGLs~gl~~~~~~  297 (550)
T KOG0605|consen  220 MEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKG--HIKLSDFGLSTGLDKKHRI  297 (550)
T ss_pred             EEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCC--CEeeccccccchhhhhhhh
Confidence            999999999999999999999999998777554       4999999999999997766  599999999852110    


Q ss_pred             --------------------CC-----C-------------------CCCCccCCcccCCccccCCCCCCcchhHHHHHH
Q 019195          146 --------------------HS-----R-------------------PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGV  181 (344)
Q Consensus       146 --------------------~~-----~-------------------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~  181 (344)
                                          ..     .                   ..+++|||-|||||++.+.+|. ..+|+|||||
T Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~-~~cDwWSLG~  376 (550)
T KOG0605|consen  298 ESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYG-KECDWWSLGC  376 (550)
T ss_pred             hhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCC-ccccHHHHHH
Confidence                                00     0                   0234799999999999999975 4599999999


Q ss_pred             HHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCHhHHHHHHHhcccCCCCCC---ChHHHhcCcccccCCC
Q 019195          182 TLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRI---TIKEIKSHPWFLKNLP  258 (344)
Q Consensus       182 il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~---s~~ell~hp~~~~~~~  258 (344)
                      |+|||+.|.+||...+..+.+.+++..  ...+.+|....+++++++||.+||+ ||.+|.   ++.||.+||||+....
T Consensus       377 ImyEmLvGyPPF~s~tp~~T~rkI~nw--r~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~HPfF~~v~W  453 (550)
T KOG0605|consen  377 IMYEMLVGYPPFCSETPQETYRKIVNW--RETLKFPEEVDLSDEAKDLITRLLC-DPENRLGSKGAEEIKKHPFFKGVDW  453 (550)
T ss_pred             HHHHHHhCCCCCCCCCHHHHHHHHHHH--hhhccCCCcCcccHHHHHHHHHHhc-CHHHhcCcccHHHHhcCCccccCCc
Confidence            999999999999998887777776653  3346677777889999999999999 999999   5899999999988766


Q ss_pred             hhhHH
Q 019195          259 RELTE  263 (344)
Q Consensus       259 ~~~~~  263 (344)
                      ..+..
T Consensus       454 ~~l~~  458 (550)
T KOG0605|consen  454 DHLRE  458 (550)
T ss_pred             chhhc
Confidence            54433

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.6e-55  Score=406.06  Aligned_cols=246  Identities=40%  Similarity=0.738  Sum_probs=230.0

Q ss_pred             CceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecC----ccccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEEe
Q 019195            3 KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERG----HKIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVME   78 (344)
Q Consensus         3 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e   78 (344)
                      =|++.+.||.|+.|.|.+|++..||+.+|||++.+.    ......+.+||.+|+.+.||||+++|++|.+..++|+|+|
T Consensus        13 pwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlE   92 (786)
T KOG0588|consen   13 PWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLE   92 (786)
T ss_pred             ceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEE
Confidence            489999999999999999999999999999999764    2345679999999999999999999999999999999999


Q ss_pred             cCCCCChHHHHHhCCCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCCCCCC
Q 019195           79 YAAGGELFERICNAGRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKS  151 (344)
Q Consensus        79 ~~~~g~L~~~i~~~~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~~~~~  151 (344)
                      |++||.|++++...+++++.+.+++++||+.+       +|+||||||+|+|+|..+.  +||+|||+|.....+....+
T Consensus        93 yv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~n--IKIADFGMAsLe~~gklLeT  170 (786)
T KOG0588|consen   93 YVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNN--IKIADFGMASLEVPGKLLET  170 (786)
T ss_pred             ecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccC--EeeeccceeecccCCccccc
Confidence            99999999999999999999999999999987       9999999999999988776  99999999998888888899


Q ss_pred             CccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCHhHHHHHH
Q 019195          152 TVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLS  231 (344)
Q Consensus       152 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~  231 (344)
                      .||+|.|.|||++.+.+|++.++||||.|||||.|++|+.||.+    .+...++.++..+.+.+|.  ++++++++||.
T Consensus       171 SCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdD----dNir~LLlKV~~G~f~MPs--~Is~eaQdLLr  244 (786)
T KOG0588|consen  171 SCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDD----DNIRVLLLKVQRGVFEMPS--NISSEAQDLLR  244 (786)
T ss_pred             cCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCC----ccHHHHHHHHHcCcccCCC--cCCHHHHHHHH
Confidence            99999999999999999999999999999999999999999985    3556677778889999996  78999999999


Q ss_pred             HhcccCCCCCCChHHHhcCcccccC
Q 019195          232 RIFVANPSRRITIKEIKSHPWFLKN  256 (344)
Q Consensus       232 ~~L~~dp~~R~s~~ell~hp~~~~~  256 (344)
                      +||..||.+|+|.+++++|||+.+.
T Consensus       245 ~ml~VDp~~RiT~~eI~kHP~l~g~  269 (786)
T KOG0588|consen  245 RMLDVDPSTRITTEEILKHPFLSGY  269 (786)
T ss_pred             HHhccCccccccHHHHhhCchhhcC
Confidence            9999999999999999999999765

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4e-56  Score=396.37  Aligned_cols=254  Identities=29%  Similarity=0.502  Sum_probs=224.0

Q ss_pred             CCCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCccc--cHHHHHHHHHHhcCC-CCCcceeeEEEEcCC-EEEEE
Q 019195            1 MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKI--DANVAREIINHKQLR-HPNIIRFKEVVLTPT-HLAIV   76 (344)
Q Consensus         1 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~ei~~l~~l~-h~niv~~~~~~~~~~-~~~lv   76 (344)
                      |+||.++++||.|+||.||+|+.+.++..||||.+++....  +..-+||+..|++|+ |||||++.+++.+.+ .+|+|
T Consensus         9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fV   88 (538)
T KOG0661|consen    9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFV   88 (538)
T ss_pred             HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeee
Confidence            68999999999999999999999999999999999875432  345679999999998 999999999999988 99999


Q ss_pred             EecCCCCChHHHHHhCC-CCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCCC
Q 019195           77 MEYAAGGELFERICNAG-RFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR  148 (344)
Q Consensus        77 ~e~~~~g~L~~~i~~~~-~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~~  148 (344)
                      |||| ..+|+++++.++ .|++..++.|++||+++       |+.|||+||+|||+..+..  |||+|||+|+.......
T Consensus        89 fE~M-d~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~--iKiaDFGLARev~SkpP  165 (538)
T KOG0661|consen   89 FEFM-DCNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDV--IKIADFGLAREVRSKPP  165 (538)
T ss_pred             HHhh-hhhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccce--eEecccccccccccCCC
Confidence            9999 679999998764 59999999999998877       9999999999999986554  99999999999988888


Q ss_pred             CCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhc---------------c
Q 019195          149 PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAV---------------Q  213 (344)
Q Consensus       149 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~---------------~  213 (344)
                      -+.++.|.+|+|||++.+..+++.++||||+|||++|+.+-++.|.+.+..+++.++..-+...               .
T Consensus       166 YTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~~mn  245 (538)
T KOG0661|consen  166 YTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLASAMN  245 (538)
T ss_pred             cchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHHHHhc
Confidence            8999999999999999998888888999999999999999999999998888877766544322               2


Q ss_pred             ccCCCC---------CCCCHhHHHHHHHhcccCCCCCCChHHHhcCcccccCC
Q 019195          214 YKIPDY---------VHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNL  257 (344)
Q Consensus       214 ~~~~~~---------~~~s~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~~~  257 (344)
                      +++|..         .+.++++.+||.+||.+||.+||||.|+|+||||+...
T Consensus       246 f~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~~  298 (538)
T KOG0661|consen  246 FRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQVGR  298 (538)
T ss_pred             cCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCccccccc
Confidence            333332         23688999999999999999999999999999997643

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-54  Score=366.46  Aligned_cols=247  Identities=34%  Similarity=0.622  Sum_probs=220.6

Q ss_pred             CCCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCcc----ccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEE
Q 019195            1 MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK----IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIV   76 (344)
Q Consensus         1 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv   76 (344)
                      +++|+.++.||.|+||.|.+++.+.+|..||+|++.+...    +.+...+|..+|+.+.||.++++++.|.+.+.+|+|
T Consensus        43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymv  122 (355)
T KOG0616|consen   43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMV  122 (355)
T ss_pred             hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEE
Confidence            4789999999999999999999999999999999987543    235677899999999999999999999999999999


Q ss_pred             EecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCCCC
Q 019195           77 MEYAAGGELFERICNAGRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP  149 (344)
Q Consensus        77 ~e~~~~g~L~~~i~~~~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~~~  149 (344)
                      |||++||.|+.++++.++|++..++.++.|++.|       +|++|||||+|||+|.++.  +||+|||+|+....  ..
T Consensus       123 meyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~--iKitDFGFAK~v~~--rT  198 (355)
T KOG0616|consen  123 MEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGH--IKITDFGFAKRVSG--RT  198 (355)
T ss_pred             EeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCc--EEEEeccceEEecC--cE
Confidence            9999999999999999999999999887776655       9999999999999987775  99999999986533  36


Q ss_pred             CCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCHhHHHH
Q 019195          150 KSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL  229 (344)
Q Consensus       150 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  229 (344)
                      .+.||||.|+|||++...+|. +++|+|||||++|||+.|.+||...+.    ..+..+|....+.+|.  .+++++++|
T Consensus       199 ~TlCGTPeYLAPEii~sk~yn-kavDWWalGVLIYEMlaG~pPF~~~~~----~~iY~KI~~~~v~fP~--~fs~~~kdL  271 (355)
T KOG0616|consen  199 WTLCGTPEYLAPEIIQSKGYN-KAVDWWALGVLIYEMLAGYPPFYDDNP----IQIYEKILEGKVKFPS--YFSSDAKDL  271 (355)
T ss_pred             EEecCCccccChHHhhcCCCC-cchhHHHHHHHHHHHHcCCCCCcCCCh----HHHHHHHHhCcccCCc--ccCHHHHHH
Confidence            778999999999999999975 569999999999999999999998776    4566677778888887  679999999


Q ss_pred             HHHhcccCCCCCC-----ChHHHhcCcccccCCC
Q 019195          230 LSRIFVANPSRRI-----TIKEIKSHPWFLKNLP  258 (344)
Q Consensus       230 i~~~L~~dp~~R~-----s~~ell~hp~~~~~~~  258 (344)
                      |+++|+.|-.+|.     ...++.+||||.....
T Consensus       272 l~~LL~vD~t~R~gnlknG~~dIk~H~wF~~v~W  305 (355)
T KOG0616|consen  272 LKKLLQVDLTKRFGNLKNGVEDIKNHPWFKGVDW  305 (355)
T ss_pred             HHHHHhhhhHhhhcCcCCCccccccCcccccccH
Confidence            9999999999995     5789999999986543

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-54  Score=392.17  Aligned_cols=250  Identities=33%  Similarity=0.554  Sum_probs=217.2

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCcc----ccHHHHHHHHHHhcC-CCCCcceeeEEEEcCCEEEEE
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK----IDANVAREIINHKQL-RHPNIIRFKEVVLTPTHLAIV   76 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~ei~~l~~l-~h~niv~~~~~~~~~~~~~lv   76 (344)
                      ++|...+.||.|+|++|++|..+.+++.||||++.+...    ..+-+.+|-.+|.+| .||.|++++..|+++..+|+|
T Consensus        73 ~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFv  152 (604)
T KOG0592|consen   73 NDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYFV  152 (604)
T ss_pred             hhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEEE
Confidence            579999999999999999999999999999999987432    224466788889999 799999999999999999999


Q ss_pred             EecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCC--
Q 019195           77 MEYAAGGELFERICNAGRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS--  147 (344)
Q Consensus        77 ~e~~~~g~L~~~i~~~~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~--  147 (344)
                      +||+++|+|.++|++.+.|++.+.+.++.+|+.+       |||||||||+|||+|.++  ++||+|||.|+......  
T Consensus       153 Le~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dm--hikITDFGsAK~l~~~~~~  230 (604)
T KOG0592|consen  153 LEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDG--HIKITDFGSAKILSPSQKS  230 (604)
T ss_pred             EEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCC--cEEEeeccccccCChhhcc
Confidence            9999999999999999999999999887777665       999999999999998776  59999999987543221  


Q ss_pred             ------------CCCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhcccc
Q 019195          148 ------------RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYK  215 (344)
Q Consensus       148 ------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  215 (344)
                                  ...+++||..|.+||++...... +.+|||+||||+|+|+.|.+||.+.+...    ++++++...+.
T Consensus       231 ~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~-~~sDiWAlGCilyQmlaG~PPFra~Neyl----iFqkI~~l~y~  305 (604)
T KOG0592|consen  231 QENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAG-PSSDLWALGCILYQMLAGQPPFRAANEYL----IFQKIQALDYE  305 (604)
T ss_pred             ccCccCcccccCcccceeeeecccCHHHhcCCCCC-cccchHHHHHHHHHHhcCCCCCccccHHH----HHHHHHHhccc
Confidence                        12457899999999999877764 55999999999999999999999987754    45556677888


Q ss_pred             CCCCCCCCHhHHHHHHHhcccCCCCCCChHHHhcCcccccCCChh
Q 019195          216 IPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLPRE  260 (344)
Q Consensus       216 ~~~~~~~s~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~~~~~~  260 (344)
                      +|.  ++++.+++||+++|..||.+|+|+.+|.+||||...-...
T Consensus       306 fp~--~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~Vdw~n  348 (604)
T KOG0592|consen  306 FPE--GFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEGVDWEN  348 (604)
T ss_pred             CCC--CCCHHHHHHHHHHHccCccccccHHHHhhCcccccCChhh
Confidence            876  7899999999999999999999999999999998764433

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-53  Score=370.29  Aligned_cols=261  Identities=30%  Similarity=0.436  Sum_probs=217.5

Q ss_pred             CceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCcc---ccHHHHHHHHHHhcCCCCCcceeeEEEEcC-----CEEE
Q 019195            3 KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK---IDANVAREIINHKQLRHPNIIRFKEVVLTP-----THLA   74 (344)
Q Consensus         3 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~ei~~l~~l~h~niv~~~~~~~~~-----~~~~   74 (344)
                      +|..++.||+|+||+|+.|.++.+|+.||||++.....   ...+..||+++|+.++|+||+.+.+++..+     +.+|
T Consensus        23 ~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvY  102 (359)
T KOG0660|consen   23 YYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVY  102 (359)
T ss_pred             eecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeE
Confidence            56678999999999999999999999999999985443   336788999999999999999999999762     5689


Q ss_pred             EEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHH-------CCeeecCCCCCCeEecCCCCCCEEEeecCCCcccCC--
Q 019195           75 IVMEYAAGGELFERICNAGRFSEDEARYFFQQLIS-------GQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLL--  145 (344)
Q Consensus        75 lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~ql~~-------~~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~--  145 (344)
                      +|+|+| +.+|...|+.++.++..+++.+++|++.       |+|+||||||+|+|++.+..  +||||||+|+....  
T Consensus       103 iV~elM-etDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~--lKI~DFGLAR~~~~~~  179 (359)
T KOG0660|consen  103 LVFELM-ETDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCD--LKICDFGLARYLDKFF  179 (359)
T ss_pred             EehhHH-hhHHHHHHHcCccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCC--EEeccccceeeccccC
Confidence            999999 6799999988888999999999888775       59999999999999988876  99999999997654  


Q ss_pred             -CCCCCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhh-------------
Q 019195          146 -HSRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMA-------------  211 (344)
Q Consensus       146 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~-------------  211 (344)
                       ....+.++-|.+|+|||++.....+++++||||+|||++||++|++.|.+.+...++..++.-+..             
T Consensus       180 ~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~  259 (359)
T KOG0660|consen  180 EDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSEK  259 (359)
T ss_pred             cccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccHH
Confidence             344567789999999999988777788899999999999999999999988766665544332111             


Q ss_pred             -------cccc--CC---CCCCCCHhHHHHHHHhcccCCCCCCChHHHhcCcccccCCChhhHHHHH
Q 019195          212 -------VQYK--IP---DYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLPRELTETAQ  266 (344)
Q Consensus       212 -------~~~~--~~---~~~~~s~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~~~~~~~~~~~~  266 (344)
                             .+..  .|   .+.+.++.+.+|+.+||+.||.+|+|++|+|+|||+.....++..+.++
T Consensus       260 ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hdp~dEP~~~  326 (359)
T KOG0660|consen  260 ARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHDPEDEPVCQ  326 (359)
T ss_pred             HHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcCCccCCCCC
Confidence                   1111  11   2346899999999999999999999999999999998877665544333

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=9.9e-53  Score=349.73  Aligned_cols=253  Identities=30%  Similarity=0.462  Sum_probs=219.3

Q ss_pred             CCCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCccc---cHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEE
Q 019195            1 MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKI---DANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVM   77 (344)
Q Consensus         1 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~   77 (344)
                      +++|..++.||+|.||+||+|++..||+.||||++......   .....|||+.|+.++|+||+.++++|...+.+.+|+
T Consensus         1 ~~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVf   80 (318)
T KOG0659|consen    1 MDRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVF   80 (318)
T ss_pred             CchhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEE
Confidence            47999999999999999999999999999999999875443   568999999999999999999999999999999999


Q ss_pred             ecCCCCChHHHHHhC-CCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCCCC
Q 019195           78 EYAAGGELFERICNA-GRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP  149 (344)
Q Consensus        78 e~~~~g~L~~~i~~~-~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~~~  149 (344)
                      ||++ .+|...|+.. ..++..+++.++.+++.+       .|+||||||.|+||+.++.  +||+|||+|+........
T Consensus        81 Efm~-tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~--lKiADFGLAr~f~~p~~~  157 (318)
T KOG0659|consen   81 EFMP-TDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQ--LKIADFGLARFFGSPNRI  157 (318)
T ss_pred             Eecc-ccHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCc--EEeecccchhccCCCCcc
Confidence            9995 5999998765 468899999998776655       9999999999999987775  999999999976655443


Q ss_pred             C-CCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhcccc-------CCC---
Q 019195          150 K-STVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYK-------IPD---  218 (344)
Q Consensus       150 ~-~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~-------~~~---  218 (344)
                      . ..+-|.+|+|||++.|...++..+||||+|||++||+.|.+-|.+.++.+++..++........+       +|+   
T Consensus       158 ~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~  237 (318)
T KOG0659|consen  158 QTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVK  237 (318)
T ss_pred             cccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHHH
Confidence            3 34799999999999998888888999999999999999999999999999998888766544321       111   


Q ss_pred             ------------CCCCCHhHHHHHHHhcccCCCCCCChHHHhcCcccccC
Q 019195          219 ------------YVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKN  256 (344)
Q Consensus       219 ------------~~~~s~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~~  256 (344)
                                  +...++++.+|+.+||..||.+|+|+.|+|+|+||...
T Consensus       238 ~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~~  287 (318)
T KOG0659|consen  238 IQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKSL  287 (318)
T ss_pred             HhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhcC
Confidence                        12256788999999999999999999999999999864

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=1.6e-53  Score=386.24  Aligned_cols=245  Identities=34%  Similarity=0.631  Sum_probs=218.0

Q ss_pred             CCCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCcccc---HHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEE
Q 019195            1 MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKID---ANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVM   77 (344)
Q Consensus         1 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~   77 (344)
                      |++|.+.+.||+|+||.||+++.+.+.+.||+|.+.+.....   ..+.+|+++++.++|||||.++++|+...++|+|+
T Consensus         1 me~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVt   80 (808)
T KOG0597|consen    1 MEQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVT   80 (808)
T ss_pred             CcchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEe
Confidence            799999999999999999999999999999999998866544   56889999999999999999999999999999999


Q ss_pred             ecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCCCC-
Q 019195           78 EYAAGGELFERICNAGRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP-  149 (344)
Q Consensus        78 e~~~~g~L~~~i~~~~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~~~-  149 (344)
                      |||.| +|+.++...+.++++.++.+..+|++|       +|+|||+||.|||++..+.  +|+||||+|+........ 
T Consensus        81 e~a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~--~KlcdFg~Ar~m~~~t~vl  157 (808)
T KOG0597|consen   81 EYAVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGT--LKLCDFGLARAMSTNTSVL  157 (808)
T ss_pred             hhhhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCc--eeechhhhhhhcccCceee
Confidence            99976 999999999999999999998777766       9999999999999987765  999999999976554433 


Q ss_pred             CCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCHhHHHH
Q 019195          150 KSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL  229 (344)
Q Consensus       150 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  229 (344)
                      +...|||.|||||++.+..|+.. +|+||||||+|||++|++||...    .+...++.|...+...|.  ..|+.+.+|
T Consensus       158 tsikGtPlYmAPElv~e~pyd~~-sDlWslGcilYE~~~G~PPF~a~----si~~Lv~~I~~d~v~~p~--~~S~~f~nf  230 (808)
T KOG0597|consen  158 TSIKGTPLYMAPELVEEQPYDHT-SDLWSLGCILYELYVGQPPFYAR----SITQLVKSILKDPVKPPS--TASSSFVNF  230 (808)
T ss_pred             eeccCcccccCHHHHcCCCccch-hhHHHHHHHHHHHhcCCCCchHH----HHHHHHHHHhcCCCCCcc--cccHHHHHH
Confidence            44569999999999999988766 99999999999999999999764    445556666666666665  789999999


Q ss_pred             HHHhcccCCCCCCChHHHhcCccccc
Q 019195          230 LSRIFVANPSRRITIKEIKSHPWFLK  255 (344)
Q Consensus       230 i~~~L~~dp~~R~s~~ell~hp~~~~  255 (344)
                      +..+|.+||.+|+|..+++.|||.++
T Consensus       231 l~gLL~kdP~~RltW~~Ll~HpF~k~  256 (808)
T KOG0597|consen  231 LQGLLIKDPAQRLTWTDLLGHPFWKG  256 (808)
T ss_pred             HHHHhhcChhhcccHHHHhcChHHhh
Confidence            99999999999999999999999654

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-54  Score=355.86  Aligned_cols=250  Identities=33%  Similarity=0.614  Sum_probs=218.7

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecC---ccccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEEe
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERG---HKIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVME   78 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e   78 (344)
                      +.|.+.+.||+|.|++||++.+..+|+.+|+|+++..   ....+.+.+|+++-+.|+|||||++.+.+.+....|+|+|
T Consensus        11 d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvFe   90 (355)
T KOG0033|consen   11 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFD   90 (355)
T ss_pred             hhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEEe
Confidence            5799999999999999999999999999999988642   2234678999999999999999999999999999999999


Q ss_pred             cCCCCChHHHHHhCCCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecC-CCCCCEEEeecCCCcccCCCCCCC
Q 019195           79 YAAGGELFERICNAGRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDG-SPAPRLKICDFGYSKSSLLHSRPK  150 (344)
Q Consensus        79 ~~~~g~L~~~i~~~~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~-~~~~~vkL~DFg~a~~~~~~~~~~  150 (344)
                      ++.|++|..-|.++..+++..+-.+++||+.+       ||||||+||.|+|+.+ ....-+||+|||+|.....+....
T Consensus        91 ~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~g~~~~  170 (355)
T KOG0033|consen   91 LVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVNDGEAWH  170 (355)
T ss_pred             cccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeCCccccc
Confidence            99999999888888888999888888888876       9999999999999953 222349999999998877666777


Q ss_pred             CCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccC--CCCCCCCHhHHH
Q 019195          151 STVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKI--PDYVHISQDCRN  228 (344)
Q Consensus       151 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~s~~~~~  228 (344)
                      ..+|||.|||||++...+|..+ +|||+.|+|+|-|+.|.+||.+.+....+    .+++...+..  |.+..+++++++
T Consensus       171 G~~GtP~fmaPEvvrkdpy~kp-vDiW~cGViLfiLL~G~~PF~~~~~~rly----e~I~~g~yd~~~~~w~~is~~Ak~  245 (355)
T KOG0033|consen  171 GFAGTPGYLSPEVLKKDPYSKP-VDIWACGVILYILLVGYPPFWDEDQHRLY----EQIKAGAYDYPSPEWDTVTPEAKS  245 (355)
T ss_pred             cccCCCcccCHHHhhcCCCCCc-chhhhhhHHHHHHHhCCCCCCCccHHHHH----HHHhccccCCCCcccCcCCHHHHH
Confidence            8899999999999999888655 99999999999999999999986654444    4555555544  468889999999


Q ss_pred             HHHHhcccCCCCCCChHHHhcCcccccC
Q 019195          229 LLSRIFVANPSRRITIKEIKSHPWFLKN  256 (344)
Q Consensus       229 li~~~L~~dp~~R~s~~ell~hp~~~~~  256 (344)
                      ||++||..||.+|+|+.|+|+|||+.+.
T Consensus       246 LvrrML~~dP~kRIta~EAL~HpWi~~r  273 (355)
T KOG0033|consen  246 LIRRMLTVNPKKRITADEALKHPWICNR  273 (355)
T ss_pred             HHHHHhccChhhhccHHHHhCCchhcch
Confidence            9999999999999999999999999764

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.8e-54  Score=361.61  Aligned_cols=235  Identities=32%  Similarity=0.521  Sum_probs=199.3

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecC---ccccHHHHHHHHHHhcCCCCCcceeeE-EEEcCCE-EEEE
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERG---HKIDANVAREIINHKQLRHPNIIRFKE-VVLTPTH-LAIV   76 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~ei~~l~~l~h~niv~~~~-~~~~~~~-~~lv   76 (344)
                      .+|+++++||+|+||.||++++..+|..+|.|.+.-.   .+.......|+.+|++|+|||||++++ .|..++. ++||
T Consensus        19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv   98 (375)
T KOG0591|consen   19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV   98 (375)
T ss_pred             HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence            3599999999999999999999999999999998743   233456889999999999999999998 5555555 8999


Q ss_pred             EecCCCCChHHHHHh----CCCCCHHHHHHHHHHHHHC---------C--eeecCCCCCCeEecCCCCCCEEEeecCCCc
Q 019195           77 MEYAAGGELFERICN----AGRFSEDEARYFFQQLISG---------Q--ICHRDLKLENTLLDGSPAPRLKICDFGYSK  141 (344)
Q Consensus        77 ~e~~~~g~L~~~i~~----~~~~~~~~~~~~~~ql~~~---------~--iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~  141 (344)
                      ||||.+|+|..+|+.    .+.+++..+|.++.||+.|         .  |+||||||.||+++.++.  +||+|||+++
T Consensus        99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gv--vKLGDfGL~r  176 (375)
T KOG0591|consen   99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGV--VKLGDFGLGR  176 (375)
T ss_pred             HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCc--eeeccchhHh
Confidence            999999999999864    4569999999999999987         3  999999999999987765  9999999998


Q ss_pred             ccCCC-CCCCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhcccc-CCCC
Q 019195          142 SSLLH-SRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYK-IPDY  219 (344)
Q Consensus       142 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~-~~~~  219 (344)
                      ..... ....+.+|||.||+||.+.+.+|+.+ |||||+||++|||+.-++||.+.    ++....++|..+.+. .|. 
T Consensus       177 ~l~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~k-SDiWslGCllyEMcaL~~PF~g~----n~~~L~~KI~qgd~~~~p~-  250 (375)
T KOG0591|consen  177 FLSSKTTFAHSLVGTPYYMSPERIHESGYNFK-SDIWSLGCLLYEMCALQSPFYGD----NLLSLCKKIEQGDYPPLPD-  250 (375)
T ss_pred             HhcchhHHHHhhcCCCcccCHHHHhcCCCCcc-hhHHHHHHHHHHHHhcCCCcccc----cHHHHHHHHHcCCCCCCcH-
Confidence            65433 33456789999999999999998755 99999999999999999999986    344555555556553 331 


Q ss_pred             CCCCHhHHHHHHHhcccCCCCCCCh
Q 019195          220 VHISQDCRNLLSRIFVANPSRRITI  244 (344)
Q Consensus       220 ~~~s~~~~~li~~~L~~dp~~R~s~  244 (344)
                      ..+|.++..||..|++.||..||+.
T Consensus       251 ~~YS~~l~~li~~ci~vd~~~RP~t  275 (375)
T KOG0591|consen  251 EHYSTDLRELINMCIAVDPEQRPDT  275 (375)
T ss_pred             HHhhhHHHHHHHHHccCCcccCCCc
Confidence            3689999999999999999999985

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.7e-52  Score=374.38  Aligned_cols=251  Identities=26%  Similarity=0.452  Sum_probs=217.6

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCc---cccHHHHHHHHHHhcCCCCCcceeeEEEEcC--CEEEEE
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH---KIDANVAREIINHKQLRHPNIIRFKEVVLTP--THLAIV   76 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~--~~~~lv   76 (344)
                      +.|+.+++||+|.||.||+|++..+|+.||+|++..+.   ....-..|||.+|++|+||||+++.++..+.  ..+|||
T Consensus       117 ~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlV  196 (560)
T KOG0600|consen  117 DSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLV  196 (560)
T ss_pred             HHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEE
Confidence            46899999999999999999999999999999998754   3345688999999999999999999999877  789999


Q ss_pred             EecCCCCChHHHHHhC-CCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCC-
Q 019195           77 MEYAAGGELFERICNA-GRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS-  147 (344)
Q Consensus        77 ~e~~~~g~L~~~i~~~-~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~-  147 (344)
                      +|||+. +|.-++... -+|++.+|+.+++||+++       ||+|||||.+|||||.++.  +||+|||+|+...... 
T Consensus       197 FeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~--LKiaDFGLAr~y~~~~~  273 (560)
T KOG0600|consen  197 FEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGV--LKIADFGLARFYTPSGS  273 (560)
T ss_pred             Eecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCC--EEeccccceeeccCCCC
Confidence            999965 888887663 479999999999999876       9999999999999987765  9999999999654443 


Q ss_pred             -CCCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccc------cCCC--
Q 019195          148 -RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQY------KIPD--  218 (344)
Q Consensus       148 -~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~------~~~~--  218 (344)
                       ..+..+-|.+|+|||++.+...++.++|+||+||||.||++|++.|.+....+++..+++.+.....      ++|.  
T Consensus       274 ~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~~~  353 (560)
T KOG0600|consen  274 APYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPHAT  353 (560)
T ss_pred             cccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCCccc
Confidence             4567789999999999999988889999999999999999999999999999999888876543322      1221  


Q ss_pred             ---------------CCCCCHhHHHHHHHhcccCCCCCCChHHHhcCccccc
Q 019195          219 ---------------YVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLK  255 (344)
Q Consensus       219 ---------------~~~~s~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~  255 (344)
                                     +..+++.+.+|+..||+.||.+|.||.++|.|+||..
T Consensus       354 ~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~t  405 (560)
T KOG0600|consen  354 IFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYFTT  405 (560)
T ss_pred             ccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCccccc
Confidence                           1236788999999999999999999999999999943

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4.3e-52  Score=341.17  Aligned_cols=246  Identities=36%  Similarity=0.659  Sum_probs=221.6

Q ss_pred             CCCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCc----cccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEE
Q 019195            1 MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH----KIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIV   76 (344)
Q Consensus         1 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv   76 (344)
                      +++|++.++||+|-||.||+|+.++++.+||+|++.++.    ....++.+|+++...|+||||+++|++|.+...+|++
T Consensus        21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi  100 (281)
T KOG0580|consen   21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI  100 (281)
T ss_pred             hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence            578999999999999999999999999999999998753    3346788999999999999999999999999999999


Q ss_pred             EecCCCCChHHHHH--hCCCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCC
Q 019195           77 MEYAAGGELFERIC--NAGRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS  147 (344)
Q Consensus        77 ~e~~~~g~L~~~i~--~~~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~  147 (344)
                      +||.++|+|+..++  ...++++...+.+++|++.|       +|+||||||+|+|++..+.  +||+|||.+.... .+
T Consensus       101 lEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~--lkiAdfGwsV~~p-~~  177 (281)
T KOG0580|consen  101 LEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGE--LKIADFGWSVHAP-SN  177 (281)
T ss_pred             EEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCC--eeccCCCceeecC-CC
Confidence            99999999999998  56689999999999998877       9999999999999976654  9999999987654 66


Q ss_pred             CCCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCHhHH
Q 019195          148 RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCR  227 (344)
Q Consensus       148 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~  227 (344)
                      ...+.|||..|.+||+..+...+.. +|+|++|++.||++.|.+||.....    .+.++++.+....+|.  .++..+.
T Consensus       178 kR~tlcgt~dyl~pEmv~~~~hd~~-Vd~w~lgvl~yeflvg~ppFes~~~----~etYkrI~k~~~~~p~--~is~~a~  250 (281)
T KOG0580|consen  178 KRKTLCGTLDYLPPEMVEGRGHDKF-VDLWSLGVLCYEFLVGLPPFESQSH----SETYKRIRKVDLKFPS--TISGGAA  250 (281)
T ss_pred             CceeeecccccCCHhhcCCCCccch-hhHHHHHHHHHHHHhcCCchhhhhh----HHHHHHHHHccccCCc--ccChhHH
Confidence            6788899999999999999988766 9999999999999999999988653    4566677777777774  7899999


Q ss_pred             HHHHHhcccCCCCCCChHHHhcCcccccC
Q 019195          228 NLLSRIFVANPSRRITIKEIKSHPWFLKN  256 (344)
Q Consensus       228 ~li~~~L~~dp~~R~s~~ell~hp~~~~~  256 (344)
                      +||.+||.++|.+|.+..|++.|||+...
T Consensus       251 dlI~~ll~~~p~~r~~l~~v~~hpwI~a~  279 (281)
T KOG0580|consen  251 DLISRLLVKNPIERLALTEVMDHPWIVAN  279 (281)
T ss_pred             HHHHHHhccCccccccHHHHhhhHHHHhc
Confidence            99999999999999999999999998654

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-51  Score=375.74  Aligned_cols=250  Identities=30%  Similarity=0.526  Sum_probs=214.2

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCccc-cHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEEecC
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKI-DANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYA   80 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~   80 (344)
                      ..|....+||+|+.|.||.|....++..||||.+...... .+-+.+|+.+|+..+|+|||++++.|...+.+|+||||+
T Consensus       273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym  352 (550)
T KOG0578|consen  273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYM  352 (550)
T ss_pred             hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeec
Confidence            4688899999999999999999999999999999876544 356889999999999999999999999999999999999


Q ss_pred             CCCChHHHHHhCCCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCC-CCCCC
Q 019195           81 AGGELFERICNAGRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS-RPKST  152 (344)
Q Consensus        81 ~~g~L~~~i~~~~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~-~~~~~  152 (344)
                      +||+|.+.+.. -.++|.+|+.+++.+++|       ||+|||||.+|||++.++.  +||+|||++....... ...+.
T Consensus       353 ~ggsLTDvVt~-~~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~--vKltDFGFcaqi~~~~~KR~Tm  429 (550)
T KOG0578|consen  353 EGGSLTDVVTK-TRMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGS--VKLTDFGFCAQISEEQSKRSTM  429 (550)
T ss_pred             CCCchhhhhhc-ccccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCc--EEEeeeeeeeccccccCccccc
Confidence            99999888855 358999999988776665       9999999999999987765  9999999988755444 56677


Q ss_pred             ccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCHhHHHHHHH
Q 019195          153 VGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSR  232 (344)
Q Consensus       153 ~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~  232 (344)
                      +|||+|||||++....|..+ +||||||++++||+-|++||...+....+. .+.  ..+...+.....+|+.+++||.+
T Consensus       430 VGTPYWMAPEVvtrk~YG~K-VDIWSLGIMaIEMveGEPPYlnE~PlrAly-LIa--~ng~P~lk~~~klS~~~kdFL~~  505 (550)
T KOG0578|consen  430 VGTPYWMAPEVVTRKPYGPK-VDIWSLGIMAIEMVEGEPPYLNENPLRALY-LIA--TNGTPKLKNPEKLSPELKDFLDR  505 (550)
T ss_pred             cCCCCccchhhhhhcccCcc-ccchhhhhHHHHHhcCCCCccCCChHHHHH-HHh--hcCCCCcCCccccCHHHHHHHHH
Confidence            89999999999999988554 999999999999999999998754433322 222  23444555555899999999999


Q ss_pred             hcccCCCCCCChHHHhcCcccccCCC
Q 019195          233 IFVANPSRRITIKEIKSHPWFLKNLP  258 (344)
Q Consensus       233 ~L~~dp~~R~s~~ell~hp~~~~~~~  258 (344)
                      ||+.|+.+|++|.+||+||||+...+
T Consensus       506 cL~~dv~~RasA~eLL~HpFl~~a~p  531 (550)
T KOG0578|consen  506 CLVVDVEQRASAKELLEHPFLKMAKP  531 (550)
T ss_pred             HhhcchhcCCCHHHHhcChhhhhcCC
Confidence            99999999999999999999966544

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-51  Score=367.44  Aligned_cols=251  Identities=36%  Similarity=0.627  Sum_probs=212.3

Q ss_pred             CCCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCcc---------------ccHHHHHHHHHHhcCCCCCcceeeE
Q 019195            1 MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK---------------IDANVAREIINHKQLRHPNIIRFKE   65 (344)
Q Consensus         1 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---------------~~~~~~~ei~~l~~l~h~niv~~~~   65 (344)
                      +++|++++.||+|.||+|.+|++..+++.||||++.+...               ..+.+.+||.+|++|.|||||++++
T Consensus        96 lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiE  175 (576)
T KOG0585|consen   96 LNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIE  175 (576)
T ss_pred             hhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEE
Confidence            5899999999999999999999999999999999975321               1147899999999999999999999


Q ss_pred             EEEcC--CEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEee
Q 019195           66 VVLTP--THLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICD  136 (344)
Q Consensus        66 ~~~~~--~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~D  136 (344)
                      +..+.  +.+|||+|||..|.+...-.....+++.+++.+++.++.+       |||||||||+|+|+++++  +|||+|
T Consensus       176 vLDDP~s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g--~VKIsD  253 (576)
T KOG0585|consen  176 VLDDPESDKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDG--TVKISD  253 (576)
T ss_pred             eecCcccCceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCC--cEEeec
Confidence            99765  6899999999999885543333348999999997776554       999999999999998775  599999


Q ss_pred             cCCCcccCCCC------CCCCCccCCcccCCccccC---CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHH
Q 019195          137 FGYSKSSLLHS------RPKSTVGTPAYIAPEVLSR---REYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTIS  207 (344)
Q Consensus       137 Fg~a~~~~~~~------~~~~~~gt~~y~aPE~~~~---~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~  207 (344)
                      ||.+.......      .....+|||.|+|||.+.+   ..+++.+.||||+||+||-|+.|+.||.+....+.    ..
T Consensus       254 FGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l----~~  329 (576)
T KOG0585|consen  254 FGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELEL----FD  329 (576)
T ss_pred             cceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHH----HH
Confidence            99886542221      1234689999999999977   56778889999999999999999999988655444    44


Q ss_pred             HHhhccccCCCCCCCCHhHHHHHHHhcccCCCCCCChHHHhcCcccccCC
Q 019195          208 RIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNL  257 (344)
Q Consensus       208 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~~~  257 (344)
                      .|....+.+|....+++.+++||.+||++||.+|+++.++..|||..+..
T Consensus       330 KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~g  379 (576)
T KOG0585|consen  330 KIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRDG  379 (576)
T ss_pred             HHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceeccCC
Confidence            55667888888888999999999999999999999999999999987763

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-51  Score=362.91  Aligned_cols=250  Identities=32%  Similarity=0.496  Sum_probs=204.3

Q ss_pred             CceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCccc-cHHHHHHHHHHhcCCCCCcceeeEEEEcCC--EEEEEEec
Q 019195            3 KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKI-DANVAREIINHKQLRHPNIIRFKEVVLTPT--HLAIVMEY   79 (344)
Q Consensus         3 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~ei~~l~~l~h~niv~~~~~~~~~~--~~~lv~e~   79 (344)
                      +|...+.||+|+||+||++.+..+|...|+|.+...... ...+.+|+.+|++++|||||++++......  .++++|||
T Consensus        18 ~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy   97 (313)
T KOG0198|consen   18 NWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFMEY   97 (313)
T ss_pred             hhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeeec
Confidence            588899999999999999999999999999998765322 355889999999999999999999854444  69999999


Q ss_pred             CCCCChHHHHHhCC-CCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecC-CCCCCEEEeecCCCcccCC----C
Q 019195           80 AAGGELFERICNAG-RFSEDEARYFFQQLISG-------QICHRDLKLENTLLDG-SPAPRLKICDFGYSKSSLL----H  146 (344)
Q Consensus        80 ~~~g~L~~~i~~~~-~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~-~~~~~vkL~DFg~a~~~~~----~  146 (344)
                      +++|+|.+++.+.+ .+++..++.+.+|++.+       ||+||||||+|||++. ++.  +||+|||+++....    .
T Consensus        98 ~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~--~KlaDFG~a~~~~~~~~~~  175 (313)
T KOG0198|consen   98 APGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGD--VKLADFGLAKKLESKGTKS  175 (313)
T ss_pred             cCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCe--EEeccCccccccccccccc
Confidence            99999999999877 89999999998877655       9999999999999987 454  99999999876542    2


Q ss_pred             CCCCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCC-CChHHHHHHHHHHhhccccCCCCCCCCHh
Q 019195          147 SRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQ-EDPKNFRKTISRIMAVQYKIPDYVHISQD  225 (344)
Q Consensus       147 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~s~~  225 (344)
                      .......||+.|||||++..+....+++|||||||++.||+||.+||... ...    ..+-.+.......+.+..+|++
T Consensus       176 ~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~----~~~~~ig~~~~~P~ip~~ls~~  251 (313)
T KOG0198|consen  176 DSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEA----EALLLIGREDSLPEIPDSLSDE  251 (313)
T ss_pred             cccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchH----HHHHHHhccCCCCCCCcccCHH
Confidence            22345679999999999986444445799999999999999999999874 221    1122222222111233368999


Q ss_pred             HHHHHHHhcccCCCCCCChHHHhcCcccccCCC
Q 019195          226 CRNLLSRIFVANPSRRITIKEIKSHPWFLKNLP  258 (344)
Q Consensus       226 ~~~li~~~L~~dp~~R~s~~ell~hp~~~~~~~  258 (344)
                      +++||.+||..+|.+||||.++|+|||..+...
T Consensus       252 a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~~  284 (313)
T KOG0198|consen  252 AKDFLRKCFKRDPEKRPTAEELLEHPFLKQNSI  284 (313)
T ss_pred             HHHHHHHHhhcCcccCcCHHHHhhChhhhcccc
Confidence            999999999999999999999999999977654

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=4.3e-51  Score=349.84  Aligned_cols=252  Identities=29%  Similarity=0.432  Sum_probs=215.1

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCcc---ccHHHHHHHHHHhcCCCCCcceeeEEEEcC--CEEEEE
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK---IDANVAREIINHKQLRHPNIIRFKEVVLTP--THLAIV   76 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~ei~~l~~l~h~niv~~~~~~~~~--~~~~lv   76 (344)
                      ++|+.+..|++|+||+||+|+++.|+++||+|+++....   ..-..+|||.+|.+++|||||.+.++....  +.+|+|
T Consensus        76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~V  155 (419)
T KOG0663|consen   76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIV  155 (419)
T ss_pred             HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence            579999999999999999999999999999999987542   235678999999999999999999998754  679999


Q ss_pred             EecCCCCChHHHHHhCC-CCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCCC
Q 019195           77 MEYAAGGELFERICNAG-RFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR  148 (344)
Q Consensus        77 ~e~~~~g~L~~~i~~~~-~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~~  148 (344)
                      ||||+. +|..++.+-+ +|...+++.++.||+.+       .|+||||||+|+|++..+.  +||+|||+|+.......
T Consensus       156 Me~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~--lKiaDFGLAR~ygsp~k  232 (419)
T KOG0663|consen  156 MEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGI--LKIADFGLAREYGSPLK  232 (419)
T ss_pred             HHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCc--EEecccchhhhhcCCcc
Confidence            999964 8999998755 89999999998888876       8999999999999976654  99999999997655533


Q ss_pred             -CCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhcccc------------
Q 019195          149 -PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYK------------  215 (344)
Q Consensus       149 -~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~------------  215 (344)
                       .+..+-|.+|+|||++.+...+++++|+||+|||+.||+++++.|.+....+++.++++....+...            
T Consensus       233 ~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~~k  312 (419)
T KOG0663|consen  233 PYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPAVK  312 (419)
T ss_pred             cCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccchhh
Confidence             4556799999999999998877888999999999999999999999999988988888765432211            


Q ss_pred             ---CCC---------C--CCCCHhHHHHHHHhcccCCCCCCChHHHhcCcccccC
Q 019195          216 ---IPD---------Y--VHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKN  256 (344)
Q Consensus       216 ---~~~---------~--~~~s~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~~  256 (344)
                         ++.         +  ..+|....+|+..+|..||.+|.||.++|+|+||.+.
T Consensus       313 ~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~  367 (419)
T KOG0663|consen  313 KMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRET  367 (419)
T ss_pred             ccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccC
Confidence               110         0  1156889999999999999999999999999999875

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=5e-52  Score=346.87  Aligned_cols=248  Identities=34%  Similarity=0.578  Sum_probs=216.2

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCcc---------ccHHHHHHHHHHhcC-CCCCcceeeEEEEcCC
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK---------IDANVAREIINHKQL-RHPNIIRFKEVVLTPT   71 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---------~~~~~~~ei~~l~~l-~h~niv~~~~~~~~~~   71 (344)
                      ++|.-.+.||+|..++|.++.++.+|..+|+|++.....         ..+.-.+|+.+|+++ .||||+++.++|+++.
T Consensus        17 ~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~s   96 (411)
T KOG0599|consen   17 AKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDA   96 (411)
T ss_pred             hhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcc
Confidence            578888999999999999999999999999999864211         123456899999998 6999999999999999


Q ss_pred             EEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccC
Q 019195           72 HLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSL  144 (344)
Q Consensus        72 ~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~  144 (344)
                      .+++|+|+|+.|.|++++...-.+++.+.+.+++||..+       +|+||||||+|||++++..  +||+|||+|+...
T Consensus        97 F~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~--i~isDFGFa~~l~  174 (411)
T KOG0599|consen   97 FVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMN--IKISDFGFACQLE  174 (411)
T ss_pred             hhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccc--eEEeccceeeccC
Confidence            999999999999999999998899999999999998876       9999999999999988776  9999999999999


Q ss_pred             CCCCCCCCccCCcccCCccccC-----CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccc--cCC
Q 019195          145 LHSRPKSTVGTPAYIAPEVLSR-----REYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQY--KIP  217 (344)
Q Consensus       145 ~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~--~~~  217 (344)
                      .+......||||+|+|||.+.-     .+.++..+|+||+|+|+|.|+.|.+||-....    .-.+..++.+.+  ..|
T Consensus       175 ~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQ----mlMLR~ImeGkyqF~sp  250 (411)
T KOG0599|consen  175 PGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQ----MLMLRMIMEGKYQFRSP  250 (411)
T ss_pred             CchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHH----HHHHHHHHhcccccCCc
Confidence            9999999999999999999843     23335669999999999999999999965332    223344555544  567


Q ss_pred             CCCCCCHhHHHHHHHhcccCCCCCCChHHHhcCccccc
Q 019195          218 DYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLK  255 (344)
Q Consensus       218 ~~~~~s~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~  255 (344)
                      .|..+|...++||++||+.||.+|+|+.|+|+||||.+
T Consensus       251 eWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q  288 (411)
T KOG0599|consen  251 EWADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQ  288 (411)
T ss_pred             chhhccccHHHHHHHHHeeCchhcccHHHHhcChHHHH
Confidence            88899999999999999999999999999999999954

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=3.1e-51  Score=355.69  Aligned_cols=252  Identities=30%  Similarity=0.474  Sum_probs=212.5

Q ss_pred             CceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcCCCCCcceeeEEEEcC--C---EEEEEE
Q 019195            3 KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKEVVLTP--T---HLAIVM   77 (344)
Q Consensus         3 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~--~---~~~lv~   77 (344)
                      .|.-.+.+|.|+||+||++...+++..||||++-.+.....   +|+++|+.+.|||||++..+|...  .   ...+||
T Consensus        25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~kn---rEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVl  101 (364)
T KOG0658|consen   25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYKN---RELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVL  101 (364)
T ss_pred             EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCcCc---HHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHH
Confidence            47889999999999999999999999999999877666444   799999999999999999988643  2   357899


Q ss_pred             ecCCCCChHHHHHh----CCCCCHHHHHHHHHHHHH-------CCeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCC
Q 019195           78 EYAAGGELFERICN----AGRFSEDEARYFFQQLIS-------GQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH  146 (344)
Q Consensus        78 e~~~~g~L~~~i~~----~~~~~~~~~~~~~~ql~~-------~~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~  146 (344)
                      ||++. +|...++.    +.+++.-.++-++.||..       .||+||||||.|+|+|.+ ++.+||||||.|+....+
T Consensus       102 eymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~-tg~LKicDFGSAK~L~~~  179 (364)
T KOG0658|consen  102 EYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPD-TGVLKICDFGSAKVLVKG  179 (364)
T ss_pred             HhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCC-CCeEEeccCCcceeeccC
Confidence            99965 89888874    466777777766666655       499999999999999855 356999999999999999


Q ss_pred             CCCCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhc----------c---
Q 019195          147 SRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAV----------Q---  213 (344)
Q Consensus       147 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~----------~---  213 (344)
                      ..+.++..|..|+|||++.+...++.+.||||.||+++||+.|++.|.+.+...++..+++-+...          .   
T Consensus       180 epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~~y~~  259 (364)
T KOG0658|consen  180 EPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNPNYTE  259 (364)
T ss_pred             CCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCccccc
Confidence            999999999999999999999888888999999999999999999999998888888877643221          1   


Q ss_pred             ccCC----------CCCCCCHhHHHHHHHhcccCCCCCCChHHHhcCcccccCCCh
Q 019195          214 YKIP----------DYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLPR  259 (344)
Q Consensus       214 ~~~~----------~~~~~s~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~~~~~  259 (344)
                      ..+|          .....++++.+|+.++|+.+|.+|.++.|+|.||||.....+
T Consensus       260 ~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~~  315 (364)
T KOG0658|consen  260 FKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRDP  315 (364)
T ss_pred             ccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhCc
Confidence            1112          123468999999999999999999999999999999765443

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=7.4e-50  Score=365.83  Aligned_cols=251  Identities=37%  Similarity=0.640  Sum_probs=218.8

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCcc----ccHHHHHHHHHHhcCC-CCCcceeeEEEEcCCEEEEE
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK----IDANVAREIINHKQLR-HPNIIRFKEVVLTPTHLAIV   76 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~ei~~l~~l~-h~niv~~~~~~~~~~~~~lv   76 (344)
                      +.|++.+.||+|.||+||+|+.+.+|+.+|+|++.+...    ....+.+|+.+|++++ |||||+++++|.+...+++|
T Consensus        35 ~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~lv  114 (382)
T KOG0032|consen   35 EKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYLV  114 (382)
T ss_pred             ccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEEE
Confidence            469999999999999999999999999999999987543    2357999999999998 99999999999999999999


Q ss_pred             EecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCC--CCCEEEeecCCCcccCCCC
Q 019195           77 MEYAAGGELFERICNAGRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSP--APRLKICDFGYSKSSLLHS  147 (344)
Q Consensus        77 ~e~~~~g~L~~~i~~~~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~--~~~vkL~DFg~a~~~~~~~  147 (344)
                      ||+|.||.|++.|.+. .+++..+..+++|++.+       ||+||||||+|+|+....  .+.+|++|||++.......
T Consensus       115 mEL~~GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~~~~  193 (382)
T KOG0032|consen  115 MELCEGGELFDRIVKK-HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIKPGE  193 (382)
T ss_pred             EEecCCchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEccCCc
Confidence            9999999999999877 49999888887776655       999999999999997543  3479999999998877766


Q ss_pred             CCCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCHhHH
Q 019195          148 RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCR  227 (344)
Q Consensus       148 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~  227 (344)
                      .....+||+.|+|||++.+..|... +||||+|+++|.|++|.+||.+.+....+.++...  ...+..+.+..+|..++
T Consensus       194 ~~~~~~Gtp~y~APEvl~~~~y~~~-~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~--~~~f~~~~w~~is~~ak  270 (382)
T KOG0032|consen  194 RLHTIVGTPEYVAPEVLGGRPYGDE-VDVWSIGVILYILLSGVPPFWGETEFEIFLAILRG--DFDFTSEPWDDISESAK  270 (382)
T ss_pred             eEeeecCCccccCchhhcCCCCCcc-cchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcC--CCCCCCCCccccCHHHH
Confidence            6778899999999999988887554 99999999999999999999998776655543332  22445567778999999


Q ss_pred             HHHHHhcccCCCCCCChHHHhcCcccccC
Q 019195          228 NLLSRIFVANPSRRITIKEIKSHPWFLKN  256 (344)
Q Consensus       228 ~li~~~L~~dp~~R~s~~ell~hp~~~~~  256 (344)
                      +||++||..||.+|+|+.++|+|||+...
T Consensus       271 d~i~~ll~~dp~~R~ta~~~L~HpWi~~~  299 (382)
T KOG0032|consen  271 DFIRKLLEFDPRKRLTAAQALQHPWIKSI  299 (382)
T ss_pred             HHHHHhcccCcccCCCHHHHhcCccccCC
Confidence            99999999999999999999999999864

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=4.5e-51  Score=357.61  Aligned_cols=244  Identities=37%  Similarity=0.668  Sum_probs=224.9

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCccc----cHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEE
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKI----DANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVM   77 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~----~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~   77 (344)
                      .||++.+.||+|.||.|-+|.....|+.||||.+.++.-.    .-.+.+||++|..|+||||+++|++|+..+.+.|||
T Consensus        53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivM  132 (668)
T KOG0611|consen   53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVM  132 (668)
T ss_pred             hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEE
Confidence            3799999999999999999999999999999999875432    246889999999999999999999999999999999


Q ss_pred             ecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCCCCC
Q 019195           78 EYAAGGELFERICNAGRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPK  150 (344)
Q Consensus        78 e~~~~g~L~~~i~~~~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~~~~  150 (344)
                      ||..+|.|+++|..++.+++.+.+.+++||++|       +++|||||.+|||+|.+++  +||+|||++..........
T Consensus       133 EYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~N--iKIADFGLSNly~~~kfLq  210 (668)
T KOG0611|consen  133 EYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNN--IKIADFGLSNLYADKKFLQ  210 (668)
T ss_pred             EecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCC--eeeeccchhhhhccccHHH
Confidence            999999999999999999999999999999987       9999999999999998876  9999999998877777888


Q ss_pred             CCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCHhHHHHH
Q 019195          151 STVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLL  230 (344)
Q Consensus       151 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li  230 (344)
                      ++||+|.|.+||++.+.+|.++.+|-|||||+||.|+.|..||.+.+    +...++++..+.++.|.   .+.++.-||
T Consensus       211 TFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~D----hk~lvrQIs~GaYrEP~---~PSdA~gLI  283 (668)
T KOG0611|consen  211 TFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRD----HKRLVRQISRGAYREPE---TPSDASGLI  283 (668)
T ss_pred             HhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCch----HHHHHHHhhcccccCCC---CCchHHHHH
Confidence            99999999999999999999999999999999999999999998864    45667778788887775   467899999


Q ss_pred             HHhcccCCCCCCChHHHhcCcccc
Q 019195          231 SRIFVANPSRRITIKEIKSHPWFL  254 (344)
Q Consensus       231 ~~~L~~dp~~R~s~~ell~hp~~~  254 (344)
                      +.||-.||.+|.|+.++-.|=|++
T Consensus       284 RwmLmVNP~RRATieDiAsHWWvN  307 (668)
T KOG0611|consen  284 RWMLMVNPERRATIEDIASHWWVN  307 (668)
T ss_pred             HHHHhcCcccchhHHHHhhhheee
Confidence            999999999999999999998864

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.3e-50  Score=354.83  Aligned_cols=258  Identities=29%  Similarity=0.430  Sum_probs=209.5

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCc--cccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEEec
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH--KIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEY   79 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~   79 (344)
                      +.|++...||.|..++||+|+...++.+||||+++...  .....+++|+..|+.++||||++++.+|..+..+|+||.|
T Consensus        26 ~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmpf  105 (516)
T KOG0582|consen   26 KDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMPF  105 (516)
T ss_pred             cceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeehh
Confidence            57999999999999999999999999999999997543  3346899999999999999999999999999999999999


Q ss_pred             CCCCChHHHHHhC--CCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCC-CC
Q 019195           80 AAGGELFERICNA--GRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS-RP  149 (344)
Q Consensus        80 ~~~g~L~~~i~~~--~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~-~~  149 (344)
                      |.+||+.++++..  ..+.|..|+.++++++.|       |.||||||+.||||+.++.  |||+|||.+....... +.
T Consensus       106 Ma~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~--VkLadFgvsa~l~~~G~R~  183 (516)
T KOG0582|consen  106 MAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGT--VKLADFGVSASLFDSGDRQ  183 (516)
T ss_pred             hcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCc--EEEcCceeeeeecccCcee
Confidence            9999999999764  348888888877766655       9999999999999988876  9999999875433322 11


Q ss_pred             ----CCCccCCcccCCccc-cCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhh----ccccCCCCC
Q 019195          150 ----KSTVGTPAYIAPEVL-SRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMA----VQYKIPDYV  220 (344)
Q Consensus       150 ----~~~~gt~~y~aPE~~-~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~----~~~~~~~~~  220 (344)
                          ...+||++|||||++ +....+..++|||||||+..||++|..||......+.+...++....    .........
T Consensus       184 ~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~t~~~~~d~~k  263 (516)
T KOG0582|consen  184 VTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLLTSGLDKDEDK  263 (516)
T ss_pred             eEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCcccccCChHHhh
Confidence                445899999999994 44333455699999999999999999999987765544433332110    000111233


Q ss_pred             CCCHhHHHHHHHhcccCCCCCCChHHHhcCcccccCCChhh
Q 019195          221 HISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLPREL  261 (344)
Q Consensus       221 ~~s~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~~~~~~~  261 (344)
                      .++..++.+|..||++||.+||||.++|+|+||++...+..
T Consensus       264 ~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k~~~~  304 (516)
T KOG0582|consen  264 KFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAKSKEY  304 (516)
T ss_pred             hhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhccchhh
Confidence            46778999999999999999999999999999998766543

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.6e-49  Score=366.31  Aligned_cols=249  Identities=34%  Similarity=0.582  Sum_probs=212.6

Q ss_pred             CCCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCccc----cHHHHHHHHHHhcC-CCCCcceeeEEEEcCCEEEE
Q 019195            1 MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKI----DANVAREIINHKQL-RHPNIIRFKEVVLTPTHLAI   75 (344)
Q Consensus         1 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~----~~~~~~ei~~l~~l-~h~niv~~~~~~~~~~~~~l   75 (344)
                      +++|+++++||+|+||+|+++..+.+++.||||++++..-.    .+....|-+++... +||.+++++.+|++++++|+
T Consensus       367 l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~f  446 (694)
T KOG0694|consen  367 LDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFF  446 (694)
T ss_pred             ccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEE
Confidence            57899999999999999999999999999999999986432    24566787787777 59999999999999999999


Q ss_pred             EEecCCCCChHHHHHhCCCCCHHHHHHHH-------HHHHHCCeeecCCCCCCeEecCCCCCCEEEeecCCCcccC-CCC
Q 019195           76 VMEYAAGGELFERICNAGRFSEDEARYFF-------QQLISGQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSL-LHS  147 (344)
Q Consensus        76 v~e~~~~g~L~~~i~~~~~~~~~~~~~~~-------~ql~~~~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~-~~~  147 (344)
                      ||||+.||++ .+++..+.|++..++.++       ..||+.|||+||||.+|||+|..+.  +||+|||+++... .+.
T Consensus       447 vmey~~Ggdm-~~~~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh--~kiADFGlcKe~m~~g~  523 (694)
T KOG0694|consen  447 VMEYVAGGDL-MHHIHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGH--VKIADFGLCKEGMGQGD  523 (694)
T ss_pred             EEEecCCCcE-EEEEecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCc--EEecccccccccCCCCC
Confidence            9999999994 445566788988887775       4456669999999999999987765  9999999999766 556


Q ss_pred             CCCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCHhHH
Q 019195          148 RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCR  227 (344)
Q Consensus       148 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~  227 (344)
                      ...+.||||.|||||++.+..|+ .++|+|||||+||||+.|+.||.+.+..+.+..+    .......|.  .+|.++.
T Consensus       524 ~TsTfCGTpey~aPEil~e~~Yt-~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI----~~d~~~yP~--~ls~ea~  596 (694)
T KOG0694|consen  524 RTSTFCGTPEFLAPEVLTEQSYT-RAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSI----VNDEVRYPR--FLSKEAI  596 (694)
T ss_pred             ccccccCChhhcChhhhccCccc-chhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH----hcCCCCCCC--cccHHHH
Confidence            67788999999999999998875 5599999999999999999999988776665554    444555565  6899999


Q ss_pred             HHHHHhcccCCCCCCC-----hHHHhcCcccccCCCh
Q 019195          228 NLLSRIFVANPSRRIT-----IKEIKSHPWFLKNLPR  259 (344)
Q Consensus       228 ~li~~~L~~dp~~R~s-----~~ell~hp~~~~~~~~  259 (344)
                      ++++++|.++|++|..     +.+|..||||+..-..
T Consensus       597 ~il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i~w~  633 (694)
T KOG0694|consen  597 AIMRRLLRKNPEKRLGSGERDAEDIKKHPFFRSIDWD  633 (694)
T ss_pred             HHHHHHhccCcccccCCCCCCchhhhhCCccccCCHH
Confidence            9999999999999994     6889999999876543

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=1.1e-48  Score=357.45  Aligned_cols=245  Identities=32%  Similarity=0.597  Sum_probs=207.4

Q ss_pred             CCCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCc----cccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEE
Q 019195            1 MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH----KIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIV   76 (344)
Q Consensus         1 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv   76 (344)
                      +++|++.+.||+|+||.||+|.+..+++.||+|++....    .....+.+|+.++++++||||+++++++..++.+|+|
T Consensus        17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv   96 (329)
T PTZ00263         17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFL   96 (329)
T ss_pred             chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEE
Confidence            478999999999999999999999999999999987542    2235688999999999999999999999999999999


Q ss_pred             EecCCCCChHHHHHhCCCCCHHHHHHHHHHHH-------HCCeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCCCC
Q 019195           77 MEYAAGGELFERICNAGRFSEDEARYFFQQLI-------SGQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP  149 (344)
Q Consensus        77 ~e~~~~g~L~~~i~~~~~~~~~~~~~~~~ql~-------~~~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~~~  149 (344)
                      |||+++|+|.+++.+.+.+++..++.++.|++       +.||+||||||+|||++.++.  +||+|||++.....  ..
T Consensus        97 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~--~kl~Dfg~~~~~~~--~~  172 (329)
T PTZ00263         97 LEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGH--VKVTDFGFAKKVPD--RT  172 (329)
T ss_pred             EcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCC--EEEeeccCceEcCC--Cc
Confidence            99999999999999888899888877766655       459999999999999987664  99999999875432  23


Q ss_pred             CCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCHhHHHH
Q 019195          150 KSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL  229 (344)
Q Consensus       150 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  229 (344)
                      ...+||+.|+|||++.+..++ .++|||||||++|+|++|+.||.......    ....+......+|.  .++..+++|
T Consensus       173 ~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~elltg~~pf~~~~~~~----~~~~i~~~~~~~p~--~~~~~~~~l  245 (329)
T PTZ00263        173 FTLCGTPEYLAPEVIQSKGHG-KAVDWWTMGVLLYEFIAGYPPFFDDTPFR----IYEKILAGRLKFPN--WFDGRARDL  245 (329)
T ss_pred             ceecCChhhcCHHHHcCCCCC-CcceeechHHHHHHHHcCCCCCCCCCHHH----HHHHHhcCCcCCCC--CCCHHHHHH
Confidence            346799999999999877764 55999999999999999999998765433    23334444444444  578999999


Q ss_pred             HHHhcccCCCCCCC-----hHHHhcCcccccC
Q 019195          230 LSRIFVANPSRRIT-----IKEIKSHPWFLKN  256 (344)
Q Consensus       230 i~~~L~~dp~~R~s-----~~ell~hp~~~~~  256 (344)
                      |.+||+.||.+||+     +.+++.||||.+.
T Consensus       246 i~~~L~~dP~~R~~~~~~~~~~ll~hp~f~~~  277 (329)
T PTZ00263        246 VKGLLQTDHTKRLGTLKGGVADVKNHPYFHGA  277 (329)
T ss_pred             HHHHhhcCHHHcCCCCCCCHHHHhcCCccCCC
Confidence            99999999999997     7999999999764

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=7.1e-49  Score=344.94  Aligned_cols=251  Identities=31%  Similarity=0.502  Sum_probs=213.6

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCcc----ccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEE
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK----IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVM   77 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~   77 (344)
                      +.|++++.||.|.-|+||+|....++..+|+|++.+...    ...++..|-+||+.+.||.++.+|..|+.+...|++|
T Consensus        77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~m  156 (459)
T KOG0610|consen   77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVM  156 (459)
T ss_pred             HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEE
Confidence            568899999999999999999999999999999987543    2356778999999999999999999999999999999


Q ss_pred             ecCCCCChHHHHHhC--CCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccC----
Q 019195           78 EYAAGGELFERICNA--GRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSL----  144 (344)
Q Consensus        78 e~~~~g~L~~~i~~~--~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~----  144 (344)
                      |||+||+|..+++++  +.|++..++.++..++-|       |||.|||||+||||.+++  +|.|+||.++....    
T Consensus       157 eyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredG--HIMLsDFDLS~~~~~~Pt  234 (459)
T KOG0610|consen  157 EYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDG--HIMLSDFDLSLRCPVSPT  234 (459)
T ss_pred             ecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCC--cEEeeeccccccCCCCCe
Confidence            999999999998775  468888888876665554       999999999999997666  59999999863110    


Q ss_pred             ------------------------------C-C----------------------CCCCCCccCCcccCCccccCCCCCC
Q 019195          145 ------------------------------L-H----------------------SRPKSTVGTPAYIAPEVLSRREYDG  171 (344)
Q Consensus       145 ------------------------------~-~----------------------~~~~~~~gt~~y~aPE~~~~~~~~~  171 (344)
                                                    . .                      ....+.+||-.|+|||++.+.+. +
T Consensus       235 ~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GH-g  313 (459)
T KOG0610|consen  235 LVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGH-G  313 (459)
T ss_pred             eeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCC-C
Confidence                                          0 0                      01134479999999999998876 5


Q ss_pred             cchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCHhHHHHHHHhcccCCCCCCC----hHHH
Q 019195          172 KLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRIT----IKEI  247 (344)
Q Consensus       172 ~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s----~~el  247 (344)
                      .++|+|+|||++|||+.|..||.+.+..+.+.+    +...+..+|....++..++|||+++|.+||.+|..    |.||
T Consensus       314 sAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~N----Iv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~kRlg~~rGA~eI  389 (459)
T KOG0610|consen  314 SAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRN----IVGQPLKFPEEPEVSSAAKDLIRKLLVKDPSKRLGSKRGAAEI  389 (459)
T ss_pred             chhhHHHHHHHHHHHHhCCCCcCCCCchhhHHH----HhcCCCcCCCCCcchhHHHHHHHHHhccChhhhhccccchHHh
Confidence            669999999999999999999999888666555    45567788888889999999999999999999997    9999


Q ss_pred             hcCcccccCCCh
Q 019195          248 KSHPWFLKNLPR  259 (344)
Q Consensus       248 l~hp~~~~~~~~  259 (344)
                      .+||||...-+.
T Consensus       390 K~HpFF~gVnWa  401 (459)
T KOG0610|consen  390 KRHPFFEGVNWA  401 (459)
T ss_pred             hcCccccCCChh
Confidence            999999876554

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-48  Score=351.37  Aligned_cols=244  Identities=33%  Similarity=0.599  Sum_probs=206.1

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCc----cccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEE
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH----KIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVM   77 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~   77 (344)
                      ++|++++.||+|+||.||+|.+..+++.||+|++....    .....+.+|+.+++.++||||+++++++.+...+|+||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   80 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM   80 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence            58999999999999999999999999999999987532    22346788999999999999999999999999999999


Q ss_pred             ecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCCCCC
Q 019195           78 EYAAGGELFERICNAGRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPK  150 (344)
Q Consensus        78 e~~~~g~L~~~i~~~~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~~~~  150 (344)
                      ||+++|+|.+++.+.+.+++..++.++.|++.+       ||+||||||+|||++.++  .+||+|||+++....  ...
T Consensus        81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~--~~kl~Dfg~~~~~~~--~~~  156 (291)
T cd05612          81 EYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEG--HIKLTDFGFAKKLRD--RTW  156 (291)
T ss_pred             eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCC--CEEEEecCcchhccC--Ccc
Confidence            999999999999988889998888777776654       999999999999997665  499999999875432  233


Q ss_pred             CCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCHhHHHHH
Q 019195          151 STVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLL  230 (344)
Q Consensus       151 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li  230 (344)
                      ..+||+.|+|||++.+..++ .++|||||||++|+|++|+.||........    ...+......+|.  .+++.+++||
T Consensus       157 ~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~il~~l~~g~~pf~~~~~~~~----~~~i~~~~~~~~~--~~~~~~~~li  229 (291)
T cd05612         157 TLCGTPEYLAPEVIQSKGHN-KAVDWWALGILIYEMLVGYPPFFDDNPFGI----YEKILAGKLEFPR--HLDLYAKDLI  229 (291)
T ss_pred             cccCChhhcCHHHHcCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHH----HHHHHhCCcCCCc--cCCHHHHHHH
Confidence            45799999999999877764 559999999999999999999987654333    3333344444443  5689999999


Q ss_pred             HHhcccCCCCCCC-----hHHHhcCcccccC
Q 019195          231 SRIFVANPSRRIT-----IKEIKSHPWFLKN  256 (344)
Q Consensus       231 ~~~L~~dp~~R~s-----~~ell~hp~~~~~  256 (344)
                      ++||+.||.+||+     +.++++||||...
T Consensus       230 ~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~  260 (291)
T cd05612         230 KKLLVVDRTRRLGNMKNGADDVKNHRWFKSV  260 (291)
T ss_pred             HHHcCCCHHHccCCccCCHHHHhcCccccCC
Confidence            9999999999995     9999999999653

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=2.8e-49  Score=366.44  Aligned_cols=250  Identities=28%  Similarity=0.404  Sum_probs=212.0

Q ss_pred             CceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcCC-C-----CCcceeeEEEEcCCEEEEE
Q 019195            3 KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLR-H-----PNIIRFKEVVLTPTHLAIV   76 (344)
Q Consensus         3 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~l~~l~-h-----~niv~~~~~~~~~~~~~lv   76 (344)
                      ||++++.||+|+||.|-+|.+..|++.||||+++.......+...|+.+|..|+ |     -|+|+++++|...+++|||
T Consensus       187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~HlciV  266 (586)
T KOG0667|consen  187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCIV  266 (586)
T ss_pred             EEEEEEEecccccceeEEEEecCCCcEEEEEeeccChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceeee
Confidence            699999999999999999999999999999999988877788889999999996 4     4999999999999999999


Q ss_pred             EecCCCCChHHHHHhCC--CCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCC
Q 019195           77 MEYAAGGELFERICNAG--RFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS  147 (344)
Q Consensus        77 ~e~~~~g~L~~~i~~~~--~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~  147 (344)
                      +|++ ..+|+++|+.+.  .++...++.+++||+.+       ||||+||||+|||+......+|||+|||+|+.....-
T Consensus       267 fELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~~q~v  345 (586)
T KOG0667|consen  267 FELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFESQRV  345 (586)
T ss_pred             ehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEecccccccCCcc
Confidence            9999 679999998764  58899999999998876       9999999999999987766789999999998654433


Q ss_pred             CCCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhh----------------
Q 019195          148 RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMA----------------  211 (344)
Q Consensus       148 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~----------------  211 (344)
                        .+++.+..|+|||++.+.+|+.. +||||||||++||++|.+.|.+.+..+++..++.-+..                
T Consensus       346 --ytYiQSRfYRAPEVILGlpY~~~-IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~~~~~kff  422 (586)
T KOG0667|consen  346 --YTYIQSRFYRAPEVILGLPYDTA-IDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTAKKAHKFF  422 (586)
T ss_pred             --eeeeeccccccchhhccCCCCCc-cceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhccccceeh
Confidence              37889999999999999999876 99999999999999999999988877766655442210                


Q ss_pred             --------------------------------ccccCC-CCC--------CCCHhHHHHHHHhcccCCCCCCChHHHhcC
Q 019195          212 --------------------------------VQYKIP-DYV--------HISQDCRNLLSRIFVANPSRRITIKEIKSH  250 (344)
Q Consensus       212 --------------------------------~~~~~~-~~~--------~~s~~~~~li~~~L~~dp~~R~s~~ell~h  250 (344)
                                                      .....| ...        .-...+.+||++||.+||.+|+|+.++|+|
T Consensus       423 ~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~tp~qal~H  502 (586)
T KOG0667|consen  423 TSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERITPAQALNH  502 (586)
T ss_pred             hccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCCHHHHhcC
Confidence                                            000111 000        012357899999999999999999999999


Q ss_pred             cccccC
Q 019195          251 PWFLKN  256 (344)
Q Consensus       251 p~~~~~  256 (344)
                      |||...
T Consensus       503 pfl~~~  508 (586)
T KOG0667|consen  503 PFLTGT  508 (586)
T ss_pred             cccccc
Confidence            999854

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=1.4e-48  Score=339.36  Aligned_cols=254  Identities=29%  Similarity=0.445  Sum_probs=214.4

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCcc---ccHHHHHHHHHHhcCCCCC-cceeeEEEEcCC------
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK---IDANVAREIINHKQLRHPN-IIRFKEVVLTPT------   71 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~ei~~l~~l~h~n-iv~~~~~~~~~~------   71 (344)
                      ..|+.+++||+|+||+||+|+.+.+|+.||+|++.....   ......+|+.+++.|+|+| ||.+++++...+      
T Consensus        11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~   90 (323)
T KOG0594|consen   11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG   90 (323)
T ss_pred             HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence            468889999999999999999999999999999987654   4567899999999999999 999999999887      


Q ss_pred             EEEEEEecCCCCChHHHHHhCC----CCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCC
Q 019195           72 HLAIVMEYAAGGELFERICNAG----RFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYS  140 (344)
Q Consensus        72 ~~~lv~e~~~~g~L~~~i~~~~----~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a  140 (344)
                      .+++|+||+. .+|..++....    .++...++.+++||+.|       +|+||||||+||||+.++  .+||+|||+|
T Consensus        91 ~l~lvfe~~d-~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G--~lKlaDFGlA  167 (323)
T KOG0594|consen   91 KLYLVFEFLD-RDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSG--VLKLADFGLA  167 (323)
T ss_pred             eEEEEEEeec-ccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCC--cEeeeccchH
Confidence            8999999994 59999987755    57778899999998876       999999999999998755  4999999999


Q ss_pred             cccCCCCC-CCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhcccc----
Q 019195          141 KSSLLHSR-PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYK----  215 (344)
Q Consensus       141 ~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~----  215 (344)
                      +....... ....++|.+|+|||++.+...++...||||+|||++||+++++.|.+..+.+++..+..........    
T Consensus       168 ra~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~  247 (323)
T KOG0594|consen  168 RAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPG  247 (323)
T ss_pred             HHhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCC
Confidence            86553333 4556899999999999998666666999999999999999999999999888877777654433111    


Q ss_pred             ----------CCCC----------CCCCHhHHHHHHHhcccCCCCCCChHHHhcCcccccCCC
Q 019195          216 ----------IPDY----------VHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLP  258 (344)
Q Consensus       216 ----------~~~~----------~~~s~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~~~~  258 (344)
                                ++.+          ...+++..+++.+||+.+|.+|.||..+|.||||.....
T Consensus       248 v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~~  310 (323)
T KOG0594|consen  248 VSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELPE  310 (323)
T ss_pred             ccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhccccc
Confidence                      1111          113358999999999999999999999999999977643

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-49  Score=355.58  Aligned_cols=246  Identities=35%  Similarity=0.670  Sum_probs=223.4

Q ss_pred             ceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCc---cccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEEecC
Q 019195            4 YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH---KIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYA   80 (344)
Q Consensus         4 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~   80 (344)
                      |.+.+.||+|.|++|.+|++.-||..||||++.+..   .....+.+|++.|+.++|||||++|++......+|+|+|+-
T Consensus        20 YDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLELG   99 (864)
T KOG4717|consen   20 YDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILELG   99 (864)
T ss_pred             ehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEec
Confidence            788899999999999999999999999999998754   33467999999999999999999999999999999999999


Q ss_pred             CCCChHHHHHhC-CCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCCCCCCC
Q 019195           81 AGGELFERICNA-GRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST  152 (344)
Q Consensus        81 ~~g~L~~~i~~~-~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~~~~~~  152 (344)
                      .+|+|+++|.+. ..+.+...+.++.||+.|       .+|||||||+|+.+-.. .|-|||+|||++....++....+.
T Consensus       100 D~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEK-lGlVKLTDFGFSNkf~PG~kL~Ts  178 (864)
T KOG4717|consen  100 DGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEK-LGLVKLTDFGFSNKFQPGKKLTTS  178 (864)
T ss_pred             CCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeee-cCceEeeeccccccCCCcchhhcc
Confidence            999999998765 469999999999998876       89999999999987532 345999999999988889999999


Q ss_pred             ccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCHhHHHHHHH
Q 019195          153 VGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSR  232 (344)
Q Consensus       153 ~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~  232 (344)
                      ||+..|-|||++.+..|+.+++||||||||||-|++|++||...++.+.+    ..|+...+..|.  .+|.++++||..
T Consensus       179 CGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETL----TmImDCKYtvPs--hvS~eCrdLI~s  252 (864)
T KOG4717|consen  179 CGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETL----TMIMDCKYTVPS--HVSKECRDLIQS  252 (864)
T ss_pred             cchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhh----hhhhcccccCch--hhhHHHHHHHHH
Confidence            99999999999999999999999999999999999999999998886654    446677888887  789999999999


Q ss_pred             hcccCCCCCCChHHHhcCcccccC
Q 019195          233 IFVANPSRRITIKEIKSHPWFLKN  256 (344)
Q Consensus       233 ~L~~dp~~R~s~~ell~hp~~~~~  256 (344)
                      ||+.||.+|.+.++|..|+|++..
T Consensus       253 MLvRdPkkRAslEeI~s~~Wlq~~  276 (864)
T KOG4717|consen  253 MLVRDPKKRASLEEIVSTSWLQAG  276 (864)
T ss_pred             HHhcCchhhccHHHHhccccccCC
Confidence            999999999999999999999754

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-50  Score=358.20  Aligned_cols=246  Identities=30%  Similarity=0.421  Sum_probs=205.2

Q ss_pred             CceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCcc--ccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEEecC
Q 019195            3 KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK--IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYA   80 (344)
Q Consensus         3 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~   80 (344)
                      .|..++.||+|+||.||+|.+..+++.||+|++.....  ....+++|+.+|.+++++||.++|+.+..+..+|++||||
T Consensus        14 ~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~   93 (467)
T KOG0201|consen   14 LYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYC   93 (467)
T ss_pred             ccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHh
Confidence            58888999999999999999999999999999986543  3367899999999999999999999999999999999999


Q ss_pred             CCCChHHHHHhCCCCCHHHHHHHHH-------HHHHCCeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCC-CCCCC
Q 019195           81 AGGELFERICNAGRFSEDEARYFFQ-------QLISGQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS-RPKST  152 (344)
Q Consensus        81 ~~g~L~~~i~~~~~~~~~~~~~~~~-------ql~~~~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~-~~~~~  152 (344)
                      .||++.+.++....+.+.++..+++       .+|..+.+|||||+.|||+...+.  +||+|||.+....... ...++
T Consensus        94 ~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~--vkl~DfgVa~ql~~~~~rr~tf  171 (467)
T KOG0201|consen   94 GGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGD--VKLADFGVAGQLTNTVKRRKTF  171 (467)
T ss_pred             cCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCc--EEEEecceeeeeechhhccccc
Confidence            9999999998877766665555544       455569999999999999987754  9999999987654433 33678


Q ss_pred             ccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCCC-CCCCCHhHHHHHH
Q 019195          153 VGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPD-YVHISQDCRNLLS  231 (344)
Q Consensus       153 ~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~s~~~~~li~  231 (344)
                      +|||.|||||++.+..|+.+ +|||||||+.+||++|.+|+........+.    .+.+..  .|. ...+|+.+++||.
T Consensus       172 vGTPfwMAPEVI~~~~Y~~K-ADIWSLGITaiEla~GePP~s~~hPmrvlf----lIpk~~--PP~L~~~~S~~~kEFV~  244 (467)
T KOG0201|consen  172 VGTPFWMAPEVIKQSGYDTK-ADIWSLGITAIELAKGEPPHSKLHPMRVLF----LIPKSA--PPRLDGDFSPPFKEFVE  244 (467)
T ss_pred             cccccccchhhhccccccch-hhhhhhhHHHHHHhcCCCCCcccCcceEEE----eccCCC--CCccccccCHHHHHHHH
Confidence            89999999999998888766 899999999999999999998765522111    111111  111 1268899999999


Q ss_pred             HhcccCCCCCCChHHHhcCcccccCC
Q 019195          232 RIFVANPSRRITIKEIKSHPWFLKNL  257 (344)
Q Consensus       232 ~~L~~dp~~R~s~~ell~hp~~~~~~  257 (344)
                      .||++||+.||+|.+||+|+|++...
T Consensus       245 ~CL~k~P~~RpsA~~LLKh~FIk~a~  270 (467)
T KOG0201|consen  245 ACLDKNPEFRPSAKELLKHKFIKRAK  270 (467)
T ss_pred             HHhhcCcccCcCHHHHhhhHHHHhcC
Confidence            99999999999999999999998754

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=8.3e-48  Score=345.29  Aligned_cols=250  Identities=28%  Similarity=0.448  Sum_probs=201.1

Q ss_pred             CCCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCc--cccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEEe
Q 019195            1 MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH--KIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVME   78 (344)
Q Consensus         1 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e   78 (344)
                      |++|++++.||.|+||.||+|.+..++..||+|++....  .....+.+|+.+++.++||||+++++++...+.+++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e   83 (288)
T cd07871           4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFE   83 (288)
T ss_pred             cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEe
Confidence            679999999999999999999999999999999987543  233567899999999999999999999999999999999


Q ss_pred             cCCCCChHHHHHhCC-CCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCC-CC
Q 019195           79 YAAGGELFERICNAG-RFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS-RP  149 (344)
Q Consensus        79 ~~~~g~L~~~i~~~~-~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~-~~  149 (344)
                      |+++ +|.+++...+ .+++..++.++.|++.|       ||+||||||+|||++.++.  +||+|||+++...... ..
T Consensus        84 ~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~--~kl~DfG~~~~~~~~~~~~  160 (288)
T cd07871          84 YLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGE--LKLADFGLARAKSVPTKTY  160 (288)
T ss_pred             CCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCC--EEECcCcceeeccCCCccc
Confidence            9975 8988886654 47888777777666654       9999999999999977654  9999999987543222 22


Q ss_pred             CCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhcc---------------c
Q 019195          150 KSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQ---------------Y  214 (344)
Q Consensus       150 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~---------------~  214 (344)
                      ....||+.|+|||++.+....+.++||||+||++|+|++|++||......+.+..+........               .
T Consensus       161 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (288)
T cd07871         161 SNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRSY  240 (288)
T ss_pred             cCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhhcc
Confidence            3457899999999987655445669999999999999999999988765544443333211100               0


Q ss_pred             cCCC---------CCCCCHhHHHHHHHhcccCCCCCCChHHHhcCccc
Q 019195          215 KIPD---------YVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF  253 (344)
Q Consensus       215 ~~~~---------~~~~s~~~~~li~~~L~~dp~~R~s~~ell~hp~~  253 (344)
                      .+|.         ...+++++.+||++||+.||.+|||+.|+|+||||
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f  288 (288)
T cd07871         241 LFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF  288 (288)
T ss_pred             ccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence            0111         12467899999999999999999999999999998

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=6.6e-48  Score=345.42  Aligned_cols=250  Identities=26%  Similarity=0.398  Sum_probs=204.7

Q ss_pred             CceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCc----cccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEEe
Q 019195            3 KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH----KIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVME   78 (344)
Q Consensus         3 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e   78 (344)
                      .|++.+.||+|+||.||++.+..+++.||+|.+....    .....+.+|+.+++.++|+||+++++++...+.+++|||
T Consensus         1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05631           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence            4899999999999999999999999999999987532    222457789999999999999999999999999999999


Q ss_pred             cCCCCChHHHHHhC--CCCCHHHHHHHHHHHHH-------CCeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCCCC
Q 019195           79 YAAGGELFERICNA--GRFSEDEARYFFQQLIS-------GQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP  149 (344)
Q Consensus        79 ~~~~g~L~~~i~~~--~~~~~~~~~~~~~ql~~-------~~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~~~  149 (344)
                      |+++|+|...+...  ..+++..++.++.|++.       .||+||||||+|||++.++.  +||+|||++.........
T Consensus        81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~--~kl~Dfg~~~~~~~~~~~  158 (285)
T cd05631          81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGH--IRISDLGLAVQIPEGETV  158 (285)
T ss_pred             ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCC--EEEeeCCCcEEcCCCCee
Confidence            99999998887543  35888888777766554       59999999999999986654  999999998765433334


Q ss_pred             CCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCHhHHHH
Q 019195          150 KSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL  229 (344)
Q Consensus       150 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  229 (344)
                      ....||+.|+|||++.+..++ .++|||||||++|+|++|+.||...............+.......  ...+++++.+|
T Consensus       159 ~~~~g~~~y~aPE~~~~~~~~-~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~s~~~~~l  235 (285)
T cd05631         159 RGRVGTVGYMAPEVINNEKYT-FSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEY--SEKFSEDAKSI  235 (285)
T ss_pred             cCCCCCCCccCHhhhcCCCCC-cccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcccccC--CccCCHHHHHH
Confidence            456799999999999877765 459999999999999999999987654333333333333322222  33679999999


Q ss_pred             HHHhcccCCCCCCC-----hHHHhcCcccccCC
Q 019195          230 LSRIFVANPSRRIT-----IKEIKSHPWFLKNL  257 (344)
Q Consensus       230 i~~~L~~dp~~R~s-----~~ell~hp~~~~~~  257 (344)
                      |.+||+.||.+||+     ++++++||||....
T Consensus       236 i~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~~~  268 (285)
T cd05631         236 CRMLLTKNPKERLGCRGNGAAGVKQHPIFKNIN  268 (285)
T ss_pred             HHHHhhcCHHHhcCCCCCCHHHHhcCHhhcCCC
Confidence            99999999999997     89999999997754

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=7.3e-48  Score=356.71  Aligned_cols=251  Identities=29%  Similarity=0.491  Sum_probs=205.3

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCc----cccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEE
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH----KIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVM   77 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~   77 (344)
                      ++|++++.||+|+||+||+|.+..+++.||+|++.+..    .....+.+|+.+++.++||||+++++.+.+...+|+||
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~   80 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM   80 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence            58999999999999999999999999999999997632    22246778999999999999999999999999999999


Q ss_pred             ecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCC---
Q 019195           78 EYAAGGELFERICNAGRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS---  147 (344)
Q Consensus        78 e~~~~g~L~~~i~~~~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~---  147 (344)
                      |||+||+|.+++.+.+.+++.+++.++.|++.+       ||+||||||+|||++.++  ++||+|||+++......   
T Consensus        81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~--~vkL~DFGla~~~~~~~~~~  158 (363)
T cd05628          81 EFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKG--HVKLSDFGLCTGLKKAHRTE  158 (363)
T ss_pred             cCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCC--CEEEeeccCccccccccccc
Confidence            999999999999988899999988887776654       999999999999998765  49999999986432110   


Q ss_pred             ---------------------------------CCCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCC
Q 019195          148 ---------------------------------RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFE  194 (344)
Q Consensus       148 ---------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~  194 (344)
                                                       .....+||+.|+|||++.+..++ .++|||||||++|+|++|+.||.
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~-~~~DvwSlGvil~ell~G~~Pf~  237 (363)
T cd05628         159 FYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYN-KLCDWWSLGVIMYEMLIGYPPFC  237 (363)
T ss_pred             ccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCC-CchhhhhhHHHHHHHHhCCCCCC
Confidence                                             01235799999999999887765 45999999999999999999998


Q ss_pred             CCCChHHHHHHHHHHhhccccCCCCCCCCHhHHHHHHHhcccCCC---CCCChHHHhcCcccccCCC
Q 019195          195 DQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPS---RRITIKEIKSHPWFLKNLP  258 (344)
Q Consensus       195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~---~R~s~~ell~hp~~~~~~~  258 (344)
                      .......+.++...  .....+|....+++++++||.+|++ +|.   .||++.++++||||.....
T Consensus       238 ~~~~~~~~~~i~~~--~~~~~~p~~~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei~~hp~f~~~~~  301 (363)
T cd05628         238 SETPQETYKKVMNW--KETLIFPPEVPISEKAKDLILRFCC-EWEHRIGAPGVEEIKTNPFFEGVDW  301 (363)
T ss_pred             CCCHHHHHHHHHcC--cCcccCCCcCCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhCCCCCCCCCH
Confidence            76654443333221  1233455555689999999999876 444   4689999999999987643

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=1.5e-47  Score=346.06  Aligned_cols=253  Identities=25%  Similarity=0.422  Sum_probs=199.2

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCcc--ccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEEec
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK--IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEY   79 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~   79 (344)
                      ++|++++.||+|+||.||+|.+..+++.||+|++.....  ....+.+|+.+++.++||||+++++++.++...++||||
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~   84 (303)
T cd07869           5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFEY   84 (303)
T ss_pred             ccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEEC
Confidence            689999999999999999999999999999999875432  234678899999999999999999999999999999999


Q ss_pred             CCCCChHHHHHhC-CCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCC-CCCC
Q 019195           80 AAGGELFERICNA-GRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH-SRPK  150 (344)
Q Consensus        80 ~~~g~L~~~i~~~-~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~-~~~~  150 (344)
                      +. ++|.+.+.+. +.+++..++.++.|++.|       ||+||||||+|||++.++.  +||+|||++...... ....
T Consensus        85 ~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~--~kl~Dfg~~~~~~~~~~~~~  161 (303)
T cd07869          85 VH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGE--LKLADFGLARAKSVPSHTYS  161 (303)
T ss_pred             CC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCC--EEECCCCcceeccCCCccCC
Confidence            95 5777777553 568888888888777665       9999999999999976654  999999998643222 2234


Q ss_pred             CCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccc--------cC------
Q 019195          151 STVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQY--------KI------  216 (344)
Q Consensus       151 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~--------~~------  216 (344)
                      ...||+.|+|||++.+....+.++|||||||++|+|++|..||.+..+.......+........        ..      
T Consensus       162 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (303)
T cd07869         162 NEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHFKPE  241 (303)
T ss_pred             CCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhccccccc
Confidence            4578999999999876654556699999999999999999999876543222211111110000        00      


Q ss_pred             ------C-------CCCCCCHhHHHHHHHhcccCCCCCCChHHHhcCcccccCC
Q 019195          217 ------P-------DYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNL  257 (344)
Q Consensus       217 ------~-------~~~~~s~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~~~  257 (344)
                            +       ....+++++.+||.+||+.||.+|||+.++|+||||....
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~~  295 (303)
T cd07869         242 RFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDLP  295 (303)
T ss_pred             cccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccccCC
Confidence                  0       0012457899999999999999999999999999997653

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.5e-48  Score=358.33  Aligned_cols=249  Identities=34%  Similarity=0.587  Sum_probs=206.5

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCc----cccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEE
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH----KIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVM   77 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~   77 (344)
                      ++|++++.||+|+||.||+|.+..+++.||||++....    .....+.+|+.+++.++||||+++++++.+++.+|+||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM   80 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence            58999999999999999999999999999999997642    22345778999999999999999999999999999999


Q ss_pred             ecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCC---
Q 019195           78 EYAAGGELFERICNAGRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS---  147 (344)
Q Consensus        78 e~~~~g~L~~~i~~~~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~---  147 (344)
                      |||++|+|.+++...+.+++..++.++.|++.+       ||+||||||+|||++.++.  +||+|||++.......   
T Consensus        81 E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~--~kl~Dfg~~~~~~~~~~~~  158 (364)
T cd05599          81 EYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGH--IKLSDFGLCTGLKKSHRTE  158 (364)
T ss_pred             CCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCC--EEEeecccceecccccccc
Confidence            999999999999888889999988888777655       9999999999999987664  9999999986432110   


Q ss_pred             ------------------------------------CCCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCC
Q 019195          148 ------------------------------------RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAY  191 (344)
Q Consensus       148 ------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~  191 (344)
                                                          .....+||+.|+|||++.+..++ .++|||||||++|+|++|.+
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~il~el~~G~~  237 (364)
T cd05599         159 FYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYN-KECDWWSLGVIMYEMLVGYP  237 (364)
T ss_pred             ccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCC-CeeeeecchhHHHHhhcCCC
Confidence                                                01134699999999999877765 55999999999999999999


Q ss_pred             CCCCCCChHHHHHHHHHHhhccccCCCCCCCCHhHHHHHHHhcccCCCCCCC---hHHHhcCcccccC
Q 019195          192 PFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRIT---IKEIKSHPWFLKN  256 (344)
Q Consensus       192 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s---~~ell~hp~~~~~  256 (344)
                      ||...........+...  ......|....+++++.+||.+||. +|.+|++   +.+++.||||...
T Consensus       238 Pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~~~~~~  302 (364)
T cd05599         238 PFCSDNPQETYRKIINW--KETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHPFFKGV  302 (364)
T ss_pred             CCCCCCHHHHHHHHHcC--CCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCCCcCCC
Confidence            99876654333332211  1223445555689999999999997 9999998   9999999999765

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=6.3e-48  Score=351.62  Aligned_cols=241  Identities=36%  Similarity=0.595  Sum_probs=201.6

Q ss_pred             eeeeecCceEEEEEEEcCCCcEEEEEEeecCc----cccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEEecCCCC
Q 019195            8 KDIGSGNFGVARLMRNKNTKELVAMKYIERGH----KIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYAAGG   83 (344)
Q Consensus         8 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g   83 (344)
                      +.||+|+||.||+|.+..+++.||+|++.+..    .....+.+|+.+++.++||||+++++++...+.+|+||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~   80 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence            46999999999999999999999999997632    22245778999999999999999999999999999999999999


Q ss_pred             ChHHHHHhCCCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCC-CCCCCCccC
Q 019195           84 ELFERICNAGRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH-SRPKSTVGT  155 (344)
Q Consensus        84 ~L~~~i~~~~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~-~~~~~~~gt  155 (344)
                      +|..++.+.+.+++.+++.++.||+.+       ||+||||||+|||++.++.  +||+|||+++..... ......+||
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~--~kl~DfG~a~~~~~~~~~~~~~~gt  158 (323)
T cd05571          81 ELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGH--IKITDFGLCKEGISDGATMKTFCGT  158 (323)
T ss_pred             cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCC--EEEeeCCCCcccccCCCcccceecC
Confidence            999999888889999888877776654       9999999999999977654  999999998753322 233456799


Q ss_pred             CcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCHhHHHHHHHhcc
Q 019195          156 PAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFV  235 (344)
Q Consensus       156 ~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~  235 (344)
                      +.|+|||++.+..+. .++|||||||++|+|++|+.||...+....    ...+......+|.  .+++++.+||.+||+
T Consensus       159 ~~y~aPE~~~~~~~~-~~~DiwSlG~il~elltg~~Pf~~~~~~~~----~~~~~~~~~~~p~--~~~~~~~~li~~~L~  231 (323)
T cd05571         159 PEYLAPEVLEDNDYG-RAVDWWGLGVVMYEMMCGRLPFYNQDHEKL----FELILMEEIRFPR--TLSPEAKSLLAGLLK  231 (323)
T ss_pred             ccccChhhhcCCCCC-ccccCcccchhhhhhhcCCCCCCCCCHHHH----HHHHHcCCCCCCC--CCCHHHHHHHHHHcc
Confidence            999999999877765 459999999999999999999987654332    2333333444443  689999999999999


Q ss_pred             cCCCCCC-----ChHHHhcCcccccCC
Q 019195          236 ANPSRRI-----TIKEIKSHPWFLKNL  257 (344)
Q Consensus       236 ~dp~~R~-----s~~ell~hp~~~~~~  257 (344)
                      .||.+||     ++.++++||||....
T Consensus       232 ~dP~~R~~~~~~~~~~ll~h~~f~~~~  258 (323)
T cd05571         232 KDPKQRLGGGPEDAKEIMEHRFFASIN  258 (323)
T ss_pred             CCHHHcCCCCCCCHHHHHcCCCcCCCC
Confidence            9999999     899999999997753

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=2.5e-47  Score=341.72  Aligned_cols=249  Identities=28%  Similarity=0.425  Sum_probs=200.6

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCc---cccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEEe
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH---KIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVME   78 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e   78 (344)
                      ++|++.+.||+|+||.||++.+..+++.||+|++....   .....+.+|+.+++.++||||+++++++..++.+|+|||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE   80 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence            58999999999999999999999999999999987643   234567899999999999999999999999999999999


Q ss_pred             cCCCCChHHHHHhCCCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCC--CC
Q 019195           79 YAAGGELFERICNAGRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS--RP  149 (344)
Q Consensus        79 ~~~~g~L~~~i~~~~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~--~~  149 (344)
                      |++++.+..+......+++..++.++.|++.+       ||+||||||+||+++.++.  +||+|||++.......  ..
T Consensus        81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~--~kl~Dfg~~~~~~~~~~~~~  158 (287)
T cd07848          81 YVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDV--LKLCDFGFARNLSEGSNANY  158 (287)
T ss_pred             cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCc--EEEeeccCcccccccccccc
Confidence            99987776665555678999888888877764       9999999999999976654  9999999987643322  22


Q ss_pred             CCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhh---------------ccc
Q 019195          150 KSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMA---------------VQY  214 (344)
Q Consensus       150 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~---------------~~~  214 (344)
                      ....||+.|+|||++.+..++ .++|||||||++|+|++|++||...........+......               ...
T Consensus       159 ~~~~~~~~y~aPE~~~~~~~~-~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (287)
T cd07848         159 TEYVATRWYRSPELLLGAPYG-KAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGL  237 (287)
T ss_pred             cccccccccCCcHHHcCCCCC-CchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhccc
Confidence            345799999999999877764 5599999999999999999999876554433322211000               000


Q ss_pred             cCCC-----------CCCCCHhHHHHHHHhcccCCCCCCChHHHhcCccc
Q 019195          215 KIPD-----------YVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF  253 (344)
Q Consensus       215 ~~~~-----------~~~~s~~~~~li~~~L~~dp~~R~s~~ell~hp~~  253 (344)
                      ..|.           ...+|.++.+||++||+.||.+|||+.++|+||||
T Consensus       238 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f  287 (287)
T cd07848         238 RFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF  287 (287)
T ss_pred             ccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence            1111           11367889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=1.1e-47  Score=352.13  Aligned_cols=245  Identities=31%  Similarity=0.530  Sum_probs=205.0

Q ss_pred             CCCceeeeeeeecCceEEEEEEEcCCC-cEEEEEEeecCc----cccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEE
Q 019195            1 MEKYELMKDIGSGNFGVARLMRNKNTK-ELVAMKYIERGH----KIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAI   75 (344)
Q Consensus         1 ~~~y~~~~~lg~G~~g~V~~~~~~~~~-~~vaiK~~~~~~----~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~l   75 (344)
                      +++|++++.||+|+||.||+|.+..++ ..||+|++.+..    .....+.+|+.+++.++||||+++++++.+.+.+|+
T Consensus        29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l  108 (340)
T PTZ00426         29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL  108 (340)
T ss_pred             hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence            368999999999999999999876654 789999987532    223467789999999999999999999999999999


Q ss_pred             EEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHH-------CCeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCCC
Q 019195           76 VMEYAAGGELFERICNAGRFSEDEARYFFQQLIS-------GQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR  148 (344)
Q Consensus        76 v~e~~~~g~L~~~i~~~~~~~~~~~~~~~~ql~~-------~~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~~  148 (344)
                      ||||+++|+|.+++...+.+++..++.++.||+.       .||+||||||+|||++.++  ++||+|||++.....  .
T Consensus       109 v~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~--~ikL~DFG~a~~~~~--~  184 (340)
T PTZ00426        109 VLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDG--FIKMTDFGFAKVVDT--R  184 (340)
T ss_pred             EEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCC--CEEEecCCCCeecCC--C
Confidence            9999999999999998888999888888777654       4999999999999997665  499999999875432  2


Q ss_pred             CCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCHhHHH
Q 019195          149 PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRN  228 (344)
Q Consensus       149 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~  228 (344)
                      ....+||+.|+|||++.+..++ .++|||||||++|+|++|.+||...+....    ...+......+|.  .+++.+.+
T Consensus       185 ~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlGvil~ell~G~~Pf~~~~~~~~----~~~i~~~~~~~p~--~~~~~~~~  257 (340)
T PTZ00426        185 TYTLCGTPEYIAPEILLNVGHG-KAADWWTLGIFIYEILVGCPPFYANEPLLI----YQKILEGIIYFPK--FLDNNCKH  257 (340)
T ss_pred             cceecCChhhcCHHHHhCCCCC-ccccccchhhHHHHHhcCCCCCCCCCHHHH----HHHHhcCCCCCCC--CCCHHHHH
Confidence            3456799999999999876664 559999999999999999999987654333    3333344444444  57899999


Q ss_pred             HHHHhcccCCCCCC-----ChHHHhcCcccccC
Q 019195          229 LLSRIFVANPSRRI-----TIKEIKSHPWFLKN  256 (344)
Q Consensus       229 li~~~L~~dp~~R~-----s~~ell~hp~~~~~  256 (344)
                      +|++||+.||.+|+     ++.++++||||...
T Consensus       258 li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~~  290 (340)
T PTZ00426        258 LMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNI  290 (340)
T ss_pred             HHHHHcccCHHHcCCCCCCCHHHHHcCCCcCCC
Confidence            99999999999996     89999999999764

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-47  Score=350.56  Aligned_cols=248  Identities=29%  Similarity=0.521  Sum_probs=206.8

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCc----cccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEE
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH----KIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVM   77 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~   77 (344)
                      ++|++++.||+|+||.||+|.+..+++.||+|++.+..    .....+.+|+.+++.++||||+++++++...+.+|+||
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~   80 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM   80 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence            57999999999999999999999999999999997642    22346788999999999999999999999999999999


Q ss_pred             ecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCCCCC
Q 019195           78 EYAAGGELFERICNAGRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPK  150 (344)
Q Consensus        78 e~~~~g~L~~~i~~~~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~~~~  150 (344)
                      ||+++++|.+++...+.+++.+++.++.||+.+       ||+||||||+|||++.++.  +||+|||++.....  ...
T Consensus        81 e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~--~kL~Dfg~a~~~~~--~~~  156 (333)
T cd05600          81 EYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGH--IKLTDFGLSKGIVT--YAN  156 (333)
T ss_pred             eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCC--EEEEeCcCCccccc--ccC
Confidence            999999999999888889998888877776654       9999999999999987654  99999999875433  345


Q ss_pred             CCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCCCC----CCCCHhH
Q 019195          151 STVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDY----VHISQDC  226 (344)
Q Consensus       151 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~s~~~  226 (344)
                      ..+||+.|+|||++.+..++ .++|||||||++|+|++|..||...+....+..+....  .....|..    ..+++++
T Consensus       157 ~~~gt~~y~aPE~~~~~~~~-~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~~~~~s~~~  233 (333)
T cd05600         157 SVVGSPDYMAPEVLRGKGYD-FTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWK--ETLQRPVYDDPRFNLSDEA  233 (333)
T ss_pred             CcccCccccChhHhcCCCCC-CccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhcc--ccccCCCCCccccccCHHH
Confidence            56799999999999887665 55999999999999999999998766544433322211  11122222    2568999


Q ss_pred             HHHHHHhcccCCCCCCChHHHhcCcccccC
Q 019195          227 RNLLSRIFVANPSRRITIKEIKSHPWFLKN  256 (344)
Q Consensus       227 ~~li~~~L~~dp~~R~s~~ell~hp~~~~~  256 (344)
                      .+||.+||..+|.+||++.++++||||...
T Consensus       234 ~~li~~~l~~~~~rr~s~~~ll~h~~~~~~  263 (333)
T cd05600         234 WDLITKLINDPSRRFGSLEDIKNHPFFKEV  263 (333)
T ss_pred             HHHHHHHhhChhhhcCCHHHHHhCcccCCC
Confidence            999999999999999999999999999764

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=2.2e-47  Score=355.65  Aligned_cols=249  Identities=31%  Similarity=0.484  Sum_probs=203.0

Q ss_pred             CceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCc----cccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEEe
Q 019195            3 KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH----KIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVME   78 (344)
Q Consensus         3 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e   78 (344)
                      .|++++.||+|+||+||+|.+..+++.||+|++.+..    .....+.+|+.+++.++||||+++++++.+.+.+|+|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E   81 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD   81 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence            6999999999999999999999999999999997643    223467889999999999999999999999999999999


Q ss_pred             cCCCCChHHHHHhCCCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCC-----
Q 019195           79 YAAGGELFERICNAGRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH-----  146 (344)
Q Consensus        79 ~~~~g~L~~~i~~~~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~-----  146 (344)
                      ||++|+|.+++.+.+.+++..++.++.||+.+       ||+||||||+|||++.++  ++||+|||+++.....     
T Consensus        82 ~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~--~~kL~DFGl~~~~~~~~~~~~  159 (381)
T cd05626          82 YIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDG--HIKLTDFGLCTGFRWTHNSKY  159 (381)
T ss_pred             cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCC--CEEEeeCcCCccccccccccc
Confidence            99999999999888889988888877776554       999999999999997665  5999999987532100     


Q ss_pred             -------------------------------------------CCCCCCccCCcccCCccccCCCCCCcchhHHHHHHHH
Q 019195          147 -------------------------------------------SRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTL  183 (344)
Q Consensus       147 -------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il  183 (344)
                                                                 ......+||+.|+|||++.+..++ .++|||||||++
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~-~~~DiwSlG~il  238 (381)
T cd05626         160 YQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYT-QLCDWWSVGVIL  238 (381)
T ss_pred             ccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCC-CccceeehhhHH
Confidence                                                       001235799999999999877765 559999999999


Q ss_pred             HHHHhCCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCHhHHHHHHHhccc--CCCCCCChHHHhcCcccccC
Q 019195          184 YVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVA--NPSRRITIKEIKSHPWFLKN  256 (344)
Q Consensus       184 ~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~--dp~~R~s~~ell~hp~~~~~  256 (344)
                      |+|++|.+||...........++.  .......|....+++++.+||.+||+.  +|..|+++.++++||||...
T Consensus       239 ~elltG~~Pf~~~~~~~~~~~i~~--~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~hp~f~~~  311 (381)
T cd05626         239 FEMLVGQPPFLAPTPTETQLKVIN--WENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHPFFSEV  311 (381)
T ss_pred             HHHHhCCCCCcCCCHHHHHHHHHc--cccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCcccCCC
Confidence            999999999987665433333221  122344555557899999999997655  44459999999999999764

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=1.1e-46  Score=344.59  Aligned_cols=252  Identities=26%  Similarity=0.442  Sum_probs=204.0

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCc--cccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEEec
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH--KIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEY   79 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~   79 (344)
                      ++|++++.||+|+||.||++.+..++..||+|++....  .....+.+|+.++++++||||+++++++..++.+++||||
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   84 (331)
T cd06649           5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH   84 (331)
T ss_pred             ccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEeec
Confidence            68999999999999999999999999999999987642  2335688999999999999999999999999999999999


Q ss_pred             CCCCChHHHHHhCCCCCHHHHHHHHHHHHHC--------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCCCCCC
Q 019195           80 AAGGELFERICNAGRFSEDEARYFFQQLISG--------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKS  151 (344)
Q Consensus        80 ~~~g~L~~~i~~~~~~~~~~~~~~~~ql~~~--------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~~~~~  151 (344)
                      +++++|.+++.....+++..++.++.|++.+        +|+||||||+|||++.++.  +||+|||++..... .....
T Consensus        85 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~-~~~~~  161 (331)
T cd06649          85 MDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGE--IKLCDFGVSGQLID-SMANS  161 (331)
T ss_pred             CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCc--EEEccCcccccccc-ccccc
Confidence            9999999999888889998888887776643        6999999999999987654  99999999875432 22345


Q ss_pred             CccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHH------------------------
Q 019195          152 TVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTIS------------------------  207 (344)
Q Consensus       152 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~------------------------  207 (344)
                      ..||+.|+|||++.+..++ .++|||||||++|+|++|+.||....... +...+.                        
T Consensus       162 ~~g~~~y~aPE~~~~~~~~-~~~DiwslG~il~el~tg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (331)
T cd06649         162 FVGTRSYMSPERLQGTHYS-VQSDIWSMGLSLVELAIGRYPIPPPDAKE-LEAIFGRPVVDGEEGEPHSISPRPRPPGRP  239 (331)
T ss_pred             CCCCcCcCCHhHhcCCCCC-chHhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHhcccccccccCCccccCccccccccc
Confidence            5799999999999877765 45999999999999999999997544321 111111                        


Q ss_pred             -------------------HHhhccccCCCCCCCCHhHHHHHHHhcccCCCCCCChHHHhcCcccccCCC
Q 019195          208 -------------------RIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLP  258 (344)
Q Consensus       208 -------------------~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~~~~  258 (344)
                                         .+............+++++.+||.+||+.||++|||+.++++||||.....
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~~  309 (331)
T cd06649         240 VSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKRSEV  309 (331)
T ss_pred             ccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhhccc
Confidence                               000000000011246889999999999999999999999999999976543

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-47  Score=356.37  Aligned_cols=249  Identities=32%  Similarity=0.525  Sum_probs=203.4

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCcc----ccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEE
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK----IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVM   77 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~   77 (344)
                      ++|++++.||+|+||.||++.+..+++.||+|++.+...    ....+.+|+.+++.++||||++++++|.+...+|+||
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~   80 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM   80 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence            589999999999999999999999999999999865321    2246778999999999999999999999999999999


Q ss_pred             ecCCCCChHHHHHhCCCCCHHHHHHHHHHHHH-------CCeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCC---
Q 019195           78 EYAAGGELFERICNAGRFSEDEARYFFQQLIS-------GQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS---  147 (344)
Q Consensus        78 e~~~~g~L~~~i~~~~~~~~~~~~~~~~ql~~-------~~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~---  147 (344)
                      ||+++|+|..++...+.+++..++.++.|++.       .||+||||||+|||++.++.  +||+|||+++......   
T Consensus        81 E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~--~kl~DfGla~~~~~~~~~~  158 (377)
T cd05629          81 EFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGH--IKLSDFGLSTGFHKQHDSA  158 (377)
T ss_pred             eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCC--EEEeecccccccccccccc
Confidence            99999999999988888999888887777665       49999999999999976654  9999999985211100   


Q ss_pred             ---------------------------------------------CCCCCccCCcccCCccccCCCCCCcchhHHHHHHH
Q 019195          148 ---------------------------------------------RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVT  182 (344)
Q Consensus       148 ---------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~i  182 (344)
                                                                   .....+||+.|+|||++.+..+. .++|||||||+
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlGvi  237 (377)
T cd05629         159 YYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYG-QECDWWSLGAI  237 (377)
T ss_pred             cccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCC-CceeeEecchh
Confidence                                                         00135699999999999877765 55999999999


Q ss_pred             HHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCHhHHHHHHHhcccCCCCC---CChHHHhcCcccccC
Q 019195          183 LYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRR---ITIKEIKSHPWFLKN  256 (344)
Q Consensus       183 l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R---~s~~ell~hp~~~~~  256 (344)
                      +|+|++|.+||........+..+...  .....+|....++.++.+||.+||+ +|.+|   +|+.+++.||||...
T Consensus       238 l~elltG~~Pf~~~~~~~~~~~i~~~--~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~hp~~~~~  311 (377)
T cd05629         238 MFECLIGWPPFCSENSHETYRKIINW--RETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSHPFFRGV  311 (377)
T ss_pred             hhhhhcCCCCCCCCCHHHHHHHHHcc--CCccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcCCCcCCC
Confidence            99999999999876654443333221  1233455555689999999999998 67765   599999999999764

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-47  Score=352.79  Aligned_cols=249  Identities=35%  Similarity=0.583  Sum_probs=209.4

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCc----cccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEE
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH----KIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVM   77 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~   77 (344)
                      ++|++++.||+|+||+||+|.+..+++.||+|++....    .....+.+|+.+++.++||||+++++++.+++.+|+||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM   80 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence            58999999999999999999999999999999997642    23356788999999999999999999999999999999


Q ss_pred             ecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCC---
Q 019195           78 EYAAGGELFERICNAGRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS---  147 (344)
Q Consensus        78 e~~~~g~L~~~i~~~~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~---  147 (344)
                      ||+++++|.+++.+.+.+++..++.++.|++.+       ||+||||||+|||++.++.  +||+|||++.......   
T Consensus        81 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~--~kL~Dfg~~~~~~~~~~~~  158 (350)
T cd05573          81 EYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGH--IKLADFGLCKKMNKAKDRE  158 (350)
T ss_pred             cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCC--EEeecCCCCccCcccCccc
Confidence            999999999999888889999888887776655       9999999999999987664  9999999987544332   


Q ss_pred             ---------------------------CCCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChH
Q 019195          148 ---------------------------RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPK  200 (344)
Q Consensus       148 ---------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~  200 (344)
                                                 ......||+.|+|||++.+..++ .++|||||||++|+|++|+.||.......
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~il~ell~g~~Pf~~~~~~~  237 (350)
T cd05573         159 YYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYG-LECDWWSLGVILYEMLYGFPPFYSDTLQE  237 (350)
T ss_pred             ccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCC-CceeeEecchhhhhhccCCCCCCCCCHHH
Confidence                                       22345699999999999888665 45999999999999999999998876543


Q ss_pred             HHHHHHHHHhhccccCCCCCCCCHhHHHHHHHhcccCCCCCCC-hHHHhcCcccccC
Q 019195          201 NFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRIT-IKEIKSHPWFLKN  256 (344)
Q Consensus       201 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s-~~ell~hp~~~~~  256 (344)
                      ....+...  ......|....+++++.+||.+||. ||.+||+ +.++++||||...
T Consensus       238 ~~~~i~~~--~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~~~~~  291 (350)
T cd05573         238 TYNKIINW--KESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFFKGI  291 (350)
T ss_pred             HHHHHhcc--CCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCCcCCC
Confidence            33332221  1334455555689999999999997 9999999 9999999999764

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=2.7e-47  Score=355.26  Aligned_cols=249  Identities=34%  Similarity=0.532  Sum_probs=203.9

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCcc----ccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEE
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK----IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVM   77 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~   77 (344)
                      .+|++++.||+|+||.||+|.+..+++.||+|++.+...    ....+.+|+.++++++||||+++++++.+++.+|+||
T Consensus         1 ~~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~   80 (382)
T cd05625           1 SMFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM   80 (382)
T ss_pred             CCcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEE
Confidence            379999999999999999999999999999999876422    2346788999999999999999999999999999999


Q ss_pred             ecCCCCChHHHHHhCCCCCHHHHHHHHHHHHH-------CCeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCC----
Q 019195           78 EYAAGGELFERICNAGRFSEDEARYFFQQLIS-------GQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH----  146 (344)
Q Consensus        78 e~~~~g~L~~~i~~~~~~~~~~~~~~~~ql~~-------~~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~----  146 (344)
                      |||++|+|.+++.+.+.+++..++.++.||+.       .||+||||||+|||++.++.  +||+|||++......    
T Consensus        81 E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~--~kL~DFGla~~~~~~~~~~  158 (382)
T cd05625          81 DYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGH--IKLTDFGLCTGFRWTHDSK  158 (382)
T ss_pred             eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCC--EEEeECCCCcccccccccc
Confidence            99999999999988888998888877777654       49999999999999987654  999999997421100    


Q ss_pred             --------------------------------------------CCCCCCccCCcccCCccccCCCCCCcchhHHHHHHH
Q 019195          147 --------------------------------------------SRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVT  182 (344)
Q Consensus       147 --------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~i  182 (344)
                                                                  ......+||+.|+|||++.+..++ .++|||||||+
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~-~~~DiwSlGvi  237 (382)
T cd05625         159 YYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYT-QLCDWWSVGVI  237 (382)
T ss_pred             ccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCC-CeeeEEechHH
Confidence                                                        001234799999999999887775 45999999999


Q ss_pred             HHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCHhHHHHHHHhcccCCCCCCC---hHHHhcCcccccC
Q 019195          183 LYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRIT---IKEIKSHPWFLKN  256 (344)
Q Consensus       183 l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s---~~ell~hp~~~~~  256 (344)
                      +|+|++|++||...........+..  .......|....+++++.+||.+|+ .+|.+|++   +.++++||||...
T Consensus       238 l~elltG~~Pf~~~~~~~~~~~i~~--~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~~  311 (382)
T cd05625         238 LYEMLVGQPPFLAQTPLETQMKVIN--WQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKAHPFFKTI  311 (382)
T ss_pred             HHHHHhCCCCCCCCCHHHHHHHHHc--cCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhcCCCcCCc
Confidence            9999999999987655433333221  1223345555578999999999986 59999997   9999999999764

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=4.5e-47  Score=347.33  Aligned_cols=250  Identities=32%  Similarity=0.574  Sum_probs=204.3

Q ss_pred             CceeeeeeeecCceEEEEEEEc---CCCcEEEEEEeecCc-----cccHHHHHHHHHHhcC-CCCCcceeeEEEEcCCEE
Q 019195            3 KYELMKDIGSGNFGVARLMRNK---NTKELVAMKYIERGH-----KIDANVAREIINHKQL-RHPNIIRFKEVVLTPTHL   73 (344)
Q Consensus         3 ~y~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~-----~~~~~~~~ei~~l~~l-~h~niv~~~~~~~~~~~~   73 (344)
                      +|++++.||+|+||+||++.+.   .+++.||+|++.+..     .....+.+|+.+++.+ +||||+++++++..++.+
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL   80 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence            5999999999999999998864   578999999987532     2224577899999999 599999999999999999


Q ss_pred             EEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCC
Q 019195           74 AIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH  146 (344)
Q Consensus        74 ~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~  146 (344)
                      ++||||+++|+|..++.....+++.+++.++.||+.+       ||+||||||+|||++.++.  +||+|||+++.....
T Consensus        81 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~--~kl~DfG~~~~~~~~  158 (332)
T cd05614          81 HLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGH--VVLTDFGLSKEFLSE  158 (332)
T ss_pred             EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCC--EEEeeCcCCcccccc
Confidence            9999999999999999888889999888887776654       9999999999999987654  999999998754332


Q ss_pred             C--CCCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCH
Q 019195          147 S--RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQ  224 (344)
Q Consensus       147 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~  224 (344)
                      .  .....+||+.|+|||++.+....+.++|||||||++|+|++|..||...........+...+......++  ..+++
T Consensus       159 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~  236 (332)
T cd05614         159 EKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFP--SFIGP  236 (332)
T ss_pred             CCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcCCCCCC--CCCCH
Confidence            2  2234579999999999987654566799999999999999999999754433333333334443333333  36799


Q ss_pred             hHHHHHHHhcccCCCCCC-----ChHHHhcCcccccC
Q 019195          225 DCRNLLSRIFVANPSRRI-----TIKEIKSHPWFLKN  256 (344)
Q Consensus       225 ~~~~li~~~L~~dp~~R~-----s~~ell~hp~~~~~  256 (344)
                      .+.+||.+||+.||.+||     ++.++++||||...
T Consensus       237 ~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~  273 (332)
T cd05614         237 EAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGL  273 (332)
T ss_pred             HHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCC
Confidence            999999999999999999     78899999999865

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.8e-47  Score=344.83  Aligned_cols=238  Identities=34%  Similarity=0.615  Sum_probs=199.6

Q ss_pred             eeecCceEEEEEEEcCCCcEEEEEEeecCc----cccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEEecCCCCCh
Q 019195           10 IGSGNFGVARLMRNKNTKELVAMKYIERGH----KIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYAAGGEL   85 (344)
Q Consensus        10 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L   85 (344)
                      ||+|+||.||+|.+..+++.||+|++.+..    .....+.+|+.++++++||||+++++++...+.+|+||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L   80 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL   80 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence            799999999999999999999999987532    2234677899999999999999999999999999999999999999


Q ss_pred             HHHHHhCCCCCHHHHHHHHHHHHH-------CCeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCC-CCCCCCccCCc
Q 019195           86 FERICNAGRFSEDEARYFFQQLIS-------GQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH-SRPKSTVGTPA  157 (344)
Q Consensus        86 ~~~i~~~~~~~~~~~~~~~~ql~~-------~~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~-~~~~~~~gt~~  157 (344)
                      .+++...+.+++..++.++.|++.       .||+||||||+|||++.++.  +||+|||+++..... ......+||+.
T Consensus        81 ~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~gt~~  158 (312)
T cd05585          81 FHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGH--IALCDFGLCKLNMKDDDKTNTFCGTPE  158 (312)
T ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCc--EEEEECcccccCccCCCccccccCCcc
Confidence            999988888999988887777665       49999999999999977664  999999998753322 22344579999


Q ss_pred             ccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCHhHHHHHHHhcccC
Q 019195          158 YIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVAN  237 (344)
Q Consensus       158 y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~d  237 (344)
                      |+|||++.+..++ .++|||||||++|+|++|+.||........    ...+......+|.  .+++.+.+||.+||+.|
T Consensus       159 y~aPE~~~~~~~~-~~~DvwslGvil~el~tg~~pf~~~~~~~~----~~~~~~~~~~~~~--~~~~~~~~li~~~L~~d  231 (312)
T cd05585         159 YLAPELLLGHGYT-KAVDWWTLGVLLYEMLTGLPPFYDENVNEM----YRKILQEPLRFPD--GFDRDAKDLLIGLLSRD  231 (312)
T ss_pred             cCCHHHHcCCCCC-CccceechhHHHHHHHhCCCCcCCCCHHHH----HHHHHcCCCCCCC--cCCHHHHHHHHHHcCCC
Confidence            9999999887765 459999999999999999999987654333    3333444444443  68899999999999999


Q ss_pred             CCCCC---ChHHHhcCcccccC
Q 019195          238 PSRRI---TIKEIKSHPWFLKN  256 (344)
Q Consensus       238 p~~R~---s~~ell~hp~~~~~  256 (344)
                      |.+||   ++.++|.||||.+.
T Consensus       232 p~~R~~~~~~~e~l~hp~~~~~  253 (312)
T cd05585         232 PTRRLGYNGAQEIKNHPFFSQL  253 (312)
T ss_pred             HHHcCCCCCHHHHHcCCCcCCC
Confidence            99997   57999999999765

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=2.8e-47  Score=354.47  Aligned_cols=249  Identities=33%  Similarity=0.536  Sum_probs=204.0

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCc----cccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEE
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH----KIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVM   77 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~   77 (344)
                      .+|++++.||+|+||.||+|.+..+++.||+|++.+..    .....+.+|+.+++.++||||+++++.+.+++.+|+||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (376)
T cd05598           1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM   80 (376)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence            47999999999999999999999999999999986532    22356788999999999999999999999999999999


Q ss_pred             ecCCCCChHHHHHhCCCCCHHHHHHHHHHHHH-------CCeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCC----
Q 019195           78 EYAAGGELFERICNAGRFSEDEARYFFQQLIS-------GQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH----  146 (344)
Q Consensus        78 e~~~~g~L~~~i~~~~~~~~~~~~~~~~ql~~-------~~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~----  146 (344)
                      |||++|+|.+++.+.+.+++..++.++.||+.       .||+||||||+|||++.++.  +||+|||+|......    
T Consensus        81 E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~--ikL~DFG~a~~~~~~~~~~  158 (376)
T cd05598          81 DYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGH--IKLTDFGLCTGFRWTHDSK  158 (376)
T ss_pred             eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCC--EEEEeCCCCcccccccccc
Confidence            99999999999998888998888877776654       49999999999999986654  999999997421100    


Q ss_pred             ----------------------------------------CCCCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHH
Q 019195          147 ----------------------------------------SRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVM  186 (344)
Q Consensus       147 ----------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el  186 (344)
                                                              ......+||+.|+|||++.+..++ .++|||||||++|+|
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlGvilyel  237 (376)
T cd05598         159 YYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYT-QLCDWWSVGVILYEM  237 (376)
T ss_pred             ccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCC-cceeeeeccceeeeh
Confidence                                                    001234799999999999887765 459999999999999


Q ss_pred             HhCCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCHhHHHHHHHhcccCCCCCC---ChHHHhcCcccccC
Q 019195          187 LVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRI---TIKEIKSHPWFLKN  256 (344)
Q Consensus       187 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~---s~~ell~hp~~~~~  256 (344)
                      ++|+.||...........+..  .......+....+++++.+||.+|+ .+|.+|+   |+.++++||||...
T Consensus       238 l~G~~Pf~~~~~~~~~~~i~~--~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h~~~~~~  307 (376)
T cd05598         238 LVGQPPFLADTPAETQLKVIN--WETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAHPFFKGI  307 (376)
T ss_pred             hhCCCCCCCCCHHHHHHHHhc--cCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCCCCcCCC
Confidence            999999988765433332221  1123344555578999999999976 5999999   99999999999764

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=3.6e-48  Score=350.56  Aligned_cols=248  Identities=31%  Similarity=0.497  Sum_probs=217.8

Q ss_pred             CCCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCccc---cHHHHHHHHHHhcCCCCCcceeeEEEEcCCE-EEEE
Q 019195            1 MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKI---DANVAREIINHKQLRHPNIIRFKEVVLTPTH-LAIV   76 (344)
Q Consensus         1 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~-~~lv   76 (344)
                      |++|.+++.+|+|+||.+++++++..+..|++|.+......   .....+|+.+++++.|||||.+.+.|..++. ++||
T Consensus         3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Iv   82 (426)
T KOG0589|consen    3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIV   82 (426)
T ss_pred             cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEE
Confidence            68999999999999999999999999999999999765433   3467899999999999999999999999988 9999


Q ss_pred             EecCCCCChHHHHHhCC--CCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCC
Q 019195           77 MEYAAGGELFERICNAG--RFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS  147 (344)
Q Consensus        77 ~e~~~~g~L~~~i~~~~--~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~  147 (344)
                      |+||+||+|.+.|.+.+  .|+++.+..|+-|++.|       +|+|||||+.|||+..++.  |||+|||+|+......
T Consensus        83 m~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~--VkLgDfGlaK~l~~~~  160 (426)
T KOG0589|consen   83 MEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKK--VKLGDFGLAKILNPED  160 (426)
T ss_pred             EeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCc--eeecchhhhhhcCCch
Confidence            99999999999997644  68999999998887766       9999999999999987775  8999999999877776


Q ss_pred             -CCCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCHhH
Q 019195          148 -RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDC  226 (344)
Q Consensus       148 -~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~  226 (344)
                       ...+.+|||.||+||++.+.+|..+ +|||||||++|||++-+++|...+......++...    . -.|....++.++
T Consensus       161 ~~a~tvvGTp~YmcPEil~d~pYn~K-SDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~----~-~~Plp~~ys~el  234 (426)
T KOG0589|consen  161 SLASTVVGTPYYMCPEILSDIPYNEK-SDIWSLGCCLYEMCTLKPAFKASNMSELILKINRG----L-YSPLPSMYSSEL  234 (426)
T ss_pred             hhhheecCCCcccCHHHhCCCCCCcc-CcchhhcchHHHHHhcccccCccchHHHHHHHhhc----c-CCCCCccccHHH
Confidence             6778899999999999999998655 99999999999999999999988765555444433    2 345556789999


Q ss_pred             HHHHHHhcccCCCCCCChHHHhcCcccccC
Q 019195          227 RNLLSRIFVANPSRRITIKEIKSHPWFLKN  256 (344)
Q Consensus       227 ~~li~~~L~~dp~~R~s~~ell~hp~~~~~  256 (344)
                      +.||+.||..+|..||++.++|.+|.+...
T Consensus       235 ~~lv~~~l~~~P~~RPsa~~LL~~P~l~~~  264 (426)
T KOG0589|consen  235 RSLVKSMLRKNPEHRPSALELLRRPHLLRY  264 (426)
T ss_pred             HHHHHHHhhcCCccCCCHHHHhhChhhhhH
Confidence            999999999999999999999999887643

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=4.5e-47  Score=359.05  Aligned_cols=250  Identities=30%  Similarity=0.415  Sum_probs=198.6

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcCCCCCcceeeEEEEcC--------CEE
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKEVVLTP--------THL   73 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~--------~~~   73 (344)
                      ++|++.+.||+|+||+||+|.+..+++.||||++.....   ...+|+.+++.++||||+++++++...        ..+
T Consensus        66 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~---~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l  142 (440)
T PTZ00036         66 KSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQ---YKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFL  142 (440)
T ss_pred             CeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCcc---hHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceEE
Confidence            479999999999999999999999999999998865432   345799999999999999999887532        247


Q ss_pred             EEEEecCCCCChHHHHH----hCCCCCHHHHHHHHHHHHH-------CCeeecCCCCCCeEecCCCCCCEEEeecCCCcc
Q 019195           74 AIVMEYAAGGELFERIC----NAGRFSEDEARYFFQQLIS-------GQICHRDLKLENTLLDGSPAPRLKICDFGYSKS  142 (344)
Q Consensus        74 ~lv~e~~~~g~L~~~i~----~~~~~~~~~~~~~~~ql~~-------~~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~  142 (344)
                      ++||||+++ +|..++.    ....+++..++.++.||+.       .||+||||||+|||++.+. +.+||+|||+|+.
T Consensus       143 ~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~-~~vkL~DFGla~~  220 (440)
T PTZ00036        143 NVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNT-HTLKLCDFGSAKN  220 (440)
T ss_pred             EEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCC-Cceeeeccccchh
Confidence            799999975 6766654    3456888887777666554       4999999999999997543 2499999999987


Q ss_pred             cCCCCCCCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhc----------
Q 019195          143 SLLHSRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAV----------  212 (344)
Q Consensus       143 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~----------  212 (344)
                      ..........+||+.|+|||++.+....+.++|||||||++|+|++|.+||.+......+..++......          
T Consensus       221 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~  300 (440)
T PTZ00036        221 LLAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMNP  300 (440)
T ss_pred             ccCCCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhch
Confidence            6555555567899999999998776545666999999999999999999999877666655554432111          


Q ss_pred             ---cccCCC----------CCCCCHhHHHHHHHhcccCCCCCCChHHHhcCcccccC
Q 019195          213 ---QYKIPD----------YVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKN  256 (344)
Q Consensus       213 ---~~~~~~----------~~~~s~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~~  256 (344)
                         ...+|.          ....++++.+||.+||+.||.+|||+.++|+||||...
T Consensus       301 ~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~  357 (440)
T PTZ00036        301 NYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDL  357 (440)
T ss_pred             hhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhh
Confidence               011111          12367899999999999999999999999999999654

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=8.3e-47  Score=350.21  Aligned_cols=250  Identities=34%  Similarity=0.541  Sum_probs=203.9

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCc----cccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEE
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH----KIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVM   77 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~   77 (344)
                      ++|++.+.||+|+||.||++.+..+++.||+|++.+..    .....+.+|+.+++.++||||+++++++.+++.+|+||
T Consensus        43 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv~  122 (370)
T cd05596          43 EDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMVM  122 (370)
T ss_pred             HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEEE
Confidence            57999999999999999999999999999999997532    22245678999999999999999999999999999999


Q ss_pred             ecCCCCChHHHHHhCCCCCHHHHHHHHHHHH-------HCCeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCC--C
Q 019195           78 EYAAGGELFERICNAGRFSEDEARYFFQQLI-------SGQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS--R  148 (344)
Q Consensus        78 e~~~~g~L~~~i~~~~~~~~~~~~~~~~ql~-------~~~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~--~  148 (344)
                      ||+++|+|..++.. ..+++..++.++.||+       +.||+||||||+|||++.++.  +||+|||++.......  .
T Consensus       123 Ey~~gg~L~~~l~~-~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~--~kL~DfG~~~~~~~~~~~~  199 (370)
T cd05596         123 EYMPGGDLVNLMSN-YDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGH--LKLADFGTCMKMDANGMVR  199 (370)
T ss_pred             cCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCC--EEEEeccceeeccCCCccc
Confidence            99999999998865 4577777766655554       559999999999999987664  9999999987543322  2


Q ss_pred             CCCCccCCcccCCccccCCC---CCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCHh
Q 019195          149 PKSTVGTPAYIAPEVLSRRE---YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQD  225 (344)
Q Consensus       149 ~~~~~gt~~y~aPE~~~~~~---~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~  225 (344)
                      ....+||+.|+|||++.+..   ..+.++|||||||++|+|++|++||........+.++...  .....+|....+|.+
T Consensus       200 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~s~~  277 (370)
T cd05596         200 CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDH--KNSLTFPDDIEISKQ  277 (370)
T ss_pred             CCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcC--CCcCCCCCcCCCCHH
Confidence            23467999999999986542   3456699999999999999999999887654444433321  123445555568999


Q ss_pred             HHHHHHHhcccCCCC--CCChHHHhcCcccccC
Q 019195          226 CRNLLSRIFVANPSR--RITIKEIKSHPWFLKN  256 (344)
Q Consensus       226 ~~~li~~~L~~dp~~--R~s~~ell~hp~~~~~  256 (344)
                      +.+||++||+.+|.+  |+|+.++++||||...
T Consensus       278 ~~~li~~~L~~~p~r~~R~s~~ell~h~~~~~~  310 (370)
T cd05596         278 AKDLICAFLTDREVRLGRNGVDEIKSHPFFKND  310 (370)
T ss_pred             HHHHHHHHccChhhccCCCCHHHHhcCcccCCC
Confidence            999999999999988  9999999999999763

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=1e-46  Score=344.32  Aligned_cols=240  Identities=37%  Similarity=0.617  Sum_probs=200.4

Q ss_pred             eeeeecCceEEEEEEEcCCCcEEEEEEeecCc----cccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEEecCCCC
Q 019195            8 KDIGSGNFGVARLMRNKNTKELVAMKYIERGH----KIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYAAGG   83 (344)
Q Consensus         8 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g   83 (344)
                      +.||+|+||.||++.+..+++.||+|++.+..    .....+.+|+.+++.++||||+++++++...+.+|+||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g   80 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG   80 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence            46999999999999999999999999997642    22346778999999999999999999999999999999999999


Q ss_pred             ChHHHHHhCCCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCC-CCCCCCccC
Q 019195           84 ELFERICNAGRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH-SRPKSTVGT  155 (344)
Q Consensus        84 ~L~~~i~~~~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~-~~~~~~~gt  155 (344)
                      +|..++...+.+++.+++.++.||+.+       ||+||||||+|||++.++.  +||+|||+++..... ......+||
T Consensus        81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~--~kL~DfG~~~~~~~~~~~~~~~~gt  158 (328)
T cd05593          81 ELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGH--IKITDFGLCKEGITDAATMKTFCGT  158 (328)
T ss_pred             CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCc--EEEecCcCCccCCCcccccccccCC
Confidence            999999888889999888887776654       9999999999999986654  999999998753222 223445799


Q ss_pred             CcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCHhHHHHHHHhcc
Q 019195          156 PAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFV  235 (344)
Q Consensus       156 ~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~  235 (344)
                      +.|+|||++.+..+. .++|||||||++|+|++|+.||.......    ....+......+|.  .+++++.+||.+||+
T Consensus       159 ~~y~aPE~~~~~~~~-~~~DiwslGvil~elltG~~Pf~~~~~~~----~~~~~~~~~~~~p~--~~~~~~~~li~~~L~  231 (328)
T cd05593         159 PEYLAPEVLEDNDYG-RAVDWWGLGVVMYEMMCGRLPFYNQDHEK----LFELILMEDIKFPR--TLSADAKSLLSGLLI  231 (328)
T ss_pred             cCccChhhhcCCCCC-ccCCccccchHHHHHhhCCCCCCCCCHHH----HHHHhccCCccCCC--CCCHHHHHHHHHHcC
Confidence            999999999877764 55999999999999999999998755432    22333333444443  689999999999999


Q ss_pred             cCCCCCC-----ChHHHhcCcccccC
Q 019195          236 ANPSRRI-----TIKEIKSHPWFLKN  256 (344)
Q Consensus       236 ~dp~~R~-----s~~ell~hp~~~~~  256 (344)
                      .||.+|+     ++.++++||||...
T Consensus       232 ~dP~~R~~~~~~~~~~il~h~~~~~~  257 (328)
T cd05593         232 KDPNKRLGGGPDDAKEIMRHSFFTGV  257 (328)
T ss_pred             CCHHHcCCCCCCCHHHHhcCCCcCCC
Confidence            9999997     89999999999764

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=2.5e-47  Score=348.73  Aligned_cols=250  Identities=29%  Similarity=0.493  Sum_probs=205.8

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCcc----ccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEE
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK----IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVM   77 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~   77 (344)
                      ++|++.+.||+|+||.||+|.+..+++.||+|++.....    ....+.+|+.+++.++||||+++++++.+.+.+|+||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM   80 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence            589999999999999999999999999999999986432    3356778999999999999999999999999999999


Q ss_pred             ecCCCCChHHHHHhC-CCCCHHHHHHHHHHHHH-------CCeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCCC-
Q 019195           78 EYAAGGELFERICNA-GRFSEDEARYFFQQLIS-------GQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR-  148 (344)
Q Consensus        78 e~~~~g~L~~~i~~~-~~~~~~~~~~~~~ql~~-------~~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~~-  148 (344)
                      ||+++|+|.+++.+. ..+++..++.++.|++.       .||+||||||+|||++.++.  +||+|||++........ 
T Consensus        81 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~--~kL~Dfg~a~~~~~~~~~  158 (330)
T cd05601          81 EYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGH--IKLADFGSAARLTANKMV  158 (330)
T ss_pred             CCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCC--EEeccCCCCeECCCCCce
Confidence            999999999999876 67888888877766665       49999999999999976654  99999999875433222 


Q ss_pred             -CCCCccCCcccCCccccC-----CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCCCCCCC
Q 019195          149 -PKSTVGTPAYIAPEVLSR-----REYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHI  222 (344)
Q Consensus       149 -~~~~~gt~~y~aPE~~~~-----~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  222 (344)
                       .....||+.|+|||++..     ....+.++|||||||++|+|++|+.||........+.++...  .....+|....+
T Consensus       159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~  236 (330)
T cd05601         159 NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNF--QRFLKFPEDPKV  236 (330)
T ss_pred             eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcC--CCccCCCCCCCC
Confidence             233479999999999863     222345699999999999999999999877655444433321  122344555568


Q ss_pred             CHhHHHHHHHhcccCCCCCCChHHHhcCcccccC
Q 019195          223 SQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKN  256 (344)
Q Consensus       223 s~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~~  256 (344)
                      ++++.+||.+||+ +|.+|||+.++++||||...
T Consensus       237 ~~~~~~li~~ll~-~p~~R~t~~~l~~h~~~~~~  269 (330)
T cd05601         237 SSDFLDLIQSLLC-GQKERLGYEGLCCHPFFSKI  269 (330)
T ss_pred             CHHHHHHHHHHcc-ChhhCCCHHHHhCCCCcCCC
Confidence            9999999999998 99999999999999999764

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=1e-46  Score=343.64  Aligned_cols=241  Identities=34%  Similarity=0.604  Sum_probs=201.2

Q ss_pred             eeeeecCceEEEEEEEcCCCcEEEEEEeecCc----cccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEEecCCCC
Q 019195            8 KDIGSGNFGVARLMRNKNTKELVAMKYIERGH----KIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYAAGG   83 (344)
Q Consensus         8 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g   83 (344)
                      +.||+|+||.||++.+..+|..||+|++....    .....+.+|+.+++.++||||++++++|...+.+|+||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence            47999999999999999999999999987632    22245678999999999999999999999999999999999999


Q ss_pred             ChHHHHHhCCCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCC-CCCCCCccC
Q 019195           84 ELFERICNAGRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH-SRPKSTVGT  155 (344)
Q Consensus        84 ~L~~~i~~~~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~-~~~~~~~gt  155 (344)
                      +|..++...+.+++..++.++.||+.+       ||+||||||+|||++.++.  +||+|||++...... ......+||
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~--~kL~Dfg~~~~~~~~~~~~~~~~gt  158 (323)
T cd05595          81 ELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGH--IKITDFGLCKEGISDGATMKTFCGT  158 (323)
T ss_pred             cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCC--EEecccHHhccccCCCCccccccCC
Confidence            999999888889999888887776654       9999999999999987654  999999998753222 223446799


Q ss_pred             CcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCHhHHHHHHHhcc
Q 019195          156 PAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFV  235 (344)
Q Consensus       156 ~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~  235 (344)
                      +.|+|||++.+..++ .++|||||||++|+|++|+.||...+.....    ..+......+|.  .+++++.+||.+||+
T Consensus       159 ~~y~aPE~~~~~~~~-~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~----~~~~~~~~~~p~--~~~~~~~~li~~~L~  231 (323)
T cd05595         159 PEYLAPEVLEDNDYG-RAVDWWGLGVVMYEMMCGRLPFYNQDHERLF----ELILMEEIRFPR--TLSPEAKSLLAGLLK  231 (323)
T ss_pred             cCcCCcccccCCCCC-chhchhhhHHHHHHHHhCCCCCCCCCHHHHH----HHHhcCCCCCCC--CCCHHHHHHHHHHcc
Confidence            999999999877764 5599999999999999999999876543332    233333444443  679999999999999


Q ss_pred             cCCCCCC-----ChHHHhcCcccccCC
Q 019195          236 ANPSRRI-----TIKEIKSHPWFLKNL  257 (344)
Q Consensus       236 ~dp~~R~-----s~~ell~hp~~~~~~  257 (344)
                      .||.+||     ++.++++||||.+..
T Consensus       232 ~dP~~R~~~~~~~~~~~l~h~~~~~~~  258 (323)
T cd05595         232 KDPKQRLGGGPSDAKEVMEHRFFLSIN  258 (323)
T ss_pred             CCHHHhCCCCCCCHHHHHcCCCcCCCC
Confidence            9999998     899999999998754

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=9.7e-47  Score=349.53  Aligned_cols=250  Identities=32%  Similarity=0.522  Sum_probs=203.2

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCc----cccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEE
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH----KIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVM   77 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~   77 (344)
                      ++|++.+.||+|+||.||++.+..+++.||+|++.+..    .....+.+|+.+++.++||||+++++++.++..+|+||
T Consensus        43 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~  122 (370)
T cd05621          43 EDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVM  122 (370)
T ss_pred             HHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            57999999999999999999999999999999987532    22345778999999999999999999999999999999


Q ss_pred             ecCCCCChHHHHHhCCCCCHHHHHHHHHHHHH-------CCeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCC--C
Q 019195           78 EYAAGGELFERICNAGRFSEDEARYFFQQLIS-------GQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS--R  148 (344)
Q Consensus        78 e~~~~g~L~~~i~~~~~~~~~~~~~~~~ql~~-------~~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~--~  148 (344)
                      |||++|+|.+++... .+++..++.++.||+.       .||+||||||+|||++.++.  +||+|||++.......  .
T Consensus       123 Ey~~gg~L~~~l~~~-~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~--~kL~DFG~a~~~~~~~~~~  199 (370)
T cd05621         123 EYMPGGDLVNLMSNY-DVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGH--LKLADFGTCMKMDETGMVR  199 (370)
T ss_pred             cCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCC--EEEEecccceecccCCcee
Confidence            999999999988654 5788877777666554       49999999999999987654  9999999987543222  2


Q ss_pred             CCCCccCCcccCCccccCCC---CCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCHh
Q 019195          149 PKSTVGTPAYIAPEVLSRRE---YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQD  225 (344)
Q Consensus       149 ~~~~~gt~~y~aPE~~~~~~---~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~  225 (344)
                      ....+||+.|+|||++.+..   +.+.++|||||||++|+|++|++||...+....+..++..  .....+|....++..
T Consensus       200 ~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~--~~~~~~p~~~~~s~~  277 (370)
T cd05621         200 CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDH--KNSLNFPEDVEISKH  277 (370)
T ss_pred             cccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhC--CcccCCCCcccCCHH
Confidence            24567999999999997543   2456699999999999999999999876654444333321  123445555568999


Q ss_pred             HHHHHHHhcccCCCC--CCChHHHhcCcccccC
Q 019195          226 CRNLLSRIFVANPSR--RITIKEIKSHPWFLKN  256 (344)
Q Consensus       226 ~~~li~~~L~~dp~~--R~s~~ell~hp~~~~~  256 (344)
                      +++||.+||+.++.+  |+|+.++++||||...
T Consensus       278 ~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~~  310 (370)
T cd05621         278 AKNLICAFLTDREVRLGRNGVEEIKQHPFFKND  310 (370)
T ss_pred             HHHHHHHHccCchhccCCCCHHHHhcCcccCCC
Confidence            999999999866544  8999999999999764

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=8.9e-47  Score=349.09  Aligned_cols=251  Identities=31%  Similarity=0.525  Sum_probs=205.4

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCc----cccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEE
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH----KIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVM   77 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~   77 (344)
                      ++|++++.||+|+||.||+|.+..+++.||+|++....    .....+.+|+.++..++||||+++++.+.+.+.+|+||
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~   80 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM   80 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            57999999999999999999999999999999997532    23356778999999999999999999999999999999


Q ss_pred             ecCCCCChHHHHHhCCCCCHHHHHHHHHHHHH-------CCeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCC---
Q 019195           78 EYAAGGELFERICNAGRFSEDEARYFFQQLIS-------GQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS---  147 (344)
Q Consensus        78 e~~~~g~L~~~i~~~~~~~~~~~~~~~~ql~~-------~~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~---  147 (344)
                      |||+||+|.+++.+.+.+++..++.++.|++.       .||+||||||+|||++.++  ++||+|||++.......   
T Consensus        81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~--~vkL~DfG~~~~~~~~~~~~  158 (360)
T cd05627          81 EFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKG--HVKLSDFGLCTGLKKAHRTE  158 (360)
T ss_pred             eCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCC--CEEEeeccCCcccccccccc
Confidence            99999999999998888999888888777654       4999999999999997665  49999999986432110   


Q ss_pred             ---------------------------------CCCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCC
Q 019195          148 ---------------------------------RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFE  194 (344)
Q Consensus       148 ---------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~  194 (344)
                                                       .....+||+.|+|||++.+..++ .++|||||||++|+|++|++||.
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~-~~~DiwSlGvilyel~tG~~Pf~  237 (360)
T cd05627         159 FYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYN-KLCDWWSLGVIMYEMLIGYPPFC  237 (360)
T ss_pred             cccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCC-CcceeccccceeeecccCCCCCC
Confidence                                             01235799999999999887775 45999999999999999999998


Q ss_pred             CCCChHHHHHHHHHHhhccccCCCCCCCCHhHHHHHHHhcccCCCCCC---ChHHHhcCcccccCCC
Q 019195          195 DQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRI---TIKEIKSHPWFLKNLP  258 (344)
Q Consensus       195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~---s~~ell~hp~~~~~~~  258 (344)
                      .......+..+...  .....+|....+++++++||.+|+ .||.+|+   ++.++++||||.....
T Consensus       238 ~~~~~~~~~~i~~~--~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~~~~  301 (360)
T cd05627         238 SETPQETYRKVMNW--KETLVFPPEVPISEKAKDLILRFC-TDSENRIGSNGVEEIKSHPFFEGVDW  301 (360)
T ss_pred             CCCHHHHHHHHHcC--CCceecCCCCCCCHHHHHHHHHhc-cChhhcCCCCCHHHHhcCCCCCCCCH
Confidence            76654443333211  122344554568999999999987 4999998   4799999999987533

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=6.9e-48  Score=328.35  Aligned_cols=252  Identities=30%  Similarity=0.524  Sum_probs=214.4

Q ss_pred             eeeeecCceEEEEEEEcCCCcEEEEEEeecCc-cccHHHHHHHHHHhcC-CCCCcceeeEEEEcCCEEEEEEecCCCCCh
Q 019195            8 KDIGSGNFGVARLMRNKNTKELVAMKYIERGH-KIDANVAREIINHKQL-RHPNIIRFKEVVLTPTHLAIVMEYAAGGEL   85 (344)
Q Consensus         8 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~ei~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~g~L   85 (344)
                      +.||+|+||.|-.+.+..++..||||++.+.. ....++.+|++++.++ .|+||++++++|+++..+|+|||.|.||+|
T Consensus        84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGpl  163 (463)
T KOG0607|consen   84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGPL  163 (463)
T ss_pred             HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCchH
Confidence            57999999999999999999999999998754 3457899999999999 599999999999999999999999999999


Q ss_pred             HHHHHhCCCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecC-CCCCCEEEeecCCCcccCCC--------CCC
Q 019195           86 FERICNAGRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDG-SPAPRLKICDFGYSKSSLLH--------SRP  149 (344)
Q Consensus        86 ~~~i~~~~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~-~~~~~vkL~DFg~a~~~~~~--------~~~  149 (344)
                      ...|+++..|++.++..+++.++++       ||.||||||+|||... +...-||||||.+.......        +..
T Consensus       164 LshI~~~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spastP~L  243 (463)
T KOG0607|consen  164 LSHIQKRKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSPASTPEL  243 (463)
T ss_pred             HHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccCCCCCCCCCccc
Confidence            9999999999999999988887766       9999999999999854 33345899999987543221        223


Q ss_pred             CCCccCCcccCCcccc----CCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC-----------hHHHHHHHHHHhhccc
Q 019195          150 KSTVGTPAYIAPEVLS----RREYDGKLADVWSCGVTLYVMLVGAYPFEDQED-----------PKNFRKTISRIMAVQY  214 (344)
Q Consensus       150 ~~~~gt~~y~aPE~~~----~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-----------~~~~~~~~~~~~~~~~  214 (344)
                      .+.+|+..|||||++.    ...++.+.+|.||||+|+|-|++|.+||.+...           .......+..|..+.+
T Consensus       244 ~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFesIQEGkY  323 (463)
T KOG0607|consen  244 LTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKY  323 (463)
T ss_pred             cCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHHHHhccCC
Confidence            4568999999999972    234455669999999999999999999987533           2234456677888888


Q ss_pred             cCCC--CCCCCHhHHHHHHHhcccCCCCCCChHHHhcCcccccCCCh
Q 019195          215 KIPD--YVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLPR  259 (344)
Q Consensus       215 ~~~~--~~~~s~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~~~~~  259 (344)
                      .+|+  |..+|.++++||+.+|..|+.+|.++.++++|||+....+.
T Consensus       324 eFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~~~e  370 (463)
T KOG0607|consen  324 EFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRCAPE  370 (463)
T ss_pred             cCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCccccccchh
Confidence            8884  77899999999999999999999999999999999876554

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=3.6e-46  Score=347.72  Aligned_cols=246  Identities=20%  Similarity=0.292  Sum_probs=195.8

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEEecCC
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYAA   81 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~   81 (344)
                      ++|++++.||+|+||.||+|.+..+++.||+|....     ..+.+|+.++++++||||++++++|......+++||++ 
T Consensus        92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~-----~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~-  165 (391)
T PHA03212         92 AGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR-----GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRY-  165 (391)
T ss_pred             CCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh-----hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecC-
Confidence            579999999999999999999999999999997543     35679999999999999999999999999999999999 


Q ss_pred             CCChHHHHHhCCCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCC--CCCCCC
Q 019195           82 GGELFERICNAGRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH--SRPKST  152 (344)
Q Consensus        82 ~g~L~~~i~~~~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~--~~~~~~  152 (344)
                      +++|..++.....+++.+++.++.|++.|       ||+||||||+|||++.++.  +||+|||+|+.....  ......
T Consensus       166 ~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~--vkL~DFG~a~~~~~~~~~~~~~~  243 (391)
T PHA03212        166 KTDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGD--VCLGDFGAACFPVDINANKYYGW  243 (391)
T ss_pred             CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCC--EEEEeCCcccccccccccccccc
Confidence            57899999888889998888887777655       9999999999999976654  999999998643222  223345


Q ss_pred             ccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC-------hHHHHHHHHHHhh--------------
Q 019195          153 VGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQED-------PKNFRKTISRIMA--------------  211 (344)
Q Consensus       153 ~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-------~~~~~~~~~~~~~--------------  211 (344)
                      +||+.|+|||++.+..+. .++|||||||++|+|++|..||.....       ...+..++.....              
T Consensus       244 ~gt~~y~aPE~~~~~~~~-~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~~~~  322 (391)
T PHA03212        244 AGTIATNAPELLARDPYG-PAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQANLD  322 (391)
T ss_pred             cCccCCCChhhhcCCCCC-cHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchhHHHH
Confidence            799999999999877764 559999999999999999988754321       1112222111110              


Q ss_pred             --------ccccC----CC---CCCCCHhHHHHHHHhcccCCCCCCChHHHhcCcccccC
Q 019195          212 --------VQYKI----PD---YVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKN  256 (344)
Q Consensus       212 --------~~~~~----~~---~~~~s~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~~  256 (344)
                              .....    +.   ...++.++.+||.+||+.||.+||||.++|+||||...
T Consensus       323 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~~  382 (391)
T PHA03212        323 EIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDI  382 (391)
T ss_pred             HHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhccC
Confidence                    00001    11   11346689999999999999999999999999999764

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=3.3e-46  Score=342.22  Aligned_cols=251  Identities=26%  Similarity=0.432  Sum_probs=196.9

Q ss_pred             CceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCc---cccHHHHHHHHHHhcCCCCCcceeeEEEEcC-----CEEE
Q 019195            3 KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH---KIDANVAREIINHKQLRHPNIIRFKEVVLTP-----THLA   74 (344)
Q Consensus         3 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~-----~~~~   74 (344)
                      +|++.+.||+|+||.||++.+..++..||+|++....   .....+.+|+.+++.++||||+++++++...     ..+|
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   80 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY   80 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence            6999999999999999999999999999999987532   2234678999999999999999999988643     3589


Q ss_pred             EEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCC
Q 019195           75 IVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS  147 (344)
Q Consensus        75 lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~  147 (344)
                      +||||| +++|.+++.....+++..++.++.||+.|       ||+||||||+|||++.++.  +||+|||+++......
T Consensus        81 lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~--~kL~Dfg~~~~~~~~~  157 (338)
T cd07859          81 VVFELM-ESDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCK--LKICDFGLARVAFNDT  157 (338)
T ss_pred             EEEecC-CCCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCc--EEEccCcccccccccc
Confidence            999999 57899999888889999888888777655       9999999999999977654  9999999987543222


Q ss_pred             C----CCCCccCCcccCCccccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHH-----------H--
Q 019195          148 R----PKSTVGTPAYIAPEVLSRR-EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISR-----------I--  209 (344)
Q Consensus       148 ~----~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~-----------~--  209 (344)
                      .    ....+||+.|+|||++.+. ...+.++|||||||++|+|++|++||.+.+....+..+...           +  
T Consensus       158 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~  237 (338)
T cd07859         158 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRN  237 (338)
T ss_pred             CccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhh
Confidence            1    2345799999999998652 23355699999999999999999999776543222111100           0  


Q ss_pred             ------h---hccccC---CCCCCCCHhHHHHHHHhcccCCCCCCChHHHhcCcccccC
Q 019195          210 ------M---AVQYKI---PDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKN  256 (344)
Q Consensus       210 ------~---~~~~~~---~~~~~~s~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~~  256 (344)
                            .   ......   ..+..+++.+.+||.+||+.||.+|||+.++|+||||...
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~  296 (338)
T cd07859         238 EKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGL  296 (338)
T ss_pred             hhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhc
Confidence                  0   000000   1123467889999999999999999999999999999764

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=2.8e-46  Score=340.27  Aligned_cols=240  Identities=33%  Similarity=0.538  Sum_probs=198.7

Q ss_pred             eeeeecCceEEEEEEEcCCCcEEEEEEeecCc----cccHHHHHHHHHHhcC-CCCCcceeeEEEEcCCEEEEEEecCCC
Q 019195            8 KDIGSGNFGVARLMRNKNTKELVAMKYIERGH----KIDANVAREIINHKQL-RHPNIIRFKEVVLTPTHLAIVMEYAAG   82 (344)
Q Consensus         8 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~ei~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~   82 (344)
                      +.||+|+||+||+|.+..+++.||+|++.+..    .....+.+|+.+++.+ +||||+++++++...+.+|+||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~   80 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG   80 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence            47999999999999999999999999987532    2234566788888776 799999999999999999999999999


Q ss_pred             CChHHHHHhCCCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCC-CCCCCCcc
Q 019195           83 GELFERICNAGRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH-SRPKSTVG  154 (344)
Q Consensus        83 g~L~~~i~~~~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~-~~~~~~~g  154 (344)
                      |+|..++.+...+++..++.++.|++.+       ||+||||||+|||++.++.  +||+|||+++..... ......+|
T Consensus        81 g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~--~kL~DfG~~~~~~~~~~~~~~~~g  158 (320)
T cd05590          81 GDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGH--CKLADFGMCKEGIFNGKTTSTFCG  158 (320)
T ss_pred             chHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCc--EEEeeCCCCeecCcCCCccccccc
Confidence            9999999888889999888887776654       9999999999999987664  999999998753322 22344579


Q ss_pred             CCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCHhHHHHHHHhc
Q 019195          155 TPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIF  234 (344)
Q Consensus       155 t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L  234 (344)
                      |+.|+|||++.+..++ .++|||||||++|+|++|+.||...+....    ...+.......|.  .+++++.+||++||
T Consensus       159 t~~y~aPE~~~~~~~~-~~~DiwslG~il~el~~g~~Pf~~~~~~~~----~~~i~~~~~~~~~--~~~~~~~~li~~~L  231 (320)
T cd05590         159 TPDYIAPEILQEMLYG-PSVDWWAMGVLLYEMLCGHAPFEAENEDDL----FEAILNDEVVYPT--WLSQDAVDILKAFM  231 (320)
T ss_pred             CccccCHHHHcCCCCC-CccchhhhHHHHHHHhhCCCCCCCCCHHHH----HHHHhcCCCCCCC--CCCHHHHHHHHHHc
Confidence            9999999999877665 459999999999999999999987654333    3333333434443  57899999999999


Q ss_pred             ccCCCCCCCh------HHHhcCcccccC
Q 019195          235 VANPSRRITI------KEIKSHPWFLKN  256 (344)
Q Consensus       235 ~~dp~~R~s~------~ell~hp~~~~~  256 (344)
                      +.||.+||++      .+++.||||...
T Consensus       232 ~~dP~~R~~~~~~~~~~~~~~h~~f~~~  259 (320)
T cd05590         232 TKNPTMRLGSLTLGGEEAILRHPFFKEL  259 (320)
T ss_pred             ccCHHHCCCCCCCCCHHHHHcCCCcCCC
Confidence            9999999998      899999999764

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=3.2e-46  Score=341.23  Aligned_cols=244  Identities=29%  Similarity=0.499  Sum_probs=199.4

Q ss_pred             eeeeecCceEEEEEEEcCCCcEEEEEEeecCcc----ccHHHHHHHHHHhcC-CCCCcceeeEEEEcCCEEEEEEecCCC
Q 019195            8 KDIGSGNFGVARLMRNKNTKELVAMKYIERGHK----IDANVAREIINHKQL-RHPNIIRFKEVVLTPTHLAIVMEYAAG   82 (344)
Q Consensus         8 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~ei~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~   82 (344)
                      +.||+|+||.||+|.+..+++.||+|++.+...    ....+.+|+.+++.+ +||||+++++++.+.+.+|+|||||++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~   80 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG   80 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence            479999999999999999999999999976422    224577899999888 799999999999999999999999999


Q ss_pred             CChHHHHHhCCCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCC-CCCCCCCcc
Q 019195           83 GELFERICNAGRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLL-HSRPKSTVG  154 (344)
Q Consensus        83 g~L~~~i~~~~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~-~~~~~~~~g  154 (344)
                      |+|..++.+.+.+++..++.++.||+.+       ||+||||||+|||++.++.  +||+|||+++.... .......+|
T Consensus        81 g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~--~kL~Dfg~~~~~~~~~~~~~~~~g  158 (329)
T cd05588          81 GDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGH--IKLTDYGMCKEGIRPGDTTSTFCG  158 (329)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCC--EEECcCccccccccCCCccccccC
Confidence            9999999888899999998887777655       9999999999999987654  99999999875322 223345679


Q ss_pred             CCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCh-----HHHHHHHHHHhhccccCCCCCCCCHhHHHH
Q 019195          155 TPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDP-----KNFRKTISRIMAVQYKIPDYVHISQDCRNL  229 (344)
Q Consensus       155 t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  229 (344)
                      |+.|+|||++.+..++ .++|||||||++|+|++|+.||......     .......+.+......+|.  .++..+.+|
T Consensus       159 t~~y~aPE~~~~~~~~-~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~--~~~~~~~~l  235 (329)
T cd05588         159 TPNYIAPEILRGEDYG-FSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPR--SLSVKASSV  235 (329)
T ss_pred             CccccCHHHHcCCCCC-CccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCCCCC--CCCHHHHHH
Confidence            9999999999887765 4599999999999999999999632211     1111223334444445554  578999999


Q ss_pred             HHHhcccCCCCCCC------hHHHhcCcccccC
Q 019195          230 LSRIFVANPSRRIT------IKEIKSHPWFLKN  256 (344)
Q Consensus       230 i~~~L~~dp~~R~s------~~ell~hp~~~~~  256 (344)
                      |.+||+.||.+|+|      +.++++||||...
T Consensus       236 i~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~~  268 (329)
T cd05588         236 LKGFLNKDPKERLGCHPQTGFRDIKSHPFFRNI  268 (329)
T ss_pred             HHHHhccCHHHcCCCCCCCCHHHHhcCCCCCCC
Confidence            99999999999997      7899999999653

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=5.3e-46  Score=339.08  Aligned_cols=245  Identities=30%  Similarity=0.564  Sum_probs=202.9

Q ss_pred             CceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCc----cccHHHHHHHHHHhcCCC-CCcceeeEEEEcCCEEEEEE
Q 019195            3 KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH----KIDANVAREIINHKQLRH-PNIIRFKEVVLTPTHLAIVM   77 (344)
Q Consensus         3 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~ei~~l~~l~h-~niv~~~~~~~~~~~~~lv~   77 (344)
                      +|++++.||+|+||.||+|.+..+++.||+|++.+..    .....+..|+.++..++| ++|+++++++...+.+|+||
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM   80 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence            5999999999999999999999999999999997632    223457788999999876 56889999999999999999


Q ss_pred             ecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCC-CCCC
Q 019195           78 EYAAGGELFERICNAGRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLL-HSRP  149 (344)
Q Consensus        78 e~~~~g~L~~~i~~~~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~-~~~~  149 (344)
                      ||+++|+|..++...+.+++..++.++.||+.+       ||+||||||+|||++.++  .+||+|||++..... ....
T Consensus        81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~--~~kL~Dfg~~~~~~~~~~~~  158 (324)
T cd05587          81 EYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEG--HIKIADFGMCKENIFGGKTT  158 (324)
T ss_pred             cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCC--CEEEeecCcceecCCCCCce
Confidence            999999999999888889998888887776654       999999999999998765  499999999864322 2223


Q ss_pred             CCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCHhHHHH
Q 019195          150 KSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL  229 (344)
Q Consensus       150 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  229 (344)
                      ...+||+.|+|||++.+..++ .++|||||||++|+|++|+.||........+    ..+......+|.  .+++++.+|
T Consensus       159 ~~~~gt~~y~aPE~~~~~~~~-~~~DiwslGvil~elltG~~pf~~~~~~~~~----~~i~~~~~~~~~--~~~~~~~~l  231 (324)
T cd05587         159 RTFCGTPDYIAPEIIAYQPYG-KSVDWWAFGVLLYEMLAGQPPFDGEDEDELF----QSIMEHNVSYPK--SLSKEAVSI  231 (324)
T ss_pred             eeecCCccccChhhhcCCCCC-cccchhhhHHHHHHHHhCCCCCCCCCHHHHH----HHHHcCCCCCCC--CCCHHHHHH
Confidence            445799999999999887765 4599999999999999999999876543333    333333334443  679999999


Q ss_pred             HHHhcccCCCCCCCh-----HHHhcCcccccC
Q 019195          230 LSRIFVANPSRRITI-----KEIKSHPWFLKN  256 (344)
Q Consensus       230 i~~~L~~dp~~R~s~-----~ell~hp~~~~~  256 (344)
                      |.+||+.||.+|+++     .++++||||...
T Consensus       232 i~~~l~~~P~~R~~~~~~~~~~~~~hp~~~~~  263 (324)
T cd05587         232 CKGLLTKHPAKRLGCGPTGERDIREHAFFRRI  263 (324)
T ss_pred             HHHHhhcCHHHcCCCCCCCHHHHhcCCCcCCC
Confidence            999999999999986     899999999764

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=8.2e-46  Score=335.65  Aligned_cols=253  Identities=25%  Similarity=0.415  Sum_probs=202.1

Q ss_pred             CCCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCc--cccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEEe
Q 019195            1 MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH--KIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVME   78 (344)
Q Consensus         1 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e   78 (344)
                      |++|++++.||+|+||.||++.+..+++.||+|.+....  .....+.+|+.+++.++||||+++++++..++.+++|||
T Consensus         5 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   84 (309)
T cd07872           5 METYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFE   84 (309)
T ss_pred             CCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEe
Confidence            578999999999999999999999999999999987543  233467789999999999999999999999999999999


Q ss_pred             cCCCCChHHHHHhC-CCCCHHHHHHHHHHHHH-------CCeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCC-CC
Q 019195           79 YAAGGELFERICNA-GRFSEDEARYFFQQLIS-------GQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS-RP  149 (344)
Q Consensus        79 ~~~~g~L~~~i~~~-~~~~~~~~~~~~~ql~~-------~~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~-~~  149 (344)
                      |+++ +|...+... ..++...++.++.|++.       .||+||||||+|||++.++.  +||+|||++....... ..
T Consensus        85 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~--~kl~Dfg~~~~~~~~~~~~  161 (309)
T cd07872          85 YLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGE--LKLADFGLARAKSVPTKTY  161 (309)
T ss_pred             CCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCC--EEECccccceecCCCcccc
Confidence            9975 888877654 45788877777766654       49999999999999987654  9999999987533222 22


Q ss_pred             CCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhc---------------cc
Q 019195          150 KSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAV---------------QY  214 (344)
Q Consensus       150 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~---------------~~  214 (344)
                      ....+|+.|+|||++.+....+.++|||||||++|+|++|++||...+..+.+..+.......               ..
T Consensus       162 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (309)
T cd07872         162 SNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKNY  241 (309)
T ss_pred             ccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhhhh
Confidence            345689999999998765545666999999999999999999998776544444333221100               01


Q ss_pred             cCC---------CCCCCCHhHHHHHHHhcccCCCCCCChHHHhcCcccccC
Q 019195          215 KIP---------DYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKN  256 (344)
Q Consensus       215 ~~~---------~~~~~s~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~~  256 (344)
                      ..+         ....+++++.+||.+||+.||.+|||+.++|+||||...
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~  292 (309)
T cd07872         242 NFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSL  292 (309)
T ss_pred             hcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhc
Confidence            111         112468899999999999999999999999999999754

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=2e-46  Score=342.05  Aligned_cols=242  Identities=36%  Similarity=0.581  Sum_probs=200.5

Q ss_pred             eeeeecCceEEEEEEEcCCCcEEEEEEeecCc----cccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEEecCCCC
Q 019195            8 KDIGSGNFGVARLMRNKNTKELVAMKYIERGH----KIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYAAGG   83 (344)
Q Consensus         8 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g   83 (344)
                      +.||+|+||.||++.+..+++.||+|++.+..    .....+.+|+++++.++||||+++++++...+.+|+||||+++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence            46999999999999999999999999997632    12245678999999999999999999999999999999999999


Q ss_pred             ChHHHHHhCCCCCHHHHHHHHHHHH-------H-CCeeecCCCCCCeEecCCCCCCEEEeecCCCcccCC-CCCCCCCcc
Q 019195           84 ELFERICNAGRFSEDEARYFFQQLI-------S-GQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLL-HSRPKSTVG  154 (344)
Q Consensus        84 ~L~~~i~~~~~~~~~~~~~~~~ql~-------~-~~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~-~~~~~~~~g  154 (344)
                      +|..++...+.+++..++.++.||+       + .||+||||||+|||++.++.  +||+|||+++.... .......+|
T Consensus        81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~--~kL~Dfg~~~~~~~~~~~~~~~~g  158 (325)
T cd05594          81 ELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGH--IKITDFGLCKEGIKDGATMKTFCG  158 (325)
T ss_pred             cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCC--EEEecCCCCeecCCCCcccccccC
Confidence            9999998888899988888776655       4 49999999999999987664  99999999875332 222344579


Q ss_pred             CCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCHhHHHHHHHhc
Q 019195          155 TPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIF  234 (344)
Q Consensus       155 t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L  234 (344)
                      |+.|+|||++.+..++ .++|||||||++|+|++|+.||........    ...+......+|.  .+++++.+||.+||
T Consensus       159 t~~y~aPE~~~~~~~~-~~~DiwslG~il~el~tG~~Pf~~~~~~~~----~~~i~~~~~~~p~--~~~~~~~~li~~~L  231 (325)
T cd05594         159 TPEYLAPEVLEDNDYG-RAVDWWGLGVVMYEMMCGRLPFYNQDHEKL----FELILMEEIRFPR--TLSPEAKSLLSGLL  231 (325)
T ss_pred             CcccCCHHHHccCCCC-CccccccccceeeeeccCCCCCCCCCHHHH----HHHHhcCCCCCCC--CCCHHHHHHHHHHh
Confidence            9999999999877765 559999999999999999999987654332    2233333444443  67999999999999


Q ss_pred             ccCCCCCC-----ChHHHhcCcccccCCC
Q 019195          235 VANPSRRI-----TIKEIKSHPWFLKNLP  258 (344)
Q Consensus       235 ~~dp~~R~-----s~~ell~hp~~~~~~~  258 (344)
                      +.||.+|+     ++.++++||||.....
T Consensus       232 ~~dP~~R~~~~~~~~~~il~h~~~~~~~~  260 (325)
T cd05594         232 KKDPKQRLGGGPDDAKEIMQHKFFAGIVW  260 (325)
T ss_pred             hcCHHHhCCCCCCCHHHHhcCCCcCCCCH
Confidence            99999997     8999999999987543

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.9e-46  Score=331.61  Aligned_cols=249  Identities=25%  Similarity=0.422  Sum_probs=204.3

Q ss_pred             CceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCcc----ccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEEe
Q 019195            3 KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK----IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVME   78 (344)
Q Consensus         3 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e   78 (344)
                      .|++.+.||+|+||.||++.+..+++.||+|++.....    ....+.+|+.+++.++||||+++++++..++.+++|||
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence            58999999999999999999999999999999875321    22456789999999999999999999999999999999


Q ss_pred             cCCCCChHHHHHhC--CCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCCCC
Q 019195           79 YAAGGELFERICNA--GRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP  149 (344)
Q Consensus        79 ~~~~g~L~~~i~~~--~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~~~  149 (344)
                      |+++|+|..++...  ..+++..+..++.|++.+       ||+||||||+||+++.++  .++|+|||++.........
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~--~~~l~Dfg~~~~~~~~~~~  158 (285)
T cd05605          81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYG--HIRISDLGLAVEIPEGETI  158 (285)
T ss_pred             ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCC--CEEEeeCCCceecCCCCcc
Confidence            99999999887653  458888888777666654       999999999999997665  4999999998765433333


Q ss_pred             CCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCHhHHHH
Q 019195          150 KSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL  229 (344)
Q Consensus       150 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  229 (344)
                      ...+|++.|+|||++.+..++ .++||||+||++|+|++|+.||.+.........+...+.......+  ..+++.+.+|
T Consensus       159 ~~~~~~~~y~aPE~~~~~~~~-~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l  235 (285)
T cd05605         159 RGRVGTVGYMAPEVVKNERYT-FSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYS--EKFSEAARSI  235 (285)
T ss_pred             ccccCCCCccCcHHhcCCCCC-ccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcccccC--cccCHHHHHH
Confidence            456799999999999877664 4599999999999999999999876554333333333333332222  3578999999


Q ss_pred             HHHhcccCCCCCC-----ChHHHhcCcccccC
Q 019195          230 LSRIFVANPSRRI-----TIKEIKSHPWFLKN  256 (344)
Q Consensus       230 i~~~L~~dp~~R~-----s~~ell~hp~~~~~  256 (344)
                      |.+||+.||.+||     ++.+++.||||...
T Consensus       236 i~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~  267 (285)
T cd05605         236 CRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTA  267 (285)
T ss_pred             HHHHccCCHHHhcCCCCCCHHHHhcCcCccCC
Confidence            9999999999999     89999999999764

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=7.2e-48  Score=325.59  Aligned_cols=250  Identities=35%  Similarity=0.579  Sum_probs=212.3

Q ss_pred             CCceee-eeeeecCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcC-CCCCcceeeEEEEcC----CEEEE
Q 019195            2 EKYELM-KDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQL-RHPNIIRFKEVVLTP----THLAI   75 (344)
Q Consensus         2 ~~y~~~-~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~l~~l-~h~niv~~~~~~~~~----~~~~l   75 (344)
                      ++|.+- ++||-|-.|.|..|.++.||+.+|+|++..+    ...++|++..... .|||||.++++|...    ..+.+
T Consensus        61 edY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLi  136 (400)
T KOG0604|consen   61 EDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLI  136 (400)
T ss_pred             hhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEe
Confidence            345543 5799999999999999999999999998664    4567899988777 599999999998643    56789


Q ss_pred             EEecCCCCChHHHHHhCCC--CCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecC-CCCCCEEEeecCCCcccCC
Q 019195           76 VMEYAAGGELFERICNAGR--FSEDEARYFFQQLISG-------QICHRDLKLENTLLDG-SPAPRLKICDFGYSKSSLL  145 (344)
Q Consensus        76 v~e~~~~g~L~~~i~~~~~--~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~-~~~~~vkL~DFg~a~~~~~  145 (344)
                      |||.++||.|+..|+.++.  |++.++..+++||..|       +|.||||||+|+|+.. ..+..+||+|||+|+....
T Consensus       137 VmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~  216 (400)
T KOG0604|consen  137 VMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQE  216 (400)
T ss_pred             eeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEecccccccccCC
Confidence            9999999999999998765  9999998888887665       9999999999999964 3334699999999998777


Q ss_pred             CCCCCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCC--CCCCCC
Q 019195          146 HSRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIP--DYVHIS  223 (344)
Q Consensus       146 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~s  223 (344)
                      .....+.|.||+|.|||++....|+ +.+|+||+||++|.|++|.+||.........-....+|..+.+.+|  .|..+|
T Consensus       217 ~~~L~TPc~TPyYvaPevlg~eKyd-kscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~FP~pEWs~VS  295 (400)
T KOG0604|consen  217 PGDLMTPCFTPYYVAPEVLGPEKYD-KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEFPEPEWSCVS  295 (400)
T ss_pred             CccccCCcccccccCHHHhCchhcC-CCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccCCChhHhHHH
Confidence            7778889999999999999777765 5599999999999999999999876543333444556777777776  467799


Q ss_pred             HhHHHHHHHhcccCCCCCCChHHHhcCcccccC
Q 019195          224 QDCRNLLSRIFVANPSRRITIKEIKSHPWFLKN  256 (344)
Q Consensus       224 ~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~~  256 (344)
                      .+++++|+++|..+|.+|.|+.++++|||+.+.
T Consensus       296 e~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~  328 (400)
T KOG0604|consen  296 EAAKDLIRKLLKTEPTERLTIEEVMDHPWINQY  328 (400)
T ss_pred             HHHHHHHHHHhcCCchhheeHHHhhcCchhccc
Confidence            999999999999999999999999999999764

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=1.2e-45  Score=337.90  Aligned_cols=251  Identities=27%  Similarity=0.446  Sum_probs=201.0

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCcc--ccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEEec
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK--IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEY   79 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~   79 (344)
                      ++|++.+.||+|+||.||++.+..++..+|+|++.....  ....+.+|+++++.++||||++++++|..++.+++||||
T Consensus         5 ~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   84 (333)
T cd06650           5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH   84 (333)
T ss_pred             hhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEec
Confidence            689999999999999999999999999999998876422  235688999999999999999999999999999999999


Q ss_pred             CCCCChHHHHHhCCCCCHHHHHHHHHHHHHC--------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCCCCCC
Q 019195           80 AAGGELFERICNAGRFSEDEARYFFQQLISG--------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKS  151 (344)
Q Consensus        80 ~~~g~L~~~i~~~~~~~~~~~~~~~~ql~~~--------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~~~~~  151 (344)
                      +++++|.+++...+.+++..++.++.|++.+        +|+||||||+|||++.++.  +||+|||++..... .....
T Consensus        85 ~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~--~kL~Dfg~~~~~~~-~~~~~  161 (333)
T cd06650          85 MDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGE--IKLCDFGVSGQLID-SMANS  161 (333)
T ss_pred             CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCC--EEEeeCCcchhhhh-hcccc
Confidence            9999999999888888888888777766543        7999999999999976654  99999999865422 22334


Q ss_pred             CccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHH-------------------------
Q 019195          152 TVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTI-------------------------  206 (344)
Q Consensus       152 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~-------------------------  206 (344)
                      ..||+.|+|||++.+..++ .++|||||||++|+|++|+.||........ ...+                         
T Consensus       162 ~~~~~~y~aPE~~~~~~~~-~~~DvwslG~il~~l~~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (333)
T cd06650         162 FVGTRSYMSPERLQGTHYS-VQSDIWSMGLSLVEMAIGRYPIPPPDAKEL-ELMFGCPVEGDPAESETSPRPRPPGRPLS  239 (333)
T ss_pred             CCCCccccCHHHhcCCCCC-cHHHHHHHHHHHHHHHHCCCCCCCcchhHH-HHHhcCcccCCccccccCcccCCccchhh
Confidence            5799999999999876654 459999999999999999999975433111 1110                         


Q ss_pred             ----------------HHHhhccccCCCCCCCCHhHHHHHHHhcccCCCCCCChHHHhcCcccccCC
Q 019195          207 ----------------SRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNL  257 (344)
Q Consensus       207 ----------------~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~~~  257 (344)
                                      ..+............++.++.+||.+||+.||.+|||+.+++.||||+...
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~  306 (333)
T cd06650         240 SYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSE  306 (333)
T ss_pred             hhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcCc
Confidence                            000000000000113578899999999999999999999999999997653

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=1.1e-45  Score=341.66  Aligned_cols=250  Identities=27%  Similarity=0.419  Sum_probs=196.0

Q ss_pred             CCCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCc---cccHHHHHHHHHHhcCCCCCcceeeEEEEcCC------
Q 019195            1 MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH---KIDANVAREIINHKQLRHPNIIRFKEVVLTPT------   71 (344)
Q Consensus         1 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~------   71 (344)
                      +++|++.+.||+|+||.||++.+..+++.||+|++....   .....+.+|+.+++.++||||+++++++....      
T Consensus        20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~   99 (359)
T cd07876          20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQ   99 (359)
T ss_pred             hhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccc
Confidence            478999999999999999999999999999999987542   22356789999999999999999999986543      


Q ss_pred             EEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHH-------CCeeecCCCCCCeEecCCCCCCEEEeecCCCcccC
Q 019195           72 HLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLIS-------GQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSL  144 (344)
Q Consensus        72 ~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~ql~~-------~~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~  144 (344)
                      .+|+||||+.+ +|...+..  .+++..+..++.|++.       .||+||||||+|||++.++.  +||+|||+++...
T Consensus       100 ~~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~--~kl~Dfg~a~~~~  174 (359)
T cd07876         100 DVYLVMELMDA-NLCQVIHM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAC  174 (359)
T ss_pred             eeEEEEeCCCc-CHHHHHhc--cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCC--EEEecCCCccccc
Confidence            57999999965 66666543  4777777777666654       49999999999999987654  9999999997654


Q ss_pred             CCCCCCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHh--------------
Q 019195          145 LHSRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIM--------------  210 (344)
Q Consensus       145 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~--------------  210 (344)
                      .........||+.|+|||++.+..+.. ++|||||||++|+|++|+.||...+....+...+....              
T Consensus       175 ~~~~~~~~~~t~~y~aPE~~~~~~~~~-~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (359)
T cd07876         175 TNFMMTPYVVTRYYRAPEVILGMGYKE-NVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTV  253 (359)
T ss_pred             cCccCCCCcccCCCCCchhccCCCCCc-chhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHHHH
Confidence            444445568999999999998877754 49999999999999999999987654433332222110              


Q ss_pred             ----hccccC--------------C----CCCCCCHhHHHHHHHhcccCCCCCCChHHHhcCcccccC
Q 019195          211 ----AVQYKI--------------P----DYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKN  256 (344)
Q Consensus       211 ----~~~~~~--------------~----~~~~~s~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~~  256 (344)
                          ......              +    .....++++++||.+||+.||.+|||+.|+|+||||...
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~  321 (359)
T cd07876         254 RNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITVW  321 (359)
T ss_pred             HHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhhh
Confidence                000000              0    001236789999999999999999999999999999654

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=6.2e-46  Score=338.49  Aligned_cols=241  Identities=34%  Similarity=0.576  Sum_probs=198.8

Q ss_pred             eeeeeecCceEEEEEEEc---CCCcEEEEEEeecCc-----cccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEEe
Q 019195            7 MKDIGSGNFGVARLMRNK---NTKELVAMKYIERGH-----KIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVME   78 (344)
Q Consensus         7 ~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~-----~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e   78 (344)
                      ++.||+|+||.||+|.+.   .+++.||+|++.+..     .....+.+|+.+++.++||||+++++++..++.+|+|||
T Consensus         1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e   80 (323)
T cd05584           1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILE   80 (323)
T ss_pred             CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEe
Confidence            468999999999999864   578899999987532     223456789999999999999999999999999999999


Q ss_pred             cCCCCChHHHHHhCCCCCHHHHHHHHHHHH-------HCCeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCC-CCCC
Q 019195           79 YAAGGELFERICNAGRFSEDEARYFFQQLI-------SGQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH-SRPK  150 (344)
Q Consensus        79 ~~~~g~L~~~i~~~~~~~~~~~~~~~~ql~-------~~~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~-~~~~  150 (344)
                      |+++++|..++.+.+.+++..++.++.|++       +.||+||||||+|||++.++  ++||+|||+++..... ....
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~--~~kl~Dfg~~~~~~~~~~~~~  158 (323)
T cd05584          81 YLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQG--HVKLTDFGLCKESIHEGTVTH  158 (323)
T ss_pred             CCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCC--CEEEeeCcCCeecccCCCccc
Confidence            999999999998888888887777666655       45999999999999997665  4999999998743322 2234


Q ss_pred             CCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCHhHHHHH
Q 019195          151 STVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLL  230 (344)
Q Consensus       151 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li  230 (344)
                      ..+||+.|+|||++.+..+. .++|||||||++|+|++|+.||........    +..+......+|.  .+++++.+||
T Consensus       159 ~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~G~~pf~~~~~~~~----~~~~~~~~~~~~~--~~~~~~~~li  231 (323)
T cd05584         159 TFCGTIEYMAPEILMRSGHG-KAVDWWSLGALMYDMLTGAPPFTAENRKKT----IDKILKGKLNLPP--YLTPEARDLL  231 (323)
T ss_pred             ccCCCccccChhhccCCCCC-CcceecccHHHHHHHhcCCCCCCCCCHHHH----HHHHHcCCCCCCC--CCCHHHHHHH
Confidence            45799999999999877664 559999999999999999999987654333    3334444444443  5789999999


Q ss_pred             HHhcccCCCCCC-----ChHHHhcCcccccC
Q 019195          231 SRIFVANPSRRI-----TIKEIKSHPWFLKN  256 (344)
Q Consensus       231 ~~~L~~dp~~R~-----s~~ell~hp~~~~~  256 (344)
                      .+||+.+|.+||     ++.++++||||...
T Consensus       232 ~~~l~~~p~~R~~~~~~~~~~l~~h~~~~~~  262 (323)
T cd05584         232 KKLLKRNPSSRLGAGPGDAAEVQSHPFFRHV  262 (323)
T ss_pred             HHHcccCHhHcCCCCCCCHHHHhcCCCcCCC
Confidence            999999999999     89999999999765

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-47  Score=371.70  Aligned_cols=257  Identities=32%  Similarity=0.518  Sum_probs=214.1

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCc----cccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEE
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH----KIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVM   77 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~   77 (344)
                      ++|+++++||+|+||.|.+++++.|+++||+|++++-.    ...+-|..|-.+|.--+.+=|++++-.|+++.++|+||
T Consensus        75 ~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYlVM  154 (1317)
T KOG0612|consen   75 EDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYLVM  154 (1317)
T ss_pred             HhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEEEE
Confidence            57999999999999999999999999999999998732    22345677788888888999999999999999999999


Q ss_pred             ecCCCCChHHHHHhCCCCCHHHHHHHHHHHH-------HCCeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCC--C
Q 019195           78 EYAAGGELFERICNAGRFSEDEARYFFQQLI-------SGQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS--R  148 (344)
Q Consensus        78 e~~~~g~L~~~i~~~~~~~~~~~~~~~~ql~-------~~~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~--~  148 (344)
                      ||++||+|..++.+..++++..++.|+..|+       +-|+|||||||+|||+|..+  ++||+|||.+-.....+  .
T Consensus       155 dY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~G--HikLADFGsClkm~~dG~V~  232 (1317)
T KOG0612|consen  155 DYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSG--HIKLADFGSCLKMDADGTVR  232 (1317)
T ss_pred             ecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccC--cEeeccchhHHhcCCCCcEE
Confidence            9999999999999999999998888865544       55999999999999997665  59999999875544333  2


Q ss_pred             CCCCccCCcccCCccccC----CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhc--cccCCCCCCC
Q 019195          149 PKSTVGTPAYIAPEVLSR----REYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAV--QYKIPDYVHI  222 (344)
Q Consensus       149 ~~~~~gt~~y~aPE~~~~----~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~  222 (344)
                      ....+|||-|.|||+++.    ...+++.+|+||+||++|||++|..||...+    +..++.+|+..  .+.+|....+
T Consensus       233 s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYads----lveTY~KIm~hk~~l~FP~~~~V  308 (1317)
T KOG0612|consen  233 SSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADS----LVETYGKIMNHKESLSFPDETDV  308 (1317)
T ss_pred             eccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHH----HHHHHHHHhchhhhcCCCccccc
Confidence            355689999999999853    2455777999999999999999999998754    45555555554  6667766779


Q ss_pred             CHhHHHHHHHhcccCCCCCCC---hHHHhcCcccccCCChhhHHHH
Q 019195          223 SQDCRNLLSRIFVANPSRRIT---IKEIKSHPWFLKNLPRELTETA  265 (344)
Q Consensus       223 s~~~~~li~~~L~~dp~~R~s---~~ell~hp~~~~~~~~~~~~~~  265 (344)
                      |+++++||+++|+ +|..|..   +.++..||||...-+..+....
T Consensus       309 SeeakdLI~~ll~-~~e~RLgrngiedik~HpFF~g~~W~~iR~~~  353 (1317)
T KOG0612|consen  309 SEEAKDLIEALLC-DREVRLGRNGIEDIKNHPFFEGIDWDNIRESV  353 (1317)
T ss_pred             CHHHHHHHHHHhc-ChhhhcccccHHHHHhCccccCCChhhhhhcC
Confidence            9999999999886 6788887   9999999999987665554433

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=1.4e-45  Score=330.98  Aligned_cols=248  Identities=28%  Similarity=0.431  Sum_probs=195.7

Q ss_pred             CCceeeeeeeecCceEEEEEEEcC-CCcEEEEEEeecCcc---ccHHHHHHHHHHhcC---CCCCcceeeEEEEc-----
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKN-TKELVAMKYIERGHK---IDANVAREIINHKQL---RHPNIIRFKEVVLT-----   69 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vaiK~~~~~~~---~~~~~~~ei~~l~~l---~h~niv~~~~~~~~-----   69 (344)
                      ++|++++.||+|+||.||+|.+.. +++.||+|++.....   ....+.+|+.+++.+   +||||+++++++..     
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~   80 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR   80 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence            589999999999999999999854 578899998875332   224566777777665   69999999999852     


Q ss_pred             CCEEEEEEecCCCCChHHHHHhC--CCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCC
Q 019195           70 PTHLAIVMEYAAGGELFERICNA--GRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYS  140 (344)
Q Consensus        70 ~~~~~lv~e~~~~g~L~~~i~~~--~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a  140 (344)
                      ...+++||||+. ++|..++...  ..+++..++.++.|++.+       ||+||||||+|||++.++.  +||+|||++
T Consensus        81 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~--~kl~Dfg~~  157 (290)
T cd07862          81 ETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQ--IKLADFGLA  157 (290)
T ss_pred             CCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCC--EEEccccce
Confidence            456899999996 6898888653  358888888887776654       9999999999999977654  999999998


Q ss_pred             cccCCCCCCCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhcc-ccCC--
Q 019195          141 KSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQ-YKIP--  217 (344)
Q Consensus       141 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~--  217 (344)
                      +............||+.|+|||++.+..+.. ++|||||||++|+|++|++||.+......+..++....... ...+  
T Consensus       158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~  236 (290)
T cd07862         158 RIYSFQMALTSVVVTLWYRAPEVLLQSSYAT-PVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRD  236 (290)
T ss_pred             EeccCCcccccccccccccChHHHhCCCCCC-ccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchhh
Confidence            7654444445567999999999998777654 59999999999999999999998776665555543221100 0000  


Q ss_pred             ------------------CCCCCCHhHHHHHHHhcccCCCCCCChHHHhcCccc
Q 019195          218 ------------------DYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF  253 (344)
Q Consensus       218 ------------------~~~~~s~~~~~li~~~L~~dp~~R~s~~ell~hp~~  253 (344)
                                        ....+++.+.+||.+||+.||.+|||+.++|+||||
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f  290 (290)
T cd07862         237 VALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF  290 (290)
T ss_pred             hcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence                              012467889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=1.1e-45  Score=337.11  Aligned_cols=244  Identities=34%  Similarity=0.597  Sum_probs=199.2

Q ss_pred             ceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCc----cccHHHHHHHHHH---hcCCCCCcceeeEEEEcCCEEEEE
Q 019195            4 YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH----KIDANVAREIINH---KQLRHPNIIRFKEVVLTPTHLAIV   76 (344)
Q Consensus         4 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~ei~~l---~~l~h~niv~~~~~~~~~~~~~lv   76 (344)
                      |++++.||+|+||.||++.+..+++.||+|++.+..    .....+.+|+.++   +.++||||+++++++...+.+|+|
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv   80 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV   80 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence            789999999999999999999999999999997532    2224566666554   566899999999999999999999


Q ss_pred             EecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCC-CC
Q 019195           77 MEYAAGGELFERICNAGRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH-SR  148 (344)
Q Consensus        77 ~e~~~~g~L~~~i~~~~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~-~~  148 (344)
                      |||+++++|...+.. +.+++.+++.++.||+.+       ||+||||||+|||++.++.  +||+|||+++..... ..
T Consensus        81 ~E~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~--~kL~Dfg~~~~~~~~~~~  157 (324)
T cd05589          81 MEYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGF--VKIADFGLCKEGMGFGDR  157 (324)
T ss_pred             EcCCCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCc--EEeCcccCCccCCCCCCc
Confidence            999999999888754 578988888887776654       9999999999999987664  999999998753322 22


Q ss_pred             CCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCHhHHH
Q 019195          149 PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRN  228 (344)
Q Consensus       149 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~  228 (344)
                      ....+||+.|+|||++.+..+. .++|||||||++|+|++|+.||...+....+.    .+.......|.  .+++.+.+
T Consensus       158 ~~~~~g~~~y~aPE~~~~~~~~-~~~DiwslG~il~el~~G~~pf~~~~~~~~~~----~i~~~~~~~p~--~~~~~~~~  230 (324)
T cd05589         158 TSTFCGTPEFLAPEVLTETSYT-RAVDWWGLGVLIYEMLVGESPFPGDDEEEVFD----SIVNDEVRYPR--FLSREAIS  230 (324)
T ss_pred             ccccccCccccCHhHhcCCCCC-cccchhhHHHHHHHHHhCCCCCCCCCHHHHHH----HHHhCCCCCCC--CCCHHHHH
Confidence            3456799999999999877764 45999999999999999999998765443333    33333444443  57899999


Q ss_pred             HHHHhcccCCCCCC-----ChHHHhcCcccccCC
Q 019195          229 LLSRIFVANPSRRI-----TIKEIKSHPWFLKNL  257 (344)
Q Consensus       229 li~~~L~~dp~~R~-----s~~ell~hp~~~~~~  257 (344)
                      ||.+||+.||.+||     ++.++++||||....
T Consensus       231 li~~~L~~dP~~R~~~~~~~~~~l~~~~~f~~~~  264 (324)
T cd05589         231 IMRRLLRRNPERRLGSGEKDAEDVKKQPFFRDIN  264 (324)
T ss_pred             HHHHHhhcCHhHcCCCCCCCHHHHhhCCCcCCCC
Confidence            99999999999999     699999999997653

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=8.2e-46  Score=353.75  Aligned_cols=252  Identities=22%  Similarity=0.366  Sum_probs=194.1

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcCC------CCCcceeeEEEEcC-CEEE
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLR------HPNIIRFKEVVLTP-THLA   74 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~l~~l~------h~niv~~~~~~~~~-~~~~   74 (344)
                      ++|++++.||+|+||+||+|.+..+++.||||++............|+.+++.+.      |.++++++++|..+ .++|
T Consensus       129 ~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~~~  208 (467)
T PTZ00284        129 QRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGHMC  208 (467)
T ss_pred             CcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCceEE
Confidence            5799999999999999999999999999999999764444445667777777664      45688999988765 5789


Q ss_pred             EEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHH--------CCeeecCCCCCCeEecCCCC--------------CCE
Q 019195           75 IVMEYAAGGELFERICNAGRFSEDEARYFFQQLIS--------GQICHRDLKLENTLLDGSPA--------------PRL  132 (344)
Q Consensus        75 lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~ql~~--------~~iiH~Dikp~NIl~~~~~~--------------~~v  132 (344)
                      +||+++ +++|.+++.+.+.+++.+++.++.||+.        .||+||||||+|||++..+.              .++
T Consensus       209 iv~~~~-g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~~~~~v  287 (467)
T PTZ00284        209 IVMPKY-GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRV  287 (467)
T ss_pred             EEEecc-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccccCCCCceE
Confidence            999998 7899999988888999988888777554        39999999999999975432              249


Q ss_pred             EEeecCCCcccCCCCCCCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhc
Q 019195          133 KICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAV  212 (344)
Q Consensus       133 kL~DFg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~  212 (344)
                      ||+|||++...  .......+||+.|+|||++.+..+. .++|||||||++|+|++|++||........+..+.......
T Consensus       288 kl~DfG~~~~~--~~~~~~~~gt~~Y~APE~~~~~~~~-~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~  364 (467)
T PTZ00284        288 RICDLGGCCDE--RHSRTAIVSTRHYRSPEVVLGLGWM-YSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEKTLGRL  364 (467)
T ss_pred             EECCCCccccC--ccccccccCCccccCcHHhhcCCCC-cHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCC
Confidence            99999987532  2233456899999999999888775 45999999999999999999998766543332221111000


Q ss_pred             c-------------------cc-CCC----------------CCCCCHhHHHHHHHhcccCCCCCCChHHHhcCcccccC
Q 019195          213 Q-------------------YK-IPD----------------YVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKN  256 (344)
Q Consensus       213 ~-------------------~~-~~~----------------~~~~s~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~~  256 (344)
                      .                   .. .+.                ....++.+.+||.+||++||.+|||+.|+|+||||.+.
T Consensus       365 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~Hp~~~~~  444 (467)
T PTZ00284        365 PSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTTHPYVLKY  444 (467)
T ss_pred             CHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhcCcccccc
Confidence            0                   00 000                00124567899999999999999999999999999764


Q ss_pred             C
Q 019195          257 L  257 (344)
Q Consensus       257 ~  257 (344)
                      .
T Consensus       445 ~  445 (467)
T PTZ00284        445 Y  445 (467)
T ss_pred             C
Confidence            3

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=8.6e-46  Score=338.31  Aligned_cols=244  Identities=30%  Similarity=0.511  Sum_probs=197.5

Q ss_pred             eeeeecCceEEEEEEEcCCCcEEEEEEeecCcc----ccHHHHHHHHHHhcC-CCCCcceeeEEEEcCCEEEEEEecCCC
Q 019195            8 KDIGSGNFGVARLMRNKNTKELVAMKYIERGHK----IDANVAREIINHKQL-RHPNIIRFKEVVLTPTHLAIVMEYAAG   82 (344)
Q Consensus         8 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~ei~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~   82 (344)
                      +.||+|+||.||+|.+..+++.||+|++.+...    ....+.+|+.++.++ +||||+++++++...+.+|+||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~   80 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG   80 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence            479999999999999999999999999986422    224567888888776 799999999999999999999999999


Q ss_pred             CChHHHHHhCCCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCC-CCCCCCCcc
Q 019195           83 GELFERICNAGRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLL-HSRPKSTVG  154 (344)
Q Consensus        83 g~L~~~i~~~~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~-~~~~~~~~g  154 (344)
                      |+|..++...+.+++..++.++.|++.+       ||+||||||+|||++.++.  +||+|||+++.... .......+|
T Consensus        81 ~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~--~kL~DfG~~~~~~~~~~~~~~~~g  158 (329)
T cd05618          81 GDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGH--IKLTDYGMCKEGLRPGDTTSTFCG  158 (329)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCC--EEEeeCCccccccCCCCccccccC
Confidence            9999999888889999888887776654       9999999999999987664  99999999875322 222345679


Q ss_pred             CCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC-----ChHHHHHHHHHHhhccccCCCCCCCCHhHHHH
Q 019195          155 TPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQE-----DPKNFRKTISRIMAVQYKIPDYVHISQDCRNL  229 (344)
Q Consensus       155 t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  229 (344)
                      |+.|+|||++.+..++ .++|||||||++|+|++|+.||....     ...........+......+|.  .++..+.+|
T Consensus       159 t~~y~aPE~~~~~~~~-~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~--~~~~~~~~l  235 (329)
T cd05618         159 TPNYIAPEILRGEDYG-FSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPR--SLSVKAASV  235 (329)
T ss_pred             CccccCHHHHcCCCCC-CccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCCCCC--CCCHHHHHH
Confidence            9999999999887765 45999999999999999999995321     111112223333344444554  678999999


Q ss_pred             HHHhcccCCCCCCC------hHHHhcCcccccC
Q 019195          230 LSRIFVANPSRRIT------IKEIKSHPWFLKN  256 (344)
Q Consensus       230 i~~~L~~dp~~R~s------~~ell~hp~~~~~  256 (344)
                      |.+||+.||.+||+      +.++++||||...
T Consensus       236 l~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~~  268 (329)
T cd05618         236 LKSFLNKDPKERLGCHPQTGFADIQGHPFFRNV  268 (329)
T ss_pred             HHHHhcCCHHHcCCCCCCCCHHHHhcCCCCCCC
Confidence            99999999999998      4799999999654

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=8.7e-46  Score=343.40  Aligned_cols=250  Identities=34%  Similarity=0.526  Sum_probs=201.2

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCc----cccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEE
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH----KIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVM   77 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~   77 (344)
                      ++|++.+.||+|+||.||+|.+..+++.||+|++.+..    .....+.+|+.+++.++||||+++++++..+..+|+||
T Consensus        43 ~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~  122 (371)
T cd05622          43 EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVM  122 (371)
T ss_pred             hhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence            68999999999999999999999999999999986532    12245678999999999999999999999999999999


Q ss_pred             ecCCCCChHHHHHhCCCCCHHHHHHHHHHHH-------HCCeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCC--C
Q 019195           78 EYAAGGELFERICNAGRFSEDEARYFFQQLI-------SGQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS--R  148 (344)
Q Consensus        78 e~~~~g~L~~~i~~~~~~~~~~~~~~~~ql~-------~~~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~--~  148 (344)
                      |||++|+|..++... .+++..++.++.||+       +.||+||||||+|||++.++.  +||+|||++.......  .
T Consensus       123 Ey~~gg~L~~~~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~--ikL~DfG~a~~~~~~~~~~  199 (371)
T cd05622         123 EYMPGGDLVNLMSNY-DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGH--LKLADFGTCMKMNKEGMVR  199 (371)
T ss_pred             cCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCC--EEEEeCCceeEcCcCCccc
Confidence            999999999988654 578877776666554       559999999999999987654  9999999987543322  2


Q ss_pred             CCCCccCCcccCCccccCCC---CCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCHh
Q 019195          149 PKSTVGTPAYIAPEVLSRRE---YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQD  225 (344)
Q Consensus       149 ~~~~~gt~~y~aPE~~~~~~---~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~  225 (344)
                      ....+||+.|+|||++.+..   ..+.++|||||||++|+|++|.+||...+....+.++...  .....+|....++..
T Consensus       200 ~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~s~~  277 (371)
T cd05622         200 CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNH--KNSLTFPDDNDISKE  277 (371)
T ss_pred             ccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcC--CCcccCCCcCCCCHH
Confidence            23567999999999986543   2456699999999999999999999876654443333221  122345555678999


Q ss_pred             HHHHHHHhcccCCCC--CCChHHHhcCcccccC
Q 019195          226 CRNLLSRIFVANPSR--RITIKEIKSHPWFLKN  256 (344)
Q Consensus       226 ~~~li~~~L~~dp~~--R~s~~ell~hp~~~~~  256 (344)
                      +++||.+||..++.+  |+++.++++||||.+.
T Consensus       278 ~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~~  310 (371)
T cd05622         278 AKNLICAFLTDREVRLGRNGVEEIKRHLFFKND  310 (371)
T ss_pred             HHHHHHHHcCChhhhcCCCCHHHHhcCcccCCC
Confidence            999999999854443  7899999999999764

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=7.7e-46  Score=337.87  Aligned_cols=246  Identities=31%  Similarity=0.538  Sum_probs=203.6

Q ss_pred             CceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCcc----ccHHHHHHHHHHhcC-CCCCcceeeEEEEcCCEEEEEE
Q 019195            3 KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK----IDANVAREIINHKQL-RHPNIIRFKEVVLTPTHLAIVM   77 (344)
Q Consensus         3 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~ei~~l~~l-~h~niv~~~~~~~~~~~~~lv~   77 (344)
                      +|++++.||+|+||.||+|.+..+++.||+|++.+...    ....+..|..++..+ .|++|+++++++...+.+|+||
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM   80 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence            58999999999999999999999999999999876432    123456677777776 5899999999999999999999


Q ss_pred             ecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCC-CCCC
Q 019195           78 EYAAGGELFERICNAGRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLL-HSRP  149 (344)
Q Consensus        78 e~~~~g~L~~~i~~~~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~-~~~~  149 (344)
                      ||+++|+|...+...+.+++.+++.++.|++.+       ||+||||||+|||++.++.  +||+|||+++.... ....
T Consensus        81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~--~kL~DfG~~~~~~~~~~~~  158 (323)
T cd05616          81 EYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGH--IKIADFGMCKENMWDGVTT  158 (323)
T ss_pred             cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCc--EEEccCCCceecCCCCCcc
Confidence            999999999999888889999888887776654       9999999999999987664  99999999875332 2233


Q ss_pred             CCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCHhHHHH
Q 019195          150 KSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL  229 (344)
Q Consensus       150 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  229 (344)
                      ...+||+.|+|||++.+..++ .++|||||||++|+|++|+.||...+....    ...+......+|.  .++.++.+|
T Consensus       159 ~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlGvil~elltg~~Pf~~~~~~~~----~~~i~~~~~~~p~--~~s~~~~~l  231 (323)
T cd05616         159 KTFCGTPDYIAPEIIAYQPYG-KSVDWWAFGVLLYEMLAGQAPFEGEDEDEL----FQSIMEHNVAYPK--SMSKEAVAI  231 (323)
T ss_pred             ccCCCChhhcCHHHhcCCCCC-CccchhchhHHHHHHHhCCCCCCCCCHHHH----HHHHHhCCCCCCC--cCCHHHHHH
Confidence            456799999999999887765 559999999999999999999987654333    3333444444443  689999999


Q ss_pred             HHHhcccCCCCCCCh-----HHHhcCcccccCC
Q 019195          230 LSRIFVANPSRRITI-----KEIKSHPWFLKNL  257 (344)
Q Consensus       230 i~~~L~~dp~~R~s~-----~ell~hp~~~~~~  257 (344)
                      +.+||+.+|.+|+++     .++++||||....
T Consensus       232 i~~~l~~~p~~R~~~~~~~~~~i~~h~~~~~~~  264 (323)
T cd05616         232 CKGLMTKHPGKRLGCGPEGERDIKEHAFFRYID  264 (323)
T ss_pred             HHHHcccCHHhcCCCCCCCHHHHhcCCCcCCCC
Confidence            999999999999984     8999999997643

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-45  Score=335.31  Aligned_cols=239  Identities=31%  Similarity=0.467  Sum_probs=194.5

Q ss_pred             ceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCccc---cHHHHHHHHHHhcCCCCCcceeeEEEEcCC-EEEEEEec
Q 019195            4 YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKI---DANVAREIINHKQLRHPNIIRFKEVVLTPT-HLAIVMEY   79 (344)
Q Consensus         4 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~ei~~l~~l~h~niv~~~~~~~~~~-~~~lv~e~   79 (344)
                      ..+.+.||+|+||+||++.+..+. .||+|++......   ...+.+|+.+|++++|||||++++++.... .+++||||
T Consensus        43 l~~~~~iG~G~~g~V~~~~~~g~~-~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy  121 (362)
T KOG0192|consen   43 LPIEEVLGSGSFGTVYKGKWRGTD-VVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEY  121 (362)
T ss_pred             hhhhhhcccCCceeEEEEEeCCce-eEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEe
Confidence            345667999999999999986542 3999999764432   458999999999999999999999998887 79999999


Q ss_pred             CCCCChHHHHHh--CCCCCHHHHHHHHHHHHH-------CC-eeecCCCCCCeEecCCCCCCEEEeecCCCcccCCC-CC
Q 019195           80 AAGGELFERICN--AGRFSEDEARYFFQQLIS-------GQ-ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH-SR  148 (344)
Q Consensus        80 ~~~g~L~~~i~~--~~~~~~~~~~~~~~ql~~-------~~-iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~-~~  148 (344)
                      +++|+|..++.+  ...++...+..++.+++.       .+ ||||||||+|||++... .++||||||+++..... ..
T Consensus       122 ~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~-~~~KI~DFGlsr~~~~~~~~  200 (362)
T KOG0192|consen  122 MPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKG-KTLKIADFGLSREKVISKTS  200 (362)
T ss_pred             CCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCC-CEEEECCCccceeecccccc
Confidence            999999999987  578888887777666655       48 99999999999998775 24999999999865544 34


Q ss_pred             CCCCccCCcccCCcccc--CCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCHhH
Q 019195          149 PKSTVGTPAYIAPEVLS--RREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDC  226 (344)
Q Consensus       149 ~~~~~gt~~y~aPE~~~--~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~  226 (344)
                      .+...||+.|||||++.  ...|+ .++|||||||++|||+||+.||......    .....+.....+.+.....++.+
T Consensus       201 ~~~~~GT~~wMAPEv~~~~~~~~~-~K~DvySFgIvlWEl~t~~~Pf~~~~~~----~~~~~v~~~~~Rp~~p~~~~~~l  275 (362)
T KOG0192|consen  201 MTSVAGTYRWMAPEVLRGEKSPYT-EKSDVYSFGIVLWELLTGEIPFEDLAPV----QVASAVVVGGLRPPIPKECPPHL  275 (362)
T ss_pred             ccCCCCCccccChhhhcCCCCcCC-ccchhhhHHHHHHHHHHCCCCCCCCCHH----HHHHHHHhcCCCCCCCccCCHHH
Confidence            44478999999999998  44665 5599999999999999999999987652    22233333333333344589999


Q ss_pred             HHHHHHhcccCCCCCCChHHHhc
Q 019195          227 RNLLSRIFVANPSRRITIKEIKS  249 (344)
Q Consensus       227 ~~li~~~L~~dp~~R~s~~ell~  249 (344)
                      ..|+.+||..||.+||+..+++.
T Consensus       276 ~~l~~~CW~~dp~~RP~f~ei~~  298 (362)
T KOG0192|consen  276 SSLMERCWLVDPSRRPSFLEIVS  298 (362)
T ss_pred             HHHHHHhCCCCCCcCCCHHHHHH
Confidence            99999999999999999999865

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=9.9e-46  Score=341.23  Aligned_cols=249  Identities=27%  Similarity=0.458  Sum_probs=195.3

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCcc--ccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEEec
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK--IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEY   79 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~   79 (344)
                      ++|+.++.||+|+||.||++.+..+++.||+|++.....  ....+.+|+.+++.++|+||+++++++...+.+++||||
T Consensus        74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  153 (353)
T PLN00034         74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEF  153 (353)
T ss_pred             HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEec
Confidence            568899999999999999999999999999999865432  235688999999999999999999999999999999999


Q ss_pred             CCCCChHHHHHhCCCCCHHHHHHHHHH-------HHHCCeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCC-CCCC
Q 019195           80 AAGGELFERICNAGRFSEDEARYFFQQ-------LISGQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS-RPKS  151 (344)
Q Consensus        80 ~~~g~L~~~i~~~~~~~~~~~~~~~~q-------l~~~~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~-~~~~  151 (344)
                      +.+++|...    ....+..++.++.|       ||+.||+||||||+|||++.++.  +||+|||+++...... ....
T Consensus       154 ~~~~~L~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~--~kL~DfG~~~~~~~~~~~~~~  227 (353)
T PLN00034        154 MDGGSLEGT----HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKN--VKIADFGVSRILAQTMDPCNS  227 (353)
T ss_pred             CCCCccccc----ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCC--EEEcccccceecccccccccc
Confidence            999998543    23445555555555       45559999999999999987654  9999999987543322 2345


Q ss_pred             CccCCcccCCccccC----CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCHhHH
Q 019195          152 TVGTPAYIAPEVLSR----REYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCR  227 (344)
Q Consensus       152 ~~gt~~y~aPE~~~~----~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~  227 (344)
                      ..||..|+|||++..    ..+.+.++|||||||++|+|++|+.||...... .+......+.. .........++.++.
T Consensus       228 ~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~-~~~~~~~~~~~-~~~~~~~~~~~~~l~  305 (353)
T PLN00034        228 SVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQG-DWASLMCAICM-SQPPEAPATASREFR  305 (353)
T ss_pred             cccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCc-cHHHHHHHHhc-cCCCCCCCccCHHHH
Confidence            679999999998743    234455799999999999999999999744322 12222222211 111222336789999


Q ss_pred             HHHHHhcccCCCCCCChHHHhcCcccccCCC
Q 019195          228 NLLSRIFVANPSRRITIKEIKSHPWFLKNLP  258 (344)
Q Consensus       228 ~li~~~L~~dp~~R~s~~ell~hp~~~~~~~  258 (344)
                      +||.+||+.||.+|||+.++|+||||.+...
T Consensus       306 ~li~~~l~~~P~~Rpt~~ell~hp~~~~~~~  336 (353)
T PLN00034        306 HFISCCLQREPAKRWSAMQLLQHPFILRAQP  336 (353)
T ss_pred             HHHHHHccCChhhCcCHHHHhcCcccccCCc
Confidence            9999999999999999999999999988644

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.5e-46  Score=338.68  Aligned_cols=251  Identities=29%  Similarity=0.534  Sum_probs=200.7

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCc----cccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEE
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH----KIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVM   77 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~   77 (344)
                      ++|++++.||+|+||.||++.+..+++.||+|++.+..    .....+.+|+.+++.++|+||+++++++..++.+|+||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM   80 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence            58999999999999999999999999999999997532    22345778999999999999999999999999999999


Q ss_pred             ecCCCCChHHHHHh-CCCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCCC-
Q 019195           78 EYAAGGELFERICN-AGRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR-  148 (344)
Q Consensus        78 e~~~~g~L~~~i~~-~~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~~-  148 (344)
                      ||+++|+|.+++.+ ...+++..++.++.|++.+       ||+||||||+|||++.++.  +||+|||++........ 
T Consensus        81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~--~kl~Dfg~~~~~~~~~~~  158 (331)
T cd05597          81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGH--IRLADFGSCLRLLADGTV  158 (331)
T ss_pred             ecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCC--EEEEECCceeecCCCCCc
Confidence            99999999999976 4578998888887776654       9999999999999976654  99999999865433222 


Q ss_pred             -CCCCccCCcccCCccccC----CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCC-CCCCC
Q 019195          149 -PKSTVGTPAYIAPEVLSR----REYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIP-DYVHI  222 (344)
Q Consensus       149 -~~~~~gt~~y~aPE~~~~----~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~  222 (344)
                       ....+||+.|+|||++..    ....+.++|||||||++|+|++|+.||........+..+...  .....++ ....+
T Consensus       159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~~  236 (331)
T cd05597         159 QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNH--KEHFQFPPDVTDV  236 (331)
T ss_pred             cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcC--CCcccCCCccCCC
Confidence             223469999999999863    233455699999999999999999999876544443333221  1112222 22357


Q ss_pred             CHhHHHHHHHhcccCCCC--CCChHHHhcCcccccC
Q 019195          223 SQDCRNLLSRIFVANPSR--RITIKEIKSHPWFLKN  256 (344)
Q Consensus       223 s~~~~~li~~~L~~dp~~--R~s~~ell~hp~~~~~  256 (344)
                      ++.+++||++||+.++.+  |+++.++++||||...
T Consensus       237 ~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~~  272 (331)
T cd05597         237 SEEAKDLIRRLICSPETRLGRNGLQDFKDHPFFEGI  272 (331)
T ss_pred             CHHHHHHHHHHccCcccccCCCCHHHHhcCCCCCCC
Confidence            899999999999765544  7899999999999764

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=1.3e-45  Score=342.75  Aligned_cols=252  Identities=25%  Similarity=0.392  Sum_probs=202.2

Q ss_pred             CceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCcc---ccHHHHHHHHHHhcCCCCCcceeeEEEEcCC-----EEE
Q 019195            3 KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK---IDANVAREIINHKQLRHPNIIRFKEVVLTPT-----HLA   74 (344)
Q Consensus         3 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~-----~~~   74 (344)
                      +|++.+.||+|+||.||++.+..+++.||+|++.....   ...++.+|+.+++.++||||+++++++....     .+|
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   80 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY   80 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence            58899999999999999999999999999999865322   2356889999999999999999999998776     799


Q ss_pred             EEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCC
Q 019195           75 IVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS  147 (344)
Q Consensus        75 lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~  147 (344)
                      +||||+. ++|...+.....+++..++.++.||+.+       ||+||||||+|||++.++.  +||+|||+++......
T Consensus        81 lv~e~~~-~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~--~kL~Dfg~a~~~~~~~  157 (372)
T cd07853          81 VVTELMQ-SDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCV--LKICDFGLARVEEPDE  157 (372)
T ss_pred             EEeeccc-cCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCC--EEeccccceeecccCc
Confidence            9999995 6898888888889999888887776654       9999999999999987654  9999999987543222


Q ss_pred             --CCCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHH----------------
Q 019195          148 --RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRI----------------  209 (344)
Q Consensus       148 --~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~----------------  209 (344)
                        ......+|+.|+|||++.+....+.++|||||||++|+|++|++||........+..+....                
T Consensus       158 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~  237 (372)
T cd07853         158 SKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGAR  237 (372)
T ss_pred             cccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHHH
Confidence              22344689999999999876555666999999999999999999998776544443332210                


Q ss_pred             ---hhccccCC-------CCCCCCHhHHHHHHHhcccCCCCCCChHHHhcCcccccCC
Q 019195          210 ---MAVQYKIP-------DYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNL  257 (344)
Q Consensus       210 ---~~~~~~~~-------~~~~~s~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~~~  257 (344)
                         .......+       .....++++.+||.+||+.||.+|||+.++|+||||.+..
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~  295 (372)
T cd07853         238 AHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEGR  295 (372)
T ss_pred             HHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCCCc
Confidence               01111111       1124578999999999999999999999999999997753

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=1.3e-45  Score=336.10  Aligned_cols=240  Identities=32%  Similarity=0.531  Sum_probs=198.2

Q ss_pred             eeeeecCceEEEEEEEcCCCcEEEEEEeecCc----cccHHHHHHHHHHhcC-CCCCcceeeEEEEcCCEEEEEEecCCC
Q 019195            8 KDIGSGNFGVARLMRNKNTKELVAMKYIERGH----KIDANVAREIINHKQL-RHPNIIRFKEVVLTPTHLAIVMEYAAG   82 (344)
Q Consensus         8 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~ei~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~   82 (344)
                      +.||+|+||.||+|.+..+++.||+|++.+..    .....+..|..+++.+ +||||+++++++...+.+|+||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~   80 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG   80 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence            46999999999999999999999999987632    1224566788888765 799999999999999999999999999


Q ss_pred             CChHHHHHhCCCCCHHHHHHHHHHHHH-------CCeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCC-CCCCCCcc
Q 019195           83 GELFERICNAGRFSEDEARYFFQQLIS-------GQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH-SRPKSTVG  154 (344)
Q Consensus        83 g~L~~~i~~~~~~~~~~~~~~~~ql~~-------~~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~-~~~~~~~g  154 (344)
                      ++|...+.+.+.+++..++.++.||+.       .||+||||||+|||++.++.  +||+|||++...... ......+|
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~--~kL~Dfg~~~~~~~~~~~~~~~~g  158 (321)
T cd05591          81 GDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGH--CKLADFGMCKEGILNGVTTTTFCG  158 (321)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCC--EEEeecccceecccCCcccccccc
Confidence            999999988888998888877766654       49999999999999987654  999999998753322 22344579


Q ss_pred             CCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCHhHHHHHHHhc
Q 019195          155 TPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIF  234 (344)
Q Consensus       155 t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L  234 (344)
                      |+.|+|||++.+..++ .++|||||||++|+|++|+.||...+....+    ..+.......|.  .+++++.+||.+||
T Consensus       159 t~~y~aPE~~~~~~~~-~~~DvwslG~il~el~tg~~Pf~~~~~~~~~----~~i~~~~~~~p~--~~~~~~~~ll~~~L  231 (321)
T cd05591         159 TPDYIAPEILQELEYG-PSVDWWALGVLMYEMMAGQPPFEADNEDDLF----ESILHDDVLYPV--WLSKEAVSILKAFM  231 (321)
T ss_pred             CccccCHHHHcCCCCC-CccceechhHHHHHHhcCCCCCCCCCHHHHH----HHHHcCCCCCCC--CCCHHHHHHHHHHh
Confidence            9999999999877765 4599999999999999999999876654333    333334444443  57899999999999


Q ss_pred             ccCCCCCC-------ChHHHhcCcccccC
Q 019195          235 VANPSRRI-------TIKEIKSHPWFLKN  256 (344)
Q Consensus       235 ~~dp~~R~-------s~~ell~hp~~~~~  256 (344)
                      +.||.+||       ++.++++||||...
T Consensus       232 ~~dp~~R~~~~~~~~~~~~~~~hp~~~~~  260 (321)
T cd05591         232 TKNPNKRLGCVASQGGEDAIKQHPFFKEI  260 (321)
T ss_pred             ccCHHHcCCCCCCCCCHHHHhcCCccCCC
Confidence            99999999       89999999999664

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=1.9e-45  Score=334.22  Aligned_cols=241  Identities=32%  Similarity=0.539  Sum_probs=196.3

Q ss_pred             eeeeecCceEEEEEEEcCCCcEEEEEEeecCc----cccHHHHHHHHHHhcC-CCCCcceeeEEEEcCCEEEEEEecCCC
Q 019195            8 KDIGSGNFGVARLMRNKNTKELVAMKYIERGH----KIDANVAREIINHKQL-RHPNIIRFKEVVLTPTHLAIVMEYAAG   82 (344)
Q Consensus         8 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~ei~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~   82 (344)
                      +.||+|+||.||+|.+..+++.||+|++.+..    ........|..++..+ +||||+++++++...+.+|+||||+.+
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~   80 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence            47999999999999999999999999997642    2234566777777654 899999999999999999999999999


Q ss_pred             CChHHHHHhCCCCCHHHHHHHHHHHHH-------CCeeecCCCCCCeEecCCCCCCEEEeecCCCcccCC-CCCCCCCcc
Q 019195           83 GELFERICNAGRFSEDEARYFFQQLIS-------GQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLL-HSRPKSTVG  154 (344)
Q Consensus        83 g~L~~~i~~~~~~~~~~~~~~~~ql~~-------~~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~-~~~~~~~~g  154 (344)
                      |+|..++...+.+++.+++.++.|++.       .||+||||||+|||++.++.  +||+|||+++.... .......+|
T Consensus        81 g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~g  158 (316)
T cd05620          81 GDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGH--IKIADFGMCKENVFGDNRASTFCG  158 (316)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCC--EEeCccCCCeecccCCCceeccCC
Confidence            999999988888998887777666654       49999999999999987664  99999999874322 222345679


Q ss_pred             CCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCHhHHHHHHHhc
Q 019195          155 TPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIF  234 (344)
Q Consensus       155 t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L  234 (344)
                      |+.|+|||++.+..++ .++|||||||++|+|++|+.||...+....    ...+.......|.  .++.++++||.+||
T Consensus       159 t~~y~aPE~~~~~~~~-~~~DiwslGvil~el~~g~~Pf~~~~~~~~----~~~~~~~~~~~~~--~~~~~~~~li~~~l  231 (316)
T cd05620         159 TPDYIAPEILQGLKYT-FSVDWWSFGVLLYEMLIGQSPFHGDDEDEL----FESIRVDTPHYPR--WITKESKDILEKLF  231 (316)
T ss_pred             CcCccCHHHHcCCCCC-cccchhhhHHHHHHHHhCCCCCCCCCHHHH----HHHHHhCCCCCCC--CCCHHHHHHHHHHc
Confidence            9999999999877765 459999999999999999999987654332    2223333333343  57899999999999


Q ss_pred             ccCCCCCCCh-HHHhcCcccccCC
Q 019195          235 VANPSRRITI-KEIKSHPWFLKNL  257 (344)
Q Consensus       235 ~~dp~~R~s~-~ell~hp~~~~~~  257 (344)
                      +.||.+||++ .++++||||....
T Consensus       232 ~~dP~~R~~~~~~~~~h~~f~~~~  255 (316)
T cd05620         232 ERDPTRRLGVVGNIRGHPFFKTIN  255 (316)
T ss_pred             cCCHHHcCCChHHHHcCCCcCCCC
Confidence            9999999998 5899999997753

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=3.6e-45  Score=338.91  Aligned_cols=250  Identities=28%  Similarity=0.407  Sum_probs=197.3

Q ss_pred             CCCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCc---cccHHHHHHHHHHhcCCCCCcceeeEEEEcC------C
Q 019195            1 MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH---KIDANVAREIINHKQLRHPNIIRFKEVVLTP------T   71 (344)
Q Consensus         1 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~------~   71 (344)
                      +++|++.+.||+|+||.||++.+..+++.||+|++....   .....+.+|+.+++.++||||+++++++...      .
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~  102 (364)
T cd07875          23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ  102 (364)
T ss_pred             hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccC
Confidence            478999999999999999999999999999999987542   2235678899999999999999999988644      3


Q ss_pred             EEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHH-------CCeeecCCCCCCeEecCCCCCCEEEeecCCCcccC
Q 019195           72 HLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLIS-------GQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSL  144 (344)
Q Consensus        72 ~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~ql~~-------~~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~  144 (344)
                      .+|+||||+++ +|...+..  .++...++.++.|++.       .||+||||||+|||++.++.  +||+|||+++...
T Consensus       103 ~~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~--~kL~DfG~a~~~~  177 (364)
T cd07875         103 DVYIVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAG  177 (364)
T ss_pred             eEEEEEeCCCC-CHHHHHHh--cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCc--EEEEeCCCccccC
Confidence            57999999964 77777643  4677777777766655       49999999999999987654  9999999998655


Q ss_pred             CCCCCCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhcc-----------
Q 019195          145 LHSRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQ-----------  213 (344)
Q Consensus       145 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~-----------  213 (344)
                      .........||+.|+|||++.+..++. ++|||||||++|+|++|+.||...+....+.+++.......           
T Consensus       178 ~~~~~~~~~~t~~y~aPE~~~~~~~~~-~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (364)
T cd07875         178 TSFMMTPYVVTRYYRAPEVILGMGYKE-NVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTV  256 (364)
T ss_pred             CCCcccCCcccCCcCCHHHHhCCCCCc-hhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhHHH
Confidence            444445567999999999998877654 59999999999999999999988765555444433211100           


Q ss_pred             ----ccCCC---------------------CCCCCHhHHHHHHHhcccCCCCCCChHHHhcCcccccC
Q 019195          214 ----YKIPD---------------------YVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKN  256 (344)
Q Consensus       214 ----~~~~~---------------------~~~~s~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~~  256 (344)
                          ...|.                     ....+..+++||.+||+.||.+|||+.++|+||||...
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~~  324 (364)
T cd07875         257 RTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVW  324 (364)
T ss_pred             HHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCcccccc
Confidence                00000                     01134678999999999999999999999999999643

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=5.6e-45  Score=326.61  Aligned_cols=247  Identities=28%  Similarity=0.435  Sum_probs=196.1

Q ss_pred             CceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCcc---ccHHHHHHHHHHhcC---CCCCcceeeEEEEc-----CC
Q 019195            3 KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK---IDANVAREIINHKQL---RHPNIIRFKEVVLT-----PT   71 (344)
Q Consensus         3 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~ei~~l~~l---~h~niv~~~~~~~~-----~~   71 (344)
                      +|++++.||+|+||+||+|.+..+++.||+|.+.....   ....+.+|+.+++.+   +||||+++++++..     ..
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~   80 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET   80 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence            69999999999999999999999999999999875322   224566777777665   79999999999864     34


Q ss_pred             EEEEEEecCCCCChHHHHHhC--CCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcc
Q 019195           72 HLAIVMEYAAGGELFERICNA--GRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKS  142 (344)
Q Consensus        72 ~~~lv~e~~~~g~L~~~i~~~--~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~  142 (344)
                      .++++|||+. ++|..++...  ..+++.+++.++.|++.+       ||+||||||+|||++.++.  +||+|||++..
T Consensus        81 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~--~kl~dfg~~~~  157 (288)
T cd07863          81 KVTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQ--VKLADFGLARI  157 (288)
T ss_pred             eEEEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCC--EEECccCcccc
Confidence            6899999997 5888888664  348899888888776654       9999999999999977664  99999999876


Q ss_pred             cCCCCCCCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhcc-------cc
Q 019195          143 SLLHSRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQ-------YK  215 (344)
Q Consensus       143 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~-------~~  215 (344)
                      ...........||+.|+|||++.+..++ .++|||||||++|+|++|++||........+.++........       ..
T Consensus       158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (288)
T cd07863         158 YSCQMALTPVVVTLWYRAPEVLLQSTYA-TPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVT  236 (288)
T ss_pred             ccCcccCCCccccccccCchHhhCCCCC-CcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCccccc
Confidence            5544444556789999999999877764 459999999999999999999987766555554443221100       00


Q ss_pred             CC--------------CCCCCCHhHHHHHHHhcccCCCCCCChHHHhcCccc
Q 019195          216 IP--------------DYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF  253 (344)
Q Consensus       216 ~~--------------~~~~~s~~~~~li~~~L~~dp~~R~s~~ell~hp~~  253 (344)
                      .+              ....++..+.+||.+||+.||.+|||+.+++.||||
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f  288 (288)
T cd07863         237 LPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF  288 (288)
T ss_pred             ccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence            00              012467789999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=2.3e-45  Score=334.02  Aligned_cols=240  Identities=35%  Similarity=0.605  Sum_probs=199.4

Q ss_pred             eeeeecCceEEEEEEEcCCCcEEEEEEeecCc----cccHHHHHHHHHHhcC-CCCCcceeeEEEEcCCEEEEEEecCCC
Q 019195            8 KDIGSGNFGVARLMRNKNTKELVAMKYIERGH----KIDANVAREIINHKQL-RHPNIIRFKEVVLTPTHLAIVMEYAAG   82 (344)
Q Consensus         8 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~ei~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~   82 (344)
                      +.||+|+||+||++.+..++..||+|++.+..    .....+.+|+.+++.+ +||||+++++++...+.+|+||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~   80 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG   80 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999999999999999997642    2234567888888877 699999999999999999999999999


Q ss_pred             CChHHHHHhCCCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCC-CCCCCCCcc
Q 019195           83 GELFERICNAGRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLL-HSRPKSTVG  154 (344)
Q Consensus        83 g~L~~~i~~~~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~-~~~~~~~~g  154 (344)
                      |+|...+.+.+.+++.+++.++.|++.+       ||+||||||+|||++.++.  +||+|||+++.... .......+|
T Consensus        81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~g  158 (318)
T cd05570          81 GDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGH--IKIADFGMCKEGILGGVTTSTFCG  158 (318)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCc--EEecccCCCeecCcCCCcccceec
Confidence            9999999888889999888887776654       9999999999999987664  99999999865322 222344579


Q ss_pred             CCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCHhHHHHHHHhc
Q 019195          155 TPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIF  234 (344)
Q Consensus       155 t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L  234 (344)
                      |+.|+|||++.+..++ .++|||||||++|+|++|+.||...+....    ...+.......|.  .++..+.+||.+||
T Consensus       159 ~~~y~aPE~~~~~~~~-~~~DiwslGvil~~l~~G~~pf~~~~~~~~----~~~i~~~~~~~~~--~~~~~~~~li~~~l  231 (318)
T cd05570         159 TPDYIAPEILSYQPYG-PAVDWWALGVLLYEMLAGQSPFEGDDEDEL----FQSILEDEVRYPR--WLSKEAKSILKSFL  231 (318)
T ss_pred             CccccCHHHhcCCCCC-cchhhhhHHHHHHHHhhCCCCCCCCCHHHH----HHHHHcCCCCCCC--cCCHHHHHHHHHHc
Confidence            9999999999887765 459999999999999999999987654332    2233333334443  57899999999999


Q ss_pred             ccCCCCCCCh-----HHHhcCcccccC
Q 019195          235 VANPSRRITI-----KEIKSHPWFLKN  256 (344)
Q Consensus       235 ~~dp~~R~s~-----~ell~hp~~~~~  256 (344)
                      +.||.+|||+     .+++.||||...
T Consensus       232 ~~dP~~R~s~~~~~~~~ll~~~~~~~~  258 (318)
T cd05570         232 TKNPEKRLGCLPTGEQDIKGHPFFREI  258 (318)
T ss_pred             cCCHHHcCCCCCCCHHHHhcCCCcCCC
Confidence            9999999999     999999999764

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=3.7e-45  Score=337.69  Aligned_cols=251  Identities=27%  Similarity=0.402  Sum_probs=196.8

Q ss_pred             CCCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCcc---ccHHHHHHHHHHhcCCCCCcceeeEEEEcC------C
Q 019195            1 MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK---IDANVAREIINHKQLRHPNIIRFKEVVLTP------T   71 (344)
Q Consensus         1 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~ei~~l~~l~h~niv~~~~~~~~~------~   71 (344)
                      +++|++++.||+|+||.||++.+..+++.||+|++.....   ....+.+|+.+++.++||||+++++++...      .
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~   95 (355)
T cd07874          16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQ   95 (355)
T ss_pred             hhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccc
Confidence            4789999999999999999999999999999999875432   235677899999999999999999998654      3


Q ss_pred             EEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHH-------CCeeecCCCCCCeEecCCCCCCEEEeecCCCcccC
Q 019195           72 HLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLIS-------GQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSL  144 (344)
Q Consensus        72 ~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~ql~~-------~~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~  144 (344)
                      .+|+||||+++ +|...+..  .++...++.++.|++.       .||+||||||+|||++.++.  +||+|||+++...
T Consensus        96 ~~~lv~e~~~~-~l~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~--~kl~Dfg~~~~~~  170 (355)
T cd07874          96 DVYLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAG  170 (355)
T ss_pred             eeEEEhhhhcc-cHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCC--EEEeeCcccccCC
Confidence            57999999965 67666643  4777777777666654       49999999999999987654  9999999998655


Q ss_pred             CCCCCCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhcc-----------
Q 019195          145 LHSRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQ-----------  213 (344)
Q Consensus       145 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~-----------  213 (344)
                      .........||+.|+|||++.+..+.. ++|||||||++|+|++|+.||.+......+...+.......           
T Consensus       171 ~~~~~~~~~~t~~y~aPE~~~~~~~~~-~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (355)
T cd07874         171 TSFMMTPYVVTRYYRAPEVILGMGYKE-NVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV  249 (355)
T ss_pred             CccccCCccccCCccCHHHHcCCCCCc-hhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcHHH
Confidence            444445668999999999998777654 49999999999999999999987665444433332211000           


Q ss_pred             -------c-----cCC-------------CCCCCCHhHHHHHHHhcccCCCCCCChHHHhcCcccccCC
Q 019195          214 -------Y-----KIP-------------DYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNL  257 (344)
Q Consensus       214 -------~-----~~~-------------~~~~~s~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~~~  257 (344)
                             .     .++             .....+.++++||.+||+.||.+|||+.|+|+||||....
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~~~  318 (355)
T cd07874         250 RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINVWY  318 (355)
T ss_pred             HHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhccc
Confidence                   0     000             0112356789999999999999999999999999996543

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=3.1e-45  Score=333.94  Aligned_cols=241  Identities=32%  Similarity=0.544  Sum_probs=195.9

Q ss_pred             eeeeecCceEEEEEEEcCCCcEEEEEEeecCcc----ccHHHHHHHH-HHhcCCCCCcceeeEEEEcCCEEEEEEecCCC
Q 019195            8 KDIGSGNFGVARLMRNKNTKELVAMKYIERGHK----IDANVAREII-NHKQLRHPNIIRFKEVVLTPTHLAIVMEYAAG   82 (344)
Q Consensus         8 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~ei~-~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~   82 (344)
                      +.||+|+||+||+|.+..+++.||+|++.+...    ....+.+|.. +++.++||||+++++++...+.+|+||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence            479999999999999999999999999875321    1233445544 46789999999999999999999999999999


Q ss_pred             CChHHHHHhCCCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCC-CCCCCCcc
Q 019195           83 GELFERICNAGRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH-SRPKSTVG  154 (344)
Q Consensus        83 g~L~~~i~~~~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~-~~~~~~~g  154 (344)
                      |+|..++.+.+.+++..++.++.||+.+       ||+||||||+|||++.++.  +||+|||++...... ......+|
T Consensus        81 g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~g  158 (323)
T cd05575          81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGH--VVLTDFGLCKEGIEHSKTTSTFCG  158 (323)
T ss_pred             CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCc--EEEeccCCCcccccCCCccccccC
Confidence            9999999888889998888877776654       9999999999999977654  999999998753322 22344579


Q ss_pred             CCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCHhHHHHHHHhc
Q 019195          155 TPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIF  234 (344)
Q Consensus       155 t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L  234 (344)
                      |+.|+|||++.+..++ .++|||||||++|+|++|..||...+....+    ..+.......+  ..+++.+.+||.+||
T Consensus       159 t~~y~aPE~~~~~~~~-~~~DvwslG~il~ell~g~~pf~~~~~~~~~----~~i~~~~~~~~--~~~~~~~~~li~~~l  231 (323)
T cd05575         159 TPEYLAPEVLRKQPYD-RTVDWWCLGAVLYEMLYGLPPFYSRDTAEMY----DNILNKPLRLK--PNISVSARHLLEGLL  231 (323)
T ss_pred             ChhhcChhhhcCCCCC-ccccccccchhhhhhhcCCCCCCCCCHHHHH----HHHHcCCCCCC--CCCCHHHHHHHHHHh
Confidence            9999999999877765 4599999999999999999999876543333    33333333333  357999999999999


Q ss_pred             ccCCCCCCCh----HHHhcCcccccCC
Q 019195          235 VANPSRRITI----KEIKSHPWFLKNL  257 (344)
Q Consensus       235 ~~dp~~R~s~----~ell~hp~~~~~~  257 (344)
                      +.||.+||++    .++++||||....
T Consensus       232 ~~~p~~R~~~~~~~~~il~~~~~~~~~  258 (323)
T cd05575         232 QKDRTKRLGAKDDFLEIKNHVFFSSIN  258 (323)
T ss_pred             hcCHHhCCCCCCCHHHHHcCCCcCCCC
Confidence            9999999988    6999999997643

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=3.4e-45  Score=327.03  Aligned_cols=242  Identities=28%  Similarity=0.432  Sum_probs=195.3

Q ss_pred             eeecCceEEEEEEEcCCCcEEEEEEeecCcc----ccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEEecCCCCCh
Q 019195           10 IGSGNFGVARLMRNKNTKELVAMKYIERGHK----IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYAAGGEL   85 (344)
Q Consensus        10 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L   85 (344)
                      ||+|+||+||++.+..+++.||+|++.....    ....+..|+.+++.++||||+++.+++..+..+|+||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L   80 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL   80 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence            7999999999999999999999999875322    124567899999999999999999999999999999999999999


Q ss_pred             HHHHHh----CCCCCHHHHHHHHHHHHH-------CCeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCC-CCCCCc
Q 019195           86 FERICN----AGRFSEDEARYFFQQLIS-------GQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS-RPKSTV  153 (344)
Q Consensus        86 ~~~i~~----~~~~~~~~~~~~~~ql~~-------~~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~-~~~~~~  153 (344)
                      ...+..    ...+++..++.++.|++.       .||+||||||+||+++.++.  +||+|||++....... ......
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~--~~l~dfg~~~~~~~~~~~~~~~~  158 (280)
T cd05608          81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGN--VRISDLGLAVELKDGQSKTKGYA  158 (280)
T ss_pred             HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCC--EEEeeCccceecCCCCccccccC
Confidence            887743    346888888877777665       49999999999999976654  9999999986543322 223457


Q ss_pred             cCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCHhHHHHHHHh
Q 019195          154 GTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRI  233 (344)
Q Consensus       154 gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~  233 (344)
                      ||+.|+|||++.+..++ .++|||||||++|+|++|+.||...............+.......+  ..+++.+.+|+.+|
T Consensus       159 g~~~y~aPE~~~~~~~~-~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~  235 (280)
T cd05608         159 GTPGFMAPELLQGEEYD-FSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYP--DKFSPASKSFCEAL  235 (280)
T ss_pred             CCcCccCHHHhcCCCCC-ccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccCCCCc--ccCCHHHHHHHHHH
Confidence            99999999999887765 4599999999999999999999875443332333333333322223  35789999999999


Q ss_pred             cccCCCCCC-----ChHHHhcCcccccC
Q 019195          234 FVANPSRRI-----TIKEIKSHPWFLKN  256 (344)
Q Consensus       234 L~~dp~~R~-----s~~ell~hp~~~~~  256 (344)
                      |+.||.+||     +++++++||||+..
T Consensus       236 l~~~P~~R~~~~~~~~~~~l~h~~~~~~  263 (280)
T cd05608         236 LAKDPEKRLGFRDGNCDGLRTHPLFRDL  263 (280)
T ss_pred             hcCCHHHhcCCCCCCHHHHhcChhhhcC
Confidence            999999999     88999999999764

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-47  Score=350.04  Aligned_cols=248  Identities=29%  Similarity=0.434  Sum_probs=207.4

Q ss_pred             CceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecC-ccccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEEecCC
Q 019195            3 KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERG-HKIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYAA   81 (344)
Q Consensus         3 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~   81 (344)
                      -|+|+..||.|+||.||+|.++.++-..|.|++... ......+..||.+|..+.||+||++++.|..++.+|++.|||.
T Consensus        33 ~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~  112 (1187)
T KOG0579|consen   33 HWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCG  112 (1187)
T ss_pred             HHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecC
Confidence            378899999999999999999999999999998753 3445779999999999999999999999999999999999999


Q ss_pred             CCChHHHHHh-CCCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccC-CCCCCCCC
Q 019195           82 GGELFERICN-AGRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSL-LHSRPKST  152 (344)
Q Consensus        82 ~g~L~~~i~~-~~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~-~~~~~~~~  152 (344)
                      ||-...++.. ...+.+.+|+.+++|++.|       +|||||||..|||+..++.  ++|+|||.+.... ......++
T Consensus       113 GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGd--irLADFGVSAKn~~t~qkRDsF  190 (1187)
T KOG0579|consen  113 GGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGD--IRLADFGVSAKNKSTRQKRDSF  190 (1187)
T ss_pred             CchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCc--EeeecccccccchhHHhhhccc
Confidence            9999888765 4569999999998887755       9999999999999987776  9999999875332 22345678


Q ss_pred             ccCCcccCCccc-----cCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCHhHH
Q 019195          153 VGTPAYIAPEVL-----SRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCR  227 (344)
Q Consensus       153 ~gt~~y~aPE~~-----~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~  227 (344)
                      +|||+|||||++     ...+|+.. +|||||||+|.+|+-+.+|-...+.-..+.++.+   ..+..+..+..++..+.
T Consensus       191 IGTPYWMAPEVvmCET~KD~PYDyk-aDiWSlGITLIEMAqiEPPHhelnpMRVllKiaK---SePPTLlqPS~Ws~~F~  266 (1187)
T KOG0579|consen  191 IGTPYWMAPEVVMCETFKDQPYDYK-ADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAK---SEPPTLLQPSHWSRSFS  266 (1187)
T ss_pred             cCCcccccchheeeccccCCCchhh-hhHHhhhhHHHHHhccCCCccccchHHHHHHHhh---cCCCcccCcchhhhHHH
Confidence            999999999987     34556544 9999999999999999999987665443333222   22333445567899999


Q ss_pred             HHHHHhcccCCCCCCChHHHhcCcccccC
Q 019195          228 NLLSRIFVANPSRRITIKEIKSHPWFLKN  256 (344)
Q Consensus       228 ~li~~~L~~dp~~R~s~~ell~hp~~~~~  256 (344)
                      +|+++||.+||..||++++||+||||...
T Consensus       267 DfLk~cL~Knp~~Rp~aaqll~Hpfv~~~  295 (1187)
T KOG0579|consen  267 DFLKRCLVKNPRNRPPAAQLLKHPFVQNA  295 (1187)
T ss_pred             HHHHHHHhcCCccCCCHHHHhhCcccccC
Confidence            99999999999999999999999999754

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=3.8e-45  Score=332.25  Aligned_cols=240  Identities=35%  Similarity=0.612  Sum_probs=195.0

Q ss_pred             eeeeecCceEEEEEEEcCCCcEEEEEEeecCcc----ccHHHHHHHHHHhc-CCCCCcceeeEEEEcCCEEEEEEecCCC
Q 019195            8 KDIGSGNFGVARLMRNKNTKELVAMKYIERGHK----IDANVAREIINHKQ-LRHPNIIRFKEVVLTPTHLAIVMEYAAG   82 (344)
Q Consensus         8 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~ei~~l~~-l~h~niv~~~~~~~~~~~~~lv~e~~~~   82 (344)
                      +.||+|+||.||+|.+..+++.||+|++.....    ....+..|..++.. .+||||+++++++.....+|+||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g   80 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            479999999999999999999999999876421    22345566666664 4899999999999999999999999999


Q ss_pred             CChHHHHHhCCCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCC-CCCCCCcc
Q 019195           83 GELFERICNAGRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH-SRPKSTVG  154 (344)
Q Consensus        83 g~L~~~i~~~~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~-~~~~~~~g  154 (344)
                      |+|..++...+.+++.+++.++.|++.+       ||+||||||+|||++.++.  +||+|||+++..... ......+|
T Consensus        81 g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~--~kL~Dfg~a~~~~~~~~~~~~~~g  158 (316)
T cd05592          81 GDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGH--IKIADFGMCKENMNGEGKASTFCG  158 (316)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCC--EEEccCcCCeECCCCCCccccccC
Confidence            9999999888889999888887776654       9999999999999976654  999999998754322 23345679


Q ss_pred             CCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCHhHHHHHHHhc
Q 019195          155 TPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIF  234 (344)
Q Consensus       155 t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L  234 (344)
                      |+.|+|||++.+..++ .++|||||||++|+|++|+.||.+.+....+.    .+......+|  ..++.++.+||.+||
T Consensus       159 t~~y~aPE~~~~~~~~-~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~----~i~~~~~~~~--~~~~~~~~~ll~~~l  231 (316)
T cd05592         159 TPDYIAPEILKGQKYN-ESVDWWSFGVLLYEMLIGQSPFHGEDEDELFD----SILNDRPHFP--RWISKEAKDCLSKLF  231 (316)
T ss_pred             CccccCHHHHcCCCCC-CcccchhHHHHHHHHHhCCCCCCCCCHHHHHH----HHHcCCCCCC--CCCCHHHHHHHHHHc
Confidence            9999999999877765 45999999999999999999998765533332    2222233333  357899999999999


Q ss_pred             ccCCCCCCChH-HHhcCcccccC
Q 019195          235 VANPSRRITIK-EIKSHPWFLKN  256 (344)
Q Consensus       235 ~~dp~~R~s~~-ell~hp~~~~~  256 (344)
                      +.||.+||++. ++++||||...
T Consensus       232 ~~~P~~R~~~~~~l~~h~~~~~~  254 (316)
T cd05592         232 ERDPTKRLGVDGDIRQHPFFRGI  254 (316)
T ss_pred             cCCHHHcCCChHHHHcCcccCCC
Confidence            99999999864 88899999764

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=4.6e-45  Score=331.65  Aligned_cols=241  Identities=33%  Similarity=0.560  Sum_probs=196.5

Q ss_pred             eeeeecCceEEEEEEEcCCCcEEEEEEeecCc----cccHHHHHHHHHHhc-CCCCCcceeeEEEEcCCEEEEEEecCCC
Q 019195            8 KDIGSGNFGVARLMRNKNTKELVAMKYIERGH----KIDANVAREIINHKQ-LRHPNIIRFKEVVLTPTHLAIVMEYAAG   82 (344)
Q Consensus         8 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~ei~~l~~-l~h~niv~~~~~~~~~~~~~lv~e~~~~   82 (344)
                      +.||+|+||.||+|.+..+++.||+|++....    ........|..+++. ++||||+++++++.+.+.+|+||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~   80 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence            47999999999999999999999999997642    223456677777775 4899999999999999999999999999


Q ss_pred             CChHHHHHhCCCCCHHHHHHHHHHHHH-------CCeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCC-CCCCCCcc
Q 019195           83 GELFERICNAGRFSEDEARYFFQQLIS-------GQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH-SRPKSTVG  154 (344)
Q Consensus        83 g~L~~~i~~~~~~~~~~~~~~~~ql~~-------~~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~-~~~~~~~g  154 (344)
                      |+|..++.....+++.++..++.|++.       .||+||||||+|||++.++.  +||+|||++...... ......+|
T Consensus        81 g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~g  158 (316)
T cd05619          81 GDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGH--IKIADFGMCKENMLGDAKTCTFCG  158 (316)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCC--EEEccCCcceECCCCCCceeeecC
Confidence            999999988888888888877776654       49999999999999987664  999999998753222 22344579


Q ss_pred             CCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCHhHHHHHHHhc
Q 019195          155 TPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIF  234 (344)
Q Consensus       155 t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L  234 (344)
                      |+.|+|||++.+..++ .++|||||||++|+|++|..||........+    ..+.......|.  .++.++.+||.+||
T Consensus       159 t~~y~aPE~~~~~~~~-~~~DvwslG~il~el~~G~~pf~~~~~~~~~----~~i~~~~~~~~~--~~~~~~~~li~~~l  231 (316)
T cd05619         159 TPDYIAPEILLGQKYN-TSVDWWSFGVLLYEMLIGQSPFHGHDEEELF----QSIRMDNPCYPR--WLTREAKDILVKLF  231 (316)
T ss_pred             CccccCHHHHcCCCCC-chhhhhhHHHHHHHHHhCCCCCCCCCHHHHH----HHHHhCCCCCCc--cCCHHHHHHHHHHh
Confidence            9999999999877765 4599999999999999999999876543322    222222333333  57899999999999


Q ss_pred             ccCCCCCCChH-HHhcCcccccCC
Q 019195          235 VANPSRRITIK-EIKSHPWFLKNL  257 (344)
Q Consensus       235 ~~dp~~R~s~~-ell~hp~~~~~~  257 (344)
                      +.||.+||++. +++.||||....
T Consensus       232 ~~~P~~R~~~~~~l~~h~~~~~~~  255 (316)
T cd05619         232 VREPERRLGVKGDIRQHPFFREID  255 (316)
T ss_pred             ccCHhhcCCChHHHHcCcccCCCC
Confidence            99999999996 899999997753

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=1.3e-45  Score=337.62  Aligned_cols=252  Identities=28%  Similarity=0.507  Sum_probs=200.3

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCc----cccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEE
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH----KIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVM   77 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~   77 (344)
                      ++|++++.||+|+||.||++.+..+++.||+|++.+..    .....+.+|+.++..++|+||+++++++.+.+.+|+||
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM   80 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence            58999999999999999999999999999999986522    12234778899999999999999999999999999999


Q ss_pred             ecCCCCChHHHHHh-CCCCCHHHHHHHHHHHHH-------CCeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCCC-
Q 019195           78 EYAAGGELFERICN-AGRFSEDEARYFFQQLIS-------GQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR-  148 (344)
Q Consensus        78 e~~~~g~L~~~i~~-~~~~~~~~~~~~~~ql~~-------~~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~~-  148 (344)
                      ||+++|+|.+++.+ ...+++..++.++.||+.       .||+||||||+|||++.++.  +||+|||++........ 
T Consensus        81 ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~--~kL~DfG~a~~~~~~~~~  158 (332)
T cd05623          81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGH--IRLADFGSCLKLMEDGTV  158 (332)
T ss_pred             eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCC--EEEeecchheecccCCcc
Confidence            99999999999976 467888888877766665       49999999999999976654  99999999865432222 


Q ss_pred             -CCCCccCCcccCCccccC----CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCCC-CCCC
Q 019195          149 -PKSTVGTPAYIAPEVLSR----REYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPD-YVHI  222 (344)
Q Consensus       149 -~~~~~gt~~y~aPE~~~~----~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~  222 (344)
                       ....+||+.|+|||++..    ....+.++|||||||++|+|++|+.||...+....+..+....  ....+|. ...+
T Consensus       159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~--~~~~~p~~~~~~  236 (332)
T cd05623         159 QSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHK--ERFQFPAQVTDV  236 (332)
T ss_pred             eecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCC--ccccCCCccccC
Confidence             233579999999999863    2334556999999999999999999998765544443332211  1122222 2357


Q ss_pred             CHhHHHHHHHhcccCCCC--CCChHHHhcCcccccCC
Q 019195          223 SQDCRNLLSRIFVANPSR--RITIKEIKSHPWFLKNL  257 (344)
Q Consensus       223 s~~~~~li~~~L~~dp~~--R~s~~ell~hp~~~~~~  257 (344)
                      ++++++||++||+.++.+  |+++.++++||||....
T Consensus       237 s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~~~  273 (332)
T cd05623         237 SEDAKDLIRRLICSREHRLGQNGIEDFKQHPFFTGID  273 (332)
T ss_pred             CHHHHHHHHHHccChhhhcCCCCHHHHhCCCCcCCCC
Confidence            999999999999776555  68999999999997653

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.5e-45  Score=338.69  Aligned_cols=251  Identities=24%  Similarity=0.405  Sum_probs=198.6

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCcc---ccHHHHHHHHHHhcCCCCCcceeeEEEEcC------CE
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK---IDANVAREIINHKQLRHPNIIRFKEVVLTP------TH   72 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~ei~~l~~l~h~niv~~~~~~~~~------~~   72 (344)
                      ++|++++.||+|+||.||+|.+..+++.||+|++.....   ....+.+|+.++++++||||+++++++...      ..
T Consensus        15 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   94 (343)
T cd07878          15 ERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNE   94 (343)
T ss_pred             hhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccCc
Confidence            689999999999999999999999999999999875432   234577899999999999999999988643      45


Q ss_pred             EEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCC
Q 019195           73 LAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLL  145 (344)
Q Consensus        73 ~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~  145 (344)
                      +|++++++ +++|..++. .+.+++..++.++.|++.+       ||+||||||+|||++.++.  +||+|||+++....
T Consensus        95 ~~~~~~~~-~~~l~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~--~kl~Dfg~~~~~~~  170 (343)
T cd07878          95 VYLVTNLM-GADLNNIVK-CQKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCE--LRILDFGLARQADD  170 (343)
T ss_pred             EEEEeecC-CCCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCC--EEEcCCccceecCC
Confidence            79999998 789987764 4578999888888777655       9999999999999987664  99999999875432


Q ss_pred             CCCCCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhc-------------
Q 019195          146 HSRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAV-------------  212 (344)
Q Consensus       146 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~-------------  212 (344)
                        .....+||+.|+|||++.+....+.++|||||||++|+|++|+.||........+..+.......             
T Consensus       171 --~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (343)
T cd07878         171 --EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEHA  248 (343)
T ss_pred             --CcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcchhhH
Confidence              23456799999999999775555667999999999999999999998765444333322211000             


Q ss_pred             ------cccCC------CCCCCCHhHHHHHHHhcccCCCCCCChHHHhcCcccccCCC
Q 019195          213 ------QYKIP------DYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLP  258 (344)
Q Consensus       213 ------~~~~~------~~~~~s~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~~~~  258 (344)
                            ....+      .....++.+.+||.+||+.||.+|||+.++|+||||.+...
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~~~  306 (343)
T cd07878         249 RKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQYHD  306 (343)
T ss_pred             HHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhccCC
Confidence                  00001      01235678899999999999999999999999999976543

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=7.8e-45  Score=331.20  Aligned_cols=246  Identities=30%  Similarity=0.543  Sum_probs=203.2

Q ss_pred             CceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCcc----ccHHHHHHHHHHhcCC-CCCcceeeEEEEcCCEEEEEE
Q 019195            3 KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK----IDANVAREIINHKQLR-HPNIIRFKEVVLTPTHLAIVM   77 (344)
Q Consensus         3 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~ei~~l~~l~-h~niv~~~~~~~~~~~~~lv~   77 (344)
                      +|+..+.||+|+||.||+|.+..+++.||+|++.+...    ....+..|+.+++.+. |++|+++++++...+.+|+||
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM   80 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence            58899999999999999999999999999999876421    2245677888888875 678889999999999999999


Q ss_pred             ecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCC-CCC
Q 019195           78 EYAAGGELFERICNAGRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH-SRP  149 (344)
Q Consensus        78 e~~~~g~L~~~i~~~~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~-~~~  149 (344)
                      ||+++|+|..++...+.+++.+++.++.|++.+       ||+||||||+|||++.++.  +||+|||+++..... ...
T Consensus        81 Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~--ikL~Dfg~~~~~~~~~~~~  158 (323)
T cd05615          81 EYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGH--IKIADFGMCKEHMVDGVTT  158 (323)
T ss_pred             cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCC--EEEeccccccccCCCCccc
Confidence            999999999999888889999988887776654       9999999999999987664  999999998753322 223


Q ss_pred             CCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCHhHHHH
Q 019195          150 KSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL  229 (344)
Q Consensus       150 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  229 (344)
                      ...+||+.|+|||++.+..++ .++|||||||++|+|++|++||........    ...+.......|.  .++.++.+|
T Consensus       159 ~~~~gt~~y~aPE~~~~~~~~-~~~DiwslGvil~elltG~~pf~~~~~~~~----~~~i~~~~~~~p~--~~~~~~~~l  231 (323)
T cd05615         159 RTFCGTPDYIAPEIIAYQPYG-KSVDWWAYGVLLYEMLAGQPPFDGEDEDEL----FQSIMEHNVSYPK--SLSKEAVSI  231 (323)
T ss_pred             cCccCCccccCHHHHcCCCCC-CccchhhhHHHHHHHHhCCCCCCCCCHHHH----HHHHHhCCCCCCc--cCCHHHHHH
Confidence            445799999999999877764 559999999999999999999987654333    3334444444443  678999999


Q ss_pred             HHHhcccCCCCCCC-----hHHHhcCcccccCC
Q 019195          230 LSRIFVANPSRRIT-----IKEIKSHPWFLKNL  257 (344)
Q Consensus       230 i~~~L~~dp~~R~s-----~~ell~hp~~~~~~  257 (344)
                      +.+||+.+|.+|++     ..++++||||....
T Consensus       232 i~~~l~~~p~~R~~~~~~~~~~i~~h~~f~~~~  264 (323)
T cd05615         232 CKGLMTKHPSKRLGCGPEGERDIREHAFFRRID  264 (323)
T ss_pred             HHHHcccCHhhCCCCCCCCHHHHhcCcccCCCC
Confidence            99999999999997     47899999997653

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-48  Score=328.80  Aligned_cols=250  Identities=22%  Similarity=0.394  Sum_probs=208.8

Q ss_pred             ceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEEecCCCC
Q 019195            4 YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYAAGG   83 (344)
Q Consensus         4 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g   83 (344)
                      |.++++||+|+||.||+|.++++|.++|||.+.-... ...+.+||.++++++.|++|++|+.+.....+|+|||||..|
T Consensus        35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~sD-LQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGAG  113 (502)
T KOG0574|consen   35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDTD-LQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGAG  113 (502)
T ss_pred             HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccch-HHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCCC
Confidence            6788999999999999999999999999999876443 357889999999999999999999999999999999999999


Q ss_pred             ChHHHHHh-CCCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCC-CCCCCCcc
Q 019195           84 ELFERICN-AGRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH-SRPKSTVG  154 (344)
Q Consensus        84 ~L~~~i~~-~~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~-~~~~~~~g  154 (344)
                      ++.++++. +..+++.++..+++.-+.+       .-||||||..|||++.++.  .||+|||.|.+.... ....+++|
T Consensus       114 SiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~--AKLADFGVAGQLTDTMAKRNTVIG  191 (502)
T KOG0574|consen  114 SISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGI--AKLADFGVAGQLTDTMAKRNTVIG  191 (502)
T ss_pred             cHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccch--hhhhhccccchhhhhHHhhCcccc
Confidence            99999875 4679999999887665554       7799999999999976664  999999999764433 34567789


Q ss_pred             CCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCHhHHHHHHHhc
Q 019195          155 TPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIF  234 (344)
Q Consensus       155 t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L  234 (344)
                      ||.|||||++..-+|+.. +||||||++..||+.|++||.+...-   ..++.-..+.+..+..+..+|+++.+||++||
T Consensus       192 TPFWMAPEVI~EIGY~~~-ADIWSLGITaIEMAEG~PPYsDIHPM---RAIFMIPT~PPPTF~KPE~WS~~F~DFi~~CL  267 (502)
T KOG0574|consen  192 TPFWMAPEVIEEIGYDTK-ADIWSLGITAIEMAEGRPPYSDIHPM---RAIFMIPTKPPPTFKKPEEWSSEFNDFIRSCL  267 (502)
T ss_pred             CcccccHHHHHHhccchh-hhHhhhcchhhhhhcCCCCccccccc---ceeEeccCCCCCCCCChHhhhhHHHHHHHHHh
Confidence            999999999999999877 89999999999999999999875432   11111112222233334468999999999999


Q ss_pred             ccCCCCCCChHHHhcCcccccCCChh
Q 019195          235 VANPSRRITIKEIKSHPWFLKNLPRE  260 (344)
Q Consensus       235 ~~dp~~R~s~~ell~hp~~~~~~~~~  260 (344)
                      .+.|++|.||.++++|||++....-+
T Consensus       268 iK~PE~R~TA~~L~~H~FiknA~g~~  293 (502)
T KOG0574|consen  268 IKKPEERKTALRLCEHTFIKNAPGCD  293 (502)
T ss_pred             cCCHHHHHHHHHHhhhhhhcCCCccc
Confidence            99999999999999999998765533

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=2.9e-45  Score=323.13  Aligned_cols=247  Identities=34%  Similarity=0.591  Sum_probs=200.6

Q ss_pred             ceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCccccH---HHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEEecC
Q 019195            4 YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDA---NVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYA   80 (344)
Q Consensus         4 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~---~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~   80 (344)
                      |++++.||+|+||+||++.+..+++.||+|++........   ...+|+.++++++||||+++++++.....++++|+|+
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~   80 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC   80 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence            8999999999999999999999999999999988654332   3356999999999999999999999999999999999


Q ss_pred             CCCChHHHHHhCCCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCccc-CCCCCCCCC
Q 019195           81 AGGELFERICNAGRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSS-LLHSRPKST  152 (344)
Q Consensus        81 ~~g~L~~~i~~~~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~-~~~~~~~~~  152 (344)
                      .+++|.+++.+.+.++..+++.++.|++.+       ||+|+||||+||+++.++.  ++|+|||++... .........
T Consensus        81 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~--~~l~Dfg~~~~~~~~~~~~~~~  158 (260)
T PF00069_consen   81 PGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGE--VKLIDFGSSVKLSENNENFNPF  158 (260)
T ss_dssp             TTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSE--EEESSGTTTEESTSTTSEBSSS
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccccc--cccccccccccccccccccccc
Confidence            999999999988889999888887776654       9999999999999986654  999999998652 233344556


Q ss_pred             ccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccc--cCCCCCCCCHhHHHHH
Q 019195          153 VGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQY--KIPDYVHISQDCRNLL  230 (344)
Q Consensus       153 ~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~s~~~~~li  230 (344)
                      .+|+.|+|||++......+.++||||||+++|+|++|..||......... ..+........  ........+..+.++|
T Consensus       159 ~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~~li  237 (260)
T PF00069_consen  159 VGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQL-EIIEKILKRPLPSSSQQSREKSEELRDLI  237 (260)
T ss_dssp             SSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHH-HHHHHHHHTHHHHHTTSHTTSHHHHHHHH
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccchhhh-hhhhhcccccccccccccchhHHHHHHHH
Confidence            79999999999983444456699999999999999999999876322222 22222222111  1111112348999999


Q ss_pred             HHhcccCCCCCCChHHHhcCccc
Q 019195          231 SRIFVANPSRRITIKEIKSHPWF  253 (344)
Q Consensus       231 ~~~L~~dp~~R~s~~ell~hp~~  253 (344)
                      .+||+.||.+|||+.++++||||
T Consensus       238 ~~~l~~~p~~R~~~~~l~~~~~~  260 (260)
T PF00069_consen  238 KKMLSKDPEQRPSAEELLKHPWF  260 (260)
T ss_dssp             HHHSSSSGGGSTTHHHHHTSGGG
T ss_pred             HHHccCChhHCcCHHHHhcCCCC
Confidence            99999999999999999999997

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=6.3e-45  Score=332.40  Aligned_cols=245  Identities=29%  Similarity=0.487  Sum_probs=199.5

Q ss_pred             eeeeecCceEEEEEEEcCCCcEEEEEEeecCcc----ccHHHHHHHHHHhcC-CCCCcceeeEEEEcCCEEEEEEecCCC
Q 019195            8 KDIGSGNFGVARLMRNKNTKELVAMKYIERGHK----IDANVAREIINHKQL-RHPNIIRFKEVVLTPTHLAIVMEYAAG   82 (344)
Q Consensus         8 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~ei~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~   82 (344)
                      +.||+|+||.||+|.+..+++.||+|++.+...    ....+.+|+.++.++ +||||+++++++...+.+|+||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG   80 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence            479999999999999999999999999986422    224577888888888 699999999999999999999999999


Q ss_pred             CChHHHHHhCCCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCC-CCCCCCCcc
Q 019195           83 GELFERICNAGRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLL-HSRPKSTVG  154 (344)
Q Consensus        83 g~L~~~i~~~~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~-~~~~~~~~g  154 (344)
                      |+|..++...+.+++..++.++.||+.+       ||+||||||+|||++.++.  +||+|||+++.... .......+|
T Consensus        81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~g  158 (327)
T cd05617          81 GDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGH--IKLTDYGMCKEGLGPGDTTSTFCG  158 (327)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCC--EEEeccccceeccCCCCceecccC
Confidence            9999999888889999988887776654       9999999999999987665  99999999875322 223345679


Q ss_pred             CCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCh---HHHHHHHHHHhhccccCCCCCCCCHhHHHHHH
Q 019195          155 TPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDP---KNFRKTISRIMAVQYKIPDYVHISQDCRNLLS  231 (344)
Q Consensus       155 t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~  231 (344)
                      |+.|+|||++.+..++ .++|||||||++|+|++|+.||......   .........+......+|.  .++..+.++|.
T Consensus       159 t~~y~aPE~~~~~~~~-~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~--~~~~~~~~li~  235 (327)
T cd05617         159 TPNYIAPEILRGEEYG-FSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPR--FLSVKASHVLK  235 (327)
T ss_pred             CcccCCHHHHCCCCCC-chheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCCCCC--CCCHHHHHHHH
Confidence            9999999999877764 4599999999999999999999643211   1112233333344444444  57899999999


Q ss_pred             HhcccCCCCCCC------hHHHhcCcccccCC
Q 019195          232 RIFVANPSRRIT------IKEIKSHPWFLKNL  257 (344)
Q Consensus       232 ~~L~~dp~~R~s------~~ell~hp~~~~~~  257 (344)
                      +||+.||.+|++      +.++++||||....
T Consensus       236 ~~L~~dP~~R~~~~~~~~~~~i~~h~~f~~~~  267 (327)
T cd05617         236 GFLNKDPKERLGCQPQTGFSDIKSHTFFRSID  267 (327)
T ss_pred             HHhccCHHHcCCCCCCCCHHHHHcCCCCCCCC
Confidence            999999999998      46999999997653

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=1.8e-45  Score=334.68  Aligned_cols=242  Identities=33%  Similarity=0.597  Sum_probs=200.2

Q ss_pred             eeeeeecCceEEEEEEE---cCCCcEEEEEEeecCcc---ccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEEecC
Q 019195            7 MKDIGSGNFGVARLMRN---KNTKELVAMKYIERGHK---IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYA   80 (344)
Q Consensus         7 ~~~lg~G~~g~V~~~~~---~~~~~~vaiK~~~~~~~---~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~   80 (344)
                      ++.||+|+||.||++.+   ..+++.||+|++.+...   ....+.+|+.++++++||||+++++++..++.+|+||||+
T Consensus         1 l~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~   80 (318)
T cd05582           1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFL   80 (318)
T ss_pred             CceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCC
Confidence            46899999999999886   36789999999976432   2245678999999999999999999999999999999999


Q ss_pred             CCCChHHHHHhCCCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCC-CCCCCC
Q 019195           81 AGGELFERICNAGRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH-SRPKST  152 (344)
Q Consensus        81 ~~g~L~~~i~~~~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~-~~~~~~  152 (344)
                      ++|+|.+++.+...+++..++.++.|++.+       ||+||||||+|||++.++.  +||+|||++...... ......
T Consensus        81 ~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~--~kL~Dfg~~~~~~~~~~~~~~~  158 (318)
T cd05582          81 RGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGH--IKLTDFGLSKESIDHEKKAYSF  158 (318)
T ss_pred             CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCc--EEEeeccCCcccCCCCCceecc
Confidence            999999999888889999988888777654       9999999999999987654  999999998754333 233456


Q ss_pred             ccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCHhHHHHHHH
Q 019195          153 VGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSR  232 (344)
Q Consensus       153 ~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~  232 (344)
                      +||+.|+|||++.+..+. .++|||||||++|+|++|+.||........    ...+......+|.  .+++.+.+||.+
T Consensus       159 ~g~~~y~aPE~~~~~~~~-~~~DiwslG~il~el~tg~~p~~~~~~~~~----~~~i~~~~~~~p~--~~~~~~~~li~~  231 (318)
T cd05582         159 CGTVEYMAPEVVNRRGHT-QSADWWSFGVLMFEMLTGSLPFQGKDRKET----MTMILKAKLGMPQ--FLSPEAQSLLRA  231 (318)
T ss_pred             cCChhhcCHHHHcCCCCC-CccceeccceEeeeeccCCCCCCCCCHHHH----HHHHHcCCCCCCC--CCCHHHHHHHHH
Confidence            799999999999877664 559999999999999999999987654333    2333333444443  578999999999


Q ss_pred             hcccCCCCCCC-----hHHHhcCcccccCC
Q 019195          233 IFVANPSRRIT-----IKEIKSHPWFLKNL  257 (344)
Q Consensus       233 ~L~~dp~~R~s-----~~ell~hp~~~~~~  257 (344)
                      ||+.||.+||+     +.+++.||||....
T Consensus       232 ~l~~~P~~R~~a~~~~~~~~~~~~~~~~~~  261 (318)
T cd05582         232 LFKRNPANRLGAGPDGVEEIKRHPFFSTID  261 (318)
T ss_pred             HhhcCHhHcCCCCCCCHHHHhCCCCcCCCC
Confidence            99999999999     67799999997653

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=2.1e-44  Score=325.19  Aligned_cols=253  Identities=26%  Similarity=0.441  Sum_probs=201.8

Q ss_pred             CCCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCc--cccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEEe
Q 019195            1 MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH--KIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVME   78 (344)
Q Consensus         1 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e   78 (344)
                      +++|++++.||.|+||.||++.+..+++.||+|.+....  .....+.+|+.+++.++||||+++++++..++.+++|||
T Consensus         5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e   84 (301)
T cd07873           5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFE   84 (301)
T ss_pred             ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEe
Confidence            578999999999999999999999999999999987543  233467789999999999999999999999999999999


Q ss_pred             cCCCCChHHHHHhC-CCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCCC-C
Q 019195           79 YAAGGELFERICNA-GRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR-P  149 (344)
Q Consensus        79 ~~~~g~L~~~i~~~-~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~~-~  149 (344)
                      |+. ++|..++.+. ..+++..++.++.|++.+       ||+||||||+||+++.++.  +||+|||++........ .
T Consensus        85 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~--~kl~dfg~~~~~~~~~~~~  161 (301)
T cd07873          85 YLD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGE--LKLADFGLARAKSIPTKTY  161 (301)
T ss_pred             ccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCc--EEECcCcchhccCCCCCcc
Confidence            996 5888888654 468888888777776654       9999999999999987654  99999999875432222 2


Q ss_pred             CCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhc---------------cc
Q 019195          150 KSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAV---------------QY  214 (344)
Q Consensus       150 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~---------------~~  214 (344)
                      ....+++.|+|||++.+....+.++|||||||++|+|++|++||...+..+....+.......               ..
T Consensus       162 ~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (301)
T cd07873         162 SNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKSY  241 (301)
T ss_pred             cccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhcccccccc
Confidence            334689999999998776555667999999999999999999998766544333222211100               01


Q ss_pred             cCCC---------CCCCCHhHHHHHHHhcccCCCCCCChHHHhcCcccccC
Q 019195          215 KIPD---------YVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKN  256 (344)
Q Consensus       215 ~~~~---------~~~~s~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~~  256 (344)
                      ..|.         ...+++.+++||.+||+.||.+|||+.++|+||||...
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~  292 (301)
T cd07873         242 NYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCL  292 (301)
T ss_pred             ccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccc
Confidence            1111         12468899999999999999999999999999999654

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=1.5e-44  Score=323.60  Aligned_cols=249  Identities=26%  Similarity=0.420  Sum_probs=200.0

Q ss_pred             CceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCccc----cHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEEe
Q 019195            3 KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKI----DANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVME   78 (344)
Q Consensus         3 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~----~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e   78 (344)
                      .|++.+.||+|+||.||++.+..+++.||+|.+......    ...+.+|+.++++++|+||+.+++.+...+.+|+|||
T Consensus         1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e   80 (285)
T cd05630           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence            488999999999999999999999999999998754321    2456789999999999999999999999999999999


Q ss_pred             cCCCCChHHHHHhC--CCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCCCC
Q 019195           79 YAAGGELFERICNA--GRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP  149 (344)
Q Consensus        79 ~~~~g~L~~~i~~~--~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~~~  149 (344)
                      |+++++|..++...  ..+++..+..++.|++.+       ||+||||||+||+++.++.  ++|+|||++.........
T Consensus        81 ~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~--~~l~Dfg~~~~~~~~~~~  158 (285)
T cd05630          81 LMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGH--IRISDLGLAVHVPEGQTI  158 (285)
T ss_pred             ecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCC--EEEeeccceeecCCCccc
Confidence            99999999888543  358888888777776654       9999999999999987654  999999998754433333


Q ss_pred             CCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCHhHHHH
Q 019195          150 KSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL  229 (344)
Q Consensus       150 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  229 (344)
                      ....||+.|+|||++.+..++ .++||||+||++|+|++|+.||.......................  ...+++++.+|
T Consensus       159 ~~~~g~~~y~aPE~~~~~~~~-~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l  235 (285)
T cd05630         159 KGRVGTVGYMAPEVVKNERYT-FSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEY--SEKFSPDARSL  235 (285)
T ss_pred             cCCCCCccccChHHHcCCCCC-CccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhhhhhc--CccCCHHHHHH
Confidence            445799999999999877765 459999999999999999999987543221111111111111112  23578899999


Q ss_pred             HHHhcccCCCCCCC-----hHHHhcCcccccC
Q 019195          230 LSRIFVANPSRRIT-----IKEIKSHPWFLKN  256 (344)
Q Consensus       230 i~~~L~~dp~~R~s-----~~ell~hp~~~~~  256 (344)
                      |.+||+.||.+|||     +.++++||||.+.
T Consensus       236 i~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~~  267 (285)
T cd05630         236 CKMLLCKDPKERLGCQGGGAREVKEHPLFKQI  267 (285)
T ss_pred             HHHHhhcCHHHccCCCCCchHHHHcChhhhcc
Confidence            99999999999999     8999999999663

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=1.4e-44  Score=358.38  Aligned_cols=252  Identities=27%  Similarity=0.438  Sum_probs=203.9

Q ss_pred             CCCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCc---cccHHHHHHHHHHhcCCCCCcceeeEEEEc--CCEEEE
Q 019195            1 MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH---KIDANVAREIINHKQLRHPNIIRFKEVVLT--PTHLAI   75 (344)
Q Consensus         1 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~ei~~l~~l~h~niv~~~~~~~~--~~~~~l   75 (344)
                      +++|++++.||+|+||+||+|.+..++..||+|++....   .....+.+|+.++++|+|||||+++++|..  ...+||
T Consensus        12 l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~lyI   91 (1021)
T PTZ00266         12 LNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYI   91 (1021)
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEEE
Confidence            478999999999999999999999999999999987532   223568899999999999999999999865  357999


Q ss_pred             EEecCCCCChHHHHHh----CCCCCHHHHHHHHHHHHHC--------------CeeecCCCCCCeEecCC----------
Q 019195           76 VMEYAAGGELFERICN----AGRFSEDEARYFFQQLISG--------------QICHRDLKLENTLLDGS----------  127 (344)
Q Consensus        76 v~e~~~~g~L~~~i~~----~~~~~~~~~~~~~~ql~~~--------------~iiH~Dikp~NIl~~~~----------  127 (344)
                      ||||+++++|..+|..    .+.+++..++.++.||+.+              +|+||||||+||||+..          
T Consensus        92 VMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~  171 (1021)
T PTZ00266         92 LMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQ  171 (1021)
T ss_pred             EEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccccccc
Confidence            9999999999999865    3579999999988887765              39999999999999642          


Q ss_pred             -----CCCCEEEeecCCCcccCCCCCCCCCccCCcccCCccccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHH
Q 019195          128 -----PAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRR-EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKN  201 (344)
Q Consensus       128 -----~~~~vkL~DFg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~  201 (344)
                           ..+.+||+|||++............+||+.|+|||++.+. ...+.++||||||||||+|++|..||........
T Consensus       172 ~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~~~q  251 (1021)
T PTZ00266        172 ANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANNFSQ  251 (1021)
T ss_pred             ccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCCcHHH
Confidence                 2335899999999865544444566799999999998643 2335569999999999999999999987655433


Q ss_pred             HHHHHHHHhhccccCCCCCCCCHhHHHHHHHhcccCCCCCCChHHHhcCcccccCC
Q 019195          202 FRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNL  257 (344)
Q Consensus       202 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~~~  257 (344)
                      +...+.   . ...+| ....+.++.+||.+||+.+|.+||++.++|.|||+....
T Consensus       252 li~~lk---~-~p~lp-i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i~  302 (1021)
T PTZ00266        252 LISELK---R-GPDLP-IKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNVG  302 (1021)
T ss_pred             HHHHHh---c-CCCCC-cCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhcC
Confidence            332222   1 12222 234689999999999999999999999999999997543

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=5.9e-45  Score=332.34  Aligned_cols=242  Identities=30%  Similarity=0.493  Sum_probs=196.8

Q ss_pred             eeeeecCceEEEEEEEcCCCcEEEEEEeecCc----cccHHHHHHHH-HHhcCCCCCcceeeEEEEcCCEEEEEEecCCC
Q 019195            8 KDIGSGNFGVARLMRNKNTKELVAMKYIERGH----KIDANVAREII-NHKQLRHPNIIRFKEVVLTPTHLAIVMEYAAG   82 (344)
Q Consensus         8 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~ei~-~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~   82 (344)
                      +.||+|+||.||+|.+..+|+.||+|++.+..    .....+.+|.. +++.++||||+++++++..++.+|+||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG   80 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence            46999999999999999999999999987532    12234455554 46778999999999999999999999999999


Q ss_pred             CChHHHHHhCCCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCC-CCCCCCcc
Q 019195           83 GELFERICNAGRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH-SRPKSTVG  154 (344)
Q Consensus        83 g~L~~~i~~~~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~-~~~~~~~g  154 (344)
                      |+|..++.+.+.+++.+++.++.||+.+       ||+||||||+|||++.++.  +||+|||+++..... ......+|
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~--~kL~DfG~~~~~~~~~~~~~~~~g  158 (325)
T cd05604          81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGH--VVLTDFGLCKEGIAQSDTTTTFCG  158 (325)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCC--EEEeecCCcccCCCCCCCcccccC
Confidence            9999999888889999888887776654       9999999999999987664  999999998753322 22345679


Q ss_pred             CCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCHhHHHHHHHhc
Q 019195          155 TPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIF  234 (344)
Q Consensus       155 t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L  234 (344)
                      |+.|+|||++.+..++. ++|||||||++|+|++|..||...+....+..    +.......+  ...+..+.++|.+||
T Consensus       159 t~~y~aPE~~~~~~~~~-~~DvwslG~il~el~~G~~pf~~~~~~~~~~~----~~~~~~~~~--~~~~~~~~~ll~~ll  231 (325)
T cd05604         159 TPEYLAPEVIRKQPYDN-TVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDN----ILHKPLVLR--PGASLTAWSILEELL  231 (325)
T ss_pred             ChhhCCHHHHcCCCCCC-cCccccccceehhhhcCCCCCCCCCHHHHHHH----HHcCCccCC--CCCCHHHHHHHHHHh
Confidence            99999999998877654 59999999999999999999987654433333    333332222  357899999999999


Q ss_pred             ccCCCCCCCh----HHHhcCcccccCCC
Q 019195          235 VANPSRRITI----KEIKSHPWFLKNLP  258 (344)
Q Consensus       235 ~~dp~~R~s~----~ell~hp~~~~~~~  258 (344)
                      +.+|.+||++    .++++||||.....
T Consensus       232 ~~~p~~R~~~~~~~~~i~~h~~f~~~~~  259 (325)
T cd05604         232 EKDRQRRLGAKEDFLEIQEHPFFESLSW  259 (325)
T ss_pred             ccCHHhcCCCCCCHHHHhcCCCcCCCCH
Confidence            9999999977    58999999976543

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.4e-45  Score=334.64  Aligned_cols=241  Identities=33%  Similarity=0.542  Sum_probs=196.0

Q ss_pred             eeecCceEEEEEEEcCCCcEEEEEEeecCcc----ccHHHHHHHHHHhcC---CCCCcceeeEEEEcCCEEEEEEecCCC
Q 019195           10 IGSGNFGVARLMRNKNTKELVAMKYIERGHK----IDANVAREIINHKQL---RHPNIIRFKEVVLTPTHLAIVMEYAAG   82 (344)
Q Consensus        10 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~ei~~l~~l---~h~niv~~~~~~~~~~~~~lv~e~~~~   82 (344)
                      ||+|+||+||+|.+..+++.||+|++.+...    .......|..++..+   .||||++++.++.....+|+||||+++
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~   80 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG   80 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence            7999999999999999999999999865321    112344566666554   699999999999999999999999999


Q ss_pred             CChHHHHHhCCCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCC-CCCCCCcc
Q 019195           83 GELFERICNAGRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH-SRPKSTVG  154 (344)
Q Consensus        83 g~L~~~i~~~~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~-~~~~~~~g  154 (344)
                      |+|..++.+.+.+++..++.++.||+.+       ||+||||||+|||++.++.  +||+|||++...... ......+|
T Consensus        81 g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~--~kl~Dfg~a~~~~~~~~~~~~~~g  158 (330)
T cd05586          81 GELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGH--IALCDFGLSKANLTDNKTTNTFCG  158 (330)
T ss_pred             ChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCC--EEEecCCcCcCCCCCCCCccCccC
Confidence            9999999988899999988888777655       9999999999999987654  999999998753322 23345679


Q ss_pred             CCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCHhHHHHHHHhc
Q 019195          155 TPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIF  234 (344)
Q Consensus       155 t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L  234 (344)
                      |+.|+|||++.+....+.++|||||||++|+|++|+.||.......    ....+......+|.. .+++++.+||++||
T Consensus       159 t~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~----~~~~i~~~~~~~~~~-~~~~~~~~li~~~L  233 (330)
T cd05586         159 TTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQ----MYRNIAFGKVRFPKN-VLSDEGRQFVKGLL  233 (330)
T ss_pred             CccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHH----HHHHHHcCCCCCCCc-cCCHHHHHHHHHHc
Confidence            9999999999765544566999999999999999999998765433    233333344444432 47899999999999


Q ss_pred             ccCCCCCC----ChHHHhcCcccccCC
Q 019195          235 VANPSRRI----TIKEIKSHPWFLKNL  257 (344)
Q Consensus       235 ~~dp~~R~----s~~ell~hp~~~~~~  257 (344)
                      +.||.+||    ++.++++||||....
T Consensus       234 ~~~P~~R~~~~~~~~~ll~h~~~~~~~  260 (330)
T cd05586         234 NRNPQHRLGAHRDAVELKEHPFFADID  260 (330)
T ss_pred             CCCHHHCCCCCCCHHHHhcCccccCCC
Confidence            99999998    789999999997643

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=2.7e-44  Score=320.76  Aligned_cols=243  Identities=24%  Similarity=0.387  Sum_probs=193.6

Q ss_pred             eeecCceEEEEEEEcCCCcEEEEEEeecCcc----ccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEEecCCCCCh
Q 019195           10 IGSGNFGVARLMRNKNTKELVAMKYIERGHK----IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYAAGGEL   85 (344)
Q Consensus        10 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L   85 (344)
                      ||+|+||.||++.+..+|+.||+|.+.....    ....+..|+++++.++||||+++++++..+..+|+||||++|++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L   80 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL   80 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence            7999999999999999999999999865321    223456799999999999999999999999999999999999999


Q ss_pred             HHHHHhCC--CCCHHHHHHHHHHHH-------HCCeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCCCCCCCccCC
Q 019195           86 FERICNAG--RFSEDEARYFFQQLI-------SGQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTP  156 (344)
Q Consensus        86 ~~~i~~~~--~~~~~~~~~~~~ql~-------~~~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~~~~~~~gt~  156 (344)
                      ..++....  .++...+..++.|++       +.||+||||||+||+++.++.  ++|+|||++.............||+
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~--~~l~Dfg~~~~~~~~~~~~~~~~~~  158 (277)
T cd05607          81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGN--CRLSDLGLAVELKDGKTITQRAGTN  158 (277)
T ss_pred             HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCC--EEEeeceeeeecCCCceeeccCCCC
Confidence            98886543  477777666666555       459999999999999987654  9999999987654433334457999


Q ss_pred             cccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCHhHHHHHHHhccc
Q 019195          157 AYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVA  236 (344)
Q Consensus       157 ~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~  236 (344)
                      .|+|||++.+..++ .++|||||||++|+|++|+.||.......................+ ...+++++.+||.+||+.
T Consensus       159 ~y~aPE~~~~~~~~-~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~L~~  236 (277)
T cd05607         159 GYMAPEILKEEPYS-YPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFE-HQNFTEESKDICRLFLAK  236 (277)
T ss_pred             CccCHHHHccCCCC-CchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhccccccc-cccCCHHHHHHHHHHhcc
Confidence            99999999877754 5599999999999999999999765433222333333332222222 235789999999999999


Q ss_pred             CCCCCCCh----HHHhcCcccccC
Q 019195          237 NPSRRITI----KEIKSHPWFLKN  256 (344)
Q Consensus       237 dp~~R~s~----~ell~hp~~~~~  256 (344)
                      ||.+||++    .+++.||||...
T Consensus       237 ~P~~R~~~~~~~~~~~~h~~f~~~  260 (277)
T cd05607         237 KPEDRLGSREKNDDPRKHEFFKTI  260 (277)
T ss_pred             CHhhCCCCccchhhhhcChhhcCC
Confidence            99999999    678899999653

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.3e-44  Score=315.42  Aligned_cols=245  Identities=31%  Similarity=0.458  Sum_probs=201.9

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCcc------ccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEE
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK------IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAI   75 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~------~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~l   75 (344)
                      +.|++.+.||+|++|.||++.+..+++.||+|.+.....      ....+.+|+.++++++||||+++++++..+..+++
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   81 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI   81 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence            579999999999999999999999999999999875422      12467889999999999999999999999999999


Q ss_pred             EEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHH-------CCeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCCC
Q 019195           76 VMEYAAGGELFERICNAGRFSEDEARYFFQQLIS-------GQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR  148 (344)
Q Consensus        76 v~e~~~~g~L~~~i~~~~~~~~~~~~~~~~ql~~-------~~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~~  148 (344)
                      ++||+++++|.+++.+.+.+++..++.++.|++.       .||+||||+|+||+++.++.  ++|+|||+++.......
T Consensus        82 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~--~~l~dfg~~~~~~~~~~  159 (263)
T cd06625          82 FMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGN--VKLGDFGASKRLQTICS  159 (263)
T ss_pred             EEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCC--EEEeecccceecccccc
Confidence            9999999999999988888888888877777654       49999999999999986654  99999999875432221


Q ss_pred             C----CCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCH
Q 019195          149 P----KSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQ  224 (344)
Q Consensus       149 ~----~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~  224 (344)
                      .    ....|+..|+|||.+.+..+ +.++||||||+++|+|++|+.||...+.......    ........+....++.
T Consensus       160 ~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~----~~~~~~~~~~~~~~~~  234 (263)
T cd06625         160 SGTGMKSVTGTPYWMSPEVISGEGY-GRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFK----IATQPTNPQLPSHVSP  234 (263)
T ss_pred             ccccccCCCcCccccCcceeccCCC-CchhhhHHHHHHHHHHHhCCCCccccchHHHHHH----HhccCCCCCCCccCCH
Confidence            1    33568899999999987765 4559999999999999999999987654333222    2222222223336789


Q ss_pred             hHHHHHHHhcccCCCCCCChHHHhcCccc
Q 019195          225 DCRNLLSRIFVANPSRRITIKEIKSHPWF  253 (344)
Q Consensus       225 ~~~~li~~~L~~dp~~R~s~~ell~hp~~  253 (344)
                      .+.++|.+||..+|.+|||+.++++||||
T Consensus       235 ~~~~li~~~l~~~p~~Rpt~~~ll~~~~~  263 (263)
T cd06625         235 DARNFLRRTFVENAKKRPSAEELLRHFFV  263 (263)
T ss_pred             HHHHHHHHHhhcCcccCCCHHHHhhCCCC
Confidence            99999999999999999999999999997

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=1.4e-44  Score=329.23  Aligned_cols=241  Identities=31%  Similarity=0.500  Sum_probs=195.6

Q ss_pred             eeeeecCceEEEEEEEcCCCcEEEEEEeecCcc----ccHHHHHHHH-HHhcCCCCCcceeeEEEEcCCEEEEEEecCCC
Q 019195            8 KDIGSGNFGVARLMRNKNTKELVAMKYIERGHK----IDANVAREII-NHKQLRHPNIIRFKEVVLTPTHLAIVMEYAAG   82 (344)
Q Consensus         8 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~ei~-~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~   82 (344)
                      +.||+|+||.||+|.+..+++.||+|++.+...    ....+.+|+. +++.++||||+++++++...+.+|+||||+++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG   80 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            479999999999999999999999999875321    2234555554 57889999999999999999999999999999


Q ss_pred             CChHHHHHhCCCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCC-CCCCCCCcc
Q 019195           83 GELFERICNAGRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLL-HSRPKSTVG  154 (344)
Q Consensus        83 g~L~~~i~~~~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~-~~~~~~~~g  154 (344)
                      ++|...+.....+++.+++.++.||+.+       ||+||||||+|||++.++.  +||+|||+++.... .......+|
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~g  158 (321)
T cd05603          81 GELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGH--VVLTDFGLCKEGVEPEETTSTFCG  158 (321)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCC--EEEccCCCCccCCCCCCccccccC
Confidence            9999999888889998888887776654       9999999999999987654  99999999875322 222344579


Q ss_pred             CCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCHhHHHHHHHhc
Q 019195          155 TPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIF  234 (344)
Q Consensus       155 t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L  234 (344)
                      |+.|+|||++.+..++. ++|||||||++|+|++|..||...+....    ...+......+|.  ..+..+.++|.+||
T Consensus       159 t~~y~aPE~~~~~~~~~-~~DiwslG~il~el~~g~~pf~~~~~~~~----~~~i~~~~~~~~~--~~~~~~~~li~~~l  231 (321)
T cd05603         159 TPEYLAPEVLRKEPYDR-TVDWWCLGAVLYEMLYGLPPFYSRDVSQM----YDNILHKPLQLPG--GKTVAACDLLVGLL  231 (321)
T ss_pred             CcccCCHHHhcCCCCCC-cCcccccchhhhhhhcCCCCCCCCCHHHH----HHHHhcCCCCCCC--CCCHHHHHHHHHHc
Confidence            99999999998777654 59999999999999999999987654332    2333333333443  57889999999999


Q ss_pred             ccCCCCCCCh----HHHhcCcccccCC
Q 019195          235 VANPSRRITI----KEIKSHPWFLKNL  257 (344)
Q Consensus       235 ~~dp~~R~s~----~ell~hp~~~~~~  257 (344)
                      +.||.+||++    .++++||||....
T Consensus       232 ~~~p~~R~~~~~~~~~~~~~~~~~~~~  258 (321)
T cd05603         232 HKDQRRRLGAKADFLEIKNHVFFSPIN  258 (321)
T ss_pred             cCCHhhcCCCCCCHHHHhCCCCcCCCC
Confidence            9999999976    4999999997543

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=6.3e-45  Score=332.95  Aligned_cols=251  Identities=27%  Similarity=0.489  Sum_probs=199.2

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCc----cccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEE
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH----KIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVM   77 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~   77 (344)
                      ++|++++.||+|+||.||++.+..+++.||+|++.+..    .....+.+|+.+++.++|+||+++++++..++.+|+||
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~   80 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM   80 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            68999999999999999999999999999999987532    12234678899999999999999999999999999999


Q ss_pred             ecCCCCChHHHHHh-CCCCCHHHHHHHHHHHH-------HCCeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCCC-
Q 019195           78 EYAAGGELFERICN-AGRFSEDEARYFFQQLI-------SGQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR-  148 (344)
Q Consensus        78 e~~~~g~L~~~i~~-~~~~~~~~~~~~~~ql~-------~~~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~~-  148 (344)
                      ||++||+|..++.+ ...+++..++.++.|++       +.||+||||||+|||++.++.  +||+|||++........ 
T Consensus        81 Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~--~kl~DfG~a~~~~~~~~~  158 (331)
T cd05624          81 DYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGH--IRLADFGSCLKMNQDGTV  158 (331)
T ss_pred             eCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCC--EEEEeccceeeccCCCce
Confidence            99999999999977 46788888777776655       459999999999999976654  99999999875433222 


Q ss_pred             -CCCCccCCcccCCccccCC----CCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCCC-CCCC
Q 019195          149 -PKSTVGTPAYIAPEVLSRR----EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPD-YVHI  222 (344)
Q Consensus       149 -~~~~~gt~~y~aPE~~~~~----~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~  222 (344)
                       ....+||+.|+|||++.+.    ...+.++|||||||++|+|++|+.||...+....+..+...  .....+|. ...+
T Consensus       159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~--~~~~~~p~~~~~~  236 (331)
T cd05624         159 QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNH--EERFQFPSHITDV  236 (331)
T ss_pred             eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcC--CCcccCCCccccC
Confidence             2235699999999998652    22345699999999999999999999876554433332221  11122232 2357


Q ss_pred             CHhHHHHHHHhcccCCCC--CCChHHHhcCcccccC
Q 019195          223 SQDCRNLLSRIFVANPSR--RITIKEIKSHPWFLKN  256 (344)
Q Consensus       223 s~~~~~li~~~L~~dp~~--R~s~~ell~hp~~~~~  256 (344)
                      ++++++||.+||+.++.+  |+++.++++||||...
T Consensus       237 ~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~~  272 (331)
T cd05624         237 SEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEGI  272 (331)
T ss_pred             CHHHHHHHHHHccCchhhcCCCCHHHHhcCCCcCCC
Confidence            899999999999976654  5689999999999754

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=5.2e-44  Score=320.20  Aligned_cols=249  Identities=24%  Similarity=0.426  Sum_probs=204.1

Q ss_pred             CceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCcc----ccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEEe
Q 019195            3 KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK----IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVME   78 (344)
Q Consensus         3 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e   78 (344)
                      .|+..+.||+|+||.||++.+..+++.||+|.+.....    ....+.+|+.+++.++|+||+++++.+..++.++++||
T Consensus         1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e   80 (285)
T cd05632           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEE
Confidence            48899999999999999999999999999999875432    12346789999999999999999999999999999999


Q ss_pred             cCCCCChHHHHHhC--CCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCCCC
Q 019195           79 YAAGGELFERICNA--GRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP  149 (344)
Q Consensus        79 ~~~~g~L~~~i~~~--~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~~~  149 (344)
                      |+++++|..++...  ..+++..+..++.|++.+       ||+||||||+||+++.++  .+||+|||++.........
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~--~~kl~Dfg~~~~~~~~~~~  158 (285)
T cd05632          81 IMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYG--HIRISDLGLAVKIPEGESI  158 (285)
T ss_pred             eccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCC--CEEEecCCcceecCCCCcc
Confidence            99999998888643  368888888887776654       999999999999998765  4999999998654433334


Q ss_pred             CCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCHhHHHH
Q 019195          150 KSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL  229 (344)
Q Consensus       150 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  229 (344)
                      ....|++.|+|||.+.+..++ .++|+|||||++|+|++|..||...........+...+.......  ...+++++.+|
T Consensus       159 ~~~~g~~~~~aPE~~~~~~~~-~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l  235 (285)
T cd05632         159 RGRVGTVGYMAPEVLNNQRYT-LSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVY--SAKFSEEAKSI  235 (285)
T ss_pred             cCCCCCcCccChHHhcCCCCC-cccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhcccccc--CccCCHHHHHH
Confidence            456799999999999877665 459999999999999999999987654333333333333322222  23578899999


Q ss_pred             HHHhcccCCCCCCC-----hHHHhcCcccccC
Q 019195          230 LSRIFVANPSRRIT-----IKEIKSHPWFLKN  256 (344)
Q Consensus       230 i~~~L~~dp~~R~s-----~~ell~hp~~~~~  256 (344)
                      +.+||+.||.+||+     +.+++.||||...
T Consensus       236 i~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~  267 (285)
T cd05632         236 CKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNM  267 (285)
T ss_pred             HHHHccCCHhHcCCCcccChHHHHcChhhhcC
Confidence            99999999999999     8899999999765

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=1.6e-44  Score=329.55  Aligned_cols=240  Identities=32%  Similarity=0.555  Sum_probs=194.5

Q ss_pred             eeeeecCceEEEEEEEcCCCcEEEEEEeecCc----cccHHHHHHHH-HHhcCCCCCcceeeEEEEcCCEEEEEEecCCC
Q 019195            8 KDIGSGNFGVARLMRNKNTKELVAMKYIERGH----KIDANVAREII-NHKQLRHPNIIRFKEVVLTPTHLAIVMEYAAG   82 (344)
Q Consensus         8 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~ei~-~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~   82 (344)
                      +.||+|+||+||+|.+..+++.||+|++.+..    .....+.+|.. +++.++||||+++++++...+.+|+||||+++
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING   80 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence            47999999999999999999999999987532    11233444443 46788999999999999999999999999999


Q ss_pred             CChHHHHHhCCCCCHHHHHHHHHHHHH-------CCeeecCCCCCCeEecCCCCCCEEEeecCCCcccCC-CCCCCCCcc
Q 019195           83 GELFERICNAGRFSEDEARYFFQQLIS-------GQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLL-HSRPKSTVG  154 (344)
Q Consensus        83 g~L~~~i~~~~~~~~~~~~~~~~ql~~-------~~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~-~~~~~~~~g  154 (344)
                      ++|..++.+.+.+++..++.++.||+.       .||+||||||+|||++.++  .+||+|||+++.... .......+|
T Consensus        81 ~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~--~~kl~DfG~a~~~~~~~~~~~~~~g  158 (325)
T cd05602          81 GELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQG--HIVLTDFGLCKENIEHNGTTSTFCG  158 (325)
T ss_pred             CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCC--CEEEccCCCCcccccCCCCcccccC
Confidence            999999988888888888877777654       4999999999999997665  499999999875332 223345679


Q ss_pred             CCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCHhHHHHHHHhc
Q 019195          155 TPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIF  234 (344)
Q Consensus       155 t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L  234 (344)
                      |+.|+|||++.+..++ .++|||||||++|+|++|.+||........+..    +.......+  ..+++.+.++|.+||
T Consensus       159 t~~y~aPE~~~~~~~~-~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~----i~~~~~~~~--~~~~~~~~~li~~~l  231 (325)
T cd05602         159 TPEYLAPEVLHKQPYD-RTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDN----ILNKPLQLK--PNITNSARHLLEGLL  231 (325)
T ss_pred             CccccCHHHHcCCCCC-CccccccccHHHHHHhcCCCCCCCCCHHHHHHH----HHhCCcCCC--CCCCHHHHHHHHHHc
Confidence            9999999999887765 459999999999999999999987655433333    222333322  368899999999999


Q ss_pred             ccCCCCCCChH----HHhcCcccccC
Q 019195          235 VANPSRRITIK----EIKSHPWFLKN  256 (344)
Q Consensus       235 ~~dp~~R~s~~----ell~hp~~~~~  256 (344)
                      +.||.+|+++.    ++++|+||...
T Consensus       232 ~~~p~~R~~~~~~~~~i~~~~~~~~~  257 (325)
T cd05602         232 QKDRTKRLGAKDDFMEIKNHIFFSPI  257 (325)
T ss_pred             ccCHHHCCCCCCCHHHHhcCcccCCC
Confidence            99999999876    89999999654

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2e-45  Score=337.77  Aligned_cols=248  Identities=40%  Similarity=0.660  Sum_probs=224.2

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCcccc---HHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEEe
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKID---ANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVME   78 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e   78 (344)
                      ..|.+.+.||+|.|+.|.++.+..++..||||.+++.....   ..+.+|+++|+.|+|||||+++.+...+..+|+|||
T Consensus        56 g~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~e  135 (596)
T KOG0586|consen   56 GLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVME  135 (596)
T ss_pred             cceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEEE
Confidence            46999999999999999999999999999999998865432   458899999999999999999999999999999999


Q ss_pred             cCCCCChHHHHHhCCCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCCCCCC
Q 019195           79 YAAGGELFERICNAGRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKS  151 (344)
Q Consensus        79 ~~~~g~L~~~i~~~~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~~~~~  151 (344)
                      |+.+|.+++++.+.+++.+...+.++.|++++       +|+|||||++|||++.+.+  +||+|||++..........+
T Consensus       136 ya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mn--ikIaDfgfS~~~~~~~~lqt  213 (596)
T KOG0586|consen  136 YASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMN--IKIADFGFSTFFDYGLMLQT  213 (596)
T ss_pred             eccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccc--eeeeccccceeecccccccc
Confidence            99999999999999999999888888887776       9999999999999988776  99999999998888888899


Q ss_pred             CccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCHhHHHHHH
Q 019195          152 TVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLS  231 (344)
Q Consensus       152 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~  231 (344)
                      .||++.|.|||++.+..|+++.+|+||+|+++|.|+.|..||.+..-    ...-.+.....+++|.  .++-++.+||+
T Consensus       214 ~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~l----k~Lr~rvl~gk~rIp~--~ms~dce~lLr  287 (596)
T KOG0586|consen  214 FCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNL----KELRPRVLRGKYRIPF--YMSCDCEDLLR  287 (596)
T ss_pred             cCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccc----ccccchheeeeecccc--eeechhHHHHH
Confidence            99999999999999999999999999999999999999999988654    2333445566777777  57889999999


Q ss_pred             HhcccCCCCCCChHHHhcCcccccCC
Q 019195          232 RIFVANPSRRITIKEIKSHPWFLKNL  257 (344)
Q Consensus       232 ~~L~~dp~~R~s~~ell~hp~~~~~~  257 (344)
                      ++|.++|.+|++.+++..|.|.....
T Consensus       288 k~lvl~Pskr~~~dqim~~~W~n~~~  313 (596)
T KOG0586|consen  288 KFLVLNPSKRGPCDQIMKDRWRNDLL  313 (596)
T ss_pred             HhhccCccccCCHHHhhhhcccchhh
Confidence            99999999999999999999976543

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=3.3e-44  Score=331.40  Aligned_cols=245  Identities=24%  Similarity=0.412  Sum_probs=190.6

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEEecCC
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYAA   81 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~   81 (344)
                      .+|++++.||+|+||.||+|.+..+++.||+|+....     ....|+.++++++||||+++++++......++||+++.
T Consensus        66 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~-----~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~  140 (357)
T PHA03209         66 LGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG-----TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYS  140 (357)
T ss_pred             cCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc-----ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEccC
Confidence            3699999999999999999999999999999975432     34579999999999999999999999999999999995


Q ss_pred             CCChHHHHHh-CCCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCCCCCCCc
Q 019195           82 GGELFERICN-AGRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTV  153 (344)
Q Consensus        82 ~g~L~~~i~~-~~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~~~~~~~  153 (344)
                       ++|..++.. ...+++.+++.++.||+.+       ||+||||||+|||++..+.  +||+|||+++............
T Consensus       141 -~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~--~kl~DfG~a~~~~~~~~~~~~~  217 (357)
T PHA03209        141 -SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQ--VCIGDLGAAQFPVVAPAFLGLA  217 (357)
T ss_pred             -CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCC--EEEecCccccccccCccccccc
Confidence             688888765 4568888888887776655       9999999999999977664  9999999987544444444567


Q ss_pred             cCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCC-CCCCCh---------HHHHHHHHHHhhccccCC------
Q 019195          154 GTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPF-EDQEDP---------KNFRKTISRIMAVQYKIP------  217 (344)
Q Consensus       154 gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf-~~~~~~---------~~~~~~~~~~~~~~~~~~------  217 (344)
                      ||+.|+|||++.+..+. .++|||||||++|+|+++..|+ ......         ..+..++.........++      
T Consensus       218 gt~~y~aPE~~~~~~~~-~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~  296 (357)
T PHA03209        218 GTVETNAPEVLARDKYN-SKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRDPGSR  296 (357)
T ss_pred             ccccccCCeecCCCCCC-chhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCCCCccH
Confidence            99999999999887765 4599999999999999865444 332211         111111111111111111      


Q ss_pred             ----------------------CCCCCCHhHHHHHHHhcccCCCCCCChHHHhcCccccc
Q 019195          218 ----------------------DYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLK  255 (344)
Q Consensus       218 ----------------------~~~~~s~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~  255 (344)
                                            ....++.++.+||.+||+.||.+||||.|+|+||||++
T Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~  356 (357)
T PHA03209        297 LVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQ  356 (357)
T ss_pred             HHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhcc
Confidence                                  01245678889999999999999999999999999965

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=5.1e-45  Score=287.76  Aligned_cols=254  Identities=29%  Similarity=0.508  Sum_probs=215.4

Q ss_pred             CCCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCc---cccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEE
Q 019195            1 MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH---KIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVM   77 (344)
Q Consensus         1 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~   77 (344)
                      |.+|.-.++||+|.||+|+++++.+++++||+|.+..+.   ......++||-+++.++|.|||+++++..++..+.+|+
T Consensus         1 m~~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvf   80 (292)
T KOG0662|consen    1 MQKYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF   80 (292)
T ss_pred             CcchHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeH
Confidence            678999999999999999999999999999999997643   34578999999999999999999999999999999999


Q ss_pred             ecCCCCChHHHHHh-CCCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCCCC
Q 019195           78 EYAAGGELFERICN-AGRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP  149 (344)
Q Consensus        78 e~~~~g~L~~~i~~-~~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~~~  149 (344)
                      |||. .+|..+... ++.+....++.++.|++.+       ++.|||+||.|+||+.++.  +||+|||+++.....-..
T Consensus        81 e~cd-qdlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~nge--lkladfglarafgipvrc  157 (292)
T KOG0662|consen   81 EFCD-QDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGE--LKLADFGLARAFGIPVRC  157 (292)
T ss_pred             HHhh-HHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCc--EEecccchhhhcCCceEe
Confidence            9994 588888765 5678999999999999876       8999999999999987765  999999999865544333


Q ss_pred             -CCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhhccc-------cCCCCC
Q 019195          150 -KSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQY-------KIPDYV  220 (344)
Q Consensus       150 -~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~-------~~~~~~  220 (344)
                       ...+-|.+|++|.++.+...+++..|+||.|||+.|+.. |++.|.+.+..+++.+++........       .+|++.
T Consensus       158 ysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk  237 (292)
T KOG0662|consen  158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYK  237 (292)
T ss_pred             eeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCc
Confidence             345689999999999998888887999999999999986 88889888888888888776543322       122221


Q ss_pred             ----------------CCCHhHHHHHHHhcccCCCCCCChHHHhcCcccccCC
Q 019195          221 ----------------HISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNL  257 (344)
Q Consensus       221 ----------------~~s~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~~~  257 (344)
                                      .++...++|++++|..+|.+|++|+.+++||||....
T Consensus       238 ~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf~d~s  290 (292)
T KOG0662|consen  238 PYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSDFS  290 (292)
T ss_pred             ccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCccccccC
Confidence                            2345678999999999999999999999999997643

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1e-44  Score=328.38  Aligned_cols=244  Identities=27%  Similarity=0.394  Sum_probs=190.2

Q ss_pred             CceeeeeeeecCceEEEEEEEcCCCcEEEEEEeec---CccccHHHHHHHHHHhcC-CCCCcceeeEEEEcCCEEEEEEe
Q 019195            3 KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIER---GHKIDANVAREIINHKQL-RHPNIIRFKEVVLTPTHLAIVME   78 (344)
Q Consensus         3 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~---~~~~~~~~~~ei~~l~~l-~h~niv~~~~~~~~~~~~~lv~e   78 (344)
                      .|+++++||+||.+.||++.....+ .||+|++..   +......+.+|+..|.+| .|.+||+++++-..++.+|+|||
T Consensus       362 ~Yeilk~iG~GGSSkV~kV~~s~~~-iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvmE  440 (677)
T KOG0596|consen  362 EYEILKQIGSGGSSKVFKVLNSDKQ-IYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVME  440 (677)
T ss_pred             hhhHHHhhcCCCcceeeeeecCCCc-chhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEee
Confidence            6999999999999999999986554 566555432   233446799999999999 49999999999999999999999


Q ss_pred             cCCCCChHHHHHhCCCCCH-HHHHH-------HHHHHHHCCeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCCC--
Q 019195           79 YAAGGELFERICNAGRFSE-DEARY-------FFQQLISGQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR--  148 (344)
Q Consensus        79 ~~~~g~L~~~i~~~~~~~~-~~~~~-------~~~ql~~~~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~~--  148 (344)
                      |- ..+|..+|++.....+ ..++.       ++..+|.+||||.||||.|+|+=   .|++||+|||+|........  
T Consensus       441 ~G-d~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlV---kG~LKLIDFGIA~aI~~DTTsI  516 (677)
T KOG0596|consen  441 CG-DIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLV---KGRLKLIDFGIANAIQPDTTSI  516 (677)
T ss_pred             cc-cccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEE---eeeEEeeeechhcccCccccce
Confidence            76 6799999987765433 34444       44555566999999999999983   34699999999986554433  


Q ss_pred             -CCCCccCCcccCCccccCCCCC----------CcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccc--c
Q 019195          149 -PKSTVGTPAYIAPEVLSRREYD----------GKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQY--K  215 (344)
Q Consensus       149 -~~~~~gt~~y~aPE~~~~~~~~----------~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~--~  215 (344)
                       ..+.+||+.|||||.+....+.          ++++||||||||||+|+.|++||...   .+....+..++....  .
T Consensus       517 ~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~---~n~~aKl~aI~~P~~~Ie  593 (677)
T KOG0596|consen  517 VKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQI---INQIAKLHAITDPNHEIE  593 (677)
T ss_pred             eeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHH---HHHHHHHHhhcCCCcccc
Confidence             2356899999999998543332          45699999999999999999999764   233445555665544  3


Q ss_pred             CCCCCCCCHhHHHHHHHhcccCCCCCCChHHHhcCccccc
Q 019195          216 IPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLK  255 (344)
Q Consensus       216 ~~~~~~~s~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~  255 (344)
                      +|.... ..++.++++.||.+||.+|||+.+||+|||+.-
T Consensus       594 fp~~~~-~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~  632 (677)
T KOG0596|consen  594 FPDIPE-NDELIDVMKCCLARDPKKRWSIPELLQHPFLQI  632 (677)
T ss_pred             ccCCCC-chHHHHHHHHHHhcCcccCCCcHHHhcCccccc
Confidence            443322 223999999999999999999999999999976

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=5.1e-44  Score=341.80  Aligned_cols=245  Identities=28%  Similarity=0.426  Sum_probs=199.4

Q ss_pred             CceeeeeeeecCceEEEEEEEcCC-CcEEEEEEeecCcc-ccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEEecC
Q 019195            3 KYELMKDIGSGNFGVARLMRNKNT-KELVAMKYIERGHK-IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYA   80 (344)
Q Consensus         3 ~y~~~~~lg~G~~g~V~~~~~~~~-~~~vaiK~~~~~~~-~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~   80 (344)
                      .|.+.+.||+|+||.||+|....+ +..||+|.+..... ....+.+|+.+++.++|||||++++++..++.+|+||||+
T Consensus        68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~  147 (478)
T PTZ00267         68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG  147 (478)
T ss_pred             eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence            499999999999999999998877 78899997754332 2345778999999999999999999999999999999999


Q ss_pred             CCCChHHHHHh----CCCCCHHHHHHHHHHHHH-------CCeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCC--
Q 019195           81 AGGELFERICN----AGRFSEDEARYFFQQLIS-------GQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS--  147 (344)
Q Consensus        81 ~~g~L~~~i~~----~~~~~~~~~~~~~~ql~~-------~~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~--  147 (344)
                      ++|+|.+.+..    ...+++.+++.++.|++.       .||+||||||+|||++.++.  +||+|||+++......  
T Consensus       148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~--~kL~DFgla~~~~~~~~~  225 (478)
T PTZ00267        148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGI--IKLGDFGFSKQYSDSVSL  225 (478)
T ss_pred             CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCc--EEEEeCcCceecCCcccc
Confidence            99999887753    346888888777766654       49999999999999987654  9999999997543322  


Q ss_pred             -CCCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCHhH
Q 019195          148 -RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDC  226 (344)
Q Consensus       148 -~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~  226 (344)
                       .....+||+.|+|||++.+..+. .++|||||||++|+|++|+.||........    +..+...... +....+++++
T Consensus       226 ~~~~~~~gt~~y~aPE~~~~~~~~-~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~----~~~~~~~~~~-~~~~~~s~~~  299 (478)
T PTZ00267        226 DVASSFCGTPYYLAPELWERKRYS-KKADMWSLGVILYELLTLHRPFKGPSQREI----MQQVLYGKYD-PFPCPVSSGM  299 (478)
T ss_pred             ccccccCCCccccCHhHhCCCCCC-cHHhHHHHHHHHHHHHhCCCCCCCCCHHHH----HHHHHhCCCC-CCCccCCHHH
Confidence             23455799999999999877664 559999999999999999999987654332    3333322222 2334678999


Q ss_pred             HHHHHHhcccCCCCCCChHHHhcCccccc
Q 019195          227 RNLLSRIFVANPSRRITIKEIKSHPWFLK  255 (344)
Q Consensus       227 ~~li~~~L~~dp~~R~s~~ell~hp~~~~  255 (344)
                      .+||.+||+.||.+||++.+++.|||+..
T Consensus       300 ~~li~~~L~~dP~~Rps~~~~l~~~~~~~  328 (478)
T PTZ00267        300 KALLDPLLSKNPALRPTTQQLLHTEFLKY  328 (478)
T ss_pred             HHHHHHHhccChhhCcCHHHHHhCHHHHH
Confidence            99999999999999999999999999854

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-45  Score=315.07  Aligned_cols=249  Identities=38%  Similarity=0.612  Sum_probs=213.8

Q ss_pred             CCCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCccc----cHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEE
Q 019195            1 MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKI----DANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIV   76 (344)
Q Consensus         1 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~----~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv   76 (344)
                      |++|..+++||+|.||.|.+|+-+.+++.||||++++.-..    .+.-+.|-++|+..+||.+..+...|+..+++|+|
T Consensus       167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFV  246 (516)
T KOG0690|consen  167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFV  246 (516)
T ss_pred             cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEE
Confidence            68899999999999999999999999999999999874322    24456788899999999999999999999999999


Q ss_pred             EecCCCCChHHHHHhCCCCCHHHHHH-------HHHHHHHCCeeecCCCCCCeEecCCCCCCEEEeecCCCcccC-CCCC
Q 019195           77 MEYAAGGELFERICNAGRFSEDEARY-------FFQQLISGQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSL-LHSR  148 (344)
Q Consensus        77 ~e~~~~g~L~~~i~~~~~~~~~~~~~-------~~~ql~~~~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~-~~~~  148 (344)
                      |||..||.|+-++.....|++...+.       .+-+||+.+||.||||.+|+|+|.++.  +||+|||+++... .+..
T Consensus       247 MeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGH--IKitDFGLCKE~I~~g~t  324 (516)
T KOG0690|consen  247 MEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGH--IKITDFGLCKEEIKYGDT  324 (516)
T ss_pred             EEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCc--eEeeecccchhcccccce
Confidence            99999999999998877777775554       466677779999999999999987765  9999999998643 3444


Q ss_pred             CCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCHhHHH
Q 019195          149 PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRN  228 (344)
Q Consensus       149 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~  228 (344)
                      .++.||||.|+|||++....| ++++|+|.+|+++|||++|+.||...+....+.    -++....++|.  .++++++.
T Consensus       325 ~kTFCGTPEYLAPEVleDnDY-graVDWWG~GVVMYEMmCGRLPFyn~dh~kLFe----LIl~ed~kFPr--~ls~eAkt  397 (516)
T KOG0690|consen  325 TKTFCGTPEYLAPEVLEDNDY-GRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFE----LILMEDLKFPR--TLSPEAKT  397 (516)
T ss_pred             eccccCChhhcCchhhccccc-cceeehhhhhHHHHHHHhccCcccccchhHHHH----HHHhhhccCCc--cCCHHHHH
Confidence            677899999999999988877 566999999999999999999999877655444    34455667776  78999999


Q ss_pred             HHHHhcccCCCCCC-----ChHHHhcCcccccCCC
Q 019195          229 LLSRIFVANPSRRI-----TIKEIKSHPWFLKNLP  258 (344)
Q Consensus       229 li~~~L~~dp~~R~-----s~~ell~hp~~~~~~~  258 (344)
                      |+..+|.+||.+|.     .|.++.+|+||...-.
T Consensus       398 LLsGLL~kdP~kRLGgGpdDakEi~~h~FF~~v~W  432 (516)
T KOG0690|consen  398 LLSGLLKKDPKKRLGGGPDDAKEIMRHRFFASVDW  432 (516)
T ss_pred             HHHHHhhcChHhhcCCCchhHHHHHhhhhhccCCH
Confidence            99999999999999     5899999999987644

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=5.5e-44  Score=342.13  Aligned_cols=247  Identities=27%  Similarity=0.419  Sum_probs=199.3

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCcc---ccHHHHHHHHHHhcCCCCCcceeeEEEEcCC-------
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK---IDANVAREIINHKQLRHPNIIRFKEVVLTPT-------   71 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~-------   71 (344)
                      ++|++.+.||+|+||+||+|.+..+++.||+|++.....   ....+.+|+..+..++|+||++++..+....       
T Consensus        32 ~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~~  111 (496)
T PTZ00283         32 KKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENV  111 (496)
T ss_pred             CCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcccc
Confidence            689999999999999999999999999999999876432   2346778999999999999999988875432       


Q ss_pred             -EEEEEEecCCCCChHHHHHhC----CCCCHHHHHHHHHHHHH-------CCeeecCCCCCCeEecCCCCCCEEEeecCC
Q 019195           72 -HLAIVMEYAAGGELFERICNA----GRFSEDEARYFFQQLIS-------GQICHRDLKLENTLLDGSPAPRLKICDFGY  139 (344)
Q Consensus        72 -~~~lv~e~~~~g~L~~~i~~~----~~~~~~~~~~~~~ql~~-------~~iiH~Dikp~NIl~~~~~~~~vkL~DFg~  139 (344)
                       .+++||||+++|+|.+++...    ..+++..++.++.|++.       .+|+||||||+|||++.++.  +||+|||+
T Consensus       112 ~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~--vkL~DFGl  189 (496)
T PTZ00283        112 LMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGL--VKLGDFGF  189 (496)
T ss_pred             eEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCC--EEEEeccc
Confidence             478999999999999988653    45888877777666554       49999999999999987654  99999999


Q ss_pred             CcccCCC---CCCCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccC
Q 019195          140 SKSSLLH---SRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKI  216 (344)
Q Consensus       140 a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  216 (344)
                      ++.....   ......+||+.|+|||++.+..++ .++|||||||++|+|++|+.||........    +..+..... .
T Consensus       190 s~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s-~k~DVwSlGvilyeLltG~~Pf~~~~~~~~----~~~~~~~~~-~  263 (496)
T PTZ00283        190 SKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYS-KKADMFSLGVLLYELLTLKRPFDGENMEEV----MHKTLAGRY-D  263 (496)
T ss_pred             CeeccccccccccccccCCcceeCHHHhCCCCCC-cHHHHHHHHHHHHHHHHCCCCCCCCCHHHH----HHHHhcCCC-C
Confidence            8754322   223456799999999999887765 459999999999999999999987654332    222222222 2


Q ss_pred             CCCCCCCHhHHHHHHHhcccCCCCCCChHHHhcCcccccC
Q 019195          217 PDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKN  256 (344)
Q Consensus       217 ~~~~~~s~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~~  256 (344)
                      +....+++++.+|+.+||+.||.+||++.++++|||+...
T Consensus       264 ~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~~  303 (496)
T PTZ00283        264 PLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKLF  303 (496)
T ss_pred             CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhCHHHHHh
Confidence            2334689999999999999999999999999999998643

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=1.2e-43  Score=317.34  Aligned_cols=248  Identities=27%  Similarity=0.462  Sum_probs=197.8

Q ss_pred             CceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCc---cccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEEec
Q 019195            3 KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH---KIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEY   79 (344)
Q Consensus         3 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~   79 (344)
                      +|++++.||+|++|.||++.+..++..||+|++....   .....+.+|+.++++++||||+++++++..+..+|+||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF   80 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence            5999999999999999999999999999999986532   2235688999999999999999999999999999999999


Q ss_pred             CCCCChHHHHHhC---CCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCCC-
Q 019195           80 AAGGELFERICNA---GRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR-  148 (344)
Q Consensus        80 ~~~g~L~~~i~~~---~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~~-  148 (344)
                      ++ ++|.+++...   ..+++..++.++.|++.+       ||+||||||+||+++.++.  +||+|||++........ 
T Consensus        81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~--~~l~dfg~~~~~~~~~~~  157 (285)
T cd07861          81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGV--IKLADFGLARAFGIPVRV  157 (285)
T ss_pred             CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCc--EEECcccceeecCCCccc
Confidence            97 6888887543   468888888888777765       9999999999999987664  99999999875432222 


Q ss_pred             CCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhc--------------cc
Q 019195          149 PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAV--------------QY  214 (344)
Q Consensus       149 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~--------------~~  214 (344)
                      .....+++.|+|||.+.+....+.++|||||||++|+|++|++||...................              ..
T Consensus       158 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (285)
T cd07861         158 YTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKN  237 (285)
T ss_pred             ccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHHh
Confidence            2334678999999998765544566999999999999999999998765443333222211100              00


Q ss_pred             cC---------CCCCCCCHhHHHHHHHhcccCCCCCCChHHHhcCccc
Q 019195          215 KI---------PDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF  253 (344)
Q Consensus       215 ~~---------~~~~~~s~~~~~li~~~L~~dp~~R~s~~ell~hp~~  253 (344)
                      ..         .....+++++.+||.+||+.||.+|||+.+++.||||
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~  285 (285)
T cd07861         238 TFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF  285 (285)
T ss_pred             hccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence            00         0122478899999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=1.3e-43  Score=317.15  Aligned_cols=250  Identities=30%  Similarity=0.462  Sum_probs=202.8

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCcc---ccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEEe
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK---IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVME   78 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e   78 (344)
                      ++|++.+.||+|+||.||++.+..+++.||+|++.....   ....+.+|+.++++++||||+++++++.....+++|||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e   80 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE   80 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence            589999999999999999999999999999998865432   23557899999999999999999999999999999999


Q ss_pred             cCCCCChHHHHHhCCCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCC-CCC
Q 019195           79 YAAGGELFERICNAGRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS-RPK  150 (344)
Q Consensus        79 ~~~~g~L~~~i~~~~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~-~~~  150 (344)
                      |+++++|..++.....+++..++.++.|++.+       |++||||||+||+++.++  ++||+|||++....... ...
T Consensus        81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~--~~~l~dfg~~~~~~~~~~~~~  158 (286)
T cd07847          81 YCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQG--QIKLCDFGFARILTGPGDDYT  158 (286)
T ss_pred             ccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCC--cEEECccccceecCCCccccc
Confidence            99998888887777789999888888777654       999999999999998665  49999999987654333 223


Q ss_pred             CCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhc---------------ccc
Q 019195          151 STVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAV---------------QYK  215 (344)
Q Consensus       151 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~---------------~~~  215 (344)
                      ...++..|+|||.+.+....+.++||||||+++|+|++|++||.+....+....+.......               ...
T Consensus       159 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (286)
T cd07847         159 DYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGLS  238 (286)
T ss_pred             CcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhccccccccccc
Confidence            45688999999998765545566999999999999999999998766544433332211100               000


Q ss_pred             CCC----------CCCCCHhHHHHHHHhcccCCCCCCChHHHhcCccc
Q 019195          216 IPD----------YVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF  253 (344)
Q Consensus       216 ~~~----------~~~~s~~~~~li~~~L~~dp~~R~s~~ell~hp~~  253 (344)
                      .|.          ...++..+.+||.+||+.+|.+|||+.+++.||||
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f  286 (286)
T cd07847         239 IPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF  286 (286)
T ss_pred             CCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence            111          12467889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-45  Score=306.16  Aligned_cols=248  Identities=25%  Similarity=0.403  Sum_probs=198.0

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCcc--ccHHHHHHHHHHhcC-CCCCcceeeEEEEcCCEEEEEEe
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK--IDANVAREIINHKQL-RHPNIIRFKEVVLTPTHLAIVME   78 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~ei~~l~~l-~h~niv~~~~~~~~~~~~~lv~e   78 (344)
                      ++.+.+..||.|+.|+|+++....+|...|||.+.+...  ..++++..+.++... .+|+||+.+++|..+..+++.||
T Consensus        92 ndl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMe  171 (391)
T KOG0983|consen   92 NDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICME  171 (391)
T ss_pred             HHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHH
Confidence            456778899999999999999999999999999987543  335677777766554 59999999999999999999999


Q ss_pred             cCCCCChHHHHHh-CCCCCHHHHHHHHHHHHHC--------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCCCC
Q 019195           79 YAAGGELFERICN-AGRFSEDEARYFFQQLISG--------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP  149 (344)
Q Consensus        79 ~~~~g~L~~~i~~-~~~~~~~~~~~~~~ql~~~--------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~~~  149 (344)
                      .|. .-+..+++. .+.++|.-+-.+...+++|        ||+||||||+|||+|..++  +||||||++.........
T Consensus       172 lMs-~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~Gn--iKlCDFGIsGrlvdSkAh  248 (391)
T KOG0983|consen  172 LMS-TCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGN--IKLCDFGISGRLVDSKAH  248 (391)
T ss_pred             HHH-HHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCC--EEeecccccceeeccccc
Confidence            983 344444433 4567777655554444444        9999999999999988776  999999999877666667


Q ss_pred             CCCccCCcccCCccccC---CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCh-HHHHHHHHHHhhccccCCCCCCCCHh
Q 019195          150 KSTVGTPAYIAPEVLSR---REYDGKLADVWSCGVTLYVMLVGAYPFEDQEDP-KNFRKTISRIMAVQYKIPDYVHISQD  225 (344)
Q Consensus       150 ~~~~gt~~y~aPE~~~~---~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~s~~  225 (344)
                      +...|.+.|||||.+.-   ..|+-+ +|||||||+++||+||+.||.+.... +.+.+++.   ..+..+|.-.++|++
T Consensus       249 trsAGC~~YMaPERidp~~~~kYDiR-aDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln---~ePP~L~~~~gFSp~  324 (391)
T KOG0983|consen  249 TRSAGCAAYMAPERIDPPDKPKYDIR-ADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLN---EEPPLLPGHMGFSPD  324 (391)
T ss_pred             ccccCCccccCccccCCCCCCccchh-hhhhhhccchhhhhcccCCCCCCCccHHHHHHHHh---cCCCCCCcccCcCHH
Confidence            77889999999999853   345555 89999999999999999999986543 22222222   333455655679999


Q ss_pred             HHHHHHHhcccCCCCCCChHHHhcCcccccC
Q 019195          226 CRNLLSRIFVANPSRRITIKEIKSHPWFLKN  256 (344)
Q Consensus       226 ~~~li~~~L~~dp~~R~s~~ell~hp~~~~~  256 (344)
                      +.+|+..||++|+.+||...++|+|||+...
T Consensus       325 F~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~y  355 (391)
T KOG0983|consen  325 FQSFVKDCLTKDHRKRPKYNKLLEHPFIKRY  355 (391)
T ss_pred             HHHHHHHHhhcCcccCcchHHHhcCcceeec
Confidence            9999999999999999999999999998754

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=2.4e-43  Score=316.57  Aligned_cols=245  Identities=33%  Similarity=0.628  Sum_probs=206.0

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCc----cccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEE
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH----KIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVM   77 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~   77 (344)
                      ++|++.+.||+|+||.||++.+..+++.||+|++....    .....+.+|++++++++||||+++++++...+.+|+||
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   80 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM   80 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence            58999999999999999999999999999999987532    23356888999999999999999999999999999999


Q ss_pred             ecCCCCChHHHHHhCCCCCHHHHHHHHHHHHH-------CCeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCCCCC
Q 019195           78 EYAAGGELFERICNAGRFSEDEARYFFQQLIS-------GQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPK  150 (344)
Q Consensus        78 e~~~~g~L~~~i~~~~~~~~~~~~~~~~ql~~-------~~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~~~~  150 (344)
                      ||+++++|.+++.+.+.+++..++.++.|++.       .|++||||+|.||+++.++.  +||+|||++......  ..
T Consensus        81 e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~--~kl~dfg~~~~~~~~--~~  156 (290)
T cd05580          81 EYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGY--IKITDFGFAKRVKGR--TY  156 (290)
T ss_pred             ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCC--EEEeeCCCccccCCC--CC
Confidence            99999999999998888999888887777665       49999999999999987654  999999998764333  34


Q ss_pred             CCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCHhHHHHH
Q 019195          151 STVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLL  230 (344)
Q Consensus       151 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li  230 (344)
                      ..+|++.|+|||.+.+... +.++||||||+++|+|++|+.||........    ...+......+|.  .+++.++++|
T Consensus       157 ~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~----~~~~~~~~~~~~~--~~~~~l~~li  229 (290)
T cd05580         157 TLCGTPEYLAPEIILSKGY-GKAVDWWALGILIYEMLAGYPPFFDDNPIQI----YEKILEGKVRFPS--FFSPDAKDLI  229 (290)
T ss_pred             CCCCCccccChhhhcCCCC-CccccHHHHHHHHHHHHhCCCCCCCCCHHHH----HHHHhcCCccCCc--cCCHHHHHHH
Confidence            5579999999999877654 4559999999999999999999987653222    2223333333443  5689999999


Q ss_pred             HHhcccCCCCCC-----ChHHHhcCcccccCC
Q 019195          231 SRIFVANPSRRI-----TIKEIKSHPWFLKNL  257 (344)
Q Consensus       231 ~~~L~~dp~~R~-----s~~ell~hp~~~~~~  257 (344)
                      .+||+.+|.+|+     ++.++++||||....
T Consensus       230 ~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~  261 (290)
T cd05580         230 RNLLQVDLTKRLGNLKNGVNDIKNHPWFAGID  261 (290)
T ss_pred             HHHccCCHHHccCcccCCHHHHHcCcccccCC
Confidence            999999999999     999999999996653

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=9.2e-44  Score=332.39  Aligned_cols=249  Identities=23%  Similarity=0.332  Sum_probs=196.9

Q ss_pred             CCceeeeeeeecCceEEEEEEEc--CCCcEEEEEEeecCccccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEEec
Q 019195            2 EKYELMKDIGSGNFGVARLMRNK--NTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEY   79 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~--~~~~~vaiK~~~~~~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~   79 (344)
                      .+|++++.||.|+||.||+|...  .+++.||+|.+...    ....+|+.+++.++||||+++++++.....+|++|++
T Consensus        92 ~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~e~  167 (392)
T PHA03207         92 MQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMPK  167 (392)
T ss_pred             CceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEehh
Confidence            36999999999999999999754  45688999987653    2356899999999999999999999999999999999


Q ss_pred             CCCCChHHHHHhCCCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCCC---C
Q 019195           80 AAGGELFERICNAGRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR---P  149 (344)
Q Consensus        80 ~~~g~L~~~i~~~~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~~---~  149 (344)
                      +. ++|..++...+.+++.+++.++.||+.+       ||+||||||+|||++.++.  +||+|||++........   .
T Consensus       168 ~~-~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~--~~l~DfG~a~~~~~~~~~~~~  244 (392)
T PHA03207        168 YK-CDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPEN--AVLGDFGAACKLDAHPDTPQC  244 (392)
T ss_pred             cC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCC--EEEccCccccccCcccccccc
Confidence            95 6899998777889999988887776654       9999999999999987654  99999999875433222   2


Q ss_pred             CCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCh---HHHHHHHHHHhhcccc-----------
Q 019195          150 KSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDP---KNFRKTISRIMAVQYK-----------  215 (344)
Q Consensus       150 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~---~~~~~~~~~~~~~~~~-----------  215 (344)
                      ....||+.|+|||++.+..++. ++|||||||++|+|++|+.||.+....   ..+..++..+......           
T Consensus       245 ~~~~gt~~y~aPE~~~~~~~~~-~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~  323 (392)
T PHA03207        245 YGWSGTLETNSPELLALDPYCA-KTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTNLCK  323 (392)
T ss_pred             cccccccCccCHhHhcCCCCCc-hhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccchhHHH
Confidence            3457999999999998777654 499999999999999999999765432   2222222211111111           


Q ss_pred             --------------CCC---CCCCCHhHHHHHHHhcccCCCCCCChHHHhcCcccccCCC
Q 019195          216 --------------IPD---YVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLP  258 (344)
Q Consensus       216 --------------~~~---~~~~s~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~~~~  258 (344)
                                    .|.   ...++.++.+||++||+.||.+|||+.++|.||||.+...
T Consensus       324 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~~~  383 (392)
T PHA03207        324 HFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKEPI  383 (392)
T ss_pred             HHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhccch
Confidence                          111   0135678999999999999999999999999999976533

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=9.9e-44  Score=323.08  Aligned_cols=245  Identities=25%  Similarity=0.392  Sum_probs=184.4

Q ss_pred             eeeeeecCceEEEEEEEc--CCCcEEEEEEeecCccccHHHHHHHHHHhcCCCCCcceeeEEEEc--CCEEEEEEecCCC
Q 019195            7 MKDIGSGNFGVARLMRNK--NTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKEVVLT--PTHLAIVMEYAAG   82 (344)
Q Consensus         7 ~~~lg~G~~g~V~~~~~~--~~~~~vaiK~~~~~~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~--~~~~~lv~e~~~~   82 (344)
                      .++||+|+||+||+|.+.  .+++.||+|.+.... ....+.+|+.+++.++||||+++++++..  +..+|++|||+. 
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~-   83 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG-ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE-   83 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC-CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC-
Confidence            468999999999999965  467899999986543 34567899999999999999999999864  467899999995 


Q ss_pred             CChHHHHHhC---------CCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecC--CCCCCEEEeecCCCcccC
Q 019195           83 GELFERICNA---------GRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDG--SPAPRLKICDFGYSKSSL  144 (344)
Q Consensus        83 g~L~~~i~~~---------~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~--~~~~~vkL~DFg~a~~~~  144 (344)
                      ++|..++...         ..+++..++.++.|++.|       ||+||||||+|||+..  +..+++||+|||+++...
T Consensus        84 ~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~  163 (317)
T cd07868          84 HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFN  163 (317)
T ss_pred             CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCceeccC
Confidence            5888877532         248888888888887655       9999999999999953  233469999999997543


Q ss_pred             CCC----CCCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCh---------HHHHHHHHHHhh
Q 019195          145 LHS----RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDP---------KNFRKTISRIMA  211 (344)
Q Consensus       145 ~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~---------~~~~~~~~~~~~  211 (344)
                      ...    ......||+.|+|||++.+....+.++||||+||++|+|++|++||......         ..+..++.....
T Consensus       164 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (317)
T cd07868         164 SPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGF  243 (317)
T ss_pred             CCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHHhcCC
Confidence            221    2234578999999999987665566799999999999999999999754321         111111111000


Q ss_pred             ------------------------ccccC--------CCCCCCCHhHHHHHHHhcccCCCCCCChHHHhcCccc
Q 019195          212 ------------------------VQYKI--------PDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF  253 (344)
Q Consensus       212 ------------------------~~~~~--------~~~~~~s~~~~~li~~~L~~dp~~R~s~~ell~hp~~  253 (344)
                                              .....        ......++.+.+||.+||+.||.+|||+.|+|+||||
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~f  317 (317)
T cd07868         244 PADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF  317 (317)
T ss_pred             CChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence                                    00000        0001235678999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=1.8e-43  Score=312.92  Aligned_cols=247  Identities=29%  Similarity=0.448  Sum_probs=203.5

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCcc--ccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEEec
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK--IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEY   79 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~   79 (344)
                      ++|++.+.||.|+||.||++....++..+|+|++.....  ....+.+|+..++.++|+||+++++.+.....+|++||+
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   80 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY   80 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence            589999999999999999999999999999999875432  346788999999999999999999999999999999999


Q ss_pred             CCCCChHHHHHhC---CCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCCCC
Q 019195           80 AAGGELFERICNA---GRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP  149 (344)
Q Consensus        80 ~~~g~L~~~i~~~---~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~~~  149 (344)
                      +++++|.+++...   ..+++..++.++.|++.+       |++||||||+||+++.++.  ++|+|||++.........
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~--~~l~df~~~~~~~~~~~~  158 (267)
T cd06610          81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGS--VKIADFGVSASLADGGDR  158 (267)
T ss_pred             cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCC--EEEcccchHHHhccCccc
Confidence            9999999999764   458888888887776654       9999999999999987654  999999998654433222


Q ss_pred             -----CCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCCC---CCC
Q 019195          150 -----KSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPD---YVH  221 (344)
Q Consensus       150 -----~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~---~~~  221 (344)
                           ....|+..|+|||.+......+.++|+|||||++|+|++|+.||...+....+.+....   .....+.   +..
T Consensus       159 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~  235 (267)
T cd06610         159 TRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQN---DPPSLETGADYKK  235 (267)
T ss_pred             cccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcC---CCCCcCCcccccc
Confidence                 34468999999999877644456699999999999999999999876554444433322   1111121   235


Q ss_pred             CCHhHHHHHHHhcccCCCCCCChHHHhcCccc
Q 019195          222 ISQDCRNLLSRIFVANPSRRITIKEIKSHPWF  253 (344)
Q Consensus       222 ~s~~~~~li~~~L~~dp~~R~s~~ell~hp~~  253 (344)
                      +++.+.+++.+||+.||.+|||+.+++.||||
T Consensus       236 ~~~~~~~li~~~l~~~p~~Rp~~~~ll~~p~~  267 (267)
T cd06610         236 YSKSFRKMISLCLQKDPSKRPTAEELLKHKFF  267 (267)
T ss_pred             ccHHHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence            78899999999999999999999999999997

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=3.1e-43  Score=318.63  Aligned_cols=249  Identities=28%  Similarity=0.499  Sum_probs=200.9

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCcc--ccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEEec
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK--IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEY   79 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~   79 (344)
                      ++|++.+.||+|+||.||++.+..++..+|+|.+.....  ....+.+|++++++++||||+++++++..++.++++|||
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey   80 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH   80 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence            579999999999999999999999999999999875422  234688999999999999999999999999999999999


Q ss_pred             CCCCChHHHHHhCCCCCHHHHHHHHHHHHH--------CCeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCCCCCC
Q 019195           80 AAGGELFERICNAGRFSEDEARYFFQQLIS--------GQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKS  151 (344)
Q Consensus        80 ~~~g~L~~~i~~~~~~~~~~~~~~~~ql~~--------~~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~~~~~  151 (344)
                      +++++|.+++.+.+.+++..++.++.|++.        .+++||||||.|||++.++.  +||+|||++..... .....
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~--~~l~dfg~~~~~~~-~~~~~  157 (308)
T cd06615          81 MDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGE--IKLCDFGVSGQLID-SMANS  157 (308)
T ss_pred             cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCc--EEEccCCCcccccc-ccccc
Confidence            999999999988888999988888877764        38999999999999987654  99999999865422 22345


Q ss_pred             CccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHH-----------------------
Q 019195          152 TVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISR-----------------------  208 (344)
Q Consensus       152 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~-----------------------  208 (344)
                      .+|++.|+|||.+.+..+. .++|+|||||++|+|++|+.||...... .....+..                       
T Consensus       158 ~~~~~~~~aPE~~~~~~~~-~~~DiwslG~~l~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (308)
T cd06615         158 FVGTRSYMSPERLQGTHYT-VQSDIWSLGLSLVEMAIGRYPIPPPDAK-ELEAMFGRPVSEGEAKESHRPVSGHPPDSPR  235 (308)
T ss_pred             CCCCcCccChhHhcCCCCC-ccchHHHHHHHHHHHHhCCCCCCCcchh-hHHHhhcCccccccccCCcccccCCCCCccc
Confidence            6789999999998776654 5599999999999999999999654321 11111110                       


Q ss_pred             ----------Hhh-ccccCCCCCCCCHhHHHHHHHhcccCCCCCCChHHHhcCcccccC
Q 019195          209 ----------IMA-VQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKN  256 (344)
Q Consensus       209 ----------~~~-~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~~  256 (344)
                                +.. .....|. ..++.++.+|+.+||..+|.+|||+.++++||||...
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~  293 (308)
T cd06615         236 PMAIFELLDYIVNEPPPKLPS-GAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRA  293 (308)
T ss_pred             hhhHHHHHHHHhcCCCccCcC-cccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhhc
Confidence                      000 0001111 1267889999999999999999999999999999654

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=1.1e-43  Score=317.60  Aligned_cols=248  Identities=29%  Similarity=0.503  Sum_probs=195.9

Q ss_pred             CceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCc---cccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEEec
Q 019195            3 KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH---KIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEY   79 (344)
Q Consensus         3 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~   79 (344)
                      +|++.+.||+|+||.||+|.+..+|..||+|.+....   .....+.+|+.++++++||||+++++++.+...+++++||
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY   80 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence            6999999999999999999999999999999986532   2235678899999999999999999999999999999999


Q ss_pred             CCCCChHHHHHh-CCCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCCC-CC
Q 019195           80 AAGGELFERICN-AGRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR-PK  150 (344)
Q Consensus        80 ~~~g~L~~~i~~-~~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~~-~~  150 (344)
                      +. ++|..++.+ .+.+++..++.++.|++.+       ||+||||||+||+++.++  ++||+|||+++....... ..
T Consensus        81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~--~~~l~dfg~~~~~~~~~~~~~  157 (284)
T cd07839          81 CD-QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNG--ELKLADFGLARAFGIPVRCYS  157 (284)
T ss_pred             CC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCC--cEEECccchhhccCCCCCCcC
Confidence            96 578887764 5678999888888777665       999999999999998765  499999999875433222 23


Q ss_pred             CCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCh-HHHHHHHHHHhhc------------cc-cC
Q 019195          151 STVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDP-KNFRKTISRIMAV------------QY-KI  216 (344)
Q Consensus       151 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-~~~~~~~~~~~~~------------~~-~~  216 (344)
                      ...+++.|+|||.+.+....+.++|||||||++|+|++|..||...... ..+..+.......            .. ..
T Consensus       158 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (284)
T cd07839         158 AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKPY  237 (284)
T ss_pred             CCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhccccccc
Confidence            3568899999999877655556699999999999999998886544332 2222222111000            00 00


Q ss_pred             C----------CCCCCCHhHHHHHHHhcccCCCCCCChHHHhcCccc
Q 019195          217 P----------DYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF  253 (344)
Q Consensus       217 ~----------~~~~~s~~~~~li~~~L~~dp~~R~s~~ell~hp~~  253 (344)
                      +          ....+++++.+||.+||+.||.+|||+.+++.||||
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f  284 (284)
T cd07839         238 PMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF  284 (284)
T ss_pred             CCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence            0          112468899999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-44  Score=344.08  Aligned_cols=240  Identities=28%  Similarity=0.465  Sum_probs=200.9

Q ss_pred             CceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCc-cccHHHHHHHHHHhcCC-CCCcceeeEEEE-c---C---CEE
Q 019195            3 KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH-KIDANVAREIINHKQLR-HPNIIRFKEVVL-T---P---THL   73 (344)
Q Consensus         3 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~ei~~l~~l~-h~niv~~~~~~~-~---~---~~~   73 (344)
                      +++|.+.|.+|||+.||+|++...+..||+|++.... .....+.+||.+|++|+ |+|||.+++... .   .   -.+
T Consensus        38 ~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~Ev  117 (738)
T KOG1989|consen   38 RVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWEV  117 (738)
T ss_pred             EEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeEE
Confidence            5789999999999999999999988999999886643 33467889999999996 999999999432 1   1   257


Q ss_pred             EEEEecCCCCChHHHHHh--CCCCCHHHHHHHHHHHHHC---------CeeecCCCCCCeEecCCCCCCEEEeecCCCcc
Q 019195           74 AIVMEYAAGGELFERICN--AGRFSEDEARYFFQQLISG---------QICHRDLKLENTLLDGSPAPRLKICDFGYSKS  142 (344)
Q Consensus        74 ~lv~e~~~~g~L~~~i~~--~~~~~~~~~~~~~~ql~~~---------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~  142 (344)
                      .|+||||.||+|.+++.+  ...|++.+++.|+++++.|         .|||||||-+||||+.++.  +||||||.|..
T Consensus       118 llLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~--~KLCDFGSatt  195 (738)
T KOG1989|consen  118 LLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGN--YKLCDFGSATT  195 (738)
T ss_pred             EeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCC--EEeCccccccc
Confidence            899999999999999974  3469999999999998877         6999999999999987765  99999999875


Q ss_pred             cCCCCCC----------CCCccCCcccCCccc---cCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHH
Q 019195          143 SLLHSRP----------KSTVGTPAYIAPEVL---SRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRI  209 (344)
Q Consensus       143 ~~~~~~~----------~~~~gt~~y~aPE~~---~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~  209 (344)
                      .......          -...-|+.|+|||++   .+.+. +.++|||||||+||-|+....||......        +|
T Consensus       196 ~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI-~eKsDIWALGclLYkLCy~t~PFe~sg~l--------aI  266 (738)
T KOG1989|consen  196 KILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPI-GEKSDIWALGCLLYKLCYFTTPFEESGKL--------AI  266 (738)
T ss_pred             ccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCC-cchhHHHHHHHHHHHHHHhCCCcCcCcce--------eE
Confidence            3333211          122479999999997   33444 55699999999999999999999886442        46


Q ss_pred             hhccccCCCCCCCCHhHHHHHHHhcccCCCCCCChHHHhcCccc
Q 019195          210 MAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF  253 (344)
Q Consensus       210 ~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~ell~hp~~  253 (344)
                      +...|.+|.+..++..+++||+.||+.||.+||++.|++.+-+.
T Consensus       267 lng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~  310 (738)
T KOG1989|consen  267 LNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFE  310 (738)
T ss_pred             EeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHH
Confidence            77899999999999999999999999999999999999887553

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.2e-45  Score=323.41  Aligned_cols=251  Identities=28%  Similarity=0.468  Sum_probs=219.0

Q ss_pred             CCCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCc----cccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEE
Q 019195            1 MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH----KIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIV   76 (344)
Q Consensus         1 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv   76 (344)
                      ++.|..-++||+|+||.||.++...||+.||+|++.+..    .-....++|-++|..++.+.||.+-.+|++.+.+|+|
T Consensus       184 ~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClV  263 (591)
T KOG0986|consen  184 KNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLV  263 (591)
T ss_pred             ccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEE
Confidence            467889999999999999999999999999999887532    2235678899999999999999999999999999999


Q ss_pred             EecCCCCChHHHHHhCC--CCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCC
Q 019195           77 MEYAAGGELFERICNAG--RFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS  147 (344)
Q Consensus        77 ~e~~~~g~L~~~i~~~~--~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~  147 (344)
                      |..|+||+|.-+|-+.+  .|++..++.++.+|+.+       +||.||+||+|||+|+.+.  ++|+|+|+|.......
T Consensus       264 LtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~Gh--vRISDLGLAvei~~g~  341 (591)
T KOG0986|consen  264 LTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGH--VRISDLGLAVEIPEGK  341 (591)
T ss_pred             EEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCC--eEeeccceEEecCCCC
Confidence            99999999988887665  79999999988777765       9999999999999987765  9999999999877777


Q ss_pred             CCCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCHhHH
Q 019195          148 RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCR  227 (344)
Q Consensus       148 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~  227 (344)
                      .....+||.+|||||++....|+.. .|+|||||++|+|+.|+.||..........++-+++.......++  .+|++++
T Consensus       342 ~~~~rvGT~GYMAPEvl~ne~Y~~s-~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~~ey~~--kFS~eak  418 (591)
T KOG0986|consen  342 PIRGRVGTVGYMAPEVLQNEVYDFS-PDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDPEEYSD--KFSEEAK  418 (591)
T ss_pred             ccccccCcccccCHHHHcCCcccCC-ccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcchhhccc--ccCHHHH
Confidence            7777899999999999998887655 899999999999999999998765544444555566666666674  7899999


Q ss_pred             HHHHHhcccCCCCCC-----ChHHHhcCcccccC
Q 019195          228 NLLSRIFVANPSRRI-----TIKEIKSHPWFLKN  256 (344)
Q Consensus       228 ~li~~~L~~dp~~R~-----s~~ell~hp~~~~~  256 (344)
                      +|.+.+|++||.+|.     ++.++.+||||+..
T Consensus       419 slc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~l  452 (591)
T KOG0986|consen  419 SLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDL  452 (591)
T ss_pred             HHHHHHHccCHHHhccCCCcCcchhhhCcccccC
Confidence            999999999999999     67899999999874

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.5e-43  Score=317.12  Aligned_cols=251  Identities=27%  Similarity=0.462  Sum_probs=201.6

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCcc--ccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEEec
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK--IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEY   79 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~   79 (344)
                      ++|++++.||+|+||.||++.+..++..||+|.+.....  ....+.+|+.++++++||||+++++++...+.+|+||||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (286)
T cd06622           1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY   80 (286)
T ss_pred             ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence            589999999999999999999999999999998865322  235688999999999999999999999999999999999


Q ss_pred             CCCCChHHHHHhC---CCCCHHHHHHHHHHHHHC--------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCCC
Q 019195           80 AAGGELFERICNA---GRFSEDEARYFFQQLISG--------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR  148 (344)
Q Consensus        80 ~~~g~L~~~i~~~---~~~~~~~~~~~~~ql~~~--------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~~  148 (344)
                      +++++|..++...   ..+++..++.++.|++.+        +|+||||||+||+++.++  .+||+|||++..... ..
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~--~~~l~dfg~~~~~~~-~~  157 (286)
T cd06622          81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNG--QVKLCDFGVSGNLVA-SL  157 (286)
T ss_pred             cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCC--CEEEeecCCcccccC-Cc
Confidence            9999998888763   368888888887776543        899999999999998754  599999999865422 22


Q ss_pred             CCCCccCCcccCCccccCCCC-----CCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhc-cccCCCCCCC
Q 019195          149 PKSTVGTPAYIAPEVLSRREY-----DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAV-QYKIPDYVHI  222 (344)
Q Consensus       149 ~~~~~gt~~y~aPE~~~~~~~-----~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~  222 (344)
                      .....+++.|+|||.+.+...     .+.++|||||||++|+|++|+.||........+. .+..+... ....+  ..+
T Consensus       158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~-~~~~~~~~~~~~~~--~~~  234 (286)
T cd06622         158 AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFA-QLSAIVDGDPPTLP--SGY  234 (286)
T ss_pred             cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHH-HHHHHhhcCCCCCC--ccc
Confidence            334568899999999855432     2456999999999999999999997654433222 22222221 12222  357


Q ss_pred             CHhHHHHHHHhcccCCCCCCChHHHhcCcccccCCC
Q 019195          223 SQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLP  258 (344)
Q Consensus       223 s~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~~~~  258 (344)
                      ++++.+||.+||+.+|.+||++.+++.||||.....
T Consensus       235 ~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~~~  270 (286)
T cd06622         235 SDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYKN  270 (286)
T ss_pred             CHHHHHHHHHHcccCcccCCCHHHHhcChhhhhccC
Confidence            899999999999999999999999999999976543

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=1.6e-43  Score=313.67  Aligned_cols=244  Identities=31%  Similarity=0.474  Sum_probs=198.5

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCccc-cHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEEecC
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKI-DANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYA   80 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~   80 (344)
                      ++|++.+.||+|+||.||+|.+..+++.||+|.+...... ...+.+|+.+++.++||||+++++++...+.+|++|||+
T Consensus         9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~   88 (267)
T cd06645           9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC   88 (267)
T ss_pred             HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence            5799999999999999999999999999999998764322 245778999999999999999999999999999999999


Q ss_pred             CCCChHHHHHhCCCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCC-CCCCC
Q 019195           81 AGGELFERICNAGRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS-RPKST  152 (344)
Q Consensus        81 ~~g~L~~~i~~~~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~-~~~~~  152 (344)
                      ++++|.+++...+.+++.+++.++.|++.+       |++|+||||+||+++.++.  +||+|||++....... .....
T Consensus        89 ~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~--~~l~dfg~~~~~~~~~~~~~~~  166 (267)
T cd06645          89 GGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGH--VKLADFGVSAQITATIAKRKSF  166 (267)
T ss_pred             CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCC--EEECcceeeeEccCcccccccc
Confidence            999999999888899999988887777654       9999999999999976654  9999999986543222 22345


Q ss_pred             ccCCcccCCcccc---CCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccC---CCCCCCCHhH
Q 019195          153 VGTPAYIAPEVLS---RREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKI---PDYVHISQDC  226 (344)
Q Consensus       153 ~gt~~y~aPE~~~---~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~s~~~  226 (344)
                      .|++.|+|||++.   ...+ +.++|+|||||++|+|++|..||............    .......   .....++..+
T Consensus       167 ~~~~~y~aPE~~~~~~~~~~-~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~  241 (267)
T cd06645         167 IGTPYWMAPEVAAVERKGGY-NQLCDIWAVGITAIELAELQPPMFDLHPMRALFLM----TKSNFQPPKLKDKMKWSNSF  241 (267)
T ss_pred             cCcccccChhhhccccCCCC-CchhhhHHHHHHHHHHhcCCCCcccccchhhHHhh----hccCCCCCcccccCCCCHHH
Confidence            7999999999974   2333 45699999999999999999999765432222111    1111111   1223467899


Q ss_pred             HHHHHHhcccCCCCCCChHHHhcCcc
Q 019195          227 RNLLSRIFVANPSRRITIKEIKSHPW  252 (344)
Q Consensus       227 ~~li~~~L~~dp~~R~s~~ell~hp~  252 (344)
                      .++|.+||+.+|.+|||+.++++|||
T Consensus       242 ~~li~~~l~~~P~~R~~~~~ll~~~~  267 (267)
T cd06645         242 HHFVKMALTKNPKKRPTAEKLLQHPF  267 (267)
T ss_pred             HHHHHHHccCCchhCcCHHHHhcCCC
Confidence            99999999999999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=4.8e-43  Score=312.90  Aligned_cols=247  Identities=23%  Similarity=0.387  Sum_probs=195.5

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCcc--ccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEEec
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK--IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEY   79 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~   79 (344)
                      ++|+++++||+|+||.||++.+..++..||+|++.....  ....+.+|+.++++++||||+++++++...+..++||||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   80 (279)
T cd06619           1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF   80 (279)
T ss_pred             CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence            579999999999999999999999999999999875422  234688999999999999999999999999999999999


Q ss_pred             CCCCChHHHHHhCCCCCHHHHHHHHHHHH-------HCCeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCCCCCCC
Q 019195           80 AAGGELFERICNAGRFSEDEARYFFQQLI-------SGQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST  152 (344)
Q Consensus        80 ~~~g~L~~~i~~~~~~~~~~~~~~~~ql~-------~~~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~~~~~~  152 (344)
                      +++++|..+    ..+++..+..++.|++       +.||+|+||||+|||++.++.  ++|+|||++...... .....
T Consensus        81 ~~~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~--~~l~dfg~~~~~~~~-~~~~~  153 (279)
T cd06619          81 MDGGSLDVY----RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQ--VKLCDFGVSTQLVNS-IAKTY  153 (279)
T ss_pred             CCCCChHHh----hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCC--EEEeeCCcceecccc-cccCC
Confidence            999998654    3466776666666655       459999999999999987664  999999998754322 23446


Q ss_pred             ccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHH---HHHHHHHHhhccccCCCCCCCCHhHHHH
Q 019195          153 VGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKN---FRKTISRIMAVQYKIPDYVHISQDCRNL  229 (344)
Q Consensus       153 ~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~s~~~~~l  229 (344)
                      +||..|+|||.+.+..+. .++|+|||||++|+|++|..||........   .......+............+++++.+|
T Consensus       154 ~~~~~y~aPE~~~~~~~~-~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  232 (279)
T cd06619         154 VGTNAYMAPERISGEQYG-IHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEKFVHF  232 (279)
T ss_pred             CCChhhcCceeecCCCCC-CcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCCCCCcCCHHHHHH
Confidence            799999999999877664 559999999999999999999975332111   1111222221111111123478899999


Q ss_pred             HHHhcccCCCCCCChHHHhcCcccccC
Q 019195          230 LSRIFVANPSRRITIKEIKSHPWFLKN  256 (344)
Q Consensus       230 i~~~L~~dp~~R~s~~ell~hp~~~~~  256 (344)
                      |.+||+.+|.+||++.+++.||||...
T Consensus       233 i~~~l~~~P~~Rp~~~eil~~~~~~~~  259 (279)
T cd06619         233 ITQCMRKQPKERPAPENLMDHPFIVQY  259 (279)
T ss_pred             HHHHhhCChhhCCCHHHHhcCcccccc
Confidence            999999999999999999999999765

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.5e-45  Score=333.44  Aligned_cols=247  Identities=29%  Similarity=0.428  Sum_probs=202.7

Q ss_pred             CceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCcccc----HHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEEe
Q 019195            3 KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKID----ANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVME   78 (344)
Q Consensus         3 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~----~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e   78 (344)
                      .|.-++.||.|+||.||-|.+..+..+||||++.-+.+..    ..++.|+.+|++++|||+|.+.++|..+...|+|||
T Consensus        27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME  106 (948)
T KOG0577|consen   27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME  106 (948)
T ss_pred             HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence            3667889999999999999999999999999997654332    469999999999999999999999999999999999


Q ss_pred             cCCCCChHHHHH-hCCCCCHHHHHHHH-------HHHHHCCeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCCCCC
Q 019195           79 YAAGGELFERIC-NAGRFSEDEARYFF-------QQLISGQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPK  150 (344)
Q Consensus        79 ~~~~g~L~~~i~-~~~~~~~~~~~~~~-------~ql~~~~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~~~~  150 (344)
                      ||- ||-.+++. ...++-+.+|..+.       .+||+.+.||||||..|||+...+.  |||+|||.|...   ....
T Consensus       107 YCl-GSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~--VKLaDFGSAsi~---~PAn  180 (948)
T KOG0577|consen  107 YCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGL--VKLADFGSASIM---APAN  180 (948)
T ss_pred             HHh-ccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCe--eeeccccchhhc---Cchh
Confidence            995 57667664 24567788887775       4566669999999999999987765  999999988654   3456


Q ss_pred             CCccCCcccCCcccc---CCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCHhHH
Q 019195          151 STVGTPAYIAPEVLS---RREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCR  227 (344)
Q Consensus       151 ~~~gt~~y~aPE~~~---~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~  227 (344)
                      +++|||+|||||++.   .+.|+++ +|||||||++.||+-.++|+...+.-..+..+.++   ....++ ...+|..|+
T Consensus       181 sFvGTPywMAPEVILAMDEGqYdgk-vDvWSLGITCIELAERkPPlFnMNAMSALYHIAQN---esPtLq-s~eWS~~F~  255 (948)
T KOG0577|consen  181 SFVGTPYWMAPEVILAMDEGQYDGK-VDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN---ESPTLQ-SNEWSDYFR  255 (948)
T ss_pred             cccCCccccchhHheeccccccCCc-cceeeccchhhhhhhcCCCccCchHHHHHHHHHhc---CCCCCC-CchhHHHHH
Confidence            789999999999984   4667777 99999999999999999999886654443333221   111222 335799999


Q ss_pred             HHHHHhcccCCCCCCChHHHhcCcccccCCChh
Q 019195          228 NLLSRIFVANPSRRITIKEIKSHPWFLKNLPRE  260 (344)
Q Consensus       228 ~li~~~L~~dp~~R~s~~ell~hp~~~~~~~~~  260 (344)
                      +|+..||++-|..|||.+++|.|+|.....+..
T Consensus       256 ~Fvd~CLqKipqeRptse~ll~H~fv~R~Rp~t  288 (948)
T KOG0577|consen  256 NFVDSCLQKIPQERPTSEELLKHRFVLRERPPT  288 (948)
T ss_pred             HHHHHHHhhCcccCCcHHHHhhcchhccCCCch
Confidence            999999999999999999999999998776643

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=4.4e-43  Score=331.39  Aligned_cols=245  Identities=21%  Similarity=0.288  Sum_probs=191.8

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEEecCC
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYAA   81 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~   81 (344)
                      .+|.+.+.||+|+||.||++.+..+++.||+|....     ..+.+|++++++++|+|||++++++...+..++||+++.
T Consensus       169 ~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~-----~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~~  243 (461)
T PHA03211        169 LGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY-----ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKYR  243 (461)
T ss_pred             CCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc-----cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEccC
Confidence            369999999999999999999999999999996322     346789999999999999999999999999999999994


Q ss_pred             CCChHHHHHhC-CCCCHHHHHHHHHHHHH-------CCeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCCC---CC
Q 019195           82 GGELFERICNA-GRFSEDEARYFFQQLIS-------GQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR---PK  150 (344)
Q Consensus        82 ~g~L~~~i~~~-~~~~~~~~~~~~~ql~~-------~~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~~---~~  150 (344)
                       ++|..++... ..++..+++.++.|++.       .||+||||||+|||++.++.  +||+|||+++.......   ..
T Consensus       244 -~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~--vkL~DFGla~~~~~~~~~~~~~  320 (461)
T PHA03211        244 -SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPED--ICLGDFGAACFARGSWSTPFHY  320 (461)
T ss_pred             -CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCC--EEEcccCCceeccccccccccc
Confidence             6888888654 46899988888777665       49999999999999976654  99999999875432211   22


Q ss_pred             CCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC-------hHHHHHHHHHHhhcc----------
Q 019195          151 STVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQED-------PKNFRKTISRIMAVQ----------  213 (344)
Q Consensus       151 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-------~~~~~~~~~~~~~~~----------  213 (344)
                      ..+||+.|+|||++.+..++ .++|||||||++|||++|..|+.....       ...+.+++.......          
T Consensus       321 ~~~GT~~Y~APE~~~~~~~~-~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~~~  399 (461)
T PHA03211        321 GIAGTVDTNAPEVLAGDPYT-PSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAGSR  399 (461)
T ss_pred             ccCCCcCCcCHHHHcCCCCC-chHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcchH
Confidence            35699999999999887765 459999999999999998776543221       122222322211000          


Q ss_pred             ----------------ccC---CCCCCCCHhHHHHHHHhcccCCCCCCChHHHhcCccccc
Q 019195          214 ----------------YKI---PDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLK  255 (344)
Q Consensus       214 ----------------~~~---~~~~~~s~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~  255 (344)
                                      ...   ..+..++.++.+||.+||+.||.+|||+.|+|+||||+.
T Consensus       400 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~  460 (461)
T PHA03211        400 LVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQS  460 (461)
T ss_pred             HHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCcccCC
Confidence                            000   111235678999999999999999999999999999964

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=2.1e-43  Score=313.04  Aligned_cols=245  Identities=29%  Similarity=0.424  Sum_probs=198.0

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCcc-ccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEEecC
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK-IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYA   80 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~   80 (344)
                      ++|++.+.||+|+||.||++.+..+++.||+|++..... ....+.+|+.++++++||||+++++++..+..+|+||||+
T Consensus         9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~   88 (267)
T cd06646           9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYC   88 (267)
T ss_pred             hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCC
Confidence            579999999999999999999999999999999875432 2346778999999999999999999999999999999999


Q ss_pred             CCCChHHHHHhCCCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCC-CCCCC
Q 019195           81 AGGELFERICNAGRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS-RPKST  152 (344)
Q Consensus        81 ~~g~L~~~i~~~~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~-~~~~~  152 (344)
                      ++++|.+++...+.+++..+..++.|++.+       ||+||||||+||+++.++.  +||+|||++....... .....
T Consensus        89 ~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~--~~l~dfg~~~~~~~~~~~~~~~  166 (267)
T cd06646          89 GGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGD--VKLADFGVAAKITATIAKRKSF  166 (267)
T ss_pred             CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCC--EEECcCccceeecccccccCcc
Confidence            999999999888889998888887776654       9999999999999976654  9999999987543222 22345


Q ss_pred             ccCCcccCCccccC--CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhcccc---CCCCCCCCHhHH
Q 019195          153 VGTPAYIAPEVLSR--REYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYK---IPDYVHISQDCR  227 (344)
Q Consensus       153 ~gt~~y~aPE~~~~--~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~s~~~~  227 (344)
                      .|++.|+|||.+..  ....+.++|+||+||++|+|++|+.||..........    .+....+.   .+....++..+.
T Consensus       167 ~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~  242 (267)
T cd06646         167 IGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALF----LMSKSNFQPPKLKDKTKWSSTFH  242 (267)
T ss_pred             ccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhhe----eeecCCCCCCCCccccccCHHHH
Confidence            68999999999853  2223456999999999999999999996543322111    11111111   122235788999


Q ss_pred             HHHHHhcccCCCCCCChHHHhcCcc
Q 019195          228 NLLSRIFVANPSRRITIKEIKSHPW  252 (344)
Q Consensus       228 ~li~~~L~~dp~~R~s~~ell~hp~  252 (344)
                      +||++||+.+|.+|||++++|+|+|
T Consensus       243 ~li~~~l~~~P~~Rp~~~~il~~l~  267 (267)
T cd06646         243 NFVKISLTKNPKKRPTAERLLTHLF  267 (267)
T ss_pred             HHHHHHhhCChhhCcCHHHHhcCCC
Confidence            9999999999999999999999987

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=2.6e-43  Score=323.20  Aligned_cols=241  Identities=22%  Similarity=0.377  Sum_probs=185.7

Q ss_pred             CCceeeeeeeecCceEEEEEEE-----cCCCcEEEEEEeecCcc--ccHHHHHHHHHHhcC-CCCCcceeeEEEEcC-CE
Q 019195            2 EKYELMKDIGSGNFGVARLMRN-----KNTKELVAMKYIERGHK--IDANVAREIINHKQL-RHPNIIRFKEVVLTP-TH   72 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~vaiK~~~~~~~--~~~~~~~ei~~l~~l-~h~niv~~~~~~~~~-~~   72 (344)
                      ++|++.+.||+|+||.||+|.+     ..+++.||+|++.....  ....+.+|+.+++.+ +||||+++++++... ..
T Consensus         7 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~   86 (338)
T cd05102           7 DRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNGP   86 (338)
T ss_pred             hHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCCc
Confidence            5899999999999999999975     24567899999875432  235688999999999 899999999988764 46


Q ss_pred             EEEEEecCCCCChHHHHHhCC-----------------------------------------------------------
Q 019195           73 LAIVMEYAAGGELFERICNAG-----------------------------------------------------------   93 (344)
Q Consensus        73 ~~lv~e~~~~g~L~~~i~~~~-----------------------------------------------------------   93 (344)
                      ++++|||+++|+|.+++....                                                           
T Consensus        87 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  166 (338)
T cd05102          87 LMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDL  166 (338)
T ss_pred             eEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcccc
Confidence            899999999999999986531                                                           


Q ss_pred             ---CCCHHHHHHHHHHH-------HHCCeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCC---CCCCCccCCcccC
Q 019195           94 ---RFSEDEARYFFQQL-------ISGQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS---RPKSTVGTPAYIA  160 (344)
Q Consensus        94 ---~~~~~~~~~~~~ql-------~~~~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~---~~~~~~gt~~y~a  160 (344)
                         .++..++..++.|+       |+.||+||||||+|||++.++  ++||+|||+++......   ......+++.|+|
T Consensus       167 ~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~--~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~a  244 (338)
T cd05102         167 WKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENN--VVKICDFGLARDIYKDPDYVRKGSARLPLKWMA  244 (338)
T ss_pred             ccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCC--cEEEeecccccccccCcchhcccCCCCCccccC
Confidence               25555555555554       555999999999999998765  49999999987543221   1223346788999


Q ss_pred             CccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCHhHHHHHHHhcccCCC
Q 019195          161 PEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPS  239 (344)
Q Consensus       161 PE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~  239 (344)
                      ||++.+..++ .++|||||||++|+|++ |..||........+...+.   .. ........+++.+.+|+.+||+.||.
T Consensus       245 PE~~~~~~~~-~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~---~~-~~~~~~~~~~~~l~~li~~cl~~dp~  319 (338)
T cd05102         245 PESIFDKVYT-TQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLK---DG-TRMRAPENATPEIYRIMLACWQGDPK  319 (338)
T ss_pred             cHHhhcCCCC-cccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHh---cC-CCCCCCCCCCHHHHHHHHHHccCChh
Confidence            9999877765 45999999999999997 9999987654333322221   11 12222346789999999999999999


Q ss_pred             CCCChHHHhc
Q 019195          240 RRITIKEIKS  249 (344)
Q Consensus       240 ~R~s~~ell~  249 (344)
                      +|||+.++++
T Consensus       320 ~RPs~~el~~  329 (338)
T cd05102         320 ERPTFSALVE  329 (338)
T ss_pred             hCcCHHHHHH
Confidence            9999999976

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=5e-43  Score=311.27  Aligned_cols=246  Identities=26%  Similarity=0.406  Sum_probs=196.7

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcC-CCCCcceeeEEEEcC------CEEE
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQL-RHPNIIRFKEVVLTP------THLA   74 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~l~~l-~h~niv~~~~~~~~~------~~~~   74 (344)
                      ++|++.+.||+|+||.||++.+..+++.||+|++.........+.+|+.+++.+ +||||+++++++...      ..+|
T Consensus         6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~   85 (272)
T cd06637           6 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLW   85 (272)
T ss_pred             hhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEEE
Confidence            368999999999999999999999999999999987666567788999999998 699999999998753      4689


Q ss_pred             EEEecCCCCChHHHHHhC--CCCCHHHHHHHHHHHHH-------CCeeecCCCCCCeEecCCCCCCEEEeecCCCcccCC
Q 019195           75 IVMEYAAGGELFERICNA--GRFSEDEARYFFQQLIS-------GQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLL  145 (344)
Q Consensus        75 lv~e~~~~g~L~~~i~~~--~~~~~~~~~~~~~ql~~-------~~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~  145 (344)
                      ++|||+++++|.+++...  ..+++..++.++.|++.       .+|+||||||+||+++.++.  +||+|||++.....
T Consensus        86 iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~--~~l~Dfg~~~~~~~  163 (272)
T cd06637          86 LVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAE--VKLVDFGVSAQLDR  163 (272)
T ss_pred             EEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCC--EEEccCCCceeccc
Confidence            999999999999998763  45788877777766554       49999999999999987665  99999999875432


Q ss_pred             C-CCCCCCccCCcccCCccccCC----CCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCCCCC
Q 019195          146 H-SRPKSTVGTPAYIAPEVLSRR----EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYV  220 (344)
Q Consensus       146 ~-~~~~~~~gt~~y~aPE~~~~~----~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  220 (344)
                      . .......|++.|+|||++.+.    ...+.++||||+||++|+|++|..||...........    ............
T Consensus       164 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~----~~~~~~~~~~~~  239 (272)
T cd06637         164 TVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFL----IPRNPAPRLKSK  239 (272)
T ss_pred             ccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHH----HhcCCCCCCCCC
Confidence            2 223445799999999998632    1224459999999999999999999976543222211    111122222223


Q ss_pred             CCCHhHHHHHHHhcccCCCCCCChHHHhcCccc
Q 019195          221 HISQDCRNLLSRIFVANPSRRITIKEIKSHPWF  253 (344)
Q Consensus       221 ~~s~~~~~li~~~L~~dp~~R~s~~ell~hp~~  253 (344)
                      .++..+.+||.+||+.+|.+|||+.+++.||||
T Consensus       240 ~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~  272 (272)
T cd06637         240 KWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI  272 (272)
T ss_pred             CcCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence            578899999999999999999999999999997

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=2.9e-43  Score=321.48  Aligned_cols=250  Identities=22%  Similarity=0.363  Sum_probs=191.8

Q ss_pred             eeeeeeeec--CceEEEEEEEcCCCcEEEEEEeecCcc---ccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEEec
Q 019195            5 ELMKDIGSG--NFGVARLMRNKNTKELVAMKYIERGHK---IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEY   79 (344)
Q Consensus         5 ~~~~~lg~G--~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~   79 (344)
                      +++++||+|  +|++||++.++.+|+.||+|.+.....   ....+.+|+.+++.++||||+++++++..++.+|+||||
T Consensus         1 ~~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~   80 (327)
T cd08227           1 ELLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSF   80 (327)
T ss_pred             ChhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEec
Confidence            367899999  678999999999999999999876432   234577899999999999999999999999999999999


Q ss_pred             CCCCChHHHHHhC--CCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCCC--
Q 019195           80 AAGGELFERICNA--GRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR--  148 (344)
Q Consensus        80 ~~~g~L~~~i~~~--~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~~--  148 (344)
                      +++|+|.+++...  ..+++..++.++.|++.+       ||+||||||+|||++.++.  ++++||+.+........  
T Consensus        81 ~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~--~~l~~~~~~~~~~~~~~~~  158 (327)
T cd08227          81 MAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGK--VYLSGLRSNLSMINHGQRL  158 (327)
T ss_pred             cCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCc--EEEcccchhhccccccccc
Confidence            9999999998653  458888888887776654       9999999999999987664  99999986543221111  


Q ss_pred             ------CCCCccCCcccCCccccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhcc--------
Q 019195          149 ------PKSTVGTPAYIAPEVLSRR-EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQ--------  213 (344)
Q Consensus       149 ------~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~--------  213 (344)
                            .....++..|+|||++.+. ...+.++|||||||++|+|++|+.||....................        
T Consensus       159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (327)
T cd08227         159 RVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPA  238 (327)
T ss_pred             cccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchhh
Confidence                  1223577889999999763 2234569999999999999999999976544332222111100000        


Q ss_pred             --------------------------------ccCCCCCCCCHhHHHHHHHhcccCCCCCCChHHHhcCcccccC
Q 019195          214 --------------------------------YKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKN  256 (344)
Q Consensus       214 --------------------------------~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~~  256 (344)
                                                      ...+....+++.+.+||.+||+.||.+|||+.++++||||.+.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~~  313 (327)
T cd08227         239 EELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQI  313 (327)
T ss_pred             hhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhhc
Confidence                                            0001112356789999999999999999999999999999764

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=7.8e-43  Score=312.18  Aligned_cols=249  Identities=26%  Similarity=0.436  Sum_probs=201.5

Q ss_pred             CceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCc---cccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEEec
Q 019195            3 KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH---KIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEY   79 (344)
Q Consensus         3 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~   79 (344)
                      +|++.+.||.|+||.||+|.+..+++.||+|++....   .....+.+|+.++++++||||+++++++.....+++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~   80 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY   80 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence            6999999999999999999999999999999987643   2335788999999999999999999999999999999999


Q ss_pred             CCCCChHHHHHh-CCCCCHHHHHHHHHHHHH-------CCeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCCC--C
Q 019195           80 AAGGELFERICN-AGRFSEDEARYFFQQLIS-------GQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR--P  149 (344)
Q Consensus        80 ~~~g~L~~~i~~-~~~~~~~~~~~~~~ql~~-------~~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~~--~  149 (344)
                      + +++|.+++.. ...+++.+++.++.|++.       .|++|+||||+||+++.++.  ++|+|||++........  .
T Consensus        81 ~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~--~~l~dfg~~~~~~~~~~~~~  157 (286)
T cd07832          81 M-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGV--LKIADFGLARLFSEEEPRLY  157 (286)
T ss_pred             c-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCc--EEEeeeeecccccCCCCCcc
Confidence            9 9999999865 456888888887777654       49999999999999987654  99999999876543321  2


Q ss_pred             CCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccc---------------
Q 019195          150 KSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQY---------------  214 (344)
Q Consensus       150 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~---------------  214 (344)
                      ....|+..|+|||.+.+....+.++||||+||++|+|++|.+||........+...+........               
T Consensus       158 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (286)
T cd07832         158 SHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKI  237 (286)
T ss_pred             ccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhhcc
Confidence            34568999999999876665567799999999999999999888776654444443332111000               


Q ss_pred             cCC---------CCCCCCHhHHHHHHHhcccCCCCCCChHHHhcCcccc
Q 019195          215 KIP---------DYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFL  254 (344)
Q Consensus       215 ~~~---------~~~~~s~~~~~li~~~L~~dp~~R~s~~ell~hp~~~  254 (344)
                      ..+         .....+..+.+||.+||+.+|.+|||+.++|.||||.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~  286 (286)
T cd07832         238 TFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT  286 (286)
T ss_pred             cCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence            000         0124578899999999999999999999999999984

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.6e-43  Score=316.43  Aligned_cols=248  Identities=34%  Similarity=0.537  Sum_probs=204.6

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCcc----ccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEE
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK----IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVM   77 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~   77 (344)
                      ++|++.+.||+|+||.||+|.+..+++.||+|.+.....    ....+.+|+.+++.++||||+++++.+......|++|
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   80 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM   80 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence            589999999999999999999999999999999976432    2246788999999999999999999999999999999


Q ss_pred             ecCCCCChHHHHHhC--CCCCHHHHHHHHHHHHH-------CCeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCC-
Q 019195           78 EYAAGGELFERICNA--GRFSEDEARYFFQQLIS-------GQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS-  147 (344)
Q Consensus        78 e~~~~g~L~~~i~~~--~~~~~~~~~~~~~ql~~-------~~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~-  147 (344)
                      ||+.+++|.+++...  ..+++..++.++.|++.       .|++||||||+||+++.++  .++|+|||++....... 
T Consensus        81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~--~~~l~dfg~~~~~~~~~~  158 (316)
T cd05574          81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESG--HIMLSDFDLSKQSDVEPP  158 (316)
T ss_pred             EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCC--CEEEeecchhhccccccc
Confidence            999999999998754  46888888777666655       4999999999999998765  49999999876432211 


Q ss_pred             -----------------------------CCCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC
Q 019195          148 -----------------------------RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQED  198 (344)
Q Consensus       148 -----------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~  198 (344)
                                                   ......||..|+|||++.+..+ +.++||||||+++|+|++|..||...+.
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~Di~slG~ll~~l~~g~~pf~~~~~  237 (316)
T cd05574         159 PVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGH-GSAVDWWTLGILLYEMLYGTTPFKGSNR  237 (316)
T ss_pred             ccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCC-CchHHHHHHHHHHHHHhhCCCCCCCCch
Confidence                                         1123468999999999987766 4559999999999999999999987765


Q ss_pred             hHHHHHHHHHHhhccccCCCCCCCCHhHHHHHHHhcccCCCCCCC----hHHHhcCcccccC
Q 019195          199 PKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRIT----IKEIKSHPWFLKN  256 (344)
Q Consensus       199 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s----~~ell~hp~~~~~  256 (344)
                      ...+.++    .......+....++..+.++|.+||+.+|.+|||    +.++|.||||...
T Consensus       238 ~~~~~~~----~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~~~~  295 (316)
T cd05574         238 DETFSNI----LKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRGV  295 (316)
T ss_pred             HHHHHHH----hcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchhhcC
Confidence            4444333    2333444544457899999999999999999999    9999999999764

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-42  Score=308.87  Aligned_cols=249  Identities=28%  Similarity=0.446  Sum_probs=205.4

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCcc--ccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEEec
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK--IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEY   79 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~   79 (344)
                      ++|++.+.||.|++|.||++.+..++..||+|.+.....  ....+.+|+.+++.++||||+++++++.++..+|+|+||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY   80 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence            589999999999999999999999999999999876432  234678999999999999999999999999999999999


Q ss_pred             CCCCChHHHHHhCCCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCC-CCCCC
Q 019195           80 AAGGELFERICNAGRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH-SRPKS  151 (344)
Q Consensus        80 ~~~g~L~~~i~~~~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~-~~~~~  151 (344)
                      +++++|.+++... .+++..++.++.|++.+       +++||||+|+||+++.++.  ++|+|||+++..... .....
T Consensus        81 ~~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~--~~l~d~g~~~~~~~~~~~~~~  157 (274)
T cd06609          81 CGGGSCLDLLKPG-KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGD--VKLADFGVSGQLTSTMSKRNT  157 (274)
T ss_pred             eCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCC--EEEcccccceeeccccccccc
Confidence            9999999998765 78899888888877765       9999999999999987664  999999998765433 23344


Q ss_pred             CccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccc-cCCCCCCCCHhHHHHH
Q 019195          152 TVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQY-KIPDYVHISQDCRNLL  230 (344)
Q Consensus       152 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~s~~~~~li  230 (344)
                      ..|++.|+|||.+.+..+ +.++|||||||++|+|++|+.||........    ...+..... ..+. ..+++.+.+++
T Consensus       158 ~~~~~~y~~PE~~~~~~~-~~~sDv~slG~il~~l~tg~~p~~~~~~~~~----~~~~~~~~~~~~~~-~~~~~~~~~~l  231 (274)
T cd06609         158 FVGTPFWMAPEVIKQSGY-DEKADIWSLGITAIELAKGEPPLSDLHPMRV----LFLIPKNNPPSLEG-NKFSKPFKDFV  231 (274)
T ss_pred             ccCCccccChhhhccCCC-CchhhHHHHHHHHHHHHhCCCCcccCchHHH----HHHhhhcCCCCCcc-cccCHHHHHHH
Confidence            578999999999987775 4559999999999999999999976543222    222222211 1222 12788999999


Q ss_pred             HHhcccCCCCCCChHHHhcCcccccCCCh
Q 019195          231 SRIFVANPSRRITIKEIKSHPWFLKNLPR  259 (344)
Q Consensus       231 ~~~L~~dp~~R~s~~ell~hp~~~~~~~~  259 (344)
                      .+||..+|.+|||+.+++.||||.+....
T Consensus       232 ~~~l~~~p~~Rpt~~~il~~~~~~~~~~~  260 (274)
T cd06609         232 SLCLNKDPKERPSAKELLKHKFIKKAKKT  260 (274)
T ss_pred             HHHhhCChhhCcCHHHHhhChhhcCCCcc
Confidence            99999999999999999999999876544

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=1.1e-42  Score=315.16  Aligned_cols=253  Identities=29%  Similarity=0.465  Sum_probs=200.4

Q ss_pred             CCCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCcc---ccHHHHHHHHHHhcCCCCCcceeeEEEEcC--CEEEE
Q 019195            1 MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK---IDANVAREIINHKQLRHPNIIRFKEVVLTP--THLAI   75 (344)
Q Consensus         1 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~ei~~l~~l~h~niv~~~~~~~~~--~~~~l   75 (344)
                      +++|++.+.||+|+||.||++.+..++..||+|.+.....   ....+.+|+.++++++|+||+++++++...  +.+++
T Consensus         6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   85 (309)
T cd07845           6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL   85 (309)
T ss_pred             ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence            4789999999999999999999999999999999875332   223567899999999999999999999765  57899


Q ss_pred             EEecCCCCChHHHHHh-CCCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCC
Q 019195           76 VMEYAAGGELFERICN-AGRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS  147 (344)
Q Consensus        76 v~e~~~~g~L~~~i~~-~~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~  147 (344)
                      ||||+. ++|.+++.. ...+++.+++.++.|++.+       |++||||||+||+++.++  .+||+|||++.......
T Consensus        86 v~e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~--~~kL~dfg~~~~~~~~~  162 (309)
T cd07845          86 VMEYCE-QDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKG--CLKIADFGLARTYGLPA  162 (309)
T ss_pred             EEecCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCC--CEEECccceeeecCCcc
Confidence            999996 588888765 3568888888887777654       999999999999997665  49999999987654332


Q ss_pred             -CCCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhc--------------
Q 019195          148 -RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAV--------------  212 (344)
Q Consensus       148 -~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~--------------  212 (344)
                       ......+++.|+|||.+.+....+.++|||||||++|+|++|++||...+....+..+.......              
T Consensus       163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (309)
T cd07845         163 KPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLV  242 (309)
T ss_pred             CCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhccccc
Confidence             22334568889999998765555666999999999999999999998776655544444321110              


Q ss_pred             -cccCCC---------CCCCCHhHHHHHHHhcccCCCCCCChHHHhcCcccccC
Q 019195          213 -QYKIPD---------YVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKN  256 (344)
Q Consensus       213 -~~~~~~---------~~~~s~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~~  256 (344)
                       .+..+.         ....++.+.+||.+||+.||.+|||+.+++.||||.+.
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~  296 (309)
T cd07845         243 GKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEK  296 (309)
T ss_pred             ccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccC
Confidence             001110         12358889999999999999999999999999999754

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=6.1e-43  Score=312.99  Aligned_cols=252  Identities=24%  Similarity=0.429  Sum_probs=202.9

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCc--cccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEEec
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH--KIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEY   79 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~   79 (344)
                      ++|++++.||+|+||+||++.+..++..||+|++....  .....+.+|+++++.++||||+++++++...+.+++||||
T Consensus         5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (284)
T cd06620           5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF   84 (284)
T ss_pred             HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence            57999999999999999999999999999999887543  2346788999999999999999999999999999999999


Q ss_pred             CCCCChHHHHHhCCCCCHHHHHHHHHHHHH--------CCeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCCCCCC
Q 019195           80 AAGGELFERICNAGRFSEDEARYFFQQLIS--------GQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKS  151 (344)
Q Consensus        80 ~~~g~L~~~i~~~~~~~~~~~~~~~~ql~~--------~~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~~~~~  151 (344)
                      +++++|..++.+.+.++...++.++.+++.        .+++||||||+||+++.++  .++|+|||++..... .....
T Consensus        85 ~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~--~~~l~d~gl~~~~~~-~~~~~  161 (284)
T cd06620          85 MDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRG--QIKLCDFGVSGELIN-SIADT  161 (284)
T ss_pred             CCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCC--cEEEccCCcccchhh-hccCc
Confidence            999999999988888888888877776654        3899999999999997665  499999998764322 22234


Q ss_pred             CccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCh-------HHHHHHHHHHhhccccCCCCCCCCH
Q 019195          152 TVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDP-------KNFRKTISRIMAVQYKIPDYVHISQ  224 (344)
Q Consensus       152 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~s~  224 (344)
                      ..|+..|+|||++.+..++ .++|||||||++|+|++|+.||......       .........+............++.
T Consensus       162 ~~~~~~~~aPE~~~~~~~~-~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (284)
T cd06620         162 FVGTSTYMSPERIQGGKYT-VKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPSSDFPE  240 (284)
T ss_pred             cccCcccCCHHHHccCCCC-ccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCCCCCchhcCH
Confidence            5799999999998776654 4599999999999999999999865432       1112222222222111111123678


Q ss_pred             hHHHHHHHhcccCCCCCCChHHHhcCcccccCC
Q 019195          225 DCRNLLSRIFVANPSRRITIKEIKSHPWFLKNL  257 (344)
Q Consensus       225 ~~~~li~~~L~~dp~~R~s~~ell~hp~~~~~~  257 (344)
                      .+.+||.+||+.||.+|||+.++++||||.+..
T Consensus       241 ~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~~  273 (284)
T cd06620         241 DLRDFVDACLLKDPTERPTPQQLCAMPPFIQAL  273 (284)
T ss_pred             HHHHHHHHHhcCCcccCcCHHHHhcCccccccc
Confidence            999999999999999999999999999997653

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=2e-42  Score=311.61  Aligned_cols=250  Identities=25%  Similarity=0.434  Sum_probs=203.1

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCcc-ccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEEecC
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK-IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYA   80 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~   80 (344)
                      .+|++++.||+|+||.||++.+..+++.||+|.+..... ....+.+|+.+++.++||||+++++.+......|+||||+
T Consensus        20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~   99 (296)
T cd06654          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   99 (296)
T ss_pred             cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeeccc
Confidence            589999999999999999999999999999999876433 2356888999999999999999999999999999999999


Q ss_pred             CCCChHHHHHhCCCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCCC-CCCC
Q 019195           81 AGGELFERICNAGRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR-PKST  152 (344)
Q Consensus        81 ~~g~L~~~i~~~~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~~-~~~~  152 (344)
                      ++++|.+++.. ..++..++..++.|++.+       ||+||||||+||+++.++.  +||+|||++........ ....
T Consensus       100 ~~~~L~~~~~~-~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~--~kl~dfg~~~~~~~~~~~~~~~  176 (296)
T cd06654         100 AGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGS--VKLTDFGFCAQITPEQSKRSTM  176 (296)
T ss_pred             CCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCC--EEECccccchhccccccccCcc
Confidence            99999998854 467888888877776654       9999999999999977654  99999999875433222 2345


Q ss_pred             ccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCHhHHHHHHH
Q 019195          153 VGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSR  232 (344)
Q Consensus       153 ~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~  232 (344)
                      .|++.|+|||.+.+..++ .++|||||||++|+|++|+.||............   ........+....++..+.+||.+
T Consensus       177 ~~~~~y~aPE~~~~~~~~-~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~l~~li~~  252 (296)
T cd06654         177 VGTPYWMAPEVVTRKAYG-PKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLI---ATNGTPELQNPEKLSAIFRDFLNR  252 (296)
T ss_pred             cCCccccCHHHHcCCCCC-ccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHH---hcCCCCCCCCccccCHHHHHHHHH
Confidence            789999999998776654 5599999999999999999999776543222211   111222223334678899999999


Q ss_pred             hcccCCCCCCChHHHhcCcccccCCC
Q 019195          233 IFVANPSRRITIKEIKSHPWFLKNLP  258 (344)
Q Consensus       233 ~L~~dp~~R~s~~ell~hp~~~~~~~  258 (344)
                      ||..+|.+|||+.+++.||||....+
T Consensus       253 ~l~~~p~~Rpt~~eil~~~~~~~~~~  278 (296)
T cd06654         253 CLDMDVEKRGSAKELLQHQFLKIAKP  278 (296)
T ss_pred             HCcCCcccCcCHHHHhhChhhhccCC
Confidence            99999999999999999999976543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=1.6e-42  Score=307.27  Aligned_cols=243  Identities=34%  Similarity=0.487  Sum_probs=198.8

Q ss_pred             CceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCccc----------cHHHHHHHHHHhcCCCCCcceeeEEEEcCCE
Q 019195            3 KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKI----------DANVAREIINHKQLRHPNIIRFKEVVLTPTH   72 (344)
Q Consensus         3 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~----------~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~   72 (344)
                      +|.+.+.||+|++|.||+|.+..+++.||+|.+......          ...+.+|+.++++++||||+++++++.....
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH   80 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence            688999999999999999999999999999988654321          1457789999999999999999999999999


Q ss_pred             EEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHH-------CCeeecCCCCCCeEecCCCCCCEEEeecCCCcccCC
Q 019195           73 LAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLIS-------GQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLL  145 (344)
Q Consensus        73 ~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~ql~~-------~~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~  145 (344)
                      .+++|||+++++|..++...+.+++..++.++.|++.       .|++||||+|+||+++.++.  ++|+|||+++....
T Consensus        81 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~--~~l~dfg~~~~~~~  158 (267)
T cd06628          81 LNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGG--IKISDFGISKKLEA  158 (267)
T ss_pred             cEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCC--EEecccCCCccccc
Confidence            9999999999999999988888888888887777664       49999999999999976664  99999999875432


Q ss_pred             CC-------CCCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCCC
Q 019195          146 HS-------RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPD  218 (344)
Q Consensus       146 ~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  218 (344)
                      ..       ......|+..|+|||.+.+..++ .++|+|||||++|+|++|+.||..........    .+... .....
T Consensus       159 ~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~-~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~----~~~~~-~~~~~  232 (267)
T cd06628         159 NSLSTKTNGARPSLQGSVFWMAPEVVKQTSYT-RKADIWSLGCLVVEMLTGKHPFPDCTQLQAIF----KIGEN-ASPEI  232 (267)
T ss_pred             ccccCCccccccccCCCcCccChhHhccCCCC-chhhhHHHHHHHHHHhhCCCCCCCccHHHHHH----HHhcc-CCCcC
Confidence            11       11234588999999999877664 45999999999999999999998754432222    21111 11122


Q ss_pred             CCCCCHhHHHHHHHhcccCCCCCCChHHHhcCccc
Q 019195          219 YVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF  253 (344)
Q Consensus       219 ~~~~s~~~~~li~~~L~~dp~~R~s~~ell~hp~~  253 (344)
                      ...++..+.++|.+||+.+|.+||++.++++||||
T Consensus       233 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~  267 (267)
T cd06628         233 PSNISSEAIDFLEKTFEIDHNKRPTAAELLKHPFL  267 (267)
T ss_pred             CcccCHHHHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence            23578999999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=2.3e-42  Score=310.54  Aligned_cols=250  Identities=26%  Similarity=0.385  Sum_probs=199.9

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCcc-ccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEEecC
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK-IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYA   80 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~   80 (344)
                      +.|++++.||.|+||.||++.+..++..||+|.+..... ....+.+|+.+++.++||||+++++++..+..+|+||||+
T Consensus        12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   91 (292)
T cd06644          12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC   91 (292)
T ss_pred             hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence            469999999999999999999999999999999875432 2356788999999999999999999999999999999999


Q ss_pred             CCCChHHHHHh-CCCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCC-CCCCC
Q 019195           81 AGGELFERICN-AGRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH-SRPKS  151 (344)
Q Consensus        81 ~~g~L~~~i~~-~~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~-~~~~~  151 (344)
                      ++++|..++.+ ...+++..++.++.|++.+       |++||||||+||+++.++  .+||+|||++...... .....
T Consensus        92 ~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~--~~kl~dfg~~~~~~~~~~~~~~  169 (292)
T cd06644          92 PGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDG--DIKLADFGVSAKNVKTLQRRDS  169 (292)
T ss_pred             CCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCC--CEEEccCccceeccccccccce
Confidence            99999888754 4568888888887777654       999999999999997655  4999999988653222 12234


Q ss_pred             CccCCcccCCccccCCC----CCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCHhHH
Q 019195          152 TVGTPAYIAPEVLSRRE----YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCR  227 (344)
Q Consensus       152 ~~gt~~y~aPE~~~~~~----~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~  227 (344)
                      ..+++.|+|||++.+..    ..+.++|||||||++|+|++|.+||..........+..   .......+....++.++.
T Consensus       170 ~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~  246 (292)
T cd06644         170 FIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIA---KSEPPTLSQPSKWSMEFR  246 (292)
T ss_pred             ecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHh---cCCCccCCCCcccCHHHH
Confidence            56899999999985322    22455999999999999999999997755332222211   111112223346788999


Q ss_pred             HHHHHhcccCCCCCCChHHHhcCcccccC
Q 019195          228 NLLSRIFVANPSRRITIKEIKSHPWFLKN  256 (344)
Q Consensus       228 ~li~~~L~~dp~~R~s~~ell~hp~~~~~  256 (344)
                      ++|.+||+.+|.+||++.++++||||...
T Consensus       247 ~li~~~l~~~p~~Rp~~~~il~~~~~~~~  275 (292)
T cd06644         247 DFLKTALDKHPETRPSAAQLLEHPFVSSV  275 (292)
T ss_pred             HHHHHHhcCCcccCcCHHHHhcCcccccc
Confidence            99999999999999999999999999654

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=1.1e-42  Score=313.44  Aligned_cols=252  Identities=28%  Similarity=0.433  Sum_probs=203.5

Q ss_pred             CceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCccc------cHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEE
Q 019195            3 KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKI------DANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIV   76 (344)
Q Consensus         3 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~------~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv   76 (344)
                      +|++.+.||+|+||.||++.+..+++.||+|.+......      ...+..|+.+++.++|+||+++++++.+.+.+++|
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV   80 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence            699999999999999999999999999999999764322      34567899999999999999999999999999999


Q ss_pred             EecCCCCChHHHHHhCC-CCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCC-
Q 019195           77 MEYAAGGELFERICNAG-RFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS-  147 (344)
Q Consensus        77 ~e~~~~g~L~~~i~~~~-~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~-  147 (344)
                      |||+ +++|..++.... .+++..++.++.|++++       ||+||||||+||+++.++.  ++|+|||++....... 
T Consensus        81 ~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~--~~l~dfg~~~~~~~~~~  157 (298)
T cd07841          81 FEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGV--LKLADFGLARSFGSPNR  157 (298)
T ss_pred             Eccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCC--EEEccceeeeeccCCCc
Confidence            9999 899999998766 78999888888877755       9999999999999987654  9999999987654332 


Q ss_pred             CCCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccc-------cC----
Q 019195          148 RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQY-------KI----  216 (344)
Q Consensus       148 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~-------~~----  216 (344)
                      ......+++.|+|||.+.+....+.++|||||||++|+|++|.+||........+.++.........       ..    
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (298)
T cd07841         158 KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYV  237 (298)
T ss_pred             cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcccccccc
Confidence            2233457889999999866555566799999999999999998888876655544443322110000       00    


Q ss_pred             -----------CCCCCCCHhHHHHHHHhcccCCCCCCChHHHhcCcccccCC
Q 019195          217 -----------PDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNL  257 (344)
Q Consensus       217 -----------~~~~~~s~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~~~  257 (344)
                                 ......+..+.+||.+||+.+|.+|||+.+++.||||....
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~  289 (298)
T cd07841         238 EFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDP  289 (298)
T ss_pred             cccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCC
Confidence                       01124578899999999999999999999999999997753

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=1.8e-42  Score=309.56  Aligned_cols=251  Identities=27%  Similarity=0.380  Sum_probs=200.3

Q ss_pred             CceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCc-cccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEEecCC
Q 019195            3 KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH-KIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYAA   81 (344)
Q Consensus         3 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~   81 (344)
                      -|++++.||+|+||.||++.+..++..+|+|.+.... .....+.+|+.+++.++||||+++++++......|+||||++
T Consensus         6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~   85 (282)
T cd06643           6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCA   85 (282)
T ss_pred             HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecC
Confidence            3789999999999999999999999999999986543 233567889999999999999999999999999999999999


Q ss_pred             CCChHHHHHh-CCCCCHHHHHHHHHHHHH-------CCeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCC-CCCCC
Q 019195           82 GGELFERICN-AGRFSEDEARYFFQQLIS-------GQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS-RPKST  152 (344)
Q Consensus        82 ~g~L~~~i~~-~~~~~~~~~~~~~~ql~~-------~~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~-~~~~~  152 (344)
                      +++|..++.+ ...+++..++.++.|++.       .|++||||||+||+++.++.  +||+|||++....... .....
T Consensus        86 ~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~--~kl~dfg~~~~~~~~~~~~~~~  163 (282)
T cd06643          86 GGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGD--IKLADFGVSAKNTRTIQRRDSF  163 (282)
T ss_pred             CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCC--EEEccccccccccccccccccc
Confidence            9999888764 456888887777766654       49999999999999976654  9999999986543222 22345


Q ss_pred             ccCCcccCCccccC----CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCHhHHH
Q 019195          153 VGTPAYIAPEVLSR----REYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRN  228 (344)
Q Consensus       153 ~gt~~y~aPE~~~~----~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~  228 (344)
                      .|++.|+|||++..    ....+.++||||+||++|+|++|++||..............   ......+....++..+.+
T Consensus       164 ~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~  240 (282)
T cd06643         164 IGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAK---SEPPTLAQPSRWSSEFKD  240 (282)
T ss_pred             cccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhh---cCCCCCCCccccCHHHHH
Confidence            68999999999842    22224569999999999999999999987654333222221   111222333457889999


Q ss_pred             HHHHhcccCCCCCCChHHHhcCcccccCCC
Q 019195          229 LLSRIFVANPSRRITIKEIKSHPWFLKNLP  258 (344)
Q Consensus       229 li~~~L~~dp~~R~s~~ell~hp~~~~~~~  258 (344)
                      ||.+||+.+|.+||++.++++||||.....
T Consensus       241 li~~~l~~~p~~Rp~~~~il~~~~~~~~~~  270 (282)
T cd06643         241 FLKKCLEKNVDARWTTTQLLQHPFVTVNSN  270 (282)
T ss_pred             HHHHHccCChhhCcCHHHHhcCCCEeccCC
Confidence            999999999999999999999999987644

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=2.3e-42  Score=311.23  Aligned_cols=248  Identities=27%  Similarity=0.456  Sum_probs=202.7

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCcc-ccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEEecC
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK-IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYA   80 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~   80 (344)
                      .+|++.+.||.|+||.||++.+..+++.||+|.+..... ....+.+|+.+++.++||||+++++++.....+|+|+||+
T Consensus        19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   98 (296)
T cd06655          19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL   98 (296)
T ss_pred             ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence            479999999999999999999999999999999875432 3356788999999999999999999999999999999999


Q ss_pred             CCCChHHHHHhCCCCCHHHHHHHHHHHHH-------CCeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCCC-CCCC
Q 019195           81 AGGELFERICNAGRFSEDEARYFFQQLIS-------GQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR-PKST  152 (344)
Q Consensus        81 ~~g~L~~~i~~~~~~~~~~~~~~~~ql~~-------~~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~~-~~~~  152 (344)
                      ++++|..++.+ ..+++.+++.++.|++.       .|++||||||+||+++.++.  +||+|||++........ ....
T Consensus        99 ~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~--~kl~dfg~~~~~~~~~~~~~~~  175 (296)
T cd06655          99 AGGSLTDVVTE-TCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGS--VKLTDFGFCAQITPEQSKRSTM  175 (296)
T ss_pred             CCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCC--EEEccCccchhcccccccCCCc
Confidence            99999998865 46888888887776654       49999999999999976654  99999999875433322 2335


Q ss_pred             ccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCHhHHHHHHH
Q 019195          153 VGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSR  232 (344)
Q Consensus       153 ~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~  232 (344)
                      .|++.|+|||.+.+..+. .++|||||||++|+|++|+.||...+..........   ...........+++.+.+||.+
T Consensus       176 ~~~~~y~aPE~~~~~~~~-~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~li~~  251 (296)
T cd06655         176 VGTPYWMAPEVVTRKAYG-PKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT---NGTPELQNPEKLSPIFRDFLNR  251 (296)
T ss_pred             CCCccccCcchhcCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh---cCCcccCCcccCCHHHHHHHHH
Confidence            689999999999776654 459999999999999999999987654333222111   1112223344678999999999


Q ss_pred             hcccCCCCCCChHHHhcCcccccC
Q 019195          233 IFVANPSRRITIKEIKSHPWFLKN  256 (344)
Q Consensus       233 ~L~~dp~~R~s~~ell~hp~~~~~  256 (344)
                      ||..+|.+|||+.+++.||||...
T Consensus       252 ~l~~dp~~Rpt~~~il~~~~~~~~  275 (296)
T cd06655         252 CLEMDVEKRGSAKELLQHPFLKLA  275 (296)
T ss_pred             HhhcChhhCCCHHHHhhChHhhhc
Confidence            999999999999999999999654

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=4.8e-43  Score=309.13  Aligned_cols=245  Identities=28%  Similarity=0.513  Sum_probs=204.9

Q ss_pred             CceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCc----cccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEEe
Q 019195            3 KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH----KIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVME   78 (344)
Q Consensus         3 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e   78 (344)
                      +|++.+.||.|+||.||+|.+..++..||+|++.+..    .....+.+|++++++++||||+++++++.....+++|+|
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD   80 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence            5999999999999999999999999999999997643    233578899999999999999999999999999999999


Q ss_pred             cCCCCChHHHHHhCCCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCCCCCC
Q 019195           79 YAAGGELFERICNAGRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKS  151 (344)
Q Consensus        79 ~~~~g~L~~~i~~~~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~~~~~  151 (344)
                      |+.+++|...+.....+++..++.++.|++.+       |++|+||+|+||+++.++.  ++|+|||++...........
T Consensus        81 ~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~--~~l~d~~~~~~~~~~~~~~~  158 (258)
T cd05578          81 LLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGH--VHITDFNIATKVTPDTLTTS  158 (258)
T ss_pred             CCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCC--EEEeecccccccCCCccccc
Confidence            99999999999887789998888887777654       9999999999999987665  99999999876555444455


Q ss_pred             CccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCHhHHHHHH
Q 019195          152 TVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLS  231 (344)
Q Consensus       152 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~  231 (344)
                      ..|+..|+|||.+.+..+ +.++|+||||+++|+|++|..||...... ................  ...++.++.++|.
T Consensus       159 ~~~~~~y~~PE~~~~~~~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~--~~~~~~~~~~~i~  234 (258)
T cd05578         159 TSGTPGYMAPEVLCRQGY-SVAVDWWSLGVTAYECLRGKRPYRGHSRT-IRDQIRAKQETADVLY--PATWSTEAIDAIN  234 (258)
T ss_pred             cCCChhhcCHHHHcccCC-CCcccchhhHHHHHHHHhCCCCCCCCCcc-HHHHHHHHhccccccC--cccCcHHHHHHHH
Confidence            678999999999977665 45599999999999999999999876542 1122222222122222  3367899999999


Q ss_pred             HhcccCCCCCCCh--HHHhcCccc
Q 019195          232 RIFVANPSRRITI--KEIKSHPWF  253 (344)
Q Consensus       232 ~~L~~dp~~R~s~--~ell~hp~~  253 (344)
                      +||+.||.+||++  .++++||||
T Consensus       235 ~~l~~~p~~R~~~~~~~l~~~~~~  258 (258)
T cd05578         235 KLLERDPQKRLGDNLKDLKNHPYF  258 (258)
T ss_pred             HHccCChhHcCCccHHHHhcCCCC
Confidence            9999999999999  999999997

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-43  Score=321.13  Aligned_cols=236  Identities=26%  Similarity=0.444  Sum_probs=201.6

Q ss_pred             ceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEEecCCCC
Q 019195            4 YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYAAGG   83 (344)
Q Consensus         4 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g   83 (344)
                      +++++.||+|.||.||.+....+ ..||+|.+.........+.+|+++|++|+|+|||++++++..+..+||||||++.|
T Consensus       208 l~l~~~LG~G~FG~V~~g~~~~~-~~vavk~ik~~~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~G  286 (468)
T KOG0197|consen  208 LKLIRELGSGQFGEVWLGKWNGS-TKVAVKTIKEGSMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKG  286 (468)
T ss_pred             HHHHHHhcCCccceEEEEEEcCC-CcccceEEeccccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccC
Confidence            56788999999999999998654 46999999887777788999999999999999999999999988999999999999


Q ss_pred             ChHHHHHh--CCCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCCCC--CCC
Q 019195           84 ELFERICN--AGRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP--KST  152 (344)
Q Consensus        84 ~L~~~i~~--~~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~~~--~~~  152 (344)
                      +|.++|+.  ...+...+...++.||+++       ++|||||-..||||+.+..  +||+|||+|+........  ...
T Consensus       287 sLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~--vKIsDFGLAr~~~d~~Y~~~~~~  364 (468)
T KOG0197|consen  287 SLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLV--VKISDFGLARLIGDDEYTASEGG  364 (468)
T ss_pred             cHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCce--EEEcccccccccCCCceeecCCC
Confidence            99999987  5678999999999999877       9999999999999987775  999999999943322221  112


Q ss_pred             ccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCHhHHHHHH
Q 019195          153 VGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLS  231 (344)
Q Consensus       153 ~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~  231 (344)
                      .-...|+|||.+....++.+ ||||||||+|+||+| |+.|+.+....+.+.     .....+++|.+..+++.+.+++.
T Consensus       365 kfPIkWtAPEa~~~~~FS~k-SDVWSFGVlL~E~fT~G~~py~~msn~ev~~-----~le~GyRlp~P~~CP~~vY~lM~  438 (468)
T KOG0197|consen  365 KFPIKWTAPEALNYGKFSSK-SDVWSFGVLLWELFTYGRVPYPGMSNEEVLE-----LLERGYRLPRPEGCPDEVYELMK  438 (468)
T ss_pred             CCCceecCHHHHhhCCcccc-cceeehhhhHHHHhccCCCCCCCCCHHHHHH-----HHhccCcCCCCCCCCHHHHHHHH
Confidence            23556999999988887655 999999999999998 899998876644433     23457788888899999999999


Q ss_pred             HhcccCCCCCCChHHHh
Q 019195          232 RIFVANPSRRITIKEIK  248 (344)
Q Consensus       232 ~~L~~dp~~R~s~~ell  248 (344)
                      .||+.+|++|||+..+.
T Consensus       439 ~CW~~~P~~RPtF~~L~  455 (468)
T KOG0197|consen  439 SCWHEDPEDRPTFETLR  455 (468)
T ss_pred             HHhhCCcccCCCHHHHH
Confidence            99999999999999654

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.3e-43  Score=312.14  Aligned_cols=249  Identities=27%  Similarity=0.417  Sum_probs=202.0

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCcc-ccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEEecC
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK-IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYA   80 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~   80 (344)
                      ++|++++.||.|+||.||++.+..++..||+|.+..... ....+.+|+.+++.++||||+++++++..+..+|+||||+
T Consensus         5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (280)
T cd06611           5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFC   84 (280)
T ss_pred             hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeecc
Confidence            589999999999999999999998999999999875432 2356888999999999999999999999999999999999


Q ss_pred             CCCChHHHHHhC-CCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCC-CCCC
Q 019195           81 AGGELFERICNA-GRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS-RPKS  151 (344)
Q Consensus        81 ~~g~L~~~i~~~-~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~-~~~~  151 (344)
                      ++++|..++.+. ..+++..++.++.|++.+       ||+||||||+||+++.++.  ++|+|||++....... ....
T Consensus        85 ~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~--~~l~d~g~~~~~~~~~~~~~~  162 (280)
T cd06611          85 DGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGD--VKLADFGVSAKNKSTLQKRDT  162 (280)
T ss_pred             CCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCC--EEEccCccchhhcccccccce
Confidence            999999998764 468999988888887654       9999999999999977654  9999999876543222 2234


Q ss_pred             CccCCcccCCccccCC----CCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhcc-ccCCCCCCCCHhH
Q 019195          152 TVGTPAYIAPEVLSRR----EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQ-YKIPDYVHISQDC  226 (344)
Q Consensus       152 ~~gt~~y~aPE~~~~~----~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~s~~~  226 (344)
                      ..|++.|+|||.+...    ...+.++|||||||++|+|++|++||..........+    +.... ..+.....++.++
T Consensus       163 ~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~  238 (280)
T cd06611         163 FIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLK----ILKSEPPTLDQPSKWSSSF  238 (280)
T ss_pred             eecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHH----HhcCCCCCcCCcccCCHHH
Confidence            5689999999998532    2224459999999999999999999977644332222    22211 1122233578899


Q ss_pred             HHHHHHhcccCCCCCCChHHHhcCcccccC
Q 019195          227 RNLLSRIFVANPSRRITIKEIKSHPWFLKN  256 (344)
Q Consensus       227 ~~li~~~L~~dp~~R~s~~ell~hp~~~~~  256 (344)
                      .++|.+||+.+|.+||++.++++||||...
T Consensus       239 ~~li~~~l~~~p~~Rps~~~il~~~~~~~~  268 (280)
T cd06611         239 NDFLKSCLVKDPDDRPTAAELLKHPFVSDQ  268 (280)
T ss_pred             HHHHHHHhccChhhCcCHHHHhcChhhccc
Confidence            999999999999999999999999999765

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=2.4e-42  Score=310.10  Aligned_cols=250  Identities=29%  Similarity=0.484  Sum_probs=195.0

Q ss_pred             CCCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCcc--ccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEEe
Q 019195            1 MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK--IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVME   78 (344)
Q Consensus         1 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e   78 (344)
                      +++|++.+.||+|++|.||++.+..+++.||+|.+.....  ....+.+|+.++++++||||+++++++..+...++|||
T Consensus         4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   83 (291)
T cd07844           4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFE   83 (291)
T ss_pred             ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEe
Confidence            5789999999999999999999999999999999875432  23457789999999999999999999999999999999


Q ss_pred             cCCCCChHHHHHhC-CCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCCC-C
Q 019195           79 YAAGGELFERICNA-GRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR-P  149 (344)
Q Consensus        79 ~~~~g~L~~~i~~~-~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~~-~  149 (344)
                      |+.+ +|..++... ..+++..++.++.|++.+       ||+||||||+||+++.++.  +||+|||+++....... .
T Consensus        84 ~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~--~kl~dfg~~~~~~~~~~~~  160 (291)
T cd07844          84 YLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGE--LKLADFGLARAKSVPSKTY  160 (291)
T ss_pred             cCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCC--EEECccccccccCCCCccc
Confidence            9974 899888654 467888888877776654       9999999999999987654  99999999865432221 2


Q ss_pred             CCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhc----------------c
Q 019195          150 KSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAV----------------Q  213 (344)
Q Consensus       150 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~----------------~  213 (344)
                      ....++..|+|||++.+....+.++||||+||++|+|++|+.||............+......                .
T Consensus       161 ~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (291)
T cd07844         161 SNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFKP  240 (291)
T ss_pred             cccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhcccccc
Confidence            234578899999998765544566999999999999999999997665322211111111000                0


Q ss_pred             ccCC---------CCCCCC--HhHHHHHHHhcccCCCCCCChHHHhcCccc
Q 019195          214 YKIP---------DYVHIS--QDCRNLLSRIFVANPSRRITIKEIKSHPWF  253 (344)
Q Consensus       214 ~~~~---------~~~~~s--~~~~~li~~~L~~dp~~R~s~~ell~hp~~  253 (344)
                      ...+         ....++  .++.++|.+||+.+|.+|||+.+++.||||
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f  291 (291)
T cd07844         241 YSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF  291 (291)
T ss_pred             ccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence            0000         011234  788999999999999999999999999998

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=1.3e-42  Score=308.65  Aligned_cols=247  Identities=32%  Similarity=0.454  Sum_probs=198.0

Q ss_pred             CceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCcc-----------ccHHHHHHHHHHhcCCCCCcceeeEEEEcCC
Q 019195            3 KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK-----------IDANVAREIINHKQLRHPNIIRFKEVVLTPT   71 (344)
Q Consensus         3 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-----------~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~   71 (344)
                      +|.+.+.||.|+||.||++.+..+++.||+|.+.....           ..+.+.+|+.+++.++||||+++++++...+
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   81 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE   81 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence            68999999999999999999999999999998864211           1135778999999999999999999999999


Q ss_pred             EEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHH-------CCeeecCCCCCCeEecCCCCCCEEEeecCCCcccC
Q 019195           72 HLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLIS-------GQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSL  144 (344)
Q Consensus        72 ~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~ql~~-------~~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~  144 (344)
                      .+++||||+++++|.+++.+.+.+++..++.++.|++.       .+++||||+|+||+++.++.  ++|+|||++....
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~--~~l~d~~~~~~~~  159 (272)
T cd06629          82 YLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGI--CKISDFGISKKSD  159 (272)
T ss_pred             ceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCe--EEEeecccccccc
Confidence            99999999999999999988888998888887777665       49999999999999987654  9999999987543


Q ss_pred             CCC---CCCCCccCCcccCCccccCCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCC--C
Q 019195          145 LHS---RPKSTVGTPAYIAPEVLSRRE-YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIP--D  218 (344)
Q Consensus       145 ~~~---~~~~~~gt~~y~aPE~~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~  218 (344)
                      ...   ......|+..|+|||.+.... ..+.++|+||||+++|+|++|..||..........+....  .....++  .
T Consensus       160 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~  237 (272)
T cd06629         160 DIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNK--RSAPPIPPDV  237 (272)
T ss_pred             ccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhcc--ccCCcCCccc
Confidence            221   123346899999999987654 2355699999999999999999999755433222221111  1111122  1


Q ss_pred             CCCCCHhHHHHHHHhcccCCCCCCChHHHhcCccc
Q 019195          219 YVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF  253 (344)
Q Consensus       219 ~~~~s~~~~~li~~~L~~dp~~R~s~~ell~hp~~  253 (344)
                      ...++..+.++|.+||..+|.+|||+.++|+|||+
T Consensus       238 ~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~  272 (272)
T cd06629         238 SMNLSPVALDFLNACFTINPDNRPTARELLQHPFI  272 (272)
T ss_pred             cccCCHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence            23568899999999999999999999999999996

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=3.1e-42  Score=303.55  Aligned_cols=243  Identities=25%  Similarity=0.464  Sum_probs=196.3

Q ss_pred             CceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCcc---ccHHHHHHHHHHhcCCCCCcceeeEEEEc-CCEEEEEEe
Q 019195            3 KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK---IDANVAREIINHKQLRHPNIIRFKEVVLT-PTHLAIVME   78 (344)
Q Consensus         3 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~ei~~l~~l~h~niv~~~~~~~~-~~~~~lv~e   78 (344)
                      +|++++.||+|++|.||++.+..+++.||+|.+.....   ....+.+|+.++++++|+|++++++.+.. +..+|++||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e   80 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG   80 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence            59999999999999999999999999999999875432   23467889999999999999999998864 456899999


Q ss_pred             cCCCCChHHHHHhC--CCCCHHHHHHHHHHHHH-------CCeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCC-CC
Q 019195           79 YAAGGELFERICNA--GRFSEDEARYFFQQLIS-------GQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH-SR  148 (344)
Q Consensus        79 ~~~~g~L~~~i~~~--~~~~~~~~~~~~~ql~~-------~~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~-~~  148 (344)
                      |+++++|.+++...  ..+++.+++.++.|++.       .|++||||||+||+++.++.  ++|+|||++...... ..
T Consensus        81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~--~~l~df~~~~~~~~~~~~  158 (257)
T cd08223          81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNI--IKVGDLGIARVLENQCDM  158 (257)
T ss_pred             ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCc--EEEecccceEEecccCCc
Confidence            99999999998763  45888888888777554       49999999999999976654  999999998754322 22


Q ss_pred             CCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCHhHHH
Q 019195          149 PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRN  228 (344)
Q Consensus       149 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~  228 (344)
                      .....|++.|+|||++.+..++ .++|+|||||++++|++|+.||...+.....    ..+..... .+....+++.+.+
T Consensus       159 ~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~----~~~~~~~~-~~~~~~~~~~~~~  232 (257)
T cd08223         159 ASTLIGTPYYMSPELFSNKPYN-YKSDVWALGCCVYEMATLKHAFNAKDMNSLV----YRIIEGKL-PPMPKDYSPELGE  232 (257)
T ss_pred             cccccCCcCccChhHhcCCCCC-chhhhHHHHHHHHHHHcCCCCCCCCCHHHHH----HHHHhcCC-CCCccccCHHHHH
Confidence            3345689999999999877665 4599999999999999999999765432222    22222221 1122357899999


Q ss_pred             HHHHhcccCCCCCCChHHHhcCccc
Q 019195          229 LLSRIFVANPSRRITIKEIKSHPWF  253 (344)
Q Consensus       229 li~~~L~~dp~~R~s~~ell~hp~~  253 (344)
                      ||.+||+.+|.+|||+.++++||||
T Consensus       233 li~~~l~~~p~~Rp~~~~~l~~~~~  257 (257)
T cd08223         233 LIATMLSKRPEKRPSVKSILRQPYI  257 (257)
T ss_pred             HHHHHhccCcccCCCHHHHhcCCCC
Confidence            9999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=2.6e-42  Score=309.93  Aligned_cols=248  Identities=25%  Similarity=0.422  Sum_probs=197.5

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcC-CCCCcceeeEEEEcC-----CEEEE
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQL-RHPNIIRFKEVVLTP-----THLAI   75 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~l~~l-~h~niv~~~~~~~~~-----~~~~l   75 (344)
                      ++|++.+.||+|+||.||++.+..+++.+|+|++.........+.+|+.+++.+ +||||+++++++...     ..+|+
T Consensus        22 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~~l  101 (291)
T cd06639          22 DTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWL  101 (291)
T ss_pred             CCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCeeEE
Confidence            579999999999999999999999999999999876555556788899999998 799999999998753     36899


Q ss_pred             EEecCCCCChHHHHHh----CCCCCHHHHHHHHHHHHH-------CCeeecCCCCCCeEecCCCCCCEEEeecCCCcccC
Q 019195           76 VMEYAAGGELFERICN----AGRFSEDEARYFFQQLIS-------GQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSL  144 (344)
Q Consensus        76 v~e~~~~g~L~~~i~~----~~~~~~~~~~~~~~ql~~-------~~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~  144 (344)
                      ||||+++++|.+++..    ...+++..++.++.|++.       .|++||||||+||+++.++.  +||+|||++....
T Consensus       102 v~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~--~kl~dfg~~~~~~  179 (291)
T cd06639         102 VLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGG--VKLVDFGVSAQLT  179 (291)
T ss_pred             EEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCC--EEEeecccchhcc
Confidence            9999999999998753    456888888877766554       49999999999999976654  9999999987543


Q ss_pred             CCC-CCCCCccCCcccCCccccCCCC----CCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCCCC
Q 019195          145 LHS-RPKSTVGTPAYIAPEVLSRREY----DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDY  219 (344)
Q Consensus       145 ~~~-~~~~~~gt~~y~aPE~~~~~~~----~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  219 (344)
                      ... ......|+..|+|||.+.....    .+.++|||||||++|+|++|++||...........+..   .........
T Consensus       180 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~---~~~~~~~~~  256 (291)
T cd06639         180 STRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPR---NPPPTLLHP  256 (291)
T ss_pred             cccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhc---CCCCCCCcc
Confidence            322 2234568999999999854321    24569999999999999999999987654333322211   111122223


Q ss_pred             CCCCHhHHHHHHHhcccCCCCCCChHHHhcCcccc
Q 019195          220 VHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFL  254 (344)
Q Consensus       220 ~~~s~~~~~li~~~L~~dp~~R~s~~ell~hp~~~  254 (344)
                      ..++..+.+||.+||+.+|.+||++.++++||||+
T Consensus       257 ~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~  291 (291)
T cd06639         257 EKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK  291 (291)
T ss_pred             cccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence            35678899999999999999999999999999984

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.5e-44  Score=332.05  Aligned_cols=244  Identities=30%  Similarity=0.484  Sum_probs=202.5

Q ss_pred             eeeecCceEEEEEEEcCCCcEEEEEEeec-CccccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEEecCCCCChHH
Q 019195            9 DIGSGNFGVARLMRNKNTKELVAMKYIER-GHKIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFE   87 (344)
Q Consensus         9 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-~~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~   87 (344)
                      +||+|.||+||.+++..|...+|||-+.. ......-+..||.+.++|+|.|||++++++..++.+-|.||-++||+|..
T Consensus       582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs  661 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS  661 (1226)
T ss_pred             EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence            69999999999999999999999998864 33344567889999999999999999999999999999999999999999


Q ss_pred             HHHh-CCCC--CHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCC-CCCCCCccCC
Q 019195           88 RICN-AGRF--SEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH-SRPKSTVGTP  156 (344)
Q Consensus        88 ~i~~-~~~~--~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~-~~~~~~~gt~  156 (344)
                      +++. .+++  ++..+..+.+||+.+       .|||||||-.|+||+. ..|.+||.|||-++....- +..-++.||.
T Consensus       662 LLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNT-ySGvlKISDFGTsKRLAginP~TETFTGTL  740 (1226)
T KOG4279|consen  662 LLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNT-YSGVLKISDFGTSKRLAGINPCTETFTGTL  740 (1226)
T ss_pred             HHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEee-ccceEEecccccchhhccCCccccccccch
Confidence            9864 5776  677777777777665       9999999999999984 4567999999988765433 3445678999


Q ss_pred             cccCCccccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCHhHHHHHHHhcc
Q 019195          157 AYIAPEVLSRR-EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFV  235 (344)
Q Consensus       157 ~y~aPE~~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~  235 (344)
                      .|||||++..+ ..+++++|||||||++.||+||++||.....+..   .+-++.-.....|.+..+|.+++.||.+|+.
T Consensus       741 QYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqA---AMFkVGmyKvHP~iPeelsaeak~FilrcFe  817 (1226)
T KOG4279|consen  741 QYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQA---AMFKVGMYKVHPPIPEELSAEAKNFILRCFE  817 (1226)
T ss_pred             hhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhH---hhhhhcceecCCCCcHHHHHHHHHHHHHHcC
Confidence            99999999543 4457889999999999999999999987665432   2222332333445555789999999999999


Q ss_pred             cCCCCCCChHHHhcCcccccC
Q 019195          236 ANPSRRITIKEIKSHPWFLKN  256 (344)
Q Consensus       236 ~dp~~R~s~~ell~hp~~~~~  256 (344)
                      ++|..||+|.++|..||++..
T Consensus       818 pd~~~R~sA~~LL~DpFlq~~  838 (1226)
T KOG4279|consen  818 PDPCDRPSAKDLLQDPFLQHN  838 (1226)
T ss_pred             CCcccCccHHHhccCcccccC
Confidence            999999999999999999765

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=7.5e-43  Score=312.42  Aligned_cols=250  Identities=27%  Similarity=0.441  Sum_probs=201.2

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCcc---ccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEEe
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK---IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVME   78 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e   78 (344)
                      ++|++.+.||+|+||.||+|.+..+++.||+|++.....   ....+.+|+.+++.++||||+++++++..+..+|+|||
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE   80 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence            589999999999999999999999999999998865332   23567889999999999999999999999999999999


Q ss_pred             cCCCCChHHHHHhCCCCCHHHHHHHHHHHHH-------CCeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCCC-CC
Q 019195           79 YAAGGELFERICNAGRFSEDEARYFFQQLIS-------GQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR-PK  150 (344)
Q Consensus        79 ~~~~g~L~~~i~~~~~~~~~~~~~~~~ql~~-------~~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~~-~~  150 (344)
                      |+++++|..++.....++..+++.++.|++.       .|++||||+|+||+++.++.  ++|+|||++........ ..
T Consensus        81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~--~~l~dfg~~~~~~~~~~~~~  158 (286)
T cd07846          81 FVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGV--VKLCDFGFARTLAAPGEVYT  158 (286)
T ss_pred             cCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCc--EEEEeeeeeeeccCCccccC
Confidence            9999999888776667888888888777665       49999999999999987654  99999999875433322 23


Q ss_pred             CCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhc---------------ccc
Q 019195          151 STVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAV---------------QYK  215 (344)
Q Consensus       151 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~---------------~~~  215 (344)
                      ...++..|+|||++.+....+.++||||||+++|+|++|++||...........+.......               ...
T Consensus       159 ~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (286)
T cd07846         159 DYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMR  238 (286)
T ss_pred             cccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhccc
Confidence            45689999999998765555567999999999999999999997665433333322211000               000


Q ss_pred             CC----------CCCCCCHhHHHHHHHhcccCCCCCCChHHHhcCccc
Q 019195          216 IP----------DYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF  253 (344)
Q Consensus       216 ~~----------~~~~~s~~~~~li~~~L~~dp~~R~s~~ell~hp~~  253 (344)
                      .+          ....++..+.+|+.+||+.+|.+||++.++++||||
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~  286 (286)
T cd07846         239 LPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF  286 (286)
T ss_pred             cccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence            11          123568899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=9.3e-43  Score=306.61  Aligned_cols=245  Identities=26%  Similarity=0.438  Sum_probs=201.5

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEEecCC
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYAA   81 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~   81 (344)
                      ++|++.+.||+|+||.||++.+..++..||+|.+..... ...+.+|+.+++.++||||+++++++.....+|+++||++
T Consensus         3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~   81 (256)
T cd06612           3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED-LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCG   81 (256)
T ss_pred             ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH-HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecCC
Confidence            689999999999999999999999899999999876543 5678999999999999999999999999999999999999


Q ss_pred             CCChHHHHHh-CCCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCC-CCCCC
Q 019195           82 GGELFERICN-AGRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS-RPKST  152 (344)
Q Consensus        82 ~g~L~~~i~~-~~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~-~~~~~  152 (344)
                      +++|.+++.. ...+++..++.++.|++.+       +++||||+|+||+++.++.  +||+|||++....... .....
T Consensus        82 ~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~--~~l~dfg~~~~~~~~~~~~~~~  159 (256)
T cd06612          82 AGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQ--AKLADFGVSGQLTDTMAKRNTV  159 (256)
T ss_pred             CCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCc--EEEcccccchhcccCccccccc
Confidence            9999999875 4568888888887776654       9999999999999987664  9999999987654333 23345


Q ss_pred             ccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCHhHHHHHHH
Q 019195          153 VGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSR  232 (344)
Q Consensus       153 ~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~  232 (344)
                      .|+..|+|||++.+..++ .++||||||+++|+|++|+.||.............   ............++..+.++|.+
T Consensus       160 ~~~~~y~~PE~~~~~~~~-~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~i~~  235 (256)
T cd06612         160 IGTPFWMAPEVIQEIGYN-NKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIP---NKPPPTLSDPEKWSPEFNDFVKK  235 (256)
T ss_pred             cCCccccCHHHHhcCCCC-chhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhc---cCCCCCCCchhhcCHHHHHHHHH
Confidence            689999999999877664 45999999999999999999998654322211110   01111122223567899999999


Q ss_pred             hcccCCCCCCChHHHhcCccc
Q 019195          233 IFVANPSRRITIKEIKSHPWF  253 (344)
Q Consensus       233 ~L~~dp~~R~s~~ell~hp~~  253 (344)
                      ||+.+|.+|||+.++|.||||
T Consensus       236 ~l~~~P~~Rps~~~il~~~~~  256 (256)
T cd06612         236 CLVKDPEERPSAIQLLQHPFI  256 (256)
T ss_pred             HHhcChhhCcCHHHHhcCCCC
Confidence            999999999999999999997

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-44  Score=325.07  Aligned_cols=242  Identities=33%  Similarity=0.616  Sum_probs=207.9

Q ss_pred             eeeeeecCceEEEEEEEcCCCcEEEEEEeecC---ccccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEEecCCCC
Q 019195            7 MKDIGSGNFGVARLMRNKNTKELVAMKYIERG---HKIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYAAGG   83 (344)
Q Consensus         7 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g   83 (344)
                      .+.||+|.||+||-++++.+|+.||||++.+-   .+....+++|+.+|.++.||.||.+--.|+..+.+++|||.+ .|
T Consensus       569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl-~G  647 (888)
T KOG4236|consen  569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKL-HG  647 (888)
T ss_pred             HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhh-cc
Confidence            36899999999999999999999999999863   455578999999999999999999999999999999999999 56


Q ss_pred             ChHHHHHh--CCCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecC-CCCCCEEEeecCCCcccCCCCCCCCCc
Q 019195           84 ELFERICN--AGRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDG-SPAPRLKICDFGYSKSSLLHSRPKSTV  153 (344)
Q Consensus        84 ~L~~~i~~--~~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~-~~~~~vkL~DFg~a~~~~~~~~~~~~~  153 (344)
                      ++.++|..  .+++++...+.++.||+.|       +|+|+||||+|||+.+ +.-+.+||||||+|+........++.+
T Consensus       648 DMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksFRrsVV  727 (888)
T KOG4236|consen  648 DMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSFRRSVV  727 (888)
T ss_pred             hHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchhhhhhhhc
Confidence            77787753  5788888777766666655       9999999999999964 444679999999999988888889999


Q ss_pred             cCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccC--CCCCCCCHhHHHHHH
Q 019195          154 GTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKI--PDYVHISQDCRNLLS  231 (344)
Q Consensus       154 gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~s~~~~~li~  231 (344)
                      |||.|+|||++..++|+.. -|+||+|+|+|.-++|.+||...++.      -.++.+..+..  ..|..+++.+.+||.
T Consensus       728 GTPAYLaPEVLrnkGyNrS-LDMWSVGVIiYVsLSGTFPFNEdEdI------ndQIQNAaFMyPp~PW~eis~~AidlIn  800 (888)
T KOG4236|consen  728 GTPAYLAPEVLRNKGYNRS-LDMWSVGVIIYVSLSGTFPFNEDEDI------NDQIQNAAFMYPPNPWSEISPEAIDLIN  800 (888)
T ss_pred             CCccccCHHHHhhcccccc-ccceeeeEEEEEEecccccCCCccch------hHHhhccccccCCCchhhcCHHHHHHHH
Confidence            9999999999999998755 89999999999999999999765442      22333344433  356789999999999


Q ss_pred             HhcccCCCCCCChHHHhcCcccccC
Q 019195          232 RIFVANPSRRITIKEIKSHPWFLKN  256 (344)
Q Consensus       232 ~~L~~dp~~R~s~~ell~hp~~~~~  256 (344)
                      .+|+..-.+|.|++..|.|||++.-
T Consensus       801 ~LLqVkm~kRysvdk~lsh~Wlq~y  825 (888)
T KOG4236|consen  801 NLLQVKMRKRYSVDKSLSHPWLQDY  825 (888)
T ss_pred             HHHHHHHHHhcchHhhccchhhhcc
Confidence            9999999999999999999999764

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=1.6e-42  Score=309.48  Aligned_cols=246  Identities=29%  Similarity=0.485  Sum_probs=195.8

Q ss_pred             ceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCcc--ccHHHHHHHHHHhcCC-CCCcceeeEEEEcC--CEEEEEEe
Q 019195            4 YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK--IDANVAREIINHKQLR-HPNIIRFKEVVLTP--THLAIVME   78 (344)
Q Consensus         4 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~ei~~l~~l~-h~niv~~~~~~~~~--~~~~lv~e   78 (344)
                      |++++.||+|+||.||++.+..+++.||+|++.....  ......+|+..++++. |+||+++++++.+.  +.+++|||
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e   80 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE   80 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence            7899999999999999999999999999999876432  2234557888888885 99999999999987  88999999


Q ss_pred             cCCCCChHHHHHhC-CCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCCCCC
Q 019195           79 YAAGGELFERICNA-GRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPK  150 (344)
Q Consensus        79 ~~~~g~L~~~i~~~-~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~~~~  150 (344)
                      |++ ++|.+.+... ..+++.+++.++.|++.+       |++||||||+||+++.   +.+||+|||++..........
T Consensus        81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~---~~~kl~dfg~~~~~~~~~~~~  156 (282)
T cd07831          81 LMD-MNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD---DILKLADFGSCRGIYSKPPYT  156 (282)
T ss_pred             cCC-ccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC---CCeEEEecccccccccCCCcC
Confidence            996 5888887653 568888888887776654       9999999999999987   459999999997655444444


Q ss_pred             CCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhh--------------ccccC
Q 019195          151 STVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMA--------------VQYKI  216 (344)
Q Consensus       151 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~--------------~~~~~  216 (344)
                      ...+++.|+|||.+......+.++|||||||++|+|++|.+||...+..+....+......              ..+..
T Consensus       157 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (282)
T cd07831         157 EYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNYNF  236 (282)
T ss_pred             CCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccccccccC
Confidence            5678999999998766555566799999999999999999999876554433332221100              01111


Q ss_pred             CC---------CCCCCHhHHHHHHHhcccCCCCCCChHHHhcCccc
Q 019195          217 PD---------YVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF  253 (344)
Q Consensus       217 ~~---------~~~~s~~~~~li~~~L~~dp~~R~s~~ell~hp~~  253 (344)
                      |.         ...++..+.+||.+||+.+|.+|||+.+++.||||
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~  282 (282)
T cd07831         237 PSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF  282 (282)
T ss_pred             cccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence            11         12467899999999999999999999999999997

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=1.5e-42  Score=310.63  Aligned_cols=247  Identities=25%  Similarity=0.417  Sum_probs=194.6

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcC-CCCCcceeeEEEE-----cCCEEEE
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQL-RHPNIIRFKEVVL-----TPTHLAI   75 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~l~~l-~h~niv~~~~~~~-----~~~~~~l   75 (344)
                      ++|++++.||+|+||.||++.+..+++.+|+|++.........+.+|+.+++.+ +||||+++++++.     .+..+++
T Consensus        18 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~l   97 (286)
T cd06638          18 DTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWL   97 (286)
T ss_pred             cceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccchHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeEEE
Confidence            689999999999999999999999999999998876544456788899999999 6999999999874     3467999


Q ss_pred             EEecCCCCChHHHHHh----CCCCCHHHHHHHHHHHHH-------CCeeecCCCCCCeEecCCCCCCEEEeecCCCcccC
Q 019195           76 VMEYAAGGELFERICN----AGRFSEDEARYFFQQLIS-------GQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSL  144 (344)
Q Consensus        76 v~e~~~~g~L~~~i~~----~~~~~~~~~~~~~~ql~~-------~~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~  144 (344)
                      ||||+++++|.+++..    ...+++..++.++.|++.       .+|+||||||+||+++.++.  +||+|||++....
T Consensus        98 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~--~kl~dfg~~~~~~  175 (286)
T cd06638          98 VLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGG--VKLVDFGVSAQLT  175 (286)
T ss_pred             EEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCC--EEEccCCceeecc
Confidence            9999999999988753    346788777777766654       49999999999999987654  9999999987543


Q ss_pred             CCC-CCCCCccCCcccCCccccCC----CCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCCCC
Q 019195          145 LHS-RPKSTVGTPAYIAPEVLSRR----EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDY  219 (344)
Q Consensus       145 ~~~-~~~~~~gt~~y~aPE~~~~~----~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  219 (344)
                      ... ......|++.|+|||++...    ...+.++||||+||++|+|++|+.||..............   .........
T Consensus       176 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~---~~~~~~~~~  252 (286)
T cd06638         176 STRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPR---NPPPTLHQP  252 (286)
T ss_pred             cCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhccc---cCCCcccCC
Confidence            322 22345699999999998532    2234569999999999999999999977544332221111   111112222


Q ss_pred             CCCCHhHHHHHHHhcccCCCCCCChHHHhcCccc
Q 019195          220 VHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF  253 (344)
Q Consensus       220 ~~~s~~~~~li~~~L~~dp~~R~s~~ell~hp~~  253 (344)
                      ..++..+.+||.+||+.+|.+|||+.++++||||
T Consensus       253 ~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~  286 (286)
T cd06638         253 ELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI  286 (286)
T ss_pred             CCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence            3467889999999999999999999999999997

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=1.9e-42  Score=309.60  Aligned_cols=248  Identities=28%  Similarity=0.455  Sum_probs=198.1

Q ss_pred             CceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCcc---ccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEEec
Q 019195            3 KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK---IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEY   79 (344)
Q Consensus         3 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~   79 (344)
                      +|++++.||.|++|.||+|.+..++..||+|.+.....   ....+.+|++++++++||||+++++++.+.+..++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF   80 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence            58999999999999999999999999999998865332   235688999999999999999999999999999999999


Q ss_pred             CCCCChHHHHHh--CCCCCHHHHHHHHHHHHH-------CCeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCC-CC
Q 019195           80 AAGGELFERICN--AGRFSEDEARYFFQQLIS-------GQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS-RP  149 (344)
Q Consensus        80 ~~~g~L~~~i~~--~~~~~~~~~~~~~~ql~~-------~~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~-~~  149 (344)
                      +. ++|..++..  ...+++..++.++.|++.       .+++||||+|+||+++.++.  +||+|||++....... ..
T Consensus        81 ~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~--~~l~dfg~~~~~~~~~~~~  157 (284)
T cd07860          81 LH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTY  157 (284)
T ss_pred             cc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCC--EEEeeccchhhcccCcccc
Confidence            95 688888865  356788888777777665       49999999999999987765  9999999987543222 12


Q ss_pred             CCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhc--------------ccc
Q 019195          150 KSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAV--------------QYK  215 (344)
Q Consensus       150 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~--------------~~~  215 (344)
                      ....+++.|+|||.+.+....+.++|||||||++|+|++|+.||...+........+......              ...
T Consensus       158 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (284)
T cd07860         158 THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPS  237 (284)
T ss_pred             ccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHHhh
Confidence            334578999999998776655666999999999999999999998766544444333221110              000


Q ss_pred             CCC---------CCCCCHhHHHHHHHhcccCCCCCCChHHHhcCccc
Q 019195          216 IPD---------YVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF  253 (344)
Q Consensus       216 ~~~---------~~~~s~~~~~li~~~L~~dp~~R~s~~ell~hp~~  253 (344)
                      ++.         ...+++.++++|.+||+.||.+|||+.++++||||
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f  284 (284)
T cd07860         238 FPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF  284 (284)
T ss_pred             cccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence            110         12467889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=2.1e-42  Score=309.75  Aligned_cols=250  Identities=31%  Similarity=0.484  Sum_probs=200.7

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecC---ccccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEEe
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERG---HKIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVME   78 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e   78 (344)
                      ++|++.+.||+|+||.||+|.+..+++.||+|++...   ......+.+|+++++.++|+||+++++++..++.++++||
T Consensus         1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   80 (288)
T cd07833           1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE   80 (288)
T ss_pred             CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence            5899999999999999999999999999999988653   2234678899999999999999999999999999999999


Q ss_pred             cCCCCChHHHHHhCCCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCC--CC
Q 019195           79 YAAGGELFERICNAGRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS--RP  149 (344)
Q Consensus        79 ~~~~g~L~~~i~~~~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~--~~  149 (344)
                      |++++.+..++.+...+++.+++.++.|++.+       +++||||+|+||+++.++.  +||+|||++.......  ..
T Consensus        81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~--~kl~d~g~~~~~~~~~~~~~  158 (288)
T cd07833          81 YVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGV--LKLCDFGFARALRARPASPL  158 (288)
T ss_pred             cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCC--EEEEeeecccccCCCccccc
Confidence            99987777666666678888888777776654       9999999999999987654  9999999987654443  23


Q ss_pred             CCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhcc------------c---
Q 019195          150 KSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQ------------Y---  214 (344)
Q Consensus       150 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~------------~---  214 (344)
                      ....++..|+|||++.+....+.++||||||+++|+|++|++||....................            +   
T Consensus       159 ~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (288)
T cd07833         159 TDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGV  238 (288)
T ss_pred             cCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCcccccc
Confidence            3457899999999998774455669999999999999999999987655433332221110000            0   


Q ss_pred             cCC-----------CCCCCCHhHHHHHHHhcccCCCCCCChHHHhcCccc
Q 019195          215 KIP-----------DYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF  253 (344)
Q Consensus       215 ~~~-----------~~~~~s~~~~~li~~~L~~dp~~R~s~~ell~hp~~  253 (344)
                      ..+           ....+++++.+||++||..+|.+|||+.++++||||
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f  288 (288)
T cd07833         239 AFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF  288 (288)
T ss_pred             ccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence            000           011247889999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.3e-42  Score=304.14  Aligned_cols=247  Identities=31%  Similarity=0.444  Sum_probs=201.3

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCcc-ccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEEecC
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK-IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYA   80 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~   80 (344)
                      ++|++.+.||.|+||.||+|.+..+++.+|+|++..... ....+.+|+.++++++||||+++++++.....+|++|||+
T Consensus         3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~   82 (262)
T cd06613           3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYC   82 (262)
T ss_pred             cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCC
Confidence            689999999999999999999999999999999876433 3467889999999999999999999999999999999999


Q ss_pred             CCCChHHHHHhC-CCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCC-CCCC
Q 019195           81 AGGELFERICNA-GRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS-RPKS  151 (344)
Q Consensus        81 ~~g~L~~~i~~~-~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~-~~~~  151 (344)
                      ++++|.+++... ..+++.+++.++.|++.+       ||+|+||||+||+++.++.  +||+|||++....... ....
T Consensus        83 ~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~--~~l~d~g~~~~~~~~~~~~~~  160 (262)
T cd06613          83 GGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGD--VKLADFGVSAQLTATIAKRKS  160 (262)
T ss_pred             CCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCC--EEECccccchhhhhhhhcccc
Confidence            999999998776 789999988888777765       9999999999999987654  9999999987543322 2334


Q ss_pred             CccCCcccCCccccCC---CCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCHhHHH
Q 019195          152 TVGTPAYIAPEVLSRR---EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRN  228 (344)
Q Consensus       152 ~~gt~~y~aPE~~~~~---~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~  228 (344)
                      ..++..|+|||.+.+.   .++ .++|+|||||++|+|++|.+||................. ..........++.++.+
T Consensus       161 ~~~~~~y~~Pe~~~~~~~~~~~-~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~  238 (262)
T cd06613         161 FIGTPYWMAPEVAAVERKGGYD-GKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNF-PPPKLKDKEKWSPVFHD  238 (262)
T ss_pred             ccCCccccCchhhcccccCCcC-chhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccC-CCccccchhhhhHHHHH
Confidence            5789999999998765   554 559999999999999999999987654333222111100 01111122245788999


Q ss_pred             HHHHhcccCCCCCCChHHHhcCcc
Q 019195          229 LLSRIFVANPSRRITIKEIKSHPW  252 (344)
Q Consensus       229 li~~~L~~dp~~R~s~~ell~hp~  252 (344)
                      ||.+||+.+|..|||+.+++.|||
T Consensus       239 li~~~l~~~p~~Rpt~~~il~~~~  262 (262)
T cd06613         239 FIKKCLTKDPKKRPTATKLLQHPF  262 (262)
T ss_pred             HHHHHcCCChhhCCCHHHHhcCCC
Confidence            999999999999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=1.9e-42  Score=311.92  Aligned_cols=250  Identities=27%  Similarity=0.451  Sum_probs=201.4

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCcc-ccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEEecC
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK-IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYA   80 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~   80 (344)
                      .+|++++.||+|+||.||++.+..+++.||+|.+..... ....+.+|+.+++.++||||+++++++.....+|+||||+
T Consensus        19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~   98 (297)
T cd06656          19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   98 (297)
T ss_pred             hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeeccc
Confidence            589999999999999999999999999999999875433 2356788999999999999999999999999999999999


Q ss_pred             CCCChHHHHHhCCCCCHHHHHHHHHHHH-------HCCeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCCC-CCCC
Q 019195           81 AGGELFERICNAGRFSEDEARYFFQQLI-------SGQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR-PKST  152 (344)
Q Consensus        81 ~~g~L~~~i~~~~~~~~~~~~~~~~ql~-------~~~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~~-~~~~  152 (344)
                      ++++|.+++.+ ..+++.++..++.|++       +.|++||||||+|||++.++.  ++|+|||++........ ....
T Consensus        99 ~~~~L~~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~--~~l~Dfg~~~~~~~~~~~~~~~  175 (297)
T cd06656          99 AGGSLTDVVTE-TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGS--VKLTDFGFCAQITPEQSKRSTM  175 (297)
T ss_pred             CCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCC--EEECcCccceEccCCccCcCcc
Confidence            99999998864 4577777777766655       459999999999999976654  99999999875433222 2345


Q ss_pred             ccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCHhHHHHHHH
Q 019195          153 VGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSR  232 (344)
Q Consensus       153 ~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~  232 (344)
                      .+++.|+|||.+.+..+. .++|+|||||++|+|++|..||...+........   .............++..+.+||.+
T Consensus       176 ~~~~~y~aPE~~~~~~~~-~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~li~~  251 (297)
T cd06656         176 VGTPYWMAPEVVTRKAYG-PKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI---ATNGTPELQNPERLSAVFRDFLNR  251 (297)
T ss_pred             cCCccccCHHHHcCCCCC-cHHHHHHHHHHHHHHHhCCCCCCCCCcchheeee---ccCCCCCCCCccccCHHHHHHHHH
Confidence            689999999999876654 5599999999999999999999775442221111   111111222334578899999999


Q ss_pred             hcccCCCCCCChHHHhcCcccccCCC
Q 019195          233 IFVANPSRRITIKEIKSHPWFLKNLP  258 (344)
Q Consensus       233 ~L~~dp~~R~s~~ell~hp~~~~~~~  258 (344)
                      ||..+|.+||++.++++||||....+
T Consensus       252 ~l~~~p~~Rps~~~il~~~~~~~~~~  277 (297)
T cd06656         252 CLEMDVDRRGSAKELLQHPFLKLAKP  277 (297)
T ss_pred             HccCChhhCcCHHHHhcCchhccccc
Confidence            99999999999999999999976544

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=1.6e-42  Score=309.18  Aligned_cols=242  Identities=29%  Similarity=0.471  Sum_probs=197.0

Q ss_pred             eeecCceEEEEEEEcCCCcEEEEEEeecCc----cccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEEecCCCCCh
Q 019195           10 IGSGNFGVARLMRNKNTKELVAMKYIERGH----KIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYAAGGEL   85 (344)
Q Consensus        10 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L   85 (344)
                      ||+|+||+||+|.+..+++.||+|.+....    .....+.+|+.++++++||||+++++++...+.+|+||||+++++|
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL   80 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence            699999999999999999999999987532    2234567899999999999999999999999999999999999999


Q ss_pred             HHHHHhCC--CCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCCCCCCCccCC
Q 019195           86 FERICNAG--RFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTP  156 (344)
Q Consensus        86 ~~~i~~~~--~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~~~~~~~gt~  156 (344)
                      .+++.+..  .+++.+++.++.|++.+       |++||||+|+||+++.++.  ++|+|||++.............++.
T Consensus        81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~  158 (277)
T cd05577          81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGN--VRISDLGLAVELKGGKKIKGRAGTP  158 (277)
T ss_pred             HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCC--EEEccCcchhhhccCCccccccCCC
Confidence            99997765  68888888777776654       9999999999999987664  9999999987544333344556889


Q ss_pred             cccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCHhHHHHHHHhccc
Q 019195          157 AYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVA  236 (344)
Q Consensus       157 ~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~  236 (344)
                      .|+|||.+.+..+ +.++|||||||++|+|++|+.||...........+...........+  ..+++.+.++|.+||+.
T Consensus       159 ~y~~PE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~l~~  235 (277)
T cd05577         159 GYMAPEVLQGEVY-DFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYP--DKFSPEAKDLCEALLQK  235 (277)
T ss_pred             CcCCHHHhcCCCC-CchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccccccccCC--ccCCHHHHHHHHHHccC
Confidence            9999999877665 45599999999999999999999776543233333333222222222  35789999999999999


Q ss_pred             CCCCCC-----ChHHHhcCcccccC
Q 019195          237 NPSRRI-----TIKEIKSHPWFLKN  256 (344)
Q Consensus       237 dp~~R~-----s~~ell~hp~~~~~  256 (344)
                      +|.+||     ++.+++.||||...
T Consensus       236 ~p~~R~~~~~~~~~~ll~h~~~~~~  260 (277)
T cd05577         236 DPEKRLGCRGGSADEVREHPLFKDL  260 (277)
T ss_pred             ChhHccCCCcccHHHHHhChhhhcC
Confidence            999999     88899999999653

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=7.4e-43  Score=308.92  Aligned_cols=250  Identities=27%  Similarity=0.502  Sum_probs=202.0

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCc--cccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEEec
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH--KIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEY   79 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~   79 (344)
                      ++|++.+.||.|+||.||++.+..+++.+|+|.+....  .....+.+|+.+++.++||||+++++++...+.+++++||
T Consensus         1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (265)
T cd06605           1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY   80 (265)
T ss_pred             CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence            57999999999999999999999999999999987653  2335688999999999999999999999999999999999


Q ss_pred             CCCCChHHHHHhC-CCCCHHHHHHHHHHHHH--------CCeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCCCCC
Q 019195           80 AAGGELFERICNA-GRFSEDEARYFFQQLIS--------GQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPK  150 (344)
Q Consensus        80 ~~~g~L~~~i~~~-~~~~~~~~~~~~~ql~~--------~~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~~~~  150 (344)
                      +++++|.+++... ..+++..+..++.|++.        .|++|+||||+||+++.++  .++|+|||++........ .
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~--~~~l~d~g~~~~~~~~~~-~  157 (265)
T cd06605          81 MDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRG--QIKLCDFGVSGQLVNSLA-K  157 (265)
T ss_pred             cCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCC--CEEEeecccchhhHHHHh-h
Confidence            9999999999876 77888888777766654        5999999999999998755  499999998865432221 2


Q ss_pred             CCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC-hHHHHHHHHHHhhccc-cCCCCCCCCHhHHH
Q 019195          151 STVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQED-PKNFRKTISRIMAVQY-KIPDYVHISQDCRN  228 (344)
Q Consensus       151 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-~~~~~~~~~~~~~~~~-~~~~~~~~s~~~~~  228 (344)
                      ...++..|+|||.+.+..+. .++||||||+++|+|++|..||..... .......+..+..... ..+. ..+++++.+
T Consensus       158 ~~~~~~~y~~PE~~~~~~~~-~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~  235 (265)
T cd06605         158 TFVGTSSYMAPERIQGNDYS-VKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPS-GKFSPDFQD  235 (265)
T ss_pred             cccCChhccCHHHHcCCCCC-chhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCCCCCCh-hhcCHHHHH
Confidence            26789999999999877654 559999999999999999999976521 1122223333222211 1222 127889999


Q ss_pred             HHHHhcccCCCCCCChHHHhcCcccccC
Q 019195          229 LLSRIFVANPSRRITIKEIKSHPWFLKN  256 (344)
Q Consensus       229 li~~~L~~dp~~R~s~~ell~hp~~~~~  256 (344)
                      +|.+||..+|.+|||+.+++.||||++.
T Consensus       236 li~~~l~~~p~~Rpt~~~ll~~~~~~~~  263 (265)
T cd06605         236 FVNLCLIKDPRERPSYKELLEHPFIKKY  263 (265)
T ss_pred             HHHHHcCCCchhCcCHHHHhhCchhhcc
Confidence            9999999999999999999999999653

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=4e-42  Score=304.46  Aligned_cols=243  Identities=23%  Similarity=0.373  Sum_probs=197.0

Q ss_pred             CceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCcc-------ccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEE
Q 019195            3 KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK-------IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAI   75 (344)
Q Consensus         3 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-------~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~l   75 (344)
                      +|++.+.||+|+||.||++.+ .+++.+|+|.+.....       ....+.+|+.++++++|+||+++++++.+.+.+++
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l   79 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISI   79 (265)
T ss_pred             CccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEE
Confidence            689999999999999999987 4788999998865321       12457889999999999999999999999999999


Q ss_pred             EEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCC---
Q 019195           76 VMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLL---  145 (344)
Q Consensus        76 v~e~~~~g~L~~~i~~~~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~---  145 (344)
                      +|||+++++|.+++.+.+.+++..++.++.|++.+       +|+|+||+|+||+++.++.  ++|+|||++.....   
T Consensus        80 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~--~~l~dfg~~~~~~~~~~  157 (265)
T cd06631          80 FMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGI--IKLIDFGCARRLAWVGL  157 (265)
T ss_pred             EEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCe--EEeccchhhHhhhhccc
Confidence            99999999999999888888998888887776654       9999999999999986654  99999998864321   


Q ss_pred             ----CCCCCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhc-cccCCCCC
Q 019195          146 ----HSRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAV-QYKIPDYV  220 (344)
Q Consensus       146 ----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~  220 (344)
                          ........|+..|+|||.+.+..++ .++|+|||||++|+|++|..||............    ... ....+...
T Consensus       158 ~~~~~~~~~~~~~~~~~~~pe~~~~~~~~-~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~----~~~~~~~~~~~~  232 (265)
T cd06631         158 HGTHSNMLKSMHGTPYWMAPEVINESGYG-RKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYI----GAHRGLMPRLPD  232 (265)
T ss_pred             cccccccccccCCCccccChhhhcCCCCc-chhhHHHHHHHHHHHHhCCCccccCChHHHHHHh----hhccCCCCCCCC
Confidence                1112345689999999999877654 4599999999999999999999765433222111    111 11112223


Q ss_pred             CCCHhHHHHHHHhcccCCCCCCChHHHhcCccc
Q 019195          221 HISQDCRNLLSRIFVANPSRRITIKEIKSHPWF  253 (344)
Q Consensus       221 ~~s~~~~~li~~~L~~dp~~R~s~~ell~hp~~  253 (344)
                      .++..+.++|.+||+.+|.+||++.+++.||||
T Consensus       233 ~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~  265 (265)
T cd06631         233 SFSAAAIDFVTSCLTRDQHERPSALQLLRHDFL  265 (265)
T ss_pred             CCCHHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence            578999999999999999999999999999997

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=3.7e-42  Score=302.98  Aligned_cols=245  Identities=29%  Similarity=0.437  Sum_probs=201.0

Q ss_pred             CceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCcc------ccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEE
Q 019195            3 KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK------IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIV   76 (344)
Q Consensus         3 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~------~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv   76 (344)
                      +|+..+.||+|++|.||+|.+..++..||+|.+.....      ....+.+|+.+++.++|+||+++++++.....++++
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF   80 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence            68999999999999999999998999999999865331      235688999999999999999999999999999999


Q ss_pred             EecCCCCChHHHHHhCCCCCHHHHHHHHHHHHH-------CCeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCCCC
Q 019195           77 MEYAAGGELFERICNAGRFSEDEARYFFQQLIS-------GQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP  149 (344)
Q Consensus        77 ~e~~~~g~L~~~i~~~~~~~~~~~~~~~~ql~~-------~~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~~~  149 (344)
                      +||+++++|.+++.+...+++..++.++.|++.       .|++|+||+|+||+++.++  .+||+|||++.........
T Consensus        81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~--~~kl~d~~~~~~~~~~~~~  158 (258)
T cd06632          81 LELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNG--VVKLADFGMAKQVVEFSFA  158 (258)
T ss_pred             EEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC--CEEEccCccceeccccccc
Confidence            999999999999988888888888877776665       4999999999999998665  4999999998765444434


Q ss_pred             CCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCHhHHHH
Q 019195          150 KSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL  229 (344)
Q Consensus       150 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  229 (344)
                      ....|++.|+|||.+......+.++|+|||||++|+|++|+.||...........    .............+++.+.+|
T Consensus       159 ~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~l  234 (258)
T cd06632         159 KSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFK----IGRSKELPPIPDHLSDEAKDF  234 (258)
T ss_pred             cccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHH----HHhcccCCCcCCCcCHHHHHH
Confidence            5567999999999987665234569999999999999999999977653222221    111111111223578999999


Q ss_pred             HHHhcccCCCCCCChHHHhcCccc
Q 019195          230 LSRIFVANPSRRITIKEIKSHPWF  253 (344)
Q Consensus       230 i~~~L~~dp~~R~s~~ell~hp~~  253 (344)
                      +.+||+.+|.+||++.+++.|||+
T Consensus       235 i~~~l~~~p~~Rp~~~~~l~~~~~  258 (258)
T cd06632         235 ILKCLQRDPSLRPTAAELLEHPFV  258 (258)
T ss_pred             HHHHhhcCcccCcCHHHHhcCCCC
Confidence            999999999999999999999996

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=2e-42  Score=306.71  Aligned_cols=249  Identities=28%  Similarity=0.457  Sum_probs=202.1

Q ss_pred             CceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCcc-------ccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEE
Q 019195            3 KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK-------IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAI   75 (344)
Q Consensus         3 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-------~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~l   75 (344)
                      +|+..+.||+|++|.||++.+..++..||+|++.....       ....+.+|+.+++.++|+||+++++++...+.+++
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   80 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL   80 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence            58999999999999999999999999999999875331       23568899999999999999999999999999999


Q ss_pred             EEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCCC
Q 019195           76 VMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR  148 (344)
Q Consensus        76 v~e~~~~g~L~~~i~~~~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~~  148 (344)
                      ||||+++++|.+++.+.+.+++..++.++.|++.|       |++|+||||+||+++.++. .+||+|||++........
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~-~~~l~dfg~~~~~~~~~~  159 (268)
T cd06630          81 FVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQ-RLRIADFGAAARLAAKGT  159 (268)
T ss_pred             EEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCC-EEEEcccccccccccccc
Confidence            99999999999999888889999888888887765       9999999999999975532 489999999865433211


Q ss_pred             -----CCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCC
Q 019195          149 -----PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHIS  223 (344)
Q Consensus       149 -----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s  223 (344)
                           .....||..|+|||.+.+..++ .++|+|||||++|+|++|..||.......... .+...............++
T Consensus       160 ~~~~~~~~~~~~~~~~~PE~~~~~~~~-~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~  237 (268)
T cd06630         160 GAGEFQGQLLGTIAFMAPEVLRGEQYG-RSCDVWSVGCVIIEMATAKPPWNAEKHSNHLA-LIFKIASATTAPSIPEHLS  237 (268)
T ss_pred             cCCccccccccccceeCHhHhccCCCC-cccchHHHHHHHHHHHhCCCCCCCCCCcchHH-HHHHHhccCCCCCCchhhC
Confidence                 1234689999999998776654 55999999999999999999997654332222 2222222222222223578


Q ss_pred             HhHHHHHHHhcccCCCCCCChHHHhcCcccc
Q 019195          224 QDCRNLLSRIFVANPSRRITIKEIKSHPWFL  254 (344)
Q Consensus       224 ~~~~~li~~~L~~dp~~R~s~~ell~hp~~~  254 (344)
                      +++.+++.+||..+|.+|||+.++++||||.
T Consensus       238 ~~~~~~i~~~l~~~p~~R~~~~~ll~~~~~~  268 (268)
T cd06630         238 PGLRDVTLRCLELQPEDRPPSRELLKHPVFR  268 (268)
T ss_pred             HHHHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence            8999999999999999999999999999984

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=6.2e-42  Score=302.73  Aligned_cols=247  Identities=30%  Similarity=0.493  Sum_probs=202.8

Q ss_pred             CceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCcc---ccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEEec
Q 019195            3 KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK---IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEY   79 (344)
Q Consensus         3 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~   79 (344)
                      ||++.+.||+|+||.||++.+..+++.||+|.+.....   ....+.+|+.+++.++|+||+++++++...+.+++|+||
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY   80 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence            79999999999999999999999999999999876544   346788999999999999999999999999999999999


Q ss_pred             CCCCChHHHHHhCCCCCHHHHHHHHHHHHH-------CCeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCCCC---
Q 019195           80 AAGGELFERICNAGRFSEDEARYFFQQLIS-------GQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP---  149 (344)
Q Consensus        80 ~~~g~L~~~i~~~~~~~~~~~~~~~~ql~~-------~~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~~~---  149 (344)
                      +++++|.+++.+...+++..++.++.|++.       .||+|+||+|+||+++.++.  +||+|||++.........   
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~--~kl~d~g~~~~~~~~~~~~~~  158 (264)
T cd06626          81 CSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGV--IKLGDFGCAVKLKNNTTTMGE  158 (264)
T ss_pred             CCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCC--EEEcccccccccCCCCCcccc
Confidence            999999999988777888888877766665       49999999999999987654  999999998764333221   


Q ss_pred             --CCCccCCcccCCccccCCC--CCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCHh
Q 019195          150 --KSTVGTPAYIAPEVLSRRE--YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQD  225 (344)
Q Consensus       150 --~~~~gt~~y~aPE~~~~~~--~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~  225 (344)
                        ....+++.|+|||.+.+..  ..+.++||||||+++|+|++|+.||............  ........+|....+++.
T Consensus       159 ~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~  236 (264)
T cd06626         159 EVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFH--VGAGHKPPIPDSLQLSPE  236 (264)
T ss_pred             cccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHH--HhcCCCCCCCcccccCHH
Confidence              1346889999999987655  2345699999999999999999999765432221111  111223345555556899


Q ss_pred             HHHHHHHhcccCCCCCCChHHHhcCccc
Q 019195          226 CRNLLSRIFVANPSRRITIKEIKSHPWF  253 (344)
Q Consensus       226 ~~~li~~~L~~dp~~R~s~~ell~hp~~  253 (344)
                      +.+||.+||+.+|.+|||+.+++.|||+
T Consensus       237 ~~~li~~~l~~~p~~R~~~~~i~~~~~~  264 (264)
T cd06626         237 GKDFLDRCLESDPKKRPTASELLQHPFV  264 (264)
T ss_pred             HHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence            9999999999999999999999999996

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=1.4e-42  Score=320.23  Aligned_cols=251  Identities=27%  Similarity=0.424  Sum_probs=197.3

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCcc---ccHHHHHHHHHHhcCCCCCcceeeEEEEcC------CE
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK---IDANVAREIINHKQLRHPNIIRFKEVVLTP------TH   72 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~ei~~l~~l~h~niv~~~~~~~~~------~~   72 (344)
                      ++|++++.||+|+||.||+|.+..+++.||+|.+.+...   ....+.+|+.+++.++||||++++++|...      ..
T Consensus        16 ~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   95 (353)
T cd07850          16 KRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQD   95 (353)
T ss_pred             cceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccCc
Confidence            689999999999999999999999999999999865322   234677899999999999999999998654      35


Q ss_pred             EEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHH-------CCeeecCCCCCCeEecCCCCCCEEEeecCCCcccCC
Q 019195           73 LAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLIS-------GQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLL  145 (344)
Q Consensus        73 ~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~ql~~-------~~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~  145 (344)
                      .|+||||+. ++|...+...  +++..++.++.|++.       .||+||||||+||+++.++.  +||+|||+++....
T Consensus        96 ~~lv~e~~~-~~l~~~~~~~--l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~--~kL~Dfg~~~~~~~  170 (353)
T cd07850          96 VYLVMELMD-ANLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGT  170 (353)
T ss_pred             EEEEEeccC-CCHHHHHhhc--CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCC--EEEccCccceeCCC
Confidence            799999995 5888877644  788887777776655       49999999999999987654  99999999986544


Q ss_pred             CCCCCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhc-------------
Q 019195          146 HSRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAV-------------  212 (344)
Q Consensus       146 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~-------------  212 (344)
                      ........+++.|+|||.+.+..+. .++|||||||++|+|++|+.||...+....+.+++......             
T Consensus       171 ~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (353)
T cd07850         171 SFMMTPYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPTVR  249 (353)
T ss_pred             CCCCCCCcccccccCHHHHhCCCCC-CchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhhhh
Confidence            4444456789999999999887765 45999999999999999999998765444433332211100             


Q ss_pred             -----ccc--------------CCC-----CCCCCHhHHHHHHHhcccCCCCCCChHHHhcCcccccCCC
Q 019195          213 -----QYK--------------IPD-----YVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLP  258 (344)
Q Consensus       213 -----~~~--------------~~~-----~~~~s~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~~~~  258 (344)
                           ...              .+.     ....++.+.+||.+||+.||.+|||+.++|.||||.....
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~~~~~  319 (353)
T cd07850         250 NYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINVWYD  319 (353)
T ss_pred             HHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHhhccC
Confidence                 000              000     1124567899999999999999999999999999976544

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=8e-42  Score=300.66  Aligned_cols=244  Identities=36%  Similarity=0.530  Sum_probs=201.1

Q ss_pred             CceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCc---cccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEEec
Q 019195            3 KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH---KIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEY   79 (344)
Q Consensus         3 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~   79 (344)
                      +|++.+.||+|+||.||+|.+..++..+|+|.+....   .....+.+|+.++++++||||+++++.+...+.+++||||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY   80 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence            6999999999999999999999999999999987643   2235688999999999999999999999999999999999


Q ss_pred             CCCCChHHHHHhC--CCCCHHHHHHHHHHHHH-------CCeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCCCCC
Q 019195           80 AAGGELFERICNA--GRFSEDEARYFFQQLIS-------GQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPK  150 (344)
Q Consensus        80 ~~~g~L~~~i~~~--~~~~~~~~~~~~~ql~~-------~~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~~~~  150 (344)
                      +++++|.+++...  ..+++..++.++.|++.       .|++||||||+||+++.+.. .+||+|||++..........
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~-~~~l~d~~~~~~~~~~~~~~  159 (256)
T cd08220          81 APGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKM-VVKIGDFGISKILSSKSKAY  159 (256)
T ss_pred             CCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCC-EEEEccCCCceecCCCcccc
Confidence            9999999999764  34788887777766664       49999999999999975432 48999999998665544445


Q ss_pred             CCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCHhHHHHH
Q 019195          151 STVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLL  230 (344)
Q Consensus       151 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li  230 (344)
                      ...|+..|+|||.+.+... +.++|+||||+++|+|++|..||...+.......+..    ... .+....+++++.+++
T Consensus       160 ~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~----~~~-~~~~~~~~~~l~~li  233 (256)
T cd08220         160 TVVGTPCYISPELCEGKPY-NQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMS----GTF-APISDRYSPDLRQLI  233 (256)
T ss_pred             ccccCCcccCchhccCCCC-CcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHh----cCC-CCCCCCcCHHHHHHH
Confidence            5678999999999987665 4559999999999999999999987654433322221    111 122235789999999


Q ss_pred             HHhcccCCCCCCChHHHhcCccc
Q 019195          231 SRIFVANPSRRITIKEIKSHPWF  253 (344)
Q Consensus       231 ~~~L~~dp~~R~s~~ell~hp~~  253 (344)
                      .+||+.+|.+|||+.++++||||
T Consensus       234 ~~~l~~~p~~Rpt~~~ll~~p~~  256 (256)
T cd08220         234 LSMLNLDPSKRPQLSQIMAQPIC  256 (256)
T ss_pred             HHHccCChhhCCCHHHHhhCCCC
Confidence            99999999999999999999996

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=5.1e-42  Score=308.48  Aligned_cols=253  Identities=27%  Similarity=0.413  Sum_probs=197.9

Q ss_pred             CCCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCc---cccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEE
Q 019195            1 MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH---KIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVM   77 (344)
Q Consensus         1 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~   77 (344)
                      |++|++.+.||+|++|.||++.+..+++.||+|.+....   .....+.+|+.++++++||||+++++++......|+||
T Consensus         1 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   80 (294)
T PLN00009          1 MDQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVF   80 (294)
T ss_pred             CCceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEE
Confidence            689999999999999999999999999999999986543   22356788999999999999999999999999999999


Q ss_pred             ecCCCCChHHHHHhCCC--CCHHHHHHHHHHHH-------HCCeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCC-
Q 019195           78 EYAAGGELFERICNAGR--FSEDEARYFFQQLI-------SGQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS-  147 (344)
Q Consensus        78 e~~~~g~L~~~i~~~~~--~~~~~~~~~~~ql~-------~~~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~-  147 (344)
                      ||++ ++|...+.....  +++..++.++.||+       +.+++||||+|+||+++..+ +.+||+|||++....... 
T Consensus        81 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~-~~~kl~dfg~~~~~~~~~~  158 (294)
T PLN00009         81 EYLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRT-NALKLADFGLARAFGIPVR  158 (294)
T ss_pred             eccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCC-CEEEEcccccccccCCCcc
Confidence            9995 588887765443  46666666666655       44999999999999997543 248999999987543222 


Q ss_pred             CCCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccc-------------
Q 019195          148 RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQY-------------  214 (344)
Q Consensus       148 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~-------------  214 (344)
                      ......+++.|+|||.+.+....+.++|||||||++|+|++|++||..........+.+........             
T Consensus       159 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (294)
T PLN00009        159 TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDYK  238 (294)
T ss_pred             ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchhhh
Confidence            2234468899999999876554456699999999999999999999876554444433321111000             


Q ss_pred             -cCC---------CCCCCCHhHHHHHHHhcccCCCCCCChHHHhcCccccc
Q 019195          215 -KIP---------DYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLK  255 (344)
Q Consensus       215 -~~~---------~~~~~s~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~  255 (344)
                       ..+         ....+++.+.++|.+||+.+|.+||++.++++||||..
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~  289 (294)
T PLN00009        239 SAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKD  289 (294)
T ss_pred             hhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhH
Confidence             000         01246889999999999999999999999999999964

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=5.5e-42  Score=308.29  Aligned_cols=251  Identities=27%  Similarity=0.393  Sum_probs=197.4

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCcc---ccHHHHHHHHHHhcCC-CCCcceeeEEEEcCCE-----
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK---IDANVAREIINHKQLR-HPNIIRFKEVVLTPTH-----   72 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~ei~~l~~l~-h~niv~~~~~~~~~~~-----   72 (344)
                      ++|++.+.||+|+||.||++.+..+++.||+|++.....   ....+.+|+.+++.++ ||||+++++++.....     
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~   80 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS   80 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence            589999999999999999999999999999998865432   2356888999999995 6999999999987665     


Q ss_pred             EEEEEecCCCCChHHHHHhC-----CCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCC
Q 019195           73 LAIVMEYAAGGELFERICNA-----GRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYS  140 (344)
Q Consensus        73 ~~lv~e~~~~g~L~~~i~~~-----~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a  140 (344)
                      +|++|||+++ +|..++...     ..+++..++.++.|++.+       ||+||||||+||+++.+. +.+||+|||++
T Consensus        81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~-~~~kl~dfg~~  158 (295)
T cd07837          81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQK-GLLKIADLGLG  158 (295)
T ss_pred             EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCC-CeEEEeecccc
Confidence            8999999975 788887542     357888888887777654       999999999999998622 35999999998


Q ss_pred             cccCCC-CCCCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccc-----
Q 019195          141 KSSLLH-SRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQY-----  214 (344)
Q Consensus       141 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~-----  214 (344)
                      ...... .......+++.|+|||.+.+....+.++||||||+++|+|++|..||..........+++..+.....     
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (295)
T cd07837         159 RAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPG  238 (295)
T ss_pred             eecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhCcc
Confidence            754322 22233467899999999876554456699999999999999999999887665554444332211000     


Q ss_pred             --------cCC---------CCCCCCHhHHHHHHHhcccCCCCCCChHHHhcCcccc
Q 019195          215 --------KIP---------DYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFL  254 (344)
Q Consensus       215 --------~~~---------~~~~~s~~~~~li~~~L~~dp~~R~s~~ell~hp~~~  254 (344)
                              ..+         ....+++.+.+||.+||+.||.+|||+.+++.||||.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~  295 (295)
T cd07837         239 VSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD  295 (295)
T ss_pred             hhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence                    000         0124788999999999999999999999999999984

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=2.9e-42  Score=308.55  Aligned_cols=231  Identities=19%  Similarity=0.213  Sum_probs=186.4

Q ss_pred             eeeeecCceEEEEEEEcCCCcEEEEEEeecCcccc----HHHHHHHHHHhcCCCCCcceeeEEEEc----CCEEEEEEec
Q 019195            8 KDIGSGNFGVARLMRNKNTKELVAMKYIERGHKID----ANVAREIINHKQLRHPNIIRFKEVVLT----PTHLAIVMEY   79 (344)
Q Consensus         8 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~----~~~~~ei~~l~~l~h~niv~~~~~~~~----~~~~~lv~e~   79 (344)
                      ..||+|++|.||++..  +|+.||+|.+.......    ..+.+|+.++++++||||+++++++.+    ...+++||||
T Consensus        26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey  103 (283)
T PHA02988         26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY  103 (283)
T ss_pred             eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence            5789999999999987  68899999997654433    456799999999999999999999877    3578999999


Q ss_pred             CCCCChHHHHHhCCCCCHHHHHHHHHHHHH--------CCeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCCCCCC
Q 019195           80 AAGGELFERICNAGRFSEDEARYFFQQLIS--------GQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKS  151 (344)
Q Consensus        80 ~~~g~L~~~i~~~~~~~~~~~~~~~~ql~~--------~~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~~~~~  151 (344)
                      +++|+|.+++.+.+.++......++.|++.        .+++||||||+|||++.++.  +||+|||+++....  ....
T Consensus       104 ~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~--~kl~dfg~~~~~~~--~~~~  179 (283)
T PHA02988        104 CTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYK--LKIICHGLEKILSS--PPFK  179 (283)
T ss_pred             CCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCc--EEEcccchHhhhcc--cccc
Confidence            999999999988888888777776665553        38899999999999987664  99999999875432  2234


Q ss_pred             CccCCcccCCccccC--CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCHhHHHH
Q 019195          152 TVGTPAYIAPEVLSR--REYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL  229 (344)
Q Consensus       152 ~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  229 (344)
                      ..||+.|+|||++.+  ..+ +.++|||||||++|+|++|+.||........+.    .+.....+.+.....++.+++|
T Consensus       180 ~~~~~~y~aPE~~~~~~~~~-~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~----~i~~~~~~~~~~~~~~~~l~~l  254 (283)
T PHA02988        180 NVNFMVYFSYKMLNDIFSEY-TIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYD----LIINKNNSLKLPLDCPLEIKCI  254 (283)
T ss_pred             ccCcccccCHHHhhhccccc-cchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHH----HHHhcCCCCCCCCcCcHHHHHH
Confidence            568999999999975  344 556999999999999999999998765433332    2322233333333578999999


Q ss_pred             HHHhcccCCCCCCChHHHhc
Q 019195          230 LSRIFVANPSRRITIKEIKS  249 (344)
Q Consensus       230 i~~~L~~dp~~R~s~~ell~  249 (344)
                      |.+||+.||.+|||+.+++.
T Consensus       255 i~~cl~~dp~~Rps~~ell~  274 (283)
T PHA02988        255 VEACTSHDSIKRPNIKEILY  274 (283)
T ss_pred             HHHHhcCCcccCcCHHHHHH
Confidence            99999999999999999985

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=6.3e-42  Score=309.63  Aligned_cols=248  Identities=33%  Similarity=0.529  Sum_probs=200.4

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCcc----ccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEE
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK----IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVM   77 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~   77 (344)
                      ++|++++.||+|+||.||++.+..+++.||+|.+.....    ....+.+|+.+++.++||||+++++.+..++.+++||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM   80 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence            579999999999999999999999999999999876432    2346778999999999999999999999999999999


Q ss_pred             ecCCCCChHHHHHhCCCCCHHHHHHHHHHHH-------HCCeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCC---
Q 019195           78 EYAAGGELFERICNAGRFSEDEARYFFQQLI-------SGQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS---  147 (344)
Q Consensus        78 e~~~~g~L~~~i~~~~~~~~~~~~~~~~ql~-------~~~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~---  147 (344)
                      ||++|++|.+++...+.+++..++.++.|++       +.|++||||||+||+++.++.  +||+|||+++......   
T Consensus        81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~--~~l~dfg~~~~~~~~~~~~  158 (305)
T cd05609          81 EYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGH--IKLTDFGLSKIGLMSLTTN  158 (305)
T ss_pred             ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCC--EEEeeCCCccccCcCcccc
Confidence            9999999999998888888888777766655       459999999999999976654  9999999886321100   


Q ss_pred             -------------CCCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccc
Q 019195          148 -------------RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQY  214 (344)
Q Consensus       148 -------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~  214 (344)
                                   ......|+..|+|||.+.+..+. .++|||||||++|+|++|..||.+......    .........
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~vl~el~~g~~pf~~~~~~~~----~~~~~~~~~  233 (305)
T cd05609         159 LYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYG-KPVDWWAMGIILYEFLVGCVPFFGDTPEEL----FGQVISDDI  233 (305)
T ss_pred             ccccccccchhhccccCCccCccccCchhccCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHH----HHHHHhccc
Confidence                         01123578899999998776664 559999999999999999999986544322    222222222


Q ss_pred             cCCCC-CCCCHhHHHHHHHhcccCCCCCCC---hHHHhcCcccccC
Q 019195          215 KIPDY-VHISQDCRNLLSRIFVANPSRRIT---IKEIKSHPWFLKN  256 (344)
Q Consensus       215 ~~~~~-~~~s~~~~~li~~~L~~dp~~R~s---~~ell~hp~~~~~  256 (344)
                      ..|.. ..++.++.++|.+||+.+|.+||+   +.++|+||||...
T Consensus       234 ~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~~  279 (305)
T cd05609         234 EWPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGL  279 (305)
T ss_pred             CCCCccccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccCC
Confidence            22221 257889999999999999999997   7999999999664

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=1.6e-42  Score=315.06  Aligned_cols=244  Identities=25%  Similarity=0.407  Sum_probs=181.1

Q ss_pred             eeeeecCceEEEEEEEcC--CCcEEEEEEeecCccccHHHHHHHHHHhcCCCCCcceeeEEEEc--CCEEEEEEecCCCC
Q 019195            8 KDIGSGNFGVARLMRNKN--TKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKEVVLT--PTHLAIVMEYAAGG   83 (344)
Q Consensus         8 ~~lg~G~~g~V~~~~~~~--~~~~vaiK~~~~~~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~--~~~~~lv~e~~~~g   83 (344)
                      .+||+|+||.||+|....  ++..||+|.+.... ....+.+|+.+++.++||||+++++++..  +..++++|||+. +
T Consensus         7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~-~   84 (317)
T cd07867           7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG-ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE-H   84 (317)
T ss_pred             eEeccCCCeeEEEEEecCCCccceEEEEEecCCC-CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC-C
Confidence            589999999999999653  66899999887543 33567899999999999999999999854  567899999995 5


Q ss_pred             ChHHHHHhC---------CCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCC--CCCCEEEeecCCCcccCC
Q 019195           84 ELFERICNA---------GRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGS--PAPRLKICDFGYSKSSLL  145 (344)
Q Consensus        84 ~L~~~i~~~---------~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~--~~~~vkL~DFg~a~~~~~  145 (344)
                      +|.+.+...         ..+++..++.++.|++.+       ||+||||||+|||+...  ..+++||+|||+++....
T Consensus        85 ~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~  164 (317)
T cd07867          85 DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNS  164 (317)
T ss_pred             cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccceeccCC
Confidence            787776421         247787777777776654       99999999999999432  234699999999975433


Q ss_pred             CC----CCCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCh---------HHHHHHHHHHh--
Q 019195          146 HS----RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDP---------KNFRKTISRIM--  210 (344)
Q Consensus       146 ~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~---------~~~~~~~~~~~--  210 (344)
                      ..    ......||+.|+|||++.+....+.++|||||||++|+|++|++||......         ..+..+.....  
T Consensus       165 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (317)
T cd07867         165 PLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVMGFP  244 (317)
T ss_pred             CcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHHhcCCC
Confidence            22    2234568999999999987655566799999999999999999999754321         11111111000  


Q ss_pred             -----------------hccccC-------------CCCCCCCHhHHHHHHHhcccCCCCCCChHHHhcCccc
Q 019195          211 -----------------AVQYKI-------------PDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF  253 (344)
Q Consensus       211 -----------------~~~~~~-------------~~~~~~s~~~~~li~~~L~~dp~~R~s~~ell~hp~~  253 (344)
                                       ...+..             ......+..+.+||.+||+.||.+|||+.|+|+||||
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~f  317 (317)
T cd07867         245 ADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF  317 (317)
T ss_pred             ChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence                             000000             0011235678899999999999999999999999998

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=3.2e-42  Score=304.53  Aligned_cols=241  Identities=30%  Similarity=0.542  Sum_probs=198.0

Q ss_pred             eeecCceEEEEEEEcCCCcEEEEEEeecCc----cccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEEecCCCCCh
Q 019195           10 IGSGNFGVARLMRNKNTKELVAMKYIERGH----KIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYAAGGEL   85 (344)
Q Consensus        10 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L   85 (344)
                      ||.|++|.||++.+..++..||+|++.+..    .....+.+|+.+++.++||||+++++.+.++..++++|||+++++|
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL   80 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence            799999999999999999999999997643    2335688999999999999999999999999999999999999999


Q ss_pred             HHHHHhCCCCCHHHHHHHHHHHHH-------CCeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCCCCCCCccCCcc
Q 019195           86 FERICNAGRFSEDEARYFFQQLIS-------GQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAY  158 (344)
Q Consensus        86 ~~~i~~~~~~~~~~~~~~~~ql~~-------~~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~~~~~~~gt~~y  158 (344)
                      .+++.+...+++..+..++.|+++       .+++|+||+|+||+++.++.  ++|+|||++.............|++.|
T Consensus        81 ~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~--~~l~df~~~~~~~~~~~~~~~~~~~~~  158 (262)
T cd05572          81 WTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGY--VKLVDFGFAKKLKSGQKTWTFCGTPEY  158 (262)
T ss_pred             HHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCC--EEEeeCCcccccCcccccccccCCcCc
Confidence            999988878888887777666554       49999999999999987654  999999998865544334456789999


Q ss_pred             cCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCHhHHHHHHHhcccCC
Q 019195          159 IAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANP  238 (344)
Q Consensus       159 ~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp  238 (344)
                      +|||.+.+..++ .++|+||+|+++|+|++|..||......  .......+.......+.....++++.++|.+||+.+|
T Consensus       159 ~~PE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p  235 (262)
T cd05572         159 VAPEIILNKGYD-FSVDYWSLGILLYELLTGRPPFGEDDED--PMEIYNDILKGNGKLEFPNYIDKAAKDLIKQLLRRNP  235 (262)
T ss_pred             cChhHhcCCCCC-ChhhhhhhHHHHHHHHhCCCCcCCCCCC--HHHHHHHHhccCCCCCCCcccCHHHHHHHHHHccCCh
Confidence            999998776664 4599999999999999999999876521  1222333332222222223458899999999999999


Q ss_pred             CCCCC-----hHHHhcCccccc
Q 019195          239 SRRIT-----IKEIKSHPWFLK  255 (344)
Q Consensus       239 ~~R~s-----~~ell~hp~~~~  255 (344)
                      .+||+     +.++++||||..
T Consensus       236 ~~R~~~~~~~~~~l~~~~~~~~  257 (262)
T cd05572         236 EERLGNLKGGIKDIKKHKWFNG  257 (262)
T ss_pred             hhCcCCcccCHHHHhcChhhhC
Confidence            99999     999999999975

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.1e-42  Score=307.22  Aligned_cols=247  Identities=27%  Similarity=0.442  Sum_probs=198.2

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcC-CCCCcceeeEEEEcCC------EEE
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQL-RHPNIIRFKEVVLTPT------HLA   74 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~l~~l-~h~niv~~~~~~~~~~------~~~   74 (344)
                      ++|++.+.||+|++|.||+|.+..+++.+|+|++.........+.+|+.+++++ .|+||+++++++....      .+|
T Consensus         6 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~   85 (275)
T cd06608           6 GIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQLW   85 (275)
T ss_pred             hheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCchhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceEEE
Confidence            689999999999999999999999999999999887666567789999999999 6999999999997644      589


Q ss_pred             EEEecCCCCChHHHHHh----CCCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCccc
Q 019195           75 IVMEYAAGGELFERICN----AGRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSS  143 (344)
Q Consensus        75 lv~e~~~~g~L~~~i~~----~~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~  143 (344)
                      +||||+++++|.+++..    ...+++..++.++.|++.+       |++|+||+|+||+++.++  .+||+|||++...
T Consensus        86 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~--~~~l~d~~~~~~~  163 (275)
T cd06608          86 LVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNA--EVKLVDFGVSAQL  163 (275)
T ss_pred             EEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCC--eEEECCCccceec
Confidence            99999999999998865    3578888888887776654       999999999999998765  4999999998653


Q ss_pred             CCC-CCCCCCccCCcccCCccccCCC----CCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCCC
Q 019195          144 LLH-SRPKSTVGTPAYIAPEVLSRRE----YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPD  218 (344)
Q Consensus       144 ~~~-~~~~~~~gt~~y~aPE~~~~~~----~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  218 (344)
                      ... .......|++.|+|||++....    ..+.++|||||||++|+|++|.+||...........+..   ........
T Consensus       164 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~---~~~~~~~~  240 (275)
T cd06608         164 DSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPR---NPPPTLKS  240 (275)
T ss_pred             ccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhc---cCCCCCCc
Confidence            322 2233456899999999985432    224559999999999999999999976544333322221   11112222


Q ss_pred             CCCCCHhHHHHHHHhcccCCCCCCChHHHhcCccc
Q 019195          219 YVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF  253 (344)
Q Consensus       219 ~~~~s~~~~~li~~~L~~dp~~R~s~~ell~hp~~  253 (344)
                      ...++..+.+||.+||..||.+|||+.++++|||+
T Consensus       241 ~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~  275 (275)
T cd06608         241 PENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI  275 (275)
T ss_pred             hhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence            23467899999999999999999999999999996

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=4.1e-44  Score=295.57  Aligned_cols=245  Identities=27%  Similarity=0.422  Sum_probs=198.9

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCc-cccHHHHHHHHHHhcCCCCCcceeeEEEEcC-----CEEEE
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH-KIDANVAREIINHKQLRHPNIIRFKEVVLTP-----THLAI   75 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~-----~~~~l   75 (344)
                      +||++.+.||.|||+.||++++..+++.||+|++.... ...+..++|+...++++|||+++++++...+     ...|+
T Consensus        21 ~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~yl  100 (302)
T KOG2345|consen   21 KRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAYL  100 (302)
T ss_pred             ceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEEE
Confidence            68999999999999999999999999999999998766 4457789999999999999999998886544     34899


Q ss_pred             EEecCCCCChHHHHHh----CCCCCHHHHHHHHHHHHHC---------CeeecCCCCCCeEecCCCCCCEEEeecCCCcc
Q 019195           76 VMEYAAGGELFERICN----AGRFSEDEARYFFQQLISG---------QICHRDLKLENTLLDGSPAPRLKICDFGYSKS  142 (344)
Q Consensus        76 v~e~~~~g~L~~~i~~----~~~~~~~~~~~~~~ql~~~---------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~  142 (344)
                      ++.|...|+|.+.|..    ...+++.++..++.+++++         .++||||||.|||+..++.  ++|.|||.++.
T Consensus       101 l~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~--~vl~D~GS~~~  178 (302)
T KOG2345|consen  101 LLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGL--PVLMDLGSATQ  178 (302)
T ss_pred             EeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCc--eEEEeccCccc
Confidence            9999999999998854    3369999999998887765         4999999999999977554  99999999876


Q ss_pred             cCCCCCCC----------CCccCCcccCCccccCCCCC--CcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHh
Q 019195          143 SLLHSRPK----------STVGTPAYIAPEVLSRREYD--GKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIM  210 (344)
Q Consensus       143 ~~~~~~~~----------~~~gt~~y~aPE~~~~~~~~--~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~  210 (344)
                      ....-...          ....|..|+|||++.-....  +.++|||||||++|.|+.|..||...-.  .=....-.+.
T Consensus       179 a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~--~GgSlaLAv~  256 (302)
T KOG2345|consen  179 APIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQ--QGGSLALAVQ  256 (302)
T ss_pred             cceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhh--cCCeEEEeee
Confidence            54332221          22478999999998654433  4559999999999999999999954210  0000111234


Q ss_pred             hccccCCCCCCCCHhHHHHHHHhcccCCCCCCChHHHhcC
Q 019195          211 AVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSH  250 (344)
Q Consensus       211 ~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~ell~h  250 (344)
                      ...+.+|....+|+.+.+||+.||+.||.+||++.+++.+
T Consensus       257 n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~  296 (302)
T KOG2345|consen  257 NAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSK  296 (302)
T ss_pred             ccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence            5566778777799999999999999999999999999875

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=2.9e-42  Score=308.22  Aligned_cols=245  Identities=26%  Similarity=0.409  Sum_probs=194.9

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcC-CCCCcceeeEEEEc------CCEEE
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQL-RHPNIIRFKEVVLT------PTHLA   74 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~l~~l-~h~niv~~~~~~~~------~~~~~   74 (344)
                      .+|++.+.||.|+||.||++.+..+++.||+|++.........+..|+.+++.+ +||||+++++++..      ...+|
T Consensus        16 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~   95 (282)
T cd06636          16 GIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLW   95 (282)
T ss_pred             hhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCEEE
Confidence            479999999999999999999999999999999877655556788899999988 69999999999853      46789


Q ss_pred             EEEecCCCCChHHHHHhC--CCCCHHHHHHHHHHHHH-------CCeeecCCCCCCeEecCCCCCCEEEeecCCCcccCC
Q 019195           75 IVMEYAAGGELFERICNA--GRFSEDEARYFFQQLIS-------GQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLL  145 (344)
Q Consensus        75 lv~e~~~~g~L~~~i~~~--~~~~~~~~~~~~~ql~~-------~~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~  145 (344)
                      ++|||+++|+|.+++...  ..+++..++.++.|++.       .||+||||||+||+++.++.  ++|+|||++.....
T Consensus        96 iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~--~~l~dfg~~~~~~~  173 (282)
T cd06636          96 LVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAE--VKLVDFGVSAQLDR  173 (282)
T ss_pred             EEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCC--EEEeeCcchhhhhc
Confidence            999999999999998653  35778777777666555       49999999999999987664  99999999875432


Q ss_pred             C-CCCCCCccCCcccCCccccC-----CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCCCC
Q 019195          146 H-SRPKSTVGTPAYIAPEVLSR-----REYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDY  219 (344)
Q Consensus       146 ~-~~~~~~~gt~~y~aPE~~~~-----~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  219 (344)
                      . .......|++.|+|||.+..     ..+ +.++|+|||||++|+|++|..||...........    +..........
T Consensus       174 ~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~-~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~----~~~~~~~~~~~  248 (282)
T cd06636         174 TVGRRNTFIGTPYWMAPEVIACDENPDATY-DYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFL----IPRNPPPKLKS  248 (282)
T ss_pred             cccCCCcccccccccCHhhcCcccCcCcCC-CcccchhHHHHHHHHHHhCCCCccccCHHhhhhh----HhhCCCCCCcc
Confidence            2 22344569999999999853     233 3459999999999999999999976543222211    11111111222


Q ss_pred             CCCCHhHHHHHHHhcccCCCCCCChHHHhcCccc
Q 019195          220 VHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF  253 (344)
Q Consensus       220 ~~~s~~~~~li~~~L~~dp~~R~s~~ell~hp~~  253 (344)
                      ..++.++.+||.+||+.||.+|||+.++|+||||
T Consensus       249 ~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~  282 (282)
T cd06636         249 KKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI  282 (282)
T ss_pred             cccCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence            3578999999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=3.8e-42  Score=309.15  Aligned_cols=250  Identities=30%  Similarity=0.479  Sum_probs=199.5

Q ss_pred             CCCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCcc---ccHHHHHHHHHHhcCCCCCcceeeEEEEcC--CEEEE
Q 019195            1 MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK---IDANVAREIINHKQLRHPNIIRFKEVVLTP--THLAI   75 (344)
Q Consensus         1 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~ei~~l~~l~h~niv~~~~~~~~~--~~~~l   75 (344)
                      +++|++.+.||.|+||.||+|.+..+++.+|+|.+.....   ....+.+|+.++++++||||+++++++...  ...|+
T Consensus         4 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~l   83 (293)
T cd07843           4 VDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYM   83 (293)
T ss_pred             hhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEE
Confidence            4689999999999999999999999999999999875432   224567899999999999999999999877  89999


Q ss_pred             EEecCCCCChHHHHHhCC-CCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCC-
Q 019195           76 VMEYAAGGELFERICNAG-RFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH-  146 (344)
Q Consensus        76 v~e~~~~g~L~~~i~~~~-~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~-  146 (344)
                      ||||+. ++|.+++.... .+++.+++.++.|++.+       |++||||||+||+++.++.  +||+|||++...... 
T Consensus        84 v~e~~~-~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~--~~l~d~g~~~~~~~~~  160 (293)
T cd07843          84 VMEYVE-HDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGI--LKICDFGLAREYGSPL  160 (293)
T ss_pred             EehhcC-cCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCc--EEEeecCceeeccCCc
Confidence            999996 58988886644 58888888887776654       9999999999999987654  999999998765443 


Q ss_pred             CCCCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhc--------------
Q 019195          147 SRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAV--------------  212 (344)
Q Consensus       147 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~--------------  212 (344)
                      .......+++.|+|||.+.+....+.++||||||+++|+|++|.+||..........++.......              
T Consensus       161 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (293)
T cd07843         161 KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGA  240 (293)
T ss_pred             cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccchh
Confidence            223345688999999998766555566999999999999999999998776554444433221100              


Q ss_pred             ---ccc-------CCCCCC--CCHhHHHHHHHhcccCCCCCCChHHHhcCccc
Q 019195          213 ---QYK-------IPDYVH--ISQDCRNLLSRIFVANPSRRITIKEIKSHPWF  253 (344)
Q Consensus       213 ---~~~-------~~~~~~--~s~~~~~li~~~L~~dp~~R~s~~ell~hp~~  253 (344)
                         ...       ...+..  +++.+.+||++||+.+|++|||+.|+|.||||
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f  293 (293)
T cd07843         241 KKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF  293 (293)
T ss_pred             cccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence               000       001111  48889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=5.4e-42  Score=303.92  Aligned_cols=245  Identities=29%  Similarity=0.422  Sum_probs=195.4

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCcc------ccHHHHHHHHHHhcCCCCCcceeeEEEEc--CCEE
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK------IDANVAREIINHKQLRHPNIIRFKEVVLT--PTHL   73 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~------~~~~~~~ei~~l~~l~h~niv~~~~~~~~--~~~~   73 (344)
                      .+|++.+.||+|+||.||++.+..++..||+|++.....      ....+.+|+.+++.++||||+++++++..  ...+
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL   81 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence            479999999999999999999999999999998865321      12457889999999999999999999875  3678


Q ss_pred             EEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHH-------CCeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCC
Q 019195           74 AIVMEYAAGGELFERICNAGRFSEDEARYFFQQLIS-------GQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH  146 (344)
Q Consensus        74 ~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~ql~~-------~~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~  146 (344)
                      ++++||+++++|.+++.+.+.+++..++.++.|++.       .+|+||||||+||+++.++.  +||+|||++......
T Consensus        82 ~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~--~~l~dfg~~~~~~~~  159 (266)
T cd06651          82 TIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGN--VKLGDFGASKRLQTI  159 (266)
T ss_pred             EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCC--EEEccCCCccccccc
Confidence            999999999999999988888888888888777665       49999999999999986654  999999998754321


Q ss_pred             ----CCCCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCCCCCCC
Q 019195          147 ----SRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHI  222 (344)
Q Consensus       147 ----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  222 (344)
                          .......++..|+|||.+.+..++ .++||||+||++|+|++|+.||...........    .............+
T Consensus       160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~----~~~~~~~~~~~~~~  234 (266)
T cd06651         160 CMSGTGIRSVTGTPYWMSPEVISGEGYG-RKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFK----IATQPTNPQLPSHI  234 (266)
T ss_pred             cccCCccccCCccccccCHHHhCCCCCC-chhhhHHHHHHHHHHHHCCCCccccchHHHHHH----HhcCCCCCCCchhc
Confidence                112234589999999999776654 559999999999999999999987644332222    11111111112346


Q ss_pred             CHhHHHHHHHhcccCCCCCCChHHHhcCcccc
Q 019195          223 SQDCRNLLSRIFVANPSRRITIKEIKSHPWFL  254 (344)
Q Consensus       223 s~~~~~li~~~L~~dp~~R~s~~ell~hp~~~  254 (344)
                      ++.+.++| +||..+|.+||++.++++||||+
T Consensus       235 ~~~~~~li-~~~~~~p~~Rp~~~eil~hp~~~  265 (266)
T cd06651         235 SEHARDFL-GCIFVEARHRPSAEELLRHPFAQ  265 (266)
T ss_pred             CHHHHHHH-HHhcCChhhCcCHHHHhcCcccc
Confidence            78899999 67778999999999999999985

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=1.3e-41  Score=305.36  Aligned_cols=249  Identities=27%  Similarity=0.413  Sum_probs=191.5

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCcc--ccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEEec
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK--IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEY   79 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~   79 (344)
                      ++|++++.||+|+||.||++.+..++..||+|.+.....  ....+.+|+.+++.++|+||+++++++..+...|+||||
T Consensus         5 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~   84 (291)
T cd07870           5 TSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFEY   84 (291)
T ss_pred             ceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEec
Confidence            679999999999999999999999999999999865432  234678899999999999999999999999999999999


Q ss_pred             CCCCChHHHHHh-CCCCCHHHHHHHHHHHHH-------CCeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCC-CCC
Q 019195           80 AAGGELFERICN-AGRFSEDEARYFFQQLIS-------GQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS-RPK  150 (344)
Q Consensus        80 ~~~g~L~~~i~~-~~~~~~~~~~~~~~ql~~-------~~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~-~~~  150 (344)
                      +. ++|...+.. ...+++.+++.++.|++.       .||+||||||+||+++.++  ++||+|||+++...... ...
T Consensus        85 ~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~--~~~l~Dfg~~~~~~~~~~~~~  161 (291)
T cd07870          85 MH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLG--ELKLADFGLARAKSIPSQTYS  161 (291)
T ss_pred             cc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCC--cEEEeccccccccCCCCCCCC
Confidence            95 677766654 355777777777766554       4999999999999997665  49999999987543222 223


Q ss_pred             CCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHH-HHHHHHHHh-----------hcc-c---
Q 019195          151 STVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKN-FRKTISRIM-----------AVQ-Y---  214 (344)
Q Consensus       151 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~-~~~~~~~~~-----------~~~-~---  214 (344)
                      ...+++.|+|||.+.+....+.++|||||||++|+|++|..||........ +.+....+.           ... +   
T Consensus       162 ~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (291)
T cd07870         162 SEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKPE  241 (291)
T ss_pred             CccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcccccch
Confidence            346899999999987654445569999999999999999999976543211 111111000           000 0   


Q ss_pred             cC----C-------CCCCCCHhHHHHHHHhcccCCCCCCChHHHhcCccc
Q 019195          215 KI----P-------DYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF  253 (344)
Q Consensus       215 ~~----~-------~~~~~s~~~~~li~~~L~~dp~~R~s~~ell~hp~~  253 (344)
                      ..    +       .....++.+.+++.+||+.||.+|||+.+++.||||
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~  291 (291)
T cd07870         242 WFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF  291 (291)
T ss_pred             hccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence            00    0       001135689999999999999999999999999997

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=5.9e-42  Score=301.47  Aligned_cols=243  Identities=30%  Similarity=0.466  Sum_probs=198.5

Q ss_pred             CceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCc---cccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEEec
Q 019195            3 KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH---KIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEY   79 (344)
Q Consensus         3 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~   79 (344)
                      +|.+.+.||+|++|.||++.+..+++.|++|.+....   .....+.+|+.+++.++||||+++++++...+.+|+||||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY   80 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence            5899999999999999999999999999999986532   3345688899999999999999999999999999999999


Q ss_pred             CCCCChHHHHHhC--CCCCHHHHHHHHHHHHH-------CCeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCCC-C
Q 019195           80 AAGGELFERICNA--GRFSEDEARYFFQQLIS-------GQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR-P  149 (344)
Q Consensus        80 ~~~g~L~~~i~~~--~~~~~~~~~~~~~ql~~-------~~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~~-~  149 (344)
                      +++++|.+++...  ..++...++.++.|++.       .|++||||||+||+++.++  .++|+|||++........ .
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~--~~~l~df~~~~~~~~~~~~~  158 (256)
T cd08529          81 AENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYD--NVKIGDLGVAKLLSDNTNFA  158 (256)
T ss_pred             CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCC--CEEEcccccceeccCccchh
Confidence            9999999999764  56788877777666554       5999999999999998765  499999999875443322 2


Q ss_pred             CCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCHhHHHH
Q 019195          150 KSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL  229 (344)
Q Consensus       150 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  229 (344)
                      ....|++.|+|||++.+..++ .++|+|||||++++|++|+.||.........    ..+..... .+....++..+.++
T Consensus       159 ~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~----~~~~~~~~-~~~~~~~~~~~~~~  232 (256)
T cd08529         159 NTIVGTPYYLSPELCEDKPYN-EKSDVWALGVVLYECCTGKHPFDANNQGALI----LKIIRGVF-PPVSQMYSQQLAQL  232 (256)
T ss_pred             hccccCccccCHHHhcCCCCC-CccchHHHHHHHHHHHhCCCCCCCCCHHHHH----HHHHcCCC-CCCccccCHHHHHH
Confidence            344689999999999877764 4599999999999999999999876532222    22222221 11122578899999


Q ss_pred             HHHhcccCCCCCCChHHHhcCccc
Q 019195          230 LSRIFVANPSRRITIKEIKSHPWF  253 (344)
Q Consensus       230 i~~~L~~dp~~R~s~~ell~hp~~  253 (344)
                      |.+||+.+|++||++.+++.|||+
T Consensus       233 i~~~l~~~p~~Rp~~~~ll~~~~~  256 (256)
T cd08529         233 IDQCLTKDYRQRPDTFQLLRNPSL  256 (256)
T ss_pred             HHHHccCCcccCcCHHHHhhCCCC
Confidence            999999999999999999999995

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=5.4e-42  Score=306.21  Aligned_cols=242  Identities=29%  Similarity=0.462  Sum_probs=189.3

Q ss_pred             eeeecCceEEEEEEEcCCCcEEEEEEeecCccc----cHHHHHHHHHHh---cCCCCCcceeeEEEEcCCEEEEEEecCC
Q 019195            9 DIGSGNFGVARLMRNKNTKELVAMKYIERGHKI----DANVAREIINHK---QLRHPNIIRFKEVVLTPTHLAIVMEYAA   81 (344)
Q Consensus         9 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~----~~~~~~ei~~l~---~l~h~niv~~~~~~~~~~~~~lv~e~~~   81 (344)
                      .||+|+||.||++.+..+++.+|+|.+.+....    .....++..+++   ...||||+.+++++...+.+++||||++
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN   80 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence            489999999999999999999999998764321    123344444333   3479999999999999999999999999


Q ss_pred             CCChHHHHHhCCCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCCCCCCCcc
Q 019195           82 GGELFERICNAGRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVG  154 (344)
Q Consensus        82 ~g~L~~~i~~~~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~~~~~~~g  154 (344)
                      +++|..++...+.+++..+..++.|++.+       +|+||||||+|||++.++.  ++|+|||++...... ......|
T Consensus        81 ~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~--~~l~dfg~~~~~~~~-~~~~~~~  157 (279)
T cd05633          81 GGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGH--VRISDLGLACDFSKK-KPHASVG  157 (279)
T ss_pred             CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCC--EEEccCCcceecccc-CccCcCC
Confidence            99999999888889999888887776654       9999999999999987664  999999998644322 2234579


Q ss_pred             CCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCHhHHHHHHHhc
Q 019195          155 TPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIF  234 (344)
Q Consensus       155 t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L  234 (344)
                      |+.|+|||.+......+.++||||+||++|+|++|..||........ ..............|  ..+++++.++|.+||
T Consensus       158 ~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~--~~~~~~~~~li~~~l  234 (279)
T cd05633         158 THGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK-HEIDRMTLTVNVELP--DSFSPELKSLLEGLL  234 (279)
T ss_pred             CcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCH-HHHHHHhhcCCcCCc--cccCHHHHHHHHHHh
Confidence            99999999986544345569999999999999999999976543221 111111112222223  357899999999999


Q ss_pred             ccCCCCCC-----ChHHHhcCcccccC
Q 019195          235 VANPSRRI-----TIKEIKSHPWFLKN  256 (344)
Q Consensus       235 ~~dp~~R~-----s~~ell~hp~~~~~  256 (344)
                      +.||.+||     |+.++++||||...
T Consensus       235 ~~~p~~R~~~~~~~~~~~~~h~~~~~~  261 (279)
T cd05633         235 QRDVSKRLGCLGRGAQEVKEHVFFKGI  261 (279)
T ss_pred             cCCHHHhcCCCCCCHHHHHhCccccCC
Confidence            99999999     69999999999764

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=1.1e-41  Score=300.06  Aligned_cols=243  Identities=30%  Similarity=0.498  Sum_probs=200.8

Q ss_pred             CceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCc---cccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEEec
Q 019195            3 KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH---KIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEY   79 (344)
Q Consensus         3 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~   79 (344)
                      +|++++.||.|+||.||.+++..+++.+++|.+....   .....+.+|+.++++++|+||+++++++.+...++++|||
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~   80 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY   80 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence            6999999999999999999999999999999887543   2335688999999999999999999999999999999999


Q ss_pred             CCCCChHHHHHhC--CCCCHHHHHHHHHHHHH-------CCeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCC-CC
Q 019195           80 AAGGELFERICNA--GRFSEDEARYFFQQLIS-------GQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS-RP  149 (344)
Q Consensus        80 ~~~g~L~~~i~~~--~~~~~~~~~~~~~ql~~-------~~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~-~~  149 (344)
                      +++++|.+++.+.  ..+++.++..++.|++.       .|++||||+|+||+++.++.  +||+|||++....... ..
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~--~kl~d~~~~~~~~~~~~~~  158 (256)
T cd08221          81 ANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGL--IKLGDFGISKILGSEYSMA  158 (256)
T ss_pred             cCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCC--EEECcCcceEEcccccccc
Confidence            9999999999764  46888888877766554       49999999999999987664  9999999987543333 23


Q ss_pred             CCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCHhHHHH
Q 019195          150 KSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL  229 (344)
Q Consensus       150 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  229 (344)
                      ....|++.|+|||.+.+..++ .++|+||||+++|+|++|..||...........    +....+. +....++.++.++
T Consensus       159 ~~~~~~~~y~ape~~~~~~~~-~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~----~~~~~~~-~~~~~~~~~~~~~  232 (256)
T cd08221         159 ETVVGTPYYMSPELCQGVKYN-FKSDIWALGCVLYELLTLKRTFDATNPLNLVVK----IVQGNYT-PVVSVYSSELISL  232 (256)
T ss_pred             cccCCCccccCHhhcCCCCCC-CcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHH----HHcCCCC-CCccccCHHHHHH
Confidence            445699999999999776654 459999999999999999999987554333332    2222222 2224578999999


Q ss_pred             HHHhcccCCCCCCChHHHhcCccc
Q 019195          230 LSRIFVANPSRRITIKEIKSHPWF  253 (344)
Q Consensus       230 i~~~L~~dp~~R~s~~ell~hp~~  253 (344)
                      |.+||+.+|.+||++.++++|||+
T Consensus       233 i~~~l~~~p~~R~s~~~ll~~~~l  256 (256)
T cd08221         233 VHSLLQQDPEKRPTADEVLDQPLL  256 (256)
T ss_pred             HHHHcccCcccCCCHHHHhhCcCC
Confidence            999999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=1.8e-41  Score=300.34  Aligned_cols=246  Identities=30%  Similarity=0.462  Sum_probs=196.5

Q ss_pred             CCCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCcc------ccHHHHHHHHHHhcCCCCCcceeeEEEEcC--CE
Q 019195            1 MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK------IDANVAREIINHKQLRHPNIIRFKEVVLTP--TH   72 (344)
Q Consensus         1 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~------~~~~~~~ei~~l~~l~h~niv~~~~~~~~~--~~   72 (344)
                      .++|++.+.||+|+||.||.+.+..+++.||+|.+.....      ....+.+|+.+++.++||||+++++++.+.  ..
T Consensus         1 ~~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   80 (265)
T cd06652           1 PTNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERT   80 (265)
T ss_pred             CCcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCce
Confidence            3689999999999999999999999999999998864321      124677899999999999999999998764  56


Q ss_pred             EEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHH-------CCeeecCCCCCCeEecCCCCCCEEEeecCCCcccCC
Q 019195           73 LAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLIS-------GQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLL  145 (344)
Q Consensus        73 ~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~ql~~-------~~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~  145 (344)
                      ++++|||+++++|.+++.+...+++..++.++.|++.       .+++|+||||+||+++.++.  ++|+|||++.....
T Consensus        81 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~--~~l~Dfg~~~~~~~  158 (265)
T cd06652          81 LSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGN--VKLGDFGASKRLQT  158 (265)
T ss_pred             EEEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCC--EEECcCcccccccc
Confidence            8899999999999999988778888888887777665       49999999999999986654  99999999875322


Q ss_pred             C----CCCCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCCCCCC
Q 019195          146 H----SRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVH  221 (344)
Q Consensus       146 ~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  221 (344)
                      .    .......|+..|+|||.+.+..+ +.++|||||||++|+|++|+.||..........    ..............
T Consensus       159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~----~~~~~~~~~~~~~~  233 (265)
T cd06652         159 ICLSGTGMKSVTGTPYWMSPEVISGEGY-GRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIF----KIATQPTNPVLPPH  233 (265)
T ss_pred             ccccccccccCCCCccccChhhhcCCCC-CcchhHHHHHHHHHHHhhCCCCCCccchHHHHH----HHhcCCCCCCCchh
Confidence            1    12233568999999999977665 455999999999999999999998754433222    22211111222235


Q ss_pred             CCHhHHHHHHHhcccCCCCCCChHHHhcCcccc
Q 019195          222 ISQDCRNLLSRIFVANPSRRITIKEIKSHPWFL  254 (344)
Q Consensus       222 ~s~~~~~li~~~L~~dp~~R~s~~ell~hp~~~  254 (344)
                      ++..+.++|.+||. +|.+||++++++.|||+.
T Consensus       234 ~~~~~~~~i~~~l~-~p~~Rp~~~~il~~~~~~  265 (265)
T cd06652         234 VSDHCRDFLKRIFV-EAKLRPSADELLRHTFVH  265 (265)
T ss_pred             hCHHHHHHHHHHhc-ChhhCCCHHHHhcCcccC
Confidence            67889999999995 999999999999999973

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=1.4e-43  Score=301.02  Aligned_cols=255  Identities=27%  Similarity=0.415  Sum_probs=201.1

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCC----cEEEEEEeecCc---cccHHHHHHHHHHhcCCCCCcceeeEEEEc-CCEE
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTK----ELVAMKYIERGH---KIDANVAREIINHKQLRHPNIIRFKEVVLT-PTHL   73 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~----~~vaiK~~~~~~---~~~~~~~~ei~~l~~l~h~niv~~~~~~~~-~~~~   73 (344)
                      ..|++++.||+|.||.||+|...+++    +.+|||+++...   ......-||+.+++.++||||+.+..+|.. +..+
T Consensus        24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v  103 (438)
T KOG0666|consen   24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKV  103 (438)
T ss_pred             HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceE
Confidence            57999999999999999999665443    279999987642   344678899999999999999999999987 7899


Q ss_pred             EEEEecCCCCChHHHHHh-----CCCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCC--CCCCEEEeecCC
Q 019195           74 AIVMEYAAGGELFERICN-----AGRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGS--PAPRLKICDFGY  139 (344)
Q Consensus        74 ~lv~e~~~~g~L~~~i~~-----~~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~--~~~~vkL~DFg~  139 (344)
                      |+++||.+. +|.++|+-     ...++...++.++.||+++       =|+||||||.|||+..+  ..|+|||+|||+
T Consensus       104 ~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaDlGl  182 (438)
T KOG0666|consen  104 WLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIADLGL  182 (438)
T ss_pred             EEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeecccH
Confidence            999999965 88888852     3468999999999998877       68999999999999654  336799999999


Q ss_pred             CcccCCCC----CCCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC---------hHHHHHHH
Q 019195          140 SKSSLLHS----RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQED---------PKNFRKTI  206 (344)
Q Consensus       140 a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~---------~~~~~~~~  206 (344)
                      ++.....-    ....++-|.+|+|||++.+..-+++++||||+|||+.||++..+.|.+.+.         ..++.+++
T Consensus       183 aR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~rIf  262 (438)
T KOG0666|consen  183 ARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDRIF  262 (438)
T ss_pred             HHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHHHH
Confidence            98654332    234567899999999999999889999999999999999999999876431         22233333


Q ss_pred             HHHhhccc-------cCCCC------------------------CCCCHhHHHHHHHhcccCCCCCCChHHHhcCccccc
Q 019195          207 SRIMAVQY-------KIPDY------------------------VHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLK  255 (344)
Q Consensus       207 ~~~~~~~~-------~~~~~------------------------~~~s~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~  255 (344)
                      .-+....-       ..|.+                        ..-++.+.+|+.+||+.||-+|+|+.++|+|+||.+
T Consensus       263 ~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~yF~~  342 (438)
T KOG0666|consen  263 EVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHPYFTE  342 (438)
T ss_pred             HHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhccccccc
Confidence            22111100       01111                        112456889999999999999999999999999988


Q ss_pred             CC
Q 019195          256 NL  257 (344)
Q Consensus       256 ~~  257 (344)
                      ..
T Consensus       343 d~  344 (438)
T KOG0666|consen  343 DP  344 (438)
T ss_pred             CC
Confidence            63

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=1.1e-41  Score=308.19  Aligned_cols=249  Identities=26%  Similarity=0.439  Sum_probs=192.4

Q ss_pred             CCCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCcc---ccHHHHHHHHHHhcCCCCCcceeeEEEEcCC------
Q 019195            1 MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK---IDANVAREIINHKQLRHPNIIRFKEVVLTPT------   71 (344)
Q Consensus         1 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~------   71 (344)
                      +++|++.+.||+|+||.||+|.+..+++.||+|.+.....   ....+.+|+.++++++||||+++++++....      
T Consensus        11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   90 (310)
T cd07865          11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY   90 (310)
T ss_pred             hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence            4789999999999999999999999999999998865322   2345678999999999999999999987543      


Q ss_pred             --EEEEEEecCCCCChHHHHHhCC-CCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCc
Q 019195           72 --HLAIVMEYAAGGELFERICNAG-RFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSK  141 (344)
Q Consensus        72 --~~~lv~e~~~~g~L~~~i~~~~-~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~  141 (344)
                        ..++||||+. ++|...+.... .+++.+++.++.|++++       |++|+||||+||+++.++.  +||+|||++.
T Consensus        91 ~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~--~kl~dfg~~~  167 (310)
T cd07865          91 KGSFYLVFEFCE-HDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGI--LKLADFGLAR  167 (310)
T ss_pred             CceEEEEEcCCC-cCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCc--EEECcCCCcc
Confidence              4699999995 58888776543 68898888887777655       9999999999999976654  9999999987


Q ss_pred             ccCCCCC-----CCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhc-c--
Q 019195          142 SSLLHSR-----PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAV-Q--  213 (344)
Q Consensus       142 ~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~-~--  213 (344)
                      .......     .....++..|+|||.+.+....+.++||||||+++|+|++|++||...........+ ..+... .  
T Consensus       168 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~-~~~~~~~~~~  246 (310)
T cd07865         168 AFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLI-SQLCGSITPE  246 (310)
T ss_pred             cccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH-HHHhCCCChh
Confidence            5433221     123457889999999876554456699999999999999999999876543332221 111100 0  


Q ss_pred             -------------ccCCC-----------CCCCCHhHHHHHHHhcccCCCCCCChHHHhcCccc
Q 019195          214 -------------YKIPD-----------YVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF  253 (344)
Q Consensus       214 -------------~~~~~-----------~~~~s~~~~~li~~~L~~dp~~R~s~~ell~hp~~  253 (344)
                                   ...+.           ....++.+.+||.+||+.||.+|||++++|+||||
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f  310 (310)
T cd07865         247 VWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF  310 (310)
T ss_pred             hcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence                         00010           00135678899999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=1e-41  Score=302.48  Aligned_cols=242  Identities=30%  Similarity=0.527  Sum_probs=192.1

Q ss_pred             CCceeeeee--eecCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcC-CCCCcceeeEEEEcCCEEEEEEe
Q 019195            2 EKYELMKDI--GSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQL-RHPNIIRFKEVVLTPTHLAIVME   78 (344)
Q Consensus         2 ~~y~~~~~l--g~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~l~~l-~h~niv~~~~~~~~~~~~~lv~e   78 (344)
                      ++|++.+.+  |.|+||.||++.+..++..+|+|.+........    |+.....+ +||||+++++++...+.+|+|||
T Consensus        14 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~----e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv~e   89 (267)
T PHA03390         14 KNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI----EPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMD   89 (267)
T ss_pred             HhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh----hHHHHHHhhcCCCEEEEEEEEecCCeeEEEEE
Confidence            467777777  999999999999999999999999875432211    22222222 79999999999999999999999


Q ss_pred             cCCCCChHHHHHhCCCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCCCCCC
Q 019195           79 YAAGGELFERICNAGRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKS  151 (344)
Q Consensus        79 ~~~~g~L~~~i~~~~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~~~~~  151 (344)
                      |+++++|.+++.....+++.+++.++.|++++       |++||||||+||+++.++ +.++|+|||++....   ....
T Consensus        90 ~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~-~~~~l~dfg~~~~~~---~~~~  165 (267)
T PHA03390         90 YIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAK-DRIYLCDYGLCKIIG---TPSC  165 (267)
T ss_pred             cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCC-CeEEEecCccceecC---CCcc
Confidence            99999999999888889999999988887765       999999999999998765 149999999886543   2234


Q ss_pred             CccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCHhHHHHHH
Q 019195          152 TVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLS  231 (344)
Q Consensus       152 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~  231 (344)
                      ..|+..|+|||++.+..+. .++||||+|+++|+|++|..||............+....  ....+....+++.+.+||.
T Consensus       166 ~~~~~~y~aPE~~~~~~~~-~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~  242 (267)
T PHA03390        166 YDGTLDYFSPEKIKGHNYD-VSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQ--QKKLPFIKNVSKNANDFVQ  242 (267)
T ss_pred             CCCCCcccChhhhcCCCCC-chhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhh--cccCCcccccCHHHHHHHH
Confidence            5689999999999877765 459999999999999999999986543221111111111  2222333468999999999


Q ss_pred             HhcccCCCCCCC-hHHHhcCcccc
Q 019195          232 RIFVANPSRRIT-IKEIKSHPWFL  254 (344)
Q Consensus       232 ~~L~~dp~~R~s-~~ell~hp~~~  254 (344)
                      +||+.+|.+||+ ++++|+||||.
T Consensus       243 ~~l~~~p~~R~~~~~~~l~h~~~~  266 (267)
T PHA03390        243 SMLKYNINYRLTNYNEIIKHPFLK  266 (267)
T ss_pred             HHhccChhhCCchHHHHhcCCccc
Confidence            999999999996 69999999995

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=4.6e-42  Score=314.72  Aligned_cols=253  Identities=28%  Similarity=0.455  Sum_probs=194.4

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCc--cccHHHHHHHHHHhcCCCCCcceeeEEEEcC-----CEEE
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH--KIDANVAREIINHKQLRHPNIIRFKEVVLTP-----THLA   74 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~-----~~~~   74 (344)
                      ++|++.+.||+|+||.||++.+..++..||+|++....  .....+.+|+.+++.++||||+++++++...     ...|
T Consensus         5 ~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   84 (336)
T cd07849           5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDVY   84 (336)
T ss_pred             cceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceEE
Confidence            58999999999999999999999999999999986422  2335678899999999999999999887654     3589


Q ss_pred             EEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHH-------CCeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCC
Q 019195           75 IVMEYAAGGELFERICNAGRFSEDEARYFFQQLIS-------GQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS  147 (344)
Q Consensus        75 lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~ql~~-------~~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~  147 (344)
                      +++||+. ++|...+. ...+++..++.++.|++.       .||+||||||+||+++.++.  +||+|||++.......
T Consensus        85 lv~e~~~-~~l~~~~~-~~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~--~kl~dfg~~~~~~~~~  160 (336)
T cd07849          85 IVQELME-TDLYKLIK-TQHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCD--LKICDFGLARIADPEH  160 (336)
T ss_pred             EEehhcc-cCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCC--EEECcccceeeccccc
Confidence            9999996 58877774 457888888777766654       49999999999999977654  9999999987543322


Q ss_pred             C----CCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhh------------
Q 019195          148 R----PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMA------------  211 (344)
Q Consensus       148 ~----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~------------  211 (344)
                      .    .....||+.|+|||.+.+....+.++|||||||++|+|++|++||...........+......            
T Consensus       161 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (336)
T cd07849         161 DHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIISL  240 (336)
T ss_pred             cccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhch
Confidence            1    123468999999998766544456699999999999999999999765433222211110000            


Q ss_pred             --------ccc--cCC---CCCCCCHhHHHHHHHhcccCCCCCCChHHHhcCcccccCCC
Q 019195          212 --------VQY--KIP---DYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLP  258 (344)
Q Consensus       212 --------~~~--~~~---~~~~~s~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~~~~  258 (344)
                              ...  ..+   ....+++++.+||.+||+.+|.+|||+.++++||||.....
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~  300 (336)
T cd07849         241 RARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHD  300 (336)
T ss_pred             hhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCC
Confidence                    000  000   01245788999999999999999999999999999987654

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=1.2e-41  Score=304.28  Aligned_cols=248  Identities=29%  Similarity=0.477  Sum_probs=198.9

Q ss_pred             CceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCcc--ccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEEecC
Q 019195            3 KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK--IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYA   80 (344)
Q Consensus         3 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~   80 (344)
                      +|++++.||.|++|.||+|.+..++..||+|++.....  ....+.+|+.++++++||||+++++++...+..++||||+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM   80 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence            69999999999999999999999999999999876432  2356778999999999999999999999999999999999


Q ss_pred             CCCChHHHHHhC---CCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCCC-C
Q 019195           81 AGGELFERICNA---GRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR-P  149 (344)
Q Consensus        81 ~~g~L~~~i~~~---~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~~-~  149 (344)
                      ++ +|.+++...   ..+++..++.++.|++.+       |++||||||+||+++.++.  ++|+|||++........ .
T Consensus        81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~--~~l~d~g~~~~~~~~~~~~  157 (284)
T cd07836          81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGE--LKLADFGLARAFGIPVNTF  157 (284)
T ss_pred             Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCc--EEEeecchhhhhcCCcccc
Confidence            75 888887654   358888888887776654       9999999999999986654  99999999875433222 2


Q ss_pred             CCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhc--------------ccc
Q 019195          150 KSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAV--------------QYK  215 (344)
Q Consensus       150 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~--------------~~~  215 (344)
                      ....+++.|+|||.+.+....+.++|||||||++|+|++|++||...........++......              ...
T Consensus       158 ~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (284)
T cd07836         158 SNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKPT  237 (284)
T ss_pred             ccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhccc
Confidence            334678999999998766555666999999999999999999998876655544433221000              000


Q ss_pred             CCC---------CCCCCHhHHHHHHHhcccCCCCCCChHHHhcCccc
Q 019195          216 IPD---------YVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF  253 (344)
Q Consensus       216 ~~~---------~~~~s~~~~~li~~~L~~dp~~R~s~~ell~hp~~  253 (344)
                      .|.         ...+++.+.++|.+||+.||.+||++.++++||||
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f  284 (284)
T cd07836         238 FPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF  284 (284)
T ss_pred             ccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence            110         12357889999999999999999999999999998

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=3e-42  Score=315.71  Aligned_cols=255  Identities=26%  Similarity=0.426  Sum_probs=201.2

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCc---cccHHHHHHHHHHhcCCCCCcceeeEEEEc----CCEEE
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH---KIDANVAREIINHKQLRHPNIIRFKEVVLT----PTHLA   74 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~ei~~l~~l~h~niv~~~~~~~~----~~~~~   74 (344)
                      ++|++.+.||.|+||.||++.+..++..||+|++....   .....+.+|+.++++++||||+++++++..    ...++
T Consensus         5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   84 (334)
T cd07855           5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVY   84 (334)
T ss_pred             hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEE
Confidence            47999999999999999999999999999999987642   233567789999999999999999998863    35789


Q ss_pred             EEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCC
Q 019195           75 IVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS  147 (344)
Q Consensus        75 lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~  147 (344)
                      +||||+. ++|..++...+.+++..++.++.|++.+       ||+||||||+||+++.++.  +||+|||++.......
T Consensus        85 lv~e~~~-~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~--~kl~dfg~~~~~~~~~  161 (334)
T cd07855          85 VVMDLME-SDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCE--LRIGDFGMARGLSSSP  161 (334)
T ss_pred             EEEehhh-hhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCc--EEecccccceeecccC
Confidence            9999995 6899999877889999888888776654       9999999999999987664  9999999987543222


Q ss_pred             C-----CCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhh-----------
Q 019195          148 R-----PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMA-----------  211 (344)
Q Consensus       148 ~-----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~-----------  211 (344)
                      .     .....|+..|+|||.+.+....+.++|||||||++|+|++|++||...+....+..+......           
T Consensus       162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~~  241 (334)
T cd07855         162 TEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGS  241 (334)
T ss_pred             cCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhch
Confidence            1     123468999999999876544566699999999999999999999776544333222211100           


Q ss_pred             ---------ccccCC-----CCCCCCHhHHHHHHHhcccCCCCCCChHHHhcCcccccCCCh
Q 019195          212 ---------VQYKIP-----DYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLPR  259 (344)
Q Consensus       212 ---------~~~~~~-----~~~~~s~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~~~~~  259 (344)
                               .....+     .....++++.++|++||+.+|.+|||+.+++.||||.+...+
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~~~~  303 (334)
T cd07855         242 DRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYHDP  303 (334)
T ss_pred             hhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhccCC
Confidence                     000000     013468899999999999999999999999999999765443

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=4.4e-42  Score=314.99  Aligned_cols=252  Identities=31%  Similarity=0.468  Sum_probs=198.3

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCc---cccHHHHHHHHHHhcCCCCCcceeeEEEEcC-----CEE
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH---KIDANVAREIINHKQLRHPNIIRFKEVVLTP-----THL   73 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~-----~~~   73 (344)
                      ++|++.+.||+|+||+||++.+..+++.||+|.+....   .....+.+|+.+++.++||||+++++++...     ..+
T Consensus         5 ~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~   84 (337)
T cd07858           5 TKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDV   84 (337)
T ss_pred             cceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcE
Confidence            58999999999999999999999999999999987532   2234677899999999999999999988654     358


Q ss_pred             EEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCC
Q 019195           74 AIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH  146 (344)
Q Consensus        74 ~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~  146 (344)
                      |+++||+. ++|.+++...+.+++..++.++.|++.+       +++||||||+||+++.++.  +||+|||++......
T Consensus        85 ~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~--~kL~Dfg~~~~~~~~  161 (337)
T cd07858          85 YIVYELMD-TDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCD--LKICDFGLARTTSEK  161 (337)
T ss_pred             EEEEeCCC-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCC--EEECcCccccccCCC
Confidence            99999995 7899999888889999988887776654       9999999999999977654  999999998765433


Q ss_pred             -CCCCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHh---------------
Q 019195          147 -SRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIM---------------  210 (344)
Q Consensus       147 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~---------------  210 (344)
                       .......++..|+|||.+......+.++|||||||++|+|++|++||...+.......+.....               
T Consensus       162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (337)
T cd07858         162 GDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKA  241 (337)
T ss_pred             cccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCchhh
Confidence             2233456899999999987644345669999999999999999999976543222211111000               


Q ss_pred             ----h-ccc--c---CCCCCCCCHhHHHHHHHhcccCCCCCCChHHHhcCcccccC
Q 019195          211 ----A-VQY--K---IPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKN  256 (344)
Q Consensus       211 ----~-~~~--~---~~~~~~~s~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~~  256 (344)
                          . ...  .   ......+++.+.+||.+||+.+|.+|||+.++++||||...
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~  297 (337)
T cd07858         242 RRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASL  297 (337)
T ss_pred             hHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhh
Confidence                0 000  0   00123578899999999999999999999999999999543

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=1.2e-41  Score=299.77  Aligned_cols=243  Identities=31%  Similarity=0.539  Sum_probs=198.8

Q ss_pred             CceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCc---cccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEEec
Q 019195            3 KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH---KIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEY   79 (344)
Q Consensus         3 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~   79 (344)
                      +|++.+.||+|+||.||++.+..+++.||+|.+....   .....+.+|+.+++.++||||+++++++...+..++||||
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY   80 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence            6999999999999999999999999999999987532   2235688999999999999999999999999999999999


Q ss_pred             CCCCChHHHHHhCC--CCCHHHHHHHHHHHHH-------CCeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCCC-C
Q 019195           80 AAGGELFERICNAG--RFSEDEARYFFQQLIS-------GQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR-P  149 (344)
Q Consensus        80 ~~~g~L~~~i~~~~--~~~~~~~~~~~~ql~~-------~~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~~-~  149 (344)
                      +++++|.+.+....  .+++.+++.++.|++.       .|++|+||+|+||+++.+..  ++|+|||++........ .
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~--~~l~d~~~~~~~~~~~~~~  158 (256)
T cd08218          81 CEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGT--IKLGDFGIARVLNSTVELA  158 (256)
T ss_pred             CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCC--EEEeeccceeecCcchhhh
Confidence            99999999987543  5788887777766665       49999999999999977654  99999999875433222 2


Q ss_pred             CCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCHhHHHH
Q 019195          150 KSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL  229 (344)
Q Consensus       150 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  229 (344)
                      ....|++.|+|||.+.+...+ .++|+|||||++++|++|..||...........+    ..... .+....++.++.++
T Consensus       159 ~~~~~~~~~~~pe~~~~~~~~-~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~----~~~~~-~~~~~~~~~~~~~l  232 (256)
T cd08218         159 RTCIGTPYYLSPEICENRPYN-NKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKI----IRGSY-PPVSSHYSYDLRNL  232 (256)
T ss_pred             hhccCCccccCHHHhCCCCCC-CccchhHHHHHHHHHHcCCCCccCCCHHHHHHHH----hcCCC-CCCcccCCHHHHHH
Confidence            234588999999999777654 4599999999999999999999876543333222    22221 12233678899999


Q ss_pred             HHHhcccCCCCCCChHHHhcCccc
Q 019195          230 LSRIFVANPSRRITIKEIKSHPWF  253 (344)
Q Consensus       230 i~~~L~~dp~~R~s~~ell~hp~~  253 (344)
                      |.+||+.+|.+||++.++++||||
T Consensus       233 i~~~l~~~p~~Rp~~~~vl~~~~~  256 (256)
T cd08218         233 VSQLFKRNPRDRPSVNSILEKNFI  256 (256)
T ss_pred             HHHHhhCChhhCcCHHHHhhCcCC
Confidence            999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=2e-41  Score=302.75  Aligned_cols=249  Identities=22%  Similarity=0.387  Sum_probs=194.1

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCcc--ccHHHHHHHHH-HhcCCCCCcceeeEEEEcCCEEEEEEe
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK--IDANVAREIIN-HKQLRHPNIIRFKEVVLTPTHLAIVME   78 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~ei~~-l~~l~h~niv~~~~~~~~~~~~~lv~e   78 (344)
                      ++|++++.||+|+||.||++.+..+|+.||+|.+.....  ....+..|+.. ++.++||||+++++++..++.+|++||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e   80 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME   80 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence            579999999999999999999999999999999876432  23455666665 666799999999999999999999999


Q ss_pred             cCCCCChHHHHHh----CCCCCHHHHHHHHHHHHH-------C-CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCC
Q 019195           79 YAAGGELFERICN----AGRFSEDEARYFFQQLIS-------G-QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH  146 (344)
Q Consensus        79 ~~~~g~L~~~i~~----~~~~~~~~~~~~~~ql~~-------~-~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~  146 (344)
                      |++ ++|.+++..    ...+++..++.++.|++.       . +++||||||+||+++.++.  +||+|||++......
T Consensus        81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~--~kl~dfg~~~~~~~~  157 (283)
T cd06617          81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQ--VKLCDFGISGYLVDS  157 (283)
T ss_pred             hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCC--EEEeecccccccccc
Confidence            996 688777653    346888888888777654       4 8999999999999987654  999999998754433


Q ss_pred             CCCCCCccCCcccCCccccCCC---CCCcchhHHHHHHHHHHHHhCCCCCCCCCCh-HHHHHHHHHHhhccccCCCCCCC
Q 019195          147 SRPKSTVGTPAYIAPEVLSRRE---YDGKLADVWSCGVTLYVMLVGAYPFEDQEDP-KNFRKTISRIMAVQYKIPDYVHI  222 (344)
Q Consensus       147 ~~~~~~~gt~~y~aPE~~~~~~---~~~~~~DiwslG~il~el~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~  222 (344)
                      .......|+..|+|||.+.+..   ..+.++|+|||||++|+|++|+.||...... ......   ........+. ..+
T Consensus       158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~---~~~~~~~~~~-~~~  233 (283)
T cd06617         158 VAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQV---VEEPSPQLPA-EKF  233 (283)
T ss_pred             cccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHH---HhcCCCCCCc-ccc
Confidence            3333456899999999886422   2245699999999999999999999754321 222211   1111222222 247


Q ss_pred             CHhHHHHHHHhcccCCCCCCChHHHhcCcccccCC
Q 019195          223 SQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNL  257 (344)
Q Consensus       223 s~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~~~  257 (344)
                      +.++.+||.+||..+|.+|||+.++++||||.+..
T Consensus       234 ~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~  268 (283)
T cd06617         234 SPEFQDFVNKCLKKNYKERPNYPELLQHPFFELHL  268 (283)
T ss_pred             CHHHHHHHHHHccCChhhCcCHHHHhcCchhhhcc
Confidence            89999999999999999999999999999998764

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=1.9e-41  Score=299.52  Aligned_cols=249  Identities=28%  Similarity=0.461  Sum_probs=205.2

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCcc--ccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEEec
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK--IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEY   79 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~   79 (344)
                      ++|++.+.||+|++|.||+|.+..+++.||+|++.....  ....+.+|+..++.++|+||+++++++.....++++|||
T Consensus         1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06623           1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY   80 (264)
T ss_pred             CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence            579999999999999999999999999999999876543  346788999999999999999999999999999999999


Q ss_pred             CCCCChHHHHHhCCCCCHHHHHHHHHHHH-------H-CCeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCCCCC-
Q 019195           80 AAGGELFERICNAGRFSEDEARYFFQQLI-------S-GQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPK-  150 (344)
Q Consensus        80 ~~~g~L~~~i~~~~~~~~~~~~~~~~ql~-------~-~~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~~~~-  150 (344)
                      +++++|.+++.....+++..++.++.|++       + .+++||||+|+||+++.++.  ++|+|||++.......... 
T Consensus        81 ~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~--~~l~df~~~~~~~~~~~~~~  158 (264)
T cd06623          81 MDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGE--VKIADFGISKVLENTLDQCN  158 (264)
T ss_pred             cCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCC--EEEccCccceecccCCCccc
Confidence            99999999998888889988887766655       5 69999999999999987654  9999999987654433332 


Q ss_pred             CCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCCCCCC-CCHhHHHH
Q 019195          151 STVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVH-ISQDCRNL  229 (344)
Q Consensus       151 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~s~~~~~l  229 (344)
                      ...++..|+|||.+....+ +.++|+||||+++|+|++|..||...... ........+..... .+.... ++..+.++
T Consensus       159 ~~~~~~~y~~pE~~~~~~~-~~~~Dv~slG~il~~l~tg~~p~~~~~~~-~~~~~~~~~~~~~~-~~~~~~~~~~~l~~l  235 (264)
T cd06623         159 TFVGTVTYMSPERIQGESY-SYAADIWSLGLTLLECALGKFPFLPPGQP-SFFELMQAICDGPP-PSLPAEEFSPEFRDF  235 (264)
T ss_pred             ceeecccccCHhhhCCCCC-CchhhHHHHHHHHHHHHhCCCCCcccccc-CHHHHHHHHhcCCC-CCCCcccCCHHHHHH
Confidence            4568999999999877755 45599999999999999999999876521 12222333322211 122223 78899999


Q ss_pred             HHHhcccCCCCCCChHHHhcCccccc
Q 019195          230 LSRIFVANPSRRITIKEIKSHPWFLK  255 (344)
Q Consensus       230 i~~~L~~dp~~R~s~~ell~hp~~~~  255 (344)
                      |.+||..+|.+|||+.++++|||++.
T Consensus       236 i~~~l~~~p~~R~~~~~ll~~~~~~~  261 (264)
T cd06623         236 ISACLQKDPKKRPSAAELLQHPFIKK  261 (264)
T ss_pred             HHHHccCChhhCCCHHHHHhCHHHHh
Confidence            99999999999999999999999954

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=2.8e-41  Score=302.73  Aligned_cols=254  Identities=28%  Similarity=0.470  Sum_probs=197.6

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCcc--ccHHHHHHHHHHhcCCCCCcceeeEEEEcC--CEEEEEE
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK--IDANVAREIINHKQLRHPNIIRFKEVVLTP--THLAIVM   77 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~ei~~l~~l~h~niv~~~~~~~~~--~~~~lv~   77 (344)
                      ++|+..+.||.|++|.||++.+..+++.||+|.+.....  ....+.+|++++++++||||+++++++...  +.+|+||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   80 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM   80 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence            579999999999999999999999999999999875433  345788999999999999999999998654  4789999


Q ss_pred             ecCCCCChHHHHHh----CCCCCHHHHHHHHHHHHH-------CCeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCC
Q 019195           78 EYAAGGELFERICN----AGRFSEDEARYFFQQLIS-------GQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH  146 (344)
Q Consensus        78 e~~~~g~L~~~i~~----~~~~~~~~~~~~~~ql~~-------~~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~  146 (344)
                      ||+++++|.+++..    ...+++..+..++.||+.       .|++|+||+|.||+++.++.  ++|+|||++......
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~--~~l~dfg~~~~~~~~  158 (287)
T cd06621          81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQ--VKLCDFGVSGELVNS  158 (287)
T ss_pred             EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCe--EEEeecccccccccc
Confidence            99999999887643    345788877777777654       49999999999999987664  999999998654322


Q ss_pred             CCCCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCh-HHHHHHHHHHhh-ccccCCC----CC
Q 019195          147 SRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDP-KNFRKTISRIMA-VQYKIPD----YV  220 (344)
Q Consensus       147 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-~~~~~~~~~~~~-~~~~~~~----~~  220 (344)
                      . .....++..|+|||.+.+..++. ++|||||||++|+|++|..||...... ....+....+.. ....++.    ..
T Consensus       159 ~-~~~~~~~~~y~~pE~~~~~~~~~-~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (287)
T cd06621         159 L-AGTFTGTSFYMAPERIQGKPYSI-TSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGNGI  236 (287)
T ss_pred             c-cccccCCccccCHHHhcCCCCCc-hhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhhccCCCCCC
Confidence            2 22456889999999998777654 599999999999999999999865220 001111222111 1111111    12


Q ss_pred             CCCHhHHHHHHHhcccCCCCCCChHHHhcCcccccCCCh
Q 019195          221 HISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLPR  259 (344)
Q Consensus       221 ~~s~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~~~~~  259 (344)
                      .+++.+.+||.+||..+|.+|||+.+++.||||.+...+
T Consensus       237 ~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~~~  275 (287)
T cd06621         237 KWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQMKK  275 (287)
T ss_pred             chHHHHHHHHHHHcCCCcccCCCHHHHHhCccccccccc
Confidence            356789999999999999999999999999999665443

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=4.2e-42  Score=308.08  Aligned_cols=250  Identities=23%  Similarity=0.349  Sum_probs=195.2

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCcc--ccHHHHHHHHHHhcCC-CCCcceeeEEEEcCCEEEEEEe
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK--IDANVAREIINHKQLR-HPNIIRFKEVVLTPTHLAIVME   78 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~ei~~l~~l~-h~niv~~~~~~~~~~~~~lv~e   78 (344)
                      ++|+..+.||+|+||.||++.+..+++.||+|.+.....  ....+.+|+.++.++. ||||+++++++..+...+++||
T Consensus         4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e   83 (288)
T cd06616           4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICME   83 (288)
T ss_pred             HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEe
Confidence            467888999999999999999999999999999875432  2346788999999986 9999999999999999999999


Q ss_pred             cCCCCChHHHH---H--hCCCCCHHHHHHHHHHHHH--------CCeeecCCCCCCeEecCCCCCCEEEeecCCCcccCC
Q 019195           79 YAAGGELFERI---C--NAGRFSEDEARYFFQQLIS--------GQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLL  145 (344)
Q Consensus        79 ~~~~g~L~~~i---~--~~~~~~~~~~~~~~~ql~~--------~~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~  145 (344)
                      |+. +++..+.   .  ....+++..+..++.|++.        .+++||||||+||+++.++.  +||+|||++.....
T Consensus        84 ~~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~--~kl~dfg~~~~~~~  160 (288)
T cd06616          84 LMD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGN--IKLCDFGISGQLVD  160 (288)
T ss_pred             ccc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCc--EEEeecchhHHhcc
Confidence            985 4554432   2  2456888888877776653        28999999999999987654  99999999875544


Q ss_pred             CCCCCCCccCCcccCCccccCC--CCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhc-cccCC--CCC
Q 019195          146 HSRPKSTVGTPAYIAPEVLSRR--EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAV-QYKIP--DYV  220 (344)
Q Consensus       146 ~~~~~~~~gt~~y~aPE~~~~~--~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~-~~~~~--~~~  220 (344)
                      ........|++.|+|||++.+.  ...+.++|||||||++|+|++|++||.....  .. ..+.+.... ....+  ...
T Consensus       161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~--~~-~~~~~~~~~~~~~~~~~~~~  237 (288)
T cd06616         161 SIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS--VF-DQLTQVVKGDPPILSNSEER  237 (288)
T ss_pred             CCccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch--HH-HHHhhhcCCCCCcCCCcCCC
Confidence            4334455789999999999766  2345569999999999999999999976542  11 222222211 11111  123


Q ss_pred             CCCHhHHHHHHHhcccCCCCCCChHHHhcCcccccCC
Q 019195          221 HISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNL  257 (344)
Q Consensus       221 ~~s~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~~~  257 (344)
                      .++.++.+||.+||+.+|.+|||+.++++||||....
T Consensus       238 ~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~~~  274 (288)
T cd06616         238 EFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKDYE  274 (288)
T ss_pred             ccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhchh
Confidence            4788999999999999999999999999999997643

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=8.8e-42  Score=317.15  Aligned_cols=242  Identities=23%  Similarity=0.353  Sum_probs=188.4

Q ss_pred             CCceeeeeeeecCceEEEEEEE-----cCCCcEEEEEEeecCcc--ccHHHHHHHHHHhcC-CCCCcceeeEEEEcCCEE
Q 019195            2 EKYELMKDIGSGNFGVARLMRN-----KNTKELVAMKYIERGHK--IDANVAREIINHKQL-RHPNIIRFKEVVLTPTHL   73 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~vaiK~~~~~~~--~~~~~~~ei~~l~~l-~h~niv~~~~~~~~~~~~   73 (344)
                      ++|++.+.||+|+||.||+|.+     ..++..||+|++.....  ....+.+|+.+++.+ +||||+++++++...+..
T Consensus        35 ~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~~  114 (375)
T cd05104          35 NRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGPT  114 (375)
T ss_pred             HHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCcc
Confidence            4799999999999999999974     35677899999865432  235688999999999 899999999999999999


Q ss_pred             EEEEecCCCCChHHHHHhCC------------------------------------------------------------
Q 019195           74 AIVMEYAAGGELFERICNAG------------------------------------------------------------   93 (344)
Q Consensus        74 ~lv~e~~~~g~L~~~i~~~~------------------------------------------------------------   93 (344)
                      ++|||||++|+|.+++....                                                            
T Consensus       115 ~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  194 (375)
T cd05104         115 LVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSY  194 (375)
T ss_pred             eeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccccccee
Confidence            99999999999999986432                                                            


Q ss_pred             ---------------CCCHHHHHHHHHHHH-------HCCeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCCC---
Q 019195           94 ---------------RFSEDEARYFFQQLI-------SGQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR---  148 (344)
Q Consensus        94 ---------------~~~~~~~~~~~~ql~-------~~~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~~---  148 (344)
                                     .++...++.++.|++       +.||+||||||+|||++.+..  +||+|||+++.......   
T Consensus       195 ~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~--~kl~DfG~a~~~~~~~~~~~  272 (375)
T cd05104         195 IDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRI--TKICDFGLARDIRNDSNYVV  272 (375)
T ss_pred             cccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCc--EEEecCccceeccCcccccc
Confidence                           245555666655554       559999999999999986554  99999999875433221   


Q ss_pred             CCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCHhHH
Q 019195          149 PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCR  227 (344)
Q Consensus       149 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~  227 (344)
                      .....++..|+|||++.+..++ .++|||||||++|+|++ |..||........+.+.+.    ...........+.++.
T Consensus       273 ~~~~~~~~~y~aPE~~~~~~~~-~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~l~  347 (375)
T cd05104         273 KGNARLPVKWMAPESIFNCVYT-FESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIK----EGYRMLSPECAPSEMY  347 (375)
T ss_pred             cCCCCCCcceeChhHhcCCCCC-CCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHH----hCccCCCCCCCCHHHH
Confidence            1223356789999999877765 55999999999999998 8999977654433333322    1222222335678999


Q ss_pred             HHHHHhcccCCCCCCChHHHhcC
Q 019195          228 NLLSRIFVANPSRRITIKEIKSH  250 (344)
Q Consensus       228 ~li~~~L~~dp~~R~s~~ell~h  250 (344)
                      +||.+||+.||.+|||+.++++.
T Consensus       348 ~li~~cl~~dP~~RPs~~eil~~  370 (375)
T cd05104         348 DIMKSCWDADPLKRPTFKQIVQL  370 (375)
T ss_pred             HHHHHHccCChhHCcCHHHHHHH
Confidence            99999999999999999999864

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-41  Score=308.27  Aligned_cols=250  Identities=26%  Similarity=0.396  Sum_probs=191.9

Q ss_pred             CceeeeeeeecCceEEEEEEEcC--CCcEEEEEEeecCc----cccHHHHHHHHHHhcCCCCCcceeeEEEEcC--CEEE
Q 019195            3 KYELMKDIGSGNFGVARLMRNKN--TKELVAMKYIERGH----KIDANVAREIINHKQLRHPNIIRFKEVVLTP--THLA   74 (344)
Q Consensus         3 ~y~~~~~lg~G~~g~V~~~~~~~--~~~~vaiK~~~~~~----~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~--~~~~   74 (344)
                      +|++.+.||+|+||.||+|.+..  ++..||+|.+....    .....+.+|+.+++.++||||+++++++.+.  ..++
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   80 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY   80 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence            69999999999999999999988  89999999987632    2335678899999999999999999999988  8899


Q ss_pred             EEEecCCCCChHHHHHhC-----CCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecC--CCCCCEEEeecCCC
Q 019195           75 IVMEYAAGGELFERICNA-----GRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDG--SPAPRLKICDFGYS  140 (344)
Q Consensus        75 lv~e~~~~g~L~~~i~~~-----~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~--~~~~~vkL~DFg~a  140 (344)
                      +||||+++ +|...+...     ..+++..++.++.|++.+       +|+||||||+||+++.  +..+.+||+|||++
T Consensus        81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~  159 (316)
T cd07842          81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLA  159 (316)
T ss_pred             EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCccc
Confidence            99999964 677666422     267888888777776654       9999999999999976  11345999999998


Q ss_pred             cccCCCCC----CCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChH---------HHHHHHH
Q 019195          141 KSSLLHSR----PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPK---------NFRKTIS  207 (344)
Q Consensus       141 ~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~---------~~~~~~~  207 (344)
                      ........    .....+|+.|+|||.+.+....+.++|||||||++|+|++|++||.......         .+..++.
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (316)
T cd07842         160 RLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFE  239 (316)
T ss_pred             cccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHHH
Confidence            75433222    2344689999999998765544566999999999999999999997654322         1111111


Q ss_pred             HHhhc-------------------cccCCCC------------CCCCHhHHHHHHHhcccCCCCCCChHHHhcCccc
Q 019195          208 RIMAV-------------------QYKIPDY------------VHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF  253 (344)
Q Consensus       208 ~~~~~-------------------~~~~~~~------------~~~s~~~~~li~~~L~~dp~~R~s~~ell~hp~~  253 (344)
                      .+...                   .......            ...+..+.++|.+||+.||.+|||+.++++||||
T Consensus       240 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~f  316 (316)
T cd07842         240 VLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPYF  316 (316)
T ss_pred             HhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCCC
Confidence            00000                   0000011            1456789999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=4.4e-42  Score=329.79  Aligned_cols=253  Identities=23%  Similarity=0.378  Sum_probs=181.1

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCC-cEEEEE------------------EeecCccccHHHHHHHHHHhcCCCCCcce
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTK-ELVAMK------------------YIERGHKIDANVAREIINHKQLRHPNIIR   62 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~-~~vaiK------------------~~~~~~~~~~~~~~ei~~l~~l~h~niv~   62 (344)
                      ++|++++.||+|+||.||+|..+... ..++.|                  .+.........+.+|+.++++++||||++
T Consensus       148 ~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv~  227 (501)
T PHA03210        148 AHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENILK  227 (501)
T ss_pred             hccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcCc
Confidence            58999999999999999998764322 222222                  11122222345789999999999999999


Q ss_pred             eeEEEEcCCEEEEEEecCCCCChHHHHHhC-----CCCCHHHHHHHHHHH-------HHCCeeecCCCCCCeEecCCCCC
Q 019195           63 FKEVVLTPTHLAIVMEYAAGGELFERICNA-----GRFSEDEARYFFQQL-------ISGQICHRDLKLENTLLDGSPAP  130 (344)
Q Consensus        63 ~~~~~~~~~~~~lv~e~~~~g~L~~~i~~~-----~~~~~~~~~~~~~ql-------~~~~iiH~Dikp~NIl~~~~~~~  130 (344)
                      +++++...+..|++++++ +++|..++...     ......+++.++.||       |+.||+||||||+|||++.++. 
T Consensus       228 l~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~~~-  305 (501)
T PHA03210        228 IEEILRSEANTYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGK-  305 (501)
T ss_pred             EeEEEEECCeeEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCC-
Confidence            999999999999999999 45777776432     223345555555554       4559999999999999976654 


Q ss_pred             CEEEeecCCCcccCCCCC--CCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCC-CCCCC--ChHHHHHH
Q 019195          131 RLKICDFGYSKSSLLHSR--PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYP-FEDQE--DPKNFRKT  205 (344)
Q Consensus       131 ~vkL~DFg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~p-f~~~~--~~~~~~~~  205 (344)
                       +||+|||+++.......  ....+||+.|+|||++.+..++ .++|||||||++|+|++|..+ |....  ....+.++
T Consensus       306 -vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~~  383 (501)
T PHA03210        306 -IVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYC-EITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKI  383 (501)
T ss_pred             -EEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCC-cHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHHH
Confidence             99999999976443222  2345799999999999887765 459999999999999998764 43322  12222222


Q ss_pred             HHHHhhccccCCC--------------------------CCCCCHhHHHHHHHhcccCCCCCCChHHHhcCcccccCCC
Q 019195          206 ISRIMAVQYKIPD--------------------------YVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLP  258 (344)
Q Consensus       206 ~~~~~~~~~~~~~--------------------------~~~~s~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~~~~  258 (344)
                      +..+......+|.                          ...++.++.++|.+||+.||.+|||+.|+|.||||.....
T Consensus       384 ~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f~~~~~  462 (501)
T PHA03210        384 IDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPLFSAEEE  462 (501)
T ss_pred             HHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChhhhcCCc
Confidence            2211111111110                          1135678889999999999999999999999999977543

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=2.5e-41  Score=301.74  Aligned_cols=243  Identities=28%  Similarity=0.456  Sum_probs=191.6

Q ss_pred             eeeecCceEEEEEEEcCCCcEEEEEEeecCccc----cHHHHHHH---HHHhcCCCCCcceeeEEEEcCCEEEEEEecCC
Q 019195            9 DIGSGNFGVARLMRNKNTKELVAMKYIERGHKI----DANVAREI---INHKQLRHPNIIRFKEVVLTPTHLAIVMEYAA   81 (344)
Q Consensus         9 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~----~~~~~~ei---~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~   81 (344)
                      .||+|+||.||+|.+..+++.||+|.+.+....    ......|.   ..++...||||+++++++...+.+++||||++
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN   80 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence            489999999999999999999999998764221    11233343   34445689999999999999999999999999


Q ss_pred             CCChHHHHHhCCCCCHHHHHHHHHHHHH-------CCeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCCCCCCCcc
Q 019195           82 GGELFERICNAGRFSEDEARYFFQQLIS-------GQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVG  154 (344)
Q Consensus        82 ~g~L~~~i~~~~~~~~~~~~~~~~ql~~-------~~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~~~~~~~g  154 (344)
                      |++|..++.+.+.+++..++.++.|++.       .+|+||||||+||+++.++.  +||+|||++...... ......|
T Consensus        81 g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~--~kl~dfg~~~~~~~~-~~~~~~~  157 (278)
T cd05606          81 GGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGH--VRISDLGLACDFSKK-KPHASVG  157 (278)
T ss_pred             CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCC--EEEccCcCccccCcc-CCcCcCC
Confidence            9999999988888999998888877665       49999999999999987654  999999998654322 2334579


Q ss_pred             CCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCHhHHHHHHHhc
Q 019195          155 TPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIF  234 (344)
Q Consensus       155 t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L  234 (344)
                      +..|+|||.+.+....+.++||||+||++|+|++|+.||........ ..............|.  .++.++.++|.+||
T Consensus       158 ~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~--~~s~~~~~li~~~l  234 (278)
T cd05606         158 THGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK-HEIDRMTLTMAVELPD--SFSPELRSLLEGLL  234 (278)
T ss_pred             CcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccch-HHHHHHhhccCCCCCC--cCCHHHHHHHHHHh
Confidence            99999999997654345569999999999999999999987532211 1122222222333333  46899999999999


Q ss_pred             ccCCCCCC-----ChHHHhcCcccccCC
Q 019195          235 VANPSRRI-----TIKEIKSHPWFLKNL  257 (344)
Q Consensus       235 ~~dp~~R~-----s~~ell~hp~~~~~~  257 (344)
                      ..+|.+||     ++.++++||||....
T Consensus       235 ~~~p~~R~~~~~~~~~~ll~~~~~~~~~  262 (278)
T cd05606         235 QRDVNRRLGCLGRGAQEVKEHPFFRSLD  262 (278)
T ss_pred             hcCHHhccCCCCCCHHHHHhCccccCCC
Confidence            99999999     999999999997753

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=1.9e-41  Score=302.94  Aligned_cols=247  Identities=29%  Similarity=0.451  Sum_probs=197.7

Q ss_pred             ceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCc---cccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEEecC
Q 019195            4 YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH---KIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYA   80 (344)
Q Consensus         4 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~   80 (344)
                      |++++.||.|++|.||++.+..+|..||+|++....   .....+.+|+.+++.++||||+++++++...+..|++|||+
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~   80 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL   80 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence            788999999999999999999999999999987543   22356888999999999999999999999999999999999


Q ss_pred             CCCChHHHHHhCC--CCCHHHHHHHHHHHHH-------CCeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCCC-CC
Q 019195           81 AGGELFERICNAG--RFSEDEARYFFQQLIS-------GQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR-PK  150 (344)
Q Consensus        81 ~~g~L~~~i~~~~--~~~~~~~~~~~~ql~~-------~~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~~-~~  150 (344)
                      + ++|.+++....  .+++..++.++.|++.       .+++||||+|+||+++.++  .++|+|||++........ ..
T Consensus        81 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~--~~~l~df~~~~~~~~~~~~~~  157 (283)
T cd07835          81 D-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREG--ALKLADFGLARAFGVPVRTYT  157 (283)
T ss_pred             C-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCC--cEEEeecccccccCCCccccC
Confidence            5 68999987765  6888888888777665       4999999999999998755  499999999875432222 23


Q ss_pred             CCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhc--------------cccC
Q 019195          151 STVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAV--------------QYKI  216 (344)
Q Consensus       151 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~--------------~~~~  216 (344)
                      ...+++.|+|||++.+....+.++||||||+++|+|++|++||...+......++.......              ....
T Consensus       158 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (283)
T cd07835         158 HEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPTF  237 (283)
T ss_pred             ccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhhhc
Confidence            34578999999988765544556999999999999999999998766544444333211000              0000


Q ss_pred             C---------CCCCCCHhHHHHHHHhcccCCCCCCChHHHhcCccc
Q 019195          217 P---------DYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF  253 (344)
Q Consensus       217 ~---------~~~~~s~~~~~li~~~L~~dp~~R~s~~ell~hp~~  253 (344)
                      +         ....++..+.++|.+||+.+|.+|||+.+++.||||
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~  283 (283)
T cd07835         238 PKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF  283 (283)
T ss_pred             ccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence            0         123567899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=4.9e-42  Score=308.45  Aligned_cols=250  Identities=27%  Similarity=0.472  Sum_probs=200.9

Q ss_pred             CceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCc-cccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEEecCC
Q 019195            3 KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH-KIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYAA   81 (344)
Q Consensus         3 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~   81 (344)
                      .|.....||+|+||.||++.+..++..||+|.+.... .....+.+|+.+++.++||||+++++.+...+..|+||||++
T Consensus        23 ~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~  102 (292)
T cd06658          23 YLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLE  102 (292)
T ss_pred             HHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCC
Confidence            4566788999999999999999999999999986533 223568899999999999999999999999999999999999


Q ss_pred             CCChHHHHHhCCCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCC-CCCCCc
Q 019195           82 GGELFERICNAGRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS-RPKSTV  153 (344)
Q Consensus        82 ~g~L~~~i~~~~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~-~~~~~~  153 (344)
                      +++|.+++.. +.+++.+++.++.|++.+       ||+||||||+||+++.++.  ++|+|||++....... ......
T Consensus       103 ~~~L~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~--~kL~dfg~~~~~~~~~~~~~~~~  179 (292)
T cd06658         103 GGALTDIVTH-TRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGR--IKLSDFGFCAQVSKEVPKRKSLV  179 (292)
T ss_pred             CCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCC--EEEccCcchhhcccccccCceee
Confidence            9999988754 568888888887776654       9999999999999987654  9999999986533222 223456


Q ss_pred             cCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCHhHHHHHHHh
Q 019195          154 GTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRI  233 (344)
Q Consensus       154 gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~  233 (344)
                      |++.|+|||.+.+..++ .++||||||+++|+|++|+.||........+.. +...  .....+....++..+.++|.+|
T Consensus       180 ~~~~y~aPE~~~~~~~~-~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~-~~~~--~~~~~~~~~~~~~~~~~li~~~  255 (292)
T cd06658         180 GTPYWMAPEVISRLPYG-TEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRR-IRDN--LPPRVKDSHKVSSVLRGFLDLM  255 (292)
T ss_pred             cCccccCHHHHccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH-HHhc--CCCccccccccCHHHHHHHHHH
Confidence            89999999999776654 459999999999999999999987654333222 1111  1122233335788999999999


Q ss_pred             cccCCCCCCChHHHhcCcccccCCCh
Q 019195          234 FVANPSRRITIKEIKSHPWFLKNLPR  259 (344)
Q Consensus       234 L~~dp~~R~s~~ell~hp~~~~~~~~  259 (344)
                      |+.||.+|||+.++++||||....++
T Consensus       256 l~~~P~~Rpt~~~il~~~~~~~~~~~  281 (292)
T cd06658         256 LVREPSQRATAQELLQHPFLKLAGPP  281 (292)
T ss_pred             ccCChhHCcCHHHHhhChhhhccCCc
Confidence            99999999999999999999865444

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=5.2e-41  Score=296.57  Aligned_cols=243  Identities=30%  Similarity=0.530  Sum_probs=196.8

Q ss_pred             CceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCcc---ccHHHHHHHHHHhcCCCCCcceeeEEEEc--CCEEEEEE
Q 019195            3 KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK---IDANVAREIINHKQLRHPNIIRFKEVVLT--PTHLAIVM   77 (344)
Q Consensus         3 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~ei~~l~~l~h~niv~~~~~~~~--~~~~~lv~   77 (344)
                      +|++++.||.|+||.||++.+..++..||+|.+.....   ....+.+|+.+++.++||||+++++.+..  ...+|++|
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM   80 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence            69999999999999999999999999999999875432   23467789999999999999999998764  45789999


Q ss_pred             ecCCCCChHHHHHh----CCCCCHHHHHHHHHHHH------------HCCeeecCCCCCCeEecCCCCCCEEEeecCCCc
Q 019195           78 EYAAGGELFERICN----AGRFSEDEARYFFQQLI------------SGQICHRDLKLENTLLDGSPAPRLKICDFGYSK  141 (344)
Q Consensus        78 e~~~~g~L~~~i~~----~~~~~~~~~~~~~~ql~------------~~~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~  141 (344)
                      ||+++++|.+++..    ...+++..++.++.||+            +.+++|+||||+||+++.++  .+||+|||++.
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~--~~kl~d~g~~~  158 (265)
T cd08217          81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANN--NVKLGDFGLAK  158 (265)
T ss_pred             hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCC--CEEEecccccc
Confidence            99999999999865    35688887777766554            55799999999999998665  49999999988


Q ss_pred             ccCCCCC-CCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCCCCC
Q 019195          142 SSLLHSR-PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYV  220 (344)
Q Consensus       142 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  220 (344)
                      ....... .....|++.|+|||.+.+..++ .++|+||||+++|+|++|+.||...... .   ....+...... +...
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~-~~~Dv~slG~il~~l~~g~~p~~~~~~~-~---~~~~~~~~~~~-~~~~  232 (265)
T cd08217         159 ILGHDSSFAKTYVGTPYYMSPEQLNHMSYD-EKSDIWSLGCLIYELCALSPPFTARNQL-Q---LASKIKEGKFR-RIPY  232 (265)
T ss_pred             cccCCcccccccccCCCccChhhhcCCCCC-chhHHHHHHHHHHHHHHCCCcccCcCHH-H---HHHHHhcCCCC-CCcc
Confidence            6544433 3445799999999999776654 5599999999999999999999876532 2   22222222221 2223


Q ss_pred             CCCHhHHHHHHHhcccCCCCCCChHHHhcCccc
Q 019195          221 HISQDCRNLLSRIFVANPSRRITIKEIKSHPWF  253 (344)
Q Consensus       221 ~~s~~~~~li~~~L~~dp~~R~s~~ell~hp~~  253 (344)
                      .++..+.+++.+||+.+|.+|||+.++++|||+
T Consensus       233 ~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~~~~  265 (265)
T cd08217         233 RYSSELNEVIKSMLNVDPDKRPSTEELLQLPLI  265 (265)
T ss_pred             ccCHHHHHHHHHHccCCcccCCCHHHHhhCCCC
Confidence            678999999999999999999999999999996

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=5.8e-43  Score=321.10  Aligned_cols=254  Identities=32%  Similarity=0.506  Sum_probs=209.3

Q ss_pred             CceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCccc----cHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEEe
Q 019195            3 KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKI----DANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVME   78 (344)
Q Consensus         3 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~----~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e   78 (344)
                      -|..++.||-|+||.|+++....|...||+|.+.+....    ...++.|-.||..-..+-||++|-.|++++.+|+||+
T Consensus       630 mFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMd  709 (1034)
T KOG0608|consen  630 MFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD  709 (1034)
T ss_pred             ceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEe
Confidence            378899999999999999999999999999998775432    2456778889999999999999999999999999999


Q ss_pred             cCCCCChHHHHHhCCCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccC-------
Q 019195           79 YAAGGELFERICNAGRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSL-------  144 (344)
Q Consensus        79 ~~~~g~L~~~i~~~~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~-------  144 (344)
                      |++||++..+|.+-+.|.|..++.++..|..|       |+|||||||+|||||.++.  |||+||||+....       
T Consensus       710 YIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGH--IKLTDFGLCTGfRWTHdskY  787 (1034)
T KOG0608|consen  710 YIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGH--IKLTDFGLCTGFRWTHDSKY  787 (1034)
T ss_pred             ccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCc--eeeeeccccccceecccccc
Confidence            99999999999999999999999888776655       9999999999999987764  9999999985210       


Q ss_pred             ----CCC--------------------------------CCCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHh
Q 019195          145 ----LHS--------------------------------RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV  188 (344)
Q Consensus       145 ----~~~--------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~  188 (344)
                          .+.                                -....+||+.|+|||++...+|... +|+||.|||||||+.
T Consensus       788 Yq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~-cdwws~gvil~em~~  866 (1034)
T KOG0608|consen  788 YQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQL-CDWWSVGVILYEMLV  866 (1034)
T ss_pred             ccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCcccc-chhhHhhHHHHHHhh
Confidence                000                                0023369999999999998888655 999999999999999


Q ss_pred             CCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCHhHHHHHHHhcccCCCCCC---ChHHHhcCcccccCCChhhH
Q 019195          189 GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRI---TIKEIKSHPWFLKNLPRELT  262 (344)
Q Consensus       189 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~---s~~ell~hp~~~~~~~~~~~  262 (344)
                      |++||..........+++.  ....+.++...++|+++.+||.++. .++++|.   .++++..||||+..-..++.
T Consensus       867 g~~pf~~~tp~~tq~kv~n--w~~~l~~~~~~~ls~e~~~li~kLc-~sad~RLGkng~d~vKaHpfFkgIDfsslR  940 (1034)
T KOG0608|consen  867 GQPPFLADTPGETQYKVIN--WRNFLHIPYQGNLSKEALDLIQKLC-CSADSRLGKNGADQVKAHPFFKGIDFSSLR  940 (1034)
T ss_pred             CCCCccCCCCCcceeeeee--hhhccccccccccCHHHHHHHHHHh-cChhhhhcccchhhhhcCccccccchHhhh
Confidence            9999988765544333322  2345567888899999999999854 5788888   57889999999876554443

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=2e-41  Score=310.39  Aligned_cols=253  Identities=25%  Similarity=0.371  Sum_probs=201.7

Q ss_pred             CCcee-eeeeeecCceEEEEEEEcCCCcEEEEEEeecCcccc---------------HHHHHHHHHHhcCCCCCcceeeE
Q 019195            2 EKYEL-MKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKID---------------ANVAREIINHKQLRHPNIIRFKE   65 (344)
Q Consensus         2 ~~y~~-~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~---------------~~~~~ei~~l~~l~h~niv~~~~   65 (344)
                      +||.. .+.||.|+||+||+|.+..+++.||+|++.......               ..+.+|+.+++.++||||+++++
T Consensus         8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~   87 (335)
T PTZ00024          8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD   87 (335)
T ss_pred             cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence            57765 477999999999999999999999999986543221               24778999999999999999999


Q ss_pred             EEEcCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecC
Q 019195           66 VVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFG  138 (344)
Q Consensus        66 ~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg  138 (344)
                      ++..++..+++|||+. ++|.+++.....+++..+..++.|++.+       |++||||||+||+++.++.  ++|+|||
T Consensus        88 ~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~--~kl~dfg  164 (335)
T PTZ00024         88 VYVEGDFINLVMDIMA-SDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGI--CKIADFG  164 (335)
T ss_pred             EEecCCcEEEEEeccc-cCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCC--EEECCcc
Confidence            9999999999999996 6999999888889999888888877655       9999999999999987664  9999999


Q ss_pred             CCcccCC---------------CCCCCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHH
Q 019195          139 YSKSSLL---------------HSRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFR  203 (344)
Q Consensus       139 ~a~~~~~---------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~  203 (344)
                      ++.....               ........+++.|+|||.+.+....+.++|||||||++|+|++|.+||...+....+.
T Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~  244 (335)
T PTZ00024        165 LARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLG  244 (335)
T ss_pred             ceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence            8865431               1111233578899999999776555667999999999999999999998877655554


Q ss_pred             HHHHHHhhcccc-C------C---------------CCCCCCHhHHHHHHHhcccCCCCCCChHHHhcCcccccCC
Q 019195          204 KTISRIMAVQYK-I------P---------------DYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNL  257 (344)
Q Consensus       204 ~~~~~~~~~~~~-~------~---------------~~~~~s~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~~~  257 (344)
                      .+.......... +      +               .....+.++.++|.+||+.+|.+|||+.++|.||||....
T Consensus       245 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~~~~~  320 (335)
T PTZ00024        245 RIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYFKSDP  320 (335)
T ss_pred             HHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcccCCCC
Confidence            443322111000 0      0               0123578899999999999999999999999999997653

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=2.2e-41  Score=305.91  Aligned_cols=245  Identities=23%  Similarity=0.323  Sum_probs=185.7

Q ss_pred             CCceeeeeeeecCceEEEEEEEcC----------------CCcEEEEEEeecCcc--ccHHHHHHHHHHhcCCCCCccee
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKN----------------TKELVAMKYIERGHK--IDANVAREIINHKQLRHPNIIRF   63 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~----------------~~~~vaiK~~~~~~~--~~~~~~~ei~~l~~l~h~niv~~   63 (344)
                      ++|++.+.||+|+||.||+|.+..                ++..||+|.+.....  ....+.+|+.+++.++||||+++
T Consensus         5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~   84 (304)
T cd05096           5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL   84 (304)
T ss_pred             hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence            489999999999999999998542                345799999876432  23468899999999999999999


Q ss_pred             eEEEEcCCEEEEEEecCCCCChHHHHHhCC-------------------CCCHHHHHHHHHHHH-------HCCeeecCC
Q 019195           64 KEVVLTPTHLAIVMEYAAGGELFERICNAG-------------------RFSEDEARYFFQQLI-------SGQICHRDL  117 (344)
Q Consensus        64 ~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~-------------------~~~~~~~~~~~~ql~-------~~~iiH~Di  117 (344)
                      ++++...+..+++|||+++++|.+++....                   .++...++.++.|++       +.||+||||
T Consensus        85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~ivH~dl  164 (304)
T cd05096          85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDL  164 (304)
T ss_pred             EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCccccCc
Confidence            999999999999999999999999886532                   245556666666655       559999999


Q ss_pred             CCCCeEecCCCCCCEEEeecCCCcccCCCC---CCCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHh--CCCC
Q 019195          118 KLENTLLDGSPAPRLKICDFGYSKSSLLHS---RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV--GAYP  192 (344)
Q Consensus       118 kp~NIl~~~~~~~~vkL~DFg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~--g~~p  192 (344)
                      ||+|||++.++.  +||+|||+++......   ......++..|+|||++....++ .++|||||||++|+|++  +..|
T Consensus       165 kp~Nill~~~~~--~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~~l~el~~~~~~~p  241 (304)
T cd05096         165 ATRNCLVGENLT--IKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFT-TASDVWAFGVTLWEILMLCKEQP  241 (304)
T ss_pred             chhheEEcCCcc--EEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCC-chhhhHHHHHHHHHHHHccCCCC
Confidence            999999987654  9999999987543222   12234468899999998777664 45999999999999986  5678


Q ss_pred             CCCCCChHHHHHHHHHHhhc--cccCCCCCCCCHhHHHHHHHhcccCCCCCCChHHHhc
Q 019195          193 FEDQEDPKNFRKTISRIMAV--QYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKS  249 (344)
Q Consensus       193 f~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~ell~  249 (344)
                      |...................  .........++..+.+|+.+||+.+|.+|||+.++.+
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~  300 (304)
T cd05096         242 YGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHA  300 (304)
T ss_pred             CCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHH
Confidence            87765433332222111111  1111122356789999999999999999999999853

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=8.4e-42  Score=317.07  Aligned_cols=241  Identities=22%  Similarity=0.354  Sum_probs=188.0

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCC-----CcEEEEEEeecCccc--cHHHHHHHHHHhcC-CCCCcceeeEEEEcCCEE
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNT-----KELVAMKYIERGHKI--DANVAREIINHKQL-RHPNIIRFKEVVLTPTHL   73 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~vaiK~~~~~~~~--~~~~~~ei~~l~~l-~h~niv~~~~~~~~~~~~   73 (344)
                      ++|++.+.||+|+||.||+|.+..+     +..||+|++......  ...+.+|+.+++.+ +|+||+++++++.....+
T Consensus        38 ~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~~  117 (374)
T cd05106          38 DNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGPV  117 (374)
T ss_pred             HHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCCe
Confidence            4699999999999999999986543     357999999764322  34678999999999 899999999999999999


Q ss_pred             EEEEecCCCCChHHHHHhCC------------------------------------------------------------
Q 019195           74 AIVMEYAAGGELFERICNAG------------------------------------------------------------   93 (344)
Q Consensus        74 ~lv~e~~~~g~L~~~i~~~~------------------------------------------------------------   93 (344)
                      ++|||||++|+|.+++....                                                            
T Consensus       118 ~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  197 (374)
T cd05106         118 LVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDS  197 (374)
T ss_pred             EEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccccc
Confidence            99999999999999885421                                                            


Q ss_pred             ----------CCCHHHHHHHHHHHH-------HCCeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCCC---CCCCc
Q 019195           94 ----------RFSEDEARYFFQQLI-------SGQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR---PKSTV  153 (344)
Q Consensus        94 ----------~~~~~~~~~~~~ql~-------~~~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~~---~~~~~  153 (344)
                                .++..+++.++.|++       +.||+||||||+|||++.+.  ++||+|||+++.......   .....
T Consensus       198 ~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~--~~kL~DfGla~~~~~~~~~~~~~~~~  275 (374)
T cd05106         198 KDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGR--VAKICDFGLARDIMNDSNYVVKGNAR  275 (374)
T ss_pred             cchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCC--eEEEeeceeeeeccCCcceeeccCCC
Confidence                      356666777766655       45999999999999998665  499999999875433221   11223


Q ss_pred             cCCcccCCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCHhHHHHHHH
Q 019195          154 GTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSR  232 (344)
Q Consensus       154 gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~  232 (344)
                      +++.|||||++.+..++ .++|||||||++|+|++ |+.||........+...+    ......+....+++++.++|.+
T Consensus       276 ~~~~y~aPE~~~~~~~~-~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~----~~~~~~~~~~~~~~~l~~li~~  350 (374)
T cd05106         276 LPVKWMAPESIFDCVYT-VQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMV----KRGYQMSRPDFAPPEIYSIMKM  350 (374)
T ss_pred             CccceeCHHHhcCCCCC-ccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHH----HcccCccCCCCCCHHHHHHHHH
Confidence            56789999999777664 45999999999999997 999998755433322222    2222333333568999999999


Q ss_pred             hcccCCCCCCChHHHhc
Q 019195          233 IFVANPSRRITIKEIKS  249 (344)
Q Consensus       233 ~L~~dp~~R~s~~ell~  249 (344)
                      ||+.||.+|||+.++++
T Consensus       351 cl~~dp~~RPs~~~l~~  367 (374)
T cd05106         351 CWNLEPTERPTFSQISQ  367 (374)
T ss_pred             HcCCChhhCcCHHHHHH
Confidence            99999999999999875

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=6.5e-42  Score=312.85  Aligned_cols=251  Identities=30%  Similarity=0.450  Sum_probs=203.7

Q ss_pred             CceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCc---cccHHHHHHHHHHhcCCCCCcceeeEEEEcCC-----EEE
Q 019195            3 KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH---KIDANVAREIINHKQLRHPNIIRFKEVVLTPT-----HLA   74 (344)
Q Consensus         3 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~-----~~~   74 (344)
                      +|++.+.||.|++|.||+|.+..++..||+|++....   .....+.+|+.++++++||||+++++++....     .+|
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY   80 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence            6999999999999999999999999999999987643   23457889999999999999999999998775     789


Q ss_pred             EEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCC
Q 019195           75 IVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS  147 (344)
Q Consensus        75 lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~  147 (344)
                      ++|+|++ ++|..++.+...+++..++.++.||+.+       ||+||||||.|||++.++  .++|+|||++.......
T Consensus        81 lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~--~~~L~dfg~~~~~~~~~  157 (330)
T cd07834          81 IVTELME-TDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNC--DLKICDFGLARGVDPDE  157 (330)
T ss_pred             EEecchh-hhHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC--CEEEcccCceEeecccc
Confidence            9999997 5899999887789999888887776654       999999999999998765  59999999987654443


Q ss_pred             ----CCCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhcccc--------
Q 019195          148 ----RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYK--------  215 (344)
Q Consensus       148 ----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~--------  215 (344)
                          ......+|+.|+|||.+.+....+.++|+||||+++|+|++|++||........+..+..........        
T Consensus       158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  237 (330)
T cd07834         158 DEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSE  237 (330)
T ss_pred             cccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhcccc
Confidence                23445689999999999877444566999999999999999999998876554444333321110000        


Q ss_pred             --------------C---CCCCCCCHhHHHHHHHhcccCCCCCCChHHHhcCcccccC
Q 019195          216 --------------I---PDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKN  256 (344)
Q Consensus       216 --------------~---~~~~~~s~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~~  256 (344)
                                    .   .....+++++.+||.+||+.+|.+|||+.+++.||||.+.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~  295 (330)
T cd07834         238 KARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQL  295 (330)
T ss_pred             chhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhh
Confidence                          0   0112367899999999999999999999999999999654

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.8e-41  Score=300.98  Aligned_cols=247  Identities=28%  Similarity=0.479  Sum_probs=199.1

Q ss_pred             CceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCc--cccHHHHHHHHHHhcCC---CCCcceeeEEEEcCCEEEEEE
Q 019195            3 KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH--KIDANVAREIINHKQLR---HPNIIRFKEVVLTPTHLAIVM   77 (344)
Q Consensus         3 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~ei~~l~~l~---h~niv~~~~~~~~~~~~~lv~   77 (344)
                      .|++++.||+|+||.||+|.+..+++.||+|.+....  .....+.+|+.+++.++   |||++++++++..+..+|++|
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~   81 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM   81 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence            5899999999999999999999999999999986542  22356788999999986   999999999999999999999


Q ss_pred             ecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCCC-C
Q 019195           78 EYAAGGELFERICNAGRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR-P  149 (344)
Q Consensus        78 e~~~~g~L~~~i~~~~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~~-~  149 (344)
                      ||+++++|.+++.. +.+++..++.++.|++.+       ||+||||+|+||+++.++  .++|+|||++........ .
T Consensus        82 e~~~~~~L~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~--~~~l~dfg~~~~~~~~~~~~  158 (277)
T cd06917          82 EYAEGGSVRTLMKA-GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTG--NVKLCDFGVAALLNQNSSKR  158 (277)
T ss_pred             ecCCCCcHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCC--CEEEccCCceeecCCCcccc
Confidence            99999999998865 478888888877776654       999999999999998755  499999999876443332 2


Q ss_pred             CCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhcc-ccCCCCCCCCHhHHH
Q 019195          150 KSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQ-YKIPDYVHISQDCRN  228 (344)
Q Consensus       150 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~s~~~~~  228 (344)
                      ....|+..|+|||.+.+....+.++|+|||||++|+|++|..||.........    ..+.... ..++. ..++.++.+
T Consensus       159 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~----~~~~~~~~~~~~~-~~~~~~~~~  233 (277)
T cd06917         159 STFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAM----MLIPKSKPPRLED-NGYSKLLRE  233 (277)
T ss_pred             ccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhh----hccccCCCCCCCc-ccCCHHHHH
Confidence            34469999999999876555556699999999999999999999765432221    1111111 11111 136789999


Q ss_pred             HHHHhcccCCCCCCChHHHhcCcccccCC
Q 019195          229 LLSRIFVANPSRRITIKEIKSHPWFLKNL  257 (344)
Q Consensus       229 li~~~L~~dp~~R~s~~ell~hp~~~~~~  257 (344)
                      ++.+||+.||.+||++.+++.||||++..
T Consensus       234 ~i~~~l~~~p~~R~~~~~il~~~~~~~~~  262 (277)
T cd06917         234 FVAACLDEEPKERLSAEELLKSKWIKAHS  262 (277)
T ss_pred             HHHHHcCCCcccCcCHHHHhhChHhhccc
Confidence            99999999999999999999999997654

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=6.7e-41  Score=293.30  Aligned_cols=244  Identities=30%  Similarity=0.507  Sum_probs=202.1

Q ss_pred             CceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCcc-ccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEEecCC
Q 019195            3 KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK-IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYAA   81 (344)
Q Consensus         3 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~   81 (344)
                      +|++.+.||+|++|.||++.+..++..+++|++..... ....+.+|+.+++.++||||+++++++......++++||++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~   80 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS   80 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence            58999999999999999999998999999999977554 45678899999999999999999999999999999999999


Q ss_pred             CCChHHHHHhC-CCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCCCCCCCc
Q 019195           82 GGELFERICNA-GRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTV  153 (344)
Q Consensus        82 ~g~L~~~i~~~-~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~~~~~~~  153 (344)
                      +++|.+++... ..+++..++.++.|++.+       |++||||+|+||+++.++.  ++|+|||++.............
T Consensus        81 ~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~--~~l~d~~~~~~~~~~~~~~~~~  158 (253)
T cd05122          81 GGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGE--VKLIDFGLSAQLSDTKARNTMV  158 (253)
T ss_pred             CCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCe--EEEeecccccccccccccccee
Confidence            99999998776 578888888887776654       9999999999999987654  9999999987654443334567


Q ss_pred             cCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCHhHHHHHHHh
Q 019195          154 GTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRI  233 (344)
Q Consensus       154 gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~  233 (344)
                      ++..|+|||.+.+... +.++|+||||+++|+|++|+.||.............   .......+....++..+.++|.+|
T Consensus       159 ~~~~~~~PE~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~i~~~  234 (253)
T cd05122         159 GTPYWMAPEVINGKPY-DYKADIWSLGITAIELAEGKPPYSELPPMKALFKIA---TNGPPGLRNPEKWSDEFKDFLKKC  234 (253)
T ss_pred             cCCcccCHHHHcCCCC-CccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHH---hcCCCCcCcccccCHHHHHHHHHH
Confidence            8999999999977664 455999999999999999999998764332222211   122222333334588999999999


Q ss_pred             cccCCCCCCChHHHhcCcc
Q 019195          234 FVANPSRRITIKEIKSHPW  252 (344)
Q Consensus       234 L~~dp~~R~s~~ell~hp~  252 (344)
                      |+.||.+|||+.+++.|||
T Consensus       235 l~~~p~~R~t~~~~l~~~~  253 (253)
T cd05122         235 LQKNPEKRPTAEQLLKHPF  253 (253)
T ss_pred             ccCChhhCCCHHHHhcCCC
Confidence            9999999999999999998

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=3.2e-41  Score=299.06  Aligned_cols=240  Identities=20%  Similarity=0.319  Sum_probs=191.6

Q ss_pred             CCceeeeeeeecCceEEEEEEEc---CCCcEEEEEEeecCcc--ccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEE
Q 019195            2 EKYELMKDIGSGNFGVARLMRNK---NTKELVAMKYIERGHK--IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIV   76 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~~--~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv   76 (344)
                      ++|++.+.||+|+||.||++...   ..+..||+|.+.....  ....+.+|+..+++++||||+++++++..++.+++|
T Consensus         5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   84 (266)
T cd05064           5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIV   84 (266)
T ss_pred             HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEE
Confidence            57999999999999999999764   4567899999876432  234688999999999999999999999999999999


Q ss_pred             EecCCCCChHHHHHhC-CCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCCC
Q 019195           77 MEYAAGGELFERICNA-GRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR  148 (344)
Q Consensus        77 ~e~~~~g~L~~~i~~~-~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~~  148 (344)
                      |||+++|+|.+++... ..+++.+++.++.|++.+       |++||||||+|||++.+.  .+||+|||.+........
T Consensus        85 ~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~--~~~l~dfg~~~~~~~~~~  162 (266)
T cd05064          85 TEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDL--VCKISGFRRLQEDKSEAI  162 (266)
T ss_pred             EEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCC--cEEECCCcccccccccch
Confidence            9999999999998764 578888888887776644       999999999999997765  499999998764322211


Q ss_pred             C--CCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCHh
Q 019195          149 P--KSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQD  225 (344)
Q Consensus       149 ~--~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~  225 (344)
                      .  ....++..|+|||.+.+..++ .++|||||||++|+|++ |..||..........    .+. .....+....++..
T Consensus       163 ~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~----~~~-~~~~~~~~~~~~~~  236 (266)
T cd05064         163 YTTMSGKSPVLWAAPEAIQYHHFS-SASDVWSFGIVMWEVMSYGERPYWDMSGQDVIK----AVE-DGFRLPAPRNCPNL  236 (266)
T ss_pred             hcccCCCCceeecCHHHHhhCCcc-chhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHH----HHH-CCCCCCCCCCCCHH
Confidence            1  123456789999999877765 45999999999999775 999998765433222    221 22334445567899


Q ss_pred             HHHHHHHhcccCCCCCCChHHHhc
Q 019195          226 CRNLLSRIFVANPSRRITIKEIKS  249 (344)
Q Consensus       226 ~~~li~~~L~~dp~~R~s~~ell~  249 (344)
                      +.+++.+||+.+|.+||++.++++
T Consensus       237 ~~~li~~c~~~~p~~RP~~~~i~~  260 (266)
T cd05064         237 LHQLMLDCWQKERGERPRFSQIHS  260 (266)
T ss_pred             HHHHHHHHcCCCchhCCCHHHHHH
Confidence            999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=5.4e-41  Score=300.66  Aligned_cols=248  Identities=29%  Similarity=0.501  Sum_probs=200.2

Q ss_pred             CceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCcc-ccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEEecCC
Q 019195            3 KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK-IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYAA   81 (344)
Q Consensus         3 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~   81 (344)
                      +|...+.||+|++|.||++.+..+++.+|+|++..... ....+.+|+.+++.++||||+++++++...+..++++||++
T Consensus        20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~   99 (285)
T cd06648          20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLE   99 (285)
T ss_pred             hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccC
Confidence            46667899999999999999999999999998865332 23457899999999999999999999999999999999999


Q ss_pred             CCChHHHHHhCCCCCHHHHHHHHHHHHH-------CCeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCC-CCCCCc
Q 019195           82 GGELFERICNAGRFSEDEARYFFQQLIS-------GQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS-RPKSTV  153 (344)
Q Consensus        82 ~g~L~~~i~~~~~~~~~~~~~~~~ql~~-------~~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~-~~~~~~  153 (344)
                      +++|.+++.. .+++...++.++.|++.       .||+||||+|+||+++.++.  ++|+|||++....... ......
T Consensus       100 ~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~--~~l~d~g~~~~~~~~~~~~~~~~  176 (285)
T cd06648         100 GGALTDIVTH-TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGR--VKLSDFGFCAQVSKEVPRRKSLV  176 (285)
T ss_pred             CCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCc--EEEcccccchhhccCCccccccc
Confidence            9999999877 67888888877776665       49999999999999987654  9999999876533222 223356


Q ss_pred             cCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhcc-ccCCCCCCCCHhHHHHHHH
Q 019195          154 GTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQ-YKIPDYVHISQDCRNLLSR  232 (344)
Q Consensus       154 gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~s~~~~~li~~  232 (344)
                      |++.|+|||.+.+..+. .++||||||+++|+|++|+.||...+......    .+.... ........++..+.+||.+
T Consensus       177 ~~~~y~aPE~~~~~~~~-~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~l~~li~~  251 (285)
T cd06648         177 GTPYWMAPEVISRLPYG-TEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMK----RIRDNLPPKLKNLHKVSPRLRSFLDR  251 (285)
T ss_pred             CCccccCHHHhcCCCCC-CcccHHHHHHHHHHHHhCCCCCcCCCHHHHHH----HHHhcCCCCCcccccCCHHHHHHHHH
Confidence            89999999999777654 45999999999999999999997755433222    222221 1122223478899999999


Q ss_pred             hcccCCCCCCChHHHhcCcccccCCC
Q 019195          233 IFVANPSRRITIKEIKSHPWFLKNLP  258 (344)
Q Consensus       233 ~L~~dp~~R~s~~ell~hp~~~~~~~  258 (344)
                      ||+.+|.+|||+.++++||||.+..+
T Consensus       252 ~l~~~p~~Rpt~~~il~~~~~~~~~~  277 (285)
T cd06648         252 MLVRDPAQRATAAELLNHPFLAKAGP  277 (285)
T ss_pred             HcccChhhCcCHHHHccCcccccCCC
Confidence            99999999999999999999987654

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=8.9e-43  Score=320.84  Aligned_cols=244  Identities=23%  Similarity=0.416  Sum_probs=201.4

Q ss_pred             eeeeeeeecCceEEEEEEEcCCCcEEEEEEee-----cCccccHHHHHHHHHHhcCCCCCcceeeEEEEcCCE--EEEEE
Q 019195            5 ELMKDIGSGNFGVARLMRNKNTKELVAMKYIE-----RGHKIDANVAREIINHKQLRHPNIIRFKEVVLTPTH--LAIVM   77 (344)
Q Consensus         5 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~-----~~~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~--~~lv~   77 (344)
                      +....||+|+|-+||+|.+..+|..||--.+.     +......++..|+.+|+.|+|||||++|.+|.+...  +.+|+
T Consensus        43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT  122 (632)
T KOG0584|consen   43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT  122 (632)
T ss_pred             ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence            34568999999999999999999988843332     223334689999999999999999999999988755  89999


Q ss_pred             ecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHC---------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCCC
Q 019195           78 EYAAGGELFERICNAGRFSEDEARYFFQQLISG---------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR  148 (344)
Q Consensus        78 e~~~~g~L~~~i~~~~~~~~~~~~~~~~ql~~~---------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~~  148 (344)
                      |++..|+|+.++++.++++...++.|++||+.+         .|||||||-+||||+++ .|.|||+|+|+|...... .
T Consensus       123 EL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~-~G~VKIGDLGLAtl~r~s-~  200 (632)
T KOG0584|consen  123 ELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGN-LGEVKIGDLGLATLLRKS-H  200 (632)
T ss_pred             ecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCC-cCceeecchhHHHHhhcc-c
Confidence            999999999999999999999999999999987         89999999999999854 357999999999754433 3


Q ss_pred             CCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCHhHHH
Q 019195          149 PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRN  228 (344)
Q Consensus       149 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~  228 (344)
                      ....+|||.|||||++. ..|+.. +||||||++++||+|+.+||.......+.   ++++..+...-....--.+++++
T Consensus       201 aksvIGTPEFMAPEmYE-E~YnE~-VDVYaFGMCmLEMvT~eYPYsEC~n~AQI---YKKV~SGiKP~sl~kV~dPevr~  275 (632)
T KOG0584|consen  201 AKSVIGTPEFMAPEMYE-ENYNEL-VDVYAFGMCMLEMVTSEYPYSECTNPAQI---YKKVTSGIKPAALSKVKDPEVRE  275 (632)
T ss_pred             cceeccCccccChHHHh-hhcchh-hhhhhhhHHHHHHHhccCChhhhCCHHHH---HHHHHcCCCHHHhhccCCHHHHH
Confidence            44589999999999986 555545 99999999999999999999887765443   33333332221111223689999


Q ss_pred             HHHHhcccCCCCCCChHHHhcCcccccC
Q 019195          229 LLSRIFVANPSRRITIKEIKSHPWFLKN  256 (344)
Q Consensus       229 li~~~L~~dp~~R~s~~ell~hp~~~~~  256 (344)
                      ||.+||.. ...|+|+.|||+||||...
T Consensus       276 fIekCl~~-~~~R~sa~eLL~d~Ff~~d  302 (632)
T KOG0584|consen  276 FIEKCLAT-KSERLSAKELLKDPFFDED  302 (632)
T ss_pred             HHHHHhcC-chhccCHHHHhhChhhccc
Confidence            99999999 8999999999999999765

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=3.8e-41  Score=332.77  Aligned_cols=244  Identities=24%  Similarity=0.354  Sum_probs=189.7

Q ss_pred             CCCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCcc----ccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEE
Q 019195            1 MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK----IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIV   76 (344)
Q Consensus         1 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv   76 (344)
                      |++|++.+.||+|+||.||+|.+..+++.||+|++.....    ...++.+|+.+++.++||||+++++++.+.+..|++
T Consensus         1 igrYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLV   80 (932)
T PRK13184          1 MQRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYT   80 (932)
T ss_pred             CCCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEE
Confidence            6899999999999999999999999999999999875422    235688999999999999999999999999999999


Q ss_pred             EecCCCCChHHHHHhC-----------CCCCHHHHHHHHHH-------HHHCCeeecCCCCCCeEecCCCCCCEEEeecC
Q 019195           77 MEYAAGGELFERICNA-----------GRFSEDEARYFFQQ-------LISGQICHRDLKLENTLLDGSPAPRLKICDFG  138 (344)
Q Consensus        77 ~e~~~~g~L~~~i~~~-----------~~~~~~~~~~~~~q-------l~~~~iiH~Dikp~NIl~~~~~~~~vkL~DFg  138 (344)
                      |||++|++|.+++...           ..++...+..++.|       +|+.||+||||||+|||++.++.  +||+|||
T Consensus        81 MEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~--vKLiDFG  158 (932)
T PRK13184         81 MPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGE--VVILDWG  158 (932)
T ss_pred             EEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCC--EEEEecC
Confidence            9999999999988642           12344445555444       55569999999999999987664  9999999


Q ss_pred             CCcccCCC-------------------CCCCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCh
Q 019195          139 YSKSSLLH-------------------SRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDP  199 (344)
Q Consensus       139 ~a~~~~~~-------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~  199 (344)
                      +++.....                   ......+||+.|+|||.+.+..++ .++|||||||++|+|++|+.||......
T Consensus       159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S-~kSDIWSLGVILyELLTG~~PF~~~~~~  237 (932)
T PRK13184        159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPAS-ESTDIYALGVILYQMLTLSFPYRRKKGR  237 (932)
T ss_pred             cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCC-cHhHHHHHHHHHHHHHHCCCCCCCcchh
Confidence            98754110                   011234699999999999887764 5599999999999999999999774432


Q ss_pred             HHHHHHHHHHhhccccCCCCCCCCHhHHHHHHHhcccCCCCCCChHHHhcC
Q 019195          200 KNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSH  250 (344)
Q Consensus       200 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~ell~h  250 (344)
                      ....   ...............+++.+.+++.+||+.||.+||+..+.+.+
T Consensus       238 ki~~---~~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~  285 (932)
T PRK13184        238 KISY---RDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQ  285 (932)
T ss_pred             hhhh---hhhccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            2111   11111122222334678999999999999999999876665543

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.9e-41  Score=298.10  Aligned_cols=240  Identities=32%  Similarity=0.527  Sum_probs=192.0

Q ss_pred             eeeeeecCceEEEEEEEcCCCcEEEEEEeecCccc----cHHHHHHHHH-HhcCCCCCcceeeEEEEcCCEEEEEEecCC
Q 019195            7 MKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKI----DANVAREIIN-HKQLRHPNIIRFKEVVLTPTHLAIVMEYAA   81 (344)
Q Consensus         7 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~----~~~~~~ei~~-l~~l~h~niv~~~~~~~~~~~~~lv~e~~~   81 (344)
                      ++.||.|+||.||+|.+..+++.||+|.+.+....    ...+..|..+ ....+|+||+++++++...+.+|++|||++
T Consensus         1 ~~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (260)
T cd05611           1 LKPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLN   80 (260)
T ss_pred             CccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccC
Confidence            36799999999999999999999999998754321    1233444443 445689999999999999999999999999


Q ss_pred             CCChHHHHHhCCCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCCCCCCCcc
Q 019195           82 GGELFERICNAGRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVG  154 (344)
Q Consensus        82 ~g~L~~~i~~~~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~~~~~~~g  154 (344)
                      +++|..++...+.+++..++.++.|++.+       +++||||+|+||+++.++.  +||+|||++.....   .....|
T Consensus        81 ~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~--~~l~dfg~~~~~~~---~~~~~~  155 (260)
T cd05611          81 GGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGH--LKLTDFGLSRNGLE---NKKFVG  155 (260)
T ss_pred             CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCc--EEEeecccceeccc---cccCCC
Confidence            99999999888889999988888887765       9999999999999987654  99999998875332   334568


Q ss_pred             CCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCC--CCCCCCHhHHHHHHH
Q 019195          155 TPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIP--DYVHISQDCRNLLSR  232 (344)
Q Consensus       155 t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~s~~~~~li~~  232 (344)
                      ++.|+|||.+.+..+ +.++||||||+++|+|++|..||...+....+..    +.......+  ....+++.+.++|.+
T Consensus       156 ~~~y~~pe~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~i~~  230 (260)
T cd05611         156 TPDYLAPETILGVGD-DKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDN----ILSRRINWPEEVKEFCSPEAVDLINR  230 (260)
T ss_pred             CcCccChhhhcCCCC-cchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHH----HHhcccCCCCcccccCCHHHHHHHHH
Confidence            999999999987764 4569999999999999999999987654333322    222222222  222578999999999


Q ss_pred             hcccCCCCCCCh---HHHhcCcccccC
Q 019195          233 IFVANPSRRITI---KEIKSHPWFLKN  256 (344)
Q Consensus       233 ~L~~dp~~R~s~---~ell~hp~~~~~  256 (344)
                      ||+.+|.+||++   .|++.||||.+.
T Consensus       231 ~l~~~p~~R~~~~~~~~~l~~~~~~~~  257 (260)
T cd05611         231 LLCMDPAKRLGANGYQEIKSHPFFKSI  257 (260)
T ss_pred             HccCCHHHccCCCcHHHHHcChHhhcC
Confidence            999999999955   799999999664

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=7.9e-41  Score=294.02  Aligned_cols=245  Identities=31%  Similarity=0.506  Sum_probs=203.4

Q ss_pred             CceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCc---cccHHHHHHHHHHhcCCCCCcceeeEEEEcC--CEEEEEE
Q 019195            3 KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH---KIDANVAREIINHKQLRHPNIIRFKEVVLTP--THLAIVM   77 (344)
Q Consensus         3 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~--~~~~lv~   77 (344)
                      +|++.+.||+|++|.||++.+..+++.|++|++....   .....+.+|+..+++++||||+++++.+...  ..+++++
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   80 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL   80 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence            5899999999999999999999999999999987654   2346788999999999999999999999988  8999999


Q ss_pred             ecCCCCChHHHHHhCCCCCHHHHHHHHHHHHH-------CCeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCCC--
Q 019195           78 EYAAGGELFERICNAGRFSEDEARYFFQQLIS-------GQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR--  148 (344)
Q Consensus        78 e~~~~g~L~~~i~~~~~~~~~~~~~~~~ql~~-------~~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~~--  148 (344)
                      ||+++++|.+++.+...+++..++.++.|++.       .|++|+||+|+||+++.++  .++|+|||.+........  
T Consensus        81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~--~~~l~d~~~~~~~~~~~~~~  158 (260)
T cd06606          81 EYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDG--VVKLADFGCAKRLGDIETGE  158 (260)
T ss_pred             EecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCC--CEEEcccccEEecccccccc
Confidence            99999999999988878999888888777665       4999999999999998755  499999999876554443  


Q ss_pred             -CCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCHhHH
Q 019195          149 -PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCR  227 (344)
Q Consensus       149 -~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~  227 (344)
                       .....++..|+|||.+.+... +.++||||||+++|+|++|..||........   .................++..+.
T Consensus       159 ~~~~~~~~~~y~~pE~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~l~  234 (260)
T cd06606         159 GTGSVRGTPYWMAPEVIRGEEY-GRAADIWSLGCTVIEMATGKPPWSELGNPMA---ALYKIGSSGEPPEIPEHLSEEAK  234 (260)
T ss_pred             cccCCCCCccccCHhhhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCchHH---HHHhccccCCCcCCCcccCHHHH
Confidence             445679999999999877764 4559999999999999999999987662222   12222211111222235689999


Q ss_pred             HHHHHhcccCCCCCCChHHHhcCccc
Q 019195          228 NLLSRIFVANPSRRITIKEIKSHPWF  253 (344)
Q Consensus       228 ~li~~~L~~dp~~R~s~~ell~hp~~  253 (344)
                      ++|.+||+.+|.+||++.+++.||||
T Consensus       235 ~~i~~~l~~~p~~Rp~~~~ll~~~~~  260 (260)
T cd06606         235 DFLRKCLRRDPKKRPTADELLQHPFL  260 (260)
T ss_pred             HHHHHhCcCChhhCCCHHHHhhCCCC
Confidence            99999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=4.3e-43  Score=318.66  Aligned_cols=230  Identities=31%  Similarity=0.458  Sum_probs=197.1

Q ss_pred             eeeeeeecCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEEecCCCCCh
Q 019195            6 LMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYAAGGEL   85 (344)
Q Consensus         6 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L   85 (344)
                      -++.||+|+.|.||+++..  ++.||||+++.-.      ..+|+-|++|+||||+.+.++|....-+|||||||..|.|
T Consensus       128 ELeWlGSGaQGAVF~Grl~--netVAVKKV~elk------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL  199 (904)
T KOG4721|consen  128 ELEWLGSGAQGAVFLGRLH--NETVAVKKVRELK------ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQL  199 (904)
T ss_pred             hhhhhccCcccceeeeecc--CceehhHHHhhhh------hhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccH
Confidence            4678999999999999864  5689999875422      3578889999999999999999999999999999999999


Q ss_pred             HHHHHhCCCCCHHHHHHHHHHHH-------HCCeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCCCCCCCccCCcc
Q 019195           86 FERICNAGRFSEDEARYFFQQLI-------SGQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAY  158 (344)
Q Consensus        86 ~~~i~~~~~~~~~~~~~~~~ql~-------~~~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~~~~~~~gt~~y  158 (344)
                      ...|+..+.+.......|..+|+       ...|||||||.-||||..+..  |||+|||-++.........+++||..|
T Consensus       200 ~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~--VKIsDFGTS~e~~~~STkMSFaGTVaW  277 (904)
T KOG4721|consen  200 YEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDV--VKISDFGTSKELSDKSTKMSFAGTVAW  277 (904)
T ss_pred             HHHHhccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccce--EEeccccchHhhhhhhhhhhhhhhHhh
Confidence            99999999888887777755554       559999999999999987765  999999988765555555678899999


Q ss_pred             cCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCHhHHHHHHHhcccCC
Q 019195          159 IAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANP  238 (344)
Q Consensus       159 ~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp  238 (344)
                      ||||++...+.+.+ +|||||||+||||+||..||.+-...    .++-.+....+.+|.+...++-++=||++||+-.|
T Consensus       278 MAPEvIrnePcsEK-VDIwSfGVVLWEmLT~EiPYkdVdss----AIIwGVGsNsL~LpvPstcP~GfklL~Kqcw~sKp  352 (904)
T KOG4721|consen  278 MAPEVIRNEPCSEK-VDIWSFGVVLWEMLTGEIPYKDVDSS----AIIWGVGSNSLHLPVPSTCPDGFKLLLKQCWNSKP  352 (904)
T ss_pred             hCHHHhhcCCcccc-cceehhHHHHHHHHhcCCCccccchh----eeEEeccCCcccccCcccCchHHHHHHHHHHhcCC
Confidence            99999988887655 99999999999999999999876542    34445556667778777889999999999999999


Q ss_pred             CCCCChHHHhcC
Q 019195          239 SRRITIKEIKSH  250 (344)
Q Consensus       239 ~~R~s~~ell~h  250 (344)
                      ..||++.++|.|
T Consensus       353 RNRPSFrqil~H  364 (904)
T KOG4721|consen  353 RNRPSFRQILLH  364 (904)
T ss_pred             CCCccHHHHHHH
Confidence            999999999999

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=7.4e-41  Score=300.36  Aligned_cols=251  Identities=30%  Similarity=0.542  Sum_probs=202.1

Q ss_pred             CceeeeeeeecCceEEEEEEEc---CCCcEEEEEEeecCc-----cccHHHHHHHHHHhcC-CCCCcceeeEEEEcCCEE
Q 019195            3 KYELMKDIGSGNFGVARLMRNK---NTKELVAMKYIERGH-----KIDANVAREIINHKQL-RHPNIIRFKEVVLTPTHL   73 (344)
Q Consensus         3 ~y~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~-----~~~~~~~~ei~~l~~l-~h~niv~~~~~~~~~~~~   73 (344)
                      .|++.+.||.|+||.||.|.+.   .+|..||+|++....     .....+.+|+.+++++ +|+||+++++++..+..+
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL   80 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence            5899999999999999999875   478999999987532     2235678899999999 599999999999999999


Q ss_pred             EEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHH-------CCeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCC
Q 019195           74 AIVMEYAAGGELFERICNAGRFSEDEARYFFQQLIS-------GQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH  146 (344)
Q Consensus        74 ~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~ql~~-------~~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~  146 (344)
                      |+||||+++++|.+++.....+++..+..++.|++.       .|++||||||+|||++.++  ++||+|||++......
T Consensus        81 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~--~~kl~dfg~~~~~~~~  158 (290)
T cd05613          81 HLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNG--HVVLTDFGLSKEFHED  158 (290)
T ss_pred             EEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCC--CEEEeeCccceecccc
Confidence            999999999999999988888888887777666554       4999999999999998765  5999999998754332


Q ss_pred             C--CCCCCccCCcccCCccccCCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCC
Q 019195          147 S--RPKSTVGTPAYIAPEVLSRRE-YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHIS  223 (344)
Q Consensus       147 ~--~~~~~~gt~~y~aPE~~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s  223 (344)
                      .  ......|+..|+|||.+.+.. ..+.++||||||+++|+|++|..||...........+...+.......|  ..++
T Consensus       159 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~  236 (290)
T cd05613         159 EVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYP--QEMS  236 (290)
T ss_pred             cccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccCCCCC--ccCC
Confidence            2  223456899999999986532 2345699999999999999999999754433333444444433333333  3578


Q ss_pred             HhHHHHHHHhcccCCCCCC-----ChHHHhcCcccccCC
Q 019195          224 QDCRNLLSRIFVANPSRRI-----TIKEIKSHPWFLKNL  257 (344)
Q Consensus       224 ~~~~~li~~~L~~dp~~R~-----s~~ell~hp~~~~~~  257 (344)
                      +.+.+|+.+||+.+|.+||     ++.+++.||||...-
T Consensus       237 ~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~  275 (290)
T cd05613         237 ALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKIN  275 (290)
T ss_pred             HHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccCC
Confidence            9999999999999999997     899999999997753

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=9.6e-42  Score=313.44  Aligned_cols=253  Identities=24%  Similarity=0.389  Sum_probs=200.1

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCc---cccHHHHHHHHHHhcCCCCCcceeeEEEEcCCE------
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH---KIDANVAREIINHKQLRHPNIIRFKEVVLTPTH------   72 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~------   72 (344)
                      ++|++.+.||+|++|.||++.+..++..||+|++....   .....+.+|+.+++.+.||||+++++++.....      
T Consensus        15 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   94 (343)
T cd07851          15 DRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQD   94 (343)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccccc
Confidence            58999999999999999999999999999999986532   223457789999999999999999998876554      


Q ss_pred             EEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCC
Q 019195           73 LAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLL  145 (344)
Q Consensus        73 ~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~  145 (344)
                      +++|+||+ +++|.+++.. ..+++..++.++.|++.+       ||+||||||+||+++.++  +++|+|||++.....
T Consensus        95 ~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~--~~kL~dfg~~~~~~~  170 (343)
T cd07851          95 VYLVTHLM-GADLNNIVKC-QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDC--ELKILDFGLARHTDD  170 (343)
T ss_pred             EEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCC--CEEEccccccccccc
Confidence            89999999 6799888865 568888888887776654       999999999999998765  499999999875432


Q ss_pred             CCCCCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhcc------------
Q 019195          146 HSRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQ------------  213 (344)
Q Consensus       146 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~------------  213 (344)
                        ......++..|+|||.+.+....+.++|||||||++|+|++|+.||........+..++.......            
T Consensus       171 --~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  248 (343)
T cd07851         171 --EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSESA  248 (343)
T ss_pred             --cccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhccchhH
Confidence              234557899999999986654455669999999999999999999987665444333322110000            


Q ss_pred             --------cc-C----CCCCCCCHhHHHHHHHhcccCCCCCCChHHHhcCcccccCCChh
Q 019195          214 --------YK-I----PDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLPRE  260 (344)
Q Consensus       214 --------~~-~----~~~~~~s~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~~~~~~  260 (344)
                              .. .    ..+..+++.+.+||.+||+.+|.+|||+.+++.||||.+...+.
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~~~~~  308 (343)
T cd07851         249 RNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYHDPE  308 (343)
T ss_pred             HHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccccCCCc
Confidence                    00 0    01124588999999999999999999999999999998765543

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.9e-41  Score=311.41  Aligned_cols=251  Identities=27%  Similarity=0.402  Sum_probs=197.9

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCcc---ccHHHHHHHHHHhcCCCCCcceeeEEEEcCC------E
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK---IDANVAREIINHKQLRHPNIIRFKEVVLTPT------H   72 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~------~   72 (344)
                      ++|++++.||+|+||.||++.+..++..||+|++.....   ....+.+|+.+++.++||||+++++++..+.      .
T Consensus        15 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   94 (343)
T cd07880          15 DRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHD   94 (343)
T ss_pred             cceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccce
Confidence            689999999999999999999999999999999865322   2346789999999999999999999997654      4


Q ss_pred             EEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCC
Q 019195           73 LAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLL  145 (344)
Q Consensus        73 ~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~  145 (344)
                      +++||+|+ +++|..++. ...+++..++.++.|++.+       ||+||||||+||+++.++  .+||+|||++.....
T Consensus        95 ~~lv~e~~-~~~l~~~~~-~~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~--~~kl~dfg~~~~~~~  170 (343)
T cd07880          95 FYLVMPFM-GTDLGKLMK-HEKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDC--ELKILDFGLARQTDS  170 (343)
T ss_pred             EEEEEecC-CCCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC--CEEEeeccccccccc
Confidence            69999999 778988775 4578898888887777654       999999999999997665  499999999875432


Q ss_pred             CCCCCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhcc------------
Q 019195          146 HSRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQ------------  213 (344)
Q Consensus       146 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~------------  213 (344)
                        ......+++.|+|||.+.+....+.++|+|||||++|+|++|.+||........+.+++.......            
T Consensus       171 --~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (343)
T cd07880         171 --EMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDA  248 (343)
T ss_pred             --CccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhcchhH
Confidence              233456899999999987644455669999999999999999999987654433333222100000            


Q ss_pred             ----ccCC---------CCCCCCHhHHHHHHHhcccCCCCCCChHHHhcCcccccCCC
Q 019195          214 ----YKIP---------DYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLP  258 (344)
Q Consensus       214 ----~~~~---------~~~~~s~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~~~~  258 (344)
                          ...+         ....+++.+.++|.+||+.||.+|||+.+++.||||.....
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~~  306 (343)
T cd07880         249 KNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHD  306 (343)
T ss_pred             HHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhcC
Confidence                0000         11356888999999999999999999999999999976533

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=4e-41  Score=300.15  Aligned_cols=247  Identities=28%  Similarity=0.421  Sum_probs=198.8

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCc--cccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEEec
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH--KIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEY   79 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~   79 (344)
                      ..|+.++.||.|+||.||++.+..++..||+|++....  .....+.+|+.+++.+.||||+++++++.++..+|+||||
T Consensus         4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (277)
T cd06640           4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY   83 (277)
T ss_pred             HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence            35889999999999999999999999999999987542  2235688899999999999999999999999999999999


Q ss_pred             CCCCChHHHHHhCCCCCHHHHHHHHHHHH-------HCCeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCCC-CCC
Q 019195           80 AAGGELFERICNAGRFSEDEARYFFQQLI-------SGQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR-PKS  151 (344)
Q Consensus        80 ~~~g~L~~~i~~~~~~~~~~~~~~~~ql~-------~~~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~~-~~~  151 (344)
                      +++++|.+++.. +.+++.++..++.|++       +.+++|+||+|+||+++.++  +++|+|||++........ ...
T Consensus        84 ~~~~~L~~~i~~-~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~--~~~l~dfg~~~~~~~~~~~~~~  160 (277)
T cd06640          84 LGGGSALDLLRA-GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQG--DVKLADFGVAGQLTDTQIKRNT  160 (277)
T ss_pred             CCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCC--CEEEcccccceeccCCcccccc
Confidence            999999998864 5688888777776655       44999999999999998665  499999999875433322 233


Q ss_pred             CccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCHhHHHHHH
Q 019195          152 TVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLS  231 (344)
Q Consensus       152 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~  231 (344)
                      ..++..|+|||.+.+...+ .++|+|||||++|+|++|.+||..........    .+.. .........++..+.++|.
T Consensus       161 ~~~~~~y~apE~~~~~~~~-~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~----~~~~-~~~~~~~~~~~~~~~~li~  234 (277)
T cd06640         161 FVGTPFWMAPEVIQQSAYD-SKADIWSLGITAIELAKGEPPNSDMHPMRVLF----LIPK-NNPPTLTGEFSKPFKEFID  234 (277)
T ss_pred             ccCcccccCHhHhccCCCc-cHHHHHHHHHHHHHHHHCCCCCCCcChHhHhh----hhhc-CCCCCCchhhhHHHHHHHH
Confidence            4688999999999776654 45999999999999999999997654322221    1111 1111112246788999999


Q ss_pred             HhcccCCCCCCChHHHhcCcccccCC
Q 019195          232 RIFVANPSRRITIKEIKSHPWFLKNL  257 (344)
Q Consensus       232 ~~L~~dp~~R~s~~ell~hp~~~~~~  257 (344)
                      +||+.+|.+||++.+++.||||.+..
T Consensus       235 ~~l~~~p~~Rp~~~~il~~~~~~~~~  260 (277)
T cd06640         235 ACLNKDPSFRPTAKELLKHKFIVKNA  260 (277)
T ss_pred             HHcccCcccCcCHHHHHhChHhhhcc
Confidence            99999999999999999999996653

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=3.3e-41  Score=301.45  Aligned_cols=242  Identities=21%  Similarity=0.356  Sum_probs=192.7

Q ss_pred             CCCceeeeeeeecCceEEEEEEEcCCC-----cEEEEEEeecCcc--ccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEE
Q 019195            1 MEKYELMKDIGSGNFGVARLMRNKNTK-----ELVAMKYIERGHK--IDANVAREIINHKQLRHPNIIRFKEVVLTPTHL   73 (344)
Q Consensus         1 ~~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~vaiK~~~~~~~--~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~   73 (344)
                      +++|++.+.||+|+||.||++.....+     ..||+|.+.....  ....+.+|+.+++.++||||+++++++......
T Consensus         4 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~   83 (283)
T cd05048           4 LSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPT   83 (283)
T ss_pred             hHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCce
Confidence            357999999999999999999876555     6899998865432  235688999999999999999999999999999


Q ss_pred             EEEEecCCCCChHHHHHhC----------------CCCCHHHHHHHHHHHHH-------CCeeecCCCCCCeEecCCCCC
Q 019195           74 AIVMEYAAGGELFERICNA----------------GRFSEDEARYFFQQLIS-------GQICHRDLKLENTLLDGSPAP  130 (344)
Q Consensus        74 ~lv~e~~~~g~L~~~i~~~----------------~~~~~~~~~~~~~ql~~-------~~iiH~Dikp~NIl~~~~~~~  130 (344)
                      |++|||+++++|.+++...                ..++...++.++.|++.       .|++||||||+||+++.++. 
T Consensus        84 ~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~~~~-  162 (283)
T cd05048          84 CMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLT-  162 (283)
T ss_pred             EEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcCCCc-
Confidence            9999999999999999764                34667777777666554       49999999999999987654 


Q ss_pred             CEEEeecCCCcccCCCC---CCCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHH
Q 019195          131 RLKICDFGYSKSSLLHS---RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTI  206 (344)
Q Consensus       131 ~vkL~DFg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~  206 (344)
                       ++|+|||++.......   ......+++.|+|||.+.+..++ .++|||||||++|+|++ |..||.+....+..    
T Consensus       163 -~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~sDv~slG~il~el~~~g~~p~~~~~~~~~~----  236 (283)
T cd05048         163 -VKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFT-TESDIWSFGVVLWEIFSYGLQPYYGFSNQEVI----  236 (283)
T ss_pred             -EEECCCcceeeccccccccccCCCcccccccCHHHhccCcCc-hhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHH----
Confidence             9999999987543221   22334578899999998777664 55999999999999998 99999876543322    


Q ss_pred             HHHhhccccCCCCCCCCHhHHHHHHHhcccCCCCCCChHHHhcC
Q 019195          207 SRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSH  250 (344)
Q Consensus       207 ~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~ell~h  250 (344)
                      ..+... ...+....+++++.+|+.+||+.||.+||++.+++++
T Consensus       237 ~~i~~~-~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~  279 (283)
T cd05048         237 EMIRSR-QLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTR  279 (283)
T ss_pred             HHHHcC-CcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            222222 1222334678999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=1.2e-40  Score=295.64  Aligned_cols=246  Identities=27%  Similarity=0.440  Sum_probs=190.9

Q ss_pred             ceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCcc-ccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEEecCCC
Q 019195            4 YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK-IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYAAG   82 (344)
Q Consensus         4 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~   82 (344)
                      ......||+|+||.||++.+..++..||+|.+..... ....+.+|+.+++.++|+||+++++++..++.+++++||+++
T Consensus        10 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~   89 (268)
T cd06624          10 NGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPG   89 (268)
T ss_pred             CCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecCCC
Confidence            3455789999999999999999999999998876433 335688999999999999999999999999999999999999


Q ss_pred             CChHHHHHhC-CCC--CHHHHHHHHHHH-------HHCCeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCC-CCCC
Q 019195           83 GELFERICNA-GRF--SEDEARYFFQQL-------ISGQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS-RPKS  151 (344)
Q Consensus        83 g~L~~~i~~~-~~~--~~~~~~~~~~ql-------~~~~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~-~~~~  151 (344)
                      ++|..++... ..+  ++..++.++.|+       |+.||+||||||+||+++... +.++|+|||++....... ....
T Consensus        90 ~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~-~~~~l~dfg~~~~~~~~~~~~~~  168 (268)
T cd06624          90 GSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYS-GVVKISDFGTSKRLAGINPCTET  168 (268)
T ss_pred             CCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCC-CeEEEecchhheecccCCCcccc
Confidence            9999998764 444  666666655554       455999999999999997533 359999999986543222 2233


Q ss_pred             CccCCcccCCccccCCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCHhHHHHH
Q 019195          152 TVGTPAYIAPEVLSRRE-YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLL  230 (344)
Q Consensus       152 ~~gt~~y~aPE~~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li  230 (344)
                      ..|++.|+|||.+.+.. ..+.++|+||||+++|+|++|+.||........... ..........+|  ..+++++.+|+
T Consensus       169 ~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~--~~~~~~~~~li  245 (268)
T cd06624         169 FTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMF-KVGMFKIHPEIP--ESLSAEAKNFI  245 (268)
T ss_pred             CCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHh-hhhhhccCCCCC--cccCHHHHHHH
Confidence            46899999999986543 234569999999999999999999976543221111 111111111222  35788999999


Q ss_pred             HHhcccCCCCCCChHHHhcCccc
Q 019195          231 SRIFVANPSRRITIKEIKSHPWF  253 (344)
Q Consensus       231 ~~~L~~dp~~R~s~~ell~hp~~  253 (344)
                      .+||+.+|.+|||+.+++.||||
T Consensus       246 ~~~l~~~p~~Rpt~~~ll~~~~~  268 (268)
T cd06624         246 LRCFEPDPDKRASAHDLLQDPFL  268 (268)
T ss_pred             HHHcCCCchhCCCHHHHHhCCCC
Confidence            99999999999999999999997

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=4.9e-41  Score=303.07  Aligned_cols=249  Identities=29%  Similarity=0.475  Sum_probs=197.1

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCc---cccHHHHHHHHHHhcCCCCCcceeeEEEEcCC-------
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH---KIDANVAREIINHKQLRHPNIIRFKEVVLTPT-------   71 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~-------   71 (344)
                      ++|++.+.||+|+||.||++.+..+++.||+|.+....   .....+.+|+.+++.++||||+++++++.+..       
T Consensus         7 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~~   86 (302)
T cd07864           7 DKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFKK   86 (302)
T ss_pred             hhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhccc
Confidence            68999999999999999999999999999999987543   23356778999999999999999999987654       


Q ss_pred             ---EEEEEEecCCCCChHHHHHhC-CCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCC
Q 019195           72 ---HLAIVMEYAAGGELFERICNA-GRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYS  140 (344)
Q Consensus        72 ---~~~lv~e~~~~g~L~~~i~~~-~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a  140 (344)
                         .+++++||+++ +|...+... ..+++.+++.++.|++.+       ||+||||||+||+++.++.  +||+|||++
T Consensus        87 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~--~kl~dfg~~  163 (302)
T cd07864          87 DKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQ--IKLADFGLA  163 (302)
T ss_pred             cCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCc--EEeCccccc
Confidence               79999999976 676766543 468888888887776654       9999999999999987664  999999998


Q ss_pred             cccCCCCC--CCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccc-cC-
Q 019195          141 KSSLLHSR--PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQY-KI-  216 (344)
Q Consensus       141 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~-  216 (344)
                      ........  .....++..|+|||.+.+....+.++|||||||++++|++|++||...+....+..+......... .. 
T Consensus       164 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (302)
T cd07864         164 RLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAVWP  243 (302)
T ss_pred             ccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhcc
Confidence            75443321  122356888999999876554456799999999999999999999876655544443332211100 00 


Q ss_pred             ----------------------CCCCCCCHhHHHHHHHhcccCCCCCCChHHHhcCccc
Q 019195          217 ----------------------PDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF  253 (344)
Q Consensus       217 ----------------------~~~~~~s~~~~~li~~~L~~dp~~R~s~~ell~hp~~  253 (344)
                                            ..+..++..+.++|.+||+.+|.+|||+.+++.||||
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~  302 (302)
T cd07864         244 DVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL  302 (302)
T ss_pred             cccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence                                  0122468899999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=3.3e-41  Score=303.81  Aligned_cols=247  Identities=27%  Similarity=0.488  Sum_probs=199.3

Q ss_pred             ceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCc-cccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEEecCCC
Q 019195            4 YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH-KIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYAAG   82 (344)
Q Consensus         4 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~   82 (344)
                      |.....||+|+||.||++.+..++..||+|++.... .....+.+|+.+++.++||||+++++++..++..|++|||+++
T Consensus        23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~  102 (297)
T cd06659          23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQG  102 (297)
T ss_pred             HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCC
Confidence            556678999999999999999999999999986533 2335688999999999999999999999999999999999999


Q ss_pred             CChHHHHHhCCCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCC-CCCCCcc
Q 019195           83 GELFERICNAGRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS-RPKSTVG  154 (344)
Q Consensus        83 g~L~~~i~~~~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~-~~~~~~g  154 (344)
                      ++|..++.. ..+++..++.++.|++.+       |++||||||+||+++.++.  +||+|||++....... ......|
T Consensus       103 ~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~--~kL~dfg~~~~~~~~~~~~~~~~~  179 (297)
T cd06659         103 GALTDIVSQ-TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGR--VKLSDFGFCAQISKDVPKRKSLVG  179 (297)
T ss_pred             CCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCc--EEEeechhHhhcccccccccceec
Confidence            999887744 568888888888776654       9999999999999987664  9999999986433222 2234579


Q ss_pred             CCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCHhHHHHHHHhc
Q 019195          155 TPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIF  234 (344)
Q Consensus       155 t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L  234 (344)
                      ++.|+|||++.+..+ +.++|||||||++|+|++|..||........... +...  ..........++..+.++|.+||
T Consensus       180 ~~~y~aPE~~~~~~~-~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~-~~~~--~~~~~~~~~~~~~~l~~~i~~~l  255 (297)
T cd06659         180 TPYWMAPEVISRTPY-GTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKR-LRDS--PPPKLKNAHKISPVLRDFLERML  255 (297)
T ss_pred             CccccCHHHHccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH-Hhcc--CCCCccccCCCCHHHHHHHHHHh
Confidence            999999999977665 4559999999999999999999986554333222 1111  11112223357889999999999


Q ss_pred             ccCCCCCCChHHHhcCcccccCC
Q 019195          235 VANPSRRITIKEIKSHPWFLKNL  257 (344)
Q Consensus       235 ~~dp~~R~s~~ell~hp~~~~~~  257 (344)
                      +.+|.+||++.++++||||.+..
T Consensus       256 ~~~P~~Rps~~~ll~~~~~~~~~  278 (297)
T cd06659         256 TREPQERATAQELLDHPFLLQTG  278 (297)
T ss_pred             cCCcccCcCHHHHhhChhhccCC
Confidence            99999999999999999998764

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=8.1e-41  Score=299.06  Aligned_cols=247  Identities=30%  Similarity=0.492  Sum_probs=198.2

Q ss_pred             ceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCc---cccHHHHHHHHHHhcCCCCCcceeeEEEEcC--CEEEEEEe
Q 019195            4 YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH---KIDANVAREIINHKQLRHPNIIRFKEVVLTP--THLAIVME   78 (344)
Q Consensus         4 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~--~~~~lv~e   78 (344)
                      |++++.||.|+||.||++.+..++..+|+|.+....   .....+.+|+.+++.++|||++++++++...  ...++|||
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e   80 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE   80 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence            789999999999999999999999999999998753   2335688899999999999999999999988  89999999


Q ss_pred             cCCCCChHHHHHhC-CCCCHHHHHHHHHHHHH-------CCeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCC--C
Q 019195           79 YAAGGELFERICNA-GRFSEDEARYFFQQLIS-------GQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS--R  148 (344)
Q Consensus        79 ~~~~g~L~~~i~~~-~~~~~~~~~~~~~ql~~-------~~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~--~  148 (344)
                      |++ ++|..++... ..+++.+++.++.|++.       .|++|+||||+||+++.++.  +||+|||++.......  .
T Consensus        81 ~~~-~~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~--~~l~d~g~~~~~~~~~~~~  157 (287)
T cd07840          81 YMD-HDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGV--LKLADFGLARPYTKRNSAD  157 (287)
T ss_pred             ccc-ccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCC--EEEccccceeeccCCCccc
Confidence            996 4898888765 57888888888777665       49999999999999987664  9999999987654433  1


Q ss_pred             CCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhcc-ccCC----------
Q 019195          149 PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQ-YKIP----------  217 (344)
Q Consensus       149 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~----------  217 (344)
                      .....++..|+|||.+.+....+.++||||||+++|+|++|+.||...........+........ ...+          
T Consensus       158 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (287)
T cd07840         158 YTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFEN  237 (287)
T ss_pred             ccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhhhh
Confidence            23346788999999887655456679999999999999999999987765544444333211100 0000          


Q ss_pred             -------------CCCC-CCHhHHHHHHHhcccCCCCCCChHHHhcCccc
Q 019195          218 -------------DYVH-ISQDCRNLLSRIFVANPSRRITIKEIKSHPWF  253 (344)
Q Consensus       218 -------------~~~~-~s~~~~~li~~~L~~dp~~R~s~~ell~hp~~  253 (344)
                                   .... +++.+.++|.+||+.+|.+||++.+++.||||
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~  287 (287)
T cd07840         238 LKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF  287 (287)
T ss_pred             ccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence                         0112 37889999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=7.4e-41  Score=296.12  Aligned_cols=240  Identities=21%  Similarity=0.329  Sum_probs=194.2

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEEecCC
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYAA   81 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~   81 (344)
                      .+|.+.+.||+|+||.||++.+..+++.||+|.+.........+.+|+.+++.++||||+++++++..++.++++|||++
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   85 (263)
T cd05052           6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMT   85 (263)
T ss_pred             HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCchHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeCC
Confidence            36889999999999999999999999999999987655444678899999999999999999999999999999999999


Q ss_pred             CCChHHHHHhC--CCCCHHHHHHHHHHHHH-------CCeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCCCC--C
Q 019195           82 GGELFERICNA--GRFSEDEARYFFQQLIS-------GQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP--K  150 (344)
Q Consensus        82 ~g~L~~~i~~~--~~~~~~~~~~~~~ql~~-------~~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~~~--~  150 (344)
                      +++|.+++...  ..++...++.++.|++.       .|++||||||+||+++.++.  +||+|||++.........  .
T Consensus        86 ~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~--~kl~df~~~~~~~~~~~~~~~  163 (263)
T cd05052          86 YGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHL--VKVADFGLSRLMTGDTYTAHA  163 (263)
T ss_pred             CCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCc--EEeCCCccccccccceeeccC
Confidence            99999998754  35788877777777654       49999999999999976654  999999998754332211  1


Q ss_pred             CCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCHhHHHH
Q 019195          151 STVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL  229 (344)
Q Consensus       151 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  229 (344)
                      ...++..|+|||.+.+..++ .++|||||||++|+|++ |..||...........    +. ..+..+....+++.+.++
T Consensus       164 ~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~----~~-~~~~~~~~~~~~~~~~~l  237 (263)
T cd05052         164 GAKFPIKWTAPESLAYNKFS-IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYEL----LE-KGYRMERPEGCPPKVYEL  237 (263)
T ss_pred             CCCCccccCCHHHhccCCCC-chhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH----HH-CCCCCCCCCCCCHHHHHH
Confidence            22346789999998777765 45999999999999998 9999977554332222    21 122333344678999999


Q ss_pred             HHHhcccCCCCCCChHHHhc
Q 019195          230 LSRIFVANPSRRITIKEIKS  249 (344)
Q Consensus       230 i~~~L~~dp~~R~s~~ell~  249 (344)
                      |.+||+.+|.+|||+.++++
T Consensus       238 i~~cl~~~p~~Rp~~~~l~~  257 (263)
T cd05052         238 MRACWQWNPSDRPSFAEIHQ  257 (263)
T ss_pred             HHHHccCCcccCCCHHHHHH
Confidence            99999999999999999875

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=3.2e-41  Score=300.58  Aligned_cols=243  Identities=34%  Similarity=0.607  Sum_probs=203.4

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCc----cccHHHHHHHHHHhcCC-CCCcceeeEEEEcCCEEEEE
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH----KIDANVAREIINHKQLR-HPNIIRFKEVVLTPTHLAIV   76 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~ei~~l~~l~-h~niv~~~~~~~~~~~~~lv   76 (344)
                      ++|++.+.||+|+||.||++.+..++..||+|++....    .....+.+|+.++++++ ||||+++++++..++.++++
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv   80 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV   80 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence            58999999999999999999999999999999987632    22356788999999998 99999999999999999999


Q ss_pred             EecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCC--
Q 019195           77 MEYAAGGELFERICNAGRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS--  147 (344)
Q Consensus        77 ~e~~~~g~L~~~i~~~~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~--  147 (344)
                      |||+++++|.+++.+.+.+++..++.++.|++.+       |++|+||+|+||+++.++  +++|+|||++.......  
T Consensus        81 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~--~~~l~df~~~~~~~~~~~~  158 (280)
T cd05581          81 LEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDM--HIKITDFGTAKVLDPNSSP  158 (280)
T ss_pred             EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCC--CEEecCCccccccCCcccc
Confidence            9999999999999988889999999888877765       999999999999997655  49999999987543222  


Q ss_pred             -------------------CCCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHH
Q 019195          148 -------------------RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISR  208 (344)
Q Consensus       148 -------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~  208 (344)
                                         ......|+..|+|||.+..... +.++||||||+++++|++|+.||........+    ..
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~----~~  233 (280)
T cd05581         159 ESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPA-GKSSDLWALGCIIYQMLTGKPPFRGSNEYLTF----QK  233 (280)
T ss_pred             ccCCCCCccccccccccccccccccCCccccCHHHhCCCCC-ChhhhHHHHHHHHHHHHhCCCCCCCccHHHHH----HH
Confidence                               1123357899999999876664 45599999999999999999999876643332    23


Q ss_pred             HhhccccCCCCCCCCHhHHHHHHHhcccCCCCCCCh----HHHhcCccc
Q 019195          209 IMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITI----KEIKSHPWF  253 (344)
Q Consensus       209 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~----~ell~hp~~  253 (344)
                      +......+|.  .+++.+.+||.+||+.+|.+|||+    .++++||||
T Consensus       234 ~~~~~~~~~~--~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~  280 (280)
T cd05581         234 ILKLEYSFPP--NFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF  280 (280)
T ss_pred             HHhcCCCCCC--ccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence            3333334443  678999999999999999999999    999999997

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=9.4e-41  Score=294.23  Aligned_cols=239  Identities=25%  Similarity=0.393  Sum_probs=191.6

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEEecCC
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYAA   81 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~   81 (344)
                      ++|++.+.||+|+||.||++.... +..+|+|.+.........+.+|+.+++.++||||+++++++.....++++|||++
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~-~~~~a~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~   82 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWRA-QIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME   82 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEecc-CceEEEEecccCCccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence            579999999999999999998754 5579999887655555788999999999999999999999999999999999999


Q ss_pred             CCChHHHHHh-CCCCCHHHHHHHHHHHHH-------CCeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCCCC--CC
Q 019195           82 GGELFERICN-AGRFSEDEARYFFQQLIS-------GQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP--KS  151 (344)
Q Consensus        82 ~g~L~~~i~~-~~~~~~~~~~~~~~ql~~-------~~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~~~--~~  151 (344)
                      +|+|.+++.. .+.++...++.++.|++.       .||+||||||+||+++.++.  +||+|||+++........  ..
T Consensus        83 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~--~kl~d~g~~~~~~~~~~~~~~~  160 (256)
T cd05114          83 NGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGV--VKVSDFGMTRYVLDDEYTSSSG  160 (256)
T ss_pred             CCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCe--EEECCCCCccccCCCceeccCC
Confidence            9999999875 346788877777766654       49999999999999987664  999999998754322211  22


Q ss_pred             CccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCHhHHHHH
Q 019195          152 TVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLL  230 (344)
Q Consensus       152 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li  230 (344)
                      ..++..|+|||.+.+..+. .++||||||+++|+|++ |+.||...........+.    ... ..+.....+..+.+++
T Consensus       161 ~~~~~~y~aPE~~~~~~~~-~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~----~~~-~~~~~~~~~~~~~~li  234 (256)
T cd05114         161 AKFPVKWSPPEVFNFSKYS-SKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMIS----RGF-RLYRPKLASMTVYEVM  234 (256)
T ss_pred             CCCchhhCChhhcccCccc-hhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH----CCC-CCCCCCCCCHHHHHHH
Confidence            3456789999999776654 45999999999999999 999998765443333322    111 1222234678899999


Q ss_pred             HHhcccCCCCCCChHHHhc
Q 019195          231 SRIFVANPSRRITIKEIKS  249 (344)
Q Consensus       231 ~~~L~~dp~~R~s~~ell~  249 (344)
                      .+||+.+|.+|||+.++++
T Consensus       235 ~~c~~~~p~~Rps~~~l~~  253 (256)
T cd05114         235 YSCWHEKPEGRPTFAELLR  253 (256)
T ss_pred             HHHccCCcccCcCHHHHHH
Confidence            9999999999999999975

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=9.8e-41  Score=293.87  Aligned_cols=240  Identities=32%  Similarity=0.517  Sum_probs=194.9

Q ss_pred             CceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCc--cccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEEecC
Q 019195            3 KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH--KIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYA   80 (344)
Q Consensus         3 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~   80 (344)
                      +|++.+.||.|+||.||++.+..++..||+|.+....  .....+.+|+.+++.++||||+++++.+..++.+|++|||+
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC   80 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence            6999999999999999999999999999999986432  23456788999999999999999999999999999999999


Q ss_pred             CCCChHHHHHh--CCCCCHHHHHHHHHHHHH-------CCeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCC-CCC
Q 019195           81 AGGELFERICN--AGRFSEDEARYFFQQLIS-------GQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS-RPK  150 (344)
Q Consensus        81 ~~g~L~~~i~~--~~~~~~~~~~~~~~ql~~-------~~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~-~~~  150 (344)
                      ++++|.+++..  ...+++..++.++.|++.       .||+|+||||+||+++.++.  ++|+|||++....... ...
T Consensus        81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~--~~l~dfg~~~~~~~~~~~~~  158 (255)
T cd08219          81 DGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGK--VKLGDFGSARLLTSPGAYAC  158 (255)
T ss_pred             CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCc--EEEcccCcceeecccccccc
Confidence            99999998864  345788877777766665       49999999999999977654  9999999987543322 223


Q ss_pred             CCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCHhHHHHH
Q 019195          151 STVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLL  230 (344)
Q Consensus       151 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li  230 (344)
                      ...|++.|+|||++.+..+ +.++|+||||+++|+|++|..||...+....    ...+...... +....++..+.+||
T Consensus       159 ~~~~~~~~~aPE~~~~~~~-~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~----~~~~~~~~~~-~~~~~~~~~~~~li  232 (255)
T cd08219         159 TYVGTPYYVPPEIWENMPY-NNKSDIWSLGCILYELCTLKHPFQANSWKNL----ILKVCQGSYK-PLPSHYSYELRSLI  232 (255)
T ss_pred             cccCCccccCHHHHccCCc-CchhhhhhhchhheehhhccCCCCCCCHHHH----HHHHhcCCCC-CCCcccCHHHHHHH
Confidence            4569999999999977665 4559999999999999999999986543222    2222222222 22335788999999


Q ss_pred             HHhcccCCCCCCChHHHhcC
Q 019195          231 SRIFVANPSRRITIKEIKSH  250 (344)
Q Consensus       231 ~~~L~~dp~~R~s~~ell~h  250 (344)
                      .+||+.||.+|||+.+++.-
T Consensus       233 ~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         233 KQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             HHHHhCCcccCCCHHHHhhc
Confidence            99999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.9e-42  Score=317.71  Aligned_cols=237  Identities=32%  Similarity=0.539  Sum_probs=197.4

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcC-CCCCcceeeEEEEcCCEEEEEEecC
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQL-RHPNIIRFKEVVLTPTHLAIVMEYA   80 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~   80 (344)
                      +.|++...+|.|+|++|..+.+..++..+++|++.+..   ....+|+.++... +||||+++++.+.+..+.|+|||++
T Consensus       322 ~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~---~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~l  398 (612)
T KOG0603|consen  322 ESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA---DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMELL  398 (612)
T ss_pred             hhhccccccCCCCccceeeeeccccccchhheeccccc---cccccccchhhhhcCCCcceeecceecCCceeeeeehhc
Confidence            57899999999999999999999999999999998762   2334677565554 7999999999999999999999999


Q ss_pred             CCCChHHHHHhCCCCCHHHHHHHHHHHHH-------CCeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCCCCCCCc
Q 019195           81 AGGELFERICNAGRFSEDEARYFFQQLIS-------GQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTV  153 (344)
Q Consensus        81 ~~g~L~~~i~~~~~~~~~~~~~~~~ql~~-------~~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~~~~~~~  153 (344)
                      .|+.|.+.|.....+. .++..|+++|++       .|++||||||+|||++ +..++++|+|||.++.....  ..+.+
T Consensus       399 ~g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~-~~~g~lrltyFG~a~~~~~~--~~tp~  474 (612)
T KOG0603|consen  399 DGGELLRRIRSKPEFC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLD-GSAGHLRLTYFGFWSELERS--CDTPA  474 (612)
T ss_pred             cccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeec-CCCCcEEEEEechhhhCchh--hcccc
Confidence            9999999998776665 666666666554       4999999999999995 23345999999998865444  45567


Q ss_pred             cCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCHhHHHHHHHh
Q 019195          154 GTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRI  233 (344)
Q Consensus       154 gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~  233 (344)
                      -|..|.|||++....|+ .++||||||++||+|++|+.||......   .++..++..+.+.    ..+|..+++||.+|
T Consensus       475 ~t~~y~APEvl~~~~yt-~acD~WSLGvlLy~ML~G~tp~~~~P~~---~ei~~~i~~~~~s----~~vS~~AKdLl~~L  546 (612)
T KOG0603|consen  475 LTLQYVAPEVLAIQEYT-EACDWWSLGVLLYEMLTGRTLFAAHPAG---IEIHTRIQMPKFS----ECVSDEAKDLLQQL  546 (612)
T ss_pred             hhhcccChhhhccCCCC-cchhhHHHHHHHHHHHhCCCccccCCch---HHHHHhhcCCccc----cccCHHHHHHHHHh
Confidence            89999999999977764 5699999999999999999999987765   3344444433333    47899999999999


Q ss_pred             cccCCCCCCChHHHhcCccc
Q 019195          234 FVANPSRRITIKEIKSHPWF  253 (344)
Q Consensus       234 L~~dp~~R~s~~ell~hp~~  253 (344)
                      |+.||.+|+++.+++.||||
T Consensus       547 L~~dP~~Rl~~~~i~~h~w~  566 (612)
T KOG0603|consen  547 LQVDPALRLGADEIGAHPWF  566 (612)
T ss_pred             ccCChhhCcChhhhccCcch
Confidence            99999999999999999999

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=1.4e-40  Score=301.05  Aligned_cols=248  Identities=26%  Similarity=0.370  Sum_probs=196.2

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCccc----cHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEE
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKI----DANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVM   77 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~----~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~   77 (344)
                      ++|++.+.||+|+||.||++.+..+++.||+|++......    ...+.+|+.+++.++||||+++++++..++..|+||
T Consensus        15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~   94 (307)
T cd06607          15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM   94 (307)
T ss_pred             hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence            4799999999999999999999999999999998653322    245789999999999999999999999999999999


Q ss_pred             ecCCCCChHHHHHh-CCCCCHHHHHHHHHHHHH-------CCeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCCCC
Q 019195           78 EYAAGGELFERICN-AGRFSEDEARYFFQQLIS-------GQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP  149 (344)
Q Consensus        78 e~~~~g~L~~~i~~-~~~~~~~~~~~~~~ql~~-------~~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~~~  149 (344)
                      ||+. |+|.+.+.. .+.+++..+..++.|++.       .||+||||+|+||+++.++.  +||+|||++.....   .
T Consensus        95 e~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~--~kL~dfg~~~~~~~---~  168 (307)
T cd06607          95 EYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGT--VKLADFGSASLVSP---A  168 (307)
T ss_pred             HhhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCC--EEEeecCcceecCC---C
Confidence            9996 577666653 456888888887777665       49999999999999987664  99999998864322   2


Q ss_pred             CCCccCCcccCCccccC--CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCHhHH
Q 019195          150 KSTVGTPAYIAPEVLSR--REYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCR  227 (344)
Q Consensus       150 ~~~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~  227 (344)
                      ....|++.|+|||++.+  ....+.++||||||+++|+|++|.+||...........+..   ......+ ...++..+.
T Consensus       169 ~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~---~~~~~~~-~~~~~~~~~  244 (307)
T cd06607         169 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ---NDSPTLS-SNDWSDYFR  244 (307)
T ss_pred             CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhc---CCCCCCC-chhhCHHHH
Confidence            34568899999999853  22234569999999999999999999977554322221111   1111111 124678999


Q ss_pred             HHHHHhcccCCCCCCChHHHhcCcccccCCCh
Q 019195          228 NLLSRIFVANPSRRITIKEIKSHPWFLKNLPR  259 (344)
Q Consensus       228 ~li~~~L~~dp~~R~s~~ell~hp~~~~~~~~  259 (344)
                      ++|.+||+.+|.+||++.+++.||||....++
T Consensus       245 ~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~  276 (307)
T cd06607         245 NFVDSCLQKIPQDRPSSEELLKHRFVLRERPP  276 (307)
T ss_pred             HHHHHHhcCChhhCcCHHHHhcChhhcccCCc
Confidence            99999999999999999999999999876654

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=6e-41  Score=303.55  Aligned_cols=250  Identities=25%  Similarity=0.426  Sum_probs=194.1

Q ss_pred             CCCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCcc---ccHHHHHHHHHHhcCCCCCcceeeEEEEcC-------
Q 019195            1 MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK---IDANVAREIINHKQLRHPNIIRFKEVVLTP-------   70 (344)
Q Consensus         1 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~ei~~l~~l~h~niv~~~~~~~~~-------   70 (344)
                      +++|++.+.||+|+||.||+|.+..+++.||+|++.....   ....+.+|+++++.++||||+++++++...       
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   86 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK   86 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence            4789999999999999999999999999999999865332   234678899999999999999999987543       


Q ss_pred             -CEEEEEEecCCCCChHHHHHh-CCCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCc
Q 019195           71 -THLAIVMEYAAGGELFERICN-AGRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSK  141 (344)
Q Consensus        71 -~~~~lv~e~~~~g~L~~~i~~-~~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~  141 (344)
                       ..+++||+|+.+ +|...+.. ...+++.+++.++.|++++       ||+||||||+||+++.++.  ++|+|||++.
T Consensus        87 ~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~--~~l~dfg~~~  163 (311)
T cd07866          87 RGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGI--LKIADFGLAR  163 (311)
T ss_pred             CceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCC--EEECcCccch
Confidence             357999999964 67776654 4578999888887776654       9999999999999987664  9999999987


Q ss_pred             ccCCCCC------------CCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHH
Q 019195          142 SSLLHSR------------PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRI  209 (344)
Q Consensus       142 ~~~~~~~------------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~  209 (344)
                      .......            .....|++.|+|||.+.+....+.++|||||||++|+|++|++||.+.........+....
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~  243 (311)
T cd07866         164 PYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLC  243 (311)
T ss_pred             hccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Confidence            5332211            1223578899999998765544566999999999999999999998776654444433321


Q ss_pred             hhccc-c------CC-----------------CCCCCCHhHHHHHHHhcccCCCCCCChHHHhcCccc
Q 019195          210 MAVQY-K------IP-----------------DYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF  253 (344)
Q Consensus       210 ~~~~~-~------~~-----------------~~~~~s~~~~~li~~~L~~dp~~R~s~~ell~hp~~  253 (344)
                      ..... .      .+                 .+..+++.+.+||.+||+.+|.+|||+.+++.||||
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f  311 (311)
T cd07866         244 GTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF  311 (311)
T ss_pred             CCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence            10000 0      00                 012345788999999999999999999999999998

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=8.5e-41  Score=299.37  Aligned_cols=250  Identities=27%  Similarity=0.477  Sum_probs=204.7

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEEecCC
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYAA   81 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~   81 (344)
                      +.|++.+.||+|++|.||++.+..++..||+|++.........+.+|+..++.++|+||+++++++......|+++||++
T Consensus        19 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~   98 (286)
T cd06614          19 ELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMD   98 (286)
T ss_pred             ccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCchhHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEeccC
Confidence            46889999999999999999999889999999998765545678899999999999999999999999999999999999


Q ss_pred             CCChHHHHHhCC-CCCHHHHHHHHHHHHH-------CCeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCCC-CCCC
Q 019195           82 GGELFERICNAG-RFSEDEARYFFQQLIS-------GQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR-PKST  152 (344)
Q Consensus        82 ~g~L~~~i~~~~-~~~~~~~~~~~~ql~~-------~~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~~-~~~~  152 (344)
                      +++|.+++.... .++...+..++.|++.       .|++|+||+|+||+++.++.  ++|+|||++........ ....
T Consensus        99 ~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~--~~l~d~~~~~~~~~~~~~~~~~  176 (286)
T cd06614          99 GGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGS--VKLADFGFAAQLTKEKSKRNSV  176 (286)
T ss_pred             CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCC--EEECccchhhhhccchhhhccc
Confidence            999999998876 7888888877766664       49999999999999986654  99999998764432222 2334


Q ss_pred             ccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCHhHHHHHHH
Q 019195          153 VGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSR  232 (344)
Q Consensus       153 ~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~  232 (344)
                      .+++.|+|||.+.+..++ .++|+||||+++|+|++|..||...........+..   ......+....++..+.+||.+
T Consensus       177 ~~~~~y~~PE~~~~~~~~-~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~l~~li~~  252 (286)
T cd06614         177 VGTPYWMAPEVIKRKDYG-PKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITT---KGIPPLKNPEKWSPEFKDFLNK  252 (286)
T ss_pred             cCCcccCCHhHhcCCCCC-CccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh---cCCCCCcchhhCCHHHHHHHHH
Confidence            588999999998877664 559999999999999999999986554332222111   1112223333478899999999


Q ss_pred             hcccCCCCCCChHHHhcCcccccCC
Q 019195          233 IFVANPSRRITIKEIKSHPWFLKNL  257 (344)
Q Consensus       233 ~L~~dp~~R~s~~ell~hp~~~~~~  257 (344)
                      ||+.+|.+|||+.++++||||.+..
T Consensus       253 ~l~~~p~~Rpt~~~il~~~~~~~~~  277 (286)
T cd06614         253 CLVKDPEKRPSAEELLQHPFLKKAC  277 (286)
T ss_pred             HhccChhhCcCHHHHhhChHhhccC
Confidence            9999999999999999999998743

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=1.3e-40  Score=292.64  Aligned_cols=243  Identities=35%  Similarity=0.560  Sum_probs=200.9

Q ss_pred             CceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCcc---ccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEEec
Q 019195            3 KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK---IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEY   79 (344)
Q Consensus         3 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~   79 (344)
                      +|++.+.||.|+||.||++.+..++..||+|++.....   ....+.+|+++++.++|||++++++.+......++++||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~   80 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY   80 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence            69999999999999999999999999999999876432   345688999999999999999999999999999999999


Q ss_pred             CCCCChHHHHHhC----CCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCC-
Q 019195           80 AAGGELFERICNA----GRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS-  147 (344)
Q Consensus        80 ~~~g~L~~~i~~~----~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~-  147 (344)
                      +++++|.+.+...    ..++..++..++.+++.+       |++|+||+|+||+++.++.  ++|+|||++....... 
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~--~~l~d~~~~~~~~~~~~  158 (258)
T cd08215          81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGL--VKLGDFGISKVLSSTVD  158 (258)
T ss_pred             cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCc--EEECCccceeecccCcc
Confidence            9999999999764    678888888887776654       9999999999999987654  9999999987543332 


Q ss_pred             CCCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCHhHH
Q 019195          148 RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCR  227 (344)
Q Consensus       148 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~  227 (344)
                      ......|++.|+|||.+.+..+. .++|+||+|+++++|++|..||...........    ...... .+....++..+.
T Consensus       159 ~~~~~~~~~~y~~pe~~~~~~~~-~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~----~~~~~~-~~~~~~~~~~~~  232 (258)
T cd08215         159 LAKTVVGTPYYLSPELCQNKPYN-YKSDIWSLGCVLYELCTLKHPFEGENLLELALK----ILKGQY-PPIPSQYSSELR  232 (258)
T ss_pred             eecceeeeecccChhHhccCCCC-ccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHH----HhcCCC-CCCCCCCCHHHH
Confidence            23345789999999998777754 459999999999999999999977653322222    222111 122226789999


Q ss_pred             HHHHHhcccCCCCCCChHHHhcCccc
Q 019195          228 NLLSRIFVANPSRRITIKEIKSHPWF  253 (344)
Q Consensus       228 ~li~~~L~~dp~~R~s~~ell~hp~~  253 (344)
                      +++.+||..+|.+|||+.++|+||||
T Consensus       233 ~~i~~~l~~~p~~Rp~~~~ll~~~~~  258 (258)
T cd08215         233 NLVSSLLQKDPEERPSIAQILQSPFI  258 (258)
T ss_pred             HHHHHHcCCChhhCcCHHHHhcCCCC
Confidence            99999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=5.7e-41  Score=296.29  Aligned_cols=240  Identities=35%  Similarity=0.577  Sum_probs=199.9

Q ss_pred             eeecCceEEEEEEEcCCCcEEEEEEeecCcc----ccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEEecCCCCCh
Q 019195           10 IGSGNFGVARLMRNKNTKELVAMKYIERGHK----IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYAAGGEL   85 (344)
Q Consensus        10 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L   85 (344)
                      ||.|+||.||++.+..+++.||+|++.....    ....+.+|+.++++++||||+++++.+..+..+|++|||+++++|
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL   80 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence            6899999999999999999999999875432    335688899999999999999999999999999999999999999


Q ss_pred             HHHHHhCCCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCC---------CC
Q 019195           86 FERICNAGRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS---------RP  149 (344)
Q Consensus        86 ~~~i~~~~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~---------~~  149 (344)
                      .+++.+.+.+++..++.++.|++.+       |++||||+|+||+++.++.  ++|+|||++.......         ..
T Consensus        81 ~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~~~  158 (265)
T cd05579          81 ASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGH--LKLTDFGLSKVGLVRRQINLNDDEKED  158 (265)
T ss_pred             HHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCC--EEEEecccchhcccCcccccccccccc
Confidence            9999887889999988888887755       9999999999999987665  9999999987543332         12


Q ss_pred             CCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCHhHHHH
Q 019195          150 KSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL  229 (344)
Q Consensus       150 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  229 (344)
                      ....++..|+|||.+..... +.++|+||||+++|+|++|..||........+    ..+.......+....++..+.+|
T Consensus       159 ~~~~~~~~~~~Pe~~~~~~~-~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~  233 (265)
T cd05579         159 KRIVGTPDYIAPEVILGQGH-SKTVDWWSLGCILYEFLVGIPPFHGETPEEIF----QNILNGKIEWPEDVEVSDEAIDL  233 (265)
T ss_pred             cCcccCccccCHHHhcCCCC-CcchhhHHHHHHHHHHHhCCCCCCCCCHHHHH----HHHhcCCcCCCccccCCHHHHHH
Confidence            33468899999999877664 45599999999999999999999876543332    33333344455444468999999


Q ss_pred             HHHhcccCCCCCCCh---HHHhcCcccccC
Q 019195          230 LSRIFVANPSRRITI---KEIKSHPWFLKN  256 (344)
Q Consensus       230 i~~~L~~dp~~R~s~---~ell~hp~~~~~  256 (344)
                      +.+||+.+|.+|||+   .++|+||||...
T Consensus       234 i~~~l~~~p~~Rpt~~~~~~~l~~~~~~~~  263 (265)
T cd05579         234 ISKLLVPDPEKRLGAKSIEEIKNHPFFKGI  263 (265)
T ss_pred             HHHHhcCCHhhcCCCccHHHHhcCccccCC
Confidence            999999999999999   999999999753

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=5.4e-41  Score=301.83  Aligned_cols=249  Identities=26%  Similarity=0.439  Sum_probs=199.8

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCc-cccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEEecC
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH-KIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYA   80 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~   80 (344)
                      ++|++++.||+|+||.||++.+..++..||+|.+.... .....+.+|+.+++.++||||+++++++......|+|+||+
T Consensus        19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~   98 (293)
T cd06647          19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL   98 (293)
T ss_pred             hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence            58999999999999999999999899999999986432 23356888999999999999999999999999999999999


Q ss_pred             CCCChHHHHHhCCCCCHHHHHHHHHHHHH-------CCeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCCC-CCCC
Q 019195           81 AGGELFERICNAGRFSEDEARYFFQQLIS-------GQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR-PKST  152 (344)
Q Consensus        81 ~~g~L~~~i~~~~~~~~~~~~~~~~ql~~-------~~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~~-~~~~  152 (344)
                      ++++|.+++.+ ..++..++..++.|++.       .|++||||||+||+++.++.  ++|+|||++........ ....
T Consensus        99 ~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~--~kL~dfg~~~~~~~~~~~~~~~  175 (293)
T cd06647          99 AGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGS--VKLTDFGFCAQITPEQSKRSTM  175 (293)
T ss_pred             CCCcHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCC--EEEccCcceecccccccccccc
Confidence            99999998865 35777777777666654       49999999999999976654  99999998765433322 2334


Q ss_pred             ccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCHhHHHHHHH
Q 019195          153 VGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSR  232 (344)
Q Consensus       153 ~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~  232 (344)
                      .|++.|+|||.+....++ .++|+|||||++|+|++|+.||.............   ......++....++..+.++|.+
T Consensus       176 ~~~~~y~~PE~~~~~~~~-~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~l~~li~~  251 (293)
T cd06647         176 VGTPYWMAPEVVTRKAYG-PKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA---TNGTPELQNPEKLSAIFRDFLNR  251 (293)
T ss_pred             cCChhhcCchhhccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCChhhheeehh---cCCCCCCCCccccCHHHHHHHHH
Confidence            689999999998776654 45999999999999999999997654422211111   11112222333567889999999


Q ss_pred             hcccCCCCCCChHHHhcCcccccCC
Q 019195          233 IFVANPSRRITIKEIKSHPWFLKNL  257 (344)
Q Consensus       233 ~L~~dp~~R~s~~ell~hp~~~~~~  257 (344)
                      ||..+|.+||++.+++.||||....
T Consensus       252 ~l~~~p~~Rp~~~~il~h~~~~~~~  276 (293)
T cd06647         252 CLEMDVEKRGSAKELLQHPFLKIAK  276 (293)
T ss_pred             HccCChhhCcCHHHHhcCHHHhcCc
Confidence            9999999999999999999997653

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=9.1e-41  Score=294.08  Aligned_cols=244  Identities=33%  Similarity=0.544  Sum_probs=197.8

Q ss_pred             CceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCc---cccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEEec
Q 019195            3 KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH---KIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEY   79 (344)
Q Consensus         3 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~   79 (344)
                      +|++.+.||+|+||.||++.+..++..+|+|.+....   .....+.+|+.+++.++|+||+++++.+......++++||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~   80 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY   80 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence            6999999999999999999999999999999987542   2345678999999999999999999999999999999999


Q ss_pred             CCCCChHHHHHhCC--CCCHHHHHHHHHHHHH-------CCeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCCC-C
Q 019195           80 AAGGELFERICNAG--RFSEDEARYFFQQLIS-------GQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR-P  149 (344)
Q Consensus        80 ~~~g~L~~~i~~~~--~~~~~~~~~~~~ql~~-------~~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~~-~  149 (344)
                      +++++|.+++....  .+++..++.++.|++.       .+++|+||||+||+++.++. .+||+|||.+........ .
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~-~~~l~d~~~~~~~~~~~~~~  159 (257)
T cd08225          81 CDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGM-VAKLGDFGIARQLNDSMELA  159 (257)
T ss_pred             CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCC-eEEecccccchhccCCcccc
Confidence            99999999987643  4778877777766654       49999999999999976643 379999998875443322 2


Q ss_pred             CCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCHhHHHH
Q 019195          150 KSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL  229 (344)
Q Consensus       150 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  229 (344)
                      ....|++.|+|||.+.+..++ .++|+||||+++++|++|..||..........    ....... .+....++.++.++
T Consensus       160 ~~~~~~~~~~ape~~~~~~~~-~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~----~~~~~~~-~~~~~~~~~~~~~~  233 (257)
T cd08225         160 YTCVGTPYYLSPEICQNRPYN-NKTDIWSLGCVLYELCTLKHPFEGNNLHQLVL----KICQGYF-APISPNFSRDLRSL  233 (257)
T ss_pred             cccCCCccccCHHHHcCCCCC-chhhHHHHHHHHHHHHhCCCCCCCccHHHHHH----HHhcccC-CCCCCCCCHHHHHH
Confidence            234689999999998776654 45999999999999999999997654433222    2222111 12233578899999


Q ss_pred             HHHhcccCCCCCCChHHHhcCccc
Q 019195          230 LSRIFVANPSRRITIKEIKSHPWF  253 (344)
Q Consensus       230 i~~~L~~dp~~R~s~~ell~hp~~  253 (344)
                      |.+||..+|.+|||+.++++||||
T Consensus       234 i~~~l~~~p~~Rpt~~~ll~~~~~  257 (257)
T cd08225         234 ISQLFKVSPRDRPSITSILKRPFL  257 (257)
T ss_pred             HHHHhccChhhCcCHHHHhhCCCC
Confidence            999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=5.9e-41  Score=303.02  Aligned_cols=242  Identities=24%  Similarity=0.350  Sum_probs=189.6

Q ss_pred             CCCceeeeeeeecCceEEEEEEEcCCCcE--EEEEEeecCc--cccHHHHHHHHHHhcC-CCCCcceeeEEEEcCCEEEE
Q 019195            1 MEKYELMKDIGSGNFGVARLMRNKNTKEL--VAMKYIERGH--KIDANVAREIINHKQL-RHPNIIRFKEVVLTPTHLAI   75 (344)
Q Consensus         1 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~--vaiK~~~~~~--~~~~~~~~ei~~l~~l-~h~niv~~~~~~~~~~~~~l   75 (344)
                      +++|++.+.||+|+||.||+|.+..++..  +|+|.+....  .....+.+|+.++.++ +||||+++++++..++.+|+
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~l   85 (303)
T cd05088           6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL   85 (303)
T ss_pred             hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceE
Confidence            46899999999999999999998877754  5777665422  2235678899999999 89999999999999999999


Q ss_pred             EEecCCCCChHHHHHhCC----------------CCCHHHHHHHHHHHHH-------CCeeecCCCCCCeEecCCCCCCE
Q 019195           76 VMEYAAGGELFERICNAG----------------RFSEDEARYFFQQLIS-------GQICHRDLKLENTLLDGSPAPRL  132 (344)
Q Consensus        76 v~e~~~~g~L~~~i~~~~----------------~~~~~~~~~~~~ql~~-------~~iiH~Dikp~NIl~~~~~~~~v  132 (344)
                      +|||+++++|.+++.+.+                .+++.+++.++.|++.       .|++||||||+|||++.++.  +
T Consensus        86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~~~--~  163 (303)
T cd05088          86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYV--A  163 (303)
T ss_pred             EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCCCc--E
Confidence            999999999999997543                4677777777766654       49999999999999986654  9


Q ss_pred             EEeecCCCcccCCCCCCCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhh
Q 019195          133 KICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMA  211 (344)
Q Consensus       133 kL~DFg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~  211 (344)
                      ||+|||++.............++..|+|||.+.+..+ +.++|||||||++|+|++ |.+||........+..    + .
T Consensus       164 kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~----~-~  237 (303)
T cd05088         164 KIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVY-TTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEK----L-P  237 (303)
T ss_pred             EeCccccCcccchhhhcccCCCcccccCHHHHhccCC-cccccchhhhhHHHHHHhcCCCCcccCChHHHHHH----H-h
Confidence            9999999864322222222335678999999877665 455999999999999998 9999976654333222    1 1


Q ss_pred             ccccCCCCCCCCHhHHHHHHHhcccCCCCCCChHHHhcC
Q 019195          212 VQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSH  250 (344)
Q Consensus       212 ~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~ell~h  250 (344)
                      .....+....+++++.+||.+||+.+|.+||++.+++.+
T Consensus       238 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  276 (303)
T cd05088         238 QGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  276 (303)
T ss_pred             cCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            222223334578999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=2e-40  Score=295.67  Aligned_cols=246  Identities=26%  Similarity=0.413  Sum_probs=197.9

Q ss_pred             CceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCcc--ccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEEecC
Q 019195            3 KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK--IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYA   80 (344)
Q Consensus         3 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~   80 (344)
                      -|++++.||+|+||.||++.+..++..||+|.+.....  ....+.+|+.+++.++||||+++++++..+..+|+||||+
T Consensus         5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   84 (277)
T cd06641           5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL   84 (277)
T ss_pred             hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence            37889999999999999999999999999998765332  2356888999999999999999999999999999999999


Q ss_pred             CCCChHHHHHhCCCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCC-CCCCC
Q 019195           81 AGGELFERICNAGRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS-RPKST  152 (344)
Q Consensus        81 ~~g~L~~~i~~~~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~-~~~~~  152 (344)
                      ++++|..++.. ..++...+..++.|++.+       |++|+||||+||+++.++.  ++|+|||++....... .....
T Consensus        85 ~~~~l~~~i~~-~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~--~~l~dfg~~~~~~~~~~~~~~~  161 (277)
T cd06641          85 GGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGE--VKLADFGVAGQLTDTQIKRNTF  161 (277)
T ss_pred             CCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCC--EEEeecccceecccchhhhccc
Confidence            99999988864 468888888887776654       9999999999999976654  9999999986543322 12334


Q ss_pred             ccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCHhHHHHHHH
Q 019195          153 VGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSR  232 (344)
Q Consensus       153 ~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~  232 (344)
                      .|+..|+|||.+.....+ .++|+|||||++|+|++|..||.........    ..+.... .......++.++.++|.+
T Consensus       162 ~~~~~y~~PE~~~~~~~~-~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~----~~~~~~~-~~~~~~~~~~~~~~~i~~  235 (277)
T cd06641         162 VGTPFWMAPEVIKQSAYD-SKADIWSLGITAIELAKGEPPHSELHPMKVL----FLIPKNN-PPTLEGNYSKPLKEFVEA  235 (277)
T ss_pred             cCCccccChhhhccCCCC-chhhHHHHHHHHHHHHcCCCCCCccchHHHH----HHHhcCC-CCCCCcccCHHHHHHHHH
Confidence            689999999998766554 4599999999999999999999765432222    1111111 111123468899999999


Q ss_pred             hcccCCCCCCChHHHhcCcccccCC
Q 019195          233 IFVANPSRRITIKEIKSHPWFLKNL  257 (344)
Q Consensus       233 ~L~~dp~~R~s~~ell~hp~~~~~~  257 (344)
                      ||+.+|.+||++.++++||||.+..
T Consensus       236 ~l~~~p~~Rp~~~~~l~~~~~~~~~  260 (277)
T cd06641         236 CLNKEPSFRPTAKELLKHKFIVRFA  260 (277)
T ss_pred             HccCChhhCcCHHHHHhCHHHhhhh
Confidence            9999999999999999999997653

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.1e-40  Score=306.53  Aligned_cols=251  Identities=24%  Similarity=0.403  Sum_probs=196.1

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCcc---ccHHHHHHHHHHhcCCCCCcceeeEEEEcC------CE
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK---IDANVAREIINHKQLRHPNIIRFKEVVLTP------TH   72 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~ei~~l~~l~h~niv~~~~~~~~~------~~   72 (344)
                      ++|++.+.||+|+||.||++.+..+++.||+|++.....   ....+.+|+.++++++||||+++++++...      ..
T Consensus        17 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   96 (345)
T cd07877          17 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND   96 (345)
T ss_pred             CceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeeccccccccc
Confidence            689999999999999999999999999999999876432   235677899999999999999999988643      34


Q ss_pred             EEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCC
Q 019195           73 LAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLL  145 (344)
Q Consensus        73 ~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~  145 (344)
                      +|++++++ +++|.+++.. ..+++..++.++.|++.+       ||+||||||+||+++.++.  +||+|||++.... 
T Consensus        97 ~~lv~~~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~--~kl~dfg~~~~~~-  171 (345)
T cd07877          97 VYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCE--LKILDFGLARHTD-  171 (345)
T ss_pred             EEEEehhc-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCC--EEEeccccccccc-
Confidence            78899887 7899887754 468888888877776654       9999999999999987664  9999999987532 


Q ss_pred             CCCCCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHh---------------
Q 019195          146 HSRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIM---------------  210 (344)
Q Consensus       146 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~---------------  210 (344)
                       .......|++.|+|||.+.+....+.++|||||||++|+|++|++||........+..+.....               
T Consensus       172 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (345)
T cd07877         172 -DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESA  250 (345)
T ss_pred             -ccccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhcccHhH
Confidence             2234457899999999987644445669999999999999999999976654443333222110               


Q ss_pred             ----hccccCC------CCCCCCHhHHHHHHHhcccCCCCCCChHHHhcCcccccCCC
Q 019195          211 ----AVQYKIP------DYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLP  258 (344)
Q Consensus       211 ----~~~~~~~------~~~~~s~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~~~~  258 (344)
                          ......+      .....++++.+||.+||+.||.+||++.+++.||||.+...
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~~~  308 (345)
T cd07877         251 RNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD  308 (345)
T ss_pred             HHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhcCC
Confidence                0000011      01245788999999999999999999999999999976543

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3e-40  Score=290.01  Aligned_cols=243  Identities=32%  Similarity=0.486  Sum_probs=202.9

Q ss_pred             CceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCcc---ccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEEec
Q 019195            3 KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK---IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEY   79 (344)
Q Consensus         3 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~   79 (344)
                      +|++.+.||+|++|.||++.+..+++.||+|.+.....   ....+.+|++++++++|||++++++++.+...++++|||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY   80 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence            69999999999999999999999999999999977543   345788999999999999999999999999999999999


Q ss_pred             CCCCChHHHHHhCCCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCCC-CCC
Q 019195           80 AAGGELFERICNAGRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR-PKS  151 (344)
Q Consensus        80 ~~~g~L~~~i~~~~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~~-~~~  151 (344)
                      +++++|.+++.....+++..++.++.|++.+       ||+||||||+||+++.++  .++|+|||++........ ...
T Consensus        81 ~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~--~~~l~d~~~~~~~~~~~~~~~~  158 (254)
T cd06627          81 AENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDG--VVKLADFGVATKLNDVSKDDAS  158 (254)
T ss_pred             CCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCC--CEEEeccccceecCCCcccccc
Confidence            9999999999888889999888887776654       999999999999998754  599999999876543332 234


Q ss_pred             CccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCHhHHHHHH
Q 019195          152 TVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLS  231 (344)
Q Consensus       152 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~  231 (344)
                      ..++..|+|||.+.+... +.++||||+|+++|+|++|+.||.............   ....  .+....+++.+.+++.
T Consensus       159 ~~~~~~y~~pe~~~~~~~-~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~---~~~~--~~~~~~~~~~~~~~i~  232 (254)
T cd06627         159 VVGTPYWMAPEVIEMSGA-STASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIV---QDDH--PPLPEGISPELKDFLM  232 (254)
T ss_pred             cccchhhcCHhhhcCCCC-CcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHh---ccCC--CCCCCCCCHHHHHHHH
Confidence            568999999999877664 456999999999999999999998655332222211   1111  2223367899999999


Q ss_pred             HhcccCCCCCCChHHHhcCccc
Q 019195          232 RIFVANPSRRITIKEIKSHPWF  253 (344)
Q Consensus       232 ~~L~~dp~~R~s~~ell~hp~~  253 (344)
                      +||..+|++|||+.+++.||||
T Consensus       233 ~~l~~~p~~R~~~~~~l~~~~~  254 (254)
T cd06627         233 QCFQKDPNLRPTAKQLLKHPWI  254 (254)
T ss_pred             HHHhCChhhCcCHHHHhcCCCC
Confidence            9999999999999999999997

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=2.4e-41  Score=301.58  Aligned_cols=246  Identities=28%  Similarity=0.407  Sum_probs=197.9

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCc--cccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEEec
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH--KIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEY   79 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~   79 (344)
                      +.|++++.||+|+||.||++.+..++..||+|.+....  .....+.+|+.+++.++||||+++++++..++.+|+||||
T Consensus         4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (277)
T cd06642           4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEY   83 (277)
T ss_pred             HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEc
Confidence            35888999999999999999999999999999887533  2235688999999999999999999999999999999999


Q ss_pred             CCCCChHHHHHhCCCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCCC-CCC
Q 019195           80 AAGGELFERICNAGRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR-PKS  151 (344)
Q Consensus        80 ~~~g~L~~~i~~~~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~~-~~~  151 (344)
                      +++++|.+++.. +.+++..++.++.|++.+       |++|+||+|+||+++.++.  ++|+|||++........ ...
T Consensus        84 ~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~--~~l~dfg~~~~~~~~~~~~~~  160 (277)
T cd06642          84 LGGGSALDLLKP-GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGD--VKLADFGVAGQLTDTQIKRNT  160 (277)
T ss_pred             cCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCC--EEEccccccccccCcchhhhc
Confidence            999999988854 568888888887776654       9999999999999987654  99999999875433222 223


Q ss_pred             CccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCHhHHHHHH
Q 019195          152 TVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLS  231 (344)
Q Consensus       152 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~  231 (344)
                      ..|+..|+|||.+.+..++ .++|+|||||++|+|++|+.||..........    .+.... .......++..+.++|.
T Consensus       161 ~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~----~~~~~~-~~~~~~~~~~~~~~li~  234 (277)
T cd06642         161 FVGTPFWMAPEVIKQSAYD-FKADIWSLGITAIELAKGEPPNSDLHPMRVLF----LIPKNS-PPTLEGQYSKPFKEFVE  234 (277)
T ss_pred             ccCcccccCHHHhCcCCCc-hhhhHHHHHHHHHHHHhCCCCCcccchhhHHh----hhhcCC-CCCCCcccCHHHHHHHH
Confidence            4689999999999877654 45999999999999999999997654322211    111111 11111246788999999


Q ss_pred             HhcccCCCCCCChHHHhcCcccccC
Q 019195          232 RIFVANPSRRITIKEIKSHPWFLKN  256 (344)
Q Consensus       232 ~~L~~dp~~R~s~~ell~hp~~~~~  256 (344)
                      +||+.+|.+||++.++++||||...
T Consensus       235 ~~l~~~p~~Rp~~~~il~~~~~~~~  259 (277)
T cd06642         235 ACLNKDPRFRPTAKELLKHKFITRY  259 (277)
T ss_pred             HHccCCcccCcCHHHHHHhHHHHHH
Confidence            9999999999999999999999654

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=8.9e-41  Score=298.07  Aligned_cols=240  Identities=25%  Similarity=0.374  Sum_probs=191.7

Q ss_pred             CCceeeeeeeecCceEEEEEEEcC-----CCcEEEEEEeecCccc--cHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEE
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKN-----TKELVAMKYIERGHKI--DANVAREIINHKQLRHPNIIRFKEVVLTPTHLA   74 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~~--~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~   74 (344)
                      ++|.+.+.||+|+||.||+|.+..     ++..||+|.+......  ...+.+|+++++.++||||+++++++......+
T Consensus         5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   84 (280)
T cd05049           5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI   84 (280)
T ss_pred             HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence            578999999999999999998753     4678999998765433  357889999999999999999999999999999


Q ss_pred             EEEecCCCCChHHHHHhCC--------------CCCHHHHHHHHHHHHH-------CCeeecCCCCCCeEecCCCCCCEE
Q 019195           75 IVMEYAAGGELFERICNAG--------------RFSEDEARYFFQQLIS-------GQICHRDLKLENTLLDGSPAPRLK  133 (344)
Q Consensus        75 lv~e~~~~g~L~~~i~~~~--------------~~~~~~~~~~~~ql~~-------~~iiH~Dikp~NIl~~~~~~~~vk  133 (344)
                      ++|||+++++|.+++...+              .+++.++..++.|++.       .|++||||||+||+++.++.  +|
T Consensus        85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~--~k  162 (280)
T cd05049          85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLV--VK  162 (280)
T ss_pred             EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCCe--EE
Confidence            9999999999999997542              3667777777666554       49999999999999987654  99


Q ss_pred             EeecCCCcccCCCC---CCCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHH
Q 019195          134 ICDFGYSKSSLLHS---RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRI  209 (344)
Q Consensus       134 L~DFg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~  209 (344)
                      |+|||++.......   ......+++.|+|||++.+..++ .++|||||||++|+|++ |..||...........    +
T Consensus       163 l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~----~  237 (280)
T cd05049         163 IGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFT-TESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIEC----I  237 (280)
T ss_pred             ECCcccceecccCcceecCCCCcccceecChhhhccCCcc-hhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH----H
Confidence            99999987532221   12334567889999999877765 45999999999999998 9999987655433222    2


Q ss_pred             hhccccCCCCCCCCHhHHHHHHHhcccCCCCCCChHHHhc
Q 019195          210 MAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKS  249 (344)
Q Consensus       210 ~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~ell~  249 (344)
                      ...... +....++..+.+++.+||+.||.+|||+.++++
T Consensus       238 ~~~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~  276 (280)
T cd05049         238 TQGRLL-QRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHE  276 (280)
T ss_pred             HcCCcC-CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            222222 222357899999999999999999999999976

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=1.1e-40  Score=305.05  Aligned_cols=254  Identities=25%  Similarity=0.401  Sum_probs=197.0

Q ss_pred             CceeeeeeeecCceEEEEEEEcCC--CcEEEEEEeecCcc---ccHHHHHHHHHHhcC-CCCCcceeeEEEEcC----CE
Q 019195            3 KYELMKDIGSGNFGVARLMRNKNT--KELVAMKYIERGHK---IDANVAREIINHKQL-RHPNIIRFKEVVLTP----TH   72 (344)
Q Consensus         3 ~y~~~~~lg~G~~g~V~~~~~~~~--~~~vaiK~~~~~~~---~~~~~~~ei~~l~~l-~h~niv~~~~~~~~~----~~   72 (344)
                      +|++.+.||+|+||.||++.+..+  +..||+|.+.....   ....+.+|+.+++++ +||||+++++.+...    ..
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~   80 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE   80 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence            699999999999999999999888  89999999865322   235678899999999 599999999875432    46


Q ss_pred             EEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCC
Q 019195           73 LAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLL  145 (344)
Q Consensus        73 ~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~  145 (344)
                      +|++++|+. ++|..++.....+++..++.++.|++.+       ||+||||||+|||++.++.  +||+|||++.....
T Consensus        81 ~~~~~e~~~-~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~--~kl~Dfg~a~~~~~  157 (332)
T cd07857          81 LYLYEELME-ADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCE--LKICDFGLARGFSE  157 (332)
T ss_pred             EEEEEeccc-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCC--EEeCcCCCceeccc
Confidence            789999985 6999999888889999888887776655       9999999999999987654  99999999875432


Q ss_pred             CC-----CCCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhc--------
Q 019195          146 HS-----RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAV--------  212 (344)
Q Consensus       146 ~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~--------  212 (344)
                      ..     ......||+.|+|||.+.+....+.++||||+||++|+|++|.+||...+....+...+......        
T Consensus       158 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (332)
T cd07857         158 NPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRI  237 (332)
T ss_pred             ccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhh
Confidence            21     12334689999999988665444566999999999999999999998765433332222211000        


Q ss_pred             ----------------cccCC-CCCCCCHhHHHHHHHhcccCCCCCCChHHHhcCcccccCCCh
Q 019195          213 ----------------QYKIP-DYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLPR  259 (344)
Q Consensus       213 ----------------~~~~~-~~~~~s~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~~~~~  259 (344)
                                      ...++ .....+..+.+|+.+||+.||.+|||+.+++.||||.+...+
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~~~~  301 (332)
T cd07857         238 GSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIWHDP  301 (332)
T ss_pred             hhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhhcCc
Confidence                            00000 122457899999999999999999999999999999766443

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=2.2e-40  Score=293.50  Aligned_cols=245  Identities=27%  Similarity=0.419  Sum_probs=193.8

Q ss_pred             CCCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCc----cccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEE
Q 019195            1 MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH----KIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIV   76 (344)
Q Consensus         1 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv   76 (344)
                      +++|++.+.||+|+||.||++.+..+++.||+|.+....    .....+.+|+.+++.++||||+++++++...+..+++
T Consensus         1 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v   80 (267)
T cd08228           1 LANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIV   80 (267)
T ss_pred             CcceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEE
Confidence            478999999999999999999999999999999876432    2234578899999999999999999999999999999


Q ss_pred             EecCCCCChHHHHHh----CCCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCC
Q 019195           77 MEYAAGGELFERICN----AGRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLL  145 (344)
Q Consensus        77 ~e~~~~g~L~~~i~~----~~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~  145 (344)
                      |||+++++|..++..    ...+++..++.++.|++.+       |++|+||||+||+++.++.  ++|+|||++.....
T Consensus        81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~--~~l~d~g~~~~~~~  158 (267)
T cd08228          81 LELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGV--VKLGDLGLGRFFSS  158 (267)
T ss_pred             EEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCC--EEECccccceeccc
Confidence            999999999988753    3457888777777666554       9999999999999977654  99999998875433


Q ss_pred             CCC-CCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCH
Q 019195          146 HSR-PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQ  224 (344)
Q Consensus       146 ~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~  224 (344)
                      ... .....|++.|+|||.+.+...+ .++|+||+|+++|+|++|+.||......  .......+............++.
T Consensus       159 ~~~~~~~~~~~~~~~aPE~~~~~~~~-~~~Di~slG~~l~el~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~  235 (267)
T cd08228         159 KTTAAHSLVGTPYYMSPERIHENGYN-FKSDIWSLGCLLYEMAALQSPFYGDKMN--LFSLCQKIEQCDYPPLPTEHYSE  235 (267)
T ss_pred             hhHHHhcCCCCccccChhhhccCCCC-chhhHHHHHHHHHHHhcCCCCCcccccc--HHHHHHHHhcCCCCCCChhhcCH
Confidence            221 2235689999999999877664 4599999999999999999999764321  12222222222211111224678


Q ss_pred             hHHHHHHHhcccCCCCCCChHHHhcC
Q 019195          225 DCRNLLSRIFVANPSRRITIKEIKSH  250 (344)
Q Consensus       225 ~~~~li~~~L~~dp~~R~s~~ell~h  250 (344)
                      .+.++|.+||+.+|.+||++.++++.
T Consensus       236 ~~~~li~~cl~~~p~~Rp~~~~vl~~  261 (267)
T cd08228         236 KLRELVSMCIYPDPDQRPDIGYVHQI  261 (267)
T ss_pred             HHHHHHHHHCCCCcccCcCHHHHHHH
Confidence            89999999999999999999999874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=7.3e-41  Score=307.50  Aligned_cols=251  Identities=26%  Similarity=0.383  Sum_probs=195.7

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCcc-ccHHHHHHHHHHhcCCCCCcceeeEEEEcC----------
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK-IDANVAREIINHKQLRHPNIIRFKEVVLTP----------   70 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~ei~~l~~l~h~niv~~~~~~~~~----------   70 (344)
                      .+|++.+.||.|+||.||+|.+..++..||+|++..... ....+.+|+.+++.++||||+++++++...          
T Consensus         5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~   84 (342)
T cd07854           5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGS   84 (342)
T ss_pred             cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccc
Confidence            589999999999999999999999999999999866433 335688999999999999999999876543          


Q ss_pred             ----CEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCC
Q 019195           71 ----THLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGY  139 (344)
Q Consensus        71 ----~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~  139 (344)
                          ..+|++|||+. ++|...+. .+.+++..++.++.|+++|       ||+||||||+||+++... +.+||+|||+
T Consensus        85 ~~~~~~~~lv~e~~~-~~L~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~-~~~kl~dfg~  161 (342)
T cd07854          85 LTELNSVYIVQEYME-TDLANVLE-QGPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTED-LVLKIGDFGL  161 (342)
T ss_pred             ccccceEEEEeeccc-ccHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCC-ceEEECCccc
Confidence                35799999996 58888775 4568899998888887765       999999999999997433 2489999999


Q ss_pred             CcccCCCCC----CCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHh-----
Q 019195          140 SKSSLLHSR----PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIM-----  210 (344)
Q Consensus       140 a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~-----  210 (344)
                      +........    .....|+..|+|||.+.+....+.++|||||||++|+|++|+.||.................     
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  241 (342)
T cd07854         162 ARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVREE  241 (342)
T ss_pred             ceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChH
Confidence            875432211    12345889999999876655455669999999999999999999987655444333322110     


Q ss_pred             -------------h---ccccCC---CCCCCCHhHHHHHHHhcccCCCCCCChHHHhcCccccc
Q 019195          211 -------------A---VQYKIP---DYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLK  255 (344)
Q Consensus       211 -------------~---~~~~~~---~~~~~s~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~  255 (344)
                                   .   .....+   ....++.++.+||.+||+.||.+|||+.++|.||||+.
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~  305 (342)
T cd07854         242 DRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSC  305 (342)
T ss_pred             HhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCcccc
Confidence                         0   000000   01246789999999999999999999999999999964

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-43  Score=345.86  Aligned_cols=247  Identities=30%  Similarity=0.459  Sum_probs=204.6

Q ss_pred             CceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecC---ccccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEEec
Q 019195            3 KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERG---HKIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEY   79 (344)
Q Consensus         3 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~   79 (344)
                      ||.-..+||.|.||.||.|.+..+|...|+|-+.-+   .+..+.+.+|..++..++|||+|++|++=...+.++|.|||
T Consensus      1236 rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEy 1315 (1509)
T KOG4645|consen 1236 RWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEY 1315 (1509)
T ss_pred             eeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHH
Confidence            577788999999999999999999999999987643   23346788999999999999999999999999999999999


Q ss_pred             CCCCChHHHHHhCCCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCC-----
Q 019195           80 AAGGELFERICNAGRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS-----  147 (344)
Q Consensus        80 ~~~g~L~~~i~~~~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~-----  147 (344)
                      |.+|+|.+.+...+...+...+.+..|++.+       |||||||||+||+++.++.  +|++|||.|.....+.     
T Consensus      1316 C~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~--iK~~DFGsa~ki~~~~~~~~~ 1393 (1509)
T KOG4645|consen 1316 CEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGL--IKYGDFGSAVKIKNNAQTMPG 1393 (1509)
T ss_pred             hccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCc--EEeecccceeEecCchhcCCH
Confidence            9999999999888777777777777666654       9999999999999987775  9999999997654432     


Q ss_pred             CCCCCccCCcccCCccccCCC--CCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHh-hccccCCCCCCCCH
Q 019195          148 RPKSTVGTPAYIAPEVLSRRE--YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIM-AVQYKIPDYVHISQ  224 (344)
Q Consensus       148 ~~~~~~gt~~y~aPE~~~~~~--~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~s~  224 (344)
                      ......||+.|||||++.+..  ....+.|||||||++.||+||+.||...+..-   .++..+. .....+|.  .+|+
T Consensus      1394 el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~---aIMy~V~~gh~Pq~P~--~ls~ 1468 (1509)
T KOG4645|consen 1394 ELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEW---AIMYHVAAGHKPQIPE--RLSS 1468 (1509)
T ss_pred             HHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchh---HHHhHHhccCCCCCch--hhhH
Confidence            224567999999999997654  23467999999999999999999998765532   2333322 22334444  5999


Q ss_pred             hHHHHHHHhcccCCCCCCChHHHhcCcccccC
Q 019195          225 DCRNLLSRIFVANPSRRITIKEIKSHPWFLKN  256 (344)
Q Consensus       225 ~~~~li~~~L~~dp~~R~s~~ell~hp~~~~~  256 (344)
                      +.++||.+||+.||.+|+++.|||+|.|-+-.
T Consensus      1469 ~g~dFle~Cl~~dP~~Rw~~~qlle~~f~~~~ 1500 (1509)
T KOG4645|consen 1469 EGRDFLEHCLEQDPKMRWTASQLLEHAFGKSC 1500 (1509)
T ss_pred             hHHHHHHHHHhcCchhhhHHHHHHHhhccccc
Confidence            99999999999999999999999999886543

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-42  Score=306.57  Aligned_cols=255  Identities=27%  Similarity=0.427  Sum_probs=211.4

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCcccc--------HHHHHHHHHHhcCCCCCcceeeEEEEcC-CE
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKID--------ANVAREIINHKQLRHPNIIRFKEVVLTP-TH   72 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--------~~~~~ei~~l~~l~h~niv~~~~~~~~~-~~   72 (344)
                      +||-++..||+|||+.||+|.+....++||+|+-..+..+.        +..-+|..+.+.|.||.||++|++|.-+ +.
T Consensus       463 ~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtds  542 (775)
T KOG1151|consen  463 DRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDS  542 (775)
T ss_pred             HHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecccc
Confidence            57999999999999999999999999999999865443322        3466899999999999999999999654 67


Q ss_pred             EEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHC---------CeeecCCCCCCeEe-cCCCCCCEEEeecCCCcc
Q 019195           73 LAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG---------QICHRDLKLENTLL-DGSPAPRLKICDFGYSKS  142 (344)
Q Consensus        73 ~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~ql~~~---------~iiH~Dikp~NIl~-~~~~~~~vkL~DFg~a~~  142 (344)
                      +|-|+|||+|.+|.-+++...-+++.+++.++.|+++|         .|||-||||.|||+ +++..|.+||+|||+++.
T Consensus       543 FCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFGLSKI  622 (775)
T KOG1151|consen  543 FCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGLSKI  622 (775)
T ss_pred             ceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecchhhh
Confidence            99999999999999999999999999999999999987         89999999999998 455567799999999987


Q ss_pred             cCCCCCC--------CCCccCCcccCCccccCC---CCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhh
Q 019195          143 SLLHSRP--------KSTVGTPAYIAPEVLSRR---EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMA  211 (344)
Q Consensus       143 ~~~~~~~--------~~~~gt~~y~aPE~~~~~---~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~  211 (344)
                      .......        ....||.+|++||.+.-+   +-.+.++||||+|||+|..+.|+.||............-.-+..
T Consensus       623 MdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeNTIlkA  702 (775)
T KOG1151|consen  623 MDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQENTILKA  702 (775)
T ss_pred             ccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhhchhcc
Confidence            5544332        344699999999998543   33355699999999999999999999876443222221112334


Q ss_pred             ccccCCCCCCCCHhHHHHHHHhcccCCCCCCChHHHhcCcccccC
Q 019195          212 VQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKN  256 (344)
Q Consensus       212 ~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~~  256 (344)
                      ....+|.-+.+++++++||++||++.-..|..+.+|-.||||...
T Consensus       703 tEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyllPh  747 (775)
T KOG1151|consen  703 TEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLLPH  747 (775)
T ss_pred             eeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHccCccccch
Confidence            455677777899999999999999999999999999999999653

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.6e-40  Score=291.90  Aligned_cols=244  Identities=32%  Similarity=0.480  Sum_probs=196.4

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCc------cccHHHHHHHHHHhcCCCCCcceeeEEEEcC--CEE
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH------KIDANVAREIINHKQLRHPNIIRFKEVVLTP--THL   73 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~--~~~   73 (344)
                      .+|++.+.||+|+||.||++.+..++..||+|.+....      .....+.+|+.++++++||||+++++++.+.  ..+
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL   81 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence            47999999999999999999999999999999875421      1224678899999999999999999998764  568


Q ss_pred             EEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCC
Q 019195           74 AIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH  146 (344)
Q Consensus        74 ~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~  146 (344)
                      +++|||+++++|.+++.+.+.+++..++.++.|++++       |++|+||||+||+++.++.  ++|+|||+++.....
T Consensus        82 ~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~--~~l~dfg~~~~~~~~  159 (264)
T cd06653          82 SIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGN--VKLGDFGASKRIQTI  159 (264)
T ss_pred             EEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCC--EEECccccccccccc
Confidence            9999999999999999887788888888877776654       9999999999999986654  999999998754321


Q ss_pred             ----CCCCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCCCCCCC
Q 019195          147 ----SRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHI  222 (344)
Q Consensus       147 ----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  222 (344)
                          .......|+..|+|||.+.+...+ .++|+|||||++|+|++|+.||..........    ++.........+..+
T Consensus       160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~----~~~~~~~~~~~p~~~  234 (264)
T cd06653         160 CMSGTGIKSVTGTPYWMSPEVISGEGYG-RKADVWSVACTVVEMLTEKPPWAEYEAMAAIF----KIATQPTKPMLPDGV  234 (264)
T ss_pred             cccCccccccCCcccccCHhhhcCCCCC-ccccHHHHHHHHHHHHhCCCCCCccCHHHHHH----HHHcCCCCCCCCccc
Confidence                112235689999999999776654 55999999999999999999998754433222    222222222223468


Q ss_pred             CHhHHHHHHHhcccCCCCCCChHHHhcCccc
Q 019195          223 SQDCRNLLSRIFVANPSRRITIKEIKSHPWF  253 (344)
Q Consensus       223 s~~~~~li~~~L~~dp~~R~s~~ell~hp~~  253 (344)
                      ++.+.++|.+||+ +|.+||++.+++.|||.
T Consensus       235 ~~~~~~~i~~~l~-~~~~r~~~~~~~~~~~~  264 (264)
T cd06653         235 SDACRDFLKQIFV-EEKRRPTAEFLLRHPFV  264 (264)
T ss_pred             CHHHHHHHHHHhc-CcccCccHHHHhcCCCC
Confidence            8999999999999 57999999999999984

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.1e-40  Score=306.29  Aligned_cols=248  Identities=28%  Similarity=0.419  Sum_probs=192.8

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCc---cccHHHHHHHHHHhcCCCCCcceeeEEEEcC------CE
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH---KIDANVAREIINHKQLRHPNIIRFKEVVLTP------TH   72 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~------~~   72 (344)
                      ++|.+.+.||+|+||.||+|.+..++..||+|++.+..   .....+.+|+.+++.++||||+++++++...      ..
T Consensus        15 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   94 (342)
T cd07879          15 ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQD   94 (342)
T ss_pred             cceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCce
Confidence            68999999999999999999999999999999987532   2234678999999999999999999998754      35


Q ss_pred             EEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHH-------CCeeecCCCCCCeEecCCCCCCEEEeecCCCcccCC
Q 019195           73 LAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLIS-------GQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLL  145 (344)
Q Consensus        73 ~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~ql~~-------~~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~  145 (344)
                      +|+|++|+. .+|...+  ...+++..++.++.|++.       .||+||||||+||+++.++  .+||+|||+++... 
T Consensus        95 ~~lv~e~~~-~~l~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~--~~kL~dfg~~~~~~-  168 (342)
T cd07879          95 FYLVMPYMQ-TDLQKIM--GHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDC--ELKILDFGLARHAD-  168 (342)
T ss_pred             EEEEecccc-cCHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC--CEEEeeCCCCcCCC-
Confidence            799999995 4776654  346788877777666654       4999999999999998765  49999999987532 


Q ss_pred             CCCCCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHh---------------
Q 019195          146 HSRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIM---------------  210 (344)
Q Consensus       146 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~---------------  210 (344)
                       .......+++.|+|||.+.+....+.++|||||||++|+|++|+.||........+..++....               
T Consensus       169 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (342)
T cd07879         169 -AEMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKAA  247 (342)
T ss_pred             -CCCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhcccch
Confidence             2233457899999999987654445669999999999999999999987654433333222100               


Q ss_pred             ----hccccCC------CCCCCCHhHHHHHHHhcccCCCCCCChHHHhcCcccccC
Q 019195          211 ----AVQYKIP------DYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKN  256 (344)
Q Consensus       211 ----~~~~~~~------~~~~~s~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~~  256 (344)
                          ......+      .+...++.+.+||.+||+.||.+||++.+++.||||...
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~  303 (342)
T cd07879         248 KSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSF  303 (342)
T ss_pred             HHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhc
Confidence                0000000      012467889999999999999999999999999999665

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=1e-40  Score=298.11  Aligned_cols=247  Identities=30%  Similarity=0.481  Sum_probs=198.3

Q ss_pred             ceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCcc--ccHHHHHHHHHHhcCC-CCCcceeeEEEEcCCEEEEEEecC
Q 019195            4 YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK--IDANVAREIINHKQLR-HPNIIRFKEVVLTPTHLAIVMEYA   80 (344)
Q Consensus         4 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~ei~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~   80 (344)
                      |++.+.||+|++|.||+|....+++.||+|.+.....  ......+|+..+++++ ||||+++++++..++..++||||+
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~   80 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM   80 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence            7899999999999999999999999999999865433  2234567999999998 999999999999999999999999


Q ss_pred             CCCChHHHHHhCC--CCCHHHHHHHHHHHHH-------CCeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCCCCCC
Q 019195           81 AGGELFERICNAG--RFSEDEARYFFQQLIS-------GQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKS  151 (344)
Q Consensus        81 ~~g~L~~~i~~~~--~~~~~~~~~~~~ql~~-------~~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~~~~~  151 (344)
                       +|+|.+.+....  .+++.++..++.|++.       .|++|+||+|.||+++.++.  ++|+|||++...........
T Consensus        81 -~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~--~~l~d~~~~~~~~~~~~~~~  157 (283)
T cd07830          81 -EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEV--VKIADFGLAREIRSRPPYTD  157 (283)
T ss_pred             -CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCC--EEEeecccceeccCCCCcCC
Confidence             789999887754  7888888888777665       49999999999999987654  99999999876555444455


Q ss_pred             CccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhc---------------cccC
Q 019195          152 TVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAV---------------QYKI  216 (344)
Q Consensus       152 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~---------------~~~~  216 (344)
                      ..++..|+|||++.+....+.++|+||||+++++|++|++||........+.+........               ....
T Consensus       158 ~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (283)
T cd07830         158 YVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGFRF  237 (283)
T ss_pred             CCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhccccccc
Confidence            6789999999998665545566999999999999999999998776554443332211000               0000


Q ss_pred             C---------CCCCCCHhHHHHHHHhcccCCCCCCChHHHhcCccc
Q 019195          217 P---------DYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF  253 (344)
Q Consensus       217 ~---------~~~~~s~~~~~li~~~L~~dp~~R~s~~ell~hp~~  253 (344)
                      +         .....+..+.+||.+||+.+|.+|||+.+++.||||
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~  283 (283)
T cd07830         238 PQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF  283 (283)
T ss_pred             cccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence            0         011236789999999999999999999999999997

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=1.1e-40  Score=305.59  Aligned_cols=242  Identities=22%  Similarity=0.375  Sum_probs=187.5

Q ss_pred             CCceeeeeeeecCceEEEEEEEc-----CCCcEEEEEEeecCccc--cHHHHHHHHHHhcC-CCCCcceeeEEEEcC-CE
Q 019195            2 EKYELMKDIGSGNFGVARLMRNK-----NTKELVAMKYIERGHKI--DANVAREIINHKQL-RHPNIIRFKEVVLTP-TH   72 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~~--~~~~~~ei~~l~~l-~h~niv~~~~~~~~~-~~   72 (344)
                      ++|++.+.||.|+||.||+|...     .+++.||+|++......  ...+.+|+.+++++ +|+||+++++++... ..
T Consensus         7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~   86 (337)
T cd05054           7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGP   86 (337)
T ss_pred             HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCC
Confidence            48999999999999999999743     34578999998754322  24577899999999 899999999988654 57


Q ss_pred             EEEEEecCCCCChHHHHHhC------------------------------------------------------------
Q 019195           73 LAIVMEYAAGGELFERICNA------------------------------------------------------------   92 (344)
Q Consensus        73 ~~lv~e~~~~g~L~~~i~~~------------------------------------------------------------   92 (344)
                      ++++|||+++++|.+++...                                                            
T Consensus        87 ~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  166 (337)
T cd05054          87 LMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELY  166 (337)
T ss_pred             EEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHh
Confidence            89999999999999988542                                                            


Q ss_pred             -CCCCHHHHHHHHHHHHH-------CCeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCC---CCCCCccCCcccCC
Q 019195           93 -GRFSEDEARYFFQQLIS-------GQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS---RPKSTVGTPAYIAP  161 (344)
Q Consensus        93 -~~~~~~~~~~~~~ql~~-------~~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~---~~~~~~gt~~y~aP  161 (344)
                       ..++...+..++.|++.       .||+||||||+|||++.++.  +||+|||++.......   ......++..|+||
T Consensus       167 ~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~--vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~aP  244 (337)
T cd05054         167 KEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNV--VKICDFGLARDIYKDPDYVRKGDARLPLKWMAP  244 (337)
T ss_pred             hcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCc--EEEeccccchhcccCcchhhccCCCCCccccCc
Confidence             14566666666666554       49999999999999987654  9999999997643222   12234467789999


Q ss_pred             ccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCHhHHHHHHHhcccCCCC
Q 019195          162 EVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSR  240 (344)
Q Consensus       162 E~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~  240 (344)
                      |++.+..++.+ +|||||||++|+|++ |..||......+.+...+..    ..........++++.+++.+||+.+|.+
T Consensus       245 E~~~~~~~~~~-~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~l~~~cl~~~p~~  319 (337)
T cd05054         245 ESIFDKVYTTQ-SDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKE----GTRMRAPEYATPEIYSIMLDCWHNNPED  319 (337)
T ss_pred             HHhcCCCCCcc-ccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhc----cCCCCCCccCCHHHHHHHHHHccCChhh
Confidence            99988777554 999999999999997 99999875543333332221    1122222357889999999999999999


Q ss_pred             CCChHHHhcC
Q 019195          241 RITIKEIKSH  250 (344)
Q Consensus       241 R~s~~ell~h  250 (344)
                      ||++.++++|
T Consensus       320 RPs~~ell~~  329 (337)
T cd05054         320 RPTFSELVEI  329 (337)
T ss_pred             CcCHHHHHHH
Confidence            9999999886

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=2.4e-40  Score=291.84  Aligned_cols=240  Identities=23%  Similarity=0.381  Sum_probs=192.9

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEEecCC
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYAA   81 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~   81 (344)
                      ++|++++.||+|+||+||.+.+.. +..+|+|.+.........+.+|+.+++.++||||+++++++.....++++|||+.
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   82 (256)
T cd05113           4 KDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS   82 (256)
T ss_pred             HHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCcccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence            579999999999999999998754 4469999987655555678999999999999999999999998899999999999


Q ss_pred             CCChHHHHHhC-CCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCCCC--CC
Q 019195           82 GGELFERICNA-GRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP--KS  151 (344)
Q Consensus        82 ~g~L~~~i~~~-~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~~~--~~  151 (344)
                      +++|.+++... ..+++.+++.++.|++.+       |++|+||||+||+++.++  ++||+|||+++........  ..
T Consensus        83 ~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~--~~kl~d~g~~~~~~~~~~~~~~~  160 (256)
T cd05113          83 NGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQG--CVKVSDFGLSRYVLDDEYTSSVG  160 (256)
T ss_pred             CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCC--CEEECCCccceecCCCceeecCC
Confidence            99999999764 468888888887776655       999999999999997665  4999999998754332211  12


Q ss_pred             CccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCHhHHHHH
Q 019195          152 TVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLL  230 (344)
Q Consensus       152 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li  230 (344)
                      ..++..|+|||.+.+..++ .++|||||||++|+|++ |..||...........+.    .. ...+.....++.+.+++
T Consensus       161 ~~~~~~y~~pe~~~~~~~~-~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~----~~-~~~~~~~~~~~~~~~li  234 (256)
T cd05113         161 SKFPVRWSPPEVLLYSKFS-SKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVS----QG-LRLYRPHLASEKVYAIM  234 (256)
T ss_pred             CccChhhCCHHHHhcCccc-chhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHh----cC-CCCCCCCCCCHHHHHHH
Confidence            3356789999999776654 45999999999999998 999998765433333222    11 12222334688999999


Q ss_pred             HHhcccCCCCCCChHHHhcC
Q 019195          231 SRIFVANPSRRITIKEIKSH  250 (344)
Q Consensus       231 ~~~L~~dp~~R~s~~ell~h  250 (344)
                      .+||+.+|.+|||+.+++.+
T Consensus       235 ~~cl~~~p~~Rp~~~~ll~~  254 (256)
T cd05113         235 YSCWHEKAEERPTFQQLLSS  254 (256)
T ss_pred             HHHcCCCcccCCCHHHHHHh
Confidence            99999999999999999864

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-40  Score=297.61  Aligned_cols=247  Identities=31%  Similarity=0.467  Sum_probs=198.6

Q ss_pred             ceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCcc---ccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEEecC
Q 019195            4 YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK---IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYA   80 (344)
Q Consensus         4 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~   80 (344)
                      |++.+.||.|++|.||++.+..+++.+|+|.+.....   ....+.+|+.++++++|+||+++++++..+..+++++||+
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   80 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM   80 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence            7889999999999999999999999999999876433   2457888999999999999999999999999999999999


Q ss_pred             CCCChHHHHHh-CCCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCC-CCCC
Q 019195           81 AGGELFERICN-AGRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS-RPKS  151 (344)
Q Consensus        81 ~~g~L~~~i~~-~~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~-~~~~  151 (344)
                      ++ +|...+.. ...+++..++.++.|++.+       +|+|+||||+||+++.++.  ++|+|||.+....... ....
T Consensus        81 ~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~--~~l~df~~~~~~~~~~~~~~~  157 (283)
T cd05118          81 DT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGV--LKLADFGLARSFGSPVRPYTH  157 (283)
T ss_pred             CC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCc--EEEeeeeeeEecCCCcccccC
Confidence            65 88887766 3578888888887776654       9999999999999986654  9999999987554333 2233


Q ss_pred             CccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhcc---------------ccC
Q 019195          152 TVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQ---------------YKI  216 (344)
Q Consensus       152 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~---------------~~~  216 (344)
                      ..++..|+|||.+.+....+.++|+||||+++|+|++|+.||...+....+..+........               ...
T Consensus       158 ~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (283)
T cd05118         158 YVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSF  237 (283)
T ss_pred             ccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhhhh
Confidence            56889999999987764456669999999999999999999987766554444332211100               000


Q ss_pred             C---------CCCCCCHhHHHHHHHhcccCCCCCCChHHHhcCccc
Q 019195          217 P---------DYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF  253 (344)
Q Consensus       217 ~---------~~~~~s~~~~~li~~~L~~dp~~R~s~~ell~hp~~  253 (344)
                      +         ....++.++.+||.+||+.||.+||++.+++.||||
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~  283 (283)
T cd05118         238 PKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF  283 (283)
T ss_pred             ccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence            0         012367889999999999999999999999999997

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=1.8e-40  Score=293.26  Aligned_cols=239  Identities=23%  Similarity=0.379  Sum_probs=191.2

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEEecCC
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYAA   81 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~   81 (344)
                      ++|+++++||+|+||.||++... ++..||+|.+.........+.+|+.+++.++|+||+++++++......+++|||++
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   84 (261)
T cd05072           6 ESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMA   84 (261)
T ss_pred             HHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCCchhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCC
Confidence            68999999999999999999865 45679999887655555678899999999999999999999999999999999999


Q ss_pred             CCChHHHHHhC--CCCCHHHHHHHHHHHH-------HCCeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCCC--CC
Q 019195           82 GGELFERICNA--GRFSEDEARYFFQQLI-------SGQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR--PK  150 (344)
Q Consensus        82 ~g~L~~~i~~~--~~~~~~~~~~~~~ql~-------~~~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~~--~~  150 (344)
                      +++|.+++...  ..++...++.++.|++       +.+++||||||+||+++.++.  +||+|||++........  ..
T Consensus        85 ~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~--~~l~dfg~~~~~~~~~~~~~~  162 (261)
T cd05072          85 KGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLM--CKIADFGLARVIEDNEYTARE  162 (261)
T ss_pred             CCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCc--EEECCCccceecCCCceeccC
Confidence            99999998653  4577776666655554       559999999999999987654  99999999875433221  12


Q ss_pred             CCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCHhHHHH
Q 019195          151 STVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL  229 (344)
Q Consensus       151 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  229 (344)
                      ...++..|+|||.+.+..++ .++|||||||++|+|++ |..||...........    +. .....+....++.++.++
T Consensus       163 ~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~----~~-~~~~~~~~~~~~~~~~~l  236 (261)
T cd05072         163 GAKFPIKWTAPEAINFGSFT-IKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSA----LQ-RGYRMPRMENCPDELYDI  236 (261)
T ss_pred             CCccceecCCHHHhccCCCC-hhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHH----HH-cCCCCCCCCCCCHHHHHH
Confidence            23466789999998776654 45999999999999998 9999976544332222    11 223444445688999999


Q ss_pred             HHHhcccCCCCCCChHHHhc
Q 019195          230 LSRIFVANPSRRITIKEIKS  249 (344)
Q Consensus       230 i~~~L~~dp~~R~s~~ell~  249 (344)
                      +.+||..+|.+|||++++++
T Consensus       237 i~~~l~~~p~~Rp~~~~i~~  256 (261)
T cd05072         237 MKTCWKEKAEERPTFDYLQS  256 (261)
T ss_pred             HHHHccCCcccCcCHHHHHH
Confidence            99999999999999999864

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=6.8e-41  Score=305.96  Aligned_cols=248  Identities=20%  Similarity=0.302  Sum_probs=187.5

Q ss_pred             eeeeeec--CceEEEEEEEcCCCcEEEEEEeecCccc---cHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEEecCC
Q 019195            7 MKDIGSG--NFGVARLMRNKNTKELVAMKYIERGHKI---DANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYAA   81 (344)
Q Consensus         7 ~~~lg~G--~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~   81 (344)
                      ...||+|  +||+||++.+..+++.||+|++......   .+.+.+|+.+++.++||||++++++|..++.+++||||+.
T Consensus         3 ~~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~   82 (328)
T cd08226           3 QVEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMA   82 (328)
T ss_pred             HHHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEeccc
Confidence            3567777  8999999999999999999998754322   2567889999999999999999999999999999999999


Q ss_pred             CCChHHHHHhC--CCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCCC----
Q 019195           82 GGELFERICNA--GRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR----  148 (344)
Q Consensus        82 ~g~L~~~i~~~--~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~~----  148 (344)
                      +++|.+++.+.  ..+++..++.++.|++.+       ||+||||||+|||++.++  .++++||+.+........    
T Consensus        83 ~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~--~~~~~~~~~~~~~~~~~~~~~~  160 (328)
T cd08226          83 YGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDG--LVSLSGLSHLYSLVRNGQKAKV  160 (328)
T ss_pred             CCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCC--cEEEechHHHhhhhccCccccc
Confidence            99999998764  358888887777776654       999999999999998665  499999985432211111    


Q ss_pred             ----CCCCccCCcccCCccccCCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHh-------------
Q 019195          149 ----PKSTVGTPAYIAPEVLSRRE-YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIM-------------  210 (344)
Q Consensus       149 ----~~~~~gt~~y~aPE~~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~-------------  210 (344)
                          .....++..|+|||++.+.. ..+.++|||||||++|+|++|.+||............+....             
T Consensus       161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (328)
T cd08226         161 VYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEE  240 (328)
T ss_pred             cccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhh
Confidence                11123566799999997642 234569999999999999999999977544332222111000             


Q ss_pred             ----------------------------hccccCCCCCCCCHhHHHHHHHhcccCCCCCCChHHHhcCcccccC
Q 019195          211 ----------------------------AVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKN  256 (344)
Q Consensus       211 ----------------------------~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~~  256 (344)
                                                  ......+....+++.+.+||++||+.||.+|||+.++|+||||...
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~  314 (328)
T cd08226         241 SRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQV  314 (328)
T ss_pred             hhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHH
Confidence                                        0000111122356789999999999999999999999999999543

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=3.2e-40  Score=295.16  Aligned_cols=242  Identities=21%  Similarity=0.343  Sum_probs=189.6

Q ss_pred             CCCceeeeeeeecCceEEEEEEE----cCCCcEEEEEEeecCcc--ccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEE
Q 019195            1 MEKYELMKDIGSGNFGVARLMRN----KNTKELVAMKYIERGHK--IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLA   74 (344)
Q Consensus         1 ~~~y~~~~~lg~G~~g~V~~~~~----~~~~~~vaiK~~~~~~~--~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~   74 (344)
                      +++|++.+.||+|+||+||++..    ..++..||+|.+.....  ....+.+|+.+++.++||||+++++++......|
T Consensus         4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~   83 (283)
T cd05090           4 LSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVC   83 (283)
T ss_pred             hhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceE
Confidence            46799999999999999999985    34567899999875332  2246788999999999999999999999999999


Q ss_pred             EEEecCCCCChHHHHHhCC-----------------CCCHHHHHHHHHHHH-------HCCeeecCCCCCCeEecCCCCC
Q 019195           75 IVMEYAAGGELFERICNAG-----------------RFSEDEARYFFQQLI-------SGQICHRDLKLENTLLDGSPAP  130 (344)
Q Consensus        75 lv~e~~~~g~L~~~i~~~~-----------------~~~~~~~~~~~~ql~-------~~~iiH~Dikp~NIl~~~~~~~  130 (344)
                      ++|||+++++|.+++....                 .+++.++..++.|++       +.|++||||||+|||++.+.. 
T Consensus        84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~~~~-  162 (283)
T cd05090          84 MLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLH-  162 (283)
T ss_pred             EEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcCCCc-
Confidence            9999999999999985322                 356666666655554       559999999999999987654 


Q ss_pred             CEEEeecCCCcccCCCC---CCCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHH
Q 019195          131 RLKICDFGYSKSSLLHS---RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTI  206 (344)
Q Consensus       131 ~vkL~DFg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~  206 (344)
                       +||+|||+++......   ......++..|+|||.+.+..++ .++|||||||++|+|++ |..||.+......    .
T Consensus       163 -~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~il~el~~~g~~p~~~~~~~~~----~  236 (283)
T cd05090         163 -VKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFS-SDSDIWSFGVVLWEIFSFGLQPYYGFSNQEV----I  236 (283)
T ss_pred             -EEeccccccccccCCcceecccCCCccceecChHHhccCCCC-chhhhHHHHHHHHHHHcCCCCCCCCCCHHHH----H
Confidence             9999999987543221   22334567789999999776654 55999999999999998 9999977543222    2


Q ss_pred             HHHhhccccCCCCCCCCHhHHHHHHHhcccCCCCCCChHHHhcC
Q 019195          207 SRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSH  250 (344)
Q Consensus       207 ~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~ell~h  250 (344)
                      ..+.. ....+....+++.+.+++.+||+.+|.+||++.+++++
T Consensus       237 ~~~~~-~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~  279 (283)
T cd05090         237 EMVRK-RQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR  279 (283)
T ss_pred             HHHHc-CCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence            22211 22233444678999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=2.4e-40  Score=298.13  Aligned_cols=242  Identities=24%  Similarity=0.338  Sum_probs=188.9

Q ss_pred             CCCceeeeeeeecCceEEEEEEEcCCCc--EEEEEEeecCc--cccHHHHHHHHHHhcC-CCCCcceeeEEEEcCCEEEE
Q 019195            1 MEKYELMKDIGSGNFGVARLMRNKNTKE--LVAMKYIERGH--KIDANVAREIINHKQL-RHPNIIRFKEVVLTPTHLAI   75 (344)
Q Consensus         1 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~--~vaiK~~~~~~--~~~~~~~~ei~~l~~l-~h~niv~~~~~~~~~~~~~l   75 (344)
                      .++|++.+.||+|+||.||+|....++.  .+++|.+....  .....+.+|+.+++++ +||||+++++++...+.+|+
T Consensus         1 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l   80 (297)
T cd05089           1 WEDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYI   80 (297)
T ss_pred             CccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceE
Confidence            3789999999999999999999877664  46888776422  2235688899999999 79999999999999999999


Q ss_pred             EEecCCCCChHHHHHhCC----------------CCCHHHHHHHHHHHHH-------CCeeecCCCCCCeEecCCCCCCE
Q 019195           76 VMEYAAGGELFERICNAG----------------RFSEDEARYFFQQLIS-------GQICHRDLKLENTLLDGSPAPRL  132 (344)
Q Consensus        76 v~e~~~~g~L~~~i~~~~----------------~~~~~~~~~~~~ql~~-------~~iiH~Dikp~NIl~~~~~~~~v  132 (344)
                      +|||+++++|.+++.+..                .++...++.++.|++.       .||+||||||+|||++.+..  +
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~--~  158 (297)
T cd05089          81 AIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLA--S  158 (297)
T ss_pred             EEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCCe--E
Confidence            999999999999997543                3677777777666554       49999999999999987654  9


Q ss_pred             EEeecCCCcccCCCCCCCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhh
Q 019195          133 KICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMA  211 (344)
Q Consensus       133 kL~DFg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~  211 (344)
                      ||+|||++..............+..|+|||.+.+..++ .++|||||||++|+|++ |..||............    ..
T Consensus       159 kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~----~~  233 (297)
T cd05089         159 KIADFGLSRGEEVYVKKTMGRLPVRWMAIESLNYSVYT-TKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKL----PQ  233 (297)
T ss_pred             EECCcCCCccccceeccCCCCcCccccCchhhccCCCC-chhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH----hc
Confidence            99999998643222222222345679999999777664 55999999999999997 99999876544333222    11


Q ss_pred             ccccCCCCCCCCHhHHHHHHHhcccCCCCCCChHHHhcC
Q 019195          212 VQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSH  250 (344)
Q Consensus       212 ~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~ell~h  250 (344)
                       ....+....++..+.+||.+||+.+|.+|||+.++++.
T Consensus       234 -~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~  271 (297)
T cd05089         234 -GYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQ  271 (297)
T ss_pred             -CCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence             22223334678999999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=2.4e-40  Score=309.00  Aligned_cols=241  Identities=24%  Similarity=0.379  Sum_probs=187.3

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCC-----CcEEEEEEeecCcc--ccHHHHHHHHHHhcCC-CCCcceeeEEEEcCCEE
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNT-----KELVAMKYIERGHK--IDANVAREIINHKQLR-HPNIIRFKEVVLTPTHL   73 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~vaiK~~~~~~~--~~~~~~~ei~~l~~l~-h~niv~~~~~~~~~~~~   73 (344)
                      ++|++.+.||+|+||.||+|.+...     +..||+|++.....  ....+.+|+.+++++. ||||+++++++.....+
T Consensus        37 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~~  116 (400)
T cd05105          37 DGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGPI  116 (400)
T ss_pred             cceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCce
Confidence            4788999999999999999987533     34699999875432  2356889999999996 99999999999999999


Q ss_pred             EEEEecCCCCChHHHHHhCC------------------------------------------------------------
Q 019195           74 AIVMEYAAGGELFERICNAG------------------------------------------------------------   93 (344)
Q Consensus        74 ~lv~e~~~~g~L~~~i~~~~------------------------------------------------------------   93 (344)
                      |+|||||++|+|.+++.+..                                                            
T Consensus       117 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  196 (400)
T cd05105         117 YIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIKE  196 (400)
T ss_pred             EEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhhh
Confidence            99999999999999886421                                                            


Q ss_pred             ------------------------------------CCCHHHHHHHHHHHH-------HCCeeecCCCCCCeEecCCCCC
Q 019195           94 ------------------------------------RFSEDEARYFFQQLI-------SGQICHRDLKLENTLLDGSPAP  130 (344)
Q Consensus        94 ------------------------------------~~~~~~~~~~~~ql~-------~~~iiH~Dikp~NIl~~~~~~~  130 (344)
                                                          .+++.++..++.|++       +.+|+||||||+|||++.+.. 
T Consensus       197 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill~~~~~-  275 (400)
T cd05105         197 ASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQGKI-  275 (400)
T ss_pred             hhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEEeCCCE-
Confidence                                                245555556655554       459999999999999987654 


Q ss_pred             CEEEeecCCCcccCCCC---CCCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHH
Q 019195          131 RLKICDFGYSKSSLLHS---RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTI  206 (344)
Q Consensus       131 ~vkL~DFg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~  206 (344)
                       +||+|||+++......   ......+++.|+|||.+.+..+. .++|||||||++|+|++ |..||........+... 
T Consensus       276 -~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~~~-  352 (400)
T cd05105         276 -VKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYT-TLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNK-  352 (400)
T ss_pred             -EEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCC-chhhHHHHHHHHHHHHHCCCCCCcccchhHHHHHH-
Confidence             9999999987543222   12334577889999999877664 55999999999999997 99999765432222222 


Q ss_pred             HHHhhccccCCCCCCCCHhHHHHHHHhcccCCCCCCChHHHhc
Q 019195          207 SRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKS  249 (344)
Q Consensus       207 ~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~ell~  249 (344)
                         .......+....++..+.+++.+||+.+|.+|||+.++.+
T Consensus       353 ---~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  392 (400)
T cd05105         353 ---IKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSD  392 (400)
T ss_pred             ---HhcCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHH
Confidence               2222333444567899999999999999999999998865

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=2.6e-40  Score=297.29  Aligned_cols=248  Identities=27%  Similarity=0.491  Sum_probs=198.2

Q ss_pred             eeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCc-cccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEEecCCCC
Q 019195            5 ELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH-KIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYAAGG   83 (344)
Q Consensus         5 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g   83 (344)
                      ....+||+|+||.||++.+..++..||+|++.... .....+.+|+.+++.++|+||+++++.+...+..+++|||++++
T Consensus        23 ~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~  102 (292)
T cd06657          23 DNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGG  102 (292)
T ss_pred             hhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCC
Confidence            34567999999999999999999999999886433 23356888999999999999999999999999999999999999


Q ss_pred             ChHHHHHhCCCCCHHHHHHHHHHHHH-------CCeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCC-CCCCCccC
Q 019195           84 ELFERICNAGRFSEDEARYFFQQLIS-------GQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS-RPKSTVGT  155 (344)
Q Consensus        84 ~L~~~i~~~~~~~~~~~~~~~~ql~~-------~~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~-~~~~~~gt  155 (344)
                      +|.+++. .+.+++..++.++.|++.       .|++||||+|+||+++.++.  ++|+|||++....... ......|+
T Consensus       103 ~L~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~  179 (292)
T cd06657         103 ALTDIVT-HTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGR--VKLSDFGFCAQVSKEVPRRKSLVGT  179 (292)
T ss_pred             cHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCC--EEEcccccceecccccccccccccC
Confidence            9998774 456788887777766654       49999999999999987654  9999999886543322 22345689


Q ss_pred             CcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCHhHHHHHHHhcc
Q 019195          156 PAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFV  235 (344)
Q Consensus       156 ~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~  235 (344)
                      +.|+|||.+.+..+ +.++|+||+|+++|+|++|..||.......... .+...  ....++....+++.+.+++.+||+
T Consensus       180 ~~y~~pE~~~~~~~-~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~-~~~~~--~~~~~~~~~~~~~~l~~li~~~l~  255 (292)
T cd06657         180 PYWMAPELISRLPY-GPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMK-MIRDN--LPPKLKNLHKVSPSLKGFLDRLLV  255 (292)
T ss_pred             ccccCHHHhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH-HHHhh--CCcccCCcccCCHHHHHHHHHHHh
Confidence            99999999876665 456999999999999999999998754432222 12111  112222334578999999999999


Q ss_pred             cCCCCCCChHHHhcCcccccCCCh
Q 019195          236 ANPSRRITIKEIKSHPWFLKNLPR  259 (344)
Q Consensus       236 ~dp~~R~s~~ell~hp~~~~~~~~  259 (344)
                      .+|.+||++.+++.||||.+..++
T Consensus       256 ~~P~~R~~~~~ll~~~~~~~~~~~  279 (292)
T cd06657         256 RDPAQRATAAELLKHPFLAKAGPP  279 (292)
T ss_pred             CCcccCcCHHHHhcChHHhccCCC
Confidence            999999999999999999877653

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-42  Score=301.40  Aligned_cols=250  Identities=29%  Similarity=0.456  Sum_probs=204.5

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcCCC--C----CcceeeEEEEcCCEEEE
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRH--P----NIIRFKEVVLTPTHLAI   75 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~l~~l~h--~----niv~~~~~~~~~~~~~l   75 (344)
                      +||+++..+|+|.||.|..+.+..++..||+|+++.-.+..+..+-|+++|.++.+  |    -+|++.++|...++.|+
T Consensus        89 ~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghiCi  168 (415)
T KOG0671|consen   89 NRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHICI  168 (415)
T ss_pred             cceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCceEE
Confidence            68999999999999999999999999999999998877777788899999999942  2    48888899999999999


Q ss_pred             EEecCCCCChHHHHHhCC--CCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCC------------------
Q 019195           76 VMEYAAGGELFERICNAG--RFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSP------------------  128 (344)
Q Consensus        76 v~e~~~~g~L~~~i~~~~--~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~------------------  128 (344)
                      |+|.+ |-|+++++.+++  +++..+++.+.+||+.+       +++|-||||+|||+-++.                  
T Consensus       169 vfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~~~~~r~~k  247 (415)
T KOG0671|consen  169 VFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKKVCFIRPLK  247 (415)
T ss_pred             EEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCccceeccCC
Confidence            99998 789999998754  68999999999998876       999999999999982111                  


Q ss_pred             CCCEEEeecCCCcccCCCCCCCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHH
Q 019195          129 APRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISR  208 (344)
Q Consensus       129 ~~~vkL~DFg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~  208 (344)
                      ...|+|+|||.|+...  ......+.|..|+|||++.+-+++.+ +||||+||||+||.+|...|...++.+.+ ..+.+
T Consensus       248 s~~I~vIDFGsAtf~~--e~hs~iVsTRHYRAPEViLgLGwS~p-CDvWSiGCIL~ElytG~~LFqtHen~EHL-aMMer  323 (415)
T KOG0671|consen  248 STAIKVIDFGSATFDH--EHHSTIVSTRHYRAPEVILGLGWSQP-CDVWSIGCILVELYTGETLFQTHENLEHL-AMMER  323 (415)
T ss_pred             CcceEEEecCCcceec--cCcceeeeccccCCchheeccCcCCc-cCceeeeeEEEEeeccceecccCCcHHHH-HHHHH
Confidence            2348999999987543  33367789999999999999999877 99999999999999999999998876644 33333


Q ss_pred             Hhhc------------------cccCCC---------------CC--------CCCHhHHHHHHHhcccCCCCCCChHHH
Q 019195          209 IMAV------------------QYKIPD---------------YV--------HISQDCRNLLSRIFVANPSRRITIKEI  247 (344)
Q Consensus       209 ~~~~------------------~~~~~~---------------~~--------~~s~~~~~li~~~L~~dp~~R~s~~el  247 (344)
                      +..+                  ....|.               +.        .-..++.+||++||..||.+|+|+.|+
T Consensus       324 IlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~RiTl~EA  403 (415)
T KOG0671|consen  324 ILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARRITLREA  403 (415)
T ss_pred             hhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccccccHHHH
Confidence            2211                  001110               00        011357899999999999999999999


Q ss_pred             hcCcccccC
Q 019195          248 KSHPWFLKN  256 (344)
Q Consensus       248 l~hp~~~~~  256 (344)
                      |.||||...
T Consensus       404 L~HpFF~~~  412 (415)
T KOG0671|consen  404 LSHPFFARL  412 (415)
T ss_pred             hcCHHhhcC
Confidence            999999754

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=5.1e-40  Score=290.37  Aligned_cols=239  Identities=22%  Similarity=0.329  Sum_probs=192.0

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEEecCC
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYAA   81 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~   81 (344)
                      ++|++.+.||+|++|.||++.+.. ++.||+|.+.........+.+|+.++++++||||+++++++...+.++++|||++
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~~-~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   84 (261)
T cd05068           6 TSIQLLRKLGAGQFGEVWEGLWNN-TTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELMK   84 (261)
T ss_pred             hheeeEEEecccCCccEEEEEecC-CeEEEEEeeCCCcccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeeccc
Confidence            579999999999999999998754 5679999987765555678899999999999999999999999999999999999


Q ss_pred             CCChHHHHHhCC--CCCHHHHHHHHHHHHH-------CCeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCCCC--C
Q 019195           82 GGELFERICNAG--RFSEDEARYFFQQLIS-------GQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP--K  150 (344)
Q Consensus        82 ~g~L~~~i~~~~--~~~~~~~~~~~~ql~~-------~~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~~~--~  150 (344)
                      +++|.+++....  .++...+..++.|++.       .||+||||||+||+++.++.  +||+|||++.........  .
T Consensus        85 ~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~--~~l~dfg~~~~~~~~~~~~~~  162 (261)
T cd05068          85 YGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNI--CKVADFGLARVIKEDIYEARE  162 (261)
T ss_pred             CCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCC--EEECCcceEEEccCCcccccC
Confidence            999999997654  6888888877766654       49999999999999987664  999999998754422111  1


Q ss_pred             CCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCHhHHHH
Q 019195          151 STVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL  229 (344)
Q Consensus       151 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  229 (344)
                      ....+..|+|||.+.+..++ .++||||||+++|+|++ |+.||.+.........    +. .....+....++..+.++
T Consensus       163 ~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~----~~-~~~~~~~~~~~~~~~~~l  236 (261)
T cd05068         163 GAKFPIKWTAPEAALYNRFS-IKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQ----VD-QGYRMPCPPGCPKELYDI  236 (261)
T ss_pred             CCcCceeccCccccccCCCC-chhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH----HH-cCCCCCCCCcCCHHHHHH
Confidence            11234579999998776654 45999999999999999 9999977654332222    21 222334444678999999


Q ss_pred             HHHhcccCCCCCCChHHHhc
Q 019195          230 LSRIFVANPSRRITIKEIKS  249 (344)
Q Consensus       230 i~~~L~~dp~~R~s~~ell~  249 (344)
                      +.+||+.+|.+||++.+++.
T Consensus       237 i~~~l~~~P~~Rp~~~~l~~  256 (261)
T cd05068         237 MLDCWKEDPDDRPTFETLQW  256 (261)
T ss_pred             HHHHhhcCcccCCCHHHHHH
Confidence            99999999999999999865

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.6e-40  Score=291.53  Aligned_cols=240  Identities=24%  Similarity=0.413  Sum_probs=192.4

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEEecCC
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYAA   81 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~   81 (344)
                      .+|++.+.||+|+||.||++.+. ++..+|+|++.........+.+|+.+++.++||||+++++++...+..|+||||++
T Consensus         4 ~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~   82 (256)
T cd05059           4 SELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMA   82 (256)
T ss_pred             HHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCC
Confidence            47899999999999999999886 46689999987665556678899999999999999999999999999999999999


Q ss_pred             CCChHHHHHhC-CCCCHHHHHHHHHHHH-------HCCeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCCCC--CC
Q 019195           82 GGELFERICNA-GRFSEDEARYFFQQLI-------SGQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP--KS  151 (344)
Q Consensus        82 ~g~L~~~i~~~-~~~~~~~~~~~~~ql~-------~~~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~~~--~~  151 (344)
                      +++|.+++... ..+++..++.++.|++       +.|++||||||+||+++.++.  +||+|||+++........  ..
T Consensus        83 ~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~--~kl~dfg~~~~~~~~~~~~~~~  160 (256)
T cd05059          83 NGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNV--VKVSDFGLARYVLDDQYTSSQG  160 (256)
T ss_pred             CCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCc--EEECCcccceecccccccccCC
Confidence            99999998763 4678888777776665       449999999999999987664  999999998754322111  11


Q ss_pred             CccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCHhHHHHH
Q 019195          152 TVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLL  230 (344)
Q Consensus       152 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li  230 (344)
                      ..++..|+|||.+.+..+. .++||||||+++|+|++ |.+||...........    +. .....+.....++.+.+++
T Consensus       161 ~~~~~~y~~Pe~~~~~~~~-~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~----~~-~~~~~~~~~~~~~~~~~li  234 (256)
T cd05059         161 TKFPVKWAPPEVFDYSRFS-SKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVES----VS-AGYRLYRPKLAPTEVYTIM  234 (256)
T ss_pred             CCCCccccCHHHhccCCCC-chhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHH----HH-cCCcCCCCCCCCHHHHHHH
Confidence            2244579999999877765 45999999999999998 8999977654333222    21 1222333345789999999


Q ss_pred             HHhcccCCCCCCChHHHhcC
Q 019195          231 SRIFVANPSRRITIKEIKSH  250 (344)
Q Consensus       231 ~~~L~~dp~~R~s~~ell~h  250 (344)
                      .+||+.+|.+|||+.++++.
T Consensus       235 ~~cl~~~p~~Rpt~~~~l~~  254 (256)
T cd05059         235 YSCWHEKPEDRPAFKKLLSQ  254 (256)
T ss_pred             HHHhcCChhhCcCHHHHHHH
Confidence            99999999999999999864

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=3.5e-40  Score=290.64  Aligned_cols=235  Identities=26%  Similarity=0.424  Sum_probs=194.8

Q ss_pred             eeeeecCceEEEEEEEcCC---CcEEEEEEeecCccc--cHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEEecCCC
Q 019195            8 KDIGSGNFGVARLMRNKNT---KELVAMKYIERGHKI--DANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYAAG   82 (344)
Q Consensus         8 ~~lg~G~~g~V~~~~~~~~---~~~vaiK~~~~~~~~--~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~   82 (344)
                      +.||+|+||.||+|.+...   +..||+|.+......  ...+.+|+..++.++|+||+++++++.....++++|||+++
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG   80 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence            4799999999999999866   889999999765443  46788999999999999999999999999999999999999


Q ss_pred             CChHHHHHhC---------CCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCC
Q 019195           83 GELFERICNA---------GRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH  146 (344)
Q Consensus        83 g~L~~~i~~~---------~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~  146 (344)
                      ++|.+++...         ..+++.+++.++.|++.+       |++||||||+||+++.++.  +||+|||.+......
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~--~~l~dfg~~~~~~~~  158 (262)
T cd00192          81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLV--VKISDFGLSRDVYDD  158 (262)
T ss_pred             CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCc--EEEcccccccccccc
Confidence            9999999875         778999999888887655       9999999999999987654  999999998765443


Q ss_pred             C---CCCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhhccccCCCCCCC
Q 019195          147 S---RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHI  222 (344)
Q Consensus       147 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  222 (344)
                      .   ......+++.|+|||.+....+ +.++|||||||++|+|++ |..||.............    . ....+....+
T Consensus       159 ~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~----~-~~~~~~~~~~  232 (262)
T cd00192         159 DYYRKKTGGKLPIRWMAPESLKDGIF-TSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLR----K-GYRLPKPEYC  232 (262)
T ss_pred             cccccccCCCcCccccCHHHhccCCc-chhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH----c-CCCCCCCccC
Confidence            2   2334568899999999877655 455999999999999999 699998875433322222    1 2233344467


Q ss_pred             CHhHHHHHHHhcccCCCCCCChHHHhcC
Q 019195          223 SQDCRNLLSRIFVANPSRRITIKEIKSH  250 (344)
Q Consensus       223 s~~~~~li~~~L~~dp~~R~s~~ell~h  250 (344)
                      ++++.+++.+||+.+|.+|||+.+++++
T Consensus       233 ~~~~~~li~~~l~~~p~~Rps~~~l~~~  260 (262)
T cd00192         233 PDELYELMLSCWQLDPEDRPTFSELVER  260 (262)
T ss_pred             ChHHHHHHHHHccCCcccCcCHHHHHHh
Confidence            8999999999999999999999999875

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=2e-40  Score=293.71  Aligned_cols=244  Identities=27%  Similarity=0.412  Sum_probs=194.2

Q ss_pred             CCCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCc----cccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEE
Q 019195            1 MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH----KIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIV   76 (344)
Q Consensus         1 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv   76 (344)
                      +++|++.+.||+|+||.||++.+..+++.||+|.+....    .....+.+|+.+++.++||||+++++++..++..+++
T Consensus         1 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v   80 (267)
T cd08229           1 LANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV   80 (267)
T ss_pred             CchhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEE
Confidence            578999999999999999999999999999999886532    2234678899999999999999999999999999999


Q ss_pred             EecCCCCChHHHHHh----CCCCCHHHHHHHHHHHH-------HCCeeecCCCCCCeEecCCCCCCEEEeecCCCcccCC
Q 019195           77 MEYAAGGELFERICN----AGRFSEDEARYFFQQLI-------SGQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLL  145 (344)
Q Consensus        77 ~e~~~~g~L~~~i~~----~~~~~~~~~~~~~~ql~-------~~~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~  145 (344)
                      |||+++++|.+++..    ...+++..++.++.|++       +.|++|+||||+||+++.++.  ++|+|||++.....
T Consensus        81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~--~~l~dfg~~~~~~~  158 (267)
T cd08229          81 LELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGV--VKLGDLGLGRFFSS  158 (267)
T ss_pred             EEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCC--EEECcchhhhcccc
Confidence            999999999998863    34578887777766655       449999999999999976654  99999998875433


Q ss_pred             CCC-CCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCH
Q 019195          146 HSR-PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQ  224 (344)
Q Consensus       146 ~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~  224 (344)
                      ... .....|+..|+|||.+.+...+ .++|+||||+++|+|++|..||......  .......+............+++
T Consensus       159 ~~~~~~~~~~~~~~~ape~~~~~~~~-~~~Dv~slG~il~~l~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~  235 (267)
T cd08229         159 KTTAAHSLVGTPYYMSPERIHENGYN-FKSDIWSLGCLLYEMAALQSPFYGDKMN--LYSLCKKIEQCDYPPLPSDHYSE  235 (267)
T ss_pred             CCcccccccCCcCccCHHHhcCCCcc-chhhHHHHHHHHHHHHhCCCCcccccch--HHHHhhhhhcCCCCCCCcccccH
Confidence            222 2345689999999999777654 4599999999999999999999764332  12222333222222112235788


Q ss_pred             hHHHHHHHhcccCCCCCCChHHHhc
Q 019195          225 DCRNLLSRIFVANPSRRITIKEIKS  249 (344)
Q Consensus       225 ~~~~li~~~L~~dp~~R~s~~ell~  249 (344)
                      .+.++|.+||+.+|.+|||+.++++
T Consensus       236 ~~~~li~~~l~~~p~~Rpt~~~i~~  260 (267)
T cd08229         236 ELRQLVNMCINPDPEKRPDITYVYD  260 (267)
T ss_pred             HHHHHHHHhcCCCcccCCCHHHHHH
Confidence            9999999999999999999998764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=1.6e-40  Score=304.71  Aligned_cols=251  Identities=31%  Similarity=0.457  Sum_probs=194.8

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCc---cccHHHHHHHHHHhcC-CCCCcceeeEEEEcC--CEEEE
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH---KIDANVAREIINHKQL-RHPNIIRFKEVVLTP--THLAI   75 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~ei~~l~~l-~h~niv~~~~~~~~~--~~~~l   75 (344)
                      ++|++.+.||+|+||.||++.+..+++.+|+|++....   .....+.+|+.+++++ +||||+++++++...  ..+|+
T Consensus         7 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~l   86 (337)
T cd07852           7 RKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIYL   86 (337)
T ss_pred             hHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEEE
Confidence            68999999999999999999999999999999886432   2234577899999999 999999999998654  46899


Q ss_pred             EEecCCCCChHHHHHhCCCCCHHHHHHHHHHH-------HHCCeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCC-
Q 019195           76 VMEYAAGGELFERICNAGRFSEDEARYFFQQL-------ISGQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS-  147 (344)
Q Consensus        76 v~e~~~~g~L~~~i~~~~~~~~~~~~~~~~ql-------~~~~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~-  147 (344)
                      ||||++ ++|..++... .+.+...+.++.|+       |+.||+||||||+||+++.++.  +||+|||++....... 
T Consensus        87 v~e~~~-~~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~--~kl~d~g~~~~~~~~~~  162 (337)
T cd07852          87 VFEYME-TDLHAVIRAN-ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCR--VKLADFGLARSLSELEE  162 (337)
T ss_pred             Eecccc-cCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCc--EEEeeccchhccccccc
Confidence            999996 5998888765 66777666665554       4559999999999999987665  9999999987543322 


Q ss_pred             -----CCCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhh-----------
Q 019195          148 -----RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMA-----------  211 (344)
Q Consensus       148 -----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~-----------  211 (344)
                           ......||+.|+|||.+.+....+.++|||||||++|+|++|+.||..................           
T Consensus       163 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (337)
T cd07852         163 NPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIKS  242 (337)
T ss_pred             cccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHHh
Confidence                 1223468999999999876555556699999999999999999999876544433322221100           


Q ss_pred             ------------cccc--CCCCCCCCHhHHHHHHHhcccCCCCCCChHHHhcCcccccC
Q 019195          212 ------------VQYK--IPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKN  256 (344)
Q Consensus       212 ------------~~~~--~~~~~~~s~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~~  256 (344)
                                  ....  ......++.++.+||.+||+.+|.+|||+.++++||||.+.
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~  301 (337)
T cd07852         243 PFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQF  301 (337)
T ss_pred             hhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhh
Confidence                        0000  00112368899999999999999999999999999999664

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=1e-39  Score=289.04  Aligned_cols=244  Identities=29%  Similarity=0.436  Sum_probs=194.2

Q ss_pred             CCCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCc----cccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEE
Q 019195            1 MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH----KIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIV   76 (344)
Q Consensus         1 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv   76 (344)
                      .++|++.+.||+|+||.||+|.+..+++.||+|.+....    .....+.+|+.++++++|+||+++++++...+..+++
T Consensus         1 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv   80 (267)
T cd08224           1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIV   80 (267)
T ss_pred             CCceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence            478999999999999999999999999999999886422    2245788999999999999999999999999999999


Q ss_pred             EecCCCCChHHHHHh----CCCCCHHHHHHHHHHHHH-------CCeeecCCCCCCeEecCCCCCCEEEeecCCCcccCC
Q 019195           77 MEYAAGGELFERICN----AGRFSEDEARYFFQQLIS-------GQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLL  145 (344)
Q Consensus        77 ~e~~~~g~L~~~i~~----~~~~~~~~~~~~~~ql~~-------~~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~  145 (344)
                      |||+++++|..++..    ...+++.+++.++.|++.       .||+||||||+||+++.++.  ++|+|||++.....
T Consensus        81 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~--~~l~d~~~~~~~~~  158 (267)
T cd08224          81 LELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGV--VKLGDLGLGRFFSS  158 (267)
T ss_pred             EecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCc--EEEeccceeeeccC
Confidence            999999999998864    345788888777666654       49999999999999976654  99999999875433


Q ss_pred             CC-CCCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCH
Q 019195          146 HS-RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQ  224 (344)
Q Consensus       146 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~  224 (344)
                      .. ......|++.|+|||.+.+..++ .++|+|||||++|+|++|+.||.....  ........+............++.
T Consensus       159 ~~~~~~~~~~~~~y~apE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~  235 (267)
T cd08224         159 KTTAAHSLVGTPYYMSPERIHENGYN-FKSDIWSLGCLLYEMAALQSPFYGDKM--NLYSLCKKIEKCDYPPLPADHYSE  235 (267)
T ss_pred             CCcccceecCCccccCHHHhccCCCC-chhcHHHHHHHHHHHHHCCCCcccCCc--cHHHHHhhhhcCCCCCCChhhcCH
Confidence            22 22345689999999999877765 459999999999999999999965442  122222222222221111125678


Q ss_pred             hHHHHHHHhcccCCCCCCChHHHhc
Q 019195          225 DCRNLLSRIFVANPSRRITIKEIKS  249 (344)
Q Consensus       225 ~~~~li~~~L~~dp~~R~s~~ell~  249 (344)
                      .+.++|.+||..+|.+|||+.++++
T Consensus       236 ~~~~~i~~cl~~~p~~Rp~~~~il~  260 (267)
T cd08224         236 ELRDLVSRCINPDPEKRPDISYVLQ  260 (267)
T ss_pred             HHHHHHHHHcCCCcccCCCHHHHHH
Confidence            9999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=8e-40  Score=294.61  Aligned_cols=252  Identities=24%  Similarity=0.387  Sum_probs=194.7

Q ss_pred             CCCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCcc--ccHHHHHHHHHHhcC-CCCCcceeeEEEEcCCEEEEEE
Q 019195            1 MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK--IDANVAREIINHKQL-RHPNIIRFKEVVLTPTHLAIVM   77 (344)
Q Consensus         1 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~ei~~l~~l-~h~niv~~~~~~~~~~~~~lv~   77 (344)
                      +++|++.+.||+|+||.||++.+..+++.||+|.+.....  ....+.+|+.++..+ .||||+++++++..+..+|++|
T Consensus        14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~   93 (296)
T cd06618          14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICM   93 (296)
T ss_pred             cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEe
Confidence            4689999999999999999999999999999999976432  224566777766666 5999999999999999999999


Q ss_pred             ecCCCCChHHHHHh-CCCCCHHHHHHHHHHHHH--------CCeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCCC
Q 019195           78 EYAAGGELFERICN-AGRFSEDEARYFFQQLIS--------GQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR  148 (344)
Q Consensus        78 e~~~~g~L~~~i~~-~~~~~~~~~~~~~~ql~~--------~~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~~  148 (344)
                      ||+. ++|..++.. ...+++..+..++.|++.        .||+||||+|+||+++.++  .+||+|||++........
T Consensus        94 e~~~-~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~--~~kL~dfg~~~~~~~~~~  170 (296)
T cd06618          94 ELMS-TCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASG--NVKLCDFGISGRLVDSKA  170 (296)
T ss_pred             eccC-cCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCC--CEEECccccchhccCCCc
Confidence            9984 577776654 456788877777666553        3899999999999998665  499999999875443333


Q ss_pred             CCCCccCCcccCCccccCCC---CCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhc-cccCCCCCCCCH
Q 019195          149 PKSTVGTPAYIAPEVLSRRE---YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAV-QYKIPDYVHISQ  224 (344)
Q Consensus       149 ~~~~~gt~~y~aPE~~~~~~---~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~s~  224 (344)
                      .....+++.|+|||.+.+..   ..+.++||||||+++|+|++|+.||.......   ..+..+... ....+....++.
T Consensus       171 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~  247 (296)
T cd06618         171 KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEF---EVLTKILQEEPPSLPPNEGFSP  247 (296)
T ss_pred             ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHH---HHHHHHhcCCCCCCCCCCCCCH
Confidence            34446888999999986553   23455999999999999999999997643221   112222221 222333335788


Q ss_pred             hHHHHHHHhcccCCCCCCChHHHhcCcccccCCC
Q 019195          225 DCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLP  258 (344)
Q Consensus       225 ~~~~li~~~L~~dp~~R~s~~ell~hp~~~~~~~  258 (344)
                      ++.+||.+||+.||.+||++.+++.||||.....
T Consensus       248 ~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~  281 (296)
T cd06618         248 DFCSFVDLCLTKDHRKRPKYRELLQHPFIRRYET  281 (296)
T ss_pred             HHHHHHHHHccCChhhCCCHHHHhcChhhhccch
Confidence            9999999999999999999999999999976543

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=2.9e-40  Score=300.21  Aligned_cols=240  Identities=20%  Similarity=0.346  Sum_probs=189.6

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcE----EEEEEeecCc--cccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEE
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKEL----VAMKYIERGH--KIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAI   75 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~----vaiK~~~~~~--~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~l   75 (344)
                      .+|++.+.||+|+||.||++.+..++..    ||+|++....  .....+.+|+.+++.++||||+++++++... ..++
T Consensus         7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~   85 (316)
T cd05108           7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL   85 (316)
T ss_pred             hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence            5799999999999999999998666554    8999986532  2335688899999999999999999998764 5779


Q ss_pred             EEecCCCCChHHHHHhC-CCCCHHHHHHHHHHHH-------HCCeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCC
Q 019195           76 VMEYAAGGELFERICNA-GRFSEDEARYFFQQLI-------SGQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS  147 (344)
Q Consensus        76 v~e~~~~g~L~~~i~~~-~~~~~~~~~~~~~ql~-------~~~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~  147 (344)
                      +++|+++|+|.+++.+. ..++...+..++.|++       +.||+||||||+|||++.+..  +||+|||+++......
T Consensus        86 v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~--~kl~DfG~a~~~~~~~  163 (316)
T cd05108          86 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQH--VKITDFGLAKLLGADE  163 (316)
T ss_pred             eeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCc--EEEccccccccccCCC
Confidence            99999999999999764 3577777666665555       459999999999999977664  9999999998654332


Q ss_pred             CC---CCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCC
Q 019195          148 RP---KSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHIS  223 (344)
Q Consensus       148 ~~---~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s  223 (344)
                      ..   ....++..|+|||.+.+..++ .++|||||||++|+|++ |..||.+..... +..    +.......+.....+
T Consensus       164 ~~~~~~~~~~~~~y~apE~~~~~~~~-~~~Di~slGv~l~el~t~g~~p~~~~~~~~-~~~----~~~~~~~~~~~~~~~  237 (316)
T cd05108         164 KEYHAEGGKVPIKWMALESILHRIYT-HQSDVWSYGVTVWELMTFGSKPYDGIPASE-ISS----ILEKGERLPQPPICT  237 (316)
T ss_pred             cceeccCCccceeecChHHhccCCCC-chhhhHHHHHHHHHHHcCCCCCCCCCCHHH-HHH----HHhCCCCCCCCCCCC
Confidence            22   122346789999999877765 45999999999999997 999997654322 222    222333444445678


Q ss_pred             HhHHHHHHHhcccCCCCCCChHHHhcC
Q 019195          224 QDCRNLLSRIFVANPSRRITIKEIKSH  250 (344)
Q Consensus       224 ~~~~~li~~~L~~dp~~R~s~~ell~h  250 (344)
                      .++.+++.+||..+|.+||++.+++.+
T Consensus       238 ~~~~~li~~cl~~~p~~Rps~~~l~~~  264 (316)
T cd05108         238 IDVYMIMVKCWMIDADSRPKFRELIIE  264 (316)
T ss_pred             HHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            899999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=5.6e-40  Score=294.48  Aligned_cols=246  Identities=22%  Similarity=0.331  Sum_probs=189.1

Q ss_pred             CCceeeeeeeecCceEEEEEEEc-----CCCcEEEEEEeecCccc--cHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEE
Q 019195            2 EKYELMKDIGSGNFGVARLMRNK-----NTKELVAMKYIERGHKI--DANVAREIINHKQLRHPNIIRFKEVVLTPTHLA   74 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~~--~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~   74 (344)
                      ++|++.+.||+|+||.||++.+.     ..+..||+|.+......  ...+.+|+.+++.++||||+++++++......+
T Consensus         6 ~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   85 (288)
T cd05061           6 EKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTL   85 (288)
T ss_pred             HHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcE
Confidence            58999999999999999998764     23568999988654322  235778999999999999999999999999999


Q ss_pred             EEEecCCCCChHHHHHhCC----------CCCHHHHHHHHHH-------HHHCCeeecCCCCCCeEecCCCCCCEEEeec
Q 019195           75 IVMEYAAGGELFERICNAG----------RFSEDEARYFFQQ-------LISGQICHRDLKLENTLLDGSPAPRLKICDF  137 (344)
Q Consensus        75 lv~e~~~~g~L~~~i~~~~----------~~~~~~~~~~~~q-------l~~~~iiH~Dikp~NIl~~~~~~~~vkL~DF  137 (344)
                      +||||+++|+|.+++.+.+          .+....++.++.|       +|+.+|+||||||+||+++.++.  ++|+||
T Consensus        86 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~--~~L~Df  163 (288)
T cd05061          86 VVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFT--VKIGDF  163 (288)
T ss_pred             EEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCc--EEECcC
Confidence            9999999999999997532          2344555555555       45569999999999999987654  999999


Q ss_pred             CCCcccCCCCC---CCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhhcc
Q 019195          138 GYSKSSLLHSR---PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQ  213 (344)
Q Consensus       138 g~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~  213 (344)
                      |+++.......   .....++..|+|||.+.+..++ .++|+|||||++|+|++ |..||.........    ..+....
T Consensus       164 g~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~-~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~----~~~~~~~  238 (288)
T cd05061         164 GMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFT-TSSDMWSFGVVLWEITSLAEQPYQGLSNEQVL----KFVMDGG  238 (288)
T ss_pred             CccccccccccccccCCCcccccccCHHHhccCCCC-hHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHH----HHHHcCC
Confidence            99875332211   1223457789999999877664 45999999999999998 78999775543322    2222111


Q ss_pred             ccCCCCCCCCHhHHHHHHHhcccCCCCCCChHHHhc------Cccccc
Q 019195          214 YKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKS------HPWFLK  255 (344)
Q Consensus       214 ~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~ell~------hp~~~~  255 (344)
                       ..+.....++.+.+++.+||+.+|.+|||+.++++      ||||..
T Consensus       239 -~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~  285 (288)
T cd05061         239 -YLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPE  285 (288)
T ss_pred             -CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCC
Confidence             11222356789999999999999999999999987      888864

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=7.2e-40  Score=293.05  Aligned_cols=246  Identities=30%  Similarity=0.464  Sum_probs=195.3

Q ss_pred             ceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCccc---cHHHHHHHHHHhcC---CCCCcceeeEEEEcCCE-----
Q 019195            4 YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKI---DANVAREIINHKQL---RHPNIIRFKEVVLTPTH-----   72 (344)
Q Consensus         4 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~ei~~l~~l---~h~niv~~~~~~~~~~~-----   72 (344)
                      |++.+.||+|+||.||++.+..++..||+|.+......   ...+.+|+.+++++   +||||+++++++.....     
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~   80 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK   80 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence            78999999999999999999989999999999753322   23466787777666   69999999999988776     


Q ss_pred             EEEEEecCCCCChHHHHHhCC--CCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCccc
Q 019195           73 LAIVMEYAAGGELFERICNAG--RFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSS  143 (344)
Q Consensus        73 ~~lv~e~~~~g~L~~~i~~~~--~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~  143 (344)
                      ++++|||+. ++|.+++....  .+++..++.++.|++.+       +++|+||+|+||+++.++  ++||+|||++...
T Consensus        81 ~~l~~e~~~-~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~--~~~l~dfg~~~~~  157 (287)
T cd07838          81 LTLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDG--QVKIADFGLARIY  157 (287)
T ss_pred             eEEEehhcc-cCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCC--CEEEeccCcceec
Confidence            999999996 58988887643  58888888887776654       999999999999998775  5999999998765


Q ss_pred             CCCCCCCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhc-cccCC-----
Q 019195          144 LLHSRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAV-QYKIP-----  217 (344)
Q Consensus       144 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~-~~~~~-----  217 (344)
                      ..........++..|+|||.+.+..+. .++|+|||||++|+|++|.+||......+...++....... ....+     
T Consensus       158 ~~~~~~~~~~~~~~~~~PE~~~~~~~~-~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (287)
T cd07838         158 SFEMALTSVVVTLWYRAPEVLLQSSYA-TPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSL  236 (287)
T ss_pred             cCCcccccccccccccChHHhccCCCC-CcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCccc
Confidence            444444455689999999999877765 45999999999999999999998877655555544422110 00000     


Q ss_pred             ---------------CCCCCCHhHHHHHHHhcccCCCCCCChHHHhcCccc
Q 019195          218 ---------------DYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF  253 (344)
Q Consensus       218 ---------------~~~~~s~~~~~li~~~L~~dp~~R~s~~ell~hp~~  253 (344)
                                     ....+++.+.++|.+||+.||.+||++.+++.||||
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~  287 (287)
T cd07838         237 PRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF  287 (287)
T ss_pred             chhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence                           011356788999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=3.6e-40  Score=294.02  Aligned_cols=243  Identities=19%  Similarity=0.306  Sum_probs=191.5

Q ss_pred             CCceeeeeeeecCceEEEEEEEcC-----CCcEEEEEEeecCcc--ccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEE
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKN-----TKELVAMKYIERGHK--IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLA   74 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~--~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~   74 (344)
                      ++|++.+.||+|+||.||+|.+..     ++..||+|.+.....  ....+.+|+.+++.++|+||+++++++......+
T Consensus         6 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   85 (277)
T cd05036           6 DSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPRF   85 (277)
T ss_pred             HHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCcE
Confidence            478999999999999999999987     788999998864332  2346889999999999999999999999999999


Q ss_pred             EEEecCCCCChHHHHHhCC-------CCCHHHHHHHHHHHH-------HCCeeecCCCCCCeEecCCC-CCCEEEeecCC
Q 019195           75 IVMEYAAGGELFERICNAG-------RFSEDEARYFFQQLI-------SGQICHRDLKLENTLLDGSP-APRLKICDFGY  139 (344)
Q Consensus        75 lv~e~~~~g~L~~~i~~~~-------~~~~~~~~~~~~ql~-------~~~iiH~Dikp~NIl~~~~~-~~~vkL~DFg~  139 (344)
                      ++|||+++++|.+++...+       .+++..+..++.|++       +.+++||||||+||+++.++ ...+||+|||+
T Consensus        86 lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~dfg~  165 (277)
T cd05036          86 ILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGM  165 (277)
T ss_pred             EEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEeccCcc
Confidence            9999999999999987643       477777777766655       45999999999999997644 23589999999


Q ss_pred             CcccCCCCC---CCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhhcccc
Q 019195          140 SKSSLLHSR---PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYK  215 (344)
Q Consensus       140 a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~  215 (344)
                      ++.......   .....++..|+|||++.+..++ .++|||||||++|+|++ |..||......... ..+   . ....
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DiwslG~il~el~~~g~~pf~~~~~~~~~-~~~---~-~~~~  239 (277)
T cd05036         166 ARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFT-SKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVM-EFV---T-GGGR  239 (277)
T ss_pred             ccccCCccceecCCCCCccHhhCCHHHHhcCCcC-chhHHHHHHHHHHHHHcCCCCCCCCCCHHHHH-HHH---H-cCCc
Confidence            875422111   1122345689999999777764 55999999999999996 99999875543322 211   1 1112


Q ss_pred             CCCCCCCCHhHHHHHHHhcccCCCCCCChHHHhcC
Q 019195          216 IPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSH  250 (344)
Q Consensus       216 ~~~~~~~s~~~~~li~~~L~~dp~~R~s~~ell~h  250 (344)
                      .+....++..+.+++.+||+.+|.+|||+.++++|
T Consensus       240 ~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~  274 (277)
T cd05036         240 LDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILER  274 (277)
T ss_pred             CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            22334678999999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=5.6e-40  Score=290.46  Aligned_cols=238  Identities=22%  Similarity=0.329  Sum_probs=188.6

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEEecCC
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYAA   81 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~   81 (344)
                      ++|++.++||+|+||.||+|.+..++ .||+|++.........+.+|+.+++.++||||+++++.+. ....++||||++
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~~~~-~valK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~   83 (262)
T cd05071           6 ESLRLEVKLGQGCFGEVWMGTWNGTT-RVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMS   83 (262)
T ss_pred             HHeeEeeecCCCCCCcEEEEEecCCc-eEEEEecccCccCHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcCC
Confidence            57999999999999999999887654 5999999875555567899999999999999999999874 456899999999


Q ss_pred             CCChHHHHHhC--CCCCHHHHHHHHHHHH-------HCCeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCCCC--C
Q 019195           82 GGELFERICNA--GRFSEDEARYFFQQLI-------SGQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP--K  150 (344)
Q Consensus        82 ~g~L~~~i~~~--~~~~~~~~~~~~~ql~-------~~~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~~~--~  150 (344)
                      +|+|.+++.+.  ..++...++.++.|++       +.+++||||||+||+++.++.  +||+|||++.........  .
T Consensus        84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~--~~L~dfg~~~~~~~~~~~~~~  161 (262)
T cd05071          84 KGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLV--CKVADFGLARLIEDNEYTARQ  161 (262)
T ss_pred             CCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCc--EEeccCCceeecccccccccc
Confidence            99999999753  3467777777766655       459999999999999987654  999999998754322211  2


Q ss_pred             CCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCHhHHHH
Q 019195          151 STVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL  229 (344)
Q Consensus       151 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  229 (344)
                      ...++..|+|||.+.+..++ .++|||||||++|+|++ |..||...........    +. .....+....++..+.++
T Consensus       162 ~~~~~~~y~~PE~~~~~~~~-~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~----~~-~~~~~~~~~~~~~~l~~l  235 (262)
T cd05071         162 GAKFPIKWTAPEAALYGRFT-IKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQ----VE-RGYRMPCPPECPESLHDL  235 (262)
T ss_pred             CCcccceecCHhHhccCCCC-chhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHH----Hh-cCCCCCCccccCHHHHHH
Confidence            23467789999998777664 45999999999999999 8889977654332222    21 122233344678999999


Q ss_pred             HHHhcccCCCCCCChHHHhc
Q 019195          230 LSRIFVANPSRRITIKEIKS  249 (344)
Q Consensus       230 i~~~L~~dp~~R~s~~ell~  249 (344)
                      +.+||+.+|.+||++.++++
T Consensus       236 i~~~l~~~p~~Rp~~~~~~~  255 (262)
T cd05071         236 MCQCWRKEPEERPTFEYLQA  255 (262)
T ss_pred             HHHHccCCcccCCCHHHHHH
Confidence            99999999999999999875

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=5.5e-40  Score=294.41  Aligned_cols=252  Identities=30%  Similarity=0.513  Sum_probs=199.0

Q ss_pred             CceeeeeeeecCceEEEEEEEc---CCCcEEEEEEeecCc-----cccHHHHHHHHHHhcC-CCCCcceeeEEEEcCCEE
Q 019195            3 KYELMKDIGSGNFGVARLMRNK---NTKELVAMKYIERGH-----KIDANVAREIINHKQL-RHPNIIRFKEVVLTPTHL   73 (344)
Q Consensus         3 ~y~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~-----~~~~~~~~ei~~l~~l-~h~niv~~~~~~~~~~~~   73 (344)
                      +|++.+.||+|++|.||++.+.   .+++.||+|.+.+..     .....+.+|+.+++++ +||||+++++++.....+
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~   80 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL   80 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence            5899999999999999999864   467899999987532     2234577899999999 599999999999999999


Q ss_pred             EEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHH-------CCeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCC
Q 019195           74 AIVMEYAAGGELFERICNAGRFSEDEARYFFQQLIS-------GQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH  146 (344)
Q Consensus        74 ~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~ql~~-------~~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~  146 (344)
                      ++||||+++++|...+.....+++..++.++.|++.       .+++||||||.||+++.++  .++|+|||++......
T Consensus        81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~--~~~l~dfg~~~~~~~~  158 (288)
T cd05583          81 HLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEG--HVVLTDFGLSKEFLAE  158 (288)
T ss_pred             EEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCC--CEEEEECccccccccc
Confidence            999999999999999988778888887777666554       4999999999999998665  4999999998754333


Q ss_pred             CC--CCCCccCCcccCCccccCCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCC
Q 019195          147 SR--PKSTVGTPAYIAPEVLSRRE-YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHIS  223 (344)
Q Consensus       147 ~~--~~~~~gt~~y~aPE~~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s  223 (344)
                      ..  .....|+..|+|||.+.+.. ..+.++|+||||+++|+|++|..||...........+...+.......  ...++
T Consensus       159 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~  236 (288)
T cd05583         159 EEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPPF--PKTMS  236 (288)
T ss_pred             cccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHccCCCC--CcccC
Confidence            22  22346899999999986654 234569999999999999999999965433222233333333333322  33578


Q ss_pred             HhHHHHHHHhcccCCCCCCC---hHHHhcCcccccCCC
Q 019195          224 QDCRNLLSRIFVANPSRRIT---IKEIKSHPWFLKNLP  258 (344)
Q Consensus       224 ~~~~~li~~~L~~dp~~R~s---~~ell~hp~~~~~~~  258 (344)
                      ..+.++|.+||+.+|.+|||   +.++|+||||+....
T Consensus       237 ~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~~~  274 (288)
T cd05583         237 AEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGIDW  274 (288)
T ss_pred             HHHHHHHHHHhcCCHhhccCcchHHHHhcCcccccCCH
Confidence            89999999999999999998   567899999976543

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-40  Score=314.15  Aligned_cols=249  Identities=27%  Similarity=0.453  Sum_probs=208.8

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcC-CCCCcceeeEEEEc-----CCEEEE
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQL-RHPNIIRFKEVVLT-----PTHLAI   75 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~l~~l-~h~niv~~~~~~~~-----~~~~~l   75 (344)
                      +.|++.+.||.|.+|.||++++..+++.+|+|++......+..+..|+++|+.+ .|||++.++++|.-     ++.+||
T Consensus        19 d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLWL   98 (953)
T KOG0587|consen   19 DIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLWL   98 (953)
T ss_pred             CccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeEEE
Confidence            468999999999999999999999999999999999888889999999999988 69999999999863     478999


Q ss_pred             EEecCCCCChHHHHHh--CCCCCHHHHHHHHHH-------HHHCCeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCC
Q 019195           76 VMEYAAGGELFERICN--AGRFSEDEARYFFQQ-------LISGQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH  146 (344)
Q Consensus        76 v~e~~~~g~L~~~i~~--~~~~~~~~~~~~~~q-------l~~~~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~  146 (344)
                      |||||.|||..+++++  ..++.+..|..+++.       ||...++|||||-.|||++.++.  |||+|||++.+....
T Consensus        99 VMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~--VKLvDFGvSaQldsT  176 (953)
T KOG0587|consen   99 VMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAE--VKLVDFGVSAQLDST  176 (953)
T ss_pred             EeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCc--EEEeeeeeeeeeecc
Confidence            9999999999999875  457888888777655       44559999999999999987765  999999998776554


Q ss_pred             C-CCCCCccCCcccCCccccC-----CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCCCCC
Q 019195          147 S-RPKSTVGTPAYIAPEVLSR-----REYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYV  220 (344)
Q Consensus       147 ~-~~~~~~gt~~y~aPE~~~~-----~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  220 (344)
                      . ...+.+|||+|||||++..     ..|+.+ +|+|||||+..||.-|.+|+.+......   .+....+++..+-.+.
T Consensus       177 ~grRnT~iGtP~WMAPEViac~e~~d~tyd~R-~D~WsLGITaIEladG~PPl~DmHPmra---LF~IpRNPPPkLkrp~  252 (953)
T KOG0587|consen  177 VGRRNTFIGTPYWMAPEVIACDESPDATYDYR-SDLWSLGITAIEMAEGAPPLCDMHPMRA---LFLIPRNPPPKLKRPK  252 (953)
T ss_pred             cccccCcCCCcccccceeeecccCCCCCcccc-cchhhccceeehhcCCCCCccCcchhhh---hccCCCCCCccccchh
Confidence            4 4456689999999999843     234444 9999999999999999999987654332   2333334444444566


Q ss_pred             CCCHhHHHHHHHhcccCCCCCCChHHHhcCcccccC
Q 019195          221 HISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKN  256 (344)
Q Consensus       221 ~~s~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~~  256 (344)
                      .++.++.+||..||.+|..+||+..++|+|||+.+.
T Consensus       253 kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~e~  288 (953)
T KOG0587|consen  253 KWSKKFNDFISTCLVKDYEQRPSTEELLKHPFITEQ  288 (953)
T ss_pred             hHHHHHHHHHHHHHhhccccCcchhhhccCCccccc
Confidence            789999999999999999999999999999999743

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=2.6e-40  Score=292.02  Aligned_cols=239  Identities=23%  Similarity=0.363  Sum_probs=194.8

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCcc-ccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEEecC
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK-IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYA   80 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~   80 (344)
                      .+|++.+.||.|+||.||+|.+.. +..+|+|.+..... ....+.+|+.+++.++||||+++++++.....++++|||+
T Consensus         6 ~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~   84 (261)
T cd05148           6 EEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELM   84 (261)
T ss_pred             HHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeec
Confidence            468999999999999999999987 88999999876544 3467889999999999999999999999999999999999


Q ss_pred             CCCChHHHHHhC--CCCCHHHHHHHHHHHHH-------CCeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCCC-CC
Q 019195           81 AGGELFERICNA--GRFSEDEARYFFQQLIS-------GQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR-PK  150 (344)
Q Consensus        81 ~~g~L~~~i~~~--~~~~~~~~~~~~~ql~~-------~~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~~-~~  150 (344)
                      ++++|.+++.+.  ..++..+++.++.|++.       .||+||||||+||+++.++.  +||+|||++........ ..
T Consensus        85 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~--~kl~d~g~~~~~~~~~~~~~  162 (261)
T cd05148          85 EKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLV--CKVADFGLARLIKEDVYLSS  162 (261)
T ss_pred             ccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCce--EEEccccchhhcCCcccccc
Confidence            999999999753  35788887777766654       49999999999999987664  99999999875432221 12


Q ss_pred             CCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCHhHHHH
Q 019195          151 STVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL  229 (344)
Q Consensus       151 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  229 (344)
                      ...++..|+|||.+.+..+. .++||||||+++|+|++ |+.||........+..+.     .....+.....++.+.++
T Consensus       163 ~~~~~~~~~~PE~~~~~~~~-~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~  236 (261)
T cd05148         163 DKKIPYKWTAPEAASHGTFS-TKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQIT-----AGYRMPCPAKCPQEIYKI  236 (261)
T ss_pred             CCCCceEecCHHHHccCCCC-chhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHH-----hCCcCCCCCCCCHHHHHH
Confidence            33467789999999776654 45999999999999998 899997765433333222     223344445788999999


Q ss_pred             HHHhcccCCCCCCChHHHhc
Q 019195          230 LSRIFVANPSRRITIKEIKS  249 (344)
Q Consensus       230 i~~~L~~dp~~R~s~~ell~  249 (344)
                      +.+||+.+|.+|||+.++++
T Consensus       237 i~~~l~~~p~~Rpt~~~l~~  256 (261)
T cd05148         237 MLECWAAEPEDRPSFKALRE  256 (261)
T ss_pred             HHHHcCCCchhCcCHHHHHH
Confidence            99999999999999999875

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=6.4e-40  Score=292.33  Aligned_cols=241  Identities=21%  Similarity=0.301  Sum_probs=185.5

Q ss_pred             CCceeeeeeeecCceEEEEEEEc-----CCCcEEEEEEeecCcc--ccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEE
Q 019195            2 EKYELMKDIGSGNFGVARLMRNK-----NTKELVAMKYIERGHK--IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLA   74 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~--~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~   74 (344)
                      ++|++.+.||+|+||+||++.+.     .++..||+|++.....  ....+.+|+.+++.++||||+++++++......+
T Consensus         6 ~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~   85 (277)
T cd05062           6 EKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTL   85 (277)
T ss_pred             HHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCeE
Confidence            57999999999999999999864     3457899998864322  2345789999999999999999999999999999


Q ss_pred             EEEecCCCCChHHHHHhCC----------CCCHHHHHHHHH-------HHHHCCeeecCCCCCCeEecCCCCCCEEEeec
Q 019195           75 IVMEYAAGGELFERICNAG----------RFSEDEARYFFQ-------QLISGQICHRDLKLENTLLDGSPAPRLKICDF  137 (344)
Q Consensus        75 lv~e~~~~g~L~~~i~~~~----------~~~~~~~~~~~~-------ql~~~~iiH~Dikp~NIl~~~~~~~~vkL~DF  137 (344)
                      +||||+++++|.+++.+..          .++...+..++.       .||+.|++||||||+||+++.++  .++|+||
T Consensus        86 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~--~~~l~df  163 (277)
T cd05062          86 VIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDF--TVKIGDF  163 (277)
T ss_pred             EEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCC--CEEECCC
Confidence            9999999999999986532          234555555544       45556999999999999998765  4999999


Q ss_pred             CCCcccCCCC---CCCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhhcc
Q 019195          138 GYSKSSLLHS---RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQ  213 (344)
Q Consensus       138 g~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~  213 (344)
                      |++.......   ......+++.|+|||.+.+..++ .++|||||||++|+|++ |..||..........    .+....
T Consensus       164 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~----~~~~~~  238 (277)
T cd05062         164 GMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFT-TYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLR----FVMEGG  238 (277)
T ss_pred             CCccccCCcceeecCCCCccCHhhcChhHhhcCCcC-chhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH----HHHcCC
Confidence            9986432221   11223567889999999876664 55999999999999998 789997765432222    222211


Q ss_pred             ccCCCCCCCCHhHHHHHHHhcccCCCCCCChHHHhcC
Q 019195          214 YKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSH  250 (344)
Q Consensus       214 ~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~ell~h  250 (344)
                      . .+.....++.+.+++.+||+.+|.+|||+.+++++
T Consensus       239 ~-~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~  274 (277)
T cd05062         239 L-LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS  274 (277)
T ss_pred             c-CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            1 12233578899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=9.1e-40  Score=298.43  Aligned_cols=251  Identities=27%  Similarity=0.460  Sum_probs=193.7

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCc---cccHHHHHHHHHHhcCCCCCcceeeEEEEc-CCEEEEEE
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH---KIDANVAREIINHKQLRHPNIIRFKEVVLT-PTHLAIVM   77 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~ei~~l~~l~h~niv~~~~~~~~-~~~~~lv~   77 (344)
                      ++|++++.||.|+||.||+|.+..+++.||+|++.+..   .....+.+|+.+++.++||||++++++|.. ...+|++|
T Consensus        10 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~lv~   89 (328)
T cd07856          10 NRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFVT   89 (328)
T ss_pred             cceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEEEe
Confidence            58999999999999999999999999999999886532   234568899999999999999999999876 56789999


Q ss_pred             ecCCCCChHHHHHhCCCCCHHHHHHHHHHHH-------HCCeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCCCCC
Q 019195           78 EYAAGGELFERICNAGRFSEDEARYFFQQLI-------SGQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPK  150 (344)
Q Consensus        78 e~~~~g~L~~~i~~~~~~~~~~~~~~~~ql~-------~~~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~~~~  150 (344)
                      ||+ +++|..++.. ..+++..+..++.|++       +.||+||||+|+||+++.++.  ++|+|||++....  ....
T Consensus        90 e~~-~~~L~~~~~~-~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~--~~l~dfg~~~~~~--~~~~  163 (328)
T cd07856          90 ELL-GTDLHRLLTS-RPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCD--LKICDFGLARIQD--PQMT  163 (328)
T ss_pred             ehh-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCC--EEeCccccccccC--CCcC
Confidence            999 6688877754 4577776666666654       459999999999999986654  9999999987432  2223


Q ss_pred             CCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHH--------------------h
Q 019195          151 STVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRI--------------------M  210 (344)
Q Consensus       151 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~--------------------~  210 (344)
                      ...+++.|+|||.+.+....+.++|||||||++|+|++|++||........+..+....                    .
T Consensus       164 ~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (328)
T cd07856         164 GYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRFVQ  243 (328)
T ss_pred             CCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhHHHHh
Confidence            45688999999998764444566999999999999999999997654322221111100                    0


Q ss_pred             hcc--ccCC---CCCCCCHhHHHHHHHhcccCCCCCCChHHHhcCcccccCCC
Q 019195          211 AVQ--YKIP---DYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLP  258 (344)
Q Consensus       211 ~~~--~~~~---~~~~~s~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~~~~  258 (344)
                      ...  ...|   ....+++.+.++|++||+.+|.+|||+.+++.||||.....
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~~~  296 (328)
T cd07856         244 SLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYHD  296 (328)
T ss_pred             hccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccccccC
Confidence            000  0011   11246789999999999999999999999999999965533

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=6.6e-40  Score=324.09  Aligned_cols=139  Identities=30%  Similarity=0.470  Sum_probs=123.7

Q ss_pred             CCCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCccc----cHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEE
Q 019195            1 MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKI----DANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIV   76 (344)
Q Consensus         1 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~----~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv   76 (344)
                      |++|+++++||+|+||.||+|.+..+++.||||++......    ...+.+|+.+++.++||||++++.++.....+|+|
T Consensus         3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV   82 (669)
T cd05610           3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV   82 (669)
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence            58999999999999999999999999999999999764322    25678899999999999999999999999999999


Q ss_pred             EecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCc
Q 019195           77 MEYAAGGELFERICNAGRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSK  141 (344)
Q Consensus        77 ~e~~~~g~L~~~i~~~~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~  141 (344)
                      |||+.+++|..++...+.+++..++.++.||+.+       +|+||||||+|||++.++  ++||+|||+++
T Consensus        83 mEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g--~vkL~DFGls~  152 (669)
T cd05610          83 MEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEG--HIKLTDFGLSK  152 (669)
T ss_pred             EeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCC--CEEEEeCCCCc
Confidence            9999999999999888888988888887776654       999999999999997665  49999999875

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=7.2e-40  Score=293.73  Aligned_cols=240  Identities=25%  Similarity=0.403  Sum_probs=190.3

Q ss_pred             CCceeeeeeeecCceEEEEEEE-----cCCCcEEEEEEeecCcc-ccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEE
Q 019195            2 EKYELMKDIGSGNFGVARLMRN-----KNTKELVAMKYIERGHK-IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAI   75 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~vaiK~~~~~~~-~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~l   75 (344)
                      ++|.+.+.||+|+||.||++.+     ..++..+|+|.+..... ....+.+|+.++++++||||+++++++...+.+++
T Consensus         5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (288)
T cd05093           5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM   84 (288)
T ss_pred             HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence            4689999999999999999985     33566799998875432 23568899999999999999999999999999999


Q ss_pred             EEecCCCCChHHHHHhCC-------------CCCHHHHHHHHHHHHH-------CCeeecCCCCCCeEecCCCCCCEEEe
Q 019195           76 VMEYAAGGELFERICNAG-------------RFSEDEARYFFQQLIS-------GQICHRDLKLENTLLDGSPAPRLKIC  135 (344)
Q Consensus        76 v~e~~~~g~L~~~i~~~~-------------~~~~~~~~~~~~ql~~-------~~iiH~Dikp~NIl~~~~~~~~vkL~  135 (344)
                      +|||+++++|.+++...+             .+++..++.++.|++.       .|++||||||+||+++.++.  +||+
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~--~kl~  162 (288)
T cd05093          85 VFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLL--VKIG  162 (288)
T ss_pred             EEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCc--EEec
Confidence            999999999999987543             3788887777766665       49999999999999987654  9999


Q ss_pred             ecCCCcccCCCC---CCCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhh
Q 019195          136 DFGYSKSSLLHS---RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMA  211 (344)
Q Consensus       136 DFg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~  211 (344)
                      |||++.......   ......+++.|+|||.+.+..++ .++|||||||++|+|++ |.+||..........    .+..
T Consensus       163 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~----~i~~  237 (288)
T cd05093         163 DFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFT-TESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIE----CITQ  237 (288)
T ss_pred             cCCccccccCCceeecCCCCCccccccCHHHhccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH----HHHc
Confidence            999987543221   12234467889999999776654 45999999999999998 999997765433322    2222


Q ss_pred             ccccCCCCCCCCHhHHHHHHHhcccCCCCCCChHHHhc
Q 019195          212 VQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKS  249 (344)
Q Consensus       212 ~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~ell~  249 (344)
                      ... .+....++.++.+|+.+||+.||.+|||+.+++.
T Consensus       238 ~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~  274 (288)
T cd05093         238 GRV-LQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHS  274 (288)
T ss_pred             CCc-CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            221 1222357889999999999999999999999855

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=3.4e-39  Score=292.88  Aligned_cols=248  Identities=25%  Similarity=0.357  Sum_probs=195.1

Q ss_pred             CceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCccc----cHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEEe
Q 019195            3 KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKI----DANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVME   78 (344)
Q Consensus         3 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~----~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e   78 (344)
                      .|...+.||+|+||.||++.+..++..||+|++......    ...+.+|+.+++.++|||++++++++.+....|+|||
T Consensus        22 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  101 (313)
T cd06633          22 IFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVME  101 (313)
T ss_pred             HhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEe
Confidence            366778899999999999999999999999998754322    2457789999999999999999999999999999999


Q ss_pred             cCCCCChHHHHHh-CCCCCHHHHHHHHHHHH-------HCCeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCCCCC
Q 019195           79 YAAGGELFERICN-AGRFSEDEARYFFQQLI-------SGQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPK  150 (344)
Q Consensus        79 ~~~~g~L~~~i~~-~~~~~~~~~~~~~~ql~-------~~~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~~~~  150 (344)
                      |+. ++|.+.+.. ...+++.+++.++.|++       +.|++||||+|+||+++.++.  +||+|||++....   ...
T Consensus       102 ~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~--~kL~dfg~~~~~~---~~~  175 (313)
T cd06633         102 YCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQ--VKLADFGSASKSS---PAN  175 (313)
T ss_pred             cCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCC--EEEeecCCCcccC---CCC
Confidence            995 577777654 45688887777766655       459999999999999976654  9999999876432   233


Q ss_pred             CCccCCcccCCccccC--CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCHhHHH
Q 019195          151 STVGTPAYIAPEVLSR--REYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRN  228 (344)
Q Consensus       151 ~~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~  228 (344)
                      ...|+..|+|||.+..  ....+.++|||||||++|+|++|.+||...+..........    ..........++..+.+
T Consensus       176 ~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~l~~  251 (313)
T cd06633         176 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ----NDSPTLQSNEWTDSFRG  251 (313)
T ss_pred             CccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHh----cCCCCCCccccCHHHHH
Confidence            4578999999999853  23234569999999999999999999987654333332221    11111112346778999


Q ss_pred             HHHHhcccCCCCCCChHHHhcCcccccCCChh
Q 019195          229 LLSRIFVANPSRRITIKEIKSHPWFLKNLPRE  260 (344)
Q Consensus       229 li~~~L~~dp~~R~s~~ell~hp~~~~~~~~~  260 (344)
                      |+.+||+.+|.+||++.+++.||||.......
T Consensus       252 li~~~l~~~P~~Rp~~~~~l~~~~~~~~~~~~  283 (313)
T cd06633         252 FVDYCLQKIPQERPASAELLRHDFVRRDRPAR  283 (313)
T ss_pred             HHHHHccCChhhCcCHHHHhcCcccCCCchhH
Confidence            99999999999999999999999998765433

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=3.8e-40  Score=294.05  Aligned_cols=247  Identities=31%  Similarity=0.495  Sum_probs=198.8

Q ss_pred             ceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCc---cccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEEecC
Q 019195            4 YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH---KIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYA   80 (344)
Q Consensus         4 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~   80 (344)
                      |++.+.||+|++|.||++++..+++.||+|++....   .....+.+|+.+++.++|+||+++++++.+...+++||||+
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~   80 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC   80 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence            788899999999999999999999999999988643   33456788999999999999999999999999999999999


Q ss_pred             CCCChHHHHHhC-CCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCC-CCCC
Q 019195           81 AGGELFERICNA-GRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS-RPKS  151 (344)
Q Consensus        81 ~~g~L~~~i~~~-~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~-~~~~  151 (344)
                      + ++|.+++.+. ..+++..++.++.|++.+       ||+||||+|+||+++.++.  ++|+|||++....... ....
T Consensus        81 ~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~--~~l~d~g~~~~~~~~~~~~~~  157 (282)
T cd07829          81 D-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGV--LKLADFGLARAFGIPLRTYTH  157 (282)
T ss_pred             C-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCC--EEEecCCcccccCCCccccCc
Confidence            7 5899999876 578888888877776654       9999999999999987654  9999999987644332 2233


Q ss_pred             CccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhc--------------cccCC
Q 019195          152 TVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAV--------------QYKIP  217 (344)
Q Consensus       152 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~--------------~~~~~  217 (344)
                      ..++..|+|||.+.+....+.++|||||||++|+|++|++||........+.++.......              ....+
T Consensus       158 ~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (282)
T cd07829         158 EVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTFP  237 (282)
T ss_pred             cccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhccccccccccc
Confidence            4578889999998776445666999999999999999999998876554444433211100              00011


Q ss_pred             ---------CCCCCCHhHHHHHHHhcccCCCCCCChHHHhcCccc
Q 019195          218 ---------DYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF  253 (344)
Q Consensus       218 ---------~~~~~s~~~~~li~~~L~~dp~~R~s~~ell~hp~~  253 (344)
                               ....++..+.++|.+||..+|.+||++.+++.||||
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~  282 (282)
T cd07829         238 KFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF  282 (282)
T ss_pred             ccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence                     112347789999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=6.5e-40  Score=288.13  Aligned_cols=234  Identities=26%  Similarity=0.391  Sum_probs=185.0

Q ss_pred             eeeeecCceEEEEEEEcCCCcEEEEEEeecCc--cccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEEecCCCCCh
Q 019195            8 KDIGSGNFGVARLMRNKNTKELVAMKYIERGH--KIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYAAGGEL   85 (344)
Q Consensus         8 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L   85 (344)
                      +.||+|+||.||++.+..+++.||+|.+....  .....+.+|+++++.++||||+++++++.....+++||||+++++|
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF   80 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence            46999999999999999999999999876532  2335688999999999999999999999999999999999999999


Q ss_pred             HHHHHhC-CCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCCCCC---CCcc
Q 019195           86 FERICNA-GRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPK---STVG  154 (344)
Q Consensus        86 ~~~i~~~-~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~~~~---~~~g  154 (344)
                      .+++... ..+++..++.++.|++.+       ||+||||||+||+++.++  .+||+|||++..........   ...+
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~--~~kl~dfg~~~~~~~~~~~~~~~~~~~  158 (252)
T cd05084          81 LTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKN--VLKISDFGMSREEEDGVYASTGGMKQI  158 (252)
T ss_pred             HHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCC--cEEECccccCcccccccccccCCCCCC
Confidence            9998764 468888888887776654       999999999999997665  49999999987533211111   1123


Q ss_pred             CCcccCCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCHhHHHHHHHh
Q 019195          155 TPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRI  233 (344)
Q Consensus       155 t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~  233 (344)
                      +..|+|||.+.+..+. .++|||||||++|+|++ |..||.......... .+.    .....+....++..+.+|+.+|
T Consensus       159 ~~~y~aPE~~~~~~~~-~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~-~~~----~~~~~~~~~~~~~~~~~li~~~  232 (252)
T cd05084         159 PVKWTAPEALNYGRYS-SESDVWSFGILLWEAFSLGAVPYANLSNQQTRE-AIE----QGVRLPCPELCPDAVYRLMERC  232 (252)
T ss_pred             ceeecCchhhcCCCCC-hHHHHHHHHHHHHHHHhCCCCCccccCHHHHHH-HHH----cCCCCCCcccCCHHHHHHHHHH
Confidence            4569999999877765 45999999999999997 899997654322211 111    1222233345789999999999


Q ss_pred             cccCCCCCCChHHHhc
Q 019195          234 FVANPSRRITIKEIKS  249 (344)
Q Consensus       234 L~~dp~~R~s~~ell~  249 (344)
                      |+.+|.+|||+.++++
T Consensus       233 l~~~p~~Rps~~~~~~  248 (252)
T cd05084         233 WEYDPGQRPSFSTVHQ  248 (252)
T ss_pred             cCCChhhCcCHHHHHH
Confidence            9999999999999874

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=1.1e-39  Score=289.06  Aligned_cols=241  Identities=26%  Similarity=0.393  Sum_probs=192.8

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCC---CcEEEEEEeecCcc--ccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEE
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNT---KELVAMKYIERGHK--IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIV   76 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~---~~~vaiK~~~~~~~--~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv   76 (344)
                      ++|++.+.||+|+||+||+|.+..+   ...||+|.+.....  ....+.+|+.+++.++||||+++++++......+++
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv   83 (266)
T cd05033           4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII   83 (266)
T ss_pred             HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence            5799999999999999999988643   45899998865432  235678899999999999999999999999999999


Q ss_pred             EecCCCCChHHHHHhC-CCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCCC
Q 019195           77 MEYAAGGELFERICNA-GRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR  148 (344)
Q Consensus        77 ~e~~~~g~L~~~i~~~-~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~~  148 (344)
                      |||+++++|.+++... +.++..+++.++.|++.+       +|+||||||+||+++.++.  ++|+|||++........
T Consensus        84 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~--~~l~dfg~~~~~~~~~~  161 (266)
T cd05033          84 TEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLV--CKVSDFGLSRRLEDSEA  161 (266)
T ss_pred             EEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCC--EEECccchhhccccccc
Confidence            9999999999998763 478888888887766654       9999999999999987664  99999999876531111


Q ss_pred             ---CCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCH
Q 019195          149 ---PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQ  224 (344)
Q Consensus       149 ---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~  224 (344)
                         .....+++.|+|||.+.+..++ .++||||||+++|+|++ |..||.........    ..+. .....+....+++
T Consensus       162 ~~~~~~~~~~~~y~~Pe~~~~~~~~-~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~----~~~~-~~~~~~~~~~~~~  235 (266)
T cd05033         162 TYTTKGGKIPIRWTAPEAIAYRKFT-SASDVWSFGIVMWEVMSYGERPYWDMSNQDVI----KAVE-DGYRLPPPMDCPS  235 (266)
T ss_pred             ceeccCCCCCccccChhhhccCCCc-cccchHHHHHHHHHHHccCCCCCCCCCHHHHH----HHHH-cCCCCCCCCCCCH
Confidence               1122356789999999877664 45999999999999997 99999765543322    2222 2223344456789


Q ss_pred             hHHHHHHHhcccCCCCCCChHHHhcC
Q 019195          225 DCRNLLSRIFVANPSRRITIKEIKSH  250 (344)
Q Consensus       225 ~~~~li~~~L~~dp~~R~s~~ell~h  250 (344)
                      .+.+|+.+||+.+|.+||++.+++++
T Consensus       236 ~l~~li~~cl~~~p~~Rp~~~ei~~~  261 (266)
T cd05033         236 ALYQLMLDCWQKDRNERPTFSQIVST  261 (266)
T ss_pred             HHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            99999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=2.2e-39  Score=294.56  Aligned_cols=247  Identities=26%  Similarity=0.370  Sum_probs=195.9

Q ss_pred             CceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCccc----cHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEEe
Q 019195            3 KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKI----DANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVME   78 (344)
Q Consensus         3 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~----~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e   78 (344)
                      .|+..+.||+|+||.||++.+..++..||+|++......    ...+.+|+.+++.++|||++++++++..+...++|||
T Consensus        26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  105 (317)
T cd06635          26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME  105 (317)
T ss_pred             hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEe
Confidence            478899999999999999999999999999998754322    2468889999999999999999999999999999999


Q ss_pred             cCCCCChHHHHHh-CCCCCHHHHHHHHHHHHH-------CCeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCCCCC
Q 019195           79 YAAGGELFERICN-AGRFSEDEARYFFQQLIS-------GQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPK  150 (344)
Q Consensus        79 ~~~~g~L~~~i~~-~~~~~~~~~~~~~~ql~~-------~~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~~~~  150 (344)
                      |+.| +|.+.+.. ...+++.++..++.|++.       .||+||||+|+||+++.++  .+||+|||++....   ...
T Consensus       106 ~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~--~~kl~dfg~~~~~~---~~~  179 (317)
T cd06635         106 YCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPG--QVKLADFGSASIAS---PAN  179 (317)
T ss_pred             CCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCC--CEEEecCCCccccC---Ccc
Confidence            9965 77777644 456888887777666654       4999999999999997665  49999999876432   233


Q ss_pred             CCccCCcccCCccccC--CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCHhHHH
Q 019195          151 STVGTPAYIAPEVLSR--REYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRN  228 (344)
Q Consensus       151 ~~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~  228 (344)
                      ...|++.|+|||.+..  ....+.++|||||||++|+|++|..||...........+    ............+++.+.+
T Consensus       180 ~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~l~~  255 (317)
T cd06635         180 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI----AQNESPTLQSNEWSDYFRN  255 (317)
T ss_pred             cccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHH----HhccCCCCCCccccHHHHH
Confidence            4578999999999742  222345699999999999999999999775443332222    2222222223357889999


Q ss_pred             HHHHhcccCCCCCCChHHHhcCcccccCCCh
Q 019195          229 LLSRIFVANPSRRITIKEIKSHPWFLKNLPR  259 (344)
Q Consensus       229 li~~~L~~dp~~R~s~~ell~hp~~~~~~~~  259 (344)
                      ||.+||+.+|.+||++.++++|||+....+.
T Consensus       256 li~~~l~~~p~~Rpt~~~il~~~~~~~~~~~  286 (317)
T cd06635         256 FVDSCLQKIPQDRPTSEELLKHMFVLRERPE  286 (317)
T ss_pred             HHHHHccCCcccCcCHHHHHhChhhhccCcc
Confidence            9999999999999999999999999776553

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=9.2e-40  Score=287.38  Aligned_cols=242  Identities=33%  Similarity=0.489  Sum_probs=198.2

Q ss_pred             CceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCcc---ccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEEec
Q 019195            3 KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK---IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEY   79 (344)
Q Consensus         3 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~   79 (344)
                      +|++.+.||+|+||.||++.+..++..+|+|.+.....   ....+.+|+.+++.++|+||+++++++......|+||||
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY   80 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence            69999999999999999999999999999999876432   234677899999999999999999999999999999999


Q ss_pred             CCCCChHHHHHh----CCCCCHHHHHHHHHHHHH-------CCeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCCC
Q 019195           80 AAGGELFERICN----AGRFSEDEARYFFQQLIS-------GQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR  148 (344)
Q Consensus        80 ~~~g~L~~~i~~----~~~~~~~~~~~~~~ql~~-------~~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~~  148 (344)
                      +++++|..++.+    ...+++..++.++.|++.       .|++|+||+|.||+++.++  ++||+|||++...... .
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~--~~kl~d~g~~~~~~~~-~  157 (256)
T cd08530          81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVAND--LVKIGDLGISKVLKKN-M  157 (256)
T ss_pred             cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCC--cEEEeeccchhhhccC-C
Confidence            999999998866    356788877777666554       4999999999999998755  4999999998765444 3


Q ss_pred             CCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCHhHHH
Q 019195          149 PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRN  228 (344)
Q Consensus       149 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~  228 (344)
                      .....+++.|+|||.+.+..++ .++|+||||+++|+|++|+.||...+.....    ..+....+. +....++.++.+
T Consensus       158 ~~~~~~~~~~~~Pe~~~~~~~~-~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~----~~~~~~~~~-~~~~~~~~~~~~  231 (256)
T cd08530         158 AKTQIGTPHYMAPEVWKGRPYS-YKSDIWSLGCLLYEMATFAPPFEARSMQDLR----YKVQRGKYP-PIPPIYSQDLQN  231 (256)
T ss_pred             cccccCCccccCHHHHCCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHH----HHHhcCCCC-CCchhhCHHHHH
Confidence            3445689999999999777664 4599999999999999999999876543222    222222221 122357889999


Q ss_pred             HHHHhcccCCCCCCChHHHhcCccc
Q 019195          229 LLSRIFVANPSRRITIKEIKSHPWF  253 (344)
Q Consensus       229 li~~~L~~dp~~R~s~~ell~hp~~  253 (344)
                      ++.+||+.+|.+|||+.++++||++
T Consensus       232 li~~~l~~~p~~Rp~~~~~l~~p~~  256 (256)
T cd08530         232 FIRSMLQVKPKLRPNCDKILASPAV  256 (256)
T ss_pred             HHHHHcCCCcccCCCHHHHhcCCCC
Confidence            9999999999999999999999974

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.5e-41  Score=295.48  Aligned_cols=248  Identities=32%  Similarity=0.572  Sum_probs=204.8

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCcccc----HHHHHHHHHHhcC-CCCCcceeeEEEEcCCEEEEE
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKID----ANVAREIINHKQL-RHPNIIRFKEVVLTPTHLAIV   76 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~----~~~~~ei~~l~~l-~h~niv~~~~~~~~~~~~~lv   76 (344)
                      .+|..+.+||+|+||.|.++..+.+.+.||||+++++....    +--..|-++|... +-|.+++++.+|+.-+.+|+|
T Consensus       349 tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFV  428 (683)
T KOG0696|consen  349 TDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFV  428 (683)
T ss_pred             cccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeE
Confidence            36788999999999999999999999999999998753221    1122455555555 578999999999999999999


Q ss_pred             EecCCCCChHHHHHhCCCCCHHHHHHHHHH-------HHHCCeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCC-CC
Q 019195           77 MEYAAGGELFERICNAGRFSEDEARYFFQQ-------LISGQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH-SR  148 (344)
Q Consensus        77 ~e~~~~g~L~~~i~~~~~~~~~~~~~~~~q-------l~~~~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~-~~  148 (344)
                      |||+.||+|...|++.+++.+..+..++..       ||+.|||.||||..|||++..+  ++||+|||+++..... ..
T Consensus       429 MEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eG--HiKi~DFGmcKEni~~~~T  506 (683)
T KOG0696|consen  429 MEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEG--HIKIADFGMCKENIFDGVT  506 (683)
T ss_pred             EEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCC--ceEeeecccccccccCCcc
Confidence            999999999999999998887776666554       4556999999999999997766  5999999999864433 33


Q ss_pred             CCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCHhHHH
Q 019195          149 PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRN  228 (344)
Q Consensus       149 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~  228 (344)
                      ..+.||||.|+|||++...+| ++++|+||+|++||||+.|++||.+.+..+.+..    ++......|.  .+|.++.+
T Consensus       507 TkTFCGTPdYiAPEIi~YqPY-gksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~a----I~ehnvsyPK--slSkEAv~  579 (683)
T KOG0696|consen  507 TKTFCGTPDYIAPEIIAYQPY-GKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQA----IMEHNVSYPK--SLSKEAVA  579 (683)
T ss_pred             eeeecCCCcccccceEEeccc-ccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHH----HHHccCcCcc--cccHHHHH
Confidence            567799999999999988887 5669999999999999999999999877655544    4455555565  78999999


Q ss_pred             HHHHhcccCCCCCCC-----hHHHhcCcccccCCC
Q 019195          229 LLSRIFVANPSRRIT-----IKEIKSHPWFLKNLP  258 (344)
Q Consensus       229 li~~~L~~dp~~R~s-----~~ell~hp~~~~~~~  258 (344)
                      +++.+|.+.|.+|..     -.++..||||+..-+
T Consensus       580 ickg~ltK~P~kRLGcg~~ge~di~~H~FFR~iDW  614 (683)
T KOG0696|consen  580 ICKGLLTKHPGKRLGCGPEGERDIREHPFFRRIDW  614 (683)
T ss_pred             HHHHHhhcCCccccCCCCccccchhhCcchhhccH
Confidence            999999999999994     468999999976544

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=7.9e-40  Score=294.37  Aligned_cols=245  Identities=24%  Similarity=0.354  Sum_probs=192.4

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCC----------------cEEEEEEeecCcc--ccHHHHHHHHHHhcCCCCCccee
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTK----------------ELVAMKYIERGHK--IDANVAREIINHKQLRHPNIIRF   63 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~----------------~~vaiK~~~~~~~--~~~~~~~ei~~l~~l~h~niv~~   63 (344)
                      ++|++++.||+|+||.||+|.+..++                ..||+|.+.....  ....+.+|++++++++||||+++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~   84 (296)
T cd05051           5 QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARL   84 (296)
T ss_pred             hhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeEE
Confidence            58999999999999999999876543                5689999876432  33568889999999999999999


Q ss_pred             eEEEEcCCEEEEEEecCCCCChHHHHHhCC-----------CCCHHHHHHHHHHHHH-------CCeeecCCCCCCeEec
Q 019195           64 KEVVLTPTHLAIVMEYAAGGELFERICNAG-----------RFSEDEARYFFQQLIS-------GQICHRDLKLENTLLD  125 (344)
Q Consensus        64 ~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~-----------~~~~~~~~~~~~ql~~-------~~iiH~Dikp~NIl~~  125 (344)
                      ++++..++.++++|||+++++|..++.+..           .+++..++.++.|++.       .||+||||||+||+++
T Consensus        85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~Nili~  164 (296)
T cd05051          85 LGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVG  164 (296)
T ss_pred             EEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhceeec
Confidence            999999999999999999999999997765           6888888888777654       4999999999999998


Q ss_pred             CCCCCCEEEeecCCCcccCCCC---CCCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHh--CCCCCCCCCChH
Q 019195          126 GSPAPRLKICDFGYSKSSLLHS---RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV--GAYPFEDQEDPK  200 (344)
Q Consensus       126 ~~~~~~vkL~DFg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~--g~~pf~~~~~~~  200 (344)
                      .++  .++|+|||+++......   ......+++.|+|||.+.+..+. .++|||||||++|+|++  |..||.......
T Consensus       165 ~~~--~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~  241 (296)
T cd05051         165 KNY--TIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFT-TKSDVWAFGVTLWEILTLCREQPYEHLTDQQ  241 (296)
T ss_pred             CCC--ceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCC-ccchhhhhHHHHHHHHhcCCCCCCCCcChHH
Confidence            775  49999999987543222   12234567889999998776654 55999999999999998  778887655443


Q ss_pred             HHHHHHHHHh--hccccCCCCCCCCHhHHHHHHHhcccCCCCCCChHHHhc
Q 019195          201 NFRKTISRIM--AVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKS  249 (344)
Q Consensus       201 ~~~~~~~~~~--~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~ell~  249 (344)
                      .+........  ......+....++.++.+++.+||+.||.+|||+.++++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~  292 (296)
T cd05051         242 VIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHL  292 (296)
T ss_pred             HHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence            3333221100  111122333456789999999999999999999999965

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=1.1e-39  Score=291.74  Aligned_cols=244  Identities=25%  Similarity=0.375  Sum_probs=186.9

Q ss_pred             CCc-eeeeeeeecCceEEEEEE----EcCCCcEEEEEEeecCcc--ccHHHHHHHHHHhcCCCCCcceeeEEEEcC--CE
Q 019195            2 EKY-ELMKDIGSGNFGVARLMR----NKNTKELVAMKYIERGHK--IDANVAREIINHKQLRHPNIIRFKEVVLTP--TH   72 (344)
Q Consensus         2 ~~y-~~~~~lg~G~~g~V~~~~----~~~~~~~vaiK~~~~~~~--~~~~~~~ei~~l~~l~h~niv~~~~~~~~~--~~   72 (344)
                      +|| ++++.||+|+||+||++.    ...++..||+|.+.....  ....+.+|+.+++.++||||+++++++...  ..
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   82 (283)
T cd05080           3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKG   82 (283)
T ss_pred             hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCce
Confidence            567 999999999999998765    345788999999876432  345688999999999999999999987653  46


Q ss_pred             EEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHH-------CCeeecCCCCCCeEecCCCCCCEEEeecCCCcccCC
Q 019195           73 LAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLIS-------GQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLL  145 (344)
Q Consensus        73 ~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~ql~~-------~~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~  145 (344)
                      ++++|||+++++|.+++.. ..+++.+++.++.|++.       .||+||||||+|||++.+..  +||+|||++.....
T Consensus        83 ~~lv~e~~~~~~l~~~~~~-~~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~--~~l~dfg~~~~~~~  159 (283)
T cd05080          83 LQLIMEYVPLGSLRDYLPK-HKLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRL--VKIGDFGLAKAVPE  159 (283)
T ss_pred             EEEEecCCCCCCHHHHHHH-cCCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCc--EEEeecccccccCC
Confidence            8999999999999999865 45899888888777665       49999999999999987654  99999999875433


Q ss_pred             CCC----CCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHH--H--------HHHHHHHhh
Q 019195          146 HSR----PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKN--F--------RKTISRIMA  211 (344)
Q Consensus       146 ~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--~--------~~~~~~~~~  211 (344)
                      ...    .....++..|+|||.+.+..++ .++||||||+++|+|++|..||........  .        .........
T Consensus       160 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~-~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (283)
T cd05080         160 GHEYYRVREDGDSPVFWYAVECLKENKFS-YASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLE  238 (283)
T ss_pred             cchhhccCCCCCCCceeeCHhHhcccCCC-cccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhhh
Confidence            221    1223466779999998776654 559999999999999999999865432100  0        000011111


Q ss_pred             ccccCCCCCCCCHhHHHHHHHhcccCCCCCCChHHHhc
Q 019195          212 VQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKS  249 (344)
Q Consensus       212 ~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~ell~  249 (344)
                      .....+....++..+.+++.+||+.+|++|||+.++++
T Consensus       239 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~  276 (283)
T cd05080         239 RGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP  276 (283)
T ss_pred             cCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence            11223333457889999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=4.4e-41  Score=328.21  Aligned_cols=245  Identities=29%  Similarity=0.426  Sum_probs=192.6

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecC--ccccHHHHHHHHHHhcCCCCCcceeeEEEEc----------
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERG--HKIDANVAREIINHKQLRHPNIIRFKEVVLT----------   69 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~----------   69 (344)
                      .+|+.++.||+||||.||+|+++-+|+.||||++...  .....++.+|+..|.+|+|||||+++..|..          
T Consensus       479 ~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ei  558 (1351)
T KOG1035|consen  479 NDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLEI  558 (1351)
T ss_pred             hhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccccc
Confidence            5788999999999999999999999999999999765  4445789999999999999999999988741          


Q ss_pred             --------------------------------------------------------------------------------
Q 019195           70 --------------------------------------------------------------------------------   69 (344)
Q Consensus        70 --------------------------------------------------------------------------------   69 (344)
                                                                                                      
T Consensus       559 ~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e~  638 (1351)
T KOG1035|consen  559 VASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSEG  638 (1351)
T ss_pred             cccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccCC
Confidence                                                                                            


Q ss_pred             ---------------------C--------CEEEEEEecCCCCChHHHHHhCCCC-CHHHHHHHHHHHHHC-------Ce
Q 019195           70 ---------------------P--------THLAIVMEYAAGGELFERICNAGRF-SEDEARYFFQQLISG-------QI  112 (344)
Q Consensus        70 ---------------------~--------~~~~lv~e~~~~g~L~~~i~~~~~~-~~~~~~~~~~ql~~~-------~i  112 (344)
                                           +        ..+||-||||+..+|.+++..+... .....|.++++|+.|       ||
T Consensus       639 ~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~~gi  718 (1351)
T KOG1035|consen  639 SVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHDQGI  718 (1351)
T ss_pred             ccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHhCce
Confidence                                 0        1258999999998888777665544 366777777776655       99


Q ss_pred             eecCCCCCCeEecCCCCCCEEEeecCCCcccC-------------------CCCCCCCCccCCcccCCccccCCC--CCC
Q 019195          113 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSL-------------------LHSRPKSTVGTPAYIAPEVLSRRE--YDG  171 (344)
Q Consensus       113 iH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~-------------------~~~~~~~~~gt~~y~aPE~~~~~~--~~~  171 (344)
                      |||||||.||+++.+..  |||+|||+|+...                   .....+..+||..|+|||++.+..  .+.
T Consensus       719 IHRDLKP~NIFLd~~~~--VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn  796 (1351)
T KOG1035|consen  719 IHRDLKPRNIFLDSRNS--VKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYN  796 (1351)
T ss_pred             eeccCCcceeEEcCCCC--eeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccccccccc
Confidence            99999999999997776  9999999997511                   011234567999999999997765  344


Q ss_pred             cchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCCC--CCCCCHhHHHHHHHhcccCCCCCCChHHHhc
Q 019195          172 KLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPD--YVHISQDCRNLLSRIFVANPSRRITIKEIKS  249 (344)
Q Consensus       172 ~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~s~~~~~li~~~L~~dp~~R~s~~ell~  249 (344)
                      .++||||||||++||+   .||...   .....++..+..+....+.  +..--+.-..+|++||+.||++||||.|+|+
T Consensus       797 ~KiDmYSLGIVlFEM~---yPF~Ts---MERa~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~  870 (1351)
T KOG1035|consen  797 SKIDMYSLGIVLFEML---YPFGTS---MERASILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTATELLN  870 (1351)
T ss_pred             chhhhHHHHHHHHHHh---ccCCch---HHHHHHHHhcccCCCCCCcccccccchHHHHHHHHHhcCCCccCCCHHHHhh
Confidence            5599999999999998   456543   2334455555555554441  1223456789999999999999999999999


Q ss_pred             Ccccc
Q 019195          250 HPWFL  254 (344)
Q Consensus       250 hp~~~  254 (344)
                      +.||.
T Consensus       871 s~llp  875 (1351)
T KOG1035|consen  871 SELLP  875 (1351)
T ss_pred             ccCCC
Confidence            99986

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.4e-39  Score=286.62  Aligned_cols=236  Identities=25%  Similarity=0.407  Sum_probs=192.6

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEEecCC
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYAA   81 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~   81 (344)
                      ++|++.+.||.|+||.||++...  ++.||+|.+........++.+|+.+++.++|+||+++++++......++||||++
T Consensus         6 ~~~~~~~~ig~g~~g~v~~~~~~--~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~   83 (256)
T cd05039           6 KELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMA   83 (256)
T ss_pred             hhccceeeeecCCCceEEEEEec--CcEEEEEEeccchhHHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecC
Confidence            57999999999999999999864  7889999998765545678899999999999999999999999999999999999


Q ss_pred             CCChHHHHHhCC--CCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCCCCCCC
Q 019195           82 GGELFERICNAG--RFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST  152 (344)
Q Consensus        82 ~g~L~~~i~~~~--~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~~~~~~  152 (344)
                      +++|.+++....  .+++..++.++.|++.+       |++||||||+||+++.++.  +||+|||+++......  ...
T Consensus        84 ~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~--~~l~d~g~~~~~~~~~--~~~  159 (256)
T cd05039          84 KGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLV--AKVSDFGLAKEASQGQ--DSG  159 (256)
T ss_pred             CCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCC--EEEccccccccccccc--ccC
Confidence            999999997765  68888888887776654       9999999999999987654  9999999987652221  233


Q ss_pred             ccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCHhHHHHHH
Q 019195          153 VGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLS  231 (344)
Q Consensus       153 ~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~  231 (344)
                      .++..|+|||.+....+. .++||||||+++|+|++ |..||......... ..+.    ..+.......+++.+.++|.
T Consensus       160 ~~~~~~~ape~~~~~~~~-~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~-~~~~----~~~~~~~~~~~~~~~~~li~  233 (256)
T cd05039         160 KLPVKWTAPEALREKKFS-TKSDVWSFGILLWEIYSFGRVPYPRIPLKDVV-PHVE----KGYRMEAPEGCPPEVYKVMK  233 (256)
T ss_pred             CCcccccCchhhcCCcCC-cHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHH-HHHh----cCCCCCCccCCCHHHHHHHH
Confidence            456779999998766654 45999999999999997 99999776443222 2111    12222223457899999999


Q ss_pred             HhcccCCCCCCChHHHhc
Q 019195          232 RIFVANPSRRITIKEIKS  249 (344)
Q Consensus       232 ~~L~~dp~~R~s~~ell~  249 (344)
                      +||..+|.+|||+.++++
T Consensus       234 ~~l~~~p~~Rp~~~~l~~  251 (256)
T cd05039         234 DCWELDPAKRPTFKQLRE  251 (256)
T ss_pred             HHhccChhhCcCHHHHHH
Confidence            999999999999999976

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=1e-39  Score=286.28  Aligned_cols=235  Identities=38%  Similarity=0.664  Sum_probs=196.1

Q ss_pred             eeecCceEEEEEEEcCCCcEEEEEEeecCcc----ccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEEecCCCCCh
Q 019195           10 IGSGNFGVARLMRNKNTKELVAMKYIERGHK----IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYAAGGEL   85 (344)
Q Consensus        10 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L   85 (344)
                      ||.|+||.||++.+..+++.||+|.+.....    ....+.+|+.++++++||||+++++.+..+...+++|||+++++|
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L   80 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL   80 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence            7999999999999998999999999876533    234688899999999999999999999999999999999999999


Q ss_pred             HHHHHhCCCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCC-CCCCCCccCCc
Q 019195           86 FERICNAGRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH-SRPKSTVGTPA  157 (344)
Q Consensus        86 ~~~i~~~~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~-~~~~~~~gt~~  157 (344)
                      .+++.....+++..+..++.|++.+       +++|+||+|+||+++.++.  ++|+|||++...... .......++..
T Consensus        81 ~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~--~~l~d~~~~~~~~~~~~~~~~~~~~~~  158 (250)
T cd05123          81 FSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGH--IKLTDFGLAKELSSEGSRTNTFCGTPE  158 (250)
T ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCc--EEEeecCcceecccCCCcccCCcCCcc
Confidence            9999888888999888887776655       9999999999999987654  999999998765433 22344568999


Q ss_pred             ccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCHhHHHHHHHhcccC
Q 019195          158 YIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVAN  237 (344)
Q Consensus       158 y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~d  237 (344)
                      |+|||.+.+... +.++|+||||+++|+|++|..||.......    ....+......++  ..++..+.++|.+||..|
T Consensus       159 ~~~Pe~~~~~~~-~~~~D~~slG~~~~~l~~g~~p~~~~~~~~----~~~~~~~~~~~~~--~~~~~~l~~~i~~~l~~~  231 (250)
T cd05123         159 YLAPEVLLGKGY-GKAVDWWSLGVLLYEMLTGKPPFYAEDRKE----IYEKILKDPLRFP--EFLSPEARDLISGLLQKD  231 (250)
T ss_pred             ccChHHhCCCCC-CchhhHHHHHHHHHHHHHCCCCCCCCCHHH----HHHHHhcCCCCCC--CCCCHHHHHHHHHHhcCC
Confidence            999999977665 445999999999999999999997655422    2223333333333  356899999999999999


Q ss_pred             CCCCCCh---HHHhcCccc
Q 019195          238 PSRRITI---KEIKSHPWF  253 (344)
Q Consensus       238 p~~R~s~---~ell~hp~~  253 (344)
                      |.+||++   .++++||||
T Consensus       232 p~~R~~~~~~~~l~~~~~f  250 (250)
T cd05123         232 PTKRLGSGGAEEIKAHPFF  250 (250)
T ss_pred             HhhCCCcccHHHHHhCCCC
Confidence            9999999   999999998

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=1.5e-39  Score=293.75  Aligned_cols=241  Identities=24%  Similarity=0.378  Sum_probs=190.8

Q ss_pred             CCceeeeeeeecCceEEEEEEE-----cCCCcEEEEEEeecCcc--ccHHHHHHHHHHhcC-CCCCcceeeEEEEcCCEE
Q 019195            2 EKYELMKDIGSGNFGVARLMRN-----KNTKELVAMKYIERGHK--IDANVAREIINHKQL-RHPNIIRFKEVVLTPTHL   73 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~vaiK~~~~~~~--~~~~~~~ei~~l~~l-~h~niv~~~~~~~~~~~~   73 (344)
                      ++|.+.+.||+|+||.||++.+     ..++..||+|++.....  ....+.+|+.+++++ +||||+++++++...+..
T Consensus        35 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~  114 (302)
T cd05055          35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPI  114 (302)
T ss_pred             HHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCce
Confidence            4789999999999999999975     23456899998875432  234688999999999 799999999999999999


Q ss_pred             EEEEecCCCCChHHHHHhCC--CCCHHHHHHHHHHHH-------HCCeeecCCCCCCeEecCCCCCCEEEeecCCCcccC
Q 019195           74 AIVMEYAAGGELFERICNAG--RFSEDEARYFFQQLI-------SGQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSL  144 (344)
Q Consensus        74 ~lv~e~~~~g~L~~~i~~~~--~~~~~~~~~~~~ql~-------~~~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~  144 (344)
                      |++|||+++|+|.+++....  .+++.++..++.|++       +.+|+|+||||+|||++.+.  .++|+|||+++...
T Consensus       115 ~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~--~~~l~dfg~~~~~~  192 (302)
T cd05055         115 LVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGK--IVKICDFGLARDIM  192 (302)
T ss_pred             EEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCC--eEEECCCccccccc
Confidence            99999999999999997543  378887777766655       45999999999999997655  49999999987543


Q ss_pred             CCCC---CCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhhccccCCCCC
Q 019195          145 LHSR---PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYV  220 (344)
Q Consensus       145 ~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  220 (344)
                      ....   .....++..|+|||.+.+..++ .++||||+||++|+|++ |..||........+.+...    .....+...
T Consensus       193 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~----~~~~~~~~~  267 (302)
T cd05055         193 NDSNYVVKGNARLPVKWMAPESIFNCVYT-FESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIK----EGYRMAQPE  267 (302)
T ss_pred             CCCceeecCCCCcccccCCHhhhccCCCC-cHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHH----cCCcCCCCC
Confidence            3221   1223467889999999877764 45999999999999998 9999987665444333222    222233334


Q ss_pred             CCCHhHHHHHHHhcccCCCCCCChHHHhc
Q 019195          221 HISQDCRNLLSRIFVANPSRRITIKEIKS  249 (344)
Q Consensus       221 ~~s~~~~~li~~~L~~dp~~R~s~~ell~  249 (344)
                      ..++.+.+|+.+||+.+|.+|||+.++++
T Consensus       268 ~~~~~~~~li~~cl~~~p~~Rpt~~ell~  296 (302)
T cd05055         268 HAPAEIYDIMKTCWDADPLKRPTFKQIVQ  296 (302)
T ss_pred             CCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence            57899999999999999999999999976

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-42  Score=308.90  Aligned_cols=251  Identities=29%  Similarity=0.512  Sum_probs=218.5

Q ss_pred             CCCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCc----cccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEE
Q 019195            1 MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH----KIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIV   76 (344)
Q Consensus         1 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv   76 (344)
                      +.+.+++..||-|+||.|-++........+|+|++++..    ...+.+..|-.+|..++.|.||++|..|.++..+|++
T Consensus       419 l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmL  498 (732)
T KOG0614|consen  419 LSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYML  498 (732)
T ss_pred             hhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhh
Confidence            356788999999999999999887766679999998743    4456788999999999999999999999999999999


Q ss_pred             EecCCCCChHHHHHhCCCCCHHHHHHH-------HHHHHHCCeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCCCC
Q 019195           77 MEYAAGGELFERICNAGRFSEDEARYF-------FQQLISGQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP  149 (344)
Q Consensus        77 ~e~~~~g~L~~~i~~~~~~~~~~~~~~-------~~ql~~~~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~~~  149 (344)
                      ||-|-||.|...+++++.|.+...+.+       +.+||+.|||.|||||+|++++.++.  +||.|||+|+....+...
T Consensus       499 mEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy--~KLVDFGFAKki~~g~KT  576 (732)
T KOG0614|consen  499 MEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGY--LKLVDFGFAKKIGSGRKT  576 (732)
T ss_pred             HHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCc--eEEeehhhHHHhccCCce
Confidence            999999999999999998877765554       56777889999999999999988877  999999999999999999


Q ss_pred             CCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCHhHHHH
Q 019195          150 KSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL  229 (344)
Q Consensus       150 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  229 (344)
                      .++||||.|.|||++..++.+. ++|.|||||++|||++|.+||.+.+.-..+..+++.+...  .+|  ..++..+.+|
T Consensus       577 wTFcGTpEYVAPEIILnKGHD~-avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i--~~P--r~I~k~a~~L  651 (732)
T KOG0614|consen  577 WTFCGTPEYVAPEIILNKGHDR-AVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKI--EFP--RRITKTATDL  651 (732)
T ss_pred             eeecCCcccccchhhhccCcch-hhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhh--hcc--cccchhHHHH
Confidence            9999999999999999888764 4999999999999999999999988877666666654332  234  4788999999


Q ss_pred             HHHhcccCCCCCCC-----hHHHhcCcccccCCC
Q 019195          230 LSRIFVANPSRRIT-----IKEIKSHPWFLKNLP  258 (344)
Q Consensus       230 i~~~L~~dp~~R~s-----~~ell~hp~~~~~~~  258 (344)
                      |+++...+|.+|..     +.++.+|.||..--.
T Consensus       652 ik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~gfdw  685 (732)
T KOG0614|consen  652 IKKLCRDNPTERLGYQKGGINDIKKHRWFEGFDW  685 (732)
T ss_pred             HHHHHhcCcHhhhccccCChHHHHhhhhhhcCCh
Confidence            99999999999995     899999999976533

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.9e-40  Score=300.01  Aligned_cols=244  Identities=23%  Similarity=0.339  Sum_probs=186.2

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCccc-cHHHHHHHHHHhcCCCCCcceeeEEEEcCC-EEEEEEec
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKI-DANVAREIINHKQLRHPNIIRFKEVVLTPT-HLAIVMEY   79 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~ei~~l~~l~h~niv~~~~~~~~~~-~~~lv~e~   79 (344)
                      ++|.-...||+|+||.||++....+ ..||||++...... ..+|.+|+.++.+++|||+|+++++|.+.+ ..+||+||
T Consensus        75 ~~Fs~~~~ig~Ggfg~VYkG~l~~~-~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~~~LVYEy  153 (361)
T KOG1187|consen   75 NNFSESNLIGEGGFGTVYKGVLSDG-TVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYCLEGGEHRLLVYEY  153 (361)
T ss_pred             hCCchhcceecCCCeEEEEEEECCC-CEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEEecCCceEEEEEEc
Confidence            3566678999999999999988654 89999988776554 667999999999999999999999999988 59999999


Q ss_pred             CCCCChHHHHHhCC--CCCHHHHHHHHHHHH-------HC---CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCC-C
Q 019195           80 AAGGELFERICNAG--RFSEDEARYFFQQLI-------SG---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLL-H  146 (344)
Q Consensus        80 ~~~g~L~~~i~~~~--~~~~~~~~~~~~ql~-------~~---~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~-~  146 (344)
                      +++|+|.+++....  .++...-..|+..++       .+   .||||||||+|||+|.+..  .||+|||+|+.... .
T Consensus       154 m~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~--aKlsDFGLa~~~~~~~  231 (361)
T KOG1187|consen  154 MPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFN--AKLSDFGLAKLGPEGD  231 (361)
T ss_pred             cCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCC--EEccCccCcccCCccc
Confidence            99999999997655  777776666655544       43   5999999999999998886  99999999976544 3


Q ss_pred             CCCCCC-ccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC--ChHHHHHHHHHHh-hccc---cCCCC
Q 019195          147 SRPKST-VGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQE--DPKNFRKTISRIM-AVQY---KIPDY  219 (344)
Q Consensus       147 ~~~~~~-~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~--~~~~~~~~~~~~~-~~~~---~~~~~  219 (344)
                      ...... .||.+|+|||++..+..+ .++||||||++++||++|+.|.....  ....+..+..... ....   --|..
T Consensus       232 ~~~~~~~~gt~gY~~PEy~~~g~lt-~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~~~~eiiD~~l  310 (361)
T KOG1187|consen  232 TSVSTTVMGTFGYLAPEYASTGKLT-EKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEGKLREIVDPRL  310 (361)
T ss_pred             cceeeecCCCCccCChhhhccCCcC-cccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCcchhheeCCCc
Confidence            333333 899999999999876654 45999999999999999998887542  2222222221111 1111   11111


Q ss_pred             --CCCC--H---hHHHHHHHhcccCCCCCCChHHHhc
Q 019195          220 --VHIS--Q---DCRNLLSRIFVANPSRRITIKEIKS  249 (344)
Q Consensus       220 --~~~s--~---~~~~li~~~L~~dp~~R~s~~ell~  249 (344)
                        ...+  .   .+..+..+|++.+|..||++.++++
T Consensus       311 ~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~  347 (361)
T KOG1187|consen  311 KEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVK  347 (361)
T ss_pred             cCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHH
Confidence              1222  2   2557778999999999999999744

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=2.1e-39  Score=286.28  Aligned_cols=238  Identities=24%  Similarity=0.388  Sum_probs=190.3

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEEecCC
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYAA   81 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~   81 (344)
                      ++|+++++||+|+||.||+|... +++.||+|.+.........+.+|+.+++.++||||+++++++. .+.++++|||+.
T Consensus         6 ~~~~~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~   83 (260)
T cd05067           6 ETLKLVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYME   83 (260)
T ss_pred             HHceeeeeeccCccceEEeeecC-CCceEEEEEecCCCCcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcCC
Confidence            57999999999999999999865 5678999998876665678899999999999999999999874 567899999999


Q ss_pred             CCChHHHHHhC--CCCCHHHHHHHHHHHHH-------CCeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCCC--CC
Q 019195           82 GGELFERICNA--GRFSEDEARYFFQQLIS-------GQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR--PK  150 (344)
Q Consensus        82 ~g~L~~~i~~~--~~~~~~~~~~~~~ql~~-------~~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~~--~~  150 (344)
                      +++|.+++...  ..++..++..++.|++.       .|++||||||+||+++.++.  ++|+|||++........  ..
T Consensus        84 ~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~--~~l~dfg~~~~~~~~~~~~~~  161 (260)
T cd05067          84 NGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLC--CKIADFGLARLIEDNEYTARE  161 (260)
T ss_pred             CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCC--EEEccCcceeecCCCCccccc
Confidence            99999998653  35777777776666554       49999999999999987664  99999999865432221  12


Q ss_pred             CCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCHhHHHH
Q 019195          151 STVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL  229 (344)
Q Consensus       151 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  229 (344)
                      ...++..|+|||.+....+. .++||||||+++|+|++ |++||............     ......+.....+.++.++
T Consensus       162 ~~~~~~~y~~pe~~~~~~~~-~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~l  235 (260)
T cd05067         162 GAKFPIKWTAPEAINYGTFT-IKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNL-----ERGYRMPRPDNCPEELYEL  235 (260)
T ss_pred             CCcccccccCHHHhccCCcC-cccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHH-----HcCCCCCCCCCCCHHHHHH
Confidence            33467789999998776654 55999999999999998 99999876543332221     2223334445678899999


Q ss_pred             HHHhcccCCCCCCChHHHhc
Q 019195          230 LSRIFVANPSRRITIKEIKS  249 (344)
Q Consensus       230 i~~~L~~dp~~R~s~~ell~  249 (344)
                      |.+||+.+|.+|||+.+++.
T Consensus       236 i~~~l~~~p~~Rp~~~~l~~  255 (260)
T cd05067         236 MRLCWKEKPEERPTFEYLRS  255 (260)
T ss_pred             HHHHccCChhhCCCHHHHHH
Confidence            99999999999999999875

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=1.4e-39  Score=287.34  Aligned_cols=238  Identities=23%  Similarity=0.345  Sum_probs=188.4

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEEecCC
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYAA   81 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~   81 (344)
                      ++|++++.||+|+||.||+|.+. .+..+|+|.+.........+.+|+.++++++|+||+++++++. ....+++|||++
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~   83 (260)
T cd05070           6 ESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYMS   83 (260)
T ss_pred             HHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCCCHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEecC
Confidence            68999999999999999999875 4567999998876555667899999999999999999999875 456899999999


Q ss_pred             CCChHHHHHhC--CCCCHHHHHHHHHHHHH-------CCeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCCC--CC
Q 019195           82 GGELFERICNA--GRFSEDEARYFFQQLIS-------GQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR--PK  150 (344)
Q Consensus        82 ~g~L~~~i~~~--~~~~~~~~~~~~~ql~~-------~~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~~--~~  150 (344)
                      +++|.+++...  ..+++.+++.++.|++.       .||+||||||+||+++.+.  .++|+|||++........  ..
T Consensus        84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~--~~~l~dfg~~~~~~~~~~~~~~  161 (260)
T cd05070          84 KGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGL--VCKIADFGLARLIEDNEYTARQ  161 (260)
T ss_pred             CCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCc--eEEeCCceeeeeccCccccccc
Confidence            99999998753  35788777777666554       4999999999999998765  499999999875432221  11


Q ss_pred             CCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCHhHHHH
Q 019195          151 STVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL  229 (344)
Q Consensus       151 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  229 (344)
                      ...++..|+|||.+.+..++ .++||||||+++|+|++ |.+||...........    +. .....+.....+..+.+|
T Consensus       162 ~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~----~~-~~~~~~~~~~~~~~~~~l  235 (260)
T cd05070         162 GAKFPIKWTAPEAALYGRFT-IKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQ----VE-RGYRMPCPQDCPISLHEL  235 (260)
T ss_pred             CCCCCccccChHHHhcCCCc-chhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH----HH-cCCCCCCCCcCCHHHHHH
Confidence            22356689999998766654 45999999999999999 8999977554332222    21 122334444678999999


Q ss_pred             HHHhcccCCCCCCChHHHhc
Q 019195          230 LSRIFVANPSRRITIKEIKS  249 (344)
Q Consensus       230 i~~~L~~dp~~R~s~~ell~  249 (344)
                      +.+||+.+|.+|||+.++++
T Consensus       236 i~~~l~~~p~~Rpt~~~l~~  255 (260)
T cd05070         236 MLQCWKKDPEERPTFEYLQS  255 (260)
T ss_pred             HHHHcccCcccCcCHHHHHH
Confidence            99999999999999999864

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=6.7e-40  Score=297.45  Aligned_cols=248  Identities=23%  Similarity=0.369  Sum_probs=187.3

Q ss_pred             eeeeec--CceEEEEEEEcCCCcEEEEEEeecCc---cccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEEecCCC
Q 019195            8 KDIGSG--NFGVARLMRNKNTKELVAMKYIERGH---KIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYAAG   82 (344)
Q Consensus         8 ~~lg~G--~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~   82 (344)
                      ..||+|  ++|.||.+++..+++.||+|++....   .....+.+|+.+++.++||||+++++++.....++++|||+++
T Consensus         4 ~~i~~~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~   83 (314)
T cd08216           4 TLIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAY   83 (314)
T ss_pred             hhhhHhhcCCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCC
Confidence            345554  55677777777899999999987642   2335788999999999999999999999999999999999999


Q ss_pred             CChHHHHHhC--CCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCCC-----
Q 019195           83 GELFERICNA--GRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR-----  148 (344)
Q Consensus        83 g~L~~~i~~~--~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~~-----  148 (344)
                      ++|.+++...  ..+++..++.++.|++.+       +|+||||||+||+++.++.  +||+|||.+........     
T Consensus        84 ~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~--~kl~d~~~~~~~~~~~~~~~~~  161 (314)
T cd08216          84 GSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGK--VVLSGLRYSVSMIKHGKRQRVV  161 (314)
T ss_pred             CCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCc--eEEecCccceeecccccccccc
Confidence            9999998753  457888888887776654       9999999999999986654  99999998864432211     


Q ss_pred             ---CCCCccCCcccCCccccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhh-------------
Q 019195          149 ---PKSTVGTPAYIAPEVLSRR-EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMA-------------  211 (344)
Q Consensus       149 ---~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~-------------  211 (344)
                         .....++..|+|||++... ...+.++||||+||++|+|++|..||............+.....             
T Consensus       162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (314)
T cd08216         162 HDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYED  241 (314)
T ss_pred             ccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcC
Confidence               2234578899999998653 22345699999999999999999999876543322221110000             


Q ss_pred             ---------------ccccCCCCCCCCHhHHHHHHHhcccCCCCCCChHHHhcCcccccCC
Q 019195          212 ---------------VQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNL  257 (344)
Q Consensus       212 ---------------~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~~~  257 (344)
                                     .....+....++.++.+|+.+||+.||.+|||+.++|+||||.+..
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~~  302 (314)
T cd08216         242 SMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQCK  302 (314)
T ss_pred             CcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhhc
Confidence                           0000011112356889999999999999999999999999997653

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.9e-39  Score=286.49  Aligned_cols=240  Identities=22%  Similarity=0.339  Sum_probs=193.8

Q ss_pred             CCCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEEecC
Q 019195            1 MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYA   80 (344)
Q Consensus         1 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~   80 (344)
                      .++|++.+.||+|+||.||++.+.. +..||+|.+.........+.+|+.+++.++||||+++++++......+++|||+
T Consensus         5 ~~~~~i~~~ig~g~~~~v~~~~~~~-~~~~~vK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~   83 (261)
T cd05034           5 RESLKLERKLGAGQFGEVWMGTWNG-TTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYM   83 (261)
T ss_pred             hhheeeeeeeccCcceEEEEEEEcC-CceEEEEEecCCccCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEecc
Confidence            3689999999999999999999764 577999998876665678999999999999999999999999889999999999


Q ss_pred             CCCChHHHHHhCC--CCCHHHHHHHHHHHHH-------CCeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCCC--C
Q 019195           81 AGGELFERICNAG--RFSEDEARYFFQQLIS-------GQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR--P  149 (344)
Q Consensus        81 ~~g~L~~~i~~~~--~~~~~~~~~~~~ql~~-------~~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~~--~  149 (344)
                      ++++|.+++.+..  .++...++.++.|++.       .|++|+||||+||+++.++.  +||+|||++........  .
T Consensus        84 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~--~~l~d~g~~~~~~~~~~~~~  161 (261)
T cd05034          84 SKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLV--CKIADFGLARLIEDDEYTAR  161 (261)
T ss_pred             CCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCC--EEECccccceeccchhhhhh
Confidence            9999999997643  6788888877777654       49999999999999987654  99999999875432111  1


Q ss_pred             CCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCHhHHH
Q 019195          150 KSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRN  228 (344)
Q Consensus       150 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~  228 (344)
                      ....++..|+|||.+.+..+ +.++||||||+++|+|++ |+.||...........+.     ..+..+.....+..+.+
T Consensus       162 ~~~~~~~~y~~PE~~~~~~~-~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~  235 (261)
T cd05034         162 EGAKFPIKWTAPEAANYGRF-TIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVE-----RGYRMPRPPNCPEELYD  235 (261)
T ss_pred             hccCCCccccCHHHhccCCc-CchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-----cCCCCCCCCCCCHHHHH
Confidence            12235678999999987665 455999999999999998 999997765433333221     22233444456889999


Q ss_pred             HHHHhcccCCCCCCChHHHhc
Q 019195          229 LLSRIFVANPSRRITIKEIKS  249 (344)
Q Consensus       229 li~~~L~~dp~~R~s~~ell~  249 (344)
                      ++.+||+.+|.+||++.++++
T Consensus       236 ~i~~~l~~~p~~Rp~~~~l~~  256 (261)
T cd05034         236 LMLQCWDKDPEERPTFEYLQS  256 (261)
T ss_pred             HHHHHcccCcccCCCHHHHHH
Confidence            999999999999999999864

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=6.7e-40  Score=293.04  Aligned_cols=241  Identities=22%  Similarity=0.340  Sum_probs=189.0

Q ss_pred             CCceeeeeeeecCceEEEEEEEcC-----CCcEEEEEEeecCcc--ccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEE
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKN-----TKELVAMKYIERGHK--IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLA   74 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~--~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~   74 (344)
                      .+|++.+.||+|+||.||++.+..     .+..||+|++.....  ....+.+|+.+++.++||||+++++++......+
T Consensus         5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~   84 (283)
T cd05091           5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLS   84 (283)
T ss_pred             HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceE
Confidence            568999999999999999998754     357899999875432  2356788999999999999999999999999999


Q ss_pred             EEEecCCCCChHHHHHhC----------------CCCCHHHHHHHHHHHH-------HCCeeecCCCCCCeEecCCCCCC
Q 019195           75 IVMEYAAGGELFERICNA----------------GRFSEDEARYFFQQLI-------SGQICHRDLKLENTLLDGSPAPR  131 (344)
Q Consensus        75 lv~e~~~~g~L~~~i~~~----------------~~~~~~~~~~~~~ql~-------~~~iiH~Dikp~NIl~~~~~~~~  131 (344)
                      ++++|+.+++|..++...                ..++...++.++.|++       +.||+||||||+||+++.+..  
T Consensus        85 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~~~--  162 (283)
T cd05091          85 MIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLN--  162 (283)
T ss_pred             EEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecCCCc--
Confidence            999999999999998532                2366666666666655       459999999999999986654  


Q ss_pred             EEEeecCCCcccCCCCC---CCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHH
Q 019195          132 LKICDFGYSKSSLLHSR---PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTIS  207 (344)
Q Consensus       132 vkL~DFg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~  207 (344)
                      +||+|||+++.......   .....+++.|+|||.+.+..++ .++|||||||++|+|++ |..||.+......    ..
T Consensus       163 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~----~~  237 (283)
T cd05091         163 VKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFS-IDSDIWSYGVVLWEVFSYGLQPYCGYSNQDV----IE  237 (283)
T ss_pred             eEecccccccccccchheeeccCccCCccccCHHHHhcCCCC-cchhHHHHHHHHHHHHcCCCCCCCCCCHHHH----HH
Confidence            99999999875432221   2234567899999999776654 45999999999999998 8889977654332    22


Q ss_pred             HHhhccccCCCCCCCCHhHHHHHHHhcccCCCCCCChHHHhcC
Q 019195          208 RIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSH  250 (344)
Q Consensus       208 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~ell~h  250 (344)
                      .+..... .+....++..+.+|+.+||+.+|.+||++.+++..
T Consensus       238 ~i~~~~~-~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~  279 (283)
T cd05091         238 MIRNRQV-LPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSR  279 (283)
T ss_pred             HHHcCCc-CCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHH
Confidence            2222222 22234678899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-42  Score=288.02  Aligned_cols=246  Identities=25%  Similarity=0.410  Sum_probs=189.7

Q ss_pred             ceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCcc--ccHHHHHHHHHH-hcCCCCCcceeeEEEEcCCEEEEEEecC
Q 019195            4 YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK--IDANVAREIINH-KQLRHPNIIRFKEVVLTPTHLAIVMEYA   80 (344)
Q Consensus         4 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~ei~~l-~~l~h~niv~~~~~~~~~~~~~lv~e~~   80 (344)
                      .+-+..||.|+||+|+++.++.+|+..|||.+.....  ...+++.|.... +.-++||||++|++...++..|+.||+|
T Consensus        66 Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELM  145 (361)
T KOG1006|consen   66 LQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELM  145 (361)
T ss_pred             HHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHH
Confidence            3446789999999999999999999999999986543  345677787654 4557999999999999999999999999


Q ss_pred             CCCChHHHH-----HhCCCCCHHHHHHHHHHHHHC--------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCC
Q 019195           81 AGGELFERI-----CNAGRFSEDEARYFFQQLISG--------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS  147 (344)
Q Consensus        81 ~~g~L~~~i-----~~~~~~~~~~~~~~~~ql~~~--------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~  147 (344)
                       ..||..+-     .+...++|.-+-.+.-..+.|        .||||||||+|||++..+.  +||||||++......-
T Consensus       146 -d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~--vKLCDFGIcGqLv~Si  222 (361)
T KOG1006|consen  146 -DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGD--VKLCDFGICGQLVDSI  222 (361)
T ss_pred             -hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCC--EeeecccchHhHHHHH
Confidence             45765443     234567777555543222222        8999999999999987776  9999999987655444


Q ss_pred             CCCCCccCCcccCCccccC--CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccC-C---CCCC
Q 019195          148 RPKSTVGTPAYIAPEVLSR--REYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKI-P---DYVH  221 (344)
Q Consensus       148 ~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-~---~~~~  221 (344)
                      ..+...|...|||||.+..  .+|+-+ ||+||||++|||++||.+|+...++  . ...+..+..+.... .   ...+
T Consensus       223 AkT~daGCrpYmAPERi~p~~~gyDiR-SDvWSLGITL~EvAtG~fPyr~w~s--v-feql~~Vv~gdpp~l~~~~~~~~  298 (361)
T KOG1006|consen  223 AKTVDAGCRPYMAPERIDPSDKGYDIR-SDVWSLGITLYEVATGNFPYRKWDS--V-FEQLCQVVIGDPPILLFDKECVH  298 (361)
T ss_pred             HhhhccCCccccChhccCCccCCcchh-hhhhhhcceEeeeecCCCCcchHHH--H-HHHHHHHHcCCCCeecCcccccc
Confidence            4556679999999999843  345555 9999999999999999999987543  2 23333333333221 1   2235


Q ss_pred             CCHhHHHHHHHhcccCCCCCCChHHHhcCcccccC
Q 019195          222 ISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKN  256 (344)
Q Consensus       222 ~s~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~~  256 (344)
                      ++..+..+|.-||.+|-+.||+..+++++||+..-
T Consensus       299 ~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~y  333 (361)
T KOG1006|consen  299 YSFSMVRFINTCLIKDRSDRPKYDDLKKFPFYRMY  333 (361)
T ss_pred             cCHHHHHHHHHHhhcccccCcchhhhhcCchhhhh
Confidence            88999999999999999999999999999998643

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.5e-39  Score=289.79  Aligned_cols=240  Identities=23%  Similarity=0.320  Sum_probs=188.8

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCC-----CcEEEEEEeecCcc--ccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEE
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNT-----KELVAMKYIERGHK--IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLA   74 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~vaiK~~~~~~~--~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~   74 (344)
                      ++|++.+.||+|+||.||++.....     +..||+|.+.....  ....+.+|+.+++.++||||+++++++......+
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~   85 (277)
T cd05032           6 EKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPTL   85 (277)
T ss_pred             HHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCcE
Confidence            6899999999999999999988643     47899999865432  2346788999999999999999999999999999


Q ss_pred             EEEecCCCCChHHHHHhCC----------CCCHHHHHHHHHHH-------HHCCeeecCCCCCCeEecCCCCCCEEEeec
Q 019195           75 IVMEYAAGGELFERICNAG----------RFSEDEARYFFQQL-------ISGQICHRDLKLENTLLDGSPAPRLKICDF  137 (344)
Q Consensus        75 lv~e~~~~g~L~~~i~~~~----------~~~~~~~~~~~~ql-------~~~~iiH~Dikp~NIl~~~~~~~~vkL~DF  137 (344)
                      +||||+++++|.+++....          .+++..+..++.|+       |+.+|+||||||+||+++.++.  +||+||
T Consensus        86 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~--~kl~df  163 (277)
T cd05032          86 VVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLT--VKIGDF  163 (277)
T ss_pred             EEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCC--EEECCc
Confidence            9999999999999986432          35566666666555       4559999999999999987665  999999


Q ss_pred             CCCcccCCCC---CCCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhhcc
Q 019195          138 GYSKSSLLHS---RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQ  213 (344)
Q Consensus       138 g~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~  213 (344)
                      |+++......   ......++..|+|||.+.+..++ .++|||||||++|+|++ |..||......... +   .+.. .
T Consensus       164 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~t~g~~p~~~~~~~~~~-~---~~~~-~  237 (277)
T cd05032         164 GMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFT-TKSDVWSFGVVLWEMATLAEQPYQGLSNEEVL-K---FVID-G  237 (277)
T ss_pred             ccchhhccCcccccCCCCCccccccCHHHHhcCCCC-cccchHHHHHHHHHhhccCCCCCccCCHHHHH-H---HHhc-C
Confidence            9987543221   22334578899999998776654 55999999999999998 99999765543322 2   2221 1


Q ss_pred             ccCCCCCCCCHhHHHHHHHhcccCCCCCCChHHHhc
Q 019195          214 YKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKS  249 (344)
Q Consensus       214 ~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~ell~  249 (344)
                      ...+....++..+.++|.+||+.+|.+|||+.++++
T Consensus       238 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~  273 (277)
T cd05032         238 GHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVS  273 (277)
T ss_pred             CCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            122223356899999999999999999999999976

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=100.00  E-value=9.6e-42  Score=306.97  Aligned_cols=250  Identities=28%  Similarity=0.438  Sum_probs=203.7

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcCC------CCCcceeeEEEEcCCEEEE
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLR------HPNIIRFKEVVLTPTHLAI   75 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~l~~l~------h~niv~~~~~~~~~~~~~l   75 (344)
                      .+|.+....|+|-|++|.+|.+...|..||||++..+....+.=++|+++|+.|+      --|+++++..|...+++||
T Consensus       432 ~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknHLCl  511 (752)
T KOG0670|consen  432 SRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNHLCL  511 (752)
T ss_pred             ceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcceeEE
Confidence            4899999999999999999999999999999999998877778889999999995      3699999999999999999


Q ss_pred             EEecCCCCChHHHHHhCCC---CCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCC
Q 019195           76 VMEYAAGGELFERICNAGR---FSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLL  145 (344)
Q Consensus        76 v~e~~~~g~L~~~i~~~~~---~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~  145 (344)
                      |+|.+ ..+|.+++++.++   |....++.+..||.-|       ||+|.||||.|||++.+.. .+||||||.|.... 
T Consensus       512 VFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~-iLKLCDfGSA~~~~-  588 (752)
T KOG0670|consen  512 VFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKN-ILKLCDFGSASFAS-  588 (752)
T ss_pred             Eehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcc-eeeeccCccccccc-
Confidence            99988 6799999998764   7778889998888765       9999999999999997665 59999999886432 


Q ss_pred             CCCCCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHH--------Hhhcccc--
Q 019195          146 HSRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISR--------IMAVQYK--  215 (344)
Q Consensus       146 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~--------~~~~~~~--  215 (344)
                      .+..+.+.-+..|.|||++.+.+|+.. .|+||+||+||||.||+..|.+......+.-.+.-        +..+.+.  
T Consensus       589 eneitPYLVSRFYRaPEIiLG~~yd~~-iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlRKgqF~dq  667 (752)
T KOG0670|consen  589 ENEITPYLVSRFYRAPEIILGLPYDYP-IDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLRKGQFKDQ  667 (752)
T ss_pred             cccccHHHHHHhccCcceeecCcccCC-ccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhhhcchhhh
Confidence            333445567889999999999999877 89999999999999999999987664433221110        0000000  


Q ss_pred             -------------------------------------------CCCC-CCCCHhHHHHHHHhcccCCCCCCChHHHhcCc
Q 019195          216 -------------------------------------------IPDY-VHISQDCRNLLSRIFVANPSRRITIKEIKSHP  251 (344)
Q Consensus       216 -------------------------------------------~~~~-~~~s~~~~~li~~~L~~dp~~R~s~~ell~hp  251 (344)
                                                                 +|.. ..+-.++.+||.+||..||.+|.|..|+|+||
T Consensus       668 HFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~nqAL~Hp  747 (752)
T KOG0670|consen  668 HFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITVNQALKHP  747 (752)
T ss_pred             hcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCCHHHHhcCC
Confidence                                                       0000 00113588999999999999999999999999


Q ss_pred             cccc
Q 019195          252 WFLK  255 (344)
Q Consensus       252 ~~~~  255 (344)
                      ||..
T Consensus       748 Fi~~  751 (752)
T KOG0670|consen  748 FITE  751 (752)
T ss_pred             cccC
Confidence            9964

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=1.7e-39  Score=294.12  Aligned_cols=249  Identities=25%  Similarity=0.355  Sum_probs=195.7

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCcc----ccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEE
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK----IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVM   77 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~   77 (344)
                      ++|...+.||+|+||.||++++..++..+|+|.+.....    ....+.+|+.+++.++|+|++++++++......++||
T Consensus        15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   94 (308)
T cd06634          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM   94 (308)
T ss_pred             HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence            357888999999999999999999999999999864322    2245778999999999999999999999999999999


Q ss_pred             ecCCCCChHHHHHh-CCCCCHHHHHHHHHHHHH-------CCeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCCCC
Q 019195           78 EYAAGGELFERICN-AGRFSEDEARYFFQQLIS-------GQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP  149 (344)
Q Consensus        78 e~~~~g~L~~~i~~-~~~~~~~~~~~~~~ql~~-------~~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~~~  149 (344)
                      ||+. |+|...+.. ...+++.+++.++.|++.       .+++||||||+||+++.++  .++|+|||++.....   .
T Consensus        95 e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~--~~kl~dfg~~~~~~~---~  168 (308)
T cd06634          95 EYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPG--LVKLGDFGSASIMAP---A  168 (308)
T ss_pred             EccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCC--cEEECCcccceeecC---c
Confidence            9996 577777643 456888888777666654       4999999999999997665  499999998865332   2


Q ss_pred             CCCccCCcccCCccccC--CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCHhHH
Q 019195          150 KSTVGTPAYIAPEVLSR--REYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCR  227 (344)
Q Consensus       150 ~~~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~  227 (344)
                      ....|++.|+|||.+.+  ....+.++|||||||++|+|++|..||.............    ...........++..+.
T Consensus       169 ~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~  244 (308)
T cd06634         169 NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIA----QNESPALQSGHWSEYFR  244 (308)
T ss_pred             ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHh----hcCCCCcCcccccHHHH
Confidence            34568999999999753  2223456999999999999999999997654332222211    11111112235788999


Q ss_pred             HHHHHhcccCCCCCCChHHHhcCcccccCCChh
Q 019195          228 NLLSRIFVANPSRRITIKEIKSHPWFLKNLPRE  260 (344)
Q Consensus       228 ~li~~~L~~dp~~R~s~~ell~hp~~~~~~~~~  260 (344)
                      +||.+||+.+|.+||++.+++.|||+....+..
T Consensus       245 ~li~~cl~~~P~~Rp~~~~ll~~~~~~~~~~~~  277 (308)
T cd06634         245 NFVDSCLQKIPQDRPTSEVLLKHRFVLRERPPT  277 (308)
T ss_pred             HHHHHHhhCCcccCCCHHHHhhCccccccCChh
Confidence            999999999999999999999999998875544

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=1.1e-39  Score=293.01  Aligned_cols=241  Identities=26%  Similarity=0.380  Sum_probs=189.8

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCC-----CcEEEEEEeecCcc--ccHHHHHHHHHHhcC-CCCCcceeeEEEEcCCEE
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNT-----KELVAMKYIERGHK--IDANVAREIINHKQL-RHPNIIRFKEVVLTPTHL   73 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~vaiK~~~~~~~--~~~~~~~ei~~l~~l-~h~niv~~~~~~~~~~~~   73 (344)
                      ++|++.+.||+|+||.||++.....     ...+|+|.+.....  ....+.+|+.+++.+ +||||+++++++..++.+
T Consensus        12 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~   91 (293)
T cd05053          12 DRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPL   91 (293)
T ss_pred             hHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCCe
Confidence            5799999999999999999987643     37899998875422  224578899999999 899999999999999999


Q ss_pred             EEEEecCCCCChHHHHHhC----------------CCCCHHHHHHHHHHHH-------HCCeeecCCCCCCeEecCCCCC
Q 019195           74 AIVMEYAAGGELFERICNA----------------GRFSEDEARYFFQQLI-------SGQICHRDLKLENTLLDGSPAP  130 (344)
Q Consensus        74 ~lv~e~~~~g~L~~~i~~~----------------~~~~~~~~~~~~~ql~-------~~~iiH~Dikp~NIl~~~~~~~  130 (344)
                      +++|||+++|+|..++...                ..+++..+..++.|++       +.+|+||||||+|||++.++. 
T Consensus        92 ~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~~~~~~-  170 (293)
T cd05053          92 YVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHV-  170 (293)
T ss_pred             EEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEEcCCCe-
Confidence            9999999999999998642                3567777777766655       449999999999999976654 


Q ss_pred             CEEEeecCCCcccCCCCC---CCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHH
Q 019195          131 RLKICDFGYSKSSLLHSR---PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTI  206 (344)
Q Consensus       131 ~vkL~DFg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~  206 (344)
                       +||+|||+++.......   .....++..|+|||.+.+..++ .++|||||||++|+|++ |..||........+....
T Consensus       171 -~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~  248 (293)
T cd05053         171 -MKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYT-HQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLK  248 (293)
T ss_pred             -EEeCccccccccccccceeccCCCCCCccccCHHHhccCCcC-cccceeehhhHHHHHhcCCCCCCCCCCHHHHHHHHH
Confidence             99999999875433221   1222356789999998776664 55999999999999997 999998765433332211


Q ss_pred             HHHhhccccCCCCCCCCHhHHHHHHHhcccCCCCCCChHHHhcC
Q 019195          207 SRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSH  250 (344)
Q Consensus       207 ~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~ell~h  250 (344)
                           .....+.....+..+.+|+.+||..+|.+|||+.+++++
T Consensus       249 -----~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~  287 (293)
T cd05053         249 -----EGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED  287 (293)
T ss_pred             -----cCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence                 222223334678899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=3.6e-39  Score=287.78  Aligned_cols=239  Identities=21%  Similarity=0.351  Sum_probs=188.6

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCc----EEEEEEeecCcc--ccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEE
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKE----LVAMKYIERGHK--IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAI   75 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~----~vaiK~~~~~~~--~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~l   75 (344)
                      ++|++++.||+|+||+||+|.+..++.    .||+|++.....  ....+.+|+.+++.++||||+++++++.. ...++
T Consensus         7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~l   85 (279)
T cd05109           7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQL   85 (279)
T ss_pred             hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcEE
Confidence            579999999999999999999877766    489998865322  23568889999999999999999999875 45789


Q ss_pred             EEecCCCCChHHHHHhC-CCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCC
Q 019195           76 VMEYAAGGELFERICNA-GRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS  147 (344)
Q Consensus        76 v~e~~~~g~L~~~i~~~-~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~  147 (344)
                      +++|+++|+|.+.+... +.+++..+..++.|++.+       +|+||||||+|||++.++.  +||+|||+++......
T Consensus        86 ~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~--~kL~dfG~~~~~~~~~  163 (279)
T cd05109          86 VTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNH--VKITDFGLARLLDIDE  163 (279)
T ss_pred             EEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCc--EEECCCCceeeccccc
Confidence            99999999999999764 568888888887776654       9999999999999976654  9999999987654322


Q ss_pred             CC---CCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCC
Q 019195          148 RP---KSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHIS  223 (344)
Q Consensus       148 ~~---~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s  223 (344)
                      ..   ....+++.|+|||.+.+..++ .++|||||||++|+|++ |..||....... ....+.    .....+.....+
T Consensus       164 ~~~~~~~~~~~~~y~~PE~~~~~~~~-~~~Di~slG~~l~el~t~g~~p~~~~~~~~-~~~~~~----~~~~~~~~~~~~  237 (279)
T cd05109         164 TEYHADGGKVPIKWMALESILHRRFT-HQSDVWSYGVTVWELMTFGAKPYDGIPARE-IPDLLE----KGERLPQPPICT  237 (279)
T ss_pred             ceeecCCCccchhhCCHHHhccCCCC-chhHHHHHHHHHHHHHcCCCCCCCCCCHHH-HHHHHH----CCCcCCCCccCC
Confidence            21   122356789999999777665 45999999999999998 999997654322 222222    222333344678


Q ss_pred             HhHHHHHHHhcccCCCCCCChHHHhc
Q 019195          224 QDCRNLLSRIFVANPSRRITIKEIKS  249 (344)
Q Consensus       224 ~~~~~li~~~L~~dp~~R~s~~ell~  249 (344)
                      .++.+++.+||+.||.+||++.+++.
T Consensus       238 ~~~~~li~~~l~~dp~~Rp~~~~l~~  263 (279)
T cd05109         238 IDVYMIMVKCWMIDSECRPRFRELVD  263 (279)
T ss_pred             HHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            99999999999999999999999985

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.8e-39  Score=285.02  Aligned_cols=233  Identities=27%  Similarity=0.369  Sum_probs=185.7

Q ss_pred             eeeeecCceEEEEEEEcCCC---cEEEEEEeecCcc--ccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEEecCCC
Q 019195            8 KDIGSGNFGVARLMRNKNTK---ELVAMKYIERGHK--IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYAAG   82 (344)
Q Consensus         8 ~~lg~G~~g~V~~~~~~~~~---~~vaiK~~~~~~~--~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~   82 (344)
                      +.||+|+||.||+|....++   ..||+|.+.....  ....+.+|+.+++.++||||+++++++. ...++++|||+++
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~   79 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL   79 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence            47999999999999876544   7899999876544  3457889999999999999999999876 4568999999999


Q ss_pred             CChHHHHHhCCCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCCCC----CC
Q 019195           83 GELFERICNAGRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP----KS  151 (344)
Q Consensus        83 g~L~~~i~~~~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~~~----~~  151 (344)
                      ++|.+++.+...+++..++.++.|++.+       +++||||||+|||++.++.  +||+|||+++........    ..
T Consensus        80 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~--~kl~df~~~~~~~~~~~~~~~~~~  157 (257)
T cd05060          80 GPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQ--AKISDFGMSRALGAGSDYYRATTA  157 (257)
T ss_pred             CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCc--EEeccccccceeecCCcccccccC
Confidence            9999999888889999888887776655       9999999999999987664  999999998754333221    11


Q ss_pred             CccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCHhHHHHH
Q 019195          152 TVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLL  230 (344)
Q Consensus       152 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li  230 (344)
                      ..++..|+|||.+.+..++ .++|||||||++|+|++ |.+||........ ...+.    .....+....++..+.++|
T Consensus       158 ~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~-~~~~~----~~~~~~~~~~~~~~l~~li  231 (257)
T cd05060         158 GRWPLKWYAPECINYGKFS-SKSDVWSYGVTLWEAFSYGAKPYGEMKGAEV-IAMLE----SGERLPRPEECPQEIYSIM  231 (257)
T ss_pred             ccccccccCHHHhcCCCCC-ccchHHHHHHHHHHHHcCCCCCcccCCHHHH-HHHHH----cCCcCCCCCCCCHHHHHHH
Confidence            1235679999999777654 45999999999999998 9999977654322 22221    1222344446789999999


Q ss_pred             HHhcccCCCCCCChHHHhc
Q 019195          231 SRIFVANPSRRITIKEIKS  249 (344)
Q Consensus       231 ~~~L~~dp~~R~s~~ell~  249 (344)
                      .+||+.+|.+||++.++++
T Consensus       232 ~~cl~~~p~~Rp~~~~l~~  250 (257)
T cd05060         232 LSCWKYRPEDRPTFSELES  250 (257)
T ss_pred             HHHhcCChhhCcCHHHHHH
Confidence            9999999999999999875

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=3.8e-39  Score=284.25  Aligned_cols=232  Identities=23%  Similarity=0.338  Sum_probs=183.2

Q ss_pred             eeeecCceEEEEEEE--cCCCcEEEEEEeecCcc---ccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEEecCCCC
Q 019195            9 DIGSGNFGVARLMRN--KNTKELVAMKYIERGHK---IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYAAGG   83 (344)
Q Consensus         9 ~lg~G~~g~V~~~~~--~~~~~~vaiK~~~~~~~---~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g   83 (344)
                      .||+|+||.||++..  ..++..+|+|++.....   ....+.+|+.+++.+.||||+++++++. ...+++||||++++
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~   80 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG   80 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence            689999999999864  46788999999865432   2356888999999999999999999875 45678999999999


Q ss_pred             ChHHHHHhCCCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCCC----CCCC
Q 019195           84 ELFERICNAGRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR----PKST  152 (344)
Q Consensus        84 ~L~~~i~~~~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~~----~~~~  152 (344)
                      +|.+++.....+++..+..++.|++.+       ||+||||||.||+++.+.  .+||+|||++........    ....
T Consensus        81 ~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~--~~kl~Dfg~~~~~~~~~~~~~~~~~~  158 (257)
T cd05116          81 PLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQH--YAKISDFGLSKALGADENYYKAKTHG  158 (257)
T ss_pred             cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCC--eEEECCCccccccCCCCCeeeecCCC
Confidence            999999888889998888887776654       999999999999998765  499999999875433221    1222


Q ss_pred             ccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCHhHHHHHH
Q 019195          153 VGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLS  231 (344)
Q Consensus       153 ~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~  231 (344)
                      .++..|+|||.+....++ .++|||||||++|+|++ |..||........    ...+... ...+....+++++.+||.
T Consensus       159 ~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~el~t~g~~p~~~~~~~~~----~~~i~~~-~~~~~~~~~~~~l~~li~  232 (257)
T cd05116         159 KWPVKWYAPECMNYYKFS-SKSDVWSFGVLMWEAFSYGQKPYKGMKGNEV----TQMIESG-ERMECPQRCPPEMYDLMK  232 (257)
T ss_pred             CCCccccCHhHhccCCcC-chhHHHHHHHHHHHHHhCCCCCCCCCCHHHH----HHHHHCC-CCCCCCCCCCHHHHHHHH
Confidence            346789999998766554 45999999999999998 9999987554322    2222221 122333468999999999


Q ss_pred             HhcccCCCCCCChHHHhc
Q 019195          232 RIFVANPSRRITIKEIKS  249 (344)
Q Consensus       232 ~~L~~dp~~R~s~~ell~  249 (344)
                      +||+.||.+||++.++..
T Consensus       233 ~~~~~~p~~Rp~~~~i~~  250 (257)
T cd05116         233 LCWTYGVDERPGFAVVEL  250 (257)
T ss_pred             HHhccCchhCcCHHHHHH
Confidence            999999999999998854

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=4.2e-39  Score=284.45  Aligned_cols=238  Identities=23%  Similarity=0.333  Sum_probs=187.7

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEEecCC
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYAA   81 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~   81 (344)
                      ++|++.+.||+|++|.||++.+..++ .+|+|.+.........+.+|+.+++.++|||++++++++. .+..+++|||+.
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~-~~~lK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~   83 (260)
T cd05069           6 ESLRLDVKLGQGCFGEVWMGTWNGTT-KVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMG   83 (260)
T ss_pred             HHeeeeeeecCcCCCeEEEEEEcCCc-eEEEEEcccCCccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCC
Confidence            57999999999999999999886654 5999988766555567889999999999999999998875 456899999999


Q ss_pred             CCChHHHHHhCC--CCCHHHHHHHHHHHH-------HCCeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCCC--CC
Q 019195           82 GGELFERICNAG--RFSEDEARYFFQQLI-------SGQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR--PK  150 (344)
Q Consensus        82 ~g~L~~~i~~~~--~~~~~~~~~~~~ql~-------~~~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~~--~~  150 (344)
                      +++|.+++....  .++...+..++.|++       +.|++||||||+||+++.++.  ++|+|||++........  ..
T Consensus        84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~--~~l~dfg~~~~~~~~~~~~~~  161 (260)
T cd05069          84 KGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLV--CKIADFGLARLIEDNEYTARQ  161 (260)
T ss_pred             CCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCe--EEECCCccceEccCCcccccC
Confidence            999999997543  467776666665554       559999999999999987654  99999999875432221  12


Q ss_pred             CCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCHhHHHH
Q 019195          151 STVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL  229 (344)
Q Consensus       151 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  229 (344)
                      ...++..|+|||.+.+...+ .++||||||+++|+|++ |..||...........    + ......+....++..+.++
T Consensus       162 ~~~~~~~y~~Pe~~~~~~~~-~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~----~-~~~~~~~~~~~~~~~~~~l  235 (260)
T cd05069         162 GAKFPIKWTAPEAALYGRFT-IKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQ----V-ERGYRMPCPQGCPESLHEL  235 (260)
T ss_pred             CCccchhhCCHHHhccCCcC-hHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH----H-HcCCCCCCCcccCHHHHHH
Confidence            23467789999998776654 55999999999999999 9999987654333222    1 1122333344678999999


Q ss_pred             HHHhcccCCCCCCChHHHhc
Q 019195          230 LSRIFVANPSRRITIKEIKS  249 (344)
Q Consensus       230 i~~~L~~dp~~R~s~~ell~  249 (344)
                      +.+||+.+|.+||++.++++
T Consensus       236 i~~~l~~~p~~Rp~~~~i~~  255 (260)
T cd05069         236 MKLCWKKDPDERPTFEYIQS  255 (260)
T ss_pred             HHHHccCCcccCcCHHHHHH
Confidence            99999999999999999875

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=2.5e-39  Score=292.91  Aligned_cols=241  Identities=24%  Similarity=0.336  Sum_probs=187.9

Q ss_pred             CCceeeeeeeecCceEEEEEEEcC-------CCcEEEEEEeecCcc--ccHHHHHHHHHHhcC-CCCCcceeeEEEEcCC
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKN-------TKELVAMKYIERGHK--IDANVAREIINHKQL-RHPNIIRFKEVVLTPT   71 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~-------~~~~vaiK~~~~~~~--~~~~~~~ei~~l~~l-~h~niv~~~~~~~~~~   71 (344)
                      ++|.+.+.||+|+||.||++.+..       +...+|+|.+.....  ....+.+|+.+++.+ +||||+++++++...+
T Consensus        18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~   97 (307)
T cd05098          18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG   97 (307)
T ss_pred             HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCC
Confidence            579999999999999999998643       235799999875422  224678899999999 7999999999999999


Q ss_pred             EEEEEEecCCCCChHHHHHhCC----------------CCCHHHHHHHHHHHHH-------CCeeecCCCCCCeEecCCC
Q 019195           72 HLAIVMEYAAGGELFERICNAG----------------RFSEDEARYFFQQLIS-------GQICHRDLKLENTLLDGSP  128 (344)
Q Consensus        72 ~~~lv~e~~~~g~L~~~i~~~~----------------~~~~~~~~~~~~ql~~-------~~iiH~Dikp~NIl~~~~~  128 (344)
                      .+|+||||+++++|.+++....                .++..+++.++.|++.       .|++||||||+||+++.++
T Consensus        98 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~~~~  177 (307)
T cd05098          98 PLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDN  177 (307)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHheEEcCCC
Confidence            9999999999999999997642                3677777777666654       4999999999999998665


Q ss_pred             CCCEEEeecCCCcccCCCCC---CCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHH
Q 019195          129 APRLKICDFGYSKSSLLHSR---PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRK  204 (344)
Q Consensus       129 ~~~vkL~DFg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~  204 (344)
                        .+||+|||+++.......   .....+++.|+|||.+.+..++ .++|||||||++|+|++ |..||...... ....
T Consensus       178 --~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DvwslG~~l~el~~~g~~p~~~~~~~-~~~~  253 (307)
T cd05098         178 --VMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYT-HQSDVWSFGVLLWEIFTLGGSPYPGVPVE-ELFK  253 (307)
T ss_pred             --cEEECCCcccccccccchhhccccCCCccceeChHHhccCCCC-cHHHHHHHHHHHHHHHcCCCCCCCcCCHH-HHHH
Confidence              499999999875432211   1122345789999999776664 55999999999999998 88999765432 2222


Q ss_pred             HHHHHhhccccCCCCCCCCHhHHHHHHHhcccCCCCCCChHHHhcC
Q 019195          205 TISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSH  250 (344)
Q Consensus       205 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~ell~h  250 (344)
                      .+.    .....+....++.++.+||.+||..+|.+|||+.+++++
T Consensus       254 ~~~----~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~  295 (307)
T cd05098         254 LLK----EGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED  295 (307)
T ss_pred             HHH----cCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence            221    222223334678999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=2.8e-39  Score=288.79  Aligned_cols=240  Identities=24%  Similarity=0.370  Sum_probs=189.3

Q ss_pred             CCceeeeeeeecCceEEEEEEEc-----CCCcEEEEEEeecCcc-ccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEE
Q 019195            2 EKYELMKDIGSGNFGVARLMRNK-----NTKELVAMKYIERGHK-IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAI   75 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~-~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~l   75 (344)
                      .+|++.++||+|+||.||++...     .++..+|+|.+..... ....+.+|+.+++.++|+||+++++++......++
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (280)
T cd05092           5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM   84 (280)
T ss_pred             HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence            47899999999999999999743     3567899998765432 23568899999999999999999999999999999


Q ss_pred             EEecCCCCChHHHHHhCC---------------CCCHHHHHHHHHHHHH-------CCeeecCCCCCCeEecCCCCCCEE
Q 019195           76 VMEYAAGGELFERICNAG---------------RFSEDEARYFFQQLIS-------GQICHRDLKLENTLLDGSPAPRLK  133 (344)
Q Consensus        76 v~e~~~~g~L~~~i~~~~---------------~~~~~~~~~~~~ql~~-------~~iiH~Dikp~NIl~~~~~~~~vk  133 (344)
                      +|||+++++|.+++....               .+++..++.++.|++.       .|++||||||+|||++.++  .+|
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~~--~~k  162 (280)
T cd05092          85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGL--VVK  162 (280)
T ss_pred             EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCCC--CEE
Confidence            999999999999987643               3677777777766654       4999999999999998655  499


Q ss_pred             EeecCCCcccCCCC---CCCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHH
Q 019195          134 ICDFGYSKSSLLHS---RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRI  209 (344)
Q Consensus       134 L~DFg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~  209 (344)
                      |+|||++.......   ......+++.|+|||.+.+..++ .++|||||||++|+|++ |.+||.............   
T Consensus       163 L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~---  238 (280)
T cd05092         163 IGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFT-TESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECIT---  238 (280)
T ss_pred             ECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcC-chhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHHH---
Confidence            99999986433221   12233467889999999877765 45999999999999998 999997765443332221   


Q ss_pred             hhccccCCCCCCCCHhHHHHHHHhcccCCCCCCChHHHhc
Q 019195          210 MAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKS  249 (344)
Q Consensus       210 ~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~ell~  249 (344)
                       .. ........+++.+.+||.+||+.||.+||++.++++
T Consensus       239 -~~-~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~  276 (280)
T cd05092         239 -QG-RELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS  276 (280)
T ss_pred             -cC-ccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence             11 122223467899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.1e-39  Score=286.83  Aligned_cols=239  Identities=21%  Similarity=0.338  Sum_probs=186.0

Q ss_pred             ceeeeeeeecCceEEEEEEEcC---CCcEEEEEEeecCccc---cHHHHHHHHHHhcCCCCCcceeeEEEEcCCE-----
Q 019195            4 YELMKDIGSGNFGVARLMRNKN---TKELVAMKYIERGHKI---DANVAREIINHKQLRHPNIIRFKEVVLTPTH-----   72 (344)
Q Consensus         4 y~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~~---~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~-----   72 (344)
                      |++.+.||+|+||.||+|....   ++..||+|.+......   ...+.+|+..++.++||||+++++++.....     
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   80 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP   80 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence            6789999999999999998764   3478999998754322   2467899999999999999999998866544     


Q ss_pred             -EEEEEecCCCCChHHHHHhC------CCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecC
Q 019195           73 -LAIVMEYAAGGELFERICNA------GRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFG  138 (344)
Q Consensus        73 -~~lv~e~~~~g~L~~~i~~~------~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg  138 (344)
                       .+++|||+++++|..++...      ..+++..++.++.|++.+       +++||||||+||+++.+..  +||+|||
T Consensus        81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~--~kl~dfg  158 (273)
T cd05035          81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMT--VCVADFG  158 (273)
T ss_pred             ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCe--EEECCcc
Confidence             79999999999999888542      357887777777666654       9999999999999987654  9999999


Q ss_pred             CCcccCCCCC---CCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhhccc
Q 019195          139 YSKSSLLHSR---PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQY  214 (344)
Q Consensus       139 ~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~  214 (344)
                      +++.......   .....++..|+|||.+.+..++ .++|||||||++|+|++ |.+||........+..    +... .
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~-~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~----~~~~-~  232 (273)
T cd05035         159 LSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYT-SKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDY----LRHG-N  232 (273)
T ss_pred             ceeeccccccccccccccCCccccCHhhcccCCCC-cccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHH----HHcC-C
Confidence            9875433221   1223456789999998766654 55999999999999999 9999977654333222    2211 1


Q ss_pred             cCCCCCCCCHhHHHHHHHhcccCCCCCCChHHHhcC
Q 019195          215 KIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSH  250 (344)
Q Consensus       215 ~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~ell~h  250 (344)
                      ..+....+++.+.+++.+||+.||.+|||+.+++++
T Consensus       233 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~  268 (273)
T cd05035         233 RLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREV  268 (273)
T ss_pred             CCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            222334678999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=1.3e-39  Score=287.44  Aligned_cols=242  Identities=30%  Similarity=0.474  Sum_probs=192.0

Q ss_pred             CceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCc------cccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEE
Q 019195            3 KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH------KIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIV   76 (344)
Q Consensus         3 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv   76 (344)
                      ||.+.+.||+|+||.||++.+..++..+++|++....      .....+.+|+.+++.++||||+++++++......+++
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII   80 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence            7999999999999999999998887777777765421      1223566789999999999999999999999999999


Q ss_pred             EecCCCCChHHHHHh----CCCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCC
Q 019195           77 MEYAAGGELFERICN----AGRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLL  145 (344)
Q Consensus        77 ~e~~~~g~L~~~i~~----~~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~  145 (344)
                      |||+++++|..++..    ...+++.+++.++.|++.+       |++|+||||+||+++.+   .++|+|||++.....
T Consensus        81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~~---~~~l~d~g~~~~~~~  157 (260)
T cd08222          81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKNN---LLKIGDFGVSRLLMG  157 (260)
T ss_pred             EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeecC---CEeecccCceeecCC
Confidence            999999999988853    3568888877777666654       99999999999999743   399999999875433


Q ss_pred             CCC-CCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCH
Q 019195          146 HSR-PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQ  224 (344)
Q Consensus       146 ~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~  224 (344)
                      ... .....|++.|+|||.+.+..++.+ +|+||||+++|+|++|..||........    ...+..... ......++.
T Consensus       158 ~~~~~~~~~~~~~~~~pe~~~~~~~~~~-~Dv~slG~~~~~l~~~~~~~~~~~~~~~----~~~~~~~~~-~~~~~~~~~  231 (260)
T cd08222         158 SCDLATTFTGTPYYMSPEALKHQGYDSK-SDIWSLGCILYEMCCLAHAFEGQNFLSV----VLRIVEGPT-PSLPETYSR  231 (260)
T ss_pred             CcccccCCCCCcCccCHHHHccCCCCch-hhHHHHHHHHHHHHhCCCCCCCccHHHH----HHHHHcCCC-CCCcchhcH
Confidence            322 234568999999999877666544 9999999999999999999976543222    222222111 111235788


Q ss_pred             hHHHHHHHhcccCCCCCCChHHHhcCccc
Q 019195          225 DCRNLLSRIFVANPSRRITIKEIKSHPWF  253 (344)
Q Consensus       225 ~~~~li~~~L~~dp~~R~s~~ell~hp~~  253 (344)
                      ++.++|.+||..+|.+||++.++++||||
T Consensus       232 ~~~~li~~~l~~~p~~Rp~~~~il~~~~~  260 (260)
T cd08222         232 QLNSIMQSMLNKDPSLRPSAAEILRNPFI  260 (260)
T ss_pred             HHHHHHHHHhcCChhhCcCHHHHhhCCCC
Confidence            99999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=2.2e-39  Score=302.35  Aligned_cols=242  Identities=24%  Similarity=0.371  Sum_probs=188.0

Q ss_pred             CCceeeeeeeecCceEEEEEEEc-----CCCcEEEEEEeecCccc--cHHHHHHHHHHhcCC-CCCcceeeEEEEcCCEE
Q 019195            2 EKYELMKDIGSGNFGVARLMRNK-----NTKELVAMKYIERGHKI--DANVAREIINHKQLR-HPNIIRFKEVVLTPTHL   73 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~~--~~~~~~ei~~l~~l~-h~niv~~~~~~~~~~~~   73 (344)
                      ++|.+.+.||+|+||.||+|.+.     .++..||+|++......  ...+.+|+.++.++. ||||+++++++...+.+
T Consensus        37 ~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~~  116 (401)
T cd05107          37 DNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGPI  116 (401)
T ss_pred             HHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCCc
Confidence            46788899999999999999853     45578999999764322  246889999999997 99999999999999999


Q ss_pred             EEEEecCCCCChHHHHHhCC------------------------------------------------------------
Q 019195           74 AIVMEYAAGGELFERICNAG------------------------------------------------------------   93 (344)
Q Consensus        74 ~lv~e~~~~g~L~~~i~~~~------------------------------------------------------------   93 (344)
                      ++|||||++|+|.+++...+                                                            
T Consensus       117 ~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  196 (401)
T cd05107         117 YIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDMK  196 (401)
T ss_pred             EEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcch
Confidence            99999999999999986532                                                            


Q ss_pred             --------------------------------------CCCHHHHHHHHH-------HHHHCCeeecCCCCCCeEecCCC
Q 019195           94 --------------------------------------RFSEDEARYFFQ-------QLISGQICHRDLKLENTLLDGSP  128 (344)
Q Consensus        94 --------------------------------------~~~~~~~~~~~~-------ql~~~~iiH~Dikp~NIl~~~~~  128 (344)
                                                            .++...++.++.       .||+.+|+||||||+|||++.+.
T Consensus       197 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~NiLl~~~~  276 (401)
T cd05107         197 GTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLICEGK  276 (401)
T ss_pred             hhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceEEEeCCC
Confidence                                                  133444444444       45556999999999999998655


Q ss_pred             CCCEEEeecCCCcccCCCC---CCCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHH
Q 019195          129 APRLKICDFGYSKSSLLHS---RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRK  204 (344)
Q Consensus       129 ~~~vkL~DFg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~  204 (344)
                        .+||+|||+++......   ......+++.|+|||.+.+..+. .++|||||||++|+|++ |..||......+....
T Consensus       277 --~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DvwslGvil~e~l~~g~~P~~~~~~~~~~~~  353 (401)
T cd05107         277 --LVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYT-TLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYN  353 (401)
T ss_pred             --EEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCC-cHhHHHHHHHHHHHHHHcCCCCCCCCCchHHHHH
Confidence              49999999987533221   12334578899999999877654 55999999999999998 8999976554333322


Q ss_pred             HHHHHhhccccCCCCCCCCHhHHHHHHHhcccCCCCCCChHHHhcC
Q 019195          205 TISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSH  250 (344)
Q Consensus       205 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~ell~h  250 (344)
                      .+.    ...+.+.+..++.++.+|+.+||+.+|.+||++.+++..
T Consensus       354 ~~~----~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~  395 (401)
T cd05107         354 AIK----RGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHL  395 (401)
T ss_pred             HHH----cCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            222    223333344678999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.7e-39  Score=291.03  Aligned_cols=245  Identities=24%  Similarity=0.351  Sum_probs=186.2

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCC--------------CcEEEEEEeecCcc--ccHHHHHHHHHHhcCCCCCcceeeE
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNT--------------KELVAMKYIERGHK--IDANVAREIINHKQLRHPNIIRFKE   65 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~--------------~~~vaiK~~~~~~~--~~~~~~~ei~~l~~l~h~niv~~~~   65 (344)
                      ++|++.+.||+|+||.||+|.+..+              ...||+|.+.....  ....+.+|++++++++||||+++++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~   84 (295)
T cd05097           5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG   84 (295)
T ss_pred             HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence            4899999999999999999987543              23589999875422  2346889999999999999999999


Q ss_pred             EEEcCCEEEEEEecCCCCChHHHHHhCC------------CCCHHHHHHHHHHHH-------HCCeeecCCCCCCeEecC
Q 019195           66 VVLTPTHLAIVMEYAAGGELFERICNAG------------RFSEDEARYFFQQLI-------SGQICHRDLKLENTLLDG  126 (344)
Q Consensus        66 ~~~~~~~~~lv~e~~~~g~L~~~i~~~~------------~~~~~~~~~~~~ql~-------~~~iiH~Dikp~NIl~~~  126 (344)
                      ++......++||||+++++|.+++....            .++...++.++.|++       +.|++||||||+||+++.
T Consensus        85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nill~~  164 (295)
T cd05097          85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGN  164 (295)
T ss_pred             EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhEEEcC
Confidence            9999999999999999999999986532            256666666665555       459999999999999986


Q ss_pred             CCCCCEEEeecCCCcccCCCCC---CCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHh--CCCCCCCCCChHH
Q 019195          127 SPAPRLKICDFGYSKSSLLHSR---PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV--GAYPFEDQEDPKN  201 (344)
Q Consensus       127 ~~~~~vkL~DFg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~--g~~pf~~~~~~~~  201 (344)
                      ++.  +||+|||++........   .....++..|+|||.+.+..+ +.++|||||||++|+|++  |..||........
T Consensus       165 ~~~--~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~~  241 (295)
T cd05097         165 HYT--IKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKF-TTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQV  241 (295)
T ss_pred             CCc--EEecccccccccccCcceeccCcCcCceeecChhhhccCCc-CchhhHHHHHHHHHHHHHcCCCCCCcccChHHH
Confidence            654  99999999875432221   122345778999999887766 455999999999999988  6778877654333


Q ss_pred             HHHHHHHHhh--ccccCCCCCCCCHhHHHHHHHhcccCCCCCCChHHHhc
Q 019195          202 FRKTISRIMA--VQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKS  249 (344)
Q Consensus       202 ~~~~~~~~~~--~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~ell~  249 (344)
                      ..........  ...........++.+.+|+.+||+.+|.+|||+.++++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~  291 (295)
T cd05097         242 IENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH  291 (295)
T ss_pred             HHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence            3322221111  11111223346789999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=4.5e-39  Score=285.35  Aligned_cols=240  Identities=25%  Similarity=0.382  Sum_probs=191.1

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCC---cEEEEEEeecCcc--ccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEE
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTK---ELVAMKYIERGHK--IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIV   76 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~---~~vaiK~~~~~~~--~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv   76 (344)
                      .+|++.+.||+|+||.||++.+..++   ..+|+|.+.....  ....+.+|+.++++++||||+++++++..++..|++
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   83 (267)
T cd05066           4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV   83 (267)
T ss_pred             HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence            57999999999999999999886444   3799998865432  235688999999999999999999999999999999


Q ss_pred             EecCCCCChHHHHHhC-CCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCCC
Q 019195           77 MEYAAGGELFERICNA-GRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR  148 (344)
Q Consensus        77 ~e~~~~g~L~~~i~~~-~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~~  148 (344)
                      |||+++++|.+++... +.++..++..++.|++.+       |++||||||+|||++.++  .++|+|||++........
T Consensus        84 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~--~~~l~dfg~~~~~~~~~~  161 (267)
T cd05066          84 TEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNL--VCKVSDFGLSRVLEDDPE  161 (267)
T ss_pred             EEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCC--eEEeCCCCcccccccccc
Confidence            9999999999999764 467888888777776654       999999999999997665  499999999875433221


Q ss_pred             C----CCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCC
Q 019195          149 P----KSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHIS  223 (344)
Q Consensus       149 ~----~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s  223 (344)
                      .    ....++..|+|||.+.+..++ .++|+|||||++|++++ |..||...........    +. .....|....++
T Consensus       162 ~~~~~~~~~~~~~y~~pe~~~~~~~~-~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~----~~-~~~~~~~~~~~~  235 (267)
T cd05066         162 AAYTTRGGKIPIRWTAPEAIAYRKFT-SASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKA----IE-EGYRLPAPMDCP  235 (267)
T ss_pred             eeeecCCCccceeecCHhHhccCccC-chhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHH----Hh-CCCcCCCCCCCC
Confidence            1    112235689999999876654 55999999999999886 9999977654332222    22 123445555678


Q ss_pred             HhHHHHHHHhcccCCCCCCChHHHhc
Q 019195          224 QDCRNLLSRIFVANPSRRITIKEIKS  249 (344)
Q Consensus       224 ~~~~~li~~~L~~dp~~R~s~~ell~  249 (344)
                      +.+.+++.+||+.+|.+||++.++++
T Consensus       236 ~~~~~li~~~l~~~p~~Rp~~~~i~~  261 (267)
T cd05066         236 AALHQLMLDCWQKDRNERPKFEQIVS  261 (267)
T ss_pred             HHHHHHHHHHcccCchhCCCHHHHHH
Confidence            99999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=4.6e-39  Score=288.98  Aligned_cols=240  Identities=25%  Similarity=0.370  Sum_probs=189.8

Q ss_pred             CCceeeeeeeecCceEEEEEEEc-----CCCcEEEEEEeecCccc-cHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEE
Q 019195            2 EKYELMKDIGSGNFGVARLMRNK-----NTKELVAMKYIERGHKI-DANVAREIINHKQLRHPNIIRFKEVVLTPTHLAI   75 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~~-~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~l   75 (344)
                      .+|.+.+.||+|+||.||++.+.     .++..+++|.+...... ...+.+|+.+++.++||||+++++++......++
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (291)
T cd05094           5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM   84 (291)
T ss_pred             HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence            46899999999999999999854     34567899988654332 2468899999999999999999999999999999


Q ss_pred             EEecCCCCChHHHHHhCC----------------CCCHHHHHHHHHHHHH-------CCeeecCCCCCCeEecCCCCCCE
Q 019195           76 VMEYAAGGELFERICNAG----------------RFSEDEARYFFQQLIS-------GQICHRDLKLENTLLDGSPAPRL  132 (344)
Q Consensus        76 v~e~~~~g~L~~~i~~~~----------------~~~~~~~~~~~~ql~~-------~~iiH~Dikp~NIl~~~~~~~~v  132 (344)
                      ||||+++++|.+++...+                .+++..++.++.||+.       .||+||||||+|||++.++.  +
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~~~--~  162 (291)
T cd05094          85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLL--V  162 (291)
T ss_pred             EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCc--E
Confidence            999999999999996532                3777877777777664       49999999999999987654  9


Q ss_pred             EEeecCCCcccCCCC---CCCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHH
Q 019195          133 KICDFGYSKSSLLHS---RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISR  208 (344)
Q Consensus       133 kL~DFg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~  208 (344)
                      +|+|||++.......   ......++..|+|||.+.+..++ .++|||||||++|+|++ |..||..........    .
T Consensus       163 ~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~----~  237 (291)
T cd05094         163 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFT-TESDVWSFGVILWEIFTYGKQPWFQLSNTEVIE----C  237 (291)
T ss_pred             EECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH----H
Confidence            999999987543322   12334578899999999877664 45999999999999998 999997765433222    2


Q ss_pred             HhhccccCCCCCCCCHhHHHHHHHhcccCCCCCCChHHHhc
Q 019195          209 IMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKS  249 (344)
Q Consensus       209 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~ell~  249 (344)
                      +..... .......+..+.+++.+||+.+|.+|||+.++++
T Consensus       238 ~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~  277 (291)
T cd05094         238 ITQGRV-LERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYK  277 (291)
T ss_pred             HhCCCC-CCCCccCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence            222221 1122346889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=4.2e-39  Score=283.68  Aligned_cols=236  Identities=24%  Similarity=0.398  Sum_probs=186.0

Q ss_pred             CCCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcCCCCCcceeeEEEE-cCCEEEEEEec
Q 019195            1 MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKEVVL-TPTHLAIVMEY   79 (344)
Q Consensus         1 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~l~~l~h~niv~~~~~~~-~~~~~~lv~e~   79 (344)
                      +++|++.+.||+|+||.||++...  +..||+|.+.... ....+.+|+.++++++|+|++++++++. .+...+++|||
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~--~~~~~~k~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~   81 (256)
T cd05082           5 MKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY   81 (256)
T ss_pred             HHhCeeeeeecccCCCeEEEEEEc--CCcEEEEEeCCCc-hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEEC
Confidence            468999999999999999999764  6789999886543 3456889999999999999999999764 55678999999


Q ss_pred             CCCCChHHHHHhCC--CCCHHHHHHHHHHHHH-------CCeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCCCCC
Q 019195           80 AAGGELFERICNAG--RFSEDEARYFFQQLIS-------GQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPK  150 (344)
Q Consensus        80 ~~~g~L~~~i~~~~--~~~~~~~~~~~~ql~~-------~~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~~~~  150 (344)
                      +++++|.+++.+..  .+++..++.++.|++.       .|++||||||+||+++.++.  +||+|||++......  ..
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~--~kl~dfg~~~~~~~~--~~  157 (256)
T cd05082          82 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNV--AKVSDFGLTKEASST--QD  157 (256)
T ss_pred             CCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCc--EEecCCccceecccc--CC
Confidence            99999999997654  3677777777666554       49999999999999977654  999999998753322  23


Q ss_pred             CCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCHhHHHH
Q 019195          151 STVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL  229 (344)
Q Consensus       151 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  229 (344)
                      ...++..|+|||++.+..++ .++|||||||++|+|++ |+.||.......    ....+.. .........+++.+.++
T Consensus       158 ~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~----~~~~~~~-~~~~~~~~~~~~~~~~l  231 (256)
T cd05082         158 TGKLPVKWTAPEALREKKFS-TKSDVWSFGILLWEIYSFGRVPYPRIPLKD----VVPRVEK-GYKMDAPDGCPPVVYDV  231 (256)
T ss_pred             CCccceeecCHHHHccCCCC-chhhhHHHHHHHHHHHhCCCCCCCCCCHHH----HHHHHhc-CCCCCCCCCCCHHHHHH
Confidence            34456789999998776664 45999999999999997 999997654322    2222211 12222234678999999


Q ss_pred             HHHhcccCCCCCCChHHHhc
Q 019195          230 LSRIFVANPSRRITIKEIKS  249 (344)
Q Consensus       230 i~~~L~~dp~~R~s~~ell~  249 (344)
                      +.+||+.+|.+|||+.++++
T Consensus       232 i~~~l~~~p~~Rpt~~~l~~  251 (256)
T cd05082         232 MKQCWHLDAATRPSFLQLRE  251 (256)
T ss_pred             HHHHhcCChhhCcCHHHHHH
Confidence            99999999999999999975

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=3.7e-39  Score=286.12  Aligned_cols=240  Identities=24%  Similarity=0.380  Sum_probs=190.8

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCc---EEEEEEeecCc--cccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEE
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKE---LVAMKYIERGH--KIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIV   76 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~---~vaiK~~~~~~--~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv   76 (344)
                      ..|++.+.||+|+||.||+|....+++   .||+|++....  .....+..|+.+++.++||||+++++++..+..+++|
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv   83 (269)
T cd05065           4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII   83 (269)
T ss_pred             HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence            579999999999999999999887664   69999987532  2235788999999999999999999999999999999


Q ss_pred             EecCCCCChHHHHHh-CCCCCHHHHHHHHHHHHH-------CCeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCCC
Q 019195           77 MEYAAGGELFERICN-AGRFSEDEARYFFQQLIS-------GQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR  148 (344)
Q Consensus        77 ~e~~~~g~L~~~i~~-~~~~~~~~~~~~~~ql~~-------~~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~~  148 (344)
                      |||+++++|..++.. .+.++..+++.++.|++.       .|++||||||+||+++.+.  .+||+|||++........
T Consensus        84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~--~~kl~dfg~~~~~~~~~~  161 (269)
T cd05065          84 TEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNL--VCKVSDFGLSRFLEDDTS  161 (269)
T ss_pred             EecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCC--cEEECCCccccccccCcc
Confidence            999999999999875 456888888887777654       4999999999999997665  499999999865432222


Q ss_pred             CCC---Cc---cCCcccCCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhhccccCCCCCC
Q 019195          149 PKS---TV---GTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVH  221 (344)
Q Consensus       149 ~~~---~~---gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  221 (344)
                      ...   ..   .+..|+|||.+.+..++ .++|||||||++|+|++ |..||..........    .+ ......|....
T Consensus       162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~-~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~----~i-~~~~~~~~~~~  235 (269)
T cd05065         162 DPTYTSSLGGKIPIRWTAPEAIAYRKFT-SASDVWSYGIVMWEVMSYGERPYWDMSNQDVIN----AI-EQDYRLPPPMD  235 (269)
T ss_pred             ccccccccCCCcceeecCHhHhccCccc-chhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHH----HH-HcCCcCCCccc
Confidence            111   11   24579999999877765 45999999999999886 999997765432222    22 12234444456


Q ss_pred             CCHhHHHHHHHhcccCCCCCCChHHHhc
Q 019195          222 ISQDCRNLLSRIFVANPSRRITIKEIKS  249 (344)
Q Consensus       222 ~s~~~~~li~~~L~~dp~~R~s~~ell~  249 (344)
                      ++..+.+++.+||+.+|.+||++.+++.
T Consensus       236 ~~~~~~~li~~~l~~~p~~Rp~~~~i~~  263 (269)
T cd05065         236 CPTALHQLMLDCWQKDRNARPKFGQIVS  263 (269)
T ss_pred             CCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            7889999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=2.4e-39  Score=297.54  Aligned_cols=242  Identities=24%  Similarity=0.385  Sum_probs=183.7

Q ss_pred             CCceeeeeeeecCceEEEEEEE-----cCCCcEEEEEEeecCcc--ccHHHHHHHHHHhcC-CCCCcceeeEEEEcC-CE
Q 019195            2 EKYELMKDIGSGNFGVARLMRN-----KNTKELVAMKYIERGHK--IDANVAREIINHKQL-RHPNIIRFKEVVLTP-TH   72 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~vaiK~~~~~~~--~~~~~~~ei~~l~~l-~h~niv~~~~~~~~~-~~   72 (344)
                      ++|++.+.||+|+||.||+|.+     ..+++.||||++.....  ....+.+|+.++.++ +||||+++++++... ..
T Consensus         7 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~   86 (343)
T cd05103           7 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP   86 (343)
T ss_pred             hHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCCc
Confidence            5899999999999999999984     35678999999875432  234678999999999 689999999988654 56


Q ss_pred             EEEEEecCCCCChHHHHHhCC-----------------------------------------------------------
Q 019195           73 LAIVMEYAAGGELFERICNAG-----------------------------------------------------------   93 (344)
Q Consensus        73 ~~lv~e~~~~g~L~~~i~~~~-----------------------------------------------------------   93 (344)
                      ++++||||++|+|.+++....                                                           
T Consensus        87 ~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  166 (343)
T cd05103          87 LMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEA  166 (343)
T ss_pred             eEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhh
Confidence            899999999999999986431                                                           


Q ss_pred             --------CCCHHHHHHHHHH-------HHHCCeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCC---CCCCCccC
Q 019195           94 --------RFSEDEARYFFQQ-------LISGQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS---RPKSTVGT  155 (344)
Q Consensus        94 --------~~~~~~~~~~~~q-------l~~~~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~---~~~~~~gt  155 (344)
                              .++..++..++.|       +|+.||+||||||+|||++.++.  +||+|||++.......   ......++
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~~~  244 (343)
T cd05103         167 EQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNV--VKICDFGLARDIYKDPDYVRKGDARLP  244 (343)
T ss_pred             hhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCc--EEEEecccccccccCcchhhcCCCCCC
Confidence                    2344444445444       55569999999999999986654  9999999987542221   11223456


Q ss_pred             CcccCCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCHhHHHHHHHhc
Q 019195          156 PAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIF  234 (344)
Q Consensus       156 ~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L  234 (344)
                      +.|+|||.+.+..++ .++|||||||++|+|++ |..||........+...+.    .....+.....++++.+++.+||
T Consensus       245 ~~y~aPE~~~~~~~~-~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~cl  319 (343)
T cd05103         245 LKWMAPETIFDRVYT-IQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLK----EGTRMRAPDYTTPEMYQTMLDCW  319 (343)
T ss_pred             cceECcHHhcCCCCC-chhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHh----ccCCCCCCCCCCHHHHHHHHHHc
Confidence            789999999777664 45999999999999997 9999976544333222221    11122222346889999999999


Q ss_pred             ccCCCCCCChHHHhcC
Q 019195          235 VANPSRRITIKEIKSH  250 (344)
Q Consensus       235 ~~dp~~R~s~~ell~h  250 (344)
                      +.+|.+|||+.++++|
T Consensus       320 ~~~p~~Rps~~eil~~  335 (343)
T cd05103         320 HGEPSQRPTFSELVEH  335 (343)
T ss_pred             cCChhhCcCHHHHHHH
Confidence            9999999999999886

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=4.8e-39  Score=289.55  Aligned_cols=245  Identities=24%  Similarity=0.375  Sum_probs=187.0

Q ss_pred             CCceeeeeeeecCceEEEEEEEcC----------------CCcEEEEEEeecCcc--ccHHHHHHHHHHhcCCCCCccee
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKN----------------TKELVAMKYIERGHK--IDANVAREIINHKQLRHPNIIRF   63 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~----------------~~~~vaiK~~~~~~~--~~~~~~~ei~~l~~l~h~niv~~   63 (344)
                      ++|++.+.||+|+||.||++.+..                ++..||+|++.....  ....+.+|+.+++.++|+||+++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~   84 (296)
T cd05095           5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL   84 (296)
T ss_pred             hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence            479999999999999999986432                345799999875432  23568899999999999999999


Q ss_pred             eEEEEcCCEEEEEEecCCCCChHHHHHhCC-----------CCCHHHHHHHHHHH-------HHCCeeecCCCCCCeEec
Q 019195           64 KEVVLTPTHLAIVMEYAAGGELFERICNAG-----------RFSEDEARYFFQQL-------ISGQICHRDLKLENTLLD  125 (344)
Q Consensus        64 ~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~-----------~~~~~~~~~~~~ql-------~~~~iiH~Dikp~NIl~~  125 (344)
                      ++++...+..+++|||+++++|.+++.+..           .++...++.++.|+       |+.|++||||||+|||++
T Consensus        85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Nili~  164 (296)
T cd05095          85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVG  164 (296)
T ss_pred             EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChheEEEc
Confidence            999999999999999999999999987643           24556666666555       455999999999999997


Q ss_pred             CCCCCCEEEeecCCCcccCCCCC---CCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHh--CCCCCCCCCChH
Q 019195          126 GSPAPRLKICDFGYSKSSLLHSR---PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV--GAYPFEDQEDPK  200 (344)
Q Consensus       126 ~~~~~~vkL~DFg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~--g~~pf~~~~~~~  200 (344)
                      .++  .++|+|||++........   .....+++.|+|||...+..++ .++|||||||++|+|++  |..||.......
T Consensus       165 ~~~--~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~-~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~  241 (296)
T cd05095         165 KNY--TIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFT-TASDVWAFGVTLWEILTLCKEQPYSQLSDEQ  241 (296)
T ss_pred             CCC--CEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCcc-chhhhhHHHHHHHHHHHhCCCCCccccChHH
Confidence            655  499999999875432221   1223456789999988777654 55999999999999998  778997665443


Q ss_pred             HHHHHHHHHhh--ccccCCCCCCCCHhHHHHHHHhcccCCCCCCChHHHhc
Q 019195          201 NFRKTISRIMA--VQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKS  249 (344)
Q Consensus       201 ~~~~~~~~~~~--~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~ell~  249 (344)
                      ...........  .....+....+++.+.+|+.+||+.||.+||++.++++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~  292 (296)
T cd05095         242 VIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHA  292 (296)
T ss_pred             HHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            33222111111  11123334467899999999999999999999999865

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=7e-39  Score=281.96  Aligned_cols=238  Identities=27%  Similarity=0.415  Sum_probs=192.6

Q ss_pred             ceeeeeeeecCceEEEEEEEcCCC----cEEEEEEeecCcc--ccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEE
Q 019195            4 YELMKDIGSGNFGVARLMRNKNTK----ELVAMKYIERGHK--IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVM   77 (344)
Q Consensus         4 y~~~~~lg~G~~g~V~~~~~~~~~----~~vaiK~~~~~~~--~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~   77 (344)
                      +++.+.||.|+||.||++.+...+    ..||+|.+.....  ....+.+|+..++.++|+||+++++++...+..+++|
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~   80 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM   80 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence            467899999999999999998766    8999999976543  3467889999999999999999999999999999999


Q ss_pred             ecCCCCChHHHHHhCCC--CCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCCC
Q 019195           78 EYAAGGELFERICNAGR--FSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR  148 (344)
Q Consensus        78 e~~~~g~L~~~i~~~~~--~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~~  148 (344)
                      ||+++++|.+++.....  +++.++..++.|++.+       +++||||||+||+++.++.  ++|+|||++........
T Consensus        81 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~--~~l~dfg~~~~~~~~~~  158 (258)
T smart00219       81 EYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLV--VKISDFGLSRDLYDDDY  158 (258)
T ss_pred             eccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCe--EEEcccCCceecccccc
Confidence            99999999999976544  8999988888887664       9999999999999987664  99999999875443311


Q ss_pred             CC--CCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCHh
Q 019195          149 PK--STVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQD  225 (344)
Q Consensus       149 ~~--~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~  225 (344)
                      ..  ...+++.|+|||.+.+..+ +.++||||||+++|+|++ |.+||...........    +... ...+....++.+
T Consensus       159 ~~~~~~~~~~~y~~Pe~~~~~~~-~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~----~~~~-~~~~~~~~~~~~  232 (258)
T smart00219      159 YKKKGGKLPIRWMAPESLKDGKF-TSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEY----LKKG-YRLPKPENCPPE  232 (258)
T ss_pred             cccccCCCcccccChHHhccCCC-CcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH----HhcC-CCCCCCCcCCHH
Confidence            11  2237789999999865555 456999999999999998 8899877544332222    2211 122333457899


Q ss_pred             HHHHHHHhcccCCCCCCChHHHhc
Q 019195          226 CRNLLSRIFVANPSRRITIKEIKS  249 (344)
Q Consensus       226 ~~~li~~~L~~dp~~R~s~~ell~  249 (344)
                      +.+++.+||+.+|.+|||+.++++
T Consensus       233 ~~~~i~~~l~~~p~~Rpt~~~ll~  256 (258)
T smart00219      233 IYKLMLQCWAEDPEDRPTFSELVE  256 (258)
T ss_pred             HHHHHHHHCcCChhhCcCHHHHHh
Confidence            999999999999999999999986

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=6.5e-39  Score=287.78  Aligned_cols=239  Identities=23%  Similarity=0.341  Sum_probs=186.8

Q ss_pred             CceeeeeeeecCceEEEEEEEcC-----CCcEEEEEEeecCcc--ccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEE
Q 019195            3 KYELMKDIGSGNFGVARLMRNKN-----TKELVAMKYIERGHK--IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAI   75 (344)
Q Consensus         3 ~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~--~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~l   75 (344)
                      +|++.+.||+|+||.||++.+..     ....+|+|.+.....  ....+.+|+.+++.++||||+++++.+...+..++
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   80 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL   80 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence            58999999999999999998753     335788998865432  23568899999999999999999999999999999


Q ss_pred             EEecCCCCChHHHHHhC------------------------CCCCHHHHHHHHHHHH-------HCCeeecCCCCCCeEe
Q 019195           76 VMEYAAGGELFERICNA------------------------GRFSEDEARYFFQQLI-------SGQICHRDLKLENTLL  124 (344)
Q Consensus        76 v~e~~~~g~L~~~i~~~------------------------~~~~~~~~~~~~~ql~-------~~~iiH~Dikp~NIl~  124 (344)
                      +|||+.+++|.+++...                        ..++...++.++.|++       +.+|+||||||+|||+
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~nill  160 (290)
T cd05045          81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLV  160 (290)
T ss_pred             EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheEEE
Confidence            99999999999998643                        2356666666665555       4599999999999999


Q ss_pred             cCCCCCCEEEeecCCCcccCCCCC---CCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChH
Q 019195          125 DGSPAPRLKICDFGYSKSSLLHSR---PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPK  200 (344)
Q Consensus       125 ~~~~~~~vkL~DFg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~  200 (344)
                      +.++.  +||+|||+++.......   .....++..|+|||.+.+..++ .++||||||+++|+|++ |..||.+.....
T Consensus       161 ~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~-~~~Di~slG~~l~el~t~g~~p~~~~~~~~  237 (290)
T cd05045         161 AEGRK--MKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYT-TQSDVWSFGVLLWEIVTLGGNPYPGIAPER  237 (290)
T ss_pred             cCCCc--EEeccccccccccCccchhcccCCCCCccccCHHHHccCCcc-hHhHHHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence            87654  99999999875432221   2233467789999998776654 55999999999999998 999997655332


Q ss_pred             HHHHHHHHHhhccccCCCCCCCCHhHHHHHHHhcccCCCCCCChHHHhc
Q 019195          201 NFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKS  249 (344)
Q Consensus       201 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~ell~  249 (344)
                      . .+..    ......+....++.++.+|+.+||+.+|.+||++.++++
T Consensus       238 ~-~~~~----~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~  281 (290)
T cd05045         238 L-FNLL----KTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISK  281 (290)
T ss_pred             H-HHHH----hCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence            2 2222    222333334467899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=9.8e-39  Score=281.20  Aligned_cols=240  Identities=25%  Similarity=0.409  Sum_probs=191.1

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEEecCC
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYAA   81 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~   81 (344)
                      .+|++.+.||+|+||.||++.+. .+..+|+|.+.........+.+|++++++++||||+++++++.....++++|||++
T Consensus         4 ~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~   82 (256)
T cd05112           4 SELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME   82 (256)
T ss_pred             hHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCCCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence            57999999999999999999875 46789999987765556788999999999999999999999999999999999999


Q ss_pred             CCChHHHHHhC-CCCCHHHHHHHHHHHH-------HCCeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCCC--CCC
Q 019195           82 GGELFERICNA-GRFSEDEARYFFQQLI-------SGQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR--PKS  151 (344)
Q Consensus        82 ~g~L~~~i~~~-~~~~~~~~~~~~~ql~-------~~~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~~--~~~  151 (344)
                      +++|.+++... +.+++..++.++.|++       +.+++||||||+||+++.++  .+||+|||++........  ...
T Consensus        83 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~--~~~l~d~g~~~~~~~~~~~~~~~  160 (256)
T cd05112          83 HGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQ--VVKVSDFGMTRFVLDDQYTSSTG  160 (256)
T ss_pred             CCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCC--eEEECCCcceeecccCcccccCC
Confidence            99999998754 4678888777766654       45999999999999997655  499999999865432211  122


Q ss_pred             CccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCHhHHHHH
Q 019195          152 TVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLL  230 (344)
Q Consensus       152 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li  230 (344)
                      ..++..|+|||.+.+..+. .++||||||+++|+|++ |..||.........    ..+... .........+..+.+|+
T Consensus       161 ~~~~~~~~aPe~~~~~~~~-~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~----~~~~~~-~~~~~~~~~~~~~~~l~  234 (256)
T cd05112         161 TKFPVKWSSPEVFSFSKYS-SKSDVWSFGVLMWEVFSEGKTPYENRSNSEVV----ETINAG-FRLYKPRLASQSVYELM  234 (256)
T ss_pred             CccchhhcCHhHhccCCcC-hHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHH----HHHhCC-CCCCCCCCCCHHHHHHH
Confidence            3356789999999776654 45999999999999998 99999765543222    222211 12222234688999999


Q ss_pred             HHhcccCCCCCCChHHHhcC
Q 019195          231 SRIFVANPSRRITIKEIKSH  250 (344)
Q Consensus       231 ~~~L~~dp~~R~s~~ell~h  250 (344)
                      .+||+.+|.+|||+.+++++
T Consensus       235 ~~~l~~~p~~Rp~~~~~l~~  254 (256)
T cd05112         235 QHCWKERPEDRPSFSLLLHQ  254 (256)
T ss_pred             HHHcccChhhCCCHHHHHHh
Confidence            99999999999999999864

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=5.1e-39  Score=285.50  Aligned_cols=234  Identities=25%  Similarity=0.353  Sum_probs=181.8

Q ss_pred             eeeeecCceEEEEEEEcCCCc--EEEEEEeecCc--cccHHHHHHHHHHhcC-CCCCcceeeEEEEcCCEEEEEEecCCC
Q 019195            8 KDIGSGNFGVARLMRNKNTKE--LVAMKYIERGH--KIDANVAREIINHKQL-RHPNIIRFKEVVLTPTHLAIVMEYAAG   82 (344)
Q Consensus         8 ~~lg~G~~g~V~~~~~~~~~~--~vaiK~~~~~~--~~~~~~~~ei~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~   82 (344)
                      +.||+|+||.||++.+..++.  .+|+|.+....  .....+.+|+.+++.+ +||||+++++++...+.+|++|||+++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH   80 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence            469999999999999988775  46888876432  2335688899999999 799999999999999999999999999


Q ss_pred             CChHHHHHhCC----------------CCCHHHHHHHHHHHHH-------CCeeecCCCCCCeEecCCCCCCEEEeecCC
Q 019195           83 GELFERICNAG----------------RFSEDEARYFFQQLIS-------GQICHRDLKLENTLLDGSPAPRLKICDFGY  139 (344)
Q Consensus        83 g~L~~~i~~~~----------------~~~~~~~~~~~~ql~~-------~~iiH~Dikp~NIl~~~~~~~~vkL~DFg~  139 (344)
                      ++|.+++.+..                .++..+++.++.|++.       .|++||||||+||+++.+..  +||+|||+
T Consensus        81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~--~kl~dfgl  158 (270)
T cd05047          81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYV--AKIADFGL  158 (270)
T ss_pred             CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCe--EEECCCCC
Confidence            99999997543                3677777777666554       49999999999999987654  99999999


Q ss_pred             CcccCCCCCCCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhhccccCCC
Q 019195          140 SKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPD  218 (344)
Q Consensus       140 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  218 (344)
                      +..............+..|+|||.+....+ +.++|||||||++|+|++ |..||........+..    +. .....+.
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~apE~~~~~~~-~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~----~~-~~~~~~~  232 (270)
T cd05047         159 SRGQEVYVKKTMGRLPVRWMAIESLNYSVY-TTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEK----LP-QGYRLEK  232 (270)
T ss_pred             ccccchhhhccCCCCccccCChHHHccCCC-CchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHH----Hh-CCCCCCC
Confidence            864322222222334667999999876665 455999999999999997 9999976544332222    21 1222233


Q ss_pred             CCCCCHhHHHHHHHhcccCCCCCCChHHHhc
Q 019195          219 YVHISQDCRNLLSRIFVANPSRRITIKEIKS  249 (344)
Q Consensus       219 ~~~~s~~~~~li~~~L~~dp~~R~s~~ell~  249 (344)
                      ...++.++.+|+.+||+.+|.+|||+.+++.
T Consensus       233 ~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  263 (270)
T cd05047         233 PLNCDDEVYDLMRQCWREKPYERPSFAQILV  263 (270)
T ss_pred             CCcCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence            3457889999999999999999999999976

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=1.4e-38  Score=284.17  Aligned_cols=239  Identities=21%  Similarity=0.326  Sum_probs=185.9

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCc----EEEEEEeecCcc--ccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEE
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKE----LVAMKYIERGHK--IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAI   75 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~----~vaiK~~~~~~~--~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~l   75 (344)
                      ++|++++.||+|+||+||++.+..++.    .+++|.+.....  ....+..|+..++.+.||||+++++++. ....++
T Consensus         7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~~   85 (279)
T cd05111           7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQL   85 (279)
T ss_pred             hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccEE
Confidence            579999999999999999999877776    467777654322  2245777888899999999999999875 456789


Q ss_pred             EEecCCCCChHHHHHh-CCCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCC
Q 019195           76 VMEYAAGGELFERICN-AGRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS  147 (344)
Q Consensus        76 v~e~~~~g~L~~~i~~-~~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~  147 (344)
                      ++||+++|+|.+++.. .+.+++..++.++.|++.+       +++||||||+|||++.++.  +||+|||+++......
T Consensus        86 i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~--~kl~Dfg~~~~~~~~~  163 (279)
T cd05111          86 VTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSI--VQIADFGVADLLYPDD  163 (279)
T ss_pred             EEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCc--EEEcCCccceeccCCC
Confidence            9999999999999976 4568888888887776654       9999999999999987654  9999999987543222


Q ss_pred             C---CCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCC
Q 019195          148 R---PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHIS  223 (344)
Q Consensus       148 ~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s  223 (344)
                      .   .....++..|+|||.+.+..++ .++|||||||++|+|++ |..||.+..... ....+    ......+.....+
T Consensus       164 ~~~~~~~~~~~~~y~~pE~~~~~~~~-~~~Dv~slG~il~el~t~g~~p~~~~~~~~-~~~~~----~~~~~~~~~~~~~  237 (279)
T cd05111         164 KKYFYSEHKTPIKWMALESILFGRYT-HQSDVWSYGVTVWEMMSYGAEPYAGMRPHE-VPDLL----EKGERLAQPQICT  237 (279)
T ss_pred             cccccCCCCCcccccCHHHhccCCcC-chhhHHHHHHHHHHHHcCCCCCCCCCCHHH-HHHHH----HCCCcCCCCCCCC
Confidence            1   1234577889999999877764 55999999999999998 999997754322 22222    1222223333467


Q ss_pred             HhHHHHHHHhcccCCCCCCChHHHhc
Q 019195          224 QDCRNLLSRIFVANPSRRITIKEIKS  249 (344)
Q Consensus       224 ~~~~~li~~~L~~dp~~R~s~~ell~  249 (344)
                      .++.+++.+||..+|.+|||+.++++
T Consensus       238 ~~~~~li~~c~~~~p~~Rps~~el~~  263 (279)
T cd05111         238 IDVYMVMVKCWMIDENVRPTFKELAN  263 (279)
T ss_pred             HHHHHHHHHHcCCCcccCcCHHHHHH
Confidence            78999999999999999999999865

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=8.7e-39  Score=283.82  Aligned_cols=236  Identities=24%  Similarity=0.355  Sum_probs=176.5

Q ss_pred             eeeeecCceEEEEEEEc--CCCcEEEEEEeecCcc--ccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEEecCCCC
Q 019195            8 KDIGSGNFGVARLMRNK--NTKELVAMKYIERGHK--IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYAAGG   83 (344)
Q Consensus         8 ~~lg~G~~g~V~~~~~~--~~~~~vaiK~~~~~~~--~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g   83 (344)
                      +.||+|+||.||++...  .++..+|+|.+.....  ....+.+|+.++++++||||+++++++.+...+++||||+++|
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG   80 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence            46999999999999754  4567899998876432  2246888999999999999999999999999999999999999


Q ss_pred             ChHHHHHhCC-----CCCHHHHHHHHHH-------HHHCCeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCC---C
Q 019195           84 ELFERICNAG-----RFSEDEARYFFQQ-------LISGQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS---R  148 (344)
Q Consensus        84 ~L~~~i~~~~-----~~~~~~~~~~~~q-------l~~~~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~---~  148 (344)
                      +|.+++....     ..+...++.++.|       +|+.+++||||||+||+++.+.  ++||+|||++.......   .
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~--~~kL~dfg~~~~~~~~~~~~~  158 (269)
T cd05087          81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADL--TVKIGDYGLSHNKYKEDYYVT  158 (269)
T ss_pred             cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCC--cEEECCccccccccCcceeec
Confidence            9999986532     3444455555544       4555999999999999998765  49999999986433221   1


Q ss_pred             CCCCccCCcccCCccccCCC------CCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhhccccCCC---
Q 019195          149 PKSTVGTPAYIAPEVLSRRE------YDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPD---  218 (344)
Q Consensus       149 ~~~~~gt~~y~aPE~~~~~~------~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~---  218 (344)
                      .....++..|+|||++.+..      ..+.++||||||+++|+|++ |+.||..............   ......+.   
T Consensus       159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~---~~~~~~~~~~~  235 (269)
T cd05087         159 PDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVR---EQQLKLPKPRL  235 (269)
T ss_pred             CCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhh---cccCCCCCCcc
Confidence            22345788899999986432      12456999999999999996 9999977654433222211   11122221   


Q ss_pred             CCCCCHhHHHHHHHhcccCCCCCCChHHHhc
Q 019195          219 YVHISQDCRNLLSRIFVANPSRRITIKEIKS  249 (344)
Q Consensus       219 ~~~~s~~~~~li~~~L~~dp~~R~s~~ell~  249 (344)
                      ....++.+.+++.+|+ .+|.+|||+.+|+.
T Consensus       236 ~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~  265 (269)
T cd05087         236 KLPLSDRWYEVMQFCW-LQPEQRPSAEEVHL  265 (269)
T ss_pred             CCCCChHHHHHHHHHh-cCcccCCCHHHHHH
Confidence            1246788999999998 68999999999874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=8e-39  Score=284.80  Aligned_cols=242  Identities=22%  Similarity=0.405  Sum_probs=194.1

Q ss_pred             CCceeeeeeeecCceEEEEEEEcC-----CCcEEEEEEeecCcc--ccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEE
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKN-----TKELVAMKYIERGHK--IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLA   74 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~--~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~   74 (344)
                      ++|++++.||.|+||.||+|+.+.     +.+.||+|.+.....  ....+.+|++++++++||||+++++++.+....|
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   84 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY   84 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence            579999999999999999999754     356899998865433  2357889999999999999999999999989999


Q ss_pred             EEEecCCCCChHHHHHhCC---------CCCHHHHHHHHHHHHH-------CCeeecCCCCCCeEecCCCCCCEEEeecC
Q 019195           75 IVMEYAAGGELFERICNAG---------RFSEDEARYFFQQLIS-------GQICHRDLKLENTLLDGSPAPRLKICDFG  138 (344)
Q Consensus        75 lv~e~~~~g~L~~~i~~~~---------~~~~~~~~~~~~ql~~-------~~iiH~Dikp~NIl~~~~~~~~vkL~DFg  138 (344)
                      +||||+++++|.+++....         .+++..+..++.|++.       .+|+||||||+||+++..+.  ++|+|||
T Consensus        85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~--~~l~~~~  162 (275)
T cd05046          85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQRE--VKVSLLS  162 (275)
T ss_pred             EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCc--EEEcccc
Confidence            9999999999999997655         6888888888777655       49999999999999987664  9999999


Q ss_pred             CCcccCCCC--CCCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhhcccc
Q 019195          139 YSKSSLLHS--RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYK  215 (344)
Q Consensus       139 ~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~  215 (344)
                      ++.......  ......++..|+|||.+.+.... .++||||||+++|+|++ |..||.......    .+.........
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~-~~~Di~slG~~l~~l~~~~~~p~~~~~~~~----~~~~~~~~~~~  237 (275)
T cd05046         163 LSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFS-TKSDVWSFGVLMWEVFTQGELPFYGLSDEE----VLNRLQAGKLE  237 (275)
T ss_pred             cccccCcccccccCCceeEEeecChhhhccCCCC-chhhHHHHHHHHHHHHhCCCCCccccchHH----HHHHHHcCCcC
Confidence            986432221  12334567889999998776654 55999999999999998 888997654432    22233333333


Q ss_pred             CCCCCCCCHhHHHHHHHhcccCCCCCCChHHHhcC
Q 019195          216 IPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSH  250 (344)
Q Consensus       216 ~~~~~~~s~~~~~li~~~L~~dp~~R~s~~ell~h  250 (344)
                      .+....++..+.+++.+||+.+|.+|||+.+++.+
T Consensus       238 ~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~  272 (275)
T cd05046         238 LPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSA  272 (275)
T ss_pred             CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence            44444678999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=1e-38  Score=285.49  Aligned_cols=245  Identities=25%  Similarity=0.393  Sum_probs=186.7

Q ss_pred             CCceeeeeeeecCceEEEEEE----EcCCCcEEEEEEeecCcc-ccHHHHHHHHHHhcCCCCCcceeeEEEEc--CCEEE
Q 019195            2 EKYELMKDIGSGNFGVARLMR----NKNTKELVAMKYIERGHK-IDANVAREIINHKQLRHPNIIRFKEVVLT--PTHLA   74 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~----~~~~~~~vaiK~~~~~~~-~~~~~~~ei~~l~~l~h~niv~~~~~~~~--~~~~~   74 (344)
                      ++|++++.||+|+||.||++.    +..+++.||+|.+..... ....+.+|+.+++.++||||+++++++..  ...++
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   83 (284)
T cd05081           4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR   83 (284)
T ss_pred             ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence            478999999999999999987    456788999999875433 23568899999999999999999998754  35689


Q ss_pred             EEEecCCCCChHHHHHhC-CCCCHHHHHHHHHHHHH-------CCeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCC
Q 019195           75 IVMEYAAGGELFERICNA-GRFSEDEARYFFQQLIS-------GQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH  146 (344)
Q Consensus        75 lv~e~~~~g~L~~~i~~~-~~~~~~~~~~~~~ql~~-------~~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~  146 (344)
                      +||||+++++|.+++.+. ..+++..++.++.|++.       .||+||||||+||+++.++.  +||+|||++......
T Consensus        84 lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~--~~l~dfg~~~~~~~~  161 (284)
T cd05081          84 LVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENR--VKIGDFGLTKVLPQD  161 (284)
T ss_pred             EEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCe--EEECCCcccccccCC
Confidence            999999999999999764 46788887777766654       49999999999999977654  999999998754332


Q ss_pred             CCC----CCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChH-----------HHHHHHHHHhh
Q 019195          147 SRP----KSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPK-----------NFRKTISRIMA  211 (344)
Q Consensus       147 ~~~----~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-----------~~~~~~~~~~~  211 (344)
                      ...    ....++..|+|||.+.+..++ .++|||||||++|+|++|..|+.......           .....+.....
T Consensus       162 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (284)
T cd05081         162 KEYYKVREPGESPIFWYAPESLTESKFS-VASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLK  240 (284)
T ss_pred             CcceeecCCCCCceEeeCHHHhccCCcC-hHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHHHh
Confidence            211    112244569999999776654 55999999999999999887764432110           00011111222


Q ss_pred             ccccCCCCCCCCHhHHHHHHHhcccCCCCCCChHHHhc
Q 019195          212 VQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKS  249 (344)
Q Consensus       212 ~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~ell~  249 (344)
                      .....+....++.++.+||.+||..+|.+|||+.++++
T Consensus       241 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  278 (284)
T cd05081         241 NNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELAL  278 (284)
T ss_pred             cCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            23334444567899999999999999999999999976

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.6e-41  Score=280.98  Aligned_cols=254  Identities=26%  Similarity=0.411  Sum_probs=201.8

Q ss_pred             CceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecC---ccccHHHHHHHHHHhcCCCCCcceeeEEEEcC--------C
Q 019195            3 KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERG---HKIDANVAREIINHKQLRHPNIIRFKEVVLTP--------T   71 (344)
Q Consensus         3 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~--------~   71 (344)
                      .|+-+.+||+|.||.||+|+.+++++.||+|++...   .......++|+.+|..|+|+|++.+++++...        .
T Consensus        18 ~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~   97 (376)
T KOG0669|consen   18 KYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRA   97 (376)
T ss_pred             HHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccc
Confidence            577788999999999999999999999999877542   23446788999999999999999999887542        4


Q ss_pred             EEEEEEecCCCCChHHHHHhC-CCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCccc
Q 019195           72 HLAIVMEYAAGGELFERICNA-GRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSS  143 (344)
Q Consensus        72 ~~~lv~e~~~~g~L~~~i~~~-~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~  143 (344)
                      .+|+||++|+ .+|.-++.+. .+++..+|+.++.+|.++       .|+|||+||.|+||+.++.  +||+|||+++..
T Consensus        98 t~ylVf~~ce-hDLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgi--lklADFGlar~f  174 (376)
T KOG0669|consen   98 TFYLVFDFCE-HDLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGI--LKLADFGLARAF  174 (376)
T ss_pred             eeeeeHHHhh-hhHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCce--EEeeccccccce
Confidence            5999999996 4898888776 689999999998887766       9999999999999977665  999999999643


Q ss_pred             CCC-----CCCCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhcccc-CC
Q 019195          144 LLH-----SRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYK-IP  217 (344)
Q Consensus       144 ~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~-~~  217 (344)
                      ...     +.-+..+-|.+|++||.+.+...+++..|||+.|||+.+|.+|.+.|.+.....++.-+..-....... +|
T Consensus       175 s~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkevWP  254 (376)
T KOG0669|consen  175 STSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEVWP  254 (376)
T ss_pred             ecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcccCC
Confidence            222     222345679999999999998888888999999999999999999998876654443332211111000 00


Q ss_pred             C------C----------------------CCCCHhHHHHHHHhcccCCCCCCChHHHhcCcccccCCCh
Q 019195          218 D------Y----------------------VHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLPR  259 (344)
Q Consensus       218 ~------~----------------------~~~s~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~~~~~  259 (344)
                      .      +                      ..-.+++.+|+.+||..||.+|++++++|+|.||.+...+
T Consensus       255 ~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~kdp~p  324 (376)
T KOG0669|consen  255 NVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWKDPMP  324 (376)
T ss_pred             CcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhcCCcc
Confidence            0      0                      0124578999999999999999999999999999876443

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=6.6e-39  Score=286.89  Aligned_cols=244  Identities=25%  Similarity=0.391  Sum_probs=187.2

Q ss_pred             CceeeeeeeecCceEEEEEEE----cCCCcEEEEEEeecCc--cccHHHHHHHHHHhcCCCCCcceeeEEEEcC--CEEE
Q 019195            3 KYELMKDIGSGNFGVARLMRN----KNTKELVAMKYIERGH--KIDANVAREIINHKQLRHPNIIRFKEVVLTP--THLA   74 (344)
Q Consensus         3 ~y~~~~~lg~G~~g~V~~~~~----~~~~~~vaiK~~~~~~--~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~--~~~~   74 (344)
                      -|++++.||+|+||.||+|..    ..++..||+|.+....  .....+.+|+.+++.++||||+++++++...  ..++
T Consensus         5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   84 (284)
T cd05079           5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIK   84 (284)
T ss_pred             hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceE
Confidence            368999999999999999974    4678899999986542  2235688999999999999999999998875  5689


Q ss_pred             EEEecCCCCChHHHHHhC-CCCCHHHHHHHHHHHHH-------CCeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCC
Q 019195           75 IVMEYAAGGELFERICNA-GRFSEDEARYFFQQLIS-------GQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH  146 (344)
Q Consensus        75 lv~e~~~~g~L~~~i~~~-~~~~~~~~~~~~~ql~~-------~~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~  146 (344)
                      +||||+++++|.+++.+. ..++..++..++.|++.       .|++||||||+||+++.++.  ++|+|||+++.....
T Consensus        85 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~--~~l~dfg~~~~~~~~  162 (284)
T cd05079          85 LIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQ--VKIGDFGLTKAIETD  162 (284)
T ss_pred             EEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCC--EEECCCccccccccC
Confidence            999999999999998664 35788877777766665       49999999999999977654  999999998764332


Q ss_pred             CC----CCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC-----------hHHHHHHHHHHhh
Q 019195          147 SR----PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQED-----------PKNFRKTISRIMA  211 (344)
Q Consensus       147 ~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-----------~~~~~~~~~~~~~  211 (344)
                      ..    .....++..|+|||.+.+..+. .++|||||||++|+|++++.|+.....           .......... ..
T Consensus       163 ~~~~~~~~~~~~~~~y~apE~~~~~~~~-~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~  240 (284)
T cd05079         163 KEYYTVKDDLDSPVFWYAPECLIQSKFY-IASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRV-LE  240 (284)
T ss_pred             ccceeecCCCCCCccccCHHHhccCCCC-ccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHH-HH
Confidence            21    1234577789999998776654 559999999999999998776533211           0001111111 11


Q ss_pred             ccccCCCCCCCCHhHHHHHHHhcccCCCCCCChHHHhcC
Q 019195          212 VQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSH  250 (344)
Q Consensus       212 ~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~ell~h  250 (344)
                      .....+....++..+.+|+.+||+.+|.+|||+.+++++
T Consensus       241 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~  279 (284)
T cd05079         241 EGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEG  279 (284)
T ss_pred             cCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence            122333444678999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=1.2e-38  Score=281.62  Aligned_cols=239  Identities=24%  Similarity=0.384  Sum_probs=188.5

Q ss_pred             CCCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEEecC
Q 019195            1 MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYA   80 (344)
Q Consensus         1 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~   80 (344)
                      .++|++.+.||+|+||.||++... .+..+|+|.+.........+.+|+.+++.++|+||+++++++.. ...+++|||+
T Consensus         5 ~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~   82 (260)
T cd05073           5 RESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFM   82 (260)
T ss_pred             ccceeEEeEecCccceEEEEEEec-CCccEEEEecCCChhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeC
Confidence            378999999999999999999865 45569999887655445678899999999999999999999887 7889999999


Q ss_pred             CCCChHHHHHhC--CCCCHHHHHHHHHHHHH-------CCeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCCC--C
Q 019195           81 AGGELFERICNA--GRFSEDEARYFFQQLIS-------GQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR--P  149 (344)
Q Consensus        81 ~~g~L~~~i~~~--~~~~~~~~~~~~~ql~~-------~~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~~--~  149 (344)
                      ++++|.+++.+.  ..++...+..++.|++.       .|++||||||+||+++..+  .+||+|||++........  .
T Consensus        83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~--~~~l~d~~~~~~~~~~~~~~~  160 (260)
T cd05073          83 AKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASL--VCKIADFGLARVIEDNEYTAR  160 (260)
T ss_pred             CCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCC--cEEECCCcceeeccCCCcccc
Confidence            999999999763  35677777666666554       4999999999999997665  499999999865432221  1


Q ss_pred             CCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCHhHHH
Q 019195          150 KSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRN  228 (344)
Q Consensus       150 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~  228 (344)
                      ....++..|+|||++....++ .++|+|||||++|+|++ |..||...........+     ...+..+.....+.++.+
T Consensus       161 ~~~~~~~~y~~PE~~~~~~~~-~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~  234 (260)
T cd05073         161 EGAKFPIKWTAPEAINFGSFT-IKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRAL-----ERGYRMPRPENCPEELYN  234 (260)
T ss_pred             cCCcccccccCHhHhccCCcC-ccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHH-----hCCCCCCCcccCCHHHHH
Confidence            223456779999999776654 45999999999999998 99999876543322221     122333444467889999


Q ss_pred             HHHHhcccCCCCCCChHHHhc
Q 019195          229 LLSRIFVANPSRRITIKEIKS  249 (344)
Q Consensus       229 li~~~L~~dp~~R~s~~ell~  249 (344)
                      ++.+||+.+|.+||++.++++
T Consensus       235 ~i~~~l~~~p~~Rp~~~~l~~  255 (260)
T cd05073         235 IMMRCWKNRPEERPTFEYIQS  255 (260)
T ss_pred             HHHHHcccCcccCcCHHHHHH
Confidence            999999999999999998864

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=9.4e-39  Score=283.30  Aligned_cols=240  Identities=24%  Similarity=0.351  Sum_probs=190.5

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCc---EEEEEEeecCcc--ccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEE
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKE---LVAMKYIERGHK--IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIV   76 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~---~vaiK~~~~~~~--~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv   76 (344)
                      ++|+..+.||+|+||.||+|....++.   .+|+|.+.....  ....+.+|+.+++.++||||+++++++...+..++|
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   84 (268)
T cd05063           5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMII   84 (268)
T ss_pred             HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEE
Confidence            478999999999999999999876554   799998865432  235688999999999999999999999999999999


Q ss_pred             EecCCCCChHHHHHhC-CCCCHHHHHHHHHHHH-------HCCeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCCC
Q 019195           77 MEYAAGGELFERICNA-GRFSEDEARYFFQQLI-------SGQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR  148 (344)
Q Consensus        77 ~e~~~~g~L~~~i~~~-~~~~~~~~~~~~~ql~-------~~~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~~  148 (344)
                      |||+++++|..++... +.++..++..++.|++       +.|++||||||+||+++.+..  +||+|||++........
T Consensus        85 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~--~kl~dfg~~~~~~~~~~  162 (268)
T cd05063          85 TEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLE--CKVSDFGLSRVLEDDPE  162 (268)
T ss_pred             EEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCc--EEECCCccceecccccc
Confidence            9999999999998753 5788888887776655       449999999999999986654  99999999875432221


Q ss_pred             CC----CCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCC
Q 019195          149 PK----STVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHIS  223 (344)
Q Consensus       149 ~~----~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s  223 (344)
                      ..    ....++.|+|||.+....++ .++|||||||++|+|++ |..||.........    ..+.. ....|.....+
T Consensus       163 ~~~~~~~~~~~~~y~~PE~~~~~~~~-~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~----~~i~~-~~~~~~~~~~~  236 (268)
T cd05063         163 GTYTTSGGKIPIRWTAPEAIAYRKFT-SASDVWSFGIVMWEVMSFGERPYWDMSNHEVM----KAIND-GFRLPAPMDCP  236 (268)
T ss_pred             cceeccCCCcCceecCHHHhhcCCcC-hHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHH----HHHhc-CCCCCCCCCCC
Confidence            11    11234579999999776664 55999999999999997 99999765543322    22222 23444445678


Q ss_pred             HhHHHHHHHhcccCCCCCCChHHHhc
Q 019195          224 QDCRNLLSRIFVANPSRRITIKEIKS  249 (344)
Q Consensus       224 ~~~~~li~~~L~~dp~~R~s~~ell~  249 (344)
                      ..+.+++.+||+.+|.+||++.++++
T Consensus       237 ~~~~~li~~c~~~~p~~Rp~~~~i~~  262 (268)
T cd05063         237 SAVYQLMLQCWQQDRARRPRFVDIVN  262 (268)
T ss_pred             HHHHHHHHHHcCCCcccCcCHHHHHH
Confidence            99999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=1.2e-38  Score=289.41  Aligned_cols=240  Identities=25%  Similarity=0.345  Sum_probs=184.7

Q ss_pred             CCceeeeeeeecCceEEEEEEEcC-------CCcEEEEEEeecCcc--ccHHHHHHHHHHhcC-CCCCcceeeEEEEcCC
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKN-------TKELVAMKYIERGHK--IDANVAREIINHKQL-RHPNIIRFKEVVLTPT   71 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~-------~~~~vaiK~~~~~~~--~~~~~~~ei~~l~~l-~h~niv~~~~~~~~~~   71 (344)
                      ++|++.+.||+|+||.||++.+..       ....+|+|.+.....  ....+.+|+.+++++ .||||+++++++....
T Consensus        12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~   91 (314)
T cd05099          12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEG   91 (314)
T ss_pred             HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCC
Confidence            478999999999999999998642       345799998875332  234678899999999 6999999999999999


Q ss_pred             EEEEEEecCCCCChHHHHHhCC----------------CCCHHHHHHHHHH-------HHHCCeeecCCCCCCeEecCCC
Q 019195           72 HLAIVMEYAAGGELFERICNAG----------------RFSEDEARYFFQQ-------LISGQICHRDLKLENTLLDGSP  128 (344)
Q Consensus        72 ~~~lv~e~~~~g~L~~~i~~~~----------------~~~~~~~~~~~~q-------l~~~~iiH~Dikp~NIl~~~~~  128 (344)
                      .+|++|||+++|+|.+++....                .++..++..++.|       +|+.|++||||||+|||++.++
T Consensus        92 ~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~~~~  171 (314)
T cd05099          92 PLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTEDN  171 (314)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeEEEcCCC
Confidence            9999999999999999997532                3666655555555       4455999999999999997665


Q ss_pred             CCCEEEeecCCCcccCCCCC---CCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHH
Q 019195          129 APRLKICDFGYSKSSLLHSR---PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRK  204 (344)
Q Consensus       129 ~~~vkL~DFg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~  204 (344)
                        ++||+|||+++.......   .....++..|+|||.+.+..++ .++|||||||++|+|++ |..||........+..
T Consensus       172 --~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~  248 (314)
T cd05099         172 --VMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYT-HQSDVWSFGILMWEIFTLGGSPYPGIPVEELFKL  248 (314)
T ss_pred             --cEEEccccccccccccccccccccCCCCccccCHHHHccCCcC-ccchhhHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence              499999999975432211   1222345689999999776654 45999999999999999 8999976544332222


Q ss_pred             HHHHHhhccccCCCCCCCCHhHHHHHHHhcccCCCCCCChHHHhc
Q 019195          205 TISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKS  249 (344)
Q Consensus       205 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~ell~  249 (344)
                       +   .. .........++.++.+|+.+||..+|.+|||+.++++
T Consensus       249 -~---~~-~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~  288 (314)
T cd05099         249 -L---RE-GHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVE  288 (314)
T ss_pred             -H---Hc-CCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence             1   11 1122223457889999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=1.7e-39  Score=286.91  Aligned_cols=237  Identities=30%  Similarity=0.488  Sum_probs=184.7

Q ss_pred             eeeeeeeecCceEEEEEEEc----CCCcEEEEEEeecCcc--ccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEEe
Q 019195            5 ELMKDIGSGNFGVARLMRNK----NTKELVAMKYIERGHK--IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVME   78 (344)
Q Consensus         5 ~~~~~lg~G~~g~V~~~~~~----~~~~~vaiK~~~~~~~--~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e   78 (344)
                      ++.+.||.|+||.||+|...    ..+..|+||.+.....  ....+.+|++.+++++||||+++++++...+.+++|||
T Consensus         2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e   81 (259)
T PF07714_consen    2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVME   81 (259)
T ss_dssp             EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE
T ss_pred             EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccccccc
Confidence            57889999999999999987    4567899999965332  24689999999999999999999999998888999999


Q ss_pred             cCCCCChHHHHHhC--CCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCC--
Q 019195           79 YAAGGELFERICNA--GRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS--  147 (344)
Q Consensus        79 ~~~~g~L~~~i~~~--~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~--  147 (344)
                      ||++|+|.+++...  ..++..++..++.|++.|       +++|++|+|+|||++.++.  +||+|||++.......  
T Consensus        82 ~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~--~Kl~~f~~~~~~~~~~~~  159 (259)
T PF07714_consen   82 YCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQ--VKLSDFGLSRPISEKSKY  159 (259)
T ss_dssp             --TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTE--EEEESTTTGEETTTSSSE
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc--cccccccccccccccccc
Confidence            99999999999886  678888888887776655       9999999999999987765  9999999987552211  


Q ss_pred             -CCCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCHh
Q 019195          148 -RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQD  225 (344)
Q Consensus       148 -~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~  225 (344)
                       ......+...|+|||.+....+ +.++||||||+++|||++ |+.||........    ...+ ......+....++..
T Consensus       160 ~~~~~~~~~~~~~aPE~~~~~~~-~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~----~~~~-~~~~~~~~~~~~~~~  233 (259)
T PF07714_consen  160 KNDSSQQLPLRYLAPEVLKDGEY-TKKSDVYSFGMLLYEILTLGKFPFSDYDNEEI----IEKL-KQGQRLPIPDNCPKD  233 (259)
T ss_dssp             EESTTSESGGGGS-HHHHHHSEE-SHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHH----HHHH-HTTEETTSBTTSBHH
T ss_pred             ccccccccccccccccccccccc-cccccccccccccccccccccccccccccccc----cccc-cccccceeccchhHH
Confidence             1233457788999999977765 556999999999999999 7899977644332    2222 222233444467999


Q ss_pred             HHHHHHHhcccCCCCCCChHHHhc
Q 019195          226 CRNLLSRIFVANPSRRITIKEIKS  249 (344)
Q Consensus       226 ~~~li~~~L~~dp~~R~s~~ell~  249 (344)
                      +.++|.+||..+|.+|||+.++++
T Consensus       234 ~~~li~~C~~~~p~~RPs~~~i~~  257 (259)
T PF07714_consen  234 IYSLIQQCWSHDPEKRPSFQEILQ  257 (259)
T ss_dssp             HHHHHHHHT-SSGGGS--HHHHHH
T ss_pred             HHHHHHHHcCCChhhCcCHHHHHh
Confidence            999999999999999999999874

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=7.6e-39  Score=284.43  Aligned_cols=239  Identities=22%  Similarity=0.348  Sum_probs=184.0

Q ss_pred             ceeeeeeeecCceEEEEEEEcCCCc--EEEEEEeecCc---cccHHHHHHHHHHhcCCCCCcceeeEEEEcC------CE
Q 019195            4 YELMKDIGSGNFGVARLMRNKNTKE--LVAMKYIERGH---KIDANVAREIINHKQLRHPNIIRFKEVVLTP------TH   72 (344)
Q Consensus         4 y~~~~~lg~G~~g~V~~~~~~~~~~--~vaiK~~~~~~---~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~------~~   72 (344)
                      |.+.+.||+|+||.||++.+..++.  .||+|.+....   .....+.+|+.+++.++||||+++++++...      ..
T Consensus         1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   80 (272)
T cd05075           1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS   80 (272)
T ss_pred             CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence            4578899999999999999887765  68999886542   2235678899999999999999999976432      25


Q ss_pred             EEEEEecCCCCChHHHHHh------CCCCCHHHHHHHHHHHHH-------CCeeecCCCCCCeEecCCCCCCEEEeecCC
Q 019195           73 LAIVMEYAAGGELFERICN------AGRFSEDEARYFFQQLIS-------GQICHRDLKLENTLLDGSPAPRLKICDFGY  139 (344)
Q Consensus        73 ~~lv~e~~~~g~L~~~i~~------~~~~~~~~~~~~~~ql~~-------~~iiH~Dikp~NIl~~~~~~~~vkL~DFg~  139 (344)
                      .+++|||+.+|+|..++..      ...+++..++.++.|++.       .+|+||||||+|||++.+..  +||+|||+
T Consensus        81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~--~kl~Dfg~  158 (272)
T cd05075          81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMN--VCVADFGL  158 (272)
T ss_pred             cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCC--EEECCCCc
Confidence            7899999999999888742      234778877777766655       49999999999999976654  99999999


Q ss_pred             CcccCCCCC---CCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhhcccc
Q 019195          140 SKSSLLHSR---PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYK  215 (344)
Q Consensus       140 a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~  215 (344)
                      ++.......   .....+++.|+|||.+.+..++ .++|||||||++|+|++ |+.||........    ...+... ..
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~-~~~Di~slG~il~el~~~g~~p~~~~~~~~~----~~~~~~~-~~  232 (272)
T cd05075         159 SKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYT-TKSDVWSFGVTMWEIATRGQTPYPGVENSEI----YDYLRQG-NR  232 (272)
T ss_pred             ccccCcccceecCCcccCCcccCCHHHccCCCcC-hHHHHHHHHHHHHHHHcCCCCCCCCCCHHHH----HHHHHcC-CC
Confidence            876433221   2233467789999999877664 55999999999999999 8999976544322    2222222 12


Q ss_pred             CCCCCCCCHhHHHHHHHhcccCCCCCCChHHHhcC
Q 019195          216 IPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSH  250 (344)
Q Consensus       216 ~~~~~~~s~~~~~li~~~L~~dp~~R~s~~ell~h  250 (344)
                      .+....++..+.++|.+||+.+|.+|||+.+++++
T Consensus       233 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~  267 (272)
T cd05075         233 LKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCE  267 (272)
T ss_pred             CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            23334678899999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=8.6e-39  Score=288.97  Aligned_cols=241  Identities=24%  Similarity=0.345  Sum_probs=187.2

Q ss_pred             CCceeeeeeeecCceEEEEEEEc-------CCCcEEEEEEeecCc--cccHHHHHHHHHHhcC-CCCCcceeeEEEEcCC
Q 019195            2 EKYELMKDIGSGNFGVARLMRNK-------NTKELVAMKYIERGH--KIDANVAREIINHKQL-RHPNIIRFKEVVLTPT   71 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~vaiK~~~~~~--~~~~~~~~ei~~l~~l-~h~niv~~~~~~~~~~   71 (344)
                      ++|++.+.||+|+||.||+|...       ..+..||+|.+....  .....+.+|+.+++.+ +||||+++++++....
T Consensus        15 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~   94 (304)
T cd05101          15 DKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG   94 (304)
T ss_pred             HHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecCC
Confidence            57899999999999999999752       234579999886532  2235688999999999 8999999999999999


Q ss_pred             EEEEEEecCCCCChHHHHHhCC----------------CCCHHHHHHHHHHHH-------HCCeeecCCCCCCeEecCCC
Q 019195           72 HLAIVMEYAAGGELFERICNAG----------------RFSEDEARYFFQQLI-------SGQICHRDLKLENTLLDGSP  128 (344)
Q Consensus        72 ~~~lv~e~~~~g~L~~~i~~~~----------------~~~~~~~~~~~~ql~-------~~~iiH~Dikp~NIl~~~~~  128 (344)
                      .+|++|||+++++|.+++.+..                .++...++.++.|++       +.||+||||||+||+++.++
T Consensus        95 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nili~~~~  174 (304)
T cd05101          95 PLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTENN  174 (304)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccceEEEcCCC
Confidence            9999999999999999997642                355555555555555       55999999999999997665


Q ss_pred             CCCEEEeecCCCcccCCCCC---CCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHH
Q 019195          129 APRLKICDFGYSKSSLLHSR---PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRK  204 (344)
Q Consensus       129 ~~~vkL~DFg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~  204 (344)
                        .+||+|||+++.......   .....+++.|+|||++.+..++ .++||||||+++|+|++ |..||.........  
T Consensus       175 --~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~--  249 (304)
T cd05101         175 --VMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYT-HQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF--  249 (304)
T ss_pred             --cEEECCCccceecccccccccccCCCCCceeeCchhhccCCCC-chhhHHHHHHHHHHHHcCCCCCcccCCHHHHH--
Confidence              499999999875432221   2223467889999999777665 45999999999999998 78888765433222  


Q ss_pred             HHHHHhhccccCCCCCCCCHhHHHHHHHhcccCCCCCCChHHHhcC
Q 019195          205 TISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSH  250 (344)
Q Consensus       205 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~ell~h  250 (344)
                        ..+. ..........++..+.+||.+||..+|.+|||+.++++.
T Consensus       250 --~~~~-~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~  292 (304)
T cd05101         250 --KLLK-EGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVED  292 (304)
T ss_pred             --HHHH-cCCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence              2222 122223334678999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=1.2e-38  Score=280.86  Aligned_cols=234  Identities=29%  Similarity=0.417  Sum_probs=186.8

Q ss_pred             eeeeecCceEEEEEEEcC-CC--cEEEEEEeecCcc--ccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEEecCCC
Q 019195            8 KDIGSGNFGVARLMRNKN-TK--ELVAMKYIERGHK--IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYAAG   82 (344)
Q Consensus         8 ~~lg~G~~g~V~~~~~~~-~~--~~vaiK~~~~~~~--~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~   82 (344)
                      +.||+|++|+||++.+.. .+  ..||+|.+.....  ....+.+|+.++++++||||+++++.+.. ..++++|||+++
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~   79 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL   79 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence            468999999999998865 33  3699999876544  34578899999999999999999999988 899999999999


Q ss_pred             CChHHHHHhCC--CCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCCC----C
Q 019195           83 GELFERICNAG--RFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR----P  149 (344)
Q Consensus        83 g~L~~~i~~~~--~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~~----~  149 (344)
                      ++|.+++.+..  .++...++.++.|++.+       |++||||||+||+++.++  .+||+|||++........    .
T Consensus        80 ~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~--~~kl~dfg~~~~~~~~~~~~~~~  157 (257)
T cd05040          80 GSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDD--KVKIGDFGLMRALPQNEDHYVME  157 (257)
T ss_pred             CcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCC--EEEeccccccccccccccceecc
Confidence            99999997754  67888888777776654       999999999999998775  499999999876543221    1


Q ss_pred             CCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCHhHHH
Q 019195          150 KSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRN  228 (344)
Q Consensus       150 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~  228 (344)
                      ....++..|+|||.+.+..++ .++|||||||++|+|++ |..||...........+    .......+.....+..+.+
T Consensus       158 ~~~~~~~~y~~pE~~~~~~~~-~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~  232 (257)
T cd05040         158 EHLKVPFAWCAPESLRTRTFS-HASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKI----DKEGERLERPEACPQDIYN  232 (257)
T ss_pred             cCCCCCceecCHHHhcccCcC-chhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH----HhcCCcCCCCccCCHHHHH
Confidence            234578899999998777664 45999999999999998 99999765543332222    2222333333457889999


Q ss_pred             HHHHhcccCCCCCCChHHHhc
Q 019195          229 LLSRIFVANPSRRITIKEIKS  249 (344)
Q Consensus       229 li~~~L~~dp~~R~s~~ell~  249 (344)
                      ++.+||+.+|.+|||+.++++
T Consensus       233 li~~~l~~~p~~Rps~~~~~~  253 (257)
T cd05040         233 VMLQCWAHNPADRPTFAALRE  253 (257)
T ss_pred             HHHHHCCCCcccCCCHHHHHH
Confidence            999999999999999999875

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-40  Score=307.70  Aligned_cols=238  Identities=33%  Similarity=0.485  Sum_probs=188.7

Q ss_pred             ceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCc--cccHHHHHHHHHHhcCCCCCcceeeEEEEcCC------EEEE
Q 019195            4 YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH--KIDANVAREIINHKQLRHPNIIRFKEVVLTPT------HLAI   75 (344)
Q Consensus         4 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~------~~~l   75 (344)
                      |...+.||+|+||.||+++++.+|+.||||.++...  ...+..-+|+++|++|+|+|||+++++=.+..      .-.+
T Consensus        15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl   94 (732)
T KOG4250|consen   15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL   94 (732)
T ss_pred             eeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence            667789999999999999999999999999987743  23356778999999999999999998865543      4579


Q ss_pred             EEecCCCCChHHHHHhC---CCCCHHHHHHHHHHHHH-------CCeeecCCCCCCeEecC--CCCCCEEEeecCCCccc
Q 019195           76 VMEYAAGGELFERICNA---GRFSEDEARYFFQQLIS-------GQICHRDLKLENTLLDG--SPAPRLKICDFGYSKSS  143 (344)
Q Consensus        76 v~e~~~~g~L~~~i~~~---~~~~~~~~~~~~~ql~~-------~~iiH~Dikp~NIl~~~--~~~~~vkL~DFg~a~~~  143 (344)
                      +||||.||+|+..+.+-   ..+++.+++.++..+..       .||+||||||.||++-.  ++....||+|||.|+..
T Consensus        95 vmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Arel  174 (732)
T KOG4250|consen   95 VMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAAREL  174 (732)
T ss_pred             EEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeecccccccC
Confidence            99999999999999653   46899988887665554       49999999999999843  34445799999999998


Q ss_pred             CCCCCCCCCccCCcccCCccccC-CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhc----------
Q 019195          144 LLHSRPKSTVGTPAYIAPEVLSR-REYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAV----------  212 (344)
Q Consensus       144 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~----------  212 (344)
                      .......+.+||+.|++||++.. +.|..+ +|.|||||++|+++||..||.....+.....++-.+...          
T Consensus       175 ~d~s~~~S~vGT~~YLhPel~E~q~~y~~t-VDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v~i~~~  253 (732)
T KOG4250|consen  175 DDNSLFTSLVGTEEYLHPELYERQKKYTAT-VDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGVAIGAQ  253 (732)
T ss_pred             CCCCeeeeecCchhhcChHHHhhccCcCce-eehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCceeEeee
Confidence            88888889999999999999985 555444 999999999999999999998876665433333322111          


Q ss_pred             ---------cccCCCCCCCCHh----HHHHHHHhcccCCCCCC
Q 019195          213 ---------QYKIPDYVHISQD----CRNLLSRIFVANPSRRI  242 (344)
Q Consensus       213 ---------~~~~~~~~~~s~~----~~~li~~~L~~dp~~R~  242 (344)
                               ...+|....+++.    +...+..+|..+|.+|.
T Consensus       254 ~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~  296 (732)
T KOG4250|consen  254 EEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRG  296 (732)
T ss_pred             cccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhC
Confidence                     1124444444543    45677888999999998

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=5.4e-39  Score=279.98  Aligned_cols=222  Identities=24%  Similarity=0.389  Sum_probs=179.7

Q ss_pred             cCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEEecCCCCChHHHHHhC
Q 019195           13 GNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNA   92 (344)
Q Consensus        13 G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~i~~~   92 (344)
                      |.+|.||+|.+..+++.||+|.+.....    ..++...+....||||+++++++.....++++|||+++|+|.+++.+.
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~~----~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~   79 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSSE----YSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKF   79 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchhh----hhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHHh
Confidence            8999999999999999999999876532    234455555667999999999999999999999999999999999887


Q ss_pred             CCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCCCCCCCccCCcccCCcccc
Q 019195           93 GRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLS  165 (344)
Q Consensus        93 ~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~~~~~~~gt~~y~aPE~~~  165 (344)
                      ..+++..+..++.|++++       ||+||||||+||+++.++.  ++|+|||++......  .....++..|+|||.+.
T Consensus        80 ~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~--~~l~df~~~~~~~~~--~~~~~~~~~y~aPE~~~  155 (237)
T cd05576          80 LNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGH--IQLTYFSRWSEVEDS--CDGEAVENMYCAPEVGG  155 (237)
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCC--EEEecccchhccccc--cccCCcCccccCCcccC
Confidence            789999888888777654       9999999999999987664  999999987543322  23345678899999987


Q ss_pred             CCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCHhHHHHHHHhcccCCCCCCCh-
Q 019195          166 RREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITI-  244 (344)
Q Consensus       166 ~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~-  244 (344)
                      +..++ .++|+||+|+++|+|++|+.||........        .......|  ..+++.+.+||.+||+.||.+||++ 
T Consensus       156 ~~~~~-~~~DvwslG~il~el~~g~~~~~~~~~~~~--------~~~~~~~~--~~~~~~~~~li~~~l~~dp~~R~~~~  224 (237)
T cd05576         156 ISEET-EACDWWSLGAILFELLTGKTLVECHPSGIN--------THTTLNIP--EWVSEEARSLLQQLLQFNPTERLGAG  224 (237)
T ss_pred             CCCCC-chhhHHHHHHHHHHHHHCcchhhcCchhcc--------cccccCCc--ccCCHHHHHHHHHHccCCHHHhcCCC
Confidence            66654 459999999999999999988864322100        01112233  3578999999999999999999986 


Q ss_pred             ----HHHhcCccc
Q 019195          245 ----KEIKSHPWF  253 (344)
Q Consensus       245 ----~ell~hp~~  253 (344)
                          .++++||||
T Consensus       225 ~~~~~~~~~h~~~  237 (237)
T cd05576         225 VAGVEDIKSHPFF  237 (237)
T ss_pred             ccchHHHHcCCCC
Confidence                999999997

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=1.1e-38  Score=286.01  Aligned_cols=240  Identities=24%  Similarity=0.377  Sum_probs=188.2

Q ss_pred             CCceeeeeeeecCceEEEEEEEc-----CCCcEEEEEEeecCcc--ccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEE
Q 019195            2 EKYELMKDIGSGNFGVARLMRNK-----NTKELVAMKYIERGHK--IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLA   74 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~--~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~   74 (344)
                      ++|++.+.||+|+||.||+|.+.     .++..||+|++.....  ....+.+|+.+++.++||||+++++++.....++
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~~   84 (288)
T cd05050           5 NNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPMC   84 (288)
T ss_pred             HhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCccE
Confidence            57999999999999999999874     3678999999875432  2356888999999999999999999999999999


Q ss_pred             EEEecCCCCChHHHHHhCC----------------------CCCHHHHHHHHHHHH-------HCCeeecCCCCCCeEec
Q 019195           75 IVMEYAAGGELFERICNAG----------------------RFSEDEARYFFQQLI-------SGQICHRDLKLENTLLD  125 (344)
Q Consensus        75 lv~e~~~~g~L~~~i~~~~----------------------~~~~~~~~~~~~ql~-------~~~iiH~Dikp~NIl~~  125 (344)
                      ++|||+++++|.+++....                      .+++.+++.++.|++       ..+++||||||+||+++
T Consensus        85 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~nil~~  164 (288)
T cd05050          85 LLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVG  164 (288)
T ss_pred             EEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhheEec
Confidence            9999999999999986432                      356666677766655       44999999999999997


Q ss_pred             CCCCCCEEEeecCCCcccCCCCC---CCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHH
Q 019195          126 GSPAPRLKICDFGYSKSSLLHSR---PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKN  201 (344)
Q Consensus       126 ~~~~~~vkL~DFg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~  201 (344)
                      .++.  ++|+|||++........   .....++..|+|||.+.+..++ .++|||||||++|+|++ |..||.+....+.
T Consensus       165 ~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~il~el~~~~~~p~~~~~~~~~  241 (288)
T cd05050         165 ENMV--VKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYT-TESDVWAYGVVLWEIFSYGMQPYYGMAHEEV  241 (288)
T ss_pred             CCCc--eEECccccceecccCccccccCCCccChhhcCHHHHhcCCCC-chhHHHHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence            6654  99999999875432221   2223456779999998777664 45999999999999997 8889976544332


Q ss_pred             HHHHHHHHhhccccCCCCCCCCHhHHHHHHHhcccCCCCCCChHHHhc
Q 019195          202 FRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKS  249 (344)
Q Consensus       202 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~ell~  249 (344)
                          ...+..... .+....++..+.+||.+||+.+|.+|||+.++++
T Consensus       242 ----~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~  284 (288)
T cd05050         242 ----IYYVRDGNV-LSCPDNCPLELYNLMRLCWSKLPSDRPSFASINR  284 (288)
T ss_pred             ----HHHHhcCCC-CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence                222222221 2223357889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-39  Score=279.70  Aligned_cols=250  Identities=30%  Similarity=0.531  Sum_probs=206.1

Q ss_pred             CCCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCc----cccHHHHHHHHHHhcC-CCCCcceeeEEEEcCCEEEE
Q 019195            1 MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH----KIDANVAREIINHKQL-RHPNIIRFKEVVLTPTHLAI   75 (344)
Q Consensus         1 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~ei~~l~~l-~h~niv~~~~~~~~~~~~~l   75 (344)
                      +++|.++++||+|+|+.|.++..+.|.++||+|++++.-    ....-++.|-.+..+- +||.+|.++.+|+.+..+++
T Consensus       249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff  328 (593)
T KOG0695|consen  249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF  328 (593)
T ss_pred             cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence            578999999999999999999999999999999997632    2223355555555554 79999999999999999999


Q ss_pred             EEecCCCCChHHHHHhCCCCCHHHHHHH-------HHHHHHCCeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCC-C
Q 019195           76 VMEYAAGGELFERICNAGRFSEDEARYF-------FQQLISGQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH-S  147 (344)
Q Consensus        76 v~e~~~~g~L~~~i~~~~~~~~~~~~~~-------~~ql~~~~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~-~  147 (344)
                      |.||++||+|.-.++++.++++++++.+       +..||+.|||.||||..|+|+|..+  ++||+|+|+++..... .
T Consensus       329 vieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeg--hikltdygmcke~l~~gd  406 (593)
T KOG0695|consen  329 VIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEG--HIKLTDYGMCKEGLGPGD  406 (593)
T ss_pred             EEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCC--ceeecccchhhcCCCCCc
Confidence            9999999999999999999999887766       4566777999999999999998766  4999999999864443 4


Q ss_pred             CCCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCC----CChHHHHHHHHHHhhccccCCCCCCCC
Q 019195          148 RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQ----EDPKNFRKTISRIMAVQYKIPDYVHIS  223 (344)
Q Consensus       148 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~s  223 (344)
                      ...+.||||.|.|||++.+..| +..+|+|+||++++||+.|+.||.--    .+...-.-.++-+...+.++|.  .+|
T Consensus       407 ~tstfcgtpnyiapeilrgeey-gfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqiripr--sls  483 (593)
T KOG0695|consen  407 TTSTFCGTPNYIAPEILRGEEY-GFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIRIPR--SLS  483 (593)
T ss_pred             ccccccCCCcccchhhhccccc-CceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcccccc--eee
Confidence            4566799999999999998887 55599999999999999999999631    1111222344555666777776  567


Q ss_pred             HhHHHHHHHhcccCCCCCC------ChHHHhcCccccc
Q 019195          224 QDCRNLLSRIFVANPSRRI------TIKEIKSHPWFLK  255 (344)
Q Consensus       224 ~~~~~li~~~L~~dp~~R~------s~~ell~hp~~~~  255 (344)
                      -.+..+++..|++||.+|.      ..+++..|+||..
T Consensus       484 vkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~  521 (593)
T KOG0695|consen  484 VKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRS  521 (593)
T ss_pred             hhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhh
Confidence            7889999999999999998      4789999999973

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=2e-38  Score=281.40  Aligned_cols=241  Identities=31%  Similarity=0.498  Sum_probs=191.5

Q ss_pred             CceeeeeeeecCceEEEEEEEcC-CCcEEEEEEeecCc-----------cccHHHHHHHHHHhc-CCCCCcceeeEEEEc
Q 019195            3 KYELMKDIGSGNFGVARLMRNKN-TKELVAMKYIERGH-----------KIDANVAREIINHKQ-LRHPNIIRFKEVVLT   69 (344)
Q Consensus         3 ~y~~~~~lg~G~~g~V~~~~~~~-~~~~vaiK~~~~~~-----------~~~~~~~~ei~~l~~-l~h~niv~~~~~~~~   69 (344)
                      .|++.+.||+|+||.||++.+.. +++.+|+|.+....           .....+.+|+.+++. ++||||+++++++..
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   80 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE   80 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence            48999999999999999999987 78899999875321           112346678887764 799999999999999


Q ss_pred             CCEEEEEEecCCCCChHHHHHh----CCCCCHHHHHHHHHHHHHC--------CeeecCCCCCCeEecCCCCCCEEEeec
Q 019195           70 PTHLAIVMEYAAGGELFERICN----AGRFSEDEARYFFQQLISG--------QICHRDLKLENTLLDGSPAPRLKICDF  137 (344)
Q Consensus        70 ~~~~~lv~e~~~~g~L~~~i~~----~~~~~~~~~~~~~~ql~~~--------~iiH~Dikp~NIl~~~~~~~~vkL~DF  137 (344)
                      ++..+++|||+++++|.+++..    ...+++..++.++.|++.+        +++|+||+|.||+++.++.  +||+||
T Consensus        81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~--~~l~df  158 (269)
T cd08528          81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDK--VTITDF  158 (269)
T ss_pred             CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCc--EEEecc
Confidence            9999999999999999888743    3468888888887776653        7999999999999977654  999999


Q ss_pred             CCCcccCCCCCCCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCC
Q 019195          138 GYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIP  217 (344)
Q Consensus       138 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  217 (344)
                      |++.............|+..|+|||.+.+..+ +.++|+||||+++|+|++|++||.........    ..+........
T Consensus       159 g~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~-~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~----~~~~~~~~~~~  233 (269)
T cd08528         159 GLAKQKQPESKLTSVVGTILYSCPEIVKNEPY-GEKADVWAFGCILYQMCTLQPPFYSTNMLSLA----TKIVEAVYEPL  233 (269)
T ss_pred             cceeecccccccccccCcccCcChhhhcCCCC-chHHHHHHHHHHHHHHHhCCCcccccCHHHHH----HHHhhccCCcC
Confidence            99876544444445679999999999987665 45599999999999999999999765443222    22222222222


Q ss_pred             CCCCCCHhHHHHHHHhcccCCCCCCChHHHhcC
Q 019195          218 DYVHISQDCRNLLSRIFVANPSRRITIKEIKSH  250 (344)
Q Consensus       218 ~~~~~s~~~~~li~~~L~~dp~~R~s~~ell~h  250 (344)
                      ....+++.+.++|.+||+.||.+||++.++.++
T Consensus       234 ~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~  266 (269)
T cd08528         234 PEGMYSEDVTDVITSCLTPDAEARPDIIQVSAM  266 (269)
T ss_pred             CcccCCHHHHHHHHHHCCCCCccCCCHHHHHHH
Confidence            222568899999999999999999999998764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=4.2e-39  Score=284.17  Aligned_cols=233  Identities=19%  Similarity=0.258  Sum_probs=181.0

Q ss_pred             eeeeecCceEEEEEEEcCCCc-------EEEEEEeecCcc-ccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEEec
Q 019195            8 KDIGSGNFGVARLMRNKNTKE-------LVAMKYIERGHK-IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEY   79 (344)
Q Consensus         8 ~~lg~G~~g~V~~~~~~~~~~-------~vaiK~~~~~~~-~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~   79 (344)
                      +.||+|+||.||++.+...+.       .+|+|.+..... ....+.+|+.+++.++||||+++++++..+...++||||
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~   80 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY   80 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence            479999999999999865543       488888765432 235678899999999999999999999999999999999


Q ss_pred             CCCCChHHHHHhCC-CCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCC------CCEEEeecCCCcccCC
Q 019195           80 AAGGELFERICNAG-RFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPA------PRLKICDFGYSKSSLL  145 (344)
Q Consensus        80 ~~~g~L~~~i~~~~-~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~------~~vkL~DFg~a~~~~~  145 (344)
                      +++|+|..++...+ .+++..++.++.|++.+       ||+||||||+||+++.++.      +.++++|||++.....
T Consensus        81 ~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~~~~  160 (258)
T cd05078          81 VKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLP  160 (258)
T ss_pred             CCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEecccccccccCC
Confidence            99999999997654 57888777777666654       9999999999999976543      2379999998864332


Q ss_pred             CCCCCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCC-CCCCCCCChHHHHHHHHHHhhccccCCCCCCCCH
Q 019195          146 HSRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGA-YPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQ  224 (344)
Q Consensus       146 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~-~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~  224 (344)
                         .....+++.|+|||.+.+....+.++|||||||++|+|++|. +||........ ..    ........|.  ..+.
T Consensus       161 ---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~-~~----~~~~~~~~~~--~~~~  230 (258)
T cd05078         161 ---KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKK-LQ----FYEDRHQLPA--PKWT  230 (258)
T ss_pred             ---chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHH-HH----HHHccccCCC--CCcH
Confidence               234568899999999987554456699999999999999984 66655433221 11    1122223333  4568


Q ss_pred             hHHHHHHHhcccCCCCCCChHHHhcC
Q 019195          225 DCRNLLSRIFVANPSRRITIKEIKSH  250 (344)
Q Consensus       225 ~~~~li~~~L~~dp~~R~s~~ell~h  250 (344)
                      ++.+||.+||+.+|.+|||+.++++.
T Consensus       231 ~~~~li~~~l~~~p~~Rps~~~il~~  256 (258)
T cd05078         231 ELANLINQCMDYEPDFRPSFRAIIRD  256 (258)
T ss_pred             HHHHHHHHHhccChhhCCCHHHHHHh
Confidence            89999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=1.6e-38  Score=291.03  Aligned_cols=241  Identities=24%  Similarity=0.343  Sum_probs=185.9

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCC-------CcEEEEEEeecCcc--ccHHHHHHHHHHhcC-CCCCcceeeEEEEcCC
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNT-------KELVAMKYIERGHK--IDANVAREIINHKQL-RHPNIIRFKEVVLTPT   71 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~-------~~~vaiK~~~~~~~--~~~~~~~ei~~l~~l-~h~niv~~~~~~~~~~   71 (344)
                      .+|++.+.||+|+||.||+|.+...       +..||+|.+.....  ....+.+|+.+++++ +||||+++++++...+
T Consensus        12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~   91 (334)
T cd05100          12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG   91 (334)
T ss_pred             hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCC
Confidence            3799999999999999999986432       23689998875332  235688999999999 7999999999999999


Q ss_pred             EEEEEEecCCCCChHHHHHhCC----------------CCCHHHHHHHHHHH-------HHCCeeecCCCCCCeEecCCC
Q 019195           72 HLAIVMEYAAGGELFERICNAG----------------RFSEDEARYFFQQL-------ISGQICHRDLKLENTLLDGSP  128 (344)
Q Consensus        72 ~~~lv~e~~~~g~L~~~i~~~~----------------~~~~~~~~~~~~ql-------~~~~iiH~Dikp~NIl~~~~~  128 (344)
                      .++++|||+++|+|.+++.+..                .++..++..++.|+       |+.||+||||||+|||++.++
T Consensus        92 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nill~~~~  171 (334)
T cd05100          92 PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDN  171 (334)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCC
Confidence            9999999999999999987532                35555555555554       455999999999999997665


Q ss_pred             CCCEEEeecCCCcccCCCCC---CCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHH
Q 019195          129 APRLKICDFGYSKSSLLHSR---PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRK  204 (344)
Q Consensus       129 ~~~vkL~DFg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~  204 (344)
                      .  +||+|||+++.......   .....++..|+|||++.+..++. ++|||||||++|+|++ |..||........+..
T Consensus       172 ~--~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~  248 (334)
T cd05100         172 V--MKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTH-QSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKL  248 (334)
T ss_pred             c--EEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCc-hhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Confidence            4  99999999875432221   12223457899999998777654 4999999999999998 8899977654332222


Q ss_pred             HHHHHhhccccCCCCCCCCHhHHHHHHHhcccCCCCCCChHHHhcC
Q 019195          205 TISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSH  250 (344)
Q Consensus       205 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~ell~h  250 (344)
                          +. .....+.....+..+.+|+.+||+.+|.+|||+.+++++
T Consensus       249 ----~~-~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~  289 (334)
T cd05100         249 ----LK-EGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVED  289 (334)
T ss_pred             ----HH-cCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence                21 122223334678899999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=1.8e-38  Score=281.75  Aligned_cols=236  Identities=21%  Similarity=0.363  Sum_probs=175.7

Q ss_pred             eeeeecCceEEEEEEEc--CCCcEEEEEEeecCcc--ccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEEecCCCC
Q 019195            8 KDIGSGNFGVARLMRNK--NTKELVAMKYIERGHK--IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYAAGG   83 (344)
Q Consensus         8 ~~lg~G~~g~V~~~~~~--~~~~~vaiK~~~~~~~--~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g   83 (344)
                      +.||+|+||+||++...  .....+|+|.+.....  ....+.+|+..++.++||||+++++.+.....+|+||||+++|
T Consensus         1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05042           1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG   80 (269)
T ss_pred             CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence            36999999999999643  3445788887754322  2245788999999999999999999999999999999999999


Q ss_pred             ChHHHHHhCC-----CCCHHHHHHHHHHH-------HHCCeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCC---C
Q 019195           84 ELFERICNAG-----RFSEDEARYFFQQL-------ISGQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS---R  148 (344)
Q Consensus        84 ~L~~~i~~~~-----~~~~~~~~~~~~ql-------~~~~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~---~  148 (344)
                      +|.+++....     .+++..++.++.|+       |+.||+||||||+|||++.++.  +||+|||++.......   .
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~--~kl~dfg~~~~~~~~~~~~~  158 (269)
T cd05042          81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLS--VKIGDYGLALEQYPEDYYIT  158 (269)
T ss_pred             cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCc--EEEeccccccccccchheec
Confidence            9999987643     23455555555555       4559999999999999987665  9999999986432221   1


Q ss_pred             CCCCccCCcccCCccccCC------CCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhhccccCCC---
Q 019195          149 PKSTVGTPAYIAPEVLSRR------EYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPD---  218 (344)
Q Consensus       149 ~~~~~gt~~y~aPE~~~~~------~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~---  218 (344)
                      .....+++.|+|||++...      ...+.++|||||||++|+|++ |..||........+...+.   .....++.   
T Consensus       159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~---~~~~~~~~~~~  235 (269)
T cd05042         159 KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVR---EQDIKLPKPQL  235 (269)
T ss_pred             cCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhh---ccCccCCCCcc
Confidence            1233467789999997532      223556999999999999999 7889977655443333322   22222221   


Q ss_pred             CCCCCHhHHHHHHHhcccCCCCCCChHHHhc
Q 019195          219 YVHISQDCRNLLSRIFVANPSRRITIKEIKS  249 (344)
Q Consensus       219 ~~~~s~~~~~li~~~L~~dp~~R~s~~ell~  249 (344)
                      ...+++.+.+++..|+ .||.+|||+.++++
T Consensus       236 ~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~  265 (269)
T cd05042         236 DLKYSDRWYEVMQFCW-LDPETRPTAEEVHE  265 (269)
T ss_pred             cccCCHHHHHHHHHHh-cCcccccCHHHHHH
Confidence            2357788999999998 59999999999875

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=6e-40  Score=300.68  Aligned_cols=237  Identities=26%  Similarity=0.389  Sum_probs=188.2

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCcc---ccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEEe
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK---IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVME   78 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e   78 (344)
                      ++..+...||+|+||+||++.+-.+   ||||+++...-   ..+.|++|+.++++-+|.||+-+.+++..+.. .||+-
T Consensus       392 ~ev~l~~rIGsGsFGtV~Rg~whGd---VAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AIiTq  467 (678)
T KOG0193|consen  392 EEVLLGERIGSGSFGTVYRGRWHGD---VAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AIITQ  467 (678)
T ss_pred             HHhhccceeccccccceeecccccc---eEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-eeeeh
Confidence            3456889999999999999998654   99999976433   34679999999999999999999999988777 99999


Q ss_pred             cCCCCChHHHHHhC-CCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCC---C
Q 019195           79 YAAGGELFERICNA-GRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH---S  147 (344)
Q Consensus        79 ~~~~g~L~~~i~~~-~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~---~  147 (344)
                      +|+|.+|+.+|+-. .+|.....+.|++|++++       +|||||||..|||+.++..  |||+|||++......   .
T Consensus       468 wCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~k--VkIgDFGLatvk~~w~g~~  545 (678)
T KOG0193|consen  468 WCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLK--VKIGDFGLATVKTRWSGEQ  545 (678)
T ss_pred             hccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCc--EEEecccceeeeeeecccc
Confidence            99999999998653 468888888888888776       9999999999999987654  999999998643222   2


Q ss_pred             CCCCCccCCcccCCccccCC--CCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCCC----CCC
Q 019195          148 RPKSTVGTPAYIAPEVLSRR--EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPD----YVH  221 (344)
Q Consensus       148 ~~~~~~gt~~y~aPE~~~~~--~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~----~~~  221 (344)
                      ......|...|||||++...  ..++..+|||||||++|||++|..||..... +   .++-.+..+.. .|+    ..+
T Consensus       546 q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~-d---qIifmVGrG~l-~pd~s~~~s~  620 (678)
T KOG0193|consen  546 QLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNR-D---QIIFMVGRGYL-MPDLSKIRSN  620 (678)
T ss_pred             ccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCCh-h---heEEEeccccc-Cccchhhhcc
Confidence            23445699999999998532  2235569999999999999999999984332 2   22222222211 121    223


Q ss_pred             CCHhHHHHHHHhcccCCCCCCChHHHhc
Q 019195          222 ISQDCRNLLSRIFVANPSRRITIKEIKS  249 (344)
Q Consensus       222 ~s~~~~~li~~~L~~dp~~R~s~~ell~  249 (344)
                      .+.++++|+..||..++++||.+.+||.
T Consensus       621 ~pk~mk~Ll~~C~~~~~~eRP~F~~il~  648 (678)
T KOG0193|consen  621 CPKAMKRLLSDCWKFDREERPLFPQLLS  648 (678)
T ss_pred             CHHHHHHHHHHHHhcCcccCccHHHHHH
Confidence            4569999999999999999999999876

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=2e-38  Score=283.26  Aligned_cols=245  Identities=25%  Similarity=0.407  Sum_probs=192.2

Q ss_pred             CCceeeeeeeecCceEEEEEEEc----CCCcEEEEEEeecCccc--cHHHHHHHHHHhcCCCCCcceeeEEEEc--CCEE
Q 019195            2 EKYELMKDIGSGNFGVARLMRNK----NTKELVAMKYIERGHKI--DANVAREIINHKQLRHPNIIRFKEVVLT--PTHL   73 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~----~~~~~vaiK~~~~~~~~--~~~~~~ei~~l~~l~h~niv~~~~~~~~--~~~~   73 (344)
                      +.|++.+.||+|+||.||++...    .++..||+|++......  ...+.+|+.+++.++||||+++++++..  ....
T Consensus         4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~   83 (284)
T cd05038           4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL   83 (284)
T ss_pred             hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence            46889999999999999999864    45889999999865543  5678999999999999999999999877  5679


Q ss_pred             EEEEecCCCCChHHHHHhCC-CCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCC
Q 019195           74 AIVMEYAAGGELFERICNAG-RFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLL  145 (344)
Q Consensus        74 ~lv~e~~~~g~L~~~i~~~~-~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~  145 (344)
                      +++|||+++++|.+++.... .++...+..++.||+.+       |++||||||+||+++.++  .++|+|||++.....
T Consensus        84 ~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~--~~~l~dfg~~~~~~~  161 (284)
T cd05038          84 RLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESED--LVKISDFGLAKVLPE  161 (284)
T ss_pred             EEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCC--CEEEccccccccccc
Confidence            99999999999999997654 68888888887776654       999999999999998765  499999999876542


Q ss_pred             CCC----CCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHH----------HHHHHHHHhh
Q 019195          146 HSR----PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKN----------FRKTISRIMA  211 (344)
Q Consensus       146 ~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~----------~~~~~~~~~~  211 (344)
                      ...    .....++..|+|||.+.+..+. .++||||||+++|+|++|..||........          ....+.....
T Consensus       162 ~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~-~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (284)
T cd05038         162 DKDYYYVKEPGESPIFWYAPECLRTSKFS-SASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLK  240 (284)
T ss_pred             CCcceeccCCCCCcccccCcHHHccCCCC-cccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHHH
Confidence            211    1122456679999998776654 459999999999999999999865432110          0111222222


Q ss_pred             ccccCCCCCCCCHhHHHHHHHhcccCCCCCCChHHHhc
Q 019195          212 VQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKS  249 (344)
Q Consensus       212 ~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~ell~  249 (344)
                      .....+....++.++.+|+.+||+.+|.+|||+.++++
T Consensus       241 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  278 (284)
T cd05038         241 EGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLIL  278 (284)
T ss_pred             cCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence            33334444456789999999999999999999999976

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=4.8e-38  Score=275.79  Aligned_cols=233  Identities=25%  Similarity=0.359  Sum_probs=183.3

Q ss_pred             eeeeecCceEEEEEEEcCCCcEEEEEEeecCcc--ccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEEecCCCCCh
Q 019195            8 KDIGSGNFGVARLMRNKNTKELVAMKYIERGHK--IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYAAGGEL   85 (344)
Q Consensus         8 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L   85 (344)
                      ++||+|+||.||++... ++..+|+|.+.....  ....+.+|+.+++.++||||+++++++...+..++||||+++++|
T Consensus         1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   79 (250)
T cd05085           1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDF   79 (250)
T ss_pred             CccCCCCCceEEEEEec-CCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcH
Confidence            47999999999999864 678899998875432  234688999999999999999999999999999999999999999


Q ss_pred             HHHHHhC-CCCCHHHHHHHHHHHH-------HCCeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCCCC--CCCccC
Q 019195           86 FERICNA-GRFSEDEARYFFQQLI-------SGQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP--KSTVGT  155 (344)
Q Consensus        86 ~~~i~~~-~~~~~~~~~~~~~ql~-------~~~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~~~--~~~~gt  155 (344)
                      ..++... ..+.+..+..++.|++       +.|++||||||+||+++.++.  +||+|||++.........  ....++
T Consensus        80 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~--~~l~d~g~~~~~~~~~~~~~~~~~~~  157 (250)
T cd05085          80 LSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNV--LKISDFGMSRQEDDGIYSSSGLKQIP  157 (250)
T ss_pred             HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCe--EEECCCccceeccccccccCCCCCCc
Confidence            9988653 4578888777776655       459999999999999977664  999999998653322211  122356


Q ss_pred             CcccCCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCHhHHHHHHHhc
Q 019195          156 PAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIF  234 (344)
Q Consensus       156 ~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L  234 (344)
                      ..|+|||++.+..+. .++||||||+++|+|++ |..||..........    .+. ..........++..+.+++.+||
T Consensus       158 ~~y~aPE~~~~~~~~-~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~----~~~-~~~~~~~~~~~~~~~~~li~~~l  231 (250)
T cd05085         158 IKWTAPEALNYGRYS-SESDVWSYGILLWETFSLGVCPYPGMTNQQARE----QVE-KGYRMSCPQKCPDDVYKVMQRCW  231 (250)
T ss_pred             ccccCHHHhccCCCC-chhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH----HHH-cCCCCCCCCCCCHHHHHHHHHHc
Confidence            779999999776654 45999999999999998 999997764432222    221 12222333467899999999999


Q ss_pred             ccCCCCCCChHHHhc
Q 019195          235 VANPSRRITIKEIKS  249 (344)
Q Consensus       235 ~~dp~~R~s~~ell~  249 (344)
                      +.+|.+||++.++++
T Consensus       232 ~~~p~~Rp~~~~l~~  246 (250)
T cd05085         232 DYKPENRPKFSELQK  246 (250)
T ss_pred             ccCcccCCCHHHHHH
Confidence            999999999999875

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=4.3e-38  Score=277.61  Aligned_cols=233  Identities=25%  Similarity=0.388  Sum_probs=180.8

Q ss_pred             eeeecCceEEEEEEEc--CCCcEEEEEEeecCcc--ccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEEecCCCCC
Q 019195            9 DIGSGNFGVARLMRNK--NTKELVAMKYIERGHK--IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYAAGGE   84 (344)
Q Consensus         9 ~lg~G~~g~V~~~~~~--~~~~~vaiK~~~~~~~--~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~   84 (344)
                      .||+|+||.||++.+.  .++..||+|++.....  ....+.+|+.++++++||||+++++++. ...+++||||+++++
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~   80 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP   80 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence            4899999999998765  4566799998875432  2356889999999999999999999885 457899999999999


Q ss_pred             hHHHHHh-CCCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCCC----CCCC
Q 019195           85 LFERICN-AGRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR----PKST  152 (344)
Q Consensus        85 L~~~i~~-~~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~~----~~~~  152 (344)
                      |.+++.. ...+++..++.++.|++.+       |++||||||+|||++.+..  +||+|||++........    ....
T Consensus        81 L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~  158 (257)
T cd05115          81 LNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHY--AKISDFGLSKALGADDSYYKARSAG  158 (257)
T ss_pred             HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCc--EEeccCCccccccCCccceeccCCC
Confidence            9999875 4578999888887776654       9999999999999976654  99999999874332221    1112


Q ss_pred             ccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCHhHHHHHH
Q 019195          153 VGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLS  231 (344)
Q Consensus       153 ~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~  231 (344)
                      .+++.|+|||.+....++ .++|||||||++|+|++ |..||......... ..+   .. ....+.....++++.++|.
T Consensus       159 ~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~-~~~---~~-~~~~~~~~~~~~~l~~li~  232 (257)
T cd05115         159 KWPLKWYAPECINFRKFS-SRSDVWSYGITMWEAFSYGQKPYKKMKGPEVM-SFI---EQ-GKRLDCPAECPPEMYALMK  232 (257)
T ss_pred             CCCcccCCHHHHccCCCC-chhhHHHHHHHHHHHhcCCCCCcCcCCHHHHH-HHH---HC-CCCCCCCCCCCHHHHHHHH
Confidence            245789999998776654 45999999999999996 99999876543322 111   11 1222333457899999999


Q ss_pred             HhcccCCCCCCChHHHhcC
Q 019195          232 RIFVANPSRRITIKEIKSH  250 (344)
Q Consensus       232 ~~L~~dp~~R~s~~ell~h  250 (344)
                      +||+.+|.+||++.++++.
T Consensus       233 ~c~~~~~~~Rp~~~~i~~~  251 (257)
T cd05115         233 DCWIYKWEDRPNFAKVEER  251 (257)
T ss_pred             HHcCCChhhCcCHHHHHHH
Confidence            9999999999999998653

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=6.1e-38  Score=282.15  Aligned_cols=241  Identities=16%  Similarity=0.160  Sum_probs=177.9

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCC---CcEEEEEEeecCcccc------------HHHHHHHHHHhcCCCCCcceeeEE
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNT---KELVAMKYIERGHKID------------ANVAREIINHKQLRHPNIIRFKEV   66 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~---~~~vaiK~~~~~~~~~------------~~~~~ei~~l~~l~h~niv~~~~~   66 (344)
                      ++|++.+.||+|+||+||+|.+..+   +..+|+|+........            .....++..+..+.|+||++++++
T Consensus        12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~   91 (294)
T PHA02882         12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGC   91 (294)
T ss_pred             CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEe
Confidence            5899999999999999999998877   6778888654322111            112233445566789999999998


Q ss_pred             EEcCC----EEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEe
Q 019195           67 VLTPT----HLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKIC  135 (344)
Q Consensus        67 ~~~~~----~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~  135 (344)
                      +....    ..+++++++ ..++.+.+......++..++.++.|++.+       +|+||||||+|||++.++  .++|+
T Consensus        92 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~--~~~l~  168 (294)
T PHA02882         92 GSFKRCRMYYRFILLEKL-VENTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNN--RGYII  168 (294)
T ss_pred             eeEecCCceEEEEEEehh-ccCHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC--cEEEE
Confidence            76543    457888887 44777777665567777777777666654       999999999999997665  49999


Q ss_pred             ecCCCcccCCCC--------CCCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHH---
Q 019195          136 DFGYSKSSLLHS--------RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRK---  204 (344)
Q Consensus       136 DFg~a~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~---  204 (344)
                      |||+|+......        ......||+.|+|||++.+..++ .++|||||||++|+|++|++||...........   
T Consensus       169 DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~-~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~~~  247 (294)
T PHA02882        169 DYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVT-RRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAAK  247 (294)
T ss_pred             EcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCC-cHHHHHHHHHHHHHHHhCCCCCCccccchHHHHHhH
Confidence            999987543211        11234699999999999877764 559999999999999999999987643332221   


Q ss_pred             --HHHHHhhccccCCCCCCCCHhHHHHHHHhcccCCCCCCChHHHhc
Q 019195          205 --TISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKS  249 (344)
Q Consensus       205 --~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~ell~  249 (344)
                        .+.++.......   ...++.+.+++..|+..+|.+||++.++++
T Consensus       248 ~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~  291 (294)
T PHA02882        248 CDFIKRLHEGKIKI---KNANKFIYDFIECVTKLSYEEKPDYDALIK  291 (294)
T ss_pred             HHHHHHhhhhhhcc---CCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence              122222222222   346789999999999999999999999875

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=100.00  E-value=7.7e-40  Score=279.34  Aligned_cols=246  Identities=28%  Similarity=0.410  Sum_probs=200.5

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCcc---ccHHHHHHHHHHhcCCCCCcceeeEEEEcC------CE
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK---IDANVAREIINHKQLRHPNIIRFKEVVLTP------TH   72 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~ei~~l~~l~h~niv~~~~~~~~~------~~   72 (344)
                      .||..++++|.|.- .|..|.+.-++++||+|++.....   .-++..+|+..+..+.|+||++++.+|...      ..
T Consensus        17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e   95 (369)
T KOG0665|consen   17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE   95 (369)
T ss_pred             eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence            48999999999999 888899999999999998866432   336788999999999999999999999754      35


Q ss_pred             EEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHH-------HHHCCeeecCCCCCCeEecCCCCCCEEEeecCCCcccCC
Q 019195           73 LAIVMEYAAGGELFERICNAGRFSEDEARYFFQQ-------LISGQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLL  145 (344)
Q Consensus        73 ~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~q-------l~~~~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~  145 (344)
                      +|+||||+ ..+|...+.  ..+.-..+..++.|       +|++||+||||||+||+++.+..  +||+|||+|+....
T Consensus        96 ~y~v~e~m-~~nl~~vi~--~elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~--lKi~dfg~ar~e~~  170 (369)
T KOG0665|consen   96 VYLVMELM-DANLCQVIL--MELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCT--LKILDFGLARTEDT  170 (369)
T ss_pred             HHHHHHhh-hhHHHHHHH--HhcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhh--eeeccchhhcccCc
Confidence            79999999 568988876  34555666666555       45569999999999999987776  99999999998777


Q ss_pred             CCCCCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccc-----------
Q 019195          146 HSRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQY-----------  214 (344)
Q Consensus       146 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~-----------  214 (344)
                      ....+.++.|..|.|||++.+.++... +||||+||++.||++|+..|.+....+++.+++........           
T Consensus       171 ~~~mtpyVvtRyyrapevil~~~~ke~-vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r  249 (369)
T KOG0665|consen  171 DFMMTPYVVTRYYRAPEVILGMGYKEN-VDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTVR  249 (369)
T ss_pred             ccccCchhheeeccCchheeccCCccc-chhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHHH
Confidence            667788899999999999999986544 99999999999999999999987766666655543322111           


Q ss_pred             ----------------cCCCC---------CCCCHhHHHHHHHhcccCCCCCCChHHHhcCcccc
Q 019195          215 ----------------KIPDY---------VHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFL  254 (344)
Q Consensus       215 ----------------~~~~~---------~~~s~~~~~li~~~L~~dp~~R~s~~ell~hp~~~  254 (344)
                                      .+|+.         ..-+..+++|+.+||..||++|.+++++|.|||++
T Consensus       250 ~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~  314 (369)
T KOG0665|consen  250 NYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIK  314 (369)
T ss_pred             HHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeee
Confidence                            11211         01245689999999999999999999999999997

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=6e-38  Score=279.93  Aligned_cols=239  Identities=23%  Similarity=0.361  Sum_probs=189.6

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCc----EEEEEEeecCcc--ccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEE
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKE----LVAMKYIERGHK--IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAI   75 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~----~vaiK~~~~~~~--~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~l   75 (344)
                      .+|++.+.||+|+||+||+|.+..++.    .+|+|.+.....  ....+.+|+.+++.++||||+++++++.. ...++
T Consensus         7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~   85 (279)
T cd05057           7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL   85 (279)
T ss_pred             HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence            579999999999999999999876654    589998766432  23568899999999999999999999987 78899


Q ss_pred             EEecCCCCChHHHHHhC-CCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCC
Q 019195           76 VMEYAAGGELFERICNA-GRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS  147 (344)
Q Consensus        76 v~e~~~~g~L~~~i~~~-~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~  147 (344)
                      +|||+++|+|.+++... ..+++..+..++.|++.+       |++||||||+||+++.++.  +||+|||+++......
T Consensus        86 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~--~kL~dfg~~~~~~~~~  163 (279)
T cd05057          86 ITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQH--VKITDFGLAKLLDVDE  163 (279)
T ss_pred             EEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCe--EEECCCcccccccCcc
Confidence            99999999999998764 468888888887777654       9999999999999976654  9999999997654332


Q ss_pred             CCCC---CccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCC
Q 019195          148 RPKS---TVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHIS  223 (344)
Q Consensus       148 ~~~~---~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s  223 (344)
                      ....   ..++..|+|||.+....++ .++|+|||||++|+|++ |+.||........ ..   .+.. ....+.....+
T Consensus       164 ~~~~~~~~~~~~~y~~PE~~~~~~~~-~~~Di~slG~~l~el~~~g~~p~~~~~~~~~-~~---~~~~-~~~~~~~~~~~  237 (279)
T cd05057         164 KEYHAEGGKVPIKWMALESILHRIYT-HKSDVWSYGVTVWELMTFGAKPYEGIPAVEI-PD---LLEK-GERLPQPPICT  237 (279)
T ss_pred             cceecCCCcccccccCHHHhhcCCcC-chhhHHHHHHHHHHHhcCCCCCCCCCCHHHH-HH---HHhC-CCCCCCCCCCC
Confidence            2111   2245679999998766654 45999999999999998 9999987654322 22   2221 22233334567


Q ss_pred             HhHHHHHHHhcccCCCCCCChHHHhc
Q 019195          224 QDCRNLLSRIFVANPSRRITIKEIKS  249 (344)
Q Consensus       224 ~~~~~li~~~L~~dp~~R~s~~ell~  249 (344)
                      .++.+++.+||..+|.+||++.++++
T Consensus       238 ~~~~~~~~~~l~~~p~~Rp~~~~l~~  263 (279)
T cd05057         238 IDVYMVLVKCWMIDAESRPTFKELIN  263 (279)
T ss_pred             HHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            89999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=3.8e-38  Score=279.77  Aligned_cols=240  Identities=24%  Similarity=0.356  Sum_probs=187.8

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCC---CcEEEEEEeecCc--cccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEE
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNT---KELVAMKYIERGH--KIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIV   76 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~---~~~vaiK~~~~~~--~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv   76 (344)
                      ++|.+.+.||+|+||.||+|.+...   ...||+|......  .....+.+|+.+++.++||||+++++++.+ ...|+|
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv   84 (270)
T cd05056           6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIV   84 (270)
T ss_pred             hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEE
Confidence            4789999999999999999987543   4578999886543  233578899999999999999999998875 557899


Q ss_pred             EecCCCCChHHHHHhCC-CCCHHHHHHHHHHHHH-------CCeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCCC
Q 019195           77 MEYAAGGELFERICNAG-RFSEDEARYFFQQLIS-------GQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR  148 (344)
Q Consensus        77 ~e~~~~g~L~~~i~~~~-~~~~~~~~~~~~ql~~-------~~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~~  148 (344)
                      |||+++++|.+++.+.. .++...++.++.|++.       .|++||||||+||+++.++.  +||+|||+++.......
T Consensus        85 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~--~~l~d~g~~~~~~~~~~  162 (270)
T cd05056          85 MELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDC--VKLGDFGLSRYLEDESY  162 (270)
T ss_pred             EEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCC--eEEccCceeeecccccc
Confidence            99999999999997644 5788887777766654       49999999999999987654  99999999875433221


Q ss_pred             --CCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCHh
Q 019195          149 --PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQD  225 (344)
Q Consensus       149 --~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~  225 (344)
                        .....++..|+|||.+....+. .++|||||||++|+|++ |..||...........+    . .....+....+++.
T Consensus       163 ~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~----~-~~~~~~~~~~~~~~  236 (270)
T cd05056         163 YKASKGKLPIKWMAPESINFRRFT-SASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRI----E-NGERLPMPPNCPPT  236 (270)
T ss_pred             eecCCCCccccccChhhhccCCCC-chhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH----H-cCCcCCCCCCCCHH
Confidence              1122345689999998766654 55999999999999986 99999876544333222    1 12223344567899


Q ss_pred             HHHHHHHhcccCCCCCCChHHHhcC
Q 019195          226 CRNLLSRIFVANPSRRITIKEIKSH  250 (344)
Q Consensus       226 ~~~li~~~L~~dp~~R~s~~ell~h  250 (344)
                      +.++|.+||..+|.+|||+.+++..
T Consensus       237 ~~~li~~~l~~~P~~Rpt~~~~~~~  261 (270)
T cd05056         237 LYSLMTKCWAYDPSKRPRFTELKAQ  261 (270)
T ss_pred             HHHHHHHHcCCChhhCcCHHHHHHH
Confidence            9999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=5.6e-38  Score=280.17  Aligned_cols=240  Identities=18%  Similarity=0.264  Sum_probs=189.0

Q ss_pred             CCceeeeeeeecCceEEEEEEEcC----CCcEEEEEEeecCcc--ccHHHHHHHHHHhcCCCCCcceeeEEEEc-CCEEE
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKN----TKELVAMKYIERGHK--IDANVAREIINHKQLRHPNIIRFKEVVLT-PTHLA   74 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~----~~~~vaiK~~~~~~~--~~~~~~~ei~~l~~l~h~niv~~~~~~~~-~~~~~   74 (344)
                      ++|++.+.||+|+||.||++.+..    ++..||+|.+.....  ....+.+|+.+++.++||||+++++++.. ....+
T Consensus         6 ~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~   85 (280)
T cd05043           6 DRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPPF   85 (280)
T ss_pred             hheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCCE
Confidence            589999999999999999999876    367899998865422  23567889999999999999999998765 46789


Q ss_pred             EEEecCCCCChHHHHHhC--------CCCCHHHHHHHHHHHHH-------CCeeecCCCCCCeEecCCCCCCEEEeecCC
Q 019195           75 IVMEYAAGGELFERICNA--------GRFSEDEARYFFQQLIS-------GQICHRDLKLENTLLDGSPAPRLKICDFGY  139 (344)
Q Consensus        75 lv~e~~~~g~L~~~i~~~--------~~~~~~~~~~~~~ql~~-------~~iiH~Dikp~NIl~~~~~~~~vkL~DFg~  139 (344)
                      ++++|+++++|..++...        ..+++.+++.++.|++.       .+++||||||+||+++.+.  .+||+|||+
T Consensus        86 ~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~--~~kl~d~g~  163 (280)
T cd05043          86 VLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEEL--QVKITDNAL  163 (280)
T ss_pred             EEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCC--cEEECCCCC
Confidence            999999999999998653        35788887777776655       4999999999999997665  499999999


Q ss_pred             CcccCCCCC---CCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhhcccc
Q 019195          140 SKSSLLHSR---PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYK  215 (344)
Q Consensus       140 a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~  215 (344)
                      ++.......   .....++..|+|||.+.+..++ .++|||||||++|++++ |++||....... ....+    .....
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~-~~~Di~slG~~l~el~~~g~~p~~~~~~~~-~~~~~----~~~~~  237 (280)
T cd05043         164 SRDLFPMDYHCLGDNENRPVKWMALESLVNKEYS-SASDVWSFGVLLWELMTLGQTPYVEIDPFE-MAAYL----KDGYR  237 (280)
T ss_pred             cccccCCceEEeCCCCCcchhccCHHHHhcCCCC-chhhHHHhHHHHHHHhcCCCCCcCcCCHHH-HHHHH----HcCCC
Confidence            875432211   1233467789999999776654 45999999999999998 999997654322 22211    12233


Q ss_pred             CCCCCCCCHhHHHHHHHhcccCCCCCCChHHHhc
Q 019195          216 IPDYVHISQDCRNLLSRIFVANPSRRITIKEIKS  249 (344)
Q Consensus       216 ~~~~~~~s~~~~~li~~~L~~dp~~R~s~~ell~  249 (344)
                      .+....+++++.+++.+||+.+|++|||+.++++
T Consensus       238 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~  271 (280)
T cd05043         238 LAQPINCPDELFAVMACCWALDPEERPSFSQLVQ  271 (280)
T ss_pred             CCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            3344457889999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=4.1e-38  Score=277.50  Aligned_cols=231  Identities=21%  Similarity=0.245  Sum_probs=181.3

Q ss_pred             eeeeecCceEEEEEEEcCCC----------cEEEEEEeecCccccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEE
Q 019195            8 KDIGSGNFGVARLMRNKNTK----------ELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVM   77 (344)
Q Consensus         8 ~~lg~G~~g~V~~~~~~~~~----------~~vaiK~~~~~~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~   77 (344)
                      +.||+|+||.||++.+..++          ..+++|.+.........+.+|+.+++.++||||+++++++.. ...++||
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~   79 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMVE   79 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhhHHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEEE
Confidence            46999999999999998776          358888776554435778899999999999999999999988 7789999


Q ss_pred             ecCCCCChHHHHHhCC-CCCHHHHHHHHHHHHH-------CCeeecCCCCCCeEecCCCC-----CCEEEeecCCCcccC
Q 019195           78 EYAAGGELFERICNAG-RFSEDEARYFFQQLIS-------GQICHRDLKLENTLLDGSPA-----PRLKICDFGYSKSSL  144 (344)
Q Consensus        78 e~~~~g~L~~~i~~~~-~~~~~~~~~~~~ql~~-------~~iiH~Dikp~NIl~~~~~~-----~~vkL~DFg~a~~~~  144 (344)
                      ||+++|+|..++.... .++...+..++.|++.       .||+||||||+|||++.++.     +.+||+|||++....
T Consensus        80 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a~~~~  159 (259)
T cd05037          80 EYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVL  159 (259)
T ss_pred             EcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCcccccc
Confidence            9999999999998765 7888887777777654       49999999999999986552     149999999987543


Q ss_pred             CCCCCCCCccCCcccCCccccCC-CCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhhccccCCCCCCC
Q 019195          145 LHSRPKSTVGTPAYIAPEVLSRR-EYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHI  222 (344)
Q Consensus       145 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  222 (344)
                      .   .....++..|+|||.+.+. ...+.++|||||||++|+|++ |..||...... .......    .....+.  ..
T Consensus       160 ~---~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~-~~~~~~~----~~~~~~~--~~  229 (259)
T cd05037         160 S---REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSS-EKERFYQ----DQHRLPM--PD  229 (259)
T ss_pred             c---ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCch-hHHHHHh----cCCCCCC--CC
Confidence            3   2344577889999998776 334566999999999999999 58888765422 2111111    1112222  22


Q ss_pred             CHhHHHHHHHhcccCCCCCCChHHHhc
Q 019195          223 SQDCRNLLSRIFVANPSRRITIKEIKS  249 (344)
Q Consensus       223 s~~~~~li~~~L~~dp~~R~s~~ell~  249 (344)
                      +..+.++|.+||..+|.+|||+.++++
T Consensus       230 ~~~~~~li~~~l~~~p~~Rpt~~~il~  256 (259)
T cd05037         230 CAELANLINQCWTYDPTKRPSFRAILR  256 (259)
T ss_pred             chHHHHHHHHHhccChhhCCCHHHHHH
Confidence            478999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=4.1e-38  Score=277.09  Aligned_cols=235  Identities=25%  Similarity=0.374  Sum_probs=184.8

Q ss_pred             CCCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEEecC
Q 019195            1 MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYA   80 (344)
Q Consensus         1 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~   80 (344)
                      +++|++.+.||+|+||.||++.  .+++.||+|.+.... ....+.+|+.+++.++||||+++++++..+ ..+++|||+
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~--~~~~~~~iK~~~~~~-~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~   80 (254)
T cd05083           5 LQKLTLGEIIGEGEFGAVLQGE--YTGQKVAVKNIKCDV-TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELM   80 (254)
T ss_pred             HHHceeeeeeccCCCCceEecc--cCCCceEEEeecCcc-hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECC
Confidence            3579999999999999999986  467889999886533 335788999999999999999999998754 579999999


Q ss_pred             CCCChHHHHHhCC--CCCHHHHHHHHHHHH-------HCCeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCCCCCC
Q 019195           81 AGGELFERICNAG--RFSEDEARYFFQQLI-------SGQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKS  151 (344)
Q Consensus        81 ~~g~L~~~i~~~~--~~~~~~~~~~~~ql~-------~~~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~~~~~  151 (344)
                      ++++|.+++....  .++...++.++.|++       +.|++||||||+||+++.++.  +||+|||++......  ...
T Consensus        81 ~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~--~kl~Dfg~~~~~~~~--~~~  156 (254)
T cd05083          81 SKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGV--AKVSDFGLARVGSMG--VDN  156 (254)
T ss_pred             CCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCc--EEECCCccceecccc--CCC
Confidence            9999999997643  467777776666655       459999999999999977654  999999998753221  122


Q ss_pred             CccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCHhHHHHH
Q 019195          152 TVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLL  230 (344)
Q Consensus       152 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li  230 (344)
                      ...+..|+|||.+.+..+. .++|+|||||++|+|++ |++||......... .   .+. .....+....+++.+.+++
T Consensus       157 ~~~~~~y~~pe~~~~~~~~-~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~-~---~~~-~~~~~~~~~~~~~~~~~li  230 (254)
T cd05083         157 SKLPVKWTAPEALKHKKFS-SKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVK-E---CVE-KGYRMEPPEGCPADVYVLM  230 (254)
T ss_pred             CCCCceecCHHHhccCCcC-chhhHHHHHHHHHHHHhCCCCCCccCCHHHHH-H---HHh-CCCCCCCCCcCCHHHHHHH
Confidence            3456789999998776654 45999999999999997 99999776543222 1   111 1222333346789999999


Q ss_pred             HHhcccCCCCCCChHHHhc
Q 019195          231 SRIFVANPSRRITIKEIKS  249 (344)
Q Consensus       231 ~~~L~~dp~~R~s~~ell~  249 (344)
                      .+||+.+|.+||++.+++.
T Consensus       231 ~~~l~~~p~~Rp~~~~l~~  249 (254)
T cd05083         231 TSCWETEPKKRPSFHKLRE  249 (254)
T ss_pred             HHHcCCChhhCcCHHHHHH
Confidence            9999999999999999875

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=6.3e-38  Score=275.24  Aligned_cols=233  Identities=26%  Similarity=0.370  Sum_probs=184.5

Q ss_pred             eeeeecCceEEEEEEEcCCCcEEEEEEeecCcc--ccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEEecCCCCCh
Q 019195            8 KDIGSGNFGVARLMRNKNTKELVAMKYIERGHK--IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYAAGGEL   85 (344)
Q Consensus         8 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L   85 (344)
                      ++||.|+||.||++.+.. ++.||+|.+.....  ....+.+|+.++++++||||+++++++......++||||+++++|
T Consensus         1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l   79 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSL   79 (251)
T ss_pred             CccccCCCceEEEEEEeC-CCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcH
Confidence            479999999999999887 89999998876433  335788999999999999999999999999999999999999999


Q ss_pred             HHHHHhC-CCCCHHHHHHHHHHH-------HHCCeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCCCC---CCCcc
Q 019195           86 FERICNA-GRFSEDEARYFFQQL-------ISGQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP---KSTVG  154 (344)
Q Consensus        86 ~~~i~~~-~~~~~~~~~~~~~ql-------~~~~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~~~---~~~~g  154 (344)
                      .+++.+. ..++...+..++.++       |+.+++||||||+||+++.++.  +||+|||++.........   ....+
T Consensus        80 ~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~--~~l~d~g~~~~~~~~~~~~~~~~~~~  157 (251)
T cd05041          80 LTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNV--LKISDFGMSREEEGGIYTVSDGLKQI  157 (251)
T ss_pred             HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCc--EEEeeccccccccCCcceeccccCcc
Confidence            9998653 457777777766554       4559999999999999976654  999999998754321111   12234


Q ss_pred             CCcccCCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCHhHHHHHHHh
Q 019195          155 TPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRI  233 (344)
Q Consensus       155 t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~  233 (344)
                      +..|+|||.+.+..+ +.++|||||||++|+|++ |..||........... +    ......+....++..+.+++.+|
T Consensus       158 ~~~y~~PE~~~~~~~-~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~-~----~~~~~~~~~~~~~~~~~~li~~~  231 (251)
T cd05041         158 PIKWTAPEALNYGRY-TSESDVWSYGILLWETFSLGDTPYPGMSNQQTRER-I----ESGYRMPAPQLCPEEIYRLMLQC  231 (251)
T ss_pred             eeccCChHhhccCCC-CcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHH-H----hcCCCCCCCccCCHHHHHHHHHH
Confidence            567999999877665 455999999999999998 8999977654322222 1    11223333346788999999999


Q ss_pred             cccCCCCCCChHHHhc
Q 019195          234 FVANPSRRITIKEIKS  249 (344)
Q Consensus       234 L~~dp~~R~s~~ell~  249 (344)
                      |+.+|.+|||+.++++
T Consensus       232 l~~~p~~Rp~~~ell~  247 (251)
T cd05041         232 WAYDPENRPSFSEIYN  247 (251)
T ss_pred             hccChhhCcCHHHHHH
Confidence            9999999999999986

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=2.6e-39  Score=307.86  Aligned_cols=238  Identities=27%  Similarity=0.417  Sum_probs=199.7

Q ss_pred             CceeeeeeeecCceEEEEEEEc-----CCCcEEEEEEeecCcc--ccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEE
Q 019195            3 KYELMKDIGSGNFGVARLMRNK-----NTKELVAMKYIERGHK--IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAI   75 (344)
Q Consensus         3 ~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~--~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~l   75 (344)
                      +-+.++.||+|+||.||+|...     .....||||.++....  ...+|+||+.++..|+|||||++++++..++.+++
T Consensus       487 ~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~M  566 (774)
T KOG1026|consen  487 DIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLCM  566 (774)
T ss_pred             heeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeEE
Confidence            3467889999999999999864     3446899999987544  35789999999999999999999999999999999


Q ss_pred             EEecCCCCChHHHHHhCC--------------CCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEE
Q 019195           76 VMEYAAGGELFERICNAG--------------RFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKI  134 (344)
Q Consensus        76 v~e~~~~g~L~~~i~~~~--------------~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL  134 (344)
                      |+|||..|+|.++|+...              .++..+.+.++.||+.+       .+|||||-..|+||.++..  |||
T Consensus       567 vFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVge~l~--VKI  644 (774)
T KOG1026|consen  567 VFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVGENLV--VKI  644 (774)
T ss_pred             EEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceeccceE--EEe
Confidence            999999999999996432              27888999999998866       9999999999999988776  999


Q ss_pred             eecCCCcccCCCCCC---CCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHh
Q 019195          135 CDFGYSKSSLLHSRP---KSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIM  210 (344)
Q Consensus       135 ~DFg~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~  210 (344)
                      +|||+++..+....-   ....-..+|||||.+..+.+++. |||||+||+|||+++ |..||.+....+    .+..+.
T Consensus       645 sDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTte-SDVWs~GVvLWEIFsyG~QPy~glSn~E----VIe~i~  719 (774)
T KOG1026|consen  645 SDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTE-SDVWSFGVVLWEIFSYGKQPYYGLSNQE----VIECIR  719 (774)
T ss_pred             cccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccch-hhhhhhhhhhhhhhccccCcccccchHH----HHHHHH
Confidence            999999865443322   23345678999999999998766 999999999999997 999999987744    344444


Q ss_pred             hccccCCCCCCCCHhHHHHHHHhcccCCCCCCChHHHh
Q 019195          211 AVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIK  248 (344)
Q Consensus       211 ~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~ell  248 (344)
                      .... ++-+.+.+.++.+|+..||+.+|.+||++.||-
T Consensus       720 ~g~l-L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~  756 (774)
T KOG1026|consen  720 AGQL-LSCPENCPTEVYSLMLECWNENPKRRPSFKEIH  756 (774)
T ss_pred             cCCc-ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHH
Confidence            4555 666668999999999999999999999999973

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=5.9e-38  Score=277.57  Aligned_cols=233  Identities=20%  Similarity=0.256  Sum_probs=178.9

Q ss_pred             eeeeecCceEEEEEEEcC------------CCcEEEEEEeecCcc-ccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEE
Q 019195            8 KDIGSGNFGVARLMRNKN------------TKELVAMKYIERGHK-IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLA   74 (344)
Q Consensus         8 ~~lg~G~~g~V~~~~~~~------------~~~~vaiK~~~~~~~-~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~   74 (344)
                      +.||+|+||.||++....            ....+|+|.+..... ....+.+|+.+++.++||||+++++++..+...+
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~   80 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI   80 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence            468999999999998542            233588898765432 2346778899999999999999999999999999


Q ss_pred             EEEecCCCCChHHHHHh-CCCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCC-----CCEEEeecCCCc
Q 019195           75 IVMEYAAGGELFERICN-AGRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPA-----PRLKICDFGYSK  141 (344)
Q Consensus        75 lv~e~~~~g~L~~~i~~-~~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~-----~~vkL~DFg~a~  141 (344)
                      ++|||+++++|..++.. ...+++..++.++.|++.+       +|+||||||+|||++.++.     +.++++|||++.
T Consensus        81 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g~~~  160 (262)
T cd05077          81 MVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPI  160 (262)
T ss_pred             EEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCCCCCc
Confidence            99999999999888865 4568888888887776655       9999999999999975432     238999999886


Q ss_pred             ccCCCCCCCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHH-hCCCCCCCCCChHHHHHHHHHHhhccccCCCCC
Q 019195          142 SSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVML-VGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYV  220 (344)
Q Consensus       142 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~-~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  220 (344)
                      ....   .....++..|+|||.+......+.++|||||||++|+|+ +|..||........ ..    ........  ..
T Consensus       161 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~-~~----~~~~~~~~--~~  230 (262)
T cd05077         161 TVLS---RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEK-ER----FYEGQCML--VT  230 (262)
T ss_pred             cccC---cccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHH-HH----HHhcCccC--CC
Confidence            4322   233568889999999875444456699999999999998 58888876433221 11    11122221  22


Q ss_pred             CCCHhHHHHHHHhcccCCCCCCChHHHhcC
Q 019195          221 HISQDCRNLLSRIFVANPSRRITIKEIKSH  250 (344)
Q Consensus       221 ~~s~~~~~li~~~L~~dp~~R~s~~ell~h  250 (344)
                      ..++++.+||.+||+.||.+||++.+|+.+
T Consensus       231 ~~~~~~~~li~~cl~~dp~~Rp~~~~il~~  260 (262)
T cd05077         231 PSCKELADLMTHCMNYDPNQRPFFRAIMRD  260 (262)
T ss_pred             CChHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence            346789999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=4.3e-38  Score=280.32  Aligned_cols=232  Identities=22%  Similarity=0.288  Sum_probs=179.2

Q ss_pred             eeeecCceEEEEEEEcC------------------------CCcEEEEEEeecCcc-ccHHHHHHHHHHhcCCCCCccee
Q 019195            9 DIGSGNFGVARLMRNKN------------------------TKELVAMKYIERGHK-IDANVAREIINHKQLRHPNIIRF   63 (344)
Q Consensus         9 ~lg~G~~g~V~~~~~~~------------------------~~~~vaiK~~~~~~~-~~~~~~~ei~~l~~l~h~niv~~   63 (344)
                      .||+|+||.||++....                        ....||+|++..... ....+.+|+.+++.++||||+++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~   81 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV   81 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence            69999999999987532                        224588898865432 23467788999999999999999


Q ss_pred             eEEEEcCCEEEEEEecCCCCChHHHHHh-CCCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCC-----CC
Q 019195           64 KEVVLTPTHLAIVMEYAAGGELFERICN-AGRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSP-----AP  130 (344)
Q Consensus        64 ~~~~~~~~~~~lv~e~~~~g~L~~~i~~-~~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~-----~~  130 (344)
                      ++++......++||||+++|+|..++.+ .+.+++..+..++.|++.+       ||+||||||+|||++..+     .+
T Consensus        82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~~~~~  161 (274)
T cd05076          82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEGTSP  161 (274)
T ss_pred             EEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCcccCccc
Confidence            9999999999999999999999998865 5678888888877776654       999999999999997532     22


Q ss_pred             CEEEeecCCCcccCCCCCCCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHH-hCCCCCCCCCChHHHHHHHHHH
Q 019195          131 RLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVML-VGAYPFEDQEDPKNFRKTISRI  209 (344)
Q Consensus       131 ~vkL~DFg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~-~g~~pf~~~~~~~~~~~~~~~~  209 (344)
                      .+||+|||++.....   .....++..|+|||.+.+....+.++|||||||++|+|+ +|..||........ ....   
T Consensus       162 ~~kl~d~g~~~~~~~---~~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~-~~~~---  234 (274)
T cd05076         162 FIKLSDPGVSFTALS---REERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEK-ERFY---  234 (274)
T ss_pred             eeeecCCcccccccc---ccccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHH-HHHH---
Confidence            489999998754322   223457888999999876544466699999999999984 79999977544322 1111   


Q ss_pred             hhccccCCCCCCCCHhHHHHHHHhcccCCCCCCChHHHhcC
Q 019195          210 MAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSH  250 (344)
Q Consensus       210 ~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~ell~h  250 (344)
                       ......|.  ..++.+.++|.+||+.+|.+|||+.++|++
T Consensus       235 -~~~~~~~~--~~~~~~~~li~~cl~~~p~~Rps~~~il~~  272 (274)
T cd05076         235 -EKKHRLPE--PSCKELATLISQCLTYEPTQRPSFRTILRD  272 (274)
T ss_pred             -HhccCCCC--CCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence             11222332  356789999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=9.7e-38  Score=282.01  Aligned_cols=240  Identities=20%  Similarity=0.363  Sum_probs=187.4

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCc----EEEEEEeecCccc--cHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEE
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKE----LVAMKYIERGHKI--DANVAREIINHKQLRHPNIIRFKEVVLTPTHLAI   75 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~----~vaiK~~~~~~~~--~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~l   75 (344)
                      ++|++.+.||+|+||.||++.+..++.    .||+|.+......  ...+.+|+.+++.++||||+++++++... ..++
T Consensus         7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~   85 (303)
T cd05110           7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQL   85 (303)
T ss_pred             hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Ccee
Confidence            578999999999999999999877775    4788887654321  23578899999999999999999998754 4679


Q ss_pred             EEecCCCCChHHHHHhCC-CCCHHHHHHHHHHHHH-------CCeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCC
Q 019195           76 VMEYAAGGELFERICNAG-RFSEDEARYFFQQLIS-------GQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS  147 (344)
Q Consensus        76 v~e~~~~g~L~~~i~~~~-~~~~~~~~~~~~ql~~-------~~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~  147 (344)
                      +++|+++|+|.+++.... .+++..+..++.|++.       .||+||||||+||+++.++.  +||+|||+++......
T Consensus        86 v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~--~kL~Dfg~~~~~~~~~  163 (303)
T cd05110          86 VTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNH--VKITDFGLARLLEGDE  163 (303)
T ss_pred             eehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCc--eEEccccccccccCcc
Confidence            999999999999987644 5788877777777654       49999999999999976654  9999999997543222


Q ss_pred             C---CCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCC
Q 019195          148 R---PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHIS  223 (344)
Q Consensus       148 ~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s  223 (344)
                      .   .....++..|+|||.+.+..++ .++|||||||++|+|++ |..||.+... ......+    ......+.....+
T Consensus       164 ~~~~~~~~~~~~~y~~PE~~~~~~~~-~~~DiwslG~~l~el~t~g~~p~~~~~~-~~~~~~~----~~~~~~~~~~~~~  237 (303)
T cd05110         164 KEYNADGGKMPIKWMALECIHYRKFT-HQSDVWSYGVTIWELMTFGGKPYDGIPT-REIPDLL----EKGERLPQPPICT  237 (303)
T ss_pred             cccccCCCccccccCCHHHhccCCCC-hHHHHHHHHHHHHHHHhCCCCCCCCCCH-HHHHHHH----HCCCCCCCCCCCC
Confidence            2   1223467789999998776654 45999999999999997 8999976542 2222222    2233344444578


Q ss_pred             HhHHHHHHHhcccCCCCCCChHHHhcC
Q 019195          224 QDCRNLLSRIFVANPSRRITIKEIKSH  250 (344)
Q Consensus       224 ~~~~~li~~~L~~dp~~R~s~~ell~h  250 (344)
                      .++.+++.+||..+|.+||++.++++.
T Consensus       238 ~~~~~li~~c~~~~p~~Rp~~~~l~~~  264 (303)
T cd05110         238 IDVYMVMVKCWMIDADSRPKFKELAAE  264 (303)
T ss_pred             HHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            899999999999999999999998774

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=4.2e-38  Score=279.20  Aligned_cols=236  Identities=23%  Similarity=0.368  Sum_probs=183.4

Q ss_pred             eeeeecCceEEEEEEEcCCC------cEEEEEEeecCc--cccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEEec
Q 019195            8 KDIGSGNFGVARLMRNKNTK------ELVAMKYIERGH--KIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEY   79 (344)
Q Consensus         8 ~~lg~G~~g~V~~~~~~~~~------~~vaiK~~~~~~--~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~   79 (344)
                      +.||+|+||.||++......      ..+|+|.+....  .....+.+|+.+++.++||||+++++++......+++|||
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL   80 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence            46999999999999986543      689999886543  2345788999999999999999999999999999999999


Q ss_pred             CCCCChHHHHHhC-------CCCCHHHHHHHHHHHH-------HCCeeecCCCCCCeEecCCC---CCCEEEeecCCCcc
Q 019195           80 AAGGELFERICNA-------GRFSEDEARYFFQQLI-------SGQICHRDLKLENTLLDGSP---APRLKICDFGYSKS  142 (344)
Q Consensus        80 ~~~g~L~~~i~~~-------~~~~~~~~~~~~~ql~-------~~~iiH~Dikp~NIl~~~~~---~~~vkL~DFg~a~~  142 (344)
                      +++++|.+++.+.       ..+++.++..++.|++       +.+++|+||||+||+++.+.   ...++|+|||++..
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~~~  160 (269)
T cd05044          81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARD  160 (269)
T ss_pred             cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCcccccc
Confidence            9999999998642       2366777777666654       55999999999999998655   12599999999875


Q ss_pred             cCCCC---CCCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhhccccCCC
Q 019195          143 SLLHS---RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPD  218 (344)
Q Consensus       143 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  218 (344)
                      .....   ......++..|+|||.+.+..+ +.++|||||||++|+|++ |..||..........    .+. .......
T Consensus       161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~----~~~-~~~~~~~  234 (269)
T cd05044         161 IYKSDYYRKEGEGLLPVRWMAPESLLDGKF-TTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQ----HVT-AGGRLQK  234 (269)
T ss_pred             cccccccccCcccCCCccccCHHHHccCCc-ccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHH----HHh-cCCccCC
Confidence            43221   1123346788999999987766 455999999999999998 999997655433222    111 1122233


Q ss_pred             CCCCCHhHHHHHHHhcccCCCCCCChHHHhc
Q 019195          219 YVHISQDCRNLLSRIFVANPSRRITIKEIKS  249 (344)
Q Consensus       219 ~~~~s~~~~~li~~~L~~dp~~R~s~~ell~  249 (344)
                      ...++..+.+||.+||+.+|.+||++.++++
T Consensus       235 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  265 (269)
T cd05044         235 PENCPDKIYQLMTNCWAQDPSERPTFDRIQE  265 (269)
T ss_pred             cccchHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            3467899999999999999999999999875

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=2e-37  Score=275.05  Aligned_cols=239  Identities=21%  Similarity=0.299  Sum_probs=175.3

Q ss_pred             eeeeecCceEEEEEEEcCC--CcEEEEEEeecCc--cccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEEecCCCC
Q 019195            8 KDIGSGNFGVARLMRNKNT--KELVAMKYIERGH--KIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYAAGG   83 (344)
Q Consensus         8 ~~lg~G~~g~V~~~~~~~~--~~~vaiK~~~~~~--~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g   83 (344)
                      +.||+|+||.||++.....  ...+++|.+....  .....+.+|+.+++.++||||+++++.+......|+||||+++|
T Consensus         1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~   80 (268)
T cd05086           1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG   80 (268)
T ss_pred             CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence            3699999999999975433  3456677665433  23357889999999999999999999999999999999999999


Q ss_pred             ChHHHHHhC----CCCCHHHHHHHHHH-------HHHCCeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCC---CCC
Q 019195           84 ELFERICNA----GRFSEDEARYFFQQ-------LISGQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH---SRP  149 (344)
Q Consensus        84 ~L~~~i~~~----~~~~~~~~~~~~~q-------l~~~~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~---~~~  149 (344)
                      +|.+++.+.    ..++...++.++.|       +|+.+++||||||+|||++.++.  +||+|||++......   ...
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~--~~l~Dfg~~~~~~~~~~~~~~  158 (268)
T cd05086          81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLT--VKVGDYGIGPSRYKEDYIETE  158 (268)
T ss_pred             cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCcc--EEecccccccccCcchhhhcc
Confidence            999998753    23455555555555       45569999999999999976654  999999987643221   122


Q ss_pred             CCCccCCcccCCccccCCC------CCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhhccccCCCCCCC
Q 019195          150 KSTVGTPAYIAPEVLSRRE------YDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHI  222 (344)
Q Consensus       150 ~~~~gt~~y~aPE~~~~~~------~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  222 (344)
                      ...+++..|+|||++....      ..+.++|||||||++|+|++ |..||........+...+........+......+
T Consensus       159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (268)
T cd05086         159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQLELPY  238 (268)
T ss_pred             cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCccCCCC
Confidence            3456889999999985321      12456999999999999996 5778876655444444332211111111122347


Q ss_pred             CHhHHHHHHHhcccCCCCCCChHHHhc
Q 019195          223 SQDCRNLLSRIFVANPSRRITIKEIKS  249 (344)
Q Consensus       223 s~~~~~li~~~L~~dp~~R~s~~ell~  249 (344)
                      ++.+.+++..|| .+|.+||++.++++
T Consensus       239 ~~~~~~l~~~c~-~~P~~Rp~~~~i~~  264 (268)
T cd05086         239 SERWYEVLQFCW-LSPEKRATAEEVHR  264 (268)
T ss_pred             cHHHHHHHHHHh-hCcccCCCHHHHHH
Confidence            889999999999 67999999999875

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-38  Score=293.78  Aligned_cols=239  Identities=27%  Similarity=0.388  Sum_probs=193.0

Q ss_pred             ceeeeeeeecCceEEEEEEEcCCC----cEEEEEEeecCc----cccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEE
Q 019195            4 YELMKDIGSGNFGVARLMRNKNTK----ELVAMKYIERGH----KIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAI   75 (344)
Q Consensus         4 y~~~~~lg~G~~g~V~~~~~~~~~----~~vaiK~~~~~~----~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~l   75 (344)
                      -.+.++||+|+||.||++.....+    ..||+|......    .....+.+|.++|++++|||||++||+...+..+++
T Consensus       159 v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~i  238 (474)
T KOG0194|consen  159 IELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLML  238 (474)
T ss_pred             ccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccEE
Confidence            355689999999999999876542    238999887522    234678899999999999999999999999999999


Q ss_pred             EEecCCCCChHHHHHhCC-CCCHHHHHHHHHH-------HHHCCeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCC
Q 019195           76 VMEYAAGGELFERICNAG-RFSEDEARYFFQQ-------LISGQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS  147 (344)
Q Consensus        76 v~e~~~~g~L~~~i~~~~-~~~~~~~~~~~~q-------l~~~~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~  147 (344)
                      |||+|+||+|.+++++.+ .++..+...++.+       ||+.+++||||-..|+|+..+..  +||+|||+++......
T Consensus       239 vmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~--vKISDFGLs~~~~~~~  316 (474)
T KOG0194|consen  239 VMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGV--VKISDFGLSRAGSQYV  316 (474)
T ss_pred             EEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCe--EEeCccccccCCccee
Confidence            999999999999999887 4888776666544       55669999999999999987664  8999999987654222


Q ss_pred             CCC-CCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCHh
Q 019195          148 RPK-STVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQD  225 (344)
Q Consensus       148 ~~~-~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~  225 (344)
                      ... ...-...|+|||.+....++ .++|||||||++||+++ |..||.+....    .....+....++.+.+...+..
T Consensus       317 ~~~~~~klPirWLAPEtl~~~~~s-~kTDV~sfGV~~~Eif~~g~~Py~g~~~~----~v~~kI~~~~~r~~~~~~~p~~  391 (474)
T KOG0194|consen  317 MKKFLKKLPIRWLAPETLNTGIFS-FKTDVWSFGVLLWEIFENGAEPYPGMKNY----EVKAKIVKNGYRMPIPSKTPKE  391 (474)
T ss_pred             eccccccCcceecChhhhccCccc-cccchhheeeeEEeeeccCCCCCCCCCHH----HHHHHHHhcCccCCCCCCCHHH
Confidence            222 12245689999999888665 55999999999999998 88899887654    3344444556666666678889


Q ss_pred             HHHHHHHhcccCCCCCCChHHHhc
Q 019195          226 CRNLLSRIFVANPSRRITIKEIKS  249 (344)
Q Consensus       226 ~~~li~~~L~~dp~~R~s~~ell~  249 (344)
                      +..++.+|+..+|+.|||+.++.+
T Consensus       392 ~~~~~~~c~~~~p~~R~tm~~i~~  415 (474)
T KOG0194|consen  392 LAKVMKQCWKKDPEDRPTMSTIKK  415 (474)
T ss_pred             HHHHHHHhccCChhhccCHHHHHH
Confidence            999999999999999999998865

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.3e-38  Score=280.22  Aligned_cols=122  Identities=25%  Similarity=0.403  Sum_probs=111.0

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcCC--------CCCcceeeEEEEc----
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLR--------HPNIIRFKEVVLT----   69 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~l~~l~--------h~niv~~~~~~~~----   69 (344)
                      .||.+.++||.|.|++||+|.+..+.+.||+|+++......+....||.+|++++        ..+||++++.|..    
T Consensus        78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGpN  157 (590)
T KOG1290|consen   78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGPN  157 (590)
T ss_pred             ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCCC
Confidence            4899999999999999999999999999999999888777888999999999983        3589999999974    


Q ss_pred             CCEEEEEEecCCCCChHHHHHhC--CCCCHHHHHHHHHHHHHC--------CeeecCCCCCCeEe
Q 019195           70 PTHLAIVMEYAAGGELFERICNA--GRFSEDEARYFFQQLISG--------QICHRDLKLENTLL  124 (344)
Q Consensus        70 ~~~~~lv~e~~~~g~L~~~i~~~--~~~~~~~~~~~~~ql~~~--------~iiH~Dikp~NIl~  124 (344)
                      +.++|+|+|++ |.+|..+|+..  +.++...++.|++|++.+        ||||-||||+|||+
T Consensus       158 G~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl  221 (590)
T KOG1290|consen  158 GQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLL  221 (590)
T ss_pred             CcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeee
Confidence            46899999999 88999999865  469999999999999987        99999999999999

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=2.6e-37  Score=273.03  Aligned_cols=235  Identities=23%  Similarity=0.315  Sum_probs=175.8

Q ss_pred             eeeeecCceEEEEEEEcC---CCcEEEEEEeecCc--cccHHHHHHHHHHhcCCCCCcceeeEEEE-cCCEEEEEEecCC
Q 019195            8 KDIGSGNFGVARLMRNKN---TKELVAMKYIERGH--KIDANVAREIINHKQLRHPNIIRFKEVVL-TPTHLAIVMEYAA   81 (344)
Q Consensus         8 ~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~--~~~~~~~~ei~~l~~l~h~niv~~~~~~~-~~~~~~lv~e~~~   81 (344)
                      +.||+|+||.||+|.+..   .+..||+|.+....  .....+.+|+.+++.++||||+++++++. .++..+++|+|+.
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~   80 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK   80 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence            468999999999998653   34679999885432  22356778999999999999999999765 4566899999999


Q ss_pred             CCChHHHHHhC-CCCCHHHHHHHHHHHH-------HCCeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCC-----C
Q 019195           82 GGELFERICNA-GRFSEDEARYFFQQLI-------SGQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS-----R  148 (344)
Q Consensus        82 ~g~L~~~i~~~-~~~~~~~~~~~~~ql~-------~~~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~-----~  148 (344)
                      +++|.+++.+. ..++...+..++.|++       +.+++||||||+|||++.++.  +||+|||+++......     .
T Consensus        81 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~--~kl~dfg~~~~~~~~~~~~~~~  158 (262)
T cd05058          81 HGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFT--VKVADFGLARDIYDKEYYSVHN  158 (262)
T ss_pred             CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCc--EEECCccccccccCCcceeecc
Confidence            99999998764 3456666566655555       459999999999999987654  9999999987543211     1


Q ss_pred             CCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhC-CCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCHhHH
Q 019195          149 PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVG-AYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCR  227 (344)
Q Consensus       149 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~  227 (344)
                      .....++..|+|||.+.+..++ .++|||||||++|+|++| .+||.......    ....+... ...+....+++.+.
T Consensus       159 ~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~el~~~~~~~~~~~~~~~----~~~~~~~~-~~~~~~~~~~~~~~  232 (262)
T cd05058         159 HTGAKLPVKWMALESLQTQKFT-TKSDVWSFGVLLWELMTRGAPPYPDVDSFD----ITVYLLQG-RRLLQPEYCPDPLY  232 (262)
T ss_pred             cccCcCCccccChhHhccCccc-hHHHHHHHHHHHHHHHcCCCCCCCCCCHHH----HHHHHhcC-CCCCCCCcCCHHHH
Confidence            1233467789999998776654 459999999999999995 66676543322    22222211 12222335688999


Q ss_pred             HHHHHhcccCCCCCCChHHHhcC
Q 019195          228 NLLSRIFVANPSRRITIKEIKSH  250 (344)
Q Consensus       228 ~li~~~L~~dp~~R~s~~ell~h  250 (344)
                      +++.+||..+|.+||++.+++..
T Consensus       233 ~li~~cl~~~p~~Rp~~~~il~~  255 (262)
T cd05058         233 EVMLSCWHPKPEMRPTFSELVSR  255 (262)
T ss_pred             HHHHHHcCCChhhCCCHHHHHHH
Confidence            99999999999999999999764

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=5.3e-37  Score=272.71  Aligned_cols=239  Identities=21%  Similarity=0.370  Sum_probs=182.5

Q ss_pred             ceeeeeeeecCceEEEEEEEc---CCCcEEEEEEeecCcc---ccHHHHHHHHHHhcCCCCCcceeeEEEEcCC------
Q 019195            4 YELMKDIGSGNFGVARLMRNK---NTKELVAMKYIERGHK---IDANVAREIINHKQLRHPNIIRFKEVVLTPT------   71 (344)
Q Consensus         4 y~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~~---~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~------   71 (344)
                      |++.+.||+|+||.||+|...   .++..||+|++.....   ....+.+|+.+++.++||||+++++++....      
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   80 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP   80 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence            788999999999999999864   4578999999875432   2346788999999999999999999886532      


Q ss_pred             EEEEEEecCCCCChHHHHHhC------CCCCHHHHHHHHHHHHH-------CCeeecCCCCCCeEecCCCCCCEEEeecC
Q 019195           72 HLAIVMEYAAGGELFERICNA------GRFSEDEARYFFQQLIS-------GQICHRDLKLENTLLDGSPAPRLKICDFG  138 (344)
Q Consensus        72 ~~~lv~e~~~~g~L~~~i~~~------~~~~~~~~~~~~~ql~~-------~~iiH~Dikp~NIl~~~~~~~~vkL~DFg  138 (344)
                      ..+++++|+.+|+|..++...      ..++...++.++.|++.       .||+||||||+||+++.+..  +||+|||
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~--~kl~dfg  158 (273)
T cd05074          81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMT--VCVADFG  158 (273)
T ss_pred             ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCC--EEECccc
Confidence            347899999999998887432      14677777777666654       49999999999999976654  9999999


Q ss_pred             CCcccCCCC---CCCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhhccc
Q 019195          139 YSKSSLLHS---RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQY  214 (344)
Q Consensus       139 ~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~  214 (344)
                      +++......   ......+++.|++||.+....++ .++|||||||++|+|++ |++||..........    .+.... 
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~-~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~----~~~~~~-  232 (273)
T cd05074         159 LSKKIYSGDYYRQGCASKLPVKWLALESLADNVYT-THSDVWAFGVTMWEIMTRGQTPYAGVENSEIYN----YLIKGN-  232 (273)
T ss_pred             ccccccCCcceecCCCccCchhhcCHhHHhcCccc-hhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHH----HHHcCC-
Confidence            987543222   12233466789999998777665 45999999999999999 899997654432222    221111 


Q ss_pred             cCCCCCCCCHhHHHHHHHhcccCCCCCCChHHHhcC
Q 019195          215 KIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSH  250 (344)
Q Consensus       215 ~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~ell~h  250 (344)
                      ..+.....+..+.+++.+||+.+|.+|||+.+++.+
T Consensus       233 ~~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~  268 (273)
T cd05074         233 RLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQ  268 (273)
T ss_pred             cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            122223567899999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-37  Score=305.31  Aligned_cols=239  Identities=23%  Similarity=0.387  Sum_probs=195.8

Q ss_pred             CceeeeeeeecCceEEEEEEEcCCC-----cEEEEEEeecCc--cccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEE
Q 019195            3 KYELMKDIGSGNFGVARLMRNKNTK-----ELVAMKYIERGH--KIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAI   75 (344)
Q Consensus         3 ~y~~~~~lg~G~~g~V~~~~~~~~~-----~~vaiK~~~~~~--~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~l   75 (344)
                      +-++.+.||+|+||.||.+....-.     ..||+|.+.+..  .....|.+|..+|+.++|||||++++++.+....+|
T Consensus       693 ~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~i  772 (1025)
T KOG1095|consen  693 NVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPLI  772 (1025)
T ss_pred             heEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcEE
Confidence            3467899999999999999876432     349999988753  345789999999999999999999999999999999


Q ss_pred             EEecCCCCChHHHHHhC-------CCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCc
Q 019195           76 VMEYAAGGELFERICNA-------GRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSK  141 (344)
Q Consensus        76 v~e~~~~g~L~~~i~~~-------~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~  141 (344)
                      ++|||.||+|..+|++.       ..++..++..+..+++.+       ++|||||-..|+|++...  .|||+|||+|+
T Consensus       773 ~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r--~VKIaDFGlAr  850 (1025)
T KOG1095|consen  773 LLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERR--VVKIADFGLAR  850 (1025)
T ss_pred             EehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccC--cEEEcccchhH
Confidence            99999999999999876       247888888887777766       999999999999998775  49999999998


Q ss_pred             ccCCCCCC---CCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhhccccCC
Q 019195          142 SSLLHSRP---KSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIP  217 (344)
Q Consensus       142 ~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  217 (344)
                      ........   ....-...|||||.+....++++ +|||||||++||+++ |..||......+.+.-.    +... +++
T Consensus       851 Diy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtsk-SDvWsFGVllWEifslG~~PY~~~~n~~v~~~~----~~gg-RL~  924 (1025)
T KOG1095|consen  851 DIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSK-SDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDV----LEGG-RLD  924 (1025)
T ss_pred             hhhhchheeccCccccceecCCHHHHhhcccccc-cchhhhHHHHHHHHhCCCCCCCCcchHHHHHHH----HhCC-ccC
Confidence            43322211   11123467999999998777555 999999999999998 89999887765443322    2222 666


Q ss_pred             CCCCCCHhHHHHHHHhcccCCCCCCChHHHhc
Q 019195          218 DYVHISQDCRNLLSRIFVANPSRRITIKEIKS  249 (344)
Q Consensus       218 ~~~~~s~~~~~li~~~L~~dp~~R~s~~ell~  249 (344)
                      .+..++..+.+++.+||+.+|++||++..|++
T Consensus       925 ~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~  956 (1025)
T KOG1095|consen  925 PPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVE  956 (1025)
T ss_pred             CCCCCChHHHHHHHHHccCChhhCccHHHHHh
Confidence            66788999999999999999999999999987

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=100.00  E-value=2.9e-38  Score=258.22  Aligned_cols=249  Identities=24%  Similarity=0.425  Sum_probs=201.5

Q ss_pred             CCCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcCC-CCCcceeeEEEEcC--CEEEEEE
Q 019195            1 MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLR-HPNIIRFKEVVLTP--THLAIVM   77 (344)
Q Consensus         1 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~l~~l~-h~niv~~~~~~~~~--~~~~lv~   77 (344)
                      .++|++++++|+|-|+.|+.+.+..+.+.++||+++....  +.+.+|+.+|..|+ ||||++++++..+.  ....+|+
T Consensus        37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVkk--kKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiF  114 (338)
T KOG0668|consen   37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVKK--KKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIF  114 (338)
T ss_pred             cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHHH--HHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHh
Confidence            3689999999999999999999999999999999876433  67899999999996 99999999999876  4578999


Q ss_pred             ecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCCCCC
Q 019195           78 EYAAGGELFERICNAGRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPK  150 (344)
Q Consensus        78 e~~~~g~L~~~i~~~~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~~~~  150 (344)
                      ||+++.+...+.   +.++...++.++.+|+.|       ||+|||+||.|++||.... .++|+|+|+|....+...-.
T Consensus       115 E~v~n~Dfk~ly---~tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~r-kLrlIDWGLAEFYHp~~eYn  190 (338)
T KOG0668|consen  115 EYVNNTDFKQLY---PTLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELR-KLRLIDWGLAEFYHPGKEYN  190 (338)
T ss_pred             hhhccccHHHHh---hhhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhc-eeeeeecchHhhcCCCceee
Confidence            999887765544   456777788887777765       9999999999999985443 59999999998777777777


Q ss_pred             CCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCC-CCCChHHHHHHHHHHhhc---------cccC----
Q 019195          151 STVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFE-DQEDPKNFRKTISRIMAV---------QYKI----  216 (344)
Q Consensus       151 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~-~~~~~~~~~~~~~~~~~~---------~~~~----  216 (344)
                      ..+.+..|--||++.....+...-|+|||||+++.|+..+.||. +.+..+++.++.+-....         ...+    
T Consensus       191 VRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~Ldp~~  270 (338)
T KOG0668|consen  191 VRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQIDLDPQF  270 (338)
T ss_pred             eeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccCCChhH
Confidence            77899999999999877666666899999999999999988875 445555655544322110         0000    


Q ss_pred             ----------C-------CCC-CCCHhHHHHHHHhcccCCCCCCChHHHhcCccccc
Q 019195          217 ----------P-------DYV-HISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLK  255 (344)
Q Consensus       217 ----------~-------~~~-~~s~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~  255 (344)
                                +       ... -+++++.+||.++|..|-.+|+||.|++.||||..
T Consensus       271 ~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~  327 (338)
T KOG0668|consen  271 EDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAP  327 (338)
T ss_pred             hhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHH
Confidence                      0       111 14699999999999999999999999999999954

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=100.00  E-value=2.1e-37  Score=299.53  Aligned_cols=252  Identities=19%  Similarity=0.215  Sum_probs=165.1

Q ss_pred             CCCceeeeeeeecCceEEEEEEEcCC----CcEEEEEEeecCccccHHHHHHHHHHhcCCCCCcceeeEE------EEcC
Q 019195            1 MEKYELMKDIGSGNFGVARLMRNKNT----KELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKEV------VLTP   70 (344)
Q Consensus         1 ~~~y~~~~~lg~G~~g~V~~~~~~~~----~~~vaiK~~~~~~~~~~~~~~ei~~l~~l~h~niv~~~~~------~~~~   70 (344)
                      +++|++.+.||+|+||.||+|.+..+    +..||+|++............   .++...+.+++.+...      ....
T Consensus       131 ~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~e~~~~e---~l~~~~~~~~~~~~~~~~~~~~~~~~  207 (566)
T PLN03225        131 KDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAVEIWMNE---RVRRACPNSCADFVYGFLEPVSSKKE  207 (566)
T ss_pred             cCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchhHHHHHH---HHHhhchhhHHHHHHhhhcccccccC
Confidence            36899999999999999999999988    899999987653321111111   1222223333333222      2345


Q ss_pred             CEEEEEEecCCCCChHHHHHhCCC--------------------CCHHHHHHHH-------HHHHHCCeeecCCCCCCeE
Q 019195           71 THLAIVMEYAAGGELFERICNAGR--------------------FSEDEARYFF-------QQLISGQICHRDLKLENTL  123 (344)
Q Consensus        71 ~~~~lv~e~~~~g~L~~~i~~~~~--------------------~~~~~~~~~~-------~ql~~~~iiH~Dikp~NIl  123 (344)
                      ..+++|+||+.+++|.+++.....                    .....++.++       .++|+.+|+||||||+|||
T Consensus       208 ~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLKP~NIL  287 (566)
T PLN03225        208 DEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQNII  287 (566)
T ss_pred             CceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCCHHHEE
Confidence            679999999999999998865421                    1122233444       4455569999999999999


Q ss_pred             ecCCCCCCEEEeecCCCcccCCC--CCCCCCccCCcccCCccccCCCCC---------------------CcchhHHHHH
Q 019195          124 LDGSPAPRLKICDFGYSKSSLLH--SRPKSTVGTPAYIAPEVLSRREYD---------------------GKLADVWSCG  180 (344)
Q Consensus       124 ~~~~~~~~vkL~DFg~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~---------------------~~~~DiwslG  180 (344)
                      ++.+. +++||+|||+|+.....  ......++|+.|+|||.+......                     ..++||||||
T Consensus       288 l~~~~-~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSlG  366 (566)
T PLN03225        288 FSEGS-GSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAG  366 (566)
T ss_pred             EeCCC-CcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHHH
Confidence            97532 35999999999753322  223456799999999976332211                     2236999999


Q ss_pred             HHHHHHHhCCCCCCCCCChHHHHHHHHHHhh-------c-cccC-C-------CCCCCCHhHHHHHHHhcccCCCCCCCh
Q 019195          181 VTLYVMLVGAYPFEDQEDPKNFRKTISRIMA-------V-QYKI-P-------DYVHISQDCRNLLSRIFVANPSRRITI  244 (344)
Q Consensus       181 ~il~el~~g~~pf~~~~~~~~~~~~~~~~~~-------~-~~~~-~-------~~~~~s~~~~~li~~~L~~dp~~R~s~  244 (344)
                      |++|+|+++..|+..  ....+...+.....       . .... +       ........+.+||.+||+.||.+|||+
T Consensus       367 viL~el~~~~~~~~~--~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~kR~ta  444 (566)
T PLN03225        367 LIFLQMAFPNLRSDS--NLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQRISA  444 (566)
T ss_pred             HHHHHHHhCcCCCch--HHHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCcccCCCH
Confidence            999999997666432  22222222211000       0 0000 0       000123345699999999999999999


Q ss_pred             HHHhcCcccccCCC
Q 019195          245 KEIKSHPWFLKNLP  258 (344)
Q Consensus       245 ~ell~hp~~~~~~~  258 (344)
                      .++|+||||.....
T Consensus       445 ~e~L~Hpff~~~~~  458 (566)
T PLN03225        445 KAALAHPYFDREGL  458 (566)
T ss_pred             HHHhCCcCcCCCCc
Confidence            99999999987543

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=100.00  E-value=1.4e-36  Score=287.38  Aligned_cols=252  Identities=19%  Similarity=0.227  Sum_probs=175.5

Q ss_pred             CCceeeeeeeecCceEEEEEEEc----------------CCCcEEEEEEeecCccc---------------cHHHHHHHH
Q 019195            2 EKYELMKDIGSGNFGVARLMRNK----------------NTKELVAMKYIERGHKI---------------DANVAREII   50 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~----------------~~~~~vaiK~~~~~~~~---------------~~~~~~ei~   50 (344)
                      ++|++.++||+|+||+||++...                ..++.||||.+......               ......|+.
T Consensus       145 d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~~  224 (507)
T PLN03224        145 DDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEAY  224 (507)
T ss_pred             cCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHHH
Confidence            68999999999999999998642                34568999998653211               122334666


Q ss_pred             HHhcCCCCCc-----ceeeEEEEc--------CCEEEEEEecCCCCChHHHHHhCC------------------------
Q 019195           51 NHKQLRHPNI-----IRFKEVVLT--------PTHLAIVMEYAAGGELFERICNAG------------------------   93 (344)
Q Consensus        51 ~l~~l~h~ni-----v~~~~~~~~--------~~~~~lv~e~~~~g~L~~~i~~~~------------------------   93 (344)
                      ++.+++|.++     ++++++|..        .+..|+||||+++++|.+++....                        
T Consensus       225 ~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~  304 (507)
T PLN03224        225 MCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQD  304 (507)
T ss_pred             HHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcccc
Confidence            7777766544     666666643        356899999999999999886421                        


Q ss_pred             CCCHHHHHHHHHH-------HHHCCeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCCCCCC--CccCCcccCCccc
Q 019195           94 RFSEDEARYFFQQ-------LISGQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKS--TVGTPAYIAPEVL  164 (344)
Q Consensus        94 ~~~~~~~~~~~~q-------l~~~~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~~~~~--~~gt~~y~aPE~~  164 (344)
                      .++...++.++.|       +|+.+|+||||||+|||++.+..  +||+|||++...........  ..+|+.|+|||.+
T Consensus       305 ~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~--~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~l  382 (507)
T PLN03224        305 KRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQ--VKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEEL  382 (507)
T ss_pred             cCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCc--EEEEeCcCccccccCCccCccccCCCcceeChhhh
Confidence            1233445555555       45559999999999999987654  99999999865433222222  2458999999998


Q ss_pred             cCCCC--------------------C-CcchhHHHHHHHHHHHHhCCC-CCCCCCChHHH-------HHHHHHHhhcccc
Q 019195          165 SRREY--------------------D-GKLADVWSCGVTLYVMLVGAY-PFEDQEDPKNF-------RKTISRIMAVQYK  215 (344)
Q Consensus       165 ~~~~~--------------------~-~~~~DiwslG~il~el~~g~~-pf~~~~~~~~~-------~~~~~~~~~~~~~  215 (344)
                      .....                    . ....||||+||++|+|++|.. ||.........       .+.........+.
T Consensus       383 ~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~~~~  462 (507)
T PLN03224        383 VMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQKYD  462 (507)
T ss_pred             cCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcccCCC
Confidence            54321                    1 123699999999999999875 77542211110       0111122233445


Q ss_pred             CCCCCCCCHhHHHHHHHhcccCC---CCCCChHHHhcCccccc
Q 019195          216 IPDYVHISQDCRNLLSRIFVANP---SRRITIKEIKSHPWFLK  255 (344)
Q Consensus       216 ~~~~~~~s~~~~~li~~~L~~dp---~~R~s~~ell~hp~~~~  255 (344)
                      ++.+...++.+++|+.+||..+|   .+|+|+.|+|+||||..
T Consensus       463 ~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~~  505 (507)
T PLN03224        463 FSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFLP  505 (507)
T ss_pred             cccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcCC
Confidence            55556789999999999999876   68999999999999954

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3e-39  Score=270.47  Aligned_cols=250  Identities=24%  Similarity=0.405  Sum_probs=200.1

Q ss_pred             ceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCc---cccHHHHHHHHHHhcCCCCCcceeeEEEEcCC-----EEEE
Q 019195            4 YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH---KIDANVAREIINHKQLRHPNIIRFKEVVLTPT-----HLAI   75 (344)
Q Consensus         4 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~-----~~~l   75 (344)
                      .+-.++||.|+||+||.+.+..+|+.||+|++..-.   ...+++.+|+.+|..++|.|++..+++.+...     .+|+
T Consensus        55 i~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV  134 (449)
T KOG0664|consen   55 IQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYV  134 (449)
T ss_pred             CCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHH
Confidence            345689999999999999999999999999886533   23478999999999999999999999887553     4689


Q ss_pred             EEecCCCCChHHHHHhCCCCCHHHHHHHHHHHH-------HCCeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCCC
Q 019195           76 VMEYAAGGELFERICNAGRFSEDEARYFFQQLI-------SGQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR  148 (344)
Q Consensus        76 v~e~~~~g~L~~~i~~~~~~~~~~~~~~~~ql~-------~~~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~~  148 (344)
                      ++|++ ..+|.++|..-+.++..+++-+++||+       +++|.||||||.|+|++++..  +||||||+|+.......
T Consensus       135 ~TELm-QSDLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCv--LKICDFGLARvee~d~~  211 (449)
T KOG0664|consen  135 LTELM-QSDLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCI--LKICDFGLARTWDQRDR  211 (449)
T ss_pred             HHHHH-HhhhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCce--EEecccccccccchhhh
Confidence            99999 468999998888888888887777655       559999999999999987775  99999999986544433


Q ss_pred             --CCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHH-----------------
Q 019195          149 --PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRI-----------------  209 (344)
Q Consensus       149 --~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~-----------------  209 (344)
                        .+..+-|.+|+|||++.+...++.++||||+|||+.||+..+..|...+...++.-+..-.                 
T Consensus       212 ~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk~  291 (449)
T KOG0664|consen  212 LNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAKN  291 (449)
T ss_pred             hhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhHH
Confidence              3344689999999999998877888999999999999999999998877655554433211                 


Q ss_pred             --hhccccCCCCC---------CCCHhHHHHHHHhcccCCCCCCChHHHhcCcccccC
Q 019195          210 --MAVQYKIPDYV---------HISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKN  256 (344)
Q Consensus       210 --~~~~~~~~~~~---------~~s~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~~  256 (344)
                        .....+.|...         .-..+..+++.+||..||++|++..+++.|+|+.+.
T Consensus       292 H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e~  349 (449)
T KOG0664|consen  292 HVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEEG  349 (449)
T ss_pred             HhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccccccc
Confidence              12222233221         123467899999999999999999999999997653

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=100.00  E-value=7.5e-36  Score=259.49  Aligned_cols=234  Identities=39%  Similarity=0.665  Sum_probs=192.2

Q ss_pred             CceEEEEEEEcCCCcEEEEEEeecCccc--cHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEEecCCCCChHHHHHh
Q 019195           14 NFGVARLMRNKNTKELVAMKYIERGHKI--DANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICN   91 (344)
Q Consensus        14 ~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~i~~   91 (344)
                      +||.||++.+..+++.+|+|++......  ...+.+|++.+++++|+||+++++++......++++||+++++|.+++..
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~   80 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK   80 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence            5899999999999999999998765433  36788999999999999999999999999999999999999999999987


Q ss_pred             CCCCCHHHHHHHHHHHH-------HCCeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCCCCCCCccCCcccCCccc
Q 019195           92 AGRFSEDEARYFFQQLI-------SGQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVL  164 (344)
Q Consensus        92 ~~~~~~~~~~~~~~ql~-------~~~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~~~~~~~gt~~y~aPE~~  164 (344)
                      ...++...++.++.+++       ..+++|+||+|.||+++.++  .++|+|||++.............++..|+|||.+
T Consensus        81 ~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~--~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pE~~  158 (244)
T smart00220       81 RGRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDG--HVKLADFGLARQLDPGGLLTTFVGTPEYMAPEVL  158 (244)
T ss_pred             ccCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCC--cEEEccccceeeeccccccccccCCcCCCCHHHH
Confidence            66688887777766655       45999999999999998765  4999999998866555455567799999999999


Q ss_pred             cCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCCCCCC-CCHhHHHHHHHhcccCCCCCCC
Q 019195          165 SRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVH-ISQDCRNLLSRIFVANPSRRIT  243 (344)
Q Consensus       165 ~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~s~~~~~li~~~L~~dp~~R~s  243 (344)
                      .+...+. ++||||||+++++|++|..||.........   ................ ++.++.+++.+||..+|.+||+
T Consensus       159 ~~~~~~~-~~Di~slG~~l~~l~~~~~p~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~  234 (244)
T smart00220      159 LGKGYGK-AVDVWSLGVILYELLTGKPPFPGDDQLLEL---FKKIGKPKPPFPPPEWKISPEAKDLIRKLLVKDPEKRLT  234 (244)
T ss_pred             ccCCCCc-hhhHHHHHHHHHHHHhCCCCCCCCCcHHHH---HHHHhccCCCCccccccCCHHHHHHHHHHccCCchhccC
Confidence            8666654 699999999999999999999774333322   2222222322222212 7889999999999999999999


Q ss_pred             hHHHhcCccc
Q 019195          244 IKEIKSHPWF  253 (344)
Q Consensus       244 ~~ell~hp~~  253 (344)
                      +.++++||||
T Consensus       235 ~~~~~~~~~~  244 (244)
T smart00220      235 AEEALQHPFF  244 (244)
T ss_pred             HHHHhhCCCC
Confidence            9999999997

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=7.8e-36  Score=272.20  Aligned_cols=243  Identities=23%  Similarity=0.352  Sum_probs=192.0

Q ss_pred             CceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCcc--ccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEEecC
Q 019195            3 KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK--IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYA   80 (344)
Q Consensus         3 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~   80 (344)
                      +..+.++||+|-||.|.+|.-.. +..||+|.++....  ....|.+|+++|.+|+|||||+++++|..++.+++|+||+
T Consensus       539 ~L~~~ekiGeGqFGEVhLCeveg-~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYm  617 (807)
T KOG1094|consen  539 RLRFKEKIGEGQFGEVHLCEVEG-PLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYM  617 (807)
T ss_pred             heehhhhhcCcccceeEEEEecC-ceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHH
Confidence            45678999999999999998643 68999999986443  2367999999999999999999999999999999999999


Q ss_pred             CCCChHHHHHhCC--CCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCCCC--
Q 019195           81 AGGELFERICNAG--RFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP--  149 (344)
Q Consensus        81 ~~g~L~~~i~~~~--~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~~~--  149 (344)
                      +.|+|..++.+..  .+.......++.||+++       ++|||||.+.|||++++++  +||+|||+++....+...  
T Consensus       618 EnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~--iKiadfgmsR~lysg~yy~v  695 (807)
T KOG1094|consen  618 ENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFT--IKIADFGMSRNLYSGDYYRV  695 (807)
T ss_pred             hcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCccc--EEecCcccccccccCCceee
Confidence            9999999998763  23344455566777665       9999999999999988876  999999999966555432  


Q ss_pred             -CCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHH--hCCCCCCCCCChHHHHHHHHHHhhc--cccCCCCCCCCH
Q 019195          150 -KSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVML--VGAYPFEDQEDPKNFRKTISRIMAV--QYKIPDYVHISQ  224 (344)
Q Consensus       150 -~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~--~g~~pf~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~s~  224 (344)
                       ...+-...|||||.+.-+..+ +++|+|+||+++||++  +...||....+.....+.-.-....  ..-++.+.-++.
T Consensus       696 qgr~vlpiRwmawEsillgkFt-taSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~l~~P~~cp~  774 (807)
T KOG1094|consen  696 QGRAVLPIRWMAWESILLGKFT-TASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVVLSRPPACPQ  774 (807)
T ss_pred             ecceeeeeeehhHHHHHhcccc-chhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcceeccCCCcCcH
Confidence             233567889999999888875 4599999999999975  5789998776644443322211111  111233345678


Q ss_pred             hHHHHHHHhcccCCCCCCChHHHhc
Q 019195          225 DCRNLLSRIFVANPSRRITIKEIKS  249 (344)
Q Consensus       225 ~~~~li~~~L~~dp~~R~s~~ell~  249 (344)
                      .+.+|+.+||..+-.+||+++++..
T Consensus       775 ~lyelml~Cw~~es~~RPsFe~lh~  799 (807)
T KOG1094|consen  775 GLYELMLRCWRRESEQRPSFEQLHL  799 (807)
T ss_pred             HHHHHHHHHhchhhhcCCCHHHHHH
Confidence            8999999999999999999999854

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=6.1e-36  Score=277.71  Aligned_cols=244  Identities=26%  Similarity=0.387  Sum_probs=200.2

Q ss_pred             CceeeeeeeecCceEEEEEEEcCC---CcEEEEEEeecCccc--cHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEE
Q 019195            3 KYELMKDIGSGNFGVARLMRNKNT---KELVAMKYIERGHKI--DANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVM   77 (344)
Q Consensus         3 ~y~~~~~lg~G~~g~V~~~~~~~~---~~~vaiK~~~~~~~~--~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~   77 (344)
                      +.++.++||+|+||+|+++.+...   -..||||++......  ...|++|+.+|.+|.|||++++|++..+ ..+.+||
T Consensus       111 ~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~  189 (1039)
T KOG0199|consen  111 QIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVF  189 (1039)
T ss_pred             HHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHh
Confidence            456778999999999999988642   246899999875443  4689999999999999999999999987 7788999


Q ss_pred             ecCCCCChHHHHHh--CCCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCCC
Q 019195           78 EYAAGGELFERICN--AGRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR  148 (344)
Q Consensus        78 e~~~~g~L~~~i~~--~~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~~  148 (344)
                      |+++.|+|.+.|.+  ...|....+..|+.||+.+       ++|||||-..|+|+-....  |||||||+.+.......
T Consensus       190 ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprt--VKI~DFGLmRaLg~ned  267 (1039)
T KOG0199|consen  190 ELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRT--VKICDFGLMRALGENED  267 (1039)
T ss_pred             hhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccce--eeeecccceeccCCCCc
Confidence            99999999999987  3467888888888888866       9999999999999976554  99999999987655554


Q ss_pred             CCCC----ccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCC
Q 019195          149 PKST----VGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHIS  223 (344)
Q Consensus       149 ~~~~----~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s  223 (344)
                      ....    .-...|+|||.+....++. ++|+|++||+||||++ |..||.+......    ++++. ...+++....++
T Consensus       268 ~Yvm~p~rkvPfAWCaPEsLrh~kFSh-aSDvWmyGVTiWEMFtyGEePW~G~~g~qI----L~~iD-~~erLpRPk~cs  341 (1039)
T KOG0199|consen  268 MYVMAPQRKVPFAWCAPESLRHRKFSH-ASDVWMYGVTIWEMFTYGEEPWVGCRGIQI----LKNID-AGERLPRPKYCS  341 (1039)
T ss_pred             ceEecCCCcCcccccCHhHhccccccc-cchhhhhhhhHHhhhccCCCCCCCCCHHHH----HHhcc-ccccCCCCCCCh
Confidence            4322    2345699999998888754 4999999999999998 8999999776443    33333 455677777889


Q ss_pred             HhHHHHHHHhcccCCCCCCChHHHhcCccccc
Q 019195          224 QDCRNLLSRIFVANPSRRITIKEIKSHPWFLK  255 (344)
Q Consensus       224 ~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~  255 (344)
                      .++.++++.||..+|.+|||+..|.+.-++..
T Consensus       342 edIY~imk~cWah~paDRptFsair~~~~l~e  373 (1039)
T KOG0199|consen  342 EDIYQIMKNCWAHNPADRPTFSAIREDLVLAE  373 (1039)
T ss_pred             HHHHHHHHHhccCCccccccHHHHHHhHHHHh
Confidence            99999999999999999999999876544443

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=8e-37  Score=282.42  Aligned_cols=253  Identities=30%  Similarity=0.473  Sum_probs=209.2

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCcc-ccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEEecC
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK-IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYA   80 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~   80 (344)
                      ++|+++..+|+|+||-||+|+++.+++..|+|+++.... ...-+.+|+-+++.++|||||.+++.+...+.+|++||||
T Consensus        15 ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEyc   94 (829)
T KOG0576|consen   15 DDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEYC   94 (829)
T ss_pred             cchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEec
Confidence            589999999999999999999999999999999987433 3356778999999999999999999999999999999999


Q ss_pred             CCCChHHHHHhCCCCCHHHHHHHHHH-------HHHCCeeecCCCCCCeEecCCCCCCEEEeecCCCccc-CCCCCCCCC
Q 019195           81 AGGELFERICNAGRFSEDEARYFFQQ-------LISGQICHRDLKLENTLLDGSPAPRLKICDFGYSKSS-LLHSRPKST  152 (344)
Q Consensus        81 ~~g~L~~~i~~~~~~~~~~~~~~~~q-------l~~~~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~-~~~~~~~~~  152 (344)
                      .||+|.+.-+-.+.+++.++....+.       +|+.|-+|||||-.|||++..+.  +||+|||.+... ..-...++.
T Consensus        95 gggslQdiy~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gD--vklaDfgvsaqitati~Krksf  172 (829)
T KOG0576|consen   95 GGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGD--VKLADFGVSAQITATIAKRKSF  172 (829)
T ss_pred             CCCcccceeeecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCc--eeecccCchhhhhhhhhhhhcc
Confidence            99999999888899999998888654       55669999999999999987776  999999987653 333456778


Q ss_pred             ccCCcccCCccc---cCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCC---CCCCCCHhH
Q 019195          153 VGTPAYIAPEVL---SRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIP---DYVHISQDC  226 (344)
Q Consensus       153 ~gt~~y~aPE~~---~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~s~~~  226 (344)
                      +||++|||||+-   ....|. ..+|||++|+...|+.--++|....-...    ...-+.+..+..|   +...+++.+
T Consensus       173 iGtpywmapEvaaverkggyn-qlcdiwa~gitAiel~eLqpplfdlhpmr----~l~LmTkS~~qpp~lkDk~kws~~f  247 (829)
T KOG0576|consen  173 IGTPYWMAPEVAAVERKGGYN-QLCDIWALGITAIELGELQPPLFDLHPMR----ALFLMTKSGFQPPTLKDKTKWSEFF  247 (829)
T ss_pred             cCCccccchhHHHHHhccccc-ccccccccccchhhhhhcCCcccccchHH----HHHHhhccCCCCCcccCCccchHHH
Confidence            999999999986   334444 45999999999999999888865543322    1222223333333   445689999


Q ss_pred             HHHHHHhcccCCCCCCChHHHhcCcccccCCChhh
Q 019195          227 RNLLSRIFVANPSRRITIKEIKSHPWFLKNLPREL  261 (344)
Q Consensus       227 ~~li~~~L~~dp~~R~s~~ell~hp~~~~~~~~~~  261 (344)
                      .+|++.+|.++|.+|||+.-+|.|||..+.+.+.+
T Consensus       248 h~fvK~altknpKkRptaeklL~h~fvs~~l~~rl  282 (829)
T KOG0576|consen  248 HNFVKGALTKNPKKRPTAEKLLQHPFVSQTLSRRL  282 (829)
T ss_pred             HHHHHHHhcCCCccCCChhhheeceeeccchhhHH
Confidence            99999999999999999999999999988755443

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=100.00  E-value=2e-36  Score=286.17  Aligned_cols=238  Identities=27%  Similarity=0.358  Sum_probs=180.2

Q ss_pred             eeeeeecCce-EEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcC-CCCCcceeeEEEEcCCEEEEEEecCCCCC
Q 019195            7 MKDIGSGNFG-VARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQL-RHPNIIRFKEVVLTPTHLAIVMEYAAGGE   84 (344)
Q Consensus         7 ~~~lg~G~~g-~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~g~   84 (344)
                      .+.+|.|+-| .||++..  .|+.||||.+-...  ..-+.+|+..|+.- .|||||++|+.-.+....||..|+| ..+
T Consensus       514 ~eilG~Gs~Gt~Vf~G~y--e~R~VAVKrll~e~--~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC-~~s  588 (903)
T KOG1027|consen  514 KEILGYGSNGTVVFRGVY--EGREVAVKRLLEEF--FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC-ACS  588 (903)
T ss_pred             HHHcccCCCCcEEEEEee--CCceehHHHHhhHh--HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh-hhh
Confidence            4578999998 6788875  47899999875532  34577999999888 6999999999999999999999999 679


Q ss_pred             hHHHHHhCC-C------CC----HHHHHHHHHHHHHCCeeecCCCCCCeEecC---CCCCCEEEeecCCCcccCCCCC--
Q 019195           85 LFERICNAG-R------FS----EDEARYFFQQLISGQICHRDLKLENTLLDG---SPAPRLKICDFGYSKSSLLHSR--  148 (344)
Q Consensus        85 L~~~i~~~~-~------~~----~~~~~~~~~ql~~~~iiH~Dikp~NIl~~~---~~~~~vkL~DFg~a~~~~~~~~--  148 (344)
                      |.+++.... .      +.    ..++..-+..||+-+||||||||.||||..   .+..+++|+|||+++.......  
T Consensus       589 L~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~sS~  668 (903)
T KOG1027|consen  589 LQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGKSSF  668 (903)
T ss_pred             HHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccccCCCcchh
Confidence            999997631 1      11    112333345566669999999999999975   4556799999999987554432  


Q ss_pred             --CCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhC-CCCCCCCCChHHHHHHHHHHhhccccCCCCCC-CCH
Q 019195          149 --PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVG-AYPFEDQEDPKNFRKTISRIMAVQYKIPDYVH-ISQ  224 (344)
Q Consensus       149 --~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~s~  224 (344)
                        .....||-+|+|||++...... +++||+||||++|+.++| ..||...-.      ...+|....+.+..... -..
T Consensus       669 ~r~s~~sGt~GW~APE~L~~~~~~-~avDiFslGCvfyYvltgG~HpFGd~~~------R~~NIl~~~~~L~~L~~~~d~  741 (903)
T KOG1027|consen  669 SRLSGGSGTSGWQAPEQLREDRKT-QAVDIFSLGCVFYYVLTGGSHPFGDSLE------RQANILTGNYTLVHLEPLPDC  741 (903)
T ss_pred             hcccCCCCcccccCHHHHhccccC-cccchhhcCceEEEEecCCccCCCchHH------hhhhhhcCccceeeeccCchH
Confidence              3445699999999999776654 469999999999998886 999976422      11223333332221111 112


Q ss_pred             hHHHHHHHhcccCCCCCCChHHHhcCcccccC
Q 019195          225 DCRNLLSRIFVANPSRRITIKEIKSHPWFLKN  256 (344)
Q Consensus       225 ~~~~li~~~L~~dp~~R~s~~ell~hp~~~~~  256 (344)
                      ++.+||.+||+++|..||+|.++|.||+|...
T Consensus       742 eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW~~  773 (903)
T KOG1027|consen  742 EAKDLISRMLNPDPQLRPSATDVLNHPLFWDS  773 (903)
T ss_pred             HHHHHHHHhcCCCcccCCCHHHHhCCCccCCh
Confidence            89999999999999999999999999999764

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=100.00  E-value=5.8e-36  Score=264.38  Aligned_cols=249  Identities=27%  Similarity=0.415  Sum_probs=193.1

Q ss_pred             CCceeeeeeeecCceEEEEEEEcC---CCcEEEEEEeecCccccHHHHHHHHHHhcC-CCCCcceeeEEEEcCCEEEEEE
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKN---TKELVAMKYIERGHKIDANVAREIINHKQL-RHPNIIRFKEVVLTPTHLAIVM   77 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~~~~~~~~ei~~l~~l-~h~niv~~~~~~~~~~~~~lv~   77 (344)
                      +.|+++++||.|+|++||++.+..   ..+.||+|.+... ....++.+|+++|..+ .+.||+++.+++..+++..+||
T Consensus        36 ~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~t-s~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~ivl  114 (418)
T KOG1167|consen   36 NAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRT-SSPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVAIVL  114 (418)
T ss_pred             hhhhhhccccccchhhhhhhhHhhhccccceEeeeecccc-cCchHHHHHHHHHHHhccchhhhcchhhhccCCeeEEEe
Confidence            568999999999999999999988   8899999998764 3456799999999999 5999999999999999999999


Q ss_pred             ecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCccc-------
Q 019195           78 EYAAGGELFERICNAGRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSS-------  143 (344)
Q Consensus        78 e~~~~g~L~~~i~~~~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~-------  143 (344)
                      +|++.....++...   ++..+++.+++.|+.|       |||||||||+|+|.+.. .++-.|+|||+|...       
T Consensus       115 p~~~H~~f~~l~~~---l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~-t~rg~LvDFgLA~~~d~~~~~~  190 (418)
T KOG1167|consen  115 PYFEHDRFRDLYRS---LSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRR-TQRGVLVDFGLAQRYDGYQQTE  190 (418)
T ss_pred             cccCccCHHHHHhc---CCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccc-cCCceEEechhHHHHHhhhhhh
Confidence            99999888887754   5677777777666655       99999999999999743 346899999998610       


Q ss_pred             ----------CC--C-------------C-------------CCCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHH
Q 019195          144 ----------LL--H-------------S-------------RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYV  185 (344)
Q Consensus       144 ----------~~--~-------------~-------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e  185 (344)
                                .+  +             .             ......||++|+|||++.+.+..++++||||.|+|+.-
T Consensus       191 ~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI~Ls  270 (418)
T KOG1167|consen  191 HSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVILLS  270 (418)
T ss_pred             hhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeeccceeeh
Confidence                      00  0             0             00122599999999999998888888999999999999


Q ss_pred             HHhCCCCCCCCCC-hHHHHHHHHH--------H----hh---------------------c----ccc--------CCCC
Q 019195          186 MLVGAYPFEDQED-PKNFRKTISR--------I----MA---------------------V----QYK--------IPDY  219 (344)
Q Consensus       186 l~~g~~pf~~~~~-~~~~~~~~~~--------~----~~---------------------~----~~~--------~~~~  219 (344)
                      +++++.||....+ ...+.++...        .    ..                     .    ...        ....
T Consensus       271 lls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~~~~~~  350 (418)
T KOG1167|consen  271 LLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNTEREIGS  350 (418)
T ss_pred             hhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccceeecccc
Confidence            9999999965432 1111111100        0    00                     0    000        0011


Q ss_pred             CCCCHhHHHHHHHhcccCCCCCCChHHHhcCccccc
Q 019195          220 VHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLK  255 (344)
Q Consensus       220 ~~~s~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~  255 (344)
                      ...+..+.+|+.+||..||.+|+||+++|+||||..
T Consensus       351 d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~  386 (418)
T KOG1167|consen  351 DVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDE  386 (418)
T ss_pred             ccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcc
Confidence            123457899999999999999999999999999973

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-35  Score=269.92  Aligned_cols=238  Identities=21%  Similarity=0.338  Sum_probs=199.1

Q ss_pred             ceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEEecCCCC
Q 019195            4 YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYAAGG   83 (344)
Q Consensus         4 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g   83 (344)
                      .....+||.|.||.||.+.++.....||||.++.+......|+.|..+|+.++|||+|+++++|..+..+|||+|||..|
T Consensus       269 ItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM~yG  348 (1157)
T KOG4278|consen  269 ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFMCYG  348 (1157)
T ss_pred             eeeeeccCCCcccceeeeeeeccceeeehhhhhhcchhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEecccCc
Confidence            34578999999999999999999999999999888777789999999999999999999999999999999999999999


Q ss_pred             ChHHHHHhCC--CCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCCCC--CCC
Q 019195           84 ELFERICNAG--RFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP--KST  152 (344)
Q Consensus        84 ~L~~~i~~~~--~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~~~--~~~  152 (344)
                      +|.++++...  .++.--+.+++.||.++       ++|||||-..|+|+..+..  ||++|||+++........  ...
T Consensus       349 NLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhi--VKvADFGLsRlMtgDTYTAHAGA  426 (1157)
T KOG4278|consen  349 NLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHI--VKVADFGLSRLMTGDTYTAHAGA  426 (1157)
T ss_pred             cHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccce--EEeeccchhhhhcCCceecccCc
Confidence            9999998754  35555566667777766       9999999999999987765  999999999864333221  112


Q ss_pred             ccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCHhHHHHHH
Q 019195          153 VGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLS  231 (344)
Q Consensus       153 ~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~  231 (344)
                      .-...|.|||-+....++.+ +|||+|||+|||++| |-.||.+.+...     +..++...+++..+.++++.+..|++
T Consensus       427 KFPIKWTAPEsLAyNtFSiK-SDVWAFGVLLWEIATYGMsPYPGidlSq-----VY~LLEkgyRM~~PeGCPpkVYeLMr  500 (1157)
T KOG4278|consen  427 KFPIKWTAPESLAYNTFSIK-SDVWAFGVLLWEIATYGMSPYPGIDLSQ-----VYGLLEKGYRMDGPEGCPPKVYELMR  500 (1157)
T ss_pred             cCcccccCcccccccccccc-hhhHHHHHHHHHHHhcCCCCCCCccHHH-----HHHHHhccccccCCCCCCHHHHHHHH
Confidence            24567999999977776555 999999999999987 888998865432     22345567777777799999999999


Q ss_pred             HhcccCCCCCCChHHHhc
Q 019195          232 RIFVANPSRRITIKEIKS  249 (344)
Q Consensus       232 ~~L~~dp~~R~s~~ell~  249 (344)
                      .||+++|..||+++++.+
T Consensus       501 aCW~WsPsDRPsFaeiHq  518 (1157)
T KOG4278|consen  501 ACWNWSPSDRPSFAEIHQ  518 (1157)
T ss_pred             HHhcCCcccCccHHHHHH
Confidence            999999999999988744

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-35  Score=270.01  Aligned_cols=236  Identities=25%  Similarity=0.364  Sum_probs=189.3

Q ss_pred             eeeeeeeecCceEEEEEEEcC--CC--cEEEEEEeecCc--cccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEEe
Q 019195            5 ELMKDIGSGNFGVARLMRNKN--TK--ELVAMKYIERGH--KIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVME   78 (344)
Q Consensus         5 ~~~~~lg~G~~g~V~~~~~~~--~~--~~vaiK~~~~~~--~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e   78 (344)
                      ++.+.||.|-||.||.+....  .|  --||||..+.+.  ...+.|+.|..+|+.++|||||++++++. +...|+|||
T Consensus       392 tl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~-e~P~WivmE  470 (974)
T KOG4257|consen  392 TLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCV-EQPMWIVME  470 (974)
T ss_pred             cHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeee-ccceeEEEe
Confidence            456789999999999997642  22  347889877643  23578999999999999999999999996 467899999


Q ss_pred             cCCCCChHHHHHhCC-CCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCCCCC
Q 019195           79 YAAGGELFERICNAG-RFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPK  150 (344)
Q Consensus        79 ~~~~g~L~~~i~~~~-~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~~~~  150 (344)
                      +++-|.|+.+++.+. .++...+..+..||..+       ++|||||-..|||+.+...  |||+|||+++.......-+
T Consensus       471 L~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~C--VKLaDFGLSR~~ed~~yYk  548 (974)
T KOG4257|consen  471 LAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQC--VKLADFGLSRYLEDDAYYK  548 (974)
T ss_pred             cccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcce--eeecccchhhhccccchhh
Confidence            999999999998654 67777777777776654       9999999999999987665  9999999999765554433


Q ss_pred             CCc--cCCcccCCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCHhHH
Q 019195          151 STV--GTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCR  227 (344)
Q Consensus       151 ~~~--gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~  227 (344)
                      ...  -...|||||.+.-..++ .++|||.|||++||++. |..||.+-...+...     ......++|.+.++++.+.
T Consensus       549 aS~~kLPIKWmaPESINfRrFT-tASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~-----~iEnGeRlP~P~nCPp~LY  622 (974)
T KOG4257|consen  549 ASRGKLPIKWMAPESINFRRFT-TASDVWMFGVCMWEILSLGVKPFQGVKNSDVIG-----HIENGERLPCPPNCPPALY  622 (974)
T ss_pred             ccccccceeecCccccchhccc-chhhHHHHHHHHHHHHHhcCCccccccccceEE-----EecCCCCCCCCCCCChHHH
Confidence            333  34569999999777764 55999999999999876 999998865543321     1233456788889999999


Q ss_pred             HHHHHhcccCCCCCCChHHHhc
Q 019195          228 NLLSRIFVANPSRRITIKEIKS  249 (344)
Q Consensus       228 ~li~~~L~~dp~~R~s~~ell~  249 (344)
                      .|+.+||..+|.+||++.++..
T Consensus       623 slmskcWayeP~kRPrftei~~  644 (974)
T KOG4257|consen  623 SLMSKCWAYEPSKRPRFTEIKA  644 (974)
T ss_pred             HHHHHHhccCcccCCcHHHHHH
Confidence            9999999999999999888754

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=2.5e-34  Score=297.51  Aligned_cols=235  Identities=17%  Similarity=0.232  Sum_probs=173.9

Q ss_pred             CceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEEecCCC
Q 019195            3 KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYAAG   82 (344)
Q Consensus         3 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~   82 (344)
                      .|...+.||+|+||.||+|....++..||+|.+.......   ..|+..+++++|||||++++++......|+||||+++
T Consensus       691 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~---~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~  767 (968)
T PLN00113        691 SLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIP---SSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEG  767 (968)
T ss_pred             hCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcccc---HHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCC
Confidence            4566778999999999999999999999999987543322   3568899999999999999999999999999999999


Q ss_pred             CChHHHHHhCCCCCHHHHHHHHHHHHHC----------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCCCCCCC
Q 019195           83 GELFERICNAGRFSEDEARYFFQQLISG----------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST  152 (344)
Q Consensus        83 g~L~~~i~~~~~~~~~~~~~~~~ql~~~----------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~~~~~~  152 (344)
                      |+|.++++.   ++..+...++.|++.|          +|+||||||+||+++.+..  .++. ||.+....   .....
T Consensus       768 g~L~~~l~~---l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~--~~~~-~~~~~~~~---~~~~~  838 (968)
T PLN00113        768 KNLSEVLRN---LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDE--PHLR-LSLPGLLC---TDTKC  838 (968)
T ss_pred             CcHHHHHhc---CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCc--eEEE-eccccccc---cCCCc
Confidence            999999863   6777666666665543          8999999999999987665  4544 55443221   12334


Q ss_pred             ccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCh-HHHHHHHHHHhhc-------cccCCC----CC
Q 019195          153 VGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDP-KNFRKTISRIMAV-------QYKIPD----YV  220 (344)
Q Consensus       153 ~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-~~~~~~~~~~~~~-------~~~~~~----~~  220 (344)
                      .||+.|+|||++.+..++ .++|||||||++|||++|+.||...... .............       ......    ..
T Consensus       839 ~~t~~y~aPE~~~~~~~~-~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  917 (968)
T PLN00113        839 FISSAYVAPETRETKDIT-EKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQ  917 (968)
T ss_pred             cccccccCcccccCCCCC-cccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCCCCccH
Confidence            789999999999877765 4599999999999999999999543211 1111111111000       000000    00


Q ss_pred             CCCHhHHHHHHHhcccCCCCCCChHHHhcC
Q 019195          221 HISQDCRNLLSRIFVANPSRRITIKEIKSH  250 (344)
Q Consensus       221 ~~s~~~~~li~~~L~~dp~~R~s~~ell~h  250 (344)
                      ....++.+++.+||+.+|.+|||+.++++.
T Consensus       918 ~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  947 (968)
T PLN00113        918 NEIVEVMNLALHCTATDPTARPCANDVLKT  947 (968)
T ss_pred             HHHHHHHHHHHhhCcCCchhCcCHHHHHHH
Confidence            112356789999999999999999999764

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-35  Score=278.23  Aligned_cols=239  Identities=27%  Similarity=0.423  Sum_probs=197.3

Q ss_pred             ceeeeeeeecCceEEEEEEEcCCC---cEEEEEEeecCc--cccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEEe
Q 019195            4 YELMKDIGSGNFGVARLMRNKNTK---ELVAMKYIERGH--KIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVME   78 (344)
Q Consensus         4 y~~~~~lg~G~~g~V~~~~~~~~~---~~vaiK~~~~~~--~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e   78 (344)
                      -++.++||.|.||.||+++.+..+   ..||||.++...  +....|+.|..||-+++||||+++.++......+.||+|
T Consensus       631 i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiTE  710 (996)
T KOG0196|consen  631 VKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIITE  710 (996)
T ss_pred             eEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEhh
Confidence            367899999999999999987655   579999998753  455789999999999999999999999999999999999


Q ss_pred             cCCCCChHHHHHhC-CCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCCC-C
Q 019195           79 YAAGGELFERICNA-GRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR-P  149 (344)
Q Consensus        79 ~~~~g~L~~~i~~~-~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~~-~  149 (344)
                      ||++|+|..+|+++ ++|..-++..+++.|+++       |+|||||-..|||+|.+-.  .|++|||+++....... .
T Consensus       711 yMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLv--CKVsDFGLSRvledd~~~~  788 (996)
T KOG0196|consen  711 YMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLV--CKVSDFGLSRVLEDDPEAA  788 (996)
T ss_pred             hhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceE--EEeccccceeecccCCCcc
Confidence            99999999999764 678777776666666655       9999999999999987775  99999999986544332 2


Q ss_pred             CCCc-c--CCcccCCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCHh
Q 019195          150 KSTV-G--TPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQD  225 (344)
Q Consensus       150 ~~~~-g--t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~  225 (344)
                      .+.. |  ...|.|||.+...... .+||+||+||+|||.++ |..||=..+..+.+    +. ....+++|.+..++..
T Consensus       789 ytt~GGKIPiRWTAPEAIa~RKFT-sASDVWSyGIVmWEVmSyGERPYWdmSNQdVI----ka-Ie~gyRLPpPmDCP~a  862 (996)
T KOG0196|consen  789 YTTLGGKIPIRWTAPEAIAYRKFT-SASDVWSYGIVMWEVMSYGERPYWDMSNQDVI----KA-IEQGYRLPPPMDCPAA  862 (996)
T ss_pred             ccccCCccceeecChhHhhhcccC-chhhccccceEEEEecccCCCcccccchHHHH----HH-HHhccCCCCCCCCcHH
Confidence            2222 2  3579999999888775 55999999999998665 99998766553333    22 3457888988899999


Q ss_pred             HHHHHHHhcccCCCCCCChHHHhcC
Q 019195          226 CRNLLSRIFVANPSRRITIKEIKSH  250 (344)
Q Consensus       226 ~~~li~~~L~~dp~~R~s~~ell~h  250 (344)
                      +..|+..||++|-.+||++.||+.+
T Consensus       863 L~qLMldCWqkdR~~RP~F~qiV~~  887 (996)
T KOG0196|consen  863 LYQLMLDCWQKDRNRRPKFAQIVST  887 (996)
T ss_pred             HHHHHHHHHHHHhhcCCCHHHHHHH
Confidence            9999999999999999999998765

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=100.00  E-value=8.4e-35  Score=234.47  Aligned_cols=191  Identities=24%  Similarity=0.396  Sum_probs=153.4

Q ss_pred             ceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecC--ccccHHHHHHHHHHhcC-CCCCcceeeEEEEcCCEEEEEEecC
Q 019195            4 YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERG--HKIDANVAREIINHKQL-RHPNIIRFKEVVLTPTHLAIVMEYA   80 (344)
Q Consensus         4 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~ei~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~   80 (344)
                      ...+..||+|++|+|-+.++..+|...|+|.+...  .+..+++++|+.+..+. .+|.+|++|+.......+|+.||.|
T Consensus        48 L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M  127 (282)
T KOG0984|consen   48 LVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELM  127 (282)
T ss_pred             hhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHh
Confidence            34567799999999999999999999999998753  34446788888776554 7999999999999999999999999


Q ss_pred             CCCChHHH----HHhCCCCCHHHHHHHHHHHHHC--------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCCC
Q 019195           81 AGGELFER----ICNAGRFSEDEARYFFQQLISG--------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR  148 (344)
Q Consensus        81 ~~g~L~~~----i~~~~~~~~~~~~~~~~ql~~~--------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~~  148 (344)
                       ..||..+    +.+.+.++|.-+-.++..++.|        .++|||+||+|||||..+  +||+||||++......-.
T Consensus       128 -~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~G--qVKiCDFGIsG~L~dSiA  204 (282)
T KOG0984|consen  128 -DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDG--QVKICDFGISGYLVDSIA  204 (282)
T ss_pred             -hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCC--cEEEcccccceeehhhhH
Confidence             4577544    4567788888766665555544        999999999999997665  599999999875544433


Q ss_pred             CCCCccCCcccCCccccC----CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC
Q 019195          149 PKSTVGTPAYIAPEVLSR----REYDGKLADVWSCGVTLYVMLVGAYPFEDQED  198 (344)
Q Consensus       149 ~~~~~gt~~y~aPE~~~~----~~~~~~~~DiwslG~il~el~~g~~pf~~~~~  198 (344)
                      .+...|...|||||.+..    ..|+- ++||||||++++||++++.||.....
T Consensus       205 kt~daGCkpYmaPEri~~e~n~~gY~v-ksDvWSLGItmiElA~lr~PY~~w~t  257 (282)
T KOG0984|consen  205 KTMDAGCKPYMAPERINPELNQKGYSV-KSDVWSLGITMIEMAILRFPYESWGT  257 (282)
T ss_pred             HHHhcCCCccCChhhcCcccCccccee-ehhhhhhhhhhhhhhhccccccccCC
Confidence            344678999999999843    34544 49999999999999999999987654

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=100.00  E-value=1e-33  Score=258.07  Aligned_cols=191  Identities=30%  Similarity=0.489  Sum_probs=168.1

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCcccc---------HHHHHHHHHHhcCC---CCCcceeeEEEEc
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKID---------ANVAREIINHKQLR---HPNIIRFKEVVLT   69 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~---------~~~~~ei~~l~~l~---h~niv~~~~~~~~   69 (344)
                      .+|..+++||.|+||.|++|.++.+...|+||.+.+.+-..         -.+-.||++|..|+   |+||++++++|++
T Consensus       561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd  640 (772)
T KOG1152|consen  561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED  640 (772)
T ss_pred             ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence            46999999999999999999999999999999998754221         13446999999996   9999999999999


Q ss_pred             CCEEEEEEecC-CCCChHHHHHhCCCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCc
Q 019195           70 PTHLAIVMEYA-AGGELFERICNAGRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSK  141 (344)
Q Consensus        70 ~~~~~lv~e~~-~~g~L~~~i~~~~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~  141 (344)
                      ++.+|++||.. +|-+|+++|.-...+.|.+...+++|++.+       ||||||||-+|+.+++++.  +||+|||.|.
T Consensus       641 dd~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~--~klidfgsaa  718 (772)
T KOG1152|consen  641 DDYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGF--VKLIDFGSAA  718 (772)
T ss_pred             CCeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCe--EEEeeccchh
Confidence            99999999965 456899999999999999999999998876       9999999999999988776  9999999886


Q ss_pred             ccCCCCCCCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 019195          142 SSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFED  195 (344)
Q Consensus       142 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~  195 (344)
                      .... ..-...+||..|.|||++.+..|-++.-|||+||+++|.++....||..
T Consensus       719 ~~ks-gpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn  771 (772)
T KOG1152|consen  719 YTKS-GPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN  771 (772)
T ss_pred             hhcC-CCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence            5433 3345678999999999999999999989999999999999999999864

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.3e-33  Score=246.80  Aligned_cols=239  Identities=27%  Similarity=0.370  Sum_probs=175.2

Q ss_pred             CceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHH--hcCCCCCcceeeEEEEcC----CEEEEE
Q 019195            3 KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINH--KQLRHPNIIRFKEVVLTP----THLAIV   76 (344)
Q Consensus         3 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~l--~~l~h~niv~~~~~~~~~----~~~~lv   76 (344)
                      +-++++.||+|.||.||++.+.  |+.||||++....+  +...+|.++.  ..|+|+||+.+++.=..+    ..+|||
T Consensus       212 qI~L~e~IGkGRyGEVwrG~wr--Ge~VAVKiF~srdE--~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwLv  287 (513)
T KOG2052|consen  212 QIVLQEIIGKGRFGEVWRGRWR--GEDVAVKIFSSRDE--RSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWLV  287 (513)
T ss_pred             eeEEEEEecCccccceeecccc--CCceEEEEecccch--hhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEEe
Confidence            4578999999999999999986  66799999876433  4455555554  456999999998875433    478999


Q ss_pred             EecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHC---------------CeeecCCCCCCeEecCCCCCCEEEeecCCCc
Q 019195           77 MEYAAGGELFERICNAGRFSEDEARYFFQQLISG---------------QICHRDLKLENTLLDGSPAPRLKICDFGYSK  141 (344)
Q Consensus        77 ~e~~~~g~L~~~i~~~~~~~~~~~~~~~~ql~~~---------------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~  141 (344)
                      ++|.+.|||+++|.. ..++...+..++..++++               .|.|||||..|||+..++.  .-|+|+|+|.
T Consensus       288 TdYHe~GSL~DyL~r-~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~--C~IADLGLAv  364 (513)
T KOG2052|consen  288 TDYHEHGSLYDYLNR-NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGT--CCIADLGLAV  364 (513)
T ss_pred             eecccCCcHHHHHhh-ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCc--EEEeeceeeE
Confidence            999999999999976 678888877777776665               7999999999999988876  9999999997


Q ss_pred             ccCCC-----CCCCCCccCCcccCCccccCCCC-----CCcchhHHHHHHHHHHHHhC----------CCCCCCCCChHH
Q 019195          142 SSLLH-----SRPKSTVGTPAYIAPEVLSRREY-----DGKLADVWSCGVTLYVMLVG----------AYPFEDQEDPKN  201 (344)
Q Consensus       142 ~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~-----~~~~~DiwslG~il~el~~g----------~~pf~~~~~~~~  201 (344)
                      .....     -..+..+||..|||||++.....     +.+.+||||||.++||++..          ++||.+--..+.
T Consensus       365 ~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~DP  444 (513)
T KOG2052|consen  365 RHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSDP  444 (513)
T ss_pred             EecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCCC
Confidence            54333     23456789999999999854321     12448999999999999853          678876433222


Q ss_pred             HHHHHHHHhh-ccc--cCCCCCCCCH---hHHHHHHHhcccCCCCCCChHHHh
Q 019195          202 FRKTISRIMA-VQY--KIPDYVHISQ---DCRNLLSRIFVANPSRRITIKEIK  248 (344)
Q Consensus       202 ~~~~~~~~~~-~~~--~~~~~~~~s~---~~~~li~~~L~~dp~~R~s~~ell  248 (344)
                      -.+-+..+.. ..+  .+|....-.+   .+..+++-||..+|.-|.||--+.
T Consensus       445 s~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriK  497 (513)
T KOG2052|consen  445 SFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIK  497 (513)
T ss_pred             CHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHH
Confidence            2222332221 222  2232212223   456788999999999999987664

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.6e-32  Score=265.52  Aligned_cols=238  Identities=26%  Similarity=0.427  Sum_probs=190.9

Q ss_pred             eeeeeeeecCceEEEEEEEc---C----CCcEEEEEEeecCcc--ccHHHHHHHHHHhcC-CCCCcceeeEEEEcCCEEE
Q 019195            5 ELMKDIGSGNFGVARLMRNK---N----TKELVAMKYIERGHK--IDANVAREIINHKQL-RHPNIIRFKEVVLTPTHLA   74 (344)
Q Consensus         5 ~~~~~lg~G~~g~V~~~~~~---~----~~~~vaiK~~~~~~~--~~~~~~~ei~~l~~l-~h~niv~~~~~~~~~~~~~   74 (344)
                      ++.+.||+|.||.|+++...   .    ....||+|.+.....  ....+..|+.+|+.+ +|+||+.+.+++...+.++
T Consensus       299 ~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~~~~  378 (609)
T KOG0200|consen  299 KLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDGPLY  378 (609)
T ss_pred             cccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCCceE
Confidence            56679999999999998743   1    256799999876443  346789999999999 5999999999999999999


Q ss_pred             EEEecCCCCChHHHHHhCC----------------CCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCC
Q 019195           75 IVMEYAAGGELFERICNAG----------------RFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPR  131 (344)
Q Consensus        75 lv~e~~~~g~L~~~i~~~~----------------~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~  131 (344)
                      +|+||+..|+|.++++..+                .++..++..+..|++.+       +++||||-..|||+..+..  
T Consensus       379 ~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNVLi~~~~~--  456 (609)
T KOG0200|consen  379 VIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNVLITKNKV--  456 (609)
T ss_pred             EEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhEEecCCCE--
Confidence            9999999999999997765                38888888998888876       9999999999999987765  


Q ss_pred             EEEeecCCCcccCCCCCCC--CCcc--CCcccCCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHH
Q 019195          132 LKICDFGYSKSSLLHSRPK--STVG--TPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTI  206 (344)
Q Consensus       132 vkL~DFg~a~~~~~~~~~~--~~~g--t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~  206 (344)
                      +||+|||+|+.........  ...|  ...|||||.+....++.+ +||||+||++||+++ |..||.+......+.+  
T Consensus       457 ~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~k-SDVWSfGI~L~EifsLG~~PYp~~~~~~~l~~--  533 (609)
T KOG0200|consen  457 IKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSK-SDVWSFGILLWEIFTLGGTPYPGIPPTEELLE--  533 (609)
T ss_pred             EEEccccceeccCCCCceEecCCCCccceeecCHHHhccCccccc-chhhHHHHHHHHHhhCCCCCCCCCCcHHHHHH--
Confidence            9999999998543333221  1222  335999999998666555 999999999999998 8899987442222222  


Q ss_pred             HHHhhccccCCCCCCCCHhHHHHHHHhcccCCCCCCChHHHhc
Q 019195          207 SRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKS  249 (344)
Q Consensus       207 ~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~ell~  249 (344)
                        ......+...+...++++.++++.||+.+|.+||+..++.+
T Consensus       534 --~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~  574 (609)
T KOG0200|consen  534 --FLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVE  574 (609)
T ss_pred             --HHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence              23344455555677999999999999999999999999865

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5e-33  Score=248.65  Aligned_cols=238  Identities=24%  Similarity=0.299  Sum_probs=171.9

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHh--cCCCCCcceeeEEEEcCC----EEEE
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHK--QLRHPNIIRFKEVVLTPT----HLAI   75 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~l~--~l~h~niv~~~~~~~~~~----~~~l   75 (344)
                      +..++++.||+|.||.||+|+..  ++.||||++.....  +.+.+|-.+.+  .+.|+||+++++.-...+    .++|
T Consensus       210 ~pl~l~eli~~Grfg~V~KaqL~--~~~VAVKifp~~~k--qs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywL  285 (534)
T KOG3653|consen  210 DPLQLLELIGRGRFGCVWKAQLD--NRLVAVKIFPEQEK--QSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWL  285 (534)
T ss_pred             CchhhHHHhhcCccceeehhhcc--CceeEEEecCHHHH--HHHHhHHHHHhccCccchhHHHhhchhccCCccccceeE
Confidence            34567889999999999999875  48999999876443  44555555554  458999999998876554    7999


Q ss_pred             EEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHC----------------CeeecCCCCCCeEecCCCCCCEEEeecCC
Q 019195           76 VMEYAAGGELFERICNAGRFSEDEARYFFQQLISG----------------QICHRDLKLENTLLDGSPAPRLKICDFGY  139 (344)
Q Consensus        76 v~e~~~~g~L~~~i~~~~~~~~~~~~~~~~ql~~~----------------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~  139 (344)
                      |++|.+.|+|.++++. ..++.....+++..|+.+                .|+|||||..||||.++.+  .-|+|||+
T Consensus       286 Vt~fh~kGsL~dyL~~-ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlT--ccIaDFGL  362 (534)
T KOG3653|consen  286 VTEFHPKGSLCDYLKA-NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLT--CCIADFGL  362 (534)
T ss_pred             EeeeccCCcHHHHHHh-ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCc--EEeeccce
Confidence            9999999999999965 457777777776665544                8999999999999988876  99999999


Q ss_pred             CcccCCC---CCCCCCccCCcccCCccccCCCCCC-----cchhHHHHHHHHHHHHhCCCCCCCC---------------
Q 019195          140 SKSSLLH---SRPKSTVGTPAYIAPEVLSRREYDG-----KLADVWSCGVTLYVMLVGAYPFEDQ---------------  196 (344)
Q Consensus       140 a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~-----~~~DiwslG~il~el~~g~~pf~~~---------------  196 (344)
                      |....+.   ......+||.+|||||++.+...-.     +..||||+|.++|||+++...+...               
T Consensus       363 Al~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~  442 (534)
T KOG3653|consen  363 ALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGN  442 (534)
T ss_pred             eEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcC
Confidence            9765433   3334568999999999997654332     4589999999999999875443210               


Q ss_pred             -CChHHHHHHHHHHhhccccCCCCC---CCCHhHHHHHHHhcccCCCCCCChHHH
Q 019195          197 -EDPKNFRKTISRIMAVQYKIPDYV---HISQDCRNLLSRIFVANPSRRITIKEI  247 (344)
Q Consensus       197 -~~~~~~~~~~~~~~~~~~~~~~~~---~~s~~~~~li~~~L~~dp~~R~s~~el  247 (344)
                       ...+.+...+-+ .+....+|+..   .--.-+++.+.-||..||+.|.||.=+
T Consensus       443 hPt~e~mq~~VV~-kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv  496 (534)
T KOG3653|consen  443 HPTLEEMQELVVR-KKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCV  496 (534)
T ss_pred             CCCHHHHHHHHHh-hccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHH
Confidence             111112211111 11222233211   112457899999999999999998654

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.97  E-value=2.6e-30  Score=219.27  Aligned_cols=203  Identities=40%  Similarity=0.655  Sum_probs=172.2

Q ss_pred             eeecCceEEEEEEEcCCCcEEEEEEeecCcc--ccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEEecCCCCChHH
Q 019195           10 IGSGNFGVARLMRNKNTKELVAMKYIERGHK--IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFE   87 (344)
Q Consensus        10 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~   87 (344)
                      ||+|++|.||++....+++.+++|++.....  ....+.+|+..++.++|++|+++++++......++++|++.+++|..
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~   80 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD   80 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence            6899999999999988899999999877544  24678999999999999999999999999999999999999999999


Q ss_pred             HHHhC-CCCCHHHHHHHHHHHH-------HCCeeecCCCCCCeEecC-CCCCCEEEeecCCCcccCCCC-CCCCCccCCc
Q 019195           88 RICNA-GRFSEDEARYFFQQLI-------SGQICHRDLKLENTLLDG-SPAPRLKICDFGYSKSSLLHS-RPKSTVGTPA  157 (344)
Q Consensus        88 ~i~~~-~~~~~~~~~~~~~ql~-------~~~iiH~Dikp~NIl~~~-~~~~~vkL~DFg~a~~~~~~~-~~~~~~gt~~  157 (344)
                      ++... ..++...++.++.+++       +.|++|+||+|.||+++. ..  +++|+|||.+....... ......++..
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~--~~~l~d~~~~~~~~~~~~~~~~~~~~~~  158 (215)
T cd00180          81 LLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNG--KVKLADFGLSKLLTSDKSLLKTIVGTPA  158 (215)
T ss_pred             HHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCC--cEEEecCCceEEccCCcchhhcccCCCC
Confidence            99775 4677777777666655       459999999999999986 44  49999999987543332 1334568899


Q ss_pred             ccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCHhHHHHHHHhcccC
Q 019195          158 YIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVAN  237 (344)
Q Consensus       158 y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~d  237 (344)
                      |++||.+......+.++|+|++|+++++|                                     ..+.+++.+|++.+
T Consensus       159 ~~~pe~~~~~~~~~~~~D~~~lg~~~~~l-------------------------------------~~~~~~l~~~l~~~  201 (215)
T cd00180         159 YMAPEVLLGKGYYSEKSDIWSLGVILYEL-------------------------------------PELKDLIRKMLQKD  201 (215)
T ss_pred             ccChhHhcccCCCCchhhhHHHHHHHHHH-------------------------------------HHHHHHHHHHhhCC
Confidence            99999987763445669999999999998                                     57899999999999


Q ss_pred             CCCCCChHHHhcCc
Q 019195          238 PSRRITIKEIKSHP  251 (344)
Q Consensus       238 p~~R~s~~ell~hp  251 (344)
                      |.+||++.++++|+
T Consensus       202 p~~R~~~~~l~~~~  215 (215)
T cd00180         202 PEKRPSAKEILEHL  215 (215)
T ss_pred             cccCcCHHHHhhCC
Confidence            99999999999875

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.97  E-value=2.8e-32  Score=228.28  Aligned_cols=249  Identities=25%  Similarity=0.415  Sum_probs=189.0

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcC-CCCCcceeeEE-EEcCCEEEEEEec
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQL-RHPNIIRFKEV-VLTPTHLAIVMEY   79 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~l~~l-~h~niv~~~~~-~~~~~~~~lv~e~   79 (344)
                      +.|.+.+.||+|.||.+.+|.++.++..+++|.+.+.....+.|.+|...--.| .|.||+.-|++ |+..+.++++|||
T Consensus        24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE~  103 (378)
T KOG1345|consen   24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQEF  103 (378)
T ss_pred             hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeecc
Confidence            579999999999999999999999999999999998888788899998766566 48999987765 7788899999999


Q ss_pred             CCCCChHHHHHhCCCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCCCCCCC
Q 019195           80 AAGGELFERICNAGRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST  152 (344)
Q Consensus        80 ~~~g~L~~~i~~~~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~~~~~~  152 (344)
                      ++.|+|...+.. ..+.+...+.++.||++|       ++||||||.+||||-....-+|||||||..+.....  ....
T Consensus       104 aP~gdL~snv~~-~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~t--V~~~  180 (378)
T KOG1345|consen  104 APRGDLRSNVEA-AGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTT--VKYL  180 (378)
T ss_pred             CccchhhhhcCc-ccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecccccccCce--ehhh
Confidence            999999988755 346677777777777665       999999999999994433338999999987632211  1122


Q ss_pred             ccCCcccCCccccCCC----CCCcchhHHHHHHHHHHHHhCCCCCCCCC-ChHHHHHHHHHHhhccccCCC-CCCCCHhH
Q 019195          153 VGTPAYIAPEVLSRRE----YDGKLADVWSCGVTLYVMLVGAYPFEDQE-DPKNFRKTISRIMAVQYKIPD-YVHISQDC  226 (344)
Q Consensus       153 ~gt~~y~aPE~~~~~~----~~~~~~DiwslG~il~el~~g~~pf~~~~-~~~~~~~~~~~~~~~~~~~~~-~~~~s~~~  226 (344)
                      ..+..|.+||++....    ...+.+|||.|||++|.+++|.+||.... ....+.+..+-........|. +..+|+.+
T Consensus       181 ~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~~P~~F~~fs~~a  260 (378)
T KOG1345|consen  181 EYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPALPKKFNPFSEKA  260 (378)
T ss_pred             hhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCccCchhhcccCHHH
Confidence            3566799999874332    22355899999999999999999998432 222333333333333334443 44689999


Q ss_pred             HHHHHHhcccCCCCC---CChHHHhcCccc
Q 019195          227 RNLLSRIFVANPSRR---ITIKEIKSHPWF  253 (344)
Q Consensus       227 ~~li~~~L~~dp~~R---~s~~ell~hp~~  253 (344)
                      ..+.++-|..+|.+|   .++.......|.
T Consensus       261 ~r~Fkk~lt~~~~drcki~~~kk~rk~~w~  290 (378)
T KOG1345|consen  261 LRLFKKSLTPRFKDRCKIWTAKKMRKCLWK  290 (378)
T ss_pred             HHHHHHhcCCcccccchhHHHHHHHHHHHH
Confidence            999999999999999   555555555554

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=99.97  E-value=2.2e-31  Score=251.24  Aligned_cols=237  Identities=24%  Similarity=0.371  Sum_probs=195.1

Q ss_pred             ceeeeeeeecCceEEEEEEEcCCCc----EEEEEEeecCcc--ccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEE
Q 019195            4 YELMKDIGSGNFGVARLMRNKNTKE----LVAMKYIERGHK--IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVM   77 (344)
Q Consensus         4 y~~~~~lg~G~~g~V~~~~~~~~~~----~vaiK~~~~~~~--~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~   77 (344)
                      .+..++||+|+||+||++.+...|+    +||||++.....  ....++.|..+|.+|.|||++++++++.... +-||+
T Consensus       698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvt  776 (1177)
T KOG1025|consen  698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVT  776 (1177)
T ss_pred             hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHH
Confidence            3567899999999999999876654    688888876443  3567999999999999999999999998766 78999


Q ss_pred             ecCCCCChHHHHHh-CCCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCCCC
Q 019195           78 EYAAGGELFERICN-AGRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP  149 (344)
Q Consensus        78 e~~~~g~L~~~i~~-~~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~~~  149 (344)
                      +|+++|+|.++++. +..+.....+.|..||+++       +++||||-..|+|+.....  +||+|||+++........
T Consensus       777 q~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~h--vkitdfgla~ll~~d~~e  854 (1177)
T KOG1025|consen  777 QLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNH--VKITDFGLAKLLAPDEKE  854 (1177)
T ss_pred             HhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCe--EEEEecchhhccCccccc
Confidence            99999999999975 4578888888898888877       8999999999999987664  999999999876655443


Q ss_pred             CCCc---cCCcccCCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCHh
Q 019195          150 KSTV---GTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQD  225 (344)
Q Consensus       150 ~~~~---gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~  225 (344)
                      ....   -.+.|||-|.+....+. .++||||+||++||++| |..|+.+....+     +........+++.+...+-+
T Consensus       855 y~~~~gK~pikwmale~i~~~~~t-hqSDVWsfGVtiWElmTFGa~Py~gi~~~e-----I~dlle~geRLsqPpiCtiD  928 (1177)
T KOG1025|consen  855 YSAPGGKVPIKWMALESIRIRKYT-HQSDVWSFGVTIWELMTFGAKPYDGIPAEE-----IPDLLEKGERLSQPPICTID  928 (1177)
T ss_pred             ccccccccCcHHHHHHHhhccCCC-chhhhhhhhhhHHHHHhcCCCccCCCCHHH-----hhHHHhccccCCCCCCccHH
Confidence            3332   34569999999877764 55999999999999987 999998866432     23334445567777788999


Q ss_pred             HHHHHHHhcccCCCCCCChHHHhc
Q 019195          226 CRNLLSRIFVANPSRRITIKEIKS  249 (344)
Q Consensus       226 ~~~li~~~L~~dp~~R~s~~ell~  249 (344)
                      +.-++.+||..|+..||+++++-.
T Consensus       929 Vy~~mvkCwmid~~~rp~fkel~~  952 (1177)
T KOG1025|consen  929 VYMVMVKCWMIDADSRPTFKELAE  952 (1177)
T ss_pred             HHHHHHHHhccCcccCccHHHHHH
Confidence            999999999999999999988754

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.97  E-value=1.9e-29  Score=217.02  Aligned_cols=189  Identities=42%  Similarity=0.699  Sum_probs=161.0

Q ss_pred             ceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCcc--ccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEEecCC
Q 019195            4 YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK--IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYAA   81 (344)
Q Consensus         4 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~   81 (344)
                      |.+.+.||.|++|.||++.+..+++.+|+|.+.....  ....+.+|+..++.++|+|++++++++......++++|+++
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE   80 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence            6789999999999999999998899999999987543  35678899999999999999999999999999999999999


Q ss_pred             CCChHHHHHhCCC-CCHHHHHHHHHHHHH-------CCeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCC--CCCC
Q 019195           82 GGELFERICNAGR-FSEDEARYFFQQLIS-------GQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS--RPKS  151 (344)
Q Consensus        82 ~g~L~~~i~~~~~-~~~~~~~~~~~ql~~-------~~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~--~~~~  151 (344)
                      +++|.+++..... +++..++.++.+++.       .+++|+||+|.||+++.+.  +++|+|||++.......  ....
T Consensus        81 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~--~~~l~d~g~~~~~~~~~~~~~~~  158 (225)
T smart00221       81 GGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDG--LVKLADFGLARFIHRDLAALLKT  158 (225)
T ss_pred             CCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC--CEEEeeCceeeEecCcccccccc
Confidence            9999999987666 788877777666554       4999999999999998764  59999999987654432  3345


Q ss_pred             CccCCcccCCccc-cCCCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 019195          152 TVGTPAYIAPEVL-SRREYDGKLADVWSCGVTLYVMLVGAYPFED  195 (344)
Q Consensus       152 ~~gt~~y~aPE~~-~~~~~~~~~~DiwslG~il~el~~g~~pf~~  195 (344)
                      ..++..|++||.+ ....+. .++|+|+||+++++|++|+.||..
T Consensus       159 ~~~~~~~~~pe~~~~~~~~~-~~~Dv~~lG~~~~~l~~g~~pf~~  202 (225)
T smart00221      159 VKGTPFYLAPEVLLGGKGYG-EAVDIWSLGVILYELLWGPEPFSG  202 (225)
T ss_pred             eeccCCcCCHhHhcCCCCCC-chhhHHHHHHHHHHHHHCCCCccc
Confidence            6788999999998 444443 469999999999999999999966

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.96  E-value=2e-30  Score=262.29  Aligned_cols=194  Identities=14%  Similarity=0.174  Sum_probs=139.5

Q ss_pred             cCCC-CCcceeeEEE-------EcCCEEEEEEecCCCCChHHHHHh-CCCCCHHHHHHHHHHHHHC-------CeeecCC
Q 019195           54 QLRH-PNIIRFKEVV-------LTPTHLAIVMEYAAGGELFERICN-AGRFSEDEARYFFQQLISG-------QICHRDL  117 (344)
Q Consensus        54 ~l~h-~niv~~~~~~-------~~~~~~~lv~e~~~~g~L~~~i~~-~~~~~~~~~~~~~~ql~~~-------~iiH~Di  117 (344)
                      .++| +||++++++|       .....++++||++ +++|.++|.. ...+++.+++.+++||+.|       ||+||||
T Consensus        28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDl  106 (793)
T PLN00181         28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNV  106 (793)
T ss_pred             hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccC
Confidence            4455 5788888877       2234678889987 6799999965 3468999988888887765       9999999


Q ss_pred             CCCCeEecC-----------------CCCCCEEEeecCCCcccCCC-----------------CCCCCCccCCcccCCcc
Q 019195          118 KLENTLLDG-----------------SPAPRLKICDFGYSKSSLLH-----------------SRPKSTVGTPAYIAPEV  163 (344)
Q Consensus       118 kp~NIl~~~-----------------~~~~~vkL~DFg~a~~~~~~-----------------~~~~~~~gt~~y~aPE~  163 (344)
                      ||+||||+.                 +..+.+||+|||+++.....                 ......+||+.|||||+
T Consensus       107 KP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~  186 (793)
T PLN00181        107 RPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEE  186 (793)
T ss_pred             CchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhh
Confidence            999999953                 22334778888877642110                 00112468999999999


Q ss_pred             ccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCHhHHHHHHHhcccCCCCCCC
Q 019195          164 LSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRIT  243 (344)
Q Consensus       164 ~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s  243 (344)
                      +.+..+. .++|||||||++|||++|.+|+....  ..+.......     ..+......+...+++.+||+++|.+||+
T Consensus       187 ~~~~~~~-~~sDVwSlGviL~ELl~~~~~~~~~~--~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~L~~~P~~Rps  258 (793)
T PLN00181        187 DNGSSSN-CASDVYRLGVLLFELFCPVSSREEKS--RTMSSLRHRV-----LPPQILLNWPKEASFCLWLLHPEPSCRPS  258 (793)
T ss_pred             hccCCCC-chhhhhhHHHHHHHHhhCCCchhhHH--HHHHHHHHhh-----cChhhhhcCHHHHHHHHHhCCCChhhCcC
Confidence            9888874 55999999999999999988875321  1111111111     11111123456789999999999999999


Q ss_pred             hHHHhcCcccccC
Q 019195          244 IKEIKSHPWFLKN  256 (344)
Q Consensus       244 ~~ell~hp~~~~~  256 (344)
                      +.++|+||||.+.
T Consensus       259 ~~eil~h~~~~~~  271 (793)
T PLN00181        259 MSELLQSEFINEP  271 (793)
T ss_pred             hHHHhhchhhhhh
Confidence            9999999999764

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.95  E-value=9.1e-28  Score=199.44  Aligned_cols=163  Identities=21%  Similarity=0.261  Sum_probs=123.6

Q ss_pred             CChHHHHHhC-CCCCHHHHHHHHHHHHHC-CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCCCCCCCccCCcccC
Q 019195           83 GELFERICNA-GRFSEDEARYFFQQLISG-QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIA  160 (344)
Q Consensus        83 g~L~~~i~~~-~~~~~~~~~~~~~ql~~~-~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~~~~~~~gt~~y~a  160 (344)
                      |+|.+++.+. ..+++.+++.++.|++.+ ..+|..-||+|||++.++.  +|+  ||++......    ...||+.|||
T Consensus         1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~kp~Nil~~~~~~--~~~--fG~~~~~~~~----~~~g~~~y~a   72 (176)
T smart00750        1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQAKSGNILLTWDGL--LKL--DGSVAFKTPE----QSRVDPYFMA   72 (176)
T ss_pred             CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccEeEcCccc--eee--ccceEeeccc----cCCCcccccC
Confidence            6899999874 469999999999999998 7888888999999976654  888  9998754322    2368999999


Q ss_pred             CccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHH-HHHHHHHHhhcccc-CCCCCCCCH--hHHHHHHHhccc
Q 019195          161 PEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKN-FRKTISRIMAVQYK-IPDYVHISQ--DCRNLLSRIFVA  236 (344)
Q Consensus       161 PE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~-~~~~~~~s~--~~~~li~~~L~~  236 (344)
                      ||++.+..++ .++|||||||++|+|++|+.||........ +............. .+....++.  .+.++|.+||..
T Consensus        73 PE~~~~~~~~-~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~  151 (176)
T smart00750       73 PEVIQGQSYT-EKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFADFMRVCASR  151 (176)
T ss_pred             hHHhcCCCCc-chhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHHHHHHHHHhc
Confidence            9999888775 459999999999999999999976543222 22222221111000 011112333  699999999999


Q ss_pred             CCCCCCChHHHhcCcccc
Q 019195          237 NPSRRITIKEIKSHPWFL  254 (344)
Q Consensus       237 dp~~R~s~~ell~hp~~~  254 (344)
                      +|.+||++.++++|+|+.
T Consensus       152 ~p~~Rp~~~~ll~~~~~~  169 (176)
T smart00750      152 LPQRREAANHYLAHCRAL  169 (176)
T ss_pred             ccccccCHHHHHHHHHHH
Confidence            999999999999999974

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.95  E-value=7.8e-29  Score=239.50  Aligned_cols=249  Identities=30%  Similarity=0.514  Sum_probs=189.2

Q ss_pred             eeeeeeeecCceEEEEEEEcCCCcEEEEEEeec----Ccc---ccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEE
Q 019195            5 ELMKDIGSGNFGVARLMRNKNTKELVAMKYIER----GHK---IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVM   77 (344)
Q Consensus         5 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~----~~~---~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~   77 (344)
                      .....+|.|++|.|+.+........++.|.+..    ...   ....+..|+-+-..++|||++.....+.......-.|
T Consensus       321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m  400 (601)
T KOG0590|consen  321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM  400 (601)
T ss_pred             CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence            456789999999888888877777677765541    111   1123566777778899999988877777666666669


Q ss_pred             ecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCC---
Q 019195           78 EYAAGGELFERICNAGRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS---  147 (344)
Q Consensus        78 e~~~~g~L~~~i~~~~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~---  147 (344)
                      |||++ +|+.++...+.+...++..+++||+.+       ||.||||||+|+++..++.  +||+|||.+.......   
T Consensus       401 E~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~--lki~Dfg~~~vf~~~~e~~  477 (601)
T KOG0590|consen  401 EYCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGI--LKIIDFGAASVFRYPWEKN  477 (601)
T ss_pred             hcccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCc--eEEeecCcceeeccCcchh
Confidence            99999 999999887788888888887777754       9999999999999987765  9999999886533222   


Q ss_pred             --CCCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhcc-c--cCCCCCCC
Q 019195          148 --RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQ-Y--KIPDYVHI  222 (344)
Q Consensus       148 --~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~-~--~~~~~~~~  222 (344)
                        .....+|+..|+|||++.+..|+.+..||||.|++++.|++|+.||......+............. .  ..+-...+
T Consensus       478 ~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  557 (601)
T KOG0590|consen  478 IHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPNRLLSLL  557 (601)
T ss_pred             hhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccChHHHHHhc
Confidence              234567999999999999999999999999999999999999999976554332110000000000 0  00111236


Q ss_pred             CHhHHHHHHHhcccCCCCCCChHHHhcCcccccC
Q 019195          223 SQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKN  256 (344)
Q Consensus       223 s~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~~  256 (344)
                      +...+.+|.+||+.+|.+|.|+.+|++.+||+..
T Consensus       558 p~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i  591 (601)
T KOG0590|consen  558 PRETRIIIYRMLQLDPTKRITIEQILNDEWIRSI  591 (601)
T ss_pred             hhhHHHHHHHHccCChhheecHHHHhhChHhhhc
Confidence            7789999999999999999999999999999764

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.94  E-value=8.2e-25  Score=197.74  Aligned_cols=248  Identities=33%  Similarity=0.551  Sum_probs=191.4

Q ss_pred             ceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCcc----ccHHHHHHHHHHhcCCCC-CcceeeEEEEcCCEEEEEEe
Q 019195            4 YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK----IDANVAREIINHKQLRHP-NIIRFKEVVLTPTHLAIVME   78 (344)
Q Consensus         4 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~ei~~l~~l~h~-niv~~~~~~~~~~~~~lv~e   78 (344)
                      |.+.+.||.|+||.||++.+.   ..+|+|.+.....    ....+.+|+.+++.+.|+ +|+++.+.+......+++++
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~   78 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVME   78 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEe
Confidence            788999999999999999987   6799999876543    246788999999999988 79999999988888999999


Q ss_pred             cCCCCChHHHHHhCC---CCCHHHHHHHHHHHHH-------CCeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCC-
Q 019195           79 YAAGGELFERICNAG---RFSEDEARYFFQQLIS-------GQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS-  147 (344)
Q Consensus        79 ~~~~g~L~~~i~~~~---~~~~~~~~~~~~ql~~-------~~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~-  147 (344)
                      ++.++++...+....   .+.......++.|++.       .+++||||||+||+++.... .++++|||++....... 
T Consensus        79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~-~~~l~dfg~~~~~~~~~~  157 (384)
T COG0515          79 YVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGR-VVKLIDFGLAKLLPDPGS  157 (384)
T ss_pred             cCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCC-eEEEeccCcceecCCCCc
Confidence            999999997777664   6888888877777664       49999999999999976552 38999999987433332 


Q ss_pred             ------CCCCCccCCcccCCccccCC--CCCCcchhHHHHHHHHHHHHhCCCCCCCCCC---hHHHHHHHHHHhhccccC
Q 019195          148 ------RPKSTVGTPAYIAPEVLSRR--EYDGKLADVWSCGVTLYVMLVGAYPFEDQED---PKNFRKTISRIMAVQYKI  216 (344)
Q Consensus       148 ------~~~~~~gt~~y~aPE~~~~~--~~~~~~~DiwslG~il~el~~g~~pf~~~~~---~~~~~~~~~~~~~~~~~~  216 (344)
                            ......||..|+|||.+.+.  .......|+||+|++++++++|..||.....   .......+..........
T Consensus       158 ~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (384)
T COG0515         158 TSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLAS  237 (384)
T ss_pred             cccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCccccc
Confidence                  23566799999999999874  3445569999999999999999999877654   222222222211110111


Q ss_pred             CCCCCC----CHhHHHHHHHhcccCCCCCCChHHHhcCccccc
Q 019195          217 PDYVHI----SQDCRNLLSRIFVANPSRRITIKEIKSHPWFLK  255 (344)
Q Consensus       217 ~~~~~~----s~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~  255 (344)
                      +.....    ...+.+++.+++..+|..|.+......++|...
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~  280 (384)
T COG0515         238 PLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAH  280 (384)
T ss_pred             ccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhhC
Confidence            111111    257899999999999999999999888866544

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.94  E-value=2e-26  Score=209.69  Aligned_cols=159  Identities=16%  Similarity=0.109  Sum_probs=119.9

Q ss_pred             CCCceeeeeeeecCceEEEEEEEcC-CCcEEEEEEeecCc------cccHHHHHHHHHHhcCCCCCcce-eeEEEEcCCE
Q 019195            1 MEKYELMKDIGSGNFGVARLMRNKN-TKELVAMKYIERGH------KIDANVAREIINHKQLRHPNIIR-FKEVVLTPTH   72 (344)
Q Consensus         1 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vaiK~~~~~~------~~~~~~~~ei~~l~~l~h~niv~-~~~~~~~~~~   72 (344)
                      +++|++.+.||+|+||+||+|.+.. +++.||||++....      .....+.+|+++|++++|+||+. ++.    .+.
T Consensus        17 ~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~----~~~   92 (365)
T PRK09188         17 SARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA----TGK   92 (365)
T ss_pred             cCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE----cCC
Confidence            4689999999999999999999876 77888999865321      12346889999999999999985 443    246


Q ss_pred             EEEEEecCCCCChHHHHHhCCC-CCHHHHHHHHHHHHHCCeeecCC-CCCCeEecCCCCCCEEEeecCCCcccCCCC---
Q 019195           73 LAIVMEYAAGGELFERICNAGR-FSEDEARYFFQQLISGQICHRDL-KLENTLLDGSPAPRLKICDFGYSKSSLLHS---  147 (344)
Q Consensus        73 ~~lv~e~~~~g~L~~~i~~~~~-~~~~~~~~~~~ql~~~~iiH~Di-kp~NIl~~~~~~~~vkL~DFg~a~~~~~~~---  147 (344)
                      .|+|||||+|++|.. +...+. --..++...+.++|+.||+|||| ||+|||++.++  ++||+|||+|+......   
T Consensus        93 ~~LVmE~~~G~~L~~-~~~~~~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~--~ikLiDFGlA~~~~~~~~~~  169 (365)
T PRK09188         93 DGLVRGWTEGVPLHL-ARPHGDPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDG--EAAVIDFQLASVFRRRGALY  169 (365)
T ss_pred             cEEEEEccCCCCHHH-hCccchHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCC--CEEEEECccceecccCcchh
Confidence            899999999999963 221111 01234556677788889999999 99999997654  49999999998543222   


Q ss_pred             ------CCCCCccCCcccCCccccC
Q 019195          148 ------RPKSTVGTPAYIAPEVLSR  166 (344)
Q Consensus       148 ------~~~~~~gt~~y~aPE~~~~  166 (344)
                            .....++++.|+|||.+..
T Consensus       170 ~~~~~~d~~~~~~~~~~~~pe~~~~  194 (365)
T PRK09188        170 RIAAYEDLRHLLKHKRTYAPDALTP  194 (365)
T ss_pred             hhhhhhhhhhhhccCccCCcccCCh
Confidence                  1134568899999999853

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.94  E-value=1e-24  Score=198.37  Aligned_cols=245  Identities=23%  Similarity=0.198  Sum_probs=181.5

Q ss_pred             CceeeeeeeecCceEEEEEEEcCCC-cEEEEEEeecCccc-cHHHHHHHHHHhcCC----CCCcceeeEEE-EcCCEEEE
Q 019195            3 KYELMKDIGSGNFGVARLMRNKNTK-ELVAMKYIERGHKI-DANVAREIINHKQLR----HPNIIRFKEVV-LTPTHLAI   75 (344)
Q Consensus         3 ~y~~~~~lg~G~~g~V~~~~~~~~~-~~vaiK~~~~~~~~-~~~~~~ei~~l~~l~----h~niv~~~~~~-~~~~~~~l   75 (344)
                      +|++.+.||+|+||.||.+.+..++ ..+|+|........ ...+..|+.+++.+.    .+|+.++++.+ ..+...|+
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i   98 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI   98 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence            7999999999999999999998774 67899987764332 226778888888886    37999999999 47788999


Q ss_pred             EEecCCCCChHHHHHhC--CCCCHHHHHHHHHH-------HHHCCeeecCCCCCCeEecCCC-C--CCEEEeecCCCc--
Q 019195           76 VMEYAAGGELFERICNA--GRFSEDEARYFFQQ-------LISGQICHRDLKLENTLLDGSP-A--PRLKICDFGYSK--  141 (344)
Q Consensus        76 v~e~~~~g~L~~~i~~~--~~~~~~~~~~~~~q-------l~~~~iiH~Dikp~NIl~~~~~-~--~~vkL~DFg~a~--  141 (344)
                      ||+++ |.+|.++....  ++++...+..+..|       ||+.|++||||||+|+++.... .  ..+.|.|||+++  
T Consensus        99 VM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar~~  177 (322)
T KOG1164|consen   99 VMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLARRF  177 (322)
T ss_pred             EEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCCccc
Confidence            99998 88999987544  57888866666544       5666999999999999997543 1  359999999998  


Q ss_pred             ccC-CC------C-C-CCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhc
Q 019195          142 SSL-LH------S-R-PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAV  212 (344)
Q Consensus       142 ~~~-~~------~-~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~  212 (344)
                      ... ..      . . .....||..|+++....+.... ++.|+||++.++.+|+.|..||..........+........
T Consensus       178 ~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~-r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~~~~  256 (322)
T KOG1164|consen  178 KYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQG-RRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDPRKL  256 (322)
T ss_pred             cccCCCCcccccCCCCccCCCCccccccHHHhCCCccC-CchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHhhhh
Confidence            321 11      1 1 1234599999999998887764 55999999999999999999998766543333222221111


Q ss_pred             cccCCCCCCCCHhHHHHHHHhcccCCCCCCChHHHhcC
Q 019195          213 QYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSH  250 (344)
Q Consensus       213 ~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~ell~h  250 (344)
                      ... ......+..+..+...+-..+...+|....+...
T Consensus       257 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~  293 (322)
T KOG1164|consen  257 LTD-RFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAEL  293 (322)
T ss_pred             ccc-cccCCChHHHHHHHHHhhccCCcCCCCHHHHHHH
Confidence            111 1122345678888888888899999988877553

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.93  E-value=1.9e-27  Score=220.50  Aligned_cols=233  Identities=30%  Similarity=0.519  Sum_probs=187.5

Q ss_pred             eeeecCceEEEEEEE---cCCCcEEEEEEeecCccc---cHHHHHHHHHHhcCC-CCCcceeeEEEEcCCEEEEEEecCC
Q 019195            9 DIGSGNFGVARLMRN---KNTKELVAMKYIERGHKI---DANVAREIINHKQLR-HPNIIRFKEVVLTPTHLAIVMEYAA   81 (344)
Q Consensus         9 ~lg~G~~g~V~~~~~---~~~~~~vaiK~~~~~~~~---~~~~~~ei~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~   81 (344)
                      .+|.|+||.|+++..   ...+..||+|+..+....   ......|-.++..++ ||.+|+++..|+.+...++++++..
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r   80 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR   80 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence            479999999887653   456788999988764321   123445666777775 9999999999999999999999999


Q ss_pred             CCChHHHHHhCCCCCHHHHHHHHHHHH-------HCCeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCCCCCCCcc
Q 019195           82 GGELFERICNAGRFSEDEARYFFQQLI-------SGQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVG  154 (344)
Q Consensus        82 ~g~L~~~i~~~~~~~~~~~~~~~~ql~-------~~~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~~~~~~~g  154 (344)
                      ||.|+..+.+...+.+...+.+...++       +-+|+|||+|++||+++..+.  +++.|||+++........   ||
T Consensus        81 gg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Gh--i~~tdfglske~v~~~~~---cg  155 (612)
T KOG0603|consen   81 GGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGH--IKLTDFGLSKEAVKEKIA---CG  155 (612)
T ss_pred             cchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCc--cccCCchhhhHhHhhhhc---cc
Confidence            999999998888888877776654444       339999999999999987764  999999998865444333   99


Q ss_pred             CCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCHhHHHHHHHhc
Q 019195          155 TPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIF  234 (344)
Q Consensus       155 t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L  234 (344)
                      |..|||||++.+  . ..++|+||+|+++++|++|..||..        .++.++....+..|.  .++..+++++..++
T Consensus       156 t~eymApEI~~g--h-~~a~D~ws~gvl~felltg~~pf~~--------~~~~~Il~~~~~~p~--~l~~~a~~~~~~l~  222 (612)
T KOG0603|consen  156 TYEYRAPEIING--H-LSAADWWSFGVLAFELLTGTLPFGG--------DTMKRILKAELEMPR--ELSAEARSLFRQLF  222 (612)
T ss_pred             chhhhhhHhhhc--c-CCcccchhhhhhHHHHhhCCCCCch--------HHHHHHhhhccCCch--hhhHHHHHHHHHHH
Confidence            999999999982  2 3458999999999999999999987        345555555555554  78999999999999


Q ss_pred             ccCCCCCCC-----hHHHhcCcccccCCCh
Q 019195          235 VANPSRRIT-----IKEIKSHPWFLKNLPR  259 (344)
Q Consensus       235 ~~dp~~R~s-----~~ell~hp~~~~~~~~  259 (344)
                      ..+|.+|.-     +.++++|+||......
T Consensus       223 ~r~p~nrLg~~~~~~~eik~h~f~~~i~~~  252 (612)
T KOG0603|consen  223 KRNPENRLGAGPDGVDEIKQHEFFQSIDWN  252 (612)
T ss_pred             hhCHHHHhccCcchhHHHhccchheeeeHh
Confidence            999999984     5799999999876543

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.93  E-value=5.4e-25  Score=181.84  Aligned_cols=240  Identities=20%  Similarity=0.222  Sum_probs=184.5

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcCC-CCCcceeeEEEEcCCEEEEEEecC
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLR-HPNIIRFKEVVLTPTHLAIVMEYA   80 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~   80 (344)
                      .+|+++++||+|+||-+|.+.+..+|..||||+-... .....+..|..+.+.|+ ...|.++..++.+...-.+||++.
T Consensus        15 gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~-a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMdLL   93 (341)
T KOG1163|consen   15 GKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSK-AKHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMDLL   93 (341)
T ss_pred             cceEEEEeecCCchhheeeeeeccCCceEEEEeeccc-CCCcchhHHHHHHHHhccCCCCchhhhhccccccceeeeecc
Confidence            5799999999999999999999999999999976543 33456788888988886 578888888888888889999998


Q ss_pred             CCCChHHHHHh-CCCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecC-CCCCCEEEeecCCCcccCC------
Q 019195           81 AGGELFERICN-AGRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDG-SPAPRLKICDFGYSKSSLL------  145 (344)
Q Consensus        81 ~~g~L~~~i~~-~~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~-~~~~~vkL~DFg~a~~~~~------  145 (344)
                       |.||.+++.- ...|+...++.++.|++..       +++||||||+|+|+.- ....++.|+|||+|+....      
T Consensus        94 -GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~t~~H  172 (341)
T KOG1163|consen   94 -GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIRTRQH  172 (341)
T ss_pred             -CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhhhcccccccc
Confidence             8899888753 3568888888888887654       9999999999999953 2223589999999975322      


Q ss_pred             --CCCCCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCC---CCC
Q 019195          146 --HSRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIP---DYV  220 (344)
Q Consensus       146 --~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~---~~~  220 (344)
                        ....+...||..|.+--...+...+.+ -|+=|+|.++.++.-|..||.+....... .....+.......|   -+.
T Consensus       173 Ipyre~r~ltGTaRYASinAh~g~eqSRR-DDmeSvgYvLmYfnrG~LPWQglka~tk~-QKyEkI~EkK~s~~ie~LC~  250 (341)
T KOG1163|consen  173 IPYREDRNLTGTARYASINAHLGIEQSRR-DDMESVGYVLMYFNRGSLPWQGLKAATKK-QKYEKISEKKMSTPIEVLCK  250 (341)
T ss_pred             CccccCCccceeeeehhhhhhhhhhhhhh-hhhhhhcceeeeeecCCCcccccchhhHH-HHHHHHHHhhcCCCHHHHhC
Confidence              233455679999999887776665544 89999999999999999999986543222 22222322222222   345


Q ss_pred             CCCHhHHHHHHHhcccCCCCCCChH
Q 019195          221 HISQDCRNLLSRIFVANPSRRITIK  245 (344)
Q Consensus       221 ~~s~~~~~li~~~L~~dp~~R~s~~  245 (344)
                      +++.++.-.+.-|-..--.+-|...
T Consensus       251 G~P~EF~myl~Y~R~L~F~E~Pdy~  275 (341)
T KOG1163|consen  251 GFPAEFAMYLNYCRGLGFEEKPDYM  275 (341)
T ss_pred             CCcHHHHHHHHHHhhcCCCCCCcHH
Confidence            6788999999999888777777644

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=99.93  E-value=2.8e-25  Score=194.96  Aligned_cols=240  Identities=15%  Similarity=0.227  Sum_probs=182.0

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCC-----cEEEEEEeecCcc--ccHHHHHHHHHHhcCCCCCcceeeEEEEcC-CEE
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTK-----ELVAMKYIERGHK--IDANVAREIINHKQLRHPNIIRFKEVVLTP-THL   73 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~vaiK~~~~~~~--~~~~~~~ei~~l~~l~h~niv~~~~~~~~~-~~~   73 (344)
                      .|+++.-.+-+|.||.||.+.+.+..     +.|-+|.++....  ....++.|--.+..+.|||+..+.++...+ ...
T Consensus       284 ~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~~P  363 (563)
T KOG1024|consen  284 CRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYATP  363 (563)
T ss_pred             hheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccCcc
Confidence            35677788899999999999876433     2344555544322  224577787788888999999999987654 567


Q ss_pred             EEEEecCCCCChHHHHHhC--------CCCCHHHHHHHHHH-------HHHCCeeecCCCCCCeEecCCCCCCEEEeecC
Q 019195           74 AIVMEYAAGGELFERICNA--------GRFSEDEARYFFQQ-------LISGQICHRDLKLENTLLDGSPAPRLKICDFG  138 (344)
Q Consensus        74 ~lv~e~~~~g~L~~~i~~~--------~~~~~~~~~~~~~q-------l~~~~iiH~Dikp~NIl~~~~~~~~vkL~DFg  138 (344)
                      ++++.+..-|+|..++...        +.+...++..+..|       ||+.||||.||-..|++|++.-  ++||+|=.
T Consensus       364 ~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~L--qVkltDsa  441 (563)
T KOG1024|consen  364 FVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQL--QVKLTDSA  441 (563)
T ss_pred             eEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhhe--eEEeccch
Confidence            8899999999999998621        12444444444444       5555999999999999998775  49999999


Q ss_pred             CCcccCCCCC---CCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhhccc
Q 019195          139 YSKSSLLHSR---PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQY  214 (344)
Q Consensus       139 ~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~  214 (344)
                      +++...+...   .........|||||.+....|+.. +|+||||+++|||+| |+.|+...+..+..     ...+..+
T Consensus       442 LSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssa-sDvWsfGVllWELmtlg~~PyaeIDPfEm~-----~ylkdGy  515 (563)
T KOG1024|consen  442 LSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSA-SDVWSFGVLLWELMTLGKLPYAEIDPFEME-----HYLKDGY  515 (563)
T ss_pred             hccccCcccccccCCCCCCcccccCHHHHhhhhhcch-hhhHHHHHHHHHHHhcCCCCccccCHHHHH-----HHHhccc
Confidence            9986543322   233445678999999988887655 999999999999998 89999877654322     2344567


Q ss_pred             cCCCCCCCCHhHHHHHHHhcccCCCCCCChHHHhc
Q 019195          215 KIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKS  249 (344)
Q Consensus       215 ~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~ell~  249 (344)
                      ++..+.++++++..++..||...|++||+..|+..
T Consensus       516 RlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~  550 (563)
T KOG1024|consen  516 RLAQPFNCPDELFTVMACCWALLPEERPSFSQLVI  550 (563)
T ss_pred             eecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence            77777799999999999999999999999999754

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.92  E-value=4.8e-25  Score=214.25  Aligned_cols=223  Identities=31%  Similarity=0.480  Sum_probs=169.8

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEEecCC
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYAA   81 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~   81 (344)
                      .+|..++.|..|+||.||.++++.+.+.+|+| +++.....+.      ++.....|.+|                    
T Consensus        83 ~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~lilRn------ilt~a~npfvv--------------------  135 (1205)
T KOG0606|consen   83 SDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQNLILRN------ILTFAGNPFVV--------------------  135 (1205)
T ss_pred             cccceeEeeccCCCCceeeeeccccccchhhc-ccccchhhhc------cccccCCccee--------------------
Confidence            47899999999999999999999999999994 5544332211      22222344433                    


Q ss_pred             CCChHHHHHhCCCCCHHHHHHHHHHHHHCCeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCC---------------
Q 019195           82 GGELFERICNAGRFSEDEARYFFQQLISGQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH---------------  146 (344)
Q Consensus        82 ~g~L~~~i~~~~~~~~~~~~~~~~ql~~~~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~---------------  146 (344)
                       |+-...++.-+.++... ...+.++++-||+|||+||+|.+|..-+  ++|++|||+++.....               
T Consensus       136 -gDc~tllk~~g~lPvdm-vla~Eylh~ygivhrdlkpdnllIT~mG--hiKlTDfgLsk~GLms~atnl~eg~I~k~t~  211 (1205)
T KOG0606|consen  136 -GDCATLLKNIGPLPVDM-VLAVEYLHSYGIVHRDLKPDNLLITSMG--HIKLTDFGLSKKGLMSLATNLKEGHIEKDTH  211 (1205)
T ss_pred             -chhhhhcccCCCCcchh-hHHhHhhccCCeecCCCCCCcceeeecc--cccccchhhhhhhhhhccchhhhcchHHHHH
Confidence             56666676666666665 4456788888999999999999996554  5999999998642111               


Q ss_pred             -CCCCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCHh
Q 019195          147 -SRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQD  225 (344)
Q Consensus       147 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~  225 (344)
                       ...+..||||.|.|||++...+|. +.+|+|++|+|+|+.+.|..||.+...++.+...+.........   ...++++
T Consensus       212 Ef~dKqvcgTPeyiaPeVilrqgyg-kpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~wpE~---dea~p~E  287 (1205)
T KOG0606|consen  212 EFQDKQVCGTPEYIAPEVILRQGYG-KPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEE---DEALPPE  287 (1205)
T ss_pred             HhhhccccCCccccChhhhhhhccC-CCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhcccccc---CcCCCHH
Confidence             123556899999999999988875 55999999999999999999999988877776666543322222   2247899


Q ss_pred             HHHHHHHhcccCCCCCC---ChHHHhcCcccccCCCh
Q 019195          226 CRNLLSRIFVANPSRRI---TIKEIKSHPWFLKNLPR  259 (344)
Q Consensus       226 ~~~li~~~L~~dp~~R~---s~~ell~hp~~~~~~~~  259 (344)
                      ++++|.++|+.+|..|.   .+-++.+|+||+..-+.
T Consensus       288 a~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~LDw~  324 (1205)
T KOG0606|consen  288 AQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQLLDWK  324 (1205)
T ss_pred             HHHHHHHHHHhChHhhcccchhhhhhhccceeecccc
Confidence            99999999999999998   57789999999765444

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.92  E-value=7.6e-24  Score=182.54  Aligned_cols=237  Identities=22%  Similarity=0.257  Sum_probs=179.7

Q ss_pred             CceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcC-CCCCcceeeEEEEcCCEEEEEEecCC
Q 019195            3 KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQL-RHPNIIRFKEVVLTPTHLAIVMEYAA   81 (344)
Q Consensus         3 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~   81 (344)
                      .|++.++||.|+||+.+.+.+.-++++||||.-.. .....++..|.+..+.| ..++|.+.|-+...+.+-.||||++ 
T Consensus        29 hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPr-kS~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL-  106 (449)
T KOG1165|consen   29 HYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPR-KSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL-  106 (449)
T ss_pred             cceeccccccCcceeeecccccccCceEEEEeccc-cCCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh-
Confidence            58999999999999999999999999999996544 33346788899999998 5899999998888888889999999 


Q ss_pred             CCChHHHHHhC-CCCCHHHHHHHHHHHHH-------CCeeecCCCCCCeEecCCC---CCCEEEeecCCCcccCCC----
Q 019195           82 GGELFERICNA-GRFSEDEARYFFQQLIS-------GQICHRDLKLENTLLDGSP---APRLKICDFGYSKSSLLH----  146 (344)
Q Consensus        82 ~g~L~~~i~~~-~~~~~~~~~~~~~ql~~-------~~iiH~Dikp~NIl~~~~~---~~~vkL~DFg~a~~~~~~----  146 (344)
                      |.||.+++.=. .+|+...+..++.||+.       ..+|.|||||+|+||...+   ...|.|+|||+|+.....    
T Consensus       107 GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp~Tkq  186 (449)
T KOG1165|consen  107 GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDPKTKQ  186 (449)
T ss_pred             CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhhhcCccccc
Confidence            88999988654 56999988888877664       4999999999999996432   235899999999854322    


Q ss_pred             ----CCCCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCC---CC
Q 019195          147 ----SRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIP---DY  219 (344)
Q Consensus       147 ----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~---~~  219 (344)
                          ...++..||..||+--...+...+.+ -|+=|||-++++++-|..||.+..... .+....+|....-..|   -+
T Consensus       187 HIPYrE~KSLsGTARYMSINTHlGrEQSRR-DDLEaLGHvFmYFLRGsLPWQGLKA~t-nK~kYeKIGe~Kr~T~i~~Lc  264 (449)
T KOG1165|consen  187 HIPYREHKSLSGTARYMSINTHLGREQSRR-DDLEALGHVFMYFLRGSLPWQGLKADT-NKEKYEKIGETKRSTPIEVLC  264 (449)
T ss_pred             cCccccccccccceeeeEeeccccchhhhh-hhHHHhhhhhhhhccCCCccccccCcc-hHHHHHHhccccccCCHHHHH
Confidence                23456679999999998888887655 899999999999999999999875432 2333334433222222   12


Q ss_pred             CCCCHhHHHHHHHhcccCCCCCCC
Q 019195          220 VHISQDCRNLLSRIFVANPSRRIT  243 (344)
Q Consensus       220 ~~~s~~~~~li~~~L~~dp~~R~s  243 (344)
                      .+++.++..-+.-.-..+..+-|.
T Consensus       265 ~g~P~efa~Yl~yvR~L~F~E~PD  288 (449)
T KOG1165|consen  265 EGFPEEFATYLRYVRRLDFFETPD  288 (449)
T ss_pred             hcCHHHHHHHHHHHHhcCcccCCC
Confidence            234555555555554555555554

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.91  E-value=3.4e-24  Score=182.07  Aligned_cols=168  Identities=13%  Similarity=0.131  Sum_probs=125.9

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCccccHH----------HHHHHHHHhcCCCCCcceeeEEEEcC-
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDAN----------VAREIINHKQLRHPNIIRFKEVVLTP-   70 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~----------~~~ei~~l~~l~h~niv~~~~~~~~~-   70 (344)
                      ++|++++.||.|+||.||++..  ++..+|+|++.......+.          +.+|+..+.++.|++|..+..++... 
T Consensus        31 ~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~  108 (232)
T PRK10359         31 YNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAE  108 (232)
T ss_pred             CceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeecc
Confidence            5899999999999999999755  3667999999754332222          57899999999999999999887643 


Q ss_pred             -------CEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHCCeeecCCCCCCeEecCCCCCCEEEeecCCCccc
Q 019195           71 -------THLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGQICHRDLKLENTLLDGSPAPRLKICDFGYSKSS  143 (344)
Q Consensus        71 -------~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~ql~~~~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~  143 (344)
                             +..+++|||++|.+|.++..... -...++...+.++|..|++|||+||+||+++.++   ++|+|||.....
T Consensus       109 ~~~~~~~~~~~lvmEyi~G~tL~~~~~~~~-~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g---i~liDfg~~~~~  184 (232)
T PRK10359        109 RKTLRYAHTYIMLIEYIEGVELNDMPEISE-DVKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG---LRIIDLSGKRCT  184 (232)
T ss_pred             cccccccCCeEEEEEEECCccHHHhhhccH-HHHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC---EEEEECCCcccc
Confidence                   35799999999999977742111 1133677778999999999999999999997654   999999987643


Q ss_pred             CCCCCCCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHH
Q 019195          144 LLHSRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVML  187 (344)
Q Consensus       144 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~  187 (344)
                      .......           -++....+. .++|+||||+++..+.
T Consensus       185 ~e~~a~d-----------~~vler~y~-~~~di~~lg~~~~~~~  216 (232)
T PRK10359        185 AQRKAKD-----------RIDLERHYG-IKNEIKDLGYYLLIYK  216 (232)
T ss_pred             cchhhHH-----------HHHHHhHhc-ccccccceeEeehHHH
Confidence            2111110           133444555 4599999999987653

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.90  E-value=1.1e-24  Score=212.14  Aligned_cols=237  Identities=20%  Similarity=0.302  Sum_probs=169.2

Q ss_pred             CceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCc--cccHHHHHHHHH--HhcCCCCCcceeeEEEEcCCEEEEEEe
Q 019195            3 KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH--KIDANVAREIIN--HKQLRHPNIIRFKEVVLTPTHLAIVME   78 (344)
Q Consensus         3 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~ei~~--l~~l~h~niv~~~~~~~~~~~~~lv~e   78 (344)
                      +|...+.||++.|=+|.+|++.+.  .|++|++-+..  .....+.++++-  ...++|||++.+..+...+...|+|-+
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~eG--~vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRq  101 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDREG--LVVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQ  101 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCCc--eEEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHH
Confidence            578889999999999999998653  38999986643  222334433333  455689999999888777788899999


Q ss_pred             cCCCCChHHHHHhCCCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCCCCCC
Q 019195           79 YAAGGELFERICNAGRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKS  151 (344)
Q Consensus        79 ~~~~g~L~~~i~~~~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~~~~~  151 (344)
                      |. .-+|+++|..++-+..-+.+.++.||+.|       ||+|||||.+||||.+-+-  +.|+||..-+.......+..
T Consensus       102 yv-khnLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW--~~LtDFAsFKPtYLPeDNPa  178 (1431)
T KOG1240|consen  102 YV-KHNLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNW--LYLTDFASFKPTYLPEDNPA  178 (1431)
T ss_pred             HH-hhhhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeech--hhhhcccccCCccCCCCCcc
Confidence            99 56999999888777777777776666544       9999999999999987555  89999998776544433321


Q ss_pred             C--------ccCCcccCCccccCCC----------CCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHH-Hhh
Q 019195          152 T--------VGTPAYIAPEVLSRRE----------YDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISR-IMA  211 (344)
Q Consensus       152 ~--------~gt~~y~aPE~~~~~~----------~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~-~~~  211 (344)
                      .        ..-.+|.|||.+....          .-+++.||||+||+++||++ |++||.-.+    +...-.. -..
T Consensus       179 df~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQ----L~aYr~~~~~~  254 (1431)
T KOG1240|consen  179 DFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQ----LLAYRSGNADD  254 (1431)
T ss_pred             cceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHH----HHhHhccCccC
Confidence            1        2345799999875421          12467899999999999987 788885321    1110000 000


Q ss_pred             ccccCCCCCCCCHhHHHHHHHhcccCCCCCCChHHHhcC
Q 019195          212 VQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSH  250 (344)
Q Consensus       212 ~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~ell~h  250 (344)
                      ....+...  -+..+++||..|++.||.+|.+|++.|+.
T Consensus       255 ~e~~Le~I--ed~~~Rnlil~Mi~rdPs~RlSAedyL~~  291 (1431)
T KOG1240|consen  255 PEQLLEKI--EDVSLRNLILSMIQRDPSKRLSAEDYLQK  291 (1431)
T ss_pred             HHHHHHhC--cCccHHHHHHHHHccCchhccCHHHHHHh
Confidence            00000000  13478999999999999999999999875

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.88  E-value=2.5e-22  Score=167.22  Aligned_cols=185  Identities=18%  Similarity=0.156  Sum_probs=135.9

Q ss_pred             ceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCccccH-----HHHHHHHHHhcCC-CCCcceeeEEEEcCCEEEEEE
Q 019195            4 YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDA-----NVAREIINHKQLR-HPNIIRFKEVVLTPTHLAIVM   77 (344)
Q Consensus         4 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~-----~~~~ei~~l~~l~-h~niv~~~~~~~~~~~~~lv~   77 (344)
                      ..+...|++|+||+||.+..  .+..++.+.+........     .+.+|+++|++|. |++|++++++    +..+++|
T Consensus         4 ~~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvm   77 (218)
T PRK12274          4 PAVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDR   77 (218)
T ss_pred             cccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEE
Confidence            34678899999999997765  567788777766544333     5789999999995 5889999886    4469999


Q ss_pred             ecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHCCeeecCC-CCCCeEecCCCCCCEEEeecCCCcccCCCCCC-------
Q 019195           78 EYAAGGELFERICNAGRFSEDEARYFFQQLISGQICHRDL-KLENTLLDGSPAPRLKICDFGYSKSSLLHSRP-------  149 (344)
Q Consensus        78 e~~~~g~L~~~i~~~~~~~~~~~~~~~~ql~~~~iiH~Di-kp~NIl~~~~~~~~vkL~DFg~a~~~~~~~~~-------  149 (344)
                      +|+.|.+|...+.....-...++...+.++|..||+|||| ||+|||++.++  .++|+|||+|.........       
T Consensus        78 eyI~G~~L~~~~~~~~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g--~i~LIDFG~A~~~~~~~~~~r~L~~r  155 (218)
T PRK12274         78 SYLAGAAMYQRPPRGDLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDG--SPAVIDFQLAVRGNPRARWMRLLARE  155 (218)
T ss_pred             eeecCccHHhhhhhhhHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCC--CEEEEECCCceecCCcchHHHHHHHH
Confidence            9999999976553221112346677888999999999999 79999997654  4999999999754433210       


Q ss_pred             -------CCCccCCcccCCccccCCC-CCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 019195          150 -------KSTVGTPAYIAPEVLSRRE-YDGKLADVWSCGVTLYVMLVGAYPFEDQ  196 (344)
Q Consensus       150 -------~~~~gt~~y~aPE~~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~  196 (344)
                             .....++.|++|+.-.-.. .+-...++++.|+-+|.++|++.|+-+.
T Consensus       156 Dl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~  210 (218)
T PRK12274        156 DLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWED  210 (218)
T ss_pred             HHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcccc
Confidence                   0113688888887643221 1223368899999999999999887543

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.88  E-value=2.1e-22  Score=168.86  Aligned_cols=131  Identities=22%  Similarity=0.214  Sum_probs=98.5

Q ss_pred             eeeeeeecCceEEEEEEEcCCCcEEEEEEeecCccc----------cH-----------------HHHHHHHHHhcCCCC
Q 019195            6 LMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKI----------DA-----------------NVAREIINHKQLRHP   58 (344)
Q Consensus         6 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~----------~~-----------------~~~~ei~~l~~l~h~   58 (344)
                      +...||+|+||.||+|.+. +|+.||+|+++.....          ..                 ...+|+++++.+.++
T Consensus         1 ~~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~   79 (190)
T cd05147           1 INGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTA   79 (190)
T ss_pred             CCCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHC
Confidence            3578999999999999987 8999999999764211          01                 223499999999888


Q ss_pred             CcceeeEEEEcCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHH-------H-HHCCeeecCCCCCCeEecCCCCC
Q 019195           59 NIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQ-------L-ISGQICHRDLKLENTLLDGSPAP  130 (344)
Q Consensus        59 niv~~~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~q-------l-~~~~iiH~Dikp~NIl~~~~~~~  130 (344)
                      ++.........  ..++||||++|+++...+.+.+.++...++.++.|       + |+.||+||||||+|||++.   +
T Consensus        80 ~v~~p~~~~~~--~~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~~---~  154 (190)
T cd05147          80 GIPCPEPILLK--SHVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYHD---G  154 (190)
T ss_pred             CCCCCcEEEec--CCEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEEC---C
Confidence            77544333222  23899999998877665545567888777666554       5 4669999999999999973   3


Q ss_pred             CEEEeecCCCcc
Q 019195          131 RLKICDFGYSKS  142 (344)
Q Consensus       131 ~vkL~DFg~a~~  142 (344)
                      +++|+|||+|..
T Consensus       155 ~v~LiDFG~a~~  166 (190)
T cd05147         155 KLYIIDVSQSVE  166 (190)
T ss_pred             cEEEEEcccccc
Confidence            599999999864

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.87  E-value=3e-22  Score=176.58  Aligned_cols=184  Identities=27%  Similarity=0.401  Sum_probs=129.5

Q ss_pred             CCCCcceeeEEEEc---------------------------CCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHH
Q 019195           56 RHPNIIRFKEVVLT---------------------------PTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLI  108 (344)
Q Consensus        56 ~h~niv~~~~~~~~---------------------------~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~ql~  108 (344)
                      +|||||++..+|.+                           ...+|+||.-. ..+|..++..+ ..+....+.++.||+
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY-~~tLr~yl~~~-~~s~r~~~~~laQlL  351 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRY-RQTLREYLWTR-HRSYRTGRVILAQLL  351 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcc-hhhHHHHHhcC-CCchHHHHHHHHHHH
Confidence            69999999998864                           23589999988 46999998653 345555555555555


Q ss_pred             H-------CCeeecCCCCCCeEe--cCCCCCCEEEeecCCCcccCCC-------CCCCCCccCCcccCCccccCCC----
Q 019195          109 S-------GQICHRDLKLENTLL--DGSPAPRLKICDFGYSKSSLLH-------SRPKSTVGTPAYIAPEVLSRRE----  168 (344)
Q Consensus       109 ~-------~~iiH~Dikp~NIl~--~~~~~~~vkL~DFg~a~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~----  168 (344)
                      +       .||.|||+|.+|||+  +.+..+.+.|+|||++-.....       ...-...|...-||||+....+    
T Consensus       352 Eav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~a  431 (598)
T KOG4158|consen  352 EAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNA  431 (598)
T ss_pred             HHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCCCce
Confidence            4       499999999999998  4566667999999986432221       1112234888999999985432    


Q ss_pred             -CCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCHhHHHHHHHhcccCCCCCCChH
Q 019195          169 -YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIK  245 (344)
Q Consensus       169 -~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~  245 (344)
                       .+..++|.|+.|.+.||++....||........-...+++   .+ ..+....+++.+++|+..+|+.||++|+++.
T Consensus       432 vvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe---~q-LPalp~~vpp~~rqlV~~lL~r~pskRvsp~  505 (598)
T KOG4158|consen  432 VVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQE---SQ-LPALPSRVPPVARQLVFDLLKRDPSKRVSPN  505 (598)
T ss_pred             eeccchhhhhhhhhhHHHHhccCCcccccchheechhhhhh---hh-CCCCcccCChHHHHHHHHHhcCCccccCCcc
Confidence             2234589999999999999999999874321111111111   11 1123346889999999999999999999853

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.87  E-value=2e-21  Score=170.01  Aligned_cols=223  Identities=20%  Similarity=0.233  Sum_probs=137.0

Q ss_pred             ceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCccc----cHHHHHHHHHHhcCC----------CCCcceeeEEEEc
Q 019195            4 YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKI----DANVAREIINHKQLR----------HPNIIRFKEVVLT   69 (344)
Q Consensus         4 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~----~~~~~~ei~~l~~l~----------h~niv~~~~~~~~   69 (344)
                      +...+.||.|+++.||.+.+..|++.+|+|++......    .+++.+|......+.          |-.++-.++....
T Consensus        14 l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i   93 (288)
T PF14531_consen   14 LVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRI   93 (288)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEE
T ss_pred             EEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEE
Confidence            46778999999999999999999999999998654321    234555554444432          2233333333321


Q ss_pred             ------------CC-----EEEEEEecCCCCChHHHHH---hCCCCC--H---------HHHHHHHHHHHHCCeeecCCC
Q 019195           70 ------------PT-----HLAIVMEYAAGGELFERIC---NAGRFS--E---------DEARYFFQQLISGQICHRDLK  118 (344)
Q Consensus        70 ------------~~-----~~~lv~e~~~~g~L~~~i~---~~~~~~--~---------~~~~~~~~ql~~~~iiH~Dik  118 (344)
                                  ..     +.+++|.-+ .++|..++.   ......  .         .++..++..++..|++|+||+
T Consensus        94 ~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi~  172 (288)
T PF14531_consen   94 PGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDIK  172 (288)
T ss_dssp             TTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-S
T ss_pred             cCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEecccc
Confidence                        11     236788877 568877753   222221  1         122334455666799999999


Q ss_pred             CCCeEecCCCCCCEEEeecCCCcccCCCCCCCCCccCCcccCCccccCC-------CCCCcchhHHHHHHHHHHHHhCCC
Q 019195          119 LENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRR-------EYDGKLADVWSCGVTLYVMLVGAY  191 (344)
Q Consensus       119 p~NIl~~~~~~~~vkL~DFg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-------~~~~~~~DiwslG~il~el~~g~~  191 (344)
                      |+|++++.++.  ++|+||+...........  ...+..|.+||.....       ...+.+.|.|+||+++|.|+||+.
T Consensus       173 ~~nfll~~~G~--v~Lg~F~~~~r~g~~~~~--~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~l  248 (288)
T PF14531_consen  173 PENFLLDQDGG--VFLGDFSSLVRAGTRYRC--SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRL  248 (288)
T ss_dssp             GGGEEE-TTS---EEE--GGGEEETTEEEEG--GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-
T ss_pred             eeeEEEcCCCC--EEEcChHHHeecCceeec--cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccC
Confidence            99999987765  999999976543222111  3455779999986432       123556899999999999999999


Q ss_pred             CCCCCCChHHHHHHHHHHhhccccCCCCCCCCHhHHHHHHHhcccCCCCC
Q 019195          192 PFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRR  241 (344)
Q Consensus       192 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R  241 (344)
                      ||........          ....+..+.++++.++.||.+||+.||.+|
T Consensus       249 Pf~~~~~~~~----------~~~~f~~C~~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  249 PFGLSSPEAD----------PEWDFSRCRDMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             STCCCGGGST----------SGGGGTTSS---HHHHHHHHHHT-SSGGGS
T ss_pred             CCCCCCcccc----------ccccchhcCCcCHHHHHHHHHHccCCcccC
Confidence            9987543211          111344555788999999999999999988

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.87  E-value=2.5e-21  Score=162.77  Aligned_cols=132  Identities=20%  Similarity=0.176  Sum_probs=98.9

Q ss_pred             eeeeeeecCceEEEEEEEcCCCcEEEEEEeecCccc---------------------------cHHHHHHHHHHhcCCCC
Q 019195            6 LMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKI---------------------------DANVAREIINHKQLRHP   58 (344)
Q Consensus         6 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---------------------------~~~~~~ei~~l~~l~h~   58 (344)
                      +.+.||+|++|.||+|.+. +|+.||||++......                           .....+|...+.++.|+
T Consensus         1 ~~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~   79 (190)
T cd05145           1 INGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEA   79 (190)
T ss_pred             CCceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhC
Confidence            3578999999999999987 8999999998764211                           11235788999999999


Q ss_pred             CcceeeEEEEcCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHH-------HHH-CCeeecCCCCCCeEecCCCCC
Q 019195           59 NIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQ-------LIS-GQICHRDLKLENTLLDGSPAP  130 (344)
Q Consensus        59 niv~~~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~q-------l~~-~~iiH~Dikp~NIl~~~~~~~  130 (344)
                      ++.....+....  .|+||||++|+++.........++..+...++.|       +|+ .||+||||||+|||++ +  +
T Consensus        80 ~i~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~--~  154 (190)
T cd05145          80 GVPVPEPILLKK--NVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-D--G  154 (190)
T ss_pred             CCCCceEEEecC--CEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-C--C
Confidence            886554444332  4899999998866544334456776666665544       555 7999999999999997 3  4


Q ss_pred             CEEEeecCCCccc
Q 019195          131 RLKICDFGYSKSS  143 (344)
Q Consensus       131 ~vkL~DFg~a~~~  143 (344)
                      +++|+|||++...
T Consensus       155 ~~~liDFG~a~~~  167 (190)
T cd05145         155 KPYIIDVSQAVEL  167 (190)
T ss_pred             CEEEEEcccceec
Confidence            5999999998743

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.86  E-value=3.4e-22  Score=168.16  Aligned_cols=234  Identities=20%  Similarity=0.312  Sum_probs=177.2

Q ss_pred             CceeeeeeeecCceEEEEEEEcCCCcEEEEEEeec---CccccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEEec
Q 019195            3 KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIER---GHKIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEY   79 (344)
Q Consensus         3 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~---~~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~   79 (344)
                      ...++.+|.....|..|+++++.+.  ++.|++.-   .......|..|.-.|+.++||||+.+++.+....++.++..|
T Consensus       191 ~lnl~tkl~e~hsgelwrgrwqgnd--ivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~  268 (448)
T KOG0195|consen  191 SLNLITKLAESHSGELWRGRWQGND--IVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQY  268 (448)
T ss_pred             hhhhhhhhccCCCcccccccccCcc--hhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeee
Confidence            3456678889999999999997654  55565543   223345688899999999999999999999999999999999


Q ss_pred             CCCCChHHHHHhCCC--CCHHHHHHHHHHHHHC---------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCCC
Q 019195           80 AAGGELFERICNAGR--FSEDEARYFFQQLISG---------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR  148 (344)
Q Consensus        80 ~~~g~L~~~i~~~~~--~~~~~~~~~~~ql~~~---------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~~  148 (344)
                      |+.|+|+..++....  ....+...++..++.+         -|.---|....++||++-+.++-.+|--++.      +
T Consensus       269 mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfsf------q  342 (448)
T KOG0195|consen  269 MPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFSF------Q  342 (448)
T ss_pred             ccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceeee------e
Confidence            999999999986543  4455555555555544         3334468888999998887667677755543      2


Q ss_pred             CCCCccCCcccCCccccCCCCCC--cchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCHhH
Q 019195          149 PKSTVGTPAYIAPEVLSRREYDG--KLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDC  226 (344)
Q Consensus       149 ~~~~~gt~~y~aPE~~~~~~~~~--~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~  226 (344)
                      ......+|.|||||.++..+.+.  .++|+|||+++++||.|...||...+.-+.=.++    .-..++...+.++++.+
T Consensus       343 e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmki----aleglrv~ippgis~hm  418 (448)
T KOG0195|consen  343 EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKI----ALEGLRVHIPPGISRHM  418 (448)
T ss_pred             ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhh----hhccccccCCCCccHHH
Confidence            23345688999999998877653  5699999999999999999999987664433222    22223333445899999


Q ss_pred             HHHHHHhcccCCCCCCChHHHh
Q 019195          227 RNLLSRIFVANPSRRITIKEIK  248 (344)
Q Consensus       227 ~~li~~~L~~dp~~R~s~~ell  248 (344)
                      ..|+.-|++.||.+||.++.+.
T Consensus       419 ~klm~icmnedpgkrpkfdmiv  440 (448)
T KOG0195|consen  419 NKLMNICMNEDPGKRPKFDMIV  440 (448)
T ss_pred             HHHHHHHhcCCCCcCCCcceeh
Confidence            9999999999999999988764

>PRK10345 hypothetical protein; Provisional

Probab=99.84  E-value=6.6e-20  Score=155.23  Aligned_cols=132  Identities=18%  Similarity=0.200  Sum_probs=100.5

Q ss_pred             ceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCc-cccHHHHHHHHHHhcC-----CCCCcceeeEEEEcCC---E-E
Q 019195            4 YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH-KIDANVAREIINHKQL-----RHPNIIRFKEVVLTPT---H-L   73 (344)
Q Consensus         4 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~ei~~l~~l-----~h~niv~~~~~~~~~~---~-~   73 (344)
                      +.-.+.||+|+||.||.  +..++.. +||++.... .....+.+|+.+++.+     .||||+++++++.++.   . +
T Consensus         4 L~~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~   80 (210)
T PRK10345          4 LSEQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVY   80 (210)
T ss_pred             cCCcceecCCCceEEEE--CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEE
Confidence            34567899999999995  6666655 699887542 2346789999999999     5799999999998873   4 4


Q ss_pred             EEEEec--CCCCChHHHHHhCCCCCHH-----HHH-HHHHHHHHCCeeecCCCCCCeEecCC--CCCCEEEeecCC
Q 019195           74 AIVMEY--AAGGELFERICNAGRFSED-----EAR-YFFQQLISGQICHRDLKLENTLLDGS--PAPRLKICDFGY  139 (344)
Q Consensus        74 ~lv~e~--~~~g~L~~~i~~~~~~~~~-----~~~-~~~~ql~~~~iiH~Dikp~NIl~~~~--~~~~vkL~DFg~  139 (344)
                      .+||||  +.+++|.+++.+. .+++.     ++. .++..||+.+|+||||||+|||++..  +..+++|+||+-
T Consensus        81 ~~I~e~~G~~~~tL~~~l~~~-~~~e~~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G  155 (210)
T PRK10345         81 DVIADFDGKPSITLTEFAEQC-RYEEDVAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIG  155 (210)
T ss_pred             EEEecCCCCcchhHHHHHHcc-cccHhHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCC
Confidence            478999  5579999999663 45553     112 23367788899999999999999743  334699999553

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.83  E-value=1.9e-20  Score=185.33  Aligned_cols=186  Identities=26%  Similarity=0.343  Sum_probs=145.0

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcCC---CCCcceeeEEEEcCCEEEEEEe
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLR---HPNIIRFKEVVLTPTHLAIVME   78 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~l~~l~---h~niv~~~~~~~~~~~~~lv~e   78 (344)
                      +.|.|.+.||+|+||+||+|.... |+.||+|+-.....++  +.--.+++.+|+   -+-|+++..++...+.-++|++
T Consensus       698 ~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WE--fYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~lv~e  774 (974)
T KOG1166|consen  698 EKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWE--FYICLQVMERLKPQMLPSIMHISSAHVFQNASVLVSE  774 (974)
T ss_pred             eeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCcee--eeehHHHHHhhchhhhcchHHHHHHHccCCcceeeee
Confidence            468999999999999999999987 9999999877655443  222223333443   3566777777777788899999


Q ss_pred             cCCCCChHHHHHhCCCCCHH-------HHHHHHHHHHHCCeeecCCCCCCeEec-----CCCCCCEEEeecCCCcccCCC
Q 019195           79 YAAGGELFERICNAGRFSED-------EARYFFQQLISGQICHRDLKLENTLLD-----GSPAPRLKICDFGYSKSSLLH  146 (344)
Q Consensus        79 ~~~~g~L~~~i~~~~~~~~~-------~~~~~~~ql~~~~iiH~Dikp~NIl~~-----~~~~~~vkL~DFg~a~~~~~~  146 (344)
                      |.+.|+|.+++...+.+++.       +++.++.+||..+|||+||||+|+||.     .....-++|+|||.+......
T Consensus       775 y~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~siDm~lf  854 (974)
T KOG1166|consen  775 YSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSIDMKLF  854 (974)
T ss_pred             ccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEecccceeeeEc
Confidence            99999999999866655544       566677778888999999999999993     122234999999988654444


Q ss_pred             CCC---CCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCC
Q 019195          147 SRP---KSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAY  191 (344)
Q Consensus       147 ~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~  191 (344)
                      ...   +..++|-.+-.+|+..+.+++.. +|.|.|+.+++.|+.|+.
T Consensus       855 p~~~~F~~~~~td~f~C~EM~~grpWtYq-~DyfGlAa~~h~mLFG~y  901 (974)
T KOG1166|consen  855 PDGTKFKAVWHTDLFDCIEMREGRPWTYQ-IDYFGLAATVHVMLFGKY  901 (974)
T ss_pred             CCCcEEeeeeccccchhHHHhcCCCCchh-hhhHHHHHHHHHHHHHHH
Confidence            333   44578999999999999998666 999999999999999853

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.82  E-value=1.2e-21  Score=189.57  Aligned_cols=252  Identities=31%  Similarity=0.509  Sum_probs=199.0

Q ss_pred             CCceeeeeeeecCceEEEEEEEc-CCCcEEEEEEeecCc---cccHHHHHHHHHHhcCC-CCCcceeeEEEEcCCEEEEE
Q 019195            2 EKYELMKDIGSGNFGVARLMRNK-NTKELVAMKYIERGH---KIDANVAREIINHKQLR-HPNIIRFKEVVLTPTHLAIV   76 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~---~~~~~~~~ei~~l~~l~-h~niv~~~~~~~~~~~~~lv   76 (344)
                      ..|.+.+.||+|+|+.|-.+.+. .+...+|.|.+....   ....++..|..+.+.++ |+|++++++........++.
T Consensus        20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~   99 (601)
T KOG0590|consen   20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLS   99 (601)
T ss_pred             ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccc
Confidence            46899999999999999888774 445567777776543   23345566888888887 99999999999999999999


Q ss_pred             EecCCCCChHHHH-HhCC-CCCHHHHHHHHHHHHHC--------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCC-
Q 019195           77 MEYAAGGELFERI-CNAG-RFSEDEARYFFQQLISG--------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLL-  145 (344)
Q Consensus        77 ~e~~~~g~L~~~i-~~~~-~~~~~~~~~~~~ql~~~--------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~-  145 (344)
                      ++|..|++++..+ .... ..+......++.|+.++        ++.||||||+|.+++.++. .+++.|||+|..... 
T Consensus       100 ~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~-~l~~~df~~At~~~~~  178 (601)
T KOG0590|consen  100 LSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGS-ALKIADFGLATAYRNK  178 (601)
T ss_pred             cCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCC-cccCCCchhhcccccc
Confidence            9999999999988 5444 56777777888887765        7999999999999987773 499999999986544 


Q ss_pred             CC---CCCCCcc-CCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCCCCCC
Q 019195          146 HS---RPKSTVG-TPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVH  221 (344)
Q Consensus       146 ~~---~~~~~~g-t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  221 (344)
                      ..   .....+| ++.|+|||...+..+..+..|+||.|+++..+++|..|+............+... ........+..
T Consensus       179 ~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~  257 (601)
T KOG0590|consen  179 NGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSN-KGRFTQLPWNS  257 (601)
T ss_pred             CCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeeccc-ccccccCcccc
Confidence            22   2234578 9999999999987777788999999999999999999997765433211111110 01222445567


Q ss_pred             CCHhHHHHHHHhcccCCCCCCChHHHhcCccccc
Q 019195          222 ISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLK  255 (344)
Q Consensus       222 ~s~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~  255 (344)
                      ++....+++.++|..+|..|.+.+++..+||+..
T Consensus       258 ~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~  291 (601)
T KOG0590|consen  258 ISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS  291 (601)
T ss_pred             CChhhhhcccccccCCchhccccccccccccccc
Confidence            8899999999999999999999999999999976

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.82  E-value=3.3e-21  Score=176.08  Aligned_cols=171  Identities=25%  Similarity=0.367  Sum_probs=128.3

Q ss_pred             EEEEEEecCCCCChHHHHHhCC---CCCHHHHHHHHHHHHH----CCeeecCCCCCCeEecCCCCCCEEEeecCCCcccC
Q 019195           72 HLAIVMEYAAGGELFERICNAG---RFSEDEARYFFQQLIS----GQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSL  144 (344)
Q Consensus        72 ~~~lv~e~~~~g~L~~~i~~~~---~~~~~~~~~~~~ql~~----~~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~  144 (344)
                      .+|+.|++|...+|.+||..+.   ..+...++.++.|+..    .+.+|||+||.||+...+..  +||+|||+.....
T Consensus       330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~yk~~ihrdlkp~nif~~~d~q--~kIgDFgl~ts~~  407 (516)
T KOG1033|consen  330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEYKGLIHRDLKPSNIFFSDDDQ--LKIGDFGLVTSQD  407 (516)
T ss_pred             chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhhccchhhhccccccccccchh--hhhhhhhheeecc
Confidence            5899999999999999997543   3566778889999997    49999999999999976654  9999999987654


Q ss_pred             CCC-------CCCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhhccccC
Q 019195          145 LHS-------RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKI  216 (344)
Q Consensus       145 ~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~  216 (344)
                      ...       ..+...||.+||+||.+.+..|..+ +||||||+|++||+. =..+|..       ...+..+....+. 
T Consensus       408 ~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~k-vdIyaLGlil~EL~~~f~T~~er-------~~t~~d~r~g~ip-  478 (516)
T KOG1033|consen  408 KDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEK-VDIYALGLILAELLIQFSTQFER-------IATLTDIRDGIIP-  478 (516)
T ss_pred             cCCcccchhhhhhhcccccccCCHHHHhhhhhhhh-cchhhHHHHHHHHHHHhccHHHH-------HHhhhhhhcCCCC-
Confidence            444       4456679999999999999988655 999999999999986 2222211       1222222222222 


Q ss_pred             CCCCCCCHhHHHHHHHhcccCCCCCCChHHHhcCccc
Q 019195          217 PDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF  253 (344)
Q Consensus       217 ~~~~~~s~~~~~li~~~L~~dp~~R~s~~ell~hp~~  253 (344)
                      |.+..-.++-..|+.+||...|.+||++.+.--|+|.
T Consensus       479 ~~~~~d~p~e~~ll~~lls~~p~~RP~~~~~~~~~~~  515 (516)
T KOG1033|consen  479 PEFLQDYPEEYTLLQQLLSPSPEERPSAIEVALHEFL  515 (516)
T ss_pred             hHHhhcCcHHHHHHHHhcCCCcccCchHHHHhhhhhc
Confidence            1222224566799999999999999988777666664

>smart00090 RIO RIO-like kinase

Probab=99.80  E-value=3.3e-19  Score=154.52  Aligned_cols=131  Identities=18%  Similarity=0.132  Sum_probs=97.1

Q ss_pred             ceeeeeeeecCceEEEEEE-EcCCCcEEEEEEeecCccc-------------------------cHHHHHHHHHHhcCCC
Q 019195            4 YELMKDIGSGNFGVARLMR-NKNTKELVAMKYIERGHKI-------------------------DANVAREIINHKQLRH   57 (344)
Q Consensus         4 y~~~~~lg~G~~g~V~~~~-~~~~~~~vaiK~~~~~~~~-------------------------~~~~~~ei~~l~~l~h   57 (344)
                      |++.+.||+|+||.||+|. +..+|+.||+|++......                         ...+.+|+.+++++.+
T Consensus        30 ~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~~  109 (237)
T smart00090       30 SAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLYE  109 (237)
T ss_pred             HHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHHh
Confidence            7889999999999999998 6778999999998753210                         0235689999999975


Q ss_pred             C--CcceeeEEEEcCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHH-------HHHHHHCC-eeecCCCCCCeEecCC
Q 019195           58 P--NIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYF-------FQQLISGQ-ICHRDLKLENTLLDGS  127 (344)
Q Consensus        58 ~--niv~~~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~-------~~ql~~~~-iiH~Dikp~NIl~~~~  127 (344)
                      .  .+.++++.    ...++||||++|.+|.........+...++..+       +.++|..| |+||||||+||+++ +
T Consensus       110 ~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli~-~  184 (237)
T smart00090      110 AGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILVH-D  184 (237)
T ss_pred             cCCCCCeeeEe----cCceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEEE-C
Confidence            3  34444432    235899999999888766544444554444444       44555668 99999999999998 3


Q ss_pred             CCCCEEEeecCCCc
Q 019195          128 PAPRLKICDFGYSK  141 (344)
Q Consensus       128 ~~~~vkL~DFg~a~  141 (344)
                        ++++|+|||++.
T Consensus       185 --~~i~LiDFg~a~  196 (237)
T smart00090      185 --GKVVIIDVSQSV  196 (237)
T ss_pred             --CCEEEEEChhhh
Confidence              359999999876

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.78  E-value=8.1e-19  Score=163.08  Aligned_cols=196  Identities=23%  Similarity=0.331  Sum_probs=143.9

Q ss_pred             HhcCCCCCcceeeEEEEcCCEEEEEEecCCCCChHHHHHhC-CCCCHHHHHHHHHHHHHC-------Ce-eecCCCCCCe
Q 019195           52 HKQLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNA-GRFSEDEARYFFQQLISG-------QI-CHRDLKLENT  122 (344)
Q Consensus        52 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~i~~~-~~~~~~~~~~~~~ql~~~-------~i-iH~Dikp~NI  122 (344)
                      |+.+.|.|+.++++.+.++..+++|.+||..|+|.+.+... ..++..-...+++.++.+       .| .|+.+++.|+
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nC   80 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNC   80 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccc
Confidence            46789999999999999999999999999999999999773 345544444444444433       33 9999999999


Q ss_pred             EecCCCCCCEEEeecCCCcccCCC---CCCCCCccCCcccCCccccCCCC------CCcchhHHHHHHHHHHHHhCCCCC
Q 019195          123 LLDGSPAPRLKICDFGYSKSSLLH---SRPKSTVGTPAYIAPEVLSRREY------DGKLADVWSCGVTLYVMLVGAYPF  193 (344)
Q Consensus       123 l~~~~~~~~vkL~DFg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~------~~~~~DiwslG~il~el~~g~~pf  193 (344)
                      +++....  +||+|||+.......   .......-...|.|||++.....      -+.+.||||+|++++|+++...||
T Consensus        81 lvd~~w~--lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~  158 (484)
T KOG1023|consen   81 LVDSRWV--LKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPF  158 (484)
T ss_pred             eeeeeEE--EEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCcc
Confidence            9998887  999999987654321   11122235567999999976421      245589999999999999999999


Q ss_pred             CCCCChHHHHHHHHHHhh-cc-ccCCC---CCCCCHhHHHHHHHhcccCCCCCCChHHHhc
Q 019195          194 EDQEDPKNFRKTISRIMA-VQ-YKIPD---YVHISQDCRNLLSRIFVANPSRRITIKEIKS  249 (344)
Q Consensus       194 ~~~~~~~~~~~~~~~~~~-~~-~~~~~---~~~~s~~~~~li~~~L~~dp~~R~s~~ell~  249 (344)
                      ..........+++.++.. .. .-.|.   .....+++..++..||..+|..||+++++-.
T Consensus       159 ~~~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~  219 (484)
T KOG1023|consen  159 DLRNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRS  219 (484)
T ss_pred             ccccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHh
Confidence            875544433445544443 11 11121   1145667999999999999999999988744

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.76  E-value=7.8e-18  Score=143.91  Aligned_cols=131  Identities=24%  Similarity=0.224  Sum_probs=102.6

Q ss_pred             eeeeeecCceEEEEEEEcCCCcEEEEEEeecCccc---------cHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEE
Q 019195            7 MKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKI---------DANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVM   77 (344)
Q Consensus         7 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---------~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~   77 (344)
                      ++.||+|++|.||++..  .+..+++|+.......         ...+.+|+.++..+.|++|+....++......+++|
T Consensus         1 ~~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~   78 (211)
T PRK14879          1 MKLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVM   78 (211)
T ss_pred             CcccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEE
Confidence            36799999999999987  5677999976532211         135778999999999999988887777788889999


Q ss_pred             ecCCCCChHHHHHhCCC---CCHHHHHHHHHHHHHCCeeecCCCCCCeEecCCCCCCEEEeecCCCcc
Q 019195           78 EYAAGGELFERICNAGR---FSEDEARYFFQQLISGQICHRDLKLENTLLDGSPAPRLKICDFGYSKS  142 (344)
Q Consensus        78 e~~~~g~L~~~i~~~~~---~~~~~~~~~~~ql~~~~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~  142 (344)
                      ||++|++|.+.+.....   --..++...+.++|+.|++|||++|.|||++ +  +.++|+|||++..
T Consensus        79 e~~~G~~L~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~--~~~~liDf~~a~~  143 (211)
T PRK14879         79 EYIEGEPLKDLINSNGMEELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-G--GKIYLIDFGLAEF  143 (211)
T ss_pred             EEeCCcCHHHHHHhccHHHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-C--CCEEEEECCcccC
Confidence            99999999998865432   1112344556778888999999999999998 3  3499999998763

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.75  E-value=5.1e-18  Score=143.63  Aligned_cols=132  Identities=24%  Similarity=0.211  Sum_probs=95.8

Q ss_pred             ceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCcc-----------------------ccHHHHHHHHHHhcCCCC--
Q 019195            4 YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK-----------------------IDANVAREIINHKQLRHP--   58 (344)
Q Consensus         4 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-----------------------~~~~~~~ei~~l~~l~h~--   58 (344)
                      |.+.++||+|+||.||++... +|+.||+|++.....                       ......+|+.++..+.|+  
T Consensus        17 ~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   95 (198)
T cd05144          17 ESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF   95 (198)
T ss_pred             hhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence            778899999999999999875 799999998765321                       012356788888888777  


Q ss_pred             CcceeeEEEEcCCEEEEEEecCCCCChHHHHHhCC-CCCHHHHHHHHHHHHHCCeeecCCCCCCeEecCCCCCCEEEeec
Q 019195           59 NIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAG-RFSEDEARYFFQQLISGQICHRDLKLENTLLDGSPAPRLKICDF  137 (344)
Q Consensus        59 niv~~~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~-~~~~~~~~~~~~ql~~~~iiH~Dikp~NIl~~~~~~~~vkL~DF  137 (344)
                      .++..++    ....+++|||++|++|........ .....++...+.+++..||+||||||+||+++.++  +++|+||
T Consensus        96 ~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~--~~~liDf  169 (198)
T cd05144          96 PVPKPID----WNRHAVVMEYIDGVELYRVRVLEDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDE--KIYIIDW  169 (198)
T ss_pred             CCCceee----cCCceEEEEEeCCcchhhccccccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCC--cEEEEEC
Confidence            4444443    244589999999999876643110 01112334445566677999999999999998655  4999999


Q ss_pred             CCCcc
Q 019195          138 GYSKS  142 (344)
Q Consensus       138 g~a~~  142 (344)
                      |++..
T Consensus       170 g~~~~  174 (198)
T cd05144         170 PQMVS  174 (198)
T ss_pred             Ccccc
Confidence            98853

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.74  E-value=1.8e-17  Score=140.33  Aligned_cols=129  Identities=21%  Similarity=0.175  Sum_probs=99.9

Q ss_pred             eeeecCceEEEEEEEcCCCcEEEEEEeecCc-cc--------cHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEEec
Q 019195            9 DIGSGNFGVARLMRNKNTKELVAMKYIERGH-KI--------DANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEY   79 (344)
Q Consensus         9 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~--------~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~   79 (344)
                      .||+|+||.||++..  ++..+++|+..... ..        ..++.+|+++++.+.|+++....-++......+++|||
T Consensus         1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~   78 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEY   78 (199)
T ss_pred             CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEE
Confidence            489999999999984  56789999864321 11        14567899999999988766665556667778999999


Q ss_pred             CCCCChHHHHHhCCCCCHHHHHHHHHHHHHCCeeecCCCCCCeEecCCCCCCEEEeecCCCcc
Q 019195           80 AAGGELFERICNAGRFSEDEARYFFQQLISGQICHRDLKLENTLLDGSPAPRLKICDFGYSKS  142 (344)
Q Consensus        80 ~~~g~L~~~i~~~~~~~~~~~~~~~~ql~~~~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~  142 (344)
                      ++|++|.+.+.....--..++...+..+|+.|++|||++|.||+++ +  ++++++|||++..
T Consensus        79 ~~g~~l~~~~~~~~~~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~--~~~~liDfg~a~~  138 (199)
T TIGR03724        79 IEGKPLKDVIEEGNDELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-D--DKLYLIDFGLGKY  138 (199)
T ss_pred             ECCccHHHHHhhcHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEE-C--CcEEEEECCCCcC
Confidence            9999999887653321234556667888899999999999999998 3  3599999998764

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.71  E-value=6e-17  Score=157.14  Aligned_cols=133  Identities=20%  Similarity=0.180  Sum_probs=101.8

Q ss_pred             ceeeeeeeecCceEEEEEEEcCCCcEEEEEEe-ecCcc--------ccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEE
Q 019195            4 YELMKDIGSGNFGVARLMRNKNTKELVAMKYI-ERGHK--------IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLA   74 (344)
Q Consensus         4 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~-~~~~~--------~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~   74 (344)
                      |...+.||+|+||+||++......  +++|+. .+...        ...++.+|+++++.++|++++....++......+
T Consensus       335 ~~~~~~iG~G~~g~Vy~~~~~~~~--~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~  412 (535)
T PRK09605        335 KIPDHLIGKGAEADIKKGEYLGRD--AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKT  412 (535)
T ss_pred             cCccceeccCCcEEEEEEeecCcc--ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCE
Confidence            456789999999999999875443  333332 21111        1245789999999999999998887777777889


Q ss_pred             EEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHCCeeecCCCCCCeEecCCCCCCEEEeecCCCcc
Q 019195           75 IVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGQICHRDLKLENTLLDGSPAPRLKICDFGYSKS  142 (344)
Q Consensus        75 lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~ql~~~~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~  142 (344)
                      +||||++|++|.+++.... .-..++...+.++|+.|++||||||+|||++ ++  +++|+|||+++.
T Consensus       413 lv~E~~~g~~L~~~l~~~~-~~~~~i~~~L~~lH~~giiHrDlkp~NILl~-~~--~~~liDFGla~~  476 (535)
T PRK09605        413 IVMEYIGGKDLKDVLEGNP-ELVRKVGEIVAKLHKAGIVHGDLTTSNFIVR-DD--RLYLIDFGLGKY  476 (535)
T ss_pred             EEEEecCCCcHHHHHHHHH-HHHHHHHHHHHHHHhCCCccCCCChHHEEEE-CC--cEEEEeCccccc
Confidence            9999999999998875221 1234566677888999999999999999994 33  499999999864

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.66  E-value=1.4e-15  Score=132.12  Aligned_cols=129  Identities=18%  Similarity=0.235  Sum_probs=97.7

Q ss_pred             eeee-ecCceEEEEEEEcCCCcEEEEEEeecCc--------------cccHHHHHHHHHHhcCCCCCc--ceeeEEEEcC
Q 019195            8 KDIG-SGNFGVARLMRNKNTKELVAMKYIERGH--------------KIDANVAREIINHKQLRHPNI--IRFKEVVLTP   70 (344)
Q Consensus         8 ~~lg-~G~~g~V~~~~~~~~~~~vaiK~~~~~~--------------~~~~~~~~ei~~l~~l~h~ni--v~~~~~~~~~   70 (344)
                      ..|| .|+.|+||.+...  +..+++|.+....              ....++.+|+.++..|.|++|  ++.+++....
T Consensus        37 ~~lg~~~g~gtv~~v~~~--~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~  114 (239)
T PRK01723         37 RVVGSAKGRGTTWFVQTP--GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR  114 (239)
T ss_pred             ceeecCCCCccEEEEEeC--CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence            4677 8999999999764  6779999875421              122567889999999998775  6677664432


Q ss_pred             C----EEEEEEecCCC-CChHHHHHhCCCCCHH---HHHHHHHHHHHCCeeecCCCCCCeEecCCCCCCEEEeecCCCc
Q 019195           71 T----HLAIVMEYAAG-GELFERICNAGRFSED---EARYFFQQLISGQICHRDLKLENTLLDGSPAPRLKICDFGYSK  141 (344)
Q Consensus        71 ~----~~~lv~e~~~~-g~L~~~i~~~~~~~~~---~~~~~~~ql~~~~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~  141 (344)
                      .    ..++|||+++| .+|.+++.. ..+++.   ++...+.++|.+||+||||||.|||++.++  .++|+|||.+.
T Consensus       115 ~~~~~~~~lV~e~l~G~~~L~~~l~~-~~l~~~~~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~--~v~LIDfg~~~  190 (239)
T PRK01723        115 HGLFYRADILIERIEGARDLVALLQE-APLSEEQWQAIGQLIARFHDAGVYHADLNAHNILLDPDG--KFWLIDFDRGE  190 (239)
T ss_pred             cCcceeeeEEEEecCCCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHCCCCCCCCCchhEEEcCCC--CEEEEECCCcc
Confidence            2    23599999997 688888754 345554   455667889999999999999999997655  49999999876

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.66  E-value=7.7e-17  Score=153.49  Aligned_cols=141  Identities=23%  Similarity=0.363  Sum_probs=102.2

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCcc-----------------------------------ccH---
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK-----------------------------------IDA---   43 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-----------------------------------~~~---   43 (344)
                      ..|+. ++||+|++|+||+|+...+|+.||||+++..-.                                   ...   
T Consensus       120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~  198 (537)
T PRK04750        120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH  198 (537)
T ss_pred             HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence            35666 799999999999999988899999999864310                                   001   


Q ss_pred             ---HHHHHHHHHhcC----CCCCcceeeEEEEc-CCEEEEEEecCCCCChHHH--HHhCC----CCCHHHHHHHHHHHHH
Q 019195           44 ---NVAREIINHKQL----RHPNIIRFKEVVLT-PTHLAIVMEYAAGGELFER--ICNAG----RFSEDEARYFFQQLIS  109 (344)
Q Consensus        44 ---~~~~ei~~l~~l----~h~niv~~~~~~~~-~~~~~lv~e~~~~g~L~~~--i~~~~----~~~~~~~~~~~~ql~~  109 (344)
                         .+.+|...+.++    .+.+.+.+-.++.+ .+..++||||+.|+.+.+.  +...+    .+.+..+..++.|++.
T Consensus       199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif~  278 (537)
T PRK04750        199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVFR  278 (537)
T ss_pred             HhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHHh
Confidence               233444444444    24444444444433 3456799999999999764  33433    4677778889999999


Q ss_pred             CCeeecCCCCCCeEecCCC--CCCEEEeecCCCccc
Q 019195          110 GQICHRDLKLENTLLDGSP--APRLKICDFGYSKSS  143 (344)
Q Consensus       110 ~~iiH~Dikp~NIl~~~~~--~~~vkL~DFg~a~~~  143 (344)
                      .|++|+|+||.||+++.++  .++++++|||++...
T Consensus       279 ~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l  314 (537)
T PRK04750        279 DGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSL  314 (537)
T ss_pred             CCeeeCCCChHHeEEecCCCCCCeEEEEecceEEEC
Confidence            9999999999999997654  236999999987644

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.65  E-value=3.1e-16  Score=131.41  Aligned_cols=129  Identities=21%  Similarity=0.217  Sum_probs=84.8

Q ss_pred             eeeeeeecCceEEEEEEEcCCCcEEEEEEeecCccccH---H----------------------HHHHHHHHhcCCCC--
Q 019195            6 LMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDA---N----------------------VAREIINHKQLRHP--   58 (344)
Q Consensus         6 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~---~----------------------~~~ei~~l~~l~h~--   58 (344)
                      +.+.||+|+||+||+|.+. +++.||||++........   .                      ...|...+..+.+.  
T Consensus         1 ~~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~   79 (187)
T cd05119           1 VGGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGV   79 (187)
T ss_pred             CCcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCC
Confidence            3578999999999999986 789999999875322111   1                      12455555555433  


Q ss_pred             CcceeeEEEEcCCEEEEEEecCCCCCh-----HHHHHh-CCCCCHHHHHHHHHHHHH-CCeeecCCCCCCeEecCCCCCC
Q 019195           59 NIIRFKEVVLTPTHLAIVMEYAAGGEL-----FERICN-AGRFSEDEARYFFQQLIS-GQICHRDLKLENTLLDGSPAPR  131 (344)
Q Consensus        59 niv~~~~~~~~~~~~~lv~e~~~~g~L-----~~~i~~-~~~~~~~~~~~~~~ql~~-~~iiH~Dikp~NIl~~~~~~~~  131 (344)
                      .+.+.+.+    ...+++|||++++.+     ...... ....-..++...+.+++. .||+||||||+||+++ +  +.
T Consensus        80 ~~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~~~~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~--~~  152 (187)
T cd05119          80 PVPKPIDL----NRHVLVMEFIGGDGIPAPRLKDVRLLEDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-D--GK  152 (187)
T ss_pred             CCCceEec----CCCEEEEEEeCCCCccChhhhhhhhcccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-C--Cc
Confidence            34444443    245899999998543     222211 000112234444566667 7999999999999998 3  35


Q ss_pred             EEEeecCCCcc
Q 019195          132 LKICDFGYSKS  142 (344)
Q Consensus       132 vkL~DFg~a~~  142 (344)
                      ++|+|||++..
T Consensus       153 ~~liDfg~a~~  163 (187)
T cd05119         153 VYIIDVPQAVE  163 (187)
T ss_pred             EEEEECccccc
Confidence            99999999864

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.62  E-value=3.2e-15  Score=120.10  Aligned_cols=131  Identities=21%  Similarity=0.214  Sum_probs=100.6

Q ss_pred             eeeeeeecCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcCCC--CCcceeeEEEEcCCEEEEEEecCCCC
Q 019195            6 LMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRH--PNIIRFKEVVLTPTHLAIVMEYAAGG   83 (344)
Q Consensus         6 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~l~~l~h--~niv~~~~~~~~~~~~~lv~e~~~~g   83 (344)
                      +++.||.|+++.||++....  ..+++|....... ...+.+|+.+++.++|  .++++++.++...+..+++|||++++
T Consensus         2 ~~~~i~~g~~~~v~~~~~~~--~~~~iK~~~~~~~-~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~   78 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTKD--EDYVLKINPSREK-GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE   78 (155)
T ss_pred             cceecccccccceEEEEecC--CeEEEEecCCCCc-hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence            56889999999999999854  6799998866543 4578899999999976  59999999888888899999999988


Q ss_pred             ChHHHHHhCCCCCHHHHHHHHHHHHHC---CeeecCCCCCCeEecCCCCCCEEEeecCCCc
Q 019195           84 ELFERICNAGRFSEDEARYFFQQLISG---QICHRDLKLENTLLDGSPAPRLKICDFGYSK  141 (344)
Q Consensus        84 ~L~~~i~~~~~~~~~~~~~~~~ql~~~---~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~  141 (344)
                      ++...-..........+...+..++..   +++|+|++|.||+++..+  .++++|||.+.
T Consensus        79 ~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~--~~~l~Df~~~~  137 (155)
T cd05120          79 TLDEVSEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGK--ILGIIDWEYAG  137 (155)
T ss_pred             ecccCCHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCc--EEEEEeccccc
Confidence            775430000001123344556666664   799999999999998643  59999999875

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.62  E-value=9e-16  Score=143.06  Aligned_cols=243  Identities=19%  Similarity=0.184  Sum_probs=185.4

Q ss_pred             Cceeeeeeee--cCceEEEEEEE--cCCCcEEEEEEeecCc---cccHHHHHHHHHHhcC-CCCCcceeeEEEEcCCEEE
Q 019195            3 KYELMKDIGS--GNFGVARLMRN--KNTKELVAMKYIERGH---KIDANVAREIINHKQL-RHPNIIRFKEVVLTPTHLA   74 (344)
Q Consensus         3 ~y~~~~~lg~--G~~g~V~~~~~--~~~~~~vaiK~~~~~~---~~~~~~~~ei~~l~~l-~h~niv~~~~~~~~~~~~~   74 (344)
                      .+.+.+.+|.  |.+|.||.+..  ..++..+|+|.-+...   ....+-.+++...+.+ .|+|.++.+..+...+..|
T Consensus       115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lf  194 (524)
T KOG0601|consen  115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILF  194 (524)
T ss_pred             hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcce
Confidence            4567788999  99999999998  8899999999854432   2233445677777777 5999999999999999999


Q ss_pred             EEEecCCCCChHHHHHhCCC-CCHHHHHHHHHHHHH----C-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcc
Q 019195           75 IVMEYAAGGELFERICNAGR-FSEDEARYFFQQLIS----G-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKS  142 (344)
Q Consensus        75 lv~e~~~~g~L~~~i~~~~~-~~~~~~~~~~~ql~~----~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~  142 (344)
                      +-+|+| +.+|..+...... ++...++..+.+..+    |       +++|-|+||.||++..+. ...+++|||+...
T Consensus       195 iqtE~~-~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~-~s~~~~df~~v~~  272 (524)
T KOG0601|consen  195 IQTELC-GESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDW-TSCKLTDFGLVSK  272 (524)
T ss_pred             eeeccc-cchhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheeccccc-ceeecCCcceeEE
Confidence            999999 5788888766544 788888888777766    4       999999999999998773 2489999999876


Q ss_pred             cCCCCCCCC------CccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCC--CChHHHHHHHHHHhhccc
Q 019195          143 SLLHSRPKS------TVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQ--EDPKNFRKTISRIMAVQY  214 (344)
Q Consensus       143 ~~~~~~~~~------~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~--~~~~~~~~~~~~~~~~~~  214 (344)
                      .........      .-|...|++||...+..  +.+.||+|+|.++.+..++..++...  ..+..+....       .
T Consensus       273 i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~--~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~-------i  343 (524)
T KOG0601|consen  273 ISDGNFSSVFKVSKRPEGDCIYAAKELLNGLA--TFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGY-------I  343 (524)
T ss_pred             ccCCccccceeeeecCCCCceEeChhhhcccc--chHhhhcchhhhhHhhHhhcccccCCCCCCcccccccc-------C
Confidence            554443222      24778899999986554  56689999999999999987776554  3332222111       1


Q ss_pred             cCCCCCCCCHhHHHHHHHhcccCCCCCCChHHHhcCcccccC
Q 019195          215 KIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKN  256 (344)
Q Consensus       215 ~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~~  256 (344)
                      ......+.+..+...+..|+..+|..|+++..+++|+++...
T Consensus       344 p~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~  385 (524)
T KOG0601|consen  344 PLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSK  385 (524)
T ss_pred             chhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccch
Confidence            112233557777889999999999999999999999998643

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.57  E-value=7.5e-16  Score=150.90  Aligned_cols=252  Identities=27%  Similarity=0.399  Sum_probs=182.3

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCcccc----HHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEE
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKID----ANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVM   77 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~----~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~   77 (344)
                      +.+.+.+.+-+|+++.++.+.-..+|...++|+........    ..+.++-.++-...+|-+++..-.+.-....+|++
T Consensus       804 d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~~  883 (1205)
T KOG0606|consen  804 DGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLVG  883 (1205)
T ss_pred             ccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchhh
Confidence            56788889999999999999988888888888765433322    22223333333334566666555555567889999


Q ss_pred             ecCCCCChHHHHHhCCCCCHHHHHHHHHH-------HHHCCeeecCCCCCCeEecCCCCCCEEEeecCCCccc-CC----
Q 019195           78 EYAAGGELFERICNAGRFSEDEARYFFQQ-------LISGQICHRDLKLENTLLDGSPAPRLKICDFGYSKSS-LL----  145 (344)
Q Consensus        78 e~~~~g~L~~~i~~~~~~~~~~~~~~~~q-------l~~~~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~-~~----  145 (344)
                      +|..+++|...+++.+..++.-.+.++..       |++..+.|||++|.|+|+..++.  .+++|||..... ..    
T Consensus       884 ~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh--~~l~~~~t~~~vg~~~p~~  961 (1205)
T KOG0606|consen  884 HYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGH--RPLTDFGTLSKVGLIPPTT  961 (1205)
T ss_pred             HHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccchhhcccccccchhhcccCC--cccCccccccccccccCcC
Confidence            99999999999988886665555544433       33336899999999999976654  899999833210 00    


Q ss_pred             -C--------------------------CCCCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC
Q 019195          146 -H--------------------------SRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQED  198 (344)
Q Consensus       146 -~--------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~  198 (344)
                       .                          .......||+.|.+||...+.... .++|+|++|+++++.++|.+||.....
T Consensus       962 ~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hg-s~ad~~~~g~~l~e~l~g~pp~na~tp 1040 (1205)
T KOG0606|consen  962 DLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHG-SAADWWSSGVCLFEVLTGIPPFNAETP 1040 (1205)
T ss_pred             CcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCC-CcchhhhhhhhhhhhhcCCCCCCCcch
Confidence             0                          001234699999999999887764 448999999999999999999988766


Q ss_pred             hHHHHHHHHHHhhccccCCC-CCCCCHhHHHHHHHhcccCCCCCCChH---HHhcCcccccCCChh
Q 019195          199 PKNFRKTISRIMAVQYKIPD-YVHISQDCRNLLSRIFVANPSRRITIK---EIKSHPWFLKNLPRE  260 (344)
Q Consensus       199 ~~~~~~~~~~~~~~~~~~~~-~~~~s~~~~~li~~~L~~dp~~R~s~~---ell~hp~~~~~~~~~  260 (344)
                      ...+.+    +.......|. ....+..+++++.++|..+|.+|..+.   ++..||||+...+..
T Consensus      1041 q~~f~n----i~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~~~~e~k~~~~~~~~~~~~ 1102 (1205)
T KOG0606|consen 1041 QQIFEN----ILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAKGAAEVKGHPFFQDVDWEN 1102 (1205)
T ss_pred             hhhhhc----cccCCCCCCCCccccChhhhhhhhhhhccCchhccCcccccccccCCccCCCCccc
Confidence            555443    4444444443 235788999999999999999999887   899999998765443

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.56  E-value=1.2e-14  Score=136.75  Aligned_cols=133  Identities=22%  Similarity=0.292  Sum_probs=91.7

Q ss_pred             eeeeecCceEEEEEEEcCCCcEEEEEEeecCccc-----------------------------------------cHHHH
Q 019195            8 KDIGSGNFGVARLMRNKNTKELVAMKYIERGHKI-----------------------------------------DANVA   46 (344)
Q Consensus         8 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-----------------------------------------~~~~~   46 (344)
                      ++||+|++|+||+|+.. +|+.||||+.+..-..                                         +-.+.
T Consensus       123 ~plasaSigQVh~A~l~-~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~  201 (437)
T TIGR01982       123 KPLAAASIAQVHRARLV-DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR  201 (437)
T ss_pred             cceeeeehhheEEEEec-CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence            68999999999999875 6899999998543100                                         00244


Q ss_pred             HHHHHHhcC----CCCCcceeeEEEE-cCCEEEEEEecCCCCChHHHHHhC--C----CCCHHHHHHHHHHHHHCCeeec
Q 019195           47 REIINHKQL----RHPNIIRFKEVVL-TPTHLAIVMEYAAGGELFERICNA--G----RFSEDEARYFFQQLISGQICHR  115 (344)
Q Consensus        47 ~ei~~l~~l----~h~niv~~~~~~~-~~~~~~lv~e~~~~g~L~~~i~~~--~----~~~~~~~~~~~~ql~~~~iiH~  115 (344)
                      +|...+.++    +|.+-+.+-.++. ..+..++||||++|++|.+.....  +    .+....+..++.|++..|++|+
T Consensus       202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~~~~~ia~~~~~~~l~ql~~~g~~H~  281 (437)
T TIGR01982       202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGLDRKALAENLARSFLNQVLRDGFFHA  281 (437)
T ss_pred             HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCCCHHHHHHHHHHHHHHHHHhCCceeC
Confidence            455555554    2333333333332 234568999999999998876432  1    1223334557889999999999


Q ss_pred             CCCCCCeEecCCCCCCEEEeecCCCccc
Q 019195          116 DLKLENTLLDGSPAPRLKICDFGYSKSS  143 (344)
Q Consensus       116 Dikp~NIl~~~~~~~~vkL~DFg~a~~~  143 (344)
                      |+||.||+++.++  +++|+|||++...
T Consensus       282 D~hPgNilv~~~g--~i~liDfG~~~~l  307 (437)
T TIGR01982       282 DLHPGNIFVLKDG--KIIALDFGIVGRL  307 (437)
T ss_pred             CCCcccEEECCCC--cEEEEeCCCeeEC
Confidence            9999999997665  5999999988643

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.48  E-value=2.7e-13  Score=111.62  Aligned_cols=127  Identities=20%  Similarity=0.251  Sum_probs=92.1

Q ss_pred             eeeeeecCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcCCCCCcc-eeeEEEEcCCEEEEEEecCCCCCh
Q 019195            7 MKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNII-RFKEVVLTPTHLAIVMEYAAGGEL   85 (344)
Q Consensus         7 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~l~~l~h~niv-~~~~~~~~~~~~~lv~e~~~~g~L   85 (344)
                      +++|+.|.++.||++...  +..|++|+..........+.+|+.+++.+.+.+++ +++...  ....++||||++|.++
T Consensus         3 ~~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l   78 (170)
T cd05151           3 ISPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTELLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSEL   78 (170)
T ss_pred             eeecCCcccCceEEEEEC--CeEEEEEeCCCCcccccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCcc
Confidence            578999999999999864  67899998765543334567899999988655544 455443  3345799999999888


Q ss_pred             HHHHHhCCCCCHHHHHHHHHHHHHCC-----eeecCCCCCCeEecCCCCCCEEEeecCCCc
Q 019195           86 FERICNAGRFSEDEARYFFQQLISGQ-----ICHRDLKLENTLLDGSPAPRLKICDFGYSK  141 (344)
Q Consensus        86 ~~~i~~~~~~~~~~~~~~~~ql~~~~-----iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~  141 (344)
                      ... .........++...+..||..+     ++|+|++|.||+++ ++  .++++|||.+.
T Consensus        79 ~~~-~~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~--~~~liDf~~a~  135 (170)
T cd05151          79 LTE-DFSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DG--RLWLIDWEYAG  135 (170)
T ss_pred             ccc-cccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CC--eEEEEeccccc
Confidence            643 1111112345667778888776     59999999999998 32  49999999765

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.44  E-value=1.3e-13  Score=128.74  Aligned_cols=242  Identities=19%  Similarity=0.196  Sum_probs=174.9

Q ss_pred             CCceeeeeeeecCceEEEEEEEc-CCCcEEEEEEeecCccc---cHHHHHHHHHHhcC-CCCCcceeeEEEEcCCEEEEE
Q 019195            2 EKYELMKDIGSGNFGVARLMRNK-NTKELVAMKYIERGHKI---DANVAREIINHKQL-RHPNIIRFKEVVLTPTHLAIV   76 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~~---~~~~~~ei~~l~~l-~h~niv~~~~~~~~~~~~~lv   76 (344)
                      .+|..+..||.|.|+.|+.+... .++..|++|.+.+....   +..-..|+.+...+ .|.|+++++..|......|+-
T Consensus       265 ~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip  344 (524)
T KOG0601|consen  265 TDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYIP  344 (524)
T ss_pred             CCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccCc
Confidence            46888999999999999987766 78899999987664322   22234566666666 599999999999888888899


Q ss_pred             EecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCCCC
Q 019195           77 MEYAAGGELFERICNAGRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP  149 (344)
Q Consensus        77 ~e~~~~g~L~~~i~~~~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~~~  149 (344)
                      .|||.++++...+.-...+.+...+....|++.+       .++|+|+||+||++..++ +..++.|||.....  ....
T Consensus       345 ~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~-~~~~~~~~~~~t~~--~~~~  421 (524)
T KOG0601|consen  345 LEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDG-FFSKLGDFGCWTRL--AFSS  421 (524)
T ss_pred             hhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccch-hhhhcccccccccc--ceec
Confidence            9999999998777555667788888888887766       889999999999997653 34799999987641  1112


Q ss_pred             CCCccCCccc-CCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCHhHHH
Q 019195          150 KSTVGTPAYI-APEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRN  228 (344)
Q Consensus       150 ~~~~gt~~y~-aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~  228 (344)
                      ....+..+++ .+|++........+.|++|||..+.+.+++...-.......       .++..  ..|...+...++..
T Consensus       422 ~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~~~-------~i~~~--~~p~~~~~~~~~q~  492 (524)
T KOG0601|consen  422 GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQSL-------TIRSG--DTPNLPGLKLQLQV  492 (524)
T ss_pred             ccccccccccccchhhccccccccccccccccccccccccCcccCcccccce-------eeecc--cccCCCchHHhhhh
Confidence            2233444455 35555554444555999999999999999854433222111       11111  22333345578899


Q ss_pred             HHHHhcccCCCCCCChHHHhcCccccc
Q 019195          229 LLSRIFVANPSRRITIKEIKSHPWFLK  255 (344)
Q Consensus       229 li~~~L~~dp~~R~s~~ell~hp~~~~  255 (344)
                      +.+.++..++..|+.+.++..|+-|..
T Consensus       493 ~~kv~~~~~~~~~~l~~~l~~~~~~~~  519 (524)
T KOG0601|consen  493 LLKVMINPDRKRRPSAVELSLHSEFYR  519 (524)
T ss_pred             hhhhhcCCccccchhhhhhcccchhhh
Confidence            999999999999999999988876643

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.41  E-value=3e-13  Score=117.42  Aligned_cols=196  Identities=16%  Similarity=0.268  Sum_probs=133.9

Q ss_pred             HHHhcCCCCCcceeeEEEEcC-----CEEEEEEecCCCCChHHHHHhC----CCCCHHHHHHHHHHHHHC---------C
Q 019195           50 INHKQLRHPNIIRFKEVVLTP-----THLAIVMEYAAGGELFERICNA----GRFSEDEARYFFQQLISG---------Q  111 (344)
Q Consensus        50 ~~l~~l~h~niv~~~~~~~~~-----~~~~lv~e~~~~g~L~~~i~~~----~~~~~~~~~~~~~ql~~~---------~  111 (344)
                      ..|-++-|.|||+++.+|.+.     ....+++||+..|+|..+|++.    ..+....+++|+.|+++|         -
T Consensus       119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Pp  198 (458)
T KOG1266|consen  119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPP  198 (458)
T ss_pred             HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCc
Confidence            445566799999999998654     4578999999999999998753    357888889999999987         8


Q ss_pred             eeecCCCCCCeEecCCCCCCEEEeecCCCcccCCC-----CCCCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHH
Q 019195          112 ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH-----SRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVM  186 (344)
Q Consensus       112 iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el  186 (344)
                      |+|+++...-|++..++-  +|++--.........     .......+-++|.|||.=......+ ++|||++|+...+|
T Consensus       199 iihgnlTc~tifiq~ngL--Ikig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~-a~dIy~fgmcAlem  275 (458)
T KOG1266|consen  199 IIHGNLTCDTIFIQHNGL--IKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTG-ASDIYKFGMCALEM  275 (458)
T ss_pred             cccCCcchhheeecCCce--EEecccCccccchhhhhhhHhhhhccccCCccccCCcCccccccc-chhhhhhhHHHHHH
Confidence            999999999999975553  565422111100000     0111224778999999754444444 49999999999999


Q ss_pred             HhCCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCHhHHHHHHHhcccCCCCCCChHHHhcCcccccC
Q 019195          187 LVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKN  256 (344)
Q Consensus       187 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~~  256 (344)
                      ..|..--......-.....+.+....   +     -+.--+.++.+||+..|..||++..+|.||.+.+.
T Consensus       276 ailEiq~tnseS~~~~ee~ia~~i~~---l-----en~lqr~~i~kcl~~eP~~rp~ar~llfHpllfeV  337 (458)
T KOG1266|consen  276 AILEIQSTNSESKVEVEENIANVIIG---L-----ENGLQRGSITKCLEGEPNGRPDARLLLFHPLLFEV  337 (458)
T ss_pred             HHheeccCCCcceeehhhhhhhheee---c-----cCccccCcCcccccCCCCCCcchhhhhcCceeeec
Confidence            98765433222211112222221110   0     11234688999999999999999999999987654

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.38  E-value=1.1e-11  Score=117.33  Aligned_cols=160  Identities=19%  Similarity=0.257  Sum_probs=118.8

Q ss_pred             EEEEcCCCcEEEEEEeecCcc-ccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEEecCCCCChHHHHHhCCCCCHH
Q 019195           20 LMRNKNTKELVAMKYIERGHK-IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSED   98 (344)
Q Consensus        20 ~~~~~~~~~~vaiK~~~~~~~-~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~   98 (344)
                      .+..+.++.+|.+........ ....+.+.++.|+.++||||+++++.+..++.+|+|+|-+.  .|..++.+.+   ..
T Consensus        30 ~~t~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l~---~~  104 (690)
T KOG1243|consen   30 DGTRKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKELG---KE  104 (690)
T ss_pred             ccceeccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHhH---HH
Confidence            355667788888888776544 33557788999999999999999999999999999999885  6666666543   55


Q ss_pred             HHHHHHHHHHHC--------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCCC-CCCCccCCcccCCccccCCCC
Q 019195           99 EARYFFQQLISG--------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR-PKSTVGTPAYIAPEVLSRREY  169 (344)
Q Consensus        99 ~~~~~~~ql~~~--------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~  169 (344)
                      .+...++||+.|        +++|++|.-..|+++..+.  .||++|-++........ .....---.|..|+.+....+
T Consensus       105 ~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~Ge--WkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~~~s~~  182 (690)
T KOG1243|consen  105 EVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGE--WKLGGLELVSKASGFNAPAKSLYLIESFDDPEEIDPSEW  182 (690)
T ss_pred             HHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCc--EEEeeeEEEeccccCCcccccchhhhcccChhhcCcccc
Confidence            566666776655        9999999999999977665  99999988754322221 222223334667776543332


Q ss_pred             CCcchhHHHHHHHHHHHHhC
Q 019195          170 DGKLADVWSCGVTLYVMLVG  189 (344)
Q Consensus       170 ~~~~~DiwslG~il~el~~g  189 (344)
                         ..|.|-|||++++++.|
T Consensus       183 ---s~D~~~Lg~li~el~ng  199 (690)
T KOG1243|consen  183 ---SIDSWGLGCLIEELFNG  199 (690)
T ss_pred             ---chhhhhHHHHHHHHhCc
Confidence               26999999999999998

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.28  E-value=5.4e-11  Score=96.22  Aligned_cols=129  Identities=22%  Similarity=0.191  Sum_probs=93.9

Q ss_pred             eeeeecCceEEEEEEEcCCCcEEEEEEe-ecCc---cc-----cHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEEe
Q 019195            8 KDIGSGNFGVARLMRNKNTKELVAMKYI-ERGH---KI-----DANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVME   78 (344)
Q Consensus         8 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~-~~~~---~~-----~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e   78 (344)
                      ..+++|+=+.+|.+...  |..+++|.= .+.-   ..     ..+-.+|.+++..+.--.|...+-++.+.+...|+||
T Consensus         2 ~~i~~GAEa~i~~~~~~--g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me   79 (204)
T COG3642           2 DLIKQGAEAIIYLTDFL--GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVME   79 (204)
T ss_pred             chhhCCcceeEEeeecc--CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEE
Confidence            46789999999988553  334666632 2211   11     1456688999988865566655556667788889999


Q ss_pred             cCCCCChHHHHHhCCCCCHHHHHHHHHHHHHCCeeecCCCCCCeEecCCCCCCEEEeecCCCc
Q 019195           79 YAAGGELFERICNAGRFSEDEARYFFQQLISGQICHRDLKLENTLLDGSPAPRLKICDFGYSK  141 (344)
Q Consensus        79 ~~~~g~L~~~i~~~~~~~~~~~~~~~~ql~~~~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~  141 (344)
                      |++|..|.+.+.....--...+-..+--||.+||+|+||.++||++.+..   +.++|||++.
T Consensus        80 ~I~G~~lkd~l~~~~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~---i~~IDfGLg~  139 (204)
T COG3642          80 YIEGELLKDALEEARPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGR---IYFIDFGLGE  139 (204)
T ss_pred             EeCChhHHHHHHhcchHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCc---EEEEECCccc
Confidence            99998888888665211233455567789999999999999999997554   8999999986

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.26  E-value=7.5e-11  Score=98.37  Aligned_cols=129  Identities=15%  Similarity=0.158  Sum_probs=85.7

Q ss_pred             eeeeeecCceEEEEEEEcC------CCcEEEEEEeecCc--------------c---------ccHH----HHHHHHHHh
Q 019195            7 MKDIGSGNFGVARLMRNKN------TKELVAMKYIERGH--------------K---------IDAN----VAREIINHK   53 (344)
Q Consensus         7 ~~~lg~G~~g~V~~~~~~~------~~~~vaiK~~~~~~--------------~---------~~~~----~~~ei~~l~   53 (344)
                      ...||.|-=+.||.|....      .+..+|||+.+.+.              .         ....    ..+|++.|+
T Consensus         2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~   81 (197)
T cd05146           2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK   81 (197)
T ss_pred             CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence            4578999999999998653      35789999874211              0         0112    337999999


Q ss_pred             cCC--CCCcceeeEEEEcCCEEEEEEecCCCCChHHHHHhCCCCCHH-------HHHHHHHHH-HHCCeeecCCCCCCeE
Q 019195           54 QLR--HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSED-------EARYFFQQL-ISGQICHRDLKLENTL  123 (344)
Q Consensus        54 ~l~--h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~-------~~~~~~~ql-~~~~iiH~Dikp~NIl  123 (344)
                      ++.  .-++.+++.+    ..-++||||+.++.+.....+...+++.       ++...+..+ |.+|++|+||+|.|||
T Consensus        82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~NIL  157 (197)
T cd05146          82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYNML  157 (197)
T ss_pred             HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEE
Confidence            884  3566666654    4567999999765442222222233332       333334444 6789999999999999


Q ss_pred             ecCCCCCCEEEeecCCCcc
Q 019195          124 LDGSPAPRLKICDFGYSKS  142 (344)
Q Consensus       124 ~~~~~~~~vkL~DFg~a~~  142 (344)
                      ++.+   .+.|+|||.+..
T Consensus       158 ~~~~---~v~iIDF~qav~  173 (197)
T cd05146         158 WHDG---KVWFIDVSQSVE  173 (197)
T ss_pred             EECC---cEEEEECCCcee
Confidence            9643   499999997754

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.16  E-value=3e-10  Score=97.44  Aligned_cols=80  Identities=18%  Similarity=0.201  Sum_probs=61.1

Q ss_pred             eeeeeecCceEEEEEEEcCCCcEEEEEEeecCcc--ccHHHHHHHHHHhcCCC--CCcceeeEEEEcC---CEEEEEEec
Q 019195            7 MKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK--IDANVAREIINHKQLRH--PNIIRFKEVVLTP---THLAIVMEY   79 (344)
Q Consensus         7 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~ei~~l~~l~h--~niv~~~~~~~~~---~~~~lv~e~   79 (344)
                      .+.|+.|.++.||++.... |+.+++|+......  ....+.+|+.+++.+.+  .++.+++.+....   +..++||||
T Consensus         3 ~~~l~~G~~n~~~~v~~~~-g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~   81 (223)
T cd05154           3 VRQLSGGQSNLTYLLTAGG-GRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMER   81 (223)
T ss_pred             ceecCCCccceEEEEEecC-CcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEE
Confidence            3678999999999998744 57899998766443  34578899999999975  3457777766553   367899999


Q ss_pred             CCCCChHH
Q 019195           80 AAGGELFE   87 (344)
Q Consensus        80 ~~~g~L~~   87 (344)
                      ++|.++..
T Consensus        82 i~G~~l~~   89 (223)
T cd05154          82 VDGRVLRD   89 (223)
T ss_pred             eCCEecCC
Confidence            99987744

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.02  E-value=1.5e-10  Score=110.06  Aligned_cols=146  Identities=17%  Similarity=0.261  Sum_probs=104.1

Q ss_pred             HCCeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCCC----------CCCCccCCcccCCccccCCCCCCcchhHHH
Q 019195          109 SGQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR----------PKSTVGTPAYIAPEVLSRREYDGKLADVWS  178 (344)
Q Consensus       109 ~~~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~~----------~~~~~gt~~y~aPE~~~~~~~~~~~~Diws  178 (344)
                      ++++||++|.|++|.++.++.  .||+.|+++........          .....-...|.|||++.... .+.++|++|
T Consensus       118 sAk~VH~ni~p~~i~~na~~~--wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~~-~~~~sd~fS  194 (700)
T KOG2137|consen  118 SAKVVHGNIQPEAIVVNANGD--WKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGTT-NTPASDVFS  194 (700)
T ss_pred             CcceeecccchhheeeccCcc--eeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcccc-cccccccee
Confidence            459999999999999987776  99999998764333111          11113566799999998744 466699999


Q ss_pred             HHHHHHHHH-hCCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCHhHHHHHHHhcccCCCCCCChHHHhcCcccccCC
Q 019195          179 CGVTLYVML-VGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNL  257 (344)
Q Consensus       179 lG~il~el~-~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~~~  257 (344)
                      +|+++|.+. .|+..+....................  +-...++++++++=|.++|..++..||++..++..|||....
T Consensus       195 lG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~~--~~~s~~~p~el~~~l~k~l~~~~~~rp~~~~l~~~~ff~D~~  272 (700)
T KOG2137|consen  195 LGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAGA--FGYSNNLPSELRESLKKLLNGDSAVRPTLDLLLSIPFFSDPG  272 (700)
T ss_pred             eeeEEEEEecCCcchhhccCCcchhhhhhccccccc--ccccccCcHHHHHHHHHHhcCCcccCcchhhhhcccccCCch
Confidence            999999998 56655555443332222111111111  112246889999999999999999999999999999997654


Q ss_pred             Ch
Q 019195          258 PR  259 (344)
Q Consensus       258 ~~  259 (344)
                      -+
T Consensus       273 ~~  274 (700)
T KOG2137|consen  273 LK  274 (700)
T ss_pred             hh
Confidence            33

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=98.99  E-value=1.7e-08  Score=93.36  Aligned_cols=204  Identities=19%  Similarity=0.259  Sum_probs=141.1

Q ss_pred             eEEEEEEEcCCCcEEEEEEeecCcccc-HHHHHHHHHHhcCCCCCcceeeEEEEc----CCEEEEEEecCCC-CChHHHH
Q 019195           16 GVARLMRNKNTKELVAMKYIERGHKID-ANVAREIINHKQLRHPNIIRFKEVVLT----PTHLAIVMEYAAG-GELFERI   89 (344)
Q Consensus        16 g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~ei~~l~~l~h~niv~~~~~~~~----~~~~~lv~e~~~~-g~L~~~i   89 (344)
                      .+.|+|....+|..|++|+++...... ...-.-++.++++.|+|||++.++|..    +..+++|++|.++ ++|.+..
T Consensus       290 ~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~~  369 (655)
T KOG3741|consen  290 ITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDLY  369 (655)
T ss_pred             ceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHHH
Confidence            478999999999999999995433221 123356778999999999999999973    4578999999987 5666654


Q ss_pred             H---------------hCCCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCC
Q 019195           90 C---------------NAGRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS  147 (344)
Q Consensus        90 ~---------------~~~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~  147 (344)
                      -               .....++..+|.++.||..+       |..-+-|.|.+||+.+..  |++|.--|+........
T Consensus       370 F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~--RIriS~C~i~Dvl~~d~  447 (655)
T KOG3741|consen  370 FANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKM--RIRISGCGIMDVLQEDP  447 (655)
T ss_pred             ccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcc--eEEEecccceeeecCCC
Confidence            2               12246788899988776654       888899999999997554  58877666544322221


Q ss_pred             CCCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCHhHH
Q 019195          148 RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCR  227 (344)
Q Consensus       148 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~  227 (344)
                            +       +.+.+    ...-|.=.||.+++.|.||..---........  .+..+         ...+|.+++
T Consensus       448 ------~-------~~le~----~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s--~~~~I---------~~~yS~D~r  499 (655)
T KOG3741|consen  448 ------T-------EPLES----QQQNDLRDLGLLLLALATGTENSNRTDSTQSS--HLTRI---------TTTYSTDLR  499 (655)
T ss_pred             ------C-------cchhH----HhhhhHHHHHHHHHHHhhcccccccccchHHH--HHHHh---------hhhhhHHHH
Confidence                  0       11221    12369999999999999995432111111111  01111         114688999


Q ss_pred             HHHHHhcccCCCCCCChHHHhcC
Q 019195          228 NLLSRIFVANPSRRITIKEIKSH  250 (344)
Q Consensus       228 ~li~~~L~~dp~~R~s~~ell~h  250 (344)
                      ++|.-+...+++. -++.+++.+
T Consensus       500 n~v~yl~s~~~~~-ksI~~llp~  521 (655)
T KOG3741|consen  500 NVVEYLESLNFRE-KSIQDLLPM  521 (655)
T ss_pred             HHHHHHHhcCccc-ccHHHHHHH
Confidence            9999999999987 578888776

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=98.98  E-value=4.1e-09  Score=85.13  Aligned_cols=135  Identities=19%  Similarity=0.122  Sum_probs=93.9

Q ss_pred             eeeeeeecCceEEEEEEEcCCCcEEEEEEee-cC--------ccccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEE
Q 019195            6 LMKDIGSGNFGVARLMRNKNTKELVAMKYIE-RG--------HKIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIV   76 (344)
Q Consensus         6 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~-~~--------~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv   76 (344)
                      .+..|-+|+=+.|+++..  .|+.+.||.-. +.        .....+..+|.+.|.++.--.|.-..-+|.+...-.++
T Consensus        11 ~l~likQGAEArv~~~~~--~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~   88 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSF--SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIY   88 (229)
T ss_pred             cceeeeccceeeEeeecc--CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEE
Confidence            567888999999998876  46777777432 21        11235677899999888655555555567677777899


Q ss_pred             EecCCC-CChHHHHHhCC---CCCHH------HHHHHHHHHHHCCeeecCCCCCCeEecCCCCC-CEEEeecCCCcc
Q 019195           77 MEYAAG-GELFERICNAG---RFSED------EARYFFQQLISGQICHRDLKLENTLLDGSPAP-RLKICDFGYSKS  142 (344)
Q Consensus        77 ~e~~~~-g~L~~~i~~~~---~~~~~------~~~~~~~ql~~~~iiH~Dikp~NIl~~~~~~~-~vkL~DFg~a~~  142 (344)
                      |||++| .++.+++....   ..++.      .+-..+.-||.++|||+||..+||++...+.. .+.|+|||++..
T Consensus        89 ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~  165 (229)
T KOG3087|consen   89 MEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV  165 (229)
T ss_pred             EEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhc
Confidence            999987 46777776532   12221      22234556778899999999999999755432 358999999764

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.95  E-value=5.1e-09  Score=87.00  Aligned_cols=117  Identities=26%  Similarity=0.249  Sum_probs=70.5

Q ss_pred             EEEEEEcCCCcEEEEEEeecCc--------------c-------------ccHHHHHHHHHHhcCCCC--CcceeeEEEE
Q 019195           18 ARLMRNKNTKELVAMKYIERGH--------------K-------------IDANVAREIINHKQLRHP--NIIRFKEVVL   68 (344)
Q Consensus        18 V~~~~~~~~~~~vaiK~~~~~~--------------~-------------~~~~~~~ei~~l~~l~h~--niv~~~~~~~   68 (344)
                      ||.|.. ..|..+|+|+.....              .             ......+|.+.|.++..-  ++.+++.+. 
T Consensus         2 Vy~~~~-~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~-   79 (188)
T PF01163_consen    2 VYHAID-PDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN-   79 (188)
T ss_dssp             EEEEEE-CTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred             EEEEEC-CCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence            888887 457799999874310              0             013567899999999654  566666543 


Q ss_pred             cCCEEEEEEecCC--CCChHHHHHhC--CCCCHH---HHHH-HHHHHHHCCeeecCCCCCCeEecCCCCCCEEEeecCCC
Q 019195           69 TPTHLAIVMEYAA--GGELFERICNA--GRFSED---EARY-FFQQLISGQICHRDLKLENTLLDGSPAPRLKICDFGYS  140 (344)
Q Consensus        69 ~~~~~~lv~e~~~--~g~L~~~i~~~--~~~~~~---~~~~-~~~ql~~~~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a  140 (344)
                         .-+|||||++  |..+..+....  ..-...   ++.. +...++.+||+|+||.+.|||++.+   .+.|+|||.+
T Consensus        80 ---~~~ivME~I~~~G~~~~~l~~~~~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~---~~~iIDf~qa  153 (188)
T PF01163_consen   80 ---RNVIVMEYIGEDGVPLPRLKDVDLSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG---KVYIIDFGQA  153 (188)
T ss_dssp             ---TTEEEEE--EETTEEGGCHHHCGGGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT---CEEE--GTTE
T ss_pred             ---CCEEEEEecCCCccchhhHHhccccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc---eEEEEecCcc
Confidence               2359999998  65554433222  111222   2222 3333557899999999999999866   3999999977


Q ss_pred             cc
Q 019195          141 KS  142 (344)
Q Consensus       141 ~~  142 (344)
                      ..
T Consensus       154 v~  155 (188)
T PF01163_consen  154 VD  155 (188)
T ss_dssp             EE
T ss_pred             ee
Confidence            53

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=98.91  E-value=2.2e-08  Score=88.20  Aligned_cols=122  Identities=13%  Similarity=0.037  Sum_probs=81.3

Q ss_pred             EEEEEEcCCCcEEEEEEeecCcc------------ccHHHHHHHHHHhcCCCCCc--ceeeEEEEc-----CCEEEEEEe
Q 019195           18 ARLMRNKNTKELVAMKYIERGHK------------IDANVAREIINHKQLRHPNI--IRFKEVVLT-----PTHLAIVME   78 (344)
Q Consensus        18 V~~~~~~~~~~~vaiK~~~~~~~------------~~~~~~~ei~~l~~l~h~ni--v~~~~~~~~-----~~~~~lv~e   78 (344)
                      |+++..  .|+.|.+|.......            -...+.+|...+..|..-+|  +..+.++..     ...-++|||
T Consensus        38 vvr~~~--~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte  115 (268)
T PRK15123         38 TLRFEL--AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITE  115 (268)
T ss_pred             EEEEEE--CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEe
Confidence            445533  467899996643221            01147789999888843333  233444432     235789999


Q ss_pred             cCCCC-ChHHHHHhC--CCCCHH-------HHHHHHHHHHHCCeeecCCCCCCeEecC-----CCCCCEEEeecCCCc
Q 019195           79 YAAGG-ELFERICNA--GRFSED-------EARYFFQQLISGQICHRDLKLENTLLDG-----SPAPRLKICDFGYSK  141 (344)
Q Consensus        79 ~~~~g-~L~~~i~~~--~~~~~~-------~~~~~~~ql~~~~iiH~Dikp~NIl~~~-----~~~~~vkL~DFg~a~  141 (344)
                      ++++. +|.+++...  ...+..       ++..++.+||.+||+|+|++++|||++.     .+...+.|+||+.+.
T Consensus       116 ~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~  193 (268)
T PRK15123        116 DLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQ  193 (268)
T ss_pred             eCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCccc
Confidence            99886 788887532  223322       4666788899999999999999999974     234569999999764

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.89  E-value=3.6e-09  Score=100.71  Aligned_cols=133  Identities=23%  Similarity=0.293  Sum_probs=93.2

Q ss_pred             eeeeecCceEEEEEEEcCCCcEEEEEEeecCcc--------------------------c---------------cHHHH
Q 019195            8 KDIGSGNFGVARLMRNKNTKELVAMKYIERGHK--------------------------I---------------DANVA   46 (344)
Q Consensus         8 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--------------------------~---------------~~~~~   46 (344)
                      .+|+.++-|+||+|.... |+.||||+.+.+-.                          .               +-.+.
T Consensus       131 ~PiAsASIaQVH~A~L~s-G~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~  209 (517)
T COG0661         131 EPIASASIAQVHRAVLKS-GEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR  209 (517)
T ss_pred             CchhhhhHhhheeEEecC-CCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence            688999999999999865 99999998743110                          0               01244


Q ss_pred             HHHHHHhcC----CCCCcceeeEEE-EcCCEEEEEEecCCCCChHHHH--HhCC----CCCHHHHHHHHHHHHHCCeeec
Q 019195           47 REIINHKQL----RHPNIIRFKEVV-LTPTHLAIVMEYAAGGELFERI--CNAG----RFSEDEARYFFQQLISGQICHR  115 (344)
Q Consensus        47 ~ei~~l~~l----~h~niv~~~~~~-~~~~~~~lv~e~~~~g~L~~~i--~~~~----~~~~~~~~~~~~ql~~~~iiH~  115 (344)
                      +|...+.++    +..--+++-.++ ...+.-.++|||++|-.+.+..  ...+    .+.+.-+..++.|+...|+.|.
T Consensus       210 ~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~ia~~~~~~f~~q~~~dgffHa  289 (517)
T COG0661         210 REAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAGIDRKELAELLVRAFLRQLLRDGFFHA  289 (517)
T ss_pred             HHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcCCCHHHHHHHHHHHHHHHHHhcCcccc
Confidence            555555554    222223333333 3345667999999999888773  3322    2445556778899999999999


Q ss_pred             CCCCCCeEecCCCCCCEEEeecCCCccc
Q 019195          116 DLKLENTLLDGSPAPRLKICDFGYSKSS  143 (344)
Q Consensus       116 Dikp~NIl~~~~~~~~vkL~DFg~a~~~  143 (344)
                      |.+|.||+++.++  ++.+.|||+....
T Consensus       290 DpHpGNi~v~~~g--~i~~lDfGi~g~l  315 (517)
T COG0661         290 DPHPGNILVRSDG--RIVLLDFGIVGRL  315 (517)
T ss_pred             CCCccceEEecCC--cEEEEcCcceecC
Confidence            9999999998775  5999999987643

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.83  E-value=1.3e-08  Score=87.38  Aligned_cols=127  Identities=21%  Similarity=0.202  Sum_probs=89.8

Q ss_pred             eeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCc-----------------------cccHHHHHHHHHHhcCCCC--C
Q 019195            5 ELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH-----------------------KIDANVAREIINHKQLRHP--N   59 (344)
Q Consensus         5 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----------------------~~~~~~~~ei~~l~~l~h~--n   59 (344)
                      .+..+||-|-=+.||.|.+. .|..+|||.-.-..                       .......+|.++|.+|...  .
T Consensus        94 ~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~  172 (304)
T COG0478          94 AIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK  172 (304)
T ss_pred             hhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence            45688999999999999886 68899999542110                       0123577899999999654  6


Q ss_pred             cceeeEEEEcCCEEEEEEecCCCCChHHHHHhCCCCCHHH----HHHHHHHHHHCCeeecCCCCCCeEecCCCCCCEEEe
Q 019195           60 IIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDE----ARYFFQQLISGQICHRDLKLENTLLDGSPAPRLKIC  135 (344)
Q Consensus        60 iv~~~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~----~~~~~~ql~~~~iiH~Dikp~NIl~~~~~~~~vkL~  135 (344)
                      +.+.+++    +.-.+||||++|-.|...-.  ..-....    +...+.-+...||||+|+.+-||+++.++.  +.++
T Consensus       173 VP~P~~~----nRHaVvMe~ieG~eL~~~r~--~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg~--~~vI  244 (304)
T COG0478         173 VPKPIAW----NRHAVVMEYIEGVELYRLRL--DVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDGD--IVVI  244 (304)
T ss_pred             CCCcccc----ccceeeeehcccceeecccC--cccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCCC--EEEE
Confidence            7776654    56679999999977755431  1112222    333333444559999999999999988765  9999


Q ss_pred             ecCCC
Q 019195          136 DFGYS  140 (344)
Q Consensus       136 DFg~a  140 (344)
                      ||--+
T Consensus       245 DwPQ~  249 (304)
T COG0478         245 DWPQA  249 (304)
T ss_pred             eCccc
Confidence            99744

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.74  E-value=2.5e-07  Score=77.87  Aligned_cols=131  Identities=17%  Similarity=0.158  Sum_probs=84.1

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCcccc----------HHHHHHHHHHhcC---CCCCcceeeEEEE
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKID----------ANVAREIINHKQL---RHPNIIRFKEVVL   68 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~----------~~~~~ei~~l~~l---~h~niv~~~~~~~   68 (344)
                      .+|++++.+-......|.+..  -.|..+++|.........          ....+.+..+..+   ..-..+.++.+..
T Consensus        31 ~~~~~~kv~k~~~r~~ValIe--i~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~e  108 (229)
T PF06176_consen   31 NNYKIIKVFKNTKRNYVALIE--IDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAE  108 (229)
T ss_pred             CCceEEEeecCCCccEEEEEE--ECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeee
Confidence            357777777776666665554  346778999765422111          1223334433333   2233333333322


Q ss_pred             -----cCCEEEEEEecCCCCChHHHHHhCCCCCH---HHHHHHHHHHHHCCeeecCCCCCCeEecCCCCCCEEEeecCCC
Q 019195           69 -----TPTHLAIVMEYAAGGELFERICNAGRFSE---DEARYFFQQLISGQICHRDLKLENTLLDGSPAPRLKICDFGYS  140 (344)
Q Consensus        69 -----~~~~~~lv~e~~~~g~L~~~i~~~~~~~~---~~~~~~~~ql~~~~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a  140 (344)
                           -....+++|||++|..|.+...    +.+   ..+...+.|||.+|++|+|.+|.|+++..++   ++++||+..
T Consensus       109 kk~~~~~~~~~ll~EYIeG~~l~d~~~----i~e~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~~---i~iID~~~k  181 (229)
T PF06176_consen  109 KKIFRYTSSYVLLMEYIEGVELNDIED----IDEDLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNNG---IRIIDTQGK  181 (229)
T ss_pred             eeeccceeEEEEEEEEecCeecccchh----cCHHHHHHHHHHHHHHHHcCCccCCCCcCcEEEECCc---EEEEECccc
Confidence                 2245678999999988866532    222   4577889999999999999999999997554   999999865


Q ss_pred             c
Q 019195          141 K  141 (344)
Q Consensus       141 ~  141 (344)
                      +
T Consensus       182 ~  182 (229)
T PF06176_consen  182 R  182 (229)
T ss_pred             c
Confidence            4

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=98.69  E-value=1.9e-09  Score=101.83  Aligned_cols=234  Identities=20%  Similarity=0.181  Sum_probs=153.2

Q ss_pred             ceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcCCCCC-cceeeEEEEcCCEEEEEEecCCC
Q 019195            4 YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPN-IIRFKEVVLTPTHLAIVMEYAAG   82 (344)
Q Consensus         4 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~l~~l~h~n-iv~~~~~~~~~~~~~lv~e~~~~   82 (344)
                      |....-+++|+++++++.+...+...+ .+.+...    ....-++++|.+++||| .++.++.+..++..++.|+++.+
T Consensus       244 s~~fh~fvK~altknpKkRptaeklL~-h~fvs~~----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~  318 (829)
T KOG0576|consen  244 SEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICST  318 (829)
T ss_pred             hHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcC
Confidence            444566789999999999887766555 6665543    34556888999999999 88888888888999999999987


Q ss_pred             C-ChHHHH-HhCCCCCHHHHHHHH-------HHHHHCCeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCCCCCCCc
Q 019195           83 G-ELFERI-CNAGRFSEDEARYFF-------QQLISGQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTV  153 (344)
Q Consensus        83 g-~L~~~i-~~~~~~~~~~~~~~~-------~ql~~~~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~~~~~~~  153 (344)
                      + +-...+ ...-.+.+-+.....       .++++---+|||    ||+..+..   .+++||+...........++..
T Consensus       319 ~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~~~---~~~~~~~v~~~L~~~~~~~t~~  391 (829)
T KOG0576|consen  319 GRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSEEE---VKLLDFAVPPQLTRTMKPRTAI  391 (829)
T ss_pred             CccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----cccccccc---cccccccCCcccCcccccccCC
Confidence            7 221111 000011111111111       112222236776    88886543   7999999987766665667788


Q ss_pred             cCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhcc--ccCCCCCCCCHhHH-HHH
Q 019195          154 GTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQ--YKIPDYVHISQDCR-NLL  230 (344)
Q Consensus       154 gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~s~~~~-~li  230 (344)
                      +|+.++|||+.....+... .|.|++|.-..+|.-|-+|-.......      ..+....  ..+.....+++... ++.
T Consensus       392 ~~~~~~~pev~~~~~~~~~-p~~~~~~~~~~~~ap~~pPr~~P~~~~------~~~g~~p~s~~L~~~~aw~~~~~~~~~  464 (829)
T KOG0576|consen  392 GTPEPLAPEVIQENTIDGC-PDSGSLAVSAIQMAPGLPPRSSPPAVL------PMIGNGPNSPMLTDKSAWSPVFHRDFP  464 (829)
T ss_pred             CCCCCCCchhhcccccccC-CCccCCCcchhhcCCCCCCCCCCcccc------CCCCCCCCccccchhhhcCcccccCCc
Confidence            9999999999988888766 899999998888888877754321100      0000000  00000011222222 477


Q ss_pred             HHhcccCCCCCCChHHHhcCcccccC
Q 019195          231 SRIFVANPSRRITIKEIKSHPWFLKN  256 (344)
Q Consensus       231 ~~~L~~dp~~R~s~~ell~hp~~~~~  256 (344)
                      ..|+..-|..|+....++.|.+|...
T Consensus       465 ~~~~~g~P~~pkv~mgacfsKvfngC  490 (829)
T KOG0576|consen  465 APCLNGLPPTPKVHMGACFSKVFNGC  490 (829)
T ss_pred             ccccCCCCCCCcchhhHHHHHHhccC
Confidence            88999999999999999999888764

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.66  E-value=1.6e-07  Score=89.28  Aligned_cols=134  Identities=20%  Similarity=0.265  Sum_probs=90.3

Q ss_pred             eeeeecCceEEEEEEEcCCCcEEEEEEeecCcc--------------------------------ccH------HHHHHH
Q 019195            8 KDIGSGNFGVARLMRNKNTKELVAMKYIERGHK--------------------------------IDA------NVAREI   49 (344)
Q Consensus         8 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--------------------------------~~~------~~~~ei   49 (344)
                      ++||.-+.|+||+|+.+. |+.||||+.+.+-.                                ..+      .+.+|.
T Consensus       167 ~piaaASlaQVhrA~L~~-G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA  245 (538)
T KOG1235|consen  167 EPIAAASLAQVHRARLKN-GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA  245 (538)
T ss_pred             chhhhcchhheEEEEecC-CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence            689999999999999876 99999998743210                                001      233444


Q ss_pred             HHHhc----CCCCC---cceeeEEEEc-CCEEEEEEecCCCCChHHH--HHhCCC----CCHHHHHHHHHHHHHCCeeec
Q 019195           50 INHKQ----LRHPN---IIRFKEVVLT-PTHLAIVMEYAAGGELFER--ICNAGR----FSEDEARYFFQQLISGQICHR  115 (344)
Q Consensus        50 ~~l~~----l~h~n---iv~~~~~~~~-~~~~~lv~e~~~~g~L~~~--i~~~~~----~~~~~~~~~~~ql~~~~iiH~  115 (344)
                      +...+    +.|-+   -|.+-.++.+ .....|+||||+|..+.+.  |.+.+.    +...-+..+..||+..|++|+
T Consensus       246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i~~~gi~~~~i~~~l~~~~~~qIf~~GffHa  325 (538)
T KOG1235|consen  246 KNAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAIDKRGISPHDILNKLVEAYLEQIFKTGFFHA  325 (538)
T ss_pred             HhHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHHHHcCCCHHHHHHHHHHHHHHHHHhcCCccC
Confidence            43333    34444   1222223322 3467899999999888655  444432    233345566788999999999


Q ss_pred             CCCCCCeEecCC--CCCCEEEeecCCCcc
Q 019195          116 DLKLENTLLDGS--PAPRLKICDFGYSKS  142 (344)
Q Consensus       116 Dikp~NIl~~~~--~~~~vkL~DFg~a~~  142 (344)
                      |=+|.||++..+  +..++.+.|||+...
T Consensus       326 DPHPGNilv~~~~~~~~~ivllDhGl~~~  354 (538)
T KOG1235|consen  326 DPHPGNILVRPNPEGDEEIVLLDHGLYAV  354 (538)
T ss_pred             CCCCCcEEEecCCCCCccEEEEccccccc
Confidence            999999999853  456799999998764

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=98.57  E-value=1.4e-06  Score=79.20  Aligned_cols=233  Identities=14%  Similarity=0.129  Sum_probs=135.1

Q ss_pred             eeeeeeecCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcC-CCCCcceeeEEE------EcC-CEEEEEE
Q 019195            6 LMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQL-RHPNIIRFKEVV------LTP-THLAIVM   77 (344)
Q Consensus         6 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~l~~l-~h~niv~~~~~~------~~~-~~~~lv~   77 (344)
                      ..+.||+|+-+.+|-.-...+   -+.|+.....-..  ..+.+..|... .||-+-.-+.+=      -.. ..+.++|
T Consensus        15 ~gr~LgqGgea~ly~l~e~~d---~VAKIYh~Pppa~--~aqk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflm   89 (637)
T COG4248          15 PGRPLGQGGEADLYTLGEVRD---QVAKIYHAPPPAA--QAQKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLM   89 (637)
T ss_pred             CCccccCCccceeeecchhhc---hhheeecCCCchH--HHHHHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEec
Confidence            457899999999997643322   2447666543211  11223333333 466443311110      112 2378889


Q ss_pred             ecCCCCChHHHH----HhCCCCC---HHH-------HHHHHHHHHHCCeeecCCCCCCeEecCCCCCCEEEeecCCCccc
Q 019195           78 EYAAGGELFERI----CNAGRFS---EDE-------ARYFFQQLISGQICHRDLKLENTLLDGSPAPRLKICDFGYSKSS  143 (344)
Q Consensus        78 e~~~~g~L~~~i----~~~~~~~---~~~-------~~~~~~ql~~~~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~  143 (344)
                      ..++|..=-..+    .+++.++   ..-       +...+..+|.+|.+-+|+.++|+|+..+..  |.|.|=..-...
T Consensus        90 P~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~--V~LVdsDsfqi~  167 (637)
T COG4248          90 PKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSK--VVLVDSDSFQIN  167 (637)
T ss_pred             ccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCce--EEEEcccceeec
Confidence            888775322222    1222233   222       333345566679999999999999976665  888887654433


Q ss_pred             CCCCCCCCCccCCcccCCcccc-----CCCCCCcchhHHHHHHHHHHHHhC-CCCCCCCCC----hHHHHHHHHH-----
Q 019195          144 LLHSRPKSTVGTPAYIAPEVLS-----RREYDGKLADVWSCGVTLYVMLVG-AYPFEDQED----PKNFRKTISR-----  208 (344)
Q Consensus       144 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~~DiwslG~il~el~~g-~~pf~~~~~----~~~~~~~~~~-----  208 (344)
                      .........+|...|.+||.-.     +..-+ ...|.|.||+++++++.| +.||.+...    .......+..     
T Consensus       168 ~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~-~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~f~y  246 (637)
T COG4248         168 ANGTLHLCPVGVSEFTPPELQTLPSFVGFERT-ANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGRFAY  246 (637)
T ss_pred             cCCceEecccCccccCCHHHhccccccccCCC-ccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcceeee
Confidence            3334444567999999999864     22222 338999999999999887 999976421    1111101110     


Q ss_pred             --Hhhccc----cCCCCCCCCHhHHHHHHHhccc--CCCCCCChHH
Q 019195          209 --IMAVQY----KIPDYVHISQDCRNLLSRIFVA--NPSRRITIKE  246 (344)
Q Consensus       209 --~~~~~~----~~~~~~~~s~~~~~li~~~L~~--dp~~R~s~~e  246 (344)
                        -....+    ..+.+.-+++++..|..+|+..  ++.-|||+..
T Consensus       247 a~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~a  292 (637)
T COG4248         247 ASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKA  292 (637)
T ss_pred             chhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHH
Confidence              000011    1112334688999999999875  3567998653

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.54  E-value=7.8e-07  Score=76.63  Aligned_cols=126  Identities=14%  Similarity=0.162  Sum_probs=82.8

Q ss_pred             eeeeecCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcCCCCC--cceeeEEEEcCCEEEEEEecCCCCC-
Q 019195            8 KDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPN--IIRFKEVVLTPTHLAIVMEYAAGGE-   84 (344)
Q Consensus         8 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~l~~l~h~n--iv~~~~~~~~~~~~~lv~e~~~~g~-   84 (344)
                      .+||+|..+.||+..    +..+++|...... ....+.+|.++++.+..-+  +.+.+.+....+..++||++++|.+ 
T Consensus         7 ~~i~~G~t~~~y~~~----~~~~VlR~~~~~~-~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~   81 (226)
T TIGR02172         7 TQTGEGGNGESYTHK----TGKWMLKLYNPGF-DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS   81 (226)
T ss_pred             eeecCCCCcceeEec----CCCEEEEeCCCCC-CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence            678999999999842    4457888876533 3456889999999885433  4677777777788899999999863 


Q ss_pred             hH--------------HHH-------HhC--CCCC------------------HHHHHHHHHHHHHC-----CeeecCCC
Q 019195           85 LF--------------ERI-------CNA--GRFS------------------EDEARYFFQQLISG-----QICHRDLK  118 (344)
Q Consensus        85 L~--------------~~i-------~~~--~~~~------------------~~~~~~~~~ql~~~-----~iiH~Dik  118 (344)
                      +.              ..+       +..  ....                  ...++..+...+..     .++|+|+.
T Consensus        82 ~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~~  161 (226)
T TIGR02172        82 FSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDFQ  161 (226)
T ss_pred             hhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCCC
Confidence            11              111       110  0001                  00112222222221     67899999


Q ss_pred             CCCeEecCCCCCCEEEeecCCCc
Q 019195          119 LENTLLDGSPAPRLKICDFGYSK  141 (344)
Q Consensus       119 p~NIl~~~~~~~~vkL~DFg~a~  141 (344)
                      |.||+++.++   +.++||+.+.
T Consensus       162 ~~Nii~~~~~---~~iIDwe~a~  181 (226)
T TIGR02172       162 IGNLITSGKG---TYWIDLGDFG  181 (226)
T ss_pred             CCcEEEcCCC---cEEEechhcC
Confidence            9999997544   8899999764

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.51  E-value=9.7e-07  Score=74.99  Aligned_cols=100  Identities=18%  Similarity=0.177  Sum_probs=71.1

Q ss_pred             cHHHHHHHHHHhcCCCC--CcceeeEEEEcC----CEEEEEEecCCCC-ChHHHHHhCCCCCH-------HHHHHHHHHH
Q 019195           42 DANVAREIINHKQLRHP--NIIRFKEVVLTP----THLAIVMEYAAGG-ELFERICNAGRFSE-------DEARYFFQQL  107 (344)
Q Consensus        42 ~~~~~~ei~~l~~l~h~--niv~~~~~~~~~----~~~~lv~e~~~~g-~L~~~i~~~~~~~~-------~~~~~~~~ql  107 (344)
                      ..+..+|...+..|..-  .+++.+.+....    ...++|+|++++. +|.+++......+.       .++..++.+|
T Consensus        55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~l  134 (206)
T PF06293_consen   55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAKL  134 (206)
T ss_pred             chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHHH
Confidence            35688898888887432  334444444432    2458999999884 78888876322222       2455667888


Q ss_pred             HHCCeeecCCCCCCeEecCCC-CCCEEEeecCCCc
Q 019195          108 ISGQICHRDLKLENTLLDGSP-APRLKICDFGYSK  141 (344)
Q Consensus       108 ~~~~iiH~Dikp~NIl~~~~~-~~~vkL~DFg~a~  141 (344)
                      |.+||+|+|++|.|||++.+. ...+.|+||+-++
T Consensus       135 H~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~  169 (206)
T PF06293_consen  135 HDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMR  169 (206)
T ss_pred             HHCcCCCCCCCcccEEEeCCCCceeEEEEcchhce
Confidence            999999999999999998664 3359999999765

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=98.46  E-value=3.3e-06  Score=70.80  Aligned_cols=126  Identities=23%  Similarity=0.238  Sum_probs=91.0

Q ss_pred             eeeeeecCceEEEEEEEcCCCcEEEEEEeecCc-----------------cccHHHHHHHHHHhcCC------CCCccee
Q 019195            7 MKDIGSGNFGVARLMRNKNTKELVAMKYIERGH-----------------KIDANVAREIINHKQLR------HPNIIRF   63 (344)
Q Consensus         7 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----------------~~~~~~~~ei~~l~~l~------h~niv~~   63 (344)
                      ...||+|+.=.||.-.+..   ..+||++....                 .......+|+.....+.      +.+|.++
T Consensus         6 ~~~i~~G~~R~cy~HP~dp---~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~   82 (199)
T PF10707_consen    6 SDLIAQGGERDCYQHPDDP---NLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF   82 (199)
T ss_pred             CcccccCCCceEEECCCCC---CeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence            4579999999998765433   36888886654                 12345667776666655      8999999


Q ss_pred             eEEEEcCCEEEEEEecCCC------CChHHHHHhCCCCCHH---HHHHHHHHHHHCCeeecCCCCCCeEecCCCCC--CE
Q 019195           64 KEVVLTPTHLAIVMEYAAG------GELFERICNAGRFSED---EARYFFQQLISGQICHRDLKLENTLLDGSPAP--RL  132 (344)
Q Consensus        64 ~~~~~~~~~~~lv~e~~~~------g~L~~~i~~~~~~~~~---~~~~~~~ql~~~~iiH~Dikp~NIl~~~~~~~--~v  132 (344)
                      +++.+++-...+|+|.+.+      -+|.+++.+ +.+++.   .+..+...++..+|+.+|++|.||++.....+  ++
T Consensus        83 ~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~-~~~~~~~~~~L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~~~~~~l  161 (199)
T PF10707_consen   83 YGFVETNLGLGLVVELIRDADGNISPTLEDYLKE-GGLTEELRQALDEFKRYLLDHHIVIRDLNPHNIVVQRRDSGEFRL  161 (199)
T ss_pred             eEEEecCCceEEEEEEEECCCCCcCccHHHHHHc-CCccHHHHHHHHHHHHHHHHcCCeecCCCcccEEEEecCCCceEE
Confidence            9999999999999998764      346777744 446552   23344566778899999999999999755443  36


Q ss_pred             EEee
Q 019195          133 KICD  136 (344)
Q Consensus       133 kL~D  136 (344)
                      .|+|
T Consensus       162 vlID  165 (199)
T PF10707_consen  162 VLID  165 (199)
T ss_pred             EEEe
Confidence            7776

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.38  E-value=3.2e-06  Score=72.10  Aligned_cols=126  Identities=19%  Similarity=0.174  Sum_probs=77.0

Q ss_pred             eeeecCceEEEEEEEcCCCcEEEEEEeecCccc-------------------c------HHHHHHHHHHhcCC--CCCcc
Q 019195            9 DIGSGNFGVARLMRNKNTKELVAMKYIERGHKI-------------------D------ANVAREIINHKQLR--HPNII   61 (344)
Q Consensus         9 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-------------------~------~~~~~ei~~l~~l~--h~niv   61 (344)
                      .|+.|--+.||+|.. ..+..+|+|++......                   .      .-..+|+..|+++.  +-.+.
T Consensus        55 ~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP  133 (268)
T COG1718          55 CISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVP  133 (268)
T ss_pred             eecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCC
Confidence            445555568999876 45789999998542210                   0      12446788888773  45555


Q ss_pred             eeeEEEEcCCEEEEEEecCCCCCh-HHHHHhCCCCC---H---HHHHHHHHHHHH-CCeeecCCCCCCeEecCCCCCCEE
Q 019195           62 RFKEVVLTPTHLAIVMEYAAGGEL-FERICNAGRFS---E---DEARYFFQQLIS-GQICHRDLKLENTLLDGSPAPRLK  133 (344)
Q Consensus        62 ~~~~~~~~~~~~~lv~e~~~~g~L-~~~i~~~~~~~---~---~~~~~~~~ql~~-~~iiH~Dikp~NIl~~~~~~~~vk  133 (344)
                      +.+.+..    -.+||||+....+ .-.|+.-+.-+   +   .++...+.-|.. +++||+||+.-|||+..+   .+.
T Consensus       134 ~Pi~~~~----nVLvMEfIg~~g~pAP~LkDv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~~~---~p~  206 (268)
T COG1718         134 EPIAFRN----NVLVMEFIGDDGLPAPRLKDVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVHDG---EPY  206 (268)
T ss_pred             CceeecC----CeEEEEeccCCCCCCCCcccCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEECC---eEE
Confidence            5555542    3599999965421 11122111111   1   123333444445 799999999999999733   389


Q ss_pred             EeecCCCcc
Q 019195          134 ICDFGYSKS  142 (344)
Q Consensus       134 L~DFg~a~~  142 (344)
                      ++|||-|..
T Consensus       207 iID~~QaV~  215 (268)
T COG1718         207 IIDVSQAVT  215 (268)
T ss_pred             EEECccccc
Confidence            999997653

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.37  E-value=3.6e-06  Score=73.50  Aligned_cols=76  Identities=11%  Similarity=0.048  Sum_probs=54.2

Q ss_pred             eeeeecCc-eEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcCC-CCCcceeeEEEEcCCEEEEEEecCCCCCh
Q 019195            8 KDIGSGNF-GVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLR-HPNIIRFKEVVLTPTHLAIVMEYAAGGEL   85 (344)
Q Consensus         8 ~~lg~G~~-g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~g~L   85 (344)
                      ..|..|.+ +.||++...  +..+.+|+.....  ...+.+|+.+++.+. +--+.+++.+....+..++||++++|.+|
T Consensus         4 ~~~~~g~~~~~v~~~~~~--~~~~~vk~~~~~~--~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l   79 (244)
T cd05150           4 ERVTEGQSGATVYRLDGK--NPGLYLKIAPSGP--TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPA   79 (244)
T ss_pred             eecCCCCCcCeEEEEcCC--CCcEEEEecCCCc--ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccH
Confidence            34555655 689999753  3578888775543  345778999988883 44466777777766778999999999777


Q ss_pred             HH
Q 019195           86 FE   87 (344)
Q Consensus        86 ~~   87 (344)
                      ..
T Consensus        80 ~~   81 (244)
T cd05150          80 AA   81 (244)
T ss_pred             hH
Confidence            53

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>PRK09902 hypothetical protein; Provisional

Probab=98.33  E-value=8.5e-06  Score=68.46  Aligned_cols=129  Identities=12%  Similarity=0.077  Sum_probs=85.6

Q ss_pred             eecCceEEEEEEEcCCCcEEEEEEeecC-------ccccHHHHHHHHHHhcCCCC--CcceeeEEE--EcC--CEEEEEE
Q 019195           11 GSGNFGVARLMRNKNTKELVAMKYIERG-------HKIDANVAREIINHKQLRHP--NIIRFKEVV--LTP--THLAIVM   77 (344)
Q Consensus        11 g~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~~~~ei~~l~~l~h~--niv~~~~~~--~~~--~~~~lv~   77 (344)
                      |+||-+-|++......  .|=+|.....       ..-...+.+|+..+.+|..-  .+.+....-  ...  -.-+||+
T Consensus        27 ~rgG~SgV~r~~~~g~--~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT  104 (216)
T PRK09902         27 RRNGMSGVQCVERNGK--KLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT  104 (216)
T ss_pred             CCCCcceEEEEEeCCc--EEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence            4688888888765433  5777766421       11346899999999988432  244444211  111  2468999


Q ss_pred             ecCCC-CChHHHHHhCC--CCCH-------HHHHHHHHHHHHCCeeecCCCCCCeEecCCCCCCEEEeecCCCc
Q 019195           78 EYAAG-GELFERICNAG--RFSE-------DEARYFFQQLISGQICHRDLKLENTLLDGSPAPRLKICDFGYSK  141 (344)
Q Consensus        78 e~~~~-g~L~~~i~~~~--~~~~-------~~~~~~~~ql~~~~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~  141 (344)
                      |-+.| -+|.+++.+..  +.+.       ..+...+.+||.+|+.|+|+.+.|||++..+.-.++++||--++
T Consensus       105 e~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r  178 (216)
T PRK09902        105 EDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSR  178 (216)
T ss_pred             EeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence            96653 67877775532  2232       34556788999999999999999999975543359999998654

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.32  E-value=6.2e-06  Score=71.06  Aligned_cols=78  Identities=15%  Similarity=0.190  Sum_probs=56.7

Q ss_pred             eeeeeecCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcCCCC--CcceeeEEEEc---CCEEEEEEecCC
Q 019195            7 MKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHP--NIIRFKEVVLT---PTHLAIVMEYAA   81 (344)
Q Consensus         7 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~l~~l~h~--niv~~~~~~~~---~~~~~lv~e~~~   81 (344)
                      ++.|+.|..+.||++....  ..+++|..... .....+.+|..+++.+...  .+.+++.....   ....+++|++++
T Consensus         2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~-~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~   78 (239)
T PF01636_consen    2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPP-DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIP   78 (239)
T ss_dssp             EEEEEESSSSEEEEEEETT--SEEEEEEESSH-HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEES
T ss_pred             CccCCCCCeeeEEEEEECC--cEEEEEEeCCC-CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEec
Confidence            5789999999999998765  48999986654 3446788888888888433  35566654322   345799999999


Q ss_pred             CCChHH
Q 019195           82 GGELFE   87 (344)
Q Consensus        82 ~g~L~~   87 (344)
                      |.++..
T Consensus        79 g~~~~~   84 (239)
T PF01636_consen   79 GRPLDD   84 (239)
T ss_dssp             SEEHHH
T ss_pred             cccccc
Confidence            987766

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=98.25  E-value=9.7e-06  Score=82.15  Aligned_cols=193  Identities=21%  Similarity=0.277  Sum_probs=135.5

Q ss_pred             HHHHHHHHhcCCCCCcceeeEEEEcCCE----EEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHC-CeeecCCCC
Q 019195           45 VAREIINHKQLRHPNIIRFKEVVLTPTH----LAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-QICHRDLKL  119 (344)
Q Consensus        45 ~~~ei~~l~~l~h~niv~~~~~~~~~~~----~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~ql~~~-~iiH~Dikp  119 (344)
                      ...|+..+....|+|++.++.+......    ..+..++|.+-++...++..+.++....+.+..++..+ ...|.. +.
T Consensus       229 ~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h~~-~l  307 (1351)
T KOG1035|consen  229 TEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLHSL-SL  307 (1351)
T ss_pred             HHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHHHh-cc
Confidence            3456667777899999999988765432    34677899999999999999999999999888887776 334444 44


Q ss_pred             CCeEecC--------CCCCCEEEe--ecCCCcccCCCCCCCCCccCCcccCCccccCCCCCC-cchhHHHHHHHHHHHHh
Q 019195          120 ENTLLDG--------SPAPRLKIC--DFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDG-KLADVWSCGVTLYVMLV  188 (344)
Q Consensus       120 ~NIl~~~--------~~~~~vkL~--DFg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-~~~DiwslG~il~el~~  188 (344)
                      .|..+..        ++.+.+.++  ||+.++............-+..+.|||......... ...|+|.+|.....+..
T Consensus       308 ~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~~~~~  387 (1351)
T KOG1035|consen  308 EHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLLQLSQ  387 (1351)
T ss_pred             ceeEEecccccccccCccceeecchhhhcccccCCCcccchhhcCccccccccccccccchhhhhhHHHHHHHHHhhhhh
Confidence            4544422        222335555  888877666555555566777888898876655432 23699999999999988


Q ss_pred             CCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCC-HhHHHHHHHhcccCCCCCCChHHHhcCcccc
Q 019195          189 GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHIS-QDCRNLLSRIFVANPSRRITIKEIKSHPWFL  254 (344)
Q Consensus       189 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s-~~~~~li~~~L~~dp~~R~s~~ell~hp~~~  254 (344)
                      |..+-........       .+      +   ..+ ....+++.+|+.-++.+|+++.+++.|||..
T Consensus       388 ~~~i~~~~~~~~~-------~l------~---~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~f~~  438 (1351)
T KOG1035|consen  388 GEDISEKSAVPVS-------LL------D---VLSTSELLDALPKCLDEDSEERLSALELLTHPFLR  438 (1351)
T ss_pred             cCcccccccchhh-------hh------c---cccchhhhhhhhhhcchhhhhccchhhhhhchhcc
Confidence            7544322111110       00      0   111 1678899999999999999999999999965

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=98.24  E-value=5.6e-06  Score=66.90  Aligned_cols=124  Identities=21%  Similarity=0.162  Sum_probs=85.6

Q ss_pred             eeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcCCCCCcce-eeEEEEcCCEEEEEEecCCCC
Q 019195            5 ELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIR-FKEVVLTPTHLAIVMEYAAGG   83 (344)
Q Consensus         5 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~l~~l~h~niv~-~~~~~~~~~~~~lv~e~~~~g   83 (344)
                      ++.+.||+|.+|+||++.+.  |..+|+|+-.. ......+..|.++|..+...++.. +|.+.    ..++.|||+.|-
T Consensus        25 ~v~~~L~KG~~s~Vyl~~~~--~~~~a~Kvrr~-ds~r~~l~kEakiLeil~g~~~~p~vy~yg----~~~i~me~i~G~   97 (201)
T COG2112          25 RVEKELAKGTTSVVYLGEWR--GGEVALKVRRR-DSPRRNLEKEAKILEILAGEGVTPEVYFYG----EDFIRMEYIDGR   97 (201)
T ss_pred             hhhhhhhcccccEEEEeecc--CceEEEEEecC-CcchhhHHHHHHHHHHhhhcCCCceEEEec----hhhhhhhhhcCc
Confidence            45678999999999999864  45799996544 445568999999999987666544 33322    234559999998


Q ss_pred             ChHHHHHhCCCCCHHHHHHHH---HHHHHCCeeecCCCC--CCeEecCCCCCCEEEeecCCCc
Q 019195           84 ELFERICNAGRFSEDEARYFF---QQLISGQICHRDLKL--ENTLLDGSPAPRLKICDFGYSK  141 (344)
Q Consensus        84 ~L~~~i~~~~~~~~~~~~~~~---~ql~~~~iiH~Dikp--~NIl~~~~~~~~vkL~DFg~a~  141 (344)
                      +|.++-...   ...++..++   .-|=..||-|+.|.-  .||+++..   .+.|+||..|+
T Consensus        98 ~L~~~~~~~---~rk~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~---~~~iIDFd~At  154 (201)
T COG2112          98 PLGKLEIGG---DRKHLLRVLEKAYKLDRLGIEHGELSRPWKNVLVNDR---DVYIIDFDSAT  154 (201)
T ss_pred             chhhhhhcc---cHHHHHHHHHHHHHHHHhccchhhhcCCceeEEecCC---cEEEEEccchh
Confidence            887765421   233333332   223334999999974  57777543   38999999876

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=98.19  E-value=2.8e-05  Score=67.38  Aligned_cols=75  Identities=17%  Similarity=0.243  Sum_probs=50.4

Q ss_pred             eeeeeecCceEEEEEEEcC-CCcEEEEEEeecCccccHHHHHHHHHHhcCCCCC-cceeeEEEEcCCEEEEEEecCCCCC
Q 019195            7 MKDIGSGNFGVARLMRNKN-TKELVAMKYIERGHKIDANVAREIINHKQLRHPN-IIRFKEVVLTPTHLAIVMEYAAGGE   84 (344)
Q Consensus         7 ~~~lg~G~~g~V~~~~~~~-~~~~vaiK~~~~~~~~~~~~~~ei~~l~~l~h~n-iv~~~~~~~~~~~~~lv~e~~~~g~   84 (344)
                      ++.|..|-...+|++.... .+..|++|+........-...+|+.+++.+...+ .++++..+.  +  .++|||++|.+
T Consensus         3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~~~d~~~E~~~~~~l~~~gl~P~v~~~~~--~--~~l~e~i~G~~   78 (235)
T cd05157           3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTELIIDRERELRIHKLLSKHGLAPKLYATFQ--N--GLIYEFIPGRT   78 (235)
T ss_pred             EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCccceecHHHHHHHHHHHHhCCCCCeEEEEeC--C--cEEEEeeCCCc
Confidence            5678888889999997543 3567889977654333234457888888885333 444444332  2  48999999876


Q ss_pred             h
Q 019195           85 L   85 (344)
Q Consensus        85 L   85 (344)
                      +
T Consensus        79 l   79 (235)
T cd05157          79 L   79 (235)
T ss_pred             C
Confidence            5

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=98.18  E-value=5.9e-06  Score=71.74  Aligned_cols=73  Identities=10%  Similarity=-0.000  Sum_probs=46.9

Q ss_pred             eeeeeecCce-EEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcCCCC---CcceeeEEEEcC---CEEEEEEec
Q 019195            7 MKDIGSGNFG-VARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHP---NIIRFKEVVLTP---THLAIVMEY   79 (344)
Q Consensus         7 ~~~lg~G~~g-~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~l~~l~h~---niv~~~~~~~~~---~~~~lv~e~   79 (344)
                      ++.|+.|+.. .||++.     ..+++|.... ......+.+|.++++.+...   -+.+++......   ...|++|++
T Consensus         2 ~~~~~~gG~~n~vy~~~-----~~~VlR~~~~-~~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~   75 (235)
T cd05155           2 IEPVDSGGTDNATFRLG-----DDMSVRLPSA-AGYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRW   75 (235)
T ss_pred             ceeccCCCcccceEEcC-----CceEEEcCCc-cchHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEe
Confidence            4678877776 599872     2477786544 22345788999999887532   344444433322   235889999


Q ss_pred             CCCCCh
Q 019195           80 AAGGEL   85 (344)
Q Consensus        80 ~~~g~L   85 (344)
                      ++|.++
T Consensus        76 i~G~~l   81 (235)
T cd05155          76 LEGETA   81 (235)
T ss_pred             ecCCCC
Confidence            999776

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>TIGR02721 ycfN_thiK thiamine kinase

Probab=98.18  E-value=1.3e-05  Score=70.49  Aligned_cols=124  Identities=15%  Similarity=0.103  Sum_probs=75.6

Q ss_pred             eeeecCceEEEEEEEcCCCcEEEEEEeecCcccc-HHHHHHHHHHhcCCCCCc-ceeeEEEEcCCEEEEEEecCCCCChH
Q 019195            9 DIGSGNFGVARLMRNKNTKELVAMKYIERGHKID-ANVAREIINHKQLRHPNI-IRFKEVVLTPTHLAIVMEYAAGGELF   86 (344)
Q Consensus         9 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~ei~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e~~~~g~L~   86 (344)
                      .+..|-.+.+|++.  .++..+++|......... -...+|..+++.+...++ .+++...  .  -++||+|++|..+.
T Consensus         3 ~~~~G~tn~~y~~~--~~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~--~--~~~v~e~i~G~~~~   76 (256)
T TIGR02721         3 TLSGGLTNRSWRIE--HPGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVN--E--HWLLVEWLEGEVIT   76 (256)
T ss_pred             cCCCcCcCCeEEEE--eCCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEe--C--CEEEEEeccCcccc
Confidence            46678888999887  346678889765433221 245789999998854333 3444333  2  26899999986653


Q ss_pred             H--------------HH---HhCC----CCCH-HHHH----------------HHHHHHHHC--------CeeecCCCCC
Q 019195           87 E--------------RI---CNAG----RFSE-DEAR----------------YFFQQLISG--------QICHRDLKLE  120 (344)
Q Consensus        87 ~--------------~i---~~~~----~~~~-~~~~----------------~~~~ql~~~--------~iiH~Dikp~  120 (344)
                      .              .+   +...    .++. ..+.                .++..+...        .++|+|+.|.
T Consensus        77 ~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~  156 (256)
T TIGR02721        77 LDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAY  156 (256)
T ss_pred             cccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcC
Confidence            1              11   1111    1111 1111                122222221        5899999999


Q ss_pred             CeEecCCCCCCEEEeecCCCc
Q 019195          121 NTLLDGSPAPRLKICDFGYSK  141 (344)
Q Consensus       121 NIl~~~~~~~~vkL~DFg~a~  141 (344)
                      ||+++.++   +.|+||..|.
T Consensus       157 Nil~~~~~---~~lIDwE~a~  174 (256)
T TIGR02721       157 NLVVTPQG---LKLIDWEYAS  174 (256)
T ss_pred             cEEEeCCC---CEEEeccccC
Confidence            99997654   7899999765

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=98.16  E-value=7.6e-05  Score=69.33  Aligned_cols=76  Identities=14%  Similarity=0.052  Sum_probs=54.6

Q ss_pred             eeeeeecCceEEEEEEEcCCCcEEEEEEeecC-----c---cccHHHHHHHHHHhcCC---CCCcceeeEEEEcCCEEEE
Q 019195            7 MKDIGSGNFGVARLMRNKNTKELVAMKYIERG-----H---KIDANVAREIINHKQLR---HPNIIRFKEVVLTPTHLAI   75 (344)
Q Consensus         7 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~---~~~~~~~~ei~~l~~l~---h~niv~~~~~~~~~~~~~l   75 (344)
                      .+.||.|.++.||++.....++.|+||.-...     .   ....+...|.+.|+.+.   ..++++++.+  +....++
T Consensus        31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~l  108 (401)
T PRK09550         31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVT  108 (401)
T ss_pred             eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEE
Confidence            46899999999999998654468999975311     1   12356777888888762   3467777765  4566789


Q ss_pred             EEecCCCCC
Q 019195           76 VMEYAAGGE   84 (344)
Q Consensus        76 v~e~~~~g~   84 (344)
                      ||||+++..
T Consensus       109 VME~L~~~~  117 (401)
T PRK09550        109 VMEDLSDHK  117 (401)
T ss_pred             EEecCCCcc
Confidence            999998744

>PLN02876 acyl-CoA dehydrogenase

Probab=98.15  E-value=3e-05  Score=79.41  Aligned_cols=79  Identities=18%  Similarity=0.198  Sum_probs=57.3

Q ss_pred             eeeeeeecCceEEEEEEEcCCC--cEEEEEEeecCcc--ccHHHHHHHHHHhcCC-CCCc--ceeeEEEEcC---CEEEE
Q 019195            6 LMKDIGSGNFGVARLMRNKNTK--ELVAMKYIERGHK--IDANVAREIINHKQLR-HPNI--IRFKEVVLTP---THLAI   75 (344)
Q Consensus         6 ~~~~lg~G~~g~V~~~~~~~~~--~~vaiK~~~~~~~--~~~~~~~ei~~l~~l~-h~ni--v~~~~~~~~~---~~~~l   75 (344)
                      -++.|+.|.++.+|++.....+  ..+++|+......  ....+.+|+++++.+. |+++  .+++.++.+.   +..|+
T Consensus        42 ~v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~fl  121 (822)
T PLN02876         42 KVSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFY  121 (822)
T ss_pred             eEEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceE
Confidence            3677899999999998765432  4677887654322  2246889999999995 6665  7777776654   46789


Q ss_pred             EEecCCCCC
Q 019195           76 VMEYAAGGE   84 (344)
Q Consensus        76 v~e~~~~g~   84 (344)
                      ||||++|..
T Consensus       122 VME~v~G~~  130 (822)
T PLN02876        122 IMEYLEGRI  130 (822)
T ss_pred             EEEecCCcc
Confidence            999998864

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=98.08  E-value=8.7e-05  Score=61.94  Aligned_cols=121  Identities=18%  Similarity=0.198  Sum_probs=85.9

Q ss_pred             CCceeeeeeeecCc-eEEEEEEEcCCCcEEEEEEeec---C------------c-------cccHHHHHHHHHHhcC---
Q 019195            2 EKYELMKDIGSGNF-GVARLMRNKNTKELVAMKYIER---G------------H-------KIDANVAREIINHKQL---   55 (344)
Q Consensus         2 ~~y~~~~~lg~G~~-g~V~~~~~~~~~~~vaiK~~~~---~------------~-------~~~~~~~~ei~~l~~l---   55 (344)
                      .+++.++.||.|.- |.||++..  .|+.||+|++..   .            .       .....+..|.+...+|   
T Consensus        37 ~~I~flefLg~g~~~~~V~kv~I--~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~  114 (207)
T PF13095_consen   37 DDIEFLEFLGHGSHDGYVFKVEI--DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA  114 (207)
T ss_pred             CcEeeeeecCCCCceeEEEEEEE--CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence            36788999999999 99999986  466999999421   0            0       0112466777766555   


Q ss_pred             CCCCc--ceeeEEEEcC------------------CEEEEEEecCCCCChHHHHHhCCCCCH---HHHHHHHHHHHHCCe
Q 019195           56 RHPNI--IRFKEVVLTP------------------THLAIVMEYAAGGELFERICNAGRFSE---DEARYFFQQLISGQI  112 (344)
Q Consensus        56 ~h~ni--v~~~~~~~~~------------------~~~~lv~e~~~~g~L~~~i~~~~~~~~---~~~~~~~~ql~~~~i  112 (344)
                      .+.++  |+++++..-.                  ....||.||++...         .+..   .+++.-+..++..||
T Consensus       115 ~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~---------~~~~~~~~~~~~dl~~~~k~gI  185 (207)
T PF13095_consen  115 GREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP---------PLQIRDIPQMLRDLKILHKLGI  185 (207)
T ss_pred             cccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc---------ccchhHHHHHHHHHHHHHHCCe
Confidence            45666  9999987422                  23578999887654         2333   345555666778899


Q ss_pred             eecCCCCCCeEecCCCCCCEEEeecCCC
Q 019195          113 CHRDLKLENTLLDGSPAPRLKICDFGYS  140 (344)
Q Consensus       113 iH~Dikp~NIl~~~~~~~~vkL~DFg~a  140 (344)
                      +-+|+++.|..   +    -||+|||.+
T Consensus       186 ~~~Dv~~~ny~---~----G~lvDfs~~  206 (207)
T PF13095_consen  186 VPRDVKPRNYR---G----GKLVDFSSS  206 (207)
T ss_pred             eeccCcccccc---C----CEEEecccC
Confidence            99999999987   2    489999964

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=98.05  E-value=3.2e-05  Score=69.55  Aligned_cols=75  Identities=13%  Similarity=0.109  Sum_probs=50.5

Q ss_pred             eeeeeecCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcCCCC--CcceeeEE------EEcCCEEEEEEe
Q 019195            7 MKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHP--NIIRFKEV------VLTPTHLAIVME   78 (344)
Q Consensus         7 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~l~~l~h~--niv~~~~~------~~~~~~~~lv~e   78 (344)
                      ++.|..|....+|++...  +..+++|+...  .....+..|+.++..+.+.  .+.+++..      ....+..+++++
T Consensus        19 i~~i~~G~~n~~y~v~~~--~~~~vLr~~~~--~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~   94 (296)
T cd05153          19 FEGISAGIENTNYFVTTD--SGRYVLTLFEK--VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVE   94 (296)
T ss_pred             eecccCccccceEEEEeC--CCcEEEEEcCC--CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEE
Confidence            667888888899998653  34688998765  2345677788888877432  24444332      223456789999


Q ss_pred             cCCCCCh
Q 019195           79 YAAGGEL   85 (344)
Q Consensus        79 ~~~~g~L   85 (344)
                      +++|.++
T Consensus        95 ~i~G~~~  101 (296)
T cd05153          95 FLAGEHL  101 (296)
T ss_pred             eCCCCCC
Confidence            9998665

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=97.98  E-value=1.1e-06  Score=90.72  Aligned_cols=199  Identities=14%  Similarity=0.077  Sum_probs=131.8

Q ss_pred             HHHHHHHhcCCCCCcceeeEEEEc--CCEEEEEEecCCCCChHHHHHhCC----CCCHHHHHHHHHHHHHC---------
Q 019195           46 AREIINHKQLRHPNIIRFKEVVLT--PTHLAIVMEYAAGGELFERICNAG----RFSEDEARYFFQQLISG---------  110 (344)
Q Consensus        46 ~~ei~~l~~l~h~niv~~~~~~~~--~~~~~lv~e~~~~g~L~~~i~~~~----~~~~~~~~~~~~ql~~~---------  110 (344)
                      ..|...++...|+++...+.-...  ....|..++|+.+|.+++.|.++-    .+...-+.....+.+.+         
T Consensus      1277 l~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tn 1356 (2724)
T KOG1826|consen 1277 LSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTN 1356 (2724)
T ss_pred             hhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhccc
Confidence            344444555689988877655543  245689999999999999986642    23333333333342332         


Q ss_pred             ---CeeecCCCCCCeEecCCCCCCEEEeecCCCcc-cCCCCCCCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHH
Q 019195          111 ---QICHRDLKLENTLLDGSPAPRLKICDFGYSKS-SLLHSRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVM  186 (344)
Q Consensus       111 ---~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~-~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el  186 (344)
                         -.+|+++|+.|.+|..+..  +|++++|+.+. .......+...+++.|++|++...-.+..+ +|+|..|+-+|.+
T Consensus      1357 lg~T~v~~~Lkf~lpmIVtny~--v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N~ik~t~r-sdilr~s~~ly~r 1433 (2724)
T KOG1826|consen 1357 LGNTNVSKSLKFTLPMIVTNYN--VKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKNEIKFTKR-SDILRRSLSLYLR 1433 (2724)
T ss_pred             CCccchhhhhhhhccceecCCc--ccccccccccccCchHhhhhhhhCCHHHHHHHHHHHHhhhhH-HHHHHHHHHHHHH
Confidence               4589999999999987665  99999999983 333333455678999999999988777555 9999999999999


Q ss_pred             HhCCCCCCCCCChHHHHHHHHHHhhc--cccCCCCCCCCHhHHHHHHHhcccCCCCCCChHHHhcCcccc
Q 019195          187 LVGAYPFEDQEDPKNFRKTISRIMAV--QYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFL  254 (344)
Q Consensus       187 ~~g~~pf~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~ell~hp~~~  254 (344)
                      ..|..+|...     ....++.+...  ...++.  -.+.++......+|-..-..||.-...+.-+.|.
T Consensus      1434 s~~n~~fi~f-----lq~~Lkgiidn~tf~sIe~--l~pgdaNve~~~~Ll~K~~~rp~q~isls~d~~a 1496 (2724)
T KOG1826|consen 1434 SDGNAYFIFF-----LQPALKGIIDNHTFFSIEK--LKPGDANVEALHRLLWKYMERPGQYISLSRDHFA 1496 (2724)
T ss_pred             hcccHHHHHH-----HHHHHcCcccccccccccc--cCCCcccHHHHHHHHHHhhhcchhhhhccccccc
Confidence            9887776321     11112111111  111121  1245566666666767778899888888877764

>PRK05231 homoserine kinase; Provisional

Probab=97.91  E-value=0.00012  Score=66.58  Aligned_cols=75  Identities=11%  Similarity=0.035  Sum_probs=45.2

Q ss_pred             eeeeeecCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcCCCCC--cceeeE------EEEcCCEEEEEEe
Q 019195            7 MKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPN--IIRFKE------VVLTPTHLAIVME   78 (344)
Q Consensus         7 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~l~~l~h~n--iv~~~~------~~~~~~~~~lv~e   78 (344)
                      ++.|+.|....+|++... +| .+++|++..  .....+..++.+++.|...+  +.+.+.      +....+..+++++
T Consensus        27 ~~~l~~G~~n~~y~v~t~-~g-~~vLK~~~~--~~~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~  102 (319)
T PRK05231         27 LKGIAEGIENSNFFLTTT-QG-EYVLTLFER--LTAEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVT  102 (319)
T ss_pred             cchhccccccceEEEEeC-CC-cEEEEEecc--CChHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEE
Confidence            456777877899998754 33 688998762  22234445666666553111  333332      1223566899999


Q ss_pred             cCCCCCh
Q 019195           79 YAAGGEL   85 (344)
Q Consensus        79 ~~~~g~L   85 (344)
                      |++|..+
T Consensus       103 ~l~G~~~  109 (319)
T PRK05231        103 FLEGKWP  109 (319)
T ss_pred             ecCCCCC
Confidence            9998653

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=97.91  E-value=0.00011  Score=66.51  Aligned_cols=77  Identities=12%  Similarity=0.080  Sum_probs=48.1

Q ss_pred             eeeeeeecCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcCCCCC--cceeeEE------EEcCCEEEEEE
Q 019195            6 LMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPN--IIRFKEV------VLTPTHLAIVM   77 (344)
Q Consensus         6 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~l~~l~h~n--iv~~~~~------~~~~~~~~lv~   77 (344)
                      .++.++.|....+|++... ++ .+++|+..... ....+..+++++..|...+  +.+++..      ....+..++++
T Consensus        26 ~i~~~~~G~~n~~y~v~t~-~~-~~vLK~~~~~~-~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~  102 (307)
T TIGR00938        26 SLKGIAEGVENSNYLLTTD-VG-RYILTLYEKRV-KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLV  102 (307)
T ss_pred             eccccCCccccceEEEEeC-CC-cEEEEEecCCC-CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEE
Confidence            3667777877899998643 33 57889765532 2345667777777773222  3444332      12245678999


Q ss_pred             ecCCCCCh
Q 019195           78 EYAAGGEL   85 (344)
Q Consensus        78 e~~~~g~L   85 (344)
                      +|++|.++
T Consensus       103 e~i~G~~~  110 (307)
T TIGR00938       103 EFLQGLSV  110 (307)
T ss_pred             EeCCCCCC
Confidence            99998553

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=97.87  E-value=0.00015  Score=65.37  Aligned_cols=76  Identities=12%  Similarity=0.135  Sum_probs=51.7

Q ss_pred             eeeeeecCceEEEEEEEcC------CCcEEEEEEeecCccccHHHHHHHHHHhcCCCCC-cceeeEEEEcCCEEEEEEec
Q 019195            7 MKDIGSGNFGVARLMRNKN------TKELVAMKYIERGHKIDANVAREIINHKQLRHPN-IIRFKEVVLTPTHLAIVMEY   79 (344)
Q Consensus         7 ~~~lg~G~~g~V~~~~~~~------~~~~vaiK~~~~~~~~~~~~~~ei~~l~~l~h~n-iv~~~~~~~~~~~~~lv~e~   79 (344)
                      ++.|..|-...+|++....      .++.|++|+............+|..+++.+...+ ..+++.++. +   .+|++|
T Consensus         3 i~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~-~---~~v~e~   78 (302)
T cd05156           3 VSKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVELLIDRERELVVFARLSERNLGPKLYGIFP-N---GRIEEF   78 (302)
T ss_pred             EEEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCcceechHHHHHHHHHHHhCCCCCceEEEeC-C---Cchhhe
Confidence            4667778888999997643      2578999997665444456778988888885333 344555543 2   358999


Q ss_pred             CCCCChH
Q 019195           80 AAGGELF   86 (344)
Q Consensus        80 ~~~g~L~   86 (344)
                      ++|.++.
T Consensus        79 i~G~~l~   85 (302)
T cd05156          79 IPSRTLT   85 (302)
T ss_pred             eCCCcCC
Confidence            9887663

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>PRK10593 hypothetical protein; Provisional

Probab=97.79  E-value=0.00045  Score=62.13  Aligned_cols=77  Identities=10%  Similarity=0.059  Sum_probs=56.0

Q ss_pred             eeeeeeecCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcCCC---CCcceeeEEEEc---CCEEEEEEec
Q 019195            6 LMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRH---PNIIRFKEVVLT---PTHLAIVMEY   79 (344)
Q Consensus         6 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~l~~l~h---~niv~~~~~~~~---~~~~~lv~e~   79 (344)
                      -.+.||.|..+.||...... + .+.+|.. +.......+.+|...|+.|.-   -.+.++++++..   .+..++|||+
T Consensus        18 ~~~~i~~G~~~~vy~~~~~~-~-~~~~k~~-~~~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~   94 (297)
T PRK10593         18 RVECISEQPYAALWALYDSQ-G-NPMPLMA-RSFSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLER   94 (297)
T ss_pred             eeeecCCccceeEEEEEcCC-C-CEEEEEe-cccccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEec
Confidence            35689999999999986533 3 4666764 332234578899999998843   367788877754   3668999999


Q ss_pred             CCCCCh
Q 019195           80 AAGGEL   85 (344)
Q Consensus        80 ~~~g~L   85 (344)
                      ++|.++
T Consensus        95 i~G~~~  100 (297)
T PRK10593         95 LRGVSV  100 (297)
T ss_pred             cCCEec
Confidence            998764

>KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only]

Probab=97.75  E-value=6.7e-05  Score=70.28  Aligned_cols=166  Identities=16%  Similarity=0.200  Sum_probs=103.8

Q ss_pred             HHHHHHHHHHhcCCCCCcceeeEEEEcC-CEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHCCeeecCCCCCC
Q 019195           43 ANVAREIINHKQLRHPNIIRFKEVVLTP-THLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGQICHRDLKLEN  121 (344)
Q Consensus        43 ~~~~~ei~~l~~l~h~niv~~~~~~~~~-~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~ql~~~~iiH~Dikp~N  121 (344)
                      .+++-..+.++.+.|+|..+++.+.... ....+|||++ +.||.+.+..+. +-.....       ..++.|     -|
T Consensus        27 ~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~~-l~~~s~~-------~~~~~~-----~~   92 (725)
T KOG1093|consen   27 IQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTGN-LKDESLL-------AHGVLH-----LN   92 (725)
T ss_pred             HHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHhcc-cchhhhc-------ccccce-----eh
Confidence            4577788899999999999999887654 4578999999 679988886544 2221111       112221     11


Q ss_pred             eEecCCCCCCEEEeecCCCcccCCCCCCCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHH
Q 019195          122 TLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKN  201 (344)
Q Consensus       122 Il~~~~~~~~vkL~DFg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~  201 (344)
                      |         ++.+| -++...      ....                 ++++||||+|.++.++..|...+......+.
T Consensus        93 ~---------~~~td-~~~t~~------~~~~-----------------~pKsdVwsl~~i~~el~L~~~l~~~~~~s~~  139 (725)
T KOG1093|consen   93 I---------IYITD-HFLTKY------PSPI-----------------GPKSDVWSLGFIILELYLGISLEAELTESEY  139 (725)
T ss_pred             h---------hhccc-cccccC------CCCC-----------------CcchhhhhHHHHHHHHHHhhHHHHHHHHHHH
Confidence            1         33444 111000      1111                 1369999999999999999877765443333


Q ss_pred             HHHHHHHHhhccccC-------CCCCCCCHhHHHHHHHhcccCCCCCCChHHHhcCcccccC
Q 019195          202 FRKTISRIMAVQYKI-------PDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKN  256 (344)
Q Consensus       202 ~~~~~~~~~~~~~~~-------~~~~~~s~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~~  256 (344)
                      ...+.+ ....+...       -....++.-+..++.+|+-..|..||...++.+++-|.+.
T Consensus       140 l~~i~k-~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~k~~i~~ev  200 (725)
T KOG1093|consen  140 LEILLK-YYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPLPMELSKRCSFTEV  200 (725)
T ss_pred             HHHHHH-hccCchhHHHHHHHHHHHHhhhHhHHHHhccCCccccccccchhHHhcCccHHHH
Confidence            222221 11100000       0001245567899999999999999999999999998765

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=97.53  E-value=5.9e-05  Score=66.91  Aligned_cols=129  Identities=16%  Similarity=0.140  Sum_probs=88.5

Q ss_pred             ceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCc-------------------cc----cHHHHHHHHHHhcCC-C-C
Q 019195            4 YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH-------------------KI----DANVAREIINHKQLR-H-P   58 (344)
Q Consensus         4 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------------------~~----~~~~~~ei~~l~~l~-h-~   58 (344)
                      |-+.+.||-|-=+-||.+-+. .|.+.++|.-....                   .+    .-...+|...|+.|. | -
T Consensus        94 ~svGnqIGVGKESDIY~v~d~-~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf  172 (465)
T KOG2268|consen   94 ESVGNQIGVGKESDIYVVADE-EGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF  172 (465)
T ss_pred             hhhccccccccccceEEEecC-CCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence            346788999999999998774 57889999542211                   01    123557888888874 2 2


Q ss_pred             CcceeeEEEEcCCEEEEEEecCCCCChHHHHHhCC-CCCHHHHHHHHHHHHHCCeeecCCCCCCeEecCCCCCCEEEeec
Q 019195           59 NIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAG-RFSEDEARYFFQQLISGQICHRDLKLENTLLDGSPAPRLKICDF  137 (344)
Q Consensus        59 niv~~~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~-~~~~~~~~~~~~ql~~~~iiH~Dikp~NIl~~~~~~~~vkL~DF  137 (344)
                      -+.+.++    -+..++|||++.|..|...-+-.. +---..+..++..|+..|+||+|..--||+++.+..  ++++||
T Consensus       173 pVPkpiD----~~RH~Vvmelv~g~Pl~~v~~v~d~~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~dd~~--i~vIDF  246 (465)
T KOG2268|consen  173 PVPKPID----HNRHCVVMELVDGYPLRQVRHVEDPPTLYDDLMGLIVRLANHGLIHGDFNEFNIMVKDDDK--IVVIDF  246 (465)
T ss_pred             CCCCccc----ccceeeHHHhhcccceeeeeecCChHHHHHHHHHHHHHHHHcCceecccchheeEEecCCC--EEEeec
Confidence            2333333    356789999999988866542211 111234556677788889999999999999986554  999999


Q ss_pred             CC
Q 019195          138 GY  139 (344)
Q Consensus       138 g~  139 (344)
                      --
T Consensus       247 PQ  248 (465)
T KOG2268|consen  247 PQ  248 (465)
T ss_pred             hH
Confidence            63

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=97.48  E-value=0.0091  Score=54.62  Aligned_cols=74  Identities=15%  Similarity=0.117  Sum_probs=49.6

Q ss_pred             eeeecCceEEEEEEEcCCCcEEEEEEeec-----C---ccccHHHHHHHHHHhcCC--CC-CcceeeEEEEcCCEEEEEE
Q 019195            9 DIGSGNFGVARLMRNKNTKELVAMKYIER-----G---HKIDANVAREIINHKQLR--HP-NIIRFKEVVLTPTHLAIVM   77 (344)
Q Consensus         9 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-----~---~~~~~~~~~ei~~l~~l~--h~-niv~~~~~~~~~~~~~lv~   77 (344)
                      .||.|....||++.+...++-|+||.-..     .   .....+...|...|+...  .| ++++++.  .++....+||
T Consensus         2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~--~D~e~~~~vM   79 (370)
T TIGR01767         2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFH--FDTEMAVTVM   79 (370)
T ss_pred             cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEE--EccccceehH
Confidence            57999999999999865446799996431     1   122356667888887663  34 4555543  3566677999


Q ss_pred             ecCCCCC
Q 019195           78 EYAAGGE   84 (344)
Q Consensus        78 e~~~~g~   84 (344)
                      |+++...
T Consensus        80 EdL~~~~   86 (370)
T TIGR01767        80 EDLSHHK   86 (370)
T ss_pred             hhCccch
Confidence            9996533

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>PLN02236 choline kinase

Probab=97.48  E-value=0.0014  Score=60.32  Aligned_cols=131  Identities=16%  Similarity=0.216  Sum_probs=78.8

Q ss_pred             eeeeeeecCceEEEEEEEcC----CCcEEEEEEeecCccccHHHHHHHHHHhcCCCCC-cceeeEEEEcCCEEEEEEecC
Q 019195            6 LMKDIGSGNFGVARLMRNKN----TKELVAMKYIERGHKIDANVAREIINHKQLRHPN-IIRFKEVVLTPTHLAIVMEYA   80 (344)
Q Consensus         6 ~~~~lg~G~~g~V~~~~~~~----~~~~vaiK~~~~~~~~~~~~~~ei~~l~~l~h~n-iv~~~~~~~~~~~~~lv~e~~   80 (344)
                      -+..|..|-...+|++....    .++.|++|+........-...+|..+++.+..-+ -.++++.+.. +   .|.+|+
T Consensus        40 ~i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~idR~~E~~~~~~l~~~gl~P~~~~~~~~-g---~v~efi  115 (344)
T PLN02236         40 QVIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFDRDDEIRTFECMSRHGQGPRLLGRFPN-G---RVEEFI  115 (344)
T ss_pred             EEEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeechHHHHHHHHHHHHcCCCCceEEEECC-c---eEEEee
Confidence            35566668888999987432    3468999987665433333468899988885333 3345555533 2   578999


Q ss_pred             CCCChHHH--------------H---HhCC----C-C-CHHHHHHHHHHH---------------------------HHC
Q 019195           81 AGGELFER--------------I---CNAG----R-F-SEDEARYFFQQL---------------------------ISG  110 (344)
Q Consensus        81 ~~g~L~~~--------------i---~~~~----~-~-~~~~~~~~~~ql---------------------------~~~  110 (344)
                      ++.+|...              +   ++..    . . ...++..++.++                           +..
T Consensus       116 ~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~  195 (344)
T PLN02236        116 HARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSG  195 (344)
T ss_pred             CCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhcc
Confidence            87666311              1   1111    0 1 112222222111                           111


Q ss_pred             -----CeeecCCCCCCeEecCCCCCCEEEeecCCCc
Q 019195          111 -----QICHRDLKLENTLLDGSPAPRLKICDFGYSK  141 (344)
Q Consensus       111 -----~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~  141 (344)
                           .++|+|+++.|||++... +.+.|+||..+.
T Consensus       196 ~~~~~~~cH~Dl~~~Nil~~~~~-~~~~lID~Eya~  230 (344)
T PLN02236        196 DDQEIGFCHNDLQYGNIMIDEET-RAITIIDYEYAS  230 (344)
T ss_pred             cCCCceEEeCCCCcCcEEEeCCC-CcEEEEeehhcc
Confidence                 689999999999997532 349999999764

>PLN02756 S-methyl-5-thioribose kinase

Probab=97.44  E-value=0.0021  Score=59.76  Aligned_cols=73  Identities=15%  Similarity=0.152  Sum_probs=50.3

Q ss_pred             eeeeeeecCceEEEEEEEcCCCcEEEEEEeec-----Cc---cccHHHHHHHHHHhcCC---CCCcceeeEEEEcCCEEE
Q 019195            6 LMKDIGSGNFGVARLMRNKNTKELVAMKYIER-----GH---KIDANVAREIINHKQLR---HPNIIRFKEVVLTPTHLA   74 (344)
Q Consensus         6 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-----~~---~~~~~~~~ei~~l~~l~---h~niv~~~~~~~~~~~~~   74 (344)
                      ..+.||.|....||++.+.  +..|+||.-..     +.   ....+...|...|+.+.   ..++.+++.+..  +..+
T Consensus        36 ~~~eiggGn~N~VyrV~~~--~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~v  111 (418)
T PLN02756         36 KIKEVGDGNLNFVYIVVSS--SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMAL  111 (418)
T ss_pred             eEEEcCCCceeeEEEEEcC--CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCE
Confidence            3668899999999999873  34588997651     11   12345556677776653   247778877765  4567


Q ss_pred             EEEecCCC
Q 019195           75 IVMEYAAG   82 (344)
Q Consensus        75 lv~e~~~~   82 (344)
                      ++||++++
T Consensus       112 lvME~L~~  119 (418)
T PLN02756        112 IGMRYLEP  119 (418)
T ss_pred             EEEeecCC
Confidence            88999977

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=97.43  E-value=0.0025  Score=57.80  Aligned_cols=129  Identities=22%  Similarity=0.213  Sum_probs=80.9

Q ss_pred             eeeeeecCceEEEEEEEcCCCcEEEEEEeecC----------------------cccc-----HHHHHHHHHHhcCCCCC
Q 019195            7 MKDIGSGNFGVARLMRNKNTKELVAMKYIERG----------------------HKID-----ANVAREIINHKQLRHPN   59 (344)
Q Consensus         7 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----------------------~~~~-----~~~~~ei~~l~~l~h~n   59 (344)
                      -..|..|-=+.||.|.. ..|..+|||+.+.+                      ....     --...|++.|++|+.-.
T Consensus       149 nGCiSTGKEANVYHat~-~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aG  227 (520)
T KOG2270|consen  149 NGCISTGKEANVYHATE-EDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAG  227 (520)
T ss_pred             ccccccCccceeEeeec-CCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcC
Confidence            34566777778999976 45777999987431                      0111     12457888888886544


Q ss_pred             cceeeEEEEcCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHH--------CCeeecCCCCCCeEecCCCCCC
Q 019195           60 IIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLIS--------GQICHRDLKLENTLLDGSPAPR  131 (344)
Q Consensus        60 iv~~~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~ql~~--------~~iiH~Dikp~NIl~~~~~~~~  131 (344)
                      |.-. .-+.-. .-.|||+++.+..-..-..+.-.++...+..+..|++.        +++||.||.--|+|+-..   .
T Consensus       228 IP~P-ePIlLk-~hVLVM~FlGrdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~LyhdG---~  302 (520)
T KOG2270|consen  228 IPCP-EPILLK-NHVLVMEFLGRDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLYHDG---K  302 (520)
T ss_pred             CCCC-Cceeee-cceEeeeeccCCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheEECC---E
Confidence            3221 111112 23599999954333222223445666666666655553        399999999999999643   4


Q ss_pred             EEEeecCCCc
Q 019195          132 LKICDFGYSK  141 (344)
Q Consensus       132 vkL~DFg~a~  141 (344)
                      +.++|.+-+.
T Consensus       303 lyiIDVSQSV  312 (520)
T KOG2270|consen  303 LYIIDVSQSV  312 (520)
T ss_pred             EEEEEccccc
Confidence            9999988554

>PRK12396 5-methylribose kinase; Reviewed

Probab=97.41  E-value=0.0056  Score=56.71  Aligned_cols=74  Identities=16%  Similarity=0.107  Sum_probs=51.2

Q ss_pred             eeeeeecCceEEEEEEEcCCCcEEEEEEeec----C---ccccHHHHHHHHHHhcCC--CC-CcceeeEEEEcCCEEEEE
Q 019195            7 MKDIGSGNFGVARLMRNKNTKELVAMKYIER----G---HKIDANVAREIINHKQLR--HP-NIIRFKEVVLTPTHLAIV   76 (344)
Q Consensus         7 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~----~---~~~~~~~~~ei~~l~~l~--h~-niv~~~~~~~~~~~~~lv   76 (344)
                      .+.||.|....||++.+...++-|+||.-..    .   .....+..-|...|+.+.  .| ++++++.  .++....+|
T Consensus        34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~--~D~e~~~~v  111 (409)
T PRK12396         34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYL--FDSVMNCCV  111 (409)
T ss_pred             eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEE--ECcHHhhHH
Confidence            6789999999999999854456789986431    1   122356777888888763  34 4555553  356667789


Q ss_pred             EecCCC
Q 019195           77 MEYAAG   82 (344)
Q Consensus        77 ~e~~~~   82 (344)
                      ||+++.
T Consensus       112 MEdL~~  117 (409)
T PRK12396        112 MEDLSD  117 (409)
T ss_pred             HHhCcc
Confidence            999965

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=97.12  E-value=0.0041  Score=56.01  Aligned_cols=76  Identities=13%  Similarity=0.044  Sum_probs=45.7

Q ss_pred             eeeeeeeecCceEEEEEEEcCCCcEEEEEEeec---CccccHHHHHHHHHHhcCCC--CCcceeeEEEEcCC--EEEEEE
Q 019195            5 ELMKDIGSGNFGVARLMRNKNTKELVAMKYIER---GHKIDANVAREIINHKQLRH--PNIIRFKEVVLTPT--HLAIVM   77 (344)
Q Consensus         5 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~---~~~~~~~~~~ei~~l~~l~h--~niv~~~~~~~~~~--~~~lv~   77 (344)
                      .+++.+..|-...+|.....  ++.+++. ...   .........+|+.+++.+.-  --+...++++.++.  ..|.||
T Consensus        28 ~~v~~~~~G~sn~t~~~~~~--~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~  104 (321)
T COG3173          28 LIVEEISGGWSNDTFRLGDT--GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVM  104 (321)
T ss_pred             ceeeeccCCcccceEEEecC--CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEE
Confidence            34555544544556666554  7778888 331   12233567788888888742  22333455555444  669999


Q ss_pred             ecCCCC
Q 019195           78 EYAAGG   83 (344)
Q Consensus        78 e~~~~g   83 (344)
                      +|+.|.
T Consensus       105 ~~veGe  110 (321)
T COG3173         105 EWVEGE  110 (321)
T ss_pred             EEecce
Confidence            999883

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=97.06  E-value=0.0093  Score=53.21  Aligned_cols=75  Identities=11%  Similarity=0.033  Sum_probs=49.1

Q ss_pred             eeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcCC---CCCcceeeEEEEcCCEEEEEEecCC
Q 019195            5 ELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLR---HPNIIRFKEVVLTPTHLAIVMEYAA   81 (344)
Q Consensus         5 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~l~~l~---h~niv~~~~~~~~~~~~~lv~e~~~   81 (344)
                      +-.+.++.|....+|++.  .+++.+.+|+-.  ......+..|..-|+.|.   .-.+.+.+.+....+.-|++|||++
T Consensus        20 ~~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~--~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~   95 (288)
T PF03881_consen   20 TSIEPVSGGDINEAYRLD--TDGGSYFVKVNS--ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLE   95 (288)
T ss_dssp             -EEEEE--SSSSEEEEEE--TTS-EEEEEEEE--GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE---
T ss_pred             eeeEecCCCChhheEEEE--CCCccEEEEecC--hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeec
Confidence            456788989999999987  567788999766  333456888888888883   4567788888887777799999998


Q ss_pred             CC
Q 019195           82 GG   83 (344)
Q Consensus        82 ~g   83 (344)
                      .+
T Consensus        96 ~~   97 (288)
T PF03881_consen   96 MG   97 (288)
T ss_dssp             --
T ss_pred             CC
Confidence            76

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=97.01  E-value=0.007  Score=55.31  Aligned_cols=75  Identities=13%  Similarity=0.150  Sum_probs=48.1

Q ss_pred             eeeeeecCceEEEEEEEcCC---CcEEEEEEeecCccccHHHHHHHHHHhcCCCCCc-ceeeEEEEcCCEEEEEEecCCC
Q 019195            7 MKDIGSGNFGVARLMRNKNT---KELVAMKYIERGHKIDANVAREIINHKQLRHPNI-IRFKEVVLTPTHLAIVMEYAAG   82 (344)
Q Consensus         7 ~~~lg~G~~g~V~~~~~~~~---~~~vaiK~~~~~~~~~~~~~~ei~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e~~~~   82 (344)
                      ++.|..|=...+|++.....   +..|++|+........-.-.+|..+++.+..-++ .+++.++. .+   +|.+|++|
T Consensus        19 i~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~~IdR~~E~~il~~l~~~gl~P~~l~~~~-~G---~i~~fi~g   94 (330)
T PLN02421         19 VERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDYVIDRERELQAIKYLSAAGFGAKLLGVFG-NG---MIQSFINA   94 (330)
T ss_pred             EEEeCCcccceEEEEEecCCCCCCceEEEEEecCCcCeEechHHHHHHHHHHHhcCCCCceeEEeC-Cc---EeehhhcC
Confidence            45566677778999875432   3478899876544333344678888888864444 34555552 22   58899987


Q ss_pred             CCh
Q 019195           83 GEL   85 (344)
Q Consensus        83 g~L   85 (344)
                      -+|
T Consensus        95 ~~l   97 (330)
T PLN02421         95 RTL   97 (330)
T ss_pred             CCC
Confidence            655

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=96.87  E-value=0.0049  Score=54.80  Aligned_cols=30  Identities=23%  Similarity=0.336  Sum_probs=23.9

Q ss_pred             CeeecCCCCCCeEecCCCCCCEEEeecCCCc
Q 019195          111 QICHRDLKLENTLLDGSPAPRLKICDFGYSK  141 (344)
Q Consensus       111 ~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~  141 (344)
                      .++|+|++|.|||++.++. ..-|+||+.+.
T Consensus       186 ~lvHGD~~~~Nilv~~~~~-~~gviDWe~a~  215 (276)
T cd05152         186 VLVHGDLHPGHILIDEDAR-VTGLIDWTEAK  215 (276)
T ss_pred             eeEeCCCCCCcEEEeCCCC-EEEEECcHhcc
Confidence            5899999999999985321 24699999775

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=96.85  E-value=0.012  Score=53.25  Aligned_cols=29  Identities=21%  Similarity=0.277  Sum_probs=25.3

Q ss_pred             CeeecCCCCCCeEecCCCCCCEEEeecCCCc
Q 019195          111 QICHRDLKLENTLLDGSPAPRLKICDFGYSK  141 (344)
Q Consensus       111 ~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~  141 (344)
                      ++||+|+.+.|+|+++++.  +.++||..+.
T Consensus       197 ~lcHgD~~~~Nvl~~~~~~--~~iIDfd~~~  225 (309)
T TIGR02904       197 VLVHGKLSLSHFLYDETRG--GYFINFEKAS  225 (309)
T ss_pred             eeeCCCCcHHhEEEcCCCC--EEEEEhhhcc
Confidence            8999999999999976654  8999999765

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=96.75  E-value=0.021  Score=51.51  Aligned_cols=64  Identities=17%  Similarity=0.149  Sum_probs=38.9

Q ss_pred             EEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcCCCC--CcceeeEE------EEcCCEEEEEEecCCCCCh
Q 019195           17 VARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHP--NIIRFKEV------VLTPTHLAIVMEYAAGGEL   85 (344)
Q Consensus        17 ~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~l~~l~h~--niv~~~~~------~~~~~~~~lv~e~~~~g~L   85 (344)
                      .||++...  +..+++|++..+   ...+..++..+..|...  .+++++..      ...++..+++++|++|.++
T Consensus        11 ~v~~v~t~--~g~~~LK~~~~~---~~~~~~~~~~~~~L~~~g~~vp~~i~t~~g~~~~~~~~~~~~l~~~i~G~~~   82 (313)
T TIGR02906        11 NVYKVETD--SGNKCLKKINYP---PERLLFILGAQEHLRKNGFNIPKILKTKDGELYVKYNGDLYVLTEWIEGREC   82 (313)
T ss_pred             cEEEEEeC--CCCeEEEEcCCC---HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEehhccCcCC
Confidence            48888743  336899987532   23455667666666322  33444332      1235678999999998554

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only]

Probab=96.72  E-value=0.015  Score=52.88  Aligned_cols=70  Identities=17%  Similarity=0.191  Sum_probs=45.1

Q ss_pred             CceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcCCC---CC---cceee----EEEEcCCEEEEEEecCCCC
Q 019195           14 NFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRH---PN---IIRFK----EVVLTPTHLAIVMEYAAGG   83 (344)
Q Consensus        14 ~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~l~~l~h---~n---iv~~~----~~~~~~~~~~lv~e~~~~g   83 (344)
                      .-..+|++..... + +++|+.... .....+.-|+..+..|.-   +=   +...=    .........+-+++|++|.
T Consensus        37 ~eN~~f~~~~~~g-~-~iLki~~~~-~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~~l~G~  113 (331)
T COG2334          37 EENSNFRVQTEDG-R-YILKIYRPG-WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFEYLPGR  113 (331)
T ss_pred             ccCceEEEEecCC-C-eEEEEecCC-CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEEecCCc
Confidence            3457888876543 3 499988887 666778888888888731   11   12211    1111123788999999997


Q ss_pred             ChH
Q 019195           84 ELF   86 (344)
Q Consensus        84 ~L~   86 (344)
                      .+.
T Consensus       114 ~~~  116 (331)
T COG2334         114 PLE  116 (331)
T ss_pred             CcC
Confidence            776

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=96.52  E-value=0.0082  Score=50.06  Aligned_cols=91  Identities=15%  Similarity=0.092  Sum_probs=65.2

Q ss_pred             HHHHHHHhcCCC-CCcceeeEEEEcCCEEEEEEecCCCCChHHH---HHhCCCCCHHHHHHHHHHHHHC----------C
Q 019195           46 AREIINHKQLRH-PNIIRFKEVVLTPTHLAIVMEYAAGGELFER---ICNAGRFSEDEARYFFQQLISG----------Q  111 (344)
Q Consensus        46 ~~ei~~l~~l~h-~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~---i~~~~~~~~~~~~~~~~ql~~~----------~  111 (344)
                      ..|..+++.+.+ +++++++|++-    .+++.||...+++...   +...-..+......++.+++..          .
T Consensus         7 ~~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~   82 (188)
T PF12260_consen    7 NNEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF   82 (188)
T ss_pred             ccHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence            357888888865 69999999982    2578999987766421   1122234566666666666643          6


Q ss_pred             eeecCCCCCCeEecCCCCCCEEEeecCCCcc
Q 019195          112 ICHRDLKLENTLLDGSPAPRLKICDFGYSKS  142 (344)
Q Consensus       112 iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~  142 (344)
                      +.-.|++|+|+-++.++.  +|++|...+..
T Consensus        83 ~~lcDv~~~nfgv~~~~~--lk~iDld~v~~  111 (188)
T PF12260_consen   83 FYLCDVSPDNFGVNDDGR--LKLIDLDDVFV  111 (188)
T ss_pred             EEEeecchHHeEEeCCCc--EEEEechhcch
Confidence            778899999999986654  99999997653

Proteins in this uncharacterised family are described as transmembrane proteins.

>KOG1236 consensus Predicted unusual protein kinase [General function prediction only]

Probab=96.25  E-value=0.015  Score=53.66  Aligned_cols=55  Identities=18%  Similarity=0.250  Sum_probs=35.1

Q ss_pred             EEEEEEecCCCCChHHHHHhCCCCCHHHHHHH-------HHHHH-HCCeeecCCCCCCeEecCC
Q 019195           72 HLAIVMEYAAGGELFERICNAGRFSEDEARYF-------FQQLI-SGQICHRDLKLENTLLDGS  127 (344)
Q Consensus        72 ~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~-------~~ql~-~~~iiH~Dikp~NIl~~~~  127 (344)
                      ...++-+|..|-++..+++... .++.-.+.+       +.|++ --+++|.|+.|.||++..+
T Consensus       319 ~~vl~E~~~~Gl~v~~~v~~~~-~pe~l~kkva~lg~~AllkMl~vDNFvHaDlHPGNVlirf~  381 (565)
T KOG1236|consen  319 DLVLVETYERGLSVLRFVKWKS-QPEALVKKVAKLGVNALLKMLIVDNFVHADLHPGNVLIRFN  381 (565)
T ss_pred             cceeeeeccccccHHhhhhccc-ChHHHHHHHHHHHHHHHHHHHHhhcceecccCCCcEEEEec
Confidence            3457777998988888775433 333222222       22222 3399999999999999543

>PRK11768 serine/threonine protein kinase; Provisional

Probab=96.25  E-value=0.12  Score=47.15  Aligned_cols=69  Identities=10%  Similarity=0.010  Sum_probs=42.8

Q ss_pred             ceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcCCCC--Ccceee---E--EEEcCCEEEEEEecCCCCC
Q 019195           15 FGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHP--NIIRFK---E--VVLTPTHLAIVMEYAAGGE   84 (344)
Q Consensus        15 ~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~l~~l~h~--niv~~~---~--~~~~~~~~~lv~e~~~~g~   84 (344)
                      -..||++.. .++..+++|+..........+..|+..+..|...  .++...   +  ....++..+.++++++|..
T Consensus        38 eN~vy~v~~-~~~~~~vlKv~r~~~~~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~G~~  113 (325)
T PRK11768         38 ENRVYQFGD-EDGRRVVAKFYRPERWSDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRGGRA  113 (325)
T ss_pred             cceEEEEec-CCCCEEEEEEcCcccCCHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeCCCC
Confidence            357888865 3456799998765444456677888888776321  122211   1  1223567888999998754

>PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2

Probab=96.20  E-value=0.0088  Score=50.85  Aligned_cols=55  Identities=16%  Similarity=0.010  Sum_probs=34.2

Q ss_pred             CcEEEEEEeecCccccHHHHHHHHHHhcCCC-CCcceeeEEEEcCCEEEEEEecCCCCCh
Q 019195           27 KELVAMKYIERGHKIDANVAREIINHKQLRH-PNIIRFKEVVLTPTHLAIVMEYAAGGEL   85 (344)
Q Consensus        27 ~~~vaiK~~~~~~~~~~~~~~ei~~l~~l~h-~niv~~~~~~~~~~~~~lv~e~~~~g~L   85 (344)
                      ++.|++|+........-...+|..+++.+.. ..-.++++.+.. +   .|.+|++|.+|
T Consensus         2 ~~~~~~Ri~g~~t~~~idr~~E~~~~~~l~~~g~~p~~~~~~~~-g---~v~e~i~g~~l   57 (211)
T PF01633_consen    2 PEKYLVRIPGEGTENFIDRENENEALKLLSEAGLGPKIIYFFEN-G---RVEEFIEGRTL   57 (211)
T ss_dssp             TSEEEEEEEESCGCSHHHHHHHHHHHHHHHHTTSSS-EEEEETT-E---EEEE--SSEE-
T ss_pred             CCEEEEEeCCCCcccccCHHHHHHHHHHHHHcCCCCeEEEEcCC-C---cEEEEeccccc
Confidence            3568888887765555667788999988854 444556665533 2   56699977664

7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B ....

>PRK06148 hypothetical protein; Provisional

Probab=96.05  E-value=0.1  Score=54.94  Aligned_cols=77  Identities=12%  Similarity=0.126  Sum_probs=44.5

Q ss_pred             eeeeecCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcC-------CCCCcceee-----EEEEc-CC--E
Q 019195            8 KDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQL-------RHPNIIRFK-----EVVLT-PT--H   72 (344)
Q Consensus         8 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~l~~l-------~h~niv~~~-----~~~~~-~~--~   72 (344)
                      +.|+ |..-.+|++.. .++..|++|+.+... ....+..+...|..|       ..|.+++-.     ..... ++  .
T Consensus        31 ~~L~-s~~d~nf~v~~-~~g~~yVLKi~~~~~-~~~~~~~q~~~L~hL~~~~~glpvP~~i~t~~G~~~~~v~~~~G~~~  107 (1013)
T PRK06148         31 TPLD-GERDLNFRLTT-DDGADYILKIVNPSE-PRVESDFQTAALDHLAAVAPDLPVPRLIPSLSGASLASAQDPDGEPR  107 (1013)
T ss_pred             eecC-CcCCceEEEEe-CCCCeEEEEEcCCcc-chhHHHHHHHHHHHHHhhCCCCCcCeeeecCCCCeEEEeecCCCceE
Confidence            5564 44578898875 456679999987642 223344455555544       233434321     11111 22  5


Q ss_pred             EEEEEecCCCCChHH
Q 019195           73 LAIVMEYAAGGELFE   87 (344)
Q Consensus        73 ~~lv~e~~~~g~L~~   87 (344)
                      ++.+++|++|..+..
T Consensus       108 ~vrLl~~l~G~~l~~  122 (1013)
T PRK06148        108 LLRLLSWLPGTPLAE  122 (1013)
T ss_pred             EEEEEeccCCCcHHh
Confidence            678999999977654

>PRK10271 thiK thiamine kinase; Provisional

Probab=95.96  E-value=0.013  Score=48.49  Aligned_cols=28  Identities=25%  Similarity=0.392  Sum_probs=24.0

Q ss_pred             CeeecCCCCCCeEecCCCCCCEEEeecCCCc
Q 019195          111 QICHRDLKLENTLLDGSPAPRLKICDFGYSK  141 (344)
Q Consensus       111 ~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~  141 (344)
                      -.+|+|+.|.||++.+++   ++|+||+.|.
T Consensus        78 ~p~H~D~~~~N~~~~~~~---~~lIDwe~a~  105 (188)
T PRK10271         78 APLHMDVHAGNLVHSASG---LRLIDWEYAG  105 (188)
T ss_pred             eeecCCCCCccEEEECCC---EEEEeCCccc
Confidence            569999999999997554   8999999875

>PF02958 EcKinase: Ecdysteroid kinase; InterPro: IPR004119 This family includes proteins of unknown function

Probab=95.65  E-value=0.07  Score=47.76  Aligned_cols=31  Identities=23%  Similarity=0.433  Sum_probs=25.6

Q ss_pred             CeeecCCCCCCeEecCCCCC---CEEEeecCCCc
Q 019195          111 QICHRDLKLENTLLDGSPAP---RLKICDFGYSK  141 (344)
Q Consensus       111 ~iiH~Dikp~NIl~~~~~~~---~vkL~DFg~a~  141 (344)
                      -++|||+++.|||+..+..+   .+++.||-+++
T Consensus       216 vl~HGD~w~nNilf~~~~~g~~~~~~liDfQ~~~  249 (294)
T PF02958_consen  216 VLCHGDFWTNNILFKYDDDGKPIDVVLIDFQLAR  249 (294)
T ss_pred             EEEcCccCHHhEeEccccccccccceeecccccc
Confidence            57999999999999765443   58999999765

All known members of this group are proteins from drosophila and Caenorhabditis elegans.

>PTZ00384 choline kinase; Provisional

Probab=95.64  E-value=0.2  Score=46.75  Aligned_cols=76  Identities=11%  Similarity=0.004  Sum_probs=46.6

Q ss_pred             eeeeeeecCceEEEEEEEcCCC-c-----EEEEEEeecCccccHHHHHHHHHHhcCCCC-CcceeeEEEEcCCEEEEEEe
Q 019195            6 LMKDIGSGNFGVARLMRNKNTK-E-----LVAMKYIERGHKIDANVAREIINHKQLRHP-NIIRFKEVVLTPTHLAIVME   78 (344)
Q Consensus         6 ~~~~lg~G~~g~V~~~~~~~~~-~-----~vaiK~~~~~~~~~~~~~~ei~~l~~l~h~-niv~~~~~~~~~~~~~lv~e   78 (344)
                      .++.|..|-...+|++...... .     .|.++.........-.-.+|+.+++.+... .-.++++.+..    +++.|
T Consensus        54 ~i~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~~----g~l~e  129 (383)
T PTZ00384         54 EIKKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTYNSLVIDNDLQYNIAKLLGDNNFGPKIIGRFGD----FTIQE  129 (383)
T ss_pred             EEEEeCCcccceEEEEEecCCCCCccccceEEEEeccCCCceEeccHHHHHHHHHHHhCCCCCeEEEecCC----EEEEE
Confidence            4556666888899999754321 2     244443322222222345789999999644 44555666532    58999


Q ss_pred             cCCCCCh
Q 019195           79 YAAGGEL   85 (344)
Q Consensus        79 ~~~~g~L   85 (344)
                      |++|-+|
T Consensus       130 fIeGr~l  136 (383)
T PTZ00384        130 WVEGNTM  136 (383)
T ss_pred             EeccccC
Confidence            9998766

>PF04655 APH_6_hur: Aminoglycoside/hydroxyurea antibiotic resistance kinase; InterPro: IPR006748 The aminoglycosides are a large group of biologically active bacterial secondary metabolites, best known for their antibiotic properties []

Probab=95.42  E-value=0.058  Score=47.16  Aligned_cols=79  Identities=13%  Similarity=0.091  Sum_probs=52.7

Q ss_pred             eeeeeeecCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEEecC-CCCC
Q 019195            6 LMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYA-AGGE   84 (344)
Q Consensus         6 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~-~~g~   84 (344)
                      +...+..|+.+.|+.+.. .+|..+++|+........... .....|+..+-...|++++.-  ...-.+++|.+ ++.+
T Consensus         6 ~~~~~~~g~~s~V~pv~~-~dG~~avLKl~~p~~~~~~E~-~g~~~L~~w~G~GaVrll~~d--~~~~AlLLErl~~g~~   81 (253)
T PF04655_consen    6 PDGPPAHGSSSLVVPVRR-ADGTPAVLKLAPPHAEAEHEA-RGEAALRWWNGRGAVRLLAAD--PERGALLLERLDPGRS   81 (253)
T ss_pred             cCCCCCCCcceEEEEEEc-CCCCeEEEEecCCcccchhhh-hHHhHhheeCCCCceeeeccc--cccchhhhhhccCCCc
Confidence            344566788999999974 568899999876543322211 122457888888899988764  34556888888 4456


Q ss_pred             hHHH
Q 019195           85 LFER   88 (344)
Q Consensus        85 L~~~   88 (344)
                      |.+.
T Consensus        82 L~~~   85 (253)
T PF04655_consen   82 LASL   85 (253)
T ss_pred             hhhc
Confidence            6443

Aminoglycoside phosphotransferases achieve inactivation of these enzymes by phosphorylation, utilising ATP. Likewise, hydroxyurea is inactivated by phosphorylation of the hydroxy group in the hydroxylamine moiety.; GO: 0016773 phosphotransferase activity, alcohol group as acceptor, 0006468 protein phosphorylation, 0019748 secondary metabolic process

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	344
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		1e-137
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		1e-136
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		1e-136
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		1e-135
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		1e-132
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		1e-130
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		3e-52
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		4e-48
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		8e-48
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		4e-47
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		4e-47
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		6e-47
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		6e-47
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		9e-47
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		1e-46
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		2e-46
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		3e-46
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		4e-46
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		8e-46
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		5e-44
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		2e-43
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		2e-43
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		2e-43
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		9e-42
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		1e-38
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		2e-38
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		3e-38
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		4e-38
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		4e-38
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		5e-38
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		5e-38
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		7e-38
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		7e-38
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		8e-38
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		8e-38
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		9e-38
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		1e-37
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		1e-37
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		2e-37
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		3e-37
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		3e-37
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		1e-36
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		1e-36
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		1e-36
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		2e-36
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		2e-36
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		3e-36
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		3e-36
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		4e-36
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		4e-36
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		5e-36
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		5e-36
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		5e-36
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		6e-36
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		6e-36
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		7e-36
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		7e-36
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		7e-36
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		7e-36
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		7e-36
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		8e-36
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		8e-36
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		8e-36
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		8e-36
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		8e-36
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		9e-36
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		9e-36
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		9e-36
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		9e-36
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		1e-35
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		1e-35
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		1e-35
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		1e-35
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		1e-35
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		2e-35
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		2e-35
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		2e-35
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		2e-35
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		2e-35
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		2e-35
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		2e-35
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		2e-35
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		2e-35
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		2e-35
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		2e-35
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		2e-35
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		3e-35
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		3e-35
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		3e-35
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		3e-35
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		3e-35
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		3e-35
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		3e-35
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		3e-35
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		3e-35
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		3e-35
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		3e-35
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		4e-35
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		4e-35
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		6e-35
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		7e-35
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		7e-35
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		7e-35
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		9e-35
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		9e-35
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		1e-34
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		3e-34
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		3e-34
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		2e-33
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		5e-33
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		9e-33
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		1e-32
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		1e-32
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		1e-32
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		1e-32
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		2e-32
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		2e-32
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		2e-32
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		2e-32
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		2e-32
3soa_A	444	Full-Length Human Camkii Length = 444		3e-32
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		3e-32
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		3e-32
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		6e-32
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		6e-32
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		7e-32
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		1e-31
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		1e-31
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		1e-31
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		2e-31
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		3e-31
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		3e-31
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		3e-31
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		3e-31
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		3e-31
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		3e-31
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		4e-31
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		4e-31
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		1e-30
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		1e-30
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		1e-30
3g51_A	325	Structural Diversity Of The Active Conformation Of		1e-30
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		2e-30
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		2e-30
3kk8_A	284	Camkii Substrate Complex A Length = 284		2e-30
3kk9_A	282	Camkii Substrate Complex B Length = 282		2e-30
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		2e-30
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		2e-30
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		3e-30
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		3e-30
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		5e-30
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		5e-30
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		5e-30
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		6e-30
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		6e-30
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		6e-30
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		7e-30
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		7e-30
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		8e-30
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		8e-30
4ae6_A	343	Structure And Function Of The Human Sperm-specific		8e-30
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		8e-30
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		8e-30
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		8e-30
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		8e-30
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		9e-30
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		9e-30
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		9e-30
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		9e-30
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		9e-30
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		9e-30
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		1e-29
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		1e-29
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		1e-29
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		1e-29
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		1e-29
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		1e-29
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		1e-29
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		1e-29
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		1e-29
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		2e-29
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		2e-29
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		2e-29
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		2e-29
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		2e-29
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		2e-29
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		2e-29
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		2e-29
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		2e-29
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		2e-29
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		2e-29
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		3e-29
4ae9_A	343	Structure And Function Of The Human Sperm-specific		3e-29
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		3e-29
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		3e-29
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		3e-29
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		3e-29
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		3e-29
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		4e-29
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		4e-29
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		4e-29
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		4e-29
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		4e-29
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		4e-29
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		4e-29
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		4e-29
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		5e-29
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		6e-29
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		6e-29
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		7e-29
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		8e-29
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		9e-29
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		1e-28
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		1e-28
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		1e-28
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		1e-28
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		1e-28
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		1e-28
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		1e-28
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		1e-28
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		2e-28
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		2e-28
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		2e-28
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		2e-28
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		2e-28
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		2e-28
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		2e-28
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		2e-28
2oza_A	356	Structure Of P38alpha Complex Length = 356		2e-28
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		2e-28
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		2e-28
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		2e-28
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		2e-28
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		3e-28
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		1e-27
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		1e-27
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		1e-27
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		1e-27
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		1e-27
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		3e-27
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		5e-27
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		1e-26
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		1e-26
1nxk_A	400	Crystal Structure Of Staurosporine Bound To Map Kap		2e-26
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		4e-26
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		5e-26
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		7e-26
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		1e-25
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		1e-25
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		2e-25
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		2e-25
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		2e-25
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		2e-25
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		3e-25
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		4e-25
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		4e-25
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		4e-25
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		4e-25
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		4e-25
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		1e-24
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		1e-24
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		2e-24
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		2e-24
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		2e-24
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		3e-24
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		4e-24
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		5e-24
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		5e-24
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		6e-24
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		8e-24
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		1e-23
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		1e-23
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		1e-23
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		2e-23
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		3e-23
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		6e-23
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		7e-23
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		8e-23
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		1e-22
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		2e-22
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		2e-22
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		2e-22
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		2e-22
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		2e-22
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		2e-22
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		3e-22
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		3e-22
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		3e-22
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		3e-22
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		3e-22
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		3e-22
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		3e-22
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		3e-22
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		3e-22
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		3e-22
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		4e-22
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		5e-22
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		5e-22
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		7e-22
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		2e-21
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		4e-21
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		4e-21
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		7e-21
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		7e-21
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		8e-21
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		1e-20
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		1e-20
4fie_A	423	Full-Length Human Pak4 Length = 423		1e-20
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		2e-20
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		2e-20
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		2e-20
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		2e-20
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		2e-20
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		2e-20
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		3e-20
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		3e-20
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		3e-20
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		3e-20
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		4e-20
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		4e-20
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		4e-20
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		4e-20
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		4e-20
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		4e-20
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		4e-20
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		4e-20
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		4e-20
3kga_A	299	Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe		4e-20
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		5e-20
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		5e-20
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		5e-20
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		5e-20
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		6e-20
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		6e-20
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		6e-20
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		6e-20
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		6e-20
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		6e-20
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		6e-20
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		6e-20
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		6e-20
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		6e-20
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		6e-20
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		7e-20
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		7e-20
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		7e-20
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		7e-20
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		7e-20
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		7e-20
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		7e-20
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		7e-20
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		8e-20
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		8e-20
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		8e-20
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		8e-20
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		8e-20
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		8e-20
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		8e-20
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		8e-20
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		9e-20
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		9e-20
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		9e-20
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		9e-20
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		9e-20
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		9e-20
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		9e-20
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		1e-19
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		1e-19
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		1e-19
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		1e-19
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		1e-19
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		1e-19
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		1e-19
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		1e-19
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		1e-19
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		1e-19
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		1e-19
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		1e-19
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		1e-19
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		1e-19
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		2e-19
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		2e-19
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		2e-19
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		2e-19
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		3e-19
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		3e-19
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		3e-19
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		3e-19
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		4e-19
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		4e-19
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		5e-19
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		5e-19
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		9e-19
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		2e-18
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		3e-18
4alu_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		3e-18
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		3e-18
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		4e-18
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		4e-18
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		5e-18
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		5e-18
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		5e-18
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		5e-18
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		9e-18
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		1e-17
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		1e-17
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-17
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-17
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-17
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		2e-17
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		2e-17
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		3e-17
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		3e-17
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		3e-17
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		4e-17
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		4e-17
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		4e-17
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		4e-17
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		5e-17
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		7e-17
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		9e-17
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		1e-16
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		2e-16
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		2e-16
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		2e-16
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		2e-16
3a7f_A	303	Human Mst3 Kinase Length = 303		2e-16
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		2e-16
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		3e-16
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		3e-16
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		4e-16
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		5e-16
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		6e-16
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		8e-16
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		9e-16
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		1e-15
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		2e-15
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		2e-15
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		2e-15
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		3e-15
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		5e-15
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		5e-15
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		5e-15
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		5e-15
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		6e-15
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		6e-15
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		7e-15
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		8e-15
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		1e-14
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		1e-14
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		1e-14
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		2e-14
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		2e-14
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		3e-14
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		3e-14
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		3e-14
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		3e-14
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		3e-14
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		4e-14
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		2e-13
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		3e-13
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		5e-13
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		9e-13
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		1e-12
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		1e-12
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		1e-12
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		1e-12
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		2e-12
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		2e-12
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		2e-12
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		2e-12
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		2e-12
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		2e-12
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		3e-12
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		3e-12
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		3e-12
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		3e-12
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		3e-12
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		3e-12
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		3e-12
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		3e-12
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		3e-12
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		4e-12
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		4e-12
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		4e-12
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		5e-12
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		5e-12
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		5e-12
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		5e-12
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		5e-12
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		5e-12
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		5e-12
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		6e-12
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		6e-12
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		6e-12
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		6e-12
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		9e-12
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		1e-11
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		1e-11
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		1e-11
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		1e-11
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		1e-11
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		1e-11
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		1e-11
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		1e-11
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		1e-11
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		1e-11
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		1e-11
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		1e-11
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		1e-11
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		1e-11
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		1e-11
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		1e-11
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		1e-11
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		1e-11
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		2e-11
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		2e-11
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		2e-11
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		2e-11
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		3e-11
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		3e-11
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		3e-11
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		4e-11
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		4e-11
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		4e-11
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		4e-11
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		4e-11
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		4e-11
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		5e-11
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		5e-11
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		5e-11
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		5e-11
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		6e-11
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		6e-11
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		6e-11
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		6e-11
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		6e-11
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		7e-11
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		7e-11
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		7e-11
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		7e-11
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		7e-11
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		7e-11
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		7e-11
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		7e-11
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		8e-11
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		8e-11
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		8e-11
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		8e-11
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		9e-11
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		9e-11
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		9e-11
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		9e-11
2oza_B	366	Structure Of P38alpha Complex Length = 366		9e-11
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		9e-11
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		9e-11
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		1e-10
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		1e-10
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		1e-10
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		1e-10
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		1e-10
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		1e-10
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		1e-10
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		1e-10
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		1e-10
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		1e-10
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		1e-10
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		1e-10
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		1e-10
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		1e-10
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		1e-10
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		1e-10
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		1e-10
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		1e-10
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		1e-10
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		1e-10
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		1e-10
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		1e-10
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		1e-10
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		1e-10
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		1e-10
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		1e-10
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		1e-10
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		1e-10
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		1e-10
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		1e-10
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		1e-10
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		1e-10
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		1e-10
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		1e-10
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		1e-10
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		1e-10
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		1e-10
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		1e-10
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		1e-10
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		1e-10
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		1e-10
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		1e-10
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		1e-10
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		1e-10
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		2e-10
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		2e-10
3hec_A	348	P38 In Complex With Imatinib Length = 348		2e-10
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-10
4exu_A	371	Mapk13, Inactive Form Length = 371		2e-10
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		2e-10
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		2e-10
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		2e-10
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		2e-10
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		2e-10
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		2e-10
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		2e-10
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		2e-10
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		2e-10
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		2e-10
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		2e-10
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		2e-10
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		2e-10
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		2e-10
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		2e-10
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		2e-10
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		2e-10
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		2e-10
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		2e-10
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		2e-10
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		2e-10
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-10
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		2e-10
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		3e-10
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		3e-10
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		3e-10
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		3e-10
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		4e-10
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		4e-10
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		4e-10
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		4e-10
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		4e-10
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		4e-10
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		5e-10
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		5e-10
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		5e-10
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		5e-10
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		5e-10
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		5e-10
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		5e-10
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		5e-10
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		5e-10
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		5e-10
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		5e-10
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		6e-10
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		7e-10
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		7e-10
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		7e-10
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		7e-10
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		7e-10
3kvw_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		8e-10
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		8e-10
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		9e-10
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		9e-10
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		1e-09
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		1e-09
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		1e-09
4azf_A	417	Human Dyrk2 In Complex With Leucettine L41 Length =		1e-09
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		1e-09
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		1e-09
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		1e-09
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-09
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		1e-09
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		1e-09
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		1e-09
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		1e-09
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		2e-09
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		2e-09
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		2e-09
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		2e-09
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		2e-09
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		2e-09
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		2e-09
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-09
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		2e-09
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		2e-09
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		2e-09
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-09
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		2e-09
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		2e-09
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-09
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		2e-09
3k2l_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		2e-09
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		2e-09
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		4e-09
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		4e-09
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		4e-09
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		4e-09
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		4e-09
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		4e-09
2vx3_A	382	Crystal Structure Of The Human Dual Specificity Tyr		4e-09
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		5e-09
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		5e-09
4aze_A	382	Human Dyrk1a In Complex With Leucettine L41 Length		5e-09
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		5e-09
3anq_A	368	Human Dyrk1aINHIBITOR COMPLEX Length = 368		5e-09
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		6e-09
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		6e-09
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		6e-09
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		6e-09
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		7e-09
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		7e-09
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		8e-09
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		8e-09
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		8e-09
3eb0_A	383	Crystal Structure Of Cgd4_240 From Cryptosporidium		9e-09
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		1e-08
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		1e-08
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		1e-08
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		1e-08
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		1e-08
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		1e-08
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		1e-08
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		1e-08
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-08
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		1e-08
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		1e-08
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		2e-08
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		2e-08
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		2e-08
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		2e-08
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		2e-08
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		2e-08
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		2e-08
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		2e-08
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		2e-08
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		2e-08
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		2e-08
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		2e-08
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		3e-08
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		4e-08
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		4e-08
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		4e-08
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		5e-08
2wtk_B	373	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		6e-08
3gni_B	389	Structure Of Strad And Mo25 Length = 389		6e-08
3a4o_X	286	Lyn Kinase Domain Length = 286		6e-08
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		7e-08
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		8e-08
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		8e-08
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		8e-08
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		8e-08
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		9e-08
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		9e-08
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		1e-07
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		1e-07
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		1e-07
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-07
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		2e-07
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		2e-07
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		2e-07
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		2e-07
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-07
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		2e-07
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		2e-07
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		3e-07
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		3e-07
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		3e-07
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		3e-07
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		3e-07
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		3e-07
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		3e-07
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		4e-07
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		4e-07
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		4e-07
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		4e-07
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		4e-07
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		4e-07
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		4e-07
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		4e-07
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		4e-07
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		4e-07
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		4e-07
4h58_A	275	Braf In Complex With Compound 3 Length = 275		4e-07
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		4e-07
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		5e-07
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		5e-07
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		5e-07
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		5e-07
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		5e-07
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		6e-07
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		7e-07
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		7e-07
2wu6_A	381	Crystal Structure Of The Human Clk3 In Complex With		8e-07
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		8e-07
2exe_A	357	Crystal Structure Of The Phosphorylated Clk3 Length		8e-07
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		9e-07
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		9e-07
2eu9_A	355	Crystal Structure Of Clk3 Length = 355		1e-06
1na7_A	329	Crystal Structure Of The Catalytic Subunit Of Human		1e-06
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		1e-06
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-06
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		2e-06
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		2e-06
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		2e-06
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		2e-06
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		2e-06
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		2e-06
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		2e-06
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		2e-06
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		2e-06
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-06
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-06
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		2e-06
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		2e-06
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-06
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-06
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		2e-06
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		2e-06
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		3e-06
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-06
1oec_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		3e-06
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		3e-06
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		3e-06
3b2t_A	311	Structure Of Phosphotransferase Length = 311		3e-06
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-06
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		3e-06
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		3e-06
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		3e-06
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		3e-06
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		4e-06
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-06
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-06
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		5e-06
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		5e-06
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		5e-06
2z2w_A	285	Humand Wee1 Kinase Complexed With Inhibitor Pf03357		5e-06
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		6e-06
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		6e-06
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		6e-06
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		6e-06
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		7e-06
2in6_A	287	Wee1 Kinase Complex With Inhibitor Pd311839 Length		7e-06
3bi6_A	287	Wee1 Kinase Complex With Inhibitor Pd352396 Length		7e-06
1how_A	373	The X-Ray Crystal Structure Of Sky1p, An Sr Protein		8e-06
1x8b_A	289	Structure Of Human Wee1a Kinase: Kinase Domain Comp		8e-06
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		8e-06
1q8y_A	373	The Structure Of The Yeast Sr Protein Kinase, Sky1p		8e-06
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		9e-06
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		9e-06
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		9e-06
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		9e-06
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		9e-06
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		9e-06
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		1e-05
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-05
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		1e-05
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		1e-05
3ofm_A	350	Structure Of A Human Ck2alpha Prime, The Paralog Is		1e-05
3e3b_X	339	Crystal Structure Of Catalytic Subunit Of Human Pro		1e-05
3llt_A	360	Crystal Structure Of Pf14_0431, Kinase Domain Lengt		1e-05
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		2e-05
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		2e-05
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		2e-05
1fvr_A	327	Tie2 Kinase Domain Length = 327		2e-05
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		3e-05
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		3e-05
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		3e-05
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		4e-05
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		4e-05
4f99_A	361	Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti		4e-05
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		5e-05
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		5e-05
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		5e-05
3juh_A	335	Crystal Structure Of A Mutant Of Human Protein Kina		6e-05
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		7e-05
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		8e-05
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		8e-05
3kmw_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		8e-05
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		9e-05
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		9e-05
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		1e-04
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		1e-04
1pjk_A	334	Crystal Structure Of A C-terminal Deletion Mutant O		1e-04
3nga_A	333	Human Ck2 Catalytic Domain In Complex With Cx-4945		1e-04
3h30_A	334	Crystal Structure Of The Catalytic Subunit Of Human		1e-04
2r7i_A	335	Crystal Structure Of Catalytic Subunit Of Protein K		1e-04
3bqc_A	335	High Ph-Value Crystal Structure Of Emodin In Comple		1e-04
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		1e-04
3nr9_A	368	Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length		1e-04
2zjw_A	340	Crystal Structure Of Human Ck2 Alpha Complexed With		1e-04
3q9w_A	336	Crystal Structure Of Human Ck2 Alpha In Complex Wit		1e-04
3mb6_A	331	Human Ck2 Catalytic Domain In Complex With A Difura		1e-04
1jwh_A	337	Crystal Structure Of Human Protein Kinase Ck2 Holoe		1e-04
3nsz_A	330	Human Ck2 Catalytic Domain In Complex With Amppn Le		1e-04
3q04_A	328	Crystal Structure Of The Apo-Form Of Human Ck2 Alph		1e-04
3u87_A	349	Structure Of A Chimeric Construct Of Human Ck2alpha		1e-04
4dgl_C	335	Crystal Structure Of The Ck2 Tetrameric Holoenzyme		2e-04
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		2e-04
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		2e-04
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		2e-04
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		2e-04
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		2e-04
3lj0_A	434	Ire1 Complexed With Adp And Quercetin Length = 434		3e-04
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		3e-04
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		3e-04
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		3e-04
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		3e-04
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		5e-04
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		6e-04
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		6e-04
3beg_A	381	Crystal Structure Of Sr Protein Kinase 1 Complexed		6e-04
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		6e-04
1wbp_A	397	Srpk1 Bound To 9mer Docking Motif Peptide Length =		6e-04
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		6e-04
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		6e-04
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		6e-04
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		7e-04
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		8e-04
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		8e-04
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		8e-04
3kmu_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		9e-04

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score =  483 bits (1244), Expect = e-137,   Method: Compositional matrix adjust.
 Identities = 229/310 (73%), Positives = 267/310 (86%), Gaps = 12/310 (3%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNII 61
           ++YEL+KDIGSGNFGVARLMR+K + ELVA+KYIERG KID NV REIINH+ LRHPNI+
Sbjct: 18  DRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKIDENVKREIINHRSLRHPNIV 77
Query: 62  RFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-------QICH 114
           RFKEV+LTPTHLAIVMEYA+GGELFERICNAGRFSEDEAR+FFQQLISG       Q+CH
Sbjct: 78  RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCH 137
Query: 115 RDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLA 174
           RDLKLENTLLDGSPAPRLKICDFGYSKSS+LHS+PKSTVGTPAYIAPEVL ++EYDGK+A
Sbjct: 138 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKVA 197
Query: 175 DVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIF 234
           DVWSCGVTLYVMLVGAYPFED E+PKNFRKTI RI+ VQY IPDYVHIS +CR+L+SRIF
Sbjct: 198 DVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPDYVHISPECRHLISRIF 257
Query: 235 VANPSRRITIKEIKSHPWFLKNLPRELT--ETAQAIYYRKENPTFSLQSVEEITKIVEEA 292
           VA+P++RI+I EI++H WFLKNLP +L    T    +   + P    QS+EEI +I+ EA
Sbjct: 258 VADPAKRISIPEIRNHEWFLKNLPADLMNDNTMTTQFAASDQPG---QSIEEIMQIIAEA 314
Query: 293 KVPPPVSRSI 302
            VPP  ++++
Sbjct: 315 TVPPAGTQNL 324

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score =  482 bits (1240), Expect = e-136,   Method: Compositional matrix adjust.
 Identities = 229/310 (73%), Positives = 267/310 (86%), Gaps = 12/310 (3%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNII 61
           ++YEL+KDIGSGNFGVARLMR+K + ELVA+KYIERG KI ANV REIINH+ LRHPNI+
Sbjct: 19  DRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKIAANVKREIINHRSLRHPNIV 78
Query: 62  RFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-------QICH 114
           RFKEV+LTPTHLAIVMEYA+GGELFERICNAGRFSEDEAR+FFQQLISG       Q+CH
Sbjct: 79  RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCH 138
Query: 115 RDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLA 174
           RDLKLENTLLDGSPAPRLKICDFGYSKSS+LHS+PKSTVGTPAYIAPEVL ++EYDGK+A
Sbjct: 139 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKVA 198
Query: 175 DVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIF 234
           DVWSCGVTLYVMLVGAYPFED E+PKNFRKTI RI+ VQY IPDYVHIS +CR+L+SRIF
Sbjct: 199 DVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPDYVHISPECRHLISRIF 258
Query: 235 VANPSRRITIKEIKSHPWFLKNLPRELT--ETAQAIYYRKENPTFSLQSVEEITKIVEEA 292
           VA+P++RI+I EI++H WFLKNLP +L    T    +   + P    QS+EEI +I+ EA
Sbjct: 259 VADPAKRISIPEIRNHEWFLKNLPADLMNDNTMTTQFDESDQPG---QSIEEIMQIIAEA 315
Query: 293 KVPPPVSRSI 302
            VPP  ++++
Sbjct: 316 TVPPAGTQNL 325

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score =  479 bits (1234), Expect = e-136,   Method: Compositional matrix adjust.
 Identities = 228/310 (73%), Positives = 266/310 (85%), Gaps = 12/310 (3%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNII 61
           ++YEL+KDIGSGNFGVARLMR+K + ELVA+KYIERG KID NV REIINH+ LRHPNI+
Sbjct: 19  DRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKIDENVKREIINHRSLRHPNIV 78
Query: 62  RFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-------QICH 114
           RFKEV+LTPTHLAIVMEYA+GGELFERICNAGRFSEDEAR+FFQQLISG       Q+CH
Sbjct: 79  RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCH 138
Query: 115 RDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLA 174
           RDLKLENTLLDGSPAPRLKIC FGYSKSS+LHS+PKSTVGTPAYIAPEVL ++EYDGK+A
Sbjct: 139 RDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKVA 198
Query: 175 DVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIF 234
           DVWSCGVTLYVMLVGAYPFED E+PKNFRKTI RI+ VQY IPDYVHIS +CR+L+SRIF
Sbjct: 199 DVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPDYVHISPECRHLISRIF 258
Query: 235 VANPSRRITIKEIKSHPWFLKNLPRELT--ETAQAIYYRKENPTFSLQSVEEITKIVEEA 292
           VA+P++RI+I EI++H WFLKNLP +L    T    +   + P    QS+EEI +I+ EA
Sbjct: 259 VADPAKRISIPEIRNHEWFLKNLPADLMNDNTMTTQFDESDQPG---QSIEEIMQIIAEA 315
Query: 293 KVPPPVSRSI 302
            VPP  ++++
Sbjct: 316 TVPPAGTQNL 325

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score =  478 bits (1229), Expect = e-135,   Method: Compositional matrix adjust.
 Identities = 227/310 (73%), Positives = 265/310 (85%), Gaps = 12/310 (3%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNII 61
           ++YEL+KDIGSGNFGVARLMR+K + ELVA+KYIERG KID NV REIINH+ LRHPNI+
Sbjct: 19  DRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKIDENVKREIINHRSLRHPNIV 78
Query: 62  RFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-------QICH 114
           RFKEV+LTPTHLAIVMEYA+GGELFERICNAGRFSEDEAR+FFQQLISG       Q+CH
Sbjct: 79  RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCH 138
Query: 115 RDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLA 174
           RDLKLENTLLDGSPAPRLKIC FGYSKSS+LHS+PK TVGTPAYIAPEVL ++EYDGK+A
Sbjct: 139 RDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQPKDTVGTPAYIAPEVLLKKEYDGKVA 198
Query: 175 DVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIF 234
           DVWSCGVTLYVMLVGAYPFED E+PKNFRKTI RI+ VQY IPDYVHIS +CR+L+SRIF
Sbjct: 199 DVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPDYVHISPECRHLISRIF 258
Query: 235 VANPSRRITIKEIKSHPWFLKNLPRELT--ETAQAIYYRKENPTFSLQSVEEITKIVEEA 292
           VA+P++RI+I EI++H WFLKNLP +L    T    +   + P    QS+EEI +I+ EA
Sbjct: 259 VADPAKRISIPEIRNHEWFLKNLPADLMNDNTMTTQFDESDQPG---QSIEEIMQIIAEA 315
Query: 293 KVPPPVSRSI 302
            VPP  ++++
Sbjct: 316 TVPPAGTQNL 325

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score =  466 bits (1199), Expect = e-132,   Method: Compositional matrix adjust.
 Identities = 222/302 (73%), Positives = 257/302 (85%), Gaps = 12/302 (3%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNII 61
           ++YEL+KDIG+GNFGVARLMR+K   ELVA+KYIERG KID NV REIINH+ LRHPNI+
Sbjct: 19  DRYELVKDIGAGNFGVARLMRDKQANELVAVKYIERGEKIDENVKREIINHRSLRHPNIV 78
Query: 62  RFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-------QICH 114
           RFKEV+LTPTHLAIVMEYA+GGELFERICNAGRFSEDEAR+FFQQLISG       Q+ H
Sbjct: 79  RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYAHAMQVAH 138
Query: 115 RDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLA 174
           RDLKLENTLLDGSPAPRLKI DFGYSK+S+LHS+PKS VGTPAYIAPEVL ++EYDGK+A
Sbjct: 139 RDLKLENTLLDGSPAPRLKIADFGYSKASVLHSQPKSAVGTPAYIAPEVLLKKEYDGKVA 198
Query: 175 DVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIF 234
           DVWSCGVTLYVMLVGAYPFED E+PKNFRKTI RI+ VQY IPDYVHIS +CR+L+SRIF
Sbjct: 199 DVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPDYVHISPECRHLISRIF 258
Query: 235 VANPSRRITIKEIKSHPWFLKNLPRELT--ETAQAIYYRKENPTFSLQSVEEITKIVEEA 292
           VA+P++RI+I EI++H WFLKNLP +L    T    +   + P    QS+EEI +I+ EA
Sbjct: 259 VADPAKRISIPEIRNHEWFLKNLPADLMNDNTMTTQFDESDQPG---QSIEEIMQIIAEA 315
Query: 293 KV 294
            V
Sbjct: 316 TV 317

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score =  460 bits (1184), Expect = e-130,   Method: Compositional matrix adjust.
 Identities = 216/301 (71%), Positives = 258/301 (85%), Gaps = 8/301 (2%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNII 61
           ++Y+ +KDIGSGNFGVARLMR+K TKELVA+KYIERG  ID NV REIINH+ LRHPNI+
Sbjct: 20  DRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIV 79
Query: 62  RFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-------QICH 114
           RFKEV+LTPTHLAI+MEYA+GGEL+ERICNAGRFSEDEAR+FFQQL+SG       QICH
Sbjct: 80  RFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICH 139
Query: 115 RDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLA 174
           RDLKLENTLLDGSPAPRLKICDFGYSKSS+LHS+PKSTVGTPAYIAPEVL R+EYDGK+A
Sbjct: 140 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRQEYDGKIA 199
Query: 175 DVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIF 234
           DVWSCGVTLYVMLVGAYPFED E+P+++RKTI RI++V+Y IPD + IS +C +L+SRIF
Sbjct: 200 DVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRISPECCHLISRIF 259
Query: 235 VANPSRRITIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTFSLQSVEEITKIVEEAKV 294
           VA+P+ RI+I EIK+H WFLKNLP +L   +      +E P   +QS++ I +I+ EA +
Sbjct: 260 VADPATRISIPEIKTHSWFLKNLPADLMNESNTGSQFQE-PEQPMQSLDTIMQIISEATI 318
Query: 295 P 295
           P
Sbjct: 319 P 319

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score =  201 bits (512), Expect = 3e-52,   Method: Compositional matrix adjust.
 Identities = 119/279 (42%), Positives = 166/279 (59%), Gaps = 22/279 (7%)
Query: 4   YELMKDIGSGNFGVARLMRNKNTKELVAMKYIER----GHKIDANVAREIINHKQLRHPN 59
           Y + + +G G+FG  +L  +  T++ VA+K+I R       +   V REI   K LRHP+
Sbjct: 11  YIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPH 70
Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-------QI 112
           II+  +V+ TPT + +V+EYA GGELF+ I    R +EDE R FFQQ+I         +I
Sbjct: 71  IIKLYDVITTPTDIVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKI 129
Query: 113 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGK 172
            HRDLK EN LLD +    +KI DFG S      +  K++ G+P Y APEV++ + Y G 
Sbjct: 130 VHRDLKPENLLLDDNL--NVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVINGKLYAGP 187
Query: 173 LADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSR 232
             DVWSCG+ LYVMLVG  PF+D+  P  F+K  S +    Y +PD+  +S   ++L+ R
Sbjct: 188 EVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCV----YVMPDF--LSPGAQSLIRR 241
Query: 233 IFVANPSRRITIKEIKSHPWFLKNLPREL--TETAQAIY 269
           + VA+P +RITI+EI+  PWF  NLP  L   E  Q  Y
Sbjct: 242 MIVADPMQRITIQEIRRDPWFNVNLPDYLRPMEEVQGSY 280

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score =  188 bits (477), Expect = 4e-48,   Method: Compositional matrix adjust.
 Identities = 107/269 (39%), Positives = 148/269 (55%), Gaps = 19/269 (7%)
Query: 4   YELMKDIGSGNFGVARLMRNKNTKELVAMKYIER----GHKIDANVAREIINHKQLRHPN 59
           Y L   +G G FG  ++  ++ T   VA+K + R       +   + REI N K  RHP+
Sbjct: 13  YVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPH 72
Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-------QI 112
           II+  +V+ TPT   +VMEY +GGELF+ IC  GR  E EAR  FQQ++S         +
Sbjct: 73  IIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMV 132
Query: 113 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGK 172
            HRDLK EN LLD       KI DFG S         +++ G+P Y APEV+S R Y G 
Sbjct: 133 VHRDLKPENVLLDAHMNA--KIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGP 190
Query: 173 LADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSR 232
             D+WSCGV LY +L G  PF+D+  P  F+K    I    + IP+Y  +++    LL  
Sbjct: 191 EVDIWSCGVILYALLCGTLPFDDEHVPTLFKK----IRGGVFYIPEY--LNRSVATLLMH 244
Query: 233 IFVANPSRRITIKEIKSHPWFLKNLPREL 261
           +   +P +R TIK+I+ H WF ++LP  L
Sbjct: 245 MLQVDPLKRATIKDIREHEWFKQDLPSYL 273

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score =  187 bits (475), Expect = 8e-48,   Method: Compositional matrix adjust.
 Identities = 107/269 (39%), Positives = 147/269 (54%), Gaps = 19/269 (7%)
Query: 4   YELMKDIGSGNFGVARLMRNKNTKELVAMKYIER----GHKIDANVAREIINHKQLRHPN 59
           Y L   +G G FG  ++  ++ T   VA+K + R       +   + REI N K  RHP+
Sbjct: 13  YVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPH 72
Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-------QI 112
           II+  +V+ TPT   +VMEY +GGELF+ IC  GR  E EAR  FQQ++S         +
Sbjct: 73  IIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMV 132
Query: 113 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGK 172
            HRDLK EN LLD       KI DFG S         + + G+P Y APEV+S R Y G 
Sbjct: 133 VHRDLKPENVLLDAHMNA--KIADFGLSNMMSDGEFLRDSCGSPNYAAPEVISGRLYAGP 190
Query: 173 LADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSR 232
             D+WSCGV LY +L G  PF+D+  P  F+K    I    + IP+Y  +++    LL  
Sbjct: 191 EVDIWSCGVILYALLCGTLPFDDEHVPTLFKK----IRGGVFYIPEY--LNRSVATLLMH 244
Query: 233 IFVANPSRRITIKEIKSHPWFLKNLPREL 261
           +   +P +R TIK+I+ H WF ++LP  L
Sbjct: 245 MLQVDPLKRATIKDIREHEWFKQDLPSYL 273

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score =  185 bits (469), Expect = 4e-47,   Method: Compositional matrix adjust.
 Identities = 103/259 (39%), Positives = 151/259 (58%), Gaps = 18/259 (6%)
Query: 4   YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVA---REIINHKQLRHPNI 60
           Y L+K IG GNF   +L R+  T + VA+K I++     +++    RE+   K L HPNI
Sbjct: 16  YRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNI 75
Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-QICH----- 114
           ++  EV+ T   L +VMEYA+GGE+F+ +   GR  E EAR  F+Q++S  Q CH     
Sbjct: 76  VKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKFIV 135
Query: 115 -RDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKL 173
            RDLK EN LLD      +KI DFG+S      ++  +  G+P Y APE+   ++YDG  
Sbjct: 136 HRDLKAENLLLDADM--NIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKKYDGPE 193
Query: 174 ADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRI 233
            DVWS GV LY ++ G+ PF+ Q    N ++   R++  +Y+IP Y  +S DC NLL + 
Sbjct: 194 VDVWSLGVILYTLVSGSLPFDGQ----NLKELRERVLRGKYRIPFY--MSTDCENLLKKF 247
Query: 234 FVANPSRRITIKEIKSHPW 252
            + NPS+R T+++I    W
Sbjct: 248 LILNPSKRGTLEQIMKDRW 266

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score =  184 bits (468), Expect = 4e-47,   Method: Compositional matrix adjust.
 Identities = 103/259 (39%), Positives = 151/259 (58%), Gaps = 18/259 (6%)
Query: 4   YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVA---REIINHKQLRHPNI 60
           Y L+K IG GNF   +L R+  T + VA+K I++     +++    RE+   K L HPNI
Sbjct: 16  YRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNI 75
Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-QICH----- 114
           ++  EV+ T   L +VMEYA+GGE+F+ +   GR  E EAR  F+Q++S  Q CH     
Sbjct: 76  VKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKFIV 135
Query: 115 -RDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKL 173
            RDLK EN LLD      +KI DFG+S      ++  +  G+P Y APE+   ++YDG  
Sbjct: 136 HRDLKAENLLLDADM--NIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKKYDGPE 193
Query: 174 ADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRI 233
            DVWS GV LY ++ G+ PF+ Q    N ++   R++  +Y+IP Y  +S DC NLL + 
Sbjct: 194 VDVWSLGVILYTLVSGSLPFDGQ----NLKELRERVLRGKYRIPFY--MSTDCENLLKKF 247
Query: 234 FVANPSRRITIKEIKSHPW 252
            + NPS+R T+++I    W
Sbjct: 248 LILNPSKRGTLEQIMKDRW 266

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score =  184 bits (467), Expect = 6e-47,   Method: Compositional matrix adjust.
 Identities = 103/259 (39%), Positives = 150/259 (57%), Gaps = 18/259 (6%)
Query: 4   YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVA---REIINHKQLRHPNI 60
           Y L+K IG GNF   +L R+  T + VA+K I++     +++    RE+   K L HPNI
Sbjct: 16  YRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNI 75
Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-QICH----- 114
           ++  EV+ T   L +VMEYA+GGE+F+ +   GR  E EAR  F+Q++S  Q CH     
Sbjct: 76  VKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKFIV 135
Query: 115 -RDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKL 173
            RDLK EN LLD      +KI DFG+S      ++  +  G P Y APE+   ++YDG  
Sbjct: 136 HRDLKAENLLLDADM--NIKIADFGFSNEFTFGNKLDAFCGAPPYAAPELFQGKKYDGPE 193
Query: 174 ADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRI 233
            DVWS GV LY ++ G+ PF+ Q    N ++   R++  +Y+IP Y  +S DC NLL + 
Sbjct: 194 VDVWSLGVILYTLVSGSLPFDGQ----NLKELRERVLRGKYRIPFY--MSTDCENLLKKF 247
Query: 234 FVANPSRRITIKEIKSHPW 252
            + NPS+R T+++I    W
Sbjct: 248 LILNPSKRGTLEQIMKDRW 266

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score =  184 bits (467), Expect = 6e-47,   Method: Compositional matrix adjust.
 Identities = 108/292 (36%), Positives = 157/292 (53%), Gaps = 28/292 (9%)
Query: 4   YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH----KIDANVAREIINHKQLRHPN 59
           Y L   +G G FG  ++ +++ T   VA+K + R       +   + REI N K  RHP+
Sbjct: 18  YILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPH 77
Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-------QI 112
           II+  +V+ TP+ + +VMEY +GGELF+ IC  GR  E E+R  FQQ++SG        +
Sbjct: 78  IIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMV 137
Query: 113 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGK 172
            HRDLK EN LLD       KI DFG S         + + G+P Y APEV+S R Y G 
Sbjct: 138 VHRDLKPENVLLDAH--MNAKIADFGLSNMMSDGEFLRXSCGSPNYAAPEVISGRLYAGP 195
Query: 173 LADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSR 232
             D+WS GV LY +L G  PF+D   P  F+K    I    +  P Y++ S    +LL  
Sbjct: 196 EVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGI----FYTPQYLNPS--VISLLKH 249
Query: 233 IFVANPSRRITIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTFSLQSVEE 284
           +   +P +R TIK+I+ H WF ++LP+         Y   E+P++S   +++
Sbjct: 250 MLQVDPMKRATIKDIREHEWFKQDLPK---------YLFPEDPSYSSTMIDD 292

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score =  184 bits (466), Expect = 9e-47,   Method: Compositional matrix adjust.
 Identities = 102/259 (39%), Positives = 151/259 (58%), Gaps = 18/259 (6%)
Query: 4   YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVA---REIINHKQLRHPNI 60
           Y L+K IG GNF   +L R+  T + VA++ I++     +++    RE+   K L HPNI
Sbjct: 16  YRLLKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNI 75
Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-QICH----- 114
           ++  EV+ T   L +VMEYA+GGE+F+ +   GR  E EAR  F+Q++S  Q CH     
Sbjct: 76  VKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKFIV 135
Query: 115 -RDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKL 173
            RDLK EN LLD      +KI DFG+S      ++  +  G+P Y APE+   ++YDG  
Sbjct: 136 HRDLKAENLLLDADM--NIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKKYDGPE 193
Query: 174 ADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRI 233
            DVWS GV LY ++ G+ PF+ Q    N ++   R++  +Y+IP Y  +S DC NLL + 
Sbjct: 194 VDVWSLGVILYTLVSGSLPFDGQ----NLKELRERVLRGKYRIPFY--MSTDCENLLKKF 247
Query: 234 FVANPSRRITIKEIKSHPW 252
            + NPS+R T+++I    W
Sbjct: 248 LILNPSKRGTLEQIMKDRW 266

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score =  183 bits (464), Expect = 1e-46,   Method: Compositional matrix adjust.
 Identities = 102/259 (39%), Positives = 150/259 (57%), Gaps = 18/259 (6%)
Query: 4   YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVA---REIINHKQLRHPNI 60
           Y L+K IG GNF   +L R+  T + VA++ I++     +++    RE+   K L HPNI
Sbjct: 16  YRLLKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNI 75
Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-QICH----- 114
           ++  EV+ T   L +VMEYA+GGE+F+ +   GR  E EAR  F+Q++S  Q CH     
Sbjct: 76  VKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKFIV 135
Query: 115 -RDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKL 173
            RDLK EN LLD      +KI DFG+S      ++     G+P Y APE+   ++YDG  
Sbjct: 136 HRDLKAENLLLDADM--NIKIADFGFSNEFTFGNKLDEFCGSPPYAAPELFQGKKYDGPE 193
Query: 174 ADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRI 233
            DVWS GV LY ++ G+ PF+ Q    N ++   R++  +Y+IP Y  +S DC NLL + 
Sbjct: 194 VDVWSLGVILYTLVSGSLPFDGQ----NLKELRERVLRGKYRIPFY--MSTDCENLLKKF 247
Query: 234 FVANPSRRITIKEIKSHPW 252
            + NPS+R T+++I    W
Sbjct: 248 LILNPSKRGTLEQIMKDRW 266

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score =  182 bits (463), Expect = 2e-46,   Method: Compositional matrix adjust.
 Identities = 102/259 (39%), Positives = 148/259 (57%), Gaps = 18/259 (6%)
Query: 4   YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVA---REIINHKQLRHPNI 60
           Y L+K IG GNF   +L R+  T   VA+K I++      ++    RE+   K L HPNI
Sbjct: 14  YRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNI 73
Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-------QIC 113
           ++  EV+ T   L ++MEYA+GGE+F+ +   GR  E EAR  F+Q++S        +I 
Sbjct: 74  VKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIV 133
Query: 114 HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKL 173
           HRDLK EN LLD      +KI DFG+S    +  +  +  G+P Y APE+   ++YDG  
Sbjct: 134 HRDLKAENLLLDADM--NIKIADFGFSNEFTVGGKLDTFCGSPPYAAPELFQGKKYDGPE 191
Query: 174 ADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRI 233
            DVWS GV LY ++ G+ PF    D +N ++   R++  +Y+IP Y  +S DC NLL R 
Sbjct: 192 VDVWSLGVILYTLVSGSLPF----DGQNLKELRERVLRGKYRIPFY--MSTDCENLLKRF 245
Query: 234 FVANPSRRITIKEIKSHPW 252
            V NP +R T+++I    W
Sbjct: 246 LVLNPIKRGTLEQIMKDRW 264

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score =  182 bits (461), Expect = 3e-46,   Method: Compositional matrix adjust.
 Identities = 102/259 (39%), Positives = 147/259 (56%), Gaps = 18/259 (6%)
Query: 4   YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVA---REIINHKQLRHPNI 60
           Y L+K IG GNF   +L R+  T   VA+K I++      ++    RE+   K L HPNI
Sbjct: 17  YRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNI 76
Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-------QIC 113
           ++  EV+ T   L ++MEYA+GGE+F+ +   GR  E EAR  F+Q++S        +I 
Sbjct: 77  VKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIV 136
Query: 114 HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKL 173
           HRDLK EN LLD      +KI DFG+S    +  +  +  G P Y APE+   ++YDG  
Sbjct: 137 HRDLKAENLLLDADM--NIKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQGKKYDGPE 194
Query: 174 ADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRI 233
            DVWS GV LY ++ G+ PF+ Q    N ++   R++  +Y+IP Y  +S DC NLL R 
Sbjct: 195 VDVWSLGVILYTLVSGSLPFDGQ----NLKELRERVLRGKYRIPFY--MSTDCENLLKRF 248
Query: 234 FVANPSRRITIKEIKSHPW 252
            V NP +R T+++I    W
Sbjct: 249 LVLNPIKRGTLEQIMKDRW 267

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score =  181 bits (460), Expect = 4e-46,   Method: Compositional matrix adjust.
 Identities = 102/259 (39%), Positives = 150/259 (57%), Gaps = 18/259 (6%)
Query: 4   YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVA---REIINHKQLRHPNI 60
           Y L+K IG GNF   +L R+  T + VA+K I++     +++    RE+   K L HPNI
Sbjct: 9   YRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNI 68
Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-QICH----- 114
           ++  EV+ T   L +VMEYA+GGE+F+ +   G   E EAR  F+Q++S  Q CH     
Sbjct: 69  VKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGWMKEKEARAKFRQIVSAVQYCHQKFIV 128
Query: 115 -RDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKL 173
            RDLK EN LLD      +KI DFG+S      ++  +  G+P Y APE+   ++YDG  
Sbjct: 129 HRDLKAENLLLDADM--NIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKKYDGPE 186
Query: 174 ADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRI 233
            DVWS GV LY ++ G+ PF+ Q    N ++   R++  +Y+IP Y  +S DC NLL + 
Sbjct: 187 VDVWSLGVILYTLVSGSLPFDGQ----NLKELRERVLRGKYRIPFY--MSTDCENLLKKF 240
Query: 234 FVANPSRRITIKEIKSHPW 252
            + NPS+R T+++I    W
Sbjct: 241 LILNPSKRGTLEQIMKDRW 259

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score =  181 bits (458), Expect = 8e-46,   Method: Compositional matrix adjust.
 Identities = 102/259 (39%), Positives = 148/259 (57%), Gaps = 18/259 (6%)
Query: 4   YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVA---REIINHKQLRHPNI 60
           Y L+K IG GNF   +L R+  T + VA+K I++     +++    RE+   K L HPNI
Sbjct: 16  YRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIXKVLNHPNI 75
Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-QICH----- 114
           ++  EV+ T   L +V EYA+GGE+F+ +   GR  E EAR  F+Q++S  Q CH     
Sbjct: 76  VKLFEVIETEKTLYLVXEYASGGEVFDYLVAHGRXKEKEARAKFRQIVSAVQYCHQKFIV 135
Query: 115 -RDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKL 173
            RDLK EN LLD      +KI DFG+S      ++  +  G P Y APE+   ++YDG  
Sbjct: 136 HRDLKAENLLLDADX--NIKIADFGFSNEFTFGNKLDAFCGAPPYAAPELFQGKKYDGPE 193
Query: 174 ADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRI 233
            DVWS GV LY ++ G+ PF+ Q    N ++   R++  +Y+IP Y   S DC NLL + 
Sbjct: 194 VDVWSLGVILYTLVSGSLPFDGQ----NLKELRERVLRGKYRIPFYX--STDCENLLKKF 247
Query: 234 FVANPSRRITIKEIKSHPW 252
            + NPS+R T+++I    W
Sbjct: 248 LILNPSKRGTLEQIXKDRW 266

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score =  174 bits (442), Expect = 5e-44,   Method: Compositional matrix adjust.
 Identities = 105/271 (38%), Positives = 150/271 (55%), Gaps = 20/271 (7%)
Query: 4   YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERG----HKIDANVAREIINHKQLRHPN 59
           Y+++K +G G+FG  +L  +  T + VA+K I +       +   + REI   + LRHP+
Sbjct: 16  YQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPH 75
Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-------QI 112
           II+  +V+ +   + +V+EYA G ELF+ I    + SE EAR FFQQ+IS        +I
Sbjct: 76  IIKLYDVIKSKDEIIMVIEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKI 134
Query: 113 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGK 172
            HRDLK EN LLD      +KI DFG S      +  K++ G+P Y APEV+S + Y G 
Sbjct: 135 VHRDLKPENLLLD--EHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAGP 192
Query: 173 LADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSR 232
             DVWSCGV LYVML    PF+D+  P  F+   + +    Y +P +  +S     L+ R
Sbjct: 193 EVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGV----YTLPKF--LSPGAAGLIKR 246
Query: 233 IFVANPSRRITIKEIKSHPWFLKNLPRELTE 263
           + + NP  RI+I EI    WF  +LP  L E
Sbjct: 247 MLIVNPLNRISIHEIMQDDWFKVDLPEYLLE 277

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score =  172 bits (437), Expect = 2e-43,   Method: Compositional matrix adjust.
 Identities = 104/269 (38%), Positives = 149/269 (55%), Gaps = 20/269 (7%)
Query: 4   YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERG----HKIDANVAREIINHKQLRHPN 59
           Y+++K +G G+FG  +L  +  T + VA+K I +       +   + REI   + LRHP+
Sbjct: 6   YQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPH 65
Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-------QI 112
           II+  +V+ +   + +V+EYA G ELF+ I    + SE EAR FFQQ+IS        +I
Sbjct: 66  IIKLYDVIKSKDEIIMVIEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKI 124
Query: 113 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGK 172
            HRDLK EN LLD      +KI DFG S      +  K++ G+P Y APEV+S + Y G 
Sbjct: 125 VHRDLKPENLLLD--EHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAGP 182
Query: 173 LADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSR 232
             DVWSCGV LYVML    PF+D+  P  F+   + +    Y +P +  +S     L+ R
Sbjct: 183 EVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGV----YTLPKF--LSPGAAGLIKR 236
Query: 233 IFVANPSRRITIKEIKSHPWFLKNLPREL 261
           + + NP  RI+I EI    WF  +LP  L
Sbjct: 237 MLIVNPLNRISIHEIMQDDWFKVDLPEYL 265

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score =  172 bits (437), Expect = 2e-43,   Method: Compositional matrix adjust.
 Identities = 104/269 (38%), Positives = 149/269 (55%), Gaps = 20/269 (7%)
Query: 4   YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERG----HKIDANVAREIINHKQLRHPN 59
           Y+++K +G G+FG  +L  +  T + VA+K I +       +   + REI   + LRHP+
Sbjct: 15  YQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPH 74
Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-------QI 112
           II+  +V+ +   + +V+EYA G ELF+ I    + SE EAR FFQQ+IS        +I
Sbjct: 75  IIKLYDVIKSKDEIIMVIEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKI 133
Query: 113 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGK 172
            HRDLK EN LLD      +KI DFG S      +  K++ G+P Y APEV+S + Y G 
Sbjct: 134 VHRDLKPENLLLD--EHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAGP 191
Query: 173 LADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSR 232
             DVWSCGV LYVML    PF+D+  P  F+   + +    Y +P +  +S     L+ R
Sbjct: 192 EVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGV----YTLPKF--LSPGAAGLIKR 245
Query: 233 IFVANPSRRITIKEIKSHPWFLKNLPREL 261
           + + NP  RI+I EI    WF  +LP  L
Sbjct: 246 MLIVNPLNRISIHEIMQDDWFKVDLPEYL 274

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score =  172 bits (437), Expect = 2e-43,   Method: Compositional matrix adjust.
 Identities = 104/269 (38%), Positives = 149/269 (55%), Gaps = 20/269 (7%)
Query: 4   YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERG----HKIDANVAREIINHKQLRHPN 59
           Y+++K +G G+FG  +L  +  T + VA+K I +       +   + REI   + LRHP+
Sbjct: 10  YQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPH 69
Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-------QI 112
           II+  +V+ +   + +V+EYA G ELF+ I    + SE EAR FFQQ+IS        +I
Sbjct: 70  IIKLYDVIKSKDEIIMVIEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKI 128
Query: 113 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGK 172
            HRDLK EN LLD      +KI DFG S      +  K++ G+P Y APEV+S + Y G 
Sbjct: 129 VHRDLKPENLLLD--EHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAGP 186
Query: 173 LADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSR 232
             DVWSCGV LYVML    PF+D+  P  F+   + +    Y +P +  +S     L+ R
Sbjct: 187 EVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGV----YTLPKF--LSPGAAGLIKR 240
Query: 233 IFVANPSRRITIKEIKSHPWFLKNLPREL 261
           + + NP  RI+I EI    WF  +LP  L
Sbjct: 241 MLIVNPLNRISIHEIMQDDWFKVDLPEYL 269

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score =  167 bits (422), Expect = 9e-42,   Method: Compositional matrix adjust.
 Identities = 103/260 (39%), Positives = 150/260 (57%), Gaps = 18/260 (6%)
Query: 4   YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVA---REIINHKQLRHPNI 60
           Y L K IG GNF   +L R+  T   VA+K I++      ++    RE+   K L HPNI
Sbjct: 17  YRLQKTIGKGNFAKVKLARHVLTGREVAVKIIDKTQLNPTSLQKLFREVRIMKILNHPNI 76
Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-QICH----- 114
           ++  EV+ T   L +VMEYA+GGE+F+ +   GR  E EAR  F+Q++S  Q CH     
Sbjct: 77  VKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKYIV 136
Query: 115 -RDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKL 173
            RDLK EN LLDG     +KI DFG+S    + ++  +  G+P Y APE+   ++YDG  
Sbjct: 137 HRDLKAENLLLDGDM--NIKIADFGFSNEFTVGNKLDTFCGSPPYAAPELFQGKKYDGPE 194
Query: 174 ADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRI 233
            DVWS GV LY ++ G+ PF+ Q    N ++   R++  +Y+IP Y  +S DC NLL ++
Sbjct: 195 VDVWSLGVILYTLVSGSLPFDGQ----NLKELRERVLRGKYRIPFY--MSTDCENLLKKL 248
Query: 234 FVANPSRRITIKEIKSHPWF 253
            V NP +R ++++I    W 
Sbjct: 249 LVLNPIKRGSLEQIMKDRWM 268

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score =  157 bits (396), Expect = 1e-38,   Method: Compositional matrix adjust.
 Identities = 95/284 (33%), Positives = 158/284 (55%), Gaps = 24/284 (8%)
Query: 4   YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDA-------NVAREIINHKQLR 56
           Y+  +++GSG F V +  R K+T    A K+I++     +       ++ RE+   K+++
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG------ 110
           HPN+I   EV    T + +++E  AGGELF+ +      +E+EA  F +Q+++G      
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS 132
Query: 111 -QICHRDLKLENTLL--DGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRR 167
            QI H DLK EN +L     P PR+KI DFG +      +  K+  GTPA++APE+++  
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPAFVAPEIVN-Y 191
Query: 168 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPD--YVHISQD 225
           E  G  AD+WS GV  Y++L GA PF    D K  ++T++ + AV Y+  D  + + S  
Sbjct: 192 EPLGLEADMWSIGVITYILLSGASPFLG--DTK--QETLANVSAVNYEFEDEYFSNTSAL 247
Query: 226 CRNLLSRIFVANPSRRITIKEIKSHPWFL-KNLPRELTETAQAI 268
            ++ + R+ V +P +R+TI++   HPW   K+  + L+  A A+
Sbjct: 248 AKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQALSRKASAV 291

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score =  156 bits (394), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 97/279 (34%), Positives = 153/279 (54%), Gaps = 20/279 (7%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINH----KQLRH 57
           ++Y+ +K +GSG +G   L ++K T    A+K I++      + +  +++     KQL H
Sbjct: 4   DRYQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLDH 63
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG------- 110
           PNI++  E      +  +VME   GGELF+ I    +FSE +A    +Q++SG       
Sbjct: 64  PNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAVIMKQVLSGTTYLHKH 123
Query: 111 QICHRDLKLENTLLDG-SPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREY 169
            I HRDLK EN LL+  S    +KI DFG S    +  + K  +GT  YIAPEVL R++Y
Sbjct: 124 NIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKERLGTAYYIAPEVL-RKKY 182
Query: 170 DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKI--PDYVHISQDCR 227
           D K  DVWSCGV LY++L G  PF  Q D    ++ + R+   ++    PD+  +S + +
Sbjct: 183 DEK-CDVWSCGVILYILLCGYPPFGGQTD----QEILKRVEKGKFSFDPPDWTQVSDEAK 237
Query: 228 NLLSRIFVANPSRRITIKEIKSHPWFLKNLPRELTETAQ 266
            L+  +    PS+RI+ +E  +HPW +K   ++ T+  +
Sbjct: 238 QLVKLMLTYEPSKRISAEEALNHPWIVKFCSQKHTDVGK 276

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score =  155 bits (392), Expect = 3e-38,   Method: Compositional matrix adjust.
 Identities = 97/288 (33%), Positives = 159/288 (55%), Gaps = 24/288 (8%)
Query: 4   YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDA-------NVAREIINHKQLR 56
           Y+  +++GSG F V +  R K+T    A K+I++     +       ++ RE+   K+++
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG------ 110
           HPN+I   EV    T + +++E  AGGELF+ +      +E+EA  F +Q+++G      
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS 132
Query: 111 -QICHRDLKLEN-TLLD-GSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRR 167
            QI H DLK EN  LLD   P PR+KI DFG +      +  K+  GTP ++APE+++  
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVN-Y 191
Query: 168 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPD--YVHISQD 225
           E  G  AD+WS GV  Y++L GA PF    D K  ++T++ + AV Y+  D  + + S  
Sbjct: 192 EPLGLEADMWSIGVITYILLSGASPF--LGDTK--QETLANVSAVNYEFEDEYFSNTSAL 247
Query: 226 CRNLLSRIFVANPSRRITIKEIKSHPWFL-KNLPRELTETAQAIYYRK 272
            ++ + R+ V +P +R+TI++   HPW   K+  + L+  A A+   K
Sbjct: 248 AKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQALSRKASAVNMEK 295

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score =  155 bits (391), Expect = 4e-38,   Method: Compositional matrix adjust.
 Identities = 96/268 (35%), Positives = 148/268 (55%), Gaps = 20/268 (7%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINH----KQLRH 57
           ++Y+ +K +GSG +G   L ++K T    A+K I++      + +  +++     KQL H
Sbjct: 21  DRYQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLDH 80
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG------- 110
           PNI++  E      +  +VME   GGELF+ I    +FSE +A    +Q++SG       
Sbjct: 81  PNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAVIMKQVLSGTTYLHKH 140
Query: 111 QICHRDLKLENTLLDG-SPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREY 169
            I HRDLK EN LL+  S    +KI DFG S    +  + K  +GT  YIAPEVL R++Y
Sbjct: 141 NIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKERLGTAYYIAPEVL-RKKY 199
Query: 170 DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKI--PDYVHISQDCR 227
           D K  DVWSCGV LY++L G  PF  Q D    ++ + R+   ++    PD+  +S + +
Sbjct: 200 DEK-CDVWSCGVILYILLCGYPPFGGQTD----QEILKRVEKGKFSFDPPDWTQVSDEAK 254
Query: 228 NLLSRIFVANPSRRITIKEIKSHPWFLK 255
            L+  +    PS+RI+ +E  +HPW +K
Sbjct: 255 QLVKLMLTYEPSKRISAEEALNHPWIVK 282

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score =  155 bits (391), Expect = 4e-38,   Method: Compositional matrix adjust.
 Identities = 96/284 (33%), Positives = 158/284 (55%), Gaps = 24/284 (8%)
Query: 4   YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDA-------NVAREIINHKQLR 56
           Y+  +++GSG F V +  R K+T    A K+I++     +       ++ RE+   K+++
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG------ 110
           HPN+I   EV    T + +++E  AGGELF+ +      +E+EA  F +Q+++G      
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS 132
Query: 111 -QICHRDLKLEN-TLLD-GSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRR 167
            QI H DLK EN  LLD   P PR+KI DFG +      +  K+  GTP ++APE+++  
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVN-Y 191
Query: 168 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPD--YVHISQD 225
           E  G  AD+WS GV  Y++L GA PF    D K  ++T++ + AV Y+  D  + + S  
Sbjct: 192 EPLGLEADMWSIGVITYILLSGASPF--LGDTK--QETLANVSAVNYEFEDEYFSNTSAL 247
Query: 226 CRNLLSRIFVANPSRRITIKEIKSHPWFL-KNLPRELTETAQAI 268
            ++ + R+ V +P +R+TI++   HPW   K+  + L+  A A+
Sbjct: 248 AKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQALSRKASAV 291

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score =  155 bits (391), Expect = 5e-38,   Method: Compositional matrix adjust.
 Identities = 96/284 (33%), Positives = 158/284 (55%), Gaps = 24/284 (8%)
Query: 4   YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDA-------NVAREIINHKQLR 56
           Y+  +++GSG F V +  R K+T    A K+I++     +       ++ RE+   K+++
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG------ 110
           HPN+I   EV    T + +++E  AGGELF+ +      +E+EA  F +Q+++G      
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS 132
Query: 111 -QICHRDLKLEN-TLLD-GSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRR 167
            QI H DLK EN  LLD   P PR+KI DFG +      +  K+  GTP ++APE+++  
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVN-Y 191
Query: 168 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPD--YVHISQD 225
           E  G  AD+WS GV  Y++L GA PF    D K  ++T++ + AV Y+  D  + + S  
Sbjct: 192 EPLGLEADMWSIGVITYILLSGASPF--LGDTK--QETLANVSAVNYEFEDEYFSNTSAL 247
Query: 226 CRNLLSRIFVANPSRRITIKEIKSHPWFL-KNLPRELTETAQAI 268
            ++ + R+ V +P +R+TI++   HPW   K+  + L+  A A+
Sbjct: 248 AKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQALSRKASAV 291

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score =  154 bits (390), Expect = 5e-38,   Method: Compositional matrix adjust.
 Identities = 96/284 (33%), Positives = 158/284 (55%), Gaps = 24/284 (8%)
Query: 4   YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDA-------NVAREIINHKQLR 56
           Y+  +++GSG F V +  R K+T    A K+I++     +       ++ RE+   K+++
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG------ 110
           HPN+I   EV    T + +++E  AGGELF+ +      +E+EA  F +Q+++G      
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS 132
Query: 111 -QICHRDLKLEN-TLLD-GSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRR 167
            QI H DLK EN  LLD   P PR+KI DFG +      +  K+  GTP ++APE+++  
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVN-Y 191
Query: 168 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPD--YVHISQD 225
           E  G  AD+WS GV  Y++L GA PF    D K  ++T++ + AV Y+  D  + + S  
Sbjct: 192 EPLGLEADMWSIGVITYILLSGASPFLG--DTK--QETLANVSAVNYEFEDEYFSNTSAL 247
Query: 226 CRNLLSRIFVANPSRRITIKEIKSHPWFL-KNLPRELTETAQAI 268
            ++ + R+ V +P +R+TI++   HPW   K+  + L+  A A+
Sbjct: 248 AKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQALSRKASAV 291

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score =  154 bits (389), Expect = 7e-38,   Method: Compositional matrix adjust.
 Identities = 98/292 (33%), Positives = 160/292 (54%), Gaps = 29/292 (9%)
Query: 4   YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDA-------NVAREIINHKQLR 56
           Y+  +++GSG F V +  R K+T    A K+I++     +       ++ RE+   K+++
Sbjct: 12  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 71
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG------ 110
           HPN+I   EV    T + +++E  AGGELF+ +      +E+EA  F +Q+++G      
Sbjct: 72  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS 131
Query: 111 -QICHRDLKLEN-TLLD-GSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRR 167
            QI H DLK EN  LLD   P PR+KI DFG +      +  K+  GTP ++APE+++  
Sbjct: 132 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVN-Y 190
Query: 168 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPD--YVHISQD 225
           E  G  AD+WS GV  Y++L GA PF    D K  ++T++ + AV Y+  D  + + S  
Sbjct: 191 EPLGLEADMWSIGVITYILLSGASPF--LGDTK--QETLANVSAVNYEFEDEYFSNTSAL 246
Query: 226 CRNLLSRIFVANPSRRITIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTF 277
            ++ + R+ V +P +R+TI++   HPW     P+   +T QA+     +P F
Sbjct: 247 AKDFIRRLLVKDPKKRMTIQDSLQHPWI---KPK---DTQQALSSAWSHPQF 292

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score =  154 bits (389), Expect = 7e-38,   Method: Compositional matrix adjust.
 Identities = 98/292 (33%), Positives = 160/292 (54%), Gaps = 29/292 (9%)
Query: 4   YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDA-------NVAREIINHKQLR 56
           Y+  +++GSG F V +  R K+T    A K+I++     +       ++ RE+   K+++
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG------ 110
           HPN+I   EV    T + +++E  AGGELF+ +      +E+EA  F +Q+++G      
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS 132
Query: 111 -QICHRDLKLEN-TLLD-GSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRR 167
            QI H DLK EN  LLD   P PR+KI DFG +      +  K+  GTP ++APE+++  
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVN-Y 191
Query: 168 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPD--YVHISQD 225
           E  G  AD+WS GV  Y++L GA PF    D K  ++T++ + AV Y+  D  + + S  
Sbjct: 192 EPLGLEADMWSIGVITYILLSGASPF--LGDTK--QETLANVSAVNYEFEDEYFSNTSAL 247
Query: 226 CRNLLSRIFVANPSRRITIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTF 277
            ++ + R+ V +P +R+TI++   HPW     P+   +T QA+     +P F
Sbjct: 248 AKDFIRRLLVKDPKKRMTIQDSLQHPWI---KPK---DTQQALSSAWSHPQF 293

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score =  154 bits (388), Expect = 8e-38,   Method: Compositional matrix adjust.
 Identities = 98/292 (33%), Positives = 160/292 (54%), Gaps = 29/292 (9%)
Query: 4   YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDA-------NVAREIINHKQLR 56
           Y+  +++GSG F V +  R K+T    A K+I++     +       ++ RE+   K+++
Sbjct: 13  YDTGEELGSGKFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG------ 110
           HPN+I   EV    T + +++E  AGGELF+ +      +E+EA  F +Q+++G      
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS 132
Query: 111 -QICHRDLKLEN-TLLD-GSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRR 167
            QI H DLK EN  LLD   P PR+KI DFG +      +  K+  GTP ++APE+++  
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVN-Y 191
Query: 168 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPD--YVHISQD 225
           E  G  AD+WS GV  Y++L GA PF    D K  ++T++ + AV Y+  D  + + S  
Sbjct: 192 EPLGLEADMWSIGVITYILLSGASPF--LGDTK--QETLANVSAVNYEFEDEYFSNTSAL 247
Query: 226 CRNLLSRIFVANPSRRITIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTF 277
            ++ + R+ V +P +R+TI++   HPW     P+   +T QA+     +P F
Sbjct: 248 AKDFIRRLLVKDPKKRMTIQDSLQHPWI---KPK---DTQQALSSAWSHPQF 293

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score =  154 bits (388), Expect = 8e-38,   Method: Compositional matrix adjust.
 Identities = 98/292 (33%), Positives = 160/292 (54%), Gaps = 29/292 (9%)
Query: 4   YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDA-------NVAREIINHKQLR 56
           Y+  +++GSG F V +  R K+T    A K+I++     +       ++ RE+   K+++
Sbjct: 12  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 71
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG------ 110
           HPN+I   EV    T + +++E  AGGELF+ +      +E+EA  F +Q+++G      
Sbjct: 72  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS 131
Query: 111 -QICHRDLKLEN-TLLD-GSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRR 167
            QI H DLK EN  LLD   P PR+KI DFG +      +  K+  GTP ++APE+++  
Sbjct: 132 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVN-Y 190
Query: 168 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPD--YVHISQD 225
           E  G  AD+WS GV  Y++L GA PF    D K  ++T++ + AV Y+  D  + + S  
Sbjct: 191 EPLGLEADMWSIGVITYILLSGASPF--LGDTK--QETLANVSAVNYEFEDEYFSNTSAL 246
Query: 226 CRNLLSRIFVANPSRRITIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTF 277
            ++ + R+ V +P +R+TI++   HPW     P+   +T QA+     +P F
Sbjct: 247 AKDFIRRLLVKDPKKRMTIQDSLQHPWI---KPK---DTQQALSSAWSHPQF 292

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score =  154 bits (388), Expect = 9e-38,   Method: Compositional matrix adjust.
 Identities = 92/267 (34%), Positives = 150/267 (56%), Gaps = 23/267 (8%)
Query: 4   YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDA-------NVAREIINHKQLR 56
           Y+  +++GSG F V +  R K+T    A K+I++     +       ++ RE+   K+++
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG------ 110
           HPN+I   EV    T + +++E  AGGELF+ +      +E+EA  F +Q+++G      
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS 132
Query: 111 -QICHRDLKLEN-TLLD-GSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRR 167
            QI H DLK EN  LLD   P PR+KI DFG +      +  K+  GTP ++APE+++  
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVN-Y 191
Query: 168 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPD--YVHISQD 225
           E  G  AD+WS GV  Y++L GA PF    D K  ++T++ + AV Y+  D  + + S  
Sbjct: 192 EPLGLEADMWSIGVITYILLSGASPF--LGDTK--QETLANVSAVNYEFEDEYFSNTSAL 247
Query: 226 CRNLLSRIFVANPSRRITIKEIKSHPW 252
            ++ + R+ V +P +R+TI++   HPW
Sbjct: 248 AKDFIRRLLVKDPKKRMTIQDSLQHPW 274

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score =  154 bits (388), Expect = 1e-37,   Method: Compositional matrix adjust.
 Identities = 92/267 (34%), Positives = 150/267 (56%), Gaps = 23/267 (8%)
Query: 4   YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDA-------NVAREIINHKQLR 56
           Y+  +++GSG F V +  R K+T    A K+I++     +       ++ RE+   K+++
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG------ 110
           HPN+I   EV    T + +++E  AGGELF+ +      +E+EA  F +Q+++G      
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS 132
Query: 111 -QICHRDLKLEN-TLLD-GSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRR 167
            QI H DLK EN  LLD   P PR+KI DFG +      +  K+  GTP ++APE+++  
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVN-Y 191
Query: 168 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPD--YVHISQD 225
           E  G  AD+WS GV  Y++L GA PF    D K  ++T++ + AV Y+  D  + + S  
Sbjct: 192 EPLGLEADMWSIGVITYILLSGASPF--LGDTK--QETLANVSAVNYEFEDEYFSNTSAL 247
Query: 226 CRNLLSRIFVANPSRRITIKEIKSHPW 252
            ++ + R+ V +P +R+TI++   HPW
Sbjct: 248 AKDFIRRLLVKDPKKRMTIQDSLQHPW 274

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score =  153 bits (387), Expect = 1e-37,   Method: Compositional matrix adjust.
 Identities = 92/267 (34%), Positives = 150/267 (56%), Gaps = 23/267 (8%)
Query: 4   YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDA-------NVAREIINHKQLR 56
           Y+  +++GSG F V +  R K+T    A K+I++     +       ++ RE+   K+++
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG------ 110
           HPN+I   EV    T + +++E  AGGELF+ +      +E+EA  F +Q+++G      
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS 132
Query: 111 -QICHRDLKLEN-TLLD-GSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRR 167
            QI H DLK EN  LLD   P PR+KI DFG +      +  K+  GTP ++APE+++  
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVN-Y 191
Query: 168 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPD--YVHISQD 225
           E  G  AD+WS GV  Y++L GA PF    D K  ++T++ + AV Y+  D  + + S  
Sbjct: 192 EPLGLEADMWSIGVITYILLSGASPF--LGDTK--QETLANVSAVNYEFEDEYFSNTSAL 247
Query: 226 CRNLLSRIFVANPSRRITIKEIKSHPW 252
            ++ + R+ V +P +R+TI++   HPW
Sbjct: 248 AKDFIRRLLVKDPKKRMTIQDSLQHPW 274

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score =  152 bits (385), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 98/292 (33%), Positives = 160/292 (54%), Gaps = 29/292 (9%)
Query: 4   YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDA-------NVAREIINHKQLR 56
           Y+  +++GSG F V +  R K+T    A K+I++     +       ++ RE+   K+++
Sbjct: 13  YDTGEELGSGVFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG------ 110
           HPN+I   EV    T + +++E  AGGELF+ +      +E+EA  F +Q+++G      
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS 132
Query: 111 -QICHRDLKLEN-TLLD-GSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRR 167
            QI H DLK EN  LLD   P PR+KI DFG +      +  K+  GTP ++APE+++  
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVN-Y 191
Query: 168 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPD--YVHISQD 225
           E  G  AD+WS GV  Y++L GA PF    D K  ++T++ + AV Y+  D  + + S  
Sbjct: 192 EPLGLEADMWSIGVITYILLSGASPF--LGDTK--QETLANVSAVNYEFEDEYFSNTSAL 247
Query: 226 CRNLLSRIFVANPSRRITIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTF 277
            ++ + R+ V +P +R+TI++   HPW     P+   +T QA+     +P F
Sbjct: 248 AKDFIRRLLVKDPKKRMTIQDSLQHPWI---KPK---DTQQALSSAWSHPQF 293

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score =  152 bits (384), Expect = 3e-37,   Method: Compositional matrix adjust.
 Identities = 98/292 (33%), Positives = 159/292 (54%), Gaps = 29/292 (9%)
Query: 4   YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDA-------NVAREIINHKQLR 56
           Y+  +++GSG F V +  R K+T    A K+I++     +       ++ RE+   K+++
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG------ 110
           HPN+I   EV    T + ++ E  AGGELF+ +      +E+EA  F +Q+++G      
Sbjct: 73  HPNVITLHEVYENKTDVILIGELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS 132
Query: 111 -QICHRDLKLEN-TLLD-GSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRR 167
            QI H DLK EN  LLD   P PR+KI DFG +      +  K+  GTP ++APE+++  
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVN-Y 191
Query: 168 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPD--YVHISQD 225
           E  G  AD+WS GV  Y++L GA PF    D K  ++T++ + AV Y+  D  + + S  
Sbjct: 192 EPLGLEADMWSIGVITYILLSGASPF--LGDTK--QETLANVSAVNYEFEDEYFSNTSAL 247
Query: 226 CRNLLSRIFVANPSRRITIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTF 277
            ++ + R+ V +P +R+TI++   HPW     P+   +T QA+     +P F
Sbjct: 248 AKDFIRRLLVKDPKKRMTIQDSLQHPWI---KPK---DTQQALSSAWSHPQF 293

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score =  152 bits (383), Expect = 3e-37,   Method: Compositional matrix adjust.
 Identities = 102/290 (35%), Positives = 148/290 (51%), Gaps = 33/290 (11%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERG---HKIDANVAREIINHKQLRHP 58
           E+Y ++  +G G+FG     +++ T++  A+K I +    +K  + + RE+   K+L HP
Sbjct: 22  ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHP 81
Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-------Q 111
           NI++  E++   +   IV E   GGELF+ I    RFSE +A    +Q+ SG        
Sbjct: 82  NIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN 141
Query: 112 ICHRDLKLENTLLDGSPAP-RLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYD 170
           I HRDLK EN LL+       +KI DFG S     +++ K  +GT  YIAPEVL R  YD
Sbjct: 142 IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVL-RGTYD 200
Query: 171 GKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQY--KIPDYVHISQDCRN 228
            K  DVWS GV LY++L G  PF      KN    + R+   +Y   +P +  IS D ++
Sbjct: 201 EK-CDVWSAGVILYILLSGTPPFY----GKNEYDILKRVETGKYAFDLPQWRTISDDAKD 255
Query: 229 LLSRIFVANPSRRITIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTFS 278
           L+ ++   +PS RIT  +   HPW  K              Y  E PT S
Sbjct: 256 LIRKMLTFHPSLRITATQCLEHPWIQK--------------YSSETPTIS 291

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score =  150 bits (378), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 97/267 (36%), Positives = 143/267 (53%), Gaps = 19/267 (7%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERG---HKIDANVAREIINHKQLRHP 58
           E+Y ++  +G G+FG     +++ T++  A+K I +    +K  + + RE+   K+L HP
Sbjct: 22  ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHP 81
Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-------Q 111
           NI++  E++   +   IV E   GGELF+ I    RFSE +A    +Q+ SG        
Sbjct: 82  NIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN 141
Query: 112 ICHRDLKLENTLLDGSPAP-RLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYD 170
           I HRDLK EN LL+       +KI DFG S     +++ K  +GT  YIAPEVL R  YD
Sbjct: 142 IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVL-RGTYD 200
Query: 171 GKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQY--KIPDYVHISQDCRN 228
            K  DVWS GV LY++L G  PF      KN    + R+   +Y   +P +  IS D ++
Sbjct: 201 EK-CDVWSAGVILYILLSGTPPFY----GKNEYDILKRVETGKYAFDLPQWRTISDDAKD 255
Query: 229 LLSRIFVANPSRRITIKEIKSHPWFLK 255
           L+ ++   +PS RIT  +   HPW  K
Sbjct: 256 LIRKMLTFHPSLRITATQCLEHPWIQK 282

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score =  150 bits (378), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 97/267 (36%), Positives = 143/267 (53%), Gaps = 19/267 (7%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERG---HKIDANVAREIINHKQLRHP 58
           E+Y ++  +G G+FG     +++ T++  A+K I +    +K  + + RE+   K+L HP
Sbjct: 22  ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHP 81
Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-------Q 111
           NI++  E++   +   IV E   GGELF+ I    RFSE +A    +Q+ SG        
Sbjct: 82  NIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN 141
Query: 112 ICHRDLKLENTLLDGSPAP-RLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYD 170
           I HRDLK EN LL+       +KI DFG S     +++ K  +GT  YIAPEVL R  YD
Sbjct: 142 IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVL-RGTYD 200
Query: 171 GKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQY--KIPDYVHISQDCRN 228
            K  DVWS GV LY++L G  PF      KN    + R+   +Y   +P +  IS D ++
Sbjct: 201 EK-CDVWSAGVILYILLSGTPPFY----GKNEYDILKRVETGKYAFDLPQWRTISDDAKD 255
Query: 229 LLSRIFVANPSRRITIKEIKSHPWFLK 255
           L+ ++   +PS RIT  +   HPW  K
Sbjct: 256 LIRKMLTFHPSLRITATQCLEHPWIQK 282

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score =  149 bits (377), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 86/269 (31%), Positives = 146/269 (54%), Gaps = 23/269 (8%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDA-------NVAREIINHKQ 54
           + YE+ +++GSG F + R  R K T +  A K+I++     +        + RE+   ++
Sbjct: 5   DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILRE 64
Query: 55  LRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG---- 110
           +RHPNII   ++    T + +++E  +GGELF+ +      +EDEA  F +Q++ G    
Sbjct: 65  IRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYL 124
Query: 111 ---QICHRDLKLENTLL--DGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLS 165
              +I H DLK EN +L     P PR+K+ DFG +      +  K+  GTP ++APE+++
Sbjct: 125 HSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIVN 184
Query: 166 RREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPD--YVHIS 223
             E  G  AD+WS GV  Y++L GA PF  +      ++T++ I AV Y   +  + + S
Sbjct: 185 -YEPLGLEADMWSIGVITYILLSGASPFLGETK----QETLTNISAVNYDFDEEYFSNTS 239
Query: 224 QDCRNLLSRIFVANPSRRITIKEIKSHPW 252
           +  ++ + R+ V +P RR+TI +   H W
Sbjct: 240 ELAKDFIRRLLVKDPKRRMTIAQSLEHSW 268

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score =  149 bits (376), Expect = 2e-36,   Method: Compositional matrix adjust.
 Identities = 91/267 (34%), Positives = 145/267 (54%), Gaps = 21/267 (7%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH----KIDANVAREIINHKQLR 56
           +E +E+ + +G G FG   L R K +K ++A+K + +       ++  + RE+     LR
Sbjct: 12  LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 71
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLI-------S 109
           HPNI+R        T + +++EYA  GE+++ +    +F E     +  +L        S
Sbjct: 72  HPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTATYITELANALSYCHS 131
Query: 110 GQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREY 169
            ++ HRD+K EN LL GS A  LKI DFG+S  +   SR  +  GT  Y+ PE++  R +
Sbjct: 132 KRVIHRDIKPENLLL-GS-AGELKIADFGWSVHA-PSSRRTTLCGTLDYLPPEMIEGRMH 188
Query: 170 DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 229
           D K+ D+WS GV  Y  LVG  PFE       +++T  RI  V++  PD+V  ++  R+L
Sbjct: 189 DEKV-DLWSLGVLCYEFLVGKPPFE----ANTYQETYKRISRVEFTFPDFV--TEGARDL 241
Query: 230 LSRIFVANPSRRITIKEIKSHPWFLKN 256
           +SR+   NPS+R  ++E+  HPW   N
Sbjct: 242 ISRLLKHNPSQRPMLREVLEHPWITAN 268

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score =  149 bits (375), Expect = 3e-36,   Method: Compositional matrix adjust.
 Identities = 94/262 (35%), Positives = 143/262 (54%), Gaps = 21/262 (8%)
Query: 4   YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAR-EIINHKQLRHPNIIR 62
           +E+  ++G G   +    + K T++  A+K +++   +D  + R EI    +L HPNII+
Sbjct: 55  FEVESELGRGATSIVYRCKQKGTQKPYALKVLKK--TVDKKIVRTEIGVLLRLSHPNIIK 112
Query: 63  FKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-------QICHR 115
            KE+  TPT +++V+E   GGELF+RI   G +SE +A    +Q++          I HR
Sbjct: 113 LKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHR 172
Query: 116 DLKLENTLLDGSPAPR--LKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKL 173
           DLK EN LL  +PAP   LKI DFG SK        K+  GTP Y APE+L    Y G  
Sbjct: 173 DLKPEN-LLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEILRGCAY-GPE 230
Query: 174 ADVWSCGVTLYVMLVGAYPFEDQE-DPKNFRKTISRIMAVQYKI--PDYVHISQDCRNLL 230
            D+WS G+  Y++L G  PF D+  D   FR    RI+  +Y    P +  +S + ++L+
Sbjct: 231 VDMWSVGIITYILLCGFEPFYDERGDQFMFR----RILNCEYYFISPWWDEVSLNAKDLV 286
Query: 231 SRIFVANPSRRITIKEIKSHPW 252
            ++ V +P +R+T  +   HPW
Sbjct: 287 RKLIVLDPKKRLTTFQALQHPW 308

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score =  148 bits (374), Expect = 3e-36,   Method: Compositional matrix adjust.
 Identities = 91/267 (34%), Positives = 144/267 (53%), Gaps = 21/267 (7%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH----KIDANVAREIINHKQLR 56
           +E +E+ + +G G FG   L R K +K ++A+K + +       ++  + RE+     LR
Sbjct: 12  LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 71
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLI-------S 109
           HPNI+R        T + +++EYA  GE+++ +    +F E     +  +L        S
Sbjct: 72  HPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTATYITELANALSYCHS 131
Query: 110 GQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREY 169
            ++ HRD+K EN LL GS A  LKI DFG+S  +   SR     GT  Y+ PE++  R +
Sbjct: 132 KRVIHRDIKPENLLL-GS-AGELKIADFGWSVHA-PSSRRXXLXGTLDYLPPEMIEGRMH 188
Query: 170 DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 229
           D K+ D+WS GV  Y  LVG  PFE       +++T  RI  V++  PD+V  ++  R+L
Sbjct: 189 DEKV-DLWSLGVLCYEFLVGKPPFE----ANTYQETYKRISRVEFTFPDFV--TEGARDL 241
Query: 230 LSRIFVANPSRRITIKEIKSHPWFLKN 256
           +SR+   NPS+R  ++E+  HPW   N
Sbjct: 242 ISRLLKHNPSQRPMLREVLEHPWITAN 268

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score =  148 bits (374), Expect = 4e-36,   Method: Compositional matrix adjust.
 Identities = 85/269 (31%), Positives = 145/269 (53%), Gaps = 23/269 (8%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDA-------NVAREIINHKQ 54
           + YE+ +++GSG F + R  R K T +  A K+I++     +        + RE+   ++
Sbjct: 26  DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLXSSRRGVSREEIEREVNILRE 85
Query: 55  LRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG---- 110
           +RHPNII   ++    T + +++E  +GGELF+ +      +EDEA  F +Q++ G    
Sbjct: 86  IRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYL 145
Query: 111 ---QICHRDLKLENTLL--DGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLS 165
              +I H DLK EN +L     P PR+K+ DFG +      +  K+  GTP ++APE+++
Sbjct: 146 HSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIVN 205
Query: 166 RREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPD--YVHIS 223
             E  G  AD+WS GV  Y++L GA PF  +      ++T++ I AV Y   +  + + S
Sbjct: 206 -YEPLGLEADMWSIGVITYILLSGASPFLGETK----QETLTNISAVNYDFDEEYFSNTS 260
Query: 224 QDCRNLLSRIFVANPSRRITIKEIKSHPW 252
           +  ++ + R+ V +P RR+ I +   H W
Sbjct: 261 ELAKDFIRRLLVKDPKRRMXIAQSLEHSW 289

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  148 bits (374), Expect = 4e-36,   Method: Compositional matrix adjust.
 Identities = 94/271 (34%), Positives = 143/271 (52%), Gaps = 17/271 (6%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDA--NVAREIINHKQLRHP 58
           +E ++L++ +G G +G  +L  N+ T+E VA+K ++    +D   N+ +EI  +K L H 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-------Q 111
           N+++F           + +EY +GGELF+RI       E +A+ FF QL++G        
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 124
Query: 112 ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPK---STVGTPAYIAPEVLSRRE 168
           I HRD+K EN LLD      LKI DFG +     ++R +      GT  Y+APE+L RRE
Sbjct: 125 ITHRDIKPENLLLDERD--NLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRRE 182
Query: 169 YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRN 228
           +  +  DVWSCG+ L  ML G  P+   + P +  +  S     +  +  +  I      
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAGELPW---DQPSDSXQEYSDWKEKKTYLNPWKKIDSAPLA 239
Query: 229 LLSRIFVANPSRRITIKEIKSHPWFLKNLPR 259
           LL +I V NPS RITI +IK   W+ K L +
Sbjct: 240 LLHKILVENPSARITIPDIKKDRWYNKPLKK 270

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score =  148 bits (373), Expect = 5e-36,   Method: Compositional matrix adjust.
 Identities = 85/269 (31%), Positives = 145/269 (53%), Gaps = 23/269 (8%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDA-------NVAREIINHKQ 54
           + YE+ +++GSG F + R  R K T +  A K+I++     +        + RE+   ++
Sbjct: 12  DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILRE 71
Query: 55  LRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG---- 110
           +RHPNII   ++    T + +++E  +GGELF+ +      +EDEA  F +Q++ G    
Sbjct: 72  IRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYL 131
Query: 111 ---QICHRDLKLENTLL--DGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLS 165
              +I H DLK EN +L     P PR+K+ DFG +      +  K+  GTP ++APE+++
Sbjct: 132 HSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIVN 191
Query: 166 RREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPD--YVHIS 223
             E  G  AD+WS GV  Y++L GA PF  +      ++T++ I AV Y   +  + + S
Sbjct: 192 -YEPLGLEADMWSIGVITYILLSGASPFLGETK----QETLTNISAVNYDFDEEYFSNTS 246
Query: 224 QDCRNLLSRIFVANPSRRITIKEIKSHPW 252
           +  ++ + R+ V +P RR+ I +   H W
Sbjct: 247 ELAKDFIRRLLVKDPKRRMXIAQSLEHSW 275

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score =  148 bits (373), Expect = 5e-36,   Method: Compositional matrix adjust.
 Identities = 91/267 (34%), Positives = 143/267 (53%), Gaps = 21/267 (7%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH----KIDANVAREIINHKQLR 56
           +E +E+ + +G G FG   L R KN+K ++A+K + +       ++  + RE+     LR
Sbjct: 7   LEDFEIGRPLGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 66
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLI-------S 109
           HPNI+R        T + +++EYA  G ++  +    +F E     +  +L        S
Sbjct: 67  HPNILRLYGYFHDSTRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 126
Query: 110 GQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREY 169
            ++ HRD+K EN LL GS A  LKI DFG+S  +   SR  +  GT  Y+ PE++  R +
Sbjct: 127 KKVIHRDIKPENLLL-GS-AGELKIADFGWSVHA-PSSRRAALCGTLDYLPPEMIEGRMH 183
Query: 170 DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 229
           D K+ D+WS GV  Y  LVG  PFE       ++ T  RI  V++  PD+V  ++  R+L
Sbjct: 184 DEKV-DLWSLGVLCYEFLVGKPPFE----ANTYQDTYKRISRVEFTFPDFV--TEGARDL 236
Query: 230 LSRIFVANPSRRITIKEIKSHPWFLKN 256
           +SR+   NPS+R  ++E+  HPW   N
Sbjct: 237 ISRLLKHNPSQRPMLREVLEHPWITAN 263

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score =  148 bits (373), Expect = 5e-36,   Method: Compositional matrix adjust.
 Identities = 106/303 (34%), Positives = 148/303 (48%), Gaps = 70/303 (23%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDA----------------- 43
           + +Y L  +IG G++GV +L  N+N     AMK + +   I                   
Sbjct: 12  LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPG 71
Query: 44  ----------NVAREIINHKQLRHPNIIRFKEVVLTPT--HLAIVMEYAAGGELFERICN 91
                      V +EI   K+L HPN+++  EV+  P   HL +V E    G + E +  
Sbjct: 72  GCIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVME-VPT 130
Query: 92  AGRFSEDEARYFFQQLISG-------QICHRDLKLENTLL--DGSPAPRLKICDFGYSK- 141
               SED+AR++FQ LI G       +I HRD+K  N L+  DG     +KI DFG S  
Sbjct: 131 LKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDG----HIKIADFGVSNE 186
Query: 142 ---SSLLHSRPKSTVGTPAYIAPEVLS--RREYDGKLADVWSCGVTLYVMLVGAYPFEDQ 196
              S  L S   +TVGTPA++APE LS  R+ + GK  DVW+ GVTLY  + G  PF D+
Sbjct: 187 FKGSDALLS---NTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDE 243
Query: 197 EDPKNFRKTISRIMAVQYKI-------PDYVHISQDCRNLLSRIFVANPSRRITIKEIKS 249
                      RIM +  KI       PD   I++D ++L++R+   NP  RI + EIK 
Sbjct: 244 -----------RIMCLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKL 292
Query: 250 HPW 252
           HPW
Sbjct: 293 HPW 295

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score =  147 bits (372), Expect = 6e-36,   Method: Compositional matrix adjust.
 Identities = 94/269 (34%), Positives = 142/269 (52%), Gaps = 17/269 (6%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDA--NVAREIINHKQLRHP 58
           +E ++L++ +G G +G  +L  N+ T+E VA+K ++    +D   N+ +EI  +K L H 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 65
Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-------Q 111
           N+++F           + +EY +GGELF+RI       E +A+ FF QL++G        
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 125
Query: 112 ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPK---STVGTPAYIAPEVLSRRE 168
           I HRD+K EN LLD      LKI DFG +     ++R +      GT  Y+APE+L RRE
Sbjct: 126 ITHRDIKPENLLLDERD--NLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183
Query: 169 YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRN 228
           +  +  DVWSCG+ L  ML G  P+   + P +  +  S     +  +  +  I      
Sbjct: 184 FHAEPVDVWSCGIVLTAMLAGELPW---DQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLA 240
Query: 229 LLSRIFVANPSRRITIKEIKSHPWFLKNL 257
           LL +I V NPS RITI +IK   W+ K L
Sbjct: 241 LLHKILVENPSARITIPDIKKDRWYNKPL 269

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score =  147 bits (372), Expect = 6e-36,   Method: Compositional matrix adjust.
 Identities = 94/269 (34%), Positives = 142/269 (52%), Gaps = 17/269 (6%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDA--NVAREIINHKQLRHP 58
           +E ++L++ +G G +G  +L  N+ T+E VA+K ++    +D   N+ +EI  +K L H 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-------Q 111
           N+++F           + +EY +GGELF+RI       E +A+ FF QL++G        
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 124
Query: 112 ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPK---STVGTPAYIAPEVLSRRE 168
           I HRD+K EN LLD      LKI DFG +     ++R +      GT  Y+APE+L RRE
Sbjct: 125 ITHRDIKPENLLLDERD--NLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 182
Query: 169 YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRN 228
           +  +  DVWSCG+ L  ML G  P+   + P +  +  S     +  +  +  I      
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAGELPW---DQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLA 239
Query: 229 LLSRIFVANPSRRITIKEIKSHPWFLKNL 257
           LL +I V NPS RITI +IK   W+ K L
Sbjct: 240 LLHKILVENPSARITIPDIKKDRWYNKPL 268

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score =  147 bits (372), Expect = 7e-36,   Method: Compositional matrix adjust.
 Identities = 94/271 (34%), Positives = 143/271 (52%), Gaps = 17/271 (6%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDA--NVAREIINHKQLRHP 58
           +E ++L++ +G G +G  +L  N+ T+E VA+K ++    +D   N+ +EI  +K L H 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-------Q 111
           N+++F           + +EY +GGELF+RI       E +A+ FF QL++G        
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 124
Query: 112 ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPK---STVGTPAYIAPEVLSRRE 168
           I HRD+K EN LLD      LKI DFG +     ++R +      GT  Y+APE+L RRE
Sbjct: 125 ITHRDIKPENLLLDERD--NLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 182
Query: 169 YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRN 228
           +  +  DVWSCG+ L  ML G  P+   + P +  +  S     +  +  +  I      
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAGELPW---DQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLA 239
Query: 229 LLSRIFVANPSRRITIKEIKSHPWFLKNLPR 259
           LL +I V NPS RITI +IK   W+ K L +
Sbjct: 240 LLHKILVENPSARITIPDIKKDRWYNKPLKK 270

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score =  147 bits (372), Expect = 7e-36,   Method: Compositional matrix adjust.
 Identities = 94/271 (34%), Positives = 143/271 (52%), Gaps = 17/271 (6%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDA--NVAREIINHKQLRHP 58
           +E ++L++ +G G +G  +L  N+ T+E VA+K ++    +D   N+ +EI  +K L H 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-------Q 111
           N+++F           + +EY +GGELF+RI       E +A+ FF QL++G        
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 124
Query: 112 ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPK---STVGTPAYIAPEVLSRRE 168
           I HRD+K EN LLD      LKI DFG +     ++R +      GT  Y+APE+L RRE
Sbjct: 125 ITHRDIKPENLLLDERD--NLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 182
Query: 169 YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRN 228
           +  +  DVWSCG+ L  ML G  P+   + P +  +  S     +  +  +  I      
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAGELPW---DQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLA 239
Query: 229 LLSRIFVANPSRRITIKEIKSHPWFLKNLPR 259
           LL +I V NPS RITI +IK   W+ K L +
Sbjct: 240 LLHKILVENPSARITIPDIKKDRWYNKPLKK 270

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score =  147 bits (372), Expect = 7e-36,   Method: Compositional matrix adjust.
 Identities = 94/271 (34%), Positives = 143/271 (52%), Gaps = 17/271 (6%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDA--NVAREIINHKQLRHP 58
           +E ++L++ +G G +G  +L  N+ T+E VA+K ++    +D   N+ +EI  +K L H 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 65
Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-------Q 111
           N+++F           + +EY +GGELF+RI       E +A+ FF QL++G        
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 125
Query: 112 ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPK---STVGTPAYIAPEVLSRRE 168
           I HRD+K EN LLD      LKI DFG +     ++R +      GT  Y+APE+L RRE
Sbjct: 126 ITHRDIKPENLLLDERD--NLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183
Query: 169 YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRN 228
           +  +  DVWSCG+ L  ML G  P+   + P +  +  S     +  +  +  I      
Sbjct: 184 FHAEPVDVWSCGIVLTAMLAGELPW---DQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLA 240
Query: 229 LLSRIFVANPSRRITIKEIKSHPWFLKNLPR 259
           LL +I V NPS RITI +IK   W+ K L +
Sbjct: 241 LLHKILVENPSARITIPDIKKDRWYNKPLKK 271

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score =  147 bits (372), Expect = 7e-36,   Method: Compositional matrix adjust.
 Identities = 94/271 (34%), Positives = 143/271 (52%), Gaps = 17/271 (6%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDA--NVAREIINHKQLRHP 58
           +E ++L++ +G G +G  +L  N+ T+E VA+K ++    +D   N+ +EI  +K L H 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 65
Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-------Q 111
           N+++F           + +EY +GGELF+RI       E +A+ FF QL++G        
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 125
Query: 112 ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPK---STVGTPAYIAPEVLSRRE 168
           I HRD+K EN LLD      LKI DFG +     ++R +      GT  Y+APE+L RRE
Sbjct: 126 ITHRDIKPENLLLDERD--NLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183
Query: 169 YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRN 228
           +  +  DVWSCG+ L  ML G  P+   + P +  +  S     +  +  +  I      
Sbjct: 184 FHAEPVDVWSCGIVLTAMLAGELPW---DQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLA 240
Query: 229 LLSRIFVANPSRRITIKEIKSHPWFLKNLPR 259
           LL +I V NPS RITI +IK   W+ K L +
Sbjct: 241 LLHKILVENPSARITIPDIKKDRWYNKPLKK 271

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score =  147 bits (372), Expect = 7e-36,   Method: Compositional matrix adjust.
 Identities = 94/271 (34%), Positives = 143/271 (52%), Gaps = 17/271 (6%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDA--NVAREIINHKQLRHP 58
           +E ++L++ +G G +G  +L  N+ T+E VA+K ++    +D   N+ +EI  +K L H 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 65
Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-------Q 111
           N+++F           + +EY +GGELF+RI       E +A+ FF QL++G        
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 125
Query: 112 ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPK---STVGTPAYIAPEVLSRRE 168
           I HRD+K EN LLD      LKI DFG +     ++R +      GT  Y+APE+L RRE
Sbjct: 126 ITHRDIKPENLLLDERD--NLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183
Query: 169 YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRN 228
           +  +  DVWSCG+ L  ML G  P+   + P +  +  S     +  +  +  I      
Sbjct: 184 FHAEPVDVWSCGIVLTAMLAGELPW---DQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLA 240
Query: 229 LLSRIFVANPSRRITIKEIKSHPWFLKNLPR 259
           LL +I V NPS RITI +IK   W+ K L +
Sbjct: 241 LLHKILVENPSARITIPDIKKDRWYNKPLKK 271

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score =  147 bits (371), Expect = 8e-36,   Method: Compositional matrix adjust.
 Identities = 94/271 (34%), Positives = 143/271 (52%), Gaps = 17/271 (6%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDA--NVAREIINHKQLRHP 58
           +E ++L++ +G G +G  +L  N+ T+E VA+K ++    +D   N+ +EI  +K L H 
Sbjct: 4   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 63
Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-------Q 111
           N+++F           + +EY +GGELF+RI       E +A+ FF QL++G        
Sbjct: 64  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 123
Query: 112 ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPK---STVGTPAYIAPEVLSRRE 168
           I HRD+K EN LLD      LKI DFG +     ++R +      GT  Y+APE+L RRE
Sbjct: 124 ITHRDIKPENLLLDERD--NLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 181
Query: 169 YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRN 228
           +  +  DVWSCG+ L  ML G  P+   + P +  +  S     +  +  +  I      
Sbjct: 182 FHAEPVDVWSCGIVLTAMLAGELPW---DQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLA 238
Query: 229 LLSRIFVANPSRRITIKEIKSHPWFLKNLPR 259
           LL +I V NPS RITI +IK   W+ K L +
Sbjct: 239 LLHKILVENPSARITIPDIKKDRWYNKPLKK 269

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  147 bits (371), Expect = 8e-36,   Method: Compositional matrix adjust.
 Identities = 94/271 (34%), Positives = 143/271 (52%), Gaps = 17/271 (6%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDA--NVAREIINHKQLRHP 58
           +E ++L++ +G G +G  +L  N+ T+E VA+K ++    +D   N+ +EI  +K L H 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-------Q 111
           N+++F           + +EY +GGELF+RI       E +A+ FF QL++G        
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 124
Query: 112 ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPK---STVGTPAYIAPEVLSRRE 168
           I HRD+K EN LLD      LKI DFG +     ++R +      GT  Y+APE+L RRE
Sbjct: 125 ITHRDIKPENLLLDERD--NLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 182
Query: 169 YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRN 228
           +  +  DVWSCG+ L  ML G  P+   + P +  +  S     +  +  +  I      
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAGELPW---DQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLA 239
Query: 229 LLSRIFVANPSRRITIKEIKSHPWFLKNLPR 259
           LL +I V NPS RITI +IK   W+ K L +
Sbjct: 240 LLHKILVENPSARITIPDIKKDRWYNKPLKK 270

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  147 bits (371), Expect = 8e-36,   Method: Compositional matrix adjust.
 Identities = 94/271 (34%), Positives = 143/271 (52%), Gaps = 17/271 (6%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDA--NVAREIINHKQLRHP 58
           +E ++L++ +G G +G  +L  N+ T+E VA+K ++    +D   N+ +EI  +K L H 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHE 64
Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-------Q 111
           N+++F           + +EY +GGELF+RI       E +A+ FF QL++G        
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 124
Query: 112 ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPK---STVGTPAYIAPEVLSRRE 168
           I HRD+K EN LLD      LKI DFG +     ++R +      GT  Y+APE+L RRE
Sbjct: 125 ITHRDIKPENLLLDERD--NLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 182
Query: 169 YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRN 228
           +  +  DVWSCG+ L  ML G  P+   + P +  +  S     +  +  +  I      
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAGELPW---DQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLA 239
Query: 229 LLSRIFVANPSRRITIKEIKSHPWFLKNLPR 259
           LL +I V NPS RITI +IK   W+ K L +
Sbjct: 240 LLHKILVENPSARITIPDIKKDRWYNKPLKK 270

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  147 bits (371), Expect = 8e-36,   Method: Compositional matrix adjust.
 Identities = 94/271 (34%), Positives = 143/271 (52%), Gaps = 17/271 (6%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDA--NVAREIINHKQLRHP 58
           +E ++L++ +G G +G  +L  N+ T+E VA+K ++    +D   N+ +EI  +K L H 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-------Q 111
           N+++F           + +EY +GGELF+RI       E +A+ FF QL++G        
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 124
Query: 112 ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPK---STVGTPAYIAPEVLSRRE 168
           I HRD+K EN LLD      LKI DFG +     ++R +      GT  Y+APE+L RRE
Sbjct: 125 ITHRDIKPENLLLDERD--NLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRRE 182
Query: 169 YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRN 228
           +  +  DVWSCG+ L  ML G  P+   + P +  +  S     +  +  +  I      
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAGELPW---DQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLA 239
Query: 229 LLSRIFVANPSRRITIKEIKSHPWFLKNLPR 259
           LL +I V NPS RITI +IK   W+ K L +
Sbjct: 240 LLHKILVENPSARITIPDIKKDRWYNKPLKK 270

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  147 bits (371), Expect = 8e-36,   Method: Compositional matrix adjust.
 Identities = 94/271 (34%), Positives = 143/271 (52%), Gaps = 17/271 (6%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDA--NVAREIINHKQLRHP 58
           +E ++L++ +G G +G  +L  N+ T+E VA+K ++    +D   N+ +EI  +K L H 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHE 64
Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-------Q 111
           N+++F           + +EY +GGELF+RI       E +A+ FF QL++G        
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 124
Query: 112 ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPK---STVGTPAYIAPEVLSRRE 168
           I HRD+K EN LLD      LKI DFG +     ++R +      GT  Y+APE+L RRE
Sbjct: 125 ITHRDIKPENLLLDERD--NLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRRE 182
Query: 169 YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRN 228
           +  +  DVWSCG+ L  ML G  P+   + P +  +  S     +  +  +  I      
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAGELPW---DQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLA 239
Query: 229 LLSRIFVANPSRRITIKEIKSHPWFLKNLPR 259
           LL +I V NPS RITI +IK   W+ K L +
Sbjct: 240 LLHKILVENPSARITIPDIKKDRWYNKPLKK 270

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score =  147 bits (371), Expect = 9e-36,   Method: Compositional matrix adjust.
 Identities = 94/269 (34%), Positives = 142/269 (52%), Gaps = 17/269 (6%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDA--NVAREIINHKQLRHP 58
           +E ++L++ +G G +G  +L  N+ T+E VA+K ++    +D   N+ +EI  +K L H 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-------Q 111
           N+++F           + +EY +GGELF+RI       E +A+ FF QL++G        
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 124
Query: 112 ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPK---STVGTPAYIAPEVLSRRE 168
           I HRD+K EN LLD      LKI DFG +     ++R +      GT  Y+APE+L RRE
Sbjct: 125 ITHRDIKPENLLLDERD--NLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 182
Query: 169 YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRN 228
           +  +  DVWSCG+ L  ML G  P+   + P +  +  S     +  +  +  I      
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAGELPW---DQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLA 239
Query: 229 LLSRIFVANPSRRITIKEIKSHPWFLKNL 257
           LL +I V NPS RITI +IK   W+ K L
Sbjct: 240 LLHKILVENPSARITIPDIKKDRWYNKPL 268

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score =  147 bits (371), Expect = 9e-36,   Method: Compositional matrix adjust.
 Identities = 94/271 (34%), Positives = 143/271 (52%), Gaps = 17/271 (6%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDA--NVAREIINHKQLRHP 58
           +E ++L++ +G G +G  +L  N+ T+E VA+K ++    +D   N+ +EI  +K L H 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 65
Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-------Q 111
           N+++F           + +EY +GGELF+RI       E +A+ FF QL++G        
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 125
Query: 112 ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPK---STVGTPAYIAPEVLSRRE 168
           I HRD+K EN LLD      LKI DFG +     ++R +      GT  Y+APE+L RRE
Sbjct: 126 ITHRDIKPENLLLDERD--NLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183
Query: 169 YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRN 228
           +  +  DVWSCG+ L  ML G  P+   + P +  +  S     +  +  +  I      
Sbjct: 184 FHAEPVDVWSCGIVLTAMLAGELPW---DQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLA 240
Query: 229 LLSRIFVANPSRRITIKEIKSHPWFLKNLPR 259
           LL +I V NPS RITI +IK   W+ K L +
Sbjct: 241 LLHKILVENPSARITIPDIKKDRWYNKPLKK 271

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score =  147 bits (371), Expect = 9e-36,   Method: Compositional matrix adjust.
 Identities = 90/267 (33%), Positives = 143/267 (53%), Gaps = 21/267 (7%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH----KIDANVAREIINHKQLR 56
           +E +E+ + +G G FG   L R K +K ++A+K + +       ++  + RE+     LR
Sbjct: 33  LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 92
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLI-------S 109
           HPNI+R        T + +++EYA  G ++  +    +F E     +  +L        S
Sbjct: 93  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 152
Query: 110 GQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREY 169
            ++ HRD+K EN LL GS A  LKI DFG+S  +   SR  +  GT  Y+ PE++  R +
Sbjct: 153 KRVIHRDIKPENLLL-GS-AGELKIADFGWSVHA-PSSRRTTLCGTLDYLPPEMIEGRMH 209
Query: 170 DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 229
           D K+ D+WS GV  Y  LVG  PFE       +++T  RI  V++  PD+V  ++  R+L
Sbjct: 210 DEKV-DLWSLGVLCYEFLVGKPPFE----ANTYQETYKRISRVEFTFPDFV--TEGARDL 262
Query: 230 LSRIFVANPSRRITIKEIKSHPWFLKN 256
           +SR+   NPS+R  ++E+  HPW   N
Sbjct: 263 ISRLLKHNPSQRPMLREVLEHPWITAN 289

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score =  147 bits (371), Expect = 9e-36,   Method: Compositional matrix adjust.
 Identities = 94/271 (34%), Positives = 143/271 (52%), Gaps = 17/271 (6%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDA--NVAREIINHKQLRHP 58
           +E ++L++ +G G +G  +L  N+ T+E VA+K ++    +D   N+ +EI  +K L H 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHE 65
Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-------Q 111
           N+++F           + +EY +GGELF+RI       E +A+ FF QL++G        
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 125
Query: 112 ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPK---STVGTPAYIAPEVLSRRE 168
           I HRD+K EN LLD      LKI DFG +     ++R +      GT  Y+APE+L RRE
Sbjct: 126 ITHRDIKPENLLLDERD--NLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRRE 183
Query: 169 YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRN 228
           +  +  DVWSCG+ L  ML G  P+   + P +  +  S     +  +  +  I      
Sbjct: 184 FHAEPVDVWSCGIVLTAMLAGELPW---DQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLA 240
Query: 229 LLSRIFVANPSRRITIKEIKSHPWFLKNLPR 259
           LL +I V NPS RITI +IK   W+ K L +
Sbjct: 241 LLHKILVENPSARITIPDIKKDRWYNKPLKK 271

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score =  147 bits (371), Expect = 1e-35,   Method: Compositional matrix adjust.
 Identities = 94/269 (34%), Positives = 142/269 (52%), Gaps = 17/269 (6%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDA--NVAREIINHKQLRHP 58
           +E ++L++ +G G +G  +L  N+ T+E VA+K ++    +D   N+ +EI  +K L H 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-------Q 111
           N+++F           + +EY +GGELF+RI       E +A+ FF QL++G        
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 124
Query: 112 ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPK---STVGTPAYIAPEVLSRRE 168
           I HRD+K EN LLD      LKI DFG +     ++R +      GT  Y+APE+L RRE
Sbjct: 125 ITHRDIKPENLLLDERD--NLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 182
Query: 169 YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRN 228
           +  +  DVWSCG+ L  ML G  P+   + P +  +  S     +  +  +  I      
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAGELPW---DQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLA 239
Query: 229 LLSRIFVANPSRRITIKEIKSHPWFLKNL 257
           LL +I V NPS RITI +IK   W+ K L
Sbjct: 240 LLHKILVENPSARITIPDIKKDRWYNKPL 268

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score =  147 bits (371), Expect = 1e-35,   Method: Compositional matrix adjust.
 Identities = 94/269 (34%), Positives = 142/269 (52%), Gaps = 17/269 (6%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDA--NVAREIINHKQLRHP 58
           +E ++L++ +G G +G  +L  N+ T+E VA+K ++    +D   N+ +EI  +K L H 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 65
Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-------Q 111
           N+++F           + +EY +GGELF+RI       E +A+ FF QL++G        
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 125
Query: 112 ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPK---STVGTPAYIAPEVLSRRE 168
           I HRD+K EN LLD      LKI DFG +     ++R +      GT  Y+APE+L RRE
Sbjct: 126 ITHRDIKPENLLLDERD--NLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183
Query: 169 YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRN 228
           +  +  DVWSCG+ L  ML G  P+   + P +  +  S     +  +  +  I      
Sbjct: 184 FHAEPVDVWSCGIVLTAMLAGELPW---DQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLA 240
Query: 229 LLSRIFVANPSRRITIKEIKSHPWFLKNL 257
           LL +I V NPS RITI +IK   W+ K L
Sbjct: 241 LLHKILVENPSARITIPDIKKDRWYNKPL 269

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score =  147 bits (370), Expect = 1e-35,   Method: Compositional matrix adjust.
 Identities = 94/269 (34%), Positives = 142/269 (52%), Gaps = 17/269 (6%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDA--NVAREIINHKQLRHP 58
           +E ++L++ +G G +G  +L  N+ T+E VA+K ++    +D   N+ +EI  +K L H 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-------Q 111
           N+++F           + +EY +GGELF+RI       E +A+ FF QL++G        
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 124
Query: 112 ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPK---STVGTPAYIAPEVLSRRE 168
           I HRD+K EN LLD      LKI DFG +     ++R +      GT  Y+APE+L RRE
Sbjct: 125 ITHRDIKPENLLLDERD--NLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRRE 182
Query: 169 YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRN 228
           +  +  DVWSCG+ L  ML G  P+   + P +  +  S     +  +  +  I      
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAGELPW---DQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLA 239
Query: 229 LLSRIFVANPSRRITIKEIKSHPWFLKNL 257
           LL +I V NPS RITI +IK   W+ K L
Sbjct: 240 LLHKILVENPSARITIPDIKKDRWYNKPL 268

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score =  146 bits (369), Expect = 1e-35,   Method: Compositional matrix adjust.
 Identities = 90/267 (33%), Positives = 143/267 (53%), Gaps = 21/267 (7%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH----KIDANVAREIINHKQLR 56
           +E +E+ + +G G FG   L R K +K ++A+K + +       ++  + RE+     LR
Sbjct: 24  LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 83
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLI-------S 109
           HPNI+R        T + +++EYA  G ++  +    +F E     +  +L        S
Sbjct: 84  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 143
Query: 110 GQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREY 169
            ++ HRD+K EN LL GS A  LKI DFG+S  +   SR  +  GT  Y+ PE++  R +
Sbjct: 144 KRVIHRDIKPENLLL-GS-AGELKIADFGWSVHA-PSSRRTTLCGTLDYLPPEMIEGRMH 200
Query: 170 DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 229
           D K+ D+WS GV  Y  LVG  PFE       +++T  RI  V++  PD+V  ++  R+L
Sbjct: 201 DEKV-DLWSLGVLCYEFLVGKPPFE----ANTYQETYKRISRVEFTFPDFV--TEGARDL 253
Query: 230 LSRIFVANPSRRITIKEIKSHPWFLKN 256
           +SR+   NPS+R  ++E+  HPW   N
Sbjct: 254 ISRLLKHNPSQRPMLREVLEHPWITAN 280

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score =  146 bits (369), Expect = 1e-35,   Method: Compositional matrix adjust.
 Identities = 90/267 (33%), Positives = 142/267 (53%), Gaps = 21/267 (7%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH----KIDANVAREIINHKQLR 56
           +E +E+ + +G G FG   L R K +K ++A+K + +       ++  + RE+     LR
Sbjct: 33  LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 92
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLI-------S 109
           HPNI+R        T + +++EYA  G ++  +    +F E     +  +L        S
Sbjct: 93  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 152
Query: 110 GQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREY 169
            ++ HRD+K EN LL GS A  LKI DFG+S  +   SR     GT  Y+ PE++  R +
Sbjct: 153 KRVIHRDIKPENLLL-GS-AGELKIADFGWSVHA-PSSRRDDLCGTLDYLPPEMIEGRMH 209
Query: 170 DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 229
           D K+ D+WS GV  Y  LVG  PFE       +++T  RI  V++  PD+V  ++  R+L
Sbjct: 210 DEKV-DLWSLGVLCYEFLVGKPPFE----ANTYQETYKRISRVEFTFPDFV--TEGARDL 262
Query: 230 LSRIFVANPSRRITIKEIKSHPWFLKN 256
           +SR+   NPS+R  ++E+  HPW   N
Sbjct: 263 ISRLLKHNPSQRPMLREVLEHPWITAN 289

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score =  146 bits (369), Expect = 2e-35,   Method: Compositional matrix adjust.
 Identities = 90/267 (33%), Positives = 143/267 (53%), Gaps = 21/267 (7%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH----KIDANVAREIINHKQLR 56
           +E +E+ + +G G FG   L R K +K ++A+K + +       ++  + RE+     LR
Sbjct: 7   LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 66
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLI-------S 109
           HPNI+R        T + +++EYA  G ++  +    +F E     +  +L        S
Sbjct: 67  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 126
Query: 110 GQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREY 169
            ++ HRD+K EN LL GS A  LKI DFG+S  +   SR  +  GT  Y+ PE++  R +
Sbjct: 127 KRVIHRDIKPENLLL-GS-AGELKIADFGWSVHA-PSSRRTTLCGTLDYLPPEMIEGRMH 183
Query: 170 DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 229
           D K+ D+WS GV  Y  LVG  PFE       +++T  RI  V++  PD+V  ++  R+L
Sbjct: 184 DEKV-DLWSLGVLCYEFLVGKPPFE----ANTYQETYKRISRVEFTFPDFV--TEGARDL 236
Query: 230 LSRIFVANPSRRITIKEIKSHPWFLKN 256
           +SR+   NPS+R  ++E+  HPW   N
Sbjct: 237 ISRLLKHNPSQRPMLREVLEHPWITAN 263

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score =  146 bits (369), Expect = 2e-35,   Method: Compositional matrix adjust.
 Identities = 90/267 (33%), Positives = 143/267 (53%), Gaps = 21/267 (7%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH----KIDANVAREIINHKQLR 56
           +E +E+ + +G G FG   L R K +K ++A+K + +       ++  + RE+     LR
Sbjct: 8   LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 67
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLI-------S 109
           HPNI+R        T + +++EYA  G ++  +    +F E     +  +L        S
Sbjct: 68  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 127
Query: 110 GQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREY 169
            ++ HRD+K EN LL GS A  LKI DFG+S  +   SR  +  GT  Y+ PE++  R +
Sbjct: 128 KRVIHRDIKPENLLL-GS-AGELKIADFGWSVHA-PSSRRDTLCGTLDYLPPEMIEGRMH 184
Query: 170 DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 229
           D K+ D+WS GV  Y  LVG  PFE       +++T  RI  V++  PD+V  ++  R+L
Sbjct: 185 DEKV-DLWSLGVLCYEFLVGKPPFE----ANTYQETYKRISRVEFTFPDFV--TEGARDL 237
Query: 230 LSRIFVANPSRRITIKEIKSHPWFLKN 256
           +SR+   NPS+R  ++E+  HPW   N
Sbjct: 238 ISRLLKHNPSQRPMLREVLEHPWITAN 264

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score =  146 bits (369), Expect = 2e-35,   Method: Compositional matrix adjust.
 Identities = 90/267 (33%), Positives = 143/267 (53%), Gaps = 21/267 (7%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH----KIDANVAREIINHKQLR 56
           +E +E+ + +G G FG   L R K +K ++A+K + +       ++  + RE+     LR
Sbjct: 6   LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 65
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLI-------S 109
           HPNI+R        T + +++EYA  G ++  +    +F E     +  +L        S
Sbjct: 66  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 125
Query: 110 GQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREY 169
            ++ HRD+K EN LL GS A  LKI DFG+S  +   SR  +  GT  Y+ PE++  R +
Sbjct: 126 KRVIHRDIKPENLLL-GS-AGELKIADFGWSVHA-PSSRRTTLCGTLDYLPPEMIEGRMH 182
Query: 170 DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 229
           D K+ D+WS GV  Y  LVG  PFE       +++T  RI  V++  PD+V  ++  R+L
Sbjct: 183 DEKV-DLWSLGVLCYEFLVGKPPFE----ANTYQETYKRISRVEFTFPDFV--TEGARDL 235
Query: 230 LSRIFVANPSRRITIKEIKSHPWFLKN 256
           +SR+   NPS+R  ++E+  HPW   N
Sbjct: 236 ISRLLKHNPSQRPMLREVLEHPWITAN 262

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score =  146 bits (368), Expect = 2e-35,   Method: Compositional matrix adjust.
 Identities = 90/267 (33%), Positives = 143/267 (53%), Gaps = 21/267 (7%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH----KIDANVAREIINHKQLR 56
           +E +E+ + +G G FG   L R K +K ++A+K + +       ++  + RE+     LR
Sbjct: 10  LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 69
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLI-------S 109
           HPNI+R        T + +++EYA  G ++  +    +F E     +  +L        S
Sbjct: 70  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 129
Query: 110 GQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREY 169
            ++ HRD+K EN LL GS A  LKI DFG+S  +   SR  +  GT  Y+ PE++  R +
Sbjct: 130 KRVIHRDIKPENLLL-GS-AGELKIADFGWSVHA-PSSRRTTLCGTLDYLPPEMIEGRMH 186
Query: 170 DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 229
           D K+ D+WS GV  Y  LVG  PFE       +++T  RI  V++  PD+V  ++  R+L
Sbjct: 187 DEKV-DLWSLGVLCYEFLVGKPPFE----ANTYQETYKRISRVEFTFPDFV--TEGARDL 239
Query: 230 LSRIFVANPSRRITIKEIKSHPWFLKN 256
           +SR+   NPS+R  ++E+  HPW   N
Sbjct: 240 ISRLLKHNPSQRPMLREVLEHPWITAN 266

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score =  146 bits (368), Expect = 2e-35,   Method: Compositional matrix adjust.
 Identities = 90/267 (33%), Positives = 143/267 (53%), Gaps = 21/267 (7%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH----KIDANVAREIINHKQLR 56
           +E +E+ + +G G FG   L R K +K ++A+K + +       ++  + RE+     LR
Sbjct: 10  LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 69
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLI-------S 109
           HPNI+R        T + +++EYA  G ++  +    +F E     +  +L        S
Sbjct: 70  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 129
Query: 110 GQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREY 169
            ++ HRD+K EN LL GS A  LKI DFG+S  +   SR  +  GT  Y+ PE++  R +
Sbjct: 130 KRVIHRDIKPENLLL-GS-AGELKIADFGWSVHA-PSSRRTTLCGTLDYLPPEMIEGRMH 186
Query: 170 DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 229
           D K+ D+WS GV  Y  LVG  PFE       +++T  RI  V++  PD+V  ++  R+L
Sbjct: 187 DEKV-DLWSLGVLCYEFLVGKPPFE----ANTYQETYKRISRVEFTFPDFV--TEGARDL 239
Query: 230 LSRIFVANPSRRITIKEIKSHPWFLKN 256
           +SR+   NPS+R  ++E+  HPW   N
Sbjct: 240 ISRLLKHNPSQRPMLREVLEHPWITAN 266

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score =  146 bits (368), Expect = 2e-35,   Method: Compositional matrix adjust.
 Identities = 90/267 (33%), Positives = 143/267 (53%), Gaps = 21/267 (7%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH----KIDANVAREIINHKQLR 56
           +E +E+ + +G G FG   L R K +K ++A+K + +       ++  + RE+     LR
Sbjct: 12  LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 71
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLI-------S 109
           HPNI+R        T + +++EYA  G ++  +    +F E     +  +L        S
Sbjct: 72  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 131
Query: 110 GQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREY 169
            ++ HRD+K EN LL GS A  LKI DFG+S  +   SR  +  GT  Y+ PE++  R +
Sbjct: 132 KRVIHRDIKPENLLL-GS-AGELKIADFGWSVHA-PSSRRTTLCGTLDYLPPEMIEGRMH 188
Query: 170 DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 229
           D K+ D+WS GV  Y  LVG  PFE       +++T  RI  V++  PD+V  ++  R+L
Sbjct: 189 DEKV-DLWSLGVLCYEFLVGKPPFE----ANTYQETYKRISRVEFTFPDFV--TEGARDL 241
Query: 230 LSRIFVANPSRRITIKEIKSHPWFLKN 256
           +SR+   NPS+R  ++E+  HPW   N
Sbjct: 242 ISRLLKHNPSQRPMLREVLEHPWITAN 268

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score =  146 bits (368), Expect = 2e-35,   Method: Compositional matrix adjust.
 Identities = 90/267 (33%), Positives = 142/267 (53%), Gaps = 21/267 (7%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH----KIDANVAREIINHKQLR 56
           +E +E+ + +G G FG   L R K +K ++A+K + +       ++  + RE+     LR
Sbjct: 12  LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 71
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLI-------S 109
           HPNI+R        T + +++EYA  G ++  +    +F E     +  +L        S
Sbjct: 72  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 131
Query: 110 GQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREY 169
            ++ HRD+K EN LL GS A  LKI DFG+S  +   SR  +  GT  Y+ PE +  R +
Sbjct: 132 KRVIHRDIKPENLLL-GS-AGELKIADFGWSVHA-PSSRRTTLCGTLDYLPPEXIEGRXH 188
Query: 170 DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 229
           D K+ D+WS GV  Y  LVG  PFE       +++T  RI  V++  PD+V  ++  R+L
Sbjct: 189 DEKV-DLWSLGVLCYEFLVGKPPFE----ANTYQETYKRISRVEFTFPDFV--TEGARDL 241
Query: 230 LSRIFVANPSRRITIKEIKSHPWFLKN 256
           +SR+   NPS+R  ++E+  HPW   N
Sbjct: 242 ISRLLKHNPSQRPXLREVLEHPWITAN 268

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score =  146 bits (368), Expect = 2e-35,   Method: Compositional matrix adjust.
 Identities = 90/267 (33%), Positives = 143/267 (53%), Gaps = 21/267 (7%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH----KIDANVAREIINHKQLR 56
           +E +E+ + +G G FG   L R K +K ++A+K + +       ++  + RE+     LR
Sbjct: 11  LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 70
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLI-------S 109
           HPNI+R        T + +++EYA  G ++  +    +F E     +  +L        S
Sbjct: 71  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 130
Query: 110 GQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREY 169
            ++ HRD+K EN LL GS A  LKI DFG+S  +   SR  +  GT  Y+ PE++  R +
Sbjct: 131 KRVIHRDIKPENLLL-GS-AGELKIADFGWSVHA-PSSRRTTLCGTLDYLPPEMIEGRMH 187
Query: 170 DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 229
           D K+ D+WS GV  Y  LVG  PFE       +++T  RI  V++  PD+V  ++  R+L
Sbjct: 188 DEKV-DLWSLGVLCYEFLVGKPPFE----ANTYQETYKRISRVEFTFPDFV--TEGARDL 240
Query: 230 LSRIFVANPSRRITIKEIKSHPWFLKN 256
           +SR+   NPS+R  ++E+  HPW   N
Sbjct: 241 ISRLLKHNPSQRPMLREVLEHPWITAN 267

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score =  146 bits (368), Expect = 2e-35,   Method: Compositional matrix adjust.
 Identities = 90/267 (33%), Positives = 143/267 (53%), Gaps = 21/267 (7%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH----KIDANVAREIINHKQLR 56
           +E +E+ + +G G FG   L R K +K ++A+K + +       ++  + RE+     LR
Sbjct: 7   LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 66
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLI-------S 109
           HPNI+R        T + +++EYA  G ++  +    +F E     +  +L        S
Sbjct: 67  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 126
Query: 110 GQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREY 169
            ++ HRD+K EN LL GS A  LKI DFG+S  +   SR  +  GT  Y+ PE++  R +
Sbjct: 127 KRVIHRDIKPENLLL-GS-AGELKIADFGWSVHA-PSSRRAALCGTLDYLPPEMIEGRMH 183
Query: 170 DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 229
           D K+ D+WS GV  Y  LVG  PFE       +++T  RI  V++  PD+V  ++  R+L
Sbjct: 184 DEKV-DLWSLGVLCYEFLVGKPPFE----ANTYQETYKRISRVEFTFPDFV--TEGARDL 236
Query: 230 LSRIFVANPSRRITIKEIKSHPWFLKN 256
           +SR+   NPS+R  ++E+  HPW   N
Sbjct: 237 ISRLLKHNPSQRPMLREVLEHPWITAN 263

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score =  146 bits (368), Expect = 2e-35,   Method: Compositional matrix adjust.
 Identities = 90/267 (33%), Positives = 143/267 (53%), Gaps = 21/267 (7%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH----KIDANVAREIINHKQLR 56
           +E +E+ + +G G FG   L R K +K ++A+K + +       ++  + RE+     LR
Sbjct: 10  LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 69
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLI-------S 109
           HPNI+R        T + +++EYA  G ++  +    +F E     +  +L        S
Sbjct: 70  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 129
Query: 110 GQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREY 169
            ++ HRD+K EN LL GS A  LKI DFG+S  +   SR  +  GT  Y+ PE++  R +
Sbjct: 130 KRVIHRDIKPENLLL-GS-AGELKIADFGWSVHA-PSSRRAALCGTLDYLPPEMIEGRMH 186
Query: 170 DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 229
           D K+ D+WS GV  Y  LVG  PFE       +++T  RI  V++  PD+V  ++  R+L
Sbjct: 187 DEKV-DLWSLGVLCYEFLVGKPPFE----ANTYQETYKRISRVEFTFPDFV--TEGARDL 239
Query: 230 LSRIFVANPSRRITIKEIKSHPWFLKN 256
           +SR+   NPS+R  ++E+  HPW   N
Sbjct: 240 ISRLLKHNPSQRPMLREVLEHPWITAN 266

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score =  145 bits (367), Expect = 2e-35,   Method: Compositional matrix adjust.
 Identities = 90/267 (33%), Positives = 142/267 (53%), Gaps = 21/267 (7%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH----KIDANVAREIINHKQLR 56
           +E +E+ + +G G FG   L R K +K ++A+K + +       ++  + RE+     LR
Sbjct: 7   LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 66
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLI-------S 109
           HPNI+R        T + +++EYA  G ++  +    +F E     +  +L        S
Sbjct: 67  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 126
Query: 110 GQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREY 169
            ++ HRD+K EN LL GS A  LKI DFG+S  +   SR     GT  Y+ PE++  R +
Sbjct: 127 KRVIHRDIKPENLLL-GS-AGELKIADFGWSVHA-PSSRRTDLCGTLDYLPPEMIEGRMH 183
Query: 170 DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 229
           D K+ D+WS GV  Y  LVG  PFE       +++T  RI  V++  PD+V  ++  R+L
Sbjct: 184 DEKV-DLWSLGVLCYEFLVGKPPFE----ANTYQETYKRISRVEFTFPDFV--TEGARDL 236
Query: 230 LSRIFVANPSRRITIKEIKSHPWFLKN 256
           +SR+   NPS+R  ++E+  HPW   N
Sbjct: 237 ISRLLKHNPSQRPMLREVLEHPWITAN 263

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score =  145 bits (367), Expect = 2e-35,   Method: Compositional matrix adjust.
 Identities = 90/267 (33%), Positives = 142/267 (53%), Gaps = 21/267 (7%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH----KIDANVAREIINHKQLR 56
           +E +E+ + +G G FG   L R K +K ++A+K + +       ++  + RE+     LR
Sbjct: 8   LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 67
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLI-------S 109
           HPNI+R        T + +++EYA  G ++  +    +F E     +  +L        S
Sbjct: 68  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 127
Query: 110 GQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREY 169
            ++ HRD+K EN LL GS A  LKI DFG+S  +   SR     GT  Y+ PE++  R +
Sbjct: 128 KRVIHRDIKPENLLL-GS-AGELKIADFGWSVHA-PSSRRTDLCGTLDYLPPEMIEGRMH 184
Query: 170 DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 229
           D K+ D+WS GV  Y  LVG  PFE       +++T  RI  V++  PD+V  ++  R+L
Sbjct: 185 DEKV-DLWSLGVLCYEFLVGKPPFE----ANTYQETYKRISRVEFTFPDFV--TEGARDL 237
Query: 230 LSRIFVANPSRRITIKEIKSHPWFLKN 256
           +SR+   NPS+R  ++E+  HPW   N
Sbjct: 238 ISRLLKHNPSQRPMLREVLEHPWITAN 264

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score =  145 bits (367), Expect = 3e-35,   Method: Compositional matrix adjust.
 Identities = 90/267 (33%), Positives = 142/267 (53%), Gaps = 21/267 (7%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH----KIDANVAREIINHKQLR 56
           +E +E+ + +G G FG   L R K +K ++A+K + +       ++  + RE+     LR
Sbjct: 9   LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 68
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLI-------S 109
           HPNI+R        T + +++EYA  G ++  +    +F E     +  +L        S
Sbjct: 69  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 128
Query: 110 GQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREY 169
            ++ HRD+K EN LL GS A  LKI DFG+S  +   SR     GT  Y+ PE++  R +
Sbjct: 129 KRVIHRDIKPENLLL-GS-AGELKIADFGWSVHA-PSSRRXXLCGTLDYLPPEMIEGRMH 185
Query: 170 DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 229
           D K+ D+WS GV  Y  LVG  PFE       +++T  RI  V++  PD+V  ++  R+L
Sbjct: 186 DEKV-DLWSLGVLCYEFLVGKPPFE----ANTYQETYKRISRVEFTFPDFV--TEGARDL 238
Query: 230 LSRIFVANPSRRITIKEIKSHPWFLKN 256
           +SR+   NPS+R  ++E+  HPW   N
Sbjct: 239 ISRLLKHNPSQRPMLREVLEHPWITAN 265

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score =  145 bits (367), Expect = 3e-35,   Method: Compositional matrix adjust.
 Identities = 90/267 (33%), Positives = 143/267 (53%), Gaps = 21/267 (7%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH----KIDANVAREIINHKQLR 56
           +E +E+ + +G G FG   L R K +K ++A+K + +       ++  + RE+     LR
Sbjct: 8   LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 67
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLI-------S 109
           HPNI+R        T + +++EYA  G ++  +    +F E     +  +L        S
Sbjct: 68  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 127
Query: 110 GQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREY 169
            ++ HRD+K EN LL GS A  LKI DFG+S  +   SR  +  GT  Y+ PE++  R +
Sbjct: 128 KRVIHRDIKPENLLL-GS-AGELKIADFGWSCHA-PSSRRTTLSGTLDYLPPEMIEGRMH 184
Query: 170 DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 229
           D K+ D+WS GV  Y  LVG  PFE       +++T  RI  V++  PD+V  ++  R+L
Sbjct: 185 DEKV-DLWSLGVLCYEFLVGKPPFE----ANTYQETYKRISRVEFTFPDFV--TEGARDL 237
Query: 230 LSRIFVANPSRRITIKEIKSHPWFLKN 256
           +SR+   NPS+R  ++E+  HPW   N
Sbjct: 238 ISRLLKHNPSQRPMLREVLEHPWITAN 264

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score =  145 bits (367), Expect = 3e-35,   Method: Compositional matrix adjust.
 Identities = 90/267 (33%), Positives = 142/267 (53%), Gaps = 21/267 (7%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH----KIDANVAREIINHKQLR 56
           +E +E+ + +G G FG   L R K +K ++A+K + +       ++  + RE+     LR
Sbjct: 7   LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 66
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLI-------S 109
           HPNI+R        T + +++EYA  G ++  +    +F E     +  +L        S
Sbjct: 67  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 126
Query: 110 GQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREY 169
            ++ HRD+K EN LL GS A  LKI DFG+S  +   SR     GT  Y+ PE++  R +
Sbjct: 127 KRVIHRDIKPENLLL-GS-AGELKIADFGWSVHA-PSSRRTELCGTLDYLPPEMIEGRMH 183
Query: 170 DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 229
           D K+ D+WS GV  Y  LVG  PFE       +++T  RI  V++  PD+V  ++  R+L
Sbjct: 184 DEKV-DLWSLGVLCYEFLVGKPPFE----ANTYQETYKRISRVEFTFPDFV--TEGARDL 236
Query: 230 LSRIFVANPSRRITIKEIKSHPWFLKN 256
           +SR+   NPS+R  ++E+  HPW   N
Sbjct: 237 ISRLLKHNPSQRPMLREVLEHPWITAN 263

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  145 bits (367), Expect = 3e-35,   Method: Compositional matrix adjust.
 Identities = 94/271 (34%), Positives = 142/271 (52%), Gaps = 17/271 (6%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDA--NVAREIINHKQLRHP 58
           +E ++L++ +G G  G  +L  N+ T+E VA+K ++    +D   N+ +EI  +K L H 
Sbjct: 5   VEDWDLVQTLGEGAAGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-------Q 111
           N+++F           + +EY +GGELF+RI       E +A+ FF QL++G        
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 124
Query: 112 ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPK---STVGTPAYIAPEVLSRRE 168
           I HRD+K EN LLD      LKI DFG +     ++R +      GT  Y+APE+L RRE
Sbjct: 125 ITHRDIKPENLLLDERD--NLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 182
Query: 169 YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRN 228
           +  +  DVWSCG+ L  ML G  P+   + P +  +  S     +  +  +  I      
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAGELPW---DQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLA 239
Query: 229 LLSRIFVANPSRRITIKEIKSHPWFLKNLPR 259
           LL +I V NPS RITI +IK   W+ K L +
Sbjct: 240 LLHKILVENPSARITIPDIKKDRWYNKPLKK 270

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score =  145 bits (367), Expect = 3e-35,   Method: Compositional matrix adjust.
 Identities = 90/267 (33%), Positives = 142/267 (53%), Gaps = 21/267 (7%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH----KIDANVAREIINHKQLR 56
           +E +E+ + +G G FG   L R K +K ++A+K + +       ++  + RE+     LR
Sbjct: 10  LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 69
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLI-------S 109
           HPNI+R        T + +++EYA  G ++  +    +F E     +  +L        S
Sbjct: 70  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 129
Query: 110 GQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREY 169
            ++ HRD+K EN LL GS A  LKI DFG+S  +   SR     GT  Y+ PE++  R +
Sbjct: 130 KRVIHRDIKPENLLL-GS-AGELKIADFGWSVHA-PSSRRDDLCGTLDYLPPEMIEGRMH 186
Query: 170 DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 229
           D K+ D+WS GV  Y  LVG  PFE       +++T  RI  V++  PD+V  ++  R+L
Sbjct: 187 DEKV-DLWSLGVLCYEFLVGKPPFE----ANTYQETYKRISRVEFTFPDFV--TEGARDL 239
Query: 230 LSRIFVANPSRRITIKEIKSHPWFLKN 256
           +SR+   NPS+R  ++E+  HPW   N
Sbjct: 240 ISRLLKHNPSQRPMLREVLEHPWITAN 266

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score =  145 bits (366), Expect = 3e-35,   Method: Compositional matrix adjust.
 Identities = 90/267 (33%), Positives = 142/267 (53%), Gaps = 21/267 (7%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH----KIDANVAREIINHKQLR 56
           +E +E+ + +G G FG   L R K +K ++A+K + +       ++  + RE+     LR
Sbjct: 7   LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 66
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLI-------S 109
           HPNI+R        T + +++EYA  G ++  +    +F E     +  +L        S
Sbjct: 67  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 126
Query: 110 GQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREY 169
            ++ HRD+K EN LL GS A  LKI DFG+S  +   SR     GT  Y+ PE++  R +
Sbjct: 127 KRVIHRDIKPENLLL-GS-AGELKIADFGWSVHA-PSSRRTDLCGTLDYLPPEMIEGRMH 183
Query: 170 DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 229
           D K+ D+WS GV  Y  LVG  PFE       +++T  RI  V++  PD+V  ++  R+L
Sbjct: 184 DEKV-DLWSLGVLCYEFLVGKPPFE----ANTYQETYKRISRVEFTFPDFV--TEGARDL 236
Query: 230 LSRIFVANPSRRITIKEIKSHPWFLKN 256
           +SR+   NPS+R  ++E+  HPW   N
Sbjct: 237 ISRLLKHNPSQRPMLREVLEHPWITAN 263

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score =  145 bits (366), Expect = 3e-35,   Method: Compositional matrix adjust.
 Identities = 90/267 (33%), Positives = 142/267 (53%), Gaps = 21/267 (7%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH----KIDANVAREIINHKQLR 56
           +E +E+ + +G G FG   L R K +K ++A+K + +       ++  + RE+     LR
Sbjct: 10  LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 69
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLI-------S 109
           HPNI+R        T + +++EYA  G ++  +    +F E     +  +L        S
Sbjct: 70  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 129
Query: 110 GQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREY 169
            ++ HRD+K EN LL GS A  LKI DFG+S  +   SR     GT  Y+ PE++  R +
Sbjct: 130 KRVIHRDIKPENLLL-GS-AGELKIADFGWSVHA-PSSRRXXLCGTLDYLPPEMIEGRMH 186
Query: 170 DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 229
           D K+ D+WS GV  Y  LVG  PFE       +++T  RI  V++  PD+V  ++  R+L
Sbjct: 187 DEKV-DLWSLGVLCYEFLVGKPPFE----ANTYQETYKRISRVEFTFPDFV--TEGARDL 239
Query: 230 LSRIFVANPSRRITIKEIKSHPWFLKN 256
           +SR+   NPS+R  ++E+  HPW   N
Sbjct: 240 ISRLLKHNPSQRPMLREVLEHPWITAN 266

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score =  145 bits (366), Expect = 3e-35,   Method: Compositional matrix adjust.
 Identities = 93/271 (34%), Positives = 142/271 (52%), Gaps = 17/271 (6%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDA--NVAREIINHKQLRHP 58
           +E ++L++ +G G +G  +L  N+ T+E VA+K ++    +D   N+ +EI  +  L H 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINAMLNHE 65
Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-------Q 111
           N+++F           + +EY +GGELF+RI       E +A+ FF QL++G        
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 125
Query: 112 ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPK---STVGTPAYIAPEVLSRRE 168
           I HRD+K EN LLD      LKI DFG +     ++R +      GT  Y+APE+L RRE
Sbjct: 126 ITHRDIKPENLLLDERD--NLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183
Query: 169 YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRN 228
           +  +  DVWSCG+ L  ML G  P+   + P +  +  S     +  +  +  I      
Sbjct: 184 FHAEPVDVWSCGIVLTAMLAGELPW---DQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLA 240
Query: 229 LLSRIFVANPSRRITIKEIKSHPWFLKNLPR 259
           LL +I V NPS RITI +IK   W+ K L +
Sbjct: 241 LLHKILVENPSARITIPDIKKDRWYNKPLKK 271

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score =  145 bits (366), Expect = 3e-35,   Method: Compositional matrix adjust.
 Identities = 90/267 (33%), Positives = 142/267 (53%), Gaps = 21/267 (7%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH----KIDANVAREIINHKQLR 56
           +E +E+ + +G G FG   L R K +K ++A+K + +       ++  + RE+     LR
Sbjct: 7   LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 66
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLI-------S 109
           HPNI+R        T + +++EYA  G ++  +    +F E     +  +L        S
Sbjct: 67  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 126
Query: 110 GQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREY 169
            ++ HRD+K EN LL GS A  LKI DFG+S  +   SR     GT  Y+ PE++  R +
Sbjct: 127 KRVIHRDIKPENLLL-GS-AGELKIADFGWSVHA-PSSRRTXLCGTLDYLPPEMIEGRMH 183
Query: 170 DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 229
           D K+ D+WS GV  Y  LVG  PFE       +++T  RI  V++  PD+V  ++  R+L
Sbjct: 184 DEKV-DLWSLGVLCYEFLVGKPPFE----ANTYQETYKRISRVEFTFPDFV--TEGARDL 236
Query: 230 LSRIFVANPSRRITIKEIKSHPWFLKN 256
           +SR+   NPS+R  ++E+  HPW   N
Sbjct: 237 ISRLLKHNPSQRPMLREVLEHPWITAN 263

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score =  145 bits (366), Expect = 3e-35,   Method: Compositional matrix adjust.
 Identities = 90/267 (33%), Positives = 142/267 (53%), Gaps = 21/267 (7%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH----KIDANVAREIINHKQLR 56
           +E +E+ + +G G FG   L R K +K ++A+K + +       ++  + RE+     LR
Sbjct: 7   LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 66
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLI-------S 109
           HPNI+R        T + +++EYA  G ++  +    +F E     +  +L        S
Sbjct: 67  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 126
Query: 110 GQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREY 169
            ++ HRD+K EN LL GS A  LKI DFG+S  +   SR     GT  Y+ PE++  R +
Sbjct: 127 KRVIHRDIKPENLLL-GS-AGELKIADFGWSVHA-PSSRRXXLCGTLDYLPPEMIEGRMH 183
Query: 170 DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 229
           D K+ D+WS GV  Y  LVG  PFE       +++T  RI  V++  PD+V  ++  R+L
Sbjct: 184 DEKV-DLWSLGVLCYEFLVGKPPFE----ANTYQETYKRISRVEFTFPDFV--TEGARDL 236
Query: 230 LSRIFVANPSRRITIKEIKSHPWFLKN 256
           +SR+   NPS+R  ++E+  HPW   N
Sbjct: 237 ISRLLKHNPSQRPMLREVLEHPWITAN 263

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score =  145 bits (366), Expect = 3e-35,   Method: Compositional matrix adjust.
 Identities = 90/267 (33%), Positives = 142/267 (53%), Gaps = 21/267 (7%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH----KIDANVAREIINHKQLR 56
           +E +E+ + +G G FG   L R K +K ++A+K + +       ++  + RE+     LR
Sbjct: 12  LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 71
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLI-------S 109
           HPNI+R        T + +++EYA  G ++  +    +F E     +  +L        S
Sbjct: 72  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 131
Query: 110 GQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREY 169
            ++ HRD+K EN LL GS A  LKI DFG+S  +   SR     GT  Y+ PE++  R +
Sbjct: 132 KRVIHRDIKPENLLL-GS-AGELKIADFGWSVHA-PSSRRTDLCGTLDYLPPEMIEGRMH 188
Query: 170 DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 229
           D K+ D+WS GV  Y  LVG  PFE       +++T  RI  V++  PD+V  ++  R+L
Sbjct: 189 DEKV-DLWSLGVLCYEFLVGKPPFE----ANTYQETYKRISRVEFTFPDFV--TEGARDL 241
Query: 230 LSRIFVANPSRRITIKEIKSHPWFLKN 256
           +SR+   NPS+R  ++E+  HPW   N
Sbjct: 242 ISRLLKHNPSQRPMLREVLEHPWITAN 268

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score =  145 bits (365), Expect = 4e-35,   Method: Compositional matrix adjust.
 Identities = 90/267 (33%), Positives = 142/267 (53%), Gaps = 21/267 (7%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH----KIDANVAREIINHKQLR 56
           +E +E+ + +G G FG   L R K  K ++A+K + +       ++  + RE+     LR
Sbjct: 4   LEDFEIGRPLGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 63
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLI-------S 109
           HPNI+R        T + +++EYA  G ++  +    +F E     +  +L        S
Sbjct: 64  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 123
Query: 110 GQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREY 169
            ++ HRD+K EN LL GS A  LKI DFG+S  +   SR  +  GT  Y+ PE++  R +
Sbjct: 124 KRVIHRDIKPENLLL-GS-AGELKIADFGWSVHA-PSSRRTTLCGTLDYLPPEMIEGRMH 180
Query: 170 DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 229
           D K+ D+WS GV  Y  LVG  PFE       +++T  RI  V++  PD+V  ++  R+L
Sbjct: 181 DEKV-DLWSLGVLCYEFLVGKPPFE----ANTYQETYKRISRVEFTFPDFV--TEGARDL 233
Query: 230 LSRIFVANPSRRITIKEIKSHPWFLKN 256
           +SR+   NPS+R  ++E+  HPW   N
Sbjct: 234 ISRLLKHNPSQRPMLREVLEHPWITAN 260

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score =  145 bits (365), Expect = 4e-35,   Method: Compositional matrix adjust.
 Identities = 93/284 (32%), Positives = 151/284 (53%), Gaps = 23/284 (8%)
Query: 6   LMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKI-DANVAREIINHKQLRHPNIIRFK 64
            M+ +GSG F    L++ + T +L A+K I++     D+++  EI   K+++H NI+  +
Sbjct: 13  FMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLE 72
Query: 65  EVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-------QICHRDL 117
           ++  + TH  +VM+  +GGELF+RI   G ++E +A    QQ++S         I HRDL
Sbjct: 73  DIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDL 132
Query: 118 KLENTL-LDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLADV 176
           K EN L L      ++ I DFG SK    +    +  GTP Y+APEVL+++ Y  K  D 
Sbjct: 133 KPENLLYLTPEENSKIMITDFGLSKME-QNGIMSTACGTPGYVAPEVLAQKPY-SKAVDC 190
Query: 177 WSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVA 236
           WS GV  Y++L G  PF ++ + K F K   +    +++ P +  IS+  ++ +  +   
Sbjct: 191 WSIGVITYILLCGYPPFYEETESKLFEKI--KEGYYEFESPFWDDISESAKDFICHLLEK 248
Query: 237 NPSRRITIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTFSLQ 280
           +P+ R T ++  SHPW   N     T   + IY     P+ SLQ
Sbjct: 249 DPNERYTCEKALSHPWIDGN-----TALHRDIY-----PSVSLQ 282

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score =  144 bits (364), Expect = 6e-35,   Method: Compositional matrix adjust.
 Identities = 89/267 (33%), Positives = 143/267 (53%), Gaps = 21/267 (7%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH----KIDANVAREIINHKQLR 56
           +E +E+ + +G G FG   L R K +K ++A+K + +       ++  + RE+     LR
Sbjct: 10  LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 69
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLI-------S 109
           HPNI+R        T + +++EYA  G ++  +    +F E     +  +L        S
Sbjct: 70  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 129
Query: 110 GQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREY 169
            ++ HRD+K EN LL GS A  LKI +FG+S  +   SR  +  GT  Y+ PE++  R +
Sbjct: 130 KRVIHRDIKPENLLL-GS-AGELKIANFGWSVHA-PSSRRTTLCGTLDYLPPEMIEGRMH 186
Query: 170 DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 229
           D K+ D+WS GV  Y  LVG  PFE       +++T  RI  V++  PD+V  ++  R+L
Sbjct: 187 DEKV-DLWSLGVLCYEFLVGKPPFE----ANTYQETYKRISRVEFTFPDFV--TEGARDL 239
Query: 230 LSRIFVANPSRRITIKEIKSHPWFLKN 256
           +SR+   NPS+R  ++E+  HPW   N
Sbjct: 240 ISRLLKHNPSQRPMLREVLEHPWITAN 266

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score =  144 bits (363), Expect = 7e-35,   Method: Compositional matrix adjust.
 Identities = 90/263 (34%), Positives = 140/263 (53%), Gaps = 21/263 (7%)
Query: 4   YELMKDIGSGNFGVARLMRNKNTKELVAMKYI--ERGHKIDANVAREIINHKQLRHPNII 61
           Y+    +G+G F    L  +K T++LVA+K I  E     + ++  EI    +++HPNI+
Sbjct: 20  YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIV 79
Query: 62  RFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSE-DEARYFFQQLISGQ------ICH 114
              ++  +  HL ++M+  +GGELF+RI   G ++E D +R  FQ L + +      I H
Sbjct: 80  ALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVH 139
Query: 115 RDLKLENTL---LDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDG 171
           RDLK EN L   LD     ++ I DFG SK     S   +  GTP Y+APEVL+++ Y  
Sbjct: 140 RDLKPENLLYYSLDED--SKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPY-S 196
Query: 172 KLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKI--PDYVHISQDCRNL 229
           K  D WS GV  Y++L G  PF D+ D K F     +I+  +Y+   P +  IS   ++ 
Sbjct: 197 KAVDCWSIGVIAYILLCGYPPFYDENDAKLFE----QILKAEYEFDSPYWDDISDSAKDF 252
Query: 230 LSRIFVANPSRRITIKEIKSHPW 252
           +  +   +P +R T ++   HPW
Sbjct: 253 IRHLMEKDPEKRFTCEQALQHPW 275

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score =  144 bits (363), Expect = 7e-35,   Method: Compositional matrix adjust.
 Identities = 89/267 (33%), Positives = 143/267 (53%), Gaps = 21/267 (7%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH----KIDANVAREIINHKQLR 56
           +E +E+ + +G G FG   L R K +K ++A+K + +       ++  + RE+     LR
Sbjct: 9   LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 68
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLI-------S 109
           HPNI+R        T + +++EYA  G ++  +    +F E     +  +L        S
Sbjct: 69  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 128
Query: 110 GQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREY 169
            ++ HRD+K EN LL GS A  LKI +FG+S  +   SR  +  GT  Y+ PE++  R +
Sbjct: 129 KRVIHRDIKPENLLL-GS-AGELKIANFGWSVHA-PSSRRTTLCGTLDYLPPEMIEGRMH 185
Query: 170 DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 229
           D K+ D+WS GV  Y  LVG  PFE       +++T  RI  V++  PD+V  ++  R+L
Sbjct: 186 DEKV-DLWSLGVLCYEFLVGKPPFE----ANTYQETYKRISRVEFTFPDFV--TEGARDL 238
Query: 230 LSRIFVANPSRRITIKEIKSHPWFLKN 256
           +SR+   NPS+R  ++E+  HPW   N
Sbjct: 239 ISRLLKHNPSQRPMLREVLEHPWITAN 265

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score =  144 bits (363), Expect = 7e-35,   Method: Compositional matrix adjust.
 Identities = 90/263 (34%), Positives = 140/263 (53%), Gaps = 21/263 (7%)
Query: 4   YELMKDIGSGNFGVARLMRNKNTKELVAMKYI--ERGHKIDANVAREIINHKQLRHPNII 61
           Y+    +G+G F    L  +K T++LVA+K I  E     + ++  EI    +++HPNI+
Sbjct: 20  YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIV 79
Query: 62  RFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSE-DEARYFFQQLISGQ------ICH 114
              ++  +  HL ++M+  +GGELF+RI   G ++E D +R  FQ L + +      I H
Sbjct: 80  ALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVH 139
Query: 115 RDLKLENTL---LDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDG 171
           RDLK EN L   LD     ++ I DFG SK     S   +  GTP Y+APEVL+++ Y  
Sbjct: 140 RDLKPENLLYYSLDED--SKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPY-S 196
Query: 172 KLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKI--PDYVHISQDCRNL 229
           K  D WS GV  Y++L G  PF D+ D K F     +I+  +Y+   P +  IS   ++ 
Sbjct: 197 KAVDCWSIGVIAYILLCGYPPFYDENDAKLFE----QILKAEYEFDSPYWDDISDSAKDF 252
Query: 230 LSRIFVANPSRRITIKEIKSHPW 252
           +  +   +P +R T ++   HPW
Sbjct: 253 IRHLMEKDPEKRFTCEQALQHPW 275

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score =  144 bits (362), Expect = 9e-35,   Method: Compositional matrix adjust.
 Identities = 90/263 (34%), Positives = 140/263 (53%), Gaps = 21/263 (7%)
Query: 4   YELMKDIGSGNFGVARLMRNKNTKELVAMKYI--ERGHKIDANVAREIINHKQLRHPNII 61
           Y+    +G+G F    L  +K T++LVA+K I  E     + ++  EI    +++HPNI+
Sbjct: 20  YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIV 79
Query: 62  RFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSE-DEARYFFQQLISGQ------ICH 114
              ++  +  HL ++M+  +GGELF+RI   G ++E D +R  FQ L + +      I H
Sbjct: 80  ALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVH 139
Query: 115 RDLKLENTL---LDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDG 171
           RDLK EN L   LD     ++ I DFG SK     S   +  GTP Y+APEVL+++ Y  
Sbjct: 140 RDLKPENLLYYSLDED--SKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPY-S 196
Query: 172 KLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKI--PDYVHISQDCRNL 229
           K  D WS GV  Y++L G  PF D+ D K F     +I+  +Y+   P +  IS   ++ 
Sbjct: 197 KAVDCWSIGVIAYILLCGYPPFYDENDAKLFE----QILKAEYEFDSPYWDDISDSAKDF 252
Query: 230 LSRIFVANPSRRITIKEIKSHPW 252
           +  +   +P +R T ++   HPW
Sbjct: 253 IRHLMEKDPEKRFTCEQALQHPW 275

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score =  144 bits (362), Expect = 9e-35,   Method: Compositional matrix adjust.
 Identities = 86/278 (30%), Positives = 144/278 (51%), Gaps = 19/278 (6%)
Query: 4   YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERG--HKIDANVAREIINHKQLRHPNII 61
           +E  + +G+G F    L   K T +L A+K I +      ++++  EI   ++++H NI+
Sbjct: 24  FEFKETLGTGAFSEVVLAEEKATGKLFAVKCIPKKALKGKESSIENEIAVLRKIKHENIV 83
Query: 62  RFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-------QICH 114
             +++  +P HL +VM+  +GGELF+RI   G ++E +A    +Q++          I H
Sbjct: 84  ALEDIYESPNHLYLVMQLVSGGELFDRIVEKGFYTEKDASTLIRQVLDAVYYLHRMGIVH 143
Query: 115 RDLKLENTL-LDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKL 173
           RDLK EN L        ++ I DFG SK         +  GTP Y+APEVL+++ Y  K 
Sbjct: 144 RDLKPENLLYYSQDEESKIMISDFGLSKMEGKGDVMSTACGTPGYVAPEVLAQKPY-SKA 202
Query: 174 ADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKI--PDYVHISQDCRNLLS 231
            D WS GV  Y++L G  PF D+ D K F     +I+  +Y+   P +  IS   ++ + 
Sbjct: 203 VDCWSIGVIAYILLCGYPPFYDENDSKLFE----QILKAEYEFDSPYWDDISDSAKDFIR 258
Query: 232 RIFVANPSRRITIKEIKSHPWFLKN--LPRELTETAQA 267
            +   +P++R T ++   HPW   +  L + + E+  A
Sbjct: 259 NLMEKDPNKRYTCEQAARHPWIAGDTALNKNIHESVSA 296

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score =  144 bits (362), Expect = 1e-34,   Method: Compositional matrix adjust.
 Identities = 89/263 (33%), Positives = 140/263 (53%), Gaps = 21/263 (7%)
Query: 4   YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERG--HKIDANVAREIINHKQLRHPNII 61
           Y+    +G+G F    L  +K T++LVA+K I +      + ++  EI    +++HPNI+
Sbjct: 20  YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIV 79
Query: 62  RFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSE-DEARYFFQQLISGQ------ICH 114
              ++  +  HL ++M+  +GGELF+RI   G ++E D +R  FQ L + +      I H
Sbjct: 80  ALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVH 139
Query: 115 RDLKLENTL---LDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDG 171
           RDLK EN L   LD     ++ I DFG SK     S   +  GTP Y+APEVL+++ Y  
Sbjct: 140 RDLKPENLLYYSLDED--SKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPY-S 196
Query: 172 KLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKI--PDYVHISQDCRNL 229
           K  D WS GV  Y++L G  PF D+ D K F     +I+  +Y+   P +  IS   ++ 
Sbjct: 197 KAVDCWSIGVIAYILLCGYPPFYDENDAKLFE----QILKAEYEFDSPYWDDISDSAKDF 252
Query: 230 LSRIFVANPSRRITIKEIKSHPW 252
           +  +   +P +R T ++   HPW
Sbjct: 253 IRHLMEKDPEKRFTCEQALQHPW 275

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score =  142 bits (358), Expect = 3e-34,   Method: Compositional matrix adjust.
 Identities = 88/267 (32%), Positives = 142/267 (53%), Gaps = 21/267 (7%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH----KIDANVAREIINHKQLR 56
           +E +++ + +G G FG   L R + +K ++A+K + +       ++  + RE+     LR
Sbjct: 11  LEDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLR 70
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLI-------S 109
           HPNI+R        T + +++EYA  G ++  +    RF E     +  +L        S
Sbjct: 71  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTATYITELANALSYCHS 130
Query: 110 GQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREY 169
            ++ HRD+K EN LL GS    LKI DFG+S  +   SR  +  GT  Y+ PE++  R +
Sbjct: 131 KRVIHRDIKPENLLL-GSNG-ELKIADFGWSVHA-PSSRRTTLCGTLDYLPPEMIEGRMH 187
Query: 170 DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 229
           D K+ D+WS GV  Y  LVG  PFE       +++T  RI  V++  PD+V  ++  R+L
Sbjct: 188 DEKV-DLWSLGVLCYEFLVGMPPFEAH----TYQETYRRISRVEFTFPDFV--TEGARDL 240
Query: 230 LSRIFVANPSRRITIKEIKSHPWFLKN 256
           +SR+   N S+R+T+ E+  HPW   N
Sbjct: 241 ISRLLKHNASQRLTLAEVLEHPWIKAN 267

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score =  142 bits (358), Expect = 3e-34,   Method: Compositional matrix adjust.
 Identities = 88/267 (32%), Positives = 142/267 (53%), Gaps = 21/267 (7%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH----KIDANVAREIINHKQLR 56
           +E +++ + +G G FG   L R + +K ++A+K + +       ++  + RE+     LR
Sbjct: 11  LEDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLR 70
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLI-------S 109
           HPNI+R        T + +++EYA  G ++  +    RF E     +  +L        S
Sbjct: 71  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTATYITELANALSYCHS 130
Query: 110 GQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREY 169
            ++ HRD+K EN LL GS    LKI DFG+S  +   SR  +  GT  Y+ PE++  R +
Sbjct: 131 KRVIHRDIKPENLLL-GSNG-ELKIADFGWSVHA-PSSRRDTLCGTLDYLPPEMIEGRMH 187
Query: 170 DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 229
           D K+ D+WS GV  Y  LVG  PFE       +++T  RI  V++  PD+V  ++  R+L
Sbjct: 188 DEKV-DLWSLGVLCYEFLVGMPPFEAH----TYQETYRRISRVEFTFPDFV--TEGARDL 240
Query: 230 LSRIFVANPSRRITIKEIKSHPWFLKN 256
           +SR+   N S+R+T+ E+  HPW   N
Sbjct: 241 ISRLLKHNASQRLTLAEVLEHPWIKAN 267

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score =  139 bits (351), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 91/262 (34%), Positives = 139/262 (53%), Gaps = 15/262 (5%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIER---GHKIDANVAREIINHKQLRHP 58
           E Y+ +K +GSG +G   L R+K T    A+K I +       ++ +  E+   K L HP
Sbjct: 37  EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHP 96
Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-------Q 111
           NI++  +      +  +VME   GGELF+ I +  +F+E +A    +Q++SG        
Sbjct: 97  NIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHN 156
Query: 112 ICHRDLKLENTLLDGSPAPRL-KICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYD 170
           I HRDLK EN LL+      L KI DFG S       + K  +GT  YIAPEVL R++YD
Sbjct: 157 IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVL-RKKYD 215
Query: 171 GKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLL 230
            K  DVWS GV L+++L G  PF  Q D +  RK         +  P++ ++S+  ++L+
Sbjct: 216 EK-CDVWSIGVILFILLAGYPPFGGQTDQEILRKV--EKGKYTFDSPEWKNVSEGAKDLI 272
Query: 231 SRIFVANPSRRITIKEIKSHPW 252
            ++   +  RRI+ ++   HPW
Sbjct: 273 KQMLQFDSQRRISAQQALEHPW 294

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score =  138 bits (347), Expect = 5e-33,   Method: Compositional matrix adjust.
 Identities = 87/267 (32%), Positives = 143/267 (53%), Gaps = 23/267 (8%)
Query: 4   YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK-------IDANVAREIINHKQLR 56
           Y++ +++GSG F + +  R K+T    A K+I++              + RE+   +Q+ 
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVL 73
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG------ 110
           HPNII   +V    T + +++E  +GGELF+ +      SE+EA  F +Q++ G      
Sbjct: 74  HPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHT 133
Query: 111 -QICHRDLKLEN-TLLDGS-PAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRR 167
            +I H DLK EN  LLD + P P +K+ DFG +         K+  GTP ++APE+++  
Sbjct: 134 KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVN-Y 192
Query: 168 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPD--YVHISQD 225
           E  G  AD+WS GV  Y++L GA PF    D K  ++T++ I AV Y   +  +   S+ 
Sbjct: 193 EPLGLEADMWSIGVITYILLSGASPFLG--DTK--QETLANITAVSYDFDEEFFSQTSEL 248
Query: 226 CRNLLSRIFVANPSRRITIKEIKSHPW 252
            ++ + ++ V    +R+TI+E   HPW
Sbjct: 249 AKDFIRKLLVKETRKRLTIQEALRHPW 275

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score =  137 bits (345), Expect = 9e-33,   Method: Compositional matrix adjust.
 Identities = 90/263 (34%), Positives = 138/263 (52%), Gaps = 16/263 (6%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIER---GHKIDA-NVAREIINHKQLRH 57
           ++Y+  + +G G+FG   L ++K T +  A+K I +     K D  ++ RE+   KQL H
Sbjct: 26  DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDH 85
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG------- 110
           PNI++  E      +  +V E   GGELF+ I +  RFSE +A    +Q++SG       
Sbjct: 86  PNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKN 145
Query: 111 QICHRDLKLENTLLDG-SPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREY 169
           +I HRDLK EN LL+  S    ++I DFG S       + K  +GT  YIAPEVL    Y
Sbjct: 146 KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVL-HGTY 204
Query: 170 DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 229
           D K  DVWS GV LY++L G  PF    +    +K         +++P +  +S+  ++L
Sbjct: 205 DEK-CDVWSTGVILYILLSGCPPFNGANEYDILKKV--EKGKYTFELPQWKKVSESAKDL 261
Query: 230 LSRIFVANPSRRITIKEIKSHPW 252
           + ++    PS RI+ ++   H W
Sbjct: 262 IRKMLTYVPSMRISARDALDHEW 284

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score =  137 bits (344), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 90/263 (34%), Positives = 138/263 (52%), Gaps = 16/263 (6%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIER---GHKIDA-NVAREIINHKQLRH 57
           ++Y+  + +G G+FG   L ++K T +  A+K I +     K D  ++ RE+   KQL H
Sbjct: 32  DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDH 91
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG------- 110
           PNI++  E      +  +V E   GGELF+ I +  RFSE +A    +Q++SG       
Sbjct: 92  PNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKN 151
Query: 111 QICHRDLKLENTLLDG-SPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREY 169
           +I HRDLK EN LL+  S    ++I DFG S       + K  +GT  YIAPEVL    Y
Sbjct: 152 KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVL-HGTY 210
Query: 170 DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 229
           D K  DVWS GV LY++L G  PF    +    +K         +++P +  +S+  ++L
Sbjct: 211 DEK-CDVWSTGVILYILLSGCPPFNGANEYDILKKV--EKGKYTFELPQWKKVSESAKDL 267
Query: 230 LSRIFVANPSRRITIKEIKSHPW 252
           + ++    PS RI+ ++   H W
Sbjct: 268 IRKMLTYVPSMRISARDALDHEW 290

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score =  137 bits (344), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 90/263 (34%), Positives = 138/263 (52%), Gaps = 16/263 (6%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIER---GHKIDA-NVAREIINHKQLRH 57
           ++Y+  + +G G+FG   L ++K T +  A+K I +     K D  ++ RE+   KQL H
Sbjct: 49  DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDH 108
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG------- 110
           PNI++  E      +  +V E   GGELF+ I +  RFSE +A    +Q++SG       
Sbjct: 109 PNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKN 168
Query: 111 QICHRDLKLENTLLDG-SPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREY 169
           +I HRDLK EN LL+  S    ++I DFG S       + K  +GT  YIAPEVL    Y
Sbjct: 169 KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVL-HGTY 227
Query: 170 DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 229
           D K  DVWS GV LY++L G  PF    +    +K         +++P +  +S+  ++L
Sbjct: 228 DEK-CDVWSTGVILYILLSGCPPFNGANEYDILKKV--EKGKYTFELPQWKKVSESAKDL 284
Query: 230 LSRIFVANPSRRITIKEIKSHPW 252
           + ++    PS RI+ ++   H W
Sbjct: 285 IRKMLTYVPSMRISARDALDHEW 307

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score =  137 bits (344), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 90/263 (34%), Positives = 138/263 (52%), Gaps = 16/263 (6%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIER---GHKIDA-NVAREIINHKQLRH 57
           ++Y+  + +G G+FG   L ++K T +  A+K I +     K D  ++ RE+   KQL H
Sbjct: 50  DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDH 109
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG------- 110
           PNI++  E      +  +V E   GGELF+ I +  RFSE +A    +Q++SG       
Sbjct: 110 PNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKN 169
Query: 111 QICHRDLKLENTLLDG-SPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREY 169
           +I HRDLK EN LL+  S    ++I DFG S       + K  +GT  YIAPEVL    Y
Sbjct: 170 KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVL-HGTY 228
Query: 170 DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 229
           D K  DVWS GV LY++L G  PF    +    +K         +++P +  +S+  ++L
Sbjct: 229 DEK-CDVWSTGVILYILLSGCPPFNGANEYDILKKV--EKGKYTFELPQWKKVSESAKDL 285
Query: 230 LSRIFVANPSRRITIKEIKSHPW 252
           + ++    PS RI+ ++   H W
Sbjct: 286 IRKMLTYVPSMRISARDALDHEW 308

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score =  136 bits (343), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 88/288 (30%), Positives = 146/288 (50%), Gaps = 27/288 (9%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIE------RGHKIDANVAREIINHKQL 55
           ++Y+L +++G G F V R      T +  A K I       R H+    + RE    + L
Sbjct: 4   DEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQ---KLEREARICRLL 60
Query: 56  RHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG----- 110
           +HPNI+R  + +       +V +   GGELFE I     +SE +A +  QQ++       
Sbjct: 61  KHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILESVNHCH 120
Query: 111 --QICHRDLKLENTLLDG-SPAPRLKICDFGYSKSSLLHSRPK-STVGTPAYIAPEVLSR 166
              I HRDLK EN LL   S    +K+ DFG +       +      GTP Y++PEVL +
Sbjct: 121 LNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVLRK 180
Query: 167 REYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDC 226
             Y GK  D+W+CGV LY++LVG  PF D++  + +++   +  A  +  P++  ++ + 
Sbjct: 181 DPY-GKPVDMWACGVILYILLVGYPPFWDEDQHRLYQQI--KAGAYDFPSPEWDTVTPEA 237
Query: 227 RNLLSRIFVANPSRRITIKEIKSHPWFLKNLPRELTETAQAIYYRKEN 274
           ++L++++   NP++RIT  E   HPW  +        T  ++ +R+E 
Sbjct: 238 KDLINKMLTINPAKRITASEALKHPWICQR------STVASMMHRQET 279

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score =  136 bits (343), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 85/267 (31%), Positives = 144/267 (53%), Gaps = 23/267 (8%)
Query: 4   YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDA-------NVAREIINHKQLR 56
           Y++ +++GSG F + +  R K+T    A K+I++     +        + RE+   +Q+ 
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL 73
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG------ 110
           H N+I   +V    T + +++E  +GGELF+ +      SE+EA  F +Q++ G      
Sbjct: 74  HHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHT 133
Query: 111 -QICHRDLKLEN-TLLDGS-PAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRR 167
            +I H DLK EN  LLD + P P +K+ DFG +         K+  GTP ++APE+++  
Sbjct: 134 KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVN-Y 192
Query: 168 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPD--YVHISQD 225
           E  G  AD+WS GV  Y++L GA PF    D K  ++T++ I +V Y   +  + H S+ 
Sbjct: 193 EPLGLEADMWSIGVITYILLSGASPFLG--DTK--QETLANITSVSYDFDEEFFSHTSEL 248
Query: 226 CRNLLSRIFVANPSRRITIKEIKSHPW 252
            ++ + ++ V    +R+TI+E   HPW
Sbjct: 249 AKDFIRKLLVKETRKRLTIQEALRHPW 275

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score =  136 bits (342), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 88/288 (30%), Positives = 146/288 (50%), Gaps = 27/288 (9%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIE------RGHKIDANVAREIINHKQL 55
           ++Y+L +++G G F V R      T +  A K I       R H+    + RE    + L
Sbjct: 4   DEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQ---KLEREARICRLL 60
Query: 56  RHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG----- 110
           +HPNI+R  + +       +V +   GGELFE I     +SE +A +  QQ++       
Sbjct: 61  KHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILESVNHCH 120
Query: 111 --QICHRDLKLENTLLDG-SPAPRLKICDFGYSKSSLLHSRPK-STVGTPAYIAPEVLSR 166
              I HRDLK EN LL   S    +K+ DFG +       +      GTP Y++PEVL +
Sbjct: 121 LNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVLRK 180
Query: 167 REYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDC 226
             Y GK  D+W+CGV LY++LVG  PF D++  + +++   +  A  +  P++  ++ + 
Sbjct: 181 DPY-GKPVDMWACGVILYILLVGYPPFWDEDQHRLYQQI--KAGAYDFPSPEWDTVTPEA 237
Query: 227 RNLLSRIFVANPSRRITIKEIKSHPWFLKNLPRELTETAQAIYYRKEN 274
           ++L++++   NP++RIT  E   HPW  +        T  ++ +R+E 
Sbjct: 238 KDLINKMLTINPAKRITASEALKHPWICQR------STVASMMHRQET 279

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score =  136 bits (342), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 85/267 (31%), Positives = 144/267 (53%), Gaps = 23/267 (8%)
Query: 4   YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDA-------NVAREIINHKQLR 56
           Y++ +++GSG F + +  R K+T    A K+I++     +        + RE+   +Q+ 
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL 73
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG------ 110
           H N+I   +V    T + +++E  +GGELF+ +      SE+EA  F +Q++ G      
Sbjct: 74  HHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHT 133
Query: 111 -QICHRDLKLEN-TLLDGS-PAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRR 167
            +I H DLK EN  LLD + P P +K+ DFG +         K+  GTP ++APE+++  
Sbjct: 134 KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVN-Y 192
Query: 168 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPD--YVHISQD 225
           E  G  AD+WS GV  Y++L GA PF    D K  ++T++ I +V Y   +  + H S+ 
Sbjct: 193 EPLGLEADMWSIGVITYILLSGASPFLG--DTK--QETLANITSVSYDFDEEFFSHTSEL 248
Query: 226 CRNLLSRIFVANPSRRITIKEIKSHPW 252
            ++ + ++ V    +R+TI+E   HPW
Sbjct: 249 AKDFIRKLLVKETRKRLTIQEALRHPW 275

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score =  135 bits (341), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 85/267 (31%), Positives = 144/267 (53%), Gaps = 23/267 (8%)
Query: 4   YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDA-------NVAREIINHKQLR 56
           Y++ +++GSG F + +  R K+T    A K+I++     +        + RE+   +Q+ 
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL 73
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG------ 110
           H N+I   +V    T + +++E  +GGELF+ +      SE+EA  F +Q++ G      
Sbjct: 74  HHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHT 133
Query: 111 -QICHRDLKLEN-TLLDGS-PAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRR 167
            +I H DLK EN  LLD + P P +K+ DFG +         K+  GTP ++APE+++  
Sbjct: 134 KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVN-Y 192
Query: 168 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPD--YVHISQD 225
           E  G  AD+WS GV  Y++L GA PF    D K  ++T++ I +V Y   +  + H S+ 
Sbjct: 193 EPLGLEADMWSIGVITYILLSGASPFLG--DTK--QETLANITSVSYDFDEEFFSHTSEL 248
Query: 226 CRNLLSRIFVANPSRRITIKEIKSHPW 252
            ++ + ++ V    +R+TI+E   HPW
Sbjct: 249 AKDFIRKLLVKETRKRLTIQEALRHPW 275

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score =  135 bits (341), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 90/288 (31%), Positives = 144/288 (50%), Gaps = 27/288 (9%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIE------RGHKIDANVAREIINHKQL 55
           ++Y+L +DIG G F V R      T    A K I       R H+    + RE    + L
Sbjct: 4   DEYQLYEDIGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSARDHQ---KLEREARICRLL 60
Query: 56  RHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG----- 110
           +H NI+R  + +       +V +   GGELFE I     +SE +A +  QQ++       
Sbjct: 61  KHSNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCH 120
Query: 111 --QICHRDLKLENTLLDG-SPAPRLKICDFGYSKSSLLHSRPK-STVGTPAYIAPEVLSR 166
              + HRDLK EN LL        +K+ DFG +       +      GTP Y++PEVL R
Sbjct: 121 QMGVVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVL-R 179
Query: 167 REYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDC 226
           +E  GK  D+W+CGV LY++LVG  PF D++  K +++   +  A  +  P++  ++ + 
Sbjct: 180 KEAYGKPVDIWACGVILYILLVGYPPFWDEDQHKLYQQI--KAGAYDFPSPEWDTVTPEA 237
Query: 227 RNLLSRIFVANPSRRITIKEIKSHPWFLKNLPRELTETAQAIYYRKEN 274
           +NL++++   NP++RIT  E   HPW  +        T  ++ +R+E 
Sbjct: 238 KNLINQMLTINPAKRITAHEALKHPWVCQR------STVASMMHRQET 279

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score =  135 bits (341), Expect = 3e-32,   Method: Compositional matrix adjust.
 Identities = 84/266 (31%), Positives = 140/266 (52%), Gaps = 21/266 (7%)
Query: 2   EKYELMKDIGSGNFGVAR-LMRNKNTKELVAM-----KYIERGHKIDANVAREIINHKQL 55
           E+Y+L +++G G F V R  ++    +E  AM     K   R H+    + RE    + L
Sbjct: 11  EEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQ---KLEREARICRLL 67
Query: 56  RHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG----- 110
           +HPNI+R  + +    H  ++ +   GGELFE I     +SE +A +  QQ++       
Sbjct: 68  KHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCH 127
Query: 111 --QICHRDLKLENTLLDGS-PAPRLKICDFGYSKSSLLHSRPK-STVGTPAYIAPEVLSR 166
              + HR+LK EN LL        +K+ DFG +       +      GTP Y++PEVL +
Sbjct: 128 QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRK 187
Query: 167 REYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDC 226
             Y GK  D+W+CGV LY++LVG  PF D++  + +++   +  A  +  P++  ++ + 
Sbjct: 188 DPY-GKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQI--KAGAYDFPSPEWDTVTPEA 244
Query: 227 RNLLSRIFVANPSRRITIKEIKSHPW 252
           ++L++++   NPS+RIT  E   HPW
Sbjct: 245 KDLINKMLTINPSKRITAAEALKHPW 270

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score =  135 bits (340), Expect = 3e-32,   Method: Compositional matrix adjust.
 Identities = 91/265 (34%), Positives = 139/265 (52%), Gaps = 20/265 (7%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIER---GHKIDA-NVAREIINHKQLRH 57
           ++Y+  + +G G+FG   L ++K T +  A+K I +     K D  ++ RE+   KQL H
Sbjct: 26  DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDH 85
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG------- 110
           PNI +  E      +  +V E   GGELF+ I +  RFSE +A    +Q++SG       
Sbjct: 86  PNIXKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYXHKN 145
Query: 111 QICHRDLKLENTLLDG-SPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREY 169
           +I HRDLK EN LL+  S    ++I DFG S       + K  +GT  YIAPEVL    Y
Sbjct: 146 KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKXKDKIGTAYYIAPEVL-HGTY 204
Query: 170 DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQY--KIPDYVHISQDCR 227
           D K  DVWS GV LY++L G  PF    +  N    + ++   +Y  ++P +  +S+  +
Sbjct: 205 DEK-CDVWSTGVILYILLSGCPPF----NGANEYDILKKVEKGKYTFELPQWKKVSESAK 259
Query: 228 NLLSRIFVANPSRRITIKEIKSHPW 252
           +L+ +     PS RI+ ++   H W
Sbjct: 260 DLIRKXLTYVPSXRISARDALDHEW 284

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score =  135 bits (340), Expect = 3e-32,   Method: Compositional matrix adjust.
 Identities = 87/288 (30%), Positives = 143/288 (49%), Gaps = 27/288 (9%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIE------RGHKIDANVAREIINHKQL 55
           + Y+L +++G G F V R    K   +  A K I       R H+    + RE    + L
Sbjct: 31  DDYQLFEELGKGAFSVVRRCVKKTPTQEYAAKIINTKKLSARDHQ---KLEREARICRLL 87
Query: 56  RHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG----- 110
           +HPNI+R  + +       +V +   GGELFE I     +SE +A +   Q++       
Sbjct: 88  KHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIHQILESVNHIH 147
Query: 111 --QICHRDLKLENTLLDG-SPAPRLKICDFGYSKSSLLHSRPK-STVGTPAYIAPEVLSR 166
              I HRDLK EN LL        +K+ DFG +       +      GTP Y++PEVL +
Sbjct: 148 QHDIVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGEQQAWFGFAGTPGYLSPEVLRK 207
Query: 167 REYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDC 226
             Y GK  D+W+CGV LY++LVG  PF D++  K +++   +  A  +  P++  ++ + 
Sbjct: 208 DPY-GKPVDIWACGVILYILLVGYPPFWDEDQHKLYQQI--KAGAYDFPSPEWDTVTPEA 264
Query: 227 RNLLSRIFVANPSRRITIKEIKSHPWFLKNLPRELTETAQAIYYRKEN 274
           +NL++++   NP++RIT  +   HPW  +        T  ++ +R+E 
Sbjct: 265 KNLINQMLTINPAKRITADQALKHPWVCQR------STVASMMHRQET 306

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score =  134 bits (338), Expect = 6e-32,   Method: Compositional matrix adjust.
 Identities = 85/269 (31%), Positives = 138/269 (51%), Gaps = 31/269 (11%)
Query: 4   YELMKDIGSGNFGVAR-----------LMRNKNTKELVAMKYIERGHKIDANVAREIINH 52
           Y+L +++G G F V R             +  NTK+L A     R H+    + RE    
Sbjct: 24  YQLFEELGKGAFSVVRRCVKVLAGQEYAAKIINTKKLSA-----RDHQ---KLEREARIC 75
Query: 53  KQLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-- 110
           + L+HPNI+R  + +    H  ++ +   GGELFE I     +SE +A +  QQ++    
Sbjct: 76  RLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVL 135
Query: 111 -----QICHRDLKLENTLLDGS-PAPRLKICDFGYSKSSLLHSRPK-STVGTPAYIAPEV 163
                 + HRDLK EN LL        +K+ DFG +       +      GTP Y++PEV
Sbjct: 136 HCHQMGVVHRDLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEV 195
Query: 164 LSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHIS 223
           L +  Y GK  D+W+CGV LY++LVG  PF D++  + +++   +  A  +  P++  ++
Sbjct: 196 LRKDPY-GKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQI--KAGAYDFPSPEWDTVT 252
Query: 224 QDCRNLLSRIFVANPSRRITIKEIKSHPW 252
            + ++L++++   NPS+RIT  E   HPW
Sbjct: 253 PEAKDLINKMLTINPSKRITAAEALKHPW 281

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score =  134 bits (337), Expect = 6e-32,   Method: Compositional matrix adjust.
 Identities = 85/267 (31%), Positives = 143/267 (53%), Gaps = 23/267 (8%)
Query: 4   YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDA-------NVAREIINHKQLR 56
           Y++ +++GSG F + +  R K+T    A K+I++     +        + RE+   +Q+ 
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL 73
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG------ 110
           H N+I   +V    T + +++E  +GGELF+ +      SE+EA  F +Q++ G      
Sbjct: 74  HHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHT 133
Query: 111 -QICHRDLKLEN-TLLDGS-PAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRR 167
            +I H DLK EN  LLD + P P +K+ DFG +         K+  GTP ++APE+++  
Sbjct: 134 KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVN-Y 192
Query: 168 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPD--YVHISQD 225
           E  G  AD+WS GV  Y++L GA PF    D K  ++T++ I AV Y   +  +   S+ 
Sbjct: 193 EPLGLEADMWSIGVITYILLSGASPFLG--DTK--QETLANITAVSYDFDEEFFSQTSEL 248
Query: 226 CRNLLSRIFVANPSRRITIKEIKSHPW 252
            ++ + ++ V    +R+TI+E   HPW
Sbjct: 249 AKDFIRKLLVKETRKRLTIQEALRHPW 275

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score =  134 bits (337), Expect = 7e-32,   Method: Compositional matrix adjust.
 Identities = 85/267 (31%), Positives = 143/267 (53%), Gaps = 23/267 (8%)
Query: 4   YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDA-------NVAREIINHKQLR 56
           Y++ +++GSG F + +  R K+T    A K+I++     +        + RE+   +Q+ 
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL 73
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG------ 110
           H N+I   +V    T + +++E  +GGELF+ +      SE+EA  F +Q++ G      
Sbjct: 74  HHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHT 133
Query: 111 -QICHRDLKLEN-TLLDGS-PAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRR 167
            +I H DLK EN  LLD + P P +K+ DFG +         K+  GTP ++APE+++  
Sbjct: 134 KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVN-Y 192
Query: 168 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPD--YVHISQD 225
           E  G  AD+WS GV  Y++L GA PF    D K  ++T++ I AV Y   +  +   S+ 
Sbjct: 193 EPLGLEADMWSIGVITYILLSGASPFLG--DTK--QETLANITAVSYDFDEEFFSQTSEL 248
Query: 226 CRNLLSRIFVANPSRRITIKEIKSHPW 252
            ++ + ++ V    +R+TI+E   HPW
Sbjct: 249 AKDFIRKLLVKETRKRLTIQEALRHPW 275

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score =  134 bits (336), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 77/265 (29%), Positives = 134/265 (50%), Gaps = 18/265 (6%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAR-EIINHKQLRHPN 59
           ++ Y++ +++G+G FGV   +  + T    A K++   H+ D    R EI     LRHP 
Sbjct: 50  LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPT 109
Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFERICNA-GRFSEDEARYFFQQLISGQICHR--- 115
           ++   +       + ++ E+ +GGELFE++ +   + SEDEA  + +Q+  G +CH    
Sbjct: 110 LVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKG-LCHMHEN 168
Query: 116 -----DLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYD 170
                DLK EN +     +  LK+ DFG +         K T GT  + APEV   +   
Sbjct: 169 NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPV- 227
Query: 171 GKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPD--YVHISQDCRN 228
           G   D+WS GV  Y++L G  PF  + D     +T+  + +  + + D  +  IS+D ++
Sbjct: 228 GYYTDMWSVGVLSYILLSGLSPFGGEND----DETLRNVKSCDWNMDDSAFSGISEDGKD 283
Query: 229 LLSRIFVANPSRRITIKEIKSHPWF 253
            + ++ +A+P+ R+TI +   HPW 
Sbjct: 284 FIRKLLLADPNTRMTIHQALEHPWL 308

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score =  134 bits (336), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 77/265 (29%), Positives = 133/265 (50%), Gaps = 18/265 (6%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAR-EIINHKQLRHPN 59
           ++ Y++ +++G+G FGV   +  + T    A K++   H+ D    R EI     LRHP 
Sbjct: 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPT 215
Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFERICNA-GRFSEDEARYFFQQLISGQICHR--- 115
           ++   +       + ++ E+ +GGELFE++ +   + SEDEA  + +Q+  G +CH    
Sbjct: 216 LVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKG-LCHMHEN 274
Query: 116 -----DLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYD 170
                DLK EN +     +  LK+ DFG +         K T GT  + APEV   +   
Sbjct: 275 NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPV- 333
Query: 171 GKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPD--YVHISQDCRN 228
           G   D+WS GV  Y++L G  PF  + D +  R     + +  + + D  +  IS+D ++
Sbjct: 334 GYYTDMWSVGVLSYILLSGLSPFGGENDDETLRN----VKSCDWNMDDSAFSGISEDGKD 389
Query: 229 LLSRIFVANPSRRITIKEIKSHPWF 253
            + ++ +A+P+ R+TI +   HPW 
Sbjct: 390 FIRKLLLADPNTRMTIHQALEHPWL 414

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score =  133 bits (335), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 97/306 (31%), Positives = 147/306 (48%), Gaps = 42/306 (13%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINH-------- 52
           M ++E +K +G G FG   L++ K T    AMK +++    +  VA++ + H        
Sbjct: 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKK----EVIVAKDEVAHTLTENRVL 202
Query: 53  KQLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-- 110
           +  RHP +   K    T   L  VMEYA GGELF  +     FSED AR++  +++S   
Sbjct: 203 QNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALD 262
Query: 111 ------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP-KSTVGTPAYIAPEV 163
                  + +RDLKLEN +LD      +KI DFG  K  +      K+  GTP Y+APEV
Sbjct: 263 YLHSEKNVVYRDLKLENLMLDKD--GHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEV 320
Query: 164 LSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHIS 223
           L   +Y G+  D W  GV +Y M+ G  PF +Q+  K F      I+  + + P    + 
Sbjct: 321 LEDNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLF----ELILMEEIRFPR--TLG 373
Query: 224 QDCRNLLSRIFVANPSRRI-----TIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTFS 278
            + ++LLS +   +P +R+       KEI  H +F   +        Q +Y +K +P F 
Sbjct: 374 PEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIV-------WQHVYEKKLSPPFK 426
Query: 279 LQSVEE 284
            Q   E
Sbjct: 427 PQVTSE 432

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score =  133 bits (334), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 97/306 (31%), Positives = 147/306 (48%), Gaps = 42/306 (13%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINH-------- 52
           M ++E +K +G G FG   L++ K T    AMK +++    +  VA++ + H        
Sbjct: 150 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKK----EVIVAKDEVAHTLTENRVL 205
Query: 53  KQLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-- 110
           +  RHP +   K    T   L  VMEYA GGELF  +     FSED AR++  +++S   
Sbjct: 206 QNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALD 265
Query: 111 ------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP-KSTVGTPAYIAPEV 163
                  + +RDLKLEN +LD      +KI DFG  K  +      K+  GTP Y+APEV
Sbjct: 266 YLHSEKNVVYRDLKLENLMLDKD--GHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEV 323
Query: 164 LSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHIS 223
           L   +Y G+  D W  GV +Y M+ G  PF +Q+  K F      I+  + + P    + 
Sbjct: 324 LEDNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLF----ELILMEEIRFPR--TLG 376
Query: 224 QDCRNLLSRIFVANPSRRI-----TIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTFS 278
            + ++LLS +   +P +R+       KEI  H +F   +        Q +Y +K +P F 
Sbjct: 377 PEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIV-------WQHVYEKKLSPPFK 429
Query: 279 LQSVEE 284
            Q   E
Sbjct: 430 PQVTSE 435

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score =  132 bits (332), Expect = 3e-31,   Method: Compositional matrix adjust.
 Identities = 82/261 (31%), Positives = 138/261 (52%), Gaps = 18/261 (6%)
Query: 8   KDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLR-HPNIIRFKEV 66
           K +G G+F + R   +K + +  A+K I +  +++AN  +EI   K    HPNI++  EV
Sbjct: 17  KPLGEGSFSICRKCVHKKSNQAFAVKIISK--RMEANTQKEITALKLCEGHPNIVKLHEV 74
Query: 67  VLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-------QICHRDLKL 119
                H  +VME   GGELFERI     FSE EA Y  ++L+S         + HRDLK 
Sbjct: 75  FHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKP 134
Query: 120 ENTLL-DGSPAPRLKICDFGYSKSSLLHSRP-KSTVGTPAYIAPEVLSRREYDGKLADVW 177
           EN L  D +    +KI DFG+++     ++P K+   T  Y APE+L++  YD +  D+W
Sbjct: 135 ENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQNGYD-ESCDLW 193
Query: 178 SCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQ-----YKIPDYVHISQDCRNLLSR 232
           S GV LY ML G  PF+  +        +  +  ++     ++   + ++SQ+ ++L+  
Sbjct: 194 SLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNVSQEAKDLIQG 253
Query: 233 IFVANPSRRITIKEIKSHPWF 253
           +   +P++R+ +  ++ + W 
Sbjct: 254 LLTVDPNKRLKMSGLRYNEWL 274

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score =  132 bits (332), Expect = 3e-31,   Method: Compositional matrix adjust.
 Identities = 97/306 (31%), Positives = 146/306 (47%), Gaps = 42/306 (13%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINH-------- 52
           M ++E +K +G G FG   L++ K T    AMK +++    +  VA++ + H        
Sbjct: 8   MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKK----EVIVAKDEVAHTLTENRVL 63
Query: 53  KQLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-- 110
           +  RHP +   K    T   L  VMEYA GGELF  +     FSED AR++  +++S   
Sbjct: 64  QNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALD 123
Query: 111 ------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP-KSTVGTPAYIAPEV 163
                  + +RDLKLEN +LD      +KI DFG  K  +      K   GTP Y+APEV
Sbjct: 124 YLHSEKNVVYRDLKLENLMLDKD--GHIKITDFGLCKEGIKDGATMKXFCGTPEYLAPEV 181
Query: 164 LSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHIS 223
           L   +Y G+  D W  GV +Y M+ G  PF +Q+  K F      I+  + + P    + 
Sbjct: 182 LEDNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLF----ELILMEEIRFPR--TLG 234
Query: 224 QDCRNLLSRIFVANPSRRI-----TIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTFS 278
            + ++LLS +   +P +R+       KEI  H +F   +        Q +Y +K +P F 
Sbjct: 235 PEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIV-------WQHVYEKKLSPPFK 287
Query: 279 LQSVEE 284
            Q   E
Sbjct: 288 PQVTSE 293

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score =  132 bits (332), Expect = 3e-31,   Method: Compositional matrix adjust.
 Identities = 93/272 (34%), Positives = 133/272 (48%), Gaps = 20/272 (7%)
Query: 4   YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDAN-VAREIINHKQLRHPNIIR 62
           Y L   IG G++G  ++   K T+   A K I +    D +   +EI   K L HPNIIR
Sbjct: 11  YTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIR 70
Query: 63  FKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-------QICHR 115
             E     T + +VME   GGELFER+ +   F E +A    + ++S         + HR
Sbjct: 71  LYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHR 130
Query: 116 DLKLENTL-LDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLA 174
           DLK EN L L  SP   LK+ DFG +         ++ VGTP Y++P+VL      G   
Sbjct: 131 DLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVLE--GLYGPEC 188
Query: 175 DVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIP--DYVHISQDCRNLLSR 232
           D WS GV +YV+L G  PF    D     + + +I    +  P  D++++S    +L+ R
Sbjct: 189 DEWSAGVMMYVLLCGYPPFSAPTD----XEVMLKIREGTFTFPEKDWLNVSPQAESLIRR 244
Query: 233 IFVANPSRRITIKEIKSHPWFLKNL---PREL 261
           +   +P +RIT  +   H WF K L   PR L
Sbjct: 245 LLTKSPKQRITSLQALEHEWFEKQLSSSPRNL 276

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score =  132 bits (332), Expect = 3e-31,   Method: Compositional matrix adjust.
 Identities = 97/306 (31%), Positives = 146/306 (47%), Gaps = 42/306 (13%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINH-------- 52
           M ++E +K +G G FG   L++ K T    AMK +++    +  VA++ + H        
Sbjct: 9   MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKK----EVIVAKDEVAHTLTENRVL 64
Query: 53  KQLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-- 110
           +  RHP +   K    T   L  VMEYA GGELF  +     FSED AR++  +++S   
Sbjct: 65  QNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALD 124
Query: 111 ------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP-KSTVGTPAYIAPEV 163
                  + +RDLKLEN +LD      +KI DFG  K  +      K   GTP Y+APEV
Sbjct: 125 YLHSEKNVVYRDLKLENLMLDKD--GHIKITDFGLCKEGIKDGATMKXFCGTPEYLAPEV 182
Query: 164 LSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHIS 223
           L   +Y G+  D W  GV +Y M+ G  PF +Q+  K F      I+  + + P    + 
Sbjct: 183 LEDNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLF----ELILMEEIRFPR--TLG 235
Query: 224 QDCRNLLSRIFVANPSRRI-----TIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTFS 278
            + ++LLS +   +P +R+       KEI  H +F   +        Q +Y +K +P F 
Sbjct: 236 PEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIV-------WQHVYEKKLSPPFK 288
Query: 279 LQSVEE 284
            Q   E
Sbjct: 289 PQVTSE 294

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score =  132 bits (332), Expect = 3e-31,   Method: Compositional matrix adjust.
 Identities = 93/272 (34%), Positives = 133/272 (48%), Gaps = 20/272 (7%)
Query: 4   YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDAN-VAREIINHKQLRHPNIIR 62
           Y L   IG G++G  ++   K T+   A K I +    D +   +EI   K L HPNIIR
Sbjct: 28  YTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIR 87
Query: 63  FKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-------QICHR 115
             E     T + +VME   GGELFER+ +   F E +A    + ++S         + HR
Sbjct: 88  LYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHR 147
Query: 116 DLKLENTL-LDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLA 174
           DLK EN L L  SP   LK+ DFG +         ++ VGTP Y++P+VL      G   
Sbjct: 148 DLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVLE--GLYGPEC 205
Query: 175 DVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIP--DYVHISQDCRNLLSR 232
           D WS GV +YV+L G  PF    D     + + +I    +  P  D++++S    +L+ R
Sbjct: 206 DEWSAGVMMYVLLCGYPPFSAPTD----XEVMLKIREGTFTFPEKDWLNVSPQAESLIRR 261
Query: 233 IFVANPSRRITIKEIKSHPWFLKNL---PREL 261
           +   +P +RIT  +   H WF K L   PR L
Sbjct: 262 LLTKSPKQRITSLQALEHEWFEKQLSSSPRNL 293

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score =  132 bits (331), Expect = 3e-31,   Method: Compositional matrix adjust.
 Identities = 97/306 (31%), Positives = 146/306 (47%), Gaps = 42/306 (13%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINH-------- 52
           M ++E +K +G G FG   L++ K T    AMK +++    +  VA++ + H        
Sbjct: 7   MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKK----EVIVAKDEVAHTLTENRVL 62
Query: 53  KQLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-- 110
           +  RHP +   K    T   L  VMEYA GGELF  +     FSED AR++  +++S   
Sbjct: 63  QNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALD 122
Query: 111 ------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP-KSTVGTPAYIAPEV 163
                  + +RDLKLEN +LD      +KI DFG  K  +      K   GTP Y+APEV
Sbjct: 123 YLHSEKNVVYRDLKLENLMLDKD--GHIKITDFGLCKEGIKDGATMKXFCGTPEYLAPEV 180
Query: 164 LSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHIS 223
           L   +Y G+  D W  GV +Y M+ G  PF +Q+  K F      I+  + + P    + 
Sbjct: 181 LEDNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLF----ELILMEEIRFPR--TLG 233
Query: 224 QDCRNLLSRIFVANPSRRI-----TIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTFS 278
            + ++LLS +   +P +R+       KEI  H +F   +        Q +Y +K +P F 
Sbjct: 234 PEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIV-------WQHVYEKKLSPPFK 286
Query: 279 LQSVEE 284
            Q   E
Sbjct: 287 PQVTSE 292

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score =  132 bits (331), Expect = 4e-31,   Method: Compositional matrix adjust.
 Identities = 92/278 (33%), Positives = 141/278 (50%), Gaps = 30/278 (10%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYI-----ERGHKIDAN---------VAR 47
           E Y  ++ +GSG +G   L + KN     A+K I     ++G   D N         +  
Sbjct: 36  ESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYN 95
Query: 48  EIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQL 107
           EI   K L HPNII+  +V     +  +V E+  GGELFE+I N  +F E +A    +Q+
Sbjct: 96  EISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQI 155
Query: 108 ISG-------QICHRDLKLENTLLDGSPA-PRLKICDFGYSKSSLLHSRPKSTVGTPAYI 159
           +SG        I HRD+K EN LL+   +   +KI DFG S       + +  +GT  YI
Sbjct: 156 LSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYI 215
Query: 160 APEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQY--KIP 217
           APEVL +++Y+ K  DVWSCGV +Y++L G  PF  Q D    +  I ++   +Y     
Sbjct: 216 APEVL-KKKYNEK-CDVWSCGVIMYILLCGYPPFGGQND----QDIIKKVEKGKYYFDFN 269
Query: 218 DYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLK 255
           D+ +IS + + L+  +   + ++R T +E  +  W  K
Sbjct: 270 DWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKK 307

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score =  132 bits (331), Expect = 4e-31,   Method: Compositional matrix adjust.
 Identities = 87/277 (31%), Positives = 143/277 (51%), Gaps = 43/277 (15%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERG---------HKIDANVAREIIN 51
           ++ +++++ +G+G+FG   L+R+++     AMK +++          H  D  +   I+ 
Sbjct: 5   LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVT 64
Query: 52  HKQLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYF-------F 104
           H     P IIR          + ++M+Y  GGELF  +  + RF    A+++        
Sbjct: 65  H-----PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLAL 119
Query: 105 QQLISGQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST---VGTPAYIAP 161
           + L S  I +RDLK EN LLD +    +KI DFG++K       P  T    GTP YIAP
Sbjct: 120 EYLHSKDIIYRDLKPENILLDKNG--HIKITDFGFAKYV-----PDVTYXLCGTPDYIAP 172
Query: 162 EVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVH 221
           EV+S + Y+ K  D WS G+ +Y ML G  PF D     N  KT  +I+  + + P +  
Sbjct: 173 EVVSTKPYN-KSIDWWSFGILIYEMLAGYTPFYD----SNTMKTYEKILNAELRFPPF-- 225
Query: 222 ISQDCRNLLSRIFVANPSRRI-----TIKEIKSHPWF 253
            ++D ++LLSR+   + S+R+       +++K+HPWF
Sbjct: 226 FNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWF 262

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score =  130 bits (327), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 83/272 (30%), Positives = 151/272 (55%), Gaps = 32/272 (11%)
Query: 3   KYELMKDIGSGNFGVARLMR---NKNTKELVAMKYIERG-----HKIDANVAREIINHKQ 54
           ++EL+K +G G+FG   L++     + ++L AMK +++       ++   + R+I+   +
Sbjct: 26  QFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILV--E 83
Query: 55  LRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLI------ 108
           + HP I++      T   L +++++  GG+LF R+     F+E++ +++  +L       
Sbjct: 84  VNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHL 143
Query: 109 -SGQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPK-STVGTPAYIAPEVLSR 166
            S  I +RDLK EN LLD      +K+ DFG SK S+ H +   S  GT  Y+APEV++R
Sbjct: 144 HSLGIIYRDLKPENILLD--EEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNR 201
Query: 167 REYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDC 226
           R +  + AD WS GV ++ ML G  PF+     K+ ++T++ I+  +  +P +  +S + 
Sbjct: 202 RGHT-QSADWWSFGVLMFEMLTGTLPFQG----KDRKETMTMILKAKLGMPQF--LSPEA 254
Query: 227 RNLLSRIFVANPSRRI-----TIKEIKSHPWF 253
           ++LL  +F  NP+ R+      ++EIK H +F
Sbjct: 255 QSLLRMLFKRNPANRLGAGPDGVEEIKRHSFF 286

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score =  130 bits (326), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 83/272 (30%), Positives = 151/272 (55%), Gaps = 32/272 (11%)
Query: 3   KYELMKDIGSGNFGVARLMR---NKNTKELVAMKYIERG-----HKIDANVAREIINHKQ 54
           ++EL+K +G G+FG   L++     + ++L AMK +++       ++   + R+I+   +
Sbjct: 25  QFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILV--E 82
Query: 55  LRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLI------ 108
           + HP I++      T   L +++++  GG+LF R+     F+E++ +++  +L       
Sbjct: 83  VNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHL 142
Query: 109 -SGQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPK-STVGTPAYIAPEVLSR 166
            S  I +RDLK EN LLD      +K+ DFG SK S+ H +   S  GT  Y+APEV++R
Sbjct: 143 HSLGIIYRDLKPENILLD--EEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNR 200
Query: 167 REYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDC 226
           R +  + AD WS GV ++ ML G  PF+     K+ ++T++ I+  +  +P +  +S + 
Sbjct: 201 RGHT-QSADWWSFGVLMFEMLTGTLPFQG----KDRKETMTMILKAKLGMPQF--LSPEA 253
Query: 227 RNLLSRIFVANPSRRI-----TIKEIKSHPWF 253
           ++LL  +F  NP+ R+      ++EIK H +F
Sbjct: 254 QSLLRMLFKRNPANRLGAGPDGVEEIKRHSFF 285

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score =  130 bits (326), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 84/281 (29%), Positives = 143/281 (50%), Gaps = 27/281 (9%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH----KIDANVAREIINHKQLR 56
           ++ +++++ +G G FG   L R K  K ++A+K + +       ++  + REI     LR
Sbjct: 13  IDDFDIVRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLR 72
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG------ 110
           HPNI+R          + +++E+A  GEL++ +   GRF E  +  F ++L         
Sbjct: 73  HPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHE 132
Query: 111 -QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS---RPKSTVGTPAYIAPEVLSR 166
            ++ HRD+K EN L+       LKI DFG+S    +H+   R +   GT  Y+ PE++  
Sbjct: 133 RKVIHRDIKPENLLMGYKGE--LKIADFGWS----VHAPSLRRRXMCGTLDYLPPEMIEG 186
Query: 167 REYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDC 226
           + +D K+ D+W  GV  Y  LVG  PF    D  +  +T  RI+ V  K P +  +S   
Sbjct: 187 KTHDEKV-DLWCAGVLCYEFLVGMPPF----DSPSHTETHRRIVNVDLKFPPF--LSDGS 239
Query: 227 RNLLSRIFVANPSRRITIKEIKSHPWFLKNLPRELTETAQA 267
           ++L+S++   +P +R+ +K +  HPW   N  R L    Q+
Sbjct: 240 KDLISKLLRYHPPQRLPLKGVMEHPWVKANSRRVLPPVYQS 280

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score =  130 bits (326), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 83/272 (30%), Positives = 151/272 (55%), Gaps = 32/272 (11%)
Query: 3   KYELMKDIGSGNFGVARLMR---NKNTKELVAMKYIERG-----HKIDANVAREIINHKQ 54
           ++EL+K +G G+FG   L++     + ++L AMK +++       ++   + R+I+   +
Sbjct: 25  QFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILV--E 82
Query: 55  LRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLI------ 108
           + HP I++      T   L +++++  GG+LF R+     F+E++ +++  +L       
Sbjct: 83  VNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHL 142
Query: 109 -SGQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPK-STVGTPAYIAPEVLSR 166
            S  I +RDLK EN LLD      +K+ DFG SK S+ H +   S  GT  Y+APEV++R
Sbjct: 143 HSLGIIYRDLKPENILLD--EEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNR 200
Query: 167 REYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDC 226
           R +  + AD WS GV ++ ML G  PF+     K+ ++T++ I+  +  +P +  +S + 
Sbjct: 201 RGHT-QSADWWSFGVLMFEMLTGTLPFQG----KDRKETMTMILKAKLGMPQF--LSPEA 253
Query: 227 RNLLSRIFVANPSRRI-----TIKEIKSHPWF 253
           ++LL  +F  NP+ R+      ++EIK H +F
Sbjct: 254 QSLLRMLFKRNPANRLGAGPDGVEEIKRHSFF 285

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score =  130 bits (326), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 82/264 (31%), Positives = 134/264 (50%), Gaps = 16/264 (6%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDA----NVAREIINHKQLRH 57
           + Y++ +++G G F V R   +K T    A K I    K+ A     + RE    ++L+H
Sbjct: 29  DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINT-KKLSARDFQKLEREARICRKLQH 87
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLI-------SG 110
           PNI+R  + +   +   +V +   GGELFE I     +SE +A +  QQ++       S 
Sbjct: 88  PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSN 147
Query: 111 QICHRDLKLENTLLDG-SPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREY 169
            I HR+LK EN LL   +    +K+ DFG +             GTP Y++PEVL +  Y
Sbjct: 148 GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPY 207
Query: 170 DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 229
             K  D+W+CGV LY++LVG  PF D++  + + +   +  A  Y  P++  ++ + ++L
Sbjct: 208 -SKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQI--KAGAYDYPSPEWDTVTPEAKSL 264
Query: 230 LSRIFVANPSRRITIKEIKSHPWF 253
           +  +   NP +RIT  +    PW 
Sbjct: 265 IDSMLTVNPKKRITADQALKVPWI 288

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score =  129 bits (325), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 82/263 (31%), Positives = 134/263 (50%), Gaps = 16/263 (6%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDA----NVAREIINHKQLRH 57
           + Y++ +++G G F V R   +K T    A K I    K+ A     + RE    ++L+H
Sbjct: 6   DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINT-KKLSARDFQKLEREARICRKLQH 64
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLI-------SG 110
           PNI+R  + +   +   +V +   GGELFE I     +SE +A +  QQ++       S 
Sbjct: 65  PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSN 124
Query: 111 QICHRDLKLENTLLDG-SPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREY 169
            I HR+LK EN LL   +    +K+ DFG +             GTP Y++PEVL +  Y
Sbjct: 125 GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPY 184
Query: 170 DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 229
             K  D+W+CGV LY++LVG  PF D++  + + +   +  A  Y  P++  ++ + ++L
Sbjct: 185 -SKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQI--KAGAYDYPSPEWDTVTPEAKSL 241
Query: 230 LSRIFVANPSRRITIKEIKSHPW 252
           +  +   NP +RIT  +    PW
Sbjct: 242 IDSMLTVNPKKRITADQALKVPW 264

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score =  129 bits (325), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 82/263 (31%), Positives = 134/263 (50%), Gaps = 16/263 (6%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDA----NVAREIINHKQLRH 57
           + Y++ +++G G F V R   +K T    A K I    K+ A     + RE    ++L+H
Sbjct: 6   DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINT-KKLSARDFQKLEREARICRKLQH 64
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLI-------SG 110
           PNI+R  + +   +   +V +   GGELFE I     +SE +A +  QQ++       S 
Sbjct: 65  PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSN 124
Query: 111 QICHRDLKLENTLLDG-SPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREY 169
            I HR+LK EN LL   +    +K+ DFG +             GTP Y++PEVL +  Y
Sbjct: 125 GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPY 184
Query: 170 DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 229
             K  D+W+CGV LY++LVG  PF D++  + + +   +  A  Y  P++  ++ + ++L
Sbjct: 185 -SKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQI--KAGAYDYPSPEWDTVTPEAKSL 241
Query: 230 LSRIFVANPSRRITIKEIKSHPW 252
           +  +   NP +RIT  +    PW
Sbjct: 242 IDSMLTVNPKKRITADQALKVPW 264

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score =  129 bits (325), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 82/263 (31%), Positives = 134/263 (50%), Gaps = 16/263 (6%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDA----NVAREIINHKQLRH 57
           + Y++ +++G G F V R   +K T    A K I    K+ A     + RE    ++L+H
Sbjct: 5   DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINT-KKLSARDFQKLEREARICRKLQH 63
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLI-------SG 110
           PNI+R  + +   +   +V +   GGELFE I     +SE +A +  QQ++       S 
Sbjct: 64  PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSN 123
Query: 111 QICHRDLKLENTLLDG-SPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREY 169
            I HR+LK EN LL   +    +K+ DFG +             GTP Y++PEVL +  Y
Sbjct: 124 GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPY 183
Query: 170 DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 229
             K  D+W+CGV LY++LVG  PF D++  + + +   +  A  Y  P++  ++ + ++L
Sbjct: 184 -SKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQI--KAGAYDYPSPEWDTVTPEAKSL 240
Query: 230 LSRIFVANPSRRITIKEIKSHPW 252
           +  +   NP +RIT  +    PW
Sbjct: 241 IDSMLTVNPKKRITADQALKVPW 263

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score =  129 bits (325), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 87/293 (29%), Positives = 148/293 (50%), Gaps = 34/293 (11%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQL----R 56
           ++++E +K +G+G+FG   L+++K T    AMK +++   +        +N K++     
Sbjct: 41  LDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 100
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYF-------FQQLIS 109
            P +++ +      ++L +VMEYA GGE+F  +   GRFSE  AR++       F+ L S
Sbjct: 101 FPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 160
Query: 110 GQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREY 169
             + +RDLK EN ++D      +K+ DFG++K   +  R     GTP Y+APE++  + Y
Sbjct: 161 LDLIYRDLKPENLMID--QQGYIKVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGY 216
Query: 170 DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 229
           + K  D W+ GV +Y M  G  PF   +  + + K +S     + + P   H S D ++L
Sbjct: 217 N-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG----KVRFPS--HFSSDLKDL 269
Query: 230 LSRIFVANPSRRI-----TIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTF 277
           L  +   + ++R       + +IK+H WF        T    AIY RK    F
Sbjct: 270 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF-------ATTDWIAIYQRKVEAPF 315

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score =  129 bits (324), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 86/293 (29%), Positives = 149/293 (50%), Gaps = 34/293 (11%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRH--- 57
           ++++E ++ +G+G+FG   L+++K T    AMK +++   +        +N K+++    
Sbjct: 41  LDQFERIRTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRIQQAVN 100
Query: 58  -PNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYF-------FQQLIS 109
            P +++ +      ++L +V+EYA GGE+F  +   GRFSE  AR++       F+ L S
Sbjct: 101 FPFLVKLEFSFKDNSNLYMVLEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 160
Query: 110 GQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREY 169
             + +RDLK EN L+D      +K+ DFG++K   +  R     GTP Y+APE++  + Y
Sbjct: 161 LDLIYRDLKPENLLIDQQ--GYIKVADFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGY 216
Query: 170 DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 229
           + K  D W+ GV +Y M  G  PF   +  + + K +S     + + P   H S D ++L
Sbjct: 217 N-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG----KVRFPS--HFSSDLKDL 269
Query: 230 LSRIFVANPSRRI-----TIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTF 277
           L  +   + ++R       + +IK+H WF        T    AIY RK    F
Sbjct: 270 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF-------ATTDWIAIYQRKVEAPF 315

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score =  129 bits (323), Expect = 3e-30,   Method: Compositional matrix adjust.
 Identities = 84/281 (29%), Positives = 142/281 (50%), Gaps = 27/281 (9%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH----KIDANVAREIINHKQLR 56
           ++ +++ + +G G FG   L R K  K ++A+K + +       ++  + REI     LR
Sbjct: 14  IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLR 73
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG------ 110
           HPNI+R          + +++E+A  GEL++ +   GRF E  +  F ++L         
Sbjct: 74  HPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHE 133
Query: 111 -QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS---RPKSTVGTPAYIAPEVLSR 166
            ++ HRD+K EN L+       LKI DFG+S    +H+   R +   GT  Y+ PE++  
Sbjct: 134 RKVIHRDIKPENLLM--GYKGELKIADFGWS----VHAPSLRRRXMCGTLDYLPPEMIEG 187
Query: 167 REYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDC 226
           + +D K+ D+W  GV  Y  LVG  PF    D  +  +T  RI+ V  K P +  +S   
Sbjct: 188 KTHDEKV-DLWCAGVLCYEFLVGMPPF----DSPSHTETHRRIVNVDLKFPPF--LSDGS 240
Query: 227 RNLLSRIFVANPSRRITIKEIKSHPWFLKNLPRELTETAQA 267
           ++L+S++   +P +R+ +K +  HPW   N  R L    Q+
Sbjct: 241 KDLISKLLRYHPPQRLPLKGVMEHPWVKANSRRVLPPVYQS 281

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score =  128 bits (322), Expect = 5e-30,   Method: Compositional matrix adjust.
 Identities = 86/293 (29%), Positives = 148/293 (50%), Gaps = 34/293 (11%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQL----R 56
           +++++ +K +G+G+FG   L+++K +    AMK +++   +        +N K++     
Sbjct: 40  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYF-------FQQLIS 109
            P +++ +      ++L +VMEY AGGE+F  +   GRFSE  AR++       F+ L S
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 110 GQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREY 169
             + +RDLK EN L+D      +++ DFG++K   +  R     GTP Y+APE++  + Y
Sbjct: 160 LDLIYRDLKPENLLID--QQGYIQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 170 DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 229
           + K  D W+ GV +Y M  G  PF   E  + + K +S     + + P   H S D ++L
Sbjct: 216 N-KAVDWWALGVLIYEMAAGYPPFFADEPIQIYEKIVSG----KVRFPS--HFSSDLKDL 268
Query: 230 LSRIFVANPSRRI-----TIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTF 277
           L  +   + ++R       + +IK+H WF        T    AIY RK    F
Sbjct: 269 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF-------ATTDWIAIYQRKVEAPF 314

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score =  128 bits (321), Expect = 5e-30,   Method: Compositional matrix adjust.
 Identities = 86/293 (29%), Positives = 147/293 (50%), Gaps = 34/293 (11%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQL----R 56
           ++++E +K +G+G+FG   L+++K T    AMK +++   +        +N K++     
Sbjct: 40  LDQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYF-------FQQLIS 109
            P +++ +      ++L +VMEY  GGE+F  +   GRFSE  AR++       F+ L S
Sbjct: 100 FPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 110 GQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREY 169
             + +RDLK EN L+D      +++ DFG++K   +  R     GTP Y+APE++  + Y
Sbjct: 160 LDLIYRDLKPENLLID--QQGYIQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 170 DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 229
           + K  D W+ GV +Y M  G  PF   +  + + K +S     + + P   H S D ++L
Sbjct: 216 N-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG----KVRFPS--HFSSDLKDL 268
Query: 230 LSRIFVANPSRRI-----TIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTF 277
           L  +   + ++R       + +IK+H WF        T    AIY RK    F
Sbjct: 269 LRNLLQVDLTKRFGNLKDGVNDIKNHKWF-------ATTDWIAIYQRKVEAPF 314

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score =  128 bits (321), Expect = 5e-30,   Method: Compositional matrix adjust.
 Identities = 86/293 (29%), Positives = 147/293 (50%), Gaps = 34/293 (11%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQL----R 56
           ++++E +K +G+G+FG   L+++K T    AMK +++   +        +N K++     
Sbjct: 40  LDQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYF-------FQQLIS 109
            P +++ +      ++L +VMEY  GGE+F  +   GRFSE  AR++       F+ L S
Sbjct: 100 FPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 110 GQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREY 169
             + +RDLK EN L+D      +++ DFG++K   +  R     GTP Y+APE++  + Y
Sbjct: 160 LDLIYRDLKPENLLID--QQGYIQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 170 DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 229
           + K  D W+ GV +Y M  G  PF   +  + + K +S     + + P   H S D ++L
Sbjct: 216 N-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG----KVRFPS--HFSSDLKDL 268
Query: 230 LSRIFVANPSRRI-----TIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTF 277
           L  +   + ++R       + +IK+H WF        T    AIY RK    F
Sbjct: 269 LRNLLQVDLTKRFGNLKDGVNDIKNHKWF-------ATTDWIAIYQRKVEAPF 314

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score =  128 bits (321), Expect = 6e-30,   Method: Compositional matrix adjust.
 Identities = 86/293 (29%), Positives = 147/293 (50%), Gaps = 34/293 (11%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQL----R 56
           ++++E +K +G+G+FG   L+++K T    AMK +++   +        +N K++     
Sbjct: 40  LDQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYF-------FQQLIS 109
            P +++ +      ++L +VMEY  GGE+F  +   GRFSE  AR++       F+ L S
Sbjct: 100 FPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 110 GQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREY 169
             + +RDLK EN L+D      +++ DFG++K   +  R     GTP Y+APE++  + Y
Sbjct: 160 LDLIYRDLKPENLLID--QQGYIQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 170 DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 229
           + K  D W+ GV +Y M  G  PF   +  + + K +S     + + P   H S D ++L
Sbjct: 216 N-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG----KVRFPS--HFSSDLKDL 268
Query: 230 LSRIFVANPSRRI-----TIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTF 277
           L  +   + ++R       + +IK+H WF        T    AIY RK    F
Sbjct: 269 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF-------ATTDWIAIYQRKVEAPF 314

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score =  127 bits (320), Expect = 6e-30,   Method: Compositional matrix adjust.
 Identities = 91/306 (29%), Positives = 146/306 (47%), Gaps = 41/306 (13%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINH-------- 52
           M  ++ +K +G G FG   L+R K T    AMK + +    +  +A++ + H        
Sbjct: 4   MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRK----EVIIAKDEVAHTVTESRVL 59
Query: 53  KQLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-- 110
           +  RHP +   K    T   L  VMEYA GGELF  +     F+E+ AR++  +++S   
Sbjct: 60  QNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALE 119
Query: 111 -----QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP-KSTVGTPAYIAPEVL 164
                 + +RD+KLEN +LD      +KI DFG  K  +      K+  GTP Y+APEVL
Sbjct: 120 YLHSRDVVYRDIKLENLMLDKD--GHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVL 177
Query: 165 SRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQ 224
              +Y G+  D W  GV +Y M+ G  PF +Q+  + F      I+  + + P    +S 
Sbjct: 178 EDNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHERLF----ELILMEEIRFPR--TLSP 230
Query: 225 DCRNLLSRIFVANPSRRI-----TIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTFSL 279
           + ++LL+ +   +P +R+       KE+  H +F       L+   Q +  +K  P F  
Sbjct: 231 EAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFF-------LSINWQDVVQKKLLPPFKP 283
Query: 280 QSVEEI 285
           Q   E+
Sbjct: 284 QVTSEV 289

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score =  127 bits (320), Expect = 6e-30,   Method: Compositional matrix adjust.
 Identities = 91/306 (29%), Positives = 146/306 (47%), Gaps = 41/306 (13%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINH-------- 52
           M  ++ +K +G G FG   L+R K T    AMK + +    +  +A++ + H        
Sbjct: 4   MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRK----EVIIAKDEVAHTVTESRVL 59
Query: 53  KQLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-- 110
           +  RHP +   K    T   L  VMEYA GGELF  +     F+E+ AR++  +++S   
Sbjct: 60  QNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALE 119
Query: 111 -----QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP-KSTVGTPAYIAPEVL 164
                 + +RD+KLEN +LD      +KI DFG  K  +      K+  GTP Y+APEVL
Sbjct: 120 YLHSRDVVYRDIKLENLMLDKD--GHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVL 177
Query: 165 SRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQ 224
              +Y G+  D W  GV +Y M+ G  PF +Q+  + F      I+  + + P    +S 
Sbjct: 178 EDNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHERLF----ELILMEEIRFPR--TLSP 230
Query: 225 DCRNLLSRIFVANPSRRI-----TIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTFSL 279
           + ++LL+ +   +P +R+       KE+  H +F       L+   Q +  +K  P F  
Sbjct: 231 EAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFF-------LSINWQDVVQKKLLPPFKP 283
Query: 280 QSVEEI 285
           Q   E+
Sbjct: 284 QVTSEV 289

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score =  127 bits (320), Expect = 7e-30,   Method: Compositional matrix adjust.
 Identities = 85/293 (29%), Positives = 148/293 (50%), Gaps = 34/293 (11%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQL----R 56
           +++++ +K +G+G+FG   L+++K +    AMK +++   +        +N K++     
Sbjct: 40  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYF-------FQQLIS 109
            P +++ +      ++L +VMEY AGGE+F  +   GRFSE  AR++       F+ L S
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 110 GQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREY 169
             + +RDLK EN L+D      +++ DFG++K   +  R     GTP Y+APE++  + Y
Sbjct: 160 LDLIYRDLKPENLLID--QQGYIQVTDFGFAKR--VKGRTWXLAGTPEYLAPEIILSKGY 215
Query: 170 DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 229
           + K  D W+ GV +Y M  G  PF   +  + + K +S     + + P   H S D ++L
Sbjct: 216 N-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG----KVRFPS--HFSSDLKDL 268
Query: 230 LSRIFVANPSRRI-----TIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTF 277
           L  +   + ++R       + +IK+H WF        T    AIY RK    F
Sbjct: 269 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF-------ATTDWIAIYQRKVEAPF 314

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score =  127 bits (320), Expect = 7e-30,   Method: Compositional matrix adjust.
 Identities = 91/306 (29%), Positives = 146/306 (47%), Gaps = 41/306 (13%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINH-------- 52
           M  ++ +K +G G FG   L+R K T    AMK + +    +  +A++ + H        
Sbjct: 7   MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRK----EVIIAKDEVAHTVTESRVL 62
Query: 53  KQLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-- 110
           +  RHP +   K    T   L  VMEYA GGELF  +     F+E+ AR++  +++S   
Sbjct: 63  QNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALE 122
Query: 111 -----QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP-KSTVGTPAYIAPEVL 164
                 + +RD+KLEN +LD      +KI DFG  K  +      K+  GTP Y+APEVL
Sbjct: 123 YLHSRDVVYRDIKLENLMLDKD--GHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVL 180
Query: 165 SRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQ 224
              +Y G+  D W  GV +Y M+ G  PF +Q+  + F      I+  + + P    +S 
Sbjct: 181 EDNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHERLF----ELILMEEIRFPR--TLSP 233
Query: 225 DCRNLLSRIFVANPSRRI-----TIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTFSL 279
           + ++LL+ +   +P +R+       KE+  H +F       L+   Q +  +K  P F  
Sbjct: 234 EAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFF-------LSINWQDVVQKKLLPPFKP 286
Query: 280 QSVEEI 285
           Q   E+
Sbjct: 287 QVTSEV 292

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score =  127 bits (320), Expect = 8e-30,   Method: Compositional matrix adjust.
 Identities = 86/293 (29%), Positives = 147/293 (50%), Gaps = 34/293 (11%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQL----R 56
           ++++E +K +G+G+FG   L+++K T    AMK +++   +        +N K++     
Sbjct: 61  LDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 120
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYF-------FQQLIS 109
            P +++ +      ++L +VMEY  GGE+F  +   GRFSE  AR++       F+ L S
Sbjct: 121 FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 180
Query: 110 GQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREY 169
             + +RDLK EN L+D      +++ DFG++K   +  R     GTP Y+APE++  + Y
Sbjct: 181 LDLIYRDLKPENLLID--QQGYIQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGY 236
Query: 170 DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 229
           + K  D W+ GV +Y M  G  PF   +  + + K +S     + + P   H S D ++L
Sbjct: 237 N-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG----KVRFPS--HFSSDLKDL 289
Query: 230 LSRIFVANPSRRI-----TIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTF 277
           L  +   + ++R       + +IK+H WF        T    AIY RK    F
Sbjct: 290 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF-------ATTDWIAIYQRKVEAPF 335

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score =  127 bits (319), Expect = 8e-30,   Method: Compositional matrix adjust.
 Identities = 87/293 (29%), Positives = 146/293 (49%), Gaps = 34/293 (11%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQL----R 56
           ++++E +K IG+G+FG   L+++  T    AMK +++   +        +N K++     
Sbjct: 40  LDQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYF-------FQQLIS 109
            P +++ +      ++L +VMEY  GGE+F  +   GRFSE  AR++       F+ L S
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 110 GQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREY 169
             + +RDLK EN L+D      +K+ DFG++K   +  R     GTP Y+APE++  + Y
Sbjct: 160 LDLIYRDLKPENLLID--QQGYIKVADFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 170 DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 229
           + K  D W+ GV +Y M  G  PF   +  + + K +S     + + P   H S D ++L
Sbjct: 216 N-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG----KVRFPS--HFSSDLKDL 268
Query: 230 LSRIFVANPSRRI-----TIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTF 277
           L  +   + ++R       + +IK+H WF        T    AIY RK    F
Sbjct: 269 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF-------ATTDWIAIYQRKVEAPF 314

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score =  127 bits (319), Expect = 8e-30,   Method: Compositional matrix adjust.
 Identities = 86/293 (29%), Positives = 147/293 (50%), Gaps = 34/293 (11%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQL----R 56
           ++++E +K +G+G+FG   L+++K T    AMK +++   +        +N K++     
Sbjct: 33  LDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 92
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYF-------FQQLIS 109
            P +++ +      ++L +VMEY  GGE+F  +   GRFSE  AR++       F+ L S
Sbjct: 93  FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 152
Query: 110 GQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREY 169
             + +RDLK EN L+D      +++ DFG++K   +  R     GTP Y+APE++  + Y
Sbjct: 153 LDLIYRDLKPENLLIDQQGY--IQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGY 208
Query: 170 DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 229
           + K  D W+ GV +Y M  G  PF   +  + + K +S     + + P   H S D ++L
Sbjct: 209 N-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG----KVRFPS--HFSSDLKDL 261
Query: 230 LSRIFVANPSRRI-----TIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTF 277
           L  +   + ++R       + +IK+H WF        T    AIY RK    F
Sbjct: 262 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF-------ATTDWIAIYQRKVEAPF 307

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score =  127 bits (319), Expect = 8e-30,   Method: Compositional matrix adjust.
 Identities = 78/269 (28%), Positives = 143/269 (53%), Gaps = 22/269 (8%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIIN----HKQLR 56
           +E +++   +G G+F       + +T   VA+K I++     A + + + N    H QL+
Sbjct: 10  IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLK 69
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGR-FSEDEARYFFQQLISGQ---- 111
           HP+I+          ++ +V+E    GE+   + N  + FSE+EAR+F  Q+I+G     
Sbjct: 70  HPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLH 129
Query: 112 ---ICHRDLKLENTLLDGSPAPRLKICDFGY-SKSSLLHSRPKSTVGTPAYIAPEVLSRR 167
              I HRDL L N LL  +    +KI DFG  ++  + H +  +  GTP YI+PE+ +R 
Sbjct: 130 SHGILHRDLTLSNLLL--TRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIATRS 187
Query: 168 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCR 227
            + G  +DVWS G   Y +L+G  PF    D    + T+++++   Y++P ++ I  + +
Sbjct: 188 AH-GLESDVWSLGCMFYTLLIGRPPF----DTDTVKNTLNKVVLADYEMPSFLSI--EAK 240
Query: 228 NLLSRIFVANPSRRITIKEIKSHPWFLKN 256
           +L+ ++   NP+ R+++  +  HP+  +N
Sbjct: 241 DLIHQLLRRNPADRLSLSSVLDHPFMSRN 269

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score =  127 bits (319), Expect = 8e-30,   Method: Compositional matrix adjust.
 Identities = 86/293 (29%), Positives = 147/293 (50%), Gaps = 34/293 (11%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQL----R 56
           ++++E +K +G+G+FG   L+++K T    AMK +++   +        +N K++     
Sbjct: 41  LDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 100
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYF-------FQQLIS 109
            P +++ +      ++L +VMEY  GGE+F  +   GRFSE  AR++       F+ L S
Sbjct: 101 FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 160
Query: 110 GQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREY 169
             + +RDLK EN L+D      +++ DFG++K   +  R     GTP Y+APE++  + Y
Sbjct: 161 LDLIYRDLKPENLLID--QQGYIQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGY 216
Query: 170 DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 229
           + K  D W+ GV +Y M  G  PF   +  + + K +S     + + P   H S D ++L
Sbjct: 217 N-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG----KVRFPS--HFSSDLKDL 269
Query: 230 LSRIFVANPSRRI-----TIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTF 277
           L  +   + ++R       + +IK+H WF        T    AIY RK    F
Sbjct: 270 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF-------ATTDWIAIYQRKVEAPF 315

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score =  127 bits (319), Expect = 8e-30,   Method: Compositional matrix adjust.
 Identities = 85/293 (29%), Positives = 148/293 (50%), Gaps = 34/293 (11%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQL----R 56
           +++++ +K +G+G+FG   L+++K +    AMK +++   +        +N K++     
Sbjct: 40  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYF-------FQQLIS 109
            P +++ +      ++L +VMEY AGGE+F  +   GRFSE  AR++       F+ L S
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 110 GQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREY 169
             + +RDLK EN L+D      +++ DFG++K   +  R     GTP Y+APE++  + Y
Sbjct: 160 LDLIYRDLKPENLLID--QQGYIQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 170 DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 229
           + K  D W+ GV +Y M  G  PF   +  + + K +S     + + P   H S D ++L
Sbjct: 216 N-KAVDWWALGVLIYQMAAGYPPFFADQPIQIYEKIVSG----KVRFPS--HFSSDLKDL 268
Query: 230 LSRIFVANPSRRI-----TIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTF 277
           L  +   + ++R       + +IK+H WF        T    AIY RK    F
Sbjct: 269 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF-------ATTDWIAIYQRKVEAPF 314

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score =  127 bits (319), Expect = 8e-30,   Method: Compositional matrix adjust.
 Identities = 86/293 (29%), Positives = 147/293 (50%), Gaps = 34/293 (11%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQL----R 56
           ++++E +K +G+G+FG   L+++K T    AMK +++   +        +N K++     
Sbjct: 41  LDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 100
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYF-------FQQLIS 109
            P +++ +      ++L +VMEY  GGE+F  +   GRFSE  AR++       F+ L S
Sbjct: 101 FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 160
Query: 110 GQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREY 169
             + +RDLK EN L+D      +++ DFG++K   +  R     GTP Y+APE++  + Y
Sbjct: 161 LDLIYRDLKPENLLID--QQGYIQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGY 216
Query: 170 DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 229
           + K  D W+ GV +Y M  G  PF   +  + + K +S     + + P   H S D ++L
Sbjct: 217 N-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG----KVRFPS--HFSSDLKDL 269
Query: 230 LSRIFVANPSRRI-----TIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTF 277
           L  +   + ++R       + +IK+H WF        T    AIY RK    F
Sbjct: 270 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF-------ATTDWIAIYQRKVEAPF 315

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score =  127 bits (319), Expect = 9e-30,   Method: Compositional matrix adjust.
 Identities = 85/293 (29%), Positives = 148/293 (50%), Gaps = 34/293 (11%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQL----R 56
           +++++ +K +G+G+FG   L+++K +    AMK +++   +        +N K++     
Sbjct: 27  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 86
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYF-------FQQLIS 109
            P +++ +      ++L +VMEY AGGE+F  +   GRFSE  AR++       F+ L S
Sbjct: 87  FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 146
Query: 110 GQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREY 169
             + +RDLK EN L+D      +++ DFG++K   +  R     GTP Y+APE++  + Y
Sbjct: 147 LDLIYRDLKPENLLID--EQGYIQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGY 202
Query: 170 DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 229
           + K  D W+ GV +Y M  G  PF   +  + + K +S     + + P   H S D ++L
Sbjct: 203 N-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG----KVRFPS--HFSSDLKDL 255
Query: 230 LSRIFVANPSRRI-----TIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTF 277
           L  +   + ++R       + +IK+H WF        T    AIY RK    F
Sbjct: 256 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF-------ATTDWIAIYQRKVEAPF 301

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score =  127 bits (319), Expect = 9e-30,   Method: Compositional matrix adjust.
 Identities = 85/293 (29%), Positives = 148/293 (50%), Gaps = 34/293 (11%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQL----R 56
           +++++ +K +G+G+FG   L+++K +    AMK +++   +        +N K++     
Sbjct: 41  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 100
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYF-------FQQLIS 109
            P +++ +      ++L +VMEY AGGE+F  +   GRFSE  AR++       F+ L S
Sbjct: 101 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 160
Query: 110 GQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREY 169
             + +RDLK EN L+D      +++ DFG++K   +  R     GTP Y+APE++  + Y
Sbjct: 161 LDLIYRDLKPENLLID--QQGYIQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGY 216
Query: 170 DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 229
           + K  D W+ GV +Y M  G  PF   +  + + K +S     + + P   H S D ++L
Sbjct: 217 N-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG----KVRFPS--HFSSDLKDL 269
Query: 230 LSRIFVANPSRRI-----TIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTF 277
           L  +   + ++R       + +IK+H WF        T    AIY RK    F
Sbjct: 270 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF-------ATTDWIAIYQRKVEAPF 315

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score =  127 bits (319), Expect = 9e-30,   Method: Compositional matrix adjust.
 Identities = 86/293 (29%), Positives = 147/293 (50%), Gaps = 34/293 (11%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQL----R 56
           ++++E +K +G+G+FG   L+++  T    AMK +++   +        +N K++     
Sbjct: 40  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYF-------FQQLIS 109
            P +++ +      ++L +VMEY AGGE+F  +   GRFSE  AR++       F+ L S
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 110 GQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREY 169
             + +RDLK EN L+D      +++ DFG++K   +  R     GTP Y+APE++  + Y
Sbjct: 160 LDLIYRDLKPENLLID--QQGYIQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 170 DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 229
           + K  D W+ GV +Y M  G  PF   +  + + K +S     + + P   H S D ++L
Sbjct: 216 N-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG----KVRFPS--HFSSDLKDL 268
Query: 230 LSRIFVANPSRRI-----TIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTF 277
           L  +   + ++R       + +IK+H WF        T    AIY RK    F
Sbjct: 269 LRNLLQVDLTKRFGNLKDGVNDIKNHKWF-------ATTDWIAIYQRKVEAPF 314

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score =  127 bits (319), Expect = 9e-30,   Method: Compositional matrix adjust.
 Identities = 85/293 (29%), Positives = 148/293 (50%), Gaps = 34/293 (11%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQL----R 56
           +++++ +K +G+G+FG   L+++K +    AMK +++   +        +N K++     
Sbjct: 40  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYF-------FQQLIS 109
            P +++ +      ++L +VMEY AGGE+F  +   GRFSE  AR++       F+ L S
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 110 GQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREY 169
             + +RDLK EN L+D      +++ DFG++K   +  R     GTP Y+APE++  + Y
Sbjct: 160 LDLIYRDLKPENLLID--QQGYIQVTDFGFAKR--VKGRTWXLXGTPEYLAPEIILSKGY 215
Query: 170 DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 229
           + K  D W+ GV +Y M  G  PF   +  + + K +S     + + P   H S D ++L
Sbjct: 216 N-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG----KVRFPS--HFSSDLKDL 268
Query: 230 LSRIFVANPSRRI-----TIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTF 277
           L  +   + ++R       + +IK+H WF        T    AIY RK    F
Sbjct: 269 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF-------ATTDWIAIYQRKVEAPF 314

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score =  127 bits (319), Expect = 9e-30,   Method: Compositional matrix adjust.
 Identities = 85/293 (29%), Positives = 148/293 (50%), Gaps = 34/293 (11%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQL----R 56
           +++++ +K +G+G+FG   L+++K +    AMK +++   +        +N K++     
Sbjct: 40  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYF-------FQQLIS 109
            P +++ +      ++L +VMEY AGGE+F  +   GRFSE  AR++       F+ L S
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 110 GQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREY 169
             + +RDLK EN L+D      +++ DFG++K   +  R     GTP Y+APE++  + Y
Sbjct: 160 LDLIYRDLKPENLLID--QQGYIQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 170 DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 229
           + K  D W+ GV +Y M  G  PF   +  + + K +S     + + P   H S D ++L
Sbjct: 216 N-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG----KVRFPS--HFSSDLKDL 268
Query: 230 LSRIFVANPSRRI-----TIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTF 277
           L  +   + ++R       + +IK+H WF        T    AIY RK    F
Sbjct: 269 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF-------ATTDWIAIYQRKVEAPF 314

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  127 bits (319), Expect = 9e-30,   Method: Compositional matrix adjust.
 Identities = 85/293 (29%), Positives = 148/293 (50%), Gaps = 34/293 (11%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQL----R 56
           +++++ +K +G+G+FG   L+++K +    AMK +++   +        +N K++     
Sbjct: 40  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYF-------FQQLIS 109
            P +++ +      ++L +VMEY AGGE+F  +   GRFSE  AR++       F+ L S
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 110 GQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREY 169
             + +RDLK EN L+D      +++ DFG++K   +  R     GTP Y+APE++  + Y
Sbjct: 160 LDLIYRDLKPENLLID--QQGYIQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 170 DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 229
           + K  D W+ GV +Y M  G  PF   +  + + K +S     + + P   H S D ++L
Sbjct: 216 N-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG----KVRFPS--HFSSDLKDL 268
Query: 230 LSRIFVANPSRRI-----TIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTF 277
           L  +   + ++R       + +IK+H WF        T    AIY RK    F
Sbjct: 269 LRNLLQVDLTKRFGNLPNGVNDIKNHKWF-------ATTDWIAIYQRKVEAPF 314

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score =  127 bits (319), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 86/293 (29%), Positives = 147/293 (50%), Gaps = 34/293 (11%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQL----R 56
           ++++E +K +G+G+FG   L+++  T    AMK +++   +        +N K++     
Sbjct: 40  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYF-------FQQLIS 109
            P +++ +      ++L +VMEYA GGE+F  +   GRFSE  AR++       F+ L S
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 110 GQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREY 169
             + +RDLK EN ++D      +K+ DFG++K   +  R     GTP Y+APE++  + Y
Sbjct: 160 LDLIYRDLKPENLMID--QQGYIKVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 170 DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 229
           + K  D W+ GV +Y M  G  PF   +  + + K +S     + + P   H S D ++L
Sbjct: 216 N-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG----KVRFPS--HFSSDLKDL 268
Query: 230 LSRIFVANPSRRI-----TIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTF 277
           L  +   + ++R       + +IK+H WF        T    AIY RK    F
Sbjct: 269 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF-------ATTDWIAIYQRKVEAPF 314

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score =  127 bits (319), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 85/293 (29%), Positives = 148/293 (50%), Gaps = 34/293 (11%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQL----R 56
           +++++ +K +G+G+FG   L+++K +    AMK +++   +        +N K++     
Sbjct: 40  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYF-------FQQLIS 109
            P +++ +      ++L +VMEY AGGE+F  +   GRFSE  AR++       F+ L S
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 110 GQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREY 169
             + +RDLK EN L+D      +++ DFG++K   +  R     GTP Y+APE++  + Y
Sbjct: 160 LDLIYRDLKPENLLID--QQGYIQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 170 DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 229
           + K  D W+ GV +Y M  G  PF   +  + + K +S     + + P   H S D ++L
Sbjct: 216 N-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG----KVRFPS--HFSSDLKDL 268
Query: 230 LSRIFVANPSRRI-----TIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTF 277
           L  +   + ++R       + +IK+H WF        T    AIY RK    F
Sbjct: 269 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF-------ATTDWIAIYQRKVEAPF 314

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score =  127 bits (318), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 91/306 (29%), Positives = 145/306 (47%), Gaps = 41/306 (13%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINH-------- 52
           M  ++ +K +G G FG   L+R K T    AMK + +    +  +A++ + H        
Sbjct: 4   MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRK----EVIIAKDEVAHTVTESRVL 59
Query: 53  KQLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-- 110
           +  RHP +   K    T   L  VMEYA GGELF  +     F+E+ AR++  +++S   
Sbjct: 60  QNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALE 119
Query: 111 -----QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP-KSTVGTPAYIAPEVL 164
                 + +RD+KLEN +LD      +KI DFG  K  +      K   GTP Y+APEVL
Sbjct: 120 YLHSRDVVYRDIKLENLMLDKD--GHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVL 177
Query: 165 SRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQ 224
              +Y G+  D W  GV +Y M+ G  PF +Q+  + F      I+  + + P    +S 
Sbjct: 178 EDNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHERLF----ELILMEEIRFPR--TLSP 230
Query: 225 DCRNLLSRIFVANPSRRI-----TIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTFSL 279
           + ++LL+ +   +P +R+       KE+  H +F       L+   Q +  +K  P F  
Sbjct: 231 EAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFF-------LSINWQDVVQKKLLPPFKP 283
Query: 280 QSVEEI 285
           Q   E+
Sbjct: 284 QVTSEV 289

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score =  127 bits (318), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 91/306 (29%), Positives = 145/306 (47%), Gaps = 41/306 (13%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINH-------- 52
           M  ++ +K +G G FG   L+R K T    AMK + +    +  +A++ + H        
Sbjct: 4   MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRK----EVIIAKDEVAHTVTESRVL 59
Query: 53  KQLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-- 110
           +  RHP +   K    T   L  VMEYA GGELF  +     F+E+ AR++  +++S   
Sbjct: 60  QNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALE 119
Query: 111 -----QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP-KSTVGTPAYIAPEVL 164
                 + +RD+KLEN +LD      +KI DFG  K  +      K   GTP Y+APEVL
Sbjct: 120 YLHSRDVVYRDIKLENLMLDKD--GHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVL 177
Query: 165 SRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQ 224
              +Y G+  D W  GV +Y M+ G  PF +Q+  + F      I+  + + P    +S 
Sbjct: 178 EDNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHERLF----ELILMEEIRFPR--TLSP 230
Query: 225 DCRNLLSRIFVANPSRRI-----TIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTFSL 279
           + ++LL+ +   +P +R+       KE+  H +F       L+   Q +  +K  P F  
Sbjct: 231 EAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFF-------LSINWQDVVQKKLLPPFKP 283
Query: 280 QSVEEI 285
           Q   E+
Sbjct: 284 QVTSEV 289

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score =  126 bits (317), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 93/273 (34%), Positives = 137/273 (50%), Gaps = 25/273 (9%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIER-----GHKIDA----NVAREIINH 52
           ++Y + K +GSG  G  +L   + T + VA+K I +     G   +A    NV  EI   
Sbjct: 10  DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEIL 69
Query: 53  KQLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEAR-YFFQQLISGQ 111
           K+L HP II+ K       +  IV+E   GGELF+++    R  E   + YF+Q L++ Q
Sbjct: 70  KKLNHPCIIKIKNFFDAEDYY-IVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQ 128
Query: 112 ------ICHRDLKLENTLLDGSPAPRL-KICDFGYSKSSLLHSRPKSTVGTPAYIAPEVL 164
                 I HRDLK EN LL       L KI DFG+SK     S  ++  GTP Y+APEVL
Sbjct: 129 YLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVL 188
Query: 165 SRREYDG--KLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYK-IPD-YV 220
                 G  +  D WS GV L++ L G  PF +     + +    +I + +Y  IP+ + 
Sbjct: 189 VSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLK---DQITSGKYNFIPEVWA 245
Query: 221 HISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 253
            +S+   +L+ ++ V +P  R T +E   HPW 
Sbjct: 246 EVSEKALDLVKKLLVVDPKARFTTEEALRHPWL 278

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score =  126 bits (317), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 91/306 (29%), Positives = 146/306 (47%), Gaps = 41/306 (13%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINH-------- 52
           M  ++ +K +G G FG   L+R K T    AMK + +    +  +A++ + H        
Sbjct: 4   MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRK----EVIIAKDEVAHTVTESRVL 59
Query: 53  KQLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-- 110
           +  RHP +   K    T   L  VMEYA GGELF  +     F+E+ AR++  +++S   
Sbjct: 60  QNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALE 119
Query: 111 -----QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH-SRPKSTVGTPAYIAPEVL 164
                 + +RD+KLEN +LD      +KI DFG  K  +   +  K   GTP Y+APEVL
Sbjct: 120 YLHSRDVVYRDIKLENLMLDKD--GHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVL 177
Query: 165 SRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQ 224
              +Y G+  D W  GV +Y M+ G  PF +Q+  + F      I+  + + P    +S 
Sbjct: 178 EDNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHERLF----ELILMEEIRFPR--TLSP 230
Query: 225 DCRNLLSRIFVANPSRRI-----TIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTFSL 279
           + ++LL+ +   +P +R+       KE+  H +F       L+   Q +  +K  P F  
Sbjct: 231 EAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFF-------LSINWQDVVQKKLLPPFKP 283
Query: 280 QSVEEI 285
           Q   E+
Sbjct: 284 QVTSEV 289

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score =  126 bits (317), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 91/306 (29%), Positives = 145/306 (47%), Gaps = 41/306 (13%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINH-------- 52
           M  ++ +K +G G FG   L+R K T    AMK + +    +  +A++ + H        
Sbjct: 9   MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRK----EVIIAKDEVAHTVTESRVL 64
Query: 53  KQLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-- 110
           +  RHP +   K    T   L  VMEYA GGELF  +     F+E+ AR++  +++S   
Sbjct: 65  QNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALE 124
Query: 111 -----QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP-KSTVGTPAYIAPEVL 164
                 + +RD+KLEN +LD      +KI DFG  K  +      K   GTP Y+APEVL
Sbjct: 125 YLHSRDVVYRDIKLENLMLDKD--GHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVL 182
Query: 165 SRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQ 224
              +Y G+  D W  GV +Y M+ G  PF +Q+  + F      I+  + + P    +S 
Sbjct: 183 EDNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHERLF----ELILMEEIRFPR--TLSP 235
Query: 225 DCRNLLSRIFVANPSRRI-----TIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTFSL 279
           + ++LL+ +   +P +R+       KE+  H +F       L+   Q +  +K  P F  
Sbjct: 236 EAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFF-------LSINWQDVVQKKLLPPFKP 288
Query: 280 QSVEEI 285
           Q   E+
Sbjct: 289 QVTSEV 294

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score =  126 bits (317), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 93/273 (34%), Positives = 137/273 (50%), Gaps = 25/273 (9%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIER-----GHKIDA----NVAREIINH 52
           ++Y + K +GSG  G  +L   + T + VA+K I +     G   +A    NV  EI   
Sbjct: 9   DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEIL 68
Query: 53  KQLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEAR-YFFQQLISGQ 111
           K+L HP II+ K       +  IV+E   GGELF+++    R  E   + YF+Q L++ Q
Sbjct: 69  KKLNHPCIIKIKNFFDAEDYY-IVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQ 127
Query: 112 ------ICHRDLKLENTLLDGSPAPRL-KICDFGYSKSSLLHSRPKSTVGTPAYIAPEVL 164
                 I HRDLK EN LL       L KI DFG+SK     S  ++  GTP Y+APEVL
Sbjct: 128 YLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVL 187
Query: 165 SRREYDG--KLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYK-IPD-YV 220
                 G  +  D WS GV L++ L G  PF +     + +    +I + +Y  IP+ + 
Sbjct: 188 VSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLK---DQITSGKYNFIPEVWA 244
Query: 221 HISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 253
            +S+   +L+ ++ V +P  R T +E   HPW 
Sbjct: 245 EVSEKALDLVKKLLVVDPKARFTTEEALRHPWL 277

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score =  126 bits (317), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 93/273 (34%), Positives = 137/273 (50%), Gaps = 25/273 (9%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIER-----GHKIDA----NVAREIINH 52
           ++Y + K +GSG  G  +L   + T + VA+K I +     G   +A    NV  EI   
Sbjct: 10  DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEIL 69
Query: 53  KQLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEAR-YFFQQLISGQ 111
           K+L HP II+ K       +  IV+E   GGELF+++    R  E   + YF+Q L++ Q
Sbjct: 70  KKLNHPCIIKIKNFFDAEDYY-IVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQ 128
Query: 112 ------ICHRDLKLENTLLDGSPAPRL-KICDFGYSKSSLLHSRPKSTVGTPAYIAPEVL 164
                 I HRDLK EN LL       L KI DFG+SK     S  ++  GTP Y+APEVL
Sbjct: 129 YLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVL 188
Query: 165 SRREYDG--KLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYK-IPD-YV 220
                 G  +  D WS GV L++ L G  PF +     + +    +I + +Y  IP+ + 
Sbjct: 189 VSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLK---DQITSGKYNFIPEVWA 245
Query: 221 HISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 253
            +S+   +L+ ++ V +P  R T +E   HPW 
Sbjct: 246 EVSEKALDLVKKLLVVDPKARFTTEEALRHPWL 278

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score =  126 bits (317), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 93/273 (34%), Positives = 137/273 (50%), Gaps = 25/273 (9%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIER-----GHKIDA----NVAREIINH 52
           ++Y + K +GSG  G  +L   + T + VA+K I +     G   +A    NV  EI   
Sbjct: 16  DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEIL 75
Query: 53  KQLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEAR-YFFQQLISGQ 111
           K+L HP II+ K       +  IV+E   GGELF+++    R  E   + YF+Q L++ Q
Sbjct: 76  KKLNHPCIIKIKNFFDAEDYY-IVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQ 134
Query: 112 ------ICHRDLKLENTLLDGSPAPRL-KICDFGYSKSSLLHSRPKSTVGTPAYIAPEVL 164
                 I HRDLK EN LL       L KI DFG+SK     S  ++  GTP Y+APEVL
Sbjct: 135 YLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVL 194
Query: 165 SRREYDG--KLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYK-IPD-YV 220
                 G  +  D WS GV L++ L G  PF +     + +    +I + +Y  IP+ + 
Sbjct: 195 VSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLK---DQITSGKYNFIPEVWA 251
Query: 221 HISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 253
            +S+   +L+ ++ V +P  R T +E   HPW 
Sbjct: 252 EVSEKALDLVKKLLVVDPKARFTTEEALRHPWL 284

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score =  126 bits (317), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 93/273 (34%), Positives = 137/273 (50%), Gaps = 25/273 (9%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIER-----GHKIDA----NVAREIINH 52
           ++Y + K +GSG  G  +L   + T + VA+K I +     G   +A    NV  EI   
Sbjct: 10  DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEIL 69
Query: 53  KQLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEAR-YFFQQLISGQ 111
           K+L HP II+ K       +  IV+E   GGELF+++    R  E   + YF+Q L++ Q
Sbjct: 70  KKLNHPCIIKIKNFFDAEDYY-IVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQ 128
Query: 112 ------ICHRDLKLENTLLDGSPAPRL-KICDFGYSKSSLLHSRPKSTVGTPAYIAPEVL 164
                 I HRDLK EN LL       L KI DFG+SK     S  ++  GTP Y+APEVL
Sbjct: 129 YLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVL 188
Query: 165 SRREYDG--KLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYK-IPD-YV 220
                 G  +  D WS GV L++ L G  PF +     + +    +I + +Y  IP+ + 
Sbjct: 189 VSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLK---DQITSGKYNFIPEVWA 245
Query: 221 HISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 253
            +S+   +L+ ++ V +P  R T +E   HPW 
Sbjct: 246 EVSEKALDLVKKLLVVDPKARFTTEEALRHPWL 278

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score =  126 bits (316), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 84/293 (28%), Positives = 148/293 (50%), Gaps = 34/293 (11%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQL----R 56
           +++++ +K +G+G+FG   L+++K +    AMK +++   +        +N K++     
Sbjct: 40  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYF-------FQQLIS 109
            P +++ +      ++L +VMEY AGGE+F  +   GRFSE  AR++       F+ L S
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 110 GQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREY 169
             + +RDLK EN ++D      +++ DFG++K   +  R     GTP Y+APE++  + Y
Sbjct: 160 LDLIYRDLKPENLIID--QQGYIQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIIISKGY 215
Query: 170 DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 229
           + K  D W+ GV +Y M  G  PF   +  + + K +S     + + P   H S D ++L
Sbjct: 216 N-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG----KVRFPS--HFSSDLKDL 268
Query: 230 LSRIFVANPSRRI-----TIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTF 277
           L  +   + ++R       + +IK+H WF        T    AIY RK    F
Sbjct: 269 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF-------ATTDWIAIYQRKVEAPF 314

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score =  126 bits (316), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 85/293 (29%), Positives = 147/293 (50%), Gaps = 34/293 (11%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQL----R 56
           ++++E +K +G+G+FG   L+++  T    AMK +++   +        +N K++     
Sbjct: 26  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 85
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYF-------FQQLIS 109
            P +++ +      ++L +VMEY  GGE+F  +   GRFSE  AR++       F+ L S
Sbjct: 86  FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 145
Query: 110 GQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREY 169
             + +RDLK EN L+D      +++ DFG++K   +  R  +  GTP Y+APE++  + Y
Sbjct: 146 LDLIYRDLKPENLLIDQQGY--IQVTDFGFAKR--VKGRTWTLCGTPEYLAPEIILSKGY 201
Query: 170 DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 229
           + K  D W+ GV +Y M  G  PF   +  + + K +S     + + P   H S D ++L
Sbjct: 202 N-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG----KVRFPS--HFSSDLKDL 254
Query: 230 LSRIFVANPSRRI-----TIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTF 277
           L  +   + ++R       + +IK+H WF        T    AIY RK    F
Sbjct: 255 LRNLLQVDLTKRFGNLKDGVNDIKNHKWF-------ATTDWIAIYQRKVEAPF 300

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score =  126 bits (316), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 84/293 (28%), Positives = 148/293 (50%), Gaps = 34/293 (11%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQL----R 56
           +++++ +K +G+G+FG   L+++K +    AMK +++   +        +N K++     
Sbjct: 40  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYF-------FQQLIS 109
            P +++ +      ++L +VMEY AGGE+F  +   GRF+E  AR++       F+ L S
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFAEPHARFYAAQIVLTFEYLHS 159
Query: 110 GQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREY 169
             + +RDLK EN L+D      +++ DFG++K   +  R     GTP Y+APE++  + Y
Sbjct: 160 LDLIYRDLKPENLLID--QQGYIQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 170 DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 229
           + K  D W+ GV +Y M  G  PF   +  + + K +S     + + P   H S D ++L
Sbjct: 216 N-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG----KVRFPS--HFSSDLKDL 268
Query: 230 LSRIFVANPSRRI-----TIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTF 277
           L  +   + ++R       + +IK+H WF        T    AIY RK    F
Sbjct: 269 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF-------ATTDWIAIYQRKVEAPF 314

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score =  126 bits (316), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 85/293 (29%), Positives = 147/293 (50%), Gaps = 34/293 (11%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQL----R 56
           ++++E +K +G+G+FG   L+++  T    AMK +++   +        +N K++     
Sbjct: 41  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 100
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYF-------FQQLIS 109
            P +++ +      ++L +VMEY  GGE+F  +   GRFSE  AR++       F+ L S
Sbjct: 101 FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 160
Query: 110 GQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREY 169
             + +RDLK EN L+D      +++ DFG++K   +  R  +  GTP Y+APE++  + Y
Sbjct: 161 LDLIYRDLKPENLLID--QQGYIQVTDFGFAKR--VKGRTWTLCGTPEYLAPEIILSKGY 216
Query: 170 DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 229
           + K  D W+ GV +Y M  G  PF   +  + + K +S     + + P   H S D ++L
Sbjct: 217 N-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG----KVRFPS--HFSSDLKDL 269
Query: 230 LSRIFVANPSRRI-----TIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTF 277
           L  +   + ++R       + +IK+H WF        T    AIY RK    F
Sbjct: 270 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF-------ATTDWIAIYQRKVEAPF 315

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score =  126 bits (316), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 86/293 (29%), Positives = 146/293 (49%), Gaps = 34/293 (11%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQL----R 56
           ++++E +K IG+G+FG   L+++  T    AMK +++   +        +N K++     
Sbjct: 40  LDQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYF-------FQQLIS 109
            P +++ +      ++L +VMEY  GG++F  +   GRFSE  AR++       F+ L S
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 110 GQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREY 169
             + +RDLK EN L+D      +K+ DFG++K   +  R     GTP Y+APE++  + Y
Sbjct: 160 LDLIYRDLKPENLLID--QQGYIKVADFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 170 DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 229
           + K  D W+ GV +Y M  G  PF   +  + + K +S     + + P   H S D ++L
Sbjct: 216 N-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG----KVRFPS--HFSSDLKDL 268
Query: 230 LSRIFVANPSRRI-----TIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTF 277
           L  +   + ++R       + +IK+H WF        T    AIY RK    F
Sbjct: 269 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF-------ATTDWIAIYQRKVEAPF 314

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score =  126 bits (316), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 85/293 (29%), Positives = 147/293 (50%), Gaps = 34/293 (11%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQL----R 56
           ++++E +K +G+G+FG   L+++  T    AMK +++   +        +N K++     
Sbjct: 40  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYF-------FQQLIS 109
            P +++ +      ++L +VMEYA GGE+F  +   GRFSE  AR++       F+ L S
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 110 GQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREY 169
             + +RDLK EN ++D      +++ DFG++K   +  R     GTP Y+APE++  + Y
Sbjct: 160 LDLIYRDLKPENLMID--QQGYIQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 170 DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 229
           + K  D W+ GV +Y M  G  PF   +  + + K +S     + + P   H S D ++L
Sbjct: 216 N-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG----KVRFPS--HFSSDLKDL 268
Query: 230 LSRIFVANPSRRI-----TIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTF 277
           L  +   + ++R       + +IK+H WF        T    AIY RK    F
Sbjct: 269 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF-------ATTDWIAIYQRKVEAPF 314

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score =  126 bits (316), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 81/255 (31%), Positives = 126/255 (49%), Gaps = 16/255 (6%)
Query: 10  IGSGNFGVARLMRNKNTKELVAMKYIE-RGHKIDANVAREIINHKQLRHPNIIRFKEVVL 68
           +G G FG         T   +A K I+ RG K    V  EI    QL H N+I+  +   
Sbjct: 97  LGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFE 156
Query: 69  TPTHLAIVMEYAAGGELFERICNAG-RFSEDEARYFFQQLISG-------QICHRDLKLE 120
           +   + +VMEY  GGELF+RI +     +E +   F +Q+  G        I H DLK E
Sbjct: 157 SKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPE 216
Query: 121 NTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCG 180
           N L     A ++KI DFG ++      + K   GTP ++APEV++  ++     D+WS G
Sbjct: 217 NILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAPEVVN-YDFVSFPTDMWSVG 275
Query: 181 VTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPD--YVHISQDCRNLLSRIFVANP 238
           V  Y++L G  PF    D     +T++ I+A ++ + D  +  IS++ +  +S++ +   
Sbjct: 276 VIAYMLLSGLSPFLGDNDA----ETLNNILACRWDLEDEEFQDISEEAKEFISKLLIKEK 331
Query: 239 SRRITIKEIKSHPWF 253
           S RI+  E   HPW 
Sbjct: 332 SWRISASEALKHPWL 346

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score =  125 bits (315), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 86/293 (29%), Positives = 146/293 (49%), Gaps = 34/293 (11%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQL----R 56
           ++++E +K IG+G+FG   L+++  T    AMK +++   +        +N K++     
Sbjct: 40  LDQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYF-------FQQLIS 109
            P +++ +      ++L +VMEY  GG++F  +   GRFSE  AR++       F+ L S
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 110 GQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREY 169
             + +RDLK EN L+D      +K+ DFG++K   +  R     GTP Y+APE++  + Y
Sbjct: 160 LDLIYRDLKPENLLID--QQGYIKVADFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 170 DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 229
           + K  D W+ GV +Y M  G  PF   +  + + K +S     + + P   H S D ++L
Sbjct: 216 N-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG----KVRFPS--HFSSDLKDL 268
Query: 230 LSRIFVANPSRRI-----TIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTF 277
           L  +   + ++R       + +IK+H WF        T    AIY RK    F
Sbjct: 269 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF-------ATTDWIAIYQRKVEAPF 314

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score =  125 bits (315), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 86/293 (29%), Positives = 146/293 (49%), Gaps = 34/293 (11%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQL----R 56
           ++++E +K +G+G+FG   L+++  T    AMK +++   +        +N K++     
Sbjct: 41  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 100
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYF-------FQQLIS 109
            P + + +      ++L +VMEYA GGE+F  +   GRFSE  AR++       F+ L S
Sbjct: 101 FPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 160
Query: 110 GQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREY 169
             + +RDLK EN ++D      +K+ DFG++K   +  R     GTP Y+APE++  + Y
Sbjct: 161 LDLIYRDLKPENLMID--QQGYIKVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGY 216
Query: 170 DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 229
           + K  D W+ GV +Y M  G  PF   +  + + K +S     + + P   H S D ++L
Sbjct: 217 N-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG----KVRFPS--HFSSDLKDL 269
Query: 230 LSRIFVANPSRRI-----TIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTF 277
           L  +   + ++R       + +IK+H WF        T    AIY RK    F
Sbjct: 270 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF-------ATTDWIAIYQRKVEAPF 315

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score =  125 bits (315), Expect = 3e-29,   Method: Compositional matrix adjust.
 Identities = 86/293 (29%), Positives = 146/293 (49%), Gaps = 34/293 (11%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQL----R 56
           ++++E +K +G+G+FG   L+++  T    AMK +++   +        +N K++     
Sbjct: 41  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 100
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYF-------FQQLIS 109
            P + + +      ++L +VMEYA GGE+F  +   GRFSE  AR++       F+ L S
Sbjct: 101 FPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 160
Query: 110 GQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREY 169
             + +RDLK EN ++D      +K+ DFG++K   +  R     GTP Y+APE++  + Y
Sbjct: 161 LDLIYRDLKPENLMID--QQGYIKVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGY 216
Query: 170 DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 229
           + K  D W+ GV +Y M  G  PF   +  + + K +S     + + P   H S D ++L
Sbjct: 217 N-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG----KVRFPS--HFSSDLKDL 269
Query: 230 LSRIFVANPSRRI-----TIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTF 277
           L  +   + ++R       + +IK+H WF        T    AIY RK    F
Sbjct: 270 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF-------ATTDWIAIYQRKVEAPF 315

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score =  125 bits (315), Expect = 3e-29,   Method: Compositional matrix adjust.
 Identities = 85/293 (29%), Positives = 146/293 (49%), Gaps = 34/293 (11%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQL----R 56
           ++++E +K +G+G+FG   L+++K T    AMK +++   +        +N K++     
Sbjct: 33  LDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 92
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYF-------FQQLIS 109
            P +++ +      ++L +VMEY  GGE+F  +   GRF E  AR++       F+ L S
Sbjct: 93  FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHS 152
Query: 110 GQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREY 169
             + +RDLK EN L+D      +++ DFG++K   +  R     GTP Y+APE++  + Y
Sbjct: 153 LDLIYRDLKPENLLIDQQGY--IQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGY 208
Query: 170 DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 229
           + K  D W+ GV +Y M  G  PF   +  + + K +S     + + P   H S D ++L
Sbjct: 209 N-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG----KVRFPS--HFSSDLKDL 261
Query: 230 LSRIFVANPSRRI-----TIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTF 277
           L  +   + ++R       + +IK+H WF        T    AIY RK    F
Sbjct: 262 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF-------ATTDWIAIYQRKVEAPF 307

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score =  125 bits (315), Expect = 3e-29,   Method: Compositional matrix adjust.
 Identities = 85/293 (29%), Positives = 146/293 (49%), Gaps = 34/293 (11%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQL----R 56
           ++++E +K +G+G+FG   L+++K T    AMK +++   +        +N K++     
Sbjct: 41  LDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 100
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYF-------FQQLIS 109
            P +++ +      ++L +VMEY  GGE+F  +   GRFSE  AR++       F+ L S
Sbjct: 101 FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 160
Query: 110 GQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREY 169
             + +RDLK EN L+D      +++ DFG++K   +  R     GTP Y+APE++  + Y
Sbjct: 161 LDLIYRDLKPENLLID--QQGYIQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGY 216
Query: 170 DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 229
           + K  D W+ GV +Y M  G  PF   +  + + K +S     + + P   H S D ++L
Sbjct: 217 N-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG----KVRFPS--HFSSDLKDL 269
Query: 230 LSRIFVANPSRRI-----TIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTF 277
           L  +   + ++R       + +I +H WF        T    AIY RK    F
Sbjct: 270 LRNLLQVDLTKRFGNLKNGVNDIXNHKWF-------ATTDWIAIYQRKVEAPF 315

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score =  125 bits (314), Expect = 3e-29,   Method: Compositional matrix adjust.
 Identities = 84/293 (28%), Positives = 147/293 (50%), Gaps = 34/293 (11%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQL----R 56
           +++++ +K +G+G+FG   L+++K +    AMK +++   +        +N K++     
Sbjct: 61  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 120
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYF-------FQQLIS 109
            P +++ +      ++L +VMEY AGGE+F  +   GRF E  AR++       F+ L S
Sbjct: 121 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHS 180
Query: 110 GQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREY 169
             + +RDLK EN L+D      +++ DFG++K   +  R     GTP Y+APE++  + Y
Sbjct: 181 LDLIYRDLKPENLLID--QQGYIQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGY 236
Query: 170 DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 229
           + K  D W+ GV +Y M  G  PF   +  + + K +S     + + P   H S D ++L
Sbjct: 237 N-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG----KVRFPS--HFSSDLKDL 289
Query: 230 LSRIFVANPSRRI-----TIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTF 277
           L  +   + ++R       + +IK+H WF        T    AIY RK    F
Sbjct: 290 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF-------ATTDWIAIYQRKVEAPF 335

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score =  125 bits (314), Expect = 3e-29,   Method: Compositional matrix adjust.
 Identities = 85/293 (29%), Positives = 146/293 (49%), Gaps = 34/293 (11%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQL----R 56
           ++++E +K +G+G+FG   L+++  T    AMK +++   +        +N K++     
Sbjct: 40  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYF-------FQQLIS 109
            P +++ +      ++L +VMEYA GGE+F  +   GRF E  AR++       F+ L S
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHS 159
Query: 110 GQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREY 169
             + +RDLK EN ++D      +K+ DFG++K   +  R     GTP Y+APE++  + Y
Sbjct: 160 LDLIYRDLKPENLMID--QQGYIKVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 170 DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 229
           + K  D W+ GV +Y M  G  PF   +  + + K +S     + + P   H S D ++L
Sbjct: 216 N-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG----KVRFPS--HFSSDLKDL 268
Query: 230 LSRIFVANPSRRI-----TIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTF 277
           L  +   + ++R       + +IK+H WF        T    AIY RK    F
Sbjct: 269 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF-------ATTDWIAIYQRKVEAPF 314

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score =  125 bits (314), Expect = 3e-29,   Method: Compositional matrix adjust.
 Identities = 84/293 (28%), Positives = 148/293 (50%), Gaps = 34/293 (11%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQL----R 56
           +++++ +K +G+G+FG   L+++K +    AMK +++   +        +N K++     
Sbjct: 61  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 120
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYF-------FQQLIS 109
            P +++ +      ++L +VMEY AGGE+F  +   GRFSE  AR++       F+ L S
Sbjct: 121 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 180
Query: 110 GQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREY 169
             + +RDLK EN L+D      +++ DFG++K   +     +  GTP Y+APE++  + Y
Sbjct: 181 LDLIYRDLKPENLLID--QQGYIQVTDFGFAKR--VKGATWTLCGTPEYLAPEIILSKGY 236
Query: 170 DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 229
           + K  D W+ GV +Y M  G  PF   +  + + K +S     + + P   H S D ++L
Sbjct: 237 N-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG----KVRFPS--HFSSDLKDL 289
Query: 230 LSRIFVANPSRRI-----TIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTF 277
           L  +   + ++R       + +IK+H WF        T    AIY RK    F
Sbjct: 290 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF-------ATTDWIAIYQRKVEAPF 335

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score =  125 bits (314), Expect = 3e-29,   Method: Compositional matrix adjust.
 Identities = 84/293 (28%), Positives = 147/293 (50%), Gaps = 34/293 (11%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQL----R 56
           +++++ +K +G+G+FG   L+++K +    AMK +++   +        +N K++     
Sbjct: 40  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYF-------FQQLIS 109
            P +++ +      ++L +VMEY AGGE+F  +   GRF E  AR++       F+ L S
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHS 159
Query: 110 GQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREY 169
             + +RDLK EN L+D      +++ DFG++K   +  R     GTP Y+APE++  + Y
Sbjct: 160 LDLIYRDLKPENLLID--QQGYIQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 170 DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 229
           + K  D W+ GV +Y M  G  PF   +  + + K +S     + + P   H S D ++L
Sbjct: 216 N-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG----KVRFPS--HFSSDLKDL 268
Query: 230 LSRIFVANPSRRI-----TIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTF 277
           L  +   + ++R       + +IK+H WF        T    AIY RK    F
Sbjct: 269 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF-------ATTDWIAIYQRKVEAPF 314

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score =  125 bits (314), Expect = 4e-29,   Method: Compositional matrix adjust.
 Identities = 86/293 (29%), Positives = 146/293 (49%), Gaps = 34/293 (11%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQL----R 56
           ++++E +K +G+G+FG   L+++  T    AMK +++   +        +N K++     
Sbjct: 40  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVN 99
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYF-------FQQLIS 109
            P +++ +      ++L +VMEYA GGE+F  +   GRFSE  AR++       F+ L S
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 110 GQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREY 169
             + +RDLK EN ++D      +K+ DFG +K   +  R     GTP Y+APE++  + Y
Sbjct: 160 LDLIYRDLKPENLMID--QQGYIKVTDFGLAKR--VKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 170 DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 229
           + K  D W+ GV +Y M  G  PF   +  + + K +S     + + P   H S D ++L
Sbjct: 216 N-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG----KVRFPS--HFSSDLKDL 268
Query: 230 LSRIFVANPSRRI-----TIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTF 277
           L  +   + ++R       + +IK+H WF        T    AIY RK    F
Sbjct: 269 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF-------ATTDWIAIYQRKVEAPF 314

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score =  125 bits (314), Expect = 4e-29,   Method: Compositional matrix adjust.
 Identities = 84/293 (28%), Positives = 147/293 (50%), Gaps = 34/293 (11%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQL----R 56
           +++++ +K +G+G+FG   L+++K +    AMK +++   +        +N K++     
Sbjct: 35  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 94
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYF-------FQQLIS 109
            P +++ +      ++L +VMEY AGGE+F  +   GRF E  AR++       F+ L S
Sbjct: 95  FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHS 154
Query: 110 GQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREY 169
             + +RDLK EN L+D      +++ DFG++K   +  R     GTP Y+APE++  + Y
Sbjct: 155 LDLIYRDLKPENLLID--QQGYIQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGY 210
Query: 170 DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 229
           + K  D W+ GV +Y M  G  PF   +  + + K +S     + + P   H S D ++L
Sbjct: 211 N-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG----KVRFPS--HFSSDLKDL 263
Query: 230 LSRIFVANPSRRI-----TIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTF 277
           L  +   + ++R       + +IK+H WF        T    AIY RK    F
Sbjct: 264 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF-------ATTDWIAIYQRKVEAPF 309

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score =  125 bits (314), Expect = 4e-29,   Method: Compositional matrix adjust.
 Identities = 85/293 (29%), Positives = 146/293 (49%), Gaps = 34/293 (11%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQL----R 56
           ++++E +K +G+G+FG   L+++  T    AMK +++   +        +N K++     
Sbjct: 40  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYF-------FQQLIS 109
            P +++ +      ++L +VMEY  GGE+F  +   GRFSE  AR++       F+ L S
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 110 GQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREY 169
             + +RDLK EN L+D      +++ DFG++K   +  R     GTP Y+APE++  + Y
Sbjct: 160 LDLIYRDLKPENLLID--QQGYIQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 170 DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 229
           + K  D W+ GV +Y M  G  PF   +  + + K +S     + + P   H S D ++L
Sbjct: 216 N-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG----KVRFPS--HFSSDLKDL 268
Query: 230 LSRIFVANPSRRI-----TIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTF 277
           L  +   + ++R       + +IK+H WF        T    AIY RK    F
Sbjct: 269 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF-------ATTDWIAIYQRKVEAPF 314

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  125 bits (314), Expect = 4e-29,   Method: Compositional matrix adjust.
 Identities = 84/293 (28%), Positives = 147/293 (50%), Gaps = 34/293 (11%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQL----R 56
           +++++ +K +G+G+FG   L+++K +    AMK +++   +        +N K++     
Sbjct: 40  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYF-------FQQLIS 109
            P +++ +      ++L +VMEY AGGE+F  +   GRF E  AR++       F+ L S
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHS 159
Query: 110 GQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREY 169
             + +RDLK EN L+D      +++ DFG++K   +  R     GTP Y+APE++  + Y
Sbjct: 160 LDLIYRDLKPENLLID--QQGYIQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 170 DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 229
           + K  D W+ GV +Y M  G  PF   +  + + K +S     + + P   H S D ++L
Sbjct: 216 N-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG----KVRFPS--HFSSDLKDL 268
Query: 230 LSRIFVANPSRRI-----TIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTF 277
           L  +   + ++R       + +IK+H WF        T    AIY RK    F
Sbjct: 269 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF-------ATTDWIAIYQRKVEAPF 314

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score =  125 bits (314), Expect = 4e-29,   Method: Compositional matrix adjust.
 Identities = 85/293 (29%), Positives = 146/293 (49%), Gaps = 34/293 (11%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQL----R 56
           ++++E +K +G+G+FG   L+++  T    AMK +++   +        +N K++     
Sbjct: 41  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 100
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYF-------FQQLIS 109
            P +++ +      ++L +VMEY  GGE+F  +   GRFSE  AR++       F+ L S
Sbjct: 101 FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 160
Query: 110 GQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREY 169
             + +RDLK EN L+D      +++ DFG++K   +  R     GTP Y+APE++  + Y
Sbjct: 161 LDLIYRDLKPENLLID--QQGYIQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGY 216
Query: 170 DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 229
           + K  D W+ GV +Y M  G  PF   +  + + K +S     + + P   H S D ++L
Sbjct: 217 N-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG----KVRFPS--HFSSDLKDL 269
Query: 230 LSRIFVANPSRRI-----TIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTF 277
           L  +   + ++R       + +IK+H WF        T    AIY RK    F
Sbjct: 270 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF-------ATTDWIAIYQRKVEAPF 315

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score =  125 bits (313), Expect = 4e-29,   Method: Compositional matrix adjust.
 Identities = 85/293 (29%), Positives = 146/293 (49%), Gaps = 34/293 (11%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQL----R 56
           ++++E +K +G+G+FG   L+++  T    AMK +++   +        +N K++     
Sbjct: 40  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYF-------FQQLIS 109
            P +++ +      ++L +VMEY  GGE+F  +   GRFSE  AR++       F+ L S
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 110 GQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREY 169
             + +RDLK EN L+D      +++ DFG++K   +  R     GTP Y+APE++  + Y
Sbjct: 160 LDLIYRDLKPENLLID--QQGYIQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 170 DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 229
           + K  D W+ GV +Y M  G  PF   +  + + K +S     + + P   H S D ++L
Sbjct: 216 N-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG----KVRFPS--HFSSDLKDL 268
Query: 230 LSRIFVANPSRRI-----TIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTF 277
           L  +   + ++R       + +IK+H WF        T    AIY RK    F
Sbjct: 269 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF-------ATTDWIAIYQRKVEAPF 314

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score =  125 bits (313), Expect = 4e-29,   Method: Compositional matrix adjust.
 Identities = 85/293 (29%), Positives = 146/293 (49%), Gaps = 34/293 (11%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQL----R 56
           ++++E +K +G+G+FG   L+++  T    AMK +++   +        +N K++     
Sbjct: 40  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYF-------FQQLIS 109
            P +++ +      ++L +VMEY  GGE+F  +   GRFSE  AR++       F+ L S
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 110 GQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREY 169
             + +RDLK EN L+D      +++ DFG++K   +  R     GTP Y+APE++  + Y
Sbjct: 160 LDLIYRDLKPENLLID--QQGYIQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 170 DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 229
           + K  D W+ GV +Y M  G  PF   +  + + K +S     + + P   H S D ++L
Sbjct: 216 N-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG----KVRFPS--HFSSDLKDL 268
Query: 230 LSRIFVANPSRRI-----TIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTF 277
           L  +   + ++R       + +IK+H WF        T    AIY RK    F
Sbjct: 269 LRNLLQVDLTKRFGNLKDGVNDIKNHKWF-------ATTDWIAIYQRKVEAPF 314

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score =  125 bits (313), Expect = 4e-29,   Method: Compositional matrix adjust.
 Identities = 84/293 (28%), Positives = 147/293 (50%), Gaps = 34/293 (11%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQL----R 56
           +++++ +K +G+G+FG   L+++K +    AMK +++   +        +N K++     
Sbjct: 40  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYF-------FQQLIS 109
            P +++ +      ++L +VMEY AGGE+F  +   GRF E  AR++       F+ L S
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHS 159
Query: 110 GQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREY 169
             + +RDLK EN L+D      +++ DFG++K   +  R     GTP Y+APE++  + Y
Sbjct: 160 LDLIYRDLKPENLLID--QQGYIQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 170 DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 229
           + K  D W+ GV +Y M  G  PF   +  + + K +S     + + P   H S D ++L
Sbjct: 216 N-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG----KVRFPS--HFSSDLKDL 268
Query: 230 LSRIFVANPSRRI-----TIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTF 277
           L  +   + ++R       + +IK+H WF        T    AIY RK    F
Sbjct: 269 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF-------ATTDWIAIYQRKVEAPF 314

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  125 bits (313), Expect = 5e-29,   Method: Compositional matrix adjust.
 Identities = 84/293 (28%), Positives = 147/293 (50%), Gaps = 34/293 (11%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQL----R 56
           +++++ +K +G+G+FG   L+++K +    AMK +++   +        +N K++     
Sbjct: 40  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYF-------FQQLIS 109
            P +++ +      ++L +VMEY AGGE+F  +   GRFSE  AR++       F+ L S
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 110 GQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREY 169
             + +RDLK EN L+D      +++ DFG++K   +  R     GTP Y+AP ++  + Y
Sbjct: 160 LDLIYRDLKPENLLID--QQGYIQVTDFGFAKR--VKGRTWXLCGTPEYLAPAIILSKGY 215
Query: 170 DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 229
           + K  D W+ GV +Y M  G  PF   +  + + K +S     + + P   H S D ++L
Sbjct: 216 N-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG----KVRFPS--HFSSDLKDL 268
Query: 230 LSRIFVANPSRRI-----TIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTF 277
           L  +   + ++R       + +IK+H WF        T    AIY RK    F
Sbjct: 269 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF-------ATTDWIAIYQRKVEAPF 314

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  124 bits (312), Expect = 6e-29,   Method: Compositional matrix adjust.
 Identities = 84/293 (28%), Positives = 147/293 (50%), Gaps = 34/293 (11%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQL----R 56
           +++++ +K +G+G+FG   L+++K +    AMK +++   +        +N K++     
Sbjct: 40  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYF-------FQQLIS 109
            P +++ +      ++L +VMEY AGGE+F  +   GRFSE  AR++       F+ L S
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 110 GQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREY 169
             + +RDLK EN L+D      +++ DFG++K   +  R     GTP Y+APE++  + Y
Sbjct: 160 LDLIYRDLKPENLLID--QQGYIQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 170 DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 229
           + K  D W+ GV +Y M  G  PF   +  + + K +S     + + P   H S D ++L
Sbjct: 216 N-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG----KVRFPS--HFSSDLKDL 268
Query: 230 LSRIFVANPSRRI-----TIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTF 277
           L  +   + ++        + +IK+H WF        T    AIY RK    F
Sbjct: 269 LRNLLQVDLTKAFGNLKNGVNDIKNHKWF-------ATTDWIAIYQRKVEAPF 314

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score =  124 bits (312), Expect = 6e-29,   Method: Compositional matrix adjust.
 Identities = 96/312 (30%), Positives = 159/312 (50%), Gaps = 39/312 (12%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNII 61
           + Y + + IG G++   +   +K T    A+K I++  +  +     ++ + Q  HPNII
Sbjct: 27  DGYVVKETIGVGSYSECKRCVHKATNMEYAVKVIDKSKRDPSEEIEILLRYGQ--HPNII 84
Query: 62  RFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFF-------QQLISGQICH 114
             K+V     H+ +V E   GGEL ++I     FSE EA +         + L S  + H
Sbjct: 85  TLKDVYDDGKHVYLVTELMRGGELLDKILRQKFFSEREASFVLHTIGKTVEYLHSQGVVH 144
Query: 115 RDLKLENTL-LDGSPAPR-LKICDFGYSKSSLLHSRPKSTVGTPAY----IAPEVLSRRE 168
           RDLK  N L +D S  P  L+ICDFG++K   L +     + TP Y    +APEVL R+ 
Sbjct: 145 RDLKPSNILYVDESGNPECLRICDFGFAKQ--LRAE-NGLLMTPCYTANFVAPEVLKRQG 201
Query: 169 YDGKLADVWSCGVTLYVMLVGAYPFED--QEDPKNFRKTISRIMAVQYKIP--DYVHISQ 224
           YD +  D+WS G+ LY ML G  PF +   + P+     ++RI + ++ +   ++  +S+
Sbjct: 202 YD-EGCDIWSLGILLYTMLAGYTPFANGPSDTPEEI---LTRIGSGKFTLSGGNWNTVSE 257
Query: 225 DCRNLLSRIFVANPSRRITIKEIKSHPWFLK--NLPR--------ELTETAQAIYYRKEN 274
             ++L+S++   +P +R+T K++  HPW  +   LP+        +L + A A  Y   N
Sbjct: 258 TAKDLVSKMLHVDPHQRLTAKQVLQHPWVTQKDKLPQSQLSHQDLQLVKGAMAATYSALN 317
Query: 275 ---PTFSLQSVE 283
              PT  L+ +E
Sbjct: 318 SSKPTPQLKPIE 329

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score =  124 bits (311), Expect = 7e-29,   Method: Compositional matrix adjust.
 Identities = 96/312 (30%), Positives = 159/312 (50%), Gaps = 39/312 (12%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNII 61
           + Y + + IG G++   +   +K T    A+K I++  +  +     ++ + Q  HPNII
Sbjct: 27  DGYVVKETIGVGSYSECKRCVHKATNMEYAVKVIDKSKRDPSEEIEILLRYGQ--HPNII 84
Query: 62  RFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFF-------QQLISGQICH 114
             K+V     H+ +V E   GGEL ++I     FSE EA +         + L S  + H
Sbjct: 85  TLKDVYDDGKHVYLVTELMRGGELLDKILRQKFFSEREASFVLHTIGKTVEYLHSQGVVH 144
Query: 115 RDLKLENTL-LDGSPAPR-LKICDFGYSKSSLLHSRPKSTVGTPAY----IAPEVLSRRE 168
           RDLK  N L +D S  P  L+ICDFG++K   L +     + TP Y    +APEVL R+ 
Sbjct: 145 RDLKPSNILYVDESGNPECLRICDFGFAKQ--LRAE-NGLLMTPCYTANFVAPEVLKRQG 201
Query: 169 YDGKLADVWSCGVTLYVMLVGAYPFED--QEDPKNFRKTISRIMAVQYKIP--DYVHISQ 224
           YD +  D+WS G+ LY ML G  PF +   + P+     ++RI + ++ +   ++  +S+
Sbjct: 202 YD-EGCDIWSLGILLYTMLAGYTPFANGPSDTPEEI---LTRIGSGKFTLSGGNWNTVSE 257
Query: 225 DCRNLLSRIFVANPSRRITIKEIKSHPWFLK--NLPR--------ELTETAQAIYYRKEN 274
             ++L+S++   +P +R+T K++  HPW  +   LP+        +L + A A  Y   N
Sbjct: 258 TAKDLVSKMLHVDPHQRLTAKQVLQHPWVTQKDKLPQSQLSHQDLQLVKGAMAATYSALN 317
Query: 275 ---PTFSLQSVE 283
              PT  L+ +E
Sbjct: 318 SSKPTPQLKPIE 329

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score =  124 bits (311), Expect = 8e-29,   Method: Compositional matrix adjust.
 Identities = 85/293 (29%), Positives = 145/293 (49%), Gaps = 34/293 (11%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQL----R 56
           ++++E +K +G+G+FG   L+++  T    AMK +++   +        +N K++     
Sbjct: 41  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 100
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYF-------FQQLIS 109
            P + + +      ++L +VMEYA GGE+F  +   GRF E  AR++       F+ L S
Sbjct: 101 FPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHS 160
Query: 110 GQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREY 169
             + +RDLK EN ++D      +K+ DFG++K   +  R     GTP Y+APE++  + Y
Sbjct: 161 LDLIYRDLKPENLMID--QQGYIKVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGY 216
Query: 170 DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 229
           + K  D W+ GV +Y M  G  PF   +  + + K +S     + + P   H S D ++L
Sbjct: 217 N-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG----KVRFPS--HFSSDLKDL 269
Query: 230 LSRIFVANPSRRI-----TIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTF 277
           L  +   + ++R       + +IK+H WF        T    AIY RK    F
Sbjct: 270 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF-------ATTDWIAIYQRKVEAPF 315

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score =  124 bits (311), Expect = 9e-29,   Method: Compositional matrix adjust.
 Identities = 85/293 (29%), Positives = 146/293 (49%), Gaps = 34/293 (11%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQL----R 56
           ++++E +K +G+G+FG   L+++  T    AMK +++   +        +N K++     
Sbjct: 40  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVN 99
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYF-------FQQLIS 109
            P +++ +      ++L +VMEYA GGE+F  +   GRFSE  AR++       F+ L S
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 110 GQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREY 169
             + +RDLK EN ++D      +++ DFG +K   +  R     GTP Y+APE++  + Y
Sbjct: 160 LDLIYRDLKPENLMID--QQGYIQVTDFGLAKR--VKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 170 DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 229
           + K  D W+ GV +Y M  G  PF   +  + + K +S     + + P   H S D ++L
Sbjct: 216 N-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG----KVRFPS--HFSSDLKDL 268
Query: 230 LSRIFVANPSRRI-----TIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTF 277
           L  +   + ++R       + +IK+H WF        T    AIY RK    F
Sbjct: 269 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF-------ATTDWIAIYQRKVEAPF 314

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  124 bits (310), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 84/293 (28%), Positives = 147/293 (50%), Gaps = 34/293 (11%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQL----R 56
           +++++ +K +G+G+FG   L+++K +    AMK +++   +        +N K++     
Sbjct: 40  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYF-------FQQLIS 109
            P +++ +      ++L +VMEY AGGE+F  +   GRFSE  AR++       F+ L S
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 110 GQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREY 169
             + +RDLK EN L+D      +++ DFG++K   +  R     GTP  +APE++  + Y
Sbjct: 160 LDLIYRDLKPENLLID--QQGYIQVTDFGFAKR--VKGRTWXLCGTPEALAPEIILSKGY 215
Query: 170 DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 229
           + K  D W+ GV +Y M  G  PF   +  + + K +S     + + P   H S D ++L
Sbjct: 216 N-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG----KVRFPS--HFSSDLKDL 268
Query: 230 LSRIFVANPSRRI-----TIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTF 277
           L  +   + ++R       + +IK+H WF        T    AIY RK    F
Sbjct: 269 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF-------ATTDWIAIYQRKVEAPF 314

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score =  124 bits (310), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 92/273 (33%), Positives = 137/273 (50%), Gaps = 25/273 (9%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIER-----GHKIDA----NVAREIINH 52
           ++Y + K +GSG  G  +L   + T + VA++ I +     G   +A    NV  EI   
Sbjct: 149 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEIL 208
Query: 53  KQLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEAR-YFFQQLISGQ 111
           K+L HP II+ K       +  IV+E   GGELF+++    R  E   + YF+Q L++ Q
Sbjct: 209 KKLNHPCIIKIKNFFDAEDYY-IVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQ 267
Query: 112 ------ICHRDLKLENTLLDGSPAPRL-KICDFGYSKSSLLHSRPKSTVGTPAYIAPEVL 164
                 I HRDLK EN LL       L KI DFG+SK     S  ++  GTP Y+APEVL
Sbjct: 268 YLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVL 327
Query: 165 SRREYDG--KLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYK-IPD-YV 220
                 G  +  D WS GV L++ L G  PF +     + +    +I + +Y  IP+ + 
Sbjct: 328 VSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLK---DQITSGKYNFIPEVWA 384
Query: 221 HISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 253
            +S+   +L+ ++ V +P  R T +E   HPW 
Sbjct: 385 EVSEKALDLVKKLLVVDPKARFTTEEALRHPWL 417

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score =  124 bits (310), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 92/273 (33%), Positives = 137/273 (50%), Gaps = 25/273 (9%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIER-----GHKIDA----NVAREIINH 52
           ++Y + K +GSG  G  +L   + T + VA++ I +     G   +A    NV  EI   
Sbjct: 135 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEIL 194
Query: 53  KQLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEAR-YFFQQLISGQ 111
           K+L HP II+ K       +  IV+E   GGELF+++    R  E   + YF+Q L++ Q
Sbjct: 195 KKLNHPCIIKIKNFFDAEDYY-IVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQ 253
Query: 112 ------ICHRDLKLENTLLDGSPAPRL-KICDFGYSKSSLLHSRPKSTVGTPAYIAPEVL 164
                 I HRDLK EN LL       L KI DFG+SK     S  ++  GTP Y+APEVL
Sbjct: 254 YLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVL 313
Query: 165 SRREYDG--KLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYK-IPD-YV 220
                 G  +  D WS GV L++ L G  PF +     + +    +I + +Y  IP+ + 
Sbjct: 314 VSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLK---DQITSGKYNFIPEVWA 370
Query: 221 HISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 253
            +S+   +L+ ++ V +P  R T +E   HPW 
Sbjct: 371 EVSEKALDLVKKLLVVDPKARFTTEEALRHPWL 403

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score =  123 bits (309), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 84/293 (28%), Positives = 145/293 (49%), Gaps = 34/293 (11%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQL----R 56
           ++++E +K +G+G+FG   L+++  T    AMK +++   +        +N K++     
Sbjct: 40  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYF-------FQQLIS 109
            P +++ +      ++L +VMEY  GGE+F  +   GRF E  AR++       F+ L S
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHS 159
Query: 110 GQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREY 169
             + +RDLK EN L+D      +++ DFG++K   +  R     GTP Y+APE++  + Y
Sbjct: 160 LDLIYRDLKPENLLID--QQGYIQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 170 DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 229
           + K  D W+ GV +Y M  G  PF   +  + + K +S     + + P   H S D ++L
Sbjct: 216 N-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG----KVRFPS--HFSSDLKDL 268
Query: 230 LSRIFVANPSRRI-----TIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTF 277
           L  +   + ++R       + +IK+H WF        T    AIY RK    F
Sbjct: 269 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF-------ATTDWIAIYQRKVEAPF 314

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score =  123 bits (309), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 80/271 (29%), Positives = 147/271 (54%), Gaps = 32/271 (11%)
Query: 4   YELMKDIGSGNFGVARLMRN---KNTKELVAMKYIERG-----HKIDANVAREIINHKQL 55
           +EL+K +G G+FG   L+R     ++  L AMK +++       ++   + R+I+    +
Sbjct: 30  FELLKVLGQGSFGKVFLVRKVTRPDSGHLYAMKVLKKATLKVRDRVRTKMERDIL--ADV 87
Query: 56  RHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG----- 110
            HP +++      T   L +++++  GG+LF R+     F+E++ +++  +L  G     
Sbjct: 88  NHPFVVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALGLDHLH 147
Query: 111 --QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPK-STVGTPAYIAPEVLSRR 167
              I +RDLK EN LLD      +K+ DFG SK ++ H +   S  GT  Y+APEV++R+
Sbjct: 148 SLGIIYRDLKPENILLD--EEGHIKLTDFGLSKEAIDHEKKAYSFCGTVEYMAPEVVNRQ 205
Query: 168 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCR 227
            +    AD WS GV ++ ML G+ PF+     K+ ++T++ I+  +  +P +  +S + +
Sbjct: 206 GHSHS-ADWWSYGVLMFEMLTGSLPFQG----KDRKETMTLILKAKLGMPQF--LSTEAQ 258
Query: 228 NLLSRIFVANPSRRI-----TIKEIKSHPWF 253
           +LL  +F  NP+ R+       +EIK H ++
Sbjct: 259 SLLRALFKRNPANRLGSGPDGAEEIKRHVFY 289

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score =  123 bits (309), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 84/293 (28%), Positives = 145/293 (49%), Gaps = 34/293 (11%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQL----R 56
           ++++E +K +G+G+FG   L+++  T    AMK +++   +        +N K++     
Sbjct: 41  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 100
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYF-------FQQLIS 109
            P +++ +      ++L +VMEY  GGE+F  +   GRF E  AR++       F+ L S
Sbjct: 101 FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHS 160
Query: 110 GQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREY 169
             + +RDLK EN L+D      +++ DFG++K   +  R     GTP Y+APE++  + Y
Sbjct: 161 LDLIYRDLKPENLLID--QQGYIQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGY 216
Query: 170 DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 229
           + K  D W+ GV +Y M  G  PF   +  + + K +S     + + P   H S D ++L
Sbjct: 217 N-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG----KVRFPS--HFSSDLKDL 269
Query: 230 LSRIFVANPSRRI-----TIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTF 277
           L  +   + ++R       + +IK+H WF        T    AIY RK    F
Sbjct: 270 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF-------ATTDWIAIYQRKVEAPF 315

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score =  123 bits (309), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 85/268 (31%), Positives = 140/268 (52%), Gaps = 25/268 (9%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKI-DANVAREIINHKQL---- 55
           +E +EL K +G G+FG   L   K T +  A+K +++   + D +V   ++  + L    
Sbjct: 17  IEDFELHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAW 76
Query: 56  RHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG----- 110
            HP +        T  +L  VMEY  GG+L   I +  +F    A ++  ++I G     
Sbjct: 77  EHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLH 136
Query: 111 --QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLL-HSRPKSTVGTPAYIAPEVLSRR 167
              I +RDLKL+N LLD      +KI DFG  K ++L  ++     GTP YIAPE+L  +
Sbjct: 137 SKGIVYRDLKLDNILLDKDG--HIKIADFGMCKENMLGDAKTNEFCGTPDYIAPEILLGQ 194
Query: 168 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVH-ISQDC 226
           +Y+  + D WS GV LY ML+G  PF  Q++ + F        +++   P Y   + ++ 
Sbjct: 195 KYNHSV-DWWSFGVLLYEMLIGQSPFHGQDEEELFH-------SIRMDNPFYPRWLEKEA 246
Query: 227 RNLLSRIFVANPSRRITIK-EIKSHPWF 253
           ++LL ++FV  P +R+ ++ +I+ HP F
Sbjct: 247 KDLLVKLFVREPEKRLGVRGDIRQHPLF 274

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score =  123 bits (309), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 89/275 (32%), Positives = 143/275 (52%), Gaps = 35/275 (12%)
Query: 4   YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDA------NVAREIINHKQLRH 57
           YEL + IG G F V R   N+ T +  A+K ++      +      ++ RE      L+H
Sbjct: 26  YELCEVIGKGAFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKH 85
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGEL-FERI--CNAGR-FSEDEARYFFQQLISG--- 110
           P+I+   E   +   L +V E+  G +L FE +   +AG  +SE  A ++ +Q++     
Sbjct: 86  PHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRY 145
Query: 111 ----QICHRDLKLENTLLDG--SPAPRLKICDFGYS----KSSLLHSRPKSTVGTPAYIA 160
                I HRD+K EN LL    + AP +K+ DFG +    +S L+       VGTP ++A
Sbjct: 146 CHDNNIIHRDVKPENVLLASKENSAP-VKLGDFGVAIQLGESGLVAG---GRVGTPHFMA 201
Query: 161 PEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIP--D 218
           PEV+ R  Y GK  DVW CGV L+++L G  PF   ++     +    I+  +YK+    
Sbjct: 202 PEVVKREPY-GKPVDVWGCGVILFILLSGCLPFYGTKE-----RLFEGIIKGKYKMNPRQ 255
Query: 219 YVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 253
           + HIS+  ++L+ R+ + +P+ RIT+ E  +HPW 
Sbjct: 256 WSHISESAKDLVRRMLMLDPAERITVYEALNHPWL 290

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score =  123 bits (308), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 84/293 (28%), Positives = 145/293 (49%), Gaps = 34/293 (11%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQL----R 56
           ++++E +K +G+G+FG   L+++  T    AMK +++   +        +N K++     
Sbjct: 40  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYF-------FQQLIS 109
            P +++ +      ++L +VMEY  GGE+F  +   GRF E  AR++       F+ L S
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHS 159
Query: 110 GQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREY 169
             + +RDLK EN L+D      +++ DFG++K   +  R     GTP Y+APE++  + Y
Sbjct: 160 LDLIYRDLKPENLLID--QQGYIQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 170 DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 229
           + K  D W+ GV +Y M  G  PF   +  + + K +S     + + P   H S D ++L
Sbjct: 216 N-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG----KVRFPS--HFSSDLKDL 268
Query: 230 LSRIFVANPSRRI-----TIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTF 277
           L  +   + ++R       + +IK+H WF        T    AIY RK    F
Sbjct: 269 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF-------ATTDWIAIYQRKVEAPF 314

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score =  123 bits (308), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 91/283 (32%), Positives = 144/283 (50%), Gaps = 24/283 (8%)
Query: 10  IGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREI-INHKQLRHPNIIR----FK 64
           +G G  G    + NK T+E  A+K ++   K      RE+ ++ +  + P+I+R    ++
Sbjct: 40  LGLGINGKVLQIFNKRTQEKFALKMLQDCPK----ARREVELHWRASQCPHIVRIVDVYE 95
Query: 65  EVVLTPTHLAIVMEYAAGGELFERICNAG--RFSEDEARYFF-------QQLISGQICHR 115
            +      L IVME   GGELF RI + G   F+E EA           Q L S  I HR
Sbjct: 96  NLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHR 155
Query: 116 DLKLENTLLDGS-PAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLA 174
           D+K EN L     P   LK+ DFG++K +  H+   +   TP Y+APEVL   +YD K  
Sbjct: 156 DVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYD-KSC 214
Query: 175 DVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPD--YVHISQDCRNLLSR 232
           D+WS GV +Y++L G  PF             +RI   QY+ P+  +  +S++ + L+  
Sbjct: 215 DMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRN 274
Query: 233 IFVANPSRRITIKEIKSHPWFLKN--LPRELTETAQAIYYRKE 273
           +    P++R+TI E  +HPW +++  +P+    T++ +   KE
Sbjct: 275 LLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKE 317

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score =  123 bits (308), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 91/283 (32%), Positives = 144/283 (50%), Gaps = 24/283 (8%)
Query: 10  IGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREI-INHKQLRHPNIIR----FK 64
           +G G  G    + NK T+E  A+K ++   K      RE+ ++ +  + P+I+R    ++
Sbjct: 30  LGLGINGKVLQIFNKRTQEKFALKMLQDCPK----ARREVELHWRASQCPHIVRIVDVYE 85
Query: 65  EVVLTPTHLAIVMEYAAGGELFERICNAG--RFSEDEARYFF-------QQLISGQICHR 115
            +      L IVME   GGELF RI + G   F+E EA           Q L S  I HR
Sbjct: 86  NLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHR 145
Query: 116 DLKLENTLLDGS-PAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLA 174
           D+K EN L     P   LK+ DFG++K +  H+   +   TP Y+APEVL   +YD K  
Sbjct: 146 DVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYD-KSC 204
Query: 175 DVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPD--YVHISQDCRNLLSR 232
           D+WS GV +Y++L G  PF             +RI   QY+ P+  +  +S++ + L+  
Sbjct: 205 DMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRN 264
Query: 233 IFVANPSRRITIKEIKSHPWFLKN--LPRELTETAQAIYYRKE 273
           +    P++R+TI E  +HPW +++  +P+    T++ +   KE
Sbjct: 265 LLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKE 307

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score =  123 bits (308), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 91/283 (32%), Positives = 144/283 (50%), Gaps = 24/283 (8%)
Query: 10  IGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREI-INHKQLRHPNIIR----FK 64
           +G G  G    + NK T+E  A+K ++   K      RE+ ++ +  + P+I+R    ++
Sbjct: 31  LGLGINGKVLQIFNKRTQEKFALKMLQDCPK----ARREVELHWRASQCPHIVRIVDVYE 86
Query: 65  EVVLTPTHLAIVMEYAAGGELFERICNAG--RFSEDEARYFF-------QQLISGQICHR 115
            +      L IVME   GGELF RI + G   F+E EA           Q L S  I HR
Sbjct: 87  NLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHR 146
Query: 116 DLKLENTLLDGS-PAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLA 174
           D+K EN L     P   LK+ DFG++K +  H+   +   TP Y+APEVL   +YD K  
Sbjct: 147 DVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYD-KSC 205
Query: 175 DVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPD--YVHISQDCRNLLSR 232
           D+WS GV +Y++L G  PF             +RI   QY+ P+  +  +S++ + L+  
Sbjct: 206 DMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRN 265
Query: 233 IFVANPSRRITIKEIKSHPWFLKN--LPRELTETAQAIYYRKE 273
           +    P++R+TI E  +HPW +++  +P+    T++ +   KE
Sbjct: 266 LLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKE 308

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score =  123 bits (308), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 91/283 (32%), Positives = 144/283 (50%), Gaps = 24/283 (8%)
Query: 10  IGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREI-INHKQLRHPNIIR----FK 64
           +G G  G    + NK T+E  A+K ++   K      RE+ ++ +  + P+I+R    ++
Sbjct: 76  LGLGINGKVLQIFNKRTQEKFALKMLQDCPK----ARREVELHWRASQCPHIVRIVDVYE 131
Query: 65  EVVLTPTHLAIVMEYAAGGELFERICNAG--RFSEDEARYFF-------QQLISGQICHR 115
            +      L IVME   GGELF RI + G   F+E EA           Q L S  I HR
Sbjct: 132 NLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHR 191
Query: 116 DLKLENTLLDGS-PAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLA 174
           D+K EN L     P   LK+ DFG++K +  H+   +   TP Y+APEVL   +YD K  
Sbjct: 192 DVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYD-KSC 250
Query: 175 DVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPD--YVHISQDCRNLLSR 232
           D+WS GV +Y++L G  PF             +RI   QY+ P+  +  +S++ + L+  
Sbjct: 251 DMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRN 310
Query: 233 IFVANPSRRITIKEIKSHPWFLKN--LPRELTETAQAIYYRKE 273
           +    P++R+TI E  +HPW +++  +P+    T++ +   KE
Sbjct: 311 LLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKE 353

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score =  123 bits (308), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 91/283 (32%), Positives = 144/283 (50%), Gaps = 24/283 (8%)
Query: 10  IGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREI-INHKQLRHPNIIR----FK 64
           +G G  G    + NK T+E  A+K ++   K      RE+ ++ +  + P+I+R    ++
Sbjct: 26  LGLGINGKVLQIFNKRTQEKFALKMLQDCPK----ARREVELHWRASQCPHIVRIVDVYE 81
Query: 65  EVVLTPTHLAIVMEYAAGGELFERICNAG--RFSEDEARYFF-------QQLISGQICHR 115
            +      L IVME   GGELF RI + G   F+E EA           Q L S  I HR
Sbjct: 82  NLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHR 141
Query: 116 DLKLENTLLDGS-PAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLA 174
           D+K EN L     P   LK+ DFG++K +  H+   +   TP Y+APEVL   +YD K  
Sbjct: 142 DVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYD-KSC 200
Query: 175 DVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPD--YVHISQDCRNLLSR 232
           D+WS GV +Y++L G  PF             +RI   QY+ P+  +  +S++ + L+  
Sbjct: 201 DMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRN 260
Query: 233 IFVANPSRRITIKEIKSHPWFLKN--LPRELTETAQAIYYRKE 273
           +    P++R+TI E  +HPW +++  +P+    T++ +   KE
Sbjct: 261 LLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKE 303

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score =  123 bits (308), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 91/283 (32%), Positives = 144/283 (50%), Gaps = 24/283 (8%)
Query: 10  IGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREI-INHKQLRHPNIIR----FK 64
           +G G  G    + NK T+E  A+K ++   K      RE+ ++ +  + P+I+R    ++
Sbjct: 70  LGLGINGKVLQIFNKRTQEKFALKMLQDCPK----ARREVELHWRASQCPHIVRIVDVYE 125
Query: 65  EVVLTPTHLAIVMEYAAGGELFERICNAGR--FSEDEARYFF-------QQLISGQICHR 115
            +      L IVME   GGELF RI + G   F+E EA           Q L S  I HR
Sbjct: 126 NLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHR 185
Query: 116 DLKLENTLLDGS-PAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLA 174
           D+K EN L     P   LK+ DFG++K +  H+   +   TP Y+APEVL   +YD K  
Sbjct: 186 DVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYD-KSC 244
Query: 175 DVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPD--YVHISQDCRNLLSR 232
           D+WS GV +Y++L G  PF             +RI   QY+ P+  +  +S++ + L+  
Sbjct: 245 DMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRN 304
Query: 233 IFVANPSRRITIKEIKSHPWFLKN--LPRELTETAQAIYYRKE 273
           +    P++R+TI E  +HPW +++  +P+    T++ +   KE
Sbjct: 305 LLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKE 347

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score =  123 bits (308), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 91/283 (32%), Positives = 144/283 (50%), Gaps = 24/283 (8%)
Query: 10  IGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREI-INHKQLRHPNIIR----FK 64
           +G G  G    + NK T+E  A+K ++   K      RE+ ++ +  + P+I+R    ++
Sbjct: 32  LGLGINGKVLQIFNKRTQEKFALKMLQDCPK----ARREVELHWRASQCPHIVRIVDVYE 87
Query: 65  EVVLTPTHLAIVMEYAAGGELFERICNAG--RFSEDEARYFF-------QQLISGQICHR 115
            +      L IVME   GGELF RI + G   F+E EA           Q L S  I HR
Sbjct: 88  NLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHR 147
Query: 116 DLKLENTLLDGS-PAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLA 174
           D+K EN L     P   LK+ DFG++K +  H+   +   TP Y+APEVL   +YD K  
Sbjct: 148 DVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYD-KSC 206
Query: 175 DVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPD--YVHISQDCRNLLSR 232
           D+WS GV +Y++L G  PF             +RI   QY+ P+  +  +S++ + L+  
Sbjct: 207 DMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRN 266
Query: 233 IFVANPSRRITIKEIKSHPWFLKN--LPRELTETAQAIYYRKE 273
           +    P++R+TI E  +HPW +++  +P+    T++ +   KE
Sbjct: 267 LLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKE 309

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score =  123 bits (308), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 91/283 (32%), Positives = 144/283 (50%), Gaps = 24/283 (8%)
Query: 10  IGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREI-INHKQLRHPNIIR----FK 64
           +G G  G    + NK T+E  A+K ++   K      RE+ ++ +  + P+I+R    ++
Sbjct: 26  LGLGINGKVLQIFNKRTQEKFALKMLQDCPK----ARREVELHWRASQCPHIVRIVDVYE 81
Query: 65  EVVLTPTHLAIVMEYAAGGELFERICNAGR--FSEDEARYFF-------QQLISGQICHR 115
            +      L IVME   GGELF RI + G   F+E EA           Q L S  I HR
Sbjct: 82  NLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHR 141
Query: 116 DLKLENTLLDGS-PAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLA 174
           D+K EN L     P   LK+ DFG++K +  H+   +   TP Y+APEVL   +YD K  
Sbjct: 142 DVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYD-KSC 200
Query: 175 DVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPD--YVHISQDCRNLLSR 232
           D+WS GV +Y++L G  PF             +RI   QY+ P+  +  +S++ + L+  
Sbjct: 201 DMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRN 260
Query: 233 IFVANPSRRITIKEIKSHPWFLKN--LPRELTETAQAIYYRKE 273
           +    P++R+TI E  +HPW +++  +P+    T++ +   KE
Sbjct: 261 LLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKE 303

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score =  123 bits (308), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 84/268 (31%), Positives = 136/268 (50%), Gaps = 22/268 (8%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNII 61
           + YE+ +DIG G++ V +   +K T    A+K I++  +        ++ + Q  HPNII
Sbjct: 22  DGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEEIEILLRYGQ--HPNII 79
Query: 62  RFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFF-------QQLISGQICH 114
             K+V     ++ +V E   GGEL ++I     FSE EA           + L +  + H
Sbjct: 80  TLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVH 139
Query: 115 RDLKLENTL-LDGSPAPR-LKICDFGYSKSSLLHSRPKSTVGTPAY----IAPEVLSRRE 168
           RDLK  N L +D S  P  ++ICDFG++K           + TP Y    +APEVL R+ 
Sbjct: 140 RDLKPSNILYVDESGNPESIRICDFGFAKQL---RAENGLLMTPCYTANFVAPEVLERQG 196
Query: 169 YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPD--YVHISQDC 226
           YD    D+WS GV LY ML G  PF +  D     + ++RI + ++ +    +  +S   
Sbjct: 197 YDAA-CDIWSLGVLLYTMLTGYTPFANGPD-DTPEEILARIGSGKFSLSGGYWNSVSDTA 254
Query: 227 RNLLSRIFVANPSRRITIKEIKSHPWFL 254
           ++L+S++   +P +R+T   +  HPW +
Sbjct: 255 KDLVSKMLHVDPHQRLTAALVLRHPWIV 282

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score =  123 bits (308), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 91/283 (32%), Positives = 144/283 (50%), Gaps = 24/283 (8%)
Query: 10  IGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREI-INHKQLRHPNIIR----FK 64
           +G G  G    + NK T+E  A+K ++   K      RE+ ++ +  + P+I+R    ++
Sbjct: 25  LGLGINGKVLQIFNKRTQEKFALKMLQDCPK----ARREVELHWRASQCPHIVRIVDVYE 80
Query: 65  EVVLTPTHLAIVMEYAAGGELFERICNAG--RFSEDEARYFF-------QQLISGQICHR 115
            +      L IVME   GGELF RI + G   F+E EA           Q L S  I HR
Sbjct: 81  NLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHR 140
Query: 116 DLKLENTLLDGS-PAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLA 174
           D+K EN L     P   LK+ DFG++K +  H+   +   TP Y+APEVL   +YD K  
Sbjct: 141 DVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYD-KSC 199
Query: 175 DVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPD--YVHISQDCRNLLSR 232
           D+WS GV +Y++L G  PF             +RI   QY+ P+  +  +S++ + L+  
Sbjct: 200 DMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRN 259
Query: 233 IFVANPSRRITIKEIKSHPWFLKN--LPRELTETAQAIYYRKE 273
           +    P++R+TI E  +HPW +++  +P+    T++ +   KE
Sbjct: 260 LLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKE 302

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score =  123 bits (308), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 91/283 (32%), Positives = 144/283 (50%), Gaps = 24/283 (8%)
Query: 10  IGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREI-INHKQLRHPNIIR----FK 64
           +G G  G    + NK T+E  A+K ++   K      RE+ ++ +  + P+I+R    ++
Sbjct: 24  LGLGINGKVLQIFNKRTQEKFALKMLQDCPK----ARREVELHWRASQCPHIVRIVDVYE 79
Query: 65  EVVLTPTHLAIVMEYAAGGELFERICNAG--RFSEDEARYFF-------QQLISGQICHR 115
            +      L IVME   GGELF RI + G   F+E EA           Q L S  I HR
Sbjct: 80  NLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHR 139
Query: 116 DLKLENTLLDGS-PAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLA 174
           D+K EN L     P   LK+ DFG++K +  H+   +   TP Y+APEVL   +YD K  
Sbjct: 140 DVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYD-KSC 198
Query: 175 DVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPD--YVHISQDCRNLLSR 232
           D+WS GV +Y++L G  PF             +RI   QY+ P+  +  +S++ + L+  
Sbjct: 199 DMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRN 258
Query: 233 IFVANPSRRITIKEIKSHPWFLKN--LPRELTETAQAIYYRKE 273
           +    P++R+TI E  +HPW +++  +P+    T++ +   KE
Sbjct: 259 LLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKE 301

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score =  122 bits (307), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 96/321 (29%), Positives = 159/321 (49%), Gaps = 39/321 (12%)
Query: 2   EKYELMKDIGSGNFG---VARLMRNKNTKELVAMKYIE-----RGHKIDANVAREIINHK 53
           E +EL++ +G G +G     R +   NT ++ AMK ++     R  K  A+   E    +
Sbjct: 17  ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILE 76
Query: 54  QLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQ------- 106
           +++HP I+       T   L +++EY +GGELF ++   G F ED A ++  +       
Sbjct: 77  EVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGH 136
Query: 107 LISGQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST-VGTPAYIAPEVLS 165
           L    I +RDLK EN +L+      +K+ DFG  K S+       T  GT  Y+APE+L 
Sbjct: 137 LHQKGIIYRDLKPENIMLNHQ--GHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILM 194
Query: 166 RREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQD 225
           R  ++ +  D WS G  +Y ML GA PF  +    N +KTI +I+  +  +P Y  ++Q+
Sbjct: 195 RSGHN-RAVDWWSLGALMYDMLTGAPPFTGE----NRKKTIDKILKCKLNLPPY--LTQE 247
Query: 226 CRNLLSRIFVANPSRRI-----TIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTFS-- 278
            R+LL ++   N + R+        E+++HP+F     R +    + +  RK  P F   
Sbjct: 248 ARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFF-----RHI--NWEELLARKVEPPFKPL 300
Query: 279 LQSVEEITKIVEEAKVPPPVS 299
           LQS E++++   +     PV 
Sbjct: 301 LQSEEDVSQFDSKFTRQTPVD 321

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score =  122 bits (306), Expect = 3e-28,   Method: Compositional matrix adjust.
 Identities = 91/283 (32%), Positives = 143/283 (50%), Gaps = 24/283 (8%)
Query: 10  IGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREI-INHKQLRHPNIIR----FK 64
           +G G  G    + NK T+E  A+K ++   K      RE+ ++ +  + P+I+R    ++
Sbjct: 24  LGLGINGKVLQIFNKRTQEKFALKMLQDCPK----ARREVELHWRASQCPHIVRIVDVYE 79
Query: 65  EVVLTPTHLAIVMEYAAGGELFERICNAG--RFSEDEARYFF-------QQLISGQICHR 115
            +      L IVME   GGELF RI + G   F+E EA           Q L S  I HR
Sbjct: 80  NLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHR 139
Query: 116 DLKLENTLLDGS-PAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLA 174
           D+K EN L     P   LK+ DFG++K +  H+       TP Y+APEVL   +YD K  
Sbjct: 140 DVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTEPCYTPYYVAPEVLGPEKYD-KSC 198
Query: 175 DVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPD--YVHISQDCRNLLSR 232
           D+WS GV +Y++L G  PF             +RI   QY+ P+  +  +S++ + L+  
Sbjct: 199 DMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRN 258
Query: 233 IFVANPSRRITIKEIKSHPWFLKN--LPRELTETAQAIYYRKE 273
           +    P++R+TI E  +HPW +++  +P+    T++ +   KE
Sbjct: 259 LLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKE 301

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score =  120 bits (301), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 83/268 (30%), Positives = 135/268 (50%), Gaps = 22/268 (8%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNII 61
           + YE+ +DIG G++ V +   +K T    A+K I++  +        ++ + Q  HPNII
Sbjct: 22  DGYEVKEDIGVGSYSVCKRCIHKATNXEFAVKIIDKSKRDPTEEIEILLRYGQ--HPNII 79
Query: 62  RFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFF-------QQLISGQICH 114
             K+V     ++ +V E   GGEL ++I     FSE EA           + L +  + H
Sbjct: 80  TLKDVYDDGKYVYVVTELXKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVH 139
Query: 115 RDLKLENTL-LDGSPAPR-LKICDFGYSKSSLLHSRPKSTVGTPAY----IAPEVLSRRE 168
           RDLK  N L +D S  P  ++ICDFG++K     +     + TP Y    +APEVL R+ 
Sbjct: 140 RDLKPSNILYVDESGNPESIRICDFGFAKQLRAEN---GLLXTPCYTANFVAPEVLERQG 196
Query: 169 YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPD--YVHISQDC 226
           YD    D+WS GV LY  L G  PF +  D     + ++RI + ++ +    +  +S   
Sbjct: 197 YDAA-CDIWSLGVLLYTXLTGYTPFANGPD-DTPEEILARIGSGKFSLSGGYWNSVSDTA 254
Query: 227 RNLLSRIFVANPSRRITIKEIKSHPWFL 254
           ++L+S+    +P +R+T   +  HPW +
Sbjct: 255 KDLVSKXLHVDPHQRLTAALVLRHPWIV 282

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score =  120 bits (301), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 84/268 (31%), Positives = 139/268 (51%), Gaps = 25/268 (9%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKI-DANVAREIINHKQL---- 55
           +E + L K +G G+FG   L   K T +  A+K +++   + D +V   ++  + L    
Sbjct: 16  IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAW 75
Query: 56  RHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG----- 110
            HP +        T  +L  VMEY  GG+L   I +  +F    A ++  ++I G     
Sbjct: 76  EHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLH 135
Query: 111 --QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLL-HSRPKSTVGTPAYIAPEVLSRR 167
              I +RDLKL+N LLD      +KI DFG  K ++L  ++     GTP YIAPE+L  +
Sbjct: 136 SKGIVYRDLKLDNILLDKDG--HIKIADFGMCKENMLGDAKTNXFCGTPDYIAPEILLGQ 193
Query: 168 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVH-ISQDC 226
           +Y+  + D WS GV LY ML+G  PF  Q++ + F        +++   P Y   + ++ 
Sbjct: 194 KYNHSV-DWWSFGVLLYEMLIGQSPFHGQDEEELFH-------SIRMDNPFYPRWLEKEA 245
Query: 227 RNLLSRIFVANPSRRITIK-EIKSHPWF 253
           ++LL ++FV  P +R+ ++ +I+ HP F
Sbjct: 246 KDLLVKLFVREPEKRLGVRGDIRQHPLF 273

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score =  120 bits (301), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 95/321 (29%), Positives = 158/321 (49%), Gaps = 39/321 (12%)
Query: 2   EKYELMKDIGSGNFG---VARLMRNKNTKELVAMKYIE-----RGHKIDANVAREIINHK 53
           E +EL++ +G G +G     R +   NT ++ AMK ++     R  K  A+   E    +
Sbjct: 17  ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILE 76
Query: 54  QLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQ------- 106
           +++HP I+       T   L +++EY +GGELF ++   G F ED A ++  +       
Sbjct: 77  EVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGH 136
Query: 107 LISGQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR-PKSTVGTPAYIAPEVLS 165
           L    I +RDLK EN +L+      +K+ DFG  K S+          GT  Y+APE+L 
Sbjct: 137 LHQKGIIYRDLKPENIMLNHQ--GHVKLTDFGLCKESIHDGTVTHXFCGTIEYMAPEILM 194
Query: 166 RREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQD 225
           R  ++ +  D WS G  +Y ML GA PF  +    N +KTI +I+  +  +P Y  ++Q+
Sbjct: 195 RSGHN-RAVDWWSLGALMYDMLTGAPPFTGE----NRKKTIDKILKCKLNLPPY--LTQE 247
Query: 226 CRNLLSRIFVANPSRRI-----TIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTFS-- 278
            R+LL ++   N + R+        E+++HP+F     R +    + +  RK  P F   
Sbjct: 248 ARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFF-----RHI--NWEELLARKVEPPFKPL 300
Query: 279 LQSVEEITKIVEEAKVPPPVS 299
           LQS E++++   +     PV 
Sbjct: 301 LQSEEDVSQFDSKFTRQTPVD 321

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score =  120 bits (301), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 84/272 (30%), Positives = 129/272 (47%), Gaps = 28/272 (10%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQL----- 55
           ++ +E ++ +G G+FG   L R K T +L A+K +++   +  +     +  K++     
Sbjct: 22  IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLAR 81
Query: 56  RHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG----- 110
            HP + +      TP  L  VME+  GG+L   I  + RF E  AR++  ++IS      
Sbjct: 82  NHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLH 141
Query: 111 --QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST-VGTPAYIAPEVLSRR 167
              I +RDLKL+N LLD       K+ DFG  K  + +    +T  GTP YIAPE+L   
Sbjct: 142 DKGIIYRDLKLDNVLLDHE--GHCKLADFGMCKEGICNGVTTATFCGTPDYIAPEILQEM 199
Query: 168 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCR 227
            Y G   D W+ GV LY ML G  PFE + +   F      I+  +   P ++H  +D  
Sbjct: 200 LY-GPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEA----ILNDEVVYPTWLH--EDAT 252
Query: 228 NLLSRIFVANPSRRITI------KEIKSHPWF 253
            +L      NP+ R+          I  HP+F
Sbjct: 253 GILKSFMTKNPTMRLGSLTQGGEHAILRHPFF 284

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score =  120 bits (300), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 84/279 (30%), Positives = 139/279 (49%), Gaps = 27/279 (9%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH----KIDANVAREIINHKQLR 56
           ++ +E+ + +G G FG   L R K +  +VA+K + +       ++  + REI     L 
Sbjct: 22  IDDFEIGRPLGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQLRREIEIQAHLH 81
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG------ 110
           HPNI+R          + +++EYA  GEL++ +  +  F E       ++L         
Sbjct: 82  HPNILRLYNYFYDRRRIYLILEYAPRGELYKELQKSCTFDEQRTATIMEELADALMYCHG 141
Query: 111 -QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS---RPKSTVGTPAYIAPEVLSR 166
            ++ HRD+K EN LL       LKI DFG+S    +H+   R K+  GT  Y+ PE++  
Sbjct: 142 KKVIHRDIKPENLLLGLKGE--LKIADFGWS----VHAPSLRRKTMCGTLDYLPPEMIEG 195
Query: 167 REYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDC 226
           R ++ K+ D+W  GV  Y +LVG  PFE     + +R    RI+ V  K P    +    
Sbjct: 196 RMHNEKV-DLWCIGVLCYELLVGNPPFESASHNETYR----RIVKVDLKFP--ASVPTGA 248
Query: 227 RNLLSRIFVANPSRRITIKEIKSHPWFLKNLPRELTETA 265
           ++L+S++   NPS R+ + ++ +HPW   N  R L  +A
Sbjct: 249 QDLISKLLRHNPSERLPLAQVSAHPWVRANSRRVLPPSA 287

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score =  119 bits (297), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 89/283 (31%), Positives = 134/283 (47%), Gaps = 27/283 (9%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIE--RGHKIDANVAREI---------I 50
           E YE  + +G G   V R   +K T +  A+K I+   G    A   +E+         I
Sbjct: 17  ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 76
Query: 51  NHKQLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG 110
             K   HPNII+ K+   T T   +V +    GELF+ +      SE E R   + L+  
Sbjct: 77  LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEV 136
Query: 111 -------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEV 163
                   I HRDLK EN LLD      +K+ DFG+S       + +S  GTP+Y+APE+
Sbjct: 137 ICALHKLNIVHRDLKPENILLDDD--MNIKLTDFGFSCQLDPGEKLRSVCGTPSYLAPEI 194
Query: 164 LSRREYD-----GKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPD 218
           +     D     GK  D+WS GV +Y +L G+ PF  ++     R  +S     Q+  P+
Sbjct: 195 IECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSG--NYQFGSPE 252
Query: 219 YVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLPREL 261
           +   S   ++L+SR  V  P +R T +E  +HP+F + +  E+
Sbjct: 253 WDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYVVEEV 295

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score =  118 bits (296), Expect = 5e-27,   Method: Compositional matrix adjust.
 Identities = 79/280 (28%), Positives = 132/280 (47%), Gaps = 17/280 (6%)
Query: 4   YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDA-NVAREIINHKQLRHPNIIR 62
           Y++++++GSG FGV      K T  +   K+I   + +D   V  EI    QL HP +I 
Sbjct: 53  YDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLIN 112
Query: 63  FKEVVLTPTHLAIVMEYAAGGELFERICNAG-RFSEDEARYFFQQLISG-------QICH 114
             +       + +++E+ +GGELF+RI     + SE E   + +Q   G        I H
Sbjct: 113 LHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVH 172
Query: 115 RDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLA 174
            D+K EN + +   A  +KI DFG +         K T  T  + APE++  RE  G   
Sbjct: 173 LDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVD-REPVGFYT 231
Query: 175 DVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPD--YVHISQDCRNLLSR 232
           D+W+ GV  YV+L G  PF  ++D     +T+  +    ++  +  +  +S + ++ +  
Sbjct: 232 DMWAIGVLGYVLLSGLSPFAGEDD----LETLQNVKRCDWEFDEDAFSSVSPEAKDFIKN 287
Query: 233 IFVANPSRRITIKEIKSHPWFLKNLPRELTETAQAIYYRK 272
           +    P +R+T+ +   HPW LK     LT    +  Y K
Sbjct: 288 LLQKEPRKRLTVHDALEHPW-LKGDHSNLTSRIPSSRYNK 326

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score =  117 bits (292), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 88/283 (31%), Positives = 133/283 (46%), Gaps = 27/283 (9%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIE--RGHKIDANVAREI---------I 50
           E YE  + +G G   V R   +K T +  A+K I+   G    A   +E+         I
Sbjct: 17  ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 76
Query: 51  NHKQLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG 110
             K   HPNII+ K+   T T   +V +    GELF+ +      SE E R   + L+  
Sbjct: 77  LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEV 136
Query: 111 -------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEV 163
                   I HRDLK EN LLD      +K+ DFG+S       + +   GTP+Y+APE+
Sbjct: 137 ICALHKLNIVHRDLKPENILLDDD--MNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEI 194
Query: 164 LSRREYD-----GKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPD 218
           +     D     GK  D+WS GV +Y +L G+ PF  ++     R  +S     Q+  P+
Sbjct: 195 IECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSG--NYQFGSPE 252
Query: 219 YVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLPREL 261
           +   S   ++L+SR  V  P +R T +E  +HP+F + +  E+
Sbjct: 253 WDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYVVEEV 295

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score =  117 bits (292), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 87/275 (31%), Positives = 129/275 (46%), Gaps = 27/275 (9%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIE--RGHKIDANVAREI---------I 50
           E YE  + +G G   V R   +K T +  A+K I+   G    A   +E+         I
Sbjct: 4   ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 63
Query: 51  NHKQLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG 110
             K   HPNII+ K+   T T   +V +    GELF+ +      SE E R   + L+  
Sbjct: 64  LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEV 123
Query: 111 -------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEV 163
                   I HRDLK EN LLD      +K+ DFG+S       + +   GTP+Y+APE+
Sbjct: 124 ICALHKLNIVHRDLKPENILLDDD--MNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEI 181
Query: 164 LSRREYD-----GKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPD 218
           +     D     GK  D+WS GV +Y +L G+ PF  ++     R  +S     Q+  P+
Sbjct: 182 IECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSG--NYQFGSPE 239
Query: 219 YVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 253
           +   S   ++L+SR  V  P +R T +E  +HP+F
Sbjct: 240 WDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFF 274

>pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400

Iteration: 1
 Score =  116 bits (291), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 91/283 (32%), Positives = 138/283 (48%), Gaps = 24/283 (8%)
Query: 10  IGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINH-KQLRHPNIIR----FK 64
           +G G  G    + NK T+E  A+K ++   K      RE+  H +  + P+I+R    ++
Sbjct: 70  LGLGINGKVLQIFNKRTQEKFALKXLQDCPK----ARREVELHWRASQCPHIVRIVDVYE 125
Query: 65  EVVLTPTHLAIVMEYAAGGELFERICNAGR--FSEDEARYF-------FQQLISGQICHR 115
            +      L IV E   GGELF RI + G   F+E EA           Q L S  I HR
Sbjct: 126 NLYAGRKCLLIVXECLDGGELFSRIQDRGDQAFTEREASEIXKSIGEAIQYLHSINIAHR 185
Query: 116 DLKLENTLLDGS-PAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLA 174
           D+K EN L     P   LK+ DFG++K +  H+   +   TP Y+APEVL   +YD K  
Sbjct: 186 DVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYD-KSC 244
Query: 175 DVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPD--YVHISQDCRNLLSR 232
           D WS GV  Y++L G  PF             +RI   QY+ P+  +  +S++ + L+  
Sbjct: 245 DXWSLGVIXYILLCGYPPFYSNHGLAISPGXKTRIRXGQYEFPNPEWSEVSEEVKXLIRN 304
Query: 233 IFVANPSRRITIKEIKSHPWFLKN--LPRELTETAQAIYYRKE 273
           +    P++R TI E  +HPW  ++  +P+    T++ +   KE
Sbjct: 305 LLKTEPTQRXTITEFXNHPWIXQSTKVPQTPLHTSRVLKEDKE 347

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score =  115 bits (288), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 86/275 (31%), Positives = 140/275 (50%), Gaps = 35/275 (12%)
Query: 4   YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDA------NVAREIINHKQLRH 57
           YEL + IG G F V R   N+ T +  A+K ++      +      ++ RE      L+H
Sbjct: 28  YELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKH 87
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGEL-FERI--CNAG-RFSEDEARYFFQQLISG--- 110
           P+I+   E   +   L +V E+  G +L FE +   +AG  +SE  A ++ +Q++     
Sbjct: 88  PHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRY 147
Query: 111 ----QICHRDLKLENTLLDG--SPAPRLKICDFGYS----KSSLLHSRPKSTVGTPAYIA 160
                I HRD+K    LL    + AP +K+  FG +    +S L+       VGTP ++A
Sbjct: 148 CHDNNIIHRDVKPHCVLLASKENSAP-VKLGGFGVAIQLGESGLVAG---GRVGTPHFMA 203
Query: 161 PEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIP--D 218
           PEV+ R  Y GK  DVW CGV L+++L G  PF   ++     +    I+  +YK+    
Sbjct: 204 PEVVKREPY-GKPVDVWGCGVILFILLSGCLPFYGTKE-----RLFEGIIKGKYKMNPRQ 257
Query: 219 YVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 253
           + HIS+  ++L+ R+ + +P+ RIT+ E  +HPW 
Sbjct: 258 WSHISESAKDLVRRMLMLDPAERITVYEALNHPWL 292

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score =  115 bits (287), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 86/275 (31%), Positives = 140/275 (50%), Gaps = 35/275 (12%)
Query: 4   YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDA------NVAREIINHKQLRH 57
           YEL + IG G F V R   N+ T +  A+K ++      +      ++ RE      L+H
Sbjct: 26  YELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKH 85
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGEL-FERI--CNAG-RFSEDEARYFFQQLISG--- 110
           P+I+   E   +   L +V E+  G +L FE +   +AG  +SE  A ++ +Q++     
Sbjct: 86  PHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRY 145
Query: 111 ----QICHRDLKLENTLLDG--SPAPRLKICDFGYS----KSSLLHSRPKSTVGTPAYIA 160
                I HRD+K    LL    + AP +K+  FG +    +S L+       VGTP ++A
Sbjct: 146 CHDNNIIHRDVKPHCVLLASKENSAP-VKLGGFGVAIQLGESGLVAG---GRVGTPHFMA 201
Query: 161 PEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIP--D 218
           PEV+ R  Y GK  DVW CGV L+++L G  PF   ++     +    I+  +YK+    
Sbjct: 202 PEVVKREPY-GKPVDVWGCGVILFILLSGCLPFYGTKE-----RLFEGIIKGKYKMNPRQ 255
Query: 219 YVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 253
           + HIS+  ++L+ R+ + +P+ RIT+ E  +HPW 
Sbjct: 256 WSHISESAKDLVRRMLMLDPAERITVYEALNHPWL 290

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score =  114 bits (285), Expect = 7e-26,   Method: Compositional matrix adjust.
 Identities = 83/280 (29%), Positives = 146/280 (52%), Gaps = 31/280 (11%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIE---RGHKIDANVAREIINHKQLRH 57
           MEKY  ++ IG G+FG A L+++        +K I       K      RE+     ++H
Sbjct: 23  MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKH 82
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGR---FSEDEARYFFQQLISG---- 110
           PNI++++E       L IVM+Y  GG+LF+RI NA +   F ED+   +F Q+       
Sbjct: 83  PNIVQYRESFEENGSLYIVMDYCEGGDLFKRI-NAQKGVLFQEDQILDWFVQICLALKHV 141
Query: 111 ---QICHRDLKLENTLL--DGSPAPRLKICDFGYSKSSLLHSR---PKSTVGTPAYIAPE 162
              +I HRD+K +N  L  DG+    +++ DFG ++  +L+S     ++ +GTP Y++PE
Sbjct: 142 HDRKILHRDIKSQNIFLTKDGT----VQLGDFGIAR--VLNSTVELARACIGTPYYLSPE 195
Query: 163 VLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHI 222
           +   + Y+ K +D+W+ G  LY +    + FE      + +  + +I++  +  P  +H 
Sbjct: 196 ICENKPYNNK-SDIWALGCVLYELCTLKHAFE----AGSMKNLVLKIISGSFP-PVSLHY 249
Query: 223 SQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLPRELT 262
           S D R+L+S++F  NP  R ++  I    +  K + + L+
Sbjct: 250 SYDLRSLVSQLFKRNPRDRPSVNSILEKGFIAKRIEKFLS 289

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score =  114 bits (284), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 83/272 (30%), Positives = 134/272 (49%), Gaps = 29/272 (10%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKI-DANVAREIINHKQL---- 55
           +  +  +  +G G+FG   L   K T EL A+K +++   I D +V   ++  + L    
Sbjct: 19  LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPG 78
Query: 56  RHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG----- 110
           + P + +      T   L  VMEY  GG+L   I   GRF E  A ++  ++  G     
Sbjct: 79  KPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQ 138
Query: 111 --QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS-RPKSTVGTPAYIAPEVLSRR 167
              I +RDLKL+N +LD      +KI DFG  K ++      K   GTP YIAPE+++ +
Sbjct: 139 SKGIIYRDLKLDNVMLDSEG--HIKIADFGMCKENIWDGVTTKXFCGTPDYIAPEIIAYQ 196
Query: 168 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIP-DYVHISQDC 226
            Y GK  D W+ GV LY ML G  PFE +++ + F+  +   +A    +  + V I   C
Sbjct: 197 PY-GKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAI---C 252
Query: 227 RNLLSRIFVANPSRRITI-----KEIKSHPWF 253
           + L+++    +P +R+       ++IK H +F
Sbjct: 253 KGLMTK----HPGKRLGCGPEGERDIKEHAFF 280

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score =  113 bits (283), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 82/265 (30%), Positives = 132/265 (49%), Gaps = 21/265 (7%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDAN----VAREIINHKQLR 56
           M++Y   + +G G F     + + +TKE+ A K + +   +  +    ++ EI  HK L 
Sbjct: 41  MKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLD 100
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG------ 110
           +P+++ F         + +V+E      L E        +E EARYF +Q I G      
Sbjct: 101 NPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYLHN 160
Query: 111 -QICHRDLKLENTLLDGSPAPRLKICDFGY-SKSSLLHSRPKSTVGTPAYIAPEVLSRRE 168
            ++ HRDLKL N  L+      +KI DFG  +K      R K+  GTP YIAPEVL ++ 
Sbjct: 161 NRVIHRDLKLGNLFLNDDMD--VKIGDFGLATKIEFDGERKKTLCGTPNYIAPEVLCKKG 218
Query: 169 YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRN 228
           +  ++ D+WS G  LY +LVG  PFE        ++T  RI   +Y +P   HI+     
Sbjct: 219 HSFEV-DIWSLGCILYTLLVGKPPFETS----CLKETYIRIKKNEYSVPR--HINPVASA 271
Query: 229 LLSRIFVANPSRRITIKEIKSHPWF 253
           L+ R+  A+P+ R ++ E+ +  +F
Sbjct: 272 LIRRMLHADPTLRPSVAELLTDEFF 296

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score =  113 bits (282), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 79/267 (29%), Positives = 131/267 (49%), Gaps = 26/267 (9%)
Query: 4   YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINH-----KQLRHP 58
           +  +K IG G+FG   L R+K  +   A+K +++   +     + I++      K ++HP
Sbjct: 40  FHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHP 99
Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-------Q 111
            ++       T   L  V++Y  GGELF  +     F E  AR++  ++ S         
Sbjct: 100 FLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLN 159
Query: 112 ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTV-GTPAYIAPEVLSRREYD 170
           I +RDLK EN LLD      + + DFG  K ++ H+   ST  GTP Y+APEVL ++ YD
Sbjct: 160 IVYRDLKPENILLDSQ--GHIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEVLHKQPYD 217
Query: 171 GKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLL 230
            +  D W  G  LY ML G  PF  +   + +   +++ + ++       +I+   R+LL
Sbjct: 218 -RTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLK------PNITNSARHLL 270
Query: 231 SRIFVANPSRRITIK----EIKSHPWF 253
             +   + ++R+  K    EIKSH +F
Sbjct: 271 EGLLQKDRTKRLGAKDDFMEIKSHVFF 297

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score =  113 bits (282), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 83/272 (30%), Positives = 134/272 (49%), Gaps = 29/272 (10%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKI-DANVAREIINHKQL---- 55
           +  +  +  +G G+FG   L   K T EL A+K +++   I D +V   ++  + L    
Sbjct: 340 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPG 399
Query: 56  RHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG----- 110
           + P + +      T   L  VMEY  GG+L   I   GRF E  A ++  ++  G     
Sbjct: 400 KPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQ 459
Query: 111 --QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS-RPKSTVGTPAYIAPEVLSRR 167
              I +RDLKL+N +LD      +KI DFG  K ++      K   GTP YIAPE+++ +
Sbjct: 460 SKGIIYRDLKLDNVMLDSEG--HIKIADFGMCKENIWDGVTTKXFCGTPDYIAPEIIAYQ 517
Query: 168 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIP-DYVHISQDC 226
            Y GK  D W+ GV LY ML G  PFE +++ + F+  +   +A    +  + V I   C
Sbjct: 518 PY-GKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAI---C 573
Query: 227 RNLLSRIFVANPSRRITI-----KEIKSHPWF 253
           + L+++    +P +R+       ++IK H +F
Sbjct: 574 KGLMTK----HPGKRLGCGPEGERDIKEHAFF 601

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score =  112 bits (281), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 82/265 (30%), Positives = 131/265 (49%), Gaps = 21/265 (7%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDAN----VAREIINHKQLR 56
           M++Y   + +G G F     + + +TKE+ A K + +   +  +    ++ EI  HK L 
Sbjct: 41  MKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLD 100
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG------ 110
           +P+++ F         + +V+E      L E        +E EARYF +Q I G      
Sbjct: 101 NPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYLHN 160
Query: 111 -QICHRDLKLENTLLDGSPAPRLKICDFGY-SKSSLLHSRPKSTVGTPAYIAPEVLSRRE 168
            ++ HRDLKL N  L+      +KI DFG  +K      R K   GTP YIAPEVL ++ 
Sbjct: 161 NRVIHRDLKLGNLFLNDDMD--VKIGDFGLATKIEFDGERKKDLCGTPNYIAPEVLCKKG 218
Query: 169 YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRN 228
           +  ++ D+WS G  LY +LVG  PFE        ++T  RI   +Y +P   HI+     
Sbjct: 219 HSFEV-DIWSLGCILYTLLVGKPPFETS----CLKETYIRIKKNEYSVPR--HINPVASA 271
Query: 229 LLSRIFVANPSRRITIKEIKSHPWF 253
           L+ R+  A+P+ R ++ E+ +  +F
Sbjct: 272 LIRRMLHADPTLRPSVAELLTDEFF 296

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score =  112 bits (281), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 82/265 (30%), Positives = 131/265 (49%), Gaps = 21/265 (7%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDAN----VAREIINHKQLR 56
           M++Y   + +G G F     + + +TKE+ A K + +   +  +    ++ EI  HK L 
Sbjct: 25  MKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLD 84
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG------ 110
           +P+++ F         + +V+E      L E        +E EARYF +Q I G      
Sbjct: 85  NPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYLHN 144
Query: 111 -QICHRDLKLENTLLDGSPAPRLKICDFGY-SKSSLLHSRPKSTVGTPAYIAPEVLSRRE 168
            ++ HRDLKL N  L+      +KI DFG  +K      R K   GTP YIAPEVL ++ 
Sbjct: 145 NRVIHRDLKLGNLFLNDDMD--VKIGDFGLATKIEFDGERKKDLCGTPNYIAPEVLCKKG 202
Query: 169 YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRN 228
           +  ++ D+WS G  LY +LVG  PFE        ++T  RI   +Y +P   HI+     
Sbjct: 203 HSFEV-DIWSLGCILYTLLVGKPPFETS----CLKETYIRIKKNEYSVPR--HINPVASA 255
Query: 229 LLSRIFVANPSRRITIKEIKSHPWF 253
           L+ R+  A+P+ R ++ E+ +  +F
Sbjct: 256 LIRRMLHADPTLRPSVAELLTDEFF 280

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score =  112 bits (280), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 82/265 (30%), Positives = 131/265 (49%), Gaps = 21/265 (7%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDAN----VAREIINHKQLR 56
           M++Y   + +G G F     + + +TKE+ A K + +   +  +    ++ EI  HK L 
Sbjct: 41  MKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLD 100
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG------ 110
           +P+++ F         + +V+E      L E        +E EARYF +Q I G      
Sbjct: 101 NPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYLHN 160
Query: 111 -QICHRDLKLENTLLDGSPAPRLKICDFGY-SKSSLLHSRPKSTVGTPAYIAPEVLSRRE 168
            ++ HRDLKL N  L+      +KI DFG  +K      R K   GTP YIAPEVL ++ 
Sbjct: 161 NRVIHRDLKLGNLFLNDDMD--VKIGDFGLATKIEFDGERKKXLCGTPNYIAPEVLCKKG 218
Query: 169 YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRN 228
           +  ++ D+WS G  LY +LVG  PFE        ++T  RI   +Y +P   HI+     
Sbjct: 219 HSFEV-DIWSLGCILYTLLVGKPPFETS----CLKETYIRIKKNEYSVPR--HINPVASA 271
Query: 229 LLSRIFVANPSRRITIKEIKSHPWF 253
           L+ R+  A+P+ R ++ E+ +  +F
Sbjct: 272 LIRRMLHADPTLRPSVAELLTDEFF 296

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score =  112 bits (279), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 84/283 (29%), Positives = 139/283 (49%), Gaps = 29/283 (10%)
Query: 8   KDIGSGNFGVARLMRNKNTKELVAMKYIE---RGHKIDANVAREIINHKQLRH-PNIIRF 63
           K++G G F V R   +K+T +  A K+++   RG    A +  EI   +  +  P +I  
Sbjct: 35  KELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINL 94
Query: 64  KEVVLTPTHLAIVMEYAAGGELFERICN---AGRFSEDEARYFFQQLISG-------QIC 113
            EV    + + +++EYAAGGE+F  +C    A   SE++     +Q++ G        I 
Sbjct: 95  HEVYENTSEIILILEYAAGGEIF-SLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIV 153
Query: 114 HRDLKLENTLLDG-SPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYD-- 170
           H DLK +N LL    P   +KI DFG S+        +  +GTP Y+APE+L+   YD  
Sbjct: 154 HLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPEILN---YDPI 210
Query: 171 GKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLL 230
               D+W+ G+  Y++L    PF  +++ + +   IS++  V Y    +  +SQ   + +
Sbjct: 211 TTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLN-ISQV-NVDYSEETFSSVSQLATDFI 268
Query: 231 SRIFVANPSRRITIKEIKSHPWF----LKNL--PRELTETAQA 267
             + V NP +R T +   SH W      +NL  P E + ++Q 
Sbjct: 269 QSLLVKNPEKRPTAEICLSHSWLQQWDFENLFHPEETSSSSQT 311

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score =  112 bits (279), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 92/273 (33%), Positives = 132/273 (48%), Gaps = 45/273 (16%)
Query: 8   KDIGSGNFGVARLMRNKNTKELVAMKYI--ERGHKIDANVAREIINHKQLRHPNIIRFKE 65
           + +GSG FG   L+  +++     +K I  +R       +  EI   K L HPNII+  E
Sbjct: 28  RKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFE 87
Query: 66  VVLTPTHLAIVMEYAAGGELFERICNA---GR-FSEDEARYFFQQLI-------SGQICH 114
           V     ++ IVME   GGEL ERI +A   G+  SE       +Q++       S  + H
Sbjct: 88  VFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVH 147
Query: 115 RDLKLENTLL-DGSPAPRLKICDFGYSKSSLLHSRPKST--VGTPAYIAPEVLSRREYDG 171
           +DLK EN L  D SP   +KI DFG ++  L  S   ST   GT  Y+APEV  +R+   
Sbjct: 148 KDLKPENILFQDTSPHSPIKIIDFGLAE--LFKSDEHSTNAAGTALYMAPEVF-KRDVTF 204
Query: 172 KLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQ----YKIPDYVHISQDCR 227
           K  D+WS GV +Y +L G  PF           T + +  VQ    YK P+Y   + +CR
Sbjct: 205 K-CDIWSAGVVMYFLLTGCLPF-----------TGTSLEEVQQKATYKEPNY---AVECR 249
Query: 228 -------NLLSRIFVANPSRRITIKEIKSHPWF 253
                  +LL ++   +P RR +  ++  H WF
Sbjct: 250 PLTPQAVDLLKQMLTKDPERRPSAAQVLHHEWF 282

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score =  112 bits (279), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 89/273 (32%), Positives = 133/273 (48%), Gaps = 29/273 (10%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQL----RH 57
           E YE++K IG G FG  +L+R+K+T+++ AMK + +   I  + +      + +      
Sbjct: 69  EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANS 128
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFERICN------AGRFSEDEARYFFQQLISGQ 111
           P +++         +L +VMEY  GG+L   + N        RF   E       + S  
Sbjct: 129 PWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMG 188
Query: 112 ICHRDLKLENTLLDGSPAPRLKICDFG----YSKSSLLHSRPKSTVGTPAYIAPEVLSRR 167
             HRD+K +N LLD S    LK+ DFG     +K  ++  R  + VGTP YI+PEVL  +
Sbjct: 189 FIHRDVKPDNMLLDKS--GHLKLADFGTCMKMNKEGMV--RCDTAVGTPDYISPEVLKSQ 244
Query: 168 ---EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKI--PDYVHI 222
               Y G+  D WS GV LY MLVG  PF       +   T S+IM  +  +  PD   I
Sbjct: 245 GGDGYYGRECDWWSVGVFLYEMLVGDTPFY----ADSLVGTYSKIMNHKNSLTFPDDNDI 300
Query: 223 SQDCRNLLSRIFVANPSR--RITIKEIKSHPWF 253
           S++ +NL+         R  R  ++EIK H +F
Sbjct: 301 SKEAKNLICAFLTDREVRLGRNGVEEIKRHLFF 333

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score =  112 bits (279), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 89/273 (32%), Positives = 133/273 (48%), Gaps = 29/273 (10%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQL----RH 57
           E YE++K IG G FG  +L+R+K+T+++ AMK + +   I  + +      + +      
Sbjct: 74  EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANS 133
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFERICN------AGRFSEDEARYFFQQLISGQ 111
           P +++         +L +VMEY  GG+L   + N        RF   E       + S  
Sbjct: 134 PWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMG 193
Query: 112 ICHRDLKLENTLLDGSPAPRLKICDFG----YSKSSLLHSRPKSTVGTPAYIAPEVLSRR 167
             HRD+K +N LLD S    LK+ DFG     +K  ++  R  + VGTP YI+PEVL  +
Sbjct: 194 FIHRDVKPDNMLLDKS--GHLKLADFGTCMKMNKEGMV--RCDTAVGTPDYISPEVLKSQ 249
Query: 168 ---EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKI--PDYVHI 222
               Y G+  D WS GV LY MLVG  PF       +   T S+IM  +  +  PD   I
Sbjct: 250 GGDGYYGRECDWWSVGVFLYEMLVGDTPFY----ADSLVGTYSKIMNHKNSLTFPDDNDI 305
Query: 223 SQDCRNLLSRIFVANPSR--RITIKEIKSHPWF 253
           S++ +NL+         R  R  ++EIK H +F
Sbjct: 306 SKEAKNLICAFLTDREVRLGRNGVEEIKRHLFF 338

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score =  112 bits (279), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 89/273 (32%), Positives = 133/273 (48%), Gaps = 29/273 (10%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQL----RH 57
           E YE++K IG G FG  +L+R+K+T+++ AMK + +   I  + +      + +      
Sbjct: 74  EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANS 133
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFERICN------AGRFSEDEARYFFQQLISGQ 111
           P +++         +L +VMEY  GG+L   + N        RF   E       + S  
Sbjct: 134 PWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMG 193
Query: 112 ICHRDLKLENTLLDGSPAPRLKICDFG----YSKSSLLHSRPKSTVGTPAYIAPEVLSRR 167
             HRD+K +N LLD S    LK+ DFG     +K  ++  R  + VGTP YI+PEVL  +
Sbjct: 194 FIHRDVKPDNMLLDKS--GHLKLADFGTCMKMNKEGMV--RCDTAVGTPDYISPEVLKSQ 249
Query: 168 EYD---GKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKI--PDYVHI 222
             D   G+  D WS GV LY MLVG  PF       +   T S+IM  +  +  PD   I
Sbjct: 250 GGDGYYGRECDWWSVGVFLYEMLVGDTPFY----ADSLVGTYSKIMNHKNSLTFPDDNDI 305
Query: 223 SQDCRNLLSRIFVANPSR--RITIKEIKSHPWF 253
           S++ +NL+         R  R  ++EIK H +F
Sbjct: 306 SKEAKNLICAFLTDREVRLGRNGVEEIKRHLFF 338

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score =  110 bits (274), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 77/271 (28%), Positives = 134/271 (49%), Gaps = 27/271 (9%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKI-DANVAREIINHKQL---- 55
           +  +  +  +G G+FG   L   K T+EL A+K +++   I D +V   ++  + L    
Sbjct: 18  LTDFNFLMVLGKGSFGKVMLADRKGTEELYAIKILKKDVVIQDDDVECTMVEKRVLALLD 77
Query: 56  RHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG----- 110
           + P + +      T   L  VMEY  GG+L   I   G+F E +A ++  ++  G     
Sbjct: 78  KPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISIGLFFLH 137
Query: 111 --QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS-RPKSTVGTPAYIAPEVLSRR 167
              I +RDLKL+N +LD      +KI DFG  K  ++     +   GTP YIAPE+++ +
Sbjct: 138 KRGIIYRDLKLDNVMLDSEG--HIKIADFGMCKEHMMDGVTTREFCGTPDYIAPEIIAYQ 195
Query: 168 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCR 227
            Y GK  D W+ GV LY ML G  PF+ +++ + F+     IM      P    +S++  
Sbjct: 196 PY-GKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQS----IMEHNVSYPK--SLSKEAV 248
Query: 228 NLLSRIFVANPSRRITI-----KEIKSHPWF 253
           ++   +   +P++R+       ++++ H +F
Sbjct: 249 SICKGLMTKHPAKRLGCGPEGERDVREHAFF 279

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score =  110 bits (274), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 90/294 (30%), Positives = 143/294 (48%), Gaps = 28/294 (9%)
Query: 2   EKYELMKDI-GSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINH--KQLRHP 58
           + Y+L K + G G  G      ++ T +  A+K +      D+  AR+ ++H  +    P
Sbjct: 28  DDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLL-----YDSPKARQEVDHHWQASGGP 82
Query: 59  NIIRFKEVVLTPTH----LAIVMEYAAGGELFERICNAGR--FSEDEARYFF-------Q 105
           +I+   +V     H    L I+ME   GGELF RI   G   F+E EA           Q
Sbjct: 83  HIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQ 142
Query: 106 QLISGQICHRDLKLENTLLDGSPAPR-LKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVL 164
            L S  I HRD+K EN L         LK+ DFG++K +  ++  ++   TP Y+APEVL
Sbjct: 143 FLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNAL-QTPCYTPYYVAPEVL 201
Query: 165 SRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPD--YVHI 222
              +YD K  D+WS GV +Y++L G  PF              RI   QY  P+  +  +
Sbjct: 202 GPEKYD-KSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSEV 260
Query: 223 SQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNL--PRELTETAQAIYYRKEN 274
           S+D + L+  +   +P+ R+TI +  +HPW  +++  P+    TA+ +   K++
Sbjct: 261 SEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSMVVPQTPLHTARVLQEDKDH 314

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score =  109 bits (273), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 90/294 (30%), Positives = 143/294 (48%), Gaps = 28/294 (9%)
Query: 2   EKYELMKDI-GSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINH--KQLRHP 58
           + Y+L K + G G  G      ++ T +  A+K +      D+  AR+ ++H  +    P
Sbjct: 9   DDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLL-----YDSPKARQEVDHHWQASGGP 63
Query: 59  NIIRFKEVVLTPTH----LAIVMEYAAGGELFERICNAGR--FSEDEARYFF-------Q 105
           +I+   +V     H    L I+ME   GGELF RI   G   F+E EA           Q
Sbjct: 64  HIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQ 123
Query: 106 QLISGQICHRDLKLENTLLDGSPAPR-LKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVL 164
            L S  I HRD+K EN L         LK+ DFG++K +  ++  ++   TP Y+APEVL
Sbjct: 124 FLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNAL-QTPCYTPYYVAPEVL 182
Query: 165 SRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPD--YVHI 222
              +YD K  D+WS GV +Y++L G  PF              RI   QY  P+  +  +
Sbjct: 183 GPEKYD-KSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSEV 241
Query: 223 SQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNL--PRELTETAQAIYYRKEN 274
           S+D + L+  +   +P+ R+TI +  +HPW  +++  P+    TA+ +   K++
Sbjct: 242 SEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSMVVPQTPLHTARVLQEDKDH 295

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score =  109 bits (273), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 86/283 (30%), Positives = 137/283 (48%), Gaps = 27/283 (9%)
Query: 10  IGSGNFGVARLMRNKNTKELVAMKYIERGHKIDAN----VAREIINHKQLRHPNIIRFKE 65
           +G G F     + + +TKE+ A K + +   +  +    ++ EI  H+ L H +++ F  
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 84
Query: 66  VVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-------QICHRDLK 118
                  + +V+E      L E        +E EARY+ +Q++ G       ++ HRDLK
Sbjct: 85  FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLK 144
Query: 119 LENTLLDGSPAPRLKICDFGY-SKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLADVW 177
           L N  L+      +KI DFG  +K      R K+  GTP YIAPEVLS++ +  ++ DVW
Sbjct: 145 LGNLFLNED--LEVKIGDFGLATKVEYDGERKKTLCGTPNYIAPEVLSKKGHSFEV-DVW 201
Query: 178 SCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVAN 237
           S G  +Y +LVG  PFE        ++T  RI   +Y IP   HI+    +L+ ++   +
Sbjct: 202 SIGCIMYTLLVGKPPFETS----CLKETYLRIKKNEYSIPK--HINPVAASLIQKMLQTD 255
Query: 238 PSRRITIKEIKSHPWFLKN-LPRELTETAQAIYYRKENPTFSL 279
           P+ R TI E+ +  +F    +P  L  T   I      P FS+
Sbjct: 256 PTARPTINELLNDEFFTSGYIPARLPITCLTI-----PPXFSI 293

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score =  109 bits (273), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 83/272 (30%), Positives = 133/272 (48%), Gaps = 22/272 (8%)
Query: 10  IGSGNFGVARLMRNKNTKELVAMKYIERGHKIDAN----VAREIINHKQLRHPNIIRFKE 65
           +G G F     + + +TKE+ A K + +   +  +    ++ EI  H+ L H +++ F  
Sbjct: 29  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 88
Query: 66  VVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-------QICHRDLK 118
                  + +V+E      L E        +E EARY+ +Q++ G       ++ HRDLK
Sbjct: 89  FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLK 148
Query: 119 LENTLLDGSPAPRLKICDFGY-SKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLADVW 177
           L N  L+      +KI DFG  +K      R K+  GTP YIAPEVLS++ +  ++ DVW
Sbjct: 149 LGNLFLNED--LEVKIGDFGLATKVEYDGERKKTLCGTPNYIAPEVLSKKGHSFEV-DVW 205
Query: 178 SCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVAN 237
           S G  +Y +LVG  PFE        ++T  RI   +Y IP   HI+    +L+ ++   +
Sbjct: 206 SIGCIMYTLLVGKPPFETS----CLKETYLRIKKNEYSIPK--HINPVAASLIQKMLQTD 259
Query: 238 PSRRITIKEIKSHPWFLKN-LPRELTETAQAI 268
           P+ R TI E+ +  +F    +P  L  T   I
Sbjct: 260 PTARPTINELLNDEFFTSGYIPARLPITCLTI 291

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score =  109 bits (272), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 83/272 (30%), Positives = 133/272 (48%), Gaps = 22/272 (8%)
Query: 10  IGSGNFGVARLMRNKNTKELVAMKYIERGHKIDAN----VAREIINHKQLRHPNIIRFKE 65
           +G G F     + + +TKE+ A K + +   +  +    ++ EI  H+ L H +++ F  
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 84
Query: 66  VVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-------QICHRDLK 118
                  + +V+E      L E        +E EARY+ +Q++ G       ++ HRDLK
Sbjct: 85  FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLK 144
Query: 119 LENTLLDGSPAPRLKICDFGY-SKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLADVW 177
           L N  L+      +KI DFG  +K      R K+  GTP YIAPEVLS++ +  ++ DVW
Sbjct: 145 LGNLFLNED--LEVKIGDFGLATKVEYDGERKKTLCGTPNYIAPEVLSKKGHSFEV-DVW 201
Query: 178 SCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVAN 237
           S G  +Y +LVG  PFE        ++T  RI   +Y IP   HI+    +L+ ++   +
Sbjct: 202 SIGCIMYTLLVGKPPFETS----CLKETYLRIKKNEYSIPK--HINPVAASLIQKMLQTD 255
Query: 238 PSRRITIKEIKSHPWFLKN-LPRELTETAQAI 268
           P+ R TI E+ +  +F    +P  L  T   I
Sbjct: 256 PTARPTINELLNDEFFTSGYIPARLPITCLTI 287

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score =  108 bits (270), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 87/310 (28%), Positives = 135/310 (43%), Gaps = 61/310 (19%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDAN------VAREIINHKQL 55
           +KY L   IG G++GV R+     T+ + A+K + +      N      +  E+   K+L
Sbjct: 26  KKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKL 85
Query: 56  RHPNIIRFKEVVLTPTHLAIVMEYAAGGELFER--------------------ICNAGRF 95
            HPNI R  EV     ++ +VME   GG L ++                    IC     
Sbjct: 86  HHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPEC 145
Query: 96  SED----------EARYFFQ--QLISG---------------QICHRDLKLENTLLDGSP 128
           +E+          E+  F Q  +LIS                 ICHRD+K EN L   + 
Sbjct: 146 NEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNK 205
Query: 129 APRLKICDFGYSK-----SSLLHSRPKSTVGTPAYIAPEVL-SRREYDGKLADVWSCGVT 182
           +  +K+ DFG SK     ++  +    +  GTP ++APEVL +  E  G   D WS GV 
Sbjct: 206 SFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVL 265
Query: 183 LYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRI 242
           L+++L+GA PF    D     + +++ +   ++ P+Y  +S   R+LLS +   N   R 
Sbjct: 266 LHLLLMGAVPFPGVNDADTISQVLNKKLC--FENPNYNVLSPLARDLLSNLLNRNVDERF 323
Query: 243 TIKEIKSHPW 252
                  HPW
Sbjct: 324 DAMRALQHPW 333

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score =  108 bits (269), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 83/272 (30%), Positives = 132/272 (48%), Gaps = 22/272 (8%)
Query: 10  IGSGNFGVARLMRNKNTKELVAMKYIERGHKIDAN----VAREIINHKQLRHPNIIRFKE 65
           +G G F     + + +TKE+ A K + +   +  +    ++ EI  H+ L H +++ F  
Sbjct: 47  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 106
Query: 66  VVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-------QICHRDLK 118
                  + +V+E      L E        +E EARY+ +Q++ G       ++ HRDLK
Sbjct: 107 FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLK 166
Query: 119 LENTLLDGSPAPRLKICDFGY-SKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLADVW 177
           L N  L+      +KI DFG  +K      R K   GTP YIAPEVLS++ +  ++ DVW
Sbjct: 167 LGNLFLNED--LEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEV-DVW 223
Query: 178 SCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVAN 237
           S G  +Y +LVG  PFE        ++T  RI   +Y IP   HI+    +L+ ++   +
Sbjct: 224 SIGCIMYTLLVGKPPFETS----CLKETYLRIKKNEYSIPK--HINPVAASLIQKMLQTD 277
Query: 238 PSRRITIKEIKSHPWFLKN-LPRELTETAQAI 268
           P+ R TI E+ +  +F    +P  L  T   I
Sbjct: 278 PTARPTINELLNDEFFTSGYIPARLPITCLTI 309

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score =  108 bits (269), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 83/272 (30%), Positives = 132/272 (48%), Gaps = 22/272 (8%)
Query: 10  IGSGNFGVARLMRNKNTKELVAMKYIERGHKIDAN----VAREIINHKQLRHPNIIRFKE 65
           +G G F     + + +TKE+ A K + +   +  +    ++ EI  H+ L H +++ F  
Sbjct: 23  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82
Query: 66  VVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-------QICHRDLK 118
                  + +V+E      L E        +E EARY+ +Q++ G       ++ HRDLK
Sbjct: 83  FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLK 142
Query: 119 LENTLLDGSPAPRLKICDFGY-SKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLADVW 177
           L N  L+      +KI DFG  +K      R K   GTP YIAPEVLS++ +  ++ DVW
Sbjct: 143 LGNLFLNED--LEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEV-DVW 199
Query: 178 SCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVAN 237
           S G  +Y +LVG  PFE        ++T  RI   +Y IP   HI+    +L+ ++   +
Sbjct: 200 SIGCIMYTLLVGKPPFETS----CLKETYLRIKKNEYSIPK--HINPVAASLIQKMLQTD 253
Query: 238 PSRRITIKEIKSHPWFLKN-LPRELTETAQAI 268
           P+ R TI E+ +  +F    +P  L  T   I
Sbjct: 254 PTARPTINELLNDEFFTSGYIPARLPITCLTI 285

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score =  108 bits (269), Expect = 6e-24,   Method: Compositional matrix adjust.
 Identities = 83/272 (30%), Positives = 132/272 (48%), Gaps = 22/272 (8%)
Query: 10  IGSGNFGVARLMRNKNTKELVAMKYIERGHKIDAN----VAREIINHKQLRHPNIIRFKE 65
           +G G F     + + +TKE+ A K + +   +  +    ++ EI  H+ L H +++ F  
Sbjct: 49  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108
Query: 66  VVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-------QICHRDLK 118
                  + +V+E      L E        +E EARY+ +Q++ G       ++ HRDLK
Sbjct: 109 FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLK 168
Query: 119 LENTLLDGSPAPRLKICDFGY-SKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLADVW 177
           L N  L+      +KI DFG  +K      R K   GTP YIAPEVLS++ +  ++ DVW
Sbjct: 169 LGNLFLNED--LEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEV-DVW 225
Query: 178 SCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVAN 237
           S G  +Y +LVG  PFE        ++T  RI   +Y IP   HI+    +L+ ++   +
Sbjct: 226 SIGCIMYTLLVGKPPFETS----CLKETYLRIKKNEYSIPK--HINPVAASLIQKMLQTD 279
Query: 238 PSRRITIKEIKSHPWFLKN-LPRELTETAQAI 268
           P+ R TI E+ +  +F    +P  L  T   I
Sbjct: 280 PTARPTINELLNDEFFTSGYIPARLPITCLTI 311

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score =  107 bits (268), Expect = 8e-24,   Method: Compositional matrix adjust.
 Identities = 83/273 (30%), Positives = 132/273 (48%), Gaps = 29/273 (10%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQL----RH 57
           E Y+++K IG G FG  +L+R+K ++++ AMK + +   I  + +      + +      
Sbjct: 75  EDYDVVKVIGRGAFGEVQLVRHKASQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANS 134
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFERICN------AGRFSEDEARYFFQQLISGQ 111
           P +++         +L +VMEY  GG+L   + N        +F   E       + S  
Sbjct: 135 PWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLALDAIHSMG 194
Query: 112 ICHRDLKLENTLLDGSPAPRLKICDFG----YSKSSLLHSRPKSTVGTPAYIAPEVLSRR 167
           + HRD+K +N LLD      LK+ DFG      ++ ++H    + VGTP YI+PEVL  +
Sbjct: 195 LIHRDVKPDNMLLD--KHGHLKLADFGTCMKMDETGMVHC--DTAVGTPDYISPEVLKSQ 250
Query: 168 EYD---GKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKI--PDYVHI 222
             D   G+  D WS GV L+ MLVG  PF       +   T S+IM  +  +  P+   I
Sbjct: 251 GGDGYYGRECDWWSVGVFLFEMLVGDTPFY----ADSLVGTYSKIMDHKNSLCFPEDAEI 306
Query: 223 SQDCRNLLSRIFVANPSR--RITIKEIKSHPWF 253
           S+  +NL+         R  R  ++EIK HP+F
Sbjct: 307 SKHAKNLICAFLTDREVRLGRNGVEEIKQHPFF 339

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score =  107 bits (267), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 81/295 (27%), Positives = 134/295 (45%), Gaps = 36/295 (12%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIER-----GHKIDANVAREIINHKQL 55
           ++ ++L++ IG G++    L+R K T  + AMK +++        ID     + +  +  
Sbjct: 4   LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQAS 63
Query: 56  RHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYF-------FQQLI 108
            HP ++       T + L  V+EY  GG+L   +    +  E+ AR++          L 
Sbjct: 64  NHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLH 123
Query: 109 SGQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTV----GTPAYIAPEVL 164
              I +RDLKL+N LLD      +K+ D+G  K  L   RP  T     GTP YIAPE+L
Sbjct: 124 ERGIIYRDLKLDNVLLDSE--GHIKLTDYGMCKEGL---RPGDTTSXFCGTPNYIAPEIL 178
Query: 165 SRREYDGKLADVWSCGVTLYVMLVGAYPFE-----DQEDPKNFRKTISRIMAVQYKIPDY 219
              +Y G   D W+ GV ++ M+ G  PF+     D  D          I+  Q +IP  
Sbjct: 179 RGEDY-GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIP-- 235
Query: 220 VHISQDCRNLLSRIFVANPSRRI------TIKEIKSHPWFLKNLPRELTETAQAI 268
             +S    ++L      +P  R+         +I+ HP+F +N+  ++ E  Q +
Sbjct: 236 RSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFF-RNVDWDMMEQKQVV 289

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score =  107 bits (266), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 80/295 (27%), Positives = 134/295 (45%), Gaps = 36/295 (12%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIER-----GHKIDANVAREIINHKQL 55
           ++ ++L++ IG G++    L+R K T  + AMK +++        ID     + +  +  
Sbjct: 19  LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQAS 78
Query: 56  RHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYF-------FQQLI 108
            HP ++       T + L  V+EY  GG+L   +    +  E+ AR++          L 
Sbjct: 79  NHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLH 138
Query: 109 SGQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTV----GTPAYIAPEVL 164
              I +RDLKL+N LLD      +K+ D+G  K  L   RP  T     GTP YIAPE+L
Sbjct: 139 ERGIIYRDLKLDNVLLDSE--GHIKLTDYGMCKEGL---RPGDTTSXFCGTPNYIAPEIL 193
Query: 165 SRREYDGKLADVWSCGVTLYVMLVGAYPFE-----DQEDPKNFRKTISRIMAVQYKIPDY 219
              +Y G   D W+ GV ++ M+ G  PF+     D  D          I+  Q +IP  
Sbjct: 194 RGEDY-GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRS 252
Query: 220 VHISQDCRNLLSRIFVANPSRRI------TIKEIKSHPWFLKNLPRELTETAQAI 268
           + +     ++L      +P  R+         +I+ HP+F +N+  ++ E  Q +
Sbjct: 253 MSVK--AASVLKSFLNKDPKERLGCLPQTGFADIQGHPFF-RNVDWDMMEQKQVV 304

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score =  107 bits (266), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 81/295 (27%), Positives = 134/295 (45%), Gaps = 36/295 (12%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIER-----GHKIDANVAREIINHKQL 55
           ++ ++L++ IG G++    L+R K T  + AMK +++        ID     + +  +  
Sbjct: 8   LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQAS 67
Query: 56  RHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYF-------FQQLI 108
            HP ++       T + L  V+EY  GG+L   +    +  E+ AR++          L 
Sbjct: 68  NHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLH 127
Query: 109 SGQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTV----GTPAYIAPEVL 164
              I +RDLKL+N LLD      +K+ D+G  K  L   RP  T     GTP YIAPE+L
Sbjct: 128 ERGIIYRDLKLDNVLLDSE--GHIKLTDYGMCKEGL---RPGDTTSXFCGTPNYIAPEIL 182
Query: 165 SRREYDGKLADVWSCGVTLYVMLVGAYPFE-----DQEDPKNFRKTISRIMAVQYKIPDY 219
              +Y G   D W+ GV ++ M+ G  PF+     D  D          I+  Q +IP  
Sbjct: 183 RGEDY-GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIP-- 239
Query: 220 VHISQDCRNLLSRIFVANPSRRI------TIKEIKSHPWFLKNLPRELTETAQAI 268
             +S    ++L      +P  R+         +I+ HP+F +N+  ++ E  Q +
Sbjct: 240 RSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFF-RNVDWDMMEQKQVV 293

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score =  106 bits (264), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 79/292 (27%), Positives = 133/292 (45%), Gaps = 30/292 (10%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIER-----GHKIDANVAREIINHKQL 55
           ++ ++L++ IG G++    L+R K T  + AM+ +++        ID     + +  +  
Sbjct: 51  LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQAS 110
Query: 56  RHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYF-------FQQLI 108
            HP ++       T + L  V+EY  GG+L   +    +  E+ AR++          L 
Sbjct: 111 NHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLH 170
Query: 109 SGQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST-VGTPAYIAPEVLSRR 167
              I +RDLKL+N LLD      +K+ D+G  K  L      ST  GTP YIAPE+L   
Sbjct: 171 ERGIIYRDLKLDNVLLDSE--GHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGE 228
Query: 168 EYDGKLADVWSCGVTLYVMLVGAYPFE-----DQEDPKNFRKTISRIMAVQYKIPDYVHI 222
           +Y G   D W+ GV ++ M+ G  PF+     D  D          I+  Q +IP    +
Sbjct: 229 DY-GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIP--RSL 285
Query: 223 SQDCRNLLSRIFVANPSRRI------TIKEIKSHPWFLKNLPRELTETAQAI 268
           S    ++L      +P  R+         +I+ HP+F +N+  ++ E  Q +
Sbjct: 286 SVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFF-RNVDWDMMEQKQVV 336

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score =  105 bits (263), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 80/280 (28%), Positives = 140/280 (50%), Gaps = 30/280 (10%)
Query: 1   MEKYELMKDIGSGNFGVARLMR---NKNTKELVAMKYIERGHKID-------ANVAREII 50
           +E +EL+K +G+G +G   L+R     +T +L AMK +++   +            R+++
Sbjct: 53  IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVL 112
Query: 51  NHKQLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG 110
            H + + P ++       T T L ++++Y  GGELF  +    RF+E E + +  +++  
Sbjct: 113 EHIR-QSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLA 171
Query: 111 -------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH--SRPKSTVGTPAYIAP 161
                   I +RD+KLEN LLD +    + + DFG SK  +     R     GT  Y+AP
Sbjct: 172 LEHLHKLGIIYRDIKLENILLDSN--GHVVLTDFGLSKEFVADETERAYDFCGTIEYMAP 229
Query: 162 EVLSRREYD-GKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYV 220
           +++   +    K  D WS GV +Y +L GA PF   +  KN +  ISR + ++ + P   
Sbjct: 230 DIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFT-VDGEKNSQAEISRRI-LKSEPPYPQ 287
Query: 221 HISQDCRNLLSRIFVANPSRRI-----TIKEIKSHPWFLK 255
            +S   ++L+ R+ + +P +R+        EIK H +F K
Sbjct: 288 EMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQK 327

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score =  104 bits (260), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 81/276 (29%), Positives = 132/276 (47%), Gaps = 30/276 (10%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIE---------RGHKIDANVAREIINH 52
           +KY+    IG G   V R   ++ T    A+K +E         +  ++     RE    
Sbjct: 94  QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHIL 153
Query: 53  KQLR-HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLI--- 108
           +Q+  HP+II   +   + + + +V +    GELF+ +      SE E R   + L+   
Sbjct: 154 RQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAV 213
Query: 109 ----SGQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVL 164
               +  I HRDLK EN LLD +   ++++ DFG+S       + +   GTP Y+APE+L
Sbjct: 214 SFLHANNIVHRDLKPENILLDDNM--QIRLSDFGFSCHLEPGEKLRELCGTPGYLAPEIL 271
Query: 165 --SRREYD---GKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKI--P 217
             S  E     GK  D+W+CGV L+ +L G+ PF  +      R     IM  QY+   P
Sbjct: 272 KCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRM----IMEGQYQFSSP 327
Query: 218 DYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 253
           ++   S   ++L+SR+   +P  R+T ++   HP+F
Sbjct: 328 EWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFF 363

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score =  104 bits (260), Expect = 7e-23,   Method: Compositional matrix adjust.
 Identities = 78/272 (28%), Positives = 129/272 (47%), Gaps = 29/272 (10%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDAN----VAREIINHKQLRH 57
           E ++  K +G G+F    L R   T    A+K +E+ H I  N    V RE     +L H
Sbjct: 29  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 88
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG------- 110
           P  ++          L   + YA  GEL + I   G F E   R++  +++S        
Sbjct: 89  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 148
Query: 111 QICHRDLKLENTLLDGSPAPRLKICDFGYSK---SSLLHSRPKSTVGTPAYIAPEVLSRR 167
            I HRDLK EN LL+      ++I DFG +K        +R  S VGT  Y++PE+L+ +
Sbjct: 149 GIIHRDLKPENILLNED--MHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEK 206
Query: 168 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCR 227
               K +D+W+ G  +Y ++ G  PF    +   F+K    I+ ++Y  P+        R
Sbjct: 207 S-ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQK----IIKLEYDFPE--KFFPKAR 259
Query: 228 NLLSRIFVANPSRRITIKE------IKSHPWF 253
           +L+ ++ V + ++R+  +E      +K+HP+F
Sbjct: 260 DLVEKLLVLDATKRLGCEEMEGYGPLKAHPFF 291

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score =  104 bits (259), Expect = 8e-23,   Method: Compositional matrix adjust.
 Identities = 78/272 (28%), Positives = 129/272 (47%), Gaps = 29/272 (10%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDAN----VAREIINHKQLRH 57
           E ++  K +G G+F    L R   T    A+K +E+ H I  N    V RE     +L H
Sbjct: 33  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 92
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG------- 110
           P  ++          L   + YA  GEL + I   G F E   R++  +++S        
Sbjct: 93  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 152
Query: 111 QICHRDLKLENTLLDGSPAPRLKICDFGYSK---SSLLHSRPKSTVGTPAYIAPEVLSRR 167
            I HRDLK EN LL+      ++I DFG +K        +R  S VGT  Y++PE+L+ +
Sbjct: 153 GIIHRDLKPENILLNED--MHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEK 210
Query: 168 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCR 227
               K +D+W+ G  +Y ++ G  PF    +   F+K    I+ ++Y  P+        R
Sbjct: 211 S-ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQK----IIKLEYDFPE--KFFPKAR 263
Query: 228 NLLSRIFVANPSRRITIKE------IKSHPWF 253
           +L+ ++ V + ++R+  +E      +K+HP+F
Sbjct: 264 DLVEKLLVLDATKRLGCEEMEGYGPLKAHPFF 295

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score =  103 bits (257), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 77/272 (28%), Positives = 129/272 (47%), Gaps = 29/272 (10%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDAN----VAREIINHKQLRH 57
           E ++  K +G G+F    L R   T    A+K +E+ H I  N    V RE     +L H
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG------- 110
           P  ++          L   + YA  GEL + I   G F E   R++  +++S        
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 149
Query: 111 QICHRDLKLENTLLDGSPAPRLKICDFGYSK---SSLLHSRPKSTVGTPAYIAPEVLSRR 167
            I HRDLK EN LL+      ++I DFG +K        +R  + VGT  Y++PE+L+ +
Sbjct: 150 GIIHRDLKPENILLNED--MHIQITDFGTAKVLSPESKQARANAFVGTAQYVSPELLTEK 207
Query: 168 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCR 227
               K +D+W+ G  +Y ++ G  PF    +   F+K    I+ ++Y  P+        R
Sbjct: 208 S-ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQK----IIKLEYDFPE--KFFPKAR 260
Query: 228 NLLSRIFVANPSRRITIKE------IKSHPWF 253
           +L+ ++ V + ++R+  +E      +K+HP+F
Sbjct: 261 DLVEKLLVLDATKRLGCEEMEGYGPLKAHPFF 292

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score =  102 bits (255), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 77/272 (28%), Positives = 128/272 (47%), Gaps = 29/272 (10%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDAN----VAREIINHKQLRH 57
           E ++  K +G G+F    L R   T    A+K +E+ H I  N    V RE     +L H
Sbjct: 7   EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 66
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG------- 110
           P  ++          L   + YA  GEL + I   G F E   R++  +++S        
Sbjct: 67  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 126
Query: 111 QICHRDLKLENTLLDGSPAPRLKICDFGYSK---SSLLHSRPKSTVGTPAYIAPEVLSRR 167
            I HRDLK EN LL+      ++I DFG +K        +R    VGT  Y++PE+L+ +
Sbjct: 127 GIIHRDLKPENILLNED--MHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 184
Query: 168 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCR 227
               K +D+W+ G  +Y ++ G  PF    +   F+K    I+ ++Y  P+        R
Sbjct: 185 S-ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQK----IIKLEYDFPE--KFFPKAR 237
Query: 228 NLLSRIFVANPSRRITIKE------IKSHPWF 253
           +L+ ++ V + ++R+  +E      +K+HP+F
Sbjct: 238 DLVEKLLVLDATKRLGCEEMEGYGPLKAHPFF 269

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score =  102 bits (255), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 76/272 (27%), Positives = 128/272 (47%), Gaps = 29/272 (10%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDAN----VAREIINHKQLRH 57
           E ++  K +G G+F    L R   T    A+K +E+ H I  N    V RE     +L H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG------- 110
           P  ++          L   + YA  GEL + I   G F E   R++  +++S        
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 151
Query: 111 QICHRDLKLENTLLDGSPAPRLKICDFGYSK---SSLLHSRPKSTVGTPAYIAPEVLSRR 167
            I HRDLK EN LL+      ++I DFG +K        +R    VGT  Y++PE+L+ +
Sbjct: 152 GIIHRDLKPENILLNED--MHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 209
Query: 168 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCR 227
               K +D+W+ G  +Y ++ G  PF    +   F    ++I+ ++Y  P+        R
Sbjct: 210 SAX-KSSDLWALGCIIYQLVAGLPPFRAGNEGLIF----AKIIKLEYDFPE--KFFPKAR 262
Query: 228 NLLSRIFVANPSRRITIKE------IKSHPWF 253
           +L+ ++ V + ++R+  +E      +K+HP+F
Sbjct: 263 DLVEKLLVLDATKRLGCEEMEGYGPLKAHPFF 294

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score =  102 bits (255), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 77/272 (28%), Positives = 128/272 (47%), Gaps = 29/272 (10%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDAN----VAREIINHKQLRH 57
           E ++  K +G G+F    L R   T    A+K +E+ H I  N    V RE     +L H
Sbjct: 8   EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 67
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG------- 110
           P  ++          L   + YA  GEL + I   G F E   R++  +++S        
Sbjct: 68  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 127
Query: 111 QICHRDLKLENTLLDGSPAPRLKICDFGYSK---SSLLHSRPKSTVGTPAYIAPEVLSRR 167
            I HRDLK EN LL+      ++I DFG +K        +R    VGT  Y++PE+L+ +
Sbjct: 128 GIIHRDLKPENILLNED--MHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 185
Query: 168 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCR 227
               K +D+W+ G  +Y ++ G  PF    +   F+K    I+ ++Y  P+        R
Sbjct: 186 S-ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQK----IIKLEYDFPE--KFFPKAR 238
Query: 228 NLLSRIFVANPSRRITIKE------IKSHPWF 253
           +L+ ++ V + ++R+  +E      +K+HP+F
Sbjct: 239 DLVEKLLVLDATKRLGCEEMEGYGPLKAHPFF 270

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score =  102 bits (255), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 77/272 (28%), Positives = 128/272 (47%), Gaps = 29/272 (10%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDAN----VAREIINHKQLRH 57
           E ++  K +G G+F    L R   T    A+K +E+ H I  N    V RE     +L H
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG------- 110
           P  ++          L   + YA  GEL + I   G F E   R++  +++S        
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 149
Query: 111 QICHRDLKLENTLLDGSPAPRLKICDFGYSK---SSLLHSRPKSTVGTPAYIAPEVLSRR 167
            I HRDLK EN LL+      ++I DFG +K        +R    VGT  Y++PE+L+ +
Sbjct: 150 GIIHRDLKPENILLNED--MHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 207
Query: 168 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCR 227
               K +D+W+ G  +Y ++ G  PF    +   F+K    I+ ++Y  P+        R
Sbjct: 208 S-ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQK----IIKLEYDFPE--KFFPKAR 260
Query: 228 NLLSRIFVANPSRRITIKE------IKSHPWF 253
           +L+ ++ V + ++R+  +E      +K+HP+F
Sbjct: 261 DLVEKLLVLDATKRLGCEEMEGYGPLKAHPFF 292

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score =  102 bits (255), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 77/272 (28%), Positives = 128/272 (47%), Gaps = 29/272 (10%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDAN----VAREIINHKQLRH 57
           E ++  K +G G+F    L R   T    A+K +E+ H I  N    V RE     +L H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG------- 110
           P  ++          L   + YA  GEL + I   G F E   R++  +++S        
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 151
Query: 111 QICHRDLKLENTLLDGSPAPRLKICDFGYSK---SSLLHSRPKSTVGTPAYIAPEVLSRR 167
            I HRDLK EN LL+      ++I DFG +K        +R    VGT  Y++PE+L+ +
Sbjct: 152 GIIHRDLKPENILLNED--MHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 209
Query: 168 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCR 227
               K +D+W+ G  +Y ++ G  PF    +   F+K    I+ ++Y  P+        R
Sbjct: 210 S-ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQK----IIKLEYDFPE--KFFPKAR 262
Query: 228 NLLSRIFVANPSRRITIKE------IKSHPWF 253
           +L+ ++ V + ++R+  +E      +K+HP+F
Sbjct: 263 DLVEKLLVLDATKRLGCEEMEGYGPLKAHPFF 294

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score =  102 bits (255), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 77/272 (28%), Positives = 128/272 (47%), Gaps = 29/272 (10%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDAN----VAREIINHKQLRH 57
           E ++  K +G G+F    L R   T    A+K +E+ H I  N    V RE     +L H
Sbjct: 30  EDFKFGKILGEGSFSTTVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG------- 110
           P  ++          L   + YA  GEL + I   G F E   R++  +++S        
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 149
Query: 111 QICHRDLKLENTLLDGSPAPRLKICDFGYSK---SSLLHSRPKSTVGTPAYIAPEVLSRR 167
            I HRDLK EN LL+      ++I DFG +K        +R    VGT  Y++PE+L+ +
Sbjct: 150 GIIHRDLKPENILLNED--MHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 207
Query: 168 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCR 227
               K +D+W+ G  +Y ++ G  PF    +   F+K    I+ ++Y  P+        R
Sbjct: 208 S-ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQK----IIKLEYDFPE--KFFPKAR 260
Query: 228 NLLSRIFVANPSRRITIKE------IKSHPWF 253
           +L+ ++ V + ++R+  +E      +K+HP+F
Sbjct: 261 DLVEKLLVLDATKRLGCEEMEGYGPLKAHPFF 292

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score =  102 bits (255), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 77/272 (28%), Positives = 128/272 (47%), Gaps = 29/272 (10%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDAN----VAREIINHKQLRH 57
           E ++  K +G G+F    L R   T    A+K +E+ H I  N    V RE     +L H
Sbjct: 9   EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 68
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG------- 110
           P  ++          L   + YA  GEL + I   G F E   R++  +++S        
Sbjct: 69  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 128
Query: 111 QICHRDLKLENTLLDGSPAPRLKICDFGYSK---SSLLHSRPKSTVGTPAYIAPEVLSRR 167
            I HRDLK EN LL+      ++I DFG +K        +R    VGT  Y++PE+L+ +
Sbjct: 129 GIIHRDLKPENILLNED--MHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 186
Query: 168 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCR 227
               K +D+W+ G  +Y ++ G  PF    +   F+K    I+ ++Y  P+        R
Sbjct: 187 S-ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQK----IIKLEYDFPE--KFFPKAR 239
Query: 228 NLLSRIFVANPSRRITIKE------IKSHPWF 253
           +L+ ++ V + ++R+  +E      +K+HP+F
Sbjct: 240 DLVEKLLVLDATKRLGCEEMEGYGPLKAHPFF 271

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score =  102 bits (255), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 77/272 (28%), Positives = 128/272 (47%), Gaps = 29/272 (10%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDAN----VAREIINHKQLRH 57
           E ++  K +G G+F    L R   T    A+K +E+ H I  N    V RE     +L H
Sbjct: 10  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 69
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG------- 110
           P  ++          L   + YA  GEL + I   G F E   R++  +++S        
Sbjct: 70  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 129
Query: 111 QICHRDLKLENTLLDGSPAPRLKICDFGYSK---SSLLHSRPKSTVGTPAYIAPEVLSRR 167
            I HRDLK EN LL+      ++I DFG +K        +R    VGT  Y++PE+L+ +
Sbjct: 130 GIIHRDLKPENILLNED--MHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 187
Query: 168 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCR 227
               K +D+W+ G  +Y ++ G  PF    +   F+K    I+ ++Y  P+        R
Sbjct: 188 S-ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQK----IIKLEYDFPE--KFFPKAR 240
Query: 228 NLLSRIFVANPSRRITIKE------IKSHPWF 253
           +L+ ++ V + ++R+  +E      +K+HP+F
Sbjct: 241 DLVEKLLVLDATKRLGCEEMEGYGPLKAHPFF 272

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score =  102 bits (255), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 84/275 (30%), Positives = 118/275 (42%), Gaps = 43/275 (15%)
Query: 3   KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIIN----------- 51
           +Y L   +G G FG          +  VA+K I R   +  +   + +            
Sbjct: 32  EYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKV 91
Query: 52  HKQLRHPNIIRFKEVVLTPTHLAIVMEYA-AGGELFERICNAGRFSEDEARYFFQQLISG 110
                HP +IR  +   T     +V+E      +LF+ I   G   E  +R FF Q+++ 
Sbjct: 92  GAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAA 151
Query: 111 -QICH------RDLKLENTLLD---GSPAPRLKICDFGYSKSSLLHSRPKSTV-GTPAYI 159
            Q CH      RD+K EN L+D   G      K+ DFG    +LLH  P +   GT  Y 
Sbjct: 152 IQHCHSRGVVHRDIKDENILIDLRRGC----AKLIDFG--SGALLHDEPYTDFDGTRVYS 205
Query: 160 APEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFE-DQEDPKNFRKTISRIMAVQYKIPD 218
            PE +SR +Y    A VWS G+ LY M+ G  PFE DQE           I+  +   P 
Sbjct: 206 PPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE-----------ILEAELHFP- 253
Query: 219 YVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 253
             H+S DC  L+ R     PS R +++EI   PW 
Sbjct: 254 -AHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWM 287

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score =  102 bits (255), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 77/272 (28%), Positives = 128/272 (47%), Gaps = 29/272 (10%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDAN----VAREIINHKQLRH 57
           E ++  K +G G+F    L R   T    A+K +E+ H I  N    V RE     +L H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG------- 110
           P  ++          L   + YA  GEL + I   G F E   R++  +++S        
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 151
Query: 111 QICHRDLKLENTLLDGSPAPRLKICDFGYSK---SSLLHSRPKSTVGTPAYIAPEVLSRR 167
            I HRDLK EN LL+      ++I DFG +K        +R    VGT  Y++PE+L+ +
Sbjct: 152 GIIHRDLKPENILLNED--MHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 209
Query: 168 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCR 227
               K +D+W+ G  +Y ++ G  PF    +   F+K    I+ ++Y  P+        R
Sbjct: 210 S-ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQK----IIKLEYDFPE--KFFPKAR 262
Query: 228 NLLSRIFVANPSRRITIKE------IKSHPWF 253
           +L+ ++ V + ++R+  +E      +K+HP+F
Sbjct: 263 DLVEKLLVLDATKRLGCEEMEGYGPLKAHPFF 294

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score =  102 bits (255), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 77/272 (28%), Positives = 128/272 (47%), Gaps = 29/272 (10%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDAN----VAREIINHKQLRH 57
           E ++  K +G G+F    L R   T    A+K +E+ H I  N    V RE     +L H
Sbjct: 14  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 73
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG------- 110
           P  ++          L   + YA  GEL + I   G F E   R++  +++S        
Sbjct: 74  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 133
Query: 111 QICHRDLKLENTLLDGSPAPRLKICDFGYSK---SSLLHSRPKSTVGTPAYIAPEVLSRR 167
            I HRDLK EN LL+      ++I DFG +K        +R    VGT  Y++PE+L+ +
Sbjct: 134 GIIHRDLKPENILLNED--MHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 191
Query: 168 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCR 227
               K +D+W+ G  +Y ++ G  PF    +   F+K    I+ ++Y  P+        R
Sbjct: 192 S-ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQK----IIKLEYDFPE--KFFPKAR 244
Query: 228 NLLSRIFVANPSRRITIKE------IKSHPWF 253
           +L+ ++ V + ++R+  +E      +K+HP+F
Sbjct: 245 DLVEKLLVLDATKRLGCEEMEGYGPLKAHPFF 276

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score =  102 bits (254), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 77/272 (28%), Positives = 128/272 (47%), Gaps = 29/272 (10%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDAN----VAREIINHKQLRH 57
           E ++  K +G G+F    L R   T    A+K +E+ H I  N    V RE     +L H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG------- 110
           P  ++          L   + YA  GEL + I   G F E   R++  +++S        
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 151
Query: 111 QICHRDLKLENTLLDGSPAPRLKICDFGYSK---SSLLHSRPKSTVGTPAYIAPEVLSRR 167
            I HRDLK EN LL+      ++I DFG +K        +R    VGT  Y++PE+L+ +
Sbjct: 152 GIIHRDLKPENILLNED--MHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 209
Query: 168 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCR 227
               K +D+W+ G  +Y ++ G  PF    +   F+K    I+ ++Y  P+        R
Sbjct: 210 S-ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQK----IIKLEYDFPE--KFFPKAR 262
Query: 228 NLLSRIFVANPSRRITIKE------IKSHPWF 253
           +L+ ++ V + ++R+  +E      +K+HP+F
Sbjct: 263 DLVEKLLVLDATKRLGCEEMEGYGPLKAHPFF 294

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score =  102 bits (254), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 77/272 (28%), Positives = 128/272 (47%), Gaps = 29/272 (10%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDAN----VAREIINHKQLRH 57
           E ++  K +G G+F    L R   T    A+K +E+ H I  N    V RE     +L H
Sbjct: 29  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 88
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG------- 110
           P  ++          L   + YA  GEL + I   G F E   R++  +++S        
Sbjct: 89  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 148
Query: 111 QICHRDLKLENTLLDGSPAPRLKICDFGYSK---SSLLHSRPKSTVGTPAYIAPEVLSRR 167
            I HRDLK EN LL+      ++I DFG +K        +R    VGT  Y++PE+L+ +
Sbjct: 149 GIIHRDLKPENILLNED--MHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 206
Query: 168 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCR 227
               K +D+W+ G  +Y ++ G  PF    +   F+K    I+ ++Y  P+        R
Sbjct: 207 S-ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQK----IIKLEYDFPE--KFFPKAR 259
Query: 228 NLLSRIFVANPSRRITIKE------IKSHPWF 253
           +L+ ++ V + ++R+  +E      +K+HP+F
Sbjct: 260 DLVEKLLVLDATKRLGCEEMEGYGPLKAHPFF 291

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score =  102 bits (254), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 77/272 (28%), Positives = 128/272 (47%), Gaps = 29/272 (10%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDAN----VAREIINHKQLRH 57
           E ++  K +G G+F    L R   T    A+K +E+ H I  N    V RE     +L H
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG------- 110
           P  ++          L   + YA  GEL + I   G F E   R++  +++S        
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 149
Query: 111 QICHRDLKLENTLLDGSPAPRLKICDFGYSK---SSLLHSRPKSTVGTPAYIAPEVLSRR 167
            I HRDLK EN LL+      ++I DFG +K        +R    VGT  Y++PE+L+ +
Sbjct: 150 GIIHRDLKPENILLNED--MHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 207
Query: 168 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCR 227
               K +D+W+ G  +Y ++ G  PF    +   F+K    I+ ++Y  P+        R
Sbjct: 208 S-ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQK----IIKLEYDFPE--KFFPKAR 260
Query: 228 NLLSRIFVANPSRRITIKE------IKSHPWF 253
           +L+ ++ V + ++R+  +E      +K+HP+F
Sbjct: 261 DLVEKLLVLDATKRLGCEEMEGYGPLKAHPFF 292

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score =  102 bits (254), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 77/272 (28%), Positives = 128/272 (47%), Gaps = 29/272 (10%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDAN----VAREIINHKQLRH 57
           E ++  K +G G+F    L R   T    A+K +E+ H I  N    V RE     +L H
Sbjct: 33  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 92
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG------- 110
           P  ++          L   + YA  GEL + I   G F E   R++  +++S        
Sbjct: 93  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 152
Query: 111 QICHRDLKLENTLLDGSPAPRLKICDFGYSK---SSLLHSRPKSTVGTPAYIAPEVLSRR 167
            I HRDLK EN LL+      ++I DFG +K        +R    VGT  Y++PE+L+ +
Sbjct: 153 GIIHRDLKPENILLNED--MHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 210
Query: 168 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCR 227
               K +D+W+ G  +Y ++ G  PF    +   F+K    I+ ++Y  P+        R
Sbjct: 211 S-ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQK----IIKLEYDFPE--KFFPKAR 263
Query: 228 NLLSRIFVANPSRRITIKE------IKSHPWF 253
           +L+ ++ V + ++R+  +E      +K+HP+F
Sbjct: 264 DLVEKLLVLDATKRLGCEEMEGYGPLKAHPFF 295

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score =  102 bits (254), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 77/272 (28%), Positives = 128/272 (47%), Gaps = 29/272 (10%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDAN----VAREIINHKQLRH 57
           E ++  K +G G+F    L R   T    A+K +E+ H I  N    V RE     +L H
Sbjct: 37  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 96
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG------- 110
           P  ++          L   + YA  GEL + I   G F E   R++  +++S        
Sbjct: 97  PFFVKLYFCFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 156
Query: 111 QICHRDLKLENTLLDGSPAPRLKICDFGYSK---SSLLHSRPKSTVGTPAYIAPEVLSRR 167
            I HRDLK EN LL+      ++I DFG +K        +R    VGT  Y++PE+L+ +
Sbjct: 157 GIIHRDLKPENILLNED--MHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 214
Query: 168 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCR 227
               K +D+W+ G  +Y ++ G  PF    +   F+K    I+ ++Y  P+        R
Sbjct: 215 S-ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQK----IIKLEYDFPE--KFFPKAR 267
Query: 228 NLLSRIFVANPSRRITIKE------IKSHPWF 253
           +L+ ++ V + ++R+  +E      +K+HP+F
Sbjct: 268 DLVEKLLVLDATKRLGCEEMEGYGPLKAHPFF 299

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score =  102 bits (253), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 76/272 (27%), Positives = 128/272 (47%), Gaps = 29/272 (10%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDAN----VAREIINHKQLRH 57
           E ++  K +G G+F    L R   T    A+K +E+ H I  N    V RE     +L H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG------- 110
           P  ++          L   + YA  GEL + I   G F E   R++  +++S        
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 151
Query: 111 QICHRDLKLENTLLDGSPAPRLKICDFGYSK---SSLLHSRPKSTVGTPAYIAPEVLSRR 167
            I HRDLK EN LL+      ++I DFG +K        +R    VGT  Y++PE+L+ +
Sbjct: 152 GIIHRDLKPENILLNED--MHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 209
Query: 168 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCR 227
               K +D+W+ G  +Y ++ G  PF    +   F    ++I+ ++Y  P+        R
Sbjct: 210 S-ACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIF----AKIIKLEYDFPE--KFFPKAR 262
Query: 228 NLLSRIFVANPSRRITIKE------IKSHPWF 253
           +L+ ++ V + ++R+  +E      +K+HP+F
Sbjct: 263 DLVEKLLVLDATKRLGCEEMEGYGPLKAHPFF 294

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score =  101 bits (252), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 77/272 (28%), Positives = 127/272 (46%), Gaps = 29/272 (10%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDAN----VAREIINHKQLRH 57
           E ++  K +G G+F    L R   T    A+K +E+ H I  N    V RE     +L H
Sbjct: 35  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 94
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG------- 110
           P  ++          L   + YA  GEL + I   G F E   R++  +++S        
Sbjct: 95  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 154
Query: 111 QICHRDLKLENTLLDGSPAPRLKICDFGYSK---SSLLHSRPKSTVGTPAYIAPEVLSRR 167
            I HRDLK EN LL+      ++I DFG +K        +R    VGT  Y++PE+L+ +
Sbjct: 155 GIIHRDLKPENILLNED--MHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 212
Query: 168 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCR 227
               K +D+W+ G  +Y ++ G  PF    +   F+K    I+ ++Y  P         R
Sbjct: 213 S-ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQK----IIKLEYDFP--AAFFPKAR 265
Query: 228 NLLSRIFVANPSRRITIKE------IKSHPWF 253
           +L+ ++ V + ++R+  +E      +K+HP+F
Sbjct: 266 DLVEKLLVLDATKRLGCEEMEGYGPLKAHPFF 297

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score =  101 bits (252), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 77/272 (28%), Positives = 128/272 (47%), Gaps = 29/272 (10%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDAN----VAREIINHKQLRH 57
           E ++  K +G G+F    L R   T    A+K +E+ H I  N    V RE     +L H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG------- 110
           P  ++          L   + YA  G L + I   G F E   R++  +++S        
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGCLLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 151
Query: 111 QICHRDLKLENTLLDGSPAPRLKICDFGYSK---SSLLHSRPKSTVGTPAYIAPEVLSRR 167
            I HRDLK EN LL+      ++I DFG +K        +R  S VGT  Y++PE+L+ +
Sbjct: 152 GIIHRDLKPENILLNED--MHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEK 209
Query: 168 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCR 227
               K +D+W+ G  +Y ++ G  PF    +   F+K    I+ ++Y  P+        R
Sbjct: 210 S-ASKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQK----IIKLEYDFPE--KFFPKAR 262
Query: 228 NLLSRIFVANPSRRITIKE------IKSHPWF 253
           +L+ ++ V + ++R+  +E      +K+HP+F
Sbjct: 263 DLVEKLLVLDATKRLGCEEMEGYGPLKAHPFF 294

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score =  101 bits (251), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 73/281 (25%), Positives = 128/281 (45%), Gaps = 15/281 (5%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNII 61
           EKY + +D+G G FG+       ++K+    K+++        V +EI      RH NI+
Sbjct: 5   EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNIL 64
Query: 62  RFKEVVLTPTHLAIVMEYAAGGELFERI-CNAGRFSEDEARYFFQQ-------LISGQIC 113
              E   +   L ++ E+ +G ++FERI  +A   +E E   +  Q       L S  I 
Sbjct: 65  HLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIG 124
Query: 114 HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKL 173
           H D++ EN +     +  +KI +FG ++        +     P Y APEV  + +     
Sbjct: 125 HFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEV-HQHDVVSTA 183
Query: 174 ADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPD--YVHISQDCRNLLS 231
            D+WS G  +YV+L G  PF  + +    ++ I  IM  +Y   +  +  IS +  + + 
Sbjct: 184 TDMWSLGTLVYVLLSGINPFLAETN----QQIIENIMNAEYTFDEEAFKEISIEAMDFVD 239
Query: 232 RIFVANPSRRITIKEIKSHPWFLKNLPRELTETAQAIYYRK 272
           R+ V     R+T  E   HPW  + + R  T+  + + +R+
Sbjct: 240 RLLVKERKSRMTASEALQHPWLKQKIERVSTKVIRTLKHRR 280

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 99.8 bits (247), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 85/295 (28%), Positives = 136/295 (46%), Gaps = 41/295 (13%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKID---------ANVAREIINH 52
           +KY  M  +GSG FG      +K   + V +K+I++   ++           V  EI   
Sbjct: 24  QKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAIL 83
Query: 53  KQLRHPNIIRFKEVVLTPTHLAIVME-YAAGGELFERICNAGRFSEDEARYFFQQLISG- 110
            ++ H NII+  ++        +VME + +G +LF  I    R  E  A Y F+QL+S  
Sbjct: 84  SRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAV 143
Query: 111 ------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPK---STVGTPAYIAP 161
                  I HRD+K EN ++  +    +K+ DFG   S+    R K   +  GT  Y AP
Sbjct: 144 GYLRLKDIIHRDIKDENIVI--AEDFTIKLIDFG---SAAYLERGKLFYTFCGTIEYCAP 198
Query: 162 EVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKI-PDYV 220
           EVL    Y G   ++WS GVTLY ++    PF + E+             V+  I P Y+
Sbjct: 199 EVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE------------TVEAAIHPPYL 246
Query: 221 HISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLPRELTETAQAIYYRKENP 275
            +S++  +L+S +    P RR T++++ + PW  +  P  L +      +R   P
Sbjct: 247 -VSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQ--PVNLADYTWEEVFRVNKP 298

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 98.6 bits (244), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 81/280 (28%), Positives = 140/280 (50%), Gaps = 38/280 (13%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDAN---VAREIINHKQLRHP 58
           E YE++  IG+G++G  + +R K+  +++  K ++ G   +A    +  E+   ++L+HP
Sbjct: 6   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65
Query: 59  NIIRFKEVVL--TPTHLAIVMEYAAGGELFERICNAGR---FSEDE--ARYFFQQLISGQ 111
           NI+R+ + ++  T T L IVMEY  GG+L   I    +   + ++E   R   Q  ++ +
Sbjct: 66  NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 125
Query: 112 IC-----------HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH--SRPKSTVGTPAY 158
            C           HRDLK  N  LDG     +K+ DFG ++  L H  S  K+ VGTP Y
Sbjct: 126 ECHRRSDGGHTVLHRDLKPANVFLDGK--QNVKLGDFGLAR-ILNHDTSFAKTFVGTPYY 182
Query: 159 IAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYP---FEDQEDPKNFRKTISRIMAVQYK 215
           ++PE ++R  Y+ K +D+WS G  LY +     P   F  +E     R+   R +  +Y 
Sbjct: 183 MSPEQMNRMSYNEK-SDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRY- 240
Query: 216 IPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLK 255
                  S +   +++R+       R +++EI  +P  L+
Sbjct: 241 -------SDELNEIITRMLNLKDYHRPSVEEILENPLILE 273

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 98.6 bits (244), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 81/280 (28%), Positives = 140/280 (50%), Gaps = 38/280 (13%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDAN---VAREIINHKQLRHP 58
           E YE++  IG+G++G  + +R K+  +++  K ++ G   +A    +  E+   ++L+HP
Sbjct: 6   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65
Query: 59  NIIRFKEVVL--TPTHLAIVMEYAAGGELFERICNAGR---FSEDE--ARYFFQQLISGQ 111
           NI+R+ + ++  T T L IVMEY  GG+L   I    +   + ++E   R   Q  ++ +
Sbjct: 66  NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 125
Query: 112 IC-----------HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH--SRPKSTVGTPAY 158
            C           HRDLK  N  LDG     +K+ DFG ++  L H  S  K+ VGTP Y
Sbjct: 126 ECHRRSDGGHTVLHRDLKPANVFLDGK--QNVKLGDFGLAR-ILNHDTSFAKAFVGTPYY 182
Query: 159 IAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYP---FEDQEDPKNFRKTISRIMAVQYK 215
           ++PE ++R  Y+ K +D+WS G  LY +     P   F  +E     R+   R +  +Y 
Sbjct: 183 MSPEQMNRMSYNEK-SDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRY- 240
Query: 216 IPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLK 255
                  S +   +++R+       R +++EI  +P  L+
Sbjct: 241 -------SDELNEIITRMLNLKDYHRPSVEEILENPLILE 273

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 97.8 bits (242), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 80/279 (28%), Positives = 141/279 (50%), Gaps = 23/279 (8%)
Query: 10  IGSGNFGVARLMRNKNTKELVAMKYIE-RGHKIDANVAREIINHKQLRHPNIIRFKEVVL 68
           IG G+ G+  L R K++   VA+K ++ R  +    +  E++  +  +H N++   +  L
Sbjct: 53  IGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYL 112
Query: 69  TPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-------QICHRDLKLEN 121
               L ++ME+  GG L + I +  R +E++     + ++          + HRD+K ++
Sbjct: 113 VGEELWVLMEFLQGGALTD-IVSQVRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDS 171
Query: 122 TLL--DGSPAPRLKICDFGY-SKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLADVWS 178
            LL  DG    R+K+ DFG+ ++ S    + K  VGTP ++APEV+SR  Y  ++ D+WS
Sbjct: 172 ILLTLDG----RVKLSDFGFCAQISKDVPKRKXLVGTPYWMAPEVISRSLYATEV-DIWS 226
Query: 179 CGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANP 238
            G+ +  M+ G  P+   + P    K +    +   K+ +   +S   R+ L R+ V +P
Sbjct: 227 LGIMVIEMVDGEPPYFS-DSPVQAMKRLRD--SPPPKLKNSHKVSPVLRDFLERMLVRDP 283
Query: 239 SRRITIKEIKSHPWFLK-NLPRELTETAQAIYYRKENPT 276
             R T +E+  HP+ L+  LP  L    Q   YRK+  T
Sbjct: 284 QERATAQELLDHPFLLQTGLPECLVPLIQ--LYRKQTST 320

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 97.8 bits (242), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 76/238 (31%), Positives = 116/238 (48%), Gaps = 36/238 (15%)
Query: 42  DANVAREIINHKQLRHPNIIRFKEVVLT--PTHLAIVMEYAAGG--ELFERICNAGRFSE 97
           +ANV +EI   ++LRH N+I+  +V+       + +VMEY   G  E+ + +    RF  
Sbjct: 50  EANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEK-RFPV 108
Query: 98  DEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH---- 146
            +A  +F QLI G        I H+D+K  N LL  +    LKI   G +++  LH    
Sbjct: 109 CQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLL--TTGGTLKISALGVAEA--LHPFAA 164
Query: 147 -SRPKSTVGTPAYIAPEVLSRRE-YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRK 204
               +++ G+PA+  PE+ +  + + G   D+WS GVTLY +  G YPFE      N  K
Sbjct: 165 DDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGD----NIYK 220
Query: 205 TISRIMAVQYKIPDYVHISQDC----RNLLSRIFVANPSRRITIKEIKSHPWFLKNLP 258
               I    Y IP       DC     +LL  +    P++R +I++I+ H WF K  P
Sbjct: 221 LFENIGKGSYAIPG------DCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHP 272

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 97.8 bits (242), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 75/271 (27%), Positives = 132/271 (48%), Gaps = 26/271 (9%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRH---- 57
           + +E + ++G+GN GV   + +K +  ++A K I    +I   +  +II   Q+ H    
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHL--EIKPAIRNQIIRELQVLHECNS 63
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG------- 110
           P I+ F     +   ++I ME+  GG L + +  AGR  E         +I G       
Sbjct: 64  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK 123
Query: 111 -QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREY 169
            +I HRD+K  N L++      +K+CDFG S   L+ S   S VGT +Y++PE L    Y
Sbjct: 124 HKIMHRDVKPSNILVNSRG--EIKLCDFGVS-GQLIDSMANSFVGTRSYMSPERLQGTHY 180
Query: 170 DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQY-------KIPDYVHI 222
             + +D+WS G++L  M VG YP    +  ++ R  ++    + Y       K+P  V  
Sbjct: 181 SVQ-SDIWSMGLSLVEMAVGRYPIPPPDAKEDSRPPMAIFELLDYIVNEPPPKLPSGV-F 238
Query: 223 SQDCRNLLSRIFVANPSRRITIKEIKSHPWF 253
           S + ++ +++  + NP+ R  +K++  H + 
Sbjct: 239 SLEFQDFVNKCLIKNPAERADLKQLMVHAFI 269

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 80/280 (28%), Positives = 138/280 (49%), Gaps = 38/280 (13%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDAN---VAREIINHKQLRHP 58
           E YE++  IG+G++G  + +R K+  +++  K ++ G   +A    +  E+   ++L+HP
Sbjct: 6   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65
Query: 59  NIIRFKEVVL--TPTHLAIVMEYAAGGELFERICNAGR---FSEDE--ARYFFQQLISGQ 111
           NI+R+ + ++  T T L IVMEY  GG+L   I    +   + ++E   R   Q  ++ +
Sbjct: 66  NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 125
Query: 112 IC-----------HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR--PKSTVGTPAY 158
            C           HRDLK  N  LDG     +K+ DFG ++  L H     K  VGTP Y
Sbjct: 126 ECHRRSDGGHTVLHRDLKPANVFLDGK--QNVKLGDFGLAR-ILNHDEDFAKEFVGTPYY 182
Query: 159 IAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYP---FEDQEDPKNFRKTISRIMAVQYK 215
           ++PE ++R  Y+ K +D+WS G  LY +     P   F  +E     R+   R +  +Y 
Sbjct: 183 MSPEQMNRMSYNEK-SDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRY- 240
Query: 216 IPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLK 255
                  S +   +++R+       R +++EI  +P  L+
Sbjct: 241 -------SDELNEIITRMLNLKDYHRPSVEEILENPLILE 273

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 80/290 (27%), Positives = 132/290 (45%), Gaps = 41/290 (14%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYI---ERGHKIDANVAREIINHKQLRH 57
           M+KYE ++ IG G +G     +N+ T E+VA+K +   +    + ++  REI   K+L+H
Sbjct: 1   MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKH 60
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGG--ELFERICNAGRFSEDEARYFFQQLISG----- 110
            NI+R  +V+ +   L +V E+      + F+  CN G    +  + F  QL+ G     
Sbjct: 61  KNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDS-CN-GDLDPEIVKSFLFQLLKGLGFCH 118
Query: 111 --QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST-VGTPAYIAPEVLSRR 167
              + HRDLK +N L++ +    LK+ DFG +++  +  R  S  V T  Y  P+VL   
Sbjct: 119 SRNVLHRDLKPQNLLINRN--GELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGA 176
Query: 168 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAV--------QYKIPDY 219
           +      D+WS G     +   A P     D  +  K I R++            K+PDY
Sbjct: 177 KLYSTSIDMWSAGCIFAELANAARPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDY 236
Query: 220 ----------------VHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 253
                             ++   R+LL  +   NP +RI+ +E   HP+F
Sbjct: 237 KPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYF 286

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 97.1 bits (240), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 75/260 (28%), Positives = 130/260 (50%), Gaps = 20/260 (7%)
Query: 10  IGSGNFGVARLMRNKNTKELVAMKYIE-RGHKIDANVAREIINHKQLRHPNIIRFKEVVL 68
           IG G+ G+  +   +++ +LVA+K ++ R  +    +  E++  +  +H N++      L
Sbjct: 159 IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 218
Query: 69  TPTHLAIVMEYAAGGELFERICNAGRFSEDEARYF-------FQQLISGQICHRDLKLEN 121
               L +VME+  GG L + I    R +E++              L +  + HRD+K ++
Sbjct: 219 VGDELWVVMEFLEGGALTD-IVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDS 277
Query: 122 TLL--DGSPAPRLKICDFGY-SKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLADVWS 178
            LL  DG    R+K+ DFG+ ++ S    R K  VGTP ++APE++SR  Y G   D+WS
Sbjct: 278 ILLTHDG----RVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPY-GPEVDIWS 332
Query: 179 CGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANP 238
            G+ +  M+ G  P+ + E P    K I   +  + K  +   +S   +  L R+ V +P
Sbjct: 333 LGIMVIEMVDGEPPYFN-EPPLKAMKMIRDNLPPRLK--NLHKVSPSLKGFLDRLLVRDP 389
Query: 239 SRRITIKEIKSHPWFLKNLP 258
           ++R T  E+  HP+  K  P
Sbjct: 390 AQRATAAELLKHPFLAKAGP 409

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 96.3 bits (238), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 75/260 (28%), Positives = 130/260 (50%), Gaps = 20/260 (7%)
Query: 10  IGSGNFGVARLMRNKNTKELVAMKYIE-RGHKIDANVAREIINHKQLRHPNIIRFKEVVL 68
           IG G+ G+  +   +++ +LVA+K ++ R  +    +  E++  +  +H N++      L
Sbjct: 39  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 98
Query: 69  TPTHLAIVMEYAAGGELFERICNAGRFSEDEARYF-------FQQLISGQICHRDLKLEN 121
               L +VME+  GG L + I    R +E++              L +  + HRD+K ++
Sbjct: 99  VGDELWVVMEFLEGGALTD-IVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDS 157
Query: 122 TLL--DGSPAPRLKICDFGY-SKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLADVWS 178
            LL  DG    R+K+ DFG+ ++ S    R K  VGTP ++APE++SR  Y G   D+WS
Sbjct: 158 ILLTHDG----RVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPY-GPEVDIWS 212
Query: 179 CGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANP 238
            G+ +  M+ G  P+ + E P    K I   +  + K  +   +S   +  L R+ V +P
Sbjct: 213 LGIMVIEMVDGEPPYFN-EPPLKAMKMIRDNLPPRLK--NLHKVSPSLKGFLDRLLVRDP 269
Query: 239 SRRITIKEIKSHPWFLKNLP 258
           ++R T  E+  HP+  K  P
Sbjct: 270 AQRATAAELLKHPFLAKAGP 289

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 96.3 bits (238), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 75/260 (28%), Positives = 130/260 (50%), Gaps = 20/260 (7%)
Query: 10  IGSGNFGVARLMRNKNTKELVAMKYIE-RGHKIDANVAREIINHKQLRHPNIIRFKEVVL 68
           IG G+ G+  +   +++ +LVA+K ++ R  +    +  E++  +  +H N++      L
Sbjct: 82  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 141
Query: 69  TPTHLAIVMEYAAGGELFERICNAGRFSEDEARYF-------FQQLISGQICHRDLKLEN 121
               L +VME+  GG L + I    R +E++              L +  + HRD+K ++
Sbjct: 142 VGDELWVVMEFLEGGALTD-IVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDS 200
Query: 122 TLL--DGSPAPRLKICDFGY-SKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLADVWS 178
            LL  DG    R+K+ DFG+ ++ S    R K  VGTP ++APE++SR  Y G   D+WS
Sbjct: 201 ILLTHDG----RVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPY-GPEVDIWS 255
Query: 179 CGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANP 238
            G+ +  M+ G  P+ + E P    K I   +  + K  +   +S   +  L R+ V +P
Sbjct: 256 LGIMVIEMVDGEPPYFN-EPPLKAMKMIRDNLPPRLK--NLHKVSPSLKGFLDRLLVRDP 312
Query: 239 SRRITIKEIKSHPWFLKNLP 258
           ++R T  E+  HP+  K  P
Sbjct: 313 AQRATAAELLKHPFLAKAGP 332

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 96.3 bits (238), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 75/260 (28%), Positives = 130/260 (50%), Gaps = 20/260 (7%)
Query: 10  IGSGNFGVARLMRNKNTKELVAMKYIE-RGHKIDANVAREIINHKQLRHPNIIRFKEVVL 68
           IG G+ G+  +   +++ +LVA+K ++ R  +    +  E++  +  +H N++      L
Sbjct: 37  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 96
Query: 69  TPTHLAIVMEYAAGGELFERICNAGRFSEDEARYF-------FQQLISGQICHRDLKLEN 121
               L +VME+  GG L + I    R +E++              L +  + HRD+K ++
Sbjct: 97  VGDELWVVMEFLEGGALTD-IVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDS 155
Query: 122 TLL--DGSPAPRLKICDFGY-SKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLADVWS 178
            LL  DG    R+K+ DFG+ ++ S    R K  VGTP ++APE++SR  Y G   D+WS
Sbjct: 156 ILLTHDG----RVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPY-GPEVDIWS 210
Query: 179 CGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANP 238
            G+ +  M+ G  P+ + E P    K I   +  + K  +   +S   +  L R+ V +P
Sbjct: 211 LGIMVIEMVDGEPPYFN-EPPLKAMKMIRDNLPPRLK--NLHKVSPSLKGFLDRLLVRDP 267
Query: 239 SRRITIKEIKSHPWFLKNLP 258
           ++R T  E+  HP+  K  P
Sbjct: 268 AQRATAAELLKHPFLAKAGP 287

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 96.3 bits (238), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 87/331 (26%), Positives = 154/331 (46%), Gaps = 46/331 (13%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKID-ANVA-----REIINHKQL 55
           E +E++K IG G FG   +++ KNT+ + AMK + +   +  A  A     R+++ +   
Sbjct: 90  EDFEIIKVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREERDVLVNGDC 149
Query: 56  RHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICN-AGRFSEDEARYFFQQLISG---- 110
           +    + +        HL +VM+Y  GG+L   +     +  ED AR++  +++      
Sbjct: 150 QWITALHY--AFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVLAIDSI 207
Query: 111 ---QICHRDLKLENTLLDGSPAPR-------LKICDFGYSKSSLLHSRPKSTVGTPAYIA 160
                 HRD+K +N LLD +   R       LK+ D G  +SS+        VGTP YI+
Sbjct: 208 HQLHYVHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSV-------AVGTPDYIS 260
Query: 161 PEVLSRREYD----GKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQ--Y 214
           PE+L   E      G   D WS GV +Y ML G  PF      ++  +T  +IM  +  +
Sbjct: 261 PEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFY----AESLVETYGKIMNHEERF 316
Query: 215 KIPDYV-HISQDCRNLLSRIFVANPSRRI---TIKEIKSHPWFLKNLPRELTETAQAIYY 270
           + P +V  +S++ ++L+ R+ + +  RR+    I++ K H  F + L  E     +A Y 
Sbjct: 317 QFPSHVTDVSEEAKDLIQRL-ICSRERRLGQNGIEDFKKHA-FFEGLNWENIRNLEAPYI 374
Query: 271 RKENPTFSLQSVEEITKIVEEAKVPPPVSRS 301
              +      + +    ++   ++ PP S +
Sbjct: 375 PDVSSPSDTSNFDVDDDVLRNTEILPPGSHT 405

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 96.3 bits (238), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 85/290 (29%), Positives = 134/290 (46%), Gaps = 41/290 (14%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIE---RGHKIDANVAREIINHKQLRH 57
           ME ++ ++ IG G +GV    RNK T E+VA+K I        + +   REI   K+L H
Sbjct: 3   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 62
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDE----ARYFFQQLISGQIC 113
           PNI++  +V+ T   L +V E+ +     ++  +A   +         Y FQ L     C
Sbjct: 63  PNIVKLLDVIHTENKLYLVFEFLSMD--LKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 120
Query: 114 ------HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP-KSTVGTPAYIAPEVLSR 166
                 HRDLK EN L++   A  +K+ DFG +++  +  R     V T  Y APE+L  
Sbjct: 121 HSHRVLHRDLKPENLLINTEGA--IKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG 178
Query: 167 REYDGKLADVWSCGVTLYVMLVGAYPFE-DQEDPKNFR--KTISRIMAVQY----KIPDY 219
            +Y     D+WS G     M+     F  D E  + FR  +T+     V +     +PDY
Sbjct: 179 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 238
Query: 220 ----------------VHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 253
                             + +D R+LLS++   +P++RI+ K   +HP+F
Sbjct: 239 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 288

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 96.3 bits (238), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 85/290 (29%), Positives = 134/290 (46%), Gaps = 41/290 (14%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIE---RGHKIDANVAREIINHKQLRH 57
           ME ++ ++ IG G +GV    RNK T E+VA+K I        + +   REI   K+L H
Sbjct: 5   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 64
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDE----ARYFFQQLISGQIC 113
           PNI++  +V+ T   L +V E+ +     ++  +A   +         Y FQ L     C
Sbjct: 65  PNIVKLLDVIHTENKLYLVFEFLSMD--LKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 122
Query: 114 ------HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP-KSTVGTPAYIAPEVLSR 166
                 HRDLK EN L++   A  +K+ DFG +++  +  R     V T  Y APE+L  
Sbjct: 123 HSHRVLHRDLKPENLLINTEGA--IKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG 180
Query: 167 REYDGKLADVWSCGVTLYVMLVGAYPFE-DQEDPKNFR--KTISRIMAVQY----KIPDY 219
            +Y     D+WS G     M+     F  D E  + FR  +T+     V +     +PDY
Sbjct: 181 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 240
Query: 220 ----------------VHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 253
                             + +D R+LLS++   +P++RI+ K   +HP+F
Sbjct: 241 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 290

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 75/260 (28%), Positives = 130/260 (50%), Gaps = 20/260 (7%)
Query: 10  IGSGNFGVARLMRNKNTKELVAMKYIE-RGHKIDANVAREIINHKQLRHPNIIRFKEVVL 68
           IG G+ G+  +   +++ +LVA+K ++ R  +    +  E++  +  +H N++      L
Sbjct: 28  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87
Query: 69  TPTHLAIVMEYAAGGELFERICNAGRFSEDEARYF-------FQQLISGQICHRDLKLEN 121
               L +VME+  GG L + I    R +E++              L +  + HRD+K ++
Sbjct: 88  VGDELWVVMEFLEGGALTD-IVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDS 146
Query: 122 TLL--DGSPAPRLKICDFGY-SKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLADVWS 178
            LL  DG    R+K+ DFG+ ++ S    R K  VGTP ++APE++SR  Y G   D+WS
Sbjct: 147 ILLTHDG----RVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPY-GPEVDIWS 201
Query: 179 CGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANP 238
            G+ +  M+ G  P+ + E P    K I   +  + K  +   +S   +  L R+ V +P
Sbjct: 202 LGIMVIEMVDGEPPYFN-EPPLKAMKMIRDNLPPRLK--NLHKVSPSLKGFLDRLLVRDP 258
Query: 239 SRRITIKEIKSHPWFLKNLP 258
           ++R T  E+  HP+  K  P
Sbjct: 259 AQRATAAELLKHPFLAKAGP 278

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 87/331 (26%), Positives = 154/331 (46%), Gaps = 46/331 (13%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKID-ANVA-----REIINHKQL 55
           E +E++K IG G FG   +++ KNT+ + AMK + +   +  A  A     R+++ +   
Sbjct: 74  EDFEIIKVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREERDVLVNGDC 133
Query: 56  RHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICN-AGRFSEDEARYFFQQLISG---- 110
           +    + +        HL +VM+Y  GG+L   +     +  ED AR++  +++      
Sbjct: 134 QWITALHY--AFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVLAIDSI 191
Query: 111 ---QICHRDLKLENTLLDGSPAPR-------LKICDFGYSKSSLLHSRPKSTVGTPAYIA 160
                 HRD+K +N LLD +   R       LK+ D G  +SS+        VGTP YI+
Sbjct: 192 HQLHYVHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSV-------AVGTPDYIS 244
Query: 161 PEVLSRREYD----GKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQ--Y 214
           PE+L   E      G   D WS GV +Y ML G  PF      ++  +T  +IM  +  +
Sbjct: 245 PEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFY----AESLVETYGKIMNHEERF 300
Query: 215 KIPDYV-HISQDCRNLLSRIFVANPSRRI---TIKEIKSHPWFLKNLPRELTETAQAIYY 270
           + P +V  +S++ ++L+ R+ + +  RR+    I++ K H  F + L  E     +A Y 
Sbjct: 301 QFPSHVTDVSEEAKDLIQRL-ICSRERRLGQNGIEDFKKHA-FFEGLNWENIRNLEAPYI 358
Query: 271 RKENPTFSLQSVEEITKIVEEAKVPPPVSRS 301
              +      + +    ++   ++ PP S +
Sbjct: 359 PDVSSPSDTSNFDVDDDVLRNTEILPPGSHT 389

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 75/260 (28%), Positives = 130/260 (50%), Gaps = 20/260 (7%)
Query: 10  IGSGNFGVARLMRNKNTKELVAMKYIE-RGHKIDANVAREIINHKQLRHPNIIRFKEVVL 68
           IG G+ G+  +   +++ +LVA+K ++ R  +    +  E++  +  +H N++      L
Sbjct: 32  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 91
Query: 69  TPTHLAIVMEYAAGGELFERICNAGRFSEDEARYF-------FQQLISGQICHRDLKLEN 121
               L +VME+  GG L + I    R +E++              L +  + HRD+K ++
Sbjct: 92  VGDELWVVMEFLEGGALTD-IVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDS 150
Query: 122 TLL--DGSPAPRLKICDFGY-SKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLADVWS 178
            LL  DG    R+K+ DFG+ ++ S    R K  VGTP ++APE++SR  Y G   D+WS
Sbjct: 151 ILLTHDG----RVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPY-GPEVDIWS 205
Query: 179 CGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANP 238
            G+ +  M+ G  P+ + E P    K I   +  + K  +   +S   +  L R+ V +P
Sbjct: 206 LGIMVIEMVDGEPPYFN-EPPLKAMKMIRDNLPPRLK--NLHKVSPSLKGFLDRLLVRDP 262
Query: 239 SRRITIKEIKSHPWFLKNLP 258
           ++R T  E+  HP+  K  P
Sbjct: 263 AQRATAAELLKHPFLAKAGP 282

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 95.5 bits (236), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 84/290 (28%), Positives = 135/290 (46%), Gaps = 41/290 (14%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIE---RGHKIDANVAREIINHKQLRH 57
           ME ++ ++ IG G +GV    RNK T E+VA+K I        + +   REI   K+L H
Sbjct: 2   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 61
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDE----ARYFFQQLISGQIC 113
           PNI++  +V+ T   L +V E+    +  ++  +A   +         Y FQ L     C
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 119
Query: 114 ------HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKS-TVGTPAYIAPEVLSR 166
                 HRDLK +N L++   A  +K+ DFG +++  +  R  +  V T  Y APE+L  
Sbjct: 120 HSHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG 177
Query: 167 REYDGKLADVWSCGVTLYVMLVGAYPFE-DQEDPKNFR--KTISRIMAVQY----KIPDY 219
            +Y     D+WS G     M+     F  D E  + FR  +T+     V +     +PDY
Sbjct: 178 XKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 237
Query: 220 ----------------VHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 253
                             + +D R+LLS++   +P++RI+ K   +HP+F
Sbjct: 238 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 287

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 95.5 bits (236), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 84/290 (28%), Positives = 135/290 (46%), Gaps = 41/290 (14%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIE---RGHKIDANVAREIINHKQLRH 57
           ME ++ ++ IG G +GV    RNK T E+VA+K I        + +   REI   K+L H
Sbjct: 9   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 68
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDE----ARYFFQQLISGQIC 113
           PNI++  +V+ T   L +V E+    +  ++  +A   +         Y FQ L     C
Sbjct: 69  PNIVKLLDVIHTENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 126
Query: 114 ------HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKS-TVGTPAYIAPEVLSR 166
                 HRDLK +N L++   A  +K+ DFG +++  +  R  +  V T  Y APE+L  
Sbjct: 127 HSHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG 184
Query: 167 REYDGKLADVWSCGVTLYVMLVGAYPFE-DQEDPKNFR--KTISRIMAVQY----KIPDY 219
            +Y     D+WS G     M+     F  D E  + FR  +T+     V +     +PDY
Sbjct: 185 XKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 244
Query: 220 ----------------VHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 253
                             + +D R+LLS++   +P++RI+ K   +HP+F
Sbjct: 245 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 294

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 95.5 bits (236), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 79/279 (28%), Positives = 127/279 (45%), Gaps = 32/279 (11%)
Query: 3   KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKID-------ANVAREIINHKQL 55
           +Y++   +GSG FG        +    VA+K++E+    D         V  E++  K++
Sbjct: 10  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 69
Query: 56  R--HPNIIRFKEVVLTPTHLAIVMEYAAG-GELFERICNAGRFSEDEARYFFQQLISG-- 110
                 +IR  +    P    +++E      +LF+ I   G   E+ AR FF Q++    
Sbjct: 70  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 129
Query: 111 -----QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLS 165
                 + HRD+K EN L+D +    LK+ DFG S + L  +      GT  Y  PE + 
Sbjct: 130 HCHNCGVLHRDIKDENILIDLNRG-ELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIR 187
Query: 166 RREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQD 225
              Y G+ A VWS G+ LY M+ G  PFE  E+             ++ ++     +S +
Sbjct: 188 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------------IIRGQVFFRQRVSSE 235
Query: 226 CRNLLSRIFVANPSRRITIKEIKSHPWFLKN-LPRELTE 263
           C++L+       PS R T +EI++HPW     LP+E  E
Sbjct: 236 CQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAE 274

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 95.5 bits (236), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 90/319 (28%), Positives = 141/319 (44%), Gaps = 57/319 (17%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYI---ERGHKIDANVAREIINHKQLRH 57
           MEKYE +  IG G++GV    RN++T ++VA+K     E    I     REI   KQL+H
Sbjct: 2   MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKH 61
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYF-----FQQLISGQI 112
           PN++   EV      L +V EY     L E      R+      +      +Q L +   
Sbjct: 62  PNLVNLLEVFRRKRRLHLVFEYCDHTVLHE----LDRYQRGVPEHLVKSITWQTLQAVNF 117
Query: 113 C------HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP----KSTVGTPAYIAPE 162
           C      HRD+K EN L+       +K+CDFG+++   L + P       V T  Y +PE
Sbjct: 118 CHKHNCIHRDVKPENILITKHSV--IKLCDFGFAR---LLTGPSDYYDDEVATRWYRSPE 172
Query: 163 VLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNF---RKTISRIM--------A 211
           +L      G   DVW+ G     +L G   +  + D       RKT+  ++         
Sbjct: 173 LLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFST 232
Query: 212 VQY----KIPD----------YVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF---- 253
            QY    KIPD          + +IS     LL      +P+ R+T +++  HP+F    
Sbjct: 233 NQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIR 292
Query: 254 -LKNLPRELTETAQAIYYR 271
            +++L +E  + A+ +Y++
Sbjct: 293 EIEDLAKEHDKPAENLYFQ 311

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 95.5 bits (236), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 85/290 (29%), Positives = 134/290 (46%), Gaps = 41/290 (14%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIE---RGHKIDANVAREIINHKQLRH 57
           ME ++ ++ IG G +GV    RNK T E+VA+K I        + +   REI   K+L H
Sbjct: 3   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 62
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDE----ARYFFQQLISGQIC 113
           PNI++  +V+ T   L +V E+    +  ++  +A   +         Y FQ L     C
Sbjct: 63  PNIVKLLDVIHTENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 120
Query: 114 ------HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP-KSTVGTPAYIAPEVLSR 166
                 HRDLK EN L++   A  +K+ DFG +++  +  R     V T  Y APE+L  
Sbjct: 121 HSHRVLHRDLKPENLLINTEGA--IKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG 178
Query: 167 REYDGKLADVWSCGVTLYVMLVGAYPFE-DQEDPKNFR--KTISRIMAVQY----KIPDY 219
            +Y     D+WS G     M+     F  D E  + FR  +T+     V +     +PDY
Sbjct: 179 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 238
Query: 220 ----------------VHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 253
                             + +D R+LLS++   +P++RI+ K   +HP+F
Sbjct: 239 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 288

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 95.5 bits (236), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 79/279 (28%), Positives = 127/279 (45%), Gaps = 32/279 (11%)
Query: 3   KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKID-------ANVAREIINHKQL 55
           +Y++   +GSG FG        +    VA+K++E+    D         V  E++  K++
Sbjct: 9   QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 68
Query: 56  R--HPNIIRFKEVVLTPTHLAIVME-YAAGGELFERICNAGRFSEDEARYFFQQLISG-- 110
                 +IR  +    P    +++E      +LF+ I   G   E+ AR FF Q++    
Sbjct: 69  SSGFSGVIRLLDWFERPDSFVLILERMEPVQDLFDFITERGALQEELARSFFWQVLEAVR 128
Query: 111 -----QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLS 165
                 + HRD+K EN L+D +    LK+ DFG S + L  +      GT  Y  PE + 
Sbjct: 129 HCHNCGVLHRDIKDENILIDLNRG-ELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIR 186
Query: 166 RREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQD 225
              Y G+ A VWS G+ LY M+ G  PFE  E+             ++ ++     +S +
Sbjct: 187 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------------IIRGQVFFRQRVSSE 234
Query: 226 CRNLLSRIFVANPSRRITIKEIKSHPWFLKN-LPRELTE 263
           C++L+       PS R T +EI++HPW     LP+E  E
Sbjct: 235 CQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAE 273

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 95.5 bits (236), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 85/290 (29%), Positives = 134/290 (46%), Gaps = 41/290 (14%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIE---RGHKIDANVAREIINHKQLRH 57
           ME ++ ++ IG G +GV    RNK T E+VA+K I        + +   REI   K+L H
Sbjct: 4   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 63
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDE----ARYFFQQLISGQIC 113
           PNI++  +V+ T   L +V E+    +  ++  +A   +         Y FQ L     C
Sbjct: 64  PNIVKLLDVIHTENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 121
Query: 114 ------HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP-KSTVGTPAYIAPEVLSR 166
                 HRDLK EN L++   A  +K+ DFG +++  +  R     V T  Y APE+L  
Sbjct: 122 HSHRVLHRDLKPENLLINTEGA--IKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG 179
Query: 167 REYDGKLADVWSCGVTLYVMLVGAYPFE-DQEDPKNFR--KTISRIMAVQY----KIPDY 219
            +Y     D+WS G     M+     F  D E  + FR  +T+     V +     +PDY
Sbjct: 180 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 239
Query: 220 ----------------VHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 253
                             + +D R+LLS++   +P++RI+ K   +HP+F
Sbjct: 240 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 289

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 95.5 bits (236), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 79/279 (28%), Positives = 127/279 (45%), Gaps = 32/279 (11%)
Query: 3   KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKID-------ANVAREIINHKQL 55
           +Y++   +GSG FG        +    VA+K++E+    D         V  E++  K++
Sbjct: 10  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 69
Query: 56  R--HPNIIRFKEVVLTPTHLAIVMEYAAG-GELFERICNAGRFSEDEARYFFQQLISG-- 110
                 +IR  +    P    +++E      +LF+ I   G   E+ AR FF Q++    
Sbjct: 70  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 129
Query: 111 -----QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLS 165
                 + HRD+K EN L+D +    LK+ DFG S + L  +      GT  Y  PE + 
Sbjct: 130 HCHNCGVLHRDIKDENILIDLNRG-ELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIR 187
Query: 166 RREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQD 225
              Y G+ A VWS G+ LY M+ G  PFE  E+             ++ ++     +S +
Sbjct: 188 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------------IIRGQVFFRQRVSSE 235
Query: 226 CRNLLSRIFVANPSRRITIKEIKSHPWFLKN-LPRELTE 263
           C++L+       PS R T +EI++HPW     LP+E  E
Sbjct: 236 CQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAE 274

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 95.5 bits (236), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 75/257 (29%), Positives = 128/257 (49%), Gaps = 21/257 (8%)
Query: 10  IGSGNFGVARLMRNKNTKELVAMKYIE-RGHKIDANVAREIINHKQLRHPNIIRFKEVVL 68
           IG G+ G+  +   K+T + VA+K ++ R  +    +  E++  +   H N++      L
Sbjct: 53  IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHDNVVDMYSSYL 112
Query: 69  TPTHLAIVMEYAAGGELFERICNAGRFSEDEARYF-------FQQLISGQICHRDLKLEN 121
               L +VME+  GG L + I    R +E++              L +  + HRD+K ++
Sbjct: 113 VGDELWVVMEFLEGGALTD-IVTHTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDS 171
Query: 122 TLL--DGSPAPRLKICDFGY-SKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLADVWS 178
            LL  DG    R+K+ DFG+ ++ S    + K  VGTP ++APEV+SR  Y G   D+WS
Sbjct: 172 ILLTSDG----RIKLSDFGFCAQVSKEVPKRKXLVGTPYWMAPEVISRLPY-GTEVDIWS 226
Query: 179 CGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANP 238
            G+ +  M+ G  P+ ++   +  R+      ++  ++ D   +S   R  L  + V  P
Sbjct: 227 LGIMVIEMIDGEPPYFNEPPLQAMRRIRD---SLPPRVKDLHKVSSVLRGFLDLMLVREP 283
Query: 239 SRRITIKEIKSHPWFLK 255
           S+R T +E+  HP FLK
Sbjct: 284 SQRATAQELLGHP-FLK 299

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 95.5 bits (236), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 79/279 (28%), Positives = 127/279 (45%), Gaps = 32/279 (11%)
Query: 3   KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKID-------ANVAREIINHKQL 55
           +Y++   +GSG FG        +    VA+K++E+    D         V  E++  K++
Sbjct: 10  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 69
Query: 56  R--HPNIIRFKEVVLTPTHLAIVMEYAAG-GELFERICNAGRFSEDEARYFFQQLISG-- 110
                 +IR  +    P    +++E      +LF+ I   G   E+ AR FF Q++    
Sbjct: 70  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 129
Query: 111 -----QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLS 165
                 + HRD+K EN L+D +    LK+ DFG S + L  +      GT  Y  PE + 
Sbjct: 130 HCHNCGVLHRDIKDENILIDLNRG-ELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIR 187
Query: 166 RREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQD 225
              Y G+ A VWS G+ LY M+ G  PFE  E+             ++ ++     +S +
Sbjct: 188 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------------IIRGQVFFRQRVSSE 235
Query: 226 CRNLLSRIFVANPSRRITIKEIKSHPWFLKN-LPRELTE 263
           C++L+       PS R T +EI++HPW     LP+E  E
Sbjct: 236 CQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAE 274

>pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299

Iteration: 1
 Score = 95.1 bits (235), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 82/283 (28%), Positives = 133/283 (46%), Gaps = 45/283 (15%)
Query: 10  IGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREI-INHKQLRHPNIIR----FK 64
           +G G  G    + NK T+E  A+K ++   K      RE+ ++ +  + P+I+R    ++
Sbjct: 26  LGLGINGKVLQIFNKRTQEKFALKMLQDCPK----ARREVELHWRASQCPHIVRIVDVYE 81
Query: 65  EVVLTPTHLAIVMEYAAGGELFERICNAG--RFSEDEARYFF-------QQLISGQICHR 115
            +      L IVME   GGELF RI + G   F+E EA           Q L S  I HR
Sbjct: 82  NLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHR 141
Query: 116 DLKLENTLLDGS-PAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLA 174
           D+K EN L     P   LK+ DFG++K +                     +  +YD K  
Sbjct: 142 DVKPENLLYTSKRPNAILKLTDFGFAKET---------------------TGEKYD-KSC 179
Query: 175 DVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPD--YVHISQDCRNLLSR 232
           D+WS GV +Y++L G  PF             +RI   QY+ P+  +  +S++ + L+  
Sbjct: 180 DMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRN 239
Query: 233 IFVANPSRRITIKEIKSHPWFLKN--LPRELTETAQAIYYRKE 273
           +    P++R+TI E  +HPW +++  +P+    T++ +   KE
Sbjct: 240 LLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKE 282

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 95.1 bits (235), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 79/279 (28%), Positives = 127/279 (45%), Gaps = 32/279 (11%)
Query: 3   KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKID-------ANVAREIINHKQL 55
           +Y++   +GSG FG        +    VA+K++E+    D         V  E++  K++
Sbjct: 9   QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 68
Query: 56  R--HPNIIRFKEVVLTPTHLAIVMEYAAG-GELFERICNAGRFSEDEARYFFQQLISG-- 110
                 +IR  +    P    +++E      +LF+ I   G   E+ AR FF Q++    
Sbjct: 69  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 128
Query: 111 -----QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLS 165
                 + HRD+K EN L+D +    LK+ DFG S + L  +      GT  Y  PE + 
Sbjct: 129 HCHNCGVLHRDIKDENILIDLNRG-ELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIR 186
Query: 166 RREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQD 225
              Y G+ A VWS G+ LY M+ G  PFE  E+             ++ ++     +S +
Sbjct: 187 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------------IIRGQVFFRQRVSSE 234
Query: 226 CRNLLSRIFVANPSRRITIKEIKSHPWFLKN-LPRELTE 263
           C++L+       PS R T +EI++HPW     LP+E  E
Sbjct: 235 CQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAE 273

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 95.1 bits (235), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 79/279 (28%), Positives = 127/279 (45%), Gaps = 32/279 (11%)
Query: 3   KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKID-------ANVAREIINHKQL 55
           +Y++   +GSG FG        +    VA+K++E+    D         V  E++  K++
Sbjct: 24  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 83
Query: 56  R--HPNIIRFKEVVLTPTHLAIVMEYAAG-GELFERICNAGRFSEDEARYFFQQLISG-- 110
                 +IR  +    P    +++E      +LF+ I   G   E+ AR FF Q++    
Sbjct: 84  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 143
Query: 111 -----QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLS 165
                 + HRD+K EN L+D +    LK+ DFG S + L  +      GT  Y  PE + 
Sbjct: 144 HCHNCGVLHRDIKDENILIDLNRG-ELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIR 201
Query: 166 RREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQD 225
              Y G+ A VWS G+ LY M+ G  PFE  E+             ++ ++     +S +
Sbjct: 202 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------------IIRGQVFFRQRVSSE 249
Query: 226 CRNLLSRIFVANPSRRITIKEIKSHPWFLKN-LPRELTE 263
           C++L+       PS R T +EI++HPW     LP+E  E
Sbjct: 250 CQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAE 288

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 95.1 bits (235), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 79/279 (28%), Positives = 127/279 (45%), Gaps = 32/279 (11%)
Query: 3   KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKID-------ANVAREIINHKQL 55
           +Y++   +GSG FG        +    VA+K++E+    D         V  E++  K++
Sbjct: 25  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 84
Query: 56  R--HPNIIRFKEVVLTPTHLAIVMEYAAG-GELFERICNAGRFSEDEARYFFQQLISG-- 110
                 +IR  +    P    +++E      +LF+ I   G   E+ AR FF Q++    
Sbjct: 85  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 144
Query: 111 -----QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLS 165
                 + HRD+K EN L+D +    LK+ DFG S + L  +      GT  Y  PE + 
Sbjct: 145 HCHNCGVLHRDIKDENILIDLNRG-ELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIR 202
Query: 166 RREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQD 225
              Y G+ A VWS G+ LY M+ G  PFE  E+             ++ ++     +S +
Sbjct: 203 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------------IIRGQVFFRQRVSSE 250
Query: 226 CRNLLSRIFVANPSRRITIKEIKSHPWFLKN-LPRELTE 263
           C++L+       PS R T +EI++HPW     LP+E  E
Sbjct: 251 CQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAE 289

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 95.1 bits (235), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 79/264 (29%), Positives = 130/264 (49%), Gaps = 19/264 (7%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDAN-VAREIINHKQLRHPNI 60
           +KY   + IG G  G      +  T + VA++ +    +     +  EI+  ++ ++PNI
Sbjct: 20  KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNI 79
Query: 61  IRFKEVVLTPTHLAIVMEYAAGGEL----FERICNAGRFSE--DEARYFFQQLISGQICH 114
           + + +  L    L +VMEY AGG L     E   + G+ +    E     + L S Q+ H
Sbjct: 80  VNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIH 139
Query: 115 RDLKLENTLL--DGSPAPRLKICDFGYSKSSLLHSRPKST-VGTPAYIAPEVLSRREYDG 171
           RD+K +N LL  DGS    +K+ DFG+          +ST VGTP ++APEV++R+ Y G
Sbjct: 140 RDIKSDNILLGMDGS----VKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAY-G 194
Query: 172 KLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLS 231
              D+WS G+    M+ G  P+ + E+P      I+     + + P+   +S   R+ L+
Sbjct: 195 PKVDIWSLGIMAIEMIEGEPPYLN-ENPLRALYLIATNGTPELQNPE--KLSAIFRDFLN 251
Query: 232 RIFVANPSRRITIKEIKSHPWFLK 255
           R    +  +R + KE+  H  FLK
Sbjct: 252 RCLDMDVEKRGSAKELLQHQ-FLK 274

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 95.1 bits (235), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 79/279 (28%), Positives = 127/279 (45%), Gaps = 32/279 (11%)
Query: 3   KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKID-------ANVAREIINHKQL 55
           +Y++   +GSG FG        +    VA+K++E+    D         V  E++  K++
Sbjct: 5   QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 64
Query: 56  R--HPNIIRFKEVVLTPTHLAIVMEYAAG-GELFERICNAGRFSEDEARYFFQQLISG-- 110
                 +IR  +    P    +++E      +LF+ I   G   E+ AR FF Q++    
Sbjct: 65  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 124
Query: 111 -----QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLS 165
                 + HRD+K EN L+D +    LK+ DFG S + L  +      GT  Y  PE + 
Sbjct: 125 HCHNXGVLHRDIKDENILIDLNRG-ELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIR 182
Query: 166 RREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQD 225
              Y G+ A VWS G+ LY M+ G  PFE  E+             ++ ++     +S +
Sbjct: 183 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------------IIRGQVFFRQRVSXE 230
Query: 226 CRNLLSRIFVANPSRRITIKEIKSHPWFLKN-LPRELTE 263
           C++L+       PS R T +EI++HPW     LP+E  E
Sbjct: 231 CQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAE 269

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 95.1 bits (235), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 79/279 (28%), Positives = 127/279 (45%), Gaps = 32/279 (11%)
Query: 3   KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKID-------ANVAREIINHKQL 55
           +Y++   +GSG FG        +    VA+K++E+    D         V  E++  K++
Sbjct: 5   QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 64
Query: 56  R--HPNIIRFKEVVLTPTHLAIVMEYAAG-GELFERICNAGRFSEDEARYFFQQLISG-- 110
                 +IR  +    P    +++E      +LF+ I   G   E+ AR FF Q++    
Sbjct: 65  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 124
Query: 111 -----QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLS 165
                 + HRD+K EN L+D +    LK+ DFG S + L  +      GT  Y  PE + 
Sbjct: 125 HCHNCGVLHRDIKDENILIDLNRG-ELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIR 182
Query: 166 RREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQD 225
              Y G+ A VWS G+ LY M+ G  PFE  E+             ++ ++     +S +
Sbjct: 183 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------------IIRGQVFFRQRVSSE 230
Query: 226 CRNLLSRIFVANPSRRITIKEIKSHPWFLKN-LPRELTE 263
           C++L+       PS R T +EI++HPW     LP+E  E
Sbjct: 231 CQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAE 269

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 94.7 bits (234), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 79/279 (28%), Positives = 127/279 (45%), Gaps = 32/279 (11%)
Query: 3   KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKID-------ANVAREIINHKQL 55
           +Y++   +GSG FG        +    VA+K++E+    D         V  E++  K++
Sbjct: 25  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 84
Query: 56  R--HPNIIRFKEVVLTPTHLAIVMEYAAG-GELFERICNAGRFSEDEARYFFQQLISG-- 110
                 +IR  +    P    +++E      +LF+ I   G   E+ AR FF Q++    
Sbjct: 85  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 144
Query: 111 -----QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLS 165
                 + HRD+K EN L+D +    LK+ DFG S + L  +      GT  Y  PE + 
Sbjct: 145 HCHNCGVLHRDIKDENILIDLNRG-ELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIR 202
Query: 166 RREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQD 225
              Y G+ A VWS G+ LY M+ G  PFE  E+             ++ ++     +S +
Sbjct: 203 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------------IIRGQVFFRQRVSXE 250
Query: 226 CRNLLSRIFVANPSRRITIKEIKSHPWFLKN-LPRELTE 263
           C++L+       PS R T +EI++HPW     LP+E  E
Sbjct: 251 CQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAE 289

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 94.7 bits (234), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 84/290 (28%), Positives = 135/290 (46%), Gaps = 41/290 (14%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIE---RGHKIDANVAREIINHKQLRH 57
           ME ++ ++ IG G +GV    RNK T E+VA+K I        + +   REI   K+L H
Sbjct: 2   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 61
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDE----ARYFFQQLISGQIC 113
           PNI++  +V+ T   L +V E+    +  ++  +A   +         Y FQ L     C
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLSFC 119
Query: 114 ------HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKS-TVGTPAYIAPEVLSR 166
                 HRDLK +N L++   A  +K+ DFG +++  +  R  +  V T  Y APE+L  
Sbjct: 120 HSHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG 177
Query: 167 REYDGKLADVWSCGVTLYVMLVGAYPFE-DQEDPKNFR--KTISRIMAVQY----KIPDY 219
            +Y     D+WS G     M+     F  D E  + FR  +T+     V +     +PDY
Sbjct: 178 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 237
Query: 220 ----------------VHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 253
                             + +D R+LLS++   +P++RI+ K   +HP+F
Sbjct: 238 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 287

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 94.7 bits (234), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 79/279 (28%), Positives = 127/279 (45%), Gaps = 32/279 (11%)
Query: 3   KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKID-------ANVAREIINHKQL 55
           +Y++   +GSG FG        +    VA+K++E+    D         V  E++  K++
Sbjct: 8   QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 67
Query: 56  R--HPNIIRFKEVVLTPTHLAIVMEYAAG-GELFERICNAGRFSEDEARYFFQQLISG-- 110
                 +IR  +    P    +++E      +LF+ I   G   E+ AR FF Q++    
Sbjct: 68  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 127
Query: 111 -----QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLS 165
                 + HRD+K EN L+D +    LK+ DFG S + L  +      GT  Y  PE + 
Sbjct: 128 HCHNCGVLHRDIKDENILIDLNRG-ELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIR 185
Query: 166 RREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQD 225
              Y G+ A VWS G+ LY M+ G  PFE  E+             ++ ++     +S +
Sbjct: 186 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------------IIRGQVFFRQRVSSE 233
Query: 226 CRNLLSRIFVANPSRRITIKEIKSHPWFLKN-LPRELTE 263
           C++L+       PS R T +EI++HPW     LP+E  E
Sbjct: 234 CQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAE 272

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 94.7 bits (234), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 79/279 (28%), Positives = 127/279 (45%), Gaps = 32/279 (11%)
Query: 3   KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKID-------ANVAREIINHKQL 55
           +Y++   +GSG FG        +    VA+K++E+    D         V  E++  K++
Sbjct: 24  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 83
Query: 56  R--HPNIIRFKEVVLTPTHLAIVMEYAAG-GELFERICNAGRFSEDEARYFFQQLISG-- 110
                 +IR  +    P    +++E      +LF+ I   G   E+ AR FF Q++    
Sbjct: 84  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 143
Query: 111 -----QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLS 165
                 + HRD+K EN L+D +    LK+ DFG S + L  +      GT  Y  PE + 
Sbjct: 144 HCHNCGVLHRDIKDENILIDLNRG-ELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIR 201
Query: 166 RREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQD 225
              Y G+ A VWS G+ LY M+ G  PFE  E+             ++ ++     +S +
Sbjct: 202 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------------IIRGQVFFRQRVSXE 249
Query: 226 CRNLLSRIFVANPSRRITIKEIKSHPWFLKN-LPRELTE 263
           C++L+       PS R T +EI++HPW     LP+E  E
Sbjct: 250 CQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAE 288

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 94.7 bits (234), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 79/279 (28%), Positives = 127/279 (45%), Gaps = 32/279 (11%)
Query: 3   KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKID-------ANVAREIINHKQL 55
           +Y++   +GSG FG        +    VA+K++E+    D         V  E++  K++
Sbjct: 37  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 96
Query: 56  R--HPNIIRFKEVVLTPTHLAIVMEYAAG-GELFERICNAGRFSEDEARYFFQQLISG-- 110
                 +IR  +    P    +++E      +LF+ I   G   E+ AR FF Q++    
Sbjct: 97  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 156
Query: 111 -----QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLS 165
                 + HRD+K EN L+D +    LK+ DFG S + L  +      GT  Y  PE + 
Sbjct: 157 HCHNCGVLHRDIKDENILIDLNRG-ELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIR 214
Query: 166 RREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQD 225
              Y G+ A VWS G+ LY M+ G  PFE  E+             ++ ++     +S +
Sbjct: 215 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------------IIRGQVFFRQRVSSE 262
Query: 226 CRNLLSRIFVANPSRRITIKEIKSHPWFLKN-LPRELTE 263
           C++L+       PS R T +EI++HPW     LP+E  E
Sbjct: 263 CQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAE 301

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 94.7 bits (234), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 79/279 (28%), Positives = 127/279 (45%), Gaps = 32/279 (11%)
Query: 3   KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKID-------ANVAREIINHKQL 55
           +Y++   +GSG FG        +    VA+K++E+    D         V  E++  K++
Sbjct: 52  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 111
Query: 56  R--HPNIIRFKEVVLTPTHLAIVMEYAAG-GELFERICNAGRFSEDEARYFFQQLISG-- 110
                 +IR  +    P    +++E      +LF+ I   G   E+ AR FF Q++    
Sbjct: 112 SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 171
Query: 111 -----QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLS 165
                 + HRD+K EN L+D +    LK+ DFG S + L  +      GT  Y  PE + 
Sbjct: 172 HCHNCGVLHRDIKDENILIDLNRG-ELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIR 229
Query: 166 RREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQD 225
              Y G+ A VWS G+ LY M+ G  PFE  E+             ++ ++     +S +
Sbjct: 230 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------------IIRGQVFFRQRVSSE 277
Query: 226 CRNLLSRIFVANPSRRITIKEIKSHPWFLKN-LPRELTE 263
           C++L+       PS R T +EI++HPW     LP+E  E
Sbjct: 278 CQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAE 316

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 94.7 bits (234), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 79/279 (28%), Positives = 127/279 (45%), Gaps = 32/279 (11%)
Query: 3   KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKID-------ANVAREIINHKQL 55
           +Y++   +GSG FG        +    VA+K++E+    D         V  E++  K++
Sbjct: 52  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 111
Query: 56  R--HPNIIRFKEVVLTPTHLAIVMEYAAG-GELFERICNAGRFSEDEARYFFQQLISG-- 110
                 +IR  +    P    +++E      +LF+ I   G   E+ AR FF Q++    
Sbjct: 112 SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 171
Query: 111 -----QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLS 165
                 + HRD+K EN L+D +    LK+ DFG S + L  +      GT  Y  PE + 
Sbjct: 172 HCHNCGVLHRDIKDENILIDLNRG-ELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIR 229
Query: 166 RREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQD 225
              Y G+ A VWS G+ LY M+ G  PFE  E+             ++ ++     +S +
Sbjct: 230 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------------IIRGQVFFRQRVSXE 277
Query: 226 CRNLLSRIFVANPSRRITIKEIKSHPWFLKN-LPRELTE 263
           C++L+       PS R T +EI++HPW     LP+E  E
Sbjct: 278 CQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAE 316

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 94.7 bits (234), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 79/279 (28%), Positives = 127/279 (45%), Gaps = 32/279 (11%)
Query: 3   KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKID-------ANVAREIINHKQL 55
           +Y++   +GSG FG        +    VA+K++E+    D         V  E++  K++
Sbjct: 32  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 91
Query: 56  R--HPNIIRFKEVVLTPTHLAIVMEYAAG-GELFERICNAGRFSEDEARYFFQQLISG-- 110
                 +IR  +    P    +++E      +LF+ I   G   E+ AR FF Q++    
Sbjct: 92  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 151
Query: 111 -----QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLS 165
                 + HRD+K EN L+D +    LK+ DFG S + L  +      GT  Y  PE + 
Sbjct: 152 HCHNCGVLHRDIKDENILIDLNRG-ELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIR 209
Query: 166 RREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQD 225
              Y G+ A VWS G+ LY M+ G  PFE  E+             ++ ++     +S +
Sbjct: 210 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------------IIRGQVFFRQRVSXE 257
Query: 226 CRNLLSRIFVANPSRRITIKEIKSHPWFLKN-LPRELTE 263
           C++L+       PS R T +EI++HPW     LP+E  E
Sbjct: 258 CQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAE 296

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 94.7 bits (234), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 84/290 (28%), Positives = 135/290 (46%), Gaps = 41/290 (14%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIE---RGHKIDANVAREIINHKQLRH 57
           ME ++ ++ IG G +GV    RNK T E+VA+K I        + +   REI   K+L H
Sbjct: 2   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 61
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDE----ARYFFQQLISGQIC 113
           PNI++  +V+ T   L +V E+    +  ++  +A   +         Y FQ L     C
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 119
Query: 114 ------HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKS-TVGTPAYIAPEVLSR 166
                 HRDLK +N L++   A  +K+ DFG +++  +  R  +  V T  Y APE+L  
Sbjct: 120 HSHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG 177
Query: 167 REYDGKLADVWSCGVTLYVMLVGAYPFE-DQEDPKNFR--KTISRIMAVQY----KIPDY 219
            +Y     D+WS G     M+     F  D E  + FR  +T+     V +     +PDY
Sbjct: 178 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 237
Query: 220 ----------------VHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 253
                             + +D R+LLS++   +P++RI+ K   +HP+F
Sbjct: 238 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 287

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 94.7 bits (234), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 79/279 (28%), Positives = 127/279 (45%), Gaps = 32/279 (11%)
Query: 3   KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKID-------ANVAREIINHKQL 55
           +Y++   +GSG FG        +    VA+K++E+    D         V  E++  K++
Sbjct: 44  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 103
Query: 56  R--HPNIIRFKEVVLTPTHLAIVMEYAAG-GELFERICNAGRFSEDEARYFFQQLISG-- 110
                 +IR  +    P    +++E      +LF+ I   G   E+ AR FF Q++    
Sbjct: 104 SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 163
Query: 111 -----QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLS 165
                 + HRD+K EN L+D +    LK+ DFG S + L  +      GT  Y  PE + 
Sbjct: 164 HCHNCGVLHRDIKDENILIDLNRG-ELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIR 221
Query: 166 RREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQD 225
              Y G+ A VWS G+ LY M+ G  PFE  E+             ++ ++     +S +
Sbjct: 222 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------------IIRGQVFFRQRVSSE 269
Query: 226 CRNLLSRIFVANPSRRITIKEIKSHPWFLKN-LPRELTE 263
           C++L+       PS R T +EI++HPW     LP+E  E
Sbjct: 270 CQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAE 308

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 94.7 bits (234), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 84/290 (28%), Positives = 135/290 (46%), Gaps = 41/290 (14%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIE---RGHKIDANVAREIINHKQLRH 57
           ME ++ ++ IG G +GV    RNK T E+VA+K I        + +   REI   K+L H
Sbjct: 3   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 62
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDE----ARYFFQQLISGQIC 113
           PNI++  +V+ T   L +V E+    +  ++  +A   +         Y FQ L     C
Sbjct: 63  PNIVKLLDVIHTENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 120
Query: 114 ------HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKS-TVGTPAYIAPEVLSR 166
                 HRDLK +N L++   A  +K+ DFG +++  +  R  +  V T  Y APE+L  
Sbjct: 121 HSHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG 178
Query: 167 REYDGKLADVWSCGVTLYVMLVGAYPFE-DQEDPKNFR--KTISRIMAVQY----KIPDY 219
            +Y     D+WS G     M+     F  D E  + FR  +T+     V +     +PDY
Sbjct: 179 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 238
Query: 220 ----------------VHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 253
                             + +D R+LLS++   +P++RI+ K   +HP+F
Sbjct: 239 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 288

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 94.7 bits (234), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 82/279 (29%), Positives = 126/279 (45%), Gaps = 32/279 (11%)
Query: 3   KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKID-------ANVAREIINHKQL 55
           +Y++   +GSG FG        +    VA+K++E+    D         V  E++  K++
Sbjct: 38  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 97
Query: 56  R--HPNIIRFKEVVLTPTHLAIVMEYAAG-GELFERICNAGRFSEDEARYFFQQLISG-- 110
                 +IR  +    P    +++E      +LF+ I   G   E+ AR FF Q++    
Sbjct: 98  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 157
Query: 111 -----QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLS 165
                 + HRD+K EN L+D +    LK+ DFG S + L  +      GT  Y  PE + 
Sbjct: 158 HCHNCGVLHRDIKDENILIDLNRG-ELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIR 215
Query: 166 RREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQD 225
              Y G+ A VWS G+ LY M+ G  PFE  E+          I+  Q      V  S +
Sbjct: 216 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE----------IIGGQVFFRQRV--SSE 263
Query: 226 CRNLLSRIFVANPSRRITIKEIKSHPWFLKN-LPRELTE 263
           C++L+       PS R T +EI++HPW     LP+E  E
Sbjct: 264 CQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAE 302

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 94.7 bits (234), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 85/288 (29%), Positives = 131/288 (45%), Gaps = 37/288 (12%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIE---RGHKIDANVAREIINHKQLRH 57
           ME ++ ++ IG G +GV    RNK T E+VA+K I        + +   REI   K+L H
Sbjct: 2   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 61
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGG--ELFERICNAGRFSEDEARYFFQQLISGQIC-- 113
           PNI++  +V+ T   L +V E+      +  +     G        Y FQ L     C  
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLHQDLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 121
Query: 114 ----HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP-KSTVGTPAYIAPEVLSRRE 168
               HRDLK EN L++   A  +K+ DFG +++  +  R     V T  Y APE+L   +
Sbjct: 122 HRVLHRDLKPENLLINTEGA--IKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCK 179
Query: 169 YDGKLADVWSCGVTLYVMLVGAYPFE-DQEDPKNFR--KTISRIMAVQY----KIPDY-- 219
           Y     D+WS G     M+     F  D E  + FR  +T+     V +     +PDY  
Sbjct: 180 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 239
Query: 220 --------------VHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 253
                           + +D R+LLS++   +P++RI+ K   +HP+F
Sbjct: 240 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 287

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 94.7 bits (234), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 84/290 (28%), Positives = 135/290 (46%), Gaps = 41/290 (14%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIE---RGHKIDANVAREIINHKQLRH 57
           ME ++ ++ IG G +GV    RNK T E+VA+K I        + +   REI   K+L H
Sbjct: 9   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 68
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDE----ARYFFQQLISGQIC 113
           PNI++  +V+ T   L +V E+    +  ++  +A   +         Y FQ L     C
Sbjct: 69  PNIVKLLDVIHTENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 126
Query: 114 ------HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKS-TVGTPAYIAPEVLSR 166
                 HRDLK +N L++   A  +K+ DFG +++  +  R  +  V T  Y APE+L  
Sbjct: 127 HSHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG 184
Query: 167 REYDGKLADVWSCGVTLYVMLVGAYPFE-DQEDPKNFR--KTISRIMAVQY----KIPDY 219
            +Y     D+WS G     M+     F  D E  + FR  +T+     V +     +PDY
Sbjct: 185 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 244
Query: 220 ----------------VHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 253
                             + +D R+LLS++   +P++RI+ K   +HP+F
Sbjct: 245 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 294

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 94.4 bits (233), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 82/279 (29%), Positives = 126/279 (45%), Gaps = 32/279 (11%)
Query: 3   KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKID-------ANVAREIINHKQL 55
           +Y++   +GSG FG        +    VA+K++E+    D         V  E++  K++
Sbjct: 38  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 97
Query: 56  R--HPNIIRFKEVVLTPTHLAIVMEYAAG-GELFERICNAGRFSEDEARYFFQQLISG-- 110
                 +IR  +    P    +++E      +LF+ I   G   E+ AR FF Q++    
Sbjct: 98  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 157
Query: 111 -----QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLS 165
                 + HRD+K EN L+D +    LK+ DFG S + L  +      GT  Y  PE + 
Sbjct: 158 HCHNCGVLHRDIKDENILIDLNRG-ELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIR 215
Query: 166 RREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQD 225
              Y G+ A VWS G+ LY M+ G  PFE  E+          I+  Q      V  S +
Sbjct: 216 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE----------IIGGQVFFRQRV--SSE 263
Query: 226 CRNLLSRIFVANPSRRITIKEIKSHPWFLKN-LPRELTE 263
           C++L+       PS R T +EI++HPW     LP+E  E
Sbjct: 264 CQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAE 302

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 94.4 bits (233), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 84/290 (28%), Positives = 135/290 (46%), Gaps = 41/290 (14%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIE---RGHKIDANVAREIINHKQLRH 57
           ME ++ ++ IG G +GV    RNK T E+VA+K I        + +   REI   K+L H
Sbjct: 2   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 61
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDE----ARYFFQQLISGQIC 113
           PNI++  +V+ T   L +V E+    +  ++  +A   +         Y FQ L     C
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 119
Query: 114 ------HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKS-TVGTPAYIAPEVLSR 166
                 HRDLK +N L++   A  +K+ DFG +++  +  R  +  V T  Y APE+L  
Sbjct: 120 HSHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG 177
Query: 167 REYDGKLADVWSCGVTLYVMLVGAYPFE-DQEDPKNFR--KTISRIMAVQY----KIPDY 219
            +Y     D+WS G     M+     F  D E  + FR  +T+     V +     +PDY
Sbjct: 178 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 237
Query: 220 ----------------VHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 253
                             + +D R+LLS++   +P++RI+ K   +HP+F
Sbjct: 238 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 287

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 94.4 bits (233), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 84/290 (28%), Positives = 135/290 (46%), Gaps = 41/290 (14%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIE---RGHKIDANVAREIINHKQLRH 57
           ME ++ ++ IG G +GV    RNK T E+VA+K I        + +   REI   K+L H
Sbjct: 1   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 60
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDE----ARYFFQQLISGQIC 113
           PNI++  +V+ T   L +V E+    +  ++  +A   +         Y FQ L     C
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 118
Query: 114 ------HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKS-TVGTPAYIAPEVLSR 166
                 HRDLK +N L++   A  +K+ DFG +++  +  R  +  V T  Y APE+L  
Sbjct: 119 HSHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG 176
Query: 167 REYDGKLADVWSCGVTLYVMLVGAYPFE-DQEDPKNFR--KTISRIMAVQY----KIPDY 219
            +Y     D+WS G     M+     F  D E  + FR  +T+     V +     +PDY
Sbjct: 177 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 236
Query: 220 ----------------VHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 253
                             + +D R+LLS++   +P++RI+ K   +HP+F
Sbjct: 237 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 286

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 94.4 bits (233), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 82/279 (29%), Positives = 126/279 (45%), Gaps = 32/279 (11%)
Query: 3   KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKID-------ANVAREIINHKQL 55
           +Y++   +GSG FG        +    VA+K++E+    D         V  E++  K++
Sbjct: 37  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 96
Query: 56  R--HPNIIRFKEVVLTPTHLAIVMEYAAG-GELFERICNAGRFSEDEARYFFQQLISG-- 110
                 +IR  +    P    +++E      +LF+ I   G   E+ AR FF Q++    
Sbjct: 97  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 156
Query: 111 -----QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLS 165
                 + HRD+K EN L+D +    LK+ DFG S + L  +      GT  Y  PE + 
Sbjct: 157 HCHNCGVLHRDIKDENILIDLNRG-ELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIR 214
Query: 166 RREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQD 225
              Y G+ A VWS G+ LY M+ G  PFE  E+          I+  Q      V  S +
Sbjct: 215 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE----------IIGGQVFFRQRV--SSE 262
Query: 226 CRNLLSRIFVANPSRRITIKEIKSHPWFLKN-LPRELTE 263
           C++L+       PS R T +EI++HPW     LP+E  E
Sbjct: 263 CQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAE 301

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 94.4 bits (233), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 84/290 (28%), Positives = 135/290 (46%), Gaps = 41/290 (14%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIE---RGHKIDANVAREIINHKQLRH 57
           ME ++ ++ IG G +GV    RNK T E+VA+K I        + +   REI   K+L H
Sbjct: 6   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 65
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDE----ARYFFQQLISGQIC 113
           PNI++  +V+ T   L +V E+    +  ++  +A   +         Y FQ L     C
Sbjct: 66  PNIVKLLDVIHTENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 123
Query: 114 ------HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKS-TVGTPAYIAPEVLSR 166
                 HRDLK +N L++   A  +K+ DFG +++  +  R  +  V T  Y APE+L  
Sbjct: 124 HSHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG 181
Query: 167 REYDGKLADVWSCGVTLYVMLVGAYPFE-DQEDPKNFR--KTISRIMAVQY----KIPDY 219
            +Y     D+WS G     M+     F  D E  + FR  +T+     V +     +PDY
Sbjct: 182 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 241
Query: 220 ----------------VHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 253
                             + +D R+LLS++   +P++RI+ K   +HP+F
Sbjct: 242 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 291

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 94.4 bits (233), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 82/279 (29%), Positives = 126/279 (45%), Gaps = 32/279 (11%)
Query: 3   KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKID-------ANVAREIINHKQL 55
           +Y++   +GSG FG        +    VA+K++E+    D         V  E++  K++
Sbjct: 5   QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 64
Query: 56  R--HPNIIRFKEVVLTPTHLAIVMEYAAG-GELFERICNAGRFSEDEARYFFQQLISG-- 110
                 +IR  +    P    +++E      +LF+ I   G   E+ AR FF Q++    
Sbjct: 65  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 124
Query: 111 -----QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLS 165
                 + HRD+K EN L+D +    LK+ DFG S + L  +      GT  Y  PE + 
Sbjct: 125 HCHNCGVLHRDIKDENILIDLNRG-ELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIR 182
Query: 166 RREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQD 225
              Y G+ A VWS G+ LY M+ G  PFE  E+          I+  Q      V  S +
Sbjct: 183 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE----------IIGGQVFFRQRV--SSE 230
Query: 226 CRNLLSRIFVANPSRRITIKEIKSHPWFLKN-LPRELTE 263
           C++L+       PS R T +EI++HPW     LP+E  E
Sbjct: 231 CQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAE 269

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 94.4 bits (233), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 79/279 (28%), Positives = 127/279 (45%), Gaps = 32/279 (11%)
Query: 3   KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKID-------ANVAREIINHKQL 55
           +Y++   +GSG FG        +    VA+K++E+    D         V  E++  K++
Sbjct: 57  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 116
Query: 56  R--HPNIIRFKEVVLTPTHLAIVMEYAAG-GELFERICNAGRFSEDEARYFFQQLISG-- 110
                 +IR  +    P    +++E      +LF+ I   G   E+ AR FF Q++    
Sbjct: 117 SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 176
Query: 111 -----QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLS 165
                 + HRD+K EN L+D +    LK+ DFG S + L  +      GT  Y  PE + 
Sbjct: 177 HCHNCGVLHRDIKDENILIDLNRG-ELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIR 234
Query: 166 RREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQD 225
              Y G+ A VWS G+ LY M+ G  PFE  E+             ++ ++     +S +
Sbjct: 235 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------------IIRGQVFFRQRVSXE 282
Query: 226 CRNLLSRIFVANPSRRITIKEIKSHPWFLKN-LPRELTE 263
           C++L+       PS R T +EI++HPW     LP+E  E
Sbjct: 283 CQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAE 321

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 94.4 bits (233), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 84/290 (28%), Positives = 134/290 (46%), Gaps = 41/290 (14%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIE---RGHKIDANVAREIINHKQLRH 57
           ME ++ ++ IG G +GV    RNK T E+VA+K I        + +   REI   K+L H
Sbjct: 5   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 64
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDE----ARYFFQQLISGQIC 113
           PNI++  +V+ T   L +V E+    +  ++  +A   +         Y FQ L     C
Sbjct: 65  PNIVKLLDVIHTENKLYLVFEHV--DQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 122
Query: 114 ------HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP-KSTVGTPAYIAPEVLSR 166
                 HRDLK +N L++   A  +K+ DFG +++  +  R     V T  Y APE+L  
Sbjct: 123 HSHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG 180
Query: 167 REYDGKLADVWSCGVTLYVMLVGAYPFE-DQEDPKNFR--KTISRIMAVQY----KIPDY 219
            +Y     D+WS G     M+     F  D E  + FR  +T+     V +     +PDY
Sbjct: 181 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 240
Query: 220 ----------------VHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 253
                             + +D R+LLS++   +P++RI+ K   +HP+F
Sbjct: 241 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 290

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 94.4 bits (233), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 82/279 (29%), Positives = 126/279 (45%), Gaps = 32/279 (11%)
Query: 3   KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKID-------ANVAREIINHKQL 55
           +Y++   +GSG FG        +    VA+K++E+    D         V  E++  K++
Sbjct: 37  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 96
Query: 56  R--HPNIIRFKEVVLTPTHLAIVMEYAAG-GELFERICNAGRFSEDEARYFFQQLISG-- 110
                 +IR  +    P    +++E      +LF+ I   G   E+ AR FF Q++    
Sbjct: 97  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 156
Query: 111 -----QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLS 165
                 + HRD+K EN L+D +    LK+ DFG S + L  +      GT  Y  PE + 
Sbjct: 157 HCHNCGVLHRDIKDENILIDLNRG-ELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIR 214
Query: 166 RREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQD 225
              Y G+ A VWS G+ LY M+ G  PFE  E+          I+  Q      V  S +
Sbjct: 215 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE----------IIGGQVFFRQRV--SSE 262
Query: 226 CRNLLSRIFVANPSRRITIKEIKSHPWFLKN-LPRELTE 263
           C++L+       PS R T +EI++HPW     LP+E  E
Sbjct: 263 CQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAE 301

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 94.4 bits (233), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 78/264 (29%), Positives = 132/264 (50%), Gaps = 19/264 (7%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDAN-VAREIINHKQLRHPNI 60
           +KY   + IG G  G      +  T + VA++ +    +     +  EI+  ++ ++PNI
Sbjct: 20  KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNI 79
Query: 61  IRFKEVVLTPTHLAIVMEYAAGGEL----FERICNAGRFSE--DEARYFFQQLISGQICH 114
           + + +  L    L +VMEY AGG L     E   + G+ +    E     + L S Q+ H
Sbjct: 80  VNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIH 139
Query: 115 RDLKLENTLL--DGSPAPRLKICDFGY-SKSSLLHSRPKSTVGTPAYIAPEVLSRREYDG 171
           RD+K +N LL  DGS    +K+ DFG+ ++ +   S+    VGTP ++APEV++R+ Y G
Sbjct: 140 RDIKSDNILLGMDGS----VKLTDFGFCAQITPEQSKRSEMVGTPYWMAPEVVTRKAY-G 194
Query: 172 KLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLS 231
              D+WS G+    M+ G  P+ + E+P      I+     + + P+   +S   R+ L+
Sbjct: 195 PKVDIWSLGIMAIEMIEGEPPYLN-ENPLRALYLIATNGTPELQNPE--KLSAIFRDFLN 251
Query: 232 RIFVANPSRRITIKEIKSHPWFLK 255
           R    +  +R + KE+  H  FLK
Sbjct: 252 RCLDMDVEKRGSAKELLQHQ-FLK 274

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 94.4 bits (233), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 84/290 (28%), Positives = 134/290 (46%), Gaps = 41/290 (14%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIE---RGHKIDANVAREIINHKQLRH 57
           ME ++ ++ IG G +GV    RNK T E+VA+K I        + +   REI   K+L H
Sbjct: 2   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 61
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDE----ARYFFQQLISGQIC 113
           PNI++  +V+ T   L +V E+    +  ++  +A   +         Y FQ L     C
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 119
Query: 114 ------HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP-KSTVGTPAYIAPEVLSR 166
                 HRDLK +N L++   A  +K+ DFG +++  +  R     V T  Y APE+L  
Sbjct: 120 HSHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG 177
Query: 167 REYDGKLADVWSCGVTLYVMLVGAYPFE-DQEDPKNFR--KTISRIMAVQY----KIPDY 219
            +Y     D+WS G     M+     F  D E  + FR  +T+     V +     +PDY
Sbjct: 178 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 237
Query: 220 ----------------VHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 253
                             + +D R+LLS++   +P++RI+ K   +HP+F
Sbjct: 238 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 287

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 94.4 bits (233), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 84/288 (29%), Positives = 132/288 (45%), Gaps = 37/288 (12%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIE---RGHKIDANVAREIINHKQLRH 57
           ME ++ ++ IG G +GV    RNK T E+VA+K I        + +   REI   K+L H
Sbjct: 4   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 63
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGG--ELFERICNAGRFSEDEARYFFQQLISGQIC-- 113
           PNI++  +V+ T   L +V E+ +    +  +     G        Y FQ L     C  
Sbjct: 64  PNIVKLLDVIHTENKLYLVFEFLSMDLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 123
Query: 114 ----HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP-KSTVGTPAYIAPEVLSRRE 168
               HRDLK +N L++   A  +K+ DFG +++  +  R     V T  Y APE+L   +
Sbjct: 124 HRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCK 181
Query: 169 YDGKLADVWSCGVTLYVMLVGAYPFE-DQEDPKNFR--KTISRIMAVQY----KIPDY-- 219
           Y     D+WS G     M+     F  D E  + FR  +T+     V +     +PDY  
Sbjct: 182 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 241
Query: 220 --------------VHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 253
                           + +D R+LLS++   +P++RI+ K   +HP+F
Sbjct: 242 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 289

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 94.4 bits (233), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 82/279 (29%), Positives = 126/279 (45%), Gaps = 32/279 (11%)
Query: 3   KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKID-------ANVAREIINHKQL 55
           +Y++   +GSG FG        +    VA+K++E+    D         V  E++  K++
Sbjct: 38  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 97
Query: 56  R--HPNIIRFKEVVLTPTHLAIVMEYAAG-GELFERICNAGRFSEDEARYFFQQLISG-- 110
                 +IR  +    P    +++E      +LF+ I   G   E+ AR FF Q++    
Sbjct: 98  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 157
Query: 111 -----QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLS 165
                 + HRD+K EN L+D +    LK+ DFG S + L  +      GT  Y  PE + 
Sbjct: 158 HCHNCGVLHRDIKDENILIDLNRG-ELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIR 215
Query: 166 RREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQD 225
              Y G+ A VWS G+ LY M+ G  PFE  E+          I+  Q      V  S +
Sbjct: 216 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE----------IIGGQVFFRQRV--SXE 263
Query: 226 CRNLLSRIFVANPSRRITIKEIKSHPWFLKN-LPRELTE 263
           C++L+       PS R T +EI++HPW     LP+E  E
Sbjct: 264 CQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAE 302

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 94.4 bits (233), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 84/288 (29%), Positives = 132/288 (45%), Gaps = 37/288 (12%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIE---RGHKIDANVAREIINHKQLRH 57
           ME ++ ++ IG G +GV    RNK T E+VA+K I        + +   REI   K+L H
Sbjct: 5   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 64
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGG--ELFERICNAGRFSEDEARYFFQQLISGQIC-- 113
           PNI++  +V+ T   L +V E+ +    +  +     G        Y FQ L     C  
Sbjct: 65  PNIVKLLDVIHTENKLYLVFEFLSMDLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 124
Query: 114 ----HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP-KSTVGTPAYIAPEVLSRRE 168
               HRDLK +N L++   A  +K+ DFG +++  +  R     V T  Y APE+L   +
Sbjct: 125 HRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCK 182
Query: 169 YDGKLADVWSCGVTLYVMLVGAYPFE-DQEDPKNFR--KTISRIMAVQY----KIPDY-- 219
           Y     D+WS G     M+     F  D E  + FR  +T+     V +     +PDY  
Sbjct: 183 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 242
Query: 220 --------------VHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 253
                           + +D R+LLS++   +P++RI+ K   +HP+F
Sbjct: 243 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 290

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 94.4 bits (233), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 84/290 (28%), Positives = 134/290 (46%), Gaps = 41/290 (14%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIE---RGHKIDANVAREIINHKQLRH 57
           ME ++ ++ IG G +GV    RNK T E+VA+K I        + +   REI   K+L H
Sbjct: 4   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 63
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDE----ARYFFQQLISGQIC 113
           PNI++  +V+ T   L +V E+    +  ++  +A   +         Y FQ L     C
Sbjct: 64  PNIVKLLDVIHTENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 121
Query: 114 ------HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP-KSTVGTPAYIAPEVLSR 166
                 HRDLK +N L++   A  +K+ DFG +++  +  R     V T  Y APE+L  
Sbjct: 122 HSHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG 179
Query: 167 REYDGKLADVWSCGVTLYVMLVGAYPFE-DQEDPKNFR--KTISRIMAVQY----KIPDY 219
            +Y     D+WS G     M+     F  D E  + FR  +T+     V +     +PDY
Sbjct: 180 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 239
Query: 220 ----------------VHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 253
                             + +D R+LLS++   +P++RI+ K   +HP+F
Sbjct: 240 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 289

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 94.4 bits (233), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 82/279 (29%), Positives = 126/279 (45%), Gaps = 32/279 (11%)
Query: 3   KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKID-------ANVAREIINHKQL 55
           +Y++   +GSG FG        +    VA+K++E+    D         V  E++  K++
Sbjct: 38  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 97
Query: 56  R--HPNIIRFKEVVLTPTHLAIVMEYAAG-GELFERICNAGRFSEDEARYFFQQLISG-- 110
                 +IR  +    P    +++E      +LF+ I   G   E+ AR FF Q++    
Sbjct: 98  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 157
Query: 111 -----QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLS 165
                 + HRD+K EN L+D +    LK+ DFG S + L  +      GT  Y  PE + 
Sbjct: 158 HCHNCGVLHRDIKDENILIDLNRG-ELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIR 215
Query: 166 RREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQD 225
              Y G+ A VWS G+ LY M+ G  PFE  E+          I+  Q      V  S +
Sbjct: 216 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE----------IIGGQVFFRQRV--SXE 263
Query: 226 CRNLLSRIFVANPSRRITIKEIKSHPWFLKN-LPRELTE 263
           C++L+       PS R T +EI++HPW     LP+E  E
Sbjct: 264 CQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAE 302

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 94.4 bits (233), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 84/290 (28%), Positives = 134/290 (46%), Gaps = 41/290 (14%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIE---RGHKIDANVAREIINHKQLRH 57
           ME ++ ++ IG G +GV    RNK T E+VA+K I        + +   REI   K+L H
Sbjct: 5   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 64
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDE----ARYFFQQLISGQIC 113
           PNI++  +V+ T   L +V E+    +  ++  +A   +         Y FQ L     C
Sbjct: 65  PNIVKLLDVIHTENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 122
Query: 114 ------HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP-KSTVGTPAYIAPEVLSR 166
                 HRDLK +N L++   A  +K+ DFG +++  +  R     V T  Y APE+L  
Sbjct: 123 HSHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG 180
Query: 167 REYDGKLADVWSCGVTLYVMLVGAYPFE-DQEDPKNFR--KTISRIMAVQY----KIPDY 219
            +Y     D+WS G     M+     F  D E  + FR  +T+     V +     +PDY
Sbjct: 181 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 240
Query: 220 ----------------VHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 253
                             + +D R+LLS++   +P++RI+ K   +HP+F
Sbjct: 241 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 290

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 94.4 bits (233), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 82/279 (29%), Positives = 126/279 (45%), Gaps = 32/279 (11%)
Query: 3   KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKID-------ANVAREIINHKQL 55
           +Y++   +GSG FG        +    VA+K++E+    D         V  E++  K++
Sbjct: 37  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 96
Query: 56  R--HPNIIRFKEVVLTPTHLAIVMEYAAG-GELFERICNAGRFSEDEARYFFQQLISG-- 110
                 +IR  +    P    +++E      +LF+ I   G   E+ AR FF Q++    
Sbjct: 97  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 156
Query: 111 -----QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLS 165
                 + HRD+K EN L+D +    LK+ DFG S + L  +      GT  Y  PE + 
Sbjct: 157 HCHNCGVLHRDIKDENILIDLNRG-ELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIR 214
Query: 166 RREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQD 225
              Y G+ A VWS G+ LY M+ G  PFE  E+          I+  Q      V  S +
Sbjct: 215 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE----------IIGGQVFFRQRV--SXE 262
Query: 226 CRNLLSRIFVANPSRRITIKEIKSHPWFLKN-LPRELTE 263
           C++L+       PS R T +EI++HPW     LP+E  E
Sbjct: 263 CQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAE 301

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 84/290 (28%), Positives = 134/290 (46%), Gaps = 41/290 (14%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIE---RGHKIDANVAREIINHKQLRH 57
           ME ++ ++ IG G +GV    RNK T E+VA+K I        + +   REI   K+L H
Sbjct: 2   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 61
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDE----ARYFFQQLISGQIC 113
           PNI++  +V+ T   L +V E+    +  ++  +A   +         Y FQ L     C
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 119
Query: 114 ------HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP-KSTVGTPAYIAPEVLSR 166
                 HRDLK +N L++   A  +K+ DFG +++  +  R     V T  Y APE+L  
Sbjct: 120 HSHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG 177
Query: 167 REYDGKLADVWSCGVTLYVMLVGAYPFE-DQEDPKNFR--KTISRIMAVQY----KIPDY 219
            +Y     D+WS G     M+     F  D E  + FR  +T+     V +     +PDY
Sbjct: 178 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 237
Query: 220 ----------------VHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 253
                             + +D R+LLS++   +P++RI+ K   +HP+F
Sbjct: 238 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 287

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 78/264 (29%), Positives = 132/264 (50%), Gaps = 19/264 (7%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDAN-VAREIINHKQLRHPNI 60
           +KY   + IG G  G      +  T + VA++ +    +     +  EI+  ++ ++PNI
Sbjct: 20  KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNI 79
Query: 61  IRFKEVVLTPTHLAIVMEYAAGGEL----FERICNAGRFSE--DEARYFFQQLISGQICH 114
           + + +  L    L +VMEY AGG L     E   + G+ +    E     + L S Q+ H
Sbjct: 80  VNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIH 139
Query: 115 RDLKLENTLL--DGSPAPRLKICDFGY-SKSSLLHSRPKSTVGTPAYIAPEVLSRREYDG 171
           RD+K +N LL  DGS    +K+ DFG+ ++ +   S+    VGTP ++APEV++R+ Y G
Sbjct: 140 RDIKSDNILLGMDGS----VKLTDFGFCAQITPEQSKRSXMVGTPYWMAPEVVTRKAY-G 194
Query: 172 KLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLS 231
              D+WS G+    M+ G  P+ + E+P      I+     + + P+   +S   R+ L+
Sbjct: 195 PKVDIWSLGIMAIEMIEGEPPYLN-ENPLRALYLIATNGTPELQNPE--KLSAIFRDFLN 251
Query: 232 RIFVANPSRRITIKEIKSHPWFLK 255
           R    +  +R + KE+  H  FLK
Sbjct: 252 RCLEMDVEKRGSAKELLQHQ-FLK 274

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 78/264 (29%), Positives = 132/264 (50%), Gaps = 19/264 (7%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDAN-VAREIINHKQLRHPNI 60
           +KY   + IG G  G      +  T + VA++ +    +     +  EI+  ++ ++PNI
Sbjct: 21  KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNI 80
Query: 61  IRFKEVVLTPTHLAIVMEYAAGGEL----FERICNAGRFSE--DEARYFFQQLISGQICH 114
           + + +  L    L +VMEY AGG L     E   + G+ +    E     + L S Q+ H
Sbjct: 81  VNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIH 140
Query: 115 RDLKLENTLL--DGSPAPRLKICDFGY-SKSSLLHSRPKSTVGTPAYIAPEVLSRREYDG 171
           RD+K +N LL  DGS    +K+ DFG+ ++ +   S+    VGTP ++APEV++R+ Y G
Sbjct: 141 RDIKSDNILLGMDGS----VKLTDFGFCAQITPEQSKRSXMVGTPYWMAPEVVTRKAY-G 195
Query: 172 KLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLS 231
              D+WS G+    M+ G  P+ + E+P      I+     + + P+   +S   R+ L+
Sbjct: 196 PKVDIWSLGIMAIEMIEGEPPYLN-ENPLRALYLIATNGTPELQNPE--KLSAIFRDFLN 252
Query: 232 RIFVANPSRRITIKEIKSHPWFLK 255
           R    +  +R + KE+  H  FLK
Sbjct: 253 RCLEMDVEKRGSAKELIQHQ-FLK 275

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 84/290 (28%), Positives = 134/290 (46%), Gaps = 41/290 (14%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIE---RGHKIDANVAREIINHKQLRH 57
           ME ++ ++ IG G +GV    RNK T E+VA+K I        + +   REI   K+L H
Sbjct: 3   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 62
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDE----ARYFFQQLISGQIC 113
           PNI++  +V+ T   L +V E+    +  ++  +A   +         Y FQ L     C
Sbjct: 63  PNIVKLLDVIHTENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 120
Query: 114 ------HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP-KSTVGTPAYIAPEVLSR 166
                 HRDLK +N L++   A  +K+ DFG +++  +  R     V T  Y APE+L  
Sbjct: 121 HSHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG 178
Query: 167 REYDGKLADVWSCGVTLYVMLVGAYPFE-DQEDPKNFR--KTISRIMAVQY----KIPDY 219
            +Y     D+WS G     M+     F  D E  + FR  +T+     V +     +PDY
Sbjct: 179 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 238
Query: 220 ----------------VHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 253
                             + +D R+LLS++   +P++RI+ K   +HP+F
Sbjct: 239 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 288

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 84/290 (28%), Positives = 134/290 (46%), Gaps = 41/290 (14%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIE---RGHKIDANVAREIINHKQLRH 57
           ME ++ ++ IG G +GV    RNK T E+VA+K I        + +   REI   K+L H
Sbjct: 3   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 62
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDE----ARYFFQQLISGQIC 113
           PNI++  +V+ T   L +V E+    +  ++  +A   +         Y FQ L     C
Sbjct: 63  PNIVKLLDVIHTENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 120
Query: 114 ------HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP-KSTVGTPAYIAPEVLSR 166
                 HRDLK +N L++   A  +K+ DFG +++  +  R     V T  Y APE+L  
Sbjct: 121 HSHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG 178
Query: 167 REYDGKLADVWSCGVTLYVMLVGAYPFE-DQEDPKNFR--KTISRIMAVQY----KIPDY 219
            +Y     D+WS G     M+     F  D E  + FR  +T+     V +     +PDY
Sbjct: 179 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 238
Query: 220 ----------------VHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 253
                             + +D R+LLS++   +P++RI+ K   +HP+F
Sbjct: 239 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 288

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 84/290 (28%), Positives = 134/290 (46%), Gaps = 41/290 (14%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIE---RGHKIDANVAREIINHKQLRH 57
           ME ++ ++ IG G +GV    RNK T E+VA+K I        + +   REI   K+L H
Sbjct: 1   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 60
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDE----ARYFFQQLISGQIC 113
           PNI++  +V+ T   L +V E+    +  ++  +A   +         Y FQ L     C
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 118
Query: 114 ------HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP-KSTVGTPAYIAPEVLSR 166
                 HRDLK +N L++   A  +K+ DFG +++  +  R     V T  Y APE+L  
Sbjct: 119 HSHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG 176
Query: 167 REYDGKLADVWSCGVTLYVMLVGAYPFE-DQEDPKNFR--KTISRIMAVQY----KIPDY 219
            +Y     D+WS G     M+     F  D E  + FR  +T+     V +     +PDY
Sbjct: 177 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 236
Query: 220 ----------------VHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 253
                             + +D R+LLS++   +P++RI+ K   +HP+F
Sbjct: 237 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 286

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 84/290 (28%), Positives = 134/290 (46%), Gaps = 41/290 (14%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIE---RGHKIDANVAREIINHKQLRH 57
           ME ++ ++ IG G +GV    RNK T E+VA+K I        + +   REI   K+L H
Sbjct: 5   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 64
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDE----ARYFFQQLISGQIC 113
           PNI++  +V+ T   L +V E+    +  ++  +A   +         Y FQ L     C
Sbjct: 65  PNIVKLLDVIHTENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 122
Query: 114 ------HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP-KSTVGTPAYIAPEVLSR 166
                 HRDLK +N L++   A  +K+ DFG +++  +  R     V T  Y APE+L  
Sbjct: 123 HSHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG 180
Query: 167 REYDGKLADVWSCGVTLYVMLVGAYPFE-DQEDPKNFR--KTISRIMAVQY----KIPDY 219
            +Y     D+WS G     M+     F  D E  + FR  +T+     V +     +PDY
Sbjct: 181 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 240
Query: 220 ----------------VHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 253
                             + +D R+LLS++   +P++RI+ K   +HP+F
Sbjct: 241 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 290

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 84/290 (28%), Positives = 134/290 (46%), Gaps = 41/290 (14%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIE---RGHKIDANVAREIINHKQLRH 57
           ME ++ ++ IG G +GV    RNK T E+VA+K I        + +   REI   K+L H
Sbjct: 4   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 63
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDE----ARYFFQQLISGQIC 113
           PNI++  +V+ T   L +V E+    +  ++  +A   +         Y FQ L     C
Sbjct: 64  PNIVKLLDVIHTENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 121
Query: 114 ------HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP-KSTVGTPAYIAPEVLSR 166
                 HRDLK +N L++   A  +K+ DFG +++  +  R     V T  Y APE+L  
Sbjct: 122 HSHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG 179
Query: 167 REYDGKLADVWSCGVTLYVMLVGAYPFE-DQEDPKNFR--KTISRIMAVQY----KIPDY 219
            +Y     D+WS G     M+     F  D E  + FR  +T+     V +     +PDY
Sbjct: 180 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 239
Query: 220 ----------------VHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 253
                             + +D R+LLS++   +P++RI+ K   +HP+F
Sbjct: 240 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 289

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 84/290 (28%), Positives = 134/290 (46%), Gaps = 41/290 (14%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIE---RGHKIDANVAREIINHKQLRH 57
           ME ++ ++ IG G +GV    RNK T E+VA+K I        + +   REI   K+L H
Sbjct: 1   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 60
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDE----ARYFFQQLISGQIC 113
           PNI++  +V+ T   L +V E+    +  ++  +A   +         Y FQ L     C
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 118
Query: 114 ------HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP-KSTVGTPAYIAPEVLSR 166
                 HRDLK +N L++   A  +K+ DFG +++  +  R     V T  Y APE+L  
Sbjct: 119 HSHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG 176
Query: 167 REYDGKLADVWSCGVTLYVMLVGAYPFE-DQEDPKNFR--KTISRIMAVQY----KIPDY 219
            +Y     D+WS G     M+     F  D E  + FR  +T+     V +     +PDY
Sbjct: 177 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 236
Query: 220 ----------------VHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 253
                             + +D R+LLS++   +P++RI+ K   +HP+F
Sbjct: 237 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 286

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 84/290 (28%), Positives = 134/290 (46%), Gaps = 41/290 (14%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIE---RGHKIDANVAREIINHKQLRH 57
           ME ++ ++ IG G +GV    RNK T E+VA+K I        + +   REI   K+L H
Sbjct: 6   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 65
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDE----ARYFFQQLISGQIC 113
           PNI++  +V+ T   L +V E+    +  ++  +A   +         Y FQ L     C
Sbjct: 66  PNIVKLLDVIHTENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 123
Query: 114 ------HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP-KSTVGTPAYIAPEVLSR 166
                 HRDLK +N L++   A  +K+ DFG +++  +  R     V T  Y APE+L  
Sbjct: 124 HSHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG 181
Query: 167 REYDGKLADVWSCGVTLYVMLVGAYPFE-DQEDPKNFR--KTISRIMAVQY----KIPDY 219
            +Y     D+WS G     M+     F  D E  + FR  +T+     V +     +PDY
Sbjct: 182 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 241
Query: 220 ----------------VHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 253
                             + +D R+LLS++   +P++RI+ K   +HP+F
Sbjct: 242 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 291

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 84/290 (28%), Positives = 134/290 (46%), Gaps = 41/290 (14%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIE---RGHKIDANVAREIINHKQLRH 57
           ME ++ ++ IG G +GV    RNK T E+VA+K I        + +   REI   K+L H
Sbjct: 2   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 61
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDE----ARYFFQQLISGQIC 113
           PNI++  +V+ T   L +V E+    +  ++  +A   +         Y FQ L     C
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 119
Query: 114 ------HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP-KSTVGTPAYIAPEVLSR 166
                 HRDLK +N L++   A  +K+ DFG +++  +  R     V T  Y APE+L  
Sbjct: 120 HSHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG 177
Query: 167 REYDGKLADVWSCGVTLYVMLVGAYPFE-DQEDPKNFR--KTISRIMAVQY----KIPDY 219
            +Y     D+WS G     M+     F  D E  + FR  +T+     V +     +PDY
Sbjct: 178 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 237
Query: 220 ----------------VHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 253
                             + +D R+LLS++   +P++RI+ K   +HP+F
Sbjct: 238 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 287

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 84/290 (28%), Positives = 134/290 (46%), Gaps = 41/290 (14%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIE---RGHKIDANVAREIINHKQLRH 57
           ME ++ ++ IG G +GV    RNK T E+VA+K I        + +   REI   K+L H
Sbjct: 2   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 61
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDE----ARYFFQQLISGQIC 113
           PNI++  +V+ T   L +V E+    +  ++  +A   +         Y FQ L     C
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 119
Query: 114 ------HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP-KSTVGTPAYIAPEVLSR 166
                 HRDLK +N L++   A  +K+ DFG +++  +  R     V T  Y APE+L  
Sbjct: 120 HSHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG 177
Query: 167 REYDGKLADVWSCGVTLYVMLVGAYPFE-DQEDPKNFR--KTISRIMAVQY----KIPDY 219
            +Y     D+WS G     M+     F  D E  + FR  +T+     V +     +PDY
Sbjct: 178 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 237
Query: 220 ----------------VHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 253
                             + +D R+LLS++   +P++RI+ K   +HP+F
Sbjct: 238 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 287

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 75/273 (27%), Positives = 132/273 (48%), Gaps = 20/273 (7%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRH---- 57
           + +E + ++G+GN GV   + +K +  ++A K I    +I   +  +II   Q+ H    
Sbjct: 25  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHL--EIKPAIRNQIIRELQVLHECNS 82
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG------- 110
           P I+ F     +   ++I ME+  GG L + +  AGR  E         +I G       
Sbjct: 83  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK 142
Query: 111 -QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREY 169
            +I HRD+K  N L++      +K+CDFG S   L+ S   S VGT +Y++PE L    Y
Sbjct: 143 HKIMHRDVKPSNILVNSRG--EIKLCDFGVS-GQLIDSMANSFVGTRSYMSPERLQGTHY 199
Query: 170 DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIM-AVQYKIPDYVHISQDCRN 228
             + +D+WS G++L  M VG YP           + +  I+     K+P  V  S + ++
Sbjct: 200 SVQ-SDIWSMGLSLVEMAVGRYPIGSGSGSMAIFELLDYIVNEPPPKLPSGV-FSLEFQD 257
Query: 229 LLSRIFVANPSRRITIKEIKSHPWFLKNLPREL 261
            +++  + NP+ R  +K++  H +  ++   E+
Sbjct: 258 FVNKCLIKNPAERADLKQLMVHAFIKRSDAEEV 290

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 78/290 (26%), Positives = 131/290 (45%), Gaps = 41/290 (14%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYI---ERGHKIDANVAREIINHKQLRH 57
           M+KYE ++ IG G +G     +N+ T E+VA+K +   +    + ++  REI   K+L+H
Sbjct: 1   MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKH 60
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGG--ELFERICNAGRFSEDEARYFFQQLISG----- 110
            NI+R  +V+ +   L +V E+      + F+  CN G    +  + F  QL+ G     
Sbjct: 61  KNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDS-CN-GDLDPEIVKSFLFQLLKGLGFCH 118
Query: 111 --QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST-VGTPAYIAPEVLSRR 167
              + HRDLK +N L++ +    LK+ +FG +++  +  R  S  V T  Y  P+VL   
Sbjct: 119 SRNVLHRDLKPQNLLINRN--GELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGA 176
Query: 168 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAV--------QYKIPDY 219
           +      D+WS G     +     P     D  +  K I R++            K+PDY
Sbjct: 177 KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDY 236
Query: 220 ----------------VHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 253
                             ++   R+LL  +   NP +RI+ +E   HP+F
Sbjct: 237 KPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYF 286

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 84/290 (28%), Positives = 134/290 (46%), Gaps = 41/290 (14%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIE---RGHKIDANVAREIINHKQLRH 57
           ME ++ ++ IG G +GV    RNK T E+VA+K I        + +   REI   K+L H
Sbjct: 1   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 60
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDE----ARYFFQQLISGQIC 113
           PNI++  +V+ T   L +V E+    +  +   +A   +         Y FQ L     C
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEHVH--QDLKTFMDASALTGIPLPLIKSYLFQLLQGLAFC 118
Query: 114 ------HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKS-TVGTPAYIAPEVLSR 166
                 HRDLK +N L++   A  +K+ DFG +++  +  R  +  V T  Y APE+L  
Sbjct: 119 HSHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG 176
Query: 167 REYDGKLADVWSCGVTLYVMLVGAYPFE-DQEDPKNFR--KTISRIMAVQY----KIPDY 219
            +Y     D+WS G     M+     F  D E  + FR  +T+     V +     +PDY
Sbjct: 177 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 236
Query: 220 ----------------VHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 253
                             + +D R+LLS++   +P++RI+ K   +HP+F
Sbjct: 237 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 286

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 78/264 (29%), Positives = 130/264 (49%), Gaps = 19/264 (7%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDAN-VAREIINHKQLRHPNI 60
           +KY   + IG G  G      +  T + VA++ +    +     +  EI+  ++ ++PNI
Sbjct: 21  KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNI 80
Query: 61  IRFKEVVLTPTHLAIVMEYAAGGEL----FERICNAGRFSE--DEARYFFQQLISGQICH 114
           + + +  L    L +VMEY AGG L     E   + G+ +    E     + L S Q+ H
Sbjct: 81  VNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIH 140
Query: 115 RDLKLENTLL--DGSPAPRLKICDFGYSKSSLLHSRPKST-VGTPAYIAPEVLSRREYDG 171
           R++K +N LL  DGS    +K+ DFG+          +ST VGTP ++APEV++R+ Y G
Sbjct: 141 RNIKSDNILLGMDGS----VKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAY-G 195
Query: 172 KLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLS 231
              D+WS G+    M+ G  P+ + E+P      I+     + + P+   +S   R+ L+
Sbjct: 196 PKVDIWSLGIMAIEMIEGEPPYLN-ENPLRALYLIATNGTPELQNPE--KLSAIFRDFLN 252
Query: 232 RIFVANPSRRITIKEIKSHPWFLK 255
           R    +  +R + KE+  H  FLK
Sbjct: 253 RCLEMDVEKRGSAKELIQHQ-FLK 275

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 84/290 (28%), Positives = 133/290 (45%), Gaps = 41/290 (14%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIE---RGHKIDANVAREIINHKQLRH 57
           ME ++ ++ IG G +GV    RNK T E+VA+K I        + +   REI   K+L H
Sbjct: 5   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 64
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDE----ARYFFQQLISGQIC 113
           PNI++  +V+ T   L +V E+    +  +   +A   +         Y FQ L     C
Sbjct: 65  PNIVKLLDVIHTENKLYLVFEFLH--QDLKTFMDASALTGIPLPLIKSYLFQLLQGLAFC 122
Query: 114 ------HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP-KSTVGTPAYIAPEVLSR 166
                 HRDLK +N L++   A  +K+ DFG +++  +  R     V T  Y APE+L  
Sbjct: 123 HSHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG 180
Query: 167 REYDGKLADVWSCGVTLYVMLVGAYPFE-DQEDPKNFR--KTISRIMAVQY----KIPDY 219
            +Y     D+WS G     M+     F  D E  + FR  +T+     V +     +PDY
Sbjct: 181 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 240
Query: 220 ----------------VHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 253
                             + +D R+LLS++   +P++RI+ K   +HP+F
Sbjct: 241 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 290

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 92.8 bits (229), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 78/279 (27%), Positives = 126/279 (45%), Gaps = 32/279 (11%)
Query: 3   KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKID-------ANVAREIINHKQL 55
           +Y++   +GSG FG        +    VA+K++E+    D         V  E++  K++
Sbjct: 25  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 84
Query: 56  R--HPNIIRFKEVVLTPTHLAIVMEYAAG-GELFERICNAGRFSEDEARYFFQQLISG-- 110
                 +IR  +    P    +++E      +LF+ I   G   E+ AR FF Q++    
Sbjct: 85  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 144
Query: 111 -----QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLS 165
                 + HRD+K EN L+D +    LK+ DFG S + L  +      GT  Y  PE + 
Sbjct: 145 HCHNCGVLHRDIKDENILIDLNRG-ELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIR 202
Query: 166 RREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQD 225
              Y G+ A VWS G+ LY M+ G  PFE  E+             ++ ++     +S +
Sbjct: 203 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------------IIRGQVFFRQRVSXE 250
Query: 226 CRNLLSRIFVANPSRRITIKEIKSHPWFLKN-LPRELTE 263
           C++L+       P  R T +EI++HPW     LP+E  E
Sbjct: 251 CQHLIRWCLALRPXDRPTFEEIQNHPWMQDVLLPQETAE 289

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 92.4 bits (228), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 83/290 (28%), Positives = 134/290 (46%), Gaps = 41/290 (14%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIE---RGHKIDANVAREIINHKQLRH 57
           ME ++ ++ IG G +GV    RNK T E+VA+  I        + +   REI   K+L H
Sbjct: 2   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNH 61
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDE----ARYFFQQLISGQIC 113
           PNI++  +V+ T   L +V E+    +  ++  +A   +         Y FQ L     C
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 119
Query: 114 ------HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKS-TVGTPAYIAPEVLSR 166
                 HRDLK +N L++   A  +K+ DFG +++  +  R  +  V T  Y APE+L  
Sbjct: 120 HSHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG 177
Query: 167 REYDGKLADVWSCGVTLYVMLVGAYPFE-DQEDPKNFR--KTISRIMAVQY----KIPDY 219
            +Y     D+WS G     M+     F  D E  + FR  +T+     V +     +PDY
Sbjct: 178 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 237
Query: 220 ----------------VHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 253
                             + +D R+LLS++   +P++RI+ K   +HP+F
Sbjct: 238 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 287

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 92.4 bits (228), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 83/290 (28%), Positives = 134/290 (46%), Gaps = 41/290 (14%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIE---RGHKIDANVAREIINHKQLRH 57
           ME ++ ++ IG G +GV    RNK T E+VA+  I        + +   REI   K+L H
Sbjct: 1   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNH 60
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDE----ARYFFQQLISGQIC 113
           PNI++  +V+ T   L +V E+    +  ++  +A   +         Y FQ L     C
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 118
Query: 114 ------HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKS-TVGTPAYIAPEVLSR 166
                 HRDLK +N L++   A  +K+ DFG +++  +  R  +  V T  Y APE+L  
Sbjct: 119 HSHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG 176
Query: 167 REYDGKLADVWSCGVTLYVMLVGAYPFE-DQEDPKNFR--KTISRIMAVQY----KIPDY 219
            +Y     D+WS G     M+     F  D E  + FR  +T+     V +     +PDY
Sbjct: 177 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 236
Query: 220 ----------------VHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 253
                             + +D R+LLS++   +P++RI+ K   +HP+F
Sbjct: 237 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 286

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 92.4 bits (228), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 71/252 (28%), Positives = 127/252 (50%), Gaps = 19/252 (7%)
Query: 10  IGSGNFGVARLMRNKNTKELVAMKYI-ERGHKIDANVAREIINHKQLRHPNIIRFKEVVL 68
           +G G +G+    R+ + +  +A+K I ER  +    +  EI  HK L+H NI+++     
Sbjct: 30  LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 89
Query: 69  TPTHLAIVMEYAAGGELFERI-CNAGRFSEDEAR--YFFQQLISG-------QICHRDLK 118
               + I ME   GG L   +    G   ++E    ++ +Q++ G       QI HRD+K
Sbjct: 90  ENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIK 149
Query: 119 LENTLLDGSPAPRLKICDFGYSKS-SLLHSRPKSTVGTPAYIAPEVLSR--REYDGKLAD 175
            +N L++ + +  LKI DFG SK  + ++   ++  GT  Y+APE++ +  R Y GK AD
Sbjct: 150 GDNVLIN-TYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGY-GKAAD 207
Query: 176 VWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFV 235
           +WS G T+  M  G  PF +  +P+     +  +  V  +IP+   +S + +  + + F 
Sbjct: 208 IWSLGCTIIEMATGKPPFYELGEPQAAMFKVG-MFKVHPEIPE--SMSAEAKAFILKCFE 264
Query: 236 ANPSRRITIKEI 247
            +P +R    ++
Sbjct: 265 PDPDKRACANDL 276

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 92.4 bits (228), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 83/289 (28%), Positives = 134/289 (46%), Gaps = 41/289 (14%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIE---RGHKIDANVAREIINHKQLRHP 58
           E ++ ++ IG G +GV    RNK T E+VA+K I        + +   REI   K+L HP
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDE----ARYFFQQLISGQIC- 113
           NI++  +V+ T   L +V E+    +  ++  +A   +         Y FQ L     C 
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 114 -----HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKS-TVGTPAYIAPEVLSRR 167
                HRDLK +N L++   A  +K+ DFG +++  +  R  +  V T  Y APE+L   
Sbjct: 120 SHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGC 177
Query: 168 EYDGKLADVWSCGVTLYVMLVGAYPFE-DQEDPKNFR--KTISRIMAVQY----KIPDY- 219
           +Y     D+WS G     M+     F  D E  + FR  +T+     V +     +PDY 
Sbjct: 178 KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYK 237
Query: 220 ---------------VHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 253
                            + +D R+LLS++   +P++RI+ K   +HP+F
Sbjct: 238 PSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 286

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 88/299 (29%), Positives = 129/299 (43%), Gaps = 40/299 (13%)
Query: 4   YELMKDI-GSGNFGVARLMRNKNTKELVAMKYIER--GHKIDANVAREIINHKQLR-HPN 59
           Y+L +D+ G G     +   N  T +  A+K IE+  GH I + V RE+    Q + H N
Sbjct: 14  YQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGH-IRSRVFREVEMLYQCQGHRN 72
Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-------QI 112
           ++   E         +V E   GG +   I     F+E EA    Q + S         I
Sbjct: 73  VLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGI 132
Query: 113 CHRDLKLENTLLDG-SPAPRLKICDFGYSKSSLLHS--RPKST------VGTPAYIAPEV 163
            HRDLK EN L +  +    +KICDFG      L+    P ST       G+  Y+APEV
Sbjct: 133 AHRDLKPENILCEHPNQVSPVKICDFGLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEV 192
Query: 164 LSRRE-----YDGKLADVWSCGVTLYVMLVGAYPF-----------EDQEDPKNFRKTIS 207
           +         YD K  D+WS GV LY++L G  PF             +  P        
Sbjct: 193 VEAFSEEASIYD-KRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFE 251
Query: 208 RIMAVQYKIPD--YVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLPRELTET 264
            I   +Y+ PD  + HIS   ++L+S++ V +  +R++  ++  HPW     P     T
Sbjct: 252 SIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPT 310

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 92.0 bits (227), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 71/252 (28%), Positives = 127/252 (50%), Gaps = 19/252 (7%)
Query: 10  IGSGNFGVARLMRNKNTKELVAMKYI-ERGHKIDANVAREIINHKQLRHPNIIRFKEVVL 68
           +G G +G+    R+ + +  +A+K I ER  +    +  EI  HK L+H NI+++     
Sbjct: 16  LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 75
Query: 69  TPTHLAIVMEYAAGGELFERI-CNAGRFSEDEAR--YFFQQLISG-------QICHRDLK 118
               + I ME   GG L   +    G   ++E    ++ +Q++ G       QI HRD+K
Sbjct: 76  ENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIK 135
Query: 119 LENTLLDGSPAPRLKICDFGYSKS-SLLHSRPKSTVGTPAYIAPEVLSR--REYDGKLAD 175
            +N L++ + +  LKI DFG SK  + ++   ++  GT  Y+APE++ +  R Y GK AD
Sbjct: 136 GDNVLIN-TYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGY-GKAAD 193
Query: 176 VWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFV 235
           +WS G T+  M  G  PF +  +P+     +  +  V  +IP+   +S + +  + + F 
Sbjct: 194 IWSLGCTIIEMATGKPPFYELGEPQAAMFKVG-MFKVHPEIPE--SMSAEAKAFILKCFE 250
Query: 236 ANPSRRITIKEI 247
            +P +R    ++
Sbjct: 251 PDPDKRACANDL 262

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 91.7 bits (226), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 66/266 (24%), Positives = 126/266 (47%), Gaps = 19/266 (7%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQ----LR 56
            + +E+++ IG G+FG   +++  +TK++ AMKY+ +   ++ N  R +    Q    L 
Sbjct: 14  FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLE 73
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLI-------S 109
           HP ++           + +V++   GG+L   +     F E+  + F  +L+       +
Sbjct: 74  HPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQN 133
Query: 110 GQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREY 169
            +I HRD+K +N LLD      + I DF  +      ++  +  GT  Y+APE+ S R+ 
Sbjct: 134 QRIIHRDMKPDNILLDEH--GHVHITDFNIAAMLPRETQITTMAGTKPYMAPEMFSSRKG 191
Query: 170 DGK--LADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCR 227
            G     D WS GVT Y +L G  P+  +    + ++ +          P     SQ+  
Sbjct: 192 AGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSS-KEIVHTFETTVVTYPSA--WSQEMV 248
Query: 228 NLLSRIFVANPSRRIT-IKEIKSHPW 252
           +LL ++   NP +R + + ++++ P+
Sbjct: 249 SLLKKLLEPNPDQRFSQLSDVQNFPY 274

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 91.7 bits (226), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 76/277 (27%), Positives = 134/277 (48%), Gaps = 33/277 (11%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKID-ANVA-----REIINHKQL 55
           E +E++K IG G FG   +++ KN  ++ AMK + +   +  A  A     R+++ +   
Sbjct: 74  EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDS 133
Query: 56  RHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICN-AGRFSEDEARYFFQQLISG---- 110
           +    + +        +L +VM+Y  GG+L   +     R  E+ AR++  +++      
Sbjct: 134 KWITTLHY--AFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSV 191
Query: 111 ---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST--VGTPAYIAPEVLS 165
                 HRD+K +N L+D +   RL   DFG     +     +S+  VGTP YI+PE+L 
Sbjct: 192 HQLHYVHRDIKPDNILMDMNGHIRLA--DFGSCLKLMEDGTVQSSVAVGTPDYISPEILQ 249
Query: 166 RREYD----GKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIM--AVQYKIPDY 219
             E      G   D WS GV +Y ML G  PF      ++  +T  +IM    +++ P  
Sbjct: 250 AMEGGKGRYGPECDWWSLGVCMYEMLYGETPFY----AESLVETYGKIMNHKERFQFPTQ 305
Query: 220 V-HISQDCRNLLSRIFVANPSR--RITIKEIKSHPWF 253
           V  +S++ ++L+ R+  +   R  +  I++ K HP+F
Sbjct: 306 VTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFF 342

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 90.9 bits (224), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 85/287 (29%), Positives = 130/287 (45%), Gaps = 41/287 (14%)
Query: 10  IGSGNFG-VARLMRNKNTKELVAMKYIER--GHKIDANVAREIINHKQLR-HPNIIRFKE 65
           +G G +  V   +  +N KE  A+K IE+  GH   + V RE+    Q + + NI+   E
Sbjct: 21  LGEGAYAKVQGAVSLQNGKEY-AVKIIEKQAGHS-RSRVFREVETLYQCQGNKNILELIE 78
Query: 66  VVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-------QICHRDLK 118
                T   +V E   GG +   I     F+E EA    + + +         I HRDLK
Sbjct: 79  FFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLK 138
Query: 119 LENTLLDGSP--APRLKICDFGYSKSSLLH------SRPKST--VGTPAYIAPEVL---- 164
            EN L + SP     +KICDF       L+      + P+ T   G+  Y+APEV+    
Sbjct: 139 PENILCE-SPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFT 197
Query: 165 SRREYDGKLADVWSCGVTLYVMLVGAYPFEDQ--EDPKNFRKTISR---------IMAVQ 213
            +  +  K  D+WS GV LY+ML G  PF      D    R  + R         I   +
Sbjct: 198 DQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGK 257
Query: 214 YKIPD--YVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLP 258
           Y+ PD  + HIS + ++L+S++ V +  +R++  ++  HPW     P
Sbjct: 258 YEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAP 304

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 85/301 (28%), Positives = 135/301 (44%), Gaps = 53/301 (17%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYI--ERGHKIDANVAREIINHKQLRHPN 59
           + YEL + IGSG   V +       KE VA+K I  E+       + +EI    Q  HPN
Sbjct: 15  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74
Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFERICN--------AGRFSEDEARYFFQQLI--- 108
           I+ +    +    L +VM+  +GG + + I +        +G   E       ++++   
Sbjct: 75  IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 134
Query: 109 -----SGQICHRDLKLENTLL--DGSPAPRLKICDFGYSK-----SSLLHSRPKST-VGT 155
                +GQI HRD+K  N LL  DGS    ++I DFG S        +  ++ + T VGT
Sbjct: 135 EYLHKNGQI-HRDVKAGNILLGEDGS----VQIADFGVSAFLATGGDITRNKVRKTFVGT 189
Query: 156 PAYIAPEVLSR-REYDGKLADVWSCGVTLYVMLVGAYPFED-----------QEDPKNFR 203
           P ++APEV+ + R YD K AD+WS G+T   +  GA P+             Q DP +  
Sbjct: 190 PCWMAPEVMEQVRGYDFK-ADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLE 248
Query: 204 KTI-SRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLPRELT 262
             +  + M  +Y         +  R ++S     +P +R T  E+  H +F K   +E  
Sbjct: 249 TGVQDKEMLKKY--------GKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAKNKEFL 300
Query: 263 E 263
           +
Sbjct: 301 Q 301

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 87/299 (29%), Positives = 128/299 (42%), Gaps = 40/299 (13%)
Query: 4   YELMKDI-GSGNFGVARLMRNKNTKELVAMKYIER--GHKIDANVAREIINHKQLR-HPN 59
           Y+L +D+ G G     +   N  T +  A+K IE+  GH I + V RE+    Q + H N
Sbjct: 14  YQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGH-IRSRVFREVEMLYQCQGHRN 72
Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-------QI 112
           ++   E         +V E   GG +   I     F+E EA    Q + S         I
Sbjct: 73  VLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGI 132
Query: 113 CHRDLKLENTLLDG-SPAPRLKICDFGYSKSSLLHS--RPKST------VGTPAYIAPEV 163
            HRDLK EN L +  +    +KICDF       L+    P ST       G+  Y+APEV
Sbjct: 133 AHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEV 192
Query: 164 LSRRE-----YDGKLADVWSCGVTLYVMLVGAYPF-----------EDQEDPKNFRKTIS 207
           +         YD K  D+WS GV LY++L G  PF             +  P        
Sbjct: 193 VEAFSEEASIYD-KRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFE 251
Query: 208 RIMAVQYKIPD--YVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLPRELTET 264
            I   +Y+ PD  + HIS   ++L+S++ V +  +R++  ++  HPW     P     T
Sbjct: 252 SIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPT 310

>pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 89.0 bits (219), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 73/252 (28%), Positives = 116/252 (46%), Gaps = 32/252 (12%)
Query: 30  VAMKYIERGHKID-------ANVAREIINHKQLR--HPNIIRFKEVVLTPTHLAIVMEYA 80
           VA+K++E+    D         V  E++  K++      +IR  +    P    +++E  
Sbjct: 79  VAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERP 138
Query: 81  AG-GELFERICNAGRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRL 132
               +LF+ I   G   E+ AR FF Q++          + HRD+K EN L+D +    L
Sbjct: 139 EPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRG-EL 197
Query: 133 KICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYP 192
           K+ DFG S + L  +      GT  Y  PE +    Y G+ A VWS G+ LY M+ G  P
Sbjct: 198 KLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP 256
Query: 193 FEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPW 252
           FE  E+             ++ ++     +S +C++L+       PS R T +EI++HPW
Sbjct: 257 FEHDEE------------IIRGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPW 304
Query: 253 FLKN-LPRELTE 263
                LP+E  E
Sbjct: 305 MQDVLLPQETAE 316

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 89.0 bits (219), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 74/273 (27%), Positives = 131/273 (47%), Gaps = 24/273 (8%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRH---- 57
           + +E + ++G+GN GV   + +K +  ++A K I    +I   +  +II   Q+ H    
Sbjct: 9   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHL--EIKPAIRNQIIRELQVLHECNS 66
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG------- 110
           P I+ F     +   ++I ME+  GG L + +  AGR  E         +I G       
Sbjct: 67  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK 126
Query: 111 -QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREY 169
            +I HRD+K  N L++      +K+CDFG S   L+       VGT +Y++PE L    Y
Sbjct: 127 HKIMHRDVKPSNILVNSRG--EIKLCDFGVS-GQLIDEMANEFVGTRSYMSPERLQGTHY 183
Query: 170 DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIM-AVQYKIPDYVHISQDCRN 228
             + +D+WS G++L  M VG YP      P    + +  I+     K+P  V  S + ++
Sbjct: 184 SVQ-SDIWSMGLSLVEMAVGRYP----RPPMAIFELLDYIVNEPPPKLPSAV-FSLEFQD 237
Query: 229 LLSRIFVANPSRRITIKEIKSHPWFLKNLPREL 261
            +++  + NP+ R  +K++  H +  ++   E+
Sbjct: 238 FVNKCLIKNPAERADLKQLMVHAFIKRSDAEEV 270

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 81/269 (30%), Positives = 123/269 (45%), Gaps = 32/269 (11%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYI-----ERGHKIDANVAREIINHKQLR 56
           E+Y+++  +G G      L  +      VA+K I     E+   +     RE+ N  QL 
Sbjct: 11  ERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETL-KRFEREVHNSSQLS 69
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG------ 110
           H NI+   +V        +VMEY  G  L E I + G  S D A  F  Q++ G      
Sbjct: 70  HQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHD 129
Query: 111 -QICHRDLKLENTLLDGSPAPRLKICDFGYSK--SSLLHSRPKSTVGTPAYIAPEVLSRR 167
            +I HRD+K +N L+D +    LKI DFG +K  S    ++    +GT  Y +PE  ++ 
Sbjct: 130 MRIVHRDIKPQNILIDSNKT--LKIFDFGIAKALSETSLTQTNHVLGTVQYFSPE-QAKG 186
Query: 168 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTIS-RIMAVQYKIPDYV-----H 221
           E   +  D++S G+ LY MLVG  PF       N    +S  I  +Q  +P+        
Sbjct: 187 EATDECTDIYSIGIVLYEMLVGEPPF-------NGETAVSIAIKHIQDSVPNVTTDVRKD 239
Query: 222 ISQDCRNLLSRIFVANPSRRI-TIKEIKS 249
           I Q   N++ R    + + R  TI+E+K 
Sbjct: 240 IPQSLSNVILRATEKDKANRYKTIQEMKD 268

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 88.6 bits (218), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 84/293 (28%), Positives = 132/293 (45%), Gaps = 53/293 (18%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYI--ERGHKIDANVAREIINHKQLRHPN 59
           + YEL + IGSG   V +       KE VA+K I  E+       + +EI    Q  HPN
Sbjct: 10  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 69
Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFERICN--------AGRFSEDEARYFFQQLI--- 108
           I+ +    +    L +VM+  +GG + + I +        +G   E       ++++   
Sbjct: 70  IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 129
Query: 109 -----SGQICHRDLKLENTLL--DGSPAPRLKICDFGYSK-----SSLLHSRPKST-VGT 155
                +GQI HRD+K  N LL  DGS    ++I DFG S        +  ++ + T VGT
Sbjct: 130 EYLHKNGQI-HRDVKAGNILLGEDGS----VQIADFGVSAFLATGGDITRNKVRKTFVGT 184
Query: 156 PAYIAPEVLSR-REYDGKLADVWSCGVTLYVMLVGAYPFED-----------QEDPKNFR 203
           P ++APEV+ + R YD K AD+WS G+T   +  GA P+             Q DP +  
Sbjct: 185 PCWMAPEVMEQVRGYDFK-ADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLE 243
Query: 204 KTI-SRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLK 255
             +  + M  +Y         +  R ++S     +P +R T  E+  H +F K
Sbjct: 244 TGVQDKEMLKKY--------GKSFRKMISLCLQKDPEKRPTAAELLRHKFFQK 288

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 88.6 bits (218), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 72/274 (26%), Positives = 126/274 (45%), Gaps = 29/274 (10%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIER-------GHKIDAN--VAREIIN 51
           M  + + + IG G FG     R  +T ++ AMK +++       G  +  N  +   +++
Sbjct: 187 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVS 246
Query: 52  HKQLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGQ 111
                 P I+       TP  L+ +++   GG+L   +   G FSE + R++  ++I G 
Sbjct: 247 TGDC--PFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGL 304
Query: 112 -------ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVL 164
                  + +RDLK  N LLD      ++I D G +       +P ++VGT  Y+APEVL
Sbjct: 305 EHMHNRFVVYRDLKPANILLD--EHGHVRISDLGLA-CDFSKKKPHASVGTHGYMAPEVL 361
Query: 165 SRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQ 224
            +       AD +S G  L+ +L G  PF  Q   K+  +     + +  ++PD    S 
Sbjct: 362 QKGVAYDSSADWFSLGCMLFKLLRGHSPFR-QHKTKDKHEIDRMTLTMAVELPD--SFSP 418
Query: 225 DCRNLLSRIFVANPSRRITI-----KEIKSHPWF 253
           + R+LL  +   + +RR+       +E+K  P+F
Sbjct: 419 ELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFF 452

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 88.2 bits (217), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 72/274 (26%), Positives = 126/274 (45%), Gaps = 29/274 (10%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIER-------GHKIDAN--VAREIIN 51
           M  + + + IG G FG     R  +T ++ AMK +++       G  +  N  +   +++
Sbjct: 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVS 247
Query: 52  HKQLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGQ 111
                 P I+       TP  L+ +++   GG+L   +   G FSE + R++  ++I G 
Sbjct: 248 TGDC--PFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGL 305
Query: 112 -------ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVL 164
                  + +RDLK  N LLD      ++I D G +       +P ++VGT  Y+APEVL
Sbjct: 306 EHMHNRFVVYRDLKPANILLD--EHGHVRISDLGLA-CDFSKKKPHASVGTHGYMAPEVL 362
Query: 165 SRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQ 224
            +       AD +S G  L+ +L G  PF  Q   K+  +     + +  ++PD    S 
Sbjct: 363 QKGVAYDSSADWFSLGCMLFKLLRGHSPFR-QHKTKDKHEIDRMTLTMAVELPD--SFSP 419
Query: 225 DCRNLLSRIFVANPSRRITI-----KEIKSHPWF 253
           + R+LL  +   + +RR+       +E+K  P+F
Sbjct: 420 ELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFF 453

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 88.2 bits (217), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 72/274 (26%), Positives = 126/274 (45%), Gaps = 29/274 (10%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIER-------GHKIDAN--VAREIIN 51
           M  + + + IG G FG     R  +T ++ AMK +++       G  +  N  +   +++
Sbjct: 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVS 247
Query: 52  HKQLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGQ 111
                 P I+       TP  L+ +++   GG+L   +   G FSE + R++  ++I G 
Sbjct: 248 TGDC--PFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGL 305
Query: 112 -------ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVL 164
                  + +RDLK  N LLD      ++I D G +       +P ++VGT  Y+APEVL
Sbjct: 306 EHMHNRFVVYRDLKPANILLD--EHGHVRISDLGLA-CDFSKKKPHASVGTHGYMAPEVL 362
Query: 165 SRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQ 224
            +       AD +S G  L+ +L G  PF  Q   K+  +     + +  ++PD    S 
Sbjct: 363 QKGVAYDSSADWFSLGCMLFKLLRGHSPFR-QHKTKDKHEIDRMTLTMAVELPD--SFSP 419
Query: 225 DCRNLLSRIFVANPSRRITI-----KEIKSHPWF 253
           + R+LL  +   + +RR+       +E+K  P+F
Sbjct: 420 ELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFF 453

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 88.2 bits (217), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 72/274 (26%), Positives = 126/274 (45%), Gaps = 29/274 (10%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIER-------GHKIDAN--VAREIIN 51
           M  + + + IG G FG     R  +T ++ AMK +++       G  +  N  +   +++
Sbjct: 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVS 247
Query: 52  HKQLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGQ 111
                 P I+       TP  L+ +++   GG+L   +   G FSE + R++  ++I G 
Sbjct: 248 TGDC--PFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGL 305
Query: 112 -------ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVL 164
                  + +RDLK  N LLD      ++I D G +       +P ++VGT  Y+APEVL
Sbjct: 306 EHMHNRFVVYRDLKPANILLD--EHGHVRISDLGLA-CDFSKKKPHASVGTHGYMAPEVL 362
Query: 165 SRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQ 224
            +       AD +S G  L+ +L G  PF  Q   K+  +     + +  ++PD    S 
Sbjct: 363 QKGVAYDSSADWFSLGCMLFKLLRGHSPFR-QHKTKDKHEIDRMTLTMAVELPD--SFSP 419
Query: 225 DCRNLLSRIFVANPSRRITI-----KEIKSHPWF 253
           + R+LL  +   + +RR+       +E+K  P+F
Sbjct: 420 ELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFF 453

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 87.4 bits (215), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 83/284 (29%), Positives = 131/284 (46%), Gaps = 28/284 (9%)
Query: 4   YELMKDIGSGNFGVARLMRNKNTKELVAMKYIE-RGHKIDANVAREIINHKQLRHPNIIR 62
           +E++ ++G G FG     +NK T  L A K I+ +  +   +   EI       HPNI++
Sbjct: 39  WEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVK 98
Query: 63  FKEVVLTPTHLAIVMEYAAGGELFERICNAGR-FSEDEARYFFQQLISG-------QICH 114
             +      +L I++E+ AGG +   +    R  +E + +   +Q +         +I H
Sbjct: 99  LLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIH 158
Query: 115 RDLKLENTL--LDGSPAPRLKICDFGYS-KSSLLHSRPKSTVGTPAYIAPEVL-----SR 166
           RDLK  N L  LDG     +K+ DFG S K++    R  S +GTP ++APEV+       
Sbjct: 159 RDLKAGNILFTLDGD----IKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKD 214
Query: 167 REYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDC 226
           R YD K ADVWS G+TL + +    P   + +P      I++        P     S + 
Sbjct: 215 RPYDYK-ADVWSLGITL-IEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPS--RWSSNF 270
Query: 227 RNLLSRIFVANPSRRITIKEIKSHPWFL--KNLP-RELTETAQA 267
           ++ L +    N   R T  ++  HP+     N P REL   A+A
Sbjct: 271 KDFLKKCLEKNVDARWTTSQLLQHPFVTVDSNKPIRELIAEAKA 314

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 83/284 (29%), Positives = 131/284 (46%), Gaps = 28/284 (9%)
Query: 4   YELMKDIGSGNFGVARLMRNKNTKELVAMKYIE-RGHKIDANVAREIINHKQLRHPNIIR 62
           +E++ ++G G FG     +NK T  L A K I+ +  +   +   EI       HPNI++
Sbjct: 39  WEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVK 98
Query: 63  FKEVVLTPTHLAIVMEYAAGGELFERICNAGR-FSEDEARYFFQQLISG-------QICH 114
             +      +L I++E+ AGG +   +    R  +E + +   +Q +         +I H
Sbjct: 99  LLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIH 158
Query: 115 RDLKLENTL--LDGSPAPRLKICDFGYS-KSSLLHSRPKSTVGTPAYIAPEVL-----SR 166
           RDLK  N L  LDG     +K+ DFG S K++    R  S +GTP ++APEV+       
Sbjct: 159 RDLKAGNILFTLDGD----IKLADFGVSAKNTRXIQRRDSFIGTPYWMAPEVVMCETSKD 214
Query: 167 REYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDC 226
           R YD K ADVWS G+TL + +    P   + +P      I++        P     S + 
Sbjct: 215 RPYDYK-ADVWSLGITL-IEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPS--RWSSNF 270
Query: 227 RNLLSRIFVANPSRRITIKEIKSHPWFL--KNLP-RELTETAQA 267
           ++ L +    N   R T  ++  HP+     N P REL   A+A
Sbjct: 271 KDFLKKCLEKNVDARWTTSQLLQHPFVTVDSNKPIRELIAEAKA 314

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 64/204 (31%), Positives = 102/204 (50%), Gaps = 18/204 (8%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRH---- 57
           + +E + ++G+GN GV   + +K +  ++A K I    +I   +  +II   Q+ H    
Sbjct: 68  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHL--EIKPAIRNQIIRELQVLHECNS 125
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG------- 110
           P I+ F     +   ++I ME+  GG L + +  AGR  E         +I G       
Sbjct: 126 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK 185
Query: 111 -QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREY 169
            +I HRD+K  N L++      +K+CDFG S   L+ S   S VGT +Y++PE L    Y
Sbjct: 186 HKIMHRDVKPSNILVNSRG--EIKLCDFGVS-GQLIDSMANSFVGTRSYMSPERLQGTHY 242
Query: 170 DGKLADVWSCGVTLYVMLVGAYPF 193
             + +D+WS G++L  M VG YP 
Sbjct: 243 SVQ-SDIWSMGLSLVEMAVGRYPI 265

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 64/203 (31%), Positives = 102/203 (50%), Gaps = 18/203 (8%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRH---- 57
           + +E + ++G+GN GV   + +K +  ++A K I    +I   +  +II   Q+ H    
Sbjct: 33  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHL--EIKPAIRNQIIRELQVLHECNS 90
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG------- 110
           P I+ F     +   ++I ME+  GG L + +  AGR  E         +I G       
Sbjct: 91  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK 150
Query: 111 -QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREY 169
            +I HRD+K  N L++      +K+CDFG S   L+ S   S VGT +Y++PE L    Y
Sbjct: 151 HKIMHRDVKPSNILVNSRG--EIKLCDFGVS-GQLIDSMANSFVGTRSYMSPERLQGTHY 207
Query: 170 DGKLADVWSCGVTLYVMLVGAYP 192
             + +D+WS G++L  M VG YP
Sbjct: 208 SVQ-SDIWSMGLSLVEMAVGRYP 229

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 64/204 (31%), Positives = 102/204 (50%), Gaps = 18/204 (8%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRH---- 57
           + +E + ++G+GN GV   + +K +  ++A K I    +I   +  +II   Q+ H    
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHL--EIKPAIRNQIIRELQVLHECNS 63
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG------- 110
           P I+ F     +   ++I ME+  GG L + +  AGR  E         +I G       
Sbjct: 64  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK 123
Query: 111 -QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREY 169
            +I HRD+K  N L++      +K+CDFG S   L+ S   S VGT +Y++PE L    Y
Sbjct: 124 HKIMHRDVKPSNILVNSRG--EIKLCDFGVS-GQLIDSMANSFVGTRSYMSPERLQGTHY 180
Query: 170 DGKLADVWSCGVTLYVMLVGAYPF 193
             + +D+WS G++L  M VG YP 
Sbjct: 181 SVQ-SDIWSMGLSLVEMAVGRYPI 203

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 64/204 (31%), Positives = 102/204 (50%), Gaps = 18/204 (8%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRH---- 57
           + +E + ++G+GN GV   + +K +  ++A K I    +I   +  +II   Q+ H    
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHL--EIKPAIRNQIIRELQVLHECNS 63
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG------- 110
           P I+ F     +   ++I ME+  GG L + +  AGR  E         +I G       
Sbjct: 64  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK 123
Query: 111 -QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREY 169
            +I HRD+K  N L++      +K+CDFG S   L+ S   S VGT +Y++PE L    Y
Sbjct: 124 HKIMHRDVKPSNILVNSRG--EIKLCDFGVS-GQLIDSMANSFVGTRSYMSPERLQGTHY 180
Query: 170 DGKLADVWSCGVTLYVMLVGAYPF 193
             + +D+WS G++L  M VG YP 
Sbjct: 181 SVQ-SDIWSMGLSLVEMAVGRYPI 203

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 64/203 (31%), Positives = 102/203 (50%), Gaps = 18/203 (8%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRH---- 57
           + +E + ++G+GN GV   + +K +  ++A K I    +I   +  +II   Q+ H    
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHL--EIKPAIRNQIIRELQVLHECNS 63
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG------- 110
           P I+ F     +   ++I ME+  GG L + +  AGR  E         +I G       
Sbjct: 64  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK 123
Query: 111 -QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREY 169
            +I HRD+K  N L++      +K+CDFG S   L+ S   S VGT +Y++PE L    Y
Sbjct: 124 HKIMHRDVKPSNILVNSRG--EIKLCDFGVS-GQLIDSMANSFVGTRSYMSPERLQGTHY 180
Query: 170 DGKLADVWSCGVTLYVMLVGAYP 192
             + +D+WS G++L  M VG YP
Sbjct: 181 SVQ-SDIWSMGLSLVEMAVGRYP 202

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 64/203 (31%), Positives = 102/203 (50%), Gaps = 18/203 (8%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRH---- 57
           + +E + ++G+GN GV   + +K +  ++A K I    +I   +  +II   Q+ H    
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHL--EIKPAIRNQIIRELQVLHECNS 63
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG------- 110
           P I+ F     +   ++I ME+  GG L + +  AGR  E         +I G       
Sbjct: 64  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK 123
Query: 111 -QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREY 169
            +I HRD+K  N L++      +K+CDFG S   L+ S   S VGT +Y++PE L    Y
Sbjct: 124 HKIMHRDVKPSNILVNSRG--EIKLCDFGVS-GQLIDSMANSFVGTRSYMSPERLQGTHY 180
Query: 170 DGKLADVWSCGVTLYVMLVGAYP 192
             + +D+WS G++L  M VG YP
Sbjct: 181 SVQ-SDIWSMGLSLVEMAVGRYP 202

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 82/293 (27%), Positives = 133/293 (45%), Gaps = 43/293 (14%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYI---ERGHKIDANVAREIINHKQLRH 57
           MEKY  ++ IG G +GV    +N N  E  A+K I   +    I +   REI   K+L+H
Sbjct: 1   MEKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKH 59
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGG--ELFERICNAGRFSEDEARYFFQQLISG----- 110
            NI++  +V+ T   L +V E+      +L + +C  G      A+ F  QL++G     
Sbjct: 60  SNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLD-VCEGG-LESVTAKSFLLQLLNGIAYCH 117
Query: 111 --QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKS-TVGTPAYIAPEVLSRR 167
             ++ HRDLK +N L++      LKI DFG +++  +  R  +  V T  Y AP+VL   
Sbjct: 118 DRRVLHRDLKPQNLLINRE--GELKIADFGLARAFGIPVRKYTHEVVTLWYRAPDVLMGS 175
Query: 168 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQ--------YKIPDY 219
           +      D+WS G     M+ GA  F    +     + I RI+            ++P Y
Sbjct: 176 KKYSTTIDIWSVGCIFAEMVNGAPLFPGVSEADQLMR-IFRILGTPNSKNWPNVTELPKY 234
Query: 220 ----------------VHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKN 256
                             + +   +LLS++   +P++RIT K+   H +F +N
Sbjct: 235 DPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKEN 287

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 68/200 (34%), Positives = 97/200 (48%), Gaps = 21/200 (10%)
Query: 10  IGSGNFGVARLMRNKNTKELVAMKYIERGHKIDAN-VAREIINHKQLRHPNIIRFKEVVL 68
           IG+G+FG         +   V +   +  H    N   RE+   K+LRHPNI+ F   V 
Sbjct: 45  IGAGSFGTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVT 104
Query: 69  TPTHLAIVMEYAAGGELFERICNAG-RFSEDEARYFFQQLISGQ-----------ICHRD 116
            P +L+IV EY + G L+  +  +G R   DE R         +           I HR+
Sbjct: 105 QPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRN 164
Query: 117 LKLENTLLDGSPAPRLKICDFGYSK---SSLLHSRPKSTVGTPAYIAPEVLSRREYDGKL 173
           LK  N L+D      +K+CDFG S+   S+ L S  KS  GTP ++APEVL R E   + 
Sbjct: 165 LKSPNLLVDKKYT--VKVCDFGLSRLKASTFLSS--KSAAGTPEWMAPEVL-RDEPSNEK 219
Query: 174 ADVWSCGVTLYVMLVGAYPF 193
           +DV+S GV L+ +     P+
Sbjct: 220 SDVYSFGVILWELATLQQPW 239

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 76/290 (26%), Positives = 129/290 (44%), Gaps = 42/290 (14%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIE---RGHKIDANVAREIINHKQLRH 57
           MEKY+ ++ +G G +GV    ++   + +VA+K I        I +   REI   K+L H
Sbjct: 20  MEKYQKLEKVGEGTYGVVYKAKDSQGR-IVALKRIRLDAEDEGIPSTAIREISLLKELHH 78
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGR--FSEDEARYFFQQLISG----- 110
           PNI+   +V+ +   L +V E+       +++ +  +    + + + +  QL+ G     
Sbjct: 79  PNIVSLIDVIHSERCLTLVFEFMEKD--LKKVLDENKTGLQDSQIKIYLYQLLRGVAHCH 136
Query: 111 --QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKS-TVGTPAYIAPEVLSRR 167
             +I HRDLK +N L++   A  LK+ DFG +++  +  R  +  V T  Y AP+VL   
Sbjct: 137 QHRILHRDLKPQNLLINSDGA--LKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMGS 194
Query: 168 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTIS-------------------- 207
           +      D+WS G     M+ G   F    D     K  S                    
Sbjct: 195 KKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWK 254
Query: 208 -RIMAVQYKIPDYVHISQDCR---NLLSRIFVANPSRRITIKEIKSHPWF 253
            R   V  K P    I   C+   +LLS +   +P++RI+ ++  +HP+F
Sbjct: 255 QRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYF 304

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 76/290 (26%), Positives = 129/290 (44%), Gaps = 42/290 (14%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIE---RGHKIDANVAREIINHKQLRH 57
           MEKY+ ++ +G G +GV    ++   + +VA+K I        I +   REI   K+L H
Sbjct: 20  MEKYQKLEKVGEGTYGVVYKAKDSQGR-IVALKRIRLDAEDEGIPSTAIREISLLKELHH 78
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGR--FSEDEARYFFQQLISG----- 110
           PNI+   +V+ +   L +V E+       +++ +  +    + + + +  QL+ G     
Sbjct: 79  PNIVSLIDVIHSERCLTLVFEFMEKD--LKKVLDENKTGLQDSQIKIYLYQLLRGVAHCH 136
Query: 111 --QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKS-TVGTPAYIAPEVLSRR 167
             +I HRDLK +N L++   A  LK+ DFG +++  +  R  +  V T  Y AP+VL   
Sbjct: 137 QHRILHRDLKPQNLLINSDGA--LKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMGS 194
Query: 168 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTIS-------------------- 207
           +      D+WS G     M+ G   F    D     K  S                    
Sbjct: 195 KKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWK 254
Query: 208 -RIMAVQYKIPDYVHISQDCR---NLLSRIFVANPSRRITIKEIKSHPWF 253
            R   V  K P    I   C+   +LLS +   +P++RI+ ++  +HP+F
Sbjct: 255 QRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYF 304

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 82/284 (28%), Positives = 130/284 (45%), Gaps = 28/284 (9%)
Query: 4   YELMKDIGSGNFGVARLMRNKNTKELVAMKYIE-RGHKIDANVAREIINHKQLRHPNIIR 62
           +E++ ++G G FG     +NK T  L A K I+ +  +   +   EI       HPNI++
Sbjct: 39  WEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVK 98
Query: 63  FKEVVLTPTHLAIVMEYAAGGELFERICNAGR-FSEDEARYFFQQLISG-------QICH 114
             +      +L I++E+ AGG +   +    R  +E + +   +Q +         +I H
Sbjct: 99  LLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIH 158
Query: 115 RDLKLENTL--LDGSPAPRLKICDFGYS-KSSLLHSRPKSTVGTPAYIAPEVL-----SR 166
           RDLK  N L  LDG     +K+ DFG S K++    R    +GTP ++APEV+       
Sbjct: 159 RDLKAGNILFTLDGD----IKLADFGVSAKNTRXIQRRDXFIGTPYWMAPEVVMCETSKD 214
Query: 167 REYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDC 226
           R YD K ADVWS G+TL + +    P   + +P      I++        P     S + 
Sbjct: 215 RPYDYK-ADVWSLGITL-IEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPS--RWSSNF 270
Query: 227 RNLLSRIFVANPSRRITIKEIKSHPWFL--KNLP-RELTETAQA 267
           ++ L +    N   R T  ++  HP+     N P REL   A+A
Sbjct: 271 KDFLKKCLEKNVDARWTTSQLLQHPFVTVDSNKPIRELIAEAKA 314

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 62/204 (30%), Positives = 103/204 (50%), Gaps = 18/204 (8%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRH---- 57
           + +E + ++G+GN GV   ++++ +  ++A K I    +I   +  +II   Q+ H    
Sbjct: 16  DDFERISELGAGNGGVVTKVQHRPSGLIMARKLIHL--EIKPAIRNQIIRELQVLHECNS 73
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG------- 110
           P I+ F     +   ++I ME+  GG L + +  A R  E+        ++ G       
Sbjct: 74  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREK 133
Query: 111 -QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREY 169
            QI HRD+K  N L++      +K+CDFG S   L+ S   S VGT +Y+APE L    Y
Sbjct: 134 HQIMHRDVKPSNILVNSRG--EIKLCDFGVS-GQLIDSMANSFVGTRSYMAPERLQGTHY 190
Query: 170 DGKLADVWSCGVTLYVMLVGAYPF 193
             + +D+WS G++L  + VG YP 
Sbjct: 191 SVQ-SDIWSMGLSLVELAVGRYPI 213

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 75/273 (27%), Positives = 126/273 (46%), Gaps = 35/273 (12%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIE--RGHKIDANVAREIINHKQLRHPN 59
           E +  ++ IG G+FG      +  T+++VA+K I+         ++ +EI    Q     
Sbjct: 23  ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSSY 82
Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-------QI 112
           + ++    L  + L I+MEY  GG   + +  AG F E +     ++++ G       + 
Sbjct: 83  VTKYYGSYLKGSKLWIIMEYLGGGSALD-LLRAGPFDEFQIATMLKEILKGLDYLHSEKK 141
Query: 113 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPK--STVGTPAYIAPEVLSRREYD 170
            HRD+K  N LL  S    +K+ DFG +   L  ++ K  + VGTP ++APEV+ +  YD
Sbjct: 142 IHRDIKAANVLL--SEQGDVKLADFGVA-GQLTDTQIKRNTFVGTPFWMAPEVIQQSAYD 198
Query: 171 GKLADVWSCGVTLYVMLVGAYPFEDQED-------PKNFRKTISRIMAVQYKIPDYVHIS 223
            K AD+WS G+T   +  G  P  D          PKN   T+         + D+   +
Sbjct: 199 SK-ADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPPTL---------VGDF---T 245
Query: 224 QDCRNLLSRIFVANPSRRITIKEIKSHPWFLKN 256
           +  +  +      +PS R T KE+  H + +KN
Sbjct: 246 KSFKEFIDACLNKDPSFRPTAKELLKHKFIVKN 278

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 85.1 bits (209), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 68/200 (34%), Positives = 95/200 (47%), Gaps = 21/200 (10%)
Query: 10  IGSGNFGVARLMRNKNTKELVAMKYIERGHKIDAN-VAREIINHKQLRHPNIIRFKEVVL 68
           IG+G+FG         +   V +   +  H    N   RE+   K+LRHPNI+ F   V 
Sbjct: 45  IGAGSFGTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVT 104
Query: 69  TPTHLAIVMEYAAGGELFERICNAG-RFSEDEARYFFQQLISGQ-----------ICHRD 116
            P +L+IV EY + G L+  +  +G R   DE R         +           I HRD
Sbjct: 105 QPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRD 164
Query: 117 LKLENTLLDGSPAPRLKICDFGYSK---SSLLHSRPKSTVGTPAYIAPEVLSRREYDGKL 173
           LK  N L+D      +K+CDFG S+   S  L S  K   GTP ++APEVL R E   + 
Sbjct: 165 LKSPNLLVDKKYT--VKVCDFGLSRLKASXFLXS--KXAAGTPEWMAPEVL-RDEPSNEK 219
Query: 174 ADVWSCGVTLYVMLVGAYPF 193
           +DV+S GV L+ +     P+
Sbjct: 220 SDVYSFGVILWELATLQQPW 239

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 84.7 bits (208), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 68/271 (25%), Positives = 122/271 (45%), Gaps = 38/271 (14%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNII 61
           E +++++ +G G++G      +K T ++VA+K +     +   + +EI   +Q   P+++
Sbjct: 29  EVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQ-EIIKEISIMQQCDSPHVV 87
Query: 62  RFKEVVLTPTHLAIVMEYAAGGELFERI-CNAGRFSEDEARYFFQQLISG-------QIC 113
           ++       T L IVMEY   G + + I       +EDE     Q  + G       +  
Sbjct: 88  KYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKI 147
Query: 114 HRDLKLENTLLDGSPAPRLKICDFGYS-KSSLLHSRPKSTVGTPAYIAPEVLSRREYDGK 172
           HRD+K  N LL+       K+ DFG + + +   ++    +GTP ++APEV+    Y+  
Sbjct: 148 HRDIKAGNILLNTEG--HAKLADFGVAGQLTDXMAKRNXVIGTPFWMAPEVIQEIGYNC- 204
Query: 173 LADVWSCGVTLYVMLVGAYPFED-----------QEDPKNFRKTISRIMAVQYKIPDYVH 221
           +AD+WS G+T   M  G  P+ D              P  FRK            P+   
Sbjct: 205 VADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRK------------PEL-- 250
Query: 222 ISQDCRNLLSRIFVANPSRRITIKEIKSHPW 252
            S +  + + +  V +P +R T  ++  HP+
Sbjct: 251 WSDNFTDFVKQCLVKSPEQRATATQLLQHPF 281

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 84.3 bits (207), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 81/293 (27%), Positives = 132/293 (45%), Gaps = 43/293 (14%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYI---ERGHKIDANVAREIINHKQLRH 57
           MEKY  ++ IG G +GV    +N N  E  A+K I   +    I +   REI   K+L+H
Sbjct: 1   MEKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKH 59
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGG--ELFERICNAGRFSEDEARYFFQQLISG----- 110
            NI++  +V+ T   L +V E+      +L + +C  G      A+ F  QL++G     
Sbjct: 60  SNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLD-VCEGG-LESVTAKSFLLQLLNGIAYCH 117
Query: 111 --QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKS-TVGTPAYIAPEVLSRR 167
             ++ HRDLK +N L++      LKI DFG +++  +  R  +  V T  Y AP+VL   
Sbjct: 118 DRRVLHRDLKPQNLLINRE--GELKIADFGLARAFGIPVRKYTHEVVTLWYRAPDVLMGS 175
Query: 168 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQ--------YKIPDY 219
           +      D+WS G     M+ G   F    +     + I RI+            ++P Y
Sbjct: 176 KKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMR-IFRILGTPNSKNWPNVTELPKY 234
Query: 220 ----------------VHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKN 256
                             + +   +LLS++   +P++RIT K+   H +F +N
Sbjct: 235 DPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKEN 287

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 72/208 (34%), Positives = 102/208 (49%), Gaps = 32/208 (15%)
Query: 10  IGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQ-------LRHPNIIR 62
           IG G FG  ++ R     + VA+K     H  D ++++ I N +Q       L+HPNII 
Sbjct: 15  IGIGGFG--KVYRAFWIGDEVAVKAAR--HDPDEDISQTIENVRQEAKLFAMLKHPNIIA 70
Query: 63  FKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGQ----------I 112
            + V L   +L +VME+A GG L  R+ +  R   D    +  Q+  G           I
Sbjct: 71  LRGVCLKEPNLCLVMEFARGGPL-NRVLSGKRIPPDILVNWAVQIARGMNYLHDEAIVPI 129
Query: 113 CHRDLKLENTLL-----DGSPAPR-LKICDFGYSKSSLLHSRPK-STVGTPAYIAPEVLS 165
            HRDLK  N L+     +G  + + LKI DFG ++    H   K S  G  A++APEV+ 
Sbjct: 130 IHRDLKSSNILILQKVENGDLSNKILKITDFGLARE--WHRTTKMSAAGAYAWMAPEVI- 186
Query: 166 RREYDGKLADVWSCGVTLYVMLVGAYPF 193
           R     K +DVWS GV L+ +L G  PF
Sbjct: 187 RASMFSKGSDVWSYGVLLWELLTGEVPF 214

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 80/293 (27%), Positives = 132/293 (45%), Gaps = 43/293 (14%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYI---ERGHKIDANVAREIINHKQLRH 57
           MEKY  ++ IG G +GV    +N N  E  A+K I   +    I +   REI   K+L+H
Sbjct: 1   MEKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKH 59
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGG--ELFERICNAGRFSEDEARYFFQQLISG----- 110
            NI++  +V+ T   L +V E+      +L + +C  G      A+ F  QL++G     
Sbjct: 60  SNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLD-VCEGG-LESVTAKSFLLQLLNGIAYCH 117
Query: 111 --QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKS-TVGTPAYIAPEVLSRR 167
             ++ HRDLK +N L++      LKI DFG +++  +  R  +  + T  Y AP+VL   
Sbjct: 118 DRRVLHRDLKPQNLLINRE--GELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGS 175
Query: 168 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQ--------YKIPDY 219
           +      D+WS G     M+ G   F    +     + I RI+            ++P Y
Sbjct: 176 KKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMR-IFRILGTPNSKNWPNVTELPKY 234
Query: 220 ----------------VHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKN 256
                             + +   +LLS++   +P++RIT K+   H +F +N
Sbjct: 235 DPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKEN 287

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 74/272 (27%), Positives = 122/272 (44%), Gaps = 33/272 (12%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIE--RGHKIDANVAREIINHKQLRHPN 59
           E +  ++ IG G+FG      +  T+++VA+K I+         ++ +EI    Q   P 
Sbjct: 7   ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 66
Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-------QI 112
           + ++    L  T L I+MEY  GG   + +   G   E +     ++++ G       + 
Sbjct: 67  VTKYYGSYLKDTKLWIIMEYLGGGSALD-LLEPGPLDETQIATILREILKGLDYLHSEKK 125
Query: 113 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPK--STVGTPAYIAPEVLSRREYD 170
            HRD+K  N LL  S    +K+ DFG +   L  ++ K  + VGTP ++APEV+ +  YD
Sbjct: 126 IHRDIKAANVLL--SEHGEVKLADFGVA-GQLTDTQIKRNTFVGTPFWMAPEVIKQSAYD 182
Query: 171 GKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDY------VHISQ 224
            K AD+WS G+T   +  G  P  +              M V + IP         + S+
Sbjct: 183 SK-ADIWSLGITAIELARGEPPHSELHP-----------MKVLFLIPKNNPPTLEGNYSK 230
Query: 225 DCRNLLSRIFVANPSRRITIKEIKSHPWFLKN 256
             +  +       PS R T KE+  H + L+N
Sbjct: 231 PLKEFVEACLNKEPSFRPTAKELLKHKFILRN 262

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 70/213 (32%), Positives = 98/213 (46%), Gaps = 28/213 (13%)
Query: 4   YELMKDIGSGNFGVARLMRNKNTKELVAMKYI--ERGHKIDANVAREIINHKQLRHPNII 61
           +E+ + +G+G FG      +++T E VA+K    E   K       EI   K+L HPN++
Sbjct: 17  WEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVV 76
Query: 62  RFKEV-----VLTPTHLAIV-MEYAAGGEL------FERICNAGRFSEDEARYFFQQLIS 109
             +EV      L P  L ++ MEY  GG+L      FE  C      E   R     + S
Sbjct: 77  SAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCG---LKEGPIRTLLSDISS 133
Query: 110 G-------QICHRDLKLENTLLDGSPAPRL--KICDFGYSKSSLLHSRPKSTVGTPAYIA 160
                   +I HRDLK EN +L   P  RL  KI D GY+K           VGT  Y+A
Sbjct: 134 ALRYLHENRIIHRDLKPENIVLQPGPQ-RLIHKIIDLGYAKELDQGELCTEFVGTLQYLA 192
Query: 161 PEVLSRREYDGKLADVWSCGVTLYVMLVGAYPF 193
           PE+L +++Y   + D WS G   +  + G  PF
Sbjct: 193 PELLEQKKYTVTV-DYWSFGTLAFECITGFRPF 224

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 74/273 (27%), Positives = 122/273 (44%), Gaps = 35/273 (12%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIE--RGHKIDANVAREIINHKQLRHPN 59
           E +  ++ IG G+FG      +  T+++VA+K I+         ++ +EI    Q   P 
Sbjct: 27  ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 86
Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-------QI 112
           + ++    L  T L I+MEY  GG   + +   G   E +     ++++ G       + 
Sbjct: 87  VTKYYGSYLKDTKLWIIMEYLGGGSALD-LLEPGPLDETQIATILREILKGLDYLHSEKK 145
Query: 113 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPK--STVGTPAYIAPEVLSRREYD 170
            HRD+K  N LL  S    +K+ DFG +   L  ++ K  + VGTP ++APEV+ +  YD
Sbjct: 146 IHRDIKAANVLL--SEHGEVKLADFGVA-GQLTDTQIKRNTFVGTPFWMAPEVIKQSAYD 202
Query: 171 GKLADVWSCGVTLYVMLVGAYPFEDQED-------PKNFRKTISRIMAVQYKIPDYVHIS 223
            K AD+WS G+T   +  G  P  +          PKN   T+              + S
Sbjct: 203 SK-ADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEG------------NYS 249
Query: 224 QDCRNLLSRIFVANPSRRITIKEIKSHPWFLKN 256
           +  +  +       PS R T KE+  H + L+N
Sbjct: 250 KPLKEFVEACLNKEPSFRPTAKELLKHKFILRN 282

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 74/273 (27%), Positives = 121/273 (44%), Gaps = 35/273 (12%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIE--RGHKIDANVAREIINHKQLRHPN 59
           E +  ++ IG G+FG      +  T+++VA+K I+         ++ +EI    Q   P 
Sbjct: 22  ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 81
Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-------QI 112
           + ++    L  T L I+MEY  GG   + +   G   E +     ++++ G       + 
Sbjct: 82  VTKYYGSYLKDTKLWIIMEYLGGGSALD-LLEPGPLDETQIATILREILKGLDYLHSEKK 140
Query: 113 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST--VGTPAYIAPEVLSRREYD 170
            HRD+K  N LL  S    +K+ DFG +   L  ++ K    VGTP ++APEV+ +  YD
Sbjct: 141 IHRDIKAANVLL--SEHGEVKLADFGVA-GQLTDTQIKRNXFVGTPFWMAPEVIKQSAYD 197
Query: 171 GKLADVWSCGVTLYVMLVGAYPFEDQED-------PKNFRKTISRIMAVQYKIPDYVHIS 223
            K AD+WS G+T   +  G  P  +          PKN   T+              + S
Sbjct: 198 SK-ADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEG------------NYS 244
Query: 224 QDCRNLLSRIFVANPSRRITIKEIKSHPWFLKN 256
           +  +  +       PS R T KE+  H + L+N
Sbjct: 245 KPLKEFVEACLNKEPSFRPTAKELLKHKFILRN 277

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 82.8 bits (203), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 70/213 (32%), Positives = 98/213 (46%), Gaps = 28/213 (13%)
Query: 4   YELMKDIGSGNFGVARLMRNKNTKELVAMKYI--ERGHKIDANVAREIINHKQLRHPNII 61
           +E+ + +G+G FG      +++T E VA+K    E   K       EI   K+L HPN++
Sbjct: 16  WEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVV 75
Query: 62  RFKEV-----VLTPTHLAIV-MEYAAGGEL------FERICNAGRFSEDEARYFFQQLIS 109
             +EV      L P  L ++ MEY  GG+L      FE  C      E   R     + S
Sbjct: 76  SAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCG---LKEGPIRTLLSDISS 132
Query: 110 G-------QICHRDLKLENTLLDGSPAPRL--KICDFGYSKSSLLHSRPKSTVGTPAYIA 160
                   +I HRDLK EN +L   P  RL  KI D GY+K           VGT  Y+A
Sbjct: 133 ALRYLHENRIIHRDLKPENIVLQPGPQ-RLIHKIIDLGYAKELDQGELCTEFVGTLQYLA 191
Query: 161 PEVLSRREYDGKLADVWSCGVTLYVMLVGAYPF 193
           PE+L +++Y   + D WS G   +  + G  PF
Sbjct: 192 PELLEQKKYTVTV-DYWSFGTLAFECITGFRPF 223

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 74/272 (27%), Positives = 121/272 (44%), Gaps = 33/272 (12%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIE--RGHKIDANVAREIINHKQLRHPN 59
           E +  ++ IG G+FG      +  T+++VA+K I+         ++ +EI    Q   P 
Sbjct: 7   ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 66
Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-------QI 112
           + ++    L  T L I+MEY  GG   + +   G   E +     ++++ G       + 
Sbjct: 67  VTKYYGSYLKDTKLWIIMEYLGGGSALD-LLEPGPLDETQIATILREILKGLDYLHSEKK 125
Query: 113 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST--VGTPAYIAPEVLSRREYD 170
            HRD+K  N LL  S    +K+ DFG +   L  ++ K    VGTP ++APEV+ +  YD
Sbjct: 126 IHRDIKAANVLL--SEHGEVKLADFGVA-GQLTDTQIKRNXFVGTPFWMAPEVIKQSAYD 182
Query: 171 GKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDY------VHISQ 224
            K AD+WS G+T   +  G  P  +              M V + IP         + S+
Sbjct: 183 SK-ADIWSLGITAIELARGEPPHSELHP-----------MKVLFLIPKNNPPTLEGNYSK 230
Query: 225 DCRNLLSRIFVANPSRRITIKEIKSHPWFLKN 256
             +  +       PS R T KE+  H + L+N
Sbjct: 231 PLKEFVEACLNKEPSFRPTAKELLKHKFILRN 262

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 82.4 bits (202), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 75/256 (29%), Positives = 123/256 (48%), Gaps = 25/256 (9%)
Query: 5   ELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFK 64
           E+ + +G G FGV  + + K   + VA+K IE   +  A +  E+    ++ HPNI++  
Sbjct: 12  EVEEVVGRGAFGV--VCKAKWRAKDVAIKQIESESERKAFIV-ELRQLSRVNHPNIVKLY 68
Query: 65  EVVLTPTHLAIVMEYAAGGELFERICNA---GRFSEDEARYFFQQLISG----------Q 111
              L P  + +VMEYA GG L+  +  A     ++   A  +  Q   G           
Sbjct: 69  GACLNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKA 126
Query: 112 ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDG 171
           + HRDLK  N LL       LKICDFG +     H    +  G+ A++APEV     Y  
Sbjct: 127 LIHRDLKPPNLLLVAG-GTVLKICDFGTACDIQTHM--TNNKGSAAWMAPEVFEGSNYSE 183
Query: 172 KLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLS 231
           K  DV+S G+ L+ ++    PF++   P  FR  I   +    + P   ++ +   +L++
Sbjct: 184 K-CDVFSWGIILWEVITRRKPFDEIGGPA-FR--IMWAVHNGTRPPLIKNLPKPIESLMT 239
Query: 232 RIFVANPSRRITIKEI 247
           R +  +PS+R +++EI
Sbjct: 240 RCWSKDPSQRPSMEEI 255

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 82.0 bits (201), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 75/256 (29%), Positives = 123/256 (48%), Gaps = 25/256 (9%)
Query: 5   ELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFK 64
           E+ + +G G FGV  + + K   + VA+K IE   +  A +  E+    ++ HPNI++  
Sbjct: 11  EVEEVVGRGAFGV--VCKAKWRAKDVAIKQIESESERKAFIV-ELRQLSRVNHPNIVKLY 67
Query: 65  EVVLTPTHLAIVMEYAAGGELFERICNA---GRFSEDEARYFFQQLISG----------Q 111
              L P  + +VMEYA GG L+  +  A     ++   A  +  Q   G           
Sbjct: 68  GACLNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKA 125
Query: 112 ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDG 171
           + HRDLK  N LL       LKICDFG +     H    +  G+ A++APEV     Y  
Sbjct: 126 LIHRDLKPPNLLLVAG-GTVLKICDFGTACDIQTHM--TNNKGSAAWMAPEVFEGSNYSE 182
Query: 172 KLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLS 231
           K  DV+S G+ L+ ++    PF++   P  FR  I   +    + P   ++ +   +L++
Sbjct: 183 K-CDVFSWGIILWEVITRRKPFDEIGGPA-FR--IMWAVHNGTRPPLIKNLPKPIESLMT 238
Query: 232 RIFVANPSRRITIKEI 247
           R +  +PS+R +++EI
Sbjct: 239 RCWSKDPSQRPSMEEI 254

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 81.6 bits (200), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 84/296 (28%), Positives = 131/296 (44%), Gaps = 49/296 (16%)
Query: 3   KYELMKDIGSGNFGVARLMRNKNTKELVAMKYI--ERGHKIDANVAREIINHKQLRHPNI 60
           +++ ++ +G+G +       NK T   VA+K +  +      +   REI   K+L+H NI
Sbjct: 6   QFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENI 65
Query: 61  IRFKEVVLTPTHLAIVMEYAAGG---ELFER-ICNAGRFSE-DEARYFFQQLISG----- 110
           +R  +V+ T   L +V E+        +  R + N  R  E +  +YF  QL+ G     
Sbjct: 66  VRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCH 125
Query: 111 --QICHRDLKLENTLLDGSPAPRLKICDFGYSKS-SLLHSRPKSTVGTPAYIAPEVL-SR 166
             +I HRDLK +N L++     +LK+ DFG +++  +  +   S V T  Y AP+VL   
Sbjct: 126 ENKILHRDLKPQNLLIN--KRGQLKLGDFGLARAFGIPVNTFSSEVVTLWYRAPDVLMGS 183
Query: 167 REYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQ--------YKIPD 218
           R Y   + D+WSCG  L  M+ G   F    D +   K I  IM            K+P 
Sbjct: 184 RTYSTSI-DIWSCGCILAEMITGKPLFPGTNDEEQL-KLIFDIMGTPNESLWPSVTKLPK 241
Query: 219 Y-VHISQ----DCR----------------NLLSRIFVANPSRRITIKEIKSHPWF 253
           Y  +I Q    D R                + L  +   NP  R++ K+   HPWF
Sbjct: 242 YNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWF 297

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 98/205 (47%), Gaps = 16/205 (7%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIE--RGHKIDANVAREIINHKQLRHPN 59
           E +  +  IG G+FG      + +TKE+VA+K I+         ++ +EI    Q   P 
Sbjct: 19  ELFTKLDRIGKGSFGEVYKGIDNHTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 78
Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-------QI 112
           I R+    L  T L I+MEY  GG   + +   G   E       ++++ G       + 
Sbjct: 79  ITRYFGSYLKSTKLWIIMEYLGGGSALD-LLKPGPLEETYIATILREILKGLDYLHSERK 137
Query: 113 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST--VGTPAYIAPEVLSRREYD 170
            HRD+K  N LL  S    +K+ DFG +   L  ++ K    VGTP ++APEV+ +  YD
Sbjct: 138 IHRDIKAANVLL--SEQGDVKLADFGVA-GQLTDTQIKRNXFVGTPFWMAPEVIKQSAYD 194
Query: 171 GKLADVWSCGVTLYVMLVGAYPFED 195
            K AD+WS G+T   +  G  P  D
Sbjct: 195 FK-ADIWSLGITAIELAKGEPPNSD 218

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 81/291 (27%), Positives = 127/291 (43%), Gaps = 44/291 (15%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK------IDANVAREIINHKQL 55
           ++YE +  +G G F      R+KNT ++VA+K I+ GH+      I+    REI   ++L
Sbjct: 10  KRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQEL 69
Query: 56  RHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERIC--NAGRFSEDEARYFFQQLISG--- 110
            HPNII   +     +++++V ++       E I   N+   +    + +    + G   
Sbjct: 70  SHPNIIGLLDAFGHKSNISLVFDFMETD--LEVIIKDNSLVLTPSHIKAYMLMTLQGLEY 127
Query: 111 ----QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP-KSTVGTPAYIAPEVLS 165
                I HRDLK  N LLD +    LK+ DFG +KS    +R     V T  Y APE+L 
Sbjct: 128 LHQHWILHRDLKPNNLLLDENGV--LKLADFGLAKSFGSPNRAYXHQVVTRWYRAPELLF 185
Query: 166 RREYDGKLADVWSCGVTLYVMLVGAYPF----EDQEDPKNFRKTISRIMAVQY----KIP 217
                G   D+W+ G  L  +L+   PF     D +      +T+      Q+     +P
Sbjct: 186 GARMYGVGVDMWAVGCILAELLL-RVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLP 244
Query: 218 DYV-----------HI----SQDCRNLLSRIFVANPSRRITIKEIKSHPWF 253
           DYV           HI      D  +L+  +F+ NP  RIT  +     +F
Sbjct: 245 DYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYF 295

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 80.9 bits (198), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 69/210 (32%), Positives = 104/210 (49%), Gaps = 15/210 (7%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAM-KYIER-GHKIDANVA-REIINHKQLRH 57
           MEKYE +  +G G++G+    RNK+T  +VA+ K++E    K+   +A REI   KQLRH
Sbjct: 24  MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRH 83
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFE-RICNAGRFSEDEARYFFQQLISG------ 110
            N++   EV        +V E+     L +  +   G   +   +Y F Q+I+G      
Sbjct: 84  ENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLF-QIINGIGFCHS 142
Query: 111 -QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP-KSTVGTPAYIAPEVLSRRE 168
             I HRD+K EN L+  S +  +K+CDFG++++           V T  Y APE+L    
Sbjct: 143 HNIIHRDIKPENILV--SQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVGDV 200
Query: 169 YDGKLADVWSCGVTLYVMLVGAYPFEDQED 198
             GK  DVW+ G  +  M +G   F    D
Sbjct: 201 KYGKAVDVWAIGCLVTEMFMGEPLFPGDSD 230

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 75/279 (26%), Positives = 130/279 (46%), Gaps = 30/279 (10%)
Query: 4   YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREI-INHKQLRHPNIIR 62
           +EL++ +G+G +G     R+  T +L A+K ++     +  + +EI +  K   H NI  
Sbjct: 26  FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIAT 85
Query: 63  FKEVVLTPT------HLAIVMEYAAGGELFERICN--AGRFSEDEARYFFQQLISG---- 110
           +    +          L +VME+   G + + I N       E+   Y  ++++ G    
Sbjct: 86  YYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHL 145
Query: 111 ---QICHRDLKLENTLLDGSPAPRLKICDFGYSKS-SLLHSRPKSTVGTPAYIAPEVLSR 166
              ++ HRD+K +N LL  +    +K+ DFG S        R  + +GTP ++APEV++ 
Sbjct: 146 HQHKVIHRDIKGQNVLL--TENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIAC 203
Query: 167 RE-----YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVH 221
            E     YD K +D+WS G+T   M  GA P  D   P      I R  A + K   +  
Sbjct: 204 DENPDATYDFK-SDLWSLGITAIEMAEGAPPLCDMH-PMRALFLIPRNPAPRLKSKKW-- 259
Query: 222 ISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLPRE 260
            S+  ++ +    V N S+R   +++  HP F+++ P E
Sbjct: 260 -SKKFQSFIESCLVKNHSQRPATEQLMKHP-FIRDQPNE 296

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 62/199 (31%), Positives = 92/199 (46%), Gaps = 23/199 (11%)
Query: 10  IGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKEVVLT 69
           +G G+FG    M +K T    A+K +    +++   A E++    L  P I+     V  
Sbjct: 101 LGRGSFGEVHRMEDKQTGFQCAVKKV----RLEVFRAEELMACAGLTSPRIVPLYGAVRE 156
Query: 70  PTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-------QICHRDLKLENT 122
              + I ME   GG L + +   G   ED A Y+  Q + G       +I H D+K +N 
Sbjct: 157 GPWVNIFMELLEGGSLGQLVKEQGCLPEDRALYYLGQALEGLEYLHSRRILHGDVKADNV 216
Query: 123 LL--DGSPAPRLKICDFGYSKSSLLHSRPKSTV------GTPAYIAPEVLSRREYDGKLA 174
           LL  DGS A    +CDFG++         KS +      GT  ++APEV+  R  D K+ 
Sbjct: 217 LLSSDGSHA---ALCDFGHAVCLQPDGLGKSLLTGDYIPGTETHMAPEVVLGRSCDAKV- 272
Query: 175 DVWSCGVTLYVMLVGAYPF 193
           DVWS    +  ML G +P+
Sbjct: 273 DVWSSCCMMLHMLNGCHPW 291

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 58/197 (29%), Positives = 90/197 (45%), Gaps = 19/197 (9%)
Query: 10  IGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKEVVLT 69
           +G G+FG    M++K T    A+K +    +++     E++    L  P I+     V  
Sbjct: 82  VGRGSFGEVHRMKDKQTGFQCAVKKV----RLEVFRVEELVACAGLSSPRIVPLYGAVRE 137
Query: 70  PTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-------QICHRDLKLENT 122
              + I ME   GG L + I   G   ED A Y+  Q + G       +I H D+K +N 
Sbjct: 138 GPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNV 197
Query: 123 LLDGSPAPRLKICDFGYSKSSLLHSRPKSTV------GTPAYIAPEVLSRREYDGKLADV 176
           LL  S   R  +CDFG++         KS +      GT  ++APEV+  +  D K+ D+
Sbjct: 198 LLS-SDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKV-DI 255
Query: 177 WSCGVTLYVMLVGAYPF 193
           WS    +  ML G +P+
Sbjct: 256 WSSCCMMLHMLNGCHPW 272

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 58/197 (29%), Positives = 90/197 (45%), Gaps = 19/197 (9%)
Query: 10  IGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKEVVLT 69
           +G G+FG    M++K T    A+K +    +++     E++    L  P I+     V  
Sbjct: 66  VGRGSFGEVHRMKDKQTGFQCAVKKV----RLEVFRVEELVACAGLSSPRIVPLYGAVRE 121
Query: 70  PTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-------QICHRDLKLENT 122
              + I ME   GG L + I   G   ED A Y+  Q + G       +I H D+K +N 
Sbjct: 122 GPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNV 181
Query: 123 LLDGSPAPRLKICDFGYSKSSLLHSRPKSTV------GTPAYIAPEVLSRREYDGKLADV 176
           LL  S   R  +CDFG++         KS +      GT  ++APEV+  +  D K+ D+
Sbjct: 182 LLS-SDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKV-DI 239
Query: 177 WSCGVTLYVMLVGAYPF 193
           WS    +  ML G +P+
Sbjct: 240 WSSCCMMLHMLNGCHPW 256

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 58/197 (29%), Positives = 90/197 (45%), Gaps = 19/197 (9%)
Query: 10  IGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKEVVLT 69
           +G G+FG    M++K T    A+K +    +++     E++    L  P I+     V  
Sbjct: 80  LGRGSFGEVHRMKDKQTGFQCAVKKV----RLEVFRVEELVACAGLSSPRIVPLYGAVRE 135
Query: 70  PTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-------QICHRDLKLENT 122
              + I ME   GG L + I   G   ED A Y+  Q + G       +I H D+K +N 
Sbjct: 136 GPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNV 195
Query: 123 LLDGSPAPRLKICDFGYSKSSLLHSRPKSTV------GTPAYIAPEVLSRREYDGKLADV 176
           LL  S   R  +CDFG++         KS +      GT  ++APEV+  +  D K+ D+
Sbjct: 196 LLS-SDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKV-DI 253
Query: 177 WSCGVTLYVMLVGAYPF 193
           WS    +  ML G +P+
Sbjct: 254 WSSCCMMLHMLNGCHPW 270

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 75/270 (27%), Positives = 123/270 (45%), Gaps = 36/270 (13%)
Query: 10  IGSGNFGVARLMRNKNTKELVA-------MKYIERGHKIDANVAREIINHKQLRHPNIIR 62
           +G G FG     + K T +L A            +G++  A V ++I+     R   I+ 
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQ-GAMVEKKILAKVHSRF--IVS 249
Query: 63  FKEVVLTPTHLAIVMEYAAGGELFERICNAGR----FSEDEARYFFQQLISG-------Q 111
                 T T L +VM    GG++   I N       F E  A ++  Q++SG        
Sbjct: 250 LAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN 309
Query: 112 ICHRDLKLENTLLDGSPAPRLKICDFGYS-KSSLLHSRPKSTVGTPAYIAPEVLSRREYD 170
           I +RDLK EN LLD      ++I D G + +     ++ K   GTP ++APE+L   EYD
Sbjct: 310 IIYRDLKPENVLLDDDG--NVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGEEYD 367
Query: 171 GKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPD-YVHISQD-CRN 228
             + D ++ GVTLY M+    PF  + +    ++   R++      PD +   S+D C  
Sbjct: 368 FSV-DYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDKFSPASKDFCEA 426
Query: 229 LLSRIFVANPSRRITIKE-----IKSHPWF 253
           LL +    +P +R+  ++     +++HP F
Sbjct: 427 LLQK----DPEKRLGFRDGSCDGLRTHPLF 452

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 75/270 (27%), Positives = 123/270 (45%), Gaps = 36/270 (13%)
Query: 10  IGSGNFGVARLMRNKNTKELVA-------MKYIERGHKIDANVAREIINHKQLRHPNIIR 62
           +G G FG     + K T +L A            +G++  A V ++I+     R   I+ 
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQ-GAMVEKKILAKVHSRF--IVS 249
Query: 63  FKEVVLTPTHLAIVMEYAAGGELFERICNAGR----FSEDEARYFFQQLISG-------Q 111
                 T T L +VM    GG++   I N       F E  A ++  Q++SG        
Sbjct: 250 LAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN 309
Query: 112 ICHRDLKLENTLLDGSPAPRLKICDFGYS-KSSLLHSRPKSTVGTPAYIAPEVLSRREYD 170
           I +RDLK EN LLD      ++I D G + +     ++ K   GTP ++APE+L   EYD
Sbjct: 310 IIYRDLKPENVLLDDDG--NVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGEEYD 367
Query: 171 GKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPD-YVHISQD-CRN 228
             + D ++ GVTLY M+    PF  + +    ++   R++      PD +   S+D C  
Sbjct: 368 FSV-DYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDKFSPASKDFCEA 426
Query: 229 LLSRIFVANPSRRITIKE-----IKSHPWF 253
           LL +    +P +R+  ++     +++HP F
Sbjct: 427 LLQK----DPEKRLGFRDGSCDGLRTHPLF 452

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 75/270 (27%), Positives = 123/270 (45%), Gaps = 36/270 (13%)
Query: 10  IGSGNFGVARLMRNKNTKELVA-------MKYIERGHKIDANVAREIINHKQLRHPNIIR 62
           +G G FG     + K T +L A            +G++  A V ++I+     R   I+ 
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQ-GAMVEKKILAKVHSRF--IVS 249
Query: 63  FKEVVLTPTHLAIVMEYAAGGELFERICNAGR----FSEDEARYFFQQLISG-------Q 111
                 T T L +VM    GG++   I N       F E  A ++  Q++SG        
Sbjct: 250 LAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN 309
Query: 112 ICHRDLKLENTLLDGSPAPRLKICDFGYS-KSSLLHSRPKSTVGTPAYIAPEVLSRREYD 170
           I +RDLK EN LLD      ++I D G + +     ++ K   GTP ++APE+L   EYD
Sbjct: 310 IIYRDLKPENVLLDDDG--NVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGEEYD 367
Query: 171 GKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPD-YVHISQD-CRN 228
             + D ++ GVTLY M+    PF  + +    ++   R++      PD +   S+D C  
Sbjct: 368 FSV-DYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDKFSPASKDFCEA 426
Query: 229 LLSRIFVANPSRRITIKE-----IKSHPWF 253
           LL +    +P +R+  ++     +++HP F
Sbjct: 427 LLQK----DPEKRLGFRDGSCDGLRTHPLF 452

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 61/199 (30%), Positives = 91/199 (45%), Gaps = 23/199 (11%)
Query: 10  IGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKEVVLT 69
           +G G+FG    M +K T    A+K +    +++   A E++    L  P I+     V  
Sbjct: 82  LGRGSFGEVHRMEDKQTGFQCAVKKV----RLEVFRAEELMACAGLTSPRIVPLYGAVRE 137
Query: 70  PTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-------QICHRDLKLENT 122
              + I ME   GG L + +   G   ED A Y+  Q + G       +I H D+K +N 
Sbjct: 138 GPWVNIFMELLEGGSLGQLVKEQGCLPEDRALYYLGQALEGLEYLHSRRILHGDVKADNV 197
Query: 123 LL--DGSPAPRLKICDFGYSKSSLLHSRPKSTV------GTPAYIAPEVLSRREYDGKLA 174
           LL  DGS A    +CDFG++         K  +      GT  ++APEV+  R  D K+ 
Sbjct: 198 LLSSDGSHA---ALCDFGHAVCLQPDGLGKDLLTGDYIPGTETHMAPEVVLGRSCDAKV- 253
Query: 175 DVWSCGVTLYVMLVGAYPF 193
           DVWS    +  ML G +P+
Sbjct: 254 DVWSSCCMMLHMLNGCHPW 272

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 78.2 bits (191), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 75/270 (27%), Positives = 123/270 (45%), Gaps = 36/270 (13%)
Query: 10  IGSGNFGVARLMRNKNTKELVA-------MKYIERGHKIDANVAREIINHKQLRHPNIIR 62
           +G G FG     + K T +L A            +G++  A V ++I+     R   I+ 
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQ-GAMVEKKILAKVHSRF--IVS 249
Query: 63  FKEVVLTPTHLAIVMEYAAGGELFERICNAGR----FSEDEARYFFQQLISG-------Q 111
                 T T L +VM    GG++   I N       F E  A ++  Q++SG        
Sbjct: 250 LAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN 309
Query: 112 ICHRDLKLENTLLDGSPAPRLKICDFGYS-KSSLLHSRPKSTVGTPAYIAPEVLSRREYD 170
           I +RDLK EN LLD      ++I D G + +     ++ K   GTP ++APE+L   EYD
Sbjct: 310 IIYRDLKPENVLLDDDG--NVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGEEYD 367
Query: 171 GKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPD-YVHISQD-CRN 228
             + D ++ GVTLY M+    PF  + +    ++   R++      PD +   S+D C  
Sbjct: 368 FSV-DYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDKFSPASKDFCEA 426
Query: 229 LLSRIFVANPSRRITIKE-----IKSHPWF 253
           LL +    +P +R+  ++     +++HP F
Sbjct: 427 LLQK----DPEKRLGFRDGSCDGLRTHPLF 452

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 78.2 bits (191), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 102/208 (49%), Gaps = 23/208 (11%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNII 61
           E+  L+K++GSG FGV +L + K   + VA+K I+ G   +    +E     +L HP ++
Sbjct: 8   EEITLLKELGSGQFGVVKLGKWKGQYD-VAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLV 66
Query: 62  RFKEVVLTPTHLAIVMEYAAGGELFERICNAGR-----------FSEDEARYFFQQLISG 110
           +F  V      + IV EY + G L   + + G+           +   E   F +   S 
Sbjct: 67  KFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLE---SH 123
Query: 111 QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTP---AYIAPEVLSRR 167
           Q  HRDL   N L+D      +K+ DFG ++  +L  +  S+VGT     + APEV    
Sbjct: 124 QFIHRDLAARNCLVDRDLC--VKVSDFGMTR-YVLDDQYVSSVGTKFPVKWSAPEVFHYF 180
Query: 168 EYDGKLADVWSCGVTLY-VMLVGAYPFE 194
           +Y  K +DVW+ G+ ++ V  +G  P++
Sbjct: 181 KYSSK-SDVWAFGILMWEVFSLGKMPYD 207

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 72/261 (27%), Positives = 112/261 (42%), Gaps = 29/261 (11%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDA----NVAREIINHKQLR 56
           +  + + K IG G F              VA+K ++    +DA    +  +EI   KQL 
Sbjct: 31  LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLN 90
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGR----FSEDEARYFFQQLISG-- 110
           HPN+I++    +    L IV+E A  G+L   I +  +      E     +F QL S   
Sbjct: 91  HPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALE 150
Query: 111 -----QICHRDLKLENTLLDGSPAPRLKICDFGY-----SKSSLLHSRPKSTVGTPAYIA 160
                ++ HRD+K  N  +  +    +K+ D G      SK++  H    S VGTP Y++
Sbjct: 151 HMHSRRVMHRDIKPANVFITATGV--VKLGDLGLGRFFSSKTTAAH----SLVGTPYYMS 204
Query: 161 PEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYV 220
           PE +    Y+ K +D+WS G  LY M     PF    D  N      +I    Y      
Sbjct: 205 PERIHENGYNFK-SDIWSLGCLLYEMAALQSPFYG--DKMNLYSLCKKIEQCDYPPLPSD 261
Query: 221 HISQDCRNLLSRIFVANPSRR 241
           H S++ R L++     +P +R
Sbjct: 262 HYSEELRQLVNMCINPDPEKR 282

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score = 77.8 bits (190), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 69/281 (24%), Positives = 120/281 (42%), Gaps = 37/281 (13%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMK------YIERGHKIDANVAREIINHKQL 55
           + +E++K IG G F    +++ K T ++ AMK       ++RG        R+++ +   
Sbjct: 61  DDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDR 120
Query: 56  RHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAG-RFSEDEARYFFQQLISG---- 110
           R    + F        +L +VMEY  GG+L   +   G R   + AR++  +++      
Sbjct: 121 RWITQLHF--AFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSV 178
Query: 111 ---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST------VGTPAYIAP 161
                 HRD+K +N LLD      +++ DFG    S L  R   T      VGTP Y++P
Sbjct: 179 HRLGYVHRDIKPDNILLD--RCGHIRLADFG----SCLKLRADGTVRSLVAVGTPDYLSP 232
Query: 162 EVLSRREYDGKL------ADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYK 215
           E+L                D W+ GV  Y M  G  PF      + + K +     +   
Sbjct: 233 EILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLP 292
Query: 216 IPDYVHISQDCRNLLSRIFVANPSR--RITIKEIKSHPWFL 254
           + D   + ++ R+ + R+     +R  R    + ++HP+F 
Sbjct: 293 LVDE-GVPEEARDFIQRLLCPPETRLGRGGAGDFRTHPFFF 332

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 63/192 (32%), Positives = 94/192 (48%), Gaps = 24/192 (12%)
Query: 7   MKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINH----KQLRHPNIIR 62
           +++IG G+FG     R+    E+VA+K +    K      ++II      ++LRHPN I+
Sbjct: 20  LREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQ 79
Query: 63  FKEVVLTPTHLAIVMEYAAG--GELFERICNAGRFSEDE-------ARYFFQQLISGQIC 113
           ++   L      +VMEY  G   +L E   +     E E       A      L S  + 
Sbjct: 80  YRGCYLREHTAWLVMEYCLGSASDLLE--VHKKPLQEVEIAAVTHGALQGLAYLHSHNMI 137
Query: 114 HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEV---LSRREYD 170
           HRD+K  N LL  S    +K+ DFG   S+ + +     VGTP ++APEV   +   +YD
Sbjct: 138 HRDVKAGNILL--SEPGLVKLGDFG---SASIMAPANXFVGTPYWMAPEVILAMDEGQYD 192
Query: 171 GKLADVWSCGVT 182
           GK+ DVWS G+T
Sbjct: 193 GKV-DVWSLGIT 203

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 76/268 (28%), Positives = 117/268 (43%), Gaps = 28/268 (10%)
Query: 7   MKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINH----KQLRHPNIIR 62
           +++IG G+FG     R+    E+VA+K +    K      ++II      ++LRHPN I+
Sbjct: 59  LREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQ 118
Query: 63  FKEVVLTPTHLAIVMEYAAG--GELFERICNAGRFSEDE-------ARYFFQQLISGQIC 113
           ++   L      +VMEY  G   +L E   +     E E       A      L S  + 
Sbjct: 119 YRGCYLREHTAWLVMEYCLGSASDLLE--VHKKPLQEVEIAAVTHGALQGLAYLHSHNMI 176
Query: 114 HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEV---LSRREYD 170
           HRD+K  N LL  S    +K+ DFG   S+ + +     VGTP ++APEV   +   +YD
Sbjct: 177 HRDVKAGNILL--SEPGLVKLGDFG---SASIMAPANXFVGTPYWMAPEVILAMDEGQYD 231
Query: 171 GKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLL 230
           GK+ DVWS G+T   +     P  +     N    +  I   +       H S+  RN +
Sbjct: 232 GKV-DVWSLGITCIELAERKPPLFNM----NAMSALYHIAQNESPALQSGHWSEYFRNFV 286
Query: 231 SRIFVANPSRRITIKEIKSHPWFLKNLP 258
                  P  R T + +  H + L+  P
Sbjct: 287 DSCLQKIPQDRPTSEVLLKHRFVLRERP 314

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 83/291 (28%), Positives = 131/291 (45%), Gaps = 37/291 (12%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK---IDANVAREIINHKQLRHP 58
           E +E++ ++G G FG     +NK T  L A K IE   +    D  V  EI+      HP
Sbjct: 19  EVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEIL--ATCDHP 76
Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGR-FSEDEARYFFQQLI-------SG 110
            I++          L I++E+  GG +   +    R  +E + +   +Q++       S 
Sbjct: 77  YIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSK 136
Query: 111 QICHRDLKLENTL--LDGSPAPRLKICDFGYSKSSL--LHSRPKSTVGTPAYIAPEV--- 163
           +I HRDLK  N L  L+G     +++ DFG S  +L  L  R  S +GTP ++APEV   
Sbjct: 137 RIIHRDLKAGNVLMTLEGD----IRLADFGVSAKNLKTLQKR-DSFIGTPYWMAPEVVMC 191
Query: 164 --LSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVH 221
             +    YD K AD+WS G+TL + +    P   + +P      I++        P    
Sbjct: 192 ETMKDTPYDYK-ADIWSLGITL-IEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPS--K 247
Query: 222 ISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLP-----RELTETAQA 267
            S + R+ L      NP  R +  ++  HP F+ ++      REL   A+A
Sbjct: 248 WSVEFRDFLKIALDKNPETRPSAAQLLEHP-FVSSITSNKALRELVAEAKA 297

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 83/291 (28%), Positives = 131/291 (45%), Gaps = 37/291 (12%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK---IDANVAREIINHKQLRHP 58
           E +E++ ++G G FG     +NK T  L A K IE   +    D  V  EI+      HP
Sbjct: 11  EVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEIL--ATCDHP 68
Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGR-FSEDEARYFFQQLI-------SG 110
            I++          L I++E+  GG +   +    R  +E + +   +Q++       S 
Sbjct: 69  YIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSK 128
Query: 111 QICHRDLKLENTL--LDGSPAPRLKICDFGYSKSSL--LHSRPKSTVGTPAYIAPEV--- 163
           +I HRDLK  N L  L+G     +++ DFG S  +L  L  R  S +GTP ++APEV   
Sbjct: 129 RIIHRDLKAGNVLMTLEGD----IRLADFGVSAKNLKTLQKR-DSFIGTPYWMAPEVVMC 183
Query: 164 --LSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVH 221
             +    YD K AD+WS G+TL + +    P   + +P      I++        P    
Sbjct: 184 ETMKDTPYDYK-ADIWSLGITL-IEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPS--K 239
Query: 222 ISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLP-----RELTETAQA 267
            S + R+ L      NP  R +  ++  HP F+ ++      REL   A+A
Sbjct: 240 WSVEFRDFLKIALDKNPETRPSAAQLLEHP-FVSSITSNKALRELVAEAKA 289

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 83/300 (27%), Positives = 122/300 (40%), Gaps = 53/300 (17%)
Query: 4   YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK--IDANVAREIINHKQLRHPNII 61
           ++L   +G G +GV     +K T E+VA+K IE   K        REI   K  +H NII
Sbjct: 13  FQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENII 72
Query: 62  RFKEVVLTPTHLAIVMEYAAGGELFE----RICNAGRFSEDEARYFFQQ-------LISG 110
               +   P       E     EL +    R+ +    S+D  +YF  Q       L   
Sbjct: 73  TIFNIQ-RPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTLRAVKVLHGS 131
Query: 111 QICHRDLKLENTLLDGSPAPRLKICDFGYSK----SSLLHSRPKS-------TVGTPAYI 159
            + HRDLK  N L++ +    LK+CDFG ++    S+  +S P          V T  Y 
Sbjct: 132 NVIHRDLKPSNLLINSNCD--LKVCDFGLARIIDESAADNSEPTGQQSGMTEXVATRWYR 189
Query: 160 APEVLSRREYDGKLADVWSCGVTLYVMLV--GAYPFED-------------QEDPKNFRK 204
           APEV+       +  DVWSCG  L  + +    +P  D                  N  +
Sbjct: 190 APEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLR 249
Query: 205 TISRIMAVQY--KIPDY---------VHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 253
            I    A +Y   +P Y           ++    +LL R+ V +P++RIT KE   HP+ 
Sbjct: 250 CIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYL 309

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 74/293 (25%), Positives = 127/293 (43%), Gaps = 46/293 (15%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDA--NVAREIINHKQLRHP 58
           ME Y  +  +G G +      ++K T  LVA+K I   H+  A     RE+   K L+H 
Sbjct: 1   METYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHA 60
Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGR-FSEDEARYFFQQLISG------- 110
           NI+   +++ T   L +V EY    +L + + + G   +    + F  QL+ G       
Sbjct: 61  NIVTLHDIIHTEKSLTLVFEY-LDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQ 119
Query: 111 QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP-KSTVGTPAYIAPEV-LSRRE 168
           ++ HRDLK +N L++      LK+ DFG +++  + ++   + V T  Y  P++ L   +
Sbjct: 120 KVLHRDLKPQNLLIN--ERGELKLADFGLARAKSIPTKTYDNEVVTLWYRPPDILLGSTD 177
Query: 169 YDGKLADVWSCGVTLYVMLVG--AYPFEDQEDPKNFRKTISRIMAV-------------- 212
           Y  ++ D+W  G   Y M  G   +P    E+  +F   I RI+                
Sbjct: 178 YSTQI-DMWGVGCIFYEMATGRPLFPGSTVEEQLHF---IFRILGTPTEETWPGILSNEE 233
Query: 213 --QYKIPDY---------VHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFL 254
              Y  P Y           +  D  +LL+++       RI+ ++   HP+FL
Sbjct: 234 FKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFL 286

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 74/266 (27%), Positives = 119/266 (44%), Gaps = 27/266 (10%)
Query: 10  IGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKEVVL- 68
           +G G FG     + + T ++ A K +E+            +N KQ+      RF   +  
Sbjct: 192 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAY 251
Query: 69  ---TPTHLAIVMEYAAGGELFERICNAGR--FSEDEARYFFQQLISG-------QICHRD 116
              T   L +V+    GG+L   I + G+  F E  A ++  ++  G       +I +RD
Sbjct: 252 AYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRD 311
Query: 117 LKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLADV 176
           LK EN LLD      ++I D G +         K  VGT  Y+APEV+    Y     D 
Sbjct: 312 LKPENILLDDHG--HIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFS-PDW 368
Query: 177 WSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYV--HISQDCRNLLSRIF 234
           W+ G  LY M+ G  PF+ Q   K  R+ + R++    ++P+      S   R+L S++ 
Sbjct: 369 WALGCLLYEMIAGQSPFQ-QRKKKIKREEVERLVK---EVPEEYSERFSPQARSLCSQLL 424
Query: 235 VANPSRRI-----TIKEIKSHPWFLK 255
             +P+ R+     + +E+K HP F K
Sbjct: 425 CKDPAERLGCRGGSAREVKEHPLFKK 450

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 83/300 (27%), Positives = 122/300 (40%), Gaps = 53/300 (17%)
Query: 4   YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK--IDANVAREIINHKQLRHPNII 61
           ++L   +G G +GV     +K T E+VA+K IE   K        REI   K  +H NII
Sbjct: 13  FQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENII 72
Query: 62  RFKEVVLTPTHLAIVMEYAAGGELFE----RICNAGRFSEDEARYFFQQ-------LISG 110
               +   P       E     EL +    R+ +    S+D  +YF  Q       L   
Sbjct: 73  TIFNIQ-RPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTLRAVKVLHGS 131
Query: 111 QICHRDLKLENTLLDGSPAPRLKICDFGYSK----SSLLHSRPKST-------VGTPAYI 159
            + HRDLK  N L++ +    LK+CDFG ++    S+  +S P          V T  Y 
Sbjct: 132 NVIHRDLKPSNLLINSNCD--LKVCDFGLARIIDESAADNSEPTGQQSGMTEYVATRWYR 189
Query: 160 APEVLSRREYDGKLADVWSCGVTLYVMLV--GAYPFED-------------QEDPKNFRK 204
           APEV+       +  DVWSCG  L  + +    +P  D                  N  +
Sbjct: 190 APEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLR 249
Query: 205 TISRIMAVQY--KIPDY---------VHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 253
            I    A +Y   +P Y           ++    +LL R+ V +P++RIT KE   HP+ 
Sbjct: 250 CIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYL 309

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 74/266 (27%), Positives = 119/266 (44%), Gaps = 27/266 (10%)
Query: 10  IGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKEVVL- 68
           +G G FG     + + T ++ A K +E+            +N KQ+      RF   +  
Sbjct: 192 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAY 251
Query: 69  ---TPTHLAIVMEYAAGGELFERICNAGR--FSEDEARYFFQQLISG-------QICHRD 116
              T   L +V+    GG+L   I + G+  F E  A ++  ++  G       +I +RD
Sbjct: 252 AYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRD 311
Query: 117 LKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLADV 176
           LK EN LLD      ++I D G +         K  VGT  Y+APEV+    Y     D 
Sbjct: 312 LKPENILLDDHG--HIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFS-PDW 368
Query: 177 WSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYV--HISQDCRNLLSRIF 234
           W+ G  LY M+ G  PF+ Q   K  R+ + R++    ++P+      S   R+L S++ 
Sbjct: 369 WALGCLLYEMIAGQSPFQ-QRKKKIKREEVERLVK---EVPEEYSERFSPQARSLCSQLL 424
Query: 235 VANPSRRI-----TIKEIKSHPWFLK 255
             +P+ R+     + +E+K HP F K
Sbjct: 425 CKDPAERLGCRGGSAREVKEHPLFKK 450

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 83/300 (27%), Positives = 122/300 (40%), Gaps = 53/300 (17%)
Query: 4   YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK--IDANVAREIINHKQLRHPNII 61
           ++L   +G G +GV     +K T E+VA+K IE   K        REI   K  +H NII
Sbjct: 13  FQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENII 72
Query: 62  RFKEVVLTPTHLAIVMEYAAGGELFE----RICNAGRFSEDEARYFFQQ-------LISG 110
               +   P       E     EL +    R+ +    S+D  +YF  Q       L   
Sbjct: 73  TIFNIQ-RPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTLRAVKVLHGS 131
Query: 111 QICHRDLKLENTLLDGSPAPRLKICDFGYSK----SSLLHSRPKST-------VGTPAYI 159
            + HRDLK  N L++ +    LK+CDFG ++    S+  +S P          V T  Y 
Sbjct: 132 NVIHRDLKPSNLLINSNCD--LKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYR 189
Query: 160 APEVLSRREYDGKLADVWSCGVTLYVMLV--GAYPFED-------------QEDPKNFRK 204
           APEV+       +  DVWSCG  L  + +    +P  D                  N  +
Sbjct: 190 APEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLR 249
Query: 205 TISRIMAVQY--KIPDY---------VHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 253
            I    A +Y   +P Y           ++    +LL R+ V +P++RIT KE   HP+ 
Sbjct: 250 CIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYL 309

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 72/236 (30%), Positives = 110/236 (46%), Gaps = 36/236 (15%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVA---REIINHKQLRHP 58
           ++YE+++ IG+G +GV    R + T + VA+K I     +  N     RE+   K  +H 
Sbjct: 54  DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHD 113
Query: 59  NIIRFKEVVLTPT-------HLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG- 110
           NII  K+ +L PT        + +V++     +L + I ++   + +  RYF  QL+ G 
Sbjct: 114 NIIAIKD-ILRPTVPYGEFKSVYVVLDLME-SDLHQIIHSSQPLTLEHVRYFLYQLLRGL 171
Query: 111 ------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST-------VGTPA 157
                 Q+ HRDLK  N L++ +    LKI DFG ++   L + P          V T  
Sbjct: 172 KYMHSAQVIHRDLKPSNLLVNEN--CELKIGDFGMARG--LCTSPAEHQYFMTEYVATRW 227
Query: 158 YIAPEV-LSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAV 212
           Y APE+ LS  EY   + D+WS G     ML     F      KN+   +  IM V
Sbjct: 228 YRAPELMLSLHEYTQAI-DLWSVGCIFGEMLARRQLFPG----KNYVHQLQLIMMV 278

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 72/236 (30%), Positives = 110/236 (46%), Gaps = 36/236 (15%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVA---REIINHKQLRHP 58
           ++YE+++ IG+G +GV    R + T + VA+K I     +  N     RE+   K  +H 
Sbjct: 55  DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHD 114
Query: 59  NIIRFKEVVLTPT-------HLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG- 110
           NII  K+ +L PT        + +V++     +L + I ++   + +  RYF  QL+ G 
Sbjct: 115 NIIAIKD-ILRPTVPYGEFKSVYVVLDLME-SDLHQIIHSSQPLTLEHVRYFLYQLLRGL 172
Query: 111 ------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST-------VGTPA 157
                 Q+ HRDLK  N L++ +    LKI DFG ++   L + P          V T  
Sbjct: 173 KYMHSAQVIHRDLKPSNLLVNEN--CELKIGDFGMARG--LCTSPAEHQYFMTEYVATRW 228
Query: 158 YIAPEV-LSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAV 212
           Y APE+ LS  EY   + D+WS G     ML     F      KN+   +  IM V
Sbjct: 229 YRAPELMLSLHEYTQAI-DLWSVGCIFGEMLARRQLFPG----KNYVHQLQLIMMV 279

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 71.6 bits (174), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 80/302 (26%), Positives = 122/302 (40%), Gaps = 55/302 (18%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK---IDANVAREIINHKQLRH 57
           +++Y  +  +G G +G      +  T E VA+K I   H+   +     RE+   K+L+H
Sbjct: 33  IDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQH 92
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-QIC--- 113
            NII  K V+     L ++ EYA   +L + +      S    + F  QLI+G   C   
Sbjct: 93  RNIIELKSVIHHNHRLHLIFEYAE-NDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSR 151
Query: 114 ---HRDLKLENTLL---DGSPAPRLKICDFGYSKSSLLHSRPKS-TVGTPAYIAPEVLSR 166
              HRDLK +N LL   D S  P LKI DFG +++  +  R  +  + T  Y  PE+L  
Sbjct: 152 RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLWYRPPEILLG 211
Query: 167 REYDGKLADVWSCGVTLYVML--------------------------------VGAYPFE 194
             +     D+WS       ML                                V A P  
Sbjct: 212 SRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTALPDW 271
Query: 195 DQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFL 254
            Q  PK   KT+ R++              +  +LL+ +   +P +RI+ K    HP+F 
Sbjct: 272 KQSFPKFRGKTLKRVLGALL--------DDEGLDLLTAMLEMDPVKRISAKNALEHPYFS 323
Query: 255 KN 256
            N
Sbjct: 324 HN 325

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 70.9 bits (172), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 72/301 (23%), Positives = 123/301 (40%), Gaps = 52/301 (17%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAR---EIINHKQLRH 57
           +++Y+ +K IGSG  G+     +      VA+K + R  +   +  R   E++  K + H
Sbjct: 21  LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNH 80
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFE-RICNAGRFSEDEAR--YFFQQLISG---- 110
            NII    V      L    +     EL +  +C       D  R  Y   Q++ G    
Sbjct: 81  KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLCGIKHL 140
Query: 111 ---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRR 167
               I HRDLK  N ++       LKI DFG ++++  +      V T  Y APEV+   
Sbjct: 141 HSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTASTNFMMTPYVVTRYYRAPEVILGM 198
Query: 168 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRI------------------ 209
            Y   + D+WS G  +  ++ G+  F+  +    + K I ++                  
Sbjct: 199 GYKENV-DIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMAALQPTVRNY 257
Query: 210 ---------MAVQYKIPDYVHISQD---------CRNLLSRIFVANPSRRITIKEIKSHP 251
                    +A +   PD++  S+           R+LLS++ V +P +RI++ E   HP
Sbjct: 258 VENRPAYPGIAFEELFPDWIFPSESERDKIKTSQARDLLSKMLVIDPDKRISVDEALRHP 317
Query: 252 W 252
           +
Sbjct: 318 Y 318

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 66/208 (31%), Positives = 101/208 (48%), Gaps = 32/208 (15%)
Query: 4   YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRF 63
           Y   K IG+G+FGV    +  ++ ELVA+K + +G    A   RE+   ++L H NI+R 
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGK---AFKNRELQIMRKLDHCNIVRL 78
Query: 64  KEVVLTP------THLAIVMEYAAGGELFERICNAGRFSEDE-------ARYFFQQLI-- 108
           +    +        +L +V++Y    E   R+  A  +S  +        + +  QL   
Sbjct: 79  RYFFYSSGEKKDEVYLNLVLDYVP--ETVYRV--ARHYSRAKQTLPVIYVKLYMYQLFRS 134
Query: 109 -----SGQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPK-STVGTPAYIAPE 162
                S  ICHRD+K +N LLD   A  LK+CDFG +K  L+   P  S + +  Y APE
Sbjct: 135 LAYIHSFGICHRDIKPQNLLLDPDTA-VLKLCDFGSAK-QLVRGEPNVSYICSRYYRAPE 192
Query: 163 -VLSRREYDGKLADVWSCGVTLYVMLVG 189
            +    +Y   + DVWS G  L  +L+G
Sbjct: 193 LIFGATDYTSSI-DVWSAGCVLAELLLG 219

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 66/208 (31%), Positives = 101/208 (48%), Gaps = 32/208 (15%)
Query: 4   YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRF 63
           Y   K IG+G+FGV    +  ++ ELVA+K + +G    A   RE+   ++L H NI+R 
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGK---AFKNRELQIMRKLDHCNIVRL 78
Query: 64  KEVVLTP------THLAIVMEYAAGGELFERICNAGRFSEDE-------ARYFFQQLI-- 108
           +    +        +L +V++Y    E   R+  A  +S  +        + +  QL   
Sbjct: 79  RYFFYSSGEKKDEVYLNLVLDYVP--ETVYRV--ARHYSRAKQTLPVIYVKLYMYQLFRS 134
Query: 109 -----SGQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPK-STVGTPAYIAPE 162
                S  ICHRD+K +N LLD   A  LK+CDFG +K  L+   P  S + +  Y APE
Sbjct: 135 LAYIHSFGICHRDIKPQNLLLDPDTA-VLKLCDFGSAK-QLVRGEPNVSYICSRYYRAPE 192
Query: 163 -VLSRREYDGKLADVWSCGVTLYVMLVG 189
            +    +Y   + DVWS G  L  +L+G
Sbjct: 193 LIFGATDYTSSI-DVWSAGCVLAELLLG 219

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 73/301 (24%), Positives = 123/301 (40%), Gaps = 52/301 (17%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAR---EIINHKQLRH 57
           +++Y+ +K IGSG  G+     +      VA+K + R  +   +  R   E++  K + H
Sbjct: 23  LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNH 82
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFE-RICNAGRFSEDEAR--YFFQQLISG---- 110
            NII    V      L    +     EL +  +C       D  R  Y   Q++ G    
Sbjct: 83  KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLCGIKHL 142
Query: 111 ---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRR 167
               I HRDLK  N ++       LKI DFG ++++  +      V T  Y APEV+   
Sbjct: 143 HSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTACTNFMMTPYVVTRYYRAPEVILGM 200
Query: 168 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRI--------MAVQYKI--- 216
            Y   + D+WS G  +  ++ G   F+  +    + K I ++         A+Q  +   
Sbjct: 201 GYAANV-DIWSVGCIMGELVKGCVIFQGTDHIDQWNKVIEQLGTPSAEFMAALQPTVRNY 259
Query: 217 ----------------PDYVHISQD---------CRNLLSRIFVANPSRRITIKEIKSHP 251
                           PD++  S+           R+LLS++ V +P +RI++ E   HP
Sbjct: 260 VENRPKYPGIKFEELFPDWIFPSESERDKIKTSQARDLLSKMLVIDPDKRISVDEALRHP 319
Query: 252 W 252
           +
Sbjct: 320 Y 320

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 75/295 (25%), Positives = 124/295 (42%), Gaps = 49/295 (16%)
Query: 3   KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIE--RGHKIDANVAREIINHKQLRHPNI 60
           +Y  ++ IG G +G+     +   K  VA+K I             REI    + RH N+
Sbjct: 44  RYTQLQYIGEGAYGMVSSAYDHVRKTRVAIKKISPFEHQTYCQRTLREIQILLRFRHENV 103
Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFE----RICNAGRFSEDEARYFFQQLISG------ 110
           I  ++++   T  A+   Y    +L E    ++  + + S D   YF  Q++ G      
Sbjct: 104 IGIRDILRASTLEAMRDVYIVQ-DLMETDLYKLLKSQQLSNDHICYFLYQILRGLKYIHS 162
Query: 111 -QICHRDLKLENTLLDGSPAPRLKICDFGYSK-SSLLHSRP---KSTVGTPAYIAPEVLS 165
             + HRDLK  N L++ +    LKICDFG ++ +   H         V T  Y APE++ 
Sbjct: 163 ANVLHRDLKPSNLLINTTCD--LKICDFGLARIADPEHDHTGFLTEXVATRWYRAPEIML 220
Query: 166 RREYDGKLADVWSCGVTLYVML------------------VGAYPFEDQED--------P 199
             +   K  D+WS G  L  ML                  +G      QED         
Sbjct: 221 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINMKA 280
Query: 200 KNFRKTI-SRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 253
           +N+ +++ S+      K+  +        +LL R+   NP++RIT++E  +HP+ 
Sbjct: 281 RNYLQSLPSKTKVAWAKL--FPKSDSKALDLLDRMLTFNPNKRITVEEALAHPYL 333

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 65/225 (28%), Positives = 106/225 (47%), Gaps = 30/225 (13%)
Query: 5   ELMKDIGSGNFGVARLMR----NKNTKELVAMKYIERGHKIDANV---AREIINHKQLRH 57
           + ++ +G GNFG   + R      NT E+VA+K ++  H  + ++    REI   K L+H
Sbjct: 16  KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ--HSTEEHLRDFEREIEILKSLQH 73
Query: 58  PNIIRFKEVVLTPT--HLAIVMEYAAGGELFERI-CNAGRFSEDEARYFFQQLISG---- 110
            NI+++K V  +    +L ++MEY   G L + +  +A R    +   +  Q+  G    
Sbjct: 74  DNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQAHAERIDHIKLLQYTSQICKGMEYL 133
Query: 111 ---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPA-----YIAPE 162
              +  HRDL   N L++     R+KI DFG +K  L   +    V  P      + APE
Sbjct: 134 GTKRYIHRDLATRNILVENE--NRVKIGDFGLTK-VLPQDKEXXKVKEPGESPIFWYAPE 190
Query: 163 VLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTIS 207
            L+  ++    +DVWS GV LY +    Y  + +  P  F + I 
Sbjct: 191 SLTESKF-SVASDVWSFGVVLYELF--TYIEKSKSPPAEFMRMIG 232

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 73/264 (27%), Positives = 113/264 (42%), Gaps = 38/264 (14%)
Query: 5   ELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDAN--------VAREIINHKQLR 56
           E  K IG G FG+    R    K +VA+K +  G                RE+     L 
Sbjct: 22  EYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLN 81
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAG---------RFSEDEARYF-FQQ 106
           HPNI++   ++  P  +  VME+   G+L+ R+ +           R   D A    + Q
Sbjct: 82  HPNIVKLYGLMHNPPRM--VMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQ 139
Query: 107 LISGQICHRDLKLENTL---LDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEV 163
             +  I HRDL+  N     LD +     K+ DFG S+ S +HS     +G   ++APE 
Sbjct: 140 NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQS-VHSV-SGLLGNFQWMAPET 197
Query: 164 LSRRE--YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVH 221
           +   E  Y  K AD +S  + LY +L G  PF++    K     + R   ++  IP    
Sbjct: 198 IGAEEESYTEK-ADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPTIP---- 252
Query: 222 ISQDC----RNLLSRIFVANPSRR 241
             +DC    RN++   +  +P +R
Sbjct: 253 --EDCPPRLRNVIELCWSGDPKKR 274

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 98/212 (46%), Gaps = 28/212 (13%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNI 60
           M+++++ +  G G FG  +L + K+T   VA+K + +  +      + + +   L HPNI
Sbjct: 22  MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLHHPNI 81
Query: 61  IRFKEVVLT-------PTHLAIVMEYAAGGELFERICNAGRFSEDEA------RYFFQQL 107
           ++ +    T         +L +VMEY    +   R C    +    A      + F  QL
Sbjct: 82  VQLQSYFYTLGERDRRDIYLNVVMEYVP--DTLHRCCR-NYYRRQVAPPPILIKVFLFQL 138
Query: 108 I---------SGQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPK-STVGTPA 157
           I         S  +CHRD+K  N L++ +    LK+CDFG +K  L  S P  + + +  
Sbjct: 139 IRSIGCLHLPSVNVCHRDIKPHNVLVNEADG-TLKLCDFGSAK-KLSPSEPNVAYICSRY 196
Query: 158 YIAPEVLSRREYDGKLADVWSCGVTLYVMLVG 189
           Y APE++   ++     D+WS G     M++G
Sbjct: 197 YRAPELIFGNQHYTTAVDIWSVGCIFAEMMLG 228

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 73/264 (27%), Positives = 113/264 (42%), Gaps = 38/264 (14%)
Query: 5   ELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDAN--------VAREIINHKQLR 56
           E  K IG G FG+    R    K +VA+K +  G                RE+     L 
Sbjct: 22  EYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLN 81
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAG---------RFSEDEARYF-FQQ 106
           HPNI++   ++  P  +  VME+   G+L+ R+ +           R   D A    + Q
Sbjct: 82  HPNIVKLYGLMHNPPRM--VMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQ 139
Query: 107 LISGQICHRDLKLENTL---LDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEV 163
             +  I HRDL+  N     LD +     K+ DFG S+ S +HS     +G   ++APE 
Sbjct: 140 NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQQS-VHSV-SGLLGNFQWMAPET 197
Query: 164 LSRRE--YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVH 221
           +   E  Y  K AD +S  + LY +L G  PF++    K     + R   ++  IP    
Sbjct: 198 IGAEEESYTEK-ADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPTIP---- 252
Query: 222 ISQDC----RNLLSRIFVANPSRR 241
             +DC    RN++   +  +P +R
Sbjct: 253 --EDCPPRLRNVIELCWSGDPKKR 274

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 99/205 (48%), Gaps = 26/205 (12%)
Query: 4   YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRF 63
           Y   K IG+G+FGV    +  ++ ELVA+K + +G    A   RE+   ++L H NI+R 
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGK---AFKNRELQIMRKLDHCNIVRL 78
Query: 64  KEVVLTP------THLAIVMEYAAGGELFERICNAGRFSED----EARYFFQQLI----- 108
           +    +        +L +V++Y     ++    +  R  +       + +  QL      
Sbjct: 79  RYFFYSSGEKKDEVYLNLVLDYVP-ATVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 137
Query: 109 --SGQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPK-STVGTPAYIAPE-VL 164
             S  ICHRD+K +N LLD   A  LK+CDFG +K  L+   P  S + +  Y APE + 
Sbjct: 138 IHSFGICHRDIKPQNLLLDPDTA-VLKLCDFGSAK-QLVRGEPNVSXICSRYYRAPELIF 195
Query: 165 SRREYDGKLADVWSCGVTLYVMLVG 189
              +Y   + DVWS G  L  +L+G
Sbjct: 196 GATDYTSSI-DVWSAGCVLAELLLG 219

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 51/178 (28%), Positives = 81/178 (45%), Gaps = 18/178 (10%)
Query: 111 QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRRE-Y 169
            ICHRD+K  N L+D +   R+K+ DFG S+  ++  + K + GT  ++ PE  S    Y
Sbjct: 172 NICHRDVKPSNILMDKNG--RVKLSDFGESEY-MVDKKIKGSRGTYEFMPPEFFSNESSY 228
Query: 170 DGKLADVWSCGVTLYVMLVGAYPFEDQ----EDPKNFR-KTISRIMAVQYKIPDYVHISQ 224
           +G   D+WS G+ LYVM     PF  +    E   N R K I   +   + +    +   
Sbjct: 229 NGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIRTKNIEYPLDRNHFLYPLTNKKS 288
Query: 225 DCRN---------LLSRIFVANPSRRITIKEIKSHPWFLKNLPRELTETAQAIYYRKE 273
            C N          L      NP+ RIT ++   H W       +L E ++ +Y +++
Sbjct: 289 TCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADTNIEDLREFSKELYKKRK 346

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 100/208 (48%), Gaps = 32/208 (15%)
Query: 4   YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRF 63
           Y   K IG+G+FGV    +  ++ ELVA+K + +  +      RE+   ++L H NI+R 
Sbjct: 56  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN---RELQIMRKLDHCNIVRL 112
Query: 64  KEVVLTP------THLAIVMEYAAGGELFERICNAGRFSEDE-------ARYFFQQLI-- 108
           +    +        +L +V++Y    E   R+  A  +S  +        + +  QL   
Sbjct: 113 RYFFYSSGEKKDEVYLNLVLDYVP--ETVYRV--ARHYSRAKQTLPVIYVKLYMYQLFRS 168
Query: 109 -----SGQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPK-STVGTPAYIAPE 162
                S  ICHRD+K +N LLD   A  LK+CDFG +K  L+   P  S + +  Y APE
Sbjct: 169 LAYIHSFGICHRDIKPQNLLLDPDTA-VLKLCDFGSAK-QLVRGEPNVSXICSRYYRAPE 226
Query: 163 -VLSRREYDGKLADVWSCGVTLYVMLVG 189
            +    +Y   + DVWS G  L  +L+G
Sbjct: 227 LIFGATDYTSSI-DVWSAGCVLAELLLG 253

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 100/208 (48%), Gaps = 32/208 (15%)
Query: 4   YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRF 63
           Y   K IG+G+FGV    +  ++ ELVA+K + +  +      RE+   ++L H NI+R 
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN---RELQIMRKLDHCNIVRL 78
Query: 64  KEVVLTP------THLAIVMEYAAGGELFERICNAGRFSEDE-------ARYFFQQLI-- 108
           +    +        +L +V++Y    E   R+  A  +S  +        + +  QL   
Sbjct: 79  RYFFYSSGEKKDEVYLNLVLDYVP--ETVYRV--ARHYSRAKQTLPVIYVKLYMYQLFRS 134
Query: 109 -----SGQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPK-STVGTPAYIAPE 162
                S  ICHRD+K +N LLD   A  LK+CDFG +K  L+   P  S + +  Y APE
Sbjct: 135 LAYIHSFGICHRDIKPQNLLLDPDTA-VLKLCDFGSAK-QLVRGEPNVSXICSRYYRAPE 192
Query: 163 -VLSRREYDGKLADVWSCGVTLYVMLVG 189
            +    +Y   + DVWS G  L  +L+G
Sbjct: 193 LIFGATDYTSSI-DVWSAGCVLAELLLG 219

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 100/208 (48%), Gaps = 32/208 (15%)
Query: 4   YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRF 63
           Y   K IG+G+FGV    +  ++ ELVA+K + +  +      RE+   ++L H NI+R 
Sbjct: 30  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN---RELQIMRKLDHCNIVRL 86
Query: 64  KEVVLTP------THLAIVMEYAAGGELFERICNAGRFSEDE-------ARYFFQQLI-- 108
           +    +        +L +V++Y    E   R+  A  +S  +        + +  QL   
Sbjct: 87  RYFFYSSGEKKDEVYLNLVLDYVP--ETVYRV--ARHYSRAKQTLPVIYVKLYMYQLFRS 142
Query: 109 -----SGQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPK-STVGTPAYIAPE 162
                S  ICHRD+K +N LLD   A  LK+CDFG +K  L+   P  S + +  Y APE
Sbjct: 143 LAYIHSFGICHRDIKPQNLLLDPDTA-VLKLCDFGSAK-QLVRGEPNVSXICSRYYRAPE 200
Query: 163 -VLSRREYDGKLADVWSCGVTLYVMLVG 189
            +    +Y   + DVWS G  L  +L+G
Sbjct: 201 LIFGATDYTSSI-DVWSAGCVLAELLLG 227

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 100/208 (48%), Gaps = 32/208 (15%)
Query: 4   YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRF 63
           Y   K IG+G+FGV    +  ++ ELVA+K + +  +      RE+   ++L H NI+R 
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN---RELQIMRKLDHCNIVRL 78
Query: 64  KEVVLTP------THLAIVMEYAAGGELFERICNAGRFSEDE-------ARYFFQQLI-- 108
           +    +        +L +V++Y    E   R+  A  +S  +        + +  QL   
Sbjct: 79  RYFFYSSGEKKDEVYLNLVLDYVP--ETVYRV--ARHYSRAKQTLPVIYVKLYMYQLFRS 134
Query: 109 -----SGQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPK-STVGTPAYIAPE 162
                S  ICHRD+K +N LLD   A  LK+CDFG +K  L+   P  S + +  Y APE
Sbjct: 135 LAYIHSFGICHRDIKPQNLLLDPDTA-VLKLCDFGSAK-QLVRGEPNVSXICSRYYRAPE 192
Query: 163 -VLSRREYDGKLADVWSCGVTLYVMLVG 189
            +    +Y   + DVWS G  L  +L+G
Sbjct: 193 LIFGATDYTSSI-DVWSAGCVLAELLLG 219

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 100/208 (48%), Gaps = 32/208 (15%)
Query: 4   YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRF 63
           Y   K IG+G+FGV    +  ++ ELVA+K + +  +      RE+   ++L H NI+R 
Sbjct: 23  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN---RELQIMRKLDHCNIVRL 79
Query: 64  KEVVLTP------THLAIVMEYAAGGELFERICNAGRFSEDE-------ARYFFQQLI-- 108
           +    +        +L +V++Y    E   R+  A  +S  +        + +  QL   
Sbjct: 80  RYFFYSSGEKKDEVYLNLVLDYVP--ETVYRV--ARHYSRAKQTLPVIYVKLYMYQLFRS 135
Query: 109 -----SGQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPK-STVGTPAYIAPE 162
                S  ICHRD+K +N LLD   A  LK+CDFG +K  L+   P  S + +  Y APE
Sbjct: 136 LAYIHSFGICHRDIKPQNLLLDPDTA-VLKLCDFGSAK-QLVRGEPNVSXICSRYYRAPE 193
Query: 163 -VLSRREYDGKLADVWSCGVTLYVMLVG 189
            +    +Y   + DVWS G  L  +L+G
Sbjct: 194 LIFGATDYTSSI-DVWSAGCVLAELLLG 220

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 100/208 (48%), Gaps = 32/208 (15%)
Query: 4   YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRF 63
           Y   K IG+G+FGV    +  ++ ELVA+K + +  +      RE+   ++L H NI+R 
Sbjct: 41  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN---RELQIMRKLDHCNIVRL 97
Query: 64  KEVVLTP------THLAIVMEYAAGGELFERICNAGRFSEDE-------ARYFFQQLI-- 108
           +    +        +L +V++Y    E   R+  A  +S  +        + +  QL   
Sbjct: 98  RYFFYSSGEKKDEVYLNLVLDYVP--ETVYRV--ARHYSRAKQTLPVIYVKLYMYQLFRS 153
Query: 109 -----SGQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPK-STVGTPAYIAPE 162
                S  ICHRD+K +N LLD   A  LK+CDFG +K  L+   P  S + +  Y APE
Sbjct: 154 LAYIHSFGICHRDIKPQNLLLDPDTA-VLKLCDFGSAK-QLVRGEPNVSXICSRYYRAPE 211
Query: 163 -VLSRREYDGKLADVWSCGVTLYVMLVG 189
            +    +Y   + DVWS G  L  +L+G
Sbjct: 212 LIFGATDYTSSI-DVWSAGCVLAELLLG 238

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 100/208 (48%), Gaps = 32/208 (15%)
Query: 4   YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRF 63
           Y   K IG+G+FGV    +  ++ ELVA+K + +  +      RE+   ++L H NI+R 
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN---RELQIMRKLDHCNIVRL 78
Query: 64  KEVVLTP------THLAIVMEYAAGGELFERICNAGRFSEDE-------ARYFFQQLI-- 108
           +    +        +L +V++Y    E   R+  A  +S  +        + +  QL   
Sbjct: 79  RYFFYSSGEKKDVVYLNLVLDYVP--ETVYRV--ARHYSRAKQTLPVIYVKLYMYQLFRS 134
Query: 109 -----SGQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPK-STVGTPAYIAPE 162
                S  ICHRD+K +N LLD   A  LK+CDFG +K  L+   P  S + +  Y APE
Sbjct: 135 LAYIHSFGICHRDIKPQNLLLDPDTA-VLKLCDFGSAK-QLVRGEPNVSXICSRYYRAPE 192
Query: 163 -VLSRREYDGKLADVWSCGVTLYVMLVG 189
            +    +Y   + DVWS G  L  +L+G
Sbjct: 193 LIFGATDYTSSI-DVWSAGCVLAELLLG 219

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 68.9 bits (167), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 100/208 (48%), Gaps = 32/208 (15%)
Query: 4   YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRF 63
           Y   K IG+G+FGV    +  ++ ELVA+K + +  +      RE+   ++L H NI+R 
Sbjct: 34  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN---RELQIMRKLDHCNIVRL 90
Query: 64  KEVVLTP------THLAIVMEYAAGGELFERICNAGRFSEDE-------ARYFFQQLI-- 108
           +    +        +L +V++Y    E   R+  A  +S  +        + +  QL   
Sbjct: 91  RYFFYSSGEKKDEVYLNLVLDYVP--ETVYRV--ARHYSRAKQTLPVIYVKLYMYQLFRS 146
Query: 109 -----SGQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPK-STVGTPAYIAPE 162
                S  ICHRD+K +N LLD   A  LK+CDFG +K  L+   P  S + +  Y APE
Sbjct: 147 LAYIHSFGICHRDIKPQNLLLDPDTA-VLKLCDFGSAK-QLVRGEPNVSXICSRYYRAPE 204
Query: 163 -VLSRREYDGKLADVWSCGVTLYVMLVG 189
            +    +Y   + DVWS G  L  +L+G
Sbjct: 205 LIFGATDYTSSI-DVWSAGCVLAELLLG 231

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 68.9 bits (167), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 100/208 (48%), Gaps = 32/208 (15%)
Query: 4   YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRF 63
           Y   K IG+G+FGV    +  ++ ELVA+K + +  +      RE+   ++L H NI+R 
Sbjct: 34  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN---RELQIMRKLDHCNIVRL 90
Query: 64  KEVVLTP------THLAIVMEYAAGGELFERICNAGRFSEDE-------ARYFFQQLI-- 108
           +    +        +L +V++Y    E   R+  A  +S  +        + +  QL   
Sbjct: 91  RYFFYSSGEKKDEVYLNLVLDYVP--ETVYRV--ARHYSRAKQTLPVIYVKLYMYQLFRS 146
Query: 109 -----SGQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPK-STVGTPAYIAPE 162
                S  ICHRD+K +N LLD   A  LK+CDFG +K  L+   P  S + +  Y APE
Sbjct: 147 LAYIHSFGICHRDIKPQNLLLDPDTA-VLKLCDFGSAK-QLVRGEPNVSXICSRYYRAPE 204
Query: 163 -VLSRREYDGKLADVWSCGVTLYVMLVG 189
            +    +Y   + DVWS G  L  +L+G
Sbjct: 205 LIFGATDYTSSI-DVWSAGCVLAELLLG 231

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 100/208 (48%), Gaps = 32/208 (15%)
Query: 4   YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRF 63
           Y   K IG+G+FGV    +  ++ ELVA+K + +  +      RE+   ++L H NI+R 
Sbjct: 26  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN---RELQIMRKLDHCNIVRL 82
Query: 64  KEVVLTP------THLAIVMEYAAGGELFERICNAGRFSEDE-------ARYFFQQLI-- 108
           +    +        +L +V++Y    E   R+  A  +S  +        + +  QL   
Sbjct: 83  RYFFYSSGEKKDEVYLNLVLDYVP--ETVYRV--ARHYSRAKQTLPVIYVKLYMYQLFRS 138
Query: 109 -----SGQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPK-STVGTPAYIAPE 162
                S  ICHRD+K +N LLD   A  LK+CDFG +K  L+   P  S + +  Y APE
Sbjct: 139 LAYIHSFGICHRDIKPQNLLLDPDTA-VLKLCDFGSAK-QLVRGEPNVSXICSRYYRAPE 196
Query: 163 -VLSRREYDGKLADVWSCGVTLYVMLVG 189
            +    +Y   + DVWS G  L  +L+G
Sbjct: 197 LIFGATDYTSSI-DVWSAGCVLAELLLG 223

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 100/208 (48%), Gaps = 32/208 (15%)
Query: 4   YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRF 63
           Y   K IG+G+FGV    +  ++ ELVA+K + +  +      RE+   ++L H NI+R 
Sbjct: 50  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN---RELQIMRKLDHCNIVRL 106
Query: 64  KEVVLTP------THLAIVMEYAAGGELFERICNAGRFSEDE-------ARYFFQQLI-- 108
           +    +        +L +V++Y    E   R+  A  +S  +        + +  QL   
Sbjct: 107 RYFFYSSGEKKDEVYLNLVLDYVP--ETVYRV--ARHYSRAKQTLPVIYVKLYMYQLFRS 162
Query: 109 -----SGQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPK-STVGTPAYIAPE 162
                S  ICHRD+K +N LLD   A  LK+CDFG +K  L+   P  S + +  Y APE
Sbjct: 163 LAYIHSFGICHRDIKPQNLLLDPDTA-VLKLCDFGSAK-QLVRGEPNVSYICSRYYRAPE 220
Query: 163 -VLSRREYDGKLADVWSCGVTLYVMLVG 189
            +    +Y   + DVWS G  L  +L+G
Sbjct: 221 LIFGATDYTSSI-DVWSAGCVLAELLLG 247

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 68.6 bits (166), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 100/208 (48%), Gaps = 32/208 (15%)
Query: 4   YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRF 63
           Y   K IG+G+FGV    +  ++ ELVA+K + +  +      RE+   ++L H NI+R 
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN---RELQIMRKLDHCNIVRL 78
Query: 64  KEVVLTP------THLAIVMEYAAGGELFERICNAGRFSEDE-------ARYFFQQLI-- 108
           +    +        +L +V++Y    E   R+  A  +S  +        + +  QL   
Sbjct: 79  RYFFYSSGEKKDEVYLNLVLDYVP--ETVYRV--ARHYSRAKQTLPVIYVKLYMYQLFRS 134
Query: 109 -----SGQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPK-STVGTPAYIAPE 162
                S  ICHRD+K +N LLD   A  LK+CDFG +K  L+   P  S + +  Y APE
Sbjct: 135 LAYIHSFGICHRDIKPQNLLLDPDTA-VLKLCDFGSAK-QLVRGEPNVSYICSRYYRAPE 192
Query: 163 -VLSRREYDGKLADVWSCGVTLYVMLVG 189
            +    +Y   + DVWS G  L  +L+G
Sbjct: 193 LIFGATDYTSSI-DVWSAGCVLAELLLG 219

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 100/208 (48%), Gaps = 32/208 (15%)
Query: 4   YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRF 63
           Y   K IG+G+FGV    +  ++ ELVA+K + +  +      RE+   ++L H NI+R 
Sbjct: 56  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN---RELQIMRKLDHCNIVRL 112
Query: 64  KEVVLTP------THLAIVMEYAAGGELFERICNAGRFSEDE-------ARYFFQQLI-- 108
           +    +        +L +V++Y    E   R+  A  +S  +        + +  QL   
Sbjct: 113 RYFFYSSGEKKDEVYLNLVLDYVP--ETVYRV--ARHYSRAKQTLPVIYVKLYMYQLFRS 168
Query: 109 -----SGQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPK-STVGTPAYIAPE 162
                S  ICHRD+K +N LLD   A  LK+CDFG +K  L+   P  S + +  Y APE
Sbjct: 169 LAYIHSFGICHRDIKPQNLLLDPDTA-VLKLCDFGSAK-QLVRGEPNVSYICSRYYRAPE 226
Query: 163 -VLSRREYDGKLADVWSCGVTLYVMLVG 189
            +    +Y   + DVWS G  L  +L+G
Sbjct: 227 LIFGATDYTSSI-DVWSAGCVLAELLLG 253

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 100/210 (47%), Gaps = 25/210 (11%)
Query: 5   ELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINH----KQLRHPNI 60
           E + ++GSG  G    MR + T  ++A+K + R    + N  R +++     K    P I
Sbjct: 28  ENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEEN-KRILMDLDVVLKSHDCPYI 86
Query: 61  IRFKEVVLTPTHLAIVMEYAAG----------GELFERICNAGRFSEDEARYFFQQLISG 110
           ++     +T T + I ME              G + ERI      +  +A Y+ ++    
Sbjct: 87  VQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKE--KH 144
Query: 111 QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVL-----S 165
            + HRD+K  N LLD     ++K+CDFG S   +       + G  AY+APE +     +
Sbjct: 145 GVIHRDVKPSNILLD--ERGQIKLCDFGISGRLVDDKAKDRSAGCAAYMAPERIDPPDPT 202
Query: 166 RREYDGKLADVWSCGVTLYVMLVGAYPFED 195
           + +YD + ADVWS G++L  +  G +P+++
Sbjct: 203 KPDYDIR-ADVWSLGISLVELATGQFPYKN 231

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 100/208 (48%), Gaps = 32/208 (15%)
Query: 4   YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRF 63
           Y   K IG+G+FGV    +  ++ ELVA+K + +  +      RE+   ++L H NI+R 
Sbjct: 27  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN---RELQIMRKLDHCNIVRL 83
Query: 64  KEVVLTP------THLAIVMEYAAGGELFERICNAGRFSEDE-------ARYFFQQLI-- 108
           +    +        +L +V++Y    E   R+  A  +S  +        + +  QL   
Sbjct: 84  RYFFYSSGEKKDEVYLNLVLDYVP--ETVYRV--ARHYSRAKQTLPVIYVKLYMYQLFRS 139
Query: 109 -----SGQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPK-STVGTPAYIAPE 162
                S  ICHRD+K +N LLD   A  LK+CDFG +K  L+   P  S + +  Y APE
Sbjct: 140 LAYIHSFGICHRDIKPQNLLLDPDTA-VLKLCDFGSAK-QLVRGEPNVSYICSRYYRAPE 197
Query: 163 -VLSRREYDGKLADVWSCGVTLYVMLVG 189
            +    +Y   + DVWS G  L  +L+G
Sbjct: 198 LIFGATDYTSSI-DVWSAGCVLAELLLG 224

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 100/208 (48%), Gaps = 32/208 (15%)
Query: 4   YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRF 63
           Y   K IG+G+FGV    +  ++ ELVA+K + +  +      RE+   ++L H NI+R 
Sbjct: 58  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN---RELQIMRKLDHCNIVRL 114
Query: 64  KEVVLTP------THLAIVMEYAAGGELFERICNAGRFSEDE-------ARYFFQQLI-- 108
           +    +        +L +V++Y    E   R+  A  +S  +        + +  QL   
Sbjct: 115 RYFFYSSGEKKDEVYLNLVLDYVP--ETVYRV--ARHYSRAKQTLPVIYVKLYMYQLFRS 170
Query: 109 -----SGQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPK-STVGTPAYIAPE 162
                S  ICHRD+K +N LLD   A  LK+CDFG +K  L+   P  S + +  Y APE
Sbjct: 171 LAYIHSFGICHRDIKPQNLLLDPDTA-VLKLCDFGSAK-QLVRGEPNVSYICSRYYRAPE 228
Query: 163 -VLSRREYDGKLADVWSCGVTLYVMLVG 189
            +    +Y   + DVWS G  L  +L+G
Sbjct: 229 LIFGATDYTSSI-DVWSAGCVLAELLLG 255

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 100/208 (48%), Gaps = 32/208 (15%)
Query: 4   YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRF 63
           Y   K IG+G+FGV    +  ++ ELVA+K + +  +      RE+   ++L H NI+R 
Sbjct: 35  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN---RELQIMRKLDHCNIVRL 91
Query: 64  KEVVLTP------THLAIVMEYAAGGELFERICNAGRFSEDE-------ARYFFQQLI-- 108
           +    +        +L +V++Y    E   R+  A  +S  +        + +  QL   
Sbjct: 92  RYFFYSSGEKKDEVYLNLVLDYVP--ETVYRV--ARHYSRAKQTLPVIYVKLYMYQLFRS 147
Query: 109 -----SGQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPK-STVGTPAYIAPE 162
                S  ICHRD+K +N LLD   A  LK+CDFG +K  L+   P  S + +  Y APE
Sbjct: 148 LAYIHSFGICHRDIKPQNLLLDPDTA-VLKLCDFGSAK-QLVRGEPNVSYICSRYYRAPE 205
Query: 163 -VLSRREYDGKLADVWSCGVTLYVMLVG 189
            +    +Y   + DVWS G  L  +L+G
Sbjct: 206 LIFGATDYTSSI-DVWSAGCVLAELLLG 232

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 76/293 (25%), Positives = 118/293 (40%), Gaps = 44/293 (15%)
Query: 2   EKYELMKDIGSGNFGVARLMRN-KNTKELVAMKYI-----ERGHKIDANVAREIINH-KQ 54
           ++YE + +IG G +G     R+ KN    VA+K +     E G  +       ++ H + 
Sbjct: 11  QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLET 70
Query: 55  LRHPNIIRFKEVVLTP-----THLAIVMEYAAGG--ELFERICNAGRFSEDEARYFFQQL 107
             HPN++R  +V         T L +V E+         +++   G  +E      FQ L
Sbjct: 71  FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLL 130
Query: 108 ------ISGQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAP 161
                  S ++ HRDLK +N L+  S   ++K+ DFG ++         S V T  Y AP
Sbjct: 131 RGLDFLHSHRVVHRDLKPQNILVTSSG--QIKLADFGLARIYSFQMALTSVVVTLWYRAP 188
Query: 162 EVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRI------------ 209
           EVL +  Y     D+WS G     M      F    D     K +  I            
Sbjct: 189 EVLLQSSY-ATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDV 247
Query: 210 ----MAVQYK----IPDYV-HISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 253
                A   K    I  +V  I +  ++LL +    NP++RI+     SHP+F
Sbjct: 248 ALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 300

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 100/208 (48%), Gaps = 32/208 (15%)
Query: 4   YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRF 63
           Y   K IG+G+FGV    +  ++ ELVA+K + +  +      RE+   ++L H NI+R 
Sbjct: 60  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN---RELQIMRKLDHCNIVRL 116
Query: 64  KEVVLTP------THLAIVMEYAAGGELFERICNAGRFSEDE-------ARYFFQQLI-- 108
           +    +        +L +V++Y    E   R+  A  +S  +        + +  QL   
Sbjct: 117 RYFFYSSGEKKDEVYLNLVLDYVP--ETVYRV--ARHYSRAKQTLPVIYVKLYMYQLFRS 172
Query: 109 -----SGQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPK-STVGTPAYIAPE 162
                S  ICHRD+K +N LLD   A  LK+CDFG +K  L+   P  S + +  Y APE
Sbjct: 173 LAYIHSFGICHRDIKPQNLLLDPDTA-VLKLCDFGSAK-QLVRGEPNVSYICSRYYRAPE 230
Query: 163 -VLSRREYDGKLADVWSCGVTLYVMLVG 189
            +    +Y   + DVWS G  L  +L+G
Sbjct: 231 LIFGATDYTSSI-DVWSAGCVLAELLLG 257

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 76/293 (25%), Positives = 118/293 (40%), Gaps = 44/293 (15%)
Query: 2   EKYELMKDIGSGNFGVARLMRN-KNTKELVAMKYI-----ERGHKIDANVAREIINH-KQ 54
           ++YE + +IG G +G     R+ KN    VA+K +     E G  +       ++ H + 
Sbjct: 11  QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLET 70
Query: 55  LRHPNIIRFKEVVLTP-----THLAIVMEYAAGG--ELFERICNAGRFSEDEARYFFQQL 107
             HPN++R  +V         T L +V E+         +++   G  +E      FQ L
Sbjct: 71  FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLL 130
Query: 108 ------ISGQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAP 161
                  S ++ HRDLK +N L+  S   ++K+ DFG ++         S V T  Y AP
Sbjct: 131 RGLDFLHSHRVVHRDLKPQNILVTSSG--QIKLADFGLARIYSFQMALTSVVVTLWYRAP 188
Query: 162 EVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRI------------ 209
           EVL +  Y     D+WS G     M      F    D     K +  I            
Sbjct: 189 EVLLQSSY-ATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDV 247
Query: 210 ----MAVQYK----IPDYV-HISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 253
                A   K    I  +V  I +  ++LL +    NP++RI+     SHP+F
Sbjct: 248 ALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 300

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 100/208 (48%), Gaps = 32/208 (15%)
Query: 4   YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRF 63
           Y   K IG+G+FGV    +  ++ ELVA+K + +  +      RE+   ++L H NI+R 
Sbjct: 101 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN---RELQIMRKLDHCNIVRL 157
Query: 64  KEVVLTP------THLAIVMEYAAGGELFERICNAGRFSEDE-------ARYFFQQLI-- 108
           +    +        +L +V++Y    E   R+  A  +S  +        + +  QL   
Sbjct: 158 RYFFYSSGEKKDEVYLNLVLDYVP--ETVYRV--ARHYSRAKQTLPVIYVKLYMYQLFRS 213
Query: 109 -----SGQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPK-STVGTPAYIAPE 162
                S  ICHRD+K +N LLD   A  LK+CDFG +K  L+   P  S + +  Y APE
Sbjct: 214 LAYIHSFGICHRDIKPQNLLLDPDTA-VLKLCDFGSAK-QLVRGEPNVSYICSRYYRAPE 271
Query: 163 -VLSRREYDGKLADVWSCGVTLYVMLVG 189
            +    +Y   + DVWS G  L  +L+G
Sbjct: 272 LIFGATDYTSSI-DVWSAGCVLAELLLG 298

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 76/293 (25%), Positives = 118/293 (40%), Gaps = 44/293 (15%)
Query: 2   EKYELMKDIGSGNFGVARLMRN-KNTKELVAMKYI-----ERGHKIDANVAREIINH-KQ 54
           ++YE + +IG G +G     R+ KN    VA+K +     E G  +       ++ H + 
Sbjct: 11  QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLET 70
Query: 55  LRHPNIIRFKEVVLTP-----THLAIVMEYAAGG--ELFERICNAGRFSEDEARYFFQQL 107
             HPN++R  +V         T L +V E+         +++   G  +E      FQ L
Sbjct: 71  FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLL 130
Query: 108 ------ISGQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAP 161
                  S ++ HRDLK +N L+  S   ++K+ DFG ++         S V T  Y AP
Sbjct: 131 RGLDFLHSHRVVHRDLKPQNILVTSSG--QIKLADFGLARIYSFQMALTSVVVTLWYRAP 188
Query: 162 EVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRI------------ 209
           EVL +  Y     D+WS G     M      F    D     K +  I            
Sbjct: 189 EVLLQSSY-ATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDV 247
Query: 210 ----MAVQYK----IPDYV-HISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 253
                A   K    I  +V  I +  ++LL +    NP++RI+     SHP+F
Sbjct: 248 ALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 300

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 75/270 (27%), Positives = 114/270 (42%), Gaps = 37/270 (13%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVA-REIINHKQLRHPNI 60
           + Y  ++ +G G F    L+   +     A+K I    + D   A RE   H+   HPNI
Sbjct: 29  KHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNI 88
Query: 61  IRFKEVVL---TPTHLA-IVMEYAAGGELF---ERICNAGRF-SEDEARYFFQQLISG-- 110
           +R     L      H A +++ +   G L+   ER+ + G F +ED+  +    +  G  
Sbjct: 89  LRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLE 148
Query: 111 -----QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH---SRPKSTV-------GT 155
                   HRDLK  N LL     P L   D G    + +H   SR   T+        T
Sbjct: 149 AIHAKGYAHRDLKPTNILLGDEGQPVLM--DLGSMNQACIHVEGSRQALTLQDWAAQRCT 206
Query: 156 PAYIAPEVLSRREYD--GKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQ 213
            +Y APE+ S + +    +  DVWS G  LY M+ G  P++       F+K  S  +AVQ
Sbjct: 207 ISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYD-----MVFQKGDSVALAVQ 261
Query: 214 YK--IPDYVHISQDCRNLLSRIFVANPSRR 241
            +  IP     S     LL+ +   +P +R
Sbjct: 262 NQLSIPQSPRHSSALWQLLNSMMTVDPHQR 291

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 72/264 (27%), Positives = 112/264 (42%), Gaps = 38/264 (14%)
Query: 5   ELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDAN--------VAREIINHKQLR 56
           E  K IG G FG+    R    K +VA+K +  G                RE+     L 
Sbjct: 22  EYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLN 81
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAG---------RFSEDEARYF-FQQ 106
           HPNI++   ++  P  +  VME+   G+L+ R+ +           R   D A    + Q
Sbjct: 82  HPNIVKLYGLMHNPPRM--VMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQ 139
Query: 107 LISGQICHRDLKLENTL---LDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEV 163
             +  I HRDL+  N     LD +     K+ DF  S+ S +HS     +G   ++APE 
Sbjct: 140 NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQQS-VHSV-SGLLGNFQWMAPET 197
Query: 164 LSRRE--YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVH 221
           +   E  Y  K AD +S  + LY +L G  PF++    K     + R   ++  IP    
Sbjct: 198 IGAEEESYTEK-ADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPTIP---- 252
Query: 222 ISQDC----RNLLSRIFVANPSRR 241
             +DC    RN++   +  +P +R
Sbjct: 253 --EDCPPRLRNVIELCWSGDPKKR 274

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 73/293 (24%), Positives = 121/293 (41%), Gaps = 45/293 (15%)
Query: 3   KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIE--RGHKIDANVAREIINHKQLRHPNI 60
           +Y  +  IG G +G+     +   K  VA+K I             REI    + RH NI
Sbjct: 44  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI 103
Query: 61  IRFKEVVLTPT----HLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG------ 110
           I   +++  PT        ++ +  G +L+ ++      S D   YF  Q++ G      
Sbjct: 104 IGINDIIRAPTIEQMKDVYLVTHLMGADLY-KLLKTQHLSNDHICYFLYQILRGLKYIHS 162
Query: 111 -QICHRDLKLENTLLDGSPAPRLKICDFGYSK-SSLLHSRP---KSTVGTPAYIAPEVLS 165
             + HRDLK  N LL+ +    LKICDFG ++ +   H         V T  Y APE++ 
Sbjct: 163 ANVLHRDLKPSNLLLNTTXD--LKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 220
Query: 166 RREYDGKLADVWSCGVTLYVML------------------VGAYPFEDQEDPKNFRKTIS 207
             +   K  D+WS G  L  ML                  +G      QED        +
Sbjct: 221 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 280
Query: 208 R--IMAVQY--KIP---DYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 253
           R  ++++ +  K+P    + +      +LL ++   NP +RI +++  +HP+ 
Sbjct: 281 RNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 333

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 64/225 (28%), Positives = 105/225 (46%), Gaps = 30/225 (13%)
Query: 5   ELMKDIGSGNFGVARLMR----NKNTKELVAMKYIERGHKIDANV---AREIINHKQLRH 57
           + ++ +G GNFG   + R      NT E+VA+K ++  H  + ++    REI   K L+H
Sbjct: 44  KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ--HSTEEHLRDFEREIEILKSLQH 101
Query: 58  PNIIRFKEVVLTPT--HLAIVMEYAAGGELFERIC-NAGRFSEDEARYFFQQLISG---- 110
            NI+++K V  +    +L ++MEY   G L + +  +  R    +   +  Q+  G    
Sbjct: 102 DNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL 161
Query: 111 ---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPA-----YIAPE 162
              +  HRDL   N L++     R+KI DFG +K  L   +    V  P      + APE
Sbjct: 162 GTKRYIHRDLATRNILVENE--NRVKIGDFGLTK-VLPQDKEXXKVKEPGESPIFWYAPE 218
Query: 163 VLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTIS 207
            L+  ++    +DVWS GV LY +    Y  + +  P  F + I 
Sbjct: 219 SLTESKF-SVASDVWSFGVVLYELF--TYIEKSKSPPAEFMRMIG 260

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 64/225 (28%), Positives = 105/225 (46%), Gaps = 30/225 (13%)
Query: 5   ELMKDIGSGNFGVARLMR----NKNTKELVAMKYIERGHKIDANV---AREIINHKQLRH 57
           + ++ +G GNFG   + R      NT E+VA+K ++  H  + ++    REI   K L+H
Sbjct: 16  KFLRQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ--HSTEEHLRDFEREIEILKSLQH 73
Query: 58  PNIIRFKEVVLTPT--HLAIVMEYAAGGELFERIC-NAGRFSEDEARYFFQQLISG---- 110
            NI+++K V  +    +L ++ME+   G L E +  +  R    +   +  Q+  G    
Sbjct: 74  DNIVKYKGVCYSAGRRNLKLIMEFLPYGSLREYLQKHKERIDHIKLLQYTSQICKGMEYL 133
Query: 111 ---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPA-----YIAPE 162
              +  HRDL   N L++     R+KI DFG +K  L   +    V  P      + APE
Sbjct: 134 GTKRYIHRDLATRNILVENE--NRVKIGDFGLTK-VLPQDKEXXKVKEPGESPIFWYAPE 190
Query: 163 VLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTIS 207
            L+  ++    +DVWS GV LY +    Y  + +  P  F + I 
Sbjct: 191 SLTESKF-SVASDVWSFGVVLYELF--TYIEKSKSPPAEFMRMIG 232

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 75/292 (25%), Positives = 120/292 (41%), Gaps = 49/292 (16%)
Query: 4   YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKID---ANVAREIINHKQLRHPNI 60
           Y  ++ +GSG +G      +  T   VA+K + R  + +       RE+   K +RH N+
Sbjct: 27  YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENV 86
Query: 61  IRFKEVVLTP-------THLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG--- 110
           I   +V  TP       T   +VM +   G    ++    +  ED  ++   Q++ G   
Sbjct: 87  IGLLDV-FTPDETLDDFTDFYLVMPFM--GTDLGKLMKHEKLGEDRIQFLVYQMLKGLRY 143
Query: 111 ----QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSR 166
                I HRDLK  N  ++      LKI DFG ++ +   S     V T  Y APEV+  
Sbjct: 144 IHAAGIIHRDLKPGNLAVNEDC--ELKILDFGLARQA--DSEMXGXVVTRWYRAPEVILN 199
Query: 167 REYDGKLADVWSCGVTLYVMLVGAYPFE--DQED------------PKNFRKTISRIMAV 212
                +  D+WS G  +  M+ G   F+  D  D            P  F + +    A 
Sbjct: 200 WMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAK 259
Query: 213 QY--KIP-----DYVHISQDCR----NLLSRIFVANPSRRITIKEIKSHPWF 253
            Y   +P     D+  I  +      NLL ++ V +  +R+T  E  +HP+F
Sbjct: 260 NYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYF 311

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 64/225 (28%), Positives = 105/225 (46%), Gaps = 30/225 (13%)
Query: 5   ELMKDIGSGNFGVARLMR----NKNTKELVAMKYIERGHKIDANV---AREIINHKQLRH 57
           + ++ +G GNFG   + R      NT E+VA+K ++  H  + ++    REI   K L+H
Sbjct: 11  KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ--HSTEEHLRDFEREIEILKSLQH 68
Query: 58  PNIIRFKEVVLTPT--HLAIVMEYAAGGELFERIC-NAGRFSEDEARYFFQQLISG---- 110
            NI+++K V  +    +L ++MEY   G L + +  +  R    +   +  Q+  G    
Sbjct: 69  DNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL 128
Query: 111 ---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPA-----YIAPE 162
              +  HRDL   N L++     R+KI DFG +K  L   +    V  P      + APE
Sbjct: 129 GTKRYIHRDLATRNILVENE--NRVKIGDFGLTK-VLPQDKEXXKVKEPGESPIFWYAPE 185
Query: 163 VLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTIS 207
            L+  ++    +DVWS GV LY +    Y  + +  P  F + I 
Sbjct: 186 SLTESKF-SVASDVWSFGVVLYELF--TYIEKSKSPPAEFMRMIG 227

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 64/225 (28%), Positives = 105/225 (46%), Gaps = 30/225 (13%)
Query: 5   ELMKDIGSGNFGVARLMR----NKNTKELVAMKYIERGHKIDANV---AREIINHKQLRH 57
           + ++ +G GNFG   + R      NT E+VA+K ++  H  + ++    REI   K L+H
Sbjct: 13  KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ--HSTEEHLRDFEREIEILKSLQH 70
Query: 58  PNIIRFKEVVLTPT--HLAIVMEYAAGGELFERIC-NAGRFSEDEARYFFQQLISG---- 110
            NI+++K V  +    +L ++MEY   G L + +  +  R    +   +  Q+  G    
Sbjct: 71  DNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL 130
Query: 111 ---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPA-----YIAPE 162
              +  HRDL   N L++     R+KI DFG +K  L   +    V  P      + APE
Sbjct: 131 GTKRYIHRDLATRNILVENE--NRVKIGDFGLTK-VLPQDKEXXKVKEPGESPIFWYAPE 187
Query: 163 VLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTIS 207
            L+  ++    +DVWS GV LY +    Y  + +  P  F + I 
Sbjct: 188 SLTESKF-SVASDVWSFGVVLYELF--TYIEKSKSPPAEFMRMIG 229

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 64/225 (28%), Positives = 105/225 (46%), Gaps = 30/225 (13%)
Query: 5   ELMKDIGSGNFGVARLMR----NKNTKELVAMKYIERGHKIDANV---AREIINHKQLRH 57
           + ++ +G GNFG   + R      NT E+VA+K ++  H  + ++    REI   K L+H
Sbjct: 12  KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ--HSTEEHLRDFEREIEILKSLQH 69
Query: 58  PNIIRFKEVVLTPT--HLAIVMEYAAGGELFERIC-NAGRFSEDEARYFFQQLISG---- 110
            NI+++K V  +    +L ++MEY   G L + +  +  R    +   +  Q+  G    
Sbjct: 70  DNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL 129
Query: 111 ---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPA-----YIAPE 162
              +  HRDL   N L++     R+KI DFG +K  L   +    V  P      + APE
Sbjct: 130 GTKRYIHRDLATRNILVENE--NRVKIGDFGLTK-VLPQDKEXXKVKEPGESPIFWYAPE 186
Query: 163 VLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTIS 207
            L+  ++    +DVWS GV LY +    Y  + +  P  F + I 
Sbjct: 187 SLTESKF-SVASDVWSFGVVLYELF--TYIEKSKSPPAEFMRMIG 228

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 64/225 (28%), Positives = 105/225 (46%), Gaps = 30/225 (13%)
Query: 5   ELMKDIGSGNFGVARLMR----NKNTKELVAMKYIERGHKIDANV---AREIINHKQLRH 57
           + ++ +G GNFG   + R      NT E+VA+K ++  H  + ++    REI   K L+H
Sbjct: 18  KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ--HSTEEHLRDFEREIEILKSLQH 75
Query: 58  PNIIRFKEVVLTPT--HLAIVMEYAAGGELFERIC-NAGRFSEDEARYFFQQLISG---- 110
            NI+++K V  +    +L ++MEY   G L + +  +  R    +   +  Q+  G    
Sbjct: 76  DNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL 135
Query: 111 ---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPA-----YIAPE 162
              +  HRDL   N L++     R+KI DFG +K  L   +    V  P      + APE
Sbjct: 136 GTKRYIHRDLATRNILVENE--NRVKIGDFGLTK-VLPQDKEXXKVKEPGESPIFWYAPE 192
Query: 163 VLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTIS 207
            L+  ++    +DVWS GV LY +    Y  + +  P  F + I 
Sbjct: 193 SLTESKF-SVASDVWSFGVVLYELF--TYIEKSKSPPAEFMRMIG 234

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 64/225 (28%), Positives = 105/225 (46%), Gaps = 30/225 (13%)
Query: 5   ELMKDIGSGNFGVARLMR----NKNTKELVAMKYIERGHKIDANV---AREIINHKQLRH 57
           + ++ +G GNFG   + R      NT E+VA+K ++  H  + ++    REI   K L+H
Sbjct: 19  KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ--HSTEEHLRDFEREIEILKSLQH 76
Query: 58  PNIIRFKEVVLTPT--HLAIVMEYAAGGELFERIC-NAGRFSEDEARYFFQQLISG---- 110
            NI+++K V  +    +L ++MEY   G L + +  +  R    +   +  Q+  G    
Sbjct: 77  DNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL 136
Query: 111 ---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPA-----YIAPE 162
              +  HRDL   N L++     R+KI DFG +K  L   +    V  P      + APE
Sbjct: 137 GTKRYIHRDLATRNILVENE--NRVKIGDFGLTK-VLPQDKEXXKVKEPGESPIFWYAPE 193
Query: 163 VLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTIS 207
            L+  ++    +DVWS GV LY +    Y  + +  P  F + I 
Sbjct: 194 SLTESKF-SVASDVWSFGVVLYELF--TYIEKSKSPPAEFMRMIG 235

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 98/207 (47%), Gaps = 17/207 (8%)
Query: 6   LMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKE 65
            +++IGSG FG+  L    N K+ VA+K I+ G   + +   E     +L HP +++   
Sbjct: 31  FVQEIGSGQFGLVHLGYWLN-KDKVAIKTIKEGSMSEDDFIEEAEVMMKLSHPKLVQLYG 89
Query: 66  VVLTPTHLAIVMEYAAGGELFERI-CNAGRFSEDEARYFFQQLISGQ-------ICHRDL 117
           V L    + +V E+   G L + +    G F+ +        +  G        + HRDL
Sbjct: 90  VCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDL 149
Query: 118 KLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTP---AYIAPEVLSRREYDGKLA 174
              N L+  +    +K+ DFG ++  +L  +  S+ GT     + +PEV S   Y  K +
Sbjct: 150 AARNCLVGENQV--IKVSDFGMTR-FVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSK-S 205
Query: 175 DVWSCGVTLY-VMLVGAYPFEDQEDPK 200
           DVWS GV ++ V   G  P+E++ + +
Sbjct: 206 DVWSFGVLMWEVFSEGKIPYENRSNSE 232

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 64/225 (28%), Positives = 105/225 (46%), Gaps = 30/225 (13%)
Query: 5   ELMKDIGSGNFGVARLMR----NKNTKELVAMKYIERGHKIDANV---AREIINHKQLRH 57
           + ++ +G GNFG   + R      NT E+VA+K ++  H  + ++    REI   K L+H
Sbjct: 13  KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ--HSTEEHLRDFEREIEILKSLQH 70
Query: 58  PNIIRFKEVVLTPT--HLAIVMEYAAGGELFERIC-NAGRFSEDEARYFFQQLISG---- 110
            NI+++K V  +    +L ++MEY   G L + +  +  R    +   +  Q+  G    
Sbjct: 71  DNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL 130
Query: 111 ---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPA-----YIAPE 162
              +  HRDL   N L++     R+KI DFG +K  L   +    V  P      + APE
Sbjct: 131 GTKRYIHRDLATRNILVENE--NRVKIGDFGLTK-VLPQDKEXXKVKEPGESPIFWYAPE 187
Query: 163 VLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTIS 207
            L+  ++    +DVWS GV LY +    Y  + +  P  F + I 
Sbjct: 188 SLTESKF-SVASDVWSFGVVLYELF--TYIEKSKSPPAEFMRMIG 229

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 64/225 (28%), Positives = 105/225 (46%), Gaps = 30/225 (13%)
Query: 5   ELMKDIGSGNFGVARLMR----NKNTKELVAMKYIERGHKIDANV---AREIINHKQLRH 57
           + ++ +G GNFG   + R      NT E+VA+K ++  H  + ++    REI   K L+H
Sbjct: 31  KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ--HSTEEHLRDFEREIEILKSLQH 88
Query: 58  PNIIRFKEVVLTPT--HLAIVMEYAAGGELFERIC-NAGRFSEDEARYFFQQLISG---- 110
            NI+++K V  +    +L ++MEY   G L + +  +  R    +   +  Q+  G    
Sbjct: 89  DNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL 148
Query: 111 ---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPA-----YIAPE 162
              +  HRDL   N L++     R+KI DFG +K  L   +    V  P      + APE
Sbjct: 149 GTKRYIHRDLATRNILVENE--NRVKIGDFGLTK-VLPQDKEXXKVKEPGESPIFWYAPE 205
Query: 163 VLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTIS 207
            L+  ++    +DVWS GV LY +    Y  + +  P  F + I 
Sbjct: 206 SLTESKF-SVASDVWSFGVVLYELF--TYIEKSKSPPAEFMRMIG 247

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 64/225 (28%), Positives = 105/225 (46%), Gaps = 30/225 (13%)
Query: 5   ELMKDIGSGNFGVARLMR----NKNTKELVAMKYIERGHKIDANV---AREIINHKQLRH 57
           + ++ +G GNFG   + R      NT E+VA+K ++  H  + ++    REI   K L+H
Sbjct: 17  KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ--HSTEEHLRDFEREIEILKSLQH 74
Query: 58  PNIIRFKEVVLTPT--HLAIVMEYAAGGELFERIC-NAGRFSEDEARYFFQQLISG---- 110
            NI+++K V  +    +L ++MEY   G L + +  +  R    +   +  Q+  G    
Sbjct: 75  DNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL 134
Query: 111 ---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPA-----YIAPE 162
              +  HRDL   N L++     R+KI DFG +K  L   +    V  P      + APE
Sbjct: 135 GTKRYIHRDLATRNILVENE--NRVKIGDFGLTK-VLPQDKEXXKVKEPGESPIFWYAPE 191
Query: 163 VLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTIS 207
            L+  ++    +DVWS GV LY +    Y  + +  P  F + I 
Sbjct: 192 SLTESKF-SVASDVWSFGVVLYELF--TYIEKSKSPPAEFMRMIG 233

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 64/225 (28%), Positives = 105/225 (46%), Gaps = 30/225 (13%)
Query: 5   ELMKDIGSGNFGVARLMR----NKNTKELVAMKYIERGHKIDANV---AREIINHKQLRH 57
           + ++ +G GNFG   + R      NT E+VA+K ++  H  + ++    REI   K L+H
Sbjct: 20  KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ--HSTEEHLRDFEREIEILKSLQH 77
Query: 58  PNIIRFKEVVLTPT--HLAIVMEYAAGGELFERIC-NAGRFSEDEARYFFQQLISG---- 110
            NI+++K V  +    +L ++MEY   G L + +  +  R    +   +  Q+  G    
Sbjct: 78  DNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL 137
Query: 111 ---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPA-----YIAPE 162
              +  HRDL   N L++     R+KI DFG +K  L   +    V  P      + APE
Sbjct: 138 GTKRYIHRDLATRNILVENE--NRVKIGDFGLTK-VLPQDKEXXKVKEPGESPIFWYAPE 194
Query: 163 VLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTIS 207
            L+  ++    +DVWS GV LY +    Y  + +  P  F + I 
Sbjct: 195 SLTESKF-SVASDVWSFGVVLYELF--TYIEKSKSPPAEFMRMIG 236

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 64/225 (28%), Positives = 105/225 (46%), Gaps = 30/225 (13%)
Query: 5   ELMKDIGSGNFGVARLMR----NKNTKELVAMKYIERGHKIDANV---AREIINHKQLRH 57
           + ++ +G GNFG   + R      NT E+VA+K ++  H  + ++    REI   K L+H
Sbjct: 16  KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ--HSTEEHLRDFEREIEILKSLQH 73
Query: 58  PNIIRFKEVVLTPT--HLAIVMEYAAGGELFERIC-NAGRFSEDEARYFFQQLISG---- 110
            NI+++K V  +    +L ++MEY   G L + +  +  R    +   +  Q+  G    
Sbjct: 74  DNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL 133
Query: 111 ---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPA-----YIAPE 162
              +  HRDL   N L++     R+KI DFG +K  L   +    V  P      + APE
Sbjct: 134 GTKRYIHRDLATRNILVENE--NRVKIGDFGLTK-VLPQDKEXXKVKEPGESPIFWYAPE 190
Query: 163 VLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTIS 207
            L+  ++    +DVWS GV LY +    Y  + +  P  F + I 
Sbjct: 191 SLTESKF-SVASDVWSFGVVLYELF--TYIEKSKSPPAEFMRMIG 232

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 64/225 (28%), Positives = 105/225 (46%), Gaps = 30/225 (13%)
Query: 5   ELMKDIGSGNFGVARLMR----NKNTKELVAMKYIERGHKIDANV---AREIINHKQLRH 57
           + ++ +G GNFG   + R      NT E+VA+K ++  H  + ++    REI   K L+H
Sbjct: 31  KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ--HSTEEHLRDFEREIEILKSLQH 88
Query: 58  PNIIRFKEVVLTPT--HLAIVMEYAAGGELFERIC-NAGRFSEDEARYFFQQLISG---- 110
            NI+++K V  +    +L ++MEY   G L + +  +  R    +   +  Q+  G    
Sbjct: 89  DNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL 148
Query: 111 ---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPA-----YIAPE 162
              +  HRDL   N L++     R+KI DFG +K  L   +    V  P      + APE
Sbjct: 149 GTKRYIHRDLATRNILVENE--NRVKIGDFGLTK-VLPQDKEXXKVKEPGESPIFWYAPE 205
Query: 163 VLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTIS 207
            L+  ++    +DVWS GV LY +    Y  + +  P  F + I 
Sbjct: 206 SLTESKF-SVASDVWSFGVVLYELF--TYIEKSKSPPAEFMRMIG 247

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 97/207 (46%), Gaps = 17/207 (8%)
Query: 6   LMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKE 65
            +++IGSG FG+  L    N K+ VA+K I  G   + +   E     +L HP +++   
Sbjct: 9   FVQEIGSGQFGLVHLGYWLN-KDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYG 67
Query: 66  VVLTPTHLAIVMEYAAGGELFERI-CNAGRFSEDEARYFFQQLISGQ-------ICHRDL 117
           V L    + +V E+   G L + +    G F+ +        +  G        + HRDL
Sbjct: 68  VCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDL 127
Query: 118 KLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTP---AYIAPEVLSRREYDGKLA 174
              N L+  +    +K+ DFG ++  +L  +  S+ GT     + +PEV S   Y  K +
Sbjct: 128 AARNCLVGENQV--IKVSDFGMTR-FVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSK-S 183
Query: 175 DVWSCGVTLY-VMLVGAYPFEDQEDPK 200
           DVWS GV ++ V   G  P+E++ + +
Sbjct: 184 DVWSFGVLMWEVFSEGKIPYENRSNSE 210

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 97/207 (46%), Gaps = 17/207 (8%)
Query: 6   LMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKE 65
            +++IGSG FG+  L    N K+ VA+K I  G   + +   E     +L HP +++   
Sbjct: 11  FVQEIGSGQFGLVHLGYWLN-KDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYG 69
Query: 66  VVLTPTHLAIVMEYAAGGELFERI-CNAGRFSEDEARYFFQQLISG-------QICHRDL 117
           V L    + +V E+   G L + +    G F+ +        +  G        + HRDL
Sbjct: 70  VCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEASVIHRDL 129
Query: 118 KLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTP---AYIAPEVLSRREYDGKLA 174
              N L+  +    +K+ DFG ++  +L  +  S+ GT     + +PEV S   Y  K +
Sbjct: 130 AARNCLVGENQV--IKVSDFGMTR-FVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSK-S 185
Query: 175 DVWSCGVTLY-VMLVGAYPFEDQEDPK 200
           DVWS GV ++ V   G  P+E++ + +
Sbjct: 186 DVWSFGVLMWEVFSEGKIPYENRSNSE 212

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 97/207 (46%), Gaps = 17/207 (8%)
Query: 6   LMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKE 65
            +++IGSG FG+  L    N K+ VA+K I  G   + +   E     +L HP +++   
Sbjct: 11  FVQEIGSGQFGLVHLGYWLN-KDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYG 69
Query: 66  VVLTPTHLAIVMEYAAGGELFERI-CNAGRFSEDEARYFFQQLISGQ-------ICHRDL 117
           V L    + +V E+   G L + +    G F+ +        +  G        + HRDL
Sbjct: 70  VCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDL 129
Query: 118 KLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTP---AYIAPEVLSRREYDGKLA 174
              N L+  +    +K+ DFG ++  +L  +  S+ GT     + +PEV S   Y  K +
Sbjct: 130 AARNCLVGENQV--IKVSDFGMTR-FVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSK-S 185
Query: 175 DVWSCGVTLY-VMLVGAYPFEDQEDPK 200
           DVWS GV ++ V   G  P+E++ + +
Sbjct: 186 DVWSFGVLMWEVFSEGKIPYENRSNSE 212

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 97/207 (46%), Gaps = 17/207 (8%)
Query: 6   LMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKE 65
            +++IGSG FG+  L    N K+ VA+K I  G   + +   E     +L HP +++   
Sbjct: 14  FVQEIGSGQFGLVHLGYWLN-KDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYG 72
Query: 66  VVLTPTHLAIVMEYAAGGELFERI-CNAGRFSEDEARYFFQQLISGQ-------ICHRDL 117
           V L    + +V E+   G L + +    G F+ +        +  G        + HRDL
Sbjct: 73  VCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDL 132
Query: 118 KLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTP---AYIAPEVLSRREYDGKLA 174
              N L+  +    +K+ DFG ++  +L  +  S+ GT     + +PEV S   Y  K +
Sbjct: 133 AARNCLVGENQV--IKVSDFGMTR-FVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSK-S 188
Query: 175 DVWSCGVTLY-VMLVGAYPFEDQEDPK 200
           DVWS GV ++ V   G  P+E++ + +
Sbjct: 189 DVWSFGVLMWEVFSEGKIPYENRSNSE 215

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 97/207 (46%), Gaps = 17/207 (8%)
Query: 6   LMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKE 65
            +++IGSG FG+  L    N K+ VA+K I  G   + +   E     +L HP +++   
Sbjct: 12  FVQEIGSGQFGLVHLGYWLN-KDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYG 70
Query: 66  VVLTPTHLAIVMEYAAGGELFERI-CNAGRFSEDEARYFFQQLISGQ-------ICHRDL 117
           V L    + +V E+   G L + +    G F+ +        +  G        + HRDL
Sbjct: 71  VCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDL 130
Query: 118 KLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTP---AYIAPEVLSRREYDGKLA 174
              N L+  +    +K+ DFG ++  +L  +  S+ GT     + +PEV S   Y  K +
Sbjct: 131 AARNCLVGENQV--IKVSDFGMTR-FVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSK-S 186
Query: 175 DVWSCGVTLY-VMLVGAYPFEDQEDPK 200
           DVWS GV ++ V   G  P+E++ + +
Sbjct: 187 DVWSFGVLMWEVFSEGKIPYENRSNSE 213

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/196 (31%), Positives = 92/196 (46%), Gaps = 22/196 (11%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNI 60
           M++ +L++ IG G FG   L   +  K  VA+K I+      A +A   +   QLRH N+
Sbjct: 5   MKELKLLQTIGKGEFGDVMLGDYRGNK--VAVKCIKNDATAQAFLAEASV-MTQLRHSNL 61
Query: 61  IRFKEVVL-TPTHLAIVMEYAAGGELFERICNAGR----------FSEDEARYFFQQLIS 109
           ++   V++     L IV EY A G L + + + GR          FS D      + L  
Sbjct: 62  VQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEA-MEYLEG 120
Query: 110 GQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPA-YIAPEVLSRRE 168
               HRDL   N L+  S     K+ DFG +K +   S  + T   P  + APE L  ++
Sbjct: 121 NNFVHRDLAARNVLV--SEDNVAKVSDFGLTKEA---SSTQDTGKLPVKWTAPEALREKK 175
Query: 169 YDGKLADVWSCGVTLY 184
           +  K +DVWS G+ L+
Sbjct: 176 FSTK-SDVWSFGILLW 190

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 61/196 (31%), Positives = 92/196 (46%), Gaps = 22/196 (11%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNI 60
           M++ +L++ IG G FG   L   +  K  VA+K I+      A +A   +   QLRH N+
Sbjct: 20  MKELKLLQTIGKGEFGDVMLGDYRGNK--VAVKCIKNDATAQAFLAEASV-MTQLRHSNL 76
Query: 61  IRFKEVVL-TPTHLAIVMEYAAGGELFERICNAGR----------FSEDEARYFFQQLIS 109
           ++   V++     L IV EY A G L + + + GR          FS D      + L  
Sbjct: 77  VQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEA-MEYLEG 135
Query: 110 GQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPA-YIAPEVLSRRE 168
               HRDL   N L+  S     K+ DFG +K +   S  + T   P  + APE L  ++
Sbjct: 136 NNFVHRDLAARNVLV--SEDNVAKVSDFGLTKEA---SSTQDTGKLPVKWTAPEALREKK 190
Query: 169 YDGKLADVWSCGVTLY 184
           +  K +DVWS G+ L+
Sbjct: 191 FSTK-SDVWSFGILLW 205

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 71/276 (25%), Positives = 118/276 (42%), Gaps = 60/276 (21%)
Query: 8   KDIGSG-NFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLR-HPNIIRF-- 63
           +D+GSG  + + RL+ N+  K              +  + +E+   K+L  HPNI++F  
Sbjct: 48  QDVGSGREYALKRLLSNEEEK--------------NRAIIQEVCFMKKLSGHPNIVQFCS 93
Query: 64  ------KEVVLTPTHLAIVMEYAAGG--ELFERICNAGRFSEDEA-RYFFQQLISGQ--- 111
                 +E         ++ E   G   E  +++ + G  S D   + F+Q   + Q   
Sbjct: 94  AASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMH 153
Query: 112 -----ICHRDLKLENTLLDGSPAPRLKICDFG----------YSKSSLLHSRPKSTVG-- 154
                I HRDLK+EN LL  S    +K+CDFG          YS S+   +  +  +   
Sbjct: 154 RQKPPIIHRDLKVENLLL--SNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRN 211
Query: 155 -TPAYIAPEVLSRREY--DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMA 211
            TP Y  PE++        G+  D+W+ G  LY++    +PFED            RI+ 
Sbjct: 212 TTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAK--------LRIVN 263
Query: 212 VQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEI 247
            +Y IP +        +L+  +   NP  R++I E+
Sbjct: 264 GKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEV 299

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 61/196 (31%), Positives = 92/196 (46%), Gaps = 22/196 (11%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNI 60
           M++ +L++ IG G FG   L   +  K  VA+K I+      A +A   +   QLRH N+
Sbjct: 192 MKELKLLQTIGKGEFGDVMLGDYRGNK--VAVKCIKNDATAQAFLAEASV-MTQLRHSNL 248
Query: 61  IRFKEVVL-TPTHLAIVMEYAAGGELFERICNAGR----------FSEDEARYFFQQLIS 109
           ++   V++     L IV EY A G L + + + GR          FS D      + L  
Sbjct: 249 VQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEA-MEYLEG 307
Query: 110 GQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPA-YIAPEVLSRRE 168
               HRDL   N L+  S     K+ DFG +K +   S  + T   P  + APE L  ++
Sbjct: 308 NNFVHRDLAARNVLV--SEDNVAKVSDFGLTKEA---SSTQDTGKLPVKWTAPEALREKK 362
Query: 169 YDGKLADVWSCGVTLY 184
           +  K +DVWS G+ L+
Sbjct: 363 FSTK-SDVWSFGILLW 377

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 64/225 (28%), Positives = 105/225 (46%), Gaps = 30/225 (13%)
Query: 5   ELMKDIGSGNFGVARLMR----NKNTKELVAMKYIERGHKIDANV---AREIINHKQLRH 57
           + ++ +G GNFG   + R      NT E+VA+K ++  H  + ++    REI   K L+H
Sbjct: 13  KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ--HSTEEHLRDFEREIEILKSLQH 70
Query: 58  PNIIRFKEVVLTPT--HLAIVMEYAAGGELFERIC-NAGRFSEDEARYFFQQLISG---- 110
            NI+++K V  +    +L ++MEY   G L + +  +  R    +   +  Q+  G    
Sbjct: 71  DNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL 130
Query: 111 ---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPA-----YIAPE 162
              +  HRDL   N L++     R+KI DFG +K  L   +    V  P      + APE
Sbjct: 131 GTKRYIHRDLATRNILVENE--NRVKIGDFGLTK-VLPQDKEFFKVKEPGESPIFWYAPE 187
Query: 163 VLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTIS 207
            L+  ++    +DVWS GV LY +    Y  + +  P  F + I 
Sbjct: 188 SLTESKF-SVASDVWSFGVVLYELF--TYIEKSKSPPAEFMRMIG 229

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 76/285 (26%), Positives = 127/285 (44%), Gaps = 55/285 (19%)
Query: 4   YELMKDIGSGNFGVARLMRNKN-TKELVAMKYI---ERGHKIDANVAREI--INHKQLRH 57
           Y ++K IGSG  G +++ +  N  K++ A+KY+   E  ++   +   EI  +N  Q   
Sbjct: 30  YSILKQIGSG--GSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 87
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG------- 110
             IIR  +  +T  ++ +VME     +L   +         E + +++ ++         
Sbjct: 88  DKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH 146
Query: 111 QICHRDLKLENTLL-DGSPAPRLKICDFGYSKSSLLHSRPKST-------VGTPAYIAPE 162
            I H DLK  N L+ DG     LK+ DFG +       +P +T       VGT  Y+ PE
Sbjct: 147 GIVHSDLKPANFLIVDG----MLKLIDFGIAN----QMQPDTTSVVKDSQVGTVNYMPPE 198
Query: 163 VL----SRRE------YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAV 212
            +    S RE           +DVWS G  LY M  G  PF+           IS++ A+
Sbjct: 199 AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ------QIINQISKLHAI 252
Query: 213 -----QYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPW 252
                + + PD     +D +++L      +P +RI+I E+ +HP+
Sbjct: 253 IDPNHEIEFPDIP--EKDLQDVLKCCLKRDPKQRISIPELLAHPY 295

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 76/285 (26%), Positives = 127/285 (44%), Gaps = 55/285 (19%)
Query: 4   YELMKDIGSGNFGVARLMRNKN-TKELVAMKYI---ERGHKIDANVAREI--INHKQLRH 57
           Y ++K IGSG  G +++ +  N  K++ A+KY+   E  ++   +   EI  +N  Q   
Sbjct: 14  YSILKQIGSG--GSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 71
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG------- 110
             IIR  +  +T  ++ +VME     +L   +         E + +++ ++         
Sbjct: 72  DKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH 130
Query: 111 QICHRDLKLENTLL-DGSPAPRLKICDFGYSKSSLLHSRPKST-------VGTPAYIAPE 162
            I H DLK  N L+ DG     LK+ DFG +       +P +T       VGT  Y+ PE
Sbjct: 131 GIVHSDLKPANFLIVDG----MLKLIDFGIAN----QMQPDTTSVVKDSQVGTVNYMPPE 182
Query: 163 VL----SRRE------YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAV 212
            +    S RE           +DVWS G  LY M  G  PF+           IS++ A+
Sbjct: 183 AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ------QIINQISKLHAI 236
Query: 213 -----QYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPW 252
                + + PD     +D +++L      +P +RI+I E+ +HP+
Sbjct: 237 IDPNHEIEFPDIP--EKDLQDVLKCCLKRDPKQRISIPELLAHPY 279

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 66/295 (22%), Positives = 126/295 (42%), Gaps = 51/295 (17%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK--IDAN-VAREIINHKQLRHP 58
           E+Y+ +  +GSG +G      +  T   VA+K + R  +  I A    RE+   K ++H 
Sbjct: 18  ERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 77
Query: 59  NIIRFKEVVLTPTHL-----AIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG--- 110
           N+I   +V      L       ++ +  G +L   I    + ++D  ++   Q++ G   
Sbjct: 78  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCAKLTDDHVQFLIYQILRGLKY 136
Query: 111 ----QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST--VGTPAYIAPEVL 164
                I HRDLK  N  ++      LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 137 IHSADIIHRDLKPSNLAVNEDC--ELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 190
Query: 165 SRREYDGKLADVWSCGVTLYVMLVG--AYPFEDQ------------------------ED 198
               +  +  D+WS G  +  +L G   +P  D                         E 
Sbjct: 191 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 250
Query: 199 PKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 253
            +N+ ++++++  + +    ++  +    +LL ++ V +  +RIT  +  +H +F
Sbjct: 251 ARNYIQSLAQMPKMNFA-NVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 304

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 76/285 (26%), Positives = 127/285 (44%), Gaps = 55/285 (19%)
Query: 4   YELMKDIGSGNFGVARLMRNKN-TKELVAMKYI---ERGHKIDANVAREI--INHKQLRH 57
           Y ++K IGSG  G +++ +  N  K++ A+KY+   E  ++   +   EI  +N  Q   
Sbjct: 11  YSILKQIGSG--GSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 68
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG------- 110
             IIR  +  +T  ++ +VME     +L   +         E + +++ ++         
Sbjct: 69  DKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH 127
Query: 111 QICHRDLKLENTLL-DGSPAPRLKICDFGYSKSSLLHSRPKST-------VGTPAYIAPE 162
            I H DLK  N L+ DG     LK+ DFG +       +P +T       VGT  Y+ PE
Sbjct: 128 GIVHSDLKPANFLIVDG----MLKLIDFGIAN----QMQPDTTSVVKDSQVGTVNYMPPE 179
Query: 163 VL----SRRE------YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAV 212
            +    S RE           +DVWS G  LY M  G  PF+           IS++ A+
Sbjct: 180 AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ------QIINQISKLHAI 233
Query: 213 -----QYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPW 252
                + + PD     +D +++L      +P +RI+I E+ +HP+
Sbjct: 234 IDPNHEIEFPDIP--EKDLQDVLKCCLKRDPKQRISIPELLAHPY 276

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 76/285 (26%), Positives = 127/285 (44%), Gaps = 55/285 (19%)
Query: 4   YELMKDIGSGNFGVARLMRNKN-TKELVAMKYI---ERGHKIDANVAREI--INHKQLRH 57
           Y ++K IGSG  G +++ +  N  K++ A+KY+   E  ++   +   EI  +N  Q   
Sbjct: 58  YSILKQIGSG--GSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 115
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG------- 110
             IIR  +  +T  ++ +VME     +L   +         E + +++ ++         
Sbjct: 116 DKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH 174
Query: 111 QICHRDLKLENTLL-DGSPAPRLKICDFGYSKSSLLHSRPKST-------VGTPAYIAPE 162
            I H DLK  N L+ DG     LK+ DFG +       +P +T       VGT  Y+ PE
Sbjct: 175 GIVHSDLKPANFLIVDG----MLKLIDFGIAN----QMQPDTTSVVKDSQVGTVNYMPPE 226
Query: 163 VL----SRRE------YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAV 212
            +    S RE           +DVWS G  LY M  G  PF+           IS++ A+
Sbjct: 227 AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ------QIINQISKLHAI 280
Query: 213 -----QYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPW 252
                + + PD     +D +++L      +P +RI+I E+ +HP+
Sbjct: 281 IDPNHEIEFPDIP--EKDLQDVLKCCLKRDPKQRISIPELLAHPY 323

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 75/281 (26%), Positives = 125/281 (44%), Gaps = 47/281 (16%)
Query: 4   YELMKDIGSGNFGVARLMRNKN-TKELVAMKYI---ERGHKIDANVAREI--INHKQLRH 57
           Y ++K IGSG  G +++ +  N  K++ A+KY+   E  ++   +   EI  +N  Q   
Sbjct: 30  YSILKQIGSG--GSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 87
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG------- 110
             IIR  +  +T  ++ +VME     +L   +         E + +++ ++         
Sbjct: 88  DKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH 146
Query: 111 QICHRDLKLENTLL-DGSPAPRLKICDFGYS---KSSLLHSRPKSTVGTPAYIAPEVL-- 164
            I H DLK  N L+ DG     LK+ DFG +   +         S VGT  Y+ PE +  
Sbjct: 147 GIVHSDLKPANFLIVDG----MLKLIDFGIANQMQPDXXXVVKDSQVGTVNYMPPEAIKD 202
Query: 165 --SRRE------YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAV---- 212
             S RE           +DVWS G  LY M  G  PF+           IS++ A+    
Sbjct: 203 MSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ------QIINQISKLHAIIDPN 256
Query: 213 -QYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPW 252
            + + PD     +D +++L      +P +RI+I E+ +HP+
Sbjct: 257 HEIEFPDIP--EKDLQDVLKCCLKRDPKQRISIPELLAHPY 295

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 76/285 (26%), Positives = 127/285 (44%), Gaps = 55/285 (19%)
Query: 4   YELMKDIGSGNFGVARLMRNKN-TKELVAMKYI---ERGHKIDANVAREI--INHKQLRH 57
           Y ++K IGSG  G +++ +  N  K++ A+KY+   E  ++   +   EI  +N  Q   
Sbjct: 10  YSILKQIGSG--GSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 67
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG------- 110
             IIR  +  +T  ++ +VME     +L   +         E + +++ ++         
Sbjct: 68  DKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH 126
Query: 111 QICHRDLKLENTLL-DGSPAPRLKICDFGYSKSSLLHSRPKST-------VGTPAYIAPE 162
            I H DLK  N L+ DG     LK+ DFG +       +P +T       VGT  Y+ PE
Sbjct: 127 GIVHSDLKPANFLIVDG----MLKLIDFGIAN----QMQPDTTSVVKDSQVGTVNYMPPE 178
Query: 163 VL----SRRE------YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAV 212
            +    S RE           +DVWS G  LY M  G  PF+           IS++ A+
Sbjct: 179 AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ------QIINQISKLHAI 232
Query: 213 -----QYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPW 252
                + + PD     +D +++L      +P +RI+I E+ +HP+
Sbjct: 233 IDPNHEIEFPDIP--EKDLQDVLKCCLKRDPKQRISIPELLAHPY 275

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 72/295 (24%), Positives = 125/295 (42%), Gaps = 51/295 (17%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK--IDAN-VAREIINHKQLRHP 58
           E+Y+ +  +GSG +G      +  +   +A+K + R  +  I A    RE+   K ++H 
Sbjct: 51  ERYQTLSPVGSGAYGSVCSSYDVKSGLKIAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 110
Query: 59  NIIRFKEVVLTPTHL-----AIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG--- 110
           N+I   +V    T L       ++ +  G +L   I    + ++D  ++   Q++ G   
Sbjct: 111 NVIGLLDVFTPATSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 169
Query: 111 ----QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST--VGTPAYIAPEVL 164
                I HRDLK  N  ++      LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 170 IHSADIIHRDLKPSNLAVNEDC--ELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 223
Query: 165 SRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIM-----AVQYKIPDY 219
               +     D+WS G  +  +L G   F    D  N  + I R+      +V  ++P +
Sbjct: 224 LNWMHYNMTVDIWSVGCIMAELLTGRTLFPGT-DHINQLQQIMRLTGTPPASVISRMPSH 282
Query: 220 -------------------VHISQD--CRNLLSRIFVANPSRRITIKEIKSHPWF 253
                              V I  +    +LL ++ V +  +RIT  E  +HP+F
Sbjct: 283 EARNYINSLPQMPKRNFADVFIGANPLAVDLLEKMLVLDTDKRITASEALAHPYF 337

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 76/285 (26%), Positives = 127/285 (44%), Gaps = 55/285 (19%)
Query: 4   YELMKDIGSGNFGVARLMRNKN-TKELVAMKYI---ERGHKIDANVAREI--INHKQLRH 57
           Y ++K IGSG  G +++ +  N  K++ A+KY+   E  ++   +   EI  +N  Q   
Sbjct: 58  YSILKQIGSG--GSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 115
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG------- 110
             IIR  +  +T  ++ +VME     +L   +         E + +++ ++         
Sbjct: 116 DKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH 174
Query: 111 QICHRDLKLENTLL-DGSPAPRLKICDFGYSKSSLLHSRPKST-------VGTPAYIAPE 162
            I H DLK  N L+ DG     LK+ DFG +       +P +T       VGT  Y+ PE
Sbjct: 175 GIVHSDLKPANFLIVDG----MLKLIDFGIAN----QMQPDTTSVVKDSQVGTVNYMPPE 226
Query: 163 VL----SRRE------YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAV 212
            +    S RE           +DVWS G  LY M  G  PF+           IS++ A+
Sbjct: 227 AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ------QIINQISKLHAI 280
Query: 213 -----QYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPW 252
                + + PD     +D +++L      +P +RI+I E+ +HP+
Sbjct: 281 IDPNHEIEFPDIP--EKDLQDVLKCCLKRDPKQRISIPELLAHPY 323

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 72/302 (23%), Positives = 119/302 (39%), Gaps = 52/302 (17%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAR---EIINHKQLRH 57
           +++Y+ +K IGSG  G+     +   +  VA+K + R  +   +  R   E++  K + H
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 82
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFE-RICNAGRFSEDEAR--YFFQQLISG---- 110
            NII    V      L    +     EL +  +C   +   D  R  Y   Q++ G    
Sbjct: 83  KNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHL 142
Query: 111 ---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRR 167
               I HRDLK  N ++       LKI DFG ++++         V T  Y APEV+   
Sbjct: 143 HSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSFMMTPEVVTRYYRAPEVILGM 200
Query: 168 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMA--------VQYKIPDY 219
            Y   + D+WS G  +  M+ G   F   +    + K I ++          +Q  +  Y
Sbjct: 201 GYKENV-DIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTY 259
Query: 220 VH----------------------------ISQDCRNLLSRIFVANPSRRITIKEIKSHP 251
           V                              +   R+LLS++ V + S+RI++ E   HP
Sbjct: 260 VENRPKYAGYSFEKLFPDVLFPADSEHNALKASQARDLLSKMLVIDASKRISVDEALQHP 319
Query: 252 WF 253
           + 
Sbjct: 320 YI 321

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 72/302 (23%), Positives = 119/302 (39%), Gaps = 52/302 (17%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVA---REIINHKQLRH 57
           +++Y+ +K IGSG  G+     +   +  VA+K + R  +   +     RE++  K + H
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 82
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFE-RICNAGRFSEDEAR--YFFQQLISG---- 110
            NII    V      L    +     EL +  +C   +   D  R  Y   Q++ G    
Sbjct: 83  KNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHL 142
Query: 111 ---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRR 167
               I HRDLK  N ++       LKI DFG ++++         V T  Y APEV+   
Sbjct: 143 HSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM 200
Query: 168 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMA--------VQYKIPDY 219
            Y   + D+WS G  +  M+ G   F   +    + K I ++          +Q  +  Y
Sbjct: 201 GYKENV-DIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQPTVRTY 259
Query: 220 VH----------------------------ISQDCRNLLSRIFVANPSRRITIKEIKSHP 251
           V                              +   R+LLS++ V + S+RI++ E   HP
Sbjct: 260 VENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHP 319
Query: 252 WF 253
           + 
Sbjct: 320 YI 321

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 74/305 (24%), Positives = 121/305 (39%), Gaps = 58/305 (19%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVA---REIINHKQLRH 57
           +++Y+ +K IGSG  G+     +   +  VA+K + R  +   +     RE++  K + H
Sbjct: 23  LKRYQNLKPIGSGAQGIVVAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNH 82
Query: 58  PNIIRFKEVVLTP-------THLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLI-- 108
            NII     V TP         + IVME         ++       E  +   +Q L+  
Sbjct: 83  KNIIGLLN-VFTPQKSLEEFQDVYIVMELMDAN--LSQVIQMELDHERMSYLLYQMLVGI 139
Query: 109 ----SGQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVL 164
               S  I HRDLK  N ++       LKI DFG ++++         V T  Y APEV+
Sbjct: 140 KHLHSAGIIHRDLKPSNIVVKSDAT--LKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 197
Query: 165 SRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMA--------VQYKI 216
               Y   + D+WS GV +  M+ G   F   +    + K I ++          +Q  +
Sbjct: 198 LGMGYKENV-DIWSVGVIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQPTV 256
Query: 217 PDYVH----------------------------ISQDCRNLLSRIFVANPSRRITIKEIK 248
             YV                              +   R+LLS++ V + S+RI++ E  
Sbjct: 257 RTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEAL 316
Query: 249 SHPWF 253
            HP+ 
Sbjct: 317 QHPYI 321

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 67/295 (22%), Positives = 126/295 (42%), Gaps = 51/295 (17%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK--IDAN-VAREIINHKQLRHP 58
           E+Y+ +  IGSG +G      +  T   VA+K + R  +  I A    RE+   K ++H 
Sbjct: 27  ERYQNLSPIGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 86
Query: 59  NIIRFKEVVLTPTHL-----AIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG--- 110
           N+I   +V      L       ++ +  G +L   I    + ++D  ++   Q++ G   
Sbjct: 87  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 145
Query: 111 ----QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST--VGTPAYIAPEVL 164
                I HRDLK  N  ++      LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 146 IHSADIIHRDLKPSNLAVNEDX--ELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 199
Query: 165 SRREYDGKLADVWSCGVTLYVMLVG--AYPFEDQ------------------------ED 198
               +  +  D+WS G  +  +L G   +P  D                         E 
Sbjct: 200 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 259
Query: 199 PKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 253
            +N+ ++++++  + +    ++  +    +LL ++ V +  +RIT  +  +H +F
Sbjct: 260 ARNYIQSLTQMPKMNFANV-FIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 313

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 64.7 bits (156), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 72/302 (23%), Positives = 119/302 (39%), Gaps = 52/302 (17%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVA---REIINHKQLRH 57
           +++Y+ +K IGSG  G+     +   +  VA+K + R  +   +     RE++  K + H
Sbjct: 24  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 83
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFE-RICNAGRFSEDEAR--YFFQQLISG---- 110
            NII    V      L    +     EL +  +C   +   D  R  Y   Q++ G    
Sbjct: 84  KNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHL 143
Query: 111 ---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRR 167
               I HRDLK  N ++       LKI DFG ++++         V T  Y APEV+   
Sbjct: 144 HSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM 201
Query: 168 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMA--------VQYKIPDY 219
            Y   + D+WS G  +  M+ G   F   +    + K I ++          +Q  +  Y
Sbjct: 202 GYKENV-DIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTY 260
Query: 220 VH----------------------------ISQDCRNLLSRIFVANPSRRITIKEIKSHP 251
           V                              +   R+LLS++ V + S+RI++ E   HP
Sbjct: 261 VENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHP 320
Query: 252 WF 253
           + 
Sbjct: 321 YI 322

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 66/295 (22%), Positives = 126/295 (42%), Gaps = 51/295 (17%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK--IDAN-VAREIINHKQLRHP 58
           E+Y+ +  +GSG +G      +  T   VA+K + R  +  I A    RE+   K ++H 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 59  NIIRFKEVVLTPTHL-----AIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG--- 110
           N+I   +V      L       ++ +  G +L   I    + ++D  ++   Q++ G   
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 140
Query: 111 ----QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST--VGTPAYIAPEVL 164
                I HRDLK  N  ++      LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 141 IHSADIIHRDLKPSNLAVNEDC--ELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 194
Query: 165 SRREYDGKLADVWSCGVTLYVMLVG--AYPFEDQ------------------------ED 198
               +  +  D+WS G  +  +L G   +P  D                         E 
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 254
Query: 199 PKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 253
            +N+ ++++++  + +    ++  +    +LL ++ V +  +RIT  +  +H +F
Sbjct: 255 ARNYIQSLAQMPKMNFANV-FIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 308

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 66/295 (22%), Positives = 126/295 (42%), Gaps = 51/295 (17%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK--IDAN-VAREIINHKQLRHP 58
           E+Y+ +  +GSG +G      +  T   VA+K + R  +  I A    RE+   K ++H 
Sbjct: 32  ERYQNLAPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 91
Query: 59  NIIRFKEVVLTPTHL-----AIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG--- 110
           N+I   +V      L       ++ +  G +L   I    + ++D  ++   Q++ G   
Sbjct: 92  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 150
Query: 111 ----QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST--VGTPAYIAPEVL 164
                I HRDLK  N  ++      LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 151 IHSADIIHRDLKPSNLAVNEDC--ELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 204
Query: 165 SRREYDGKLADVWSCGVTLYVMLVG--AYPFEDQ------------------------ED 198
               +  +  D+WS G  +  +L G   +P  D                         E 
Sbjct: 205 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 264
Query: 199 PKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 253
            +N+ ++++++  + +    ++  +    +LL ++ V +  +RIT  +  +H +F
Sbjct: 265 ARNYIQSLAQMPKMNFANV-FIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 318

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 72/302 (23%), Positives = 119/302 (39%), Gaps = 52/302 (17%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVA---REIINHKQLRH 57
           +++Y+ +K IGSG  G+     +   +  VA+K + R  +   +     RE++  K + H
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 82
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFE-RICNAGRFSEDEAR--YFFQQLISG---- 110
            NII    V      L    +     EL +  +C   +   D  R  Y   Q++ G    
Sbjct: 83  KNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHL 142
Query: 111 ---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRR 167
               I HRDLK  N ++       LKI DFG ++++         V T  Y APEV+   
Sbjct: 143 HSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM 200
Query: 168 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMA--------VQYKIPDY 219
            Y   + D+WS G  +  M+ G   F   +    + K I ++          +Q  +  Y
Sbjct: 201 GYKENV-DIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTY 259
Query: 220 VH----------------------------ISQDCRNLLSRIFVANPSRRITIKEIKSHP 251
           V                              +   R+LLS++ V + S+RI++ E   HP
Sbjct: 260 VENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHP 319
Query: 252 WF 253
           + 
Sbjct: 320 YI 321

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 66/295 (22%), Positives = 126/295 (42%), Gaps = 51/295 (17%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK--IDAN-VAREIINHKQLRHP 58
           E+Y+ +  +GSG +G      +  T   VA+K + R  +  I A    RE+   K ++H 
Sbjct: 24  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 83
Query: 59  NIIRFKEVVLTPTHL-----AIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG--- 110
           N+I   +V      L       ++ +  G +L   I    + ++D  ++   Q++ G   
Sbjct: 84  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 142
Query: 111 ----QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST--VGTPAYIAPEVL 164
                I HRDLK  N  ++      LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 143 IHSADIIHRDLKPSNLAVNEDS--ELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 196
Query: 165 SRREYDGKLADVWSCGVTLYVMLVG--AYPFEDQ------------------------ED 198
               +  +  D+WS G  +  +L G   +P  D                         E 
Sbjct: 197 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 256
Query: 199 PKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 253
            +N+ ++++++  + +    ++  +    +LL ++ V +  +RIT  +  +H +F
Sbjct: 257 ARNYIQSLTQMPKMNFANV-FIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 310

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 100/203 (49%), Gaps = 25/203 (12%)
Query: 7   MKDIGSGNFGVARLMR----NKNTKELVAMKYI--ERGHKIDANVAREIINHKQLRHPNI 60
           ++D+G G+FG   L R      NT E VA+K +  E G    A++ +EI   + L H NI
Sbjct: 26  IRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENI 85
Query: 61  IRFKEVVLTP--THLAIVMEYAAGGELFERIC-NAGRFSEDEARYFFQQLISG------- 110
           +++K +        + ++ME+   G L E +  N  + +  +   +  Q+  G       
Sbjct: 86  VKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSR 145
Query: 111 QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTV----GTPAY-IAPEVLS 165
           Q  HRDL   N L++     ++KI DFG +K+ +   +   TV     +P +  APE L 
Sbjct: 146 QYVHRDLAARNVLVESEH--QVKIGDFGLTKA-IETDKEXXTVKDDRDSPVFWYAPECLM 202
Query: 166 RREYDGKLADVWSCGVTLYVMLV 188
           + ++    +DVWS GVTL+ +L 
Sbjct: 203 QSKF-YIASDVWSFGVTLHELLT 224

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 66/295 (22%), Positives = 126/295 (42%), Gaps = 51/295 (17%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK--IDAN-VAREIINHKQLRHP 58
           E+Y+ +  +GSG +G      +  T   VA+K + R  +  I A    RE+   K ++H 
Sbjct: 28  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 87
Query: 59  NIIRFKEVVLTPTHL-----AIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG--- 110
           N+I   +V      L       ++ +  G +L   I    + ++D  ++   Q++ G   
Sbjct: 88  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 146
Query: 111 ----QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST--VGTPAYIAPEVL 164
                I HRDLK  N  ++      LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 147 IHSADIIHRDLKPSNLAVNEDS--ELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 200
Query: 165 SRREYDGKLADVWSCGVTLYVMLVG--AYPFEDQ------------------------ED 198
               +  +  D+WS G  +  +L G   +P  D                         E 
Sbjct: 201 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 260
Query: 199 PKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 253
            +N+ ++++++  + +    ++  +    +LL ++ V +  +RIT  +  +H +F
Sbjct: 261 ARNYIQSLTQMPKMNFANV-FIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 314

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 66/295 (22%), Positives = 126/295 (42%), Gaps = 51/295 (17%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK--IDAN-VAREIINHKQLRHP 58
           E+Y+ +  +GSG +G      +  T   VA+K + R  +  I A    RE+   K ++H 
Sbjct: 41  ERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 100
Query: 59  NIIRFKEVVLTPTHL-----AIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG--- 110
           N+I   +V      L       ++ +  G +L   I    + ++D  ++   Q++ G   
Sbjct: 101 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 159
Query: 111 ----QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST--VGTPAYIAPEVL 164
                I HRDLK  N  ++      LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 160 IHSADIIHRDLKPSNLAVNEDC--ELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 213
Query: 165 SRREYDGKLADVWSCGVTLYVMLVG--AYPFEDQ------------------------ED 198
               +  +  D+WS G  +  +L G   +P  D                         E 
Sbjct: 214 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 273
Query: 199 PKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 253
            +N+ ++++++  + +    ++  +    +LL ++ V +  +RIT  +  +H +F
Sbjct: 274 ARNYIQSLAQMPKMNFANV-FIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 327

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 66/295 (22%), Positives = 126/295 (42%), Gaps = 51/295 (17%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK--IDAN-VAREIINHKQLRHP 58
           E+Y+ +  +GSG +G      +  T   VA+K + R  +  I A    RE+   K ++H 
Sbjct: 42  ERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 101
Query: 59  NIIRFKEVVLTPTHL-----AIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG--- 110
           N+I   +V      L       ++ +  G +L   I    + ++D  ++   Q++ G   
Sbjct: 102 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 160
Query: 111 ----QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST--VGTPAYIAPEVL 164
                I HRDLK  N  ++      LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 161 IHSADIIHRDLKPSNLAVNEDC--ELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 214
Query: 165 SRREYDGKLADVWSCGVTLYVMLVG--AYPFEDQ------------------------ED 198
               +  +  D+WS G  +  +L G   +P  D                         E 
Sbjct: 215 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 274
Query: 199 PKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 253
            +N+ ++++++  + +    ++  +    +LL ++ V +  +RIT  +  +H +F
Sbjct: 275 ARNYIQSLAQMPKMNFANV-FIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 328

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 102/221 (46%), Gaps = 31/221 (14%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYI--ERGHKIDANV-AREIINHKQLRH 57
            E+ E+ + IG G FG     R       VA++ I  ER ++       RE++ ++Q RH
Sbjct: 32  FEQLEIGELIGKGRFGQVYHGRWHGE---VAIRLIDIERDNEDQLKAFKREVMAYRQTRH 88
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAG-RFSEDEARYFFQQLISGQ----- 111
            N++ F    ++P HLAI+     G  L+  + +A      ++ R   Q+++ G      
Sbjct: 89  ENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHA 148
Query: 112 --ICHRDLKLENTLLDGSPAPRLKICDFG-YSKSSLLHS-----RPKSTVGTPAYIAPEV 163
             I H+DLK +N   D     ++ I DFG +S S +L +     + +   G   ++APE+
Sbjct: 149 KGILHKDLKSKNVFYDNG---KVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEI 205
Query: 164 LSRREYD--------GKLADVWSCGVTLYVMLVGAYPFEDQ 196
           + +   D         K +DV++ G   Y +    +PF+ Q
Sbjct: 206 IRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQ 246

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 64.3 bits (155), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 64/293 (21%), Positives = 123/293 (41%), Gaps = 47/293 (16%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK--IDAN-VAREIINHKQLRHP 58
           E+Y+ +  +GSG +G      +  T   VA+K + R  +  I A    RE+   K ++H 
Sbjct: 42  ERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 101
Query: 59  NIIRFKEVVLTPTHL-----AIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG--- 110
           N+I   +V      L       ++ +  G +L   I    + ++D  ++   Q++ G   
Sbjct: 102 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 160
Query: 111 ----QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSR 166
                I HRDLK  N  ++      LKI DFG ++ +         V T  Y APE++  
Sbjct: 161 IHSADIIHRDLKPSNLAVNEDC--ELKILDFGLARHT--DDEMXGXVATRWYRAPEIMLN 216
Query: 167 REYDGKLADVWSCGVTLYVMLVG--AYPFEDQ------------------------EDPK 200
             +  +  D+WS G  +  +L G   +P  D                         E  +
Sbjct: 217 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESAR 276
Query: 201 NFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 253
           N+ ++++++  + +    ++  +    +LL ++ V +  +RIT  +  +H +F
Sbjct: 277 NYIQSLAQMPKMNFANV-FIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 328

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 64.3 bits (155), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 66/295 (22%), Positives = 126/295 (42%), Gaps = 51/295 (17%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK--IDAN-VAREIINHKQLRHP 58
           E+Y+ +  +GSG +G      +  T   VA+K + R  +  I A    RE+   K ++H 
Sbjct: 18  ERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 77
Query: 59  NIIRFKEVVLTPTHL-----AIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG--- 110
           N+I   +V      L       ++ +  G +L   I    + ++D  ++   Q++ G   
Sbjct: 78  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 136
Query: 111 ----QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST--VGTPAYIAPEVL 164
                I HRDLK  N  ++      LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 137 IHSADIIHRDLKPSNLAVNEDC--ELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 190
Query: 165 SRREYDGKLADVWSCGVTLYVMLVG--AYPFEDQ------------------------ED 198
               +  +  D+WS G  +  +L G   +P  D                         E 
Sbjct: 191 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 250
Query: 199 PKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 253
            +N+ ++++++  + +    ++  +    +LL ++ V +  +RIT  +  +H +F
Sbjct: 251 ARNYIQSLAQMPKMNFA-NVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 304

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 64.3 bits (155), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 100/203 (49%), Gaps = 25/203 (12%)
Query: 7   MKDIGSGNFGVARLMR----NKNTKELVAMKYI--ERGHKIDANVAREIINHKQLRHPNI 60
           ++D+G G+FG   L R      NT E VA+K +  E G    A++ +EI   + L H NI
Sbjct: 14  IRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENI 73
Query: 61  IRFKEVVLTP--THLAIVMEYAAGGELFERIC-NAGRFSEDEARYFFQQLISG------- 110
           +++K +        + ++ME+   G L E +  N  + +  +   +  Q+  G       
Sbjct: 74  VKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSR 133
Query: 111 QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTV----GTPAY-IAPEVLS 165
           Q  HRDL   N L++     ++KI DFG +K+ +   +   TV     +P +  APE L 
Sbjct: 134 QYVHRDLAARNVLVESEH--QVKIGDFGLTKA-IETDKEXXTVKDDRDSPVFWYAPECLM 190
Query: 166 RREYDGKLADVWSCGVTLYVMLV 188
           + ++    +DVWS GVTL+ +L 
Sbjct: 191 QSKF-YIASDVWSFGVTLHELLT 212

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 64.3 bits (155), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 72/302 (23%), Positives = 119/302 (39%), Gaps = 52/302 (17%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVA---REIINHKQLRH 57
           +++Y+ +K IGSG  G+     +   +  VA+K + R  +   +     RE++  K + H
Sbjct: 25  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 84
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFE-RICNAGRFSEDEAR--YFFQQLISG---- 110
            NII    V      L    +     EL +  +C   +   D  R  Y   Q++ G    
Sbjct: 85  KNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHL 144
Query: 111 ---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRR 167
               I HRDLK  N ++       LKI DFG ++++         V T  Y APEV+   
Sbjct: 145 HSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSFMMVPFVVTRYYRAPEVILGM 202
Query: 168 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMA--------VQYKIPDY 219
            Y   + D+WS G  +  M+ G   F   +    + K I ++          +Q  +  Y
Sbjct: 203 GYKENV-DIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTY 261
Query: 220 VH----------------------------ISQDCRNLLSRIFVANPSRRITIKEIKSHP 251
           V                              +   R+LLS++ V + S+RI++ E   HP
Sbjct: 262 VENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHP 321
Query: 252 WF 253
           + 
Sbjct: 322 YI 323

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 64.3 bits (155), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 74/305 (24%), Positives = 121/305 (39%), Gaps = 58/305 (19%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVA---REIINHKQLRH 57
           +++Y+ +K IGSG  G+     +   +  VA+K + R  +   +     RE++  K + H
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNH 82
Query: 58  PNIIRFKEVVLTP-------THLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLI-- 108
            NII     V TP         + IVME         ++       E  +   +Q L+  
Sbjct: 83  KNIIGLLN-VFTPQKSLEEFQDVYIVMELMDAN--LSQVIQMELDHERMSYLLYQMLVGI 139
Query: 109 ----SGQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVL 164
               S  I HRDLK  N ++       LKI DFG ++++         V T  Y APEV+
Sbjct: 140 KHLHSAGIIHRDLKPSNIVVKSDAT--LKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 197
Query: 165 SRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMA--------VQYKI 216
               Y   + D+WS GV +  M+ G   F   +    + K I ++          +Q  +
Sbjct: 198 LGMGYKENV-DIWSVGVIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQPTV 256
Query: 217 PDYVH----------------------------ISQDCRNLLSRIFVANPSRRITIKEIK 248
             YV                              +   R+LLS++ V + S+RI++ E  
Sbjct: 257 RTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEAL 316
Query: 249 SHPWF 253
            HP+ 
Sbjct: 317 QHPYI 321

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 64.3 bits (155), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 63/225 (28%), Positives = 105/225 (46%), Gaps = 30/225 (13%)
Query: 5   ELMKDIGSGNFGVARLMR----NKNTKELVAMKYIERGHKIDANV---AREIINHKQLRH 57
           + ++ +G GNFG   + R      NT E+VA+K ++  H  + ++    REI   K L+H
Sbjct: 14  KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ--HSTEEHLRDFEREIEILKSLQH 71
Query: 58  PNIIRFKEVVLTPT--HLAIVMEYAAGGELFERIC-NAGRFSEDEARYFFQQLISG---- 110
            NI+++K V  +    +L ++MEY   G L + +  +  R    +   +  Q+  G    
Sbjct: 72  DNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL 131
Query: 111 ---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPA-----YIAPE 162
              +  HR+L   N L++     R+KI DFG +K  L   +    V  P      + APE
Sbjct: 132 GTKRYIHRNLATRNILVENE--NRVKIGDFGLTK-VLPQDKEYYKVKEPGESPIFWYAPE 188
Query: 163 VLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTIS 207
            L+  ++    +DVWS GV LY +    Y  + +  P  F + I 
Sbjct: 189 SLTESKF-SVASDVWSFGVVLYELF--TYIEKSKSPPAEFMRMIG 230

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 64.3 bits (155), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 73/293 (24%), Positives = 120/293 (40%), Gaps = 45/293 (15%)
Query: 3   KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIE--RGHKIDANVAREIINHKQLRHPNI 60
           +Y  +  IG G +G+     +   K  VA+K I             REI    + RH NI
Sbjct: 24  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI 83
Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFE----RICNAGRFSEDEARYFFQQLISG------ 110
           I   +++  PT +  + +     +L E    ++      S D   YF  Q++ G      
Sbjct: 84  IGINDIIRAPT-IEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS 142
Query: 111 -QICHRDLKLENTLLDGSPAPRLKICDFGYSK-SSLLHSRP---KSTVGTPAYIAPEVLS 165
             + HRDLK  N LL+ +    LKICDFG ++ +   H         V T  Y APE++ 
Sbjct: 143 ANVLHRDLKPSNLLLNTTXD--LKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 200
Query: 166 RREYDGKLADVWSCGVTLYVML------------------VGAYPFEDQEDPKNFRKTIS 207
             +   K  D+WS G  L  ML                  +G      QED        +
Sbjct: 201 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNXIINLKA 260
Query: 208 R--IMAVQY--KIP---DYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 253
           R  ++++ +  K+P    + +      +LL ++   NP +RI +++  +HP+ 
Sbjct: 261 RNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 313

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 64.3 bits (155), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 66/295 (22%), Positives = 126/295 (42%), Gaps = 51/295 (17%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK--IDAN-VAREIINHKQLRHP 58
           E+Y+ +  +GSG +G      +  T   VA+K + R  +  I A    RE+   K ++H 
Sbjct: 28  ERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 87
Query: 59  NIIRFKEVVLTPTHL-----AIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG--- 110
           N+I   +V      L       ++ +  G +L   I    + ++D  ++   Q++ G   
Sbjct: 88  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 146
Query: 111 ----QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST--VGTPAYIAPEVL 164
                I HRDLK  N  ++      LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 147 IHSADIIHRDLKPSNLAVNEDC--ELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 200
Query: 165 SRREYDGKLADVWSCGVTLYVMLVG--AYPFEDQ------------------------ED 198
               +  +  D+WS G  +  +L G   +P  D                         E 
Sbjct: 201 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 260
Query: 199 PKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 253
            +N+ ++++++  + +    ++  +    +LL ++ V +  +RIT  +  +H +F
Sbjct: 261 ARNYIQSLAQMPKMNFANV-FIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 314

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 64.3 bits (155), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 73/293 (24%), Positives = 120/293 (40%), Gaps = 45/293 (15%)
Query: 3   KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIE--RGHKIDANVAREIINHKQLRHPNI 60
           +Y  +  IG G +G+     +   K  VA+K I             REI    + RH NI
Sbjct: 28  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYXQRTLREIKILLRFRHENI 87
Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFE----RICNAGRFSEDEARYFFQQLISG------ 110
           I   +++  PT +  + +     +L E    ++      S D   YF  Q++ G      
Sbjct: 88  IGINDIIRAPT-IEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS 146
Query: 111 -QICHRDLKLENTLLDGSPAPRLKICDFGYSK-SSLLHSRP---KSTVGTPAYIAPEVLS 165
             + HRDLK  N LL+ +    LKICDFG ++ +   H         V T  Y APE++ 
Sbjct: 147 ANVLHRDLKPSNLLLNTTXD--LKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 204
Query: 166 RREYDGKLADVWSCGVTLYVML------------------VGAYPFEDQEDPKNFRKTIS 207
             +   K  D+WS G  L  ML                  +G      QED        +
Sbjct: 205 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 264
Query: 208 R--IMAVQY--KIP---DYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 253
           R  ++++ +  K+P    + +      +LL ++   NP +RI +++  +HP+ 
Sbjct: 265 RNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 317

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 64.3 bits (155), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 66/295 (22%), Positives = 126/295 (42%), Gaps = 51/295 (17%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK--IDAN-VAREIINHKQLRHP 58
           E+Y+ +  +GSG +G      +  T   VA+K + R  +  I A    RE+   K ++H 
Sbjct: 33  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 92
Query: 59  NIIRFKEVVLTPTHL-----AIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG--- 110
           N+I   +V      L       ++ +  G +L   I    + ++D  ++   Q++ G   
Sbjct: 93  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 151
Query: 111 ----QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST--VGTPAYIAPEVL 164
                I HRDLK  N  ++      LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 152 IHSADIIHRDLKPSNLAVNEDX--ELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 205
Query: 165 SRREYDGKLADVWSCGVTLYVMLVG--AYPFEDQ------------------------ED 198
               +  +  D+WS G  +  +L G   +P  D                         E 
Sbjct: 206 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 265
Query: 199 PKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 253
            +N+ ++++++  + +    ++  +    +LL ++ V +  +RIT  +  +H +F
Sbjct: 266 ARNYIQSLTQMPKMNFANV-FIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 319

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 66/295 (22%), Positives = 126/295 (42%), Gaps = 51/295 (17%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK--IDAN-VAREIINHKQLRHP 58
           E+Y+ +  +GSG +G      +  T   VA+K + R  +  I A    RE+   K ++H 
Sbjct: 27  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 86
Query: 59  NIIRFKEVVLTPTHL-----AIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG--- 110
           N+I   +V      L       ++ +  G +L   I    + ++D  ++   Q++ G   
Sbjct: 87  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 145
Query: 111 ----QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST--VGTPAYIAPEVL 164
                I HRDLK  N  ++      LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 146 IHSADIIHRDLKPSNLAVNEDX--ELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 199
Query: 165 SRREYDGKLADVWSCGVTLYVMLVG--AYPFEDQ------------------------ED 198
               +  +  D+WS G  +  +L G   +P  D                         E 
Sbjct: 200 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 259
Query: 199 PKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 253
            +N+ ++++++  + +    ++  +    +LL ++ V +  +RIT  +  +H +F
Sbjct: 260 ARNYIQSLTQMPKMNFANV-FIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 313

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 66/295 (22%), Positives = 126/295 (42%), Gaps = 51/295 (17%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK--IDAN-VAREIINHKQLRHP 58
           E+Y+ +  +GSG +G      +  T   VA+K + R  +  I A    RE+   K ++H 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 59  NIIRFKEVVLTPTHL-----AIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG--- 110
           N+I   +V      L       ++ +  G +L   I  + + ++D  ++   Q++ G   
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKSQKLTDDHVQFLIYQILRGLKY 140
Query: 111 ----QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST--VGTPAYIAPEVL 164
                I HRDLK  N  ++      LKI DFG  +    H+  + T  V T  Y APE++
Sbjct: 141 IHSADIIHRDLKPSNLAVNEDS--ELKILDFGLCR----HTDDEMTGYVATRWYRAPEIM 194
Query: 165 SRREYDGKLADVWSCGVTLYVMLVG--AYPFEDQ------------------------ED 198
               +  +  D+WS G  +  +L G   +P  D                         E 
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 254
Query: 199 PKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 253
            +N+ ++++++  + +    ++  +    +LL ++ V +  +RIT  +  +H +F
Sbjct: 255 ARNYIQSLTQMPKMNFANV-FIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 308

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 64/293 (21%), Positives = 123/293 (41%), Gaps = 47/293 (16%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK--IDAN-VAREIINHKQLRHP 58
           E+Y+ +  +GSG +G      +  T   VA+K + R  +  I A    RE+   K ++H 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 59  NIIRFKEVVLTPTHL-----AIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG--- 110
           N+I   +V      L       ++ +  G +L   I    + ++D  ++   Q++ G   
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 140
Query: 111 ----QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSR 166
                I HRDLK  N  ++      LKI DFG ++ +         V T  Y APE++  
Sbjct: 141 IHSADIIHRDLKPSNLAVNEDC--ELKILDFGLARHT--DDEMAGFVATRWYRAPEIMLN 196
Query: 167 REYDGKLADVWSCGVTLYVMLVG--AYPFEDQ------------------------EDPK 200
             +  +  D+WS G  +  +L G   +P  D                         E  +
Sbjct: 197 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESAR 256
Query: 201 NFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 253
           N+ ++++++  + +    ++  +    +LL ++ V +  +RIT  +  +H +F
Sbjct: 257 NYIQSLTQMPKMNFANV-FIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 308

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 77/306 (25%), Positives = 133/306 (43%), Gaps = 63/306 (20%)
Query: 10  IGSGNFGVARLMRNKNTKELVAMKYIERGHK--IDANVA-REIINHKQLRHPNIIRFKEV 66
           +GSG +G      +K + E VA+K + R  +  I A  A RE++  K ++H N+I   +V
Sbjct: 32  VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDV 91
Query: 67  VLTPTHL------AIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-------QIC 113
               + L       +VM +       ++I    +FSE++ +Y   Q++ G        + 
Sbjct: 92  FTPASSLRNFYDFYLVMPFMQTD--LQKIMGL-KFSEEKIQYLVYQMLKGLKYIHSAGVV 148
Query: 114 HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST--VGTPAYIAPEVLSRREYDG 171
           HRDLK  N  ++      LKI DFG ++    H+  + T  V T  Y APEV+    +  
Sbjct: 149 HRDLKPGNLAVNEDC--ELKILDFGLAR----HADAEMTGYVVTRWYRAPEVILSWMHYN 202
Query: 172 KLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAV------------------- 212
           +  D+WS G  +  ML G   F+     K++   +++I+ V                   
Sbjct: 203 QTVDIWSVGCIMAEMLTGKTLFKG----KDYLDQLTQILKVTGVPGTEFVQKLNDKAAKS 258
Query: 213 ------QYKIPDYVHI----SQDCRNLLSRIFVANPSRRITIKEIKSHPWF--LKNLPRE 260
                 Q    D+  +    S    +LL ++   +  +R+T  +  +HP+F   ++ P E
Sbjct: 259 YIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRD-PEE 317
Query: 261 LTETAQ 266
            TE  Q
Sbjct: 318 ETEAQQ 323

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 64/293 (21%), Positives = 123/293 (41%), Gaps = 47/293 (16%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK--IDAN-VAREIINHKQLRHP 58
           E+Y+ +  +GSG +G      +  T   VA+K + R  +  I A    RE+   K ++H 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 59  NIIRFKEVVLTPTHL-----AIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG--- 110
           N+I   +V      L       ++ +  G +L   I    + ++D  ++   Q++ G   
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 140
Query: 111 ----QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSR 166
                I HRDLK  N  ++      LKI DFG ++ +         V T  Y APE++  
Sbjct: 141 IHSADIIHRDLKPSNLAVNEDC--ELKILDFGLARHT--DDEMAGFVATRWYRAPEIMLN 196
Query: 167 REYDGKLADVWSCGVTLYVMLVG--AYPFEDQ------------------------EDPK 200
             +  +  D+WS G  +  +L G   +P  D                         E  +
Sbjct: 197 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESAR 256
Query: 201 NFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 253
           N+ ++++++  + +    ++  +    +LL ++ V +  +RIT  +  +H +F
Sbjct: 257 NYIQSLAQMPKMNFANV-FIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 308

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 61/196 (31%), Positives = 90/196 (45%), Gaps = 22/196 (11%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNI 60
           M++ +L++ IG G FG   L   +  K  VA+K I+      A +A   +   QLRH N+
Sbjct: 11  MKELKLLQTIGKGEFGDVMLGDYRGNK--VAVKCIKNDATAQAFLAEASV-MTQLRHSNL 67
Query: 61  IRFKEVVL-TPTHLAIVMEYAAGGELFERICNAGR----------FSEDEARYFFQQLIS 109
           ++   V++     L IV EY A G L + + + GR          FS D      + L  
Sbjct: 68  VQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEA-MEYLEG 126
Query: 110 GQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPA-YIAPEVLSRRE 168
               HRDL   N L+  S     K+ DFG +K +   S  + T   P  + APE L    
Sbjct: 127 NNFVHRDLAARNVLV--SEDNVAKVSDFGLTKEA---SSTQDTGKLPVKWTAPEALREAA 181
Query: 169 YDGKLADVWSCGVTLY 184
           +  K +DVWS G+ L+
Sbjct: 182 FSTK-SDVWSFGILLW 196

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 66/295 (22%), Positives = 126/295 (42%), Gaps = 51/295 (17%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK--IDAN-VAREIINHKQLRHP 58
           E+Y+ +  +GSG +G      +  T   VA+K + R  +  I A    RE+   K ++H 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 59  NIIRFKEVVLTPTHL-----AIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG--- 110
           N+I   +V      L       ++ +  G +L   I    + ++D  ++   Q++ G   
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKXQKLTDDHVQFLIYQILRGLKY 140
Query: 111 ----QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST--VGTPAYIAPEVL 164
                I HRDLK  N  ++      LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 141 IHSADIIHRDLKPSNLAVNEDX--ELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 194
Query: 165 SRREYDGKLADVWSCGVTLYVMLVG--AYPFEDQ------------------------ED 198
               +  +  D+WS G  +  +L G   +P  D                         E 
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 254
Query: 199 PKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 253
            +N+ ++++++  + +    ++  +    +LL ++ V +  +RIT  +  +H +F
Sbjct: 255 ARNYIQSLTQMPKMNFANV-FIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 308

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 92/207 (44%), Gaps = 29/207 (14%)
Query: 6   LMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKE 65
            +K++G+G FGV +  + +   + VA+K I+ G   +     E      L H  +++   
Sbjct: 8   FLKELGTGQFGVVKYGKWRGQYD-VAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYG 66
Query: 66  VVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLI--------------SGQ 111
           V      + I+ EY A G      C      E   R+  QQL+              S Q
Sbjct: 67  VCTKQRPIFIITEYMANG------CLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ 120
Query: 112 ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPA---YIAPEVLSRRE 168
             HRDL   N L++      +K+ DFG S+  +L     S+VG+     +  PEVL   +
Sbjct: 121 FLHRDLAARNCLVNDQGV--VKVSDFGLSR-YVLDDEYTSSVGSKFPVRWSPPEVLMYSK 177
Query: 169 YDGKLADVWSCGVTLY-VMLVGAYPFE 194
           +  K +D+W+ GV ++ +  +G  P+E
Sbjct: 178 FSSK-SDIWAFGVLMWEIYSLGKMPYE 203

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 67/295 (22%), Positives = 126/295 (42%), Gaps = 51/295 (17%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK--IDAN-VAREIINHKQLRHP 58
           E+Y+ +  +GSG +G      +  T   VA+K + R  +  I A    RE+   K ++H 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 59  NIIRFKEVVLTPTHL-----AIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG--- 110
           N+I   +V      L       ++ +  G +L   I    + ++D  ++   Q++ G   
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 140
Query: 111 ----QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST--VGTPAYIAPEVL 164
                I HRDLK  N  L  +    LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 141 IHSADIIHRDLKPSN--LAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 194
Query: 165 SRREYDGKLADVWSCGVTLYVMLVG--AYPFEDQ------------------------ED 198
               +  +  D+WS G  +  +L G   +P  D                         E 
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 254
Query: 199 PKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 253
            +N+ ++++++  + +    ++  +    +LL ++ V +  +RIT  +  +H +F
Sbjct: 255 ARNYIQSLTQMPKMNFANV-FIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 308

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 73/293 (24%), Positives = 121/293 (41%), Gaps = 45/293 (15%)
Query: 3   KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIE--RGHKIDANVAREIINHKQLRHPNI 60
           +Y  +  IG G +G+     +   K  VA+K I             REI    + RH NI
Sbjct: 22  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI 81
Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFE----RICNAGRFSEDEARYFFQQLISG------ 110
           I   +++  PT +  + +     +L E    ++      S D   YF  Q++ G      
Sbjct: 82  IGINDIIRAPT-IEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS 140
Query: 111 -QICHRDLKLENTLLDGSPAPRLKICDFGYSK-SSLLHSRP---KSTVGTPAYIAPEVLS 165
             + HRDLK  N LL+ +    LKICDFG ++ +   H         V T  Y APE++ 
Sbjct: 141 ANVLHRDLKPSNLLLNTTCD--LKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 198
Query: 166 RREYDGKLADVWSCGVTLYVML------------------VGAYPFEDQEDPKNFRKTIS 207
             +   K  D+WS G  L  ML                  +G     +QED        +
Sbjct: 199 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPEQEDLNCIINLKA 258
Query: 208 R--IMAVQY--KIP---DYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 253
           R  ++++ +  K+P    + +      +LL ++   NP +RI +++  +HP+ 
Sbjct: 259 RNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 311

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 92/207 (44%), Gaps = 29/207 (14%)
Query: 6   LMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKE 65
            +K++G+G FGV +  + +   + VA+K I+ G   +     E      L H  +++   
Sbjct: 12  FLKELGTGQFGVVKYGKWRGQYD-VAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYG 70
Query: 66  VVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLI--------------SGQ 111
           V      + I+ EY A G      C      E   R+  QQL+              S Q
Sbjct: 71  VCTKQRPIFIITEYMANG------CLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ 124
Query: 112 ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPA---YIAPEVLSRRE 168
             HRDL   N L++      +K+ DFG S+  +L     S+VG+     +  PEVL   +
Sbjct: 125 FLHRDLAARNCLVNDQGV--VKVSDFGLSR-YVLDDEYTSSVGSKFPVRWSPPEVLMYSK 181
Query: 169 YDGKLADVWSCGVTLY-VMLVGAYPFE 194
           +  K +D+W+ GV ++ +  +G  P+E
Sbjct: 182 FSSK-SDIWAFGVLMWEIYSLGKMPYE 207

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 64/293 (21%), Positives = 123/293 (41%), Gaps = 47/293 (16%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK--IDAN-VAREIINHKQLRHP 58
           E+Y+ +  +GSG +G      +  T   VA+K + R  +  I A    RE+   K ++H 
Sbjct: 18  ERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 77
Query: 59  NIIRFKEVVLTPTHL-----AIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG--- 110
           N+I   +V      L       ++ +  G +L   I    + ++D  ++   Q++ G   
Sbjct: 78  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 136
Query: 111 ----QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSR 166
                I HRDLK  N  ++      LKI DFG ++ +         V T  Y APE++  
Sbjct: 137 IHSADIIHRDLKPSNLAVNEDC--ELKILDFGLARHT--DDEMAGFVATRWYRAPEIMLN 192
Query: 167 REYDGKLADVWSCGVTLYVMLVG--AYPFEDQ------------------------EDPK 200
             +  +  D+WS G  +  +L G   +P  D                         E  +
Sbjct: 193 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESAR 252
Query: 201 NFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 253
           N+ ++++++  + +    ++  +    +LL ++ V +  +RIT  +  +H +F
Sbjct: 253 NYIQSLAQMPKMNFA-NVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 304

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 92/207 (44%), Gaps = 29/207 (14%)
Query: 6   LMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKE 65
            +K++G+G FGV +  + +   + VA+K I+ G   +     E      L H  +++   
Sbjct: 28  FLKELGTGQFGVVKYGKWRGQYD-VAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYG 86
Query: 66  VVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLI--------------SGQ 111
           V      + I+ EY A G      C      E   R+  QQL+              S Q
Sbjct: 87  VCTKQRPIFIITEYMANG------CLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ 140
Query: 112 ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTP---AYIAPEVLSRRE 168
             HRDL   N L++      +K+ DFG S+  +L     S+VG+     +  PEVL   +
Sbjct: 141 FLHRDLAARNCLVNDQGV--VKVSDFGLSR-YVLDDEETSSVGSKFPVRWSPPEVLMYSK 197
Query: 169 YDGKLADVWSCGVTLY-VMLVGAYPFE 194
           +  K +D+W+ GV ++ +  +G  P+E
Sbjct: 198 FSSK-SDIWAFGVLMWEIYSLGKMPYE 223

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 66/295 (22%), Positives = 126/295 (42%), Gaps = 51/295 (17%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK--IDAN-VAREIINHKQLRHP 58
           E+Y+ +  +GSG +G      +  T   VA+K + R  +  I A    RE+   K ++H 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 59  NIIRFKEVVLTPTHL-----AIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG--- 110
           N+I   +V      L       ++ +  G +L   I    + ++D  ++   Q++ G   
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 140
Query: 111 ----QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST--VGTPAYIAPEVL 164
                I HRDLK  N  ++      LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 141 IHSADIIHRDLKPSNLAVNEDC--ELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 194
Query: 165 SRREYDGKLADVWSCGVTLYVMLVG--AYPFEDQ------------------------ED 198
               +  +  D+WS G  +  +L G   +P  D                         E 
Sbjct: 195 LNAMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 254
Query: 199 PKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 253
            +N+ ++++++  + +    ++  +    +LL ++ V +  +RIT  +  +H +F
Sbjct: 255 ARNYIQSLTQMPKMNFANV-FIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 308

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 66/295 (22%), Positives = 126/295 (42%), Gaps = 51/295 (17%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK--IDAN-VAREIINHKQLRHP 58
           E+Y+ +  +GSG +G      +  T   VA+K + R  +  I A    RE+   K ++H 
Sbjct: 29  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 88
Query: 59  NIIRFKEVVLTPTHL-----AIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG--- 110
           N+I   +V      L       ++ +  G +L   I    + ++D  ++   Q++ G   
Sbjct: 89  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 147
Query: 111 ----QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST--VGTPAYIAPEVL 164
                I HRDLK  N  ++      LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 148 IHSADIIHRDLKPSNLAVNEDC--ELKILDFGLAR----HTADEMTGYVATRWYRAPEIM 201
Query: 165 SRREYDGKLADVWSCGVTLYVMLVG--AYPFEDQ------------------------ED 198
               +  +  D+WS G  +  +L G   +P  D                         E 
Sbjct: 202 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 261
Query: 199 PKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 253
            +N+ ++++++  + +    ++  +    +LL ++ V +  +RIT  +  +H +F
Sbjct: 262 ARNYIQSLTQMPKMNFA-NVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 315

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 66/295 (22%), Positives = 126/295 (42%), Gaps = 51/295 (17%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK--IDAN-VAREIINHKQLRHP 58
           E+Y+ +  +GSG +G      +  T   VA+K + R  +  I A    RE+   K ++H 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 59  NIIRFKEVVLTPTHL-----AIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG--- 110
           N+I   +V      L       ++ +  G +L   I    + ++D  ++   Q++ G   
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 140
Query: 111 ----QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST--VGTPAYIAPEVL 164
                I HRDLK  N  ++      LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 141 IHSADIIHRDLKPSNLAVNEDC--ELKILDFGLAR----HTDDEMTGXVATRWYRAPEIM 194
Query: 165 SRREYDGKLADVWSCGVTLYVMLVG--AYPFEDQ------------------------ED 198
               +  +  D+WS G  +  +L G   +P  D                         E 
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 254
Query: 199 PKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 253
            +N+ ++++++  + +    ++  +    +LL ++ V +  +RIT  +  +H +F
Sbjct: 255 ARNYIQSLTQMPKMNFANV-FIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 308

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 66/295 (22%), Positives = 126/295 (42%), Gaps = 51/295 (17%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK--IDAN-VAREIINHKQLRHP 58
           E+Y+ +  +GSG +G      +  T   VA+K + R  +  I A    RE+   K ++H 
Sbjct: 29  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 88
Query: 59  NIIRFKEVVLTPTHL-----AIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG--- 110
           N+I   +V      L       ++ +  G +L   I    + ++D  ++   Q++ G   
Sbjct: 89  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 147
Query: 111 ----QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST--VGTPAYIAPEVL 164
                I HRDLK  N  ++      LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 148 IHSADIIHRDLKPSNLAVNEDC--ELKILDFGLAR----HTADEMTGYVATRWYRAPEIM 201
Query: 165 SRREYDGKLADVWSCGVTLYVMLVG--AYPFEDQ------------------------ED 198
               +  +  D+WS G  +  +L G   +P  D                         E 
Sbjct: 202 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 261
Query: 199 PKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 253
            +N+ ++++++  + +    ++  +    +LL ++ V +  +RIT  +  +H +F
Sbjct: 262 ARNYIQSLTQMPKMNFA-NVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 315

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 67/295 (22%), Positives = 126/295 (42%), Gaps = 51/295 (17%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK--IDAN-VAREIINHKQLRHP 58
           E+Y+ +  +GSG +G      +  T   VA+K + R  +  I A    RE+   K ++H 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 59  NIIRFKEVVLTPTHL-----AIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG--- 110
           N+I   +V      L       ++ +  G +L   I    + ++D  ++   Q++ G   
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 140
Query: 111 ----QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST--VGTPAYIAPEVL 164
                I HRDLK  N  L  +    LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 141 IHSADIIHRDLKPSN--LAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 194
Query: 165 SRREYDGKLADVWSCGVTLYVMLVG--AYPFEDQ------------------------ED 198
               +  +  D+WS G  +  +L G   +P  D                         E 
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 254
Query: 199 PKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 253
            +N+ ++++++  + +    ++  +    +LL ++ V +  +RIT  +  +H +F
Sbjct: 255 ARNYIQSLTQMPKMNFANV-FIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 308

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 66/295 (22%), Positives = 126/295 (42%), Gaps = 51/295 (17%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK--IDAN-VAREIINHKQLRHP 58
           E+Y+ +  +GSG +G      +  T   VA+K + R  +  I A    RE+   K ++H 
Sbjct: 24  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 83
Query: 59  NIIRFKEVVLTPTHL-----AIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG--- 110
           N+I   +V      L       ++ +  G +L   I    + ++D  ++   Q++ G   
Sbjct: 84  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 142
Query: 111 ----QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST--VGTPAYIAPEVL 164
                I HRDLK  N  ++      LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 143 IHSADIIHRDLKPSNLAVNEDC--ELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 196
Query: 165 SRREYDGKLADVWSCGVTLYVMLVG--AYPFEDQ------------------------ED 198
               +  +  D+WS G  +  +L G   +P  D                         E 
Sbjct: 197 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 256
Query: 199 PKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 253
            +N+ ++++++  + +    ++  +    +LL ++ V +  +RIT  +  +H +F
Sbjct: 257 ARNYIQSLTQMPKMNFANV-FIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 310

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 66/295 (22%), Positives = 126/295 (42%), Gaps = 51/295 (17%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK--IDAN-VAREIINHKQLRHP 58
           E+Y+ +  +GSG +G      +  T   VA+K + R  +  I A    RE+   K ++H 
Sbjct: 34  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 93
Query: 59  NIIRFKEVVLTPTHL-----AIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG--- 110
           N+I   +V      L       ++ +  G +L   I    + ++D  ++   Q++ G   
Sbjct: 94  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 152
Query: 111 ----QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST--VGTPAYIAPEVL 164
                I HRDLK  N  ++      LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 153 IHSADIIHRDLKPSNLAVNEDC--ELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 206
Query: 165 SRREYDGKLADVWSCGVTLYVMLVG--AYPFEDQ------------------------ED 198
               +  +  D+WS G  +  +L G   +P  D                         E 
Sbjct: 207 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 266
Query: 199 PKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 253
            +N+ ++++++  + +    ++  +    +LL ++ V +  +RIT  +  +H +F
Sbjct: 267 ARNYIQSLTQMPKMNFANV-FIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 320

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 66/295 (22%), Positives = 126/295 (42%), Gaps = 51/295 (17%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK--IDAN-VAREIINHKQLRHP 58
           E+Y+ +  +GSG +G      +  T   VA+K + R  +  I A    RE+   K ++H 
Sbjct: 29  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 88
Query: 59  NIIRFKEVVLTPTHL-----AIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG--- 110
           N+I   +V      L       ++ +  G +L   I    + ++D  ++   Q++ G   
Sbjct: 89  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 147
Query: 111 ----QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST--VGTPAYIAPEVL 164
                I HRDLK  N  ++      LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 148 IHSADIIHRDLKPSNLAVNEDC--ELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 201
Query: 165 SRREYDGKLADVWSCGVTLYVMLVG--AYPFEDQ------------------------ED 198
               +  +  D+WS G  +  +L G   +P  D                         E 
Sbjct: 202 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 261
Query: 199 PKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 253
            +N+ ++++++  + +    ++  +    +LL ++ V +  +RIT  +  +H +F
Sbjct: 262 ARNYIQSLTQMPKMNFANV-FIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 315

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 66/295 (22%), Positives = 126/295 (42%), Gaps = 51/295 (17%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK--IDAN-VAREIINHKQLRHP 58
           E+Y+ +  +GSG +G      +  T   VA+K + R  +  I A    RE+   K ++H 
Sbjct: 34  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 93
Query: 59  NIIRFKEVVLTPTHL-----AIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG--- 110
           N+I   +V      L       ++ +  G +L   I    + ++D  ++   Q++ G   
Sbjct: 94  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 152
Query: 111 ----QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST--VGTPAYIAPEVL 164
                I HRDLK  N  ++      LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 153 IHSADIIHRDLKPSNLAVNEDC--ELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 206
Query: 165 SRREYDGKLADVWSCGVTLYVMLVG--AYPFEDQ------------------------ED 198
               +  +  D+WS G  +  +L G   +P  D                         E 
Sbjct: 207 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 266
Query: 199 PKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 253
            +N+ ++++++  + +    ++  +    +LL ++ V +  +RIT  +  +H +F
Sbjct: 267 ARNYIQSLTQMPKMNFANV-FIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 320

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 66/295 (22%), Positives = 126/295 (42%), Gaps = 51/295 (17%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK--IDAN-VAREIINHKQLRHP 58
           E+Y+ +  +GSG +G      +  T   VA+K + R  +  I A    RE+   K ++H 
Sbjct: 24  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 83
Query: 59  NIIRFKEVVLTPTHL-----AIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG--- 110
           N+I   +V      L       ++ +  G +L   I    + ++D  ++   Q++ G   
Sbjct: 84  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 142
Query: 111 ----QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST--VGTPAYIAPEVL 164
                I HRDLK  N  ++      LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 143 IHSADIIHRDLKPSNLAVNEDC--ELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 196
Query: 165 SRREYDGKLADVWSCGVTLYVMLVG--AYPFEDQ------------------------ED 198
               +  +  D+WS G  +  +L G   +P  D                         E 
Sbjct: 197 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 256
Query: 199 PKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 253
            +N+ ++++++  + +    ++  +    +LL ++ V +  +RIT  +  +H +F
Sbjct: 257 ARNYIQSLTQMPKMNFANV-FIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 310

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 67/295 (22%), Positives = 126/295 (42%), Gaps = 51/295 (17%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK--IDAN-VAREIINHKQLRHP 58
           E+Y+ +  +GSG +G      +  T   VA+K + R  +  I A    RE+   K ++H 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 59  NIIRFKEVVLTPTHL-----AIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG--- 110
           N+I   +V      L       ++ +  G +L   I    + ++D  ++   Q++ G   
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 140
Query: 111 ----QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST--VGTPAYIAPEVL 164
                I HRDLK  N  L  +    LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 141 IHSADIIHRDLKPSN--LAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 194
Query: 165 SRREYDGKLADVWSCGVTLYVMLVG--AYPFEDQ------------------------ED 198
               +  +  D+WS G  +  +L G   +P  D                         E 
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 254
Query: 199 PKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 253
            +N+ ++++++  + +    ++  +    +LL ++ V +  +RIT  +  +H +F
Sbjct: 255 ARNYIQSLTQMPKMNFANV-FIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 308

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 66/295 (22%), Positives = 126/295 (42%), Gaps = 51/295 (17%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK--IDAN-VAREIINHKQLRHP 58
           E+Y+ +  +GSG +G      +  T   VA+K + R  +  I A    RE+   K ++H 
Sbjct: 27  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 86
Query: 59  NIIRFKEVVLTPTHL-----AIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG--- 110
           N+I   +V      L       ++ +  G +L   I    + ++D  ++   Q++ G   
Sbjct: 87  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 145
Query: 111 ----QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST--VGTPAYIAPEVL 164
                I HRDLK  N  ++      LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 146 IHSADIIHRDLKPSNLAVNEDC--ELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 199
Query: 165 SRREYDGKLADVWSCGVTLYVMLVG--AYPFEDQ------------------------ED 198
               +  +  D+WS G  +  +L G   +P  D                         E 
Sbjct: 200 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 259
Query: 199 PKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 253
            +N+ ++++++  + +    ++  +    +LL ++ V +  +RIT  +  +H +F
Sbjct: 260 ARNYIQSLTQMPKMNFANV-FIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 313

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 66/295 (22%), Positives = 126/295 (42%), Gaps = 51/295 (17%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK--IDAN-VAREIINHKQLRHP 58
           E+Y+ +  +GSG +G      +  T   VA+K + R  +  I A    RE+   K ++H 
Sbjct: 21  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 80
Query: 59  NIIRFKEVVLTPTHL-----AIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG--- 110
           N+I   +V      L       ++ +  G +L   I    + ++D  ++   Q++ G   
Sbjct: 81  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 139
Query: 111 ----QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST--VGTPAYIAPEVL 164
                I HRDLK  N  ++      LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 140 IHSADIIHRDLKPSNLAVNEDC--ELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 193
Query: 165 SRREYDGKLADVWSCGVTLYVMLVG--AYPFEDQ------------------------ED 198
               +  +  D+WS G  +  +L G   +P  D                         E 
Sbjct: 194 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 253
Query: 199 PKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 253
            +N+ ++++++  + +    ++  +    +LL ++ V +  +RIT  +  +H +F
Sbjct: 254 ARNYIQSLTQMPKMNFANV-FIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 307

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 66/295 (22%), Positives = 126/295 (42%), Gaps = 51/295 (17%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK--IDAN-VAREIINHKQLRHP 58
           E+Y+ +  +GSG +G      +  T   VA+K + R  +  I A    RE+   K ++H 
Sbjct: 45  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 104
Query: 59  NIIRFKEVVLTPTHL-----AIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG--- 110
           N+I   +V      L       ++ +  G +L   I    + ++D  ++   Q++ G   
Sbjct: 105 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 163
Query: 111 ----QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST--VGTPAYIAPEVL 164
                I HRDLK  N  ++      LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 164 IHSADIIHRDLKPSNLAVNEDC--ELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 217
Query: 165 SRREYDGKLADVWSCGVTLYVMLVG--AYPFEDQ------------------------ED 198
               +  +  D+WS G  +  +L G   +P  D                         E 
Sbjct: 218 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 277
Query: 199 PKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 253
            +N+ ++++++  + +    ++  +    +LL ++ V +  +RIT  +  +H +F
Sbjct: 278 ARNYIQSLTQMPKMNFA-NVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 331

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 66/295 (22%), Positives = 126/295 (42%), Gaps = 51/295 (17%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK--IDAN-VAREIINHKQLRHP 58
           E+Y+ +  +GSG +G      +  T   VA+K + R  +  I A    RE+   K ++H 
Sbjct: 24  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 83
Query: 59  NIIRFKEVVLTPTHL-----AIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG--- 110
           N+I   +V      L       ++ +  G +L   I    + ++D  ++   Q++ G   
Sbjct: 84  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 142
Query: 111 ----QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST--VGTPAYIAPEVL 164
                I HRDLK  N  ++      LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 143 IHSADIIHRDLKPSNLAVNEDC--ELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 196
Query: 165 SRREYDGKLADVWSCGVTLYVMLVG--AYPFEDQ------------------------ED 198
               +  +  D+WS G  +  +L G   +P  D                         E 
Sbjct: 197 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 256
Query: 199 PKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 253
            +N+ ++++++  + +    ++  +    +LL ++ V +  +RIT  +  +H +F
Sbjct: 257 ARNYIQSLTQMPKMNFANV-FIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 310

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 67/295 (22%), Positives = 126/295 (42%), Gaps = 51/295 (17%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK--IDAN-VAREIINHKQLRHP 58
           E+Y+ +  +GSG +G      +  T   VA+K + R  +  I A    RE+   K ++H 
Sbjct: 28  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 87
Query: 59  NIIRFKEVVLTPTHL-----AIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG--- 110
           N+I   +V      L       ++ +  G +L   I    + ++D  ++   Q++ G   
Sbjct: 88  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 146
Query: 111 ----QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST--VGTPAYIAPEVL 164
                I HRDLK  N  L  +    LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 147 IHSADIIHRDLKPSN--LAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 200
Query: 165 SRREYDGKLADVWSCGVTLYVMLVG--AYPFEDQ------------------------ED 198
               +  +  D+WS G  +  +L G   +P  D                         E 
Sbjct: 201 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 260
Query: 199 PKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 253
            +N+ ++++++  + +    ++  +    +LL ++ V +  +RIT  +  +H +F
Sbjct: 261 ARNYIQSLTQMPKMNFANV-FIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 314

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 73/293 (24%), Positives = 120/293 (40%), Gaps = 45/293 (15%)
Query: 3   KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIE--RGHKIDANVAREIINHKQLRHPNI 60
           +Y  +  IG G +G+     +   K  VA+K I             REI    + RH NI
Sbjct: 24  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI 83
Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFE----RICNAGRFSEDEARYFFQQLISG------ 110
           I   +++  PT +  + +     +L E    ++      S D   YF  Q++ G      
Sbjct: 84  IGINDIIRAPT-IEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS 142
Query: 111 -QICHRDLKLENTLLDGSPAPRLKICDFGYSK-SSLLHSRP---KSTVGTPAYIAPEVLS 165
             + HRDLK  N LL+ +    LKICDFG ++ +   H         V T  Y APE++ 
Sbjct: 143 ANVLHRDLKPSNLLLNTTXD--LKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 200
Query: 166 RREYDGKLADVWSCGVTLYVML------------------VGAYPFEDQEDPKNFRKTIS 207
             +   K  D+WS G  L  ML                  +G      QED        +
Sbjct: 201 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 260
Query: 208 R--IMAVQY--KIP---DYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 253
           R  ++++ +  K+P    + +      +LL ++   NP +RI +++  +HP+ 
Sbjct: 261 RNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 313

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 66/295 (22%), Positives = 126/295 (42%), Gaps = 51/295 (17%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK--IDAN-VAREIINHKQLRHP 58
           E+Y+ +  +GSG +G      +  T   VA+K + R  +  I A    RE+   K ++H 
Sbjct: 27  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 86
Query: 59  NIIRFKEVVLTPTHL-----AIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG--- 110
           N+I   +V      L       ++ +  G +L   I    + ++D  ++   Q++ G   
Sbjct: 87  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 145
Query: 111 ----QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST--VGTPAYIAPEVL 164
                I HRDLK  N  ++      LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 146 IHSADIIHRDLKPSNLAVNEDC--ELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 199
Query: 165 SRREYDGKLADVWSCGVTLYVMLVG--AYPFEDQ------------------------ED 198
               +  +  D+WS G  +  +L G   +P  D                         E 
Sbjct: 200 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 259
Query: 199 PKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 253
            +N+ ++++++  + +    ++  +    +LL ++ V +  +RIT  +  +H +F
Sbjct: 260 ARNYIQSLTQMPKMNFA-NVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 313

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 66/295 (22%), Positives = 126/295 (42%), Gaps = 51/295 (17%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK--IDAN-VAREIINHKQLRHP 58
           E+Y+ +  +GSG +G      +  T   VA+K + R  +  I A    RE+   K ++H 
Sbjct: 29  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 88
Query: 59  NIIRFKEVVLTPTHL-----AIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG--- 110
           N+I   +V      L       ++ +  G +L   I    + ++D  ++   Q++ G   
Sbjct: 89  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 147
Query: 111 ----QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST--VGTPAYIAPEVL 164
                I HRDLK  N  ++      LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 148 IHSADIIHRDLKPSNLAVNEDC--ELKILDFGLAR----HTADEMTGYVATRWYRAPEIM 201
Query: 165 SRREYDGKLADVWSCGVTLYVMLVG--AYPFEDQ------------------------ED 198
               +  +  D+WS G  +  +L G   +P  D                         E 
Sbjct: 202 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 261
Query: 199 PKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 253
            +N+ ++++++  + +    ++  +    +LL ++ V +  +RIT  +  +H +F
Sbjct: 262 ARNYIQSLTQMPKMNFA-NVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 315

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 66/295 (22%), Positives = 126/295 (42%), Gaps = 51/295 (17%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK--IDAN-VAREIINHKQLRHP 58
           E+Y+ +  +GSG +G      +  T   VA+K + R  +  I A    RE+   K ++H 
Sbjct: 19  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 78
Query: 59  NIIRFKEVVLTPTHL-----AIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG--- 110
           N+I   +V      L       ++ +  G +L   I    + ++D  ++   Q++ G   
Sbjct: 79  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 137
Query: 111 ----QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST--VGTPAYIAPEVL 164
                I HRDLK  N  ++      LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 138 IHSADIIHRDLKPSNLAVNEDC--ELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 191
Query: 165 SRREYDGKLADVWSCGVTLYVMLVG--AYPFEDQ------------------------ED 198
               +  +  D+WS G  +  +L G   +P  D                         E 
Sbjct: 192 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 251
Query: 199 PKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 253
            +N+ ++++++  + +    ++  +    +LL ++ V +  +RIT  +  +H +F
Sbjct: 252 ARNYIQSLTQMPKMNFANV-FIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 305

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 67/295 (22%), Positives = 126/295 (42%), Gaps = 51/295 (17%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK--IDAN-VAREIINHKQLRHP 58
           E+Y+ +  +GSG +G      +  T   VA+K + R  +  I A    RE+   K ++H 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 59  NIIRFKEVVLTPTHL-----AIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG--- 110
           N+I   +V      L       ++ +  G +L   I    + ++D  ++   Q++ G   
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 140
Query: 111 ----QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST--VGTPAYIAPEVL 164
                I HRDLK  N  L  +    LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 141 IHSADIIHRDLKPSN--LAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 194
Query: 165 SRREYDGKLADVWSCGVTLYVMLVG--AYPFEDQ------------------------ED 198
               +  +  D+WS G  +  +L G   +P  D                         E 
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 254
Query: 199 PKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 253
            +N+ ++++++  + +    ++  +    +LL ++ V +  +RIT  +  +H +F
Sbjct: 255 ARNYIQSLTQMPKMNFANV-FIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 308

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 67/295 (22%), Positives = 126/295 (42%), Gaps = 51/295 (17%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK--IDAN-VAREIINHKQLRHP 58
           E+Y+ +  +GSG +G      +  T   VA+K + R  +  I A    RE+   K ++H 
Sbjct: 19  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 78
Query: 59  NIIRFKEVVLTPTHL-----AIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG--- 110
           N+I   +V      L       ++ +  G +L   I    + ++D  ++   Q++ G   
Sbjct: 79  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 137
Query: 111 ----QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST--VGTPAYIAPEVL 164
                I HRDLK  N  L  +    LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 138 IHSADIIHRDLKPSN--LAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 191
Query: 165 SRREYDGKLADVWSCGVTLYVMLVG--AYPFEDQ------------------------ED 198
               +  +  D+WS G  +  +L G   +P  D                         E 
Sbjct: 192 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 251
Query: 199 PKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 253
            +N+ ++++++  + +    ++  +    +LL ++ V +  +RIT  +  +H +F
Sbjct: 252 ARNYIQSLTQMPKMNFA-NVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 305

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 66/295 (22%), Positives = 126/295 (42%), Gaps = 51/295 (17%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK--IDAN-VAREIINHKQLRHP 58
           E+Y+ +  +GSG +G      +  T   VA+K + R  +  I A    RE+   K ++H 
Sbjct: 42  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 101
Query: 59  NIIRFKEVVLTPTHL-----AIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG--- 110
           N+I   +V      L       ++ +  G +L   I    + ++D  ++   Q++ G   
Sbjct: 102 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 160
Query: 111 ----QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST--VGTPAYIAPEVL 164
                I HRDLK  N  ++      LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 161 IHSADIIHRDLKPSNLAVNEDC--ELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 214
Query: 165 SRREYDGKLADVWSCGVTLYVMLVG--AYPFEDQ------------------------ED 198
               +  +  D+WS G  +  +L G   +P  D                         E 
Sbjct: 215 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 274
Query: 199 PKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 253
            +N+ ++++++  + +    ++  +    +LL ++ V +  +RIT  +  +H +F
Sbjct: 275 ARNYIQSLTQMPKMNFANV-FIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 328

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 66/295 (22%), Positives = 126/295 (42%), Gaps = 51/295 (17%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK--IDAN-VAREIINHKQLRHP 58
           E+Y+ +  +GSG +G      +  T   VA+K + R  +  I A    RE+   K ++H 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 59  NIIRFKEVVLTPTHL-----AIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG--- 110
           N+I   +V      L       ++ +  G +L   I    + ++D  ++   Q++ G   
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 140
Query: 111 ----QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST--VGTPAYIAPEVL 164
                I HRDLK  N  ++      LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 141 IHSADIIHRDLKPSNLAVNEDC--ELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 194
Query: 165 SRREYDGKLADVWSCGVTLYVMLVG--AYPFEDQ------------------------ED 198
               +  +  D+WS G  +  +L G   +P  D                         E 
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 254
Query: 199 PKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 253
            +N+ ++++++  + +    ++  +    +LL ++ V +  +RIT  +  +H +F
Sbjct: 255 ARNYIQSLTQMPKMNFANV-FIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 308

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 73/293 (24%), Positives = 120/293 (40%), Gaps = 45/293 (15%)
Query: 3   KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIE--RGHKIDANVAREIINHKQLRHPNI 60
           +Y  +  IG G +G+     +   K  VA+K I             REI    + RH NI
Sbjct: 28  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI 87
Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFE----RICNAGRFSEDEARYFFQQLISG------ 110
           I   +++  PT +  + +     +L E    ++      S D   YF  Q++ G      
Sbjct: 88  IGINDIIRAPT-IEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS 146
Query: 111 -QICHRDLKLENTLLDGSPAPRLKICDFGYSK-SSLLHSRP---KSTVGTPAYIAPEVLS 165
             + HRDLK  N LL+ +    LKICDFG ++ +   H         V T  Y APE++ 
Sbjct: 147 ANVLHRDLKPSNLLLNTTCD--LKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIML 204
Query: 166 RREYDGKLADVWSCGVTLYVML------------------VGAYPFEDQEDPKNFRKTIS 207
             +   K  D+WS G  L  ML                  +G      QED        +
Sbjct: 205 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 264
Query: 208 R--IMAVQY--KIP---DYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 253
           R  ++++ +  K+P    + +      +LL ++   NP +RI +++  +HP+ 
Sbjct: 265 RNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 317

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 92/207 (44%), Gaps = 29/207 (14%)
Query: 6   LMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKE 65
            +K++G+G FGV +  + +   + VA+K I+ G   +     E      L H  +++   
Sbjct: 13  FLKELGTGQFGVVKYGKWRGQYD-VAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYG 71
Query: 66  VVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLI--------------SGQ 111
           V      + I+ EY A G      C      E   R+  QQL+              S Q
Sbjct: 72  VCTKQRPIFIITEYMANG------CLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ 125
Query: 112 ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPA---YIAPEVLSRRE 168
             HRDL   N L++      +K+ DFG S+  +L     S+VG+     +  PEVL   +
Sbjct: 126 FLHRDLAARNCLVNDQGV--VKVSDFGLSR-YVLDDEYTSSVGSKFPVRWSPPEVLMYSK 182
Query: 169 YDGKLADVWSCGVTLY-VMLVGAYPFE 194
           +  K +D+W+ GV ++ +  +G  P+E
Sbjct: 183 FSSK-SDIWAFGVLMWEIYSLGKMPYE 208

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 66/295 (22%), Positives = 126/295 (42%), Gaps = 51/295 (17%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK--IDAN-VAREIINHKQLRHP 58
           E+Y+ +  +GSG +G      +  T   VA+K + R  +  I A    RE+   K ++H 
Sbjct: 33  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 92
Query: 59  NIIRFKEVVLTPTHL-----AIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG--- 110
           N+I   +V      L       ++ +  G +L   I    + ++D  ++   Q++ G   
Sbjct: 93  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 151
Query: 111 ----QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST--VGTPAYIAPEVL 164
                I HRDLK  N  ++      LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 152 IHSADIIHRDLKPSNLAVNEDC--ELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 205
Query: 165 SRREYDGKLADVWSCGVTLYVMLVG--AYPFEDQ------------------------ED 198
               +  +  D+WS G  +  +L G   +P  D                         E 
Sbjct: 206 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 265
Query: 199 PKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 253
            +N+ ++++++  + +    ++  +    +LL ++ V +  +RIT  +  +H +F
Sbjct: 266 ARNYIQSLTQMPKMNFANV-FIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 319

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 66/295 (22%), Positives = 126/295 (42%), Gaps = 51/295 (17%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK--IDAN-VAREIINHKQLRHP 58
           E+Y+ +  +GSG +G      +  T   VA+K + R  +  I A    RE+   K ++H 
Sbjct: 41  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 100
Query: 59  NIIRFKEVVLTPTHL-----AIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG--- 110
           N+I   +V      L       ++ +  G +L   I    + ++D  ++   Q++ G   
Sbjct: 101 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 159
Query: 111 ----QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST--VGTPAYIAPEVL 164
                I HRDLK  N  ++      LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 160 IHSADIIHRDLKPSNLAVNEDC--ELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 213
Query: 165 SRREYDGKLADVWSCGVTLYVMLVG--AYPFEDQ------------------------ED 198
               +  +  D+WS G  +  +L G   +P  D                         E 
Sbjct: 214 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 273
Query: 199 PKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 253
            +N+ ++++++  + +    ++  +    +LL ++ V +  +RIT  +  +H +F
Sbjct: 274 ARNYIQSLTQMPKMNFA-NVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 327

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 73/293 (24%), Positives = 120/293 (40%), Gaps = 45/293 (15%)
Query: 3   KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIE--RGHKIDANVAREIINHKQLRHPNI 60
           +Y  +  IG G +G+     +   K  VA+K I             REI    + RH NI
Sbjct: 29  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI 88
Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFE----RICNAGRFSEDEARYFFQQLISG------ 110
           I   +++  PT +  + +     +L E    ++      S D   YF  Q++ G      
Sbjct: 89  IGINDIIRAPT-IEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS 147
Query: 111 -QICHRDLKLENTLLDGSPAPRLKICDFGYSK-SSLLHSRP---KSTVGTPAYIAPEVLS 165
             + HRDLK  N LL+ +    LKICDFG ++ +   H         V T  Y APE++ 
Sbjct: 148 ANVLHRDLKPSNLLLNTTCD--LKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIML 205
Query: 166 RREYDGKLADVWSCGVTLYVML------------------VGAYPFEDQEDPKNFRKTIS 207
             +   K  D+WS G  L  ML                  +G      QED        +
Sbjct: 206 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 265
Query: 208 R--IMAVQY--KIP---DYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 253
           R  ++++ +  K+P    + +      +LL ++   NP +RI +++  +HP+ 
Sbjct: 266 RNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 318

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 66/295 (22%), Positives = 126/295 (42%), Gaps = 51/295 (17%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK--IDAN-VAREIINHKQLRHP 58
           E+Y+ +  +GSG +G      +  T   VA+K + R  +  I A    RE+   K ++H 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 59  NIIRFKEVVLTPTHL-----AIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG--- 110
           N+I   +V      L       ++ +  G +L   I    + ++D  ++   Q++ G   
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 140
Query: 111 ----QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST--VGTPAYIAPEVL 164
                I HRDLK  N  ++      LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 141 IHSADIIHRDLKPSNLAVNEDC--ELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 194
Query: 165 SRREYDGKLADVWSCGVTLYVMLVG--AYPFEDQ------------------------ED 198
               +  +  D+WS G  +  +L G   +P  D                         E 
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 254
Query: 199 PKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 253
            +N+ ++++++  + +    ++  +    +LL ++ V +  +RIT  +  +H +F
Sbjct: 255 ARNYIQSLTQMPKMNFANV-FIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 308

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 66/295 (22%), Positives = 126/295 (42%), Gaps = 51/295 (17%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK--IDAN-VAREIINHKQLRHP 58
           E+Y+ +  +GSG +G      +  T   VA+K + R  +  I A    RE+   K ++H 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 59  NIIRFKEVVLTPTHL-----AIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG--- 110
           N+I   +V      L       ++ +  G +L   I    + ++D  ++   Q++ G   
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 140
Query: 111 ----QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST--VGTPAYIAPEVL 164
                I HRDLK  N  ++      LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 141 IHSADIIHRDLKPSNLAVNEDC--ELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 194
Query: 165 SRREYDGKLADVWSCGVTLYVMLVG--AYPFEDQ------------------------ED 198
               +  +  D+WS G  +  +L G   +P  D                         E 
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 254
Query: 199 PKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 253
            +N+ ++++++  + +    ++  +    +LL ++ V +  +RIT  +  +H +F
Sbjct: 255 ARNYIQSLTQMPKMNFANV-FIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 308

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 73/293 (24%), Positives = 120/293 (40%), Gaps = 45/293 (15%)
Query: 3   KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIE--RGHKIDANVAREIINHKQLRHPNI 60
           +Y  +  IG G +G+     +   K  VA+K I             REI    + RH NI
Sbjct: 28  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI 87
Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFE----RICNAGRFSEDEARYFFQQLISG------ 110
           I   +++  PT +  + +     +L E    ++      S D   YF  Q++ G      
Sbjct: 88  IGINDIIRAPT-IEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS 146
Query: 111 -QICHRDLKLENTLLDGSPAPRLKICDFGYSK-SSLLHSRP---KSTVGTPAYIAPEVLS 165
             + HRDLK  N LL+ +    LKICDFG ++ +   H         V T  Y APE++ 
Sbjct: 147 ANVLHRDLKPSNLLLNTTXD--LKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 204
Query: 166 RREYDGKLADVWSCGVTLYVML------------------VGAYPFEDQEDPKNFRKTIS 207
             +   K  D+WS G  L  ML                  +G      QED        +
Sbjct: 205 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 264
Query: 208 R--IMAVQY--KIP---DYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 253
           R  ++++ +  K+P    + +      +LL ++   NP +RI +++  +HP+ 
Sbjct: 265 RNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 317

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 66/295 (22%), Positives = 126/295 (42%), Gaps = 51/295 (17%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK--IDAN-VAREIINHKQLRHP 58
           E+Y+ +  +GSG +G      +  T   VA+K + R  +  I A    RE+   K ++H 
Sbjct: 20  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 79
Query: 59  NIIRFKEVVLTPTHL-----AIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG--- 110
           N+I   +V      L       ++ +  G +L   I    + ++D  ++   Q++ G   
Sbjct: 80  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 138
Query: 111 ----QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST--VGTPAYIAPEVL 164
                I HRDLK  N  ++      LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 139 IHSADIIHRDLKPSNLAVNEDC--ELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 192
Query: 165 SRREYDGKLADVWSCGVTLYVMLVG--AYPFEDQ------------------------ED 198
               +  +  D+WS G  +  +L G   +P  D                         E 
Sbjct: 193 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 252
Query: 199 PKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 253
            +N+ ++++++  + +    ++  +    +LL ++ V +  +RIT  +  +H +F
Sbjct: 253 ARNYIQSLTQMPKMNFA-NVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 306

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 66/295 (22%), Positives = 126/295 (42%), Gaps = 51/295 (17%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK--IDAN-VAREIINHKQLRHP 58
           E+Y+ +  +GSG +G      +  T   VA+K + R  +  I A    RE+   K ++H 
Sbjct: 18  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 77
Query: 59  NIIRFKEVVLTPTHL-----AIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG--- 110
           N+I   +V      L       ++ +  G +L   I    + ++D  ++   Q++ G   
Sbjct: 78  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 136
Query: 111 ----QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST--VGTPAYIAPEVL 164
                I HRDLK  N  ++      LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 137 IHSADIIHRDLKPSNLAVNEDC--ELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 190
Query: 165 SRREYDGKLADVWSCGVTLYVMLVG--AYPFEDQ------------------------ED 198
               +  +  D+WS G  +  +L G   +P  D                         E 
Sbjct: 191 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 250
Query: 199 PKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 253
            +N+ ++++++  + +    ++  +    +LL ++ V +  +RIT  +  +H +F
Sbjct: 251 ARNYIQSLTQMPKMNFA-NVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 304

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 73/293 (24%), Positives = 120/293 (40%), Gaps = 45/293 (15%)
Query: 3   KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIE--RGHKIDANVAREIINHKQLRHPNI 60
           +Y  +  IG G +G+     +   K  VA+K I             REI    + RH NI
Sbjct: 26  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI 85
Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFE----RICNAGRFSEDEARYFFQQLISG------ 110
           I   +++  PT +  + +     +L E    ++      S D   YF  Q++ G      
Sbjct: 86  IGINDIIRAPT-IEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS 144
Query: 111 -QICHRDLKLENTLLDGSPAPRLKICDFGYSK-SSLLHSRP---KSTVGTPAYIAPEVLS 165
             + HRDLK  N LL+ +    LKICDFG ++ +   H         V T  Y APE++ 
Sbjct: 145 ANVLHRDLKPSNLLLNTTCD--LKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 202
Query: 166 RREYDGKLADVWSCGVTLYVML------------------VGAYPFEDQEDPKNFRKTIS 207
             +   K  D+WS G  L  ML                  +G      QED        +
Sbjct: 203 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 262
Query: 208 R--IMAVQY--KIP---DYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 253
           R  ++++ +  K+P    + +      +LL ++   NP +RI +++  +HP+ 
Sbjct: 263 RNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 315

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 77/306 (25%), Positives = 132/306 (43%), Gaps = 63/306 (20%)
Query: 10  IGSGNFGVARLMRNKNTKELVAMKYIERGHK--IDANVA-REIINHKQLRHPNIIRFKEV 66
           +GSG +G      +K + E VA+K + R  +  I A  A RE++  K ++H N+I   +V
Sbjct: 50  VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDV 109
Query: 67  VLTPTHL------AIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-------QIC 113
               + L       +VM +       ++I     FSE++ +Y   Q++ G        + 
Sbjct: 110 FTPASSLRNFYDFYLVMPFMQTD--LQKIMGM-EFSEEKIQYLVYQMLKGLKYIHSAGVV 166
Query: 114 HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST--VGTPAYIAPEVLSRREYDG 171
           HRDLK  N  ++      LKI DFG ++    H+  + T  V T  Y APEV+    +  
Sbjct: 167 HRDLKPGNLAVNEDC--ELKILDFGLAR----HADAEMTGYVVTRWYRAPEVILSWMHYN 220
Query: 172 KLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAV------------------- 212
           +  D+WS G  +  ML G   F+     K++   +++I+ V                   
Sbjct: 221 QTVDIWSVGCIMAEMLTGKTLFKG----KDYLDQLTQILKVTGVPGTEFVQKLNDKAAKS 276
Query: 213 ------QYKIPDYVHI----SQDCRNLLSRIFVANPSRRITIKEIKSHPWF--LKNLPRE 260
                 Q    D+  +    S    +LL ++   +  +R+T  +  +HP+F   ++ P E
Sbjct: 277 YIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRD-PEE 335
Query: 261 LTETAQ 266
            TE  Q
Sbjct: 336 ETEAQQ 341

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 66/295 (22%), Positives = 126/295 (42%), Gaps = 51/295 (17%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK--IDAN-VAREIINHKQLRHP 58
           E+Y+ +  +GSG +G      +  T   VA+K + R  +  I A    RE+   K ++H 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 59  NIIRFKEVVLTPTHL-----AIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG--- 110
           N+I   +V      L       ++ +  G +L   I    + ++D  ++   Q++ G   
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKXQKLTDDHVQFLIYQILRGLKY 140
Query: 111 ----QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST--VGTPAYIAPEVL 164
                I HRDLK  N  ++      LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 141 IHSADIIHRDLKPSNLAVNEDC--ELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 194
Query: 165 SRREYDGKLADVWSCGVTLYVMLVG--AYPFEDQ------------------------ED 198
               +  +  D+WS G  +  +L G   +P  D                         E 
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 254
Query: 199 PKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 253
            +N+ ++++++  + +    ++  +    +LL ++ V +  +RIT  +  +H +F
Sbjct: 255 ARNYIQSLTQMPKMNFANV-FIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 308

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 73/293 (24%), Positives = 120/293 (40%), Gaps = 45/293 (15%)
Query: 3   KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIE--RGHKIDANVAREIINHKQLRHPNI 60
           +Y  +  IG G +G+     +   K  VA+K I             REI    + RH NI
Sbjct: 24  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI 83
Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFE----RICNAGRFSEDEARYFFQQLISG------ 110
           I   +++  PT +  + +     +L E    ++      S D   YF  Q++ G      
Sbjct: 84  IGINDIIRAPT-IEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS 142
Query: 111 -QICHRDLKLENTLLDGSPAPRLKICDFGYSK-SSLLHSRP---KSTVGTPAYIAPEVLS 165
             + HRDLK  N LL+ +    LKICDFG ++ +   H         V T  Y APE++ 
Sbjct: 143 ANVLHRDLKPSNLLLNTTCD--LKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 200
Query: 166 RREYDGKLADVWSCGVTLYVML------------------VGAYPFEDQEDPKNFRKTIS 207
             +   K  D+WS G  L  ML                  +G      QED        +
Sbjct: 201 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 260
Query: 208 R--IMAVQY--KIP---DYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 253
           R  ++++ +  K+P    + +      +LL ++   NP +RI +++  +HP+ 
Sbjct: 261 RNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 313

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 66/295 (22%), Positives = 126/295 (42%), Gaps = 51/295 (17%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK--IDAN-VAREIINHKQLRHP 58
           E+Y+ +  +GSG +G      +  T   VA+K + R  +  I A    RE+   K ++H 
Sbjct: 28  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 87
Query: 59  NIIRFKEVVLTPTHL-----AIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG--- 110
           N+I   +V      L       ++ +  G +L   I    + ++D  ++   Q++ G   
Sbjct: 88  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 146
Query: 111 ----QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST--VGTPAYIAPEVL 164
                I HRDLK  N  ++      LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 147 IHSADIIHRDLKPSNLAVNEDC--ELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 200
Query: 165 SRREYDGKLADVWSCGVTLYVMLVG--AYPFEDQ------------------------ED 198
               +  +  D+WS G  +  +L G   +P  D                         E 
Sbjct: 201 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 260
Query: 199 PKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 253
            +N+ ++++++  + +    ++  +    +LL ++ V +  +RIT  +  +H +F
Sbjct: 261 ARNYIQSLTQMPKMNFANV-FIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 314

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 73/293 (24%), Positives = 120/293 (40%), Gaps = 45/293 (15%)
Query: 3   KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIE--RGHKIDANVAREIINHKQLRHPNI 60
           +Y  +  IG G +G+     +   K  VA+K I             REI    + RH NI
Sbjct: 28  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI 87
Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFE----RICNAGRFSEDEARYFFQQLISG------ 110
           I   +++  PT +  + +     +L E    ++      S D   YF  Q++ G      
Sbjct: 88  IGINDIIRAPT-IEQMKDVYIVQDLMETDLYKLLKCQHLSNDHICYFLYQILRGLKYIHS 146
Query: 111 -QICHRDLKLENTLLDGSPAPRLKICDFGYSK-SSLLHSRP---KSTVGTPAYIAPEVLS 165
             + HRDLK  N LL+ +    LKICDFG ++ +   H         V T  Y APE++ 
Sbjct: 147 ANVLHRDLKPSNLLLNTTCD--LKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 204
Query: 166 RREYDGKLADVWSCGVTLYVML------------------VGAYPFEDQEDPKNFRKTIS 207
             +   K  D+WS G  L  ML                  +G      QED        +
Sbjct: 205 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 264
Query: 208 R--IMAVQY--KIP---DYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 253
           R  ++++ +  K+P    + +      +LL ++   NP +RI +++  +HP+ 
Sbjct: 265 RNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 317

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 92/207 (44%), Gaps = 29/207 (14%)
Query: 6   LMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKE 65
            +K++G+G FGV +  + +   + VA+K I+ G   +     E      L H  +++   
Sbjct: 19  FLKELGTGQFGVVKYGKWRGQYD-VAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYG 77
Query: 66  VVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLI--------------SGQ 111
           V      + I+ EY A G      C      E   R+  QQL+              S Q
Sbjct: 78  VCTKQRPIFIITEYMANG------CLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ 131
Query: 112 ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPA---YIAPEVLSRRE 168
             HRDL   N L++      +K+ DFG S+  +L     S+VG+     +  PEVL   +
Sbjct: 132 FLHRDLAARNCLVNDQGV--VKVSDFGLSR-YVLDDEYTSSVGSKFPVRWSPPEVLMYSK 188
Query: 169 YDGKLADVWSCGVTLY-VMLVGAYPFE 194
           +  K +D+W+ GV ++ +  +G  P+E
Sbjct: 189 FSSK-SDIWAFGVLMWEIYSLGKMPYE 214

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 73/293 (24%), Positives = 120/293 (40%), Gaps = 45/293 (15%)
Query: 3   KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIE--RGHKIDANVAREIINHKQLRHPNI 60
           +Y  +  IG G +G+     +   K  VA+K I             REI    + RH NI
Sbjct: 29  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI 88
Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFE----RICNAGRFSEDEARYFFQQLISG------ 110
           I   +++  PT +  + +     +L E    ++      S D   YF  Q++ G      
Sbjct: 89  IGINDIIRAPT-IEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS 147
Query: 111 -QICHRDLKLENTLLDGSPAPRLKICDFGYSK-SSLLHSRP---KSTVGTPAYIAPEVLS 165
             + HRDLK  N LL+ +    LKICDFG ++ +   H         V T  Y APE++ 
Sbjct: 148 ANVLHRDLKPSNLLLNTTCD--LKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 205
Query: 166 RREYDGKLADVWSCGVTLYVML------------------VGAYPFEDQEDPKNFRKTIS 207
             +   K  D+WS G  L  ML                  +G      QED        +
Sbjct: 206 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 265
Query: 208 R--IMAVQY--KIP---DYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 253
           R  ++++ +  K+P    + +      +LL ++   NP +RI +++  +HP+ 
Sbjct: 266 RNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 318

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 73/293 (24%), Positives = 120/293 (40%), Gaps = 45/293 (15%)
Query: 3   KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIE--RGHKIDANVAREIINHKQLRHPNI 60
           +Y  +  IG G +G+     +   K  VA+K I             REI    + RH NI
Sbjct: 30  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI 89
Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFE----RICNAGRFSEDEARYFFQQLISG------ 110
           I   +++  PT +  + +     +L E    ++      S D   YF  Q++ G      
Sbjct: 90  IGINDIIRAPT-IEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS 148
Query: 111 -QICHRDLKLENTLLDGSPAPRLKICDFGYSK-SSLLHSRP---KSTVGTPAYIAPEVLS 165
             + HRDLK  N LL+ +    LKICDFG ++ +   H         V T  Y APE++ 
Sbjct: 149 ANVLHRDLKPSNLLLNTTCD--LKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 206
Query: 166 RREYDGKLADVWSCGVTLYVML------------------VGAYPFEDQEDPKNFRKTIS 207
             +   K  D+WS G  L  ML                  +G      QED        +
Sbjct: 207 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 266
Query: 208 R--IMAVQY--KIP---DYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 253
           R  ++++ +  K+P    + +      +LL ++   NP +RI +++  +HP+ 
Sbjct: 267 RNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 319

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 73/293 (24%), Positives = 120/293 (40%), Gaps = 45/293 (15%)
Query: 3   KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIE--RGHKIDANVAREIINHKQLRHPNI 60
           +Y  +  IG G +G+     +   K  VA+K I             REI    + RH NI
Sbjct: 21  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI 80
Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFE----RICNAGRFSEDEARYFFQQLISG------ 110
           I   +++  PT +  + +     +L E    ++      S D   YF  Q++ G      
Sbjct: 81  IGINDIIRAPT-IEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS 139
Query: 111 -QICHRDLKLENTLLDGSPAPRLKICDFGYSK-SSLLHSRP---KSTVGTPAYIAPEVLS 165
             + HRDLK  N LL+ +    LKICDFG ++ +   H         V T  Y APE++ 
Sbjct: 140 ANVLHRDLKPSNLLLNTTCD--LKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 197
Query: 166 RREYDGKLADVWSCGVTLYVML------------------VGAYPFEDQEDPKNFRKTIS 207
             +   K  D+WS G  L  ML                  +G      QED        +
Sbjct: 198 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 257
Query: 208 R--IMAVQY--KIP---DYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 253
           R  ++++ +  K+P    + +      +LL ++   NP +RI +++  +HP+ 
Sbjct: 258 RNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 310

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 73/293 (24%), Positives = 120/293 (40%), Gaps = 45/293 (15%)
Query: 3   KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIE--RGHKIDANVAREIINHKQLRHPNI 60
           +Y  +  IG G +G+     +   K  VA+K I             REI    + RH NI
Sbjct: 28  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI 87
Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFE----RICNAGRFSEDEARYFFQQLISG------ 110
           I   +++  PT +  + +     +L E    ++      S D   YF  Q++ G      
Sbjct: 88  IGINDIIRAPT-IEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS 146
Query: 111 -QICHRDLKLENTLLDGSPAPRLKICDFGYSK-SSLLHSRP---KSTVGTPAYIAPEVLS 165
             + HRDLK  N LL+ +    LKICDFG ++ +   H         V T  Y APE++ 
Sbjct: 147 ANVLHRDLKPSNLLLNTTCD--LKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 204
Query: 166 RREYDGKLADVWSCGVTLYVML------------------VGAYPFEDQEDPKNFRKTIS 207
             +   K  D+WS G  L  ML                  +G      QED        +
Sbjct: 205 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 264
Query: 208 R--IMAVQY--KIP---DYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 253
           R  ++++ +  K+P    + +      +LL ++   NP +RI +++  +HP+ 
Sbjct: 265 RNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 317

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 73/293 (24%), Positives = 120/293 (40%), Gaps = 45/293 (15%)
Query: 3   KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIE--RGHKIDANVAREIINHKQLRHPNI 60
           +Y  +  IG G +G+     +   K  VA+K I             REI    + RH NI
Sbjct: 22  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI 81
Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFE----RICNAGRFSEDEARYFFQQLISG------ 110
           I   +++  PT +  + +     +L E    ++      S D   YF  Q++ G      
Sbjct: 82  IGINDIIRAPT-IEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS 140
Query: 111 -QICHRDLKLENTLLDGSPAPRLKICDFGYSK-SSLLHSRP---KSTVGTPAYIAPEVLS 165
             + HRDLK  N LL+ +    LKICDFG ++ +   H         V T  Y APE++ 
Sbjct: 141 ANVLHRDLKPSNLLLNTTCD--LKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 198
Query: 166 RREYDGKLADVWSCGVTLYVML------------------VGAYPFEDQEDPKNFRKTIS 207
             +   K  D+WS G  L  ML                  +G      QED        +
Sbjct: 199 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 258
Query: 208 R--IMAVQY--KIP---DYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 253
           R  ++++ +  K+P    + +      +LL ++   NP +RI +++  +HP+ 
Sbjct: 259 RNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 311

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 92/207 (44%), Gaps = 29/207 (14%)
Query: 6   LMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKE 65
            +K++G+G FGV +  + +   + VA+K I+ G   +     E      L H  +++   
Sbjct: 28  FLKELGTGQFGVVKYGKWRGQYD-VAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYG 86
Query: 66  VVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLI--------------SGQ 111
           V      + I+ EY A G      C      E   R+  QQL+              S Q
Sbjct: 87  VCTKQRPIFIITEYMANG------CLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ 140
Query: 112 ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPA---YIAPEVLSRRE 168
             HRDL   N L++      +K+ DFG S+  +L     S+VG+     +  PEVL   +
Sbjct: 141 FLHRDLAARNCLVNDQGV--VKVSDFGLSR-YVLDDEYTSSVGSKFPVRWSPPEVLMYSK 197
Query: 169 YDGKLADVWSCGVTLY-VMLVGAYPFE 194
           +  K +D+W+ GV ++ +  +G  P+E
Sbjct: 198 FSSK-SDIWAFGVLMWEIYSLGKMPYE 223

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 73/293 (24%), Positives = 120/293 (40%), Gaps = 45/293 (15%)
Query: 3   KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIE--RGHKIDANVAREIINHKQLRHPNI 60
           +Y  +  IG G +G+     +   K  VA+K I             REI    + RH NI
Sbjct: 44  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI 103
Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFE----RICNAGRFSEDEARYFFQQLISG------ 110
           I   +++  PT +  + +     +L E    ++      S D   YF  Q++ G      
Sbjct: 104 IGINDIIRAPT-IEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS 162
Query: 111 -QICHRDLKLENTLLDGSPAPRLKICDFGYSK-SSLLHSRP---KSTVGTPAYIAPEVLS 165
             + HRDLK  N LL+ +    LKICDFG ++ +   H         V T  Y APE++ 
Sbjct: 163 ANVLHRDLKPSNLLLNTTCD--LKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 220
Query: 166 RREYDGKLADVWSCGVTLYVML------------------VGAYPFEDQEDPKNFRKTIS 207
             +   K  D+WS G  L  ML                  +G      QED        +
Sbjct: 221 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 280
Query: 208 R--IMAVQY--KIP---DYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 253
           R  ++++ +  K+P    + +      +LL ++   NP +RI +++  +HP+ 
Sbjct: 281 RNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 333

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 73/293 (24%), Positives = 120/293 (40%), Gaps = 45/293 (15%)
Query: 3   KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIE--RGHKIDANVAREIINHKQLRHPNI 60
           +Y  +  IG G +G+     +   K  VA+K I             REI    + RH NI
Sbjct: 32  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI 91
Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFE----RICNAGRFSEDEARYFFQQLISG------ 110
           I   +++  PT +  + +     +L E    ++      S D   YF  Q++ G      
Sbjct: 92  IGINDIIRAPT-IEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS 150
Query: 111 -QICHRDLKLENTLLDGSPAPRLKICDFGYSK-SSLLHSRP---KSTVGTPAYIAPEVLS 165
             + HRDLK  N LL+ +    LKICDFG ++ +   H         V T  Y APE++ 
Sbjct: 151 ANVLHRDLKPSNLLLNTTCD--LKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 208
Query: 166 RREYDGKLADVWSCGVTLYVML------------------VGAYPFEDQEDPKNFRKTIS 207
             +   K  D+WS G  L  ML                  +G      QED        +
Sbjct: 209 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 268
Query: 208 R--IMAVQY--KIP---DYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 253
           R  ++++ +  K+P    + +      +LL ++   NP +RI +++  +HP+ 
Sbjct: 269 RNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 321

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 73/293 (24%), Positives = 120/293 (40%), Gaps = 45/293 (15%)
Query: 3   KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIE--RGHKIDANVAREIINHKQLRHPNI 60
           +Y  +  IG G +G+     +   K  VA+K I             REI    + RH NI
Sbjct: 24  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI 83
Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFE----RICNAGRFSEDEARYFFQQLISG------ 110
           I   +++  PT +  + +     +L E    ++      S D   YF  Q++ G      
Sbjct: 84  IGINDIIRAPT-IEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS 142
Query: 111 -QICHRDLKLENTLLDGSPAPRLKICDFGYSK-SSLLHSRP---KSTVGTPAYIAPEVLS 165
             + HRDLK  N LL+ +    LKICDFG ++ +   H         V T  Y APE++ 
Sbjct: 143 ANVLHRDLKPSNLLLNTTCD--LKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 200
Query: 166 RREYDGKLADVWSCGVTLYVML------------------VGAYPFEDQEDPKNFRKTIS 207
             +   K  D+WS G  L  ML                  +G      QED        +
Sbjct: 201 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 260
Query: 208 R--IMAVQY--KIP---DYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 253
           R  ++++ +  K+P    + +      +LL ++   NP +RI +++  +HP+ 
Sbjct: 261 RNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 313

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 75/285 (26%), Positives = 126/285 (44%), Gaps = 55/285 (19%)
Query: 4   YELMKDIGSGNFGVARLMRNKN-TKELVAMKYI---ERGHKIDANVAREI--INHKQLRH 57
           Y ++K IGSG  G +++ +  N  K++ A+KY+   E  ++   +   EI  +N  Q   
Sbjct: 58  YSILKQIGSG--GSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 115
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG------- 110
             IIR  +  +T  ++ +VME     +L   +         E + +++ ++         
Sbjct: 116 DKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH 174
Query: 111 QICHRDLKLENTLL-DGSPAPRLKICDFGYSKSSLLHSRPKST-------VGTPAYIAPE 162
            I H DLK  N L+ DG     LK+ DFG +       +P +T       VG   Y+ PE
Sbjct: 175 GIVHSDLKPANFLIVDG----MLKLIDFGIAN----QMQPDTTSVVKDSQVGAVNYMPPE 226
Query: 163 VL----SRRE------YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAV 212
            +    S RE           +DVWS G  LY M  G  PF+           IS++ A+
Sbjct: 227 AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ------QIINQISKLHAI 280
Query: 213 -----QYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPW 252
                + + PD     +D +++L      +P +RI+I E+ +HP+
Sbjct: 281 IDPNHEIEFPDIP--EKDLQDVLKCCLKRDPKQRISIPELLAHPY 323

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 65/293 (22%), Positives = 123/293 (41%), Gaps = 47/293 (16%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK--IDAN-VAREIINHKQLRHP 58
           E+Y+ +  +GSG +G      +  T   VA+K + R  +  I A    RE+   K ++H 
Sbjct: 45  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 104
Query: 59  NIIRFKEVVLTPTHL-----AIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG--- 110
           N+I   +V      L       ++ +  G +L   I    + ++D  ++   Q++ G   
Sbjct: 105 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 163
Query: 111 ----QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSR 166
                I HRDLK  N  L  +    LKI DFG ++ +         V T  Y APE++  
Sbjct: 164 IHSADIIHRDLKPSN--LAVNEDCELKILDFGLARHT--DDEMXGYVATRWYRAPEIMLN 219
Query: 167 REYDGKLADVWSCGVTLYVMLVG--AYPFEDQ------------------------EDPK 200
             +  +  D+WS G  +  +L G   +P  D                         E  +
Sbjct: 220 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESAR 279
Query: 201 NFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 253
           N+ ++++++  + +    ++  +    +LL ++ V +  +RIT  +  +H +F
Sbjct: 280 NYIQSLTQMPKMNFANV-FIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 331

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 95/212 (44%), Gaps = 27/212 (12%)
Query: 8   KDIGSGNFG---VARLMRNKNTKELVAMKYIERGH--KIDANVAREIINHKQLRHPNIIR 62
           K IG G FG     RL      +  VA+K ++ G+  K   +   E     Q  HPNII 
Sbjct: 35  KVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIH 94
Query: 63  FKEVVLTPTHLAIVMEYAAGGEL--FERICNAGRFSEDEARYFFQQLISG-------QIC 113
            + VV     + I+ EY   G L  F R  N GRF+  +     + + SG          
Sbjct: 95  LEGVVTKCKPVMIITEYMENGSLDAFLRK-NDGRFTVIQLVGMLRGIGSGMKYLSDMSAV 153
Query: 114 HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPA------YIAPEVLSRR 167
           HRDL   N L++ +     K+ DFG S+  +L   P++   T        + APE ++ R
Sbjct: 154 HRDLAARNILVNSNLV--CKVSDFGMSR--VLEDDPEAAYTTRGGKIPIRWTAPEAIAYR 209
Query: 168 EYDGKLADVWSCGVTLY-VMLVGAYPFEDQED 198
           ++    +DVWS G+ ++ VM  G  P+ D  +
Sbjct: 210 KFTSA-SDVWSYGIVMWEVMSYGERPYWDMSN 240

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 65/234 (27%), Positives = 101/234 (43%), Gaps = 32/234 (13%)
Query: 6   LMKDI-GSGNFGVARLMRNKNTKELVAMKY---IERGHKIDANVAREIINHKQLRHPNII 61
           L+ DI G G        R+K T +L A+K    I     +D  + RE    K+L H NI+
Sbjct: 12  LLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQM-REFEVLKKLNHKNIV 70
Query: 62  RF--KEVVLTPTHLAIVMEYAAGGELF---ERICNAGRFSEDEARYFFQQLISGQ----- 111
           +    E   T  H  ++ME+   G L+   E   NA    E E     + ++ G      
Sbjct: 71  KLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE 130
Query: 112 --ICHRDLKLENTLL----DGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLS 165
             I HR++K  N +     DG      K+ DFG ++      +  S  GT  Y+ P++  
Sbjct: 131 NGIVHRNIKPGNIMRVIGEDGQSV--YKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYE 188
Query: 166 R--------REYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMA 211
           R        ++Y G   D+WS GVT Y    G+ PF   E P+  ++ + +I+ 
Sbjct: 189 RAVLRKDHQKKY-GATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT 241

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 85/335 (25%), Positives = 129/335 (38%), Gaps = 94/335 (28%)
Query: 10  IGSGNFGVARLMRNKNTKELVAMKYIERGHK--IDAN-VAREIINHKQLRHPNIIRFKEV 66
           IG G++G   L  +KNT++ VA+K + R  +  ID   + REI    +L+   IIR  ++
Sbjct: 34  IGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDL 93
Query: 67  V-----LTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGQ-------ICH 114
           +     L    L IV+E  A  +L +        +E+  +     L+ G+       I H
Sbjct: 94  IIPDDLLKFDELYIVLE-IADSDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIH 152
Query: 115 RDLKLENTLLDGSPAPRLKICDFGYSKS-----------------------SLLHSRPKS 151
           RDLK  N LL+   +  +K+CDFG +++                         L  +  S
Sbjct: 153 RDLKPANCLLNQDCS--VKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTS 210
Query: 152 TVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVML----------VGAYPF-------- 193
            V T  Y APE++  +E   K  D+WS G     +L             +P         
Sbjct: 211 HVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPLFPGSSCFP 270
Query: 194 ---------------EDQ-------------EDPKNFRK--TISRIMAVQYKIP-----D 218
                           DQ             +D KN  K   I  I    ++ P      
Sbjct: 271 LSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQK 330
Query: 219 YVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 253
           Y  IS D  NLL  +   NP++RITI +   HP+ 
Sbjct: 331 YPSISDDGINLLESMLKFNPNKRITIDQALDHPYL 365

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 95/212 (44%), Gaps = 27/212 (12%)
Query: 8   KDIGSGNFG---VARLMRNKNTKELVAMKYIERGH--KIDANVAREIINHKQLRHPNIIR 62
           K IG G FG     RL      +  VA+K ++ G+  K   +   E     Q  HPNII 
Sbjct: 20  KVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIH 79
Query: 63  FKEVVLTPTHLAIVMEYAAGGEL--FERICNAGRFSEDEARYFFQQLISG-------QIC 113
            + VV     + I+ EY   G L  F R  N GRF+  +     + + SG          
Sbjct: 80  LEGVVTKCKPVMIITEYMENGSLDAFLRK-NDGRFTVIQLVGMLRGIGSGMKYLSDMSYV 138
Query: 114 HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPA------YIAPEVLSRR 167
           HRDL   N L++ +     K+ DFG S+  +L   P++   T        + APE ++ R
Sbjct: 139 HRDLAARNILVNSNLV--CKVSDFGMSR--VLEDDPEAAYTTRGGKIPIRWTAPEAIAYR 194
Query: 168 EYDGKLADVWSCGVTLY-VMLVGAYPFEDQED 198
           ++    +DVWS G+ ++ VM  G  P+ D  +
Sbjct: 195 KFTSA-SDVWSYGIVMWEVMSYGERPYWDMSN 225

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 66/275 (24%), Positives = 120/275 (43%), Gaps = 28/275 (10%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINH-----KQLR 56
           E  + + +IG G +G    M +K + +++A+K I     +D    ++++       +   
Sbjct: 22  EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIR--STVDEKEQKQLLMDLDVVMRSSD 79
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGG--ELFERICNA----------GRFSEDEARYFF 104
            P I++F   +       I ME  +    + ++ + +           G+ +    +   
Sbjct: 80  CPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALN 139
Query: 105 QQLISGQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKS-TVGTPAYIAPEV 163
               + +I HRD+K  N LLD S    +K+CDFG S   L+ S  K+   G   Y+APE 
Sbjct: 140 HLKENLKIIHRDIKPSNILLDRSG--NIKLCDFGIS-GQLVDSIAKTRDAGCRPYMAPER 196
Query: 164 L----SRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDY 219
           +    SR+ YD + +DVWS G+TLY +  G +P+       +    + +    Q    + 
Sbjct: 197 IDPSASRQGYDVR-SDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLSNSEE 255
Query: 220 VHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFL 254
              S    N ++     + S+R   KE+  HP+ L
Sbjct: 256 REFSPSFINFVNLCLTKDESKRPKYKELLKHPFIL 290

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 73/293 (24%), Positives = 119/293 (40%), Gaps = 45/293 (15%)
Query: 3   KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIE--RGHKIDANVAREIINHKQLRHPNI 60
           +Y  +  IG G +G+     +   K  VA+K I             REI      RH NI
Sbjct: 26  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHENI 85
Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFE----RICNAGRFSEDEARYFFQQLISG------ 110
           I   +++  PT +  + +     +L E    ++      S D   YF  Q++ G      
Sbjct: 86  IGINDIIRAPT-IEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS 144
Query: 111 -QICHRDLKLENTLLDGSPAPRLKICDFGYSK-SSLLHSRP---KSTVGTPAYIAPEVLS 165
             + HRDLK  N LL+ +    LKICDFG ++ +   H         V T  Y APE++ 
Sbjct: 145 ANVLHRDLKPSNLLLNTTC--DLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 202
Query: 166 RREYDGKLADVWSCGVTLYVML------------------VGAYPFEDQEDPKNFRKTIS 207
             +   K  D+WS G  L  ML                  +G      QED        +
Sbjct: 203 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 262
Query: 208 R--IMAVQY--KIP---DYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 253
           R  ++++ +  K+P    + +      +LL ++   NP +RI +++  +HP+ 
Sbjct: 263 RNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 315

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 95/212 (44%), Gaps = 27/212 (12%)
Query: 8   KDIGSGNFG---VARLMRNKNTKELVAMKYIERGH--KIDANVAREIINHKQLRHPNIIR 62
           K IG G FG     RL      +  VA+K ++ G+  K   +   E     Q  HPNII 
Sbjct: 14  KVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIH 73
Query: 63  FKEVVLTPTHLAIVMEYAAGGEL--FERICNAGRFSEDEARYFFQQLISG-------QIC 113
            + VV     + I+ EY   G L  F R  N GRF+  +     + + SG          
Sbjct: 74  LEGVVTKCKPVMIITEYMENGSLDAFLRK-NDGRFTVIQLVGMLRGIGSGMKYLSDMSYV 132
Query: 114 HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPA------YIAPEVLSRR 167
           HRDL   N L++ +     K+ DFG S+  +L   P++   T        + APE ++ R
Sbjct: 133 HRDLAARNILVNSNLV--CKVSDFGMSR--VLEDDPEAAYTTRGGKIPIRWTAPEAIAYR 188
Query: 168 EYDGKLADVWSCGVTLY-VMLVGAYPFEDQED 198
           ++    +DVWS G+ ++ VM  G  P+ D  +
Sbjct: 189 KFTSA-SDVWSYGIVMWEVMSYGERPYWDMSN 219

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 70/301 (23%), Positives = 120/301 (39%), Gaps = 52/301 (17%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAR---EIINHKQLRH 57
           +++Y+ +K IGSG  G+     +      VA+K + R  +   +  R   E++  K + H
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNH 82
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFE-RICNAGRFSEDEAR--YFFQQLISG---- 110
            NII    V      L    +     EL +  +C   +   D  R  Y   Q++ G    
Sbjct: 83  KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHL 142
Query: 111 ---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRR 167
               I HRDLK  N ++       LKI DFG ++++         V T  Y APEV+   
Sbjct: 143 HSAGIIHRDLKPSNIVVKSDXT--LKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM 200
Query: 168 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMA--------VQYKIPDY 219
            Y   + D+WS G  +  M+     F  ++    + K I ++          +Q  + +Y
Sbjct: 201 GYKENV-DIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNY 259
Query: 220 VH----------------------------ISQDCRNLLSRIFVANPSRRITIKEIKSHP 251
           V                              +   R+LLS++ V +P++RI++ +   HP
Sbjct: 260 VENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHP 319
Query: 252 W 252
           +
Sbjct: 320 Y 320

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 71/302 (23%), Positives = 121/302 (40%), Gaps = 52/302 (17%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAR---EIINHKQLRH 57
           +++Y+ +K IGSG  G+     +   +  VA+K + R  +   +  R   E++  K + H
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 82
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFE-RICNAGRFSEDEAR--YFFQQLISG---- 110
            NII    V      L    +     EL +  +C   +   D  R  Y   Q++ G    
Sbjct: 83  KNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHL 142
Query: 111 ---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRR 167
               I HRDLK  N ++       LKI DFG ++++      +  V T  Y APEV+   
Sbjct: 143 HSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSFMMEPEVVTRYYRAPEVILGM 200
Query: 168 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMA--------VQYKIPDY 219
            Y   + D+WS G  +  M+     F  ++    + K I ++          +Q  + +Y
Sbjct: 201 GYKENV-DIWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPCPAFMKKLQPTVRNY 259
Query: 220 VH----------------------------ISQDCRNLLSRIFVANPSRRITIKEIKSHP 251
           V                              +   R+LLS++ V + S+RI++ E   HP
Sbjct: 260 VENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHP 319
Query: 252 WF 253
           + 
Sbjct: 320 YI 321

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 72/294 (24%), Positives = 116/294 (39%), Gaps = 47/294 (15%)
Query: 3   KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIE--RGHKIDANVAREIINHKQLRHPNI 60
           +Y  +  IG G +G+     +   K  VA+K I             REI      RH NI
Sbjct: 26  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHENI 85
Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFE----RICNAGRFSEDEARYFFQQLISG------ 110
           I   +++  PT +  + +     +L E    ++      S D   YF  Q++ G      
Sbjct: 86  IGINDIIRAPT-IEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS 144
Query: 111 -QICHRDLKLENTLLDGSPAPRLKICDFGYSK-SSLLHSRP---KSTVGTPAYIAPEVLS 165
             + HRDLK  N LL+ +    LKICDFG ++ +   H         V T  Y APE++ 
Sbjct: 145 ANVLHRDLKPSNLLLNTTS--DLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 202
Query: 166 RREYDGKLADVWSCGVTLYVML------------------VGAYPFEDQED--------P 199
             +   K  D+WS G  L  ML                  +G      QED         
Sbjct: 203 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCGINLKA 262
Query: 200 KNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 253
           +N+  ++     V +    + +      +LL ++   NP +RI +++  +HP+ 
Sbjct: 263 RNYLLSLPHKNKVPWNRL-FPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 315

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 66/295 (22%), Positives = 126/295 (42%), Gaps = 51/295 (17%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK--IDAN-VAREIINHKQLRHP 58
           E+Y+ +  +GSG +G      +  T   VA+K + +  +  I A    RE+   K ++H 
Sbjct: 34  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSKPFQSIIHAKRTYRELRLLKHMKHE 93
Query: 59  NIIRFKEVVLTPTHL-----AIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG--- 110
           N+I   +V      L       ++ +  G +L   I    + ++D  ++   Q++ G   
Sbjct: 94  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 152
Query: 111 ----QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST--VGTPAYIAPEVL 164
                I HRDLK  N  L  +    LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 153 IHSADIIHRDLKPSN--LAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 206
Query: 165 SRREYDGKLADVWSCGVTLYVMLVG--AYPFEDQ------------------------ED 198
               +  +  D+WS G  +  +L G   +P  D                         E 
Sbjct: 207 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 266
Query: 199 PKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 253
            +N+ ++++++  + +    ++  +    +LL ++ V +  +RIT  +  +H +F
Sbjct: 267 ARNYIQSLTQMPKMNFANV-FIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 320

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 65/295 (22%), Positives = 126/295 (42%), Gaps = 51/295 (17%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK--IDAN-VAREIINHKQLRHP 58
           E+Y+ +  +GSG +G      +  T   VA+K + R  +  I A    RE+   K ++H 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 59  NIIRFKEVVLTPTHL-----AIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG--- 110
           N+I   +V      L       ++ +  G +L   I    + ++D  ++   Q++ G   
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 140
Query: 111 ----QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST--VGTPAYIAPEVL 164
                I HRDLK  N  ++      LKI D+G ++    H+  + T  V T  Y APE++
Sbjct: 141 IHSADIIHRDLKPSNLAVNEDC--ELKILDYGLAR----HTDDEMTGYVATRWYRAPEIM 194
Query: 165 SRREYDGKLADVWSCGVTLYVMLVG--AYPFEDQ------------------------ED 198
               +  +  D+WS G  +  +L G   +P  D                         E 
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 254
Query: 199 PKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 253
            +N+ ++++++  + +    ++  +    +LL ++ V +  +RIT  +  +H +F
Sbjct: 255 ARNYIQSLTQMPKMNFANV-FIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 308

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 73/305 (23%), Positives = 120/305 (39%), Gaps = 58/305 (19%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVA---REIINHKQLRH 57
           +++Y+ +K IGSG  G+     +   +  VA+K + R  +   +     RE++  K + H
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNH 82
Query: 58  PNIIRFKEVVLTP-------THLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLI-- 108
            NII     V TP         + IVME         ++       E  +   +Q L+  
Sbjct: 83  KNIIGLLN-VFTPQKSLEEFQDVYIVMELMDAN--LSQVIQMELDHERMSYLLYQMLVGI 139
Query: 109 ----SGQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVL 164
               S  I HRDLK  N ++       LKI DFG ++++         V T  Y APEV+
Sbjct: 140 KHLHSAGIIHRDLKPSNIVVKSDAT--LKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 197
Query: 165 SRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMA--------VQYKI 216
               Y   + D+WS G  +  M+ G   F   +    + K I ++          +Q  +
Sbjct: 198 LGMGYKENV-DIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQPTV 256
Query: 217 PDYVH----------------------------ISQDCRNLLSRIFVANPSRRITIKEIK 248
             YV                              +   R+LLS++ V + S+RI++ E  
Sbjct: 257 RTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEAL 316
Query: 249 SHPWF 253
            HP+ 
Sbjct: 317 QHPYI 321

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 72/293 (24%), Positives = 120/293 (40%), Gaps = 45/293 (15%)
Query: 3   KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIE--RGHKIDANVAREIINHKQLRHPNI 60
           +Y  +  IG G +G+     +   K  VA++ I             REI    + RH NI
Sbjct: 28  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIRKISPFEHQTYCQRTLREIKILLRFRHENI 87
Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFE----RICNAGRFSEDEARYFFQQLISG------ 110
           I   +++  PT +  + +     +L E    ++      S D   YF  Q++ G      
Sbjct: 88  IGINDIIRAPT-IEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS 146
Query: 111 -QICHRDLKLENTLLDGSPAPRLKICDFGYSK-SSLLHSRP---KSTVGTPAYIAPEVLS 165
             + HRDLK  N LL+ +    LKICDFG ++ +   H         V T  Y APE++ 
Sbjct: 147 ANVLHRDLKPSNLLLNTTCD--LKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 204
Query: 166 RREYDGKLADVWSCGVTLYVML------------------VGAYPFEDQEDPKNFRKTIS 207
             +   K  D+WS G  L  ML                  +G      QED        +
Sbjct: 205 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 264
Query: 208 R--IMAVQY--KIP---DYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 253
           R  ++++ +  K+P    + +      +LL ++   NP +RI +++  +HP+ 
Sbjct: 265 RNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 317

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 70/301 (23%), Positives = 120/301 (39%), Gaps = 52/301 (17%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAR---EIINHKQLRH 57
           +++Y+ +K IGSG  G+     +      VA+K + R  +   +  R   E++  K + H
Sbjct: 17  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 76
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFE-RICNAGRFSEDEAR--YFFQQLISG---- 110
            NII    V      L    +     EL +  +C   +   D  R  Y   Q++ G    
Sbjct: 77  KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHL 136
Query: 111 ---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRR 167
               I HRDLK  N ++       LKI DFG ++++         V T  Y APEV+   
Sbjct: 137 HSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM 194
Query: 168 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMA--------VQYKIPDY 219
            Y   + D+WS G  +  M+     F  ++    + K I ++          +Q  + +Y
Sbjct: 195 GYKENV-DIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNY 253
Query: 220 VH----------------------------ISQDCRNLLSRIFVANPSRRITIKEIKSHP 251
           V                              +   R+LLS++ V +P++RI++ +   HP
Sbjct: 254 VENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHP 313
Query: 252 W 252
           +
Sbjct: 314 Y 314

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 73/224 (32%), Positives = 102/224 (45%), Gaps = 33/224 (14%)
Query: 7   MKDIGSGNFGVARLM----RNKNTKELVAMKYI--ERGHKIDANVAREIINHKQLRHPNI 60
           ++D+G G+FG   L      N  T E+VA+K +  + G +  +   +EI   + L H +I
Sbjct: 36  IRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHI 95
Query: 61  IRFKEVV--LTPTHLAIVMEYAAGGELFERICNAGRFSEDEARY--FFQQLISG------ 110
           I++K          L +VMEY   G L + +    R S   A+   F QQ+  G      
Sbjct: 96  IKYKGCCEDAGAASLQLVMEYVPLGSLRDYL---PRHSIGLAQLLLFAQQICEGMAYLHA 152
Query: 111 -QICHRDLKLENTLLDGSPAPRL-KICDFGYSKS---SLLHSRPKSTVGTPAY-IAPEVL 164
               HRDL   N LLD     RL KI DFG +K+        R +    +P +  APE L
Sbjct: 153 QHYIHRDLAARNVLLDND---RLVKIGDFGLAKAVPEGHEXYRVREDGDSPVFWYAPECL 209
Query: 165 SRREYDGKLA-DVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTIS 207
             +EY    A DVWS GVTLY +L   +    Q  P  F + I 
Sbjct: 210 --KEYKFYYASDVWSFGVTLYELLT--HCDSSQSPPTKFLELIG 249

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 70/301 (23%), Positives = 120/301 (39%), Gaps = 52/301 (17%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAR---EIINHKQLRH 57
           +++Y+ +K IGSG  G+     +      VA+K + R  +   +  R   E++  K + H
Sbjct: 17  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 76
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFE-RICNAGRFSEDEAR--YFFQQLISG---- 110
            NII    V      L    +     EL +  +C   +   D  R  Y   Q++ G    
Sbjct: 77  KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHL 136
Query: 111 ---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRR 167
               I HRDLK  N ++       LKI DFG ++++         V T  Y APEV+   
Sbjct: 137 HSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM 194
Query: 168 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMA--------VQYKIPDY 219
            Y   + D+WS G  +  M+     F  ++    + K I ++          +Q  + +Y
Sbjct: 195 GYKENV-DIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNY 253
Query: 220 VH----------------------------ISQDCRNLLSRIFVANPSRRITIKEIKSHP 251
           V                              +   R+LLS++ V +P++RI++ +   HP
Sbjct: 254 VENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHP 313
Query: 252 W 252
           +
Sbjct: 314 Y 314

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 70/302 (23%), Positives = 120/302 (39%), Gaps = 52/302 (17%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAR---EIINHKQLRH 57
           +++Y+ +K IGSG  G+     +      VA+K + R  +   +  R   E++  K + H
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 82
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFE-RICNAGRFSEDEAR--YFFQQLISG---- 110
            NII    V      L    +     EL +  +C   +   D  R  Y   Q++ G    
Sbjct: 83  KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHL 142
Query: 111 ---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRR 167
               I HRDLK  N ++       LKI DFG ++++         V T  Y APEV+   
Sbjct: 143 HSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM 200
Query: 168 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMA--------VQYKIPDY 219
            Y   + D+WS G  +  M+     F  ++    + K I ++          +Q  + +Y
Sbjct: 201 GYKENV-DIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNY 259
Query: 220 VH----------------------------ISQDCRNLLSRIFVANPSRRITIKEIKSHP 251
           V                              +   R+LLS++ V +P++RI++ +   HP
Sbjct: 260 VENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHP 319
Query: 252 WF 253
           + 
Sbjct: 320 YI 321

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 70/301 (23%), Positives = 120/301 (39%), Gaps = 52/301 (17%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAR---EIINHKQLRH 57
           +++Y+ +K IGSG  G+     +      VA+K + R  +   +  R   E++  K + H
Sbjct: 61  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 120
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFE-RICNAGRFSEDEAR--YFFQQLISG---- 110
            NII    V      L    +     EL +  +C   +   D  R  Y   Q++ G    
Sbjct: 121 KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHL 180
Query: 111 ---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRR 167
               I HRDLK  N ++       LKI DFG ++++         V T  Y APEV+   
Sbjct: 181 HSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM 238
Query: 168 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMA--------VQYKIPDY 219
            Y   + D+WS G  +  M+     F  ++    + K I ++          +Q  + +Y
Sbjct: 239 GYKENV-DIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNY 297
Query: 220 VH----------------------------ISQDCRNLLSRIFVANPSRRITIKEIKSHP 251
           V                              +   R+LLS++ V +P++RI++ +   HP
Sbjct: 298 VENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHP 357
Query: 252 W 252
           +
Sbjct: 358 Y 358

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 70/302 (23%), Positives = 120/302 (39%), Gaps = 52/302 (17%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAR---EIINHKQLRH 57
           +++Y+ +K IGSG  G+     +      VA+K + R  +   +  R   E++  K + H
Sbjct: 24  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 83
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFE-RICNAGRFSEDEAR--YFFQQLISG---- 110
            NII    V      L    +     EL +  +C   +   D  R  Y   Q++ G    
Sbjct: 84  KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHL 143
Query: 111 ---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRR 167
               I HRDLK  N ++       LKI DFG ++++         V T  Y APEV+   
Sbjct: 144 HSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM 201
Query: 168 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMA--------VQYKIPDY 219
            Y   + D+WS G  +  M+     F  ++    + K I ++          +Q  + +Y
Sbjct: 202 GYKENV-DIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNY 260
Query: 220 VH----------------------------ISQDCRNLLSRIFVANPSRRITIKEIKSHP 251
           V                              +   R+LLS++ V +P++RI++ +   HP
Sbjct: 261 VENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHP 320
Query: 252 WF 253
           + 
Sbjct: 321 YI 322

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 71/287 (24%), Positives = 122/287 (42%), Gaps = 44/287 (15%)
Query: 4   YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRF 63
           +E +  +G G FG     RN       A+K I    +  + +  E++    L H  ++R+
Sbjct: 8   FEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRY 67
Query: 64  KEVVL-------------TPTHLAIVMEYAAGGELFERICNAGRFSE-DEARYFFQQLI- 108
               L               + L I MEY   G L++ I +     + DE    F+Q++ 
Sbjct: 68  YAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILE 127
Query: 109 ------SGQICHRDLKLENTLLDGSPAPRLKICDFGYSKS---SL----LHSRP------ 149
                 S  I HRDLK  N  +D S    +KI DFG +K+   SL    L S+       
Sbjct: 128 ALSYIHSQGIIHRDLKPMNIFIDESR--NVKIGDFGLAKNVHRSLDILKLDSQNLPGSSD 185
Query: 150 --KSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTIS 207
              S +GT  Y+A EVL    +  +  D++S G+  + M+   YPF    +  N  K + 
Sbjct: 186 NLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI---YPFSTGMERVNILKKL- 241
Query: 208 RIMAVQYKIPDYVHISQDCRNLLSRIFVA-NPSRRITIKEIKSHPWF 253
           R +++++  PD+          + R+ +  +P++R   + + +  W 
Sbjct: 242 RSVSIEFP-PDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWL 287

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 70/302 (23%), Positives = 120/302 (39%), Gaps = 52/302 (17%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAR---EIINHKQLRH 57
           +++Y+ +K IGSG  G+     +      VA+K + R  +   +  R   E++  K + H
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 82
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFE-RICNAGRFSEDEAR--YFFQQLISG---- 110
            NII    V      L    +     EL +  +C   +   D  R  Y   Q++ G    
Sbjct: 83  KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHL 142
Query: 111 ---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRR 167
               I HRDLK  N ++       LKI DFG ++++         V T  Y APEV+   
Sbjct: 143 HSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM 200
Query: 168 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMA--------VQYKIPDY 219
            Y   + D+WS G  +  M+     F  ++    + K I ++          +Q  + +Y
Sbjct: 201 GYKENV-DIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNY 259
Query: 220 VH----------------------------ISQDCRNLLSRIFVANPSRRITIKEIKSHP 251
           V                              +   R+LLS++ V +P++RI++ +   HP
Sbjct: 260 VENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHP 319
Query: 252 WF 253
           + 
Sbjct: 320 YI 321

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 65/206 (31%), Positives = 89/206 (43%), Gaps = 32/206 (15%)
Query: 7   MKDIGSGNFGVARLMR----NKNTKELVAMKYIER-GHKIDANVAREIINHKQLRHPNII 61
           +  +G GNFG   L R      NT  LVA+K ++  G     +  REI   K L    I+
Sbjct: 12  ISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIV 71
Query: 62  RFKEVVLTPT--HLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGQIC------ 113
           +++ V   P    L +VMEY   G L + +    R   D +R     L S QIC      
Sbjct: 72  KYRGVSYGPGRPELRLVMEYLPSGCLRDFL-QRHRARLDASRLL---LYSSQICKGMEYL 127
Query: 114 ------HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPA-----YIAPE 162
                 HRDL   N L++      +KI DFG +K   L  +    V  P      + APE
Sbjct: 128 GSRRCVHRDLAARNILVESEA--HVKIADFGLAKLLPL-DKDXXVVREPGQSPIFWYAPE 184
Query: 163 VLSRREYDGKLADVWSCGVTLYVMLV 188
            LS   +  + +DVWS GV LY +  
Sbjct: 185 SLSDNIFS-RQSDVWSFGVVLYELFT 209

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 70/302 (23%), Positives = 120/302 (39%), Gaps = 52/302 (17%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAR---EIINHKQLRH 57
           +++Y+ +K IGSG  G+     +      VA+K + R  +   +  R   E++  K + H
Sbjct: 24  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 83
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFE-RICNAGRFSEDEAR--YFFQQLISG---- 110
            NII    V      L    +     EL +  +C   +   D  R  Y   Q++ G    
Sbjct: 84  KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHL 143
Query: 111 ---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRR 167
               I HRDLK  N ++       LKI DFG ++++         V T  Y APEV+   
Sbjct: 144 HSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM 201
Query: 168 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMA--------VQYKIPDY 219
            Y   + D+WS G  +  M+     F  ++    + K I ++          +Q  + +Y
Sbjct: 202 GYKENV-DIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNY 260
Query: 220 VH----------------------------ISQDCRNLLSRIFVANPSRRITIKEIKSHP 251
           V                              +   R+LLS++ V +P++RI++ +   HP
Sbjct: 261 VENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHP 320
Query: 252 WF 253
           + 
Sbjct: 321 YI 322

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 70/302 (23%), Positives = 120/302 (39%), Gaps = 52/302 (17%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAR---EIINHKQLRH 57
           +++Y+ +K IGSG  G+     +      VA+K + R  +   +  R   E++  K + H
Sbjct: 61  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 120
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFE-RICNAGRFSEDEAR--YFFQQLISG---- 110
            NII    V      L    +     EL +  +C   +   D  R  Y   Q++ G    
Sbjct: 121 KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHL 180
Query: 111 ---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRR 167
               I HRDLK  N ++       LKI DFG ++++         V T  Y APEV+   
Sbjct: 181 HSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM 238
Query: 168 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMA--------VQYKIPDY 219
            Y   + D+WS G  +  M+     F  ++    + K I ++          +Q  + +Y
Sbjct: 239 GYKENV-DIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNY 297
Query: 220 VH----------------------------ISQDCRNLLSRIFVANPSRRITIKEIKSHP 251
           V                              +   R+LLS++ V +P++RI++ +   HP
Sbjct: 298 VENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHP 357
Query: 252 WF 253
           + 
Sbjct: 358 YI 359

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 70/302 (23%), Positives = 120/302 (39%), Gaps = 52/302 (17%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAR---EIINHKQLRH 57
           +++Y+ +K IGSG  G+     +      VA+K + R  +   +  R   E++  K + H
Sbjct: 22  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 81
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFE-RICNAGRFSEDEAR--YFFQQLISG---- 110
            NII    V      L    +     EL +  +C   +   D  R  Y   Q++ G    
Sbjct: 82  KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHL 141
Query: 111 ---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRR 167
               I HRDLK  N ++       LKI DFG ++++         V T  Y APEV+   
Sbjct: 142 HSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM 199
Query: 168 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMA--------VQYKIPDY 219
            Y   + D+WS G  +  M+     F  ++    + K I ++          +Q  + +Y
Sbjct: 200 GYKENV-DIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNY 258
Query: 220 VH----------------------------ISQDCRNLLSRIFVANPSRRITIKEIKSHP 251
           V                              +   R+LLS++ V +P++RI++ +   HP
Sbjct: 259 VENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHP 318
Query: 252 WF 253
           + 
Sbjct: 319 YI 320

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 70/301 (23%), Positives = 120/301 (39%), Gaps = 52/301 (17%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAR---EIINHKQLRH 57
           +++Y+ +K IGSG  G+     +      VA+K + R  +   +  R   E++  K + H
Sbjct: 16  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 75
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFE-RICNAGRFSEDEAR--YFFQQLISG---- 110
            NII    V      L    +     EL +  +C   +   D  R  Y   Q++ G    
Sbjct: 76  KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHL 135
Query: 111 ---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRR 167
               I HRDLK  N ++       LKI DFG ++++         V T  Y APEV+   
Sbjct: 136 HSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM 193
Query: 168 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMA--------VQYKIPDY 219
            Y   + D+WS G  +  M+     F  ++    + K I ++          +Q  + +Y
Sbjct: 194 GYKENV-DIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNY 252
Query: 220 VH----------------------------ISQDCRNLLSRIFVANPSRRITIKEIKSHP 251
           V                              +   R+LLS++ V +P++RI++ +   HP
Sbjct: 253 VENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHP 312
Query: 252 W 252
           +
Sbjct: 313 Y 313

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 61.6 bits (148), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 75/308 (24%), Positives = 123/308 (39%), Gaps = 64/308 (20%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVA---REIINHKQLRH 57
           +++Y+ +K IGSG  G+     +   +  VA+K + R  +   +     RE++  K + H
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNH 82
Query: 58  PNIIRFKEVVLTP-------THLAIVMEY--AAGGELFERICNAGRFSEDEARYFFQQLI 108
            NII     V TP         + IVME   A   ++ +   +  R S     Y   Q++
Sbjct: 83  KNIIGLLN-VFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMS-----YLLYQML 136
Query: 109 SG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAP 161
            G        I HRDLK  N ++       LKI DFG ++++         V T  Y AP
Sbjct: 137 CGIKHLHSAGIIHRDLKPSNIVVKSDAT--LKILDFGLARTAGTSFMMTPYVVTRYYRAP 194
Query: 162 EVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMA--------VQ 213
           EV+    Y   + D+WS G  +  M+ G   F   +    + K I ++          +Q
Sbjct: 195 EVILGMGYKENV-DIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQ 253
Query: 214 YKIPDYVH----------------------------ISQDCRNLLSRIFVANPSRRITIK 245
             +  YV                              +   R+LLS++ V + S+RI++ 
Sbjct: 254 PTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVD 313
Query: 246 EIKSHPWF 253
           E   HP+ 
Sbjct: 314 EALQHPYI 321

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 75/308 (24%), Positives = 123/308 (39%), Gaps = 64/308 (20%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVA---REIINHKQLRH 57
           +++Y+ +K IGSG  G+     +   +  VA+K + R  +   +     RE++  K + H
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 82
Query: 58  PNIIRFKEVVLTP-------THLAIVMEY--AAGGELFERICNAGRFSEDEARYFFQQLI 108
            NII     V TP         + IVME   A   ++ +   +  R S     Y   Q++
Sbjct: 83  KNIIGLLN-VFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMS-----YLLYQML 136
Query: 109 SG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAP 161
            G        I HRDLK  N ++       LKI DFG ++++         V T  Y AP
Sbjct: 137 CGIKHLHSAGIIHRDLKPSNIVVKSDAT--LKILDFGLARTAGTSFMMTPYVVTRYYRAP 194
Query: 162 EVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMA--------VQ 213
           EV+    Y   + D+WS G  +  M+ G   F   +    + K I ++          +Q
Sbjct: 195 EVILGMGYKENV-DIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQ 253
Query: 214 YKIPDYVH----------------------------ISQDCRNLLSRIFVANPSRRITIK 245
             +  YV                              +   R+LLS++ V + S+RI++ 
Sbjct: 254 PTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVD 313
Query: 246 EIKSHPWF 253
           E   HP+ 
Sbjct: 314 EALQHPYI 321

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 97/212 (45%), Gaps = 29/212 (13%)
Query: 10  IGSGNFGV---ARLMRNKNTKELVAMKYIERGHKIDANVAREIINHK----QLRHPNIIR 62
           IG+G FG     RL      +  VA+K ++ G+       RE ++      Q  HPNIIR
Sbjct: 22  IGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYT--ERQRREFLSEASIMGQFEHPNIIR 79
Query: 63  FKEVVLTPTHLAIVMEYAAGGEL--FERICNAGRFSEDEARYFFQQLISG-------QIC 113
            + VV     + I+ E+   G L  F R+ N G+F+  +     + + SG          
Sbjct: 80  LEGVVTNSMPVMILTEFMENGALDSFLRL-NDGQFTVIQLVGMLRGIASGMRYLAEMSYV 138
Query: 114 HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP---KSTVGTPA---YIAPEVLSRR 167
           HRDL   N L++ +     K+ DFG S+    +S      S++G      + APE ++ R
Sbjct: 139 HRDLAARNILVNSNLV--CKVSDFGLSRFLEENSSDPTYTSSLGGKIPIRWTAPEAIAFR 196
Query: 168 EYDGKLADVWSCGVTLY-VMLVGAYPFEDQED 198
           ++    +D WS G+ ++ VM  G  P+ D  +
Sbjct: 197 KFTSA-SDAWSYGIVMWEVMSFGERPYWDMSN 227

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 55/198 (27%), Positives = 93/198 (46%), Gaps = 27/198 (13%)
Query: 10  IGSGNFGVARLMRNKNTKELVAMKYIER-GHKIDANVAREIINHKQLRHPNIIRFKEVVL 68
           +G G FG A  + ++ T E++ MK + R   +      +E+   + L HPN+++F  V+ 
Sbjct: 18  LGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLY 77
Query: 69  TPTHLAIVMEYAAGGELFERICNA-GRFSEDEARYFFQQLISG-------QICHRDLKLE 120
               L  + EY  GG L   I +   ++   +   F + + SG        I HRDL   
Sbjct: 78  KDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSH 137
Query: 121 NTLLDGSPAPRLKICDFGYSKSSL--------LHSRPK-------STVGTPAYIAPEVLS 165
           N L+  +    + + DFG ++  +        L S  K       + VG P ++APE+++
Sbjct: 138 NCLVREN--KNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMIN 195
Query: 166 RREYDGKLADVWSCGVTL 183
            R YD K+ DV+S G+ L
Sbjct: 196 GRSYDEKV-DVFSFGIVL 212

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 61.2 bits (147), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 72/294 (24%), Positives = 118/294 (40%), Gaps = 54/294 (18%)
Query: 4   YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRF 63
           Y   K IG+G+FGV    +   + E VA+K + +  +      RE+   + ++HPN++  
Sbjct: 42  YTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRFKN---RELQIMRIVKHPNVVDL 97
Query: 64  KEVVLT------PTHLAIVMEYAAGGELFERICNAGRFSEDEAR---------YFFQQLI 108
           K    +         L +V+EY       E +  A R      +         Y +Q L 
Sbjct: 98  KAFFYSNGDKKDEVFLNLVLEYVP-----ETVYRASRHYAKLKQTMPMLLIKLYMYQLLR 152
Query: 109 SGQ------ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPE 162
           S        ICHRD+K +N LLD  P+  LK+ DFG +K  +      S + +  Y APE
Sbjct: 153 SLAYIHSIGICHRDIKPQNLLLD-PPSGVLKLIDFGSAKILIAGEPNVSXICSRYYRAPE 211
Query: 163 VLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMA-----VQYKIP 217
           ++          D+WS G  +  ++ G   F  +       + I  +       ++   P
Sbjct: 212 LIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNP 271
Query: 218 DYVH------------------ISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 253
           +Y+                      D  +L+SR+    PS R+T  E   HP+F
Sbjct: 272 NYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFF 325

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 61.2 bits (147), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 62/206 (30%), Positives = 87/206 (42%), Gaps = 17/206 (8%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKID--ANVAREIINHKQLRHPN 59
           E   L + IG GNFG     R +    LVA+K        D  A   +E    KQ  HPN
Sbjct: 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPN 173
Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSE--------DEARYFFQQLISGQ 111
           I+R   V      + IVME   GG+    +   G             +A    + L S  
Sbjct: 174 IVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKC 233
Query: 112 ICHRDLKLENTLLDGSPAPRLKICDFGYSK--SSLLHSRPKSTVGTPA-YIAPEVLSRRE 168
             HRDL   N L+  +    LKI DFG S+  +  +++        P  + APE L+   
Sbjct: 234 CIHRDLAARNCLV--TEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGR 291
Query: 169 YDGKLADVWSCGVTLY-VMLVGAYPF 193
           Y  + +DVWS G+ L+    +GA P+
Sbjct: 292 YSSE-SDVWSFGILLWETFSLGASPY 316

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 61.2 bits (147), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 95/212 (44%), Gaps = 29/212 (13%)
Query: 10  IGSGNFGV---ARLMRNKNTKELVAMKYIERGHKIDANVAREIINHK----QLRHPNIIR 62
           IG+G FG     RL      +  VA+K ++ G+       RE ++      Q  HPNIIR
Sbjct: 24  IGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYT--ERQRREFLSEASIMGQFEHPNIIR 81
Query: 63  FKEVVLTPTHLAIVMEYAAGGEL--FERICNAGRFSEDEARYFFQQLISG-------QIC 113
            + VV     + I+ E+   G L  F R+ N G+F+  +     + + SG          
Sbjct: 82  LEGVVTNSMPVMILTEFMENGALDSFLRL-NDGQFTVIQLVGMLRGIASGMRYLAEMSYV 140
Query: 114 HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPA------YIAPEVLSRR 167
           HRDL   N L++ +     K+ DFG S+    +S   +   +        + APE ++ R
Sbjct: 141 HRDLAARNILVNSNLV--CKVSDFGLSRFLEENSSDPTETSSLGGKIPIRWTAPEAIAFR 198
Query: 168 EYDGKLADVWSCGVTLY-VMLVGAYPFEDQED 198
           ++    +D WS G+ ++ VM  G  P+ D  +
Sbjct: 199 KFTSA-SDAWSYGIVMWEVMSFGERPYWDMSN 229

>pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 89/211 (42%), Gaps = 20/211 (9%)
Query: 3   KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHP---- 58
           +YE++K IG G+FG      +    + VA+K +    +     A EI   + LR      
Sbjct: 98  RYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDN 157
Query: 59  --NIIRFKEVVLTPTHLAIVMEYAAGG--ELFERICNAGRFSEDEARYFFQQLIS----- 109
             N+I   E      H+ +  E  +    EL ++    G FS    R F   ++      
Sbjct: 158 TMNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQG-FSLPLVRKFAHSILQCLDAL 216
Query: 110 --GQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRR 167
              +I H DLK EN LL       +K+ DFG   S   H R  + + +  Y APEV+   
Sbjct: 217 HKNRIIHCDLKPENILLKQQGRSGIKVIDFG--SSCYEHQRVYTXIQSRFYRAPEVILGA 274
Query: 168 EYDGKLADVWSCGVTLYVMLVGAYPFEDQED 198
            Y G   D+WS G  L  +L G YP    ED
Sbjct: 275 RY-GMPIDMWSLGCILAELLTG-YPLLPGED 303

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 65/295 (22%), Positives = 125/295 (42%), Gaps = 51/295 (17%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK--IDAN-VAREIINHKQLRHP 58
           E+Y+ +  +GSG +G      +  T   VA+K + R  +  I A    RE+   K ++H 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 59  NIIRFKEVVLTPTHL-----AIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG--- 110
           N+I   +V      L       ++ +  G +L   I    + ++D  ++   Q++ G   
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 140
Query: 111 ----QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST--VGTPAYIAPEVL 164
                I HRDLK  N  ++      LKI DF  ++    H+  + T  V T  Y APE++
Sbjct: 141 IHSADIIHRDLKPSNLAVNEDC--ELKILDFYLAR----HTDDEMTGYVATRWYRAPEIM 194
Query: 165 SRREYDGKLADVWSCGVTLYVMLVG--AYPFEDQ------------------------ED 198
               +  +  D+WS G  +  +L G   +P  D                         E 
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 254
Query: 199 PKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 253
            +N+ ++++++  + +    ++  +    +LL ++ V +  +RIT  +  +H +F
Sbjct: 255 ARNYIQSLTQMPKMNFANV-FIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 308

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 71/302 (23%), Positives = 120/302 (39%), Gaps = 52/302 (17%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAR---EIINHKQLRH 57
           +++Y+ +K IGSG  G+     +   +  VA+K + R  +   +  R   E++  K + H
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 82
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFE-RICNAGRFSEDEAR--YFFQQLISG---- 110
            NII    V      L    +     EL +  +C   +   D  R  Y   Q++ G    
Sbjct: 83  KNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHL 142
Query: 111 ---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRR 167
               I HRDLK  N ++       LKI DFG ++++      +  V T  Y APEV+   
Sbjct: 143 HSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSFMMEPEVVTRYYRAPEVILGM 200
Query: 168 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMA--------VQYKIPDY 219
            Y   + D+WS G  +  M+     F  ++    + K I ++          +Q  +  Y
Sbjct: 201 GYKENV-DLWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRTY 259
Query: 220 VH----------------------------ISQDCRNLLSRIFVANPSRRITIKEIKSHP 251
           V                              +   R+LLS++ V + S+RI++ E   HP
Sbjct: 260 VENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHP 319
Query: 252 WF 253
           + 
Sbjct: 320 YI 321

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 60.8 bits (146), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 66/295 (22%), Positives = 125/295 (42%), Gaps = 51/295 (17%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK--IDAN-VAREIINHKQLRHP 58
           E+Y+ +  +GSG +G      +  T   VA+K + R  +  I A    RE+   K ++H 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 59  NIIRFKEVVLTPTHL-----AIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG--- 110
           N+I   +V      L       ++ +  G +L   I    + ++D  ++   Q++ G   
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 140
Query: 111 ----QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST--VGTPAYIAPEVL 164
                I HRDLK  N  L  +    LKI  FG ++    H+  + T  V T  Y APE++
Sbjct: 141 IHSADIIHRDLKPSN--LAVNEDCELKILGFGLAR----HTDDEMTGYVATRWYRAPEIM 194
Query: 165 SRREYDGKLADVWSCGVTLYVMLVG--AYPFEDQ------------------------ED 198
               +  +  D+WS G  +  +L G   +P  D                         E 
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 254
Query: 199 PKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 253
            +N+ ++++++  + +    ++  +    +LL ++ V +  +RIT  +  +H +F
Sbjct: 255 ARNYIQSLTQMPKMNFA-NVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 308

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 65/206 (31%), Positives = 89/206 (43%), Gaps = 32/206 (15%)
Query: 7   MKDIGSGNFGVARLMR----NKNTKELVAMKYIER-GHKIDANVAREIINHKQLRHPNII 61
           +  +G GNFG   L R      NT  LVA+K ++  G     +  REI   K L    I+
Sbjct: 15  ISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIV 74
Query: 62  RFKEVVLTPTH--LAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGQIC------ 113
           +++ V   P    L +VMEY   G L + +    R   D +R     L S QIC      
Sbjct: 75  KYRGVSYGPGRQSLRLVMEYLPSGCLRDFL-QRHRARLDASRLL---LYSSQICKGMEYL 130
Query: 114 ------HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPA-----YIAPE 162
                 HRDL   N L++      +KI DFG +K   L  +    V  P      + APE
Sbjct: 131 GSRRCVHRDLAARNILVESEA--HVKIADFGLAKLLPL-DKDYYVVREPGQSPIFWYAPE 187
Query: 163 VLSRREYDGKLADVWSCGVTLYVMLV 188
            LS   +  + +DVWS GV LY +  
Sbjct: 188 SLSDNIFS-RQSDVWSFGVVLYELFT 212

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 91/207 (43%), Gaps = 29/207 (14%)
Query: 6   LMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKE 65
            +K++G+G FGV +  + +   + VA+K I+ G   +     E      L H  +++   
Sbjct: 13  FLKELGTGQFGVVKYGKWRGQYD-VAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYG 71
Query: 66  VVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLI--------------SGQ 111
           V      + I+ EY A G      C      E   R+  QQL+              S Q
Sbjct: 72  VCTKQRPIFIITEYMANG------CLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ 125
Query: 112 ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPA---YIAPEVLSRRE 168
             HRDL   N L++      +K+ DFG S+  +L     S+ G+     +  PEVL   +
Sbjct: 126 FLHRDLAARNCLVNDQGV--VKVSDFGLSR-YVLDDEYTSSRGSKFPVRWSPPEVLMYSK 182
Query: 169 YDGKLADVWSCGVTLY-VMLVGAYPFE 194
           +  K +D+W+ GV ++ +  +G  P+E
Sbjct: 183 FSSK-SDIWAFGVLMWEIYSLGKMPYE 208

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 75/308 (24%), Positives = 123/308 (39%), Gaps = 64/308 (20%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVA---REIINHKQLRH 57
           +++Y+ +K IGSG  G+     +   +  VA+K + R  +   +     RE++  K + H
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 82
Query: 58  PNIIRFKEVVLTP-------THLAIVMEY--AAGGELFERICNAGRFSEDEARYFFQQLI 108
            NII     V TP         + IVME   A   ++ +   +  R S     Y   Q++
Sbjct: 83  KNIIGLLN-VFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMS-----YLLYQML 136
Query: 109 SG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAP 161
            G        I HRDLK  N ++       LKI DFG ++++         V T  Y AP
Sbjct: 137 CGIKHLHSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSFMMTPYVVTRYYRAP 194
Query: 162 EVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMA--------VQ 213
           EV+    Y   + D+WS G  +  M+ G   F   +    + K I ++          +Q
Sbjct: 195 EVILGMGYKENV-DIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQ 253
Query: 214 YKIPDYVH----------------------------ISQDCRNLLSRIFVANPSRRITIK 245
             +  YV                              +   R+LLS++ V + S+RI++ 
Sbjct: 254 PTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVD 313
Query: 246 EIKSHPWF 253
           E   HP+ 
Sbjct: 314 EALQHPYI 321

>pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 89/211 (42%), Gaps = 20/211 (9%)
Query: 3   KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHP---- 58
           +YE++K IG G+FG      +    + VA+K +    +     A EI   + LR      
Sbjct: 98  RYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDN 157
Query: 59  --NIIRFKEVVLTPTHLAIVMEYAAGG--ELFERICNAGRFSEDEARYFFQQLIS----- 109
             N+I   E      H+ +  E  +    EL ++    G FS    R F   ++      
Sbjct: 158 TMNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQG-FSLPLVRKFAHSILQCLDAL 216
Query: 110 --GQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRR 167
              +I H DLK EN LL       +K+ DFG   S   H R  + + +  Y APEV+   
Sbjct: 217 HKNRIIHCDLKPENILLKQQGRSGIKVIDFG--SSCYEHQRVYTXIQSRFYRAPEVILGA 274
Query: 168 EYDGKLADVWSCGVTLYVMLVGAYPFEDQED 198
            Y G   D+WS G  L  +L G YP    ED
Sbjct: 275 RY-GMPIDMWSLGCILAELLTG-YPLLPGED 303

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 65/206 (31%), Positives = 89/206 (43%), Gaps = 32/206 (15%)
Query: 7   MKDIGSGNFGVARLMR----NKNTKELVAMKYIER-GHKIDANVAREIINHKQLRHPNII 61
           +  +G GNFG   L R      NT  LVA+K ++  G     +  REI   K L    I+
Sbjct: 28  ISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIV 87
Query: 62  RFKEVVLTPTH--LAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGQIC------ 113
           +++ V   P    L +VMEY   G L + +    R   D +R     L S QIC      
Sbjct: 88  KYRGVSYGPGRQSLRLVMEYLPSGCLRDFL-QRHRARLDASRLL---LYSSQICKGMEYL 143
Query: 114 ------HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPA-----YIAPE 162
                 HRDL   N L++      +KI DFG +K   L  +    V  P      + APE
Sbjct: 144 GSRRCVHRDLAARNILVESEA--HVKIADFGLAKLLPL-DKDYYVVREPGQSPIFWYAPE 200
Query: 163 VLSRREYDGKLADVWSCGVTLYVMLV 188
            LS   +  + +DVWS GV LY +  
Sbjct: 201 SLSDNIFS-RQSDVWSFGVVLYELFT 225

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 96/208 (46%), Gaps = 28/208 (13%)
Query: 8   KDIGSGNFG---VARLMRNKNTKEL-VAMKYIERGH--KIDANVAREIINHKQLRHPNII 61
           K IG+G FG      L  +   KE+ VA+K ++ G+  K   +   E     Q  H NII
Sbjct: 50  KVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNII 109
Query: 62  RFKEVVLTPTHLAIVMEYAAGGEL--FERICNAGRFSEDEARYFFQQLISG-------QI 112
           R + V+     + I+ EY   G L  F R  + G FS  +     + + +G         
Sbjct: 110 RLEGVISKYKPMMIITEYMENGALDKFLREKD-GEFSVLQLVGMLRGIAAGMKYLANMNY 168
Query: 113 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPA------YIAPEVLSR 166
            HRDL   N L++ +     K+ DFG S+  +L   P++T  T        + APE +S 
Sbjct: 169 VHRDLAARNILVNSNLV--CKVSDFGLSR--VLEDDPEATYTTSGGKIPIRWTAPEAISY 224
Query: 167 REYDGKLADVWSCGVTLY-VMLVGAYPF 193
           R++    +DVWS G+ ++ VM  G  P+
Sbjct: 225 RKFTSA-SDVWSFGIVMWEVMTYGERPY 251

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 65/206 (31%), Positives = 89/206 (43%), Gaps = 32/206 (15%)
Query: 7   MKDIGSGNFGVARLMR----NKNTKELVAMKYIER-GHKIDANVAREIINHKQLRHPNII 61
           +  +G GNFG   L R      NT  LVA+K ++  G     +  REI   K L    I+
Sbjct: 16  ISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIV 75
Query: 62  RFKEVVLTPTH--LAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGQIC------ 113
           +++ V   P    L +VMEY   G L + +    R   D +R     L S QIC      
Sbjct: 76  KYRGVSYGPGRQSLRLVMEYLPSGCLRDFL-QRHRARLDASRLL---LYSSQICKGMEYL 131
Query: 114 ------HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPA-----YIAPE 162
                 HRDL   N L++      +KI DFG +K   L  +    V  P      + APE
Sbjct: 132 GSRRCVHRDLAARNILVESEA--HVKIADFGLAKLLPL-DKDYYVVREPGQSPIFWYAPE 188
Query: 163 VLSRREYDGKLADVWSCGVTLYVMLV 188
            LS   +  + +DVWS GV LY +  
Sbjct: 189 SLSDNIFS-RQSDVWSFGVVLYELFT 213

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 99/207 (47%), Gaps = 27/207 (13%)
Query: 8   KDIGSGNFG--VARLMRNKNTKEL-VAMKYIERGH--KIDANVAREIINHKQLRHPNIIR 62
           K +G+G FG   +  ++  + KE+ VA+K ++ G+  K   +   E     Q  HPNIIR
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 110
Query: 63  FKEVVLTPTHLAIVMEYAAGGEL--FERICNAGRFSEDEARYFFQQLISGQ-------IC 113
            + VV     + IV EY   G L  F R  +A +F+  +     + + SG          
Sbjct: 111 LEGVVTKSKPVMIVTEYMENGSLDSFLRKHDA-QFTVIQLVGMLRGIASGMKYLSDMGFV 169
Query: 114 HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPA------YIAPEVLSRR 167
           HRDL   N L++ +     K+ DFG S+  +L   P++   T        + +PE ++ R
Sbjct: 170 HRDLAARNILINSNLV--CKVSDFGLSR--VLEDDPEAAYTTRGGKIPIRWTSPEAIAYR 225
Query: 168 EYDGKLADVWSCGVTLY-VMLVGAYPF 193
           ++    +DVWS G+ L+ VM  G  P+
Sbjct: 226 KFTSA-SDVWSYGIVLWEVMSYGERPY 251

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 71/302 (23%), Positives = 119/302 (39%), Gaps = 52/302 (17%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVA---REIINHKQLRH 57
           +++Y+ +K IGSG  G+     +   +  VA+K + R  +   +     RE++  K + H
Sbjct: 28  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 87
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFE-RICNAGRFSEDEAR--YFFQQLISG---- 110
            NII    V      L    +     EL +  +C   +   D  R  Y   Q++ G    
Sbjct: 88  KNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHL 147
Query: 111 ---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRR 167
               I HRDLK  N ++       LKI DFG ++++         V T  Y APEV+   
Sbjct: 148 HSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM 205
Query: 168 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMA--------VQYKIPDY 219
            Y   + D+WS G  +  M+     F  ++    + K I ++          +Q  +  Y
Sbjct: 206 GYKENV-DLWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRTY 264
Query: 220 VH----------------------------ISQDCRNLLSRIFVANPSRRITIKEIKSHP 251
           V                              +   R+LLS++ V + S+RI++ E   HP
Sbjct: 265 VENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHP 324
Query: 252 WF 253
           + 
Sbjct: 325 YI 326

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 64/234 (27%), Positives = 100/234 (42%), Gaps = 32/234 (13%)
Query: 6   LMKDI-GSGNFGVARLMRNKNTKELVAMKY---IERGHKIDANVAREIINHKQLRHPNII 61
           L+ DI G G        R+K T +L A+K    I     +D  + RE    K+L H NI+
Sbjct: 12  LLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQM-REFEVLKKLNHKNIV 70
Query: 62  RF--KEVVLTPTHLAIVMEYAAGGELF---ERICNAGRFSEDEARYFFQQLISGQ----- 111
           +    E   T  H  ++ME+   G L+   E   NA    E E     + ++ G      
Sbjct: 71  KLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE 130
Query: 112 --ICHRDLKLENTLL----DGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLS 165
             I HR++K  N +     DG      K+ DFG ++      +     GT  Y+ P++  
Sbjct: 131 NGIVHRNIKPGNIMRVIGEDGQSV--YKLTDFGAARELEDDEQFVXLYGTEEYLHPDMYE 188
Query: 166 R--------REYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMA 211
           R        ++Y G   D+WS GVT Y    G+ PF   E P+  ++ + +I+ 
Sbjct: 189 RAVLRKDHQKKY-GATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT 241

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 70/301 (23%), Positives = 119/301 (39%), Gaps = 52/301 (17%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVA---REIINHKQLRH 57
           +++Y+ +K IGSG  G+     +   +  VA+K + R  +   +     RE++  K + H
Sbjct: 17  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 76
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFE-RICNAGRFSEDEAR--YFFQQLISG---- 110
            NII    V      L    +     EL +  +C   +   D  R  Y   Q++ G    
Sbjct: 77  KNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHL 136
Query: 111 ---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRR 167
               I HRDLK  N ++       LKI DFG ++++         V T  Y APEV+   
Sbjct: 137 HSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM 194
Query: 168 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRI------------------ 209
            Y   + D+WS G  +  M+     F  ++    + K I ++                  
Sbjct: 195 GYKENV-DLWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRTY 253
Query: 210 ---------MAVQYKIPDYVHISQD---------CRNLLSRIFVANPSRRITIKEIKSHP 251
                     + +   PD +  +            R+LLS++ V + S+RI++ E   HP
Sbjct: 254 VENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHP 313
Query: 252 W 252
           +
Sbjct: 314 Y 314

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 79/328 (24%), Positives = 125/328 (38%), Gaps = 80/328 (24%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERG--HKIDAN-VAREIINHKQLR- 56
           + KYEL+K +G G +G+     ++ T E+VA+K I     +  DA    REI+   +L  
Sbjct: 8   LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSG 67
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLI-------S 109
           H NI+    V+       + + +         +  A        +Y   QLI       S
Sbjct: 68  HENIVNLLNVLRADNDRDVYLVFDYMETDLHAVIRANILEPVHKQYVVYQLIKVIKYLHS 127
Query: 110 GQICHRDLKLENTLLDGSPAPRLKICDFGYSKS-----SLLHSRPKST------------ 152
           G + HRD+K  N LL+      +K+ DFG S+S      + ++ P S             
Sbjct: 128 GGLLHRDMKPSNILLNAE--CHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQP 185
Query: 153 -----VGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVML------------------VG 189
                V T  Y APE+L       K  D+WS G  L  +L                  +G
Sbjct: 186 ILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERIIG 245
Query: 190 AYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQ---------------------DCR- 227
              F   ED ++ +   ++ M    K  + V I Q                     DC  
Sbjct: 246 VIDFPSNEDVESIQSPFAKTMIESLK--EKVEIRQSNKRDIFTKWKNLLLKINPKADCNE 303
Query: 228 ---NLLSRIFVANPSRRITIKEIKSHPW 252
              +LL ++   NP++RI+  +   HP+
Sbjct: 304 EALDLLDKLLQFNPNKRISANDALKHPF 331

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 65/295 (22%), Positives = 125/295 (42%), Gaps = 51/295 (17%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK--IDAN-VAREIINHKQLRHP 58
           E+Y+ +  +GSG +G      +  T   VA+K + R  +  I A    RE+   K ++H 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 59  NIIRFKEVVLTPTHL-----AIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG--- 110
           N+I   +V      L       ++ +  G +L   I    + ++D  ++   Q++ G   
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 140
Query: 111 ----QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST--VGTPAYIAPEVL 164
                I HRDLK  N  ++      LKI D G ++    H+  + T  V T  Y APE++
Sbjct: 141 IHSADIIHRDLKPSNLAVNEDC--ELKILDAGLAR----HTDDEMTGYVATRWYRAPEIM 194
Query: 165 SRREYDGKLADVWSCGVTLYVMLVG--AYPFEDQ------------------------ED 198
               +  +  D+WS G  +  +L G   +P  D                         E 
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 254
Query: 199 PKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 253
            +N+ ++++++  + +    ++  +    +LL ++ V +  +RIT  +  +H +F
Sbjct: 255 ARNYIQSLTQMPKMNFANV-FIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 308

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 64/246 (26%), Positives = 113/246 (45%), Gaps = 21/246 (8%)
Query: 10  IGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKEVVLT 69
           IGSG+FG     +      +  +K ++   +       E+   ++ RH NI+ F    +T
Sbjct: 44  IGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGY-MT 102
Query: 70  PTHLAIVMEYAAGGELFERI-CNAGRFSE----DEARYFFQQ---LISGQICHRDLKLEN 121
             +LAIV ++  G  L++ +     +F      D AR   Q    L +  I HRD+K  N
Sbjct: 103 KDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNN 162
Query: 122 TLLDGSPAPRLKICDFGYS--KSSLLHSRP-KSTVGTPAYIAPEVLSRREYD--GKLADV 176
             L       +KI DFG +  KS    S+  +   G+  ++APEV+  ++ +     +DV
Sbjct: 163 IFL--HEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDV 220
Query: 177 WSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVA 236
           +S G+ LY ++ G  P+       N R  I  ++   Y  PD   + ++C   + R+ VA
Sbjct: 221 YSYGIVLYELMTGELPYSH----INNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRL-VA 275
Query: 237 NPSRRI 242
           +  +++
Sbjct: 276 DCVKKV 281

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 62/206 (30%), Positives = 86/206 (41%), Gaps = 17/206 (8%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKID--ANVAREIINHKQLRHPN 59
           E   L + IG GNFG     R +    LVA+K        D  A   +E    KQ  HPN
Sbjct: 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPN 173
Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSE--------DEARYFFQQLISGQ 111
           I+R   V      + IVME   GG+    +   G             +A    + L S  
Sbjct: 174 IVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKC 233
Query: 112 ICHRDLKLENTLLDGSPAPRLKICDFGYSK--SSLLHSRPKSTVGTPA-YIAPEVLSRRE 168
             HRDL   N L+  +    LKI DFG S+  +  + +        P  + APE L+   
Sbjct: 234 CIHRDLAARNCLV--TEKNVLKISDFGMSREEADGVXAASGGLRQVPVKWTAPEALNYGR 291
Query: 169 YDGKLADVWSCGVTLY-VMLVGAYPF 193
           Y  + +DVWS G+ L+    +GA P+
Sbjct: 292 YSSE-SDVWSFGILLWETFSLGASPY 316

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 99/207 (47%), Gaps = 27/207 (13%)
Query: 8   KDIGSGNFG--VARLMRNKNTKEL-VAMKYIERGH--KIDANVAREIINHKQLRHPNIIR 62
           K +G+G FG   +  ++  + KE+ VA+K ++ G+  K   +   E     Q  HPNIIR
Sbjct: 22  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 81
Query: 63  FKEVVLTPTHLAIVMEYAAGGEL--FERICNAGRFSEDEARYFFQQLISGQ-------IC 113
            + VV     + IV EY   G L  F R  +A +F+  +     + + SG          
Sbjct: 82  LEGVVTKSKPVMIVTEYMENGSLDSFLRKHDA-QFTVIQLVGMLRGIASGMKYLSDMGYV 140
Query: 114 HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPA------YIAPEVLSRR 167
           HRDL   N L++ +     K+ DFG S+  +L   P++   T        + +PE ++ R
Sbjct: 141 HRDLAARNILINSNLV--CKVSDFGLSR--VLEDDPEAAYTTRGGKIPIRWTSPEAIAYR 196
Query: 168 EYDGKLADVWSCGVTLY-VMLVGAYPF 193
           ++    +DVWS G+ L+ VM  G  P+
Sbjct: 197 KFTSA-SDVWSYGIVLWEVMSYGERPY 222

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 99/207 (47%), Gaps = 27/207 (13%)
Query: 8   KDIGSGNFG--VARLMRNKNTKEL-VAMKYIERGH--KIDANVAREIINHKQLRHPNIIR 62
           K +G+G FG   +  ++  + KE+ VA+K ++ G+  K   +   E     Q  HPNIIR
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 110
Query: 63  FKEVVLTPTHLAIVMEYAAGGEL--FERICNAGRFSEDEARYFFQQLISGQ-------IC 113
            + VV     + IV EY   G L  F R  +A +F+  +     + + SG          
Sbjct: 111 LEGVVTKSKPVMIVTEYMENGSLDSFLRKHDA-QFTVIQLVGMLRGIASGMKYLSDMGYV 169
Query: 114 HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPA------YIAPEVLSRR 167
           HRDL   N L++ +     K+ DFG S+  +L   P++   T        + +PE ++ R
Sbjct: 170 HRDLAARNILINSNLV--CKVSDFGLSR--VLEDDPEAAYTTRGGKIPIRWTSPEAIAYR 225
Query: 168 EYDGKLADVWSCGVTLY-VMLVGAYPF 193
           ++    +DVWS G+ L+ VM  G  P+
Sbjct: 226 KFTSA-SDVWSYGIVLWEVMSYGERPY 251

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 99/207 (47%), Gaps = 27/207 (13%)
Query: 8   KDIGSGNFG--VARLMRNKNTKEL-VAMKYIERGH--KIDANVAREIINHKQLRHPNIIR 62
           K +G+G FG   +  ++  + KE+ VA+K ++ G+  K   +   E     Q  HPNIIR
Sbjct: 39  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 98
Query: 63  FKEVVLTPTHLAIVMEYAAGGEL--FERICNAGRFSEDEARYFFQQLISGQ-------IC 113
            + VV     + IV EY   G L  F R  +A +F+  +     + + SG          
Sbjct: 99  LEGVVTKSKPVMIVTEYMENGSLDSFLRKHDA-QFTVIQLVGMLRGIASGMKYLSDMGYV 157
Query: 114 HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPA------YIAPEVLSRR 167
           HRDL   N L++ +     K+ DFG S+  +L   P++   T        + +PE ++ R
Sbjct: 158 HRDLAARNILINSNLV--CKVSDFGLSR--VLEDDPEAAYTTRGGKIPIRWTSPEAIAYR 213
Query: 168 EYDGKLADVWSCGVTLY-VMLVGAYPF 193
           ++    +DVWS G+ L+ VM  G  P+
Sbjct: 214 KFTSA-SDVWSYGIVLWEVMSYGERPY 239

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 99/207 (47%), Gaps = 27/207 (13%)
Query: 8   KDIGSGNFG--VARLMRNKNTKEL-VAMKYIERGH--KIDANVAREIINHKQLRHPNIIR 62
           K +G+G FG   +  ++  + KE+ VA+K ++ G+  K   +   E     Q  HPNIIR
Sbjct: 49  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 108
Query: 63  FKEVVLTPTHLAIVMEYAAGGEL--FERICNAGRFSEDEARYFFQQLISGQ-------IC 113
            + VV     + IV EY   G L  F R  +A +F+  +     + + SG          
Sbjct: 109 LEGVVTKSKPVMIVTEYMENGSLDSFLRKHDA-QFTVIQLVGMLRGIASGMKYLSDMGYV 167
Query: 114 HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPA------YIAPEVLSRR 167
           HRDL   N L++ +     K+ DFG S+  +L   P++   T        + +PE ++ R
Sbjct: 168 HRDLAARNILINSNLV--CKVSDFGLSR--VLEDDPEAAYTTRGGKIPIRWTSPEAIAYR 223
Query: 168 EYDGKLADVWSCGVTLY-VMLVGAYPF 193
           ++    +DVWS G+ L+ VM  G  P+
Sbjct: 224 KFTSA-SDVWSYGIVLWEVMSYGERPY 249

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 65/295 (22%), Positives = 125/295 (42%), Gaps = 51/295 (17%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK--IDAN-VAREIINHKQLRHP 58
           E+Y+ +  +GSG +G      +  T   VA+K + R  +  I A    RE+   K ++H 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 59  NIIRFKEVVLTPTHL-----AIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG--- 110
           N+I   +V      L       ++ +  G +L   I    + ++D  ++   Q++ G   
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 140
Query: 111 ----QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST--VGTPAYIAPEVL 164
                I HRDLK  N  ++      LKI D G ++    H+  + T  V T  Y APE++
Sbjct: 141 IHSADIIHRDLKPSNLAVNEDC--ELKILDGGLAR----HTDDEMTGYVATRWYRAPEIM 194
Query: 165 SRREYDGKLADVWSCGVTLYVMLVG--AYPFEDQ------------------------ED 198
               +  +  D+WS G  +  +L G   +P  D                         E 
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 254
Query: 199 PKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 253
            +N+ ++++++  + +    ++  +    +LL ++ V +  +RIT  +  +H +F
Sbjct: 255 ARNYIQSLTQMPKMNFANV-FIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 308

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 72/300 (24%), Positives = 116/300 (38%), Gaps = 51/300 (17%)
Query: 3   KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVA-REIINHKQLRHPNII 61
           +Y  +K +G G  G+     + +  + VA+K I          A REI   ++L H NI+
Sbjct: 12  RYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIV 71
Query: 62  RFKEVVLTPTHLAIVMEYAAGGEL-------------FERICNAGRFSEDEARYFFQQLI 108
           +  E+ L P+   +  +  +  EL                +   G   E+ AR F  QL+
Sbjct: 72  KVFEI-LGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHARLFMYQLL 130
Query: 109 SG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVG----TPA 157
            G        + HRDLK  N  ++      LKI DFG ++    H   K  +     T  
Sbjct: 131 RGLKYIHSANVLHRDLKPANLFINTEDL-VLKIGDFGLARIMDPHYSHKGHLSEGLVTKW 189
Query: 158 YIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYK-- 215
           Y +P +L       K  D+W+ G     ML G   F    + +  +  +  I  V  +  
Sbjct: 190 YRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHEEDR 249
Query: 216 ------IPDYVH----------------ISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 253
                 IP Y+                 IS++  + L +I   +P  R+T +E  SHP+ 
Sbjct: 250 QELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYM 309

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 99/207 (47%), Gaps = 27/207 (13%)
Query: 8   KDIGSGNFG--VARLMRNKNTKEL-VAMKYIERGH--KIDANVAREIINHKQLRHPNIIR 62
           K +G+G FG   +  ++  + KE+ VA+K ++ G+  K   +   E     Q  HPNIIR
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 110
Query: 63  FKEVVLTPTHLAIVMEYAAGGEL--FERICNAGRFSEDEARYFFQQLISGQ-------IC 113
            + VV     + IV EY   G L  F R  +A +F+  +     + + SG          
Sbjct: 111 LEGVVTKSKPVMIVTEYMENGSLDSFLRKHDA-QFTVIQLVGMLRGIASGMKYLSDMGYV 169
Query: 114 HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPA------YIAPEVLSRR 167
           HRDL   N L++ +     K+ DFG S+  +L   P++   T        + +PE ++ R
Sbjct: 170 HRDLAARNILINSNLV--CKVSDFGLSR--VLEDDPEAAYTTRGGKIPIRWTSPEAIAYR 225
Query: 168 EYDGKLADVWSCGVTLY-VMLVGAYPF 193
           ++    +DVWS G+ L+ VM  G  P+
Sbjct: 226 KFTSA-SDVWSYGIVLWEVMSYGERPY 251

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 99/207 (47%), Gaps = 27/207 (13%)
Query: 8   KDIGSGNFG--VARLMRNKNTKEL-VAMKYIERGH--KIDANVAREIINHKQLRHPNIIR 62
           K +G+G FG   +  ++  + KE+ VA+K ++ G+  K   +   E     Q  HPNIIR
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 110
Query: 63  FKEVVLTPTHLAIVMEYAAGGEL--FERICNAGRFSEDEARYFFQQLISGQ-------IC 113
            + VV     + IV EY   G L  F R  +A +F+  +     + + SG          
Sbjct: 111 LEGVVTKSKPVMIVTEYMENGSLDSFLRKHDA-QFTVIQLVGMLRGIASGMKYLSDMGYV 169
Query: 114 HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPA------YIAPEVLSRR 167
           HRDL   N L++ +     K+ DFG S+  +L   P++   T        + +PE ++ R
Sbjct: 170 HRDLAARNILINSNLV--CKVSDFGLSR--VLEDDPEAAYTTRGGKIPIRWTSPEAIAYR 225
Query: 168 EYDGKLADVWSCGVTLY-VMLVGAYPF 193
           ++    +DVWS G+ L+ VM  G  P+
Sbjct: 226 KFTSA-SDVWSYGIVLWEVMSYGERPY 251

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 99/207 (47%), Gaps = 27/207 (13%)
Query: 8   KDIGSGNFG--VARLMRNKNTKEL-VAMKYIERGH--KIDANVAREIINHKQLRHPNIIR 62
           K +G+G FG   +  ++  + KE+ VA+K ++ G+  K   +   E     Q  HPNIIR
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 110
Query: 63  FKEVVLTPTHLAIVMEYAAGGEL--FERICNAGRFSEDEARYFFQQLISGQ-------IC 113
            + VV     + IV EY   G L  F R  +A +F+  +     + + SG          
Sbjct: 111 LEGVVTKSKPVMIVTEYMENGSLDSFLRKHDA-QFTVIQLVGMLRGIASGMKYLSDMGYV 169
Query: 114 HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPA------YIAPEVLSRR 167
           HRDL   N L++ +     K+ DFG S+  +L   P++   T        + +PE ++ R
Sbjct: 170 HRDLAARNILINSNLV--CKVSDFGLSR--VLEDDPEAAYTTRGGKIPIRWTSPEAIAYR 225
Query: 168 EYDGKLADVWSCGVTLY-VMLVGAYPF 193
           ++    +DVWS G+ L+ VM  G  P+
Sbjct: 226 KFTSA-SDVWSYGIVLWEVMSYGERPY 251

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 66/267 (24%), Positives = 111/267 (41%), Gaps = 35/267 (13%)
Query: 9   DIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINH-----KQLRHPNIIRF 63
           +IG G+F    + +  +T+  V + + E   +      R+         K L+HPNI+RF
Sbjct: 33  EIGRGSFKT--VYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEXLKGLQHPNIVRF 90
Query: 64  ----KEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG--------- 110
               +  V     + +V E    G L   +           R + +Q++ G         
Sbjct: 91  YDSWESTVKGKKCIVLVTELXTSGTLKTYLKRFKVXKIKVLRSWCRQILKGLQFLHTRTP 150
Query: 111 QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYD 170
            I HRDLK +N  + G P   +KI D G + +    S  K+ +GTP + APE    + YD
Sbjct: 151 PIIHRDLKCDNIFITG-PTGSVKIGDLGLA-TLKRASFAKAVIGTPEFXAPEXYEEK-YD 207
Query: 171 GKLADVWSCGVTLYVMLVGAYPF-EDQEDPKNFRKTISRIMAVQYK---IPDYVHISQDC 226
             + DV++ G          YP+ E Q   + +R+  S +    +    IP+   I + C
Sbjct: 208 ESV-DVYAFGXCXLEXATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGC 266
Query: 227 RNLLSRIFVANPSRRITIKEIKSHPWF 253
                     N   R +IK++ +H +F
Sbjct: 267 -------IRQNKDERYSIKDLLNHAFF 286

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 72/293 (24%), Positives = 119/293 (40%), Gaps = 45/293 (15%)
Query: 3   KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIE--RGHKIDANVAREIINHKQLRHPNI 60
           +Y  +  IG G +G+     +   K  VA+K I             REI    + RH NI
Sbjct: 24  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI 83
Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFE----RICNAGRFSEDEARYFFQQLISG------ 110
           I   +++  PT +  + +     +L E    ++      S D   YF  Q++ G      
Sbjct: 84  IGINDIIRAPT-IEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS 142
Query: 111 -QICHRDLKLENTLLDGSPAPRLKICDFGYSK-SSLLHSRP---KSTVGTPAYIAPEVLS 165
             + HRDLK  N LL+ +    LKI DFG ++ +   H         V T  Y APE++ 
Sbjct: 143 ANVLHRDLKPSNLLLNTTXD--LKIXDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 200
Query: 166 RREYDGKLADVWSCGVTLYVML------------------VGAYPFEDQEDPKNFRKTIS 207
             +   K  D+WS G  L  ML                  +G      QED        +
Sbjct: 201 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNXIINLKA 260
Query: 208 R--IMAVQY--KIP---DYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 253
           R  ++++ +  K+P    + +      +LL ++   NP +RI +++  +HP+ 
Sbjct: 261 RNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 313

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 65/295 (22%), Positives = 125/295 (42%), Gaps = 51/295 (17%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK--IDAN-VAREIINHKQLRHP 58
           E+Y+ +  +GSG +G      +  T   VA+K + R  +  I A    RE+   K ++H 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 59  NIIRFKEVVLTPTHL-----AIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG--- 110
           N+I   +V      L       ++ +  G +L   I    + ++D  ++   Q++ G   
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 140
Query: 111 ----QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST--VGTPAYIAPEVL 164
                I HRDLK  N  ++      LKI D G ++    H+  + T  V T  Y APE++
Sbjct: 141 IHSADIIHRDLKPSNLAVNEDC--ELKILDRGLAR----HTDDEMTGYVATRWYRAPEIM 194
Query: 165 SRREYDGKLADVWSCGVTLYVMLVG--AYPFEDQ------------------------ED 198
               +  +  D+WS G  +  +L G   +P  D                         E 
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 254
Query: 199 PKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 253
            +N+ ++++++  + +    ++  +    +LL ++ V +  +RIT  +  +H +F
Sbjct: 255 ARNYIQSLTQMPKMNFANV-FIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 308

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 70/223 (31%), Positives = 102/223 (45%), Gaps = 31/223 (13%)
Query: 7   MKDIGSGNFGVARLM----RNKNTKELVAMKYI--ERGHKIDANVAREIINHKQLRHPNI 60
           ++D+G G+FG   L      N  T E+VA+K +  + G +  +   +EI   + L H +I
Sbjct: 19  IRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHI 78
Query: 61  IRFKEVV--LTPTHLAIVMEYAAGGELFERICNAGRFSEDEARY--FFQQLISG------ 110
           I++K          L +VMEY   G L + +    R S   A+   F QQ+  G      
Sbjct: 79  IKYKGCCEDQGEKSLQLVMEYVPLGSLRDYL---PRHSIGLAQLLLFAQQICEGMAYLHS 135
Query: 111 -QICHRDLKLENTLLDGSPAPRLKICDFGYSKS---SLLHSRPKSTVGTPA-YIAPEVLS 165
               HR+L   N LLD      +KI DFG +K+      + R +    +P  + APE L 
Sbjct: 136 QHYIHRNLAARNVLLDNDRL--VKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECL- 192
Query: 166 RREYDGKLA-DVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTIS 207
            +EY    A DVWS GVTLY +L   +    Q  P  F + I 
Sbjct: 193 -KEYKFYYASDVWSFGVTLYELLT--HCDSSQSPPTKFLELIG 232

>pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 87/211 (41%), Gaps = 20/211 (9%)
Query: 3   KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHP---- 58
           +YE++K IG G FG      +    + VA+K +    +     A EI   + LR      
Sbjct: 98  RYEVLKVIGKGXFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDN 157
Query: 59  --NIIRFKEVVLTPTHLAIVMEYAAGG--ELFERICNAGRFSEDEARYFFQQLIS----- 109
             N+I   E      H+ +  E  +    EL ++    G FS    R F   ++      
Sbjct: 158 TMNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQG-FSLPLVRKFAHSILQCLDAL 216
Query: 110 --GQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRR 167
              +I H DLK EN LL       +K+ DFG   S   H R    + +  Y APEV+   
Sbjct: 217 HKNRIIHCDLKPENILLKQQGRSGIKVIDFG--SSCYEHQRVYXXIQSRFYRAPEVILGA 274
Query: 168 EYDGKLADVWSCGVTLYVMLVGAYPFEDQED 198
            Y G   D+WS G  L  +L G YP    ED
Sbjct: 275 RY-GMPIDMWSLGCILAELLTG-YPLLPGED 303

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 70/223 (31%), Positives = 102/223 (45%), Gaps = 31/223 (13%)
Query: 7   MKDIGSGNFGVARLM----RNKNTKELVAMKYI--ERGHKIDANVAREIINHKQLRHPNI 60
           ++D+G G+FG   L      N  T E+VA+K +  + G +  +   +EI   + L H +I
Sbjct: 19  IRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHI 78
Query: 61  IRFKEVV--LTPTHLAIVMEYAAGGELFERICNAGRFSEDEARY--FFQQLISG------ 110
           I++K          L +VMEY   G L + +    R S   A+   F QQ+  G      
Sbjct: 79  IKYKGCCEDQGEKSLQLVMEYVPLGSLRDYL---PRHSIGLAQLLLFAQQICEGMAYLHA 135
Query: 111 -QICHRDLKLENTLLDGSPAPRLKICDFGYSKS---SLLHSRPKSTVGTPA-YIAPEVLS 165
               HR+L   N LLD      +KI DFG +K+      + R +    +P  + APE L 
Sbjct: 136 QHYIHRNLAARNVLLDNDRL--VKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECL- 192
Query: 166 RREYDGKLA-DVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTIS 207
            +EY    A DVWS GVTLY +L   +    Q  P  F + I 
Sbjct: 193 -KEYKFYYASDVWSFGVTLYELLT--HCDSSQSPPTKFLELIG 232

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 92/204 (45%), Gaps = 29/204 (14%)
Query: 7   MKDIGSGNFGVARLM----RNKNTKELVAMKYIERGH--KIDANVAREIINHKQLRHPNI 60
           ++D+G G+FG   L      N  T E+VA+K ++ G   ++ +   REI   + L H +I
Sbjct: 14  IRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHI 73
Query: 61  IRFKEVV--LTPTHLAIVMEYAAGGEL---FERICNAGRFSEDEARYFFQQLISG----- 110
           +++K          + +VMEY   G L     R C        +   F QQ+  G     
Sbjct: 74  VKYKGCCEDQGEKSVQLVMEYVPLGSLRDYLPRHC----VGLAQLLLFAQQICEGMAYLH 129
Query: 111 --QICHRDLKLENTLLDGSPAPRLKICDFGYSKS---SLLHSRPKSTVGTPA-YIAPEVL 164
                HR L   N LLD      +KI DFG +K+      + R +    +P  + APE L
Sbjct: 130 AQHYIHRALAARNVLLDNDRL--VKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECL 187
Query: 165 SRREYDGKLADVWSCGVTLYVMLV 188
              ++    +DVWS GVTLY +L 
Sbjct: 188 KECKFY-YASDVWSFGVTLYELLT 210

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 89/214 (41%), Gaps = 28/214 (13%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANV----AREIINHKQLRH 57
           ++YEL + +G G      L R+      VA+K +      D +      RE  N   L H
Sbjct: 12  DRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNH 71
Query: 58  PNIIRFKEVVLTPTHLA----IVMEYAAGGELFERICNAGRFSED----------EARYF 103
           P I+   +     T       IVMEY  G  L + +   G  +            +A  F
Sbjct: 72  PAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNF 131
Query: 104 FQQLISGQICHRDLKLENTLLDGSPAPRLKICDFGYSK----SSLLHSRPKSTVGTPAYI 159
             Q     I HRD+K  N L+  + A  +K+ DFG ++    S     +  + +GT  Y+
Sbjct: 132 SHQ---NGIIHRDVKPANILISATNA--VKVVDFGIARAIADSGNSVXQTAAVIGTAQYL 186
Query: 160 APEVLSRREYDGKLADVWSCGVTLYVMLVGAYPF 193
           +PE       D + +DV+S G  LY +L G  PF
Sbjct: 187 SPEQARGDSVDAR-SDVYSLGCVLYEVLTGEPPF 219

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 92/204 (45%), Gaps = 29/204 (14%)
Query: 7   MKDIGSGNFGVARLM----RNKNTKELVAMKYIERGH--KIDANVAREIINHKQLRHPNI 60
           ++D+G G+FG   L      N  T E+VA+K ++ G   ++ +   REI   + L H +I
Sbjct: 13  IRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHI 72
Query: 61  IRFKEVV--LTPTHLAIVMEYAAGGEL---FERICNAGRFSEDEARYFFQQLISG----- 110
           +++K          + +VMEY   G L     R C        +   F QQ+  G     
Sbjct: 73  VKYKGCCEDQGEKSVQLVMEYVPLGSLRDYLPRHC----VGLAQLLLFAQQICEGMAYLH 128
Query: 111 --QICHRDLKLENTLLDGSPAPRLKICDFGYSKS---SLLHSRPKSTVGTPA-YIAPEVL 164
                HR L   N LLD      +KI DFG +K+      + R +    +P  + APE L
Sbjct: 129 AQHYIHRALAARNVLLDNDRL--VKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECL 186
Query: 165 SRREYDGKLADVWSCGVTLYVMLV 188
              ++    +DVWS GVTLY +L 
Sbjct: 187 KECKFY-YASDVWSFGVTLYELLT 209

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 90/214 (42%), Gaps = 28/214 (13%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANV----AREIINHKQLRH 57
           ++YEL + +G G      L R+      VA+K +      D +      RE  N   L H
Sbjct: 12  DRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNH 71
Query: 58  PNIIRFKEVVLTPTHLA----IVMEYAAGGELFERICNAGRFSED----------EARYF 103
           P I+   +     T       IVMEY  G  L + +   G  +            +A  F
Sbjct: 72  PAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNF 131
Query: 104 FQQLISGQICHRDLKLENTLLDGSPAPRLKICDFGYSK----SSLLHSRPKSTVGTPAYI 159
             Q     I HRD+K  N ++  + A  +K+ DFG ++    S    ++  + +GT  Y+
Sbjct: 132 SHQ---NGIIHRDVKPANIMISATNA--VKVMDFGIARAIADSGNSVTQTAAVIGTAQYL 186
Query: 160 APEVLSRREYDGKLADVWSCGVTLYVMLVGAYPF 193
           +PE       D + +DV+S G  LY +L G  PF
Sbjct: 187 SPEQARGDSVDAR-SDVYSLGCVLYEVLTGEPPF 219

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 69/301 (22%), Positives = 119/301 (39%), Gaps = 52/301 (17%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAR---EIINHKQLRH 57
           +++Y+ +K IGSG  G+     +      VA+K + R  +   +  R   E++  K + H
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNH 82
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFE-RICNAGRFSEDEAR--YFFQQLISG---- 110
            NII    V      L    +     EL +  +    +   D  R  Y   Q++ G    
Sbjct: 83  KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSYLLYQMLXGIKHL 142
Query: 111 ---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRR 167
               I HRDLK  N ++       LKI DFG ++++         V T  Y APEV+   
Sbjct: 143 HSAGIIHRDLKPSNIVVKSDXT--LKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM 200
Query: 168 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMA--------VQYKIPDY 219
            Y   + D+WS G  +  M+     F  ++    + K I ++          +Q  + +Y
Sbjct: 201 GYKENV-DIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNY 259
Query: 220 VH----------------------------ISQDCRNLLSRIFVANPSRRITIKEIKSHP 251
           V                              +   R+LLS++ V +P++RI++ +   HP
Sbjct: 260 VENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHP 319
Query: 252 W 252
           +
Sbjct: 320 Y 320

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 99/207 (47%), Gaps = 27/207 (13%)
Query: 8   KDIGSGNFG--VARLMRNKNTKEL-VAMKYIERGH--KIDANVAREIINHKQLRHPNIIR 62
           K +G+G FG   +  ++  + KE+ VA+K ++ G+  K   +   E     Q  HPNIIR
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 110
Query: 63  FKEVVLTPTHLAIVMEYAAGGEL--FERICNAGRFSEDEARYFFQQLISGQ-------IC 113
            + VV     + IV EY   G L  F R  +A +F+  +     + + SG          
Sbjct: 111 LEGVVTKSKPVMIVTEYMENGSLDSFLRKHDA-QFTVIQLVGMLRGIASGMKYLSDMGYV 169
Query: 114 HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPA------YIAPEVLSRR 167
           HRDL   N L++ +     K+ DFG ++  +L   P++   T        + +PE ++ R
Sbjct: 170 HRDLAARNILINSNLV--CKVSDFGLAR--VLEDDPEAAYTTRGGKIPIRWTSPEAIAYR 225
Query: 168 EYDGKLADVWSCGVTLY-VMLVGAYPF 193
           ++    +DVWS G+ L+ VM  G  P+
Sbjct: 226 KFTSA-SDVWSYGIVLWEVMSYGERPY 251

>pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 66/224 (29%), Positives = 95/224 (42%), Gaps = 23/224 (10%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAR------EIIN-HK 53
           M++YE+   IG G+FG      ++  +E VA+K I +  K   N A+      E++N H 
Sbjct: 53  MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKII-KNKKAFLNQAQIEVRLLELMNKHD 111
Query: 54  QLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFE--RICNAGRFSEDEARYFFQQLISG- 110
                 I+  K   +   HL +V E  +   L++  R  N    S +  R F QQ+ +  
Sbjct: 112 TEMKYYIVHLKRHFMFRNHLCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTAL 170
Query: 111 --------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPE 162
                    I H DLK EN LL       +KI DFG   S  L  R    + +  Y +PE
Sbjct: 171 LFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFG--SSCQLGQRIYQXIQSRFYRSPE 228
Query: 163 VLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTI 206
           VL    YD  + D+WS G  L  M  G   F    +     K +
Sbjct: 229 VLLGMPYDLAI-DMWSLGCILVEMHTGEPLFSGANEVDQMNKIV 271

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 90/214 (42%), Gaps = 28/214 (13%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANV----AREIINHKQLRH 57
           ++YEL + +G G      L R+      VA+K +      D +      RE  N   L H
Sbjct: 12  DRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNH 71
Query: 58  PNIIRFKEVVLTPTHLA----IVMEYAAGGELFERICNAGRFSED----------EARYF 103
           P I+   +     T       IVMEY  G  L + +   G  +            +A  F
Sbjct: 72  PAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNF 131
Query: 104 FQQLISGQICHRDLKLENTLLDGSPAPRLKICDFGYSK----SSLLHSRPKSTVGTPAYI 159
             Q     I HRD+K  N ++  + A  +K+ DFG ++    S    ++  + +GT  Y+
Sbjct: 132 SHQ---NGIIHRDVKPANIMISATNA--VKVMDFGIARAIADSGNSVTQTAAVIGTAQYL 186
Query: 160 APEVLSRREYDGKLADVWSCGVTLYVMLVGAYPF 193
           +PE       D + +DV+S G  LY +L G  PF
Sbjct: 187 SPEQARGDSVDAR-SDVYSLGCVLYEVLTGEPPF 219

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 65/212 (30%), Positives = 96/212 (45%), Gaps = 27/212 (12%)
Query: 9   DIGSGNFGVAR--LMRNKNTKELVAMKYIERG-HKIDAN-VAREIINHKQLRHPNIIRFK 64
           ++G GNFG  R  + R +  +  VA+K +++G  K D   + RE     QL +P I+R  
Sbjct: 17  ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 76
Query: 65  EVVLTPTHLAIVMEYAAGGELFERICNAGRFSE---DEARYFFQQLISG-------QICH 114
            V      L +VME A GG L + +   G+  E           Q+  G          H
Sbjct: 77  GVCQAEA-LMLVMEMAGGGPLHKFL--VGKREEIPVSNVAELLHQVSMGMKYLEEKNFVH 133
Query: 115 RDLKLENTLLDGSPAPRLKICDFGYSKS-----SLLHSRPKSTVGTPAYIAPEVLSRREY 169
           RDL   N LL        KI DFG SK+     S   +R         Y APE ++ R++
Sbjct: 134 RDLAARNVLLVNRHYA--KISDFGLSKALGADDSYYTARSAGKWPLKWY-APECINFRKF 190
Query: 170 DGKLADVWSCGVTLYVML-VGAYPFEDQEDPK 200
             + +DVWS GVT++  L  G  P++  + P+
Sbjct: 191 SSR-SDVWSYGVTMWEALSYGQKPYKKMKGPE 221

>pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 66/224 (29%), Positives = 95/224 (42%), Gaps = 23/224 (10%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAR------EIIN-HK 53
           M++YE+   IG G+FG      ++  +E VA+K I +  K   N A+      E++N H 
Sbjct: 53  MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKII-KNKKAFLNQAQIEVRLLELMNKHD 111
Query: 54  QLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFE--RICNAGRFSEDEARYFFQQLISG- 110
                 I+  K   +   HL +V E  +   L++  R  N    S +  R F QQ+ +  
Sbjct: 112 TEMKYYIVHLKRHFMFRNHLCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTAL 170
Query: 111 --------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPE 162
                    I H DLK EN LL       +KI DFG   S  L  R    + +  Y +PE
Sbjct: 171 LFLATPELSIIHCDLKPENILLCNPKRXAIKIVDFG--SSCQLGQRIYQXIQSRFYRSPE 228
Query: 163 VLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTI 206
           VL    YD  + D+WS G  L  M  G   F    +     K +
Sbjct: 229 VLLGMPYDLAI-DMWSLGCILVEMHTGEPLFSGANEVDQMNKIV 271

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 90/214 (42%), Gaps = 28/214 (13%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANV----AREIINHKQLRH 57
           ++YEL + +G G      L R+      VA+K +      D +      RE  N   L H
Sbjct: 12  DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNH 71
Query: 58  PNIIRFKEVVLTPTHLA----IVMEYAAGGELFERICNAGRFSED----------EARYF 103
           P I+   +     T       IVMEY  G  L + +   G  +            +A  F
Sbjct: 72  PAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNF 131
Query: 104 FQQLISGQICHRDLKLENTLLDGSPAPRLKICDFGYSK----SSLLHSRPKSTVGTPAYI 159
             Q     I HRD+K  N ++  + A  +K+ DFG ++    S    ++  + +GT  Y+
Sbjct: 132 SHQ---NGIIHRDVKPANIMISATNA--VKVMDFGIARAIADSGNSVTQTAAVIGTAQYL 186
Query: 160 APEVLSRREYDGKLADVWSCGVTLYVMLVGAYPF 193
           +PE       D + +DV+S G  LY +L G  PF
Sbjct: 187 SPEQARGDSVDAR-SDVYSLGCVLYEVLTGEPPF 219

>pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 66/224 (29%), Positives = 95/224 (42%), Gaps = 23/224 (10%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAR------EIIN-HK 53
           M++YE+   IG G+FG      ++  +E VA+K I +  K   N A+      E++N H 
Sbjct: 34  MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKII-KNKKAFLNQAQIEVRLLELMNKHD 92
Query: 54  QLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFE--RICNAGRFSEDEARYFFQQLISG- 110
                 I+  K   +   HL +V E  +   L++  R  N    S +  R F QQ+ +  
Sbjct: 93  TEMKYYIVHLKRHFMFRNHLCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTAL 151
Query: 111 --------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPE 162
                    I H DLK EN LL       +KI DFG   S  L  R    + +  Y +PE
Sbjct: 152 LFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFG--SSCQLGQRIYQXIQSRFYRSPE 209
Query: 163 VLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTI 206
           VL    YD  + D+WS G  L  M  G   F    +     K +
Sbjct: 210 VLLGMPYDLAI-DMWSLGCILVEMHTGEPLFSGANEVDQMNKIV 252

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 69/301 (22%), Positives = 119/301 (39%), Gaps = 52/301 (17%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAR---EIINHKQLRH 57
           +++Y+ +K IGSG  G+     +      VA+K + R  +   +  R   E++  K + H
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNH 82
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFE-RICNAGRFSEDEAR--YFFQQLISG---- 110
            NII    V      L    +     EL +  +    +   D  R  Y   Q++ G    
Sbjct: 83  KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSYLLYQMLCGIKHL 142
Query: 111 ---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRR 167
               I HRDLK  N ++       LKI DFG ++++         V T  Y APEV+   
Sbjct: 143 HSAGIIHRDLKPSNIVVKSDXT--LKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM 200
Query: 168 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMA--------VQYKIPDY 219
            Y   + D+WS G  +  M+     F  ++    + K I ++          +Q  + +Y
Sbjct: 201 GYKENV-DIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNY 259
Query: 220 VH----------------------------ISQDCRNLLSRIFVANPSRRITIKEIKSHP 251
           V                              +   R+LLS++ V +P++RI++ +   HP
Sbjct: 260 VENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHP 319
Query: 252 W 252
           +
Sbjct: 320 Y 320

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 58.2 bits (139), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 98/207 (47%), Gaps = 27/207 (13%)
Query: 8   KDIGSGNFG--VARLMRNKNTKEL-VAMKYIERGH--KIDANVAREIINHKQLRHPNIIR 62
           K +G+G FG   +  ++  + KE+ VA+K ++ G+  K   +   E     Q  HPNIIR
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 110
Query: 63  FKEVVLTPTHLAIVMEYAAGGEL--FERICNAGRFSEDEARYFFQQLISGQ-------IC 113
            + VV     + IV EY   G L  F R  +A +F+  +     + + SG          
Sbjct: 111 LEGVVTKSKPVMIVTEYMENGSLDSFLRKHDA-QFTVIQLVGMLRGIASGMKYLSDMGYV 169
Query: 114 HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPA------YIAPEVLSRR 167
           HRDL   N L++ +     K+ DFG  +  +L   P++   T        + +PE ++ R
Sbjct: 170 HRDLAARNILINSNLV--CKVSDFGLGR--VLEDDPEAAYTTRGGKIPIRWTSPEAIAYR 225
Query: 168 EYDGKLADVWSCGVTLY-VMLVGAYPF 193
           ++    +DVWS G+ L+ VM  G  P+
Sbjct: 226 KFTSA-SDVWSYGIVLWEVMSYGERPY 251

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 58.2 bits (139), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 70/287 (24%), Positives = 121/287 (42%), Gaps = 44/287 (15%)
Query: 4   YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRF 63
           +E +  +G G FG     RN       A+K I    +  + +  E++    L H  ++R+
Sbjct: 8   FEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRY 67
Query: 64  KEVVL-------------TPTHLAIVMEYAAGGELFERICNAGRFSE-DEARYFFQQLI- 108
               L               + L I MEY     L++ I +     + DE    F+Q++ 
Sbjct: 68  YAAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQRDEYWRLFRQILE 127
Query: 109 ------SGQICHRDLKLENTLLDGSPAPRLKICDFGYSKS---SL----LHSRP------ 149
                 S  I HRDLK  N  +D S    +KI DFG +K+   SL    L S+       
Sbjct: 128 ALSYIHSQGIIHRDLKPMNIFIDESR--NVKIGDFGLAKNVHRSLDILKLDSQNLPGSSD 185
Query: 150 --KSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTIS 207
              S +GT  Y+A EVL    +  +  D++S G+  + M+   YPF    +  N  K + 
Sbjct: 186 NLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI---YPFSTGMERVNILKKL- 241
Query: 208 RIMAVQYKIPDYVHISQDCRNLLSRIFVA-NPSRRITIKEIKSHPWF 253
           R +++++  PD+          + R+ +  +P++R   + + +  W 
Sbjct: 242 RSVSIEFP-PDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWL 287

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 58.2 bits (139), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 90/214 (42%), Gaps = 28/214 (13%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANV----AREIINHKQLRH 57
           ++YEL + +G G      L R+      VA+K +      D +      RE  N   L H
Sbjct: 29  DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNH 88
Query: 58  PNIIRFKEVVLTPTHLA----IVMEYAAGGELFERICNAGRFSED----------EARYF 103
           P I+   +     T       IVMEY  G  L + +   G  +            +A  F
Sbjct: 89  PAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNF 148
Query: 104 FQQLISGQICHRDLKLENTLLDGSPAPRLKICDFGYSK----SSLLHSRPKSTVGTPAYI 159
             Q     I HRD+K  N ++  + A  +K+ DFG ++    S    ++  + +GT  Y+
Sbjct: 149 SHQ---NGIIHRDVKPANIMISATNA--VKVMDFGIARAIADSGNSVTQTAAVIGTAQYL 203
Query: 160 APEVLSRREYDGKLADVWSCGVTLYVMLVGAYPF 193
           +PE       D + +DV+S G  LY +L G  PF
Sbjct: 204 SPEQARGDSVDAR-SDVYSLGCVLYEVLTGEPPF 236

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 75/279 (26%), Positives = 117/279 (41%), Gaps = 32/279 (11%)
Query: 8   KDIGSGNFG---VARLMRNKNTKELVAMKYIERGH--KIDANVAREIINHKQLRHPNIIR 62
           K IGSG+ G     RL         VA+K ++ G+  +   +   E     Q  HPNIIR
Sbjct: 55  KIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIR 114
Query: 63  FKEVVLTPTHLAIVMEYAAGGEL--FERICNAGRFSEDEARYFFQQLISGQ-------IC 113
            + VV       IV EY   G L  F R  + G+F+  +     + + +G          
Sbjct: 115 LEGVVTRGRLAMIVTEYMENGSLDTFLR-THDGQFTIMQLVGMLRGVGAGMRYLSDLGYV 173
Query: 114 HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPA------YIAPEVLSRR 167
           HRDL   N L+D +     K+ DFG S+  +L   P +   T        + APE ++ R
Sbjct: 174 HRDLAARNVLVDSNLV--CKVSDFGLSR--VLEDDPDAAXTTTGGKIPIRWTAPEAIAFR 229
Query: 168 EYDGKLADVWSCGVTLY-VMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDC 226
            +    +DVWS GV ++ V+  G  P+ +  +    R  IS +    Y++P  +      
Sbjct: 230 TFS-SASDVWSFGVVMWEVLAYGERPYWNMTN----RDVISSVEE-GYRLPAPMGCPHAL 283
Query: 227 RNLLSRIFVANPSRRITIKEIKSHPWFLKNLPRELTETA 265
             L+   +  + ++R    +I S    L   P  L  TA
Sbjct: 284 HQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPESLRATA 322

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 69/301 (22%), Positives = 119/301 (39%), Gaps = 52/301 (17%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAR---EIINHKQLRH 57
           +++Y+ +K IGSG  G+     +      VA+K + R  +   +  R   E++  K + H
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 82
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFE-RICNAGRFSEDEAR--YFFQQLISG---- 110
            NII    V      L    +     EL +  +    +   D  R  Y   Q++ G    
Sbjct: 83  KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSYLLYQMLXGIKHL 142
Query: 111 ---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRR 167
               I HRDLK  N ++       LKI DFG ++++         V T  Y APEV+   
Sbjct: 143 HSAGIIHRDLKPSNIVVKSDXT--LKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM 200
Query: 168 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMA--------VQYKIPDY 219
            Y   + D+WS G  +  M+     F  ++    + K I ++          +Q  + +Y
Sbjct: 201 GYKENV-DIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNY 259
Query: 220 VH----------------------------ISQDCRNLLSRIFVANPSRRITIKEIKSHP 251
           V                              +   R+LLS++ V +P++RI++ +   HP
Sbjct: 260 VENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHP 319
Query: 252 W 252
           +
Sbjct: 320 Y 320

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 75/279 (26%), Positives = 117/279 (41%), Gaps = 32/279 (11%)
Query: 8   KDIGSGNFG---VARLMRNKNTKELVAMKYIERGH--KIDANVAREIINHKQLRHPNIIR 62
           K IGSG+ G     RL         VA+K ++ G+  +   +   E     Q  HPNIIR
Sbjct: 55  KIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIR 114
Query: 63  FKEVVLTPTHLAIVMEYAAGGEL--FERICNAGRFSEDEARYFFQQLISGQ-------IC 113
            + VV       IV EY   G L  F R  + G+F+  +     + + +G          
Sbjct: 115 LEGVVTRGRLAMIVTEYMENGSLDTFLR-THDGQFTIMQLVGMLRGVGAGMRYLSDLGYV 173
Query: 114 HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPA------YIAPEVLSRR 167
           HRDL   N L+D +     K+ DFG S+  +L   P +   T        + APE ++ R
Sbjct: 174 HRDLAARNVLVDSNLV--CKVSDFGLSR--VLEDDPDAAYTTTGGKIPIRWTAPEAIAFR 229
Query: 168 EYDGKLADVWSCGVTLY-VMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDC 226
            +    +DVWS GV ++ V+  G  P+ +  +    R  IS +    Y++P  +      
Sbjct: 230 TFS-SASDVWSFGVVMWEVLAYGERPYWNMTN----RDVISSVEE-GYRLPAPMGCPHAL 283
Query: 227 RNLLSRIFVANPSRRITIKEIKSHPWFLKNLPRELTETA 265
             L+   +  + ++R    +I S    L   P  L  TA
Sbjct: 284 HQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPESLRATA 322

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 57.8 bits (138), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 75/265 (28%), Positives = 118/265 (44%), Gaps = 30/265 (11%)
Query: 6   LMKDIGSGNFGVARL--MRNKNTKEL-VAMKYIE-----RGHKIDANVAREIINHKQLRH 57
           L++ +G G+FGV R       + K + VA+K ++     +   +D +  RE+     L H
Sbjct: 22  LLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMD-DFIREVNAMHSLDH 80
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFERI-CNAGRFSEDE-ARYFFQ------QLIS 109
            N+IR   VVLTP  + +V E A  G L +R+  + G F     +RY  Q       L S
Sbjct: 81  RNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLES 139
Query: 110 GQICHRDLKLENTLLDGSPAPRLKICDFGYSKS---SLLHSRPKSTVGTP-AYIAPEVLS 165
            +  HRDL   N LL  +    +KI DFG  ++   +  H   +     P A+ APE L 
Sbjct: 140 KRFIHRDLAARNLLL--ATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPESLK 197
Query: 166 RREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQ 224
            R +    +D W  GVTL+ M   G  P+       N  + + +I     ++P      Q
Sbjct: 198 TRTF-SHASDTWMFGVTLWEMFTYGQEPWIGL----NGSQILHKIDKEGERLPRPEDCPQ 252
Query: 225 DCRNLLSRIFVANPSRRITIKEIKS 249
           D  N++ + +   P  R T   ++ 
Sbjct: 253 DIYNVMVQCWAHKPEDRPTFVALRD 277

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 57.8 bits (138), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 69/301 (22%), Positives = 119/301 (39%), Gaps = 52/301 (17%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAR---EIINHKQLRH 57
           +++Y+ +K IGSG  G+     +      VA+K + R  +   +  R   E++  K + H
Sbjct: 16  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 75
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFE-RICNAGRFSEDEAR--YFFQQLISG---- 110
            NII    V      L    +     EL +  +    +   D  R  Y   Q++ G    
Sbjct: 76  KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSYLLYQMLXGIKHL 135
Query: 111 ---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRR 167
               I HRDLK  N ++       LKI DFG ++++         V T  Y APEV+   
Sbjct: 136 HSAGIIHRDLKPSNIVVKSDXT--LKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM 193
Query: 168 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMA--------VQYKIPDY 219
            Y   + D+WS G  +  M+     F  ++    + K I ++          +Q  + +Y
Sbjct: 194 GYKENV-DIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNY 252
Query: 220 VH----------------------------ISQDCRNLLSRIFVANPSRRITIKEIKSHP 251
           V                              +   R+LLS++ V +P++RI++ +   HP
Sbjct: 253 VENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHP 312
Query: 252 W 252
           +
Sbjct: 313 Y 313

>pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 80/326 (24%), Positives = 133/326 (40%), Gaps = 81/326 (24%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNII 61
           +KY L K +G+G+FG+   + +  + +  A+K + +  +      RE+   K L H NII
Sbjct: 7   KKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKN---RELDIMKVLDHVNII 63
Query: 62  RF-----------------------------------KEVVLTPT---HLAIVMEYAAGG 83
           +                                    K V++ P+   +L ++MEY    
Sbjct: 64  KLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDT 123
Query: 84  --ELFERICNAGR-FSEDEARYFFQQLI-------SGQICHRDLKLENTLLDGSPAPRLK 133
             ++ +    +GR    +    +  QL        S  ICHRD+K +N L++ S    LK
Sbjct: 124 LHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVN-SKDNTLK 182
Query: 134 ICDFGYSKSSLLHSRPK-STVGTPAYIAPEV-LSRREYDGKLADVWSCGVTLYVMLVGAY 191
           +CDFG +K  L+ S P  + + +  Y APE+ L   EY   + D+WS G     +++G  
Sbjct: 183 LCDFGSAK-KLIPSEPSVAXICSRFYRAPELMLGATEYTPSI-DLWSIGCVFGELILGKP 240
Query: 192 PFEDQEDPKNFRKTISRIMAVQYK------IPDYVHI------SQDCR------------ 227
            F  +       + I +IM    K       P Y  +      ++D R            
Sbjct: 241 LFSGETSIDQLVRII-QIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAI 299
Query: 228 NLLSRIFVANPSRRITIKEIKSHPWF 253
           +LL +I    P  RI   E  +HP+F
Sbjct: 300 DLLEQILRYEPDLRINPYEAMAHPFF 325

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 75/265 (28%), Positives = 118/265 (44%), Gaps = 30/265 (11%)
Query: 6   LMKDIGSGNFGVARL--MRNKNTKEL-VAMKYIE-----RGHKIDANVAREIINHKQLRH 57
           L++ +G G+FGV R       + K + VA+K ++     +   +D +  RE+     L H
Sbjct: 12  LLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMD-DFIREVNAMHSLDH 70
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFERI-CNAGRFSEDE-ARYFFQ------QLIS 109
            N+IR   VVLTP  + +V E A  G L +R+  + G F     +RY  Q       L S
Sbjct: 71  RNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLES 129
Query: 110 GQICHRDLKLENTLLDGSPAPRLKICDFGYSKS---SLLHSRPKSTVGTP-AYIAPEVLS 165
            +  HRDL   N LL  +    +KI DFG  ++   +  H   +     P A+ APE L 
Sbjct: 130 KRFIHRDLAARNLLL--ATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPESLK 187
Query: 166 RREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQ 224
            R +    +D W  GVTL+ M   G  P+       N  + + +I     ++P      Q
Sbjct: 188 TRTF-SHASDTWMFGVTLWEMFTYGQEPWIGL----NGSQILHKIDKEGERLPRPEDCPQ 242
Query: 225 DCRNLLSRIFVANPSRRITIKEIKS 249
           D  N++ + +   P  R T   ++ 
Sbjct: 243 DIYNVMVQCWAHKPEDRPTFVALRD 267

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 89/214 (41%), Gaps = 28/214 (13%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANV----AREIINHKQLRH 57
           ++YEL + +G G      L R+      VA+K +      D +      RE  N   L H
Sbjct: 12  DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNH 71
Query: 58  PNIIRFKEVVLTPTHLA----IVMEYAAGGELFERICNAGRFSED----------EARYF 103
           P I+         T       IVMEY  G  L + +   G  +            +A  F
Sbjct: 72  PAIVAVYATGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNF 131
Query: 104 FQQLISGQICHRDLKLENTLLDGSPAPRLKICDFGYSK----SSLLHSRPKSTVGTPAYI 159
             Q     I HRD+K  N ++  + A  +K+ DFG ++    S    ++  + +GT  Y+
Sbjct: 132 SHQ---NGIIHRDVKPANIMISATNA--VKVMDFGIARAIADSGNSVTQTAAVIGTAQYL 186
Query: 160 APEVLSRREYDGKLADVWSCGVTLYVMLVGAYPF 193
           +PE       D + +DV+S G  LY +L G  PF
Sbjct: 187 SPEQARGDSVDAR-SDVYSLGCVLYEVLTGEPPF 219

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 75/265 (28%), Positives = 118/265 (44%), Gaps = 30/265 (11%)
Query: 6   LMKDIGSGNFGVARL--MRNKNTKEL-VAMKYIE-----RGHKIDANVAREIINHKQLRH 57
           L++ +G G+FGV R       + K + VA+K ++     +   +D +  RE+     L H
Sbjct: 16  LLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMD-DFIREVNAMHSLDH 74
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFERI-CNAGRFSEDE-ARYFFQ------QLIS 109
            N+IR   VVLTP  + +V E A  G L +R+  + G F     +RY  Q       L S
Sbjct: 75  RNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLES 133
Query: 110 GQICHRDLKLENTLLDGSPAPRLKICDFGYSKS---SLLHSRPKSTVGTP-AYIAPEVLS 165
            +  HRDL   N LL  +    +KI DFG  ++   +  H   +     P A+ APE L 
Sbjct: 134 KRFIHRDLAARNLLL--ATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLK 191
Query: 166 RREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQ 224
            R +    +D W  GVTL+ M   G  P+       N  + + +I     ++P      Q
Sbjct: 192 TRTF-SHASDTWMFGVTLWEMFTYGQEPWIGL----NGSQILHKIDKEGERLPRPEDCPQ 246
Query: 225 DCRNLLSRIFVANPSRRITIKEIKS 249
           D  N++ + +   P  R T   ++ 
Sbjct: 247 DIYNVMVQCWAHKPEDRPTFVALRD 271

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/225 (24%), Positives = 96/225 (42%), Gaps = 22/225 (9%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK--IDAN-VAREIINHKQLRHP 58
           ++ + ++ +GSG +G      +   ++ VA+K + R  +  I A    RE+   K L+H 
Sbjct: 28  QRLQGLRPVGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHE 87
Query: 59  NIIRFKEVVLTPTHLA----IVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG---- 110
           N+I   +V    T +     + +     G     I  +   S++  ++   QL+ G    
Sbjct: 88  NVIGLLDVFTPATSIEDFSEVYLVTTLMGADLNNIVKSQALSDEHVQFLVYQLLRGLKYI 147
Query: 111 ---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRR 167
               I HRDLK  N  ++      L+I DFG ++ +         V T  Y APE++   
Sbjct: 148 HSAGIIHRDLKPSNVAVNEDS--ELRILDFGLARQA--DEEMTGYVATRWYRAPEIMLNW 203
Query: 168 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAV 212
            +  +  D+WS G  +  +L G   F       ++   + RIM V
Sbjct: 204 MHYNQTVDIWSVGCIMAELLQGKALFPG----SDYIDQLKRIMEV 244

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 75/265 (28%), Positives = 118/265 (44%), Gaps = 30/265 (11%)
Query: 6   LMKDIGSGNFGVARL--MRNKNTKEL-VAMKYIE-----RGHKIDANVAREIINHKQLRH 57
           L++ +G G+FGV R       + K + VA+K ++     +   +D +  RE+     L H
Sbjct: 22  LLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMD-DFIREVNAMHSLDH 80
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFERI-CNAGRFSEDE-ARYFFQ------QLIS 109
            N+IR   VVLTP  + +V E A  G L +R+  + G F     +RY  Q       L S
Sbjct: 81  RNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLES 139
Query: 110 GQICHRDLKLENTLLDGSPAPRLKICDFGYSKS---SLLHSRPKSTVGTP-AYIAPEVLS 165
            +  HRDL   N LL  +    +KI DFG  ++   +  H   +     P A+ APE L 
Sbjct: 140 KRFIHRDLAARNLLL--ATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLK 197
Query: 166 RREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQ 224
            R +    +D W  GVTL+ M   G  P+       N  + + +I     ++P      Q
Sbjct: 198 TRTF-SHASDTWMFGVTLWEMFTYGQEPWIGL----NGSQILHKIDKEGERLPRPEDCPQ 252
Query: 225 DCRNLLSRIFVANPSRRITIKEIKS 249
           D  N++ + +   P  R T   ++ 
Sbjct: 253 DIYNVMVQCWAHKPEDRPTFVALRD 277

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 94/209 (44%), Gaps = 29/209 (13%)
Query: 10  IGSGNFG--VARLMRNKNTKEL-VAMKYIERGH--KIDANVAREIINHKQLRHPNIIRFK 64
           IG+G FG   +  ++    +E+ VA+K ++ G+  K   +   E     Q  HPN+I  +
Sbjct: 41  IGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLE 100
Query: 65  EVVLTPTHLAIVMEYAAGGEL--FERICNAGRFSEDEARYFFQQLISG-------QICHR 115
            VV   T + I+ E+   G L  F R  N G+F+  +     + + +G          HR
Sbjct: 101 GVVTKSTPVMIITEFMENGSLDSFLR-QNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHR 159
Query: 116 DLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPA--------YIAPEVLSRR 167
           DL   N L++ +     K+ DFG S+   L         T A        + APE +  R
Sbjct: 160 DLAARNILVNSNLV--CKVSDFGLSR--FLEDDTSDPTYTSALGGKIPIRWTAPEAIQYR 215
Query: 168 EYDGKLADVWSCGVTLY-VMLVGAYPFED 195
           ++    +DVWS G+ ++ VM  G  P+ D
Sbjct: 216 KFTSA-SDVWSYGIVMWEVMSYGERPYWD 243

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 75/265 (28%), Positives = 118/265 (44%), Gaps = 30/265 (11%)
Query: 6   LMKDIGSGNFGVARL--MRNKNTKEL-VAMKYIE-----RGHKIDANVAREIINHKQLRH 57
           L++ +G G+FGV R       + K + VA+K ++     +   +D +  RE+     L H
Sbjct: 12  LLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMD-DFIREVNAMHSLDH 70
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFERI-CNAGRFSEDE-ARYFFQ------QLIS 109
            N+IR   VVLTP  + +V E A  G L +R+  + G F     +RY  Q       L S
Sbjct: 71  RNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLES 129
Query: 110 GQICHRDLKLENTLLDGSPAPRLKICDFGYSKS---SLLHSRPKSTVGTP-AYIAPEVLS 165
            +  HRDL   N LL  +    +KI DFG  ++   +  H   +     P A+ APE L 
Sbjct: 130 KRFIHRDLAARNLLL--ATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLK 187
Query: 166 RREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQ 224
            R +    +D W  GVTL+ M   G  P+       N  + + +I     ++P      Q
Sbjct: 188 TRTF-SHASDTWMFGVTLWEMFTYGQEPWIGL----NGSQILHKIDKEGERLPRPEDCPQ 242
Query: 225 DCRNLLSRIFVANPSRRITIKEIKS 249
           D  N++ + +   P  R T   ++ 
Sbjct: 243 DIYNVMVQCWAHKPEDRPTFVALRD 267

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 60/273 (21%), Positives = 122/273 (44%), Gaps = 30/273 (10%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREI-----INHKQLR 56
           +  E + ++G G +GV   MR+  + +++A+K I     +++   + +     I+ + + 
Sbjct: 51  DDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRA--TVNSQEQKRLLMDLDISMRTVD 108
Query: 57  HPNIIRFKEVVLTPTHLAIVMEY--AAGGELFERICNAGR-FSEDEARYFFQQLISG--- 110
            P  + F   +     + I ME    +  + ++++ + G+   ED        ++     
Sbjct: 109 CPFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEH 168
Query: 111 -----QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST-VGTPAYIAPE-- 162
                 + HRD+K  N L++     ++K+CDFG S   L+ S  K+   G   Y+APE  
Sbjct: 169 LHSKLSVIHRDVKPSNVLINA--LGQVKMCDFGIS-GYLVDSVAKTIDAGCKPYMAPERI 225
Query: 163 --VLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYV 220
              L+++ Y  K +D+WS G+T+  + +  +P++    P    K +    + Q     + 
Sbjct: 226 NPELNQKGYSVK-SDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADKF- 283
Query: 221 HISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 253
             S +  +  S+    N   R T  E+  HP+F
Sbjct: 284 --SAEFVDFTSQCLKKNSKERPTYPELMQHPFF 314

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 98/207 (47%), Gaps = 27/207 (13%)
Query: 8   KDIGSGNFG--VARLMRNKNTKEL-VAMKYIERGH--KIDANVAREIINHKQLRHPNIIR 62
           K +G+G FG   +  ++  + KE+ VA+K ++ G+  K   +   E     Q  HPNIIR
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 110
Query: 63  FKEVVLTPTHLAIVMEYAAGGEL--FERICNAGRFSEDEARYFFQQLISGQ-------IC 113
            + VV     + IV E    G L  F R  +A +F+  +     + + SG          
Sbjct: 111 LEGVVTKSKPVMIVTEXMENGSLDSFLRKHDA-QFTVIQLVGMLRGIASGMKYLSDMGAV 169
Query: 114 HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPA------YIAPEVLSRR 167
           HRDL   N L++ +     K+ DFG S+  +L   P++   T        + +PE ++ R
Sbjct: 170 HRDLAARNILINSNLV--CKVSDFGLSR--VLEDDPEAAYTTRGGKIPIRWTSPEAIAYR 225
Query: 168 EYDGKLADVWSCGVTLY-VMLVGAYPF 193
           ++    +DVWS G+ L+ VM  G  P+
Sbjct: 226 KFTSA-SDVWSYGIVLWEVMSYGERPY 251

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 75/265 (28%), Positives = 118/265 (44%), Gaps = 30/265 (11%)
Query: 6   LMKDIGSGNFGVARL--MRNKNTKEL-VAMKYIE-----RGHKIDANVAREIINHKQLRH 57
           L++ +G G+FGV R       + K + VA+K ++     +   +D +  RE+     L H
Sbjct: 16  LLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMD-DFIREVNAMHSLDH 74
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFERI-CNAGRFSEDE-ARYFFQ------QLIS 109
            N+IR   VVLTP  + +V E A  G L +R+  + G F     +RY  Q       L S
Sbjct: 75  RNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLES 133
Query: 110 GQICHRDLKLENTLLDGSPAPRLKICDFGYSKS---SLLHSRPKSTVGTP-AYIAPEVLS 165
            +  HRDL   N LL  +    +KI DFG  ++   +  H   +     P A+ APE L 
Sbjct: 134 KRFIHRDLAARNLLL--ATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLK 191
Query: 166 RREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQ 224
            R +    +D W  GVTL+ M   G  P+       N  + + +I     ++P      Q
Sbjct: 192 TRTF-SHASDTWMFGVTLWEMFTYGQEPWIGL----NGSQILHKIDKEGERLPRPEDCPQ 246
Query: 225 DCRNLLSRIFVANPSRRITIKEIKS 249
           D  N++ + +   P  R T   ++ 
Sbjct: 247 DIYNVMVQCWAHKPEDRPTFVALRD 271

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 75/265 (28%), Positives = 118/265 (44%), Gaps = 30/265 (11%)
Query: 6   LMKDIGSGNFGVARL--MRNKNTKEL-VAMKYIE-----RGHKIDANVAREIINHKQLRH 57
           L++ +G G+FGV R       + K + VA+K ++     +   +D +  RE+     L H
Sbjct: 12  LLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMD-DFIREVNAMHSLDH 70
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFERI-CNAGRFSEDE-ARYFFQ------QLIS 109
            N+IR   VVLTP  + +V E A  G L +R+  + G F     +RY  Q       L S
Sbjct: 71  RNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLES 129
Query: 110 GQICHRDLKLENTLLDGSPAPRLKICDFGYSKS---SLLHSRPKSTVGTP-AYIAPEVLS 165
            +  HRDL   N LL  +    +KI DFG  ++   +  H   +     P A+ APE L 
Sbjct: 130 KRFIHRDLAARNLLL--ATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLK 187
Query: 166 RREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQ 224
            R +    +D W  GVTL+ M   G  P+       N  + + +I     ++P      Q
Sbjct: 188 TRTF-SHASDTWMFGVTLWEMFTYGQEPWIGL----NGSQILHKIDKEGERLPRPEDCPQ 242
Query: 225 DCRNLLSRIFVANPSRRITIKEIKS 249
           D  N++ + +   P  R T   ++ 
Sbjct: 243 DIYNVMVQCWAHKPEDRPTFVALRD 267

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 98/207 (47%), Gaps = 27/207 (13%)
Query: 8   KDIGSGNFG--VARLMRNKNTKEL-VAMKYIERGH--KIDANVAREIINHKQLRHPNIIR 62
           K +G+G FG   +  ++  + KE+ VA+K ++ G+  K   +   E     Q  HPNIIR
Sbjct: 22  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 81
Query: 63  FKEVVLTPTHLAIVMEYAAGGEL--FERICNAGRFSEDEARYFFQQLISGQ-------IC 113
            + VV     + IV E    G L  F R  +A +F+  +     + + SG          
Sbjct: 82  LEGVVTKSKPVMIVTEXMENGSLDSFLRKHDA-QFTVIQLVGMLRGIASGMKYLSDMGYV 140
Query: 114 HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPA------YIAPEVLSRR 167
           HRDL   N L++ +     K+ DFG S+  +L   P++   T        + +PE ++ R
Sbjct: 141 HRDLAARNILINSNLV--CKVSDFGLSR--VLEDDPEAAYTTRGGKIPIRWTSPEAIAYR 196
Query: 168 EYDGKLADVWSCGVTLY-VMLVGAYPF 193
           ++    +DVWS G+ L+ VM  G  P+
Sbjct: 197 KFTSA-SDVWSYGIVLWEVMSYGERPY 222

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/225 (24%), Positives = 95/225 (42%), Gaps = 22/225 (9%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK--IDAN-VAREIINHKQLRHP 58
           ++ + ++ +GSG +G      +   ++ VA+K + R  +  I A    RE+   K L+H 
Sbjct: 28  QRLQGLRPVGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHE 87
Query: 59  NIIRFKEVVLTPTHLA----IVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG---- 110
           N+I   +V    T +     + +     G     I      S++  ++   QL+ G    
Sbjct: 88  NVIGLLDVFTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQFLVYQLLRGLKYI 147
Query: 111 ---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRR 167
               I HRDLK  N  ++      L+I DFG ++ +         V T  Y APE++   
Sbjct: 148 HSAGIIHRDLKPSNVAVNEDS--ELRILDFGLARQA--DEEMTGYVATRWYRAPEIMLNW 203
Query: 168 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAV 212
            +  +  D+WS G  +  +L G   F       ++   + RIM V
Sbjct: 204 MHYNQTVDIWSVGCIMAELLQGKALFPG----SDYIDQLKRIMEV 244

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 95/227 (41%), Gaps = 44/227 (19%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK--IDAN-VAREIINHKQLRHP 58
           + YE+   IG G++G   L  +KN  + VA+K + R  +  ID   + REI    +L+  
Sbjct: 28  DNYEIKHLIGRGSYGYVYLAYDKNANKNVAIKKVNRMFEDLIDCKRILREITILNRLKSD 87
Query: 59  NIIRFKEVV-----LTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGQ-- 111
            IIR  +++     L    L IV+E  A  +L +        +E   +     L+ G+  
Sbjct: 88  YIIRLHDLIIPEDLLKFDELYIVLE-IADSDLKKLFKTPIFLTEQHVKTILYNLLLGEKF 146
Query: 112 -----ICHRDLKLENTLLDGSPAPRLKICDFGYSKS------------------------ 142
                I HRDLK  N LL+   +  +KICDFG +++                        
Sbjct: 147 IHESGIIHRDLKPANCLLNQDCS--VKICDFGLARTINSDKDIHIVNDLEEKEENEEPGP 204
Query: 143 --SLLHSRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVML 187
               L  +  S V T  Y APE++  +E      D+WS G     +L
Sbjct: 205 HNKNLKKQLTSHVVTRWYRAPELILLQENYTNSIDIWSTGCIFAELL 251

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 98/207 (47%), Gaps = 27/207 (13%)
Query: 8   KDIGSGNFG--VARLMRNKNTKEL-VAMKYIERGH--KIDANVAREIINHKQLRHPNIIR 62
           K +G+G FG   +  ++  + KE+ VA+K ++ G+  K   +   E     Q  HPNIIR
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 110
Query: 63  FKEVVLTPTHLAIVMEYAAGGEL--FERICNAGRFSEDEARYFFQQLISGQ-------IC 113
            + VV     + IV E    G L  F R  +A +F+  +     + + SG          
Sbjct: 111 LEGVVTKSKPVMIVTEXMENGSLDSFLRKHDA-QFTVIQLVGMLRGIASGMKYLSDMGYV 169
Query: 114 HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPA------YIAPEVLSRR 167
           HRDL   N L++ +     K+ DFG S+  +L   P++   T        + +PE ++ R
Sbjct: 170 HRDLAARNILINSNLV--CKVSDFGLSR--VLEDDPEAAYTTRGGKIPIRWTSPEAIAYR 225
Query: 168 EYDGKLADVWSCGVTLY-VMLVGAYPF 193
           ++    +DVWS G+ L+ VM  G  P+
Sbjct: 226 KFTSA-SDVWSYGIVLWEVMSYGERPY 251

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 73/313 (23%), Positives = 125/313 (39%), Gaps = 67/313 (21%)
Query: 10  IGSGNFG--VARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKEVV 67
           +G G +G       ++    +  A+K IE G  I  +  REI   ++L+HPN+I  ++V 
Sbjct: 29  VGRGTYGHVYKAKRKDGKDDKDYALKQIE-GTGISMSACREIALLRELKHPNVISLQKVF 87
Query: 68  LTPTH--LAIVMEYAAGGEL----FERICNAGR----FSEDEARYFFQQLISG------- 110
           L+     + ++ +YA         F R   A +          +    Q++ G       
Sbjct: 88  LSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN 147
Query: 111 QICHRDLKLENTLL--DGSPAPRLKICDFGYSKSSLLHSRPKS----TVGTPAYIAPEVL 164
            + HRDLK  N L+  +G    R+KI D G+++      +P +     V T  Y APE+L
Sbjct: 148 WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELL 207
Query: 165 SRREYDGKLADVWSCGVTLYVMLVGAYPFE-DQEDPKN----FRKTISRIMAVQ------ 213
               +  K  D+W+ G     +L     F   QED K         + RI  V       
Sbjct: 208 LGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADK 267
Query: 214 -----YKIPDYVHISQDCR-------------------------NLLSRIFVANPSRRIT 243
                 K+P++  + +D R                         +LL ++   +P +RIT
Sbjct: 268 DWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRIT 327
Query: 244 IKEIKSHPWFLKN 256
            ++    P+FL++
Sbjct: 328 SEQAMQDPYFLED 340

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 95/204 (46%), Gaps = 25/204 (12%)
Query: 10  IGSGNFG--VARLMRNKNTKEL-VAMKYIERGH--KIDANVAREIINHKQLRHPNIIRFK 64
           IG+G FG   +  ++    +EL VA+K ++ G+  K   +   E     Q  HPNII  +
Sbjct: 30  IGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIHLE 89
Query: 65  EVVLTPTHLAIVMEYAAGGELFERI-CNAGRFSEDEARYFFQQLISGQ-------ICHRD 116
            VV     + IV EY   G L   +  N G+F+  +     + + +G          HRD
Sbjct: 90  GVVTKSKPVMIVTEYMENGSLDTFLKKNDGQFTVIQLVGMLRGISAGMKYLSDMGYVHRD 149
Query: 117 LKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPA------YIAPEVLSRREYD 170
           L   N L++ +     K+ DFG S+  +L   P++   T        + APE ++ R++ 
Sbjct: 150 LAARNILINSNLV--CKVSDFGLSR--VLEDDPEAAYTTRGGKIPIRWTAPEAIAFRKFT 205
Query: 171 GKLADVWSCGVTLY-VMLVGAYPF 193
              +DVWS G+ ++ V+  G  P+
Sbjct: 206 SA-SDVWSYGIVMWEVVSYGERPY 228

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 63/260 (24%), Positives = 112/260 (43%), Gaps = 36/260 (13%)
Query: 10  IGSGNFGVA------RLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRF 63
           IG G+FGV          +N+    + ++  I    +++A + RE +  + L HPN++  
Sbjct: 29  IGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFL-REGLLMRGLNHPNVLAL 87
Query: 64  KEVVLTPTHLA-IVMEYAAGGELFERICNAGR---------FSEDEARYFFQQLISGQIC 113
             ++L P  L  +++ Y   G+L + I +  R         F    AR   + L   +  
Sbjct: 88  IGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVAR-GMEYLAEQKFV 146
Query: 114 HRDLKLENTLLDGSPAPRLKICDFGYSKSSL--------LHSRPKSTVGTPAYIAPEVLS 165
           HRDL   N +LD S    +K+ DFG ++  L         H   +  V    + A E L 
Sbjct: 147 HRDLAARNCMLDESFT--VKVADFGLARDILDREYYSVQQHRHARLPV---KWTALESLQ 201
Query: 166 RREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQD 225
              +  K +DVWS GV L+ +L    P     DP +    ++  +A   ++P   +    
Sbjct: 202 TYRFTTK-SDVWSFGVLLWELLTRGAPPYRHIDPFD----LTHFLAQGRRLPQPEYCPDS 256
Query: 226 CRNLLSRIFVANPSRRITIK 245
              ++ + + A+P+ R T +
Sbjct: 257 LYQVMQQCWEADPAVRPTFR 276

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 100/215 (46%), Gaps = 37/215 (17%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYI-----ERGHKIDANVAREIINHKQL 55
           + KYE +  IG G FG     R++ T + VA+K +     + G  I A   REI   + L
Sbjct: 17  VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITA--LREIKILQLL 74
Query: 56  RHPNIIRFKEVVLTPT--------HLAIVMEYAAGGELFERICNA-GRFSEDEARYFFQQ 106
           +H N++   E+  T           + +V ++    +L   + N   +F+  E +   Q 
Sbjct: 75  KHENVVNLIEICRTKASPYNRCKGSIYLVFDFCE-HDLAGLLSNVLVKFTLSEIKRVMQM 133
Query: 107 LISG-------QICHRDLKLENTLL--DGSPAPRLKICDFGYSKSSLL--HSRPK---ST 152
           L++G       +I HRD+K  N L+  DG     LK+ DFG +++  L  +S+P    + 
Sbjct: 134 LLNGLYYIHRNKILHRDMKAANVLITRDGV----LKLADFGLARAFSLAKNSQPNRYXNR 189
Query: 153 VGTPAYIAPE-VLSRREYDGKLADVWSCGVTLYVM 186
           V T  Y  PE +L  R+Y G   D+W  G  +  M
Sbjct: 190 VVTLWYRPPELLLGERDY-GPPIDLWGAGCIMAEM 223

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/225 (24%), Positives = 95/225 (42%), Gaps = 22/225 (9%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK--IDAN-VAREIINHKQLRHP 58
           ++ + ++ +GSG +G      +   ++ VA+K + R  +  I A    RE+   K L+H 
Sbjct: 20  QRLQGLRPVGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHE 79
Query: 59  NIIRFKEVVLTPTHLA----IVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG---- 110
           N+I   +V    T +     + +     G     I      S++  ++   QL+ G    
Sbjct: 80  NVIGLLDVFTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQFLVYQLLRGLKYI 139
Query: 111 ---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRR 167
               I HRDLK  N  ++      L+I DFG ++ +         V T  Y APE++   
Sbjct: 140 HSAGIIHRDLKPSNVAVNEDC--ELRILDFGLARQA--DEEMTGYVATRWYRAPEIMLNW 195
Query: 168 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAV 212
            +  +  D+WS G  +  +L G   F       ++   + RIM V
Sbjct: 196 MHYNQTVDIWSVGCIMAELLQGKALFPG----SDYIDQLKRIMEV 236

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 100/215 (46%), Gaps = 37/215 (17%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYI-----ERGHKIDANVAREIINHKQL 55
           + KYE +  IG G FG     R++ T + VA+K +     + G  I A   REI   + L
Sbjct: 17  VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITA--LREIKILQLL 74
Query: 56  RHPNIIRFKEVVLTPT--------HLAIVMEYAAGGELFERICNA-GRFSEDEARYFFQQ 106
           +H N++   E+  T           + +V ++    +L   + N   +F+  E +   Q 
Sbjct: 75  KHENVVNLIEICRTKASPYNRCKGSIYLVFDFCE-HDLAGLLSNVLVKFTLSEIKRVMQM 133
Query: 107 LISG-------QICHRDLKLENTLL--DGSPAPRLKICDFGYSKSSLL--HSRPK---ST 152
           L++G       +I HRD+K  N L+  DG     LK+ DFG +++  L  +S+P    + 
Sbjct: 134 LLNGLYYIHRNKILHRDMKAANVLITRDGV----LKLADFGLARAFSLAKNSQPNRYXNR 189
Query: 153 VGTPAYIAPE-VLSRREYDGKLADVWSCGVTLYVM 186
           V T  Y  PE +L  R+Y G   D+W  G  +  M
Sbjct: 190 VVTLWYRPPELLLGERDY-GPPIDLWGAGCIMAEM 223

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 92/215 (42%), Gaps = 36/215 (16%)
Query: 10  IGSGNFGVARLMRNKNT----KELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKE 65
           +G G FGV       NT    K+L AM  I    ++     +EI    + +H N++    
Sbjct: 39  MGEGGFGVVYKGYVNNTTVAVKKLAAMVDITT-EELKQQFDQEIKVMAKCQHENLVELLG 97
Query: 66  VVLTPTHLAIVMEYAAGGELFERI--------------CNAGRFSEDEARYFFQQLISGQ 111
                  L +V  Y   G L +R+              C   + + +   +  +      
Sbjct: 98  FSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHEN----H 153
Query: 112 ICHRDLKLENTLLDGSPAPRLKICDFGYSKSS------LLHSRPKSTVGTPAYIAPEVLS 165
             HRD+K  N LLD   A   KI DFG +++S      ++ SR    VGT AY+APE L 
Sbjct: 154 HIHRDIKSANILLD--EAFTAKISDFGLARASEKFAQTVMXSR---IVGTTAYMAPEAL- 207
Query: 166 RREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPK 200
           R E   K +D++S GV L  ++ G    ++  +P+
Sbjct: 208 RGEITPK-SDIYSFGVVLLEIITGLPAVDEHREPQ 241

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 100/215 (46%), Gaps = 37/215 (17%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYI-----ERGHKIDANVAREIINHKQL 55
           + KYE +  IG G FG     R++ T + VA+K +     + G  I A   REI   + L
Sbjct: 17  VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITA--LREIKILQLL 74
Query: 56  RHPNIIRFKEVVLT--------PTHLAIVMEYAAGGELFERICNA-GRFSEDEARYFFQQ 106
           +H N++   E+  T           + +V ++    +L   + N   +F+  E +   Q 
Sbjct: 75  KHENVVNLIEICRTKASPYNRCKASIYLVFDFCE-HDLAGLLSNVLVKFTLSEIKRVMQM 133
Query: 107 LISG-------QICHRDLKLENTLL--DGSPAPRLKICDFGYSKSSLL--HSRPK---ST 152
           L++G       +I HRD+K  N L+  DG     LK+ DFG +++  L  +S+P    + 
Sbjct: 134 LLNGLYYIHRNKILHRDMKAANVLITRDGV----LKLADFGLARAFSLAKNSQPNRYXNR 189
Query: 153 VGTPAYIAPE-VLSRREYDGKLADVWSCGVTLYVM 186
           V T  Y  PE +L  R+Y G   D+W  G  +  M
Sbjct: 190 VVTLWYRPPELLLGERDY-GPPIDLWGAGCIMAEM 223

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 100/215 (46%), Gaps = 37/215 (17%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYI-----ERGHKIDANVAREIINHKQL 55
           + KYE +  IG G FG     R++ T + VA+K +     + G  I A   REI   + L
Sbjct: 16  VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITA--LREIKILQLL 73
Query: 56  RHPNIIRFKEVVLTPT--------HLAIVMEYAAGGELFERICNA-GRFSEDEARYFFQQ 106
           +H N++   E+  T           + +V ++    +L   + N   +F+  E +   Q 
Sbjct: 74  KHENVVNLIEICRTKASPYNRCKGSIYLVFDFCE-HDLAGLLSNVLVKFTLSEIKRVMQM 132
Query: 107 LISG-------QICHRDLKLENTLL--DGSPAPRLKICDFGYSKSSLL--HSRPK---ST 152
           L++G       +I HRD+K  N L+  DG     LK+ DFG +++  L  +S+P    + 
Sbjct: 133 LLNGLYYIHRNKILHRDMKAANVLITRDGV----LKLADFGLARAFSLAKNSQPNRYXNR 188
Query: 153 VGTPAYIAPE-VLSRREYDGKLADVWSCGVTLYVM 186
           V T  Y  PE +L  R+Y G   D+W  G  +  M
Sbjct: 189 VVTLWYRPPELLLGERDY-GPPIDLWGAGCIMAEM 222

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 57/272 (20%), Positives = 118/272 (43%), Gaps = 28/272 (10%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREI-----INHKQLR 56
           +  E + ++G G +GV   MR+  + +++A+K I     +++   + +     I+ + + 
Sbjct: 7   DDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRA--TVNSQEQKRLLMDLDISMRTVD 64
Query: 57  HPNIIRFKEVVLTPTHLAIVMEY--AAGGELFERICNAGR-FSEDEARYFFQQLISG--- 110
            P  + F   +     + I ME    +  + ++++ + G+   ED        ++     
Sbjct: 65  CPFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEH 124
Query: 111 -----QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPE--- 162
                 + HRD+K  N L++     ++K+CDFG S   +         G   Y+APE   
Sbjct: 125 LHSKLSVIHRDVKPSNVLINA--LGQVKMCDFGISGYLVDDVAKDIDAGCKPYMAPERIN 182
Query: 163 -VLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVH 221
             L+++ Y  K +D+WS G+T+  + +  +P++    P    K +    + Q     +  
Sbjct: 183 PELNQKGYSVK-SDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADKF-- 239
Query: 222 ISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 253
            S +  +  S+    N   R T  E+  HP+F
Sbjct: 240 -SAEFVDFTSQCLKKNSKERPTYPELMQHPFF 270

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 96/212 (45%), Gaps = 27/212 (12%)
Query: 9   DIGSGNFGVAR--LMRNKNTKELVAMKYIERG-HKIDAN-VAREIINHKQLRHPNIIRFK 64
           ++G GNFG  R  + R +  +  VA+K +++G  K D   + RE     QL +P I+R  
Sbjct: 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 402
Query: 65  EVVLTPTHLAIVMEYAAGGELFERICNAGRFSE---DEARYFFQQLISG-------QICH 114
            V      L +VME A GG L + +   G+  E           Q+  G          H
Sbjct: 403 GVCQAEA-LMLVMEMAGGGPLHKFL--VGKREEIPVSNVAELLHQVSMGMKYLEEKNFVH 459
Query: 115 RDLKLENTLLDGSPAPRLKICDFGYSKS-----SLLHSRPKSTVGTPAYIAPEVLSRREY 169
           R+L   N LL        KI DFG SK+     S   +R         Y APE ++ R++
Sbjct: 460 RNLAARNVLLVNRH--YAKISDFGLSKALGADDSYYTARSAGKWPLKWY-APECINFRKF 516
Query: 170 DGKLADVWSCGVTLYVML-VGAYPFEDQEDPK 200
             + +DVWS GVT++  L  G  P++  + P+
Sbjct: 517 SSR-SDVWSYGVTMWEALSYGQKPYKKMKGPE 547

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 61/253 (24%), Positives = 102/253 (40%), Gaps = 26/253 (10%)
Query: 10  IGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKEVVLT 69
           +G G FG       K     VA+K ++          +E    K+++HPN+++   V   
Sbjct: 19  LGGGQFGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 78
Query: 70  PTHLAIVMEYAAGGELFE--RICNAGRFSEDEARYFFQQLISG-------QICHRDLKLE 120
                I+ E+   G L +  R CN    S     Y   Q+ S           HRDL   
Sbjct: 79  EPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAAR 138
Query: 121 NTLLDGSPAPRLKICDFGYSK-----SSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLAD 175
           N L+  +    +K+ DFG S+     +   H+  K  +    + APE L+  ++  K +D
Sbjct: 139 NCLVGENHL--VKVADFGLSRLMTGDTXTAHAGAKFPI---KWTAPESLAYNKFSIK-SD 192
Query: 176 VWSCGVTLY-VMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIF 234
           VW+ GV L+ +   G  P+    DP      +  ++   Y++       +    L+   +
Sbjct: 193 VWAFGVLLWEIATYGMSPYPGI-DPSQ----VYELLEKDYRMERPEGCPEKVYELMRACW 247
Query: 235 VANPSRRITIKEI 247
             NPS R +  EI
Sbjct: 248 QWNPSDRPSFAEI 260

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 55.1 bits (131), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 90/212 (42%), Gaps = 30/212 (14%)
Query: 10  IGSGNFGVARLMRNKNT----KELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKE 65
           +G G FGV       NT    K+L AM  I    ++     +EI    + +H N++    
Sbjct: 39  MGEGGFGVVYKGYVNNTTVAVKKLAAMVDITT-EELKQQFDQEIKVMAKCQHENLVELLG 97
Query: 66  VVLTPTHLAIVMEYAAGGELFERI--------------CNAGRFSEDEARYFFQQLISGQ 111
                  L +V  Y   G L +R+              C   + + +   +  +      
Sbjct: 98  FSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHEN----H 153
Query: 112 ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP---KSTVGTPAYIAPEVLSRRE 168
             HRD+K  N LLD   A   KI DFG +++S   ++       VGT AY+APE L R E
Sbjct: 154 HIHRDIKSANILLD--EAFTAKISDFGLARASEKFAQTVMXXRIVGTTAYMAPEAL-RGE 210
Query: 169 YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPK 200
              K +D++S GV L  ++ G    ++  +P+
Sbjct: 211 ITPK-SDIYSFGVVLLEIITGLPAVDEHREPQ 241

>pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 55/215 (25%), Positives = 93/215 (43%), Gaps = 25/215 (11%)
Query: 4   YELMKDIGSG--NFGVARLMRNKNTKELVAMKYIER---GHKIDANVAREIINHKQLRHP 58
           YEL+  IG G  +     L R K T E V ++ I      +++   +  E+   K   HP
Sbjct: 11  YELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHP 70
Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGELFERICN--AGRFSEDEARYFFQQLISG------ 110
           NI+ ++   +    L +V  + A G   + IC       +E    Y  Q ++        
Sbjct: 71  NIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHH 130
Query: 111 -QICHRDLKLENTLL--DG-----SPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPE 162
               HR +K  + L+  DG          L +   G  +  ++H  PK +V    +++PE
Sbjct: 131 MGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHG-QRQRVVHDFPKYSVKVLPWLSPE 189
Query: 163 VLSR--REYDGKLADVWSCGVTLYVMLVGAYPFED 195
           VL +  + YD K +D++S G+T   +  G  PF+D
Sbjct: 190 VLQQNLQGYDAK-SDIYSVGITACELANGHVPFKD 223

>pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 55/215 (25%), Positives = 93/215 (43%), Gaps = 25/215 (11%)
Query: 4   YELMKDIGSG--NFGVARLMRNKNTKELVAMKYIER---GHKIDANVAREIINHKQLRHP 58
           YEL+  IG G  +     L R K T E V ++ I      +++   +  E+   K   HP
Sbjct: 27  YELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHP 86
Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGELFERICN--AGRFSEDEARYFFQQLISG------ 110
           NI+ ++   +    L +V  + A G   + IC       +E    Y  Q ++        
Sbjct: 87  NIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHH 146
Query: 111 -QICHRDLKLENTLL--DG-----SPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPE 162
               HR +K  + L+  DG          L +   G  +  ++H  PK +V    +++PE
Sbjct: 147 MGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHG-QRQRVVHDFPKYSVKVLPWLSPE 205
Query: 163 VLSR--REYDGKLADVWSCGVTLYVMLVGAYPFED 195
           VL +  + YD K +D++S G+T   +  G  PF+D
Sbjct: 206 VLQQNLQGYDAK-SDIYSVGITACELANGHVPFKD 239

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 62/265 (23%), Positives = 113/265 (42%), Gaps = 31/265 (11%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNII 61
           E  +L+K +G+G FG   +    N+ + VA+K ++ G         E    K L+H  ++
Sbjct: 13  ESIKLVKRLGAGQFGEVWMGYYNNSTK-VAVKTLKPGTMSVQAFLEEANLMKTLQHDKLV 71
Query: 62  RFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLI--SGQIC------ 113
           R   VV     + I+ EY A G L + +      S++  +    +LI  S QI       
Sbjct: 72  RLYAVVTREEPIYIITEYMAKGSLLDFLK-----SDEGGKVLLPKLIDFSAQIAEGMAYI 126
Query: 114 ------HRDLKLENTLLDGSPAPRLKICDFGYSK--SSLLHSRPKSTVGTPAYIAPEVLS 165
                 HRDL+  N L+  S +   KI DFG ++      ++  +       + APE ++
Sbjct: 127 ERKNYIHRDLRAANVLV--SESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAIN 184
Query: 166 RREYDGKLADVWSCGVTLY-VMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQ 224
              +  K +DVWS G+ LY ++  G  P+     P      +   ++  Y++P   +   
Sbjct: 185 FGCFTIK-SDVWSFGILLYEIVTYGKIPY-----PGRTNADVMTALSQGYRMPRVENCPD 238
Query: 225 DCRNLLSRIFVANPSRRITIKEIKS 249
           +  +++   +      R T   ++S
Sbjct: 239 ELYDIMKMCWKEKAEERPTFDYLQS 263

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score = 54.7 bits (130), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 90/212 (42%), Gaps = 30/212 (14%)
Query: 10  IGSGNFGVARLMRNKNT----KELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKE 65
           +G G FGV       NT    K+L AM  I    ++     +EI    + +H N++    
Sbjct: 33  MGEGGFGVVYKGYVNNTTVAVKKLAAMVDITT-EELKQQFDQEIKVMAKCQHENLVELLG 91
Query: 66  VVLTPTHLAIVMEYAAGGELFERI--------------CNAGRFSEDEARYFFQQLISGQ 111
                  L +V  Y   G L +R+              C   + + +   +  +      
Sbjct: 92  FSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHEN----H 147
Query: 112 ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP---KSTVGTPAYIAPEVLSRRE 168
             HRD+K  N LLD   A   KI DFG +++S   ++       VGT AY+APE L R E
Sbjct: 148 HIHRDIKSANILLD--EAFTAKISDFGLARASEKFAQXVMXXRIVGTTAYMAPEAL-RGE 204
Query: 169 YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPK 200
              K +D++S GV L  ++ G    ++  +P+
Sbjct: 205 ITPK-SDIYSFGVVLLEIITGLPAVDEHREPQ 235

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 57/250 (22%), Positives = 100/250 (40%), Gaps = 20/250 (8%)
Query: 10  IGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKEVVLT 69
           +G G +G       K     VA+K ++          +E    K+++HPN+++   V   
Sbjct: 22  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 81
Query: 70  PTHLAIVMEYAAGGELFE--RICNAGRFSEDEARYFFQQLISG-------QICHRDLKLE 120
                I+ E+   G L +  R CN    +     Y   Q+ S           HRDL   
Sbjct: 82  EPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAAR 141
Query: 121 NTLLDGSPAPRLKICDFGYSK--SSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLADVWS 178
           N L+  +    +K+ DFG S+  +   ++ P        + APE L+  ++  K +DVW+
Sbjct: 142 NCLVGENHL--VKVADFGLSRLMTGDTYTAPAGAKFPIKWTAPESLAYNKFSIK-SDVWA 198
Query: 179 CGVTLY-VMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVAN 237
            GV L+ +   G  P+     P      +  ++   Y++       +    L+   +  N
Sbjct: 199 FGVLLWEIATYGMSPY-----PGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWN 253
Query: 238 PSRRITIKEI 247
           PS R +  EI
Sbjct: 254 PSDRPSFAEI 263

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 60/253 (23%), Positives = 103/253 (40%), Gaps = 26/253 (10%)
Query: 10  IGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKEVVLT 69
           +G G +G       K     VA+K ++          +E    K+++HPN+++   V   
Sbjct: 19  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 78
Query: 70  PTHLAIVMEYAAGGELFE--RICNAGRFSEDEARYFFQQLISG-------QICHRDLKLE 120
                I++E+   G L +  R CN    S     Y   Q+ S           HRDL   
Sbjct: 79  EPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAAR 138
Query: 121 NTLLDGSPAPRLKICDFGYSK-----SSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLAD 175
           N L+  +    +K+ DFG S+     +   H+  K  +    + APE L+  ++  K +D
Sbjct: 139 NCLVGENHL--VKVADFGLSRLMTGDTXTAHAGAKFPI---KWTAPESLAYNKFSIK-SD 192
Query: 176 VWSCGVTLY-VMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIF 234
           VW+ GV L+ +   G  P+    DP      +  ++   Y++       +    L+   +
Sbjct: 193 VWAFGVLLWEIATYGMSPYPGI-DPSQ----VYELLEKDYRMERPEGCPEKVYELMRACW 247
Query: 235 VANPSRRITIKEI 247
             NPS R +  EI
Sbjct: 248 QWNPSDRPSFAEI 260

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 89/206 (43%), Gaps = 26/206 (12%)
Query: 3   KYELMKDIGSGNFGVARLMRNKNTKELVAMKYI-----ERGHKIDANVAREIINHKQLR- 56
           +YE + +IG G +G     R+ ++   VA+K +     E G  I  +  RE+   ++L  
Sbjct: 5   RYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPI--STVREVALLRRLEA 62
Query: 57  --HPNIIRFKEVVLTP-----THLAIVMEYAAGG--ELFERICNAGRFSE---DEARYFF 104
             HPN++R  +V  T        + +V E+         ++    G  +E   D  R F 
Sbjct: 63  FEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFL 122
Query: 105 QQLI---SGQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAP 161
           + L    +  I HRDLK EN L+  +    +K+ DFG ++           V T  Y AP
Sbjct: 123 RGLDFLHANCIVHRDLKPENILV--TSGGTVKLADFGLARIYSYQMALDPVVVTLWYRAP 180
Query: 162 EVLSRREYDGKLADVWSCGVTLYVML 187
           EVL +  Y     D+WS G     M 
Sbjct: 181 EVLLQSTY-ATPVDMWSVGCIFAEMF 205

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 94/210 (44%), Gaps = 27/210 (12%)
Query: 10  IGSGNFG---VARLMRNKNTKELVAMKYIERGH--KIDANVAREIINHKQLRHPNIIRFK 64
           IG+G FG     RL         VA+K ++ G+  K   +   E     Q  HPN++  +
Sbjct: 51  IGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYTEKQRRDFLCEASIMGQFDHPNVVHLE 110
Query: 65  EVVLTPTHLAIVMEYAAGGEL--FERICNAGRFSEDEARYFFQQLISGQ-------ICHR 115
            VV     + IV+E+   G L  F R  + G+F+  +     + + +G          HR
Sbjct: 111 GVVTRGKPVMIVIEFMENGALDAFLRK-HDGQFTVIQLVGMLRGIAAGMRYLADMGYVHR 169
Query: 116 DLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPA------YIAPEVLSRREY 169
           DL   N L++ +     K+ DFG S+  ++   P++   T        + APE +  R++
Sbjct: 170 DLAARNILVNSNLV--CKVSDFGLSR--VIEDDPEAVYTTTGGKIPVRWTAPEAIQYRKF 225
Query: 170 DGKLADVWSCGVTLY-VMLVGAYPFEDQED 198
               +DVWS G+ ++ VM  G  P+ D  +
Sbjct: 226 TSA-SDVWSYGIVMWEVMSYGERPYWDMSN 254

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 54.3 bits (129), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 89/206 (43%), Gaps = 26/206 (12%)
Query: 3   KYELMKDIGSGNFGVARLMRNKNTKELVAMKYI-----ERGHKIDANVAREIINHKQLR- 56
           +YE + +IG G +G     R+ ++   VA+K +     E G  I  +  RE+   ++L  
Sbjct: 5   RYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPI--STVREVALLRRLEA 62
Query: 57  --HPNIIRFKEVVLTP-----THLAIVMEYAAGG--ELFERICNAGRFSE---DEARYFF 104
             HPN++R  +V  T        + +V E+         ++    G  +E   D  R F 
Sbjct: 63  FEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFL 122
Query: 105 QQLI---SGQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAP 161
           + L    +  I HRDLK EN L+  +    +K+ DFG ++           V T  Y AP
Sbjct: 123 RGLDFLHANCIVHRDLKPENILV--TSGGTVKLADFGLARIYSYQMALAPVVVTLWYRAP 180
Query: 162 EVLSRREYDGKLADVWSCGVTLYVML 187
           EVL +  Y     D+WS G     M 
Sbjct: 181 EVLLQSTY-ATPVDMWSVGCIFAEMF 205

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 54.3 bits (129), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 57/250 (22%), Positives = 100/250 (40%), Gaps = 20/250 (8%)
Query: 10  IGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKEVVLT 69
           +G G +G       K     VA+K ++          +E    K+++HPN+++   V   
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 82
Query: 70  PTHLAIVMEYAAGGELFE--RICNAGRFSEDEARYFFQQLISG-------QICHRDLKLE 120
                I+ E+   G L +  R CN    +     Y   Q+ S           HRDL   
Sbjct: 83  EPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAAR 142
Query: 121 NTLLDGSPAPRLKICDFGYSK--SSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLADVWS 178
           N L+  +    +K+ DFG S+  +   ++ P        + APE L+  ++  K +DVW+
Sbjct: 143 NCLVGENHL--VKVADFGLSRLMTGDTYTAPAGAKFPIKWTAPESLAYNKFSIK-SDVWA 199
Query: 179 CGVTLY-VMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVAN 237
            GV L+ +   G  P+     P      +  ++   Y++       +    L+   +  N
Sbjct: 200 FGVLLWEIATYGMSPY-----PGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWN 254
Query: 238 PSRRITIKEI 247
           PS R +  EI
Sbjct: 255 PSDRPSFAEI 264

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 94/212 (44%), Gaps = 29/212 (13%)
Query: 10  IGSGNFG--VARLMRNKNTKEL-VAMKYIERGH--KIDANVAREIINHKQLRHPNIIRFK 64
           IG+G FG   +  ++    +E+ VA+K ++ G+  K   +   E     Q  HPN+I  +
Sbjct: 15  IGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLE 74
Query: 65  EVVLTPTHLAIVMEYAAGGEL--FERICNAGRFSEDEARYFFQQLISG-------QICHR 115
            VV   T + I+ E+   G L  F R  N G+F+  +     + + +G          HR
Sbjct: 75  GVVTKSTPVMIITEFMENGSLDSFLR-QNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHR 133
Query: 116 DLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPA--------YIAPEVLSRR 167
            L   N L++ +     K+ DFG S+   L         T A        + APE +  R
Sbjct: 134 ALAARNILVNSNLV--CKVSDFGLSR--FLEDDTSDPTYTSALGGKIPIRWTAPEAIQYR 189
Query: 168 EYDGKLADVWSCGVTLY-VMLVGAYPFEDQED 198
           ++    +DVWS G+ ++ VM  G  P+ D  +
Sbjct: 190 KFTSA-SDVWSYGIVMWEVMSYGERPYWDMTN 220

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 59/253 (23%), Positives = 102/253 (40%), Gaps = 26/253 (10%)
Query: 10  IGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKEVVLT 69
           +G G +G       K     VA+K ++          +E    K+++HPN+++   V   
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 80
Query: 70  PTHLAIVMEYAAGGELFE--RICNAGRFSEDEARYFFQQLISG-------QICHRDLKLE 120
                I++E+   G L +  R CN    S     Y   Q+ S           HRDL   
Sbjct: 81  EPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAAR 140
Query: 121 NTLLDGSPAPRLKICDFGYSK-----SSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLAD 175
           N L+  +    +K+ DFG S+     +   H+  K  +    + APE L+  ++  K +D
Sbjct: 141 NCLVGENHL--VKVADFGLSRLMTGDTYTAHAGAKFPI---KWTAPESLAYNKFSIK-SD 194
Query: 176 VWSCGVTLY-VMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIF 234
           VW+ GV L+ +   G  P+     P      +  ++   Y++       +    L+   +
Sbjct: 195 VWAFGVLLWEIATYGMSPY-----PGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACW 249
Query: 235 VANPSRRITIKEI 247
             NPS R +  EI
Sbjct: 250 QWNPSDRPSFAEI 262

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 59/253 (23%), Positives = 102/253 (40%), Gaps = 26/253 (10%)
Query: 10  IGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKEVVLT 69
           +G G +G       K     VA+K ++          +E    K+++HPN+++   V   
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 80
Query: 70  PTHLAIVMEYAAGGELFE--RICNAGRFSEDEARYFFQQLISG-------QICHRDLKLE 120
                I++E+   G L +  R CN    S     Y   Q+ S           HRDL   
Sbjct: 81  EPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAAR 140
Query: 121 NTLLDGSPAPRLKICDFGYSK-----SSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLAD 175
           N L+  +    +K+ DFG S+     +   H+  K  +    + APE L+  ++  K +D
Sbjct: 141 NCLVGENHL--VKVADFGLSRLMTGDTYTAHAGAKFPI---KWTAPESLAYNKFSIK-SD 194
Query: 176 VWSCGVTLY-VMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIF 234
           VW+ GV L+ +   G  P+     P      +  ++   Y++       +    L+   +
Sbjct: 195 VWAFGVLLWEIATYGMSPY-----PGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACW 249
Query: 235 VANPSRRITIKEI 247
             NPS R +  EI
Sbjct: 250 QWNPSDRPSFAEI 262

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 89/206 (43%), Gaps = 26/206 (12%)
Query: 3   KYELMKDIGSGNFGVARLMRNKNTKELVAMKYI-----ERGHKIDANVAREIINHKQLR- 56
           +YE + +IG G +G     R+ ++   VA+K +     E G  I  +  RE+   ++L  
Sbjct: 5   RYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPI--STVREVALLRRLEA 62
Query: 57  --HPNIIRFKEVVLTP-----THLAIVMEYAAGG--ELFERICNAGRFSE---DEARYFF 104
             HPN++R  +V  T        + +V E+         ++    G  +E   D  R F 
Sbjct: 63  FEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFL 122
Query: 105 QQLI---SGQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAP 161
           + L    +  I HRDLK EN L+  +    +K+ DFG ++           V T  Y AP
Sbjct: 123 RGLDFLHANCIVHRDLKPENILV--TSGGTVKLADFGLARIYSYQMALFPVVVTLWYRAP 180
Query: 162 EVLSRREYDGKLADVWSCGVTLYVML 187
           EVL +  Y     D+WS G     M 
Sbjct: 181 EVLLQSTY-ATPVDMWSVGCIFAEMF 205

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 88/211 (41%), Gaps = 30/211 (14%)
Query: 11  GSGNFGVARLMRNKNT----KELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKEV 66
           G G FGV       NT    K+L AM  I    ++     +EI    + +H N++     
Sbjct: 31  GEGGFGVVYKGYVNNTTVAVKKLAAMVDITT-EELKQQFDQEIKVXAKCQHENLVELLGF 89
Query: 67  VLTPTHLAIVMEYAAGGELFERI--------------CNAGRFSEDEARYFFQQLISGQI 112
                 L +V  Y   G L +R+              C   + + +   +  +       
Sbjct: 90  SSDGDDLCLVYVYXPNGSLLDRLSCLDGTPPLSWHXRCKIAQGAANGINFLHEN----HH 145
Query: 113 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP---KSTVGTPAYIAPEVLSRREY 169
            HRD+K  N LLD   A   KI DFG +++S   ++       VGT AY APE L R E 
Sbjct: 146 IHRDIKSANILLD--EAFTAKISDFGLARASEKFAQXVXXSRIVGTTAYXAPEAL-RGEI 202
Query: 170 DGKLADVWSCGVTLYVMLVGAYPFEDQEDPK 200
             K +D++S GV L  ++ G    ++  +P+
Sbjct: 203 TPK-SDIYSFGVVLLEIITGLPAVDEHREPQ 232

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 59/253 (23%), Positives = 101/253 (39%), Gaps = 26/253 (10%)
Query: 10  IGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKEVVLT 69
           +G G +G       K     VA+K ++          +E    K+++HPN+++   V   
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 80
Query: 70  PTHLAIVMEYAAGGELFE--RICNAGRFSEDEARYFFQQLISG-------QICHRDLKLE 120
                I+ E+   G L +  R CN    S     Y   Q+ S           HRDL   
Sbjct: 81  EPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAAR 140
Query: 121 NTLLDGSPAPRLKICDFGYSK-----SSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLAD 175
           N L+  +    +K+ DFG S+     +   H+  K  +    + APE L+  ++  K +D
Sbjct: 141 NCLVGENHL--VKVADFGLSRLMTGDTYTAHAGAKFPI---KWTAPESLAYNKFSIK-SD 194
Query: 176 VWSCGVTLY-VMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIF 234
           VW+ GV L+ +   G  P+     P      +  ++   Y++       +    L+   +
Sbjct: 195 VWAFGVLLWEIATYGMSPY-----PGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACW 249
Query: 235 VANPSRRITIKEI 247
             NPS R +  EI
Sbjct: 250 QWNPSDRPSFAEI 262

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 59/253 (23%), Positives = 101/253 (39%), Gaps = 26/253 (10%)
Query: 10  IGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKEVVLT 69
           +G G +G       K     VA+K ++          +E    K+++HPN+++   V   
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 85
Query: 70  PTHLAIVMEYAAGGELFE--RICNAGRFSEDEARYFFQQLISG-------QICHRDLKLE 120
                I+ E+   G L +  R CN    S     Y   Q+ S           HRDL   
Sbjct: 86  EPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAAR 145
Query: 121 NTLLDGSPAPRLKICDFGYSK-----SSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLAD 175
           N L+  +    +K+ DFG S+     +   H+  K  +    + APE L+  ++  K +D
Sbjct: 146 NCLVGENHL--VKVADFGLSRLMTGDTYTAHAGAKFPI---KWTAPESLAYNKFSIK-SD 199
Query: 176 VWSCGVTLY-VMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIF 234
           VW+ GV L+ +   G  P+     P      +  ++   Y++       +    L+   +
Sbjct: 200 VWAFGVLLWEIATYGMSPY-----PGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACW 254
Query: 235 VANPSRRITIKEI 247
             NPS R +  EI
Sbjct: 255 QWNPSDRPSFAEI 267

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 59/253 (23%), Positives = 101/253 (39%), Gaps = 26/253 (10%)
Query: 10  IGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKEVVLT 69
           +G G +G       K     VA+K ++          +E    K+++HPN+++   V   
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 80
Query: 70  PTHLAIVMEYAAGGELFE--RICNAGRFSEDEARYFFQQLISG-------QICHRDLKLE 120
                I+ E+   G L +  R CN    S     Y   Q+ S           HRDL   
Sbjct: 81  EPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAAR 140
Query: 121 NTLLDGSPAPRLKICDFGYSK-----SSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLAD 175
           N L+  +    +K+ DFG S+     +   H+  K  +    + APE L+  ++  K +D
Sbjct: 141 NCLVGENHL--VKVADFGLSRLMTGDTYTAHAGAKFPI---KWTAPESLAYNKFSIK-SD 194
Query: 176 VWSCGVTLY-VMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIF 234
           VW+ GV L+ +   G  P+     P      +  ++   Y++       +    L+   +
Sbjct: 195 VWAFGVLLWEIATYGMSPY-----PGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACW 249
Query: 235 VANPSRRITIKEI 247
             NPS R +  EI
Sbjct: 250 QWNPSDRPSFAEI 262

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 60/253 (23%), Positives = 102/253 (40%), Gaps = 26/253 (10%)
Query: 10  IGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKEVVLT 69
           +G G +G       K     VA+K ++          +E    K+++HPN+++   V   
Sbjct: 19  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 78
Query: 70  PTHLAIVMEYAAGGELFE--RICNAGRFSEDEARYFFQQLISG-------QICHRDLKLE 120
                I+ E+   G L +  R CN    S     Y   Q+ S           HRDL   
Sbjct: 79  EPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAAR 138
Query: 121 NTLLDGSPAPRLKICDFGYSK-----SSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLAD 175
           N L+  +    +K+ DFG S+     +   H+  K  +    + APE L+  ++  K +D
Sbjct: 139 NCLVGENHL--VKVADFGLSRLMTGDTFTAHAGAKFPI---KWTAPESLAYNKFSIK-SD 192
Query: 176 VWSCGVTLY-VMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIF 234
           VW+ GV L+ +   G  P+    DP      +  ++   Y++       +    L+   +
Sbjct: 193 VWAFGVLLWEIATYGMSPYPGI-DPSQ----VYELLEKDYRMERPEGCPEKVYELMRACW 247
Query: 235 VANPSRRITIKEI 247
             NPS R +  EI
Sbjct: 248 QWNPSDRPSFAEI 260

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 58/253 (22%), Positives = 102/253 (40%), Gaps = 26/253 (10%)
Query: 10  IGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKEVVLT 69
           +G G +G       K     VA+K ++          +E    K+++HPN+++   V   
Sbjct: 22  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 81
Query: 70  PTHLAIVMEYAAGGELFE--RICNAGRFSEDEARYFFQQLISG-------QICHRDLKLE 120
                I++E+   G L +  R CN    +     Y   Q+ S           HRDL   
Sbjct: 82  EPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAAR 141
Query: 121 NTLLDGSPAPRLKICDFGYSK-----SSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLAD 175
           N L+  +    +K+ DFG S+     +   H+  K  +    + APE L+  ++  K +D
Sbjct: 142 NCLVGENHL--VKVADFGLSRLMTGDTXTAHAGAKFPI---KWTAPESLAYNKFSIK-SD 195
Query: 176 VWSCGVTLY-VMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIF 234
           VW+ GV L+ +   G  P+     P      +  ++   Y++       +    L+   +
Sbjct: 196 VWAFGVLLWEIATYGMSPY-----PGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACW 250
Query: 235 VANPSRRITIKEI 247
             NPS R +  EI
Sbjct: 251 QWNPSDRPSFAEI 263

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 91/215 (42%), Gaps = 28/215 (13%)
Query: 1   MEKYEL------MK-DIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHK 53
           M+K+E+      MK  +G G +G   +   K     VA+K ++          +E    K
Sbjct: 24  MDKWEMERTDITMKHKLGGGQYGEVYVGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMK 83
Query: 54  QLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFE--RICNAGRFSEDEARYFFQQLISG- 110
           +++HPN+++   V        IV EY   G L +  R CN    +     Y   Q+ S  
Sbjct: 84  EIKHPNLVQLLGVCTLEPPFYIVTEYMPYGNLLDYLRECNREEVTAVVLLYMATQISSAM 143
Query: 111 ------QICHRDLKLENTLLDGSPAPRLKICDFGYSK-----SSLLHSRPKSTVGTPAYI 159
                    HRDL   N L+  +    +K+ DFG S+     +   H+  K  +    + 
Sbjct: 144 EYLEKKNFIHRDLAARNCLVGENHV--VKVADFGLSRLMTGDTYTAHAGAKFPI---KWT 198
Query: 160 APEVLSRREYDGKLADVWSCGVTLY-VMLVGAYPF 193
           APE L+   +  K +DVW+ GV L+ +   G  P+
Sbjct: 199 APESLAYNTFSIK-SDVWAFGVLLWEIATYGMSPY 232

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 58/253 (22%), Positives = 102/253 (40%), Gaps = 26/253 (10%)
Query: 10  IGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKEVVLT 69
           +G G +G       K     VA+K ++          +E    K+++HPN+++   V   
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 85
Query: 70  PTHLAIVMEYAAGGELFE--RICNAGRFSEDEARYFFQQLISG-------QICHRDLKLE 120
                I++E+   G L +  R CN    +     Y   Q+ S           HRDL   
Sbjct: 86  EPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAAR 145
Query: 121 NTLLDGSPAPRLKICDFGYSK-----SSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLAD 175
           N L+  +    +K+ DFG S+     +   H+  K  +    + APE L+  ++  K +D
Sbjct: 146 NCLVGENHL--VKVADFGLSRLMTGDTYTAHAGAKFPI---KWTAPESLAYNKFSIK-SD 199
Query: 176 VWSCGVTLY-VMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIF 234
           VW+ GV L+ +   G  P+     P      +  ++   Y++       +    L+   +
Sbjct: 200 VWAFGVLLWEIATYGMSPY-----PGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACW 254
Query: 235 VANPSRRITIKEI 247
             NPS R +  EI
Sbjct: 255 QWNPSDRPSFAEI 267

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 64/264 (24%), Positives = 112/264 (42%), Gaps = 28/264 (10%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIE---RGHKIDANVAREIINHKQL-RH 57
           + ++ +  +G G++G    +R+K    L A+K      RG K  A    E+ +H+++ +H
Sbjct: 57  QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQH 116
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYF---------FQQLI 108
           P  +R ++       L +  E    G   ++ C A   S  EA+ +            L 
Sbjct: 117 PCCVRLEQAWEEGGILYLQTELC--GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLH 174
Query: 109 SGQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRRE 168
           S  + H D+K  N  L   P  R K+ DFG           +   G P Y+APE+L +  
Sbjct: 175 SQGLVHLDVKPANIFL--GPRGRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPELL-QGS 231
Query: 169 YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDY-VHISQDCR 227
           Y G  ADV+S G+T+  +          E  +  R+         Y  P++   +S + R
Sbjct: 232 Y-GTAADVFSLGLTILEVACNMELPHGGEGWQQLRQG--------YLPPEFTAGLSSELR 282
Query: 228 NLLSRIFVANPSRRITIKEIKSHP 251
           ++L  +   +P  R T + + + P
Sbjct: 283 SVLVMMLEPDPKLRATAEALLALP 306

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 58/253 (22%), Positives = 101/253 (39%), Gaps = 26/253 (10%)
Query: 10  IGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKEVVLT 69
           +G G +G       K     VA+K ++          +E    K+++HPN+++   V   
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 85
Query: 70  PTHLAIVMEYAAGGELFE--RICNAGRFSEDEARYFFQQLISG-------QICHRDLKLE 120
                I+ E+   G L +  R CN    +     Y   Q+ S           HRDL   
Sbjct: 86  EPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAAR 145
Query: 121 NTLLDGSPAPRLKICDFGYSK-----SSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLAD 175
           N L+  +    +K+ DFG S+     +   H+  K  +    + APE L+  ++  K +D
Sbjct: 146 NCLVGENHL--VKVADFGLSRLMTGDTXTAHAGAKFPI---KWTAPESLAYNKFSIK-SD 199
Query: 176 VWSCGVTLY-VMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIF 234
           VW+ GV L+ +   G  P+     P      +  ++   Y++       +    L+   +
Sbjct: 200 VWAFGVLLWEIATYGMSPY-----PGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACW 254
Query: 235 VANPSRRITIKEI 247
             NPS R +  EI
Sbjct: 255 QWNPSDRPSFAEI 267

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 78/311 (25%), Positives = 136/311 (43%), Gaps = 51/311 (16%)
Query: 2   EKYELMKDIGSGNFGVARL-----MRNKNTKE--LVAMKYI--ERGHKIDANVAREIINH 52
           +K  L K +G G FG   +     +     KE   VA+K +  +   K  +++  E+   
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 53  KQL-RHPNIIRFKEVVLTPTHLAIVMEYAAGGELFE----RICNAGRFSED-----EARY 102
           K + +H NII           L +++EYA+ G L E    R      +S D     E + 
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 103 FFQQLIS-------------GQIC-HRDLKLENTLLDGSPAPRLKICDFGYSKS-SLLHS 147
            F+ L+S              Q C HRDL   N L+  +    +KI DFG ++  + +  
Sbjct: 155 TFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNV--MKIADFGLARDINNIDX 212
Query: 148 RPKSTVG-TPA-YIAPEVLSRREYDGKLADVWSCGVTLY-VMLVGAYPFEDQEDPKNFRK 204
             K+T G  P  ++APE L  R Y  + +DVWS GV ++ +  +G  P+     P    +
Sbjct: 213 XKKTTNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGVLMWEIFTLGGSPY-----PGIPVE 266
Query: 205 TISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLPRELTET 264
            + +++   +++    + + +   ++   + A PS+R T K++      +++L R LT T
Sbjct: 267 ELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQL------VEDLDRILTLT 320
Query: 265 AQAIYYRKENP 275
               Y     P
Sbjct: 321 TNEEYLDLSQP 331

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 51/200 (25%), Positives = 87/200 (43%), Gaps = 30/200 (15%)
Query: 53  KQLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFE------------RICNAGRFSEDEA 100
           ++ RH NI+ F      P  LAIV ++  G  L+             ++ +  R +    
Sbjct: 59  RKTRHVNILLFMGYSTAP-QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGM 117
Query: 101 RYFFQQLISGQICHRDLKLENTLLDGSPAPRLKICDFGY----SKSSLLHSRPKSTVGTP 156
            Y    L +  I HRDLK  N  L       +KI DFG     S+ S  H   + + G+ 
Sbjct: 118 DY----LHAKSIIHRDLKSNNIFLHEDLT--VKIGDFGLATVKSRWSGSHQFEQLS-GSI 170
Query: 157 AYIAPEVLSRREYD--GKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQY 214
            ++APEV+  ++ +     +DV++ G+ LY ++ G  P+ +     N R  I  ++   Y
Sbjct: 171 LWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSN----INNRDQIIFMVGRGY 226
Query: 215 KIPDYVHISQDCRNLLSRIF 234
             PD   +  +C   + R+ 
Sbjct: 227 LSPDLSKVRSNCPKAMKRLM 246

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 51/200 (25%), Positives = 87/200 (43%), Gaps = 30/200 (15%)
Query: 53  KQLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFE------------RICNAGRFSEDEA 100
           ++ RH NI+ F      P  LAIV ++  G  L+             ++ +  R +    
Sbjct: 79  RKTRHVNILLFMGYSTKP-QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGM 137
Query: 101 RYFFQQLISGQICHRDLKLENTLLDGSPAPRLKICDFGY----SKSSLLHSRPKSTVGTP 156
            Y    L +  I HRDLK  N  L       +KI DFG     S+ S  H   + + G+ 
Sbjct: 138 DY----LHAKSIIHRDLKSNNIFLHEDLT--VKIGDFGLATEKSRWSGSHQFEQLS-GSI 190
Query: 157 AYIAPEVLSRREYD--GKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQY 214
            ++APEV+  ++ +     +DV++ G+ LY ++ G  P+ +     N R  I  ++   Y
Sbjct: 191 LWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSN----INNRDQIIFMVGRGY 246
Query: 215 KIPDYVHISQDCRNLLSRIF 234
             PD   +  +C   + R+ 
Sbjct: 247 LSPDLSKVRSNCPKAMKRLM 266

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 51/200 (25%), Positives = 87/200 (43%), Gaps = 30/200 (15%)
Query: 53  KQLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFE------------RICNAGRFSEDEA 100
           ++ RH NI+ F      P  LAIV ++  G  L+             ++ +  R +    
Sbjct: 86  RKTRHVNILLFMGYSTKP-QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGM 144
Query: 101 RYFFQQLISGQICHRDLKLENTLLDGSPAPRLKICDFGY----SKSSLLHSRPKSTVGTP 156
            Y    L +  I HRDLK  N  L       +KI DFG     S+ S  H   + + G+ 
Sbjct: 145 DY----LHAKSIIHRDLKSNNIFLHEDLT--VKIGDFGLATVKSRWSGSHQFEQLS-GSI 197
Query: 157 AYIAPEVLSRREYD--GKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQY 214
            ++APEV+  ++ +     +DV++ G+ LY ++ G  P+ +     N R  I  ++   Y
Sbjct: 198 LWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSN----INNRDQIIFMVGRGY 253
Query: 215 KIPDYVHISQDCRNLLSRIF 234
             PD   +  +C   + R+ 
Sbjct: 254 LSPDLSKVRSNCPKAMKRLM 273

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 51/201 (25%), Positives = 87/201 (43%), Gaps = 30/201 (14%)
Query: 53  KQLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFE------------RICNAGRFSEDEA 100
           ++ RH NI+ F      P  LAIV ++  G  L+             ++ +  R +    
Sbjct: 87  RKTRHVNILLFMGYSTKP-QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGM 145
Query: 101 RYFFQQLISGQICHRDLKLENTLLDGSPAPRLKICDFGY----SKSSLLHSRPKSTVGTP 156
            Y    L +  I HRDLK  N  L       +KI DFG     S+ S  H   + + G+ 
Sbjct: 146 DY----LHAKSIIHRDLKSNNIFLHEDLT--VKIGDFGLATEKSRWSGSHQFEQLS-GSI 198
Query: 157 AYIAPEVLSRREYD--GKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQY 214
            ++APEV+  ++ +     +DV++ G+ LY ++ G  P+ +     N R  I  ++   Y
Sbjct: 199 LWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSN----INNRDQIIFMVGRGY 254
Query: 215 KIPDYVHISQDCRNLLSRIFV 235
             PD   +  +C   + R+  
Sbjct: 255 LSPDLSKVRSNCPKAMKRLMA 275

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 51/200 (25%), Positives = 87/200 (43%), Gaps = 30/200 (15%)
Query: 53  KQLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFE------------RICNAGRFSEDEA 100
           ++ RH NI+ F      P  LAIV ++  G  L+             ++ +  R +    
Sbjct: 59  RKTRHVNILLFMGYSTKP-QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGM 117
Query: 101 RYFFQQLISGQICHRDLKLENTLLDGSPAPRLKICDFGY----SKSSLLHSRPKSTVGTP 156
            Y    L +  I HRDLK  N  L       +KI DFG     S+ S  H   + + G+ 
Sbjct: 118 DY----LHAKSIIHRDLKSNNIFLHEDLT--VKIGDFGLATEKSRWSGSHQFEQLS-GSI 170
Query: 157 AYIAPEVLSRREYD--GKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQY 214
            ++APEV+  ++ +     +DV++ G+ LY ++ G  P+ +     N R  I  ++   Y
Sbjct: 171 LWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSN----INNRDQIIFMVGRGY 226
Query: 215 KIPDYVHISQDCRNLLSRIF 234
             PD   +  +C   + R+ 
Sbjct: 227 LSPDLSKVRSNCPKAMKRLM 246

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 60/265 (22%), Positives = 113/265 (42%), Gaps = 31/265 (11%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNII 61
           E  +L+K +G+G FG   +    N+ + VA+K ++ G         E    K L+H  ++
Sbjct: 12  ESIKLVKKLGAGQFGEVWMGYYNNSTK-VAVKTLKPGTMSVQAFLEEANLMKTLQHDKLV 70
Query: 62  RFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLI--SGQIC------ 113
           R   VV     + I+ E+ A G L + +      S++  +    +LI  S QI       
Sbjct: 71  RLYAVVTKEEPIYIITEFMAKGSLLDFLK-----SDEGGKVLLPKLIDFSAQIAEGMAYI 125
Query: 114 ------HRDLKLENTLLDGSPAPRLKICDFGYSK--SSLLHSRPKSTVGTPAYIAPEVLS 165
                 HRDL+  N L+  S +   KI DFG ++      ++  +       + APE ++
Sbjct: 126 ERKNYIHRDLRAANVLV--SESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAIN 183
Query: 166 RREYDGKLADVWSCGVTLY-VMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQ 224
              +  K ++VWS G+ LY ++  G  P+     P      +   ++  Y++P   +   
Sbjct: 184 FGCFTIK-SNVWSFGILLYEIVTYGKIPY-----PGRTNADVMSALSQGYRMPRMENCPD 237
Query: 225 DCRNLLSRIFVANPSRRITIKEIKS 249
           +  +++   +      R T   ++S
Sbjct: 238 ELYDIMKMCWKEKAEERPTFDYLQS 262

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 51/200 (25%), Positives = 87/200 (43%), Gaps = 30/200 (15%)
Query: 53  KQLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFE------------RICNAGRFSEDEA 100
           ++ RH NI+ F      P  LAIV ++  G  L+             ++ +  R +    
Sbjct: 87  RKTRHVNILLFMGYSTKP-QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGM 145
Query: 101 RYFFQQLISGQICHRDLKLENTLLDGSPAPRLKICDFGY----SKSSLLHSRPKSTVGTP 156
            Y    L +  I HRDLK  N  L       +KI DFG     S+ S  H   + + G+ 
Sbjct: 146 DY----LHAKSIIHRDLKSNNIFLHEDLT--VKIGDFGLATVKSRWSGSHQFEQLS-GSI 198
Query: 157 AYIAPEVLSRREYD--GKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQY 214
            ++APEV+  ++ +     +DV++ G+ LY ++ G  P+ +     N R  I  ++   Y
Sbjct: 199 LWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSN----INNRDQIIFMVGRGY 254
Query: 215 KIPDYVHISQDCRNLLSRIF 234
             PD   +  +C   + R+ 
Sbjct: 255 LSPDLSKVRSNCPKAMKRLM 274

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 51/200 (25%), Positives = 87/200 (43%), Gaps = 30/200 (15%)
Query: 53  KQLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFE------------RICNAGRFSEDEA 100
           ++ RH NI+ F      P  LAIV ++  G  L+             ++ +  R +    
Sbjct: 61  RKTRHVNILLFMGYSTKP-QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGM 119
Query: 101 RYFFQQLISGQICHRDLKLENTLLDGSPAPRLKICDFGY----SKSSLLHSRPKSTVGTP 156
            Y    L +  I HRDLK  N  L       +KI DFG     S+ S  H   + + G+ 
Sbjct: 120 DY----LHAKSIIHRDLKSNNIFLHEDLT--VKIGDFGLATVKSRWSGSHQFEQLS-GSI 172
Query: 157 AYIAPEVLSRREYD--GKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQY 214
            ++APEV+  ++ +     +DV++ G+ LY ++ G  P+ +     N R  I  ++   Y
Sbjct: 173 LWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSN----INNRDQIIFMVGRGY 228
Query: 215 KIPDYVHISQDCRNLLSRIF 234
             PD   +  +C   + R+ 
Sbjct: 229 LSPDLSKVRSNCPKAMKRLM 248

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 58/253 (22%), Positives = 101/253 (39%), Gaps = 26/253 (10%)
Query: 10  IGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKEVVLT 69
           +G G +G       K     VA+K ++          +E    K+++HPN+++   V   
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 85
Query: 70  PTHLAIVMEYAAGGELFE--RICNAGRFSEDEARYFFQQLISG-------QICHRDLKLE 120
                I+ E+   G L +  R CN    +     Y   Q+ S           HRDL   
Sbjct: 86  EPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAAR 145
Query: 121 NTLLDGSPAPRLKICDFGYSK-----SSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLAD 175
           N L+  +    +K+ DFG S+     +   H+  K  +    + APE L+  ++  K +D
Sbjct: 146 NCLVGENHL--VKVADFGLSRLMTGDTYTAHAGAKFPI---KWTAPESLAYNKFSIK-SD 199
Query: 176 VWSCGVTLY-VMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIF 234
           VW+ GV L+ +   G  P+     P      +  ++   Y++       +    L+   +
Sbjct: 200 VWAFGVLLWEIATYGMSPY-----PGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACW 254
Query: 235 VANPSRRITIKEI 247
             NPS R +  EI
Sbjct: 255 QWNPSDRPSFAEI 267

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 58/253 (22%), Positives = 101/253 (39%), Gaps = 26/253 (10%)
Query: 10  IGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKEVVLT 69
           +G G +G       K     VA+K ++          +E    K+++HPN+++   V   
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 85
Query: 70  PTHLAIVMEYAAGGELFE--RICNAGRFSEDEARYFFQQLISG-------QICHRDLKLE 120
                I+ E+   G L +  R CN    +     Y   Q+ S           HRDL   
Sbjct: 86  EPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAAR 145
Query: 121 NTLLDGSPAPRLKICDFGYSK-----SSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLAD 175
           N L+  +    +K+ DFG S+     +   H+  K  +    + APE L+  ++  K +D
Sbjct: 146 NCLVGENHL--VKVADFGLSRLMTGDTYTAHAGAKFPI---KWTAPESLAYNKFSIK-SD 199
Query: 176 VWSCGVTLY-VMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIF 234
           VW+ GV L+ +   G  P+     P      +  ++   Y++       +    L+   +
Sbjct: 200 VWAFGVLLWEIATYGMSPY-----PGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACW 254
Query: 235 VANPSRRITIKEI 247
             NPS R +  EI
Sbjct: 255 QWNPSDRPSFAEI 267

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 51/200 (25%), Positives = 87/200 (43%), Gaps = 30/200 (15%)
Query: 53  KQLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFE------------RICNAGRFSEDEA 100
           ++ RH NI+ F      P  LAIV ++  G  L+             ++ +  R +    
Sbjct: 64  RKTRHVNILLFMGYSTKP-QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGM 122
Query: 101 RYFFQQLISGQICHRDLKLENTLLDGSPAPRLKICDFGY----SKSSLLHSRPKSTVGTP 156
            Y    L +  I HRDLK  N  L       +KI DFG     S+ S  H   + + G+ 
Sbjct: 123 DY----LHAKSIIHRDLKSNNIFLHEDLT--VKIGDFGLATVKSRWSGSHQFEQLS-GSI 175
Query: 157 AYIAPEVLSRREYD--GKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQY 214
            ++APEV+  ++ +     +DV++ G+ LY ++ G  P+ +     N R  I  ++   Y
Sbjct: 176 LWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSN----INNRDQIIFMVGRGY 231
Query: 215 KIPDYVHISQDCRNLLSRIF 234
             PD   +  +C   + R+ 
Sbjct: 232 LSPDLSKVRSNCPKAMKRLM 251

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 51/200 (25%), Positives = 87/200 (43%), Gaps = 30/200 (15%)
Query: 53  KQLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFE------------RICNAGRFSEDEA 100
           ++ RH NI+ F      P  LAIV ++  G  L+             ++ +  R +    
Sbjct: 64  RKTRHVNILLFMGYSTKP-QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGM 122
Query: 101 RYFFQQLISGQICHRDLKLENTLLDGSPAPRLKICDFGY----SKSSLLHSRPKSTVGTP 156
            Y    L +  I HRDLK  N  L       +KI DFG     S+ S  H   + + G+ 
Sbjct: 123 DY----LHAKSIIHRDLKSNNIFLHEDLT--VKIGDFGLATVKSRWSGSHQFEQLS-GSI 175
Query: 157 AYIAPEVLSRREYD--GKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQY 214
            ++APEV+  ++ +     +DV++ G+ LY ++ G  P+ +     N R  I  ++   Y
Sbjct: 176 LWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSN----INNRDQIIFMVGRGY 231
Query: 215 KIPDYVHISQDCRNLLSRIF 234
             PD   +  +C   + R+ 
Sbjct: 232 LSPDLSKVRSNCPKAMKRLM 251

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 87/207 (42%), Gaps = 25/207 (12%)
Query: 3   KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIE------RGHKIDANVAREIINHKQLR 56
           +YE + +IG G +G     R+ ++   VA+K +        G  +  +  RE+   ++L 
Sbjct: 10  RYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLE 69
Query: 57  ---HPNIIRFKEVVLTP-----THLAIVMEYAAGG--ELFERICNAGRFSE---DEARYF 103
              HPN++R  +V  T        + +V E+         ++    G  +E   D  R F
Sbjct: 70  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQF 129
Query: 104 FQQLI---SGQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIA 160
            + L    +  I HRDLK EN L+       +K+ DFG ++           V T  Y A
Sbjct: 130 LRGLDFLHANCIVHRDLKPENILVTSGGT--VKLADFGLARIYSYQMALTPVVVTLWYRA 187
Query: 161 PEVLSRREYDGKLADVWSCGVTLYVML 187
           PEVL +  Y     D+WS G     M 
Sbjct: 188 PEVLLQSTY-ATPVDMWSVGCIFAEMF 213

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 58/253 (22%), Positives = 101/253 (39%), Gaps = 26/253 (10%)
Query: 10  IGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKEVVLT 69
           +G G +G       K     VA+K ++          +E    K+++HPN+++   V   
Sbjct: 25  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 84
Query: 70  PTHLAIVMEYAAGGELFE--RICNAGRFSEDEARYFFQQLISG-------QICHRDLKLE 120
                I+ E+   G L +  R CN    +     Y   Q+ S           HRDL   
Sbjct: 85  EPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAAR 144
Query: 121 NTLLDGSPAPRLKICDFGYSK-----SSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLAD 175
           N L+  +    +K+ DFG S+     +   H+  K  +    + APE L+  ++  K +D
Sbjct: 145 NCLVGENHL--VKVADFGLSRLMTGDTYTAHAGAKFPI---KWTAPESLAYNKFSIK-SD 198
Query: 176 VWSCGVTLY-VMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIF 234
           VW+ GV L+ +   G  P+     P      +  ++   Y++       +    L+   +
Sbjct: 199 VWAFGVLLWEIATYGMSPY-----PGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACW 253
Query: 235 VANPSRRITIKEI 247
             NPS R +  EI
Sbjct: 254 QWNPSDRPSFAEI 266

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 51/200 (25%), Positives = 87/200 (43%), Gaps = 30/200 (15%)
Query: 53  KQLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFE------------RICNAGRFSEDEA 100
           ++ RH NI+ F      P  LAIV ++  G  L+             ++ +  R +    
Sbjct: 59  RKTRHVNILLFMGYSTKP-QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGM 117
Query: 101 RYFFQQLISGQICHRDLKLENTLLDGSPAPRLKICDFGY----SKSSLLHSRPKSTVGTP 156
            Y    L +  I HRDLK  N  L       +KI DFG     S+ S  H   + + G+ 
Sbjct: 118 DY----LHAKSIIHRDLKSNNIFLHEDLT--VKIGDFGLATVKSRWSGSHQFEQLS-GSI 170
Query: 157 AYIAPEVLSRREYD--GKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQY 214
            ++APEV+  ++ +     +DV++ G+ LY ++ G  P+ +     N R  I  ++   Y
Sbjct: 171 LWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSN----INNRDQIIFMVGRGY 226
Query: 215 KIPDYVHISQDCRNLLSRIF 234
             PD   +  +C   + R+ 
Sbjct: 227 LSPDLSKVRSNCPKAMKRLM 246

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 58/253 (22%), Positives = 101/253 (39%), Gaps = 26/253 (10%)
Query: 10  IGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKEVVLT 69
           +G G +G       K     VA+K ++          +E    K+++HPN+++   V   
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 82
Query: 70  PTHLAIVMEYAAGGELFE--RICNAGRFSEDEARYFFQQLISG-------QICHRDLKLE 120
                I+ E+   G L +  R CN    +     Y   Q+ S           HRDL   
Sbjct: 83  EPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAAR 142
Query: 121 NTLLDGSPAPRLKICDFGYSK-----SSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLAD 175
           N L+  +    +K+ DFG S+     +   H+  K  +    + APE L+  ++  K +D
Sbjct: 143 NCLVGENHL--VKVADFGLSRLMTGDTYTAHAGAKFPI---KWTAPESLAYNKFSIK-SD 196
Query: 176 VWSCGVTLY-VMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIF 234
           VW+ GV L+ +   G  P+     P      +  ++   Y++       +    L+   +
Sbjct: 197 VWAFGVLLWEIATYGMSPY-----PGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACW 251
Query: 235 VANPSRRITIKEI 247
             NPS R +  EI
Sbjct: 252 QWNPSDRPSFAEI 264

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 58/253 (22%), Positives = 101/253 (39%), Gaps = 26/253 (10%)
Query: 10  IGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKEVVLT 69
           +G G +G       K     VA+K ++          +E    K+++HPN+++   V   
Sbjct: 34  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 93
Query: 70  PTHLAIVMEYAAGGELFE--RICNAGRFSEDEARYFFQQLISG-------QICHRDLKLE 120
                I+ E+   G L +  R CN    +     Y   Q+ S           HRDL   
Sbjct: 94  EPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAAR 153
Query: 121 NTLLDGSPAPRLKICDFGYSK-----SSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLAD 175
           N L+  +    +K+ DFG S+     +   H+  K  +    + APE L+  ++  K +D
Sbjct: 154 NCLVGENHL--VKVADFGLSRLMTGDTYTAHAGAKFPI---KWTAPESLAYNKFSIK-SD 207
Query: 176 VWSCGVTLY-VMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIF 234
           VW+ GV L+ +   G  P+     P      +  ++   Y++       +    L+   +
Sbjct: 208 VWAFGVLLWEIATYGMSPY-----PGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACW 262
Query: 235 VANPSRRITIKEI 247
             NPS R +  EI
Sbjct: 263 QWNPSDRPSFAEI 275

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 58/253 (22%), Positives = 101/253 (39%), Gaps = 26/253 (10%)
Query: 10  IGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKEVVLT 69
           +G G +G       K     VA+K ++          +E    K+++HPN+++   V   
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 80
Query: 70  PTHLAIVMEYAAGGELFE--RICNAGRFSEDEARYFFQQLISG-------QICHRDLKLE 120
                I+ E+   G L +  R CN    +     Y   Q+ S           HRDL   
Sbjct: 81  EPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAAR 140
Query: 121 NTLLDGSPAPRLKICDFGYSK-----SSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLAD 175
           N L+  +    +K+ DFG S+     +   H+  K  +    + APE L+  ++  K +D
Sbjct: 141 NCLVGENHL--VKVADFGLSRLMTGDTYTAHAGAKFPI---KWTAPESLAYNKFSIK-SD 194
Query: 176 VWSCGVTLY-VMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIF 234
           VW+ GV L+ +   G  P+     P      +  ++   Y++       +    L+   +
Sbjct: 195 VWAFGVLLWEIATYGMSPY-----PGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACW 249
Query: 235 VANPSRRITIKEI 247
             NPS R +  EI
Sbjct: 250 QWNPSDRPSFAEI 262

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 58/253 (22%), Positives = 101/253 (39%), Gaps = 26/253 (10%)
Query: 10  IGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKEVVLT 69
           +G G +G       K     VA+K ++          +E    K+++HPN+++   V   
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 82
Query: 70  PTHLAIVMEYAAGGELFE--RICNAGRFSEDEARYFFQQLISG-------QICHRDLKLE 120
                I+ E+   G L +  R CN    +     Y   Q+ S           HRDL   
Sbjct: 83  EPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAAR 142
Query: 121 NTLLDGSPAPRLKICDFGYSK-----SSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLAD 175
           N L+  +    +K+ DFG S+     +   H+  K  +    + APE L+  ++  K +D
Sbjct: 143 NCLVGENHL--VKVADFGLSRLMTGDTYTAHAGAKFPI---KWTAPESLAYNKFSIK-SD 196
Query: 176 VWSCGVTLY-VMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIF 234
           VW+ GV L+ +   G  P+     P      +  ++   Y++       +    L+   +
Sbjct: 197 VWAFGVLLWEIATYGMSPY-----PGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACW 251
Query: 235 VANPSRRITIKEI 247
             NPS R +  EI
Sbjct: 252 QWNPSDRPSFAEI 264

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 50/203 (24%), Positives = 87/203 (42%), Gaps = 34/203 (16%)
Query: 53  KQLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLI---- 108
           ++ RH NI+ F      P  LAIV ++  G  L+  +         E ++  ++LI    
Sbjct: 75  RKTRHVNILLFMGYSTAP-QLAIVTQWCEGSSLYHHL------HASETKFEMKKLIDIAR 127
Query: 109 ----------SGQICHRDLKLENTLLDGSPAPRLKICDFGY----SKSSLLHSRPKSTVG 154
                     +  I HRDLK  N  L       +KI DFG     S+ S  H   + + G
Sbjct: 128 QTARGMDYLHAKSIIHRDLKSNNIFLHEDNT--VKIGDFGLATEKSRWSGSHQFEQLS-G 184
Query: 155 TPAYIAPEVLSRREYD--GKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAV 212
           +  ++APEV+  ++ +     +DV++ G+ LY ++ G  P+ +     N R  I  ++  
Sbjct: 185 SILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSN----INNRDQIIEMVGR 240
Query: 213 QYKIPDYVHISQDCRNLLSRIFV 235
               PD   +  +C   + R+  
Sbjct: 241 GSLSPDLSKVRSNCPKRMKRLMA 263

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 92/207 (44%), Gaps = 25/207 (12%)
Query: 10  IGSGNFGV---ARLMRNKNTKELVAMKYIERGHKID--ANVAREIINHKQLRHPNIIRFK 64
           IG G+FG      L+ N   K   A+K + R   I   +    E I  K   HPN++   
Sbjct: 39  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 98
Query: 65  EVVL-TPTHLAIVMEYAAGGELFERICNAGR--FSEDEARYFFQQ------LISGQICHR 115
            + L +     +V+ Y   G+L   I N       +D   +  Q       L S +  HR
Sbjct: 99  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHR 158
Query: 116 DLKLENTLLDGSPAPRLKICDFGYSKSSL------LHSRPKSTVGTPAYIAPEVLSRREY 169
           DL   N +LD      +K+ DFG ++  L      +H++  + +    ++A E L  +++
Sbjct: 159 DLAARNCMLDEKFT--VKVADFGLARDMLDKEFDSVHNKTGAKLPV-KWMALESLQTQKF 215
Query: 170 DGKLADVWSCGVTLY-VMLVGAYPFED 195
             K +DVWS GV L+ +M  GA P+ D
Sbjct: 216 TTK-SDVWSFGVLLWELMTRGAPPYPD 241

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 58/253 (22%), Positives = 101/253 (39%), Gaps = 26/253 (10%)
Query: 10  IGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKEVVLT 69
           +G G +G       K     VA+K ++          +E    K+++HPN+++   V   
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 80
Query: 70  PTHLAIVMEYAAGGELFE--RICNAGRFSEDEARYFFQQLISG-------QICHRDLKLE 120
                I+ E+   G L +  R CN    +     Y   Q+ S           HRDL   
Sbjct: 81  EPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAAR 140
Query: 121 NTLLDGSPAPRLKICDFGYSK-----SSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLAD 175
           N L+  +    +K+ DFG S+     +   H+  K  +    + APE L+  ++  K +D
Sbjct: 141 NCLVGENHL--VKVADFGLSRLMTGDTYTAHAGAKFPI---KWTAPESLAYNKFSIK-SD 194
Query: 176 VWSCGVTLY-VMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIF 234
           VW+ GV L+ +   G  P+     P      +  ++   Y++       +    L+   +
Sbjct: 195 VWAFGVLLWEIATYGMSPY-----PGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACW 249
Query: 235 VANPSRRITIKEI 247
             NPS R +  EI
Sbjct: 250 QWNPSDRPSFAEI 262

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 50/203 (24%), Positives = 87/203 (42%), Gaps = 34/203 (16%)
Query: 53  KQLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLI---- 108
           ++ RH NI+ F      P  LAIV ++  G  L+  +         E ++  ++LI    
Sbjct: 75  RKTRHVNILLFMGYSTKP-QLAIVTQWCEGSSLYHHL------HASETKFEMKKLIDIAR 127
Query: 109 ----------SGQICHRDLKLENTLLDGSPAPRLKICDFGY----SKSSLLHSRPKSTVG 154
                     +  I HRDLK  N  L       +KI DFG     S+ S  H   + + G
Sbjct: 128 QTARGMDYLHAKSIIHRDLKSNNIFLHEDNT--VKIGDFGLATEKSRWSGSHQFEQLS-G 184
Query: 155 TPAYIAPEVLSRREYD--GKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAV 212
           +  ++APEV+  ++ +     +DV++ G+ LY ++ G  P+ +     N R  I  ++  
Sbjct: 185 SILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSN----INNRDQIIEMVGR 240
Query: 213 QYKIPDYVHISQDCRNLLSRIFV 235
               PD   +  +C   + R+  
Sbjct: 241 GSLSPDLSKVRSNCPKRMKRLMA 263

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 51.2 bits (121), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 50/197 (25%), Positives = 86/197 (43%), Gaps = 22/197 (11%)
Query: 53  KQLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERI-CNAGRFSEDEARYFFQQLISG- 110
           ++ RH NI+ F      P  LAIV ++  G  L+  +  +  +F   +     +Q   G 
Sbjct: 63  RKTRHVNILLFMGYSTKP-QLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGM 121
Query: 111 ------QICHRDLKLENTLLDGSPAPRLKICDFGY----SKSSLLHSRPKSTVGTPAYIA 160
                  I HRDLK  N  L       +KI DFG     S+ S  H   + + G+  ++A
Sbjct: 122 DYLHAKSIIHRDLKSNNIFLHEDNT--VKIGDFGLATVKSRWSGSHQFEQLS-GSILWMA 178
Query: 161 PEVLSRREYD--GKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPD 218
           PEV+  ++ +     +DV++ G+ LY ++ G  P+ +     N R  I  ++      PD
Sbjct: 179 PEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSN----INNRDQIIEMVGRGSLSPD 234
Query: 219 YVHISQDCRNLLSRIFV 235
              +  +C   + R+  
Sbjct: 235 LSKVRSNCPKRMKRLMA 251

>pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 73/341 (21%), Positives = 121/341 (35%), Gaps = 97/341 (28%)
Query: 2   EKYELMKDIGSGNFG-VARLMRNKNTKELVAMKYI------ERGHKIDANVAREIINHKQ 54
           E+YE++ ++G G FG V   + +   K  VA+K I          +++ NV ++I    +
Sbjct: 51  ERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDK 110
Query: 55  LRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFE--------------------RICNAGR 94
                 +   +      H+ I  E   G   FE                    ++C+A R
Sbjct: 111 ENKFLCVLMSDWFNFHGHMCIAFE-LLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALR 169
Query: 95  FSEDEARYFFQQLISGQICHRDLKLENTLLDGSPAPRL-----------------KICDF 137
           F           L   Q+ H DLK EN L   S    L                 ++ DF
Sbjct: 170 F-----------LHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADF 218
Query: 138 GYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQE 197
           G   ++  H    + V T  Y  PEV+    +  +  DVWS G  L+    G   F+  E
Sbjct: 219 G--SATFDHEHHTTIVATRHYRPPEVILELGW-AQPCDVWSIGCILFEYYRGFTLFQTHE 275
Query: 198 DPKNF-----------RKTISRIMAVQY----------KIPDYVHISQDCR--------- 227
           + ++               I R    +Y             D  ++ ++C+         
Sbjct: 276 NREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQD 335
Query: 228 --------NLLSRIFVANPSRRITIKEIKSHPWFLKNLPRE 260
                   +L+ R+   +P++RIT+ E   HP+F    P E
Sbjct: 336 SLEHVQLFDLMRRMLEFDPAQRITLAEALLHPFFAGLTPEE 376

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 73/311 (23%), Positives = 133/311 (42%), Gaps = 51/311 (16%)
Query: 2   EKYELMKDIGSGNFGVARL-----MRNKNTKE--LVAMKYI--ERGHKIDANVAREIINH 52
           +K  L K +G G FG   +     +     KE   VA+K +  +   K  +++  E+   
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 53  KQL-RHPNIIRFKEVVLTPTHLAIVMEYAAGGEL-----------FERICNAGRFSEDEA 100
           K + +H NII           L +++EYA+ G L            E   +  R  E++ 
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXSYDINRVPEEQM 154
Query: 101 RY------------FFQQLISGQICHRDLKLENTLLDGSPAPRLKICDFGYSKS-SLLHS 147
            +              + L S +  HRDL   N L+  +    +KI DFG ++  + +  
Sbjct: 155 TFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNV--MKIADFGLARDINNIDX 212
Query: 148 RPKSTVG-TPA-YIAPEVLSRREYDGKLADVWSCGVTLY-VMLVGAYPFEDQEDPKNFRK 204
             K+T G  P  ++APE L  R Y  + +DVWS GV ++ +  +G  P+     P    +
Sbjct: 213 XKKTTNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGVLMWEIFTLGGSPY-----PGIPVE 266
Query: 205 TISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLPRELTET 264
            + +++   +++    + + +   ++   + A PS+R T K++      +++L R LT T
Sbjct: 267 ELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQL------VEDLDRILTLT 320
Query: 265 AQAIYYRKENP 275
               Y     P
Sbjct: 321 TNEEYLDLSQP 331

>pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 73/341 (21%), Positives = 121/341 (35%), Gaps = 97/341 (28%)
Query: 2   EKYELMKDIGSGNFG-VARLMRNKNTKELVAMKYI------ERGHKIDANVAREIINHKQ 54
           E+YE++ ++G G FG V   + +   K  VA+K I          +++ NV ++I    +
Sbjct: 28  ERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDK 87
Query: 55  LRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFE--------------------RICNAGR 94
                 +   +      H+ I  E   G   FE                    ++C+A R
Sbjct: 88  ENKFLCVLMSDWFNFHGHMCIAFE-LLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALR 146
Query: 95  FSEDEARYFFQQLISGQICHRDLKLENTLLDGSPAPRL-----------------KICDF 137
           F           L   Q+ H DLK EN L   S    L                 ++ DF
Sbjct: 147 F-----------LHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADF 195
Query: 138 GYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQE 197
           G   ++  H    + V T  Y  PEV+    +  +  DVWS G  L+    G   F+  E
Sbjct: 196 G--SATFDHEHHTTIVATRHYRPPEVILELGW-AQPCDVWSIGCILFEYYRGFTLFQTHE 252
Query: 198 DPKNF-----------RKTISRIMAVQY----------KIPDYVHISQDCR--------- 227
           + ++               I R    +Y             D  ++ ++C+         
Sbjct: 253 NREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQD 312
Query: 228 --------NLLSRIFVANPSRRITIKEIKSHPWFLKNLPRE 260
                   +L+ R+   +P++RIT+ E   HP+F    P E
Sbjct: 313 SLEHVQLFDLMRRMLEFDPAQRITLAEALLHPFFAGLTPEE 353

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 95/208 (45%), Gaps = 26/208 (12%)
Query: 7   MKDIGSGNFGVA----RLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLR----HP 58
           +K +GSG FG       +   +N K  VA+K +       AN  +EI++   +      P
Sbjct: 22  VKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKAN--KEILDEAYVMAGVGSP 79
Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGELFERIC-NAGRFSEDEARYFFQQLISG------- 110
            + R   + LT T + +V +    G L + +  N GR    +   +  Q+  G       
Sbjct: 80  YVSRLLGICLTST-VQLVTQLMPYGCLLDHVRENRGRLGSQDLLNWCMQIAKGMSYLEDV 138
Query: 111 QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPA---YIAPEVLSRR 167
           ++ HRDL   N L+  SP   +KI DFG ++   +        G      ++A E + RR
Sbjct: 139 RLVHRDLAARNVLVK-SPN-HVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILRR 196
Query: 168 EYDGKLADVWSCGVTLY-VMLVGAYPFE 194
            +  + +DVWS GVT++ +M  GA P++
Sbjct: 197 RFTHQ-SDVWSYGVTVWELMTFGAKPYD 223

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 50.8 bits (120), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 58/253 (22%), Positives = 101/253 (39%), Gaps = 26/253 (10%)
Query: 10  IGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKEVVLT 69
           +G G +G       K     VA+K ++          +E    K+++HPN+++   V   
Sbjct: 228 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 287
Query: 70  PTHLAIVMEYAAGGELFE--RICNAGRFSEDEARYFFQQLISG-------QICHRDLKLE 120
                I+ E+   G L +  R CN    S     Y   Q+ S           HR+L   
Sbjct: 288 EPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAAR 347
Query: 121 NTLLDGSPAPRLKICDFGYSK-----SSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLAD 175
           N L+  +    +K+ DFG S+     +   H+  K  +    + APE L+  ++  K +D
Sbjct: 348 NCLVGENHL--VKVADFGLSRLMTGDTYTAHAGAKFPI---KWTAPESLAYNKFSIK-SD 401
Query: 176 VWSCGVTLY-VMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIF 234
           VW+ GV L+ +   G  P+     P      +  ++   Y++       +    L+   +
Sbjct: 402 VWAFGVLLWEIATYGMSPY-----PGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACW 456
Query: 235 VANPSRRITIKEI 247
             NPS R +  EI
Sbjct: 457 QWNPSDRPSFAEI 469

>pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 73/341 (21%), Positives = 121/341 (35%), Gaps = 97/341 (28%)
Query: 2   EKYELMKDIGSGNFG-VARLMRNKNTKELVAMKYI------ERGHKIDANVAREIINHKQ 54
           E+YE++ ++G G FG V   + +   K  VA+K I          +++ NV ++I    +
Sbjct: 19  ERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDK 78
Query: 55  LRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFE--------------------RICNAGR 94
                 +   +      H+ I  E   G   FE                    ++C+A R
Sbjct: 79  ENKFLCVLMSDWFNFHGHMCIAFE-LLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALR 137
Query: 95  FSEDEARYFFQQLISGQICHRDLKLENTLLDGSPAPRL-----------------KICDF 137
           F           L   Q+ H DLK EN L   S    L                 ++ DF
Sbjct: 138 F-----------LHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADF 186
Query: 138 GYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQE 197
           G   ++  H    + V T  Y  PEV+    +  +  DVWS G  L+    G   F+  E
Sbjct: 187 G--SATFDHEHHTTIVATRHYRPPEVILELGW-AQPCDVWSIGCILFEYYRGFTLFQTHE 243
Query: 198 DPKNF-----------RKTISRIMAVQY----------KIPDYVHISQDCR--------- 227
           + ++               I R    +Y             D  ++ ++C+         
Sbjct: 244 NREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQD 303
Query: 228 --------NLLSRIFVANPSRRITIKEIKSHPWFLKNLPRE 260
                   +L+ R+   +P++RIT+ E   HP+F    P E
Sbjct: 304 SLEHVQLFDLMRRMLEFDPAQRITLAEALLHPFFAGLTPEE 344

>pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 65/295 (22%), Positives = 123/295 (41%), Gaps = 50/295 (16%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRH-PNI 60
           + Y+L++ +G G +       N    E V +K ++   K    + REI   + LR  PNI
Sbjct: 37  DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKK--NKIKREIKILENLRGGPNI 94
Query: 61  IRFKEVVLTPTHL--AIVMEYAAGGELFERICNAGRFSEDEARYFFQQLI-------SGQ 111
           I   ++V  P     A+V E+    + F+++      ++ + R++  +++       S  
Sbjct: 95  ITLADIVKDPVSRTPALVFEHVNNTD-FKQLYQT--LTDYDIRFYMYEILKALDYCHSMG 151
Query: 112 ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVL-SRREYD 170
           I HRD+K  N ++D     +L++ D+G ++           V +  +  PE+L   + YD
Sbjct: 152 IMHRDVKPHNVMIDHEHR-KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYD 210
Query: 171 GKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQ--YKIPD---------- 218
             L D+WS G  L  M+    PF    D  +    I++++  +  Y   D          
Sbjct: 211 YSL-DMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRF 269
Query: 219 --------------YVH------ISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 253
                         +VH      +S +  + L ++   +   R+T +E   HP+F
Sbjct: 270 NDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 324

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 91/208 (43%), Gaps = 27/208 (12%)
Query: 10  IGSGNFGV---ARLMRNKNTKELVAMKYIERGHKID--ANVAREIINHKQLRHPNIIRFK 64
           IG G+FG      L+ N   K   A+K + R   I   +    E I  K   HPN++   
Sbjct: 57  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 116
Query: 65  EVVL-TPTHLAIVMEYAAGGELFERICNAGR---------FSEDEARYFFQQLISGQICH 114
            + L +     +V+ Y   G+L   I N            F    A+   + L S +  H
Sbjct: 117 GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGM-KYLASKKFVH 175
Query: 115 RDLKLENTLLDGSPAPRLKICDFGYSKSSL------LHSRPKSTVGTPAYIAPEVLSRRE 168
           RDL   N +LD      +K+ DFG ++         +H++  + +    ++A E L  ++
Sbjct: 176 RDLAARNCMLDEKFT--VKVADFGLARDMYDKEYYSVHNKTGAKLPV-KWMALESLQTQK 232
Query: 169 YDGKLADVWSCGVTLY-VMLVGAYPFED 195
           +  K +DVWS GV L+ +M  GA P+ D
Sbjct: 233 FTTK-SDVWSFGVLLWELMTRGAPPYPD 259

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 67/287 (23%), Positives = 117/287 (40%), Gaps = 44/287 (15%)
Query: 4   YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRF 63
           +E +  +G G FG     RN       A+K I    +  + +  E+     L H  ++R+
Sbjct: 8   FEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVXLLASLNHQYVVRY 67
Query: 64  -------------KEVVLTPTHLAIVMEYAAGGELFERICNAGRFSE-DEARYFFQQLI- 108
                           V   + L I  EY     L++ I +     + DE    F+Q++ 
Sbjct: 68  YAAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQRDEYWRLFRQILE 127
Query: 109 ------SGQICHRDLKLENTLLDGSPAPRLKICDFGYSKS---SL----LHSRP------ 149
                 S  I HR+LK  N  +D S    +KI DFG +K+   SL    L S+       
Sbjct: 128 ALSYIHSQGIIHRNLKPXNIFIDESR--NVKIGDFGLAKNVHRSLDILKLDSQNLPGSSD 185
Query: 150 --KSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTIS 207
              S +GT  Y+A EVL    +  +  D +S G+  +  +   YPF    +  N  K + 
Sbjct: 186 NLTSAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFFEXI---YPFSTGXERVNILKKL- 241
Query: 208 RIMAVQYKIPDYVHISQDCRNLLSRIFVA-NPSRRITIKEIKSHPWF 253
           R +++++  PD+          + R+ +  +P++R   + + +  W 
Sbjct: 242 RSVSIEFP-PDFDDNKXKVEKKIIRLLIDHDPNKRPGARTLLNSGWL 287

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 91/208 (43%), Gaps = 27/208 (12%)
Query: 10  IGSGNFGV---ARLMRNKNTKELVAMKYIERGHKID--ANVAREIINHKQLRHPNIIRFK 64
           IG G+FG      L+ N   K   A+K + R   I   +    E I  K   HPN++   
Sbjct: 37  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 96
Query: 65  EVVL-TPTHLAIVMEYAAGGELFERICNAGR---------FSEDEARYFFQQLISGQICH 114
            + L +     +V+ Y   G+L   I N            F    A+   + L S +  H
Sbjct: 97  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGM-KYLASKKFVH 155
Query: 115 RDLKLENTLLDGSPAPRLKICDFGYSKSSL------LHSRPKSTVGTPAYIAPEVLSRRE 168
           RDL   N +LD      +K+ DFG ++         +H++  + +    ++A E L  ++
Sbjct: 156 RDLAARNCMLDEKFT--VKVADFGLARDMYDKEXXSVHNKTGAKLPV-KWMALESLQTQK 212
Query: 169 YDGKLADVWSCGVTLY-VMLVGAYPFED 195
           +  K +DVWS GV L+ +M  GA P+ D
Sbjct: 213 FTTK-SDVWSFGVLLWELMTRGAPPYPD 239

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 91/208 (43%), Gaps = 27/208 (12%)
Query: 10  IGSGNFGV---ARLMRNKNTKELVAMKYIERGHKID--ANVAREIINHKQLRHPNIIRFK 64
           IG G+FG      L+ N   K   A+K + R   I   +    E I  K   HPN++   
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 97
Query: 65  EVVL-TPTHLAIVMEYAAGGELFERICNAGR---------FSEDEARYFFQQLISGQICH 114
            + L +     +V+ Y   G+L   I N            F    A+   + L S +  H
Sbjct: 98  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGM-KYLASKKFVH 156
Query: 115 RDLKLENTLLDGSPAPRLKICDFGYSKSSL------LHSRPKSTVGTPAYIAPEVLSRRE 168
           RDL   N +LD      +K+ DFG ++         +H++  + +    ++A E L  ++
Sbjct: 157 RDLAARNCMLDEKFT--VKVADFGLARDMYDKEYYSVHNKTGAKLPV-KWMALESLQTQK 213
Query: 169 YDGKLADVWSCGVTLY-VMLVGAYPFED 195
           +  K +DVWS GV L+ +M  GA P+ D
Sbjct: 214 FTTK-SDVWSFGVLLWELMTRGAPPYPD 240

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 91/208 (43%), Gaps = 27/208 (12%)
Query: 10  IGSGNFGV---ARLMRNKNTKELVAMKYIERGHKID--ANVAREIINHKQLRHPNIIRFK 64
           IG G+FG      L+ N   K   A+K + R   I   +    E I  K   HPN++   
Sbjct: 33  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 92
Query: 65  EVVL-TPTHLAIVMEYAAGGELFERICNAGR---------FSEDEARYFFQQLISGQICH 114
            + L +     +V+ Y   G+L   I N            F    A+   + L S +  H
Sbjct: 93  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGM-KYLASKKFVH 151
Query: 115 RDLKLENTLLDGSPAPRLKICDFGYSKSSL------LHSRPKSTVGTPAYIAPEVLSRRE 168
           RDL   N +LD      +K+ DFG ++         +H++  + +    ++A E L  ++
Sbjct: 152 RDLAARNCMLDEKFT--VKVADFGLARDMYDKEYYSVHNKTGAKLPV-KWMALESLQTQK 208
Query: 169 YDGKLADVWSCGVTLY-VMLVGAYPFED 195
           +  K +DVWS GV L+ +M  GA P+ D
Sbjct: 209 FTTK-SDVWSFGVLLWELMTRGAPPYPD 235

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 91/208 (43%), Gaps = 27/208 (12%)
Query: 10  IGSGNFGV---ARLMRNKNTKELVAMKYIERGHKID--ANVAREIINHKQLRHPNIIRFK 64
           IG G+FG      L+ N   K   A+K + R   I   +    E I  K   HPN++   
Sbjct: 35  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 94
Query: 65  EVVL-TPTHLAIVMEYAAGGELFERICNAGR---------FSEDEARYFFQQLISGQICH 114
            + L +     +V+ Y   G+L   I N            F    A+   + L S +  H
Sbjct: 95  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGM-KYLASKKFVH 153
Query: 115 RDLKLENTLLDGSPAPRLKICDFGYSKSSL------LHSRPKSTVGTPAYIAPEVLSRRE 168
           RDL   N +LD      +K+ DFG ++         +H++  + +    ++A E L  ++
Sbjct: 154 RDLAARNCMLDEKFT--VKVADFGLARDMYDKEYYSVHNKTGAKLPV-KWMALESLQTQK 210
Query: 169 YDGKLADVWSCGVTLY-VMLVGAYPFED 195
           +  K +DVWS GV L+ +M  GA P+ D
Sbjct: 211 FTTK-SDVWSFGVLLWELMTRGAPPYPD 237

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 91/208 (43%), Gaps = 27/208 (12%)
Query: 10  IGSGNFGV---ARLMRNKNTKELVAMKYIERGHKID--ANVAREIINHKQLRHPNIIRFK 64
           IG G+FG      L+ N   K   A+K + R   I   +    E I  K   HPN++   
Sbjct: 30  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 89
Query: 65  EVVL-TPTHLAIVMEYAAGGELFERICNAGR---------FSEDEARYFFQQLISGQICH 114
            + L +     +V+ Y   G+L   I N            F    A+   + L S +  H
Sbjct: 90  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGM-KYLASKKFVH 148
Query: 115 RDLKLENTLLDGSPAPRLKICDFGYSKSSL------LHSRPKSTVGTPAYIAPEVLSRRE 168
           RDL   N +LD      +K+ DFG ++         +H++  + +    ++A E L  ++
Sbjct: 149 RDLAARNCMLDEKFT--VKVADFGLARDMYDKEYYSVHNKTGAKLPV-KWMALESLQTQK 205
Query: 169 YDGKLADVWSCGVTLY-VMLVGAYPFED 195
           +  K +DVWS GV L+ +M  GA P+ D
Sbjct: 206 FTTK-SDVWSFGVLLWELMTRGAPPYPD 232

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 91/208 (43%), Gaps = 27/208 (12%)
Query: 10  IGSGNFGV---ARLMRNKNTKELVAMKYIERGHKID--ANVAREIINHKQLRHPNIIRFK 64
           IG G+FG      L+ N   K   A+K + R   I   +    E I  K   HPN++   
Sbjct: 56  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 115
Query: 65  EVVL-TPTHLAIVMEYAAGGELFERICNAGR---------FSEDEARYFFQQLISGQICH 114
            + L +     +V+ Y   G+L   I N            F    A+   + L S +  H
Sbjct: 116 GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGM-KYLASKKFVH 174
Query: 115 RDLKLENTLLDGSPAPRLKICDFGYSKSSL------LHSRPKSTVGTPAYIAPEVLSRRE 168
           RDL   N +LD      +K+ DFG ++         +H++  + +    ++A E L  ++
Sbjct: 175 RDLAARNCMLDEKFT--VKVADFGLARDMYDKEYYSVHNKTGAKLPV-KWMALESLQTQK 231
Query: 169 YDGKLADVWSCGVTLY-VMLVGAYPFED 195
           +  K +DVWS GV L+ +M  GA P+ D
Sbjct: 232 FTTK-SDVWSFGVLLWELMTRGAPPYPD 258

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 91/208 (43%), Gaps = 27/208 (12%)
Query: 10  IGSGNFGV---ARLMRNKNTKELVAMKYIERGHKID--ANVAREIINHKQLRHPNIIRFK 64
           IG G+FG      L+ N   K   A+K + R   I   +    E I  K   HPN++   
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 97
Query: 65  EVVL-TPTHLAIVMEYAAGGELFERICNAGR---------FSEDEARYFFQQLISGQICH 114
            + L +     +V+ Y   G+L   I N            F    A+   + L S +  H
Sbjct: 98  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGM-KYLASKKFVH 156
Query: 115 RDLKLENTLLDGSPAPRLKICDFGYSKSSL------LHSRPKSTVGTPAYIAPEVLSRRE 168
           RDL   N +LD      +K+ DFG ++         +H++  + +    ++A E L  ++
Sbjct: 157 RDLAARNCMLDEKFT--VKVADFGLARDMYDKEYYSVHNKTGAKLPV-KWMALESLQTQK 213
Query: 169 YDGKLADVWSCGVTLY-VMLVGAYPFED 195
           +  K +DVWS GV L+ +M  GA P+ D
Sbjct: 214 FTTK-SDVWSFGVLLWELMTRGAPPYPD 240

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 91/208 (43%), Gaps = 27/208 (12%)
Query: 10  IGSGNFGV---ARLMRNKNTKELVAMKYIERGHKID--ANVAREIINHKQLRHPNIIRFK 64
           IG G+FG      L+ N   K   A+K + R   I   +    E I  K   HPN++   
Sbjct: 37  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 96
Query: 65  EVVL-TPTHLAIVMEYAAGGELFERICNAGR---------FSEDEARYFFQQLISGQICH 114
            + L +     +V+ Y   G+L   I N            F    A+   + L S +  H
Sbjct: 97  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGM-KYLASKKFVH 155
Query: 115 RDLKLENTLLDGSPAPRLKICDFGYSKSSL------LHSRPKSTVGTPAYIAPEVLSRRE 168
           RDL   N +LD      +K+ DFG ++         +H++  + +    ++A E L  ++
Sbjct: 156 RDLAARNCMLDEKFT--VKVADFGLARDMYDKEYYSVHNKTGAKLPV-KWMALESLQTQK 212
Query: 169 YDGKLADVWSCGVTLY-VMLVGAYPFED 195
           +  K +DVWS GV L+ +M  GA P+ D
Sbjct: 213 FTTK-SDVWSFGVLLWELMTRGAPPYPD 239

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 91/208 (43%), Gaps = 27/208 (12%)
Query: 10  IGSGNFGV---ARLMRNKNTKELVAMKYIERGHKID--ANVAREIINHKQLRHPNIIRFK 64
           IG G+FG      L+ N   K   A+K + R   I   +    E I  K   HPN++   
Sbjct: 36  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 95
Query: 65  EVVL-TPTHLAIVMEYAAGGELFERICNAGR---------FSEDEARYFFQQLISGQICH 114
            + L +     +V+ Y   G+L   I N            F    A+   + L S +  H
Sbjct: 96  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGM-KYLASKKFVH 154
Query: 115 RDLKLENTLLDGSPAPRLKICDFGYSKSSL------LHSRPKSTVGTPAYIAPEVLSRRE 168
           RDL   N +LD      +K+ DFG ++         +H++  + +    ++A E L  ++
Sbjct: 155 RDLAARNCMLDEKFT--VKVADFGLARDMYDKEYYSVHNKTGAKLPV-KWMALESLQTQK 211
Query: 169 YDGKLADVWSCGVTLY-VMLVGAYPFED 195
           +  K +DVWS GV L+ +M  GA P+ D
Sbjct: 212 FTTK-SDVWSFGVLLWELMTRGAPPYPD 238

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 91/207 (43%), Gaps = 25/207 (12%)
Query: 10  IGSGNFGV---ARLMRNKNTKELVAMKYIERGHKID--ANVAREIINHKQLRHPNIIRFK 64
           IG G+FG      L+ N   K   A+K + R   I   +    E I  K   HPN++   
Sbjct: 36  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 95
Query: 65  EVVL-TPTHLAIVMEYAAGGELFERICNAGR--FSEDEARYFFQQ------LISGQICHR 115
            + L +     +V+ Y   G+L   I N       +D   +  Q       L S +  HR
Sbjct: 96  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHR 155
Query: 116 DLKLENTLLDGSPAPRLKICDFGYSKSSL------LHSRPKSTVGTPAYIAPEVLSRREY 169
           DL   N +LD      +K+ DFG ++         +H++  + +    ++A E L  +++
Sbjct: 156 DLAARNCMLDEKFT--VKVADFGLARDMYDKEFDSVHNKTGAKLPV-KWMALESLQTQKF 212
Query: 170 DGKLADVWSCGVTLY-VMLVGAYPFED 195
             K +DVWS GV L+ +M  GA P+ D
Sbjct: 213 TTK-SDVWSFGVLLWELMTRGAPPYPD 238

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 76/302 (25%), Positives = 134/302 (44%), Gaps = 51/302 (16%)
Query: 2   EKYELMKDIGSGNFGVARL-----MRNKNTKE--LVAMKYI--ERGHKIDANVAREIINH 52
           +K  L K +G G FG   +     +     KE   VA+K +  +   K  +++  E+   
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 53  KQL-RHPNIIRFKEVVLTPTHLAIVMEYAAGGELFE----RICNAGRFSED-----EARY 102
           K + +H NII           L +++EYA+ G L E    R      +S D     E + 
Sbjct: 95  KMIGKHKNIIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 103 FFQQLIS-------------GQIC-HRDLKLENTLLDGSPAPRLKICDFGYSKS-SLLHS 147
            F+ L+S              Q C HRDL   N L+  +    +KI DFG ++  + +  
Sbjct: 155 TFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNV--MKIADFGLARDINNIDY 212
Query: 148 RPKSTVG-TPA-YIAPEVLSRREYDGKLADVWSCGVTLY-VMLVGAYPFEDQEDPKNFRK 204
             K+T G  P  ++APE L  R Y  + +DVWS GV ++ +  +G  P+     P    +
Sbjct: 213 YKKTTNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGVLMWEIFTLGGSPY-----PGIPVE 266
Query: 205 TISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLPRELTET 264
            + +++   +++    + + +   ++   + A PS+R T K++      +++L R LT T
Sbjct: 267 ELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQL------VEDLDRILTLT 320
Query: 265 AQ 266
Sbjct: 321 TN 322

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 91/207 (43%), Gaps = 25/207 (12%)
Query: 10  IGSGNFGV---ARLMRNKNTKELVAMKYIERGHKID--ANVAREIINHKQLRHPNIIRFK 64
           IG G+FG      L+ N   K   A+K + R   I   +    E I  K   HPN++   
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 97
Query: 65  EVVL-TPTHLAIVMEYAAGGELFERICNAGR--FSEDEARYFFQQ------LISGQICHR 115
            + L +     +V+ Y   G+L   I N       +D   +  Q       L S +  HR
Sbjct: 98  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHR 157
Query: 116 DLKLENTLLDGSPAPRLKICDFGYSKSSL------LHSRPKSTVGTPAYIAPEVLSRREY 169
           DL   N +LD      +K+ DFG ++         +H++  + +    ++A E L  +++
Sbjct: 158 DLAARNCMLDEKFT--VKVADFGLARDMYDKEFDSVHNKTGAKLPV-KWMALESLQTQKF 214
Query: 170 DGKLADVWSCGVTLY-VMLVGAYPFED 195
             K +DVWS GV L+ +M  GA P+ D
Sbjct: 215 TTK-SDVWSFGVLLWELMTRGAPPYPD 240

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 93/208 (44%), Gaps = 26/208 (12%)
Query: 7   MKDIGSGNFGVA----RLMRNKNTKELVAMKYIER--GHKIDANVAREIINHKQLRHPNI 60
           +K +GSG FG       +   +  K  VA+K +    G K +     E +    + HP++
Sbjct: 43  VKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHL 102
Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFERIC-NAGRFSEDEARYFFQQLISG-------QI 112
           +R   V L+PT + +V +    G L E +  +           +  Q+  G       ++
Sbjct: 103 VRLLGVCLSPT-IQLVTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRL 161
Query: 113 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPA-----YIAPEVLSRR 167
            HRDL   N L+  SP   +KI DFG ++  LL    K            ++A E +  R
Sbjct: 162 VHRDLAARNVLVK-SPN-HVKITDFGLAR--LLEGDEKEYNADGGKMPIKWMALECIHYR 217
Query: 168 EYDGKLADVWSCGVTLY-VMLVGAYPFE 194
           ++  + +DVWS GVT++ +M  G  P++
Sbjct: 218 KFTHQ-SDVWSYGVTIWELMTFGGKPYD 244

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 91/207 (43%), Gaps = 25/207 (12%)
Query: 10  IGSGNFGV---ARLMRNKNTKELVAMKYIERGHKID--ANVAREIINHKQLRHPNIIRFK 64
           IG G+FG      L+ N   K   A+K + R   I   +    E I  K   HPN++   
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 97
Query: 65  EVVL-TPTHLAIVMEYAAGGELFERICNAGR--FSEDEARYFFQQ------LISGQICHR 115
            + L +     +V+ Y   G+L   I N       +D   +  Q       L S +  HR
Sbjct: 98  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHR 157
Query: 116 DLKLENTLLDGSPAPRLKICDFGYSKSSL------LHSRPKSTVGTPAYIAPEVLSRREY 169
           DL   N +LD      +K+ DFG ++         +H++  + +    ++A E L  +++
Sbjct: 158 DLAARNCMLDEKFT--VKVADFGLARDMYDKEFDSVHNKTGAKLPV-KWMALESLQTQKF 214
Query: 170 DGKLADVWSCGVTLY-VMLVGAYPFED 195
             K +DVWS GV L+ +M  GA P+ D
Sbjct: 215 TTK-SDVWSFGVLLWELMTRGAPPYPD 240

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 76/302 (25%), Positives = 134/302 (44%), Gaps = 51/302 (16%)
Query: 2   EKYELMKDIGSGNFGVARL-----MRNKNTKE--LVAMKYI--ERGHKIDANVAREIINH 52
           +K  L K +G G FG   +     +     KE   VA+K +  +   K  +++  E+   
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 53  KQL-RHPNIIRFKEVVLTPTHLAIVMEYAAGGELFE----RICNAGRFSED-----EARY 102
           K + +H NII           L +++EYA+ G L E    R      +S D     E + 
Sbjct: 95  KMIGKHKNIITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 103 FFQQLIS-------------GQIC-HRDLKLENTLLDGSPAPRLKICDFGYSKS-SLLHS 147
            F+ L+S              Q C HRDL   N L+  +    +KI DFG ++  + +  
Sbjct: 155 TFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNV--MKIADFGLARDINNIDY 212
Query: 148 RPKSTVG-TPA-YIAPEVLSRREYDGKLADVWSCGVTLY-VMLVGAYPFEDQEDPKNFRK 204
             K+T G  P  ++APE L  R Y  + +DVWS GV ++ +  +G  P+     P    +
Sbjct: 213 YKKTTNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGVLMWEIFTLGGSPY-----PGIPVE 266
Query: 205 TISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLPRELTET 264
            + +++   +++    + + +   ++   + A PS+R T K++      +++L R LT T
Sbjct: 267 ELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQL------VEDLDRILTLT 320
Query: 265 AQ 266
Sbjct: 321 TN 322

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 91/207 (43%), Gaps = 25/207 (12%)
Query: 10  IGSGNFGV---ARLMRNKNTKELVAMKYIERGHKID--ANVAREIINHKQLRHPNIIRFK 64
           IG G+FG      L+ N   K   A+K + R   I   +    E I  K   HPN++   
Sbjct: 43  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 102
Query: 65  EVVL-TPTHLAIVMEYAAGGELFERICNAGR--FSEDEARYFFQQ------LISGQICHR 115
            + L +     +V+ Y   G+L   I N       +D   +  Q       L S +  HR
Sbjct: 103 GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHR 162
Query: 116 DLKLENTLLDGSPAPRLKICDFGYSKSSL------LHSRPKSTVGTPAYIAPEVLSRREY 169
           DL   N +LD      +K+ DFG ++         +H++  + +    ++A E L  +++
Sbjct: 163 DLAARNCMLDEKFT--VKVADFGLARDMYDKEFDSVHNKTGAKLPV-KWMALESLQTQKF 219
Query: 170 DGKLADVWSCGVTLY-VMLVGAYPFED 195
             K +DVWS GV L+ +M  GA P+ D
Sbjct: 220 TTK-SDVWSFGVLLWELMTRGAPPYPD 245

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 76/302 (25%), Positives = 134/302 (44%), Gaps = 51/302 (16%)
Query: 2   EKYELMKDIGSGNFGVARL-----MRNKNTKE--LVAMKYI--ERGHKIDANVAREIINH 52
           +K  L K +G G FG   +     +     KE   VA+K +  +   K  +++  E+   
Sbjct: 81  DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 140
Query: 53  KQL-RHPNIIRFKEVVLTPTHLAIVMEYAAGGELFE----RICNAGRFSED-----EARY 102
           K + +H NII           L +++EYA+ G L E    R      +S D     E + 
Sbjct: 141 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 200
Query: 103 FFQQLIS-------------GQIC-HRDLKLENTLLDGSPAPRLKICDFGYSKS-SLLHS 147
            F+ L+S              Q C HRDL   N L+  +    +KI DFG ++  + +  
Sbjct: 201 TFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNV--MKIADFGLARDINNIDY 258
Query: 148 RPKSTVG-TPA-YIAPEVLSRREYDGKLADVWSCGVTLY-VMLVGAYPFEDQEDPKNFRK 204
             K+T G  P  ++APE L  R Y  + +DVWS GV ++ +  +G  P+     P    +
Sbjct: 259 YKKTTNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGVLMWEIFTLGGSPY-----PGIPVE 312
Query: 205 TISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLPRELTET 264
            + +++   +++    + + +   ++   + A PS+R T K++      +++L R LT T
Sbjct: 313 ELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQL------VEDLDRILTLT 366
Query: 265 AQ 266
Sbjct: 367 TN 368

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 91/207 (43%), Gaps = 25/207 (12%)
Query: 10  IGSGNFGV---ARLMRNKNTKELVAMKYIERGHKID--ANVAREIINHKQLRHPNIIRFK 64
           IG G+FG      L+ N   K   A+K + R   I   +    E I  K   HPN++   
Sbjct: 39  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 98
Query: 65  EVVL-TPTHLAIVMEYAAGGELFERICNAGR--FSEDEARYFFQQ------LISGQICHR 115
            + L +     +V+ Y   G+L   I N       +D   +  Q       L S +  HR
Sbjct: 99  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHR 158
Query: 116 DLKLENTLLDGSPAPRLKICDFGYSKSSL------LHSRPKSTVGTPAYIAPEVLSRREY 169
           DL   N +LD      +K+ DFG ++         +H++  + +    ++A E L  +++
Sbjct: 159 DLAARNCMLDEKFT--VKVADFGLARDMYDKEFDSVHNKTGAKLPV-KWMALESLQTQKF 215
Query: 170 DGKLADVWSCGVTLY-VMLVGAYPFED 195
             K +DVWS GV L+ +M  GA P+ D
Sbjct: 216 TTK-SDVWSFGVLLWELMTRGAPPYPD 241

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 91/207 (43%), Gaps = 25/207 (12%)
Query: 10  IGSGNFGV---ARLMRNKNTKELVAMKYIERGHKID--ANVAREIINHKQLRHPNIIRFK 64
           IG G+FG      L+ N   K   A+K + R   I   +    E I  K   HPN++   
Sbjct: 97  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 156
Query: 65  EVVL-TPTHLAIVMEYAAGGELFERICNAGR--FSEDEARYFFQQ------LISGQICHR 115
            + L +     +V+ Y   G+L   I N       +D   +  Q       L S +  HR
Sbjct: 157 GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHR 216
Query: 116 DLKLENTLLDGSPAPRLKICDFGYSKSSL------LHSRPKSTVGTPAYIAPEVLSRREY 169
           DL   N +LD      +K+ DFG ++         +H++  + +    ++A E L  +++
Sbjct: 217 DLAARNCMLDEKFT--VKVADFGLARDMYDKEFDSVHNKTGAKLPV-KWMALESLQTQKF 273
Query: 170 DGKLADVWSCGVTLY-VMLVGAYPFED 195
             K +DVWS GV L+ +M  GA P+ D
Sbjct: 274 TTK-SDVWSFGVLLWELMTRGAPPYPD 299

>pdb|1OEC|A Chain A, Fgfr2 Kinase Domain Length = 316

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 76/302 (25%), Positives = 134/302 (44%), Gaps = 51/302 (16%)
Query: 2   EKYELMKDIGSGNFGVARL-----MRNKNTKE--LVAMKYI--ERGHKIDANVAREIINH 52
           +K  L K +G G FG   +     +     KE   VA+K +  +   K  +++  E+   
Sbjct: 27  DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 86
Query: 53  KQL-RHPNIIRFKEVVLTPTHLAIVMEYAAGGELFE----RICNAGRFSED-----EARY 102
           K + +H NII           L +++EYA+ G L E    R      +S D     E + 
Sbjct: 87  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 146
Query: 103 FFQQLIS-------------GQIC-HRDLKLENTLLDGSPAPRLKICDFGYSKS-SLLHS 147
            F+ L+S              Q C HRDL   N L+  +    +KI DFG ++  + +  
Sbjct: 147 TFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNV--MKIADFGLARDINNIDY 204
Query: 148 RPKSTVG-TPA-YIAPEVLSRREYDGKLADVWSCGVTLY-VMLVGAYPFEDQEDPKNFRK 204
             K+T G  P  ++APE L  R Y  + +DVWS GV ++ +  +G  P+     P    +
Sbjct: 205 YKKTTNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGVLMWEIFTLGGSPY-----PGIPVE 258
Query: 205 TISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLPRELTET 264
            + +++   +++    + + +   ++   + A PS+R T K++      +++L R LT T
Sbjct: 259 ELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQL------VEDLDRILTLT 312
Query: 265 AQ 266
Sbjct: 313 TN 314

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 93/208 (44%), Gaps = 26/208 (12%)
Query: 7   MKDIGSGNFGVA----RLMRNKNTKELVAMKYIER--GHKIDANVAREIINHKQLRHPNI 60
           +K +GSG FG       +   +  K  VA+K +    G K +     E +    + HP++
Sbjct: 20  VKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHL 79
Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFERIC-NAGRFSEDEARYFFQQLISG-------QI 112
           +R   V L+PT + +V +    G L E +  +           +  Q+  G       ++
Sbjct: 80  VRLLGVCLSPT-IQLVTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRL 138
Query: 113 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPA-----YIAPEVLSRR 167
            HRDL   N L+  SP   +KI DFG ++  LL    K            ++A E +  R
Sbjct: 139 VHRDLAARNVLVK-SPN-HVKITDFGLAR--LLEGDEKEYNADGGKMPIKWMALECIHYR 194
Query: 168 EYDGKLADVWSCGVTLY-VMLVGAYPFE 194
           ++  + +DVWS GVT++ +M  G  P++
Sbjct: 195 KFTHQ-SDVWSYGVTIWELMTFGGKPYD 221

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 64/274 (23%), Positives = 109/274 (39%), Gaps = 47/274 (17%)
Query: 45  VAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYAAGGEL---FERICNAGRF--SEDE 99
           V REI       HPNI+  +++ +     A+   Y     +     ++ +  R   S   
Sbjct: 76  VLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQH 135
Query: 100 ARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST 152
            +YF   ++ G        + HRDL   N LL  +    + ICDF  ++     +     
Sbjct: 136 IQYFMYHILLGLHVLHEAGVVHRDLHPGNILL--ADNNDITICDFNLAREDTADANKTHY 193
Query: 153 VGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVM-----LVGAYPFEDQ----------- 196
           V    Y APE++ + +   KL D+WS G  +  M     L     F +Q           
Sbjct: 194 VTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTP 253
Query: 197 --EDPKNF---------RKTISRIMAVQYK--IPDYVHISQDCRNLLSRIFVANPSRRIT 243
             ED   F         R ++S + A  +   +P    ++ D   L++++   NP RRI+
Sbjct: 254 KIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALD---LIAKMLEFNPQRRIS 310
Query: 244 IKEIKSHPWFLKNL-PRELTETAQAIYYRKENPT 276
            ++   HP+F     P +LTE     ++  E+ T
Sbjct: 311 TEQALRHPYFESLFDPLDLTEGLSERFHFDESVT 344

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 76/302 (25%), Positives = 134/302 (44%), Gaps = 51/302 (16%)
Query: 2   EKYELMKDIGSGNFGVARL-----MRNKNTKE--LVAMKYI--ERGHKIDANVAREIINH 52
           +K  L K +G G FG   +     +     KE   VA+K +  +   K  +++  E+   
Sbjct: 22  DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 81
Query: 53  KQL-RHPNIIRFKEVVLTPTHLAIVMEYAAGGELFE----RICNAGRFSED-----EARY 102
           K + +H NII           L +++EYA+ G L E    R      +S D     E + 
Sbjct: 82  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 141
Query: 103 FFQQLIS-------------GQIC-HRDLKLENTLLDGSPAPRLKICDFGYSKS-SLLHS 147
            F+ L+S              Q C HRDL   N L+  +    +KI DFG ++  + +  
Sbjct: 142 TFKDLVSCTYQLARGMEYLASQKCIHRDLTARNVLVTENNV--MKIADFGLARDINNIDY 199
Query: 148 RPKSTVG-TPA-YIAPEVLSRREYDGKLADVWSCGVTLY-VMLVGAYPFEDQEDPKNFRK 204
             K+T G  P  ++APE L  R Y  + +DVWS GV ++ +  +G  P+     P    +
Sbjct: 200 YKKTTNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGVLMWEIFTLGGSPY-----PGIPVE 253
Query: 205 TISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLPRELTET 264
            + +++   +++    + + +   ++   + A PS+R T K++      +++L R LT T
Sbjct: 254 ELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQL------VEDLDRILTLT 307
Query: 265 AQ 266
Sbjct: 308 TN 309

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 61/238 (25%), Positives = 107/238 (44%), Gaps = 41/238 (17%)
Query: 56  RHPNIIRFKEVVLTPTHLAIVMEYAAGGELFE----RICNAGRFSED-----EARYFFQQ 106
           +H NII           L +++EYA+ G L E    R      +S D     E +  F+ 
Sbjct: 99  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158
Query: 107 LIS-------------GQIC-HRDLKLENTLLDGSPAPRLKICDFGYSKS-SLLHSRPKS 151
           L+S              Q C HRDL   N L+  +    +KI DFG ++  + +    K+
Sbjct: 159 LVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNV--MKIADFGLARDINNIDYYKKT 216
Query: 152 TVG-TPA-YIAPEVLSRREYDGKLADVWSCGVTLY-VMLVGAYPFEDQEDPKNFRKTISR 208
           T G  P  ++APE L  R Y  + +DVWS GV ++ +  +G  P+     P    + + +
Sbjct: 217 TNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGVLMWEIFTLGGSPY-----PGIPVEELFK 270
Query: 209 IMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLPRELTETAQ 266
           ++   +++    + + +   ++   + A PS+R T K++      +++L R LT T  
Sbjct: 271 LLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQL------VEDLDRILTLTTN 322

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 64/274 (23%), Positives = 109/274 (39%), Gaps = 47/274 (17%)
Query: 45  VAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYAAGGEL---FERICNAGRF--SEDE 99
           V REI       HPNI+  +++ +     A+   Y     +     ++ +  R   S   
Sbjct: 76  VLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQH 135
Query: 100 ARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST 152
            +YF   ++ G        + HRDL   N LL  +    + ICDF  ++     +     
Sbjct: 136 IQYFMYHILLGLHVLHEAGVVHRDLHPGNILL--ADNNDITICDFNLAREDTADANKTHY 193
Query: 153 VGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVM-----LVGAYPFEDQ----------- 196
           V    Y APE++ + +   KL D+WS G  +  M     L     F +Q           
Sbjct: 194 VTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTP 253
Query: 197 --EDPKNF---------RKTISRIMAVQYK--IPDYVHISQDCRNLLSRIFVANPSRRIT 243
             ED   F         R ++S + A  +   +P    ++ D   L++++   NP RRI+
Sbjct: 254 KIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALD---LIAKMLEFNPQRRIS 310
Query: 244 IKEIKSHPWFLKNL-PRELTETAQAIYYRKENPT 276
            ++   HP+F     P +LTE     ++  E+ T
Sbjct: 311 TEQALRHPYFESLFDPLDLTEGLSERFHFDESVT 344

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 76/302 (25%), Positives = 134/302 (44%), Gaps = 51/302 (16%)
Query: 2   EKYELMKDIGSGNFGVARL-----MRNKNTKE--LVAMKYI--ERGHKIDANVAREIINH 52
           +K  L K +G G FG   +     +     KE   VA+K +  +   K  +++  E+   
Sbjct: 24  DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 83
Query: 53  KQL-RHPNIIRFKEVVLTPTHLAIVMEYAAGGELFE----RICNAGRFSED-----EARY 102
           K + +H NII           L +++EYA+ G L E    R      +S D     E + 
Sbjct: 84  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 143
Query: 103 FFQQLIS-------------GQIC-HRDLKLENTLLDGSPAPRLKICDFGYSKS-SLLHS 147
            F+ L+S              Q C HRDL   N L+  +    +KI DFG ++  + +  
Sbjct: 144 TFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNV--MKIADFGLARDINNIDY 201
Query: 148 RPKSTVG-TPA-YIAPEVLSRREYDGKLADVWSCGVTLY-VMLVGAYPFEDQEDPKNFRK 204
             K+T G  P  ++APE L  R Y  + +DVWS GV ++ +  +G  P+     P    +
Sbjct: 202 YKKTTNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGVLMWEIFTLGGSPY-----PGIPVE 255
Query: 205 TISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLPRELTET 264
            + +++   +++    + + +   ++   + A PS+R T K++      +++L R LT T
Sbjct: 256 ELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQL------VEDLDRILTLT 309
Query: 265 AQ 266
Sbjct: 310 TN 311

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 57/253 (22%), Positives = 101/253 (39%), Gaps = 26/253 (10%)
Query: 10  IGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKEVVLT 69
           +G G +G       K     VA+K ++          +E    K+++HPN+++   V   
Sbjct: 267 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 326
Query: 70  PTHLAIVMEYAAGGELFE--RICNAGRFSEDEARYFFQQLISG-------QICHRDLKLE 120
                I+ E+   G L +  R CN    +     Y   Q+ S           HR+L   
Sbjct: 327 EPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRNLAAR 386
Query: 121 NTLLDGSPAPRLKICDFGYSK-----SSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLAD 175
           N L+  +    +K+ DFG S+     +   H+  K  +    + APE L+  ++  K +D
Sbjct: 387 NCLVGENHL--VKVADFGLSRLMTGDTYTAHAGAKFPI---KWTAPESLAYNKFSIK-SD 440
Query: 176 VWSCGVTLY-VMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIF 234
           VW+ GV L+ +   G  P+     P      +  ++   Y++       +    L+   +
Sbjct: 441 VWAFGVLLWEIATYGMSPY-----PGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACW 495
Query: 235 VANPSRRITIKEI 247
             NPS R +  EI
Sbjct: 496 QWNPSDRPSFAEI 508

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 38/146 (26%), Positives = 64/146 (43%), Gaps = 10/146 (6%)
Query: 112 ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPE----VLSRR 167
           + HRD+K  N L++     ++K CDFG S   +         G   Y APE     L+++
Sbjct: 158 VIHRDVKPSNVLINA--LGQVKXCDFGISGYLVDDVAKDIDAGCKPYXAPERINPELNQK 215
Query: 168 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCR 227
            Y  K +D+WS G+T   + +  +P++    P    K +    + Q     +   S +  
Sbjct: 216 GYSVK-SDIWSLGITXIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADKF---SAEFV 271
Query: 228 NLLSRIFVANPSRRITIKEIKSHPWF 253
           +  S+    N   R T  E+  HP+F
Sbjct: 272 DFTSQCLKKNSKERPTYPELXQHPFF 297

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 73/302 (24%), Positives = 134/302 (44%), Gaps = 51/302 (16%)
Query: 2   EKYELMKDIGSGNFGVARL-----MRNKNTKE--LVAMKYI--ERGHKIDANVAREIINH 52
           +K  L K +G G FG   +     +     KE   VA+K +  +   K  +++  E+   
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 53  KQL-RHPNIIRFKEVVLTPTHLAIVMEYAAGGELFE----RICNAGRFSED-----EARY 102
           K + +H NII           L +++EYA+ G L E    R      +S D     E + 
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 103 FFQQLIS-------------GQIC-HRDLKLENTLLDGSPAPRLKICDFGYSK--SSLLH 146
            F+ L+S              Q C HRDL   N L+  +    +KI DFG ++  +++ +
Sbjct: 155 TFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNV--MKIADFGLARDINNIDY 212
Query: 147 SRPKSTVGTPA-YIAPEVLSRREYDGKLADVWSCGVTLY-VMLVGAYPFEDQEDPKNFRK 204
            +  +    P  ++APE L  R Y  + +DVWS GV ++ +  +G  P+     P    +
Sbjct: 213 YKNTTNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGVLMWEIFTLGGSPY-----PGIPVE 266
Query: 205 TISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLPRELTET 264
            + +++   +++    + + +   ++   + A PS+R T K++      +++L R LT T
Sbjct: 267 ELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQL------VEDLDRILTLT 320
Query: 265 AQ 266
Sbjct: 321 TN 322

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 75/302 (24%), Positives = 134/302 (44%), Gaps = 51/302 (16%)
Query: 2   EKYELMKDIGSGNFGVARL-----MRNKNTKE--LVAMKYI--ERGHKIDANVAREIINH 52
           +K  L K +G G FG   +     +     KE   VA+K +  +   K  +++  E+   
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 53  KQL-RHPNIIRFKEVVLTPTHLAIVMEYAAGGELFE----RICNAGRFSED-----EARY 102
           K + +H NII           L +++EYA+ G L E    R      +S D     E + 
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 103 FFQQLIS-------------GQIC-HRDLKLENTLLDGSPAPRLKICDFGYSKS-SLLHS 147
            F+ L+S              Q C HRDL   N L+  +    ++I DFG ++  + +  
Sbjct: 155 TFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNV--MRIADFGLARDINNIDY 212
Query: 148 RPKSTVG-TPA-YIAPEVLSRREYDGKLADVWSCGVTLY-VMLVGAYPFEDQEDPKNFRK 204
             K+T G  P  ++APE L  R Y  + +DVWS GV ++ +  +G  P+     P    +
Sbjct: 213 YKKTTNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGVLMWEIFTLGGSPY-----PGIPVE 266
Query: 205 TISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLPRELTET 264
            + +++   +++    + + +   ++   + A PS+R T K++      +++L R LT T
Sbjct: 267 ELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQL------VEDLDRILTLT 320
Query: 265 AQ 266
Sbjct: 321 TN 322

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 85/207 (41%), Gaps = 32/207 (15%)
Query: 6   LMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRF-- 63
           L + IG G FG   + R K   E VA+K      +       EI     LRH NI+ F  
Sbjct: 7   LQESIGKGRFG--EVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIA 64
Query: 64  --KEVVLTPTHLAIVMEYAAGGELF----------ERICNAGRFSEDEARYFFQQLISGQ 111
              +   T T L +V +Y   G LF          E +      +     +   +++  Q
Sbjct: 65  ADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQ 124
Query: 112 ----ICHRDLKLENTLLDGSPAPRLKICDFGY-----SKSSLLHSRPKSTVGTPAYIAPE 162
               I HRDLK +N L+  +      I D G      S +  +   P   VGT  Y+APE
Sbjct: 125 GKPAIAHRDLKSKNILVKKNGT--CCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPE 182
Query: 163 VL----SRREYDG-KLADVWSCGVTLY 184
           VL    + + ++  K AD+++ G+  +
Sbjct: 183 VLDDSINMKHFESFKRADIYAMGLVFW 209

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 95/220 (43%), Gaps = 37/220 (16%)
Query: 6   LMKDIGSGNFGVARLMRNKNT-----KELVAMKYI-ERGHKIDANVAREIINHKQLRHPN 59
           L +++G G FG   L    N      K LVA+K + +       +  RE      L+H +
Sbjct: 17  LKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEH 76
Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFERICNAG-------------RFSEDEARYFFQQ 106
           I++F  V +    L +V EY   G+L + +   G               ++ +  +  QQ
Sbjct: 77  IVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQ 136
Query: 107 LISGQI-------CHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPA-- 157
           + +G +        HRDL   N L+  +    +KI DFG S+   ++S     VG     
Sbjct: 137 IAAGMVYLASQHFVHRDLATRNCLVGENLL--VKIGDFGMSRD--VYSTDYYRVGGHTML 192
Query: 158 ---YIAPEVLSRREYDGKLADVWSCGVTLY-VMLVGAYPF 193
              ++ PE +  R++  + +DVWS GV L+ +   G  P+
Sbjct: 193 PIRWMPPESIMYRKFTTE-SDVWSLGVVLWEIFTYGKQPW 231

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 70/280 (25%), Positives = 118/280 (42%), Gaps = 47/280 (16%)
Query: 6   LMKDIGSGNFGVARLMR---------NKNTKELVAMKYIERGHKIDANVAREIINHKQL- 55
           L K +G G FG   L           N+ TK  V M   +   K  +++  E+   K + 
Sbjct: 32  LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG 91
Query: 56  RHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGR------------------FSE 97
           +H NII           L +++EYA+ G L E +  A R                   S+
Sbjct: 92  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYL-QARRPPGLEFSFNPSHNPEEQLSSK 150
Query: 98  DEARYFFQ------QLISGQICHRDLKLENTLLDGSPAPRLKICDFGYSKS-SLLHSRPK 150
           D     +Q       L S +  HRDL   N L+       +KI DFG ++    +    K
Sbjct: 151 DLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNV--MKIADFGLARDIHHIDXXKK 208
Query: 151 STVG-TPA-YIAPEVLSRREYDGKLADVWSCGVTLY-VMLVGAYPFEDQEDPKNFRKTIS 207
           +T G  P  ++APE L  R Y  + +DVWS GV L+ +  +G  P+     P    + + 
Sbjct: 209 TTNGRLPVKWMAPEALFDRIYTHQ-SDVWSFGVLLWEIFTLGGSPY-----PGVPVEELF 262
Query: 208 RIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEI 247
           +++   +++    + + +   ++   + A PS+R T K++
Sbjct: 263 KLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQL 302

>pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 70/285 (24%), Positives = 109/285 (38%), Gaps = 44/285 (15%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIER---GHKIDANVAREIINHKQL-RH 57
           E +EL K IGSG FG       +    + A+K  ++   G   + N  RE+  H  L +H
Sbjct: 8   EFHELEK-IGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQH 66
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGR----FSEDEARYFFQQLISG--- 110
            +++R+        H+ I  EY  GG L + I    R    F E E +    Q+  G   
Sbjct: 67  SHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRY 126
Query: 111 ----QICHRDLKLENTLLDGSPAPR-----------------LKICDFGYSKSSLLHSRP 149
                + H D+K  N  +  +  P                   KI D G+       S P
Sbjct: 127 IHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRI---SSP 183
Query: 150 KSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRI 209
           +   G   ++A EVL         AD+++  +T+ V   GA P      P+N  +     
Sbjct: 184 QVEEGDSRFLANEVLQENYTHLPKADIFALALTV-VXAAGAEPL-----PRNGDQWHEIR 237
Query: 210 MAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFL 254
                +IP    +SQ+   LL  +   +P RR +   +  H   L
Sbjct: 238 QGRLPRIPQV--LSQEFTELLKVMIHPDPERRPSAMALVKHSVLL 280

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 85/207 (41%), Gaps = 32/207 (15%)
Query: 6   LMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRF-- 63
           L + IG G FG   + R K   E VA+K      +       EI     LRH NI+ F  
Sbjct: 46  LQESIGKGRFG--EVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIA 103
Query: 64  --KEVVLTPTHLAIVMEYAAGGELF----------ERICNAGRFSEDEARYFFQQLISGQ 111
              +   T T L +V +Y   G LF          E +      +     +   +++  Q
Sbjct: 104 ADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQ 163
Query: 112 ----ICHRDLKLENTLLDGSPAPRLKICDFGY-----SKSSLLHSRPKSTVGTPAYIAPE 162
               I HRDLK +N L+  +      I D G      S +  +   P   VGT  Y+APE
Sbjct: 164 GKPAIAHRDLKSKNILVKKNGT--CCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPE 221
Query: 163 VL----SRREYDG-KLADVWSCGVTLY 184
           VL    + + ++  K AD+++ G+  +
Sbjct: 222 VLDDSINMKHFESFKRADIYAMGLVFW 248

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 85/207 (41%), Gaps = 32/207 (15%)
Query: 6   LMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRF-- 63
           L + IG G FG   + R K   E VA+K      +       EI     LRH NI+ F  
Sbjct: 33  LQESIGKGRFG--EVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIA 90
Query: 64  --KEVVLTPTHLAIVMEYAAGGELF----------ERICNAGRFSEDEARYFFQQLISGQ 111
              +   T T L +V +Y   G LF          E +      +     +   +++  Q
Sbjct: 91  ADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQ 150
Query: 112 ----ICHRDLKLENTLLDGSPAPRLKICDFGY-----SKSSLLHSRPKSTVGTPAYIAPE 162
               I HRDLK +N L+  +      I D G      S +  +   P   VGT  Y+APE
Sbjct: 151 GKPAIAHRDLKSKNILVKKNGT--CCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPE 208
Query: 163 VL----SRREYDG-KLADVWSCGVTLY 184
           VL    + + ++  K AD+++ G+  +
Sbjct: 209 VLDDSINMKHFESFKRADIYAMGLVFW 235

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 85/207 (41%), Gaps = 32/207 (15%)
Query: 6   LMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRF-- 63
           L + IG G FG   + R K   E VA+K      +       EI     LRH NI+ F  
Sbjct: 10  LQESIGKGRFG--EVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIA 67
Query: 64  --KEVVLTPTHLAIVMEYAAGGELF----------ERICNAGRFSEDEARYFFQQLISGQ 111
              +   T T L +V +Y   G LF          E +      +     +   +++  Q
Sbjct: 68  ADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQ 127
Query: 112 ----ICHRDLKLENTLLDGSPAPRLKICDFGY-----SKSSLLHSRPKSTVGTPAYIAPE 162
               I HRDLK +N L+  +      I D G      S +  +   P   VGT  Y+APE
Sbjct: 128 GKPAIAHRDLKSKNILVKKNGT--CCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPE 185
Query: 163 VL----SRREYDG-KLADVWSCGVTLY 184
           VL    + + ++  K AD+++ G+  +
Sbjct: 186 VLDDSINMKHFESFKRADIYAMGLVFW 212

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 85/207 (41%), Gaps = 32/207 (15%)
Query: 6   LMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRF-- 63
           L + IG G FG   + R K   E VA+K      +       EI     LRH NI+ F  
Sbjct: 8   LQESIGKGRFG--EVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIA 65
Query: 64  --KEVVLTPTHLAIVMEYAAGGELF----------ERICNAGRFSEDEARYFFQQLISGQ 111
              +   T T L +V +Y   G LF          E +      +     +   +++  Q
Sbjct: 66  ADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQ 125
Query: 112 ----ICHRDLKLENTLLDGSPAPRLKICDFGY-----SKSSLLHSRPKSTVGTPAYIAPE 162
               I HRDLK +N L+  +      I D G      S +  +   P   VGT  Y+APE
Sbjct: 126 GKPAIAHRDLKSKNILVKKNGT--CCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPE 183
Query: 163 VL----SRREYDG-KLADVWSCGVTLY 184
           VL    + + ++  K AD+++ G+  +
Sbjct: 184 VLDDSINMKHFESFKRADIYAMGLVFW 210

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 85/207 (41%), Gaps = 32/207 (15%)
Query: 6   LMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRF-- 63
           L + IG G FG   + R K   E VA+K      +       EI     LRH NI+ F  
Sbjct: 13  LQESIGKGRFG--EVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIA 70
Query: 64  --KEVVLTPTHLAIVMEYAAGGELF----------ERICNAGRFSEDEARYFFQQLISGQ 111
              +   T T L +V +Y   G LF          E +      +     +   +++  Q
Sbjct: 71  ADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQ 130
Query: 112 ----ICHRDLKLENTLLDGSPAPRLKICDFGY-----SKSSLLHSRPKSTVGTPAYIAPE 162
               I HRDLK +N L+  +      I D G      S +  +   P   VGT  Y+APE
Sbjct: 131 GKPAIAHRDLKSKNILVKKNGT--CCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPE 188
Query: 163 VL----SRREYDG-KLADVWSCGVTLY 184
           VL    + + ++  K AD+++ G+  +
Sbjct: 189 VLDDSINMKHFESFKRADIYAMGLVFW 215

>pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 70/285 (24%), Positives = 109/285 (38%), Gaps = 44/285 (15%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIER---GHKIDANVAREIINHKQL-RH 57
           E +EL K IGSG FG       +    + A+K  ++   G   + N  RE+  H  L +H
Sbjct: 10  EFHELEK-IGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQH 68
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGR----FSEDEARYFFQQLISG--- 110
            +++R+        H+ I  EY  GG L + I    R    F E E +    Q+  G   
Sbjct: 69  SHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRY 128
Query: 111 ----QICHRDLKLENTLLDGSPAPR-----------------LKICDFGYSKSSLLHSRP 149
                + H D+K  N  +  +  P                   KI D G+       S P
Sbjct: 129 IHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRI---SSP 185
Query: 150 KSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRI 209
           +   G   ++A EVL         AD+++  +T+ V   GA P      P+N  +     
Sbjct: 186 QVEEGDSRFLANEVLQENYTHLPKADIFALALTV-VCAAGAEPL-----PRNGDQWHEIR 239
Query: 210 MAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFL 254
                +IP    +SQ+   LL  +   +P RR +   +  H   L
Sbjct: 240 QGRLPRIPQV--LSQEFTELLKVMIHPDPERRPSAMALVKHSVLL 282

>pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 70/285 (24%), Positives = 109/285 (38%), Gaps = 44/285 (15%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIER---GHKIDANVAREIINHKQL-RH 57
           E +EL K IGSG FG       +    + A+K  ++   G   + N  RE+  H  L +H
Sbjct: 10  EFHELEK-IGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQH 68
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGR----FSEDEARYFFQQLISG--- 110
            +++R+        H+ I  EY  GG L + I    R    F E E +    Q+  G   
Sbjct: 69  SHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRY 128
Query: 111 ----QICHRDLKLENTLLDGSPAPR-----------------LKICDFGYSKSSLLHSRP 149
                + H D+K  N  +  +  P                   KI D G+       S P
Sbjct: 129 IHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRI---SSP 185
Query: 150 KSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRI 209
           +   G   ++A EVL         AD+++  +T+ V   GA P      P+N  +     
Sbjct: 186 QVEEGDSRFLANEVLQENYTHLPKADIFALALTV-VCAAGAEPL-----PRNGDQWHEIR 239
Query: 210 MAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFL 254
                +IP    +SQ+   LL  +   +P RR +   +  H   L
Sbjct: 240 QGRLPRIPQV--LSQEFTELLKVMIHPDPERRPSAMALVKHSVLL 282

>pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 61/260 (23%), Positives = 109/260 (41%), Gaps = 57/260 (21%)
Query: 3   KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKI----------------DANVA 46
           +Y L++ +G G+F    L ++      VAMK I RG K+                DA+  
Sbjct: 20  RYILVRKLGWGHFSTVWLAKDMVNNTHVAMK-IVRGDKVYTEAAEDEIKLLQRVNDADNT 78
Query: 47  RE----------IINHKQLRHPNIIRFKEV--VLTPTHLAIVMEYAAGGELFERICNAGR 94
           +E          +++H   + PN +    V  VL    LA++ +Y   G     +     
Sbjct: 79  KEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYV----- 133
Query: 95  FSEDEARYFFQQLISG--------QICHRDLKLENTLLDGSPAP----RLKICDFGYSKS 142
                 +   +QL+ G         I H D+K EN L++   +P    ++KI D G   +
Sbjct: 134 ------KQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLG--NA 185
Query: 143 SLLHSRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNF 202
                   +++ T  Y +PEVL    + G  AD+WS    ++ ++ G + FE  E     
Sbjct: 186 CWYDEHYTNSIQTREYRSPEVLLGAPW-GCGADIWSTACLIFELITGDFLFEPDEGHSYT 244
Query: 203 RKT--ISRIMAVQYKIPDYV 220
           +    I++I+ +  ++P Y+
Sbjct: 245 KDDDHIAQIIELLGELPSYL 264

>pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 70/285 (24%), Positives = 109/285 (38%), Gaps = 44/285 (15%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIER---GHKIDANVAREIINHKQL-RH 57
           E +EL K IGSG FG       +    + A+K  ++   G   + N  RE+  H  L +H
Sbjct: 12  EFHELEK-IGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQH 70
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGR----FSEDEARYFFQQLISG--- 110
            +++R+        H+ I  EY  GG L + I    R    F E E +    Q+  G   
Sbjct: 71  SHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRY 130
Query: 111 ----QICHRDLKLENTLLDGSPAPR-----------------LKICDFGYSKSSLLHSRP 149
                + H D+K  N  +  +  P                   KI D G+       S P
Sbjct: 131 IHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRI---SSP 187
Query: 150 KSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRI 209
           +   G   ++A EVL         AD+++  +T+ V   GA P      P+N  +     
Sbjct: 188 QVEEGDSRFLANEVLQENYTHLPKADIFALALTV-VCAAGAEPL-----PRNGDQWHEIR 241
Query: 210 MAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFL 254
                +IP    +SQ+   LL  +   +P RR +   +  H   L
Sbjct: 242 QGRLPRIPQV--LSQEFTELLKVMIHPDPERRPSAMALVKHSVLL 284

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 69/280 (24%), Positives = 117/280 (41%), Gaps = 47/280 (16%)
Query: 6   LMKDIGSGNFGVARLMR---------NKNTKELVAMKYIERGHKIDANVAREIINHKQL- 55
           L K +G G FG   L           N+ TK  V M   +   K  +++  E+   K + 
Sbjct: 17  LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG 76
Query: 56  RHPNIIRFKEVVLTPTHLAIVMEYAAGGEL-----------FERICNAGRFSEDE----- 99
           +H NII           L +++EYA+ G L            E   N     E++     
Sbjct: 77  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKD 136
Query: 100 --------ARYFFQQLISGQICHRDLKLENTLLDGSPAPRLKICDFGYSKS-SLLHSRPK 150
                   AR   + L S +  HRDL   N L+       +KI DFG ++    +    K
Sbjct: 137 LVSCAYQVAR-GMEYLASKKCIHRDLAARNVLVTEDNV--MKIADFGLARDIHHIDYYKK 193
Query: 151 STVG-TPA-YIAPEVLSRREYDGKLADVWSCGVTLY-VMLVGAYPFEDQEDPKNFRKTIS 207
           +T G  P  ++APE L  R Y  + +DVWS GV L+ +  +G  P+     P    + + 
Sbjct: 194 TTNGRLPVKWMAPEALFDRIYTHQ-SDVWSFGVLLWEIFTLGGSPY-----PGVPVEELF 247
Query: 208 RIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEI 247
           +++   +++    + + +   ++   + A PS+R T K++
Sbjct: 248 KLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQL 287

>pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373

Iteration: 1
 Score = 47.8 bits (112), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 61/260 (23%), Positives = 109/260 (41%), Gaps = 57/260 (21%)
Query: 3   KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKI----------------DANVA 46
           +Y L++ +G G+F    L ++      VAMK I RG K+                DA+  
Sbjct: 20  RYILVRKLGWGHFSTVWLAKDMVNNTHVAMK-IVRGDKVYTEAAEDEIKLLQRVNDADNT 78
Query: 47  RE----------IINHKQLRHPNIIRFKEV--VLTPTHLAIVMEYAAGGELFERICNAGR 94
           +E          +++H   + PN +    V  VL    LA++ +Y   G     +     
Sbjct: 79  KEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYV----- 133
Query: 95  FSEDEARYFFQQLISG--------QICHRDLKLENTLLDGSPAP----RLKICDFGYSKS 142
                 +   +QL+ G         I H D+K EN L++   +P    ++KI D G   +
Sbjct: 134 ------KQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLG--NA 185
Query: 143 SLLHSRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNF 202
                   +++ T  Y +PEVL    + G  AD+WS    ++ ++ G + FE  E     
Sbjct: 186 CWYDEHYTNSIQTREYRSPEVLLGAPW-GCGADIWSTACLIFELITGDFLFEPDEGHSYT 244
Query: 203 RKT--ISRIMAVQYKIPDYV 220
           +    I++I+ +  ++P Y+
Sbjct: 245 KDDDHIAQIIELLGELPSYL 264

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 47.8 bits (112), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 69/280 (24%), Positives = 117/280 (41%), Gaps = 47/280 (16%)
Query: 6   LMKDIGSGNFGVARLMR---------NKNTKELVAMKYIERGHKIDANVAREIINHKQL- 55
           L K +G G FG   L           N+ TK  V M   +   K  +++  E+   K + 
Sbjct: 32  LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG 91
Query: 56  RHPNIIRFKEVVLTPTHLAIVMEYAAGGEL-----------FERICNAGRFSEDE----- 99
           +H NII           L +++EYA+ G L            E   N     E++     
Sbjct: 92  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKD 151
Query: 100 --------ARYFFQQLISGQICHRDLKLENTLLDGSPAPRLKICDFGYSKS-SLLHSRPK 150
                   AR   + L S +  HRDL   N L+       +KI DFG ++    +    K
Sbjct: 152 LVSCAYQVAR-GMEYLASKKCIHRDLAARNVLVTEDNV--MKIADFGLARDIHHIDYYKK 208
Query: 151 STVG-TPA-YIAPEVLSRREYDGKLADVWSCGVTLY-VMLVGAYPFEDQEDPKNFRKTIS 207
           +T G  P  ++APE L  R Y  + +DVWS GV L+ +  +G  P+     P    + + 
Sbjct: 209 TTNGRLPVKWMAPEALFDRIYTHQ-SDVWSFGVLLWEIFTLGGSPY-----PGVPVEELF 262
Query: 208 RIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEI 247
           +++   +++    + + +   ++   + A PS+R T K++
Sbjct: 263 KLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQL 302

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 47.8 bits (112), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 69/280 (24%), Positives = 116/280 (41%), Gaps = 47/280 (16%)
Query: 6   LMKDIGSGNFGVARLMR---------NKNTKELVAMKYIERGHKIDANVAREIINHKQL- 55
           L K +G G FG   L           N+ TK  V M   +   K  +++  E+   K + 
Sbjct: 21  LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG 80
Query: 56  RHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARY------------- 102
           +H NII           L +++EYA+ G L E +  A R    E  Y             
Sbjct: 81  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYL-QARRPPGLEYSYNPSHNPEEQLSSK 139
Query: 103 -----------FFQQLISGQICHRDLKLENTLLDGSPAPRLKICDFGYSKS-SLLHSRPK 150
                        + L S +  HRDL   N L+       +KI DFG ++    +    K
Sbjct: 140 DLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNV--MKIADFGLARDIHHIDYYKK 197
Query: 151 STVG-TPA-YIAPEVLSRREYDGKLADVWSCGVTLY-VMLVGAYPFEDQEDPKNFRKTIS 207
           +T G  P  ++APE L  R Y  + +DVWS GV L+ +  +G  P+     P    + + 
Sbjct: 198 TTNGRLPVKWMAPEALFDRIYTHQ-SDVWSFGVLLWEIFTLGGSPY-----PGVPVEELF 251
Query: 208 RIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEI 247
           +++   +++    + + +   ++   + A PS+R T K++
Sbjct: 252 KLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQL 291

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 47.8 bits (112), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 69/280 (24%), Positives = 116/280 (41%), Gaps = 47/280 (16%)
Query: 6   LMKDIGSGNFGVARLMR---------NKNTKELVAMKYIERGHKIDANVAREIINHKQL- 55
           L K +G G FG   L           N+ TK  V M   +   K  +++  E+   K + 
Sbjct: 25  LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG 84
Query: 56  RHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARY------------- 102
           +H NII           L +++EYA+ G L E +  A R    E  Y             
Sbjct: 85  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYL-QARRPPGLEYSYNPSHNPEEQLSSK 143
Query: 103 -----------FFQQLISGQICHRDLKLENTLLDGSPAPRLKICDFGYSKS-SLLHSRPK 150
                        + L S +  HRDL   N L+       +KI DFG ++    +    K
Sbjct: 144 DLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNV--MKIADFGLARDIHHIDYYKK 201
Query: 151 STVG-TPA-YIAPEVLSRREYDGKLADVWSCGVTLY-VMLVGAYPFEDQEDPKNFRKTIS 207
           +T G  P  ++APE L  R Y  + +DVWS GV L+ +  +G  P+     P    + + 
Sbjct: 202 TTNGRLPVKWMAPEALFDRIYTHQ-SDVWSFGVLLWEIFTLGGSPY-----PGVPVEELF 255
Query: 208 RIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEI 247
           +++   +++    + + +   ++   + A PS+R T K++
Sbjct: 256 KLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQL 295

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 47.8 bits (112), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 61/233 (26%), Positives = 97/233 (41%), Gaps = 43/233 (18%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDA--NVAREIINHKQLRHP 58
           +  +E ++ +G G FGV    +NK      A+K I   ++  A   V RE+    +L HP
Sbjct: 4   LTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHP 63
Query: 59  NIIRFKEVVL-----------TP-THLAIVMEYAAGGELFERICNAGRFSEDE---ARYF 103
            I+R+    L           +P  +L I M+      L + +       E E     + 
Sbjct: 64  GIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHI 123
Query: 104 FQQ-------LISGQICHRDLKLENTLLDGSPAPRLKICDFGY--------SKSSLL--- 145
           F Q       L S  + HRDLK  N          +K+ DFG          + ++L   
Sbjct: 124 FLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDV--VKVGDFGLVTAMDQDEEEQTVLTPM 181
Query: 146 --HSRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQ 196
             ++R    VGT  Y++PE +    Y  K+ D++S G+ L+ +L   YPF  Q
Sbjct: 182 PAYARHTGQVGTKLYMSPEQIHGNSYSHKV-DIFSLGLILFELL---YPFSTQ 230

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 47.8 bits (112), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 69/280 (24%), Positives = 116/280 (41%), Gaps = 47/280 (16%)
Query: 6   LMKDIGSGNFGVARLMR---------NKNTKELVAMKYIERGHKIDANVAREIINHKQL- 55
           L K +G G FG   L           N+ TK  V M   +   K  +++  E+   K + 
Sbjct: 32  LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG 91
Query: 56  RHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARY------------- 102
           +H NII           L +++EYA+ G L E +  A R    E  Y             
Sbjct: 92  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYL-QARRPPGLEYSYNPSHNPEEQLSSK 150
Query: 103 -----------FFQQLISGQICHRDLKLENTLLDGSPAPRLKICDFGYSKS-SLLHSRPK 150
                        + L S +  HRDL   N L+       +KI DFG ++    +    K
Sbjct: 151 DLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNV--MKIADFGLARDIHHIDYYKK 208
Query: 151 STVG-TPA-YIAPEVLSRREYDGKLADVWSCGVTLY-VMLVGAYPFEDQEDPKNFRKTIS 207
           +T G  P  ++APE L  R Y  + +DVWS GV L+ +  +G  P+     P    + + 
Sbjct: 209 TTNGRLPVKWMAPEALFDRIYTHQ-SDVWSFGVLLWEIFTLGGSPY-----PGVPVEELF 262
Query: 208 RIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEI 247
           +++   +++    + + +   ++   + A PS+R T K++
Sbjct: 263 KLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQL 302

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 47.8 bits (112), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 69/280 (24%), Positives = 118/280 (42%), Gaps = 47/280 (16%)
Query: 6   LMKDIGSGNFGVARLMR---------NKNTKELVAMKYIERGHKIDANVAREIINHKQL- 55
           L K +G G FG   L           N+ TK  V M   +   K  +++  E+   K + 
Sbjct: 32  LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG 91
Query: 56  RHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERI-----------CNAGRFSEDE----- 99
           +H NII           L +++EYA+ G L E +            N     E++     
Sbjct: 92  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGLEYSYNPSHNPEEQLSSKD 151
Query: 100 --------ARYFFQQLISGQICHRDLKLENTLLDGSPAPRLKICDFGYSKS-SLLHSRPK 150
                   AR   + L S +  HRDL   N L+       +KI DFG ++    +    K
Sbjct: 152 LVSCAYQVAR-GMEYLASKKCIHRDLAARNVLVTEDNV--MKIADFGLARDIHHIDYYKK 208
Query: 151 STVG-TPA-YIAPEVLSRREYDGKLADVWSCGVTLY-VMLVGAYPFEDQEDPKNFRKTIS 207
           +T G  P  ++APE L  R Y  + +DVWS GV L+ +  +G  P+     P    + + 
Sbjct: 209 TTNGRLPVKWMAPEALFDRIYTHQ-SDVWSFGVLLWEIFTLGGSPY-----PGVPVEELF 262
Query: 208 RIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEI 247
           +++   +++    + + +   ++   + A PS+R T K++
Sbjct: 263 KLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQL 302

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 69/280 (24%), Positives = 116/280 (41%), Gaps = 47/280 (16%)
Query: 6   LMKDIGSGNFGVARLMR---------NKNTKELVAMKYIERGHKIDANVAREIINHKQL- 55
           L K +G G FG   L           N+ TK  V M   +   K  +++  E+   K + 
Sbjct: 24  LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG 83
Query: 56  RHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARY------------- 102
           +H NII           L +++EYA+ G L E +  A R    E  Y             
Sbjct: 84  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYL-QARRPPGLEYSYNPSHNPEEQLSSK 142
Query: 103 -----------FFQQLISGQICHRDLKLENTLLDGSPAPRLKICDFGYSKS-SLLHSRPK 150
                        + L S +  HRDL   N L+       +KI DFG ++    +    K
Sbjct: 143 DLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNV--MKIADFGLARDIHHIDYYKK 200
Query: 151 STVG-TPA-YIAPEVLSRREYDGKLADVWSCGVTLY-VMLVGAYPFEDQEDPKNFRKTIS 207
           +T G  P  ++APE L  R Y  + +DVWS GV L+ +  +G  P+     P    + + 
Sbjct: 201 TTNGRLPVKWMAPEALFDRIYTHQ-SDVWSFGVLLWEIFTLGGSPY-----PGVPVEELF 254
Query: 208 RIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEI 247
           +++   +++    + + +   ++   + A PS+R T K++
Sbjct: 255 KLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQL 294

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 75/302 (24%), Positives = 133/302 (44%), Gaps = 51/302 (16%)
Query: 2   EKYELMKDIGSGNFGVARL-----MRNKNTKE--LVAMKYI--ERGHKIDANVAREIINH 52
           +K  L K +G G FG   +     +     KE   VA+K +  +   K  +++  E+   
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 53  KQL-RHPNIIRFKEVVLTPTHLAIVMEYAAGGELFE----RICNAGRFSED-----EARY 102
           K + +H NII           L +++ YA+ G L E    R      +S D     E + 
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 103 FFQQLIS-------------GQIC-HRDLKLENTLLDGSPAPRLKICDFGYSKS-SLLHS 147
            F+ L+S              Q C HRDL   N L+  +    +KI DFG ++  + +  
Sbjct: 155 TFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNV--MKIADFGLARDINNIDY 212
Query: 148 RPKSTVG-TPA-YIAPEVLSRREYDGKLADVWSCGVTLY-VMLVGAYPFEDQEDPKNFRK 204
             K+T G  P  ++APE L  R Y  + +DVWS GV ++ +  +G  P+     P    +
Sbjct: 213 YKKTTNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGVLMWEIFTLGGSPY-----PGIPVE 266
Query: 205 TISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLPRELTET 264
            + +++   +++    + + +   ++   + A PS+R T K++      +++L R LT T
Sbjct: 267 ELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQL------VEDLDRILTLT 320
Query: 265 AQ 266
Sbjct: 321 TN 322

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 69/280 (24%), Positives = 116/280 (41%), Gaps = 47/280 (16%)
Query: 6   LMKDIGSGNFGVARLMR---------NKNTKELVAMKYIERGHKIDANVAREIINHKQL- 55
           L K +G G FG   L           N+ TK  V M   +   K  +++  E+   K + 
Sbjct: 73  LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG 132
Query: 56  RHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARY------------- 102
           +H NII           L +++EYA+ G L E +  A R    E  Y             
Sbjct: 133 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYL-QARRPPGLEYSYNPSHNPEEQLSSK 191
Query: 103 -----------FFQQLISGQICHRDLKLENTLLDGSPAPRLKICDFGYSKS-SLLHSRPK 150
                        + L S +  HRDL   N L+       +KI DFG ++    +    K
Sbjct: 192 DLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNV--MKIADFGLARDIHHIDYYKK 249
Query: 151 STVG-TPA-YIAPEVLSRREYDGKLADVWSCGVTLY-VMLVGAYPFEDQEDPKNFRKTIS 207
           +T G  P  ++APE L  R Y  + +DVWS GV L+ +  +G  P+     P    + + 
Sbjct: 250 TTNGRLPVKWMAPEALFDRIYTHQ-SDVWSFGVLLWEIFTLGGSPY-----PGVPVEELF 303
Query: 208 RIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEI 247
           +++   +++    + + +   ++   + A PS+R T K++
Sbjct: 304 KLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQL 343

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 58/230 (25%), Positives = 100/230 (43%), Gaps = 48/230 (20%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK--IDAN-VAREIINHKQLRHP 58
           ++YE+   IG+G++G      +K  K +VA+K I R  +  ID   + REI    +L H 
Sbjct: 53  DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHD 112
Query: 59  NIIRFKEVVLTP-----THLAIVMEYAAGGELFERICNAGRF-SEDEARYFFQQLISG-- 110
           ++++  ++V+         L +V+E A     F+++     + +E   +     L+ G  
Sbjct: 113 HVVKVLDIVIPKDVEKFDELYVVLEIADSD--FKKLFRTPVYLTELHIKTLLYNLLVGVK 170
Query: 111 -----QICHRDLKLENTLLDGSPAPRLKICDFGYSKS--------SLLHSRPKST----- 152
                 I HRDLK  N L++   +  +K+CDFG +++        S L   P+       
Sbjct: 171 YVHSAGILHRDLKPANCLVNQDCS--VKVCDFGLARTVDYPENGNSQLPISPREDDMNLV 228
Query: 153 ---------------VGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVML 187
                          V T  Y APE++  +E   +  DVWS G     +L
Sbjct: 229 TFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELL 278

>pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 53/237 (22%), Positives = 101/237 (42%), Gaps = 47/237 (19%)
Query: 59  NIIRFKEVVLTPTHL--AIVMEYAAGGELFERICNAGRFSEDEARYFFQQLI-------S 109
           NII+  + V  P     A+V EY    + F+++      ++ + R++  +L+       S
Sbjct: 94  NIIKLIDTVKDPVSKTPALVFEYINNTD-FKQLYQI--LTDFDIRFYMYELLKALDYCHS 150
Query: 110 GQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVL-SRRE 168
             I HRD+K  N ++D     +L++ D+G ++           V +  +  PE+L   + 
Sbjct: 151 KGIMHRDVKPHNVMIDHQ-QKKLRLIDWGLAEFYHPAQEYNVRVASRYFKGPELLVDYQM 209
Query: 169 YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQ--------YKIP--- 217
           YD  L D+WS G  L  M+    PF   +D  +    I++++  +        Y I    
Sbjct: 210 YDYSL-DMWSLGCMLASMIFRREPFFHGQDNYDQLVRIAKVLGTEELYGYLKKYHIDLDP 268
Query: 218 ---------------DYVH------ISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 253
                          +++H      +S +  +LL ++   +  +R+T KE   HP+F
Sbjct: 269 HFNDILGQHSRKRWENFIHSENRHLVSPEALDLLDKLLRYDHQQRLTAKEAMEHPYF 325

>pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 53/237 (22%), Positives = 101/237 (42%), Gaps = 47/237 (19%)
Query: 59  NIIRFKEVVLTPTHL--AIVMEYAAGGELFERICNAGRFSEDEARYFFQQLI-------S 109
           NII+  + V  P     A+V EY    + F+++      ++ + R++  +L+       S
Sbjct: 99  NIIKLIDTVKDPVSKTPALVFEYINNTD-FKQLYQI--LTDFDIRFYMYELLKALDYCHS 155
Query: 110 GQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVL-SRRE 168
             I HRD+K  N ++D     +L++ D+G ++           V +  +  PE+L   + 
Sbjct: 156 KGIMHRDVKPHNVMIDHQ-QKKLRLIDWGLAEFYHPAQEYNVRVASRYFKGPELLVDYQM 214
Query: 169 YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQ--------YKIP--- 217
           YD  L D+WS G  L  M+    PF   +D  +    I++++  +        Y I    
Sbjct: 215 YDYSL-DMWSLGCMLASMIFRREPFFHGQDNYDQLVRIAKVLGTEELYGYLKKYHIDLDP 273
Query: 218 ---------------DYVH------ISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 253
                          +++H      +S +  +LL ++   +  +R+T KE   HP+F
Sbjct: 274 HFNDILGQHSRKRWENFIHSENRHLVSPEALDLLDKLLRYDHQQRLTAKEAMEHPYF 330

>pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 52/232 (22%), Positives = 100/232 (43%), Gaps = 43/232 (18%)
Query: 4   YELMKDIGSGNFGVARLMRNKNTKELVAMKYIE------RGHKIDANVAREIINHKQLRH 57
           + +++ +G G FG   L ++ + K+  A+K +       R  KI+A++ ++ I +  + +
Sbjct: 37  FLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKK-IQNDDINN 95
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFERIC--NAGRFSEDEARYFFQQLISG----- 110
            NI+++    +   H+ ++ E   G  L+E I   N   F  ++ + +  +++       
Sbjct: 96  NNIVKYHGKFMYYDHMCLIFE-PLGPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLR 154
Query: 111 --QICHRDLKLENTLLDG-----------------------SPAPRLKICDFGYSKSSLL 145
              + H DLK EN LLD                        + +  +K+ DFG   ++  
Sbjct: 155 KMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGC--ATFK 212
Query: 146 HSRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQE 197
                S + T  Y APEV+    +D   +D+WS G  L  +  G+  F   E
Sbjct: 213 SDYHGSIINTRQYRAPEVILNLGWDVS-SDMWSFGCVLAELYTGSLLFRTHE 263

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 97/209 (46%), Gaps = 30/209 (14%)
Query: 7   MKDIGSGNFGVAR----LMRNKNTKELVAMKYIE--RGHKIDANVAREIINHKQLRHPNI 60
           +K +GSG FG       +   ++ K  V +K IE   G +    V   ++    L H +I
Sbjct: 36  LKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHI 95
Query: 61  IRFKEVVLTP-THLAIVMEYAAGGELFERI-CNAGRFSEDEARYFFQQLISGQ------- 111
           +R   + L P + L +V +Y   G L + +  + G         +  Q+  G        
Sbjct: 96  VRL--LGLCPGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHG 153
Query: 112 ICHRDLKLENTLLDGSPAPRLKICDFGYSK------SSLLHSRPKSTVGTPAYIAPEVLS 165
           + HR+L   N LL  SP+ ++++ DFG +         LL+S  K+ +    ++A E + 
Sbjct: 154 MVHRNLAARNVLLK-SPS-QVQVADFGVADLLPPDDKQLLYSEAKTPI---KWMALESIH 208
Query: 166 RREYDGKLADVWSCGVTLY-VMLVGAYPF 193
             +Y  + +DVWS GVT++ +M  GA P+
Sbjct: 209 FGKYTHQ-SDVWSYGVTVWELMTFGAEPY 236

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 97/209 (46%), Gaps = 30/209 (14%)
Query: 7   MKDIGSGNFGVAR----LMRNKNTKELVAMKYIE--RGHKIDANVAREIINHKQLRHPNI 60
           +K +GSG FG       +   ++ K  V +K IE   G +    V   ++    L H +I
Sbjct: 18  LKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHI 77
Query: 61  IRFKEVVLTP-THLAIVMEYAAGGELFERI-CNAGRFSEDEARYFFQQLISGQ------- 111
           +R   + L P + L +V +Y   G L + +  + G         +  Q+  G        
Sbjct: 78  VRL--LGLCPGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHG 135
Query: 112 ICHRDLKLENTLLDGSPAPRLKICDFGYSK------SSLLHSRPKSTVGTPAYIAPEVLS 165
           + HR+L   N LL  SP+ ++++ DFG +         LL+S  K+ +    ++A E + 
Sbjct: 136 MVHRNLAARNVLLK-SPS-QVQVADFGVADLLPPDDKQLLYSEAKTPI---KWMALESIH 190
Query: 166 RREYDGKLADVWSCGVTLY-VMLVGAYPF 193
             +Y  + +DVWS GVT++ +M  GA P+
Sbjct: 191 FGKYTHQ-SDVWSYGVTVWELMTFGAEPY 218

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 90/215 (41%), Gaps = 36/215 (16%)
Query: 10  IGSGNFGV---ARLMRNKNTKELVAMKYIERGHKIDA-NVAREI-INHKQLRHPNIIRFK 64
           IG GNFG    AR+ ++    +    +  E   K D  + A E+ +  K   HPNII   
Sbjct: 23  IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 82
Query: 65  EVVLTPTHLAIVMEYAAGGELFERI----------------CNAGRFSEDEARYFFQQLI 108
                  +L + +EYA  G L + +                  A   S  +  +F   + 
Sbjct: 83  GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 142
Query: 109 SG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVG-TPA-YI 159
            G       Q  HRDL   N L+  +     KI DFG S+   ++   K T+G  P  ++
Sbjct: 143 RGMDYLSQKQFIHRDLAARNILVGENYVA--KIADFGLSRGQEVYV--KKTMGRLPVRWM 198
Query: 160 APEVLSRREYDGKLADVWSCGVTLY-VMLVGAYPF 193
           A E L+   Y    +DVWS GV L+ ++ +G  P+
Sbjct: 199 AIESLNYSVYTTN-SDVWSYGVLLWEIVSLGGTPY 232

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 90/215 (41%), Gaps = 36/215 (16%)
Query: 10  IGSGNFGV---ARLMRNKNTKELVAMKYIERGHKIDA-NVAREI-INHKQLRHPNIIRFK 64
           IG GNFG    AR+ ++    +    +  E   K D  + A E+ +  K   HPNII   
Sbjct: 33  IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 92
Query: 65  EVVLTPTHLAIVMEYAAGGELFERI----------------CNAGRFSEDEARYFFQQLI 108
                  +L + +EYA  G L + +                  A   S  +  +F   + 
Sbjct: 93  GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 152
Query: 109 SG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVG-TPA-YI 159
            G       Q  HRDL   N L+  +     KI DFG S+   ++   K T+G  P  ++
Sbjct: 153 RGMDYLSQKQFIHRDLAARNILVGENYVA--KIADFGLSRGQEVYV--KKTMGRLPVRWM 208
Query: 160 APEVLSRREYDGKLADVWSCGVTLY-VMLVGAYPF 193
           A E L+   Y    +DVWS GV L+ ++ +G  P+
Sbjct: 209 AIESLNYSVYTTN-SDVWSYGVLLWEIVSLGGTPY 242

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 74/294 (25%), Positives = 116/294 (39%), Gaps = 62/294 (21%)
Query: 6   LMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKE 65
           L++ +G G +G   + R     E VA+K      +       E+ N   LRH NI+ F  
Sbjct: 12  LLECVGKGRYG--EVWRGSWQGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIA 69
Query: 66  VVLTPTH----LAIVMEYAAGGELFERI---------CNAGRFSEDEARYFFQQLISGQ- 111
             +T  H    L ++  Y   G L++ +         C     S           I G  
Sbjct: 70  SDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQ 129
Query: 112 ----ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST--------VGTPAYI 159
               I HRDLK +N L+  +   +  I D G +   ++HS+  +         VGT  Y+
Sbjct: 130 GKPAIAHRDLKSKNILVKKNG--QCCIADLGLA---VMHSQSTNQLDVGNNPRVGTKRYM 184
Query: 160 APEVLSRR----EYDG-KLADVWSCGVTLYVM--------LVGAY--PFED--QEDP--K 200
           APEVL        +D  K  D+W+ G+ L+ +        +V  Y  PF D    DP  +
Sbjct: 185 APEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFE 244
Query: 201 NFRKTIS------RIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIK 248
           + RK +        I    +  P    +++    L+   +  NPS R+T   IK
Sbjct: 245 DMRKVVCVDQQRPNIPNRWFSDPTLTSLAK----LMKECWYQNPSARLTALRIK 294

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 74/294 (25%), Positives = 116/294 (39%), Gaps = 62/294 (21%)
Query: 6   LMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKE 65
           L++ +G G +G   + R     E VA+K      +       E+ N   LRH NI+ F  
Sbjct: 12  LLECVGKGRYG--EVWRGSWQGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIA 69
Query: 66  VVLTPTH----LAIVMEYAAGGELFERI---------CNAGRFSEDEARYFFQQLISGQ- 111
             +T  H    L ++  Y   G L++ +         C     S           I G  
Sbjct: 70  SDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQ 129
Query: 112 ----ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST--------VGTPAYI 159
               I HRDLK +N L+  +   +  I D G +   ++HS+  +         VGT  Y+
Sbjct: 130 GKPAIAHRDLKSKNILVKKNG--QCCIADLGLA---VMHSQSTNQLDVGNNPRVGTKRYM 184
Query: 160 APEVLSRR----EYDG-KLADVWSCGVTLYVM--------LVGAY--PFED--QEDP--K 200
           APEVL        +D  K  D+W+ G+ L+ +        +V  Y  PF D    DP  +
Sbjct: 185 APEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFE 244
Query: 201 NFRKTIS------RIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIK 248
           + RK +        I    +  P    +++    L+   +  NPS R+T   IK
Sbjct: 245 DMRKVVCVDQQRPNIPNRWFSDPTLTSLAK----LMKECWYQNPSARLTALRIK 294

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 55/232 (23%), Positives = 96/232 (41%), Gaps = 39/232 (16%)
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARY--------FFQQLI 108
           HPN+IR+     T   L I +E        + +  +   S++  +           +Q+ 
Sbjct: 86  HPNVIRYYCSETTDRFLYIALELCNLN--LQDLVESKNVSDENLKLQKEYNPISLLRQIA 143
Query: 109 SG-------QICHRDLKLENTLLD-----------GSPAPRLKICDFGYSK-----SSLL 145
           SG       +I HRDLK +N L+            G+   R+ I DFG  K         
Sbjct: 144 SGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXF 203
Query: 146 HSRPKSTVGTPAYIAPEVL--SRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNF 202
                +  GT  + APE+L  S +    +  D++S G   Y +L  G +PF D+   ++ 
Sbjct: 204 RXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRES- 262
Query: 203 RKTISRIMAV-QYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 253
              I  I ++ + K      +  +  +L+S++   +P +R T  ++  HP F
Sbjct: 263 -NIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLF 313

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 74/294 (25%), Positives = 116/294 (39%), Gaps = 62/294 (21%)
Query: 6   LMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKE 65
           L++ +G G +G   + R     E VA+K      +       E+ N   LRH NI+ F  
Sbjct: 41  LLECVGKGRYG--EVWRGSWQGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIA 98
Query: 66  VVLTPTH----LAIVMEYAAGGELFERI---------CNAGRFSEDEARYFFQQLISGQ- 111
             +T  H    L ++  Y   G L++ +         C     S           I G  
Sbjct: 99  SDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQ 158
Query: 112 ----ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST--------VGTPAYI 159
               I HRDLK +N L+  +   +  I D G +   ++HS+  +         VGT  Y+
Sbjct: 159 GKPAIAHRDLKSKNILVKKNG--QCCIADLGLA---VMHSQSTNQLDVGNNPRVGTKRYM 213
Query: 160 APEVLSRR----EYDG-KLADVWSCGVTLYVM--------LVGAY--PFED--QEDP--K 200
           APEVL        +D  K  D+W+ G+ L+ +        +V  Y  PF D    DP  +
Sbjct: 214 APEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFE 273
Query: 201 NFRKTIS------RIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIK 248
           + RK +        I    +  P    +++    L+   +  NPS R+T   IK
Sbjct: 274 DMRKVVCVDQQRPNIPNRWFSDPTLTSLAK----LMKECWYQNPSARLTALRIK 323

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 55/232 (23%), Positives = 96/232 (41%), Gaps = 39/232 (16%)
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARY--------FFQQLI 108
           HPN+IR+     T   L I +E        + +  +   S++  +           +Q+ 
Sbjct: 86  HPNVIRYYCSETTDRFLYIALELCNLN--LQDLVESKNVSDENLKLQKEYNPISLLRQIA 143
Query: 109 SG-------QICHRDLKLENTLLD-----------GSPAPRLKICDFGYSK-----SSLL 145
           SG       +I HRDLK +N L+            G+   R+ I DFG  K         
Sbjct: 144 SGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXF 203
Query: 146 HSRPKSTVGTPAYIAPEVL--SRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNF 202
                +  GT  + APE+L  S +    +  D++S G   Y +L  G +PF D+   ++ 
Sbjct: 204 RXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRES- 262
Query: 203 RKTISRIMAV-QYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 253
              I  I ++ + K      +  +  +L+S++   +P +R T  ++  HP F
Sbjct: 263 -NIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLF 313

>pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 63/240 (26%), Positives = 90/240 (37%), Gaps = 55/240 (22%)
Query: 4   YELMKDIGSGNFGVARLMRNK---NTKELVAMKY-IERGH--KIDANVAREIINHKQLRH 57
           +++   IG G F    L   +     +E +A+K+ I   H  +I A +    +   Q   
Sbjct: 23  FKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSHPIRIAAELQCLTVAGGQ--- 79
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG------- 110
            N++  K       H+ I M Y    E F  I N+  F E   R +   L          
Sbjct: 80  DNVMGVKYCFRKNDHVVIAMPYLEH-ESFLDILNSLSFQE--VREYMLNLFKALKRIHQF 136
Query: 111 QICHRDLKLENTLLDGSPAPRLK---ICDFGYS--------------------------K 141
            I HRD+K  N L +     RLK   + DFG +                          K
Sbjct: 137 GIVHRDVKPSNFLYNR----RLKKYALVDFGLAQGTHDTKIELLKFVQSEAQQERCSQNK 192
Query: 142 SSLLHSRPKSTV---GTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQED 198
            S+  SR +      GTP + APEVL++        D+WS GV    +L G YPF    D
Sbjct: 193 CSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKASD 252

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 70/268 (26%), Positives = 114/268 (42%), Gaps = 38/268 (14%)
Query: 2   EKYELMKDIGSGNFG-VARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNI 60
           E  +L+K +G+G FG V     N NTK  VA+K ++ G     +   E    K+L+H  +
Sbjct: 9   ESLQLIKRLGNGQFGEVWMGTWNGNTK--VAIKTLKPGTMSPESFLEEAQIMKKLKHDKL 66
Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFERICNA-GR-FSEDEARYFFQQLISG-------Q 111
           ++   VV +   + IV EY   G L + + +  GR            Q+ +G        
Sbjct: 67  VQLYAVV-SEEPIYIVTEYMNKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMN 125
Query: 112 ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPA-----YIAPEVLSR 166
             HRDL+  N L+        KI DFG ++   L    + T    A     + APE    
Sbjct: 126 YIHRDLRSANILVGNGLI--CKIADFGLAR---LIEDNEXTARQGAKFPIKWTAPEAALY 180
Query: 167 REYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQD 225
             +  K +DVWS G+ L  ++  G  P+       N R+ + ++    Y++P      QD
Sbjct: 181 GRFTIK-SDVWSFGILLTELVTKGRVPYPGM----NNREVLEQV-ERGYRMP----CPQD 230
Query: 226 C----RNLLSRIFVANPSRRITIKEIKS 249
           C      L+   +  +P  R T + ++S
Sbjct: 231 CPISLHELMIHCWKKDPEERPTFEYLQS 258

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 84/205 (40%), Gaps = 26/205 (12%)
Query: 10  IGSGNFGVARLMRNKNTKELVAMKYI--ERGHKIDANVAREIINHKQLRHPNIIRFKEVV 67
           +G G FG     R  +   LVA+K +  ER    +     E+       H N++R +   
Sbjct: 46  LGRGGFGKVYKGRLADGT-LVAVKRLKEERXQGGELQFQTEVEMISMAVHRNLLRLRGFC 104
Query: 68  LTPTHLAIVMEYAAGGE----LFER--------ICNAGRFSEDEAR--YFFQQLISGQIC 113
           +TPT   +V  Y A G     L ER             R +   AR   +       +I 
Sbjct: 105 MTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKII 164
Query: 114 HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP----KSTVGTPAYIAPEVLSRREY 169
           HRD+K  N LLD        + DFG +K  L+  +      +  GT  +IAPE LS  + 
Sbjct: 165 HRDVKAANILLD--EEFEAVVGDFGLAK--LMDYKDXHVXXAVRGTIGHIAPEYLSTGKS 220
Query: 170 DGKLADVWSCGVTLYVMLVGAYPFE 194
             K  DV+  GV L  ++ G   F+
Sbjct: 221 SEK-TDVFGYGVMLLELITGQRAFD 244

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 45.1 bits (105), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 64/288 (22%), Positives = 122/288 (42%), Gaps = 48/288 (16%)
Query: 5   ELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFK 64
           +++K IG G +G   + + +  K  VA+K      +       EI     +RH NI+ F 
Sbjct: 40  QMVKQIGKGRYGEVWMGKWRGEK--VAVKVFFTTEEASWFRETEIYQTVLMRHENILGFI 97
Query: 65  EVVL----TPTHLAIVMEYAAGGELFERICNAGRFSEDEAR----------YFFQQLISG 110
              +    + T L ++ +Y   G L++ + +    ++   +          +   ++ S 
Sbjct: 98  AADIKGTGSWTQLYLITDYHENGSLYDYLKSTTLDAKSMLKLAYSSVSGLCHLHTEIFST 157
Query: 111 Q----ICHRDLKLENTLLDGSPAPRLKICDFGY-----SKSSLLHSRPKSTVGTPAYIAP 161
           Q    I HRDLK +N L+  +      I D G      S ++ +   P + VGT  Y+ P
Sbjct: 158 QGKPAIAHRDLKSKNILVKKNGT--CCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPP 215
Query: 162 EV----LSRREYDGK-LADVWSCGVTLYVM--------LVGAY--PFEDQEDPKNFRKTI 206
           EV    L+R  +    +AD++S G+ L+ +        +V  Y  P+ D        + +
Sbjct: 216 EVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDM 275
Query: 207 SRIMAVQYKIPDYVH--ISQDC----RNLLSRIFVANPSRRITIKEIK 248
             I+ ++   P + +   S +C      L++  +  NP+ R+T   +K
Sbjct: 276 REIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVK 323

>pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 52/238 (21%), Positives = 98/238 (41%), Gaps = 47/238 (19%)
Query: 58  PNIIRFKEVVLTPTHL--AIVMEYAAGGELFERICNAGRFSEDEARYFFQQLI------- 108
           PNII   ++V  P     A+V E+    + F+++      ++ + R++  +++       
Sbjct: 92  PNIITLADIVKDPVSRTPALVFEHVNNTD-FKQLYQT--LTDYDIRFYMYEILKALDYCH 148
Query: 109 SGQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVL-SRR 167
           S  I HRD+K  N L+D     +L++ D+G ++           V +  +  PE+L   +
Sbjct: 149 SMGIMHRDVKPHNVLIDHEHR-KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 207
Query: 168 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQ--YKIPD------- 218
            YD  L D+WS G  L  M+    PF    D  +    I++++  +  Y   D       
Sbjct: 208 MYDYSL-DMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELD 266
Query: 219 -----------------YVH------ISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 253
                            +VH      +S +  + L ++   +   R+T +E   HP+F
Sbjct: 267 PRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 324

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 44.7 bits (104), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 56/237 (23%), Positives = 99/237 (41%), Gaps = 45/237 (18%)
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARY--------FFQQLI 108
           HPN+IR+     T   L I +E        + +  +   S++  +           +Q+ 
Sbjct: 68  HPNVIRYYCSETTDRFLYIALELCNLN--LQDLVESKNVSDENLKLQKEYNPISLLRQIA 125
Query: 109 SG-------QICHRDLKLENTLLD-----------GSPAPRLKICDFGYSK-----SSLL 145
           SG       +I HRDLK +N L+            G+   R+ I DFG  K      S  
Sbjct: 126 SGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSF 185
Query: 146 HSRPKSTVGTPAYIAPEVL-------SRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQE 197
            +   +  GT  + APE+L       ++R     + D++S G   Y +L  G +PF D+ 
Sbjct: 186 RTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSI-DIFSMGCVFYYILSKGKHPFGDKY 244
Query: 198 DPKNFRKTISRIMAV-QYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 253
             ++    I  I ++ + K      +  +  +L+S++   +P +R T  ++  HP F
Sbjct: 245 SRES--NIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLF 299

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 44.7 bits (104), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 37/124 (29%), Positives = 59/124 (47%), Gaps = 12/124 (9%)
Query: 73  LAIVMEYAAGGELFERICN--AGRFSEDEARYFFQQLISG-------QICHRDLKLENTL 123
           L I ME+   G L + I      +  +  A   F+Q+  G       ++ HRDLK  N  
Sbjct: 109 LFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIF 168
Query: 124 LDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTL 183
           L      ++KI DFG   S     +   + GT  Y++PE +S ++Y GK  D+++ G+ L
Sbjct: 169 L--VDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDY-GKEVDLYALGLIL 225
Query: 184 YVML 187
             +L
Sbjct: 226 AELL 229

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 44.7 bits (104), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 51/203 (25%), Positives = 88/203 (43%), Gaps = 31/203 (15%)
Query: 10  IGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRF------ 63
           IGSG FG     +++   +   +K ++  ++      RE+    +L H NI+ +      
Sbjct: 19  IGSGGFGQVFKAKHRIDGKTYVIKRVKYNNE---KAEREVKALAKLDHVNIVHYNGCWDG 75
Query: 64  ---------KEVVLTPTH-LAIVMEYAAGGELFERICN--AGRFSEDEARYFFQQLISG- 110
                    K    + T  L I ME+   G L + I      +  +  A   F+Q+  G 
Sbjct: 76  FDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGV 135
Query: 111 ------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVL 164
                 ++ +RDLK  N  L      ++KI DFG   S     +   + GT  Y++PE +
Sbjct: 136 DYIHSKKLINRDLKPSNIFL--VDTKQVKIGDFGLVTSLKNDGKRXRSKGTLRYMSPEQI 193
Query: 165 SRREYDGKLADVWSCGVTLYVML 187
           S ++Y GK  D+++ G+ L  +L
Sbjct: 194 SSQDY-GKEVDLYALGLILAELL 215

>pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271

Iteration: 1
 Score = 44.7 bits (104), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 36/154 (23%), Positives = 63/154 (40%), Gaps = 21/154 (13%)
Query: 57  HPNIIRFKEVVLTPT--HLAIVMEYAAGGELFERI----------CNAGRFSEDEARYF- 103
           HPN++       +P   H  ++  +   G L+  +            A +F+ D AR   
Sbjct: 66  HPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMA 125
Query: 104 FQQLISGQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEV 163
           F   +   I    L   + ++D     R+ + D  +S  S         +  PA++APE 
Sbjct: 126 FLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQS------PGRMYAPAWVAPEA 179
Query: 164 LSRREYDG--KLADVWSCGVTLYVMLVGAYPFED 195
           L ++  D   + AD+WS  V L+ ++    PF D
Sbjct: 180 LQKKPEDTNRRSADMWSFAVLLWELVTREVPFAD 213

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 102/218 (46%), Gaps = 38/218 (17%)
Query: 3   KYELMKDIGSGNFGVA----RLMRNKNTKELVAMKYIERGHKIDANVAREIINHK----Q 54
           +++ +K +GSG FG       +   +  K  VA+K +       AN  +EI++       
Sbjct: 17  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDEAYVMAS 74
Query: 55  LRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDE--ARYFFQ---QLIS 109
           + +P++ R   + LT T + ++M+    G L + +    R  +D   ++Y      Q+  
Sbjct: 75  VDNPHVCRLLGICLTST-VQLIMQLMPFGXLLDYV----REHKDNIGSQYLLNWCVQIAK 129
Query: 110 G-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPA----- 157
           G       ++ HRDL   N L+  +P   +KI DFG +K  LL +  K            
Sbjct: 130 GMNYLEDRRLVHRDLAARNVLVK-TPQ-HVKITDFGLAK--LLGAEEKEYHAEGGKVPIK 185
Query: 158 YIAPEVLSRREYDGKLADVWSCGVTLY-VMLVGAYPFE 194
           ++A E +  R Y  + +DVWS GVT++ +M  G+ P++
Sbjct: 186 WMALESILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYD 222

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 44.3 bits (103), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 90/215 (41%), Gaps = 36/215 (16%)
Query: 10  IGSGNFGV---ARLMRNKNTKELVAMKYIERGHKIDA-NVAREI-INHKQLRHPNIIRFK 64
           IG GNFG    AR+ ++    +    +  E   K D  + A E+ +  K   HPNII   
Sbjct: 30  IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 89
Query: 65  EVVLTPTHLAIVMEYAAGGELFERI----------------CNAGRFSEDEARYFFQQLI 108
                  +L + +EYA  G L + +                  A   S  +  +F   + 
Sbjct: 90  GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 149
Query: 109 SG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVG-TPA-YI 159
            G       Q  HR+L   N L+  +     KI DFG S+   ++   K T+G  P  ++
Sbjct: 150 RGMDYLSQKQFIHRNLAARNILVGENYVA--KIADFGLSRGQEVYV--KKTMGRLPVRWM 205
Query: 160 APEVLSRREYDGKLADVWSCGVTLY-VMLVGAYPF 193
           A E L+   Y    +DVWS GV L+ ++ +G  P+
Sbjct: 206 AIESLNYSVYTTN-SDVWSYGVLLWEIVSLGGTPY 239

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 54/221 (24%), Positives = 89/221 (40%), Gaps = 44/221 (19%)
Query: 5   ELMKDIGSGNFGVARLMRNKNTK-----ELVAMKYI--ERGHKIDANVAREIINHKQLRH 57
           E ++DIG G FG     R           +VA+K +  E    + A+  RE     +  +
Sbjct: 50  EYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDN 109
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFE----------------------RICNAG-- 93
           PNI++   V      + ++ EY A G+L E                      R+ + G  
Sbjct: 110 PNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPP 169
Query: 94  RFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKS--SL 144
             S  E     +Q+ +G       +  HRDL   N L+  +    +KI DFG S++  S 
Sbjct: 170 PLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMV--VKIADFGLSRNIYSA 227
Query: 145 LHSRPKSTVGTPA-YIAPEVLSRREYDGKLADVWSCGVTLY 184
            + +       P  ++ PE +    Y  + +DVW+ GV L+
Sbjct: 228 DYYKADGNDAIPIRWMPPESIFYNRYTTE-SDVWAYGVVLW 267

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 69/281 (24%), Positives = 114/281 (40%), Gaps = 53/281 (18%)
Query: 6   LMKDIGSGNFGVARLMRNKNT-----KELVAMKYIERGHKIDANVA------REIINHKQ 54
           L +++G G FG   L    N      K LVA+K ++     D  +A      RE      
Sbjct: 19  LKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALK-----DPTLAARKDFQREAELLTN 73
Query: 55  LRHPNIIRFKEVVLTPTHLAIVMEYAAGGEL--FERICN--------------AGRFSED 98
           L+H +I++F  V      L +V EY   G+L  F R                  G     
Sbjct: 74  LQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLS 133
Query: 99  EARYFFQQLISGQI-------CHRDLKLENTLLDGSPAPRLKICDFGYSK---SSLLHSR 148
           +  +   Q+ SG +        HRDL   N L+  +    +KI DFG S+   S+  +  
Sbjct: 134 QMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLL--VKIGDFGMSRDVYSTDYYRV 191
Query: 149 PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLY-VMLVGAYPFEDQEDPKNFRK-TI 206
              T+    ++ PE +  R++  + +DVWS GV L+ +   G  P+    + +     T 
Sbjct: 192 GGHTMLPIRWMPPESIMYRKFTTE-SDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQ 250
Query: 207 SRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEI 247
            R++      P  V+      +++   +   P +R+ IKEI
Sbjct: 251 GRVLERPRVCPKEVY------DVMLGCWQREPQQRLNIKEI 285

>pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 51/238 (21%), Positives = 98/238 (41%), Gaps = 47/238 (19%)
Query: 58  PNIIRFKEVVLTPTHL--AIVMEYAAGGELFERICNAGRFSEDEARYFFQQLI------- 108
           PNII   ++V  P     A+V E+    + F+++      ++ + R++  +++       
Sbjct: 91  PNIITLADIVKDPVSRTPALVFEHVNNTD-FKQLYQT--LTDYDIRFYMYEILKALDYCH 147
Query: 109 SGQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVL-SRR 167
           S  I HRD+K  N ++D     +L++ D+G ++           V +  +  PE+L   +
Sbjct: 148 SMGIMHRDVKPHNVMIDHEHR-KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 206
Query: 168 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQ--YKIPD------- 218
            YD  L D+WS G  L  M+    PF    D  +    I++++  +  Y   D       
Sbjct: 207 MYDYSL-DMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELD 265
Query: 219 -----------------YVH------ISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 253
                            +VH      +S +  + L ++   +   R+T +E   HP+F
Sbjct: 266 PRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 323

>pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 51/238 (21%), Positives = 98/238 (41%), Gaps = 47/238 (19%)
Query: 58  PNIIRFKEVVLTPTHL--AIVMEYAAGGELFERICNAGRFSEDEARYFFQQLI------- 108
           PNII   ++V  P     A+V E+    + F+++      ++ + R++  +++       
Sbjct: 92  PNIITLADIVKDPVSRTPALVFEHVNNTD-FKQLYQT--LTDYDIRFYMYEILKALDYCH 148
Query: 109 SGQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVL-SRR 167
           S  I HRD+K  N ++D     +L++ D+G ++           V +  +  PE+L   +
Sbjct: 149 SMGIMHRDVKPHNVMIDHEHR-KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 207
Query: 168 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQ--YKIPD------- 218
            YD  L D+WS G  L  M+    PF    D  +    I++++  +  Y   D       
Sbjct: 208 MYDYSL-DMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELD 266
Query: 219 -----------------YVH------ISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 253
                            +VH      +S +  + L ++   +   R+T +E   HP+F
Sbjct: 267 PRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 324

>pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 51/238 (21%), Positives = 98/238 (41%), Gaps = 47/238 (19%)
Query: 58  PNIIRFKEVVLTPTHL--AIVMEYAAGGELFERICNAGRFSEDEARYFFQQLI------- 108
           PNII   ++V  P     A+V E+    + F+++      ++ + R++  +++       
Sbjct: 92  PNIITLADIVKDPVSRTPALVFEHVNNTD-FKQLYQT--LTDYDIRFYMYEILKALDYCH 148
Query: 109 SGQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVL-SRR 167
           S  I HRD+K  N ++D     +L++ D+G ++           V +  +  PE+L   +
Sbjct: 149 SMGIMHRDVKPHNVMIDHEHR-KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 207
Query: 168 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQ--YKIPD------- 218
            YD  L D+WS G  L  M+    PF    D  +    I++++  +  Y   D       
Sbjct: 208 MYDYSL-DMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELD 266
Query: 219 -----------------YVH------ISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 253
                            +VH      +S +  + L ++   +   R+T +E   HP+F
Sbjct: 267 PRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 324

>pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 51/238 (21%), Positives = 98/238 (41%), Gaps = 47/238 (19%)
Query: 58  PNIIRFKEVVLTPTHL--AIVMEYAAGGELFERICNAGRFSEDEARYFFQQLI------- 108
           PNII   ++V  P     A+V E+    + F+++      ++ + R++  +++       
Sbjct: 92  PNIITLADIVKDPVSRTPALVFEHVNNTD-FKQLYQT--LTDYDIRFYMYEILKALDYCH 148
Query: 109 SGQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVL-SRR 167
           S  I HRD+K  N ++D     +L++ D+G ++           V +  +  PE+L   +
Sbjct: 149 SMGIMHRDVKPHNVMIDHEHR-KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 207
Query: 168 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQ--YKIPD------- 218
            YD  L D+WS G  L  M+    PF    D  +    I++++  +  Y   D       
Sbjct: 208 MYDYSL-DMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELD 266
Query: 219 -----------------YVH------ISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 253
                            +VH      +S +  + L ++   +   R+T +E   HP+F
Sbjct: 267 PRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 324

>pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 51/238 (21%), Positives = 98/238 (41%), Gaps = 47/238 (19%)
Query: 58  PNIIRFKEVVLTPTHL--AIVMEYAAGGELFERICNAGRFSEDEARYFFQQLI------- 108
           PNII   ++V  P     A+V E+    + F+++      ++ + R++  +++       
Sbjct: 92  PNIITLADIVKDPVSRTPALVFEHVNNTD-FKQLYQT--LTDYDIRFYMYEILKALDYCH 148
Query: 109 SGQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVL-SRR 167
           S  I HRD+K  N ++D     +L++ D+G ++           V +  +  PE+L   +
Sbjct: 149 SMGIMHRDVKPHNVMIDHEHR-KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 207
Query: 168 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQ--YKIPD------- 218
            YD  L D+WS G  L  M+    PF    D  +    I++++  +  Y   D       
Sbjct: 208 MYDYSL-DMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELD 266
Query: 219 -----------------YVH------ISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 253
                            +VH      +S +  + L ++   +   R+T +E   HP+F
Sbjct: 267 PRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 324

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 69/292 (23%), Positives = 114/292 (39%), Gaps = 58/292 (19%)
Query: 6   LMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKE 65
           L++ +G G +G   + R     E VA+K      +       EI N   LRH NI+ F  
Sbjct: 12  LVECVGKGRYG--EVWRGLWHGESVAVKIFSSRDEQSWFRETEIYNTVLLRHDNILGFIA 69
Query: 66  VVLTP----THLAIVMEYAAGGELFERICN-------AGRFSEDEA---RYFFQQLISGQ 111
             +T     T L ++  Y   G L++ +         A R +   A    +   ++   Q
Sbjct: 70  SDMTSRNSSTQLWLITHYHEHGSLYDFLQRQTLEPHLALRLAVSAACGLAHLHVEIFGTQ 129
Query: 112 ----ICHRDLKLENTLLDGSPAPRLKIC--DFGYSKSSLLHSRPKS--------TVGTPA 157
               I HRD K  N L+  +    L+ C  D G +   ++HS+            VGT  
Sbjct: 130 GKPAIAHRDFKSRNVLVKSN----LQCCIADLGLA---VMHSQGSDYLDIGNNPRVGTKR 182
Query: 158 YIAPEVLSRREYDG-----KLADVWSCGVTLYVM--------LVGAY--PFEDQEDPKNF 202
           Y+APEVL  +         K  D+W+ G+ L+ +        +V  Y  PF D       
Sbjct: 183 YMAPEVLDEQIRTDCFESYKWTDIWAFGLVLWEIARRTIVNGIVEDYRPPFYDVVPNDPS 242
Query: 203 RKTISRIMAVQYKIPDYVH------ISQDCRNLLSRIFVANPSRRITIKEIK 248
            + + +++ V  + P   +      +      ++   +  NPS R+T   IK
Sbjct: 243 FEDMKKVVCVDQQTPTIPNRLAADPVLSGLAQMMRECWYPNPSARLTALRIK 294

>pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 56/242 (23%), Positives = 97/242 (40%), Gaps = 36/242 (14%)
Query: 2   EKYELMKDIGSGNFG-VARLMRNKNTKELVAMKYIERGHKIDANVAREI-----INHKQL 55
           E+YE++  +G G FG V + + ++     VA+K I+   K       EI     IN K  
Sbjct: 33  ERYEIVSTLGEGTFGRVVQCVDHRRGGARVALKIIKNVEKYKEAARLEINVLEKINEKDP 92
Query: 56  RHPNI-IRFKEVVLTPTHLAIVMEYAAGGEL-FERICNAGRFSEDEARYFFQQLISG--- 110
            + N+ ++  +      H+ I  E        F +  N   +   + R+   QL      
Sbjct: 93  DNKNLCVQMFDWFDYHGHMCISFELLGLSTFDFLKDNNYLPYPIHQVRHMAFQLCQAVKF 152
Query: 111 ----QICHRDLKLENTLLDGSP-----------------APRLKICDFGYSKSSLLHSRP 149
               ++ H DLK EN L   S                  +  +++ DFG   ++  H   
Sbjct: 153 LHDNKLTHTDLKPENILFVNSDYELTYNLEKKRDERSVKSTAVRVVDFG--SATFDHEHH 210
Query: 150 KSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRI 209
            + V T  Y APEV+    +  +  DVWS G  ++   VG   F+  ++ ++    + RI
Sbjct: 211 STIVSTRHYRAPEVILELGW-SQPCDVWSIGCIIFEYYVGFTLFQTHDNREHL-AMMERI 268
Query: 210 MA 211
           + 
Sbjct: 269 LG 270

>pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 51/238 (21%), Positives = 98/238 (41%), Gaps = 47/238 (19%)
Query: 58  PNIIRFKEVVLTPTHL--AIVMEYAAGGELFERICNAGRFSEDEARYFFQQLI------- 108
           PNII   ++V  P     A+V E+    + F+++      ++ + R++  +++       
Sbjct: 97  PNIITLADIVKDPVSRTPALVFEHVNNTD-FKQLYQT--LTDYDIRFYMYEILKALDYCH 153
Query: 109 SGQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVL-SRR 167
           S  I HRD+K  N ++D     +L++ D+G ++           V +  +  PE+L   +
Sbjct: 154 SMGIMHRDVKPHNVMIDHEHR-KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 212
Query: 168 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQ--YKIPD------- 218
            YD  L D+WS G  L  M+    PF    D  +    I++++  +  Y   D       
Sbjct: 213 MYDYSL-DMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELD 271
Query: 219 -----------------YVH------ISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 253
                            +VH      +S +  + L ++   +   R+T +E   HP+F
Sbjct: 272 PRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 329

>pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 51/238 (21%), Positives = 98/238 (41%), Gaps = 47/238 (19%)
Query: 58  PNIIRFKEVVLTPTHL--AIVMEYAAGGELFERICNAGRFSEDEARYFFQQLI------- 108
           PNII   ++V  P     A+V E+    + F+++      ++ + R++  +++       
Sbjct: 92  PNIITLADIVKDPVSRTPALVFEHVNNTD-FKQLYQT--LTDYDIRFYMYEILKALDYCH 148
Query: 109 SGQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVL-SRR 167
           S  I HRD+K  N ++D     +L++ D+G ++           V +  +  PE+L   +
Sbjct: 149 SMGIMHRDVKPHNVMIDHEHR-KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 207
Query: 168 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQ--YKIPD------- 218
            YD  L D+WS G  L  M+    PF    D  +    I++++  +  Y   D       
Sbjct: 208 MYDYSL-DMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELD 266
Query: 219 -----------------YVH------ISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 253
                            +VH      +S +  + L ++   +   R+T +E   HP+F
Sbjct: 267 PRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 324

>pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 51/238 (21%), Positives = 98/238 (41%), Gaps = 47/238 (19%)
Query: 58  PNIIRFKEVVLTPTHL--AIVMEYAAGGELFERICNAGRFSEDEARYFFQQLI------- 108
           PNII   ++V  P     A+V E+    + F+++      ++ + R++  +++       
Sbjct: 92  PNIITLADIVKDPVSRTPALVFEHVNNTD-FKQLYQT--LTDYDIRFYMYEILKALDYCH 148
Query: 109 SGQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVL-SRR 167
           S  I HRD+K  N ++D     +L++ D+G ++           V +  +  PE+L   +
Sbjct: 149 SMGIMHRDVKPHNVMIDHEHR-KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 207
Query: 168 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQ--YKIPD------- 218
            YD  L D+WS G  L  M+    PF    D  +    I++++  +  Y   D       
Sbjct: 208 MYDYSL-DMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELD 266
Query: 219 -----------------YVH------ISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 253
                            +VH      +S +  + L ++   +   R+T +E   HP+F
Sbjct: 267 PRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 324

>pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 51/238 (21%), Positives = 98/238 (41%), Gaps = 47/238 (19%)
Query: 58  PNIIRFKEVVLTPTHL--AIVMEYAAGGELFERICNAGRFSEDEARYFFQQLI------- 108
           PNII   ++V  P     A+V E+    + F+++      ++ + R++  +++       
Sbjct: 92  PNIITLADIVKDPVSRTPALVFEHVNNTD-FKQLYQT--LTDYDIRFYMYEILKALDYCH 148
Query: 109 SGQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVL-SRR 167
           S  I HRD+K  N ++D     +L++ D+G ++           V +  +  PE+L   +
Sbjct: 149 SMGIMHRDVKPHNVMIDHEHR-KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 207
Query: 168 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQ--YKIPD------- 218
            YD  L D+WS G  L  M+    PF    D  +    I++++  +  Y   D       
Sbjct: 208 MYDYSL-DMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELD 266
Query: 219 -----------------YVH------ISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 253
                            +VH      +S +  + L ++   +   R+T +E   HP+F
Sbjct: 267 PRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 324

>pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 51/238 (21%), Positives = 98/238 (41%), Gaps = 47/238 (19%)
Query: 58  PNIIRFKEVVLTPTHL--AIVMEYAAGGELFERICNAGRFSEDEARYFFQQLI------- 108
           PNII   ++V  P     A+V E+    + F+++      ++ + R++  +++       
Sbjct: 91  PNIITLADIVKDPVSRTPALVFEHVNNTD-FKQLYQT--LTDYDIRFYMYEILKALDYCH 147
Query: 109 SGQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVL-SRR 167
           S  I HRD+K  N ++D     +L++ D+G ++           V +  +  PE+L   +
Sbjct: 148 SMGIMHRDVKPHNVMIDHEHR-KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 206
Query: 168 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQ--YKIPD------- 218
            YD  L D+WS G  L  M+    PF    D  +    I++++  +  Y   D       
Sbjct: 207 MYDYSL-DMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELD 265
Query: 219 -----------------YVH------ISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 253
                            +VH      +S +  + L ++   +   R+T +E   HP+F
Sbjct: 266 PRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 323

>pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 51/238 (21%), Positives = 98/238 (41%), Gaps = 47/238 (19%)
Query: 58  PNIIRFKEVVLTPTHL--AIVMEYAAGGELFERICNAGRFSEDEARYFFQQLI------- 108
           PNII   ++V  P     A+V E+    + F+++      ++ + R++  +++       
Sbjct: 90  PNIITLADIVKDPVSRTPALVFEHVNNTD-FKQLYQT--LTDYDIRFYMYEILKALDYCH 146
Query: 109 SGQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVL-SRR 167
           S  I HRD+K  N ++D     +L++ D+G ++           V +  +  PE+L   +
Sbjct: 147 SMGIMHRDVKPHNVMIDHEHR-KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 205
Query: 168 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQ--YKIPD------- 218
            YD  L D+WS G  L  M+    PF    D  +    I++++  +  Y   D       
Sbjct: 206 MYDYSL-DMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELD 264
Query: 219 -----------------YVH------ISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 253
                            +VH      +S +  + L ++   +   R+T +E   HP+F
Sbjct: 265 PRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 322

>pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 51/238 (21%), Positives = 98/238 (41%), Gaps = 47/238 (19%)
Query: 58  PNIIRFKEVVLTPTHL--AIVMEYAAGGELFERICNAGRFSEDEARYFFQQLI------- 108
           PNII   ++V  P     A+V E+    + F+++      ++ + R++  +++       
Sbjct: 92  PNIITLADIVKDPVSRTPALVFEHVNNTD-FKQLYQT--LTDYDIRFYMYEILKALDYCH 148
Query: 109 SGQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVL-SRR 167
           S  I HRD+K  N ++D     +L++ D+G ++           V +  +  PE+L   +
Sbjct: 149 SMGIMHRDVKPHNVMIDHEHR-KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 207
Query: 168 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQ--YKIPD------- 218
            YD  L D+WS G  L  M+    PF    D  +    I++++  +  Y   D       
Sbjct: 208 MYDYSL-DMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELD 266
Query: 219 -----------------YVH------ISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 253
                            +VH      +S +  + L ++   +   R+T +E   HP+F
Sbjct: 267 PRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 324

>pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 51/238 (21%), Positives = 98/238 (41%), Gaps = 47/238 (19%)
Query: 58  PNIIRFKEVVLTPTHL--AIVMEYAAGGELFERICNAGRFSEDEARYFFQQLI------- 108
           PNII   ++V  P     A+V E+    + F+++      ++ + R++  +++       
Sbjct: 92  PNIITLADIVKDPVSRTPALVFEHVNNTD-FKQLRQT--LTDYDIRFYMYEILKALDYCH 148
Query: 109 SGQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVL-SRR 167
           S  I HRD+K  N ++D     +L++ D+G ++           V +  +  PE+L   +
Sbjct: 149 SMGIMHRDVKPHNVMIDHEHR-KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 207
Query: 168 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQ--YKIPD------- 218
            YD  L D+WS G  L  M+    PF    D  +    I++++  +  Y   D       
Sbjct: 208 MYDYSL-DMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELD 266
Query: 219 -----------------YVH------ISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 253
                            +VH      +S +  + L ++   +   R+T +E   HP+F
Sbjct: 267 PRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 324

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 102/218 (46%), Gaps = 38/218 (17%)
Query: 3   KYELMKDIGSGNFGVA----RLMRNKNTKELVAMKYIERGHKIDANVAREIINHK----Q 54
           +++ +K +GSG FG       +   +  K  VA+K +       AN  +EI++       
Sbjct: 17  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDEAYVMAS 74
Query: 55  LRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDE--ARYFFQ---QLIS 109
           + +P++ R   + LT T + ++M+    G L + +    R  +D   ++Y      Q+  
Sbjct: 75  VDNPHVCRLLGICLTST-VQLIMQLMPFGCLLDYV----REHKDNIGSQYLLNWCVQIAK 129
Query: 110 G-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPA----- 157
           G       ++ HRDL   N L+  +P   +KI DFG +K  LL +  K            
Sbjct: 130 GMNYLEDRRLVHRDLAARNVLVK-TPQ-HVKITDFGLAK--LLGAEEKEYHAEGGKVPIK 185
Query: 158 YIAPEVLSRREYDGKLADVWSCGVTLY-VMLVGAYPFE 194
           ++A E +  R Y  + +DVWS GVT++ +M  G+ P++
Sbjct: 186 WMALESILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYD 222

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 102/218 (46%), Gaps = 38/218 (17%)
Query: 3   KYELMKDIGSGNFGVA----RLMRNKNTKELVAMKYIERGHKIDANVAREIINHK----Q 54
           +++ +K +GSG FG       +   +  K  VA+K +       AN  +EI++       
Sbjct: 20  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDEAYVMAS 77
Query: 55  LRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDE--ARYFFQ---QLIS 109
           + +P++ R   + LT T + ++M+    G L + +    R  +D   ++Y      Q+  
Sbjct: 78  VDNPHVCRLLGICLTST-VQLIMQLMPFGCLLDYV----REHKDNIGSQYLLNWCVQIAK 132
Query: 110 G-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPA----- 157
           G       ++ HRDL   N L+  +P   +KI DFG +K  LL +  K            
Sbjct: 133 GMNYLEDRRLVHRDLAARNVLVK-TPQ-HVKITDFGLAK--LLGAEEKEYHAEGGKVPIK 188
Query: 158 YIAPEVLSRREYDGKLADVWSCGVTLY-VMLVGAYPFE 194
           ++A E +  R Y  + +DVWS GVT++ +M  G+ P++
Sbjct: 189 WMALESILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYD 225

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 100/216 (46%), Gaps = 34/216 (15%)
Query: 3   KYELMKDIGSGNFGVA----RLMRNKNTKELVAMKYIERGHKIDANVAREIINHK----Q 54
           +++ +K +GSG FG       +   +  K  VA+K +       AN  +EI++       
Sbjct: 18  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDEAYVMAS 75
Query: 55  LRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDE--ARYFFQ---QLIS 109
           + +P++ R   + LT T + ++M+    G L + +    R  +D   ++Y      Q+  
Sbjct: 76  VDNPHVCRLLGICLTST-VQLIMQLMPFGCLLDYV----REHKDNIGSQYLLNWCVQIAK 130
Query: 110 G-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPA---YI 159
           G       ++ HRDL   N L+  +P   +KI DFG +K      +     G      ++
Sbjct: 131 GMNYLEDRRLVHRDLAARNVLVK-TPQ-HVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 188
Query: 160 APEVLSRREYDGKLADVWSCGVTLY-VMLVGAYPFE 194
           A E +  R Y  + +DVWS GVT++ +M  G+ P++
Sbjct: 189 ALESILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYD 223

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 102/218 (46%), Gaps = 38/218 (17%)
Query: 3   KYELMKDIGSGNFGVA----RLMRNKNTKELVAMKYIERGHKIDANVAREIINHK----Q 54
           +++ +K +GSG FG       +   +  K  VA+K +       AN  +EI++       
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDEAYVMAS 73
Query: 55  LRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDE--ARYFFQ---QLIS 109
           + +P++ R   + LT T + ++M+    G L + +    R  +D   ++Y      Q+  
Sbjct: 74  VDNPHVCRLLGICLTST-VQLIMQLMPFGCLLDYV----REHKDNIGSQYLLNWCVQIAK 128
Query: 110 G-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPA----- 157
           G       ++ HRDL   N L+  +P   +KI DFG +K  LL +  K            
Sbjct: 129 GMNYLEDRRLVHRDLAARNVLVK-TPQ-HVKITDFGLAK--LLGAEEKEYHAEGGKVPIK 184
Query: 158 YIAPEVLSRREYDGKLADVWSCGVTLY-VMLVGAYPFE 194
           ++A E +  R Y  + +DVWS GVT++ +M  G+ P++
Sbjct: 185 WMALESILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYD 221

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 102/218 (46%), Gaps = 38/218 (17%)
Query: 3   KYELMKDIGSGNFGVA----RLMRNKNTKELVAMKYIERGHKIDANVAREIINHK----Q 54
           +++ +K +GSG FG       +   +  K  VA+K +       AN  +EI++       
Sbjct: 19  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDEAYVMAS 76
Query: 55  LRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDE--ARYFFQ---QLIS 109
           + +P++ R   + LT T + ++M+    G L + +    R  +D   ++Y      Q+  
Sbjct: 77  VDNPHVCRLLGICLTST-VQLIMQLMPFGCLLDYV----REHKDNIGSQYLLNWCVQIAK 131
Query: 110 G-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPA----- 157
           G       ++ HRDL   N L+  +P   +KI DFG +K  LL +  K            
Sbjct: 132 GMNYLEDRRLVHRDLAARNVLVK-TPQ-HVKITDFGLAK--LLGAEEKEYHAEGGKVPIK 187
Query: 158 YIAPEVLSRREYDGKLADVWSCGVTLY-VMLVGAYPFE 194
           ++A E +  R Y  + +DVWS GVT++ +M  G+ P++
Sbjct: 188 WMALESILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYD 224

>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 55/237 (23%), Positives = 97/237 (40%), Gaps = 45/237 (18%)
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARY--------FFQQLI 108
           HPN+IR+     T   L I +E        + +  +   S++  +           +Q+ 
Sbjct: 68  HPNVIRYYCSETTDRFLYIALELCNLN--LQDLVESKNVSDENLKLQKEYNPISLLRQIA 125
Query: 109 SG-------QICHRDLKLENTLLD-----------GSPAPRLKICDFGYSK-----SSLL 145
           SG       +I HRDLK +N L+            G+   R+ I DFG  K         
Sbjct: 126 SGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXF 185
Query: 146 HSRPKSTVGTPAYIAPEVL-------SRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQE 197
                +  GT  + APE+L       ++R     + D++S G   Y +L  G +PF D+ 
Sbjct: 186 RXNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSI-DIFSMGCVFYYILSKGKHPFGDKY 244
Query: 198 DPKNFRKTISRIMAV-QYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 253
             ++    I  I ++ + K      +  +  +L+S++   +P +R T  ++  HP F
Sbjct: 245 SRES--NIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLF 299

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 83/205 (40%), Gaps = 26/205 (12%)
Query: 10  IGSGNFGVARLMRNKNTKELVAMKYI--ERGHKIDANVAREIINHKQLRHPNIIRFKEVV 67
           +G G FG     R  +   LVA+K +  ER    +     E+       H N++R +   
Sbjct: 38  LGRGGFGKVYKGRLADGX-LVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFC 96
Query: 68  LTPTHLAIVMEYAAGGE----LFER--------ICNAGRFSEDEAR--YFFQQLISGQIC 113
           +TPT   +V  Y A G     L ER             R +   AR   +       +I 
Sbjct: 97  MTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKII 156
Query: 114 HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP----KSTVGTPAYIAPEVLSRREY 169
           HRD+K  N LLD        + DFG +K  L+  +      +  G   +IAPE LS  + 
Sbjct: 157 HRDVKAANILLD--EEFEAVVGDFGLAK--LMDYKDXHVXXAVRGXIGHIAPEYLSTGKS 212
Query: 170 DGKLADVWSCGVTLYVMLVGAYPFE 194
             K  DV+  GV L  ++ G   F+
Sbjct: 213 SEK-TDVFGYGVMLLELITGQRAFD 236

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 102/218 (46%), Gaps = 38/218 (17%)
Query: 3   KYELMKDIGSGNFGVA----RLMRNKNTKELVAMKYIERGHKIDANVAREIINHK----Q 54
           +++ +K +GSG FG       +   +  K  VA+K +       AN  +EI++       
Sbjct: 18  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDEAYVMAS 75
Query: 55  LRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDE--ARYFFQ---QLIS 109
           + +P++ R   + LT T + ++M+    G L + +    R  +D   ++Y      Q+  
Sbjct: 76  VDNPHVCRLLGICLTST-VQLIMQLMPFGCLLDYV----REHKDNIGSQYLLNWCVQIAK 130
Query: 110 G-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPA----- 157
           G       ++ HRDL   N L+  +P   +KI DFG +K  LL +  K            
Sbjct: 131 GMNYLEDRRLVHRDLAARNVLVK-TPQ-HVKITDFGRAK--LLGAEEKEYHAEGGKVPIK 186
Query: 158 YIAPEVLSRREYDGKLADVWSCGVTLY-VMLVGAYPFE 194
           ++A E +  R Y  + +DVWS GVT++ +M  G+ P++
Sbjct: 187 WMALESILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYD 223

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 100/216 (46%), Gaps = 34/216 (15%)
Query: 3   KYELMKDIGSGNFGVA----RLMRNKNTKELVAMKYIERGHKIDANVAREIINHK----Q 54
           +++ +K +GSG FG       +   +  K  VA+K +       AN  +EI++       
Sbjct: 20  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDEAYVMAS 77
Query: 55  LRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDE--ARYFFQ---QLIS 109
           + +P++ R   + LT T + ++M+    G L + +    R  +D   ++Y      Q+  
Sbjct: 78  VDNPHVCRLLGICLTST-VQLIMQLMPFGCLLDYV----REHKDNIGSQYLLNWCVQIAK 132
Query: 110 G-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPA---YI 159
           G       ++ HRDL   N L+  +P   +KI DFG +K      +     G      ++
Sbjct: 133 GMNYLEDRRLVHRDLAARNVLVK-TPQ-HVKITDFGRAKLLGAEEKEYHAEGGKVPIKWM 190
Query: 160 APEVLSRREYDGKLADVWSCGVTLY-VMLVGAYPFE 194
           A E +  R Y  + +DVWS GVT++ +M  G+ P++
Sbjct: 191 ALESILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYD 225

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 102/218 (46%), Gaps = 38/218 (17%)
Query: 3   KYELMKDIGSGNFGVA----RLMRNKNTKELVAMKYIERGHKIDANVAREIINHK----Q 54
           +++ +K +GSG FG       +   +  K  VA+K +       AN  +EI++       
Sbjct: 18  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDEAYVMAS 75
Query: 55  LRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDE--ARYFFQ---QLIS 109
           + +P++ R   + LT T + ++M+    G L + +    R  +D   ++Y      Q+  
Sbjct: 76  VDNPHVCRLLGICLTST-VQLIMQLMPFGCLLDYV----REHKDNIGSQYLLNWCVQIAK 130
Query: 110 G-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPA----- 157
           G       ++ HRDL   N L+  +P   +KI DFG +K  LL +  K            
Sbjct: 131 GMNYLEDRRLVHRDLAARNVLVK-TPQ-HVKITDFGRAK--LLGAEEKEYHAEGGKVPIK 186
Query: 158 YIAPEVLSRREYDGKLADVWSCGVTLY-VMLVGAYPFE 194
           ++A E +  R Y  + +DVWS GVT++ +M  G+ P++
Sbjct: 187 WMALESILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYD 223

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 42.0 bits (97), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 101/218 (46%), Gaps = 38/218 (17%)
Query: 3   KYELMKDIGSGNFGVA----RLMRNKNTKELVAMKYIERGHKIDANVAREIINHK----Q 54
           +++ +K +GSG FG       +   +  K  VA+K +       AN  +EI++       
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDEAYVMAS 73
Query: 55  LRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDE--ARYFFQ---QLIS 109
           + +P++ R   + LT T + ++ +    G L + +    R  +D   ++Y      Q+  
Sbjct: 74  VDNPHVCRLLGICLTST-VQLITQLMPFGXLLDYV----REHKDNIGSQYLLNWCVQIAK 128
Query: 110 G-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPA----- 157
           G       ++ HRDL   N L+  +P   +KI DFG +K  LL +  K            
Sbjct: 129 GMNYLEDRRLVHRDLAARNVLVK-TPQ-HVKITDFGLAK--LLGAEEKEYHAEGGKVPIK 184
Query: 158 YIAPEVLSRREYDGKLADVWSCGVTLY-VMLVGAYPFE 194
           ++A E +  R Y  + +DVWS GVT++ +M  G+ P++
Sbjct: 185 WMALESILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYD 221

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 60/222 (27%), Positives = 90/222 (40%), Gaps = 39/222 (17%)
Query: 6   LMKDIGSGNFGVARLMRNKNT-----KELVAMKYI-ERGHKIDANVAREIINHKQLRHPN 59
           L  ++G G FG   L    N      K LVA+K + E       +  RE      L+H +
Sbjct: 22  LKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQH 81
Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFERICNAG------RFSEDEA---------RYFF 104
           I+RF  V      L +V EY   G+L   + + G         ED A             
Sbjct: 82  IVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVA 141
Query: 105 QQLISGQI-------CHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPA 157
            Q+ +G +        HRDL   N L+       +KI DFG S+   ++S     VG   
Sbjct: 142 SQVAAGMVYLAGLHFVHRDLATRNCLVGQGLV--VKIGDFGMSRD--IYSTDYYRVGGRT 197
Query: 158 -----YIAPEVLSRREYDGKLADVWSCGVTLY-VMLVGAYPF 193
                ++ PE +  R++  + +DVWS GV L+ +   G  P+
Sbjct: 198 MLPIRWMPPESILYRKFTTE-SDVWSFGVVLWEIFTYGKQPW 238

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 41.6 bits (96), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 60/222 (27%), Positives = 90/222 (40%), Gaps = 39/222 (17%)
Query: 6   LMKDIGSGNFGVARLMRNKNT-----KELVAMKYI-ERGHKIDANVAREIINHKQLRHPN 59
           L  ++G G FG   L    N      K LVA+K + E       +  RE      L+H +
Sbjct: 16  LKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQH 75
Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFERICNAG------RFSEDEA---------RYFF 104
           I+RF  V      L +V EY   G+L   + + G         ED A             
Sbjct: 76  IVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVA 135
Query: 105 QQLISGQI-------CHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPA 157
            Q+ +G +        HRDL   N L+       +KI DFG S+   ++S     VG   
Sbjct: 136 SQVAAGMVYLAGLHFVHRDLATRNCLVGQGLV--VKIGDFGMSRD--IYSTDYYRVGGRT 191
Query: 158 -----YIAPEVLSRREYDGKLADVWSCGVTLY-VMLVGAYPF 193
                ++ PE +  R++  + +DVWS GV L+ +   G  P+
Sbjct: 192 MLPIRWMPPESILYRKFTTE-SDVWSFGVVLWEIFTYGKQPW 232

>pdb|3BEG|A Chain A, Crystal Structure Of Sr Protein Kinase 1 Complexed To Its Substrate AsfSF2 Length = 381

Iteration: 1
 Score = 41.6 bits (96), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 64/286 (22%), Positives = 102/286 (35%), Gaps = 75/286 (26%)
Query: 3   KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRH--PN- 59
           +Y +++ +G G+F    L  +   K+ VAMK ++           EI   K +R+  PN 
Sbjct: 22  RYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPND 81
Query: 60  ---------IIRFKEVVLTPTHLAIVMEYAAGGELFERI--CNAGRFSEDEARYFFQQLI 108
                    +  FK   +  TH+ +V E   G  L + I   N         +   QQ++
Sbjct: 82  PNREMVVQLLDDFKISGVNGTHICMVFE-VLGHHLLKWIIKSNYQGLPLPCVKKIIQQVL 140
Query: 109 SG--------QICHRDLKLENTLL-------------------DGSPAP----------- 130
            G        +I H D+K EN LL                    G+P P           
Sbjct: 141 QGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPAT 200
Query: 131 -----------------RLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKL 173
                            ++KI D G   +  +H      + T  Y + EVL    Y+   
Sbjct: 201 AGNFLVNPLEPKNAEKLKVKIADLG--NACWVHKHFTEDIQTRQYRSLEVLIGSGYNTP- 257
Query: 174 ADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKT--ISRIMAVQYKIP 217
           AD+WS     + +  G Y FE     +  R    I+ I+ +  K+P
Sbjct: 258 ADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVP 303

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score = 41.6 bits (96), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 33/79 (41%), Positives = 42/79 (53%), Gaps = 6/79 (7%)
Query: 112 ICHRDLKLENTLLDGSPAPRLKICDFGYSK--SSLLHSRPKSTV-GTPAYIAPEVLSRRE 168
           I HRD+K  N LLD +  P  KI DFG SK  + L  +     V GT  YI PE   +  
Sbjct: 160 IIHRDVKSINILLDENFVP--KITDFGISKKGTELGQTHLXXVVKGTLGYIDPEYFIKGR 217
Query: 169 YDGKLADVWSCGVTLYVML 187
              K +DV+S GV L+ +L
Sbjct: 218 LTEK-SDVYSFGVVLFEVL 235

>pdb|1WBP|A Chain A, Srpk1 Bound To 9mer Docking Motif Peptide Length = 397

Iteration: 1
 Score = 41.6 bits (96), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 64/286 (22%), Positives = 102/286 (35%), Gaps = 75/286 (26%)
Query: 3   KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRH--PN- 59
           +Y +++ +G G+F    L  +   K+ VAMK ++           EI   K +R+  PN 
Sbjct: 38  RYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPND 97
Query: 60  ---------IIRFKEVVLTPTHLAIVMEYAAGGELFERI--CNAGRFSEDEARYFFQQLI 108
                    +  FK   +  TH+ +V E   G  L + I   N         +   QQ++
Sbjct: 98  PNREMVVQLLDDFKISGVNGTHICMVFE-VLGHHLLKWIIKSNYQGLPLPCVKKIIQQVL 156
Query: 109 SG--------QICHRDLKLENTLL-------------------DGSPAP----------- 130
            G        +I H D+K EN LL                    G+P P           
Sbjct: 157 QGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPAT 216
Query: 131 -----------------RLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKL 173
                            ++KI D G   +  +H      + T  Y + EVL    Y+   
Sbjct: 217 AGNFLVNPLEPKNAEKLKVKIADLG--NACWVHKHFTEDIQTRQYRSLEVLIGSGYNTP- 273
Query: 174 ADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKT--ISRIMAVQYKIP 217
           AD+WS     + +  G Y FE     +  R    I+ I+ +  K+P
Sbjct: 274 ADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVP 319

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 41.6 bits (96), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 50/194 (25%), Positives = 81/194 (41%), Gaps = 22/194 (11%)
Query: 8   KDIGSGNFG-VARLMRNKNTKELVAMKYIERGHKIDANVAREIINH----KQLRHPNIIR 62
           K++GSGNFG V +               I +    D  +  E++      +QL +P I+R
Sbjct: 33  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 92
Query: 63  FKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSED--------EARYFFQQLISGQICH 114
              +    + + +VME A  G L  +     R  +D        +     + L      H
Sbjct: 93  MIGICEAESWM-LVMEMAELGPL-NKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVH 150
Query: 115 RDLKLENTLLDGSPAPRLKICDFGYSKSSLL---HSRPKSTVGTPA-YIAPEVLSRREYD 170
           RDL   N LL        KI DFG SK+      + + ++    P  + APE ++  ++ 
Sbjct: 151 RDLAARNVLL--VTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFS 208
Query: 171 GKLADVWSCGVTLY 184
            K +DVWS GV ++
Sbjct: 209 SK-SDVWSFGVLMW 221

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 41.6 bits (96), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 50/194 (25%), Positives = 81/194 (41%), Gaps = 22/194 (11%)
Query: 8   KDIGSGNFG-VARLMRNKNTKELVAMKYIERGHKIDANVAREIINH----KQLRHPNIIR 62
           K++GSGNFG V +               I +    D  +  E++      +QL +P I+R
Sbjct: 33  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 92
Query: 63  FKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSED--------EARYFFQQLISGQICH 114
              +    + + +VME A  G L  +     R  +D        +     + L      H
Sbjct: 93  MIGICEAESWM-LVMEMAELGPL-NKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVH 150
Query: 115 RDLKLENTLLDGSPAPRLKICDFGYSKSSLL---HSRPKSTVGTPA-YIAPEVLSRREYD 170
           RDL   N LL        KI DFG SK+      + + ++    P  + APE ++  ++ 
Sbjct: 151 RDLAARNVLL--VTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFS 208
Query: 171 GKLADVWSCGVTLY 184
            K +DVWS GV ++
Sbjct: 209 SK-SDVWSFGVLMW 221

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score = 41.6 bits (96), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 33/79 (41%), Positives = 42/79 (53%), Gaps = 6/79 (7%)
Query: 112 ICHRDLKLENTLLDGSPAPRLKICDFGYSK--SSLLHSRPKSTV-GTPAYIAPEVLSRRE 168
           I HRD+K  N LLD +  P  KI DFG SK  + L  +     V GT  YI PE   +  
Sbjct: 160 IIHRDVKSINILLDENFVP--KITDFGISKKGTELDQTHLXXVVKGTLGYIDPEYFIKGR 217
Query: 169 YDGKLADVWSCGVTLYVML 187
              K +DV+S GV L+ +L
Sbjct: 218 LTEK-SDVYSFGVVLFEVL 235

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 41.6 bits (96), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 60/222 (27%), Positives = 90/222 (40%), Gaps = 39/222 (17%)
Query: 6   LMKDIGSGNFGVARLMRNKN-----TKELVAMKYI-ERGHKIDANVAREIINHKQLRHPN 59
           L  ++G G FG   L    N      K LVA+K + E       +  RE      L+H +
Sbjct: 45  LKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQH 104
Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFERICNAG------RFSEDEA---------RYFF 104
           I+RF  V      L +V EY   G+L   + + G         ED A             
Sbjct: 105 IVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVA 164
Query: 105 QQLISGQI-------CHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPA 157
            Q+ +G +        HRDL   N L+       +KI DFG S+   ++S     VG   
Sbjct: 165 SQVAAGMVYLAGLHFVHRDLATRNCLV--GQGLVVKIGDFGMSRD--IYSTDYYRVGGRT 220
Query: 158 -----YIAPEVLSRREYDGKLADVWSCGVTLY-VMLVGAYPF 193
                ++ PE +  R++  + +DVWS GV L+ +   G  P+
Sbjct: 221 MLPIRWMPPESILYRKFTTE-SDVWSFGVVLWEIFTYGKQPW 261

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 41.2 bits (95), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 50/194 (25%), Positives = 81/194 (41%), Gaps = 22/194 (11%)
Query: 8   KDIGSGNFG-VARLMRNKNTKELVAMKYIERGHKIDANVAREIINH----KQLRHPNIIR 62
           K++GSGNFG V +               I +    D  +  E++      +QL +P I+R
Sbjct: 23  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 82
Query: 63  FKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSED--------EARYFFQQLISGQICH 114
              +    + + +VME A  G L  +     R  +D        +     + L      H
Sbjct: 83  MIGICEAESWM-LVMEMAELGPL-NKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVH 140
Query: 115 RDLKLENTLLDGSPAPRLKICDFGYSKSSLL---HSRPKSTVGTPA-YIAPEVLSRREYD 170
           RDL   N LL        KI DFG SK+      + + ++    P  + APE ++  ++ 
Sbjct: 141 RDLAARNVLL--VTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFS 198
Query: 171 GKLADVWSCGVTLY 184
            K +DVWS GV ++
Sbjct: 199 SK-SDVWSFGVLMW 211

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 41.2 bits (95), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 50/194 (25%), Positives = 81/194 (41%), Gaps = 22/194 (11%)
Query: 8   KDIGSGNFG-VARLMRNKNTKELVAMKYIERGHKIDANVAREIINH----KQLRHPNIIR 62
           K++GSGNFG V +               I +    D  +  E++      +QL +P I+R
Sbjct: 31  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 90
Query: 63  FKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSED--------EARYFFQQLISGQICH 114
              +    + + +VME A  G L  +     R  +D        +     + L      H
Sbjct: 91  MIGICEAESWM-LVMEMAELGPL-NKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVH 148
Query: 115 RDLKLENTLLDGSPAPRLKICDFGYSKSSLL---HSRPKSTVGTPA-YIAPEVLSRREYD 170
           RDL   N LL        KI DFG SK+      + + ++    P  + APE ++  ++ 
Sbjct: 149 RDLAARNVLL--VTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFS 206
Query: 171 GKLADVWSCGVTLY 184
            K +DVWS GV ++
Sbjct: 207 SK-SDVWSFGVLMW 219

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 41.2 bits (95), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 50/194 (25%), Positives = 81/194 (41%), Gaps = 22/194 (11%)
Query: 8   KDIGSGNFG-VARLMRNKNTKELVAMKYIERGHKIDANVAREIINH----KQLRHPNIIR 62
           K++GSGNFG V +               I +    D  +  E++      +QL +P I+R
Sbjct: 13  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 72
Query: 63  FKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSED--------EARYFFQQLISGQICH 114
              +    + + +VME A  G L  +     R  +D        +     + L      H
Sbjct: 73  MIGICEAESWM-LVMEMAELGPL-NKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVH 130
Query: 115 RDLKLENTLLDGSPAPRLKICDFGYSKSSLL---HSRPKSTVGTPA-YIAPEVLSRREYD 170
           RDL   N LL        KI DFG SK+      + + ++    P  + APE ++  ++ 
Sbjct: 131 RDLAARNVLL--VTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFS 188
Query: 171 GKLADVWSCGVTLY 184
            K +DVWS GV ++
Sbjct: 189 SK-SDVWSFGVLMW 201

>pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271

Iteration: 1
 Score = 41.2 bits (95), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 36/154 (23%), Positives = 59/154 (38%), Gaps = 21/154 (13%)
Query: 57  HPNIIRFKEVVLTPT--HLAIVMEYAAGGELFERI----------CNAGRFSEDEAR-YF 103
           HPN++       +P   H  ++  +   G L+  +            A +F+ D AR   
Sbjct: 66  HPNVLPVLGACQSPPAPHPTLITHWXPYGSLYNVLHEGTNFVVDQSQAVKFALDXARGXA 125
Query: 104 FQQLISGQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEV 163
           F   +   I    L   +  +D     R+   D  +S  S            PA++APE 
Sbjct: 126 FLHTLEPLIPRHALNSRSVXIDEDXTARISXADVKFSFQS------PGRXYAPAWVAPEA 179
Query: 164 LSRREYDG--KLADVWSCGVTLYVMLVGAYPFED 195
           L ++  D   + AD WS  V L+ ++    PF D
Sbjct: 180 LQKKPEDTNRRSADXWSFAVLLWELVTREVPFAD 213

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	344
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	0.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	1e-143
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	1e-138
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	1e-108
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	1e-107
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	1e-106
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	1e-105
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	1e-105
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	1e-104
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	1e-102
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	1e-102
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	1e-101
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	1e-101
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	1e-100
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	3e-99
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	9e-99
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	1e-97
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	1e-96
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	3e-92
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	1e-83
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	2e-83
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	3e-83
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	1e-82
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	1e-82
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	6e-82
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	1e-81
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	9e-81
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	2e-80
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	3e-80
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	1e-79
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	5e-79
3bhy_A	283	Death-associated protein kinase 3; death associate	7e-79
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	1e-78
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	2e-78
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	4e-78
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	6e-78
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	1e-77
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	1e-77
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	2e-77
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	3e-77
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	3e-77
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	4e-77
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	9e-77
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	2e-76
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	3e-76
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	3e-76
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	4e-76
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	5e-76
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	1e-75
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	2e-75
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	8e-75
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	1e-74
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	3e-74
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	6e-74
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	2e-73
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	7e-73
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	9e-73
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	1e-72
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	2e-72
2a19_B	284	Interferon-induced, double-stranded RNA-activated	2e-72
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	3e-72
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	8e-72
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	3e-69
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	3e-68
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	2e-67
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	1e-63
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	1e-63
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	6e-63
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	2e-61
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	1e-60
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	1e-58
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	2e-58
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	2e-58
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	3e-58
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	4e-58
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	1e-57
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	3e-57
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	2e-56
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	4e-56
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	5e-56
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	7e-56
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	1e-55
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	2e-55
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	4e-55
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	4e-55
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	1e-54
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	1e-54
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	1e-54
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	3e-54
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	1e-53
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	1e-53
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	2e-53
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	4e-53
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	6e-53
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	6e-52
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	2e-51
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	2e-49
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	3e-46
2dyl_A	318	Dual specificity mitogen-activated protein kinase	7e-45
3fme_A	290	Dual specificity mitogen-activated protein kinase;	1e-43
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	2e-43
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	2e-42
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	3e-42
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	5e-42
3an0_A	340	Dual specificity mitogen-activated protein kinase;	7e-42
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	7e-42
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	8e-42
3aln_A	327	Dual specificity mitogen-activated protein kinase;	1e-41
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	2e-41
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	3e-39
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	2e-10
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	5e-39
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	8e-38
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	8e-38
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	1e-37
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	1e-37
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	2e-37
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	2e-37
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	3e-37
3o0g_A	292	Cell division protein kinase 5; kinase activator c	4e-37
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	1e-36
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	1e-36
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	2e-36
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	3e-36
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	1e-35
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	2e-35
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	4e-35
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	2e-34
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	2e-34
3niz_A	311	Rhodanese family protein; structural genomics, str	3e-34
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	3e-34
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	6e-34
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	6e-34
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	1e-33
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	4e-33
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	2e-32
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	6e-32
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	8e-32
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	1e-31
3q4u_A	301	Activin receptor type-1; structural genomics conso	1e-31
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	2e-31
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	2e-31
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	4e-31
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	4e-31
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	7e-31
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	3e-30
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	4e-30
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	5e-30
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	1e-29
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	2e-29
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	3e-29
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	3e-29
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	7e-29
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	2e-28
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	3e-27
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	1e-26
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	1e-26
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	2e-26
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	3e-26
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	9e-25
3soc_A	322	Activin receptor type-2A; structural genomics cons	2e-24
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	2e-23
3rp9_A	458	Mitogen-activated protein kinase; structural genom	4e-23
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	4e-23
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	4e-23
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	1e-22
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	1e-22
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	1e-21
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	2e-21
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	2e-21
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	2e-21
3ork_A	311	Serine/threonine protein kinase; structural genomi	4e-21
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	4e-21
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	1e-20
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	1e-20
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	1e-20
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	4e-20
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	5e-20
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	2e-19
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	6e-19
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	1e-18
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	1e-18
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	2e-18
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	2e-18
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	2e-18
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	4e-18
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	4e-18
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	6e-18
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	7e-18
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	2e-17
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	2e-17
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	2e-17
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	2e-17
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	2e-17
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	2e-17
3uqc_A	286	Probable conserved transmembrane protein; structur	3e-17
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	3e-17
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	5e-17
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	5e-17
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	6e-17
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	6e-17
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	7e-17
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	1e-16
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	1e-16
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	1e-16
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	2e-16
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	4e-16
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	2e-15
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	2e-15
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	2e-15
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	2e-15
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	4e-15
3pls_A	298	Macrophage-stimulating protein receptor; protein k	2e-14
4aoj_A	329	High affinity nerve growth factor receptor; transf	3e-14
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	5e-14
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	5e-14
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	1e-13
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	2e-13
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	2e-13
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	2e-13
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	8e-13
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	8e-13
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	1e-12
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	3e-12
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	6e-12
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	4e-10
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	7e-10
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	1e-09
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	2e-09
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	4e-09
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	4e-09
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	1e-08
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	1e-07
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	3e-07
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	4e-06
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	2e-05
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	2e-04
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	8e-04

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score =  508 bits (1309), Expect = 0.0
 Identities = 221/333 (66%), Positives = 269/333 (80%), Gaps = 8/333 (2%)

Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNI 60
            ++Y+ +KDIGSGNFGVARLMR+K TKELVA+KYIERG  ID NV REIINH+ LRHPNI
Sbjct: 19  SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNI 78

Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-------QIC 113
           +RFKEV+LTPTHLAI+MEYA+GGEL+ERICNAGRFSEDEAR+FFQQL+SG       QIC
Sbjct: 79  VRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQIC 138

Query: 114 HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKL 173
           HRDLKLENTLLDGSPAPRLKICDFGYSKSS+LHS+PKSTVGTPAYIAPEVL R+EYDGK+
Sbjct: 139 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRQEYDGKI 198

Query: 174 ADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRI 233
           ADVWSCGVTLYVMLVGAYPFED E+P+++RKTI RI++V+Y IPD + IS +C +L+SRI
Sbjct: 199 ADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRISPECCHLISRI 258

Query: 234 FVANPSRRITIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTFSLQSVEEITKIVEEAK 293
           FVA+P+ RI+I EIK+H WFLKNLP +L   +      +E P   +QS++ I +I+ EA 
Sbjct: 259 FVADPATRISIPEIKTHSWFLKNLPADLMNESNTGSQFQE-PEQPMQSLDTIMQIISEAT 317

Query: 294 VPPPVSRSIGGFGWGGEEDGDEKEEETDADEED 326
           +P   +R +  F     +  D+ ++     E D
Sbjct: 318 IPAVRNRCLDDFMTDNLDLDDDMDDFDSESEID 350

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score =  407 bits (1047), Expect = e-143
 Identities = 102/328 (31%), Positives = 159/328 (48%), Gaps = 30/328 (9%)

Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDA--NVAREIINHKQLRHP 58
           +E ++L++ +G G +G  +L  N+ T+E VA+K ++    +D   N+ +EI  +K L H 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 65

Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-------Q 111
           N+++F           + +EY +GGELF+RI       E +A+ FF QL++G        
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 125

Query: 112 ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP---KSTVGTPAYIAPEVLSRRE 168
           I HRD+K EN LLD      LKI DFG +     ++R        GT  Y+APE+L RRE
Sbjct: 126 ITHRDIKPENLLLDER--DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183

Query: 169 YDGKLADVWSCGVTLYVMLVGAYPFEDQEDP-KNFRKTISRIMAVQYKIPDYVHISQDCR 227
           +  +  DVWSCG+ L  ML G  P++   D  + +     +    +  +  +  I     
Sbjct: 184 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEK----KTYLNPWKKIDSAPL 239

Query: 228 NLLSRIFVANPSRRITIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTF---SLQSVEE 284
            LL +I V NPS RITI +IK   W+ K L +             E+P+     +QS  +
Sbjct: 240 ALLHKILVENPSARITIPDIKKDRWYNKPLKKGAKRPRVTSGGVSESPSGFSKHIQSNLD 299

Query: 285 ITKIVEEAKVPPPVSRSIGGFGWGGEED 312
            + +   ++ P        G GW  E  
Sbjct: 300 FSPVNSASRTP--------GSGWSKEHH 319

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score =  393 bits (1012), Expect = e-138
 Identities = 93/274 (33%), Positives = 142/274 (51%), Gaps = 19/274 (6%)

Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDA--NVAREIINHKQLRHP 58
           +E ++L++ +G G +G  +L  N+ T+E VA+K ++    +D   N+ +EI  +K L H 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 65

Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-------Q 111
           N+++F           + +EY +GGELF+RI       E +A+ FF QL++G        
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 125

Query: 112 ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP---KSTVGTPAYIAPEVLSRRE 168
           I HRD+K EN LLD      LKI DFG +     ++R        GT  Y+APE+L RRE
Sbjct: 126 ITHRDIKPENLLLDER--DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183

Query: 169 YDGKLADVWSCGVTLYVMLVGAYPFEDQEDP-KNFRKTISRIMAVQYKIPDYVHISQDCR 227
           +  +  DVWSCG+ L  ML G  P++   D  + +     +    +  +  +  I     
Sbjct: 184 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEK----KTYLNPWKKIDSAPL 239

Query: 228 NLLSRIFVANPSRRITIKEIKSHPWFLKNLPREL 261
            LL +I V NPS RITI +IK   W+ K L +  
Sbjct: 240 ALLHKILVENPSARITIPDIKKDRWYNKPLKKGA 273

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score =  317 bits (814), Expect = e-108
 Identities = 107/276 (38%), Positives = 149/276 (53%), Gaps = 27/276 (9%)

Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDAN----VAREIINHKQLR 56
           +  Y L   +G G FG  ++  ++ T   VA+K + R      +    + REI N K  R
Sbjct: 10  IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFR 69

Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG------ 110
           HP+II+  +V+ TPT   +VMEY +GGELF+ IC  GR  E EAR  FQQ++S       
Sbjct: 70  HPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHR 129

Query: 111 -QICHRDLKLENTLLDGSPAPRLKICDFGYS----KSSLLHSRPKSTVGTPAYIAPEVLS 165
             + HRDLK EN LLD       KI DFG S        L     ++ G+P Y APEV+S
Sbjct: 130 HMVVHRDLKPENVLLDAH--MNAKIADFGLSNMMSDGEFLR----TSCGSPNYAAPEVIS 183

Query: 166 RREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQD 225
            R Y G   D+WSCGV LY +L G  PF+D+  P  F+K    I    + IP+  ++++ 
Sbjct: 184 GRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKK----IRGGVFYIPE--YLNRS 237

Query: 226 CRNLLSRIFVANPSRRITIKEIKSHPWFLKNLPREL 261
              LL  +   +P +R TIK+I+ H WF ++LP  L
Sbjct: 238 VATLLMHMLQVDPLKRATIKDIREHEWFKQDLPSYL 273

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score =  312 bits (801), Expect = e-106
 Identities = 100/271 (36%), Positives = 147/271 (54%), Gaps = 18/271 (6%)

Query: 3   KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDAN---VAREIINHKQLRHPN 59
            Y L+K IG GNF   +L R+  T   VA+K I++      +   + RE+   K L HPN
Sbjct: 16  NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPN 75

Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-------QI 112
           I++  EV+ T   L ++MEYA+GGE+F+ +   GR  E EAR  F+Q++S        +I
Sbjct: 76  IVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRI 135

Query: 113 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGK 172
            HRDLK EN LLD      +KI DFG+S    +  +  +  G P Y APE+   ++YDG 
Sbjct: 136 VHRDLKAENLLLDAD--MNIKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQGKKYDGP 193

Query: 173 LADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSR 232
             DVWS GV LY ++ G+ PF+ Q   +   +    ++  +Y+IP Y+  S DC NLL R
Sbjct: 194 EVDVWSLGVILYTLVSGSLPFDGQNLKELRER----VLRGKYRIPFYM--STDCENLLKR 247

Query: 233 IFVANPSRRITIKEIKSHPWFLKNLPRELTE 263
             V NP +R T+++I    W       +  +
Sbjct: 248 FLVLNPIKRGTLEQIMKDRWINAGHEEDELK 278

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score =  311 bits (798), Expect = e-105
 Identities = 115/274 (41%), Positives = 162/274 (59%), Gaps = 28/274 (10%)

Query: 3   KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERG----HKIDANVAREIINHKQLRHP 58
            Y + + +G G+FG  +L  +  T++ VA+K+I R       +   V REI   K LRHP
Sbjct: 10  PYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHP 69

Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-------Q 111
           +II+  +V+ TPT + +V+EYA GGELF+ I    R +EDE R FFQQ+I         +
Sbjct: 70  HIIKLYDVITTPTDIVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHK 128

Query: 112 ICHRDLKLENTLLDGSPAPRLKICDFGYS----KSSLLHSRPKSTVGTPAYIAPEVLSRR 167
           I HRDLK EN LLD +    +KI DFG S      + L +    + G+P Y APEV++ +
Sbjct: 129 IVHRDLKPENLLLDDNL--NVKIADFGLSNIMTDGNFLKT----SCGSPNYAAPEVINGK 182

Query: 168 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCR 227
            Y G   DVWSCG+ LYVMLVG  PF+D+  P  F+K    + +  Y +PD   +S   +
Sbjct: 183 LYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKK----VNSCVYVMPD--FLSPGAQ 236

Query: 228 NLLSRIFVANPSRRITIKEIKSHPWFLKNLPREL 261
           +L+ R+ VA+P +RITI+EI+  PWF  NLP  L
Sbjct: 237 SLIRRMIVADPMQRITIQEIRRDPWFNVNLPDYL 270

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score =  315 bits (809), Expect = e-105
 Identities = 106/277 (38%), Positives = 151/277 (54%), Gaps = 29/277 (10%)

Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDAN-----VAREIINHKQL 55
           +  Y L   +G G FG  ++ +++ T   VA+K + R  KI +      + REI N K  
Sbjct: 15  IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNR-QKIRSLDVVGKIRREIQNLKLF 73

Query: 56  RHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG----- 110
           RHP+II+  +V+ TP+ + +VMEY +GGELF+ IC  GR  E E+R  FQQ++SG     
Sbjct: 74  RHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCH 133

Query: 111 --QICHRDLKLENTLLDGSPAPRLKICDFGYS----KSSLLHSRPKSTVGTPAYIAPEVL 164
              + HRDLK EN LLD       KI DFG S        L     ++ G+P Y APEV+
Sbjct: 134 RHMVVHRDLKPENVLLDAH--MNAKIADFGLSNMMSDGEFLR----TSCGSPNYAAPEVI 187

Query: 165 SRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQ 224
           S R Y G   D+WS GV LY +L G  PF+D   P  F+K    I    +  P   +++ 
Sbjct: 188 SGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKK----ICDGIFYTPQ--YLNP 241

Query: 225 DCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLPREL 261
              +LL  +   +P +R TIK+I+ H WF ++LP+ L
Sbjct: 242 SVISLLKHMLQVDPMKRATIKDIREHEWFKQDLPKYL 278

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  306 bits (786), Expect = e-104
 Identities = 81/278 (29%), Positives = 130/278 (46%), Gaps = 22/278 (7%)

Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERG----HKIDANVAREIINHKQLR 56
             +Y   + +G G F     + + +TKE+ A K + +           ++ EI  H+ L 
Sbjct: 14  RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLA 73

Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG------ 110
           H +++ F         + +V+E      L E        +E EARY+ +Q++ G      
Sbjct: 74  HQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHR 133

Query: 111 -QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTV-GTPAYIAPEVLSRRE 168
            ++ HRDLKL N  L+      +KI DFG +         K  + GTP YIAPEVLS++ 
Sbjct: 134 NRVIHRDLKLGNLFLNED--LEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKG 191

Query: 169 YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRN 228
           +  +  DVWS G  +Y +LVG  PFE        ++T  RI   +Y IP   HI+    +
Sbjct: 192 HSFE-VDVWSIGCIMYTLLVGKPPFET----SCLKETYLRIKKNEYSIPK--HINPVAAS 244

Query: 229 LLSRIFVANPSRRITIKEIKSHPWFLKN-LPRELTETA 265
           L+ ++   +P+ R TI E+ +  +F    +P  L  T 
Sbjct: 245 LIQKMLQTDPTARPTINELLNDEFFTSGYIPARLPITC 282

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  303 bits (779), Expect = e-102
 Identities = 81/278 (29%), Positives = 130/278 (46%), Gaps = 22/278 (7%)

Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERG----HKIDANVAREIINHKQLR 56
             +Y   + +G G F     + + +TKE+ A K + +           ++ EI  H+ L 
Sbjct: 40  RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLA 99

Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG------ 110
           H +++ F         + +V+E      L E        +E EARY+ +Q++ G      
Sbjct: 100 HQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHR 159

Query: 111 -QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTV-GTPAYIAPEVLSRRE 168
            ++ HRDLKL N  L+      +KI DFG +         K  + GTP YIAPEVLS++ 
Sbjct: 160 NRVIHRDLKLGNLFLNED--LEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKG 217

Query: 169 YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRN 228
           +  +  DVWS G  +Y +LVG  PFE        ++T  RI   +Y IP   HI+    +
Sbjct: 218 HSFE-VDVWSIGCIMYTLLVGKPPFET----SCLKETYLRIKKNEYSIPK--HINPVAAS 270

Query: 229 LLSRIFVANPSRRITIKEIKSHPWFLKN-LPRELTETA 265
           L+ ++   +P+ R TI E+ +  +F    +P  L  T 
Sbjct: 271 LIQKMLQTDPTARPTINELLNDEFFTSGYIPARLPITC 308

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score =  302 bits (775), Expect = e-102
 Identities = 80/283 (28%), Positives = 126/283 (44%), Gaps = 37/283 (13%)

Query: 3   KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH-----KIDANVAREIINHKQLRH 57
           KY +   +G G++G  + + +  T    A+K +++         +ANV +EI   ++LRH
Sbjct: 6   KYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRH 65

Query: 58  PNIIRFKEVVL--TPTHLAIVMEYAAGG--ELFERICNAGRFSEDEARYFFQQLISG--- 110
            N+I+  +V+       + +VMEY   G  E+ + +    RF   +A  +F QLI G   
Sbjct: 66  KNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPE-KRFPVCQAHGYFCQLIDGLEY 124

Query: 111 ----QICHRDLKLENTLLDGSPAPRLKICDFGYS-------KSSLLHSRPKSTVGTPAYI 159
                I H+D+K  N LL       LKI   G +             +    + G+PA+ 
Sbjct: 125 LHSQGIVHKDIKPGNLLLTTGG--TLKISALGVAEALHPFAADDTCRT----SQGSPAFQ 178

Query: 160 APEVLS-RREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPD 218
            PE+ +    + G   D+WS GVTLY +  G YPFE      N  K    I    Y IP 
Sbjct: 179 PPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGD----NIYKLFENIGKGSYAIPG 234

Query: 219 YVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLPREL 261
                    +LL  +    P++R +I++I+ H WF K  P   
Sbjct: 235 D--CGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHPPAE 275

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score =  299 bits (768), Expect = e-101
 Identities = 100/296 (33%), Positives = 144/296 (48%), Gaps = 54/296 (18%)

Query: 3   KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKID-------------------- 42
           +Y L  +IG G++GV +L  N+N     AMK + +   I                     
Sbjct: 14  QYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGC 73

Query: 43  -------ANVAREIINHKQLRHPNIIRFKEVVLTPT--HLAIVMEYAAGGELFERICNAG 93
                    V +EI   K+L HPN+++  EV+  P   HL +V E    G + E +    
Sbjct: 74  IQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVME-VPTLK 132

Query: 94  RFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYS-----K 141
             SED+AR++FQ LI G       +I HRD+K  N L+       +KI DFG S      
Sbjct: 133 PLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDG--HIKIADFGVSNEFKGS 190

Query: 142 SSLLHSRPKSTVGTPAYIAPEVLS--RREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDP 199
            +LL +    TVGTPA++APE LS  R+ + GK  DVW+ GVTLY  + G  PF D+   
Sbjct: 191 DALLSN----TVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIM 246

Query: 200 KNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLK 255
               K    I +   + PD   I++D ++L++R+   NP  RI + EIK HPW  +
Sbjct: 247 CLHSK----IKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVTR 298

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  297 bits (764), Expect = e-101
 Identities = 76/278 (27%), Positives = 140/278 (50%), Gaps = 22/278 (7%)

Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERG----HKIDANVAREIINHKQLR 56
           +E +++   +G G+F       + +T   VA+K I++       +   V  E+  H QL+
Sbjct: 10  IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLK 69

Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICN-AGRFSEDEARYFFQQLISG----- 110
           HP+I+          ++ +V+E    GE+   + N    FSE+EAR+F  Q+I+G     
Sbjct: 70  HPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLH 129

Query: 111 --QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTV-GTPAYIAPEVLSRR 167
              I HRDL L N LL  +    +KI DFG +    +      T+ GTP YI+PE+ +R 
Sbjct: 130 SHGILHRDLTLSNLLLTRN--MNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIATRS 187

Query: 168 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCR 227
            +  + +DVWS G   Y +L+G  PF+        + T+++++   Y++P    +S + +
Sbjct: 188 AHGLE-SDVWSLGCMFYTLLIGRPPFDT----DTVKNTLNKVVLADYEMPS--FLSIEAK 240

Query: 228 NLLSRIFVANPSRRITIKEIKSHPWFLKNLPRELTETA 265
           +L+ ++   NP+ R+++  +  HP+  +N   +  +  
Sbjct: 241 DLIHQLLRRNPADRLSLSSVLDHPFMSRNSSTKSKDEG 278

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  296 bits (761), Expect = e-100
 Identities = 81/279 (29%), Positives = 139/279 (49%), Gaps = 21/279 (7%)

Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERG----HKIDANVAREIINHKQLR 56
           ++ +++ + +G G FG   L R K  K ++A+K + +       ++  + REI     LR
Sbjct: 13  IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLR 72

Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG------ 110
           HPNI+R          + +++E+A  GEL++ +   GRF E  +  F ++L         
Sbjct: 73  HPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHE 132

Query: 111 -QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREY 169
            ++ HRD+K EN L+       LKI DFG+S  +    R ++  GT  Y+ PE++  + +
Sbjct: 133 RKVIHRDIKPENLLMGYK--GELKIADFGWSVHA-PSLRRRTMCGTLDYLPPEMIEGKTH 189

Query: 170 DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 229
           D K  D+W  GV  Y  LVG  PF+     +  R+    I+ V  K P ++  S   ++L
Sbjct: 190 DEK-VDLWCAGVLCYEFLVGMPPFDSPSHTETHRR----IVNVDLKFPPFL--SDGSKDL 242

Query: 230 LSRIFVANPSRRITIKEIKSHPWFLKNLPRELTETAQAI 268
           +S++   +P +R+ +K +  HPW   N  R L    Q+ 
Sbjct: 243 ISKLLRYHPPQRLPLKGVMEHPWVKANSRRVLPPVYQST 281

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  293 bits (753), Expect = 3e-99
 Identities = 85/273 (31%), Positives = 139/273 (50%), Gaps = 21/273 (7%)

Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERG----HKIDANVAREIINHKQLR 56
           +E +E+ + +G G FG   L R K +K ++A+K + +       ++  + RE+     LR
Sbjct: 8   LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 67

Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG------ 110
           HPNI+R        T + +++EYA  G ++  +    +F E     +  +L +       
Sbjct: 68  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 127

Query: 111 -QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREY 169
            ++ HRD+K EN LL  +    LKI DFG+S  +   SR     GT  Y+ PE++  R +
Sbjct: 128 KRVIHRDIKPENLLLGSA--GELKIADFGWSVHA-PSSRRTDLCGTLDYLPPEMIEGRMH 184

Query: 170 DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 229
           D K  D+WS GV  Y  LVG  PFE       +++T  RI  V++  PD   +++  R+L
Sbjct: 185 DEK-VDLWSLGVLCYEFLVGKPPFEA----NTYQETYKRISRVEFTFPD--FVTEGARDL 237

Query: 230 LSRIFVANPSRRITIKEIKSHPWFLKNLPRELT 262
           +SR+   NPS+R  ++E+  HPW   N  +   
Sbjct: 238 ISRLLKHNPSQRPMLREVLEHPWITANSSKPSN 270

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score =  293 bits (753), Expect = 9e-99
 Identities = 80/283 (28%), Positives = 125/283 (44%), Gaps = 40/283 (14%)

Query: 3   KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDAN--------VAREIINHKQ 54
           +Y++   +GSG FG        +    VA+K++E+  +I           V  E++  K+
Sbjct: 44  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEK-DRISDWGELPNGTRVPMEVVLLKK 102

Query: 55  LRH--PNIIRFKEVVLTPTHLAIVMEYAAG-GELFERICNAGRFSEDEARYFFQQLISG- 110
           +      +IR  +    P    +++E      +LF+ I   G   E+ AR FF Q++   
Sbjct: 103 VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAV 162

Query: 111 ------QICHRDLKLENTLLDGSPAPRLKICDFGYS---KSSLLHSRPKSTVGTPAYIAP 161
                  + HRD+K EN L+D +    LK+ DFG     K ++         GT  Y  P
Sbjct: 163 RHCHNCGVLHRDIKDENILIDLNRG-ELKLIDFGSGALLKDTVYTD----FDGTRVYSPP 217

Query: 162 EVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVH 221
           E +    Y G+ A VWS G+ LY M+ G  PFE  E           I+  Q        
Sbjct: 218 EWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE----------EIIRGQVFFRQ--R 265

Query: 222 ISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLK-NLPRELTE 263
           +S +C++L+       PS R T +EI++HPW     LP+E  E
Sbjct: 266 VSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAE 308

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score =  290 bits (745), Expect = 1e-97
 Identities = 75/278 (26%), Positives = 109/278 (39%), Gaps = 39/278 (14%)

Query: 3   KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKID-------ANVAREIINHKQL 55
           +Y L   +G G FG          +  VA+K I R   +             E+    ++
Sbjct: 32  EYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKV 91

Query: 56  R----HPNIIRFKEVVLTPTHLAIVMEYAA-GGELFERICNAGRFSEDEARYFFQQLISG 110
                HP +IR  +   T     +V+E      +LF+ I   G   E  +R FF Q+++ 
Sbjct: 92  GAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAA 151

Query: 111 -------QICHRDLKLENTLLDGSPAPRLKICDFGYS---KSSLLHSRPKSTVGTPAYIA 160
                   + HRD+K EN L+D       K+ DFG                  GT  Y  
Sbjct: 152 IQHCHSRGVVHRDIKDENILIDLRRG-CAKLIDFGSGALLHDEPYTD----FDGTRVYSP 206

Query: 161 PEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYV 220
           PE +SR +Y    A VWS G+ LY M+ G  PFE  +           I+  +   P   
Sbjct: 207 PEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ----------EILEAELHFPA-- 254

Query: 221 HISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLP 258
           H+S DC  L+ R     PS R +++EI   PW      
Sbjct: 255 HVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPAE 292

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score =  288 bits (740), Expect = 1e-96
 Identities = 76/279 (27%), Positives = 121/279 (43%), Gaps = 39/279 (13%)

Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIER---------GHKIDANVAREIIN 51
            +KY  M  +GSG FG      +K   + V +K+I++                V  EI  
Sbjct: 23  SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAI 82

Query: 52  HKQLRHPNIIRFKEVVLTPTHLAIVMEYAA-GGELFERICNAGRFSEDEARYFFQQLISG 110
             ++ H NII+  ++        +VME    G +LF  I    R  E  A Y F+QL+S 
Sbjct: 83  LSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSA 142

Query: 111 -------QICHRDLKLENTLLDGSPAPRLKICDFGYS----KSSLLHSRPKSTVGTPAYI 159
                   I HRD+K EN ++       +K+ DFG +    +  L ++      GT  Y 
Sbjct: 143 VGYLRLKDIIHRDIKDENIVIAEDF--TIKLIDFGSAAYLERGKLFYT----FCGTIEYC 196

Query: 160 APEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDY 219
           APEVL    Y G   ++WS GVTLY ++    PF +          +   +      P  
Sbjct: 197 APEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCE----------LEETVEAAIHPPYL 246

Query: 220 VHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLP 258
           V  S++  +L+S +    P RR T++++ + PW  + + 
Sbjct: 247 V--SKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQPVN 283

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  278 bits (713), Expect = 3e-92
 Identities = 57/329 (17%), Positives = 114/329 (34%), Gaps = 66/329 (20%)

Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIER------------------GHKID 42
           +  Y +++ +  G F    L       +  A+K  E+                       
Sbjct: 30  INDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKY 87

Query: 43  ANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAG--------R 94
            +   E+     +++   +  + ++     + I+ EY     + +               
Sbjct: 88  DDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCF 147

Query: 95  FSEDEARYFFQQLISG--------QICHRDLKLENTLLDGSPAPRLKICDFGYSK---SS 143
                 +   + +++          ICHRD+K  N L+D +   R+K+ DFG S+     
Sbjct: 148 IPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKN--GRVKLSDFGESEYMVDK 205

Query: 144 LLHSRPKSTVGTPAYIAPEVLSRRE-YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNF 202
            +      + GT  ++ PE  S    Y+G   D+WS G+ LYVM     PF  +    + 
Sbjct: 206 KIK----GSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKI---SL 258

Query: 203 RKTISRIMAVQYKIPDYV-----------------HISQDCRNLLSRIFVANPSRRITIK 245
            +  + I     + P                     +S +  + L      NP+ RIT +
Sbjct: 259 VELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSE 318

Query: 246 EIKSHPWFLKNLPRELTETAQAIYYRKEN 274
           +   H W       +L E ++ +Y +++ 
Sbjct: 319 DALKHEWLADTNIEDLREFSKELYKKRKK 347

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  254 bits (652), Expect = 1e-83
 Identities = 64/281 (22%), Positives = 113/281 (40%), Gaps = 33/281 (11%)

Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDA---NVAREIINHKQLRH 57
              Y ++K IGSG       + N+  K++ A+KY+      +    +   EI    +L+ 
Sbjct: 27  GRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQ 85

Query: 58  PN--IIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG----- 110
            +  IIR  +  +T  ++ +VME     +L   +         E + +++ ++       
Sbjct: 86  HSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIH 144

Query: 111 --QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP---KSTVGTPAYIAPEVLS 165
              I H DLK  N L+       LK+ DFG +      +      S VGT  Y+ PE + 
Sbjct: 145 QHGIVHSDLKPANFLIVDG---MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIK 201

Query: 166 RREYD----------GKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYK 215
                             +DVWS G  LY M  G  PF+   +       +  I+   ++
Sbjct: 202 DMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI---SKLHAIIDPNHE 258

Query: 216 IPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKN 256
           I       +D +++L      +P +RI+I E+ +HP+    
Sbjct: 259 IEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ 299

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  253 bits (648), Expect = 2e-83
 Identities = 90/268 (33%), Positives = 129/268 (48%), Gaps = 17/268 (6%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDAN-VAREIINHKQLRHPNI 60
           + Y L   IG G++G  ++   K T+   A K I +    D +   +EI   K L HPNI
Sbjct: 9   QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNI 68

Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-------QIC 113
           IR  E     T + +VME   GGELFER+ +   F E +A    + ++S         + 
Sbjct: 69  IRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVA 128

Query: 114 HRDLKLENTLLDG-SPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGK 172
           HRDLK EN L    SP   LK+ DFG +         ++ VGTP Y++P+VL    Y G 
Sbjct: 129 HRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVL-EGLY-GP 186

Query: 173 LADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKI--PDYVHISQDCRNLL 230
             D WS GV +YV+L G  PF    D +   K    I    +     D++++S    +L+
Sbjct: 187 ECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLK----IREGTFTFPEKDWLNVSPQAESLI 242

Query: 231 SRIFVANPSRRITIKEIKSHPWFLKNLP 258
            R+   +P +RIT  +   H WF K L 
Sbjct: 243 RRLLTKSPKQRITSLQALEHEWFEKQLS 270

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  254 bits (650), Expect = 3e-83
 Identities = 61/304 (20%), Positives = 111/304 (36%), Gaps = 46/304 (15%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDA--NVAREIINHKQLRHPN 59
             + L   +G G        R+K T +L A+K       +       RE    K+L H N
Sbjct: 9   HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKN 68

Query: 60  IIRFKEVV--LTPTHLAIVMEYAAGGELFERIC---NAGRFSEDEARYFFQQLISG---- 110
           I++   +    T  H  ++ME+   G L+  +    NA    E E     + ++ G    
Sbjct: 69  IVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHL 128

Query: 111 ---QICHRDLKLENTLLDGSPAPR--LKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLS 165
               I HR++K  N +       +   K+ DFG ++      +  S  GT  Y+ P++  
Sbjct: 129 RENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYE 188

Query: 166 RREYD-------GKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQY---- 214
           R           G   D+WS GVT Y    G+ PF   E P+  ++ + +I+  +     
Sbjct: 189 RAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAI 248

Query: 215 ---------------KIPDYVHISQDCRN----LLSRIFVANPSRRITIKEIKSHPWFLK 255
                           +P    +S+  +     +L+ I  A+  +     +  +    + 
Sbjct: 249 SGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDIL 308

Query: 256 NLPR 259
           +   
Sbjct: 309 HRGN 312

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  256 bits (655), Expect = 1e-82
 Identities = 82/278 (29%), Positives = 126/278 (45%), Gaps = 21/278 (7%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIER---------GHKIDANVAREIINH 52
           ++Y + K +GSG  G  +L   + T + VA++ I +               NV  EI   
Sbjct: 135 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEIL 194

Query: 53  KQLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-- 110
           K+L HP II+ K       +  IV+E   GGELF+++    R  E   + +F Q++    
Sbjct: 195 KKLNHPCIIKIKNFFDAEDYY-IVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQ 253

Query: 111 -----QICHRDLKLENTLLDG-SPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVL 164
                 I HRDLK EN LL        +KI DFG+SK     S  ++  GTP Y+APEVL
Sbjct: 254 YLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVL 313

Query: 165 SRREYD--GKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHI 222
                    +  D WS GV L++ L G  PF +     + +  I+      +    +  +
Sbjct: 314 VSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITS-GKYNFIPEVWAEV 372

Query: 223 SQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLPRE 260
           S+   +L+ ++ V +P  R T +E   HPW      + 
Sbjct: 373 SEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKR 410

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score =  252 bits (646), Expect = 1e-82
 Identities = 85/274 (31%), Positives = 126/274 (45%), Gaps = 27/274 (9%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIER---------GHKIDANVAREIINH 52
           ++Y + K +GSG  G  +L   + T + VA+K I +               NV  EI   
Sbjct: 10  DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEIL 69

Query: 53  KQLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-- 110
           K+L HP II+ K       +  IV+E   GGELF+++    R  E   + +F Q++    
Sbjct: 70  KKLNHPCIIKIKNFFDAEDYY-IVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQ 128

Query: 111 -----QICHRDLKLENTLLDG-SPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVL 164
                 I HRDLK EN LL        +KI DFG+SK     S  ++  GTP Y+APEVL
Sbjct: 129 YLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVL 188

Query: 165 SRREYD--GKLADVWSCGVTLYVMLVGAYPFEDQEDPKN-FRKTISRIMAVQYKIPDYV- 220
                    +  D WS GV L++ L G  PF +     +   +    I + +Y     V 
Sbjct: 189 VSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQ----ITSGKYNFIPEVW 244

Query: 221 -HISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 253
             +S+   +L+ ++ V +P  R T +E   HPW 
Sbjct: 245 AEVSEKALDLVKKLLVVDPKARFTTEEALRHPWL 278

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  251 bits (644), Expect = 6e-82
 Identities = 64/282 (22%), Positives = 114/282 (40%), Gaps = 33/282 (11%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDA---NVAREIINHKQLRHP 58
             Y ++K IGSG       + N+  K++ A+KY+      +    +   EI    +L+  
Sbjct: 9   RIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQH 67

Query: 59  N--IIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG------ 110
           +  IIR  +  +T  ++ +VME     +L   +         E + +++ ++        
Sbjct: 68  SDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ 126

Query: 111 -QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP---KSTVGTPAYIAPEVLSR 166
             I H DLK  N L+       LK+ DFG +      +      S VGT  Y+ PE +  
Sbjct: 127 HGIVHSDLKPANFLIVDG---MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKD 183

Query: 167 REYD----------GKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKI 216
                            +DVWS G  LY M  G  PF+   +  +    +  I+   ++I
Sbjct: 184 MSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS---KLHAIIDPNHEI 240

Query: 217 PDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLP 258
                  +D +++L      +P +RI+I E+ +HP+      
Sbjct: 241 EFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTH 282

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  248 bits (636), Expect = 1e-81
 Identities = 80/271 (29%), Positives = 131/271 (48%), Gaps = 18/271 (6%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIER---GHKIDANVAREIINHKQLRHP 58
           + Y++ +++G G F V R   +K T    A K I       +    + RE    ++L+HP
Sbjct: 6   DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHP 65

Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-------Q 111
           NI+R  + +   +   +V +   GGELFE I     +SE +A +  QQ++          
Sbjct: 66  NIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNG 125

Query: 112 ICHRDLKLENTLL-DGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYD 170
           I HR+LK EN LL   +    +K+ DFG +             GTP Y++PEVL +  Y 
Sbjct: 126 IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPY- 184

Query: 171 GKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQY--KIPDYVHISQDCRN 228
            K  D+W+CGV LY++LVG  PF D++  + + +    I A  Y    P++  ++ + ++
Sbjct: 185 SKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQ----IKAGAYDYPSPEWDTVTPEAKS 240

Query: 229 LLSRIFVANPSRRITIKEIKSHPWFLKNLPR 259
           L+  +   NP +RIT  +    PW       
Sbjct: 241 LIDSMLTVNPKKRITADQALKVPWICNRERV 271

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  250 bits (639), Expect = 9e-81
 Identities = 68/318 (21%), Positives = 126/318 (39%), Gaps = 34/318 (10%)

Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDA---NVAREIINHKQLRH 57
              Y ++K IGSG       + N+  K++ A+KY+      +    +   EI    +L+ 
Sbjct: 55  GRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQ 113

Query: 58  PN--IIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG----- 110
            +  IIR  +  +T  ++ +VME     +L   +         E + +++ ++       
Sbjct: 114 HSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIH 172

Query: 111 --QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP---KSTVGTPAYIAPEVLS 165
              I H DLK  N L+       LK+ DFG +      +      S VG   Y+ PE + 
Sbjct: 173 QHGIVHSDLKPANFLIVDG---MLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIK 229

Query: 166 RREYD----------GKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYK 215
                             +DVWS G  LY M  G  PF+   +  +    +  I+   ++
Sbjct: 230 DMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS---KLHAIIDPNHE 286

Query: 216 IPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLPRELTETAQAIYYRKENP 275
           I       +D +++L      +P +RI+I E+ +HP+  +     + + A+      +  
Sbjct: 287 IEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYV-QIQTHPVNQMAKGTTEEMKYV 345

Query: 276 TFSLQSVEEITKIVEEAK 293
              L  +     I++ AK
Sbjct: 346 LGQLVGLNSPNSILKAAK 363

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  245 bits (628), Expect = 2e-80
 Identities = 74/267 (27%), Positives = 118/267 (44%), Gaps = 21/267 (7%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIE-RGHKIDAN-VAREIINHKQLRHPN 59
           + +   + +GSG FG   L+  +++     +K I     ++    +  EI   K L HPN
Sbjct: 22  DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPN 81

Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFERIC----NAGRFSEDEARYFFQQLISG----- 110
           II+  EV     ++ IVME   GGEL ERI          SE       +Q+++      
Sbjct: 82  IIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFH 141

Query: 111 --QICHRDLKLENTLLDG-SPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRR 167
              + H+DLK EN L    SP   +KI DFG ++         +  GT  Y+APEV  +R
Sbjct: 142 SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPEVF-KR 200

Query: 168 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYK-IPDYVHISQDC 226
           +      D+WS GV +Y +L G  PF      +  +K        +     +   ++   
Sbjct: 201 DV-TFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQK----ATYKEPNYAVECRPLTPQA 255

Query: 227 RNLLSRIFVANPSRRITIKEIKSHPWF 253
            +LL ++   +P RR +  ++  H WF
Sbjct: 256 VDLLKQMLTKDPERRPSAAQVLHHEWF 282

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  246 bits (629), Expect = 3e-80
 Identities = 88/285 (30%), Positives = 134/285 (47%), Gaps = 31/285 (10%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYI----------ERGHKIDANVAREI-I 50
           E YE  + +G G   V R   +K T +  A+K I          E   ++     +E+ I
Sbjct: 17  ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 76

Query: 51  NHKQLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG 110
             K   HPNII+ K+   T T   +V +    GELF+ +      SE E R   + L+  
Sbjct: 77  LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEV 136

Query: 111 -------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEV 163
                   I HRDLK EN LLD      +K+ DFG+S       + +   GTP+Y+APE+
Sbjct: 137 ICALHKLNIVHRDLKPENILLDDD--MNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEI 194

Query: 164 LSRREYD-----GKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKI-- 216
           +     D     GK  D+WS GV +Y +L G+ PF  ++     R     IM+  Y+   
Sbjct: 195 IECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRM----IMSGNYQFGS 250

Query: 217 PDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLPREL 261
           P++   S   ++L+SR  V  P +R T +E  +HP+F + +  E+
Sbjct: 251 PEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYVVEEV 295

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  247 bits (633), Expect = 1e-79
 Identities = 68/342 (19%), Positives = 123/342 (35%), Gaps = 52/342 (15%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDA--NVAREIINHKQLRHPN 59
             + L   +G G        R+K T +L A+K       +       RE    K+L H N
Sbjct: 9   HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKN 68

Query: 60  IIRFKEVV--LTPTHLAIVMEYAAGGELFERIC---NAGRFSEDEARYFFQQLISG---- 110
           I++   +    T  H  ++ME+   G L+  +    NA    E E     + ++ G    
Sbjct: 69  IVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHL 128

Query: 111 ---QICHRDLKLENTLLDGSPAPR--LKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLS 165
               I HR++K  N +       +   K+ DFG ++      +  S  GT  Y+ P++  
Sbjct: 129 RENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYE 188

Query: 166 RREYD-------GKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQY---- 214
           R           G   D+WS GVT Y    G+ PF   E P+  ++ + +I+  +     
Sbjct: 189 RAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAI 248

Query: 215 ---------------KIPDYVHISQDCR----NLLSRIFVANPSRRITIKEIKSHPWFLK 255
                           +P    +S+  +     +L+ I  A+  +     +  +    + 
Sbjct: 249 SGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDIL 308

Query: 256 NLP----RELTETAQAIYYRKENPTFS--LQSVEEITKIVEE 291
           +        L +      Y     T +   + V + TKI+  
Sbjct: 309 HRMVIHVFSLQQMTAHKIYIHSYNTATIFHELVYKQTKIISS 350

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  242 bits (621), Expect = 5e-79
 Identities = 86/267 (32%), Positives = 142/267 (53%), Gaps = 19/267 (7%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKID-ANVAREIINHKQLRHPNI 60
           + +  M+ +GSG F    L++ + T +L A+K I++      +++  EI   K+++H NI
Sbjct: 9   KTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENI 68

Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-------QIC 113
           +  +++  + TH  +VM+  +GGELF+RI   G ++E +A    QQ++S         I 
Sbjct: 69  VTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIV 128

Query: 114 HRDLKLENTLL-DGSPAPRLKICDFGYSKSSLLHSRP-KSTVGTPAYIAPEVLSRREYDG 171
           HRDLK EN L        ++ I DFG SK  +  +    +  GTP Y+APEVL+++ Y  
Sbjct: 129 HRDLKPENLLYLTPEENSKIMITDFGLSK--MEQNGIMSTACGTPGYVAPEVLAQKPY-S 185

Query: 172 KLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYK--IPDYVHISQDCRNL 229
           K  D WS GV  Y++L G  PF ++ + K F K    I    Y+   P +  IS+  ++ 
Sbjct: 186 KAVDCWSIGVITYILLCGYPPFYEETESKLFEK----IKEGYYEFESPFWDDISESAKDF 241

Query: 230 LSRIFVANPSRRITIKEIKSHPWFLKN 256
           +  +   +P+ R T ++  SHPW   N
Sbjct: 242 ICHLLEKDPNERYTCEKALSHPWIDGN 268

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score =  241 bits (618), Expect = 7e-79
 Identities = 85/270 (31%), Positives = 139/270 (51%), Gaps = 23/270 (8%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYI-------ERGHKIDANVAREIINHKQ 54
           + YE+ +++GSG F + R  R K T +  A K+I        R       + RE+   ++
Sbjct: 5   DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILRE 64

Query: 55  LRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG---- 110
           +RHPNII   ++    T + +++E  +GGELF+ +      +EDEA  F +Q++ G    
Sbjct: 65  IRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYL 124

Query: 111 ---QICHRDLKLENTLLD--GSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLS 165
              +I H DLK EN +L     P PR+K+ DFG +      +  K+  GTP ++APE+++
Sbjct: 125 HSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIVN 184

Query: 166 RREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPD--YVHIS 223
                G  AD+WS GV  Y++L GA PF  +   +        I AV Y   +  + + S
Sbjct: 185 YEPL-GLEADMWSIGVITYILLSGASPFLGETKQETLTN----ISAVNYDFDEEYFSNTS 239

Query: 224 QDCRNLLSRIFVANPSRRITIKEIKSHPWF 253
           +  ++ + R+ V +P RR+TI +   H W 
Sbjct: 240 ELAKDFIRRLLVKDPKRRMTIAQSLEHSWI 269

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  241 bits (617), Expect = 1e-78
 Identities = 93/272 (34%), Positives = 143/272 (52%), Gaps = 19/272 (6%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIER---GHKIDANVAREIINHKQLRHP 58
           E+Y ++  +G G+FG     +++ T++  A+K I +    +K  + + RE+   K+L HP
Sbjct: 22  ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHP 81

Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-------Q 111
           NI++  E++   +   IV E   GGELF+ I    RFSE +A    +Q+ SG        
Sbjct: 82  NIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN 141

Query: 112 ICHRDLKLENTLLDG-SPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYD 170
           I HRDLK EN LL+       +KI DFG S     +++ K  +GT  YIAPEVL R  Y 
Sbjct: 142 IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVL-RGTY- 199

Query: 171 GKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQY--KIPDYVHISQDCRN 228
            +  DVWS GV LY++L G  PF  + +    ++    +   +Y   +P +  IS D ++
Sbjct: 200 DEKCDVWSAGVILYILLSGTPPFYGKNEYDILKR----VETGKYAFDLPQWRTISDDAKD 255

Query: 229 LLSRIFVANPSRRITIKEIKSHPWFLKNLPRE 260
           L+ ++   +PS RIT  +   HPW  K    E
Sbjct: 256 LIRKMLTFHPSLRITATQCLEHPWIQKYSSEE 287

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  241 bits (618), Expect = 2e-78
 Identities = 61/290 (21%), Positives = 109/290 (37%), Gaps = 46/290 (15%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNII 61
             +E +  +G G FG     RN       A+K I    +  + +  E++    L H  ++
Sbjct: 6   SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVV 65

Query: 62  RFKEV-------------VLTPTHLAIVMEYAAGGELFERICNAGRF-SEDEARYFFQQL 107
           R+                V   + L I MEY   G L++ I +       DE    F+Q+
Sbjct: 66  RYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQI 125

Query: 108 ISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKS---------------SLL 145
           +          I HRDLK  N  +D S    +KI DFG +K+                  
Sbjct: 126 LEALSYIHSQGIIHRDLKPMNIFIDES--RNVKIGDFGLAKNVHRSLDILKLDSQNLPGS 183

Query: 146 HSRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKT 205
                S +GT  Y+A EVL    +  +  D++S G+  + M+         E     +K 
Sbjct: 184 SDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP--FSTGMERVNILKK- 240

Query: 206 ISRIMAVQYKIPDYV--HISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 253
              + +V  + P     +  +  + ++  +   +P++R   + + +  W 
Sbjct: 241 ---LRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWL 287

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score =  242 bits (620), Expect = 4e-78
 Identities = 78/278 (28%), Positives = 125/278 (44%), Gaps = 30/278 (10%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIER---------GHKIDANVAREI-IN 51
           +KY+    IG G   V R   ++ T    A+K +E            ++     RE  I 
Sbjct: 94  QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHIL 153

Query: 52  HKQLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG- 110
            +   HP+II   +   + + + +V +    GELF+ +      SE E R   + L+   
Sbjct: 154 RQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAV 213

Query: 111 ------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVL 164
                  I HRDLK EN LLD +    +++ DFG+S       + +   GTP Y+APE+L
Sbjct: 214 SFLHANNIVHRDLKPENILLDDNMQ--IRLSDFGFSCHLEPGEKLRELCGTPGYLAPEIL 271

Query: 165 SRREYD-----GKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDY 219
                +     GK  D+W+CGV L+ +L G+ PF  +      R     IM  QY+    
Sbjct: 272 KCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRM----IMEGQYQFSSP 327

Query: 220 V--HISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLK 255
                S   ++L+SR+   +P  R+T ++   HP+F +
Sbjct: 328 EWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFER 365

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  250 bits (640), Expect = 6e-78
 Identities = 77/337 (22%), Positives = 126/337 (37%), Gaps = 45/337 (13%)

Query: 3   KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIER--GHKIDANVAREIINHKQLRHPNI 60
            +E+ + +G+G FG      +++T E VA+K   +    K       EI   K+L HPN+
Sbjct: 15  PWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNV 74

Query: 61  IRFKEVVLTPTHLA------IVMEYAAGGELFERIC---NAGRFSEDEARYFFQQLISG- 110
           +  +EV      LA      + MEY  GG+L + +    N     E   R     + S  
Sbjct: 75  VSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSAL 134

Query: 111 ------QICHRDLKLENTLLD-GSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEV 163
                 +I HRDLK EN +L  G      KI D GY+K           VGT  Y+APE+
Sbjct: 135 RYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAPEL 194

Query: 164 LSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTI--------------SRI 209
           L +++Y     D WS G   +  + G  PF     P  +   +              +  
Sbjct: 195 LEQKKYTVT-VDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLTGA 253

Query: 210 MAVQYKIPDYVHISQDCRNLLSRIF----VANPSRRITIKEIKSHPWFLKNLPRELTETA 265
           +     +P   H+S      L R      + +  +R T  +  +   F + L   L+   
Sbjct: 254 VKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCF-QALDSILSLKL 312

Query: 266 QAIYYRKENPTFSLQSVEEIT------KIVEEAKVPP 296
            ++         +    E          + ++  +P 
Sbjct: 313 LSVMNMVSGRVHTYPVTENENLQNLKSWLQQDTGIPE 349

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  241 bits (617), Expect = 1e-77
 Identities = 81/268 (30%), Positives = 132/268 (49%), Gaps = 18/268 (6%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIE--RGHKID-ANVAREIINHKQLRHP 58
           + Y++ +++G G F V R   +K T    A K I   +    D   + RE    ++L+HP
Sbjct: 29  DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHP 88

Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-------Q 111
           NI+R  + +   +   +V +   GGELFE I     +SE +A +  QQ++          
Sbjct: 89  NIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNG 148

Query: 112 ICHRDLKLENTLLDG-SPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYD 170
           I HR+LK EN LL   +    +K+ DFG +             GTP Y++PEVL +  Y 
Sbjct: 149 IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPY- 207

Query: 171 GKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQY--KIPDYVHISQDCRN 228
            K  D+W+CGV LY++LVG  PF D++  + + +    I A  Y    P++  ++ + ++
Sbjct: 208 SKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQ----IKAGAYDYPSPEWDTVTPEAKS 263

Query: 229 LLSRIFVANPSRRITIKEIKSHPWFLKN 256
           L+  +   NP +RIT  +    PW    
Sbjct: 264 LIDSMLTVNPKKRITADQALKVPWICNR 291

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  240 bits (615), Expect = 1e-77
 Identities = 80/316 (25%), Positives = 125/316 (39%), Gaps = 65/316 (20%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIER------GHKIDANVAREIINHKQL 55
           +KY L   IG G++GV R+     T+ + A+K + +        K    +  E+   K+L
Sbjct: 26  KKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKL 85

Query: 56  RHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGR--------------------- 94
            HPNI R  EV     ++ +VME   GG L +++                          
Sbjct: 86  HHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPEC 145

Query: 95  -------------------FSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSP 128
                                E       +Q+ S         ICHRD+K EN L   + 
Sbjct: 146 NEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNK 205

Query: 129 APRLKICDFGYSK-----SSLLHSRPKSTVGTPAYIAPEVLSRREYD-GKLADVWSCGVT 182
           +  +K+ DFG SK     ++  +    +  GTP ++APEVL+      G   D WS GV 
Sbjct: 206 SFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVL 265

Query: 183 LYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKI--PDYVHISQDCRNLLSRIFVANPSR 240
           L+++L+GA PF    D     +    ++  +     P+Y  +S   R+LLS +   N   
Sbjct: 266 LHLLLMGAVPFPGVNDADTISQ----VLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDE 321

Query: 241 RITIKEIKSHPWFLKN 256
           R        HPW  + 
Sbjct: 322 RFDAMRALQHPWISQF 337

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score =  240 bits (614), Expect = 2e-77
 Identities = 82/265 (30%), Positives = 129/265 (48%), Gaps = 18/265 (6%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREI-INHKQLRHPNI 60
           + YE+ +DIG G++ V +   +K T    A+K I+   K   +   EI I  +  +HPNI
Sbjct: 22  DGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIID---KSKRDPTEEIEILLRYGQHPNI 78

Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-------QIC 113
           I  K+V     ++ +V E   GGEL ++I     FSE EA      +           + 
Sbjct: 79  ITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVV 138

Query: 114 HRDLKLENTLLDGSP--APRLKICDFGYSKSSLLHSRPKST-VGTPAYIAPEVLSRREYD 170
           HRDLK  N L          ++ICDFG++K     +    T   T  ++APEVL R+ YD
Sbjct: 139 HRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLERQGYD 198

Query: 171 GKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQY--KIPDYVHISQDCRN 228
               D+WS GV LY ML G  PF +  D     + ++RI + ++      +  +S   ++
Sbjct: 199 -AACDIWSLGVLLYTMLTGYTPFANGPD-DTPEEILARIGSGKFSLSGGYWNSVSDTAKD 256

Query: 229 LLSRIFVANPSRRITIKEIKSHPWF 253
           L+S++   +P +R+T   +  HPW 
Sbjct: 257 LVSKMLHVDPHQRLTAALVLRHPWI 281

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score =  239 bits (611), Expect = 3e-77
 Identities = 80/270 (29%), Positives = 134/270 (49%), Gaps = 23/270 (8%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYI-------ERGHKIDANVAREIINHKQ 54
           + Y++ +++GSG F + +  R K+T    A K+I        R       + RE+   +Q
Sbjct: 12  DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQ 71

Query: 55  LRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG---- 110
           + H N+I   +V    T + +++E  +GGELF+ +      SE+EA  F +Q++ G    
Sbjct: 72  VLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYL 131

Query: 111 ---QICHRDLKLENTLLD--GSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLS 165
              +I H DLK EN +L     P P +K+ DFG +         K+  GTP ++APE+++
Sbjct: 132 HTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVN 191

Query: 166 RREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPD--YVHIS 223
                G  AD+WS GV  Y++L GA PF      +        I +V Y   +  + H S
Sbjct: 192 YEPL-GLEADMWSIGVITYILLSGASPFLGDTKQETLAN----ITSVSYDFDEEFFSHTS 246

Query: 224 QDCRNLLSRIFVANPSRRITIKEIKSHPWF 253
           +  ++ + ++ V    +R+TI+E   HPW 
Sbjct: 247 ELAKDFIRKLLVKETRKRLTIQEALRHPWI 276

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  243 bits (623), Expect = 3e-77
 Identities = 90/268 (33%), Positives = 140/268 (52%), Gaps = 19/268 (7%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDAN---VAREIINHKQLRHP 58
           E+Y ++  +G G+FG     +++ T++  A+K I +    + +   + RE+   K+L HP
Sbjct: 22  ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHP 81

Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-------Q 111
           NI++  E++   +   IV E   GGELF+ I    RFSE +A    +Q+ SG        
Sbjct: 82  NIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN 141

Query: 112 ICHRDLKLENTLLDG-SPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYD 170
           I HRDLK EN LL+       +KI DFG S     +++ K  +GT  YIAPEVL R  Y 
Sbjct: 142 IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVL-RGTY- 199

Query: 171 GKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMA--VQYKIPDYVHISQDCRN 228
            +  DVWS GV LY++L G  PF  + +    ++    +      + +P +  IS D ++
Sbjct: 200 DEKCDVWSAGVILYILLSGTPPFYGKNEYDILKR----VETGKYAFDLPQWRTISDDAKD 255

Query: 229 LLSRIFVANPSRRITIKEIKSHPWFLKN 256
           L+ ++   +PS RIT  +   HPW  K 
Sbjct: 256 LIRKMLTFHPSLRITATQCLEHPWIQKY 283

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score =  238 bits (610), Expect = 4e-77
 Identities = 86/270 (31%), Positives = 140/270 (51%), Gaps = 23/270 (8%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYI-------ERGHKIDANVAREIINHKQ 54
           + Y+  +++GSG F V +  R K+T    A K+I        R      ++ RE+   K+
Sbjct: 11  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70

Query: 55  LRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG---- 110
           ++HPN+I   EV    T + +++E  AGGELF+ +      +E+EA  F +Q+++G    
Sbjct: 71  IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYL 130

Query: 111 ---QICHRDLKLENTLL--DGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLS 165
              QI H DLK EN +L     P PR+KI DFG +      +  K+  GTP ++APE+++
Sbjct: 131 HSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVN 190

Query: 166 RREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQY--KIPDYVHIS 223
                G  AD+WS GV  Y++L GA PF      +        + AV Y  +   + + S
Sbjct: 191 YEPL-GLEADMWSIGVITYILLSGASPFLGDTKQETLAN----VSAVNYEFEDEYFSNTS 245

Query: 224 QDCRNLLSRIFVANPSRRITIKEIKSHPWF 253
              ++ + R+ V +P +R+TI++   HPW 
Sbjct: 246 ALAKDFIRRLLVKDPKKRMTIQDSLQHPWI 275

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score =  239 bits (611), Expect = 9e-77
 Identities = 82/270 (30%), Positives = 134/270 (49%), Gaps = 23/270 (8%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYI-------ERGHKIDANVAREIINHKQ 54
           + Y++ +++GSG F + +  R K+T    A K+I        R       + RE+   +Q
Sbjct: 12  DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQ 71

Query: 55  LRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG---- 110
           + HPNII   +V    T + +++E  +GGELF+ +      SE+EA  F +Q++ G    
Sbjct: 72  VLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYL 131

Query: 111 ---QICHRDLKLENTLLD--GSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLS 165
              +I H DLK EN +L     P P +K+ DFG +         K+  GTP ++APE+++
Sbjct: 132 HTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVN 191

Query: 166 RREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPD--YVHIS 223
                G  AD+WS GV  Y++L GA PF      +        I AV Y   +  +   S
Sbjct: 192 YEPL-GLEADMWSIGVITYILLSGASPFLGDTKQETLAN----ITAVSYDFDEEFFSQTS 246

Query: 224 QDCRNLLSRIFVANPSRRITIKEIKSHPWF 253
           +  ++ + ++ V    +R+TI+E   HPW 
Sbjct: 247 ELAKDFIRKLLVKETRKRLTIQEALRHPWI 276

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  241 bits (618), Expect = 2e-76
 Identities = 86/274 (31%), Positives = 137/274 (50%), Gaps = 20/274 (7%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDAN----VAREIINHKQLRH 57
           ++Y+  + +G G+FG   L ++K T +  A+K I +           + RE+   KQL H
Sbjct: 26  DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDH 85

Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG------- 110
           PNI++  E      +  +V E   GGELF+ I +  RFSE +A    +Q++SG       
Sbjct: 86  PNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKN 145

Query: 111 QICHRDLKLENTLLDG-SPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREY 169
           +I HRDLK EN LL+  S    ++I DFG S       + K  +GT  YIAPEVL    Y
Sbjct: 146 KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVL-HGTY 204

Query: 170 DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMA--VQYKIPDYVHISQDCR 227
             +  DVWS GV LY++L G  PF    +    +K    +      +++P +  +S+  +
Sbjct: 205 -DEKCDVWSTGVILYILLSGCPPFNGANEYDILKK----VEKGKYTFELPQWKKVSESAK 259

Query: 228 NLLSRIFVANPSRRITIKEIKSHPWFLKNLPREL 261
           +L+ ++    PS RI+ ++   H W       ++
Sbjct: 260 DLIRKMLTYVPSMRISARDALDHEWIQTYTKEQI 293

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  241 bits (618), Expect = 3e-76
 Identities = 88/272 (32%), Positives = 141/272 (51%), Gaps = 19/272 (6%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIER---GHKIDANVAREIINHKQLRHP 58
           E Y+ +K +GSG +G   L R+K T    A+K I +       ++ +  E+   K L HP
Sbjct: 37  EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHP 96

Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-------Q 111
           NI++  +      +  +VME   GGELF+ I +  +F+E +A    +Q++SG        
Sbjct: 97  NIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHN 156

Query: 112 ICHRDLKLENTLL-DGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYD 170
           I HRDLK EN LL        +KI DFG S       + K  +GT  YIAPEVL R++Y 
Sbjct: 157 IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVL-RKKY- 214

Query: 171 GKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMA--VQYKIPDYVHISQDCRN 228
            +  DVWS GV L+++L G  PF  Q D +  RK    +      +  P++ ++S+  ++
Sbjct: 215 DEKCDVWSIGVILFILLAGYPPFGGQTDQEILRK----VEKGKYTFDSPEWKNVSEGAKD 270

Query: 229 LLSRIFVANPSRRITIKEIKSHPWFLKNLPRE 260
           L+ ++   +  RRI+ ++   HPW  +   ++
Sbjct: 271 LIKQMLQFDSQRRISAQQALEHPWIKEMCSKK 302

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score =  237 bits (606), Expect = 3e-76
 Identities = 87/267 (32%), Positives = 136/267 (50%), Gaps = 15/267 (5%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNII 61
           + +E+  ++G G   +    + K T++  A+K +++       V  EI    +L HPNII
Sbjct: 53  DFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKI-VRTEIGVLLRLSHPNII 111

Query: 62  RFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-------QICH 114
           + KE+  TPT +++V+E   GGELF+RI   G +SE +A    +Q++          I H
Sbjct: 112 KLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVH 171

Query: 115 RDLKLENTLL-DGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKL 173
           RDLK EN L    +P   LKI DFG SK        K+  GTP Y APE+L    Y G  
Sbjct: 172 RDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEILRGCAY-GPE 230

Query: 174 ADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYK--IPDYVHISQDCRNLLS 231
            D+WS G+  Y++L G  PF D+   +       RI+  +Y    P +  +S + ++L+ 
Sbjct: 231 VDMWSVGIITYILLCGFEPFYDERGDQF---MFRRILNCEYYFISPWWDEVSLNAKDLVR 287

Query: 232 RIFVANPSRRITIKEIKSHPWFLKNLP 258
           ++ V +P +R+T  +   HPW      
Sbjct: 288 KLIVLDPKKRLTTFQALQHPWVTGKAA 314

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  237 bits (606), Expect = 4e-76
 Identities = 83/316 (26%), Positives = 146/316 (46%), Gaps = 30/316 (9%)

Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDA---NVAREIINHKQLRH 57
           MEKY  ++ IG G+FG A L+++        +K I              RE+     ++H
Sbjct: 23  MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKH 82

Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFERI--CNAGRFSEDEARYFFQQLISG----- 110
           PNI++++E       L IVM+Y  GG+LF+RI       F ED+   +F Q+        
Sbjct: 83  PNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVH 142

Query: 111 --QICHRDLKLENTLLDGSPAPRLKICDFGYSKS-SLLHSRPKSTVGTPAYIAPEVLSRR 167
             +I HRD+K +N  L       +++ DFG ++  +      ++ +GTP Y++PE+   +
Sbjct: 143 DRKILHRDIKSQNIFLTKD--GTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICENK 200

Query: 168 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYK-IPDYVHISQDC 226
            Y+ K +D+W+ G  LY +    + FE      + +  + +I++  +  +    H S D 
Sbjct: 201 PYNNK-SDIWALGCVLYELCTLKHAFEA----GSMKNLVLKIISGSFPPVSL--HYSYDL 253

Query: 227 RNLLSRIFVANPSRRITIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTFSLQSVEEIT 286
           R+L+S++F  NP  R ++  I    +  K + + L+    A         F L++  +  
Sbjct: 254 RSLVSQLFKRNPRDRPSVNSILEKGFIAKRIEKFLSPQLIA-------EEFCLKTFSKFG 306

Query: 287 KIVEEAKVPPPVSRSI 302
                AK P     SI
Sbjct: 307 SQPIPAKRPASGQNSI 322

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score =  236 bits (603), Expect = 5e-76
 Identities = 85/273 (31%), Positives = 142/273 (52%), Gaps = 21/273 (7%)

Query: 2   EKYELM---KDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLR-H 57
           + Y+L    K +G G+F + R   +K + +  A+K I +  +++AN  +EI   K    H
Sbjct: 8   QHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISK--RMEANTQKEITALKLCEGH 65

Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG------- 110
           PNI++  EV     H  +VME   GGELFERI     FSE EA Y  ++L+S        
Sbjct: 66  PNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDV 125

Query: 111 QICHRDLKLENTLL-DGSPAPRLKICDFGYSKSSLLHSRP-KSTVGTPAYIAPEVLSRRE 168
            + HRDLK EN L  D +    +KI DFG+++     ++P K+   T  Y APE+L++  
Sbjct: 126 GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQNG 185

Query: 169 YDGKLADVWSCGVTLYVMLVGAYPF---EDQEDPKNFRKTISRIMAVQY--KIPDYVHIS 223
           YD +  D+WS GV LY ML G  PF   +      +  + + +I    +  +   + ++S
Sbjct: 186 YD-ESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNVS 244

Query: 224 QDCRNLLSRIFVANPSRRITIKEIKSHPWFLKN 256
           Q+ ++L+  +   +P++R+ +  ++ + W    
Sbjct: 245 QEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDG 277

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  233 bits (596), Expect = 1e-75
 Identities = 76/280 (27%), Positives = 136/280 (48%), Gaps = 32/280 (11%)

Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDA---NVAREIINHKQLRH 57
            E YE++  IG+G++G  + +R K+  +++  K ++ G   +A    +  E+   ++L+H
Sbjct: 5   AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKH 64

Query: 58  PNIIRFKEVVLTPT--HLAIVMEYAAGGELFERICNAGR----FSEDEARYFFQQLISG- 110
           PNI+R+ + ++  T   L IVMEY  GG+L   I    +      E+       QL    
Sbjct: 65  PNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 124

Query: 111 -----------QICHRDLKLENTLLDGSPAPRLKICDFGYSKS-SLLHSRPKSTVGTPAY 158
                       + HRDLK  N  LDG     +K+ DFG ++  +   S  K+ VGTP Y
Sbjct: 125 KECHRRSDGGHTVLHRDLKPANVFLDGK--QNVKLGDFGLARILNHDTSFAKTFVGTPYY 182

Query: 159 IAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQY-KIP 217
           ++PE ++R  Y+ K +D+WS G  LY +     PF       + ++   +I   ++ +IP
Sbjct: 183 MSPEQMNRMSYNEK-SDIWSLGCLLYELCALMPPFTA----FSQKELAGKIREGKFRRIP 237

Query: 218 DYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNL 257
                S +   +++R+       R +++EI  +P  L++ 
Sbjct: 238 Y--RYSDELNEIITRMLNLKDYHRPSVEEILENPLILEHH 275

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score =  234 bits (599), Expect = 2e-75
 Identities = 67/262 (25%), Positives = 113/262 (43%), Gaps = 15/262 (5%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNII 61
           EKY + +D+G G FG+       ++K+    K+++        V +EI      RH NI+
Sbjct: 5   EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNIL 64

Query: 62  RFKEVVLTPTHLAIVMEYAAGGELFERICNAG-RFSEDEARYFFQQLISG-------QIC 113
              E   +   L ++ E+ +G ++FERI  +    +E E   +  Q+           I 
Sbjct: 65  HLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIG 124

Query: 114 HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKL 173
           H D++ EN +     +  +KI +FG ++        +     P Y APEV          
Sbjct: 125 HFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVV-STA 183

Query: 174 ADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQY--KIPDYVHISQDCRNLLS 231
            D+WS G  +YV+L G  PF  + +    ++ I  IM  +Y      +  IS +  + + 
Sbjct: 184 TDMWSLGTLVYVLLSGINPFLAETN----QQIIENIMNAEYTFDEEAFKEISIEAMDFVD 239

Query: 232 RIFVANPSRRITIKEIKSHPWF 253
           R+ V     R+T  E   HPW 
Sbjct: 240 RLLVKERKSRMTASEALQHPWL 261

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  234 bits (600), Expect = 8e-75
 Identities = 72/266 (27%), Positives = 124/266 (46%), Gaps = 16/266 (6%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKID-ANVAREIINHKQLRHPNI 60
           + Y++++++GSG FGV      K T  +   K+I   + +D   V  EI    QL HP +
Sbjct: 51  DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKL 110

Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFERICNAG-RFSEDEARYFFQQLISG-------QI 112
           I   +       + +++E+ +GGELF+RI     + SE E   + +Q   G        I
Sbjct: 111 INLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSI 170

Query: 113 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGK 172
            H D+K EN + +   A  +KI DFG +         K T  T  + APE++ R    G 
Sbjct: 171 VHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPV-GF 229

Query: 173 LADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQY--KIPDYVHISQDCRNLL 230
             D+W+ GV  YV+L G  PF  ++D     +T+  +    +      +  +S + ++ +
Sbjct: 230 YTDMWAIGVLGYVLLSGLSPFAGEDD----LETLQNVKRCDWEFDEDAFSSVSPEAKDFI 285

Query: 231 SRIFVANPSRRITIKEIKSHPWFLKN 256
             +    P +R+T+ +   HPW   +
Sbjct: 286 KNLLQKEPRKRLTVHDALEHPWLKGD 311

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  238 bits (608), Expect = 1e-74
 Identities = 88/279 (31%), Positives = 136/279 (48%), Gaps = 30/279 (10%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIER--------------GHKIDANVAR 47
           E Y  ++ +GSG +G   L + KN     A+K I++                K    +  
Sbjct: 36  ESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYN 95

Query: 48  EIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQL 107
           EI   K L HPNII+  +V     +  +V E+  GGELFE+I N  +F E +A    +Q+
Sbjct: 96  EISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQI 155

Query: 108 ISG-------QICHRDLKLENTLL-DGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYI 159
           +SG        I HRD+K EN LL + +    +KI DFG S       + +  +GT  YI
Sbjct: 156 LSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYI 215

Query: 160 APEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMA--VQYKIP 217
           APEVL +++Y  +  DVWSCGV +Y++L G  PF  Q D    +K    +      +   
Sbjct: 216 APEVL-KKKY-NEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKK----VEKGKYYFDFN 269

Query: 218 DYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKN 256
           D+ +IS + + L+  +   + ++R T +E  +  W  K 
Sbjct: 270 DWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKY 308

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  235 bits (601), Expect = 3e-74
 Identities = 83/272 (30%), Positives = 136/272 (50%), Gaps = 25/272 (9%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDAN---VAREIINHKQLRHP 58
           E+Y+L +++G G F V R        +  A   I        +   + RE    + L+HP
Sbjct: 11  EEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHP 70

Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-------Q 111
           NI+R  + +    H  ++ +   GGELFE I     +SE +A +  QQ++          
Sbjct: 71  NIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMG 130

Query: 112 ICHRDLKLENTLL----DGSPAPRLKICDFGYSKSSLLHSRP-KSTVGTPAYIAPEVLSR 166
           + HR+LK EN LL     G+    +K+ DFG +       +      GTP Y++PEVL +
Sbjct: 131 VVHRNLKPENLLLASKLKGAA---VKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRK 187

Query: 167 REYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYK--IPDYVHISQ 224
             Y GK  D+W+CGV LY++LVG  PF D++  + +++    I A  Y    P++  ++ 
Sbjct: 188 DPY-GKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQ----IKAGAYDFPSPEWDTVTP 242

Query: 225 DCRNLLSRIFVANPSRRITIKEIKSHPWFLKN 256
           + ++L++++   NPS+RIT  E   HPW    
Sbjct: 243 EAKDLINKMLTINPSKRITAAEALKHPWISHR 274

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score =  230 bits (589), Expect = 6e-74
 Identities = 76/269 (28%), Positives = 125/269 (46%), Gaps = 22/269 (8%)

Query: 2   EKYELM-KDIGSGNFGVARLMRNKNTKELVAMKYIE---RGHKIDANVAREIINHKQLRH 57
             Y L  K++G G F V R   +K+T +  A K+++   RG    A +  EI   +  + 
Sbjct: 28  NFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKS 87

Query: 58  -PNIIRFKEVVLTPTHLAIVMEYAAGGELFERIC--NAGRFSEDEARYFFQQLISG---- 110
            P +I   EV    + + +++EYAAGGE+F       A   SE++     +Q++ G    
Sbjct: 88  CPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYL 147

Query: 111 ---QICHRDLKLENTLL-DGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSR 166
               I H DLK +N LL    P   +KI DFG S+        +  +GTP Y+APE+L+ 
Sbjct: 148 HQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPEILNY 207

Query: 167 REYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPD--YVHISQ 224
                   D+W+ G+  Y++L    PF  +++ + +      I  V     +  +  +SQ
Sbjct: 208 DPI-TTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLN----ISQVNVDYSEETFSSVSQ 262

Query: 225 DCRNLLSRIFVANPSRRITIKEIKSHPWF 253
              + +  + V NP +R T +   SH W 
Sbjct: 263 LATDFIQSLLVKNPEKRPTAEICLSHSWL 291

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  236 bits (604), Expect = 2e-73
 Identities = 75/266 (28%), Positives = 130/266 (48%), Gaps = 16/266 (6%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKID-ANVAREIINHKQLRHPNI 60
           + Y++ +++G+G FGV   +  + T    A K++   H+ D   V +EI     LRHP +
Sbjct: 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 216

Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFERICN-AGRFSEDEARYFFQQLISG-------QI 112
           +   +       + ++ E+ +GGELFE++ +   + SEDEA  + +Q+  G         
Sbjct: 217 VNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNY 276

Query: 113 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGK 172
            H DLK EN +     +  LK+ DFG +         K T GT  + APEV   +   G 
Sbjct: 277 VHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPV-GY 335

Query: 173 LADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQY--KIPDYVHISQDCRNLL 230
             D+WS GV  Y++L G  PF  + D     +T+  + +  +      +  IS+D ++ +
Sbjct: 336 YTDMWSVGVLSYILLSGLSPFGGEND----DETLRNVKSCDWNMDDSAFSGISEDGKDFI 391

Query: 231 SRIFVANPSRRITIKEIKSHPWFLKN 256
            ++ +A+P+ R+TI +   HPW    
Sbjct: 392 RKLLLADPNTRMTIHQALEHPWLTPG 417

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  229 bits (586), Expect = 7e-73
 Identities = 84/286 (29%), Positives = 133/286 (46%), Gaps = 19/286 (6%)

Query: 2   EKYELMK--DIGSGNFGVARLMRNKNTKELVAMKYIERGHKID-ANVAREIINHKQLRHP 58
             Y + K   +G G FG         T   +A K I+     D   V  EI    QL H 
Sbjct: 87  SFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHA 146

Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAG-RFSEDEARYFFQQLISG------- 110
           N+I+  +   +   + +VMEY  GGELF+RI +     +E +   F +Q+  G       
Sbjct: 147 NLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQM 206

Query: 111 QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYD 170
            I H DLK EN L     A ++KI DFG ++      + K   GTP ++APEV+   ++ 
Sbjct: 207 YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAPEVV-NYDFV 265

Query: 171 GKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQY--KIPDYVHISQDCRN 228
               D+WS GV  Y++L G  PF    D     +T++ I+A ++  +  ++  IS++ + 
Sbjct: 266 SFPTDMWSVGVIAYMLLSGLSPFLGDND----AETLNNILACRWDLEDEEFQDISEEAKE 321

Query: 229 LLSRIFVANPSRRITIKEIKSHPWFLKNLPRELTETAQAIYYRKEN 274
            +S++ +   S RI+  E   HPW L +       +AQ    R  +
Sbjct: 322 FISKLLIKEKSWRISASEALKHPW-LSDHKLHSRLSAQKKKNRGSD 366

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  227 bits (580), Expect = 9e-73
 Identities = 63/283 (22%), Positives = 105/283 (37%), Gaps = 33/283 (11%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVA-REIINHKQLRHPNI 60
           + Y  ++ +G G F    L+   +     A+K I    + D   A RE   H+   HPNI
Sbjct: 29  KHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNI 88

Query: 61  IRFKEVVLTPT----HLAIVMEYAAGGELFERI----CNAGRFSEDEARYFFQQLISG-- 110
           +R     L          +++ +   G L+  I          +ED+  +    +  G  
Sbjct: 89  LRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLE 148

Query: 111 -----QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST----------VGT 155
                   HRDLK  N LL      +  + D G    + +H                  T
Sbjct: 149 AIHAKGYAHRDLKPTNILLGDEG--QPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCT 206

Query: 156 PAYIAPEVLSRREYD--GKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQ 213
            +Y APE+ S + +    +  DVWS G  LY M+ G  P++      +   +++  +  Q
Sbjct: 207 ISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGD---SVALAVQNQ 263

Query: 214 YKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKN 256
             IP     S     LL+ +   +P +R  I  + S    L+ 
Sbjct: 264 LSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQP 306

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  227 bits (582), Expect = 1e-72
 Identities = 79/276 (28%), Positives = 129/276 (46%), Gaps = 27/276 (9%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIE------RGHKIDANVAREIINHKQL 55
           + YEL + IG G F V R   N+ T +  A+K ++             ++ RE      L
Sbjct: 24  DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHML 83

Query: 56  RHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGR----FSEDEARYFFQQLISG- 110
           +HP+I+   E   +   L +V E+  G +L   I         +SE  A ++ +Q++   
Sbjct: 84  KHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEAL 143

Query: 111 ------QICHRDLKLENTLLDG-SPAPRLKICDFGYSKS-SLLHSRPKSTVGTPAYIAPE 162
                  I HRD+K    LL     +  +K+  FG +             VGTP ++APE
Sbjct: 144 RYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPE 203

Query: 163 VLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYK--IPDYV 220
           V+ R  Y GK  DVW CGV L+++L G  PF   ++     +    I+  +YK     + 
Sbjct: 204 VVKREPY-GKPVDVWGCGVILFILLSGCLPFYGTKE-----RLFEGIIKGKYKMNPRQWS 257

Query: 221 HISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKN 256
           HIS+  ++L+ R+ + +P+ RIT+ E  +HPW  + 
Sbjct: 258 HISESAKDLVRRMLMLDPAERITVYEALNHPWLKER 293

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score =  226 bits (578), Expect = 2e-72
 Identities = 79/302 (26%), Positives = 122/302 (40%), Gaps = 38/302 (12%)

Query: 2   EKYELMKD-IGSGNFGVARLMRNKNTKELVAMKYIE-RGHKIDANVAREIINHKQLR-HP 58
           + Y+L +D +G G     +   N  T +  A+K IE +   I + V RE+    Q + H 
Sbjct: 12  DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHR 71

Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-------Q 111
           N++   E         +V E   GG +   I     F+E EA    Q + S         
Sbjct: 72  NVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKG 131

Query: 112 ICHRDLKLENTLLD--GSPAPRLKICDFGYSK--------SSLLHSRPKSTVGTPAYIAP 161
           I HRDLK EN L +     +P +KICDF            S +      +  G+  Y+AP
Sbjct: 132 IAHRDLKPENILCEHPNQVSP-VKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAP 190

Query: 162 EVLSRREYD----GKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKI- 216
           EV+     +     K  D+WS GV LY++L G  PF  +              A Q  + 
Sbjct: 191 EVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLF 250

Query: 217 ------------PDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLPRELTET 264
                        D+ HIS   ++L+S++ V +  +R++  ++  HPW     P     T
Sbjct: 251 ESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPT 310

Query: 265 AQ 266
             
Sbjct: 311 PM 312

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  225 bits (575), Expect = 2e-72
 Identities = 58/283 (20%), Positives = 107/283 (37%), Gaps = 41/283 (14%)

Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNI 60
              ++ ++ IGSG FG     +++   +   +K ++  ++      RE+    +L H NI
Sbjct: 10  GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNE---KAEREVKALAKLDHVNI 66

Query: 61  IRFKE----------------VVLTPTHLAIVMEYAAGGELFERI--CNAGRFSEDEARY 102
           + +                         L I ME+   G L + I      +  +  A  
Sbjct: 67  VHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALE 126

Query: 103 FFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGT 155
            F+Q+  G       ++ +RDLK  N  L  +   ++KI DFG   S     +   + GT
Sbjct: 127 LFEQITKGVDYIHSKKLINRDLKPSNIFLVDTK--QVKIGDFGLVTSLKNDGKRTRSKGT 184

Query: 156 PAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYK 215
             Y++PE +S ++Y  +  D+++ G+ L  +L       +        K  + +      
Sbjct: 185 LRYMSPEQISSQDYGKE-VDLYALGLILAELLHVCDTAFETS------KFFTDLR--DGI 235

Query: 216 IPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLP 258
           I D     +  + LL ++    P  R    EI       K  P
Sbjct: 236 ISD--IFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSP 276

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score =  228 bits (583), Expect = 3e-72
 Identities = 86/273 (31%), Positives = 137/273 (50%), Gaps = 23/273 (8%)

Query: 2   EKYELM-KDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREI-INHKQLRHPN 59
           + Y++  + +G G  G    + NK T+E  A+K ++   K      RE+ ++ +  + P+
Sbjct: 61  DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPK----ARREVELHWRASQCPH 116

Query: 60  IIRFKEV----VLTPTHLAIVMEYAAGGELFERICNAG--RFSEDEARYFFQQLISG--- 110
           I+R  +V          L IVME   GGELF RI + G   F+E EA    + +      
Sbjct: 117 IVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQY 176

Query: 111 ----QICHRDLKLENTLL-DGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLS 165
                I HRD+K EN L     P   LK+ DFG++K +  H+   +   TP Y+APEVL 
Sbjct: 177 LHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLG 236

Query: 166 RREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQY--KIPDYVHIS 223
             +YD K  D+WS GV +Y++L G  PF             +RI   QY    P++  +S
Sbjct: 237 PEKYD-KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVS 295

Query: 224 QDCRNLLSRIFVANPSRRITIKEIKSHPWFLKN 256
           ++ + L+  +    P++R+TI E  +HPW +++
Sbjct: 296 EEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 328

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score =  225 bits (576), Expect = 8e-72
 Identities = 80/274 (29%), Positives = 126/274 (45%), Gaps = 26/274 (9%)

Query: 2   EKYELMKD-IGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREI-INHKQLRHPN 59
           + Y+L K  +G G  G      ++ T +  A+K +    K      +E+  + +    P+
Sbjct: 28  DDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPK----ARQEVDHHWQASGGPH 83

Query: 60  IIRFKEVVLTPTHLA----IVMEYAAGGELFERICNAG--RFSEDEARYFFQQLISG--- 110
           I+   +V     H      I+ME   GGELF RI   G   F+E EA    + + +    
Sbjct: 84  IVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQF 143

Query: 111 ----QICHRDLKLENTLL-DGSPAPRLKICDFGYSKSSLLHSRP-KSTVGTPAYIAPEVL 164
                I HRD+K EN L         LK+ DFG++K         ++   TP Y+APEVL
Sbjct: 144 LHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAK--ETTQNALQTPCYTPYYVAPEVL 201

Query: 165 SRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQY--KIPDYVHI 222
              +YD K  D+WS GV +Y++L G  PF              RI   QY    P++  +
Sbjct: 202 GPEKYD-KSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSEV 260

Query: 223 SQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKN 256
           S+D + L+  +   +P+ R+TI +  +HPW  ++
Sbjct: 261 SEDAKQLIRLLLKTDPTERLTITQFMNHPWINQS 294

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  218 bits (558), Expect = 3e-69
 Identities = 65/292 (22%), Positives = 110/292 (37%), Gaps = 46/292 (15%)

Query: 3   KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDAN-VAREIINHKQLR-HPNI 60
           +  + + +  G F      ++  +    A+K +    +     + +E+   K+L  HPNI
Sbjct: 29  RLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNI 88

Query: 61  IRF-------KEVVLTPTHLAIVMEYAAGGELFERICNA---GRFSEDEARYFFQQLISG 110
           ++F       KE   T     +++     G+L E +      G  S D     F Q    
Sbjct: 89  VQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRA 148

Query: 111 ---------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST--------- 152
                     I HRDLK+EN LL       +K+CDFG + +   +     +         
Sbjct: 149 VQHMHRQKPPIIHRDLKVENLLLSNQG--TIKLCDFGSATTISHYPDYSWSAQRRALVEE 206

Query: 153 ----VGTPAYIAPEV--LSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTI 206
                 TP Y  PE+  L      G+  D+W+ G  LY++    +PFED           
Sbjct: 207 EITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDG--------AK 258

Query: 207 SRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLP 258
            RI+  +Y IP +        +L+  +   NP  R++I E+      +    
Sbjct: 259 LRIVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAAR 310

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  215 bits (550), Expect = 3e-68
 Identities = 71/277 (25%), Positives = 115/277 (41%), Gaps = 23/277 (8%)

Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDA----NVAREIINHKQLR 56
           +  + + K IG G F              VA+K ++    +DA    +  +EI   KQL 
Sbjct: 31  LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLN 90

Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGR----FSEDEARYFFQQLISG-- 110
           HPN+I++    +    L IV+E A  G+L   I +  +      E     +F QL S   
Sbjct: 91  HPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALE 150

Query: 111 -----QICHRDLKLENTLLDGSPAPRLKICDFGYSKS-SLLHSRPKSTVGTPAYIAPEVL 164
                ++ HRD+K  N  +  +    +K+ D G  +  S   +   S VGTP Y++PE +
Sbjct: 151 HMHSRRVMHRDIKPANVFITAT--GVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERI 208

Query: 165 SRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYK-IPDYVHIS 223
               Y+ K +D+WS G  LY M     PF    D  N      +I    Y  +P   H S
Sbjct: 209 HENGYNFK-SDIWSLGCLLYEMAALQSPFYG--DKMNLYSLCKKIEQCDYPPLPS-DHYS 264

Query: 224 QDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLPRE 260
           ++ R L++     +P +R  +  +      +      
Sbjct: 265 EELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTAS 301

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  213 bits (544), Expect = 2e-67
 Identities = 57/265 (21%), Positives = 105/265 (39%), Gaps = 24/265 (9%)

Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYI---ERGHKIDANVAREIINHKQL-R 56
            + ++ +  +G G++G    +R+K    L A+K      RG K  A    E+ +H+++ +
Sbjct: 56  QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQ 115

Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAG-RFSEDEARYFFQQLISG----- 110
           HP  +R ++       L +  E   G  L +     G    E +   + +  +       
Sbjct: 116 HPCCVRLEQAWEEGGILYLQTEL-CGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLH 174

Query: 111 --QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRRE 168
              + H D+K  N  L   P  R K+ DFG           +   G P Y+APE+L +  
Sbjct: 175 SQGLVHLDVKPANIFLG--PRGRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPELL-QGS 231

Query: 169 YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRN 228
           Y    ADV+S G+T+  +          E  +  R+          +      +S + R+
Sbjct: 232 YGTA-ADVFSLGLTILEVACNMELPHGGEGWQQLRQGYLPP-----EFTA--GLSSELRS 283

Query: 229 LLSRIFVANPSRRITIKEIKSHPWF 253
           +L  +   +P  R T + + + P  
Sbjct: 284 VLVMMLEPDPKLRATAEALLALPVL 308

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score =  203 bits (518), Expect = 1e-63
 Identities = 77/272 (28%), Positives = 120/272 (44%), Gaps = 43/272 (15%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREI-INHKQLRHPNI 60
           +     + +G G  G    + NK T+E  A+K ++   K      RE+ ++ +  + P+I
Sbjct: 18  DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPK----ARREVELHWRASQCPHI 73

Query: 61  IRFKEV----VLTPTHLAIVMEYAAGGELFERICNAG--RFSEDEARYFFQQLISG---- 110
           +R  +V          L IVME   GGELF RI + G   F+E EA    + +       
Sbjct: 74  VRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYL 133

Query: 111 ---QICHRDLKLENTLL-DGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSR 166
               I HRD+K EN L     P   LK+ DFG                     A E    
Sbjct: 134 HSINIAHRDVKPENLLYTSKRPNAILKLTDFG--------------------FAKETT-G 172

Query: 167 REYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYV--HISQ 224
            +YD K  D+WS GV +Y++L G  PF             +RI   QY+ P+     +S+
Sbjct: 173 EKYD-KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSE 231

Query: 225 DCRNLLSRIFVANPSRRITIKEIKSHPWFLKN 256
           + + L+  +    P++R+TI E  +HPW +++
Sbjct: 232 EVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 263

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  203 bits (518), Expect = 1e-63
 Identities = 63/304 (20%), Positives = 112/304 (36%), Gaps = 48/304 (15%)

Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDA--NVAREIINHKQLRHP 58
           +  +E ++ +G G FGV    +NK      A+K I   ++  A   V RE+    +L HP
Sbjct: 4   LTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHP 63

Query: 59  NIIRFKEVVLT------------PTHLAIVMEYAAGGELFERI---CNAGRFSEDEARYF 103
            I+R+    L               +L I M+      L + +   C           + 
Sbjct: 64  GIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHI 123

Query: 104 FQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSK-------------SS 143
           F Q+           + HRDLK  N          +K+ DFG                  
Sbjct: 124 FLQIAEAVEFLHSKGLMHRDLKPSNIFFTMD--DVVKVGDFGLVTAMDQDEEEQTVLTPM 181

Query: 144 LLHSRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFR 203
             ++R    VGT  Y++PE +    Y  K  D++S G+ L+ +L   YPF  Q +     
Sbjct: 182 PAYARHTGQVGTKLYMSPEQIHGNSYSHK-VDIFSLGLILFELL---YPFSTQMERV--- 234

Query: 204 KTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLK-NLPRELT 262
           +T++ +  +++  P +         ++  +   +P  R     I  +  F   + P +  
Sbjct: 235 RTLTDVRNLKFP-PLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPGKTV 293

Query: 263 ETAQ 266
              +
Sbjct: 294 LRQR 297

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score =  201 bits (514), Expect = 6e-63
 Identities = 73/273 (26%), Positives = 126/273 (46%), Gaps = 29/273 (10%)

Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHK----QLR 56
            E ++  K +G G+F    L R   T    A+K +E+ H I  N    +   +    +L 
Sbjct: 29  PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD 88

Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG------ 110
           HP  ++          L   + YA  GEL + I   G F E   R++  +++S       
Sbjct: 89  HPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG 148

Query: 111 -QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST---VGTPAYIAPEVLSR 166
             I HRDLK EN LL+      ++I DFG +K     S+       VGT  Y++PE+L+ 
Sbjct: 149 KGIIHRDLKPENILLNED--MHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTE 206

Query: 167 REYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDC 226
           +    K +D+W+ G  +Y ++ G  PF    +   F+K    I+ ++Y  P+        
Sbjct: 207 KSA-CKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQK----IIKLEYDFPE--KFFPKA 259

Query: 227 RNLLSRIFVANPSRRITIK------EIKSHPWF 253
           R+L+ ++ V + ++R+  +       +K+HP+F
Sbjct: 260 RDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFF 292

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  201 bits (513), Expect = 2e-61
 Identities = 63/301 (20%), Positives = 106/301 (35%), Gaps = 53/301 (17%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQL-RHPNI 60
                 K +G G+ G     +       VA+K +            EI    +   HPN+
Sbjct: 15  NLVVSEKILGYGSSGTVVF-QGSFQGRPVAVKRMLIDF--CDIALMEIKLLTESDDHPNV 71

Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSED-------EARYFFQQLISG--- 110
           IR+     T   L I +E      L + + +     E+             +Q+ SG   
Sbjct: 72  IRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAH 130

Query: 111 ----QICHRDLKLENTLLDGSPAP-----------RLKICDFGYSK-----SSLLHSRPK 150
               +I HRDLK +N L+  S              R+ I DFG  K      S   +   
Sbjct: 131 LHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLN 190

Query: 151 STVGTPAYIAPEVLSRREYD------GKLADVWSCGVTLYVMLVGAY-PFEDQEDPKNFR 203
           +  GT  + APE+L             +  D++S G   Y +L     PF D+       
Sbjct: 191 NPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYS----- 245

Query: 204 KTISRIMAVQYKIPDYV-----HISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLP 258
              S I+   + + +        +  +  +L+S++   +P +R T  ++  HP F     
Sbjct: 246 -RESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWPKSK 304

Query: 259 R 259
           +
Sbjct: 305 K 305

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score =  198 bits (505), Expect = 1e-60
 Identities = 67/269 (24%), Positives = 125/269 (46%), Gaps = 23/269 (8%)

Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQ----LR 56
            + +E+++ IG G+FG   +++  +TK++ AMKY+ +   ++ N  R +    Q    L 
Sbjct: 14  FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLE 73

Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG------ 110
           HP ++           + +V++   GG+L   +     F E+  + F  +L+        
Sbjct: 74  HPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQN 133

Query: 111 -QICHRDLKLENTLLD--GSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRR 167
            +I HRD+K +N LLD  G     + I DF  +      ++  +  GT  Y+APE+ S R
Sbjct: 134 QRIIHRDMKPDNILLDEHG----HVHITDFNIAAMLPRETQITTMAGTKPYMAPEMFSSR 189

Query: 168 EYDG--KLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQD 225
           +  G     D WS GVT Y +L G  P+  +    + ++ +          P     SQ+
Sbjct: 190 KGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSS-TSSKEIVHTFETTVVTYPSA--WSQE 246

Query: 226 CRNLLSRIFVANPSRRI-TIKEIKSHPWF 253
             +LL ++   NP +R   + ++++ P+ 
Sbjct: 247 MVSLLKKLLEPNPDQRFSQLSDVQNFPYM 275

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score =  190 bits (486), Expect = 1e-58
 Identities = 83/275 (30%), Positives = 140/275 (50%), Gaps = 39/275 (14%)

Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINH-------- 52
           ++ +++++ +G+G+FG   L+R+++     AMK +    K +  V  + + H        
Sbjct: 5   LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVL----KKEIVVRLKQVEHTNDERLML 60

Query: 53  KQLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-- 110
             + HP IIR          + ++M+Y  GGELF  +  + RF    A+++  ++     
Sbjct: 61  SIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALE 120

Query: 111 -----QICHRDLKLENTLLD--GSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEV 163
                 I +RDLK EN LLD  G     +KI DFG++K   +     +  GTP YIAPEV
Sbjct: 121 YLHSKDIIYRDLKPENILLDKNG----HIKITDFGFAK--YVPDVTYTLCGTPDYIAPEV 174

Query: 164 LSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHIS 223
           +S + Y  K  D WS G+ +Y ML G  PF D  +     KT  +I+  + + P     +
Sbjct: 175 VSTKPY-NKSIDWWSFGILIYEMLAGYTPFYD-SNTM---KTYEKILNAELRFPP--FFN 227

Query: 224 QDCRNLLSRIFVANPSRRI-----TIKEIKSHPWF 253
           +D ++LLSR+   + S+R+       +++K+HPWF
Sbjct: 228 EDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWF 262

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  193 bits (493), Expect = 2e-58
 Identities = 64/271 (23%), Positives = 96/271 (35%), Gaps = 28/271 (10%)

Query: 3   KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQL-RHPNII 61
            +     +G G  G     R       VA+K I    +  +   RE+   ++   HPN+I
Sbjct: 25  SFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILP--ECFSFADREVQLLRESDEHPNVI 81

Query: 62  RFKEVVLTPTHLAIVMEYAAGGELFERICNAG-RFSEDEARYFFQQLISG-------QIC 113
           R+           I +E      L E +          E     QQ  SG        I 
Sbjct: 82  RYFCTEKDRQFQYIAIELC-AATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIV 140

Query: 114 HRDLKLENTLL---DGSPAPRLKICDFGYSK----SSLLHSRPKSTVGTPAYIAPEVLSR 166
           HRDLK  N L+   +     +  I DFG  K         SR     GT  +IAPE+LS 
Sbjct: 141 HRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSE 200

Query: 167 REYD--GKLADVWSCGVTLYVMLVGAY-PFEDQEDPKNFRKTISRIMAVQYKIPDY-VHI 222
              +      D++S G   Y ++     PF         R+    + A          H 
Sbjct: 201 DCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQ----RQANILLGACSLDCLHPEKHE 256

Query: 223 SQDCRNLLSRIFVANPSRRITIKEIKSHPWF 253
               R L+ ++   +P +R + K +  HP+F
Sbjct: 257 DVIARELIEKMIAMDPQKRPSAKHVLKHPFF 287

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  192 bits (488), Expect = 2e-58
 Identities = 39/313 (12%), Positives = 75/313 (23%), Gaps = 70/313 (22%)

Query: 3   KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDAN----VAREIINHKQLR-- 56
                  +G  +        ++ T E   +       +  +N    +  E++  + LR  
Sbjct: 74  TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGI 133

Query: 57  -----------------------HPNIIRFKEVVLTPTHLAIVMEYAA--------GGEL 85
                                     +IR +        L+    Y          G  L
Sbjct: 134 KNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVL 193

Query: 86  FERICNAGRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFG 138
                               Q+I          + H  L+  + +LD      + +  F 
Sbjct: 194 LSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRG--GVFLTGFE 251

Query: 139 YSKSSLLHSRPKSTVGTPAYIAPEVLSRRE----------YDGKLADVWSCGVTLYVMLV 188
           +            +  +  +  PE+ +RR                 D W+ G+ +Y +  
Sbjct: 252 HLVR---DGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWC 308

Query: 189 GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIK 248
              P                            +I Q  R LL          R+   +  
Sbjct: 309 ADLPITKDAALGGSEWIFRSCK----------NIPQPVRALLEGFLRYPKEDRLLPLQAM 358

Query: 249 SHPWFLKNLPREL 261
             P + + L  EL
Sbjct: 359 ETPEY-EQLRTEL 370

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score =  190 bits (484), Expect = 3e-58
 Identities = 81/276 (29%), Positives = 149/276 (53%), Gaps = 36/276 (13%)

Query: 1   MEKYELMKDIGSGNFG---VARLMRNKNTKELVAMKYIERGHKIDANVA-----REIINH 52
             ++EL+K +G G+FG   + + +   + ++L AMK +++      +       R+I+  
Sbjct: 23  PSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDIL-- 80

Query: 53  KQLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-- 110
            ++ HP I++      T   L +++++  GG+LF R+     F+E++ +++  +L     
Sbjct: 81  VEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALD 140

Query: 111 -----QICHRDLKLENTLLD--GSPAPRLKICDFGYSKSSLLHSRPKSTV-GTPAYIAPE 162
                 I +RDLK EN LLD  G     +K+ DFG SK S+ H +   +  GT  Y+APE
Sbjct: 141 HLHSLGIIYRDLKPENILLDEEG----HIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPE 196

Query: 163 VLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHI 222
           V++RR +  + AD WS GV ++ ML G  PF+     K+ ++T++ I+  +  +P +  +
Sbjct: 197 VVNRRGH-TQSADWWSFGVLMFEMLTGTLPFQG----KDRKETMTMILKAKLGMPQF--L 249

Query: 223 SQDCRNLLSRIFVANPSRRI-----TIKEIKSHPWF 253
           S + ++LL  +F  NP+ R+      ++EIK H +F
Sbjct: 250 SPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFF 285

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score =  190 bits (485), Expect = 4e-58
 Identities = 76/271 (28%), Positives = 140/271 (51%), Gaps = 31/271 (11%)

Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHK----QLR 56
           +++++ +K +G+G+FG   L+++K +    AMK +++   +        +N K     + 
Sbjct: 40  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99

Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG------ 110
            P +++ +      ++L +VMEY AGGE+F  +   GRFSE  AR++  Q++        
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159

Query: 111 -QICHRDLKLENTLLD--GSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRR 167
             + +RDLK EN L+D  G     +++ DFG++K   +  R  +  GTP  +APE++  +
Sbjct: 160 LDLIYRDLKPENLLIDQQG----YIQVTDFGFAKR--VKGRTWTLCGTPEALAPEIILSK 213

Query: 168 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCR 227
            Y  K  D W+ GV +Y M  G  PF   + P    +   +I++ + + P   H S D +
Sbjct: 214 GY-NKAVDWWALGVLIYEMAAGYPPFFA-DQPI---QIYEKIVSGKVRFPS--HFSSDLK 266

Query: 228 NLLSRIFVANPSRRI-----TIKEIKSHPWF 253
           +LL  +   + ++R       + +IK+H WF
Sbjct: 267 DLLRNLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score =  188 bits (481), Expect = 1e-57
 Identities = 85/276 (30%), Positives = 135/276 (48%), Gaps = 38/276 (13%)

Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINH-------- 52
           M  ++ +K +G G FG   L+R K T    AMK +    + +  +A++ + H        
Sbjct: 4   MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKIL----RKEVIIAKDEVAHTVTESRVL 59

Query: 53  KQLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-- 110
           +  RHP +   K    T   L  VMEYA GGELF  +     F+E+ AR++  +++S   
Sbjct: 60  QNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALE 119

Query: 111 -----QICHRDLKLENTLLD--GSPAPRLKICDFGYSKSSLLHSRPKSTV-GTPAYIAPE 162
                 + +RD+KLEN +LD  G     +KI DFG  K  +       T  GTP Y+APE
Sbjct: 120 YLHSRDVVYRDIKLENLMLDKDG----HIKITDFGLCKEGISDGATMKTFCGTPEYLAPE 175

Query: 163 VLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHI 222
           VL   +Y G+  D W  GV +Y M+ G  PF +Q+  + F      I+  + + P    +
Sbjct: 176 VLEDNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFEL----ILMEEIRFPRT--L 228

Query: 223 SQDCRNLLSRIFVANPSRRI-----TIKEIKSHPWF 253
           S + ++LL+ +   +P +R+       KE+  H +F
Sbjct: 229 SPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFF 264

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score =  187 bits (478), Expect = 3e-57
 Identities = 84/278 (30%), Positives = 141/278 (50%), Gaps = 38/278 (13%)

Query: 1   MEKYELMKDIGSGNFG---VARLMRNKNTKELVAMKYIERGHKIDAN--VA-----REII 50
            E +EL++ +G G +G     R +   NT ++ AMK +++   +      A     R I+
Sbjct: 16  PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNIL 75

Query: 51  NHKQLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG 110
             ++++HP I+       T   L +++EY +GGELF ++   G F ED A ++  ++   
Sbjct: 76  --EEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMA 133

Query: 111 -------QICHRDLKLENTLLD--GSPAPRLKICDFGYSKSSLLHSRPKSTV-GTPAYIA 160
                   I +RDLK EN +L+  G     +K+ DFG  K S+       T  GT  Y+A
Sbjct: 134 LGHLHQKGIIYRDLKPENIMLNHQG----HVKLTDFGLCKESIHDGTVTHTFCGTIEYMA 189

Query: 161 PEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYV 220
           PE+L R  +  +  D WS G  +Y ML GA PF  +    N +KTI +I+  +  +P Y 
Sbjct: 190 PEILMRSGH-NRAVDWWSLGALMYDMLTGAPPFTGE----NRKKTIDKILKCKLNLPPY- 243

Query: 221 HISQDCRNLLSRIFVANPSRRI-----TIKEIKSHPWF 253
            ++Q+ R+LL ++   N + R+        E+++HP+F
Sbjct: 244 -LTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFF 280

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score =  185 bits (473), Expect = 2e-56
 Identities = 85/273 (31%), Positives = 131/273 (47%), Gaps = 35/273 (12%)

Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINH-------- 52
           +E + L K +G G+FG   L   K T +  A+K +    K D  +  + +          
Sbjct: 16  IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKAL----KKDVVLMDDDVECTMVEKRVL 71

Query: 53  -KQLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG- 110
                HP +        T  +L  VMEY  GG+L   I +  +F    A ++  ++I G 
Sbjct: 72  SLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGL 131

Query: 111 ------QICHRDLKLENTLLD--GSPAPRLKICDFGYSKSSLLHSRPKSTV-GTPAYIAP 161
                  I +RDLKL+N LLD  G     +KI DFG  K ++L     +T  GTP YIAP
Sbjct: 132 QFLHSKGIVYRDLKLDNILLDKDG----HIKIADFGMCKENMLGDAKTNTFCGTPDYIAP 187

Query: 162 EVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVH 221
           E+L  ++Y     D WS GV LY ML+G  PF  Q++ + F      I       P +  
Sbjct: 188 EILLGQKY-NHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHS----IRMDNPFYPRW-- 240

Query: 222 ISQDCRNLLSRIFVANPSRRITIK-EIKSHPWF 253
           + ++ ++LL ++FV  P +R+ ++ +I+ HP F
Sbjct: 241 LEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLF 273

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score =  188 bits (478), Expect = 4e-56
 Identities = 91/275 (33%), Positives = 134/275 (48%), Gaps = 35/275 (12%)

Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINH-------- 52
           M ++E +K +G G FG   L++ K T    AMK +    K +  VA++ + H        
Sbjct: 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKIL----KKEVIVAKDEVAHTLTENRVL 202

Query: 53  KQLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-- 110
           +  RHP +   K    T   L  VMEYA GGELF  +     FSED AR++  +++S   
Sbjct: 203 QNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALD 262

Query: 111 ------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTV-GTPAYIAPEV 163
                  + +RDLKLEN +LD      +KI DFG  K  +       T  GTP Y+APEV
Sbjct: 263 YLHSEKNVVYRDLKLENLMLDKD--GHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEV 320

Query: 164 LSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHIS 223
           L   +Y G+  D W  GV +Y M+ G  PF +Q+  K F      I+  + + P    + 
Sbjct: 321 LEDNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFEL----ILMEEIRFPRT--LG 373

Query: 224 QDCRNLLSRIFVANPSRRI-----TIKEIKSHPWF 253
            + ++LLS +   +P +R+       KEI  H +F
Sbjct: 374 PEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFF 408

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score =  185 bits (473), Expect = 5e-56
 Identities = 80/276 (28%), Positives = 127/276 (46%), Gaps = 38/276 (13%)

Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINH-------- 52
              +  +K IG G+FG   L R+K  +   A+K +    +  A + ++   H        
Sbjct: 37  PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVL----QKKAILKKKEEKHIMSERNVL 92

Query: 53  -KQLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG- 110
            K ++HP ++       T   L  V++Y  GGELF  +     F E  AR++  ++ S  
Sbjct: 93  LKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASAL 152

Query: 111 ------QICHRDLKLENTLLD--GSPAPRLKICDFGYSKSSLLHSRPKSTV-GTPAYIAP 161
                  I +RDLK EN LLD  G     + + DFG  K ++ H+   ST  GTP Y+AP
Sbjct: 153 GYLHSLNIVYRDLKPENILLDSQG----HIVLTDFGLCKENIEHNSTTSTFCGTPEYLAP 208

Query: 162 EVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVH 221
           EVL ++ Y  +  D W  G  LY ML G  PF  +   + +      I+    ++    +
Sbjct: 209 EVLHKQPY-DRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDN----ILNKPLQLKP--N 261

Query: 222 ISQDCRNLLSRIFVANPSRRI----TIKEIKSHPWF 253
           I+   R+LL  +   + ++R+       EIKSH +F
Sbjct: 262 ITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFF 297

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score =  184 bits (470), Expect = 7e-56
 Identities = 84/276 (30%), Positives = 124/276 (44%), Gaps = 36/276 (13%)

Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINH-------- 52
           ++ +E ++ +G G+FG   L R K T +L A+K +    K D  +  + +          
Sbjct: 22  IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVL----KKDVILQDDDVECTMTEKRIL 77

Query: 53  -KQLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG- 110
                HP + +      TP  L  VME+  GG+L   I  + RF E  AR++  ++IS  
Sbjct: 78  SLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISAL 137

Query: 111 ------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST-VGTPAYIAPEV 163
                  I +RDLKL+N LLD       K+ DFG  K  + +    +T  GTP YIAPE+
Sbjct: 138 MFLHDKGIIYRDLKLDNVLLDHE--GHCKLADFGMCKEGICNGVTTATFCGTPDYIAPEI 195

Query: 164 LSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHIS 223
           L    Y G   D W+ GV LY ML G  PFE + +   F      I+  +   P    + 
Sbjct: 196 LQEMLY-GPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEA----ILNDEVVYPT--WLH 248

Query: 224 QDCRNLLSRIFVANPSRRI------TIKEIKSHPWF 253
           +D   +L      NP+ R+          I  HP+F
Sbjct: 249 EDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFF 284

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score =  184 bits (469), Expect = 1e-55
 Identities = 81/273 (29%), Positives = 128/273 (46%), Gaps = 31/273 (11%)

Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQ-----L 55
           +  +  +  +G G+FG   L   K T EL A+K +++   I  +     +  K+      
Sbjct: 19  LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPG 78

Query: 56  RHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG----- 110
           + P + +      T   L  VMEY  GG+L   I   GRF E  A ++  ++  G     
Sbjct: 79  KPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQ 138

Query: 111 --QICHRDLKLENTLLD--GSPAPRLKICDFGYSKSSLLHSRPKSTV-GTPAYIAPEVLS 165
              I +RDLKL+N +LD  G     +KI DFG  K ++       T  GTP YIAPE+++
Sbjct: 139 SKGIIYRDLKLDNVMLDSEG----HIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIA 194

Query: 166 RREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQD 225
            + Y GK  D W+ GV LY ML G  PFE +++ + F+     IM      P    +S++
Sbjct: 195 YQPY-GKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQS----IMEHNVAYPKS--MSKE 247

Query: 226 CRNLLSRIFVANPSRRI-----TIKEIKSHPWF 253
              +   +   +P +R+       ++IK H +F
Sbjct: 248 AVAICKGLMTKHPGKRLGCGPEGERDIKEHAFF 280

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score =  184 bits (468), Expect = 2e-55
 Identities = 76/283 (26%), Positives = 130/283 (45%), Gaps = 40/283 (14%)

Query: 1   MEKYELMKDIGSGNFG---VARLMRNKNTKELVAMKYIERGHKI--DANVAR-------- 47
           +E +EL+K +G+G +G   + R +   +T +L AMK +++   +                
Sbjct: 53  IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVL 112

Query: 48  EIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQL 107
           E I       P ++       T T L ++++Y  GGELF  +    RF+E E + +  ++
Sbjct: 113 EHIRQ----SPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEI 168

Query: 108 ISG-------QICHRDLKLENTLLD--GSPAPRLKICDFGYSKSSLLH--SRPKSTVGTP 156
           +          I +RD+KLEN LLD  G     + + DFG SK  +     R     GT 
Sbjct: 169 VLALEHLHKLGIIYRDIKLENILLDSNG----HVVLTDFGLSKEFVADETERAYDFCGTI 224

Query: 157 AYIAPEVLSRREY-DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYK 215
            Y+AP+++   +    K  D WS GV +Y +L GA PF    +  +  +   RI+  +  
Sbjct: 225 EYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPP 284

Query: 216 IPDYVHISQDCRNLLSRIFVANPSRRI-----TIKEIKSHPWF 253
            P    +S   ++L+ R+ + +P +R+        EIK H +F
Sbjct: 285 YPQE--MSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFF 325

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score =  182 bits (465), Expect = 4e-55
 Identities = 77/279 (27%), Positives = 124/279 (44%), Gaps = 33/279 (11%)

Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQ-----L 55
           ++ ++L++ IG G++    L+R K T  + AMK +++    D      +   K       
Sbjct: 8   LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQAS 67

Query: 56  RHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG----- 110
            HP ++       T + L  V+EY  GG+L   +    +  E+ AR++  ++        
Sbjct: 68  NHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLH 127

Query: 111 --QICHRDLKLENTLLD--GSPAPRLKICDFGYSKSSLLHSRPKSTV-GTPAYIAPEVLS 165
              I +RDLKL+N LLD  G     +K+ D+G  K  L      ST  GTP YIAPE+L 
Sbjct: 128 ERGIIYRDLKLDNVLLDSEG----HIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILR 183

Query: 166 RREYDGKLADVWSCGVTLYVMLVGAYPF-----EDQEDPKNFRKTISRIMAVQYKIPDYV 220
             +Y G   D W+ GV ++ M+ G  PF      D  D          I+  Q +IP   
Sbjct: 184 GEDY-GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRS- 241

Query: 221 HISQDCRNLLSRIFVANPSRRI------TIKEIKSHPWF 253
            +S    ++L      +P  R+         +I+ HP+F
Sbjct: 242 -LSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFF 279

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  180 bits (460), Expect = 4e-55
 Identities = 62/287 (21%), Positives = 104/287 (36%), Gaps = 45/287 (15%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIE---RGHKIDANVAREIINHKQL-RH 57
            ++  ++ IGSG FG       +    + A+K  +    G   + N  RE+  H  L +H
Sbjct: 11  TEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQH 70

Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGR----FSEDEARYFFQQLISG--- 110
            +++R+        H+ I  EY  GG L + I    R    F E E +    Q+  G   
Sbjct: 71  SHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRY 130

Query: 111 ----QICHRDLKLENTLLD-----------------GSPAPRLKICDFGYSKSSLLHSRP 149
                + H D+K  N  +                   S     KI D G+       S P
Sbjct: 131 IHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTR---ISSP 187

Query: 150 KSTVGTPAYIAPEVLS-RREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISR 208
           +   G   ++A EVL     +  K AD+++  +T+           + +     R+    
Sbjct: 188 QVEEGDSRFLANEVLQENYTHLPK-ADIFALALTVVCAAGAEPLPRNGDQWHEIRQGRLP 246

Query: 209 IMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLK 255
                 +IP    +SQ+   LL  +   +P RR +   +  H   L 
Sbjct: 247 ------RIPQ--VLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLS 285

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  182 bits (463), Expect = 1e-54
 Identities = 42/306 (13%), Positives = 82/306 (26%), Gaps = 52/306 (16%)

Query: 3   KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVA----REIINHKQLRHP 58
           K +L++ +  G+  V  L+R+    E  A+K    G +   +             +L   
Sbjct: 63  KLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGE 122

Query: 59  NIIRFKEV--------------------------VLTPTHLAIVMEYAAG------GELF 86
           +    ++                                +  ++M  A+         L 
Sbjct: 123 SPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLD 182

Query: 87  ERICNAGRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGY 139
                 G            QLI          + H     +N  +      RL + D   
Sbjct: 183 FVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDG--RLMLGDVSA 240

Query: 140 SKSSLLHSRPKSTVGTPAYIAPEVLSRREYD-GKLADVWSCGVTLYVMLVGAYPFEDQED 198
                + +R  ++     Y   E L+          + W  G+++Y +     PF     
Sbjct: 241 LWK--VGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTP 298

Query: 199 PKNF---RKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLK 255
                  R ++               +    + L+ R    +  RR+   E    P F  
Sbjct: 299 GIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEF-L 357

Query: 256 NLPREL 261
            L  E+
Sbjct: 358 QLQNEI 363

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  181 bits (461), Expect = 1e-54
 Identities = 47/298 (15%), Positives = 97/298 (32%), Gaps = 46/298 (15%)

Query: 2   EKYELMKDIGSGNFGVARL-----MRNKNTKELVAMKYIERGHKIDANVAREIIN-HKQL 55
           +   +   +G G F          + +   K+   +K  +  +  +  +  +++   K  
Sbjct: 65  KLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPS 124

Query: 56  RHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERIC-----NAGRFSEDEARYFFQQLI-- 108
                ++F    L      +V E  + G L   I            +     F  +++  
Sbjct: 125 MQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYM 184

Query: 109 -----SGQICHRDLKLENTLLDGSPAPR---------LKICDFGYSKSSLLHSRP---KS 151
                  +I H D+K +N +L      +         L + D G S    L  +     +
Sbjct: 185 IEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTA 244

Query: 152 TVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTI----- 206
              T  +   E+LS + ++ +  D +    T+Y ML G Y     E  +   + +     
Sbjct: 245 KCETSGFQCVEMLSNKPWNYQ-IDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLP 303

Query: 207 -----SRIMAVQYKIPDYVHIS--QDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNL 257
                +    V   IPD  H+      R  L ++F  + + +I       +   +  L
Sbjct: 304 HLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKI---RALRNRLIVLLL 358

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score =  182 bits (465), Expect = 1e-54
 Identities = 86/278 (30%), Positives = 129/278 (46%), Gaps = 37/278 (13%)

Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINH-------- 52
            E YE++K IG G FG  +L+R+K+T+++ AMK +         + R             
Sbjct: 68  AEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLL----SKFEMIKRSDSAFFWEERDIM 123

Query: 53  KQLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-- 110
                P +++         +L +VMEY  GG+L   + +     E  AR++  +++    
Sbjct: 124 AFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLV-NLMSNYDVPEKWARFYTAEVVLALD 182

Query: 111 -----QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLL--HSRPKSTVGTPAYIAPEV 163
                   HRD+K +N LLD S    LK+ DFG           R  + VGTP YI+PEV
Sbjct: 183 AIHSMGFIHRDVKPDNMLLDKS--GHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEV 240

Query: 164 LSRREYD---GKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMA--VQYKIPD 218
           L  +  D   G+  D WS GV LY MLVG  PF       +   T S+IM        PD
Sbjct: 241 LKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYAD----SLVGTYSKIMNHKNSLTFPD 296

Query: 219 YVHISQDCRNLLSRIFVANPSRRIT---IKEIKSHPWF 253
              IS++ +NL+   F+ +   R+    ++EIK H +F
Sbjct: 297 DNDISKEAKNLICA-FLTDREVRLGRNGVEEIKRHLFF 333

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score =  181 bits (462), Expect = 3e-54
 Identities = 76/279 (27%), Positives = 124/279 (44%), Gaps = 33/279 (11%)

Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQ-----L 55
           ++ ++L++ IG G++    L+R K T  + AM+ +++    D      +   K       
Sbjct: 51  LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQAS 110

Query: 56  RHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG----- 110
            HP ++       T + L  V+EY  GG+L   +    +  E+ AR++  ++        
Sbjct: 111 NHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLH 170

Query: 111 --QICHRDLKLENTLLD--GSPAPRLKICDFGYSKSSLLHSRPKSTV-GTPAYIAPEVLS 165
              I +RDLKL+N LLD  G     +K+ D+G  K  L      ST  GTP YIAPE+L 
Sbjct: 171 ERGIIYRDLKLDNVLLDSEG----HIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILR 226

Query: 166 RREYDGKLADVWSCGVTLYVMLVGAYPF-----EDQEDPKNFRKTISRIMAVQYKIPDYV 220
             +Y G   D W+ GV ++ M+ G  PF      D  D          I+  Q +IP   
Sbjct: 227 GEDY-GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPR-- 283

Query: 221 HISQDCRNLLSRIFVANPSRRI------TIKEIKSHPWF 253
            +S    ++L      +P  R+         +I+ HP+F
Sbjct: 284 SLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFF 322

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score =  185 bits (472), Expect = 1e-53
 Identities = 80/271 (29%), Positives = 127/271 (46%), Gaps = 27/271 (9%)

Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQ-----L 55
           +  +  +  +G G+FG   L   K T EL A+K +++   I  +     +  K+      
Sbjct: 340 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPG 399

Query: 56  RHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG----- 110
           + P + +      T   L  VMEY  GG+L   I   GRF E  A ++  ++  G     
Sbjct: 400 KPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQ 459

Query: 111 --QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTV-GTPAYIAPEVLSRR 167
              I +RDLKL+N +LD      +KI DFG  K ++       T  GTP YIAPE+++ +
Sbjct: 460 SKGIIYRDLKLDNVMLD--SEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQ 517

Query: 168 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCR 227
            Y GK  D W+ GV LY ML G  PFE +++ + F+     IM      P    +S++  
Sbjct: 518 PY-GKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQS----IMEHNVAYPKS--MSKEAV 570

Query: 228 NLLSRIFVANPSRRI-----TIKEIKSHPWF 253
            +   +   +P +R+       ++IK H +F
Sbjct: 571 AICKGLMTKHPGKRLGCGPEGERDIKEHAFF 601

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  178 bits (453), Expect = 1e-53
 Identities = 61/282 (21%), Positives = 97/282 (34%), Gaps = 38/282 (13%)

Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNI 60
           +        +G G+FG    M++K T    A+K +     ++     E++    L  P I
Sbjct: 57  VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVR----LEVFRVEELVACAGLSSPRI 112

Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-------QIC 113
           +     V     + I ME   GG L + I   G   ED A Y+  Q + G       +I 
Sbjct: 113 VPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRIL 172

Query: 114 HRDLKLENTLLDGSPAPRLKICDFGYSK------SSLLHSRPKSTVGTPAYIAPEVLSRR 167
           H D+K +N LL      R  +CDFG++                   GT  ++APEV+  +
Sbjct: 173 HGDVKADNVLLSSD-GSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGK 231

Query: 168 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYV------- 220
             D K  D+WS    +  ML G +P+                  +  KI           
Sbjct: 232 PCDAK-VDIWSSCCMMLHMLNGCHPWTQYFR-----------GPLCLKIASEPPPIREIP 279

Query: 221 -HISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLPREL 261
              +      +       P  R +  E++            L
Sbjct: 280 PSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGL 321

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score =  181 bits (460), Expect = 2e-53
 Identities = 75/278 (26%), Positives = 132/278 (47%), Gaps = 33/278 (11%)

Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKI-DANVA-----REIINHKQ 54
            E +E++K IG G FG   +++ KN  ++ AMK + +   +  A  A     R+++    
Sbjct: 73  REDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVL--VN 130

Query: 55  LRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNA-GRFSEDEARYFFQQLISG--- 110
                I           +L +VM+Y  GG+L   +     R  E+ AR++  +++     
Sbjct: 131 GDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDS 190

Query: 111 ----QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST--VGTPAYIAPEVL 164
                  HRD+K +N L+D +    +++ DFG     +     +S+  VGTP YI+PE+L
Sbjct: 191 VHQLHYVHRDIKPDNILMDMNG--HIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEIL 248

Query: 165 SRREYD----GKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMA--VQYKIPD 218
              E      G   D WS GV +Y ML G  PF  +    +  +T  +IM    +++ P 
Sbjct: 249 QAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAE----SLVETYGKIMNHKERFQFPT 304

Query: 219 YV-HISQDCRNLLSRIFVANPSR--RITIKEIKSHPWF 253
            V  +S++ ++L+ R+  +   R  +  I++ K HP+F
Sbjct: 305 QVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFF 342

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score =  179 bits (455), Expect = 4e-53
 Identities = 66/281 (23%), Positives = 118/281 (41%), Gaps = 37/281 (13%)

Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKI-DANVA-----REIINHKQ 54
            + +E++K IG G F    +++ K T ++ AMK + +   +    V+     R+++    
Sbjct: 60  RDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVL--VN 117

Query: 55  LRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAG-RFSEDEARYFFQQLISG--- 110
                I +         +L +VMEY  GG+L   +   G R   + AR++  +++     
Sbjct: 118 GDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDS 177

Query: 111 ----QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLL--HSRPKSTVGTPAYIAPEVL 164
                  HRD+K +N LLD      +++ DFG           R    VGTP Y++PE+L
Sbjct: 178 VHRLGYVHRDIKPDNILLDRCG--HIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEIL 235

Query: 165 SRREYD------GKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMA--VQYKI 216
                       G   D W+ GV  Y M  G  PF       +  +T  +I+       +
Sbjct: 236 QAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYAD----STAETYGKIVHYKEHLSL 291

Query: 217 PDY-VHISQDCRNLLSRIFVANPSRRIT---IKEIKSHPWF 253
           P     + ++ R+ + R  +  P  R+      + ++HP+F
Sbjct: 292 PLVDEGVPEEARDFIQR-LLCPPETRLGRGGAGDFRTHPFF 331

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score =  184 bits (468), Expect = 6e-53
 Identities = 70/272 (25%), Positives = 122/272 (44%), Gaps = 25/272 (9%)

Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQL----- 55
           M  + + + IG G FG     R  +T ++ AMK +++            +N + +     
Sbjct: 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVS 247

Query: 56  --RHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG--- 110
               P I+       TP  L+ +++   GG+L   +   G FSE + R++  ++I G   
Sbjct: 248 TGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEH 307

Query: 111 ----QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSR 166
                + +RDLK  N LLD      ++I D G +       +P ++VGT  Y+APEVL +
Sbjct: 308 MHNRFVVYRDLKPANILLDEHG--HVRISDLGLACD-FSKKKPHASVGTHGYMAPEVLQK 364

Query: 167 REYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDC 226
                  AD +S G  L+ +L G  PF      K+  +     + +  ++PD    S + 
Sbjct: 365 GVAYDSSADWFSLGCMLFKLLRGHSPFRQ-HKTKDKHEIDRMTLTMAVELPDS--FSPEL 421

Query: 227 RNLLSRIFVANPSRRI-----TIKEIKSHPWF 253
           R+LL  +   + +RR+       +E+K  P+F
Sbjct: 422 RSLLEGLLQRDVNRRLGCLGRGAQEVKESPFF 453

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score =  179 bits (457), Expect = 6e-52
 Identities = 67/271 (24%), Positives = 114/271 (42%), Gaps = 23/271 (8%)

Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQ----LR 56
              +   + +G G FG     + + T ++ A K +E+            +N KQ    + 
Sbjct: 183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVN 242

Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGR--FSEDEARYFFQQLISG---- 110
              ++       T   L +V+    GG+L   I + G+  F E  A ++  ++  G    
Sbjct: 243 SRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDL 302

Query: 111 ---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRR 167
              +I +RDLK EN LLD      ++I D G +         K  VGT  Y+APEV+   
Sbjct: 303 HRERIVYRDLKPENILLDDHG--HIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNE 360

Query: 168 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCR 227
            Y     D W+ G  LY M+ G  PF+ ++      +    +  V  +  +    S   R
Sbjct: 361 RY-TFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSER--FSPQAR 417

Query: 228 NLLSRIFVANPSRRI-----TIKEIKSHPWF 253
           +L S++   +P+ R+     + +E+K HP F
Sbjct: 418 SLCSQLLCKDPAERLGCRGGSAREVKEHPLF 448

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score =  177 bits (451), Expect = 2e-51
 Identities = 68/276 (24%), Positives = 116/276 (42%), Gaps = 30/276 (10%)

Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQ----LR 56
            + +   + +G G FG     + K T +L A K + +         +  +  K+    + 
Sbjct: 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVH 243

Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICN----AGRFSEDEARYFFQQLISG-- 110
              I+       T T L +VM    GG++   I N       F E  A ++  Q++SG  
Sbjct: 244 SRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLE 303

Query: 111 -----QICHRDLKLENTLLD--GSPAPRLKICDFGYSKSSLLH-SRPKSTVGTPAYIAPE 162
                 I +RDLK EN LLD  G     ++I D G +       ++ K   GTP ++APE
Sbjct: 304 HLHQRNIIYRDLKPENVLLDDDG----NVRISDLGLAVELKAGQTKTKGYAGTPGFMAPE 359

Query: 163 VLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHI 222
           +L   EY     D ++ GVTLY M+    PF  + +    ++   R++      PD    
Sbjct: 360 LLLGEEY-DFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDK--F 416

Query: 223 SQDCRNLLSRIFVANPSRRI-----TIKEIKSHPWF 253
           S   ++    +   +P +R+     +   +++HP F
Sbjct: 417 SPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLF 452

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  166 bits (423), Expect = 2e-49
 Identities = 66/267 (24%), Positives = 118/267 (44%), Gaps = 39/267 (14%)

Query: 10  IGSGNFGVARLMRNKNTKELVAMKYIE--RGHKIDANVAREIINHKQLRHPNIIRFKEVV 67
           +G G +G+    R+ + +  +A+K I           +  EI  HK L+H NI+++    
Sbjct: 30  LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQP-LHEEIALHKHLKHKNIVQYLGSF 88

Query: 68  LTPTHLAIVMEYAAGG---ELFERICNAGRFSEDEARYFFQQLISG-------QICHRDL 117
                + I ME   GG    L        + +E    ++ +Q++ G       QI HRD+
Sbjct: 89  SENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDI 148

Query: 118 KLENTLLDGSPAPRLKICDFGYSK-SSLLHSRPKSTVGTPAYIAPEVL--SRREYDGKLA 174
           K +N L++ + +  LKI DFG SK  + ++   ++  GT  Y+APE++    R Y    A
Sbjct: 149 KGDNVLIN-TYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKA-A 206

Query: 175 DVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKI---------PDYVHISQD 225
           D+WS G T+  M  G  PF +  +P           A  +K+         P+   +S +
Sbjct: 207 DIWSLGCTIIEMATGKPPFYELGEP----------QAAMFKVGMFKVHPEIPE--SMSAE 254

Query: 226 CRNLLSRIFVANPSRRITIKEIKSHPW 252
            +  + + F  +P +R    ++    +
Sbjct: 255 AKAFILKCFEPDPDKRACANDLLVDEF 281

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  161 bits (408), Expect = 3e-46
 Identities = 39/308 (12%), Positives = 75/308 (24%), Gaps = 63/308 (20%)

Query: 10  IGSGNFGVARLMRNKNTKELVAMKYIERGHKIDAN------------------------- 44
           +G  +        ++ T E   +       +  +N                         
Sbjct: 86  LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 145

Query: 45  -VAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYAA-----------GGELFERICNA 92
              R I     ++ P   +   V L    + ++  +             G  L       
Sbjct: 146 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 205

Query: 93  GRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKS--S 143
                        Q+I          + H  L+  + +LD      + +  F +     +
Sbjct: 206 KSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLD--QRGGVFLTGFEHLVRDGA 263

Query: 144 LLHSRPKSTVGTPAYIAPEVLSRREYDGKL----ADVWSCGVTLYVMLVGAYPFEDQEDP 199
              S        P   A  +L   ++   L     D W+ G+ +Y +     P  D    
Sbjct: 264 SAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAAL 323

Query: 200 KNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLPR 259
                                +I Q  R LL          R+   +    P + + L  
Sbjct: 324 GGSEWIFRSC----------KNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEY-EQLRT 372

Query: 260 ELTETAQA 267
           EL+     
Sbjct: 373 ELSAALPL 380

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  155 bits (393), Expect = 7e-45
 Identities = 61/280 (21%), Positives = 119/280 (42%), Gaps = 29/280 (10%)

Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYI--ERGHKIDANVAREI-INHKQLRH 57
           +   E + ++GSG  G    MR + T  ++A+K +      + +  +  ++ +  K    
Sbjct: 24  INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDC 83

Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG------- 110
           P I++     +T T + I ME         +    G   E         ++         
Sbjct: 84  PYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEK 143

Query: 111 -QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST-VGTPAYIAPEVLSRRE 168
             + HRD+K  N LLD     ++K+CDFG S   L+  + K    G  AY+APE +   +
Sbjct: 144 HGVIHRDVKPSNILLDER--GQIKLCDFGISG-RLVDDKAKDRSAGCAAYMAPERIDPPD 200

Query: 169 -----YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIP---DYV 220
                YD + ADVWS G++L  +  G +P+   ++ K   + ++++  +Q + P    ++
Sbjct: 201 PTKPDYDIR-ADVWSLGISLVELATGQFPY---KNCKTDFEVLTKV--LQEEPPLLPGHM 254

Query: 221 HISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLPRE 260
             S D ++ +      +  +R    ++  H +  +    E
Sbjct: 255 GFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRYETLE 294

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  150 bits (382), Expect = 1e-43
 Identities = 56/281 (19%), Positives = 113/281 (40%), Gaps = 40/281 (14%)

Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDAN--VAREI-INHKQLRH 57
            +  E + ++G G +GV   MR+  + +++A+K I           +  ++ I+ + +  
Sbjct: 6   ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDC 65

Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGG--ELFERICN-AGRFSEDEARYFFQQLISG---- 110
           P  + F   +     + I ME       + ++++ +      ED        ++      
Sbjct: 66  PFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHL 125

Query: 111 ----QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST-VGTPAYIAPEV-- 163
                + HRD+K  N L++     ++K+CDFG S   L+    K    G   Y+APE   
Sbjct: 126 HSKLSVIHRDVKPSNVLINAL--GQVKMCDFGISG-YLVDDVAKDIDAGCKPYMAPERIN 182

Query: 164 --LSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDY-- 219
             L+++ Y  K +D+WS G+T+  + +  +P++    P               ++ +   
Sbjct: 183 PELNQKGYSVK-SDIWSLGITMIELAILRFPYDSWGTP----------FQQLKQVVEEPS 231

Query: 220 -----VHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLK 255
                   S +  +  S+    N   R T  E+  HP+F  
Sbjct: 232 PQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTL 272

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  152 bits (386), Expect = 2e-43
 Identities = 74/304 (24%), Positives = 123/304 (40%), Gaps = 54/304 (17%)

Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDAN--VAREI-INHKQLRH 57
            + +E + ++G+GN GV   + +K +  ++A K I    K      + RE+ + H +   
Sbjct: 32  DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLH-ECNS 90

Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG------- 110
           P I+ F     +   ++I ME+  GG L + +  AGR  E         +I G       
Sbjct: 91  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK 150

Query: 111 -QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREY 169
            +I HRD+K  N L++      +K+CDFG S   L+ S   S VGT +Y++PE L    Y
Sbjct: 151 HKIMHRDVKPSNILVNSR--GEIKLCDFGVS-GQLIDSMANSFVGTRSYMSPERLQGTHY 207

Query: 170 DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDY---------- 219
             + +D+WS G++L  M VG YP    +  +       ++     + P            
Sbjct: 208 SVQ-SDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNK 266

Query: 220 ----VHISQDCRNLLSRI-------------------FVA-----NPSRRITIKEIKSHP 251
                        LL  I                   FV      NP+ R  +K++  H 
Sbjct: 267 FGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHA 326

Query: 252 WFLK 255
           +  +
Sbjct: 327 FIKR 330

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  148 bits (375), Expect = 2e-42
 Identities = 62/261 (23%), Positives = 107/261 (40%), Gaps = 25/261 (9%)

Query: 10  IGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAR---EIINHKQLRHPNIIRF--- 63
           IG G+F       +  T   VA   ++      +   R   E    K L+HPNI+RF   
Sbjct: 34  IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDS 93

Query: 64  -KEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG---------QIC 113
            +  V     + +V E    G L   +           R + +Q++ G          I 
Sbjct: 94  WESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPII 153

Query: 114 HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKL 173
           HRDLK +N  + G P   +KI D G +      S  K+ +GTP ++APE+    +YD   
Sbjct: 154 HRDLKCDNIFITG-PTGSVKIGDLGLATL-KRASFAKAVIGTPEFMAPEMY-EEKYDES- 209

Query: 174 ADVWSCGVTLYVMLVGAYPFEDQEDPKN-FRKTISRIMAVQYKIPDYVHISQDCRNLLSR 232
            DV++ G+ +  M    YP+ + ++    +R+  S +               + + ++  
Sbjct: 210 VDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVK--PASFDK--VAIPEVKEIIEG 265

Query: 233 IFVANPSRRITIKEIKSHPWF 253
               N   R +IK++ +H +F
Sbjct: 266 CIRQNKDERYSIKDLLNHAFF 286

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  147 bits (374), Expect = 3e-42
 Identities = 73/271 (26%), Positives = 120/271 (44%), Gaps = 31/271 (11%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYI--ERGHKIDANVAREIINHKQLRHPN 59
           E +  ++ IG G+FG      +  T+++VA+K I  E       ++ +EI    Q   P 
Sbjct: 22  ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 81

Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-------QI 112
           + ++    L  T L I+MEY  GG   + +   G   E +     ++++ G       + 
Sbjct: 82  VTKYYGSYLKDTKLWIIMEYLGGGSALD-LLEPGPLDETQIATILREILKGLDYLHSEKK 140

Query: 113 CHRDLKLENTLLDGSPAPRLKICDFGYSKS-SLLHSRPKSTVGTPAYIAPEVLSRREYDG 171
            HRD+K  N LL       +K+ DFG +   +    +  + VGTP ++APEV+ +  YD 
Sbjct: 141 IHRDIKAANVLLSEH--GEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDS 198

Query: 172 KLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYV------HISQD 225
           K AD+WS G+T   +  G  P  +   P          M V + IP         + S+ 
Sbjct: 199 K-ADIWSLGITAIELARGEPPHSE-LHP----------MKVLFLIPKNNPPTLEGNYSKP 246

Query: 226 CRNLLSRIFVANPSRRITIKEIKSHPWFLKN 256
            +  +       PS R T KE+  H + L+N
Sbjct: 247 LKEFVEACLNKEPSFRPTAKELLKHKFILRN 277

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  147 bits (373), Expect = 5e-42
 Identities = 75/304 (24%), Positives = 133/304 (43%), Gaps = 41/304 (13%)

Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNI 60
            ++ E+ + +G G FGV  + + K   + VA+K IE           E+    ++ HPNI
Sbjct: 7   YKEIEVEEVVGRGAFGV--VCKAKWRAKDVAIKQIESE-SERKAFIVELRQLSRVNHPNI 63

Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFERICNAG-----------RFSEDEAR--YFFQQL 107
           ++     L P  + +VMEYA GG L+  +  A             +    ++   +   +
Sbjct: 64  VKLYGACLNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSM 121

Query: 108 ISGQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRR 167
               + HRDLK  N LL       LKICDFG +    + +   +  G+ A++APEV    
Sbjct: 122 QPKALIHRDLKPPNLLLVAG-GTVLKICDFGTAC--DIQTHMTNNKGSAAWMAPEVFEGS 178

Query: 168 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYK-----IPDYVHI 222
            Y  K  DV+S G+ L+ ++    PF++   P        RIM   +      +   +  
Sbjct: 179 NYSEK-CDVFSWGIILWEVITRRKPFDEIGGPA------FRIMWAVHNGTRPPLIKNLP- 230

Query: 223 SQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTFSLQSV 282
            +   +L++R +  +PS+R +++EI      + +L R      + + Y  ++   SL   
Sbjct: 231 -KPIESLMTRCWSKDPSQRPSMEEIVKI---MTHLMRYFPGADEPLQYPCQH---SLPPG 283

Query: 283 EEIT 286
           E+  
Sbjct: 284 EDGR 287

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  146 bits (371), Expect = 7e-42
 Identities = 75/283 (26%), Positives = 129/283 (45%), Gaps = 39/283 (13%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDAN-VAREIINHKQLRHPNI 60
           +KY   + IG G  G      +  T + VA++ +    +     +  EI+  ++ ++PNI
Sbjct: 20  KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNI 79

Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-------QIC 113
           + + +  L    L +VMEY AGG L + +       E +     ++ +         Q+ 
Sbjct: 80  VNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQALEFLHSNQVI 138

Query: 114 HRDLKLENTLL--DGSPAPRLKICDFGYS-KSSLLHSRPKSTVGTPAYIAPEVLSRREYD 170
           HRD+K +N LL  DG     +K+ DFG+  + +   S+  + VGTP ++APEV++R+ Y 
Sbjct: 139 HRDIKSDNILLGMDG----SVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYG 194

Query: 171 GKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIP--------DYVHI 222
            K  D+WS G+    M+ G  P+ + E+P          +   Y I         +   +
Sbjct: 195 PK-VDIWSLGIMAIEMIEGEPPYLN-ENP----------LRALYLIATNGTPELQNPEKL 242

Query: 223 SQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKN--LPRELTE 263
           S   R+ L+R    +  +R + KE+  H  FLK       LT 
Sbjct: 243 SAIFRDFLNRCLEMDVEKRGSAKELLQHQ-FLKIAKPLSSLTP 284

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  147 bits (372), Expect = 8e-42
 Identities = 74/283 (26%), Positives = 131/283 (46%), Gaps = 39/283 (13%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKID-ANVAREIINHKQLRHPNI 60
              +    IG G+ G+  L R K++   VA+K ++   +     +  E++  +  +H N+
Sbjct: 45  LLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNV 104

Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-------QIC 113
           +   +  L    L ++ME+  GG L + I +  R +E++     + ++          + 
Sbjct: 105 VEMYKSYLVGEELWVLMEFLQGGALTD-IVSQVRLNEEQIATVCEAVLQALAYLHAQGVI 163

Query: 114 HRDLKLENTLL--DGSPAPRLKICDFGYS-KSSLLHSRPKSTVGTPAYIAPEVLSRREYD 170
           HRD+K ++ LL  DG    R+K+ DFG+  + S    + KS VGTP ++APEV+SR  Y 
Sbjct: 164 HRDIKSDSILLTLDG----RVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRSLYA 219

Query: 171 GKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIP--------DYVHI 222
            +  D+WS G+ +  M+ G  P+   + P          +    ++         +   +
Sbjct: 220 TE-VDIWSLGIMVIEMVDGEPPYFS-DSP----------VQAMKRLRDSPPPKLKNSHKV 267

Query: 223 SQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKN--LPRELTE 263
           S   R+ L R+ V +P  R T +E+  HP FL    LP  L  
Sbjct: 268 SPVLRDFLERMLVRDPQERATAQELLDHP-FLLQTGLPECLVP 309

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  147 bits (372), Expect = 1e-41
 Identities = 65/275 (23%), Positives = 116/275 (42%), Gaps = 24/275 (8%)

Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDAN--VAREI-INHKQLRH 57
            E  + + +IG G +G    M +K + +++A+K I           +  ++ +  +    
Sbjct: 21  AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDC 80

Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGG--ELFERICNA--GRFSEDEARYFFQQLISG--- 110
           P I++F   +       I ME  +    + ++ + +       E+         +     
Sbjct: 81  PYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNH 140

Query: 111 -----QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKS-TVGTPAYIAPEVL 164
                +I HRD+K  N LLD S    +K+CDFG S   L+ S  K+   G   Y+APE +
Sbjct: 141 LKENLKIIHRDIKPSNILLDRS--GNIKLCDFGISG-QLVDSIAKTRDAGCRPYMAPERI 197

Query: 165 ----SRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYV 220
               SR+ YD + +DVWS G+TLY +  G +P+       +    + +    Q    +  
Sbjct: 198 DPSASRQGYDVR-SDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLSNSEER 256

Query: 221 HISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLK 255
             S    N ++     + S+R   KE+  HP+ L 
Sbjct: 257 EFSPSFINFVNLCLTKDESKRPKYKELLKHPFILM 291

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  145 bits (369), Expect = 2e-41
 Identities = 74/298 (24%), Positives = 132/298 (44%), Gaps = 44/298 (14%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNII 61
           E +++++ +G G++G      +K T ++VA+K +     +   + +EI   +Q   P+++
Sbjct: 29  EVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQ-EIIKEISIMQQCDSPHVV 87

Query: 62  RFKEVVLTPTHLAIVMEYAAGGELFERI-CNAGRFSEDEARYFFQQLISG-------QIC 113
           ++       T L IVMEY   G + + I       +EDE     Q  + G       +  
Sbjct: 88  KYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKI 147

Query: 114 HRDLKLENTLL--DGSPAPRLKICDFGYSKSSLLHSRPK--STVGTPAYIAPEVLSRREY 169
           HRD+K  N LL  +G      K+ DFG +   L  +  K  + +GTP ++APEV+    Y
Sbjct: 148 HRDIKAGNILLNTEG----HAKLADFGVA-GQLTDTMAKRNTVIGTPFWMAPEVIQEIGY 202

Query: 170 DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIP--------DYVH 221
           +   AD+WS G+T   M  G  P+ D   P          M   + IP            
Sbjct: 203 NCV-ADIWSLGITAIEMAEGKPPYAD-IHP----------MRAIFMIPTNPPPTFRKPEL 250

Query: 222 ISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLP-----RELTETAQAIYYRKEN 274
            S +  + + +  V +P +R T  ++  HP F+++       R+L   A  +  +++ 
Sbjct: 251 WSDNFTDFVKQCLVKSPEQRATATQLLQHP-FVRSAKGVSILRDLINEAMDVKLKRQE 307

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  140 bits (355), Expect = 3e-39
 Identities = 40/238 (16%), Positives = 79/238 (33%), Gaps = 33/238 (13%)

Query: 39  HKIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERI---CNAGRF 95
                  + +I         N +   +      +L I M+      L + +   C+    
Sbjct: 102 PSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDR 161

Query: 96  SEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR 148
                 + F Q+           + HRDLK  N          +K+ DFG   +      
Sbjct: 162 EHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDD--VVKVGDFGLVTAMDQDEE 219

Query: 149 PKST-------------VGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFED 195
            ++              VGT  Y++PE +    Y  K  D++S G+ L+ +L   Y F  
Sbjct: 220 EQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHK-VDIFSLGLILFELL---YSFST 275

Query: 196 QEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 253
           Q       + I+ +  +++    +         ++  +   +P+ R    +I  +  F
Sbjct: 276 QM---ERVRIITDVRNLKFP-LLFTQKYPQEHMMVQDMLSPSPTERPEATDIIENAIF 329

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 60.7 bits (147), Expect = 2e-10
 Identities = 20/67 (29%), Positives = 33/67 (49%), Gaps = 2/67 (2%)

Query: 1  MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDAN--VAREIINHKQLRHP 58
          +  +E ++ +G G FGV    +NK      A+K I   ++  A   V RE+    +L HP
Sbjct: 5  LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHP 64

Query: 59 NIIRFKE 65
           I+R+  
Sbjct: 65 GIVRYFN 71

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  138 bits (351), Expect = 5e-39
 Identities = 71/273 (26%), Positives = 109/273 (39%), Gaps = 44/273 (16%)

Query: 5   ELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVA--------REIINHKQLR 56
           E  K IG G FG+    R    K +VA+K +  G                RE+     L 
Sbjct: 22  EYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLN 81

Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAG---------RFSEDEAR---YFF 104
           HPNI++   ++  P    +VME+   G+L+ R+ +           R   D A    Y  
Sbjct: 82  HPNIVKLYGLMHNP--PRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQ 139

Query: 105 QQLISGQICHRDLKLENTLLDG---SPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAP 161
            Q  +  I HRDL+  N  L     +     K+ DFG S+ S         +G   ++AP
Sbjct: 140 NQ--NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQS--VHSVSGLLGNFQWMAP 195

Query: 162 EVLSRRE--YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYK---- 215
           E +   E  Y  K AD +S  + LY +L G  PF++    K     I  I  ++ +    
Sbjct: 196 ETIGAEEESYTEK-ADTYSFAMILYTILTGEGPFDEYSYGK-----IKFINMIREEGLRP 249

Query: 216 -IPDYVHISQDCRNLLSRIFVANPSRRITIKEI 247
            IP+        RN++   +  +P +R     I
Sbjct: 250 TIPEDCP--PRLRNVIELCWSGDPKKRPHFSYI 280

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  136 bits (345), Expect = 8e-38
 Identities = 73/290 (25%), Positives = 128/290 (44%), Gaps = 48/290 (16%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQL-RHPNI 60
             +EL++ +G+G +G     R+  T +L A+K ++     +  + +EI   K+   H NI
Sbjct: 24  GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNI 83

Query: 61  IRF------KEVVLTPTHLAIVMEYAAGGELFE--RICNAGRFSEDEARYFFQQLISG-- 110
             +      K        L +VME+   G + +  +        E+   Y  ++++ G  
Sbjct: 84  ATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLS 143

Query: 111 -----QICHRDLKLENTLL--DGSPAPRLKICDFGYS-KSSLLHSRPKSTVGTPAYIAPE 162
                ++ HRD+K +N LL  +      +K+ DFG S +      R  + +GTP ++APE
Sbjct: 144 HLHQHKVIHRDIKGQNVLLTENA----EVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPE 199

Query: 163 VLSRRE-----YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIP 217
           V++  E     YD K +D+WS G+T   M  GA P  D   P          M   + IP
Sbjct: 200 VIACDENPDATYDFK-SDLWSLGITAIEMAEGAPPLCD-MHP----------MRALFLIP 247

Query: 218 -------DYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLPRE 260
                       S+  ++ +    V N S+R   +++  HP F+++ P E
Sbjct: 248 RNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHP-FIRDQPNE 296

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  135 bits (343), Expect = 1e-37
 Identities = 77/296 (26%), Positives = 124/296 (41%), Gaps = 47/296 (15%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYI--ERGHKIDANVAREIINHKQLRHPN 59
           E +E++ ++G G FG     +NK T  L A K I  +   +++ +   EI       HP 
Sbjct: 19  EVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELE-DYIVEIEILATCDHPY 77

Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFERICNA-GRFSEDEARYFFQQLISG-------Q 111
           I++          L I++E+  GG +   +       +E + +   +Q++         +
Sbjct: 78  IVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKR 137

Query: 112 ICHRDLKLENTLL--DGSPAPRLKICDFGYS-KSSLLHSRPKSTVGTPAYIAPEVLSRRE 168
           I HRDLK  N L+  +G     +++ DFG S K+     +  S +GTP ++APEV+    
Sbjct: 138 IIHRDLKAGNVLMTLEGD----IRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCET 193

Query: 169 -----YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIP------ 217
                YD K AD+WS G+TL  M     P  +  +P          M V  KI       
Sbjct: 194 MKDTPYDYK-ADIWSLGITLIEMAQIEPPHHE-LNP----------MRVLLKIAKSDPPT 241

Query: 218 --DYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLP----RELTETAQA 267
                  S + R+ L      NP  R +  ++  HP+          REL   A+A
Sbjct: 242 LLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSITSNKALRELVAEAKA 297

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  135 bits (343), Expect = 1e-37
 Identities = 80/295 (27%), Positives = 128/295 (43%), Gaps = 40/295 (13%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYI--ERGHKIDANVAREIINHKQLRHPN 59
           + YEL + IGSG   V +       KE VA+K I  E+       + +EI    Q  HPN
Sbjct: 15  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74

Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELF--------ERICNAGRFSEDEARYFFQQLISG- 110
           I+ +    +    L +VM+  +GG +         +    +G   E       ++++ G 
Sbjct: 75  IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 134

Query: 111 -------QICHRDLKLENTLLDGSPAPRLKICDFGYS------KSSLLHSRPKSTVGTPA 157
                  QI HRD+K  N LL    +  ++I DFG S           +   K+ VGTP 
Sbjct: 135 EYLHKNGQI-HRDVKAGNILLGEDGS--VQIADFGVSAFLATGGDITRNKVRKTFVGTPC 191

Query: 158 YIAPEVLSR-REYDGKLADVWSCGVTLYVMLVGAYPFEDQED-------PKNFRKTISRI 209
           ++APEV+ + R YD K AD+WS G+T   +  GA P+             +N   ++   
Sbjct: 192 WMAPEVMEQVRGYDFK-ADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLETG 250

Query: 210 MAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLPRE-LTE 263
           +  +  +  Y    +  R ++S     +P +R T  E+  H +F K   +E L E
Sbjct: 251 VQDKEMLKKY---GKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAKNKEFLQE 302

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score =  135 bits (342), Expect = 2e-37
 Identities = 83/320 (25%), Positives = 129/320 (40%), Gaps = 61/320 (19%)

Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK---IDANVAREIINHKQLRH 57
           MEKYE +  IG G++GV    RN++T ++VA+K          I     REI   KQL+H
Sbjct: 2   MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKH 61

Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAG--GELFERICNAGRFSEDEARYFFQQLISG----- 110
           PN++   EV      L +V EY         +R        E   +    Q +       
Sbjct: 62  PNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDR--YQRGVPEHLVKSITWQTLQAVNFCH 119

Query: 111 --QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST-VGTPAYIAPEVL-SR 166
                HRD+K EN L+       +K+CDFG+++     S      V T  Y +PE+L   
Sbjct: 120 KHNCIHRDVKPENILITKH--SVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVGD 177

Query: 167 REYDGKLADVWSCGVTLYVMLVGAYPF-----EDQEDPKNFRKTISRIM----------- 210
            +Y G   DVW+ G     +L G   +      DQ         I + +           
Sbjct: 178 TQY-GPPVDVWAIGCVFAELLSGVPLWPGKSDVDQ------LYLIRKTLGDLIPRHQQVF 230

Query: 211 -----AVQYKIPDYV----------HISQDCRNLLSRIFVANPSRRITIKEIKSHPWF-- 253
                    KIPD            +IS     LL      +P+ R+T +++  HP+F  
Sbjct: 231 STNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFEN 290

Query: 254 ---LKNLPRELTETAQAIYY 270
              +++L +E  + A+ +Y+
Sbjct: 291 IREIEDLAKEHDKPAENLYF 310

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score =  135 bits (342), Expect = 2e-37
 Identities = 77/304 (25%), Positives = 124/304 (40%), Gaps = 56/304 (18%)

Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK---IDANVAREIINHKQLRH 57
           +++Y  +  +G G +G      +  T E VA+K I   H+   +     RE+   K+L+H
Sbjct: 33  IDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQH 92

Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG------- 110
            NII  K V+     L ++ EYA   +L + +      S    + F  QLI+G       
Sbjct: 93  RNIIELKSVIHHNHRLHLIFEYAE-NDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSR 151

Query: 111 QICHRDLKLENTLLDGSPAPR---LKICDFGYSKSSLLHSRPKST-VGTPAYIAPEVL-S 165
           +  HRDLK +N LL  S A     LKI DFG +++  +  R  +  + T  Y  PE+L  
Sbjct: 152 RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLWYRPPEILLG 211

Query: 166 RREYDGKLADVWSCGVTLYVMLVGAYPF-----EDQEDPKNFRKTISRIM---------A 211
            R Y   + D+WS       ML+    F      DQ         I  ++          
Sbjct: 212 SRHYSTSV-DIWSIACIWAEMLMKTPLFPGDSEIDQLF------KIFEVLGLPDDTTWPG 264

Query: 212 VQYKIPDYV-----------------HISQDCRNLLSRIFVANPSRRITIKEIKSHPWFL 254
           V   +PD+                   +  +  +LL+ +   +P +RI+ K    HP+F 
Sbjct: 265 VT-ALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYF- 322

Query: 255 KNLP 258
            +  
Sbjct: 323 SHND 326

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  133 bits (337), Expect = 3e-37
 Identities = 70/271 (25%), Positives = 102/271 (37%), Gaps = 38/271 (14%)

Query: 5   ELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDA-----NVAREIINHKQLRHPN 59
            L + IG G FG          +  VA+K        D      NV +E      L+HPN
Sbjct: 10  TLEEIIGIGGFGKVYRAFWIGDE--VAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPN 67

Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFERICN-------AGRFSEDEAR--YFFQQLISG 110
           II  + V L   +L +VME+A GG L   +            ++   AR   +       
Sbjct: 68  IIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKRIPPDILVNWAVQIARGMNYLHDEAIV 127

Query: 111 QICHRDLKLENTLLDGSPAPR------LKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVL 164
            I HRDLK  N L+             LKI DFG ++     +   S  G  A++APEV+
Sbjct: 128 PIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR-EWHRTTKMSAAGAYAWMAPEVI 186

Query: 165 SRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYK-----IPDY 219
               +    +DVWS GV L+ +L G  PF   +        ++    V        IP  
Sbjct: 187 RASMFSKG-SDVWSYGVLLWELLTGEVPFRGID-------GLAVAYGVAMNKLALPIPST 238

Query: 220 VHISQDCRNLLSRIFVANPSRRITIKEIKSH 250
               +    L+   +  +P  R +   I   
Sbjct: 239 CP--EPFAKLMEDCWNPDPHSRPSFTNILDQ 267

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score =  134 bits (339), Expect = 4e-37
 Identities = 77/306 (25%), Positives = 131/306 (42%), Gaps = 62/306 (20%)

Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK---IDANVAREIINHKQLRH 57
           M+KYE ++ IG G +G     +N+ T E+VA+K +        + ++  REI   K+L+H
Sbjct: 1   MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKH 60

Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAG--GELFERICNAGRFSEDEARYFFQQLISG----- 110
            NI+R  +V+ +   L +V E+      + F+     G    +  + F  QL+ G     
Sbjct: 61  KNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDS--CNGDLDPEIVKSFLFQLLKGLGFCH 118

Query: 111 --QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST-VGTPAYIAPEVL-SR 166
              + HRDLK +N L++ +    LK+ +FG +++  +  R  S  V T  Y  P+VL   
Sbjct: 119 SRNVLHRDLKPQNLLINRN--GELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGA 176

Query: 167 REYDGKLADVWSCGVTLYVMLVGAYPF------EDQEDPKNFRKTISRIMAV-------- 212
           + Y   + D+WS G     +     P       +DQ         + RI  +        
Sbjct: 177 KLYSTSI-DMWSAGCIFAELANAGRPLFPGNDVDDQ---------LKRIFRLLGTPTEEQ 226

Query: 213 ---QYKIPDYV----------------HISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 253
                K+PDY                  ++   R+LL  +   NP +RI+ +E   HP+F
Sbjct: 227 WPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYF 286

Query: 254 LKNLPR 259
             +   
Sbjct: 287 -SDFCP 291

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  133 bits (337), Expect = 1e-36
 Identities = 77/284 (27%), Positives = 120/284 (42%), Gaps = 40/284 (14%)

Query: 5   ELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVA---REIINHKQLRHPNII 61
            + + IG+G+FG   + R +     VA+K +         V    RE+   K+LRHPNI+
Sbjct: 40  NIKEKIGAGSFG--TVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIV 97

Query: 62  RFKEVVLTPTHLAIVMEYAAGGELFERICNAGR---FSEDEARYFFQQLISG-------- 110
            F   V  P +L+IV EY + G L+  +  +G      E         +  G        
Sbjct: 98  LFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRN 157

Query: 111 -QICHRDLKLENTLLDGSPAPRLKICDFGYS--KSSLLHSRPKSTVGTPAYIAPEVLSRR 167
             I HR+LK  N L+D      +K+CDFG S  K+S   S  KS  GTP ++APEVL   
Sbjct: 158 PPIVHRNLKSPNLLVDKK--YTVKVCDFGLSRLKASTFLSS-KSAAGTPEWMAPEVLRDE 214

Query: 168 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYK-----IPDYVHI 222
             + K +DV+S GV L+ +     P+ +             + AV +K     IP  ++ 
Sbjct: 215 PSNEK-SDVYSFGVILWELATLQQPWGNLNP-------AQVVAAVGFKCKRLEIPRNLN- 265

Query: 223 SQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLPRELTETAQ 266
                 ++   +   P +R +   I      L+ L +       
Sbjct: 266 -PQVAAIIEGCWTNEPWKRPSFATIMDL---LRPLIKSAVPPPN 305

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score =  133 bits (338), Expect = 1e-36
 Identities = 78/315 (24%), Positives = 124/315 (39%), Gaps = 61/315 (19%)

Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYI-----ERGHKIDANVAREIINHKQL 55
           MEKYE +  +G G++G+    RNK+T  +VA+K       ++  K  A   REI   KQL
Sbjct: 24  MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIA--MREIKLLKQL 81

Query: 56  RHPNIIRFKEVVLTPTHLAIVMEYAAG--GELFERICNAGRFSEDEARYFFQQLISG--- 110
           RH N++   EV        +V E+      +  E   N         + +  Q+I+G   
Sbjct: 82  RHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNG--LDYQVVQKYLFQIINGIGF 139

Query: 111 ----QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST-VGTPAYIAPEVLS 165
                I HRD+K EN L+  S    +K+CDFG++++           V T  Y APE+L 
Sbjct: 140 CHSHNIIHRDIKPENILVSQS--GVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLV 197

Query: 166 R-REYDGKLADVWSCGVTLYVMLVGAYPF-----EDQEDPKNFRKTISRIM--------- 210
              +Y GK  DVW+ G  +  M +G   F      DQ         I   +         
Sbjct: 198 GDVKY-GKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQ------LYHIMMCLGNLIPRHQE 250

Query: 211 -------AVQYKIPDYVH----------ISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 253
                      ++P+             +S+   +L  +    +P +R    E+  H +F
Sbjct: 251 LFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFF 310

Query: 254 LK-NLPRELTETAQA 267
                    ++  Q 
Sbjct: 311 QMDGFAERFSQELQL 325

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  134 bits (338), Expect = 2e-36
 Identities = 74/300 (24%), Positives = 126/300 (42%), Gaps = 46/300 (15%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYI----ERGHKIDANVAREIINHKQLRH 57
           + +  +++IG G+FG     R+    E+VA+K +    ++ ++   ++ +E+   ++LRH
Sbjct: 54  KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRH 113

Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG------- 110
           PN I+++   L      +VMEY  G        +     E E        + G       
Sbjct: 114 PNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH 173

Query: 111 QICHRDLKLENTLL--DGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLS--- 165
            + HRD+K  N LL   G     +K+ DFG   +S++     S VGTP ++APEV+    
Sbjct: 174 NMIHRDVKAGNILLSEPG----LVKLGDFGS--ASIMAPA-NSFVGTPYWMAPEVILAMD 226

Query: 166 RREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIP-------D 218
             +YDGK  DVWS G+T   +     P  +  +           M+  Y I         
Sbjct: 227 EGQYDGK-VDVWSLGITCIELAERKPPLFN-MNA----------MSALYHIAQNESPALQ 274

Query: 219 YVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLP----RELTETAQAIYYRKEN 274
             H S+  RN +       P  R T + +  H + L+  P     +L +  +      +N
Sbjct: 275 SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPPTVIMDLIQRTKDAVRELDN 334

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  131 bits (332), Expect = 3e-36
 Identities = 63/281 (22%), Positives = 113/281 (40%), Gaps = 35/281 (12%)

Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVA---REIINHKQLRH 57
             +  + + IGSG+FG     +       VA+K +         +     E+   ++ RH
Sbjct: 23  DGQITVGQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRH 79

Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFERI-CNAGRFSEDEARYFFQQLISG------ 110
            NI+ F     T   LAIV ++  G  L+  +  +  +F   +     +Q   G      
Sbjct: 80  VNILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHA 138

Query: 111 -QICHRDLKLENTLLDGSPAPRLKICDFGYSK---SSLLHSRPKSTVGTPAYIAPEVLSR 166
             I HRDLK  N  L       +KI DFG +          + +   G+  ++APEV+  
Sbjct: 139 KSIIHRDLKSNNIFLHED--NTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRM 196

Query: 167 RE---YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHIS 223
           ++   Y  + +DV++ G+ LY ++ G  P+ +     N R  I  ++      PD   + 
Sbjct: 197 QDSNPYSFQ-SDVYAFGIVLYELMTGQLPYSN----INNRDQIIEMVGRGSLSPDLSKVR 251

Query: 224 QDC----RNLLSRIFVANPSRRITIKEIKSHPWFLKNLPRE 260
            +C    + L++         R +   I +    ++ L RE
Sbjct: 252 SNCPKRMKRLMAECLKKKRDERPSFPRILAE---IEELARE 289

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score =  130 bits (330), Expect = 1e-35
 Identities = 74/303 (24%), Positives = 125/303 (41%), Gaps = 48/303 (15%)

Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK--IDANVAREIINHKQLRHP 58
             +++ ++ +G+G +       NK T   VA+K ++   +    +   REI   K+L+H 
Sbjct: 4   SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHE 63

Query: 59  NIIRFKEVVLTPTHLAIVMEY-----AAGGELFERICNAGRFSEDEARYFFQQLISG--- 110
           NI+R  +V+ T   L +V E+         +             +  +YF  QL+ G   
Sbjct: 64  NIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAF 123

Query: 111 ----QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST-VGTPAYIAPEVL- 164
               +I HRDLK +N L++     +LK+ DFG +++  +     S+ V T  Y AP+VL 
Sbjct: 124 CHENKILHRDLKPQNLLINKR--GQLKLGDFGLARAFGIPVNTFSSEVVTLWYRAPDVLM 181

Query: 165 SRREYDGKLADVWSCGVTLYVMLVGAYPF-----EDQ------------ED--P------ 199
             R Y   + D+WSCG  L  M+ G   F     E+Q            E   P      
Sbjct: 182 GSRTYSTSI-DIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLP 240

Query: 200 ---KNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKN 256
               N ++   R +    +      +  +  + L  +   NP  R++ K+   HPWF   
Sbjct: 241 KYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWF-AE 299

Query: 257 LPR 259
              
Sbjct: 300 YYH 302

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  130 bits (329), Expect = 2e-35
 Identities = 58/289 (20%), Positives = 114/289 (39%), Gaps = 54/289 (18%)

Query: 5   ELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVA---REIINHKQLRHPNII 61
           E+ + IG G FG     R       VA++ I+     +  +    RE++ ++Q RH N++
Sbjct: 36  EIGELIGKGRFGQVYHGRWHGE---VAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVV 92

Query: 62  RFKEVVLTPTHLAIVMEYAAGGELFERICNAGR-FSEDEARYFFQQLISG-------QIC 113
            F    ++P HLAI+     G  L+  + +A      ++ R   Q+++ G        I 
Sbjct: 93  LFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGIL 152

Query: 114 HRDLKLENTLLDGSPAPRLKICDFGYSK------SSLLHSRPKSTVGTPAYIAPEVLSRR 167
           H+DLK +N   D     ++ I DFG         +     + +   G   ++APE++ + 
Sbjct: 153 HKDLKSKNVFYDNG---KVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQL 209

Query: 168 E---------YDGKLADVWSCGVTLYVMLVGAYPFEDQEDP-------KNFRKTISRIMA 211
                     +    +DV++ G   Y +    +PF+ Q             +  +S+I  
Sbjct: 210 SPDTEEDKLPFSKH-SDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKPNLSQI-- 266

Query: 212 VQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLPRE 260
                     + ++  ++L   +      R T  ++      L+ LP+ 
Sbjct: 267 ---------GMGKEISDILLFCWAFEQEERPTFTKLMDM---LEKLPKR 303

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score =  129 bits (327), Expect = 4e-35
 Identities = 68/305 (22%), Positives = 121/305 (39%), Gaps = 57/305 (18%)

Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK--IDANVAREIINHKQLRHP 58
           ME Y  +  +G G +      ++K T  LVA+K I   H+        RE+   K L+H 
Sbjct: 1   METYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHA 60

Query: 59  NIIRFKEVVLTPTHLAIVMEYAAG--GELFERICNAGRFSEDEARYFFQQLISG------ 110
           NI+   +++ T   L +V EY      +  +        +    + F  QL+ G      
Sbjct: 61  NIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDD--CGNIINMHNVKLFLFQLLRGLAYCHR 118

Query: 111 -QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST-VGTPAYIAPEVL-SRR 167
            ++ HRDLK +N L++      LK+ DFG +++  + ++     V T  Y  P++L    
Sbjct: 119 QKVLHRDLKPQNLLINERGE--LKLADFGLARAKSIPTKTYDNEVVTLWYRPPDILLGST 176

Query: 168 EYDGKLADVWSCGVTLYVMLVGAYPF-----EDQEDPKNFRKTISRIM---------AVQ 213
           +Y  ++ D+W  G   Y M  G   F     E+Q         I RI+          + 
Sbjct: 177 DYSTQI-DMWGVGCIFYEMATGRPLFPGSTVEEQLH------FIFRILGTPTEETWPGIL 229

Query: 214 YKIPDYV-----------------HISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKN 256
               ++                   +  D  +LL+++       RI+ ++   HP+F  +
Sbjct: 230 -SNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFF-LS 287

Query: 257 LPREL 261
           L   +
Sbjct: 288 LGERI 292

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score =  126 bits (320), Expect = 2e-34
 Identities = 81/297 (27%), Positives = 131/297 (44%), Gaps = 57/297 (19%)

Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK---IDANVAREIINHKQLRH 57
           MEKY  ++ IG G +GV    +N    E  A+K I    +   I +   REI   K+L+H
Sbjct: 1   MEKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKH 59

Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAG--GELFERICNAGRFSEDEARYFFQQLISG----- 110
            NI++  +V+ T   L +V E+      +L +     G      A+ F  QL++G     
Sbjct: 60  SNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDV--CEGGLESVTAKSFLLQLLNGIAYCH 117

Query: 111 --QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST-VGTPAYIAPEVL-SR 166
             ++ HRDLK +N L++      LKI DFG +++  +  R  +  + T  Y AP+VL   
Sbjct: 118 DRRVLHRDLKPQNLLINRE--GELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGS 175

Query: 167 REYDGKLADVWSCGVTLYVMLVGAYPF-----EDQEDPKNFRKTISRIM---------AV 212
           ++Y   + D+WS G     M+ G   F      DQ         I RI+          V
Sbjct: 176 KKYSTTI-DIWSVGCIFAEMVNGTPLFPGVSEADQLM------RIFRILGTPNSKNWPNV 228

Query: 213 QYKIPDYV----------------HISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 253
             ++P Y                  + +   +LLS++   +P++RIT K+   H +F
Sbjct: 229 T-ELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYF 284

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score =  126 bits (320), Expect = 3e-34
 Identities = 78/306 (25%), Positives = 139/306 (45%), Gaps = 59/306 (19%)

Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK---IDANVAREIINHKQLRH 57
           MEKY+ ++ +G G +GV    ++     +VA+K I    +   I +   REI   K+L H
Sbjct: 20  MEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGIPSTAIREISLLKELHH 78

Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAG--GELFERICNAGRFSEDEARYFFQQLISG----- 110
           PNI+   +V+ +   L +V E+      ++ +   N     + + + +  QL+ G     
Sbjct: 79  PNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDE--NKTGLQDSQIKIYLYQLLRGVAHCH 136

Query: 111 --QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST-VGTPAYIAPEVL-SR 166
             +I HRDLK +N L++      LK+ DFG +++  +  R  +  V T  Y AP+VL   
Sbjct: 137 QHRILHRDLKPQNLLINSD--GALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMGS 194

Query: 167 REYDGKLADVWSCGVTLYVMLVGAYPF-----EDQEDPKNFRKTISRIM---------AV 212
           ++Y   + D+WS G     M+ G   F     +DQ         I  I+          V
Sbjct: 195 KKYSTSV-DIWSIGCIFAEMITGKPLFPGVTDDDQLP------KIFSILGTPNPREWPQV 247

Query: 213 QYKIPDYV-----------------HISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLK 255
           Q ++P +                     Q+  +LLS +   +P++RI+ ++  +HP+F K
Sbjct: 248 Q-ELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYF-K 305

Query: 256 NLPREL 261
           +L  ++
Sbjct: 306 DLDPQI 311

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  125 bits (317), Expect = 3e-34
 Identities = 45/266 (16%), Positives = 90/266 (33%), Gaps = 40/266 (15%)

Query: 5   ELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH---KIDANVAREIINHKQLRHPNII 61
             +  +   + G   L + +     + +K ++      +   +   E    +   HPN++
Sbjct: 13  NFLTKLNENHSG--ELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVL 70

Query: 62  RFKEVVLTP--THLAIVMEYAAGGELFERICNAGRFSEDEARYF-----------FQQLI 108
                  +P   H  ++  +   G L+  +     F  D+++             F   +
Sbjct: 71  PVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTL 130

Query: 109 SGQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRRE 168
              I    L   + ++D       +I       S     +    +  PA++APE L ++ 
Sbjct: 131 EPLIPRHALNSRSVMIDEDM--TARISMADVKFSF----QSPGRMYAPAWVAPEALQKKP 184

Query: 169 YDG--KLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYK-----IPDYVH 221
            D   + AD+WS  V L+ ++    PF D          +   M V  +     IP    
Sbjct: 185 EDTNRRSADMWSFAVLLWELVTREVPFADL-------SNMEIGMKVALEGLRPTIPP--G 235

Query: 222 ISQDCRNLLSRIFVANPSRRITIKEI 247
           IS     L+      +P++R     I
Sbjct: 236 ISPHVSKLMKICMNEDPAKRPKFDMI 261

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score =  126 bits (320), Expect = 6e-34
 Identities = 82/310 (26%), Positives = 129/310 (41%), Gaps = 69/310 (22%)

Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK------IDANVAREIINHKQ 54
            ++YE +  +G G F      R+KNT ++VA+K I+ GH+      I+    REI   ++
Sbjct: 9   AKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQE 68

Query: 55  LRHPNIIRFKEVVLTPTHLAIVMEYAAG--GELFERICNAGRFSEDEARYFFQQLISG-- 110
           L HPNII   +     +++++V ++       + +   N+   +    + +    + G  
Sbjct: 69  LSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKD--NSLVLTPSHIKAYMLMTLQGLE 126

Query: 111 -----QICHRDLKLENTLLD--GSPAPRLKICDFGYSKSSLLHSRPKST-VGTPAYIAPE 162
                 I HRDLK  N LLD  G     LK+ DFG +KS    +R  +  V T  Y APE
Sbjct: 127 YLHQHWILHRDLKPNNLLLDENG----VLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPE 182

Query: 163 VL-SRREYDGKLADVWSCGVTLYVMLVGAYPF------EDQEDPKNFRKTISRIMAV--- 212
           +L   R Y   + D+W+ G  L  +L+   PF       DQ         ++RI      
Sbjct: 183 LLFGARMYGVGV-DMWAVGCILAELLLRV-PFLPGDSDLDQ---------LTRIFETLGT 231

Query: 213 --------QYKIPDYV---------------HISQDCRNLLSRIFVANPSRRITIKEIKS 249
                      +PDYV                   D  +L+  +F+ NP  RIT  +   
Sbjct: 232 PTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 291

Query: 250 HPWFLKNLPR 259
             +F  N P 
Sbjct: 292 MKYF-SNRPG 300

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  127 bits (321), Expect = 6e-34
 Identities = 63/327 (19%), Positives = 110/327 (33%), Gaps = 70/327 (21%)

Query: 2   EKYELMKDIGSG--NFGVARLMRNKNTKELVAMKYI--ERGHKIDAN-VAREIINHKQLR 56
             YEL+  IG G  +     L R K T E V ++ I  E         +  E+   K   
Sbjct: 25  GCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFN 84

Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNA--GRFSEDEARYFFQQLISG---- 110
           HPNI+ ++   +    L +V  + A G   + IC       +E    Y  Q ++      
Sbjct: 85  HPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYI 144

Query: 111 ----QICHRDLKLENTLLDGSPAPRLKICDFGYS--------KSSLLHSRPKSTVGTPAY 158
                + HR +K  + L+       + +     +        +  ++H  PK +V    +
Sbjct: 145 HHMGYV-HRSVKASHILISVDGK--VYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPW 201

Query: 159 IAPEVLSR--REYDGKLADVWSCGVTLYVMLVGAYPFED-----------QEDP------ 199
           ++PEVL +  + YD K +D++S G+T   +  G  PF+D                     
Sbjct: 202 LSPEVLQQNLQGYDAK-SDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDT 260

Query: 200 -----------------------KNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVA 236
                                       T           P +   S    + + +    
Sbjct: 261 STIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQR 320

Query: 237 NPSRRITIKEIKSHPWFLKNLPRELTE 263
           NP  R +   + +H  F K + R  +E
Sbjct: 321 NPDARPSASTLLNHS-FFKQIKRRASE 346

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score =  127 bits (322), Expect = 1e-33
 Identities = 76/297 (25%), Positives = 121/297 (40%), Gaps = 55/297 (18%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNII 61
             Y   K IG+G+FGV    +  ++ ELVA+K +    K   N  RE+   ++L H NI+
Sbjct: 54  VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKRFKN--RELQIMRKLDHCNIV 110

Query: 62  RFKEVVLTPT------HLAIVMEYAAGGELFERI----CNAGRFSEDEARYFFQQLI--- 108
           R +    +        +L +V++Y     ++                  + +  QL    
Sbjct: 111 RLRYFFYSSGEKKDEVYLNLVLDY-VPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 169

Query: 109 ----SGQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST--VGTPAYIAPE 162
               S  ICHRD+K +N LLD   A  LK+CDFG +K   L     +   + +  Y APE
Sbjct: 170 AYIHSFGICHRDIKPQNLLLDPDTA-VLKLCDFGSAKQ--LVRGEPNVSYICSRYYRAPE 226

Query: 163 V-LSRREYDGKLADVWSCGVTLYVMLVGA--YPFEDQED-----------PKNFRKTISR 208
           +     +Y   + DVWS G  L  +L+G   +P +   D           P   R+ I  
Sbjct: 227 LIFGATDYTSSI-DVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPT--REQIRE 283

Query: 209 I--MAVQYKIPDYV----------HISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 253
           +     ++K P                 +   L SR+    P+ R+T  E  +H +F
Sbjct: 284 MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFF 340

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score =  124 bits (313), Expect = 4e-33
 Identities = 71/302 (23%), Positives = 110/302 (36%), Gaps = 53/302 (17%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVA-REIINHKQLRHPNI 60
            +Y  +K +G G  G+     + +  + VA+K I          A REI   ++L H NI
Sbjct: 11  SRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNI 70

Query: 61  IRFKEVVLTPTHLAIVMEYAAGG--------ELFE----RICNAGRFSEDEARYFFQQLI 108
           ++  E++            +           E  E     +   G   E+ AR F  QL+
Sbjct: 71  VKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHARLFMYQLL 130

Query: 109 -------SGQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST----VGTPA 157
                  S  + HRDLK  N  ++ +    LKI DFG ++    H   K      + T  
Sbjct: 131 RGLKYIHSANVLHRDLKPANLFIN-TEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKW 189

Query: 158 YIAPEV-LSRREYDGKLADVWSCGVTLYVMLVGAYPFE------------------DQED 198
           Y +P + LS   Y  K  D+W+ G     ML G   F                    +ED
Sbjct: 190 YRSPRLLLSPNNYT-KAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHEED 248

Query: 199 ----PKNFRKTISRIMAVQYKIP---DYVHISQDCRNLLSRIFVANPSRRITIKEIKSHP 251
                      I      +   P       IS++  + L +I   +P  R+T +E  SHP
Sbjct: 249 RQELLSVIPVYIRN-DMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHP 307

Query: 252 WF 253
           + 
Sbjct: 308 YM 309

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score =  123 bits (311), Expect = 2e-32
 Identities = 70/302 (23%), Positives = 120/302 (39%), Gaps = 54/302 (17%)

Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDAN-VAREIINHKQLRHPN 59
           M+++++ +  G G FG  +L + K+T   VA+K +        N   + + +   L HPN
Sbjct: 22  MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKV-IQDPRFRNRELQIMQDLAVLHHPN 80

Query: 60  IIRFKEVVLTPTH-------LAIVMEYAAGGELFERICNAGR----FSEDEARYFFQQLI 108
           I++ +    T          L +VMEY     L     N  R          + F  QLI
Sbjct: 81  IVQLQSYFYTLGERDRRDIYLNVVMEY-VPDTLHRCCRNYYRRQVAPPPILIKVFLFQLI 139

Query: 109 ---------SGQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPK-STVGTPAY 158
                    S  +CHRD+K  N L++ +    LK+CDFG +K  L  S P  + + +  Y
Sbjct: 140 RSIGCLHLPSVNVCHRDIKPHNVLVNEADG-TLKLCDFGSAK-KLSPSEPNVAYICSRYY 197

Query: 159 IAPEV-LSRREYDGKLADVWSCGVTLYVMLVGA--YPFEDQED----------------- 198
            APE+    + Y   + D+WS G     M++G   +  ++                    
Sbjct: 198 RAPELIFGNQHYTTAV-DIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVL 256

Query: 199 ----PKNFRKTISRIMAVQYK--IPDYV-HISQDCRNLLSRIFVANPSRRITIKEIKSHP 251
               P +    +     + +     D+    +++  +LLS +    P  R+   E   HP
Sbjct: 257 RKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHP 316

Query: 252 WF 253
           +F
Sbjct: 317 YF 318

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score =  120 bits (304), Expect = 6e-32
 Identities = 63/311 (20%), Positives = 107/311 (34%), Gaps = 66/311 (21%)

Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVA------REIINHKQ 54
             +YE + +IG G +G     R+ ++   VA+K +   +             RE+   ++
Sbjct: 8   TSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRR 67

Query: 55  LR---HPNIIRFKEVVLTPTH-----LAIVMEYAAG--GELFERICNAGRFSEDEARYFF 104
           L    HPN++R  +V  T        + +V E+         ++         +  +   
Sbjct: 68  LEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDK-APPPGLPAETIKDLM 126

Query: 105 QQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPA 157
           +Q + G        I HRDLK EN L+       +K+ DFG ++           V T  
Sbjct: 127 RQFLRGLDFLHANCIVHRDLKPENILVTSG--GTVKLADFGLARIYSYQMALTPVVVTLW 184

Query: 158 YIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPF-----EDQEDPKNFRKTISRIMAV 212
           Y APEVL +  Y   + D+WS G     M      F      DQ         + +I  +
Sbjct: 185 YRAPEVLLQSTYATPV-DMWSVGCIFAEMFRRKPLFCGNSEADQ---------LGKIFDL 234

Query: 213 ----------------QYKIPDYV---------HISQDCRNLLSRIFVANPSRRITIKEI 247
                           +   P             + +    LL  +   NP +RI+    
Sbjct: 235 IGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRA 294

Query: 248 KSHPWFLKNLP 258
             H +  K+  
Sbjct: 295 LQHSYLHKDEG 305

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score =  121 bits (306), Expect = 8e-32
 Identities = 75/296 (25%), Positives = 123/296 (41%), Gaps = 53/296 (17%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIER--GHKIDAN-VAREIINHKQLRHP 58
             Y  ++ +GSG +G      +  T   VA+K + R    ++ A    RE+   K +RH 
Sbjct: 25  AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHE 84

Query: 59  NIIRFKEVVLTPTHLA------IVMEYAAGGELFERICNAGRFSEDEARYFFQQLI---- 108
           N+I   +V      L       +VM +  G +L  ++    +  ED  ++   Q++    
Sbjct: 85  NVIGLLDVFTPDETLDDFTDFYLVMPF-MGTDL-GKLMKHEKLGEDRIQFLVYQMLKGLR 142

Query: 109 ---SGQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST--VGTPAYIAPEV 163
              +  I HRDLK  N  ++      LKI DFG ++     +  + T  V T  Y APEV
Sbjct: 143 YIHAAGIIHRDLKPGNLAVNED--CELKILDFGLARQ----ADSEMTGYVVTRWYRAPEV 196

Query: 164 -LSRREYDGKLADVWSCGVTLYVMLVGAYPFE-----DQED---------PKNFRKTISR 208
            L+   Y  +  D+WS G  +  M+ G   F+     DQ           P  F + +  
Sbjct: 197 ILNWMRYT-QTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQS 255

Query: 209 IMAVQY--KIPD---------YVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 253
             A  Y   +P+           + S    NLL ++ V +  +R+T  E  +HP+F
Sbjct: 256 DEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYF 311

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score =  120 bits (304), Expect = 1e-31
 Identities = 76/296 (25%), Positives = 128/296 (43%), Gaps = 54/296 (18%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIER--GHKIDANVA-REIINHKQLRHP 58
           + Y     +GSG +G      +K + E VA+K + R    +I A  A RE++  K ++H 
Sbjct: 24  KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHE 83

Query: 59  NIIRFKEVVLTPTHLA------IVMEYAAGGELFERICNAGRFSEDEARYFFQQLI---- 108
           N+I   +V    + L       +VM +    +L + +    +FSE++ +Y   Q++    
Sbjct: 84  NVIGLLDVFTPASSLRNFYDFYLVMPF-MQTDLQKIM--GLKFSEEKIQYLVYQMLKGLK 140

Query: 109 ---SGQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST--VGTPAYIAPEV 163
              S  + HRDLK  N  ++      LKI DFG ++     +  + T  V T  Y APEV
Sbjct: 141 YIHSAGVVHRDLKPGNLAVNED--CELKILDFGLARH----ADAEMTGYVVTRWYRAPEV 194

Query: 164 -LSRREYDGKLADVWSCGVTLYVMLVGAYPFE-----DQED---------PKNFRKTISR 208
            LS   Y+ +  D+WS G  +  ML G   F+     DQ              F + ++ 
Sbjct: 195 ILSWMHYN-QTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLND 253

Query: 209 IMAVQY--KIPD---------YVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 253
             A  Y   +P          +   S    +LL ++   +  +R+T  +  +HP+F
Sbjct: 254 KAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFF 309

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  119 bits (300), Expect = 1e-31
 Identities = 65/297 (21%), Positives = 101/297 (34%), Gaps = 64/297 (21%)

Query: 5   ELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRF- 63
            L++ +G G +G   + R     E VA+K      +       E+ N   LRH NI+ F 
Sbjct: 11  TLLECVGKGRYG--EVWRGSWQGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFI 68

Query: 64  ---KEVVLTPTHLAIVMEYAAGGELFERI-------CNAGRFSEDEAR-------YFFQQ 106
                   + T L ++  Y   G L++ +        +  R     A          F  
Sbjct: 69  ASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGT 128

Query: 107 LISGQICHRDLKLENTLLDGSPAPRLKICDFGYSK-----SSLLHSRPKSTVGTPAYIAP 161
                I HRDLK +N L+  +   +  I D G +      ++ L       VGT  Y+AP
Sbjct: 129 QGKPAIAHRDLKSKNILVKKN--GQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAP 186

Query: 162 EVL------SRREYDGKLADVWSCGVTLYVMLVGAY----------PFEDQ--EDP---- 199
           EVL         +   +  D+W+ G+ L+ +               PF D    DP    
Sbjct: 187 EVLDETIQVDCFDSYKR-VDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFED 245

Query: 200 -------KNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKS 249
                     R  I         +     + ++C          NPS R+T   IK 
Sbjct: 246 MRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWY-------QNPSARLTALRIKK 295

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score =  120 bits (304), Expect = 2e-31
 Identities = 72/296 (24%), Positives = 119/296 (40%), Gaps = 53/296 (17%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIER--GHKIDAN-VAREIINHKQLRHP 58
           E+Y+ +  +GSG +G      +  T   VA+K + R     I A    RE+   K ++H 
Sbjct: 29  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 88

Query: 59  NIIRFKEVVLTPTHLA------IVMEYAAGGELFERICNAGRFSEDEARYFFQQLI---- 108
           N+I   +V      L       +V     G +L   I    + ++D  ++   Q++    
Sbjct: 89  NVIGLLDVFTPARSLEEFNDVYLVTHL-MGADL-NNIVKCQKLTDDHVQFLIYQILRGLK 146

Query: 109 ---SGQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST--VGTPAYIAPEV 163
              S  I HRDLK  N  ++      LKI DFG ++     +  + T  V T  Y APE+
Sbjct: 147 YIHSADIIHRDLKPSNLAVNED--CELKILDFGLARH----TADEMTGYVATRWYRAPEI 200

Query: 164 -LSRREYDGKLADVWSCGVTLYVMLVGAYPFE-----DQED---------PKNFRKTISR 208
            L+   Y+ +  D+WS G  +  +L G   F      DQ                K IS 
Sbjct: 201 MLNWMHYN-QTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 259

Query: 209 IMAVQY--KIPD---------YVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 253
             A  Y   +           ++  +    +LL ++ V +  +RIT  +  +H +F
Sbjct: 260 ESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 315

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score =  120 bits (302), Expect = 2e-31
 Identities = 63/298 (21%), Positives = 120/298 (40%), Gaps = 54/298 (18%)

Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLR-HPN 59
            + Y+L++ +G G +       N    E V +K ++   K      REI   + LR  PN
Sbjct: 35  QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIK--REIKILENLRGGPN 92

Query: 60  IIRFKEVVLTPTH--LAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLI-------SG 110
           II   ++V  P     A+V E+    +  +        ++ + R++  +++       S 
Sbjct: 93  IITLADIVKDPVSRTPALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSM 149

Query: 111 QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST--VGTPAYIAPEVL-SRR 167
            I HRD+K  N ++D     +L++ D+G ++    H   +    V +  +  PE+L   +
Sbjct: 150 GIMHRDVKPHNVMIDHEHR-KLRLIDWGLAEFY--HPGQEYNVRVASRYFKGPELLVDYQ 206

Query: 168 EYDGKLADVWSCGVTLYVMLVGAYPF------EDQ----------EDPKNFRKTISRIMA 211
            YD  L D+WS G  L  M+    PF       DQ          ED  ++    +  + 
Sbjct: 207 MYDYSL-DMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELD 265

Query: 212 VQYK--IPDY--------------VHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 253
            ++   +  +                +S +  + L ++   +   R+T +E   HP+F
Sbjct: 266 PRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 323

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score =  120 bits (302), Expect = 4e-31
 Identities = 75/299 (25%), Positives = 118/299 (39%), Gaps = 58/299 (19%)

Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNI 60
              Y   K IG+G+FGV    +   + E VA+K +    K   N  RE+   + ++HPN+
Sbjct: 39  EIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKV-LQDKRFKN--RELQIMRIVKHPNV 94

Query: 61  IRFKEVVLTPTH------LAIVMEYAAGGELFERIC-----NAGRFSEDEARYFFQQLIS 109
           +  K    +         L +V+EY    E   R                 + +  QL+ 
Sbjct: 95  VDLKAFFYSNGDKKDEVFLNLVLEYV--PETVYRASRHYAKLKQTMPMLLIKLYMYQLLR 152

Query: 110 G-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST--VGTPAYIA 160
                    ICHRD+K +N LLD      LK+ DFG +K   L +   +   + +  Y A
Sbjct: 153 SLAYIHSIGICHRDIKPQNLLLDPPSG-VLKLIDFGSAKI--LIAGEPNVSYICSRYYRA 209

Query: 161 PEV-LSRREYDGKLADVWSCGVTLYVMLVGA--YPFEDQED-----------PKNFRKTI 206
           PE+      Y   + D+WS G  +  ++ G   +P E   D           P   R+ I
Sbjct: 210 PELIFGATNYTTNI-DIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPS--REQI 266

Query: 207 SRIMA--VQYKIPDYV----------HISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 253
             +    +++K P                 D  +L+SR+    PS R+T  E   HP+F
Sbjct: 267 KTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFF 325

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  117 bits (296), Expect = 7e-31
 Identities = 64/294 (21%), Positives = 115/294 (39%), Gaps = 49/294 (16%)

Query: 5   ELMKDIGSGNFGVARLMRNKNTKELVAMKYIER-GHKIDANVAREIINHKQLRHPNIIRF 63
              + +G G FG A  + ++ T E++ MK + R   +      +E+   + L HPN+++F
Sbjct: 13  IHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKF 72

Query: 64  KEVVLTPTHLAIVMEYAAGGELFERICNAG---------RFSEDEAR---YFFQQLISGQ 111
             V+     L  + EY  GG L   I +            F++D A    Y    L S  
Sbjct: 73  IGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAY----LHSMN 128

Query: 112 ICHRDLKLENTLLDGSPAPRLKICDFGYSK---------------SSLLHSRPKSTVGTP 156
           I HRDL   N L+  +    + + DFG ++                     +  + VG P
Sbjct: 129 IIHRDLNSHNCLVREN--KNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNP 186

Query: 157 AYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKI 216
            ++APE+++ R YD K  DV+S G+ L  ++       D   P+           +  + 
Sbjct: 187 YWMAPEMINGRSYDEK-VDVFSFGIVLCEIIGRVNADPD-YLPRT------MDFGLNVRG 238

Query: 217 PDYVHISQDC----RNLLSRIFVANPSRRITIKEIKSHPWFLKNLPRELTETAQ 266
               +   +C      +  R    +P +R +  +++    +L+ L   L     
Sbjct: 239 FLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLE---HWLETLRMHLAGHLP 289

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score =  117 bits (295), Expect = 3e-30
 Identities = 76/296 (25%), Positives = 119/296 (40%), Gaps = 49/296 (16%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIER-GHKIDAN-VAREIINHKQLRHPN 59
            +Y  +  IG G +G+     +   K  VA+K I    H+       REI    + RH N
Sbjct: 27  PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHEN 86

Query: 60  IIRFKEVVLTPTH-----LAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLI------ 108
           II   +++  PT      + IV +     +L  ++      S D   YF  Q++      
Sbjct: 87  IIGINDIIRAPTIEQMKDVYIVQDL-METDL-YKLLKTQHLSNDHICYFLYQILRGLKYI 144

Query: 109 -SGQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST----VGTPAYIAPEV 163
            S  + HRDLK  N LL+ +    LKICDFG ++ +             V T  Y APE+
Sbjct: 145 HSANVLHRDLKPSNLLLNTT--CDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 202

Query: 164 -LSRREYDGKLADVWSCGVTLYVMLVGAYPFE-----DQED---------PKNFRKTISR 208
            L+ + Y  K  D+WS G  L  ML     F      DQ +          +     I  
Sbjct: 203 MLNSKGYT-KSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIIN 261

Query: 209 IMAVQY--KIPD---------YVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 253
           + A  Y   +P          + +      +LL ++   NP +RI +++  +HP+ 
Sbjct: 262 LKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 317

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  116 bits (293), Expect = 4e-30
 Identities = 71/308 (23%), Positives = 111/308 (36%), Gaps = 67/308 (21%)

Query: 5   ELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRF- 63
            L + IG G FG   + R K   E VA+K      +       EI     LRH NI+ F 
Sbjct: 45  VLQESIGKGRFG--EVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFI 102

Query: 64  ---KEVVLTPTHLAIVMEYAAGGELFERI-------CNAGRFSEDEAR---YFFQQLISG 110
               +   T T L +V +Y   G LF+ +           + +   A    +   +++  
Sbjct: 103 AADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGT 162

Query: 111 Q----ICHRDLKLENTLLDGSPAPRLKICDFGYSK-----SSLLHSRPKSTVGTPAYIAP 161
           Q    I HRDLK +N L+  +      I D G +      +  +   P   VGT  Y+AP
Sbjct: 163 QGKPAIAHRDLKSKNILVKKN--GTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAP 220

Query: 162 EVL------SRREYDGKLADVWSCGVTLYVMLVG----------AYPFEDQ--EDP---- 199
           EVL         E   + AD+++ G+  + +               P+ D    DP    
Sbjct: 221 EVLDDSINMKHFESFKR-ADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEE 279

Query: 200 -------KNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPW 252
                  +  R  I         +     I ++C       + AN + R+T   IK    
Sbjct: 280 MRKVVCEQKLRPNIPNRWQSCEALRVMAKIMREC-------WYANGAARLTALRIKKT-- 330

Query: 253 FLKNLPRE 260
            L  L ++
Sbjct: 331 -LSQLSQQ 337

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score =  116 bits (292), Expect = 5e-30
 Identities = 72/311 (23%), Positives = 123/311 (39%), Gaps = 69/311 (22%)

Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYI----ER-GHKIDANVAREIINHKQL 55
           + KYE +  IG G FG     R++ T + VA+K +    E+ G  I A   REI   + L
Sbjct: 16  VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITA--LREIKILQLL 73

Query: 56  RHPNIIRFKEVVLTPTHLA--------IVMEYA----AGGELFERICNAGRFSEDEARYF 103
           +H N++   E+  T             +V ++     AG  L   +    +F+  E +  
Sbjct: 74  KHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAG--LLSNV--LVKFTLSEIKRV 129

Query: 104 FQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFG----YSKSSLLHSRP-KS 151
            Q L++G       +I HRD+K  N L+       LK+ DFG    +S +         +
Sbjct: 130 MQMLLNGLYYIHRNKILHRDMKAANVLITRD--GVLKLADFGLARAFSLAKNSQPNRYTN 187

Query: 152 TVGTPAYIAPEVL-SRREYDGKLADVWSCGVTLYVMLVGAYPF------EDQ-------- 196
            V T  Y  PE+L   R+Y   + D+W  G  +  M   + P       + Q        
Sbjct: 188 RVVTLWYRPPELLLGERDYGPPI-DLWGAGCIMAEMWTRS-PIMQGNTEQHQLALISQLC 245

Query: 197 --------------EDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRI 242
                         E  +       +   V+ ++  YV       +L+ ++ V +P++RI
Sbjct: 246 GSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYV-RDPYALDLIDKLLVLDPAQRI 304

Query: 243 TIKEIKSHPWF 253
              +  +H +F
Sbjct: 305 DSDDALNHDFF 315

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score =  115 bits (291), Expect = 1e-29
 Identities = 82/304 (26%), Positives = 125/304 (41%), Gaps = 57/304 (18%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIER-GHKIDAN-VAREIINHKQLRHPN 59
             ++L   +G G +GV     +K T E+VA+K IE     + A    REI   K  +H N
Sbjct: 11  SDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHEN 70

Query: 60  IIRFKEVVLTPTHLA-----IVMEYAAGGELFERICNAGRFSEDEARYFFQQLI------ 108
           II    +    +        I+ E     +L  R+ +    S+D  +YF  Q +      
Sbjct: 71  IITIFNIQRPDSFENFNEVYIIQEL-MQTDL-HRVISTQMLSDDHIQYFIYQTLRAVKVL 128

Query: 109 -SGQICHRDLKLENTLLDGSPAPRLKICDFG----YSKSSLLHSRPKST-------VGTP 156
               + HRDLK  N L++ +    LK+CDFG      +S+  +S P          V T 
Sbjct: 129 HGSNVIHRDLKPSNLLINSN--CDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATR 186

Query: 157 AYIAPEV-LSRREYDGKLADVWSCGVTLYVMLVGAYPFE-----DQED----------PK 200
            Y APEV L+  +Y  +  DVWSCG  L  + +    F       Q              
Sbjct: 187 WYRAPEVMLTSAKYS-RAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSD 245

Query: 201 NFRKTISRIMAVQY--KIPD---------YVHISQDCRNLLSRIFVANPSRRITIKEIKS 249
           N  + I    A +Y   +P          +  ++    +LL R+ V +P++RIT KE   
Sbjct: 246 NDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE 305

Query: 250 HPWF 253
           HP+ 
Sbjct: 306 HPYL 309

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  114 bits (287), Expect = 2e-29
 Identities = 60/297 (20%), Positives = 105/297 (35%), Gaps = 64/297 (21%)

Query: 5   ELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFK 64
           +++K IG G +G   +   K   E VA+K      +       EI     +RH NI+ F 
Sbjct: 40  QMVKQIGKGRYG--EVWMGKWRGEKVAVKVFFTTEEASWFRETEIYQTVLMRHENILGFI 97

Query: 65  EVVLTP----THLAIVMEYAAGGELFERICN-------AGRFSEDEAR-------YFFQQ 106
              +      T L ++ +Y   G L++ + +         + +              F  
Sbjct: 98  AADIKGTGSWTQLYLITDYHENGSLYDYLKSTTLDAKSMLKLAYSSVSGLCHLHTEIFST 157

Query: 107 LISGQICHRDLKLENTLLDGSPAPRLKICDFGYSK-----SSLLHSRPKSTVGTPAYIAP 161
                I HRDLK +N L+  +      I D G +      ++ +   P + VGT  Y+ P
Sbjct: 158 QGKPAIAHRDLKSKNILVKKN--GTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPP 215

Query: 162 EVL------SRREYDGKLADVWSCGVTLYVMLVG----------AYPFED--QEDP---- 199
           EVL      +  +     AD++S G+ L+ +               P+ D    DP    
Sbjct: 216 EVLDESLNRNHFQSYIM-ADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYED 274

Query: 200 -------KNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKS 249
                  K  R +     +    +     +  +C       +  NP+ R+T   +K 
Sbjct: 275 MREIVCIKKLRPSFPNRWSSDECLRQMGKLMTEC-------WAHNPASRLTALRVKK 324

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score =  115 bits (289), Expect = 3e-29
 Identities = 68/325 (20%), Positives = 116/325 (35%), Gaps = 73/325 (22%)

Query: 3   KYELMKDIGSGNFGV---ARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPN 59
           +YE  K +G G +G    A+  ++    +  A+K IE    I  +  REI   ++L+HPN
Sbjct: 23  EYEGCK-VGRGTYGHVYKAK-RKDGKDDKDYALKQIEG-TGISMSACREIALLRELKHPN 79

Query: 60  IIRFKEVVLTPTHLAI--VMEYA--------AGGELFERICNAGRFSEDEARYFFQQLIS 109
           +I  ++V L+     +  + +YA              +      +      +    Q++ 
Sbjct: 80  VISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILD 139

Query: 110 G-------QICHRDLKLENTLLDGSPAPR--LKICDFGYSKSSLLHSRPKST----VGTP 156
           G        + HRDLK  N L+ G    R  +KI D G+++      +P +     V T 
Sbjct: 140 GIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTF 199

Query: 157 AYIAPEVL-SRREYDGKLADVWSCGVTLYVML---------------------------- 187
            Y APE+L   R Y  K  D+W+ G     +L                            
Sbjct: 200 WYRAPELLLGARHY-TKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIF 258

Query: 188 -------------VGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIF 234
                        +   P          R T +    ++Y     V       +LL ++ 
Sbjct: 259 NVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLL 318

Query: 235 VANPSRRITIKEIKSHPWFLKNLPR 259
             +P +RIT ++    P+F    P 
Sbjct: 319 TMDPIKRITSEQAMQDPYF-LEDPL 342

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score =  114 bits (287), Expect = 3e-29
 Identities = 73/305 (23%), Positives = 115/305 (37%), Gaps = 58/305 (19%)

Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIER--GHKIDAN-VAREIINHKQLRH 57
           +++Y+ +K IGSG  G+     +   +  VA+K + R   ++  A    RE++  K + H
Sbjct: 24  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 83

Query: 58  PNIIRFKEVVLTPTHLA------IVMEYAAGGELFERICNAGRFSEDEARYFFQQLI--- 108
            NII    V      L       IVME      L  ++        +   Y   Q++   
Sbjct: 84  KNIIGLLNVFTPQKSLEEFQDVYIVMEL-MDANL-CQVIQM-ELDHERMSYLLYQMLCGI 140

Query: 109 ----SGQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVL 164
               S  I HRDLK  N ++       LKI DFG ++++         V T  Y APEV+
Sbjct: 141 KHLHSAGIIHRDLKPSNIVVKSD--CTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 198

Query: 165 SRREYDGKLADVWSCGVTLYVMLVGAYPFE------------------DQED-------- 198
               Y  +  D+WS G  +  M+ G   F                     E         
Sbjct: 199 LGMGYK-ENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTV 257

Query: 199 -------PKNFRKTISRIMAVQYKIPDYVHISQ---DCRNLLSRIFVANPSRRITIKEIK 248
                  PK    +  ++        D  H        R+LLS++ V + S+RI++ E  
Sbjct: 258 RTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEAL 317

Query: 249 SHPWF 253
            HP+ 
Sbjct: 318 QHPYI 322

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score =  112 bits (283), Expect = 7e-29
 Identities = 73/316 (23%), Positives = 120/316 (37%), Gaps = 77/316 (24%)

Query: 1   MEKYELMKDIGSGNFGV---ARLMRNKNTKELVAMKYIERGHKIDANV-------AREII 50
            ++YE + +IG G +G    AR    KN    VA+K +    ++            RE+ 
Sbjct: 10  DQQYECVAEIGEGAYGKVFKAR--DLKNGGRFVALKRV----RVQTGEEGMPLSTIREVA 63

Query: 51  NHKQLR---HPNIIRFKEVVLTP-----THLAIVMEYAAG--GELFERICNAGRFSEDEA 100
             + L    HPN++R  +V         T L +V E+         ++         +  
Sbjct: 64  VLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDK-VPEPGVPTETI 122

Query: 101 RYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTV 153
           +    QL+ G       ++ HRDLK +N L+  S   ++K+ DFG ++         S V
Sbjct: 123 KDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSS--GQIKLADFGLARIYSFQMALTSVV 180

Query: 154 GTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPF-----EDQEDPKNFRKTISR 208
            T  Y APEVL +  Y   + D+WS G     M      F      DQ         + +
Sbjct: 181 VTLWYRAPEVLLQSSYATPV-DLWSVGCIFAEMFRRKPLFRGSSDVDQ---------LGK 230

Query: 209 IMAV----------------QYKIPDYV---------HISQDCRNLLSRIFVANPSRRIT 243
           I+ V                +                 I +  ++LL +    NP++RI+
Sbjct: 231 ILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRIS 290

Query: 244 IKEIKSHPWFLKNLPR 259
                SHP+F ++L R
Sbjct: 291 AYSALSHPYF-QDLER 305

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score =  112 bits (282), Expect = 2e-28
 Identities = 60/304 (19%), Positives = 103/304 (33%), Gaps = 57/304 (18%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERG-----------HKIDAN-VAREI 49
             Y + + I SG++G      +      VA+K +                     V REI
Sbjct: 22  SPYTVQRFISSGSYGAVCAGVDS-EGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREI 80

Query: 50  INHKQLRHPNIIRFKEVVLTPTH-----LAIVMEYAAGGELFERI-CNAGRFSEDEARYF 103
                  HPNI+  +++ +         L +V E     +L + I       S    +YF
Sbjct: 81  RLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTEL-MRTDLAQVIHDQRIVISPQHIQYF 139

Query: 104 FQQLI-------SGQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTP 156
              ++          + HRDL   N LL  +    + ICDF  ++     +     V   
Sbjct: 140 MYHILLGLHVLHEAGVVHRDLHPGNILLADN--NDITICDFNLAREDTADANKTHYVTHR 197

Query: 157 AYIAPEV-LSRREYDGKLADVWSCGVTLYVMLVGAYPFE------------------DQE 197
            Y APE+ +  + +  KL D+WS G  +  M      F                     E
Sbjct: 198 WYRAPELVMQFKGFT-KLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIE 256

Query: 198 D-----PKNFRKTISRIMAVQYKIP---DYVHISQDCRNLLSRIFVANPSRRITIKEIKS 249
           D       + R  +   ++                   +L++++   NP RRI+ ++   
Sbjct: 257 DVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALR 316

Query: 250 HPWF 253
           HP+F
Sbjct: 317 HPYF 320

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score =  110 bits (277), Expect = 3e-27
 Identities = 69/305 (22%), Positives = 111/305 (36%), Gaps = 60/305 (19%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIER--GHKIDAN-VAREIINHKQLRHP 58
           ++Y+ +K IGSG  G+     +      VA+K + R   ++  A    RE++  K + H 
Sbjct: 62  KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 121

Query: 59  NIIRFKEVVLTPTHLA------IVMEYAAGGELFERICNAGRFSEDEARYFFQQLI---- 108
           NII    V      L       +VME      L + I        +   Y   Q++    
Sbjct: 122 NIISLLNVFTPQKTLEEFQDVYLVMEL-MDANLCQVI--QMELDHERMSYLLYQMLCGIK 178

Query: 109 ---SGQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLS 165
              S  I HRDLK  N ++       LKI DFG ++++         V T  Y APEV+ 
Sbjct: 179 HLHSAGIIHRDLKPSNIVVKSD--CTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL 236

Query: 166 RREYDGKLADVWSCGVTLYVMLVGAYPFE------------------DQED--------- 198
              Y  +  D+WS G  +  M+     F                     E          
Sbjct: 237 GMGYK-ENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVR 295

Query: 199 ----------PKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIK 248
                        F K     +       +    +   R+LLS++ V +P++RI++ +  
Sbjct: 296 NYVENRPKYAGLTFPKLFPDSLFPADSEHNK-LKASQARDLLSKMLVIDPAKRISVDDAL 354

Query: 249 SHPWF 253
            HP+ 
Sbjct: 355 QHPYI 359

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score =  108 bits (271), Expect = 1e-26
 Identities = 76/344 (22%), Positives = 120/344 (34%), Gaps = 96/344 (27%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIER--GHKIDAN-VAREIINHKQLRHP 58
           + Y +   IG G++G   L  +KNT++ VA+K + R     ID   + REI    +L+  
Sbjct: 26  DNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSD 85

Query: 59  NIIRFKEVVLTPTHLA-----IVMEYAAGGELFERICNAGRFSEDEARYFFQQLI----- 108
            IIR  ++++    L      IV+E A   +L +        +E+  +     L+     
Sbjct: 86  YIIRLYDLIIPDDLLKFDELYIVLEIA-DSDLKKLFKTPIFLTEEHIKTILYNLLLGENF 144

Query: 109 --SGQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPA--------- 157
                I HRDLK  N LL+      +K+CDFG +++                        
Sbjct: 145 IHESGIIHRDLKPANCLLNQDC--SVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNK 202

Query: 158 --------------YIAPEV-LSRREYDGKLADVWSCGVTLYVMLVG------------- 189
                         Y APE+ L +  Y  K  D+WS G     +L               
Sbjct: 203 NLKKQLTSHVVTRWYRAPELILLQENYT-KSIDIWSTGCIFAELLNMLQSHINDPTNRFP 261

Query: 190 -----------AYPFEDQEDPKNFRKTISRIM------------------AVQY--KIPD 218
                            +   K+ R  ++ I                    ++Y    P 
Sbjct: 262 LFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPH 321

Query: 219 ---------YVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 253
                    Y  IS D  NLL  +   NP++RITI +   HP+ 
Sbjct: 322 RKPINLKQKYPSISDDGINLLESMLKFNPNKRITIDQALDHPYL 365

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score =  107 bits (268), Expect = 1e-26
 Identities = 65/330 (19%), Positives = 117/330 (35%), Gaps = 77/330 (23%)

Query: 3   KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAR-EI-----INHKQLR 56
           +Y L++ +G G+F    L ++      VAMK + RG K+    A  EI     +N     
Sbjct: 20  RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIV-RGDKVYTEAAEDEIKLLQRVNDADNT 78

Query: 57  HP------NIIRFKEV----VLTPTHLAIVMEYAAGGELFE--RICNAGRFSEDEARYFF 104
                   +I++  +          H+ +V E   G  L    +            +   
Sbjct: 79  KEDSMGANHILKLLDHFNHKGPNGVHVVMVFE-VLGENLLALIKKYEHRGIPLIYVKQIS 137

Query: 105 QQLISG--------QICHRDLKLENTLLDGSPAPR----LKICDFGYSKSSLLHSRPKST 152
           +QL+ G         I H D+K EN L++   +P     +KI D G   +        ++
Sbjct: 138 KQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLG--NACWYDEHYTNS 195

Query: 153 VGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKT--ISRIM 210
           + T  Y +PEVL    +    AD+WS    ++ ++ G + FE  E     +    I++I+
Sbjct: 196 IQTREYRSPEVLLGAPWGCG-ADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQII 254

Query: 211 AV------------------------------------QYKIPDYVHISQDCR----NLL 230
            +                                    +  + +    S+D      + L
Sbjct: 255 ELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFL 314

Query: 231 SRIFVANPSRRITIKEIKSHPWFLKNLPRE 260
           S +   +P +R     + +HPW    L  E
Sbjct: 315 SPMLQLDPRKRADAGGLVNHPWLKDTLGME 344

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score =  107 bits (269), Expect = 2e-26
 Identities = 76/329 (23%), Positives = 124/329 (37%), Gaps = 82/329 (24%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIER--GHKIDANVA-REIINHKQLR-H 57
            KYEL+K +G G +G+     ++ T E+VA+K I     +  DA    REI+   +L  H
Sbjct: 9   RKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGH 68

Query: 58  PNIIRFKEVVLTPT--HLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLI------- 108
            NI+    V+       + +V +Y    +L   +  A        +Y   QLI       
Sbjct: 69  ENIVNLLNVLRADNDRDVYLVFDY-METDL-HAVIRANILEPVHKQYVVYQLIKVIKYLH 126

Query: 109 SGQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST---------------- 152
           SG + HRD+K  N LL+      +K+ DFG S+S +   R  +                 
Sbjct: 127 SGGLLHRDMKPSNILLNAE--CHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQ 184

Query: 153 ------VGTPAYIAPEV-LSRREYDGKLADVWSCGVTLYVMLVG---------------- 189
                 V T  Y APE+ L   +Y  K  D+WS G  L  +L G                
Sbjct: 185 PILTDYVATRWYRAPEILLGSTKYT-KGIDMWSLGCILGEILCGKPIFPGSSTMNQLERI 243

Query: 190 -------------------------AYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQ 224
                                    +   + +    N R   ++   +  KI      ++
Sbjct: 244 IGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNE 303

Query: 225 DCRNLLSRIFVANPSRRITIKEIKSHPWF 253
           +  +LL ++   NP++RI+  +   HP+ 
Sbjct: 304 EALDLLDKLLQFNPNKRISANDALKHPFV 332

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score =  106 bits (266), Expect = 3e-26
 Identities = 69/329 (20%), Positives = 111/329 (33%), Gaps = 85/329 (25%)

Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNI 60
            +KY L K +G+G+FG+   + +  + +  A+K + +      N  RE+   K L H NI
Sbjct: 6   SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQ-DPRYKN--RELDIMKVLDHVNI 62

Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFERICNAG--------------------------- 93
           I+  +   T                     N G                           
Sbjct: 63  IKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD 122

Query: 94  --------------RFSEDEARYFFQQLI-------SGQICHRDLKLENTLLDGSPAPRL 132
                             +    +  QL        S  ICHRD+K +N L++      L
Sbjct: 123 TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDN-TL 181

Query: 133 KICDFGYSKSSLLHSRPKST--VGTPAYIAPEV-LSRREYDGKLADVWSCGVTLYVMLVG 189
           K+CDFG +K   L     S   + +  Y APE+ L   EY   + D+WS G     +++G
Sbjct: 182 KLCDFGSAKK--LIPSEPSVAYICSRFYRAPELMLGATEYTPSI-DLWSIGCVFGELILG 238

Query: 190 A--YPFEDQED-----------PKNFRKTISRI--MAVQYKIPDYVHIS----------Q 224
              +  E   D           P   ++ + R+     + + P                 
Sbjct: 239 KPLFSGETSIDQLVRIIQIMGTPT--KEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPS 296

Query: 225 DCRNLLSRIFVANPSRRITIKEIKSHPWF 253
              +LL +I    P  RI   E  +HP+F
Sbjct: 297 LAIDLLEQILRYEPDLRINPYEAMAHPFF 325

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  101 bits (254), Expect = 9e-25
 Identities = 66/346 (19%), Positives = 116/346 (33%), Gaps = 74/346 (21%)

Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNI 60
           ++  +L++ IG G +G   + +    +  VA+K     ++ +    + I     + H NI
Sbjct: 12  LDNLKLLELIGRGRYG--AVYKGSLDERPVAVKVFSFANRQNFINEKNIYRVPLMEHDNI 69

Query: 61  IRF-----KEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG----- 110
            RF     +          +VMEY   G L + + +        +      +  G     
Sbjct: 70  ARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYL-SLHTSDWVSSCRLAHSVTRGLAYLH 128

Query: 111 -----------QICHRDLKLENTLLDGSPAPRLKICDFGYSK---------SSLLHSRPK 150
                       I HRDL   N L+         I DFG S               +   
Sbjct: 129 TELPRGDHYKPAISHRDLNSRNVLVKNDG--TCVISDFGLSMRLTGNRLVRPGEEDNAAI 186

Query: 151 STVGTPAYIAPEVLSRR------EYDGKLADVWSCGVTLYVML---VGAYPFEDQEDPKN 201
           S VGT  Y+APEVL         E   K  D+++ G+  + +       +P E   +   
Sbjct: 187 SEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPE--- 243

Query: 202 FRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKE-IKSHPWFLKNLPRE 260
                       Y++     +         ++ V+   +R    E  K +   +++L +E
Sbjct: 244 ------------YQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSL-KE 290

Query: 261 LTET-----AQAIYYRKENPTFS--LQSVEEITKIVEEAKVPPPVS 299
             E      A+A   R    T     + + E+  I E  K   P +
Sbjct: 291 TIEDCWDQDAEA---R---LTAQXAEERMAELMMIWERNKSVSPTA 330

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  100 bits (252), Expect = 2e-24
 Identities = 54/299 (18%), Positives = 99/299 (33%), Gaps = 64/299 (21%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNII 61
              +L++    G FG     +  N    VA+K      K       E+ +   ++H NI+
Sbjct: 24  MPLQLLEVKARGRFGCVWKAQLLNEY--VAVKIFPIQDKQSWQNEYEVYSLPGMKHENIL 81

Query: 62  RF----KEVVLTPTHLAIVMEYAAGGELFERICN-------AGRFSEDEAR--------- 101
           +F    K        L ++  +   G L + +             +E  AR         
Sbjct: 82  QFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANVVSWNELCHIAETMARGLAYLHEDI 141

Query: 102 YFFQQLISGQICHRDLKLENTLLDGSPAPRLKICDFGYSK---SSLLHSRPKSTVGTPAY 158
              +      I HRD+K +N LL  +      I DFG +    +          VGT  Y
Sbjct: 142 PGLKDGHKPAISHRDIKSKNVLLKNNLTA--CIADFGLALKFEAGKSAGDTHGQVGTRRY 199

Query: 159 IAPEVLS-----RREYDGKLADVWSCGVTL--------------------YVMLVGAYP- 192
           +APEVL      +R+   +  D+++ G+ L                    +   +G +P 
Sbjct: 200 MAPEVLEGAINFQRDAFLR-IDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPS 258

Query: 193 FEDQED---PKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIK 248
            ED ++    K  R  +         +       ++C +        +   R++   + 
Sbjct: 259 LEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWD-------HDAEARLSAGCVG 310

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score = 97.3 bits (243), Expect = 2e-23
 Identities = 65/204 (31%), Positives = 91/204 (44%), Gaps = 16/204 (7%)

Query: 4   YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVA----REIINHKQLRHPN 59
           Y+++  +G G      L  +      VA+K I    +          RE+ N  QL H N
Sbjct: 13  YKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQN 72

Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-------QI 112
           I+   +V        +VMEY  G  L E I + G  S D A  F  Q++ G       +I
Sbjct: 73  IVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRI 132

Query: 113 CHRDLKLENTLLDGSPAPRLKICDFGYSK--SSLLHSRPKSTVGTPAYIAPEVLSRREYD 170
            HRD+K +N L+D      LKI DFG +K  S    ++    +GT  Y +PE       D
Sbjct: 133 VHRDIKPQNILID--SNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEATD 190

Query: 171 GKLADVWSCGVTLYVMLVGAYPFE 194
               D++S G+ LY MLVG  PF 
Sbjct: 191 EC-TDIYSIGIVLYEMLVGEPPFN 213

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 98.7 bits (246), Expect = 4e-23
 Identities = 65/312 (20%), Positives = 119/312 (38%), Gaps = 62/312 (19%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIER--GHKIDAN-VAREIINHKQLRHP 58
           ++YE+   IG+G++G      +K  K +VA+K I R     ID   + REI    +L H 
Sbjct: 53  DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHD 112

Query: 59  NIIRFKEVVLTPT-----HLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLI----- 108
           ++++  ++V+         L +V+E  A  +  +        +E   +     L+     
Sbjct: 113 HVVKVLDIVIPKDVEKFDELYVVLEI-ADSDFKKLFRTPVYLTELHIKTLLYNLLVGVKY 171

Query: 109 --SGQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPA--------- 157
             S  I HRDLK  N L++      +K+CDFG +++        S +             
Sbjct: 172 VHSAGILHRDLKPANCLVNQD--CSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVT 229

Query: 158 -------------------YIAPEV-LSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQE 197
                              Y APE+ L +  Y  +  DVWS G     +L      ++  
Sbjct: 230 FPHTKNLKRQLTGHVVTRWYRAPELILLQENYT-EAIDVWSIGCIFAELLNMI---KENV 285

Query: 198 DPKNFRKTI------SRIMAVQYKIPDYVHISQDCRNLLSRIF--VANPSRRITIKEIKS 249
                R  +        +   Q    D+   ++  R+ L+ IF  +  PS    I+ ++ 
Sbjct: 286 AYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEE-DIEALEK 344

Query: 250 HPW--FLKNLPR 259
                +++  P+
Sbjct: 345 EDAKRYIRIFPK 356

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score = 96.6 bits (241), Expect = 4e-23
 Identities = 49/206 (23%), Positives = 83/206 (40%), Gaps = 20/206 (9%)

Query: 4   YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVA----REIINHKQLRHPN 59
           Y L + +G G  G      +   + +VA+K +      D        RE     +L+ P+
Sbjct: 36  YRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPH 95

Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-------QI 112
           ++   +       L + M    G +L   +   G  +   A    +Q+ S          
Sbjct: 96  VVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGA 155

Query: 113 CHRDLKLENTLLDGSPAPRLKICDFG----YSKSSLLHSRPKSTVGTPAYIAPEVLSRRE 168
            HRD+K EN L+  S      + DFG     +   L  ++  +TVGT  Y+APE  S   
Sbjct: 156 THRDVKPENILV--SADDFAYLVDFGIASATTDEKL--TQLGNTVGTLYYMAPERFSESH 211

Query: 169 YDGKLADVWSCGVTLYVMLVGAYPFE 194
              + AD+++    LY  L G+ P++
Sbjct: 212 ATYR-ADIYALTCVLYECLTGSPPYQ 236

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 98.3 bits (245), Expect = 4e-23
 Identities = 70/336 (20%), Positives = 110/336 (32%), Gaps = 76/336 (22%)

Query: 3   KYELMKDIGSGNFG-VARLMRNKNTKELVAMKYIERGHKIDANVAR---EIINHKQLRHP 58
           +YE++K IG G+FG V +   +    + VA+K + R  K     A     I+ H + +  
Sbjct: 98  RYEVLKVIGKGSFGQVVK-AYDHKVHQHVALKMV-RNEKRFHRQAAEEIRILEHLRKQDK 155

Query: 59  ----NIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAG--RFSEDEARYFFQQLISG-- 110
               N+I   E      H+ +  E      L+E I       FS    R F   ++    
Sbjct: 156 DNTMNVIHMLENFTFRNHICMTFELL-SMNLYELIKKNKFQGFSLPLVRKFAHSILQCLD 214

Query: 111 -----QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLS 165
                +I H DLK EN LL       +K+ DFG   S   H R  + + +  Y APEV+ 
Sbjct: 215 ALHKNRIIHCDLKPENILLKQQGRSGIKVIDFG--SSCYEHQRVYTYIQSRFYRAPEVIL 272

Query: 166 RREYDGKLADVWSCGVTLYVMLVGAYPF-------------------------------- 193
              Y   + D+WS G  L  +L G                                    
Sbjct: 273 GARYGMPI-DMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDASKRAKN 331

Query: 194 -------------EDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCR--------NLLSR 232
                            D                  P+        +        + L +
Sbjct: 332 FVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQ 391

Query: 233 IFVANPSRRITIKEIKSHPWFLKNLPRELTETAQAI 268
               +P+ R+T  +   HPW  + LP+  T    ++
Sbjct: 392 CLEWDPAVRMTPGQALRHPWLRRRLPKPPTGEKTSV 427

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score = 98.0 bits (244), Expect = 1e-22
 Identities = 33/155 (21%), Positives = 58/155 (37%), Gaps = 22/155 (14%)

Query: 54  QLRHPNIIRFKEVVLTPTHLA-----IVMEYAAGGELFERICNAGRFSEDEARYFFQQLI 108
           ++ HP+I++    V            IVMEY  G  L        +    EA  +  +++
Sbjct: 135 EVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSK--GQKLPVAEAIAYLLEIL 192

Query: 109 SG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAP 161
                     + + DLK EN +L      +LK+ D G        +      GTP + AP
Sbjct: 193 PALSYLHSIGLVYNDLKPENIMLTEE---QLKLIDLGAVSR---INSFGYLYGTPGFQAP 246

Query: 162 EVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQ 196
           E++          D+++ G TL  + +       +
Sbjct: 247 EIVRTGPTVA--TDIYTVGRTLAALTLDLPTRNGR 279

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score = 95.5 bits (238), Expect = 1e-22
 Identities = 67/237 (28%), Positives = 92/237 (38%), Gaps = 39/237 (16%)

Query: 5   ELMKDIGSGNFGVARL----MRNKNTKELVAMKYI-ERGHKIDANVAREIINHKQLRHPN 59
           + +  +G GNFG   L        NT  LVA+K +   G     +  REI   K L    
Sbjct: 26  KYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDF 85

Query: 60  IIRFKEVVLTPTH--LAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLI--SGQIC-- 113
           I++++ V   P    L +VMEY   G L + +          AR    +L+  S QIC  
Sbjct: 86  IVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFL------QRHRARLDASRLLLYSSQICKG 139

Query: 114 ----------HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKS-TVGTPAYI--- 159
                     HRDL   N L+  S A  +KI DFG +K  LL        V  P      
Sbjct: 140 MEYLGSRRCVHRDLAARNILV-ESEA-HVKIADFGLAK--LLPLDKDYYVVREPGQSPIF 195

Query: 160 --APEVLSRREYDGKLADVWSCGVTLY-VMLVGAYPFEDQEDPKNFRKTISRIMAVQ 213
             APE LS   +  + +DVWS GV LY +            +          + A+ 
Sbjct: 196 WYAPESLSDNIFSRQ-SDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALS 251

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score = 92.3 bits (230), Expect = 1e-21
 Identities = 56/212 (26%), Positives = 85/212 (40%), Gaps = 26/212 (12%)

Query: 5   ELMKDIGSGNFGV---ARLMRNKNTKELVAMKYIERGHKIDANVAREIINH----KQLRH 57
            L++ +G G+FGV               VA+K ++           + I        L H
Sbjct: 21  RLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDH 80

Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFERI-CNAGRFSEDEARYFFQQLISG------ 110
            N+IR   VVLTP  + +V E A  G L +R+  + G F       +  Q+  G      
Sbjct: 81  RNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLES 139

Query: 111 -QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYI-----APEVL 164
            +  HRDL   N LL  +    +KI DFG  + +L  +     +     +     APE L
Sbjct: 140 KRFIHRDLAARNLLL-ATRD-LVKIGDFGLMR-ALPQNDDHYVMQEHRKVPFAWCAPESL 196

Query: 165 SRREYDGKLADVWSCGVTLY-VMLVGAYPFED 195
             R +    +D W  GVTL+ +   G  P+  
Sbjct: 197 KTRTFSHA-SDTWMFGVTLWEMFTYGQEPWIG 227

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score = 93.1 bits (232), Expect = 2e-21
 Identities = 67/275 (24%), Positives = 102/275 (37%), Gaps = 29/275 (10%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVA--REIINHKQLRHPN 59
           E   L + IG GNFG     R +    LVA+K        D      +E    KQ  HPN
Sbjct: 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPN 173

Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFERI-CNAGRFSEDEARYFFQQLISG-------Q 111
           I+R   V      + IVME   GG+    +     R              +G        
Sbjct: 174 IVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKC 233

Query: 112 ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYI-----APEVLSR 166
             HRDL   N L+       LKI DFG S+         +  G    +     APE L+ 
Sbjct: 234 CIHRDLAARNCLVTEKNV--LKISDFGMSR--EEADGVYAASGGLRQVPVKWTAPEALNY 289

Query: 167 REYDGKLADVWSCGVTLY-VMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQD 225
             Y  + +DVWS G+ L+    +GA P+ +     N ++T   +     ++P        
Sbjct: 290 GRYSSE-SDVWSFGILLWETFSLGASPYPNL---SN-QQTREFVEK-GGRLPCPELCPDA 343

Query: 226 CRNLLSRIFVANPSRRITIKEIKSHPWFLKNLPRE 260
              L+ + +   P +R +   I      L+++ + 
Sbjct: 344 VFRLMEQCWAYEPGQRPSFSTIY---QELQSIRKR 375

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score = 91.6 bits (228), Expect = 2e-21
 Identities = 60/206 (29%), Positives = 94/206 (45%), Gaps = 36/206 (17%)

Query: 5   ELMKDIGSGNFGVARL----MRNKNTKELVAMKYIERGH-KIDANVAREIINHKQLRHPN 59
           + ++ +G GNFG   +        NT E+VA+K ++    +   +  REI   K L+H N
Sbjct: 13  KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDN 72

Query: 60  IIRFKEVVLTPTH--LAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLI--SGQIC-- 113
           I+++K V  +     L ++MEY   G L + +       + + R    +L+  + QIC  
Sbjct: 73  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL------QKHKERIDHIKLLQYTSQICKG 126

Query: 114 ----------HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYI---- 159
                     HRDL   N L+  +   R+KI DFG +K  L   +    V  P       
Sbjct: 127 MEYLGTKRYIHRDLATRNILV-ENEN-RVKIGDFGLTK-VLPQDKEFFKVKEPGESPIFW 183

Query: 160 -APEVLSRREYDGKLADVWSCGVTLY 184
            APE L+  ++    +DVWS GV LY
Sbjct: 184 YAPESLTESKFSVA-SDVWSFGVVLY 208

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score = 92.1 bits (229), Expect = 2e-21
 Identities = 58/200 (29%), Positives = 92/200 (46%), Gaps = 24/200 (12%)

Query: 5   ELMKDIGSGNFGVARL----MRNKNTKELVAMKYIERGH-KIDANVAREIINHKQLRHPN 59
           + ++ +G GNFG   +        NT E+VA+K ++    +   +  REI   K L+H N
Sbjct: 44  KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDN 103

Query: 60  IIRFKEVVLTPTH--LAIVMEYAAGGELFERI-CNAGRFSEDEARYFFQQLISG------ 110
           I+++K V  +     L ++MEY   G L + +  +  R    +   +  Q+  G      
Sbjct: 104 IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 163

Query: 111 -QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYI-----APEVL 164
            +  HRDL   N L+  +   R+KI DFG +K  L   +    V  P        APE L
Sbjct: 164 KRYIHRDLATRNILV-ENEN-RVKIGDFGLTK-VLPQDKEYYKVKEPGESPIFWYAPESL 220

Query: 165 SRREYDGKLADVWSCGVTLY 184
           +  ++    +DVWS GV LY
Sbjct: 221 TESKFSVA-SDVWSFGVVLY 239

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score = 91.2 bits (227), Expect = 4e-21
 Identities = 56/218 (25%), Positives = 85/218 (38%), Gaps = 38/218 (17%)

Query: 4   YELMKDIGSGNFGVA--------RLMRNKNTKELVAMKYIERGHKIDAN-VAR---EIIN 51
           YEL + +G G  G++        R  R+      VA+K +      D +   R   E  N
Sbjct: 14  YELGEILGFG--GMSEVHLARDLRDHRD------VAVKVLRADLARDPSFYLRFRREAQN 65

Query: 52  HKQLRHPNIIRF----KEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQL 107
              L HP I+      +          IVMEY  G  L + +   G  +   A       
Sbjct: 66  AAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADA 125

Query: 108 ISG-------QICHRDLKLENTLLDGSPAPRLKICDFG----YSKSSLLHSRPKSTVGTP 156
                      I HRD+K  N ++  S    +K+ DFG     + S    ++  + +GT 
Sbjct: 126 CQALNFSHQNGIIHRDVKPANIMI--SATNAVKVMDFGIARAIADSGNSVTQTAAVIGTA 183

Query: 157 AYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFE 194
            Y++PE       D + +DV+S G  LY +L G  PF 
Sbjct: 184 QYLSPEQARGDSVDAR-SDVYSLGCVLYEVLTGEPPFT 220

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score = 90.8 bits (226), Expect = 4e-21
 Identities = 55/202 (27%), Positives = 92/202 (45%), Gaps = 27/202 (13%)

Query: 5   ELMKDIGSGNFGV---ARL-MRNKNTKELVAMKYIERGHKIDANVA--REIINHKQLRHP 58
           + ++D+G G+FG     R      NT E VA+K ++     +      +EI   + L H 
Sbjct: 24  KRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHE 83

Query: 59  NIIRFKEVVLTPTH--LAIVMEYAAGGELFERI-CNAGRFSEDEARYFFQQLISG----- 110
           NI+++K +        + ++ME+   G L E +  N  + +  +   +  Q+  G     
Sbjct: 84  NIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLG 143

Query: 111 --QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKS-TVGTPAYI-----APE 162
             Q  HRDL   N L+  S   ++KI DFG +K   + +  +  TV           APE
Sbjct: 144 SRQYVHRDLAARNVLV-ESEH-QVKIGDFGLTK--AIETDKEYYTVKDDRDSPVFWYAPE 199

Query: 163 VLSRREYDGKLADVWSCGVTLY 184
            L + ++    +DVWS GVTL+
Sbjct: 200 CLMQSKFYIA-SDVWSFGVTLH 220

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score = 91.8 bits (228), Expect = 1e-20
 Identities = 47/206 (22%), Positives = 79/206 (38%), Gaps = 15/206 (7%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNII 61
               +   +G G +G       K     VA+K ++          +E    K+++HPN++
Sbjct: 220 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLV 279

Query: 62  RFKEVVLTPTHLAIVMEYAAGGEL--FERICNAGRFSEDEARYFFQQLISG-------QI 112
           +   V        I+ E+   G L  + R CN    S     Y   Q+ S          
Sbjct: 280 QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNF 339

Query: 113 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAY--IAPEVLSRREYD 170
            HR+L   N L+  +    +K+ DFG S+     +              APE L+  ++ 
Sbjct: 340 IHRNLAARNCLVGENHL--VKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFS 397

Query: 171 GKLADVWSCGVTLY-VMLVGAYPFED 195
            K +DVW+ GV L+ +   G  P+  
Sbjct: 398 IK-SDVWAFGVLLWEIATYGMSPYPG 422

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 90.9 bits (226), Expect = 1e-20
 Identities = 73/333 (21%), Positives = 113/333 (33%), Gaps = 81/333 (24%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAR-EIINHKQLRHP-- 58
           ++YE+   IG G+FG      ++  +E VA+K I +  K   N A+ E+   + +     
Sbjct: 54  DRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKII-KNKKAFLNQAQIEVRLLELMNKHDT 112

Query: 59  ----NIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGR--FSEDEARYFFQQLISG-- 110
                I+  K   +   HL +V E      L++ + N      S +  R F QQ+ +   
Sbjct: 113 EMKYYIVHLKRHFMFRNHLCLVFEML-SYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALL 171

Query: 111 -------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEV 163
                   I H DLK EN LL       +KI DFG   S  L  R    + +  Y +PEV
Sbjct: 172 FLATPELSIIHCDLKPENILLCNPKRSAIKIVDFG--SSCQLGQRIYQYIQSRFYRSPEV 229

Query: 164 LSRREYDGKLADVWSCGVTLYVMLVG---------------------------------- 189
           L    YD  + D+WS G  L  M  G                                  
Sbjct: 230 LLGMPYDLAI-DMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAPKA 288

Query: 190 ----------AYPFEDQEDPKN-----FRKTISRIMAVQYKIPDYVHISQDCRN------ 228
                      +  +  +D K        + +  I+ V+   P      +          
Sbjct: 289 RKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLK 348

Query: 229 ---LLSRIFVANPSRRITIKEIKSHPWFLKNLP 258
              L+ R+   +P  RI       H +F K   
Sbjct: 349 FKDLILRMLDYDPKTRIQPYYALQHSFFKKTAD 381

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score = 90.0 bits (224), Expect = 1e-20
 Identities = 52/218 (23%), Positives = 92/218 (42%), Gaps = 40/218 (18%)

Query: 5   ELMKDIGSGNFGVAR----LMRNKNTKELVAMKYIERGHKIDANVAREIINH----KQLR 56
           + +K +GSG FG       +   +  K  VA+K +           +EI++       + 
Sbjct: 18  KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVD 75

Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERI-CNAGRFSEDEARYFFQQLIS--GQIC 113
           +P++ R   + LT T + ++ +    G L + +  +             Q L++   QI 
Sbjct: 76  NPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIG-------SQYLLNWCVQIA 127

Query: 114 ------------HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGT--P-AY 158
                       HRDL   N L+  +P   +KI DFG +K      +     G   P  +
Sbjct: 128 KGMNYLEDRRLVHRDLAARNVLV-KTPQ-HVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 185

Query: 159 IAPEVLSRREYDGKLADVWSCGVTLY-VMLVGAYPFED 195
           +A E +  R Y  + +DVWS GVT++ +M  G+ P++ 
Sbjct: 186 MALESILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYDG 222

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 88.9 bits (221), Expect = 4e-20
 Identities = 71/331 (21%), Positives = 112/331 (33%), Gaps = 77/331 (23%)

Query: 2   EKYELMKDIGSGNFG-VARLMRNKNTKELVAMKYIERGHKIDANVAR-EIINHKQLRHP- 58
           E+YE++ ++G G FG V   + +   K  VA+K I R        AR EI   K+++   
Sbjct: 19  ERYEIVGNLGEGTFGKVVECLDHARGKSQVALKII-RNVGKYREAARLEINVLKKIKEKD 77

Query: 59  -----NIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGR--FSEDEARYFFQQLISG- 110
                  +   +      H+ I  E   G   FE +       +     R+   QL    
Sbjct: 78  KENKFLCVLMSDWFNFHGHMCIAFE-LLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHAL 136

Query: 111 ------QICHRDLKLENTLLDGSPA-----------------PRLKICDFGYSKSSLLHS 147
                 Q+ H DLK EN L   S                     +++ DFG S ++  H 
Sbjct: 137 RFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFG-S-ATFDHE 194

Query: 148 RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLY---------------------VM 186
              + V T  Y  PEV+    +     DVWS G  L+                       
Sbjct: 195 HHTTIVATRHYRPPEVILELGWAQPC-DVWSIGCILFEYYRGFTLFQTHENREHLVMMEK 253

Query: 187 LVGAYP------------FEDQEDPKNFRKTISRIMAVQYKIPDYVHISQD-----CRNL 229
           ++G  P            F       +   +  R +    K      +          +L
Sbjct: 254 ILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDL 313

Query: 230 LSRIFVANPSRRITIKEIKSHPWFLKNLPRE 260
           + R+   +P++RIT+ E   HP+F    P E
Sbjct: 314 MRRMLEFDPAQRITLAEALLHPFFAGLTPEE 344

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score = 88.2 bits (219), Expect = 5e-20
 Identities = 57/200 (28%), Positives = 84/200 (42%), Gaps = 25/200 (12%)

Query: 5   ELMKDIGSGNFGVARL----MRNKNTKELVAMKYIERGHKIDANVA--REIINHKQLRHP 58
           + ++D+G G+FG   L      N  T E+VA+K ++            +EI   + L H 
Sbjct: 34  KKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHE 93

Query: 59  NIIRFKEVVLTPTH--LAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG------ 110
           +II++K          L +VMEY   G L + +         +   F QQ+  G      
Sbjct: 94  HIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYL-PRHSIGLAQLLLFAQQICEGMAYLHA 152

Query: 111 -QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYI-----APEVL 164
               HRDL   N LL  +    +KI DFG +K ++        V           APE L
Sbjct: 153 QHYIHRDLAARNVLL-DNDR-LVKIGDFGLAK-AVPEGHEYYRVREDGDSPVFWYAPECL 209

Query: 165 SRREYDGKLADVWSCGVTLY 184
              ++    +DVWS GVTLY
Sbjct: 210 KEYKFYYA-SDVWSFGVTLY 228

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score = 86.1 bits (214), Expect = 2e-19
 Identities = 49/206 (23%), Positives = 81/206 (39%), Gaps = 15/206 (7%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNII 61
               +   +G G +G       K     VA+K ++          +E    K+++HPN++
Sbjct: 13  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLV 72

Query: 62  RFKEVVLTPTHLAIVMEYAAGGEL--FERICNAGRFSEDEARYFFQQLISG-------QI 112
           +   V        I+ E+   G L  + R CN    S     Y   Q+ S          
Sbjct: 73  QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNF 132

Query: 113 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGT-PA-YIAPEVLSRREYD 170
            HRDL   N L+  +    +K+ DFG S+     +         P  + APE L+  ++ 
Sbjct: 133 IHRDLAARNCLVGENHL--VKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFS 190

Query: 171 GKLADVWSCGVTLY-VMLVGAYPFED 195
            K +DVW+ GV L+ +   G  P+  
Sbjct: 191 IK-SDVWAFGVLLWEIATYGMSPYPG 215

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score = 84.6 bits (210), Expect = 6e-19
 Identities = 55/207 (26%), Positives = 86/207 (41%), Gaps = 25/207 (12%)

Query: 8   KDIGSGNFGVAR--LMRNKNTKELVAMKYIERGHKIDANVA---REIINHKQLRHPNIIR 62
           K++GSGNFG  +    + K   + VA+K ++      A       E    +QL +P I+R
Sbjct: 23  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 82

Query: 63  FKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-------QICHR 115
              +    + + +VME A  G L + +       +        Q+  G          HR
Sbjct: 83  MIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHR 141

Query: 116 DLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP---KSTVGT--P-AYIAPEVLSRREY 169
           DL   N LL  +     KI DFG SK   L +     K+      P  + APE ++  ++
Sbjct: 142 DLAARNVLL-VTQH-YAKISDFGLSK--ALRADENYYKAQTHGKWPVKWYAPECINYYKF 197

Query: 170 DGKLADVWSCGVTLY-VMLVGAYPFED 195
             K +DVWS GV ++     G  P+  
Sbjct: 198 SSK-SDVWSFGVLMWEAFSYGQKPYRG 223

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score = 84.3 bits (209), Expect = 1e-18
 Identities = 61/210 (29%), Positives = 89/210 (42%), Gaps = 23/210 (10%)

Query: 5   ELMKDIGSGNFGV---ARLMRNKNTKELVAMKYIERGHKIDANVA--REIINHKQLRHPN 59
            + K IGSG+ G     RL         VA+K ++ G+          E     Q  HPN
Sbjct: 52  HIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPN 111

Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGEL--FERICNAGRFSEDEARYFFQQLISG------- 110
           IIR + VV       IV EY   G L  F R  + G+F+  +     + + +G       
Sbjct: 112 IIRLEGVVTRGRLAMIVTEYMENGSLDTFLR-THDGQFTIMQLVGMLRGVGAGMRYLSDL 170

Query: 111 QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP-KSTVGTPAYI---APEVLSR 166
              HRDL   N L+D +     K+ DFG S+          +T G    I   APE ++ 
Sbjct: 171 GYVHRDLAARNVLVDSNLV--CKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAF 228

Query: 167 REYDGKLADVWSCGVTLY-VMLVGAYPFED 195
           R +    +DVWS GV ++ V+  G  P+ +
Sbjct: 229 RTFSSA-SDVWSFGVVMWEVLAYGERPYWN 257

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score = 84.3 bits (209), Expect = 1e-18
 Identities = 54/218 (24%), Positives = 90/218 (41%), Gaps = 40/218 (18%)

Query: 5   ELMKDIGSGNFGVAR----LMRNKNTKELVAMKYIERGHKIDANVA--REIINHKQLRHP 58
           + +K +GSG FG       +   +  K  VA+K +       AN     E      + +P
Sbjct: 18  KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNP 77

Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGELFERI-CNAGRFSEDEARYFFQQLIS--GQIC-- 113
           ++ R   + LT T + ++ +    G L + +  +             Q L++   QI   
Sbjct: 78  HVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIG-------SQYLLNWCVQIAKG 129

Query: 114 ----------HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYI---- 159
                     HRDL   N L+  +P   +KI DFG +K  LL +  K        +    
Sbjct: 130 MNYLEDRRLVHRDLAARNVLV-KTPQ-HVKITDFGLAK--LLGAEEKEYHAEGGKVPIKW 185

Query: 160 -APEVLSRREYDGKLADVWSCGVTLY-VMLVGAYPFED 195
            A E +  R Y  + +DVWS GVT++ +M  G+ P++ 
Sbjct: 186 MALESILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYDG 222

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score = 85.3 bits (211), Expect = 2e-18
 Identities = 50/206 (24%), Positives = 78/206 (37%), Gaps = 17/206 (8%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNII 61
           E   L   +G G FG   +     T   VA+K ++ G        +E    K+LRH  ++
Sbjct: 267 ESLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLV 325

Query: 62  RFKEVVLTPTHLAIVMEYAAGGEL--FERICNAGRFSEDEARYFFQQLISG-------QI 112
           +   VV +   + IV EY + G L  F +          +      Q+ SG         
Sbjct: 326 QLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNY 384

Query: 113 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAY--IAPEVLSRREYD 170
            HRDL+  N L+  +     K+ DFG ++    +               APE      + 
Sbjct: 385 VHRDLRAANILVGENLV--CKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFT 442

Query: 171 GKLADVWSCGVTLY-VMLVGAYPFED 195
            K +DVWS G+ L  +   G  P+  
Sbjct: 443 IK-SDVWSFGILLTELTTKGRVPYPG 467

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 83.9 bits (208), Expect = 2e-18
 Identities = 67/333 (20%), Positives = 112/333 (33%), Gaps = 80/333 (24%)

Query: 2   EKYELMKDIGSGNFG-VARLMRNKNTKELVAMKYIERGHK-------IDANVAREIINHK 53
            +YE++  +G G FG V   + +K     VA+K + +           +  V   +    
Sbjct: 14  ARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIV-KNVDRYCEAARSEIQVLEHLNTTD 72

Query: 54  QLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGR--FSEDEARYFFQQLISG- 110
                  ++  E      H+ IV E   G   ++ I   G   F  D  R    Q+    
Sbjct: 73  PNSTFRCVQMLEWFEHHGHICIVFE-LLGLSTYDFIKENGFLPFRLDHIRKMAYQICKSV 131

Query: 111 ------QICHRDLKLENTLLDGSPA-----------------PRLKICDFGYSKSSLLHS 147
                 ++ H DLK EN L   S                   P +K+ DFG   S+    
Sbjct: 132 NFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFG---SATYDD 188

Query: 148 RPKST-VGTPAYIAPEVLSRREYDGKLADVWSCGVTLY---------------------V 185
              ST V T  Y APEV+    +     DVWS G  L                       
Sbjct: 189 EHHSTLVSTRHYRAPEVILALGWSQPC-DVWSIGCILIEYYLGFTVFPTHDSKEHLAMME 247

Query: 186 MLVGAYP-------------FEDQEDPKNFRKTISRIMAVQYKIPDYVHIS----QDCRN 228
            ++G  P               D+ D          +      + +++       +   +
Sbjct: 248 RILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFD 307

Query: 229 LLSRIFVANPSRRITIKEIKSHPWFLKNLPREL 261
           L+ ++   +P++RIT++E   HP+F   L + +
Sbjct: 308 LIQKMLEYDPAKRITLREALKHPFF-DLLKKSI 339

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score = 84.4 bits (209), Expect = 2e-18
 Identities = 50/206 (24%), Positives = 78/206 (37%), Gaps = 17/206 (8%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNII 61
           E   L   +G G FG   +     T   VA+K ++ G        +E    K+LRH  ++
Sbjct: 184 ESLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLV 242

Query: 62  RFKEVVLTPTHLAIVMEYAAGGEL--FERICNAGRFSEDEARYFFQQLISG-------QI 112
           +   VV +   + IV EY + G L  F +          +      Q+ SG         
Sbjct: 243 QLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNY 301

Query: 113 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAY--IAPEVLSRREYD 170
            HRDL+  N L+  +     K+ DFG ++    +               APE      + 
Sbjct: 302 VHRDLRAANILVGENLV--CKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFT 359

Query: 171 GKLADVWSCGVTLY-VMLVGAYPFED 195
            K +DVWS G+ L  +   G  P+  
Sbjct: 360 IK-SDVWSFGILLTELTTKGRVPYPG 384

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score = 81.9 bits (203), Expect = 4e-18
 Identities = 57/205 (27%), Positives = 91/205 (44%), Gaps = 21/205 (10%)

Query: 5   ELMKDIGSGNFG-VARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRF 63
             +++IGSG FG V         K  VA+K I  G   + +   E     +L HP +++ 
Sbjct: 11  TFVQEIGSGQFGLVHLGYWLNKDK--VAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQL 68

Query: 64  KEVVLTPTHLAIVMEYAAGGEL--FERICNAGRFSEDEARYFFQQLISG-------QICH 114
             V L    + +V E+   G L  + R    G F+ +        +  G        + H
Sbjct: 69  YGVCLEQAPICLVTEFMEHGCLSDYLR-TQRGLFAAETLLGMCLDVCEGMAYLEEACVIH 127

Query: 115 RDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYI---APEVLSRREYDG 171
           RDL   N L+  +    +K+ DFG ++  +L  +  S+ GT   +   +PEV S   Y  
Sbjct: 128 RDLAARNCLVGENQV--IKVSDFGMTR-FVLDDQYTSSTGTKFPVKWASPEVFSFSRYSS 184

Query: 172 KLADVWSCGVTLY-VMLVGAYPFED 195
           K +DVWS GV ++ V   G  P+E+
Sbjct: 185 K-SDVWSFGVLMWEVFSEGKIPYEN 208

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score = 81.9 bits (203), Expect = 4e-18
 Identities = 60/220 (27%), Positives = 93/220 (42%), Gaps = 31/220 (14%)

Query: 2   EKYELMKD--------IGSGNFG-VAR-LMRNKNTKELVAMKYIERGHKIDANVA--REI 49
           +K  L +D        +G GNFG V + + R +  +  VA+K +++G +        RE 
Sbjct: 2   KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREA 61

Query: 50  INHKQLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERI-CNAGRFSEDEARYFFQQLI 108
               QL +P I+R   V      + +VME A GG L + +                 Q+ 
Sbjct: 62  QIMHQLDNPYIVRLIGVCQAEALM-LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVS 120

Query: 109 SG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYI-- 159
            G          HRDL   N LL  +     KI DFG SK +L       T  +      
Sbjct: 121 MGMKYLEEKNFVHRDLAARNVLL-VNRH-YAKISDFGLSK-ALGADDSYYTARSAGKWPL 177

Query: 160 ---APEVLSRREYDGKLADVWSCGVTLY-VMLVGAYPFED 195
              APE ++ R++  + +DVWS GVT++  +  G  P++ 
Sbjct: 178 KWYAPECINFRKFSSR-SDVWSYGVTMWEALSYGQKPYKK 216

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score = 83.8 bits (207), Expect = 6e-18
 Identities = 55/205 (26%), Positives = 87/205 (42%), Gaps = 25/205 (12%)

Query: 10  IGSGNFGVAR--LMRNKNTKELVAMKYIERGHKIDANVA--REIINHKQLRHPNIIRFKE 65
           +G GNFG  R  + R +  +  VA+K +++G +        RE     QL +P I+R   
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 403

Query: 66  VVLTPTHLAIVMEYAAGGELFERI-CNAGRFSEDEARYFFQQLISG-------QICHRDL 117
           V      + +VME A GG L + +                 Q+  G          HR+L
Sbjct: 404 VCQAEALM-LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNL 462

Query: 118 KLENTLLDGSPAPRLKICDFGYSKSSLLHSRP---KSTVGTPAYI---APEVLSRREYDG 171
              N LL  +     KI DFG SK   L +      +       +   APE ++ R++  
Sbjct: 463 AARNVLL-VNRH-YAKISDFGLSK--ALGADDSYYTARSAGKWPLKWYAPECINFRKFSS 518

Query: 172 KLADVWSCGVTLY-VMLVGAYPFED 195
           + +DVWS GVT++  +  G  P++ 
Sbjct: 519 R-SDVWSYGVTMWEALSYGQKPYKK 542

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score = 82.4 bits (204), Expect = 7e-18
 Identities = 55/218 (25%), Positives = 91/218 (41%), Gaps = 40/218 (18%)

Query: 5   ELMKDIGSGNFGVAR----LMRNKNTKELVAMKYIERGHKIDANVA--REIINHKQLRHP 58
             +K +GSG FG       +   ++ K  V +K IE      +  A    ++    L H 
Sbjct: 16  RKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHA 75

Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGELFERI-CNAGRFSEDEARYFFQQLI--SGQIC-- 113
           +I+R   +    + L +V +Y   G L + +  + G           Q L+    QI   
Sbjct: 76  HIVRLLGLCPGSS-LQLVTQYLPLGSLLDHVRQHRGALG-------PQLLLNWGVQIAKG 127

Query: 114 ----------HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYI---- 159
                     HR+L   N LL  SP+ ++++ DFG +   LL    K  + + A      
Sbjct: 128 MYYLEEHGMVHRNLAARNVLL-KSPS-QVQVADFGVAD--LLPPDDKQLLYSEAKTPIKW 183

Query: 160 -APEVLSRREYDGKLADVWSCGVTLY-VMLVGAYPFED 195
            A E +   +Y  + +DVWS GVT++ +M  GA P+  
Sbjct: 184 MALESIHFGKYTHQ-SDVWSYGVTVWELMTFGAEPYAG 220

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score = 82.0 bits (203), Expect = 2e-17
 Identities = 55/205 (26%), Positives = 82/205 (40%), Gaps = 25/205 (12%)

Query: 5   ELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFK 64
           +L++ IG G FG   L   +  K  VA+K I+      A    E     QLRH N+++  
Sbjct: 196 KLLQTIGKGEFGDVMLGDYRGNK--VAVKCIKNDATAQA-FLAEASVMTQLRHSNLVQLL 252

Query: 65  EVVLT-PTHLAIVMEYAAGGEL--FERICNAGRFSEDEARYFFQQLISG-------QICH 114
            V++     L IV EY A G L  + R         D    F   +             H
Sbjct: 253 GVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVH 312

Query: 115 RDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYI---APEVLSRREYDG 171
           RDL   N L+        K+ DFG +K +       +       +   APE L  +++  
Sbjct: 313 RDLAARNVLVSEDNV--AKVSDFGLTKEAS-----STQDTGKLPVKWTAPEALREKKFST 365

Query: 172 KLADVWSCGVTLY-VMLVGAYPFED 195
           K +DVWS G+ L+ +   G  P+  
Sbjct: 366 K-SDVWSFGILLWEIYSFGRVPYPR 389

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score = 80.3 bits (199), Expect = 2e-17
 Identities = 55/211 (26%), Positives = 92/211 (43%), Gaps = 27/211 (12%)

Query: 2   EKYELMKDIGSGNFG-VARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNI 60
           E  +L++ +G+G FG V     N +TK  VA+K +++G         E    KQL+H  +
Sbjct: 13  ETLKLVERLGAGQFGEVWMGYYNGHTK--VAVKSLKQGSMSPDAFLAEANLMKQLQHQRL 70

Query: 61  IRFKEVVLTPTHLAIVMEYAAGGEL--FERICNAGRFSEDEARYFFQQLISG-------Q 111
           +R   VV T   + I+ EY   G L  F +  +  + + ++      Q+  G        
Sbjct: 71  VRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN 129

Query: 112 ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVG------TPAYIAPEVLS 165
             HRDL+  N L+  + +   KI DFG ++    +              T    APE ++
Sbjct: 130 YIHRDLRAANILVSDTLS--CKIADFGLARLIEDNEYTAREGAKFPIKWT----APEAIN 183

Query: 166 RREYDGKLADVWSCGVTLY-VMLVGAYPFED 195
              +  K +DVWS G+ L  ++  G  P+  
Sbjct: 184 YGTFTIK-SDVWSFGILLTEIVTHGRIPYPG 213

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score = 82.1 bits (203), Expect = 2e-17
 Identities = 53/207 (25%), Positives = 87/207 (42%), Gaps = 19/207 (9%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNII 61
           E  +L K +G+G FG   +       + VA+K ++ G         E    K L+H  ++
Sbjct: 188 ESLKLEKKLGAGQFGEVWMATYNKHTK-VAVKTMKPGSMSVEAFLAEANVMKTLQHDKLV 246

Query: 62  RFKEVVLTPTHLAIVMEYAAGGEL--FERICNAGRFSEDEARYFFQQLISG-------QI 112
           +   VV T   + I+ E+ A G L  F +     +    +   F  Q+  G         
Sbjct: 247 KLHAVV-TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNY 305

Query: 113 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYI---APEVLSRREY 169
            HRDL+  N L+  S     KI DFG ++  +  +   +  G    I   APE ++   +
Sbjct: 306 IHRDLRAANILVSASLV--CKIADFGLAR-VIEDNEYTAREGAKFPIKWTAPEAINFGSF 362

Query: 170 DGKLADVWSCGVTLY-VMLVGAYPFED 195
             K +DVWS G+ L  ++  G  P+  
Sbjct: 363 TIK-SDVWSFGILLMEIVTYGRIPYPG 388

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score = 80.3 bits (199), Expect = 2e-17
 Identities = 56/210 (26%), Positives = 86/210 (40%), Gaps = 29/210 (13%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNII 61
           ++ +L++ IG G FG   L   +  K  VA+K I+      A +  E     QLRH N++
Sbjct: 21  KELKLLQTIGKGEFGDVMLGDYRGNK--VAVKCIKNDATAQAFL-AEASVMTQLRHSNLV 77

Query: 62  RFKEVVLTPT-HLAIVMEYAAGGEL--FERICNAGRFSEDEARYFFQQLISG-------Q 111
           +   V++     L IV EY A G L  + R         D    F   +           
Sbjct: 78  QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN 137

Query: 112 ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYI-----APEVLSR 166
             HRDL   N L+  S     K+ DFG        ++  S+      +     APE L  
Sbjct: 138 FVHRDLAARNVLV--SEDNVAKVSDFGL-------TKEASSTQDTGKLPVKWTAPEALRE 188

Query: 167 REYDGKLADVWSCGVTLY-VMLVGAYPFED 195
           +++  K +DVWS G+ L+ +   G  P+  
Sbjct: 189 KKFSTK-SDVWSFGILLWEIYSFGRVPYPR 217

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score = 79.9 bits (198), Expect = 2e-17
 Identities = 51/227 (22%), Positives = 83/227 (36%), Gaps = 54/227 (23%)

Query: 2   EKYELMKDIGSGNFGV---ARLMRNKNTKELVAMKYIERGHKIDANVA--REIINHKQLR 56
           E   L + +G G FG         +K  K  VA+K  ++   +D       E +  K L 
Sbjct: 12  EDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLD 71

Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERI-CNAGRFSEDEARYFFQQLI--SGQIC 113
           HP+I++   ++       I+ME    GEL   +  N               L+  S QIC
Sbjct: 72  HPHIVKLIGIIEEEPTW-IIMELYPYGELGHYLERNKNSLK-------VLTLVLYSLQIC 123

Query: 114 ------------HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYI-- 159
                       HRD+ + N L+       +K+ DFG S+           +    Y   
Sbjct: 124 KAMAYLESINCVHRDIAVRNILVASPEC--VKLGDFGLSRY----------IEDEDYYKA 171

Query: 160 ----------APEVLSRREYDGKLADVWSCGVTLY-VMLVGAYPFED 195
                     +PE ++ R +    +DVW   V ++ ++  G  PF  
Sbjct: 172 SVTRLPIKWMSPESINFRRFTTA-SDVWMFAVCMWEILSFGKQPFFW 217

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score = 81.3 bits (201), Expect = 2e-17
 Identities = 60/215 (27%), Positives = 93/215 (43%), Gaps = 27/215 (12%)

Query: 2   EKYELMKDIGSGNFGV---ARLMRNKNTKELVAMKYIERGHKIDANVA--REIINHKQLR 56
               + K +G+G FG     RL      +  VA+K ++ G+          E     Q  
Sbjct: 45  TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFD 104

Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGEL--FERICNAGRFSEDEARYFFQQLISG---- 110
           HPNIIR + VV     + IV EY   G L  F R  +  +F+  +     + + SG    
Sbjct: 105 HPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLR-KHDAQFTVIQLVGMLRGIASGMKYL 163

Query: 111 ---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP---KSTVGTPAYI---AP 161
                 HRDL   N L++ +     K+ DFG  +  +L   P    +T G    I   +P
Sbjct: 164 SDMGYVHRDLAARNILINSNLV--CKVSDFGLGR--VLEDDPEAAYTTRGGKIPIRWTSP 219

Query: 162 EVLSRREYDGKLADVWSCGVTLY-VMLVGAYPFED 195
           E ++ R++    +DVWS G+ L+ VM  G  P+ +
Sbjct: 220 EAIAYRKFTSA-SDVWSYGIVLWEVMSYGERPYWE 253

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 79.8 bits (197), Expect = 3e-17
 Identities = 31/207 (14%), Positives = 57/207 (27%), Gaps = 42/207 (20%)

Query: 4   YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVA----REIINHKQLRHPN 59
           Y L+   G           +      VA+ +++    +  +V        +   ++  P 
Sbjct: 33  YRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPG 92

Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-------QI 112
           + R  +VV T     +V E+  GG L E        S   A    Q L +         +
Sbjct: 93  VARVLDVVHTRAGGLVVAEWIRGGSLQEVA--DTSPSPVGAIRAMQSLAAAADAAHRAGV 150

Query: 113 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGK 172
                      +  S    +                    +  PA +             
Sbjct: 151 ALSIDHPSRVRV--SIDGDVV-------------------LAYPATMPDA--------NP 181

Query: 173 LADVWSCGVTLYVMLVGAYPFEDQEDP 199
             D+   G +LY +LV  +P  +    
Sbjct: 182 QDDIRGIGASLYALLVNRWPLPEAGVR 208

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score = 79.5 bits (197), Expect = 3e-17
 Identities = 58/208 (27%), Positives = 94/208 (45%), Gaps = 21/208 (10%)

Query: 2   EKYELMKDIGSGNFG-VARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNI 60
           E+  L+K++GSG FG V            VA+K I+ G   +    +E     +L HP +
Sbjct: 8   EEITLLKELGSGQFGVVKLGKWKGQYD--VAVKMIKEGSMSEDEFFQEAQTMMKLSHPKL 65

Query: 61  IRFKEVVLTPTHLAIVMEYAAGGEL--FERICNAGRFSEDEARYFFQQLISG-------Q 111
           ++F  V      + IV EY + G L  + R  +       +       +  G       Q
Sbjct: 66  VKFYGVCSKEYPIYIVTEYISNGCLLNYLR-SHGKGLEPSQLLEMCYDVCEGMAFLESHQ 124

Query: 112 ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYI---APEVLSRRE 168
             HRDL   N L+D      +K+ DFG ++  +L  +  S+VGT   +   APEV    +
Sbjct: 125 FIHRDLAARNCLVDRDLC--VKVSDFGMTR-YVLDDQYVSSVGTKFPVKWSAPEVFHYFK 181

Query: 169 YDGKLADVWSCGVTLY-VMLVGAYPFED 195
           Y  K +DVW+ G+ ++ V  +G  P++ 
Sbjct: 182 YSSK-SDVWAFGILMWEVFSLGKMPYDL 208

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score = 79.2 bits (196), Expect = 5e-17
 Identities = 52/208 (25%), Positives = 88/208 (42%), Gaps = 21/208 (10%)

Query: 2   EKYELMKDIGSGNFG-VARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNI 60
           +    +K++G+G FG V            VA+K I+ G   +     E      L H  +
Sbjct: 24  KDLTFLKELGTGQFGVVKYGKWRGQYD--VAIKMIKEGSMSEDEFIEEAKVMMNLSHEKL 81

Query: 61  IRFKEVVLTPTHLAIVMEYAAGGEL--FERICNAGRFSEDEARYFFQQLISG-------Q 111
           ++   V      + I+ EY A G L  + R     RF   +     + +          Q
Sbjct: 82  VQLYGVCTKQRPIFIITEYMANGCLLNYLR-EMRHRFQTQQLLEMCKDVCEAMEYLESKQ 140

Query: 112 ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYI---APEVLSRRE 168
             HRDL   N L++      +K+ DFG S+  +L     S+VG+   +    PEVL   +
Sbjct: 141 FLHRDLAARNCLVNDQGV--VKVSDFGLSR-YVLDDEYTSSVGSKFPVRWSPPEVLMYSK 197

Query: 169 YDGKLADVWSCGVTLY-VMLVGAYPFED 195
           +  K +D+W+ GV ++ +  +G  P+E 
Sbjct: 198 FSSK-SDIWAFGVLMWEIYSLGKMPYER 224

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score = 79.7 bits (197), Expect = 5e-17
 Identities = 61/214 (28%), Positives = 91/214 (42%), Gaps = 24/214 (11%)

Query: 2   EKYELMKDIGSGNFGV---ARLMRNKNTKEL-VAMKYIERGHKIDANVA--REIINHKQL 55
                 K IG+G FG      L  +   KE+ VA+K ++ G+     V    E     Q 
Sbjct: 44  SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 103

Query: 56  RHPNIIRFKEVVLTPTHLAIVMEYAAGGEL--FERICNAGRFSEDEARYFFQQLISG--- 110
            H NIIR + V+     + I+ EY   G L  F R    G FS  +     + + +G   
Sbjct: 104 SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLR-EKDGEFSVLQLVGMLRGIAAGMKY 162

Query: 111 ----QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP-KSTVGTPAYI---APE 162
                  HRDL   N L++ +     K+ DFG S+          +T G    I   APE
Sbjct: 163 LANMNYVHRDLAARNILVNSNLV--CKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPE 220

Query: 163 VLSRREYDGKLADVWSCGVTLY-VMLVGAYPFED 195
            +S R++    +DVWS G+ ++ VM  G  P+ +
Sbjct: 221 AISYRKFTSA-SDVWSFGIVMWEVMTYGERPYWE 253

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 79.7 bits (197), Expect = 6e-17
 Identities = 61/333 (18%), Positives = 119/333 (35%), Gaps = 89/333 (26%)

Query: 2   EKYELMKDIGSGNFG-VARLMRNKNTKELVAMKYIERGHK-------IDANVAREIINHK 53
             + +++ +G G FG V    ++ + K+  A+K + R  K       I+A++ ++I N  
Sbjct: 35  NAFLVIRKMGDGTFGRVLL-CQHIDNKKYYAVKVV-RNIKKYTRSAKIEADILKKIQNDD 92

Query: 54  QLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGR--FSEDEARYFFQQLISG- 110
              + NI+++    +   H+ ++ E   G  L+E I       F  ++ + +  +++   
Sbjct: 93  INNN-NIVKYHGKFMYYDHMCLIFE-PLGPSLYEIITRNNYNGFHIEDIKLYCIEILKAL 150

Query: 111 ------QICHRDLKLENTLLDGSPA-----------------------PRLKICDFGYSK 141
                  + H DLK EN LLD                             +K+ DFG   
Sbjct: 151 NYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFG--- 207

Query: 142 SSLLHSRPKST-VGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGA--YPFEDQED 198
            +   S    + + T  Y APEV+    +D    D+WS G  L  +  G+  +   +  +
Sbjct: 208 CATFKSDYHGSIINTRQYRAPEVILNLGWDVSS-DMWSFGCVLAELYTGSLLFRTHEHME 266

Query: 199 ------------PKNFRKTISRIMAVQY--------------KIPDYVHISQDCR----- 227
                       PKN     ++    +Y                 + +   + C      
Sbjct: 267 HLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKI 326

Query: 228 -------NLLSRIFVANPSRRITIKEIKSHPWF 253
                  + L  I   +P+ R +  E+  H + 
Sbjct: 327 IKHELFCDFLYSILQIDPTLRPSPAELLKHKFL 359

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score = 79.3 bits (196), Expect = 6e-17
 Identities = 51/220 (23%), Positives = 79/220 (35%), Gaps = 31/220 (14%)

Query: 2   EKYELMKDIGSGNFG-----VARLMRNKNTKELVAMKYIERGHKIDANVA--REIINHKQ 54
           +   L++ +G G FG         M N  +   VA+K +         +    E +   +
Sbjct: 30  KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 89

Query: 55  LRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLIS--GQI 112
             H NI+R   V L      I+ME  AGG+L   +          +      L+     I
Sbjct: 90  FNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 149

Query: 113 C------------HRDLKLENTLLDGSPAPRL-KICDFGYSKSSLLHSRPKSTVGTPAYI 159
                        HRD+   N LL      R+ KI DFG ++   ++       G  A +
Sbjct: 150 ACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR--DIYRASYYRKGGCAML 207

Query: 160 -----APEVLSRREYDGKLADVWSCGVTLY-VMLVGAYPF 193
                 PE      +  K  D WS GV L+ +  +G  P+
Sbjct: 208 PVKWMPPEAFMEGIFTSK-TDTWSFGVLLWEIFSLGYMPY 246

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score = 79.3 bits (196), Expect = 7e-17
 Identities = 51/226 (22%), Positives = 91/226 (40%), Gaps = 42/226 (18%)

Query: 2   EKYELMKDIGSGNFGV---ARLMRNKNTKELVAMKYIERGHKIDANVA---REIINHKQL 55
           +++ L + +G G FG    A+L +   +   VA+K ++      +++    RE    K+ 
Sbjct: 23  QQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEF 82

Query: 56  RHPNIIRFKEVVL------TPTHLAIVMEYAAGGEL--FERICNAGRFSEDEARYFFQQL 107
            HP++ +   V L            +++ +   G+L  F     A R  E+      Q L
Sbjct: 83  DHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLL---ASRIGENPFNLPLQTL 139

Query: 108 IS--GQIC------------HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTV 153
           +     I             HRDL   N +L       + + DFG S+   ++S      
Sbjct: 140 VRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMT--VCVADFGLSR--KIYSGDYYRQ 195

Query: 154 GTPAYI-----APEVLSRREYDGKLADVWSCGVTLY-VMLVGAYPF 193
           G  + +     A E L+   Y    +DVW+ GVT++ +M  G  P+
Sbjct: 196 GCASKLPVKWLALESLADNLYTVH-SDVWAFGVTMWEIMTRGQTPY 240

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score = 79.4 bits (196), Expect = 1e-16
 Identities = 50/220 (22%), Positives = 79/220 (35%), Gaps = 31/220 (14%)

Query: 2   EKYELMKDIGSGNFG-----VARLMRNKNTKELVAMKYIERGHKIDANVA--REIINHKQ 54
           +   L++ +G G FG         M N  +   VA+K +         +    E +   +
Sbjct: 71  KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 130

Query: 55  LRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLIS--GQI 112
             H NI+R   V L      I++E  AGG+L   +          +      L+     I
Sbjct: 131 FNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 190

Query: 113 C------------HRDLKLENTLLDGSPAPRL-KICDFGYSKSSLLHSRPKSTVGTPAYI 159
                        HRD+   N LL      R+ KI DFG ++   ++       G  A +
Sbjct: 191 ACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARD--IYRAGYYRKGGCAML 248

Query: 160 -----APEVLSRREYDGKLADVWSCGVTLY-VMLVGAYPF 193
                 PE      +  K  D WS GV L+ +  +G  P+
Sbjct: 249 PVKWMPPEAFMEGIFTSK-TDTWSFGVLLWEIFSLGYMPY 287

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score = 77.7 bits (192), Expect = 1e-16
 Identities = 53/219 (24%), Positives = 88/219 (40%), Gaps = 38/219 (17%)

Query: 2   EKYELMKDIGSGNFGV---ARLMRNKNTKELVAMKYIERGHKIDANVA--REIINHKQLR 56
           E+ EL + IG G FG       M  +N    VA+K  +            +E +  +Q  
Sbjct: 15  ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 74

Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGEL--FERICNAGRFSEDEARYFFQQLI--SGQI 112
           HP+I++   V+       I+ME    GEL  F +                  LI  + Q+
Sbjct: 75  HPHIVKLIGVITENPVW-IIMELCTLGELRSFLQ-VRKYSLD-------LASLILYAYQL 125

Query: 113 C------------HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGT--PA- 157
                        HRD+   N L+  +    +K+ DFG S+  +  S          P  
Sbjct: 126 STALAYLESKRFVHRDIAARNVLVSSNDC--VKLGDFGLSR-YMEDSTYYKASKGKLPIK 182

Query: 158 YIAPEVLSRREYDGKLADVWSCGVTLY-VMLVGAYPFED 195
           ++APE ++ R +    +DVW  GV ++ +++ G  PF+ 
Sbjct: 183 WMAPESINFRRFTSA-SDVWMFGVCMWEILMHGVKPFQG 220

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score = 79.5 bits (196), Expect = 1e-16
 Identities = 53/217 (24%), Positives = 90/217 (41%), Gaps = 34/217 (15%)

Query: 2   EKYELMKDIGSGNFGV---ARLMRNKNTKELVAMKYIERGHKIDANVA--REIINHKQLR 56
           E+ EL + IG G FG       M  +N    VA+K  +            +E +  +Q  
Sbjct: 390 ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFD 449

Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERI-CNAGRFSEDEARYFFQQLI--SGQIC 113
           HP+I++   V+       I+ME    GEL   +                  LI  + Q+ 
Sbjct: 450 HPHIVKLIGVITENPVW-IIMELCTLGELRSFLQVRKFSLD-------LASLILYAYQLS 501

Query: 114 ------------HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVG-TPA-YI 159
                       HRD+   N L+  +    +K+ DFG S+     +  K++ G  P  ++
Sbjct: 502 TALAYLESKRFVHRDIAARNVLVSSNDC--VKLGDFGLSRYMEDSTYYKASKGKLPIKWM 559

Query: 160 APEVLSRREYDGKLADVWSCGVTLY-VMLVGAYPFED 195
           APE ++ R +    +DVW  GV ++ +++ G  PF+ 
Sbjct: 560 APESINFRRFTSA-SDVWMFGVCMWEILMHGVKPFQG 595

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score = 77.7 bits (192), Expect = 2e-16
 Identities = 53/225 (23%), Positives = 82/225 (36%), Gaps = 41/225 (18%)

Query: 2   EKYELMKDIGSGNFGV---ARLMRNKNTKELVAMKYIERGHKIDANVA---REIINHKQL 55
               L K +G G FG      L +   T   VA+K ++  +     +     E    K  
Sbjct: 34  NLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDF 93

Query: 56  RHPNIIRFKEVVL-----TPTHLAIVMEYAAGGEL--FERICNAGRFSEDEARYFFQQLI 108
            HPN+IR   V +           +++ +   G+L  +       R          Q L+
Sbjct: 94  SHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYS---RLETGPKHIPLQTLL 150

Query: 109 S--GQIC------------HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVG 154
                I             HRDL   N +L       + + DFG SK   ++S      G
Sbjct: 151 KFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMT--VCVADFGLSK--KIYSGDYYRQG 206

Query: 155 TPAYI-----APEVLSRREYDGKLADVWSCGVTLY-VMLVGAYPF 193
             A +     A E L+ R Y  K +DVW+ GVT++ +   G  P+
Sbjct: 207 RIAKMPVKWIAIESLADRVYTSK-SDVWAFGVTMWEIATRGMTPY 250

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 77.6 bits (191), Expect = 4e-16
 Identities = 70/363 (19%), Positives = 113/363 (31%), Gaps = 115/363 (31%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREI-----INHKQLR 56
            +Y +++ +G G+F    L  +   K+ VAMK ++           EI     + +    
Sbjct: 37  GRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPN 96

Query: 57  HPN--IIR-----FKEVVLTPTHLAIVMEYAAGGELFERIC--NAGRFSEDEARYFFQQL 107
            PN  ++      FK   +  TH+ +V E   G  L + I   N         +   QQ+
Sbjct: 97  DPNREMVVQLLDDFKISGVNGTHICMVFE-VLGHHLLKWIIKSNYQGLPLPCVKKIIQQV 155

Query: 108 ISG--------QICHRDLKLENTLLD---------------------------------- 125
           + G        +I H D+K EN LL                                   
Sbjct: 156 LQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPA 215

Query: 126 -------------GSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGK 172
                         +   ++KI D G   +  +H      + T  Y + EVL    Y+  
Sbjct: 216 TAGNFLVNPLEPKNAEKLKVKIADLG--NACWVHKHFTEDIQTRQYRSLEVLIGSGYNTP 273

Query: 173 LADVWSCGVTLYVMLVGAYPFE--DQEDPKNFRKTISRIMAVQYKIP------------- 217
            AD+WS     + +  G Y FE    E+       I+ I+ +  K+P             
Sbjct: 274 -ADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEF 332

Query: 218 -----DYVHIS----------------------QDCRNLLSRIFVANPSRRITIKEIKSH 250
                D  HI+                          + L  +    P +R T  E   H
Sbjct: 333 FTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRH 392

Query: 251 PWF 253
           PW 
Sbjct: 393 PWL 395

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score = 75.6 bits (186), Expect = 2e-15
 Identities = 56/210 (26%), Positives = 84/210 (40%), Gaps = 25/210 (11%)

Query: 5   ELMKDIGSGNFGV---ARLMRNKNTKELVAMKYIERGHKIDANVA--REIINHKQLRHPN 59
              + IG G+FG      L+ N   K   A+K + R   I        E I  K   HPN
Sbjct: 92  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 151

Query: 60  IIRFKEVVLTPTH-LAIVMEYAAGGEL--FERICNAGRFSEDEARYFFQQLISG------ 110
           ++    + L       +V+ Y   G+L  F R       +  +   F  Q+  G      
Sbjct: 152 VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIR-NETHNPTVKDLIGFGLQVAKGMKFLAS 210

Query: 111 -QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYI-----APEVL 164
            +  HRDL   N +LD      +K+ DFG ++             T A +     A E L
Sbjct: 211 KKFVHRDLAARNCMLDEKFT--VKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESL 268

Query: 165 SRREYDGKLADVWSCGVTLY-VMLVGAYPF 193
             +++  K +DVWS GV L+ +M  GA P+
Sbjct: 269 QTQKFTTK-SDVWSFGVLLWELMTRGAPPY 297

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score = 74.6 bits (184), Expect = 2e-15
 Identities = 46/222 (20%), Positives = 86/222 (38%), Gaps = 35/222 (15%)

Query: 2   EKYELMKDIGSGNFG-----VARLMRNKNTKELVAMKYIERGHKIDANVA--REIINHKQ 54
           EK  + +++G G+FG     VA+ +     +  VA+K +     +   +    E    K+
Sbjct: 25  EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 84

Query: 55  LRHPNIIRFKEVVLTPTHLAIVMEYAAGGEL--FERICNAGRFSEDEARYF-FQQLIS-- 109
               +++R   VV       ++ME    G+L  + R       +          ++I   
Sbjct: 85  FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 144

Query: 110 GQIC------------HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPA 157
           G+I             HRDL   N ++  +    +KI DFG ++   ++       G   
Sbjct: 145 GEIADGMAYLNANKFVHRDLAARNCMV--AEDFTVKIGDFGMTR--DIYETDYYRKGGKG 200

Query: 158 YI-----APEVLSRREYDGKLADVWSCGVTLY-VMLVGAYPF 193
            +     +PE L    +    +DVWS GV L+ +  +   P+
Sbjct: 201 LLPVRWMSPESLKDGVFTTY-SDVWSFGVVLWEIATLAEQPY 241

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score = 74.2 bits (183), Expect = 2e-15
 Identities = 37/222 (16%), Positives = 74/222 (33%), Gaps = 36/222 (16%)

Query: 2   EKYELMKDIGSGNFGV-------ARLMRNKNTKELVAMKYIERGHKIDANVAREIINH-- 52
           E     + +G G F               +  +  V +K +++ H    N +        
Sbjct: 8   EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAH---RNYSESFFEAAS 64

Query: 53  --KQLRHPNIIRFKEVVLTPTHLAIVMEYAAGGEL--FERICNAGRFSEDEARYFFQQLI 108
              +L H +++    V +      +V E+   G L  + +  N    +        +QL 
Sbjct: 65  MMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLK-KNKNCINILWKLEVAKQLA 123

Query: 109 SG-------QICHRDLKLENTLLDGSPAPRL------KICDFGYSKSSLLHSRPKSTVGT 155
           +         + H ++  +N LL      +       K+ D G S + L     +  +  
Sbjct: 124 AAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERI-- 181

Query: 156 PAYIAPEVLS-RREYDGKLADVWSCGVTLY-VMLVGAYPFED 195
             ++ PE +   +  +    D WS G TL+ +   G  P   
Sbjct: 182 -PWVPPECIENPKNLNLA-TDKWSFGTTLWEICSGGDKPLSA 221

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score = 74.2 bits (183), Expect = 2e-15
 Identities = 56/210 (26%), Positives = 84/210 (40%), Gaps = 25/210 (11%)

Query: 5   ELMKDIGSGNFGV---ARLMRNKNTKELVAMKYIERGHKIDANVA--REIINHKQLRHPN 59
              + IG G+FG      L+ N   K   A+K + R   I        E I  K   HPN
Sbjct: 28  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 87

Query: 60  IIRFKEVVLTPTH-LAIVMEYAAGGEL--FERICNAGRFSEDEARYFFQQLISG------ 110
           ++    + L       +V+ Y   G+L  F R       +  +   F  Q+  G      
Sbjct: 88  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIR-NETHNPTVKDLIGFGLQVAKGMKYLAS 146

Query: 111 -QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYI-----APEVL 164
            +  HRDL   N +LD      +K+ DFG ++             T A +     A E L
Sbjct: 147 KKFVHRDLAARNCMLDEKFT--VKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESL 204

Query: 165 SRREYDGKLADVWSCGVTLY-VMLVGAYPF 193
             +++  K +DVWS GV L+ +M  GA P+
Sbjct: 205 QTQKFTTK-SDVWSFGVLLWELMTRGAPPY 233

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score = 73.8 bits (182), Expect = 4e-15
 Identities = 67/293 (22%), Positives = 109/293 (37%), Gaps = 52/293 (17%)

Query: 2   EKYELMKDIGSGNFG-----VARLMRNKNTKELVAMKYIERGHKID-ANVAREIINHKQL 55
               L +++G G FG         +     K LVA+K ++        +  RE      L
Sbjct: 15  RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNL 74

Query: 56  RHPNIIRFKEVVLTPTHLAIVMEYAAGGELFE---------RICNAGRFSEDEARYFFQQ 106
           +H +I++F  V      L +V EY   G+L +          I   G+  + +      Q
Sbjct: 75  QHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQ 134

Query: 107 LIS--GQIC------------HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST 152
           ++    QI             HRDL   N L+       +KI DFG S+   ++S     
Sbjct: 135 MLHIASQIASGMVYLASQHFVHRDLATRNCLV--GANLLVKIGDFGMSR--DVYSTDYYR 190

Query: 153 VGTPAYI-----APEVLSRREYDGKLADVWSCGVTLY-VMLVGAYPFEDQEDPKNFRKTI 206
           VG    +      PE +  R++  + +DVWS GV L+ +   G  P+    + +      
Sbjct: 191 VGGHTMLPIRWMPPESIMYRKFTTE-SDVWSFGVILWEIFTYGKQPWFQLSNTEVIECIT 249

Query: 207 S-RIMAVQYKIPDYVH-ISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNL 257
             R++      P  V+ +   C           P +R+ IKEI      L  L
Sbjct: 250 QGRVLERPRVCPKEVYDVMLGCWQ-------REPQQRLNIKEIY---KILHAL 292

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score = 71.9 bits (177), Expect = 2e-14
 Identities = 54/217 (24%), Positives = 87/217 (40%), Gaps = 39/217 (17%)

Query: 5   ELMKDIGSGNFGV---ARLMRNKNTKELVAMKYIERGHKIDANVA--REIINHKQLRHPN 59
              + IG G+FGV      +     +   A+K + R  ++    A  RE +  + L HPN
Sbjct: 24  HSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPN 83

Query: 60  IIRFKEVVLT--PTHLAIVMEYAAGGELFERICNAGRFSEDEARYF-FQQLIS--GQIC- 113
           ++    ++L        +++ Y   G+L +       F     R    + LIS   Q+  
Sbjct: 84  VLALIGIMLPPEGLPH-VLLPYMCHGDLLQ-------FIRSPQRNPTVKDLISFGLQVAR 135

Query: 114 -----------HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYI--- 159
                      HRDL   N +LD S    +K+ DFG ++  L            A +   
Sbjct: 136 GMEYLAEQKFVHRDLAARNCMLDESFT--VKVADFGLARDILDREYYSVQQHRHARLPVK 193

Query: 160 --APEVLSRREYDGKLADVWSCGVTLY-VMLVGAYPF 193
             A E L    +  K +DVWS GV L+ ++  GA P+
Sbjct: 194 WTALESLQTYRFTTK-SDVWSFGVLLWELLTRGAPPY 229

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score = 71.6 bits (176), Expect = 3e-14
 Identities = 66/298 (22%), Positives = 108/298 (36%), Gaps = 51/298 (17%)

Query: 2   EKYELMKDIGSGNFG-----VARLMRNKNTKELVAMKYIERGHKID-ANVAREIINHKQL 55
               L  ++G G FG         +  +  K LVA+K ++   +    +  RE      L
Sbjct: 41  RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTML 100

Query: 56  RHPNIIRFKEVVLTPTHLAIVMEYAAGGELFE--------RICNAGRFSEDEARYFFQQL 107
           +H +I+RF  V      L +V EY   G+L              AG            QL
Sbjct: 101 QHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQL 160

Query: 108 IS--GQIC------------HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTV 153
           ++   Q+             HRDL   N L+       +KI DFG S+   ++S     V
Sbjct: 161 LAVASQVAAGMVYLAGLHFVHRDLATRNCLV--GQGLVVKIGDFGMSRD--IYSTDYYRV 216

Query: 154 GTPAYI-----APEVLSRREYDGKLADVWSCGVTLY-VMLVGAYPFEDQEDPKNFRKTIS 207
           G    +      PE +  R++  + +DVWS GV L+ +   G  P+    + +       
Sbjct: 217 GGRTMLPIRWMPPESILYRKFTTE-SDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQ 275

Query: 208 R-IMAVQYKIPDYVH-ISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLPRELTE 263
              +      P  V+ I + C           P +R +IK++      L+ L +    
Sbjct: 276 GRELERPRACPPEVYAIMRGCWQ-------REPQQRHSIKDVH---ARLQALAQAPPV 323

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score = 70.7 bits (174), Expect = 5e-14
 Identities = 47/228 (20%), Positives = 86/228 (37%), Gaps = 41/228 (17%)

Query: 2   EKYELMKDIGSGNFG-----VARLMRNKNTKELVAMKYIERGHKIDANVA--REIINHKQ 54
                M+++G   FG                + VA+K ++   +         E +   +
Sbjct: 9   SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRAR 68

Query: 55  LRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFE----RICNAGRFSEDEARYFFQQL--- 107
           L+HPN++    VV     L+++  Y + G+L E    R  ++   S D+ R     L   
Sbjct: 69  LQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPP 128

Query: 108 ----ISGQIC------------HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKS 151
               +  QI             H+DL   N L+       +KI D G  +   +++    
Sbjct: 129 DFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLV--YDKLNVKISDLGLFR--EVYAADYY 184

Query: 152 TVGTPAYI-----APEVLSRREYDGKLADVWSCGVTLY-VMLVGAYPF 193
            +   + +     APE +   ++    +D+WS GV L+ V   G  P+
Sbjct: 185 KLLGNSLLPIRWMAPEAIMYGKFSID-SDIWSYGVVLWEVFSYGLQPY 231

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score = 70.7 bits (174), Expect = 5e-14
 Identities = 51/230 (22%), Positives = 83/230 (36%), Gaps = 44/230 (19%)

Query: 2   EKYELMKDIGSGNFG-----VARLMRNKNTKELVAMKYIERGHKIDANVA--REIINHKQ 54
            +    K +G+G FG      A  +   +    VA+K ++    +    A   E+     
Sbjct: 23  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82

Query: 55  L-RHPNIIRFKEVVLTPTHLAIVMEYAAGGEL-----------FERICNAGRFSEDEARY 102
           L  H NI+             ++ EY   G+L                +     +DE   
Sbjct: 83  LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142

Query: 103 FFQQLIS--GQIC------------HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR 148
             + L+S   Q+             HRDL   N LL        KICDFG ++   + + 
Sbjct: 143 DLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRI--TKICDFGLAR--DIKND 198

Query: 149 PKSTVGTPAYI-----APEVLSRREYDGKLADVWSCGVTLY-VMLVGAYP 192
               V   A +     APE +    Y  + +DVWS G+ L+ +  +G+ P
Sbjct: 199 SNYVVKGNARLPVKWMAPESIFNCVYTFE-SDVWSYGIFLWELFSLGSSP 247

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score = 70.0 bits (172), Expect = 1e-13
 Identities = 54/226 (23%), Positives = 83/226 (36%), Gaps = 44/226 (19%)

Query: 2   EKYELMKDIGSGNFGV---ARLMRNKNTKELVAMKYIERGHKIDANVA--REIINHKQL- 55
              +    IG GNFG    AR+ +    +   A+K ++     D +     E+    +L 
Sbjct: 25  NDIKFQDVIGEGNFGQVLKARI-KKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLG 83

Query: 56  RHPNIIRFKEVVLTPTHLAIVMEYAAGGEL---------FERICNAGRFSEDEARYFFQQ 106
            HPNII          +L + +EYA  G L          E        +   +    QQ
Sbjct: 84  HHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQ 143

Query: 107 LIS--GQIC------------HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST 152
           L+     +             HRDL   N L+  +     KI DFG S+   ++      
Sbjct: 144 LLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYV--AKIADFGLSRGQEVY-----V 196

Query: 153 VGTPAYI-----APEVLSRREYDGKLADVWSCGVTLY-VMLVGAYP 192
             T   +     A E L+   Y    +DVWS GV L+ ++ +G  P
Sbjct: 197 KKTMGRLPVRWMAIESLNYSVYTTN-SDVWSYGVLLWEIVSLGGTP 241

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score = 69.3 bits (170), Expect = 2e-13
 Identities = 51/236 (21%), Positives = 83/236 (35%), Gaps = 49/236 (20%)

Query: 2   EKYELMKDIGSGNFG-----VARLMRNKNTKELVAMKYIERGHKIDANVA--REIINHKQ 54
              E ++DIG G FG      A  +       +VA+K ++     D      RE     +
Sbjct: 47  NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 106

Query: 55  LRHPNIIRFKEVVLTPTHLAIVMEYAAGGEL-----------------FERICNAGRFSE 97
             +PNI++   V      + ++ EY A G+L                  +    A   S 
Sbjct: 107 FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 166

Query: 98  DEARYFFQQLIS--GQIC------------HRDLKLENTLLDGSPAPRLKICDFGYSKSS 143
                   + +    Q+             HRDL   N L+       +KI DFG S++ 
Sbjct: 167 GPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLV--GENMVVKIADFGLSRN- 223

Query: 144 LLHSRPKSTVGTPAYI-----APEVLSRREYDGKLADVWSCGVTLY-VMLVGAYPF 193
            ++S           I      PE +    Y  + +DVW+ GV L+ +   G  P+
Sbjct: 224 -IYSADYYKADGNDAIPIRWMPPESIFYNRYTTE-SDVWAYGVVLWEIFSYGLQPY 277

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score = 68.8 bits (169), Expect = 2e-13
 Identities = 55/236 (23%), Positives = 85/236 (36%), Gaps = 49/236 (20%)

Query: 2   EKYELMKDIGSGNFG-----VARLMRNKNTKELVAMKYIERGHKIDANVA--REIINHKQ 54
           +   L K +G G FG      A  ++ +     VA+K ++             E    KQ
Sbjct: 23  KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQ 82

Query: 55  LRHPNIIRFKEVVLTPTHLAIVMEYAAGGEL-----------------FERICNAGRFSE 97
           + HP++I+          L +++EYA  G L                      ++     
Sbjct: 83  VNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHP 142

Query: 98  DEARYFFQQLIS--GQIC------------HRDLKLENTLLDGSPAPRLKICDFGYSKSS 143
           DE       LIS   QI             HRDL   N L+       +KI DFG S+  
Sbjct: 143 DERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRK--MKISDFGLSR-- 198

Query: 144 LLHSRPKSTVGTPAYI-----APEVLSRREYDGKLADVWSCGVTLY-VMLVGAYPF 193
            ++        +   I     A E L    Y  + +DVWS GV L+ ++ +G  P+
Sbjct: 199 DVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQ-SDVWSFGVLLWEIVTLGGNPY 253

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score = 68.8 bits (169), Expect = 2e-13
 Identities = 62/287 (21%), Positives = 103/287 (35%), Gaps = 50/287 (17%)

Query: 2   EKYELMKDIGSGNFG-----VARLMRNKNTKELVAMKYIERGHKIDANVA--REIINHKQ 54
              +  K +G+G FG      A  +  ++    VA+K ++     D   A   E+     
Sbjct: 46  NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 105

Query: 55  L-RHPNIIRFKEVVLTPTHLAIVMEYAAGGEL--FERICNAGRFSEDEARYFFQQL---- 107
           L +H NI+           + ++ EY   G+L  F R  +    ++              
Sbjct: 106 LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRD 165

Query: 108 ---ISGQIC------------HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST 152
               S Q+             HRD+   N LL  +     KI DFG ++   + +     
Sbjct: 166 LLHFSSQVAQGMAFLASKNCIHRDVAARNVLL--TNGHVAKIGDFGLAR--DIMNDSNYI 221

Query: 153 VGTPAYI-----APEVLSRREYDGKLADVWSCGVTLY-VMLVGAYPFEDQEDPKNFRKTI 206
           V   A +     APE +    Y  + +DVWS G+ L+ +  +G  P+        F K +
Sbjct: 222 VKGNARLPVKWMAPESIFDCVYTVQ-SDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLV 280

Query: 207 SR--IMAVQYKIPDYVH-ISQDCRNLLSRIFVANPSRRITIKEIKSH 250
                MA     P  ++ I Q C           P+ R T ++I S 
Sbjct: 281 KDGYQMAQPAFAPKNIYSIMQACWA-------LEPTHRPTFQQICSF 320

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score = 67.3 bits (165), Expect = 8e-13
 Identities = 70/313 (22%), Positives = 118/313 (37%), Gaps = 55/313 (17%)

Query: 2   EKYELMKDIGSGNFG-----VARLMRNKNTKE--LVAMKYIERGHKIDANVA--REIINH 52
           +K  L K +G G FG      A  +     KE   VA+K ++             E+   
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94

Query: 53  KQL-RHPNIIRFKEVVLTPTHLAIVMEYAAGGEL---------FERICNAGRFSEDEARY 102
           K + +H NII           L +++EYA+ G L              +       E + 
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154

Query: 103 FFQQLIS--GQIC------------HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR 148
            F+ L+S   Q+             HRDL   N L+  +    +KI DFG ++   +++ 
Sbjct: 155 TFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNV--MKIADFGLAR--DINNI 210

Query: 149 PKSTVGTPAYI-----APEVLSRREYDGKLADVWSCGVTLY-VMLVGAYPFEDQEDPKNF 202
                 T   +     APE L  R Y  + +DVWS GV ++ +  +G  P+      + F
Sbjct: 211 DYYKKTTNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGVLMWEIFTLGGSPYPGIPVEELF 269

Query: 203 RKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLPRELT 262
           +          +++    + + +   ++   + A PS+R T K++         L R LT
Sbjct: 270 KLLKEG-----HRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED------LDRILT 318

Query: 263 ETAQAIYYRKENP 275
            T    Y     P
Sbjct: 319 LTTNEEYLDLSQP 331

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score = 67.8 bits (166), Expect = 8e-13
 Identities = 64/323 (19%), Positives = 118/323 (36%), Gaps = 52/323 (16%)

Query: 2   EKYELMKDIGSGNFG-----VARLMRNKNTKE--LVAMKYIERGHKIDANVA--REIINH 52
           ++  L K +G G FG      A  +          VA+K ++             E+   
Sbjct: 69  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 128

Query: 53  KQL-RHPNIIRFKEVVLTPTHLAIVMEYAAGGEL---------FERICNAGRFSEDEARY 102
           K + +H NII           L +++EYA+ G L              +       E + 
Sbjct: 129 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 188

Query: 103 FFQQLIS--GQIC------------HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR 148
             + L+S   Q+             HRDL   N L+  +    +KI DFG ++   +H  
Sbjct: 189 SSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV--TEDNVMKIADFGLAR--DIHHI 244

Query: 149 PKSTVGTPAYI-----APEVLSRREYDGKLADVWSCGVTLY-VMLVGAYPFEDQEDPKNF 202
                 T   +     APE L  R Y  + +DVWS GV L+ +  +G  P+      + F
Sbjct: 245 DYYKKTTNGRLPVKWMAPEALFDRIYTHQ-SDVWSFGVLLWEIFTLGGSPYPGVPVEELF 303

Query: 203 RKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLPRELT 262
           +          +++    + + +   ++   + A PS+R T K++      L  +    +
Sbjct: 304 KLLKEG-----HRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLV---EDLDRIVALTS 355

Query: 263 ETAQAIYYRKENPTFSLQSVEEI 285
                 Y+   +  + + + E +
Sbjct: 356 NQEMGYYHHHHHHDYDIPTTENL 378

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score = 67.4 bits (165), Expect = 1e-12
 Identities = 68/304 (22%), Positives = 116/304 (38%), Gaps = 55/304 (18%)

Query: 2   EKYELMKDIGSGNFG-----VARLMRNKNTKE--LVAMKYIERGHKIDANVA--REIINH 52
           +K  L K +G G FG      A  +     KE   VA+K ++             E+   
Sbjct: 81  DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 140

Query: 53  KQL-RHPNIIRFKEVVLTPTHLAIVMEYAAGGEL---------FERICNAGRFSEDEARY 102
           K + +H NII           L +++EYA+ G L              +       E + 
Sbjct: 141 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 200

Query: 103 FFQQLIS--GQIC------------HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR 148
            F+ L+S   Q+             HRDL   N L+  +    +KI DFG ++   +++ 
Sbjct: 201 TFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLV--TENNVMKIADFGLAR--DINNI 256

Query: 149 PKSTVGTPAYI-----APEVLSRREYDGKLADVWSCGVTLY-VMLVGAYPFEDQEDPKNF 202
                 T   +     APE L  R Y  + +DVWS GV ++ +  +G  P+      + F
Sbjct: 257 DYYKKTTNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGVLMWEIFTLGGSPYPGIPVEELF 315

Query: 203 RKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLPRELT 262
           +          +++    + + +   ++   + A PS+R T K++         L R LT
Sbjct: 316 KLLKEG-----HRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED------LDRILT 364

Query: 263 ETAQ 266
            T  
Sbjct: 365 LTTN 368

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score = 65.8 bits (161), Expect = 3e-12
 Identities = 54/230 (23%), Positives = 87/230 (37%), Gaps = 43/230 (18%)

Query: 2   EKYELMKDIGSGNFG-----VARLMRNKNTKELVAMKYIERGHKIDANVA--REIINHKQ 54
           ++ +L K +G G FG      A  +    T   VA+K ++ G     + A   E+     
Sbjct: 27  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 86

Query: 55  L-RHPNIIRFKEVVLTP-THLAIVMEYAAGGEL---------FERICNAGRFSEDEARYF 103
           +  H N++        P   L +++E+   G L                      +    
Sbjct: 87  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 146

Query: 104 FQQLIS--GQIC------------HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP 149
            + LI    Q+             HRDL   N LL       +KICDFG ++   ++  P
Sbjct: 147 LEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNV--VKICDFGLARD--IYKDP 202

Query: 150 KSTVGTPAYI-----APEVLSRREYDGKLADVWSCGVTLY-VMLVGAYPF 193
                  A +     APE +  R Y  + +DVWS GV L+ +  +GA P+
Sbjct: 203 DYVRKGDARLPLKWMAPETIFDRVYTIQ-SDVWSFGVLLWEIFSLGASPY 251

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score = 65.0 bits (159), Expect = 6e-12
 Identities = 71/315 (22%), Positives = 109/315 (34%), Gaps = 65/315 (20%)

Query: 2   EKYELMKDIGSGNFG-----VARLMRNKNTKELVAMKYIERGHKIDANVA--REIINHKQ 54
           E  E  K +GSG FG      A  +        VA+K ++         A   E+    Q
Sbjct: 45  ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 104

Query: 55  L-RHPNIIRFKEVVLTPTHLAIVMEYAAGGEL----------------FERICNAGRFSE 97
           L  H NI+           + ++ EY   G+L                           E
Sbjct: 105 LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 164

Query: 98  DEARYFFQQLIS--GQIC------------HRDLKLENTLLDGSPAPRLKICDFGYSKSS 143
           D     F+ L+    Q+             HRDL   N L+       +KICDFG ++  
Sbjct: 165 DLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKV--VKICDFGLARD- 221

Query: 144 LLHSRPKSTVGTPAYI-----APEVLSRREYDGKLADVWSCGVTLY-VMLVGAYPFEDQE 197
            + S     V   A +     APE L    Y  K +DVWS G+ L+ +  +G  P+    
Sbjct: 222 -IMSDSNYVVRGNARLPVKWMAPESLFEGIYTIK-SDVWSYGILLWEIFSLGVNPYPGIP 279

Query: 198 DPKNFRKTISR--IMAVQYKIPDYVH-ISQDCRNLLSRIFVANPSRRITIKEIKSHPWFL 254
              NF K I     M   +   + ++ I Q C          +  +R +   + S     
Sbjct: 280 VDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWA-------FDSRKRPSFPNLTSF---- 328

Query: 255 KNLPRELTETAQAIY 269
             L  +L +  +A+Y
Sbjct: 329 --LGCQLADAEEAMY 341

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 58.9 bits (143), Expect = 4e-10
 Identities = 57/269 (21%), Positives = 101/269 (37%), Gaps = 56/269 (20%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRH---- 57
             Y++ + IG G+FGV     N    + VA+K+ E        +  E   +K L      
Sbjct: 10  VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKF-EPRRSDAPQLRDEYRTYKLLAGCTGI 68

Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAG---GELFERICNAGRFSEDEARYFFQQLIS----- 109
           PN+  F +      H  +V++   G    +L   +C   +FS        +Q+++     
Sbjct: 69  PNVYYFGQ---EGLHNVLVIDL-LGPSLEDLL-DLCG-RKFSVKTVAMAAKQMLARVQSI 122

Query: 110 ---GQICHRDLKLENTLL---DGSPAPRLKICDFGYSK-----SSLLH---SRPKSTVGT 155
                + +RD+K +N L+   +   A  + + DFG  K      +  H      K+  GT
Sbjct: 123 HEKSLV-YRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGT 181

Query: 156 PAYIAP-----EVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIM 210
             Y++         SRR+      D+ + G      L G+ P++  +   N +K   RI 
Sbjct: 182 ARYMSINTHLGREQSRRD------DLEALGHVFMYFLRGSLPWQGLKAATNKQKY-ERIG 234

Query: 211 AVQYKIP----------DYVHISQDCRNL 229
             +   P          ++       RNL
Sbjct: 235 EKKQSTPLRELCAGFPEEFYKYMHYARNL 263

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 58.7 bits (141), Expect = 7e-10
 Identities = 51/227 (22%), Positives = 67/227 (29%), Gaps = 66/227 (29%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDAN---------VAREIINH 52
           EK +  + IG G FG        +T   VA+K I        N         +  EII  
Sbjct: 20  EKLQRCEKIGEGVFGEVFQTIADHTP--VAIKIIAIEGPDLVNGSHQKTFEEILPEIIIS 77

Query: 53  KQL---------RHPNIIRFKEVVL------------------------------TPTHL 73
           K+L         R    I    V                                    L
Sbjct: 78  KELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQL 137

Query: 74  AIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG--------QICHRDLKLENTLLD 125
            IV+E+  GG   E++      S   A+    QL +         +  HRDL   N LL 
Sbjct: 138 FIVLEFEFGGIDLEQMRT-KLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLK 196

Query: 126 GSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGK 172
                  K+      KSS +      + G    I    LSR E DG 
Sbjct: 197 --KTSLKKLHYTLNGKSSTIP-----SCGLQVSIIDYTLSRLERDGI 236

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 58.1 bits (140), Expect = 1e-09
 Identities = 59/216 (27%), Positives = 87/216 (40%), Gaps = 35/216 (16%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLR-HPNI 60
            K+ L + IGSG+FG   L  N  T E VA+K  E        +  E   ++ L+    I
Sbjct: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL-ENVKTKHPQLLYESKIYRILQGGTGI 65

Query: 61  IRFKEVVLTPTHLAIVMEYAAG---GELFERICNAGRFSEDEARYFFQQLI-------SG 110
              +   +   +  +VM+   G    +LF   C+  + S         Q+I       S 
Sbjct: 66  PNVRWFGVEGDYNVLVMDL-LGPSLEDLF-NFCS-RKLSLKTVLMLADQMINRVEFVHSK 122

Query: 111 QICHRDLKLENTLLD-GSPAPRLKICDFGYSK-----SSLLHSRP---KSTVGTPAYIAP 161
              HRD+K +N L+  G  A ++ I DFG +K     S+  H      K+  GT  Y + 
Sbjct: 123 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASV 182

Query: 162 EV-----LSRREYDGKLADVWSCGVTLYVMLVGAYP 192
                   SRR  D    D+ S G  L   L G+ P
Sbjct: 183 NTHLGIEQSRR--D----DLESLGYVLMYFLRGSLP 212

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 57.0 bits (138), Expect = 2e-09
 Identities = 66/283 (23%), Positives = 104/283 (36%), Gaps = 62/283 (21%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRH-PNI 60
            +Y L + IGSG+FG   L  +    E VA+K  E        +  E   +K ++    I
Sbjct: 9   NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKL-ECVKTKHPQLHIESKIYKMMQGGVGI 67

Query: 61  IRFKEVVLTPTHLAIVMEYAAG---GELFERICNAGRFSEDEARYFFQQLI-------SG 110
              +       +  +VME   G    +LF   C+  +FS         Q+I       S 
Sbjct: 68  PTIRWCGAEGDYNVMVMEL-LGPSLEDLF-NFCS-RKFSLKTVLLLADQMISRIEYIHSK 124

Query: 111 QICHRDLKLENTLL-DGSPAPRLKICDFGYSK-----SSLLH---SRPKSTVGTPAYIAP 161
              HRD+K +N L+  G     + I DFG +K      +  H      K+  GT  Y + 
Sbjct: 125 NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASI 184

Query: 162 -----EVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQED------------------ 198
                   SRR  D    D+ S G  L    +G+ P++  +                   
Sbjct: 185 NTHLGIEQSRR--D----DLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP 238

Query: 199 --------PKNFRKTISRIMAVQYKI-PDYVHISQDCRNLLSR 232
                   P  F   ++   ++++   PDY ++ Q  RNL  R
Sbjct: 239 IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR 281

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 56.2 bits (136), Expect = 4e-09
 Identities = 59/233 (25%), Positives = 91/233 (39%), Gaps = 45/233 (19%)

Query: 3   KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRH----P 58
            + + K IG GNFG  RL +N  T E VA+K +E        +  E   +KQL      P
Sbjct: 10  NFRVGKKIGCGNFGELRLGKNLYTNEYVAIK-LEPMKSRAPQLHLEYRFYKQLGSGDGIP 68

Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGG----ELFERICNAGRFSEDEARYFFQQLI------ 108
            +  F        + A+V+E    G    +LF  +C+   FS         QLI      
Sbjct: 69  QVYYFGP---CGKYNAMVLELL--GPSLEDLF-DLCD-RTFSLKTVLMIAIQLISRMEYV 121

Query: 109 -SGQICHRDLKLENTLLDGSPAPRLKIC---DFGYSK-----SSLLH---SRPKSTVGTP 156
            S  + +RD+K EN L+        ++    DF  +K      +  H      KS  GT 
Sbjct: 122 HSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTA 181

Query: 157 AYIAP-----EVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRK 204
            Y++      +  SRR  D    D+ + G      L G+ P++  +      +
Sbjct: 182 RYMSINTHLGKEQSRR--D----DLEALGHMFMYFLRGSLPWQGLKADTLKER 228

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 57.2 bits (137), Expect = 4e-09
 Identities = 49/370 (13%), Positives = 111/370 (30%), Gaps = 88/370 (23%)

Query: 4   YELMKDIGSGNFG--VARLMRNKNTKELVAMKYIERGHKI--------DANVAR-----E 48
            + ++++   N+   ++ +   +    ++   YIE+  ++          NV+R     +
Sbjct: 80  QKFVEEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQPYLK 139

Query: 49  IINH-KQLR-HPNIIRF------KEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEA 100
           +     +LR   N++        K  V     L+  ++     ++F    N    +  E 
Sbjct: 140 LRQALLELRPAKNVLIDGVLGSGKTWVALDVCLSYKVQCKMDFKIF--WLNLKNCNSPET 197

Query: 101 RYFFQQLISGQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIA 160
                Q    ++ ++      +  D S   +L+I         LL S+P         + 
Sbjct: 198 VLEMLQ----KLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYEN----CLL- 248

Query: 161 PEVLSRREYDGKLADVWS----------C---------GVTLYVMLVGAYPFEDQEDPKN 201
             VL          +V +          C          VT ++                
Sbjct: 249 --VL-----L----NVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMT 297

Query: 202 FRKTISR-IMAVQYKIPDYVHIS-QDCRNLLSRIFVANPSRRITI--KEIKSHP--W-FL 254
                 + ++        Y+    QD    +      NP RR++I  + I+     W   
Sbjct: 298 LTPDEVKSLLL------KYLDCRPQDLPREVLTT---NP-RRLSIIAESIRDGLATWDNW 347

Query: 255 KNLPRELTETAQAIYYRKENPTFSLQSVEEITKIVEEAKVPPPVSRSIGGFGWGGEEDGD 314
           K++  +   T          P    +  + ++     A +P  +   I    W    D  
Sbjct: 348 KHVNCDKLTTIIESSLNVLEPAEYRKMFDRLSVFPPSAHIPTILLSLI----WF---DVI 400

Query: 315 EKEEETDADE 324
           + +     ++
Sbjct: 401 KSDVMVVVNK 410

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score = 54.5 bits (132), Expect = 1e-08
 Identities = 29/99 (29%), Positives = 48/99 (48%), Gaps = 17/99 (17%)

Query: 111 QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTV-----GTPAYIAPEVLS 165
              HRD+K  N LLD +     KI DFG ++        ++ +     GT AY+APE L 
Sbjct: 153 HHIHRDIKSANILLDEAFTA--KISDFGLAR--ASEKFAQTVMTSRIVGTTAYMAPEALR 208

Query: 166 RREYDGKL---ADVWSCGVTLYVMLVGAYPFEDQEDPKN 201
                G++   +D++S GV L  ++ G    ++  +P+ 
Sbjct: 209 -----GEITPKSDIYSFGVVLLEIITGLPAVDEHREPQL 242

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score = 51.8 bits (125), Expect = 1e-07
 Identities = 35/86 (40%), Positives = 44/86 (51%), Gaps = 12/86 (13%)

Query: 110 GQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPK-STV--GTPAYIAPEVLSR 166
             I HRD+K  N LLD +  P  KI DFG SK      +   STV  GT  YI PE   +
Sbjct: 158 RAIIHRDVKSINILLDENFVP--KITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIK 215

Query: 167 REYDGKL---ADVWSCGVTLYVMLVG 189
               G+L   +DV+S GV L+ +L  
Sbjct: 216 ----GRLTEKSDVYSFGVVLFEVLCA 237

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score = 50.7 bits (122), Expect = 3e-07
 Identities = 30/80 (37%), Positives = 36/80 (45%), Gaps = 17/80 (21%)

Query: 112 ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTV-----GTPAYIAPEVLSR 166
           I HRD+K  N LLD        + DFG +K   L     + V     GT  +IAPE LS 
Sbjct: 155 IIHRDVKAANILLDEEFEA--VVGDFGLAK---LMDYKDTHVTTAVRGTIGHIAPEYLST 209

Query: 167 REYDGKL---ADVWSCGVTL 183
               GK     DV+  GV L
Sbjct: 210 ----GKSSEKTDVFGYGVML 225

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 47.0 bits (112), Expect = 4e-06
 Identities = 50/248 (20%), Positives = 87/248 (35%), Gaps = 59/248 (23%)

Query: 3   KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIR 62
           ++ L K IGSG FG+  L    N  E  A   ++  ++ +  +  E+  ++++   + I+
Sbjct: 38  QWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIK 97

Query: 63  FKEVVLTPTHLAI-------------------VMEYAAGGELFERICNAGRFSEDEARYF 103
                    +L I                   VME   G +L +     G F +      
Sbjct: 98  KWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMER-LGIDLQKISGQNGTFKKSTVLQL 156

Query: 104 FQQLI-------SGQICHRDLKLENTLLDGSPAPRLKICDFGYSK-----SSLLHSRP-- 149
             +++         +  H D+K  N LL      ++ + D+G S       +    +   
Sbjct: 157 GIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENP 216

Query: 150 -KSTVGTPAY--------IAPEVLSRREYDGKLADVWSCGVTLYVM---LVGAYPFED-Q 196
            K   GT  +        +A    SRR      +DV   G   Y M   L G  P+E   
Sbjct: 217 RKGHNGTIEFTSLDAHKGVAL---SRR------SDVEILG---YCMLRWLCGKLPWEQNL 264

Query: 197 EDPKNFRK 204
           +DP   + 
Sbjct: 265 KDPVAVQT 272

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 45.3 bits (107), Expect = 2e-05
 Identities = 33/104 (31%), Positives = 50/104 (48%), Gaps = 7/104 (6%)

Query: 107 LISGQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS--RPKSTVGTPA-YIAPEV 163
           L S +  HRDL   N LL       +KICDFG ++          K     P  ++APE 
Sbjct: 209 LASRKCIHRDLAARNILLSEKNV--VKICDFGLARDIYKDPDYVRKGDARLPLKWMAPET 266

Query: 164 LSRREYDGKLADVWSCGVTLY-VMLVGAYPFEDQEDPKNFRKTI 206
           +  R Y  + +DVWS GV L+ +  +GA P+   +  + F + +
Sbjct: 267 IFDRVYTIQ-SDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL 309

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 42.0 bits (99), Expect = 2e-04
 Identities = 33/233 (14%), Positives = 68/233 (29%), Gaps = 62/233 (26%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNT--------KELVAMKYIERGH---KIDANVAREII 50
            +++L       N G+       +T        K+  ++K ++        + N  +   
Sbjct: 42  RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLK-LDAKDGRLFNEQNFFQRAA 100

Query: 51  NHKQLRHPNIIRFKEVVLTPT----------HLAIVMEYAAG---GELFERICNAGRFSE 97
              Q+     +    ++  PT          +  +V+    G       +        SE
Sbjct: 101 KPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDV-SPKHVLSE 158

Query: 98  DEARYFFQQLI-------SGQICHRDLKLENTLLDGSPAPRLKICDFGYSK---SSLLH- 146
                   +L+         +  H ++  EN  +D     ++ +  +G++     S  H 
Sbjct: 159 RSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHV 218

Query: 147 ----SRPKSTVGTPAY--------IAPEVLSRREYDGKLADVWSCGVTLYVML 187
                      G   +          P   SRR      +D+ S G   Y ML
Sbjct: 219 AYVEGSRSPHEGDLEFISMDLHKGCGP---SRR------SDLQSLG---YCML 259

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 39.8 bits (93), Expect = 8e-04
 Identities = 34/229 (14%), Positives = 70/229 (30%), Gaps = 56/229 (24%)

Query: 3   KYELMKDIGSGNFGV---ARLMRNKN--TKELVAMKYIERGHK---------IDANVARE 48
            +++   IG G FG    A +  +++  +     +K     +            A    +
Sbjct: 36  AWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQ 95

Query: 49  IINHKQLRH------PNIIRF-KEVVLTPTHLAIVMEYAAG---GELFERICNAGRFSE- 97
           I    + R       P             ++  ++M+   G    +++E      RFS  
Sbjct: 96  IQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEA-NA-KRFSRK 152

Query: 98  ------DEARYFFQQLISGQICHRDLKLENTLLDGSPAPRLKICDFGYSK-----SSLLH 146
                        + +   +  H D+K  N LL+     ++ + D+G +           
Sbjct: 153 TVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKA 212

Query: 147 SRP---KSTVGTPAYIAPEV-----LSRREYDGKLADVWSCGVTLYVML 187
                 +   GT  + + +       SRR       D+   G   Y M+
Sbjct: 213 YAADPKRCHDGTIEFTSIDAHNGVAPSRR------GDLEILG---YCMI 252

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	344
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.98
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.94
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.9
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.83
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.69
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.4
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.3
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.03
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	98.81
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.6
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.5
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.46
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.46
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	98.43
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.31
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	98.02
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.92
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.91
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.88
3ats_A	357	Putative uncharacterized protein; hypothetical pro	97.66
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.65
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	97.55
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	97.54
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	97.51
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.5
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	97.33
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	97.28
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	97.22
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.16
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	96.75
3mes_A	424	Choline kinase; malaria, structural genomics, stru	96.67
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	96.61
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	93.34
3cxl_A	463	N-chimerin; SH2, RHO-GAP, structural genomics cons	84.78

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=5.9e-66  Score=454.89  Aligned_cols=251  Identities=41%  Similarity=0.718  Sum_probs=205.8

Q ss_pred             CCCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCc----cccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEE
Q 019195            1 MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH----KIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIV   76 (344)
Q Consensus         1 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv   76 (344)
                      +++|++++.||+|+||+||+|.+..+|+.||+|++.+..    .....+.+|+.++++++|||||+++++|.+++.+|+|
T Consensus        12 ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv   91 (275)
T 3hyh_A           12 IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMV   91 (275)
T ss_dssp             --CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             eeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEE
Confidence            478999999999999999999999999999999997643    2235789999999999999999999999999999999


Q ss_pred             EecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCCCC
Q 019195           77 MEYAAGGELFERICNAGRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP  149 (344)
Q Consensus        77 ~e~~~~g~L~~~i~~~~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~~~  149 (344)
                      |||| +|+|.+++.+.+.+++.+++.++.||+.|       ||+||||||+|||++.++.  +||+|||+|+........
T Consensus        92 mEy~-~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~--vkl~DFGla~~~~~~~~~  168 (275)
T 3hyh_A           92 IEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLN--VKIADFGLSNIMTDGNFL  168 (275)
T ss_dssp             EECC-CEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCC--EEECCSSCC---------
T ss_pred             EeCC-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCC--EEEeecCCCeecCCCCcc
Confidence            9999 78999999999999999999999887766       9999999999999977654  999999999876666666


Q ss_pred             CCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCHhHHHH
Q 019195          150 KSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL  229 (344)
Q Consensus       150 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  229 (344)
                      .+.+||+.|||||++.+..+++.++|||||||++|+|++|++||.+.+..    .++..+....+.+|.  .+|+++++|
T Consensus       169 ~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~----~~~~~i~~~~~~~p~--~~s~~~~~l  242 (275)
T 3hyh_A          169 KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIP----VLFKNISNGVYTLPK--FLSPGAAGL  242 (275)
T ss_dssp             ------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHHHHHHTCCCCCT--TSCHHHHHH
T ss_pred             CCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHH----HHHHHHHcCCCCCCC--CCCHHHHHH
Confidence            67899999999999999888877799999999999999999999876543    344445555655554  689999999


Q ss_pred             HHHhcccCCCCCCChHHHhcCcccccCCChh
Q 019195          230 LSRIFVANPSRRITIKEIKSHPWFLKNLPRE  260 (344)
Q Consensus       230 i~~~L~~dp~~R~s~~ell~hp~~~~~~~~~  260 (344)
                      |.+||+.||.+|||+.|+|+||||+..++..
T Consensus       243 i~~~L~~dP~~R~s~~eil~hpw~k~~~p~~  273 (275)
T 3hyh_A          243 IKRMLIVNPLNRISIHEIMQDDWFKVDLPEY  273 (275)
T ss_dssp             HHHHSCSSGGGSCCHHHHHHCHHHHTTCCGG
T ss_pred             HHHHccCChhHCcCHHHHHcCcccccCCChh
Confidence            9999999999999999999999998776643

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=5.5e-65  Score=454.86  Aligned_cols=248  Identities=30%  Similarity=0.533  Sum_probs=216.7

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCc----cccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEE
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH----KIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVM   77 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~   77 (344)
                      ++|++++.||+|+||+||+|++..+++.||||++.+..    .....+.+|+.+|++|+|||||+++++|.+++.+|+||
T Consensus        32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm  111 (311)
T 4aw0_A           32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL  111 (311)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            57999999999999999999999999999999997632    33467899999999999999999999999999999999


Q ss_pred             ecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCC---C
Q 019195           78 EYAAGGELFERICNAGRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH---S  147 (344)
Q Consensus        78 e~~~~g~L~~~i~~~~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~---~  147 (344)
                      |||+||+|.++|.+.+.+++.+++.++.||+.|       ||+||||||+|||++.++.  +||+|||+|+.....   .
T Consensus       112 Ey~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~--vKl~DFGla~~~~~~~~~~  189 (311)
T 4aw0_A          112 SYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMH--IQITDFGTAKVLSPESKQA  189 (311)
T ss_dssp             CCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSC--EEECCCTTCEECCTTTTCC
T ss_pred             ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCC--EEEEEcCCceecCCCCCcc
Confidence            999999999999999999999999998887766       9999999999999987664  999999999865432   2


Q ss_pred             CCCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCHhHH
Q 019195          148 RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCR  227 (344)
Q Consensus       148 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~  227 (344)
                      ...+.+||+.|||||++.+..|+ .++|||||||++|+|++|++||.+.+...    ++.++....+.+|.  .+|++++
T Consensus       190 ~~~~~~GTp~YmAPEvl~~~~y~-~~~DiWSlGvilyeml~G~~PF~~~~~~~----~~~~i~~~~~~~p~--~~s~~~~  262 (311)
T 4aw0_A          190 RANSFVGTAQYVSPELLTEKSAC-KSSDLWALGCIIYQLVAGLPPFRAGNEGL----IFAKIIKLEYDFPE--KFFPKAR  262 (311)
T ss_dssp             CBCCCCSCGGGCCHHHHHHSCBC-HHHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHHHHHHTCCCCCT--TCCHHHH
T ss_pred             cccCcccCcccCCHHHHcCCCCC-cHHHHHHHHHHHHHHHhCCCCCCCCCHHH----HHHHHHcCCCCCCc--ccCHHHH
Confidence            34567899999999999888874 56999999999999999999998765433    44455556666665  6899999


Q ss_pred             HHHHHhcccCCCCCCChHH------HhcCcccccCCC
Q 019195          228 NLLSRIFVANPSRRITIKE------IKSHPWFLKNLP  258 (344)
Q Consensus       228 ~li~~~L~~dp~~R~s~~e------ll~hp~~~~~~~  258 (344)
                      +||.+||++||.+|||+.|      +++||||...-.
T Consensus       263 dli~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~idw  299 (311)
T 4aw0_A          263 DLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTW  299 (311)
T ss_dssp             HHHHHHSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCC
T ss_pred             HHHHHHccCCHhHCcChHHHcCCHHHHCCCCcCCCCH
Confidence            9999999999999999988      589999976533

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=3.4e-64  Score=456.19  Aligned_cols=251  Identities=25%  Similarity=0.473  Sum_probs=215.4

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCcc-ccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEEecC
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK-IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYA   80 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~   80 (344)
                      +.|+++++||+|+||+||+|.+..+|+.||||++..... ....+.+|+.+|++++|||||+++++|.+++.+|||||||
T Consensus        74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~  153 (346)
T 4fih_A           74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL  153 (346)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence            469999999999999999999999999999999976433 3456889999999999999999999999999999999999


Q ss_pred             CCCChHHHHHhCCCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCC-CCCCCC
Q 019195           81 AGGELFERICNAGRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH-SRPKST  152 (344)
Q Consensus        81 ~~g~L~~~i~~~~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~-~~~~~~  152 (344)
                      +||+|.+++.+ +.+++.+++.++.||+.|       |||||||||+|||++.++.  +||+|||+|+..... ....+.
T Consensus       154 ~gg~L~~~l~~-~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~--vKl~DFGla~~~~~~~~~~~~~  230 (346)
T 4fih_A          154 EGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGR--VKLSDFGFCAQVSKEVPRRKSL  230 (346)
T ss_dssp             TTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCC--EEECCCTTCEECCSSSCCBCCC
T ss_pred             CCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCC--EEEecCcCceecCCCCCccccc
Confidence            99999998865 579999999998887766       9999999999999987664  999999999865433 345667


Q ss_pred             ccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCHhHHHHHHH
Q 019195          153 VGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSR  232 (344)
Q Consensus       153 ~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~  232 (344)
                      +||+.|||||++.+..|+ .++|||||||++|+|++|++||.+.+....+..+..   .....++.+..+|+++++||.+
T Consensus       231 ~GTp~YmAPEvl~~~~y~-~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~---~~~~~~~~~~~~s~~~~dli~~  306 (346)
T 4fih_A          231 VGTPYWMAPELISRLPYG-PEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRD---NLPPRLKNLHKVSPSLKGFLDR  306 (346)
T ss_dssp             CSCGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH---SSCCCCSCGGGSCHHHHHHHHH
T ss_pred             ccCcCcCCHHHHCCCCCC-cHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHc---CCCCCCCccccCCHHHHHHHHH
Confidence            899999999999888875 559999999999999999999988765444433322   1223444556789999999999


Q ss_pred             hcccCCCCCCChHHHhcCcccccCCCh
Q 019195          233 IFVANPSRRITIKEIKSHPWFLKNLPR  259 (344)
Q Consensus       233 ~L~~dp~~R~s~~ell~hp~~~~~~~~  259 (344)
                      ||+.||.+|||+.|+|+||||++..++
T Consensus       307 ~L~~dP~~R~ta~e~l~Hp~~~~~~~p  333 (346)
T 4fih_A          307 LLVRDPAQRATAAELLKHPFLAKAGPP  333 (346)
T ss_dssp             HSCSSTTTSCCHHHHTTCGGGGGCCCG
T ss_pred             HcCCChhHCcCHHHHhcCHhhcCCCCC
Confidence            999999999999999999999876553

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=1.9e-64  Score=458.55  Aligned_cols=253  Identities=30%  Similarity=0.524  Sum_probs=208.8

Q ss_pred             CCCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCcc---ccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEE
Q 019195            1 MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK---IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVM   77 (344)
Q Consensus         1 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~   77 (344)
                      |++|++++.||+|+||+||+|++..+|+.||||++.+...   ....+.+|+.+|++|+|||||+++++|.+++.+||||
T Consensus        23 me~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVm  102 (350)
T 4b9d_A           23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVM  102 (350)
T ss_dssp             CCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             ccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEE
Confidence            6899999999999999999999999999999999986543   2357889999999999999999999999999999999


Q ss_pred             ecCCCCChHHHHHhC--CCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCC-
Q 019195           78 EYAAGGELFERICNA--GRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS-  147 (344)
Q Consensus        78 e~~~~g~L~~~i~~~--~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~-  147 (344)
                      |||+||+|.++|...  ..+++.+++.++.||+.|       ||+||||||+|||++.++.  +||+|||+|+...... 
T Consensus       103 Ey~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~--vKl~DFGla~~~~~~~~  180 (350)
T 4b9d_A          103 DYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGT--VQLGDFGIARVLNSTVE  180 (350)
T ss_dssp             ECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCC--EEECSTTEESCCCHHHH
T ss_pred             eCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCC--EEEcccccceeecCCcc
Confidence            999999999999754  357899988888887765       9999999999999987654  9999999998654322 


Q ss_pred             CCCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCHhHH
Q 019195          148 RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCR  227 (344)
Q Consensus       148 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~  227 (344)
                      .....+||+.|||||++.+..|+ .++|||||||++|+|++|++||.+.+....+.    ++....+. +....+|++++
T Consensus       181 ~~~~~~GT~~YmAPE~l~~~~y~-~~~DiwSlGvilyemltG~~PF~~~~~~~~~~----~i~~~~~~-~~~~~~s~~~~  254 (350)
T 4b9d_A          181 LARACIGTPYYLSPEICENKPYN-NKSDIWALGCVLYELCTLKHAFEAGSMKNLVL----KIISGSFP-PVSLHYSYDLR  254 (350)
T ss_dssp             HHHHHHSCCTTCCHHHHTTCCCC-HHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH----HHHHTCCC-CCCTTSCHHHH
T ss_pred             cccccCCCccccCHHHHCCCCCC-cHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHH----HHHcCCCC-CCCccCCHHHH
Confidence            22345799999999999988875 55999999999999999999998876544433    33333332 33457899999


Q ss_pred             HHHHHhcccCCCCCCChHHHhcCcccccCCChhh
Q 019195          228 NLLSRIFVANPSRRITIKEIKSHPWFLKNLPREL  261 (344)
Q Consensus       228 ~li~~~L~~dp~~R~s~~ell~hp~~~~~~~~~~  261 (344)
                      +||.+||++||.+|||+.|+|+||||.+...+.+
T Consensus       255 ~li~~~L~~dP~~R~s~~e~l~hp~~~~~~~~~~  288 (350)
T 4b9d_A          255 SLVSQLFKRNPRDRPSVNSILEKGFIAKRIEKFL  288 (350)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHTSHHHHTTGGGTS
T ss_pred             HHHHHHccCChhHCcCHHHHhcCHHhhcCCCcCC
Confidence            9999999999999999999999999987655443

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=1.1e-62  Score=456.70  Aligned_cols=251  Identities=25%  Similarity=0.473  Sum_probs=215.4

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCcc-ccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEEecC
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK-IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYA   80 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~   80 (344)
                      +.|++++.||+|+||+||+|.+..+|+.||||++..... ....+.+|+.+|+.++|||||+++++|.+++.+|||||||
T Consensus       151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~  230 (423)
T 4fie_A          151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL  230 (423)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCC
Confidence            469999999999999999999999999999999976443 3456889999999999999999999999999999999999


Q ss_pred             CCCChHHHHHhCCCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCC-CCCCCC
Q 019195           81 AGGELFERICNAGRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH-SRPKST  152 (344)
Q Consensus        81 ~~g~L~~~i~~~~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~-~~~~~~  152 (344)
                      +||+|.+++.. +.+++.+++.++.||+.|       |||||||||+|||++.++.  +||+|||+|+..... ....+.
T Consensus       231 ~gG~L~~~i~~-~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~--vKl~DFGla~~~~~~~~~~~~~  307 (423)
T 4fie_A          231 EGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGR--VKLSDFGFCAQVSKEVPRRKSL  307 (423)
T ss_dssp             TTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCC--EEECCCTTCEECCSSCCCBCCC
T ss_pred             CCCcHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCC--EEEecCccceECCCCCcccccc
Confidence            99999998865 569999999998887766       9999999999999987664  999999999865433 345667


Q ss_pred             ccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCHhHHHHHHH
Q 019195          153 VGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSR  232 (344)
Q Consensus       153 ~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~  232 (344)
                      +||+.|||||++.+..|+ .++|||||||++|+|++|++||.+.+....+..+..   .....++.+..+|+++++||.+
T Consensus       308 ~GTp~YmAPEvl~~~~y~-~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~---~~~~~~~~~~~~s~~~~dli~~  383 (423)
T 4fie_A          308 VGTPYWMAPELISRLPYG-PEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRD---NLPPRLKNLHKVSPSLKGFLDR  383 (423)
T ss_dssp             EECTTTCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH---SCCCCCSCTTSSCHHHHHHHHH
T ss_pred             ccCcCcCCHHHHCCCCCC-cHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHc---CCCCCCcccccCCHHHHHHHHH
Confidence            899999999999888875 559999999999999999999988765444433322   1223444556789999999999


Q ss_pred             hcccCCCCCCChHHHhcCcccccCCCh
Q 019195          233 IFVANPSRRITIKEIKSHPWFLKNLPR  259 (344)
Q Consensus       233 ~L~~dp~~R~s~~ell~hp~~~~~~~~  259 (344)
                      ||+.||.+|||+.|+|+||||++..++
T Consensus       384 ~L~~dP~~R~ta~ell~Hp~~~~~~~p  410 (423)
T 4fie_A          384 LLVRDPAQRATAAELLKHPFLAKAGPP  410 (423)
T ss_dssp             HSCSSTTTSCCHHHHTTCGGGGGCCCG
T ss_pred             HcCCChhHCcCHHHHhcCHHhcCCCCC
Confidence            999999999999999999999876543

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=3.7e-63  Score=442.83  Aligned_cols=246  Identities=32%  Similarity=0.589  Sum_probs=205.8

Q ss_pred             CCceeeeeeeecCceEEEEEEEc---CCCcEEEEEEeecCc---cccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEE
Q 019195            2 EKYELMKDIGSGNFGVARLMRNK---NTKELVAMKYIERGH---KIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAI   75 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~---~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~l   75 (344)
                      ++|++++.||+|+||+||+|++.   .+++.||+|++.+..   ....++.+|+.+|++++|||||+++++|.+++.+|+
T Consensus        24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i  103 (304)
T 3ubd_A           24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL  103 (304)
T ss_dssp             GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred             cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence            57999999999999999999874   578899999997642   223468899999999999999999999999999999


Q ss_pred             EEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCC-CC
Q 019195           76 VMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLL-HS  147 (344)
Q Consensus        76 v~e~~~~g~L~~~i~~~~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~-~~  147 (344)
                      |||||+||+|.++|.+.+.+++.+++.++.||+.|       ||+||||||+|||++.++.  +||+|||+|+.... ..
T Consensus       104 vmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~--vKl~DFGla~~~~~~~~  181 (304)
T 3ubd_A          104 ILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGH--IKLTDFGLSKESIDHEK  181 (304)
T ss_dssp             EECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSC--EEEESSEEEEC-----C
T ss_pred             EEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCC--EEecccccceeccCCCc
Confidence            99999999999999999999999999998887765       9999999999999987664  99999999986433 33


Q ss_pred             CCCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCHhHH
Q 019195          148 RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCR  227 (344)
Q Consensus       148 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~  227 (344)
                      ...+.+||+.|||||++.+..|+. ++|||||||++|+|++|++||.+.+....    +..+......+|.  .+|++++
T Consensus       182 ~~~~~~GT~~YmAPE~~~~~~y~~-~~DiwSlGvilyemltG~~PF~~~~~~~~----~~~i~~~~~~~p~--~~s~~~~  254 (304)
T 3ubd_A          182 KAYSFCGTVEYMAPEVVNRRGHTQ-SADWWSFGVLMFEMLTGTLPFQGKDRKET----MTMILKAKLGMPQ--FLSPEAQ  254 (304)
T ss_dssp             CCCSCCCCGGGCCHHHHHTSCCCT-HHHHHHHHHHHHHHHHSSCSSCCSSHHHH----HHHHHHCCCCCCT--TSCHHHH
T ss_pred             cccccccCcccCCHHHhccCCCCC-CCcccchHHHHHHHHhCCCCCCCcCHHHH----HHHHHcCCCCCCC--cCCHHHH
Confidence            456678999999999999888765 59999999999999999999988655433    4444555555554  6899999


Q ss_pred             HHHHHhcccCCCCCCCh-----HHHhcCcccccC
Q 019195          228 NLLSRIFVANPSRRITI-----KEIKSHPWFLKN  256 (344)
Q Consensus       228 ~li~~~L~~dp~~R~s~-----~ell~hp~~~~~  256 (344)
                      +||.+||++||.+|||+     +|+++||||+..
T Consensus       255 ~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~i  288 (304)
T 3ubd_A          255 SLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTI  288 (304)
T ss_dssp             HHHHHHTCSSGGGSTTCSTTTHHHHHTSGGGTTC
T ss_pred             HHHHHHcccCHHHCCCCCcCCHHHHHcCccccCC
Confidence            99999999999999984     799999999764

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=4.9e-62  Score=433.48  Aligned_cols=246  Identities=23%  Similarity=0.382  Sum_probs=203.4

Q ss_pred             Cc-eeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCcc---ccHHHHHHHHHHhcCCCCCcceeeEEEEc----CCEEE
Q 019195            3 KY-ELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK---IDANVAREIINHKQLRHPNIIRFKEVVLT----PTHLA   74 (344)
Q Consensus         3 ~y-~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~ei~~l~~l~h~niv~~~~~~~~----~~~~~   74 (344)
                      +| ++.+.||+|+||+||+|.+..+++.||+|++.....   ....+.+|+.++++|+|||||+++++|.+    +..+|
T Consensus        26 r~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~  105 (290)
T 3fpq_A           26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV  105 (290)
T ss_dssp             SEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred             ceEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEE
Confidence            44 778889999999999999999999999999976432   23568899999999999999999999975    35689


Q ss_pred             EEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHC-------C--eeecCCCCCCeEecCCCCCCEEEeecCCCcccCC
Q 019195           75 IVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-------Q--ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLL  145 (344)
Q Consensus        75 lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~ql~~~-------~--iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~  145 (344)
                      ||||||+||+|.+++.+.+.+++..++.++.|++.|       |  |+||||||+|||++.. .+++||+|||+|+... 
T Consensus       106 lvmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~-~g~vKl~DFGla~~~~-  183 (290)
T 3fpq_A          106 LVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGP-TGSVKIGDLGLATLKR-  183 (290)
T ss_dssp             EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESST-TSCEEECCTTGGGGCC-
T ss_pred             EEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECC-CCCEEEEeCcCCEeCC-
Confidence            999999999999999999999999999998888766       6  9999999999999742 2359999999997532 


Q ss_pred             CCCCCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCHh
Q 019195          146 HSRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQD  225 (344)
Q Consensus       146 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~  225 (344)
                      .....+.+||+.|||||++.+ .| +.++|||||||++|+|++|++||.+......+.   ..+............++++
T Consensus       184 ~~~~~~~~GTp~YmAPE~~~~-~y-~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~---~~i~~~~~~~~~~~~~~~~  258 (290)
T 3fpq_A          184 ASFAKAVIGTPEFMAPEMYEE-KY-DESVDVYAFGMCMLEMATSEYPYSECQNAAQIY---RRVTSGVKPASFDKVAIPE  258 (290)
T ss_dssp             TTSBEESCSSCCCCCGGGGGT-CC-CTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHH---HHHTTTCCCGGGGGCCCHH
T ss_pred             CCccCCcccCccccCHHHcCC-CC-CcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHH---HHHHcCCCCCCCCccCCHH
Confidence            333456789999999999865 45 456999999999999999999998765544332   3333332222223357899


Q ss_pred             HHHHHHHhcccCCCCCCChHHHhcCccccc
Q 019195          226 CRNLLSRIFVANPSRRITIKEIKSHPWFLK  255 (344)
Q Consensus       226 ~~~li~~~L~~dp~~R~s~~ell~hp~~~~  255 (344)
                      +++||.+||+.||.+|||+.|+|+||||++
T Consensus       259 ~~~li~~~L~~dP~~R~s~~e~l~Hp~~~~  288 (290)
T 3fpq_A          259 VKEIIEGCIRQNKDERYSIKDLLNHAFFQE  288 (290)
T ss_dssp             HHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred             HHHHHHHHccCChhHCcCHHHHhcCccccC
Confidence            999999999999999999999999999975

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=1.5e-61  Score=437.54  Aligned_cols=245  Identities=25%  Similarity=0.339  Sum_probs=207.0

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEEecCC
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYAA   81 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~   81 (344)
                      +.|++.++||+|+||+||+|+++.+|+.||||+++....    ..+|+.+++.|+|||||+++++|.+++.+|||||||+
T Consensus        58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~  133 (336)
T 4g3f_A           58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLE  133 (336)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCCT
T ss_pred             hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccC
Confidence            468899999999999999999999999999999986433    2479999999999999999999999999999999999


Q ss_pred             CCChHHHHHhCCCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCCC------
Q 019195           82 GGELFERICNAGRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR------  148 (344)
Q Consensus        82 ~g~L~~~i~~~~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~~------  148 (344)
                      ||+|.++|++.+.+++.+++.++.|++.|       |||||||||+|||++.++. ++||+|||+|+.......      
T Consensus       134 gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~-~vKl~DFGla~~~~~~~~~~~~~~  212 (336)
T 4g3f_A          134 GGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGS-RAALCDFGHALCLQPDGLGKSLLT  212 (336)
T ss_dssp             TCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSC-CEEECCCTTCEEC-----------
T ss_pred             CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCC-EEEEeeCCCCeEccCCCcccceec
Confidence            99999999999999999999998887765       9999999999999986652 499999999986443221      


Q ss_pred             CCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccC-CCCCCCCHhHH
Q 019195          149 PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKI-PDYVHISQDCR  227 (344)
Q Consensus       149 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~s~~~~  227 (344)
                      ....+||+.|||||++.+..|+. ++|||||||++|+|++|++||.+......+..+...    .... ..+..+++++.
T Consensus       213 ~~~~~GT~~YmAPE~~~~~~y~~-~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~----~~~~~~~~~~~s~~~~  287 (336)
T 4g3f_A          213 GDYIPGTETHMAPEVVMGKPCDA-KVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASE----PPPIREIPPSCAPLTA  287 (336)
T ss_dssp             -CCCCCCGGGCCHHHHTTCCCCT-HHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHS----CCGGGGSCTTSCHHHH
T ss_pred             CCccccCccccCHHHHCCCCCCc-HHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcC----CCCchhcCccCCHHHH
Confidence            23457999999999999888765 599999999999999999999887765555544432    2211 12346899999


Q ss_pred             HHHHHhcccCCCCCCChHHH-------------hcCcccccC
Q 019195          228 NLLSRIFVANPSRRITIKEI-------------KSHPWFLKN  256 (344)
Q Consensus       228 ~li~~~L~~dp~~R~s~~el-------------l~hp~~~~~  256 (344)
                      +||.+||++||.+|||+.|+             |+|||+.+.
T Consensus       288 ~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~~  329 (336)
T 4g3f_A          288 QAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGEY  329 (336)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSSC
T ss_pred             HHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCCC
Confidence            99999999999999999997             679998664

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.9e-60  Score=442.07  Aligned_cols=254  Identities=27%  Similarity=0.427  Sum_probs=213.7

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCccc---cHHHHHHHHHHhcCCCCCcceeeEEEEc------CCE
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKI---DANVAREIINHKQLRHPNIIRFKEVVLT------PTH   72 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~ei~~l~~l~h~niv~~~~~~~~------~~~   72 (344)
                      ++|++++.||+|+||+||+|.+..+|+.||||++.+....   ...+.+|+.+|+.|+|||||++++++..      .+.
T Consensus        54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~  133 (398)
T 4b99_A           54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS  133 (398)
T ss_dssp             SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred             CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence            5799999999999999999999999999999999764432   3567899999999999999999999864      367


Q ss_pred             EEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCC
Q 019195           73 LAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLL  145 (344)
Q Consensus        73 ~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~  145 (344)
                      +|||||||. |+|.+++.+.+.+++.+++.+++||+.|       |||||||||+|||++.++.  +||+|||+|+....
T Consensus       134 ~~ivmE~~~-g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~--~Ki~DFGla~~~~~  210 (398)
T 4b99_A          134 VYVVLDLME-SDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCE--LKIGDFGMARGLCT  210 (398)
T ss_dssp             EEEEEECCS-EEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCC--EEECCCTTCBCC--
T ss_pred             EEEEEeCCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCC--EEEeecceeeeccc
Confidence            999999995 6899999999999999999998887766       9999999999999987664  99999999986432


Q ss_pred             -----CCCCCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhcccc-----
Q 019195          146 -----HSRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYK-----  215 (344)
Q Consensus       146 -----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~-----  215 (344)
                           .....+.+||+.|||||++.+..+++.++||||+||++|+|++|++||.+.+....+..++.........     
T Consensus       211 ~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~~~  290 (398)
T 4b99_A          211 SPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAV  290 (398)
T ss_dssp             -----CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC--
T ss_pred             CccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhh
Confidence                 2234567899999999999888777788999999999999999999999887777666665443222111     


Q ss_pred             -----------CCC---------CCCCCHhHHHHHHHhcccCCCCCCChHHHhcCcccccCCC
Q 019195          216 -----------IPD---------YVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLP  258 (344)
Q Consensus       216 -----------~~~---------~~~~s~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~~~~  258 (344)
                                 +|.         +..+++++.+||.+||+.||.+||||.|+|+||||++...
T Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~  353 (398)
T 4b99_A          291 GAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYHD  353 (398)
T ss_dssp             ---CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTTCC
T ss_pred             hhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcCCC
Confidence                       111         1357899999999999999999999999999999987544

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=2.3e-59  Score=431.93  Aligned_cols=296  Identities=73%  Similarity=1.227  Sum_probs=235.2

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEEecCC
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYAA   81 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~   81 (344)
                      ++|++++.||+|+||+||++++..+++.||+|++.........+.+|+.+++.++||||+++++++...+.+|+||||++
T Consensus        20 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~   99 (361)
T 3uc3_A           20 DRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYAS   99 (361)
T ss_dssp             TTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCC
T ss_pred             CcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEeCC
Confidence            68999999999999999999999999999999998877777889999999999999999999999999999999999999


Q ss_pred             CCChHHHHHhCCCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCCCCCCCcc
Q 019195           82 GGELFERICNAGRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVG  154 (344)
Q Consensus        82 ~g~L~~~i~~~~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~~~~~~~g  154 (344)
                      +|+|.+++...+.+++..++.++.||+.+       ||+||||||+|||++.++.+++||+|||+++...........+|
T Consensus       100 ~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~g  179 (361)
T 3uc3_A          100 GGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG  179 (361)
T ss_dssp             SCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC--------------
T ss_pred             CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCccccccccCCCCCCcC
Confidence            99999999888899999999888887655       99999999999999877766799999999986555555566789


Q ss_pred             CCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCHhHHHHHHHhc
Q 019195          155 TPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIF  234 (344)
Q Consensus       155 t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L  234 (344)
                      |+.|+|||++.+..++++++|||||||++|+|++|+.||........+...+..+.......|....+++++.+||.+||
T Consensus       180 t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L  259 (361)
T 3uc3_A          180 TPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRISPECCHLISRIF  259 (361)
T ss_dssp             -CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCCTTSCCCHHHHHHHHHHS
T ss_pred             CCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCCCcCCCCHHHHHHHHHHc
Confidence            99999999998888877779999999999999999999998777777777888888888888887789999999999999


Q ss_pred             ccCCCCCCChHHHhcCcccccCCChhhHHHHHHhhhhccCCCCCccCHHHHHHHHHHhCCCCCc
Q 019195          235 VANPSRRITIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTFSLQSVEEITKIVEEAKVPPPV  298 (344)
Q Consensus       235 ~~dp~~R~s~~ell~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (344)
                      +.||.+|||+.++++||||.+..+..+...... ......+....++.+.+.....+...+...
T Consensus       260 ~~dP~~Rps~~ell~hp~f~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  322 (361)
T 3uc3_A          260 VADPATRISIPEIKTHSWFLKNLPADLMNESNT-GSQFQEPEQPMQSLDTIMQIISEATIPAVR  322 (361)
T ss_dssp             CSCTTTSCCHHHHHTSHHHHTTCCCC-------------------CCHHHHHHHHHHHTCC---
T ss_pred             cCChhHCcCHHHHHhCcchhcCCchhhhccccc-cccccCCcccccCHHHHHHHHhhccCcccc
Confidence            999999999999999999988776654332221 122234455667788888887777766543

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=1.5e-58  Score=424.72  Aligned_cols=249  Identities=24%  Similarity=0.424  Sum_probs=199.8

Q ss_pred             CCceeeeeeeecCceEEEEEEEc---CCCcEEEEEEeecCccccHHHHHHHHHHhcC-CCCCcceeeEEEEcCCEEEEEE
Q 019195            2 EKYELMKDIGSGNFGVARLMRNK---NTKELVAMKYIERGHKIDANVAREIINHKQL-RHPNIIRFKEVVLTPTHLAIVM   77 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~~~~~~~~~ei~~l~~l-~h~niv~~~~~~~~~~~~~lv~   77 (344)
                      ++|++.+.||+|+||+||+|.++   .+++.||+|++.+.. ...++.+|+++|+.+ +|||||+++++|.+.+++|+||
T Consensus        21 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~-~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~lvm   99 (361)
T 4f9c_A           21 NVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS-HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVIAM   99 (361)
T ss_dssp             GTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS-CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEEEE
T ss_pred             CcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc-CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEEEE
Confidence            57999999999999999999875   468899999987643 345788999999998 6999999999999999999999


Q ss_pred             ecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCC----
Q 019195           78 EYAAGGELFERICNAGRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH----  146 (344)
Q Consensus        78 e~~~~g~L~~~i~~~~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~----  146 (344)
                      |||+||+|.+++.   .+++.+++.+++||+.|       ||+||||||+|||++.+. +++||+|||+|+.....    
T Consensus       100 E~~~g~~L~~~~~---~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~-~~~kl~DFGla~~~~~~~~~~  175 (361)
T 4f9c_A          100 PYLEHESFLDILN---SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRL-KKYALVDFGLAQGTHDTKIEL  175 (361)
T ss_dssp             ECCCCCCHHHHHT---TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTT-TEEEECCCTTCEECTTCSCGG
T ss_pred             eCCCcccHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCC-CeEEECcCCCCcccCCccccc
Confidence            9999999999983   58999999998887766       999999999999997652 35999999999743221    


Q ss_pred             -------------------------CCCCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChH-
Q 019195          147 -------------------------SRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPK-  200 (344)
Q Consensus       147 -------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-  200 (344)
                                               ....+.+||+.|||||++.+..+++.++||||+||++|+|++|++||....+.. 
T Consensus       176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~~~~~~  255 (361)
T 4f9c_A          176 LKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKASDDLT  255 (361)
T ss_dssp             GGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHH
T ss_pred             cccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCCCCHHH
Confidence                                     112345799999999999887766777999999999999999999997655432 


Q ss_pred             HHHHHHHHHh----------------------------------hcc--------------ccCCCCCCCCHhHHHHHHH
Q 019195          201 NFRKTISRIM----------------------------------AVQ--------------YKIPDYVHISQDCRNLLSR  232 (344)
Q Consensus       201 ~~~~~~~~~~----------------------------------~~~--------------~~~~~~~~~s~~~~~li~~  232 (344)
                      .+..+.....                                  ...              ...+.+..+|+++.+||.+
T Consensus       256 ~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~a~DLl~~  335 (361)
T 4f9c_A          256 ALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEAYDLLDK  335 (361)
T ss_dssp             HHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCHHHHHHHHH
T ss_pred             HHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHHHHHHHHH
Confidence            2222221100                                  000              0112234689999999999


Q ss_pred             hcccCCCCCCChHHHhcCccccc
Q 019195          233 IFVANPSRRITIKEIKSHPWFLK  255 (344)
Q Consensus       233 ~L~~dp~~R~s~~ell~hp~~~~  255 (344)
                      ||+.||.+||||.|+|+||||++
T Consensus       336 lL~~dP~~R~ta~eaL~Hp~f~~  358 (361)
T 4f9c_A          336 LLDLNPASRITAEEALLHPFFKD  358 (361)
T ss_dssp             HTCSCTTTSCCHHHHHTSGGGTT
T ss_pred             HCcCChhHCcCHHHHhcCcccCC
Confidence            99999999999999999999965

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=1.8e-58  Score=447.29  Aligned_cols=251  Identities=27%  Similarity=0.453  Sum_probs=212.2

Q ss_pred             CCCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCc----cccHHHH---HHHHHHhcCCCCCcceeeEEEEcCCEE
Q 019195            1 MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH----KIDANVA---REIINHKQLRHPNIIRFKEVVLTPTHL   73 (344)
Q Consensus         1 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~---~ei~~l~~l~h~niv~~~~~~~~~~~~   73 (344)
                      |++|++++.||+|+||+||+|+++.+|+.||||++.+..    .....+.   +++.+++.++|||||+++++|.+++.+
T Consensus       188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l  267 (689)
T 3v5w_A          188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL  267 (689)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred             hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence            579999999999999999999999999999999997532    1122233   346677788999999999999999999


Q ss_pred             EEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCC
Q 019195           74 AIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH  146 (344)
Q Consensus        74 ~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~  146 (344)
                      |+|||||+||+|..+|.+.+.+++..++.++.||+.|       |||||||||+|||++.++.  +||+|||+|+.... 
T Consensus       268 ylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~--vKL~DFGlA~~~~~-  344 (689)
T 3v5w_A          268 SFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGH--VRISDLGLACDFSK-  344 (689)
T ss_dssp             EEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSC--EEECCCTTCEECSS-
T ss_pred             EEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCC--EEecccceeeecCC-
Confidence            9999999999999999999999999999998887766       9999999999999987664  99999999976433 


Q ss_pred             CCCCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCHhH
Q 019195          147 SRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDC  226 (344)
Q Consensus       147 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~  226 (344)
                      ....+.+||+.|||||++.++..++.++|||||||++|+|++|++||.+..... ...+...+......+|.  .+|+++
T Consensus       345 ~~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~-~~~i~~~i~~~~~~~p~--~~S~~a  421 (689)
T 3v5w_A          345 KKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD-KHEIDRMTLTMAVELPD--SFSPEL  421 (689)
T ss_dssp             CCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCC-HHHHHHHHHHCCCCCCT--TSCHHH
T ss_pred             CCCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHhhcCCCCCCCc--cCCHHH
Confidence            345667999999999999765444566999999999999999999997654322 23455555566666664  689999


Q ss_pred             HHHHHHhcccCCCCCCC-----hHHHhcCcccccCC
Q 019195          227 RNLLSRIFVANPSRRIT-----IKEIKSHPWFLKNL  257 (344)
Q Consensus       227 ~~li~~~L~~dp~~R~s-----~~ell~hp~~~~~~  257 (344)
                      ++||.+||++||.+|++     +.++++||||+..-
T Consensus       422 ~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~id  457 (689)
T 3v5w_A          422 RSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLD  457 (689)
T ss_dssp             HHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTTCC
T ss_pred             HHHHHHHccCCHhHCCCCCCCCHHHHhcCccccCCC
Confidence            99999999999999998     79999999997653

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=1e-58  Score=415.23  Aligned_cols=245  Identities=24%  Similarity=0.369  Sum_probs=186.9

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCcc--ccHHHHHHHHHHhcCCCCCcceeeEEEEcCC--------
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK--IDANVAREIINHKQLRHPNIIRFKEVVLTPT--------   71 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~--------   71 (344)
                      ++|++++.||+|+||+||+|.++.+|+.||||++.....  ....+.+|+.+|++|+|||||+++++|.+.+        
T Consensus         5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~   84 (299)
T 4g31_A            5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS   84 (299)
T ss_dssp             HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred             hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence            579999999999999999999999999999999976443  2356889999999999999999999997644        


Q ss_pred             ----EEEEEEecCCCCChHHHHHhCCCC---CHHHHHHHHHHHH-------HCCeeecCCCCCCeEecCCCCCCEEEeec
Q 019195           72 ----HLAIVMEYAAGGELFERICNAGRF---SEDEARYFFQQLI-------SGQICHRDLKLENTLLDGSPAPRLKICDF  137 (344)
Q Consensus        72 ----~~~lv~e~~~~g~L~~~i~~~~~~---~~~~~~~~~~ql~-------~~~iiH~Dikp~NIl~~~~~~~~vkL~DF  137 (344)
                          .+|+|||||+||+|.+++.....+   ....++.++.||+       +.||+||||||+|||++.++.  +||+||
T Consensus        85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~--vKl~DF  162 (299)
T 4g31_A           85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDV--VKVGDF  162 (299)
T ss_dssp             --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC--EEECCC
T ss_pred             CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCc--EEEccC
Confidence                479999999999999999876654   3444666666655       459999999999999987664  999999


Q ss_pred             CCCcccCCCC-------------CCCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHH
Q 019195          138 GYSKSSLLHS-------------RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRK  204 (344)
Q Consensus       138 g~a~~~~~~~-------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~  204 (344)
                      |+|+......             ...+.+||+.|||||++.+..|+ .++|||||||++|||++   ||....   ....
T Consensus       163 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~-~~~DiwSlGvilyell~---Pf~~~~---~~~~  235 (299)
T 4g31_A          163 GLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYS-HKVDIFSLGLILFELLY---PFSTQM---ERVR  235 (299)
T ss_dssp             CCC--------------------------CCCTTSCHHHHTTCCCC-THHHHHHHHHHHHHHHS---CCSSHH---HHHH
T ss_pred             ccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCC-CHHHHHHHHHHHHHHcc---CCCCcc---HHHH
Confidence            9998643321             12345799999999999988875 45999999999999996   775421   1122


Q ss_pred             HHHHHhhccccCCCCCCCCHhHHHHHHHhcccCCCCCCChHHHhcCcccccC
Q 019195          205 TISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKN  256 (344)
Q Consensus       205 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~~  256 (344)
                      .+..+....+. +.+...++.+.+||.+||+.||.+|||+.|+|+||||+..
T Consensus       236 ~~~~~~~~~~p-~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~~  286 (299)
T 4g31_A          236 TLTDVRNLKFP-PLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDL  286 (299)
T ss_dssp             HHHHHHTTCCC-HHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCCC
T ss_pred             HHHHHhcCCCC-CCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCCC
Confidence            23333222211 1223457788999999999999999999999999999764

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=2.2e-58  Score=447.63  Aligned_cols=253  Identities=28%  Similarity=0.591  Sum_probs=219.6

Q ss_pred             CCCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCcc-ccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEEec
Q 019195            1 MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK-IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEY   79 (344)
Q Consensus         1 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~   79 (344)
                      |++|++++.||+|+||+||+|.++.+|+.||+|++..... ....+.+|+.+|+.|+|||||+++++|.+++.+|+||||
T Consensus       156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~  235 (573)
T 3uto_A          156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF  235 (573)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence            4789999999999999999999999999999999976543 235688999999999999999999999999999999999


Q ss_pred             CCCCChHHHHHh-CCCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCCCCCC
Q 019195           80 AAGGELFERICN-AGRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKS  151 (344)
Q Consensus        80 ~~~g~L~~~i~~-~~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~~~~~  151 (344)
                      |+||+|.++|.+ .+.+++.+++.+++||+.|       ||+||||||+|||++.+..+.+||+|||+|+..........
T Consensus       236 ~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~~~~~  315 (573)
T 3uto_A          236 MSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKV  315 (573)
T ss_dssp             CCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTSEEEE
T ss_pred             cCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEccCCCceee
Confidence            999999999964 4689999999998887765       99999999999999876556799999999987766655667


Q ss_pred             CccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCC--CCCCCCHhHHHH
Q 019195          152 TVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIP--DYVHISQDCRNL  229 (344)
Q Consensus       152 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~s~~~~~l  229 (344)
                      .+||+.|||||++.+..|+ .++|||||||++|+|++|++||.+.+....+    ..+....+.++  .+..+|+++++|
T Consensus       316 ~~GT~~y~APEv~~~~~y~-~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~----~~i~~~~~~~~~~~~~~~s~~~~dl  390 (573)
T 3uto_A          316 TTGTAEFAAPEVAEGKPVG-YYTDMWSVGVLSYILLSGLSPFGGENDDETL----RNVKSCDWNMDDSAFSGISEDGKDF  390 (573)
T ss_dssp             ECSSGGGCCHHHHTTCCBC-HHHHHHHHHHHHHHHHHSCCSSCCSSHHHHH----HHHHTTCCCCCSGGGTTSCHHHHHH
T ss_pred             eEECccccCHHHhCCCCCC-cHHHHHHHHHHHHHHHHCCCCCCCcCHHHHH----HHHHhCCCCCCcccccCCCHHHHHH
Confidence            7899999999999988874 5599999999999999999999887654443    34444444443  345789999999


Q ss_pred             HHHhcccCCCCCCChHHHhcCcccccCCC
Q 019195          230 LSRIFVANPSRRITIKEIKSHPWFLKNLP  258 (344)
Q Consensus       230 i~~~L~~dp~~R~s~~ell~hp~~~~~~~  258 (344)
                      |.+||+.||.+|||+.|+|+||||+....
T Consensus       391 i~~~L~~dp~~R~t~~e~l~Hpw~~~~~~  419 (573)
T 3uto_A          391 IRKLLLADPNTRMTIHQALEHPWLTPGNA  419 (573)
T ss_dssp             HHTTSCSSGGGSCCHHHHHHSTTTSCCCC
T ss_pred             HHHHccCChhHCcCHHHHhcCcCcCCCCC
Confidence            99999999999999999999999987543

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=3.6e-56  Score=398.53  Aligned_cols=243  Identities=23%  Similarity=0.325  Sum_probs=190.7

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCcc---ccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEEe
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK---IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVME   78 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e   78 (344)
                      +++++.+.||+|+||+||+|....   .||||+++....   ....+.+|+.++++++|||||++++++. ++.+|||||
T Consensus        36 ~~l~l~~~iG~G~fG~Vy~~~~~~---~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~-~~~~~iVmE  111 (307)
T 3omv_A           36 SEVMLSTRIGSGSFGTVYKGKWHG---DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMT-KDNLAIVTQ  111 (307)
T ss_dssp             TSCCEEEECCCCSSSEEEEEESSS---EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEEE
T ss_pred             HHeEEeeEEeeCCCcEEEEEEECC---cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE-CCeEEEEEE
Confidence            578899999999999999998653   599999875432   2357889999999999999999999875 467899999


Q ss_pred             cCCCCChHHHHHhC-CCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCC---C
Q 019195           79 YAAGGELFERICNA-GRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH---S  147 (344)
Q Consensus        79 ~~~~g~L~~~i~~~-~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~---~  147 (344)
                      ||+||+|.++|... ..+++.++..++.|++.|       +||||||||+|||++.++.  +||+|||+|+.....   .
T Consensus       112 y~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~--~Ki~DFGla~~~~~~~~~~  189 (307)
T 3omv_A          112 WCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLT--VKIGDFGLATVKSRWSGSQ  189 (307)
T ss_dssp             CCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEE--EEECCCSSCBC--------
T ss_pred             cCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCc--EEEeeccCceecccCCcce
Confidence            99999999999764 579999888887776655       9999999999999987765  999999999764322   2


Q ss_pred             CCCCCccCCcccCCccccCCC--CCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCHh
Q 019195          148 RPKSTVGTPAYIAPEVLSRRE--YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQD  225 (344)
Q Consensus       148 ~~~~~~gt~~y~aPE~~~~~~--~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~  225 (344)
                      .....+||+.|||||++.+..  .++.++|||||||++|||+||+.||.+.+........+......+.....+..++++
T Consensus       190 ~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~  269 (307)
T 3omv_A          190 QVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKA  269 (307)
T ss_dssp             ----CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCCSTTSCTTSCHH
T ss_pred             eecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCCcccccccchHH
Confidence            234568999999999996432  235669999999999999999999988766544443333211111111123467899


Q ss_pred             HHHHHHHhcccCCCCCCChHHHhcC
Q 019195          226 CRNLLSRIFVANPSRRITIKEIKSH  250 (344)
Q Consensus       226 ~~~li~~~L~~dp~~R~s~~ell~h  250 (344)
                      +.+||.+||+.||.+|||+.+++++
T Consensus       270 l~~li~~cl~~dP~~RPs~~ei~~~  294 (307)
T 3omv_A          270 MKRLVADCVKKVKEERPLFPQILSS  294 (307)
T ss_dssp             HHHHHHHHTCSSSTTSCCHHHHHHH
T ss_pred             HHHHHHHHcCCCHhHCcCHHHHHHH
Confidence            9999999999999999999988654

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=1.7e-56  Score=400.32  Aligned_cols=239  Identities=25%  Similarity=0.383  Sum_probs=196.1

Q ss_pred             CCceeeeeeeecCceEEEEEEEc-----CCCcEEEEEEeecCcc-ccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEE
Q 019195            2 EKYELMKDIGSGNFGVARLMRNK-----NTKELVAMKYIERGHK-IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAI   75 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~-~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~l   75 (344)
                      ++|.+.+.||+|+||+||+|.+.     .++..||||+++.... ....+.+|+.+|++++|||||++++++.+++.+|+
T Consensus        13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l   92 (299)
T 4asz_A           13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM   92 (299)
T ss_dssp             GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence            47899999999999999999875     4678999999976432 34678999999999999999999999999999999


Q ss_pred             EEecCCCCChHHHHHhC-------------CCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEe
Q 019195           76 VMEYAAGGELFERICNA-------------GRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKIC  135 (344)
Q Consensus        76 v~e~~~~g~L~~~i~~~-------------~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~  135 (344)
                      |||||++|+|.++|.+.             ..+++.+++.++.|+++|       +|+||||||+|||++.++.  +||+
T Consensus        93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~~~--~Ki~  170 (299)
T 4asz_A           93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLL--VKIG  170 (299)
T ss_dssp             EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC--EEEC
T ss_pred             EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCCCc--EEEC
Confidence            99999999999999764             368999888888877765       9999999999999987765  9999


Q ss_pred             ecCCCcccCCCC---CCCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhh
Q 019195          136 DFGYSKSSLLHS---RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMA  211 (344)
Q Consensus       136 DFg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~  211 (344)
                      |||+|+......   .....+||+.|||||++.+..|+ .++|||||||++|||+| |+.||.+.+..+.+    ..+..
T Consensus       171 DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~-~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~----~~i~~  245 (299)
T 4asz_A          171 DFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFT-TESDVWSLGVVLWEIFTYGKQPWYQLSNNEVI----ECITQ  245 (299)
T ss_dssp             CCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHH----HHHHH
T ss_pred             CcccceecCCCCceeecCceecChhhcCHHHHcCCCCC-chhhHHHHHHHHHHHHcCCCCCCCCCCHHHHH----HHHHc
Confidence            999997543322   22345699999999999888875 55999999999999998 89999887654333    33333


Q ss_pred             ccccCCCCCCCCHhHHHHHHHhcccCCCCCCChHHHh
Q 019195          212 VQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIK  248 (344)
Q Consensus       212 ~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~ell  248 (344)
                      .. ..+.+..+++++.+||.+||+.||.+|||+.+++
T Consensus       246 ~~-~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~  281 (299)
T 4asz_A          246 GR-VLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIH  281 (299)
T ss_dssp             TC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred             CC-CCCCCccchHHHHHHHHHHcCCChhHCcCHHHHH
Confidence            22 2333457899999999999999999999999984

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=8.3e-56  Score=401.09  Aligned_cols=241  Identities=24%  Similarity=0.374  Sum_probs=193.0

Q ss_pred             CCceeeeeeeecCceEEEEEEEc-----CCCcEEEEEEeecCcc-ccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEE
Q 019195            2 EKYELMKDIGSGNFGVARLMRNK-----NTKELVAMKYIERGHK-IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAI   75 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~-~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~l   75 (344)
                      ++|.+.++||+|+||+||+|...     .+++.||||+++.... ....+.+|+.+|++++|||||++++++.+.+.+||
T Consensus        41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l  120 (329)
T 4aoj_A           41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM  120 (329)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence            46788999999999999999864     4688999999976432 34679999999999999999999999999999999


Q ss_pred             EEecCCCCChHHHHHhC---------------CCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEE
Q 019195           76 VMEYAAGGELFERICNA---------------GRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLK  133 (344)
Q Consensus        76 v~e~~~~g~L~~~i~~~---------------~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vk  133 (344)
                      |||||++|+|.+++.+.               +.+++.+++.++.|++.|       +|+||||||+|||++.++.  +|
T Consensus       121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~~~~~--~K  198 (329)
T 4aoj_A          121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLV--VK  198 (329)
T ss_dssp             EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTE--EE
T ss_pred             EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEECCCCc--EE
Confidence            99999999999999754               358888888888777655       9999999999999987765  99


Q ss_pred             EeecCCCcccCCCC---CCCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHH
Q 019195          134 ICDFGYSKSSLLHS---RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRI  209 (344)
Q Consensus       134 L~DFg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~  209 (344)
                      |+|||+|+......   .....+||+.|||||++.+..++ .++|||||||++|||+| |+.||...+..+.+..    +
T Consensus       199 i~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~-~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~----i  273 (329)
T 4aoj_A          199 IGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFT-TESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDC----I  273 (329)
T ss_dssp             ECCCC----------------CCCCGGGCCHHHHTTCCCC-HHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHH----H
T ss_pred             EcccccceeccCCCcceecCcccccccccChhhhcCCCCC-ccccccchHHHHHHHHcCCCCCCCCCCHHHHHHH----H
Confidence            99999998643322   23456799999999999888875 55999999999999998 8999988765443332    2


Q ss_pred             hhccccCCCCCCCCHhHHHHHHHhcccCCCCCCChHHHhcC
Q 019195          210 MAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSH  250 (344)
Q Consensus       210 ~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~ell~h  250 (344)
                      ... .+.+.+..+++++.+|+.+||+.||.+|||+.+++++
T Consensus       274 ~~g-~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~  313 (329)
T 4aoj_A          274 TQG-RELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHAR  313 (329)
T ss_dssp             HHT-CCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHH
T ss_pred             HcC-CCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence            222 2334445789999999999999999999999999764

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=1.9e-55  Score=395.22  Aligned_cols=241  Identities=21%  Similarity=0.351  Sum_probs=198.0

Q ss_pred             CCceeeeeeeecCceEEEEEEEc-----CCCcEEEEEEeecCc--cccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEE
Q 019195            2 EKYELMKDIGSGNFGVARLMRNK-----NTKELVAMKYIERGH--KIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLA   74 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~--~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~   74 (344)
                      .++++++.||+|+||+||+|...     .+++.||||++....  .....+.+|+.++++++|||||++++++..++.++
T Consensus        26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~  105 (308)
T 4gt4_A           26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLS  105 (308)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred             HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEE
Confidence            46789999999999999999853     467899999997543  23467999999999999999999999999999999


Q ss_pred             EEEecCCCCChHHHHHhC----------------CCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCC
Q 019195           75 IVMEYAAGGELFERICNA----------------GRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPR  131 (344)
Q Consensus        75 lv~e~~~~g~L~~~i~~~----------------~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~  131 (344)
                      +|||||++|+|.++|...                ..+++.++..++.|++.|       +||||||||+|||++.++.  
T Consensus       106 lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~~~~~--  183 (308)
T 4gt4_A          106 MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLN--  183 (308)
T ss_dssp             EEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC--
T ss_pred             EEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEECCCCC--
Confidence            999999999999999653                347888877777776655       9999999999999987765  


Q ss_pred             EEEeecCCCcccCCC---CCCCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHH
Q 019195          132 LKICDFGYSKSSLLH---SRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTIS  207 (344)
Q Consensus       132 vkL~DFg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~  207 (344)
                      +||+|||+|+.....   ......+||+.|||||++.+..++ .++|||||||++|||+| |+.||.+.+..+.    +.
T Consensus       184 ~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s-~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~----~~  258 (308)
T 4gt4_A          184 VKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFS-IDSDIWSYGVVLWEVFSYGLQPYCGYSNQDV----VE  258 (308)
T ss_dssp             EEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTTCCTTTTCCHHHH----HH
T ss_pred             EEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCC-ccchhhhHHHHHHHHHhCCCCCCCCCCHHHH----HH
Confidence            999999999864332   233456899999999999888875 55999999999999998 8999988765333    33


Q ss_pred             HHhhccccCCCCCCCCHhHHHHHHHhcccCCCCCCChHHHhcC
Q 019195          208 RIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSH  250 (344)
Q Consensus       208 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~ell~h  250 (344)
                      .+.. ....|.+..+++.+.+|+.+||+.||.+|||+.+|+++
T Consensus       259 ~i~~-~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~  300 (308)
T 4gt4_A          259 MIRN-RQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSR  300 (308)
T ss_dssp             HHHT-TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHc-CCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            3332 23344555789999999999999999999999999875

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=2.6e-54  Score=393.01  Aligned_cols=249  Identities=40%  Similarity=0.689  Sum_probs=218.5

Q ss_pred             CCCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCcc---ccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEE
Q 019195            1 MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK---IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVM   77 (344)
Q Consensus         1 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~   77 (344)
                      +++|++++.||+|+||.||+|.+..+|+.||+|++.....   ....+.+|+.+++.++||||+++++++...+.+|+||
T Consensus        14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~   93 (328)
T 3fe3_A           14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM   93 (328)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence            4689999999999999999999999999999999976432   2356889999999999999999999999999999999


Q ss_pred             ecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCCCCC
Q 019195           78 EYAAGGELFERICNAGRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPK  150 (344)
Q Consensus        78 e~~~~g~L~~~i~~~~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~~~~  150 (344)
                      ||+++|+|.+++...+.+++.+++.++.|++.+       ||+||||||+|||++.++.  +||+|||++..........
T Consensus        94 e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~--~kl~DFG~a~~~~~~~~~~  171 (328)
T 3fe3_A           94 EYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMN--IKIADFGFSNEFTVGGKLD  171 (328)
T ss_dssp             CCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSC--EEECSTTCCGGGSSSCGGG
T ss_pred             ECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCC--EEEeeccCceecCCCCccc
Confidence            999999999999988999999998888877655       9999999999999977664  9999999998766555566


Q ss_pred             CCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCHhHHHHH
Q 019195          151 STVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLL  230 (344)
Q Consensus       151 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li  230 (344)
                      ..+||+.|+|||++.+..+++.++|||||||++|+|++|+.||.+.+..    .....+....+..|.  .+++++.+||
T Consensus       172 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~----~~~~~i~~~~~~~p~--~~s~~~~~li  245 (328)
T 3fe3_A          172 AFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLK----ELRERVLRGKYRIPF--YMSTDCENLL  245 (328)
T ss_dssp             TTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHHHHHHCCCCCCT--TSCHHHHHHH
T ss_pred             cccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHH----HHHHHHHhCCCCCCC--CCCHHHHHHH
Confidence            7789999999999999888877899999999999999999999876543    333444555555554  5799999999


Q ss_pred             HHhcccCCCCCCChHHHhcCcccccCC
Q 019195          231 SRIFVANPSRRITIKEIKSHPWFLKNL  257 (344)
Q Consensus       231 ~~~L~~dp~~R~s~~ell~hp~~~~~~  257 (344)
                      .+||+.||.+|||+.++++||||....
T Consensus       246 ~~~L~~dP~~R~t~~eil~h~~~~~~~  272 (328)
T 3fe3_A          246 KRFLVLNPIKRGTLEQIMKDRWINAGH  272 (328)
T ss_dssp             HHHCCSSTTTSCCHHHHTTCTTTTTTC
T ss_pred             HHHCCCChhHCcCHHHHhcCHhhcCCC
Confidence            999999999999999999999997653

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=1.1e-54  Score=396.79  Aligned_cols=242  Identities=23%  Similarity=0.367  Sum_probs=197.9

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCC-----CcEEEEEEeecCcc--ccHHHHHHHHHHhcCCC-CCcceeeEEEEcC-CE
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNT-----KELVAMKYIERGHK--IDANVAREIINHKQLRH-PNIIRFKEVVLTP-TH   72 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~vaiK~~~~~~~--~~~~~~~ei~~l~~l~h-~niv~~~~~~~~~-~~   72 (344)
                      ++|++.+.||+|+||+||+|.+..+     ++.||+|++.....  ....+.+|+.+|++++| ||||+++++|... +.
T Consensus        64 ~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~~~  143 (353)
T 4ase_A           64 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP  143 (353)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSC
T ss_pred             HHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecCCE
Confidence            5799999999999999999997654     46899999976433  23568899999999965 8999999998664 57


Q ss_pred             EEEEEecCCCCChHHHHHhC----------------CCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCC
Q 019195           73 LAIVMEYAAGGELFERICNA----------------GRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPA  129 (344)
Q Consensus        73 ~~lv~e~~~~g~L~~~i~~~----------------~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~  129 (344)
                      +|+|||||++|+|.++|++.                ..+++.++..++.|++.|       +||||||||+|||++.++.
T Consensus       144 ~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NILl~~~~~  223 (353)
T 4ase_A          144 LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNV  223 (353)
T ss_dssp             CEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC
T ss_pred             EEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccceeeCCCCC
Confidence            89999999999999999753                247888877777776655       9999999999999987765


Q ss_pred             CCEEEeecCCCcccCCCCC---CCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHH
Q 019195          130 PRLKICDFGYSKSSLLHSR---PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKT  205 (344)
Q Consensus       130 ~~vkL~DFg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~  205 (344)
                        +||+|||+|+.......   ....+||+.|||||++.+..|+ .++|||||||++|||+| |+.||.+......+...
T Consensus       224 --vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~-~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~~~~~  300 (353)
T 4ase_A          224 --VKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYT-IQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR  300 (353)
T ss_dssp             --EEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHH
T ss_pred             --EEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCC-CcccEeehHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence              99999999986543322   2345799999999999888775 55999999999999998 99999887655444433


Q ss_pred             HHHHhhccccCCCCCCCCHhHHHHHHHhcccCCCCCCChHHHhcC
Q 019195          206 ISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSH  250 (344)
Q Consensus       206 ~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~ell~h  250 (344)
                      +.    ...+.+.+..+++++.+||.+||+.||.+|||+.++++|
T Consensus       301 i~----~g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~  341 (353)
T 4ase_A          301 LK----EGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  341 (353)
T ss_dssp             HH----HTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HH----cCCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence            32    223344445789999999999999999999999999987

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=1.2e-52  Score=386.69  Aligned_cols=250  Identities=32%  Similarity=0.588  Sum_probs=214.8

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCcc-------ccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEE
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK-------IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLA   74 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-------~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~   74 (344)
                      ++|++.+.||+|+||+||+|.+..+|+.||+|++.+...       ....+.+|+.++++++||||+++++++.+.+.+|
T Consensus        12 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~   91 (361)
T 2yab_A           12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVV   91 (361)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred             hceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEEE
Confidence            579999999999999999999999999999999976432       2357889999999999999999999999999999


Q ss_pred             EEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCC--CCEEEeecCCCcccCC
Q 019195           75 IVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPA--PRLKICDFGYSKSSLL  145 (344)
Q Consensus        75 lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~--~~vkL~DFg~a~~~~~  145 (344)
                      +||||++||+|.+++...+.+++..++.++.||+.+       ||+||||||+|||++.++.  ..+||+|||++.....
T Consensus        92 lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~~~~  171 (361)
T 2yab_A           92 LILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIED  171 (361)
T ss_dssp             EEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSCEECCT
T ss_pred             EEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCceEcCC
Confidence            999999999999999888899999999888887655       9999999999999976542  2599999999987665


Q ss_pred             CCCCCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCC--CCCCCC
Q 019195          146 HSRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIP--DYVHIS  223 (344)
Q Consensus       146 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~s  223 (344)
                      .......+||+.|+|||++.+..++ .++|||||||++|+|++|.+||.+......+    ..+....+.++  .+..++
T Consensus       172 ~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~----~~i~~~~~~~~~~~~~~~s  246 (361)
T 2yab_A          172 GVEFKNIFGTPEFVAPEIVNYEPLG-LEADMWSIGVITYILLSGASPFLGDTKQETL----ANITAVSYDFDEEFFSQTS  246 (361)
T ss_dssp             TCCCCCCCSCGGGCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSCCSSCCSSHHHHH----HHHHTTCCCCCHHHHTTSC
T ss_pred             CCccccCCCCccEECchHHcCCCCC-ccccHHHHHHHHHHHHhCCCCCCCCCHHHHH----HHHHhcCCCCCchhccCCC
Confidence            5556677899999999999877764 5599999999999999999999886554333    33444444433  234689


Q ss_pred             HhHHHHHHHhcccCCCCCCChHHHhcCcccccC
Q 019195          224 QDCRNLLSRIFVANPSRRITIKEIKSHPWFLKN  256 (344)
Q Consensus       224 ~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~~  256 (344)
                      +.+++||.+||+.||.+|||+.++|+||||...
T Consensus       247 ~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~  279 (361)
T 2yab_A          247 ELAKDFIRKLLVKETRKRLTIQEALRHPWITPV  279 (361)
T ss_dssp             HHHHHHHHHHSCSSTTTSCCHHHHHTSTTTSCS
T ss_pred             HHHHHHHHHHCCCChhHCcCHHHHhcCcCcCCC
Confidence            999999999999999999999999999999754

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=3.2e-52  Score=380.40  Aligned_cols=248  Identities=33%  Similarity=0.604  Sum_probs=212.7

Q ss_pred             CCCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecC----ccccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEE
Q 019195            1 MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERG----HKIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIV   76 (344)
Q Consensus         1 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv   76 (344)
                      +++|++++.||+|+||.||+|.+..+++.||+|++.+.    ......+.+|+.+++.++||||+++++++.+.+.+|+|
T Consensus         4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv   83 (337)
T 1o6l_A            4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV   83 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence            47899999999999999999999999999999999763    23345788999999999999999999999999999999


Q ss_pred             EecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCC-CCC
Q 019195           77 MEYAAGGELFERICNAGRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLL-HSR  148 (344)
Q Consensus        77 ~e~~~~g~L~~~i~~~~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~-~~~  148 (344)
                      |||++||+|..++.+.+.+++..++.++.||+.+       ||+||||||+|||++.++  ++||+|||+++.... ...
T Consensus        84 ~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g--~vkL~DFG~a~~~~~~~~~  161 (337)
T 1o6l_A           84 MEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDG--HIKITDFGLCKEGISDGAT  161 (337)
T ss_dssp             EECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTS--CEEECCCTTCBCSCCTTCC
T ss_pred             EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCC--CEEEeeccchhhcccCCCc
Confidence            9999999999999988899999888887776654       999999999999997766  499999999976332 333


Q ss_pred             CCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCHhHHH
Q 019195          149 PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRN  228 (344)
Q Consensus       149 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~  228 (344)
                      ....+||+.|+|||++.+..++ .++|||||||++|+|++|+.||...+....    ...+......+|.  .+++++.+
T Consensus       162 ~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~Pf~~~~~~~~----~~~i~~~~~~~p~--~~s~~~~~  234 (337)
T 1o6l_A          162 MKTFCGTPEYLAPEVLEDNDYG-RAVDWWGLGVVMYEMMCGRLPFYNQDHERL----FELILMEEIRFPR--TLSPEAKS  234 (337)
T ss_dssp             BCCCEECGGGCCGGGGSSSCBC-TTHHHHHHHHHHHHHHHSSCSSCCSSHHHH----HHHHHHCCCCCCT--TSCHHHHH
T ss_pred             ccccccChhhCChhhhcCCCCC-chhhcccchhHHHHHhcCCCCCCCCCHHHH----HHHHHcCCCCCCC--CCCHHHHH
Confidence            4567899999999999887764 559999999999999999999987654333    3334444555554  68999999


Q ss_pred             HHHHhcccCCCCCC-----ChHHHhcCcccccCC
Q 019195          229 LLSRIFVANPSRRI-----TIKEIKSHPWFLKNL  257 (344)
Q Consensus       229 li~~~L~~dp~~R~-----s~~ell~hp~~~~~~  257 (344)
                      ||.+||+.||.+||     ++.++++||||....
T Consensus       235 li~~lL~~dP~~R~g~~~~~~~ei~~h~~f~~~~  268 (337)
T 1o6l_A          235 LLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSIN  268 (337)
T ss_dssp             HHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCC
T ss_pred             HHHHHhhcCHHHhcCCCCCCHHHHHcCCCcCCCC
Confidence            99999999999999     899999999997653

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=4.4e-53  Score=385.81  Aligned_cols=250  Identities=45%  Similarity=0.804  Sum_probs=215.9

Q ss_pred             CCCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecC----ccccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEE
Q 019195            1 MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERG----HKIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIV   76 (344)
Q Consensus         1 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv   76 (344)
                      +++|++.+.||+|+||.||+|.+..+++.||+|++.+.    ......+.+|+.+++.++||||+++++++...+.+++|
T Consensus         8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv   87 (336)
T 3h4j_B            8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV   87 (336)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence            47899999999999999999999999999999998753    23346789999999999999999999999999999999


Q ss_pred             EecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCCCC
Q 019195           77 MEYAAGGELFERICNAGRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP  149 (344)
Q Consensus        77 ~e~~~~g~L~~~i~~~~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~~~  149 (344)
                      |||+ +|+|.+++...+.+++.+++.++.|++++       ||+||||||+|||++.++.  +||+|||++.........
T Consensus        88 ~E~~-~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~--~kl~DFG~s~~~~~~~~~  164 (336)
T 3h4j_B           88 IEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLN--VKIADFGLSNIMTDGNFL  164 (336)
T ss_dssp             ECCC-CEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCC--EEECCSSCTBTTTTSBTT
T ss_pred             EECC-CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCC--EEEEEeccceeccCCccc
Confidence            9999 78999999888899999999998888766       9999999999999987654  999999999876666666


Q ss_pred             CCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCHhHHHH
Q 019195          150 KSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL  229 (344)
Q Consensus       150 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  229 (344)
                      ...+||+.|+|||++.+..+.+.++|||||||++|+|++|+.||.........    ..+....+..|.  .+++.+.+|
T Consensus       165 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~----~~i~~~~~~~p~--~~s~~~~~l  238 (336)
T 3h4j_B          165 KTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLF----KKVNSCVYVMPD--FLSPGAQSL  238 (336)
T ss_dssp             CCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCB----CCCCSSCCCCCT--TSCHHHHHH
T ss_pred             ccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHH----HHHHcCCCCCcc--cCCHHHHHH
Confidence            67789999999999998887777899999999999999999999875443221    112222333333  579999999


Q ss_pred             HHHhcccCCCCCCChHHHhcCcccccCCCh
Q 019195          230 LSRIFVANPSRRITIKEIKSHPWFLKNLPR  259 (344)
Q Consensus       230 i~~~L~~dp~~R~s~~ell~hp~~~~~~~~  259 (344)
                      |.+||+.||.+|||+.++++||||....+.
T Consensus       239 i~~~L~~dP~~Rpt~~eil~hp~~~~~~~~  268 (336)
T 3h4j_B          239 IRRMIVADPMQRITIQEIRRDPWFNVNLPD  268 (336)
T ss_dssp             HHTTSCSSGGGSCCHHHHTTCHHHHTTCCG
T ss_pred             HHHHcCCChhHCcCHHHHHhChhhccCCcc
Confidence            999999999999999999999999876554

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=5.2e-52  Score=386.10  Aligned_cols=251  Identities=28%  Similarity=0.505  Sum_probs=211.4

Q ss_pred             CCCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCcc----ccHHHHHHHHHHhcC-CCCCcceeeEEEEcCCEEEE
Q 019195            1 MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK----IDANVAREIINHKQL-RHPNIIRFKEVVLTPTHLAI   75 (344)
Q Consensus         1 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~ei~~l~~l-~h~niv~~~~~~~~~~~~~l   75 (344)
                      +++|++++.||+|+||.||+|++..+++.||+|++.+...    ....+.+|..+++++ +||||++++++|.+.+.+|+
T Consensus        51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l  130 (396)
T 4dc2_A           51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF  130 (396)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence            4689999999999999999999999999999999986432    234578899999877 89999999999999999999


Q ss_pred             EEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCccc-CCCC
Q 019195           76 VMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSS-LLHS  147 (344)
Q Consensus        76 v~e~~~~g~L~~~i~~~~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~-~~~~  147 (344)
                      |||||+||+|..++.+.+.+++..++.++.||+.+       ||+||||||+|||++.++.  +||+|||+++.. ....
T Consensus       131 V~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~--ikL~DFGla~~~~~~~~  208 (396)
T 4dc2_A          131 VIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGH--IKLTDYGMCKEGLRPGD  208 (396)
T ss_dssp             EEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSC--EEECCCTTCBCCCCTTC
T ss_pred             EEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCC--EEEeecceeeecccCCC
Confidence            99999999999999988899999998888776654       9999999999999987664  999999999863 3334


Q ss_pred             CCCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChH-----HHHHHHHHHhhccccCCCCCCC
Q 019195          148 RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPK-----NFRKTISRIMAVQYKIPDYVHI  222 (344)
Q Consensus       148 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~  222 (344)
                      .....+||+.|+|||++.+..++ .++|||||||++|+|++|++||.......     ........+......+|.  .+
T Consensus       209 ~~~~~~gt~~Y~aPE~l~~~~~~-~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~--~~  285 (396)
T 4dc2_A          209 TTSTFCGTPNYIAPEILRGEDYG-FSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPR--SL  285 (396)
T ss_dssp             CBCCCCBCGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCCCCCT--TS
T ss_pred             ccccccCCcccCCchhhcCCCCC-hHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccccCCCC--cC
Confidence            45567899999999999888775 55999999999999999999996532211     122334445555555665  68


Q ss_pred             CHhHHHHHHHhcccCCCCCCCh------HHHhcCcccccC
Q 019195          223 SQDCRNLLSRIFVANPSRRITI------KEIKSHPWFLKN  256 (344)
Q Consensus       223 s~~~~~li~~~L~~dp~~R~s~------~ell~hp~~~~~  256 (344)
                      ++++.+||++||+.||.+||++      .++++||||...
T Consensus       286 s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~i  325 (396)
T 4dc2_A          286 SVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNV  325 (396)
T ss_dssp             CHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTTC
T ss_pred             CHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccCC
Confidence            9999999999999999999985      799999999764

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=2.3e-52  Score=383.74  Aligned_cols=248  Identities=32%  Similarity=0.535  Sum_probs=207.6

Q ss_pred             CCCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCc----cccHHHHHHHHHHhcC-CCCCcceeeEEEEcCCEEEE
Q 019195            1 MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH----KIDANVAREIINHKQL-RHPNIIRFKEVVLTPTHLAI   75 (344)
Q Consensus         1 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~ei~~l~~l-~h~niv~~~~~~~~~~~~~l   75 (344)
                      +++|++++.||+|+||.||+|.+..+++.||+|++.+..    .....+.+|..+++.+ +||||+++++++.+.+.+|+
T Consensus        22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l  101 (353)
T 3txo_A           22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFF  101 (353)
T ss_dssp             -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEE
Confidence            478999999999999999999999999999999997632    2335678899999988 79999999999999999999


Q ss_pred             EEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccC-CCC
Q 019195           76 VMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSL-LHS  147 (344)
Q Consensus        76 v~e~~~~g~L~~~i~~~~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~-~~~  147 (344)
                      |||||+||+|..++.+.+.+++.+++.++.||+.+       ||+||||||+|||++.++.  +||+|||+++... ...
T Consensus       102 v~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~--ikL~DFG~a~~~~~~~~  179 (353)
T 3txo_A          102 VMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGH--CKLADFGMCKEGICNGV  179 (353)
T ss_dssp             EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSC--EEECCCTTCBCSCC---
T ss_pred             EEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCC--EEEccccceeecccCCc
Confidence            99999999999999998999999988887776654       9999999999999977654  9999999998533 233


Q ss_pred             CCCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCHhHH
Q 019195          148 RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCR  227 (344)
Q Consensus       148 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~  227 (344)
                      .....+||+.|+|||++.+..++ .++|||||||++|+|++|++||...+....    ...+......+|.  .+++++.
T Consensus       180 ~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~G~~Pf~~~~~~~~----~~~i~~~~~~~p~--~~~~~~~  252 (353)
T 3txo_A          180 TTATFCGTPDYIAPEILQEMLYG-PAVDWWAMGVLLYEMLCGHAPFEAENEDDL----FEAILNDEVVYPT--WLHEDAT  252 (353)
T ss_dssp             ------CCGGGCCHHHHHHHHCT-THHHHHHHHHHHHHHHHSSCSSCCSSHHHH----HHHHHHCCCCCCT--TSCHHHH
T ss_pred             cccccCCCcCeEChhhcCCCCcC-CccCCCcchHHHHHHHhCCCCCCCCCHHHH----HHHHHcCCCCCCC--CCCHHHH
Confidence            34566899999999999877765 459999999999999999999988665433    3444455555554  5899999


Q ss_pred             HHHHHhcccCCCCCCCh------HHHhcCcccccCC
Q 019195          228 NLLSRIFVANPSRRITI------KEIKSHPWFLKNL  257 (344)
Q Consensus       228 ~li~~~L~~dp~~R~s~------~ell~hp~~~~~~  257 (344)
                      +||++||+.||.+||++      .++++||||....
T Consensus       253 ~li~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~~~  288 (353)
T 3txo_A          253 GILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEID  288 (353)
T ss_dssp             HHHHHHTCSSGGGSTTSGGGTCTHHHHTSGGGTTCC
T ss_pred             HHHHHHhhhCHHHccCCcccCCHHHHhhCCcccCCC
Confidence            99999999999999998      8999999997653

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6.1e-53  Score=382.99  Aligned_cols=251  Identities=26%  Similarity=0.484  Sum_probs=214.4

Q ss_pred             CCCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEEecC
Q 019195            1 MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYA   80 (344)
Q Consensus         1 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~   80 (344)
                      .++|++.+.||+|+||+||+|.+..+++.||+|++.........+.+|+.+++.++||||+++++++.+.+.+++|||||
T Consensus         4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~   83 (321)
T 1tki_A            4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFI   83 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCcccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEeC
Confidence            37899999999999999999999999999999999866555567889999999999999999999999999999999999


Q ss_pred             CCCChHHHHHhCC-CCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCCCCCCC
Q 019195           81 AGGELFERICNAG-RFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST  152 (344)
Q Consensus        81 ~~g~L~~~i~~~~-~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~~~~~~  152 (344)
                      +|++|.+++.... .+++.+++.++.|++.+       ||+||||||+|||++....+.+||+|||++............
T Consensus        84 ~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~  163 (321)
T 1tki_A           84 SGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLL  163 (321)
T ss_dssp             CCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCEEEEE
T ss_pred             CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCCccccc
Confidence            9999999997654 79999988888776655       999999999999998754567999999999866554444556


Q ss_pred             ccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCC--CCCCCCHhHHHHH
Q 019195          153 VGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIP--DYVHISQDCRNLL  230 (344)
Q Consensus       153 ~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~s~~~~~li  230 (344)
                      .||+.|+|||++.+..+ +.++|||||||++|+|++|.+||........+    ..+......++  .+..+++++.+||
T Consensus       164 ~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~----~~i~~~~~~~~~~~~~~~s~~~~~li  238 (321)
T 1tki_A          164 FTAPEYYAPEVHQHDVV-STATDMWSLGTLVYVLLSGINPFLAETNQQII----ENIMNAEYTFDEEAFKEISIEAMDFV  238 (321)
T ss_dssp             ESCGGGSCHHHHTTCEE-CHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH----HHHHHTCCCCCHHHHTTSCHHHHHHH
T ss_pred             cCChhhcCcHHhcCCCC-CchhhHHHHHHHHHHHHhCCCCCcCCCHHHHH----HHHHcCCCCCChhhhccCCHHHHHHH
Confidence            79999999999987765 45699999999999999999999886654333    33333443333  2346899999999


Q ss_pred             HHhcccCCCCCCChHHHhcCcccccC
Q 019195          231 SRIFVANPSRRITIKEIKSHPWFLKN  256 (344)
Q Consensus       231 ~~~L~~dp~~R~s~~ell~hp~~~~~  256 (344)
                      .+||+.||.+|||+.++|+||||.+.
T Consensus       239 ~~~L~~dp~~Rpt~~e~l~hp~~~~~  264 (321)
T 1tki_A          239 DRLLVKERKSRMTASEALQHPWLKQK  264 (321)
T ss_dssp             HTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred             HHHcCCChhHCcCHHHHhcChhhccC
Confidence            99999999999999999999999765

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=2.2e-51  Score=367.65  Aligned_cols=255  Identities=27%  Similarity=0.452  Sum_probs=204.1

Q ss_pred             CCCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCccc---cHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEE
Q 019195            1 MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKI---DANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVM   77 (344)
Q Consensus         1 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~   77 (344)
                      |++|++++.||+|+||+||+|.+..+++.||+|++......   ...+.+|+.++++++||||+++++++.+++.+++||
T Consensus         1 l~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   80 (292)
T 3o0g_A            1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF   80 (292)
T ss_dssp             CCSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             CCCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEE
Confidence            68999999999999999999999999999999999764432   257889999999999999999999999999999999


Q ss_pred             ecCCCCChHHHHH-hCCCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCC-CC
Q 019195           78 EYAAGGELFERIC-NAGRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH-SR  148 (344)
Q Consensus        78 e~~~~g~L~~~i~-~~~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~-~~  148 (344)
                      ||+.+ +|...+. ..+.+++..++.++.|++.+       ||+||||||+|||++.++.  +||+|||+++..... ..
T Consensus        81 e~~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~  157 (292)
T 3o0g_A           81 EFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGE--LKLANFGLARAFGIPVRC  157 (292)
T ss_dssp             ECCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC--EEECCCTTCEECCSCCSC
T ss_pred             ecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCC--EEEeecccceecCCcccc
Confidence            99976 5555554 46789999999888877655       9999999999999987664  999999999764332 23


Q ss_pred             CCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChH-HHHHHHHHHhhcccc------------
Q 019195          149 PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPK-NFRKTISRIMAVQYK------------  215 (344)
Q Consensus       149 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~------------  215 (344)
                      .....||+.|+|||++.+....+.++|||||||++|+|++|..||....... .+..+..........            
T Consensus       158 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  237 (292)
T 3o0g_A          158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYK  237 (292)
T ss_dssp             CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCC
T ss_pred             ccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhccccccc
Confidence            3456799999999999887755677999999999999999888865544433 333333221111000            


Q ss_pred             -----------CCCCCCCCHhHHHHHHHhcccCCCCCCChHHHhcCcccccCCC
Q 019195          216 -----------IPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLP  258 (344)
Q Consensus       216 -----------~~~~~~~s~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~~~~  258 (344)
                                 ......+++.+.+||.+||+.||.+|||+.|+|+||||.+..+
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~p  291 (292)
T 3o0g_A          238 PYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFCP  291 (292)
T ss_dssp             CCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTC--
T ss_pred             ccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCcccccCCC
Confidence                       0011247889999999999999999999999999999987543

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=5.1e-51  Score=366.40  Aligned_cols=251  Identities=25%  Similarity=0.440  Sum_probs=211.0

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCcc-ccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEEecC
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK-IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYA   80 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~   80 (344)
                      ++|++++.||+|+||+||+|.+..+++.||+|++..... ....+.+|+.+++.++||||+++++++...+.+|+||||+
T Consensus        20 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~   99 (297)
T 3fxz_A           20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   99 (297)
T ss_dssp             GTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             hceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEECC
Confidence            589999999999999999999999999999999875433 3456889999999999999999999999999999999999


Q ss_pred             CCCChHHHHHhCCCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCC-CCCCC
Q 019195           81 AGGELFERICNAGRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS-RPKST  152 (344)
Q Consensus        81 ~~g~L~~~i~~~~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~-~~~~~  152 (344)
                      ++|+|.+++... .+++.+++.++.|++.+       ||+||||||+|||++.++.  +||+|||++....... .....
T Consensus       100 ~~~~L~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~~~~~  176 (297)
T 3fxz_A          100 AGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGS--VKLTDFGFCAQITPEQSKRSTM  176 (297)
T ss_dssp             TTCBHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCC--EEECCCTTCEECCSTTCCBCCC
T ss_pred             CCCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCC--EEEeeCCCceecCCcccccCCc
Confidence            999999998764 68898888887776654       9999999999999976664  9999999987644333 23456


Q ss_pred             ccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCHhHHHHHHH
Q 019195          153 VGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSR  232 (344)
Q Consensus       153 ~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~  232 (344)
                      +||+.|+|||++.+..++ .++|||||||++|+|++|+.||...........+..   ......+....+++.+.+||.+
T Consensus       177 ~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~li~~  252 (297)
T 3fxz_A          177 VGTPYWMAPEVVTRKAYG-PKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIAT---NGTPELQNPEKLSAIFRDFLNR  252 (297)
T ss_dssp             CSCGGGCCHHHHHCSCBC-THHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH---HCSCCCSCGGGSCHHHHHHHHH
T ss_pred             cCCcCccChhhhcCCCCC-cHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh---CCCCCCCCccccCHHHHHHHHH
Confidence            799999999999888775 459999999999999999999987665443332222   2222334445789999999999


Q ss_pred             hcccCCCCCCChHHHhcCcccccCCCh
Q 019195          233 IFVANPSRRITIKEIKSHPWFLKNLPR  259 (344)
Q Consensus       233 ~L~~dp~~R~s~~ell~hp~~~~~~~~  259 (344)
                      ||+.||.+|||+.++|+||||+...+.
T Consensus       253 ~l~~dp~~Rps~~ell~h~~~~~~~~~  279 (297)
T 3fxz_A          253 CLEMDVEKRGSAKELLQHQFLKIAKPL  279 (297)
T ss_dssp             HSCSSTTTSCCHHHHTTCGGGGGCCCG
T ss_pred             HccCChhHCcCHHHHhhChhhcccCcc
Confidence            999999999999999999999876543

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=9.2e-53  Score=378.03  Aligned_cols=244  Identities=25%  Similarity=0.289  Sum_probs=180.8

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcCCCCCcceeeEEEEcCC----EEEEEE
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKEVVLTPT----HLAIVM   77 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~----~~~lv~   77 (344)
                      ++|.+.+.||+|+||+||+|.+  +|+.||||++...........+|+..+.+++|||||++++++..++    .+||||
T Consensus         3 r~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~   80 (303)
T 3hmm_A            3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS   80 (303)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccchhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEe
Confidence            4789999999999999999987  5889999999765433333445666677889999999999998654    689999


Q ss_pred             ecCCCCChHHHHHhCCCCCHHHHHHHHHHHHH-------C--------CeeecCCCCCCeEecCCCCCCEEEeecCCCcc
Q 019195           78 EYAAGGELFERICNAGRFSEDEARYFFQQLIS-------G--------QICHRDLKLENTLLDGSPAPRLKICDFGYSKS  142 (344)
Q Consensus        78 e~~~~g~L~~~i~~~~~~~~~~~~~~~~ql~~-------~--------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~  142 (344)
                      |||++|+|.+++.. ..++...+..++.|++.       .        +|+||||||+|||++.++.  +||+|||+|+.
T Consensus        81 Ey~~~gsL~~~l~~-~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~--~Ki~DFGla~~  157 (303)
T 3hmm_A           81 DYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGT--CCIADLGLAVR  157 (303)
T ss_dssp             ECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSC--EEECCCTTCEE
T ss_pred             cCCCCCcHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCC--EEEEeCCCCcc
Confidence            99999999999976 45788877777666553       3        7999999999999987765  99999999976


Q ss_pred             cCCCC-----CCCCCccCCcccCCccccCCCC-----CCcchhHHHHHHHHHHHHhCCCCCCCCCCh-----------HH
Q 019195          143 SLLHS-----RPKSTVGTPAYIAPEVLSRREY-----DGKLADVWSCGVTLYVMLVGAYPFEDQEDP-----------KN  201 (344)
Q Consensus       143 ~~~~~-----~~~~~~gt~~y~aPE~~~~~~~-----~~~~~DiwslG~il~el~~g~~pf~~~~~~-----------~~  201 (344)
                      .....     .....+||+.|||||++.+...     .+.++|||||||++|||+||.+||......           ..
T Consensus       158 ~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~  237 (303)
T 3hmm_A          158 HDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS  237 (303)
T ss_dssp             EETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCC
T ss_pred             ccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccch
Confidence            43332     2234579999999999976431     245699999999999999998876432210           11


Q ss_pred             HHHHHHHHhhcccc--CCCCC---CCCHhHHHHHHHhcccCCCCCCChHHHhcC
Q 019195          202 FRKTISRIMAVQYK--IPDYV---HISQDCRNLLSRIFVANPSRRITIKEIKSH  250 (344)
Q Consensus       202 ~~~~~~~~~~~~~~--~~~~~---~~s~~~~~li~~~L~~dp~~R~s~~ell~h  250 (344)
                      .......+.....+  +|...   ..+..+.+|+.+||+.||.+|||+.++++.
T Consensus       238 ~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~  291 (303)
T 3hmm_A          238 VEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT  291 (303)
T ss_dssp             HHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence            22222222222222  22111   123468899999999999999999999763

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=1.8e-51  Score=372.68  Aligned_cols=247  Identities=32%  Similarity=0.628  Sum_probs=212.4

Q ss_pred             CCCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCc----cccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEE
Q 019195            1 MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH----KIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIV   76 (344)
Q Consensus         1 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv   76 (344)
                      +++|++++.||+|+||.||+|.+..+|+.||+|++.+..    .....+.+|+.+++.++||||+++++++.+...+|+|
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv   84 (318)
T 1fot_A            5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI   84 (318)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred             hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence            478999999999999999999999999999999997632    2345678899999999999999999999999999999


Q ss_pred             EecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCCCC
Q 019195           77 MEYAAGGELFERICNAGRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP  149 (344)
Q Consensus        77 ~e~~~~g~L~~~i~~~~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~~~  149 (344)
                      |||++||+|.+++.+.+.+++..++.++.|++.+       ||+||||||+|||++.++  ++||+|||+++...  ...
T Consensus        85 ~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g--~~kL~Dfg~a~~~~--~~~  160 (318)
T 1fot_A           85 MDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNG--HIKITDFGFAKYVP--DVT  160 (318)
T ss_dssp             ECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTS--CEEECCCSSCEECS--SCB
T ss_pred             EeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCC--CEEEeecCcceecC--Ccc
Confidence            9999999999999998899999888887776654       999999999999997665  49999999997543  233


Q ss_pred             CCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCHhHHHH
Q 019195          150 KSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL  229 (344)
Q Consensus       150 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  229 (344)
                      ...+||+.|+|||++.+..++ .++|||||||++|+|++|+.||...+....+    ..+......+|.  .+++++.+|
T Consensus       161 ~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~pf~~~~~~~~~----~~i~~~~~~~p~--~~~~~~~~l  233 (318)
T 1fot_A          161 YTLCGTPDYIAPEVVSTKPYN-KSIDWWSFGILIYEMLAGYTPFYDSNTMKTY----EKILNAELRFPP--FFNEDVKDL  233 (318)
T ss_dssp             CCCCSCTTTCCHHHHTTCCBC-TTHHHHHHHHHHHHHHHSSCTTCCSSHHHHH----HHHHHCCCCCCT--TSCHHHHHH
T ss_pred             ccccCCccccCHhHhcCCCCC-cccchhhhHHHHHHHHhCCCCCCCCCHHHHH----HHHHhCCCCCCC--CCCHHHHHH
Confidence            456899999999999887765 4599999999999999999999876654333    344444555554  689999999


Q ss_pred             HHHhcccCCCCCC-----ChHHHhcCcccccCCC
Q 019195          230 LSRIFVANPSRRI-----TIKEIKSHPWFLKNLP  258 (344)
Q Consensus       230 i~~~L~~dp~~R~-----s~~ell~hp~~~~~~~  258 (344)
                      |.+||+.||.+||     ++.++++||||.....
T Consensus       234 i~~lL~~dp~~R~~~~~~~~~~i~~hp~f~~~~~  267 (318)
T 1fot_A          234 LSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVW  267 (318)
T ss_dssp             HHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCCH
T ss_pred             HHHHhccCHHHcCCCcCCCHHHHhcCccccCCCH
Confidence            9999999999999     9999999999976543

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=2e-51  Score=380.87  Aligned_cols=252  Identities=26%  Similarity=0.476  Sum_probs=214.1

Q ss_pred             CCCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCc----cccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEE
Q 019195            1 MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH----KIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIV   76 (344)
Q Consensus         1 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv   76 (344)
                      +++|++++.||+|+||.||+|.+..+++.||+|++.+..    .....+.+|+.+++.++||||++++++|.+...+|+|
T Consensus        14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv   93 (384)
T 4fr4_A           14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMV   93 (384)
T ss_dssp             GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence            478999999999999999999999999999999997532    2336788999999999999999999999999999999


Q ss_pred             EecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCCCC
Q 019195           77 MEYAAGGELFERICNAGRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP  149 (344)
Q Consensus        77 ~e~~~~g~L~~~i~~~~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~~~  149 (344)
                      |||+.||+|..++...+.+++..++.++.||+.|       ||+||||||+|||++.++.  +||+|||+++........
T Consensus        94 ~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~--vkL~DFG~a~~~~~~~~~  171 (384)
T 4fr4_A           94 VDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGH--VHITDFNIAAMLPRETQI  171 (384)
T ss_dssp             ECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC--EEECCCTTCEECCTTCCB
T ss_pred             EecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCC--EEEeccceeeeccCCCce
Confidence            9999999999999998899999988887776654       9999999999999977664  999999999876655666


Q ss_pred             CCCccCCcccCCccccCC--CCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCHhHH
Q 019195          150 KSTVGTPAYIAPEVLSRR--EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCR  227 (344)
Q Consensus       150 ~~~~gt~~y~aPE~~~~~--~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~  227 (344)
                      ...+||+.|+|||++.+.  ...+.++|||||||++|+|++|+.||...... ........+.......|.  .+++.+.
T Consensus       172 ~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~-~~~~~~~~~~~~~~~~p~--~~s~~~~  248 (384)
T 4fr4_A          172 TTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSST-SSKEIVHTFETTVVTYPS--AWSQEMV  248 (384)
T ss_dssp             CCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTS-CHHHHHHHHHHCCCCCCT--TSCHHHH
T ss_pred             eccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCc-cHHHHHHHHhhcccCCCC--cCCHHHH
Confidence            778899999999999643  22345699999999999999999999865432 223344444444444443  6899999


Q ss_pred             HHHHHhcccCCCCCCC-hHHHhcCcccccCC
Q 019195          228 NLLSRIFVANPSRRIT-IKEIKSHPWFLKNL  257 (344)
Q Consensus       228 ~li~~~L~~dp~~R~s-~~ell~hp~~~~~~  257 (344)
                      +||.+||+.||.+||+ +.++++||||....
T Consensus       249 ~li~~lL~~dP~~R~s~~~~l~~hp~f~~~~  279 (384)
T 4fr4_A          249 SLLKKLLEPNPDQRFSQLSDVQNFPYMNDIN  279 (384)
T ss_dssp             HHHHHHSCSSGGGSCCSHHHHHTSGGGTTCC
T ss_pred             HHHHHHhcCCHhHhcccHHHHHcChhhhcCC
Confidence            9999999999999998 89999999997653

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=3.7e-51  Score=374.76  Aligned_cols=251  Identities=29%  Similarity=0.517  Sum_probs=210.2

Q ss_pred             CCCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCccc----cHHHHHHHHHHhcC-CCCCcceeeEEEEcCCEEEE
Q 019195            1 MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKI----DANVAREIINHKQL-RHPNIIRFKEVVLTPTHLAI   75 (344)
Q Consensus         1 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~----~~~~~~ei~~l~~l-~h~niv~~~~~~~~~~~~~l   75 (344)
                      +++|++++.||+|+||.||+|++..+++.||+|++.+....    ...+.+|+.+++++ +||||+++++++.+.+.+|+
T Consensus         8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l   87 (345)
T 3a8x_A            8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF   87 (345)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEE
Confidence            46899999999999999999999999999999999865332    24577899999887 89999999999999999999


Q ss_pred             EEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccC-CCC
Q 019195           76 VMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSL-LHS  147 (344)
Q Consensus        76 v~e~~~~g~L~~~i~~~~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~-~~~  147 (344)
                      ||||+++|+|..++.+.+.+++..++.++.||+.+       ||+||||||+|||++.++  ++||+|||+++... ...
T Consensus        88 v~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g--~~kL~DFG~a~~~~~~~~  165 (345)
T 3a8x_A           88 VIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEG--HIKLTDYGMCKEGLRPGD  165 (345)
T ss_dssp             EECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTS--CEEECCGGGCBCSCCTTC
T ss_pred             EEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCC--CEEEEeccccccccCCCC
Confidence            99999999999999988899999988887776654       999999999999997665  49999999997533 233


Q ss_pred             CCCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCh-----HHHHHHHHHHhhccccCCCCCCC
Q 019195          148 RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDP-----KNFRKTISRIMAVQYKIPDYVHI  222 (344)
Q Consensus       148 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~  222 (344)
                      .....+||+.|+|||++.+..++ .++|||||||++|+|++|+.||......     .........+......+|.  .+
T Consensus       166 ~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~--~~  242 (345)
T 3a8x_A          166 TTSTFCGTPNYIAPEILRGEDYG-FSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPR--SL  242 (345)
T ss_dssp             CBCCCCSCGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCCCCCT--TS
T ss_pred             cccccCCCccccCccccCCCCCC-hHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCCCCCC--CC
Confidence            34566899999999999887764 5599999999999999999999753221     1122334444555555554  68


Q ss_pred             CHhHHHHHHHhcccCCCCCCCh------HHHhcCcccccC
Q 019195          223 SQDCRNLLSRIFVANPSRRITI------KEIKSHPWFLKN  256 (344)
Q Consensus       223 s~~~~~li~~~L~~dp~~R~s~------~ell~hp~~~~~  256 (344)
                      ++++.+||.+||+.||.+||++      .++++||||...
T Consensus       243 s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~~  282 (345)
T 3a8x_A          243 SVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNV  282 (345)
T ss_dssp             CHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTTC
T ss_pred             CHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCCC
Confidence            9999999999999999999996      799999999754

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=1.4e-51  Score=377.11  Aligned_cols=248  Identities=33%  Similarity=0.563  Sum_probs=211.5

Q ss_pred             CCCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCc----cccHHHHHHHHHHhcC-CCCCcceeeEEEEcCCEEEE
Q 019195            1 MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH----KIDANVAREIINHKQL-RHPNIIRFKEVVLTPTHLAI   75 (344)
Q Consensus         1 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~ei~~l~~l-~h~niv~~~~~~~~~~~~~l   75 (344)
                      +++|++.+.||+|+||.||+|.+..+++.||+|++.+..    .....+.+|..+++.+ +||||+++++++.+.+.+|+
T Consensus        16 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~l   95 (345)
T 1xjd_A           16 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFF   95 (345)
T ss_dssp             CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred             hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEEE
Confidence            478999999999999999999999999999999997642    2335677899998876 89999999999999999999


Q ss_pred             EEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCC-CC
Q 019195           76 VMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLL-HS  147 (344)
Q Consensus        76 v~e~~~~g~L~~~i~~~~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~-~~  147 (344)
                      ||||++||+|..++.+.+.+++.+++.++.||+.|       ||+||||||+|||++.++  ++||+|||+++.... ..
T Consensus        96 v~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g--~vkL~DFG~a~~~~~~~~  173 (345)
T 1xjd_A           96 VMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDG--HIKIADFGMCKENMLGDA  173 (345)
T ss_dssp             EEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTS--CEEECCCTTCBCCCCTTC
T ss_pred             EEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCC--CEEEeEChhhhhcccCCC
Confidence            99999999999999988899999988887776654       999999999999997765  499999999975432 23


Q ss_pred             CCCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCHhHH
Q 019195          148 RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCR  227 (344)
Q Consensus       148 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~  227 (344)
                      .....+||+.|+|||++.+..++ .++|||||||++|+|++|++||...+....    ...+......+|.  .+++++.
T Consensus       174 ~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~Pf~~~~~~~~----~~~i~~~~~~~p~--~~s~~~~  246 (345)
T 1xjd_A          174 KTNTFCGTPDYIAPEILLGQKYN-HSVDWWSFGVLLYEMLIGQSPFHGQDEEEL----FHSIRMDNPFYPR--WLEKEAK  246 (345)
T ss_dssp             CBCCCCSCGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHH----HHHHHHCCCCCCT--TSCHHHH
T ss_pred             cccCCCCCcccCChhhhcCCCCC-ChhhhHHHHHHHHHHhcCCCCCCCCCHHHH----HHHHHhCCCCCCc--ccCHHHH
Confidence            34567899999999999887765 559999999999999999999987655433    3334444444454  6899999


Q ss_pred             HHHHHhcccCCCCCCChH-HHhcCcccccCC
Q 019195          228 NLLSRIFVANPSRRITIK-EIKSHPWFLKNL  257 (344)
Q Consensus       228 ~li~~~L~~dp~~R~s~~-ell~hp~~~~~~  257 (344)
                      +||.+||+.||.+||++. ++++||||....
T Consensus       247 ~li~~lL~~dp~~R~~~~~~i~~hp~f~~~~  277 (345)
T 1xjd_A          247 DLLVKLFVREPEKRLGVRGDIRQHPLFREIN  277 (345)
T ss_dssp             HHHHHHSCSSGGGSBTTBSCGGGSGGGTTCC
T ss_pred             HHHHHHhcCCHhHcCCChHHHHcCccccCCC
Confidence            999999999999999998 999999997653

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=2.8e-51  Score=387.00  Aligned_cols=249  Identities=33%  Similarity=0.606  Sum_probs=210.6

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCcc---ccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEEe
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK---IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVME   78 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e   78 (344)
                      ++|++.+.||+|+||+||+|.+..+++.||+|++.....   ....+.+|+.+++.++||||+++++++.+++.+|+|||
T Consensus        11 ~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~E   90 (444)
T 3soa_A           11 EEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFD   90 (444)
T ss_dssp             HHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEEC
T ss_pred             CCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEEE
Confidence            479999999999999999999999999999999976542   23568899999999999999999999999999999999


Q ss_pred             cCCCCChHHHHHhCCCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCC-CCCCEEEeecCCCcccCCCCC-C
Q 019195           79 YAAGGELFERICNAGRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGS-PAPRLKICDFGYSKSSLLHSR-P  149 (344)
Q Consensus        79 ~~~~g~L~~~i~~~~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~-~~~~vkL~DFg~a~~~~~~~~-~  149 (344)
                      ||.||+|.+.+...+.+++.+++.++.||+.+       ||+||||||+|||++.. ..+.+||+|||++........ .
T Consensus        91 ~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~~~~~  170 (444)
T 3soa_A           91 LVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAW  170 (444)
T ss_dssp             CCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTTCCBC
T ss_pred             eCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEecCCCcee
Confidence            99999999999999999999999888887765       99999999999999753 335699999999976543322 3


Q ss_pred             CCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhcccc--CCCCCCCCHhHH
Q 019195          150 KSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYK--IPDYVHISQDCR  227 (344)
Q Consensus       150 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~s~~~~  227 (344)
                      ...+||+.|+|||++.+..++ .++|||||||++|+|++|.+||.+......+    ..+....+.  .+.+..+++++.
T Consensus       171 ~~~~gt~~Y~APE~l~~~~~~-~~~DIwSlGvilyell~G~~Pf~~~~~~~~~----~~i~~~~~~~~~~~~~~~s~~~~  245 (444)
T 3soa_A          171 FGFAGTPGYLSPEVLRKDPYG-KPVDLWACGVILYILLVGYPPFWDEDQHRLY----QQIKAGAYDFPSPEWDTVTPEAK  245 (444)
T ss_dssp             CCSCSCGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCSCCCSSHHHHH----HHHHHTCCCCCTTTTTTSCHHHH
T ss_pred             ecccCCcccCCHHHhcCCCCC-CccccHHHHHHHHHHHhCCCCCCCccHHHHH----HHHHhCCCCCCccccccCCHHHH
Confidence            456899999999999887775 4599999999999999999999876654333    333444433  344557899999


Q ss_pred             HHHHHhcccCCCCCCChHHHhcCccccc
Q 019195          228 NLLSRIFVANPSRRITIKEIKSHPWFLK  255 (344)
Q Consensus       228 ~li~~~L~~dp~~R~s~~ell~hp~~~~  255 (344)
                      +||.+||+.||.+|||+.++|+||||..
T Consensus       246 ~li~~~L~~dP~~Rpta~e~L~hp~~~~  273 (444)
T 3soa_A          246 DLINKMLTINPSKRITAAEALKHPWISH  273 (444)
T ss_dssp             HHHHHHSCSSTTTSCCHHHHHHSCTTHH
T ss_pred             HHHHHHcCCChhHCCCHHHHhcCccccC
Confidence            9999999999999999999999999964

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=1.7e-51  Score=379.49  Aligned_cols=249  Identities=32%  Similarity=0.590  Sum_probs=212.7

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCccc---cHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEEe
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKI---DANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVME   78 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e   78 (344)
                      ++|++.+.||+|+||.||+|.+..+++.||+|++......   ...+.+|+.+++.++||||+++++++.+.+.+|+|||
T Consensus        29 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~e  108 (362)
T 2bdw_A           29 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFD  108 (362)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             cCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence            4699999999999999999999999999999999764332   2568899999999999999999999999999999999


Q ss_pred             cCCCCChHHHHHhCCCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCC-CCCEEEeecCCCcccCCCCCCC
Q 019195           79 YAAGGELFERICNAGRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSP-APRLKICDFGYSKSSLLHSRPK  150 (344)
Q Consensus        79 ~~~~g~L~~~i~~~~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~-~~~vkL~DFg~a~~~~~~~~~~  150 (344)
                      ||++|+|.+.+.....+++.+++.++.||+.+       ||+||||||+|||++... .+.+||+|||++..........
T Consensus       109 ~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~~~~~  188 (362)
T 2bdw_A          109 LVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWH  188 (362)
T ss_dssp             CCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTCCSCC
T ss_pred             cCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecCCcccc
Confidence            99999999999888889999988888776655       999999999999997543 2469999999998766555556


Q ss_pred             CCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCC--CCCCCCHhHHH
Q 019195          151 STVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIP--DYVHISQDCRN  228 (344)
Q Consensus       151 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~s~~~~~  228 (344)
                      ..+||+.|+|||++.+..++ .++|||||||++|+|++|.+||........    ...+....+.++  .+..+++++.+
T Consensus       189 ~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~~ll~g~~Pf~~~~~~~~----~~~i~~~~~~~~~~~~~~~~~~~~~  263 (362)
T 2bdw_A          189 GFAGTPGYLSPEVLKKDPYS-KPVDIWACGVILYILLVGYPPFWDEDQHRL----YAQIKAGAYDYPSPEWDTVTPEAKS  263 (362)
T ss_dssp             CSCSCTTTCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHH----HHHHHHTCCCCCTTGGGGSCHHHHH
T ss_pred             cCCCCccccCHHHHccCCCC-chhhHHHHHHHHHHHHHCCCCCCCCCHHHH----HHHHHhCCCCCCcccccCCCHHHHH
Confidence            67899999999999887765 459999999999999999999987654333    333334444333  34568999999


Q ss_pred             HHHHhcccCCCCCCChHHHhcCccccc
Q 019195          229 LLSRIFVANPSRRITIKEIKSHPWFLK  255 (344)
Q Consensus       229 li~~~L~~dp~~R~s~~ell~hp~~~~  255 (344)
                      ||.+||+.||.+|||+.++|+||||..
T Consensus       264 li~~~L~~dP~~R~t~~e~l~hp~~~~  290 (362)
T 2bdw_A          264 LIDSMLTVNPKKRITADQALKVPWICN  290 (362)
T ss_dssp             HHHHHSCSSGGGSCCHHHHTTSHHHHT
T ss_pred             HHHHHcCCChhhCcCHHHHhcCcccCC
Confidence            999999999999999999999999964

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=1.2e-51  Score=374.86  Aligned_cols=253  Identities=36%  Similarity=0.599  Sum_probs=212.4

Q ss_pred             CCCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCcc--ccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEEe
Q 019195            1 MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK--IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVME   78 (344)
Q Consensus         1 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e   78 (344)
                      +++|++++.||+|+||+||+|.+..+++.||+|++.....  ....+.+|+.+++.++||||+++++++...+..|+|||
T Consensus         6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e   85 (323)
T 3tki_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   85 (323)
T ss_dssp             TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence            5799999999999999999999999999999999875432  23568899999999999999999999999999999999


Q ss_pred             cCCCCChHHHHHhCCCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCC---CC
Q 019195           79 YAAGGELFERICNAGRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH---SR  148 (344)
Q Consensus        79 ~~~~g~L~~~i~~~~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~---~~  148 (344)
                      ||++++|.+++.....+++.+++.++.|++.+       ||+||||||+|||++.++.  +||+|||++......   ..
T Consensus        86 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~--~kl~Dfg~a~~~~~~~~~~~  163 (323)
T 3tki_A           86 YCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDN--LKISDFGLATVFRYNNRERL  163 (323)
T ss_dssp             CCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC--EEECCCTTCEECEETTEECC
T ss_pred             cCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCC--EEEEEeeccceeccCCcccc
Confidence            99999999999888889999999888887755       9999999999999977664  999999999753222   22


Q ss_pred             CCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCHhHHH
Q 019195          149 PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRN  228 (344)
Q Consensus       149 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~  228 (344)
                      ....+||+.|+|||++.+..+.+.++|||||||++|+|++|+.||...........   .........+.+..+++.+.+
T Consensus       164 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~  240 (323)
T 3tki_A          164 LNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYS---DWKEKKTYLNPWKKIDSAPLA  240 (323)
T ss_dssp             BCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHH---HHHTTCTTSTTGGGSCHHHHH
T ss_pred             cCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHH---HHhcccccCCccccCCHHHHH
Confidence            34568999999999998888767779999999999999999999987655322222   222233334445578999999


Q ss_pred             HHHHhcccCCCCCCChHHHhcCcccccCCC
Q 019195          229 LLSRIFVANPSRRITIKEIKSHPWFLKNLP  258 (344)
Q Consensus       229 li~~~L~~dp~~R~s~~ell~hp~~~~~~~  258 (344)
                      ||.+||+.||.+|||+.|+++||||.+...
T Consensus       241 li~~~L~~dP~~R~t~~eil~h~~~~~~~~  270 (323)
T 3tki_A          241 LLHKILVENPSARITIPDIKKDRWYNKPLK  270 (323)
T ss_dssp             HHHHHSCSSTTTSCCHHHHTTCTTTTCCCC
T ss_pred             HHHHHccCChhhCcCHHHHhhChhhccccc
Confidence            999999999999999999999999987654

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.7e-51  Score=374.32  Aligned_cols=251  Identities=33%  Similarity=0.616  Sum_probs=213.0

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCcc-------ccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEE
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK-------IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLA   74 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-------~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~   74 (344)
                      ++|++.+.||+|+||.||+|.+..+++.||+|++.....       ....+.+|+.+++.++||||+++++++.....++
T Consensus        11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~   90 (326)
T 2y0a_A           11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI   90 (326)
T ss_dssp             HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence            469999999999999999999999999999999976432       2357889999999999999999999999999999


Q ss_pred             EEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCC--CCCEEEeecCCCcccCC
Q 019195           75 IVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSP--APRLKICDFGYSKSSLL  145 (344)
Q Consensus        75 lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~--~~~vkL~DFg~a~~~~~  145 (344)
                      +||||+++++|.+++...+.+++.+++.++.|++.+       ||+||||||+|||++.++  ..++||+|||+++....
T Consensus        91 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~  170 (326)
T 2y0a_A           91 LILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF  170 (326)
T ss_dssp             EEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCEECCT
T ss_pred             EEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeECCC
Confidence            999999999999999888889999998888777655       999999999999997654  22599999999987655


Q ss_pred             CCCCCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCC--CCCCCC
Q 019195          146 HSRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIP--DYVHIS  223 (344)
Q Consensus       146 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~s  223 (344)
                      .......+||+.|+|||++.+..++ .++|||||||++|+|++|..||.+......+..    +......++  .+..++
T Consensus       171 ~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~----~~~~~~~~~~~~~~~~~  245 (326)
T 2y0a_A          171 GNEFKNIFGTPEFVAPEIVNYEPLG-LEADMWSIGVITYILLSGASPFLGDTKQETLAN----VSAVNYEFEDEYFSNTS  245 (326)
T ss_dssp             TSCCCCCCSCTTTCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHH----HHHTCCCCCHHHHTTSC
T ss_pred             CCccccccCCcCcCCceeecCCCCC-cHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHH----HHhcCCCcCccccccCC
Confidence            5555667899999999999877764 559999999999999999999987655433332    333333332  224678


Q ss_pred             HhHHHHHHHhcccCCCCCCChHHHhcCcccccCC
Q 019195          224 QDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNL  257 (344)
Q Consensus       224 ~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~~~  257 (344)
                      +.+.+||.+||+.||.+|||+.++|+||||....
T Consensus       246 ~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~  279 (326)
T 2y0a_A          246 ALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKD  279 (326)
T ss_dssp             HHHHHHHHHHSCSSGGGSCCHHHHHHSTTTSCCS
T ss_pred             HHHHHHHHHHccCChhhCCCHHHHhcCCCccCCc
Confidence            9999999999999999999999999999997653

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=2e-51  Score=390.71  Aligned_cols=250  Identities=40%  Similarity=0.738  Sum_probs=218.1

Q ss_pred             CCCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCc----cccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEE
Q 019195            1 MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH----KIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIV   76 (344)
Q Consensus         1 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv   76 (344)
                      +++|++.+.||+|+||.||+|.+..+|+.||+|++....    .....+.+|+.+++.++||||+++++++...+.+|+|
T Consensus        15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv   94 (476)
T 2y94_A           15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMV   94 (476)
T ss_dssp             ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence            368999999999999999999999999999999997532    2335788999999999999999999999999999999


Q ss_pred             EecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCCCC
Q 019195           77 MEYAAGGELFERICNAGRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP  149 (344)
Q Consensus        77 ~e~~~~g~L~~~i~~~~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~~~  149 (344)
                      ||||++|+|.+++.+.+.+++.+++.++.||+.+       ||+||||||+|||++.++.  +||+|||++.........
T Consensus        95 ~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~--vkL~DFG~a~~~~~~~~~  172 (476)
T 2y94_A           95 MEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMN--AKIADFGLSNMMSDGEFL  172 (476)
T ss_dssp             EECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCC--EEECCCSSCEECCTTCCB
T ss_pred             EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCC--eEEEeccchhhccccccc
Confidence            9999999999999888899999999998887765       9999999999999987664  999999999876555555


Q ss_pred             CCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCHhHHHH
Q 019195          150 KSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL  229 (344)
Q Consensus       150 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  229 (344)
                      ...+||+.|+|||++.+..+.+.++|||||||++|+|++|+.||........+.    .+....+..|.  .+++++.+|
T Consensus       173 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~----~i~~~~~~~p~--~~s~~~~~L  246 (476)
T 2y94_A          173 RTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFK----KICDGIFYTPQ--YLNPSVISL  246 (476)
T ss_dssp             CCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHH----HHHTTCCCCCT--TCCHHHHHH
T ss_pred             cccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHH----HHhcCCcCCCc--cCCHHHHHH
Confidence            677899999999999988877778999999999999999999998876544433    33344444443  679999999


Q ss_pred             HHHhcccCCCCCCChHHHhcCcccccCCC
Q 019195          230 LSRIFVANPSRRITIKEIKSHPWFLKNLP  258 (344)
Q Consensus       230 i~~~L~~dp~~R~s~~ell~hp~~~~~~~  258 (344)
                      |.+||+.||.+|||+.++++||||.+..+
T Consensus       247 i~~~L~~dP~~Rpt~~eil~hp~~~~~~~  275 (476)
T 2y94_A          247 LKHMLQVDPMKRATIKDIREHEWFKQDLP  275 (476)
T ss_dssp             HHHHTCSSTTTSCCHHHHHTCHHHHTTCC
T ss_pred             HHHHcCCCchhCcCHHHHHhCHHhhhcCc
Confidence            99999999999999999999999987654

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=4.6e-51  Score=374.73  Aligned_cols=245  Identities=30%  Similarity=0.584  Sum_probs=211.6

Q ss_pred             CCCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCc----cccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEE
Q 019195            1 MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH----KIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIV   76 (344)
Q Consensus         1 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv   76 (344)
                      +++|++++.||+|+||.||+|.+..+++.||+|++.+..    .....+.+|+.+++.++||||+++++++.+...+|+|
T Consensus        40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv  119 (350)
T 1rdq_E           40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV  119 (350)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEE
Confidence            468999999999999999999999999999999997632    2345788999999999999999999999999999999


Q ss_pred             EecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCCCC
Q 019195           77 MEYAAGGELFERICNAGRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP  149 (344)
Q Consensus        77 ~e~~~~g~L~~~i~~~~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~~~  149 (344)
                      |||++||+|.+++.+.+.+++.+++.++.||+.+       ||+||||||+|||++.++.  +||+|||+++....  ..
T Consensus       120 ~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~--~kL~DFg~a~~~~~--~~  195 (350)
T 1rdq_E          120 MEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGY--IQVTDFGFAKRVKG--RT  195 (350)
T ss_dssp             EECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC--EEECCCTTCEECSS--CB
T ss_pred             EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCC--EEEcccccceeccC--Cc
Confidence            9999999999999988899999988887776654       9999999999999976654  99999999975432  23


Q ss_pred             CCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCHhHHHH
Q 019195          150 KSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL  229 (344)
Q Consensus       150 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  229 (344)
                      ...+||+.|+|||++.+..++ .++|||||||++|+|++|++||...+...    ....+......+|.  .+++++.+|
T Consensus       196 ~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~Pf~~~~~~~----~~~~i~~~~~~~p~--~~~~~~~~l  268 (350)
T 1rdq_E          196 WTLCGTPEALAPEIILSKGYN-KAVDWWALGVLIYEMAAGYPPFFADQPIQ----IYEKIVSGKVRFPS--HFSSDLKDL  268 (350)
T ss_dssp             CCCEECGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHHHHHHCCCCCCT--TCCHHHHHH
T ss_pred             ccccCCccccCHHHhcCCCCC-CcCCEecccHhHhHHhhCCCCCCCCCHHH----HHHHHHcCCCCCCC--CCCHHHHHH
Confidence            456899999999999887765 55999999999999999999998765433    33344445555554  689999999


Q ss_pred             HHHhcccCCCCCCC-----hHHHhcCcccccC
Q 019195          230 LSRIFVANPSRRIT-----IKEIKSHPWFLKN  256 (344)
Q Consensus       230 i~~~L~~dp~~R~s-----~~ell~hp~~~~~  256 (344)
                      |.+||+.||.+||+     +.++++||||...
T Consensus       269 i~~lL~~dp~~R~~~~~~~~~ei~~h~~f~~~  300 (350)
T 1rdq_E          269 LRNLLQVDLTKRFGNLKNGVNDIKNHKWFATT  300 (350)
T ss_dssp             HHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTC
T ss_pred             HHHHhhcCHHhccCCccCCHHHHHhCcCcCCC
Confidence            99999999999998     9999999999754

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=5.4e-51  Score=374.49  Aligned_cols=248  Identities=31%  Similarity=0.534  Sum_probs=212.0

Q ss_pred             CCCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCc----cccHHHHHHHHHHhcC-CCCCcceeeEEEEcCCEEEE
Q 019195            1 MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH----KIDANVAREIINHKQL-RHPNIIRFKEVVLTPTHLAI   75 (344)
Q Consensus         1 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~ei~~l~~l-~h~niv~~~~~~~~~~~~~l   75 (344)
                      +++|++++.||+|+||.||+|.+..+++.||+|++.+..    .....+.+|..+++.+ +||||+++++++.+.+.+|+
T Consensus        19 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l   98 (353)
T 2i0e_A           19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF   98 (353)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEE
T ss_pred             hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEE
Confidence            478999999999999999999999999999999997642    2335678899999988 79999999999999999999


Q ss_pred             EEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccC-CCC
Q 019195           76 VMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSL-LHS  147 (344)
Q Consensus        76 v~e~~~~g~L~~~i~~~~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~-~~~  147 (344)
                      ||||++||+|..++.+.+.+++.+++.++.||+.|       ||+||||||+|||++.++  ++||+|||+++... ...
T Consensus        99 v~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g--~vkL~DFG~a~~~~~~~~  176 (353)
T 2i0e_A           99 VMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEG--HIKIADFGMCKENIWDGV  176 (353)
T ss_dssp             EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTS--CEEECCCTTCBCCCCTTC
T ss_pred             EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCC--cEEEEeCCcccccccCCc
Confidence            99999999999999988899999988887776654       999999999999997765  49999999998633 233


Q ss_pred             CCCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCHhHH
Q 019195          148 RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCR  227 (344)
Q Consensus       148 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~  227 (344)
                      .....+||+.|+|||++.+..++ .++|||||||++|+|++|++||...+...    +...+......+|.  .+++++.
T Consensus       177 ~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~G~~Pf~~~~~~~----~~~~i~~~~~~~p~--~~s~~~~  249 (353)
T 2i0e_A          177 TTKTFCGTPDYIAPEIIAYQPYG-KSVDWWAFGVLLYEMLAGQAPFEGEDEDE----LFQSIMEHNVAYPK--SMSKEAV  249 (353)
T ss_dssp             CBCCCCSCGGGCCHHHHTTCCBS-THHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHHHHHHCCCCCCT--TSCHHHH
T ss_pred             ccccccCCccccChhhhcCCCcC-CcccccchHHHHHHHHcCCCCCCCCCHHH----HHHHHHhCCCCCCC--CCCHHHH
Confidence            34567899999999999887774 55999999999999999999998765433    33444445555554  6899999


Q ss_pred             HHHHHhcccCCCCCCC-----hHHHhcCcccccCC
Q 019195          228 NLLSRIFVANPSRRIT-----IKEIKSHPWFLKNL  257 (344)
Q Consensus       228 ~li~~~L~~dp~~R~s-----~~ell~hp~~~~~~  257 (344)
                      +||.+||+.||.+||+     +.++++||||....
T Consensus       250 ~li~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~~~  284 (353)
T 2i0e_A          250 AICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYID  284 (353)
T ss_dssp             HHHHHHTCSCTTSCTTCSTTHHHHHHTSGGGTTCC
T ss_pred             HHHHHHhhcCHHHcCCCCCCCHHHHhcCccccCCC
Confidence            9999999999999994     69999999997643

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=8.1e-51  Score=379.92  Aligned_cols=250  Identities=34%  Similarity=0.500  Sum_probs=210.2

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecC----ccccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEE
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERG----HKIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVM   77 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~   77 (344)
                      ++|++++.||+|+||.||+|.+..+++.||+|++.+.    ......+.+|+.+++.++||||++++++|.+...+|+||
T Consensus        69 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~  148 (410)
T 3v8s_A           69 EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVM  148 (410)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEE
Confidence            6899999999999999999999999999999999752    223356889999999999999999999999999999999


Q ss_pred             ecCCCCChHHHHHhCCCCCHHHHHHHHHHHHH-------CCeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCC--C
Q 019195           78 EYAAGGELFERICNAGRFSEDEARYFFQQLIS-------GQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS--R  148 (344)
Q Consensus        78 e~~~~g~L~~~i~~~~~~~~~~~~~~~~ql~~-------~~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~--~  148 (344)
                      |||+||+|.+++.+ ..+++..++.++.||+.       .||+||||||+|||++.++.  +||+|||+++......  .
T Consensus       149 E~~~gg~L~~~l~~-~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~--ikL~DFG~a~~~~~~~~~~  225 (410)
T 3v8s_A          149 EYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGH--LKLADFGTCMKMNKEGMVR  225 (410)
T ss_dssp             CCCTTEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC--EEECCCTTCEECCTTSEEE
T ss_pred             eCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCC--EEEeccceeEeeccCCccc
Confidence            99999999999865 46899888887766655       49999999999999977664  9999999997544332  2


Q ss_pred             CCCCccCCcccCCccccCCCC---CCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCHh
Q 019195          149 PKSTVGTPAYIAPEVLSRREY---DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQD  225 (344)
Q Consensus       149 ~~~~~gt~~y~aPE~~~~~~~---~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~  225 (344)
                      ....+||+.|+|||++.+...   .+.++|||||||++|+|++|++||...+....+.+++...  ....+|....++++
T Consensus       226 ~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~--~~~~~p~~~~~s~~  303 (410)
T 3v8s_A          226 CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHK--NSLTFPDDNDISKE  303 (410)
T ss_dssp             CCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHH--HHCCCCTTCCCCHH
T ss_pred             ccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhcc--ccccCCCcccccHH
Confidence            346789999999999976541   3456999999999999999999998876655544443322  23455666679999


Q ss_pred             HHHHHHHhcccCCCC--CCChHHHhcCcccccC
Q 019195          226 CRNLLSRIFVANPSR--RITIKEIKSHPWFLKN  256 (344)
Q Consensus       226 ~~~li~~~L~~dp~~--R~s~~ell~hp~~~~~  256 (344)
                      +++||++||+.+|.+  ||++.++++||||+..
T Consensus       304 ~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~  336 (410)
T 3v8s_A          304 AKNLICAFLTDREVRLGRNGVEEIKRHLFFKND  336 (410)
T ss_dssp             HHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCCS
T ss_pred             HHHHHHHHccChhhhCCCCCHHHHhcCccccCC
Confidence            999999999999988  9999999999999865

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=9.5e-51  Score=366.99  Aligned_cols=253  Identities=28%  Similarity=0.458  Sum_probs=203.8

Q ss_pred             CCCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCccc---cHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEE
Q 019195            1 MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKI---DANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVM   77 (344)
Q Consensus         1 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~   77 (344)
                      +++|++++.||+|+||+||+|.+. +++.||+|++......   ...+.+|+.++++++||||+++++++.++..+++||
T Consensus        20 ~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   98 (311)
T 3niz_A           20 MEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVF   98 (311)
T ss_dssp             SCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEE
T ss_pred             HhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEE
Confidence            479999999999999999999985 5899999998754322   356889999999999999999999999999999999


Q ss_pred             ecCCCCChHHHHHhC-CCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCC-CC
Q 019195           78 EYAAGGELFERICNA-GRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH-SR  148 (344)
Q Consensus        78 e~~~~g~L~~~i~~~-~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~-~~  148 (344)
                      ||+++ +|.+.+... ..+++.+++.++.|++.+       ||+||||||+|||++.++.  +||+|||+++..... ..
T Consensus        99 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~--~kl~Dfg~a~~~~~~~~~  175 (311)
T 3niz_A           99 EFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGA--LKLADFGLARAFGIPVRS  175 (311)
T ss_dssp             ECCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC--EEECCCTTCEETTSCCC-
T ss_pred             cCCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCC--EEEccCcCceecCCCccc
Confidence            99975 888877654 458999888888777655       9999999999999987664  999999999764433 23


Q ss_pred             CCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhcccc-CC----------
Q 019195          149 PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYK-IP----------  217 (344)
Q Consensus       149 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~-~~----------  217 (344)
                      ....+||+.|+|||++.+....+.++|||||||++|+|++|+.||.+.........+.......... .+          
T Consensus       176 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~  255 (311)
T 3niz_A          176 YTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQ  255 (311)
T ss_dssp             --CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHHHHS
T ss_pred             ccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccchhhh
Confidence            3445799999999999876555667999999999999999999999887766666555433221110 00          


Q ss_pred             -------------CCCCCCHhHHHHHHHhcccCCCCCCChHHHhcCcccccCC
Q 019195          218 -------------DYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNL  257 (344)
Q Consensus       218 -------------~~~~~s~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~~~  257 (344)
                                   ....+++++.+||.+||+.||.+|||+.++|+||||++..
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~  308 (311)
T 3niz_A          256 RTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDLD  308 (311)
T ss_dssp             CCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTSC
T ss_pred             cccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcccccCC
Confidence                         0124678999999999999999999999999999997653

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=8.1e-51  Score=363.34  Aligned_cols=251  Identities=29%  Similarity=0.454  Sum_probs=202.7

Q ss_pred             CCCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCc---cccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEE
Q 019195            1 MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH---KIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVM   77 (344)
Q Consensus         1 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~   77 (344)
                      |++|++++.||+|+||+||+|.+ .+++.||+|++....   .....+.+|+.+++.++||||+++++++...+.+++||
T Consensus         1 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   79 (288)
T 1ob3_A            1 MEKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVF   79 (288)
T ss_dssp             CCSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEE
T ss_pred             CccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEE
Confidence            68999999999999999999998 678999999986543   23467889999999999999999999999999999999


Q ss_pred             ecCCCCChHHHHHhC-CCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCC-CC
Q 019195           78 EYAAGGELFERICNA-GRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH-SR  148 (344)
Q Consensus        78 e~~~~g~L~~~i~~~-~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~-~~  148 (344)
                      ||+++ +|.+++... +.+++..++.++.|++.+       ||+||||||+|||++.++.  +||+|||+++..... ..
T Consensus        80 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~  156 (288)
T 1ob3_A           80 EHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGE--LKIADFGLARAFGIPVRK  156 (288)
T ss_dssp             ECCSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSC--EEECCTTHHHHHCC----
T ss_pred             EecCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCC--EEEeECccccccCccccc
Confidence            99975 999888764 678998888887776654       9999999999999976654  999999998754322 22


Q ss_pred             CCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhcccc-------CC----
Q 019195          149 PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYK-------IP----  217 (344)
Q Consensus       149 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~-------~~----  217 (344)
                      .....||+.|+|||++.+....+.++|||||||++|+|++|++||........+..+..........       .+    
T Consensus       157 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (288)
T 1ob3_A          157 YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDP  236 (288)
T ss_dssp             -----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCT
T ss_pred             cccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhccccccc
Confidence            3445799999999999776555667999999999999999999998877655555544432211100       00    


Q ss_pred             ------------CCCCCCHhHHHHHHHhcccCCCCCCChHHHhcCccccc
Q 019195          218 ------------DYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLK  255 (344)
Q Consensus       218 ------------~~~~~s~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~  255 (344)
                                  ....+++++.+||.+||+.||.+|||+.++|+||||++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~  286 (288)
T 1ob3_A          237 NFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE  286 (288)
T ss_dssp             TCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred             ccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhh
Confidence                        11347899999999999999999999999999999975

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=3.3e-51  Score=380.25  Aligned_cols=251  Identities=28%  Similarity=0.561  Sum_probs=212.7

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCcc-ccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEEecC
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK-IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYA   80 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~   80 (344)
                      ++|++++.||+|+||.||+|.+..+++.||+|++..... ....+.+|+.+++.++||||+++++++.+...+++|||||
T Consensus        51 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~~  130 (387)
T 1kob_A           51 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL  130 (387)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred             cceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEcC
Confidence            579999999999999999999999999999999976532 2356889999999999999999999999999999999999


Q ss_pred             CCCChHHHHHhCC-CCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCCCCCCC
Q 019195           81 AGGELFERICNAG-RFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST  152 (344)
Q Consensus        81 ~~g~L~~~i~~~~-~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~~~~~~  152 (344)
                      .+|+|.+++.... .+++.+++.++.||+.+       ||+||||||+|||++.+..+.+||+|||+++...........
T Consensus       131 ~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~~~~~~  210 (387)
T 1kob_A          131 SGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVT  210 (387)
T ss_dssp             CCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSCEEEE
T ss_pred             CCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecCCCcceeee
Confidence            9999999987654 78999988888777655       999999999999998655567999999999866544444556


Q ss_pred             ccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccC--CCCCCCCHhHHHHH
Q 019195          153 VGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKI--PDYVHISQDCRNLL  230 (344)
Q Consensus       153 ~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~s~~~~~li  230 (344)
                      +||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+......+..    +....+.+  +.+..+++++.+||
T Consensus       211 ~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~----i~~~~~~~~~~~~~~~s~~~~~li  285 (387)
T 1kob_A          211 TATAEFAAPEIVDREPV-GFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQN----VKRCDWEFDEDAFSSVSPEAKDFI  285 (387)
T ss_dssp             CSSGGGCCHHHHTTCCB-CHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHH----HHHCCCCCCSSTTTTSCHHHHHHH
T ss_pred             ccCCCccCchhccCCCC-CCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHH----HHhCCCCCCccccccCCHHHHHHH
Confidence            79999999999987776 4569999999999999999999988665443333    33333322  23456899999999


Q ss_pred             HHhcccCCCCCCChHHHhcCcccccCC
Q 019195          231 SRIFVANPSRRITIKEIKSHPWFLKNL  257 (344)
Q Consensus       231 ~~~L~~dp~~R~s~~ell~hp~~~~~~  257 (344)
                      .+||+.||.+|||+.++|+||||....
T Consensus       286 ~~~L~~dP~~Rpt~~ell~hp~~~~~~  312 (387)
T 1kob_A          286 KNLLQKEPRKRLTVHDALEHPWLKGDH  312 (387)
T ss_dssp             HTTSCSSGGGSCCHHHHHTSTTTSSCC
T ss_pred             HHHcCCChhHCcCHHHHhhCccccCCc
Confidence            999999999999999999999998653

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=8.1e-51  Score=365.04  Aligned_cols=247  Identities=38%  Similarity=0.634  Sum_probs=202.9

Q ss_pred             CCCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCcc---------------------------ccHHHHHHHHHHh
Q 019195            1 MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK---------------------------IDANVAREIINHK   53 (344)
Q Consensus         1 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---------------------------~~~~~~~ei~~l~   53 (344)
                      +++|++.+.||+|+||.||+|.+..+++.||+|++.....                           ....+.+|+.+++
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~   91 (298)
T 2zv2_A           12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK   91 (298)
T ss_dssp             ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred             ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence            4789999999999999999999999999999999875431                           1246889999999


Q ss_pred             cCCCCCcceeeEEEEc--CCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEe
Q 019195           54 QLRHPNIIRFKEVVLT--PTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-------QICHRDLKLENTLL  124 (344)
Q Consensus        54 ~l~h~niv~~~~~~~~--~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~  124 (344)
                      +++||||+++++++..  ...+|+||||+++++|.+++ ....+++.+++.++.|++.+       ||+||||||+|||+
T Consensus        92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~  170 (298)
T 2zv2_A           92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP-TLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLV  170 (298)
T ss_dssp             TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSS-CSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE
T ss_pred             hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEE
Confidence            9999999999999987  57899999999999998764 44678999888887776654       99999999999999


Q ss_pred             cCCCCCCEEEeecCCCcccCCCC-CCCCCccCCcccCCccccCCCC--CCcchhHHHHHHHHHHHHhCCCCCCCCCChHH
Q 019195          125 DGSPAPRLKICDFGYSKSSLLHS-RPKSTVGTPAYIAPEVLSRREY--DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKN  201 (344)
Q Consensus       125 ~~~~~~~vkL~DFg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~--~~~~~DiwslG~il~el~~g~~pf~~~~~~~~  201 (344)
                      +.++.  +||+|||+++...... ......||+.|+|||++.+...  .+.++|||||||++|+|++|+.||......  
T Consensus       171 ~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~--  246 (298)
T 2zv2_A          171 GEDGH--IKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIM--  246 (298)
T ss_dssp             CTTSC--EEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSHH--
T ss_pred             CCCCC--EEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccHH--
Confidence            76654  9999999997544322 2345679999999999976543  356799999999999999999999875432  


Q ss_pred             HHHHHHHHhhccccCCCCCCCCHhHHHHHHHhcccCCCCCCChHHHhcCcccc
Q 019195          202 FRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFL  254 (344)
Q Consensus       202 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~ell~hp~~~  254 (344)
                        .....+.......|....+++++.+||.+||+.||.+|||+.++|+||||.
T Consensus       247 --~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~~~  297 (298)
T 2zv2_A          247 --CLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVT  297 (298)
T ss_dssp             --HHHHHHHHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHHHH
T ss_pred             --HHHHHHhcccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcCcccc
Confidence              233334445555666667899999999999999999999999999999995

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=1.1e-50  Score=388.43  Aligned_cols=249  Identities=37%  Similarity=0.642  Sum_probs=211.3

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecC---ccccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEEe
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERG---HKIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVME   78 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e   78 (344)
                      ++|++++.||+|+||+||+|.+..+++.||+|++.+.   ......+.+|+.++++++||||+++++++.+...+|+|||
T Consensus        22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  101 (486)
T 3mwu_A           22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGE  101 (486)
T ss_dssp             HHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             cceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEEE
Confidence            5799999999999999999999999999999998653   2334678899999999999999999999999999999999


Q ss_pred             cCCCCChHHHHHhCCCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCC-CCCCEEEeecCCCcccCCCCCCC
Q 019195           79 YAAGGELFERICNAGRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGS-PAPRLKICDFGYSKSSLLHSRPK  150 (344)
Q Consensus        79 ~~~~g~L~~~i~~~~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~-~~~~vkL~DFg~a~~~~~~~~~~  150 (344)
                      ||.+|+|.+.+...+.+++.+++.++.||+.+       ||+||||||+|||++.. ..+.+||+|||+++.........
T Consensus       102 ~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~~~  181 (486)
T 3mwu_A          102 LYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMK  181 (486)
T ss_dssp             CCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC----
T ss_pred             cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCCCccC
Confidence            99999999999888899999999888877655       99999999999999643 33469999999998765555566


Q ss_pred             CCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccc--cCCCCCCCCHhHHH
Q 019195          151 STVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQY--KIPDYVHISQDCRN  228 (344)
Q Consensus       151 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~s~~~~~  228 (344)
                      ..+||+.|+|||++.+. + +.++|||||||++|+|++|.+||.+......+.    .+....+  ..|.+..+|+++++
T Consensus       182 ~~~gt~~y~aPE~~~~~-~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~----~i~~~~~~~~~~~~~~~s~~~~~  255 (486)
T 3mwu_A          182 DRIGTAYYIAPEVLRGT-Y-DEKCDVWSAGVILYILLSGTPPFYGKNEYDILK----RVETGKYAFDLPQWRTISDDAKD  255 (486)
T ss_dssp             CCTTGGGGCCGGGGGSC-C-CHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH----HHHHTCCCSCSGGGGGSCHHHHH
T ss_pred             CCcCCCCCCCHHHhCCC-C-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH----HHHhCCCCCCCcccCCCCHHHHH
Confidence            67899999999999764 4 566999999999999999999998876544333    3333333  34555678999999


Q ss_pred             HHHHhcccCCCCCCChHHHhcCcccccC
Q 019195          229 LLSRIFVANPSRRITIKEIKSHPWFLKN  256 (344)
Q Consensus       229 li~~~L~~dp~~R~s~~ell~hp~~~~~  256 (344)
                      ||.+||+.||.+|||+.++|+||||++.
T Consensus       256 li~~~L~~dp~~R~t~~~~l~hp~~~~~  283 (486)
T 3mwu_A          256 LIRKMLTFHPSLRITATQCLEHPWIQKY  283 (486)
T ss_dssp             HHHHHTCSSTTTSCCHHHHHHCHHHHHT
T ss_pred             HHHHHcCCChhhCcCHHHHhcCHhhccC
Confidence            9999999999999999999999999764

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=2.7e-50  Score=364.98  Aligned_cols=256  Identities=27%  Similarity=0.434  Sum_probs=194.8

Q ss_pred             CCCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCc--cccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEEe
Q 019195            1 MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH--KIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVME   78 (344)
Q Consensus         1 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e   78 (344)
                      .++|++++.||+|+||.||+|.+..+++.||+|++....  .....+.+|+.++++++||||+++++++..++.+|+|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   83 (317)
T 2pmi_A            4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE   83 (317)
T ss_dssp             ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred             ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence            368999999999999999999999999999999997543  234678899999999999999999999999999999999


Q ss_pred             cCCCCChHHHHHhC------CCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCC
Q 019195           79 YAAGGELFERICNA------GRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLL  145 (344)
Q Consensus        79 ~~~~g~L~~~i~~~------~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~  145 (344)
                      |++ ++|.+++...      ..+++..++.++.|++.+       ||+||||||+|||++.++.  +||+|||+++....
T Consensus        84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~--~kl~Dfg~~~~~~~  160 (317)
T 2pmi_A           84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQ--LKLGDFGLARAFGI  160 (317)
T ss_dssp             CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC--EEECCCSSCEETTS
T ss_pred             ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCC--EEECcCccceecCC
Confidence            997 5999988653      358888887777776654       9999999999999987664  99999999976443


Q ss_pred             C-CCCCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccc-------cC-
Q 019195          146 H-SRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQY-------KI-  216 (344)
Q Consensus       146 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~-------~~-  216 (344)
                      . ......+||+.|+|||++.+....+.++|||||||++|+|++|++||.+......+..+.........       .. 
T Consensus       161 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  240 (317)
T 2pmi_A          161 PVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLP  240 (317)
T ss_dssp             CCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGGCT
T ss_pred             CcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhhhh
Confidence            2 23345679999999999987554566699999999999999999999987766655554443221100       00 


Q ss_pred             --------------------CCCCCCCHhHHHHHHHhcccCCCCCCChHHHhcCcccccCCCh
Q 019195          217 --------------------PDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLPR  259 (344)
Q Consensus       217 --------------------~~~~~~s~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~~~~~  259 (344)
                                          .....+++++.+||.+||+.||.+|||+.++|+||||.+....
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~  303 (317)
T 2pmi_A          241 KYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYYHH  303 (317)
T ss_dssp             TCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCC-
T ss_pred             hcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhcccch
Confidence                                0112478899999999999999999999999999999876543

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=1.9e-50  Score=370.79  Aligned_cols=252  Identities=34%  Similarity=0.593  Sum_probs=196.4

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEEecCC
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYAA   81 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~   81 (344)
                      ++|++.+.||+|+||.||+|.+..+++.||+|++.... ....+.+|+.++++++||||+++++++...+.+++||||++
T Consensus        53 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  131 (349)
T 2w4o_A           53 DFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV-DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVT  131 (349)
T ss_dssp             GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC-----------CHHHHHCCCTTBCCEEEEEECSSEEEEEECCCC
T ss_pred             CcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch-hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEeCC
Confidence            46999999999999999999999999999999997643 34567899999999999999999999999999999999999


Q ss_pred             CCChHHHHHhCCCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecC-CCCCCEEEeecCCCcccCCCCCCCCCc
Q 019195           82 GGELFERICNAGRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDG-SPAPRLKICDFGYSKSSLLHSRPKSTV  153 (344)
Q Consensus        82 ~g~L~~~i~~~~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~-~~~~~vkL~DFg~a~~~~~~~~~~~~~  153 (344)
                      +++|.+++...+.+++.+++.++.|++.+       ||+||||||+|||++. +..+.+||+|||+++...........+
T Consensus       132 ~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~  211 (349)
T 2w4o_A          132 GGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVC  211 (349)
T ss_dssp             SCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC---------------
T ss_pred             CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccCccccccccc
Confidence            99999999888889999988888877655       9999999999999975 234569999999998655444455678


Q ss_pred             cCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccC--CCCCCCCHhHHHHHH
Q 019195          154 GTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKI--PDYVHISQDCRNLLS  231 (344)
Q Consensus       154 gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~s~~~~~li~  231 (344)
                      ||+.|+|||++.+..++ .++|||||||++|+|++|..||.........   ...+.......  +.+..++.++.+||.
T Consensus       212 gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~pf~~~~~~~~~---~~~i~~~~~~~~~~~~~~~~~~~~~li~  287 (349)
T 2w4o_A          212 GTPGYCAPEILRGCAYG-PEVDMWSVGIITYILLCGFEPFYDERGDQFM---FRRILNCEYYFISPWWDEVSLNAKDLVR  287 (349)
T ss_dssp             -CGGGSCHHHHTTCCCC-THHHHHHHHHHHHHHHHSSCTTCCTTCHHHH---HHHHHTTCCCCCTTTTTTSCHHHHHHHH
T ss_pred             CCCCccCHHHhcCCCCC-cccchHHHHHHHHHHHhCCCCCCCCcccHHH---HHHHHhCCCccCCchhhhCCHHHHHHHH
Confidence            99999999999887764 5599999999999999999999876654322   22333333322  334578999999999


Q ss_pred             HhcccCCCCCCChHHHhcCcccccCCC
Q 019195          232 RIFVANPSRRITIKEIKSHPWFLKNLP  258 (344)
Q Consensus       232 ~~L~~dp~~R~s~~ell~hp~~~~~~~  258 (344)
                      +||+.||.+|||+.++|+||||.....
T Consensus       288 ~~L~~dP~~Rpt~~e~l~hp~~~~~~~  314 (349)
T 2w4o_A          288 KLIVLDPKKRLTTFQALQHPWVTGKAA  314 (349)
T ss_dssp             TTSCSSGGGSCCHHHHHHSTTTTSTTC
T ss_pred             HHccCChhhCcCHHHHhcCcccCCCcc
Confidence            999999999999999999999986543

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=1.8e-50  Score=380.36  Aligned_cols=255  Identities=27%  Similarity=0.492  Sum_probs=211.0

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCc----cccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEE
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH----KIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVM   77 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~   77 (344)
                      ++|++++.||+|+||+||+|++..+++.||+|++.+..    .....+.+|+.+++.++||||++++++|.+.+.+|+||
T Consensus        74 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lV~  153 (437)
T 4aw2_A           74 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVM  153 (437)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEE
T ss_pred             hheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEEEEE
Confidence            68999999999999999999999999999999997522    22345889999999999999999999999999999999


Q ss_pred             ecCCCCChHHHHHh-CCCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCCC-
Q 019195           78 EYAAGGELFERICN-AGRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR-  148 (344)
Q Consensus        78 e~~~~g~L~~~i~~-~~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~~-  148 (344)
                      |||+||+|.+++.+ .+.+++..++.++.|++.+       ||+||||||+|||++.++.  +||+|||+|+....... 
T Consensus       154 Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~--vkL~DFGla~~~~~~~~~  231 (437)
T 4aw2_A          154 DYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGH--IRLADFGSCLKLMEDGTV  231 (437)
T ss_dssp             CCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC--EEECCCTTCEECCTTSCE
T ss_pred             ecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCC--EEEcchhhhhhcccCCCc
Confidence            99999999999987 5789999988888776654       9999999999999987664  99999999975433322 


Q ss_pred             -CCCCccCCcccCCccccC----CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCCCC-CCC
Q 019195          149 -PKSTVGTPAYIAPEVLSR----REYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDY-VHI  222 (344)
Q Consensus       149 -~~~~~gt~~y~aPE~~~~----~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~  222 (344)
                       ....+||+.|+|||++..    ....+.++|||||||++|+|++|++||...+....+.+++...  ..+.+|.. ..+
T Consensus       232 ~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~--~~~~~p~~~~~~  309 (437)
T 4aw2_A          232 QSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHK--ERFQFPTQVTDV  309 (437)
T ss_dssp             ECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHH--HHCCCCSSCCCS
T ss_pred             ccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhcc--ccccCCcccccC
Confidence             234689999999999862    2333556999999999999999999999876655555544322  12334432 458


Q ss_pred             CHhHHHHHHHhcccCCCC--CCChHHHhcCcccccCCChh
Q 019195          223 SQDCRNLLSRIFVANPSR--RITIKEIKSHPWFLKNLPRE  260 (344)
Q Consensus       223 s~~~~~li~~~L~~dp~~--R~s~~ell~hp~~~~~~~~~  260 (344)
                      ++++++||++||+.+|.+  |+++.++++||||...-...
T Consensus       310 s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~i~w~~  349 (437)
T 4aw2_A          310 SENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGIDWDN  349 (437)
T ss_dssp             CHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTTCCTTT
T ss_pred             CHHHHHHHHHHhcccccccCCCCHHHHhCCCccCCCCHHH
Confidence            999999999999998888  99999999999998754433

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.6e-50  Score=376.46  Aligned_cols=254  Identities=29%  Similarity=0.415  Sum_probs=195.1

Q ss_pred             CCCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCcc---ccHHHHHHHHHHhcCC-CCCcceeeEEEEcCC--EEE
Q 019195            1 MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK---IDANVAREIINHKQLR-HPNIIRFKEVVLTPT--HLA   74 (344)
Q Consensus         1 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~ei~~l~~l~-h~niv~~~~~~~~~~--~~~   74 (344)
                      +++|++++.||+|+||.||+|.+..+++.||+|++.....   ....+.+|+.+++.+. ||||+++++++...+  .+|
T Consensus         8 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~   87 (388)
T 3oz6_A            8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVY   87 (388)
T ss_dssp             HTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEE
T ss_pred             cCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEE
Confidence            3689999999999999999999999999999999865432   2356789999999997 999999999998654  799


Q ss_pred             EEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHH-------HCCeeecCCCCCCeEecCCCCCCEEEeecCCCcccCC--
Q 019195           75 IVMEYAAGGELFERICNAGRFSEDEARYFFQQLI-------SGQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLL--  145 (344)
Q Consensus        75 lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~ql~-------~~~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~--  145 (344)
                      +|||||. ++|..++.. +.+++..++.++.||+       +.||+||||||+|||++.++.  +||+|||+|+....  
T Consensus        88 lv~e~~~-~~L~~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~--~kl~DFG~a~~~~~~~  163 (388)
T 3oz6_A           88 LVFDYME-TDLHAVIRA-NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECH--VKVADFGLSRSFVNIR  163 (388)
T ss_dssp             EEEECCS-EEHHHHHHH-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC--EEECCCTTCEESSSCC
T ss_pred             EEecccC-cCHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCC--EEecCCcccccccccc
Confidence            9999996 689888865 5788888777766655       459999999999999987664  99999999975422  


Q ss_pred             --------------------CCCCCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHH
Q 019195          146 --------------------HSRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKT  205 (344)
Q Consensus       146 --------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~  205 (344)
                                          .......+||+.|+|||++.+....+.++|||||||++|+|++|++||.+.+....+..+
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i  243 (388)
T 3oz6_A          164 RVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERI  243 (388)
T ss_dssp             CCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH
T ss_pred             cccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence                                111234579999999999987555567799999999999999999999988766665555


Q ss_pred             HHHHhhccc-----------------------------------------cCCCCCCCCHhHHHHHHHhcccCCCCCCCh
Q 019195          206 ISRIMAVQY-----------------------------------------KIPDYVHISQDCRNLLSRIFVANPSRRITI  244 (344)
Q Consensus       206 ~~~~~~~~~-----------------------------------------~~~~~~~~s~~~~~li~~~L~~dp~~R~s~  244 (344)
                      +..+.....                                         .......+++++.+||.+||+.||.+|||+
T Consensus       244 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t~  323 (388)
T 3oz6_A          244 IGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISA  323 (388)
T ss_dssp             HHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCCH
T ss_pred             HHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCCCH
Confidence            432211100                                         001112578999999999999999999999


Q ss_pred             HHHhcCcccccCCC
Q 019195          245 KEIKSHPWFLKNLP  258 (344)
Q Consensus       245 ~ell~hp~~~~~~~  258 (344)
                      .|+|+||||.....
T Consensus       324 ~e~l~Hp~~~~~~~  337 (388)
T 3oz6_A          324 NDALKHPFVSIFHN  337 (388)
T ss_dssp             HHHTTSTTTTTTCC
T ss_pred             HHHhCCHHHHHhcC
Confidence            99999999976544

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=6.6e-50  Score=361.07  Aligned_cols=255  Identities=29%  Similarity=0.432  Sum_probs=204.3

Q ss_pred             CCCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCccc---cHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEE
Q 019195            1 MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKI---DANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVM   77 (344)
Q Consensus         1 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~   77 (344)
                      +++|++++.||+|+||+||+|.+..+++.||+|++......   ...+.+|+.++++++||||+++++++...+.+++||
T Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   81 (311)
T 4agu_A            2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVF   81 (311)
T ss_dssp             -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEE
Confidence            58999999999999999999999999999999998664432   356778999999999999999999999999999999


Q ss_pred             ecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCC-CCC
Q 019195           78 EYAAGGELFERICNAGRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH-SRP  149 (344)
Q Consensus        78 e~~~~g~L~~~i~~~~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~-~~~  149 (344)
                      ||+++++|..++...+.+++..++.++.|++.+       ||+||||||+||+++.++.  +||+|||++...... ...
T Consensus        82 e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~~  159 (311)
T 4agu_A           82 EYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSV--IKLCDFGFARLLTGPSDYY  159 (311)
T ss_dssp             ECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC--EEECCCTTCEECC------
T ss_pred             EeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCC--EEEeeCCCchhccCccccc
Confidence            999999999998888889999888887776654       9999999999999976654  999999999764422 223


Q ss_pred             CCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhc---------------cc
Q 019195          150 KSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAV---------------QY  214 (344)
Q Consensus       150 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~---------------~~  214 (344)
                      ...+||+.|+|||++.+....+.++|||||||++|+|++|++||.+.........+.......               ..
T Consensus       160 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (311)
T 4agu_A          160 DDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGV  239 (311)
T ss_dssp             ------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTTC
T ss_pred             CCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccccccC
Confidence            456799999999999875555667999999999999999999998877655544333221110               01


Q ss_pred             cCCC----------CCCCCHhHHHHHHHhcccCCCCCCChHHHhcCcccccCC
Q 019195          215 KIPD----------YVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNL  257 (344)
Q Consensus       215 ~~~~----------~~~~s~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~~~  257 (344)
                      ..+.          ...+++++.+||.+||+.||.+|||+.++|+||||++..
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~  292 (311)
T 4agu_A          240 KIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIR  292 (311)
T ss_dssp             CCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred             cCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhcc
Confidence            1111          135788999999999999999999999999999997653

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=1.3e-49  Score=354.47  Aligned_cols=252  Identities=32%  Similarity=0.582  Sum_probs=213.9

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCccc---cHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEEe
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKI---DANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVME   78 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e   78 (344)
                      ++|++.+.||+|+||.||+|.+..+++.||+|++......   ...+.+|+.++++++||||+++++++...+..++|||
T Consensus         6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   85 (284)
T 3kk8_A            6 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFD   85 (284)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             hhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEEe
Confidence            6899999999999999999999999999999999764322   2567899999999999999999999999999999999


Q ss_pred             cCCCCChHHHHHhCCCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCC-CCCEEEeecCCCcccCCCCCCC
Q 019195           79 YAAGGELFERICNAGRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSP-APRLKICDFGYSKSSLLHSRPK  150 (344)
Q Consensus        79 ~~~~g~L~~~i~~~~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~-~~~vkL~DFg~a~~~~~~~~~~  150 (344)
                      |+++++|.+.+.....+++..++.++.|++.+       ||+||||||+||+++.++ .+.+||+|||++..........
T Consensus        86 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~~  165 (284)
T 3kk8_A           86 LVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWH  165 (284)
T ss_dssp             CCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSSCBCC
T ss_pred             cCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccCcccc
Confidence            99999999999888889999988887776654       999999999999997543 2459999999997665555556


Q ss_pred             CCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccc--cCCCCCCCCHhHHH
Q 019195          151 STVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQY--KIPDYVHISQDCRN  228 (344)
Q Consensus       151 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~s~~~~~  228 (344)
                      ...||+.|+|||++.+..++ .++||||||+++|+|++|+.||...........    +.....  ..+.+..+++++.+
T Consensus       166 ~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~  240 (284)
T 3kk8_A          166 GFAGTPGYLSPEVLKKDPYS-KPVDIWACGVILYILLVGYPPFWDEDQHRLYAQ----IKAGAYDYPSPEWDTVTPEAKS  240 (284)
T ss_dssp             CSCSCGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH----HHHTCCCCCTTTTTTSCHHHHH
T ss_pred             CCCCCcCCcCchhhcCCCCC-cccchHHHHHHHHHHHHCCCCCCCCchhHHHHH----HHhccccCCchhhcccCHHHHH
Confidence            67899999999999887764 459999999999999999999987665433332    223333  33344578999999


Q ss_pred             HHHHhcccCCCCCCChHHHhcCcccccCCC
Q 019195          229 LLSRIFVANPSRRITIKEIKSHPWFLKNLP  258 (344)
Q Consensus       229 li~~~L~~dp~~R~s~~ell~hp~~~~~~~  258 (344)
                      ||.+||+.||.+|||+.++|+||||.....
T Consensus       241 li~~~l~~dp~~Rps~~~~l~h~~~~~~~~  270 (284)
T 3kk8_A          241 LIDSMLTVNPKKRITADQALKVPWICNRER  270 (284)
T ss_dssp             HHHHHSCSSTTTSCCHHHHTTSHHHHSCCC
T ss_pred             HHHHHcccChhhCCCHHHHhcCccccCChh
Confidence            999999999999999999999999976543

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=2.4e-50  Score=386.63  Aligned_cols=249  Identities=35%  Similarity=0.604  Sum_probs=208.9

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCc---cccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEEe
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH---KIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVME   78 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e   78 (344)
                      ++|++++.||+|+||+||+|.+..++..||+|++.+..   .....+.+|+.+++.++||||+++++++.+...+|+|||
T Consensus        37 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  116 (494)
T 3lij_A           37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVME  116 (494)
T ss_dssp             HHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             cCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence            36999999999999999999999999999999997643   335678999999999999999999999999999999999


Q ss_pred             cCCCCChHHHHHhCCCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCC-CCCEEEeecCCCcccCCCCCCC
Q 019195           79 YAAGGELFERICNAGRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSP-APRLKICDFGYSKSSLLHSRPK  150 (344)
Q Consensus        79 ~~~~g~L~~~i~~~~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~-~~~vkL~DFg~a~~~~~~~~~~  150 (344)
                      ||++|+|.+.+.....+++.+++.++.||+.+       ||+||||||+|||++... .+.+||+|||++..........
T Consensus       117 ~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~~~~~  196 (494)
T 3lij_A          117 CYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMK  196 (494)
T ss_dssp             CCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTTBCBC
T ss_pred             cCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCCcccc
Confidence            99999999999888899999888888776655       999999999999997533 3469999999998766555556


Q ss_pred             CCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhcccc--CCCCCCCCHhHHH
Q 019195          151 STVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYK--IPDYVHISQDCRN  228 (344)
Q Consensus       151 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~s~~~~~  228 (344)
                      ..+||+.|+|||++.+ .+ +.++|||||||++|+|++|.+||.+......+    ..+....+.  .+.+..+++.+.+
T Consensus       197 ~~~gt~~y~aPE~l~~-~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~----~~i~~~~~~~~~~~~~~~s~~~~~  270 (494)
T 3lij_A          197 ERLGTAYYIAPEVLRK-KY-DEKCDVWSIGVILFILLAGYPPFGGQTDQEIL----RKVEKGKYTFDSPEWKNVSEGAKD  270 (494)
T ss_dssp             CCCSCTTTCCHHHHTT-CB-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH----HHHHHTCCCCCSGGGTTSCHHHHH
T ss_pred             ccCCCcCeeCHHHHcc-cC-CCchhHHHHHHHHHHHHhCCCCCCCCCHHHHH----HHHHhCCCCCCchhcccCCHHHHH
Confidence            6789999999999864 44 45699999999999999999999887654433    333333333  3445678999999


Q ss_pred             HHHHhcccCCCCCCChHHHhcCcccccC
Q 019195          229 LLSRIFVANPSRRITIKEIKSHPWFLKN  256 (344)
Q Consensus       229 li~~~L~~dp~~R~s~~ell~hp~~~~~  256 (344)
                      ||.+||+.||.+|||+.++|+||||++.
T Consensus       271 li~~~L~~dp~~R~s~~e~l~hp~~~~~  298 (494)
T 3lij_A          271 LIKQMLQFDSQRRISAQQALEHPWIKEM  298 (494)
T ss_dssp             HHHHHTCSSTTTSCCHHHHHTCHHHHHH
T ss_pred             HHHHHCCCChhhCccHHHHhcCcccccC
Confidence            9999999999999999999999999753

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=2.8e-50  Score=372.23  Aligned_cols=248  Identities=31%  Similarity=0.534  Sum_probs=202.9

Q ss_pred             CCCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCcc----ccHHHHHHHHH-HhcCCCCCcceeeEEEEcCCEEEE
Q 019195            1 MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK----IDANVAREIIN-HKQLRHPNIIRFKEVVLTPTHLAI   75 (344)
Q Consensus         1 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~ei~~-l~~l~h~niv~~~~~~~~~~~~~l   75 (344)
                      +++|++++.||+|+||.||+|++..+++.||+|++.+...    ....+.+|..+ ++.++||||++++++|.+.+.+|+
T Consensus        37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l  116 (373)
T 2r5t_A           37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF  116 (373)
T ss_dssp             GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence            3689999999999999999999999999999999976432    22445667666 577899999999999999999999


Q ss_pred             EEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHH-------CCeeecCCCCCCeEecCCCCCCEEEeecCCCcccC-CCC
Q 019195           76 VMEYAAGGELFERICNAGRFSEDEARYFFQQLIS-------GQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSL-LHS  147 (344)
Q Consensus        76 v~e~~~~g~L~~~i~~~~~~~~~~~~~~~~ql~~-------~~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~-~~~  147 (344)
                      ||||++||+|..++.+.+.+++..++.++.||+.       .||+||||||+|||++.++  ++||+|||+++... ...
T Consensus       117 v~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g--~ikL~DFG~a~~~~~~~~  194 (373)
T 2r5t_A          117 VLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQG--HIVLTDFGLCKENIEHNS  194 (373)
T ss_dssp             EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTS--CEEECCCCBCGGGBCCCC
T ss_pred             EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCC--CEEEeeCccccccccCCC
Confidence            9999999999999998889999988888777665       4999999999999997765  49999999998633 333


Q ss_pred             CCCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCHhHH
Q 019195          148 RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCR  227 (344)
Q Consensus       148 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~  227 (344)
                      .....+||+.|+|||++.+..++ .++|||||||++|+|++|.+||...+....+    ..+......++.  .+++.+.
T Consensus       195 ~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~G~~Pf~~~~~~~~~----~~i~~~~~~~~~--~~~~~~~  267 (373)
T 2r5t_A          195 TTSTFCGTPEYLAPEVLHKQPYD-RTVDWWCLGAVLYEMLYGLPPFYSRNTAEMY----DNILNKPLQLKP--NITNSAR  267 (373)
T ss_dssp             CCCSBSCCCCCCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSSCTTCCSBHHHHH----HHHHHSCCCCCS--SSCHHHH
T ss_pred             ccccccCCccccCHHHhCCCCCC-chhhhHHHHHHHHHHHcCCCCCCCCCHHHHH----HHHHhcccCCCC--CCCHHHH
Confidence            45567899999999999887765 5599999999999999999999876554433    334444444443  6899999


Q ss_pred             HHHHHhcccCCCCCCCh----HHHhcCcccccCC
Q 019195          228 NLLSRIFVANPSRRITI----KEIKSHPWFLKNL  257 (344)
Q Consensus       228 ~li~~~L~~dp~~R~s~----~ell~hp~~~~~~  257 (344)
                      +||.+||+.||.+||++    .++++||||...-
T Consensus       268 ~li~~lL~~dp~~R~~~~~~~~~i~~h~~f~~~~  301 (373)
T 2r5t_A          268 HLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSLIN  301 (373)
T ss_dssp             HHHHHHTCSSGGGSTTTTTTHHHHHTSGGGTTCC
T ss_pred             HHHHHHcccCHHhCCCCCCCHHHHhCCccccCCC
Confidence            99999999999999987    6999999997653

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=2.4e-50  Score=381.94  Aligned_cols=247  Identities=36%  Similarity=0.604  Sum_probs=201.0

Q ss_pred             CCCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecC----ccccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEE
Q 019195            1 MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERG----HKIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIV   76 (344)
Q Consensus         1 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv   76 (344)
                      +++|++++.||+|+||.||+|.+..+++.||+|++...    ......+.+|+.+++.++||||+++++++...+.+|+|
T Consensus       147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv  226 (446)
T 4ejn_A          147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV  226 (446)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred             hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence            36899999999999999999999999999999999753    22335677899999999999999999999999999999


Q ss_pred             EecCCCCChHHHHHhCCCCCHHHHHHHHHHHH-------H-CCeeecCCCCCCeEecCCCCCCEEEeecCCCcccC-CCC
Q 019195           77 MEYAAGGELFERICNAGRFSEDEARYFFQQLI-------S-GQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSL-LHS  147 (344)
Q Consensus        77 ~e~~~~g~L~~~i~~~~~~~~~~~~~~~~ql~-------~-~~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~-~~~  147 (344)
                      |||+++|+|..++...+.+++..++.++.||+       + .||+||||||+|||++.++.  +||+|||+++... ...
T Consensus       227 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~--~kl~DFG~a~~~~~~~~  304 (446)
T 4ejn_A          227 MEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGH--IKITDFGLCKEGIKDGA  304 (446)
T ss_dssp             ECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSC--EEECCCCCCCTTCC---
T ss_pred             EeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCC--EEEccCCCceeccCCCc
Confidence            99999999999999888999998888766655       4 59999999999999987664  9999999997533 233


Q ss_pred             CCCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCHhHH
Q 019195          148 RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCR  227 (344)
Q Consensus       148 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~  227 (344)
                      .....+||+.|+|||++.+..++ .++|||||||++|+|++|+.||........+    ..+......+|.  .+++++.
T Consensus       305 ~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~Pf~~~~~~~~~----~~i~~~~~~~p~--~~~~~~~  377 (446)
T 4ejn_A          305 TMKTFCGTPEYLAPEVLEDNDYG-RAVDWWGLGVVMYEMMCGRLPFYNQDHEKLF----ELILMEEIRFPR--TLGPEAK  377 (446)
T ss_dssp             --CCSSSCGGGCCHHHHHTSCCC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHH----HHHHHCCCCCCT--TSCHHHH
T ss_pred             ccccccCCccccCHhhcCCCCCC-CccchhhhHHHHHHHhhCCCCCCCCCHHHHH----HHHHhCCCCCCc--cCCHHHH
Confidence            34567899999999999887775 5599999999999999999999876554333    333344444554  6899999


Q ss_pred             HHHHHhcccCCCCCC-----ChHHHhcCcccccC
Q 019195          228 NLLSRIFVANPSRRI-----TIKEIKSHPWFLKN  256 (344)
Q Consensus       228 ~li~~~L~~dp~~R~-----s~~ell~hp~~~~~  256 (344)
                      +||.+||+.||.+||     |+.++++||||...
T Consensus       378 ~li~~~L~~dP~~R~~~~~~t~~ell~hp~f~~~  411 (446)
T 4ejn_A          378 SLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGI  411 (446)
T ss_dssp             HHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred             HHHHHHcccCHHHhCCCCCCCHHHHHhCccccCC
Confidence            999999999999999     99999999999764

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=4e-50  Score=368.91  Aligned_cols=248  Identities=31%  Similarity=0.576  Sum_probs=204.6

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCc------cccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEE
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH------KIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAI   75 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~l   75 (344)
                      ++|++.+.||+|+||+||+|.+..+++.||+|++....      .....+.+|+.+++.++||||+++++++..++.+|+
T Consensus        24 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l  103 (351)
T 3c0i_A           24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYM  103 (351)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             cceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence            46999999999999999999999999999999986421      134678999999999999999999999999999999


Q ss_pred             EEecCCCCChHHHHHhC----CCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCC-CCCEEEeecCCCccc
Q 019195           76 VMEYAAGGELFERICNA----GRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSP-APRLKICDFGYSKSS  143 (344)
Q Consensus        76 v~e~~~~g~L~~~i~~~----~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~-~~~vkL~DFg~a~~~  143 (344)
                      |||||++++|.+.+.+.    ..+++..++.++.||+.+       ||+||||||+|||++.++ ...+||+|||++...
T Consensus       104 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~~  183 (351)
T 3c0i_A          104 VFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQL  183 (351)
T ss_dssp             EEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTTCEEC
T ss_pred             EEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCcceeEe
Confidence            99999999998887543    358888888887776654       999999999999997543 345999999999765


Q ss_pred             CCCCC-CCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCC--CCC
Q 019195          144 LLHSR-PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIP--DYV  220 (344)
Q Consensus       144 ~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~  220 (344)
                      ..... ....+||+.|+|||++.+..++ .++|||||||++|+|++|..||.....     .....+....+..+  .+.
T Consensus       184 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~~ll~g~~pf~~~~~-----~~~~~i~~~~~~~~~~~~~  257 (351)
T 3c0i_A          184 GESGLVAGGRVGTPHFMAPEVVKREPYG-KPVDVWGCGVILFILLSGCLPFYGTKE-----RLFEGIIKGKYKMNPRQWS  257 (351)
T ss_dssp             CTTSCBCCCCCSCGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCSSCSSHH-----HHHHHHHHTCCCCCHHHHT
T ss_pred             cCCCeeecCCcCCcCccCHHHHcCCCCC-chHhhHHHHHHHHHHHHCCCCCCCcHH-----HHHHHHHcCCCCCCccccc
Confidence            43322 3456799999999999887764 559999999999999999999987421     22333333333322  234


Q ss_pred             CCCHhHHHHHHHhcccCCCCCCChHHHhcCccccc
Q 019195          221 HISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLK  255 (344)
Q Consensus       221 ~~s~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~  255 (344)
                      .+++++.+||.+||+.||.+|||+.++|+||||..
T Consensus       258 ~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~  292 (351)
T 3c0i_A          258 HISESAKDLVRRMLMLDPAERITVYEALNHPWLKE  292 (351)
T ss_dssp             TSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHT
T ss_pred             cCCHHHHHHHHHHCCCChhHCcCHHHHhcChhhcC
Confidence            68999999999999999999999999999999964

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=1.1e-49  Score=359.43  Aligned_cols=251  Identities=25%  Similarity=0.412  Sum_probs=204.9

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCc------cccHHHHHHHHHHhcCC---CCCcceeeEEEEcCC-
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH------KIDANVAREIINHKQLR---HPNIIRFKEVVLTPT-   71 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~~~~ei~~l~~l~---h~niv~~~~~~~~~~-   71 (344)
                      ++|++++.||+|+||+||+|.+..+++.||+|++....      .....+.+|+.+++.++   ||||+++++++.... 
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~~   88 (308)
T 3g33_A            9 SRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSRT   88 (308)
T ss_dssp             -CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECCS
T ss_pred             cceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccCC
Confidence            68999999999999999999999999999999987432      23356778888887774   999999999998765 


Q ss_pred             ----EEEEEEecCCCCChHHHHHhCCC--CCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecC
Q 019195           72 ----HLAIVMEYAAGGELFERICNAGR--FSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFG  138 (344)
Q Consensus        72 ----~~~lv~e~~~~g~L~~~i~~~~~--~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg  138 (344)
                          .++++|||+. ++|.+++.....  +++.+++.++.|++.+       ||+||||||+|||++.++.  +||+|||
T Consensus        89 ~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~--~kl~Dfg  165 (308)
T 3g33_A           89 DREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGT--VKLADFG  165 (308)
T ss_dssp             SSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSC--EEECSCS
T ss_pred             CCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCC--EEEeeCc
Confidence                5899999996 699999987654  8999998888887655       9999999999999976664  9999999


Q ss_pred             CCcccCCCCCCCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhcccc-CC
Q 019195          139 YSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYK-IP  217 (344)
Q Consensus       139 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~-~~  217 (344)
                      +++...........+||+.|+|||++.+..++ .++|||||||++|+|++|++||...........+.......... .+
T Consensus       166 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  244 (308)
T 3g33_A          166 LARIYSYQMALTPVVVTLWYRAPEVLLQSTYA-TPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWP  244 (308)
T ss_dssp             CTTTSTTCCCSGGGGCCCSSCCHHHHHTSCCC-STHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTTTSC
T ss_pred             cccccCCCcccCCccccccccCchHHcCCCCC-chHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcc
Confidence            99876555555667899999999999887765 45999999999999999999999887766665555433211110 00


Q ss_pred             --------------------CCCCCCHhHHHHHHHhcccCCCCCCChHHHhcCcccccC
Q 019195          218 --------------------DYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKN  256 (344)
Q Consensus       218 --------------------~~~~~s~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~~  256 (344)
                                          ....+++.+.+||.+||+.||.+|||+.++|+||||.+.
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~  303 (308)
T 3g33_A          245 RDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKD  303 (308)
T ss_dssp             SSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC---
T ss_pred             chhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccCC
Confidence                                012478899999999999999999999999999999764

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=5.5e-50  Score=364.51  Aligned_cols=246  Identities=32%  Similarity=0.569  Sum_probs=200.0

Q ss_pred             CCceeeeeeeecCceEEEEEEEc---CCCcEEEEEEeecCc-----cccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEE
Q 019195            2 EKYELMKDIGSGNFGVARLMRNK---NTKELVAMKYIERGH-----KIDANVAREIINHKQLRHPNIIRFKEVVLTPTHL   73 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~-----~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~   73 (344)
                      ++|++++.||+|+||.||+|.+.   .+++.||+|++.+..     .....+.+|+.+++.++||||+++++++...+.+
T Consensus        17 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~   96 (327)
T 3a62_A           17 ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKL   96 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSCE
T ss_pred             HHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCEE
Confidence            68999999999999999999985   689999999997642     2234577899999999999999999999999999


Q ss_pred             EEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHH-------CCeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCC
Q 019195           74 AIVMEYAAGGELFERICNAGRFSEDEARYFFQQLIS-------GQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH  146 (344)
Q Consensus        74 ~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~ql~~-------~~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~  146 (344)
                      |+||||+++++|.+++...+.+++..++.++.||+.       .||+||||||+|||++.++  ++||+|||+++.....
T Consensus        97 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~--~~kl~Dfg~~~~~~~~  174 (327)
T 3a62_A           97 YLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQG--HVKLTDFGLCKESIHD  174 (327)
T ss_dssp             EEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTS--CEEECCCSCC------
T ss_pred             EEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCC--cEEEEeCCcccccccC
Confidence            999999999999999998888999988888777665       4999999999999997665  4999999998753322


Q ss_pred             -CCCCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCHh
Q 019195          147 -SRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQD  225 (344)
Q Consensus       147 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~  225 (344)
                       ......+||+.|+|||++.+..++ .++|||||||++|+|++|+.||.........    ..+......+|.  .++++
T Consensus       175 ~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~el~~g~~pf~~~~~~~~~----~~i~~~~~~~p~--~~~~~  247 (327)
T 3a62_A          175 GTVTHTFCGTIEYMAPEILMRSGHN-RAVDWWSLGALMYDMLTGAPPFTGENRKKTI----DKILKCKLNLPP--YLTQE  247 (327)
T ss_dssp             ----CTTSSCCTTSCHHHHTTSCCC-THHHHHHHHHHHHHHHHSSCSCCCSSHHHHH----HHHHHTCCCCCT--TSCHH
T ss_pred             CccccccCCCcCccCHhhCcCCCCC-CcccchhHHHHHHHHHHCCCCCCCCCHHHHH----HHHHhCCCCCCC--CCCHH
Confidence             234456799999999999877764 5599999999999999999999876654333    334444444443  68999


Q ss_pred             HHHHHHHhcccCCCCCC-----ChHHHhcCcccccC
Q 019195          226 CRNLLSRIFVANPSRRI-----TIKEIKSHPWFLKN  256 (344)
Q Consensus       226 ~~~li~~~L~~dp~~R~-----s~~ell~hp~~~~~  256 (344)
                      +.+||.+||+.||.+||     ++.++++||||...
T Consensus       248 ~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~~  283 (327)
T 3a62_A          248 ARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHI  283 (327)
T ss_dssp             HHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSSC
T ss_pred             HHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcccCC
Confidence            99999999999999999     88999999999764

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=2.8e-50  Score=388.39  Aligned_cols=250  Identities=27%  Similarity=0.437  Sum_probs=212.7

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCc----cccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEE
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH----KIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVM   77 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~   77 (344)
                      ++|++++.||+|+||.||+|.+..+|+.||+|++.+..    .....+.+|+.+++.++||||+++++++.+.+.+|+||
T Consensus       184 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVm  263 (576)
T 2acx_A          184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVL  263 (576)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEEE
Confidence            57999999999999999999999999999999997532    23456889999999999999999999999999999999


Q ss_pred             ecCCCCChHHHHHhCCC--CCHHHHHHHHHHHHH-------CCeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCCC
Q 019195           78 EYAAGGELFERICNAGR--FSEDEARYFFQQLIS-------GQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR  148 (344)
Q Consensus        78 e~~~~g~L~~~i~~~~~--~~~~~~~~~~~ql~~-------~~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~~  148 (344)
                      ||++||+|..++...+.  +++..++.++.||+.       .||+||||||+|||++.++  ++||+|||+++.......
T Consensus       264 Ey~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g--~vKL~DFGla~~~~~~~~  341 (576)
T 2acx_A          264 TLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHG--HIRISDLGLAVHVPEGQT  341 (576)
T ss_dssp             CCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTS--CEEECCCTTCEECCTTCC
T ss_pred             EcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCC--CeEEEecccceecccCcc
Confidence            99999999999987554  899988888777665       4999999999999998665  499999999986654444


Q ss_pred             CCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCHhHHH
Q 019195          149 PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRN  228 (344)
Q Consensus       149 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~  228 (344)
                      ....+||+.|+|||++.+..++ .++|||||||++|+|++|++||...........+...+......++  ..+++++.+
T Consensus       342 ~~~~~GT~~Y~APEvl~~~~~~-~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~~~~p--~~~s~~~~d  418 (576)
T 2acx_A          342 IKGRVGTVGYMAPEVVKNERYT-FSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYS--ERFSPQARS  418 (576)
T ss_dssp             EECCCSCGGGCCHHHHTTCEES-SHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCCCCCC--TTSCHHHHH
T ss_pred             ccccCCCccccCHHHHcCCCCC-ccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcccccCC--ccCCHHHHH
Confidence            4567899999999999887765 5599999999999999999999876543333444444554554444  368999999


Q ss_pred             HHHHhcccCCCCCC-----ChHHHhcCcccccC
Q 019195          229 LLSRIFVANPSRRI-----TIKEIKSHPWFLKN  256 (344)
Q Consensus       229 li~~~L~~dp~~R~-----s~~ell~hp~~~~~  256 (344)
                      ||.+||+.||.+||     ++.++++||||...
T Consensus       419 LI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~i  451 (576)
T 2acx_A          419 LCSQLLCKDPAERLGCRGGSAREVKEHPLFKKL  451 (576)
T ss_dssp             HHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTTC
T ss_pred             HHHHhccCCHHHcCCCCCCCHHHHHhChhhccC
Confidence            99999999999999     79999999999764

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=2e-50  Score=366.90  Aligned_cols=254  Identities=26%  Similarity=0.430  Sum_probs=200.3

Q ss_pred             CCCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCccc--cHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEEe
Q 019195            1 MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKI--DANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVME   78 (344)
Q Consensus         1 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e   78 (344)
                      |++|++++.||+|+||+||+|.+..+++.||+|++......  ...+.+|+.+++.++||||+++++++...+.+++|||
T Consensus         1 l~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (324)
T 3mtl_A            1 METYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFE   80 (324)
T ss_dssp             CCSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred             CCceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEec
Confidence            68999999999999999999999999999999998754321  2245579999999999999999999999999999999


Q ss_pred             cCCCCChHHHHHhCC-CCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCC-CC
Q 019195           79 YAAGGELFERICNAG-RFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS-RP  149 (344)
Q Consensus        79 ~~~~g~L~~~i~~~~-~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~-~~  149 (344)
                      |+. |+|.+++...+ .+++..++.++.||+.+       ||+||||||+|||++.++.  +||+|||++....... ..
T Consensus        81 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~--~kl~Dfg~a~~~~~~~~~~  157 (324)
T 3mtl_A           81 YLD-KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGE--LKLADFGLARAKSIPTKTY  157 (324)
T ss_dssp             CCS-EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCC--EEECSSSEEECC-------
T ss_pred             ccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCC--EEEccCcccccccCCcccc
Confidence            996 58988887654 58888888887776654       9999999999999987654  9999999987543222 23


Q ss_pred             CCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccc---------------
Q 019195          150 KSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQY---------------  214 (344)
Q Consensus       150 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~---------------  214 (344)
                      ...+||+.|+|||++.+....+.++|||||||++|+|++|+.||.+.........+.........               
T Consensus       158 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  237 (324)
T 3mtl_A          158 DNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTY  237 (324)
T ss_dssp             -----CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHHHT
T ss_pred             ccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhccc
Confidence            44578999999999987555566799999999999999999999987766555544443221110               


Q ss_pred             cCC---------CCCCCCHhHHHHHHHhcccCCCCCCChHHHhcCcccccCC
Q 019195          215 KIP---------DYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNL  257 (344)
Q Consensus       215 ~~~---------~~~~~s~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~~~  257 (344)
                      ..+         ....+++++.+||.+||+.||.+|||+.|+|+||||....
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  289 (324)
T 3mtl_A          238 NYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLG  289 (324)
T ss_dssp             CCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGC
T ss_pred             ccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhcc
Confidence            000         1124688999999999999999999999999999997653

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=2e-50  Score=367.65  Aligned_cols=255  Identities=28%  Similarity=0.430  Sum_probs=202.5

Q ss_pred             CCCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCcc---ccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEE
Q 019195            1 MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK---IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVM   77 (344)
Q Consensus         1 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~   77 (344)
                      +++|++++.||+|+||+||+|.+..+++.||+|++.....   ....+.+|+.++++++||||+++++++..+..+|+||
T Consensus        33 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  112 (329)
T 3gbz_A           33 IDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIF  112 (329)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEEE
Confidence            4789999999999999999999999999999999975432   2345779999999999999999999999999999999


Q ss_pred             ecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCC---CCCCEEEeecCCCcccCCC-
Q 019195           78 EYAAGGELFERICNAGRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGS---PAPRLKICDFGYSKSSLLH-  146 (344)
Q Consensus        78 e~~~~g~L~~~i~~~~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~---~~~~vkL~DFg~a~~~~~~-  146 (344)
                      ||+. |+|.+++...+.+++..++.++.||+.+       ||+||||||+|||++.+   ..+.+||+|||+++..... 
T Consensus       113 e~~~-~~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~~~~  191 (329)
T 3gbz_A          113 EYAE-NDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPI  191 (329)
T ss_dssp             ECCS-EEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC---
T ss_pred             ecCC-CCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCccccCCcc
Confidence            9997 5999999998899999998888887655       99999999999999532   2345999999998754322 


Q ss_pred             CCCCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhcccc-----------
Q 019195          147 SRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYK-----------  215 (344)
Q Consensus       147 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~-----------  215 (344)
                      ......+||+.|+|||++.+....+.++|||||||++|+|++|++||........+..+..........           
T Consensus       192 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  271 (329)
T 3gbz_A          192 RQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTALPDW  271 (329)
T ss_dssp             --------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTC
T ss_pred             cccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhhhhhhhh
Confidence            233455789999999999876655667999999999999999999998877666555554432211100           


Q ss_pred             ---CCCC----------CCCCHhHHHHHHHhcccCCCCCCChHHHhcCcccccC
Q 019195          216 ---IPDY----------VHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKN  256 (344)
Q Consensus       216 ---~~~~----------~~~s~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~~  256 (344)
                         .+..          ..+++++.+||.+||+.||.+|||+.++|+||||...
T Consensus       272 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~  325 (329)
T 3gbz_A          272 KQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHN  325 (329)
T ss_dssp             CTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSS
T ss_pred             hhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCCC
Confidence               0000          0167899999999999999999999999999999765

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=1.8e-50  Score=384.08  Aligned_cols=252  Identities=27%  Similarity=0.414  Sum_probs=199.4

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCc---cccHHHHHHHHHHhcCCCCCcceeeEEEEcC------CE
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH---KIDANVAREIINHKQLRHPNIIRFKEVVLTP------TH   72 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~------~~   72 (344)
                      ++|++++.||+|+||+||+|.+..+++.||||++.+..   ....++.+|+.+++.++||||+++++++...      ..
T Consensus        62 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~  141 (464)
T 3ttj_A           62 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD  141 (464)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred             CCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCCe
Confidence            68999999999999999999999999999999997643   2235688999999999999999999999654      46


Q ss_pred             EEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCC
Q 019195           73 LAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLL  145 (344)
Q Consensus        73 ~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~  145 (344)
                      +|+||||+.+ +|...+..  .+++.+++.++.||+.+       ||+||||||+|||++.++.  +||+|||+++....
T Consensus       142 ~~lv~E~~~~-~l~~~~~~--~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~--~kl~DFG~a~~~~~  216 (464)
T 3ttj_A          142 VYLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGT  216 (464)
T ss_dssp             EEEEEECCSE-EHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSC--EEECCCCCC-----
T ss_pred             EEEEEeCCCC-CHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCC--EEEEEEEeeeecCC
Confidence            8999999965 57666643  48888888887776654       9999999999999987664  99999999987665


Q ss_pred             CCCCCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccc-----------
Q 019195          146 HSRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQY-----------  214 (344)
Q Consensus       146 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~-----------  214 (344)
                      .......+||+.|+|||++.+..++ .++|||||||++|+|++|++||.+.+....+..++........           
T Consensus       217 ~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~~~~  295 (464)
T 3ttj_A          217 SFMMTPYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVR  295 (464)
T ss_dssp             CCCC----CCCTTCCHHHHTTCCCC-TTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSCHHHH
T ss_pred             CcccCCCcccccccCHHHHcCCCCC-HHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcchhhh
Confidence            5556677899999999999888775 4599999999999999999999988776666665543321100           


Q ss_pred             ----cCCCCCC---------------------CCHhHHHHHHHhcccCCCCCCChHHHhcCcccccCCCh
Q 019195          215 ----KIPDYVH---------------------ISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLPR  259 (344)
Q Consensus       215 ----~~~~~~~---------------------~s~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~~~~~  259 (344)
                          ..+....                     .++++.+||.+||+.||.+|||+.|+|+||||.....+
T Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~~~~~  365 (464)
T 3ttj_A          296 NYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDP  365 (464)
T ss_dssp             HHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGCCH
T ss_pred             hHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhhhccCc
Confidence                0111000                     15679999999999999999999999999999875543

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=3.1e-50  Score=386.87  Aligned_cols=250  Identities=35%  Similarity=0.603  Sum_probs=210.8

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCc--------------cccHHHHHHHHHHhcCCCCCcceeeEEE
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH--------------KIDANVAREIINHKQLRHPNIIRFKEVV   67 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--------------~~~~~~~~ei~~l~~l~h~niv~~~~~~   67 (344)
                      ++|++++.||+|+||+||+|.+..+++.||+|++.+..              .....+.+|+.++++++||||+++++++
T Consensus        36 ~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~  115 (504)
T 3q5i_A           36 ESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVF  115 (504)
T ss_dssp             GTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             cceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence            58999999999999999999999999999999997643              2235788999999999999999999999


Q ss_pred             EcCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCC-CCEEEeecCC
Q 019195           68 LTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPA-PRLKICDFGY  139 (344)
Q Consensus        68 ~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~-~~vkL~DFg~  139 (344)
                      .+...+|+|||||++|+|.+.+.+.+.+++..++.++.||+.+       ||+||||||+|||++.++. ..+||+|||+
T Consensus       116 ~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~  195 (504)
T 3q5i_A          116 EDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGL  195 (504)
T ss_dssp             ECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEECCCTT
T ss_pred             EcCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEEEECCC
Confidence            9999999999999999999999988899999988888877655       9999999999999986542 3599999999


Q ss_pred             CcccCCCCCCCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccC--C
Q 019195          140 SKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKI--P  217 (344)
Q Consensus       140 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--~  217 (344)
                      +............+||+.|+|||++.+ .+ +.++|||||||++|+|++|.+||.+......+    ..+....+.+  +
T Consensus       196 a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~----~~i~~~~~~~~~~  269 (504)
T 3q5i_A          196 SSFFSKDYKLRDRLGTAYYIAPEVLKK-KY-NEKCDVWSCGVIMYILLCGYPPFGGQNDQDII----KKVEKGKYYFDFN  269 (504)
T ss_dssp             CEECCTTSCBCCCCSCTTTCCHHHHTT-CB-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH----HHHHHCCCCCCHH
T ss_pred             CEEcCCCCccccccCCcCCCCHHHhcc-CC-CchHHHHHHHHHHHHHHhCCCCCCCCCHHHHH----HHHHcCCCCCCcc
Confidence            987655555566789999999999864 44 45699999999999999999999887654333    3333333332  2


Q ss_pred             CCCCCCHhHHHHHHHhcccCCCCCCChHHHhcCcccccCC
Q 019195          218 DYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNL  257 (344)
Q Consensus       218 ~~~~~s~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~~~  257 (344)
                      .+..+++++.+||.+||+.||.+|||+.++|+||||++..
T Consensus       270 ~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~  309 (504)
T 3q5i_A          270 DWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYA  309 (504)
T ss_dssp             HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHTC
T ss_pred             ccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhch
Confidence            3457899999999999999999999999999999997654

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=2.4e-50  Score=368.85  Aligned_cols=249  Identities=32%  Similarity=0.556  Sum_probs=208.3

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcC-CCCCcceeeEEEEcCCEEEEEEecC
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQL-RHPNIIRFKEVVLTPTHLAIVMEYA   80 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~   80 (344)
                      ++|++.+.||+|+||+||+|.+..+++.||+|++.+....   ..+|+.++.++ +||||+++++++.+...+|+|||||
T Consensus        22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~---~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~   98 (342)
T 2qr7_A           22 DGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD---PTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELM   98 (342)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC---CHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCC
T ss_pred             ccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC---hHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEeCC
Confidence            4799999999999999999999999999999999875432   35788888887 7999999999999999999999999


Q ss_pred             CCCChHHHHHhCCCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCC--CCCEEEeecCCCcccCCC-CCCC
Q 019195           81 AGGELFERICNAGRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSP--APRLKICDFGYSKSSLLH-SRPK  150 (344)
Q Consensus        81 ~~g~L~~~i~~~~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~--~~~vkL~DFg~a~~~~~~-~~~~  150 (344)
                      +||+|.+++.+.+.+++.+++.++.|++.+       ||+||||||+|||+....  .+.+||+|||+++..... ....
T Consensus        99 ~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~  178 (342)
T 2qr7_A           99 KGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLM  178 (342)
T ss_dssp             CSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCTTCCBC
T ss_pred             CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCCCCcee
Confidence            999999999998899999988888776655       999999999999985432  235999999999764433 2344


Q ss_pred             CCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCC--CCCCCCHhHHH
Q 019195          151 STVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIP--DYVHISQDCRN  228 (344)
Q Consensus       151 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~s~~~~~  228 (344)
                      ..+||+.|+|||++.+..++ .++|||||||++|+|++|..||..... .....++..+....+.++  .+..+++++.+
T Consensus       179 ~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~Pf~~~~~-~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~  256 (342)
T 2qr7_A          179 TPCYTANFVAPEVLERQGYD-AACDIWSLGVLLYTMLTGYTPFANGPD-DTPEEILARIGSGKFSLSGGYWNSVSDTAKD  256 (342)
T ss_dssp             CSSCCSSCCCHHHHHHHHHH-HHHHHHHHHHHHHHHHHSSCSSCSSTT-SCHHHHHHHHHHCCCCCCSTTTTTSCHHHHH
T ss_pred             ccCCCccccCHHHhcCCCCC-CccCeeeHhHHHHHHhcCCCCCCCCCc-CCHHHHHHHHccCCcccCccccccCCHHHHH
Confidence            56899999999999776654 559999999999999999999986432 233445555555555443  34568999999


Q ss_pred             HHHHhcccCCCCCCChHHHhcCccccc
Q 019195          229 LLSRIFVANPSRRITIKEIKSHPWFLK  255 (344)
Q Consensus       229 li~~~L~~dp~~R~s~~ell~hp~~~~  255 (344)
                      ||.+||+.||.+|||+.++++||||..
T Consensus       257 li~~~L~~dP~~R~t~~~il~hp~~~~  283 (342)
T 2qr7_A          257 LVSKMLHVDPHQRLTAALVLRHPWIVH  283 (342)
T ss_dssp             HHHHHTCSSTTTSCCHHHHTTSHHHHT
T ss_pred             HHHHHCCCChhHCcCHHHHhcCCeecC
Confidence            999999999999999999999999954

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=1.5e-50  Score=369.41  Aligned_cols=243  Identities=31%  Similarity=0.496  Sum_probs=209.1

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCcc---------ccHHHHHHHHHHhcCCCCCcceeeEEEEcCCE
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK---------IDANVAREIINHKQLRHPNIIRFKEVVLTPTH   72 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---------~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~   72 (344)
                      ++|++++.||+|+||.||+|.+..+++.||+|++.....         ....+.+|+.++++++||||+++++++...+.
T Consensus        24 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~  103 (335)
T 3dls_A           24 QKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGF  103 (335)
T ss_dssp             HHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred             cceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCCE
Confidence            479999999999999999999999999999999976532         22357789999999999999999999999999


Q ss_pred             EEEEEecCCCC-ChHHHHHhCCCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccC
Q 019195           73 LAIVMEYAAGG-ELFERICNAGRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSL  144 (344)
Q Consensus        73 ~~lv~e~~~~g-~L~~~i~~~~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~  144 (344)
                      +++||||+.+| +|..++...+.+++..++.++.||+.+       ||+||||||+|||++.++  .+||+|||++....
T Consensus       104 ~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~--~~kL~Dfg~a~~~~  181 (335)
T 3dls_A          104 FQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDF--TIKLIDFGSAAYLE  181 (335)
T ss_dssp             EEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTS--CEEECCCTTCEECC
T ss_pred             EEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCC--cEEEeecccceECC
Confidence            99999999776 999999988899999999888887755       999999999999998765  49999999998665


Q ss_pred             CCCCCCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCH
Q 019195          145 LHSRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQ  224 (344)
Q Consensus       145 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~  224 (344)
                      ........+||+.|+|||++.+..+.+.++|||||||++|+|++|+.||.....          .....  ......+++
T Consensus       182 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~----------~~~~~--~~~~~~~~~  249 (335)
T 3dls_A          182 RGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE----------TVEAA--IHPPYLVSK  249 (335)
T ss_dssp             TTCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG----------GTTTC--CCCSSCCCH
T ss_pred             CCCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH----------HHhhc--cCCCcccCH
Confidence            555555678999999999998888777779999999999999999999976321          11112  222335799


Q ss_pred             hHHHHHHHhcccCCCCCCChHHHhcCcccccCCC
Q 019195          225 DCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLP  258 (344)
Q Consensus       225 ~~~~li~~~L~~dp~~R~s~~ell~hp~~~~~~~  258 (344)
                      ++.+||.+||+.||.+|||+.++++||||.+...
T Consensus       250 ~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~~~  283 (335)
T 3dls_A          250 ELMSLVSGLLQPVPERRTTLEKLVTDPWVTQPVN  283 (335)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHHCTTTTCCCC
T ss_pred             HHHHHHHHHccCChhhCcCHHHHhcCccccCCcc
Confidence            9999999999999999999999999999987544

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=1.1e-49  Score=355.48  Aligned_cols=248  Identities=29%  Similarity=0.516  Sum_probs=199.8

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCcc--ccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEEec
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK--IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEY   79 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~   79 (344)
                      ++|++.+.||+|+||.||+|.+..++..||+|++.....  ....+.+|+.++++++||||+++++++.....+++||||
T Consensus        22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~  101 (285)
T 3is5_A           22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMET  101 (285)
T ss_dssp             HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEe
Confidence            479999999999999999999999999999999976543  336788999999999999999999999999999999999


Q ss_pred             CCCCChHHHHHh----CCCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecC-CCCCCEEEeecCCCcccCCCC
Q 019195           80 AAGGELFERICN----AGRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDG-SPAPRLKICDFGYSKSSLLHS  147 (344)
Q Consensus        80 ~~~g~L~~~i~~----~~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~-~~~~~vkL~DFg~a~~~~~~~  147 (344)
                      +++++|.+.+..    ...+++..++.++.|++.+       ||+||||||+|||++. +..+.+||+|||++.......
T Consensus       102 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~  181 (285)
T 3is5_A          102 CEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDE  181 (285)
T ss_dssp             CSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-----
T ss_pred             CCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecceecCCcc
Confidence            999999998854    3679999888888776654       9999999999999964 234569999999998655555


Q ss_pred             CCCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccC-CCCCCCCHhH
Q 019195          148 RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKI-PDYVHISQDC  226 (344)
Q Consensus       148 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~s~~~  226 (344)
                      ......||+.|+|||++.+ .+ +.++|||||||++|+|++|+.||..........    ......... .....+++++
T Consensus       182 ~~~~~~~t~~y~aPE~~~~-~~-~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~  255 (285)
T 3is5_A          182 HSTNAAGTALYMAPEVFKR-DV-TFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQ----KATYKEPNYAVECRPLTPQA  255 (285)
T ss_dssp             -----CTTGGGCCHHHHTT-CC-CHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH----HHHHCCCCCCC--CCCCHHH
T ss_pred             cCcCcccccCcCChHHhcc-CC-CcccCeehHHHHHHHHHhCCCCCCCCCHHHHHh----hhccCCcccccccCcCCHHH
Confidence            5566789999999999854 33 566999999999999999999998765433222    222222221 1223478999


Q ss_pred             HHHHHHhcccCCCCCCChHHHhcCccccc
Q 019195          227 RNLLSRIFVANPSRRITIKEIKSHPWFLK  255 (344)
Q Consensus       227 ~~li~~~L~~dp~~R~s~~ell~hp~~~~  255 (344)
                      .+||.+||+.||.+|||+.++|+||||++
T Consensus       256 ~~li~~~L~~dP~~Rps~~e~l~hp~f~~  284 (285)
T 3is5_A          256 VDLLKQMLTKDPERRPSAAQVLHHEWFKQ  284 (285)
T ss_dssp             HHHHHHHTCSCTTTSCCHHHHHTSGGGGC
T ss_pred             HHHHHHHccCChhhCcCHHHHhcCHHhhc
Confidence            99999999999999999999999999975

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=2.9e-49  Score=380.21  Aligned_cols=250  Identities=27%  Similarity=0.419  Sum_probs=211.8

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCc----cccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEE
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH----KIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVM   77 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~   77 (344)
                      ++|++++.||+|+||.||+|++..+|+.||+|++.+..    .....+.+|+.+++.++||||++++++|.+...+|+||
T Consensus       185 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVm  264 (543)
T 3c4z_A          185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVM  264 (543)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEE
Confidence            68999999999999999999999999999999997632    23356889999999999999999999999999999999


Q ss_pred             ecCCCCChHHHHHhC----CCCCHHHHHHHHHHHHH-------CCeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCC
Q 019195           78 EYAAGGELFERICNA----GRFSEDEARYFFQQLIS-------GQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH  146 (344)
Q Consensus        78 e~~~~g~L~~~i~~~----~~~~~~~~~~~~~ql~~-------~~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~  146 (344)
                      ||++||+|..++...    ..+++..++.++.||+.       .||+||||||+|||++.++.  +||+|||+++.....
T Consensus       265 E~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~--vkL~DFGla~~~~~~  342 (543)
T 3c4z_A          265 TIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGN--VRISDLGLAVELKAG  342 (543)
T ss_dssp             CCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSC--EEECCCTTCEECCTT
T ss_pred             EeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCC--EEEeecceeeeccCC
Confidence            999999999999764    36899988888777665       49999999999999987664  999999999765443


Q ss_pred             CC-CCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCHh
Q 019195          147 SR-PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQD  225 (344)
Q Consensus       147 ~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~  225 (344)
                      .. ....+||+.|+|||++.+..++ .++|||||||++|+|++|++||...........+...+......+|.  .+++.
T Consensus       343 ~~~~~~~~GT~~Y~APE~l~~~~~~-~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~~~~p~--~~s~~  419 (543)
T 3c4z_A          343 QTKTKGYAGTPGFMAPELLLGEEYD-FSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPD--KFSPA  419 (543)
T ss_dssp             CCCBCCCCSCTTTSCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCCCCCCT--TSCHH
T ss_pred             CcccccccCCccccChhhhcCCCCC-hHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhcccCCCc--ccCHH
Confidence            33 3345899999999999887765 55999999999999999999998765433344455555555555553  68999


Q ss_pred             HHHHHHHhcccCCCCCCC-----hHHHhcCcccccC
Q 019195          226 CRNLLSRIFVANPSRRIT-----IKEIKSHPWFLKN  256 (344)
Q Consensus       226 ~~~li~~~L~~dp~~R~s-----~~ell~hp~~~~~  256 (344)
                      +.+||.+||+.||.+||+     +.++++||||...
T Consensus       420 ~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~i  455 (543)
T 3c4z_A          420 SKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDI  455 (543)
T ss_dssp             HHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTTC
T ss_pred             HHHHHHHhccCCHhHCCCCcccCHHHHHcCccccCC
Confidence            999999999999999995     5899999999764

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=6.5e-50  Score=363.01  Aligned_cols=252  Identities=31%  Similarity=0.578  Sum_probs=212.6

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCcc-------ccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEE
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK-------IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLA   74 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-------~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~   74 (344)
                      ++|++.+.||+|+||.||+|.+..+++.||+|++.....       ....+.+|+.++++++||||+++++++...+.++
T Consensus        12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   91 (321)
T 2a2a_A           12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVV   91 (321)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             ccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence            469999999999999999999999999999999976432       2356889999999999999999999999999999


Q ss_pred             EEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCC--CCEEEeecCCCcccCC
Q 019195           75 IVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPA--PRLKICDFGYSKSSLL  145 (344)
Q Consensus        75 lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~--~~vkL~DFg~a~~~~~  145 (344)
                      +||||+++++|.+++...+.+++..++.++.|++.+       ||+||||||+|||++.++.  .++||+|||++.....
T Consensus        92 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~~~~  171 (321)
T 2a2a_A           92 LILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIED  171 (321)
T ss_dssp             EEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCEECCT
T ss_pred             EEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCccceecCc
Confidence            999999999999999988889999888887776654       9999999999999976552  1599999999987655


Q ss_pred             CCCCCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCCC--CCCCC
Q 019195          146 HSRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPD--YVHIS  223 (344)
Q Consensus       146 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~s  223 (344)
                      ........||+.|+|||++.+..++ .++|||||||++|+|++|..||.........    ..+.......+.  +..++
T Consensus       172 ~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~pf~~~~~~~~~----~~i~~~~~~~~~~~~~~~~  246 (321)
T 2a2a_A          172 GVEFKNIFGTPEFVAPEIVNYEPLG-LEADMWSIGVITYILLSGASPFLGDTKQETL----ANITSVSYDFDEEFFSHTS  246 (321)
T ss_dssp             TCCCCCCCSCGGGCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSCCSSCCSSHHHHH----HHHHTTCCCCCHHHHTTCC
T ss_pred             cccccccCCCCCccCcccccCCCCC-CccccHHHHHHHHHHHHCCCCCCCCCHHHHH----HHHHhcccccChhhhcccC
Confidence            5555667899999999999877764 5599999999999999999999876554333    233333333221  24678


Q ss_pred             HhHHHHHHHhcccCCCCCCChHHHhcCcccccCCC
Q 019195          224 QDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLP  258 (344)
Q Consensus       224 ~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~~~~  258 (344)
                      +.+.+||.+||+.||.+|||+.++++||||.....
T Consensus       247 ~~~~~li~~~l~~dp~~Rps~~e~l~hp~~~~~~~  281 (321)
T 2a2a_A          247 ELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDN  281 (321)
T ss_dssp             HHHHHHHHTTSCSSTTTSCCHHHHHHSTTTSCSSH
T ss_pred             HHHHHHHHHHcCCChhhCcCHHHHhcCccccCCCc
Confidence            99999999999999999999999999999976543

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=4.4e-50  Score=381.42  Aligned_cols=256  Identities=27%  Similarity=0.400  Sum_probs=188.7

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCcc---ccHHHHHHHHHHhcCCCCCcceeeEEEEcC-----CEE
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK---IDANVAREIINHKQLRHPNIIRFKEVVLTP-----THL   73 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~ei~~l~~l~h~niv~~~~~~~~~-----~~~   73 (344)
                      ++|++++.||+|+||+||+|.+..+++.||||++.....   ...++.+|+.+|+.++||||+++++++...     ..+
T Consensus        53 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  132 (458)
T 3rp9_A           53 DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDEL  132 (458)
T ss_dssp             TTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCE
T ss_pred             CCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceE
Confidence            689999999999999999999999999999999876432   235688999999999999999999999543     579


Q ss_pred             EEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCC
Q 019195           74 AIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH  146 (344)
Q Consensus        74 ~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~  146 (344)
                      |+||||+ +++|..++.....+++.+++.++.||+.+       ||+||||||+|||++.++.  +||+|||+|+.....
T Consensus       133 ~lv~e~~-~~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~--~kl~DFGla~~~~~~  209 (458)
T 3rp9_A          133 YVVLEIA-DSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCS--VKVCDFGLARTVDYP  209 (458)
T ss_dssp             EEEECCC-SEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCC--EEECCCTTCBCTTSC
T ss_pred             EEEEecc-ccchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCC--EeecccccchhccCc
Confidence            9999998 67999999988889999998888776654       9999999999999987664  999999999764322


Q ss_pred             C----------------------------CCCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHh----------
Q 019195          147 S----------------------------RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV----------  188 (344)
Q Consensus       147 ~----------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~----------  188 (344)
                      .                            .....+||+.|+|||++......+.++|||||||++|+|++          
T Consensus       210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~~~~  289 (458)
T 3rp9_A          210 ENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHA  289 (458)
T ss_dssp             TTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCSSGG
T ss_pred             cccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccccccccc
Confidence            1                            22345789999999987655545667999999999999998          


Q ss_pred             -CCCCCCCCCC--------------------hHHHHHHHHHHhhcc----------------ccC---------CCCCCC
Q 019195          189 -GAYPFEDQED--------------------PKNFRKTISRIMAVQ----------------YKI---------PDYVHI  222 (344)
Q Consensus       189 -g~~pf~~~~~--------------------~~~~~~~~~~~~~~~----------------~~~---------~~~~~~  222 (344)
                       |+++|.+...                    ...+..++..+....                ..+         ..+..+
T Consensus       290 ~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  369 (458)
T 3rp9_A          290 DRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFPAS  369 (458)
T ss_dssp             GCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGGSTTS
T ss_pred             cccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHHCCCC
Confidence             7777765431                    111111111110000                000         112356


Q ss_pred             CHhHHHHHHHhcccCCCCCCChHHHhcCcccccCCChh
Q 019195          223 SQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLPRE  260 (344)
Q Consensus       223 s~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~~~~~~  260 (344)
                      ++++.+||.+||+.||.+|||+.|+|+||||.......
T Consensus       370 s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~~~~~  407 (458)
T 3rp9_A          370 SADAIHLLKRMLVFNPNKRITINECLAHPFFKEVRIAE  407 (458)
T ss_dssp             CHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTCCGG
T ss_pred             CHHHHHHHHHHhccCccccCCHHHHhcCHhhhhcCCCc
Confidence            89999999999999999999999999999998765543

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=5.6e-50  Score=374.49  Aligned_cols=252  Identities=25%  Similarity=0.438  Sum_probs=206.6

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCc----cccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEE
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH----KIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVM   77 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~   77 (344)
                      ++|++++.||+|+||.||+|++..+++.||+|++.+..    .....+.+|..++..++||||++++++|.+.+.+|+||
T Consensus        61 ~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lVm  140 (412)
T 2vd5_A           61 DDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVM  140 (412)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEE
T ss_pred             hhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEE
Confidence            68999999999999999999999999999999997532    22345788999999999999999999999999999999


Q ss_pred             ecCCCCChHHHHHhC-CCCCHHHHHHHHHHHHH-------CCeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCCC-
Q 019195           78 EYAAGGELFERICNA-GRFSEDEARYFFQQLIS-------GQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR-  148 (344)
Q Consensus        78 e~~~~g~L~~~i~~~-~~~~~~~~~~~~~ql~~-------~~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~~-  148 (344)
                      ||++||+|.+++.+. ..+++..++.++.|++.       .||+||||||+|||++.++.  +||+|||+++....... 
T Consensus       141 E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~--vkL~DFGla~~~~~~~~~  218 (412)
T 2vd5_A          141 EYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGH--IRLADFGSCLKLRADGTV  218 (412)
T ss_dssp             CCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC--EEECCCTTCEECCTTSCE
T ss_pred             cCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCC--EEEeechhheeccCCCcc
Confidence            999999999999875 47999988888777665       49999999999999987664  99999999976543322 


Q ss_pred             -CCCCccCCcccCCccccC-------CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCCC-C
Q 019195          149 -PKSTVGTPAYIAPEVLSR-------REYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPD-Y  219 (344)
Q Consensus       149 -~~~~~gt~~y~aPE~~~~-------~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~-~  219 (344)
                       ....+||+.|+|||++..       ..+ +.++|||||||++|+|++|++||...+....+.+++...  ....+|. .
T Consensus       219 ~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~-~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~--~~~~~p~~~  295 (412)
T 2vd5_A          219 RSLVAVGTPDYLSPEILQAVGGGPGTGSY-GPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYK--EHLSLPLVD  295 (412)
T ss_dssp             ECSSCCSCGGGCCHHHHHHHHTCTTCSEE-CTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHH--HHCCCC---
T ss_pred             ccceeccccCcCCHHHHhhcccCcCCCCC-ChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcc--cCcCCCccc
Confidence             234689999999999973       334 556999999999999999999998876655544443321  1223332 2


Q ss_pred             CCCCHhHHHHHHHhcccCCCCC---CChHHHhcCcccccCCCh
Q 019195          220 VHISQDCRNLLSRIFVANPSRR---ITIKEIKSHPWFLKNLPR  259 (344)
Q Consensus       220 ~~~s~~~~~li~~~L~~dp~~R---~s~~ell~hp~~~~~~~~  259 (344)
                      ..+++++++||++||+ +|.+|   |++.++++||||...-..
T Consensus       296 ~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~i~w~  337 (412)
T 2vd5_A          296 EGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFGLDWD  337 (412)
T ss_dssp             -CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTTCCST
T ss_pred             cCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCCCCHH
Confidence            4689999999999999 99998   599999999999865443

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=3.6e-50  Score=375.36  Aligned_cols=250  Identities=34%  Similarity=0.594  Sum_probs=196.9

Q ss_pred             CCceee-eeeeecCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHH-hcCCCCCcceeeEEEEc----CCEEEE
Q 019195            2 EKYELM-KDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINH-KQLRHPNIIRFKEVVLT----PTHLAI   75 (344)
Q Consensus         2 ~~y~~~-~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~l-~~l~h~niv~~~~~~~~----~~~~~l   75 (344)
                      ++|.+. +.||+|+||+||+|.+..+++.||||++...    ..+.+|+.++ +..+||||++++++|..    ...+|+
T Consensus        61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~l  136 (400)
T 1nxk_A           61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLI  136 (400)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEE
T ss_pred             ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEE
Confidence            578887 7899999999999999999999999998643    4677888887 45589999999999875    567999


Q ss_pred             EEecCCCCChHHHHHhCC--CCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCC-CCCEEEeecCCCcccCC
Q 019195           76 VMEYAAGGELFERICNAG--RFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSP-APRLKICDFGYSKSSLL  145 (344)
Q Consensus        76 v~e~~~~g~L~~~i~~~~--~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~-~~~vkL~DFg~a~~~~~  145 (344)
                      |||||+||+|.+++...+  .+++.+++.++.||+.+       ||+||||||+|||++... .+.+||+|||+++....
T Consensus       137 v~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~  216 (400)
T 1nxk_A          137 VMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTS  216 (400)
T ss_dssp             EEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCTTCEECC-
T ss_pred             EEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEecccccccCC
Confidence            999999999999998754  58999988888776654       999999999999998632 35699999999986655


Q ss_pred             CCCCCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccC--CCCCCCC
Q 019195          146 HSRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKI--PDYVHIS  223 (344)
Q Consensus       146 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~s  223 (344)
                      .......+||+.|+|||++.+..++ .++|||||||++|+|++|+.||...............+....+.+  +.+..++
T Consensus       217 ~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s  295 (400)
T 1nxk_A          217 HNSLTTPCYTPYYVAPEVLGPEKYD-KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVS  295 (400)
T ss_dssp             ----------CTTCCGGGSCCCCSS-SHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCCCTTTTTTSC
T ss_pred             CCccccCCCCCCccCHhhcCCCCCC-CcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccCCCcccccCC
Confidence            5555677899999999999877765 459999999999999999999987543221111222333334433  3445789


Q ss_pred             HhHHHHHHHhcccCCCCCCChHHHhcCcccccC
Q 019195          224 QDCRNLLSRIFVANPSRRITIKEIKSHPWFLKN  256 (344)
Q Consensus       224 ~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~~  256 (344)
                      +++.+||.+||+.||.+|||+.++|+||||.+.
T Consensus       296 ~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~  328 (400)
T 1nxk_A          296 EEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS  328 (400)
T ss_dssp             HHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHTT
T ss_pred             HHHHHHHHHHCCCChhHCcCHHHHhcCccccCC
Confidence            999999999999999999999999999999764

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=6.9e-50  Score=355.07  Aligned_cols=249  Identities=35%  Similarity=0.587  Sum_probs=210.3

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCc-cccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEEecC
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH-KIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYA   80 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~   80 (344)
                      ++|++.+.||+|+||.||+|.+..++..||+|++.... .....+.+|+.++++++||||+++++++.....+++||||+
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   88 (277)
T 3f3z_A            9 QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELC   88 (277)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred             hhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEecc
Confidence            47999999999999999999999999999999997643 33467889999999999999999999999999999999999


Q ss_pred             CCCChHHHHHhCCCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecC-CCCCCEEEeecCCCcccCCCCCCCCC
Q 019195           81 AGGELFERICNAGRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDG-SPAPRLKICDFGYSKSSLLHSRPKST  152 (344)
Q Consensus        81 ~~g~L~~~i~~~~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~-~~~~~vkL~DFg~a~~~~~~~~~~~~  152 (344)
                      ++++|.+++...+.+++.+++.++.|++.+       ||+||||||+|||+.. +..+.+||+|||++............
T Consensus        89 ~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~~~~~~  168 (277)
T 3f3z_A           89 TGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTK  168 (277)
T ss_dssp             CSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTSCBCCC
T ss_pred             CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCccchhcc
Confidence            999999999888889999988888776654       9999999999999932 22335999999999866555555667


Q ss_pred             ccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCCC--CCCCCHhHHHHH
Q 019195          153 VGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPD--YVHISQDCRNLL  230 (344)
Q Consensus       153 ~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~s~~~~~li  230 (344)
                      .||+.|+|||++.+. + +.++||||||+++|+|++|+.||..........    .+.......+.  +..+++.+.+||
T Consensus       169 ~~t~~y~aPE~~~~~-~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~li  242 (277)
T 3f3z_A          169 VGTPYYVSPQVLEGL-Y-GPECDEWSAGVMMYVLLCGYPPFSAPTDSEVML----KIREGTFTFPEKDWLNVSPQAESLI  242 (277)
T ss_dssp             CSCTTTCCHHHHTTC-B-CTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH----HHHHCCCCCCHHHHTTSCHHHHHHH
T ss_pred             CCCCCccChHHhccc-C-CchhhehhHHHHHHHHHHCCCCCCCCCHHHHHH----HHHhCCCCCCchhhhcCCHHHHHHH
Confidence            899999999998654 4 556999999999999999999998866543333    33333333332  236799999999


Q ss_pred             HHhcccCCCCCCChHHHhcCcccccC
Q 019195          231 SRIFVANPSRRITIKEIKSHPWFLKN  256 (344)
Q Consensus       231 ~~~L~~dp~~R~s~~ell~hp~~~~~  256 (344)
                      .+||+.||.+|||+.++|+||||.+.
T Consensus       243 ~~~l~~dp~~R~s~~~~l~h~~~~~~  268 (277)
T 3f3z_A          243 RRLLTKSPKQRITSLQALEHEWFEKQ  268 (277)
T ss_dssp             HHHTCSSTTTSCCHHHHTTSHHHHHH
T ss_pred             HHHccCChhhCcCHHHHhcCHHHhcc
Confidence            99999999999999999999999654

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=1.8e-49  Score=369.46  Aligned_cols=253  Identities=23%  Similarity=0.376  Sum_probs=202.8

Q ss_pred             CCceeeeeeeec--CceEEEEEEEcCCCcEEEEEEeecCcc---ccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEE
Q 019195            2 EKYELMKDIGSG--NFGVARLMRNKNTKELVAMKYIERGHK---IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIV   76 (344)
Q Consensus         2 ~~y~~~~~lg~G--~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv   76 (344)
                      ++|++++.||+|  +||.||+|.+..+++.||+|++.....   ....+.+|+.+++.++||||+++++++...+.+|+|
T Consensus        25 ~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  104 (389)
T 3gni_B           25 GCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVV  104 (389)
T ss_dssp             GGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             CcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEEE
Confidence            589999999999  999999999999999999999976432   235677899999999999999999999999999999


Q ss_pred             EecCCCCChHHHHHhC--CCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCC-
Q 019195           77 MEYAAGGELFERICNA--GRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH-  146 (344)
Q Consensus        77 ~e~~~~g~L~~~i~~~--~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~-  146 (344)
                      ||||++|+|.+++...  ..+++..++.++.||+.+       ||+||||||+|||++.++  .+||+|||++...... 
T Consensus       105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~--~~kl~dfg~~~~~~~~~  182 (389)
T 3gni_B          105 TSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDG--KVYLSGLRSNLSMISHG  182 (389)
T ss_dssp             EECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTC--CEEECCGGGCEECEETT
T ss_pred             EEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC--CEEEcccccceeecccc
Confidence            9999999999999875  679999888888777655       999999999999997665  4999999987542211 


Q ss_pred             -------CCCCCCccCCcccCCccccC--CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhc-----
Q 019195          147 -------SRPKSTVGTPAYIAPEVLSR--REYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAV-----  212 (344)
Q Consensus       147 -------~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~-----  212 (344)
                             ......+||+.|+|||++.+  ..+ +.++|||||||++|+|++|+.||.+..........+......     
T Consensus       183 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  261 (389)
T 3gni_B          183 QRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGY-DAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTS  261 (389)
T ss_dssp             EECSCBCCCCTTCTTTGGGSCHHHHSTTSSCB-CTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC------------
T ss_pred             ccccccccccccccccccccCHHHHhccCCCC-CcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCcccccc
Confidence                   22234579999999999987  344 456999999999999999999998766554443322211000     


Q ss_pred             -----------------------------------cccCCCCCCCCHhHHHHHHHhcccCCCCCCChHHHhcCcccccCC
Q 019195          213 -----------------------------------QYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNL  257 (344)
Q Consensus       213 -----------------------------------~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~~~  257 (344)
                                                         ....+....+++++.+||.+||+.||.+|||+.++|+||||.+..
T Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~f~~~~  341 (389)
T 3gni_B          262 TIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIK  341 (389)
T ss_dssp             --------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGGGC-
T ss_pred             ccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHHHHHHh
Confidence                                               001122345789999999999999999999999999999997654

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=7.1e-50  Score=369.36  Aligned_cols=252  Identities=26%  Similarity=0.385  Sum_probs=200.1

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCcc---ccHHHHHHHHHHhcCCCCCcceeeEEEEcC------CE
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK---IDANVAREIINHKQLRHPNIIRFKEVVLTP------TH   72 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~ei~~l~~l~h~niv~~~~~~~~~------~~   72 (344)
                      ++|++++.||+|+||.||+|.+..+|+.||||++.....   ...++.+|+.+++.++||||+++++++...      ..
T Consensus        25 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~  104 (367)
T 1cm8_A           25 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTD  104 (367)
T ss_dssp             SSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCC
T ss_pred             ceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCce
Confidence            589999999999999999999999999999999865432   235688999999999999999999999865      35


Q ss_pred             EEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHH-------CCeeecCCCCCCeEecCCCCCCEEEeecCCCcccCC
Q 019195           73 LAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLIS-------GQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLL  145 (344)
Q Consensus        73 ~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~ql~~-------~~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~  145 (344)
                      +|+||||+ +++|.+++.. +.+++.+++.++.||+.       .||+||||||+|||++.++.  +||+|||+++....
T Consensus       105 ~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~--~kl~Dfg~a~~~~~  180 (367)
T 1cm8_A          105 FYLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCE--LKILDFGLARQADS  180 (367)
T ss_dssp             CEEEEECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC--EEECCCTTCEECCS
T ss_pred             EEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCC--EEEEeeeccccccc
Confidence            69999999 8899998876 67899988888777665       49999999999999987654  99999999976432


Q ss_pred             CCCCCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccc-----------
Q 019195          146 HSRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQY-----------  214 (344)
Q Consensus       146 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~-----------  214 (344)
                        .....+||+.|+|||++.+....+.++|||||||++|+|++|++||.+.+....+..++........           
T Consensus       181 --~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~  258 (367)
T 1cm8_A          181 --EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEA  258 (367)
T ss_dssp             --SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHH
T ss_pred             --ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhHHH
Confidence              3455689999999999987444566699999999999999999999987766665555443211100           


Q ss_pred             -----cCC---------CCCCCCHhHHHHHHHhcccCCCCCCChHHHhcCcccccCCCh
Q 019195          215 -----KIP---------DYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLPR  259 (344)
Q Consensus       215 -----~~~---------~~~~~s~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~~~~~  259 (344)
                           .+|         .+..+++.+.+||.+||+.||.+|||+.++|+||||......
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~~~  317 (367)
T 1cm8_A          259 KNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDT  317 (367)
T ss_dssp             HHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC--
T ss_pred             HHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhcCC
Confidence                 000         123578999999999999999999999999999999876543

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=1.1e-49  Score=375.71  Aligned_cols=256  Identities=29%  Similarity=0.416  Sum_probs=199.8

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCcc---ccHHHHHHHHHHhcCCCCCcceeeEEEEcC-----CEE
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK---IDANVAREIINHKQLRHPNIIRFKEVVLTP-----THL   73 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~ei~~l~~l~h~niv~~~~~~~~~-----~~~   73 (344)
                      ++|++++.||+|+||.||+|.+..+++.||||++.....   ...++.+|+.+++.++||||+++++++...     ..+
T Consensus        26 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~  105 (432)
T 3n9x_A           26 DNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDEL  105 (432)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCE
T ss_pred             CCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCeE
Confidence            689999999999999999999999999999999976432   235788999999999999999999999776     579


Q ss_pred             EEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCC
Q 019195           74 AIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH  146 (344)
Q Consensus        74 ~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~  146 (344)
                      |+||||+. ++|.+++.....+++.+++.++.||+.|       ||+||||||+|||++.++.  +||+|||+++.....
T Consensus       106 ~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~--~kL~DFGla~~~~~~  182 (432)
T 3n9x_A          106 YIVLEIAD-SDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCS--VKVCDFGLARTINSE  182 (432)
T ss_dssp             EEEEECCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC--EEECCCTTCEEC---
T ss_pred             EEEEecCC-cCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCC--EEEccCCCccccccc
Confidence            99999995 6999999988889999999888887654       9999999999999977654  999999999764332


Q ss_pred             C-----------------------CCCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhC-----------CCC
Q 019195          147 S-----------------------RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVG-----------AYP  192 (344)
Q Consensus       147 ~-----------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g-----------~~p  192 (344)
                      .                       .....+||+.|+|||++......+.++|||||||++|+|++|           .++
T Consensus       183 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~p~  262 (432)
T 3n9x_A          183 KDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPL  262 (432)
T ss_dssp             ----------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGGCCCS
T ss_pred             ccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccccccccccccc
Confidence            2                       235668999999999976555556779999999999999984           444


Q ss_pred             CCCCCC-----------------hHHHHHHHHHHh--------------------hccccCC-----CCCCCCHhHHHHH
Q 019195          193 FEDQED-----------------PKNFRKTISRIM--------------------AVQYKIP-----DYVHISQDCRNLL  230 (344)
Q Consensus       193 f~~~~~-----------------~~~~~~~~~~~~--------------------~~~~~~~-----~~~~~s~~~~~li  230 (344)
                      |.+...                 ...+..++..+.                    ......+     .+..+++++.+||
T Consensus       263 f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl  342 (432)
T 3n9x_A          263 FPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGINLL  342 (432)
T ss_dssp             CCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHH
T ss_pred             CCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHH
Confidence            443321                 111111111111                    0111111     1235799999999


Q ss_pred             HHhcccCCCCCCChHHHhcCcccccCCChh
Q 019195          231 SRIFVANPSRRITIKEIKSHPWFLKNLPRE  260 (344)
Q Consensus       231 ~~~L~~dp~~R~s~~ell~hp~~~~~~~~~  260 (344)
                      .+||+.||.+|||+.|+|+||||.......
T Consensus       343 ~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~~  372 (432)
T 3n9x_A          343 ESMLKFNPNKRITIDQALDHPYLKDVRKKK  372 (432)
T ss_dssp             HHHSCSSTTTSCCHHHHHTCGGGTTTCCTT
T ss_pred             HHHhcCCcccCCCHHHHhcChhhhhccCcc
Confidence            999999999999999999999998865544

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=1.8e-49  Score=352.04  Aligned_cols=252  Identities=41%  Similarity=0.729  Sum_probs=206.0

Q ss_pred             CCCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCc----cccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEE
Q 019195            1 MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH----KIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIV   76 (344)
Q Consensus         1 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv   76 (344)
                      +++|++.+.||+|+||.||+|.+..+++.||+|++....    .....+.+|+.+++.++||||+++++++...+.+|+|
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   89 (276)
T 2h6d_A           10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMV   89 (276)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEE
Confidence            368999999999999999999999999999999987532    2335788999999999999999999999999999999


Q ss_pred             EecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCCCC
Q 019195           77 MEYAAGGELFERICNAGRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP  149 (344)
Q Consensus        77 ~e~~~~g~L~~~i~~~~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~~~  149 (344)
                      |||+++++|.+++...+.+++..++.++.|++.+       ||+||||||+||+++.++.  +||+|||++.........
T Consensus        90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~--~~l~dfg~~~~~~~~~~~  167 (276)
T 2h6d_A           90 MEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMN--AKIADFGLSNMMSDGEFL  167 (276)
T ss_dssp             EECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSC--EEECCCCGGGCCCC----
T ss_pred             EeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCC--EEEeecccccccCCCcce
Confidence            9999999999999888889999998888887765       9999999999999976654  999999998765554444


Q ss_pred             CCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCHhHHHH
Q 019195          150 KSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL  229 (344)
Q Consensus       150 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  229 (344)
                      ....||+.|+|||++.+..+.+.++||||||+++|+|++|+.||........    ...+.......|.  .+++.+.+|
T Consensus       168 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~----~~~~~~~~~~~~~--~~~~~l~~l  241 (276)
T 2h6d_A          168 RTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTL----FKKIRGGVFYIPE--YLNRSVATL  241 (276)
T ss_dssp             ---------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH----HHHHHHCCCCCCT--TSCHHHHHH
T ss_pred             ecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHH----HHHhhcCcccCch--hcCHHHHHH
Confidence            5667999999999998877666779999999999999999999987654332    2333333333443  578999999


Q ss_pred             HHHhcccCCCCCCChHHHhcCcccccCCChh
Q 019195          230 LSRIFVANPSRRITIKEIKSHPWFLKNLPRE  260 (344)
Q Consensus       230 i~~~L~~dp~~R~s~~ell~hp~~~~~~~~~  260 (344)
                      |.+||+.||.+|||+.++++||||++..+..
T Consensus       242 i~~~l~~~p~~Rps~~~~l~h~~~~~~~~~~  272 (276)
T 2h6d_A          242 LMHMLQVDPLKRATIKDIREHEWFKQDLPSY  272 (276)
T ss_dssp             HHHHTCSSGGGSCCHHHHHHSHHHHTTCCGG
T ss_pred             HHHHccCChhhCCCHHHHHhChhhccCchhc
Confidence            9999999999999999999999998876543

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=2.1e-50  Score=386.25  Aligned_cols=249  Identities=35%  Similarity=0.601  Sum_probs=212.2

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCc----cccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEE
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH----KIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVM   77 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~   77 (344)
                      ++|++.+.||+|+||.||+|.+..+++.||+|++.+..    .....+.+|+.++++++||||+++++++...+.+|+||
T Consensus        26 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  105 (484)
T 3nyv_A           26 DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVG  105 (484)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence            47999999999999999999999999999999997542    23467899999999999999999999999999999999


Q ss_pred             ecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecC-CCCCCEEEeecCCCcccCCCCCC
Q 019195           78 EYAAGGELFERICNAGRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDG-SPAPRLKICDFGYSKSSLLHSRP  149 (344)
Q Consensus        78 e~~~~g~L~~~i~~~~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~-~~~~~vkL~DFg~a~~~~~~~~~  149 (344)
                      |||.+|+|.+.+...+.+++.+++.++.||+.+       ||+||||||+|||++. +..+.+||+|||+++........
T Consensus       106 e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~~  185 (484)
T 3nyv_A          106 EVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKM  185 (484)
T ss_dssp             CCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCCCCSH
T ss_pred             ecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEccccccc
Confidence            999999999999998999999988888877655       9999999999999963 23346999999998765544444


Q ss_pred             CCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccc--cCCCCCCCCHhHH
Q 019195          150 KSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQY--KIPDYVHISQDCR  227 (344)
Q Consensus       150 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~s~~~~  227 (344)
                      ...+||+.|+|||++.+ .+ +.++|||||||++|+|++|.+||.+......+.    .+....+  ..|.+..++++++
T Consensus       186 ~~~~gt~~y~aPE~~~~-~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~----~i~~~~~~~~~~~~~~~s~~~~  259 (484)
T 3nyv_A          186 KDKIGTAYYIAPEVLHG-TY-DEKCDVWSTGVILYILLSGCPPFNGANEYDILK----KVEKGKYTFELPQWKKVSESAK  259 (484)
T ss_dssp             HHHTTGGGTCCHHHHHT-CC-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH----HHHHCCCCCCSGGGGGSCHHHH
T ss_pred             ccCCCCccccCceeecC-CC-CCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHH----HHHcCCCCCCCcccccCCHHHH
Confidence            55679999999999976 44 456999999999999999999998876544333    3333333  3445567899999


Q ss_pred             HHHHHhcccCCCCCCChHHHhcCcccccC
Q 019195          228 NLLSRIFVANPSRRITIKEIKSHPWFLKN  256 (344)
Q Consensus       228 ~li~~~L~~dp~~R~s~~ell~hp~~~~~  256 (344)
                      +||.+||+.||.+|||+.++|+||||...
T Consensus       260 ~li~~~L~~dp~~R~s~~e~l~h~~~~~~  288 (484)
T 3nyv_A          260 DLIRKMLTYVPSMRISARDALDHEWIQTY  288 (484)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHTSHHHHHH
T ss_pred             HHHHHHCCCChhHCcCHHHHhhChhhccc
Confidence            99999999999999999999999999754

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=7.6e-50  Score=363.26  Aligned_cols=252  Identities=33%  Similarity=0.619  Sum_probs=190.5

Q ss_pred             CCceee---eeeeecCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcCC-CCCcceeeEEEEcCCEEEEEE
Q 019195            2 EKYELM---KDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLR-HPNIIRFKEVVLTPTHLAIVM   77 (344)
Q Consensus         2 ~~y~~~---~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~l~~l~-h~niv~~~~~~~~~~~~~lv~   77 (344)
                      ++|++.   +.||+|+||+||+|.+..+++.||+|++.+.  ....+.+|+.+++.+. ||||+++++++.+....|+||
T Consensus         8 ~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~   85 (325)
T 3kn6_A            8 QHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR--MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVM   85 (325)
T ss_dssp             HHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG--GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             hccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChh--hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEE
Confidence            467775   7899999999999999999999999999753  3356789999999997 999999999999999999999


Q ss_pred             ecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCC-CCCEEEeecCCCcccCCCC-C
Q 019195           78 EYAAGGELFERICNAGRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSP-APRLKICDFGYSKSSLLHS-R  148 (344)
Q Consensus        78 e~~~~g~L~~~i~~~~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~-~~~vkL~DFg~a~~~~~~~-~  148 (344)
                      ||+++|+|.+++...+.+++.+++.++.|++.+       ||+||||||+|||++.++ ...+||+|||+++...... .
T Consensus        86 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~  165 (325)
T 3kn6_A           86 ELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQP  165 (325)
T ss_dssp             CCCCSCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC----
T ss_pred             EccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCCc
Confidence            999999999999999999999999888877655       999999999999997543 2259999999997543332 2


Q ss_pred             CCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCh---HHHHHHHHHHhhccccCCC--CCCCC
Q 019195          149 PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDP---KNFRKTISRIMAVQYKIPD--YVHIS  223 (344)
Q Consensus       149 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~---~~~~~~~~~~~~~~~~~~~--~~~~s  223 (344)
                      ....+||+.|+|||++.+..++ .++|||||||++|+|++|+.||......   ......+..+....+.++.  +..++
T Consensus       166 ~~~~~~t~~y~aPE~~~~~~~~-~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s  244 (325)
T 3kn6_A          166 LKTPCFTLHYAAPELLNQNGYD-ESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNVS  244 (325)
T ss_dssp             ------------------CCCC-HHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCCSHHHHTSC
T ss_pred             ccccCCCcCccCHHHhcCCCCC-CccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCCcccccCCC
Confidence            3456799999999999877764 5599999999999999999999865431   1223444455554444332  23589


Q ss_pred             HhHHHHHHHhcccCCCCCCChHHHhcCcccccC
Q 019195          224 QDCRNLLSRIFVANPSRRITIKEIKSHPWFLKN  256 (344)
Q Consensus       224 ~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~~  256 (344)
                      +++.+||.+||+.||.+|||+.++++||||...
T Consensus       245 ~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~  277 (325)
T 3kn6_A          245 QEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDG  277 (325)
T ss_dssp             HHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTT
T ss_pred             HHHHHHHHHHCCCChhHCCCHHHHhcChhhccC
Confidence            999999999999999999999999999999865

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=5.1e-50  Score=370.99  Aligned_cols=246  Identities=30%  Similarity=0.524  Sum_probs=202.0

Q ss_pred             eeeeeeecCceEEEEEEEcCCCcEEEEEEeecCc-cccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEEecCCCCC
Q 019195            6 LMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH-KIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYAAGGE   84 (344)
Q Consensus         6 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~   84 (344)
                      ..+.||+|+||.||+|.+..+++.||+|++.... .....+.+|+.++++++||||+++++++...+.+++||||+++++
T Consensus        93 ~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~  172 (373)
T 2x4f_A           93 KTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGE  172 (373)
T ss_dssp             EEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCE
T ss_pred             cceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCc
Confidence            3678999999999999999999999999998654 234678899999999999999999999999999999999999999


Q ss_pred             hHHHHHhC-CCCCHHHHHHHHHHHHH-------CCeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCCCCCCCccCC
Q 019195           85 LFERICNA-GRFSEDEARYFFQQLIS-------GQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTP  156 (344)
Q Consensus        85 L~~~i~~~-~~~~~~~~~~~~~ql~~-------~~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~~~~~~~gt~  156 (344)
                      |.+++... ..+++..++.++.||+.       .||+||||||+|||+..+..+++||+|||+++...........+||+
T Consensus       173 L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~  252 (373)
T 2x4f_A          173 LFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGTP  252 (373)
T ss_dssp             EHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCBCCCCCSSC
T ss_pred             HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccccccccCCC
Confidence            99988654 46888888887777665       49999999999999965444569999999998766555556678999


Q ss_pred             cccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCC--CCCCCCHhHHHHHHHhc
Q 019195          157 AYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIP--DYVHISQDCRNLLSRIF  234 (344)
Q Consensus       157 ~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~s~~~~~li~~~L  234 (344)
                      .|+|||++.+..+ +.++|||||||++|+|++|+.||.+......+..+..    ..+.++  .+..+++++.+||.+||
T Consensus       253 ~y~aPE~~~~~~~-~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~----~~~~~~~~~~~~~~~~~~~li~~~L  327 (373)
T 2x4f_A          253 EFLAPEVVNYDFV-SFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILA----CRWDLEDEEFQDISEEAKEFISKLL  327 (373)
T ss_dssp             TTCCHHHHTTCBC-CHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHH----TCCCSCSGGGTTSCHHHHHHHHTTS
T ss_pred             cEeChhhccCCCC-CcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh----ccCCCChhhhccCCHHHHHHHHHHc
Confidence            9999999977665 4569999999999999999999988766544444333    333322  23468999999999999


Q ss_pred             ccCCCCCCChHHHhcCcccccC
Q 019195          235 VANPSRRITIKEIKSHPWFLKN  256 (344)
Q Consensus       235 ~~dp~~R~s~~ell~hp~~~~~  256 (344)
                      +.||.+|||+.++|+||||...
T Consensus       328 ~~dp~~Rps~~e~l~hp~~~~~  349 (373)
T 2x4f_A          328 IKEKSWRISASEALKHPWLSDH  349 (373)
T ss_dssp             CSSGGGSCCHHHHHHSHHHHCH
T ss_pred             CCChhhCCCHHHHhcCcCcCCC
Confidence            9999999999999999999654

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=2.1e-49  Score=368.33  Aligned_cols=249  Identities=25%  Similarity=0.400  Sum_probs=203.8

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcCCCCCcceeeEEEEc------------
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKEVVLT------------   69 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~------------   69 (344)
                      ++|++.+.||+|+||+||+|.+..+++.||+|++.......   .+|+.+++.++||||++++++|..            
T Consensus         7 ~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~~---~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~   83 (383)
T 3eb0_A            7 KKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYK---NRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPP   83 (383)
T ss_dssp             TTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTSC---CHHHHHHTTCCCTTBCCEEEEEEEC-----------
T ss_pred             ceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcchH---HHHHHHHHHcCCCCccchhheeeecCcccccccccc
Confidence            68999999999999999999999999999999987654332   379999999999999999999854            


Q ss_pred             --------------------------CCEEEEEEecCCCCChHHHHH----hCCCCCHHHHHHHHHHHHHC-------Ce
Q 019195           70 --------------------------PTHLAIVMEYAAGGELFERIC----NAGRFSEDEARYFFQQLISG-------QI  112 (344)
Q Consensus        70 --------------------------~~~~~lv~e~~~~g~L~~~i~----~~~~~~~~~~~~~~~ql~~~-------~i  112 (344)
                                                ...+++||||++ ++|.+.+.    ....+++..++.++.||+.+       ||
T Consensus        84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~gi  162 (383)
T 3eb0_A           84 DDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGI  162 (383)
T ss_dssp             --------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTE
T ss_pred             cccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCcC
Confidence                                      334899999997 57766654    45779999988888887765       99


Q ss_pred             eecCCCCCCeEecC-CCCCCEEEeecCCCcccCCCCCCCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCC
Q 019195          113 CHRDLKLENTLLDG-SPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAY  191 (344)
Q Consensus       113 iH~Dikp~NIl~~~-~~~~~vkL~DFg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~  191 (344)
                      +||||||+|||++. ++  .+||+|||+++............||+.|+|||++.+....+.++|||||||++|+|++|++
T Consensus       163 ~H~Dikp~Nil~~~~~~--~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~  240 (383)
T 3eb0_A          163 CHRDIKPQNLLVNSKDN--TLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKP  240 (383)
T ss_dssp             ECSCCCGGGEEEETTTT--EEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSC
T ss_pred             ccCccCHHHEEEcCCCC--cEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHhCCC
Confidence            99999999999973 43  5999999999876666666777899999999999876655667999999999999999999


Q ss_pred             CCCCCCChHHHHHHHHHHhhc-------------cccCC----------CCCCCCHhHHHHHHHhcccCCCCCCChHHHh
Q 019195          192 PFEDQEDPKNFRKTISRIMAV-------------QYKIP----------DYVHISQDCRNLLSRIFVANPSRRITIKEIK  248 (344)
Q Consensus       192 pf~~~~~~~~~~~~~~~~~~~-------------~~~~~----------~~~~~s~~~~~li~~~L~~dp~~R~s~~ell  248 (344)
                      ||.+......+..++......             ...+|          ....+++++.+||.+||+.||.+|||+.|+|
T Consensus       241 pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l  320 (383)
T 3eb0_A          241 LFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPYEAM  320 (383)
T ss_dssp             SSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHH
T ss_pred             CCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCCHHHHh
Confidence            999887766666655432211             01111          1124788999999999999999999999999


Q ss_pred             cCcccccC
Q 019195          249 SHPWFLKN  256 (344)
Q Consensus       249 ~hp~~~~~  256 (344)
                      +||||...
T Consensus       321 ~hp~f~~~  328 (383)
T 3eb0_A          321 AHPFFDHL  328 (383)
T ss_dssp             TSGGGHHH
T ss_pred             cCHHHHHH
Confidence            99999653

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=8.7e-50  Score=375.02  Aligned_cols=251  Identities=33%  Similarity=0.556  Sum_probs=197.6

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCcc---------ccHHHHHHHHHHhcCCCCCcceeeEEEEcCCE
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK---------IDANVAREIINHKQLRHPNIIRFKEVVLTPTH   72 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---------~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~   72 (344)
                      ++|++.+.||+|+||.||+|.+..+++.||+|++.+...         ....+.+|+.++++++||||+++++++. ...
T Consensus       135 ~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-~~~  213 (419)
T 3i6u_A          135 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD-AED  213 (419)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-SSE
T ss_pred             ccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCc
Confidence            589999999999999999999999999999999875321         1135789999999999999999999985 456


Q ss_pred             EEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCC-CCCEEEeecCCCcccC
Q 019195           73 LAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSP-APRLKICDFGYSKSSL  144 (344)
Q Consensus        73 ~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~-~~~vkL~DFg~a~~~~  144 (344)
                      +|+||||+++|+|.+++...+.+++.+++.++.|++.+       ||+||||||+|||++..+ ...+||+|||+++...
T Consensus       214 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~  293 (419)
T 3i6u_A          214 YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG  293 (419)
T ss_dssp             EEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTTTSCC
T ss_pred             eEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeecccceecC
Confidence            89999999999999999888899999888887776654       999999999999997532 3459999999998765


Q ss_pred             CCCCCCCCccCCcccCCccccC--CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCC--CCC
Q 019195          145 LHSRPKSTVGTPAYIAPEVLSR--REYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIP--DYV  220 (344)
Q Consensus       145 ~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~  220 (344)
                      ........+||+.|+|||++.+  ....+.++|||||||++|+|++|++||........+...+.   ......+  .+.
T Consensus       294 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~---~~~~~~~~~~~~  370 (419)
T 3i6u_A          294 ETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQIT---SGKYNFIPEVWA  370 (419)
T ss_dssp             -----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHH---TTCCCCCHHHHT
T ss_pred             CCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHh---cCCCCCCchhhc
Confidence            5555566789999999999864  23335669999999999999999999987655444333322   2222221  224


Q ss_pred             CCCHhHHHHHHHhcccCCCCCCChHHHhcCcccccC
Q 019195          221 HISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKN  256 (344)
Q Consensus       221 ~~s~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~~  256 (344)
                      .+++.+.+||.+||+.||.+|||+.++|+||||+..
T Consensus       371 ~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~  406 (419)
T 3i6u_A          371 EVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDE  406 (419)
T ss_dssp             TSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCCH
T ss_pred             ccCHHHHHHHHHHccCChhHCcCHHHHhCCcccCCh
Confidence            679999999999999999999999999999999653

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=3.3e-49  Score=350.26  Aligned_cols=253  Identities=36%  Similarity=0.600  Sum_probs=211.4

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCcc--ccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEEec
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK--IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEY   79 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~   79 (344)
                      ++|++++.||+|+||.||+|.+..+++.||+|++.....  ....+.+|+.+++.++||||+++++++...+..|+||||
T Consensus         7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   86 (276)
T 2yex_A            7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY   86 (276)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             cceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEEe
Confidence            579999999999999999999999999999999875432  336788999999999999999999999999999999999


Q ss_pred             CCCCChHHHHHhCCCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCC---CCC
Q 019195           80 AAGGELFERICNAGRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH---SRP  149 (344)
Q Consensus        80 ~~~g~L~~~i~~~~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~---~~~  149 (344)
                      +++++|.+++.....+++.+++.++.|++.+       ||+||||||+||+++.++.  +||+|||++......   ...
T Consensus        87 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~--~kl~dfg~~~~~~~~~~~~~~  164 (276)
T 2yex_A           87 CSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDN--LKISDFGLATVFRYNNRERLL  164 (276)
T ss_dssp             CTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC--EEECCCTTCEECEETTEECCB
T ss_pred             cCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCC--EEEeeCCCccccCCCcchhcc
Confidence            9999999999887889999888887776654       9999999999999986654  999999998754322   223


Q ss_pred             CCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCHhHHHH
Q 019195          150 KSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL  229 (344)
Q Consensus       150 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  229 (344)
                      ....||+.|+|||++.+..+.+.++|||||||++|+|++|+.||...........   .+.......+....+++.+.+|
T Consensus       165 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~l  241 (276)
T 2yex_A          165 NKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYS---DWKEKKTYLNPWKKIDSAPLAL  241 (276)
T ss_dssp             CCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHH---HHHTTCTTSTTGGGSCHHHHHH
T ss_pred             cCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHH---HhhhcccccCchhhcCHHHHHH
Confidence            4567999999999998877766779999999999999999999987654322222   1222222334445689999999


Q ss_pred             HHHhcccCCCCCCChHHHhcCcccccCCCh
Q 019195          230 LSRIFVANPSRRITIKEIKSHPWFLKNLPR  259 (344)
Q Consensus       230 i~~~L~~dp~~R~s~~ell~hp~~~~~~~~  259 (344)
                      |.+||+.||.+|||+.++++||||.+...+
T Consensus       242 i~~~l~~~p~~Rps~~~il~~~~~~~~~~~  271 (276)
T 2yex_A          242 LHKILVENPSARITIPDIKKDRWYNKPLKK  271 (276)
T ss_dssp             HHHHSCSSTTTSCCHHHHTTCTTTTCCCC-
T ss_pred             HHHHCCCCchhCCCHHHHhcCccccChhhc
Confidence            999999999999999999999999877553

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=3.4e-49  Score=357.17  Aligned_cols=256  Identities=30%  Similarity=0.501  Sum_probs=202.5

Q ss_pred             CCceee-eeeeecCceEEEEEEEcCCCcEEEEEEeecCcc-ccHHHHHHHHHHhcC-CCCCcceeeEEEEcCCEEEEEEe
Q 019195            2 EKYELM-KDIGSGNFGVARLMRNKNTKELVAMKYIERGHK-IDANVAREIINHKQL-RHPNIIRFKEVVLTPTHLAIVME   78 (344)
Q Consensus         2 ~~y~~~-~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~ei~~l~~l-~h~niv~~~~~~~~~~~~~lv~e   78 (344)
                      ++|++. +.||+|+||.||+|.+..+++.||+|++..... ....+.+|+.+++++ +||||+++++++..++.+|+|||
T Consensus        12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e   91 (316)
T 2ac3_A           12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFE   91 (316)
T ss_dssp             TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEE
Confidence            579986 789999999999999999999999999976543 346788999999885 79999999999999999999999


Q ss_pred             cCCCCChHHHHHhCCCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCC-CCEEEeecCCCcccCCCC---
Q 019195           79 YAAGGELFERICNAGRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPA-PRLKICDFGYSKSSLLHS---  147 (344)
Q Consensus        79 ~~~~g~L~~~i~~~~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~-~~vkL~DFg~a~~~~~~~---  147 (344)
                      |+++++|.+++...+.+++.+++.++.|++.+       ||+||||||+|||++.++. ..+||+|||++.......   
T Consensus        92 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~~  171 (316)
T 2ac3_A           92 KMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCS  171 (316)
T ss_dssp             CCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC---------
T ss_pred             cCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCccccccCCccc
Confidence            99999999999988889999988888776654       9999999999999976442 359999999987543211   


Q ss_pred             -----CCCCCccCCcccCCccccC-----CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChH-----------HHHHHH
Q 019195          148 -----RPKSTVGTPAYIAPEVLSR-----REYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPK-----------NFRKTI  206 (344)
Q Consensus       148 -----~~~~~~gt~~y~aPE~~~~-----~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-----------~~~~~~  206 (344)
                           .....+||+.|+|||++.+     ..+ +.++|||||||++|+|++|+.||.......           ......
T Consensus       172 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~-~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  250 (316)
T 2ac3_A          172 PISTPELLTPCGSAEYMAPEVVEAFSEEASIY-DKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLF  250 (316)
T ss_dssp             ----------CCSGGGCCHHHHHHTSHHHHHH-TTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHHHHH
T ss_pred             cccccccccccCCcCccChHHhhcccccccCC-CcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHHHHHH
Confidence                 1234469999999999865     333 456999999999999999999998754311           112233


Q ss_pred             HHHhhccccCCC--CCCCCHhHHHHHHHhcccCCCCCCChHHHhcCcccccCCC
Q 019195          207 SRIMAVQYKIPD--YVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLP  258 (344)
Q Consensus       207 ~~~~~~~~~~~~--~~~~s~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~~~~  258 (344)
                      ..+......+|.  +..+++.+.+||.+||+.||.+|||+.++|+||||....+
T Consensus       251 ~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~~  304 (316)
T 2ac3_A          251 ESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAP  304 (316)
T ss_dssp             HHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC----
T ss_pred             HHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhcCCCC
Confidence            444444444442  2468999999999999999999999999999999976543

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=4.7e-49  Score=361.68  Aligned_cols=255  Identities=24%  Similarity=0.388  Sum_probs=203.9

Q ss_pred             CCCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCc---cccHHHHHHHHHHhcCCCCCcceeeEEEEc--------
Q 019195            1 MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH---KIDANVAREIINHKQLRHPNIIRFKEVVLT--------   69 (344)
Q Consensus         1 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~ei~~l~~l~h~niv~~~~~~~~--------   69 (344)
                      +++|++++.||+|+||.||+|.+..+++.||+|++....   .....+.+|+.+++.++||||+++++++..        
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   95 (351)
T 3mi9_A           16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   95 (351)
T ss_dssp             GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred             ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence            468999999999999999999999999999999986543   234578899999999999999999999987        


Q ss_pred             CCEEEEEEecCCCCChHHHHHhC-CCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCc
Q 019195           70 PTHLAIVMEYAAGGELFERICNA-GRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSK  141 (344)
Q Consensus        70 ~~~~~lv~e~~~~g~L~~~i~~~-~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~  141 (344)
                      .+.+|+||||+.+ +|...+... ..+++.+++.++.||+.+       ||+||||||+|||++.++.  +||+|||+++
T Consensus        96 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~--~kl~Dfg~a~  172 (351)
T 3mi9_A           96 KGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGV--LKLADFGLAR  172 (351)
T ss_dssp             -CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC--EEECCCTTCE
T ss_pred             CceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCC--EEEccchhcc
Confidence            4578999999975 777777654 579999998888887755       9999999999999987664  9999999987


Q ss_pred             ccCC-----CCCCCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhcccc-
Q 019195          142 SSLL-----HSRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYK-  215 (344)
Q Consensus       142 ~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~-  215 (344)
                      ....     .......+||+.|+|||++.+....+.++|||||||++|+|++|++||.+.........+.......... 
T Consensus       173 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  252 (351)
T 3mi9_A          173 AFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEV  252 (351)
T ss_dssp             ECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTT
T ss_pred             cccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhh
Confidence            5431     2223456799999999999876555667999999999999999999999876655544443322211111 


Q ss_pred             CCCCC-------------------------CCCHhHHHHHHHhcccCCCCCCChHHHhcCcccccCCC
Q 019195          216 IPDYV-------------------------HISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLP  258 (344)
Q Consensus       216 ~~~~~-------------------------~~s~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~~~~  258 (344)
                      .+...                         ..++.+.+||.+||+.||.+|||+.|+|+||||.....
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~  320 (351)
T 3mi9_A          253 WPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPM  320 (351)
T ss_dssp             STTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGSSSC
T ss_pred             ccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCCCCC
Confidence            11100                         02678999999999999999999999999999976543

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=2.9e-48  Score=352.28  Aligned_cols=249  Identities=27%  Similarity=0.474  Sum_probs=206.6

Q ss_pred             ceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCccc-cHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEEecCCC
Q 019195            4 YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKI-DANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYAAG   82 (344)
Q Consensus         4 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~   82 (344)
                      |+..+.||+|+||.||+|.+..+|+.||||++...... ...+.+|+.+++.++||||+++++++...+..++||||+++
T Consensus        47 ~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  126 (321)
T 2c30_A           47 LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQG  126 (321)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECCCCS
T ss_pred             hhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEecCCC
Confidence            77889999999999999999999999999999765433 35688999999999999999999999999999999999999


Q ss_pred             CChHHHHHhCCCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCC-CCCCCcc
Q 019195           83 GELFERICNAGRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS-RPKSTVG  154 (344)
Q Consensus        83 g~L~~~i~~~~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~-~~~~~~g  154 (344)
                      ++|.+++.. ..+++..++.++.|++.+       ||+||||||+|||++.++.  +||+|||++....... ......|
T Consensus       127 ~~L~~~l~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~g  203 (321)
T 2c30_A          127 GALTDIVSQ-VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGR--VKLSDFGFCAQISKDVPKRKSLVG  203 (321)
T ss_dssp             CBHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCC--EEECCCTTCEECCSSSCCBCCCCS
T ss_pred             CCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCc--EEEeeeeeeeecccCccccccccC
Confidence            999998754 568999888887776654       9999999999999976654  9999999987644332 3345679


Q ss_pred             CCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhc-cccCCCCCCCCHhHHHHHHHh
Q 019195          155 TPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAV-QYKIPDYVHISQDCRNLLSRI  233 (344)
Q Consensus       155 t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~s~~~~~li~~~  233 (344)
                      |+.|+|||++.+..++ .++|||||||++|+|++|+.||...........    +... .........+++.+.+||.+|
T Consensus       204 t~~y~aPE~~~~~~~~-~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~l~~li~~~  278 (321)
T 2c30_A          204 TPYWMAPEVISRSLYA-TEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKR----LRDSPPPKLKNSHKVSPVLRDFLERM  278 (321)
T ss_dssp             CGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH----HHHSSCCCCTTGGGSCHHHHHHHHHH
T ss_pred             CccccCHhhhcCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH----HhcCCCCCcCccccCCHHHHHHHHHH
Confidence            9999999999877765 459999999999999999999987654333222    2222 112233346789999999999


Q ss_pred             cccCCCCCCChHHHhcCcccccCCChh
Q 019195          234 FVANPSRRITIKEIKSHPWFLKNLPRE  260 (344)
Q Consensus       234 L~~dp~~R~s~~ell~hp~~~~~~~~~  260 (344)
                      |+.||.+|||+.++++||||.+...+.
T Consensus       279 l~~dp~~Rps~~ell~hp~~~~~~~~~  305 (321)
T 2c30_A          279 LVRDPQERATAQELLDHPFLLQTGLPE  305 (321)
T ss_dssp             SCSSTTTSCCHHHHHTSGGGGGCCCGG
T ss_pred             ccCChhhCcCHHHHhcChhhccCCCcc
Confidence            999999999999999999998765443

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=3.6e-49  Score=371.84  Aligned_cols=254  Identities=26%  Similarity=0.383  Sum_probs=205.5

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcC------CCCCcceeeEEEEcCCEEEE
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQL------RHPNIIRFKEVVLTPTHLAI   75 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~l~~l------~h~niv~~~~~~~~~~~~~l   75 (344)
                      .+|++++.||+|+||+||+|.+..+++.||||++.........+.+|+.+++.+      +|+||+++++++...+.+++
T Consensus        97 ~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~l  176 (429)
T 3kvw_A           97 YRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICM  176 (429)
T ss_dssp             TTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEEEE
T ss_pred             CcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeEEE
Confidence            579999999999999999999999999999999987655556777888888776      57899999999999999999


Q ss_pred             EEecCCCCChHHHHHhCC--CCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCC
Q 019195           76 VMEYAAGGELFERICNAG--RFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH  146 (344)
Q Consensus        76 v~e~~~~g~L~~~i~~~~--~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~  146 (344)
                      ||||+. ++|.+++....  .+++..++.++.||+.+       ||+||||||+|||++.++...+||+|||++....  
T Consensus       177 v~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~~~--  253 (429)
T 3kvw_A          177 TFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEH--  253 (429)
T ss_dssp             EECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCCTTCEETT--
T ss_pred             EEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeecccceecC--
Confidence            999995 69999987654  48999988888887765       9999999999999987765559999999986432  


Q ss_pred             CCCCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhcccc-----------
Q 019195          147 SRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYK-----------  215 (344)
Q Consensus       147 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~-----------  215 (344)
                      ......+||+.|+|||++.+..++ .++|||||||++|+|++|.+||.+......+..++.........           
T Consensus       254 ~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~~~~~~~~~~  332 (429)
T 3kvw_A          254 QRVYTYIQSRFYRAPEVILGARYG-MPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDASKRAKNF  332 (429)
T ss_dssp             CCCCSSCSCGGGCCHHHHHTBCCC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTBTTHHHH
T ss_pred             CcccccCCCCCccChHHHhCCCCC-chHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHhhhhhhhc
Confidence            334567899999999999888775 55999999999999999999999887666555544322110000           


Q ss_pred             -----C-----------------------------CC--------CCCCCHhHHHHHHHhcccCCCCCCChHHHhcCccc
Q 019195          216 -----I-----------------------------PD--------YVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF  253 (344)
Q Consensus       216 -----~-----------------------------~~--------~~~~s~~~~~li~~~L~~dp~~R~s~~ell~hp~~  253 (344)
                           .                             +.        ....++.+.+||.+||+.||.+|||+.|+|+||||
T Consensus       333 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta~e~L~Hpw~  412 (429)
T 3kvw_A          333 VSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQALRHPWL  412 (429)
T ss_dssp             BCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTT
T ss_pred             cCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCHHHHhCChhh
Confidence                 0                             00        01237789999999999999999999999999999


Q ss_pred             ccCCCh
Q 019195          254 LKNLPR  259 (344)
Q Consensus       254 ~~~~~~  259 (344)
                      ++..++
T Consensus       413 ~~~~~~  418 (429)
T 3kvw_A          413 RRRLPK  418 (429)
T ss_dssp             C-----
T ss_pred             ccCCCC
Confidence            877554

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=9.2e-49  Score=351.33  Aligned_cols=253  Identities=33%  Similarity=0.533  Sum_probs=210.8

Q ss_pred             CCCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCc----------cccHHHHHHHHHHhcCC-CCCcceeeEEEEc
Q 019195            1 MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH----------KIDANVAREIINHKQLR-HPNIIRFKEVVLT   69 (344)
Q Consensus         1 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----------~~~~~~~~ei~~l~~l~-h~niv~~~~~~~~   69 (344)
                      +++|++.+.||+|+||.||+|.+..+++.||+|++....          .....+.+|+.+++++. ||||+++++++..
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~   95 (298)
T 1phk_A           16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET   95 (298)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred             hhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeecc
Confidence            478999999999999999999999999999999997643          12246779999999995 9999999999999


Q ss_pred             CCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcc
Q 019195           70 PTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKS  142 (344)
Q Consensus        70 ~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~  142 (344)
                      ...+++||||+++++|.+++.....+++..++.++.|++.+       ||+||||||+||+++.++.  +||+|||++..
T Consensus        96 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~--~kl~dfg~~~~  173 (298)
T 1phk_A           96 NTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMN--IKLTDFGFSCQ  173 (298)
T ss_dssp             SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC--EEECCCTTCEE
T ss_pred             CCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCc--EEEecccchhh
Confidence            99999999999999999999988889999988888776654       9999999999999977664  99999999986


Q ss_pred             cCCCCCCCCCccCCcccCCccccC-----CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhcccc--
Q 019195          143 SLLHSRPKSTVGTPAYIAPEVLSR-----REYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYK--  215 (344)
Q Consensus       143 ~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~--  215 (344)
                      ...........||+.|+|||++.+     ....+.++||||||+++|+|++|+.||...........    +......  
T Consensus       174 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~----~~~~~~~~~  249 (298)
T 1phk_A          174 LDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRM----IMSGNYQFG  249 (298)
T ss_dssp             CCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH----HHHTCCCCC
T ss_pred             cCCCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHH----HhcCCcccC
Confidence            655555566789999999999852     22235569999999999999999999987654433332    2233333  


Q ss_pred             CCCCCCCCHhHHHHHHHhcccCCCCCCChHHHhcCcccccCCCh
Q 019195          216 IPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLPR  259 (344)
Q Consensus       216 ~~~~~~~s~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~~~~~  259 (344)
                      .+.+..+++.+.+||.+||+.||.+|||+.++|+||||.+....
T Consensus       250 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~  293 (298)
T 1phk_A          250 SPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYVVE  293 (298)
T ss_dssp             TTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTTC--
T ss_pred             cccccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhhccch
Confidence            23345689999999999999999999999999999999876543

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=6.2e-49  Score=388.85  Aligned_cols=248  Identities=31%  Similarity=0.538  Sum_probs=213.9

Q ss_pred             CCCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecC----ccccHHHHHHHHHHhcC-CCCCcceeeEEEEcCCEEEE
Q 019195            1 MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERG----HKIDANVAREIINHKQL-RHPNIIRFKEVVLTPTHLAI   75 (344)
Q Consensus         1 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~ei~~l~~l-~h~niv~~~~~~~~~~~~~l   75 (344)
                      +++|++++.||+|+||.||+|.+..+++.||||++.+.    ......+.+|..++..+ +||||++++++|.+.+.+|+
T Consensus       340 ~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~l  419 (674)
T 3pfq_A          340 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF  419 (674)
T ss_dssp             CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEE
T ss_pred             ccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEE
Confidence            46899999999999999999999999999999999753    23346788899999988 79999999999999999999


Q ss_pred             EEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccC-CCC
Q 019195           76 VMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSL-LHS  147 (344)
Q Consensus        76 v~e~~~~g~L~~~i~~~~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~-~~~  147 (344)
                      ||||++||+|..++...+.+++..++.++.||+.|       ||+||||||+|||++.++.  +||+|||+++... ...
T Consensus       420 V~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~--ikL~DFGla~~~~~~~~  497 (674)
T 3pfq_A          420 VMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGH--IKIADFGMCKENIWDGV  497 (674)
T ss_dssp             EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSC--EEECCCTTCEECCCTTC
T ss_pred             EEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCc--EEEeecceeeccccCCc
Confidence            99999999999999988899999998888777655       9999999999999987664  9999999998533 333


Q ss_pred             CCCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCHhHH
Q 019195          148 RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCR  227 (344)
Q Consensus       148 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~  227 (344)
                      .....+||+.|+|||++.+..++ .++|||||||++|+|++|++||.+.+...    ++..+......+|.  .+++++.
T Consensus       498 ~~~~~~GT~~Y~APE~l~~~~~~-~~~DvwSlGvilyelltG~~Pf~~~~~~~----~~~~i~~~~~~~p~--~~s~~~~  570 (674)
T 3pfq_A          498 TTKTFCGTPDYIAPEIIAYQPYG-KSVDWWAFGVLLYEMLAGQAPFEGEDEDE----LFQSIMEHNVAYPK--SMSKEAV  570 (674)
T ss_dssp             CBCCCCSCSSSCCHHHHTCCCBS-THHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHHHHHSSCCCCCT--TSCHHHH
T ss_pred             ccccccCCCcccCHhhhcCCCCC-ccceEechHHHHHHHHcCCCCCCCCCHHH----HHHHHHhCCCCCCc--cCCHHHH
Confidence            44567899999999999888775 55999999999999999999998865533    44445555555554  6899999


Q ss_pred             HHHHHhcccCCCCCCCh-----HHHhcCcccccCC
Q 019195          228 NLLSRIFVANPSRRITI-----KEIKSHPWFLKNL  257 (344)
Q Consensus       228 ~li~~~L~~dp~~R~s~-----~ell~hp~~~~~~  257 (344)
                      +||.+||+.||.+||++     .++++||||...-
T Consensus       571 ~li~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~i~  605 (674)
T 3pfq_A          571 AICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYID  605 (674)
T ss_dssp             HHHHHHSCSSSTTCTTCSTTHHHHHHSSGGGSSCC
T ss_pred             HHHHHHccCCHHHCCCCCCCcHHHHhcCccccCCC
Confidence            99999999999999997     9999999997653

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=9.1e-50  Score=365.29  Aligned_cols=254  Identities=31%  Similarity=0.527  Sum_probs=201.4

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecC------ccccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEE
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERG------HKIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAI   75 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~l   75 (344)
                      ++|++.+.||+|+||+||+|.+..+++.||+|++...      ......+.+|+.++++++||||+++++++.+.+.+++
T Consensus        26 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l  105 (345)
T 3hko_A           26 KKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICL  105 (345)
T ss_dssp             HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             hheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEEE
Confidence            4799999999999999999999999999999998753      2233678899999999999999999999999999999


Q ss_pred             EEecCCCCChHHHHHhC----------------------------------------CCCCHHHHHHHHHHHH-------
Q 019195           76 VMEYAAGGELFERICNA----------------------------------------GRFSEDEARYFFQQLI-------  108 (344)
Q Consensus        76 v~e~~~~g~L~~~i~~~----------------------------------------~~~~~~~~~~~~~ql~-------  108 (344)
                      |||||++|+|.+++...                                        ..+++..++.++.|++       
T Consensus       106 v~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH  185 (345)
T 3hko_A          106 VMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLH  185 (345)
T ss_dssp             EEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             EEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHH
Confidence            99999999999988421                                        1124555666665555       


Q ss_pred             HCCeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCC-----CCCCCccCCcccCCccccCC-CCCCcchhHHHHHHH
Q 019195          109 SGQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS-----RPKSTVGTPAYIAPEVLSRR-EYDGKLADVWSCGVT  182 (344)
Q Consensus       109 ~~~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~i  182 (344)
                      +.||+||||||+|||++.++..++||+|||+++......     ......||+.|+|||++.+. ...+.++|||||||+
T Consensus       186 ~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~i  265 (345)
T 3hko_A          186 NQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVL  265 (345)
T ss_dssp             HTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHHHHHH
T ss_pred             HCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHHHHHH
Confidence            459999999999999987665569999999997543221     13455799999999999752 334566999999999


Q ss_pred             HHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCHhHHHHHHHhcccCCCCCCChHHHhcCcccccCC
Q 019195          183 LYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNL  257 (344)
Q Consensus       183 l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~~~  257 (344)
                      +|+|++|+.||...........+...  ......+.+..+++.+.+||.+||+.||.+|||+.++|+||||.+..
T Consensus       266 l~el~~g~~pf~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~hp~~~~~~  338 (345)
T 3hko_A          266 LHLLLMGAVPFPGVNDADTISQVLNK--KLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQFS  338 (345)
T ss_dssp             HHHHHHSSCSSCCSSHHHHHHHHHHC--CCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHSHHHHTTS
T ss_pred             HHHHHHCCCCCCCCChHHHHHHHHhc--ccccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHHhcChhhccCh
Confidence            99999999999887665444433322  11222333445899999999999999999999999999999997653

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=3.7e-49  Score=350.80  Aligned_cols=246  Identities=34%  Similarity=0.641  Sum_probs=205.6

Q ss_pred             CCCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCc----cccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEE
Q 019195            1 MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH----KIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIV   76 (344)
Q Consensus         1 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv   76 (344)
                      +++|++.+.||+|+||.||+|.+..++..||+|++....    .....+.+|+.+++.++||||+++++++.+....++|
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   87 (279)
T 3fdn_A            8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI   87 (279)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence            478999999999999999999999999999999986532    2345688999999999999999999999999999999


Q ss_pred             EecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCCCC
Q 019195           77 MEYAAGGELFERICNAGRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP  149 (344)
Q Consensus        77 ~e~~~~g~L~~~i~~~~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~~~  149 (344)
                      |||+++++|.+.+.+...+++..++.++.|++.+       ||+||||||+|||++.++.  +||+|||++..... ...
T Consensus        88 ~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~--~~l~Dfg~~~~~~~-~~~  164 (279)
T 3fdn_A           88 LEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGE--LKIADFGWSVHAPS-SRR  164 (279)
T ss_dssp             ECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSC--EEECSCCEESCC------
T ss_pred             EecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCC--EEEEeccccccCCc-ccc
Confidence            9999999999999988889999888887776654       9999999999999976664  99999998854322 223


Q ss_pred             CCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCHhHHHH
Q 019195          150 KSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL  229 (344)
Q Consensus       150 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  229 (344)
                      ....||+.|+|||++.+..++ .++||||||+++|+|++|..||........    ...+.......|.  .+++.+.+|
T Consensus       165 ~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~----~~~~~~~~~~~~~--~~~~~~~~l  237 (279)
T 3fdn_A          165 TDLCGTLDYLPPEMIEGRMHD-EKVDLWSLGVLCYEFLVGKPPFEANTYQET----YKRISRVEFTFPD--FVTEGARDL  237 (279)
T ss_dssp             ---CCCCTTCCHHHHTTCCCC-TTHHHHHHHHHHHHHHHSSCTTCCSSHHHH----HHHHHHTCCCCCT--TSCHHHHHH
T ss_pred             cccCCCCCccCHhHhccCCCC-ccchhHhHHHHHHHHHHCCCCCCCCcHHHH----HHHHHhCCCCCCC--cCCHHHHHH
Confidence            456799999999999877664 459999999999999999999987654333    3333334444443  578999999


Q ss_pred             HHHhcccCCCCCCChHHHhcCcccccC
Q 019195          230 LSRIFVANPSRRITIKEIKSHPWFLKN  256 (344)
Q Consensus       230 i~~~L~~dp~~R~s~~ell~hp~~~~~  256 (344)
                      |.+||+.||.+|||+.++++||||...
T Consensus       238 i~~~l~~~p~~Rps~~e~l~h~~~~~~  264 (279)
T 3fdn_A          238 ISRLLKHNPSQRPMLREVLEHPWITAN  264 (279)
T ss_dssp             HHHHCCSSGGGSCCHHHHHHCHHHHHH
T ss_pred             HHHHhccChhhCCCHHHHhhCccccCC
Confidence            999999999999999999999999654

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=5.1e-49  Score=363.39  Aligned_cols=248  Identities=32%  Similarity=0.546  Sum_probs=208.7

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCccc---------cHHHHHHHHHHhcC-CCCCcceeeEEEEcCC
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKI---------DANVAREIINHKQL-RHPNIIRFKEVVLTPT   71 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---------~~~~~~ei~~l~~l-~h~niv~~~~~~~~~~   71 (344)
                      ++|++.+.||+|+||.||+|.+..+|+.||||++......         ...+.+|+.+++++ +||||+++++++...+
T Consensus        94 ~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~  173 (365)
T 2y7j_A           94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSS  173 (365)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSS
T ss_pred             hhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCC
Confidence            4699999999999999999999999999999998764321         24577899999999 7999999999999999


Q ss_pred             EEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHH-------CCeeecCCCCCCeEecCCCCCCEEEeecCCCcccC
Q 019195           72 HLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLIS-------GQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSL  144 (344)
Q Consensus        72 ~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~ql~~-------~~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~  144 (344)
                      ..|+||||+++++|.+++.....+++..++.++.|++.       .||+||||||+|||++.++  ++||+|||++....
T Consensus       174 ~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~--~ikl~DfG~~~~~~  251 (365)
T 2y7j_A          174 FMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNM--QIRLSDFGFSCHLE  251 (365)
T ss_dssp             EEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC--CEEECCCTTCEECC
T ss_pred             EEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCC--CEEEEecCcccccC
Confidence            99999999999999999988888999999998888776       5999999999999997665  49999999998766


Q ss_pred             CCCCCCCCccCCcccCCccccCC-----CCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccC--C
Q 019195          145 LHSRPKSTVGTPAYIAPEVLSRR-----EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKI--P  217 (344)
Q Consensus       145 ~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--~  217 (344)
                      ........+||+.|+|||++.+.     ...+.++|||||||++|+|++|+.||..........    .+.......  +
T Consensus       252 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~----~i~~~~~~~~~~  327 (365)
T 2y7j_A          252 PGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLR----MIMEGQYQFSSP  327 (365)
T ss_dssp             TTCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH----HHHHTCCCCCHH
T ss_pred             CCcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHH----HHHhCCCCCCCc
Confidence            55555667899999999998632     123456999999999999999999998765433322    233333322  2


Q ss_pred             CCCCCCHhHHHHHHHhcccCCCCCCChHHHhcCccccc
Q 019195          218 DYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLK  255 (344)
Q Consensus       218 ~~~~~s~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~  255 (344)
                      .+..+++.+.+||.+||+.||.+|||+.++|+||||++
T Consensus       328 ~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~r  365 (365)
T 2y7j_A          328 EWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFER  365 (365)
T ss_dssp             HHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred             ccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcccCC
Confidence            33467899999999999999999999999999999963

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=4.8e-49  Score=358.78  Aligned_cols=254  Identities=28%  Similarity=0.428  Sum_probs=205.8

Q ss_pred             CCCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCccc---cHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEE
Q 019195            1 MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKI---DANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVM   77 (344)
Q Consensus         1 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~   77 (344)
                      +++|++++.||+|+||.||+|.+..+++.||+|++......   ...+.+|+.++++++||||+++++++...+.+|+||
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  103 (331)
T 4aaa_A           24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF  103 (331)
T ss_dssp             GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence            57999999999999999999999999999999998664332   345778999999999999999999999999999999


Q ss_pred             ecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCC-CCC
Q 019195           78 EYAAGGELFERICNAGRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH-SRP  149 (344)
Q Consensus        78 e~~~~g~L~~~i~~~~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~-~~~  149 (344)
                      ||+++++|..++.....+++..++.++.||+.+       ||+||||||+|||++.++  .+||+|||++...... ...
T Consensus       104 e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~--~~kl~Dfg~~~~~~~~~~~~  181 (331)
T 4aaa_A          104 EFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSG--VVKLCDFGFARTLAAPGEVY  181 (331)
T ss_dssp             ECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTS--CEEECCCTTC----------
T ss_pred             ecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCC--cEEEEeCCCceeecCCcccc
Confidence            999999998888878889999988888777654       999999999999997666  4999999999754332 233


Q ss_pred             CCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhh---------------ccc
Q 019195          150 KSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMA---------------VQY  214 (344)
Q Consensus       150 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~---------------~~~  214 (344)
                      ....||+.|+|||++.+....+.++|||||||++|+|++|++||...........+......               ...
T Consensus       182 ~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  261 (331)
T 4aaa_A          182 DDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGV  261 (331)
T ss_dssp             --CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGGTTC
T ss_pred             CCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhccccccc
Confidence            45679999999999987655567799999999999999999999887765555444332111               001


Q ss_pred             cCCC----------CCCCCHhHHHHHHHhcccCCCCCCChHHHhcCcccccC
Q 019195          215 KIPD----------YVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKN  256 (344)
Q Consensus       215 ~~~~----------~~~~s~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~~  256 (344)
                      ..+.          +..+++.+.+||.+||+.||.+|||+.++|+||||+..
T Consensus       262 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~~  313 (331)
T 4aaa_A          262 RLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMD  313 (331)
T ss_dssp             CCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHGG
T ss_pred             cCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhccC
Confidence            1111          12578999999999999999999999999999999654

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=1.5e-49  Score=367.14  Aligned_cols=253  Identities=23%  Similarity=0.401  Sum_probs=190.2

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCcc---ccHHHHHHHHHHhcCCCCCcceeeEEEEcC------CE
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK---IDANVAREIINHKQLRHPNIIRFKEVVLTP------TH   72 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~ei~~l~~l~h~niv~~~~~~~~~------~~   72 (344)
                      ++|++++.||+|+||.||+|.+..+|+.||||++.....   ....+.+|+.+++.++||||+++++++...      ..
T Consensus        29 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~  108 (367)
T 2fst_X           29 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND  108 (367)
T ss_dssp             TTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred             CceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCe
Confidence            589999999999999999999999999999999976432   235678999999999999999999999754      56


Q ss_pred             EEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCC
Q 019195           73 LAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLL  145 (344)
Q Consensus        73 ~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~  145 (344)
                      +|++|+|+ +++|.+++.. +.+++.+++.++.||+.+       ||+||||||+|||++.++.  +||+|||+++....
T Consensus       109 ~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~--~kL~DFG~a~~~~~  184 (367)
T 2fst_X          109 VYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCE--LKILDFGLARHTAD  184 (367)
T ss_dssp             CEEEEECC-CEECC------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC--EEECC---------
T ss_pred             EEEEeccc-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCC--EEEeeccccccccc
Confidence            89999999 7899988865 679999888888776654       9999999999999987664  99999999975432


Q ss_pred             CCCCCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhcc------------
Q 019195          146 HSRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQ------------  213 (344)
Q Consensus       146 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~------------  213 (344)
                        .....+||+.|+|||++.+....+.++|||||||++|+|++|++||.+.+....+..++.......            
T Consensus       185 --~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~  262 (367)
T 2fst_X          185 --EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESA  262 (367)
T ss_dssp             --------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCCCHHH
T ss_pred             --cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHH
Confidence              234568999999999998755456679999999999999999999998876666555544322110            


Q ss_pred             -------ccCC------CCCCCCHhHHHHHHHhcccCCCCCCChHHHhcCcccccCCChh
Q 019195          214 -------YKIP------DYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLPRE  260 (344)
Q Consensus       214 -------~~~~------~~~~~s~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~~~~~~  260 (344)
                             ...+      .+...++.+.+||.+||+.||.+|||+.++|+||||.+...+.
T Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~~~~~  322 (367)
T 2fst_X          263 RNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD  322 (367)
T ss_dssp             HHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCGG
T ss_pred             HHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhccCCC
Confidence                   0001      0124688999999999999999999999999999998765543

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=2.8e-49  Score=364.29  Aligned_cols=249  Identities=23%  Similarity=0.402  Sum_probs=202.3

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcCC-----CCCcceeeEEEEcCCEEEEE
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLR-----HPNIIRFKEVVLTPTHLAIV   76 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~l~~l~-----h~niv~~~~~~~~~~~~~lv   76 (344)
                      ++|++++.||+|+||+||+|.+..+++.||+|++.........+.+|+.+++.+.     ||||+++++++...+.+|+|
T Consensus        35 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~~~~lv  114 (360)
T 3llt_A           35 NAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDHMCLI  114 (360)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETTEEEEE
T ss_pred             CEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccchhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECCeeEEE
Confidence            6899999999999999999999999999999999865555567888999999986     99999999999999999999


Q ss_pred             EecCCCCChHHHHHhCC--CCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCC--------------------
Q 019195           77 MEYAAGGELFERICNAG--RFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGS--------------------  127 (344)
Q Consensus        77 ~e~~~~g~L~~~i~~~~--~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~--------------------  127 (344)
                      |||+ +++|.+++....  .+++.+++.++.||+.+       ||+||||||+|||++..                    
T Consensus       115 ~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~  193 (360)
T 3llt_A          115 FEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQI  193 (360)
T ss_dssp             ECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEEECTTTCCEEEE
T ss_pred             EcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccchhcccccccccc
Confidence            9999 999999997754  58998888887776654       99999999999999751                    


Q ss_pred             ---CCCCEEEeecCCCcccCCCCCCCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHH
Q 019195          128 ---PAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRK  204 (344)
Q Consensus       128 ---~~~~vkL~DFg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~  204 (344)
                         ..+.+||+|||++....  ......+||+.|+|||++.+..++ .++|||||||++|+|++|+.||........+..
T Consensus       194 ~~~~~~~~kl~DFG~a~~~~--~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~  270 (360)
T 3llt_A          194 YRTKSTGIKLIDFGCATFKS--DYHGSIINTRQYRAPEVILNLGWD-VSSDMWSFGCVLAELYTGSLLFRTHEHMEHLAM  270 (360)
T ss_dssp             EEESCCCEEECCCTTCEETT--SCCCSCCSCGGGCCHHHHTTCCCC-TTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH
T ss_pred             cccCCCCEEEEeccCceecC--CCCcCccCcccccCcHHHcCCCCC-CccchHHHHHHHHHHHHCCCCCCCCcHHHHHHH
Confidence               24569999999997532  234566899999999999888765 459999999999999999999988765444333


Q ss_pred             HHHHHhhcc----------------------ccCCCC------------------CCCCHhHHHHHHHhcccCCCCCCCh
Q 019195          205 TISRIMAVQ----------------------YKIPDY------------------VHISQDCRNLLSRIFVANPSRRITI  244 (344)
Q Consensus       205 ~~~~~~~~~----------------------~~~~~~------------------~~~s~~~~~li~~~L~~dp~~R~s~  244 (344)
                      +........                      ...|..                  ...++.+.+||.+||+.||.+|||+
T Consensus       271 ~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta  350 (360)
T 3llt_A          271 MESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQIDPTLRPSP  350 (360)
T ss_dssp             HHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCCSSGGGSCCH
T ss_pred             HHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHhcCChhhCCCH
Confidence            222110000                      000100                  0123678899999999999999999


Q ss_pred             HHHhcCcccc
Q 019195          245 KEIKSHPWFL  254 (344)
Q Consensus       245 ~ell~hp~~~  254 (344)
                      .++|+||||+
T Consensus       351 ~elL~hp~f~  360 (360)
T 3llt_A          351 AELLKHKFLE  360 (360)
T ss_dssp             HHHTTSGGGC
T ss_pred             HHHhcCcccC
Confidence            9999999994

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=2.7e-49  Score=364.20  Aligned_cols=253  Identities=25%  Similarity=0.392  Sum_probs=195.3

Q ss_pred             CCCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcCCCCCcceeeEEEEcCCE-------E
Q 019195            1 MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKEVVLTPTH-------L   73 (344)
Q Consensus         1 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~-------~   73 (344)
                      +++|++.+.||+|+||.||+|.+..+++.||+|++...........++++.++.++||||+++++++.....       +
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~  101 (360)
T 3e3p_A           22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYL  101 (360)
T ss_dssp             HTTEEEC----------CEEEEETTTCCEEEEEEEECCTTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCEEE
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccccHHHHHHHHHHHhcCCCCcccHHHhhhccccccccceeE
Confidence            478999999999999999999999999999999998766666678888999999999999999999976433       8


Q ss_pred             EEEEecCCCCChHHHH----HhCCCCCHHHHHHHHHHHH---------HCCeeecCCCCCCeEecC-CCCCCEEEeecCC
Q 019195           74 AIVMEYAAGGELFERI----CNAGRFSEDEARYFFQQLI---------SGQICHRDLKLENTLLDG-SPAPRLKICDFGY  139 (344)
Q Consensus        74 ~lv~e~~~~g~L~~~i----~~~~~~~~~~~~~~~~ql~---------~~~iiH~Dikp~NIl~~~-~~~~~vkL~DFg~  139 (344)
                      ++||||+++ +|...+    .....+++..++.++.|++         +.||+||||||+|||++. ++  ++||+|||+
T Consensus       102 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~--~~kl~Dfg~  178 (360)
T 3e3p_A          102 NVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADG--TLKLCDFGS  178 (360)
T ss_dssp             EEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTT--EEEECCCTT
T ss_pred             EEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCC--cEEEeeCCC
Confidence            999999976 554433    3456788888888877765         449999999999999985 44  599999999


Q ss_pred             CcccCCCCCCCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccc-----
Q 019195          140 SKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQY-----  214 (344)
Q Consensus       140 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~-----  214 (344)
                      ++............||+.|+|||++.+....+.++|||||||++|+|++|+.||........+..+.........     
T Consensus       179 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (360)
T 3e3p_A          179 AKKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRK  258 (360)
T ss_dssp             CBCCCTTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHH
T ss_pred             ceecCCCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCHHHHHh
Confidence            987666655667789999999999977665567799999999999999999999987766665555442211100     


Q ss_pred             --------c-------------CCCCCCCCHhHHHHHHHhcccCCCCCCChHHHhcCcccccC
Q 019195          215 --------K-------------IPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKN  256 (344)
Q Consensus       215 --------~-------------~~~~~~~s~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~~  256 (344)
                              .             .......++++.+||.+||+.||.+|||+.++|+||||.+.
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~  321 (360)
T 3e3p_A          259 LNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDEL  321 (360)
T ss_dssp             HCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGG
T ss_pred             cccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCcccccc
Confidence                    0             00111256789999999999999999999999999999765

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=1.3e-48  Score=348.20  Aligned_cols=246  Identities=31%  Similarity=0.634  Sum_probs=209.0

Q ss_pred             CCCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCc----cccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEE
Q 019195            1 MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH----KIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIV   76 (344)
Q Consensus         1 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv   76 (344)
                      +++|++.+.||+|+||.||+|.+..+++.||+|++....    .....+.+|+.+++.++||||+++++++...+.+|+|
T Consensus        13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   92 (284)
T 2vgo_A           13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLM   92 (284)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEE
Confidence            478999999999999999999999999999999986532    2345788999999999999999999999999999999


Q ss_pred             EecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCCCC
Q 019195           77 MEYAAGGELFERICNAGRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP  149 (344)
Q Consensus        77 ~e~~~~g~L~~~i~~~~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~~~  149 (344)
                      |||+++++|.+++...+.+++..++.++.|++.+       ||+||||||+||+++.++.  +||+|||++..... ...
T Consensus        93 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~--~kl~Dfg~~~~~~~-~~~  169 (284)
T 2vgo_A           93 LEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGE--LKIADFGWSVHAPS-LRR  169 (284)
T ss_dssp             ECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCC--EEECCCTTCEECSS-SCB
T ss_pred             EEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCC--EEEecccccccCcc-ccc
Confidence            9999999999999988889999988888776654       9999999999999976654  99999999865432 223


Q ss_pred             CCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCHhHHHH
Q 019195          150 KSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL  229 (344)
Q Consensus       150 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  229 (344)
                      ....||+.|+|||++.+..++ .++||||||+++|+|++|..||.........    ..+......+|  ..+++.+.+|
T Consensus       170 ~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~pf~~~~~~~~~----~~~~~~~~~~~--~~~~~~~~~l  242 (284)
T 2vgo_A          170 RTMCGTLDYLPPEMIEGKTHD-EKVDLWCAGVLCYEFLVGMPPFDSPSHTETH----RRIVNVDLKFP--PFLSDGSKDL  242 (284)
T ss_dssp             CCCCSCGGGCCHHHHTTCCBC-TTHHHHHHHHHHHHHHHSSCTTCCSSHHHHH----HHHHTTCCCCC--TTSCHHHHHH
T ss_pred             ccccCCCCcCCHHHhccCCCC-cccchhhHHHHHHHHHHCCCCCCCCCHhHHH----HHHhccccCCC--CcCCHHHHHH
Confidence            456799999999999887765 4599999999999999999999876543332    23333444444  3689999999


Q ss_pred             HHHhcccCCCCCCChHHHhcCcccccC
Q 019195          230 LSRIFVANPSRRITIKEIKSHPWFLKN  256 (344)
Q Consensus       230 i~~~L~~dp~~R~s~~ell~hp~~~~~  256 (344)
                      |.+||+.||.+|||+.++++||||...
T Consensus       243 i~~~l~~~p~~Rps~~~ll~h~~~~~~  269 (284)
T 2vgo_A          243 ISKLLRYHPPQRLPLKGVMEHPWVKAN  269 (284)
T ss_dssp             HHHHSCSSGGGSCCHHHHHTCHHHHHH
T ss_pred             HHHHhhcCHhhCCCHHHHhhCHHHHhh
Confidence            999999999999999999999999643

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.1e-48  Score=358.56  Aligned_cols=253  Identities=28%  Similarity=0.412  Sum_probs=202.4

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCcc------ccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEE
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK------IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAI   75 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~------~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~l   75 (344)
                      ++|++++.||+|+||.||+|.+..+++.||+|++.....      ....+.+|+.+++.++||||+++++++...+.+++
T Consensus        10 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   89 (346)
T 1ua2_A           10 KRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISL   89 (346)
T ss_dssp             ---CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEE
T ss_pred             cccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCceEE
Confidence            689999999999999999999999999999999875322      23468899999999999999999999999999999


Q ss_pred             EEecCCCCChHHHHHhC-CCCCHHHHHHHHHHHHH-------CCeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCC-
Q 019195           76 VMEYAAGGELFERICNA-GRFSEDEARYFFQQLIS-------GQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH-  146 (344)
Q Consensus        76 v~e~~~~g~L~~~i~~~-~~~~~~~~~~~~~ql~~-------~~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~-  146 (344)
                      ||||+.+ +|...+... ..+++.+++.++.|++.       .||+||||||+|||++.++.  +||+|||+++..... 
T Consensus        90 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~--~kl~Dfg~a~~~~~~~  166 (346)
T 1ua2_A           90 VFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGV--LKLADFGLAKSFGSPN  166 (346)
T ss_dssp             EEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC--EEECCCGGGSTTTSCC
T ss_pred             EEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCC--EEEEecccceeccCCc
Confidence            9999975 888888664 35888877777766654       49999999999999977654  999999999765333 


Q ss_pred             CCCCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccc-cCCC-------
Q 019195          147 SRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQY-KIPD-------  218 (344)
Q Consensus       147 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~-------  218 (344)
                      ......+||+.|+|||++.+....+.++|||||||++|+|++|.+||.+......+..++........ ..+.       
T Consensus       167 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  246 (346)
T 1ua2_A          167 RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDY  246 (346)
T ss_dssp             CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTC
T ss_pred             ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhccCccc
Confidence            23345679999999999977665567799999999999999999999988776666655544322111 0010       


Q ss_pred             --------------CCCCCHhHHHHHHHhcccCCCCCCChHHHhcCcccccCC
Q 019195          219 --------------YVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNL  257 (344)
Q Consensus       219 --------------~~~~s~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~~~  257 (344)
                                    +..+++++.+||.+||+.||.+|||+.|+|+||||....
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~~  299 (346)
T 1ua2_A          247 VTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRP  299 (346)
T ss_dssp             CCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSS
T ss_pred             ccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcCC
Confidence                          134578999999999999999999999999999997653

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=1.3e-48  Score=352.89  Aligned_cols=242  Identities=21%  Similarity=0.300  Sum_probs=191.3

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCccc---cHHHHHHHHHHhcC-CCCCcceeeEEEEcCCEEEEEE
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKI---DANVAREIINHKQL-RHPNIIRFKEVVLTPTHLAIVM   77 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~ei~~l~~l-~h~niv~~~~~~~~~~~~~lv~   77 (344)
                      ++|+++++||+|+||+||+|.+..+++.||||++......   .....+|+..+..+ +||||+++++++...+.+|+||
T Consensus        57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~  136 (311)
T 3p1a_A           57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT  136 (311)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEE
Confidence            4699999999999999999999999999999998654332   23445555555544 8999999999999999999999


Q ss_pred             ecCCCCChHHHHHhC-CCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCCCC
Q 019195           78 EYAAGGELFERICNA-GRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP  149 (344)
Q Consensus        78 e~~~~g~L~~~i~~~-~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~~~  149 (344)
                      ||+ +++|.+++... ..+++..++.++.|++.+       ||+||||||+|||++.++.  +||+|||++.........
T Consensus       137 e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~--~kl~DFG~a~~~~~~~~~  213 (311)
T 3p1a_A          137 ELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGR--CKLGDFGLLVELGTAGAG  213 (311)
T ss_dssp             ECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGC--EEECCCTTCEECC-----
T ss_pred             ecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCC--EEEccceeeeecccCCCC
Confidence            999 67998887664 469999888888776655       9999999999999977664  999999998766555555


Q ss_pred             CCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCHhHHHH
Q 019195          150 KSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL  229 (344)
Q Consensus       150 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  229 (344)
                      ....||+.|+|||++.+ .+ +.++|||||||++|+|++|..||.....   .    ..+............+++++.+|
T Consensus       214 ~~~~gt~~y~aPE~~~~-~~-~~~~DiwslG~il~el~~g~~~~~~~~~---~----~~~~~~~~~~~~~~~~~~~l~~l  284 (311)
T 3p1a_A          214 EVQEGDPRYMAPELLQG-SY-GTAADVFSLGLTILEVACNMELPHGGEG---W----QQLRQGYLPPEFTAGLSSELRSV  284 (311)
T ss_dssp             -CCCCCGGGCCGGGGGT-CC-STHHHHHHHHHHHHHHHHTCCCCSSHHH---H----HHHTTTCCCHHHHTTSCHHHHHH
T ss_pred             cccCCCccccCHhHhcC-CC-CchhhHHHHHHHHHHHHhCCCCCCCccH---H----HHHhccCCCcccccCCCHHHHHH
Confidence            66679999999999876 44 4569999999999999999777655321   1    11222211111223678999999


Q ss_pred             HHHhcccCCCCCCChHHHhcCccccc
Q 019195          230 LSRIFVANPSRRITIKEIKSHPWFLK  255 (344)
Q Consensus       230 i~~~L~~dp~~R~s~~ell~hp~~~~  255 (344)
                      |.+||+.||.+|||+.++|+||||++
T Consensus       285 i~~~L~~dP~~Rpt~~ell~hp~~~~  310 (311)
T 3p1a_A          285 LVMMLEPDPKLRATAEALLALPVLRQ  310 (311)
T ss_dssp             HHHHSCSSTTTSCCHHHHHTSGGGSC
T ss_pred             HHHHcCCChhhCcCHHHHHhCccccC
Confidence            99999999999999999999999975

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=1.3e-48  Score=351.74  Aligned_cols=250  Identities=34%  Similarity=0.612  Sum_probs=206.5

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCcc-ccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEEecC
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK-IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYA   80 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~   80 (344)
                      ++|++.+.||+|+||.||+|.+..+++.||+|++..... ....+.+|+.+++.++||||+++++++...+.+|+||||+
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   88 (304)
T 2jam_A            9 KTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLV   88 (304)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred             ccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEcC
Confidence            479999999999999999999999999999999986533 3356889999999999999999999999999999999999


Q ss_pred             CCCChHHHHHhCCCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecC-CCCCCEEEeecCCCcccCCCCCCCCC
Q 019195           81 AGGELFERICNAGRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDG-SPAPRLKICDFGYSKSSLLHSRPKST  152 (344)
Q Consensus        81 ~~g~L~~~i~~~~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~-~~~~~vkL~DFg~a~~~~~~~~~~~~  152 (344)
                      ++++|.+++...+.+++..++.++.|++.+       ||+||||||+||++.. +..+.+||+|||++...... .....
T Consensus        89 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~-~~~~~  167 (304)
T 2jam_A           89 SGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG-IMSTA  167 (304)
T ss_dssp             CSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCB-TTHHH
T ss_pred             CCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCCC-ccccc
Confidence            999999999888889999988887776654       9999999999999932 23345999999998753322 22345


Q ss_pred             ccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhcccc--CCCCCCCCHhHHHHH
Q 019195          153 VGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYK--IPDYVHISQDCRNLL  230 (344)
Q Consensus       153 ~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~s~~~~~li  230 (344)
                      +||+.|+|||++.+..+ +.++|||||||++|+|++|..||..........    .+......  .+.+..+++.+.+||
T Consensus       168 ~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~----~i~~~~~~~~~~~~~~~~~~~~~li  242 (304)
T 2jam_A          168 CGTPGYVAPEVLAQKPY-SKAVDCWSIGVITYILLCGYPPFYEETESKLFE----KIKEGYYEFESPFWDDISESAKDFI  242 (304)
T ss_dssp             HSCCCBCCTTTBSSCSC-CHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH----HHHHCCCCCCTTTTTTSCHHHHHHH
T ss_pred             cCCCCccChHHhccCCC-CchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHH----HHHcCCCCCCccccccCCHHHHHHH
Confidence            69999999999987766 456999999999999999999998765543333    33333332  233457899999999


Q ss_pred             HHhcccCCCCCCChHHHhcCcccccCC
Q 019195          231 SRIFVANPSRRITIKEIKSHPWFLKNL  257 (344)
Q Consensus       231 ~~~L~~dp~~R~s~~ell~hp~~~~~~  257 (344)
                      .+||+.||.+|||+.++|+||||....
T Consensus       243 ~~~l~~dp~~Rps~~~~l~h~~~~~~~  269 (304)
T 2jam_A          243 CHLLEKDPNERYTCEKALSHPWIDGNT  269 (304)
T ss_dssp             HHHHCSSTTTSCCHHHHHTSHHHHSSC
T ss_pred             HHHcCCChhHCcCHHHHhcCccccCCC
Confidence            999999999999999999999997653

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=1.3e-48  Score=367.20  Aligned_cols=249  Identities=28%  Similarity=0.428  Sum_probs=201.9

Q ss_pred             CceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcCCCCCcceeeEEEEcC------CEEEEE
Q 019195            3 KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKEVVLTP------THLAIV   76 (344)
Q Consensus         3 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~------~~~~lv   76 (344)
                      +|++.+.||+|+||+||+|.+..+++.||||++......   ..+|+.+++.++||||++++++|...      ..+++|
T Consensus        55 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~---~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv  131 (420)
T 1j1b_A           55 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF---KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLV  131 (420)
T ss_dssp             EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTTS---CCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEEE
T ss_pred             eEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccchh---HHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEee
Confidence            699999999999999999999999999999998765432   34799999999999999999998542      247899


Q ss_pred             EecCCCCChHHHHH----hCCCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCC
Q 019195           77 MEYAAGGELFERIC----NAGRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLL  145 (344)
Q Consensus        77 ~e~~~~g~L~~~i~----~~~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~  145 (344)
                      |||+++ +|...+.    ....+++..++.++.||+.+       ||+||||||+|||++.+.. .+||+|||+++....
T Consensus       132 ~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~-~~kl~DFG~a~~~~~  209 (420)
T 1j1b_A          132 LDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTA-VLKLCDFGSAKQLVR  209 (420)
T ss_dssp             EECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTT-EEEECCCTTCEECCT
T ss_pred             hhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCC-eEEeccchhhhhccc
Confidence            999975 6665553    35678988888887776654       9999999999999985432 489999999987655


Q ss_pred             CCCCCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhc-------------
Q 019195          146 HSRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAV-------------  212 (344)
Q Consensus       146 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~-------------  212 (344)
                      .......+||+.|+|||++.+....+.++|||||||++|+|++|++||.+......+.+++......             
T Consensus       210 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~~~~~~~  289 (420)
T 1j1b_A          210 GEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYT  289 (420)
T ss_dssp             TCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHHHCSCCC
T ss_pred             CCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhhh
Confidence            5556677899999999999876545667999999999999999999999887766666665532211             


Q ss_pred             cccCCC----------CCCCCHhHHHHHHHhcccCCCCCCChHHHhcCcccccC
Q 019195          213 QYKIPD----------YVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKN  256 (344)
Q Consensus       213 ~~~~~~----------~~~~s~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~~  256 (344)
                      .+.+|.          ...+++++.+||.+||+.||.+|||+.++|+||||...
T Consensus       290 ~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~  343 (420)
T 1j1b_A          290 EFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL  343 (420)
T ss_dssp             CCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGG
T ss_pred             hhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhccc
Confidence            111221          12468899999999999999999999999999999764

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=4.8e-49  Score=350.56  Aligned_cols=250  Identities=33%  Similarity=0.623  Sum_probs=205.8

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCcc-------ccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEE
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK-------IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLA   74 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-------~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~   74 (344)
                      ++|++.+.||+|+||.||+|.+..+++.||+|++.....       ....+.+|+.++++++||||+++++++.....++
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   84 (283)
T 3bhy_A            5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV   84 (283)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence            479999999999999999999999999999999876432       2467889999999999999999999999999999


Q ss_pred             EEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCC--CCCEEEeecCCCcccCC
Q 019195           75 IVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSP--APRLKICDFGYSKSSLL  145 (344)
Q Consensus        75 lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~--~~~vkL~DFg~a~~~~~  145 (344)
                      +||||+++++|.+++.+...+++.+++.++.|++.+       ||+||||||+||+++.++  ..++||+|||++.....
T Consensus        85 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~~~  164 (283)
T 3bhy_A           85 LILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEA  164 (283)
T ss_dssp             EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEECC-
T ss_pred             EEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccceeccC
Confidence            999999999999999888889999988888776654       999999999999997654  23599999999986555


Q ss_pred             CCCCCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCC--CCCCCC
Q 019195          146 HSRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIP--DYVHIS  223 (344)
Q Consensus       146 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~s  223 (344)
                      ........||+.|+|||++.+..++ .++||||||+++|+|++|..||..........    .+.......+  .+..++
T Consensus       165 ~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~  239 (283)
T 3bhy_A          165 GNEFKNIFGTPEFVAPEIVNYEPLG-LEADMWSIGVITYILLSGASPFLGETKQETLT----NISAVNYDFDEEYFSNTS  239 (283)
T ss_dssp             -------CCCGGGCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH----HHHTTCCCCCHHHHTTCC
T ss_pred             CCcccccCCCcCccCcceecCCCCC-cchhhhhHHHHHHHHHHCCCCCCCcchHHHHH----HhHhcccCCcchhcccCC
Confidence            4445566799999999999877764 55999999999999999999998765433332    2222222222  124678


Q ss_pred             HhHHHHHHHhcccCCCCCCChHHHhcCcccccC
Q 019195          224 QDCRNLLSRIFVANPSRRITIKEIKSHPWFLKN  256 (344)
Q Consensus       224 ~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~~  256 (344)
                      +.+.+||.+||+.||.+|||+.++++||||+..
T Consensus       240 ~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~  272 (283)
T 3bhy_A          240 ELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAI  272 (283)
T ss_dssp             HHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHH
T ss_pred             HHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHH
Confidence            999999999999999999999999999999643

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.3e-49  Score=362.60  Aligned_cols=252  Identities=31%  Similarity=0.555  Sum_probs=208.0

Q ss_pred             CCCceeeeeeeecCceEEEEEEEc---CCCcEEEEEEeecCc-----cccHHHHHHHHHHhcC-CCCCcceeeEEEEcCC
Q 019195            1 MEKYELMKDIGSGNFGVARLMRNK---NTKELVAMKYIERGH-----KIDANVAREIINHKQL-RHPNIIRFKEVVLTPT   71 (344)
Q Consensus         1 ~~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~-----~~~~~~~~ei~~l~~l-~h~niv~~~~~~~~~~   71 (344)
                      +++|++++.||+|+||.||+|.+.   .+++.||||++....     .....+.+|+.+++.+ +||||+++++++....
T Consensus        53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~  132 (355)
T 1vzo_A           53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET  132 (355)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred             ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence            368999999999999999999984   589999999986532     2335577899999999 6999999999999999


Q ss_pred             EEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccC
Q 019195           72 HLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSL  144 (344)
Q Consensus        72 ~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~  144 (344)
                      .+++||||+++++|.+++...+.+++.+++.++.|++.+       ||+||||||+|||++.++.  +||+|||+++...
T Consensus       133 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~--~kl~DfG~a~~~~  210 (355)
T 1vzo_A          133 KLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGH--VVLTDFGLSKEFV  210 (355)
T ss_dssp             EEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSC--EEESCSSEEEECC
T ss_pred             eEEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCc--EEEeeCCCCeecc
Confidence            999999999999999999988889999888887776654       9999999999999977654  9999999987543


Q ss_pred             CC--CCCCCCccCCcccCCccccCCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCCCCCC
Q 019195          145 LH--SRPKSTVGTPAYIAPEVLSRRE-YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVH  221 (344)
Q Consensus       145 ~~--~~~~~~~gt~~y~aPE~~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  221 (344)
                      ..  ......+||+.|+|||++.+.. ..+.++|||||||++|+|++|+.||...........+...+.......+  ..
T Consensus       211 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~  288 (355)
T 1vzo_A          211 ADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYP--QE  288 (355)
T ss_dssp             GGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCC--TT
T ss_pred             cCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhccCCCCC--cc
Confidence            22  2233457999999999997632 3456699999999999999999999866544444455555544444333  46


Q ss_pred             CCHhHHHHHHHhcccCCCCCC-----ChHHHhcCcccccC
Q 019195          222 ISQDCRNLLSRIFVANPSRRI-----TIKEIKSHPWFLKN  256 (344)
Q Consensus       222 ~s~~~~~li~~~L~~dp~~R~-----s~~ell~hp~~~~~  256 (344)
                      +++.+.+||.+||+.||.+||     |+.++++||||.+.
T Consensus       289 ~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~~  328 (355)
T 1vzo_A          289 MSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKI  328 (355)
T ss_dssp             SCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTC
T ss_pred             cCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhcC
Confidence            899999999999999999999     99999999999764

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=3.1e-48  Score=352.97  Aligned_cols=250  Identities=21%  Similarity=0.375  Sum_probs=202.4

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcCC-CCCcceeeEEEEc--CCEEEEEEe
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLR-HPNIIRFKEVVLT--PTHLAIVME   78 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~l~~l~-h~niv~~~~~~~~--~~~~~lv~e   78 (344)
                      ++|++++.||+|+||.||+|.+..+++.||+|++....  ...+.+|+.++++++ ||||+++++++..  ....++|||
T Consensus        36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~e  113 (330)
T 3nsz_A           36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK--KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFE  113 (330)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC--HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEEE
T ss_pred             CceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc--hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEEe
Confidence            57999999999999999999999999999999987533  367889999999997 9999999999988  678999999


Q ss_pred             cCCCCChHHHHHhCCCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCCCCCC
Q 019195           79 YAAGGELFERICNAGRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKS  151 (344)
Q Consensus        79 ~~~~g~L~~~i~~~~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~~~~~  151 (344)
                      |+.+++|..++..   +++.+++.++.||+.+       ||+||||||+|||++.++. .+||+|||+++..........
T Consensus       114 ~~~~~~l~~~~~~---~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~-~~kl~Dfg~a~~~~~~~~~~~  189 (330)
T 3nsz_A          114 HVNNTDFKQLYQT---LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHR-KLRLIDWGLAEFYHPGQEYNV  189 (330)
T ss_dssp             CCCCCCHHHHGGG---CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTT-EEEECCCTTCEECCTTCCCCS
T ss_pred             ccCchhHHHHHHh---CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCC-EEEEEeCCCceEcCCCCcccc
Confidence            9999999888753   7888888777776654       9999999999999985542 499999999987665555667


Q ss_pred             CccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChH-HHHHHHHHHh---------hcccc------
Q 019195          152 TVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPK-NFRKTISRIM---------AVQYK------  215 (344)
Q Consensus       152 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-~~~~~~~~~~---------~~~~~------  215 (344)
                      ..||+.|+|||++.+....+.++|||||||++|+|++|+.||....... .+..+.....         .....      
T Consensus       190 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~  269 (330)
T 3nsz_A          190 RVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFN  269 (330)
T ss_dssp             CCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCTHHH
T ss_pred             ccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhccccccchh
Confidence            7899999999999875555667999999999999999999996554322 2222111110         00000      


Q ss_pred             ----------------CCCCCCCCHhHHHHHHHhcccCCCCCCChHHHhcCcccccCC
Q 019195          216 ----------------IPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNL  257 (344)
Q Consensus       216 ----------------~~~~~~~s~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~~~  257 (344)
                                      ......+++++.+||.+||+.||.+|||+.++|+||||+...
T Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~  327 (330)
T 3nsz_A          270 DILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVV  327 (330)
T ss_dssp             HHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTTCC
T ss_pred             hhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhhhc
Confidence                            011122789999999999999999999999999999998654

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=8.9e-49  Score=348.08  Aligned_cols=247  Identities=30%  Similarity=0.561  Sum_probs=185.5

Q ss_pred             CCCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCc----cccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEE
Q 019195            1 MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH----KIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIV   76 (344)
Q Consensus         1 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv   76 (344)
                      +++|++.+.||+|+||.||+|.+..+++.||+|++....    .....+.+|+.++++++||||+++++++...+..++|
T Consensus        10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   89 (278)
T 3cok_A           10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV   89 (278)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred             cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence            468999999999999999999999999999999997532    2236788999999999999999999999999999999


Q ss_pred             EecCCCCChHHHHHhC-CCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCC-C
Q 019195           77 MEYAAGGELFERICNA-GRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH-S  147 (344)
Q Consensus        77 ~e~~~~g~L~~~i~~~-~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~-~  147 (344)
                      |||+++++|.+++... ..+++.+++.++.|++.+       ||+||||||+||+++.++.  +||+|||++...... .
T Consensus        90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~--~kl~dfg~~~~~~~~~~  167 (278)
T 3cok_A           90 LEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMN--IKIADFGLATQLKMPHE  167 (278)
T ss_dssp             EECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCC--EEECCCTTCEECC----
T ss_pred             EecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCC--EEEEeecceeeccCCCC
Confidence            9999999999999875 578999888888776654       9999999999999976654  999999998764422 2


Q ss_pred             CCCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCHhHH
Q 019195          148 RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCR  227 (344)
Q Consensus       148 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~  227 (344)
                      ......||+.|+|||++.+..+. .++|||||||++|+|++|+.||.........    ..+.......|  ..++.++.
T Consensus       168 ~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~----~~~~~~~~~~~--~~~~~~~~  240 (278)
T 3cok_A          168 KHYTLCGTPNYISPEIATRSAHG-LESDVWSLGCMFYTLLIGRPPFDTDTVKNTL----NKVVLADYEMP--SFLSIEAK  240 (278)
T ss_dssp             -------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC---------CCSSCCCCC--TTSCHHHH
T ss_pred             cceeccCCCCcCCcchhcCCCCC-chhhHHHHHHHHHHHHhCCCCCCChhHHHHH----HHHhhcccCCc--cccCHHHH
Confidence            23446799999999999876654 5599999999999999999999876543322    22222233333  35789999


Q ss_pred             HHHHHhcccCCCCCCChHHHhcCcccccC
Q 019195          228 NLLSRIFVANPSRRITIKEIKSHPWFLKN  256 (344)
Q Consensus       228 ~li~~~L~~dp~~R~s~~ell~hp~~~~~  256 (344)
                      +||.+||+.||.+|||+.++++||||.+.
T Consensus       241 ~li~~~l~~dp~~Rps~~~~l~h~~~~~~  269 (278)
T 3cok_A          241 DLIHQLLRRNPADRLSLSSVLDHPFMSRN  269 (278)
T ss_dssp             HHHHHHSCSSGGGSCCHHHHTTSTTTC--
T ss_pred             HHHHHHcccCHhhCCCHHHHhcCccccCC
Confidence            99999999999999999999999999764

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=7.2e-49  Score=361.65  Aligned_cols=251  Identities=27%  Similarity=0.447  Sum_probs=204.2

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCcc--ccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEEec
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK--IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEY   79 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~   79 (344)
                      ++|++++.||+|+||.||+|.+..++..||+|++.....  ....+.+|+.+++.++||||+++++++..++.+|+||||
T Consensus        33 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  112 (360)
T 3eqc_A           33 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH  112 (360)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             ccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEEC
Confidence            589999999999999999999999999999999976532  235688999999999999999999999999999999999


Q ss_pred             CCCCChHHHHHhCCCCCHHHHHHHHHHHHHC--------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCCCCCC
Q 019195           80 AAGGELFERICNAGRFSEDEARYFFQQLISG--------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKS  151 (344)
Q Consensus        80 ~~~g~L~~~i~~~~~~~~~~~~~~~~ql~~~--------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~~~~~  151 (344)
                      +++++|.+++...+.+++..++.++.|++.+        ||+||||||+|||++.++.  +||+|||++..... .....
T Consensus       113 ~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~-~~~~~  189 (360)
T 3eqc_A          113 MDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGE--IKLCDFGVSGQLID-SMANS  189 (360)
T ss_dssp             CTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCC--EEECCCCCCHHHHH-HC---
T ss_pred             CCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCC--EEEEECCCCccccc-ccccC
Confidence            9999999999988889999888887776653        8999999999999987664  99999999864322 22345


Q ss_pred             CccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHH----------------------------
Q 019195          152 TVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFR----------------------------  203 (344)
Q Consensus       152 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~----------------------------  203 (344)
                      ..||+.|+|||++.+..++ .++|||||||++|+|++|+.||..........                            
T Consensus       190 ~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  268 (360)
T 3eqc_A          190 FVGTRSYMSPERLQGTHYS-VQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFG  268 (360)
T ss_dssp             -CCCCTTCCHHHHTTCCCS-HHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC-------------------------
T ss_pred             CCCCCCeECHHHHcCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCcccccc
Confidence            6799999999999877664 56999999999999999999998754322111                            


Q ss_pred             ----------HHHHHHhhccccCCCCCCCCHhHHHHHHHhcccCCCCCCChHHHhcCcccccC
Q 019195          204 ----------KTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKN  256 (344)
Q Consensus       204 ----------~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~~  256 (344)
                                .....+............+++++.+||.+||+.||.+|||+.++|+||||+..
T Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~  331 (360)
T 3eqc_A          269 MDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS  331 (360)
T ss_dssp             -----CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHHH
T ss_pred             cCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhcc
Confidence                      11111222221112223478899999999999999999999999999999653

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=2.3e-48  Score=358.96  Aligned_cols=254  Identities=26%  Similarity=0.425  Sum_probs=206.7

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCcc--ccHHHHHHHHHHhcCCCCCcceeeEEEEcC-----CEEE
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK--IDANVAREIINHKQLRHPNIIRFKEVVLTP-----THLA   74 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~ei~~l~~l~h~niv~~~~~~~~~-----~~~~   74 (344)
                      ++|++++.||+|+||.||+|.+..+++.||+|++.....  ....+.+|+.++++++||||+++++++...     ..+|
T Consensus        27 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  106 (364)
T 3qyz_A           27 PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVY  106 (364)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEE
T ss_pred             ccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceEE
Confidence            489999999999999999999999999999999975332  235688999999999999999999999765     4789


Q ss_pred             EEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCC
Q 019195           75 IVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS  147 (344)
Q Consensus        75 lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~  147 (344)
                      +||||+. ++|.+++.. +.+++.+++.++.||+.+       ||+||||||+|||++.++.  +||+|||++.......
T Consensus       107 iv~e~~~-~~L~~~l~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~--~kl~Dfg~a~~~~~~~  182 (364)
T 3qyz_A          107 IVQDLME-TDLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCD--LKICDFGLARVADPDH  182 (364)
T ss_dssp             EEEECCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC--EEECCCTTCEECCGGG
T ss_pred             EEEcccC-cCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCC--EEEEeCcceEecCCCC
Confidence            9999996 599998865 568999888887776654       9999999999999977664  9999999997543322


Q ss_pred             C----CCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccc---------
Q 019195          148 R----PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQY---------  214 (344)
Q Consensus       148 ~----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~---------  214 (344)
                      .    ....+||+.|+|||++.+....+.++|||||||++|+|++|++||.+......+..+.........         
T Consensus       183 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  262 (364)
T 3qyz_A          183 DHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL  262 (364)
T ss_dssp             CBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTCCCH
T ss_pred             CccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhh
Confidence            1    344589999999999876665566799999999999999999999988776666555432211100         


Q ss_pred             -------cCC---------CCCCCCHhHHHHHHHhcccCCCCCCChHHHhcCcccccCCCh
Q 019195          215 -------KIP---------DYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLPR  259 (344)
Q Consensus       215 -------~~~---------~~~~~s~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~~~~~  259 (344)
                             ..+         ....+++++.+||.+||+.||.+|||+.++|+||||.+...+
T Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~~~  323 (364)
T 3qyz_A          263 KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDP  323 (364)
T ss_dssp             HHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTTCCG
T ss_pred             hHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhccCc
Confidence                   001         013578999999999999999999999999999999876543

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=8.4e-49  Score=365.54  Aligned_cols=250  Identities=27%  Similarity=0.407  Sum_probs=200.1

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcCCCCCcceeeEEEEcCC------EEEE
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKEVVLTPT------HLAI   75 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~------~~~l   75 (344)
                      .+|++.+.||+|+||+||+|.+..++. ||+|++.......   .+|+.+++.++||||++++++|....      .+++
T Consensus        40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~~~---~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l  115 (394)
T 4e7w_A           40 IAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRFK---NRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNL  115 (394)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTTSC---CHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEE
T ss_pred             ceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcchH---HHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEE
Confidence            379999999999999999999988776 8888776544332   37999999999999999999996543      3889


Q ss_pred             EEecCCCCChHHHHH----hCCCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEec-CCCCCCEEEeecCCCccc
Q 019195           76 VMEYAAGGELFERIC----NAGRFSEDEARYFFQQLISG-------QICHRDLKLENTLLD-GSPAPRLKICDFGYSKSS  143 (344)
Q Consensus        76 v~e~~~~g~L~~~i~----~~~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~-~~~~~~vkL~DFg~a~~~  143 (344)
                      ||||++++ +...+.    ....+++..++.++.||+.+       ||+||||||+|||++ .++  .+||+|||+++..
T Consensus       116 v~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~--~~kL~DFG~a~~~  192 (394)
T 4e7w_A          116 VLEYVPET-VYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSG--VLKLIDFGSAKIL  192 (394)
T ss_dssp             EEECCSEE-HHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTT--EEEECCCTTCEEC
T ss_pred             EeeccCcc-HHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCC--cEEEeeCCCcccc
Confidence            99999764 433332    35678998888887776654       999999999999997 444  5999999999876


Q ss_pred             CCCCCCCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhc----------c
Q 019195          144 LLHSRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAV----------Q  213 (344)
Q Consensus       144 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~----------~  213 (344)
                      .........+||+.|+|||++.+....+.++|||||||++|+|++|++||.+.+....+..++......          .
T Consensus       193 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~  272 (394)
T 4e7w_A          193 IAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNPN  272 (394)
T ss_dssp             CTTCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCGG
T ss_pred             cCCCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChh
Confidence            666666778899999999999876655667999999999999999999999887766666655432111          0


Q ss_pred             ---ccCCC----------CCCCCHhHHHHHHHhcccCCCCCCChHHHhcCcccccCCC
Q 019195          214 ---YKIPD----------YVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLP  258 (344)
Q Consensus       214 ---~~~~~----------~~~~s~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~~~~  258 (344)
                         ..+|.          ...+++++.+||.+||+.||.+|||+.++|+||||.+...
T Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~  330 (394)
T 4e7w_A          273 YMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELRT  330 (394)
T ss_dssp             GSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTTS
T ss_pred             hhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhcc
Confidence               11111          1247889999999999999999999999999999986533

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=1.5e-48  Score=354.96  Aligned_cols=253  Identities=28%  Similarity=0.494  Sum_probs=205.1

Q ss_pred             Cceee-eeeeecCceEEEEEEEcCCCcEEEEEEeecCc---cccHHHHHHHHHHhcC-CCCCcceeeEEEEcCCEEEEEE
Q 019195            3 KYELM-KDIGSGNFGVARLMRNKNTKELVAMKYIERGH---KIDANVAREIINHKQL-RHPNIIRFKEVVLTPTHLAIVM   77 (344)
Q Consensus         3 ~y~~~-~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~ei~~l~~l-~h~niv~~~~~~~~~~~~~lv~   77 (344)
                      +|.+. +.||+|+||+||+|.+..+++.||+|++....   .....+.+|+.+++.+ .||||+++++++.....+++||
T Consensus        29 ~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~lv~  108 (327)
T 3lm5_A           29 FYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILIL  108 (327)
T ss_dssp             HEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             EEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEEEEE
Confidence            57777 89999999999999999999999999987643   2346788999999999 5699999999999999999999


Q ss_pred             ecCCCCChHHHHHhC--CCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCC-CCCEEEeecCCCcccCCCC
Q 019195           78 EYAAGGELFERICNA--GRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSP-APRLKICDFGYSKSSLLHS  147 (344)
Q Consensus        78 e~~~~g~L~~~i~~~--~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~-~~~vkL~DFg~a~~~~~~~  147 (344)
                      ||+.+|+|.+++...  ..+++.+++.++.||+.+       ||+||||||+|||++... .+.+||+|||+++......
T Consensus       109 e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~  188 (327)
T 3lm5_A          109 EYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHAC  188 (327)
T ss_dssp             ECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC----
T ss_pred             EecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCccccccCCcc
Confidence            999999999998553  678999988888877655       999999999999997621 3469999999998765555


Q ss_pred             CCCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCHhHH
Q 019195          148 RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCR  227 (344)
Q Consensus       148 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~  227 (344)
                      .....+||+.|+|||++.+..++ .++|||||||++|+|++|+.||...........+...  ...+..+.+..+++.+.
T Consensus       189 ~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~~~~~~  265 (327)
T 3lm5_A          189 ELREIMGTPEYLAPEILNYDPIT-TATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQV--NVDYSEETFSSVSQLAT  265 (327)
T ss_dssp             -----CCCGGGCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT--CCCCCTTTTTTSCHHHH
T ss_pred             ccccccCCcCccCCeeecCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhc--ccccCchhhcccCHHHH
Confidence            55667899999999999877765 4599999999999999999999887654443333221  22233334457899999


Q ss_pred             HHHHHhcccCCCCCCChHHHhcCcccccCCC
Q 019195          228 NLLSRIFVANPSRRITIKEIKSHPWFLKNLP  258 (344)
Q Consensus       228 ~li~~~L~~dp~~R~s~~ell~hp~~~~~~~  258 (344)
                      +||.+||+.||.+|||+.++|+||||++...
T Consensus       266 ~li~~~L~~dP~~Rpt~~~ll~h~~~~~~~~  296 (327)
T 3lm5_A          266 DFIQSLLVKNPEKRPTAEICLSHSWLQQWDF  296 (327)
T ss_dssp             HHHHHHSCSSGGGSCCHHHHTTCGGGCCCCT
T ss_pred             HHHHHHcCCChhhCcCHHHHhCCHhhccccc
Confidence            9999999999999999999999999977543

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=8.6e-48  Score=344.57  Aligned_cols=247  Identities=32%  Similarity=0.523  Sum_probs=209.4

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCcc----ccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEE
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK----IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVM   77 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~   77 (344)
                      ++|++.+.||+|+||.||+|.+..+++.||+|++.....    ....+.+|+.+++.++||||+++++++...+.+++||
T Consensus        15 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   94 (294)
T 2rku_A           15 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVL   94 (294)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEEE
Confidence            579999999999999999999999999999999876432    2356788999999999999999999999999999999


Q ss_pred             ecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCC-CCC
Q 019195           78 EYAAGGELFERICNAGRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH-SRP  149 (344)
Q Consensus        78 e~~~~g~L~~~i~~~~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~-~~~  149 (344)
                      ||+++++|.+++...+.+++.+++.++.|++.+       ||+||||||+||+++.++.  +||+|||++...... ...
T Consensus        95 e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~--~kl~dfg~~~~~~~~~~~~  172 (294)
T 2rku_A           95 ELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLE--VKIGDFGLATKVEYDGERK  172 (294)
T ss_dssp             ECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC--EEECCCTTCEECCSTTCCB
T ss_pred             ecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCC--EEEEeccCceecccCcccc
Confidence            999999999999888889999988887776654       9999999999999986654  999999998764432 223


Q ss_pred             CCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCHhHHHH
Q 019195          150 KSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL  229 (344)
Q Consensus       150 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  229 (344)
                      ....||+.|+|||++.+..++ .++||||||+++|+|++|+.||........    ...+.......|.  .+++.+.+|
T Consensus       173 ~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~~l~~g~~p~~~~~~~~~----~~~~~~~~~~~~~--~~~~~~~~l  245 (294)
T 2rku_A          173 KVLCGTPNYIAPEVLSKKGHS-FEVDVWSIGCIMYTLLVGKPPFETSCLKET----YLRIKKNEYSIPK--HINPVAASL  245 (294)
T ss_dssp             CCCCSCCSSCCHHHHTTSCBC-THHHHHHHHHHHHHHHHSSCTTCCSSHHHH----HHHHHTTCCCCCT--TSCHHHHHH
T ss_pred             ccccCCCCcCCcchhccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHH----HHHHhhccCCCcc--ccCHHHHHH
Confidence            446799999999999877664 559999999999999999999987654333    2333334444443  688999999


Q ss_pred             HHHhcccCCCCCCChHHHhcCcccccCC
Q 019195          230 LSRIFVANPSRRITIKEIKSHPWFLKNL  257 (344)
Q Consensus       230 i~~~L~~dp~~R~s~~ell~hp~~~~~~  257 (344)
                      |.+||+.||.+|||+.++++||||....
T Consensus       246 i~~~l~~~p~~Rps~~~ll~~~~~~~~~  273 (294)
T 2rku_A          246 IQKMLQTDPTARPTINELLNDEFFTSGY  273 (294)
T ss_dssp             HHHHTCSSGGGSCCGGGGGGSHHHHTSC
T ss_pred             HHHHcccChhhCcCHHHHhhChheecCC
Confidence            9999999999999999999999997653

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=6.7e-48  Score=351.90  Aligned_cols=247  Identities=32%  Similarity=0.531  Sum_probs=210.1

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCcc----ccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEE
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK----IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVM   77 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~   77 (344)
                      ++|++.+.||+|+||.||++.+..+++.||+|++.....    ....+.+|+.+++.++||||+++++++.+.+.+|+||
T Consensus        41 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  120 (335)
T 2owb_A           41 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVL  120 (335)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEE
Confidence            579999999999999999999999999999999876432    2356889999999999999999999999999999999


Q ss_pred             ecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCC-CCC
Q 019195           78 EYAAGGELFERICNAGRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH-SRP  149 (344)
Q Consensus        78 e~~~~g~L~~~i~~~~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~-~~~  149 (344)
                      ||+.+++|.+++.....+++.+++.++.||+.+       ||+||||||+|||++.++.  +||+|||++...... ...
T Consensus       121 e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~--~kl~Dfg~~~~~~~~~~~~  198 (335)
T 2owb_A          121 ELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLE--VKIGDFGLATKVEYDGERK  198 (335)
T ss_dssp             CCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCC--EEECCCTTCEECCSTTCCB
T ss_pred             ecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCC--EEEeeccCceecccCcccc
Confidence            999999999999888889999988887776654       9999999999999987654  999999999765432 233


Q ss_pred             CCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCHhHHHH
Q 019195          150 KSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL  229 (344)
Q Consensus       150 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  229 (344)
                      ....||+.|+|||++.+..+. .++|||||||++|+|++|+.||........+    ..+......++.  .+++.+.+|
T Consensus       199 ~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~pf~~~~~~~~~----~~~~~~~~~~~~--~~~~~~~~l  271 (335)
T 2owb_A          199 KVLCGTPNYIAPEVLSKKGHS-FEVDVWSIGCIMYTLLVGKPPFETSCLKETY----LRIKKNEYSIPK--HINPVAASL  271 (335)
T ss_dssp             CCCCSCCSSCCHHHHHTSCBC-THHHHHHHHHHHHHHHHSSCTTCCSSHHHHH----HHHHHTCCCCCT--TSCHHHHHH
T ss_pred             cccCCCccccCHHHhccCCCC-chhhHHHHHHHHHHHHHCcCCCCCCCHHHHH----HHHhcCCCCCCc--cCCHHHHHH
Confidence            456799999999999877764 4599999999999999999999876543332    333334444443  678999999


Q ss_pred             HHHhcccCCCCCCChHHHhcCcccccCC
Q 019195          230 LSRIFVANPSRRITIKEIKSHPWFLKNL  257 (344)
Q Consensus       230 i~~~L~~dp~~R~s~~ell~hp~~~~~~  257 (344)
                      |.+||+.||.+|||+.++|+||||....
T Consensus       272 i~~~l~~dp~~Rps~~ell~~~~~~~~~  299 (335)
T 2owb_A          272 IQKMLQTDPTARPTINELLNDEFFTSGY  299 (335)
T ss_dssp             HHHHTCSSGGGSCCGGGGGGSHHHHTSC
T ss_pred             HHHHccCChhHCcCHHHHhcCccccCCC
Confidence            9999999999999999999999997653

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=1.9e-48  Score=360.47  Aligned_cols=251  Identities=28%  Similarity=0.426  Sum_probs=191.4

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCcc---ccHHHHHHHHHHhcCCCCCcceeeEEEEcCC------E
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK---IDANVAREIINHKQLRHPNIIRFKEVVLTPT------H   72 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~------~   72 (344)
                      ++|++++.||+|+||.||+|.+..+++.||+|++.....   ....+.+|+.+++.++||||+++++++....      .
T Consensus        25 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~  104 (371)
T 2xrw_A           25 KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQD  104 (371)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCE
T ss_pred             hheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccccc
Confidence            689999999999999999999999999999999976432   2356789999999999999999999997664      7


Q ss_pred             EEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCC
Q 019195           73 LAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLL  145 (344)
Q Consensus        73 ~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~  145 (344)
                      +|+||||+. ++|.+.+.  ..+++..++.++.|++.+       ||+||||||+|||++.++.  +||+|||+++....
T Consensus       105 ~~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~--~kl~Dfg~a~~~~~  179 (371)
T 2xrw_A          105 VYIVMELMD-ANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGT  179 (371)
T ss_dssp             EEEEEECCS-EEHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSC--EEECCCCC------
T ss_pred             eEEEEEcCC-CCHHHHHh--hccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCC--EEEEEeeccccccc
Confidence            899999996 57888875  458888888887776654       9999999999999987654  99999999986554


Q ss_pred             CCCCCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhcc------------
Q 019195          146 HSRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQ------------  213 (344)
Q Consensus       146 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~------------  213 (344)
                      .......+||+.|+|||++.+..++ .++|||||||++|+|++|+.||.+.+....+..++.......            
T Consensus       180 ~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  258 (371)
T 2xrw_A          180 SFMMTPYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVR  258 (371)
T ss_dssp             ----------CTTCCHHHHTTCCCC-TTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSCHHHH
T ss_pred             ccccCCceecCCccCHHHhcCCCCC-chHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHH
Confidence            4445567899999999999887765 459999999999999999999988766555444432211000            


Q ss_pred             ---ccCCCCC---------------------CCCHhHHHHHHHhcccCCCCCCChHHHhcCcccccCCC
Q 019195          214 ---YKIPDYV---------------------HISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLP  258 (344)
Q Consensus       214 ---~~~~~~~---------------------~~s~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~~~~  258 (344)
                         ...+.+.                     ..++++.+||.+||+.||.+|||+.++|+||||.....
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~~  327 (371)
T 2xrw_A          259 TYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYD  327 (371)
T ss_dssp             HHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTTCC
T ss_pred             HHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhhhcC
Confidence               0011100                     01567999999999999999999999999999975433

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=1.7e-48  Score=348.11  Aligned_cols=249  Identities=37%  Similarity=0.638  Sum_probs=210.3

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCc---cccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEEe
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH---KIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVME   78 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e   78 (344)
                      ++|++++.||+|+||.||+|.+..+++.||+|++....   .....+.+|+.++++++||||+++++++...+.+++|||
T Consensus        22 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  101 (287)
T 2wei_A           22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGE  101 (287)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             hcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEEE
Confidence            47999999999999999999999999999999987543   234678899999999999999999999999999999999


Q ss_pred             cCCCCChHHHHHhCCCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCC-CCCEEEeecCCCcccCCCCCCC
Q 019195           79 YAAGGELFERICNAGRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSP-APRLKICDFGYSKSSLLHSRPK  150 (344)
Q Consensus        79 ~~~~g~L~~~i~~~~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~-~~~vkL~DFg~a~~~~~~~~~~  150 (344)
                      |+++++|.+.+.....+++.+++.++.|++.+       ||+||||||+||+++.+. .+.+||+|||++..........
T Consensus       102 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~~~~~  181 (287)
T 2wei_A          102 LYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMK  181 (287)
T ss_dssp             CCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCCSSCS
T ss_pred             ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeecCCCccc
Confidence            99999999999888889999988888877655       999999999999997543 3469999999987655544445


Q ss_pred             CCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccc--cCCCCCCCCHhHHH
Q 019195          151 STVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQY--KIPDYVHISQDCRN  228 (344)
Q Consensus       151 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~s~~~~~  228 (344)
                      ...||+.|+|||++.+. + +.++||||||+++|+|++|..||........    ...+.....  ..+.+..+++++.+
T Consensus       182 ~~~~~~~y~aPE~~~~~-~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~  255 (287)
T 2wei_A          182 DRIGTAYYIAPEVLRGT-Y-DEKCDVWSAGVILYILLSGTPPFYGKNEYDI----LKRVETGKYAFDLPQWRTISDDAKD  255 (287)
T ss_dssp             CHHHHHTTCCHHHHTTC-C-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH----HHHHHHCCCCCCSGGGTTSCHHHHH
T ss_pred             cccCcccccChHHhcCC-C-CCchhhHhHHHHHHHHHhCCCCCCCCCHHHH----HHHHHcCCCCCCchhhhhcCHHHHH
Confidence            56799999999998764 4 4569999999999999999999988654333    233333333  33444578999999


Q ss_pred             HHHHhcccCCCCCCChHHHhcCcccccC
Q 019195          229 LLSRIFVANPSRRITIKEIKSHPWFLKN  256 (344)
Q Consensus       229 li~~~L~~dp~~R~s~~ell~hp~~~~~  256 (344)
                      ||.+||+.||.+|||+.++|+||||.+.
T Consensus       256 li~~~l~~dp~~Rps~~ell~hp~~~~~  283 (287)
T 2wei_A          256 LIRKMLTFHPSLRITATQCLEHPWIQKY  283 (287)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHHSHHHHHH
T ss_pred             HHHHHcccChhhCcCHHHHhcCHHHhcc
Confidence            9999999999999999999999999654

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=3.5e-48  Score=359.98  Aligned_cols=253  Identities=28%  Similarity=0.378  Sum_probs=204.0

Q ss_pred             CCCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcCC-CC-----CcceeeEEEEcCCEEE
Q 019195            1 MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLR-HP-----NIIRFKEVVLTPTHLA   74 (344)
Q Consensus         1 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~l~~l~-h~-----niv~~~~~~~~~~~~~   74 (344)
                      +++|++.+.||+|+||+||+|.+..+++.||||++.........+.+|+.+++.++ |+     +|+++++++...+.+|
T Consensus        53 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~  132 (382)
T 2vx3_A           53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLC  132 (382)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEEE
T ss_pred             eeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCceE
Confidence            47899999999999999999999999999999999866555566778888888874 54     4999999999999999


Q ss_pred             EEEecCCCCChHHHHHhC--CCCCHHHHHHHHHHHHHC---------CeeecCCCCCCeEecCCCCCCEEEeecCCCccc
Q 019195           75 IVMEYAAGGELFERICNA--GRFSEDEARYFFQQLISG---------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSS  143 (344)
Q Consensus        75 lv~e~~~~g~L~~~i~~~--~~~~~~~~~~~~~ql~~~---------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~  143 (344)
                      +||||+. ++|.+++...  ..+++..++.++.|++.+         ||+||||||+|||++.+..+.+||+|||+++..
T Consensus       133 lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a~~~  211 (382)
T 2vx3_A          133 LVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQL  211 (382)
T ss_dssp             EEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECCCTTCEET
T ss_pred             EEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEeccCceec
Confidence            9999995 5999999765  468999999888887754         899999999999997655556999999999754


Q ss_pred             CCCCCCCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccc---------
Q 019195          144 LLHSRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQY---------  214 (344)
Q Consensus       144 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~---------  214 (344)
                      .  ......+||+.|+|||++.+..++ .++|||||||++|+|++|++||.+......+..+.........         
T Consensus       212 ~--~~~~~~~~t~~y~aPE~~~~~~~~-~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  288 (382)
T 2vx3_A          212 G--QRIYQYIQSRFYRSPEVLLGMPYD-LAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAPKA  288 (382)
T ss_dssp             T--CCCCSSCSCGGGCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTCTTH
T ss_pred             c--cccccccCCccccChHHHcCCCCC-cHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhHHH
Confidence            3  234567899999999999888765 5599999999999999999999988766665555543211100         


Q ss_pred             -----cCCC-------------------CCC-------------------------CCHhHHHHHHHhcccCCCCCCChH
Q 019195          215 -----KIPD-------------------YVH-------------------------ISQDCRNLLSRIFVANPSRRITIK  245 (344)
Q Consensus       215 -----~~~~-------------------~~~-------------------------~s~~~~~li~~~L~~dp~~R~s~~  245 (344)
                           ..|.                   ...                         .++++.+||.+||+.||.+|||+.
T Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~Rpta~  368 (382)
T 2vx3_A          289 RKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQPY  368 (382)
T ss_dssp             HHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSCTTTSCCHH
T ss_pred             HHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCCChhhCCCHH
Confidence                 0000                   000                         013789999999999999999999


Q ss_pred             HHhcCcccccCC
Q 019195          246 EIKSHPWFLKNL  257 (344)
Q Consensus       246 ell~hp~~~~~~  257 (344)
                      |+|+||||++..
T Consensus       369 e~L~hp~f~~~~  380 (382)
T 2vx3_A          369 YALQHSFFKKTA  380 (382)
T ss_dssp             HHTTSGGGCC--
T ss_pred             HHhcCcccccCC
Confidence            999999997653

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=5.5e-48  Score=343.98  Aligned_cols=244  Identities=23%  Similarity=0.323  Sum_probs=199.0

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCcc---ccHHHHHHHHHHhcC-CCCCcceeeEEEEcCCEEEEEE
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK---IDANVAREIINHKQL-RHPNIIRFKEVVLTPTHLAIVM   77 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~ei~~l~~l-~h~niv~~~~~~~~~~~~~lv~   77 (344)
                      ++|++++.||+|+||+||+|.+..+++.||+|++.....   ....+.+|+..+..+ +||||+++++++...+.+++||
T Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv~   90 (289)
T 1x8b_A           11 TEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQN   90 (289)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEEE
T ss_pred             chhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence            479999999999999999999999999999999986432   335688899999999 8999999999999999999999


Q ss_pred             ecCCCCChHHHHHhC----CCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCC-----------------CC
Q 019195           78 EYAAGGELFERICNA----GRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGS-----------------PA  129 (344)
Q Consensus        78 e~~~~g~L~~~i~~~----~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~-----------------~~  129 (344)
                      ||+++++|.+++...    ..+++.+++.++.||+.+       ||+||||||+|||++.+                 ..
T Consensus        91 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~  170 (289)
T 1x8b_A           91 EYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNK  170 (289)
T ss_dssp             ECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC--------------------C
T ss_pred             EecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccccccccCCc
Confidence            999999999999764    678999988888887655       99999999999999743                 23


Q ss_pred             CCEEEeecCCCcccCCCCCCCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHH
Q 019195          130 PRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRI  209 (344)
Q Consensus       130 ~~vkL~DFg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~  209 (344)
                      ..+||+|||++.....   .....||+.|+|||++.+....+.++|||||||++|+|++|.+|+....   ....    +
T Consensus       171 ~~~kl~Dfg~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~---~~~~----~  240 (289)
T 1x8b_A          171 VMFKIGDLGHVTRISS---PQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD---QWHE----I  240 (289)
T ss_dssp             CCEEECCCTTCEETTC---SCCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSH---HHHH----H
T ss_pred             eEEEEcccccccccCC---ccccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchh---HHHH----H
Confidence            3599999999875433   2345699999999999876555567999999999999999988875432   2221    1


Q ss_pred             hhccccCCCCCCCCHhHHHHHHHhcccCCCCCCChHHHhcCcccccC
Q 019195          210 MAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKN  256 (344)
Q Consensus       210 ~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~~  256 (344)
                      ..... ......+++.+.+||.+||+.||.+|||+.++++||||...
T Consensus       241 ~~~~~-~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  286 (289)
T 1x8b_A          241 RQGRL-PRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSA  286 (289)
T ss_dssp             HTTCC-CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC---
T ss_pred             HcCCC-CCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhhhh
Confidence            11111 12233689999999999999999999999999999999764

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=1.1e-47  Score=343.27  Aligned_cols=246  Identities=23%  Similarity=0.364  Sum_probs=200.7

Q ss_pred             CceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCcc---ccHHHHHHHHHHhcCCCCCcceeeEEEEc----CCEEEE
Q 019195            3 KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK---IDANVAREIINHKQLRHPNIIRFKEVVLT----PTHLAI   75 (344)
Q Consensus         3 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~ei~~l~~l~h~niv~~~~~~~~----~~~~~l   75 (344)
                      .|++.+.||+|+||.||+|.+..++..||+|++.....   ....+.+|+.+++.++||||+++++++..    ...+++
T Consensus        27 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l  106 (290)
T 1t4h_A           27 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL  106 (290)
T ss_dssp             EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred             eEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEE
Confidence            58999999999999999999999999999999876432   23568899999999999999999999875    356899


Q ss_pred             EEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHC-------C--eeecCCCCCCeEec-CCCCCCEEEeecCCCcccCC
Q 019195           76 VMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-------Q--ICHRDLKLENTLLD-GSPAPRLKICDFGYSKSSLL  145 (344)
Q Consensus        76 v~e~~~~g~L~~~i~~~~~~~~~~~~~~~~ql~~~-------~--iiH~Dikp~NIl~~-~~~~~~vkL~DFg~a~~~~~  145 (344)
                      ||||+++++|.+++...+.+++..++.++.||+.+       |  |+||||||+|||++ .++  .+||+|||++.... 
T Consensus       107 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~--~~kl~Dfg~~~~~~-  183 (290)
T 1t4h_A          107 VTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTG--SVKIGDLGLATLKR-  183 (290)
T ss_dssp             EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTS--CEEECCTTGGGGCC-
T ss_pred             EEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCC--CEEEeeCCCccccc-
Confidence            99999999999999988889999988888887765       7  99999999999997 344  59999999986432 


Q ss_pred             CCCCCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCHh
Q 019195          146 HSRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQD  225 (344)
Q Consensus       146 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~  225 (344)
                      ........||+.|+|||++.+. + +.++|||||||++|+|++|+.||...........   .+.............+++
T Consensus       184 ~~~~~~~~~t~~y~aPE~~~~~-~-~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~  258 (290)
T 1t4h_A          184 ASFAKAVIGTPEFMAPEMYEEK-Y-DESVDVYAFGMCMLEMATSEYPYSECQNAAQIYR---RVTSGVKPASFDKVAIPE  258 (290)
T ss_dssp             TTSBEESCSSCCCCCGGGGGTC-C-CTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHH---HHTTTCCCGGGGGCCCHH
T ss_pred             ccccccccCCcCcCCHHHHhcc-C-CCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHH---HHhccCCccccCCCCCHH
Confidence            2223445799999999988643 4 5569999999999999999999987665443332   222222222223356789


Q ss_pred             HHHHHHHhcccCCCCCCChHHHhcCcccccC
Q 019195          226 CRNLLSRIFVANPSRRITIKEIKSHPWFLKN  256 (344)
Q Consensus       226 ~~~li~~~L~~dp~~R~s~~ell~hp~~~~~  256 (344)
                      +.+||.+||+.||.+|||+.++|+||||++.
T Consensus       259 l~~li~~~l~~dp~~Rps~~ell~h~~f~~~  289 (290)
T 1t4h_A          259 VKEIIEGCIRQNKDERYSIKDLLNHAFFQEE  289 (290)
T ss_dssp             HHHHHHHHSCSSGGGSCCHHHHHTSGGGC--
T ss_pred             HHHHHHHHccCChhhCCCHHHHhhCcccccC
Confidence            9999999999999999999999999999753

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=9.3e-49  Score=356.17  Aligned_cols=244  Identities=22%  Similarity=0.333  Sum_probs=191.2

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCcc--ccHHHHHHHHHHhcCCCCCcceeeEEEEcCC--------
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK--IDANVAREIINHKQLRHPNIIRFKEVVLTPT--------   71 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~--------   71 (344)
                      ++|++++.||+|+||.||+|.+..+++.||||++.....  ....+.+|+.++++++||||++++++|....        
T Consensus         6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   85 (332)
T 3qd2_B            6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEM   85 (332)
T ss_dssp             HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHH
T ss_pred             hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhh
Confidence            579999999999999999999999999999999975432  3467899999999999999999999986543        


Q ss_pred             -------------------------------------------------EEEEEEecCCCCChHHHHHhCCC---CCHHH
Q 019195           72 -------------------------------------------------HLAIVMEYAAGGELFERICNAGR---FSEDE   99 (344)
Q Consensus        72 -------------------------------------------------~~~lv~e~~~~g~L~~~i~~~~~---~~~~~   99 (344)
                                                                       .+++|||||++++|.+++.....   .....
T Consensus        86 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~  165 (332)
T 3qd2_B           86 DEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGV  165 (332)
T ss_dssp             HC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHHH
T ss_pred             hhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhHH
Confidence                                                             38999999999999999987654   34444


Q ss_pred             HHHHHHHHH-------HCCeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCC-------------CCCCCccCCccc
Q 019195          100 ARYFFQQLI-------SGQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS-------------RPKSTVGTPAYI  159 (344)
Q Consensus       100 ~~~~~~ql~-------~~~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~-------------~~~~~~gt~~y~  159 (344)
                      ++.++.|++       +.||+||||||+|||++.++  ++||+|||+++......             .....+||+.|+
T Consensus       166 ~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~--~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~  243 (332)
T 3qd2_B          166 CLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDD--VVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYM  243 (332)
T ss_dssp             HHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC--CEEECCCTTCEECSCC--------------CCCSCC-CGGGS
T ss_pred             HHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCC--CEEEeecCcccccccchhhccccccccccccccccCCCcCcc
Confidence            555655554       55999999999999997665  49999999997654331             234457999999


Q ss_pred             CCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCHhHHHHHHHhcccCCC
Q 019195          160 APEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPS  239 (344)
Q Consensus       160 aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~  239 (344)
                      |||++.+..++ .++|||||||++|+|++|..|+..      .............. ......++++.+||.+||+.||.
T Consensus       244 aPE~~~~~~~~-~~~Di~slG~il~el~~~~~~~~~------~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~p~  315 (332)
T 3qd2_B          244 SPEQIHGNNYS-HKVDIFSLGLILFELLYSFSTQME------RVRIITDVRNLKFP-LLFTQKYPQEHMMVQDMLSPSPT  315 (332)
T ss_dssp             CHHHHHCCCCC-THHHHHHHHHHHHHHHSCCCCHHH------HHHHHHHHHTTCCC-HHHHHHCHHHHHHHHHHHCSSGG
T ss_pred             ChHHhcCCCCc-chhhHHHHHHHHHHHHHcCCChhH------HHHHHHHhhccCCC-cccccCChhHHHHHHHHccCCCC
Confidence            99999887764 559999999999999998766521      12222222222111 11224578899999999999999


Q ss_pred             CCCChHHHhcCccccc
Q 019195          240 RRITIKEIKSHPWFLK  255 (344)
Q Consensus       240 ~R~s~~ell~hp~~~~  255 (344)
                      +|||+.++|+||||++
T Consensus       316 ~Rps~~~~l~~~~f~~  331 (332)
T 3qd2_B          316 ERPEATDIIENAIFEN  331 (332)
T ss_dssp             GSCCHHHHHHSTTCCC
T ss_pred             cCCCHHHHhhchhhhc
Confidence            9999999999999964

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=6.7e-48  Score=353.57  Aligned_cols=247  Identities=26%  Similarity=0.395  Sum_probs=203.3

Q ss_pred             CceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCccc----cHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEEe
Q 019195            3 KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKI----DANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVME   78 (344)
Q Consensus         3 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~----~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e   78 (344)
                      +|++++.||+|+||+||+|.+..+++.||+|++......    ...+.+|+.++++++||||+++++++..++..|+|||
T Consensus        55 ~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  134 (348)
T 1u5q_A           55 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME  134 (348)
T ss_dssp             HEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             heeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEEe
Confidence            589999999999999999999999999999999764322    2468899999999999999999999999999999999


Q ss_pred             cCCCCChHHHHH-hCCCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCCCCC
Q 019195           79 YAAGGELFERIC-NAGRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPK  150 (344)
Q Consensus        79 ~~~~g~L~~~i~-~~~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~~~~  150 (344)
                      |+. |+|.+.+. ....+++.+++.++.|++.+       ||+||||||+|||++.++.  +||+|||++.....   ..
T Consensus       135 ~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~--~kL~DfG~a~~~~~---~~  208 (348)
T 1u5q_A          135 YCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGL--VKLGDFGSASIMAP---AN  208 (348)
T ss_dssp             CCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTE--EEECCCTTCBSSSS---BC
T ss_pred             cCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCC--EEEeeccCceecCC---CC
Confidence            997 68877775 45679999888887776654       9999999999999987654  99999999875432   34


Q ss_pred             CCccCCcccCCcccc---CCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCHhHH
Q 019195          151 STVGTPAYIAPEVLS---RREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCR  227 (344)
Q Consensus       151 ~~~gt~~y~aPE~~~---~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~  227 (344)
                      ..+||+.|+|||++.   ...+ +.++|||||||++|+|++|++||...........+    ............+++.+.
T Consensus       209 ~~~gt~~y~aPE~~~~~~~~~~-~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~l~  283 (348)
T 1u5q_A          209 SFVGTPYWMAPEVILAMDEGQY-DGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI----AQNESPALQSGHWSEYFR  283 (348)
T ss_dssp             CCCSCGGGCCHHHHHTTSSCCB-CTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH----HHSCCCCCCCTTSCHHHH
T ss_pred             cccCCcceeCHhhhccccCCCC-CcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHH----HhcCCCCCCCCCCCHHHH
Confidence            567999999999985   3344 45699999999999999999999876654433322    222222223346799999


Q ss_pred             HHHHHhcccCCCCCCChHHHhcCcccccCCChh
Q 019195          228 NLLSRIFVANPSRRITIKEIKSHPWFLKNLPRE  260 (344)
Q Consensus       228 ~li~~~L~~dp~~R~s~~ell~hp~~~~~~~~~  260 (344)
                      +||.+||+.||.+|||+.++++||||....++.
T Consensus       284 ~li~~~l~~dP~~Rps~~~ll~h~~~~~~~~~~  316 (348)
T 1u5q_A          284 NFVDSCLQKIPQDRPTSEVLLKHRFVLRERPPT  316 (348)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHTTCHHHHSCCCTT
T ss_pred             HHHHHHcccChhhCcCHHHHhhChhhhccCCcc
Confidence            999999999999999999999999998765543

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=1.2e-48  Score=354.66  Aligned_cols=251  Identities=33%  Similarity=0.555  Sum_probs=201.0

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCcc---------ccHHHHHHHHHHhcCCCCCcceeeEEEEcCCE
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK---------IDANVAREIINHKQLRHPNIIRFKEVVLTPTH   72 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---------~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~   72 (344)
                      ++|++.+.||+|+||.||+|.+..+++.||+|++.....         ....+.+|+.++++++||||+++++++..+. 
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-   88 (322)
T 2ycf_A           10 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED-   88 (322)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS-
T ss_pred             hceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc-
Confidence            479999999999999999999999999999999865321         1235789999999999999999999997665 


Q ss_pred             EEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCC-CCCEEEeecCCCcccC
Q 019195           73 LAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSP-APRLKICDFGYSKSSL  144 (344)
Q Consensus        73 ~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~-~~~vkL~DFg~a~~~~  144 (344)
                      +|+||||+++++|.+++.....+++..++.++.||+.+       ||+||||||+|||++.++ ...+||+|||++....
T Consensus        89 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~  168 (322)
T 2ycf_A           89 YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG  168 (322)
T ss_dssp             EEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTCEECC
T ss_pred             eEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCccceecc
Confidence            89999999999999999888899999888887776654       999999999999997543 3459999999987543


Q ss_pred             CCCCCCCCccCCcccCCcccc--CCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCC--CCC
Q 019195          145 LHSRPKSTVGTPAYIAPEVLS--RREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIP--DYV  220 (344)
Q Consensus       145 ~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~  220 (344)
                      .........||+.|+|||++.  +....+.++|||||||++|+|++|..||............+.   .......  .+.
T Consensus       169 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~---~~~~~~~~~~~~  245 (322)
T 2ycf_A          169 ETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQIT---SGKYNFIPEVWA  245 (322)
T ss_dssp             CCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHH---HTCCCCCHHHHT
T ss_pred             cccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHH---hCccccCchhhh
Confidence            332223456999999999974  233335669999999999999999999987654433333222   1222111  123


Q ss_pred             CCCHhHHHHHHHhcccCCCCCCChHHHhcCcccccC
Q 019195          221 HISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKN  256 (344)
Q Consensus       221 ~~s~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~~  256 (344)
                      .+++.+.+||.+||+.||.+|||+.++|+||||...
T Consensus       246 ~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~~  281 (322)
T 2ycf_A          246 EVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDE  281 (322)
T ss_dssp             TSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCCH
T ss_pred             hcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCcCCH
Confidence            578999999999999999999999999999999764

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=2.4e-48  Score=352.36  Aligned_cols=250  Identities=23%  Similarity=0.361  Sum_probs=201.9

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCcc--ccHHHHHHHHHHhcCCCCCcceeeEEEEcCC--EEEEEE
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK--IDANVAREIINHKQLRHPNIIRFKEVVLTPT--HLAIVM   77 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~--~~~lv~   77 (344)
                      ++|++.+.||+|+||+||+|.+..+++.||+|++.....  ....+.+|+.++++++||||+++++++....  .+++||
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   88 (319)
T 4euu_A            9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM   88 (319)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred             CCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEE
Confidence            479999999999999999999999999999999976432  2366789999999999999999999998765  789999


Q ss_pred             ecCCCCChHHHHHhCCC---CCHHHHHHHHHHHHHC-------CeeecCCCCCCeEec--CCCCCCEEEeecCCCcccCC
Q 019195           78 EYAAGGELFERICNAGR---FSEDEARYFFQQLISG-------QICHRDLKLENTLLD--GSPAPRLKICDFGYSKSSLL  145 (344)
Q Consensus        78 e~~~~g~L~~~i~~~~~---~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~--~~~~~~vkL~DFg~a~~~~~  145 (344)
                      ||+++++|.+++.....   +++.+++.++.|++.+       ||+||||||+|||+.  .+..+.+||+|||+++....
T Consensus        89 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~~~  168 (319)
T 4euu_A           89 EFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELED  168 (319)
T ss_dssp             ECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCTTCEECCT
T ss_pred             eCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCCCceecCC
Confidence            99999999999976443   8999888888777655       999999999999982  12233499999999987665


Q ss_pred             CCCCCCCccCCcccCCcccc--------CCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccc---
Q 019195          146 HSRPKSTVGTPAYIAPEVLS--------RREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQY---  214 (344)
Q Consensus       146 ~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~---  214 (344)
                      .......+||+.|+|||++.        +..+ +.++|||||||++|+|++|+.||............+..+.....   
T Consensus       169 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~-~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~p~~~  247 (319)
T 4euu_A          169 DEQFVSLYGTEEYLHPDMYERAVLRKDHQKKY-GATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGA  247 (319)
T ss_dssp             TCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCB-CTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHHCCTTC
T ss_pred             CCceeecccCCCccCHHHhhhccccccccCCC-CcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcCCCccc
Confidence            55556678999999999986        3344 45699999999999999999999876554444455544443322   


Q ss_pred             ----------------cCCCCC----CCCHhHHHHHHHhcccCCCCCCChHHHhcCcc
Q 019195          215 ----------------KIPDYV----HISQDCRNLLSRIFVANPSRRITIKEIKSHPW  252 (344)
Q Consensus       215 ----------------~~~~~~----~~s~~~~~li~~~L~~dp~~R~s~~ell~hp~  252 (344)
                                      ..+...    .+++.+.+||.+||+.||.+|||+.|+|+||-
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~  305 (319)
T 4euu_A          248 ISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETS  305 (319)
T ss_dssp             CEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHH
T ss_pred             chhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccH
Confidence                            111111    23457889999999999999999999999964

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=7.3e-48  Score=358.65  Aligned_cols=247  Identities=26%  Similarity=0.384  Sum_probs=199.1

Q ss_pred             CceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCcc---ccHHHHHHHHHHhcCC--CCCcceeeEEEEcCCEEEEEE
Q 019195            3 KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK---IDANVAREIINHKQLR--HPNIIRFKEVVLTPTHLAIVM   77 (344)
Q Consensus         3 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~ei~~l~~l~--h~niv~~~~~~~~~~~~~lv~   77 (344)
                      +|++++.||+|+||.||+|.+.. ++.||||++.....   ....+.+|+.+++.++  ||||+++++++..++.+|+||
T Consensus        57 ~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~  135 (390)
T 2zmd_A           57 IYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM  135 (390)
T ss_dssp             EEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             ceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence            59999999999999999999865 88999999976432   2356889999999996  599999999999999999999


Q ss_pred             ecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCC---
Q 019195           78 EYAAGGELFERICNAGRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS---  147 (344)
Q Consensus        78 e~~~~g~L~~~i~~~~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~---  147 (344)
                      | +.+++|.+++.....+++.+++.++.||+.+       ||+||||||+|||++.   +.+||+|||+++......   
T Consensus       136 E-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~---~~~kl~DFG~a~~~~~~~~~~  211 (390)
T 2zmd_A          136 E-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD---GMLKLIDFGIANQMQPDTTSV  211 (390)
T ss_dssp             E-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEESS---SCEEECCCSSSCCC-------
T ss_pred             e-cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEEC---CeEEEEecCccccccCCCccc
Confidence            9 5688999999998899998888887777655       9999999999999953   359999999998654332   


Q ss_pred             CCCCCccCCcccCCccccCC----------CCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCC
Q 019195          148 RPKSTVGTPAYIAPEVLSRR----------EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIP  217 (344)
Q Consensus       148 ~~~~~~gt~~y~aPE~~~~~----------~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  217 (344)
                      .....+||+.|+|||++.+.          ...+.++|||||||++|+|++|++||.......   ..+..+.......+
T Consensus       212 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~---~~~~~~~~~~~~~~  288 (390)
T 2zmd_A          212 VKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI---SKLHAIIDPNHEIE  288 (390)
T ss_dssp             --CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH---HHHHHHHCTTSCCC
T ss_pred             cCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHH---HHHHHHhCccccCC
Confidence            23456799999999998652          234567999999999999999999998754321   22233333333333


Q ss_pred             CCCCCCHhHHHHHHHhcccCCCCCCChHHHhcCcccccCC
Q 019195          218 DYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNL  257 (344)
Q Consensus       218 ~~~~~s~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~~~  257 (344)
                      .....++++.+||.+||+.||.+|||+.++|+||||....
T Consensus       289 ~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~~  328 (390)
T 2zmd_A          289 FPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT  328 (390)
T ss_dssp             CCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCC
T ss_pred             CCccchHHHHHHHHHHcccChhhCCCHHHHhhCcCccccC
Confidence            3345688999999999999999999999999999997654

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=6.2e-48  Score=344.47  Aligned_cols=248  Identities=21%  Similarity=0.336  Sum_probs=185.5

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCcccc---HHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEEe
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKID---ANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVME   78 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e   78 (344)
                      ++|++++.||+|+||.||+|.+..+++.||+|++.......   ..+.++...++.++||||+++++++..++..++|||
T Consensus         7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~e   86 (290)
T 3fme_A            7 DDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICME   86 (290)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEEE
T ss_pred             HhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEEe
Confidence            68999999999999999999999999999999997643222   223444555788899999999999999999999999


Q ss_pred             cCCCCChHHHHH----hCCCCCHHHHHHHHHHHHH-------C-CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCC
Q 019195           79 YAAGGELFERIC----NAGRFSEDEARYFFQQLIS-------G-QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH  146 (344)
Q Consensus        79 ~~~~g~L~~~i~----~~~~~~~~~~~~~~~ql~~-------~-~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~  146 (344)
                      |++ |+|.+++.    ....+++..++.++.|++.       . ||+||||||+|||++.++  ++||+|||++......
T Consensus        87 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~--~~kl~Dfg~~~~~~~~  163 (290)
T 3fme_A           87 LMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALG--QVKMCDFGISGYLVDD  163 (290)
T ss_dssp             CCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTC--CEEBCCC---------
T ss_pred             hhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCC--CEEEeecCCccccccc
Confidence            997 58877664    3567999988888777654       4 999999999999997765  4999999999866555


Q ss_pred             CCCCCCccCCcccCCcccc---CCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCC
Q 019195          147 SRPKSTVGTPAYIAPEVLS---RREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHIS  223 (344)
Q Consensus       147 ~~~~~~~gt~~y~aPE~~~---~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s  223 (344)
                      .......||+.|+|||++.   .....+.++|||||||++|+|++|+.||.........  . ...............++
T Consensus       164 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~--~-~~~~~~~~~~~~~~~~~  240 (290)
T 3fme_A          164 VAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQ--L-KQVVEEPSPQLPADKFS  240 (290)
T ss_dssp             ------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHH--H-HHHHHSCCCCCCTTTSC
T ss_pred             ccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHH--H-HHHhccCCCCcccccCC
Confidence            5555568999999999972   3333456799999999999999999999865433221  1 12222222222234689


Q ss_pred             HhHHHHHHHhcccCCCCCCChHHHhcCccccc
Q 019195          224 QDCRNLLSRIFVANPSRRITIKEIKSHPWFLK  255 (344)
Q Consensus       224 ~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~  255 (344)
                      +++.+||.+||+.||.+|||+.++++||||..
T Consensus       241 ~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~  272 (290)
T 3fme_A          241 AEFVDFTSQCLKKNSKERPTYPELMQHPFFTL  272 (290)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHH
T ss_pred             HHHHHHHHHHhhcChhhCcCHHHHHhCccccc
Confidence            99999999999999999999999999999964

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=4.7e-48  Score=354.33  Aligned_cols=256  Identities=22%  Similarity=0.409  Sum_probs=209.3

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCcccc------------------HHHHHHHHHHhcCCCCCccee
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKID------------------ANVAREIINHKQLRHPNIIRF   63 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~------------------~~~~~ei~~l~~l~h~niv~~   63 (344)
                      ++|++.+.||+|+||.||+|.+  +++.||+|++.......                  ..+.+|+.++++++||||+++
T Consensus        31 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~  108 (348)
T 2pml_X           31 NDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC  108 (348)
T ss_dssp             TTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred             CceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence            6899999999999999999998  89999999987532211                  789999999999999999999


Q ss_pred             eEEEEcCCEEEEEEecCCCCChHHH------HHh--CCCCCHHHHHHHHHHHH-------H-CCeeecCCCCCCeEecCC
Q 019195           64 KEVVLTPTHLAIVMEYAAGGELFER------ICN--AGRFSEDEARYFFQQLI-------S-GQICHRDLKLENTLLDGS  127 (344)
Q Consensus        64 ~~~~~~~~~~~lv~e~~~~g~L~~~------i~~--~~~~~~~~~~~~~~ql~-------~-~~iiH~Dikp~NIl~~~~  127 (344)
                      ++++...+.+|+||||+++++|.++      +..  ...+++..++.++.|++       + .||+||||||+|||++.+
T Consensus       109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Nil~~~~  188 (348)
T 2pml_X          109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKN  188 (348)
T ss_dssp             SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGEEECTT
T ss_pred             EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhEEEcCC
Confidence            9999999999999999999999998      655  56789888888776655       5 699999999999999766


Q ss_pred             CCCCEEEeecCCCcccCCCCCCCCCccCCcccCCccccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHH
Q 019195          128 PAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRR-EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTI  206 (344)
Q Consensus       128 ~~~~vkL~DFg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~  206 (344)
                      +.  +||+|||++...... ......||+.|+|||++.+. .+.+.++|||||||++|+|++|+.||........   ..
T Consensus       189 ~~--~kl~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~---~~  262 (348)
T 2pml_X          189 GR--VKLSDFGESEYMVDK-KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVE---LF  262 (348)
T ss_dssp             SC--EEECCCTTCEECBTT-EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHH---HH
T ss_pred             Cc--EEEeccccccccccc-cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHH---HH
Confidence            64  999999998754332 33456799999999999877 4444379999999999999999999988765322   23


Q ss_pred             HHHhhccccCCCC-----------------CCCCHhHHHHHHHhcccCCCCCCChHHHhcCcccccCCChhhHHHH
Q 019195          207 SRIMAVQYKIPDY-----------------VHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLPRELTETA  265 (344)
Q Consensus       207 ~~~~~~~~~~~~~-----------------~~~s~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~~~~~~~~~~~  265 (344)
                      ..+.......|..                 ..+++.+.+||.+||+.||.+|||+.++++||||.......+....
T Consensus       263 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~~~~~~~~~~~~  338 (348)
T 2pml_X          263 NNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADTNIEDLREFS  338 (348)
T ss_dssp             HHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGTTCCHHHHHHHH
T ss_pred             HHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCccccCCCHHHHHHHH
Confidence            3333333444421                 4688999999999999999999999999999999876555444333

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.1e-47  Score=351.61  Aligned_cols=249  Identities=26%  Similarity=0.386  Sum_probs=197.5

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCccc---cHHHHHHHHHHhcCCC--CCcceeeEEEEcCCEEEEE
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKI---DANVAREIINHKQLRH--PNIIRFKEVVLTPTHLAIV   76 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~ei~~l~~l~h--~niv~~~~~~~~~~~~~lv   76 (344)
                      ++|++++.||+|+||.||++.+. +++.||+|++......   ...+.+|+.+++.++|  |||+++++++..+..+|+|
T Consensus         9 ~~y~i~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv   87 (343)
T 3dbq_A            9 RIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV   87 (343)
T ss_dssp             CEEEEEEEESCCSSEEEEEEECT-TSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             CEEEEEEEEecCCCeEEEEEEeC-CCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEE
Confidence            47999999999999999999884 6889999999764332   2568899999999976  9999999999999999999


Q ss_pred             EecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCCC-
Q 019195           77 MEYAAGGELFERICNAGRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR-  148 (344)
Q Consensus        77 ~e~~~~g~L~~~i~~~~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~~-  148 (344)
                      ||+ .+++|.+++...+.+++.+++.++.|++.+       ||+||||||+|||++.   +.+||+|||+++....... 
T Consensus        88 ~e~-~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~~---~~~kl~DFG~a~~~~~~~~~  163 (343)
T 3dbq_A           88 MEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD---GMLKLIDFGIANQMQPDTTS  163 (343)
T ss_dssp             ECC-CSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEET---TEEEECCCSSSCCC------
T ss_pred             EeC-CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEEC---CcEEEeecccccccCccccc
Confidence            995 588999999999999999888887776655       9999999999999963   3499999999976543322 


Q ss_pred             --CCCCccCCcccCCccccC----------CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccC
Q 019195          149 --PKSTVGTPAYIAPEVLSR----------REYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKI  216 (344)
Q Consensus       149 --~~~~~gt~~y~aPE~~~~----------~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  216 (344)
                        ....+||+.|+|||++.+          ....+.++|||||||++|+|++|+.||.......   ..+..+.......
T Consensus       164 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~---~~~~~~~~~~~~~  240 (343)
T 3dbq_A          164 VVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI---SKLHAIIDPNHEI  240 (343)
T ss_dssp             ------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHH---HHHHHHHCTTSCC
T ss_pred             ccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHH---HHHHHHhcCCccc
Confidence              235579999999999864          1334566999999999999999999998754422   1222223233333


Q ss_pred             CCCCCCCHhHHHHHHHhcccCCCCCCChHHHhcCcccccCCC
Q 019195          217 PDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLP  258 (344)
Q Consensus       217 ~~~~~~s~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~~~~  258 (344)
                      ......++++.+||.+||+.||.+|||+.++|+||||.....
T Consensus       241 ~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~  282 (343)
T 3dbq_A          241 EFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTH  282 (343)
T ss_dssp             CCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCCC
T ss_pred             CCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCccccccCC
Confidence            333456789999999999999999999999999999976543

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=6e-48  Score=355.69  Aligned_cols=254  Identities=24%  Similarity=0.363  Sum_probs=194.7

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCccc------------cHHHHHHHHHHhcCCCCCcceeeEEEEc
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKI------------DANVAREIINHKQLRHPNIIRFKEVVLT   69 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~------------~~~~~~ei~~l~~l~h~niv~~~~~~~~   69 (344)
                      ++|++.+.||+|+||.||+|.+.. ++.||+|++......            ...+.+|+.++++++||||+++++++..
T Consensus        22 ~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~  100 (362)
T 3pg1_A           22 SPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVH  100 (362)
T ss_dssp             CSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEEE
T ss_pred             cceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEEe
Confidence            689999999999999999999865 899999998653221            1678899999999999999999999854


Q ss_pred             -----CCEEEEEEecCCCCChHHHHHhC-CCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEee
Q 019195           70 -----PTHLAIVMEYAAGGELFERICNA-GRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICD  136 (344)
Q Consensus        70 -----~~~~~lv~e~~~~g~L~~~i~~~-~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~D  136 (344)
                           ...+|+||||+. |+|.+.+... ..+++..++.++.||+.+       ||+||||||+|||++.++.  +||+|
T Consensus       101 ~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~--~kl~D  177 (362)
T 3pg1_A          101 FEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNND--ITICD  177 (362)
T ss_dssp             CCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC--EEECC
T ss_pred             ccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCC--EEEEe
Confidence                 347899999997 6888887654 468999888887776654       9999999999999976654  99999


Q ss_pred             cCCCcccCCCCCCCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccc--
Q 019195          137 FGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQY--  214 (344)
Q Consensus       137 Fg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~--  214 (344)
                      ||++.............||+.|+|||++.+....+.++|||||||++|+|++|+.||.+.........+.........  
T Consensus       178 fg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  257 (362)
T 3pg1_A          178 FNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIED  257 (362)
T ss_dssp             TTC---------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred             cCcccccccccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChHH
Confidence            999986555555566789999999999987554566799999999999999999999987765555544432211100  


Q ss_pred             ------------------cCC------CCCCCCHhHHHHHHHhcccCCCCCCChHHHhcCcccccCCCh
Q 019195          215 ------------------KIP------DYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLPR  259 (344)
Q Consensus       215 ------------------~~~------~~~~~s~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~~~~~  259 (344)
                                        ..+      ....+++.+.+||.+||+.||.+|||+.++|+||||.....+
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~  326 (362)
T 3pg1_A          258 VVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESLFDP  326 (362)
T ss_dssp             HHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTTCCG
T ss_pred             hhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhccCc
Confidence                              001      112468899999999999999999999999999999876543

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=9.2e-47  Score=340.92  Aligned_cols=251  Identities=25%  Similarity=0.417  Sum_probs=203.9

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEEecCC
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYAA   81 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~   81 (344)
                      ++|++++.||+|+||.||+|.+..+++.||+|++.... ....+.+|+.+++.++||||+++++++...+.+|+||||++
T Consensus        29 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~  107 (314)
T 3com_A           29 EVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES-DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCG  107 (314)
T ss_dssp             -CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS-CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred             hhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH-HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEeecCC
Confidence            57999999999999999999999999999999997643 34678999999999999999999999999999999999999


Q ss_pred             CCChHHHHH-hCCCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCC-CCCCCC
Q 019195           82 GGELFERIC-NAGRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH-SRPKST  152 (344)
Q Consensus        82 ~g~L~~~i~-~~~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~-~~~~~~  152 (344)
                      +++|.+++. ....+++..++.++.|++.+       ||+||||||+||+++.++.  +||+|||++...... ......
T Consensus       108 ~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~--~kl~dfg~~~~~~~~~~~~~~~  185 (314)
T 3com_A          108 AGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGH--AKLADFGVAGQLTDTMAKRNTV  185 (314)
T ss_dssp             TEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCC--EEECCCTTCEECBTTBSCBCCC
T ss_pred             CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCC--EEEeecccchhhhhhccccCcc
Confidence            999999987 45679999888887776654       9999999999999976654  999999998754332 223455


Q ss_pred             ccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCHhHHHHHHH
Q 019195          153 VGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSR  232 (344)
Q Consensus       153 ~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~  232 (344)
                      .||+.|+|||++.+..++ .++|||||||++|+|++|+.||.............   ............+++.+.+||.+
T Consensus       186 ~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~l~~li~~  261 (314)
T 3com_A          186 IGTPFWMAPEVIQEIGYN-CVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIP---TNPPPTFRKPELWSDNFTDFVKQ  261 (314)
T ss_dssp             CSCGGGCCHHHHSSSCBC-TTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH---HSCCCCCSSGGGSCHHHHHHHHH
T ss_pred             CCCCCccChhhcCCCCCC-ccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHh---cCCCcccCCcccCCHHHHHHHHH
Confidence            799999999999887765 45999999999999999999998765433222111   11222223334578999999999


Q ss_pred             hcccCCCCCCChHHHhcCcccccCCCh
Q 019195          233 IFVANPSRRITIKEIKSHPWFLKNLPR  259 (344)
Q Consensus       233 ~L~~dp~~R~s~~ell~hp~~~~~~~~  259 (344)
                      ||+.||.+|||+.++++||||......
T Consensus       262 ~l~~dp~~Rpt~~~ll~~~~~~~~~~~  288 (314)
T 3com_A          262 CLVKSPEQRATATQLLQHPFVRSAKGV  288 (314)
T ss_dssp             HTCSCTTTSCCHHHHTTSHHHHTCCCG
T ss_pred             HccCChhhCcCHHHHHhCHHHhcCCcc
Confidence            999999999999999999999876543

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=3.7e-47  Score=345.30  Aligned_cols=251  Identities=25%  Similarity=0.390  Sum_probs=200.4

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcC-CCCCcceeeEEEEc------CCEEE
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQL-RHPNIIRFKEVVLT------PTHLA   74 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~l~~l-~h~niv~~~~~~~~------~~~~~   74 (344)
                      ++|++++.||+|+||.||+|.+..+++.||+|++.........+.+|+.+++++ +||||+++++++..      ...+|
T Consensus        24 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~~  103 (326)
T 2x7f_A           24 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLW  103 (326)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCCEEE
T ss_pred             CcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccceEE
Confidence            689999999999999999999999999999999987766678899999999999 79999999999987      46899


Q ss_pred             EEEecCCCCChHHHHHhC--CCCCHHHHHHHHHHHHH-------CCeeecCCCCCCeEecCCCCCCEEEeecCCCcccCC
Q 019195           75 IVMEYAAGGELFERICNA--GRFSEDEARYFFQQLIS-------GQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLL  145 (344)
Q Consensus        75 lv~e~~~~g~L~~~i~~~--~~~~~~~~~~~~~ql~~-------~~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~  145 (344)
                      +||||+++++|.+++...  ..+++..++.++.||+.       .||+||||||+|||++.++.  +||+|||++.....
T Consensus       104 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~--~kl~Dfg~~~~~~~  181 (326)
T 2x7f_A          104 LVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAE--VKLVDFGVSAQLDR  181 (326)
T ss_dssp             EEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCC--EEECCCTTTC----
T ss_pred             EEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCC--EEEeeCcCceecCc
Confidence            999999999999999764  56888888888777665       49999999999999976654  99999999875433


Q ss_pred             C-CCCCCCccCCcccCCccccC----CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCCCCC
Q 019195          146 H-SRPKSTVGTPAYIAPEVLSR----REYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYV  220 (344)
Q Consensus       146 ~-~~~~~~~gt~~y~aPE~~~~----~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  220 (344)
                      . .......||+.|+|||++..    ....+.++|||||||++|+|++|..||...........    +...........
T Consensus       182 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~----~~~~~~~~~~~~  257 (326)
T 2x7f_A          182 TVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFL----IPRNPAPRLKSK  257 (326)
T ss_dssp             ---------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH----HHHSCCCCCSCS
T ss_pred             CccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHH----hhcCccccCCcc
Confidence            2 22344579999999999862    22234569999999999999999999987654333222    222222222334


Q ss_pred             CCCHhHHHHHHHhcccCCCCCCChHHHhcCcccccCCC
Q 019195          221 HISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLP  258 (344)
Q Consensus       221 ~~s~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~~~~  258 (344)
                      .+++.+.+||.+||+.||.+|||+.++++||||.....
T Consensus       258 ~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~~  295 (326)
T 2x7f_A          258 KWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQPN  295 (326)
T ss_dssp             CSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHCCTT
T ss_pred             ccCHHHHHHHHHHhccChhhCCCHHHHhhChHHhhCcc
Confidence            67999999999999999999999999999999976543

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=1.5e-48  Score=352.56  Aligned_cols=246  Identities=25%  Similarity=0.353  Sum_probs=197.1

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCcccc----HHHHHHHHHHhcCCCCCcceeeEEEEcCC----EE
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKID----ANVAREIINHKQLRHPNIIRFKEVVLTPT----HL   73 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~----~~~~~ei~~l~~l~h~niv~~~~~~~~~~----~~   73 (344)
                      ++|++.+.||+|+||.||+|.+..+++.||+|++.......    ..+.+|+.++++++||||+++++++....    ..
T Consensus        12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~   91 (311)
T 3ork_A           12 DRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLP   91 (311)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred             CcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCccc
Confidence            68999999999999999999999999999999997653322    46789999999999999999999987653    45


Q ss_pred             EEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCC
Q 019195           74 AIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH  146 (344)
Q Consensus        74 ~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~  146 (344)
                      |+||||+++++|.+++...+.+++.+++.++.|++.+       ||+||||||+|||++.++.  +||+|||++......
T Consensus        92 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~--~kl~Dfg~a~~~~~~  169 (311)
T 3ork_A           92 YIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNA--VKVMDFGIARAIADS  169 (311)
T ss_dssp             EEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSC--EEECCCSCC------
T ss_pred             EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCC--EEEeeccCccccccc
Confidence            9999999999999999988899999988887776654       9999999999999987665  999999998754332


Q ss_pred             C----CCCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCC--CCC
Q 019195          147 S----RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIP--DYV  220 (344)
Q Consensus       147 ~----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~  220 (344)
                      .    .....+||+.|+|||++.+..++ .++|||||||++|+|++|+.||...............    ....+  ...
T Consensus       170 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~----~~~~~~~~~~  244 (311)
T 3ork_A          170 GNSVTQTAAVIGTAQYLSPEQARGDSVD-ARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVRE----DPIPPSARHE  244 (311)
T ss_dssp             ------------CCTTCCHHHHHTCCCC-HHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHC----CCCCHHHHST
T ss_pred             ccccccccccCcCcccCCHHHhcCCCCC-chHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcC----CCCCcccccC
Confidence            2    22345699999999999887764 5599999999999999999999876654433332221    11111  123


Q ss_pred             CCCHhHHHHHHHhcccCCCCCCChHHHhcCcccc
Q 019195          221 HISQDCRNLLSRIFVANPSRRITIKEIKSHPWFL  254 (344)
Q Consensus       221 ~~s~~~~~li~~~L~~dp~~R~s~~ell~hp~~~  254 (344)
                      .+++++.+||.+||+.||.+||++.+++.|+|+.
T Consensus       245 ~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~  278 (311)
T 3ork_A          245 GLSADLDAVVLKALAKNPENRYQTAAEMRADLVR  278 (311)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred             CCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHH
Confidence            5899999999999999999999999999999984

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=1.8e-47  Score=353.88  Aligned_cols=249  Identities=26%  Similarity=0.402  Sum_probs=198.9

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCccc---cHHHHHHHHHHhcCCCCCcceeeEEEEcCCEE-----
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKI---DANVAREIINHKQLRHPNIIRFKEVVLTPTHL-----   73 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~-----   73 (344)
                      ++|++.+.||+|+||.||+|.+..+++.||+|++......   ...+.+|+.+++.++||||+++++++...+..     
T Consensus        42 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  121 (371)
T 4exu_A           42 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD  121 (371)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCC
T ss_pred             ccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCccccee
Confidence            5899999999999999999999999999999999764332   35688999999999999999999999877654     


Q ss_pred             -EEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCC
Q 019195           74 -AIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLL  145 (344)
Q Consensus        74 -~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~  145 (344)
                       |+||||+. ++|...+.  ..+++..++.++.|++.+       ||+||||||+|||++.++.  +||+|||+++... 
T Consensus       122 ~~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~--~kL~Dfg~a~~~~-  195 (371)
T 4exu_A          122 FYLVMPFMQ-TDLQKIMG--MEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCE--LKILDFGLARHAD-  195 (371)
T ss_dssp             CEEEEECCC-EEHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCC--EEECSTTCC-----
T ss_pred             EEEEEcccc-ccHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCC--EEEEecCcccccc-
Confidence             99999996 68887763  358999888887776654       9999999999999977654  9999999987543 


Q ss_pred             CCCCCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccc-----------
Q 019195          146 HSRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQY-----------  214 (344)
Q Consensus       146 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~-----------  214 (344)
                       ......+||+.|+|||++.+....+.++|||||||++|+|++|+.||.+.+....+..++........           
T Consensus       196 -~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  274 (371)
T 4exu_A          196 -AEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAA  274 (371)
T ss_dssp             -----CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCSCHHH
T ss_pred             -cCcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhhhhhh
Confidence             23445679999999999987444566699999999999999999999887765555544432211100           


Q ss_pred             --------cCC------CCCCCCHhHHHHHHHhcccCCCCCCChHHHhcCcccccCC
Q 019195          215 --------KIP------DYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNL  257 (344)
Q Consensus       215 --------~~~------~~~~~s~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~~~  257 (344)
                              ..+      .+..+++++.+||.+||+.||.+|||+.++|+||||....
T Consensus       275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~  331 (371)
T 4exu_A          275 KSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFR  331 (371)
T ss_dssp             HHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTC
T ss_pred             hhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccccCC
Confidence                    000      1135689999999999999999999999999999997653

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=2.3e-47  Score=342.93  Aligned_cols=253  Identities=26%  Similarity=0.375  Sum_probs=200.5

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCcc-ccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEEecC
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK-IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYA   80 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~   80 (344)
                      ++|++++.||+|+||.||+|.+..+++.||+|++..... ....+.+|+.+++.++||||+++++++...+.+++||||+
T Consensus        19 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   98 (302)
T 2j7t_A           19 EVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFC   98 (302)
T ss_dssp             GTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEECC
T ss_pred             cceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEeC
Confidence            579999999999999999999999999999999876433 3467889999999999999999999999999999999999


Q ss_pred             CCCChHHHHHh-CCCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCC-CCCCCC
Q 019195           81 AGGELFERICN-AGRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLL-HSRPKS  151 (344)
Q Consensus        81 ~~g~L~~~i~~-~~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~-~~~~~~  151 (344)
                      ++++|..++.. ...+++..++.++.|++.+       ||+||||||+||+++.++.  +||+|||++..... ......
T Consensus        99 ~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~~~~  176 (302)
T 2j7t_A           99 PGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGD--IRLADFGVSAKNLKTLQKRDS  176 (302)
T ss_dssp             TTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSC--EEECCCHHHHHHHHHHHC---
T ss_pred             CCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCC--EEEEECCCCcccccccccccc
Confidence            99999998865 5679999888887776654       9999999999999976654  99999998753211 122344


Q ss_pred             CccCCcccCCcccc----CCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCHhHH
Q 019195          152 TVGTPAYIAPEVLS----RREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCR  227 (344)
Q Consensus       152 ~~gt~~y~aPE~~~----~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~  227 (344)
                      ..||+.|+|||++.    .....+.++|||||||++|+|++|..||..............   ...........++..+.
T Consensus       177 ~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~l~  253 (302)
T 2j7t_A          177 FIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAK---SDPPTLLTPSKWSVEFR  253 (302)
T ss_dssp             --CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH---SCCCCCSSGGGSCHHHH
T ss_pred             ccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhc---cCCcccCCccccCHHHH
Confidence            57999999999984    223335569999999999999999999987665433322221   11112223346789999


Q ss_pred             HHHHHhcccCCCCCCChHHHhcCcccccCCCh
Q 019195          228 NLLSRIFVANPSRRITIKEIKSHPWFLKNLPR  259 (344)
Q Consensus       228 ~li~~~L~~dp~~R~s~~ell~hp~~~~~~~~  259 (344)
                      +||.+||+.||.+|||+.++++||||......
T Consensus       254 ~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~  285 (302)
T 2j7t_A          254 DFLKIALDKNPETRPSAAQLLEHPFVSSITSN  285 (302)
T ss_dssp             HHHHHHSCSCTTTSCCHHHHTTSTTTTTCCCC
T ss_pred             HHHHHHcccChhhCCCHHHHhcChHHhhhccc
Confidence            99999999999999999999999999876543

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=2.4e-47  Score=347.66  Aligned_cols=251  Identities=25%  Similarity=0.368  Sum_probs=201.1

Q ss_pred             CCceeeeeeeecCceEEEEEEE-cCCCcEEEEEEeecCccccHHHHHHHHHHhcCCCC------CcceeeEEEEcCCEEE
Q 019195            2 EKYELMKDIGSGNFGVARLMRN-KNTKELVAMKYIERGHKIDANVAREIINHKQLRHP------NIIRFKEVVLTPTHLA   74 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~vaiK~~~~~~~~~~~~~~ei~~l~~l~h~------niv~~~~~~~~~~~~~   74 (344)
                      ++|++++.||+|+||.||+|.+ ..+++.||+|++.........+.+|+.+++.++|+      +|+++++++...+.++
T Consensus        14 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~~~   93 (339)
T 1z57_A           14 ARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHIC   93 (339)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTEEE
T ss_pred             CceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCCchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCcEE
Confidence            6899999999999999999998 56889999999987655556788999999888655      5999999999999999


Q ss_pred             EEEecCCCCChHHHHHhCC--CCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCC-----------------
Q 019195           75 IVMEYAAGGELFERICNAG--RFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSP-----------------  128 (344)
Q Consensus        75 lv~e~~~~g~L~~~i~~~~--~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~-----------------  128 (344)
                      +||||+ +++|.+++...+  .+++.+++.++.|++.+       ||+||||||+|||++...                 
T Consensus        94 lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~~~~~  172 (339)
T 1z57_A           94 IVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLI  172 (339)
T ss_dssp             EEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC----CEEEEES
T ss_pred             EEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCcccccccccc
Confidence            999999 899999998765  68888888887776654       999999999999997643                 


Q ss_pred             CCCEEEeecCCCcccCCCCCCCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHH
Q 019195          129 APRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISR  208 (344)
Q Consensus       129 ~~~vkL~DFg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~  208 (344)
                      .+++||+|||+++...  ......+||+.|+|||++.+..++ .++|||||||++|+|++|..||...........+...
T Consensus       173 ~~~~kl~Dfg~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~  249 (339)
T 1z57_A          173 NPDIKVVDFGSATYDD--EHHSTLVSTRHYRAPEVILALGWS-QPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMERI  249 (339)
T ss_dssp             CCCEEECCCSSCEETT--SCCCSSCSCGGGCCHHHHTTSCCC-THHHHHHHHHHHHHHHHSSCSCCCSCHHHHHHHHHHH
T ss_pred             CCCceEeeCcccccCc--cccccccCCccccChHHhhCCCCC-cchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Confidence            4469999999987533  234556899999999999887765 4599999999999999999999887654433322221


Q ss_pred             Hhhccc-----------------c---------------------CCCCCCCCHhHHHHHHHhcccCCCCCCChHHHhcC
Q 019195          209 IMAVQY-----------------K---------------------IPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSH  250 (344)
Q Consensus       209 ~~~~~~-----------------~---------------------~~~~~~~s~~~~~li~~~L~~dp~~R~s~~ell~h  250 (344)
                      ......                 .                     .......++++.+||.+||+.||.+|||+.++|+|
T Consensus       250 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h  329 (339)
T 1z57_A          250 LGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREALKH  329 (339)
T ss_dssp             HCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred             hCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccCHHHHhcC
Confidence            110000                 0                     00011235678999999999999999999999999


Q ss_pred             cccccC
Q 019195          251 PWFLKN  256 (344)
Q Consensus       251 p~~~~~  256 (344)
                      |||+..
T Consensus       330 p~f~~~  335 (339)
T 1z57_A          330 PFFDLL  335 (339)
T ss_dssp             GGGGGG
T ss_pred             HHHHHH
Confidence            999753

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=2e-47  Score=342.43  Aligned_cols=247  Identities=30%  Similarity=0.403  Sum_probs=196.2

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCccc----cHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEE
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKI----DANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVM   77 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~----~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~   77 (344)
                      ++|++++.||+|+||.||+|.+..+++.||+|++......    ...+.+|+.++++++||||+++++++...+.+|+||
T Consensus        11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   90 (294)
T 4eqm_A           11 ERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVM   90 (294)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             ccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEEE
Confidence            5899999999999999999999999999999998654332    256889999999999999999999999999999999


Q ss_pred             ecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCC--C
Q 019195           78 EYAAGGELFERICNAGRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS--R  148 (344)
Q Consensus        78 e~~~~g~L~~~i~~~~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~--~  148 (344)
                      ||+++++|.+++...+.+++..++.++.|++.+       ||+||||||+|||++.++.  +||+|||++.......  .
T Consensus        91 e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~~  168 (294)
T 4eqm_A           91 EYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKT--LKIFDFGIAKALSETSLTQ  168 (294)
T ss_dssp             ECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSC--EEECCCSSSTTC-------
T ss_pred             eCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCC--EEEEeCCCccccccccccc
Confidence            999999999999988899999988887776654       9999999999999976654  9999999997643332  2


Q ss_pred             CCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCHhHHH
Q 019195          149 PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRN  228 (344)
Q Consensus       149 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~  228 (344)
                      ....+||+.|+|||++.+..++ .++|||||||++|+|++|+.||.+..........+.... ..........+++.+.+
T Consensus       169 ~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~  246 (294)
T 4eqm_A          169 TNHVLGTVQYFSPEQAKGEATD-ECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSV-PNVTTDVRKDIPQSLSN  246 (294)
T ss_dssp             ------CCSSCCHHHHHTCCCC-TTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCC-CCHHHHSCTTSCHHHHH
T ss_pred             cCccccCccccCHhHhcCCCCC-chHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccC-CCcchhcccCCCHHHHH
Confidence            3345799999999999887764 459999999999999999999988665433322221100 00001122467899999


Q ss_pred             HHHHhcccCCCCCCChHHHhcCcc
Q 019195          229 LLSRIFVANPSRRITIKEIKSHPW  252 (344)
Q Consensus       229 li~~~L~~dp~~R~s~~ell~hp~  252 (344)
                      +|.+||+.||.+||+..+.+.+.|
T Consensus       247 li~~~l~~dp~~R~~~~~~l~~~l  270 (294)
T 4eqm_A          247 VILRATEKDKANRYKTIQEMKDDL  270 (294)
T ss_dssp             HHHHHSCSSGGGSCSSHHHHHHHH
T ss_pred             HHHHHhcCCHhHccccHHHHHHHH
Confidence            999999999999996665555555

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=6.4e-47  Score=347.48  Aligned_cols=252  Identities=29%  Similarity=0.440  Sum_probs=200.9

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCcc--ccHHHHHHHHHHhcCCCCCcceeeEEEEcC-----CEEE
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK--IDANVAREIINHKQLRHPNIIRFKEVVLTP-----THLA   74 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~ei~~l~~l~h~niv~~~~~~~~~-----~~~~   74 (344)
                      ++|++.+.||+|+||.||+|.+..+++.||+|++.....  ....+.+|+.+++.++||||+++++++...     ...|
T Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   90 (353)
T 2b9h_A           11 SDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVY   90 (353)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCEE
T ss_pred             cceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceEE
Confidence            589999999999999999999999999999999965332  235678999999999999999999988754     6799


Q ss_pred             EEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCC
Q 019195           75 IVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS  147 (344)
Q Consensus        75 lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~  147 (344)
                      +||||+. ++|.+++.. +.+++..++.++.|++.+       ||+||||||+|||++.++.  +||+|||++.......
T Consensus        91 lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~--~kl~Dfg~a~~~~~~~  166 (353)
T 2b9h_A           91 IIQELMQ-TDLHRVIST-QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCD--LKVCDFGLARIIDESA  166 (353)
T ss_dssp             EEECCCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCC--EEECCCTTCEECC---
T ss_pred             EEEeccC-ccHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCc--EEEEeccccccccccc
Confidence            9999996 689988866 578998888887776654       9999999999999977654  9999999987543221


Q ss_pred             -----------CCCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccc--
Q 019195          148 -----------RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQY--  214 (344)
Q Consensus       148 -----------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~--  214 (344)
                                 .....+||+.|+|||++.+....+.++|||||||++|+|++|++||.+......+..+.........  
T Consensus       167 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  246 (353)
T 2b9h_A          167 ADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDN  246 (353)
T ss_dssp             -------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCSTT
T ss_pred             ccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCchhc
Confidence                       1223578999999999876555567799999999999999999999887654444333322111100  


Q ss_pred             ---------------cCC---------CCCCCCHhHHHHHHHhcccCCCCCCChHHHhcCcccccCC
Q 019195          215 ---------------KIP---------DYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNL  257 (344)
Q Consensus       215 ---------------~~~---------~~~~~s~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~~~  257 (344)
                                     ..+         .+..+++++.+||.+||+.||.+|||+.++|+||||....
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~  313 (353)
T 2b9h_A          247 DLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYH  313 (353)
T ss_dssp             TTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred             cccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccccC
Confidence                           000         0135789999999999999999999999999999997653

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=7.8e-48  Score=358.70  Aligned_cols=249  Identities=24%  Similarity=0.375  Sum_probs=196.0

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcCC--------CCCcceeeEEEE----c
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLR--------HPNIIRFKEVVL----T   69 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~l~~l~--------h~niv~~~~~~~----~   69 (344)
                      ++|++++.||+|+||+||+|.+..+++.||+|++.........+.+|+.+++.++        |+||+++++++.    .
T Consensus        37 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~~~  116 (397)
T 1wak_A           37 GRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGVN  116 (397)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEETT
T ss_pred             CeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecCCC
Confidence            6899999999999999999999999999999999876555677889999999885        788999999998    5


Q ss_pred             CCEEEEEEecCCCCChHHHHHhC--CCCCHHHHHHHHHHHH-------HC-CeeecCCCCCCeEecCCC-----------
Q 019195           70 PTHLAIVMEYAAGGELFERICNA--GRFSEDEARYFFQQLI-------SG-QICHRDLKLENTLLDGSP-----------  128 (344)
Q Consensus        70 ~~~~~lv~e~~~~g~L~~~i~~~--~~~~~~~~~~~~~ql~-------~~-~iiH~Dikp~NIl~~~~~-----------  128 (344)
                      ...+|+||||+ +++|.+.+...  +.+++.+++.++.||+       +. ||+||||||+|||++.++           
T Consensus       117 ~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~~~~~~~~~  195 (397)
T 1wak_A          117 GTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEAT  195 (397)
T ss_dssp             EEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHHHHHHHHHC
T ss_pred             CceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhhhhhhhhhH
Confidence            56899999999 66777776554  4689998888877755       55 899999999999997553           


Q ss_pred             ------------------------------------CCCEEEeecCCCcccCCCCCCCCCccCCcccCCccccCCCCCCc
Q 019195          129 ------------------------------------APRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGK  172 (344)
Q Consensus       129 ------------------------------------~~~vkL~DFg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~  172 (344)
                                                          ..++||+|||++.....  .....+||+.|+|||++.+..++ .
T Consensus       196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~--~~~~~~gt~~y~aPE~~~~~~~~-~  272 (397)
T 1wak_A          196 EWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHK--HFTEDIQTRQYRSLEVLIGSGYN-T  272 (397)
T ss_dssp             ---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTB--CSCSCCSCGGGCCHHHHHTSCCC-T
T ss_pred             HHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccc--cCccCCCCCcccCChhhcCCCCC-c
Confidence                                                12599999999875432  24456799999999999888765 4


Q ss_pred             chhHHHHHHHHHHHHhCCCCCCCCCChH------HHHHHHHHHhhc--------ccc-----------------------
Q 019195          173 LADVWSCGVTLYVMLVGAYPFEDQEDPK------NFRKTISRIMAV--------QYK-----------------------  215 (344)
Q Consensus       173 ~~DiwslG~il~el~~g~~pf~~~~~~~------~~~~~~~~~~~~--------~~~-----------------------  215 (344)
                      ++|||||||++|+|++|+.||.......      ....+.......        .+.                       
T Consensus       273 ~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  352 (397)
T 1wak_A          273 PADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFE  352 (397)
T ss_dssp             HHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCCCCHHH
T ss_pred             HHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCCcchhH
Confidence            5999999999999999999998654321      111111111100        000                       


Q ss_pred             -----CCCCCCCCHhHHHHHHHhcccCCCCCCChHHHhcCcccc
Q 019195          216 -----IPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFL  254 (344)
Q Consensus       216 -----~~~~~~~s~~~~~li~~~L~~dp~~R~s~~ell~hp~~~  254 (344)
                           .......++.+.+||.+||+.||.+|||+.++|+||||.
T Consensus       353 ~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~  396 (397)
T 1wak_A          353 VLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLN  396 (397)
T ss_dssp             HHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGG
T ss_pred             hhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCcccc
Confidence                 000112346788999999999999999999999999995

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=4.7e-48  Score=347.23  Aligned_cols=255  Identities=28%  Similarity=0.397  Sum_probs=183.5

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCc--cccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEEec
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH--KIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEY   79 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~   79 (344)
                      ++|++.+.||+|+||.||+|.+..+++.||+|++....  .....+.+|+.++++++||||+++++++...+..++||||
T Consensus        15 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   94 (303)
T 2vwi_A           15 DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKL   94 (303)
T ss_dssp             CCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEEEC
T ss_pred             hhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEehh
Confidence            68999999999999999999999999999999986542  2345688999999999999999999999999999999999


Q ss_pred             CCCCChHHHHHh--------CCCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccC
Q 019195           80 AAGGELFERICN--------AGRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSL  144 (344)
Q Consensus        80 ~~~g~L~~~i~~--------~~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~  144 (344)
                      +++++|.+++..        .+.+++..++.++.|++.+       ||+||||||+||+++.++.  +||+|||++....
T Consensus        95 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~--~kl~dfg~~~~~~  172 (303)
T 2vwi_A           95 LSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGS--VQIADFGVSAFLA  172 (303)
T ss_dssp             CTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCC--EEECCCHHHHHCC
T ss_pred             ccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCC--EEEEeccchheec
Confidence            999999999864        4568999888887776654       9999999999999976654  9999999886443


Q ss_pred             CCC------CCCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhcc----c
Q 019195          145 LHS------RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQ----Y  214 (344)
Q Consensus       145 ~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~----~  214 (344)
                      ...      ......||+.|+|||++.+....+.++|||||||++|+|++|+.||....................    .
T Consensus       173 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  252 (303)
T 2vwi_A          173 TGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLETGVQ  252 (303)
T ss_dssp             ---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCCCTTC---
T ss_pred             cCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCCCccccccc
Confidence            221      123457999999999987643345669999999999999999999988765544333222110000    0


Q ss_pred             cCCCCCCCCHhHHHHHHHhcccCCCCCCChHHHhcCcccccCCC
Q 019195          215 KIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLP  258 (344)
Q Consensus       215 ~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~~~~  258 (344)
                      .......+++++.+||.+||+.||.+|||+.++++||||.+...
T Consensus       253 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~  296 (303)
T 2vwi_A          253 DKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAKN  296 (303)
T ss_dssp             --CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC-----
T ss_pred             cchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhcCCC
Confidence            01122457889999999999999999999999999999976543

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=1.3e-47  Score=358.90  Aligned_cols=253  Identities=25%  Similarity=0.398  Sum_probs=183.9

Q ss_pred             Ccee-eeeeeecCceEEEEEEEc--CCCcEEEEEEeecCccccHHHHHHHHHHhcCCCCCcceeeEEEEc--CCEEEEEE
Q 019195            3 KYEL-MKDIGSGNFGVARLMRNK--NTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKEVVLT--PTHLAIVM   77 (344)
Q Consensus         3 ~y~~-~~~lg~G~~g~V~~~~~~--~~~~~vaiK~~~~~~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~--~~~~~lv~   77 (344)
                      .|++ .++||+|+||+||+|.+.  .+++.||+|++... .....+.+|+.+++.++||||+++++++..  ...+|+||
T Consensus        21 ~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~   99 (405)
T 3rgf_A           21 LFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGT-GISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLF   99 (405)
T ss_dssp             HEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSS-SCCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEE
T ss_pred             hhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCC-CCCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEE
Confidence            4666 458999999999999965  57889999999754 334578899999999999999999999954  67899999


Q ss_pred             ecCCCCChHHHHHhC---------CCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecC--CCCCCEEEeecCC
Q 019195           78 EYAAGGELFERICNA---------GRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDG--SPAPRLKICDFGY  139 (344)
Q Consensus        78 e~~~~g~L~~~i~~~---------~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~--~~~~~vkL~DFg~  139 (344)
                      ||+. ++|.+++...         ..+++..++.++.||+.|       ||+||||||+|||+..  +..+.+||+|||+
T Consensus       100 e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~  178 (405)
T 3rgf_A          100 DYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGF  178 (405)
T ss_dssp             ECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCEEECCTTC
T ss_pred             eCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcEEEEECCC
Confidence            9996 5888877532         248898888888777655       9999999999999942  2334699999999


Q ss_pred             CcccCCC----CCCCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCh---------HHHHHHH
Q 019195          140 SKSSLLH----SRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDP---------KNFRKTI  206 (344)
Q Consensus       140 a~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~---------~~~~~~~  206 (344)
                      ++.....    ......+||+.|+|||++.+....+.++|||||||++|+|++|++||......         ..+..++
T Consensus       179 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~~i~  258 (405)
T 3rgf_A          179 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIF  258 (405)
T ss_dssp             CC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHHHHH
T ss_pred             ceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHHHHH
Confidence            9764332    22345679999999999988665677799999999999999999999765431         2333333


Q ss_pred             HHHhhcccc-------C-------------------------CCCCCCCHhHHHHHHHhcccCCCCCCChHHHhcCcccc
Q 019195          207 SRIMAVQYK-------I-------------------------PDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFL  254 (344)
Q Consensus       207 ~~~~~~~~~-------~-------------------------~~~~~~s~~~~~li~~~L~~dp~~R~s~~ell~hp~~~  254 (344)
                      ..+......       .                         ......++.+.+||.+||+.||.+|||+.|+|+||||.
T Consensus       259 ~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~hp~f~  338 (405)
T 3rgf_A          259 NVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYFL  338 (405)
T ss_dssp             HHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHTSGGGT
T ss_pred             HhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhc
Confidence            222111000       0                         00012277899999999999999999999999999998


Q ss_pred             cCC
Q 019195          255 KNL  257 (344)
Q Consensus       255 ~~~  257 (344)
                      +..
T Consensus       339 ~~~  341 (405)
T 3rgf_A          339 EDP  341 (405)
T ss_dssp             SSS
T ss_pred             cCC
Confidence            753

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=3.4e-47  Score=342.25  Aligned_cols=249  Identities=32%  Similarity=0.550  Sum_probs=201.1

Q ss_pred             CCCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCc-----cccHHHHHHHHHHhcCCCCCcceeeEEEE--cCCEE
Q 019195            1 MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH-----KIDANVAREIINHKQLRHPNIIRFKEVVL--TPTHL   73 (344)
Q Consensus         1 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~~ei~~l~~l~h~niv~~~~~~~--~~~~~   73 (344)
                      +++|++.+.||+|+||.||+|.+..+++.||+|++....     .....+.+|+.+++.++||||+++++++.  ....+
T Consensus         4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (305)
T 2wtk_C            4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM   83 (305)
T ss_dssp             -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred             ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence            478999999999999999999999999999999997532     23467889999999999999999999985  44689


Q ss_pred             EEEEecCCCCChHHHHHh--CCCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccC
Q 019195           74 AIVMEYAAGGELFERICN--AGRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSL  144 (344)
Q Consensus        74 ~lv~e~~~~g~L~~~i~~--~~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~  144 (344)
                      |+||||+.++ |.+++..  ...+++..++.++.|++.+       ||+||||||+|||++.++.  +||+|||++....
T Consensus        84 ~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~--~kl~dfg~~~~~~  160 (305)
T 2wtk_C           84 YMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGT--LKISALGVAEALH  160 (305)
T ss_dssp             EEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC--EEECCCTTCEECC
T ss_pred             EEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCc--EEeeccccccccC
Confidence            9999999776 7777765  4568888888887776654       9999999999999976654  9999999987543


Q ss_pred             CCC---CCCCCccCCcccCCccccCCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCCCCC
Q 019195          145 LHS---RPKSTVGTPAYIAPEVLSRRE-YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYV  220 (344)
Q Consensus       145 ~~~---~~~~~~gt~~y~aPE~~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  220 (344)
                      ...   ......||+.|+|||++.+.. ..+.++|||||||++|+|++|+.||.......    ....+.......+  .
T Consensus       161 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~----~~~~i~~~~~~~~--~  234 (305)
T 2wtk_C          161 PFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYK----LFENIGKGSYAIP--G  234 (305)
T ss_dssp             TTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHH----HHHHHHHCCCCCC--S
T ss_pred             ccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHH----HHHHHhcCCCCCC--C
Confidence            221   223456999999999987643 33566999999999999999999998765433    3333444444444  3


Q ss_pred             CCCHhHHHHHHHhcccCCCCCCChHHHhcCcccccCCC
Q 019195          221 HISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLP  258 (344)
Q Consensus       221 ~~s~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~~~~  258 (344)
                      .+++.+.+||.+||+.||.+|||+.++++||||.+..+
T Consensus       235 ~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~  272 (305)
T 2wtk_C          235 DCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHP  272 (305)
T ss_dssp             SSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSCCC
T ss_pred             ccCHHHHHHHHHHccCChhhCCCHHHHhcCcccccCCC
Confidence            68999999999999999999999999999999977654

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=1.3e-46  Score=338.24  Aligned_cols=248  Identities=27%  Similarity=0.427  Sum_probs=205.7

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCc--cccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEEec
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH--KIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEY   79 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~   79 (344)
                      ++|++++.||+|+||.||+|.+..+++.||+|++....  .....+.+|+.+++.++||||+++++++.....+|+||||
T Consensus        22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  101 (303)
T 3a7i_A           22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY  101 (303)
T ss_dssp             GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEe
Confidence            47999999999999999999999999999999997643  2346789999999999999999999999999999999999


Q ss_pred             CCCCChHHHHHhCCCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCC-CCCC
Q 019195           80 AAGGELFERICNAGRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS-RPKS  151 (344)
Q Consensus        80 ~~~g~L~~~i~~~~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~-~~~~  151 (344)
                      +++++|.+++.. +.+++..++.++.|++.+       ||+||||||+||+++.++.  +||+|||++....... ....
T Consensus       102 ~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~~~~  178 (303)
T 3a7i_A          102 LGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGE--VKLADFGVAGQLTDTQIKRNT  178 (303)
T ss_dssp             CTTEEHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC--EEECCCTTCEECBTTBCCBCC
T ss_pred             CCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCC--EEEeecccceecCccccccCc
Confidence            999999998854 578999888887776654       9999999999999976654  9999999987543332 2345


Q ss_pred             CccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCHhHHHHHH
Q 019195          152 TVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLS  231 (344)
Q Consensus       152 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~  231 (344)
                      ..||+.|+|||++.+..++. ++|||||||++|+|++|+.||...........    +.... .......++..+.+||.
T Consensus       179 ~~~~~~y~aPE~~~~~~~~~-~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~----~~~~~-~~~~~~~~~~~l~~li~  252 (303)
T 3a7i_A          179 FVGTPFWMAPEVIKQSAYDS-KADIWSLGITAIELARGEPPHSELHPMKVLFL----IPKNN-PPTLEGNYSKPLKEFVE  252 (303)
T ss_dssp             CCSCGGGCCHHHHTTCCBCT-HHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH----HHHSC-CCCCCSSCCHHHHHHHH
T ss_pred             cCCCcCccCHHHHhcCCCCc-hhhhHHHHHHHHHHccCCCCCCCcCHHHHHHH----hhcCC-CCCCccccCHHHHHHHH
Confidence            67999999999998877654 59999999999999999999987654332222    11111 11223467899999999


Q ss_pred             HhcccCCCCCCChHHHhcCcccccCCC
Q 019195          232 RIFVANPSRRITIKEIKSHPWFLKNLP  258 (344)
Q Consensus       232 ~~L~~dp~~R~s~~ell~hp~~~~~~~  258 (344)
                      +||+.||.+|||+.++++||||.....
T Consensus       253 ~~l~~dp~~Rps~~~ll~~~~~~~~~~  279 (303)
T 3a7i_A          253 ACLNKEPSFRPTAKELLKHKFILRNAK  279 (303)
T ss_dssp             HHCCSSGGGSCCHHHHTTCHHHHHHCC
T ss_pred             HHcCCChhhCcCHHHHhhChhhhcCCC
Confidence            999999999999999999999976543

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=1.7e-46  Score=340.87  Aligned_cols=251  Identities=27%  Similarity=0.415  Sum_probs=203.0

Q ss_pred             CCceeeeeeeecCceEEEEEEEc-CCCcEEEEEEeecCc---cccHHHHHHHHHHhcC---CCCCcceeeEEEE-----c
Q 019195            2 EKYELMKDIGSGNFGVARLMRNK-NTKELVAMKYIERGH---KIDANVAREIINHKQL---RHPNIIRFKEVVL-----T   69 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~---~~~~~~~~ei~~l~~l---~h~niv~~~~~~~-----~   69 (344)
                      ++|++++.||+|+||.||+|.+. .+++.||+|++....   .....+.+|+.+++.+   +||||+++++++.     .
T Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~   90 (326)
T 1blx_A           11 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR   90 (326)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSS
T ss_pred             hceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccCC
Confidence            58999999999999999999995 678999999987532   2234567788777766   8999999999987     5


Q ss_pred             CCEEEEEEecCCCCChHHHHHhCC--CCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCC
Q 019195           70 PTHLAIVMEYAAGGELFERICNAG--RFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYS  140 (344)
Q Consensus        70 ~~~~~lv~e~~~~g~L~~~i~~~~--~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a  140 (344)
                      ...+++||||+. |+|.+++....  .+++..++.++.|++.+       ||+||||||+|||++.++.  +||+|||++
T Consensus        91 ~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~--~kl~Dfg~~  167 (326)
T 1blx_A           91 ETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQ--IKLADFGLA  167 (326)
T ss_dssp             EEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC--EEECSCCSC
T ss_pred             CceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCC--EEEecCccc
Confidence            578999999997 69999997754  48999888887776654       9999999999999977654  999999999


Q ss_pred             cccCCCCCCCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccc-cC---
Q 019195          141 KSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQY-KI---  216 (344)
Q Consensus       141 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~---  216 (344)
                      +............||+.|+|||++.+..++ .++|||||||++|+|++|++||........+..++........ ..   
T Consensus       168 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  246 (326)
T 1blx_A          168 RIYSFQMALTSVVVTLWYRAPEVLLQSSYA-TPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRD  246 (326)
T ss_dssp             CCCCGGGGGCCCCCCCTTCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTT
T ss_pred             ccccCCCCccccccccceeCHHHHhcCCCC-cchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcccCccc
Confidence            765544444566799999999999877765 4599999999999999999999987766555555443221100 00   


Q ss_pred             -----------------CCCCCCCHhHHHHHHHhcccCCCCCCChHHHhcCcccccC
Q 019195          217 -----------------PDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKN  256 (344)
Q Consensus       217 -----------------~~~~~~s~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~~  256 (344)
                                       .....+++.+.+||.+||+.||.+|||+.++|+||||...
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~  303 (326)
T 1blx_A          247 VALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDL  303 (326)
T ss_dssp             CSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTC
T ss_pred             cccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCcccccc
Confidence                             0123578899999999999999999999999999999764

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=6e-47  Score=339.74  Aligned_cols=250  Identities=24%  Similarity=0.400  Sum_probs=194.8

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcCCCCCcceeeEEEEc------------
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKEVVLT------------   69 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~------------   69 (344)
                      ++|++++.||+|+||.||+|.+..+++.||+|++.........+.+|+.++++++||||+++++++..            
T Consensus         6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~   85 (303)
T 1zy4_A            6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVK   85 (303)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC------
T ss_pred             ccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcccc
Confidence            47999999999999999999999999999999997655555678899999999999999999998865            


Q ss_pred             -CCEEEEEEecCCCCChHHHHHhCC-CCCHHHHHHHHHHHHH-------CCeeecCCCCCCeEecCCCCCCEEEeecCCC
Q 019195           70 -PTHLAIVMEYAAGGELFERICNAG-RFSEDEARYFFQQLIS-------GQICHRDLKLENTLLDGSPAPRLKICDFGYS  140 (344)
Q Consensus        70 -~~~~~lv~e~~~~g~L~~~i~~~~-~~~~~~~~~~~~ql~~-------~~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a  140 (344)
                       ...+|+||||+++++|.+++.... .+++..++.++.|++.       .||+||||||+|||++.++.  +||+|||++
T Consensus        86 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~--~kl~dfg~~  163 (303)
T 1zy4_A           86 KKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRN--VKIGDFGLA  163 (303)
T ss_dssp             CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSC--EEECCCCCC
T ss_pred             cCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCC--EEEeeCcch
Confidence             457899999999999999998644 5777777777666654       49999999999999976654  999999998


Q ss_pred             cccCCC---------------CCCCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHH
Q 019195          141 KSSLLH---------------SRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKT  205 (344)
Q Consensus       141 ~~~~~~---------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~  205 (344)
                      ......               .......||+.|+|||++.+....+.++|||||||++|+|++   ||....   .....
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~---~~~~~  237 (303)
T 1zy4_A          164 KNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGM---ERVNI  237 (303)
T ss_dssp             SCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHH---HHHHH
T ss_pred             hhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCch---hHHHH
Confidence            754321               122345699999999999876545667999999999999998   554322   22233


Q ss_pred             HHHHhhccccCCC--CCCCCHhHHHHHHHhcccCCCCCCChHHHhcCcccccCCCh
Q 019195          206 ISRIMAVQYKIPD--YVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLPR  259 (344)
Q Consensus       206 ~~~~~~~~~~~~~--~~~~s~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~~~~~  259 (344)
                      ...+......+|.  ....++.+.+||.+||+.||.+|||+.++++||||......
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~  293 (303)
T 1zy4_A          238 LKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVKHQD  293 (303)
T ss_dssp             HHHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSCCCCHH
T ss_pred             HHhccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcCCCChH
Confidence            3333333333332  23467789999999999999999999999999999766443

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=1.1e-46  Score=340.15  Aligned_cols=239  Identities=27%  Similarity=0.424  Sum_probs=189.5

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCccc---cHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEEe
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKI---DANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVME   78 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e   78 (344)
                      ++|++.+.||+|+||+||+|.+  ++..||+|++......   ...+.+|+.++++++||||+++++++...+.+++|||
T Consensus        37 ~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e  114 (309)
T 3p86_A           37 CDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTE  114 (309)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEEE
T ss_pred             hHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEEe
Confidence            5899999999999999999987  5788999998764432   2468899999999999999999999999999999999


Q ss_pred             cCCCCChHHHHHhCCC---CCHHHHHHHHHHHHHC-------C--eeecCCCCCCeEecCCCCCCEEEeecCCCcccCCC
Q 019195           79 YAAGGELFERICNAGR---FSEDEARYFFQQLISG-------Q--ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH  146 (344)
Q Consensus        79 ~~~~g~L~~~i~~~~~---~~~~~~~~~~~ql~~~-------~--iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~  146 (344)
                      |+++|+|.+++.+.+.   +++..++.++.|++.+       |  |+||||||+|||++.++.  +||+|||+++.....
T Consensus       115 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~--~kL~Dfg~a~~~~~~  192 (309)
T 3p86_A          115 YLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYT--VKVCDFGLSRLKAST  192 (309)
T ss_dssp             CCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCC--EEECCCC--------
T ss_pred             cCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCc--EEECCCCCCcccccc
Confidence            9999999999987653   8888888887777655       8  999999999999977654  999999998754332


Q ss_pred             C-CCCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCHh
Q 019195          147 S-RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQD  225 (344)
Q Consensus       147 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~  225 (344)
                      . ......||+.|+|||++.+..++ .++|||||||++|+|++|+.||.........    ..+.......+....+++.
T Consensus       193 ~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~elltg~~Pf~~~~~~~~~----~~~~~~~~~~~~~~~~~~~  267 (309)
T 3p86_A          193 FLSSKSAAGTPEWMAPEVLRDEPSN-EKSDVYSFGVILWELATLQQPWGNLNPAQVV----AAVGFKCKRLEIPRNLNPQ  267 (309)
T ss_dssp             ---------CCTTSCHHHHTTCCCC-TTHHHHHHHHHHHHHHHCCCTTTTSCHHHHH----HHHHHSCCCCCCCTTSCHH
T ss_pred             ccccccCCCCccccChhhhcCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHH----HHHHhcCCCCCCCccCCHH
Confidence            2 23456799999999999887764 5599999999999999999999876543332    2222222333344578999


Q ss_pred             HHHHHHHhcccCCCCCCChHHHhc
Q 019195          226 CRNLLSRIFVANPSRRITIKEIKS  249 (344)
Q Consensus       226 ~~~li~~~L~~dp~~R~s~~ell~  249 (344)
                      +.+||.+||+.||.+|||+.++++
T Consensus       268 l~~li~~~l~~dP~~Rps~~~ll~  291 (309)
T 3p86_A          268 VAAIIEGCWTNEPWKRPSFATIMD  291 (309)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHccCChhhCcCHHHHHH
Confidence            999999999999999999999987

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=1.5e-46  Score=345.26  Aligned_cols=250  Identities=25%  Similarity=0.389  Sum_probs=198.4

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCccc---cHHHHHHHHHHhcCCCCCcceeeEEEEcCCE------
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKI---DANVAREIINHKQLRHPNIIRFKEVVLTPTH------   72 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~------   72 (344)
                      ++|++.+.||+|+||.||+|.+..+|+.||+|++......   ...+.+|+.+++.++||||+++++++.....      
T Consensus        24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  103 (353)
T 3coi_A           24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD  103 (353)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred             ceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEeccccccccee
Confidence            5899999999999999999999999999999999764322   3567899999999999999999999987653      


Q ss_pred             EEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCC
Q 019195           73 LAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLL  145 (344)
Q Consensus        73 ~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~  145 (344)
                      +|+||||+. ++|.+++.  ..+++.+++.++.|++.+       ||+||||||+|||++.++.  +||+|||+++....
T Consensus       104 ~~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~--~kl~Dfg~~~~~~~  178 (353)
T 3coi_A          104 FYLVMPFMQ-TDLQKIMG--LKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCE--LKILDFGLARHADA  178 (353)
T ss_dssp             CEEEEECCS-EEGGGTTT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCC--EEECSTTCTTC---
T ss_pred             EEEEecccc-CCHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCc--EEEeecccccCCCC
Confidence            599999996 68887764  358998888887776654       9999999999999987654  99999999875432


Q ss_pred             CCCCCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhc-------------
Q 019195          146 HSRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAV-------------  212 (344)
Q Consensus       146 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~-------------  212 (344)
                        ......||+.|+|||++.+....+.++|||||||++|+|++|+.||.+.+....+..+.......             
T Consensus       179 --~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  256 (353)
T 3coi_A          179 --EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAA  256 (353)
T ss_dssp             -------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCSCHHH
T ss_pred             --CccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHhhHHH
Confidence              23456799999999999874445666999999999999999999998877655544443321110             


Q ss_pred             -----------cccC-CCCCCCCHhHHHHHHHhcccCCCCCCChHHHhcCcccccCCC
Q 019195          213 -----------QYKI-PDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLP  258 (344)
Q Consensus       213 -----------~~~~-~~~~~~s~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~~~~  258 (344)
                                 ...+ .....+++++.+||.+||+.||.+|||+.++|+||||.....
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~~  314 (353)
T 3coi_A          257 KSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRD  314 (353)
T ss_dssp             HHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTCC
T ss_pred             HHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhccC
Confidence                       0000 112357899999999999999999999999999999976543

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=6.9e-47  Score=343.03  Aligned_cols=243  Identities=30%  Similarity=0.498  Sum_probs=204.9

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCcc-------ccHHHHHHHHHHhcCC--CCCcceeeEEEEcCCE
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK-------IDANVAREIINHKQLR--HPNIIRFKEVVLTPTH   72 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-------~~~~~~~ei~~l~~l~--h~niv~~~~~~~~~~~   72 (344)
                      ++|++.+.||+|+||.||+|.+..+++.||+|++.....       ....+.+|+.++++++  ||||+++++++...+.
T Consensus        43 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~~~  122 (320)
T 3a99_A           43 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS  122 (320)
T ss_dssp             TTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred             CceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecCCc
Confidence            589999999999999999999999999999999976432       2245678999999996  5999999999999999


Q ss_pred             EEEEEecCCC-CChHHHHHhCCCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEec-CCCCCCEEEeecCCCccc
Q 019195           73 LAIVMEYAAG-GELFERICNAGRFSEDEARYFFQQLISG-------QICHRDLKLENTLLD-GSPAPRLKICDFGYSKSS  143 (344)
Q Consensus        73 ~~lv~e~~~~-g~L~~~i~~~~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~-~~~~~~vkL~DFg~a~~~  143 (344)
                      +++|||++.+ ++|.+++...+.+++..++.++.|++.+       ||+||||||+|||++ .++  .+||+|||+++..
T Consensus       123 ~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~--~~kL~Dfg~~~~~  200 (320)
T 3a99_A          123 FVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRG--ELKLIDFGSGALL  200 (320)
T ss_dssp             EEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTT--EEEECCCTTCEEC
T ss_pred             EEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCC--CEEEeeCcccccc
Confidence            9999999976 8999999988899999988888776655       999999999999997 344  4999999998754


Q ss_pred             CCCCCCCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCC
Q 019195          144 LLHSRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHIS  223 (344)
Q Consensus       144 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s  223 (344)
                      .. .......||+.|+|||++.+..+.+.++|||||||++|+|++|+.||....      ..    .......  ...++
T Consensus       201 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~------~~----~~~~~~~--~~~~~  267 (320)
T 3a99_A          201 KD-TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EI----IRGQVFF--RQRVS  267 (320)
T ss_dssp             CS-SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HH----HHCCCCC--SSCCC
T ss_pred             cc-ccccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh------hh----hcccccc--cccCC
Confidence            33 223446799999999999877776777999999999999999999996531      11    1122222  23689


Q ss_pred             HhHHHHHHHhcccCCCCCCChHHHhcCcccccCCCh
Q 019195          224 QDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLPR  259 (344)
Q Consensus       224 ~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~~~~~  259 (344)
                      +++.+||.+||+.||.+|||+.++++||||.....+
T Consensus       268 ~~~~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~~~  303 (320)
T 3a99_A          268 SECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLP  303 (320)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCCCH
T ss_pred             HHHHHHHHHHccCChhhCcCHHHHhcCHhhcCccCc
Confidence            999999999999999999999999999999887654

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=5.2e-47  Score=346.15  Aligned_cols=249  Identities=31%  Similarity=0.537  Sum_probs=174.8

Q ss_pred             CCceeee-eeeecCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHH-HHHhcCCCCCcceeeEEEEc----CCEEEE
Q 019195            2 EKYELMK-DIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREI-INHKQLRHPNIIRFKEVVLT----PTHLAI   75 (344)
Q Consensus         2 ~~y~~~~-~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei-~~l~~l~h~niv~~~~~~~~----~~~~~l   75 (344)
                      ++|++++ .||+|+||+||+|.+..+++.||+|++....    ...+|+ ..++.++||||+++++++..    ...+++
T Consensus        28 ~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~l  103 (336)
T 3fhr_A           28 DDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP----KARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLI  103 (336)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH----HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEE
T ss_pred             ceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH----HHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEEE
Confidence            6899965 6999999999999999999999999987643    233333 34566799999999999976    456899


Q ss_pred             EEecCCCCChHHHHHhCC--CCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCC-CCCEEEeecCCCcccCC
Q 019195           76 VMEYAAGGELFERICNAG--RFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSP-APRLKICDFGYSKSSLL  145 (344)
Q Consensus        76 v~e~~~~g~L~~~i~~~~--~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~-~~~vkL~DFg~a~~~~~  145 (344)
                      |||||++|+|.+++...+  .+++.+++.++.||+.+       ||+||||||+|||++.++ .+.+||+|||++.....
T Consensus       104 v~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~~  183 (336)
T 3fhr_A          104 IMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQ  183 (336)
T ss_dssp             EEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC--
T ss_pred             EEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEeccccceeccc
Confidence            999999999999998764  69999999888887655       999999999999997532 35699999999875432


Q ss_pred             CCCCCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhcc--ccCCCCCCCC
Q 019195          146 HSRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQ--YKIPDYVHIS  223 (344)
Q Consensus       146 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~s  223 (344)
                       ......+||+.|+|||++.+..++ .++|||||||++|+|++|..||...............+....  ...+.+..++
T Consensus       184 -~~~~~~~~t~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  261 (336)
T 3fhr_A          184 -NALQTPCYTPYYVAPEVLGPEKYD-KSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSEVS  261 (336)
T ss_dssp             ---------------------CHHH-HHHHHHHHHHHHHHHHHSSCCC---------------------CCCTTTSTTCC
T ss_pred             -cccccCCCCcCccChhhhCCCCCC-chhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhccccccCchhhccCC
Confidence             233456799999999999776664 559999999999999999999977654332222222222222  2334445789


Q ss_pred             HhHHHHHHHhcccCCCCCCChHHHhcCcccccC
Q 019195          224 QDCRNLLSRIFVANPSRRITIKEIKSHPWFLKN  256 (344)
Q Consensus       224 ~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~~  256 (344)
                      +++.+||.+||+.||.+|||+.++|+||||.+.
T Consensus       262 ~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~  294 (336)
T 3fhr_A          262 EDAKQLIRLLLKTDPTERLTITQFMNHPWINQS  294 (336)
T ss_dssp             HHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTG
T ss_pred             HHHHHHHHHHCCCChhHCcCHHHHhcCcccccc
Confidence            999999999999999999999999999999764

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=1.2e-46  Score=345.34  Aligned_cols=253  Identities=25%  Similarity=0.364  Sum_probs=200.2

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCC-cEEEEEEeecCccccHHHHHHHHHHhcCCCCC------cceeeEEEEcCCEEE
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTK-ELVAMKYIERGHKIDANVAREIINHKQLRHPN------IIRFKEVVLTPTHLA   74 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~-~~vaiK~~~~~~~~~~~~~~ei~~l~~l~h~n------iv~~~~~~~~~~~~~   74 (344)
                      ++|++++.||+|+||+||+|.+..++ ..||+|++.........+.+|+.+++.++|++      ++.+++++...+.++
T Consensus        19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~   98 (355)
T 2eu9_A           19 ERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHMC   98 (355)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTEEE
T ss_pred             ccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCeEE
Confidence            68999999999999999999998776 79999999876555667888999999987655      999999999999999


Q ss_pred             EEEecCCCCChHHHHHhCC--CCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCC-----------------C
Q 019195           75 IVMEYAAGGELFERICNAG--RFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGS-----------------P  128 (344)
Q Consensus        75 lv~e~~~~g~L~~~i~~~~--~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~-----------------~  128 (344)
                      +||||+ +++|.+.+....  .+++.+++.++.||+.+       ||+||||||+|||++..                 .
T Consensus        99 lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~~~~~  177 (355)
T 2eu9_A           99 IAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVK  177 (355)
T ss_dssp             EEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC-CCCEEEES
T ss_pred             EEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecccccccccccccccccccC
Confidence            999999 677777776553  68999888888777655       99999999999999432                 2


Q ss_pred             CCCEEEeecCCCcccCCCCCCCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHH
Q 019195          129 APRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISR  208 (344)
Q Consensus       129 ~~~vkL~DFg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~  208 (344)
                      .+.+||+|||+++...  ......+||+.|+|||++.+..++ .++|||||||++|+|++|+.||...........+...
T Consensus       178 ~~~~kl~Dfg~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~  254 (355)
T 2eu9_A          178 NTSIRVADFGSATFDH--EHHTTIVATRHYRPPEVILELGWA-QPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEKI  254 (355)
T ss_dssp             CCCEEECCCTTCEETT--SCCCSSCSCGGGCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHH
T ss_pred             CCcEEEeecCcccccc--ccccCCcCCCcccCCeeeecCCCC-CccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence            3459999999987532  233556899999999999887765 4599999999999999999999887654443332221


Q ss_pred             Hhhccc--------------------------------------cCCCCCCCCHhHHHHHHHhcccCCCCCCChHHHhcC
Q 019195          209 IMAVQY--------------------------------------KIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSH  250 (344)
Q Consensus       209 ~~~~~~--------------------------------------~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~ell~h  250 (344)
                      ......                                      ........++++.+||.+||+.||.+|||+.++|+|
T Consensus       255 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~h  334 (355)
T 2eu9_A          255 LGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALLH  334 (355)
T ss_dssp             HCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred             cCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence            110000                                      000111124578999999999999999999999999


Q ss_pred             cccccCCC
Q 019195          251 PWFLKNLP  258 (344)
Q Consensus       251 p~~~~~~~  258 (344)
                      |||.+..+
T Consensus       335 p~f~~~~~  342 (355)
T 2eu9_A          335 PFFAGLTP  342 (355)
T ss_dssp             GGGGGCCH
T ss_pred             hhhcCCCh
Confidence            99986543

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=8.2e-47  Score=341.61  Aligned_cols=253  Identities=27%  Similarity=0.383  Sum_probs=195.9

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCc-cccHHHHHHHHHHhcCCCCCcceeeEEEE------------
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH-KIDANVAREIINHKQLRHPNIIRFKEVVL------------   68 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~ei~~l~~l~h~niv~~~~~~~------------   68 (344)
                      ++|++++.||+|+||.||+|.+..+++.||+|++.... .....+.+|+.++++++||||+++++++.            
T Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~   90 (320)
T 2i6l_A           11 SRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGS   90 (320)
T ss_dssp             TTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----
T ss_pred             CceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccccccc
Confidence            68999999999999999999999999999999987643 23356889999999999999999999874            


Q ss_pred             --cCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCC
Q 019195           69 --TPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGY  139 (344)
Q Consensus        69 --~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~  139 (344)
                        ....+|+||||+. |+|.+++.+ +.+++..++.++.|++.+       ||+||||||+|||++... +.+||+|||+
T Consensus        91 ~~~~~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~-~~~kl~Dfg~  167 (320)
T 2i6l_A           91 LTELNSVYIVQEYME-TDLANVLEQ-GPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTED-LVLKIGDFGL  167 (320)
T ss_dssp             CCSCSEEEEEEECCS-EEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTT-TEEEECCCTT
T ss_pred             ccccCceeEEeeccC-CCHHHHhhc-CCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCC-CeEEEccCcc
Confidence              3468899999997 699998854 678888888887776654       999999999999997433 3599999999


Q ss_pred             CcccCCC----CCCCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhh----
Q 019195          140 SKSSLLH----SRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMA----  211 (344)
Q Consensus       140 a~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~----  211 (344)
                      ++.....    .......+|+.|+|||++.+....+.++|||||||++|+|++|+.||...........+......    
T Consensus       168 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  247 (320)
T 2i6l_A          168 ARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHEE  247 (320)
T ss_dssp             CBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSCCCCHH
T ss_pred             ccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCchh
Confidence            9764322    22234568999999999877555567799999999999999999999987765544443332100    


Q ss_pred             --------------ccccCC------CCCCCCHhHHHHHHHhcccCCCCCCChHHHhcCcccccCC
Q 019195          212 --------------VQYKIP------DYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNL  257 (344)
Q Consensus       212 --------------~~~~~~------~~~~~s~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~~~  257 (344)
                                    .....+      ....+++++.+||.+||+.||.+|||+.++|+||||....
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~  313 (320)
T 2i6l_A          248 DRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIYS  313 (320)
T ss_dssp             HHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTTC
T ss_pred             hhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCccccccc
Confidence                          000001      1135789999999999999999999999999999997643

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=3.3e-48  Score=359.56  Aligned_cols=237  Identities=14%  Similarity=0.127  Sum_probs=186.2

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCc----cccHHHHHHHH---HHhcCCCCCcceee-------EEE
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH----KIDANVAREII---NHKQLRHPNIIRFK-------EVV   67 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~ei~---~l~~l~h~niv~~~-------~~~   67 (344)
                      ++|++.+.||+|+||.||+|.+..+++.||||++....    .....+.+|+.   .++.++|||||+++       +++
T Consensus        73 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~  152 (377)
T 3byv_A           73 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV  152 (377)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEE
T ss_pred             ceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhhh
Confidence            57999999999999999999999999999999997532    23367889994   55556899999998       777


Q ss_pred             EcCC-----------------EEEEEEecCCCCChHHHHHhCCCCCH-------HHHHHHHHHHHH-------CCeeecC
Q 019195           68 LTPT-----------------HLAIVMEYAAGGELFERICNAGRFSE-------DEARYFFQQLIS-------GQICHRD  116 (344)
Q Consensus        68 ~~~~-----------------~~~lv~e~~~~g~L~~~i~~~~~~~~-------~~~~~~~~ql~~-------~~iiH~D  116 (344)
                      .+.+                 ..|++|||+ +|+|.+++...+.+++       ..++.++.|++.       .||+|||
T Consensus       153 ~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrD  231 (377)
T 3byv_A          153 KDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTY  231 (377)
T ss_dssp             ECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEECSC
T ss_pred             hccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCC
Confidence            6654                 289999999 6899999987655555       666667666665       5999999


Q ss_pred             CCCCCeEecCCCCCCEEEeecCCCcccCCCCCCCCCccCCcccCCccccCC-----------CCCCcchhHHHHHHHHHH
Q 019195          117 LKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRR-----------EYDGKLADVWSCGVTLYV  185 (344)
Q Consensus       117 ikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~~~DiwslG~il~e  185 (344)
                      |||+|||++.++  ++||+|||+++...  ......+| +.|+|||++.+.           .+ +.++|||||||++|+
T Consensus       232 ikp~NIll~~~~--~~kL~DFG~a~~~~--~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~-~~~~DvwSlG~il~e  305 (377)
T 3byv_A          232 LRPVDIVLDQRG--GVFLTGFEHLVRDG--ARVVSSVS-RGFEPPELEARRATISYHRDRRTLM-TFSFDAWALGLVIYW  305 (377)
T ss_dssp             CCGGGEEECTTC--CEEECCGGGCEETT--CEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEEC-CHHHHHHHHHHHHHH
T ss_pred             CCHHHEEEcCCC--CEEEEechhheecC--CcccCCCC-cCccChhhhcccccccccccccccC-ChhhhHHHHHHHHHH
Confidence            999999998665  49999999997532  23345568 999999999876           44 566999999999999


Q ss_pred             HHhCCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCHhHHHHHHHhcccCCCCCCChHHHhcCccccc
Q 019195          186 MLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLK  255 (344)
Q Consensus       186 l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~  255 (344)
                      |++|+.||..........          ........+++++.+||.+||+.||.+|||+.++++||||.+
T Consensus       306 lltg~~Pf~~~~~~~~~~----------~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~  365 (377)
T 3byv_A          306 IWCADLPITKDAALGGSE----------WIFRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQ  365 (377)
T ss_dssp             HHHSSCCC------CCSG----------GGGSSCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHHHHH
T ss_pred             HHHCCCCCcccccccchh----------hhhhhccCCCHHHHHHHHHHcCCCchhCCCHHHHhhChHHHH
Confidence            999999997654322111          111223468999999999999999999999999999999954

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=6.8e-46  Score=332.06  Aligned_cols=250  Identities=25%  Similarity=0.402  Sum_probs=197.1

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCc-cccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEEecC
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH-KIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYA   80 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~   80 (344)
                      ++|.....||+|+||.||+|.+..+++.||+|++.... .....+.+|+.+++.++||||+++++++...+.+++||||+
T Consensus        22 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  101 (295)
T 2clq_A           22 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQV  101 (295)
T ss_dssp             CTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             cCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeC
Confidence            45566679999999999999999999999999987643 33467889999999999999999999999999999999999


Q ss_pred             CCCChHHHHHhCC---CCCHHHHHHHHHHHH-------HCCeeecCCCCCCeEecC-CCCCCEEEeecCCCcccCCC-CC
Q 019195           81 AGGELFERICNAG---RFSEDEARYFFQQLI-------SGQICHRDLKLENTLLDG-SPAPRLKICDFGYSKSSLLH-SR  148 (344)
Q Consensus        81 ~~g~L~~~i~~~~---~~~~~~~~~~~~ql~-------~~~iiH~Dikp~NIl~~~-~~~~~vkL~DFg~a~~~~~~-~~  148 (344)
                      ++++|.+++....   .+++..++.++.|++       +.||+||||||+||+++. ++  .+||+|||++...... ..
T Consensus       102 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~--~~kl~Dfg~~~~~~~~~~~  179 (295)
T 2clq_A          102 PGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSG--VLKISDFGTSKRLAGINPC  179 (295)
T ss_dssp             SEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTC--CEEECCTTTCEESCC----
T ss_pred             CCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCC--CEEEeecccccccCCCCCc
Confidence            9999999997652   456777766665555       559999999999999986 44  5999999998754332 22


Q ss_pred             CCCCccCCcccCCccccCCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCHhHH
Q 019195          149 PKSTVGTPAYIAPEVLSRRE-YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCR  227 (344)
Q Consensus       149 ~~~~~gt~~y~aPE~~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~  227 (344)
                      .....||+.|+|||++.+.. ..+.++|||||||++|+|++|+.||...........   ..............+++++.
T Consensus       180 ~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~  256 (295)
T 2clq_A          180 TETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMF---KVGMFKVHPEIPESMSAEAK  256 (295)
T ss_dssp             -CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHH---HHHHHCCCCCCCTTSCHHHH
T ss_pred             ccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHH---hhccccccccccccCCHHHH
Confidence            34557999999999986543 235669999999999999999999976544322111   11111222223346899999


Q ss_pred             HHHHHhcccCCCCCCChHHHhcCcccccC
Q 019195          228 NLLSRIFVANPSRRITIKEIKSHPWFLKN  256 (344)
Q Consensus       228 ~li~~~L~~dp~~R~s~~ell~hp~~~~~  256 (344)
                      +||.+||+.||.+|||+.++|+||||...
T Consensus       257 ~li~~~l~~dp~~Rps~~~ll~~~~~~~~  285 (295)
T 2clq_A          257 AFILKCFEPDPDKRACANDLLVDEFLKVS  285 (295)
T ss_dssp             HHHHHTTCSSTTTSCCHHHHHTSGGGCC-
T ss_pred             HHHHHHccCChhhCCCHHHHhcChhhhhc
Confidence            99999999999999999999999999765

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=2.7e-46  Score=337.44  Aligned_cols=241  Identities=23%  Similarity=0.348  Sum_probs=195.0

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCc-cccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEEecC
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH-KIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYA   80 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~   80 (344)
                      ++|++.+.||+|+||+||+|.+..+++.||+|++.... .....+.+|+.++++++||||+++++++.+++.+++||||+
T Consensus        10 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~   89 (310)
T 3s95_A           10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYI   89 (310)
T ss_dssp             GGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             hHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEec
Confidence            68999999999999999999999999999999886532 33467889999999999999999999999999999999999


Q ss_pred             CCCChHHHHHh-CCCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCCCC---
Q 019195           81 AGGELFERICN-AGRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP---  149 (344)
Q Consensus        81 ~~g~L~~~i~~-~~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~~~---  149 (344)
                      ++++|.+++.. ...+++.+++.++.|++.+       ||+||||||+|||++.++.  +||+|||+++........   
T Consensus        90 ~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~~~~  167 (310)
T 3s95_A           90 KGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKN--VVVADFGLARLMVDEKTQPEG  167 (310)
T ss_dssp             TTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSC--EEECCCTTCEECC--------
T ss_pred             CCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCC--EEEeecccceecccccccccc
Confidence            99999999987 5678988888887776654       9999999999999987654  999999998754322211   


Q ss_pred             ------------CCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHH-HHHHHHHhhccccC
Q 019195          150 ------------KSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNF-RKTISRIMAVQYKI  216 (344)
Q Consensus       150 ------------~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~-~~~~~~~~~~~~~~  216 (344)
                                  ...+||+.|+|||++.+..++ .++|||||||++|+|++|..||......... .........    .
T Consensus       168 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~----~  242 (310)
T 3s95_A          168 LRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYD-EKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLD----R  242 (310)
T ss_dssp             ------------CCCCSCGGGCCHHHHTTCCCC-THHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHH----H
T ss_pred             cccccccccccccccCCCcceeCHHHhcCCCCC-cHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhcccc----c
Confidence                        145799999999999887765 4599999999999999999998764321110 000001010    1


Q ss_pred             CCCCCCCHhHHHHHHHhcccCCCCCCChHHHhc
Q 019195          217 PDYVHISQDCRNLLSRIFVANPSRRITIKEIKS  249 (344)
Q Consensus       217 ~~~~~~s~~~~~li~~~L~~dp~~R~s~~ell~  249 (344)
                      .....+++.+.+||.+||+.||.+|||+.++++
T Consensus       243 ~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~  275 (310)
T 3s95_A          243 YCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEH  275 (310)
T ss_dssp             TCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             cCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            112367889999999999999999999999986

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=7.5e-47  Score=335.72  Aligned_cols=249  Identities=29%  Similarity=0.501  Sum_probs=201.6

Q ss_pred             CCCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCcc---ccHHHHHHHHHHhcCCCCCcceeeEEEEc--CCEEEE
Q 019195            1 MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK---IDANVAREIINHKQLRHPNIIRFKEVVLT--PTHLAI   75 (344)
Q Consensus         1 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~ei~~l~~l~h~niv~~~~~~~~--~~~~~l   75 (344)
                      +++|++++.||+|+||.||++.+..+++.||+|++.....   ....+.+|+.++++++||||+++++++..  ...+|+
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   84 (279)
T 2w5a_A            5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI   84 (279)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred             hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence            3689999999999999999999999999999999976432   23568899999999999999999998854  578999


Q ss_pred             EEecCCCCChHHHHHhC----CCCCHHHHHHHHHHHHHC-------C-----eeecCCCCCCeEecCCCCCCEEEeecCC
Q 019195           76 VMEYAAGGELFERICNA----GRFSEDEARYFFQQLISG-------Q-----ICHRDLKLENTLLDGSPAPRLKICDFGY  139 (344)
Q Consensus        76 v~e~~~~g~L~~~i~~~----~~~~~~~~~~~~~ql~~~-------~-----iiH~Dikp~NIl~~~~~~~~vkL~DFg~  139 (344)
                      ||||+++++|.+++...    ..+++..++.++.|++.+       |     |+||||||+|||++.++.  +||+|||+
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~--~kl~dfg~  162 (279)
T 2w5a_A           85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQN--VKLGDFGL  162 (279)
T ss_dssp             EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSC--EEECCCCH
T ss_pred             EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCC--EEEecCch
Confidence            99999999999998653    348999999988887765       7     999999999999986654  99999999


Q ss_pred             CcccCCCCC-CCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCCC
Q 019195          140 SKSSLLHSR-PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPD  218 (344)
Q Consensus       140 a~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  218 (344)
                      +........ .....||+.|+|||++.+..++ .++||||||+++|+|++|+.||........    ...+..... .+.
T Consensus       163 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~----~~~i~~~~~-~~~  236 (279)
T 2w5a_A          163 ARILNHDTSFAKTFVGTPYYMSPEQMNRMSYN-EKSDIWSLGCLLYELCALMPPFTAFSQKEL----AGKIREGKF-RRI  236 (279)
T ss_dssp             HHHC---CHHHHHHHSCCTTCCHHHHHCC-CC-HHHHHHHHHHHHHHHHHSSCSSCCSSHHHH----HHHHHHTCC-CCC
T ss_pred             heeeccccccccccCCCccccChHHhccCCCC-chhhHHHHHHHHHHHHHCCCCCcccCHHHH----HHHHhhccc-ccC
Confidence            865432211 1234699999999999877664 569999999999999999999987654322    222222222 122


Q ss_pred             CCCCCHhHHHHHHHhcccCCCCCCChHHHhcCcccccCC
Q 019195          219 YVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNL  257 (344)
Q Consensus       219 ~~~~s~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~~~  257 (344)
                      ...+++++.+||.+||+.||.+|||+.++++|||+.+..
T Consensus       237 ~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~  275 (279)
T 2w5a_A          237 PYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILEHH  275 (279)
T ss_dssp             CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGGG
T ss_pred             CcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhhhc
Confidence            336899999999999999999999999999999997654

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=3.1e-46  Score=330.22  Aligned_cols=240  Identities=23%  Similarity=0.414  Sum_probs=199.2

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEEecCC
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYAA   81 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~   81 (344)
                      ++|++++.||+|+||.||++.+. +++.||+|++.........+.+|+.++++++||||+++++++.+.+.+++||||++
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   88 (269)
T 4hcu_A           10 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME   88 (269)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCT
T ss_pred             hhceeeheecCCCccEEEEEEec-CCCeEEEEEecccccCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCC
Confidence            58999999999999999999987 46779999998877667789999999999999999999999999999999999999


Q ss_pred             CCChHHHHHhC-CCCCHHHHHHHHHHHHH-------CCeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCC--CCCCC
Q 019195           82 GGELFERICNA-GRFSEDEARYFFQQLIS-------GQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH--SRPKS  151 (344)
Q Consensus        82 ~g~L~~~i~~~-~~~~~~~~~~~~~ql~~-------~~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~--~~~~~  151 (344)
                      +++|.+++... +.+++..++.++.|++.       .||+||||||+||+++.++.  +||+|||++......  .....
T Consensus        89 ~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~~~~~  166 (269)
T 4hcu_A           89 HGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQV--IKVSDFGMTRFVLDDQYTSSTG  166 (269)
T ss_dssp             TCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGC--EEECCTTGGGGBCCHHHHSTTS
T ss_pred             CCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCC--EEeccccccccccccccccccC
Confidence            99999999654 46888888887776654       49999999999999976654  999999998754322  12334


Q ss_pred             CccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCHhHHHHH
Q 019195          152 TVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLL  230 (344)
Q Consensus       152 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li  230 (344)
                      ..+|+.|+|||++.+..++ .++||||||+++|+|++ |+.||...........    +.. .........+++.+.+||
T Consensus       167 ~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~----~~~-~~~~~~~~~~~~~~~~li  240 (269)
T 4hcu_A          167 TKFPVKWASPEVFSFSRYS-SKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVED----IST-GFRLYKPRLASTHVYQIM  240 (269)
T ss_dssp             TTCCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHH----HHT-TCCCCCCTTSCHHHHHHH
T ss_pred             cccccccCCHHHhcCCCCC-chhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHH----Hhc-CccCCCCCcCCHHHHHHH
Confidence            5678899999999777664 56999999999999999 9999987665433322    222 223333446799999999


Q ss_pred             HHhcccCCCCCCChHHHhcC
Q 019195          231 SRIFVANPSRRITIKEIKSH  250 (344)
Q Consensus       231 ~~~L~~dp~~R~s~~ell~h  250 (344)
                      .+||+.||.+|||+.++++|
T Consensus       241 ~~~l~~~p~~Rps~~~ll~~  260 (269)
T 4hcu_A          241 NHCWRERPEDRPAFSRLLRQ  260 (269)
T ss_dssp             HHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHccCCcccCcCHHHHHHH
Confidence            99999999999999999886

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=8.3e-46  Score=334.99  Aligned_cols=249  Identities=22%  Similarity=0.372  Sum_probs=182.4

Q ss_pred             CCCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCcccc---HHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEE
Q 019195            1 MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKID---ANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVM   77 (344)
Q Consensus         1 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~   77 (344)
                      +++|++++.||+|+||.||+|.+..+++.||+|++.......   ..+.++..+++.++||||+++++++...+.+++||
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~  103 (318)
T 2dyl_A           24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM  103 (318)
T ss_dssp             GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence            468999999999999999999999999999999997654322   22334445678889999999999999999999999


Q ss_pred             ecCCCCChHHHHHh-CCCCCHHHHHHHHHHHHHC--------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCCC
Q 019195           78 EYAAGGELFERICN-AGRFSEDEARYFFQQLISG--------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR  148 (344)
Q Consensus        78 e~~~~g~L~~~i~~-~~~~~~~~~~~~~~ql~~~--------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~~  148 (344)
                      ||+ ++.+..+... ...+++..++.++.|++.+        ||+||||||+|||++.++.  +||+|||++........
T Consensus       104 e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~--~kl~dfg~~~~~~~~~~  180 (318)
T 2dyl_A          104 ELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQ--IKLCDFGISGRLVDDKA  180 (318)
T ss_dssp             CCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSC--EEECCCTTC--------
T ss_pred             ecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCC--EEEEECCCchhccCCcc
Confidence            999 5556555543 5678999888887776543        9999999999999976654  99999999876554444


Q ss_pred             CCCCccCCcccCCccccC----CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHh-hccccCCCCCCCC
Q 019195          149 PKSTVGTPAYIAPEVLSR----REYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIM-AVQYKIPDYVHIS  223 (344)
Q Consensus       149 ~~~~~gt~~y~aPE~~~~----~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~s  223 (344)
                      .....||+.|+|||++..    ....+.++|||||||++|+|++|+.||.........   +..+. ......+....++
T Consensus       181 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~---~~~~~~~~~~~~~~~~~~~  257 (318)
T 2dyl_A          181 KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEV---LTKVLQEEPPLLPGHMGFS  257 (318)
T ss_dssp             ------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHH---HHHHHHSCCCCCCSSSCCC
T ss_pred             ccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHH---HHHHhccCCCCCCccCCCC
Confidence            555679999999999852    223345699999999999999999999875443222   22222 2223344445689


Q ss_pred             HhHHHHHHHhcccCCCCCCChHHHhcCccccc
Q 019195          224 QDCRNLLSRIFVANPSRRITIKEIKSHPWFLK  255 (344)
Q Consensus       224 ~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~  255 (344)
                      +++.+||.+||+.||.+|||+.++++||||.+
T Consensus       258 ~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~  289 (318)
T 2dyl_A          258 GDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKR  289 (318)
T ss_dssp             HHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHH
T ss_pred             HHHHHHHHHHccCChhHCcCHHHHhhCHHHHh
Confidence            99999999999999999999999999999954

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=4e-46  Score=329.22  Aligned_cols=240  Identities=25%  Similarity=0.405  Sum_probs=199.3

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEEecCC
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYAA   81 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~   81 (344)
                      ++|++++.||+|+||.||++.+. ++..||+|++.........+.+|+.++++++||||+++++++.....+++||||++
T Consensus         8 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   86 (268)
T 3sxs_A            8 EEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYIS   86 (268)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTBCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCT
T ss_pred             hheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCCcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEccC
Confidence            68999999999999999999876 56779999998876667789999999999999999999999999999999999999


Q ss_pred             CCChHHHHHhCC-CCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCC--CCCC
Q 019195           82 GGELFERICNAG-RFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS--RPKS  151 (344)
Q Consensus        82 ~g~L~~~i~~~~-~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~--~~~~  151 (344)
                      +++|.+++...+ .+++.+++.++.|++.+       ||+||||||+||+++.++.  +||+|||++.......  ....
T Consensus        87 ~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~--~~l~Dfg~~~~~~~~~~~~~~~  164 (268)
T 3sxs_A           87 NGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLC--VKVSDFGMTRYVLDDQYVSSVG  164 (268)
T ss_dssp             TCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCC--EEECCTTCEEECCTTCEEECCS
T ss_pred             CCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCC--EEEccCccceecchhhhhcccC
Confidence            999999997754 58999888888776654       9999999999999977664  9999999987543322  1233


Q ss_pred             CccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCHhHHHHH
Q 019195          152 TVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLL  230 (344)
Q Consensus       152 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li  230 (344)
                      ..+|+.|+|||++.+..++. ++||||||+++|+|++ |+.||............    .. .........+++.+.+||
T Consensus       165 ~~~~~~y~aPE~~~~~~~~~-~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~----~~-~~~~~~~~~~~~~l~~li  238 (268)
T 3sxs_A          165 TKFPVKWSAPEVFHYFKYSS-KSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKV----SQ-GHRLYRPHLASDTIYQIM  238 (268)
T ss_dssp             CCCCGGGCCHHHHHHSEEET-THHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHH----HT-TCCCCCCTTSCHHHHHHH
T ss_pred             CCcCcccCCHHHHhccCCch-hhhhHHHHHHHHHHHcCCCCCccccChHHHHHHH----Hc-CCCCCCCCcChHHHHHHH
Confidence            45778899999998777654 5999999999999999 99999876654333222    21 122233345789999999


Q ss_pred             HHhcccCCCCCCChHHHhcC
Q 019195          231 SRIFVANPSRRITIKEIKSH  250 (344)
Q Consensus       231 ~~~L~~dp~~R~s~~ell~h  250 (344)
                      .+||+.||.+|||+.+++++
T Consensus       239 ~~~l~~~p~~Rps~~~ll~~  258 (268)
T 3sxs_A          239 YSCWHELPEKRPTFQQLLSS  258 (268)
T ss_dssp             HHTTCSSGGGSCCHHHHHHH
T ss_pred             HHHcCCChhhCcCHHHHHHH
Confidence            99999999999999999986

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=2.2e-46  Score=340.56  Aligned_cols=248  Identities=24%  Similarity=0.389  Sum_probs=176.2

Q ss_pred             CCCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCcc--ccHHHHHHHH-HHhcCCCCCcceeeEEEEcCCEEEEEE
Q 019195            1 MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK--IDANVAREII-NHKQLRHPNIIRFKEVVLTPTHLAIVM   77 (344)
Q Consensus         1 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~ei~-~l~~l~h~niv~~~~~~~~~~~~~lv~   77 (344)
                      .++|++++.||+|+||.||+|.+..+++.||+|++.....  ....+.+|+. +++.++||||+++++++...+..++||
T Consensus        21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~  100 (327)
T 3aln_A           21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICM  100 (327)
T ss_dssp             SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEE
Confidence            3689999999999999999999999999999999976432  2234556665 677789999999999999999999999


Q ss_pred             ecCCCCChHHHHHh-----CCCCCHHHHHHHHHHHHH-------C-CeeecCCCCCCeEecCCCCCCEEEeecCCCcccC
Q 019195           78 EYAAGGELFERICN-----AGRFSEDEARYFFQQLIS-------G-QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSL  144 (344)
Q Consensus        78 e~~~~g~L~~~i~~-----~~~~~~~~~~~~~~ql~~-------~-~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~  144 (344)
                      ||+.+ +|.+++..     ...+++..++.++.|++.       . ||+||||||+|||++.++.  +||+|||+++...
T Consensus       101 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~--~kl~Dfg~~~~~~  177 (327)
T 3aln_A          101 ELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGN--IKLCDFGISGQLV  177 (327)
T ss_dssp             CCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTE--EEECCCSSSCC--
T ss_pred             eecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCC--EEEccCCCceecc
Confidence            99975 88777753     567888888888777654       4 9999999999999987664  9999999998655


Q ss_pred             CCCCCCCCccCCcccCCcccc----CCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhcc-ccCC--
Q 019195          145 LHSRPKSTVGTPAYIAPEVLS----RREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQ-YKIP--  217 (344)
Q Consensus       145 ~~~~~~~~~gt~~y~aPE~~~----~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~--  217 (344)
                      .........||+.|+|||++.    +..+ +.++|||||||++|+|++|+.||.......   ..+..+.... ..++  
T Consensus       178 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~~~~~~~~~~~~~~~~~  253 (327)
T 3aln_A          178 DSIAKTRDAGCRPYMAPERIDPSASRQGY-DVRSDVWSLGITLYELATGRFPYPKWNSVF---DQLTQVVKGDPPQLSNS  253 (327)
T ss_dssp             ----------------------------C-CSHHHHHHHHHHHHHHHHSCCCSSCC----------CCCCCSCCCCCCCC
T ss_pred             cccccccCCCCccccCceeeccccCcCCC-CchhhHHHHHHHHHHHHHCCCCCCCcchHH---HHHHHHhcCCCCCCCCc
Confidence            444445557999999999983    3344 456999999999999999999997643211   1111111111 1111  


Q ss_pred             CCCCCCHhHHHHHHHhcccCCCCCCChHHHhcCccccc
Q 019195          218 DYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLK  255 (344)
Q Consensus       218 ~~~~~s~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~  255 (344)
                      ....+++.+.+||.+||+.||.+|||+.++++||||..
T Consensus       254 ~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~  291 (327)
T 3aln_A          254 EEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILM  291 (327)
T ss_dssp             SSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHH
T ss_pred             ccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHH
Confidence            12357899999999999999999999999999999954

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=1.5e-46  Score=347.34  Aligned_cols=253  Identities=22%  Similarity=0.345  Sum_probs=196.7

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcCC-----------CCCcceeeEEEEcC
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLR-----------HPNIIRFKEVVLTP   70 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~l~~l~-----------h~niv~~~~~~~~~   70 (344)
                      ++|++++.||+|+||+||+|.+..+++.||+|++.........+.+|+.++++++           ||||+++++++...
T Consensus        19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~~   98 (373)
T 1q8y_A           19 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK   98 (373)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred             CeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhcc
Confidence            5899999999999999999999999999999999876555567889999998886           89999999999865


Q ss_pred             C----EEEEEEecCCCCChHHHHHhC--CCCCHHHHHHHHHHHH-------HC-CeeecCCCCCCeEecCC----CCCCE
Q 019195           71 T----HLAIVMEYAAGGELFERICNA--GRFSEDEARYFFQQLI-------SG-QICHRDLKLENTLLDGS----PAPRL  132 (344)
Q Consensus        71 ~----~~~lv~e~~~~g~L~~~i~~~--~~~~~~~~~~~~~ql~-------~~-~iiH~Dikp~NIl~~~~----~~~~v  132 (344)
                      +    .++++|||+ +++|.+++...  ..+++..++.++.||+       +. ||+||||||+|||++..    ..+.+
T Consensus        99 ~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~~~~~~~  177 (373)
T 1q8y_A           99 GPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQI  177 (373)
T ss_dssp             ETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEEE
T ss_pred             CCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCCCcCcceE
Confidence            4    789999999 89999999763  4588888877766655       55 99999999999999532    22359


Q ss_pred             EEeecCCCcccCCCCCCCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC------hHHHHHHH
Q 019195          133 KICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQED------PKNFRKTI  206 (344)
Q Consensus       133 kL~DFg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~------~~~~~~~~  206 (344)
                      ||+|||++.....  ......||+.|+|||++.+..++ .++|||||||++|+|++|+.||.....      ......++
T Consensus       178 kl~Dfg~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~  254 (373)
T 1q8y_A          178 KIADLGNACWYDE--HYTNSIQTREYRSPEVLLGAPWG-CGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQII  254 (373)
T ss_dssp             EECCCTTCEETTB--CCCSCCSCGGGCCHHHHHTCCCC-THHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHH
T ss_pred             EEcccccccccCC--CCCCCCCCccccCcHHHhCCCCC-chHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHHHHHH
Confidence            9999999875432  23456799999999999887764 559999999999999999999986542      11222222


Q ss_pred             HHHhhcc------------------------------------ccCCCCCCCCHhHHHHHHHhcccCCCCCCChHHHhcC
Q 019195          207 SRIMAVQ------------------------------------YKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSH  250 (344)
Q Consensus       207 ~~~~~~~------------------------------------~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~ell~h  250 (344)
                      ......+                                    ........+++++.+||.+||+.||.+|||+.++|+|
T Consensus       255 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  334 (373)
T 1q8y_A          255 ELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNH  334 (373)
T ss_dssp             HHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTC
T ss_pred             HhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHHHHhhC
Confidence            1111000                                    0001112345788999999999999999999999999


Q ss_pred             cccccCCC
Q 019195          251 PWFLKNLP  258 (344)
Q Consensus       251 p~~~~~~~  258 (344)
                      |||.+...
T Consensus       335 p~f~~~~~  342 (373)
T 1q8y_A          335 PWLKDTLG  342 (373)
T ss_dssp             GGGTTCTT
T ss_pred             hhhhcccC
Confidence            99987643

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=1.1e-47  Score=355.18  Aligned_cols=247  Identities=16%  Similarity=0.182  Sum_probs=178.0

Q ss_pred             CceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCcc----ccHHHHHHH---HHHhcCCCCCcceee-------EEEE
Q 019195            3 KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK----IDANVAREI---INHKQLRHPNIIRFK-------EVVL   68 (344)
Q Consensus         3 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~ei---~~l~~l~h~niv~~~-------~~~~   68 (344)
                      +|++.+.||+|+||+||+|.+..+++.||+|++.....    ....+.+|+   ..|+. +||||++++       +++.
T Consensus        63 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~-~hp~iv~~~~~~~~p~d~~~  141 (371)
T 3q60_A           63 KLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLG-ESPEEARDRRRLLLPSDAVA  141 (371)
T ss_dssp             EEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC-----------CBCCCCEEEE
T ss_pred             eeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcc-cChhhhhhceeEEeeehhee
Confidence            59999999999999999999999999999999987543    234566774   45555 799988755       5554


Q ss_pred             cC-----------------CEEEEEEecCCCCChHHHHHhCC-CCCH-------------HHHHHHHHHHHHCCeeecCC
Q 019195           69 TP-----------------THLAIVMEYAAGGELFERICNAG-RFSE-------------DEARYFFQQLISGQICHRDL  117 (344)
Q Consensus        69 ~~-----------------~~~~lv~e~~~~g~L~~~i~~~~-~~~~-------------~~~~~~~~ql~~~~iiH~Di  117 (344)
                      ..                 ..+|+|||||+ |+|.+++...+ .+..             .++...+..||+.||+||||
T Consensus       142 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrDi  220 (371)
T 3q60_A          142 VQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHF  220 (371)
T ss_dssp             ETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETTC
T ss_pred             cCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCcC
Confidence            33                 34899999998 89999997632 2222             23333345566669999999


Q ss_pred             CCCCeEecCCCCCCEEEeecCCCcccCCCCCCCCCccCCcccCCccccC--CCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 019195          118 KLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSR--REYDGKLADVWSCGVTLYVMLVGAYPFED  195 (344)
Q Consensus       118 kp~NIl~~~~~~~~vkL~DFg~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~il~el~~g~~pf~~  195 (344)
                      ||+|||++.++.  +||+|||+++....  ......+|+.|+|||++.+  ..+ +.++|||||||++|+|++|+.||..
T Consensus       221 kp~NIll~~~~~--~kL~DFG~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~-~~~~DiwSlG~il~elltg~~Pf~~  295 (371)
T 3q60_A          221 TPDNLFIMPDGR--LMLGDVSALWKVGT--RGPASSVPVTYAPREFLNASTATF-THALNAWQLGLSIYRVWCLFLPFGL  295 (371)
T ss_dssp             SGGGEEECTTSC--EEECCGGGEEETTC--EEEGGGSCGGGCCHHHHTCSEEEC-CHHHHHHHHHHHHHHHHHSSCSTTB
T ss_pred             CHHHEEECCCCC--EEEEecceeeecCC--CccCccCCcCCcChhhccCCCCCc-CccccHHHHHHHHHHHHhCCCCCCC
Confidence            999999987654  99999999875422  2224567899999999976  444 5669999999999999999999987


Q ss_pred             CCChHH--HHH-HHHHHhhccccCCCCCCCCHhHHHHHHHhcccCCCCCCChHHHhcCcccccC
Q 019195          196 QEDPKN--FRK-TISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKN  256 (344)
Q Consensus       196 ~~~~~~--~~~-~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~~  256 (344)
                      ......  +.. ...........++....+++.+.+||.+||+.||.+|||+.++|+||||.+.
T Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~  359 (371)
T 3q60_A          296 VTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQL  359 (371)
T ss_dssp             CCTTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHHHH
T ss_pred             cCcccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHHHH
Confidence            632110  000 0000112233445556789999999999999999999999999999999643

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=3.4e-46  Score=338.57  Aligned_cols=249  Identities=21%  Similarity=0.362  Sum_probs=182.6

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCc---EEEEEEeecCc---cccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEE--
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKE---LVAMKYIERGH---KIDANVAREIINHKQLRHPNIIRFKEVVLTPTHL--   73 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~---~vaiK~~~~~~---~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~--   73 (344)
                      ++|++.+.||+|+||.||+|.+..++.   .||+|++....   .....+.+|+.++++++||||+++++++......  
T Consensus        23 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  102 (323)
T 3qup_A           23 QQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGR  102 (323)
T ss_dssp             --CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC-----
T ss_pred             hHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccccC
Confidence            579999999999999999999887765   89999987642   2336788999999999999999999999877655  


Q ss_pred             ----EEEEecCCCCChHHHHHhCC------CCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEee
Q 019195           74 ----AIVMEYAAGGELFERICNAG------RFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICD  136 (344)
Q Consensus        74 ----~lv~e~~~~g~L~~~i~~~~------~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~D  136 (344)
                          ++||||+.+|+|.+++....      .+++.+++.++.|++.+       ||+||||||+|||++.++  .+||+|
T Consensus       103 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~--~~kl~D  180 (323)
T 3qup_A          103 LPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDM--TVCVAD  180 (323)
T ss_dssp             --CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTS--CEEECC
T ss_pred             CCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCC--CEEEee
Confidence                99999999999999986532      58888888888776654       999999999999998765  499999


Q ss_pred             cCCCcccCCCCC---CCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhhc
Q 019195          137 FGYSKSSLLHSR---PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAV  212 (344)
Q Consensus       137 Fg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~  212 (344)
                      ||+++.......   .....+|+.|+|||.+.+..+ +.++|||||||++|+|++ |+.||...........+..     
T Consensus       181 fg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~-----  254 (323)
T 3qup_A          181 FGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLY-TVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIG-----  254 (323)
T ss_dssp             CCC-----------------CCGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHT-----
T ss_pred             ccccccccccccccccccccCcccccCchhhcCCCC-CCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHhc-----
Confidence            999975433322   223457889999999987766 456999999999999999 9999988776554433222     


Q ss_pred             cccCCCCCCCCHhHHHHHHHhcccCCCCCCC-------hHHHhcCcccccCCC
Q 019195          213 QYKIPDYVHISQDCRNLLSRIFVANPSRRIT-------IKEIKSHPWFLKNLP  258 (344)
Q Consensus       213 ~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s-------~~ell~hp~~~~~~~  258 (344)
                      ....+....+++++.+||.+||+.||.+|||       +.+++.|||+.....
T Consensus       255 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~~~  307 (323)
T 3qup_A          255 GNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLSTSQ  307 (323)
T ss_dssp             TCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC--------
T ss_pred             CCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCCCC
Confidence            1223344578999999999999999999999       788899999976543

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=3.7e-46  Score=338.95  Aligned_cols=240  Identities=25%  Similarity=0.365  Sum_probs=195.4

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCc---EEEEEEeecCcc--ccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEE
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKE---LVAMKYIERGHK--IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIV   76 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~---~vaiK~~~~~~~--~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv   76 (344)
                      ++|++.+.||+|+||.||++.+..++.   .||+|++.....  ....+.+|+.++++++||||+++++++...+.+|+|
T Consensus        49 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  128 (325)
T 3kul_A           49 SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIV  128 (325)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEEE
T ss_pred             hHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEEE
Confidence            579999999999999999999986554   599999976432  335688999999999999999999999999999999


Q ss_pred             EecCCCCChHHHHHhC-CCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCCC
Q 019195           77 MEYAAGGELFERICNA-GRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR  148 (344)
Q Consensus        77 ~e~~~~g~L~~~i~~~-~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~~  148 (344)
                      |||+++++|.+++... +.+++.+++.++.|++.+       ||+||||||+|||++.++  .+||+|||+++.......
T Consensus       129 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~--~~kl~Dfg~a~~~~~~~~  206 (325)
T 3kul_A          129 TEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNL--VCKVSDFGLSRVLEDDPD  206 (325)
T ss_dssp             EECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC--CEEECCCSSCEECC----
T ss_pred             eeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCC--CEEECCCCcccccccCcc
Confidence            9999999999999754 579999888887776654       999999999999997665  499999999976433322


Q ss_pred             ----CCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCC
Q 019195          149 ----PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHIS  223 (344)
Q Consensus       149 ----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s  223 (344)
                          .....+|+.|+|||++.+..++ .++|||||||++|+|++ |..||...........    +. .....+....++
T Consensus       207 ~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~----~~-~~~~~~~~~~~~  280 (325)
T 3kul_A          207 AAYTTTGGKIPIRWTAPEAIAFRTFS-SASDVWSFGVVMWEVLAYGERPYWNMTNRDVISS----VE-EGYRLPAPMGCP  280 (325)
T ss_dssp             CCEECC---CCGGGSCHHHHHHCEEC-HHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHH----HH-TTCCCCCCTTCC
T ss_pred             ceeeccCCCCcccccCHhHhcCCCCC-cHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHH----HH-cCCCCCCCCCcC
Confidence                1223468889999999877764 55999999999999999 9999987665433222    22 223445555789


Q ss_pred             HhHHHHHHHhcccCCCCCCChHHHhc
Q 019195          224 QDCRNLLSRIFVANPSRRITIKEIKS  249 (344)
Q Consensus       224 ~~~~~li~~~L~~dp~~R~s~~ell~  249 (344)
                      +.+.+||.+||+.||.+|||+.++++
T Consensus       281 ~~l~~li~~~l~~dp~~Rps~~eil~  306 (325)
T 3kul_A          281 HALHQLMLDCWHKDRAQRPRFSQIVS  306 (325)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHHHccCChhhCcCHHHHHH
Confidence            99999999999999999999999986

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=8.1e-46  Score=342.54  Aligned_cols=241  Identities=24%  Similarity=0.349  Sum_probs=195.7

Q ss_pred             CCceeeeeeeecCceEEEEEEEc-------CCCcEEEEEEeecCcc--ccHHHHHHHHHHhcC-CCCCcceeeEEEEcCC
Q 019195            2 EKYELMKDIGSGNFGVARLMRNK-------NTKELVAMKYIERGHK--IDANVAREIINHKQL-RHPNIIRFKEVVLTPT   71 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~vaiK~~~~~~~--~~~~~~~ei~~l~~l-~h~niv~~~~~~~~~~   71 (344)
                      ++|++.+.||+|+||.||+|.+.       .++..||+|++.....  ....+.+|+.+++.+ +||||+++++++...+
T Consensus        81 ~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~  160 (370)
T 2psq_A           81 DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG  160 (370)
T ss_dssp             GGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSSS
T ss_pred             HHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccCC
Confidence            57999999999999999999874       3556899999976532  235688999999999 8999999999999999


Q ss_pred             EEEEEEecCCCCChHHHHHhCC----------------CCCHHHHHHHHHHHHH-------CCeeecCCCCCCeEecCCC
Q 019195           72 HLAIVMEYAAGGELFERICNAG----------------RFSEDEARYFFQQLIS-------GQICHRDLKLENTLLDGSP  128 (344)
Q Consensus        72 ~~~lv~e~~~~g~L~~~i~~~~----------------~~~~~~~~~~~~ql~~-------~~iiH~Dikp~NIl~~~~~  128 (344)
                      .+|+||||+++|+|.+++....                .++..+++.++.||+.       .||+||||||+|||++.++
T Consensus       161 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~  240 (370)
T 2psq_A          161 PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENN  240 (370)
T ss_dssp             SCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTC
T ss_pred             CEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhEEECCCC
Confidence            9999999999999999997653                4677777777666654       4999999999999997665


Q ss_pred             CCCEEEeecCCCcccCCCC---CCCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHH
Q 019195          129 APRLKICDFGYSKSSLLHS---RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRK  204 (344)
Q Consensus       129 ~~~vkL~DFg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~  204 (344)
                      .  +||+|||+++......   ......+|+.|+|||++.+..++ .++|||||||++|+|++ |..||........+..
T Consensus       241 ~--~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~DvwslG~il~ellt~g~~p~~~~~~~~~~~~  317 (370)
T 2psq_A          241 V--MKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYT-HQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKL  317 (370)
T ss_dssp             C--EEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCC-HHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHH
T ss_pred             C--EEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCC-cHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence            4  9999999997543322   22334678999999999887764 56999999999999999 9999988765443322


Q ss_pred             HHHHHhhccccCCCCCCCCHhHHHHHHHhcccCCCCCCChHHHhcC
Q 019195          205 TISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSH  250 (344)
Q Consensus       205 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~ell~h  250 (344)
                      +    . .....+....+++.+.+||.+||+.||.+|||+.+++++
T Consensus       318 ~----~-~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~  358 (370)
T 2psq_A          318 L----K-EGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED  358 (370)
T ss_dssp             H----H-TTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             H----h-cCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            1    1 122233344789999999999999999999999999874

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.8e-46  Score=338.78  Aligned_cols=241  Identities=31%  Similarity=0.516  Sum_probs=196.3

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCcc-------ccHHHHHHHHHHhcC----CCCCcceeeEEEEcC
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK-------IDANVAREIINHKQL----RHPNIIRFKEVVLTP   70 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-------~~~~~~~ei~~l~~l----~h~niv~~~~~~~~~   70 (344)
                      ++|++.+.||+|+||.||+|.+..+++.||+|++.....       ....+.+|+.+++++    +||||+++++++...
T Consensus        31 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~~~  110 (312)
T 2iwi_A           31 AEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQ  110 (312)
T ss_dssp             --CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC---
T ss_pred             hceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEecC
Confidence            589999999999999999999999999999999976432       123455789988888    899999999999999


Q ss_pred             CEEEEEEec-CCCCChHHHHHhCCCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEec-CCCCCCEEEeecCCCc
Q 019195           71 THLAIVMEY-AAGGELFERICNAGRFSEDEARYFFQQLISG-------QICHRDLKLENTLLD-GSPAPRLKICDFGYSK  141 (344)
Q Consensus        71 ~~~~lv~e~-~~~g~L~~~i~~~~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~-~~~~~~vkL~DFg~a~  141 (344)
                      +..++|||+ +.+++|.+++...+.+++..++.++.|++.+       ||+||||||+||+++ .++  .+||+|||++.
T Consensus       111 ~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~--~~kl~dfg~~~  188 (312)
T 2iwi_A          111 EGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRG--CAKLIDFGSGA  188 (312)
T ss_dssp             --CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTT--EEEECCCSSCE
T ss_pred             CeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCC--eEEEEEcchhh
Confidence            999999999 7899999999988889999999988887765       999999999999997 444  59999999987


Q ss_pred             ccCCCCCCCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCCCCCC
Q 019195          142 SSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVH  221 (344)
Q Consensus       142 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  221 (344)
                      ..... ......||+.|+|||++.+..+.+.++|||||||++|+|++|+.||....      .    +......++  ..
T Consensus       189 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~------~----~~~~~~~~~--~~  255 (312)
T 2iwi_A          189 LLHDE-PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ------E----ILEAELHFP--AH  255 (312)
T ss_dssp             ECCSS-CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------H----HHHTCCCCC--TT
T ss_pred             hcccC-cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH------H----HhhhccCCc--cc
Confidence            54432 33456799999999999877776667999999999999999999996521      1    122233333  36


Q ss_pred             CCHhHHHHHHHhcccCCCCCCChHHHhcCcccccCC
Q 019195          222 ISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNL  257 (344)
Q Consensus       222 ~s~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~~~  257 (344)
                      +++.+.+||.+||+.||.+|||+.++++||||....
T Consensus       256 ~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~~~  291 (312)
T 2iwi_A          256 VSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPA  291 (312)
T ss_dssp             SCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC--
T ss_pred             CCHHHHHHHHHHccCChhhCcCHHHHhcChhhcCch
Confidence            899999999999999999999999999999997653

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=3.4e-46  Score=343.38  Aligned_cols=242  Identities=23%  Similarity=0.385  Sum_probs=197.0

Q ss_pred             CCceeeeeeeecCceEEEEEE-----EcCCCcEEEEEEeecCcc--ccHHHHHHHHHHhcC-CCCCcceeeEEEEcCC-E
Q 019195            2 EKYELMKDIGSGNFGVARLMR-----NKNTKELVAMKYIERGHK--IDANVAREIINHKQL-RHPNIIRFKEVVLTPT-H   72 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~-----~~~~~~~vaiK~~~~~~~--~~~~~~~ei~~l~~l-~h~niv~~~~~~~~~~-~   72 (344)
                      ++|++.+.||+|+||.||+|.     +..+++.||+|++.....  ....+.+|+.+++++ +||||+++++++...+ .
T Consensus        22 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~  101 (359)
T 3vhe_A           22 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP  101 (359)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSC
T ss_pred             cceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecCCCc
Confidence            689999999999999999999     566779999999976433  235688999999999 7999999999998765 4


Q ss_pred             EEEEEecCCCCChHHHHHhCCC----------------------------------------------------------
Q 019195           73 LAIVMEYAAGGELFERICNAGR----------------------------------------------------------   94 (344)
Q Consensus        73 ~~lv~e~~~~g~L~~~i~~~~~----------------------------------------------------------   94 (344)
                      +++|||||++|+|.+++.....                                                          
T Consensus       102 ~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  181 (359)
T 3vhe_A          102 LMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEA  181 (359)
T ss_dssp             CEEEEECCTTEEHHHHHHTTTTSBCSCC----------------------------------------------------
T ss_pred             eEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhhccc
Confidence            8999999999999999976543                                                          


Q ss_pred             --------CCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCCC---CCCCccCC
Q 019195           95 --------FSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR---PKSTVGTP  156 (344)
Q Consensus        95 --------~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~~---~~~~~gt~  156 (344)
                              +++..++.++.||+.+       ||+||||||+|||++.++.  +||+|||+++.......   .....||+
T Consensus       182 ~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~--~kl~Dfg~a~~~~~~~~~~~~~~~~~t~  259 (359)
T 3vhe_A          182 PEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNV--VKICDFGLARDIYKDPDYVRKGDARLPL  259 (359)
T ss_dssp             --CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC--EEECCCGGGSCTTSCTTCEEC--CEECG
T ss_pred             ccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCc--EEEEeccceeeecccccchhccccCCCc
Confidence                    7888887777776654       9999999999999986664  99999999975433222   23456899


Q ss_pred             cccCCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCHhHHHHHHHhcc
Q 019195          157 AYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFV  235 (344)
Q Consensus       157 ~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~  235 (344)
                      .|+|||++.+..++ .++|||||||++|+|++ |..||............+..    ....+....+++++.+||.+||+
T Consensus       260 ~y~aPE~~~~~~~~-~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~l~~li~~~l~  334 (359)
T 3vhe_A          260 KWMAPETIFDRVYT-IQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKE----GTRMRAPDYTTPEMYQTMLDCWH  334 (359)
T ss_dssp             GGCCHHHHHHCCCC-HHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHH----TCCCCCCTTCCHHHHHHHHHHTC
T ss_pred             eeEChhhhcCCCCC-chhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHc----CCCCCCCCCCCHHHHHHHHHHcc
Confidence            99999999877764 56999999999999998 99999887655444433322    22333344689999999999999


Q ss_pred             cCCCCCCChHHHhcC
Q 019195          236 ANPSRRITIKEIKSH  250 (344)
Q Consensus       236 ~dp~~R~s~~ell~h  250 (344)
                      .||.+|||+.++++|
T Consensus       335 ~dP~~Rps~~ell~~  349 (359)
T 3vhe_A          335 GEPSQRPTFSELVEH  349 (359)
T ss_dssp             SSGGGSCCHHHHHHH
T ss_pred             CChhhCCCHHHHHHH
Confidence            999999999999987

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=2.1e-46  Score=346.14  Aligned_cols=246  Identities=19%  Similarity=0.289  Sum_probs=197.5

Q ss_pred             CCceeeeeeeecCceEEEEEE-----EcCCCcEEEEEEeecCcc--ccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEE
Q 019195            2 EKYELMKDIGSGNFGVARLMR-----NKNTKELVAMKYIERGHK--IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLA   74 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~-----~~~~~~~vaiK~~~~~~~--~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~   74 (344)
                      ++|++++.||+|+||+||+|.     +..+++.||+|++.....  ....+.+|+.++++++||||+++++++......|
T Consensus        71 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  150 (367)
T 3l9p_A           71 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRF  150 (367)
T ss_dssp             GGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred             hHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCE
Confidence            579999999999999999999     556788999999865322  2346889999999999999999999999999999


Q ss_pred             EEEecCCCCChHHHHHhCC-------CCCHHHHHHHHHHHHH-------CCeeecCCCCCCeEecCCC-CCCEEEeecCC
Q 019195           75 IVMEYAAGGELFERICNAG-------RFSEDEARYFFQQLIS-------GQICHRDLKLENTLLDGSP-APRLKICDFGY  139 (344)
Q Consensus        75 lv~e~~~~g~L~~~i~~~~-------~~~~~~~~~~~~ql~~-------~~iiH~Dikp~NIl~~~~~-~~~vkL~DFg~  139 (344)
                      +|||||++|+|.+++....       .++..+++.++.|++.       .||+||||||+|||++.++ ...+||+|||+
T Consensus       151 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~kL~DFG~  230 (367)
T 3l9p_A          151 ILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGM  230 (367)
T ss_dssp             EEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECCCHH
T ss_pred             EEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceEEECCCcc
Confidence            9999999999999997643       4888888877777654       4999999999999997433 23599999999


Q ss_pred             CcccC---CCCCCCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhhcccc
Q 019195          140 SKSSL---LHSRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYK  215 (344)
Q Consensus       140 a~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~  215 (344)
                      ++...   .........||+.|+|||++.+..++ .++|||||||++|+|++ |..||..........    .+... ..
T Consensus       231 a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~----~i~~~-~~  304 (367)
T 3l9p_A          231 ARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFT-SKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLE----FVTSG-GR  304 (367)
T ss_dssp             HHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHH----HHHTT-CC
T ss_pred             ccccccccccccCCCcCCcccEECHHHhcCCCCC-cHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHH----HHHcC-CC
Confidence            86432   22233445689999999999877764 56999999999999998 999998866533322    22222 22


Q ss_pred             CCCCCCCCHhHHHHHHHhcccCCCCCCChHHHhcCccc
Q 019195          216 IPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF  253 (344)
Q Consensus       216 ~~~~~~~s~~~~~li~~~L~~dp~~R~s~~ell~hp~~  253 (344)
                      .+....+++.+.+||.+||+.||.+|||+.+++++.++
T Consensus       305 ~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~  342 (367)
T 3l9p_A          305 MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEY  342 (367)
T ss_dssp             CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             CCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence            33344689999999999999999999999999998775

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=6.6e-46  Score=330.43  Aligned_cols=240  Identities=22%  Similarity=0.370  Sum_probs=197.1

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEEecCC
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYAA   81 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~   81 (344)
                      ++|++++.||+|+||+||++.+. ++..||+|++.........+.+|+.++++++||||+++++++...+.+++||||++
T Consensus        24 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~  102 (283)
T 3gen_A           24 KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA  102 (283)
T ss_dssp             GGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCCT
T ss_pred             HHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCCCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEeccC
Confidence            58999999999999999999886 57789999998876667789999999999999999999999999999999999999


Q ss_pred             CCChHHHHHh-CCCCCHHHHHHHHHHHHH-------CCeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCC--CCCCC
Q 019195           82 GGELFERICN-AGRFSEDEARYFFQQLIS-------GQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH--SRPKS  151 (344)
Q Consensus        82 ~g~L~~~i~~-~~~~~~~~~~~~~~ql~~-------~~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~--~~~~~  151 (344)
                      +++|.+++.. ...+++.+++.++.|++.       .||+||||||+|||++.++.  +||+|||++......  .....
T Consensus       103 ~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~--~kl~Dfg~~~~~~~~~~~~~~~  180 (283)
T 3gen_A          103 NGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGV--VKVSDFGLSRYVLDDEYTSSVG  180 (283)
T ss_dssp             TCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSC--EEECSTTGGGGBCCHHHHSTTS
T ss_pred             CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCC--EEEccccccccccccccccccC
Confidence            9999999976 567999988888777665       49999999999999976654  999999998754322  12233


Q ss_pred             CccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCHhHHHHH
Q 019195          152 TVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLL  230 (344)
Q Consensus       152 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li  230 (344)
                      ..+|+.|+|||++.+..+ +.++||||||+++|+|++ |+.||...........+    .. .........+++.+.+||
T Consensus       181 ~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~----~~-~~~~~~~~~~~~~l~~li  254 (283)
T 3gen_A          181 SKFPVRWSPPEVLMYSKF-SSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHI----AQ-GLRLYRPHLASEKVYTIM  254 (283)
T ss_dssp             TTSCGGGCCHHHHHHCCC-SHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHH----HT-TCCCCCCTTCCHHHHHHH
T ss_pred             CccCcccCCHHHhccCCC-CchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHH----hc-ccCCCCCCcCCHHHHHHH
Confidence            457889999999987765 456999999999999998 99999887654333322    21 222233346789999999


Q ss_pred             HHhcccCCCCCCChHHHhcC
Q 019195          231 SRIFVANPSRRITIKEIKSH  250 (344)
Q Consensus       231 ~~~L~~dp~~R~s~~ell~h  250 (344)
                      .+||+.||.+|||+.++++|
T Consensus       255 ~~~l~~~p~~Rps~~~ll~~  274 (283)
T 3gen_A          255 YSCWHEKADERPTFKILLSN  274 (283)
T ss_dssp             HHTTCSSGGGSCCHHHHHHH
T ss_pred             HHHccCChhHCcCHHHHHHH
Confidence            99999999999999999986

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=3.1e-45  Score=330.97  Aligned_cols=248  Identities=26%  Similarity=0.388  Sum_probs=195.8

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCcc---ccHHHHHHHHHHhcCC--CCCcceeeEEEEcCCEEEEE
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK---IDANVAREIINHKQLR--HPNIIRFKEVVLTPTHLAIV   76 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~ei~~l~~l~--h~niv~~~~~~~~~~~~~lv   76 (344)
                      ++|++++.||+|+||.||++.+. +++.||+|++.....   ....+.+|+.++++++  ||||+++++++...+.+++|
T Consensus        28 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv  106 (313)
T 3cek_A           28 RIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV  106 (313)
T ss_dssp             EEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEEE
T ss_pred             ceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEEE
Confidence            47999999999999999999985 488999999975432   2356889999999997  59999999999999999999


Q ss_pred             EecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCCC-
Q 019195           77 MEYAAGGELFERICNAGRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR-  148 (344)
Q Consensus        77 ~e~~~~g~L~~~i~~~~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~~-  148 (344)
                      || +.+++|.+++...+.+++.+++.++.|++.+       ||+||||||+|||++.   +.+||+|||++........ 
T Consensus       107 ~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~---~~~kL~Dfg~~~~~~~~~~~  182 (313)
T 3cek_A          107 ME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD---GMLKLIDFGIANQMQPDTTS  182 (313)
T ss_dssp             EC-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEET---TEEEECCCSSSCC-------
T ss_pred             Ee-cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEEC---CeEEEeeccccccccCcccc
Confidence            99 5588999999998899999888887776655       9999999999999964   3599999999976433222 


Q ss_pred             --CCCCccCCcccCCccccCC----------CCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccC
Q 019195          149 --PKSTVGTPAYIAPEVLSRR----------EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKI  216 (344)
Q Consensus       149 --~~~~~gt~~y~aPE~~~~~----------~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  216 (344)
                        .....||+.|+|||++.+.          ...+.++|||||||++|+|++|+.||........   .+..+.......
T Consensus       183 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~---~~~~~~~~~~~~  259 (313)
T 3cek_A          183 VVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS---KLHAIIDPNHEI  259 (313)
T ss_dssp             -------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHH---HHHHHHCTTSCC
T ss_pred             ccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHH---HHHHHHhccccc
Confidence              2345799999999998652          2345679999999999999999999987544221   222233333333


Q ss_pred             CCCCCCCHhHHHHHHHhcccCCCCCCChHHHhcCcccccCC
Q 019195          217 PDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNL  257 (344)
Q Consensus       217 ~~~~~~s~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~~~  257 (344)
                      +.....++++.+||.+||+.||.+|||+.++|+||||....
T Consensus       260 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~~~  300 (313)
T 3cek_A          260 EFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT  300 (313)
T ss_dssp             CCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC-
T ss_pred             CCcccchHHHHHHHHHHccCCcccCcCHHHHhcCccccCCC
Confidence            33345688999999999999999999999999999997653

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=1.8e-45  Score=325.38  Aligned_cols=241  Identities=29%  Similarity=0.406  Sum_probs=188.2

Q ss_pred             CCCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCcc-----ccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEE
Q 019195            1 MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK-----IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAI   75 (344)
Q Consensus         1 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~l   75 (344)
                      +++|++.+.||+|+||.||+|.+.  ++.||+|++.....     ....+.+|+.+++.++||||+++++++...+.+++
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   83 (271)
T 3dtc_A            6 FAELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCL   83 (271)
T ss_dssp             TTSEEEEEEEEEETTEEEEEEEET--TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEE
T ss_pred             hhheeeeeeeccCCCeEEEEEEEc--CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEE
Confidence            478999999999999999999974  78899999875432     23578899999999999999999999999999999


Q ss_pred             EEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHC-------C---eeecCCCCCCeEecCC------CCCCEEEeecCC
Q 019195           76 VMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-------Q---ICHRDLKLENTLLDGS------PAPRLKICDFGY  139 (344)
Q Consensus        76 v~e~~~~g~L~~~i~~~~~~~~~~~~~~~~ql~~~-------~---iiH~Dikp~NIl~~~~------~~~~vkL~DFg~  139 (344)
                      ||||+++++|.+++. .+.+++..++.++.|++.+       |   |+||||||+|||++..      ..+.+||+|||+
T Consensus        84 v~e~~~~~~L~~~~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~  162 (271)
T 3dtc_A           84 VMEFARGGPLNRVLS-GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGL  162 (271)
T ss_dssp             EEECCTTEEHHHHHT-SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC
T ss_pred             EEEcCCCCCHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCCc
Confidence            999999999988884 5679999888888777655       6   9999999999999752      134699999999


Q ss_pred             CcccCCCCCCCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCCCC
Q 019195          140 SKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDY  219 (344)
Q Consensus       140 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  219 (344)
                      +...... ......||+.|+|||++.+..+ +.++||||||+++|+|++|+.||.........    ..........+..
T Consensus       163 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~----~~~~~~~~~~~~~  236 (271)
T 3dtc_A          163 AREWHRT-TKMSAAGAYAWMAPEVIRASMF-SKGSDVWSYGVLLWELLTGEVPFRGIDGLAVA----YGVAMNKLALPIP  236 (271)
T ss_dssp             --------------CCGGGSCHHHHHHCCC-SHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHH----HHHHTSCCCCCCC
T ss_pred             ccccccc-cccCCCCccceeCHHHhccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH----HhhhcCCCCCCCC
Confidence            8754332 2335579999999999987765 45699999999999999999999876543322    2233334444445


Q ss_pred             CCCCHhHHHHHHHhcccCCCCCCChHHHhcC
Q 019195          220 VHISQDCRNLLSRIFVANPSRRITIKEIKSH  250 (344)
Q Consensus       220 ~~~s~~~~~li~~~L~~dp~~R~s~~ell~h  250 (344)
                      ..+++.+.+||.+||+.||.+|||+.+++++
T Consensus       237 ~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~  267 (271)
T 3dtc_A          237 STCPEPFAKLMEDCWNPDPHSRPSFTNILDQ  267 (271)
T ss_dssp             TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             cccCHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence            5789999999999999999999999999875

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=6.6e-46  Score=336.86  Aligned_cols=243  Identities=20%  Similarity=0.229  Sum_probs=188.4

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcCCCCCcceeeEEEEcCC----EEEEEE
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKEVVLTPT----HLAIVM   77 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~----~~~lv~   77 (344)
                      ++|++.+.||+|+||+||+|.+.  ++.||+|++...........+|+.++++++||||+++++++....    .+++||
T Consensus        24 ~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~  101 (322)
T 3soc_A           24 MPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLIT  101 (322)
T ss_dssp             EEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred             hhchhhheecccCceEEEEEEEC--CCEEEEEEeecCchHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEEE
Confidence            58999999999999999999875  789999999776555556777999999999999999999998743    479999


Q ss_pred             ecCCCCChHHHHHhCCCCCHHHHHHHHHHHHH-------C----------CeeecCCCCCCeEecCCCCCCEEEeecCCC
Q 019195           78 EYAAGGELFERICNAGRFSEDEARYFFQQLIS-------G----------QICHRDLKLENTLLDGSPAPRLKICDFGYS  140 (344)
Q Consensus        78 e~~~~g~L~~~i~~~~~~~~~~~~~~~~ql~~-------~----------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a  140 (344)
                      |||++|+|.+++.. ..+++..++.++.|++.       .          ||+||||||+|||++.++.  +||+|||++
T Consensus       102 e~~~~g~L~~~l~~-~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~--~kL~DFg~a  178 (322)
T 3soc_A          102 AFHEKGSLSDFLKA-NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLT--ACIADFGLA  178 (322)
T ss_dssp             ECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCC--EEECCCTTC
T ss_pred             ecCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCe--EEEccCCcc
Confidence            99999999999976 45888888888777654       4          8999999999999977654  999999999


Q ss_pred             cccCCCC---CCCCCccCCcccCCccccCCCC----CCcchhHHHHHHHHHHHHhCCCCCCCCCChH------------H
Q 019195          141 KSSLLHS---RPKSTVGTPAYIAPEVLSRREY----DGKLADVWSCGVTLYVMLVGAYPFEDQEDPK------------N  201 (344)
Q Consensus       141 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~----~~~~~DiwslG~il~el~~g~~pf~~~~~~~------------~  201 (344)
                      +......   .....+||+.|+|||++.+...    .+.++|||||||++|+|++|+.||.+.....            .
T Consensus       179 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~  258 (322)
T 3soc_A          179 LKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPS  258 (322)
T ss_dssp             EEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSCC
T ss_pred             cccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccCCc
Confidence            7543322   2334579999999999976432    2345899999999999999999997643211            1


Q ss_pred             HHHHHHHHhhccccCCCCC------CCCHhHHHHHHHhcccCCCCCCChHHHhcC
Q 019195          202 FRKTISRIMAVQYKIPDYV------HISQDCRNLLSRIFVANPSRRITIKEIKSH  250 (344)
Q Consensus       202 ~~~~~~~~~~~~~~~~~~~------~~s~~~~~li~~~L~~dp~~R~s~~ell~h  250 (344)
                      ............ ..|...      ..++.+.+||.+||+.||.+|||+.++++.
T Consensus       259 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~  312 (322)
T 3soc_A          259 LEDMQEVVVHKK-KRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGER  312 (322)
T ss_dssp             HHHHHHHHTTSC-CCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             hhhhhhhhhccc-CCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            111222111111 112111      123459999999999999999999999863

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=4.1e-45  Score=329.74  Aligned_cols=243  Identities=22%  Similarity=0.318  Sum_probs=189.8

Q ss_pred             CCCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCccc----cHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEE
Q 019195            1 MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKI----DANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIV   76 (344)
Q Consensus         1 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~----~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv   76 (344)
                      +++|++.+.||+|+||.||+|.+..+++.||+|++......    ...+.+|+.++++++||||+++++++..++.+|+|
T Consensus        33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv  112 (309)
T 2h34_A           33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD  112 (309)
T ss_dssp             -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence            47899999999999999999999999999999999764332    25688999999999999999999999999999999


Q ss_pred             EecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCC--
Q 019195           77 MEYAAGGELFERICNAGRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS--  147 (344)
Q Consensus        77 ~e~~~~g~L~~~i~~~~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~--  147 (344)
                      |||+++++|.+++...+.+++.+++.++.|++.+       ||+||||||+|||++.++  .+||+|||++.......  
T Consensus       113 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~--~~kl~Dfg~~~~~~~~~~~  190 (309)
T 2h34_A          113 MRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADD--FAYLVDFGIASATTDEKLT  190 (309)
T ss_dssp             EECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTS--CEEECSCCC----------
T ss_pred             EEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCC--CEEEecCccCccccccccc
Confidence            9999999999999988889999988888777654       999999999999997665  49999999987543322  


Q ss_pred             CCCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCHhHH
Q 019195          148 RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCR  227 (344)
Q Consensus       148 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~  227 (344)
                      ......||+.|+|||++.+..++ .++||||||+++|+|++|+.||...... .....+...  ..........+++.+.
T Consensus       191 ~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~pf~~~~~~-~~~~~~~~~--~~~~~~~~~~~~~~l~  266 (309)
T 2h34_A          191 QLGNTVGTLYYMAPERFSESHAT-YRADIYALTCVLYECLTGSPPYQGDQLS-VMGAHINQA--IPRPSTVRPGIPVAFD  266 (309)
T ss_dssp             ------CCGGGCCGGGTCC-----CCCHHHHHHHHHHHHHHSSCSSCSCHHH-HHHHHHHSC--CCCGGGTSTTCCTHHH
T ss_pred             cccccCCCcCccCHHHHcCCCCC-chHhHHHHHHHHHHHHHCCCCCCCchHH-HHHHHhccC--CCCccccCCCCCHHHH
Confidence            22345799999999999877664 4599999999999999999999875432 211211111  0111112346889999


Q ss_pred             HHHHHhcccCCCCCC-ChHHHhc
Q 019195          228 NLLSRIFVANPSRRI-TIKEIKS  249 (344)
Q Consensus       228 ~li~~~L~~dp~~R~-s~~ell~  249 (344)
                      +||.+||+.||.+|| |+.++++
T Consensus       267 ~li~~~l~~dP~~Rp~s~~~l~~  289 (309)
T 2h34_A          267 AVIARGMAKNPEDRYVTCGDLSA  289 (309)
T ss_dssp             HHHHHHTCSSGGGSCSSHHHHHH
T ss_pred             HHHHHhccCCHHHHHHhHHHHHH
Confidence            999999999999999 7888765

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=3.3e-45  Score=333.31  Aligned_cols=244  Identities=23%  Similarity=0.235  Sum_probs=196.5

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcC-CCCCcceeeEEEEcCCEEEEEEecC
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQL-RHPNIIRFKEVVLTPTHLAIVMEYA   80 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~   80 (344)
                      ++|++.+.||+|+||.||+|.+..+++.||||++..... ...+.+|+.+++.+ +||||+++++++...+..++||||+
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~   87 (330)
T 2izr_A            9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR-APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLELL   87 (330)
T ss_dssp             TTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS-SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEECC
T ss_pred             CCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc-hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEeC
Confidence            579999999999999999999999999999999876433 34688999999999 9999999999999999999999999


Q ss_pred             CCCChHHHHHh-CCCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCC---CCEEEeecCCCcccCCCCC-
Q 019195           81 AGGELFERICN-AGRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPA---PRLKICDFGYSKSSLLHSR-  148 (344)
Q Consensus        81 ~~g~L~~~i~~-~~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~---~~vkL~DFg~a~~~~~~~~-  148 (344)
                       +++|.+++.. .+.+++..++.++.|++.+       ||+||||||+|||++.++.   ..+||+|||+++....... 
T Consensus        88 -~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~~~~~  166 (330)
T 2izr_A           88 -GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETK  166 (330)
T ss_dssp             -CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBCTTTC
T ss_pred             -CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceeeecCCCC
Confidence             9999999986 4679999888887776655       9999999999999975442   2399999999975433221 


Q ss_pred             -------CCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCCC--C
Q 019195          149 -------PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPD--Y  219 (344)
Q Consensus       149 -------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~--~  219 (344)
                             ....+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||....... ....+..+.......+.  .
T Consensus       167 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~ell~g~~Pf~~~~~~~-~~~~~~~i~~~~~~~~~~~~  244 (330)
T 2izr_A          167 KHIPYREHKSLTGTARYMSINTHLGKEQ-SRRDDLEALGHMFMYFLRGSLPWQGLKADT-LKERYQKIGDTKRATPIEVL  244 (330)
T ss_dssp             CBCCCCCCCCCCSCTTTCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSSCTTTTCCCSS-HHHHHHHHHHHHHHSCHHHH
T ss_pred             ccccccccCCcCCCccccChHHHcCCCC-CchhHHHHHHHHHHHHhcCCCCcccccccc-HHHHHHHHHhhhccCCHHHH
Confidence                   245679999999999988776 456999999999999999999998764322 22333333222222221  1


Q ss_pred             CCCCHhHHHHHHHhcccCCCCCCChHHHhc
Q 019195          220 VHISQDCRNLLSRIFVANPSRRITIKEIKS  249 (344)
Q Consensus       220 ~~~s~~~~~li~~~L~~dp~~R~s~~ell~  249 (344)
                      ....+++.+||.+||+.||.+||++.++++
T Consensus       245 ~~~~p~~~~li~~~l~~~p~~RP~~~~l~~  274 (330)
T 2izr_A          245 CENFPEMATYLRYVRRLDFFEKPDYDYLRK  274 (330)
T ss_dssp             TTTCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred             hccChHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence            112349999999999999999999999876

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=1.1e-44  Score=323.10  Aligned_cols=242  Identities=26%  Similarity=0.393  Sum_probs=195.0

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCccc--------cHHHHHHHHHHhcCCCCCcceeeEEEEcCCEE
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKI--------DANVAREIINHKQLRHPNIIRFKEVVLTPTHL   73 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--------~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~   73 (344)
                      ++|++.+.||+|+||.||+|.+..+++.||+|++......        ...+.+|+.++++++||||+++++++....  
T Consensus        19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--   96 (287)
T 4f0f_A           19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP--   96 (287)
T ss_dssp             TTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT--
T ss_pred             ccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC--
Confidence            6899999999999999999999999999999998654322        157889999999999999999999997665  


Q ss_pred             EEEEecCCCCChHHHHHhC-CCCCHHHHHHHHHHHHHC-------C--eeecCCCCCCeEecCCCC---CCEEEeecCCC
Q 019195           74 AIVMEYAAGGELFERICNA-GRFSEDEARYFFQQLISG-------Q--ICHRDLKLENTLLDGSPA---PRLKICDFGYS  140 (344)
Q Consensus        74 ~lv~e~~~~g~L~~~i~~~-~~~~~~~~~~~~~ql~~~-------~--iiH~Dikp~NIl~~~~~~---~~vkL~DFg~a  140 (344)
                      ++||||+++++|.+.+... ..+++..++.++.|++.+       |  |+||||||+|||++.++.   ..+||+|||++
T Consensus        97 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~Dfg~~  176 (287)
T 4f0f_A           97 RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLS  176 (287)
T ss_dssp             EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEECCCTTC
T ss_pred             eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeCCCCcc
Confidence            6999999999998888654 468999888888777655       8  999999999999965432   23899999998


Q ss_pred             cccCCCCCCCCCccCCcccCCccccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCCCC
Q 019195          141 KSSLLHSRPKSTVGTPAYIAPEVLSRR-EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDY  219 (344)
Q Consensus       141 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  219 (344)
                      +....  ......||+.|+|||++... ...+.++|||||||++|+|++|+.||.........  ....+.......+..
T Consensus       177 ~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~--~~~~~~~~~~~~~~~  252 (287)
T 4f0f_A          177 QQSVH--SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIK--FINMIREEGLRPTIP  252 (287)
T ss_dssp             BCCSS--CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHH--HHHHHHHSCCCCCCC
T ss_pred             ccccc--cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHH--HHHHHhccCCCCCCC
Confidence            74322  33456799999999998432 22356699999999999999999999876543321  122223333333444


Q ss_pred             CCCCHhHHHHHHHhcccCCCCCCChHHHhc
Q 019195          220 VHISQDCRNLLSRIFVANPSRRITIKEIKS  249 (344)
Q Consensus       220 ~~~s~~~~~li~~~L~~dp~~R~s~~ell~  249 (344)
                      ..+++.+.+||.+||+.||.+|||+.++++
T Consensus       253 ~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  282 (287)
T 4f0f_A          253 EDCPPRLRNVIELCWSGDPKKRPHFSYIVK  282 (287)
T ss_dssp             TTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             cccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence            578999999999999999999999999986

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=1.9e-45  Score=329.51  Aligned_cols=245  Identities=23%  Similarity=0.383  Sum_probs=192.6

Q ss_pred             CCceeeeeeeecCceEEEEEE----EcCCCcEEEEEEeecCcc-ccHHHHHHHHHHhcCCCCCcceeeEEEEcC--CEEE
Q 019195            2 EKYELMKDIGSGNFGVARLMR----NKNTKELVAMKYIERGHK-IDANVAREIINHKQLRHPNIIRFKEVVLTP--THLA   74 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~----~~~~~~~vaiK~~~~~~~-~~~~~~~ei~~l~~l~h~niv~~~~~~~~~--~~~~   74 (344)
                      ++|++++.||+|+||+||+|.    +..+++.||+|++..... ....+.+|+.++++++||||+++++++...  ..++
T Consensus        10 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   89 (295)
T 3ugc_A           10 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK   89 (295)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSCE
T ss_pred             HHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCceE
Confidence            589999999999999999998    667899999999876433 235688999999999999999999998654  5689


Q ss_pred             EEEecCCCCChHHHHHhCC-CCCHHHHHHHHHHHHH-------CCeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCC
Q 019195           75 IVMEYAAGGELFERICNAG-RFSEDEARYFFQQLIS-------GQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH  146 (344)
Q Consensus        75 lv~e~~~~g~L~~~i~~~~-~~~~~~~~~~~~ql~~-------~~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~  146 (344)
                      +||||+++++|.+++.... .+++.+++.++.|++.       .||+||||||+|||++.++.  +||+|||++......
T Consensus        90 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~--~kl~Dfg~~~~~~~~  167 (295)
T 3ugc_A           90 LIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENR--VKIGDFGLTKVLPQD  167 (295)
T ss_dssp             EEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTE--EEECCCCSCC-----
T ss_pred             EEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCe--EEEccCcccccccCC
Confidence            9999999999999997754 4888888887777665       49999999999999987764  999999999764332


Q ss_pred             C----CCCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCh-----------HHHHHHHHHHhh
Q 019195          147 S----RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDP-----------KNFRKTISRIMA  211 (344)
Q Consensus       147 ~----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-----------~~~~~~~~~~~~  211 (344)
                      .    ......+|+.|+|||++.+..+ +.++|||||||++|+|++|..||......           ............
T Consensus       168 ~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (295)
T 3ugc_A          168 KEFFKVKEPGESPIFWYAPESLTESKF-SVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLK  246 (295)
T ss_dssp             --------CTTCGGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHHHHH
T ss_pred             cceeeeccCCCCccceeCcHHhcCCCC-ChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHHHHh
Confidence            2    1233457888999999987776 45699999999999999999998653210           111111122223


Q ss_pred             ccccCCCCCCCCHhHHHHHHHhcccCCCCCCChHHHhc
Q 019195          212 VQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKS  249 (344)
Q Consensus       212 ~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~ell~  249 (344)
                      .....+....+++++.+||.+||+.||.+|||+.++++
T Consensus       247 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~  284 (295)
T 3ugc_A          247 NNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL  284 (295)
T ss_dssp             TTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             ccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            33345555678999999999999999999999999976

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=4.7e-45  Score=322.36  Aligned_cols=237  Identities=18%  Similarity=0.278  Sum_probs=196.9

Q ss_pred             CCCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCcc---ccHHHHHHHHHHhcCCCCCcceeeEEEEcC--CEEEE
Q 019195            1 MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK---IDANVAREIINHKQLRHPNIIRFKEVVLTP--THLAI   75 (344)
Q Consensus         1 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~ei~~l~~l~h~niv~~~~~~~~~--~~~~l   75 (344)
                      +++|++.+.||+|+||.||+|.+.  ++.||+|++.....   ....+.+|+.++++++||||+++++++...  ..+++
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l   86 (271)
T 3kmu_A            9 FKQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTL   86 (271)
T ss_dssp             GGGCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEE
T ss_pred             HHHhHHHHHhcCCCcceEEEEEEC--CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEe
Confidence            468999999999999999999985  78899999976432   235688999999999999999999999887  78899


Q ss_pred             EEecCCCCChHHHHHhCC--CCCHHHHHHHHHHHHHC-------C--eeecCCCCCCeEecCCCCCCEEEeecCCCcccC
Q 019195           76 VMEYAAGGELFERICNAG--RFSEDEARYFFQQLISG-------Q--ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSL  144 (344)
Q Consensus        76 v~e~~~~g~L~~~i~~~~--~~~~~~~~~~~~ql~~~-------~--iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~  144 (344)
                      ||||+++|+|.+++....  .+++.+++.++.|++.+       |  |+||||||+|||++.++.  ++|+|||++..  
T Consensus        87 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~--~~l~~~~~~~~--  162 (271)
T 3kmu_A           87 ITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMT--ARISMADVKFS--  162 (271)
T ss_dssp             EEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSC--EEEEGGGSCCT--
T ss_pred             eecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcc--eeEEeccceee--
Confidence            999999999999998765  48999999998888765       7  999999999999987665  89998887653  


Q ss_pred             CCCCCCCCccCCcccCCccccCCCCCC--cchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCCCCCCC
Q 019195          145 LHSRPKSTVGTPAYIAPEVLSRREYDG--KLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHI  222 (344)
Q Consensus       145 ~~~~~~~~~gt~~y~aPE~~~~~~~~~--~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  222 (344)
                        .......||+.|+|||++.+..+..  .++|||||||++|+|++|+.||...........    ........+....+
T Consensus       163 --~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~----~~~~~~~~~~~~~~  236 (271)
T 3kmu_A          163 --FQSPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMK----VALEGLRPTIPPGI  236 (271)
T ss_dssp             --TSCTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHH----HHHSCCCCCCCTTC
T ss_pred             --ecccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHH----HHhcCCCCCCCCCC
Confidence              2234467899999999998765544  269999999999999999999987665433322    22233333444578


Q ss_pred             CHhHHHHHHHhcccCCCCCCChHHHhc
Q 019195          223 SQDCRNLLSRIFVANPSRRITIKEIKS  249 (344)
Q Consensus       223 s~~~~~li~~~L~~dp~~R~s~~ell~  249 (344)
                      ++++.+||.+||+.||.+|||+.++++
T Consensus       237 ~~~~~~li~~~l~~~p~~Rps~~~il~  263 (271)
T 3kmu_A          237 SPHVSKLMKICMNEDPAKRPKFDMIVP  263 (271)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            999999999999999999999999986

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=1.4e-44  Score=324.00  Aligned_cols=245  Identities=20%  Similarity=0.222  Sum_probs=198.0

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcC-CCCCcceeeEEEEcCCEEEEEEecC
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQL-RHPNIIRFKEVVLTPTHLAIVMEYA   80 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~   80 (344)
                      ++|++.+.||+|+||.||+|.+..+++.||+|++.... ....+.+|+.+++.+ +|+|++++++++......++||||+
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~   88 (298)
T 1csn_A           10 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS-DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL   88 (298)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT-TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC
T ss_pred             cceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC-ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEec
Confidence            57999999999999999999999999999999987543 334688999999999 7999999999999999999999999


Q ss_pred             CCCChHHHHHhCC-CCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCC---CCCEEEeecCCCcccCCCC--
Q 019195           81 AGGELFERICNAG-RFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSP---APRLKICDFGYSKSSLLHS--  147 (344)
Q Consensus        81 ~~g~L~~~i~~~~-~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~---~~~vkL~DFg~a~~~~~~~--  147 (344)
                       +++|.+++...+ .+++.+++.++.|++.+       ||+||||||+|||++.++   .+++||+|||+++......  
T Consensus        89 -~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~  167 (298)
T 1csn_A           89 -GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTK  167 (298)
T ss_dssp             -CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTC
T ss_pred             -CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECcccccccccccc
Confidence             999999998754 59999998888877755       999999999999997543   2349999999997543322  


Q ss_pred             ------CCCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCC---C
Q 019195          148 ------RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIP---D  218 (344)
Q Consensus       148 ------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~---~  218 (344)
                            ......||+.|+|||++.+..+ +.++|||||||++|+|++|+.||......... ..+..+.......+   .
T Consensus       168 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~g~~pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~  245 (298)
T 1csn_A          168 QHIPYREKKNLSGTARYMSINTHLGREQ-SRRDDLEALGHVFMYFLRGSLPWQGLKAATNK-QKYERIGEKKQSTPLREL  245 (298)
T ss_dssp             CBCCCCCCCCCCSCTTTCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHH-HHHHHHHHHHHHSCHHHH
T ss_pred             ccccccCccCCCCCcccCCchhhcCCCC-ChHHHHHHHHHHHHHHHcCCCCcchhhccccH-HHHHHHHhhccCccHHHH
Confidence                  2345579999999999987776 56699999999999999999999875432221 11112211111111   1


Q ss_pred             CCCCCHhHHHHHHHhcccCCCCCCChHHHhcC
Q 019195          219 YVHISQDCRNLLSRIFVANPSRRITIKEIKSH  250 (344)
Q Consensus       219 ~~~~s~~~~~li~~~L~~dp~~R~s~~ell~h  250 (344)
                      ...+++++.+||.+||+.||.+|||+.++++.
T Consensus       246 ~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~  277 (298)
T 1csn_A          246 CAGFPEEFYKYMHYARNLAFDATPDYDYLQGL  277 (298)
T ss_dssp             TTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHH
T ss_pred             HhhCcHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence            23678999999999999999999999998763

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=1.6e-45  Score=334.82  Aligned_cols=242  Identities=24%  Similarity=0.352  Sum_probs=197.3

Q ss_pred             CCCceeeeeeeecCceEEEEEEEcCCCcEE--EEEEeecCc--cccHHHHHHHHHHhcC-CCCCcceeeEEEEcCCEEEE
Q 019195            1 MEKYELMKDIGSGNFGVARLMRNKNTKELV--AMKYIERGH--KIDANVAREIINHKQL-RHPNIIRFKEVVLTPTHLAI   75 (344)
Q Consensus         1 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~v--aiK~~~~~~--~~~~~~~~ei~~l~~l-~h~niv~~~~~~~~~~~~~l   75 (344)
                      +++|++.+.||+|+||.||+|.+..++..+  |+|.+....  .....+.+|+.+++++ +||||+++++++...+.+|+
T Consensus        24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l  103 (327)
T 1fvr_A           24 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL  103 (327)
T ss_dssp             GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEE
T ss_pred             HHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEE
Confidence            368999999999999999999999888865  999887532  2345688999999999 89999999999999999999


Q ss_pred             EEecCCCCChHHHHHhCC----------------CCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCE
Q 019195           76 VMEYAAGGELFERICNAG----------------RFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRL  132 (344)
Q Consensus        76 v~e~~~~g~L~~~i~~~~----------------~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~v  132 (344)
                      ||||+++++|.+++.+..                .+++.+++.++.||+.+       ||+||||||+|||++.++.  +
T Consensus       104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~--~  181 (327)
T 1fvr_A          104 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYV--A  181 (327)
T ss_dssp             EECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGC--E
T ss_pred             EEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcCCCe--E
Confidence            999999999999997654                68999888888776654       9999999999999976654  9


Q ss_pred             EEeecCCCcccCCCCCCCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhh
Q 019195          133 KICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMA  211 (344)
Q Consensus       133 kL~DFg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~  211 (344)
                      ||+|||+++............+|+.|+|||++.+..++ .++|||||||++|+|++ |+.||........    ...+. 
T Consensus       182 kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~ellt~g~~pf~~~~~~~~----~~~~~-  255 (327)
T 1fvr_A          182 KIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYT-TNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL----YEKLP-  255 (327)
T ss_dssp             EECCTTCEESSCEECCC----CCTTTCCHHHHHHCEEC-HHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH----HHHGG-
T ss_pred             EEcccCcCccccccccccCCCCCccccChhhhccccCC-chhcchHHHHHHHHHHcCCCCCCCCCcHHHH----HHHhh-
Confidence            99999998754444444555688999999999776654 56999999999999998 9999987654332    22222 


Q ss_pred             ccccCCCCCCCCHhHHHHHHHhcccCCCCCCChHHHhcC
Q 019195          212 VQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSH  250 (344)
Q Consensus       212 ~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~ell~h  250 (344)
                      .....+....+++.+.+||.+||+.||.+|||+.+++++
T Consensus       256 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  294 (327)
T 1fvr_A          256 QGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  294 (327)
T ss_dssp             GTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             cCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            222334445789999999999999999999999999875

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.7e-45  Score=335.53  Aligned_cols=243  Identities=23%  Similarity=0.370  Sum_probs=198.2

Q ss_pred             CCceeeeeeeecCceEEEEEEE-----cCCCcEEEEEEeecCc--cccHHHHHHHHHHhcC-CCCCcceeeEEEEcCCEE
Q 019195            2 EKYELMKDIGSGNFGVARLMRN-----KNTKELVAMKYIERGH--KIDANVAREIINHKQL-RHPNIIRFKEVVLTPTHL   73 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~vaiK~~~~~~--~~~~~~~~ei~~l~~l-~h~niv~~~~~~~~~~~~   73 (344)
                      ++|++.+.||+|+||.||+|.+     ..++..||+|++....  .....+.+|+.+++++ +||||+++++++...+.+
T Consensus        45 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~  124 (344)
T 1rjb_A           45 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPI  124 (344)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             HHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCCcc
Confidence            5799999999999999999997     3466789999997532  3446799999999999 899999999999999999


Q ss_pred             EEEEecCCCCChHHHHHhCC-----------------------CCCHHHHHHHHHHHHHC-------CeeecCCCCCCeE
Q 019195           74 AIVMEYAAGGELFERICNAG-----------------------RFSEDEARYFFQQLISG-------QICHRDLKLENTL  123 (344)
Q Consensus        74 ~lv~e~~~~g~L~~~i~~~~-----------------------~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl  123 (344)
                      ++||||+++|+|.+++....                       .+++..++.++.||+.+       ||+||||||+|||
T Consensus       125 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl  204 (344)
T 1rjb_A          125 YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVL  204 (344)
T ss_dssp             EEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGEE
T ss_pred             EEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEE
Confidence            99999999999999997653                       26788778777776654       9999999999999


Q ss_pred             ecCCCCCCEEEeecCCCcccCCCCC---CCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCh
Q 019195          124 LDGSPAPRLKICDFGYSKSSLLHSR---PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDP  199 (344)
Q Consensus       124 ~~~~~~~~vkL~DFg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~  199 (344)
                      ++.++  .+||+|||++........   .....||+.|+|||++.+..+ +.++|||||||++|+|++ |..||......
T Consensus       205 l~~~~--~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~Di~slG~il~el~t~g~~p~~~~~~~  281 (344)
T 1rjb_A          205 VTHGK--VVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIY-TIKSDVWSYGILLWEIFSLGVNPYPGIPVD  281 (344)
T ss_dssp             EETTT--EEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHTTTSCCSSTTCCCS
T ss_pred             EcCCC--cEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCC-ChhHhHHHHHHHHHHHHcCCCCCcccCCcH
Confidence            98765  499999999975443322   233457889999999987766 456999999999999998 99999887665


Q ss_pred             HHHHHHHHHHhhccccCCCCCCCCHhHHHHHHHhcccCCCCCCChHHHhcCc
Q 019195          200 KNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHP  251 (344)
Q Consensus       200 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~ell~hp  251 (344)
                      ..+...+.    .....+....+++++.+||.+||+.||.+|||+.++++|.
T Consensus       282 ~~~~~~~~----~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l  329 (344)
T 1rjb_A          282 ANFYKLIQ----NGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFL  329 (344)
T ss_dssp             HHHHHHHH----TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             HHHHHHHh----cCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHH
Confidence            54444333    2333344456899999999999999999999999999873

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=2.2e-45  Score=327.70  Aligned_cols=241  Identities=22%  Similarity=0.337  Sum_probs=201.9

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEEecCC
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYAA   81 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~   81 (344)
                      ++|++.+.||+|+||.||+|.+..++..||+|++.........+.+|+.++++++||||+++++++...+.+|+||||++
T Consensus        13 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~   92 (288)
T 3kfa_A           13 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMT   92 (288)
T ss_dssp             GGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCSTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCT
T ss_pred             cceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEEcCC
Confidence            57999999999999999999999999999999998766666789999999999999999999999999999999999999


Q ss_pred             CCChHHHHHhC--CCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCCC--CC
Q 019195           82 GGELFERICNA--GRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR--PK  150 (344)
Q Consensus        82 ~g~L~~~i~~~--~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~~--~~  150 (344)
                      +++|.+++...  ..+++..++.++.|++.+       ||+||||||+||+++.++.  +||+|||++........  ..
T Consensus        93 ~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~--~~l~Dfg~~~~~~~~~~~~~~  170 (288)
T 3kfa_A           93 YGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHL--VKVADFGLSRLMTGDTYTAHA  170 (288)
T ss_dssp             TEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGC--EEECCCCGGGTSCSSSSEEET
T ss_pred             CCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCC--EEEccCccceeccCCcccccc
Confidence            99999999864  358888888877776654       9999999999999976654  99999999875443322  22


Q ss_pred             CCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCHhHHHH
Q 019195          151 STVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL  229 (344)
Q Consensus       151 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  229 (344)
                      ...+|+.|+|||++.+..+ +.++||||||+++|+|++ |..||........... +    ......+....+++.+.+|
T Consensus       171 ~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~-~----~~~~~~~~~~~~~~~l~~l  244 (288)
T 3kfa_A          171 GAKFPIKWTAPESLAYNKF-SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYEL-L----EKDYRMERPEGCPEKVYEL  244 (288)
T ss_dssp             TEEECGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHH-H----HTTCCCCCCTTCCHHHHHH
T ss_pred             CCccccCcCChhhhccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH-H----hccCCCCCCCCCCHHHHHH
Confidence            3457889999999987766 456999999999999999 9999987665433222 2    1223334445789999999


Q ss_pred             HHHhcccCCCCCCChHHHhcC
Q 019195          230 LSRIFVANPSRRITIKEIKSH  250 (344)
Q Consensus       230 i~~~L~~dp~~R~s~~ell~h  250 (344)
                      |.+||+.||.+|||+.++++.
T Consensus       245 i~~~l~~dp~~Rps~~~~~~~  265 (288)
T 3kfa_A          245 MRACWQWNPSDRPSFAEIHQA  265 (288)
T ss_dssp             HHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHhCCChhhCcCHHHHHHH
Confidence            999999999999999999763

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=7.5e-45  Score=337.56  Aligned_cols=241  Identities=24%  Similarity=0.366  Sum_probs=197.8

Q ss_pred             CCceeeeeeeecCceEEEEEEEcC-------CCcEEEEEEeecCccc--cHHHHHHHHHHhcC-CCCCcceeeEEEEcCC
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKN-------TKELVAMKYIERGHKI--DANVAREIINHKQL-RHPNIIRFKEVVLTPT   71 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~-------~~~~vaiK~~~~~~~~--~~~~~~ei~~l~~l-~h~niv~~~~~~~~~~   71 (344)
                      ++|++.+.||+|+||.||+|.+..       .+..||+|++......  ...+.+|+.+++++ +||||+++++++...+
T Consensus        69 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~  148 (382)
T 3tt0_A           69 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG  148 (382)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             hheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccCC
Confidence            579999999999999999999754       3357999999765332  25688999999999 8999999999999999


Q ss_pred             EEEEEEecCCCCChHHHHHhCC----------------CCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCC
Q 019195           72 HLAIVMEYAAGGELFERICNAG----------------RFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSP  128 (344)
Q Consensus        72 ~~~lv~e~~~~g~L~~~i~~~~----------------~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~  128 (344)
                      .+++||||+++|+|.+++....                .+++.+++.++.|++.+       ||+||||||+|||++.++
T Consensus       149 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~  228 (382)
T 3tt0_A          149 PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDN  228 (382)
T ss_dssp             SCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTC
T ss_pred             ceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcceEEEcCCC
Confidence            9999999999999999998754                48999988888777655       999999999999998765


Q ss_pred             CCCEEEeecCCCcccCCC---CCCCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHH
Q 019195          129 APRLKICDFGYSKSSLLH---SRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRK  204 (344)
Q Consensus       129 ~~~vkL~DFg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~  204 (344)
                      .  +||+|||+++.....   .......||+.|+|||++.+..++ .++|||||||++|+|++ |..||.........  
T Consensus       229 ~--~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~DiwslG~il~ellt~g~~p~~~~~~~~~~--  303 (382)
T 3tt0_A          229 V--MKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYT-HQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF--  303 (382)
T ss_dssp             C--EEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCC-HHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH--
T ss_pred             c--EEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCC-chhHHHHHHHHHHHHHhCCCCCCCCCCHHHHH--
Confidence            4  999999999754432   223345688999999999877664 56999999999999999 99999876543322  


Q ss_pred             HHHHHhhccccCCCCCCCCHhHHHHHHHhcccCCCCCCChHHHhcC
Q 019195          205 TISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSH  250 (344)
Q Consensus       205 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~ell~h  250 (344)
                        ..+. .....+....+++++.+||.+||+.||.+|||+.+++++
T Consensus       304 --~~~~-~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  346 (382)
T 3tt0_A          304 --KLLK-EGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED  346 (382)
T ss_dssp             --HHHH-TTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             --HHHH-cCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence              2222 222333345789999999999999999999999999875

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=3.5e-45  Score=330.29  Aligned_cols=241  Identities=23%  Similarity=0.352  Sum_probs=197.0

Q ss_pred             CCceeeeeeeecCceEEEEEEEc-----CCCcEEEEEEeecCcc--ccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEE
Q 019195            2 EKYELMKDIGSGNFGVARLMRNK-----NTKELVAMKYIERGHK--IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLA   74 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~--~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~   74 (344)
                      ++|++.+.||+|+||.||+|.+.     .++..||+|++.....  ....+.+|+.++++++||||+++++++...+.++
T Consensus        23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~  102 (314)
T 2ivs_A           23 KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLL  102 (314)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCE
T ss_pred             hheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCceE
Confidence            57999999999999999999883     4568999999976432  2356889999999999999999999999999999


Q ss_pred             EEEecCCCCChHHHHHhCCC------------------------CCHHHHHHHHHHHHHC-------CeeecCCCCCCeE
Q 019195           75 IVMEYAAGGELFERICNAGR------------------------FSEDEARYFFQQLISG-------QICHRDLKLENTL  123 (344)
Q Consensus        75 lv~e~~~~g~L~~~i~~~~~------------------------~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl  123 (344)
                      +||||+++++|.+++.....                        +++.+++.++.|++.+       ||+||||||+|||
T Consensus       103 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~NIl  182 (314)
T 2ivs_A          103 LIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNIL  182 (314)
T ss_dssp             EEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEE
T ss_pred             EEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCcccccchheEE
Confidence            99999999999999987543                        7888888877776654       9999999999999


Q ss_pred             ecCCCCCCEEEeecCCCcccCCCC---CCCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCh
Q 019195          124 LDGSPAPRLKICDFGYSKSSLLHS---RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDP  199 (344)
Q Consensus       124 ~~~~~~~~vkL~DFg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~  199 (344)
                      ++.++.  +||+|||++.......   ......+|+.|+|||++.+..++ .++|||||||++|+|++ |..||......
T Consensus       183 i~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~t~g~~p~~~~~~~  259 (314)
T 2ivs_A          183 VAEGRK--MKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYT-TQSDVWSFGVLLWEIVTLGGNPYPGIPPE  259 (314)
T ss_dssp             EETTTE--EEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEEC-HHHHHHHHHHHHHHHHTTSCCSSTTCCGG
T ss_pred             EcCCCC--EEEccccccccccccccceeccCCCCcccccChhhhcCCCcC-chhhHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence            987654  9999999987543322   22344578999999999877654 56999999999999999 99999887654


Q ss_pred             HHHHHHHHHHhhccccCCCCCCCCHhHHHHHHHhcccCCCCCCChHHHhcC
Q 019195          200 KNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSH  250 (344)
Q Consensus       200 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~ell~h  250 (344)
                      ..... +.    .....+....+++.+.+||.+||+.||.+|||+.+++++
T Consensus       260 ~~~~~-~~----~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~  305 (314)
T 2ivs_A          260 RLFNL-LK----TGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKD  305 (314)
T ss_dssp             GHHHH-HH----TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHH-hh----cCCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            43322 21    122233345789999999999999999999999999875

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=4.2e-45  Score=329.62  Aligned_cols=242  Identities=23%  Similarity=0.363  Sum_probs=200.2

Q ss_pred             CCceeeeeeeecCceEEEEEEE-----cCCCcEEEEEEeecCcc--ccHHHHHHHHHHhcC-CCCCcceeeEEEEcCCEE
Q 019195            2 EKYELMKDIGSGNFGVARLMRN-----KNTKELVAMKYIERGHK--IDANVAREIINHKQL-RHPNIIRFKEVVLTPTHL   73 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~vaiK~~~~~~~--~~~~~~~ei~~l~~l-~h~niv~~~~~~~~~~~~   73 (344)
                      ++|++.+.||+|+||.||+|.+     ..+++.||+|++.....  ....+.+|+.+++++ +||||+++++++...+..
T Consensus        23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~  102 (313)
T 1t46_A           23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPT  102 (313)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             hhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCCc
Confidence            5899999999999999999985     46788999999976543  236788999999999 999999999999999999


Q ss_pred             EEEEecCCCCChHHHHHhCC------------------CCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCC
Q 019195           74 AIVMEYAAGGELFERICNAG------------------RFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSP  128 (344)
Q Consensus        74 ~lv~e~~~~g~L~~~i~~~~------------------~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~  128 (344)
                      ++||||+++|+|.+++....                  .+++.+++.++.|++.+       ||+||||||+|||++.++
T Consensus       103 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~  182 (313)
T 1t46_A          103 LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGR  182 (313)
T ss_dssp             EEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEETTT
T ss_pred             EEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEcCCC
Confidence            99999999999999997654                  38888888887776654       999999999999998765


Q ss_pred             CCCEEEeecCCCcccCCCCC---CCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHH
Q 019195          129 APRLKICDFGYSKSSLLHSR---PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRK  204 (344)
Q Consensus       129 ~~~vkL~DFg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~  204 (344)
                      .  +||+|||++........   .....||+.|+|||++.+..+ +.++|||||||++|+|++ |+.||...........
T Consensus       183 ~--~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~  259 (313)
T 1t46_A          183 I--TKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVY-TFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYK  259 (313)
T ss_dssp             E--EEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHH
T ss_pred             C--EEEccccccccccccccceeccCCCCcceeeChHHhcCCCC-ChHHHHHHHHHHHHHHHhCCCCCCCcccchhHHHH
Confidence            4  99999999876543332   234457889999999977765 456999999999999998 9999988766554444


Q ss_pred             HHHHHhhccccCCCCCCCCHhHHHHHHHhcccCCCCCCChHHHhcC
Q 019195          205 TISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSH  250 (344)
Q Consensus       205 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~ell~h  250 (344)
                      .+..    ....+....+++.+.+||.+||+.||.+|||+.+++++
T Consensus       260 ~~~~----~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  301 (313)
T 1t46_A          260 MIKE----GFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL  301 (313)
T ss_dssp             HHHH----TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             Hhcc----CCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence            3332    23333345689999999999999999999999999875

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=1.6e-45  Score=337.44  Aligned_cols=247  Identities=20%  Similarity=0.212  Sum_probs=190.1

Q ss_pred             CCceeeeeeeecCceEEEEEEEcC---CCcEEEEEEeecCcc------------ccHHHHHHHHHHhcCCCCCcceeeEE
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKN---TKELVAMKYIERGHK------------IDANVAREIINHKQLRHPNIIRFKEV   66 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~------------~~~~~~~ei~~l~~l~h~niv~~~~~   66 (344)
                      ++|++.+.||+|+||.||+|.+..   ++..||+|++.....            ....+.+|+..++.++||||++++++
T Consensus        37 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~  116 (345)
T 2v62_A           37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGS  116 (345)
T ss_dssp             CEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEE
T ss_pred             ceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecc
Confidence            579999999999999999999987   788999999876432            22456788889999999999999999


Q ss_pred             EEc----CCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEe
Q 019195           67 VLT----PTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKIC  135 (344)
Q Consensus        67 ~~~----~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~  135 (344)
                      +..    ...+|+||||+ +++|.+++...+.+++.+++.++.|++.+       ||+||||||+|||++.++.+++||+
T Consensus       117 ~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kL~  195 (345)
T 2v62_A          117 GLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLA  195 (345)
T ss_dssp             EEEESSSCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTTSEEEC
T ss_pred             cccccCCCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCCcEEEE
Confidence            988    67899999999 99999999887789999999888887655       9999999999999987765569999


Q ss_pred             ecCCCcccCCCCC--------CCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC-hHHHHHHH
Q 019195          136 DFGYSKSSLLHSR--------PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQED-PKNFRKTI  206 (344)
Q Consensus       136 DFg~a~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-~~~~~~~~  206 (344)
                      |||+++.......        .....||+.|+|||++.+..+ +.++|||||||++|+|++|+.||..... ........
T Consensus       196 Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~  274 (345)
T 2v62_A          196 DYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVAL-SRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQTAK  274 (345)
T ss_dssp             CCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCC-CHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHHHHH
T ss_pred             eCCCceecccccccccchhccccccCCCccccCHHHhcCCCC-CchhhHHHHHHHHHHHHhCCCCccccccccHHHHHHH
Confidence            9999975432211        134579999999999987765 4569999999999999999999965322 22222222


Q ss_pred             HHHhhccc----cCCCCCCCCHhHHHHHHHhcccCCCCCCChHHHhcC
Q 019195          207 SRIMAVQY----KIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSH  250 (344)
Q Consensus       207 ~~~~~~~~----~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~ell~h  250 (344)
                      ........    .......+++++.+||.+||+.||.+|||+.++++.
T Consensus       275 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~  322 (345)
T 2v62_A          275 TNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKI  322 (345)
T ss_dssp             HHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHH
T ss_pred             HhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHH
Confidence            11111000    001112678999999999999999999999998763

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=2.8e-45  Score=327.25  Aligned_cols=240  Identities=18%  Similarity=0.204  Sum_probs=193.3

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCC-------cEEEEEEeecCc-cccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEE
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTK-------ELVAMKYIERGH-KIDANVAREIINHKQLRHPNIIRFKEVVLTPTHL   73 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~-------~~vaiK~~~~~~-~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~   73 (344)
                      ++|++.+.||+|+||+||+|.+..++       ..||+|++.... .....+.+|+.++++++||||+++++++..++..
T Consensus         8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   87 (289)
T 4fvq_A            8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDEN   87 (289)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTCC
T ss_pred             hHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCCC
Confidence            68999999999999999999998877       479999987643 3346788999999999999999999999999999


Q ss_pred             EEEEecCCCCChHHHHHhCCC-CCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCC------CCEEEeecCC
Q 019195           74 AIVMEYAAGGELFERICNAGR-FSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPA------PRLKICDFGY  139 (344)
Q Consensus        74 ~lv~e~~~~g~L~~~i~~~~~-~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~------~~vkL~DFg~  139 (344)
                      ++||||+++++|.+++...+. +++..++.++.|++.+       ||+||||||+|||++.++.      +.+||+|||+
T Consensus        88 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~Dfg~  167 (289)
T 4fvq_A           88 ILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGI  167 (289)
T ss_dssp             EEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEEEECCCCS
T ss_pred             EEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcccccccceeeeccCcc
Confidence            999999999999999987654 8888888887776654       9999999999999976553      1299999999


Q ss_pred             CcccCCCCCCCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCCCC
Q 019195          140 SKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDY  219 (344)
Q Consensus       140 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  219 (344)
                      +.....   .....||+.|+|||++.+....+.++|||||||++|+|++|..|+.............    ......+. 
T Consensus       168 ~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~----~~~~~~~~-  239 (289)
T 4fvq_A          168 SITVLP---KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFY----EDRHQLPA-  239 (289)
T ss_dssp             CTTTSC---HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHH----HTTCCCCC-
T ss_pred             cccccC---ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHh----hccCCCCC-
Confidence            864321   2334689999999999875555677999999999999999655444433332222221    22222332 


Q ss_pred             CCCCHhHHHHHHHhcccCCCCCCChHHHhcC
Q 019195          220 VHISQDCRNLLSRIFVANPSRRITIKEIKSH  250 (344)
Q Consensus       220 ~~~s~~~~~li~~~L~~dp~~R~s~~ell~h  250 (344)
                       ..++++.+||.+||+.||.+|||+.++++|
T Consensus       240 -~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  269 (289)
T 4fvq_A          240 -PKAAELANLINNCMDYEPDHRPSFRAIIRD  269 (289)
T ss_dssp             -CSSCTTHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred             -CCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence             468899999999999999999999999987

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.6e-45  Score=343.70  Aligned_cols=249  Identities=23%  Similarity=0.348  Sum_probs=197.0

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCcc--ccHHHHHHHHHHhcCCCCCcceeeEEEEcCC--EEEEEE
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK--IDANVAREIINHKQLRHPNIIRFKEVVLTPT--HLAIVM   77 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~--~~~lv~   77 (344)
                      ++|++.+.||+|+||.||+|.+..+++.||+|++.....  ....+.+|+.++++++||||+++++++...+  .+++||
T Consensus         9 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~   88 (396)
T 4eut_A            9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM   88 (396)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred             CceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEE
Confidence            479999999999999999999999999999999976432  2366789999999999999999999998765  789999


Q ss_pred             ecCCCCChHHHHHhCC---CCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEec--CCCCCCEEEeecCCCcccCC
Q 019195           78 EYAAGGELFERICNAG---RFSEDEARYFFQQLISG-------QICHRDLKLENTLLD--GSPAPRLKICDFGYSKSSLL  145 (344)
Q Consensus        78 e~~~~g~L~~~i~~~~---~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~--~~~~~~vkL~DFg~a~~~~~  145 (344)
                      |||++|+|.+++....   .+++..++.++.|++.+       ||+||||||+|||+.  .+..+.+||+|||+++....
T Consensus        89 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~~~  168 (396)
T 4eut_A           89 EFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELED  168 (396)
T ss_dssp             CCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGGGCEECCC
T ss_pred             ecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCCCceEccC
Confidence            9999999999997643   38999888888777655       999999999999982  12233599999999986655


Q ss_pred             CCCCCCCccCCcccCCccccCC-------CCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccc----
Q 019195          146 HSRPKSTVGTPAYIAPEVLSRR-------EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQY----  214 (344)
Q Consensus       146 ~~~~~~~~gt~~y~aPE~~~~~-------~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~----  214 (344)
                      .......+||+.|+|||++.+.       ...+.++|||||||++|+|++|+.||............+..+.....    
T Consensus       169 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~p~~~~  248 (396)
T 4eut_A          169 DEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAI  248 (396)
T ss_dssp             GGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHSCCTTCC
T ss_pred             CCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcCCCcccc
Confidence            5555667899999999998652       22345699999999999999999999765443333344444433221    


Q ss_pred             ---------------cCCCCC----CCCHhHHHHHHHhcccCCCCCCChHHHhcC
Q 019195          215 ---------------KIPDYV----HISQDCRNLLSRIFVANPSRRITIKEIKSH  250 (344)
Q Consensus       215 ---------------~~~~~~----~~s~~~~~li~~~L~~dp~~R~s~~ell~h  250 (344)
                                     ..+...    .+++.+.+||.+||+.||.+|||+.+++++
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~  303 (396)
T 4eut_A          249 SGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAE  303 (396)
T ss_dssp             EEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHH
T ss_pred             hhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHH
Confidence                           111111    234578899999999999999999998654

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=8.3e-45  Score=323.11  Aligned_cols=239  Identities=24%  Similarity=0.337  Sum_probs=198.4

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcCCCCCcceeeEEEEc------------
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKEVVLT------------   69 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~------------   69 (344)
                      ++|++++.||+|+||.||+|.+..+++.||+|++....   ..+.+|+.++++++||||+++++++..            
T Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~   87 (284)
T 2a19_B           11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN---EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNS   87 (284)
T ss_dssp             HHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS---GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC--------
T ss_pred             cccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc---HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccccccc
Confidence            47999999999999999999999999999999997653   457799999999999999999999864            


Q ss_pred             ----CCEEEEEEecCCCCChHHHHHhC--CCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEee
Q 019195           70 ----PTHLAIVMEYAAGGELFERICNA--GRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICD  136 (344)
Q Consensus        70 ----~~~~~lv~e~~~~g~L~~~i~~~--~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~D  136 (344)
                          ...+++||||+++++|.+++...  ..+++..++.++.|++.+       ||+||||||+|||++.++.  +||+|
T Consensus        88 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~--~kl~D  165 (284)
T 2a19_B           88 SRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQ--VKIGD  165 (284)
T ss_dssp             -CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTE--EEECC
T ss_pred             cccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCCC--EEECc
Confidence                34589999999999999999754  578988888887776654       9999999999999987664  99999


Q ss_pred             cCCCcccCCCCCCCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccC
Q 019195          137 FGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKI  216 (344)
Q Consensus       137 Fg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  216 (344)
                      ||++.............||+.|+|||++.+..++ .++|||||||++|+|++|..||...      ......+...  ..
T Consensus       166 fg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~~~~~~~~~------~~~~~~~~~~--~~  236 (284)
T 2a19_B          166 FGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYG-KEVDLYALGLILAELLHVCDTAFET------SKFFTDLRDG--II  236 (284)
T ss_dssp             CTTCEESSCCSCCCCCCSCCTTSCHHHHHCSCCC-THHHHHHHHHHHHHHHSCCSSHHHH------HHHHHHHHTT--CC
T ss_pred             chhheeccccccccccCCcccccChhhhccCCCc-chhhhHHHHHHHHHHHhcCCcchhH------HHHHHHhhcc--cc
Confidence            9999876555555667899999999999877764 5599999999999999999887431      1122222221  12


Q ss_pred             CCCCCCCHhHHHHHHHhcccCCCCCCChHHHhcCcccccC
Q 019195          217 PDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKN  256 (344)
Q Consensus       217 ~~~~~~s~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~~  256 (344)
                      +  ..+++.+.+||.+||+.||.+|||+.++++|++..+.
T Consensus       237 ~--~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~  274 (284)
T 2a19_B          237 S--DIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKK  274 (284)
T ss_dssp             C--TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC
T ss_pred             c--ccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhh
Confidence            2  3578999999999999999999999999999886544

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=1.2e-44  Score=325.05  Aligned_cols=244  Identities=24%  Similarity=0.374  Sum_probs=194.6

Q ss_pred             CCceeeeeeeecCceEEEEEE----EcCCCcEEEEEEeecCc--cccHHHHHHHHHHhcCCCCCcceeeEEEEcC--CEE
Q 019195            2 EKYELMKDIGSGNFGVARLMR----NKNTKELVAMKYIERGH--KIDANVAREIINHKQLRHPNIIRFKEVVLTP--THL   73 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~----~~~~~~~vaiK~~~~~~--~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~--~~~   73 (344)
                      ++|++++.||+|+||.||+|.    +..+++.||+|++....  .....+.+|+.+++.++||||+++++++...  ..+
T Consensus        21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~  100 (302)
T 4e5w_A           21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI  100 (302)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred             hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence            469999999999999999999    67789999999987543  2336788999999999999999999999877  678


Q ss_pred             EEEEecCCCCChHHHHHh-CCCCCHHHHHHHHHHHHH-------CCeeecCCCCCCeEecCCCCCCEEEeecCCCcccCC
Q 019195           74 AIVMEYAAGGELFERICN-AGRFSEDEARYFFQQLIS-------GQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLL  145 (344)
Q Consensus        74 ~lv~e~~~~g~L~~~i~~-~~~~~~~~~~~~~~ql~~-------~~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~  145 (344)
                      ++||||+++++|.+++.. ...+++.+++.++.|++.       .||+||||||+|||++.++.  +||+|||++.....
T Consensus       101 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~--~kl~Dfg~~~~~~~  178 (302)
T 4e5w_A          101 KLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQ--VKIGDFGLTKAIET  178 (302)
T ss_dssp             EEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTE--EEECCCTTCEECCT
T ss_pred             EEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCC--EEECcccccccccC
Confidence            999999999999999954 467999988888777665       49999999999999987664  99999999976543


Q ss_pred             CC----CCCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC-----------ChHHHHHHHHHHh
Q 019195          146 HS----RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQE-----------DPKNFRKTISRIM  210 (344)
Q Consensus       146 ~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~-----------~~~~~~~~~~~~~  210 (344)
                      ..    ......||+.|+|||++.+..++ .++|||||||++|+|++|..|+....           ......... ...
T Consensus       179 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~~~  256 (302)
T 4e5w_A          179 DKEYYTVKDDRDSPVFWYAPECLMQSKFY-IASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLV-NTL  256 (302)
T ss_dssp             TCCEEECCCCTTCCGGGCCHHHHHHCEEE-HHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHH-HHH
T ss_pred             CCcceeccCCCCCCccccCCeeecCCCCC-cchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHH-HHH
Confidence            32    23345689999999999877764 55999999999999999999864321           111112222 222


Q ss_pred             hccccCCCCCCCCHhHHHHHHHhcccCCCCCCChHHHhc
Q 019195          211 AVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKS  249 (344)
Q Consensus       211 ~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~ell~  249 (344)
                      ......+....+++.+.+||.+||+.||.+|||+.++++
T Consensus       257 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  295 (302)
T 4e5w_A          257 KEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE  295 (302)
T ss_dssp             HTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred             hccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence            233344555678999999999999999999999999976

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=1.7e-45  Score=341.30  Aligned_cols=240  Identities=26%  Similarity=0.364  Sum_probs=195.9

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCcc--ccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEEec
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK--IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEY   79 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~   79 (344)
                      ++|++.+.||+|+||.||+|.+..+++.||+|++.....  ....+.+|+.++++++||||+++++++...+.+|+||||
T Consensus       114 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~  193 (377)
T 3cbl_A          114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMEL  193 (377)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred             HHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEEc
Confidence            579999999999999999999999999999999875422  224578999999999999999999999999999999999


Q ss_pred             CCCCChHHHHHhCC-CCCHHHHHHHHHHHHH-------CCeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCC---C
Q 019195           80 AAGGELFERICNAG-RFSEDEARYFFQQLIS-------GQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS---R  148 (344)
Q Consensus        80 ~~~g~L~~~i~~~~-~~~~~~~~~~~~ql~~-------~~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~---~  148 (344)
                      +++|+|.+++...+ .+++.+++.++.|++.       .||+||||||+|||++.++.  +||+|||+++......   .
T Consensus       194 ~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~--~kl~DfG~s~~~~~~~~~~~  271 (377)
T 3cbl_A          194 VQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNV--LKISDFGMSREEADGVYAAS  271 (377)
T ss_dssp             CTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC--EEECCGGGCEECTTSEEECC
T ss_pred             CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCc--EEECcCCCceecCCCceeec
Confidence            99999999997654 6888888887776654       49999999999999976654  9999999987533221   1


Q ss_pred             CCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCHhHH
Q 019195          149 PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCR  227 (344)
Q Consensus       149 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~  227 (344)
                      .....+++.|+|||++.+..+ +.++|||||||++|+|++ |..||......... ..    .......+....+++.+.
T Consensus       272 ~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~-~~----~~~~~~~~~~~~~~~~l~  345 (377)
T 3cbl_A          272 GGLRQVPVKWTAPEALNYGRY-SSESDVWSFGILLWETFSLGASPYPNLSNQQTR-EF----VEKGGRLPCPELCPDAVF  345 (377)
T ss_dssp             SSCCEEEGGGSCHHHHHHCEE-EHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHH-HH----HHTTCCCCCCTTCCHHHH
T ss_pred             CCCCCCCcCcCCHhHhccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHH-HH----HHcCCCCCCCCCCCHHHH
Confidence            122346778999999987766 455999999999999998 99999876543322 11    222334454556899999


Q ss_pred             HHHHHhcccCCCCCCChHHHhc
Q 019195          228 NLLSRIFVANPSRRITIKEIKS  249 (344)
Q Consensus       228 ~li~~~L~~dp~~R~s~~ell~  249 (344)
                      +||.+||+.||.+|||+.++++
T Consensus       346 ~li~~cl~~dP~~Rps~~~i~~  367 (377)
T 3cbl_A          346 RLMEQCWAYEPGQRPSFSTIYQ  367 (377)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHcCCCchhCcCHHHHHH
Confidence            9999999999999999999975

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=3.7e-45  Score=334.34  Aligned_cols=241  Identities=23%  Similarity=0.350  Sum_probs=195.7

Q ss_pred             CCceeeeeeeecCceEEEEEEEc-----CCCcEEEEEEeecCcc--ccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEE
Q 019195            2 EKYELMKDIGSGNFGVARLMRNK-----NTKELVAMKYIERGHK--IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLA   74 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~--~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~   74 (344)
                      ++|++++.||+|+||.||+|.+.     .+++.||+|++.....  ....+.+|+.++++++||||+++++++...+.+|
T Consensus        47 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~  126 (343)
T 1luf_A           47 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMC  126 (343)
T ss_dssp             GGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCE
T ss_pred             HHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCceE
Confidence            58999999999999999999987     4558999999976432  2356889999999999999999999999999999


Q ss_pred             EEEecCCCCChHHHHHhC------------------------CCCCHHHHHHHHHHHHH-------CCeeecCCCCCCeE
Q 019195           75 IVMEYAAGGELFERICNA------------------------GRFSEDEARYFFQQLIS-------GQICHRDLKLENTL  123 (344)
Q Consensus        75 lv~e~~~~g~L~~~i~~~------------------------~~~~~~~~~~~~~ql~~-------~~iiH~Dikp~NIl  123 (344)
                      +||||+++|+|.+++...                        ..+++.+++.++.||+.       .||+||||||+|||
T Consensus       127 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl  206 (343)
T 1luf_A          127 LLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCL  206 (343)
T ss_dssp             EEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred             EEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEE
Confidence            999999999999999764                        56888888888777654       49999999999999


Q ss_pred             ecCCCCCCEEEeecCCCcccCCC---CCCCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCh
Q 019195          124 LDGSPAPRLKICDFGYSKSSLLH---SRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDP  199 (344)
Q Consensus       124 ~~~~~~~~vkL~DFg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~  199 (344)
                      ++.++.  +||+|||+++.....   .......||+.|+|||++.+..+ +.++|||||||++|+|++ |..||......
T Consensus       207 ~~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~Di~slG~il~el~t~g~~p~~~~~~~  283 (343)
T 1luf_A          207 VGENMV--VKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRY-TTESDVWAYGVVLWEIFSYGLQPYYGMAHE  283 (343)
T ss_dssp             ECGGGC--EEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTTCCTTTTSCHH
T ss_pred             ECCCCe--EEEeecCCCcccccCccccccCCCcccceecChhhhccCCc-CcccccHHHHHHHHHHHhcCCCcCCCCChH
Confidence            987654  999999998653222   22344568999999999987775 456999999999999999 99999876543


Q ss_pred             HHHHHHHHHHhhccccCCCCCCCCHhHHHHHHHhcccCCCCCCChHHHhcC
Q 019195          200 KNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSH  250 (344)
Q Consensus       200 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~ell~h  250 (344)
                      ...    ..+..... .+....+++.+.+||.+||+.||.+|||+.+++++
T Consensus       284 ~~~----~~~~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~  329 (343)
T 1luf_A          284 EVI----YYVRDGNI-LACPENCPLELYNLMRLCWSKLPADRPSFCSIHRI  329 (343)
T ss_dssp             HHH----HHHHTTCC-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHH----HHHhCCCc-CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHH
Confidence            322    22222222 22334688999999999999999999999999874

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=9.5e-45  Score=319.98  Aligned_cols=240  Identities=23%  Similarity=0.407  Sum_probs=198.8

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEEecCC
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYAA   81 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~   81 (344)
                      ++|++.+.||+|+||.||++.+. +++.||+|++.........+.+|+.++++++||||+++++++...+.+++||||++
T Consensus         8 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   86 (267)
T 3t9t_A            8 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFME   86 (267)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCT
T ss_pred             hheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCCCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCC
Confidence            58999999999999999999986 57789999998876666789999999999999999999999999999999999999


Q ss_pred             CCChHHHHHhC-CCCCHHHHHHHHHHHHH-------CCeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCC--CCCCC
Q 019195           82 GGELFERICNA-GRFSEDEARYFFQQLIS-------GQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH--SRPKS  151 (344)
Q Consensus        82 ~g~L~~~i~~~-~~~~~~~~~~~~~ql~~-------~~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~--~~~~~  151 (344)
                      +++|.+++... ..+++..++.++.|++.       .||+||||||+||+++.++.  +||+|||++......  .....
T Consensus        87 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~--~kl~dfg~~~~~~~~~~~~~~~  164 (267)
T 3t9t_A           87 HGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQV--IKVSDFGMTRFVLDDQYTSSTG  164 (267)
T ss_dssp             TCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGC--EEECCTTGGGGBCCHHHHSTTS
T ss_pred             CCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCC--EEEccccccccccccccccccc
Confidence            99999999765 56888888887777654       49999999999999976654  999999998754322  12234


Q ss_pred             CccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCHhHHHHH
Q 019195          152 TVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLL  230 (344)
Q Consensus       152 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li  230 (344)
                      ..+|+.|+|||++.+..+ +.++||||||+++|+|++ |+.||..........    .+... ........+++.+.+||
T Consensus       165 ~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~----~i~~~-~~~~~~~~~~~~l~~li  238 (267)
T 3t9t_A          165 TKFPVKWASPEVFSFSRY-SSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVE----DISTG-FRLYKPRLASTHVYQIM  238 (267)
T ss_dssp             TTCCGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHH----HHHTT-CCCCCCTTSCHHHHHHH
T ss_pred             ccccccccChhhhcCCCc-cchhchhhhHHHHHHHhccCCCCCCCCCHHHHHH----HHhcC-CcCCCCccCcHHHHHHH
Confidence            567889999999977665 456999999999999999 899998765433322    22222 22233346789999999


Q ss_pred             HHhcccCCCCCCChHHHhcC
Q 019195          231 SRIFVANPSRRITIKEIKSH  250 (344)
Q Consensus       231 ~~~L~~dp~~R~s~~ell~h  250 (344)
                      .+||+.||.+|||+.+++++
T Consensus       239 ~~~l~~~p~~Rps~~~ll~~  258 (267)
T 3t9t_A          239 NHCWRERPEDRPAFSRLLRQ  258 (267)
T ss_dssp             HHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHccCChhhCcCHHHHHHH
Confidence            99999999999999999875

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=5.8e-45  Score=331.38  Aligned_cols=240  Identities=21%  Similarity=0.351  Sum_probs=189.1

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEE----EEEEeecCc--cccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEE
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELV----AMKYIERGH--KIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAI   75 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~v----aiK~~~~~~--~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~l   75 (344)
                      ++|++++.||+|+||+||+|.+..+++.+    |+|.+....  .....+.+|+.++++++||||+++++++.... .++
T Consensus        15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~   93 (327)
T 3poz_A           15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL   93 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EEE
T ss_pred             HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eEE
Confidence            57999999999999999999998777654    777765432  33467899999999999999999999998755 789


Q ss_pred             EEecCCCCChHHHHHh-CCCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCC
Q 019195           76 VMEYAAGGELFERICN-AGRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS  147 (344)
Q Consensus        76 v~e~~~~g~L~~~i~~-~~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~  147 (344)
                      +++|+.+|+|.+++.. ...+++..++.++.|++.+       ||+||||||+|||++.++.  +||+|||+++......
T Consensus        94 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~--~kl~Dfg~a~~~~~~~  171 (327)
T 3poz_A           94 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQH--VKITDFGLAKLLGAEE  171 (327)
T ss_dssp             EEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTE--EEECCTTHHHHHTTTC
T ss_pred             EEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCC--EEEccCcceeEccCCc
Confidence            9999999999999977 4578988888887776654       9999999999999987664  9999999987543332


Q ss_pred             C---CCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCC
Q 019195          148 R---PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHIS  223 (344)
Q Consensus       148 ~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s  223 (344)
                      .   .....||+.|+|||++.+..++ .++|||||||++|+|++ |+.||........ ...+    ......+....++
T Consensus       172 ~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~Di~slG~il~ellt~g~~p~~~~~~~~~-~~~~----~~~~~~~~~~~~~  245 (327)
T 3poz_A          172 KEYHAEGGKVPIKWMALESILHRIYT-HQSDVWSYGVTVWELMTFGSKPYDGIPASEI-SSIL----EKGERLPQPPICT  245 (327)
T ss_dssp             C-------CCCGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH-HHHH----HTTCCCCCCTTBC
T ss_pred             ccccccCCCccccccChHHhccCCCC-chhhhhhhHHHHHHHHhcCCCCccCCCHHHH-HHHH----HcCCCCCCCccCC
Confidence            2   2234578899999999877764 56999999999999999 9999987665432 2222    2233344455789


Q ss_pred             HhHHHHHHHhcccCCCCCCChHHHhcC
Q 019195          224 QDCRNLLSRIFVANPSRRITIKEIKSH  250 (344)
Q Consensus       224 ~~~~~li~~~L~~dp~~R~s~~ell~h  250 (344)
                      .++.+|+.+||+.||.+|||+.+++++
T Consensus       246 ~~~~~li~~~l~~~p~~Rps~~ell~~  272 (327)
T 3poz_A          246 IDVYMIMVKCWMIDADSRPKFRELIIE  272 (327)
T ss_dssp             HHHHHHHHHHTCSCGGGSCCHHHHHHH
T ss_pred             HHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence            999999999999999999999999876

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=6.4e-45  Score=323.89  Aligned_cols=240  Identities=24%  Similarity=0.377  Sum_probs=184.6

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCC---CcEEEEEEeecCcc--ccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEE
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNT---KELVAMKYIERGHK--IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIV   76 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~---~~~vaiK~~~~~~~--~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv   76 (344)
                      ++|++.+.||+|+||.||+|.+..+   +..||+|++.....  ....+.+|+.++++++||||+++++++ .++..|+|
T Consensus        15 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-~~~~~~lv   93 (281)
T 1mp8_A           15 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI-TENPVWII   93 (281)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-CSSSCEEE
T ss_pred             HHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEE-ccCccEEE
Confidence            5899999999999999999998653   56799999875432  235688999999999999999999998 45678999


Q ss_pred             EecCCCCChHHHHHhCC-CCCHHHHHHHHHHHHH-------CCeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCCC
Q 019195           77 MEYAAGGELFERICNAG-RFSEDEARYFFQQLIS-------GQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR  148 (344)
Q Consensus        77 ~e~~~~g~L~~~i~~~~-~~~~~~~~~~~~ql~~-------~~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~~  148 (344)
                      |||+++++|.+++.... .+++..++.++.|++.       .||+||||||+|||++.++.  +||+|||+++.......
T Consensus        94 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~  171 (281)
T 1mp8_A           94 MELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDC--VKLGDFGLSRYMEDSTY  171 (281)
T ss_dssp             EECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTE--EEECC------------
T ss_pred             EecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCC--EEECccccccccCcccc
Confidence            99999999999997654 6888888877766654       49999999999999987654  99999999876433322


Q ss_pred             --CCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCHh
Q 019195          149 --PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQD  225 (344)
Q Consensus       149 --~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~  225 (344)
                        .....+|+.|+|||++.+..++ .++|||||||++|+|++ |..||...........+.    . ....+....+++.
T Consensus       172 ~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~----~-~~~~~~~~~~~~~  245 (281)
T 1mp8_A          172 YKASKGKLPIKWMAPESINFRRFT-SASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE----N-GERLPMPPNCPPT  245 (281)
T ss_dssp             -------CCGGGCCHHHHHHCCCS-HHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH----T-TCCCCCCTTCCHH
T ss_pred             cccccCCCcccccChhhcccCCCC-CccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHH----c-CCCCCCCCCCCHH
Confidence              2334578899999999877664 56999999999999996 999998876544433221    1 1223344578999


Q ss_pred             HHHHHHHhcccCCCCCCChHHHhcC
Q 019195          226 CRNLLSRIFVANPSRRITIKEIKSH  250 (344)
Q Consensus       226 ~~~li~~~L~~dp~~R~s~~ell~h  250 (344)
                      +.+||.+||+.||.+|||+.+++++
T Consensus       246 l~~li~~~l~~~p~~Rps~~~l~~~  270 (281)
T 1mp8_A          246 LYSLMTKCWAYDPSRRPRFTELKAQ  270 (281)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHccCChhhCcCHHHHHHH
Confidence            9999999999999999999999874

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=3.5e-44  Score=323.51  Aligned_cols=245  Identities=27%  Similarity=0.394  Sum_probs=187.1

Q ss_pred             CCCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCcc----ccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEE
Q 019195            1 MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK----IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIV   76 (344)
Q Consensus         1 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv   76 (344)
                      +++|++.+.||+|+||.||+|.+..+++.||+|++.....    ....+.+|+.+++.++||||+++++++...+.+++|
T Consensus        31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv  110 (310)
T 2wqm_A           31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV  110 (310)
T ss_dssp             GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEE
Confidence            3689999999999999999999999999999999875322    235688999999999999999999999999999999


Q ss_pred             EecCCCCChHHHHHh----CCCCCHHHHHHHHHHHHH-------CCeeecCCCCCCeEecCCCCCCEEEeecCCCcccCC
Q 019195           77 MEYAAGGELFERICN----AGRFSEDEARYFFQQLIS-------GQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLL  145 (344)
Q Consensus        77 ~e~~~~g~L~~~i~~----~~~~~~~~~~~~~~ql~~-------~~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~  145 (344)
                      |||+++++|.+++..    ...+++..++.++.|++.       .||+||||||+||+++.++  .+||+|||++.....
T Consensus       111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~--~~kl~Dfg~~~~~~~  188 (310)
T 2wqm_A          111 LELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATG--VVKLGDLGLGRFFSS  188 (310)
T ss_dssp             EECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTS--CEEECCC--------
T ss_pred             EecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCC--CEEEEeccceeeecC
Confidence            999999999998864    456888888888777665       4999999999999997665  499999999875433


Q ss_pred             CC-CCCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCH
Q 019195          146 HS-RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQ  224 (344)
Q Consensus       146 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~  224 (344)
                      .. ......||+.|+|||++.+..++ .++||||||+++|+|++|+.||.+....  .......+............+++
T Consensus       189 ~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~il~~l~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~  265 (310)
T 2wqm_A          189 KTTAAHSLVGTPYYMSPERIHENGYN-FKSDIWSLGCLLYEMAALQSPFYGDKMN--LYSLCKKIEQCDYPPLPSDHYSE  265 (310)
T ss_dssp             ----------CCSSCCHHHHTTCCCC-HHHHHHHHHHHHHHHHHSSCTTC---CC--HHHHHHHHHTTCSCCCCTTTSCH
T ss_pred             CCccccccCCCeeEeChHHhCCCCCC-chhhHHHHHHHHHHHHhCCCCCcccchh--HHHHHHHhhcccCCCCcccccCH
Confidence            22 22345799999999999877664 5699999999999999999999765432  12233333333332222346899


Q ss_pred             hHHHHHHHhcccCCCCCCChHHHhcC
Q 019195          225 DCRNLLSRIFVANPSRRITIKEIKSH  250 (344)
Q Consensus       225 ~~~~li~~~L~~dp~~R~s~~ell~h  250 (344)
                      ++.+||.+||+.||.+|||+.+++++
T Consensus       266 ~l~~li~~~l~~dp~~Rps~~~il~~  291 (310)
T 2wqm_A          266 ELRQLVNMCINPDPEKRPDVTYVYDV  291 (310)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHHcCCChhhCCCHHHHHHH
Confidence            99999999999999999999999874

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=2.4e-44  Score=340.99  Aligned_cols=235  Identities=24%  Similarity=0.390  Sum_probs=193.1

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcCCCCCcceeeEEEEcCC-EEEEEEecC
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKEVVLTPT-HLAIVMEYA   80 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~-~~~lv~e~~   80 (344)
                      ++|++.+.||+|+||.||++.+.  ++.||||++.... ....+.+|+.++++++||||+++++++.... .+|+|||||
T Consensus       193 ~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~  269 (450)
T 1k9a_A          193 KELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM  269 (450)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCT-TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEECC
T ss_pred             HHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCch-HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEec
Confidence            57999999999999999999875  6799999997654 4578999999999999999999999987665 799999999


Q ss_pred             CCCChHHHHHhCCC--CCHHHHHHHHHHHHH-------CCeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCCCCCC
Q 019195           81 AGGELFERICNAGR--FSEDEARYFFQQLIS-------GQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKS  151 (344)
Q Consensus        81 ~~g~L~~~i~~~~~--~~~~~~~~~~~ql~~-------~~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~~~~~  151 (344)
                      ++|+|.+++.+.+.  +++..++.++.|++.       .||+||||||+|||++.++.  +||+|||+++.....  ...
T Consensus       270 ~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~--~kl~DfG~a~~~~~~--~~~  345 (450)
T 1k9a_A          270 AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNV--AKVSDFGLTKEASST--QDT  345 (450)
T ss_dssp             TTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSC--EEECCCTTCEECC-------
T ss_pred             CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCC--EEEeeCCCccccccc--ccC
Confidence            99999999987553  788888777766655       49999999999999976654  999999998743322  233


Q ss_pred             CccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCHhHHHHH
Q 019195          152 TVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLL  230 (344)
Q Consensus       152 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li  230 (344)
                      ..+++.|+|||++.+..++ .++|||||||++|+|++ |+.||...........+    . ...+.+.+..+++.+.+||
T Consensus       346 ~~~~~~y~aPE~~~~~~~~-~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i----~-~~~~~~~p~~~~~~l~~li  419 (450)
T 1k9a_A          346 GKLPVKWTAPEALREKKFS-TKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRV----E-KGYKMDAPDGCPPAVYDVM  419 (450)
T ss_dssp             -CCCTTTSCHHHHHSSCCC-HHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHH----H-TTCCCCCCTTCCHHHHHHH
T ss_pred             CCCCcceeCHHHhcCCCCC-cHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH----H-cCCCCCCCCcCCHHHHHHH
Confidence            4678999999999887764 55999999999999998 99999887654433222    1 2234444557899999999


Q ss_pred             HHhcccCCCCCCChHHHhc
Q 019195          231 SRIFVANPSRRITIKEIKS  249 (344)
Q Consensus       231 ~~~L~~dp~~R~s~~ell~  249 (344)
                      .+||+.||.+|||+.++++
T Consensus       420 ~~cl~~dp~~Rpt~~~l~~  438 (450)
T 1k9a_A          420 KNCWHLDAATRPTFLQLRE  438 (450)
T ss_dssp             HHHTCSSGGGSCCHHHHHH
T ss_pred             HHHcCCChhHCcCHHHHHH
Confidence            9999999999999999875

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=8.7e-45  Score=334.97  Aligned_cols=245  Identities=14%  Similarity=0.205  Sum_probs=189.2

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCC-----CcEEEEEEeecCcc------------ccHHHHHHHHHHhcCCCCCcceee
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNT-----KELVAMKYIERGHK------------IDANVAREIINHKQLRHPNIIRFK   64 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~vaiK~~~~~~~------------~~~~~~~ei~~l~~l~h~niv~~~   64 (344)
                      ++|++.+.||+|+||.||+|.+..+     ++.||+|++.....            ....+.+|+..++.++||||++++
T Consensus        35 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~  114 (364)
T 3op5_A           35 AAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYW  114 (364)
T ss_dssp             CEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCEE
T ss_pred             CeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeEE
Confidence            4899999999999999999998765     58899999876432            113345566677788999999999


Q ss_pred             EEEEcC----CEEEEEEecCCCCChHHHHHhC-CCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCE
Q 019195           65 EVVLTP----THLAIVMEYAAGGELFERICNA-GRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRL  132 (344)
Q Consensus        65 ~~~~~~----~~~~lv~e~~~~g~L~~~i~~~-~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~v  132 (344)
                      +++...    ...|+||||+ +++|.+++... +.+++.+++.++.||+.+       ||+||||||+|||++.+..+.+
T Consensus       115 ~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~~~~~  193 (364)
T 3op5_A          115 GSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQV  193 (364)
T ss_dssp             EEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSCTTCE
T ss_pred             eeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCCCCeE
Confidence            998764    5689999999 99999999876 679999988888777654       9999999999999984444569


Q ss_pred             EEeecCCCcccCCCC--------CCCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHH
Q 019195          133 KICDFGYSKSSLLHS--------RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRK  204 (344)
Q Consensus       133 kL~DFg~a~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~  204 (344)
                      ||+|||+++......        .....+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||...........
T Consensus       194 kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~~~~  272 (364)
T 3op5_A          194 YLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAP-SRRGDLEILGYCMIQWLTGHLPWEDNLKDPKYVR  272 (364)
T ss_dssp             EECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHHH
T ss_pred             EEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCC-CchhhHHHHHHHHHHHHhCCCCccccccCHHHHH
Confidence            999999996543221        1234459999999999988776 5669999999999999999999986443333222


Q ss_pred             HHHHHhhccc------cCCCCCCCCHhHHHHHHHhcccCCCCCCChHHHhc
Q 019195          205 TISRIMAVQY------KIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKS  249 (344)
Q Consensus       205 ~~~~~~~~~~------~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~ell~  249 (344)
                      ..........      .++ ...+++++.+||.+||+.||.+||++.++++
T Consensus       273 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~  322 (364)
T 3op5_A          273 DSKIRYRENIASLMDKCFP-AANAPGEIAKYMETVKLLDYTEKPLYENLRD  322 (364)
T ss_dssp             HHHHHHHHCHHHHHHHHSC-TTCCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             HHHHHhhhhHHHHHHHhcc-cccCHHHHHHHHHHHhcCCCCCCCCHHHHHH
Confidence            2211110000      011 1367899999999999999999999999876

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=7.4e-45  Score=330.33  Aligned_cols=240  Identities=21%  Similarity=0.307  Sum_probs=190.9

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcE----EEEEEeecCc--cccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEE
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKEL----VAMKYIERGH--KIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAI   75 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~----vaiK~~~~~~--~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~l   75 (344)
                      ++|++++.||+|+||+||+|.+..++..    ||+|.+....  .....+.+|+.++++++||||+++++++. ....++
T Consensus        13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~   91 (325)
T 3kex_A           13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQL   91 (325)
T ss_dssp             TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEE
T ss_pred             hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEE
Confidence            6899999999999999999999888876    6777665432  22356778999999999999999999886 567899


Q ss_pred             EEecCCCCChHHHHHhC-CCCCHHHHHHHHHHHHH-------CCeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCC
Q 019195           76 VMEYAAGGELFERICNA-GRFSEDEARYFFQQLIS-------GQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS  147 (344)
Q Consensus        76 v~e~~~~g~L~~~i~~~-~~~~~~~~~~~~~ql~~-------~~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~  147 (344)
                      ||||+.+|+|.+++... +.+++..++.++.|++.       .||+||||||+|||++.++.  +||+|||+++......
T Consensus        92 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~--~kl~Dfg~a~~~~~~~  169 (325)
T 3kex_A           92 VTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQ--VQVADFGVADLLPPDD  169 (325)
T ss_dssp             EEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSC--EEECSCSGGGGSCCCT
T ss_pred             EEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCe--EEECCCCcccccCccc
Confidence            99999999999999764 56888777777666554       59999999999999976654  9999999998654332


Q ss_pred             C---CCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCC
Q 019195          148 R---PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHIS  223 (344)
Q Consensus       148 ~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s  223 (344)
                      .   .....||+.|+|||++.+..+ +.++|||||||++|+|++ |+.||........... +   . .....+....++
T Consensus       170 ~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~-~---~-~~~~~~~~~~~~  243 (325)
T 3kex_A          170 KQLLYSEAKTPIKWMALESIHFGKY-THQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDL-L---E-KGERLAQPQICT  243 (325)
T ss_dssp             TCCC-----CCTTTSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHH-H---H-TTCBCCCCTTBC
T ss_pred             ccccccCCCCcccccChHHhccCCC-ChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHH-H---H-cCCCCCCCCcCc
Confidence            2   234468889999999987776 456999999999999999 9999988665433222 1   1 122333344678


Q ss_pred             HhHHHHHHHhcccCCCCCCChHHHhcC
Q 019195          224 QDCRNLLSRIFVANPSRRITIKEIKSH  250 (344)
Q Consensus       224 ~~~~~li~~~L~~dp~~R~s~~ell~h  250 (344)
                      +++.+||.+||+.||.+|||+.+++++
T Consensus       244 ~~~~~li~~~l~~dp~~Rps~~el~~~  270 (325)
T 3kex_A          244 IDVYMVMVKCWMIDENIRPTFKELANE  270 (325)
T ss_dssp             TTTTHHHHHHTCSCTTTSCCHHHHHHH
T ss_pred             HHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            899999999999999999999999987

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=8e-45  Score=348.12  Aligned_cols=240  Identities=21%  Similarity=0.336  Sum_probs=200.6

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEEecCC
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYAA   81 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~   81 (344)
                      ++|++.+.||+|+||.||++.+..++..||||++.........+.+|+.++++++||||+++++++.....+|+||||++
T Consensus       220 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~~~  299 (495)
T 1opk_A          220 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMT  299 (495)
T ss_dssp             GGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred             HHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEccC
Confidence            46899999999999999999999999999999998766666789999999999999999999999999999999999999


Q ss_pred             CCChHHHHHhC--CCCCHHHHHHHHHHHHH-------CCeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCC--CCC
Q 019195           82 GGELFERICNA--GRFSEDEARYFFQQLIS-------GQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS--RPK  150 (344)
Q Consensus        82 ~g~L~~~i~~~--~~~~~~~~~~~~~ql~~-------~~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~--~~~  150 (344)
                      +|+|.+++...  ..+++..++.++.|++.       .||+||||||+|||++.++.  +||+|||+++......  ...
T Consensus       300 ~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~--~kl~DFG~a~~~~~~~~~~~~  377 (495)
T 1opk_A          300 YGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHL--VKVADFGLSRLMTGDTYTAHA  377 (495)
T ss_dssp             TCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGC--EEECCTTCEECCTTCCEECCT
T ss_pred             CCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCc--EEEeecccceeccCCceeecC
Confidence            99999999864  45888877777666554       59999999999999976654  9999999997543221  123


Q ss_pred             CCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCHhHHHH
Q 019195          151 STVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL  229 (344)
Q Consensus       151 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  229 (344)
                      ...+++.|+|||++.+..++ .++|||||||++|+|++ |..||.+......... +    ....+.+....+++.+.+|
T Consensus       378 ~~~~~~~y~aPE~~~~~~~~-~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~-~----~~~~~~~~~~~~~~~l~~l  451 (495)
T 1opk_A          378 GAKFPIKWTAPESLAYNKFS-IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYEL-L----EKDYRMERPEGCPEKVYEL  451 (495)
T ss_dssp             TCCCCGGGCCHHHHHHCEEC-HHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHH-H----HTTCCCCCCTTCCHHHHHH
T ss_pred             CCcCCcceeCHhHHhcCCCC-cHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHH-H----HcCCCCCCCCCCCHHHHHH
Confidence            34577899999999877764 55999999999999999 9999988765433222 2    2234444555789999999


Q ss_pred             HHHhcccCCCCCCChHHHhc
Q 019195          230 LSRIFVANPSRRITIKEIKS  249 (344)
Q Consensus       230 i~~~L~~dp~~R~s~~ell~  249 (344)
                      |.+||+.||.+|||+.++++
T Consensus       452 i~~cl~~dP~~RPs~~el~~  471 (495)
T 1opk_A          452 MRACWQWNPSDRPSFAEIHQ  471 (495)
T ss_dssp             HHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHcCcChhHCcCHHHHHH
Confidence            99999999999999999976

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=7.8e-45  Score=333.77  Aligned_cols=242  Identities=12%  Similarity=0.163  Sum_probs=193.9

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCC--------CcEEEEEEeecCccccHHHHHHHHHHhcCCCCCcce-----------
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNT--------KELVAMKYIERGHKIDANVAREIINHKQLRHPNIIR-----------   62 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~--------~~~vaiK~~~~~~~~~~~~~~ei~~l~~l~h~niv~-----------   62 (344)
                      ++|++.+.||+|+||.||+|.+..+        ++.||+|++...    ..+.+|+.++++++||||++           
T Consensus        42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  117 (352)
T 2jii_A           42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPLL  117 (352)
T ss_dssp             CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT----STHHHHHHHHHHHCCHHHHHHHHHHTTCTTC
T ss_pred             CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc----chHHHHHHHHHHhcccchhhhhhhhccCCcc
Confidence            5899999999999999999999874        889999998764    46889999999999999988           


Q ss_pred             ----eeEEEEc-CCEEEEEEecCCCCChHHHHHhC--CCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCC
Q 019195           63 ----FKEVVLT-PTHLAIVMEYAAGGELFERICNA--GRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSP  128 (344)
Q Consensus        63 ----~~~~~~~-~~~~~lv~e~~~~g~L~~~i~~~--~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~  128 (344)
                          +++++.. +..+|+||||+ +++|.+++...  ..+++.+++.++.||+.+       ||+||||||+|||++.++
T Consensus       118 ~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl~~~~~  196 (352)
T 2jii_A          118 AIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPED  196 (352)
T ss_dssp             SCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEEEETTE
T ss_pred             CccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEEcCCC
Confidence                6677765 68899999999 99999999876  789999999888887765       999999999999998765


Q ss_pred             CCCEEEeecCCCcccCCCC--------CCCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC-Ch
Q 019195          129 APRLKICDFGYSKSSLLHS--------RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQE-DP  199 (344)
Q Consensus       129 ~~~vkL~DFg~a~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~-~~  199 (344)
                      ..++||+|||+++......        ......||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.... ..
T Consensus       197 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~g~~pf~~~~~~~  275 (352)
T 2jii_A          197 QSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGP-SRRSDLQSLGYCMLKWLYGFLPWTNCLPNT  275 (352)
T ss_dssp             EEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSCCTTGGGTTCH
T ss_pred             CceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCC-CchhhHHHHHHHHHHHHhCCCCcccCCcCH
Confidence            3359999999997543222        1233479999999999987765 456999999999999999999998764 33


Q ss_pred             HHHHHHHHHHhhccccCC----CCCCCCHhHHHHHHHhcccCCCCCCChHHHhc
Q 019195          200 KNFRKTISRIMAVQYKIP----DYVHISQDCRNLLSRIFVANPSRRITIKEIKS  249 (344)
Q Consensus       200 ~~~~~~~~~~~~~~~~~~----~~~~~s~~~~~li~~~L~~dp~~R~s~~ell~  249 (344)
                      ................++    .+..+++.+.+||.+||+.||.+|||+.++++
T Consensus       276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  329 (352)
T 2jii_A          276 EDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRN  329 (352)
T ss_dssp             HHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             HHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHH
Confidence            333333333222222221    12357899999999999999999999999976

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=1.3e-44  Score=328.93  Aligned_cols=245  Identities=24%  Similarity=0.401  Sum_probs=197.8

Q ss_pred             CCceeeeeeeecCceEEEEEE----EcCCCcEEEEEEeecCcc-ccHHHHHHHHHHhcCCCCCcceeeEEEE--cCCEEE
Q 019195            2 EKYELMKDIGSGNFGVARLMR----NKNTKELVAMKYIERGHK-IDANVAREIINHKQLRHPNIIRFKEVVL--TPTHLA   74 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~----~~~~~~~vaiK~~~~~~~-~~~~~~~ei~~l~~l~h~niv~~~~~~~--~~~~~~   74 (344)
                      ++|++++.||+|+||.||+|.    +..+++.||+|++..... ....+.+|+.++++++||||+++++++.  ....++
T Consensus        23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~  102 (327)
T 3lxl_A           23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLR  102 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEE
T ss_pred             hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEE
Confidence            589999999999999999999    577899999999876533 2356889999999999999999999987  456799


Q ss_pred             EEEecCCCCChHHHHHh-CCCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCC
Q 019195           75 IVMEYAAGGELFERICN-AGRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH  146 (344)
Q Consensus        75 lv~e~~~~g~L~~~i~~-~~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~  146 (344)
                      +||||+++++|.+++.. ...+++.+++.++.|++.+       ||+||||||+|||++.++.  +||+|||++......
T Consensus       103 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~--~kl~Dfg~~~~~~~~  180 (327)
T 3lxl_A          103 LVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAH--VKIADFGLAKLLPLD  180 (327)
T ss_dssp             EEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTE--EEECCGGGCEECCTT
T ss_pred             EEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCC--EEEcccccceecccC
Confidence            99999999999999976 4569999888887776654       9999999999999987664  999999999754333


Q ss_pred             C----CCCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCh-----------HHHHHHHHHHhh
Q 019195          147 S----RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDP-----------KNFRKTISRIMA  211 (344)
Q Consensus       147 ~----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-----------~~~~~~~~~~~~  211 (344)
                      .    ......||+.|+|||++.+..+ +.++|||||||++|+|++|+.||......           ...... .....
T Consensus       181 ~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~  258 (327)
T 3lxl_A          181 KDYYVVREPGQSPIFWYAPESLSDNIF-SRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRL-LELLE  258 (327)
T ss_dssp             CSEEECSSCCCSCGGGSCHHHHHHCEE-EHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHH-HHHHH
T ss_pred             CccceeeccCCccccccCHHHhccCCC-ChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHH-HHHhh
Confidence            2    2234568999999999977765 45699999999999999999998653221           011111 12222


Q ss_pred             ccccCCCCCCCCHhHHHHHHHhcccCCCCCCChHHHhcC
Q 019195          212 VQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSH  250 (344)
Q Consensus       212 ~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~ell~h  250 (344)
                      .....+....+++.+.+||.+||+.||.+|||+.+++++
T Consensus       259 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  297 (327)
T 3lxl_A          259 EGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQ  297 (327)
T ss_dssp             TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             cccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            333445556789999999999999999999999999765

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=9.5e-45  Score=341.70  Aligned_cols=246  Identities=26%  Similarity=0.335  Sum_probs=181.6

Q ss_pred             CceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcC-CCCCcceeeEEEEcCCEEEEEEecCC
Q 019195            3 KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQL-RHPNIIRFKEVVLTPTHLAIVMEYAA   81 (344)
Q Consensus         3 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~   81 (344)
                      +|.+.+.||+|+||+|+. ....+++.||||++.....  ..+.+|+.+++.+ +||||+++++++.+...+|+|||||.
T Consensus        25 ~y~~~~~LG~G~~G~V~~-~~~~~~~~vAvK~~~~~~~--~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~  101 (432)
T 3p23_A           25 SFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPECF--SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA  101 (432)
T ss_dssp             EEEEEEEEEECGGGCEEE-EEESSSSEEEEEEECTTTE--EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred             EEecCCeeecCcCEEEEE-EEEeCCeEEEEEEECHHHH--HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECCC
Confidence            589999999999998764 4456789999999865432  3456899999999 79999999999999999999999995


Q ss_pred             CCChHHHHHhCC-CCCHHH-------HHHHHHHHHHCCeeecCCCCCCeEecC---CCCCCEEEeecCCCcccCCC----
Q 019195           82 GGELFERICNAG-RFSEDE-------ARYFFQQLISGQICHRDLKLENTLLDG---SPAPRLKICDFGYSKSSLLH----  146 (344)
Q Consensus        82 ~g~L~~~i~~~~-~~~~~~-------~~~~~~ql~~~~iiH~Dikp~NIl~~~---~~~~~vkL~DFg~a~~~~~~----  146 (344)
                       |+|.+++.... .+.+.+       +...+..||+.||+||||||+|||++.   ++..++||+|||+++.....    
T Consensus       102 -g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~~~~  180 (432)
T 3p23_A          102 -ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSF  180 (432)
T ss_dssp             -EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC-------
T ss_pred             -CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCCCcce
Confidence             69999997654 344333       334455566669999999999999953   33345889999998765433    


Q ss_pred             CCCCCCccCCcccCCccccCC--CCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhhcccc-CCCCCCC
Q 019195          147 SRPKSTVGTPAYIAPEVLSRR--EYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYK-IPDYVHI  222 (344)
Q Consensus       147 ~~~~~~~gt~~y~aPE~~~~~--~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~  222 (344)
                      ......+||+.|+|||++.+.  ...+.++|||||||++|+|++ |..||....... .. ..  ....... .......
T Consensus       181 ~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~-~~-~~--~~~~~~~~~~~~~~~  256 (432)
T 3p23_A          181 SRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQ-AN-IL--LGACSLDCLHPEKHE  256 (432)
T ss_dssp             -----CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHH-HH-HH--TTCCCCTTSCTTCHH
T ss_pred             eeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHH-HH-HH--hccCCccccCccccc
Confidence            223456799999999999742  223456999999999999999 999996544321 11 11  1111111 1111234


Q ss_pred             CHhHHHHHHHhcccCCCCCCChHHHhcCcccccC
Q 019195          223 SQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKN  256 (344)
Q Consensus       223 s~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~~  256 (344)
                      +..+.+||.+||+.||.+|||+.++++||||...
T Consensus       257 ~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~~  290 (432)
T 3p23_A          257 DVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSL  290 (432)
T ss_dssp             HHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCCH
T ss_pred             cHHHHHHHHHHHhCCHhhCCCHHHHHhCccccCh
Confidence            5668999999999999999999999999999653

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2e-44  Score=328.59  Aligned_cols=242  Identities=24%  Similarity=0.404  Sum_probs=182.8

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhc--CCCCCcceeeEEEEcC----CEEEE
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQ--LRHPNIIRFKEVVLTP----THLAI   75 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~l~~--l~h~niv~~~~~~~~~----~~~~l   75 (344)
                      ++|++++.||+|+||.||+|.+.  ++.||+|++.....  ....+|.+++..  ++||||+++++++...    ..+|+
T Consensus        37 ~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~--~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~l  112 (337)
T 3mdy_A           37 KQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTEE--ASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYL  112 (337)
T ss_dssp             HHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGGGH--HHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEEEE
T ss_pred             cceEEEeEeecCCCeEEEEEEEC--CceEEEEEEecccc--chhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCceEE
Confidence            47999999999999999999875  88999999865433  344555555555  4899999999999887    78999


Q ss_pred             EEecCCCCChHHHHHhCCCCCHHHHHHHHHHHH-------HC--------CeeecCCCCCCeEecCCCCCCEEEeecCCC
Q 019195           76 VMEYAAGGELFERICNAGRFSEDEARYFFQQLI-------SG--------QICHRDLKLENTLLDGSPAPRLKICDFGYS  140 (344)
Q Consensus        76 v~e~~~~g~L~~~i~~~~~~~~~~~~~~~~ql~-------~~--------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a  140 (344)
                      ||||+++|+|.+++... .+++..++.++.|++       +.        ||+||||||+|||++.++  ++||+|||++
T Consensus       113 v~e~~~~g~L~~~l~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~--~~kl~Dfg~a  189 (337)
T 3mdy_A          113 ITDYHENGSLYDYLKST-TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNG--TCCIADLGLA  189 (337)
T ss_dssp             EECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTS--CEEECCCTTC
T ss_pred             EEeccCCCcHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCC--CEEEEeCCCc
Confidence            99999999999999654 688888887766655       44        899999999999997665  4999999998


Q ss_pred             cccCCCCC-----CCCCccCCcccCCccccCCCCCCc-----chhHHHHHHHHHHHHhC----------CCCCCCCCChH
Q 019195          141 KSSLLHSR-----PKSTVGTPAYIAPEVLSRREYDGK-----LADVWSCGVTLYVMLVG----------AYPFEDQEDPK  200 (344)
Q Consensus       141 ~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~-----~~DiwslG~il~el~~g----------~~pf~~~~~~~  200 (344)
                      ........     ....+||+.|+|||++.+..+...     ++|||||||++|+|++|          +.||.......
T Consensus       190 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~~~~  269 (337)
T 3mdy_A          190 VKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSD  269 (337)
T ss_dssp             EECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSS
T ss_pred             eeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhcCCC
Confidence            65433222     234579999999999977665443     48999999999999999          77776543222


Q ss_pred             HHHHHHHHHh-hcccc--CCC---CCCCCHhHHHHHHHhcccCCCCCCChHHHhcC
Q 019195          201 NFRKTISRIM-AVQYK--IPD---YVHISQDCRNLLSRIFVANPSRRITIKEIKSH  250 (344)
Q Consensus       201 ~~~~~~~~~~-~~~~~--~~~---~~~~s~~~~~li~~~L~~dp~~R~s~~ell~h  250 (344)
                      .......... .....  .+.   ...+++++.+||.+||+.||.+|||+.++++|
T Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  325 (337)
T 3mdy_A          270 PSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKT  325 (337)
T ss_dssp             CCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred             CchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHH
Confidence            1112222211 11111  111   11345679999999999999999999999886

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=1e-44  Score=327.54  Aligned_cols=242  Identities=23%  Similarity=0.383  Sum_probs=196.2

Q ss_pred             CCceeeeeeeecCceEEEEEEE-----cCCCcEEEEEEeecCcc--ccHHHHHHHHHHhcC-CCCCcceeeEEEEcCC-E
Q 019195            2 EKYELMKDIGSGNFGVARLMRN-----KNTKELVAMKYIERGHK--IDANVAREIINHKQL-RHPNIIRFKEVVLTPT-H   72 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~vaiK~~~~~~~--~~~~~~~ei~~l~~l-~h~niv~~~~~~~~~~-~   72 (344)
                      ++|++.+.||+|+||.||+|.+     ..+++.||+|++.....  ....+.+|+.+++++ +||||+++++++...+ .
T Consensus        27 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~  106 (316)
T 2xir_A           27 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP  106 (316)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSC
T ss_pred             hheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecCCCc
Confidence            5899999999999999999985     45778999999976543  234688999999999 7999999999987754 5


Q ss_pred             EEEEEecCCCCChHHHHHhCCC----------------CCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCC
Q 019195           73 LAIVMEYAAGGELFERICNAGR----------------FSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPA  129 (344)
Q Consensus        73 ~~lv~e~~~~g~L~~~i~~~~~----------------~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~  129 (344)
                      +++||||+++++|.+++.....                +++..++.++.|++.+       ||+||||||+||+++.++.
T Consensus       107 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~  186 (316)
T 2xir_A          107 LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNV  186 (316)
T ss_dssp             CEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC
T ss_pred             eEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCC
Confidence            8999999999999999987553                7888888777776654       9999999999999976654


Q ss_pred             CCEEEeecCCCcccCCCCC---CCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHH
Q 019195          130 PRLKICDFGYSKSSLLHSR---PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKT  205 (344)
Q Consensus       130 ~~vkL~DFg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~  205 (344)
                        +||+|||+++.......   .....||+.|+|||++.+..++ .++|||||||++|+|++ |..||........+...
T Consensus       187 --~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~  263 (316)
T 2xir_A          187 --VKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYT-IQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR  263 (316)
T ss_dssp             --EEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHH
T ss_pred             --EEECCCccccccccCccceeccCCCcceeecCchhhcccccc-chhHHHHHHHHHHHHHhCCCCCCcccchhHHHHHH
Confidence              99999999875433322   2234588999999999877764 56999999999999998 99999887654444333


Q ss_pred             HHHHhhccccCCCCCCCCHhHHHHHHHhcccCCCCCCChHHHhcC
Q 019195          206 ISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSH  250 (344)
Q Consensus       206 ~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~ell~h  250 (344)
                      +..    ....+....+++.+.++|.+||+.||.+|||+.++++|
T Consensus       264 ~~~----~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  304 (316)
T 2xir_A          264 LKE----GTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  304 (316)
T ss_dssp             HHH----TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             hcc----CccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            322    22233334679999999999999999999999999986

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=8.5e-45  Score=328.45  Aligned_cols=243  Identities=25%  Similarity=0.392  Sum_probs=191.9

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCc-cccHHHHHHHHHHhcCCCCCcceeeEEEE----cCCEEEEE
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH-KIDANVAREIINHKQLRHPNIIRFKEVVL----TPTHLAIV   76 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~ei~~l~~l~h~niv~~~~~~~----~~~~~~lv   76 (344)
                      ++|++++.||+|+||.||+|.+..+++.||+|++.... .....+.+|+.+++.++||||+++++++.    ....+|+|
T Consensus        29 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv  108 (317)
T 2buj_A           29 KHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLL  108 (317)
T ss_dssp             EEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEEE
T ss_pred             eEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEEE
Confidence            57999999999999999999999999999999986543 23457889999999999999999999987    34578999


Q ss_pred             EecCCCCChHHHHHh----CCCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCC
Q 019195           77 MEYAAGGELFERICN----AGRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLL  145 (344)
Q Consensus        77 ~e~~~~g~L~~~i~~----~~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~  145 (344)
                      |||+.+|+|.+++..    ...+++.+++.++.|++.+       ||+||||||+|||++.++.  +||+|||++.....
T Consensus       109 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~--~kl~dfg~~~~~~~  186 (317)
T 2buj_A          109 LPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQ--PVLMDLGSMNQACI  186 (317)
T ss_dssp             EECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSC--EEECCCSSCEESCE
T ss_pred             EEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCC--EEEEecCcchhccc
Confidence            999999999999875    4679999988888777654       9999999999999976654  99999998865332


Q ss_pred             CCCC----------CCCccCCcccCCccccCCCC--CCcchhHHHHHHHHHHHHhCCCCCCCCCC-hHHHHHHHHHHhhc
Q 019195          146 HSRP----------KSTVGTPAYIAPEVLSRREY--DGKLADVWSCGVTLYVMLVGAYPFEDQED-PKNFRKTISRIMAV  212 (344)
Q Consensus       146 ~~~~----------~~~~gt~~y~aPE~~~~~~~--~~~~~DiwslG~il~el~~g~~pf~~~~~-~~~~~~~~~~~~~~  212 (344)
                      ....          ....||+.|+|||++.+...  .+.++|||||||++|+|++|+.||..... ......    ....
T Consensus       187 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~----~~~~  262 (317)
T 2buj_A          187 HVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVAL----AVQN  262 (317)
T ss_dssp             EEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHH----HHHC
T ss_pred             ccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhH----Hhhc
Confidence            1111          12347999999999875542  24569999999999999999999953110 001111    1122


Q ss_pred             cccCCCCCCCCHhHHHHHHHhcccCCCCCCChHHHhcC
Q 019195          213 QYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSH  250 (344)
Q Consensus       213 ~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~ell~h  250 (344)
                      ....|....+++.+.+||.+||+.||.+|||+.+++++
T Consensus       263 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  300 (317)
T 2buj_A          263 QLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQ  300 (317)
T ss_dssp             C--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             cCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHH
Confidence            34455556789999999999999999999999999986

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=1.1e-44  Score=335.37  Aligned_cols=240  Identities=23%  Similarity=0.365  Sum_probs=185.7

Q ss_pred             CCceeeeeeeecCceEEEEEEEc---CCCcEEEEEEeecCcc--ccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEE
Q 019195            2 EKYELMKDIGSGNFGVARLMRNK---NTKELVAMKYIERGHK--IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIV   76 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~~--~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv   76 (344)
                      ++|++.+.||+|+||.||+|.+.   .++..||+|++.....  ....+.+|+.++++++||||+++++++...+.+++|
T Consensus        45 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  124 (373)
T 2qol_A           45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIV  124 (373)
T ss_dssp             GGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred             hhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEE
Confidence            47999999999999999999887   5677899999976432  335688999999999999999999999999999999


Q ss_pred             EecCCCCChHHHHHhCC-CCCHHHHHHHHHHHHH-------CCeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCCC
Q 019195           77 MEYAAGGELFERICNAG-RFSEDEARYFFQQLIS-------GQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR  148 (344)
Q Consensus        77 ~e~~~~g~L~~~i~~~~-~~~~~~~~~~~~ql~~-------~~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~~  148 (344)
                      |||+++|+|.+++.+.+ .+++.+++.++.|++.       .||+||||||+|||++.++.  +||+|||+++.......
T Consensus       125 ~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~--~kl~Dfg~a~~~~~~~~  202 (373)
T 2qol_A          125 TEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLV--CKVSDFGLGRVLEDDPE  202 (373)
T ss_dssp             EECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCC--EEECCC-----------
T ss_pred             EeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCC--EEECcCccccccccCCc
Confidence            99999999999997754 6898888887777655       49999999999999977654  99999999976433221


Q ss_pred             ----CCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCC
Q 019195          149 ----PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHIS  223 (344)
Q Consensus       149 ----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s  223 (344)
                          .....+|+.|+|||++.+..++ .++|||||||++|+|++ |+.||.........    ..+ ......+....++
T Consensus       203 ~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~----~~i-~~~~~~~~~~~~~  276 (373)
T 2qol_A          203 AAYTTRGGKIPIRWTSPEAIAYRKFT-SASDVWSYGIVLWEVMSYGERPYWEMSNQDVI----KAV-DEGYRLPPPMDCP  276 (373)
T ss_dssp             -----------CTTSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHH----HHH-HTTEECCCCTTCB
T ss_pred             cceeccCCCcCCCccChhhhccCCcC-chhcHHHHHHHHHHHHhCCCCCCCCCCHHHHH----HHH-HcCCCCCCCcccc
Confidence                1122467889999999877764 56999999999999998 99999876543322    222 2233445555788


Q ss_pred             HhHHHHHHHhcccCCCCCCChHHHhc
Q 019195          224 QDCRNLLSRIFVANPSRRITIKEIKS  249 (344)
Q Consensus       224 ~~~~~li~~~L~~dp~~R~s~~ell~  249 (344)
                      ..+.+||.+||+.||.+||++.++++
T Consensus       277 ~~l~~li~~cl~~dp~~RPs~~~i~~  302 (373)
T 2qol_A          277 AALYQLMLDCWQKDRNNRPKFEQIVS  302 (373)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHHHhCcChhhCcCHHHHHH
Confidence            99999999999999999999999876

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=2.2e-44  Score=323.10  Aligned_cols=241  Identities=25%  Similarity=0.343  Sum_probs=182.3

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhc--CCCCCcceeeEEEEc----CCEEEE
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQ--LRHPNIIRFKEVVLT----PTHLAI   75 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~l~~--l~h~niv~~~~~~~~----~~~~~l   75 (344)
                      ++|++++.||+|+||+||++.+  +++.||+|++....  ...+.+|.+++..  ++||||+++++++..    ...+|+
T Consensus         8 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~--~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~l   83 (301)
T 3q4u_A            8 RDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSRD--EKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWL   83 (301)
T ss_dssp             GGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGGG--HHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEE
T ss_pred             CcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEecccc--chhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEE
Confidence            5899999999999999999987  68899999986543  2445566666655  799999999998654    356899


Q ss_pred             EEecCCCCChHHHHHhCCCCCHHHHHHHHHH-------HH--------HCCeeecCCCCCCeEecCCCCCCEEEeecCCC
Q 019195           76 VMEYAAGGELFERICNAGRFSEDEARYFFQQ-------LI--------SGQICHRDLKLENTLLDGSPAPRLKICDFGYS  140 (344)
Q Consensus        76 v~e~~~~g~L~~~i~~~~~~~~~~~~~~~~q-------l~--------~~~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a  140 (344)
                      ||||+++|+|.+++. ...+++..++.++.|       ||        +.||+||||||+|||++.++.  +||+|||++
T Consensus        84 v~e~~~~g~L~~~l~-~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~--~kl~Dfg~a  160 (301)
T 3q4u_A           84 ITHYHEMGSLYDYLQ-LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQ--CCIADLGLA  160 (301)
T ss_dssp             EECCCTTCBHHHHHT-TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSC--EEECCCTTC
T ss_pred             ehhhccCCCHHHHHh-hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCC--EEEeeCCCe
Confidence            999999999999995 456888877776555       55        569999999999999986654  999999998


Q ss_pred             cccCCCCC-----CCCCccCCcccCCccccCCCCC-----CcchhHHHHHHHHHHHHhC----------CCCCCCCCChH
Q 019195          141 KSSLLHSR-----PKSTVGTPAYIAPEVLSRREYD-----GKLADVWSCGVTLYVMLVG----------AYPFEDQEDPK  200 (344)
Q Consensus       141 ~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~-----~~~~DiwslG~il~el~~g----------~~pf~~~~~~~  200 (344)
                      +.......     ....+||+.|+|||++.+....     +.++|||||||++|+|++|          ..||.......
T Consensus       161 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~~  240 (301)
T 3q4u_A          161 VMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPND  240 (301)
T ss_dssp             EEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSS
T ss_pred             eecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCCCC
Confidence            64332221     2345799999999999776332     2469999999999999999          88886643222


Q ss_pred             HHHHHHHHHhhccccCCCC------CCCCHhHHHHHHHhcccCCCCCCChHHHhc
Q 019195          201 NFRKTISRIMAVQYKIPDY------VHISQDCRNLLSRIFVANPSRRITIKEIKS  249 (344)
Q Consensus       201 ~~~~~~~~~~~~~~~~~~~------~~~s~~~~~li~~~L~~dp~~R~s~~ell~  249 (344)
                      .....+..........+..      ...++.+.+||.+||+.||.+|||+.++++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~  295 (301)
T 3q4u_A          241 PSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK  295 (301)
T ss_dssp             CCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred             cchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHH
Confidence            2222222222222222211      124567999999999999999999999986

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=3.2e-44  Score=327.29  Aligned_cols=241  Identities=24%  Similarity=0.365  Sum_probs=194.3

Q ss_pred             CCceeeeeeeecCceEEEEEEEc-------CCCcEEEEEEeecCcc--ccHHHHHHHHHHhcC-CCCCcceeeEEEEcCC
Q 019195            2 EKYELMKDIGSGNFGVARLMRNK-------NTKELVAMKYIERGHK--IDANVAREIINHKQL-RHPNIIRFKEVVLTPT   71 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~vaiK~~~~~~~--~~~~~~~ei~~l~~l-~h~niv~~~~~~~~~~   71 (344)
                      ++|++.+.||+|+||.||+|.+.       .++..||+|++.....  ....+.+|+.+++++ +||||+++++++...+
T Consensus        35 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~  114 (334)
T 2pvf_A           35 DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG  114 (334)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             hHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccCC
Confidence            58999999999999999999975       4677899999976432  235688999999999 8999999999999999


Q ss_pred             EEEEEEecCCCCChHHHHHhCC----------------CCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCC
Q 019195           72 HLAIVMEYAAGGELFERICNAG----------------RFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSP  128 (344)
Q Consensus        72 ~~~lv~e~~~~g~L~~~i~~~~----------------~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~  128 (344)
                      .+|+||||+++|+|.+++....                .++..+++.++.||+.+       ||+||||||+|||++.++
T Consensus       115 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~  194 (334)
T 2pvf_A          115 PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENN  194 (334)
T ss_dssp             CCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC
T ss_pred             ceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccceEEEcCCC
Confidence            9999999999999999997654                37888888777776654       999999999999997665


Q ss_pred             CCCEEEeecCCCcccCCCC---CCCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHH
Q 019195          129 APRLKICDFGYSKSSLLHS---RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRK  204 (344)
Q Consensus       129 ~~~vkL~DFg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~  204 (344)
                        ++||+|||+++......   ......+|+.|+|||++.+..+ +.++|||||||++|+|++ |..||...........
T Consensus       195 --~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~  271 (334)
T 2pvf_A          195 --VMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVY-THQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKL  271 (334)
T ss_dssp             --CEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEE-CHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHH
T ss_pred             --CEEEccccccccccccccccccCCCCcccceeChHHhcCCCc-ChHHHHHHHHHHHHHHHhCCCCCcCcCCHHHHHHH
Confidence              49999999987543322   2234457899999999977665 456999999999999999 9999987654333222


Q ss_pred             HHHHHhhccccCCCCCCCCHhHHHHHHHhcccCCCCCCChHHHhcC
Q 019195          205 TISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSH  250 (344)
Q Consensus       205 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~ell~h  250 (344)
                          +.. ....+....+++.+.+||.+||+.||.+|||+.+++++
T Consensus       272 ----~~~-~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  312 (334)
T 2pvf_A          272 ----LKE-GHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED  312 (334)
T ss_dssp             ----HHH-TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ----Hhc-CCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence                221 12233344689999999999999999999999999875

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=2.9e-44  Score=321.05  Aligned_cols=243  Identities=22%  Similarity=0.315  Sum_probs=181.9

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCccc---cHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEEe
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKI---DANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVME   78 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e   78 (344)
                      ++|++.+.||+|+||.||++.+..   .||+|++......   ...+.+|+.++++++||||++++++. ....+++|||
T Consensus        24 ~~y~~~~~lG~G~~g~Vy~~~~~~---~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e   99 (289)
T 3og7_A           24 GQITVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQ   99 (289)
T ss_dssp             TSCEEEEEEEECSSEEEEEEESSS---EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEE
T ss_pred             cceeeeeEecCCCCeEEEEEEEcC---ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEE
Confidence            589999999999999999998654   4999998754332   35688999999999999999999955 5667899999


Q ss_pred             cCCCCChHHHHHh-CCCCCHHHHHHHHHHHHH-------CCeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCC---C
Q 019195           79 YAAGGELFERICN-AGRFSEDEARYFFQQLIS-------GQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH---S  147 (344)
Q Consensus        79 ~~~~g~L~~~i~~-~~~~~~~~~~~~~~ql~~-------~~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~---~  147 (344)
                      |+++++|.+++.. ...+++.+++.++.|++.       .||+||||||+|||++.++  ++||+|||++......   .
T Consensus       100 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~--~~kl~Dfg~~~~~~~~~~~~  177 (289)
T 3og7_A          100 WCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDN--TVKIGDFGLATEKSRWSGSH  177 (289)
T ss_dssp             CCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTT--EEEECCCC------------
T ss_pred             ecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCC--CEEEccceeccccccccccc
Confidence            9999999999964 456888888888777665       4999999999999998765  4999999998754321   2


Q ss_pred             CCCCCccCCcccCCccccC--CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCHh
Q 019195          148 RPKSTVGTPAYIAPEVLSR--REYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQD  225 (344)
Q Consensus       148 ~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~  225 (344)
                      ......||+.|+|||++..  ....+.++|||||||++|+|++|+.||............+...............+++.
T Consensus       178 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (289)
T 3og7_A          178 QFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKR  257 (289)
T ss_dssp             ------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCCTTSSCTTSCHH
T ss_pred             cccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcchhhccccCCHH
Confidence            2234569999999999862  22234569999999999999999999988776555444433211111111122367899


Q ss_pred             HHHHHHHhcccCCCCCCChHHHhcC
Q 019195          226 CRNLLSRIFVANPSRRITIKEIKSH  250 (344)
Q Consensus       226 ~~~li~~~L~~dp~~R~s~~ell~h  250 (344)
                      +.+||.+||+.||.+|||+.++++.
T Consensus       258 l~~li~~~l~~~p~~Rps~~ell~~  282 (289)
T 3og7_A          258 MKRLMAECLKKKRDERPSFPRILAE  282 (289)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHccCChhhCCCHHHHHHH
Confidence            9999999999999999999999863

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=4.4e-44  Score=325.55  Aligned_cols=240  Identities=21%  Similarity=0.347  Sum_probs=189.4

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEE----EEEEeecC--ccccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEE
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELV----AMKYIERG--HKIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAI   75 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~v----aiK~~~~~--~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~l   75 (344)
                      ++|++++.||+|+||.||+|.+..+++.+    |+|.+...  ......+.+|+.++++++||||+++++++.... .++
T Consensus        15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~   93 (327)
T 3lzb_A           15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL   93 (327)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EEE
T ss_pred             hHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ceE
Confidence            68999999999999999999998888765    66655432  234467899999999999999999999998765 789


Q ss_pred             EEecCCCCChHHHHHh-CCCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCC
Q 019195           76 VMEYAAGGELFERICN-AGRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS  147 (344)
Q Consensus        76 v~e~~~~g~L~~~i~~-~~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~  147 (344)
                      +++|+.+|+|.+++.. .+.+++..++.++.|++.+       ||+||||||+|||++.++.  +||+|||+++......
T Consensus        94 v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~--~kL~DfG~a~~~~~~~  171 (327)
T 3lzb_A           94 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQH--VKITDFGLAKLLGAEE  171 (327)
T ss_dssp             EECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTE--EEECCTTC--------
T ss_pred             EEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCC--EEEccCcceeEccCcc
Confidence            9999999999999976 4578998888887776654       9999999999999987664  9999999997643332


Q ss_pred             C---CCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCC
Q 019195          148 R---PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHIS  223 (344)
Q Consensus       148 ~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s  223 (344)
                      .   .....||+.|+|||++.+..++ .++|||||||++|+|++ |..||......... ..+    ......+....++
T Consensus       172 ~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~Di~slG~il~ell~~g~~p~~~~~~~~~~-~~~----~~~~~~~~~~~~~  245 (327)
T 3lzb_A          172 KEYHAEGGKVPIKWMALESILHRIYT-HQSDVWSYGVTVWELMTFGSKPYDGIPASEIS-SIL----EKGERLPQPPICT  245 (327)
T ss_dssp             --------CCCGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHH-HHH----HTTCCCCCCTTBC
T ss_pred             ccccccCCCccccccCHHHHcCCCCC-hHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHH-HHH----HcCCCCCCCccCC
Confidence            2   2234578899999999877764 56999999999999999 99999887654332 222    2233444555789


Q ss_pred             HhHHHHHHHhcccCCCCCCChHHHhcC
Q 019195          224 QDCRNLLSRIFVANPSRRITIKEIKSH  250 (344)
Q Consensus       224 ~~~~~li~~~L~~dp~~R~s~~ell~h  250 (344)
                      +++.+||.+||+.||.+|||+.++++.
T Consensus       246 ~~l~~li~~~l~~dp~~Rps~~ell~~  272 (327)
T 3lzb_A          246 IDVYMIMRKCWMIDADSRPKFRELIIE  272 (327)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            999999999999999999999999873

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=2.3e-45  Score=333.06  Aligned_cols=246  Identities=20%  Similarity=0.196  Sum_probs=191.9

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCcc-ccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEEecC
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK-IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYA   80 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~   80 (344)
                      ++|++.+.||+|+||.||+|.+. +++.||+|++..... ....+.+|+.+++.++||||+++++++...+.+++||||+
T Consensus        39 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  117 (321)
T 2qkw_B           39 NNFDHKFLIGHGVFGKVYKGVLR-DGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYM  117 (321)
T ss_dssp             CCCSCCCCSCBCSSSEEEEEECT-TCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEEEECC
T ss_pred             hccCccceeecCCCeeEEEEEEC-CCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEEcC
Confidence            68999999999999999999964 688999998876433 3367889999999999999999999999999999999999


Q ss_pred             CCCChHHHHHhCC----CCCHHHHHHHHHHHHH-------CCeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCC--
Q 019195           81 AGGELFERICNAG----RFSEDEARYFFQQLIS-------GQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS--  147 (344)
Q Consensus        81 ~~g~L~~~i~~~~----~~~~~~~~~~~~ql~~-------~~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~--  147 (344)
                      ++|+|.+++....    .+++.+++.++.|++.       .||+||||||+|||++.++  ++||+|||+++......  
T Consensus       118 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~--~~kl~Dfg~~~~~~~~~~~  195 (321)
T 2qkw_B          118 ENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENF--VPKITDFGISKKGTELDQT  195 (321)
T ss_dssp             TTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTC--CEEECCCTTCEECSSSSCC
T ss_pred             CCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCC--CEEEeeccccccccccccc
Confidence            9999999986543    5888888887776654       4999999999999997665  49999999987533222  


Q ss_pred             -CCCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHH--HHHH-HHHhhcccc--------
Q 019195          148 -RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNF--RKTI-SRIMAVQYK--------  215 (344)
Q Consensus       148 -~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~--~~~~-~~~~~~~~~--------  215 (344)
                       ......||+.|+|||++.+..++ .++|||||||++|+|++|+.||.........  .... .........        
T Consensus       196 ~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (321)
T 2qkw_B          196 HLSTVVKGTLGYIDPEYFIKGRLT-EKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLA  274 (321)
T ss_dssp             CCBCCCEEETTTCCHHHHHHCBCC-THHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSSSSSCT
T ss_pred             ccccccCCCccccCHHHhcCCCCC-cccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHhcChhhc
Confidence             22344699999999999877765 5599999999999999999999765432211  1111 011111100        


Q ss_pred             CCCCCCCCHhHHHHHHHhcccCCCCCCChHHHhcCc
Q 019195          216 IPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHP  251 (344)
Q Consensus       216 ~~~~~~~s~~~~~li~~~L~~dp~~R~s~~ell~hp  251 (344)
                      .......+..+.+++.+||+.||.+|||+.+++++.
T Consensus       275 ~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L  310 (321)
T 2qkw_B          275 DKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKL  310 (321)
T ss_dssp             TCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             cccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence            001112356789999999999999999999999763

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=2.1e-44  Score=328.21  Aligned_cols=242  Identities=21%  Similarity=0.340  Sum_probs=198.1

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCc-----EEEEEEeecCcc--ccHHHHHHHHHHhcC-CCCCcceeeEEEEcCCEE
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKE-----LVAMKYIERGHK--IDANVAREIINHKQL-RHPNIIRFKEVVLTPTHL   73 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~-----~vaiK~~~~~~~--~~~~~~~ei~~l~~l-~h~niv~~~~~~~~~~~~   73 (344)
                      ++|++.+.||+|+||.||+|.+..++.     .||+|++.....  ....+.+|+.+++.+ +||||+++++++...+.+
T Consensus        46 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~  125 (333)
T 2i1m_A           46 NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPV  125 (333)
T ss_dssp             TSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             HHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCCce
Confidence            579999999999999999999977664     799999876432  235688999999999 899999999999999999


Q ss_pred             EEEEecCCCCChHHHHHhC--------------CCCCHHHHHHHHHHHHH-------CCeeecCCCCCCeEecCCCCCCE
Q 019195           74 AIVMEYAAGGELFERICNA--------------GRFSEDEARYFFQQLIS-------GQICHRDLKLENTLLDGSPAPRL  132 (344)
Q Consensus        74 ~lv~e~~~~g~L~~~i~~~--------------~~~~~~~~~~~~~ql~~-------~~iiH~Dikp~NIl~~~~~~~~v  132 (344)
                      ++||||+++|+|.+++...              ..+++..++.++.|++.       .||+||||||+|||++.++.  +
T Consensus       126 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~--~  203 (333)
T 2i1m_A          126 LVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHV--A  203 (333)
T ss_dssp             EEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEEGGGE--E
T ss_pred             EEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEECCCCe--E
Confidence            9999999999999998653              35788888877777654       49999999999999987654  9


Q ss_pred             EEeecCCCcccCCCCC---CCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHH
Q 019195          133 KICDFGYSKSSLLHSR---PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISR  208 (344)
Q Consensus       133 kL~DFg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~  208 (344)
                      ||+|||++........   .....||+.|+|||++.+..++ .++|||||||++|+|++ |..||........+..... 
T Consensus       204 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~-  281 (333)
T 2i1m_A          204 KIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYT-VQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVK-  281 (333)
T ss_dssp             EBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHHHHHH-
T ss_pred             EECccccccccccccceeecCCCCCCccccCHHHhccCCCC-hHHHHHHHHHHHHHHHcCCCCCCcccchhHHHHHHHh-
Confidence            9999999975433322   2344578899999999877664 56999999999999998 9999988765554443333 


Q ss_pred             HhhccccCCCCCCCCHhHHHHHHHhcccCCCCCCChHHHhcC
Q 019195          209 IMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSH  250 (344)
Q Consensus       209 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~ell~h  250 (344)
                         .....+.....++.+.+||.+||+.||.+|||+.+++++
T Consensus       282 ---~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~  320 (333)
T 2i1m_A          282 ---DGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSF  320 (333)
T ss_dssp             ---HTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ---cCCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHH
Confidence               233334444678999999999999999999999999874

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=2.3e-44  Score=341.60  Aligned_cols=238  Identities=24%  Similarity=0.389  Sum_probs=195.7

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEEecCC
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYAA   81 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~   81 (344)
                      ++|++.+.||+|+||.||++.+. ++..||||++.........+.+|+.++++++||||+++++++. ...+|+|||||+
T Consensus       188 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~~~  265 (454)
T 1qcf_A          188 ESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEFMA  265 (454)
T ss_dssp             GGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECCCT
T ss_pred             HHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCCccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEeecC
Confidence            57999999999999999999986 4678999999876666678999999999999999999999986 667899999999


Q ss_pred             CCChHHHHHhC--CCCCHHHHHHHHHHHH-------HCCeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCC--CCCC
Q 019195           82 GGELFERICNA--GRFSEDEARYFFQQLI-------SGQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH--SRPK  150 (344)
Q Consensus        82 ~g~L~~~i~~~--~~~~~~~~~~~~~ql~-------~~~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~--~~~~  150 (344)
                      +|+|.+++...  ..++...++.++.|++       +.||+||||||+|||++.++.  +||+|||+++.....  ....
T Consensus       266 ~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~--~kl~DFG~a~~~~~~~~~~~~  343 (454)
T 1qcf_A          266 KGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLV--CKIADFGLARVIEDNEYTARE  343 (454)
T ss_dssp             TCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCC--EEECSTTGGGGBCCHHHHTTC
T ss_pred             CCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCc--EEEeeCCCceEcCCCceeccC
Confidence            99999999754  3678877777766655       459999999999999987654  999999999754322  1123


Q ss_pred             CCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCHhHHHH
Q 019195          151 STVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL  229 (344)
Q Consensus       151 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  229 (344)
                      ...+|+.|+|||++....+ +.++|||||||++|+|++ |+.||.+.........+    . ...+.+....+++++.+|
T Consensus       344 ~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i----~-~~~~~~~~~~~~~~l~~l  417 (454)
T 1qcf_A          344 GAKFPIKWTAPEAINFGSF-TIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRAL----E-RGYRMPRPENCPEELYNI  417 (454)
T ss_dssp             SSSSCGGGSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHH----H-HTCCCCCCTTSCHHHHHH
T ss_pred             CCcccccccCHHHhccCCC-CcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHH----H-cCCCCCCCCCCCHHHHHH
Confidence            3457889999999987766 456999999999999999 99999876654333222    1 234455556789999999


Q ss_pred             HHHhcccCCCCCCChHHHhc
Q 019195          230 LSRIFVANPSRRITIKEIKS  249 (344)
Q Consensus       230 i~~~L~~dp~~R~s~~ell~  249 (344)
                      |.+||+.||.+|||+.+++.
T Consensus       418 i~~cl~~dp~~RPt~~~i~~  437 (454)
T 1qcf_A          418 MMRCWKNRPEERPTFEYIQS  437 (454)
T ss_dssp             HHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHccCChhHCcCHHHHHH
Confidence            99999999999999999875

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=7.9e-45  Score=330.34  Aligned_cols=247  Identities=19%  Similarity=0.287  Sum_probs=193.8

Q ss_pred             CCceeeeeeeecCceEEEEEE-----EcCCCcEEEEEEeecCc--cccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEE
Q 019195            2 EKYELMKDIGSGNFGVARLMR-----NKNTKELVAMKYIERGH--KIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLA   74 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~-----~~~~~~~vaiK~~~~~~--~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~   74 (344)
                      ++|++++.||+|+||.||+|.     +..++..||+|++....  .....+.+|+.++++++||||+++++++......|
T Consensus        30 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  109 (327)
T 2yfx_A           30 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRF  109 (327)
T ss_dssp             GGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred             hheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCcE
Confidence            589999999999999999999     55678899999996532  23356889999999999999999999999999999


Q ss_pred             EEEecCCCCChHHHHHhCC-------CCCHHHHHHHHHHHHH-------CCeeecCCCCCCeEecCCC-CCCEEEeecCC
Q 019195           75 IVMEYAAGGELFERICNAG-------RFSEDEARYFFQQLIS-------GQICHRDLKLENTLLDGSP-APRLKICDFGY  139 (344)
Q Consensus        75 lv~e~~~~g~L~~~i~~~~-------~~~~~~~~~~~~ql~~-------~~iiH~Dikp~NIl~~~~~-~~~vkL~DFg~  139 (344)
                      +||||+++++|.+++....       .+++.+++.++.|++.       .||+||||||+|||++.++ ...+||+|||+
T Consensus       110 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~kl~Dfg~  189 (327)
T 2yfx_A          110 ILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGM  189 (327)
T ss_dssp             EEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECCCHH
T ss_pred             EEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceEEECcccc
Confidence            9999999999999998753       4788888877777654       4999999999999997432 33599999999


Q ss_pred             CcccCCC---CCCCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhhcccc
Q 019195          140 SKSSLLH---SRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYK  215 (344)
Q Consensus       140 a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~  215 (344)
                      +......   .......||+.|+|||++.+..+ +.++|||||||++|+|++ |..||.........    ..+... ..
T Consensus       190 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~----~~~~~~-~~  263 (327)
T 2yfx_A          190 ARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIF-TSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVL----EFVTSG-GR  263 (327)
T ss_dssp             HHHHHC------CCGGGSCGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH----HHHHTT-CC
T ss_pred             ccccccccccccCCCcCCCcceeCHhHhcCCCC-CchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHH----HHHhcC-CC
Confidence            8643222   22334568999999999977765 456999999999999998 99999876543322    222222 22


Q ss_pred             CCCCCCCCHhHHHHHHHhcccCCCCCCChHHHhcCcccc
Q 019195          216 IPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFL  254 (344)
Q Consensus       216 ~~~~~~~s~~~~~li~~~L~~dp~~R~s~~ell~hp~~~  254 (344)
                      .+....+++.+.+||.+||+.||.+|||+.++++|+|+.
T Consensus       264 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~  302 (327)
T 2yfx_A          264 MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC  302 (327)
T ss_dssp             CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence            233346899999999999999999999999999998763

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=8.4e-44  Score=335.79  Aligned_cols=244  Identities=25%  Similarity=0.308  Sum_probs=181.3

Q ss_pred             CceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcC-CCCCcceeeEEEEcCCEEEEEEecCC
Q 019195            3 KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQL-RHPNIIRFKEVVLTPTHLAIVMEYAA   81 (344)
Q Consensus         3 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~   81 (344)
                      .|.+.+.||+|+||+||.+ ...+|+.||||++....  ...+.+|+.+++++ +||||+++++++.+++.+|+|||||.
T Consensus        16 ~~~~~~~LG~G~~g~V~~~-~~~~g~~vAvK~~~~~~--~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~   92 (434)
T 2rio_A           16 LVVSEKILGYGSSGTVVFQ-GSFQGRPVAVKRMLIDF--CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN   92 (434)
T ss_dssp             CEEEEEEEEECSTTCEEEE-EESSSSEEEEEEEEGGG--HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS
T ss_pred             eeeccCeEeeCCCeEEEEE-EEECCeEEEEEEEcHHH--HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC
Confidence            4566789999999999865 44679999999987643  34678999999876 89999999999999999999999995


Q ss_pred             CCChHHHHHhCCCCCH--------------HHHHHHHHHHHHCCeeecCCCCCCeEecCC-----------CCCCEEEee
Q 019195           82 GGELFERICNAGRFSE--------------DEARYFFQQLISGQICHRDLKLENTLLDGS-----------PAPRLKICD  136 (344)
Q Consensus        82 ~g~L~~~i~~~~~~~~--------------~~~~~~~~ql~~~~iiH~Dikp~NIl~~~~-----------~~~~vkL~D  136 (344)
                       |+|.+++........              .++...+..||+.||+||||||+|||++.+           ...++||+|
T Consensus        93 -gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~D  171 (434)
T 2rio_A           93 -LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISD  171 (434)
T ss_dssp             -EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEECC
T ss_pred             -CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCCceEEEEcc
Confidence             699999976543221              233334455666699999999999999753           234699999


Q ss_pred             cCCCcccCCCCC-----CCCCccCCcccCCccccC------CCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHH
Q 019195          137 FGYSKSSLLHSR-----PKSTVGTPAYIAPEVLSR------REYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRK  204 (344)
Q Consensus       137 Fg~a~~~~~~~~-----~~~~~gt~~y~aPE~~~~------~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~  204 (344)
                      ||+++.......     ....+||+.|+|||++.+      ....+.++|||||||++|+|++ |+.||.......  ..
T Consensus       172 FG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~--~~  249 (434)
T 2rio_A          172 FGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE--SN  249 (434)
T ss_dssp             CTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH--HH
T ss_pred             cccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH--HH
Confidence            999976543321     234579999999999965      1334566999999999999999 999997654322  22


Q ss_pred             HHHHHhhccccCCCC-----CCCCHhHHHHHHHhcccCCCCCCChHHHhcCcccccC
Q 019195          205 TISRIMAVQYKIPDY-----VHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKN  256 (344)
Q Consensus       205 ~~~~~~~~~~~~~~~-----~~~s~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~~  256 (344)
                      ++    ......+..     ..+++++.+||.+||+.||.+|||+.++++||||...
T Consensus       250 i~----~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f~~~  302 (434)
T 2rio_A          250 II----RGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWPK  302 (434)
T ss_dssp             HH----HTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSCH
T ss_pred             Hh----cCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCccCCc
Confidence            22    222222221     1245789999999999999999999999999999653

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=2.1e-44  Score=323.56  Aligned_cols=230  Identities=33%  Similarity=0.582  Sum_probs=180.6

Q ss_pred             CCCceee-eeeeecCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHH-hcCCCCCcceeeEEEEc----CCEEE
Q 019195            1 MEKYELM-KDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINH-KQLRHPNIIRFKEVVLT----PTHLA   74 (344)
Q Consensus         1 ~~~y~~~-~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~l-~~l~h~niv~~~~~~~~----~~~~~   74 (344)
                      +++|.++ +.||+|+||.||+|.+..+++.||+|++..    ...+.+|+.++ +.++||||+++++++..    ...++
T Consensus        16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~   91 (299)
T 3m2w_A           16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL   91 (299)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred             ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc----cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEE
Confidence            3678888 789999999999999999999999999865    34677899888 66699999999999987    67899


Q ss_pred             EEEecCCCCChHHHHHhCC--CCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCC-CCCEEEeecCCCcccC
Q 019195           75 IVMEYAAGGELFERICNAG--RFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSP-APRLKICDFGYSKSSL  144 (344)
Q Consensus        75 lv~e~~~~g~L~~~i~~~~--~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~-~~~vkL~DFg~a~~~~  144 (344)
                      +||||+++++|.+++....  .+++.+++.++.|++.+       ||+||||||+|||++... .+.+||+|||++....
T Consensus        92 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~  171 (299)
T 3m2w_A           92 IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT  171 (299)
T ss_dssp             EEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECT
T ss_pred             EEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEeccccccccc
Confidence            9999999999999998754  69999988888777655       999999999999998632 3469999999886322


Q ss_pred             CCCCCCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCC--CCCCC
Q 019195          145 LHSRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIP--DYVHI  222 (344)
Q Consensus       145 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~  222 (344)
                                           +..+ +.++|||||||++|+|++|+.||...............+.......+  .+..+
T Consensus       172 ---------------------~~~~-~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (299)
T 3m2w_A          172 ---------------------GEKY-DKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEV  229 (299)
T ss_dssp             ---------------------TCGG-GGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSCTTCCSSCHHHHTTS
T ss_pred             ---------------------cccC-CchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhhccccCCchhcccC
Confidence                                 1222 45699999999999999999999765432211111111111122222  11467


Q ss_pred             CHhHHHHHHHhcccCCCCCCChHHHhcCcccccC
Q 019195          223 SQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKN  256 (344)
Q Consensus       223 s~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~~  256 (344)
                      ++++.+||.+||+.||.+|||+.++|+||||.+.
T Consensus       230 ~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~  263 (299)
T 3m2w_A          230 SEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS  263 (299)
T ss_dssp             CHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTG
T ss_pred             CHHHHHHHHHHcccChhhCCCHHHHhcChhhccc
Confidence            9999999999999999999999999999999654

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=7.7e-44  Score=318.51  Aligned_cols=239  Identities=22%  Similarity=0.310  Sum_probs=192.0

Q ss_pred             CCceeee-eeeecCceEEEEEE--EcCCCcEEEEEEeecCccc---cHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEE
Q 019195            2 EKYELMK-DIGSGNFGVARLMR--NKNTKELVAMKYIERGHKI---DANVAREIINHKQLRHPNIIRFKEVVLTPTHLAI   75 (344)
Q Consensus         2 ~~y~~~~-~lg~G~~g~V~~~~--~~~~~~~vaiK~~~~~~~~---~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~l   75 (344)
                      ++|++.+ .||+|+||.||++.  ...+++.||+|++......   ...+.+|+.+++.++||||+++++++ ..+.+++
T Consensus        16 ~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~l   94 (291)
T 1xbb_A           16 KLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWML   94 (291)
T ss_dssp             GGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEEE
T ss_pred             hhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcEE
Confidence            4799998 99999999999994  4667889999999764322   35788999999999999999999999 5677899


Q ss_pred             EEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCCC
Q 019195           76 VMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR  148 (344)
Q Consensus        76 v~e~~~~g~L~~~i~~~~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~~  148 (344)
                      ||||+++++|.+++...+.+++.+++.++.|++.+       ||+||||||+|||++.++.  +||+|||++........
T Consensus        95 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~  172 (291)
T 1xbb_A           95 VMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHY--AKISDFGLSKALRADEN  172 (291)
T ss_dssp             EEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTE--EEECCCTTCEECCTTCS
T ss_pred             EEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCc--EEEccCCcceeeccCCC
Confidence            99999999999999988889999988888776654       9999999999999987664  99999999875433322


Q ss_pred             ----CCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCC
Q 019195          149 ----PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHIS  223 (344)
Q Consensus       149 ----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s  223 (344)
                          .....+|+.|+|||++.+..++ .++||||||+++|+|++ |+.||.........    ..+.. ....+....++
T Consensus       173 ~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~----~~~~~-~~~~~~~~~~~  246 (291)
T 1xbb_A          173 YYKAQTHGKWPVKWYAPECINYYKFS-SKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVT----AMLEK-GERMGCPAGCP  246 (291)
T ss_dssp             EEEC----CCCGGGCCHHHHHHCEEE-HHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHH----HHHHT-TCCCCCCTTCC
T ss_pred             cccccccCCCCceeeChHHhccCCCC-hhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHH----HHHHc-CCCCCCCCCCC
Confidence                2233477899999999776654 56999999999999999 99999876543322    22221 22233334689


Q ss_pred             HhHHHHHHHhcccCCCCCCChHHHhc
Q 019195          224 QDCRNLLSRIFVANPSRRITIKEIKS  249 (344)
Q Consensus       224 ~~~~~li~~~L~~dp~~R~s~~ell~  249 (344)
                      +.+.++|.+||+.||.+|||+.++++
T Consensus       247 ~~l~~li~~~l~~dp~~Rps~~~l~~  272 (291)
T 1xbb_A          247 REMYDLMNLCWTYDVENRPGFAAVEL  272 (291)
T ss_dssp             HHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             HHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            99999999999999999999999976

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=4.1e-44  Score=318.19  Aligned_cols=238  Identities=22%  Similarity=0.370  Sum_probs=194.5

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEEecCC
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYAA   81 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~   81 (344)
                      ++|++++.||+|+||.||+|.+. ++..||+|++.........+.+|+.++++++||||+++++++. .+..++||||++
T Consensus        13 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~   90 (279)
T 1qpc_A           13 ETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYME   90 (279)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECCT
T ss_pred             HhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCcccHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEEEecCC
Confidence            57999999999999999999975 5678999999876666678999999999999999999999886 456899999999


Q ss_pred             CCChHHHHHhCC--CCCHHHHHHHHHHHHH-------CCeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCC--CCC
Q 019195           82 GGELFERICNAG--RFSEDEARYFFQQLIS-------GQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS--RPK  150 (344)
Q Consensus        82 ~g~L~~~i~~~~--~~~~~~~~~~~~ql~~-------~~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~--~~~  150 (344)
                      +++|.+++....  .+++.+++.++.|++.       .||+||||||+||+++.++.  +||+|||++.......  ...
T Consensus        91 ~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~~~~  168 (279)
T 1qpc_A           91 NGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLS--CKIADFGLARLIEDNEYTARE  168 (279)
T ss_dssp             TCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSC--EEECCCTTCEECSSSCEECCT
T ss_pred             CCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCC--EEECCCcccccccCccccccc
Confidence            999999986543  6888888887777654       49999999999999976654  9999999987543322  223


Q ss_pred             CCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCHhHHHH
Q 019195          151 STVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL  229 (344)
Q Consensus       151 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  229 (344)
                      ...+|+.|+|||++.+..+ +.++|||||||++|+|++ |+.||...........    +.. ....+....+++.+.+|
T Consensus       169 ~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~----~~~-~~~~~~~~~~~~~l~~l  242 (279)
T 1qpc_A          169 GAKFPIKWTAPEAINYGTF-TIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQN----LER-GYRMVRPDNCPEELYQL  242 (279)
T ss_dssp             TCCCCTTTSCHHHHHHCEE-CHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHH----HHT-TCCCCCCTTCCHHHHHH
T ss_pred             CCCCccCccChhhhccCCC-CchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHH----Hhc-ccCCCCcccccHHHHHH
Confidence            3457889999999977665 455999999999999999 9999987655433222    221 22333445789999999


Q ss_pred             HHHhcccCCCCCCChHHHhc
Q 019195          230 LSRIFVANPSRRITIKEIKS  249 (344)
Q Consensus       230 i~~~L~~dp~~R~s~~ell~  249 (344)
                      |.+||+.||.+|||+.++++
T Consensus       243 i~~~l~~~p~~Rps~~~l~~  262 (279)
T 1qpc_A          243 MRLCWKERPEDRPTFDYLRS  262 (279)
T ss_dssp             HHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHhccChhhCCCHHHHHH
Confidence            99999999999999999876

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=2.7e-44  Score=325.86  Aligned_cols=241  Identities=21%  Similarity=0.305  Sum_probs=195.0

Q ss_pred             CCceeeeeeeecCceEEEEEEEc-----CCCcEEEEEEeecCcc--ccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEE
Q 019195            2 EKYELMKDIGSGNFGVARLMRNK-----NTKELVAMKYIERGHK--IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLA   74 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~--~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~   74 (344)
                      ++|++.+.||+|+||.||+|.+.     .+++.||+|++.....  ....+.+|+.+++.++||||+++++++...+..+
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~  104 (322)
T 1p4o_A           25 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTL  104 (322)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCE
T ss_pred             hheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccCCccE
Confidence            57999999999999999999876     4678899999976433  2346889999999999999999999999999999


Q ss_pred             EEEecCCCCChHHHHHhC----------CCCCHHHHHHHHHHHHH-------CCeeecCCCCCCeEecCCCCCCEEEeec
Q 019195           75 IVMEYAAGGELFERICNA----------GRFSEDEARYFFQQLIS-------GQICHRDLKLENTLLDGSPAPRLKICDF  137 (344)
Q Consensus        75 lv~e~~~~g~L~~~i~~~----------~~~~~~~~~~~~~ql~~-------~~iiH~Dikp~NIl~~~~~~~~vkL~DF  137 (344)
                      +||||+++|+|.+++...          ..+++..++.++.|++.       .||+||||||+|||++.++.  +||+||
T Consensus       105 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~--~kl~Df  182 (322)
T 1p4o_A          105 VIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFT--VKIGDF  182 (322)
T ss_dssp             EEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCC--EEECCT
T ss_pred             EEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCCe--EEECcC
Confidence            999999999999998653          35678887777666554       59999999999999987654  999999


Q ss_pred             CCCcccCCCC---CCCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhhcc
Q 019195          138 GYSKSSLLHS---RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQ  213 (344)
Q Consensus       138 g~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~  213 (344)
                      |+++......   ......||+.|+|||++.+..+ +.++|||||||++|+|++ |..||..........    .+....
T Consensus       183 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~----~~~~~~  257 (322)
T 1p4o_A          183 GMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVF-TTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLR----FVMEGG  257 (322)
T ss_dssp             TCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHH----HHHTTC
T ss_pred             ccccccccccccccccCCCCCCCccChhhhccCCC-CchhhHHHHHHHHHHHHhcCCCccccCCHHHHHH----HHHcCC
Confidence            9987543322   1233457899999999987765 456999999999999999 899998765433222    222222


Q ss_pred             ccCCCCCCCCHhHHHHHHHhcccCCCCCCChHHHhcC
Q 019195          214 YKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSH  250 (344)
Q Consensus       214 ~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~ell~h  250 (344)
                       ..+....+++.+.+||.+||+.||.+|||+.++++|
T Consensus       258 -~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~  293 (322)
T 1p4o_A          258 -LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS  293 (322)
T ss_dssp             -CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             -cCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence             223334689999999999999999999999999987

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=2.6e-43  Score=315.45  Aligned_cols=242  Identities=21%  Similarity=0.208  Sum_probs=191.9

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcCCCCCcceeeEEE-EcCCEEEEEEecC
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKEVV-LTPTHLAIVMEYA   80 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~l~~l~h~niv~~~~~~-~~~~~~~lv~e~~   80 (344)
                      ++|++.+.||+|+||.||+|.+..+++.||+|++..... ...+.+|+.+++.++|++++..+..+ ......++||||+
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~   87 (296)
T 3uzp_A            9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL   87 (296)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS-CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC
T ss_pred             cEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc-hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEEec
Confidence            689999999999999999999999999999999876443 34688999999999988766655554 6678899999999


Q ss_pred             CCCChHHHHHh-CCCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEec---CCCCCCEEEeecCCCcccCCCCC-
Q 019195           81 AGGELFERICN-AGRFSEDEARYFFQQLISG-------QICHRDLKLENTLLD---GSPAPRLKICDFGYSKSSLLHSR-  148 (344)
Q Consensus        81 ~~g~L~~~i~~-~~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~---~~~~~~vkL~DFg~a~~~~~~~~-  148 (344)
                       +++|.+++.. ...+++.+++.++.|++.+       ||+||||||+|||++   .++  .+||+|||++........ 
T Consensus        88 -~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~--~~kl~Dfg~~~~~~~~~~~  164 (296)
T 3uzp_A           88 -GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGN--LVYIIDFGLAKKYRDARTH  164 (296)
T ss_dssp             -CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTT--CEEECCCTTCEECBCTTTC
T ss_pred             -CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCC--eEEEeeCCCcccccccccc
Confidence             9999999974 4579999888887776654       999999999999994   444  599999999875443322 


Q ss_pred             -------CCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC---hHHHHHHHHHHhhccccCCC
Q 019195          149 -------PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQED---PKNFRKTISRIMAVQYKIPD  218 (344)
Q Consensus       149 -------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~---~~~~~~~~~~~~~~~~~~~~  218 (344)
                             .....||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.....   ...+..+.......... ..
T Consensus       165 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~-~~  242 (296)
T 3uzp_A          165 QHIPYRENKNLTGTARYASINTHLGIEQ-SRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIE-VL  242 (296)
T ss_dssp             CBCCCCCSCCCCSCTTTCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHH-HH
T ss_pred             cccccccccccccccccCChhhhcCCCC-CcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCchH-HH
Confidence                   245679999999999988775 4569999999999999999999987432   22222222221111100 01


Q ss_pred             CCCCCHhHHHHHHHhcccCCCCCCChHHHhc
Q 019195          219 YVHISQDCRNLLSRIFVANPSRRITIKEIKS  249 (344)
Q Consensus       219 ~~~~s~~~~~li~~~L~~dp~~R~s~~ell~  249 (344)
                      ...+++++.+||.+||+.||.+|||+.++++
T Consensus       243 ~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  273 (296)
T 3uzp_A          243 CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ  273 (296)
T ss_dssp             TTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred             HhhCCHHHHHHHHHHHhcCcCcCCCHHHHHH
Confidence            1357899999999999999999999999876

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5.5e-44  Score=318.84  Aligned_cols=242  Identities=25%  Similarity=0.375  Sum_probs=194.7

Q ss_pred             CCceeee-eeeecCceEEEEEEEc--CCCcEEEEEEeecCcc--ccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEE
Q 019195            2 EKYELMK-DIGSGNFGVARLMRNK--NTKELVAMKYIERGHK--IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIV   76 (344)
Q Consensus         2 ~~y~~~~-~lg~G~~g~V~~~~~~--~~~~~vaiK~~~~~~~--~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv   76 (344)
                      ++|.+.+ .||+|+||.||+|.+.  .++..||+|++.....  ....+.+|+.++++++||||+++++++ ..+.+++|
T Consensus         9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv   87 (287)
T 1u59_A            9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLV   87 (287)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEE
T ss_pred             HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEE
Confidence            4688887 9999999999999854  5688899999976432  345688999999999999999999999 45678999


Q ss_pred             EecCCCCChHHHHHhC-CCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCC-
Q 019195           77 MEYAAGGELFERICNA-GRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS-  147 (344)
Q Consensus        77 ~e~~~~g~L~~~i~~~-~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~-  147 (344)
                      |||+++++|.+++... ..+++..++.++.|++.+       ||+||||||+||+++.++.  +||+|||++....... 
T Consensus        88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~--~kl~Dfg~~~~~~~~~~  165 (287)
T 1u59_A           88 MEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHY--AKISDFGLSKALGADDS  165 (287)
T ss_dssp             EECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTE--EEECCCTTCEECTTCSC
T ss_pred             EEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCC--EEECcccceeeeccCcc
Confidence            9999999999998654 568999888887776654       9999999999999987654  9999999987543222 


Q ss_pred             ---CCCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCC
Q 019195          148 ---RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHIS  223 (344)
Q Consensus       148 ---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s  223 (344)
                         ......||+.|+|||++.+..++ .++|||||||++|+|++ |+.||...........    +.. ....+....++
T Consensus       166 ~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~----i~~-~~~~~~~~~~~  239 (287)
T 1u59_A          166 YYTARSAGKWPLKWYAPECINFRKFS-SRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAF----IEQ-GKRMECPPECP  239 (287)
T ss_dssp             EECCCCSSCCCGGGCCHHHHHHCEEC-HHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHH----HHT-TCCCCCCTTCC
T ss_pred             eeeccccccccccccCHHHhccCCCC-chhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHH----Hhc-CCcCCCCCCcC
Confidence               12334578999999999776654 56999999999999998 9999988765433322    222 12223334789


Q ss_pred             HhHHHHHHHhcccCCCCCCChHHHhcCcc
Q 019195          224 QDCRNLLSRIFVANPSRRITIKEIKSHPW  252 (344)
Q Consensus       224 ~~~~~li~~~L~~dp~~R~s~~ell~hp~  252 (344)
                      +.+.+||.+||+.||.+|||+.+++++.+
T Consensus       240 ~~l~~li~~~l~~~p~~Rps~~~l~~~l~  268 (287)
T 1u59_A          240 PELYALMSDCWIYKWEDRPDFLTVEQRMR  268 (287)
T ss_dssp             HHHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred             HHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence            99999999999999999999999998733

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1e-43  Score=323.89  Aligned_cols=241  Identities=24%  Similarity=0.352  Sum_probs=190.2

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCC----cEEEEEEeecCcc--ccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEE
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTK----ELVAMKYIERGHK--IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAI   75 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~----~~vaiK~~~~~~~--~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~l   75 (344)
                      ++|++.+.||+|+||.||+|.+..++    ..||+|++.....  ....+.+|+.++++++||||+++++++...+.+++
T Consensus        44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  123 (333)
T 1mqb_A           44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI  123 (333)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEE
Confidence            57999999999999999999887553    4699999876432  23468899999999999999999999999999999


Q ss_pred             EEecCCCCChHHHHHhC-CCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCC
Q 019195           76 VMEYAAGGELFERICNA-GRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS  147 (344)
Q Consensus        76 v~e~~~~g~L~~~i~~~-~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~  147 (344)
                      ||||+++++|.+++... +.+++.+++.++.|++.+       ||+||||||+|||++.++  .+||+|||+++......
T Consensus       124 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~--~~kl~Dfg~~~~~~~~~  201 (333)
T 1mqb_A          124 ITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNL--VCKVSDFGLSRVLEDDP  201 (333)
T ss_dssp             EEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTC--CEEECCCCC--------
T ss_pred             EEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCC--cEEECCCCcchhhcccc
Confidence            99999999999999764 578999888887776654       999999999999998665  49999999987643322


Q ss_pred             C----CCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhhccccCCCCCCC
Q 019195          148 R----PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHI  222 (344)
Q Consensus       148 ~----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  222 (344)
                      .    .....+|+.|+|||++.+..++ .++|||||||++|+|++ |+.||.........    ..+. .....+....+
T Consensus       202 ~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~ellt~g~~pf~~~~~~~~~----~~~~-~~~~~~~~~~~  275 (333)
T 1mqb_A          202 EATYTTSGGKIPIRWTAPEAISYRKFT-SASDVWSFGIVMWEVMTYGERPYWELSNHEVM----KAIN-DGFRLPTPMDC  275 (333)
T ss_dssp             ---------CCCGGGSCHHHHHSCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH----HHHH-TTCCCCCCTTC
T ss_pred             ccccccCCCCccccccCchhcccCCCC-chhhhHHHHHHHHHHHcCCCCCcccCCHHHHH----HHHH-CCCcCCCcccC
Confidence            1    1223468899999999877664 56999999999999998 99999876543322    2222 22344445578


Q ss_pred             CHhHHHHHHHhcccCCCCCCChHHHhcC
Q 019195          223 SQDCRNLLSRIFVANPSRRITIKEIKSH  250 (344)
Q Consensus       223 s~~~~~li~~~L~~dp~~R~s~~ell~h  250 (344)
                      ++.+.+||.+||+.||.+||++.+++++
T Consensus       276 ~~~l~~li~~~l~~~p~~Rps~~~l~~~  303 (333)
T 1mqb_A          276 PSAIYQLMMQCWQQERARRPKFADIVSI  303 (333)
T ss_dssp             BHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             CHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            9999999999999999999999999875

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=1.1e-43  Score=317.70  Aligned_cols=239  Identities=21%  Similarity=0.223  Sum_probs=188.7

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcCCCCCcceeeEEE-EcCCEEEEEEecC
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKEVV-LTPTHLAIVMEYA   80 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~l~~l~h~niv~~~~~~-~~~~~~~lv~e~~   80 (344)
                      ++|++.+.||+|+||.||+|.+..+++.||+|++..... ...+.+|+.+++.++|++++..+..+ ...+..++||||+
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~   87 (296)
T 4hgt_A            9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL   87 (296)
T ss_dssp             --CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC
T ss_pred             CceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc-chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEEcc
Confidence            589999999999999999999999999999998765433 34588999999999887766666555 6678899999999


Q ss_pred             CCCChHHHHHh-CCCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEe---cCCCCCCEEEeecCCCcccCCCC--
Q 019195           81 AGGELFERICN-AGRFSEDEARYFFQQLISG-------QICHRDLKLENTLL---DGSPAPRLKICDFGYSKSSLLHS--  147 (344)
Q Consensus        81 ~~g~L~~~i~~-~~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~---~~~~~~~vkL~DFg~a~~~~~~~--  147 (344)
                       +++|.+++.. ...+++.+++.++.|++.+       ||+||||||+|||+   +.++  .+||+|||+++......  
T Consensus        88 -~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~--~~kL~Dfg~a~~~~~~~~~  164 (296)
T 4hgt_A           88 -GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGN--LVYIIDFGLAKKYRDARTH  164 (296)
T ss_dssp             -CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTT--CEEECCCTTCEECBCTTTC
T ss_pred             -CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCC--eEEEecCccceeccCcccC
Confidence             9999999975 4579999988888776654       99999999999999   4444  49999999997543322  


Q ss_pred             ------CCCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCh---HHHHHHHHHHhhccccCC-
Q 019195          148 ------RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDP---KNFRKTISRIMAVQYKIP-  217 (344)
Q Consensus       148 ------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~---~~~~~~~~~~~~~~~~~~-  217 (344)
                            ......||+.|+|||++.+..+ +.++|||||||++|+|++|+.||......   ..+..+...    ....+ 
T Consensus       165 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~----~~~~~~  239 (296)
T 4hgt_A          165 QHIPYRENKNLTGTARYASINTHLGIEQ-SRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEK----KMSTPI  239 (296)
T ss_dssp             CBCCCCCSCCCCSCGGGCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHH----HHHSCH
T ss_pred             ccCCCCcccccCCCccccchHHhcCCCC-CchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcc----cccchh
Confidence                  2235579999999999988775 45699999999999999999999875432   222222222    11122 


Q ss_pred             --CCCCCCHhHHHHHHHhcccCCCCCCChHHHhc
Q 019195          218 --DYVHISQDCRNLLSRIFVANPSRRITIKEIKS  249 (344)
Q Consensus       218 --~~~~~s~~~~~li~~~L~~dp~~R~s~~ell~  249 (344)
                        ....+++++.+||.+||+.||.+|||+.++++
T Consensus       240 ~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~  273 (296)
T 4hgt_A          240 EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ  273 (296)
T ss_dssp             HHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred             hhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHH
Confidence              11357899999999999999999999999976

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=5.5e-44  Score=325.36  Aligned_cols=238  Identities=26%  Similarity=0.432  Sum_probs=175.0

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCcc-ccHHHHHHHHHHhcCC-CCCcceeeEEEE--------cCC
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK-IDANVAREIINHKQLR-HPNIIRFKEVVL--------TPT   71 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~ei~~l~~l~-h~niv~~~~~~~--------~~~   71 (344)
                      .+|++.+.||+|+||.||+|.+..+++.||+|++..... ....+.+|+.+++++. ||||+++++++.        ...
T Consensus        28 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~  107 (337)
T 3ll6_A           28 LRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQA  107 (337)
T ss_dssp             EEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSE
T ss_pred             ceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCCc
Confidence            379999999999999999999999999999998865432 3456889999999996 999999999994        345


Q ss_pred             EEEEEEecCCCCChHHHHHh---CCCCCHHHHHHHHHHHHHC-------C--eeecCCCCCCeEecCCCCCCEEEeecCC
Q 019195           72 HLAIVMEYAAGGELFERICN---AGRFSEDEARYFFQQLISG-------Q--ICHRDLKLENTLLDGSPAPRLKICDFGY  139 (344)
Q Consensus        72 ~~~lv~e~~~~g~L~~~i~~---~~~~~~~~~~~~~~ql~~~-------~--iiH~Dikp~NIl~~~~~~~~vkL~DFg~  139 (344)
                      .++++|||+. |+|.+++..   .+.+++.+++.++.||+.+       |  |+||||||+|||++.++.  +||+|||+
T Consensus       108 ~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~--~kl~Dfg~  184 (337)
T 3ll6_A          108 EFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGT--IKLCDFGS  184 (337)
T ss_dssp             EEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSC--EEBCCCTT
T ss_pred             eEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCC--EEEecCcc
Confidence            6899999995 799888764   5679999999888887765       7  999999999999987654  99999999


Q ss_pred             CcccCCCCC-------------CCCCccCCcccCCcccc--CCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHH
Q 019195          140 SKSSLLHSR-------------PKSTVGTPAYIAPEVLS--RREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRK  204 (344)
Q Consensus       140 a~~~~~~~~-------------~~~~~gt~~y~aPE~~~--~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~  204 (344)
                      ++.......             ....+||+.|+|||++.  .....+.++|||||||++|+|++|+.||.......    
T Consensus       185 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~----  260 (337)
T 3ll6_A          185 ATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLR----  260 (337)
T ss_dssp             CBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-----------
T ss_pred             ceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHH----
Confidence            976443222             11456999999999983  22233566999999999999999999997644321    


Q ss_pred             HHHHHhhccccCCCCCCCCHhHHHHHHHhcccCCCCCCChHHHhcC
Q 019195          205 TISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSH  250 (344)
Q Consensus       205 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~ell~h  250 (344)
                          +.......+.....++.+.+||.+||+.||.+|||+.++++|
T Consensus       261 ----~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~  302 (337)
T 3ll6_A          261 ----IVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQ  302 (337)
T ss_dssp             ---------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred             ----hhcCcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHH
Confidence                122233444455678899999999999999999999999987

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=1.1e-43  Score=320.79  Aligned_cols=241  Identities=21%  Similarity=0.323  Sum_probs=186.2

Q ss_pred             CCceeeeeeeecCceEEEEEEEcC---CCcEEEEEEeecCccc---cHHHHHHHHHHhcCCCCCcceeeEEEEcCC----
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKN---TKELVAMKYIERGHKI---DANVAREIINHKQLRHPNIIRFKEVVLTPT----   71 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~~---~~~~~~ei~~l~~l~h~niv~~~~~~~~~~----   71 (344)
                      ++|++.+.||+|+||.||+|.+..   ++..||+|++......   ...+.+|+.++++++||||+++++++....    
T Consensus        34 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~  113 (313)
T 3brb_A           34 NLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGI  113 (313)
T ss_dssp             GGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC------
T ss_pred             HHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccccCC
Confidence            579999999999999999998765   5668999998764332   256889999999999999999999998764    


Q ss_pred             -EEEEEEecCCCCChHHHHHh------CCCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeec
Q 019195           72 -HLAIVMEYAAGGELFERICN------AGRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDF  137 (344)
Q Consensus        72 -~~~lv~e~~~~g~L~~~i~~------~~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DF  137 (344)
                       ..++||||+++++|.+++..      ...+++..++.++.|++.+       ||+||||||+|||++.++.  +||+||
T Consensus       114 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~--~kl~Df  191 (313)
T 3brb_A          114 PKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMT--VCVADF  191 (313)
T ss_dssp             -CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTSC--EEECSC
T ss_pred             cccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCc--EEEeec
Confidence             35999999999999999843      3568999888888777655       9999999999999987654  999999


Q ss_pred             CCCcccCCCC---CCCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhhcc
Q 019195          138 GYSKSSLLHS---RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQ  213 (344)
Q Consensus       138 g~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~  213 (344)
                      |++.......   ......+++.|+|||.+.+..++ .++|||||||++|+|++ |..||...........+..     .
T Consensus       192 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~-----~  265 (313)
T 3brb_A          192 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYT-SKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLH-----G  265 (313)
T ss_dssp             SCC----------------CCGGGSCHHHHHSSCCC-HHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHT-----T
T ss_pred             CcceecccccccCcccccCCCccccCchhhcCCCcc-chhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHc-----C
Confidence            9987543322   22334578899999999877664 56999999999999999 9999988766544333221     1


Q ss_pred             ccCCCCCCCCHhHHHHHHHhcccCCCCCCChHHHhcC
Q 019195          214 YKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSH  250 (344)
Q Consensus       214 ~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~ell~h  250 (344)
                      ...+....+++.+.+||.+||+.||.+|||+.+++++
T Consensus       266 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~  302 (313)
T 3brb_A          266 HRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQ  302 (313)
T ss_dssp             CCCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             CCCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            2233345688999999999999999999999999875

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=9.1e-44  Score=316.38  Aligned_cols=240  Identities=23%  Similarity=0.279  Sum_probs=191.2

Q ss_pred             CCceeeeeeeecCceEEEEEEEcC---CCcEEEEEEeecCcc--ccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEE
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKN---TKELVAMKYIERGHK--IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIV   76 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~--~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv   76 (344)
                      ++|++.+.||+|+||.||+|.+..   ++..||+|++.....  ....+.+|+.+++.++||||+++++++.. +..|+|
T Consensus        12 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v   90 (281)
T 3cc6_A           12 EDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTWII   90 (281)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCEEE
T ss_pred             cceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCEEE
Confidence            589999999999999999998653   345799999876532  34678899999999999999999999865 456899


Q ss_pred             EecCCCCChHHHHHhC-CCCCHHHHHHHHHHHHH-------CCeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCC-
Q 019195           77 MEYAAGGELFERICNA-GRFSEDEARYFFQQLIS-------GQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS-  147 (344)
Q Consensus        77 ~e~~~~g~L~~~i~~~-~~~~~~~~~~~~~ql~~-------~~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~-  147 (344)
                      |||+++++|.+++... ..+++..++.++.|++.       .||+||||||+|||++.++.  +||+|||++....... 
T Consensus        91 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~  168 (281)
T 3cc6_A           91 MELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPEC--VKLGDFGLSRYIEDEDY  168 (281)
T ss_dssp             EECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTE--EEECCCCGGGCC-----
T ss_pred             EecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCc--EEeCccCCCcccccccc
Confidence            9999999999999764 45888888877766654       49999999999999987664  9999999987543322 


Q ss_pred             -CCCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCHh
Q 019195          148 -RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQD  225 (344)
Q Consensus       148 -~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~  225 (344)
                       ......+|+.|+|||++.+..+ +.++|||||||++|+|++ |+.||...........+.     .....+....+++.
T Consensus       169 ~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~  242 (281)
T 3cc6_A          169 YKASVTRLPIKWMSPESINFRRF-TTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLE-----KGDRLPKPDLCPPV  242 (281)
T ss_dssp             ----CCCCCGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHH-----HTCCCCCCTTCCHH
T ss_pred             cccccCCCCcceeCchhhccCCC-CchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHh-----cCCCCCCCCCCCHH
Confidence             1234457889999999977665 456999999999999998 999998766544332221     12233444568999


Q ss_pred             HHHHHHHhcccCCCCCCChHHHhcC
Q 019195          226 CRNLLSRIFVANPSRRITIKEIKSH  250 (344)
Q Consensus       226 ~~~li~~~L~~dp~~R~s~~ell~h  250 (344)
                      +.+||.+||+.||.+|||+.+++++
T Consensus       243 l~~li~~~l~~~p~~Rps~~ell~~  267 (281)
T 3cc6_A          243 LYTLMTRCWDYDPSDRPRFTELVCS  267 (281)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHccCCchhCcCHHHHHHH
Confidence            9999999999999999999999875

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=9.3e-44  Score=322.13  Aligned_cols=243  Identities=26%  Similarity=0.386  Sum_probs=192.1

Q ss_pred             Cc-eeeeeeeecCceEEEEEE----EcCCCcEEEEEEeecCcc--ccHHHHHHHHHHhcCCCCCcceeeEEEEc--CCEE
Q 019195            3 KY-ELMKDIGSGNFGVARLMR----NKNTKELVAMKYIERGHK--IDANVAREIINHKQLRHPNIIRFKEVVLT--PTHL   73 (344)
Q Consensus         3 ~y-~~~~~lg~G~~g~V~~~~----~~~~~~~vaiK~~~~~~~--~~~~~~~ei~~l~~l~h~niv~~~~~~~~--~~~~   73 (344)
                      +| ++++.||+|+||.||++.    +..+++.||+|++.....  ....+.+|+.++++++||||+++++++..  ...+
T Consensus        31 r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  110 (318)
T 3lxp_A           31 RYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASL  110 (318)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEE
T ss_pred             HHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceE
Confidence            55 999999999999997775    446889999999976532  23568899999999999999999999987  4689


Q ss_pred             EEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCC
Q 019195           74 AIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH  146 (344)
Q Consensus        74 ~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~  146 (344)
                      ++||||+++++|.+++... .+++.+++.++.||+.+       ||+||||||+|||++.++.  +||+|||++......
T Consensus       111 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~--~kl~Dfg~a~~~~~~  187 (318)
T 3lxp_A          111 QLVMEYVPLGSLRDYLPRH-SIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRL--VKIGDFGLAKAVPEG  187 (318)
T ss_dssp             EEEECCCTTCBHHHHGGGS-CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC--EEECCGGGCEECCTT
T ss_pred             EEEEecccCCcHHHHHhhC-CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCC--EEECCcccccccccc
Confidence            9999999999999998664 48999888887776654       9999999999999977654  999999999765433


Q ss_pred             C----CCCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCh----------HHHHHHHHHHhhc
Q 019195          147 S----RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDP----------KNFRKTISRIMAV  212 (344)
Q Consensus       147 ~----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~----------~~~~~~~~~~~~~  212 (344)
                      .    ......||+.|+|||++.+..++ .++|||||||++|+|++|..||......          ......+......
T Consensus       188 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  266 (318)
T 3lxp_A          188 HEYYRVREDGDSPVFWYAPECLKEYKFY-YASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLER  266 (318)
T ss_dssp             CSEEEC---CCCCGGGCCHHHHHHCEEE-HHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHHT
T ss_pred             ccccccccCCCCCceeeChHHhcCCCCC-cHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHHhc
Confidence            2    12345688999999999877764 5599999999999999999999753211          0111112222333


Q ss_pred             cccCCCCCCCCHhHHHHHHHhcccCCCCCCChHHHhc
Q 019195          213 QYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKS  249 (344)
Q Consensus       213 ~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~ell~  249 (344)
                      ....+....+++++.+||.+||+.||.+|||+.++++
T Consensus       267 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~  303 (318)
T 3lxp_A          267 GERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIP  303 (318)
T ss_dssp             TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence            3445555678999999999999999999999999985

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=7e-44  Score=338.02  Aligned_cols=238  Identities=22%  Similarity=0.332  Sum_probs=191.3

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEEecCC
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYAA   81 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~   81 (344)
                      ++|++.+.||+|+||.||++.+.. +..||||++.........+.+|+.++++++||||+++++++.. +.+|+||||++
T Consensus       184 ~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~~  261 (452)
T 1fmk_A          184 ESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMS  261 (452)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCT
T ss_pred             hHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehhhc
Confidence            479999999999999999999875 4579999998766556789999999999999999999999865 67899999999


Q ss_pred             CCChHHHHHh--CCCCCHHHHHHHHHHHHH-------CCeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCC--CCC
Q 019195           82 GGELFERICN--AGRFSEDEARYFFQQLIS-------GQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS--RPK  150 (344)
Q Consensus        82 ~g~L~~~i~~--~~~~~~~~~~~~~~ql~~-------~~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~--~~~  150 (344)
                      +|+|.+++..  ...+++.+++.++.|++.       .||+||||||+|||++.++.  +||+|||+++......  ...
T Consensus       262 ~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~--~kl~DfG~a~~~~~~~~~~~~  339 (452)
T 1fmk_A          262 KGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLV--CKVADFGLARLIEDNEYTARQ  339 (452)
T ss_dssp             TCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC--EEECCCCTTC-----------
T ss_pred             CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCC--EEECCCccceecCCCceeccc
Confidence            9999999964  356888888887777665       49999999999999976654  9999999997643322  122


Q ss_pred             CCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCHhHHHH
Q 019195          151 STVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL  229 (344)
Q Consensus       151 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  229 (344)
                      ...+|+.|+|||++.+..+ +.++|||||||++|+|++ |+.||.+........    .+ ....+.+....+++.+.+|
T Consensus       340 ~~~~~~~y~aPE~~~~~~~-~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~----~i-~~~~~~~~~~~~~~~l~~l  413 (452)
T 1fmk_A          340 GAKFPIKWTAPEAALYGRF-TIKSDVWSFGILLTELTTKGRVPYPGMVNREVLD----QV-ERGYRMPCPPECPESLHDL  413 (452)
T ss_dssp             ---CCGGGSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHH----HH-HTTCCCCCCTTSCHHHHHH
T ss_pred             CCcccccccCHhHHhcCCC-CccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHH----HH-HcCCCCCCCCCCCHHHHHH
Confidence            3457889999999987766 456999999999999999 999998765433322    22 2233445555789999999


Q ss_pred             HHHhcccCCCCCCChHHHhc
Q 019195          230 LSRIFVANPSRRITIKEIKS  249 (344)
Q Consensus       230 i~~~L~~dp~~R~s~~ell~  249 (344)
                      |.+||+.||.+|||+.++++
T Consensus       414 i~~cl~~dP~~Rpt~~~l~~  433 (452)
T 1fmk_A          414 MCQCWRKEPEERPTFEYLQA  433 (452)
T ss_dssp             HHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHccCChhhCcCHHHHHH
Confidence            99999999999999999876

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=6.8e-44  Score=316.69  Aligned_cols=236  Identities=24%  Similarity=0.388  Sum_probs=185.4

Q ss_pred             CCCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcCCCCCcceeeEEEEcC-CEEEEEEec
Q 019195            1 MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKEVVLTP-THLAIVMEY   79 (344)
Q Consensus         1 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~-~~~~lv~e~   79 (344)
                      +++|++.+.||+|+||.||++.+.  ++.||+|++.... ....+.+|+.++++++||||+++++++... +.+++||||
T Consensus        20 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~-~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~   96 (278)
T 1byg_A           20 MKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY   96 (278)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCCC---HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred             hhhceEEeEEecCCCceEEEEEEc--CCEEEEEEecchh-HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEec
Confidence            368999999999999999999874  7899999987643 456789999999999999999999997654 478999999


Q ss_pred             CCCCChHHHHHhCCC--CCHHHHHHHHHHHHH-------CCeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCCCCC
Q 019195           80 AAGGELFERICNAGR--FSEDEARYFFQQLIS-------GQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPK  150 (344)
Q Consensus        80 ~~~g~L~~~i~~~~~--~~~~~~~~~~~ql~~-------~~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~~~~  150 (344)
                      +++++|.+++.+.+.  +++..++.++.|++.       .||+||||||+||+++.++  ++||+|||++......  ..
T Consensus        97 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~--~~~l~Dfg~~~~~~~~--~~  172 (278)
T 1byg_A           97 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDN--VAKVSDFGLTKEASST--QD  172 (278)
T ss_dssp             CTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTS--CEEECCCCC-----------
T ss_pred             CCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCC--cEEEeecccccccccc--cc
Confidence            999999999976543  788877777666554       4999999999999997665  4999999998743322  23


Q ss_pred             CCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCHhHHHH
Q 019195          151 STVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL  229 (344)
Q Consensus       151 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  229 (344)
                      ...+++.|+|||++.+..+ +.++||||||+++|+|++ |+.||...........    +. .....+....+++.+.++
T Consensus       173 ~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~----~~-~~~~~~~~~~~~~~l~~l  246 (278)
T 1byg_A          173 TGKLPVKWTAPEALREKKF-STKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPR----VE-KGYKMDAPDGCPPAVYEV  246 (278)
T ss_dssp             ---CCTTTSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHH----HT-TTCCCCCCTTCCHHHHHH
T ss_pred             CCCccccccCHHHhCCCCC-CchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH----Hh-cCCCCCCcccCCHHHHHH
Confidence            4468899999999977665 456999999999999998 9999987665433222    21 122333445789999999


Q ss_pred             HHHhcccCCCCCCChHHHhc
Q 019195          230 LSRIFVANPSRRITIKEIKS  249 (344)
Q Consensus       230 i~~~L~~dp~~R~s~~ell~  249 (344)
                      |.+||+.||.+|||+.++++
T Consensus       247 i~~~l~~~p~~Rps~~~l~~  266 (278)
T 1byg_A          247 MKNCWHLDAAMRPSFLQLRE  266 (278)
T ss_dssp             HHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHhcCChhhCCCHHHHHH
Confidence            99999999999999999976

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.2e-43  Score=314.39  Aligned_cols=241  Identities=23%  Similarity=0.351  Sum_probs=189.9

Q ss_pred             CceeeeeeeecCceEEEEEEEcCCCc---EEEEEEeecCcc--ccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEE-EEE
Q 019195            3 KYELMKDIGSGNFGVARLMRNKNTKE---LVAMKYIERGHK--IDANVAREIINHKQLRHPNIIRFKEVVLTPTHL-AIV   76 (344)
Q Consensus         3 ~y~~~~~lg~G~~g~V~~~~~~~~~~---~vaiK~~~~~~~--~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~-~lv   76 (344)
                      +|++.+.||+|+||+||+|.+..++.   .||+|++.....  ....+.+|+.+++.++||||+++++++...+.. +++
T Consensus        22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v  101 (298)
T 3pls_A           22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL  101 (298)
T ss_dssp             EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred             EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence            46777999999999999999765544   799999876433  235688999999999999999999999876655 999


Q ss_pred             EecCCCCChHHHHHh-CCCCCHHHHHHHHHHHHH-------CCeeecCCCCCCeEecCCCCCCEEEeecCCCcccCC---
Q 019195           77 MEYAAGGELFERICN-AGRFSEDEARYFFQQLIS-------GQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLL---  145 (344)
Q Consensus        77 ~e~~~~g~L~~~i~~-~~~~~~~~~~~~~~ql~~-------~~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~---  145 (344)
                      |||+.+++|.+++.. ...+++.+++.++.|++.       .||+||||||+|||++.++.  +||+|||+++....   
T Consensus       102 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~--~kl~Dfg~~~~~~~~~~  179 (298)
T 3pls_A          102 LPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFT--VKVADFGLARDILDREY  179 (298)
T ss_dssp             ECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCC--EEECCTTSSCTTTTGGG
T ss_pred             EecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCc--EEeCcCCCcccccCCcc
Confidence            999999999999976 456888888877766655       49999999999999976654  99999999975322   


Q ss_pred             --CCCCCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCC
Q 019195          146 --HSRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHIS  223 (344)
Q Consensus       146 --~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s  223 (344)
                        ........+|+.|+|||.+.+..++ .++|||||||++|+|++|..||............+..    ....+....++
T Consensus       180 ~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~  254 (298)
T 3pls_A          180 YSVQQHRHARLPVKWTALESLQTYRFT-TKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQ----GRRLPQPEYCP  254 (298)
T ss_dssp             GCSCCSSCTTCGGGGSCHHHHTTCCCC-HHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHT----TCCCCCCTTCC
T ss_pred             cccccCcCCCCCccccChhhhccCCCC-hhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhc----CCCCCCCccch
Confidence              1223445689999999999877764 5699999999999999955554444433333332222    22334445689


Q ss_pred             HhHHHHHHHhcccCCCCCCChHHHhcC
Q 019195          224 QDCRNLLSRIFVANPSRRITIKEIKSH  250 (344)
Q Consensus       224 ~~~~~li~~~L~~dp~~R~s~~ell~h  250 (344)
                      +.+.+||.+||+.||.+|||+.++++.
T Consensus       255 ~~l~~li~~~l~~~p~~Rps~~~ll~~  281 (298)
T 3pls_A          255 DSLYQVMQQCWEADPAVRPTFRVLVGE  281 (298)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            999999999999999999999999763

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=1.7e-43  Score=318.85  Aligned_cols=237  Identities=29%  Similarity=0.470  Sum_probs=183.1

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEEecCC
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYAA   81 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~   81 (344)
                      ++|++.+.||+|+||.||++.+.  ++.||+|++... .....+.+|+.++++++||||+++++++.+  ..++||||++
T Consensus         8 ~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~~~   82 (307)
T 2eva_A            8 KEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIESE-SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYAE   82 (307)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEET--TEEEEEEECSST-THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEECCT
T ss_pred             hHeeeeeEeecCCCceEEEEEEC--CeeEEEEEecCh-hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEcCC
Confidence            68999999999999999999874  678999998653 334678899999999999999999998863  4789999999


Q ss_pred             CCChHHHHHhCC---CCCHHHHHHHHHH-------HHH---CCeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCCC
Q 019195           82 GGELFERICNAG---RFSEDEARYFFQQ-------LIS---GQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR  148 (344)
Q Consensus        82 ~g~L~~~i~~~~---~~~~~~~~~~~~q-------l~~---~~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~~  148 (344)
                      +++|.+++....   .++...++.++.|       ||+   .||+||||||+|||++.++. .+||+|||++.....  .
T Consensus        83 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~-~~kl~Dfg~~~~~~~--~  159 (307)
T 2eva_A           83 GGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGT-VLKICDFGTACDIQT--H  159 (307)
T ss_dssp             TCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTT-EEEECCCCC---------
T ss_pred             CCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCC-EEEEccccccccccc--c
Confidence            999999998765   3677776666555       445   58999999999999976543 379999999874332  2


Q ss_pred             CCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCHhHHH
Q 019195          149 PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRN  228 (344)
Q Consensus       149 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~  228 (344)
                      .....||+.|+|||++.+..++ .++|||||||++|+|++|+.||........  ....... .....+....+++.+.+
T Consensus       160 ~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~g~~p~~~~~~~~~--~~~~~~~-~~~~~~~~~~~~~~l~~  235 (307)
T 2eva_A          160 MTNNKGSAAWMAPEVFEGSNYS-EKCDVFSWGIILWEVITRRKPFDEIGGPAF--RIMWAVH-NGTRPPLIKNLPKPIES  235 (307)
T ss_dssp             -----CCTTSSCHHHHTCCCCC-THHHHHHHHHHHHHHHHTCCTTTTTCSSHH--HHHHHHH-TTCCCCCBTTCCHHHHH
T ss_pred             cccCCCCCceEChhhhCCCCCC-cHHHHHHHHHHHHHHHHCCCCchhhCccHH--HHHHHHh-cCCCCCcccccCHHHHH
Confidence            2345699999999999877764 559999999999999999999986544321  1111111 12233344578999999


Q ss_pred             HHHHhcccCCCCCCChHHHhcC
Q 019195          229 LLSRIFVANPSRRITIKEIKSH  250 (344)
Q Consensus       229 li~~~L~~dp~~R~s~~ell~h  250 (344)
                      ||.+||+.||.+|||+.+++++
T Consensus       236 li~~~l~~dp~~Rps~~ell~~  257 (307)
T 2eva_A          236 LMTRCWSKDPSQRPSMEEIVKI  257 (307)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHhcCChhhCcCHHHHHHH
Confidence            9999999999999999999874

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=6.1e-44  Score=324.20  Aligned_cols=247  Identities=21%  Similarity=0.252  Sum_probs=190.1

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCcc--ccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEEec
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK--IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEY   79 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~   79 (344)
                      ++|++.+.||+|+||.||+|.+. +++.||+|++.....  ....+.+|+.+++.++||||+++++++...+..++||||
T Consensus        30 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  108 (326)
T 3uim_A           30 DNFSNKNILGRGGFGKVYKGRLA-DGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPY  108 (326)
T ss_dssp             TSSCSTTEEECCSSSEEEEECCS-SSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEECCSSCCEEEEEC
T ss_pred             hccccceeEecCCCcEEEEEEec-CCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEEecCCceEEEEEe
Confidence            68999999999999999999854 688999999876432  234689999999999999999999999999999999999


Q ss_pred             CCCCChHHHHHhCC----CCCHHHHHHHHHH-------HHHC---CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCC
Q 019195           80 AAGGELFERICNAG----RFSEDEARYFFQQ-------LISG---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLL  145 (344)
Q Consensus        80 ~~~g~L~~~i~~~~----~~~~~~~~~~~~q-------l~~~---~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~  145 (344)
                      +++|+|.+++....    .+++..++.++.|       ||+.   ||+||||||+|||++.++.  +||+|||++.....
T Consensus       109 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~  186 (326)
T 3uim_A          109 MANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFE--AVVGDFGLAKLMDY  186 (326)
T ss_dssp             CTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCC--EEECCCSSCEECCS
T ss_pred             ccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCC--EEeccCccccccCc
Confidence            99999999997653    3888877777655       4556   9999999999999987654  99999999975432


Q ss_pred             CCC--CCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCC----CCChHHHHHHHHHHhhccc-----
Q 019195          146 HSR--PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFED----QEDPKNFRKTISRIMAVQY-----  214 (344)
Q Consensus       146 ~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~----~~~~~~~~~~~~~~~~~~~-----  214 (344)
                      ...  .....||+.|+|||++.+..+ +.++|||||||++|+|++|+.||..    ..........+........     
T Consensus       187 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  265 (326)
T 3uim_A          187 KDTHVTTAVRGTIGHIAPEYLSTGKS-SEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEALV  265 (326)
T ss_dssp             SSSCEECCCCSCGGGCCHHHHHHSEE-CHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTSSCCSTTSS
T ss_pred             ccccccccccCCcCccCHHHhccCCC-CccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhhchhhhhhc
Confidence            222  234469999999999977776 4569999999999999999999952    1111111222211111000     


Q ss_pred             ----cCCCCCCCCHhHHHHHHHhcccCCCCCCChHHHhcCcc
Q 019195          215 ----KIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPW  252 (344)
Q Consensus       215 ----~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~ell~hp~  252 (344)
                          ........++.+.+|+.+||+.||.+|||+.++++|..
T Consensus       266 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~  307 (326)
T 3uim_A          266 DVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE  307 (326)
T ss_dssp             CTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHH
T ss_pred             ChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhc
Confidence                00011122467999999999999999999999999844

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=3.5e-43  Score=319.39  Aligned_cols=245  Identities=23%  Similarity=0.384  Sum_probs=193.8

Q ss_pred             CCceeeeeeeecCceEEEEEE----EcCCCcEEEEEEeecCcc-ccHHHHHHHHHHhcCCCCCcceeeEEEEcCC--EEE
Q 019195            2 EKYELMKDIGSGNFGVARLMR----NKNTKELVAMKYIERGHK-IDANVAREIINHKQLRHPNIIRFKEVVLTPT--HLA   74 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~----~~~~~~~vaiK~~~~~~~-~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~--~~~   74 (344)
                      ++|++++.||+|+||.||+|.    +..+++.||+|++..... ....+.+|+.++++++||||+++++++...+  .++
T Consensus        41 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  120 (326)
T 2w1i_A           41 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK  120 (326)
T ss_dssp             GGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CCE
T ss_pred             HHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCceE
Confidence            469999999999999999998    467899999999876432 2357889999999999999999999987654  789


Q ss_pred             EEEecCCCCChHHHHHhC-CCCCHHHHHHHHHHHHH-------CCeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCC
Q 019195           75 IVMEYAAGGELFERICNA-GRFSEDEARYFFQQLIS-------GQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH  146 (344)
Q Consensus        75 lv~e~~~~g~L~~~i~~~-~~~~~~~~~~~~~ql~~-------~~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~  146 (344)
                      +||||+++++|.+++.+. ..+++.+++.++.|++.       .||+||||||+|||++.++.  +||+|||++......
T Consensus       121 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~--~kL~Dfg~~~~~~~~  198 (326)
T 2w1i_A          121 LIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENR--VKIGDFGLTKVLPQD  198 (326)
T ss_dssp             EEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTE--EEECCCTTCEECCSS
T ss_pred             EEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCc--EEEecCcchhhcccc
Confidence            999999999999999875 46898888888777665       49999999999999987654  999999999765433


Q ss_pred             CC----CCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC-----------hHHHHHHHHHHhh
Q 019195          147 SR----PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQED-----------PKNFRKTISRIMA  211 (344)
Q Consensus       147 ~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-----------~~~~~~~~~~~~~  211 (344)
                      ..    .....++..|+|||++.+..+ +.++|||||||++|+|++|..||.....           .......+.....
T Consensus       199 ~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (326)
T 2w1i_A          199 KEYYKVKEPGESPIFWYAPESLTESKF-SVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLK  277 (326)
T ss_dssp             CSEEECSSCCSCCGGGCCHHHHHHCEE-EHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHHHHH
T ss_pred             ccccccccCCCCceeEECchhhcCCCC-CchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHHHhh
Confidence            22    233457888999999987765 4569999999999999999999864210           0111111122222


Q ss_pred             ccccCCCCCCCCHhHHHHHHHhcccCCCCCCChHHHhc
Q 019195          212 VQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKS  249 (344)
Q Consensus       212 ~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~ell~  249 (344)
                      .....+....+++++.+||.+||+.||.+|||+.++++
T Consensus       278 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~  315 (326)
T 2w1i_A          278 NNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL  315 (326)
T ss_dssp             TTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             cCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            23344455578999999999999999999999999976

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=5.4e-45  Score=355.29  Aligned_cols=254  Identities=27%  Similarity=0.374  Sum_probs=195.6

Q ss_pred             CCCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCc--cccHHHHHHHHHHhcCCCCCcceeeEEEEc------CCE
Q 019195            1 MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH--KIDANVAREIINHKQLRHPNIIRFKEVVLT------PTH   72 (344)
Q Consensus         1 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~ei~~l~~l~h~niv~~~~~~~~------~~~   72 (344)
                      +++|++.+.||+|+||.||+|.+..+|+.||+|++....  .....+.+|+.+++.++||||+++++++..      .+.
T Consensus        13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~   92 (676)
T 3qa8_A           13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL   92 (676)
T ss_dssp             ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred             CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence            468999999999999999999999999999999987542  223568899999999999999999998765      677


Q ss_pred             EEEEEecCCCCChHHHHHhCC---CCCHHHHHHHHHHHHH-------CCeeecCCCCCCeEecCCCC-CCEEEeecCCCc
Q 019195           73 LAIVMEYAAGGELFERICNAG---RFSEDEARYFFQQLIS-------GQICHRDLKLENTLLDGSPA-PRLKICDFGYSK  141 (344)
Q Consensus        73 ~~lv~e~~~~g~L~~~i~~~~---~~~~~~~~~~~~ql~~-------~~iiH~Dikp~NIl~~~~~~-~~vkL~DFg~a~  141 (344)
                      .|+|||||++|+|.+++....   .+++..++.++.|++.       .||+||||||+|||++.++. ..+||+|||++.
T Consensus        93 ~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a~  172 (676)
T 3qa8_A           93 PLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAK  172 (676)
T ss_dssp             CCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCCCCC
T ss_pred             EEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEccccccc
Confidence            899999999999999998754   5888877777766654       49999999999999985542 248999999998


Q ss_pred             ccCCCCCCCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHH-----HH-----Hhh
Q 019195          142 SSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTI-----SR-----IMA  211 (344)
Q Consensus       142 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~-----~~-----~~~  211 (344)
                      ............||+.|+|||++.+..++ .++|||||||++|+|++|..||........+...+     ..     ...
T Consensus       173 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~s-~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~l~  251 (676)
T 3qa8_A          173 ELDQGELCTEFVGTLQYLAPELLEQKKYT-VTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLT  251 (676)
T ss_dssp             BTTSCCCCCCCCSCCTTCSSCSSCCSCCS-TTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSCCCCS
T ss_pred             ccccccccccccCCcccCChHHhccCCCC-chhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhhhhhc
Confidence            76666556667899999999999877765 45999999999999999999997643221110000     00     000


Q ss_pred             cccc----CCC----CCCCCHhHHHHHHHhcccCCCCCCChHHHhcCccccc
Q 019195          212 VQYK----IPD----YVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLK  255 (344)
Q Consensus       212 ~~~~----~~~----~~~~s~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~  255 (344)
                      ....    .|.    ...+++.+.+||.+||+.||.+|||+.++++||||..
T Consensus       252 g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~  303 (676)
T 3qa8_A          252 GAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQA  303 (676)
T ss_dssp             SSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHH
T ss_pred             cccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHH
Confidence            1111    111    1125678999999999999999999999999999954

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=1.2e-43  Score=316.87  Aligned_cols=241  Identities=27%  Similarity=0.430  Sum_probs=186.8

Q ss_pred             CCceeeeeeeecCceEEEEEEEcC-CC--cEEEEEEeecCc----cccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEE
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKN-TK--ELVAMKYIERGH----KIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLA   74 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~-~~--~~vaiK~~~~~~----~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~   74 (344)
                      ++|++.+.||+|+||+||+|.+.. ++  ..||+|++....    .....+.+|+.++++++||||+++++++..+. .+
T Consensus        18 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~   96 (291)
T 1u46_A           18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MK   96 (291)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-CE
T ss_pred             hHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-ce
Confidence            589999999999999999998643 33  368999987542    22357889999999999999999999998765 88


Q ss_pred             EEEecCCCCChHHHHHhC-CCCCHHHHHHHHHHHHH-------CCeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCC
Q 019195           75 IVMEYAAGGELFERICNA-GRFSEDEARYFFQQLIS-------GQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH  146 (344)
Q Consensus        75 lv~e~~~~g~L~~~i~~~-~~~~~~~~~~~~~ql~~-------~~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~  146 (344)
                      +||||+++++|.+++... +.+++..++.++.|++.       .||+||||||+||+++.++.  +||+|||++......
T Consensus        97 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~--~kl~Dfg~~~~~~~~  174 (291)
T 1u46_A           97 MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDL--VKIGDFGLMRALPQN  174 (291)
T ss_dssp             EEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTE--EEECCCTTCEECCC-
T ss_pred             eeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCC--EEEcccccccccccc
Confidence            999999999999998764 56899888888777665       49999999999999987664  999999998754333


Q ss_pred             CC----CCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhhccccCCCCCC
Q 019195          147 SR----PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVH  221 (344)
Q Consensus       147 ~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  221 (344)
                      ..    .....+|+.|+|||++.+..++ .++||||||+++|+|++ |+.||.......    ....+.......+....
T Consensus       175 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~~g~~p~~~~~~~~----~~~~~~~~~~~~~~~~~  249 (291)
T 1u46_A          175 DDHYVMQEHRKVPFAWCAPESLKTRTFS-HASDTWMFGVTLWEMFTYGQEPWIGLNGSQ----ILHKIDKEGERLPRPED  249 (291)
T ss_dssp             CCEEEC-----CCGGGCCHHHHHHCEEE-HHHHHHHHHHHHHHHHTTSCCTTTTCCHHH----HHHHHHTSCCCCCCCTT
T ss_pred             ccchhhhccCCCCceeeCchhhcCCCCC-chhhHHHHHHHHHHHHhCCCCCcccCCHHH----HHHHHHccCCCCCCCcC
Confidence            22    2334588899999999776654 56999999999999999 999998765433    33334444445555567


Q ss_pred             CCHhHHHHHHHhcccCCCCCCChHHHhcC
Q 019195          222 ISQDCRNLLSRIFVANPSRRITIKEIKSH  250 (344)
Q Consensus       222 ~s~~~~~li~~~L~~dp~~R~s~~ell~h  250 (344)
                      +++.+.++|.+||+.||.+|||+.+++++
T Consensus       250 ~~~~l~~li~~~l~~~p~~Rps~~~l~~~  278 (291)
T 1u46_A          250 CPQDIYNVMVQCWAHKPEDRPTFVALRDF  278 (291)
T ss_dssp             CCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             cCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence            89999999999999999999999999874

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=1.7e-43  Score=322.49  Aligned_cols=244  Identities=21%  Similarity=0.269  Sum_probs=174.7

Q ss_pred             CCCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcCCCCCcceeeEEEEc-----CCEEEE
Q 019195            1 MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKEVVLT-----PTHLAI   75 (344)
Q Consensus         1 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~-----~~~~~l   75 (344)
                      +++|++++.||+|+||.||++..  +++.||+|++............++..++.++||||+++++.+..     ...+++
T Consensus        12 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~l   89 (336)
T 3g2f_A           12 LDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFANRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLL   89 (336)
T ss_dssp             TTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEEE
T ss_pred             hHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccchhhHHHHHHHHHHHhccCcchhhheecccccccCCCceEEE
Confidence            57999999999999999999976  67899999997654322223344444556899999999986542     236799


Q ss_pred             EEecCCCCChHHHHHhCCCCCHHHHHHHHHH-------HHHC---------CeeecCCCCCCeEecCCCCCCEEEeecCC
Q 019195           76 VMEYAAGGELFERICNAGRFSEDEARYFFQQ-------LISG---------QICHRDLKLENTLLDGSPAPRLKICDFGY  139 (344)
Q Consensus        76 v~e~~~~g~L~~~i~~~~~~~~~~~~~~~~q-------l~~~---------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~  139 (344)
                      |||||++|+|.+++.... .+...++.++.|       ||+.         ||+||||||+|||++.++  ++||+|||+
T Consensus        90 v~e~~~~g~L~~~l~~~~-~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~--~~kL~DFG~  166 (336)
T 3g2f_A           90 VMEYYPNGSLXKYLSLHT-SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDG--TCVISDFGL  166 (336)
T ss_dssp             EECCCTTCBHHHHHHHCC-BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTS--CEEECCCTT
T ss_pred             EEecCCCCcHHHHHhhcc-cchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCC--cEEEeeccc
Confidence            999999999999996644 466666666555       5556         999999999999997665  499999999


Q ss_pred             CcccCCC---------CCCCCCccCCcccCCccccCCC------CCCcchhHHHHHHHHHHHHhCCCCCCCCCChHH---
Q 019195          140 SKSSLLH---------SRPKSTVGTPAYIAPEVLSRRE------YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKN---  201 (344)
Q Consensus       140 a~~~~~~---------~~~~~~~gt~~y~aPE~~~~~~------~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~---  201 (344)
                      ++.....         ......+||+.|+|||++.+..      ..+.++|||||||++|+|++|..||........   
T Consensus       167 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~  246 (336)
T 3g2f_A          167 SMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQM  246 (336)
T ss_dssp             CEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCCC
T ss_pred             eeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHHHH
Confidence            9754322         1223457999999999997632      223569999999999999999777654322110   


Q ss_pred             -----------HHHHHHHHhhcc--ccCCC----CCCCCHhHHHHHHHhcccCCCCCCChHHHhc
Q 019195          202 -----------FRKTISRIMAVQ--YKIPD----YVHISQDCRNLLSRIFVANPSRRITIKEIKS  249 (344)
Q Consensus       202 -----------~~~~~~~~~~~~--~~~~~----~~~~s~~~~~li~~~L~~dp~~R~s~~ell~  249 (344)
                                 ............  ..+|.    ...+++.+.+||.+||+.||.+|||+.++++
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~  311 (336)
T 3g2f_A          247 AFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEE  311 (336)
T ss_dssp             TTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             hhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHH
Confidence                       111111111111  11111    1113457999999999999999999999955

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=6.5e-43  Score=313.36  Aligned_cols=239  Identities=22%  Similarity=0.285  Sum_probs=186.8

Q ss_pred             CceeeeeeeecCceEEEEEEEcCC---CcEEEEEEeecCcc--ccHHHHHHHHHHhcCCCCCcceeeEEEE-cCCEEEEE
Q 019195            3 KYELMKDIGSGNFGVARLMRNKNT---KELVAMKYIERGHK--IDANVAREIINHKQLRHPNIIRFKEVVL-TPTHLAIV   76 (344)
Q Consensus         3 ~y~~~~~lg~G~~g~V~~~~~~~~---~~~vaiK~~~~~~~--~~~~~~~ei~~l~~l~h~niv~~~~~~~-~~~~~~lv   76 (344)
                      +|++.+.||+|+||+||+|.+..+   ...+|+|.+.....  ....+.+|+.++++++||||+++++++. .++..++|
T Consensus        26 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v  105 (298)
T 3f66_A           26 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV  105 (298)
T ss_dssp             EEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred             ehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEEE
Confidence            689999999999999999996543   34689998876432  2356889999999999999999999864 55688999


Q ss_pred             EecCCCCChHHHHHhC-CCCCHHHHHHHHHHHHH-------CCeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCC-
Q 019195           77 MEYAAGGELFERICNA-GRFSEDEARYFFQQLIS-------GQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS-  147 (344)
Q Consensus        77 ~e~~~~g~L~~~i~~~-~~~~~~~~~~~~~ql~~-------~~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~-  147 (344)
                      |||+++|+|.+++... ..+++..++.++.|++.       .||+||||||+|||++.++  .+||+|||+++...... 
T Consensus       106 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~--~~kl~Dfg~a~~~~~~~~  183 (298)
T 3f66_A          106 LPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKF--TVKVADFGLARDMYDKEY  183 (298)
T ss_dssp             EECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTC--CEEECSCGGGCCCSCGGG
T ss_pred             EeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCC--CEEECcccccccccccch
Confidence            9999999999999763 45888888777766654       4999999999999997665  49999999987543221 


Q ss_pred             ----CCCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhhccccCCCCCCC
Q 019195          148 ----RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHI  222 (344)
Q Consensus       148 ----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  222 (344)
                          ......||+.|+|||.+.+..++ .++|||||||++|+|++ |.+||.............    .. ........+
T Consensus       184 ~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~----~~-~~~~~~~~~  257 (298)
T 3f66_A          184 YSVHNKTGAKLPVKWMALESLQTQKFT-TKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL----QG-RRLLQPEYC  257 (298)
T ss_dssp             CBC-----CCBCGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHH----TT-CCCCCCTTC
T ss_pred             hccccccCCCCCccccChHHhcCCCCC-hHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHh----cC-CCCCCCccC
Confidence                22344688999999999877764 56999999999999999 667776655543332222    11 122233467


Q ss_pred             CHhHHHHHHHhcccCCCCCCChHHHhc
Q 019195          223 SQDCRNLLSRIFVANPSRRITIKEIKS  249 (344)
Q Consensus       223 s~~~~~li~~~L~~dp~~R~s~~ell~  249 (344)
                      ++.+.++|.+||+.||.+|||+.++++
T Consensus       258 ~~~l~~li~~~l~~~p~~Rps~~ell~  284 (298)
T 3f66_A          258 PDPLYEVMLKCWHPKAEMRPSFSELVS  284 (298)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            899999999999999999999999986

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=3.2e-43  Score=324.57  Aligned_cols=236  Identities=15%  Similarity=0.170  Sum_probs=185.2

Q ss_pred             CCceeeeeeeecCceEEEEE-----EEcCCCcEEEEEEeecCccccHHHHHHHHHHhcCC---CCCcceeeEEEEcCCEE
Q 019195            2 EKYELMKDIGSGNFGVARLM-----RNKNTKELVAMKYIERGHKIDANVAREIINHKQLR---HPNIIRFKEVVLTPTHL   73 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~-----~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~l~~l~---h~niv~~~~~~~~~~~~   73 (344)
                      ++|++.+.||+|+||+||+|     .+..+++.||+|++....  ...+.+|+.+++.++   |+||+++++++...+..
T Consensus        65 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~~~  142 (365)
T 3e7e_A           65 KLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN--PWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGS  142 (365)
T ss_dssp             SEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC--HHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSSCE
T ss_pred             EEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC--hhHHHHHHHHHHHhhhhhhhhhhhhheeeecCCCc
Confidence            57999999999999999999     467789999999987643  356778888888886   99999999999999999


Q ss_pred             EEEEecCCCCChHHHHHh-----CCCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecC---------CCCCCE
Q 019195           74 AIVMEYAAGGELFERICN-----AGRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDG---------SPAPRL  132 (344)
Q Consensus        74 ~lv~e~~~~g~L~~~i~~-----~~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~---------~~~~~v  132 (344)
                      |+|||||++|+|.+++..     ...+++..++.++.||+.+       ||+||||||+|||++.         ...+.+
T Consensus       143 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~~~~~~~~~  222 (365)
T 3e7e_A          143 VLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGL  222 (365)
T ss_dssp             EEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC------CTTE
T ss_pred             EEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCccccccccCCE
Confidence            999999999999999974     4579999988888877655       9999999999999976         113459


Q ss_pred             EEeecCCCcccC---CCCCCCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHH
Q 019195          133 KICDFGYSKSSL---LHSRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRI  209 (344)
Q Consensus       133 kL~DFg~a~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~  209 (344)
                      ||+|||+|+...   ........+||+.|+|||++.+..++ .++|||||||++|+|++|+.||........        
T Consensus       223 kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~elltg~~pf~~~~~~~~--------  293 (365)
T 3e7e_A          223 ALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWN-YQIDYFGVAATVYCMLFGTYMKVKNEGGEC--------  293 (365)
T ss_dssp             EECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBS-THHHHHHHHHHHHHHHHSSCCCEEEETTEE--------
T ss_pred             EEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCC-ccccHHHHHHHHHHHHhCCCccccCCCCce--------
Confidence            999999996432   22233456799999999999888765 559999999999999999999965432110        


Q ss_pred             hhccccCCCCCCCCHhHHHHHHHhcccCCCCCCChHHHhcC
Q 019195          210 MAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSH  250 (344)
Q Consensus       210 ~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~ell~h  250 (344)
                       .....++.. ..++.+.+++.+||+.+|.+|++..+.+.+
T Consensus       294 -~~~~~~~~~-~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~  332 (365)
T 3e7e_A          294 -KPEGLFRRL-PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQ  332 (365)
T ss_dssp             -EECSCCTTC-SSHHHHHHHHHHHHCCCCTTCCCCHHHHHH
T ss_pred             -eechhcccc-CcHHHHHHHHHHHcCCCCCCcchHHHHHHH
Confidence             001111111 246789999999999999999765554443

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=4.6e-43  Score=315.68  Aligned_cols=241  Identities=23%  Similarity=0.314  Sum_probs=188.3

Q ss_pred             ceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCc-----cccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEEe
Q 019195            4 YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH-----KIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVME   78 (344)
Q Consensus         4 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e   78 (344)
                      |...+.||+|+||.||+|.+  +++.||+|++....     .....+.+|+.++++++||||+++++++...+..++|||
T Consensus        33 ~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  110 (307)
T 2nru_A           33 SVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYV  110 (307)
T ss_dssp             TTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred             cccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEEE
Confidence            45558999999999999986  57899999987532     223578899999999999999999999999999999999


Q ss_pred             cCCCCChHHHHHh---CCCCCHHHHHHHHHHHH-------HCCeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCCC
Q 019195           79 YAAGGELFERICN---AGRFSEDEARYFFQQLI-------SGQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR  148 (344)
Q Consensus        79 ~~~~g~L~~~i~~---~~~~~~~~~~~~~~ql~-------~~~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~~  148 (344)
                      |+++++|.+++..   ...+++..++.++.|++       +.||+||||||+||+++.++  .+||+|||++........
T Consensus       111 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~--~~kl~Dfg~~~~~~~~~~  188 (307)
T 2nru_A          111 YMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAF--TAKISDFGLARASEKFAQ  188 (307)
T ss_dssp             CCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTC--CEEECCCTTCEECCSCSS
T ss_pred             ecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCC--cEEEeecccccccccccc
Confidence            9999999999864   34688888777776655       45999999999999997665  499999999875433221


Q ss_pred             ---CCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccc--------cCC
Q 019195          149 ---PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQY--------KIP  217 (344)
Q Consensus       149 ---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~--------~~~  217 (344)
                         .....||+.|+|||++.+. + +.++|||||||++|+|++|.+||...........+...+.....        ..+
T Consensus       189 ~~~~~~~~g~~~y~aPE~~~~~-~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  266 (307)
T 2nru_A          189 TVMTSRIVGTTAYMAPEALRGE-I-TPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMN  266 (307)
T ss_dssp             CEECSSCCSCGGGCCHHHHTTE-E-CTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHHSCSSCS
T ss_pred             cccccccCCCcCcCChHHhcCC-C-CccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhhcccccc
Confidence               2345799999999998654 3 45699999999999999999999876544333333322221111        011


Q ss_pred             -CCCCCCHhHHHHHHHhcccCCCCCCChHHHhcC
Q 019195          218 -DYVHISQDCRNLLSRIFVANPSRRITIKEIKSH  250 (344)
Q Consensus       218 -~~~~~s~~~~~li~~~L~~dp~~R~s~~ell~h  250 (344)
                       .....+..+.+++.+||+.||.+|||+.+++++
T Consensus       267 ~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~  300 (307)
T 2nru_A          267 DADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQL  300 (307)
T ss_dssp             CCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             ccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence             112245678999999999999999999999874

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=4.3e-43  Score=339.12  Aligned_cols=239  Identities=22%  Similarity=0.332  Sum_probs=195.6

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEEecCC
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYAA   81 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~   81 (344)
                      ++|++.+.||+|+||.||++.+.. +..||||++.........+.+|+.+|++++||||+++++++.. ..+|+||||+.
T Consensus       267 ~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~~~  344 (535)
T 2h8h_A          267 ESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMS  344 (535)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCT
T ss_pred             hhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeehhc
Confidence            479999999999999999999875 4579999998766556789999999999999999999999865 67899999999


Q ss_pred             CCChHHHHHhC--CCCCHHHHHHHHHHHHH-------CCeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCC--CCCC
Q 019195           82 GGELFERICNA--GRFSEDEARYFFQQLIS-------GQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH--SRPK  150 (344)
Q Consensus        82 ~g~L~~~i~~~--~~~~~~~~~~~~~ql~~-------~~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~--~~~~  150 (344)
                      +|+|.+++...  ..+++.+++.++.||+.       .||+||||||+|||++.++.  +||+|||+++.....  ....
T Consensus       345 ~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~--~kl~DFG~a~~~~~~~~~~~~  422 (535)
T 2h8h_A          345 KGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLV--CKVADFGLARLIEDNEYTARQ  422 (535)
T ss_dssp             TEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC--EEECCTTSTTTCCCHHHHTTC
T ss_pred             CCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCc--EEEcccccceecCCCceeccc
Confidence            99999999643  56888888887777665       49999999999999976654  999999999754321  1123


Q ss_pred             CCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCHhHHHH
Q 019195          151 STVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL  229 (344)
Q Consensus       151 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  229 (344)
                      ...++..|+|||++....+ +.++|||||||++|+|++ |+.||.+....+...    .+ ....+.+....+++.+.+|
T Consensus       423 ~~~~~~~y~aPE~~~~~~~-~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~----~i-~~~~~~~~~~~~~~~l~~l  496 (535)
T 2h8h_A          423 GAKFPIKWTAPEAALYGRF-TIKSDVWSFGILLTELTTKGRVPYPGMVNREVLD----QV-ERGYRMPCPPECPESLHDL  496 (535)
T ss_dssp             STTSCGGGSCHHHHHHCCC-CHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHH----HH-HTTCCCCCCTTCCHHHHHH
T ss_pred             CCcCcccccCHHHhccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH----HH-HcCCCCCCCCCCCHHHHHH
Confidence            3457889999999987765 456999999999999999 999998765433322    22 2233445555789999999


Q ss_pred             HHHhcccCCCCCCChHHHhcC
Q 019195          230 LSRIFVANPSRRITIKEIKSH  250 (344)
Q Consensus       230 i~~~L~~dp~~R~s~~ell~h  250 (344)
                      |.+||+.||.+|||+.+|++.
T Consensus       497 i~~cl~~dP~~RPt~~~l~~~  517 (535)
T 2h8h_A          497 MCQCWRKEPEERPTFEYLQAF  517 (535)
T ss_dssp             HHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHcCCChhHCcCHHHHHHH
Confidence            999999999999999998763

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.1e-43  Score=324.60  Aligned_cols=240  Identities=22%  Similarity=0.288  Sum_probs=181.3

Q ss_pred             CceeeeeeeecCceEEEEEEEcCC---CcEEEEEEeecCcc--ccHHHHHHHHHHhcCCCCCcceeeEEEE-cCCEEEEE
Q 019195            3 KYELMKDIGSGNFGVARLMRNKNT---KELVAMKYIERGHK--IDANVAREIINHKQLRHPNIIRFKEVVL-TPTHLAIV   76 (344)
Q Consensus         3 ~y~~~~~lg~G~~g~V~~~~~~~~---~~~vaiK~~~~~~~--~~~~~~~ei~~l~~l~h~niv~~~~~~~-~~~~~~lv   76 (344)
                      +|++.+.||+|+||.||+|.+..+   +..||+|.+.....  ....+.+|+.++++++||||+++++++. .++..++|
T Consensus        90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv  169 (373)
T 3c1x_A           90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV  169 (373)
T ss_dssp             EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred             eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence            478899999999999999987543   34689998875332  2357889999999999999999999865 45688999


Q ss_pred             EecCCCCChHHHHHhC-CCCCHHHHHHHHHHHH-------HCCeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCC-
Q 019195           77 MEYAAGGELFERICNA-GRFSEDEARYFFQQLI-------SGQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS-  147 (344)
Q Consensus        77 ~e~~~~g~L~~~i~~~-~~~~~~~~~~~~~ql~-------~~~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~-  147 (344)
                      |||+++|+|.+++... ..+++.+++.++.|++       +.||+||||||+|||++.++.  +||+|||+++...... 
T Consensus       170 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~--~kL~DFG~a~~~~~~~~  247 (373)
T 3c1x_A          170 LPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFT--VKVADFGLARDMYDKEF  247 (373)
T ss_dssp             EECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCC--EEECCC-----------
T ss_pred             EECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCC--EEEeecccccccccccc
Confidence            9999999999999765 4578777777766655       459999999999999976654  9999999997543222 


Q ss_pred             ----CCCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhhccccCCCCCCC
Q 019195          148 ----RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHI  222 (344)
Q Consensus       148 ----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  222 (344)
                          ......+|+.|+|||++.+..++ .++|||||||++|+|++ |.+||...........+.    .. ...+....+
T Consensus       248 ~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~----~~-~~~~~p~~~  321 (373)
T 3c1x_A          248 DSVHNKTGAKLPVKWMALESLQTQKFT-TKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL----QG-RRLLQPEYC  321 (373)
T ss_dssp             ----------CCGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHH----TT-CCCCCCTTC
T ss_pred             ccccccCCCCCcccccChHHhcCCCCC-cHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHH----cC-CCCCCCCCC
Confidence                12334578899999999877764 56999999999999999 788887765544332221    11 122333468


Q ss_pred             CHhHHHHHHHhcccCCCCCCChHHHhcC
Q 019195          223 SQDCRNLLSRIFVANPSRRITIKEIKSH  250 (344)
Q Consensus       223 s~~~~~li~~~L~~dp~~R~s~~ell~h  250 (344)
                      ++.+.++|.+||+.||.+|||+.+++++
T Consensus       322 ~~~l~~li~~cl~~dp~~RPs~~ell~~  349 (373)
T 3c1x_A          322 PDPLYEVMLKCWHPKAEMRPSFSELVSR  349 (373)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            8999999999999999999999999874

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=1.3e-42  Score=317.20  Aligned_cols=242  Identities=25%  Similarity=0.330  Sum_probs=187.6

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhc--CCCCCcceeeEEEEcCC----EEEE
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQ--LRHPNIIRFKEVVLTPT----HLAI   75 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~l~~--l~h~niv~~~~~~~~~~----~~~l   75 (344)
                      ++|++.+.||+|+||.||++.+  +++.||+|++....  ...+.+|+++++.  ++||||+++++++....    .+|+
T Consensus        42 ~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~--~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~l  117 (342)
T 1b6c_B           42 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE--ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL  117 (342)
T ss_dssp             HHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGGG--HHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCCEEE
T ss_pred             ccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCchh--HHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccceeEE
Confidence            4799999999999999999998  48899999986532  3567788888877  78999999999998876    8999


Q ss_pred             EEecCCCCChHHHHHhCCCCCHHHHHHHHHH-------HH--------HCCeeecCCCCCCeEecCCCCCCEEEeecCCC
Q 019195           76 VMEYAAGGELFERICNAGRFSEDEARYFFQQ-------LI--------SGQICHRDLKLENTLLDGSPAPRLKICDFGYS  140 (344)
Q Consensus        76 v~e~~~~g~L~~~i~~~~~~~~~~~~~~~~q-------l~--------~~~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a  140 (344)
                      ||||+++|+|.+++.+ ..+++.+++.++.|       ||        +.||+||||||+|||++.++.  +||+|||++
T Consensus       118 v~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~--~kL~Dfg~~  194 (342)
T 1b6c_B          118 VSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGT--CCIADLGLA  194 (342)
T ss_dssp             EECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSC--EEECCCTTC
T ss_pred             EEeecCCCcHHHHHhc-cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCC--EEEEECCCc
Confidence            9999999999999976 46888877777666       45        558999999999999977664  999999998


Q ss_pred             cccCCCC-----CCCCCccCCcccCCccccCCCCCC-----cchhHHHHHHHHHHHHhC----------CCCCCCCCChH
Q 019195          141 KSSLLHS-----RPKSTVGTPAYIAPEVLSRREYDG-----KLADVWSCGVTLYVMLVG----------AYPFEDQEDPK  200 (344)
Q Consensus       141 ~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~-----~~~DiwslG~il~el~~g----------~~pf~~~~~~~  200 (344)
                      .......     ......||+.|+|||++.+.....     .++|||||||++|+|++|          ..||.......
T Consensus       195 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~~~~  274 (342)
T 1b6c_B          195 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD  274 (342)
T ss_dssp             EEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSS
T ss_pred             eeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccCcCc
Confidence            7544333     234557999999999997653322     569999999999999999          78887653221


Q ss_pred             -HHHHHHHHHhhcccc--CCC---CCCCCHhHHHHHHHhcccCCCCCCChHHHhcC
Q 019195          201 -NFRKTISRIMAVQYK--IPD---YVHISQDCRNLLSRIFVANPSRRITIKEIKSH  250 (344)
Q Consensus       201 -~~~~~~~~~~~~~~~--~~~---~~~~s~~~~~li~~~L~~dp~~R~s~~ell~h  250 (344)
                       ........+......  ++.   ....++.+.+||.+||+.||.+|||+.++++|
T Consensus       275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~  330 (342)
T 1b6c_B          275 PSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT  330 (342)
T ss_dssp             CCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred             ccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence             122222222222222  111   01234578999999999999999999999876

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=3.8e-42  Score=327.47  Aligned_cols=242  Identities=22%  Similarity=0.229  Sum_probs=192.2

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcCCC-CCcceeeEEEEcCCEEEEEEecC
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRH-PNIIRFKEVVLTPTHLAIVMEYA   80 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~l~~l~h-~niv~~~~~~~~~~~~~lv~e~~   80 (344)
                      ++|++++.||+|+||.||+|.+..+++.||||++..... ...+.+|+.+++.+.| ++|..+..++......++||||+
T Consensus         7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~~   85 (483)
T 3sv0_A            7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDLL   85 (483)
T ss_dssp             TTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS-SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEECC
T ss_pred             CcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc-cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEECC
Confidence            689999999999999999999999999999998876443 3468899999999976 66666777777888999999999


Q ss_pred             CCCChHHHHHh-CCCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEec---CCCCCCEEEeecCCCcccCCCCC-
Q 019195           81 AGGELFERICN-AGRFSEDEARYFFQQLISG-------QICHRDLKLENTLLD---GSPAPRLKICDFGYSKSSLLHSR-  148 (344)
Q Consensus        81 ~~g~L~~~i~~-~~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~---~~~~~~vkL~DFg~a~~~~~~~~-  148 (344)
                       +++|.+++.. ...+++.+++.++.||+.+       ||+||||||+||||+   .++  .+||+|||+++....... 
T Consensus        86 -g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~--~vkL~DFGla~~~~~~~~~  162 (483)
T 3sv0_A           86 -GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRAN--QVYIIDFGLAKKYRDTSTH  162 (483)
T ss_dssp             -CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTT--CEEECCCTTCEECBCTTTC
T ss_pred             -CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCC--eEEEEeCCcceeccCCccc
Confidence             9999999975 5679999988888777655       999999999999994   444  599999999975443221 


Q ss_pred             -------CCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccC---CC
Q 019195          149 -------PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKI---PD  218 (344)
Q Consensus       149 -------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~---~~  218 (344)
                             ....+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||........... +..+.......   ..
T Consensus       163 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~-s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~-~~~i~~~~~~~~~~~l  240 (483)
T 3sv0_A          163 QHIPYRENKNLTGTARYASVNTHLGIEQ-SRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQK-YEKISEKKVATSIEAL  240 (483)
T ss_dssp             CBCCCCCCCCCCSCTTTCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHH-HHHHHHHHHHSCHHHH
T ss_pred             cccccccccccCCCccccCHHHhcCCCC-ChHHHHHHHHHHHHHHHhCCCCCccccchhHHHH-HHHHhhccccccHHHH
Confidence                   235679999999999988776 4569999999999999999999987654222211 11111111111   11


Q ss_pred             CCCCCHhHHHHHHHhcccCCCCCCChHHHhc
Q 019195          219 YVHISQDCRNLLSRIFVANPSRRITIKEIKS  249 (344)
Q Consensus       219 ~~~~s~~~~~li~~~L~~dp~~R~s~~ell~  249 (344)
                      ...+++++.+||.+||+.+|.+||++.+|++
T Consensus       241 ~~~~p~~l~~li~~cl~~dP~~RPs~~el~~  271 (483)
T 3sv0_A          241 CRGYPTEFASYFHYCRSLRFDDKPDYSYLKR  271 (483)
T ss_dssp             HTTSCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             hcCCcHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence            1367899999999999999999999988765

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=5.6e-43  Score=316.70  Aligned_cols=240  Identities=23%  Similarity=0.355  Sum_probs=189.8

Q ss_pred             CCCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCc---cccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEE
Q 019195            1 MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH---KIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVM   77 (344)
Q Consensus         1 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~   77 (344)
                      +++|++.+.||+|+||.||++.+..   .||+|++....   .....+.+|+.++++++||||+++++++...+.+++||
T Consensus        32 ~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~  108 (319)
T 2y4i_B           32 FEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIIT  108 (319)
T ss_dssp             CSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEEC
T ss_pred             HHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEe
Confidence            4789999999999999999999864   39999987532   22345778999999999999999999999999999999


Q ss_pred             ecCCCCChHHHHHhCC-CCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCC----
Q 019195           78 EYAAGGELFERICNAG-RFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLL----  145 (344)
Q Consensus        78 e~~~~g~L~~~i~~~~-~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~----  145 (344)
                      ||+++++|.+++...+ .+++..++.++.|++.+       ||+||||||+|||++.   +.+||+|||++.....    
T Consensus       109 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~~---~~~~l~Dfg~~~~~~~~~~~  185 (319)
T 2y4i_B          109 SLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYDN---GKVVITDFGLFSISGVLQAG  185 (319)
T ss_dssp             BCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC-----CCEECCCSCCC--------
T ss_pred             ecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEeC---CCEEEeecCCcccccccccc
Confidence            9999999999997654 68888888887776654       9999999999999973   3599999999864321    


Q ss_pred             --CCCCCCCccCCcccCCccccCC--------CCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhcccc
Q 019195          146 --HSRPKSTVGTPAYIAPEVLSRR--------EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYK  215 (344)
Q Consensus       146 --~~~~~~~~gt~~y~aPE~~~~~--------~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  215 (344)
                        ........||+.|+|||++.+.        ...+.++|||||||++|+|++|+.||.........    ..+......
T Consensus       186 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~----~~~~~~~~~  261 (319)
T 2y4i_B          186 RREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAII----WQMGTGMKP  261 (319)
T ss_dssp             --CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHH----HHHHTTCCC
T ss_pred             ccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH----HHhccCCCC
Confidence              1222344699999999998652        22356799999999999999999999876543332    222222222


Q ss_pred             CCCCCCCCHhHHHHHHHhcccCCCCCCChHHHhcC
Q 019195          216 IPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSH  250 (344)
Q Consensus       216 ~~~~~~~s~~~~~li~~~L~~dp~~R~s~~ell~h  250 (344)
                      ......+++++.+||.+||+.||.+|||+.++++.
T Consensus       262 ~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~  296 (319)
T 2y4i_B          262 NLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDM  296 (319)
T ss_dssp             CCCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHH
T ss_pred             CCCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence            22233578999999999999999999999999874

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=3.4e-42  Score=337.58  Aligned_cols=238  Identities=25%  Similarity=0.375  Sum_probs=188.2

Q ss_pred             Cceeee-eeeecCceEEEEEEEc--CCCcEEEEEEeecCc--cccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEE
Q 019195            3 KYELMK-DIGSGNFGVARLMRNK--NTKELVAMKYIERGH--KIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVM   77 (344)
Q Consensus         3 ~y~~~~-~lg~G~~g~V~~~~~~--~~~~~vaiK~~~~~~--~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~   77 (344)
                      ++.+.+ .||+|+||.||+|.+.  .++..||||++....  .....+.+|+.++++++|||||++++++.. +.+++||
T Consensus       336 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~  414 (613)
T 2ozo_A          336 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVM  414 (613)
T ss_dssp             SEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEE
T ss_pred             ceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEE
Confidence            345555 8999999999999875  456789999997643  234679999999999999999999999976 5689999


Q ss_pred             ecCCCCChHHHHHhC-CCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCCC-
Q 019195           78 EYAAGGELFERICNA-GRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR-  148 (344)
Q Consensus        78 e~~~~g~L~~~i~~~-~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~~-  148 (344)
                      |||++|+|.+++... ..+++.+++.++.|++.+       ||+||||||+|||++.++.  +||+|||+++....... 
T Consensus       415 E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~--vkL~DFGla~~~~~~~~~  492 (613)
T 2ozo_A          415 EMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHY--AKISDFGLSKALGADDSY  492 (613)
T ss_dssp             ECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTE--EEECCCSTTTTCC-----
T ss_pred             EeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCc--EEEeeccCcccccCCCce
Confidence            999999999999754 468998888887776654       9999999999999987664  99999999986433221 


Q ss_pred             ---CCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCH
Q 019195          149 ---PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQ  224 (344)
Q Consensus       149 ---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~  224 (344)
                         .....+|+.|+|||++.+..++ .++|||||||++|+|++ |+.||......+....    +.. ..+.+....+++
T Consensus       493 ~~~~~~~~~~~~y~APE~~~~~~~~-~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~----i~~-~~~~~~p~~~~~  566 (613)
T 2ozo_A          493 YTARSAGKWPLKWYAPECINFRKFS-SRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAF----IEQ-GKRMECPPECPP  566 (613)
T ss_dssp             ---------CCTTSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHH----HHT-TCCCCCCTTCCH
T ss_pred             eeeccCCCCccceeCHhhhcCCCCC-cHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHH----HHc-CCCCCCCCcCCH
Confidence               1223467899999999877764 56999999999999998 9999988776543322    222 223344457899


Q ss_pred             hHHHHHHHhcccCCCCCCChHHHhc
Q 019195          225 DCRNLLSRIFVANPSRRITIKEIKS  249 (344)
Q Consensus       225 ~~~~li~~~L~~dp~~R~s~~ell~  249 (344)
                      ++.+||.+||+.||.+|||+.++++
T Consensus       567 ~l~~li~~cl~~dP~~RPs~~~l~~  591 (613)
T 2ozo_A          567 ELYALMSDCWIYKWEDRPDFLTVEQ  591 (613)
T ss_dssp             HHHHHHHHTTCSSTTTSCCHHHHHH
T ss_pred             HHHHHHHHHcCCChhHCcCHHHHHH
Confidence            9999999999999999999999864

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=1.5e-42  Score=340.94  Aligned_cols=233  Identities=22%  Similarity=0.322  Sum_probs=187.1

Q ss_pred             eeeeecCceEEEEEEE--cCCCcEEEEEEeecCcc---ccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEEecCCC
Q 019195            8 KDIGSGNFGVARLMRN--KNTKELVAMKYIERGHK---IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYAAG   82 (344)
Q Consensus         8 ~~lg~G~~g~V~~~~~--~~~~~~vaiK~~~~~~~---~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~   82 (344)
                      +.||+|+||.||+|.+  ..+++.||||++.....   ....+.+|+.++++++|||||++++++.. +.+++|||||++
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~  453 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL  453 (635)
T ss_dssp             EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence            4799999999999954  46778999999976432   23679999999999999999999999965 558899999999


Q ss_pred             CChHHHHHhCCCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCC----CCCC
Q 019195           83 GELFERICNAGRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS----RPKS  151 (344)
Q Consensus        83 g~L~~~i~~~~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~----~~~~  151 (344)
                      |+|.+++...+.+++.+++.++.||+.+       ||+||||||+|||++.++.  +||+|||+++......    ....
T Consensus       454 g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~--~kL~DFGla~~~~~~~~~~~~~~~  531 (635)
T 4fl3_A          454 GPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHY--AKISDFGLSKALRADENYYKAQTH  531 (635)
T ss_dssp             EEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTE--EEECCTTHHHHTTC----------
T ss_pred             CCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCC--EEEEEcCCccccccCccccccccC
Confidence            9999999988899999888887776654       9999999999999987764  9999999987543322    1223


Q ss_pred             CccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCHhHHHHH
Q 019195          152 TVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLL  230 (344)
Q Consensus       152 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li  230 (344)
                      ..+|+.|+|||++.+..++ .++|||||||++|+|++ |+.||.+........    .+. .....+....+++++.+||
T Consensus       532 ~~~t~~y~APE~~~~~~~~-~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~----~i~-~~~~~~~p~~~~~~l~~li  605 (635)
T 4fl3_A          532 GKWPVKWYAPECINYYKFS-SKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTA----MLE-KGERMGCPAGCPREMYDLM  605 (635)
T ss_dssp             ---CGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHH----HHH-TTCCCCCCTTCCHHHHHHH
T ss_pred             CCCceeeeChhhhcCCCCC-cHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHH----HHH-cCCCCCCCCCCCHHHHHHH
Confidence            3578899999999877764 56999999999999998 999998866533222    222 2223344457899999999


Q ss_pred             HHhcccCCCCCCChHHHhc
Q 019195          231 SRIFVANPSRRITIKEIKS  249 (344)
Q Consensus       231 ~~~L~~dp~~R~s~~ell~  249 (344)
                      .+||+.||.+|||+.++++
T Consensus       606 ~~cl~~dP~~RPs~~~l~~  624 (635)
T 4fl3_A          606 NLCWTYDVENRPGFAAVEL  624 (635)
T ss_dssp             HHHTCSSTTTSCCHHHHHH
T ss_pred             HHHcCCCHhHCcCHHHHHH
Confidence            9999999999999999875

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=1.1e-44  Score=330.72  Aligned_cols=236  Identities=20%  Similarity=0.224  Sum_probs=180.3

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCcc---------ccHHHHHHHHHHhcCC---------CCCccee
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK---------IDANVAREIINHKQLR---------HPNIIRF   63 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---------~~~~~~~ei~~l~~l~---------h~niv~~   63 (344)
                      ++|++++.||+|+||+||+|.+  +++.||||++.....         ....+.+|+.+++.++         ||||+++
T Consensus        20 ~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l   97 (336)
T 2vuw_A           20 EKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL   97 (336)
T ss_dssp             HHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred             ccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence            5799999999999999999998  679999999986532         1267889999988885         7777777


Q ss_pred             eEEEE-----------------c-------------CCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHH-----
Q 019195           64 KEVVL-----------------T-------------PTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLI-----  108 (344)
Q Consensus        64 ~~~~~-----------------~-------------~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~ql~-----  108 (344)
                      .+++.                 +             .+.+|+|||||++|++.+.+.+ +.+++.+++.++.||+     
T Consensus        98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-~~~~~~~~~~i~~qi~~aL~~  176 (336)
T 2vuw_A           98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-KLSSLATAKSILHQLTASLAV  176 (336)
T ss_dssp             EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-TCCCHHHHHHHHHHHHHHHHH
T ss_pred             cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-cCCCHHHHHHHHHHHHHHHHH
Confidence            76643                 2             6789999999999987777744 6789999888887765     


Q ss_pred             ---HCCeeecCCCCCCeEecCCCC------------------CCEEEeecCCCcccCCCCCCCCCccCCcccCCccccCC
Q 019195          109 ---SGQICHRDLKLENTLLDGSPA------------------PRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRR  167 (344)
Q Consensus       109 ---~~~iiH~Dikp~NIl~~~~~~------------------~~vkL~DFg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~  167 (344)
                         +.||+||||||+|||++.++.                  .++||+|||+|+....    ...+||+.|+|||++.+.
T Consensus       177 lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~----~~~~gt~~y~aPE~~~g~  252 (336)
T 2vuw_A          177 AEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD----GIVVFCDVSMDEDLFTGD  252 (336)
T ss_dssp             HHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET----TEEECCCCTTCSGGGCCC
T ss_pred             HHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC----CcEEEeecccChhhhcCC
Confidence               449999999999999987641                  1599999999985432    245899999999999876


Q ss_pred             CCCCcchhHHHHHHH-HHHHHhCCCCCCCCCChHHHHHHHHHHhh-ccccCC----CCCCCCHhHHHHHHHhcccCCCCC
Q 019195          168 EYDGKLADVWSCGVT-LYVMLVGAYPFEDQEDPKNFRKTISRIMA-VQYKIP----DYVHISQDCRNLLSRIFVANPSRR  241 (344)
Q Consensus       168 ~~~~~~~DiwslG~i-l~el~~g~~pf~~~~~~~~~~~~~~~~~~-~~~~~~----~~~~~s~~~~~li~~~L~~dp~~R  241 (344)
                      .  +.++||||||++ .+++++|..||.....   .......+.. ......    ....+++++.+||.+||+.|    
T Consensus       253 ~--~~~~Diwsl~~~~~~~~~~g~~p~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d----  323 (336)
T 2vuw_A          253 G--DYQFDIYRLMKKENNNRWGEYHPYSNVLW---LHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS----  323 (336)
T ss_dssp             S--SHHHHHHHHHHHHHTTCTTSCCTHHHHHH---HHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS----
T ss_pred             C--ccceehhhhhCCCCcccccccCCCcchhh---hhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhccC----
Confidence            5  567999998777 7788899999843110   0111112211 111111    12246889999999999977    


Q ss_pred             CChHHHh-cCcccc
Q 019195          242 ITIKEIK-SHPWFL  254 (344)
Q Consensus       242 ~s~~ell-~hp~~~  254 (344)
                       |+.|+| +||||+
T Consensus       324 -sa~e~l~~Hp~f~  336 (336)
T 2vuw_A          324 -SATDLLCQHSLFK  336 (336)
T ss_dssp             -SHHHHHHHCGGGC
T ss_pred             -CHHHHHhcCCCcC
Confidence             999999 999994

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=1.2e-41  Score=335.81  Aligned_cols=240  Identities=23%  Similarity=0.373  Sum_probs=190.2

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCC---CcEEEEEEeecCcc--ccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEE
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNT---KELVAMKYIERGHK--IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIV   76 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~---~~~vaiK~~~~~~~--~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv   76 (344)
                      ++|++.+.||+|+||.||+|.+..+   +..||+|.+.....  ....+.+|+.++++++||||+++++++. ++.+|+|
T Consensus       390 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~lv  468 (656)
T 2j0j_A          390 ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWII  468 (656)
T ss_dssp             GGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEE
T ss_pred             ccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCceEEE
Confidence            5799999999999999999998643   56799998865432  2357889999999999999999999984 5678999


Q ss_pred             EecCCCCChHHHHHhCC-CCCHHHHHHHHHHHHH-------CCeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCCC
Q 019195           77 MEYAAGGELFERICNAG-RFSEDEARYFFQQLIS-------GQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR  148 (344)
Q Consensus        77 ~e~~~~g~L~~~i~~~~-~~~~~~~~~~~~ql~~-------~~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~~  148 (344)
                      |||+++|+|.+++...+ .+++..++.++.|++.       .||+||||||+|||++.++.  +||+|||+++.......
T Consensus       469 ~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~--vkL~DFG~a~~~~~~~~  546 (656)
T 2j0j_A          469 MELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDC--VKLGDFGLSRYMEDSTY  546 (656)
T ss_dssp             EECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTE--EEECCCCCCCSCCC---
T ss_pred             EEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCC--EEEEecCCCeecCCCcc
Confidence            99999999999998654 6888887777666554       49999999999999987664  99999999976533322


Q ss_pred             --CCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCHh
Q 019195          149 --PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQD  225 (344)
Q Consensus       149 --~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~  225 (344)
                        .....+|+.|+|||++.+..+ +.++|||||||++|+|++ |..||.+.........+    .. ....+....+++.
T Consensus       547 ~~~~~~~~t~~y~aPE~~~~~~~-~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i----~~-~~~~~~~~~~~~~  620 (656)
T 2j0j_A          547 YKASKGKLPIKWMAPESINFRRF-TSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI----EN-GERLPMPPNCPPT  620 (656)
T ss_dssp             -------CCGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHH----HH-TCCCCCCTTCCHH
T ss_pred             eeccCCCCCcceeCHHHhcCCCC-CchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH----Hc-CCCCCCCccccHH
Confidence              223457889999999987766 456999999999999997 99999876654333222    22 1223344578999


Q ss_pred             HHHHHHHhcccCCCCCCChHHHhcC
Q 019195          226 CRNLLSRIFVANPSRRITIKEIKSH  250 (344)
Q Consensus       226 ~~~li~~~L~~dp~~R~s~~ell~h  250 (344)
                      +.+||.+||+.||.+|||+.++++.
T Consensus       621 l~~li~~~l~~dP~~RPs~~el~~~  645 (656)
T 2j0j_A          621 LYSLMTKCWAYDPSRRPRFTELKAQ  645 (656)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHcCCChhHCcCHHHHHHH
Confidence            9999999999999999999999763

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=2.5e-42  Score=323.68  Aligned_cols=236  Identities=14%  Similarity=0.087  Sum_probs=176.9

Q ss_pred             CceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCc----cccHHHHHHHHHHhcCCC-CCcc---------eeeEE--
Q 019195            3 KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH----KIDANVAREIINHKQLRH-PNII---------RFKEV--   66 (344)
Q Consensus         3 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~ei~~l~~l~h-~niv---------~~~~~--   66 (344)
                      +|++.+.||+|+||+||+|.+..+|+.||||++....    .....+.+|+.+++.++| +|..         .....  
T Consensus        79 ~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~  158 (413)
T 3dzo_A           79 TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVK  158 (413)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEE
T ss_pred             eEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhcc
Confidence            4788999999999999999999999999999987432    234678999999999977 3211         11111  


Q ss_pred             ----------EEc-----CCEEEEEEecCCCCChHHHHHh-------CCCCCHHHHHHHHHHH-------HHCCeeecCC
Q 019195           67 ----------VLT-----PTHLAIVMEYAAGGELFERICN-------AGRFSEDEARYFFQQL-------ISGQICHRDL  117 (344)
Q Consensus        67 ----------~~~-----~~~~~lv~e~~~~g~L~~~i~~-------~~~~~~~~~~~~~~ql-------~~~~iiH~Di  117 (344)
                                +..     ...++++|+++ +++|.+++..       ...+++..++.++.|+       |+.||+||||
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHrDi  237 (413)
T 3dzo_A          159 DPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYL  237 (413)
T ss_dssp             CCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECSCC
T ss_pred             cCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCc
Confidence                      111     12467888876 6899988841       2235555555555555       4559999999


Q ss_pred             CCCCeEecCCCCCCEEEeecCCCcccCCCCCCCCCccCCcccCCcccc----------CCCCCCcchhHHHHHHHHHHHH
Q 019195          118 KLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLS----------RREYDGKLADVWSCGVTLYVML  187 (344)
Q Consensus       118 kp~NIl~~~~~~~~vkL~DFg~a~~~~~~~~~~~~~gt~~y~aPE~~~----------~~~~~~~~~DiwslG~il~el~  187 (344)
                      ||+|||++.++.  +||+|||+++.....  ....+| +.|+|||++.          +..+ +.++|||||||++|+|+
T Consensus       238 Kp~NILl~~~~~--~kL~DFG~a~~~~~~--~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~-~~~~DvwSlGvil~ell  311 (413)
T 3dzo_A          238 RPVDIVLDQRGG--VFLTGFEHLVRDGAS--AVSPIG-RGFAPPETTAERMLPFGQHHPTLM-TFAFDTWTLGLAIYWIW  311 (413)
T ss_dssp             CGGGEEECTTCC--EEECCGGGCEETTEE--ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEE-CHHHHHHHHHHHHHHHH
T ss_pred             ccceEEEecCCe--EEEEeccceeecCCc--cccCCC-CceeCchhhhccccccccccCcCC-CchhhHHHHHHHHHHHH
Confidence            999999987765  999999998754333  345678 9999999993          3333 45699999999999999


Q ss_pred             hCCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCHhHHHHHHHhcccCCCCCCChHHHhcCccccc
Q 019195          188 VGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLK  255 (344)
Q Consensus       188 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~  255 (344)
                      +|+.||..........          ..++....+++.+.+||.+||+.||.+|||+.++++||||.+
T Consensus       312 tg~~Pf~~~~~~~~~~----------~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~~~~~~  369 (413)
T 3dzo_A          312 CADLPNTDDAALGGSE----------WIFRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQ  369 (413)
T ss_dssp             HSSCCCCTTGGGSCSG----------GGGSSCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHH
T ss_pred             HCCCCCCCcchhhhHH----------HHHhhcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHHH
Confidence            9999998754322111          112333467899999999999999999999999999999954

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=5.9e-42  Score=340.36  Aligned_cols=230  Identities=23%  Similarity=0.274  Sum_probs=185.9

Q ss_pred             CCceeeeeeeecCceEEEEEEEcC-CCcEEEEEEeecCcc--ccHHHHHHHHHHhcCCCCCcceeeEEEEcCCE-----E
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKN-TKELVAMKYIERGHK--IDANVAREIINHKQLRHPNIIRFKEVVLTPTH-----L   73 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vaiK~~~~~~~--~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~-----~   73 (344)
                      ++|++.+.||+|+||+||++.+.. +++.||||++.....  ....+.+|+.++++++||||+++++++...+.     .
T Consensus        80 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~  159 (681)
T 2pzi_A           80 GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVG  159 (681)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred             CceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCcee
Confidence            689999999999999999999976 789999999865432  23467899999999999999999999987655     7


Q ss_pred             EEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCC
Q 019195           74 AIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH  146 (344)
Q Consensus        74 ~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~  146 (344)
                      |+||||++|++|.+++..  .+++.+++.++.||+.+       ||+||||||+|||++.+   .+||+|||+++.....
T Consensus       160 ~lv~E~~~g~~L~~~~~~--~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~---~~kl~DFG~a~~~~~~  234 (681)
T 2pzi_A          160 YIVMEYVGGQSLKRSKGQ--KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE---QLKLIDLGAVSRINSF  234 (681)
T ss_dssp             EEEEECCCCEECC----C--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS---CEEECCCTTCEETTCC
T ss_pred             EEEEEeCCCCcHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC---cEEEEecccchhcccC
Confidence            999999999999987754  78999888887776654       99999999999999864   4999999998754332


Q ss_pred             CCCCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCHhH
Q 019195          147 SRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDC  226 (344)
Q Consensus       147 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~  226 (344)
                         ...+||+.|+|||++.+..  +.++|||||||++|+|++|.+||........           . ........++.+
T Consensus       235 ---~~~~gt~~y~aPE~~~~~~--~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~-----------~-~~~~~~~~~~~l  297 (681)
T 2pzi_A          235 ---GYLYGTPGFQAPEIVRTGP--TVATDIYTVGRTLAALTLDLPTRNGRYVDGL-----------P-EDDPVLKTYDSY  297 (681)
T ss_dssp             ---SCCCCCTTTSCTTHHHHCS--CHHHHHHHHHHHHHHHHSCCCEETTEECSSC-----------C-TTCHHHHHCHHH
T ss_pred             ---CccCCCccccCHHHHcCCC--CCceehhhhHHHHHHHHhCCCCCcccccccc-----------c-ccccccccCHHH
Confidence               5567999999999987654  5679999999999999999999865321100           0 000011246789


Q ss_pred             HHHHHHhcccCCCCCCChHHHhcCccc
Q 019195          227 RNLLSRIFVANPSRRITIKEIKSHPWF  253 (344)
Q Consensus       227 ~~li~~~L~~dp~~R~s~~ell~hp~~  253 (344)
                      .+||.+||+.||.+||+..+.+.|+|+
T Consensus       298 ~~li~~~l~~dP~~R~~~~~~l~~~l~  324 (681)
T 2pzi_A          298 GRLLRRAIDPDPRQRFTTAEEMSAQLT  324 (681)
T ss_dssp             HHHHHHHTCSSGGGSCSSHHHHHHHHH
T ss_pred             HHHHhhhccCChhhCCCHHHHHHHHHH
Confidence            999999999999999999999999886

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=1.4e-40  Score=296.88  Aligned_cols=216  Identities=15%  Similarity=0.116  Sum_probs=171.1

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCcccc----HHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEE
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKID----ANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVM   77 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~----~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~   77 (344)
                      ++|++.+.||+|+||.||+|.+..+++.||+|++.......    ..+.+|+.++++++||||+++++++...+.+|+||
T Consensus        31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~  110 (286)
T 3uqc_A           31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVA  110 (286)
T ss_dssp             TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEE
Confidence            57999999999999999999999999999999998754433    67889999999999999999999999999999999


Q ss_pred             ecCCCCChHHHHHhCCCCCHHHHHHHHHHHH-------HCCeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCCCCC
Q 019195           78 EYAAGGELFERICNAGRFSEDEARYFFQQLI-------SGQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPK  150 (344)
Q Consensus        78 e~~~~g~L~~~i~~~~~~~~~~~~~~~~ql~-------~~~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~~~~  150 (344)
                      ||++|++|.+++...  ....++..++.|++       +.||+||||||+|||++.++.  +||+++|            
T Consensus       111 e~~~g~~L~~~l~~~--~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~--~kl~~~~------------  174 (286)
T 3uqc_A          111 EWIRGGSLQEVADTS--PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGD--VVLAYPA------------  174 (286)
T ss_dssp             ECCCEEEHHHHHTTC--CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSC--EEECSCC------------
T ss_pred             EecCCCCHHHHHhcC--CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCC--EEEEecc------------
Confidence            999999999998543  35556666666655       459999999999999987664  8988554            


Q ss_pred             CCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccC--CCCCCCCHhHHH
Q 019195          151 STVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKI--PDYVHISQDCRN  228 (344)
Q Consensus       151 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~s~~~~~  228 (344)
                             |++|        .+.++|||||||++|+|++|+.||.+......+...... .......  .....+++++.+
T Consensus       175 -------~~~~--------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~  238 (286)
T 3uqc_A          175 -------TMPD--------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERD-TAGQPIEPADIDRDIPFQISA  238 (286)
T ss_dssp             -------CCTT--------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBC-TTSCBCCHHHHCTTSCHHHHH
T ss_pred             -------ccCC--------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHH-hccCCCChhhcccCCCHHHHH
Confidence                   3333        356699999999999999999999876542211000000 0000000  012358899999


Q ss_pred             HHHHhcccCCCCCCChHHHhcC
Q 019195          229 LLSRIFVANPSRRITIKEIKSH  250 (344)
Q Consensus       229 li~~~L~~dp~~R~s~~ell~h  250 (344)
                      ||.+||+.||.+| |+.++++.
T Consensus       239 li~~~l~~dP~~R-s~~el~~~  259 (286)
T 3uqc_A          239 VAARSVQGDGGIR-SASTLLNL  259 (286)
T ss_dssp             HHHHHHCTTSSCC-CHHHHHHH
T ss_pred             HHHHHcccCCccC-CHHHHHHH
Confidence            9999999999999 99999873

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.98  E-value=1.8e-33  Score=272.83  Aligned_cols=222  Identities=14%  Similarity=0.028  Sum_probs=143.3

Q ss_pred             eeeecCceEEEEEEEcCCCcEEEEEEeecCcc-----------ccHHHHHHHHHHhcC-CCCCcceeeEEEEcCCEEEEE
Q 019195            9 DIGSGNFGVARLMRNKNTKELVAMKYIERGHK-----------IDANVAREIINHKQL-RHPNIIRFKEVVLTPTHLAIV   76 (344)
Q Consensus         9 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-----------~~~~~~~ei~~l~~l-~h~niv~~~~~~~~~~~~~lv   76 (344)
                      .++.|+.|.+..++....|+.||+|++.+...           ...++.+|+++|+++ .|+||+++++++++++.+|||
T Consensus       241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV  320 (569)
T 4azs_A          241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV  320 (569)
T ss_dssp             C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred             ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence            35677788887777777899999999976421           124688999999999 799999999999999999999


Q ss_pred             EecCCCCChHHHHHhCCCCCHHH----HHHHHHHHHHCCeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCC-CCCCC
Q 019195           77 MEYAAGGELFERICNAGRFSEDE----ARYFFQQLISGQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH-SRPKS  151 (344)
Q Consensus        77 ~e~~~~g~L~~~i~~~~~~~~~~----~~~~~~ql~~~~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~-~~~~~  151 (344)
                      ||||+|++|.++|.+.+.+++.+    +...+..+|+.|||||||||+|||++.++  ++||+|||+|+..... ....+
T Consensus       321 MEyv~G~~L~d~i~~~~~l~~~~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg--~vKL~DFGlAr~~~~~~~~~~t  398 (569)
T 4azs_A          321 MEKLPGRLLSDMLAAGEEIDREKILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQ--HARLIDFGSIVTTPQDCSWPTN  398 (569)
T ss_dssp             EECCCSEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTS--CEEECCCTTEESCC---CCSHH
T ss_pred             EecCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHCCceeccCchHhEEECCCC--CEEEeecccCeeCCCCCccccC
Confidence            99999999999999998888764    23334555566999999999999997765  4999999999865433 33445


Q ss_pred             CccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCHhHHHHHH
Q 019195          152 TVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLS  231 (344)
Q Consensus       152 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~  231 (344)
                      .+||+.|||||++.+..  ..++|+||+|++++.|.++..+|.         .   .+.    ..+.   ....+..+..
T Consensus       399 ~vGTp~YmAPE~l~g~~--~~~~d~~s~g~~~~~l~~~~~~~~---------~---~l~----~~~~---~~~~~~~l~~  457 (569)
T 4azs_A          399 LVQSFFVFVNELFAENK--SWNGFWRSAPVHPFNLPQPWSNWL---------Y---AVW----QEPV---ERWNFVLLLA  457 (569)
T ss_dssp             HHHHHHHHHHHHC-------------------CCCCTTHHHHH---------H---HHH----TSCG---GGCSHHHHHH
T ss_pred             ceechhhccHHHhCCCC--CCcccccccccchhhhccccchhH---------H---Hhh----cCCC---CCCcHHHHHH
Confidence            68999999999997653  344899999999888766543321         0   000    0110   0112455666


Q ss_pred             HhcccCCCCCCChHHHhcCccc
Q 019195          232 RIFVANPSRRITIKEIKSHPWF  253 (344)
Q Consensus       232 ~~L~~dp~~R~s~~ell~hp~~  253 (344)
                      .++..+|..|+.......++|.
T Consensus       458 ~l~~~~~~~~~~~~~~~~~~~~  479 (569)
T 4azs_A          458 LFEKKAKLPSAEQQRGATEQWI  479 (569)
T ss_dssp             HHHTGGGSCCGGGSSCCHHHHH
T ss_pred             HHhCCCCCCCCChhhhccchhH
Confidence            6666667666665555555553

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.94  E-value=4.4e-28  Score=233.79  Aligned_cols=181  Identities=20%  Similarity=0.133  Sum_probs=134.9

Q ss_pred             eeeeeeecCceEEEEEEEcCCCcEEEEEEeecCccc---------cHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEE
Q 019195            6 LMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKI---------DANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIV   76 (344)
Q Consensus         6 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---------~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv   76 (344)
                      ..+.||+|+||.||++.  ..++.+|+|+.......         ..++.+|+.++++++||||+++..++...+..|+|
T Consensus       340 ~~~~LG~G~fg~Vy~~~--~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV  417 (540)
T 3en9_A          340 PEHLIGKGAEADIKRDS--YLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM  417 (540)
T ss_dssp             --------CCEEEEEEE--CSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred             CCCEEeeCCCEEEEEEE--ECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence            35689999999999994  45678899876542211         23478999999999999999666566677778999


Q ss_pred             EecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHCCeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCCC--------
Q 019195           77 MEYAAGGELFERICNAGRFSEDEARYFFQQLISGQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR--------  148 (344)
Q Consensus        77 ~e~~~~g~L~~~i~~~~~~~~~~~~~~~~ql~~~~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~~--------  148 (344)
                      ||||++++|.+++.. ...-..++...+..||+.||+||||||+|||++.    ++||+|||+++.......        
T Consensus       418 mE~~~ggsL~~~l~~-~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~----~~kL~DFGla~~~~~~~~~~~~~~~~  492 (540)
T 3en9_A          418 MSYINGKLAKDVIED-NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK----DLYIIDFGLGKISNLDEDKAVDLIVF  492 (540)
T ss_dssp             EECCCSEEHHHHSTT-CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS----SEEECCCTTCEECCCHHHHHHHHHHH
T ss_pred             EECCCCCCHHHHHHH-HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC----eEEEEECccCEECCCccccccchhhh
Confidence            999999999999876 2222456666778888889999999999999986    499999999986543221        


Q ss_pred             CCCCccCCcccCCccccC--CCCCCcchhHHHHHHHHHHHHhCCCCCC
Q 019195          149 PKSTVGTPAYIAPEVLSR--REYDGKLADVWSCGVTLYVMLVGAYPFE  194 (344)
Q Consensus       149 ~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~il~el~~g~~pf~  194 (344)
                      ....+||+.|||||++..  ..|. ..+|+||..+-..+.+.++.+|.
T Consensus       493 ~~~~~GT~~y~APEv~~~~~~~Y~-~~~d~ws~vl~~l~~v~~r~rY~  539 (540)
T 3en9_A          493 KKAVLSTHHEKFDEIWERFLEGYK-SVYDRWEIILELMKDVERRARYV  539 (540)
T ss_dssp             HHHHHHHCGGGHHHHHHHHHHHHH-HHCTTHHHHHHHHHHHHTCSCCC
T ss_pred             hhhhcCCCCcCCHHHHHHHHHHHH-HHHhHHHHHHHHHHHHHhccccC
Confidence            134579999999999976  4443 34899999999988888777763

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.90  E-value=2.1e-24  Score=191.55  Aligned_cols=141  Identities=19%  Similarity=0.135  Sum_probs=106.7

Q ss_pred             ceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCcc-------------------ccHHHHHHHHHHhcCCCCCcceee
Q 019195            4 YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK-------------------IDANVAREIINHKQLRHPNIIRFK   64 (344)
Q Consensus         4 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-------------------~~~~~~~ei~~l~~l~h~niv~~~   64 (344)
                      |.+.+.||+|+||.||+|.+ .+|+.||+|++.....                   ....+.+|+.++++++  | +++.
T Consensus        92 ~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~  167 (282)
T 1zar_A           92 DAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVP  167 (282)
T ss_dssp             SEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSC
T ss_pred             EEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcC
Confidence            45569999999999999999 8899999999864321                   1245889999999998  4 6666


Q ss_pred             EEEEcCCEEEEEEecCCCCChHHHHHhCCC-CCHHHHHHHHHHHHHCCeeecCCCCCCeEecCCCCCCEEEeecCCCccc
Q 019195           65 EVVLTPTHLAIVMEYAAGGELFERICNAGR-FSEDEARYFFQQLISGQICHRDLKLENTLLDGSPAPRLKICDFGYSKSS  143 (344)
Q Consensus        65 ~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~-~~~~~~~~~~~ql~~~~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~  143 (344)
                      +++.. +..|+||||++|++|.+ +..... .-..++...+..+|+.||+||||||+|||++ +  +++||+|||+|+  
T Consensus       168 ~~~~~-~~~~lvmE~~~g~~L~~-l~~~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~--~~vkl~DFG~a~--  240 (282)
T 1zar_A          168 KVYAW-EGNAVLMELIDAKELYR-VRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-E--EGIWIIDFPQSV--  240 (282)
T ss_dssp             CEEEE-ETTEEEEECCCCEEGGG-CCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-T--TEEEECCCTTCE--
T ss_pred             eEEec-cceEEEEEecCCCcHHH-cchhhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-C--CcEEEEECCCCe--
Confidence            65543 55699999999999988 422110 1123455556677788999999999999998 4  459999999986  


Q ss_pred             CCCCCCCCCccCCcccCCcccc
Q 019195          144 LLHSRPKSTVGTPAYIAPEVLS  165 (344)
Q Consensus       144 ~~~~~~~~~~gt~~y~aPE~~~  165 (344)
                                .+..++|||++.
T Consensus       241 ----------~~~~~~a~e~l~  252 (282)
T 1zar_A          241 ----------EVGEEGWREILE  252 (282)
T ss_dssp             ----------ETTSTTHHHHHH
T ss_pred             ----------ECCCCCHHHHHH
Confidence                      345678999874

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.83  E-value=8.7e-21  Score=166.11  Aligned_cols=131  Identities=13%  Similarity=0.063  Sum_probs=96.4

Q ss_pred             ceeeeeeeecCceEEEEEEEcCCCcE--EEEEEeecCccc-------------------------cHHHHHHHHHHhcCC
Q 019195            4 YELMKDIGSGNFGVARLMRNKNTKEL--VAMKYIERGHKI-------------------------DANVAREIINHKQLR   56 (344)
Q Consensus         4 y~~~~~lg~G~~g~V~~~~~~~~~~~--vaiK~~~~~~~~-------------------------~~~~~~ei~~l~~l~   56 (344)
                      |++.+.||+|+||.||+|.+..+|+.  ||||++......                         ...+.+|+.+++.+.
T Consensus        49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~  128 (258)
T 1zth_A           49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK  128 (258)
T ss_dssp             EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred             hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence            67899999999999999999778888  999987543211                         125789999999998


Q ss_pred             CCCc--ceeeEEEEcCCEEEEEEecCCC-C----ChHHHHHhCCC----CCHHHHHHHHHHHH-HCCeeecCCCCCCeEe
Q 019195           57 HPNI--IRFKEVVLTPTHLAIVMEYAAG-G----ELFERICNAGR----FSEDEARYFFQQLI-SGQICHRDLKLENTLL  124 (344)
Q Consensus        57 h~ni--v~~~~~~~~~~~~~lv~e~~~~-g----~L~~~i~~~~~----~~~~~~~~~~~ql~-~~~iiH~Dikp~NIl~  124 (344)
                      |+++  +.++..    ...++||||+.+ |    +|.+.......    .-..++...+..|| +.||+||||||+|||+
T Consensus       129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp~NILl  204 (258)
T 1zth_A          129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRELKELDVEGIFNDVVENVKRLYQEAELVHADLSEYNIMY  204 (258)
T ss_dssp             HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGGGGGSCHHHHHHHHHHHHHHHHHTSCEECSSCSTTSEEE
T ss_pred             hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhccChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEE
Confidence            8764  334432    356899999942 3    66665433110    11234555677788 8899999999999999


Q ss_pred             cCCCCCCEEEeecCCCcc
Q 019195          125 DGSPAPRLKICDFGYSKS  142 (344)
Q Consensus       125 ~~~~~~~vkL~DFg~a~~  142 (344)
                      +.    .++|+|||+|..
T Consensus       205 ~~----~~~liDFG~a~~  218 (258)
T 1zth_A          205 ID----KVYFIDMGQAVT  218 (258)
T ss_dssp             SS----SEEECCCTTCEE
T ss_pred             cC----cEEEEECccccc
Confidence            76    499999999864

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.69  E-value=4.1e-17  Score=148.99  Aligned_cols=135  Identities=14%  Similarity=0.087  Sum_probs=90.9

Q ss_pred             ceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCccc---------------c--------HHHHHHHHHHhcCCCCCc
Q 019195            4 YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKI---------------D--------ANVAREIINHKQLRHPNI   60 (344)
Q Consensus         4 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---------------~--------~~~~~ei~~l~~l~h~ni   60 (344)
                      |.+.+.||+|+||.||+|.+. +|+.||||+++.....               .        ....+|...|.++.+.++
T Consensus        97 Y~I~~~IG~Gk~a~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv  175 (397)
T 4gyi_A           97 YSVGSRIGVGKESDIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF  175 (397)
T ss_dssp             SEEEEEEEECSSEEEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             EEecCEeeeCCceEEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence            899999999999999999985 6899999987542110               0        012356777777754443


Q ss_pred             ceeeEEEEcCCEEEEEEecCCCCChHHHHHhCCC-CCHHHHHHHHHHHHHCCeeecCCCCCCeEecCCCCC--------C
Q 019195           61 IRFKEVVLTPTHLAIVMEYAAGGELFERICNAGR-FSEDEARYFFQQLISGQICHRDLKLENTLLDGSPAP--------R  131 (344)
Q Consensus        61 v~~~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~-~~~~~~~~~~~ql~~~~iiH~Dikp~NIl~~~~~~~--------~  131 (344)
                      .-..-+...  ..+|||||++|++|..+...... --..++...+..+|++|||||||||.|||++.++.+        .
T Consensus       176 ~vp~p~~~~--~~~LVME~i~G~~L~~l~~~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~~d~~~~~~~  253 (397)
T 4gyi_A          176 PVPEPIAQS--RHTIVMSLVDALPMRQVSSVPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKDAEDPSSITLT  253 (397)
T ss_dssp             SCCCEEEEE--TTEEEEECCSCEEGGGCCCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECSSCTTSEEEE
T ss_pred             CCCeeeecc--CceEEEEecCCccHhhhcccHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCcccccccccc
Confidence            222111111  22799999999888654321100 012345566777888899999999999999765532        2


Q ss_pred             EEEeecCCCc
Q 019195          132 LKICDFGYSK  141 (344)
Q Consensus       132 vkL~DFg~a~  141 (344)
                      +.|+||+-+.
T Consensus       254 ~~iID~~Q~V  263 (397)
T 4gyi_A          254 PIIIXFPQMV  263 (397)
T ss_dssp             EEECCCTTCE
T ss_pred             eEEEEeCCcc
Confidence            7899999554

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.40  E-value=7.8e-13  Score=115.46  Aligned_cols=136  Identities=17%  Similarity=0.056  Sum_probs=101.2

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCc-cccHHHHHHHHHHhcCC-CCCcceeeEEEEcCCEEEEEEec
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH-KIDANVAREIINHKQLR-HPNIIRFKEVVLTPTHLAIVMEY   79 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~ei~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~   79 (344)
                      +.|++...++.|+.+.||++...  +..+++|+..... .....+.+|+.+++.+. +..+.++++++...+..|+||||
T Consensus        14 ~~~~~~~~~~g~s~~~v~~~~~~--~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~   91 (263)
T 3tm0_A           14 EKYRCVKDTEGMSPAKVYKLVGE--NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSE   91 (263)
T ss_dssp             TTSEEEECCSCCSSSEEEEEECS--SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEEC
T ss_pred             ccceeEeeccCCCCCeEEEEECC--CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEe
Confidence            57899999999999999999753  5789999986532 22346889999999884 67788999999888999999999


Q ss_pred             CCCCChHHHHHhCCC--CCHHHHHHHHHHHHH------------------------------------------------
Q 019195           80 AAGGELFERICNAGR--FSEDEARYFFQQLIS------------------------------------------------  109 (344)
Q Consensus        80 ~~~g~L~~~i~~~~~--~~~~~~~~~~~ql~~------------------------------------------------  109 (344)
                      ++|.+|...+.....  --..++...+..||+                                                
T Consensus        92 i~G~~l~~~~~~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  171 (263)
T 3tm0_A           92 ADGVLCSEEYEDEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELY  171 (263)
T ss_dssp             CSSEEHHHHCCTTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSSHHHHH
T ss_pred             cCCeehhhccCCcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCCCHHHHH
Confidence            999998765311100  001234445555665                                                


Q ss_pred             -----------CCeeecCCCCCCeEecCCCCCCEEEeecCCCc
Q 019195          110 -----------GQICHRDLKLENTLLDGSPAPRLKICDFGYSK  141 (344)
Q Consensus       110 -----------~~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~  141 (344)
                                 ..++|+|++|.||+++.+.  .+.|+||+.+.
T Consensus       172 ~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~--~~~lIDwe~a~  212 (263)
T 3tm0_A          172 DFLKTEKPEEELVFSHGDLGDSNIFVKDGK--VSGFIDLGRSG  212 (263)
T ss_dssp             HHHHHCCCCCCEEEECSSCCTTSEEEETTE--EEEECCCTTCE
T ss_pred             HHHHhcCCCCCceEECCCCCcCcEEEECCc--EEEEEEchhcc
Confidence                       2489999999999997542  25699999764

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.30  E-value=3.1e-12  Score=111.17  Aligned_cols=82  Identities=11%  Similarity=0.053  Sum_probs=61.0

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcCCCCC--cceeeEEEEcCCEEEEEEec
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPN--IIRFKEVVLTPTHLAIVMEY   79 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~l~~l~h~n--iv~~~~~~~~~~~~~lv~e~   79 (344)
                      ..|.+....+.|+.+.||++.. .+|..+++|+....  ....+.+|+.+++.+.+.+  +.+++.+....+..++||||
T Consensus        20 ~~~~~~~~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~--~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~   96 (264)
T 1nd4_A           20 FGYDWAQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSG--ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGE   96 (264)
T ss_dssp             TTCEEEECSCTTSSCEEEEEEC-TTSCCEEEEEECSC--TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEEC
T ss_pred             CCCceEecccCCCCceEEEEec-CCCCeEEEEeCCcc--cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEe
Confidence            3455544444566699999964 45678999987654  2346788999999885444  56688888888889999999


Q ss_pred             CCCCChH
Q 019195           80 AAGGELF   86 (344)
Q Consensus        80 ~~~g~L~   86 (344)
                      ++|.+|.
T Consensus        97 i~G~~l~  103 (264)
T 1nd4_A           97 VPGQDLL  103 (264)
T ss_dssp             CSSEETT
T ss_pred             cCCcccC
Confidence            9998874

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.03  E-value=1e-09  Score=100.14  Aligned_cols=134  Identities=14%  Similarity=0.194  Sum_probs=88.7

Q ss_pred             eeeeeeeecCceEEEEEEEcCCCcEEEEEEee--cCc--cccHHHHHHHHHHhcCC--CCCcceeeEEEEcC---CEEEE
Q 019195            5 ELMKDIGSGNFGVARLMRNKNTKELVAMKYIE--RGH--KIDANVAREIINHKQLR--HPNIIRFKEVVLTP---THLAI   75 (344)
Q Consensus         5 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~--~~~--~~~~~~~~ei~~l~~l~--h~niv~~~~~~~~~---~~~~l   75 (344)
                      ..++.|+.|.++.||++...  +..+++|+..  ...  .....+.+|+.+++.|.  +..+++++.++.+.   +..|+
T Consensus        41 ~~~~~l~~G~sn~~y~v~~~--~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~  118 (359)
T 3dxp_A           41 LSVEQFKGGQSNPTFKLVTP--GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFY  118 (359)
T ss_dssp             CEEEECCC-CCSCEEEEECS--SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEE
T ss_pred             ceEEEcCCcccceEEEEEEC--CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEE
Confidence            35778999999999999864  3578888776  332  12346889999999986  45678888888766   45899


Q ss_pred             EEecCCCCChHHHHHhCCCCCHH-------HHHHHHHHHHH---------------------------------------
Q 019195           76 VMEYAAGGELFERICNAGRFSED-------EARYFFQQLIS---------------------------------------  109 (344)
Q Consensus        76 v~e~~~~g~L~~~i~~~~~~~~~-------~~~~~~~ql~~---------------------------------------  109 (344)
                      ||||++|..+.+..  ...++..       ++...+.+||+                                       
T Consensus       119 vme~v~G~~l~~~~--~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  196 (359)
T 3dxp_A          119 IMEFVSGRVLWDQS--LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPA  196 (359)
T ss_dssp             EEECCCCBCCCCTT--CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHH
T ss_pred             EEEecCCeecCCCc--cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChH
Confidence            99999987773210  0111211       12222222332                                       


Q ss_pred             -------------------CCeeecCCCCCCeEecCCCCCCEEEeecCCCcc
Q 019195          110 -------------------GQICHRDLKLENTLLDGSPAPRLKICDFGYSKS  142 (344)
Q Consensus       110 -------------------~~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~  142 (344)
                                         ..++|+|++|.|||++.++...+.|+||+.+..
T Consensus       197 ~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          197 MDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             HHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             HHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence                               368999999999999865433368999998763

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=98.81  E-value=1.9e-09  Score=96.01  Aligned_cols=178  Identities=17%  Similarity=0.157  Sum_probs=102.2

Q ss_pred             eeeeeecCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcCC-CCC--cceeeEEEEcCC---EEEEEEecC
Q 019195            7 MKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLR-HPN--IIRFKEVVLTPT---HLAIVMEYA   80 (344)
Q Consensus         7 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~l~~l~-h~n--iv~~~~~~~~~~---~~~lv~e~~   80 (344)
                      ++.++.|.+..||++.     ..+++|+.... .....+.+|..+++.+. +..  +.+++.......   ..|+||+++
T Consensus        25 i~~~~~G~~n~v~~v~-----~~~vlR~~~~~-~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i   98 (304)
T 3sg8_A           25 IEISGEGNDCIAYEIN-----RDFIFKFPKHS-RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI   98 (304)
T ss_dssp             CCEEEECSSEEEEEST-----TSEEEEEESSH-HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred             eEecCCCCcceEEEEC-----CEEEEEecCCc-chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence            5678999999999874     35888975432 23457889999998873 333  344444433332   348899999


Q ss_pred             CCCChHHHHHhC-----------------------C--------CCCH------------------------HHHHHHHH
Q 019195           81 AGGELFERICNA-----------------------G--------RFSE------------------------DEARYFFQ  105 (344)
Q Consensus        81 ~~g~L~~~i~~~-----------------------~--------~~~~------------------------~~~~~~~~  105 (344)
                      +|.+|.......                       .        ....                        ..+...+.
T Consensus        99 ~G~~l~~~~~~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~  178 (304)
T 3sg8_A           99 KGVPLTPLLLNNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDDFYR  178 (304)
T ss_dssp             CCEECCHHHHHTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHHHHH
T ss_pred             CCeECCccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHHHHH
Confidence            998875421100                       0        0000                        01111122


Q ss_pred             HHHH--------CCeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCCCCCCCccCCcccCCc---------------
Q 019195          106 QLIS--------GQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPE---------------  162 (344)
Q Consensus       106 ql~~--------~~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~~~~~~~gt~~y~aPE---------------  162 (344)
                      +++.        ..++|+|++|.||+++.+....+.|+||+.+.................-..|+               
T Consensus       179 ~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~~~~~~  258 (304)
T 3sg8_A          179 DILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYKHKDIP  258 (304)
T ss_dssp             HHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHTCSCHH
T ss_pred             HHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcCCCCcH
Confidence            2222        16899999999999986422247899999876432211100000000001222               


Q ss_pred             -cccCCCCCCcchhHHHHHHHHHHHHhCCCCC
Q 019195          163 -VLSRREYDGKLADVWSCGVTLYVMLVGAYPF  193 (344)
Q Consensus       163 -~~~~~~~~~~~~DiwslG~il~el~~g~~pf  193 (344)
                       ......   .-.+.|++|.++|.+.+|..+|
T Consensus       259 ~~~~r~~---~~~~~~~l~~~~~~~~~g~~~~  287 (304)
T 3sg8_A          259 TVLEKYR---MKEKYWSFEKIIYGKEYGYMDW  287 (304)
T ss_dssp             HHHHHHH---HHHHHHHHHHHHHHHHTTCHHH
T ss_pred             HHHHHHH---HHHHHHHHHHHHHHHHcCCHHH
Confidence             211111   1158999999999999998776

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.60  E-value=3.6e-07  Score=79.61  Aligned_cols=80  Identities=15%  Similarity=0.176  Sum_probs=60.5

Q ss_pred             eeeeecCce-EEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcCC-CCCcceeeEEEEcCCEEEEEEecCCCCCh
Q 019195            8 KDIGSGNFG-VARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLR-HPNIIRFKEVVLTPTHLAIVMEYAAGGEL   85 (344)
Q Consensus         8 ~~lg~G~~g-~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~g~L   85 (344)
                      +.+..|..| .||+......+..+++|+-...  ....+.+|...|+.+. +--+.+++.++.+.+..|+||++++|.++
T Consensus        30 ~~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~--~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~  107 (272)
T 4gkh_A           30 ARDNVGQSGATIYRLYGKPNAPELFLKHGKGS--VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTA  107 (272)
T ss_dssp             EEEECSSSSCEEEEEECCTTCCCEEEEEEETH--HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEH
T ss_pred             EEccCCCcCCeEEEEEecCCCeEEEEEECCCC--CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccc
Confidence            345566665 6999988877888999976543  2345788999998874 33367788888888999999999999887


Q ss_pred             HHHH
Q 019195           86 FERI   89 (344)
Q Consensus        86 ~~~i   89 (344)
                      .+..
T Consensus       108 ~~~~  111 (272)
T 4gkh_A          108 FQVL  111 (272)
T ss_dssp             HHHH
T ss_pred             cccc
Confidence            6544

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=98.43  E-value=1.2e-06  Score=80.74  Aligned_cols=76  Identities=14%  Similarity=0.043  Sum_probs=50.4

Q ss_pred             eeeeeeecCceEEEEEEEcCCCcEEEEEEeecCc--------cccHHHHHHHHHHhcCCC--C-CcceeeEEEEcCCEEE
Q 019195            6 LMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH--------KIDANVAREIINHKQLRH--P-NIIRFKEVVLTPTHLA   74 (344)
Q Consensus         6 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--------~~~~~~~~ei~~l~~l~h--~-niv~~~~~~~~~~~~~   74 (344)
                      -++.||.|.++.||++....+++.+++|......        ....++..|..+++.+..  | .+.+++.+  +....+
T Consensus        34 ~~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~  111 (397)
T 2olc_A           34 TCQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAV  111 (397)
T ss_dssp             EEEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTE
T ss_pred             EEEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccE
Confidence            3678999999999999776667889999764321        123456789888887732  3 34455543  344568


Q ss_pred             EEEecCCCC
Q 019195           75 IVMEYAAGG   83 (344)
Q Consensus        75 lv~e~~~~g   83 (344)
                      +|||++++.
T Consensus       112 lvmE~l~g~  120 (397)
T 2olc_A          112 TVMEDLSHL  120 (397)
T ss_dssp             EEECCCTTS
T ss_pred             EEEEeCCCc
Confidence            999999774

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.31  E-value=3.5e-06  Score=74.86  Aligned_cols=75  Identities=16%  Similarity=0.103  Sum_probs=54.6

Q ss_pred             eeeeeecCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcCCCC---CcceeeEEEE-cCCEEEEEEecCCC
Q 019195            7 MKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHP---NIIRFKEVVL-TPTHLAIVMEYAAG   82 (344)
Q Consensus         7 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~l~~l~h~---niv~~~~~~~-~~~~~~lv~e~~~~   82 (344)
                      ++.++.|....||++     +..+++|+-.. ......+.+|..+|+.|.+.   .+.+.+.+.. ..+..|+||++++|
T Consensus        24 v~~l~~G~~n~v~~v-----g~~~VlR~~~~-~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G   97 (306)
T 3tdw_A           24 VESLGEGFRNYAILV-----NGDWVFRFPKS-QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG   97 (306)
T ss_dssp             EEEEEECSSEEEEEE-----TTTEEEEEESS-HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred             eeecCCCcceeEEEE-----CCEEEEEecCC-chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence            567888999999998     45688887432 22345788999999998642   3556666664 44567899999999


Q ss_pred             CChHH
Q 019195           83 GELFE   87 (344)
Q Consensus        83 g~L~~   87 (344)
                      .+|..
T Consensus        98 ~~l~~  102 (306)
T 3tdw_A           98 QILGE  102 (306)
T ss_dssp             EECHH
T ss_pred             eECch
Confidence            87754

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=98.02  E-value=6.9e-05  Score=67.15  Aligned_cols=74  Identities=18%  Similarity=0.251  Sum_probs=43.2

Q ss_pred             eeeeeecCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcCC-----CCCcceee-E--EEEcCCEEEEEEe
Q 019195            7 MKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLR-----HPNIIRFK-E--VVLTPTHLAIVME   78 (344)
Q Consensus         7 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~l~~l~-----h~niv~~~-~--~~~~~~~~~lv~e   78 (344)
                      ++.|+.|..+.||++... ++ .+++|+.....   ..+..|+.+++.|.     .|.++... +  +....+..+++|+
T Consensus        37 ~~~l~gG~~n~~~~v~~~-~~-~~vlk~~~~~~---~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~  111 (346)
T 2q83_A           37 IDVIQGNQMALVWKVHTD-SG-AVCLKRIHRPE---KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYD  111 (346)
T ss_dssp             EEECC----CEEEEEEET-TE-EEEEEEECSCH---HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEE
T ss_pred             eeeccccccCcEEEEEeC-CC-CEEEEecCCCH---HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEE
Confidence            456766788999999763 33 58999887532   34445556555552     34444310 0  1234677899999


Q ss_pred             cCCCCCh
Q 019195           79 YAAGGEL   85 (344)
Q Consensus        79 ~~~~g~L   85 (344)
                      |++|.++
T Consensus       112 ~i~G~~~  118 (346)
T 2q83_A          112 WIEGRPF  118 (346)
T ss_dssp             CCCCBCC
T ss_pred             eecCccC
Confidence            9998654

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.92  E-value=2.4e-05  Score=69.12  Aligned_cols=75  Identities=13%  Similarity=0.132  Sum_probs=47.5

Q ss_pred             CceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcCCCCCc-ceeeEEEEcCCEEEEEEecC-
Q 019195            3 KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNI-IRFKEVVLTPTHLAIVMEYA-   80 (344)
Q Consensus         3 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e~~-   80 (344)
                      ++.-++.|+.|....+|++      ..+++|+............+|+.+++.+...++ .+++..  +...-+++++|+ 
T Consensus        19 ~~~~i~~l~gG~tN~~~~~------~~~vlR~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~   90 (301)
T 3dxq_A           19 GYTGPLERLGGLTNLVFRA------GDLCLRIPGKGTEEYINRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIA   90 (301)
T ss_dssp             TCCSCEEEESCSSEEEEEE------TTEEEEEECC----CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCT
T ss_pred             cccceeEcCCcccccccee------eeEEEECCCCCccceeCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecC
Confidence            3555788999999999999      358889876543222234578888877742222 455543  333446899999 


Q ss_pred             CCCCh
Q 019195           81 AGGEL   85 (344)
Q Consensus        81 ~~g~L   85 (344)
                      +|.+|
T Consensus        91 ~g~~l   95 (301)
T 3dxq_A           91 GAQTM   95 (301)
T ss_dssp             TCEEC
T ss_pred             CCccC
Confidence            66554

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.91  E-value=0.00027  Score=62.72  Aligned_cols=76  Identities=16%  Similarity=0.087  Sum_probs=60.4

Q ss_pred             eeeeeeecCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcCC---CCCcceeeEEEEcCCEEEEEEecCCC
Q 019195            6 LMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLR---HPNIIRFKEVVLTPTHLAIVMEYAAG   82 (344)
Q Consensus         6 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~l~~l~---h~niv~~~~~~~~~~~~~lv~e~~~~   82 (344)
                      -++.|+.|.+..+|++..  .+..+++|+....  ....+.+|...|+.|.   ...+++++.+....+..|+||||++|
T Consensus        40 ~~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~--~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G  115 (312)
T 3jr1_A           40 HKEKLYSGEMNEIWLIND--EVQTVFVKINERS--YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNK  115 (312)
T ss_dssp             EEEEECCSSSSEEEEEES--SSCEEEEEEEEGG--GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCC
T ss_pred             eeEEeCCccceeeeEEEE--CCCeEEEEeCCcc--cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccC
Confidence            457899999999999975  3567888987643  2456788999888883   36788888888888899999999998


Q ss_pred             CCh
Q 019195           83 GEL   85 (344)
Q Consensus        83 g~L   85 (344)
                      ..+
T Consensus       116 ~~~  118 (312)
T 3jr1_A          116 SKN  118 (312)
T ss_dssp             CCC
T ss_pred             CCC
Confidence            764

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.88  E-value=8.4e-05  Score=68.95  Aligned_cols=73  Identities=14%  Similarity=0.154  Sum_probs=45.0

Q ss_pred             eeeeeeecCceEEEEEEEcCCCcEEEEEEeec-------C-ccccHHHHHHHHHHhcC---CCCCcceeeEEEEcCCEEE
Q 019195            6 LMKDIGSGNFGVARLMRNKNTKELVAMKYIER-------G-HKIDANVAREIINHKQL---RHPNIIRFKEVVLTPTHLA   74 (344)
Q Consensus         6 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-------~-~~~~~~~~~ei~~l~~l---~h~niv~~~~~~~~~~~~~   74 (344)
                      -++.||.|..+.||++..  +++.+++|....       . .....+...|.+++..+   ....+.+++.+.  .+..+
T Consensus        38 ~i~~l~~G~~n~vyrv~~--~~~~~vvK~~~p~~~~~~~~~~~~~~~~~~E~e~l~~~~~~~~~~vP~v~~~~--~~~~~  113 (420)
T 2pyw_A           38 VIKEVGDGNLNFVFIVVG--SSGSLVIKQALPYIRCIGESWPMTKERAYFEATTLRKHGNLSPDHVPEVYHFD--RTMAL  113 (420)
T ss_dssp             EEEECCCSSSCEEEEEEC--SSCEEEEEECCSBCTTTCTTSBCCTTHHHHHHHHHHHHHHHSGGGSCCEEEEE--TTTTE
T ss_pred             EEEEccCCCcEEEEEEEc--CCceEEEEECchhhcccCcccccchhHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCccE
Confidence            467899999999999964  466899994321       1 11112223333333322   234566776665  56678


Q ss_pred             EEEecC-CC
Q 019195           75 IVMEYA-AG   82 (344)
Q Consensus        75 lv~e~~-~~   82 (344)
                      +|||++ +|
T Consensus       114 lv~e~l~~g  122 (420)
T 2pyw_A          114 IGMRYLEPP  122 (420)
T ss_dssp             EEECCCCTT
T ss_pred             EEEeecCCc
Confidence            999999 76

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=97.66  E-value=0.00019  Score=64.85  Aligned_cols=80  Identities=8%  Similarity=0.084  Sum_probs=55.6

Q ss_pred             eeeee-eecCceEEEEEEEc---C---CCcEEEEEEeecCc---c-ccHHHHHHHHHHhcCC-C--CCcceeeEEEEcC-
Q 019195            6 LMKDI-GSGNFGVARLMRNK---N---TKELVAMKYIERGH---K-IDANVAREIINHKQLR-H--PNIIRFKEVVLTP-   70 (344)
Q Consensus         6 ~~~~l-g~G~~g~V~~~~~~---~---~~~~vaiK~~~~~~---~-~~~~~~~ei~~l~~l~-h--~niv~~~~~~~~~-   70 (344)
                      .++.| +.|..+.+|++...   .   ++..+++|+.....   . ....+.+|+.+++.|. +  -.+.+++.+..+. 
T Consensus        24 ~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~  103 (357)
T 3ats_A           24 VESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGD  103 (357)
T ss_dssp             EEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSST
T ss_pred             EEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCC
Confidence            35677 88888999988753   1   15678899765433   1 1246788999888884 2  3567777776554 


Q ss_pred             --CEEEEEEecCCCCCh
Q 019195           71 --THLAIVMEYAAGGEL   85 (344)
Q Consensus        71 --~~~~lv~e~~~~g~L   85 (344)
                        +..|+|||+++|.++
T Consensus       104 ~~g~~~~v~e~l~G~~l  120 (357)
T 3ats_A          104 VLGTPFFLMDYVEGVVP  120 (357)
T ss_dssp             TTSSCEEEEECCCCBCC
T ss_pred             ccCCceEEEEecCCCCh
Confidence              356899999998654

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.65  E-value=0.00063  Score=59.49  Aligned_cols=77  Identities=9%  Similarity=0.028  Sum_probs=53.5

Q ss_pred             ceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCcc-ccHHHHHHHHHHhcCCC---CCcceeeEEEEcCCEEEEEEec
Q 019195            4 YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK-IDANVAREIINHKQLRH---PNIIRFKEVVLTPTHLAIVMEY   79 (344)
Q Consensus         4 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~ei~~l~~l~h---~niv~~~~~~~~~~~~~lv~e~   79 (344)
                      ..-++.+|.|..+.||++.. .+|+.|.+|+-..... ....+.+|...|+.|.-   --+.+++.+  +.  -++||||
T Consensus        17 v~~v~~~g~G~~~~vyrv~l-~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~--~~--~~lv~e~   91 (288)
T 3f7w_A           17 VAAVAERGHSHRWHLYRVEL-ADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW--DD--RTLAMEW   91 (288)
T ss_dssp             EEEEEEEEEETTEEEEEEEE-TTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE--ET--TEEEEEC
T ss_pred             eEEEEecCCCCCeEEEEEEE-CCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec--cC--ceEEEEe
Confidence            34577899999999999986 4678899997654332 23457889999988742   234444443  22  3689999


Q ss_pred             CCCCCh
Q 019195           80 AAGGEL   85 (344)
Q Consensus        80 ~~~g~L   85 (344)
                      +.++..
T Consensus        92 l~~~~~   97 (288)
T 3f7w_A           92 VDERPP   97 (288)
T ss_dssp             CCCCCC
T ss_pred             ecccCC
Confidence            987654

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=97.55  E-value=0.0013  Score=61.55  Aligned_cols=76  Identities=14%  Similarity=0.080  Sum_probs=50.1

Q ss_pred             eeeeeeecCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcCCCCCc-ceeeEEEEcCCEEEEEEecCCCCC
Q 019195            6 LMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNI-IRFKEVVLTPTHLAIVMEYAAGGE   84 (344)
Q Consensus         6 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e~~~~g~   84 (344)
                      -++.|+.|-...+|++.....+..+++|+........-...+|..+++.|...++ .++++.+.  +  .+||+|++|.+
T Consensus       112 ~i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~  187 (458)
T 2qg7_A          112 EFQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEIINREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYA  187 (458)
T ss_dssp             EEEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCSCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEE
T ss_pred             EEEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhcCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCcc
Confidence            3567888888999999876545788899875432222223689999988864444 56776662  3  25999998854


Q ss_pred             h
Q 019195           85 L   85 (344)
Q Consensus        85 L   85 (344)
                      |
T Consensus       188 l  188 (458)
T 2qg7_A          188 L  188 (458)
T ss_dssp             C
T ss_pred             C
Confidence            4

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=97.54  E-value=0.00063  Score=62.07  Aligned_cols=131  Identities=15%  Similarity=0.145  Sum_probs=78.0

Q ss_pred             eeeeeecCceEEEEEEEcC-------CCcEEEEEEeecCccccHHHHHHHHHHhcCC-CCCcceeeEEEEcCCEEEEEEe
Q 019195            7 MKDIGSGNFGVARLMRNKN-------TKELVAMKYIERGHKIDANVAREIINHKQLR-HPNIIRFKEVVLTPTHLAIVME   78 (344)
Q Consensus         7 ~~~lg~G~~g~V~~~~~~~-------~~~~vaiK~~~~~~~~~~~~~~ei~~l~~l~-h~niv~~~~~~~~~~~~~lv~e   78 (344)
                      ++.|..|-...+|++....       .++.|++|+.-........+.+|..+++.|. +.-..++++.+.+    .+|||
T Consensus        55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e  130 (379)
T 3feg_A           55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAILQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQ  130 (379)
T ss_dssp             CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC---CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEE
T ss_pred             EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCccchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEE
Confidence            4567778888999998642       3578999986432223355678999998884 3334566666543    39999


Q ss_pred             cCCCCChHH--------------HH---HhCC-----CC--CHHHHHHHHHHH---------------------------
Q 019195           79 YAAGGELFE--------------RI---CNAG-----RF--SEDEARYFFQQL---------------------------  107 (344)
Q Consensus        79 ~~~~g~L~~--------------~i---~~~~-----~~--~~~~~~~~~~ql---------------------------  107 (344)
                      |++|.+|..              .+   +...     ..  ...++..++.++                           
T Consensus       131 ~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~  210 (379)
T 3feg_A          131 YIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLR  210 (379)
T ss_dssp             CCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHH
T ss_pred             EecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHH
Confidence            999855421              11   1110     11  124445444333                           


Q ss_pred             --HHC-----CeeecCCCCCCeEecCC--CCCCEEEeecCCCc
Q 019195          108 --ISG-----QICHRDLKLENTLLDGS--PAPRLKICDFGYSK  141 (344)
Q Consensus       108 --~~~-----~iiH~Dikp~NIl~~~~--~~~~vkL~DFg~a~  141 (344)
                        +..     .++|+|+.+.||+++.+  ..+.+.|+||..+.
T Consensus       211 ~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~  253 (379)
T 3feg_A          211 KLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS  253 (379)
T ss_dssp             HHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred             HHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence              111     78999999999999865  12359999999764

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=97.51  E-value=0.0009  Score=59.55  Aligned_cols=77  Identities=8%  Similarity=0.048  Sum_probs=49.4

Q ss_pred             eeeeeecCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcCCCC--CcceeeEE-----EEcCCEEEEEEec
Q 019195            7 MKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHP--NIIRFKEV-----VLTPTHLAIVMEY   79 (344)
Q Consensus         7 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~l~~l~h~--niv~~~~~-----~~~~~~~~lv~e~   79 (344)
                      +..|+ |....||++... +|+.+++|+..........+..|..+++.|...  .+++++..     ....+..+++|++
T Consensus        31 ~~~l~-g~~n~~y~v~~~-~g~~~vlK~~~~~~~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~  108 (328)
T 1zyl_A           31 LTPLN-SYENRVYQFQDE-DRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPS  108 (328)
T ss_dssp             CEEEC-CSSSEEEEECCT-TCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEEC
T ss_pred             EEeec-CcccceEEEEcC-CCCEEEEEEcCCCCCCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEe
Confidence            34566 778899988643 456799998864433345677788888777321  23444332     2235667899999


Q ss_pred             CCCCCh
Q 019195           80 AAGGEL   85 (344)
Q Consensus        80 ~~~g~L   85 (344)
                      ++|.++
T Consensus       109 i~G~~~  114 (328)
T 1zyl_A          109 VGGRQF  114 (328)
T ss_dssp             CCCEEC
T ss_pred             cCCCCC
Confidence            988543

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.50  E-value=0.00047  Score=61.23  Aligned_cols=76  Identities=14%  Similarity=0.087  Sum_probs=44.8

Q ss_pred             eeeeeecCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcCC-----CCCcceee-E--EEEcCCEEEEEEe
Q 019195            7 MKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLR-----HPNIIRFK-E--VVLTPTHLAIVME   78 (344)
Q Consensus         7 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~l~~l~-----h~niv~~~-~--~~~~~~~~~lv~e   78 (344)
                      ++.|+.|....+|++.... + .+++|+.... .....+..|+.+++.|.     .|.++... +  +....+..+++|+
T Consensus        27 ~~~i~~G~~n~~~~v~~~~-g-~~vlk~~~~~-~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~~  103 (322)
T 2ppq_A           27 YKGIAEGVENSNFLLHTTK-D-PLILTLYEKR-VEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALIS  103 (322)
T ss_dssp             EEEECC---EEEEEEEESS-C-CEEEEEECC----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEE
T ss_pred             eeccCCCcccceEEEEeCC-c-cEEEEEeCCC-CCHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEEE
Confidence            5667788889999997643 3 5889987653 12345667777777663     23333211 0  1123467799999


Q ss_pred             cCCCCCh
Q 019195           79 YAAGGEL   85 (344)
Q Consensus        79 ~~~~g~L   85 (344)
                      |++|..+
T Consensus       104 ~l~G~~~  110 (322)
T 2ppq_A          104 FLEGMWL  110 (322)
T ss_dssp             CCCCBCC
T ss_pred             eCCCcCC
Confidence            9998653

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=97.33  E-value=0.00094  Score=62.04  Aligned_cols=75  Identities=13%  Similarity=0.115  Sum_probs=50.9

Q ss_pred             eeeeeeecCceEEEEEEEcC-------CCcEEEEEEeecCccccHHHHHHHHHHhcCCCCC-cceeeEEEEcCCEEEEEE
Q 019195            6 LMKDIGSGNFGVARLMRNKN-------TKELVAMKYIERGHKIDANVAREIINHKQLRHPN-IIRFKEVVLTPTHLAIVM   77 (344)
Q Consensus         6 ~~~~lg~G~~g~V~~~~~~~-------~~~~vaiK~~~~~~~~~~~~~~ei~~l~~l~h~n-iv~~~~~~~~~~~~~lv~   77 (344)
                      -++.|+.|....+|++....       .++.+++|+.... .....+.+|..+++.|...+ ..++++.+.  +  .+|+
T Consensus        77 ~v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~-~~~~~li~E~~~l~~L~~~g~~P~l~~~~~--~--g~v~  151 (429)
T 1nw1_A           77 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP-ETESHLVAESVIFTLLSERHLGPKLYGIFS--G--GRLE  151 (429)
T ss_dssp             EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC-CCHHHHHHHHHHHHHHHHTTSSSCEEEEET--T--EEEE
T ss_pred             EEEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC-CcHHHHHHHHHHHHHHHhCCCCCcEEEEeC--C--CEEE
Confidence            35678888889999998653       2578999987432 11145668999988885333 356666553  2  3899


Q ss_pred             ecCCCCCh
Q 019195           78 EYAAGGEL   85 (344)
Q Consensus        78 e~~~~g~L   85 (344)
                      +|++|.+|
T Consensus       152 e~l~G~~l  159 (429)
T 1nw1_A          152 EYIPSRPL  159 (429)
T ss_dssp             CCCCEEEC
T ss_pred             EEeCCccc
Confidence            99987443

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=97.28  E-value=0.002  Score=53.46  Aligned_cols=115  Identities=15%  Similarity=0.047  Sum_probs=70.3

Q ss_pred             CChHHHHHh-CCCCCHHHHHHHHHHHHHC--C------eeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCCCCCCCc
Q 019195           83 GELFERICN-AGRFSEDEARYFFQQLISG--Q------ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTV  153 (344)
Q Consensus        83 g~L~~~i~~-~~~~~~~~~~~~~~ql~~~--~------iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~~~~~~~  153 (344)
                      -+|.++|+. ..++++.++|.++.|.+..  .      -..+=+.|..|++..++.  |-..+ +.+           ..
T Consensus        33 vSL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~--V~f~~-~~s-----------~~   98 (229)
T 2yle_A           33 LSLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGA--VTLAP-AAD-----------DA   98 (229)
T ss_dssp             EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSC--EEECC-C---------------
T ss_pred             ccHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCc--eeccc-ccc-----------cc
Confidence            478888875 4689999999999997765  2      223444568888877765  54432 111           12


Q ss_pred             cCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCHhHHHHHHHh
Q 019195          154 GTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRI  233 (344)
Q Consensus       154 gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~  233 (344)
                      ....+.|||...  ...+.+.=|||||+++|..+--..|=                       .....+|+++..||..|
T Consensus        99 ~~~~~~~pe~~~--~~~te~~~IysLG~tLY~ALDygL~e-----------------------~eE~eLS~~LE~LL~~M  153 (229)
T 2yle_A           99 GEPPPVAGKLGY--SQCMETEVIESLGIIIYKALDYGLKE-----------------------NEERELSPPLEQLIDHM  153 (229)
T ss_dssp             --------CCSS--SSSCHHHHHHHHHHHHHHHHTTTCCT-----------------------TEEECCCHHHHHHHHHH
T ss_pred             cccCCCChhhcc--ccchHHHHHHHHHHHHHHHhhcCCCc-----------------------ccchhhCHHHHHHHHHH
Confidence            233566888763  22344578999999999876421111                       11236899999999999


Q ss_pred             ccc
Q 019195          234 FVA  236 (344)
Q Consensus       234 L~~  236 (344)
                      ...
T Consensus       154 t~~  156 (229)
T 2yle_A          154 ANT  156 (229)
T ss_dssp             TTC
T ss_pred             Hhc
Confidence            866

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=97.22  E-value=0.00084  Score=60.95  Aligned_cols=75  Identities=16%  Similarity=0.057  Sum_probs=46.0

Q ss_pred             eeeeeecCceEEEEEEEcC--------CCcEEEEEEeecCccccHHHHHHHHHHhcCCCCC-cceeeEEEEcCCEEEEEE
Q 019195            7 MKDIGSGNFGVARLMRNKN--------TKELVAMKYIERGHKIDANVAREIINHKQLRHPN-IIRFKEVVLTPTHLAIVM   77 (344)
Q Consensus         7 ~~~lg~G~~g~V~~~~~~~--------~~~~vaiK~~~~~~~~~~~~~~ei~~l~~l~h~n-iv~~~~~~~~~~~~~lv~   77 (344)
                      ++.|+.|....+|++....        .++.+++|+............+|..+++.+...+ +.+++..+  .+  ++||
T Consensus        38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~~--~~v~  113 (369)
T 3c5i_A           38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDELYNTISEFEVYKTMSKYKIAPQLLNTF--NG--GRIE  113 (369)
T ss_dssp             EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGGTSCHHHHHHHHHHHHHTTSSCCEEEEE--TT--EEEE
T ss_pred             EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccceecHHHHHHHHHHHHhcCCCCceEEec--CC--cEEE
Confidence            5678888889999998643        1367889987554322223467888888774333 44666554  22  6899


Q ss_pred             ecCCCCCh
Q 019195           78 EYAAGGEL   85 (344)
Q Consensus        78 e~~~~g~L   85 (344)
                      +|++|.++
T Consensus       114 e~i~G~~l  121 (369)
T 3c5i_A          114 EWLYGDPL  121 (369)
T ss_dssp             ECCCSEEC
T ss_pred             EEecCCcC
Confidence            99988543

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.16  E-value=0.0031  Score=56.21  Aligned_cols=77  Identities=8%  Similarity=-0.038  Sum_probs=39.3

Q ss_pred             eeeeeecCceE-EEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcCCC--CCcceeeEEEEcCCEEEEEEecCCCC
Q 019195            7 MKDIGSGNFGV-ARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRH--PNIIRFKEVVLTPTHLAIVMEYAAGG   83 (344)
Q Consensus         7 ~~~lg~G~~g~-V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~l~~l~h--~niv~~~~~~~~~~~~~lv~e~~~~g   83 (344)
                      ++.|+.|+... +|++.. .++..+++|.......  ..+..|+.+++.+..  -.+.+++.+....+  +++||++.+.
T Consensus        23 ~~~l~gg~s~~~~~r~~~-~~~~~~vlk~~~~~~~--~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l~~~   97 (333)
T 3csv_A           23 RTPLAGDASSRRYQRLRS-PTGAKAVLMDWSPEEG--GDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDLGDA   97 (333)
T ss_dssp             ECC--------CCEEEEC-TTCCEEEEEECCTTTT--CCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCCCSC
T ss_pred             eeECCCCCCCceEEEEEc-CCCCeEEEEECCCCCC--ccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeCCCc
Confidence            45676666554 667753 2256677776544321  234567777766632  23556665533333  6899999776


Q ss_pred             ChHHH
Q 019195           84 ELFER   88 (344)
Q Consensus        84 ~L~~~   88 (344)
                      ++...
T Consensus        98 ~l~~~  102 (333)
T 3csv_A           98 LFTEV  102 (333)
T ss_dssp             BHHHH
T ss_pred             chHHH
Confidence            66443

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=96.75  E-value=0.021  Score=51.02  Aligned_cols=66  Identities=12%  Similarity=-0.041  Sum_probs=41.7

Q ss_pred             cCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcCC---CCCcceeeEE------EEcCCEEEEEEecCCCC
Q 019195           13 GNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLR---HPNIIRFKEV------VLTPTHLAIVMEYAAGG   83 (344)
Q Consensus        13 G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~l~~l~---h~niv~~~~~------~~~~~~~~lv~e~~~~g   83 (344)
                      |....||++... +| .+++|+......     .+|+.+++.|.   -|++++.+..      ....+..+++|+|++|.
T Consensus        34 g~~N~vy~v~~~-~g-~~vLK~~~~~~~-----~~E~~~l~~L~~~g~~~vp~pi~~~~G~~~~~~~g~~~~l~~~i~G~  106 (339)
T 3i1a_A           34 DTNAFAYQADSE-SK-SYFIKLKYGYHD-----EINLSIIRLLHDSGIKEIIFPIHTLEAKLFQQLKHFKIIAYPFIHAP  106 (339)
T ss_dssp             CSSCEEEEEECS-SC-EEEEEEEECSSC-----CHHHHHHHHHHHTTCCSSCCCCCCTTSCSSEECSSEEEEEEECCCCC
T ss_pred             ccccceEEEEeC-CC-CEEEEEecCccc-----hHHHHHHHHHHhcCCcccccceecCCCCEEEEECCEEEEEEeccCCC
Confidence            336799999753 34 899998766442     34555555552   2324444432      23457789999999987


Q ss_pred             Ch
Q 019195           84 EL   85 (344)
Q Consensus        84 ~L   85 (344)
                      .+
T Consensus       107 ~~  108 (339)
T 3i1a_A          107 NG  108 (339)
T ss_dssp             BT
T ss_pred             cC
Confidence            65

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=96.67  E-value=0.011  Score=54.66  Aligned_cols=76  Identities=14%  Similarity=0.038  Sum_probs=50.4

Q ss_pred             eeeeeeecCceEEEEEEEcCC-------CcEEEEEEeecCccccHHHHHHHHHHhcCC-CCCcceeeEEEEcCCEEEEEE
Q 019195            6 LMKDIGSGNFGVARLMRNKNT-------KELVAMKYIERGHKIDANVAREIINHKQLR-HPNIIRFKEVVLTPTHLAIVM   77 (344)
Q Consensus         6 ~~~~lg~G~~g~V~~~~~~~~-------~~~vaiK~~~~~~~~~~~~~~ei~~l~~l~-h~niv~~~~~~~~~~~~~lv~   77 (344)
                      -++.|..|-...+|++.....       +..|++|+........-...+|..+++.+. +.-..++++.+  .+  ++||
T Consensus        74 ~v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~idR~~E~~~l~~L~~~gi~P~l~~~~--~~--~~I~  149 (424)
T 3mes_A           74 EVKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKFYDSKVELDVFRYLSNINIAPNIIADF--PE--GRIE  149 (424)
T ss_dssp             EEEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CCCCHHHHHHHHHHHHHTTSSCCEEEEE--TT--EEEE
T ss_pred             EEEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchhcCHHHHHHHHHHHHhcCCCCCEEEEc--CC--CEEE
Confidence            356787788889999987521       577999986543332223468888888874 33345555543  22  6899


Q ss_pred             ecCCCCCh
Q 019195           78 EYAAGGEL   85 (344)
Q Consensus        78 e~~~~g~L   85 (344)
                      +|++|.+|
T Consensus       150 efI~G~~l  157 (424)
T 3mes_A          150 EFIDGEPL  157 (424)
T ss_dssp             ECCCSEEC
T ss_pred             EEeCCccC
Confidence            99998654

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=93.34  E-value=0.26  Score=44.96  Aligned_cols=31  Identities=39%  Similarity=0.580  Sum_probs=24.3

Q ss_pred             CeeecCCCCCCeEecC----CCCCCEEEeecCCCc
Q 019195          111 QICHRDLKLENTLLDG----SPAPRLKICDFGYSK  141 (344)
Q Consensus       111 ~iiH~Dikp~NIl~~~----~~~~~vkL~DFg~a~  141 (344)
                      .++|+|+.+.|||+..    +....+.++||-+|.
T Consensus       245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~  279 (401)
T 3g15_A          245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSS  279 (401)
T ss_dssp             EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCE
T ss_pred             eeEEecCCCCeEEEecCcccCcCCeEEEechHhcc
Confidence            4689999999999943    223459999999775

>3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A

Probab=84.78  E-value=0.07  Score=49.88  Aligned_cols=60  Identities=8%  Similarity=0.087  Sum_probs=17.5

Q ss_pred             eeeeeeecCceEEEEEEEcCCCcEEEE------EEeecCc---cccHHHHHHHHHHhcCCCCCcceeeEEEE
Q 019195            6 LMKDIGSGNFGVARLMRNKNTKELVAM------KYIERGH---KIDANVAREIINHKQLRHPNIIRFKEVVL   68 (344)
Q Consensus         6 ~~~~lg~G~~g~V~~~~~~~~~~~vai------K~~~~~~---~~~~~~~~ei~~l~~l~h~niv~~~~~~~   68 (344)
                      +.+.||   ||.||++.......+||+      |......   .....+.++..+++.++|||+++.+.+..
T Consensus       146 l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~  214 (463)
T 3cxl_A          146 IYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKV  214 (463)
T ss_dssp             STTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEE
T ss_pred             ccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEE
Confidence            345666   999999988765567888      6554322   12235778888888899999999988754

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	344
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	1e-76
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	1e-75
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	4e-75
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	2e-73
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	3e-73
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	7e-71
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	1e-69
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	2e-68
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	3e-68
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	1e-67
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	3e-67
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	3e-67
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	4e-67
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	6e-66
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	2e-65
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	5e-64
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	2e-63
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	3e-63
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	1e-61
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	6e-59
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	2e-58
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	1e-56
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	1e-55
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	4e-55
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	1e-54
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	2e-54
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	3e-54
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	9e-54
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	1e-53
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	6e-53
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	8e-53
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	1e-52
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	2e-52
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	6e-52
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	2e-51
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	4e-50
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	2e-49
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	4e-49
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	6e-49
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	1e-48
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	2e-48
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	2e-47
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	3e-47
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	6e-47
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	1e-46
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	3e-46
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	4e-46
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	1e-45
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	2e-45
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	2e-45
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	2e-44
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	3e-44
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	6e-43
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	8e-42
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	9e-42
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	2e-41
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	3e-40
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	5e-40
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	3e-39
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	3e-38
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	1e-37
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	1e-36
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	3e-10

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  234 bits (598), Expect = 1e-76
 Identities = 94/270 (34%), Positives = 142/270 (52%), Gaps = 17/270 (6%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDA--NVAREIINHKQLRHPN 59
           E ++L++ +G G +G  +L  N+ T+E VA+K ++    +D   N+ +EI  +K L H N
Sbjct: 5   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64

Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-------QI 112
           +++F           + +EY +GGELF+RI       E +A+ FF QL++G        I
Sbjct: 65  VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGI 124

Query: 113 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST---VGTPAYIAPEVLSRREY 169
            HRD+K EN LLD      LKI DFG +     ++R +      GT  Y+APE+L RRE+
Sbjct: 125 THRDIKPENLLLDER--DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 182

Query: 170 DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 229
             +  DVWSCG+ L  ML G  P+   + P +  +  S     +  +  +  I      L
Sbjct: 183 HAEPVDVWSCGIVLTAMLAGELPW---DQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLAL 239

Query: 230 LSRIFVANPSRRITIKEIKSHPWFLKNLPR 259
           L +I V NPS RITI +IK   W+ K L +
Sbjct: 240 LHKILVENPSARITIPDIKKDRWYNKPLKK 269

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  232 bits (592), Expect = 1e-75
 Identities = 87/267 (32%), Positives = 137/267 (51%), Gaps = 21/267 (7%)

Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVA----REIINHKQLR 56
           +E +E+ + +G G FG   L R K +K ++A+K + +     A V     RE+     LR
Sbjct: 5   LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 64

Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG------ 110
           HPNI+R        T + +++EYA  G ++  +    +F E     +  +L +       
Sbjct: 65  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 124

Query: 111 -QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREY 169
            ++ HRD+K EN LL  +    LKI DFG+S      SR  +  GT  Y+ PE++  R +
Sbjct: 125 KRVIHRDIKPENLLLGSA--GELKIADFGWSV-HAPSSRRTTLCGTLDYLPPEMIEGRMH 181

Query: 170 DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 229
           D K  D+WS GV  Y  LVG  PFE       +++T  RI  V++  PD   +++  R+L
Sbjct: 182 DEK-VDLWSLGVLCYEFLVGKPPFEA----NTYQETYKRISRVEFTFPD--FVTEGARDL 234

Query: 230 LSRIFVANPSRRITIKEIKSHPWFLKN 256
           +SR+   NPS+R  ++E+  HPW   N
Sbjct: 235 ISRLLKHNPSQRPMLREVLEHPWITAN 261

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  232 bits (593), Expect = 4e-75
 Identities = 77/315 (24%), Positives = 136/315 (43%), Gaps = 19/315 (6%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNII 61
           EKY + +D+G G FG+       ++K+    K+++        V +EI      RH NI+
Sbjct: 5   EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNIL 64

Query: 62  RFKEVVLTPTHLAIVMEYAAGGELFERI-CNAGRFSEDEARYFFQQLISG-------QIC 113
              E   +   L ++ E+ +G ++FERI  +A   +E E   +  Q+           I 
Sbjct: 65  HLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIG 124

Query: 114 HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKL 173
           H D++ EN +     +  +KI +FG ++        +     P Y APEV          
Sbjct: 125 HFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVSTA- 183

Query: 174 ADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPD--YVHISQDCRNLLS 231
            D+WS G  +YV+L G  PF      +  ++ I  IM  +Y   +  +  IS +  + + 
Sbjct: 184 TDMWSLGTLVYVLLSGINPFLA----ETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVD 239

Query: 232 RIFVANPSRRITIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTFSLQSVEEITKIVEE 291
           R+ V     R+T  E   HPW  + + R  T+  + + +R+   T      +++  +V  
Sbjct: 240 RLLVKERKSRMTASEALQHPWLKQKIERVSTKVIRTLKHRRYYHTLIK---KDLNMVVSA 296

Query: 292 AKV-PPPVSRSIGGF 305
           A++      RS  G 
Sbjct: 297 ARISCGGAIRSQKGV 311

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  228 bits (583), Expect = 2e-73
 Identities = 74/291 (25%), Positives = 132/291 (45%), Gaps = 19/291 (6%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDAN-VAREIINHKQLRHPNI 60
           + Y++++++GSG FGV      K T  +   K+I   + +D   V  EI    QL HP +
Sbjct: 29  DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKL 88

Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFERICNAG-RFSEDEARYFFQQLISG-------QI 112
           I   +       + +++E+ +GGELF+RI     + SE E   + +Q   G        I
Sbjct: 89  INLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSI 148

Query: 113 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGK 172
            H D+K EN + +   A  +KI DFG +         K T  T  + APE++ R      
Sbjct: 149 VHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVG-F 207

Query: 173 LADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPD--YVHISQDCRNLL 230
             D+W+ GV  YV+L G  PF  ++D     +T+  +    ++  +  +  +S + ++ +
Sbjct: 208 YTDMWAIGVLGYVLLSGLSPFAGEDDL----ETLQNVKRCDWEFDEDAFSSVSPEAKDFI 263

Query: 231 SRIFVANPSRRITIKEIKSHPWF---LKNLPRELTETAQAIYYRKENPTFS 278
             +    P +R+T+ +   HPW      NL   +  +      +K    ++
Sbjct: 264 KNLLQKEPRKRLTVHDALEHPWLKGDHSNLTSRIPSSRYNKIRQKIKEKYA 314

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  228 bits (583), Expect = 3e-73
 Identities = 81/310 (26%), Positives = 144/310 (46%), Gaps = 19/310 (6%)

Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDAN-VAREIINHKQLRHPN 59
           ++ Y++ +++G+G FGV   +  + T    A K++   H+ D   V +EI     LRHP 
Sbjct: 25  LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPT 84

Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFERICNA-GRFSEDEARYFFQQLISG-------Q 111
           ++   +       + ++ E+ +GGELFE++ +   + SEDEA  + +Q+  G        
Sbjct: 85  LVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN 144

Query: 112 ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDG 171
             H DLK EN +     +  LK+ DFG +         K T GT  + APEV   +    
Sbjct: 145 YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGY 204

Query: 172 KLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPD--YVHISQDCRNL 229
              D+WS GV  Y++L G  PF      +N  +T+  + +  + + D  +  IS+D ++ 
Sbjct: 205 Y-TDMWSVGVLSYILLSGLSPFGG----ENDDETLRNVKSCDWNMDDSAFSGISEDGKDF 259

Query: 230 LSRIFVANPSRRITIKEIKSHPWFLK-NLPRELTETAQAIY--YRKENPTFSLQSVEEIT 286
           + ++ +A+P+ R+TI +   HPW    N P   ++   + Y   R    T      E + 
Sbjct: 260 IRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQIPSSRYTKIRDSIKTKYDAWPEPLP 319

Query: 287 KIVEEAKVPP 296
            +   +    
Sbjct: 320 PLGRISNYSS 329

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  221 bits (563), Expect = 7e-71
 Identities = 81/269 (30%), Positives = 135/269 (50%), Gaps = 13/269 (4%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH--KIDANVAREIINHKQLRHPN 59
           + Y+    +G+G F    L  +K T++LVA+K I +      + ++  EI    +++HPN
Sbjct: 9   DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPN 68

Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-------QI 112
           I+   ++  +  HL ++M+  +GGELF+RI   G ++E +A     Q++          I
Sbjct: 69  IVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGI 128

Query: 113 CHRDLKLENTLLDGSPAP-RLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDG 171
            HRDLK EN L        ++ I DFG SK     S   +  GTP Y+APEVL+++ Y  
Sbjct: 129 VHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPYSK 188

Query: 172 KLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLS 231
              D WS GV  Y++L G  PF D+ D K F + +      ++  P +  IS   ++ + 
Sbjct: 189 A-VDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAE--YEFDSPYWDDISDSAKDFIR 245

Query: 232 RIFVANPSRRITIKEIKSHPWFLKNLPRE 260
            +   +P +R T ++   HPW   +   +
Sbjct: 246 HLMEKDPEKRFTCEQALQHPWIAGDTALD 274

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  217 bits (554), Expect = 1e-69
 Identities = 74/272 (27%), Positives = 124/272 (45%), Gaps = 29/272 (10%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINH----KQLRH 57
           E ++  K +G G+F    L R   T    A+K +E+ H I  N    +        +L H
Sbjct: 8   EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 67

Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG------- 110
           P  ++          L   + YA  GEL + I   G F E   R++  +++S        
Sbjct: 68  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 127

Query: 111 QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS---RPKSTVGTPAYIAPEVLSRR 167
            I HRDLK EN LL+      ++I DFG +K     S   R  S VGT  Y++PE+L+ +
Sbjct: 128 GIIHRDLKPENILLNED--MHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEK 185

Query: 168 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCR 227
                 +D+W+ G  +Y ++ G  PF       N      +I+ ++Y  P+        R
Sbjct: 186 SACKS-SDLWALGCIIYQLVAGLPPFRA----GNEYLIFQKIIKLEYDFPE--KFFPKAR 238

Query: 228 NLLSRIFVANPSRRITIKE------IKSHPWF 253
           +L+ ++ V + ++R+  +E      +K+HP+F
Sbjct: 239 DLVEKLLVLDATKRLGCEEMEGYGPLKAHPFF 270

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  214 bits (547), Expect = 2e-68
 Identities = 72/303 (23%), Positives = 126/303 (41%), Gaps = 52/303 (17%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYI--ERGHKIDANVAREIINHKQLRHPN 59
           + +E + ++G+GN GV   + +K +  ++A K I  E    I   + RE+    +   P 
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65

Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG--------Q 111
           I+ F     +   ++I ME+  GG L + +  AGR  E         +I G        +
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK 125

Query: 112 ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDG 171
           I HRD+K  N L++      +K+CDFG S   L+ S   S VGT +Y++PE L    Y  
Sbjct: 126 IMHRDVKPSNILVNSR--GEIKLCDFGVSG-QLIDSMANSFVGTRSYMSPERLQGTHYSV 182

Query: 172 KLADVWSCGVTLYVMLVGAYPFE------------------------------------- 194
           + +D+WS G++L  M VG YP                                       
Sbjct: 183 Q-SDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYG 241

Query: 195 -DQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 253
            D   P    + +  I+            S + ++ +++  + NP+ R  +K++  H + 
Sbjct: 242 MDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFI 301

Query: 254 LKN 256
            ++
Sbjct: 302 KRS 304

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  213 bits (544), Expect = 3e-68
 Identities = 66/266 (24%), Positives = 120/266 (45%), Gaps = 16/266 (6%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDAN-VAREIINHKQLRHPNI 60
           +KY   + IG G  G      +  T + VA++ +    +     +  EI+  ++ ++PNI
Sbjct: 20  KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNI 79

Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-------QIC 113
           + + +  L    L +VMEY AGG L + +       E +     ++ +         Q+ 
Sbjct: 80  VNYLDSYLVGDELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVI 138

Query: 114 HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST-VGTPAYIAPEVLSRREYDGK 172
           HRD+K +N LL       +K+ DFG+          +ST VGTP ++APEV++R+ Y  K
Sbjct: 139 HRDIKSDNILLGMD--GSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPK 196

Query: 173 LADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSR 232
             D+WS G+    M+ G  P+ ++   +              ++ +   +S   R+ L+R
Sbjct: 197 -VDIWSLGIMAIEMIEGEPPYLNENPLRALYL---IATNGTPELQNPEKLSAIFRDFLNR 252

Query: 233 IFVANPSRRITIKEIKSHPWFLKNLP 258
               +  +R + KE+  H +     P
Sbjct: 253 CLDMDVEKRGSAKELLQHQFLKIAKP 278

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  212 bits (540), Expect = 1e-67
 Identities = 86/270 (31%), Positives = 145/270 (53%), Gaps = 23/270 (8%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDAN-------VAREIINHKQ 54
           + Y+  +++GSG F V +  R K+T    A K+I++     +        + RE+   K+
Sbjct: 10  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69

Query: 55  LRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG---- 110
           ++HPN+I   EV    T + +++E  AGGELF+ +      +E+EA  F +Q+++G    
Sbjct: 70  IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYL 129

Query: 111 ---QICHRDLKLENTLLD--GSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLS 165
              QI H DLK EN +L     P PR+KI DFG +      +  K+  GTP ++APE+++
Sbjct: 130 HSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVN 189

Query: 166 RREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPD--YVHIS 223
                   AD+WS GV  Y++L GA PF         ++T++ + AV Y+  D  + + S
Sbjct: 190 YEPLG-LEADMWSIGVITYILLSGASPFLG----DTKQETLANVSAVNYEFEDEYFSNTS 244

Query: 224 QDCRNLLSRIFVANPSRRITIKEIKSHPWF 253
              ++ + R+ V +P +R+TI++   HPW 
Sbjct: 245 ALAKDFIRRLLVKDPKKRMTIQDSLQHPWI 274

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  210 bits (536), Expect = 3e-67
 Identities = 84/275 (30%), Positives = 130/275 (47%), Gaps = 27/275 (9%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYI----------ERGHKIDANVAREIIN 51
           E YE  + +G G   V R   +K T +  A+K I          E   ++     +E+  
Sbjct: 3   ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62

Query: 52  HKQLR-HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG 110
            +++  HPNII+ K+   T T   +V +    GELF+ +      SE E R   + L+  
Sbjct: 63  LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEV 122

Query: 111 -------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEV 163
                   I HRDLK EN LLD      +K+ DFG+S       + +   GTP+Y+APE+
Sbjct: 123 ICALHKLNIVHRDLKPENILLDDD--MNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEI 180

Query: 164 LSRREYD-----GKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPD 218
           +     D     GK  D+WS GV +Y +L G+ PF  ++     R  +S     Q+  P+
Sbjct: 181 IECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSG--NYQFGSPE 238

Query: 219 YVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 253
           +   S   ++L+SR  V  P +R T +E  +HP+F
Sbjct: 239 WDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFF 273

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  211 bits (539), Expect = 3e-67
 Identities = 70/273 (25%), Positives = 114/273 (41%), Gaps = 24/273 (8%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKID----ANVAREIINHKQLRH 57
           + +  +++IG G+FG     R+    E+VA+K +    K       ++ +E+   ++LRH
Sbjct: 15  KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRH 74

Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG------- 110
           PN I+++   L      +VMEY  G        +     E E        + G       
Sbjct: 75  PNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH 134

Query: 111 QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVL---SRR 167
            + HRD+K  N LL       +K+ DFG +    + +   S VGTP ++APEV+      
Sbjct: 135 NMIHRDVKAGNILLSEP--GLVKLGDFGSAS---IMAPANSFVGTPYWMAPEVILAMDEG 189

Query: 168 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCR 227
           +YDGK  DVWS G+T   +     P  +     N    +  I   +       H S+  R
Sbjct: 190 QYDGK-VDVWSLGITCIELAERKPPLFN----MNAMSALYHIAQNESPALQSGHWSEYFR 244

Query: 228 NLLSRIFVANPSRRITIKEIKSHPWFLKNLPRE 260
           N +       P  R T + +  H + L+  P  
Sbjct: 245 NFVDSCLQKIPQDRPTSEVLLKHRFVLRERPPT 277

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  210 bits (536), Expect = 4e-67
 Identities = 68/276 (24%), Positives = 117/276 (42%), Gaps = 19/276 (6%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKID-ANVAREIINHKQLRHPNI 60
           + +E++ ++G G FG     +NK T  L A K I+   + +  +   EI       HPNI
Sbjct: 12  DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNI 71

Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFERICNAGR-FSEDEARYFFQQLISG-------QI 112
           ++  +      +L I++E+ AGG +   +    R  +E + +   +Q +         +I
Sbjct: 72  VKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKI 131

Query: 113 CHRDLKLENTLLDGSPAPRLKICDFGYSKS-SLLHSRPKSTVGTPAYIAPEVLSRREYDG 171
            HRDLK  N L        +K+ DFG S   +    R  S +GTP ++APEV+       
Sbjct: 132 IHRDLKAGNILFTLD--GDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKD 189

Query: 172 KL----ADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCR 227
           +     ADVWS G+TL  M     P  +    +   K      +    +      S + +
Sbjct: 190 RPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAK---SEPPTLAQPSRWSSNFK 246

Query: 228 NLLSRIFVANPSRRITIKEIKSHPWFLKNLPRELTE 263
           + L +    N   R T  ++  HP+   +  + + E
Sbjct: 247 DFLKKCLEKNVDARWTTSQLLQHPFVTVDSNKPIRE 282

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  209 bits (533), Expect = 6e-66
 Identities = 90/312 (28%), Positives = 150/312 (48%), Gaps = 24/312 (7%)

Query: 1   MEKYELMKD-IGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREI-INHKQLRHP 58
           ++ Y++    +G G  G    + NK T+E  A+K ++   K      RE+ ++ +  + P
Sbjct: 10  IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKAR----REVELHWRASQCP 65

Query: 59  NIIRFKEVVLTP----THLAIVMEYAAGGELFERICNAG--RFSEDEARYFFQQLISG-- 110
           +I+R  +V          L IVME   GGELF RI + G   F+E EA    + +     
Sbjct: 66  HIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQ 125

Query: 111 -----QICHRDLKLENTLLDG-SPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVL 164
                 I HRD+K EN L     P   LK+ DFG++K +  H+   +   TP Y+APEVL
Sbjct: 126 YLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVL 185

Query: 165 SRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPD--YVHI 222
              +YD    D+WS GV +Y++L G  PF             +RI   QY+ P+  +  +
Sbjct: 186 GPEKYDKS-CDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEV 244

Query: 223 SQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTFSLQSV 282
           S++ + L+  +    P++R+TI E  +HPW +++     T    +   +++   +     
Sbjct: 245 SEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWE-DVK 303

Query: 283 EEITKIVEEAKV 294
           EE+T  +   +V
Sbjct: 304 EEMTSALATMRV 315

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  205 bits (524), Expect = 2e-65
 Identities = 75/273 (27%), Positives = 132/273 (48%), Gaps = 30/273 (10%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVA---REIINHKQLRHP 58
           E YE++  IG+G++G  + +R K+  +++  K ++ G   +A       E+   ++L+HP
Sbjct: 4   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 63

Query: 59  NIIRFKEVVL--TPTHLAIVMEYAAGGELFERICNAGR----FSEDEARYFFQQLISG-- 110
           NI+R+ + ++  T T L IVMEY  GG+L   I    +      E+       QL     
Sbjct: 64  NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 123

Query: 111 ----------QICHRDLKLENTLLDGSPAPRLKICDFGYSKS-SLLHSRPKSTVGTPAYI 159
                      + HRDLK  N  LDG     +K+ DFG ++  +   S  K+ VGTP Y+
Sbjct: 124 ECHRRSDGGHTVLHRDLKPANVFLDGKQ--NVKLGDFGLARILNHDTSFAKAFVGTPYYM 181

Query: 160 APEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDY 219
           +PE ++R  Y+ K +D+WS G  LY +     PF       + ++   +I   +++   Y
Sbjct: 182 SPEQMNRMSYNEK-SDIWSLGCLLYELCALMPPFTA----FSQKELAGKIREGKFRRIPY 236

Query: 220 VHISQDCRNLLSRIFVANPSRRITIKEIKSHPW 252
              S +   +++R+       R +++EI  +P 
Sbjct: 237 -RYSDELNEIITRMLNLKDYHRPSVEEILENPL 268

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  203 bits (518), Expect = 5e-64
 Identities = 80/267 (29%), Positives = 130/267 (48%), Gaps = 23/267 (8%)

Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH-----KIDANVAREIINHKQL 55
           +E + L K +G G+FG   L   K T +  A+K +++        ++  +  + +     
Sbjct: 1   IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAW 60

Query: 56  RHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG----- 110
            HP +        T  +L  VMEY  GG+L   I +  +F    A ++  ++I G     
Sbjct: 61  EHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLH 120

Query: 111 --QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST-VGTPAYIAPEVLSRR 167
              I +RDLKL+N LLD      +KI DFG  K ++L     +T  GTP YIAPE+L  +
Sbjct: 121 SKGIVYRDLKLDNILLDKD--GHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQ 178

Query: 168 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCR 227
           +Y+    D WS GV LY ML+G  PF      ++  +    I       P    + ++ +
Sbjct: 179 KYNHS-VDWWSFGVLLYEMLIGQSPFHG----QDEEELFHSIRMDNPFYPR--WLEKEAK 231

Query: 228 NLLSRIFVANPSRRITIK-EIKSHPWF 253
           +LL ++FV  P +R+ ++ +I+ HP F
Sbjct: 232 DLLVKLFVREPEKRLGVRGDIRQHPLF 258

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  200 bits (510), Expect = 2e-63
 Identities = 59/266 (22%), Positives = 107/266 (40%), Gaps = 23/266 (8%)

Query: 4   YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVA---REIINHKQLRHPNI 60
            +   +IG G+F       +  T   VA   ++      +       E    K L+HPNI
Sbjct: 11  LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNI 70

Query: 61  IRFKEVVLTPT----HLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG------ 110
           +RF +   +       + +V E    G L   +           R + +Q++ G      
Sbjct: 71  VRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHT 130

Query: 111 ---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRR 167
               I HRDLK +N  + G P   +KI D G +      S  K+ +GTP ++APE+    
Sbjct: 131 RTPPIIHRDLKCDNIFITG-PTGSVKIGDLGLATL-KRASFAKAVIGTPEFMAPEMY-EE 187

Query: 168 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCR 227
           +YD    DV++ G+ +  M    YP+ + ++     +   R+ +             + +
Sbjct: 188 KYDES-VDVYAFGMCMLEMATSEYPYSECQNAAQIYR---RVTSGVKPASFDKVAIPEVK 243

Query: 228 NLLSRIFVANPSRRITIKEIKSHPWF 253
            ++      N   R +IK++ +H +F
Sbjct: 244 EIIEGCIRQNKDERYSIKDLLNHAFF 269

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  200 bits (509), Expect = 3e-63
 Identities = 80/279 (28%), Positives = 124/279 (44%), Gaps = 32/279 (11%)

Query: 3   KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDAN-------VAREIINHKQL 55
           +Y++   +GSG FG        +    VA+K++E+    D         V  E++  K++
Sbjct: 5   QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 64

Query: 56  R--HPNIIRFKEVVLTPTHLAIVMEYAAGG-ELFERICNAGRFSEDEARYFFQQLISG-- 110
                 +IR  +    P    +++E      +LF+ I   G   E+ AR FF Q++    
Sbjct: 65  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 124

Query: 111 -----QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLS 165
                 + HRD+K EN L+D +    LK+ DFG     L  +      GT  Y  PE + 
Sbjct: 125 HCHNCGVLHRDIKDENILIDLNR-GELKLIDFGSGAL-LKDTVYTDFDGTRVYSPPEWIR 182

Query: 166 RREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQD 225
              Y G+ A VWS G+ LY M+ G  PFE  E+          I+  Q        +S +
Sbjct: 183 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE----------IIRGQVFFRQ--RVSSE 230

Query: 226 CRNLLSRIFVANPSRRITIKEIKSHPWFLKN-LPRELTE 263
           C++L+       PS R T +EI++HPW     LP+E  E
Sbjct: 231 CQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAE 269

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  197 bits (502), Expect = 1e-61
 Identities = 81/269 (30%), Positives = 140/269 (52%), Gaps = 27/269 (10%)

Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDAN----VAREIINHKQLR 56
           ++ +++++ +G+G+FG   L+R+++     AMK +++   +          E +    + 
Sbjct: 3   LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVT 62

Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLI-------S 109
           HP IIR          + ++M+Y  GGELF  +  + RF    A+++  ++        S
Sbjct: 63  HPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHS 122

Query: 110 GQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREY 169
             I +RDLK EN LLD +    +KI DFG++K   +     +  GTP YIAPEV+S + Y
Sbjct: 123 KDIIYRDLKPENILLDKN--GHIKITDFGFAK--YVPDVTYTLCGTPDYIAPEVVSTKPY 178

Query: 170 DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 229
           +    D WS G+ +Y ML G  PF D     N  KT  +I+  + + P     ++D ++L
Sbjct: 179 NKS-IDWWSFGILIYEMLAGYTPFYD----SNTMKTYEKILNAELRFPP--FFNEDVKDL 231

Query: 230 LSRIFVANPSRRI-----TIKEIKSHPWF 253
           LSR+   + S+R+       +++K+HPWF
Sbjct: 232 LSRLITRDLSQRLGNLQNGTEDVKNHPWF 260

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  192 bits (488), Expect = 6e-59
 Identities = 71/272 (26%), Positives = 121/272 (44%), Gaps = 25/272 (9%)

Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINH-------K 53
           M  + + + IG G FG     R  +T ++ AMK +++            +N         
Sbjct: 3   MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVS 62

Query: 54  QLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG--- 110
               P I+       TP  L+ +++   GG+L   +   G FSE + R++  ++I G   
Sbjct: 63  TGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEH 122

Query: 111 ----QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSR 166
                + +RDLK  N LLD      ++I D G +       +P ++VGT  Y+APEVL +
Sbjct: 123 MHNRFVVYRDLKPANILLD--EHGHVRISDLGLAC-DFSKKKPHASVGTHGYMAPEVLQK 179

Query: 167 REYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDC 226
                  AD +S G  L+ +L G  PF  Q   K+  +     + +  ++PD    S + 
Sbjct: 180 GVAYDSSADWFSLGCMLFKLLRGHSPF-RQHKTKDKHEIDRMTLTMAVELPD--SFSPEL 236

Query: 227 RNLLSRIFVANPSRRIT-----IKEIKSHPWF 253
           R+LL  +   + +RR+       +E+K  P+F
Sbjct: 237 RSLLEGLLQRDVNRRLGCLGRGAQEVKESPFF 268

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  189 bits (482), Expect = 2e-58
 Identities = 82/270 (30%), Positives = 130/270 (48%), Gaps = 26/270 (9%)

Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKID----ANVAREIINHKQLR 56
           M  ++ +K +G G FG   L+R K T    AMK + +   I     A+   E    +  R
Sbjct: 4   MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR 63

Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG------ 110
           HP +   K    T   L  VMEYA GGELF  +     F+E+ AR++  +++S       
Sbjct: 64  HPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHS 123

Query: 111 -QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH-SRPKSTVGTPAYIAPEVLSRRE 168
             + +RD+KLEN +LD      +KI DFG  K  +   +  K+  GTP Y+APEVL   +
Sbjct: 124 RDVVYRDIKLENLMLDKD--GHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDND 181

Query: 169 YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRN 228
           Y     D W  GV +Y M+ G  PF +    ++  +    I+  + + P    +S + ++
Sbjct: 182 YGRA-VDWWGLGVVMYEMMCGRLPFYN----QDHERLFELILMEEIRFPR--TLSPEAKS 234

Query: 229 LLSRIFVANPSRRI-----TIKEIKSHPWF 253
           LL+ +   +P +R+       KE+  H +F
Sbjct: 235 LLAGLLKKDPKQRLGGGPSDAKEVMEHRFF 264

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  184 bits (467), Expect = 1e-56
 Identities = 73/290 (25%), Positives = 115/290 (39%), Gaps = 39/290 (13%)

Query: 5   ELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDAN------VAREIINHKQLRHP 58
           E +  +G G F      R+KNT ++VA+K I+ GH+ +A         REI   ++L HP
Sbjct: 1   EKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHP 60

Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-------Q 111
           NII   +     +++++V ++           N+   +    + +    + G        
Sbjct: 61  NIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW 120

Query: 112 ICHRDLKLENTLLDGSPAPRLKICDFGYSKS-SLLHSRPKSTVGTPAYIAPEVLSRREYD 170
           I HRDLK  N LLD +    LK+ DFG +KS    +      V T  Y APE+L      
Sbjct: 121 ILHRDLKPNNLLLDEN--GVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMY 178

Query: 171 GKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRI-------MAVQYKIPDYV--- 220
           G   D+W+ G  L  +L+         D     +    +             +PDYV   
Sbjct: 179 GVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFK 238

Query: 221 ------------HISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLP 258
                           D  +L+  +F+ NP  RIT  +     +F  N P
Sbjct: 239 SFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYF-SNRP 287

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  180 bits (458), Expect = 1e-55
 Identities = 59/265 (22%), Positives = 98/265 (36%), Gaps = 21/265 (7%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVA----REIINHKQLRH 57
           ++YEL + +G G      L R+      VA+K +      D +      RE  N   L H
Sbjct: 7   DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNH 66

Query: 58  PNIIRFKEVVLTPTH----LAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG--- 110
           P I+   +     T       IVMEY  G  L + +   G  +   A             
Sbjct: 67  PAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNF 126

Query: 111 ----QICHRDLKLENTLLDGSPAPRLKICDFG--YSKSSLLHSRPKSTVGTPAYIAPEVL 164
                I HRD+K  N ++  + A ++         + S    ++  + +GT  Y++PE  
Sbjct: 127 SHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQA 186

Query: 165 SRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQ 224
                D + +DV+S G  LY +L G  PF          + +           +   +S 
Sbjct: 187 RGDSVDAR-SDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHE--GLSA 243

Query: 225 DCRNLLSRIFVANPSRRI-TIKEIK 248
           D   ++ +    NP  R  T  E++
Sbjct: 244 DLDAVVLKALAKNPENRYQTAAEMR 268

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  179 bits (456), Expect = 4e-55
 Identities = 57/275 (20%), Positives = 107/275 (38%), Gaps = 23/275 (8%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVA---REIINHKQLRHP 58
            +  + + IGSG+FG     +       VA+K +         +     E+   ++ RH 
Sbjct: 8   GQITVGQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHV 64

Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGELFERICNA-GRFSEDEARYFFQQLISG------- 110
           NI+ F     T   LAIV ++  G  L+  +     +F   +     +Q   G       
Sbjct: 65  NILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAK 123

Query: 111 QICHRDLKLENTLLDGSPAPRLKICDFGYSK---SSLLHSRPKSTVGTPAYIAPEVLSRR 167
            I HRDLK  N  L       +KI DFG +          + +   G+  ++APEV+  +
Sbjct: 124 SIIHRDLKSNNIFLHEDL--TVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 181

Query: 168 EYD--GKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQD 225
           + +     +DV++ G+ LY ++ G  P+ +  +       + R            +  + 
Sbjct: 182 DKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKA 241

Query: 226 CRNLLSRIFVANPSRRITIKEIKSHPWFL-KNLPR 259
            + L++         R    +I +    L ++LP+
Sbjct: 242 MKRLMAECLKKKRDERPLFPQILASIELLARSLPK 276

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  178 bits (453), Expect = 1e-54
 Identities = 75/296 (25%), Positives = 131/296 (44%), Gaps = 38/296 (12%)

Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYI---ERGHKIDANVAREIINHKQLRH 57
           ME ++ ++ IG G +GV    RNK T E+VA+K I        + +   REI   K+L H
Sbjct: 1   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 60

Query: 58  PNIIRFKEVVLTPTHLAIVMEYAA-GGELFERICNAGRFSEDEARYFFQQLISG------ 110
           PNI++  +V+ T   L +V E+     + F              + +  QL+ G      
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120

Query: 111 -QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST-VGTPAYIAPEVLSRRE 168
            ++ HRDLK +N L++      +K+ DFG +++  +  R  +  V T  Y APE+L   +
Sbjct: 121 HRVLHRDLKPQNLLINTEG--AIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCK 178

Query: 169 YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTI-------SRIMAVQYKIPDYV- 220
           Y     D+WS G     M+     F    +     +           +      +PDY  
Sbjct: 179 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 238

Query: 221 ---------------HISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLPREL 261
                           + +D R+LLS++   +P++RI+ K   +HP+F +++ + +
Sbjct: 239 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF-QDVTKPV 293

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  178 bits (452), Expect = 2e-54
 Identities = 76/293 (25%), Positives = 126/293 (43%), Gaps = 37/293 (12%)

Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH---KIDANVAREIINHKQLRH 57
           M+KYE ++ IG G +G     +N+ T E+VA+K +        + ++  REI   K+L+H
Sbjct: 1   MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKH 60

Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG------- 110
            NI+R  +V+ +   L +V E+             G    +  + F  QL+ G       
Sbjct: 61  KNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSR 120

Query: 111 QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKS-TVGTPAYIAPEVLSRREY 169
            + HRDLK +N L++ +    LK+ +FG +++  +  R  S  V T  Y  P+VL   + 
Sbjct: 121 NVLHRDLKPQNLLINRN--GELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKL 178

Query: 170 DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIM--------AVQYKIPDYV- 220
                D+WS G     +     P     D  +  K I R++            K+PDY  
Sbjct: 179 YSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKP 238

Query: 221 ---------------HISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLP 258
                           ++   R+LL  +   NP +RI+ +E   HP+F    P
Sbjct: 239 YPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFCP 291

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  178 bits (452), Expect = 3e-54
 Identities = 63/315 (20%), Positives = 118/315 (37%), Gaps = 60/315 (19%)

Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDA---NVAREIINHKQLRH 57
           + KYE +  IG G FG     R++ T + VA+K +   ++ +       REI   + L+H
Sbjct: 9   VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKH 68

Query: 58  PNIIRFKEVVLTPT--------HLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLIS 109
            N++   E+  T           + +V ++              +F+  E +   Q L++
Sbjct: 69  ENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLN 128

Query: 110 G-------QICHRDLKLENTLLDGSPAPRLKICDFGYSK-----SSLLHSRPKSTVGTPA 157
           G       +I HRD+K  N L+       LK+ DFG ++      +   +R  + V T  
Sbjct: 129 GLYYIHRNKILHRDMKAANVLITRDG--VLKLADFGLARAFSLAKNSQPNRYTNRVVTLW 186

Query: 158 YIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIP 217
           Y  PE+L      G   D+W  G  +  M   +   +        +  ++ I  +   I 
Sbjct: 187 YRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQG----NTEQHQLALISQLCGSIT 242

Query: 218 DYVH------------------------------ISQDCRNLLSRIFVANPSRRITIKEI 247
             V                                     +L+ ++ V +P++RI   + 
Sbjct: 243 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDA 302

Query: 248 KSHPWFLKN-LPREL 261
            +H +F  + +P +L
Sbjct: 303 LNHDFFWSDPMPSDL 317

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  178 bits (451), Expect = 9e-54
 Identities = 76/337 (22%), Positives = 128/337 (37%), Gaps = 49/337 (14%)

Query: 4   YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRF 63
           Y   K IG+G+FGV    +  ++ ELVA+K + +  +      RE+   ++L H NI+R 
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF---KNRELQIMRKLDHCNIVRL 78

Query: 64  KEVVLTP------THLAIVMEYAAGG---ELFERICNAGRFSEDEARYFFQQLISG---- 110
           +    +        +L +V++Y                        + +  QL       
Sbjct: 79  RYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 138

Query: 111 ---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRR 167
               ICHRD+K +N LLD   A   K+CDFG +K  +      S + +  Y APE++   
Sbjct: 139 HSFGICHRDIKPQNLLLDPDTAVL-KLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGA 197

Query: 168 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIM-------------AVQY 214
                  DVWS G  L  +L+G   F          + I  +                ++
Sbjct: 198 TDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEF 257

Query: 215 KIPDY----------VHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLPRELTET 264
           K P                 +   L SR+    P+ R+T  E  +H +F      EL + 
Sbjct: 258 KFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFF-----DELRDP 312

Query: 265 AQAIYYRKENPTFSLQSVEEITKIVEEA-KVPPPVSR 300
              +   ++ P     + +E++     A  + PP +R
Sbjct: 313 NVKLPNGRDTPALFNFTTQELSSNPPLATILIPPHAR 349

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  178 bits (451), Expect = 1e-53
 Identities = 72/269 (26%), Positives = 135/269 (50%), Gaps = 27/269 (10%)

Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDAN----VAREIINHKQLR 56
           +++++ +K +G+G+FG   L+++K +    AMK +++   +          E    + + 
Sbjct: 40  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99

Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG------ 110
            P +++ +      ++L +VMEY AGGE+F  +   GRFSE  AR++  Q++        
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159

Query: 111 -QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREY 169
             + +RDLK EN L+D      +++ DFG++K      R  +  GTP  +APE++  + Y
Sbjct: 160 LDLIYRDLKPENLLIDQQ--GYIQVTDFGFAKRV--KGRTWTLCGTPEALAPEIILSKGY 215

Query: 170 DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 229
           +    D W+ GV +Y M  G  PF          +   +I++ + + P   H S D ++L
Sbjct: 216 NKA-VDWWALGVLIYEMAAGYPPFFA----DQPIQIYEKIVSGKVRFPS--HFSSDLKDL 268

Query: 230 LSRIFVANPSRRI-----TIKEIKSHPWF 253
           L  +   + ++R       + +IK+H WF
Sbjct: 269 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  173 bits (439), Expect = 6e-53
 Identities = 54/260 (20%), Positives = 101/260 (38%), Gaps = 20/260 (7%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNII 61
           +    +K++G+G FGV +  + +   + VA+K I+ G   +     E      L H  ++
Sbjct: 4   KDLTFLKELGTGQFGVVKYGKWRGQYD-VAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLV 62

Query: 62  RFKEVVLTPTHLAIVMEYAAGGELFERICNA-GRFSEDEARYFFQQLISG-------QIC 113
           +   V      + I+ EY A G L   +     RF   +     + +          Q  
Sbjct: 63  QLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFL 122

Query: 114 HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST--VGTPAYIAPEVLSRREYDG 171
           HRDL   N L++      +K+ DFG S+  L      S        +  PEVL   ++  
Sbjct: 123 HRDLAARNCLVNDQ--GVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSS 180

Query: 172 KLADVWSCGVTLYVML-VGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLL 230
           K +D+W+ GV ++ +  +G  P+E   + +              ++      S+    ++
Sbjct: 181 K-SDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQG-----LRLYRPHLASEKVYTIM 234

Query: 231 SRIFVANPSRRITIKEIKSH 250
              +      R T K + S+
Sbjct: 235 YSCWHEKADERPTFKILLSN 254

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  173 bits (439), Expect = 8e-53
 Identities = 60/260 (23%), Positives = 103/260 (39%), Gaps = 22/260 (8%)

Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNI 60
           M++ +L++ IG G FG   L   +  K  VA+K I+      A    E     QLRH N+
Sbjct: 6   MKELKLLQTIGKGEFGDVMLGDYRGNK--VAVKCIKNDATAQA-FLAEASVMTQLRHSNL 62

Query: 61  IRFKEVVL-TPTHLAIVMEYAAGGELFERICNAGR--FSEDEARYFFQQLISG------- 110
           ++   V++     L IV EY A G L + + + GR     D    F   +          
Sbjct: 63  VQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN 122

Query: 111 QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYD 170
              HRDL   N L+        K+ DFG +K     S   +      + APE L  +++ 
Sbjct: 123 NFVHRDLAARNVLVSEDN--VAKVSDFGLTK--EASSTQDTGKLPVKWTAPEALREKKFS 178

Query: 171 GKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLL 230
            K +DVWS G+ L+ +         +   K+    + +    +   PD          ++
Sbjct: 179 TK-SDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK--GYKMDAPD--GCPPAVYEVM 233

Query: 231 SRIFVANPSRRITIKEIKSH 250
              +  + + R +  +++  
Sbjct: 234 KNCWHLDAAMRPSFLQLREQ 253

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  174 bits (442), Expect = 1e-52
 Identities = 56/295 (18%), Positives = 112/295 (37%), Gaps = 48/295 (16%)

Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLR-HPN 59
            + Y+L++ +G G +       N    E V +K ++   K    + REI   + LR  PN
Sbjct: 34  QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKK--KKIKREIKILENLRGGPN 91

Query: 60  IIRFKEVVLTPTH--LAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGQ------ 111
           II   ++V  P     A+V E+    +  +        ++ + R++  +++         
Sbjct: 92  IITLADIVKDPVSRTPALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSM 148

Query: 112 -ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYD 170
            I HRD+K  N ++D     +L++ D+G ++           V +  +  PE+L   +  
Sbjct: 149 GIMHRDVKPHNVMID-HEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMY 207

Query: 171 GKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQY---------------- 214
               D+WS G  L  M+    PF    D  +    I++++  +                 
Sbjct: 208 DYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRF 267

Query: 215 ----------------KIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 253
                              +   +S +  + L ++   +   R+T +E   HP+F
Sbjct: 268 NDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 322

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  172 bits (437), Expect = 2e-52
 Identities = 73/287 (25%), Positives = 119/287 (41%), Gaps = 37/287 (12%)

Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYI---ERGHKIDANVAREIINHKQLRH 57
           MEKY  ++ IG G +GV    +N    E  A+K I   +    I +   REI   K+L+H
Sbjct: 1   MEKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKH 59

Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG------- 110
            NI++  +V+ T   L +V E+             G      A+ F  QL++G       
Sbjct: 60  SNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDR 119

Query: 111 QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST-VGTPAYIAPEVLSRREY 169
           ++ HRDLK +N L++      LKI DFG +++  +  R  +  + T  Y AP+VL   + 
Sbjct: 120 RVLHRDLKPQNLLINRE--GELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKK 177

Query: 170 DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYV--------- 220
                D+WS G     M+ G   F    +     +    +     K    V         
Sbjct: 178 YSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPN 237

Query: 221 --------------HISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 253
                          + +   +LLS++   +P++RIT K+   H +F
Sbjct: 238 FTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYF 284

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  173 bits (439), Expect = 6e-52
 Identities = 78/347 (22%), Positives = 131/347 (37%), Gaps = 56/347 (16%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYI--ERGHKIDANVAREIINHKQLRHPN 59
            +Y  +  IG G +G+     +   K  VA+K I             REI    + RH N
Sbjct: 8   PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHEN 67

Query: 60  IIRFKEVVLTPTH----LAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG----- 110
           II   +++  PT        ++ +  G +L++ +      S D   YF  Q++ G     
Sbjct: 68  IIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLL-KTQHLSNDHICYFLYQILRGLKYIH 126

Query: 111 --QICHRDLKLENTLLDGSPAPRLKICDFGYSK----SSLLHSRPKSTVGTPAYIAPEVL 164
              + HRDLK  N LL+ +    LKICDFG ++               V T  Y APE++
Sbjct: 127 SANVLHRDLKPSNLLLNTTC--DLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 184

Query: 165 SRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPD------ 218
              +   K  D+WS G  L  ML     F      K++   ++ I+ +            
Sbjct: 185 LNSKGYTKSIDIWSVGCILAEMLSNRPIFPG----KHYLDQLNHILGILGSPSQEDLNCI 240

Query: 219 -----------------------YVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLK 255
                                  + +      +LL ++   NP +RI +++  +HP+  +
Sbjct: 241 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQ 300

Query: 256 NLPRELTETAQAIY-YRKENPTFSLQSVEEITKIVEEAKVPPPVSRS 301
                    A+A + +  E      + ++E+  I EE     P  RS
Sbjct: 301 YYDPSDEPIAEAPFKFDMELDDLPKEKLKEL--IFEETARFQPGYRS 345

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  171 bits (434), Expect = 2e-51
 Identities = 72/275 (26%), Positives = 126/275 (45%), Gaps = 24/275 (8%)

Query: 1   MEKYELMKDIGSGNFGV---ARLMRNKNTKELVAMKYIERGH-----KIDANVAREIINH 52
           +E +EL+K +G+G +G     R +   +T +L AMK +++       K   +   E    
Sbjct: 23  IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVL 82

Query: 53  KQLRH-PNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG- 110
           + +R  P ++       T T L ++++Y  GGELF  +    RF+E E + +  +++   
Sbjct: 83  EHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLAL 142

Query: 111 ------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVL 164
                  I +RD+KLEN LLD +    L          +    R     GT  Y+AP+++
Sbjct: 143 EHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIV 202

Query: 165 SRREY-DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHIS 223
              +    K  D WS GV +Y +L GA PF    +  +  +   RI+  +   P    +S
Sbjct: 203 RGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQ--EMS 260

Query: 224 QDCRNLLSRIFVANPSRRI-----TIKEIKSHPWF 253
              ++L+ R+ + +P +R+        EIK H +F
Sbjct: 261 ALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFF 295

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  166 bits (420), Expect = 4e-50
 Identities = 54/259 (20%), Positives = 99/259 (38%), Gaps = 18/259 (6%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNII 61
            +   +++IGSG FG+  L    N  + VA+K I  G   + +   E     +L HP ++
Sbjct: 5   SELTFVQEIGSGQFGLVHLGYWLNKDK-VAIKTIREGAMSEEDFIEEAEVMMKLSHPKLV 63

Query: 62  RFKEVVLTPTHLAIVMEYAAGGELFE-RICNAGRFSEDEARYFFQQLISG-------QIC 113
           +   V L    + +V E+   G L +      G F+ +        +  G        + 
Sbjct: 64  QLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVI 123

Query: 114 HRDLKLENTLLDGSPAPRLKICDFGYSK--SSLLHSRPKSTVGTPAYIAPEVLSRREYDG 171
           HRDL   N L+  +    +K+ DFG ++      ++    T     + +PEV S   Y  
Sbjct: 124 HRDLAARNCLVGEN--QVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSS 181

Query: 172 KLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLS 231
           K +DVWS GV ++ +        +        + IS      +++      S     +++
Sbjct: 182 K-SDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIST----GFRLYKPRLASTHVYQIMN 236

Query: 232 RIFVANPSRRITIKEIKSH 250
             +   P  R     +   
Sbjct: 237 HCWKERPEDRPAFSRLLRQ 255

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  165 bits (418), Expect = 2e-49
 Identities = 56/271 (20%), Positives = 102/271 (37%), Gaps = 22/271 (8%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNII 61
           E   L   +G G FG   +     T   VA+K ++ G        +E    K+LRH  ++
Sbjct: 17  ESLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLV 75

Query: 62  RFKEVVLTPTHLAIVMEYAAGGELFE--RICNAGRFSEDEARYFFQQLISG-------QI 112
           +   VV +   + IV EY + G L +  +          +      Q+ SG         
Sbjct: 76  QLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNY 134

Query: 113 CHRDLKLENTLLDGSPAPRLKICDFGYSK--SSLLHSRPKSTVGTPAYIAPEVLSRREYD 170
            HRDL+  N L+  +     K+ DFG ++      ++  +       + APE      + 
Sbjct: 135 VHRDLRAANILVGEN--LVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFT 192

Query: 171 GKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLL 230
            K +DVWS G+ L  +             +     + R     Y++P      +   +L+
Sbjct: 193 IK-SDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER----GYRMPCPPECPESLHDLM 247

Query: 231 SRIFVANPSRRITIKEIKS--HPWFLKNLPR 259
            + +   P  R T + +++    +F    P+
Sbjct: 248 CQCWRKEPEERPTFEYLQAFLEDYFTSTEPQ 278

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  164 bits (415), Expect = 4e-49
 Identities = 54/270 (20%), Positives = 100/270 (37%), Gaps = 21/270 (7%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNII 61
               +   +G G +G       K     VA+K ++          +E    K+++HPN++
Sbjct: 17  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLV 76

Query: 62  RFKEVVLTPTHLAIVMEYAAGGELFERICNAGR--FSEDEARYFFQQLISGQ-------I 112
           +   V        I+ E+   G L + +    R   S     Y   Q+ S          
Sbjct: 77  QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNF 136

Query: 113 CHRDLKLENTLLDGSPAPRLKICDFGYSK--SSLLHSRPKSTVGTPAYIAPEVLSRREYD 170
            HRDL   N L+  +    +K+ DFG S+  +   ++          + APE L+  ++ 
Sbjct: 137 IHRDLAARNCLVGEN--HLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFS 194

Query: 171 GKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLL 230
            K +DVW+ GV L+ +           D     + + +     Y++       +    L+
Sbjct: 195 IK-SDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK----DYRMERPEGCPEKVYELM 249

Query: 231 SRIFVANPSRRITIKEIKSHPWFLKNLPRE 260
              +  NPS R +  EI       + + +E
Sbjct: 250 RACWQWNPSDRPSFAEIHQ---AFETMFQE 276

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  165 bits (418), Expect = 6e-49
 Identities = 75/333 (22%), Positives = 128/333 (38%), Gaps = 57/333 (17%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVA---REIINHKQLRHP 58
             Y  ++ +GSG +G      +  T   VA+K + R  + +       RE+   K +RH 
Sbjct: 18  AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHE 77

Query: 59  NIIRFKEVVLTP------THLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-- 110
           N+I   +V          T   +VM +   G    ++    +  ED  ++   Q++ G  
Sbjct: 78  NVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHEKLGEDRIQFLVYQMLKGLR 135

Query: 111 -----QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLS 165
                 I HRDLK  N  ++      LKI DFG ++     S     V T  Y APEV+ 
Sbjct: 136 YIHAAGIIHRDLKPGNLAVNEDC--ELKILDFGLARQ--ADSEMTGYVVTRWYRAPEVIL 191

Query: 166 RREYDGKLADVWSCGVTLYVMLVGAYPFEDQED--------------PKNFRKTISRIMA 211
                 +  D+WS G  +  M+ G   F+  +               P  F + +    A
Sbjct: 192 NWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEA 251

Query: 212 VQYKIPD-----------YVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLPRE 260
             Y                 + S    NLL ++ V +  +R+T  E  +HP+F       
Sbjct: 252 KNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYF-----ES 306

Query: 261 LTETAQAIYYRKENPTFSLQSVEEITKIVEEAK 293
           L +T      +K + +F     +++ + ++E K
Sbjct: 307 LHDTEDEPQVQKYDDSF-----DDVDRTLDEWK 334

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  162 bits (411), Expect = 1e-48
 Identities = 67/269 (24%), Positives = 107/269 (39%), Gaps = 28/269 (10%)

Query: 2   EKYELMKDIGSGNFGV---ARLMRNKNTKELVAMKYIERGHKID----ANVAREIINHKQ 54
           +   L++ +G G+FGV               VA+K ++           +  RE+     
Sbjct: 8   KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67

Query: 55  LRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERIC-NAGRFSEDEARYFFQQLISG--- 110
           L H N+IR   VVLTP  + +V E A  G L +R+  + G F       +  Q+  G   
Sbjct: 68  LDHRNLIRLYGVVLTP-PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGY 126

Query: 111 ----QICHRDLKLENTLLDGSPAPRLKICDFGYSK----SSLLHSRPKSTVGTPAYIAPE 162
               +  HRDL   N LL       +KI DFG  +    +   +   +      A+ APE
Sbjct: 127 LESKRFIHRDLAARNLLLATR--DLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPE 184

Query: 163 VLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVH 221
            L  R +    +D W  GVTL+ M   G  P+       N  + + +I     ++P    
Sbjct: 185 SLKTRTFSHA-SDTWMFGVTLWEMFTYGQEPWIG----LNGSQILHKIDKEGERLPRPED 239

Query: 222 ISQDCRNLLSRIFVANPSRRITIKEIKSH 250
             QD  N++ + +   P  R T   ++  
Sbjct: 240 CPQDIYNVMVQCWAHKPEDRPTFVALRDF 268

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  162 bits (411), Expect = 2e-48
 Identities = 73/299 (24%), Positives = 118/299 (39%), Gaps = 45/299 (15%)

Query: 2   EKYELMKDIGSGNFGVARLMRN-KNTKELVAMKYIERGHKIDA---NVAREIINHKQL-- 55
           ++YE + +IG G +G     R+ KN    VA+K +      +    +  RE+   + L  
Sbjct: 7   QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLET 66

Query: 56  -RHPNIIRFKEVVLTP-----THLAIVMEYAAGGEL-FERICNAGRFSEDEARYFFQQLI 108
             HPN++R  +V         T L +V E+       +           +  +    QL+
Sbjct: 67  FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLL 126

Query: 109 SG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAP 161
            G       ++ HRDLK +N L+  S   ++K+ DFG ++         S V T  Y AP
Sbjct: 127 RGLDFLHSHRVVHRDLKPQNILVTSSG--QIKLADFGLARIYSFQMALTSVVVTLWYRAP 184

Query: 162 EVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRI-MAVQYKIPDYV 220
           EVL +  Y     D+WS G     M      F    D     K +  I +  +   P  V
Sbjct: 185 EVLLQSSYATP-VDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDV 243

Query: 221 --------------------HISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLPR 259
                                I +  ++LL +    NP++RI+     SHP+F ++L R
Sbjct: 244 ALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF-QDLER 301

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  161 bits (409), Expect = 2e-47
 Identities = 65/338 (19%), Positives = 125/338 (36%), Gaps = 49/338 (14%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVA---REIINHKQLRHP 58
           E+Y+ +  +GSG +G      +  T   VA+K + R  +   +     RE+   K ++H 
Sbjct: 18  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 77

Query: 59  NIIRFKEVVLTPTHLA-----IVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG--- 110
           N+I   +V      L       ++ +  G      I    + ++D  ++   Q++ G   
Sbjct: 78  NVIGLLDVFTPARSLEEFNDVYLVTHLMGA-DLNNIVKCQKLTDDHVQFLIYQILRGLKY 136

Query: 111 ----QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSR 166
                I HRDLK  N  ++      LKI DFG ++           V T  Y APE++  
Sbjct: 137 IHSADIIHRDLKPSNLAVN--EDCELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLN 192

Query: 167 REYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPD-------- 218
             +  +  D+WS G  +  +L G   F   +     +  +  +     ++          
Sbjct: 193 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESAR 252

Query: 219 -----------------YVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLPREL 261
                            ++  +    +LL ++ V +  +RIT  +  +H +F +    + 
Sbjct: 253 NYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDD 312

Query: 262 TETAQAIYYRKENPTFSLQSVEEITKIVEEAK--VPPP 297
              A       E+    +   + +    +E    VPPP
Sbjct: 313 EPVADPYDQSFESRDLLIDEWKSL--TYDEVISFVPPP 348

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  160 bits (405), Expect = 3e-47
 Identities = 55/309 (17%), Positives = 105/309 (33%), Gaps = 28/309 (9%)

Query: 4   YELMKDIGSGNFGVARLMRNKNTKELVAMKYI------ERGHKIDANVAREIINHKQLRH 57
           ++ +K +GSG FG           E V +             K +  +  E      + +
Sbjct: 11  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70

Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG------- 110
           P++ R   + LT T   I      G  L     +           +  Q+  G       
Sbjct: 71  PHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR 130

Query: 111 QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST---VGTPAYIAPEVLSRR 167
           ++ HRDL   N L+       +KI DFG +K      +            ++A E +  R
Sbjct: 131 RLVHRDLAARNVLVKTP--QHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 188

Query: 168 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCR 227
            Y  + +DVWS GVT++ ++       D          + +      ++P     + D  
Sbjct: 189 IYTHQ-SDVWSYGVTVWELMTFGSKPYDGIPASEISSILEK----GERLPQPPICTIDVY 243

Query: 228 NLLSRIFVANPSRRITIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTFS-----LQSV 282
            ++ + ++ +   R   +E+      +   P+              +PT S     L   
Sbjct: 244 MIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDE 303

Query: 283 EEITKIVEE 291
           E++  +V+ 
Sbjct: 304 EDMDDVVDA 312

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  158 bits (400), Expect = 6e-47
 Identities = 55/265 (20%), Positives = 106/265 (40%), Gaps = 22/265 (8%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNII 61
           E  +L++ +G+G FG   +       + VA+K +++G         E    KQL+H  ++
Sbjct: 13  ETLKLVERLGAGQFGEVWMGYYNGHTK-VAVKSLKQGSMSPDAFLAEANLMKQLQHQRLV 71

Query: 62  RFKEVVLTPTHLAIVMEYAAGGELFERI--CNAGRFSEDEARYFFQQLISG-------QI 112
           R   VV T   + I+ EY   G L + +   +  + + ++      Q+  G         
Sbjct: 72  RLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNY 130

Query: 113 CHRDLKLENTLLDGSPAPRLKICDFGYSK--SSLLHSRPKSTVGTPAYIAPEVLSRREYD 170
            HRDL+  N L+        KI DFG ++      ++  +       + APE ++   + 
Sbjct: 131 IHRDLRAANILVS--DTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFT 188

Query: 171 GKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLL 230
            K +DVWS G+ L  ++                + + R     Y++    +  ++   L+
Sbjct: 189 IK-SDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER----GYRMVRPDNCPEELYQLM 243

Query: 231 SRIFVANPSRRITIKEIKS--HPWF 253
              +   P  R T   ++S    +F
Sbjct: 244 RLCWKERPEDRPTFDYLRSVLEDFF 268

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  157 bits (397), Expect = 1e-46
 Identities = 58/264 (21%), Positives = 108/264 (40%), Gaps = 23/264 (8%)

Query: 2   EKYELMKDIGSGNFGV---ARLMRNKNTKELVAMKYIERG--HKIDANVAREIINHKQLR 56
           E+ EL + IG G FG       M  +N    VA+K  +      +     +E +  +Q  
Sbjct: 7   ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 66

Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICN-AGRFSEDEARYFFQQLISG----- 110
           HP+I++   V+ T   + I+ME    GEL   +              +  QL +      
Sbjct: 67  HPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE 125

Query: 111 --QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST--VGTPAYIAPEVLSR 166
             +  HRD+   N L+  +    +K+ DFG S+     +  K++       ++APE ++ 
Sbjct: 126 SKRFVHRDIAARNVLVSSN--DCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINF 183

Query: 167 REYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDC 226
           R +    +DVW  GV ++ +L+            +    I        ++P   +     
Sbjct: 184 RRFTSA-SDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIEN----GERLPMPPNCPPTL 238

Query: 227 RNLLSRIFVANPSRRITIKEIKSH 250
            +L+++ +  +PSRR    E+K+ 
Sbjct: 239 YSLMTKCWAYDPSRRPRFTELKAQ 262

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  156 bits (395), Expect = 3e-46
 Identities = 54/266 (20%), Positives = 105/266 (39%), Gaps = 29/266 (10%)

Query: 8   KDIGSGNFGVARL--MRNKNTKELVAMKYIERGHKIDA---NVAREIINHKQLRHPNIIR 62
           K++GSGNFG  +    + K   + VA+K ++      A    +  E    +QL +P I+R
Sbjct: 13  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 72

Query: 63  FKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-------QICHR 115
              +    + + +VME A  G L + +       +        Q+  G          HR
Sbjct: 73  MIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHR 131

Query: 116 DLKLENTLLDGSPAPRLKICDFGYSKS----SLLHSRPKSTVGTPAYIAPEVLSRREYDG 171
           DL   N LL        KI DFG SK+       +           + APE ++  ++  
Sbjct: 132 DLAARNVLLV--TQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSS 189

Query: 172 KLADVWSCGVTLYVML-VGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLL 230
           K +DVWS GV ++     G  P+   +  +     ++ ++    ++       ++  +L+
Sbjct: 190 K-SDVWSFGVLMWEAFSYGQKPYRGMKGSE-----VTAMLEKGERMGCPAGCPREMYDLM 243

Query: 231 SRIFVANPSRRITIKEIKS---HPWF 253
           +  +  +   R     ++    + ++
Sbjct: 244 NLCWTYDVENRPGFAAVELRLRNYYY 269

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  156 bits (396), Expect = 4e-46
 Identities = 60/282 (21%), Positives = 110/282 (39%), Gaps = 35/282 (12%)

Query: 1   MEKYELMKDIGSGNFGV---ARLMRNKNTKELVAMKYIERGH--KIDANVAREIINHKQL 55
           +   ++ + IG+G FG      L      +  VA+K ++ G+  K   +   E     Q 
Sbjct: 25  ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQF 84

Query: 56  RHPNIIRFKEVVLTPTHLAIVMEYAAGGELFE-RICNAGRFSEDEARYFFQQLISG---- 110
            HPN+I  + VV   T + I+ E+   G L      N G+F+  +     + + +G    
Sbjct: 85  DHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYL 144

Query: 111 ---QICHRDLKLENTLLDGSPAPRLKICDFGYSK------SSLLHSRPKSTVGTPAYIAP 161
                 HRDL   N L++ +     K+ DFG S+      S   ++          + AP
Sbjct: 145 ADMNYVHRDLAARNILVNSN--LVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAP 202

Query: 162 EVLSRREYDGKLADVWSCGVTLYVML-VGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYV 220
           E +  R++    +DVWS G+ ++ ++  G  P+ D  +               Y++P  +
Sbjct: 203 EAIQYRKFTSA-SDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQD-----YRLPPPM 256

Query: 221 HISQDCRNLLSRIFVANPSRRITIKEI-------KSHPWFLK 255
                   L+   +  + + R    +I         +P  LK
Sbjct: 257 DCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRNPNSLK 298

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  155 bits (392), Expect = 1e-45
 Identities = 61/264 (23%), Positives = 103/264 (39%), Gaps = 29/264 (10%)

Query: 10  IGSGNFGVARL--MRNKNTKELVAMKYIERGHKID--ANVAREIINHKQLRHPNIIRFKE 65
           +G GNFG  R    R +  +  VA+K +++G +      + RE     QL +P I+R   
Sbjct: 17  LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 76

Query: 66  VVLTPTHLAIVMEYAAGGELFERICNA-GRFSEDEARYFFQQLISG-------QICHRDL 117
           V      L +VME A GG L + +                 Q+  G          HRDL
Sbjct: 77  VC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDL 135

Query: 118 KLENTLLDGSPAPRLKICDFGYSK----SSLLHSRPKSTVGTPAYIAPEVLSRREYDGKL 173
              N LL      +  I DFG SK        ++   +      + APE ++ R++  + 
Sbjct: 136 AARNVLLVNRHYAK--ISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSR- 192

Query: 174 ADVWSCGVTLYVML-VGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSR 232
           +DVWS GVT++  L  G  P++  + P+            + + P       +   L+S 
Sbjct: 193 SDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQ---GKRMECPP--ECPPELYALMSD 247

Query: 233 IFVANPSRRITIKEIKS---HPWF 253
            ++     R     ++      ++
Sbjct: 248 CWIYKWEDRPDFLTVEQRMRACYY 271

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  155 bits (392), Expect = 2e-45
 Identities = 58/278 (20%), Positives = 100/278 (35%), Gaps = 35/278 (12%)

Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKEL--VAMKYIERGHKIDA--NVAREIINHKQL- 55
               +    IG GNFG     R K        A+K ++     D   + A E+    +L 
Sbjct: 9   WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLG 68

Query: 56  RHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERI----------------CNAGRFSEDE 99
            HPNII          +L + +EYA  G L + +                  A   S  +
Sbjct: 69  HHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQ 128

Query: 100 ARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST 152
             +F   +  G       Q  HRDL   N L+  +     KI DFG S+   ++ +    
Sbjct: 129 LLHFAADVARGMDYLSQKQFIHRDLAARNILVGEN--YVAKIADFGLSRGQEVYVKKTMG 186

Query: 153 VGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAV 212
                ++A E L+   Y    +DVWS GV L+ ++                + + +    
Sbjct: 187 RLPVRWMAIESLNYSVYTTN-SDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ---- 241

Query: 213 QYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSH 250
            Y++   ++   +  +L+ + +   P  R +  +I   
Sbjct: 242 GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 279

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  154 bits (391), Expect = 2e-45
 Identities = 54/279 (19%), Positives = 98/279 (35%), Gaps = 26/279 (9%)

Query: 3   KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIR 62
           +Y L + IGSG+FG   L  +    E VA+K +E        +  E   +K ++    I 
Sbjct: 8   RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIK-LECVKTKHPQLHIESKIYKMMQGGVGIP 66

Query: 63  -FKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-------QICH 114
             +       +  +VME             + +FS         Q+IS           H
Sbjct: 67  TIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIH 126

Query: 115 RDLKLENTLL-DGSPAPRLKICDFGYSK--------SSLLHSRPKSTVGTPAYIAPEVLS 165
           RD+K +N L+  G     + I DFG +K          + +   K+  GT  Y +     
Sbjct: 127 RDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHL 186

Query: 166 RREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYV---HI 222
             E   +  D+ S G  L    +G+ P++  +     +K   RI   +   P  V     
Sbjct: 187 GIEQSRR-DDLESLGYVLMYFNLGSLPWQGLKAATKRQK-YERISEKKMSTPIEVLCKGY 244

Query: 223 SQDCRNLLSRIFVANPSRRIT---IKEIKSHPWFLKNLP 258
             +    L+         +     ++++  + +  +   
Sbjct: 245 PSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFS 283

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  153 bits (387), Expect = 2e-44
 Identities = 57/291 (19%), Positives = 104/291 (35%), Gaps = 49/291 (16%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKEL-----VAMKYIERGHKID--ANVAREIINHKQ 54
           E  E  K +GSG FG           +      VA+K ++          +  E+    Q
Sbjct: 37  ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 96

Query: 55  L-RHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERI-----------------------C 90
           L  H NI+           + ++ EY   G+L   +                        
Sbjct: 97  LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 156

Query: 91  NAGRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSK-- 141
           +    + ++   F  Q+  G          HRDL   N L+       +KICDFG ++  
Sbjct: 157 DLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGK--VVKICDFGLARDI 214

Query: 142 -SSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVML-VGAYPFEDQEDP 199
            S   +    +      ++APE L    Y  K +DVWS G+ L+ +  +G  P+      
Sbjct: 215 MSDSNYVVRGNARLPVKWMAPESLFEGIYTIK-SDVWSYGILLWEIFSLGVNPYPGIPVD 273

Query: 200 KNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSH 250
            NF K    ++   +K+    + +++   ++   +  +  +R +   + S 
Sbjct: 274 ANFYK----LIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  152 bits (384), Expect = 3e-44
 Identities = 52/260 (20%), Positives = 95/260 (36%), Gaps = 26/260 (10%)

Query: 10  IGSGNFGV---ARLMRNKNTKELVAMKYIERGHKID--ANVAREIINHKQLRHPNIIRFK 64
           IG G+FG      L+ N   K   A+K + R   I   +    E I  K   HPN++   
Sbjct: 35  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 94

Query: 65  EVVL-TPTHLAIVMEYAAGGELFE-RICNAGRFSEDEARYFFQQLISG-------QICHR 115
            + L +     +V+ Y   G+L           +  +   F  Q+  G       +  HR
Sbjct: 95  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHR 154

Query: 116 DLKLENTLLDGSPAPRLKICDFGYSK-----SSLLHSRPKSTVGTPAYIAPEVLSRREYD 170
           DL   N +LD      +K+ DFG ++                     ++A E L  +++ 
Sbjct: 155 DLAARNCMLDEKF--TVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFT 212

Query: 171 GKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLL 230
            K +DVWS GV L+ ++    P     +  +    + +      ++    +       ++
Sbjct: 213 TK-SDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ----GRRLLQPEYCPDPLYEVM 267

Query: 231 SRIFVANPSRRITIKEIKSH 250
            + +      R +  E+ S 
Sbjct: 268 LKCWHPKAEMRPSFSELVSR 287

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  148 bits (373), Expect = 6e-43
 Identities = 62/282 (21%), Positives = 105/282 (37%), Gaps = 25/282 (8%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKE----LVAMKYIERGH--KIDANVAREIINHKQL 55
                 K IG+G FG       K +       VA+K ++ G+  K   +   E     Q 
Sbjct: 7   SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 66

Query: 56  RHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICN-AGRFSEDEARYFFQQLISGQ--- 111
            H NIIR + V+     + I+ EY   G L + +    G FS  +     + + +G    
Sbjct: 67  SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYL 126

Query: 112 ----ICHRDLKLENTLLDGSPAPRLKICDFGYSK----SSLLHSRPKSTVGTPAYIAPEV 163
                 HRDL   N L++ +     K+ DFG S+                    + APE 
Sbjct: 127 ANMNYVHRDLAARNILVNSN--LVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEA 184

Query: 164 LSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHIS 223
           +S R++    +DVWS G+ ++ ++        +       K I+      +++P  +   
Sbjct: 185 ISYRKFTSA-SDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIND----GFRLPTPMDCP 239

Query: 224 QDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLPRELTETA 265
                L+ + +    +RR    +I S    L   P  L   A
Sbjct: 240 SAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDSLKTLA 281

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  145 bits (366), Expect = 8e-42
 Identities = 46/290 (15%), Positives = 92/290 (31%), Gaps = 28/290 (9%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNII 61
             Y++ + IG G+FGV     N    + VA+K+  R       +  E   +K L     I
Sbjct: 5   VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPR-RSDAPQLRDEYRTYKLLAGCTGI 63

Query: 62  -RFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-------QIC 113
                      H  +V++               +FS        +Q+++         + 
Sbjct: 64  PNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLV 123

Query: 114 HRDLKLENTLLDGSPAP---RLKICDFGYSK--------SSLLHSRPKSTVGTPAYIAPE 162
           +RD+K +N L+    +     + + DFG  K          + +   K+  GT  Y++  
Sbjct: 124 YRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSIN 183

Query: 163 VLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYV-- 220
               RE   +  D+ + G      L G+ P++        ++   RI   +   P     
Sbjct: 184 THLGREQSRR-DDLEALGHVFMYFLRGSLPWQG-LKAATNKQKYERIGEKKQSTPLRELC 241

Query: 221 -HISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLPRELTETAQAIY 269
               ++    +                ++        +   L  T    +
Sbjct: 242 AGFPEEFYKYMHYARNLAFDATPDYDYLQG---LFSKVLERLNTTEDENF 288

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  147 bits (370), Expect = 9e-42
 Identities = 64/305 (20%), Positives = 111/305 (36%), Gaps = 58/305 (19%)

Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVA---REIINHKQLRH 57
           +++Y+ +K IGSG  G+     +      VA+K + R  +   +     RE++  K + H
Sbjct: 16  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 75

Query: 58  PNIIRFKEVVLTP------THLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG- 110
            NII    V            + +VME                   +   Y   Q++ G 
Sbjct: 76  KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ---MELDHERMSYLLYQMLCGI 132

Query: 111 ------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVL 164
                  I HRDLK  N ++       LKI DFG ++++         V T  Y APEV+
Sbjct: 133 KHLHSAGIIHRDLKPSNIVVKSD--CTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 190

Query: 165 SRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVH--- 221
               Y     D+WS G  +  M+     F  ++    + K I ++     +    +    
Sbjct: 191 LGMGYKEN-VDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 249

Query: 222 ---------------------------------ISQDCRNLLSRIFVANPSRRITIKEIK 248
                                             +   R+LLS++ V +P++RI++ +  
Sbjct: 250 RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDAL 309

Query: 249 SHPWF 253
            HP+ 
Sbjct: 310 QHPYI 314

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  144 bits (364), Expect = 2e-41
 Identities = 56/287 (19%), Positives = 101/287 (35%), Gaps = 48/287 (16%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKN-----TKELVAMKYIERGHKID--ANVAREIINHKQ 54
              E ++DIG G FG     R           +VA+K ++     D  A+  RE     +
Sbjct: 13  NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 72

Query: 55  LRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGR-------------------- 94
             +PNI++   V      + ++ EY A G+L E + +                       
Sbjct: 73  FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 132

Query: 95  ----FSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSK-- 141
                S  E     +Q+ +G       +  HRDL   N L+  +    +KI DFG S+  
Sbjct: 133 GPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENM--VVKIADFGLSRNI 190

Query: 142 -SSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPK 200
            S+  +    +      ++ PE +    Y  + +DVW+ GV L+ +             +
Sbjct: 191 YSADYYKADGNDAIPIRWMPPESIFYNRYTTE-SDVWAYGVVLWEIFSYGLQPYYGMAHE 249

Query: 201 NFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEI 247
                +         +    +   +  NL+   +   P+ R +   I
Sbjct: 250 EVIYYVRD----GNILACPENCPLELYNLMRLCWSKLPADRPSFCSI 292

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  141 bits (357), Expect = 3e-40
 Identities = 53/299 (17%), Positives = 106/299 (35%), Gaps = 48/299 (16%)

Query: 2   EKYELMKDIGSGNFGV-----ARLMRNKNTKELVAMKYIERGHKID--ANVAREIINHKQ 54
            +    K +G+G FG      A  +   +    VA+K ++    +     +  E+     
Sbjct: 23  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82

Query: 55  L-RHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERIC------------------NAGRF 95
           L  H NI+             ++ EY   G+L   +                   +    
Sbjct: 83  LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142

Query: 96  SEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR 148
             ++   F  Q+  G          HRDL   N LL        KICDFG ++     S 
Sbjct: 143 DLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHG--RITKICDFGLARDIKNDSN 200

Query: 149 PKST---VGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKT 205
                       ++APE +    Y  + +DVWS G+ L+ +              +    
Sbjct: 201 YVVKGNARLPVKWMAPESIFNCVYTFE-SDVWSYGIFLWELFSLGSSPYPGMPVDS---K 256

Query: 206 ISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLPRELTET 264
             +++   +++    H   +  +++   + A+P +R T K+I      ++ + ++++E+
Sbjct: 257 FYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQI------VQLIEKQISES 309

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  140 bits (354), Expect = 5e-40
 Identities = 63/291 (21%), Positives = 95/291 (32%), Gaps = 48/291 (16%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNII 61
               L + IG G FG   + R K   E VA+K      +       EI     LRH NI+
Sbjct: 3   RTIVLQESIGKGRFGE--VWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENIL 60

Query: 62  RFKEVV----LTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLI--------- 108
            F         T T L +V +Y   G LF+ +       E   +                
Sbjct: 61  GFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEI 120

Query: 109 -----SGQICHRDLKLENTLLDGSPAPRLKICDFG-----YSKSSLLHSRPKSTVGTPAY 158
                   I HRDLK +N L+  +      I D G      S +  +   P   VGT  Y
Sbjct: 121 VGTQGKPAIAHRDLKSKNILVKKN--GTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRY 178

Query: 159 IAPEVLSRREYDGKL-----ADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQ 213
           +APEVL              AD+++ G+  + +          ED +     +       
Sbjct: 179 MAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSV 238

Query: 214 YKIPDYV----------------HISQDCRNLLSRIFVANPSRRITIKEIK 248
            ++   V                   +    ++   + AN + R+T   IK
Sbjct: 239 EEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIK 289

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  140 bits (353), Expect = 3e-39
 Identities = 55/326 (16%), Positives = 109/326 (33%), Gaps = 69/326 (21%)

Query: 3   KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIR 62
           +Y L++ +G G+F    L ++      VAMK +            EI   +++   +  +
Sbjct: 14  RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTK 73

Query: 63  ---------------FKEVVLTPTHLAIVMEYAAGGEL-FERICNAGRFSEDEARYFFQQ 106
                          F        H+ +V E      L   +            +   +Q
Sbjct: 74  EDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQ 133

Query: 107 LISG--------QICHRDLKLENTLLD--GSPAPRLKICDFGYSKSSLLHSRPKSTVGTP 156
           L+ G         I H D+K EN L++   SP   ++I       +        +++ T 
Sbjct: 134 LLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTR 193

Query: 157 AYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPF--EDQEDPKNFRKTISRIMAVQY 214
            Y +PEVL    +    AD+WS    ++ ++ G + F  ++          I++I+ +  
Sbjct: 194 EYRSPEVLLGAPWGCG-ADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLG 252

Query: 215 KIPDYV----------------------------------------HISQDCRNLLSRIF 234
           ++P Y+                                          +++  + LS + 
Sbjct: 253 ELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPML 312

Query: 235 VANPSRRITIKEIKSHPWFLKNLPRE 260
             +P +R     + +HPW    L  E
Sbjct: 313 QLDPRKRADAGGLVNHPWLKDTLGME 338

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  136 bits (342), Expect = 3e-38
 Identities = 53/280 (18%), Positives = 101/280 (36%), Gaps = 39/280 (13%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKE-------LVAMKYI--ERGHKIDANVAREIINH 52
           ++  L K +G G FG   L       +        VA+K +  +   K  +++  E+   
Sbjct: 13  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72

Query: 53  KQL-RHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERI----------------CNAGRF 95
           K + +H NII           L +++EYA+ G L E +                    + 
Sbjct: 73  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132

Query: 96  SEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRL-KICDFGYSKSSLLHS 147
           S  +      Q+  G       +  HRDL   N L+      ++              + 
Sbjct: 133 SSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYK 192

Query: 148 RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTIS 207
           +  +      ++APE L  R Y  + +DVWS GV L+ +             +   K + 
Sbjct: 193 KTTNGRLPVKWMAPEALFDRIYTHQ-SDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLK 251

Query: 208 RIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEI 247
                 +++    + + +   ++   + A PS+R T K++
Sbjct: 252 E----GHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQL 287

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  134 bits (338), Expect = 1e-37
 Identities = 52/285 (18%), Positives = 99/285 (34%), Gaps = 40/285 (14%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKN-----TKELVAMKYIERGHKID--ANVAREIINHKQ 54
           EK  + +++G G+FG+      K       +  VA+K +     +        E    K+
Sbjct: 20  EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79

Query: 55  LRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRF----------SEDEARYFF 104
               +++R   VV       ++ME    G+L   + +              S  +     
Sbjct: 80  FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 139

Query: 105 QQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSK---SSLLHSRPKSTVG 154
            ++  G       +  HRDL   N ++       +KI DFG ++    +  + +    + 
Sbjct: 140 GEIADGMAYLNANKFVHRDLAARNCMVAED--FTVKIGDFGMTRDIYETDYYRKGGKGLL 197

Query: 155 TPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQY 214
              +++PE L    +    +DVWS GV L+ +   A         +   + +        
Sbjct: 198 PVRWMSPESLKDGVFTTY-SDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVME--GGLL 254

Query: 215 KIPDYVHISQDCRNLLSRIFVANPSRRITIKEI------KSHPWF 253
             PD  +       L+   +  NP  R +  EI      +  P F
Sbjct: 255 DKPD--NCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGF 297

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  131 bits (330), Expect = 1e-36
 Identities = 59/285 (20%), Positives = 108/285 (37%), Gaps = 43/285 (15%)

Query: 2   EKYELMKDIGSGNFGV-----ARLMRNKNTKELVAMKYIERGHKIDAN---VAREIINHK 53
           ++ +L K +G G FG      A  +    T   VA+K ++ G     +   ++   I   
Sbjct: 13  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72

Query: 54  QLRHPNIIRFKEVVLTP-THLAIVMEYAAGGELFERICNAGR----------------FS 96
              H N++        P   L +++E+   G L   + +                    +
Sbjct: 73  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132

Query: 97  EDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSK---SSLLH 146
            +    +  Q+  G       +  HRDL   N LL       +KICDFG ++       +
Sbjct: 133 LEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEK--NVVKICDFGLARDIYKDPDY 190

Query: 147 SRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVG-AYPFEDQEDPKNFRKT 205
            R         ++APE +  R Y  + +DVWS GV L+ +    A P+   +  + F + 
Sbjct: 191 VRKGDARLPLKWMAPETIFDRVYTIQ-SDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR 249

Query: 206 ISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSH 250
           +      + + PD  + + +    +   +   PS+R T  E+  H
Sbjct: 250 LKE--GTRMRAPD--YTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 56.7 bits (136), Expect = 3e-10
 Identities = 29/195 (14%), Positives = 56/195 (28%), Gaps = 32/195 (16%)

Query: 4   YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERG-----------HKIDANVAREIINH 52
             + K +G G         ++   E   +K+ + G              D + +   I  
Sbjct: 2   DAIGKLMGEGKESAVFNCYSEKFGE-CVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRS 60

Query: 53  KQLRHPNIIRFKEVVLTPTH----LAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLI 108
            +     + + + + +   +     A++ME     EL+           D       +  
Sbjct: 61  ARNEFRALQKLQGLAVPKVYAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFY 120

Query: 109 SGQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLS--- 165
              I H DL   N L+       + I DF  S                  +  +V +   
Sbjct: 121 HRGIVHGDLSQYNVLVSE---EGIWIIDFPQSVE---VGEEGW----REILERDVRNIIT 170

Query: 166 --RREYDGKLADVWS 178
              R Y  +  D+ S
Sbjct: 171 YFSRTYRTE-KDINS 184

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	344
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.9
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.63
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	98.19
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	98.18
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	97.6
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	97.13
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	97.12

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.4e-64  Score=441.98  Aligned_cols=254  Identities=36%  Similarity=0.601  Sum_probs=216.3

Q ss_pred             CCCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCcc--ccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEEe
Q 019195            1 MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK--IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVME   78 (344)
Q Consensus         1 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e   78 (344)
                      +++|++++.||+|+||+||+|.++.+|+.||||++.....  ....+.+|+.++++++|||||++++++.+++.+|+|||
T Consensus         4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE   83 (271)
T d1nvra_           4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   83 (271)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEe
Confidence            4789999999999999999999999999999999976432  33578999999999999999999999999999999999


Q ss_pred             cCCCCChHHHHHhCCCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCC---CC
Q 019195           79 YAAGGELFERICNAGRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH---SR  148 (344)
Q Consensus        79 ~~~~g~L~~~i~~~~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~---~~  148 (344)
                      ||++|+|.+++.+.+.+++.+++.++.||++|       ||+||||||+|||++.++.  +||+|||+|+.....   ..
T Consensus        84 y~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~--~KL~DFG~a~~~~~~~~~~~  161 (271)
T d1nvra_          84 YCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDN--LKISDFGLATVFRYNNRERL  161 (271)
T ss_dssp             CCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCC--EEECCCTTCEECEETTEECC
T ss_pred             ccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCC--EEEccchhheeeccCCcccc
Confidence            99999999999888899999999999888776       9999999999999987654  999999999864322   23


Q ss_pred             CCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCHhHHH
Q 019195          149 PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRN  228 (344)
Q Consensus       149 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~  228 (344)
                      ....+||+.|||||++.+..+++.++|||||||++|+|++|++||............   ........+.+..+|+++.+
T Consensus       162 ~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~---~~~~~~~~~~~~~~s~~~~~  238 (271)
T d1nvra_         162 LNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSD---WKEKKTYLNPWKKIDSAPLA  238 (271)
T ss_dssp             BCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHH---HHTTCTTSTTGGGSCHHHHH
T ss_pred             ccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHH---HhcCCCCCCccccCCHHHHH
Confidence            455689999999999998888777799999999999999999999876543332222   22233334445578999999


Q ss_pred             HHHHhcccCCCCCCChHHHhcCcccccCCCh
Q 019195          229 LLSRIFVANPSRRITIKEIKSHPWFLKNLPR  259 (344)
Q Consensus       229 li~~~L~~dp~~R~s~~ell~hp~~~~~~~~  259 (344)
                      ||.+||+.||.+|||+.|+|+||||++.+.+
T Consensus       239 li~~~L~~dP~~R~t~~eil~hpwf~~~l~k  269 (271)
T d1nvra_         239 LLHKILVENPSARITIPDIKKDRWYNKPLKK  269 (271)
T ss_dssp             HHHHHSCSSTTTSCCHHHHTTCTTTTCCCCC
T ss_pred             HHHHHcCCChhHCcCHHHHhcCHhhCcCCCC
Confidence            9999999999999999999999999877654

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-62  Score=430.76  Aligned_cols=245  Identities=34%  Similarity=0.640  Sum_probs=214.0

Q ss_pred             CCCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecC----ccccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEE
Q 019195            1 MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERG----HKIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIV   76 (344)
Q Consensus         1 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv   76 (344)
                      |++|++++.||+|+||+||+|.++.+++.||+|++.+.    ......+.+|+.++++++|||||++++++.+++.+|+|
T Consensus         5 l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~iv   84 (263)
T d2j4za1           5 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI   84 (263)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEE
Confidence            57999999999999999999999999999999998753    23346788999999999999999999999999999999


Q ss_pred             EecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCCCC
Q 019195           77 MEYAAGGELFERICNAGRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP  149 (344)
Q Consensus        77 ~e~~~~g~L~~~i~~~~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~~~  149 (344)
                      ||||++|+|.+++.+.+.+++.+++.++.||++|       ||+||||||+|||++.++.  +||+|||+|+.... ...
T Consensus        85 mEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~--~kl~DFG~a~~~~~-~~~  161 (263)
T d2j4za1          85 LEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGE--LKIADFGWSVHAPS-SRR  161 (263)
T ss_dssp             EECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSC--EEECCCCSCSCCCC-CCC
T ss_pred             EeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCC--EeecccceeeecCC-Ccc
Confidence            9999999999999998999999999998887766       9999999999999987654  99999999975432 334


Q ss_pred             CCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCHhHHHH
Q 019195          150 KSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL  229 (344)
Q Consensus       150 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  229 (344)
                      ...+||+.|||||++.+..++ .++|||||||++|+|++|++||.+.+..    ..+..+....+.+|.  .+|+++++|
T Consensus       162 ~~~~Gt~~Y~APE~~~~~~~~-~~~DiwSlGvilyell~G~~Pf~~~~~~----~~~~~i~~~~~~~p~--~~s~~~~~l  234 (263)
T d2j4za1         162 TTLCGTLDYLPPEMIEGRMHD-EKVDLWSLGVLCYEFLVGKPPFEANTYQ----ETYKRISRVEFTFPD--FVTEGARDL  234 (263)
T ss_dssp             EETTEEGGGCCHHHHTTCCCC-TTHHHHHHHHHHHHHHHSSCTTCCSSHH----HHHHHHHTTCCCCCT--TSCHHHHHH
T ss_pred             cccCCCCcccCHHHHcCCCCC-chhhhhhHhHHHHHHhcCCCCCCCCCHH----HHHHHHHcCCCCCCc--cCCHHHHHH
Confidence            556899999999999988775 5599999999999999999999876543    334445555555554  689999999


Q ss_pred             HHHhcccCCCCCCChHHHhcCccccc
Q 019195          230 LSRIFVANPSRRITIKEIKSHPWFLK  255 (344)
Q Consensus       230 i~~~L~~dp~~R~s~~ell~hp~~~~  255 (344)
                      |.+||+.||.+|||+.|+|+||||..
T Consensus       235 i~~~L~~dp~~R~t~~eil~hp~~~~  260 (263)
T d2j4za1         235 ISRLLKHNPSQRPMLREVLEHPWITA  260 (263)
T ss_dssp             HHHHTCSSGGGSCCHHHHHTCHHHHH
T ss_pred             HHHHccCCHhHCcCHHHHHcCcCcCC
Confidence            99999999999999999999999964

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.8e-61  Score=427.63  Aligned_cols=250  Identities=26%  Similarity=0.440  Sum_probs=213.4

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCcc-ccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEEecC
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK-IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYA   80 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~   80 (344)
                      ++|++++.||+|+||+||+|.+..+|+.||||++..... ....+.+|+.++++++|||||+++++|.+++.+|+|||||
T Consensus        20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~   99 (293)
T d1yhwa1          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   99 (293)
T ss_dssp             TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence            479999999999999999999999999999999976443 3457899999999999999999999999999999999999


Q ss_pred             CCCChHHHHHhCCCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCC-CCCCCC
Q 019195           81 AGGELFERICNAGRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH-SRPKST  152 (344)
Q Consensus        81 ~~g~L~~~i~~~~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~-~~~~~~  152 (344)
                      +||+|.+++.+ +.+++.+++.++.||+.|       ||+||||||+|||++.++  ++||+|||+|+..... ......
T Consensus       100 ~gg~L~~~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~--~vkl~DFG~a~~~~~~~~~~~~~  176 (293)
T d1yhwa1         100 AGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDG--SVKLTDFGFCAQITPEQSKRSTM  176 (293)
T ss_dssp             TTCBHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTC--CEEECCCTTCEECCSTTCCBCCC
T ss_pred             CCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCC--cEeeccchhheeecccccccccc
Confidence            99999998765 569999999998887766       999999999999997665  4999999999865433 334556


Q ss_pred             ccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCHhHHHHHHH
Q 019195          153 VGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSR  232 (344)
Q Consensus       153 ~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~  232 (344)
                      +||+.|+|||++.+..++. ++|||||||++|+|++|++||.+.+....+..+..   .....++.+..+|+++++||.+
T Consensus       177 ~gt~~Y~aPE~~~~~~~~~-~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~---~~~~~~~~~~~~s~~~~~li~~  252 (293)
T d1yhwa1         177 VGTPYWMAPEVVTRKAYGP-KVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIAT---NGTPELQNPEKLSAIFRDFLNR  252 (293)
T ss_dssp             CSCGGGCCHHHHSSSCBCT-HHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH---HCSCCCSSGGGSCHHHHHHHHH
T ss_pred             ccCCCccChhhhcCCCCCc-hhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHh---CCCCCCCCcccCCHHHHHHHHH
Confidence            7999999999999887754 59999999999999999999987765444333322   2333344455789999999999


Q ss_pred             hcccCCCCCCChHHHhcCcccccCCC
Q 019195          233 IFVANPSRRITIKEIKSHPWFLKNLP  258 (344)
Q Consensus       233 ~L~~dp~~R~s~~ell~hp~~~~~~~  258 (344)
                      ||+.||.+|||+.|+|+||||+...+
T Consensus       253 ~L~~dP~~R~s~~eil~Hp~~~~~~~  278 (293)
T d1yhwa1         253 CLDMDVEKRGSAKELLQHQFLKIAKP  278 (293)
T ss_dssp             HTCSSTTTSCCHHHHTTCGGGGGCCC
T ss_pred             HccCChhHCcCHHHHhcCHhhCCCCC
Confidence            99999999999999999999975543

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.2e-61  Score=434.14  Aligned_cols=250  Identities=34%  Similarity=0.639  Sum_probs=198.8

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCc--cccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEEec
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH--KIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEY   79 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~   79 (344)
                      ++|++++.||+|+||+||+|.+..+++.||||++.+..  .....+.+|+.+|++++|||||++++++.+++.+|+||||
T Consensus         9 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE~   88 (307)
T d1a06a_           9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQL   88 (307)
T ss_dssp             GTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             cceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence            46999999999999999999999999999999997643  2335678999999999999999999999999999999999


Q ss_pred             CCCCChHHHHHhCCCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecC-CCCCCEEEeecCCCcccCCCCCCCC
Q 019195           80 AAGGELFERICNAGRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDG-SPAPRLKICDFGYSKSSLLHSRPKS  151 (344)
Q Consensus        80 ~~~g~L~~~i~~~~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~-~~~~~vkL~DFg~a~~~~~~~~~~~  151 (344)
                      |+||+|.+++.+.+.+++.+++.++.||+.|       ||+||||||+|||+.. +..+++||+|||+|+..........
T Consensus        89 ~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~~~~~  168 (307)
T d1a06a_          89 VSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLST  168 (307)
T ss_dssp             CCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC--------------
T ss_pred             cCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEccCCCeeee
Confidence            9999999999999999999999998888766       9999999999999964 3345699999999987666666667


Q ss_pred             CccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhcccc--CCCCCCCCHhHHHH
Q 019195          152 TVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYK--IPDYVHISQDCRNL  229 (344)
Q Consensus       152 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~s~~~~~l  229 (344)
                      .+||+.|||||++.+..++ .++|||||||++|+|++|++||.+.......    ..+......  .+....+|+++.+|
T Consensus       169 ~~GT~~y~APE~~~~~~~~-~~~DiwSlGvilyell~g~~Pf~~~~~~~~~----~~i~~~~~~~~~~~~~~~s~~~~~l  243 (307)
T d1a06a_         169 ACGTPGYVAPEVLAQKPYS-KAVDCWSIGVIAYILLCGYPPFYDENDAKLF----EQILKAEYEFDSPYWDDISDSAKDF  243 (307)
T ss_dssp             ----CTTSCHHHHTTCCCC-THHHHHHHHHHHHHHHHSSCSCCCSSHHHHH----HHHHTTCCCCCTTTTTTSCHHHHHH
T ss_pred             eeeCccccCcHHHcCCCCC-cHHHhhhhhHHHHHHHhCCCCCCCCCHHHHH----HHHhccCCCCCCccccCCCHHHHHH
Confidence            7899999999999888775 4599999999999999999999876654433    333333333  34445789999999


Q ss_pred             HHHhcccCCCCCCChHHHhcCcccccC
Q 019195          230 LSRIFVANPSRRITIKEIKSHPWFLKN  256 (344)
Q Consensus       230 i~~~L~~dp~~R~s~~ell~hp~~~~~  256 (344)
                      |.+||+.||.+|||+.|+|+||||.+.
T Consensus       244 i~~~L~~dP~~R~s~~eil~hp~~~~~  270 (307)
T d1a06a_         244 IRHLMEKDPEKRFTCEQALQHPWIAGD  270 (307)
T ss_dssp             HHHHSCSSGGGSCCHHHHHHSTTTTSS
T ss_pred             HHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence            999999999999999999999999754

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=2.3e-61  Score=439.51  Aligned_cols=251  Identities=29%  Similarity=0.605  Sum_probs=217.2

Q ss_pred             CCCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCcc-ccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEEec
Q 019195            1 MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK-IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEY   79 (344)
Q Consensus         1 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~   79 (344)
                      |++|++++.||+|+||+||+|.+..+|+.||||++..... ....+.+|+.+|++++|||||+++++|.+++.+|+||||
T Consensus        25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~  104 (350)
T d1koaa2          25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF  104 (350)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            5789999999999999999999999999999999976543 235688999999999999999999999999999999999


Q ss_pred             CCCCChHHHHHh-CCCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCCCCCC
Q 019195           80 AAGGELFERICN-AGRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKS  151 (344)
Q Consensus        80 ~~~g~L~~~i~~-~~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~~~~~  151 (344)
                      |+||+|.+++.+ .+.+++.+++.++.||+.|       ||+||||||+|||++.+..+++||+|||+|+..........
T Consensus       105 ~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~~~~~  184 (350)
T d1koaa2         105 MSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKV  184 (350)
T ss_dssp             CCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTSCEEE
T ss_pred             CCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheecccccccce
Confidence            999999999854 5679999999998887766       99999999999999765556799999999987666655666


Q ss_pred             CccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCC--CCCCCCHhHHHH
Q 019195          152 TVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIP--DYVHISQDCRNL  229 (344)
Q Consensus       152 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~s~~~~~l  229 (344)
                      .+||+.|||||++.+..++ .++|||||||++|+|++|+.||.+.+..+.+.    .+....+.++  .+..+|+++++|
T Consensus       185 ~~gT~~Y~aPEv~~~~~~~-~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~----~i~~~~~~~~~~~~~~~s~~~~~l  259 (350)
T d1koaa2         185 TTGTAEFAAPEVAEGKPVG-YYTDMWSVGVLSYILLSGLSPFGGENDDETLR----NVKSCDWNMDDSAFSGISEDGKDF  259 (350)
T ss_dssp             ECSCTTTCCHHHHHTCCBC-HHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH----HHHHTCCCSCCGGGGGCCHHHHHH
T ss_pred             ecCcccccCHHHHcCCCCC-hhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHH----HHHhCCCCCCcccccCCCHHHHHH
Confidence            7899999999999888875 56999999999999999999998766544433    3444444433  234689999999


Q ss_pred             HHHhcccCCCCCCChHHHhcCcccccC
Q 019195          230 LSRIFVANPSRRITIKEIKSHPWFLKN  256 (344)
Q Consensus       230 i~~~L~~dp~~R~s~~ell~hp~~~~~  256 (344)
                      |.+||+.||.+|||+.|+|+||||...
T Consensus       260 i~~~L~~dP~~R~t~~eil~hp~~~~~  286 (350)
T d1koaa2         260 IRKLLLADPNTRMTIHQALEHPWLTPG  286 (350)
T ss_dssp             HHHHCCSSGGGSCCHHHHHHSTTTSCT
T ss_pred             HHHHccCChhHCcCHHHHhcCcccCCC
Confidence            999999999999999999999999764

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.8e-61  Score=434.43  Aligned_cols=250  Identities=28%  Similarity=0.442  Sum_probs=205.7

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCcc--ccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEEec
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK--IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEY   79 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~   79 (344)
                      ++|++++.||+|+||+||+|.+..+|+.||+|+++....  ....+.+|+.+|++++|||||+++++|.+++++|+||||
T Consensus         6 d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmEy   85 (322)
T d1s9ja_           6 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH   85 (322)
T ss_dssp             GGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             cCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            689999999999999999999999999999999976432  235788999999999999999999999999999999999


Q ss_pred             CCCCChHHHHHhCCCCCHHHHHHHHHHHHHC--------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCCCCCC
Q 019195           80 AAGGELFERICNAGRFSEDEARYFFQQLISG--------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKS  151 (344)
Q Consensus        80 ~~~g~L~~~i~~~~~~~~~~~~~~~~ql~~~--------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~~~~~  151 (344)
                      |+||+|.+++.+.+.+++..++.++.||+.|        ||+||||||+|||++.++  ++||+|||+|+.... ....+
T Consensus        86 ~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~--~vkl~DFGla~~~~~-~~~~~  162 (322)
T d1s9ja_          86 MDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRG--EIKLCDFGVSGQLID-SMANS  162 (322)
T ss_dssp             CTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTC--CEEECCCCCCHHHHH-HTC--
T ss_pred             CCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCC--CEEEeeCCCccccCC-Ccccc
Confidence            9999999999998999999999998886654        899999999999997765  499999999985432 23456


Q ss_pred             CccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHH---------------------------
Q 019195          152 TVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRK---------------------------  204 (344)
Q Consensus       152 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~---------------------------  204 (344)
                      .+||+.|||||++.+..|+. ++||||+||++|||++|+.||.+.+.......                           
T Consensus       163 ~~GT~~Y~APEvl~~~~y~~-~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (322)
T d1s9ja_         163 FVGTRSYMSPERLQGTHYSV-QSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYG  241 (322)
T ss_dssp             -CCSSCCCCHHHHHCSCCCT-THHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC--------------------------
T ss_pred             ccCCccccCchHHcCCCCCc-HHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccccccccccc
Confidence            78999999999999888755 59999999999999999999987553221110                           


Q ss_pred             -----------HHHHHhhccccCCCCCCCCHhHHHHHHHhcccCCCCCCChHHHhcCccccc
Q 019195          205 -----------TISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLK  255 (344)
Q Consensus       205 -----------~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~  255 (344)
                                 ....+............+|+++.+||.+||+.||.+||||.|+|+||||++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~  303 (322)
T d1s9ja_         242 MDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKR  303 (322)
T ss_dssp             ----CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHH
T ss_pred             cccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCc
Confidence                       000111111111111246889999999999999999999999999999965

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.6e-60  Score=428.51  Aligned_cols=247  Identities=34%  Similarity=0.607  Sum_probs=216.7

Q ss_pred             CCCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCc----cccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEE
Q 019195            1 MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH----KIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIV   76 (344)
Q Consensus         1 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv   76 (344)
                      |++|++++.||+|+||+||+|+++.+|+.||||++.+..    .....+.+|+.+|++++||||++++++|.+++.+|+|
T Consensus         4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv   83 (337)
T d1o6la_           4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV   83 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccc
Confidence            689999999999999999999999999999999997632    2346788999999999999999999999999999999


Q ss_pred             EecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCC-CCC
Q 019195           77 MEYAAGGELFERICNAGRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLL-HSR  148 (344)
Q Consensus        77 ~e~~~~g~L~~~i~~~~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~-~~~  148 (344)
                      ||||+||+|..++.+.+.+++..++.++.||+.|       ||+||||||+|||++.++  ++||+|||+|+.... ...
T Consensus        84 ~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g--~vkl~DFG~a~~~~~~~~~  161 (337)
T d1o6la_          84 MEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDG--HIKITDFGLCKEGISDGAT  161 (337)
T ss_dssp             EECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTS--CEEECCCTTCBCSCCTTCC
T ss_pred             eeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCC--CEEEeecccccccccCCcc
Confidence            9999999999999999999999999998887766       999999999999998765  499999999986543 334


Q ss_pred             CCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCHhHHH
Q 019195          149 PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRN  228 (344)
Q Consensus       149 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~  228 (344)
                      ....+||+.|||||++.+..|+ .++|||||||++|+|++|++||.+.+...    +...+......+|.  .+|+++++
T Consensus       162 ~~~~~GT~~Y~aPE~~~~~~y~-~~~DiwSlGvilyeml~G~~pf~~~~~~~----~~~~i~~~~~~~p~--~~s~~~~d  234 (337)
T d1o6la_         162 MKTFCGTPEYLAPEVLEDNDYG-RAVDWWGLGVVMYEMMCGRLPFYNQDHER----LFELILMEEIRFPR--TLSPEAKS  234 (337)
T ss_dssp             BCCCEECGGGCCGGGGSSSCBC-TTHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHHHHHHCCCCCCT--TSCHHHHH
T ss_pred             cccceeCHHHhhhhhccCCCCC-hhhcccchhhHHHHHHHCCCCCCCcCHHH----HHHHHhcCCCCCCc--cCCHHHHH
Confidence            4567899999999999988885 55999999999999999999998876533    34444555555554  78999999


Q ss_pred             HHHHhcccCCCCCCC-----hHHHhcCcccccC
Q 019195          229 LLSRIFVANPSRRIT-----IKEIKSHPWFLKN  256 (344)
Q Consensus       229 li~~~L~~dp~~R~s-----~~ell~hp~~~~~  256 (344)
                      ||.+||++||.+|++     +.++++||||.+.
T Consensus       235 li~~~L~~dP~~R~~~~~~~~~eil~Hp~f~~i  267 (337)
T d1o6la_         235 LLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSI  267 (337)
T ss_dssp             HHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred             HHHhhccCCchhhcccccccHHHHHcCcccccC
Confidence            999999999999994     8999999999764

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=7.5e-61  Score=436.45  Aligned_cols=250  Identities=28%  Similarity=0.565  Sum_probs=216.8

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCccc-cHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEEecC
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKI-DANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYA   80 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~   80 (344)
                      ++|++++.||+|+||+||+|.+..+|+.||||++...... ...+.+|+.+|++++|||||+++++|.+++.+|+|||||
T Consensus        29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~  108 (352)
T d1koba_          29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL  108 (352)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred             cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence            6799999999999999999999999999999999875432 356789999999999999999999999999999999999


Q ss_pred             CCCChHHHHHhCC-CCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCCCCCCC
Q 019195           81 AGGELFERICNAG-RFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST  152 (344)
Q Consensus        81 ~~g~L~~~i~~~~-~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~~~~~~  152 (344)
                      +||+|.+.+.+.+ ++++.+++.++.||+.|       ||+||||||+|||++....+++||+|||+|+...........
T Consensus       109 ~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~~~~~~  188 (352)
T d1koba_         109 SGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVT  188 (352)
T ss_dssp             CCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSCEEEE
T ss_pred             CCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecCCCCceeec
Confidence            9999998876554 69999999998887766       999999999999998656667999999999877666556667


Q ss_pred             ccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCC--CCCCCCHhHHHHH
Q 019195          153 VGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIP--DYVHISQDCRNLL  230 (344)
Q Consensus       153 ~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~s~~~~~li  230 (344)
                      +||+.|||||++.+..++ .++|||||||++|+|++|++||.+.+....+.    .+......++  .+..+|+++.+||
T Consensus       189 ~gt~~y~aPE~~~~~~~~-~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~----~i~~~~~~~~~~~~~~~s~~~~~li  263 (352)
T d1koba_         189 TATAEFAAPEIVDREPVG-FYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQ----NVKRCDWEFDEDAFSSVSPEAKDFI  263 (352)
T ss_dssp             CSSGGGCCHHHHTTCCBC-HHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHH----HHHHCCCCCCSSTTTTSCHHHHHHH
T ss_pred             cCcccccCHHHHcCCCCC-CccchHHHHHHHHHHHhCCCCCCCCCHHHHHH----HHHhCCCCCCcccccCCCHHHHHHH
Confidence            899999999999888775 55999999999999999999998876544433    3444444333  3457899999999


Q ss_pred             HHhcccCCCCCCChHHHhcCcccccC
Q 019195          231 SRIFVANPSRRITIKEIKSHPWFLKN  256 (344)
Q Consensus       231 ~~~L~~dp~~R~s~~ell~hp~~~~~  256 (344)
                      .+||+.||.+|||+.|+|+||||+..
T Consensus       264 ~~~L~~dp~~R~s~~eil~Hp~~~~~  289 (352)
T d1koba_         264 KNLLQKEPRKRLTVHDALEHPWLKGD  289 (352)
T ss_dssp             HTTSCSSGGGSCCHHHHHTSTTTSSC
T ss_pred             HHHccCChhHCcCHHHHhcCHhhCCC
Confidence            99999999999999999999999764

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-60  Score=422.72  Aligned_cols=253  Identities=26%  Similarity=0.381  Sum_probs=211.8

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCc-cccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEEecC
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH-KIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYA   80 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~   80 (344)
                      +.|++++.||+|+||+||+|.+..+++.||+|++.... .....+.+|+.+|++++|||||++++++.+++.+|+|||||
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~   91 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC   91 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence            35999999999999999999999999999999997643 33467899999999999999999999999999999999999


Q ss_pred             CCCChHHHHHh-CCCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCC-CCCCC
Q 019195           81 AGGELFERICN-AGRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH-SRPKS  151 (344)
Q Consensus        81 ~~g~L~~~i~~-~~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~-~~~~~  151 (344)
                      ++|+|..++.+ .+.+++.+++.++.||++|       ||+||||||+|||++.++.  +||+|||+|+..... .....
T Consensus        92 ~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~--~Kl~DFG~a~~~~~~~~~~~~  169 (288)
T d2jfla1          92 AGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGD--IKLADFGVSAKNTRTIQRRDS  169 (288)
T ss_dssp             TTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC--EEECCCTTCEECHHHHHHHTC
T ss_pred             CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCC--EEEEechhhhccCCCcccccc
Confidence            99999998765 4579999999998887766       9999999999999987664  999999998653322 22345


Q ss_pred             CccCCcccCCccccC----CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCHhHH
Q 019195          152 TVGTPAYIAPEVLSR----REYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCR  227 (344)
Q Consensus       152 ~~gt~~y~aPE~~~~----~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~  227 (344)
                      .+||+.|||||++..    ...++.++|||||||++|+|++|++||.+.+..+.+.++...   ....++.+..+|+++.
T Consensus       170 ~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~---~~~~~~~~~~~s~~~~  246 (288)
T d2jfla1         170 FIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKS---EPPTLAQPSRWSSNFK  246 (288)
T ss_dssp             CCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHS---CCCCCSSGGGSCHHHH
T ss_pred             cccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcC---CCCCCCccccCCHHHH
Confidence            689999999999843    222345699999999999999999999887765555443322   1223344457899999


Q ss_pred             HHHHHhcccCCCCCCChHHHhcCcccccCCCh
Q 019195          228 NLLSRIFVANPSRRITIKEIKSHPWFLKNLPR  259 (344)
Q Consensus       228 ~li~~~L~~dp~~R~s~~ell~hp~~~~~~~~  259 (344)
                      +||.+||+.||.+|||+.|+|+||||+....+
T Consensus       247 ~li~~~L~~dp~~R~t~~ell~hp~~~~~~~~  278 (288)
T d2jfla1         247 DFLKKCLEKNVDARWTTSQLLQHPFVTVDSNK  278 (288)
T ss_dssp             HHHHHHSCSSTTTSCCHHHHTTSGGGCCCCCH
T ss_pred             HHHHHHccCChhHCcCHHHHhcCcccCCCCCC
Confidence            99999999999999999999999999866544

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.7e-61  Score=424.23  Aligned_cols=246  Identities=30%  Similarity=0.542  Sum_probs=210.5

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCc----cccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEE
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH----KIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVM   77 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~   77 (344)
                      ++|++++.||+|+||+||+|.+..+++.||||++.+..    .....+.+|+.++++++|||||+++++|.+++.+|+||
T Consensus         8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm   87 (288)
T d1uu3a_           8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL   87 (288)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred             CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence            57999999999999999999999999999999997532    23357899999999999999999999999999999999


Q ss_pred             ecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCC---C
Q 019195           78 EYAAGGELFERICNAGRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH---S  147 (344)
Q Consensus        78 e~~~~g~L~~~i~~~~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~---~  147 (344)
                      |||+||+|.+++...+.+++.+++.++.|++.|       ||+||||||+|||++.++.  +||+|||+|+.....   .
T Consensus        88 Ey~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~--vkl~DFG~a~~~~~~~~~~  165 (288)
T d1uu3a_          88 SYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMH--IQITDFGTAKVLSPESKQA  165 (288)
T ss_dssp             CCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSC--EEECCCTTCEECC------
T ss_pred             EccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCce--EEecccccceecccCCccc
Confidence            999999999999999999999999998887766       9999999999999987664  999999999865332   2


Q ss_pred             CCCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCHhHH
Q 019195          148 RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCR  227 (344)
Q Consensus       148 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~  227 (344)
                      .....+||+.|||||++.+..++ .++|||||||++|+|++|++||...+...    ...++....+.+|.  .++++++
T Consensus       166 ~~~~~~GT~~Y~APE~~~~~~~~-~~~DiwSlGvilyell~g~~Pf~~~~~~~----~~~~i~~~~~~~p~--~~s~~~~  238 (288)
T d1uu3a_         166 RANSFVGTAQYVSPELLTEKSAC-KSSDLWALGCIIYQLVAGLPPFRAGNEYL----IFQKIIKLEYDFPE--KFFPKAR  238 (288)
T ss_dssp             ----CCCCGGGCCHHHHHTCCCC-HHHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHHHHHTTCCCCCT--TCCHHHH
T ss_pred             ccccccCCccccCceeeccCCCC-cccceehhhHHHHHHhhCCCCCCCcCHHH----HHHHHHcCCCCCCc--cCCHHHH
Confidence            33456899999999999888774 56999999999999999999998765433    33445555555554  6899999


Q ss_pred             HHHHHhcccCCCCCCChHH------HhcCcccccC
Q 019195          228 NLLSRIFVANPSRRITIKE------IKSHPWFLKN  256 (344)
Q Consensus       228 ~li~~~L~~dp~~R~s~~e------ll~hp~~~~~  256 (344)
                      +||.+||+.||.+|||+.|      +++||||...
T Consensus       239 ~li~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~i  273 (288)
T d1uu3a_         239 DLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV  273 (288)
T ss_dssp             HHHHTTSCSSGGGSTTSGGGTCHHHHHTSGGGTTC
T ss_pred             HHHHHHccCCHhHCcCHHHHcCCHHHHcCCccCCC
Confidence            9999999999999999988      5889999764

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-60  Score=422.92  Aligned_cols=250  Identities=33%  Similarity=0.626  Sum_probs=215.8

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCcc-------ccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEE
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK-------IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLA   74 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-------~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~   74 (344)
                      ++|++++.||+|+||+||+|.++.+|+.||||++.+...       ....+.+|+.+|++++|||||+++++|.+++.+|
T Consensus        10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~   89 (293)
T d1jksa_          10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI   89 (293)
T ss_dssp             GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence            579999999999999999999999999999999975321       2357899999999999999999999999999999


Q ss_pred             EEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCC--CCEEEeecCCCcccCC
Q 019195           75 IVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPA--PRLKICDFGYSKSSLL  145 (344)
Q Consensus        75 lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~--~~vkL~DFg~a~~~~~  145 (344)
                      +|||||+||+|.+++.+.+.+++.+++.++.|+++|       ||+||||||+|||++.++.  .++||+|||+|.....
T Consensus        90 iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~~~  169 (293)
T d1jksa_          90 LILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF  169 (293)
T ss_dssp             EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEECTT
T ss_pred             EEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhhhcCC
Confidence            999999999999999988899999999998887766       9999999999999976543  3599999999987766


Q ss_pred             CCCCCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCC--CCCCCC
Q 019195          146 HSRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIP--DYVHIS  223 (344)
Q Consensus       146 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~s  223 (344)
                      .......+||+.|+|||++.+..++ .++|||||||++|+|++|+.||.+.+..+.+    ..+......++  .+..+|
T Consensus       170 ~~~~~~~~~t~~y~APE~~~~~~~~-~~~DiwSlGvilyell~g~~Pf~~~~~~~~~----~~i~~~~~~~~~~~~~~~s  244 (293)
T d1jksa_         170 GNEFKNIFGTPEFVAPEIVNYEPLG-LEADMWSIGVITYILLSGASPFLGDTKQETL----ANVSAVNYEFEDEYFSNTS  244 (293)
T ss_dssp             SCBCSCCCCCGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHH----HHHHTTCCCCCHHHHTTSC
T ss_pred             CccccccCCCCcccCHHHHcCCCCC-CcccchhhhHHHHHHHcCCCCCCCCCHHHHH----HHHHhcCCCCCchhcCCCC
Confidence            6666778899999999999887765 5599999999999999999999876654433    33344444333  234689


Q ss_pred             HhHHHHHHHhcccCCCCCCChHHHhcCcccccC
Q 019195          224 QDCRNLLSRIFVANPSRRITIKEIKSHPWFLKN  256 (344)
Q Consensus       224 ~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~~  256 (344)
                      +++++||++||+.||.+|||+.|+|+||||+..
T Consensus       245 ~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~  277 (293)
T d1jksa_         245 ALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPK  277 (293)
T ss_dssp             HHHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC-
T ss_pred             HHHHHHHHHHccCChhHCcCHHHHhcCcccCCC
Confidence            999999999999999999999999999999754

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=5e-60  Score=423.76  Aligned_cols=249  Identities=26%  Similarity=0.362  Sum_probs=210.9

Q ss_pred             CceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCccc----cHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEEe
Q 019195            3 KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKI----DANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVME   78 (344)
Q Consensus         3 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~----~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e   78 (344)
                      +|++++.||+|+||+||+|.+..+++.||||++......    ...+.+|+.+|++++|||||++++++.+++.+|+|||
T Consensus        16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E   95 (309)
T d1u5ra_          16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME   95 (309)
T ss_dssp             HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence            499999999999999999999999999999999865432    2468899999999999999999999999999999999


Q ss_pred             cCCCCChHHHHHhCCCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCCCCCC
Q 019195           79 YAAGGELFERICNAGRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKS  151 (344)
Q Consensus        79 ~~~~g~L~~~i~~~~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~~~~~  151 (344)
                      ||.+|+|..++...+.+++.+++.++.||++|       ||+||||||+|||++.++.  +||+|||+|+....   ...
T Consensus        96 ~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~--~Kl~DFG~a~~~~~---~~~  170 (309)
T d1u5ra_          96 YCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGL--VKLGDFGSASIMAP---ANS  170 (309)
T ss_dssp             CCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTE--EEECCCTTCBSSSS---BCC
T ss_pred             ecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCC--EEEeecccccccCC---CCc
Confidence            99999998888888899999999998887766       9999999999999987654  99999999975432   345


Q ss_pred             CccCCcccCCccccCC--CCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCHhHHHH
Q 019195          152 TVGTPAYIAPEVLSRR--EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL  229 (344)
Q Consensus       152 ~~gt~~y~aPE~~~~~--~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  229 (344)
                      .+||+.|||||++.+.  ..++.++|||||||++|+|++|+.||.+......+..    +.......+....+|+++.+|
T Consensus       171 ~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~----i~~~~~~~~~~~~~s~~~~~l  246 (309)
T d1u5ra_         171 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYH----IAQNESPALQSGHWSEYFRNF  246 (309)
T ss_dssp             CCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH----HHHSCCCCCSCTTSCHHHHHH
T ss_pred             cccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHH----HHhCCCCCCCCCCCCHHHHHH
Confidence            6899999999998643  2234569999999999999999999987665443333    333333333445689999999


Q ss_pred             HHHhcccCCCCCCChHHHhcCcccccCCChh
Q 019195          230 LSRIFVANPSRRITIKEIKSHPWFLKNLPRE  260 (344)
Q Consensus       230 i~~~L~~dp~~R~s~~ell~hp~~~~~~~~~  260 (344)
                      |.+||+.||.+|||+.|+|+||||.+..++.
T Consensus       247 i~~~L~~dP~~Rpt~~ell~Hp~~~~~~~~~  277 (309)
T d1u5ra_         247 VDSCLQKIPQDRPTSEVLLKHRFVLRERPPT  277 (309)
T ss_dssp             HHHHTCSSGGGSCCHHHHTTCHHHHSCCCTT
T ss_pred             HHHHCcCChhHCcCHHHHHhCHHhcCCCCch
Confidence            9999999999999999999999998765543

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-60  Score=430.91  Aligned_cols=251  Identities=27%  Similarity=0.492  Sum_probs=219.1

Q ss_pred             CCCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEEecC
Q 019195            1 MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYA   80 (344)
Q Consensus         1 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~   80 (344)
                      +++|++++.||+|+||+||+|.+..+++.||+|++.........+.+|+.+|++++|||||+++++|.+++.+|+|||||
T Consensus         4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~   83 (321)
T d1tkia_           4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFI   83 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecC
Confidence            58999999999999999999999999999999999876655567889999999999999999999999999999999999


Q ss_pred             CCCChHHHHHhCC-CCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCCCCCCC
Q 019195           81 AGGELFERICNAG-RFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST  152 (344)
Q Consensus        81 ~~g~L~~~i~~~~-~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~~~~~~  152 (344)
                      +||+|.++|...+ .+++.+++.++.||+.|       ||+||||||+|||++.+...++||+|||+++...........
T Consensus        84 ~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~~~~~~  163 (321)
T d1tkia_          84 SGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLL  163 (321)
T ss_dssp             CCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCEEEEE
T ss_pred             CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhccccCCccccc
Confidence            9999999998765 79999999998887766       999999999999998766667999999999876555555667


Q ss_pred             ccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCCC--CCCCCHhHHHHH
Q 019195          153 VGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPD--YVHISQDCRNLL  230 (344)
Q Consensus       153 ~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~s~~~~~li  230 (344)
                      +||+.|+|||.+.+..++ .++|||||||++|+|++|.+||...+....    +..+....+.++.  +..+|+++++||
T Consensus       164 ~~t~~y~ape~~~~~~~~-~~~DiWSlGvily~ll~G~~Pf~~~~~~~~----~~~i~~~~~~~~~~~~~~~s~~~~~li  238 (321)
T d1tkia_         164 FTAPEYYAPEVHQHDVVS-TATDMWSLGTLVYVLLSGINPFLAETNQQI----IENIMNAEYTFDEEAFKEISIEAMDFV  238 (321)
T ss_dssp             ESCGGGSCHHHHTTCEEC-HHHHHHHHHHHHHHHHHSSCTTCCSSHHHH----HHHHHHTCCCCCHHHHTTSCHHHHHHH
T ss_pred             ccccccccchhccCCCCC-chhhcccHHHHHHHHHhCCCCCCCCCHHHH----HHHHHhCCCCCChhhccCCCHHHHHHH
Confidence            899999999999887765 569999999999999999999988765443    3344444444432  346899999999


Q ss_pred             HHhcccCCCCCCChHHHhcCcccccC
Q 019195          231 SRIFVANPSRRITIKEIKSHPWFLKN  256 (344)
Q Consensus       231 ~~~L~~dp~~R~s~~ell~hp~~~~~  256 (344)
                      .+||+.||.+|||+.|+|+||||++.
T Consensus       239 ~~~L~~dp~~R~s~~eil~hp~~~~~  264 (321)
T d1tkia_         239 DRLLVKERKSRMTASEALQHPWLKQK  264 (321)
T ss_dssp             HTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred             HHHccCChhHCcCHHHHhcCHhhccC
Confidence            99999999999999999999999765

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=2.7e-59  Score=420.46  Aligned_cols=246  Identities=32%  Similarity=0.624  Sum_probs=214.5

Q ss_pred             CCCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecC----ccccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEE
Q 019195            1 MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERG----HKIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIV   76 (344)
Q Consensus         1 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv   76 (344)
                      |++|++++.||+|+||+||+|+++.+|+.||||++.+.    ......+.+|+.++++++|||||++++++.+++.+|+|
T Consensus         3 l~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv   82 (316)
T d1fota_           3 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI   82 (316)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred             hhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeE
Confidence            57899999999999999999999999999999999753    22346788999999999999999999999999999999


Q ss_pred             EecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCCCC
Q 019195           77 MEYAAGGELFERICNAGRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP  149 (344)
Q Consensus        77 ~e~~~~g~L~~~i~~~~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~~~  149 (344)
                      ||||.||+|..++.....+++..++.++.||+.|       ||+||||||+|||++.++  ++||+|||+|+...  ...
T Consensus        83 mE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g--~vkL~DFG~a~~~~--~~~  158 (316)
T d1fota_          83 MDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNG--HIKITDFGFAKYVP--DVT  158 (316)
T ss_dssp             ECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTS--CEEECCCSSCEECS--SCB
T ss_pred             eeecCCccccccccccccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCC--CEEEecCccceEec--ccc
Confidence            9999999999999999999999988888887765       999999999999998765  49999999998643  234


Q ss_pred             CCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCHhHHHH
Q 019195          150 KSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL  229 (344)
Q Consensus       150 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  229 (344)
                      .+.+||+.|||||++.+..++. ++|||||||++|+|++|+.||.+.+....    +.++......+|.  .+++++.++
T Consensus       159 ~~~~Gt~~Y~APE~l~~~~y~~-~~DiwSlGvilyemltG~~Pf~~~~~~~~----~~~i~~~~~~~p~--~~s~~~~~l  231 (316)
T d1fota_         159 YTLCGTPDYIAPEVVSTKPYNK-SIDWWSFGILIYEMLAGYTPFYDSNTMKT----YEKILNAELRFPP--FFNEDVKDL  231 (316)
T ss_dssp             CCCCSCTTTCCHHHHTTCCBCT-THHHHHHHHHHHHHHHSSCTTCCSSHHHH----HHHHHHCCCCCCT--TSCHHHHHH
T ss_pred             ccccCcccccCHHHHcCCCCCc-hhhccccchhHHHHHhCCCCCCCcCHHHH----HHHHHcCCCCCCC--CCCHHHHHH
Confidence            5678999999999998888764 59999999999999999999988655433    3444455555554  689999999


Q ss_pred             HHHhcccCCCCCC-----ChHHHhcCcccccCC
Q 019195          230 LSRIFVANPSRRI-----TIKEIKSHPWFLKNL  257 (344)
Q Consensus       230 i~~~L~~dp~~R~-----s~~ell~hp~~~~~~  257 (344)
                      |.+||++||.+|+     |++++|+||||++..
T Consensus       232 i~~~L~~dp~~R~~~~r~t~~~il~Hp~f~~i~  264 (316)
T d1fota_         232 LSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVV  264 (316)
T ss_dssp             HHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCC
T ss_pred             HHHHhhhCHHhccccchhhHHHHHcCcccccCC
Confidence            9999999999996     999999999997753

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-59  Score=411.39  Aligned_cols=245  Identities=23%  Similarity=0.384  Sum_probs=202.4

Q ss_pred             Cc-eeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCcc---ccHHHHHHHHHHhcCCCCCcceeeEEEEc----CCEEE
Q 019195            3 KY-ELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK---IDANVAREIINHKQLRHPNIIRFKEVVLT----PTHLA   74 (344)
Q Consensus         3 ~y-~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~ei~~l~~l~h~niv~~~~~~~~----~~~~~   74 (344)
                      || ++.+.||+|+||+||+|.+..+++.||+|++.....   ....+.+|+++|++++|||||+++++|.+    +..+|
T Consensus         9 ry~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~   88 (270)
T d1t4ha_           9 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV   88 (270)
T ss_dssp             CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred             CEEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEE
Confidence            45 778899999999999999999999999999876432   23568899999999999999999999875    35689


Q ss_pred             EEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHC-------C--eeecCCCCCCeEecCCCCCCEEEeecCCCcccCC
Q 019195           75 IVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-------Q--ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLL  145 (344)
Q Consensus        75 lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~ql~~~-------~--iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~  145 (344)
                      +|||||++|+|.+++.+.+.+++.+++.++.||++|       +  |+||||||+|||++.. .+.+||+|||+|+... 
T Consensus        89 ivmE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~-~~~~Kl~DFGla~~~~-  166 (270)
T d1t4ha_          89 LVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGP-TGSVKIGDLGLATLKR-  166 (270)
T ss_dssp             EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESST-TSCEEECCTTGGGGCC-
T ss_pred             EEEeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCC-CCCEEEeecCcceecc-
Confidence            999999999999999998999999999998888876       6  9999999999999642 2359999999997432 


Q ss_pred             CCCCCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCHh
Q 019195          146 HSRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQD  225 (344)
Q Consensus       146 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~  225 (344)
                      .......+||+.|||||++.+. + +.++|||||||++|+|++|+.||..........   ..+.............+++
T Consensus       167 ~~~~~~~~GT~~Y~aPE~~~~~-~-~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~---~~i~~~~~~~~~~~~~~~~  241 (270)
T d1t4ha_         167 ASFAKAVIGTPEFMAPEMYEEK-Y-DESVDVYAFGMCMLEMATSEYPYSECQNAAQIY---RRVTSGVKPASFDKVAIPE  241 (270)
T ss_dssp             TTSBEESCSSCCCCCGGGGGTC-C-CTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHH---HHHTTTCCCGGGGGCCCHH
T ss_pred             CCccCCcccCccccCHHHhCCC-C-CCcCchhhHHHHHHHHHHCCCCCCCcccHHHHH---HHHHcCCCCcccCccCCHH
Confidence            2334466899999999998754 5 456999999999999999999998766544333   3333322222223357899


Q ss_pred             HHHHHHHhcccCCCCCCChHHHhcCcccc
Q 019195          226 CRNLLSRIFVANPSRRITIKEIKSHPWFL  254 (344)
Q Consensus       226 ~~~li~~~L~~dp~~R~s~~ell~hp~~~  254 (344)
                      +.+||.+||+.||.+|||+.|+|+||||+
T Consensus       242 ~~~li~~~l~~dp~~R~s~~ell~Hp~fk  270 (270)
T d1t4ha_         242 VKEIIEGCIRQNKDERYSIKDLLNHAFFQ  270 (270)
T ss_dssp             HHHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred             HHHHHHHHccCCHhHCcCHHHHhCCcccC
Confidence            99999999999999999999999999995

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=4.3e-59  Score=411.56  Aligned_cols=249  Identities=33%  Similarity=0.526  Sum_probs=215.0

Q ss_pred             CCCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCccc----------cHHHHHHHHHHhcCC-CCCcceeeEEEEc
Q 019195            1 MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKI----------DANVAREIINHKQLR-HPNIIRFKEVVLT   69 (344)
Q Consensus         1 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~----------~~~~~~ei~~l~~l~-h~niv~~~~~~~~   69 (344)
                      .++|++++.||+|+||+||+|++..+++.||||++.+....          ...+.+|+.++++++ ||||+++++++.+
T Consensus         2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~   81 (277)
T d1phka_           2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET   81 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred             cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence            47999999999999999999999999999999999764321          235789999999997 9999999999999


Q ss_pred             CCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcc
Q 019195           70 PTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKS  142 (344)
Q Consensus        70 ~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~  142 (344)
                      ++.+|+|||||++|+|.++|...+.+++.+++.++.||+.|       ||+||||||+|||++.++.  +||+|||+++.
T Consensus        82 ~~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~--~kl~DFG~a~~  159 (277)
T d1phka_          82 NTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMN--IKLTDFGFSCQ  159 (277)
T ss_dssp             SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC--EEECCCTTCEE
T ss_pred             CcceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCC--eEEccchheeE
Confidence            99999999999999999999999999999999999888766       9999999999999976664  99999999987


Q ss_pred             cCCCCCCCCCccCCcccCCccccCC-----CCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccc--c
Q 019195          143 SLLHSRPKSTVGTPAYIAPEVLSRR-----EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQY--K  215 (344)
Q Consensus       143 ~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~--~  215 (344)
                      ..........+||+.|+|||.+.+.     ...+.++||||+||++|+|++|+.||.+.+.......    +.....  .
T Consensus       160 ~~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~----i~~~~~~~~  235 (277)
T d1phka_         160 LDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRM----IMSGNYQFG  235 (277)
T ss_dssp             CCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH----HHHTCCCCC
T ss_pred             ccCCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHH----HHhCCCCCC
Confidence            7666666677899999999998532     2235669999999999999999999988765443333    333333  3


Q ss_pred             CCCCCCCCHhHHHHHHHhcccCCCCCCChHHHhcCccccc
Q 019195          216 IPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLK  255 (344)
Q Consensus       216 ~~~~~~~s~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~  255 (344)
                      .+...++|+++++||.+||+.||.+|||+.|+|+||||++
T Consensus       236 ~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~  275 (277)
T d1phka_         236 SPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ  275 (277)
T ss_dssp             TTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCT
T ss_pred             CcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHHHH
Confidence            4455579999999999999999999999999999999975

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.9e-60  Score=414.38  Aligned_cols=244  Identities=29%  Similarity=0.512  Sum_probs=195.4

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCccc---cHHHHHHHHHHhcCCCCCcceeeEEEEc--CCEEEEE
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKI---DANVAREIINHKQLRHPNIIRFKEVVLT--PTHLAIV   76 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~ei~~l~~l~h~niv~~~~~~~~--~~~~~lv   76 (344)
                      ++|++++.||+|+||+||+|+++.+|+.||+|++......   ...+.+|++++++++|||||++++++.+  .+.+|+|
T Consensus         4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv   83 (269)
T d2java1           4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV   83 (269)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred             hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence            6899999999999999999999999999999999765432   2468899999999999999999999965  4568999


Q ss_pred             EecCCCCChHHHHHh----CCCCCHHHHHHHHHHHHHC-------C-----eeecCCCCCCeEecCCCCCCEEEeecCCC
Q 019195           77 MEYAAGGELFERICN----AGRFSEDEARYFFQQLISG-------Q-----ICHRDLKLENTLLDGSPAPRLKICDFGYS  140 (344)
Q Consensus        77 ~e~~~~g~L~~~i~~----~~~~~~~~~~~~~~ql~~~-------~-----iiH~Dikp~NIl~~~~~~~~vkL~DFg~a  140 (344)
                      ||||++|+|.+++.+    .+.+++..++.++.||++|       |     |+||||||+|||++.++.  +||+|||+|
T Consensus        84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~--vkl~DFG~a  161 (269)
T d2java1          84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQN--VKLGDFGLA  161 (269)
T ss_dssp             EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSC--EEECCHHHH
T ss_pred             EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCc--EEEeeccce
Confidence            999999999999854    4679999999999888876       4     999999999999987654  999999999


Q ss_pred             cccCCCC-CCCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCCCC
Q 019195          141 KSSLLHS-RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDY  219 (344)
Q Consensus       141 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  219 (344)
                      +...... .....+||+.|||||++.+..++ .++|||||||++|+|++|++||...+..+    +...+...... +.+
T Consensus       162 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~-~~~DIwSlGvilyel~tg~~Pf~~~~~~~----~~~~i~~~~~~-~~~  235 (269)
T d2java1         162 RILNHDTSFAKAFVGTPYYMSPEQMNRMSYN-EKSDIWSLGCLLYELCALMPPFTAFSQKE----LAGKIREGKFR-RIP  235 (269)
T ss_dssp             HHC-----------CCCSCCCHHHHTTCCCC-HHHHHHHHHHHHHHHHHSSCSCCCSSHHH----HHHHHHHTCCC-CCC
T ss_pred             eecccCCCccccCCCCcccCCHHHHcCCCCC-hHHHHHhhCHHHHHHhhCCCCCCCCCHHH----HHHHHHcCCCC-CCC
Confidence            7654332 34557899999999999887765 56999999999999999999998765433    33333333332 223


Q ss_pred             CCCCHhHHHHHHHhcccCCCCCCChHHHhcCccc
Q 019195          220 VHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF  253 (344)
Q Consensus       220 ~~~s~~~~~li~~~L~~dp~~R~s~~ell~hp~~  253 (344)
                      ..+|+++.+||.+||+.||.+|||+.|+|+|||+
T Consensus       236 ~~~s~~l~~li~~~L~~dp~~Rps~~ell~hp~i  269 (269)
T d2java1         236 YRYSDELNEIITRMLNLKDYHRPSVEEILENPLI  269 (269)
T ss_dssp             TTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred             cccCHHHHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence            4689999999999999999999999999999995

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=7.6e-59  Score=425.26  Aligned_cols=250  Identities=27%  Similarity=0.455  Sum_probs=209.1

Q ss_pred             CCCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCc----cccHHHH---HHHHHHhcCCCCCcceeeEEEEcCCEE
Q 019195            1 MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH----KIDANVA---REIINHKQLRHPNIIRFKEVVLTPTHL   73 (344)
Q Consensus         1 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~---~ei~~l~~l~h~niv~~~~~~~~~~~~   73 (344)
                      |++|++++.||+|+||.||+|++..+|+.||||++.+..    .....+.   +++.+++.++|||||+++++|.+++.+
T Consensus         3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~   82 (364)
T d1omwa3           3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL   82 (364)
T ss_dssp             STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred             HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEE
Confidence            689999999999999999999999999999999987532    1122233   446777888999999999999999999


Q ss_pred             EEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCC
Q 019195           74 AIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH  146 (344)
Q Consensus        74 ~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~  146 (344)
                      |+|||||+||+|..+|.+...+++.+++.++.||+.|       ||+||||||+|||++.++.  +||+|||+|+.... 
T Consensus        83 ~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~--iKl~DFGla~~~~~-  159 (364)
T d1omwa3          83 SFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGH--VRISDLGLACDFSK-  159 (364)
T ss_dssp             EEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSC--EEECCCTTCEECSS-
T ss_pred             EEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCc--EEEeeeceeeecCC-
Confidence            9999999999999999999999999999998887766       9999999999999987664  99999999975443 


Q ss_pred             CCCCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCHhH
Q 019195          147 SRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDC  226 (344)
Q Consensus       147 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~  226 (344)
                      ......+||+.|||||++.....++.++|||||||++|+|++|+.||........ ..+...........|  ..+|+++
T Consensus       160 ~~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~-~~~~~~~~~~~~~~~--~~~s~~~  236 (364)
T d1omwa3         160 KKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK-HEIDRMTLTMAVELP--DSFSPEL  236 (364)
T ss_dssp             SCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCH-HHHHHHSSSCCCCCC--SSSCHHH
T ss_pred             CcccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHhcccCCCCCC--CCCCHHH
Confidence            3445678999999999997665556669999999999999999999987654332 233333333333333  4789999


Q ss_pred             HHHHHHhcccCCCCCCC-----hHHHhcCcccccC
Q 019195          227 RNLLSRIFVANPSRRIT-----IKEIKSHPWFLKN  256 (344)
Q Consensus       227 ~~li~~~L~~dp~~R~s-----~~ell~hp~~~~~  256 (344)
                      ++||.+||+.||.+|||     |.++++||||+..
T Consensus       237 ~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~i  271 (364)
T d1omwa3         237 RSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSL  271 (364)
T ss_dssp             HHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTTC
T ss_pred             HHHHHHHcccCHHHhCCCcccCHHHHHcCccccCC
Confidence            99999999999999999     7999999999764

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.1e-58  Score=422.07  Aligned_cols=245  Identities=30%  Similarity=0.585  Sum_probs=213.9

Q ss_pred             CCCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCc----cccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEE
Q 019195            1 MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH----KIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIV   76 (344)
Q Consensus         1 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv   76 (344)
                      |++|++++.||+|+||+||+|.++.+|+.||||++.+..    .....+.+|+.+|+.++|||||++++++.....+++|
T Consensus        40 ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v  119 (350)
T d1rdqe_          40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV  119 (350)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccccccccc
Confidence            579999999999999999999999999999999997532    2335788999999999999999999999999999999


Q ss_pred             EecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCCCC
Q 019195           77 MEYAAGGELFERICNAGRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP  149 (344)
Q Consensus        77 ~e~~~~g~L~~~i~~~~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~~~  149 (344)
                      |||+.+|+|..++.+.+.+++.+++.++.||+.|       |||||||||+|||++.++  ++||+|||+|+....  ..
T Consensus       120 ~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g--~ikL~DFG~a~~~~~--~~  195 (350)
T d1rdqe_         120 MEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQG--YIQVTDFGFAKRVKG--RT  195 (350)
T ss_dssp             EECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS--CEEECCCTTCEECSS--CB
T ss_pred             cccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCC--CEEeeeceeeeeccc--cc
Confidence            9999999999999998999999999998887766       999999999999997765  499999999986532  34


Q ss_pred             CCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCHhHHHH
Q 019195          150 KSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL  229 (344)
Q Consensus       150 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  229 (344)
                      ...+||+.|||||++.+..++ .++|||||||++|+|++|++||.+.+...    .+.++.......|.  .+++++.+|
T Consensus       196 ~~~~Gt~~Y~APE~~~~~~~~-~~~DiwSlGvilyemltG~~Pf~~~~~~~----~~~~i~~~~~~~p~--~~s~~~~~l  268 (350)
T d1rdqe_         196 WTLCGTPEALAPEIILSKGYN-KAVDWWALGVLIYEMAAGYPPFFADQPIQ----IYEKIVSGKVRFPS--HFSSDLKDL  268 (350)
T ss_dssp             CCCEECGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHHHHHHCCCCCCT--TCCHHHHHH
T ss_pred             ccccCccccCCHHHHcCCCCC-ccccccchhHHHHHHHhCCCCCCCcCHHH----HHHHHhcCCCCCCc--cCCHHHHHH
Confidence            457899999999999988875 55999999999999999999998765433    34444555555554  789999999


Q ss_pred             HHHhcccCCCCCC-----ChHHHhcCcccccC
Q 019195          230 LSRIFVANPSRRI-----TIKEIKSHPWFLKN  256 (344)
Q Consensus       230 i~~~L~~dp~~R~-----s~~ell~hp~~~~~  256 (344)
                      |++||+.||.+|+     |+.++++||||...
T Consensus       269 i~~~L~~dP~kR~~~~r~t~~ell~Hp~f~~~  300 (350)
T d1rdqe_         269 LRNLLQVDLTKRFGNLKNGVNDIKNHKWFATT  300 (350)
T ss_dssp             HHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTC
T ss_pred             HHHHhhhCHHhccccccccHHHHHcCccccCC
Confidence            9999999999995     99999999999765

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.9e-59  Score=422.09  Aligned_cols=252  Identities=33%  Similarity=0.572  Sum_probs=210.0

Q ss_pred             CCCceeee-eeeecCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhc-CCCCCcceeeEEEEc----CCEEE
Q 019195            1 MEKYELMK-DIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQ-LRHPNIIRFKEVVLT----PTHLA   74 (344)
Q Consensus         1 ~~~y~~~~-~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~l~~-l~h~niv~~~~~~~~----~~~~~   74 (344)
                      +++|+++. .||+|+||+||+|.+..+++.||||++...    ..+.+|+.++.+ ++|||||+++++|.+    +..+|
T Consensus        10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~   85 (335)
T d2ozaa1          10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL   85 (335)
T ss_dssp             GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred             ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc----HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEE
Confidence            47899986 599999999999999999999999998653    567889988654 589999999999975    46799


Q ss_pred             EEEecCCCCChHHHHHhC--CCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCC-CCCEEEeecCCCcccC
Q 019195           75 IVMEYAAGGELFERICNA--GRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSP-APRLKICDFGYSKSSL  144 (344)
Q Consensus        75 lv~e~~~~g~L~~~i~~~--~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~-~~~vkL~DFg~a~~~~  144 (344)
                      +|||||+||+|.++|.+.  ..+++.+++.++.||+.|       ||+||||||+|||++... .+.+||+|||+|+...
T Consensus        86 ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~  165 (335)
T d2ozaa1          86 IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT  165 (335)
T ss_dssp             EEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCTTCEECC
T ss_pred             EEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccccceeeecc
Confidence            999999999999999875  369999999998888766       999999999999997533 4569999999998777


Q ss_pred             CCCCCCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCCC--CCCC
Q 019195          145 LHSRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPD--YVHI  222 (344)
Q Consensus       145 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~  222 (344)
                      ........+||+.|||||++.+..|+ .++|||||||++|+|++|++||.+.........+...+....+.+|.  +..+
T Consensus       166 ~~~~~~~~~gt~~y~aPE~~~~~~y~-~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~  244 (335)
T d2ozaa1         166 SHNSLTTPCYTPYYVAPEVLGPEKYD-KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEV  244 (335)
T ss_dssp             CCCCCCCCSCCCSSCCCCCCCGGGGS-HHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSSSCCTTHHHHS
T ss_pred             CCCccccccCCcccCCcHHHcCCCCC-HHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCcccccC
Confidence            66667778899999999999887775 55999999999999999999998876655555555555555555543  2358


Q ss_pred             CHhHHHHHHHhcccCCCCCCChHHHhcCcccccCC
Q 019195          223 SQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNL  257 (344)
Q Consensus       223 s~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~~~  257 (344)
                      |+++.+||++||+.||.+|||+.|+|+||||.+..
T Consensus       245 s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~  279 (335)
T d2ozaa1         245 SEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST  279 (335)
T ss_dssp             CHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHTTT
T ss_pred             CHHHHHHHHHHccCChhHCcCHHHHHcCHHhhCCC
Confidence            99999999999999999999999999999997653

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.4e-58  Score=412.16  Aligned_cols=247  Identities=33%  Similarity=0.568  Sum_probs=210.8

Q ss_pred             CCCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCc----cccHHHHHHHHHHh-cCCCCCcceeeEEEEcCCEEEE
Q 019195            1 MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH----KIDANVAREIINHK-QLRHPNIIRFKEVVLTPTHLAI   75 (344)
Q Consensus         1 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~ei~~l~-~l~h~niv~~~~~~~~~~~~~l   75 (344)
                      |++|++++.||+|+||+||+|.+..+++.||||++.+..    .....+.+|+.++. .++|||||++++++.+++.+|+
T Consensus         1 iddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yi   80 (320)
T d1xjda_           1 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFF   80 (320)
T ss_dssp             CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred             CCCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeE
Confidence            689999999999999999999999999999999997532    22345667777654 6899999999999999999999


Q ss_pred             EEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCC-
Q 019195           76 VMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS-  147 (344)
Q Consensus        76 v~e~~~~g~L~~~i~~~~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~-  147 (344)
                      |||||++|+|..++...+.+++.+++.++.||+.|       ||+||||||+|||++.++  ++||+|||+++...... 
T Consensus        81 vmEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~--~~kl~DFG~a~~~~~~~~  158 (320)
T d1xjda_          81 VMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDG--HIKIADFGMCKENMLGDA  158 (320)
T ss_dssp             EEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTS--CEEECCCTTCBCCCCTTC
T ss_pred             EEeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCC--ceeccccchhhhcccccc
Confidence            99999999999999999999999999998887765       999999999999998665  49999999998654333 


Q ss_pred             CCCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCHhHH
Q 019195          148 RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCR  227 (344)
Q Consensus       148 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~  227 (344)
                      .....+||+.|+|||++.+..++ .++|||||||++|+|++|+.||.+.+....    +..+......+|.  .+|+++.
T Consensus       159 ~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlGvilyemltG~~PF~~~~~~~~----~~~i~~~~~~~p~--~~s~~~~  231 (320)
T d1xjda_         159 KTNTFCGTPDYIAPEILLGQKYN-HSVDWWSFGVLLYEMLIGQSPFHGQDEEEL----FHSIRMDNPFYPR--WLEKEAK  231 (320)
T ss_dssp             CBCCCCSCGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHH----HHHHHHCCCCCCT--TSCHHHH
T ss_pred             cccccCCCCCcCCHHHHcCCCCC-chhhhhhhhHHHHHHHhCCCCCCCCCHHHH----HHHHHcCCCCCCc--cCCHHHH
Confidence            33456899999999999988876 459999999999999999999987665433    3334444555554  6899999


Q ss_pred             HHHHHhcccCCCCCCChH-HHhcCcccccC
Q 019195          228 NLLSRIFVANPSRRITIK-EIKSHPWFLKN  256 (344)
Q Consensus       228 ~li~~~L~~dp~~R~s~~-ell~hp~~~~~  256 (344)
                      +||.+||+.||.+|||+. ++++||||++.
T Consensus       232 dli~~~L~~dP~~R~s~~~~l~~hpff~~~  261 (320)
T d1xjda_         232 DLLVKLFVREPEKRLGVRGDIRQHPLFREI  261 (320)
T ss_dssp             HHHHHHSCSSGGGSBTTBSCGGGSGGGTTC
T ss_pred             HHHHHhcccCCCCCcCHHHHHHhCchhccC
Confidence            999999999999999995 89999999764

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-57  Score=406.32  Aligned_cols=254  Identities=28%  Similarity=0.431  Sum_probs=208.5

Q ss_pred             CCCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCc---cccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEE
Q 019195            1 MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH---KIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVM   77 (344)
Q Consensus         1 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~   77 (344)
                      |++|++++.||+|+||+||+|.+..+|+.||||++....   ....++.+|+.++++++|||||+++++|.+++.+|+||
T Consensus         1 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~   80 (298)
T d1gz8a_           1 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVF   80 (298)
T ss_dssp             CTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             CCCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEE
Confidence            799999999999999999999999999999999996543   23578899999999999999999999999999999999


Q ss_pred             ecCCCCChHHHHHh-CCCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCC-CC
Q 019195           78 EYAAGGELFERICN-AGRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH-SR  148 (344)
Q Consensus        78 e~~~~g~L~~~i~~-~~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~-~~  148 (344)
                      |||.++.+...... ...+++.+++.++.|++.|       |||||||||+|||++.++.  +||+|||+|+..... ..
T Consensus        81 e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~--~kl~DFG~a~~~~~~~~~  158 (298)
T d1gz8a_          81 EFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRT  158 (298)
T ss_dssp             ECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSC--EEECSTTHHHHHCCCSBC
T ss_pred             eecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCc--ceeccCCcceeccCCccc
Confidence            99965444333333 4579999999998887766       9999999999999986654  999999999765433 33


Q ss_pred             CCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhcccc-------------
Q 019195          149 PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYK-------------  215 (344)
Q Consensus       149 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~-------------  215 (344)
                      ....+||+.|+|||++....+.+.++|||||||++|+|++|++||.+.+....+.++..........             
T Consensus       159 ~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~  238 (298)
T d1gz8a_         159 YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP  238 (298)
T ss_dssp             TTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCT
T ss_pred             ceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcccccccccccc
Confidence            4456899999999999888887888999999999999999999998877666555554432211100             


Q ss_pred             -CCC---------CCCCCHhHHHHHHHhcccCCCCCCChHHHhcCcccccC
Q 019195          216 -IPD---------YVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKN  256 (344)
Q Consensus       216 -~~~---------~~~~s~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~~  256 (344)
                       .+.         ...+|+++.+||++||+.||.+|||+.|+|+||||++.
T Consensus       239 ~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~  289 (298)
T d1gz8a_         239 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV  289 (298)
T ss_dssp             TSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTC
T ss_pred             ccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccC
Confidence             000         12467899999999999999999999999999999764

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.9e-58  Score=409.30  Aligned_cols=250  Identities=27%  Similarity=0.397  Sum_probs=206.4

Q ss_pred             eeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCcc------ccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEEe
Q 019195            5 ELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK------IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVME   78 (344)
Q Consensus         5 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~------~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e   78 (344)
                      +.+++||+|+||+||+|.+..+|+.||||++.....      ....+.+|+.++++++|||||++++++..++.+|+|||
T Consensus         1 E~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE   80 (299)
T d1ua2a_           1 EKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFD   80 (299)
T ss_dssp             CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEE
T ss_pred             CcceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhh
Confidence            457899999999999999999999999999975432      23568899999999999999999999999999999999


Q ss_pred             cCCCCChHHHHHhCCCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCC-CCC
Q 019195           79 YAAGGELFERICNAGRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS-RPK  150 (344)
Q Consensus        79 ~~~~g~L~~~i~~~~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~-~~~  150 (344)
                      ||.++++..++.....+++.+++.+++||++|       ||+||||||+|||++.++.  +||+|||+|+...... ...
T Consensus        81 ~~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~--~KL~DFG~a~~~~~~~~~~~  158 (299)
T d1ua2a_          81 FMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGV--LKLADFGLAKSFGSPNRAYT  158 (299)
T ss_dssp             CCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC--EEECCCGGGSTTTSCCCCCC
T ss_pred             hhcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCc--cccccCccccccCCCccccc
Confidence            99988887777777789999998888887766       9999999999999987664  9999999997654333 344


Q ss_pred             CCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhcccc---------------
Q 019195          151 STVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYK---------------  215 (344)
Q Consensus       151 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~---------------  215 (344)
                      ..+||+.|+|||++.+...++.++|||||||++|+|++|.+||.+....+.+..+..........               
T Consensus       159 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~  238 (299)
T d1ua2a_         159 HQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFK  238 (299)
T ss_dssp             CSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCC
T ss_pred             ceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhhhc
Confidence            56899999999999877666778999999999999999999999887766666655443221110               


Q ss_pred             -CCC------CCCCCHhHHHHHHHhcccCCCCCCChHHHhcCcccccC
Q 019195          216 -IPD------YVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKN  256 (344)
Q Consensus       216 -~~~------~~~~s~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~~  256 (344)
                       .+.      ...+++++.+||.+||+.||.+||||.|+|+||||+..
T Consensus       239 ~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~  286 (299)
T d1ua2a_         239 SFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNR  286 (299)
T ss_dssp             CCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSS
T ss_pred             cCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCC
Confidence             000      12468899999999999999999999999999999754

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.9e-58  Score=402.70  Aligned_cols=244  Identities=31%  Similarity=0.502  Sum_probs=207.7

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCcc-------ccHHHHHHHHHHhcCC--CCCcceeeEEEEcCCE
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK-------IDANVAREIINHKQLR--HPNIIRFKEVVLTPTH   72 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-------~~~~~~~ei~~l~~l~--h~niv~~~~~~~~~~~   72 (344)
                      ++|++.+.||+|+||+||+|.+..+|+.||||++.+...       ...++.+|+.++++++  |||||++++++.+++.
T Consensus         4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~   83 (273)
T d1xwsa_           4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS   83 (273)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred             CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence            589999999999999999999999999999999975421       1234678999999986  8999999999999999


Q ss_pred             EEEEEecCCC-CChHHHHHhCCCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccC
Q 019195           73 LAIVMEYAAG-GELFERICNAGRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSL  144 (344)
Q Consensus        73 ~~lv~e~~~~-g~L~~~i~~~~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~  144 (344)
                      +|+||||+.+ +++.+++.+...+++.+++.++.||+.|       ||+||||||+|||++.+. +.+||+|||+|+...
T Consensus        84 ~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~-~~vkl~DFG~a~~~~  162 (273)
T d1xwsa_          84 FVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNR-GELKLIDFGSGALLK  162 (273)
T ss_dssp             EEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTT-TEEEECCCTTCEECC
T ss_pred             EEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCC-CeEEECccccceecc
Confidence            9999999976 6788888888899999999998887766       999999999999998543 359999999997543


Q ss_pred             CCCCCCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCH
Q 019195          145 LHSRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQ  224 (344)
Q Consensus       145 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~  224 (344)
                       .......+||+.|+|||++.+..+++.++|||||||++|+|++|+.||...+          .+......++  ..+|+
T Consensus       163 -~~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~----------~i~~~~~~~~--~~~s~  229 (273)
T d1xwsa_         163 -DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE----------EIIRGQVFFR--QRVSS  229 (273)
T ss_dssp             -SSCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH----------HHHHCCCCCS--SCCCH
T ss_pred             -cccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch----------HHhhcccCCC--CCCCH
Confidence             2334567899999999999888877777999999999999999999997521          1223333344  36899


Q ss_pred             hHHHHHHHhcccCCCCCCChHHHhcCcccccCCCh
Q 019195          225 DCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLPR  259 (344)
Q Consensus       225 ~~~~li~~~L~~dp~~R~s~~ell~hp~~~~~~~~  259 (344)
                      ++++||.+||+.||.+|||+.|+|+||||++...+
T Consensus       230 ~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~~~p  264 (273)
T d1xwsa_         230 ECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLP  264 (273)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCCCH
T ss_pred             HHHHHHHHHccCCHhHCcCHHHHhcCHhhCCCCCC
Confidence            99999999999999999999999999999876543

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=9.3e-57  Score=399.48  Aligned_cols=252  Identities=28%  Similarity=0.413  Sum_probs=208.0

Q ss_pred             CCCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCc---cccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEE
Q 019195            1 MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH---KIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVM   77 (344)
Q Consensus         1 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~   77 (344)
                      |+||+++++||+|+||+||+|.++ +++.||||++....   ....++.+|+.+|++++|||||+++++|..++..+++|
T Consensus         1 ~~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~   79 (286)
T d1ob3a_           1 MEKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVF   79 (286)
T ss_dssp             CCSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEE
T ss_pred             CCCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEE
Confidence            799999999999999999999985 78999999997643   23468999999999999999999999999999999999


Q ss_pred             ecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCC-CC
Q 019195           78 EYAAGGELFERICNAGRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS-RP  149 (344)
Q Consensus        78 e~~~~g~L~~~i~~~~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~-~~  149 (344)
                      +|+.++.+..+....+.+++.+++.++.||+.|       ||+||||||+|||++.++.  +||+|||+|....... ..
T Consensus        80 e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~--~kl~DfG~a~~~~~~~~~~  157 (286)
T d1ob3a_          80 EHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGE--LKIADFGLARAFGIPVRKY  157 (286)
T ss_dssp             ECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSC--EEECCTTHHHHHCC-----
T ss_pred             EeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCC--EEecccccceecccCcccc
Confidence            999887777777778889999999999888766       9999999999999987664  9999999987643332 23


Q ss_pred             CCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhcccc-------C------
Q 019195          150 KSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYK-------I------  216 (344)
Q Consensus       150 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~-------~------  216 (344)
                      ....||+.|+|||.+.+..+.+.++|||||||++|+|++|++||.+.+....+.++..........       .      
T Consensus       158 ~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  237 (286)
T d1ob3a_         158 THEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPN  237 (286)
T ss_dssp             ----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTT
T ss_pred             ceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhcccc
Confidence            455799999999999887777788999999999999999999998877666555544322111000       0      


Q ss_pred             ----------CCCCCCCHhHHHHHHHhcccCCCCCCChHHHhcCccccc
Q 019195          217 ----------PDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLK  255 (344)
Q Consensus       217 ----------~~~~~~s~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~  255 (344)
                                .....+++++.+||++||+.||.+|||+.|+|+||||++
T Consensus       238 ~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~~  286 (286)
T d1ob3a_         238 FTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE  286 (286)
T ss_dssp             CCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred             cccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCc
Confidence                      012346889999999999999999999999999999964

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.7e-55  Score=388.19  Aligned_cols=256  Identities=27%  Similarity=0.442  Sum_probs=213.5

Q ss_pred             CCCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCcc---ccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEE
Q 019195            1 MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK---IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVM   77 (344)
Q Consensus         1 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~   77 (344)
                      |+||++++.||+|+||+||+|++..+++.||||+++....   ...++.+|+.+++.++||||+++++++.....+++++
T Consensus         1 ~~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~   80 (292)
T d1unla_           1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF   80 (292)
T ss_dssp             CCSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CCCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEe
Confidence            7999999999999999999999999999999999976432   2367889999999999999999999999999999999


Q ss_pred             ecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCC-CC
Q 019195           78 EYAAGGELFERICNAGRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS-RP  149 (344)
Q Consensus        78 e~~~~g~L~~~i~~~~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~-~~  149 (344)
                      +++.+++|..++...+.+++.+++.++.|++.|       ||+||||||+|||++.++.  +||+|||+|+...... ..
T Consensus        81 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~--~kl~DFG~a~~~~~~~~~~  158 (292)
T d1unla_          81 EFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGE--LKLANFGLARAFGIPVRCY  158 (292)
T ss_dssp             ECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCC--EEECCCTTCEECCSCCSCC
T ss_pred             eeccccccccccccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCc--eeeeecchhhcccCCCccc
Confidence            999999999998888999999999998888876       9999999999999987654  9999999998654433 33


Q ss_pred             CCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccc---------------
Q 019195          150 KSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQY---------------  214 (344)
Q Consensus       150 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~---------------  214 (344)
                      ....+++.|+|||++....+.+.++|||||||++|+|++|+.||....+.......+........               
T Consensus       159 ~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (292)
T d1unla_         159 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKP  238 (292)
T ss_dssp             CSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCC
T ss_pred             eeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhcccccc
Confidence            44568899999999988877677799999999999999999997665554433332222211100               


Q ss_pred             ---------cCCCCCCCCHhHHHHHHHhcccCCCCCCChHHHhcCcccccCCC
Q 019195          215 ---------KIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLP  258 (344)
Q Consensus       215 ---------~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~~~~  258 (344)
                               .......+++.+.+||.+||+.||.+||||.|+|+||||++-.+
T Consensus       239 ~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~~~~  291 (292)
T d1unla_         239 YPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFCP  291 (292)
T ss_dssp             CCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSSCSC
T ss_pred             cccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcCCCC
Confidence                     00112346889999999999999999999999999999987544

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-55  Score=394.45  Aligned_cols=252  Identities=27%  Similarity=0.381  Sum_probs=204.3

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCC-CcEEEEEEeecCc---cccHHHHHHHHHHhcC---CCCCcceeeEEEEc-----
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNT-KELVAMKYIERGH---KIDANVAREIINHKQL---RHPNIIRFKEVVLT-----   69 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~-~~~vaiK~~~~~~---~~~~~~~~ei~~l~~l---~h~niv~~~~~~~~-----   69 (344)
                      ++|++++.||+|+||+||+|.+..+ ++.||||++....   .....+.+|+.+++.|   +||||++++++|..     
T Consensus         7 ~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~   86 (305)
T d1blxa_           7 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR   86 (305)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSS
T ss_pred             CCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccccc
Confidence            6899999999999999999999755 6789999986532   2234577888877766   79999999999863     


Q ss_pred             CCEEEEEEecCCCCChHHHHH-hCCCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCc
Q 019195           70 PTHLAIVMEYAAGGELFERIC-NAGRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSK  141 (344)
Q Consensus        70 ~~~~~lv~e~~~~g~L~~~i~-~~~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~  141 (344)
                      ...++++||||.++.+..... ....+++..++.++.|+++|       ||+||||||+|||++..+.  +||+|||+++
T Consensus        87 ~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~--~kl~dfg~~~  164 (305)
T d1blxa_          87 ETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQ--IKLADFGLAR  164 (305)
T ss_dssp             EEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC--EEECSCCSCC
T ss_pred             CceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCC--eeecchhhhh
Confidence            357899999998877754443 34568999999888887766       9999999999999977664  9999999998


Q ss_pred             ccCCCCCCCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccc-cC----
Q 019195          142 SSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQY-KI----  216 (344)
Q Consensus       142 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~----  216 (344)
                      ...........+||+.|+|||++.+..++. ++|||||||++|+|++|++||.+.+....+..++........ ..    
T Consensus       165 ~~~~~~~~~~~~gT~~Y~APE~~~~~~y~~-~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  243 (305)
T d1blxa_         165 IYSFQMALTSVVVTLWYRAPEVLLQSSYAT-PVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDV  243 (305)
T ss_dssp             CCCGGGGGCCCCCCCTTCCHHHHTTCCCCT-HHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTC
T ss_pred             hhcccccCCCcccChhhcCcchhcCCCCCh-hehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhcccccc
Confidence            766666667788999999999998888754 599999999999999999999988776666665543321110 00    


Q ss_pred             ----------------CCCCCCCHhHHHHHHHhcccCCCCCCChHHHhcCcccccC
Q 019195          217 ----------------PDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKN  256 (344)
Q Consensus       217 ----------------~~~~~~s~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~~  256 (344)
                                      .....+++.+.+||.+||+.||.+||||.|+|+||||++.
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i  299 (305)
T d1blxa_         244 ALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDL  299 (305)
T ss_dssp             SSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTC
T ss_pred             cchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCc
Confidence                            0123578899999999999999999999999999999754

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=2.1e-55  Score=390.12  Aligned_cols=241  Identities=21%  Similarity=0.298  Sum_probs=203.5

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEEecCC
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYAA   81 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~   81 (344)
                      ++|++.+.||+|+||+||+|.+..+++.||||++..+....+++.+|+.+|++++|||||++++++.+++.+|+|||||+
T Consensus        17 ~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~   96 (287)
T d1opja_          17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMT   96 (287)
T ss_dssp             GGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred             HHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccchHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeeccc
Confidence            47899999999999999999999999999999998877667789999999999999999999999999999999999999


Q ss_pred             CCChHHHHHhC--CCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCCC--CC
Q 019195           82 GGELFERICNA--GRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR--PK  150 (344)
Q Consensus        82 ~g~L~~~i~~~--~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~~--~~  150 (344)
                      +|+|..++.+.  ..+++..++.++.|+++|       ||+||||||+|||++.++.  +||+|||+|+.......  ..
T Consensus        97 ~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~--~Kl~DFG~a~~~~~~~~~~~~  174 (287)
T d1opja_          97 YGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHL--VKVADFGLSRLMTGDTYTAHA  174 (287)
T ss_dssp             TCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC--EEECCCCCTTTCCSSSSEEET
T ss_pred             CcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCc--EEEccccceeecCCCCceeec
Confidence            99999999764  568888888887776665       9999999999999987764  99999999986443322  22


Q ss_pred             CCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCHhHHHHH
Q 019195          151 STVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLL  230 (344)
Q Consensus       151 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li  230 (344)
                      ...||+.|+|||++.+..++ .++|||||||++|||++|..||..........+.+    ......+.+..+++++.+||
T Consensus       175 ~~~g~~~y~aPE~~~~~~~~-~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i----~~~~~~~~~~~~~~~l~~li  249 (287)
T d1opja_         175 GAKFPIKWTAPESLAYNKFS-IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL----EKDYRMERPEGCPEKVYELM  249 (287)
T ss_dssp             TEEECGGGCCHHHHHHCCCS-HHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHH----HTTCCCCCCTTCCHHHHHHH
T ss_pred             cccccccccChHHHcCCCCC-chhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHH----hcCCCCCCCccchHHHHHHH
Confidence            34589999999999888774 56999999999999999777766555544433332    23344455557899999999


Q ss_pred             HHhcccCCCCCCChHHHhc
Q 019195          231 SRIFVANPSRRITIKEIKS  249 (344)
Q Consensus       231 ~~~L~~dp~~R~s~~ell~  249 (344)
                      .+||+.||.+|||+.++++
T Consensus       250 ~~cl~~dP~~Rps~~ei~~  268 (287)
T d1opja_         250 RACWQWNPSDRPSFAEIHQ  268 (287)
T ss_dssp             HHHTCSSGGGSCCHHHHHH
T ss_pred             HHHcCCCHhHCcCHHHHHH
Confidence            9999999999999999976

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-54  Score=391.58  Aligned_cols=254  Identities=23%  Similarity=0.346  Sum_probs=202.2

Q ss_pred             CCCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCc---cccHHHHHHHHHHhcCCCCCcceeeEEEEc--------
Q 019195            1 MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH---KIDANVAREIINHKQLRHPNIIRFKEVVLT--------   69 (344)
Q Consensus         1 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~ei~~l~~l~h~niv~~~~~~~~--------   69 (344)
                      ++||+++++||+|+||+||+|++..+|+.||||++....   ....++.+|+.+|++++||||+++++++..        
T Consensus         9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~   88 (318)
T d3blha1           9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   88 (318)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred             cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence            479999999999999999999999999999999986542   344678999999999999999999999865        


Q ss_pred             CCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcc
Q 019195           70 PTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKS  142 (344)
Q Consensus        70 ~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~  142 (344)
                      ++.+|+|||||.++.+.........+++..++.+++|++.|       ||+||||||+|||++.++.  +||+|||+++.
T Consensus        89 ~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~--~kl~dfg~~~~  166 (318)
T d3blha1          89 KGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGV--LKLADFGLARA  166 (318)
T ss_dssp             --CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSC--EEECCCTTCEE
T ss_pred             CceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCc--EEeeecceeee
Confidence            34689999999887776666667789999999888887766       9999999999999987665  99999999964


Q ss_pred             cCC-----CCCCCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCC
Q 019195          143 SLL-----HSRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIP  217 (344)
Q Consensus       143 ~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  217 (344)
                      ...     .......+||+.|+|||++.+...++.++|||||||++|+|++|++||.+.........+............
T Consensus       167 ~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  246 (318)
T d3blha1         167 FSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVW  246 (318)
T ss_dssp             CCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTS
T ss_pred             cccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChhhc
Confidence            332     223345679999999999987765567799999999999999999999877665544443333221111100


Q ss_pred             C-C-------------------------CCCCHhHHHHHHHhcccCCCCCCChHHHhcCcccccC
Q 019195          218 D-Y-------------------------VHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKN  256 (344)
Q Consensus       218 ~-~-------------------------~~~s~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~~  256 (344)
                      . .                         ...++++.+||.+||+.||++||||.|+|+||||+..
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~~  311 (318)
T d3blha1         247 PNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSD  311 (318)
T ss_dssp             TTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSSS
T ss_pred             cccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhccC
Confidence            0 0                         0136788999999999999999999999999999754

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-54  Score=396.37  Aligned_cols=250  Identities=28%  Similarity=0.402  Sum_probs=204.4

Q ss_pred             CceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcCCCCCcceeeEEEEcC------CEEEEE
Q 019195            3 KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKEVVLTP------THLAIV   76 (344)
Q Consensus         3 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~------~~~~lv   76 (344)
                      +|+.+++||+|+||+||+|++..+|+.||||++.+.....   .+|+.+|++++||||++++++|...      .++|+|
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~---~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv   97 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK---NRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLV   97 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSSC---CHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEE
T ss_pred             CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchHH---HHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEE
Confidence            5999999999999999999999999999999998755433   4799999999999999999998543      458999


Q ss_pred             EecCCCCChHHH---HHhCCCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCC
Q 019195           77 MEYAAGGELFER---ICNAGRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH  146 (344)
Q Consensus        77 ~e~~~~g~L~~~---i~~~~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~  146 (344)
                      ||||+++.+..+   ......+++.+++.+++||+.|       ||+||||||+|||++.++. .+||+|||+++.....
T Consensus        98 ~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~-~~kl~DFG~a~~~~~~  176 (350)
T d1q5ka_          98 LDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTA-VLKLCDFGSAKQLVRG  176 (350)
T ss_dssp             EECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTC-CEEECCCTTCEECCTT
T ss_pred             EeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCC-ceeEecccchhhccCC
Confidence            999976543332   2345679999999998887766       9999999999999986542 4999999999877666


Q ss_pred             CCCCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhc-------------c
Q 019195          147 SRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAV-------------Q  213 (344)
Q Consensus       147 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~-------------~  213 (344)
                      ......+||+.|+|||.+.+...++.++||||+||++|+|++|++||...+....+..++......             .
T Consensus       177 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~  256 (350)
T d1q5ka_         177 EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTE  256 (350)
T ss_dssp             SCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC---C
T ss_pred             cccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhccchhh
Confidence            666778899999999998876666677999999999999999999998877666655554322110             0


Q ss_pred             ccCC----------CCCCCCHhHHHHHHHhcccCCCCCCChHHHhcCcccccC
Q 019195          214 YKIP----------DYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKN  256 (344)
Q Consensus       214 ~~~~----------~~~~~s~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~~  256 (344)
                      ..++          ....+++++.+||.+||+.||.+||||.|+|+||||.+.
T Consensus       257 ~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~  309 (350)
T d1q5ka_         257 FKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL  309 (350)
T ss_dssp             CCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGG
T ss_pred             ccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccc
Confidence            0111          123478999999999999999999999999999999764

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.6e-55  Score=398.76  Aligned_cols=250  Identities=26%  Similarity=0.389  Sum_probs=199.9

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCccc---cHHHHHHHHHHhcCCCCCcceeeEEEEcCC------E
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKI---DANVAREIINHKQLRHPNIIRFKEVVLTPT------H   72 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~ei~~l~~l~h~niv~~~~~~~~~~------~   72 (344)
                      ++|+++++||+|+||+||+|.+..+|+.||||++.+....   ...+.+|+.+|++++|||||+++++|...+      .
T Consensus        18 ~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~   97 (346)
T d1cm8a_          18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTD   97 (346)
T ss_dssp             SSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCC
T ss_pred             CcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccce
Confidence            5899999999999999999999999999999999764332   356889999999999999999999997654      5


Q ss_pred             EEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCC
Q 019195           73 LAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLL  145 (344)
Q Consensus        73 ~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~  145 (344)
                      +|+||||| +.+|..++ +.+.+++..++.++.||+.|       ||+||||||+|||++.++.  +||+|||+|+... 
T Consensus        98 ~~lv~e~~-~~~l~~~~-~~~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~--~kl~Dfg~a~~~~-  172 (346)
T d1cm8a_          98 FYLVMPFM-GTDLGKLM-KHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCE--LKILDFGLARQAD-  172 (346)
T ss_dssp             CEEEEECC-SEEHHHHH-HHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC--EEECCCTTCEECC-
T ss_pred             EEEEEecc-cccHHHHH-HhccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccc--cccccccceeccC-
Confidence            79999999 66776665 45689999999998887766       9999999999999987665  9999999997543 


Q ss_pred             CCCCCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhc-------------
Q 019195          146 HSRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAV-------------  212 (344)
Q Consensus       146 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~-------------  212 (344)
                       ......+||+.|+|||++.+..+.+.++||||+||++|+|++|++||.+.+....+..........             
T Consensus       173 -~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (346)
T d1cm8a_         173 -SEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEA  251 (346)
T ss_dssp             -SSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHH
T ss_pred             -CccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcchhh
Confidence             334567899999999999887777777999999999999999999998876655444333221110             


Q ss_pred             ------cccC------CCCCCCCHhHHHHHHHhcccCCCCCCChHHHhcCcccccCC
Q 019195          213 ------QYKI------PDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNL  257 (344)
Q Consensus       213 ------~~~~------~~~~~~s~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~~~  257 (344)
                            ....      .....+++++.+||.+||+.||.+||||.|+|+||||+...
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~  308 (346)
T d1cm8a_         252 KNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH  308 (346)
T ss_dssp             HHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred             hhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCC
Confidence                  0000      01235789999999999999999999999999999998654

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=2.4e-54  Score=391.27  Aligned_cols=249  Identities=22%  Similarity=0.395  Sum_probs=205.8

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcCC-CCCcceeeEEEEcC--CEEEEEEe
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLR-HPNIIRFKEVVLTP--THLAIVME   78 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~l~~l~-h~niv~~~~~~~~~--~~~~lv~e   78 (344)
                      ++|+++++||+|+||+||+|++..+++.||||++....  ..++.+|+.+|+.++ ||||++++++|...  ..+++|||
T Consensus        35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~--~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e  112 (328)
T d3bqca1          35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK--KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFE  112 (328)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC--HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEE
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH--HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEEe
Confidence            68999999999999999999999999999999987543  367889999999995 99999999999854  57999999


Q ss_pred             cCCCCChHHHHHhCCCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCCCCCC
Q 019195           79 YAAGGELFERICNAGRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKS  151 (344)
Q Consensus        79 ~~~~g~L~~~i~~~~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~~~~~  151 (344)
                      ||.+++|....   +.+++.+++.+++||+.|       ||+||||||+|||++.++. .+||+|||+|+..........
T Consensus       113 ~~~~~~L~~~~---~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~-~vkl~DFG~a~~~~~~~~~~~  188 (328)
T d3bqca1         113 HVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHR-KLRLIDWGLAEFYHPGQEYNV  188 (328)
T ss_dssp             CCCSCBGGGTT---TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTT-EEEECCGGGCEECCTTCCCCS
T ss_pred             ecCCCcHHHHh---cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCC-eeeecccccceeccCCCcccc
Confidence            99999997753   469999999998887765       9999999999999985442 489999999987766666777


Q ss_pred             CccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhc-------------------
Q 019195          152 TVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAV-------------------  212 (344)
Q Consensus       152 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~-------------------  212 (344)
                      .+||+.|+|||.+.+....+.++||||+||++|+|++|+.||............+......                   
T Consensus       189 ~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~  268 (328)
T d3bqca1         189 RVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFN  268 (328)
T ss_dssp             CCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCGGGG
T ss_pred             cccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccccCcccc
Confidence            8899999999999887666677999999999999999999998776543322222211100                   


Q ss_pred             -------------cccCCCCCCCCHhHHHHHHHhcccCCCCCCChHHHhcCcccccC
Q 019195          213 -------------QYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKN  256 (344)
Q Consensus       213 -------------~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~~  256 (344)
                                   ....+....+++++.+||++||+.||.+|||++|+|+||||+..
T Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~v  325 (328)
T d3bqca1         269 DILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTV  325 (328)
T ss_dssp             GTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTS
T ss_pred             hhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCC
Confidence                         00111223478899999999999999999999999999999764

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=5.8e-55  Score=386.01  Aligned_cols=245  Identities=24%  Similarity=0.334  Sum_probs=195.4

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCccc----cHHHHHHHHHHhcCCCCCcceeeEEEEcCC----EE
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKI----DANVAREIINHKQLRHPNIIRFKEVVLTPT----HL   73 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~----~~~~~~ei~~l~~l~h~niv~~~~~~~~~~----~~   73 (344)
                      ++|++.+.||+|+||+||+|.+..+++.||||++.+....    ...+.+|+.+++.++|||||++++++...+    .+
T Consensus         7 drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~   86 (277)
T d1o6ya_           7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLP   86 (277)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred             ceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceE
Confidence            6899999999999999999999999999999999765432    246889999999999999999999998654    48


Q ss_pred             EEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCC
Q 019195           74 AIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH  146 (344)
Q Consensus        74 ~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~  146 (344)
                      |+|||||+|++|..++...+.+++.+++.++.||+.|       ||+||||||+|||++.++.  ++|+|||++......
T Consensus        87 ~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~--~~l~d~~~~~~~~~~  164 (277)
T d1o6ya_          87 YIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNA--VKVMDFGIARAIADS  164 (277)
T ss_dssp             EEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSC--EEECCCTTCEECC--
T ss_pred             EEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCcccc--ceeehhhhhhhhccc
Confidence            9999999999999999999999999999998887766       9999999999999987765  999999988643322


Q ss_pred             ----CCCCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccC--CCCC
Q 019195          147 ----SRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKI--PDYV  220 (344)
Q Consensus       147 ----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~  220 (344)
                          ......+||+.|||||++.+..++ .++|||||||++|+|++|++||.+.+....+..++.    .....  ....
T Consensus       165 ~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~-~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~----~~~~~~~~~~~  239 (277)
T d1o6ya_         165 GNSVTQTAAVIGTAQYLSPEQARGDSVD-ARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVR----EDPIPPSARHE  239 (277)
T ss_dssp             --------------TTCCHHHHTTCCCC-HHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH----CCCCCGGGTSS
T ss_pred             cccccccccccCcccccCHHHHcCCCCC-cceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHh----cCCCCCchhcc
Confidence                233456799999999999887765 559999999999999999999988765444443332    22221  2334


Q ss_pred             CCCHhHHHHHHHhcccCCCCCCChHHHhcCccc
Q 019195          221 HISQDCRNLLSRIFVANPSRRITIKEIKSHPWF  253 (344)
Q Consensus       221 ~~s~~~~~li~~~L~~dp~~R~s~~ell~hp~~  253 (344)
                      .+|+++.+||.+||++||.+||+..+.+.|+|.
T Consensus       240 ~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~  272 (277)
T d1o6ya_         240 GLSADLDAVVLKALAKNPENRYQTAAEMRADLV  272 (277)
T ss_dssp             SCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHH
T ss_pred             CCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHH
Confidence            789999999999999999999944444445554

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.5e-55  Score=393.46  Aligned_cols=252  Identities=31%  Similarity=0.568  Sum_probs=213.3

Q ss_pred             CCCceeeeeeeecCceEEEEEEE---cCCCcEEEEEEeecCc-----cccHHHHHHHHHHhcCCC-CCcceeeEEEEcCC
Q 019195            1 MEKYELMKDIGSGNFGVARLMRN---KNTKELVAMKYIERGH-----KIDANVAREIINHKQLRH-PNIIRFKEVVLTPT   71 (344)
Q Consensus         1 ~~~y~~~~~lg~G~~g~V~~~~~---~~~~~~vaiK~~~~~~-----~~~~~~~~ei~~l~~l~h-~niv~~~~~~~~~~   71 (344)
                      |++|++++.||+|+||+||+|.+   ..+|+.||||++.+..     .....+.+|+.++++++| |||+++++++.+..
T Consensus        23 l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~  102 (322)
T d1vzoa_          23 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET  102 (322)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred             hhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCC
Confidence            57899999999999999999987   4578999999986532     234568899999999976 89999999999999


Q ss_pred             EEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccC
Q 019195           72 HLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSL  144 (344)
Q Consensus        72 ~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~  144 (344)
                      .++++|||+.+|+|..++...+.+++..++.++.||+.|       ||+||||||+|||++.++  .+||+|||+|+...
T Consensus       103 ~~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~--~vkL~DFG~a~~~~  180 (322)
T d1vzoa_         103 KLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNG--HVVLTDFGLSKEFV  180 (322)
T ss_dssp             EEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTS--CEEESCSSEEEECC
T ss_pred             ceeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCC--CEEEeeccchhhhc
Confidence            999999999999999999999999999999888887766       999999999999998765  49999999987543


Q ss_pred             C--CCCCCCCccCCcccCCccccCCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCCCCCC
Q 019195          145 L--HSRPKSTVGTPAYIAPEVLSRRE-YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVH  221 (344)
Q Consensus       145 ~--~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  221 (344)
                      .  ........||+.|+|||.+.+.. +.+.++|||||||++|+|++|+.||...+.......+...........|.  .
T Consensus       181 ~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~~--~  258 (322)
T d1vzoa_         181 ADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQ--E  258 (322)
T ss_dssp             GGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCT--T
T ss_pred             ccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCCCCcc--c
Confidence            2  22334567999999999997654 34566999999999999999999998887766666666655555444443  6


Q ss_pred             CCHhHHHHHHHhcccCCCCCC-----ChHHHhcCcccccC
Q 019195          222 ISQDCRNLLSRIFVANPSRRI-----TIKEIKSHPWFLKN  256 (344)
Q Consensus       222 ~s~~~~~li~~~L~~dp~~R~-----s~~ell~hp~~~~~  256 (344)
                      +|+++.+||.+||++||.+||     |++|+|+||||++.
T Consensus       259 ~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~i  298 (322)
T d1vzoa_         259 MSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKI  298 (322)
T ss_dssp             SCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTC
T ss_pred             CCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcCC
Confidence            899999999999999999999     58999999999653

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-54  Score=382.09  Aligned_cols=243  Identities=22%  Similarity=0.306  Sum_probs=191.5

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCcc---ccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEEe
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK---IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVME   78 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e   78 (344)
                      ++|++.+.||+|+||+||+|+..   ..||||+++....   ....+.+|+.++++++|||||++++++. ++.+++|||
T Consensus         8 ~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~-~~~~~lv~E   83 (276)
T d1uwha_           8 GQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQLAIVTQ   83 (276)
T ss_dssp             TCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEEE
T ss_pred             ccEEEEEEEeeCCCcEEEEEEEC---CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEe-ccEEEEEEe
Confidence            57999999999999999999754   3599999975432   2357889999999999999999999864 567899999


Q ss_pred             cCCCCChHHHHHhC-CCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCC---
Q 019195           79 YAAGGELFERICNA-GRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS---  147 (344)
Q Consensus        79 ~~~~g~L~~~i~~~-~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~---  147 (344)
                      ||++|+|.+++... ..+++.++..++.|+++|       ||+||||||+|||++.++.  +||+|||+|+......   
T Consensus        84 y~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~--~Kl~DFGla~~~~~~~~~~  161 (276)
T d1uwha_          84 WCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLT--VKIGDFGLATVKSRWSGSH  161 (276)
T ss_dssp             CCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSS--EEECCCCCSCC--------
T ss_pred             cCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCC--EEEccccceeeccccCCcc
Confidence            99999999999764 569999888887776655       9999999999999987764  9999999997643322   


Q ss_pred             CCCCCccCCcccCCccccCCC--CCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCHh
Q 019195          148 RPKSTVGTPAYIAPEVLSRRE--YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQD  225 (344)
Q Consensus       148 ~~~~~~gt~~y~aPE~~~~~~--~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~  225 (344)
                      ......||+.|||||++.+..  ..+.++|||||||++|||+||+.||.+..........+.+....+........++++
T Consensus       162 ~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~  241 (276)
T d1uwha_         162 QFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKA  241 (276)
T ss_dssp             ----CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCGGGSCTTCCHH
T ss_pred             cccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCcchhccccchHH
Confidence            234567999999999986532  235669999999999999999999988766555444433211111111123467899


Q ss_pred             HHHHHHHhcccCCCCCCChHHHhcC
Q 019195          226 CRNLLSRIFVANPSRRITIKEIKSH  250 (344)
Q Consensus       226 ~~~li~~~L~~dp~~R~s~~ell~h  250 (344)
                      +.+||.+||+.||.+|||+.+++++
T Consensus       242 l~~li~~cl~~dp~~RPt~~~il~~  266 (276)
T d1uwha_         242 MKRLMAECLKKKRDERPLFPQILAS  266 (276)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHcCCCHhHCcCHHHHHHH
Confidence            9999999999999999999999886

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-54  Score=378.80  Aligned_cols=240  Identities=23%  Similarity=0.408  Sum_probs=191.0

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEEecCC
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYAA   81 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~   81 (344)
                      ++|++++.||+|+||+||+|.+. ++..||||++.........+.+|+.++++++|||||++++++..++.+|+|||||+
T Consensus         5 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~   83 (263)
T d1sm2a_           5 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME   83 (263)
T ss_dssp             SCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred             HHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCcCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecC
Confidence            58999999999999999999986 46789999998877777889999999999999999999999999999999999999


Q ss_pred             CCChHHHHHhC-CCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCCC--CCC
Q 019195           82 GGELFERICNA-GRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR--PKS  151 (344)
Q Consensus        82 ~g~L~~~i~~~-~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~~--~~~  151 (344)
                      +|+|.+++... ..+++..++.++.|++.|       +|+||||||+|||++.++.  +||+|||+++.......  ...
T Consensus        84 ~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~--~Kl~DFGla~~~~~~~~~~~~~  161 (263)
T d1sm2a_          84 HGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQV--IKVSDFGMTRFVLDDQYTSSTG  161 (263)
T ss_dssp             TCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGC--EEECSCC---------------
T ss_pred             CCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCC--eEecccchheeccCCCceeecc
Confidence            99999998765 568888888888777765       9999999999999987765  99999999976543332  233


Q ss_pred             CccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhC-CCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCHhHHHHH
Q 019195          152 TVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVG-AYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLL  230 (344)
Q Consensus       152 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li  230 (344)
                      ..||+.|+|||++.+..++ .++|||||||++|||+|+ .+||.........    ..+.. ..+.+.+...++++.+||
T Consensus       162 ~~gt~~y~aPE~l~~~~~~-~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~----~~i~~-~~~~~~p~~~~~~l~~li  235 (263)
T d1sm2a_         162 TKFPVKWASPEVFSFSRYS-SKSDVWSFGVLMWEVFSEGKIPYENRSNSEVV----EDIST-GFRLYKPRLASTHVYQIM  235 (263)
T ss_dssp             ---CTTSCCHHHHTTCCCC-HHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHH----HHHHH-TCCCCCCTTSCHHHHHHH
T ss_pred             eecCcccCChHHhcCCCCC-chhhhcchHHHHHHHHHCCCCCCCCCCHHHHH----HHHHh-cCCCCCccccCHHHHHHH
Confidence            5699999999999888765 569999999999999995 5666554432222    22222 233344456799999999


Q ss_pred             HHhcccCCCCCCChHHHhcC
Q 019195          231 SRIFVANPSRRITIKEIKSH  250 (344)
Q Consensus       231 ~~~L~~dp~~R~s~~ell~h  250 (344)
                      .+||+.||.+|||++++++|
T Consensus       236 ~~cl~~~p~~Rps~~~il~~  255 (263)
T d1sm2a_         236 NHCWKERPEDRPAFSRLLRQ  255 (263)
T ss_dssp             HHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHccCCHhHCcCHHHHHHH
Confidence            99999999999999999886

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.9e-55  Score=398.01  Aligned_cols=252  Identities=23%  Similarity=0.389  Sum_probs=203.2

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCccc---cHHHHHHHHHHhcCCCCCcceeeEEEEcC-----CEE
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKI---DANVAREIINHKQLRHPNIIRFKEVVLTP-----THL   73 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~ei~~l~~l~h~niv~~~~~~~~~-----~~~   73 (344)
                      +||+++++||+|+||+||+|++..+|+.||||++.+....   ..++.+|+.+|++++|||||++++++...     ...
T Consensus        18 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~   97 (348)
T d2gfsa1          18 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND   97 (348)
T ss_dssp             TTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCC
T ss_pred             CCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCce
Confidence            6899999999999999999999999999999999765432   24688999999999999999999999643     334


Q ss_pred             EEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCC
Q 019195           74 AIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH  146 (344)
Q Consensus        74 ~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~  146 (344)
                      +++|+|+.+|+|.+++. .+++++.+++.++.||+.|       ||+||||||+|||++.++.  +|++|||++....  
T Consensus        98 ~~i~~~~~gg~L~~~~~-~~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~--~kl~dfg~a~~~~--  172 (348)
T d2gfsa1          98 VYLVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCE--LKILDFGLARHTD--  172 (348)
T ss_dssp             CEEEEECCSEEHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC--EEECCC----CCT--
T ss_pred             EEEEEeecCCchhhhcc-cccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCcccccccccc--ccccccchhcccC--
Confidence            66677788999999885 4579999999998887766       9999999999999987654  9999999987432  


Q ss_pred             CCCCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccc------------
Q 019195          147 SRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQY------------  214 (344)
Q Consensus       147 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~------------  214 (344)
                      .......||+.|+|||++.+..+.+.++|||||||++|+|++|++||.+.+.......+.........            
T Consensus       173 ~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  252 (348)
T d2gfsa1         173 DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESAR  252 (348)
T ss_dssp             GGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCCHHHH
T ss_pred             cccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccchhhh
Confidence            33455689999999999888777777799999999999999999999887765555444433211110            


Q ss_pred             -------cCC------CCCCCCHhHHHHHHHhcccCCCCCCChHHHhcCcccccCCC
Q 019195          215 -------KIP------DYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLP  258 (344)
Q Consensus       215 -------~~~------~~~~~s~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~~~~  258 (344)
                             ..+      ....+++++.+||.+||+.||.+||||.|+|+||||++...
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~~  309 (348)
T d2gfsa1         253 NYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD  309 (348)
T ss_dssp             HHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCC
T ss_pred             hhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCCC
Confidence                   001      02357899999999999999999999999999999987543

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-54  Score=381.34  Aligned_cols=244  Identities=22%  Similarity=0.324  Sum_probs=198.3

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEEecCC
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYAA   81 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~   81 (344)
                      ++|++.+.||+|+||.||+|.++ ++..||||++.........+.+|+.++++++|||||++++++. ++.+|+|||||+
T Consensus        13 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~-~~~~~iv~Ey~~   90 (272)
T d1qpca_          13 ETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYME   90 (272)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECCT
T ss_pred             HHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCcCCHHHHHHHHHHHHhCCCCCEeEEEeeec-cCCeEEEEEeCC
Confidence            57999999999999999999985 5778999999887766778999999999999999999999875 456799999999


Q ss_pred             CCChHHHHHhC--CCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCC--CCC
Q 019195           82 GGELFERICNA--GRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS--RPK  150 (344)
Q Consensus        82 ~g~L~~~i~~~--~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~--~~~  150 (344)
                      +|+|.+++...  ..+++.+++.++.|++.|       +|+||||||+|||++.++.  +||+|||+|+......  ...
T Consensus        91 ~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~--~Kl~DFGla~~~~~~~~~~~~  168 (272)
T d1qpca_          91 NGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLS--CKIADFGLARLIEDNEYTARE  168 (272)
T ss_dssp             TCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSC--EEECCCTTCEECSSSCEECCT
T ss_pred             CCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccc--eeeccccceEEccCCcccccc
Confidence            99999877543  368999888887777655       9999999999999987665  9999999998654332  234


Q ss_pred             CCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCHhHHHHH
Q 019195          151 STVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLL  230 (344)
Q Consensus       151 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li  230 (344)
                      ...||+.|||||++.+..++ .++|||||||++|||+||..|+.........   +..+.. ..+.+.+..+++++.+||
T Consensus       169 ~~~gt~~y~APE~~~~~~~~-~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~---~~~i~~-~~~~~~p~~~~~~l~~li  243 (272)
T d1qpca_         169 GAKFPIKWTAPEAINYGTFT-IKSDVWSFGILLTEIVTHGRIPYPGMTNPEV---IQNLER-GYRMVRPDNCPEELYQLM  243 (272)
T ss_dssp             TCCCCTTTSCHHHHHHCEEC-HHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH---HHHHHT-TCCCCCCTTCCHHHHHHH
T ss_pred             ccCCcccccChHHHhCCCCC-chhhhhhhHHHHHHHHhCCCCCCCCCCHHHH---HHHHHh-cCCCCCcccChHHHHHHH
Confidence            45799999999999877764 5699999999999999965554443332222   222222 233444457899999999


Q ss_pred             HHhcccCCCCCCChHHHhc--Ccccc
Q 019195          231 SRIFVANPSRRITIKEIKS--HPWFL  254 (344)
Q Consensus       231 ~~~L~~dp~~R~s~~ell~--hp~~~  254 (344)
                      .+||+.||.+|||+.++++  |+||.
T Consensus       244 ~~cl~~~P~~Rpt~~ei~~~L~~~ft  269 (272)
T d1qpca_         244 RLCWKERPEDRPTFDYLRSVLEDFFT  269 (272)
T ss_dssp             HHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHcCCCHhHCcCHHHHHHHhhhhhh
Confidence            9999999999999999988  67774

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.7e-54  Score=389.89  Aligned_cols=254  Identities=27%  Similarity=0.428  Sum_probs=200.4

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCcc--ccHHHHHHHHHHhcCCCCCcceeeEEEEcCC-----EEE
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK--IDANVAREIINHKQLRHPNIIRFKEVVLTPT-----HLA   74 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~-----~~~   74 (344)
                      +||++++.||+|+||+||+|.+..+|+.||||++.+...  ....+.+|+.+|++++||||+++++++....     .+|
T Consensus         8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~   87 (345)
T d1pmea_           8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVY   87 (345)
T ss_dssp             TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEE
T ss_pred             CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEE
Confidence            579999999999999999999999999999999976432  2356889999999999999999999997653     345


Q ss_pred             EEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCC-
Q 019195           75 IVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH-  146 (344)
Q Consensus        75 lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~-  146 (344)
                      ++ +|+.+|+|.+++.. +.+++..++.++.|++.|       ||+||||||+|||++.++  .+||+|||+|+..... 
T Consensus        88 l~-~~~~~g~L~~~l~~-~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~--~~kl~DfG~a~~~~~~~  163 (345)
T d1pmea_          88 LV-THLMGADLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTC--DLKICDFGLARVADPDH  163 (345)
T ss_dssp             EE-EECCCEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC--CEEECCCTTCEECCGGG
T ss_pred             EE-EeecCCchhhhhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCC--CEEEcccCceeeccCCC
Confidence            55 55669999999865 479999999998887766       999999999999998665  4999999999754332 


Q ss_pred             ---CCCCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhc-----------
Q 019195          147 ---SRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAV-----------  212 (344)
Q Consensus       147 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~-----------  212 (344)
                         ......+||+.|+|||++.....++.++||||+||++|+|++|++||...+...............           
T Consensus       164 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (345)
T d1pmea_         164 DHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL  243 (345)
T ss_dssp             CBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCCH
T ss_pred             ccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhhhh
Confidence               223456799999999999777666777999999999999999999998776544443332211100           


Q ss_pred             -----cccCC---------CCCCCCHhHHHHHHHhcccCCCCCCChHHHhcCcccccCCCh
Q 019195          213 -----QYKIP---------DYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLPR  259 (344)
Q Consensus       213 -----~~~~~---------~~~~~s~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~~~~~  259 (344)
                           ....+         ....+++++.+||.+||+.||.+||||.|+|+||||.+....
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~~~  304 (345)
T d1pmea_         244 KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDP  304 (345)
T ss_dssp             HHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTCCG
T ss_pred             hhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCCCC
Confidence                 00011         123578899999999999999999999999999999866443

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-54  Score=389.44  Aligned_cols=242  Identities=24%  Similarity=0.379  Sum_probs=199.9

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCc-----EEEEEEeecC--ccccHHHHHHHHHHhcC-CCCCcceeeEEEEcCCEE
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKE-----LVAMKYIERG--HKIDANVAREIINHKQL-RHPNIIRFKEVVLTPTHL   73 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~-----~vaiK~~~~~--~~~~~~~~~ei~~l~~l-~h~niv~~~~~~~~~~~~   73 (344)
                      ++|++.+.||+|+||+||+|.+..+++     .||+|.+...  ......+.+|+.+++++ +|||||++++++.+.+.+
T Consensus        37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~  116 (325)
T d1rjba_          37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPI  116 (325)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeE
Confidence            579999999999999999999876543     6999988653  33446789999999998 899999999999999999


Q ss_pred             EEEEecCCCCChHHHHHhCC-----------------------CCCHHHHHHHHHHHHHC-------CeeecCCCCCCeE
Q 019195           74 AIVMEYAAGGELFERICNAG-----------------------RFSEDEARYFFQQLISG-------QICHRDLKLENTL  123 (344)
Q Consensus        74 ~lv~e~~~~g~L~~~i~~~~-----------------------~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl  123 (344)
                      |+|||||++|+|.++|.+..                       .+++.+++.++.|+++|       ||+||||||+|||
T Consensus       117 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDlKp~Nil  196 (325)
T d1rjba_         117 YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVL  196 (325)
T ss_dssp             EEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGEE
T ss_pred             EEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCchhccc
Confidence            99999999999999997643                       37788888887776655       9999999999999


Q ss_pred             ecCCCCCCEEEeecCCCcccCCCCCC---CCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCh
Q 019195          124 LDGSPAPRLKICDFGYSKSSLLHSRP---KSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDP  199 (344)
Q Consensus       124 ~~~~~~~~vkL~DFg~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~  199 (344)
                      ++.++.  +||+|||+|+........   ....||+.|||||++.+..++ .++|||||||++|||++ |++||.+.+..
T Consensus       197 l~~~~~--~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~-~~~DiwS~Gvil~emlt~g~~Pf~~~~~~  273 (325)
T d1rjba_         197 VTHGKV--VKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYT-IKSDVWSYGILLWEIFSLGVNPYPGIPVD  273 (325)
T ss_dssp             EETTTE--EEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHTTTSCCSSTTCCCS
T ss_pred             cccCCe--EEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCC-cceeccchhHHHHHHHhCCCCCCCCCCHH
Confidence            987764  999999999865443322   345689999999999887764 56999999999999997 89999887665


Q ss_pred             HHHHHHHHHHhhccccCCCCCCCCHhHHHHHHHhcccCCCCCCChHHHhcC
Q 019195          200 KNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSH  250 (344)
Q Consensus       200 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~ell~h  250 (344)
                      ..+.+++.    ...+++.+..+++++.+||.+||+.||.+|||+.||++|
T Consensus       274 ~~~~~~~~----~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~  320 (325)
T d1rjba_         274 ANFYKLIQ----NGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF  320 (325)
T ss_dssp             HHHHHHHH----TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHh----cCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            55544433    344555556789999999999999999999999999886

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-53  Score=373.40  Aligned_cols=240  Identities=22%  Similarity=0.375  Sum_probs=204.4

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEEecCC
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYAA   81 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~   81 (344)
                      ++|+++++||+|+||+||+|+++ +++.||||++++.......+.+|+.++++++||||+++++++.+++.+++||||++
T Consensus         4 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~   82 (258)
T d1k2pa_           4 KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA   82 (258)
T ss_dssp             CCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSSCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred             HHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcCCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccC
Confidence            68999999999999999999985 77899999999877777889999999999999999999999999999999999999


Q ss_pred             CCChHHHHHh-CCCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCCC--CCC
Q 019195           82 GGELFERICN-AGRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR--PKS  151 (344)
Q Consensus        82 ~g~L~~~i~~-~~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~~--~~~  151 (344)
                      +|+|..++.. ...+++..++.++.|+++|       ||+||||||+|||++.++.  +||+|||+++.......  ...
T Consensus        83 ~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~--~kl~DfG~a~~~~~~~~~~~~~  160 (258)
T d1k2pa_          83 NGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGV--VKVSDFGLSRYVLDDEYTSSVG  160 (258)
T ss_dssp             TEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCC--EEECCCSSCCBCSSSSCCCCCC
T ss_pred             CCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCc--EEECcchhheeccCCCceeecc
Confidence            9999998654 4578888888888777766       9999999999999987664  99999999975443322  233


Q ss_pred             CccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCHhHHHHH
Q 019195          152 TVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLL  230 (344)
Q Consensus       152 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li  230 (344)
                      ..||+.|+|||++.+..++ .++|||||||++|||+| |+.||...+..+..    ..+.. ..+.+.+...++.+.+||
T Consensus       161 ~~~t~~y~aPE~~~~~~~~-~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~----~~i~~-~~~~~~p~~~~~~l~~li  234 (258)
T d1k2pa_         161 SKFPVRWSPPEVLMYSKFS-SKSDIWAFGVLMWEIYSLGKMPYERFTNSETA----EHIAQ-GLRLYRPHLASEKVYTIM  234 (258)
T ss_dssp             SCCCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHH----HHHHT-TCCCCCCTTCCHHHHHHH
T ss_pred             cCCCCCcCCcHHhcCCCCC-cceeecccchhhHhHHhcCCCCCCCCCHHHHH----HHHHh-CCCCCCcccccHHHHHHH
Confidence            5699999999999888775 56999999999999998 89999887654333    23322 234445557899999999


Q ss_pred             HHhcccCCCCCCChHHHhcC
Q 019195          231 SRIFVANPSRRITIKEIKSH  250 (344)
Q Consensus       231 ~~~L~~dp~~R~s~~ell~h  250 (344)
                      .+||+.||.+|||+.++++|
T Consensus       235 ~~cl~~dP~~RPt~~eil~~  254 (258)
T d1k2pa_         235 YSCWHEKADERPTFKILLSN  254 (258)
T ss_dssp             HHTTCSSGGGSCCHHHHHHH
T ss_pred             HHHccCCHhHCcCHHHHHHH
Confidence            99999999999999999987

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-53  Score=390.83  Aligned_cols=253  Identities=26%  Similarity=0.397  Sum_probs=193.1

Q ss_pred             CCCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCccc---cHHHHHHHHHHhcCCCCCcceeeEEEEc------CC
Q 019195            1 MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKI---DANVAREIINHKQLRHPNIIRFKEVVLT------PT   71 (344)
Q Consensus         1 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~ei~~l~~l~h~niv~~~~~~~~------~~   71 (344)
                      +++|+++++||+|+||+||+|.+..+|+.||||++.+....   ..++.+|+.++++++|||||+++++|..      .+
T Consensus        16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~   95 (355)
T d2b1pa1          16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ   95 (355)
T ss_dssp             ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred             cCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCc
Confidence            37899999999999999999999999999999999865332   2468899999999999999999999964      36


Q ss_pred             EEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccC
Q 019195           72 HLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSL  144 (344)
Q Consensus        72 ~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~  144 (344)
                      .+|+|||||.++ +...+  ...+++.+++.+++|++.|       ||+||||||+|||++.++.  +|++|||+++...
T Consensus        96 ~~~iv~Ey~~~~-l~~~~--~~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~--~kl~df~~~~~~~  170 (355)
T d2b1pa1          96 DVYLVMELMDAN-LCQVI--QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAG  170 (355)
T ss_dssp             EEEEEEECCSEE-HHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCC--EEECCCCC-----
T ss_pred             eeEEEEeccchH-HHHhh--hcCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccc--eeeechhhhhccc
Confidence            899999999654 54544  3568999999998888766       9999999999999987665  9999999998777


Q ss_pred             CCCCCCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhh-------------
Q 019195          145 LHSRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMA-------------  211 (344)
Q Consensus       145 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~-------------  211 (344)
                      ........+||+.|+|||++.+..++ .++||||+||++|+|++|++||.+.+.......++.....             
T Consensus       171 ~~~~~~~~~~t~~y~aPE~l~~~~~~-~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  249 (355)
T d2b1pa1         171 TSFMMTPYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV  249 (355)
T ss_dssp             ----------CCTTCCHHHHTTCCCC-TTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHHH
T ss_pred             cccccccccccccccChhhhcCCCCC-CCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhhH
Confidence            76777778899999999999887765 4599999999999999999999887665555444332211             


Q ss_pred             -----ccccCC--------------C----CCCCCHhHHHHHHHhcccCCCCCCChHHHhcCcccccCCCh
Q 019195          212 -----VQYKIP--------------D----YVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLPR  259 (344)
Q Consensus       212 -----~~~~~~--------------~----~~~~s~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~~~~~  259 (344)
                           ......              .    ....++++.+||++||+.||.+||||+|+|+||||+.....
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~~~~~  320 (355)
T d2b1pa1         250 RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDP  320 (355)
T ss_dssp             HHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGCCH
T ss_pred             HHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCCCCc
Confidence                 000000              0    01136789999999999999999999999999999876543

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.4e-53  Score=380.50  Aligned_cols=241  Identities=23%  Similarity=0.373  Sum_probs=189.0

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCc---EEEEEEeecCcc--ccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEE
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKE---LVAMKYIERGHK--IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIV   76 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~---~vaiK~~~~~~~--~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv   76 (344)
                      ++|++.+.||+|+||+||+|.+..+++   .||||.+.....  ....+.+|+.+|++++|||||++++++..++.+|+|
T Consensus        26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv  105 (299)
T d1jpaa_          26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII  105 (299)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred             hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence            578999999999999999999986654   688998865432  235789999999999999999999999999999999


Q ss_pred             EecCCCCChHHHHHhC-CCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCCC
Q 019195           77 MEYAAGGELFERICNA-GRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR  148 (344)
Q Consensus        77 ~e~~~~g~L~~~i~~~-~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~~  148 (344)
                      ||||++|+|.+++... +.+++.+++.++.|+++|       ||+||||||+|||++.++.  +||+|||+|+.......
T Consensus       106 ~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~--~Kl~DFGla~~~~~~~~  183 (299)
T d1jpaa_         106 TEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLV--CKVSDFGLSRFLEDDTS  183 (299)
T ss_dssp             EECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCC--EEECCC-----------
T ss_pred             EEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCc--EEECCcccceEccCCCC
Confidence            9999999999988764 578999888888877765       9999999999999987665  99999999976433222


Q ss_pred             C------CCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhhccccCCCCCC
Q 019195          149 P------KSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVH  221 (344)
Q Consensus       149 ~------~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  221 (344)
                      .      ....||+.|||||++.+..++ .++|||||||++|||+| |++||.+.......    ..+. ...+.|....
T Consensus       184 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~----~~i~-~~~~~~~~~~  257 (299)
T d1jpaa_         184 DPTYTSALGGKIPIRWTAPEAIQYRKFT-SASDVWSYGIVMWEVMSYGERPYWDMTNQDVI----NAIE-QDYRLPPPMD  257 (299)
T ss_dssp             ------------CGGGSCHHHHHSCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH----HHHH-TTCCCCCCTT
T ss_pred             cceeeecccccCCccccCHHHHhcCCCC-cccccccchHHHHHHHhCCCCCCCCCCHHHHH----HHHH-cCCCCCCCcc
Confidence            1      223589999999999887765 55999999999999998 89999876653322    2222 2344555567


Q ss_pred             CCHhHHHHHHHhcccCCCCCCChHHHhcC
Q 019195          222 ISQDCRNLLSRIFVANPSRRITIKEIKSH  250 (344)
Q Consensus       222 ~s~~~~~li~~~L~~dp~~R~s~~ell~h  250 (344)
                      +++.+.+||.+||+.||.+|||+.+++++
T Consensus       258 ~~~~l~~li~~cl~~~P~~RPs~~ei~~~  286 (299)
T d1jpaa_         258 CPSALHQLMLDCWQKDRNHRPKFGQIVNT  286 (299)
T ss_dssp             CCHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             chHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence            89999999999999999999999999764

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-53  Score=376.87  Aligned_cols=237  Identities=22%  Similarity=0.329  Sum_probs=190.4

Q ss_pred             eeeeecCceEEEEEEEc--CCCcEEEEEEeecCcc---ccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEEecCCC
Q 019195            8 KDIGSGNFGVARLMRNK--NTKELVAMKYIERGHK---IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYAAG   82 (344)
Q Consensus         8 ~~lg~G~~g~V~~~~~~--~~~~~vaiK~~~~~~~---~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~   82 (344)
                      ++||+|+||+||+|.+.  .+++.||||++.....   ..+.+.+|+.+|++++|||||++++++..+ .+++|||||++
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~-~~~lvmE~~~~   91 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAEL   91 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS-SEEEEEECCTT
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC-CEEEEEEcCCC
Confidence            46999999999999764  4568899999965432   235789999999999999999999999654 57899999999


Q ss_pred             CChHHHHHhCCCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCCC----CCC
Q 019195           83 GELFERICNAGRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR----PKS  151 (344)
Q Consensus        83 g~L~~~i~~~~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~~----~~~  151 (344)
                      |+|.+++.+...+++.+++.++.|++.|       ||+||||||+|||++.++.  +||+|||+|+.......    ...
T Consensus        92 g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~--~kl~DFGla~~~~~~~~~~~~~~~  169 (277)
T d1xbba_          92 GPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHY--AKISDFGLSKALRADENYYKAQTH  169 (277)
T ss_dssp             EEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTE--EEECCCTTCEECCTTCSEEEC---
T ss_pred             CcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCc--ccccchhhhhhccccccccccccc
Confidence            9999999999999999999888887765       9999999999999987765  99999999975433322    233


Q ss_pred             CccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCHhHHHHH
Q 019195          152 TVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLL  230 (344)
Q Consensus       152 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li  230 (344)
                      ..||+.|||||++.+..++ .++|||||||++|||++ |++||.+.+....    ...+.. ..+.+.+..+++++.+||
T Consensus       170 ~~gt~~y~APE~l~~~~~~-~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~----~~~i~~-~~~~~~p~~~~~~~~~li  243 (277)
T d1xbba_         170 GKWPVKWYAPECINYYKFS-SKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV----TAMLEK-GERMGCPAGCPREMYDLM  243 (277)
T ss_dssp             -CCCGGGCCHHHHHHCEEE-HHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH----HHHHHT-TCCCCCCTTCCHHHHHHH
T ss_pred             cCCCceecCchhhcCCCCC-chhhhccchhhhhHHhhCCCCCCCCCCHHHH----HHHHHc-CCCCCCCcccCHHHHHHH
Confidence            4699999999999887764 55999999999999997 8999988654332    222222 233444457899999999


Q ss_pred             HHhcccCCCCCCChHHH---hcCccc
Q 019195          231 SRIFVANPSRRITIKEI---KSHPWF  253 (344)
Q Consensus       231 ~~~L~~dp~~R~s~~el---l~hp~~  253 (344)
                      .+||+.||.+|||+.++   |+|+|+
T Consensus       244 ~~cl~~dp~~RPs~~~i~~~L~~~~~  269 (277)
T d1xbba_         244 NLCWTYDVENRPGFAAVELRLRNYYY  269 (277)
T ss_dssp             HHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             HHHcCCCHhHCcCHHHHHHHhhCHHh
Confidence            99999999999999998   455554

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.5e-53  Score=373.83  Aligned_cols=243  Identities=25%  Similarity=0.366  Sum_probs=196.3

Q ss_pred             CCceeeee-eeecCceEEEEEEEcC--CCcEEEEEEeecCcc--ccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEE
Q 019195            2 EKYELMKD-IGSGNFGVARLMRNKN--TKELVAMKYIERGHK--IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIV   76 (344)
Q Consensus         2 ~~y~~~~~-lg~G~~g~V~~~~~~~--~~~~vaiK~~~~~~~--~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv   76 (344)
                      ++|.+.+. ||+|+||+||+|.+..  ++..||||++.....  ....+.+|+.+|++++|||||++++++.+ +.+|+|
T Consensus         8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lv   86 (285)
T d1u59a_           8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV   86 (285)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred             cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEE
Confidence            45778884 9999999999998753  456899999976432  23578999999999999999999999875 468999


Q ss_pred             EecCCCCChHHHHHh-CCCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCC-
Q 019195           77 MEYAAGGELFERICN-AGRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS-  147 (344)
Q Consensus        77 ~e~~~~g~L~~~i~~-~~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~-  147 (344)
                      ||||++|+|.+++.. ...+++.+++.++.|++.|       ||+||||||+|||++.++.  +||+|||+|+...... 
T Consensus        87 mE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~--~Kl~DFGla~~~~~~~~  164 (285)
T d1u59a_          87 MEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHY--AKISDFGLSKALGADDS  164 (285)
T ss_dssp             EECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTE--EEECCCTTCEECTTCSC
T ss_pred             EEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCc--eeeccchhhhccccccc
Confidence            999999999998765 4579999999988887765       9999999999999987764  9999999997643322 


Q ss_pred             ---CCCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCC
Q 019195          148 ---RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHIS  223 (344)
Q Consensus       148 ---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s  223 (344)
                         .....+||+.|||||++.+..++ .++|||||||++|||+| |+.||.+....+...    .+.. ..+.+.+..++
T Consensus       165 ~~~~~~~~~gt~~y~aPE~~~~~~~~-~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~----~i~~-~~~~~~p~~~~  238 (285)
T d1u59a_         165 YYTARSAGKWPLKWYAPECINFRKFS-SRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMA----FIEQ-GKRMECPPECP  238 (285)
T ss_dssp             EECCCCSSCCCGGGCCHHHHHHCEEC-HHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHH----HHHT-TCCCCCCTTCC
T ss_pred             ccccccccccCccccChHHHhCCCCC-ccchhhcchHHHHHHHhCCCCCCCCCCHHHHHH----HHHc-CCCCCCCCcCC
Confidence               23345699999999999877764 55999999999999998 999998876543332    2222 22334445789


Q ss_pred             HhHHHHHHHhcccCCCCCCChHHH---hcCccc
Q 019195          224 QDCRNLLSRIFVANPSRRITIKEI---KSHPWF  253 (344)
Q Consensus       224 ~~~~~li~~~L~~dp~~R~s~~el---l~hp~~  253 (344)
                      +++.+||.+||+.||.+|||+.++   |+|+|+
T Consensus       239 ~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~  271 (285)
T d1u59a_         239 PELYALMSDCWIYKWEDRPDFLTVEQRMRACYY  271 (285)
T ss_dssp             HHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence            999999999999999999999888   456664

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.3e-53  Score=372.16  Aligned_cols=246  Identities=22%  Similarity=0.306  Sum_probs=197.2

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEEEecCC
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYAA   81 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~   81 (344)
                      ++|++.+.||+|+||.||+|.+..+ ..||||++.......+.+.+|+.++++++|||||++++++. ++.+|+|||||+
T Consensus        17 ~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~-~~~~~lv~Ey~~   94 (285)
T d1fmka3          17 ESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMS   94 (285)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEECCCT
T ss_pred             HHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECcccCCHHHHHHHHHHHHhcccCCEeEEEEEEe-cCCeEEEEEecC
Confidence            6899999999999999999998765 56999999877766778999999999999999999999985 456789999999


Q ss_pred             CCChHHHHHh--CCCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCC--CCC
Q 019195           82 GGELFERICN--AGRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS--RPK  150 (344)
Q Consensus        82 ~g~L~~~i~~--~~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~--~~~  150 (344)
                      +|+|..++..  .+.+++.+++.++.|++.|       ||+||||||+|||++.++.  +||+|||+|+......  ...
T Consensus        95 ~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~--~kl~DfGla~~~~~~~~~~~~  172 (285)
T d1fmka3          95 KGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLV--CKVADFGLARLIEDNEYTARQ  172 (285)
T ss_dssp             TCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC--EEECCCCTTC-----------
T ss_pred             CCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCc--EEEcccchhhhccCCCceeec
Confidence            9999988754  4579999998888887765       9999999999999987765  9999999997643322  223


Q ss_pred             CCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCHhHHHHH
Q 019195          151 STVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLL  230 (344)
Q Consensus       151 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li  230 (344)
                      ...||+.|+|||++....++ .++|||||||++|||++|..||............+   .. ..+.+....+++++++||
T Consensus       173 ~~~gt~~y~aPE~~~~~~~~-~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i---~~-~~~~~~~~~~~~~l~~li  247 (285)
T d1fmka3         173 GAKFPIKWTAPEAALYGRFT-IKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV---ER-GYRMPCPPECPESLHDLM  247 (285)
T ss_dssp             ---CCGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHH---HT-TCCCCCCTTSCHHHHHHH
T ss_pred             cccccccccChHHHhCCCCC-cHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHH---Hh-cCCCCCCcccCHHHHHHH
Confidence            45699999999999887775 56999999999999999666555544433332222   22 234455567899999999


Q ss_pred             HHhcccCCCCCCChHHHhc--CcccccC
Q 019195          231 SRIFVANPSRRITIKEIKS--HPWFLKN  256 (344)
Q Consensus       231 ~~~L~~dp~~R~s~~ell~--hp~~~~~  256 (344)
                      .+||+.||++|||+.++++  ++||...
T Consensus       248 ~~cl~~dP~~Rps~~~i~~~L~~~~~~~  275 (285)
T d1fmka3         248 CQCWRKEPEERPTFEYLQAFLEDYFTST  275 (285)
T ss_dssp             HHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred             HHHcccCHhHCcCHHHHHHHHhhhhcCC
Confidence            9999999999999999987  7888654

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-51  Score=364.38  Aligned_cols=241  Identities=24%  Similarity=0.314  Sum_probs=189.0

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCC----cEEEEEEeecCcc--ccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEE
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTK----ELVAMKYIERGHK--IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAI   75 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~----~~vaiK~~~~~~~--~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~l   75 (344)
                      +.|++.+.||+|+||.||+|....++    ..||||++.....  ....+.+|+.++++++|||||++++++.+.+.+++
T Consensus         7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~   86 (283)
T d1mqba_           7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI   86 (283)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence            46999999999999999999987654    4799999875432  23468899999999999999999999999999999


Q ss_pred             EEecCCCCChHHHHHhC-CCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCC
Q 019195           76 VMEYAAGGELFERICNA-GRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS  147 (344)
Q Consensus        76 v~e~~~~g~L~~~i~~~-~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~  147 (344)
                      |||||.++++.+.+... +.+++.++..++.|++.|       +|+||||||+|||++.++.  +||+|||+|+......
T Consensus        87 v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~--~Kl~DFGla~~~~~~~  164 (283)
T d1mqba_          87 ITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLV--CKVSDFGLSRVLEDDP  164 (283)
T ss_dssp             EEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCC--EEECCCCC--------
T ss_pred             EEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCe--EEEcccchhhcccCCC
Confidence            99999999999987654 579999888887777654       9999999999999987765  9999999998643322


Q ss_pred             C----CCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCC
Q 019195          148 R----PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHIS  223 (344)
Q Consensus       148 ~----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s  223 (344)
                      .    .....||+.|||||++.+..++ .++|||||||++|||++|..||...........   .+ ....+.+....++
T Consensus       165 ~~~~~~~~~~gt~~Y~APE~l~~~~~~-~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~---~i-~~~~~~~~~~~~~  239 (283)
T d1mqba_         165 EATYTTSGGKIPIRWTAPEAISYRKFT-SASDVWSFGIVMWEVMTYGERPYWELSNHEVMK---AI-NDGFRLPTPMDCP  239 (283)
T ss_dssp             ---------CCCGGGSCHHHHHSCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHH---HH-HTTCCCCCCTTCB
T ss_pred             ccceEeccCCCCccccCHHHHccCCCC-CcccccccHHHHHHHHhCCCCccccCCHHHHHH---HH-hccCCCCCchhhH
Confidence            1    2234689999999999887765 559999999999999996665554443333222   22 2234455556789


Q ss_pred             HhHHHHHHHhcccCCCCCCChHHHhc
Q 019195          224 QDCRNLLSRIFVANPSRRITIKEIKS  249 (344)
Q Consensus       224 ~~~~~li~~~L~~dp~~R~s~~ell~  249 (344)
                      +.+.+||.+||+.||.+|||+.++++
T Consensus       240 ~~l~~li~~cl~~~p~~RPt~~eil~  265 (283)
T d1mqba_         240 SAIYQLMMQCWQQERARRPKFADIVS  265 (283)
T ss_dssp             HHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             HHHHHHHHHHCcCCHhHCcCHHHHHH
Confidence            99999999999999999999999976

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.9e-52  Score=366.92  Aligned_cols=240  Identities=23%  Similarity=0.378  Sum_probs=188.5

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCC---CcEEEEEEeecCcc--ccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEEE
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNT---KELVAMKYIERGHK--IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIV   76 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~---~~~vaiK~~~~~~~--~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv   76 (344)
                      ++|++.+.||+|+||+||+|.+..+   +..||||.+.....  ....+.+|+.++++++|||||++++++. ++.+|+|
T Consensus         7 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~iv   85 (273)
T d1mp8a_           7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWII   85 (273)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEE
T ss_pred             HHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEEE
Confidence            6899999999999999999998654   45689998865432  2356889999999999999999999985 5678999


Q ss_pred             EecCCCCChHHHHHh-CCCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCC-
Q 019195           77 MEYAAGGELFERICN-AGRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS-  147 (344)
Q Consensus        77 ~e~~~~g~L~~~i~~-~~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~-  147 (344)
                      ||||++|+|..++.. ...+++.+++.++.|+++|       +|+||||||+||+++.++.  +||+|||+|+...... 
T Consensus        86 ~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~--~Kl~DfG~a~~~~~~~~  163 (273)
T d1mp8a_          86 MELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDC--VKLGDFGLSRYMEDSTY  163 (273)
T ss_dssp             EECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTE--EEECC------------
T ss_pred             EEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCc--EEEccchhheeccCCcc
Confidence            999999999998765 4578999998888887765       9999999999999987765  9999999998643322 


Q ss_pred             -CCCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCHh
Q 019195          148 -RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQD  225 (344)
Q Consensus       148 -~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~  225 (344)
                       ......||+.|+|||++.+..++ .++|||||||++|||++ |.+||......+....+    .. ....+.+.++++.
T Consensus       164 ~~~~~~~gt~~y~apE~l~~~~~~-~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i----~~-~~~~~~~~~~~~~  237 (273)
T d1mp8a_         164 YKASKGKLPIKWMAPESINFRRFT-SASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI----EN-GERLPMPPNCPPT  237 (273)
T ss_dssp             -------CCGGGCCHHHHHHCCCS-HHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHH----HT-TCCCCCCTTCCHH
T ss_pred             eeccceecCcccchhhHhccCCCC-CccccccchHHHHHHHhcCCCCCCCCCHHHHHHHH----Hc-CCCCCCCCCCCHH
Confidence             23345689999999999877764 56999999999999998 89999887765444332    22 2234455688999


Q ss_pred             HHHHHHHhcccCCCCCCChHHHhcC
Q 019195          226 CRNLLSRIFVANPSRRITIKEIKSH  250 (344)
Q Consensus       226 ~~~li~~~L~~dp~~R~s~~ell~h  250 (344)
                      +.+||.+||+.||.+|||+.++++|
T Consensus       238 ~~~li~~cl~~dp~~Rps~~ei~~~  262 (273)
T d1mp8a_         238 LYSLMTKCWAYDPSRRPRFTELKAQ  262 (273)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHcCCCHhHCcCHHHHHHH
Confidence            9999999999999999999999876

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-51  Score=369.83  Aligned_cols=242  Identities=24%  Similarity=0.340  Sum_probs=197.2

Q ss_pred             CCCceeeeeeeecCceEEEEEEEcCCCcE--EEEEEeecCc--cccHHHHHHHHHHhcC-CCCCcceeeEEEEcCCEEEE
Q 019195            1 MEKYELMKDIGSGNFGVARLMRNKNTKEL--VAMKYIERGH--KIDANVAREIINHKQL-RHPNIIRFKEVVLTPTHLAI   75 (344)
Q Consensus         1 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~--vaiK~~~~~~--~~~~~~~~ei~~l~~l-~h~niv~~~~~~~~~~~~~l   75 (344)
                      +++|++.+.||+|+||+||+|.+..++..  ||||.+....  .....+.+|+.+|+++ +|||||++++++..++.+|+
T Consensus         9 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~i   88 (309)
T d1fvra_           9 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL   88 (309)
T ss_dssp             GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEE
T ss_pred             HHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEE
Confidence            36899999999999999999999888764  6778775432  2345789999999999 79999999999999999999


Q ss_pred             EEecCCCCChHHHHHhC----------------CCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCE
Q 019195           76 VMEYAAGGELFERICNA----------------GRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRL  132 (344)
Q Consensus        76 v~e~~~~g~L~~~i~~~----------------~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~v  132 (344)
                      |||||++|+|.++|++.                ..+++.+++.++.|++.|       +|+||||||+|||++.++.  +
T Consensus        89 V~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~~~--~  166 (309)
T d1fvra_          89 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYV--A  166 (309)
T ss_dssp             EECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGC--E
T ss_pred             EEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCCCc--e
Confidence            99999999999999754                568888888888887765       9999999999999987765  9


Q ss_pred             EEeecCCCcccCCCCCCCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCC-CCCCCCCChHHHHHHHHHHhh
Q 019195          133 KICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGA-YPFEDQEDPKNFRKTISRIMA  211 (344)
Q Consensus       133 kL~DFg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~-~pf~~~~~~~~~~~~~~~~~~  211 (344)
                      ||+|||+|+............||+.|+|||.+.+..++ .++|||||||++|||++|. +||...+...    +...+..
T Consensus       167 kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~-~~sDvwSfGvil~ell~~~~~p~~~~~~~~----~~~~i~~  241 (309)
T d1fvra_         167 KIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYT-TNSDVWSYGVLLWEIVSLGGTPYCGMTCAE----LYEKLPQ  241 (309)
T ss_dssp             EECCTTCEESSCEECCC----CCTTTCCHHHHHHCEEC-HHHHHHHHHHHHHHHHTTSCCTTTTCCHHH----HHHHGGG
T ss_pred             EEccccccccccccccccceecCCcccchHHhccCCCC-ccceeehhHHHHHHHHhcCCCCCCCCCHHH----HHHHHHh
Confidence            99999999876655555666799999999999888774 5599999999999999975 5676654333    2333322


Q ss_pred             ccccCCCCCCCCHhHHHHHHHhcccCCCCCCChHHHhcC
Q 019195          212 VQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSH  250 (344)
Q Consensus       212 ~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~ell~h  250 (344)
                       ..+.+.+..+++++.+||.+||+.||++|||+.++++|
T Consensus       242 -~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~  279 (309)
T d1fvra_         242 -GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  279 (309)
T ss_dssp             -TCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             -cCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence             23445556789999999999999999999999999976

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.4e-51  Score=364.98  Aligned_cols=242  Identities=23%  Similarity=0.365  Sum_probs=186.9

Q ss_pred             CCceeeeeeeecCceEEEEEEEcC-----CCcEEEEEEeecCcc--ccHHHHHHHHHHhcC-CCCCcceeeEEEEcC-CE
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKN-----TKELVAMKYIERGHK--IDANVAREIINHKQL-RHPNIIRFKEVVLTP-TH   72 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~--~~~~~~~ei~~l~~l-~h~niv~~~~~~~~~-~~   72 (344)
                      ++|++.+.||+|+||.||+|.+..     +++.||||++.....  ....+.+|..++.++ +|+||+.+++++... ..
T Consensus        13 ~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~   92 (299)
T d1ywna1          13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP   92 (299)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSC
T ss_pred             HHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCCe
Confidence            579999999999999999999754     457899999875432  235677888887776 689999999998664 56


Q ss_pred             EEEEEecCCCCChHHHHHhCC----------------CCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCC
Q 019195           73 LAIVMEYAAGGELFERICNAG----------------RFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPA  129 (344)
Q Consensus        73 ~~lv~e~~~~g~L~~~i~~~~----------------~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~  129 (344)
                      +++|||||++|+|.+++....                .+++.+++.++.|+++|       ||+||||||+|||++.++.
T Consensus        93 ~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl~~~~~  172 (299)
T d1ywna1          93 LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNV  172 (299)
T ss_dssp             CEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGC
T ss_pred             EEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccceeECCCCc
Confidence            899999999999999996532                47888888887776655       9999999999999987664


Q ss_pred             CCEEEeecCCCcccCCCC---CCCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhC-CCCCCCCCChHHHHHH
Q 019195          130 PRLKICDFGYSKSSLLHS---RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVG-AYPFEDQEDPKNFRKT  205 (344)
Q Consensus       130 ~~vkL~DFg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g-~~pf~~~~~~~~~~~~  205 (344)
                        +||+|||+|+......   ......||+.|||||++.+..+ +.++|||||||++|||++| .+||........+...
T Consensus       173 --~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~-~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~~~~  249 (299)
T d1ywna1         173 --VKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVY-TIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR  249 (299)
T ss_dssp             --EEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHH
T ss_pred             --EEEccCcchhhccccccccccCceeeCccccchhHhhcCCC-CcccceeehHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence              9999999997543322   2345579999999999988776 4569999999999999986 5688776655544443


Q ss_pred             HHHHhhccccCCCCCCCCHhHHHHHHHhcccCCCCCCChHHHhcC
Q 019195          206 ISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSH  250 (344)
Q Consensus       206 ~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~ell~h  250 (344)
                      +..    ....+....+++++.+||.+||+.||.+|||+.++++|
T Consensus       250 ~~~----~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~  290 (299)
T d1ywna1         250 LKE----GTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  290 (299)
T ss_dssp             HHH----TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             Hhc----CCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            332    23334444689999999999999999999999999987

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-51  Score=358.52  Aligned_cols=237  Identities=24%  Similarity=0.386  Sum_probs=188.9

Q ss_pred             CCCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcCCCCCcceeeEEEEc-CCEEEEEEec
Q 019195            1 MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKEVVLT-PTHLAIVMEY   79 (344)
Q Consensus         1 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~-~~~~~lv~e~   79 (344)
                      +++|++++.||+|+||.||+|..+  |..||||++++. ...+.+.+|+.++++++||||+++++++.+ ++.+|+||||
T Consensus         6 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~i~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey   82 (262)
T d1byga_           6 MKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKND-ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY   82 (262)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCC-C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred             HHHeEEeEEEecCCCeEEEEEEEC--CeEEEEEEECcH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEec
Confidence            478999999999999999999984  678999999764 344679999999999999999999999865 4678999999


Q ss_pred             CCCCChHHHHHhCC--CCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCCCCC
Q 019195           80 AAGGELFERICNAG--RFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPK  150 (344)
Q Consensus        80 ~~~g~L~~~i~~~~--~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~~~~  150 (344)
                      +++|+|.+++.+.+  .+++..++.++.|++.|       +|+||||||+|||++.++.  +||+|||+++...  ....
T Consensus        83 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~--~kl~dfg~s~~~~--~~~~  158 (262)
T d1byga_          83 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNV--AKVSDFGLTKEAS--STQD  158 (262)
T ss_dssp             CTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSC--EEECCCCC-----------
T ss_pred             cCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCC--EeecccccceecC--CCCc
Confidence            99999999997643  48999888888887766       9999999999999987765  9999999987533  2234


Q ss_pred             CCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCHhHHHH
Q 019195          151 STVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL  229 (344)
Q Consensus       151 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  229 (344)
                      ...+|+.|+|||++.+..+ +.++|||||||++|||+| |++||...........+    .. ..+.+....+++.+.+|
T Consensus       159 ~~~~~~~y~aPE~l~~~~~-t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i----~~-~~~~~~~~~~~~~~~~l  232 (262)
T d1byga_         159 TGKLPVKWTAPEALREKKF-STKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRV----EK-GYKMDAPDGCPPAVYEV  232 (262)
T ss_dssp             ---CCTTTSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHH----TT-TCCCCCCTTCCHHHHHH
T ss_pred             cccccccCCChHHHhCCCC-ChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHH----Hc-CCCCCCCccCCHHHHHH
Confidence            4578999999999988776 566999999999999998 78888776554433322    21 23344445789999999


Q ss_pred             HHHhcccCCCCCCChHHHhcC
Q 019195          230 LSRIFVANPSRRITIKEIKSH  250 (344)
Q Consensus       230 i~~~L~~dp~~R~s~~ell~h  250 (344)
                      |.+||+.||.+|||+.+++++
T Consensus       233 i~~cl~~dP~~Rps~~~l~~~  253 (262)
T d1byga_         233 MKNCWHLDAAMRPSFLQLREQ  253 (262)
T ss_dssp             HHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHcccCHhHCcCHHHHHHH
Confidence            999999999999999999874

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.3e-51  Score=358.64  Aligned_cols=240  Identities=28%  Similarity=0.427  Sum_probs=188.0

Q ss_pred             CCceeeeeeeecCceEEEEEEEcC-CC--cEEEEEEeecCcc----ccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEE
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKN-TK--ELVAMKYIERGHK----IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLA   74 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~-~~--~~vaiK~~~~~~~----~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~   74 (344)
                      ++|++++.||+|+||.||+|.... ++  ..||||++.+...    ..+.+.+|+.+|++++|||||++++++.+ ..++
T Consensus         8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~   86 (273)
T d1u46a_           8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK   86 (273)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred             HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence            579999999999999999998643 33  4689999876422    23578999999999999999999999965 5678


Q ss_pred             EEEecCCCCChHHHHHh-CCCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCC
Q 019195           75 IVMEYAAGGELFERICN-AGRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH  146 (344)
Q Consensus        75 lv~e~~~~g~L~~~i~~-~~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~  146 (344)
                      +|||||++|+|.+.+.. .+.+++..++.++.|++.|       ||+||||||+|||++.++.  +||+|||+++.....
T Consensus        87 lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~--vkl~DfGl~~~~~~~  164 (273)
T d1u46a_          87 MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDL--VKIGDFGLMRALPQN  164 (273)
T ss_dssp             EEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTE--EEECCCTTCEECCC-
T ss_pred             eeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccc--eeeccchhhhhcccC
Confidence            99999999999988765 4579999988888887765       9999999999999987764  999999999865333


Q ss_pred             CC----CCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhhccccCCCCCC
Q 019195          147 SR----PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVH  221 (344)
Q Consensus       147 ~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  221 (344)
                      ..    .....||+.|+|||++.+..+ +.++|||||||++|||++ |+.||.+.+..+    .+..+.....+++....
T Consensus       165 ~~~~~~~~~~~~~~~~~aPE~~~~~~~-~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~----~~~~i~~~~~~~~~~~~  239 (273)
T d1u46a_         165 DDHYVMQEHRKVPFAWCAPESLKTRTF-SHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ----ILHKIDKEGERLPRPED  239 (273)
T ss_dssp             CCEEEC-----CCGGGCCHHHHHHCEE-EHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH----HHHHHHTSCCCCCCCTT
T ss_pred             CCcceecCccccCcccCCHHHHhCCCC-CcchhhhhhHHHHHHHHhCCCCCCCCcCHHH----HHHHHHhCCCCCCCccc
Confidence            22    233458889999999988776 455999999999999998 899998766543    33444455566666678


Q ss_pred             CCHhHHHHHHHhcccCCCCCCChHHHhc
Q 019195          222 ISQDCRNLLSRIFVANPSRRITIKEIKS  249 (344)
Q Consensus       222 ~s~~~~~li~~~L~~dp~~R~s~~ell~  249 (344)
                      +++.+.+||.+||+.||.+|||+.++++
T Consensus       240 ~~~~l~~li~~cl~~dp~~RPt~~ei~~  267 (273)
T d1u46a_         240 CPQDIYNVMVQCWAHKPEDRPTFVALRD  267 (273)
T ss_dssp             CCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            9999999999999999999999999864

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-50  Score=363.19  Aligned_cols=240  Identities=20%  Similarity=0.343  Sum_probs=191.9

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCc----EEEEEEeecCc--cccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEEE
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKE----LVAMKYIERGH--KIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAI   75 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~----~vaiK~~~~~~--~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~l   75 (344)
                      ++|++++.||+|+||+||+|.+..+|+    .||+|.+....  ...+.+.+|+.++++++|||||++++++.++ ..++
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~   87 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL   87 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred             HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence            479999999999999999999988776    58888876532  3346799999999999999999999999865 5678


Q ss_pred             EEecCCCCChHHHHHh-CCCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCC
Q 019195           76 VMEYAAGGELFERICN-AGRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS  147 (344)
Q Consensus        76 v~e~~~~g~L~~~i~~-~~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~  147 (344)
                      +|+|+.+|+|.+.+.. ...+++..++.++.|++.|       ||+||||||+|||++.++.  +||+|||+|+......
T Consensus        88 v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~--~kl~DFGla~~~~~~~  165 (317)
T d1xkka_          88 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQH--VKITDFGLAKLLGAEE  165 (317)
T ss_dssp             EEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTE--EEECCCSHHHHTTTTC
T ss_pred             EEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCC--eEeeccccceeccccc
Confidence            8899999999988765 4578999888888776655       9999999999999987765  9999999998654333


Q ss_pred             C---CCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCC
Q 019195          148 R---PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHIS  223 (344)
Q Consensus       148 ~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s  223 (344)
                      .   .....||+.|||||++.+..++ .++|||||||++|||+| |.+||.+....... ..+.    ...+.+.+..++
T Consensus       166 ~~~~~~~~~gt~~y~APE~l~~~~~~-~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~-~~i~----~~~~~~~p~~~~  239 (317)
T d1xkka_         166 KEYHAEGGKVPIKWMALESILHRIYT-HQSDVWSYGVTVWELMTFGSKPYDGIPASEIS-SILE----KGERLPQPPICT  239 (317)
T ss_dssp             C--------CCTTTSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHH-HHHH----HTCCCCCCTTBC
T ss_pred             ccccccccccCccccChHHHhcCCCC-hhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHH-HHHH----cCCCCCCCcccC
Confidence            2   2234689999999999888764 56999999999999998 89999876654432 2222    233445555789


Q ss_pred             HhHHHHHHHhcccCCCCCCChHHHhcC
Q 019195          224 QDCRNLLSRIFVANPSRRITIKEIKSH  250 (344)
Q Consensus       224 ~~~~~li~~~L~~dp~~R~s~~ell~h  250 (344)
                      +++.+||.+||+.||.+|||+.++++|
T Consensus       240 ~~~~~li~~cl~~dP~~RPs~~eil~~  266 (317)
T d1xkka_         240 IDVYMIMVKCWMIDADSRPKFRELIIE  266 (317)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHHhCCCChhhCcCHHHHHHH
Confidence            999999999999999999999999988

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.4e-50  Score=358.18  Aligned_cols=240  Identities=25%  Similarity=0.369  Sum_probs=193.6

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCC-------cEEEEEEeecCcc--ccHHHHHHHHHHhcC-CCCCcceeeEEEEcCC
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTK-------ELVAMKYIERGHK--IDANVAREIINHKQL-RHPNIIRFKEVVLTPT   71 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~-------~~vaiK~~~~~~~--~~~~~~~ei~~l~~l-~h~niv~~~~~~~~~~   71 (344)
                      ++|++.+.||+|+||.||+|+...++       ..||||++.+...  ....+.+|...+.++ +|||||++++++.+++
T Consensus        13 ~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~   92 (299)
T d1fgka_          13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG   92 (299)
T ss_dssp             GGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             HHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccCC
Confidence            68999999999999999999976554       4799999976543  336788899998888 7999999999999999


Q ss_pred             EEEEEEecCCCCChHHHHHhCC----------------CCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCC
Q 019195           72 HLAIVMEYAAGGELFERICNAG----------------RFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSP  128 (344)
Q Consensus        72 ~~~lv~e~~~~g~L~~~i~~~~----------------~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~  128 (344)
                      .+++|||||++|+|.++|....                .+++.+++.++.||+.|       +|+||||||+|||++.++
T Consensus        93 ~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~NiLl~~~~  172 (299)
T d1fgka_          93 PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDN  172 (299)
T ss_dssp             SCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTC
T ss_pred             eEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecccceeecCCC
Confidence            9999999999999999997543                48999999888886655       999999999999998776


Q ss_pred             CCCEEEeecCCCcccCCCC---CCCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHH
Q 019195          129 APRLKICDFGYSKSSLLHS---RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRK  204 (344)
Q Consensus       129 ~~~vkL~DFg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~  204 (344)
                      .  +||+|||+++......   ......||+.|+|||.+.+..++ .++|||||||++|+|++ |.+||........+  
T Consensus       173 ~--~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~-~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~~--  247 (299)
T d1fgka_         173 V--MKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYT-HQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF--  247 (299)
T ss_dssp             C--EEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH--
T ss_pred             C--eEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCC-chhhhHHhHHHHHHhccCCCCCCCCCCHHHHH--
Confidence            5  9999999998654333   23446799999999999888775 55999999999999998 78899776543322  


Q ss_pred             HHHHHhhccccCCCCCCCCHhHHHHHHHhcccCCCCCCChHHHhc
Q 019195          205 TISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKS  249 (344)
Q Consensus       205 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~ell~  249 (344)
                        ..+ .....++.+..+++++.+||.+||+.||.+|||+.++++
T Consensus       248 --~~i-~~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~  289 (299)
T d1fgka_         248 --KLL-KEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE  289 (299)
T ss_dssp             --HHH-HTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             --HHH-HcCCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence              222 223444555678999999999999999999999999986

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=3.8e-50  Score=358.99  Aligned_cols=240  Identities=23%  Similarity=0.355  Sum_probs=194.8

Q ss_pred             CCceeeeeeeecCceEEEEEEEc-----CCCcEEEEEEeecCcc--ccHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEE
Q 019195            2 EKYELMKDIGSGNFGVARLMRNK-----NTKELVAMKYIERGHK--IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLA   74 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~--~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~   74 (344)
                      ++|++++.||+|+||+||+|+..     .+++.||||++.....  ....+.+|+.++++++||||+++++++...+..+
T Consensus        13 ~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~   92 (301)
T d1lufa_          13 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMC   92 (301)
T ss_dssp             GGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCE
T ss_pred             HHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCceE
Confidence            57999999999999999999875     3568899999876433  2357899999999999999999999999999999


Q ss_pred             EEEecCCCCChHHHHHhCC------------------------CCCHHHHHHHHHHHHHC-------CeeecCCCCCCeE
Q 019195           75 IVMEYAAGGELFERICNAG------------------------RFSEDEARYFFQQLISG-------QICHRDLKLENTL  123 (344)
Q Consensus        75 lv~e~~~~g~L~~~i~~~~------------------------~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl  123 (344)
                      ++|||+++|+|.+++....                        .++..+++.++.|++.|       +|+||||||+|||
T Consensus        93 ~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDlKp~NIL  172 (301)
T d1lufa_          93 LLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCL  172 (301)
T ss_dssp             EEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred             EEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEEcccceE
Confidence            9999999999999986532                        37777888887776655       9999999999999


Q ss_pred             ecCCCCCCEEEeecCCCcccCCC---CCCCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCC-CCCCCCCCh
Q 019195          124 LDGSPAPRLKICDFGYSKSSLLH---SRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGA-YPFEDQEDP  199 (344)
Q Consensus       124 ~~~~~~~~vkL~DFg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~-~pf~~~~~~  199 (344)
                      ++.++.  +||+|||+|+.....   ....+.+||+.|+|||.+.+..++ .++|||||||++|||++|. +||......
T Consensus       173 ld~~~~--~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t-~ksDVwS~Gvvl~ell~~~~~p~~~~~~~  249 (301)
T d1lufa_         173 VGENMV--VKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYT-TESDVWAYGVVLWEIFSYGLQPYYGMAHE  249 (301)
T ss_dssp             ECGGGC--EEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTTCCTTTTSCHH
T ss_pred             ECCCCc--EEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCC-hhhhhccchhhHHHHHccCCCCCCCCCHH
Confidence            987665  999999998754322   233456799999999999888775 5699999999999999985 677766554


Q ss_pred             HHHHHHHHHHhhccccCCCCCCCCHhHHHHHHHhcccCCCCCCChHHHhc
Q 019195          200 KNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKS  249 (344)
Q Consensus       200 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~ell~  249 (344)
                      +..    ..+.... ..+.+..+++++.+||.+||+.+|.+|||+.|+++
T Consensus       250 e~~----~~v~~~~-~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~  294 (301)
T d1lufa_         250 EVI----YYVRDGN-ILACPENCPLELYNLMRLCWSKLPADRPSFCSIHR  294 (301)
T ss_dssp             HHH----HHHHTTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHH----HHHHcCC-CCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            333    2333332 23334578999999999999999999999999965

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-49  Score=356.01  Aligned_cols=241  Identities=23%  Similarity=0.364  Sum_probs=198.6

Q ss_pred             CCceeeeeeeecCceEEEEEEE-----cCCCcEEEEEEeecCcc--ccHHHHHHHHHHhcC-CCCCcceeeEEEEcCCEE
Q 019195            2 EKYELMKDIGSGNFGVARLMRN-----KNTKELVAMKYIERGHK--IDANVAREIINHKQL-RHPNIIRFKEVVLTPTHL   73 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~vaiK~~~~~~~--~~~~~~~ei~~l~~l-~h~niv~~~~~~~~~~~~   73 (344)
                      ++|++.+.||+|+||.||+|..     ..+++.||||++.....  ....+.+|+.+++.+ +|||||++++++.+...+
T Consensus        23 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~~  102 (311)
T d1t46a_          23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPT  102 (311)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             HHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCEE
Confidence            5789999999999999999985     35678999999976443  234688999999999 699999999999999999


Q ss_pred             EEEEecCCCCChHHHHHhCC------------------CCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCC
Q 019195           74 AIVMEYAAGGELFERICNAG------------------RFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSP  128 (344)
Q Consensus        74 ~lv~e~~~~g~L~~~i~~~~------------------~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~  128 (344)
                      ++|||||++|+|.+++....                  .+++..++.++.|++.|       +|+||||||+|||++.++
T Consensus       103 ~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~NIl~~~~~  182 (311)
T d1t46a_         103 LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGR  182 (311)
T ss_dssp             EEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEETTT
T ss_pred             EEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeecccccccccccccC
Confidence            99999999999999997543                  47888888888877665       999999999999998766


Q ss_pred             CCCEEEeecCCCcccCCCCC---CCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHH
Q 019195          129 APRLKICDFGYSKSSLLHSR---PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRK  204 (344)
Q Consensus       129 ~~~vkL~DFg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~  204 (344)
                      .  +||+|||+++.......   ....+||+.|+|||++.+..+ +.++|||||||++|||+| |.+||........+.+
T Consensus       183 ~--~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~~~  259 (311)
T d1t46a_         183 I--TKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVY-TFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYK  259 (311)
T ss_dssp             E--EEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHH
T ss_pred             c--ccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCC-CCcccccchHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence            4  99999999986443322   234579999999999987766 456999999999999998 6666766665555544


Q ss_pred             HHHHHhhccccCCCCCCCCHhHHHHHHHhcccCCCCCCChHHHhc
Q 019195          205 TISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKS  249 (344)
Q Consensus       205 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~ell~  249 (344)
                      ++.    ...+.+....+++.+.+||.+||+.||.+|||+.++++
T Consensus       260 ~i~----~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~  300 (311)
T d1t46a_         260 MIK----EGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ  300 (311)
T ss_dssp             HHH----HTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHh----cCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            443    23444444578999999999999999999999999986

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-49  Score=356.06  Aligned_cols=241  Identities=21%  Similarity=0.298  Sum_probs=195.1

Q ss_pred             CCceeeeeeeecCceEEEEEEEc-----CCCcEEEEEEeecCccc--cHHHHHHHHHHhcCCCCCcceeeEEEEcCCEEE
Q 019195            2 EKYELMKDIGSGNFGVARLMRNK-----NTKELVAMKYIERGHKI--DANVAREIINHKQLRHPNIIRFKEVVLTPTHLA   74 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~~--~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~   74 (344)
                      ++|++.+.||+|+||.||+|.+.     .++..||||+++.....  ...+.+|+.++++++|||||++++++..++.++
T Consensus        20 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~   99 (308)
T d1p4oa_          20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTL   99 (308)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCE
T ss_pred             HHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCcee
Confidence            68999999999999999999875     24578999999764332  245889999999999999999999999999999


Q ss_pred             EEEecCCCCChHHHHHhC----------CCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeec
Q 019195           75 IVMEYAAGGELFERICNA----------GRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDF  137 (344)
Q Consensus        75 lv~e~~~~g~L~~~i~~~----------~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DF  137 (344)
                      +|||||++|+|.+++...          ..++..++..++.|+++|       +|+||||||+|||++.+..  +||+||
T Consensus       100 lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~~--~Kl~DF  177 (308)
T d1p4oa_         100 VIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFT--VKIGDF  177 (308)
T ss_dssp             EEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCC--EEECCT
T ss_pred             EEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCce--EEEeec
Confidence            999999999999988542          236777777777776655       9999999999999987765  999999


Q ss_pred             CCCcccCCCCC---CCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhC-CCCCCCCCChHHHHHHHHHHhhcc
Q 019195          138 GYSKSSLLHSR---PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVG-AYPFEDQEDPKNFRKTISRIMAVQ  213 (344)
Q Consensus       138 g~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g-~~pf~~~~~~~~~~~~~~~~~~~~  213 (344)
                      |+|+.......   ....+||+.|+|||.+.+..++ .++|||||||++|||++| .+||.+.+....+    ..+... 
T Consensus       178 Gla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~-~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~----~~i~~~-  251 (308)
T d1p4oa_         178 GMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFT-TYSDVWSFGVVLWEIATLAEQPYQGLSNEQVL----RFVMEG-  251 (308)
T ss_dssp             TCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHH----HHHHTT-
T ss_pred             ccceeccCCcceeeccceecccccCCHHHHccCCCC-cccccccHHHHHHHHHhCCCCCCCCCCHHHHH----HHHHhC-
Confidence            99975433322   2344699999999999888775 559999999999999998 5778765544333    223322 


Q ss_pred             ccCCCCCCCCHhHHHHHHHhcccCCCCCCChHHHhcC
Q 019195          214 YKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSH  250 (344)
Q Consensus       214 ~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~ell~h  250 (344)
                      ...+....+++.+.+||.+||+.||.+|||+.+++++
T Consensus       252 ~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~  288 (308)
T d1p4oa_         252 GLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS  288 (308)
T ss_dssp             CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            2333445789999999999999999999999999984

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1e-48  Score=349.56  Aligned_cols=249  Identities=21%  Similarity=0.184  Sum_probs=190.1

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcCCCCC-cceeeEEEEcCCEEEEEEecC
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPN-IIRFKEVVLTPTHLAIVMEYA   80 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~l~~l~h~n-iv~~~~~~~~~~~~~lv~e~~   80 (344)
                      ++|++++.||+|+||+||+|.+..+|+.||||++..... ..++.+|+++++.++|+| |+.+..++...+..++||||+
T Consensus         7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~   85 (299)
T d1ckia_           7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL   85 (299)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT-SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECC
T ss_pred             CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc-CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEEc
Confidence            589999999999999999999999999999998876443 346889999999997665 555666677888999999999


Q ss_pred             CCCChHHHHH-hCCCCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecC-CCCCCEEEeecCCCcccCCCC----
Q 019195           81 AGGELFERIC-NAGRFSEDEARYFFQQLISG-------QICHRDLKLENTLLDG-SPAPRLKICDFGYSKSSLLHS----  147 (344)
Q Consensus        81 ~~g~L~~~i~-~~~~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~-~~~~~vkL~DFg~a~~~~~~~----  147 (344)
                       +++|...+. ..+.+++..++.++.|++.+       ||+||||||+|||++. +....+||+|||+|+......    
T Consensus        86 -~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~~~~  164 (299)
T d1ckia_          86 -GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQH  164 (299)
T ss_dssp             -CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTTCCB
T ss_pred             -CCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceeccccccccc
Confidence             556666554 45689999988888776655       9999999999999863 223459999999997543221    


Q ss_pred             ----CCCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCC---CCC
Q 019195          148 ----RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIP---DYV  220 (344)
Q Consensus       148 ----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~---~~~  220 (344)
                          .....+||+.|||||++.+..++ .++|||||||++|+|++|+.||............... .......|   ...
T Consensus       165 ~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~  242 (299)
T d1ckia_         165 IPYRENKNLTGTARYASINTHLGIEQS-RRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERI-SEKKMSTPIEVLCK  242 (299)
T ss_dssp             CCCCBCCSCCCCSSSCCHHHHTTBCCC-HHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHH-HHHHHHSCHHHHTT
T ss_pred             eeccccCCcCCCccccCHHHHhCCCCC-ChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHh-hcccCCCChhHhcc
Confidence                23455799999999999887764 5699999999999999999999876554333322211 11111111   123


Q ss_pred             CCCHhHHHHHHHhcccCCCCCCChHH---HhcCcccc
Q 019195          221 HISQDCRNLLSRIFVANPSRRITIKE---IKSHPWFL  254 (344)
Q Consensus       221 ~~s~~~~~li~~~L~~dp~~R~s~~e---ll~hp~~~  254 (344)
                      .+|+++.+||.+||+.+|.+||++.+   +|+|+|..
T Consensus       243 ~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~  279 (299)
T d1ckia_         243 GYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR  279 (299)
T ss_dssp             TSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHH
T ss_pred             CCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHH
Confidence            68899999999999999999999875   46666653

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.2e-49  Score=350.31  Aligned_cols=244  Identities=25%  Similarity=0.294  Sum_probs=180.9

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcCCCCCcceeeEEEEcCC----EEEEEE
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKEVVLTPT----HLAIVM   77 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~----~~~lv~   77 (344)
                      .+|.+.+.||+|+||.||+|+.  +|+.||||++...........+|+..+++++|||||++++++..++    .+|+||
T Consensus         3 ~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~   80 (303)
T d1vjya_           3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS   80 (303)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccchhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEE
Confidence            4689999999999999999986  5789999998765433233344555667789999999999998654    689999


Q ss_pred             ecCCCCChHHHHHhCCCCCHHHHHHHHHHHHH---------------CCeeecCCCCCCeEecCCCCCCEEEeecCCCcc
Q 019195           78 EYAAGGELFERICNAGRFSEDEARYFFQQLIS---------------GQICHRDLKLENTLLDGSPAPRLKICDFGYSKS  142 (344)
Q Consensus        78 e~~~~g~L~~~i~~~~~~~~~~~~~~~~ql~~---------------~~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~  142 (344)
                      |||++|+|..++++. .++..+.+.++.|++.               .||+||||||+|||++.++.  +||+|||+++.
T Consensus        81 Ey~~~g~L~~~l~~~-~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~--~Kl~DFGl~~~  157 (303)
T d1vjya_          81 DYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGT--CCIADLGLAVR  157 (303)
T ss_dssp             ECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSC--EEECCCTTCEE
T ss_pred             ecccCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCC--eEEEecCcccc
Confidence            999999999999764 6888887777777664               28999999999999987664  99999999976


Q ss_pred             cCCCC-----CCCCCccCCcccCCccccCCCC-----CCcchhHHHHHHHHHHHHhCCCCCCCCCCh-----------HH
Q 019195          143 SLLHS-----RPKSTVGTPAYIAPEVLSRREY-----DGKLADVWSCGVTLYVMLVGAYPFEDQEDP-----------KN  201 (344)
Q Consensus       143 ~~~~~-----~~~~~~gt~~y~aPE~~~~~~~-----~~~~~DiwslG~il~el~~g~~pf~~~~~~-----------~~  201 (344)
                      .....     .....+||+.|+|||++.+...     .+.++|||||||++|||+||.+||......           ..
T Consensus       158 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~  237 (303)
T d1vjya_         158 HDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS  237 (303)
T ss_dssp             EETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCC
T ss_pred             ccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccch
Confidence            43332     2334679999999999876432     234689999999999999998887542211           11


Q ss_pred             HHHHHHHHhhcccc--CCCC---CCCCHhHHHHHHHhcccCCCCCCChHHHhcC
Q 019195          202 FRKTISRIMAVQYK--IPDY---VHISQDCRNLLSRIFVANPSRRITIKEIKSH  250 (344)
Q Consensus       202 ~~~~~~~~~~~~~~--~~~~---~~~s~~~~~li~~~L~~dp~~R~s~~ell~h  250 (344)
                      .............+  +|..   ......+.+|+.+||+.||.+|||+.|++++
T Consensus       238 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~  291 (303)
T d1vjya_         238 VEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT  291 (303)
T ss_dssp             HHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence            12222222222222  1111   1122458899999999999999999999764

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.5e-48  Score=347.21  Aligned_cols=237  Identities=21%  Similarity=0.274  Sum_probs=185.7

Q ss_pred             eeeeeecCceEEEEEEEcCCC---cEEEEEEeecCcc--ccHHHHHHHHHHhcCCCCCcceeeEEEEc-CCEEEEEEecC
Q 019195            7 MKDIGSGNFGVARLMRNKNTK---ELVAMKYIERGHK--IDANVAREIINHKQLRHPNIIRFKEVVLT-PTHLAIVMEYA   80 (344)
Q Consensus         7 ~~~lg~G~~g~V~~~~~~~~~---~~vaiK~~~~~~~--~~~~~~~ei~~l~~l~h~niv~~~~~~~~-~~~~~lv~e~~   80 (344)
                      .++||+|+||+||+|.+..++   ..||||++.+...  ...++.+|+.+|++++|||||++++++.. ++.+++|||||
T Consensus        32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~  111 (311)
T d1r0pa_          32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM  111 (311)
T ss_dssp             EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred             ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence            578999999999999986543   4699999875322  33679999999999999999999999765 56899999999


Q ss_pred             CCCChHHHHHhCC-CCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCCCCCCEEEeecCCCcccCCCCC----
Q 019195           81 AGGELFERICNAG-RFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR----  148 (344)
Q Consensus        81 ~~g~L~~~i~~~~-~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~~~~~~----  148 (344)
                      ++|+|.+++.... .++...+..++.|++.|       +|+||||||+|||++.++.  +||+|||+++.......    
T Consensus       112 ~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~--~kL~DFG~~~~~~~~~~~~~~  189 (311)
T d1r0pa_         112 KHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFT--VKVADFGLARDMYDKEFDSVH  189 (311)
T ss_dssp             TTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCC--EEECSSGGGCCTTTTTCCCTT
T ss_pred             ecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCC--EEEecccchhhccccccccce
Confidence            9999999887544 56777777777777665       9999999999999987665  99999999986433322    


Q ss_pred             -CCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCCCCCCCCHhHH
Q 019195          149 -PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCR  227 (344)
Q Consensus       149 -~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~  227 (344)
                       .....||+.|+|||.+....+ +.++|||||||++|||++|..||.........   ...+... .+.+.+..+++.+.
T Consensus       190 ~~~~~~gt~~y~aPE~~~~~~~-~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~---~~~i~~g-~~~~~p~~~~~~l~  264 (311)
T d1r0pa_         190 NKTGAKLPVKWMALESLQTQKF-TTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI---TVYLLQG-RRLLQPEYCPDPLY  264 (311)
T ss_dssp             CTTCSSCCGGGSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCSCC------C---HHHHHTT-CCCCCCTTCCHHHH
T ss_pred             ecccccccccccChHHHhcCCC-CChhHhhhhHHHHHHHHHCCCCCCCCCCHHHH---HHHHHcC-CCCCCcccCcHHHH
Confidence             233468999999999987776 55699999999999999988877654432222   2222222 23334457889999


Q ss_pred             HHHHHhcccCCCCCCChHHHhcC
Q 019195          228 NLLSRIFVANPSRRITIKEIKSH  250 (344)
Q Consensus       228 ~li~~~L~~dp~~R~s~~ell~h  250 (344)
                      +||.+||+.||.+|||+.|+++|
T Consensus       265 ~li~~cl~~dP~~RPs~~ei~~~  287 (311)
T d1r0pa_         265 EVMLKCWHPKAEMRPSFSELVSR  287 (311)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHcCCCHhHCcCHHHHHHH
Confidence            99999999999999999999986

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=2.4e-47  Score=339.40  Aligned_cols=244  Identities=20%  Similarity=0.232  Sum_probs=194.0

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcCCC-CCcceeeEEEEcCCEEEEEEecC
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRH-PNIIRFKEVVLTPTHLAIVMEYA   80 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~l~~l~h-~niv~~~~~~~~~~~~~lv~e~~   80 (344)
                      ++|++++.||+|+||+||+|++..+|+.||||++.... ....+.+|++.++.++| +||+.+++++......++||||+
T Consensus         5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~~   83 (293)
T d1csna_           5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS-DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL   83 (293)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT-TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC
T ss_pred             CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc-CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEec
Confidence            58999999999999999999999999999999886643 33467889999999965 99999999999999999999999


Q ss_pred             CCCChHHHHHhCC-CCCHHHHHHHHHHHHHC-------CeeecCCCCCCeEecCC---CCCCEEEeecCCCcccCCC---
Q 019195           81 AGGELFERICNAG-RFSEDEARYFFQQLISG-------QICHRDLKLENTLLDGS---PAPRLKICDFGYSKSSLLH---  146 (344)
Q Consensus        81 ~~g~L~~~i~~~~-~~~~~~~~~~~~ql~~~-------~iiH~Dikp~NIl~~~~---~~~~vkL~DFg~a~~~~~~---  146 (344)
                       +++|.+++...+ .++..++..++.|++.+       ||+||||||+|||++..   ..+.+||+|||+|+.....   
T Consensus        84 -~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~~~~  162 (293)
T d1csna_          84 -GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTK  162 (293)
T ss_dssp             -CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTC
T ss_pred             -CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEcccCccc
Confidence             789999887654 68998888887776654       99999999999999642   3456999999999753321   


Q ss_pred             -----CCCCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhccccCC---C
Q 019195          147 -----SRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIP---D  218 (344)
Q Consensus       147 -----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~---~  218 (344)
                           ......+||+.|||||++.+..++ .++|||||||++|+|++|+.||.+......... ...+.......+   .
T Consensus       163 ~~~~~~~~~~~~GT~~y~aPE~~~~~~~~-~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~-~~~i~~~~~~~~~~~l  240 (293)
T d1csna_         163 QHIPYREKKNLSGTARYMSINTHLGREQS-RRDDLEALGHVFMYFLRGSLPWQGLKAATNKQK-YERIGEKKQSTPLREL  240 (293)
T ss_dssp             CBCCCCCCCCCCSCTTTCCHHHHTTCCCC-HHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHH-HHHHHHHHHHSCHHHH
T ss_pred             cceeecccCceEEchhhcCHHHhcCCCCC-hHHHHHHhhHHHHHHHhCCCcCCCccchhHHHH-HHHHHhccCCCChHHh
Confidence                 223456799999999999887764 559999999999999999999986554332221 111111111111   1


Q ss_pred             CCCCCHhHHHHHHHhcccCCCCCCChHHHhc
Q 019195          219 YVHISQDCRNLLSRIFVANPSRRITIKEIKS  249 (344)
Q Consensus       219 ~~~~s~~~~~li~~~L~~dp~~R~s~~ell~  249 (344)
                      ...+++++.+++..|+..+|.+||++..+.+
T Consensus       241 ~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~  271 (293)
T d1csna_         241 CAGFPEEFYKYMHYARNLAFDATPDYDYLQG  271 (293)
T ss_dssp             TTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred             cCCCCHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence            2357899999999999999999999877643

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=1.2e-46  Score=344.86  Aligned_cols=252  Identities=22%  Similarity=0.352  Sum_probs=188.7

Q ss_pred             CceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcCC-----------CCCcceeeEEEEc--
Q 019195            3 KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLR-----------HPNIIRFKEVVLT--   69 (344)
Q Consensus         3 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~l~~l~-----------h~niv~~~~~~~~--   69 (344)
                      ||+++++||+|+||+||+|++..+|+.||||++++.......+.+|+.+++.++           |+||+++++++..  
T Consensus        14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~~   93 (362)
T d1q8ya_          14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKG   93 (362)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEE
T ss_pred             cEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeecc
Confidence            699999999999999999999999999999999876555567888999888774           5889999998864  


Q ss_pred             CCEEEEEEecCCCCChHHHH---HhCCCCCHHHHHHHHHHHHH--------CCeeecCCCCCCeEecCCCC----CCEEE
Q 019195           70 PTHLAIVMEYAAGGELFERI---CNAGRFSEDEARYFFQQLIS--------GQICHRDLKLENTLLDGSPA----PRLKI  134 (344)
Q Consensus        70 ~~~~~lv~e~~~~g~L~~~i---~~~~~~~~~~~~~~~~ql~~--------~~iiH~Dikp~NIl~~~~~~----~~vkL  134 (344)
                      ....+++|.++..+......   .....+++..++.++.|++.        .||+||||||+|||++.++.    ..++|
T Consensus        94 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~~~~kl  173 (362)
T d1q8ya_          94 PNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKI  173 (362)
T ss_dssp             TTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEEEEE
T ss_pred             ccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCcccccceeeE
Confidence            35677777777665543332   23457899999998888764        38999999999999975432    24899


Q ss_pred             eecCCCcccCCCCCCCCCccCCcccCCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCh------HHHHHHHHH
Q 019195          135 CDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDP------KNFRKTISR  208 (344)
Q Consensus       135 ~DFg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~------~~~~~~~~~  208 (344)
                      +|||.+....  ......+||+.|+|||++....++. ++||||+||++++|++|+.||......      ......+..
T Consensus       174 ~dfg~s~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~-~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~~~~~  250 (362)
T d1q8ya_         174 ADLGNACWYD--EHYTNSIQTREYRSPEVLLGAPWGC-GADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIEL  250 (362)
T ss_dssp             CCCTTCEETT--BCCCSCCSCGGGCCHHHHHTCCCCT-HHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHH
T ss_pred             eecccccccc--cccccccccccccChhhccccCCCc-cccccchHHHHHHHHHCCCCCCCCccccccchhHHHHHHHHH
Confidence            9999987543  2345678999999999999888754 599999999999999999999754321      111111111


Q ss_pred             Hhhc--------------------cc----------------cCCCCCCCCHhHHHHHHHhcccCCCCCCChHHHhcCcc
Q 019195          209 IMAV--------------------QY----------------KIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPW  252 (344)
Q Consensus       209 ~~~~--------------------~~----------------~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~ell~hp~  252 (344)
                      +...                    ..                ........++++.+||.+||+.||.+||||.|+|+|||
T Consensus       251 lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L~Hp~  330 (362)
T d1q8ya_         251 LGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPW  330 (362)
T ss_dssp             HCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTCGG
T ss_pred             hCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHHhcCcc
Confidence            0000                    00                00011124678999999999999999999999999999


Q ss_pred             cccCC
Q 019195          253 FLKNL  257 (344)
Q Consensus       253 ~~~~~  257 (344)
                      |++..
T Consensus       331 f~~~~  335 (362)
T d1q8ya_         331 LKDTL  335 (362)
T ss_dssp             GTTCT
T ss_pred             cCCCC
Confidence            98553

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.90  E-value=1.4e-24  Score=179.56  Aligned_cols=132  Identities=18%  Similarity=0.108  Sum_probs=97.6

Q ss_pred             ceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCccc-------------------cHHHHHHHHHHhcCCCCCcceee
Q 019195            4 YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKI-------------------DANVAREIINHKQLRHPNIIRFK   64 (344)
Q Consensus         4 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-------------------~~~~~~ei~~l~~l~h~niv~~~   64 (344)
                      |.+.++||+|+||+||+|.+. +|+.||||+++.....                   .....+|...+.++.|++++..+
T Consensus         2 ~~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~   80 (191)
T d1zara2           2 DAIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY   80 (191)
T ss_dssp             SEEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred             chhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEE
Confidence            468899999999999999985 6889999987532110                   12345688899999999999988


Q ss_pred             EEEEcCCEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHCCeeecCCCCCCeEecCCCCCCEEEeecCCCccc
Q 019195           65 EVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGQICHRDLKLENTLLDGSPAPRLKICDFGYSKSS  143 (344)
Q Consensus        65 ~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~ql~~~~iiH~Dikp~NIl~~~~~~~~vkL~DFg~a~~~  143 (344)
                      ++..    .+++|||+++..+..+-......-..++...+.+||+.||+||||||+|||++.++   ++|+|||+|...
T Consensus        81 ~~~~----~~lvme~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~~---~~liDFG~a~~~  152 (191)
T d1zara2          81 AWEG----NAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEEG---IWIIDFPQSVEV  152 (191)
T ss_dssp             EEET----TEEEEECCCCEEGGGCCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETTE---EEECCCTTCEET
T ss_pred             EecC----CEEEEEeeccccccchhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCCC---EEEEECCCcccC
Confidence            6542    26999999887664321111011124566667888888999999999999998544   899999998643

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.63  E-value=1.3e-07  Score=79.95  Aligned_cols=85  Identities=18%  Similarity=0.064  Sum_probs=61.3

Q ss_pred             CCceeeeeeeecCceEEEEEEEcCCCcEEEEEEeecCc-cccHHHHHHHHHHhcCC-CCCcceeeEEEEcCCEEEEEEec
Q 019195            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH-KIDANVAREIINHKQLR-HPNIIRFKEVVLTPTHLAIVMEY   79 (344)
Q Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~ei~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~   79 (344)
                      +.|++++..+.++.+.||++..  .+..+++|+..... .....+.+|...++.+. +--+.+++.+...++..|+||++
T Consensus        14 ~~~~~~~~~~G~s~~~v~rv~~--~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~   91 (263)
T d1j7la_          14 EKYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSE   91 (263)
T ss_dssp             TTSEEEECSCCCSSSEEEEEEC--SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEEC
T ss_pred             hceEEEEcCCCCCCCcEEEEEe--CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEe
Confidence            5678877766666678998863  45567788776543 23345778888887774 33367778888888999999999


Q ss_pred             CCCCChHHH
Q 019195           80 AAGGELFER   88 (344)
Q Consensus        80 ~~~g~L~~~   88 (344)
                      ++|.++...
T Consensus        92 l~G~~~~~~  100 (263)
T d1j7la_          92 ADGVLCSEE  100 (263)
T ss_dssp             CSSEEHHHH
T ss_pred             ccccccccc
Confidence            999877543

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=98.19  E-value=3.8e-06  Score=75.16  Aligned_cols=77  Identities=16%  Similarity=0.103  Sum_probs=49.9

Q ss_pred             eeeeeecCceEEEEEEEcCCCcEEEEEEeec-----Cc---cccHHHHHHHHHHhcCC-C--CCcceeeEEEEcCCEEEE
Q 019195            7 MKDIGSGNFGVARLMRNKNTKELVAMKYIER-----GH---KIDANVAREIINHKQLR-H--PNIIRFKEVVLTPTHLAI   75 (344)
Q Consensus         7 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-----~~---~~~~~~~~ei~~l~~l~-h--~niv~~~~~~~~~~~~~l   75 (344)
                      .+.||.|....||++.+..+++.|++|.-..     ..   ....+...|...|+.+. +  ..+++++.+  ++...++
T Consensus        31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l  108 (392)
T d2pula1          31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT  108 (392)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred             EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence            5679999999999999888888999996432     11   12245667888887662 2  345555543  4555678


Q ss_pred             EEecCCCCCh
Q 019195           76 VMEYAAGGEL   85 (344)
Q Consensus        76 v~e~~~~g~L   85 (344)
                      |||++.+..+
T Consensus       109 vmE~L~~~~~  118 (392)
T d2pula1         109 VMEDLSHLKI  118 (392)
T ss_dssp             EECCCTTSEE
T ss_pred             EEeccCCccc
Confidence            9999987543

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=98.18  E-value=7.6e-06  Score=68.24  Aligned_cols=75  Identities=12%  Similarity=0.037  Sum_probs=53.4

Q ss_pred             eeeeecCc-eEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcCC--CCCcceeeEEEEcCCEEEEEEecCCCCC
Q 019195            8 KDIGSGNF-GVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLR--HPNIIRFKEVVLTPTHLAIVMEYAAGGE   84 (344)
Q Consensus         8 ~~lg~G~~-g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~l~~l~--h~niv~~~~~~~~~~~~~lv~e~~~~g~   84 (344)
                      +.+..|.. +.||++.. .++..+++|......  ...+.+|...++.+.  .-.+.+++.+..+++..++||++++|.+
T Consensus        16 ~~~~~G~s~~~v~r~~~-~~~~~~vlK~~~~~~--~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~   92 (255)
T d1nd4a_          16 AQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSGA--LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQD   92 (255)
T ss_dssp             EECSCTTSSCEEEEEEC-TTSCCEEEEEECSCT--TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEE
T ss_pred             EEcCCcccCCeEEEEEe-CCCCEEEEEeCCccC--HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeeccc
Confidence            35566654 58899876 446668889765433  235778888887773  3336777888888889999999999866


Q ss_pred             h
Q 019195           85 L   85 (344)
Q Consensus        85 L   85 (344)
                      +
T Consensus        93 ~   93 (255)
T d1nd4a_          93 L   93 (255)
T ss_dssp             T
T ss_pred             c
Confidence            5

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=97.60  E-value=0.00013  Score=63.07  Aligned_cols=68  Identities=10%  Similarity=0.145  Sum_probs=46.3

Q ss_pred             eEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcCCCCCc-----cee--eEEEEcCCEEEEEEecCCCCC
Q 019195           16 GVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNI-----IRF--KEVVLTPTHLAIVMEYAAGGE   84 (344)
Q Consensus        16 g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~l~~l~h~ni-----v~~--~~~~~~~~~~~lv~e~~~~g~   84 (344)
                      ..||++.. .+|..|++|+........+++..|+..+..|...+|     +..  -..+...+..+.+++++.|..
T Consensus        36 N~vy~v~~-~dg~~~VlK~~rp~~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~  110 (325)
T d1zyla1          36 NRVYQFQD-EDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQ  110 (325)
T ss_dssp             SEEEEECC-TTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEE
T ss_pred             ceeEEEEc-CCCCEEEEEEeCCCCCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcC
Confidence            47999976 467889999987765566778889988877732111     111  112234677899999998744

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=97.13  E-value=0.00049  Score=61.02  Aligned_cols=74  Identities=14%  Similarity=0.110  Sum_probs=51.2

Q ss_pred             eeeeeecCceEEEEEEEcC-------CCcEEEEEEeecCccccHHHHHHHHHHhcCC-CCCcceeeEEEEcCCEEEEEEe
Q 019195            7 MKDIGSGNFGVARLMRNKN-------TKELVAMKYIERGHKIDANVAREIINHKQLR-HPNIIRFKEVVLTPTHLAIVME   78 (344)
Q Consensus         7 ~~~lg~G~~g~V~~~~~~~-------~~~~vaiK~~~~~~~~~~~~~~ei~~l~~l~-h~niv~~~~~~~~~~~~~lv~e   78 (344)
                      ++.|+.|-.-.+|++....       ..+.|.+++.-. ....-...+|..+++.+. +.-..++++++..    ++|++
T Consensus        47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~-~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~e  121 (395)
T d1nw1a_          47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN-PETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE  121 (395)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS-CCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred             EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCC-cchhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEE
Confidence            5678888889999998753       245677777653 333345678999998885 4334577777643    58999


Q ss_pred             cCCCCCh
Q 019195           79 YAAGGEL   85 (344)
Q Consensus        79 ~~~~g~L   85 (344)
                      |++|.+|
T Consensus       122 fi~g~~l  128 (395)
T d1nw1a_         122 YIPSRPL  128 (395)
T ss_dssp             CCCEEEC
T ss_pred             EeccccC
Confidence            9987544

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=97.12  E-value=0.00099  Score=56.86  Aligned_cols=75  Identities=13%  Similarity=0.061  Sum_probs=40.5

Q ss_pred             eeeeeecCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcCC-----CCCcceee---EEEEcCCEEEEEEe
Q 019195            7 MKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLR-----HPNIIRFK---EVVLTPTHLAIVME   78 (344)
Q Consensus         7 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~l~~l~-----h~niv~~~---~~~~~~~~~~lv~e   78 (344)
                      ++.|..|---+.|++.... | .|++|+..... ....+..++.++..|.     .|..+...   .+.......+.++.
T Consensus        23 ~~~i~~G~~N~ny~v~t~~-g-~yVLri~~~~~-~~~~l~~~~~~l~~L~~~g~pvp~pi~~~~g~~~~~~~~~~~~~~~   99 (316)
T d2ppqa1          23 YKGIAEGVENSNFLLHTTK-D-PLILTLYEKRV-EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALIS   99 (316)
T ss_dssp             EEEECC---EEEEEEEESS-C-CEEEEEECC----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEE
T ss_pred             eecCCCCcccCeEEEEECC-C-cEEEEEcCCCC-CHHHHHHHHHHHHhhhhccccccccceecCCCcceeeecccceeee
Confidence            4445566667899987653 4 48999886542 3345666777777663     23322211   01122456677777


Q ss_pred             cCCCCC
Q 019195           79 YAAGGE   84 (344)
Q Consensus        79 ~~~~g~   84 (344)
                      +..+..
T Consensus       100 ~~~g~~  105 (316)
T d2ppqa1         100 FLEGMW  105 (316)
T ss_dssp             CCCCBC
T ss_pred             eccccc
Confidence            776643